PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Teki, S; Kumar, S; Griffiths, TD				Teki, Sundeep; Kumar, Sukhbinder; Griffiths, Timothy D.			Large-Scale Analysis of Auditory Segregation Behavior Crowdsourced via a Smartphone App	PLOS ONE			English	Article							STREAM SEGREGATION; SCENE ANALYSIS; INFORMATIONAL MASKING; PATTERNS; HEARING; RECOGNITION; PERCEPTION; COHERENCE; AWARENESS; CORTEX	The human auditory system is adept at detecting sound sources of interest from a complex mixture of several other simultaneous sounds. The ability to selectively attend to the speech of one speaker whilst ignoring other speakers and background noise is of vital biological significance-the capacity to make sense of complex 'auditory scenes' is significantly impaired in aging populations as well as those with hearing loss. We investigated this problem by designing a synthetic signal, termed the 'stochastic figure-ground' stimulus that captures essential aspects of complex sounds in the natural environment. Previously, we showed that under controlled laboratory conditions, young listeners sampled from the university subject pool (n = 10) performed very well in detecting targets embedded in the stochastic figure- ground signal. Here, we presented a modified version of this cocktail party paradigm as a 'game' featured in a smartphone app (The Great Brain Experiment) and obtained data from a large population with diverse demographical patterns (n = 5148). Despite differences in paradigms and experimental settings, the observed target-detection performance by users of the app was robust and consistent with our previous results from the psychophysical study. Our results highlight the potential use of smartphone apps in capturing robust large-scale auditory behavioral data from normal healthy volunteers, which can also be extended to study auditory deficits in clinical populations with hearing impairments and central auditory disorders.	[Teki, Sundeep; Kumar, Sukhbinder; Griffiths, Timothy D.] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Teki, Sundeep; Kumar, Sukhbinder; Griffiths, Timothy D.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Teki, Sundeep] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England	University of London; University College London; Newcastle University - UK; University of Oxford	Teki, S (corresponding author), UCL, Wellcome Trust Ctr Neuroimaging, London, England.; Teki, S (corresponding author), Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.; Teki, S (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.	sundeep.teki@gmail.com	Teki, Sundeep/H-2756-2019	Teki, Sundeep/0000-0002-7951-6581; Griffiths, Timothy/0000-0001-8066-4381; Kumar, Sukhbinder/0000-0003-3025-9040	Wellcome Trust [WT091681MA, WT106084/Z/14/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work is supported by a Wellcome Trust grant (WT091681MA) awarded to Timothy D. Griffiths. Sundeep Teki is supported by the Wellcome Trust (WT106084/Z/14/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel SM, 2000, SCAND AUDIOL, V29, P131, DOI 10.1080/010503900750042699; ABEL SM, 1990, SCAND AUDIOL, V19, P43, DOI 10.3109/01050399009070751; Akram S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114427; Bregman A.S., 1990, AUDITORY SCENE ANAL; Brown HR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100662; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; Crump MJC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057410; DUQUESNOY AJ, 1983, J ACOUST SOC AM, V74, P739, DOI 10.1121/1.389859; Dykstra AR, 2013, ELIFE, V2, DOI 10.7554/eLife.01136; Elhilali M, 2009, NEURON, V61, P317, DOI 10.1016/j.neuron.2008.12.005; Fishman Y. I., 2010, OXFORD HDB AUDITORY; Fishman YI, 2004, J ACOUST SOC AM, V116, P1656, DOI 10.1121/1.1778903; Fishman YI, 2001, HEARING RES, V151, P167, DOI 10.1016/S0378-5955(00)00224-0; Gutschalk A, 2014, HEARING RES, V307, P98, DOI 10.1016/j.heares.2013.08.003; Gutschalk A, 2008, PLOS BIOL, V6, P1156, DOI 10.1371/journal.pbio.0060138; HUMES LE, 1994, J SPEECH HEAR RES, V37, P465, DOI 10.1044/jshr.3702.465; Khatib F, 2011, P NATL ACAD SCI USA, V108, P18949, DOI 10.1073/pnas.1115898108; KIDD G, 1995, J ACOUST SOC AM, V97, P3782, DOI 10.1121/1.413107; KIDD G, 1994, J ACOUST SOC AM, V95, P3475, DOI 10.1121/1.410023; Krishnan L, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003985; LYNCH MP, 1994, J GERONTOL, V49, pP165, DOI 10.1093/geronj/49.4.P165; McDermott JH, 2009, CURR BIOL, V19, pR1024, DOI 10.1016/j.cub.2009.09.005; Mcnab F, 2014, J EXP PSYCHOL HUMAN, V40, P960, DOI 10.1037/a0036013; Micheyl C, 2013, J EXP PSYCHOL HUMAN, V39, P1568, DOI 10.1037/a0032241; Micheyl C, 2013, J ACOUST SOC AM, V133, pEL188, DOI 10.1121/1.4789866; Morrell CH, 1996, J ACOUST SOC AM, V100, P1949, DOI 10.1121/1.417906; Nelken I, 2014, J NEUROSCI, V34, P15135, DOI 10.1523/JNEUROSCI.2989-14.2014; Perez P, 2011, AGING DIS, V2, P231; Rimmele J, 2012, HEARING RES, V289, P98, DOI 10.1016/j.heares.2012.04.006; Rimmele JM, 2015, INT J PSYCHOPHYSIOL, V95, P175, DOI 10.1016/j.ijpsycho.2014.06.010; Rutledge RB, 2014, P NATL ACAD SCI USA, V111, P12252, DOI 10.1073/pnas.1407535111; Shamma SA, 2011, TRENDS NEUROSCI, V34, P114, DOI 10.1016/j.tins.2010.11.002; Snyder JS, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00015; Teki S, 2013, ELIFE, V2, DOI 10.7554/eLife.00699; Teki S, 2011, J NEUROSCI, V31, P164, DOI 10.1523/JNEUROSCI.3788-10.2011; TRAINOR LJ, 1989, PERCEPT PSYCHOPHYS, V45, P417, DOI 10.3758/BF03210715; van Noorden LPAS, 1975, TEMPORAL COHERENCE P; von Ahn L, 2008, SCIENCE, V321, P1465, DOI 10.1126/science.1160379; Zekveld AA, 2011, EAR HEARING, V32, P498, DOI 10.1097/AUD.0b013e31820512bb	39	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153916	10.1371/journal.pone.0153916	http://dx.doi.org/10.1371/journal.pone.0153916			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096165	Green Published, gold			2022-12-26	WOS:000374543600070
J	Tourret, J; Willing, BP; Croxen, MA; Dufour, N; Dion, S; Wachtel, S; Denamur, E; Finlay, BB				Tourret, Jerome; Willing, Benjamin P.; Croxen, Matthew A.; Dufour, Nicolas; Dion, Sara; Wachtel, Sarah; Denamur, Erick; Finlay, B. Brett			Small Intestine Early Innate Immunity Response during Intestinal Colonization by Escherichia coli Depends on Its Extra-Intestinal Virulence Status	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; PATHOGENICITY ISLAND; CLONAL GROUP; EPITHELIAL-CELLS; GENOMIC ISLANDS; P-FIMBRIAE; STRAINS; MICROBIOTA; HOST; HEMOLYSIN	Uropathogenic Escherichia coli (UPEC) strains live as commensals in the digestive tract of the host, but they can also initiate urinary tract infections. The aim of this work was to determine how a host detects the presence of a new UPEC strain in the digestive tract. Mice were orally challenged with UPEC strains 536 and CFT073, non-pathogenic strain K12 MG1655, and.PAI-536, an isogenic mutant of strain 536 lacking all 7 pathogenicity islands whose virulence is drastically attenuated. Intestinal colonization was measured, and cytokine expression was determined in various organs recovered from mice after oral challenge. UPEC strain 536 efficiently colonized the mouse digestive tract, and prior Enterobacteriaceae colonization was found to impact strain 536 colonization efficiency. An innate immune response, detected as the production of TNF alpha, IL-6 and IL-10 cytokines, was activated in the ileum 48 hours after oral challenge with strain 536, and returned to baseline within 8 days, without a drop in fecal pathogen load. Although inflammation was detected in the ileum, histology was normal at the time of cytokine peak. Comparison of cytokine secretion 48h after oral gavage with E. coli strain 536, CFT073, MG1655 or.PAI-536 showed that inflammation was more pronounced with UPECs than with non-pathogenic or attenuated strains. Pathogenicity islands also seemed to be involved in host detection, as IL-6 intestinal secretion was increased after administration of E. coli strain 536, but not after administration of Delta PAI-536. In conclusion, UPEC colonization of the mouse digestive tract activates acute phase inflammatory cytokine secretion but does not trigger any pathological changes, illustrating the opportunistic nature of UPECs. This digestive tract colonization model will be useful for studying the factors controlling the switch from commensalism to pathogenicity.	[Tourret, Jerome; Dufour, Nicolas; Dion, Sara; Wachtel, Sarah; Denamur, Erick] INSERM, UMR 1137, IAME, Paris, France; [Tourret, Jerome; Dufour, Nicolas; Dion, Sara; Wachtel, Sarah; Denamur, Erick] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Tourret, Jerome] Grp Hosp Univ Pitie Salpetriere Charles Foix, AP HP, Dept Urol Nephrol & Transplantat, Paris, France; [Tourret, Jerome] Univ Paris 06, Sorbonne Univ, Paris, France; [Willing, Benjamin P.; Croxen, Matthew A.; Finlay, B. Brett] Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada; [Willing, Benjamin P.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Croxen, Matthew A.] British Columbia Ctr Dis Control, Publ Hlth Lab, Vancouver, BC, Canada; [Wachtel, Sarah] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Lurie Childrens Hosp,Chicago Res Ctr, Chicago, IL 60611 USA; [Dufour, Nicolas] Inst Pasteur, Mol Biol Gene Extremophiles, Dept Microbiol, Paris, France; [Dufour, Nicolas] Hop Louis Mourier, AP HP, Serv Reanimat Medicochirurg, F-92701 Colombes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; University of British Columbia; University of Alberta; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite	Tourret, J (corresponding author), INSERM, UMR 1137, IAME, Paris, France.; Tourret, J (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Paris, France.; Tourret, J (corresponding author), Grp Hosp Univ Pitie Salpetriere Charles Foix, AP HP, Dept Urol Nephrol & Transplantat, Paris, France.; Tourret, J (corresponding author), Univ Paris 06, Sorbonne Univ, Paris, France.	jerome.tourret@psl.aphp.fr	DUFOUR, Nicolas N/U-4634-2018; Willing, Benjamin/AAA-9650-2019	DUFOUR, Nicolas N/0000-0002-1359-6689; Croxen, Matthew/0000-0002-9564-7952; Tourret, Jerome/0000-0003-2998-6531	"Fondation Recherche Medicale"; "Societe de Nephrologie"; Novartis pharma(R); Canada Research Chairs program; Canadian Institutes of Health Research (CIHR)	"Fondation Recherche Medicale"; "Societe de Nephrologie"; Novartis pharma(R); Canada Research Chairs program(Canada Research Chairs); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	J.T. received funding from "Fondation Recherche Medicale", "Societe de Nephrologie", and Novartis pharma (R). B.P.W. is supported by the Canada Research Chairs program. Work in BBF's laboratory is funded by the Canadian Institutes of Health Research (CIHR). BBF is the University of British Columbia Peter Wall Distinguished Professor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLERBERTH I, 1995, MICROB PATHOGENESIS, V18, P373, DOI 10.1006/mpat.1995.0034; BERGER H, 1982, J BACTERIOL, V152, P1241; Brzuszkiewicz E, 2006, P NATL ACAD SCI USA, V103, P12879, DOI 10.1073/pnas.0603038103; Chiurchiu C, 2003, AM J KIDNEY DIS, V41, DOI 10.1053/ajkd.2003.50022; Clermont O, 2014, J MICROBIOL METH, V101, P24, DOI 10.1016/j.mimet.2014.03.008; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; Croxen MA, 2013, CLIN MICROBIOL REV, V26, P822, DOI 10.1128/CMR.00022-13; Diard M, 2010, J BACTERIOL, V192, P4885, DOI 10.1128/JB.00804-10; Escobar-Paramo P, 2004, MOL BIOL EVOL, V21, P1085, DOI 10.1093/molbev/msh118; Foxman B, 2010, NAT REV UROL, V7, P653, DOI 10.1038/nrurol.2010.190; Gadea MD, 2012, REV ARGENT MICROBIOL, V44, P94; Giamarellos-Bourboulis EJ, 2010, INT J ANTIMICROB AG, V36, pS2, DOI 10.1016/j.ijantimicag.2010.11.003; GRUNEBERG RN, 1969, LANCET, V2, P766; HACKER J, 1983, J BACTERIOL, V154, P1145, DOI 10.1128/JB.154.3.1145-1152.1983; Herias MV, 1997, INFECT IMMUN, V65, P531; HERIAS MV, 1995, INFECT IMMUN, V63, P4781; Johnson JR, 2011, EMERG INFECT DIS, V17, P2001, DOI 10.3201/eid1711.110488; Johnson JR, 2002, LANCET, V359, P2249, DOI 10.1016/S0140-6736(02)09264-4; Kaiser P, 2012, IMMUNOL REV, V245, P56, DOI 10.1111/j.1600-065X.2011.01070.x; KALLENIUS G, 1981, LANCET, V2, P1369; Kao JS, 1997, INFECT IMMUN, V65, P2812, DOI 10.1128/IAI.65.7.2812-2820.1997; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Le Gall T, 2007, MOL BIOL EVOL, V24, P2373, DOI 10.1093/molbev/msm172; Lefort A, 2011, J CLIN MICROBIOL, V49, P777, DOI 10.1128/JCM.01902-10; Lloyd AL, 2007, J BACTERIOL, V189, P3532, DOI 10.1128/JB.01744-06; Lloyd AL, 2009, J BACTERIOL, V191, P3469, DOI 10.1128/JB.01717-08; Manges AR, 2001, NEW ENGL J MED, V345, P1007, DOI 10.1056/NEJMoa011265; Mead PS, 1998, LANCET, V352, P1207, DOI 10.1016/S0140-6736(98)01267-7; MOBLEY HLT, 1990, INFECT IMMUN, V58, P1281, DOI 10.1128/IAI.58.5.1281-1289.1990; Moreno E, 2008, J CLIN MICROBIOL, V46, P2529, DOI 10.1128/JCM.00813-08; Myhal M L, 1982, Eur J Clin Microbiol, V1, P186, DOI 10.1007/BF02019621; Nowrouzian F, 2001, EPIDEMIOL INFECT, V126, P19, DOI 10.1017/S095026880100512X; Nowrouzian FL, 2006, MICROBES INFECT, V8, P834, DOI 10.1016/j.micinf.2005.10.011; Payros D, 2014, GUT MICROBES, V5, P313, DOI 10.4161/gmic.28932; Picard B, 1999, INFECT IMMUN, V67, P546, DOI 10.1128/IAI.67.2.546-553.1999; Rasko DA, 2001, J INFECT DIS, V184, P1041, DOI 10.1086/323602; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Russo TA, 2003, MICROBES INFECT, V5, P449, DOI 10.1016/S1286-4579(03)00049-2; Sansonetti PJ, 2011, MUCOSAL IMMUNOL, V4, P8, DOI 10.1038/mi.2010.77; Sansonetti PJ, 2009, CELL, V138, P416, DOI 10.1016/j.cell.2009.07.024; Schneider G, 2004, INFECT IMMUN, V72, P5993, DOI 10.1128/IAI.72.10.5993-6001.2004; Sekirov I, 2008, INFECT IMMUN, V76, P4726, DOI 10.1128/IAI.00319-08; Skjot-Rasmussen L, 2013, CLIN MICROBIOL INFEC, V19, P656, DOI 10.1111/j.1469-0691.2012.03961.x; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Tourret J, 2010, INT J MED MICROBIOL, V300, P435, DOI 10.1016/j.ijmm.2010.04.013; van der Woude MW, 2008, ANNU REV MICROBIOL, V62, P153, DOI 10.1146/annurev.micro.62.081307.162938; Willing BP, 2011, NAT REV MICROBIOL, V9, P233, DOI 10.1038/nrmicro2536; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Wlodarska M, 2010, MUCOSAL IMMUNOL, V3, P100, DOI 10.1038/mi.2009.135	51	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153034	10.1371/journal.pone.0153034	http://dx.doi.org/10.1371/journal.pone.0153034			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096607	Green Published, Green Submitted, gold			2022-12-26	WOS:000374543600024
J	Grimes, DR; Kannan, P; McIntyre, A; Kavanagh, A; Siddiky, A; Wigfield, S; Harris, A; Partridge, M				Grimes, David Robert; Kannan, Pavitra; McIntyre, Alan; Kavanagh, Anthony; Siddiky, Abul; Wigfield, Simon; Harris, Adrian; Partridge, Mike			The Role of Oxygen in Avascular Tumor Growth	PLOS ONE			English	Article							MATHEMATICAL-MODEL; SPHEROIDS; CELLS; RADIOSENSITIZATION; GEMCITABINE; DELIVERY; CULTURE	We oxygen status of a tumor has significant clinical implications for treatment prognosis, with well-oxygenated subvolumes responding markedly better to radiotherapy than poorly supplied regions. Oxygen is essential for tumor growth, yet estimation of local oxygen distribution can be difficult to ascertain in situ, due to chaotic patterns of vasculature. It is possible to avoid this confounding influence by using avascular tumor models, such as tumor spheroids, a much better approximation of realistic tumor dynamics than monolayers, where oxygen supply can be described by diffusion alone. Similar to in situ tumours, spheroids exhibit an approximately sigmoidal growth curve, often approximated and fitted by logistic and Gompertzian sigmoid functions. These describe the basic rate of growth well, but do not offer an explicitly mechanistic explanation. This work examines the oxygen dynamics of spheroids and demonstrates that this growth can be derived mechanistically with cellular doubling time and oxygen consumption rate (OCR) being key parameters. The model is fitted to growth curves for a range of cell lines and derived values of OCR are validated using clinical measurement. Finally, we illustrate how changes in OCR due to gemcitabine treatment can be directly inferred using this model.	[Grimes, David Robert; Kannan, Pavitra; Siddiky, Abul; Partridge, Mike] Univ Oxford, Gray Labs, Canc Res UK MRC Oxford Inst Radiat Oncol, Old Rd Campus, Oxford OX3 7DQ, England; [McIntyre, Alan; Wigfield, Simon; Harris, Adrian] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Headley Way, Oxford OX3 9DS, England; [Kavanagh, Anthony] Univ Oxford, Dept Oncol, Adv Technol Dev Grp, Old Rd Campus Res Bldg, Oxford OX3 7DQ, England	University of Oxford; University of Oxford; University of Oxford	Grimes, DR (corresponding author), Univ Oxford, Gray Labs, Canc Res UK MRC Oxford Inst Radiat Oncol, Old Rd Campus, Oxford OX3 7DQ, England.	davidrobert.grimes@oncology.ox.ac.uk	Grimes, David Robert/J-7384-2013; Harris, Adrian L/ABA-3343-2020; Kannan, Pavitra/I-2796-2019	Grimes, David Robert/0000-0003-3140-3278; Harris, Adrian L/0000-0003-1376-8409; Kannan, Pavitra/0000-0002-9170-6062; McIntyre, Alan/0000-0002-4791-7292	Cancer Research UK [C5255/A15935, C53469/A19834]; Cancer Research UK [16049, 19834, 18974, 11359, 16466] Funding Source: researchfish; Medical Research Council [G0300648] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10163] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors gratefully acknowledge funding from Cancer Research UK, grant references C5255/A15935 and C53469/A19834.	CONGER AD, 1983, CANCER RES, V43, P556; Dubessy C, 2000, CRIT REV ONCOL HEMAT, V36, P179, DOI 10.1016/S1040-8428(00)00085-8; Dufau I, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-15; Fang DD, 2010, BRIT J CANCER, V102, P1265, DOI 10.1038/sj.bjc.6605610; FELLER W., 1940, ACTA BIOTHEORETICA, V5, P51, DOI 10.1007/BF01602862; FREYER JP, 1988, CANCER RES, V48, P2432; FUKAMACHI H, 1987, J CELL SCI, V87, P615; Gerlee P., 2013, CANC RES; Grimes DR, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0070; Grimes DR, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140080; Grimes DR, 2015, BIOMED PHYS ENG EXPR, V1, DOI 10.1088/2057-1976/1/4/045209; Grimes DR, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1124; Gyllenberg M, 1989, RES REPORTS HELSINKI; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Ivascu A, 2006, J BIOMOL SCREEN, V11, P922, DOI 10.1177/1087057106292763; Jones AF, 2000, J MATH BIOL, V40, P473, DOI 10.1007/s002850000033; Kal HB, 2006, ANTICANCER RES, V26, P139; Kelly CJ, 2012, NUCL MED BIOL, V39, P986, DOI 10.1016/j.nucmedbio.2012.04.006; Kempf H, 2010, EUR PHYS J D, V60, P177, DOI 10.1140/epjd/e2010-00178-4; Kim TH, 2010, BIOMATERIALS, V31, P7386, DOI 10.1016/j.biomaterials.2010.06.004; Kunz-Schughart L, 2000, AM J PHYSIOL-CELL PH, V278, pC765, DOI 10.1152/ajpcell.2000.278.4.C765; Lawrence TS, 1999, ONCOLOGY-NY, V13, P55; Madsen SJ, 2006, LASER SURG MED, V38, P555, DOI 10.1002/lsm.20350; Mahyar-Roemer M, 2001, INT J CANCER, V94, P615, DOI 10.1002/ijc.1516; MARUSIC M, 1994, CELL PROLIFERAT, V27, P73, DOI 10.1111/j.1365-2184.1994.tb01407.x; Mehta G, 2012, J CONTROL RELEASE, V164, P192, DOI 10.1016/j.jconrel.2012.04.045; Park K, 2008, LAB CHIP, V8, P1034, DOI 10.1039/b803601b; Roose T, 2007, SIAM REV, V49, P179, DOI 10.1137/S0036144504446291; Santini MT IP, MULTICELLULAR TUMOUR; Sherratt JA, 2001, J MATH BIOL, V43, P291, DOI 10.1007/s002850100088; Shewach DS, 1996, INVEST NEW DRUG, V14, P257, DOI 10.1007/BF00194528; Steel GG, 1977, GROWTH KINETICS TUMO; SUTHERLAND RM, 1971, JNCI-J NATL CANCER I, V46, P113; SWAN GW, 1990, MATH BIOSCI, V101, P237, DOI 10.1016/0025-5564(90)90021-P; TEICHER BA, 1987, CANCER RES, V47, P388; Vinci M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-29; Ward JP, 1997, IMA J MATH APPL MED, V14, P39; Wheldon T. E., 1988, MED SCI SERIES; WOLFF DA, 1972, J CELL BIOL, V55, P579, DOI 10.1083/jcb.55.3.579; Wrzesinski K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106973	41	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153692	10.1371/journal.pone.0153692	http://dx.doi.org/10.1371/journal.pone.0153692			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088720	Green Submitted, Green Published, gold			2022-12-26	WOS:000374527000042
J	Hu, NP; Duan, JL; Li, HH; Wang, YH; Wang, F; Chu, JJ; Sun, J; Liu, MY; Wang, C; Lu, CT; Wen, AD				Hu, Naping; Duan, Jialin; Li, Huihui; Wang, Yanhua; Wang, Fang; Chu, Jianjie; Sun, Jin; Liu, Meiyou; Wang, Chao; Lu, Chengtao; Wen, Aidong			Hydroxysafflor Yellow A Ameliorates Renal Fibrosis by Suppressing TGF-beta 1-Induced Epithelial-to-Mesenchymal Transition	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; TGF-BETA; OBSTRUCTIVE NEPHROPATHY; IN-VITRO; CARTHAMUS-TINCTORIUS; FIBROBLASTS; DIFFERENTIATION; MYOFIBROBLASTS; PROGRESSION; ACTIVATION	Objective Renal fibrosis is the common pathological foundation of many chronic kidney diseases (CKDs). The aim of this study was to investigate whether Hydroxysafflor yellow A (HSYA) can preserve renal function by inhibiting the progression of renal fibrosis and the potential mechanisms. Methods Renal fibrosis was induced by unilateral ureteral obstruction (UUO) performed on 7-week-old C57BL/6 mice. HSYA (10, 50 and 100 mg/kg) were intragastrically administered. Sham group and model group were administered with the same volume of vehicle. Serum and kidney samples were collected 14 days after the UUO surgery. Serum biochemical indicators were measured by automatic biochemical analyzer. Histological changes were evaluated by HE and Masson staining. In vitro, the anti-fibrotic effect of HSYA was tested on human recombinant transforming growth factor-beta 1 (TGF-beta 1) stimulated HK-2 cells. The protein levels of alpha-SMA, collagen-I and fibronectin in kidney tissue andHK-2 cells were measured by immunohistochemistry and immunofluorescence. The protein levels of apoptosis-relative and TGF-beta 1/Smad3 signaling were detected by western blot. Results HSYA slowed the development of renal fibrosis both in vivo and in vitro. In UUO rats, renal function index suggested that HSYA treatment decreased the level of serum creatinine (Scr) and blood urea nitrogen (BUN) rose by UUO (P< 0.05). HE staining and Masson staining demonstrated that kidney interstitial fibrosis, tubular atrophy, and inflammatory cell infiltration were notably attenuated in the high-dose HSYA group compared with the model group. The expressions of alpha-SMA, collagen-I and fibronectin were decreased in the UUO kidney and HK-2 cells of the HSYA-treatment group. Moreover, HSYA reduced the apoptotic rate of HK-2 cells stimulated by TGF-beta 1. Further study revealed that HSYA regulated the TGF-beta 1/Smads signaling pathway both in kidney tissue and HK-2 cells. Conclusions These results suggested that HSYA had a protective effect against fibrosis in renal cells, at least partly, through inhibiting TGF-beta 1/smad3-mediated Epithelial-mesenchymal transition signaling pathway.	[Hu, Naping; Duan, Jialin; Li, Huihui; Wang, Fang; Chu, Jianjie; Sun, Jin; Liu, Meiyou; Wang, Chao; Lu, Chengtao; Wen, Aidong] Fourth Mil Med Univ, Xijing Hosp, Dept Pharm, Xian 710032, Peoples R China; [Hu, Naping; Duan, Jialin; Li, Huihui; Wang, Yanhua; Wang, Fang; Chu, Jianjie; Sun, Jin; Wen, Aidong] Shaanxi Univ Chinese Med, Coll Pharm, Xianyang 712046, Peoples R China	Air Force Military Medical University; Shaanxi University of Chinese Medicine	Lu, CT; Wen, AD (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Pharm, Xian 710032, Peoples R China.; Wen, AD (corresponding author), Shaanxi Univ Chinese Med, Coll Pharm, Xianyang 712046, Peoples R China.	lu-009@163.com; 18991397171@163.com	wang, yi/GVT-8516-2022; Wang, Yuan/HHC-1520-2022; Wang, Yanbo/HFZ-8018-2022; Duan, Jialin/N-1630-2017; Wen, Aidong/P-2654-2019; wang, yan/GSE-6489-2022	Wen, Aidong/0000-0002-4535-0501; 	National Natural Science Foundation of China [81373947, 81302695]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The National Natural Science Foundation of China, Grant Nos. 81373947 (to ADW) and 81302695 (CTL). They all played a role in the study design, data collection and analysis.	Badid C, 2002, NEPHROL DIAL TRANSPL, V17, P1993, DOI 10.1093/ndt/17.11.1993; Barnes JL, 2011, KIDNEY INT, V79, P944, DOI 10.1038/ki.2010.516; Becker GJ, 2000, CURR OPIN NEPHROL HY, V9, P133, DOI 10.1097/00041552-200003000-00006; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Bottinger EP, 2007, SEMIN NEPHROL, V27, P309, DOI 10.1016/j.semnephrol.2007.02.009; Burns WC, 2007, CELLS TISSUES ORGANS, V185, P222, DOI 10.1159/000101323; Chen HY, 2011, DIABETES, V60, P590, DOI 10.2337/db10-0403; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Docherty NG, 2006, AM J PHYSIOL-RENAL, V290, pF1202, DOI 10.1152/ajprenal.00406.2005; Eddy AA, 2006, J AM SOC NEPHROL, V17, P2964, DOI 10.1681/ASN.2006070704; Feng ZM, 2013, J NAT PROD, V76, P270, DOI 10.1021/np300814k; Hu Q, 2009, NEPHROL DIAL TRANSPL, V24, P3033, DOI 10.1093/ndt/gfp245; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Jia LN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117757; Kohan DE, 2014, KIDNEY INT, V86, P896, DOI 10.1038/ki.2014.143; Lan HY, 2011, INT J BIOL SCI, V7, P1056, DOI 10.7150/ijbs.7.1056; Li JH, 2009, AM J PATHOL, V175, P1380, DOI 10.2353/ajpath.2009.090096; Li R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058848; Liu GX, 2014, CLIN SCI, V127, P195, DOI 10.1042/CS20130706; Liu N, 2011, J PHARMACOL EXP THER, V338, P758, DOI 10.1124/jpet.111.181727; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Meng XM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00082; Meng XM, 2015, ONCOTARGET, DOI 10.18632/oncotarget.6100; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Shi YL, 2013, MOL MED REP, V7, P419, DOI 10.3892/mmr.2012.1213; Wang CY, 2013, PHYTOMEDICINE, V20, P592, DOI 10.1016/j.phymed.2013.02.001; Wang L, 2011, BIOL PHARM BULL, V34, P511, DOI 10.1248/bpb.34.511; Wang QL, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-31; Xu WJ, 2014, J PHARMACOL EXP THER, V350, P552, DOI 10.1124/jpet.114.214205; Yang FY, 2010, J PATHOL, V221, P390, DOI 10.1002/path.2721; Yang JW, 2003, AM J PHYSIOL-RENAL, V284, pF349, DOI 10.1152/ajprenal.00154.2002; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3; Yang Y, 2008, J ETHNOPHARMACOL, V118, P264, DOI 10.1016/j.jep.2008.04.012; Yang YL, 2008, J CELL BIOCHEM, V104, P908, DOI 10.1002/jcb.21676; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513; Zhang GQ, 2003, J AM SOC NEPHROL, V14, P1254, DOI 10.1097/01.ASN.0000064292.37793.FB; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zhang YB, 2011, EUR J PHARMACOL, V660, P438, DOI 10.1016/j.ejphar.2011.04.015; Zhao TT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090807; Zhou L, 2010, AM J PHYSIOL-RENAL, V298, pF1006, DOI 10.1152/ajprenal.00675.2009; Zhou Y, 2010, J AM SOC NEPHROL, V21, P598, DOI 10.1681/ASN.2009050552	44	25	28	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153409	10.1371/journal.pone.0153409	http://dx.doi.org/10.1371/journal.pone.0153409			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088510	Green Submitted, Green Published, gold			2022-12-26	WOS:000374527000020
J	Singh, A; Ubaid-Ullah, S; Ramteke, AK; Batra, JK				Singh, Alla; Ubaid-Ullah, Shah; Ramteke, Anup K.; Batra, Janendra K.			Influence of Conformation of M. tuberculosis RNase P Protein Subunit on Its Function	PLOS ONE			English	Article							EUKARYOTIC RIBONUCLEASE-P; PRECURSOR-TRANSFER-RNA; MYCOBACTERIUM-TUBERCULOSIS; SUBSTRATE RECOGNITION; MESSENGER-RNA; COMPONENT; CLEAVAGE; ENZYME; MECHANISM; EVOLUTION	RNase P is an essential enzyme that processes 5' end leader sequence of pre-tRNA to generate mature tRNA. The bacterial RNase Ps contain a RNA subunit and one protein subunit, where the RNA subunit contains the catalytic activity. The protein subunit which lacks any catalytic activity, relaxes the ionic requirements for holoenzyme reaction and is indispensable for pre-tRNA cleavage in vivo. In the current study, we reconstituted the M. tuberculosis RNase P holoenzyme in vitro. We prepared the RNase P protein through two different strategies that differ in the conditions under which the recombinant M. tuberculosis protein, expressed in E. coli was purified. The mycobacterial RNase P protein which was purified under native conditions subsequent to isolation from inclusion bodies and in vitro renaturation, was capable of cleaving pre-tRNA specifically without the requirement of RNase P RNA. However, the preparation that was purified under denaturing conditions and refolded subsequently lacked any inherent pre-tRNA processing activity and cleaved the substrate only as a component of the holoenzyme with the RNA subunit. We found that the two RNase P protein preparations attained alternative conformations and differed with respect to their stability as well.	[Singh, Alla; Ubaid-Ullah, Shah; Ramteke, Anup K.; Batra, Janendra K.] Natl Inst Immunol, Immunochem Lab, Aruna Asaf Ali Marg, New Delhi 110067, India; [Ubaid-Ullah, Shah] Cent Univ Kashmir CUK, Sch Life Sci, Dept Biotechnol, Transit Campus Sonwar, Srinagar 190004, Jammu & Kashmir, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Central University of Kashmir	Batra, JK (corresponding author), Natl Inst Immunol, Immunochem Lab, Aruna Asaf Ali Marg, New Delhi 110067, India.	janendra@nii.res.in	SHAH, UBAID Ullah/C-4193-2018; Batra, Janendra/GWQ-8031-2022	SHAH, UBAID Ullah/0000-0002-6546-301X; Batra, Janendra/0000-0003-2206-3398	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by grants to the National Institute of Immunology from the Department of Biotechnology, Government of India.	Behr MA, 2013, ADV EXP MED BIOL, V783, P81, DOI 10.1007/978-1-4614-6111-1_4; BERNHARDT D, 1969, J MOL BIOL, V42, P43, DOI 10.1016/0022-2836(69)90485-9; BLANK A, 1982, ANAL BIOCHEM, V120, P267, DOI 10.1016/0003-2697(82)90347-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Crary SM, 1998, BIOCHEMISTRY-US, V37, P9409, DOI 10.1021/bi980613c; Demeshkina N, 2010, CURR OPIN STRUC BIOL, V20, P325, DOI 10.1016/j.sbi.2010.03.002; Esakova O, 2010, RNA, V16, P1725, DOI 10.1261/rna.2214510; Evans D, 2006, TRENDS BIOCHEM SCI, V31, P333, DOI 10.1016/j.tibs.2006.04.007; Gobert A, 2010, NAT STRUCT MOL BIOL, V17, P740, DOI 10.1038/nsmb.1812; Goldfarb KC, 2012, GENE DEV, V26, P1005, DOI 10.1101/gad.193581.112; Gossringer Markus, 2012, Methods Mol Biol, V848, P61, DOI 10.1007/978-1-61779-545-9_5; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Hall TA, 2002, RNA, V8, P296, DOI 10.1017/S1355838202028492; Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013; Howard MJ, 2012, P NATL ACAD SCI USA, V109, P16149, DOI 10.1073/pnas.1209062109; Hu YM, 1998, FEMS MICROBIOL LETT, V158, P139; Kazantsev AV, 2006, NAT REV MICROBIOL, V4, P729, DOI 10.1038/nrmicro1491; Kikovska E, 2007, P NATL ACAD SCI USA, V104, P2062, DOI 10.1073/pnas.0607326104; Kirsebom LA, 2007, BIOCHIMIE, V89, P1183, DOI 10.1016/j.biochi.2007.05.009; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; Kurz JC, 2002, BIOCHEMISTRY-US, V41, P9545, DOI 10.1021/bi025553w; Kurz JC, 1998, BIOCHEMISTRY-US, V37, P2393, DOI 10.1021/bi972530m; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Maraia RJ, 2011, WIRES RNA, V2, P362, DOI 10.1002/wrna.64; Morl M, 2001, EMBO REP, V2, P17, DOI 10.1093/embo-reports/kve006; Niranjanakumari S, 1998, P NATL ACAD SCI USA, V95, P15212, DOI 10.1073/pnas.95.26.15212; O'Brien RJ, 2001, AM J RESP CRIT CARE, V163, P1055, DOI 10.1164/ajrccm.163.5.2007122; OCONNOR JP, 1991, MOL CELL BIOL, V11, P425, DOI 10.1128/MCB.11.1.425; Pannucci JA, 1999, P NATL ACAD SCI USA, V96, P7803, DOI 10.1073/pnas.96.14.7803; Reiter NJ, 2010, NATURE, V468, P784, DOI 10.1038/nature09516; Rodnina MV, 2011, BIOCHEM SOC T, V39, P658, DOI 10.1042/BST0390658; Rossmanith W, 1998, BIOCHEM BIOPH RES CO, V247, P234, DOI 10.1006/bbrc.1998.8766; Singh A, 2016, IUBMB LIFE, V68, P178, DOI 10.1002/iub.1472; SMITH D, 1993, BIOCHEMISTRY-US, V32, P5273, DOI 10.1021/bi00071a001; True HL, 1998, J BIOL CHEM, V273, P7193, DOI 10.1074/jbc.273.13.7193; Turrini PCG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032456; WANG MJ, 1988, EMBO J, V7, P1567, DOI 10.1002/j.1460-2075.1988.tb02981.x; Westhof E, 1996, J MOL BIOL, V258, P600, DOI 10.1006/jmbi.1996.0272; Xiao SH, 2002, ANNU REV BIOCHEM, V71, P165, DOI 10.1146/annurev.biochem.71.110601.135352; Zhang YJJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002946	42	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153798	10.1371/journal.pone.0153798	http://dx.doi.org/10.1371/journal.pone.0153798			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088505	Green Published, Green Submitted, gold			2022-12-26	WOS:000374527000050
J	Assega, FM; Birindelli, JLO; Bialetzki, A; Shibatta, OA				Assega, Fernando Massayuki; Olivan Birindelli, Jose Luis; Bialetzki, Andrea; Shibatta, Oscar Akio			External Morphology of Lophiosilurus alexandri Steindachner, 1876 during Early Stages of Development, and Its Implications for the Evolution of Pseudopimelodidae (Siluriformes)	PLOS ONE			English	Article							OSTARIOPHYSI; PHYLOGENY; ONTOGENY	Pseudopimelodidae are Neotropical catfishes characterized by having slightly to strongly depressed body in fully developed specimens. The largest species of the family with 500 mm SL, Lophiosilurus alexandri, experiences impressive changes in body shape during development, becoming extremely depressed when fully developed. Accordingly, Lophiosilurus alexandri is an ideal species to observe the morphological changes during ontogeny, and to seek solid interpretations on the polarity of characters. Specimens of distinct larval periods (yolk sac, flexion and postflexion; n = 186 specimens) and juvenile stages (n = 20) were analyzed. Changes in body shape, position of mouth and eye, morphology of fins and pigmentation were observed during the development of Lophiosilurus. Larvae (5.7-11.2 mm standard length) had pigmentation concentrated on the head and parts of body, eyes small and pigmented, short barbels, and well-developed finfold. Juveniles (15.9-28.1 mm standard length) had body shape similar to adult, with head depressed and bearing bony ridges, large mouth, dorsally-oriented eyes, small barbels and well-developed shoulder bulges (cleithral width). The greatest morphological changes in the development of L. alexandri occurred during the postflexion larval stage. Relative to standard length, measurements of snout length, head depth and body depth are smaller in juveniles than in larvae, but body width is larger. New interpretations on the phylogenetic characters related to these changes are provided in view of the two alternative hypotheses of the evolution of Pseudopimelodidae.	[Assega, Fernando Massayuki; Olivan Birindelli, Jose Luis; Shibatta, Oscar Akio] Univ Estadual Londrina, Ctr Ciencias Biol, Programa Posgrad Ciencias Biol, Dept Biol Anim & Vegetal, BR-86051980 Londrina, PR, Brazil; [Bialetzki, Andrea] Univ Estadual Maringa, Dept Biol, Programa Posgrad Ecol Ambientes Aquat Continentai, Maringa, Parana, Brazil	Universidade Estadual de Londrina; Universidade Estadual de Maringa	Shibatta, OA (corresponding author), Univ Estadual Londrina, Ctr Ciencias Biol, Programa Posgrad Ciencias Biol, Dept Biol Anim & Vegetal, BR-86051980 Londrina, PR, Brazil.	shibatta@uel.br	Birindelli, Jose LO/F-4991-2015; Shibatta, Oscar A/I-1392-2012; Birindelli, José L.O./AAS-7096-2020; Fapesp, Biota/F-8655-2017; Bialetzki, Andrea/D-5883-2013	Shibatta, Oscar A/0000-0003-2883-5934; Birindelli, José L.O./0000-0001-9646-9636; Fapesp, Biota/0000-0002-9887-8449; Bialetzki, Andrea/0000-0002-8048-5049	CNPq; Fundacao Araucaria; CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FAFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The work was supported by CNPq (to AB), Fundacao Araucaria (to OAS and JLOB) and fellowship grants from CAPES (to FMA). This is part of author FMA's Msc thesis, developed under the Programa de Pos-Graduacao em Ciencias Biologicas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlstrom E. H., 1954, Fishery Bulletin United States, V56, P209; ALEXANDER RM, 1966, J ZOOL, V148, P88; [Anonymous], 1991, HETEROCHRONY EVOLUTI; Arratia F. G., 1984, Museo Nacional de Historia Natural Boletin (Santiago), P49; Arratia G, 2003, CATFISHES, VOLS 1-2, P121; ARRATIA G, 1992, J MORPHOL, V214, P187, DOI 10.1002/jmor.1052140209; Balon E. K., 1984, EARLY LIFE HIST FISH, P13; Bialetzki Andrea, 2008, Acta Scientiarum Biological Sciences, V30, P141; Birindelli JLO, 2014, NEOTROP ICHTHYOL, V12, P451, DOI 10.1590/1982-0224-20120027; Birindelli JLO, 2011, J MORPHOL, V272, P890, DOI 10.1002/jmor.10961; Blaxter J.H.S., 1988, P1; BRITSKI H.A., 1986, MANUAL IDENTIFICACAO; Collette BB, 1977, S ZOOL SOC LOND, V39, P25; de Pinna M.C.C., 1996, FIELDIANA ZOOLOGY, V84, P1, DOI DOI 10.5962/BHL.TITLE.5359; DEQUEIROZ K, 1985, SYST ZOOL, V34, P280, DOI 10.1093/sysbio/34.3.280; de Mello GCG, 2015, NEOTROP ICHTHYOL, V13, P677, DOI 10.1590/1982-0224-20140161; Guimaraes-Cruz RJ, 2009, J APPL ICHTHYOL, V25, P321, DOI 10.1111/j.1439-0426.2008.01153.x; Haeckel Ernst, 1866, GENERELLE MORPHOLOGI, V2; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Kendall A.W. Jr, 1984, American Society of Ichthyologists and Herpetologists Special Publication, P11; Lovejoy NR, 2004, INTEGR COMP BIOL, V44, P366, DOI 10.1093/icb/44.5.366; Lundberg J.G., 1969, American Museum Novitates, VNo. 2398, P1; Nakatani K, 2001, OVOS LARVAS PEIXES A; Nakatani K., 1997, PLAN CO INUNDA O ALT, P281; NELSON G, 1978, SYST ZOOL, V27, P324, DOI 10.2307/2412883; Ortega-Lara A, 2006, NEOTROP ICHTHYOL, V4, P147, DOI 10.1590/S1679-62252006000200002; Ponton D, 2001, FOLIA ZOOL, V50, P2; ROBERTS TR, 1982, ZOOL SCR, V11, P55, DOI 10.1111/j.1463-6409.1982.tb00518.x; Sabaj Perez M. H., 2014, STANDARD SYMBOLIC CO; Sato Y., 2003, AGUAS PEIXES PESCADO, V1st edition, P229; Sato Y, 1999, ESTUDOS ECOLOGICOS C, P401; SATO Y, 2006, GUIA ILUSTRADO PEIXE, P69; Schultze Hans-Peter, 2013, P187; Shibatta O. A., 1998, THESIS U FEDERAL SAO; Shibatta OA, 2005, ZOOTAXA, P21; Sullivan JP, 2006, MOL PHYLOGENET EVOL, V41, P636, DOI 10.1016/j.ympev.2006.05.044; Taguti TL, 1903, BIOTA NEOTROP, V9; Tenorio RA, 2003, ASPECTOS BIOL REPROD; WAYNE RK, 1986, EVOLUTION, V40, P243, DOI 10.1111/j.1558-5646.1986.tb00467.x; Wiley ML., 1970, B AM MUS NAT HIST, V143, P145	40	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153123	10.1371/journal.pone.0153123	http://dx.doi.org/10.1371/journal.pone.0153123			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082430	Green Published, gold			2022-12-26	WOS:000374291800012
J	Lai, MC; Chang, CM; Sun, HS				Lai, Ming-Chih; Chang, Chiao-May; Sun, H. Sunny			Hypoxia Induces Autophagy through Translational Up-Regulation of Lysosomal Proteins in Human Colon Cancer Cells	PLOS ONE			English	Article							MESSENGER-RNA TRANSLATION; INTERNAL RIBOSOME ENTRY; INDUCIBLE FACTOR-I; GENE-EXPRESSION; COLORECTAL TUMORIGENESIS; CYCLE ARREST; STRESS; MTOR; PHOSPHORYLATION; ANGIOGENESIS	Hypoxia occurs in a wide variety of physiological and pathological conditions, including tumorigenesis. Tumor cells have to adapt to hypoxia by altering their gene expression and protein synthesis. Here, we showed that hypoxia inhibits translation through activation of PERK and inactivation of mTOR in human colon cancer HCT116 cells. Prolonged hypoxia (1% O-2, 16 h) dramatically inhibits general translation in HCT116 cells, yet selected mRNAs remain efficiently translated under such a condition. Using microarray analysis of polysome-associated mRNAs, we identified a large number of hypoxia-regulated genes at the translational level. Efficiently translated mRNAs during hypoxia were validated by polysome profiling and quantitative real-time RT-PCR. Pathway enrichment analysis showed that many of the up-regulated genes are involved in lysosome, glycan and lipid metabolism, antigen presentation, cell adhesion, and remodeling of the extracellular matrix and cytoskeleton. The majority of down-regulated genes are involved in apoptosis, ubiquitin-mediated proteolysis, and oxidative phosphorylation. Further investigation showed that hypoxia induces lysosomal autophagy and mitochondrial dysfunction through translational regulation in HCT116 cells. The abundance of several translation factors and the mTOR kinase activity are involved in hypoxia-induced mitochondrial autophagy in HCT116 cells. Our studies highlight the importance of translational regulation for tumor cell adaptation to hypoxia.	[Lai, Ming-Chih] Chang Gung Univ, Dept Biomed Sci, Taoyuan, Taiwan; [Lai, Ming-Chih] Chang Gung Mem Hosp, Dept Obstet & Gynecol, Taoyuan, Taiwan; [Chang, Chiao-May; Sun, H. Sunny] Natl Cheng Kung Univ, Bioinformat Ctr, Tainan 701, Taiwan; [Sun, H. Sunny] Natl Cheng Kung Univ, Inst Mol Med, Tainan 701, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; National Cheng Kung University; National Cheng Kung University	Sun, HS (corresponding author), Chang Gung Univ, Dept Biomed Sci, Taoyuan, Taiwan.	mclai@mail.cgu.edu.tw; hssun@mail.ncku.edu.tw		Hung, Li-Man/0000-0002-6032-7668; Sun, Sunny/0000-0002-3661-4448	Ministry of Science and Technology, Taiwan [NSC100-2320-B-006-021-MY3, NSC101-2627-B-006-005]; Chang Gung Memorial Hospital, Taiwan [CMRPD3E0012]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	This work was supported by grants from Ministry of Science and Technology, Taiwan (NSC100-2320-B-006-021-MY3 to MCL and NSC101-2627-B-006-005 to HSS) and Chang Gung Memorial Hospital, Taiwan (CMRPD3E0012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Blais JD, 2006, MOL CELL BIOL, V26, P9517, DOI 10.1128/MCB.01145-06; Blais JD, 2004, MOL CELL BIOL, V24, P7469, DOI 10.1128/MCB.24.17.7469-7482.2004; Brown JM, 2002, INT J RADIAT ONCOL, V54, P1299, DOI 10.1016/S0360-3016(02)03936-6; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Chen TM, 2014, NUCLEIC ACIDS RES, V42, P2932, DOI 10.1093/nar/gkt1286; Connolly E, 2006, MOL CELL BIOL, V26, P3955, DOI 10.1128/MCB.26.10.3955-3965.2006; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Eskelinen EL, 2002, MOL BIOL CELL, V13, P3355, DOI 10.1091/mbc.E02-02-0114; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Flamant L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-191; Frezza C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024411; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; He MF, 2010, INT J CANCER, V126, P266, DOI 10.1002/ijc.24694; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Hu YL, 2012, CANCER RES, V72, P1773, DOI 10.1158/0008-5472.CAN-11-3831; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Koritzinsky M, 2006, EMBO J, V25, P1114, DOI 10.1038/sj.emboj.7600998; Koritzinsky M, 2005, RADIOTHER ONCOL, V76, P177, DOI 10.1016/j.radonc.2005.06.036; Koritzinsky M, 2007, METHOD ENZYMOL, V435, P247, DOI 10.1016/S0076-6879(07)35013-1; Koshiji M, 2004, EMBO J, V23, P1949, DOI 10.1038/sj.emboj.7600196; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Kuballa P, 2012, ANNU REV IMMUNOL, V30, P611, DOI 10.1146/annurev-immunol-020711-074948; Kunz Manfred, 2003, Mol Cancer, V2, P23, DOI 10.1186/1476-4598-2-23; Lang KJD, 2002, MOL BIOL CELL, V13, P1792, DOI 10.1091/mbc.02-02-0017; Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lobo MR, 2013, NEURO-ONCOLOGY, V15, P1673, DOI 10.1093/neuonc/not119; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Miyazaki K, 2002, J BIOL CHEM, V277, P47014, DOI 10.1074/jbc.M204938200; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nazio F, 2013, NAT CELL BIOL, V15, P406, DOI 10.1038/ncb2708; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; PETTERSEN EO, 1986, CANCER RES, V46, P4346; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Rosenberger P, 2009, NAT IMMUNOL, V10, P195, DOI 10.1038/ni.1683; Ruan K, 2009, J CELL BIOCHEM, V107, P1053, DOI 10.1002/jcb.22214; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Spriggs KA, 2008, BIOL CELL, V100, P27, DOI 10.1042/BC20070098; Stein I, 1998, MOL CELL BIOL, V18, P3112, DOI 10.1128/MCB.18.6.3112; Sun Y, 2013, AUTOPHAGY, V9, P1115, DOI 10.4161/auto.24919; TEICHER BA, 1994, CANCER METAST REV, V13, P139, DOI 10.1007/BF00689633; Thomas JD, 2007, RNA, V13, P1116, DOI 10.1261/rna.534807; van den Beucken T, 2011, RADIOTHER ONCOL, V99, P379, DOI 10.1016/j.radonc.2011.05.058; Vaupel P, 2004, ONCOLOGIST, V9, P10, DOI 10.1634/theoncologist.9-90005-10; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Waldner MJ, 2010, MOL ASPECTS MED, V31, P171, DOI 10.1016/j.mam.2010.02.005; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007; Zavoral M, 2014, WORLD J GASTROENTERO, V20, P3825, DOI 10.3748/wjg.v20.i14.3825; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001	60	28	29	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153627	10.1371/journal.pone.0153627	http://dx.doi.org/10.1371/journal.pone.0153627			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078027	gold, Green Published, Green Submitted			2022-12-26	WOS:000374131700097
J	Li, ZY; Ji, XM; Wang, WC; Liu, JJ; Liang, XF; Wu, H; Liu, J; Eggert, US; Liu, QS; Zhang, X				Li, Zhiyuan; Ji, Xinmiao; Wang, Wenchao; Liu, Juanjuan; Liang, Xiaofei; Wu, Hong; Liu, Jing; Eggert, Ulrike S.; Liu, Qingsong; Zhang, Xin			Ammonia Induces Autophagy through Dopamine Receptor D3 and MTOR	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; LIVER-FAILURE; HUMAN-DISEASE; BRAIN; ANTAGONIST; INHIBITOR; CANCER; ROLES; CELLS; HYPERAMMONEMIA	Hyperammonemia is frequently seen in tumor microenvironments as well as in liver diseases where it can lead to severe brain damage or death. Ammonia induces autophagy, a mechanism that tumor cells may use to protect themselves from external stresses. However, how cells sense ammonia has been unclear. Here we show that culture medium alone containing Glutamine can generate milimolar of ammonia at 37 degrees in the absence of cells. In addition, we reveal that ammonia acts through the G protein-coupled receptor DRD3 (Dopamine receptor D3) to induce autophagy. At the same time, ammonia induces DRD3 degradation, which involves PIK3C3/VPS34-dependent pathways. Ammonia inhibits MTOR (mechanistic target of Rapamycin) activity and localization in cells, which is mediated by DRD3. Therefore, ammonia has dual roles in autophagy: one to induce autophagy through DRD3 and MTOR, the other to increase autophagosomal pH to inhibit autophagic flux. Our study not only adds a new sensing and output pathway for DRD3 that bridges ammonia sensing and autophagy induction, but also provides potential mechanisms for the clinical consequences of hyperammonemia in brain damage, neurodegenerative diseases and tumors.	[Li, Zhiyuan; Ji, Xinmiao; Wang, Wenchao; Liu, Juanjuan; Liang, Xiaofei; Wu, Hong; Liu, Jing; Liu, Qingsong; Zhang, Xin] Chinese Acad Sci, High Field Magnet Lab, Hefei, Anhui, Peoples R China; [Liu, Juanjuan; Wu, Hong; Liu, Qingsong] Univ Sci & Technol China, Hefei 230026, Anhui, Peoples R China; [Eggert, Ulrike S.] Kings Coll London, Dept Chem, London WC2R 2LS, England; [Eggert, Ulrike S.] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England	Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of London; King's College London; University of London; King's College London	Zhang, X (corresponding author), Chinese Acad Sci, High Field Magnet Lab, Hefei, Anhui, Peoples R China.	xinzhang@hmfl.ac.cn	Liu, Jing/C-9666-2014; li, zhiyuan/M-5096-2015; Zhang, Xin/AAB-9359-2020	Liu, Jing/0000-0001-9513-3591; li, zhiyuan/0000-0003-1496-3521; Zhang, Xin/0000-0002-3499-2189; Eggert, Ulrike/0000-0003-0932-5525; Liang, Xiaofei/0000-0001-8722-694X	Chinese Academy of Sciences "Hundred Talent program"; National Natural Science Foundation of China [31301112]	Chinese Academy of Sciences "Hundred Talent program"(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Chinese Academy of Sciences "Hundred Talent program" and National Natural Science Foundation of China (Project No. 31301112) to Xin Zhang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bago R, 2014, BIOCHEM J, V463, P413, DOI 10.1042/BJ20140889; BARTON AC, 1991, BRAIN RES, V547, P199, DOI 10.1016/0006-8993(91)90963-V; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Bouschet T, 2005, CR BIOL, V328, P691, DOI 10.1016/j.crvi.2004.10.006; Broadbridge V, 2010, J CLIN GASTROENTEROL, V44, pE186, DOI 10.1097/MCG.0b013e3181d96aad; CHANCE WT, 1988, LIFE SCI, V43, P67, DOI 10.1016/0024-3205(88)90238-X; CHANCE WT, 1991, LIFE SCI, V48, P425, DOI 10.1016/0024-3205(91)90498-Z; Cheong H, 2011, P NATL ACAD SCI USA, V108, P11121, DOI 10.1073/pnas.1107969108; Cuervo AM, 2012, MOL ASPECTS MED, V33, P2, DOI 10.1016/j.mam.2011.09.001; Damink SWMO, 2009, METAB BRAIN DIS, V24, P169, DOI 10.1007/s11011-008-9122-5; Elphick GF, 2004, SCIENCE, V306, P1380, DOI 10.1126/science.1103492; Eng CH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000911; Flombaum CD, 2000, SEMIN ONCOL, V27, P322; Gimenez-Xavier P, 2009, NEUROTOXICOLOGY, V30, P658, DOI 10.1016/j.neuro.2009.04.007; Harder LM, 2014, AUTOPHAGY, V10, P339, DOI 10.4161/auto.26863; Heng BC, 2013, BIOTECHNOL ADV, V31, P1676, DOI 10.1016/j.biotechadv.2013.08.017; Hofer AM, 2003, NAT REV MOL CELL BIO, V4, P530, DOI 10.1038/nrm1154; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kinnamon SC, 2012, ACTA PHYSIOL, V204, P158, DOI 10.1111/j.1748-1716.2011.02308.x; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Kossaify A, 2013, BIOMARK INSIGHTS, V8, P115, DOI 10.4137/BMI.S12703; Lim J, 2011, AUTOPHAGY, V7, P51, DOI 10.4161/auto.7.1.13909; Liu QS, 2013, CANCER RES, V73, P2574, DOI 10.1158/0008-5472.CAN-12-1702; Macintosh RL, 2013, SEMIN CANCER BIOL, V23, P344, DOI 10.1016/j.semcancer.2013.05.006; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mouille B, 2003, BBA-GEN SUBJECTS, V1624, P88, DOI 10.1016/j.bbagen.2003.09.014; Murrow L, 2013, ANNU REV PATHOL-MECH, V8, P105, DOI 10.1146/annurev-pathol-020712-163918; Ni HM, 2011, AUTOPHAGY, V7, P188, DOI 10.4161/auto.7.2.14181; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Ott P, 2004, NEUROCHEM INT, V44, P185, DOI 10.1016/S0197-0186(03)00153-0; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Palczewski K, 2013, ANNU REV NEUROSCI, V36, P139, DOI 10.1146/annurev-neuro-062012-170313; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Polletta L, 2015, AUTOPHAGY, V11, P253, DOI 10.1080/15548627.2015.1009778; Ronan B, 2014, NAT CHEM BIOL, V10, P1013, DOI 10.1038/nchembio.1681; Rose C, 2005, METAB BRAIN DIS, V20, P275, DOI 10.1007/s11011-005-7906-4; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sachlos E, 2012, CELL, V149, P1284, DOI 10.1016/j.cell.2012.03.049; Schneider JL, 2014, CURR OPIN GENET DEV, V26, P16, DOI 10.1016/j.gde.2014.04.003; Shin JH, 2012, BIOL PHARM BULL, V35, P1069, DOI 10.1248/bpb.b12-00009; Takei N, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00028; Wauson EM, 2014, TRENDS ENDOCRIN MET, V25, P274, DOI 10.1016/j.tem.2014.03.006; Wauson EM, 2012, MOL CELL, V47, P851, DOI 10.1016/j.molcel.2012.08.001; Yan H, 2013, J CELL BIOCHEM, V114, P103, DOI 10.1002/jcb.24306; Yang YP, 2005, ACTA PHARMACOL SIN, V26, P1421, DOI 10.1111/j.1745-7254.2005.00235.x; Zhang X, 2013, MOL BIOSYST, V9, P586, DOI 10.1039/c2mb25429h; Zhang X, 2012, CYTOSKELETON, V69, P810, DOI 10.1002/cm.21055; Zhang X, 2012, P NATL ACAD SCI USA, V109, P12485, DOI 10.1073/pnas.1207821109	49	20	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153526	10.1371/journal.pone.0153526	http://dx.doi.org/10.1371/journal.pone.0153526			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077655	Green Published, gold, Green Submitted			2022-12-26	WOS:000374131700074
J	Martinuzzi, A; Montanaro, D; Vavla, M; Paparella, G; Bonanni, P; Musumeci, O; Brighina, E; Hlavata, H; Rossi, G; Aghakhanyan, G; Martino, N; Baratto, A; D'Angelo, MG; Peruch, F; Fantin, M; Arnoldi, A; Citterio, A; Vantaggiato, C; Rizzo, V; Toscano, A; Bresolin, N; Bassi, MT				Martinuzzi, Andrea; Montanaro, Domenico; Vavla, Marinela; Paparella, Gabriella; Bonanni, Paolo; Musumeci, Olimpia; Brighina, Erika; Hlavata, Hana; Rossi, Giuseppe; Aghakhanyan, Gayane; Martino, Nicola; Baratto, Alessandra; D'Angelo, Maria Grazia; Peruch, Francesca; Fantin, Marianna; Arnoldi, Alessia; Citterio, Andrea; Vantaggiato, Chiara; Rizzo, Vincenzo; Toscano, Antonio; Bresolin, Nereo; Bassi, Maria Teresa			Clinical and Paraclinical Indicators of Motor System Impairment in Hereditary Spastic Paraplegia: A Pilot Study	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT; MUTATIONS; WHITE; PARAPARESIS; SPECTRUM; FEATURES; SPG11; PHENOTYPE; FREQUENT; PROTEIN	Background Hereditary spastic paraplegias (HSP) are a composite and genetically heterogeneous group of conditions mainly expressed by the impairment of the central motor system ("pure" forms). The involvement of other components of the central nervous system or of other systems is described in the "complicate" forms. The definition of an investigation protocol capable, by assembling clinical and paraclinical indicators to fully represent the extent of the motor system impairment, would help both the clinical handling of these conditions and contribute to our understanding of their pathogenesis. Methods We applied a clinical and paraclinical protocol which included tools exploring motor and non motor functioning, neurophysiology and MRI to a composite cohort of 70 molecularly defined HSP patients aged 3 to 65, to define for each indicator its significance in detailing the presence and the severity of the pathology. Results Clinically increased deep tendon reflexes and lower limb (LL) weakness are constant findings in all patients. The "complicated" forms are characterized by peripheral motor impairment, cognitive and cerebellar involvement. The Spastic Paraplegia Rating Scale efficiently reflects the severity of functional problems and correlates with disease duration. Neurophysiology consistently documents the impairment of the central motor pathway to the LLs. Nevertheless, the upper extremities and sensory system involvement is a frequent finding. MRI diffusion tensor imaging (DTI) highlighted a significant alteration of FA and MD. Combining the sampling of the various portion of the cortico-spinal tract (CST) DTI consistently discriminated patients from controls. Conclusion We propose a graded clinical and paraclinical protocol for HSP phenotype definition, indicating for each tool the discriminative and descriptive capacity. Our protocol applied to 9 different forms of HSP showed that the functional impairment often extends beyond the CST. The novel DTI approach may add significant elements in disease recognition, staging and mapping.	[Martinuzzi, Andrea; Vavla, Marinela; Paparella, Gabriella; Bonanni, Paolo; Peruch, Francesca; Fantin, Marianna] IRCCS E Medea, Polo Reg Conegliano, Conegliano, TV, Italy; [Montanaro, Domenico; Hlavata, Hana; Aghakhanyan, Gayane] Fdn CNR Reg Toscana G Monasterio, Unit Neuroradiol, Pisa, Italy; [Musumeci, Olimpia; Rizzo, Vincenzo; Toscano, Antonio] Univ Messina, Dept Neurosci, Messina, Italy; [Brighina, Erika; D'Angelo, Maria Grazia] IRCCS E Medea, Neurorehabil Dept, Bosisio Parini, LC, Italy; [Rossi, Giuseppe] CNR, Inst Clin Physiol, Unit Epidemiol & Biostat, Pisa, Italy; [Martino, Nicola; Baratto, Alessandra] ULSS 7 Pieve Soligo, Dept Imaging, Conegliano, TV, Italy; [Arnoldi, Alessia; Citterio, Andrea; Vantaggiato, Chiara; Bassi, Maria Teresa] IRCCS E Medea, Mol Biol Lab, Bosisio Parini, LC, Italy; [Bresolin, Nereo] Univ Milan, Dept Neurosci, IRCCS Fdn Policlin, Milan, Italy	IRCCS Eugenio Medea; University of Messina; IRCCS Eugenio Medea; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); IRCCS Eugenio Medea; University of Milan	Martinuzzi, A (corresponding author), IRCCS E Medea, Polo Reg Conegliano, Conegliano, TV, Italy.	andrea.martinuzzi@lanostrafamiglia.it	Rizzo, Vincenzo/K-8989-2016; Citterio, Andrea/K-4379-2016; D'Angelo, Maria Grazia/K-4685-2016; Martinuzzi, Andrea/K-3887-2016; Vantaggiato, Chiara/AAH-5702-2019; Paparella, Gabriella/AAA-6540-2020; Bassi, Maria Teresa T/A-3517-2014; Montanaro, Domenico/K-5938-2016; Martinuzzi, Andrea/AAC-3127-2022; Toscano, Antonio/AHE-4657-2022; Martino, Nicola/AAP-9891-2020; Aghakhanyan, Gayane/AAC-7691-2022; bonanni, paolo/T-7360-2017; Montanaro, Domenico/AAB-9718-2022; Vavla, Marinela/J-7312-2016	Citterio, Andrea/0000-0003-4462-5646; D'Angelo, Maria Grazia/0000-0003-1241-4350; Martinuzzi, Andrea/0000-0002-0319-3579; Vantaggiato, Chiara/0000-0002-3910-6836; Paparella, Gabriella/0000-0002-9986-9907; Bassi, Maria Teresa T/0000-0002-8236-1197; Aghakhanyan, Gayane/0000-0001-5152-497X; bonanni, paolo/0000-0002-9448-9059; Montanaro, Domenico/0000-0002-9895-7016; Fantin, Marianna/0000-0002-5746-5453; Vavla, Marinela/0000-0002-3598-2978; Bresolin, Nereo/0000-0001-6694-3595	Italian Ministry of health; ERA-Net for Research on Rare Diseases grant NEUROLIPID;  [RF-IEM-2006-365041]	Italian Ministry of health(Ministry of Health, Italy); ERA-Net for Research on Rare Diseases grant NEUROLIPID; 	This work was supported by the Italian Ministry of health under the frame of E-Rare-2, the ERA-Net for Research on Rare Diseases grant NEUROLIPID and grant n. RF-IEM-2006-365041, RC 2009 (1.6); 2010 (10.4); 2011 (10.3); 2012(10.2) and RC 2013 (4.7) to AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghakhanyan G, 2014, AM J NEURORADIOL, V35, P1533, DOI 10.3174/ajnr.A3897; Agosta F, 2015, RADIOLOGY; Agosta F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042816; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Beetz C, 2008, BRAIN, V131, P1078, DOI 10.1093/brain/awn026; Blackstone C, 2012, ANNU REV NEUROSCI, V35, P25, DOI 10.1146/annurev-neuro-062111-150400; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; Chen Q, 2008, NEUROSCI LETT, V441, P21, DOI 10.1016/j.neulet.2008.05.114; Chetta A, 2006, RESP MED, V100, P1573, DOI 10.1016/j.rmed.2006.01.001; Compston A, 2010, BRAIN, V133, P2835, DOI 10.1093/brain/awq274; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; de Bot ST, 2010, J NEUROL NEUROSUR PS, V81, P1073, DOI 10.1136/jnnp.2009.201103; DeLuca GC, 2004, NEUROPATH APPL NEURO, V30, P576, DOI 10.1111/j.1365-2990.2004.00587.x; Depienne C, 2006, J MED GENET, V43, P259, DOI 10.1136/jmg.2005.035311; Dini Leandro I, 2013, Surg Neurol Int, V4, P51, DOI 10.4103/2152-7806.110508; Duning T, 2010, MOVEMENT DISORD, V25, P1986, DOI 10.1002/mds.23211; Faber I, 2014, ARQ NEURO-PSIQUIAT, V72, P219, DOI 10.1590/0004-282X20130248; Fink JK, 2013, ACTA NEUROPATHOL, V126, P307, DOI 10.1007/s00401-013-1115-8; Finsterer J, 2012, J NEUROL SCI, V318, P1, DOI 10.1016/j.jns.2012.03.025; Franca MC, 2012, J NEUROL NEUROSUR PS, V83, P828, DOI 10.1136/jnnp-2011-300129; Goizet C, 2011, HUM MUTAT, V32, P1118, DOI 10.1002/humu.21542; HARDING AE, 1983, LANCET, V1, P1151; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Hewamadduma C, 2009, NEUROGENETICS, V10, P105, DOI 10.1007/s10048-008-0163-z; Hopkins HG, 2006, NEW VIEW STAT EFFECT; Karle KN, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-158; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Lindig T, 2015, J NEUROL, V262, P1961, DOI 10.1007/s00415-015-7791-7; Lo Giudice T, 2014, EXP NEUROL, V261, P518, DOI 10.1016/j.expneurol.2014.06.011; Loureiro JL, 2013, JAMA NEUROL, V70, P481, DOI 10.1001/jamaneurol.2013.1956; Manganelli F, 2011, CLIN NEUROPHYSIOL, V122, P819, DOI 10.1016/j.clinph.2010.10.025; McDermott CJ, 2006, NEUROLOGY, V67, P45, DOI 10.1212/01.wnl.0000223315.62404.00; Mondini S., 2011, ESAME NEUROPSICOLOGI; MSALL ME, 1994, CLIN PEDIATR, V33, P421, DOI 10.1177/000992289403300708; Musumeci O, 2011, NEUROL SCI, V32, P665, DOI 10.1007/s10072-010-0445-8; Novarino G, 2014, SCIENCE, V343, P506, DOI 10.1126/science.1247363; Oguz KK, 2013, DIAGN INTERV RADIOL, V19, P181, DOI 10.5152/dir.2013.046; Pacheco FT, 2014, J NEUROIMAGING, V24, P205, DOI 10.1111/j.1552-6569.2012.00714.x; Pensato V, 2014, BRAIN, V137, P1907, DOI 10.1093/brain/awu121; Proukakis C, 2011, J NEUROL SCI, V306, P62, DOI 10.1016/j.jns.2011.03.043; Reid E, 2002, AM J HUM GENET, V71, P1189, DOI 10.1086/344210; Sartucci F, 2007, BRAIN RES BULL, V74, P243, DOI 10.1016/j.brainresbull.2007.06.018; Schule R, 2006, NEUROLOGY, V67, P430, DOI 10.1212/01.wnl.0000228242.53336.90; Stevanin G, 2007, NAT GENET, V39, P366, DOI 10.1038/ng1980; Svenson IK, 2004, NEUROGENETICS, V5, P157, DOI 10.1007/s10048-004-0186-z; Tesson C, 2012, AM J HUM GENET, V91, P1051, DOI 10.1016/j.ajhg.2012.11.001; Tsaousidou MK, 2008, AM J HUM GENET, V82, P510, DOI 10.1016/j.ajhg.2007.10.001; van Gassen KLI, 2012, BRAIN, V135, P2994, DOI 10.1093/brain/aws224; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th ed; Wechsler DW., 1999, INTELLIGENCE SCALE C; White KD, 2000, NEUROLOGY, V55, P89, DOI 10.1212/WNL.55.1.89; Windpassinger C, 2004, NAT GENET, V36, P271, DOI 10.1038/ng1313; Zhao XP, 2001, NAT GENET, V29, P326, DOI 10.1038/ng758; Zuchner S, 2006, AM J HUM GENET, V79, P365, DOI 10.1086/505361	55	22	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153283	10.1371/journal.pone.0153283	http://dx.doi.org/10.1371/journal.pone.0153283			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077743	Green Submitted, Green Published, gold			2022-12-26	WOS:000374131700035
J	Matsuu, A; Kobayashi, T; Patchimasiri, T; Shiina, T; Suzuki, S; Chaichoune, K; Ratanakorn, P; Hiromoto, Y; Abe, H; Parchariyanon, S; Saito, T				Matsuu, Aya; Kobayashi, Tomoko; Patchimasiri, Tuangthong; Shiina, Takashi; Suzuki, Shingo; Chaichoune, Kridsada; Ratanakorn, Parntep; Hiromoto, Yasuaki; Abe, Haruka; Parchariyanon, Sujira; Saito, Takehiko			Pathogenicity of Genetically Similar, H5N1 Highly Pathogenic Avian Influenza Virus Strains in Chicken and the Differences in Sensitivity among Different Chicken Breeds	PLOS ONE			English	Article							A VIRUS; MX PROTEIN; PA-X; ANTIVIRAL ACTIVITY; IMMUNE-RESPONSES; HOST RESPONSE; HONG-KONG; GENE; REPLICATION; RESISTANCE	Differences in the pathogenicity of genetically closely related H5N1 highly pathogenic avian influenza viruses (HPAIVs) were evaluated in White Leghorn chickens. These viruses varied in the clinical symptoms they induced, including lethality, virus shedding, and replication in host tissues. A comparison of the host responses in the lung, brain, and spleen suggested that the differences in viral replication efficiency were related to the host cytokine response at the early phase of infection, especially variations in the proinflammatory cytokine IL-6. Based on these findings, we inoculated the virus that showed the mildest pathogenicity among the five tested, A/pigeon/Thailand/VSMU-7-NPT/2004, into four breeds of Thai indigenous chicken, Phadu-Hung-Dang (PHD), Chee, Dang, and Luang-Hung-Khao (LHK), to explore effects of genetic background on host response. Among these breeds, Chee, Dang, and LHK showed significantly longer survival times than White Leghorns. Virus shedding from dead Thai indigenous chickens was significantly lower than that from White Leghorns. Although polymorphisms were observed in the Mx and MHC class I genes, there was no significant association between the polymorphisms in these loci and resistance to HPAIV.	[Matsuu, Aya; Kobayashi, Tomoko; Hiromoto, Yasuaki; Abe, Haruka; Saito, Takehiko] Thailand Japan Zoonot Dis Collaborating Ctr ZDCC, Bangkok, Thailand; [Matsuu, Aya; Kobayashi, Tomoko; Hiromoto, Yasuaki; Abe, Haruka; Saito, Takehiko] Natl Agr & Food Res Org NARO, Natl Inst Anim Hlth, Res Team Zoonot Dis, Tsukuba, Ibaraki, Japan; [Matsuu, Aya] Kagoshima Univ, Joint Fac Vet, Transboundary Anim Dis Res Ctr, Kagoshima 890, Japan; [Shiina, Takashi; Suzuki, Shingo] Tokai Univ, Sch Med, Dept Mol Life Sci, Isehara, Kanagawa 25911, Japan; [Chaichoune, Kridsada; Ratanakorn, Parntep] Mahidol Univ, Fac Vet Sci, Monitoring & Surveillance Ctr Zoonot Dis Wildlife, Phuttamonthon, Nakhon Pathom, Thailand; [Patchimasiri, Tuangthong; Parchariyanon, Sujira] Natl Inst Anim Hlth, Bangkok, Thailand; [Abe, Haruka; Saito, Takehiko] Natl Agr & Food Res Org NARO, Natl Inst Anim Hlth, Influenza & Prion Dis Res Ctr, Tsukuba, Ibaraki, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Kagoshima University; Tokai University; Mahidol University; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan	Saito, T (corresponding author), Thailand Japan Zoonot Dis Collaborating Ctr ZDCC, Bangkok, Thailand.; Saito, T (corresponding author), Natl Agr & Food Res Org NARO, Natl Inst Anim Hlth, Res Team Zoonot Dis, Tsukuba, Ibaraki, Japan.; Saito, T (corresponding author), Natl Agr & Food Res Org NARO, Natl Inst Anim Hlth, Influenza & Prion Dis Res Ctr, Tsukuba, Ibaraki, Japan.	taksaito@affrc.go.jp	Saito, Takehiko/AFM-3038-2022	Suzuki, Shingo/0000-0003-1880-582X; Abe, Haruka/0000-0003-0141-5059; Shiina, Takashi/0000-0002-2067-6708	Founding Research Center for Emerging and Reemerging Infectious Diseases	Founding Research Center for Emerging and Reemerging Infectious Diseases	This work was supported by a program of the Founding Research Center for Emerging and Reemerging Infectious Diseases, which was launched via a project commissioned by the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Grant number: not applicable, http://www.amed.go.jp/program/list/01/06/jgrid02.html; in Japanese) to T. Saito. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNHEITER H, 1990, New Biologist, V2, P851; Banat GR, 2013, DEV COMP IMMUNOL, V39, P430, DOI 10.1016/j.dci.2012.10.006; Benfield CTO, 2008, J VIROL, V82, P7533, DOI 10.1128/JVI.00185-08; BRILES WE, 1977, SCIENCE, V195, P193, DOI 10.1126/science.831269; Ellis TM, 2004, AVIAN PATHOL, V33, P492, DOI 10.1080/03079450400003601; Ewald SJ, 2011, IMMUNOGENETICS, V63, P363, DOI 10.1007/s00251-010-0509-1; Feng X, 2015, J VIROL; Firth AE, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120109; Gao HJ, 2015, J GEN VIROL, V96, P2036, DOI 10.1099/vir.0.000143; Grimm D, 2007, P NATL ACAD SCI USA, V104, P6806, DOI 10.1073/pnas.0701849104; Haller O, 2011, J INTERF CYTOK RES, V31, P79, DOI 10.1089/jir.2010.0076; Hayashi T, 2015, J VIROL, V89, P6442, DOI 10.1128/JVI.00319-15; Hayashi T, 2011, VIROLOGY, V412, P9, DOI 10.1016/j.virol.2010.12.040; Hillel J, 2003, GENET SEL EVOL, V35, P533, DOI [10.1051/gse:2003038, 10.1186/1297-9686-35-6-533]; Hosomichi K, 2008, J IMMUNOL, V181, P3393, DOI 10.4049/jimmunol.181.5.3393; Hovanessian AG, 2007, CYTOKINE GROWTH F R, V18, P351, DOI 10.1016/j.cytogfr.2007.06.003; Hu J, 2015, J VIROL, V89, P4126, DOI 10.1128/JVI.02132-14; Hui RK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0111771; Hunt HD, 2010, AVIAN DIS, V54, P572, DOI 10.1637/8888-042409-ResNote.1; Jagger BW, 2012, SCIENCE, V337, P199, DOI 10.1126/science.1222213; Jiao PR, 2008, J VIROL, V82, P1146, DOI 10.1128/JVI.01698-07; Kalaya B, 2006, J POULT SCI, V43, P120; Kamal RP, 2015, J VIROL, V89, P5835, DOI 10.1128/JVI.03137-14; Karpala AJ, 2011, J INTERF CYTOK RES, V31, P393, DOI 10.1089/jir.2010.0069; Ko JH, 2004, JPN J VET RES, V51, P123; Ko JH, 2004, ANIM GENET, V35, P119, DOI 10.1111/j.1365-2052.2004.01096.x; Ko JH, 2002, GENOME RES, V12, P595, DOI 10.1101/gr.210702. Article published online before print in March ; Kuchipudi SV, 2014, VET RES, V45, DOI 10.1186/s13567-014-0118-3; Lamont SJ, 1998, POULTRY SCI, V77, P1111, DOI 10.1093/ps/77.8.1111; Lee SH, 2002, GENOME RES, V12, P527, DOI 10.1101/gr.20102; Lima-Rosa CAV, 2004, ANIM GENET, V35, P278, DOI 10.1111/j.1365-2052.2004.01160.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long JS, 2013, J VIROL, V87, P9983, DOI 10.1128/JVI.01399-13; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Nao N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137989; OIE, UPD HIGHL PATH AV IN; Rajagopal R, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-25; REED L. J., 1938, AMER JOUR HYG, V27, P493; SCHUMACHER B, 1994, VIROLOGY, V203, P144, DOI 10.1006/viro.1994.1464; Silva MC, 2009, J MOL EVOL, V68, P279, DOI 10.1007/s00239-009-9200-2; Sironi L, 2008, VIROLOGY, V380, P152, DOI 10.1016/j.virol.2008.07.022; Sironi Laura, 2011, BMC Proc, V5 Suppl 4, pS25, DOI 10.1186/1753-6561-5-S4-S25; Spickler AR, 2008, AVIAN PATHOL, V37, P555, DOI 10.1080/03079450802499118; STAEHELI P, 1986, CELL, V44, P147, DOI 10.1016/0092-8674(86)90493-9; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Suzuki K, 2009, J VIROL, V83, P7475, DOI 10.1128/JVI.01434-08; Suzuki Y, 2014, J VIROL, V88, P11130, DOI 10.1128/JVI.01564-14; Uchida Y, 2008, VIRUS RES, V138, P70, DOI 10.1016/j.virusres.2008.08.007; Wallny HJ, 2006, P NATL ACAD SCI USA, V103, P1434, DOI 10.1073/pnas.0507386103; Wasilenko JL, 2009, ARCH VIROL, V154, P969, DOI 10.1007/s00705-009-0399-4; Watanabe C, 2011, VET IMMUNOL IMMUNOP, V144, P187, DOI 10.1016/j.vetimm.2011.10.002; Watanabe T, 2007, CYTOGENET GENOME RES, V117, P370, DOI 10.1159/000103200; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820; Zhu WF, 2015, SCI REP-UK, V5, DOI 10.1038/srep14170	54	22	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153649	10.1371/journal.pone.0153649	http://dx.doi.org/10.1371/journal.pone.0153649			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078641	Green Submitted, gold, Green Published			2022-12-26	WOS:000374131700100
J	Norton, N; Advani, PP; Serie, DJ; Geiger, XJ; Necela, BM; Axenfeld, BC; Kachergus, JM; Feathers, RW; Carr, JM; Crook, JE; Moreno-Aspitia, A; Anastasiadis, PZ; Perez, EA; Thompson, EA				Norton, Nadine; Advani, Pooja P.; Serie, Daniel J.; Geiger, Xochiquetzal J.; Necela, Brian M.; Axenfeld, Bianca C.; Kachergus, Jennifer M.; Feathers, Ryan W.; Carr, Jennifer M.; Crook, Julia E.; Moreno-Aspitia, Alvaro; Anastasiadis, Panos Z.; Perez, Edith A.; Thompson, E. Aubrey			Assessment of Tumor Heterogeneity, as Evidenced by Gene Expression Profiles, Pathway Activation, and Gene Copy Number, in Patients with Multifocal Invasive Lobular Breast Tumors	PLOS ONE			English	Article							E-CADHERIN; CONSERVING THERAPY; DUCTAL CARCINOMA; CANCER SUBTYPES; RECEPTOR; METASTASIS; RECURRENCE; DISCRIMINATION; SUPPRESSION; PROGRESSION	Background Invasive lobular carcinoma (ILC) comprises approximately similar to 10-20% of breast cancers. In general, multifocal/multicentric (MF/MC) breast cancer has been associated with an increased rate of regional lymph node metastases. Tumor heterogeneity between foci represents a largely unstudied source of genomic variation in those rare patients with MF/MC ILC. Methods We characterized gene expression and copy number in 2 or more foci from 11 patients with MF/MC ILC (all ER+, HER2-) and adjacent normal tissue. RNA and DNA were extracted from 3x1.5mm cores from all foci. Gene expression (730 genes) and copy number (80 genes) were measured using Nanostring PanCancer and Cancer CNV panels. Linear mixed models were employed to compare expression in tumor versus normal samples from the same patient, and to assess heterogeneity (variability) in expression among multiple ILC within an individual. Results 35 and 34 genes were upregulated (FC>2) and down-regulated (FC<0.5) respectively in ILC tumor relative to adjacent normal tissue, q<0.05. 9/34 down-regulated genes (FIGF, RELN, PROM1, SFRP1, MMP7, NTRK2, LAMB3, SPRY2, KIT) had changes larger than CDH1, a hallmark of ILC. Copy number changes in these patients were relatively few but consistent across foci within each patient. Amplification of three genes (CCND1, FADD, ORAOV1) at 11q13.3 was present in 2/11 patients in both foci. We observed significant evidence of within-patient between-foci variability (heterogeneity) in gene expression for 466 genes (p<0.05 with FDR 8%), including CDH1, FIGF, RELN, SFRP1, MMP7, NTRK2, LAMB3, SPRY2 and KIT. Conclusions There was substantial variation in gene expression between ILC foci within patients, including known markers of ILC, suggesting an additional level of complexity that should be addressed.	[Norton, Nadine; Necela, Brian M.; Axenfeld, Bianca C.; Kachergus, Jennifer M.; Feathers, Ryan W.; Carr, Jennifer M.; Anastasiadis, Panos Z.; Thompson, E. Aubrey] Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA; [Advani, Pooja P.; Moreno-Aspitia, Alvaro; Perez, Edith A.] Mayo Clin, Div Hematol Oncol, Jacksonville, FL 32224 USA; [Serie, Daniel J.; Crook, Julia E.] Mayo Clin, Dept Hlth Sci Res, Jacksonville, FL 32224 USA; [Geiger, Xochiquetzal J.] Mayo Clin, Dept Lab Med & Pathol, Jacksonville, FL 32224 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Thompson, EA (corresponding author), Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA.	Thompson.aubrey@mayo.edu			Mayo Clinic Cancer Focus Research Team; 26.2 with Donna Foundation; Serene M. and Frances C. Durling endowment	Mayo Clinic Cancer Focus Research Team; 26.2 with Donna Foundation; Serene M. and Frances C. Durling endowment	This study was funded by Mayo Clinic Cancer Focus Research Team (AMA), the 26.2 with Donna Foundation (EAP) and the Serene M. and Frances C. Durling endowment (EAP).; This study was funded by Mayo Clinic Cancer Focus Research Team, the 26.2 with Donna Foundation and the Serene M. and Frances C. Durling endowment.	Acerbi I, 2015, INTEGR BIOL-UK, V7, P1120, DOI 10.1039/c5ib00040h; Alizadeh AA, 2015, NAT MED, V21, P846, DOI 10.1038/nm.3915; Andl CD, 2005, CANCER BIOL THER, V4, P28, DOI 10.4161/cbt.4.1.1431; Arpino G, 2004, BREAST CANCER RES, V6, pR149, DOI 10.1186/bcr767; Arvold ND, 2011, J CLIN ONCOL, V29, P3885, DOI 10.1200/JCO.2011.36.1105; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cabioglu N, 2009, J AM COLL SURGEONS, V208, P67, DOI 10.1016/j.jamcollsurg.2008.09.001; Choi EJ, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-137; Choi Y, 2012, HUM PATHOL, V43, P48, DOI 10.1016/j.humpath.2010.08.026; Chua B, 2001, ANZ J SURG, V71, P723, DOI 10.1046/j.1445-1433.2001.02266.x; Chung AP, 2012, J AM COLL SURGEONS, V215, P137, DOI 10.1016/j.jamcollsurg.2012.05.006; Coombs NJ, 2005, J CLIN ONCOL, V23, P7497, DOI 10.1200/JCO.2005.02.1147; Courjal F, 1997, CANCER RES, V57, P4360; Dabbs DJ, 2013, AM J SURG PATHOL, V37, pE1, DOI 10.1097/PAS.0b013e3182918a2b; Desmedt C, 2015, J PATHOL, V236, P457, DOI 10.1002/path.4540; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Geiger TR, 2007, CANCER RES, V67, P6221, DOI 10.1158/0008-5472.CAN-07-0121; Ghazani AA, 2007, NEOPLASIA, V9, P511, DOI 10.1593/neo.07301; Gruel N, 2010, EUR J CANCER, V46, P2399, DOI 10.1016/j.ejca.2010.05.013; Hirsch E, 2014, ONCOGENE, V33, P3083, DOI 10.1038/onc.2013.265; HOLM S, 1979, SCAND J STAT, V6, P65; Iyengar P, 2005, J CLIN INVEST, V115, P1163, DOI 10.1172/JCI200523424; Korkola JE, 2003, CANCER RES, V63, P7167; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo TL, 2004, CANCER RES, V64, P6127, DOI 10.1158/0008-5472.CAN-04-1207; Metzger O, 2013, J CLIN ONCOL, V31, P3083, DOI 10.1200/JCO.2012.46.1574; NOGUCHI S, 1994, CANCER, V74, P872, DOI 10.1002/1097-0142(19940801)74:3<872::AID-CNCR2820740313>3.0.CO;2-P; Noorlag R, 2015, VIRCHOWS ARCH, V466, P363, DOI 10.1007/s00428-015-1719-6; Norton N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081925; Oyama T, 1998, CANCER RES, V58, P2876; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pekar G, 2013, CANCER-AM CANCER SOC, V119, P1132, DOI 10.1002/cncr.27877; PETERS G, 1995, BREAST CANCER RES TR, V33, P125, DOI 10.1007/BF00682720; Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11; Qian XL, 2004, EMBO J, V23, P1739, DOI 10.1038/sj.emboj.7600136; Reed AEM, 2013, VIRCHOWS ARCH, V463, P535, DOI 10.1007/s00428-013-1468-3; Rezo A, 2011, BREAST, V20, P259, DOI 10.1016/j.breast.2011.01.005; Shields MA, 2011, J BIOL CHEM, V286, P10495, DOI 10.1074/jbc.M110.195628; TEIXEIRA MR, 1994, BRIT J CANCER, V70, P922, DOI 10.1038/bjc.1994.421; Teixeira MR, 1997, GENE CHROMOSOME CANC, V18, P170, DOI 10.1002/(SICI)1098-2264(199703)18:3<170::AID-GCC3>3.0.CO;2-Z; Turashvili G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-55; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Viale G, 2009, BREAST CANCER RES TR, V117, P211, DOI 10.1007/s10549-008-0112-4; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Weigelt B, 2008, J PATHOL, V216, P141, DOI 10.1002/path.2407; Wolters R, 2013, BREAST CANCER RES TR, V142, P579, DOI 10.1007/s10549-013-2772-y; Yates LR, 2015, NAT MED, V21, P751, DOI 10.1038/nm.3886	48	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153411	10.1371/journal.pone.0153411	http://dx.doi.org/10.1371/journal.pone.0153411			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078887	Green Submitted, Green Published, gold			2022-12-26	WOS:000374131700052
J	Wu, CH; Tung, YC; Lin, TK; Chai, CY; Su, YF; Tsai, TH; Tsai, CY; Lu, YY; Lin, CL				Wu, Chieh-Hsin; Tung, Yi-Ching; Lin, Tzu-Kang; Chai, Chee-Yin; Su, Yu-Feng; Tsai, Tai-Hsin; Tsai, Cheng-Yu; Lu, Ying-Yi; Lin, Chih-Lung			Hip Fracture in People with Erectile Dysfunction: A Nationwide Population-Based Cohort Study	PLOS ONE			English	Article							BONE-MINERAL DENSITY; INCREASED RISK; CARDIOVASCULAR-DISEASES; COGNITIVE FUNCTION; MEN; DEPRESSION; PREVALENCE; TESTOSTERONE; METAANALYSIS; ASSOCIATION	The aims of this study were to investigate the risk of hip fracture and contributing factors in patients with erectile dysfunction(ED). This population-based study was performed using the Taiwan National Health Insurance Research Database. The analysis included4636 patients aged >= 40 years who had been diagnosed with ED (International Classification of Diseases, Ninth Revision, Clinical Modification codes 302.72, 607.84) during 1996-2010. The control group included 18,544 randomly selected age-matched patients without ED (1: 4 ratio). The association between ED and hip fracture risk was estimated using a Cox proportional hazard regression model. During the follow-up period, 59 (1.27%) patients in the ED group and 140 (0.75%) patients in the non-ED group developed hip fracture. After adjusting for covariates, the overall incidence of hip fracture was 3.74-times higher in the ED group than in the non-ED group (2.03 vs. 0.50 per 1000 person-years, respectively). The difference in the overall incidence of hip fracture was largest during the 3-year follow-up period (hazard ratio = 7.85; 95% confidence interval = 2.94-20.96; P < 0.0001). To the best of our knowledge, this nationwide population-based study is the first to investigate the relationship between ED and subsequent hip fracture in an Asian population. The results showed that ED patients had a higher risk of developing hip fracture. Patients with ED, particularly those aged 40-59 years, should undergo bone mineral density examinations as early as possible and should take measures to reduce the risk of falls.	[Wu, Chieh-Hsin; Chai, Chee-Yin; Lu, Ying-Yi; Lin, Chih-Lung] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Wu, Chieh-Hsin; Su, Yu-Feng; Tsai, Tai-Hsin; Lin, Chih-Lung] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Neurosurg, Kaohsiung, Taiwan; [Tung, Yi-Ching] Kaohsiung Med Univ, Dept Publ Hlth & Environm Med, Coll Med, Kaohsiung, Taiwan; [Lin, Tzu-Kang] Chang Gung Univ, Chang Gung Mem Hosp Linkou, Dept Neurosurg, Taoyuan, Taiwan; [Chai, Chee-Yin] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Pathol, Kaohsiung, Taiwan; [Chai, Chee-Yin] Kaohsiung Med Univ, Dept Pathol, Coll Med, Fac Med, Kaohsiung, Taiwan; [Chai, Chee-Yin] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 80424, Taiwan; [Lu, Ying-Yi] Kaohsiung Vet Gen Hosp, Dept Dermatol, Kaohsiung, Taiwan; [Lu, Ying-Yi] Yuh Ing Jr Coll Hlth Care & Management, Cosmet Applicat & Management Dept, Kaohsiung, Taiwan; [Lin, Chih-Lung] Kaohsiung Med Univ, Dept Neurosurg, Coll Med, Fac Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Chang Gung Memorial Hospital; Chang Gung University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; National Sun Yat Sen University; Kaohsiung Veterans General Hospital; Kaohsiung Medical University	Lu, YY; Lin, CL (corresponding author), Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan.; Lin, CL (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Neurosurg, Kaohsiung, Taiwan.; Lu, YY (corresponding author), Kaohsiung Vet Gen Hosp, Dept Dermatol, Kaohsiung, Taiwan.; Lu, YY (corresponding author), Yuh Ing Jr Coll Hlth Care & Management, Cosmet Applicat & Management Dept, Kaohsiung, Taiwan.; Lin, CL (corresponding author), Kaohsiung Med Univ, Dept Neurosurg, Coll Med, Fac Med, Kaohsiung, Taiwan.	actinpactinp@yahoo.com.tw; chihlung1@yahoo.com	MPRAH, ANDY/J-5558-2016; Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Chai, Chee-Yin/0000-0003-0486-9742; Su, Yu-feng/0000-0003-0355-3981				Autier P, 2000, OSTEOPOROSIS INT, V11, P373, DOI 10.1007/s001980070102; Aytac IA, 1999, BJU INT, V84, P50; Barassi A, 2014, J SEX MED, V11, P2792, DOI 10.1111/jsm.12661; Barron Anna M, 2012, Front Biosci (Elite Ed), V4, P976, DOI 10.2741/E434; Billups KL, 2008, INT J IMPOT RES, V20, P236, DOI 10.1038/sj.ijir.3901634; Blanker MH, 2001, J AM GERIATR SOC, V49, P436, DOI 10.1046/j.1532-5415.2001.49088.x; Chao CH, 2015, ANDROLOGY-US, V3, P666, DOI 10.1111/andr.12052; Chou PS, 2015, J SEX MED, V12, P804, DOI 10.1111/jsm.12792; Chun J, 2001, UROL CLIN N AM, V28, P249, DOI 10.1016/S0094-0143(05)70135-X; Chung SD, 2011, J SEX MED, V8, P240, DOI 10.1111/j.1743-6109.2010.01973.x; COOPER C, 1992, OSTEOPOROSIS INT, V2, P285, DOI 10.1007/BF01623184; Corsonello A, 2011, CURR OPIN PULM MED, V17, pS21, DOI 10.1097/01.mcp.0000410744.75216.d0; Diem SJ, 2013, OSTEOPOROSIS INT, V24, P111, DOI 10.1007/s00198-012-1975-0; Frost M, 2012, OSTEOPOROSIS INT, V23, P521, DOI 10.1007/s00198-011-1575-4; Gandaglia G, 2014, EUR UROL, V65, P968, DOI 10.1016/j.eururo.2013.08.023; Gao X, 2007, AM J EPIDEMIOL, V166, P1446, DOI 10.1093/aje/kwm246; Giuliano FA, 2004, UROLOGY, V64, P1196, DOI 10.1016/j.urology.2004.08.059; Huang CY, 2012, CEPHALALGIA, V32, P366, DOI 10.1177/0333102412439801; Jacka FN, 2005, MENOPAUSE, V12, P88, DOI 10.1097/00042192-200512010-00015; Keller JJ, 2012, J SEX MED, V9, P1745, DOI 10.1111/j.1743-6109.2012.02736.x; Keller JJ, 2012, ANN RHEUM DIS, V71, P1102, DOI 10.1136/annrheumdis-2011-200890; Koseoglu N, 2005, J UROLOGY, V174, P249, DOI 10.1097/01.ju.0000163259.33846.74; Kronzon I, 2006, CIRCULATION, V114, P63, DOI 10.1161/CIRCULATIONAHA.105.593418; Lai SW, 2013, J EPIDEMIOL, V23, P109, DOI 10.2188/jea.JE20120071; Martinez-Reig M, 2012, J AM MED DIR ASSOC, V13, P770, DOI 10.1016/j.jamda.2012.07.011; McFarlane Samy I, 2006, J Cardiometab Syndr, V1, P53, DOI 10.1111/j.0197-3118.2006.05457.x; McFarlane SI, 2004, ENDOCRINE, V23, P1, DOI 10.1385/ENDO:23:1:01; Michelson D, 1996, NEW ENGL J MED, V335, P1176, DOI 10.1056/NEJM199610173351602; Moore CS, 2014, PSYCHOL AGING, V29, P163, DOI 10.1037/a0035463; Mourikis I, 2015, ANN GEN PSYCHIATR, V14, DOI 10.1186/s12991-015-0074-y; Muneer A, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g129; Nagai K, 2012, J AM GERIATR SOC, V60, P1188, DOI 10.1111/j.1532-5415.2012.03982.x; Nazir A, 2012, J AM MED DIR ASSOC, V13, DOI 10.1016/j.jamda.2012.07.018; Nordstrom P, 2012, J BONE MINER RES, V27, P2291, DOI 10.1002/jbmr.1683; Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530; Pastuszak Alexander W, 2014, Curr Sex Health Rep, V6, P164; Polonsky TS, 2009, ATHEROSCLEROSIS, V207, P440, DOI 10.1016/j.atherosclerosis.2009.05.005; Rhoden EL, 2002, INT J IMPOT RES, V14, P245, DOI 10.1038/sj.ijir.3900859; Rosen RC, 2001, UROL CLIN N AM, V28, P269, DOI 10.1016/S0094-0143(05)70137-3; SCHWEIGER U, 1994, AM J PSYCHIAT, V151, P1691; Seftel AD, 2004, J UROLOGY, V171, P2341, DOI 10.1097/01.ju.0000125198.32936.38; Sennerby U, 2007, OSTEOPOROSIS INT, V18, P1355, DOI 10.1007/s00198-007-0386-0; Sennerby U, 2009, JAMA-J AM MED ASSOC, V302, P1666, DOI 10.1001/jama.2009.1463; Shabsigh R, 2008, INT J CLIN PRACT, V62, P791, DOI 10.1111/j.1742-1241.2008.01696.x; Shen TC, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000448; Solomon H, 2003, HEART, V89, P251, DOI 10.1136/heart.89.3.251; Tang ZY, 2014, BMC UROL, V14, DOI 10.1186/1471-2490-14-52; Vlachopoulos CV, 2013, CIRC-CARDIOVASC QUAL, V6, P99, DOI 10.1161/CIRCOUTCOMES.112.966903; Whitney J, 2012, J AM MED DIR ASSOC, V13, P535, DOI 10.1016/j.jamda.2012.03.009; Wittert G, 2014, ASIAN J ANDROL, V16, P262, DOI 10.4103/1008-682X.122586; Wong SYS, 2005, OSTEOPOROSIS INT, V16, P610, DOI 10.1007/s00198-004-1730-2; Yang CM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000990	52	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153467	10.1371/journal.pone.0153467	http://dx.doi.org/10.1371/journal.pone.0153467			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UH	27078254	Green Published, gold, Green Submitted			2022-12-26	WOS:000374131700059
J	Ojji, DB; Lecour, S; Atherton, JJ; Blauwet, LA; Alfa, J; Sliwa, K				Ojji, Dike B.; Lecour, Sandrine; Atherton, John J.; Blauwet, Lori A.; Alfa, Jacob; Sliwa, Karen			Right Ventricular Systolic Dysfunction Is Common in Hypertensive Heart Failure: A Prospective Study in Sub-Saharan Africa	PLOS ONE			English	Article							LONG-TERM MORTALITY; ECHOCARDIOGRAPHIC-ASSESSMENT; INDEPENDENT PREDICTOR; HYPERTROPHY; SURVIVAL; ADULTS; SOWETO	Introduction Right ventricular (RV) systolic dysfunction is now recognized widely as a strong and independent predictor of adverse outcomes in patients with heart failure (HF). Reduction of RV systolic function more closely predicts impaired exercise tolerance and poor survival than does left ventricular (LV) systolic function. In spite of this, there is a dearth of data on RV function in hypertensive HF which is the commonest form of HF in sub-Saharan Africa. We therefore conducted a prospective cohort study of hypertensive HF patients presenting to the University of Abuja Teaching Hospital, Abuja, Nigeria over an 8 year period. Methods Each subject had transthoracic echocardiography performed on them according to the guidelines of American Society of Echocardiography. RV systolic function was defined as a tricuspid annular plane systolic excursion (TAPSE) <15mm using M-mode echocardiography. Results RV systolic dysfunction was identified in 272 (44.5%) of the 611 subjects that were studied. Subjects with TAPSE less than 15mm had worse prognosis compared to those with TAPSE >= 15mm. There was a significant correlation between TAPSE and other adverse prognostic markers including left and right atrial area, LV size, LV mass, LV ejection fraction, restrictive mitral inflow and RV systolic pressure (RVSP). However, LV ejection fraction and right atrial area were the only independent determinants of RV systolic dysfunction. Conclusions Hypertensive HF is a major cause of RV systolic dysfunction even in a population with a low prevalence of coronary artery disease, and RV systolic dysfunction is associated with poor prognosis in hypertensive HF. Detailed assessment of RV function should therefore be part of the echocardiography evaluation of patients with hypertensive HF.	[Ojji, Dike B.; Alfa, Jacob] Univ Abuja Teaching Hosp, Dept Med, Cardiol Unit, Gwagwalada, Abuja, Nigeria; [Ojji, Dike B.; Lecour, Sandrine; Sliwa, Karen] Univ Cape Town, Dept Med, Hatter Inst Cardiovasc Res Africa, Fac Hlth Sci, ZA-7925 Cape Town, South Africa; [Atherton, John J.] Royal Brisbane & Women Hosp, Dept Cardiol, Brisbane, Qld, Australia; [Atherton, John J.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Blauwet, Lori A.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA	University of Cape Town; Royal Brisbane & Women's Hospital; University of Queensland; Mayo Clinic	Ojji, DB (corresponding author), Univ Abuja Teaching Hosp, Dept Med, Cardiol Unit, Gwagwalada, Abuja, Nigeria.; Ojji, DB (corresponding author), Univ Cape Town, Dept Med, Hatter Inst Cardiovasc Res Africa, Fac Hlth Sci, ZA-7925 Cape Town, South Africa.	dikeojji@yahoo.co.uk	Atherton, John J/B-9994-2011	Atherton, John J/0000-0003-2271-578X; , sandrine/0000-0003-1942-8974				Akintunde AA, 2010, CARDIOVASC J AFR, V21, P252, DOI CVJ-21.007; [Anonymous], 1964, DIS HEART BLOOD VESS; Atherton JJ, 1997, LANCET, V349, P1720, DOI 10.1016/S0140-6736(96)05109-4; Damasceno A, 2012, ARCH INTERN MED, V172, P1386, DOI 10.1001/archinternmed.2012.3310; de Groote P, 1998, J AM COLL CARDIOL, V32, P948, DOI 10.1016/S0735-1097(98)00337-4; Devereux RB, 2001, HYPERTENSION, V38, P417, DOI 10.1161/01.HYP.38.3.417; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Dini FL, 2012, EUR J HEART FAIL, V14, P287, DOI 10.1093/eurjhf/hfr176; Drazner MH, 2005, HYPERTENSION, V46, P124, DOI 10.1161/01.HYP.0000169972.96201.8e; Field ME, 2006, J CARD FAIL, V12, P616, DOI 10.1016/j.cardfail.2006.06.472; Ghio S, 2000, AM J CARDIOL, V85, P837, DOI 10.1016/S0002-9149(99)00877-2; Ghio Stefano, 2005, Ital Heart J, V6, P852; Guglin Maya, 2012, Congest Heart Fail, V18, P278, DOI 10.1111/j.1751-7133.2012.00289.x; Isezuo A S, 2003, Afr J Med Med Sci, V32, P143; JUILLIERE Y, 1994, AM J CARDIOL, V73, P588, DOI 10.1016/0002-9149(94)90339-5; Jurcut R, 2010, EUR J ECHOCARDIOGR, V11, P81, DOI 10.1093/ejechocard/jep234; Karaye KM, 2010, CARDIOVASC J AFR, V21, P186; Kizer JR, 2004, HYPERTENSION, V43, P1182, DOI 10.1161/01.HYP.0000128738.94190.9f; Kjaergaard J, 2007, EUR J HEART FAIL, V9, P610, DOI 10.1016/j.ejheart.2007.03.001; La Gerche A, 2008, HEART, V94, P860, DOI 10.1136/hrt.2006.101063; Lopez-Candales A, 2006, AM J CARDIOL, V98, P973, DOI 10.1016/j.amjcard.2006.04.041; National High Blood Pressure Education Program, 2004, 045230 NAT HIGHBL PR; Ojji DB, 2014, J HUM HYPERTENS, V28, P432, DOI 10.1038/jhh.2013.130; Ojji D, 2015, AM J HYPERTENS, V28, P924, DOI 10.1093/ajh/hpu247; Ojji D, 2013, EUR J HEART FAIL, V15, P835, DOI 10.1093/eurjhf/hft061; Palmieri V, 1999, J AM COLL CARDIOL, V34, P1625, DOI 10.1016/S0735-1097(99)00396-4; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Shah RV, 2009, CIRC-HEART FAIL, V2, P311, DOI 10.1161/CIRCHEARTFAILURE.108.833707; Stewart S, 2011, EUR J HEART FAIL, V13, P1070, DOI 10.1093/eurjhf/hfr108; Stewart S, 2008, CIRCULATION, V118, P2360, DOI 10.1161/CIRCULATIONAHA.108.786244; Swedberg K, 2005, EUR HEART J, V26, P1115, DOI 10.1093/eurheartj/ehi204; TEICHHOLZ LE, 1976, AM J CARDIOL, V37, P7, DOI 10.1016/0002-9149(76)90491-4	32	8	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153479	10.1371/journal.pone.0153479	http://dx.doi.org/10.1371/journal.pone.0153479			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073856	Green Published, gold, Green Submitted			2022-12-26	WOS:000374131200098
J	King, AJ; Sonsma, JA; Vriend, HJ; van der Sande, MAB; Feltkamp, MC; Boot, HJ; Koopmans, MPG				King, Audrey J.; Sonsma, Jan A.; Vriend, Henrike J.; van der Sande, Marianne A. B.; Feltkamp, Mariet C.; Boot, Hein J.; Koopmans, Marion P. G.		Med Microbiological Labs Municipal	Genetic Diversity in the Major Capsid L1 Protein of HPV-16 and HPV-18 in the Netherlands	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; VARIANTS; RISK; POLYMORPHISM; PERSISTENCE; INFECTIONS; WOMEN	Objectives Intratypic molecular variants of human papillomavirus (HPV) type-16 and -18 exist. In the Netherlands, a bivalent vaccine, composed of recombinant L1 proteins from HPV-16 and -18, is used to prevent cervical cancer since 2009. Long-term vaccination could lead to changes in HPV-16 and -18 virus population, thereby hampering vaccination strategies. We determined the genetic diversity of the L1 gene in HPV-16 and -18 viral strains circulating in the Netherlands at the start of vaccination in order to understand the baseline genetic diversity in the Dutch population. Methods DNA sequences of the L1 gene were determined in HPV-16 (n = 241) and HPV-18 (n = 108) positive anogenital samples collected in 2009 and 2011 among Dutch 16-to 24-year old female and male attendees of the sexually transmitted infection (STI) clinics. Phylogenetic analysis was performed and sequences were compared to reference sequences HPV-16 (AF536179) and HPV-18 (X05015) using BioNumerics 7.1. Results For HPV-16, ninety-five single nucleotide polymorphism (SNPs) were identified, twentyseven (28%) were non-synonymous variations. For HPV-18, seventy-one SNPs were identified, twenty-nine (41%) were non-synonymous. The majority of the non-silent variations were located in sequences encoding alpha helix, beta sheet or surface loops, in particular in the immunodominant FG loop, and may influence the protein secondary structure and immune recognition. Conclusions This study provides unique pre-vaccination/baseline data on the genetic L1 diversity of HPV-16 and - 18 viruses circulating in the Netherlands among adolescents and young adults.	[King, Audrey J.; Sonsma, Jan A.; Vriend, Henrike J.; van der Sande, Marianne A. B.; Boot, Hein J.; Koopmans, Marion P. G.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands; [van der Sande, Marianne A. B.] Univ Med Ctr, Julius Ctr Primary Care & Publ Hlth, Utrecht, Netherlands; [Feltkamp, Mariet C.] Leiden Univ, Med Ctr, Dept Med Microbiol, Leiden, Netherlands	Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	King, AJ (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands.	audrey.king@rivm.nl	Koopmans, Marion/Y-9170-2019; Feltkamp, Mariet/A-3788-2010	Koopmans, Marion/0000-0002-5204-2312; Feltkamp, Mariet/0000-0001-5993-9846; van der Sande, Marianne AB/0000-0002-4778-6739	Ministry of Health, Welfare and Sport, the Netherlands	Ministry of Health, Welfare and Sport, the Netherlands	This work was supported by the Ministry of Health, Welfare and Sport, the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard HU, 2006, INT J CANCER, V118, P1071, DOI 10.1002/ijc.21655; Bishop B, 2007, J BIOL CHEM, V282, P31803, DOI 10.1074/jbc.M706380200; Burk RD, 2003, CANCER RES, V63, P7215; Burk RD, 2013, VIROLOGY, V445, P232, DOI 10.1016/j.virol.2013.07.018; Chen ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072565; Christensen ND, 1996, VIROLOGY, V223, P174, DOI 10.1006/viro.1996.0466; Cornet I, 2013, INFECT AGENTS CANCER, V8, DOI 10.1186/1750-9378-8-4; Cornut G, 2010, J MED VIROL, V82, P1168, DOI 10.1002/jmv.21777; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Frati E, 2011, INFECT GENET EVOL, V11, P2119, DOI 10.1016/j.meegid.2011.06.014; Gagnon S, 2007, JAIDS-J ACQ IMM DEF, V44, P61, DOI 10.1097/01.qai.0000247226.45375.01; HO L, 1993, J VIROL, V67, P6413, DOI 10.1128/JVI.67.11.6413-6423.1993; KORBER B, 2000, COMPUTATIONAL ANAL H, P55, DOI DOI 10.1007/B112102; Malagon T, 2012, LANCET INFECT DIS, V12, P781, DOI 10.1016/S1473-3099(12)70187-1; Mollers M, 2013, VACCINE, V31, P394, DOI 10.1016/j.vaccine.2012.10.087; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; NEI M, 1986, MOL BIOL EVOL, V3, P418; Pastrana DV, 2001, VIROLOGY, V279, P361, DOI 10.1006/viro.2000.0702; Rector A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r57; Roden RBS, 1997, J VIROL, V71, P6247, DOI 10.1128/JVI.71.8.6247-6252.1997; Schiffman M, 2010, OBSTET GYNECOL, V116, P177, DOI 10.1097/AOG.0b013e3181e4629f; Stewart ACM, 1996, J VIROL, V70, P3127, DOI 10.1128/JVI.70.5.3127-3136.1996; Varsani A, 2006, VIRUS RES, V122, P154, DOI 10.1016/j.virusres.2006.07.012; Villa LL, 2000, J GEN VIROL, V81, P2959, DOI 10.1099/0022-1317-81-12-2959; Vriend HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060696; Vriend HJ, 2012, SEX TRANSM DIS, V39, P72, DOI 10.1097/OLQ.0b013e318235b3b0; Xi LF, 2007, CANCER EPIDEM BIOMAR, V16, P4, DOI 10.1158/1055-9965.EPI-06-0670; Xi LF, 2006, J NATL CANCER I, V98, P1045, DOI 10.1093/jnci/djj297; Yue YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055204	29	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0152782	10.1371/journal.pone.0152782	http://dx.doi.org/10.1371/journal.pone.0152782			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070907	Green Published, gold, Green Submitted			2022-12-26	WOS:000373900700016
J	Hoeksema, MA; Laan, LC; Postma, JJ; Cummings, RD; de Winther, MPJ; Dijkstra, CD; van Die, I; Kooij, G				Hoeksema, Marten A.; Laan, Lisa C.; Postma, Juliette J.; Cummings, Richard D.; de Winther, Menno P. J.; Dijkstra, Christine D.; van Die, Irma; Kooij, Gijs			Treatment with Trichuris suis soluble products during monocyte-to-macrophage differentiation reduces inflammatory responses through epigenetic remodeling	FASEB JOURNAL			English	Article						helminth; multiple sclerosis; autoimmunity; TNF; IL-10	MATRIX METALLOPROTEINASES; MULTIPLE-SCLEROSIS; HELMINTH THERAPY; BOWEL-DISEASE; POLARIZATION; ACTIVATION; COLITIS; EXPRESSION; INFECTION; PROTEINS	Helminths have strong immunoregulatory properties that may be exploited in treatment of chronic immune disorders, such as multiple sclerosis and inflammatory bowel disease. Essential players in the pathogenesis of these diseases are proinflammatory macrophages. We present evidence that helminths modulate the function and phenotype of these innate immune cells. We found that soluble products derived from the Trichuris suis (TsSP) significantly affect the differentiation of monocytes into macrophages and their subsequent polarization. TsSPs reduce the expression and production of inflammatory cytokines, including IL-6 and TNF, in human proinflammatory M1 macrophages. TsSPs induce a concomitant anti-inflammatory M2 signature, with increased IL-10 production. Furthermore, they suppress CHIT activity and enhance secretion of matrix metalloproteinase 9. Shortterm triggering of monocytes with TsSPs early during monocyte-to-macrophage differentiation imprinted these phenotypic alterations, suggesting long-lasting epigenetic changes. The TsSP-induced effects in M1 macrophages were completely reversed by inhibiting histone deacetylases, which corresponded with decreased histone acetylation at the TNF and IL6 promoters. These results demonstrate that TsSPs have a potent and sustained immunomodulatory effect on human macrophage differentiation and polarization through epigenetic remodeling and provide new insights into the mechanisms by which helminths modulate human immune responses.	[Hoeksema, Marten A.; de Winther, Menno P. J.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1012 WX Amsterdam, Netherlands; [Laan, Lisa C.; Postma, Juliette J.; Dijkstra, Christine D.; van Die, Irma; Kooij, Gijs] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, Neurosci Campus Amsterdam, Amsterdam, Netherlands; [Cummings, Richard D.] Harvard Med Sch, Natl Ctr Funct Glyc, Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA USA	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Kooij, G (corresponding author), Vrije Univ Amsterdam, Med Ctr, VUmc MS Ctr Amsterdam, Dept Mol Cell Biol & Immunol, Neurosci Campus Amsterdam,OI2 Bldg,Room 11E41, NL-1007 MB Amsterdam, Netherlands.	g.kooij@vumc.nl	Kooij, Gijs/AAA-4268-2020	de Winther, Menno/0000-0002-4038-6636; Hoeksema, Marten/0000-0001-5981-121X; Kooij, Gijs/0000-0002-9488-2918	Dutch Multiple Sclerosis Research Foundation [MS11-771]; U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases Grant [AI101982]; Netherlands Heart Foundation [2007T067, 2010B022]; NWO Grant [TOP91208001]; Netherlands Cardiovascular Research Initiative Grant [CVON2011-19]; European Union Grant Horizon2020 ITN (EPIMAC); Academisch Medisch Centrum (AMC) fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101982] Funding Source: NIH RePORTER	Dutch Multiple Sclerosis Research Foundation; U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases Grant; Netherlands Heart Foundation(Netherlands Heart Foundation); NWO Grant; Netherlands Cardiovascular Research Initiative Grant; European Union Grant Horizon2020 ITN (EPIMAC); Academisch Medisch Centrum (AMC) fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank Dr. Helene Kringel (University of Copenhagen, Copenhagen, Denmark) for providing the Trichuris suis worms. This work was supported by Dutch Multiple Sclerosis Research Foundation Grant MS11-771 (to I.vD.), and by U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases Grant AI101982 (to R.D.C.). M.P.J.D.W. is an established investigator of the Netherlands Heart Foundation (2007T067), supported by Netherlands Heart Foundation Grant 2010B022, NWO Grant TOP91208001, Netherlands Cardiovascular Research Initiative Grant CVON2011-19 (GENIUS), and European Union Grant Horizon2020 ITN (EPIMAC), and holds an Academisch Medisch Centrum (AMC) fellowship. The authors declare no conflicts of interest.	Alvarez-Errico D, 2015, NAT REV IMMUNOL, V15, P7, DOI 10.1038/nri3777; Avolio C, 2003, J NEUROIMMUNOL, V136, P46, DOI 10.1016/S0165-5728(03)00006-7; Bogie JFJ, 2014, ACTA NEUROPATHOL, V128, P191, DOI 10.1007/s00401-014-1310-2; Comabella M, 2010, BRAIN, V133, P1082, DOI 10.1093/brain/awq035; Correale J, 2011, MULT SCLER J, V17, P521, DOI 10.1177/1352458510392619; Donnelly S, 2005, INFECT IMMUN, V73, P166, DOI 10.1128/IAI.73.1.166-173.2005; Donnelly S, 2008, FASEB J, V22, P4022, DOI 10.1096/fj.08-106278; Ebner F, 2014, ALLERGY, V69, P1489, DOI 10.1111/all.12496; Elliott DE, 2012, ANN NY ACAD SCI, V1247, P83, DOI 10.1111/j.1749-6632.2011.06292.x; Faubion WA, 2013, AM J GASTROENTEROL, V108, P1891, DOI 10.1038/ajg.2013.354; Fleming JO, 2015, PARASITE IMMUNOL, V37, P277, DOI 10.1111/pim.12175; Fleming JO, 2013, INT J PARASITOL, V43, P259, DOI 10.1016/j.ijpara.2012.10.025; Fleming JO, 2011, MULT SCLER J, V17, P743, DOI 10.1177/1352458511398054; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Gao Q, 2007, INFLAMM BOWEL DIS, V13, P693, DOI 10.1002/ibd.20100; Garcia-Vallejo JJ, 2008, MOL IMMUNOL, V45, P2359, DOI 10.1016/j.molimm.2007.11.001; Garg SK, 2014, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD009400.PUB2; Gause WC, 2013, NAT REV IMMUNOL, V13, P607, DOI 10.1038/nri3476; Han SB, 2009, ARCH PHARM RES, V32, P613, DOI 10.1007/s12272-009-1418-4; Hoeksema MA, 2012, CURR ATHEROSCLER REP, V14, P254, DOI 10.1007/s11883-012-0240-5; Ivashkiv LB, 2013, TRENDS IMMUNOL, V34, P216, DOI 10.1016/j.it.2012.11.001; Klaver EJ, 2013, INT J PARASITOL, V43, P191, DOI 10.1016/j.ijpara.2012.10.021; Kooij G, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0223-1; Kreider T, 2007, CURR OPIN IMMUNOL, V19, P448, DOI 10.1016/j.coi.2007.07.002; Kuijk LM, 2012, MOL IMMUNOL, V51, P210, DOI 10.1016/j.molimm.2012.03.020; Kzhyshkowska J, 2007, BIOMARK INSIGHTS, V2, P128; Liu HC, 2013, AM J PHYSIOL-GASTR L, V304, pG793, DOI 10.1152/ajpgi.00249.2012; Maizels RM, 2014, CLIN EXP IMMUNOL, V177, P38, DOI 10.1111/cei.12353; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mizoguchi E, 2006, GASTROENTEROLOGY, V130, P398, DOI 10.1053/j.gastro.2005.12.007; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nance JP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002990; Neele AE, 2015, EUR J PHARMACOL, V763, P79, DOI 10.1016/j.ejphar.2015.03.101; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; Ottow MK, 2014, GENES IMMUN, V15, P477, DOI 10.1038/gene.2014.38; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; Ravi A, 2007, INFLAMM BOWEL DIS, V13, P97, DOI 10.1002/ibd.20011; Reyes JL, 2011, CELL IMMUNOL, V267, P77, DOI 10.1016/j.cellimm.2010.11.006; Rosenberg GA, 2009, LANCET NEUROL, V8, P205, DOI 10.1016/S1474-4422(09)70016-X; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Smith P, 2007, J IMMUNOL, V178, P4557, DOI 10.4049/jimmunol.178.7.4557; Summers RW, 2005, GASTROENTEROLOGY, V128, P825, DOI 10.1053/j.gastro.2005.01.005; Summers RW, 2005, GUT, V54, P87, DOI 10.1136/gut.2004.041749; Takeuch O, 2011, EUR J IMMUNOL, V41, P2490, DOI 10.1002/eji.201141792; Van den Bossche J, 2014, CURR OPIN LIPIDOL, V25, P367, DOI 10.1097/MOL.0000000000000109; van Stijn CMW, 2009, MOL IMMUNOL, V46, P3292, DOI 10.1016/j.molimm.2009.07.026; Vogel DYS, 2014, IMMUNOBIOLOGY, V219, P695, DOI 10.1016/j.imbio.2014.05.002; Weinstock JV, 2009, INFLAMM BOWEL DIS, V15, P128, DOI 10.1002/ibd.20633; Wolfs IMJ, 2014, FASEB J, V28, P288, DOI 10.1096/fj.13-235911; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490; Zaccone P, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/795210	56	23	23	2	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2826	2836		10.1096/fj.201600343R	http://dx.doi.org/10.1096/fj.201600343R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27095802	Green Published			2022-12-26	WOS:000380994000018
J	Holzem, KM; Vinnakota, KC; Ravikumar, VK; Madden, EJ; Ewald, GA; Dikranian, K; Beard, DA; Efimov, IR				Holzem, Katherine M.; Vinnakota, Kalyan C.; Ravikumar, Vinod K.; Madden, Eli J.; Ewald, Gregory A.; Dikranian, Krikor; Beard, Daniel A.; Efimov, Igor R.			Mitochondrial structure and function are not different between nonfailing donor and end-stage failing human hearts	FASEB JOURNAL			English	Article						oxidative respiration; electron microscopy; energy substrate; lipid droplet; perilipin 5	HUMAN SKELETAL-MUSCLE; METABOLIC GENE-EXPRESSION; PERILIPIN 5; OXIDATIVE-PHOSPHORYLATION; ULTRASTRUCTURAL FEATURES; FAILURE; MYOCARDIUM; CARDIOMYOPATHY; PROTEIN; DYSFUNCTION	During human heart failure, the balance of cardiac energy use switches from predominantly fatty acids (FAs) to glucose. We hypothesized that this substrate shift was the result of mitochondrial degeneration; therefore, we examined mitochondrial oxidation and ultrastructure in the failing human heart by using respirometry, transmission electron microscopy, and gene expression studies of demographically matched donor and failing human heart left ventricular (LV) tissues. Surprisingly, respiratory capacities for failing LV isolated mitochondria (n = 9) were not significantly diminished compared with donor LV isolated mitochondria (n = 7) for glycolysis (pyruvate + malate)- or FA (palmitoylcarnitine)-derived substrates, and mitochondrial densities, assessed via citrate synthase activity, were consistent between groups. Transmission electron microscopy images also showed no ultrastructural remodeling for failing vs. donor mitochondria; however, the fraction of lipid droplets (LDs) in direct contact with a mitochondrion was reduced, and the average distance between an LD and its nearest neigh boring mitochondrion was increased. Analysis of FA processing gene expression between donor and failing LVs revealed 0.64-fold reduced transcript levels for the mitochondrial-LD tether, perilipin 5, in the failing myocardium (P = 0.003). Thus, reduced FA use in heart failure may result from improper delivery, potentially via decreased perilipin 5 expression and mitochondrial-LD tethering, and not from intrinsic mitochondrial dysfunction.	[Ewald, Gregory A.; Dikranian, Krikor] Washington Univ, Sch Med, St Louis, MO USA; [Holzem, Katherine M.; Ravikumar, Vinod K.; Madden, Eli J.; Efimov, Igor R.] Washington Univ, Dept Biomed Engn, St Louis, MO USA; [Vinnakota, Kalyan C.; Beard, Daniel A.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Efimov, Igor R.] George Washington Univ, Washington, DC USA	Washington University (WUSTL); Washington University (WUSTL); University of Michigan System; University of Michigan; George Washington University	Efimov, IR (corresponding author), George Washington Univ, Dept Biomed Engn, 5000C Sci & Engn Hall,800 22nd St NW, Washington, DC 20052 USA.	efimov@gwu.edu	Efimov, Igor/R-5544-2017; Efimov, Igor R/B-8040-2010; Efimov, Igor R./AAJ-3234-2021; Vinnakota, Kalyan/G-4706-2010	Efimov, Igor/0000-0002-1483-5039; Efimov, Igor R/0000-0002-1483-5039; Vinnakota, Kalyan/0000-0003-2185-2213	U.S. National Institutes of Health (NIH) Clinical and Translational Science Awards program [UL1TR000448]; Richard J. Wilkinson Trust; NIH National Heart, Lung, and Blood Institute [R01HL114395, F30HL114310]; American Heart Association [12PRE12050315]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126802, R01HL114395, F30HL114310, R01HL072011] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) Clinical and Translational Science Awards program; Richard J. Wilkinson Trust; NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank the surgical teams at Barnes-Jewish Hospital and Mid-America Transplant Services for their assistance with human heart procurement, most notably Drs. Scott Silvestry and Michael Pasque. The authors recognize the Translational Cardiovascular Biobank and Repository (Washington University in St. Louis), which is supported by the U.S. National Institutes of Health (NIH) Clinical and Translational Science Awards program (Grant UL1TR000448), and the Richard J. Wilkinson Trust, for the provision of patient records. The authors also recognize the Nutrition and Obesity Research Center for the use of their Orobos Oxygraph-O2k, and the laboratories of Jan Bieschke and Jeanne Nerbonne for the use of the NanoPhotometer P-Class and 7900HT equipment, respectively. The authors thank Marlyn Levy (Washington University Department of Cell Biology and Physiology Electron Microscopy Facility) for processing samples. This work was supported by the NIH National Heart, Lung, and Blood Institute [Grants R01HL114395 and F30HL114310 (to K.H.)], and by the American Heart Association [Grant 12PRE12050315 (to K.H.)]. The authors declare no conflicts of interest.	Ahuja P, 2013, CIRCULATION, V127, P1957, DOI 10.1161/CIRCULATIONAHA.112.001219; Anson RM, 2000, J AM AGING ASSOC, V23, P199, DOI 10.1007/s11357-000-0020-y; Barrientos A, 1996, BIOCHEM BIOPH RES CO, V229, P536, DOI 10.1006/bbrc.1996.1839; BOFFOLI D, 1994, BBA-MOL BASIS DIS, V1226, P73, DOI 10.1016/0925-4439(94)90061-2; Bosma M, 2012, HISTOCHEM CELL BIOL, V137, P205, DOI 10.1007/s00418-011-0888-x; Brattelid T, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-22; CHIDSEY CA, 1966, J CLIN INVEST, V45, P40, DOI 10.1172/JCI105322; Chokshi A, 2012, CIRCULATION, V125, P2844, DOI 10.1161/CIRCULATIONAHA.111.060889; Chretien D, 1998, BIOCHEM J, V329, P249, DOI 10.1042/bj3290249; Cordero-Reyes AM, 2014, J MOL CELL CARDIOL, V68, P98, DOI 10.1016/j.yjmcc.2013.12.029; FERRANS VJ, 1972, CIRCULATION, V45, P769, DOI 10.1161/01.CIR.45.4.769; Fillmore N, 2013, BBA-MOL CELL RES, V1833, P857, DOI 10.1016/j.bbamcr.2012.08.014; Goldberg IJ, 2012, CELL METAB, V15, P805, DOI 10.1016/j.cmet.2012.04.006; Ingwall JS, 2009, CARDIOVASC RES, V81, P412, DOI 10.1093/cvr/cvn301; Jarreta D, 2000, CARDIOVASC RES, V45, P860, DOI 10.1016/S0008-6363(99)00388-0; Kuramoto K, 2012, J BIOL CHEM, V287, P23852, DOI 10.1074/jbc.M111.328708; Lemieux H, 2011, INT J BIOCHEM CELL B, V43, P1729, DOI 10.1016/j.biocel.2011.08.008; Lenaz G, 1998, BBA-BIOENERGETICS, V1366, P53, DOI 10.1016/S0005-2728(98)00120-0; LEYTON RA, 1969, AM J MED SCI, V258, P304; Marin-Garcia J, 2008, HEART FAIL REV, V13, P137, DOI 10.1007/s10741-007-9079-1; MARON BJ, 1978, PROG CARDIOVASC DIS, V21, P207, DOI 10.1016/0033-0620(78)90026-9; MARON BJ, 1975, AM J PATHOL, V79, P387; Mason RR, 2015, TRENDS ENDOCRIN MET, V26, P144, DOI 10.1016/j.tem.2015.01.005; Milger K, 2006, J CELL SCI, V119, P4678, DOI 10.1242/jcs.03280; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Ng FS, 2014, CIRC-ARRHYTHMIA ELEC, V7, P875, DOI 10.1161/CIRCEP.113.001477; Picard M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018317; Picard Martin, 2010, Aging Cell, V9, P1032, DOI 10.1111/j.1474-9726.2010.00628.x; Pollak NM, 2015, J BIOL CHEM, V290, P1295, DOI 10.1074/jbc.M114.604744; Rasmussen UF, 2003, EXP GERONTOL, V38, P877, DOI 10.1016/S0531-5565(03)00092-5; Razeghi P, 2001, CIRCULATION, V104, P2923, DOI 10.1161/hc4901.100526; Roger VL, 2013, CIRC RES, V113, P646, DOI 10.1161/CIRCRESAHA.113.300268; Rosca MG, 2008, CARDIOVASC RES, V80, P30, DOI 10.1093/cvr/cvn184; Rossi M A, 2001, Med Sci Monit, V7, P820; SABBAH HN, 1992, J MOL CELL CARDIOL, V24, P1333, DOI 10.1016/0022-2828(92)93098-5; SEKIGUCHI M, 1974, J MOL CELL CARDIOL, V6, P111, DOI 10.1016/0022-2828(74)90015-7; Sharma S, 2004, FASEB J, V18, P1692, DOI 10.1096/fj.04-2263com; Sharov VG, 1998, J MOL CELL CARDIOL, V30, P1757, DOI 10.1006/jmcc.1998.0739; Sharov VG, 2000, J MOL CELL CARDIOL, V32, P2361, DOI 10.1006/jmcc.2000.1266; Smith JR, 2008, PROTEOMICS, V8, P446, DOI 10.1002/pmic.200701009; SMITH MN, 1976, AM HEART J, V91, P563, DOI 10.1016/S0002-8703(76)80140-8; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Stride N, 2013, EUR J HEART FAIL, V15, P150, DOI 10.1093/eurjhf/hfs172; TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0; Wang H, 2013, J LIPID RES, V54, P953, DOI 10.1194/jlr.M032466; Wang H, 2011, J LIPID RES, V52, P2159, DOI 10.1194/jlr.M017939; Wang H, 2011, TRENDS ENDOCRIN MET, V22, P197, DOI 10.1016/j.tem.2011.03.008; Yagyu H, 2003, J CLIN INVEST, V111, P419, DOI [10.1172/JCI200316751, 10.1172/JCI16751]; Zick M, 2009, BBA-MOL CELL RES, V1793, P5, DOI 10.1016/j.bbamcr.2008.06.013	49	16	18	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2698	2707		10.1096/fj.201500118R	http://dx.doi.org/10.1096/fj.201500118R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27075244	Green Published, Green Submitted			2022-12-26	WOS:000380994000007
J	Camerota, M; Bollen, KA				Camerota, Marie; Bollen, Kenneth A.			Birth Weight, Birth Length, and Gestational Age as Indicators of Favorable Fetal Growth Conditions in a US Sample	PLOS ONE			English	Article							ORIGINS; RISK	The "fetal origins" hypothesis suggests that fetal conditions not only affect birth characteristics such as birth weight and gestational age, but also have lifelong health implications. Despite widespread interest in this hypothesis, few methodological advances have been proposed to improve the measurement and modeling of fetal conditions. A Statistics in Medicine paper by Bollen, Noble, and Adair examined favorable fetal growth conditions (FFGC) as a latent variable. Their study of Filipino children from Cebu provided evidence consistent with treating FFGC as a latent variable that largely mediates the effects of mother's characteristics on birth weight, birth length, and gestational age. This innovative method may have widespread utility, but only if the model applies equally well across diverse settings. Our study assesses whether the FFGC model of Cebu replicates and generalizes to a very different population of children from North Carolina (N = 705) and Pennsylvania (N = 494). Using a series of structural equation models, we find that key features of the Cebu analysis replicate and generalize while we also highlight differences between these studies. Our results support treating fetal conditions as a latent variable when researchers test the fetal origins hypothesis. In addition to contributing to the substantive literature on measuring fetal conditions, we also discuss the meaning and challenges involved in replicating prior research.	[Camerota, Marie; Bollen, Kenneth A.] Univ N Carolina, Dept Psychol & Neurosci, Chapel Hill, NC USA; [Bollen, Kenneth A.] Univ N Carolina, Dept Sociol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Camerota, M (corresponding author), Univ N Carolina, Dept Psychol & Neurosci, Chapel Hill, NC USA.	marie.camerota@unc.edu	Camerota, Marie/AAD-4789-2021	Camerota, Marie/0000-0001-8293-6467	National Institute of Child Health and Human Development [P01 HD39667]; National Institute on Drug Abuse; Eunice Kennedy Shriver National Institute of Child Health and Human Development [P01 HD031921]; Carolina Population Center and its NIH/NICHD center [P2C HD050924]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD031921, P2CHD050924] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD039667] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Carolina Population Center and its NIH/NICHD center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Support for the Family Life Project was provided by National Institute of Child Health and Human Development Grant P01 HD39667, with co-funding from the National Institute on Drug Abuse (https://www.nichd.nih.gov). Bollen acknowledges partial support from Grant P01 HD031921, "National Longitudinal Study of Adolescent to Adult Health: Wave V," from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and general support from the Carolina Population Center and its NIH/NICHD center grant (P2C HD050924). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almond D, 2011, J ECON PERSPECT, V25, P153, DOI 10.1257/jep.25.3.153; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Bollen K., 2015, SOCIAL BEHAV EC SCI, P1; Bollen KA, 1989, STRUCTURAL EQUATIONS; Bollen KA, 2013, STAT MED, V32, P2950, DOI 10.1002/sim.5771; Brandt MJ, 2014, J EXP SOC PSYCHOL, V50, P217, DOI 10.1016/j.jesp.2013.10.005; Burchinal M, 2008, PARENT-SCI PRACT, V8, P41, DOI 10.1080/15295190701830672; Caughey AB, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.02.034; Collins FS, 2014, NATURE, V505, P612, DOI 10.1038/505612a; Dill BT, 2001, BLACKWELL COMPANIONS, P197; Fabricius-Bjerre S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020595; Huxley R, 2002, LANCET, V360, P659, DOI 10.1016/S0140-6736(02)09834-3; Huxley RR, 2000, J HYPERTENS, V18, P815, DOI 10.1097/00004872-200018070-00002; Kline R.B., 2005, PRINCIPLES PRACTICE, V2, DOI DOI 10.1038/156278A0; Lederman S A, 1998, Matern Child Health J, V2, P123; Martin Joyce A, 2005, Natl Vital Stat Rep, V54, P1; Moonesinghe R, 2007, PLOS MED, V4, P218, DOI 10.1371/journal.pmed.0040028; Muthen L.K., 2020, MPLUS; Paternoster R, 1998, CRIMINOLOGY, V36, P859, DOI 10.1111/j.1745-9125.1998.tb01268.x; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; Satorra A, 2001, PSYCHOMETRIKA, V66, P507, DOI 10.1007/BF02296192; Vernon-Feagans L, 2014, FAMILY LIFE PROJECT, DOI 10.3886/ICPSR34602.v1; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886; Zhang JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064542	24	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153800	10.1371/journal.pone.0153800	http://dx.doi.org/10.1371/journal.pone.0153800			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097023	Green Published, gold, Green Submitted			2022-12-26	WOS:000374543600059
J	Yuan, SM; Nie, WC; He, F; Jia, ZW; Gao, XD				Yuan, Si-Min; Nie, Wen-Chao; He, Fei; Jia, Zhi-Wen; Gao, Xiang-Dong			Kin2, the Budding Yeast Ortholog of Animal MARK/PAR-1 Kinases, Localizes to the Sites of Polarized Growth and May Regulate Septin Organization and the Cell Wall	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; CAENORHABDITIS-ELEGANS; ACTIN CYTOSKELETON; PLASMA-MEMBRANE; FISSION YEAST; CYCLE; EXOCYTOSIS; GTPASE; FAMILY	MARK/PAR-1 protein kinases play important roles in cell polarization in animals. Kin1 and Kin2 are a pair of MARK/PAR-1 orthologs in the budding yeast Saccharomyces cerevisiae. They participate in the regulation of secretion and ER stress response. However, neither the subcellular localization of these two kinases nor whether they may have other cellular functions is clear. Here, we show that Kin2 localizes to the sites of polarized growth in addition to localization on the plasma membrane. The localization to polarity sites is mediated by two targeting domains-TD1 and TD2. TD1 locates in the N-terminal region that spans the protein kinase domain whereas TD2 locates in the C-terminal end that covers the KA1 domain. We also show that an excess of Kin2 activity impaired growth, septin organization, and chitin deposition in the cell wall. Both TD1 and TD2 contribute to this function. Moreover, we find that the C-terminal region of Kin2 interacts with Cdc11, a septin subunit, and Pea2, a component of the polarisome that is known to play a role in septin organization. These findings suggest that Kin2 may play a role in the regulation of the septin cytoskeleton and the cell wall. Finally, we show that the C-terminal region of Kin2 interacts with Rho3, a Rho GTPase, whereas the N-terminal region of Kin2 interacts with Bmh1, a 14-3-3 protein. We speculate that Kin2 may be regulated by Bmh1, Rho3, or Pea2 in vivo. Our study provides new insight in the localization, function, and regulation of Kin2.	[Yuan, Si-Min; Nie, Wen-Chao; He, Fei; Jia, Zhi-Wen; Gao, Xiang-Dong] Wuhan Univ, Coll Life Sci, Dept Microbiol, Wuhan 430072, Peoples R China; [Gao, Xiang-Dong] Hubei Prov Cooperat Innovat Ctr Ind Fermentat, Wuhan, Peoples R China	Wuhan University	Gao, XD (corresponding author), Wuhan Univ, Coll Life Sci, Dept Microbiol, Wuhan 430072, Peoples R China.; Gao, XD (corresponding author), Hubei Prov Cooperat Innovat Ctr Ind Fermentat, Wuhan, Peoples R China.	xdgao@whu.edu.cn		Gao, Xiang-Dong/0000-0002-1008-2324	National Natural Science Foundation of China [31370124, 31570076]; National Infrastructure of Natural Resources for Science and Technology Program of China [NIMR-2014-8]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Infrastructure of Natural Resources for Science and Technology Program of China	This work was supported by the National Natural Science Foundation of China (grant no. 31370124 and 31570076) to XDG and by National Infrastructure of Natural Resources for Science and Technology Program of China (no. NIMR-2014-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo JE, 2001, J CELL BIOL, V155, P581, DOI 10.1083/jcb.200106065; Adamo JE, 1999, MOL BIOL CELL, V10, P4121, DOI 10.1091/mbc.10.12.4121; Anshu A, 2015, MOL CELL BIOL, V35, P199, DOI 10.1128/MCB.00981-14; Barral Y, 1999, GENE DEV, V13, P176, DOI 10.1101/gad.13.2.176; Benton R, 2002, DEV CELL, V3, P659, DOI 10.1016/S1534-5807(02)00320-9; Bi EF, 1996, MOL CELL BIOL, V16, P5264; Biernat J, 2002, MOL BIOL CELL, V13, P4013, DOI 10.1091/mbc.02-03-0046; Bohm H, 1997, CURR BIOL, V7, P603, DOI 10.1016/S0960-9822(06)00260-0; Bouquin N, 2000, J CELL SCI, V113, P1435; Cadou A, 2010, MOL MICROBIOL, V77, P1186, DOI 10.1111/j.1365-2958.2010.07281.x; Donavan M, 1994, YEAST, V10, P113; Drewes G, 2003, FEBS LETT, V554, P45, DOI 10.1016/S0014-5793(03)01080-9; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Elbert M, 2005, MOL BIOL CELL, V16, P532, DOI 10.1091/mbc.E04-07-0549; Finger FP, 1998, CELL, V92, P559, DOI 10.1016/S0092-8674(00)80948-4; Gao XD, 2004, MOL BIOL CELL, V15, P3977, DOI 10.1091/mbc.E04-01-0079; Gao XD, 2003, J CELL BIOL, V162, P635, DOI 10.1083/jcb.200302038; Gao XD, 2007, MOL BIOL CELL, V18, P2542, DOI 10.1091/mbc.e06-09-0822; Gasser B, 2007, APPL ENVIRON MICROB, V73, P6499, DOI 10.1128/AEM.01196-07; Gladfelter AS, 2005, J CELL SCI, V118, P1617, DOI 10.1242/jcs.02286; Gladfelter AS, 2001, CURR OPIN MICROBIOL, V4, P681, DOI 10.1016/S1369-5274(01)00269-7; Gong T, 2013, EUKARYOT CELL, V12, P368, DOI 10.1128/EC.00277-12; Guo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016744; Guo S, 1996, NATURE, V382, P455, DOI 10.1038/382455a0; He F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123326; James P, 1996, GENETICS, V144, P1425; Katoda J, 2004, MOL BIOL CELL, V15, P5329; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; LAMB A, 1991, YEAST, V7, P219, DOI 10.1002/yea.320070304; LEVIN DE, 1990, P NATL ACAD SCI USA, V87, P8272, DOI 10.1073/pnas.87.21.8272; Longtine MS, 2000, MOL CELL BIOL, V20, P4049, DOI 10.1128/MCB.20.11.4049-4061.2000; Longtine MS, 2003, TRENDS CELL BIOL, V13, P403, DOI 10.1016/S0962-8924(03)00151-X; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Luo JY, 2004, J CELL BIOL, V165, P843, DOI 10.1083/jcb.200401040; Luo YP, 2014, NEW PHYTOL, V204, P943, DOI 10.1111/nph.12953; MATSUI Y, 1992, MOL CELL BIOL, V12, P5690, DOI 10.1128/MCB.12.12.5690; Moravcevic K, 2010, CELL, V143, P966, DOI 10.1016/j.cell.2010.11.028; Mortensen EM, 2002, MOL BIOL CELL, V13, P2091, DOI 10.1091/mbc.01-10-0500; Morton DG, 2002, DEV BIOL, V241, P47, DOI 10.1006/dbio.2001.0489; Mylonakis E, 2004, MOL MICROBIOL, V54, P407, DOI 10.1111/j.1365-2958.2004.04310.x; Park HO, 2007, MICROBIOL MOL BIOL R, V71, P48, DOI 10.1128/MMBR.00028-06; Pruyne D, 2000, J CELL SCI, V113, P571; Richman TJ, 2002, EUKARYOT CELL, V1, P458, DOI 10.1128/EC.1.3.458-468.2002; Robinson NCG, 1999, MOL CELL BIOL, V19, P3580; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Sheu YJ, 1998, MOL CELL BIOL, V18, P4053, DOI 10.1128/MCB.18.7.4053; Steczkiewicz K, 2010, CELL CYCLE, V9, P201, DOI 10.4161/cc.9.1.10510; Suzuki A, 2004, CURR BIOL, V14, P1425, DOI 10.1016/j.cub.2004.08.021; Tassan JP, 2004, BIOL CELL, V96, P193, DOI 10.1016/j.biolcel.2003.10.009; TIBBETTS M, 1994, EXP CELL RES, V213, P93, DOI 10.1006/excr.1994.1177; Tochio N, 2006, PROTEIN SCI, V15, P2534, DOI 10.1110/ps.062391106; Valtz N, 1996, J CELL BIOL, V135, P725, DOI 10.1083/jcb.135.3.725; van Heusden GPH, 2006, YEAST, V23, P159, DOI 10.1002/yea.1338; Wu H, 2010, MOL CELL BIOL, V30, P5207, DOI 10.1128/MCB.00366-10; Yin QY, 2005, J BIOL CHEM, V280, P20894, DOI 10.1074/jbc.M500334200	55	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153992	10.1371/journal.pone.0153992	http://dx.doi.org/10.1371/journal.pone.0153992			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096577	Green Submitted, Green Published, gold			2022-12-26	WOS:000374543600080
J	Dawson, SJ; Chivers, ML				Dawson, Samantha J.; Chivers, Meredith L.			Gender-Specificity of Initial and Controlled Visual Attention to Sexual Stimuli in Androphilic Women and Gynephilic Men	PLOS ONE			English	Article							GENERALIZED ANXIETY DISORDER; EYE-MOVEMENTS; INSTRUCTIONAL-CONTROL; HETEROSEXUAL WOMEN; PHALLOMETRIC TEST; VOLUNTARY CONTROL; AROUSAL; PATTERNS; INHIBITION; VALIDATION	Research across groups and methods consistently finds a gender difference in patterns of specificity of genital response; however, empirically supported mechanisms to explain this difference are lacking. The information-processing model of sexual arousal posits that automatic and controlled cognitive processes are requisite for the generation of sexual responses. Androphilic women's gender-nonspecific response patterns may be the result of sexually-relevant cues that are common to both preferred and nonpreferred genders capturing attention and initiating an automatic sexual response, whereas men's attentional system may be biased towards the detection and response to sexually-preferred cues only. In the present study, we used eye tracking to assess visual attention to sexually-preferred and nonpreferred cues in a sample of androphilic women and gynephilic men. Results support predictions from the information-processing model regarding gendered processing of sexual stimuli in men and women. Men's initial attention patterns were gender-specific, whereas women's were nonspecific. In contrast, both men and women exhibited gender-specific patterns of controlled attention, although this effect was stronger among men. Finally, measures of attention and self-reported attraction were positively related in both men and women. These findings are discussed in the context of the information-processing model and evolutionary mechanisms that may have evolved to promote gendered attentional systems.	[Dawson, Samantha J.; Chivers, Meredith L.] Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Chivers, ML (corresponding author), Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada.	Meredith.Chivers@queensu.ca			Natural Sciences and Engineering Research Council of Canada Discover Grant; Canada Foundation for Innovation Infrastructure Operating Fund; Ontario Trillium Scholarship	Natural Sciences and Engineering Research Council of Canada Discover Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation Infrastructure Operating Fund; Ontario Trillium Scholarship	This work was supported by the Natural Sciences and Engineering Research Council of Canada Discover Grant (MLC), Canada Foundation for Innovation Infrastructure Operating Fund (MLC), and Ontario Trillium Scholarship (SJD). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, CAUSES RAPE UNDERSTA; [Anonymous], 2007, PSYCHOPHYSIOLOGY SEX; Bancroft J, 2003, ENCY COGNITIVE SCI; BECK JG, 1994, ARCH SEX BEHAV, V23, P665, DOI 10.1007/BF01541818; Bjorklund DF, 1996, PSYCHOL BULL, V120, P163, DOI 10.1037/0033-2909.120.2.163; Blanchard R, 2001, PSYCHOL ASSESSMENT, V13, P118, DOI 10.1037/1040-3590.13.1.118; Bradley BP, 2000, COGNITION EMOTION, V14, P789, DOI 10.1080/02699930050156636; Bradley MM, 2015, INT J PSYCHOPHYSIOL, V98, P54, DOI 10.1016/j.ijpsycho.2015.06.008; Buodo G, 2002, MOTIV EMOTION, V26, P123, DOI 10.1023/A:1019886501965; Calvo MG, 2004, MOTIV EMOTION, V28, P221, DOI 10.1023/B:MOEM.0000040153.26156.ed; CASH TF, 1995, J PERS ASSESS, V64, P466, DOI 10.1207/s15327752jpa6403_6; CERNY JA, 1978, BEHAV THER, V9, P847, DOI 10.1016/S0005-7894(78)80016-1; Chivers ML, 2007, J PERS SOC PSYCHOL, V93, P1108, DOI 10.1037/0022-3514.93.6.1108; Chivers ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142575; Chivers ML, 2012, ARCH SEX BEHAV, V41, P185, DOI 10.1007/s10508-012-9937-3; Chivers ML, 2004, PSYCHOL SCI, V15, P736, DOI 10.1111/j.0956-7976.2004.00750.x; Chivers ML, 2005, BIOL PSYCHOL, V70, P115, DOI 10.1016/j.biopsycho.2004.12.002; de Jong DC, 2009, J SEX RES, V46, P237, DOI 10.1080/00224490902747230; DEKKER J, 1985, BEHAV RES THER, V23, P139, DOI 10.1016/0005-7967(85)90022-1; FISHER WA, 1988, J SEX RES, V25, P123, DOI 10.1080/00224498809551448; Forsythe A, 2008, BEHAV RES METHODS, V40, P116, DOI 10.3758/BRM.40.1.116; FREUND K, 1989, J CONSULT CLIN PSYCH, V57, P100, DOI 10.1037/0022-006X.57.1.100; Freund K, 1991, PSYCHOL ASSESSMENT J, V3, P254, DOI DOI 10.1037/1040-3590.3.2.254; Fromberger P, 2013, J ABNORM PSYCHOL, V122, P587, DOI 10.1037/a0030659; Fromberger P, 2012, J SEX MED, V9, P1868, DOI 10.1111/j.1743-6109.2012.02754.x; Fromberger P, 2012, ARCH SEX BEHAV, V41, P919, DOI 10.1007/s10508-011-9816-3; Gerdes ABM, 2009, J NEURAL TRANSM, V116, P725, DOI 10.1007/s00702-008-0167-8; Graham CA, 2006, ARCH SEX BEHAV, V35, P397, DOI 10.1007/s10508-006-9041-7; HEIMAN JR, 1983, J PSYCHOSOM RES, V27, P105, DOI 10.1016/0022-3999(83)90086-7; Henderson JM, 1999, ANNU REV PSYCHOL, V50, P243, DOI 10.1146/annurev.psych.50.1.243; Henderson JM, 2003, TRENDS COGN SCI, V7, P498, DOI 10.1016/j.tics.2003.09.006; Henderson JM., 1992, EYE MOVEMENTS VISUAL, P260, DOI [DOI 10.1007/978-1-4612-2852-3_15, 10.1007/978-1-4612-2852-3_15]; Herbenick D, 2013, J SEX MED, V10, P1516, DOI 10.1111/jsm.12124; Herbenick D, 2010, J SEX MED, V7, P1822, DOI 10.1111/j.1743-6109.2010.01728.x; Hermans D, 1999, COGNITION EMOTION, V13, P419, DOI 10.1080/026999399379249; Hoffman JE, 1998, ATTENTION, P119; Huberman JS, 2015, PSYCHOPHYSIOLOGY, V52, P1382, DOI 10.1111/psyp.12466; Huberman JS, J SEX RES IN PRESS, P1; Janssen E, 2002, J SEX RES, V39, P114, DOI 10.1080/00224490209552130; Janssen E, 2000, J SEX RES, V37, P8, DOI 10.1080/00224490009552016; Kinsey A, 1948, SEXUAL BEHAV HUMAN M, DOI 10.1037/t17515-000; Kinsey Alfred, 1953, SEXUAL BEHAV HUMAN F; LAAN E, 1993, BEHAV RES THER, V31, P25, DOI 10.1016/0005-7967(93)90039-W; Laan E., 1994, THESIS U AMSTERDAM A; LALUMIERE ML, 1992, BEHAV ASSESS, V14, P121; LAWS DR, 1969, J APPL BEHAV ANAL, V2, P93, DOI 10.1901/jaba.1969.2-93; Lykins AD, 2008, ARCH SEX BEHAV, V37, P219, DOI 10.1007/s10508-007-9208-x; Lykins AD, 2006, ARCH SEX BEHAV, V35, P569, DOI 10.1007/s10508-006-9065-z; Mogg K, 2000, J ABNORM PSYCHOL, V109, P695, DOI 10.1037/0021-843X.109.4.695; Mogg K, 2007, BIOL PSYCHOL, V76, P163, DOI 10.1016/j.biopsycho.2007.07.005; Morrison MA, 2002, J HOMOSEXUAL, V43, P15, DOI 10.1300/J082v43n02_02; Nummenmaa L, 2006, EMOTION, V6, P257, DOI 10.1037/1528-3542.6.2.257; Nummenmaa L, 2012, ARCH SEX BEHAV, V41, P1439, DOI 10.1007/s10508-012-9911-0; Ohman A, 2005, PSYCHONEUROENDOCRINO, V30, P953, DOI 10.1016/j.psyneuen.2005.03.019; Olatunji BO, 2007, J ANXIETY DISORD, V21, P918, DOI 10.1016/j.janxdis.2006.12.005; Pessoa L, 2005, EMOTION, V5, P243, DOI 10.1037/1528-3542.5.2.243; Peterson ZD, 2010, ARCH SEX BEHAV, V39, P880, DOI 10.1007/s10508-009-9546-y; Ponseti J, 2010, ARCH SEX BEHAV, V39, P1073, DOI 10.1007/s10508-009-9587-2; Renfro KJ, 2015, HORM BEHAV, V75, P33, DOI 10.1016/j.yhbeh.2015.07.013; Rieger G, 2005, PSYCHOL SCI, V16, P579, DOI 10.1111/j.1467-9280.2005.01578.x; Rieger G, 2015, BIOL PSYCHOL, V104, P56, DOI 10.1016/j.biopsycho.2014.11.009; Rieger G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040256; Rinck M, 2006, J ABNORM PSYCHOL, V115, P231, DOI 10.1037/0021-843X.115.2.231; Rohner JC, 2002, COGNITION EMOTION, V16, P837, DOI 10.1080/02699930143000572; Rosen R, 2000, J SEX MARITAL THER, V26, P191, DOI 10.1080/009262300278597; Rosen RC, 1997, UROLOGY, V49, P822, DOI 10.1016/S0090-4295(97)00238-0; Rupp HA, 2007, HORM BEHAV, V51, P524, DOI 10.1016/j.yhbeh.2007.01.008; Seto MC, 2000, PSYCHOL ASSESSMENT, V12, P319, DOI 10.1037/1040-3590.12.3.319; Sheen J, 2009, J SEX RES, V46, P358, DOI 10.1080/00224490902775843; Snowden RJ, 2013, ARCH SEX BEHAV, V42, P475, DOI 10.1007/s10508-012-9920-z; Spape J, 2014, BIOL PSYCHOL, V102, P1, DOI 10.1016/j.biopsycho.2014.07.008; Spector IP, 1996, J SEX MARITAL THER, V22, P175; Spiering M, 2003, J SEX RES, V40, P134, DOI 10.1080/00224490309552175; Spiering M, 2006, J SEX RES, V43, P268, DOI 10.1080/00224490609552325; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; STEINMAN DL, 1981, ARCH SEX BEHAV, V10, P529, DOI 10.1007/BF01541588; Suschinsky KD, 2011, PSYCHOL SCI, V22, P159, DOI 10.1177/0956797610394660; Suschinsky KD, 2009, ARCH SEX BEHAV, V38, P559, DOI 10.1007/s10508-008-9339-8; Tollison CD., 1979, J BEHAV ASSESS, V1, P305, DOI [10.1007/BF01321372, DOI 10.1007/BF01321372]; Toothaker LE, 1991, MULTIPLE COMP RES; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Tsujimura A, 2009, J SEX MED, V6, P1011, DOI 10.1111/j.1743-6109.2008.01031.x; van Lunsen RHW, 2004, MENOPAUSE, V11, P741, DOI 10.1097/01.GME.0000143704.48324.46; Wallen K, 2010, HORM BEHAV, V57, P263, DOI 10.1016/j.yhbeh.2009.12.005; WINCZE JP, 1984, ARCH SEX BEHAV, V13, P361, DOI 10.1007/BF01541908; Yarbus A.L., 1965, ROLE EYE MOVEMENTS V	87	36	37	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0152785	10.1371/journal.pone.0152785	http://dx.doi.org/10.1371/journal.pone.0152785			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9IK	27088358	gold, Green Published, Green Submitted			2022-12-26	WOS:000374527000009
J	Liu, J; Hao, ZY; Ma, LL; Ji, YR; Bartlam, M; Wang, YY				Liu, Jie; Hao, Zhenyu; Ma, Lili; Ji, Yurui; Bartlam, Mark; Wang, Yingying			Spatio-Temporal Variations of High and Low Nucleic Acid Content Bacteria in an Exorheic River	PLOS ONE			English	Article							SEASONAL DYNAMICS; COASTAL WATERS; CYTOMETRIC CHARACTERISTICS; PICOPLANKTON COMMUNITY; CELLS; HNA; POPULATIONS; DIVERSITY; GROWTH; BLOOM	Bacteria with high nucleic acid (HNA) and low nucleic acid (LNA) content are commonly observed in aquatic environments. To date, limited knowledge is available on their temporal and spatial variations in freshwater environments. Here an investigation of HNA and LNA bacterial abundance and their flow cytometric characteristics was conducted in an exorheic river (Haihe River, Northern China) over a one year period covering September (autumn) 2011, December (winter) 2011, April (spring) 2012, and July (summer) 2012. The results showed that LNA and HNA bacteria contributed similarly to the total bacterial abundance on both the spatial and temporal scale. The variability of HNA on abundance, fluorescence intensity (FL1) and side scatter (SSC) were more sensitive to environmental factors than that of LNA bacteria. Meanwhile, the relative distance of SSC between HNA and LNA was more variable than that of FL1. Multivariate analysis further demonstrated that the influence of geographical distance (reflected by the salinity gradient along river to ocean) and temporal changes (as temperature variation due to seasonal succession) on the patterns of LNA and HNA were stronger than the effects of nutrient conditions. Furthermore, the results demonstrated that the distribution of LNA and HNA bacteria, including the abundance, FL1 and SSC, was controlled by different variables. The results suggested that LNA and HNA bacteria might play different ecological roles in the exorheic river.	[Liu, Jie; Hao, Zhenyu; Ma, Lili; Ji, Yurui; Wang, Yingying] Nankai Univ, Minist Educ, Key Lab Pollut Proc & Environm Criteria, Coll Environm Sci & Engn, Tianjin 300071, Peoples R China; [Wang, Yingying] Nankai Univ, Coll Environm Sci & Engn, Tianjin Key Lab Environm Remediat & Pollut Contro, Tianjin 300071, Peoples R China; [Bartlam, Mark] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Bartlam, Mark] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Liu, Jie] Tsinghua Univ, Grad Sch Shenzhen, State Environm Protect Key Lab Microorganism Appl, Shenzhen 518057, Guangdong, Peoples R China; [Ma, Lili] Southwest Petr Univ, Coll Chem & Chem Engn, Chengdu, Sichuan, Peoples R China	Nankai University; Nankai University; Nankai University; Nankai University; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Southwest Petroleum University	Wang, YY (corresponding author), Nankai Univ, Minist Educ, Key Lab Pollut Proc & Environm Criteria, Coll Environm Sci & Engn, Tianjin 300071, Peoples R China.; Wang, YY (corresponding author), Nankai Univ, Coll Environm Sci & Engn, Tianjin Key Lab Environm Remediat & Pollut Contro, Tianjin 300071, Peoples R China.	wangyy@nankai.edu.cn	wang, yan/GSE-6489-2022; HAO, ZHENYU/AAF-3810-2019; wang, yingying/GRS-3058-2022; Liu, Jie/GRN-8750-2022	Bartlam, Mark/0000-0001-5173-5080; Liu, Jie/0000-0002-3849-6414	National Key Basic Research Program of China [2015CB459000]; National Natural Science Foundation, China [31322012]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation, China(National Natural Science Foundation of China (NSFC))	The authors are grateful to the financial support from National Key Basic Research Program of China (2015CB459000) and National Natural Science Foundation, China (31322012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade L, 2007, BRAZ J MICROBIOL, V38, P330, DOI 10.1590/S1517-83822007000200028; Bouvier T, 2007, ENVIRON MICROBIOL, V9, P2050, DOI 10.1111/j.1462-2920.2007.01321.x; Bouvier T, 2011, MICROB ECOL, V62, P669, DOI 10.1007/s00248-011-9862-3; Calvo-Diaz A, 2006, AQUAT MICROB ECOL, V42, P159, DOI 10.3354/ame042159; Carlson CA, 2009, ISME J, V3, P283, DOI 10.1038/ismej.2008.117; Eiler A, 2009, ENVIRON MICROBIOL, V11, P2291, DOI 10.1111/j.1462-2920.2009.01954.x; Gilbert JA, 2012, ISME J, V6, P298, DOI 10.1038/ismej.2011.107; Gomes A, 2015, DEEP-SEA RES PT I, V96, P59, DOI 10.1016/j.dsr.2014.11.007; Gozdereliler E, 2013, APPL ENVIRON MICROB, V79, P367, DOI 10.1128/AEM.02536-12; Huete-Stauffer TM, 2012, AQUAT MICROB ECOL, V67, P211, DOI 10.3354/ame01590; Jochem FJ, 2004, MAR BIOL, V145, P1213, DOI 10.1007/s00227-004-1406-7; Lebaron P, 2001, APPL ENVIRON MICROB, V67, P1775, DOI 10.1128/AEM.67.4.1775-1782.2001; Lebaron P, 2002, AQUAT MICROB ECOL, V28, P131, DOI 10.3354/ame028131; Liu J, 2015, FRONT MICROBIOL, V6, DOI [10.3389/fmicb.7015.00329, 10.3389/fmicb.2015.00329]; Longnecker K, 2005, APPL ENVIRON MICROB, V71, P7737, DOI 10.1128/AEM.71.12.7737-7749.2005; Ma Lili, 2016, Front Microbiol, V7, P250, DOI 10.3389/fmicb.2016.00250; Ma LL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/526362; Nishimura Y, 2005, APPL ENVIRON MICROB, V71, P5828, DOI 10.1128/AEM.71.10.5828-5836.2005; Palesse S, 2014, MICROB ECOL, V68, P740, DOI 10.1007/s00248-014-0441-2; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Ramseier MK, 2011, WATER RES, V45, P1490, DOI 10.1016/j.watres.2010.11.016; Read DS, 2015, ISME J, V9, P516, DOI 10.1038/ismej.2014.166; Rosel S, 2012, AQUAT MICROB ECOL, V66, P169, DOI 10.3354/ame01568; Salcher MM, 2011, ISME J, V5, P1242, DOI 10.1038/ismej.2011.8; Salter I, 2015, ISME J, V9, P347, DOI 10.1038/ismej.2014.129; Santic D, 2014, MEDITERR MAR SCI, V15, P179; Santic D, 2013, HELGOLAND MAR RES, V67, P471, DOI 10.1007/s10152-012-0336-x; Santic D, 2012, ACTA ADRIAT, V53, P25; Schattenhofer M, 2011, SYST APPL MICROBIOL, V34, P470, DOI 10.1016/j.syapm.2011.01.008; Solic M, 2009, AQUAT MICROB ECOL, V58, P15, DOI 10.3354/ame01342; Van Wambeke F, 2011, BIOGEOSCIENCES, V8, P1853, DOI 10.5194/bg-8-1853-2011; Vila-Costa M, 2012, ENVIRON MICROBIOL, V14, P1390, DOI 10.1111/j.1462-2920.2012.02720.x; Wang YY, 2009, ISME J, V3, P889, DOI 10.1038/ismej.2009.46; Williams TJ, 2009, ISME J, V3, P1036, DOI 10.1038/ismej.2009.52; Worden AZ, 2004, LIMNOL OCEANOGR, V49, P168, DOI 10.4319/lo.2004.49.1.0168	35	13	16	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153678	10.1371/journal.pone.0153678	http://dx.doi.org/10.1371/journal.pone.0153678			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082986	gold, Green Submitted, Green Published			2022-12-26	WOS:000374291800044
J	Yuen, CM; Kammerer, JS; Marks, K; Navin, TR; France, AM				Yuen, Courtney M.; Kammerer, J. Steve; Marks, Kala; Navin, Thomas R.; France, Anne Marie			Recent Transmission of Tuberculosis - United States, 2011-2014	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; RISK-FACTORS; OUTBREAK; HOMELESS; COUNTY; GENOTYPE	Tuberculosis is an infectious disease that may result from recent transmission or from an infection acquired many years in the past; there is no diagnostic test to distinguish the two causes. Cases resulting from recent transmission are particularly concerning from a public health standpoint. To describe recent tuberculosis transmission in the United States, we used a field-validated plausible source-case method to estimate cases likely resulting from recent transmission during January 2011-September 2014. We classified cases as resulting from either limited or extensive recent transmission based on transmission cluster size. We used logistic regression to analyze patient characteristics associated with recent transmission. Of 26,586 genotyped cases, 14% were attributable to recent transmission, 39% of which were attributable to extensive recent transmission. The burden of cases attributed to recent transmission was geographically heterogeneous and poorly predicted by tuberculosis incidence. Extensive recent transmission was positively associated with American Indian/Alaska Native (adjusted prevalence ratio [aPR] = 3.6 (95% confidence interval [CI] 2.9-4.4), Native Hawaiian/Pacific Islander (aPR = 3.2, 95% CI 2.3-4.5), and black (aPR = 3.0, 95% CI 2.6-3.5) race, and homelessness (aPR = 2.3, 95% CI 2.0-2.5). Extensive recent transmission was negatively associated with foreign birth (aPR = 0.2, 95% CI 0.2-0.2). Tuberculosis control efforts should prioritize reducing transmission among higher-risk populations.	[Yuen, Courtney M.; Kammerer, J. Steve; Marks, Kala; Navin, Thomas R.; France, Anne Marie] Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA; [Yuen, Courtney M.] Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA; [France, Anne Marie] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Harvard University; Brigham & Women's Hospital; Centers for Disease Control & Prevention - USA	France, AM (corresponding author), Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA.	hgj6@cdc.gov		Yuen, Courtney/0000-0002-5219-2599				Althomsons SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048754; Bamrah S, 2013, INT J TUBERC LUNG D, V17, P1414, DOI 10.5588/ijtld.13.0270; Bloss E, 2011, PUBLIC HEALTH REP, V126, P677, DOI 10.1177/003335491112600510; Bruchfeld J, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a017871; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P232; Centers for Disease Control and Prevention, 2015, REP TUB US 2014; Centers for Disease Control and Prevention (CDC), 2012, MMWR Morb Mortal Wkly Rep, V61, P539; Dobbins Claire, 2012, Morbidity and Mortality Weekly Report, V61, P186; Fok A, 2008, INT J TUBERC LUNG D, V12, P480; France AM, 2015, AM J EPIDEMIOL, V182, P799, DOI 10.1093/aje/kwv121; Funk EA, 2003, INT J TUBERC LUNG D, V7, pS349; Kaushik KS, 2011, J MED MICROBIOL, V60, P408, DOI 10.1099/jmm.0.027540-0; Knorr J, 2013, MMWR-MORBID MORTAL W, V62, P904; Lofy KH, 2006, INT J TUBERC LUNG D, V10, P683; McMillen CW, 2008, B HIST MED, V82, P608, DOI 10.1353/bhm.0.0094; Mitruka K, 2011, EMERG INFECT DIS, V17, P425, DOI 10.3201/eid1703.101550; Moonan PK, 2012, EMERG INFECT DIS, V18, P458, DOI 10.3201/eid1803.111107; Nava-Aguilera E, 2009, INT J TUBERC LUNG D, V13, P17; Nguyen LN, 2004, RESPIROLOGY, V9, P313, DOI 10.1111/j.1440-1843.2004.00603.x; Oeltmann JE, 2006, EMERG INFECT DIS, V12, P1156, DOI 10.3201/eid1207.051436; Pevzner ES, 2010, AM J PUBLIC HEALTH, V100, P2481, DOI 10.2105/AJPH.2009.162388; Ricks PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027405; Rodwell TC, 2012, INFECT GENET EVOL, V12, P1917, DOI 10.1016/j.meegid.2012.08.022; Schneider E, 2005, CLIN CHEST MED, V26, P183, DOI 10.1016/j.ccm.2005.02.007; Simet SM, 2015, ALCOHOL RES-CURR REV, V37, P199	25	88	88	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153728	10.1371/journal.pone.0153728	http://dx.doi.org/10.1371/journal.pone.0153728			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082644	Green Published, Green Submitted, gold			2022-12-26	WOS:000374291800049
J	Chen, CH				Chen, Chia-Hsiang			Development of a Melting Curve-Based Allele-Specific PCR of Apolipoprotein E (APOE) Genotyping Method for Genomic DNA, Guthrie Blood Spot, and Whole Blood	PLOS ONE			English	Article							E GENE POLYMORPHISM; ALZHEIMERS-DISEASE; EPSILON-4 ALLELE; ASSOCIATION; SCHIZOPHRENIA; METAANALYSIS; DEPRESSION; DISORDERS; AUTISM; PTSD	Genetic polymorphisms of apolipoprotein E (APOE) are associated with various health conditions and diseases, such as Alzheimer's disease, cardiovascular diseases, type 2 diabetes, etc. Hence, genotyping of APOE has broad applications in biomedical research and clinical settings, particularly in the era of precision medicine. The study aimed to develop a convenient and accurate method with flexible throughput to genotype the APOE polymorphisms. A melting curve-based allele-specific PCR method was developed to genotype two single nucleotide polymorphisms (SNPs) of APOE, i.e. rs429358 at codon 112 and rs7412 at codon 158. These two SNPs determine the genotype of APOE2, E3, and E4. PCR-based Sanger sequencing was used as the reference method for APOE genotyping. A 100% concordance rate was obtained in 300 subjects between the melting curve-based allele-specific PCR method and the Sanger sequencing method. This method was applied to a genetic association analysis of APOE and schizophrenia consisting of 711 patients with schizophrenia and 665 control subjects from Taiwan. However, no significant differences in the allele and genotype frequencies were detected between these two groups. Further experiments showed that DNA dissolved from blood collected on Guthrie filter paper and total blood cell lysate without DNA extraction can be used in the melting curve-based allele-specific PCR method. Thus, we suggest that this is a fast, accurate and robust APOE genotyping method with a flexible throughput and suitable for DNA template from different preparations. This convenient method shall meet the different needs of various research and clinical laboratories.	[Chen, Chia-Hsiang] Chang Gung Mem Hosp Linkou, Dept Psychiat, Taoyuan, Taiwan; [Chen, Chia-Hsiang] Chang Gung Univ, Dept & Grad Inst Biomed Sci, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Chen, CH (corresponding author), Chang Gung Mem Hosp Linkou, Dept Psychiat, Taoyuan, Taiwan.; Chen, CH (corresponding author), Chang Gung Univ, Dept & Grad Inst Biomed Sci, Taoyuan, Taiwan.	cchen3801@gmail.com		Chen, Chia-Hsiang/0000-0002-8232-2403	Chang Gung Memorial Hospital-Linkou, Taiwan [CMRPG3C1771, CMRPG3C1772]	Chang Gung Memorial Hospital-Linkou, Taiwan(Chang Gung Memorial Hospital)	The study was supported by grants CMRPG3C1771 and CMRPG3C1772 from Chang Gung Memorial Hospital-Linkou, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Ashley-Koch AE, 2007, PSYCHIAT GENET, V17, P221, DOI 10.1097/YPG.0b013e32809c2f75; Gonzalez-Castro TB, 2015, SCHIZOPHR RES, V169, P355, DOI 10.1016/j.schres.2015.08.031; Bellivier F, 1997, NEUROSCI LETT, V233, P45, DOI 10.1016/S0304-3940(97)00624-1; Calero O, 2009, J NEUROSCI METH, V183, P238, DOI 10.1016/j.jneumeth.2009.06.033; Chaudhary R, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-36; Feng F, 2015, J CLIN NEUROSCI, V22, P1232, DOI 10.1016/j.jocn.2015.02.012; Gatt JM, 2015, J PSYCHIATR RES, V60, P1, DOI 10.1016/j.jpsychires.2014.09.014; Gibbons AS, 2011, FRONT BIOSCI-LANDMRK, V16, P962, DOI 10.2741/3729; Giunco CT, 2009, PSYCHIAT GENET, V19, P338, DOI 10.1097/YPG.0b013e3283328e41; Johnson LA, 2015, NEUROPSYCHOPHARMACOL, V40, P2443, DOI 10.1038/npp.2015.95; Kassam I, 2016, J NEUROL NEUROSUR PS, V87, P433, DOI 10.1136/jnnp-2015-310500; Kessing LV, 1999, BIOL PSYCHIAT, V45, P430, DOI 10.1016/S0006-3223(98)00038-9; Liu WQ, 2003, SCHIZOPHR RES, V62, P225, DOI 10.1016/S0920-9964(02)00384-5; Liu Y, 2015, J NEUROL NEUROSUR PS, V86, P127, DOI 10.1136/jnnp-2014-307719; Lopez MF, 2014, EXPERT REV PROTEOMIC, V11, P371, DOI 10.1586/14789450.2014.901892; Lyons MJ, 2013, AM J MED GENET B, V162, P762, DOI 10.1002/ajmg.b.32154; Martinez-Barrondo S, 2006, EUR PSYCHIAT, V21, P59, DOI 10.1016/j.eurpsy.2005.04.012; Martorelli L, 2001, MOL PSYCHIATR, V6, P307, DOI 10.1038/sj.mp.4000855; Ozder A, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-183; Persico AM, 2004, PSYCHIAT GENET, V14, P73, DOI 10.1097/01.ypg.0000128768.37838.17; Phillips MC, 2014, IUBMB LIFE, V66, P616, DOI 10.1002/iub.1314; Rihn BH, 2009, CLIN EXP MED, V9, P61, DOI 10.1007/s10238-008-0012-2; Skoog I, 2015, BIOL PSYCHIAT, V78, P730, DOI 10.1016/j.biopsych.2015.01.006; de Souza MGS, 2010, CNS NEUROSCI THER, V16, P316, DOI 10.1111/j.1755-5949.2010.00153.x; Thomas EA, 2002, MOL NEUROBIOL, V26, P369, DOI 10.1385/MN:26:2-3:369; Villeneuve S, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00154; Wang J, 2005, BIOTECHNIQUES, V39, P885, DOI 10.2144/000112028; Ward A, 2012, NEUROEPIDEMIOLOGY, V38, P1, DOI 10.1159/000334607; Xu MQ, 2006, SCHIZOPHR RES, V84, P228, DOI 10.1016/j.schres.2006.02.015; Yu JT, 2014, ANNU REV NEUROSCI, V37, P79, DOI 10.1146/annurev-neuro-071013-014300; Zhan XH, 2015, EXP THER MED, V9, P469, DOI 10.3892/etm.2014.2097	32	3	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153593	10.1371/journal.pone.0153593	http://dx.doi.org/10.1371/journal.pone.0153593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078154	Green Submitted, gold, Green Published			2022-12-26	WOS:000374131700088
J	Voronin, D; Bachu, S; Shlossman, M; Unnasch, TR; Ghedin, E; Lustigman, S				Voronin, Denis; Bachu, Saheed; Shlossman, Michael; Unnasch, Thomas R.; Ghedin, Elodie; Lustigman, Sara			Glucose and Glycogen Metabolism in Brugia malayi Is Associated with Wolbachia Symbiont Fitness	PLOS ONE			English	Article							FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE; ONCHOCERCA-VOLVULUS; FILARIAL; ENDOBACTERIA; ENDOSYMBIONT; DOXYCYCLINE; DEPLETION; GENOME; INHIBITION; EFFICACY	Wolbachia are endosymbiotic bacteria found in the majority of arthropods and filarial nematodes of medical and veterinary importance. They have evolved a wide range of symbiotic associations. In filarial nematodes that cause human lymphatic filariasis (Wuchereria bancrofti, Brugia malayi) or onchocerciasis (Onchocerca volvulus), Wolbachia are important for parasite development, reproduction and survival. The symbiotic bacteria rely in part on nutrients and energy sources provided by the host. Genomic analyses suggest that the strain of Wolbachia found in B. malayi (wBm) lacks the genes for two glycolytic enzymes-6-phosphofructokinase and pyruvate kinase-and is thus potentially unable to convert glucose into pyruvate, an important substrate for energy generation. The Wolbachia surface protein, wBm00432, is complexed to six B. malayi glycolytic enzymes, including aldolase. In this study we characterized two B. malayi aldolase isozymes and found that their expression is dependent on Wolbachia fitness and number. We confirmed by immuno-transmission electron microscopy that aldolase is associated with the Wolbachia surface. RNAi experiments suggested that aldolase-2 plays a significant role in both Wolbachia survival and embryogenesis in B. malayi. Treatment with doxycycline reduced Wolbachia fitness and increased the amount of both glucose and glycogen detected in the filarial parasite, indicating that glucose metabolism and glycogen storage in B. malayi are associated with Wolbachia fitness. This metabolic co-dependency between Wolbachia and its filarial nematode indicates that glycolysis could be a shared metabolic pathway between the bacteria and B. malayi, and thus a potential new target for anti-filarial therapy.	[Voronin, Denis; Bachu, Saheed; Shlossman, Michael; Lustigman, Sara] New York Blood Ctr, Lindsley F Kimball Res Inst, Mol Parasitol, New York, NY 10065 USA; [Unnasch, Thomas R.] Univ S Florida, Coll Publ Hlth, Dept Global Hlth, Global Hlth Infect Dis Res Program, Tampa, FL 33612 USA; [Ghedin, Elodie] NYU, Ctr Genom & Syst Biol, Dept Biol, New York, NY 10003 USA; [Ghedin, Elodie] NYU, Coll Global Publ Hlth, New York, NY 10003 USA	New York Blood Center; State University System of Florida; University of South Florida; New York University; New York University	Voronin, D (corresponding author), New York Blood Ctr, Lindsley F Kimball Res Inst, Mol Parasitol, New York, NY 10065 USA.	DVoronin@NYBloodCenter.org	Ghedin, Elodie/Y-5654-2019	Ghedin, Elodie/0000-0002-1515-725X; Voronin, Denis/0000-0003-2652-0787	National Institutes of Health [AI072465, R56AI101372]; New York Blood Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI101372, R01AI072465] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Blood Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health grant number AI072465 and R56AI101372 to TRU, EG and SL, and in part also by New York Blood Center intramural funding to SL.; We thank the National Institute of Allergy and Infectious Diseases (NIAID, USA)/National Institutes of Health (NIH, USA) Filariasis Research Reagent Repository Center (FR3) for supplying B. malayi adult female worms and microfilariae, and for also supplying the A. viteae adult female worms. This study was supported by National Institutes of Health grant number AI072465 and R56AI101372 to TRU, EG and SL, and in part also by New York Blood Center intramural funding to SL.	Bandi C, 1999, INT J PARASITOL, V29, P357, DOI 10.1016/S0020-7519(98)00200-8; Bandi C, 2001, VET PARASITOL, V98, P215, DOI 10.1016/S0304-4017(01)00432-0; Bulman CA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003534; Darby AC, 2012, GENOME RES, V22, P2467, DOI 10.1101/gr.138420.112; Diaz-Ramos A, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/156795; Dudkina N.V., 2004, Tsitologiya, V46, P208; El Ridi RAF, 2013, J ADV RES, V4, P467, DOI 10.1016/j.jare.2012.05.002; Fischer K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086383; Ford L, 2005, J BIOL CHEM, V280, P40845, DOI 10.1074/jbc.M504434200; Foster J, 2005, PLOS BIOL, V3, P599, DOI 10.1371/journal.pbio.0030121; Foster JM, 2009, PARASITOL RES, V104, P1047, DOI 10.1007/s00436-008-1287-7; Fraga A, 2013, PLOS ONE, P8; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Ganapathy-Kanniappan S, 2013, ANTICANCER RES, V33, P13; Ghedin E, 2008, SYMBIOSIS, V46, P77; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Gill AC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003224; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hoerauf A, 2003, MICROBES INFECT, V5, P261, DOI 10.1016/S1286-4579(03)00026-1; Hoerauf A, 2001, LANCET, V357, P1415, DOI 10.1016/S0140-6736(00)04581-5; Hoerauf A, 2008, MED MICROBIOL IMMUN, V197, P295, DOI 10.1007/s00430-007-0062-1; Inoue T, 1997, ARCH BIOCHEM BIOPHYS, V339, P226, DOI 10.1006/abbi.1996.9813; Isayev O, 2014, ONCOTARGET, V5, P5177, DOI 10.18632/oncotarget.2120; JOHNSON LN, 1992, FASEB J, V6, P2274, DOI 10.1096/fasebj.6.6.1544539; Kim H, 1998, BIOCHEMISTRY-US, V37, P4388, DOI 10.1021/bi972233h; Kremer N, 2009, PLOS PATHOG, P5; Landmann F, 2011, PLOS PATHOG, P7; Landmann F, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-16; Li BW, 2004, MOL BIOCHEM PARASIT, V137, P329, DOI 10.1016/j.molbiopara.2004.07.002; Lustigman S, 2014, INT J PARASITOL-DRUG, V4, P267, DOI 10.1016/j.ijpddr.2014.08.001; McGarry HF, 2004, MOL BIOCHEM PARASIT, V135, P57, DOI 10.1016/j.molbiopara.2004.01.006; Melnikow E, 2013, PLOS NEGLECT TROP D, P7; Moullan N, 2015, CELL REP, V10, P1681, DOI 10.1016/j.celrep.2015.02.034; Nguyen BD, 2012, P NATL ACAD SCI USA, V109, P1263, DOI 10.1073/pnas.1117884109; Olszewski KL, 2009, CELL HOST MICROBE, V5, P191, DOI 10.1016/j.chom.2009.01.004; Palm DC, 2013, FEBS J, V280, P2, DOI 10.1111/febs.12059; Raverdy S, 2008, MOL BIOCHEM PARASIT, V160, P163, DOI 10.1016/j.molbiopara.2008.04.014; Say RF, 2010, NATURE, V464, P1077, DOI 10.1038/nature08884; Scatena R, 2008, EXPERT OPIN INV DRUG, V17, P1533, DOI 10.1517/13543784.17.10.1533 ; Slatko BE, 2014, MOL BIOCH PARASITOLO; Specht S, 2008, PARASITOL RES, V103, P1303, DOI 10.1007/s00436-008-1133-y; Strubing U, 2010, INT J PARASITOL, V40, P1193, DOI 10.1016/j.ijpara.2010.03.004; Taylor MJ, 2013, CELL MICROBIOL, V15, P520, DOI 10.1111/cmi.12084; Townson Simon, 2006, Filaria J, V5, P4, DOI 10.1186/1475-2883-5-4; Voronin D, 2012, P NATL ACAD SCI USA, V109, pE1638, DOI 10.1073/pnas.1203519109; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Wu B., 2009, P 1 ACM INT WORKSH C, P3, DOI DOI 10.1145/1651274.1651277	47	18	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153812	10.1371/journal.pone.0153812	http://dx.doi.org/10.1371/journal.pone.0153812			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078260	Green Submitted, Green Published, gold			2022-12-26	WOS:000374131700109
J	Kim, K; Heo, DH; Kim, I; Suh, JY; Kim, M				Kim, Kyumin; Heo, Dong-hyuk; Kim, Iktae; Suh, Jeong-Yong; Kim, Minkyu			Exosome Cofactors Connect Transcription Termination to RNA Processing by Guiding Terminated Transcripts to the Appropriate Exonuclease within the Nuclear Exosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYPTIC UNSTABLE TRANSCRIPTS; POLYMERASE-II TRANSCRIPTS; SMALL NUCLEOLAR RNAS; BINDING PROTEIN; SACCHAROMYCES-CEREVISIAE; POLY(A) POLYMERASE; QUALITY-CONTROL; YEAST; DEGRADATION; NRD1	The yeast Nrd1 interacts with the C-terminal domain (CTD) of RNA polymerase II (RNApII) through its CTD-interacting domain (CID) and also associates with the nuclear exosome, thereby acting as both a transcription termination and RNA processing factor. Previously, we found that the Nrd1 CID is required to recruit the nuclear exosome to the Nrd1 complex, but it was not clear which exosome subunits were contacted. Here, we show that two nuclear exosome cofactors, Mpp6 and Trf4, directly and competitively interact with the Nrd1 CID and differentially regulate the association of Nrd1 with two catalytic subunits of the exosome. Importantly, Mpp6 promotes the processing of Nrd1-terminated transcripts preferentially by Dis3, whereas Trf4 leads to Rrp6-dependent processing. This suggests that Mpp6 and Trf4 may play a role in choosing a particular RNA processing route for Nrd1-terminated transcripts within the exosome by guiding the transcripts to the appropriate exonuclease.	[Kim, Kyumin; Kim, Minkyu] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, 1650 Owens St, San Francisco, CA 94158 USA; [Kim, Kyumin; Kim, Minkyu] Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; [Heo, Dong-hyuk] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Kim, Iktae; Suh, Jeong-Yong] Seoul Natl Univ, Dept Agr Biotechnol, 1 Gwanak Ro, Seoul 08826, South Korea; [Suh, Jeong-Yong] Shinshu Univ, Interdisciplinary Cluster Cutting Edge Res, Inst Biomed Sci, Matsumoto, Nagano 3908621, Japan	University of California System; University of California San Francisco; University of Oxford; Seoul National University (SNU); Shinshu University	Kim, M (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, 1650 Owens St, San Francisco, CA 94158 USA.	minkyu.kim@ucsf.edu	Kim, Minkyu/AAZ-8535-2021	Kim, Minkyu/0000-0001-9317-1658; Kim, Kyu-Min/0000-0002-1880-7801	Cancer Cell Map Initiative; California Institute for Quantitative Biosciences at UCSF; National Research Foundation of Korea [2013R1A1A2A10013757, 2013R1A1A2010856]	Cancer Cell Map Initiative; California Institute for Quantitative Biosciences at UCSF; National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the Cancer Cell Map Initiative and the California Institute for Quantitative Biosciences at UCSF (to M. K.) and by the National Research Foundation of Korea (Basic Science Research Program Grants 2013R1A1A2A10013757 (to M. K.) and 2013R1A1A2010856 (to J.-Y. S.)). The authors declare that they have no conflict of interest with the contents of this article.	Allmang C, 2000, NUCLEIC ACIDS RES, V28, P1684, DOI 10.1093/nar/28.8.1684; Arigo JT, 2006, MOL CELL, V23, P841, DOI 10.1016/j.molcel.2006.07.024; Bodenmiller B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001182; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Butler JS, 2002, TRENDS CELL BIOL, V12, P90, DOI 10.1016/S0962-8924(01)02225-5; Callahan KP, 2008, NUCLEIC ACIDS RES, V36, P6645, DOI 10.1093/nar/gkn743; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gudipati RK, 2012, MOL CELL, V48, P409, DOI 10.1016/j.molcel.2012.08.018; Heo DH, 2013, J BIOL CHEM, V288, P36676, DOI 10.1074/jbc.M113.508267; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; James P, 1996, GENETICS, V144, P1425; Kim M, 2006, MOL CELL, V24, P723, DOI 10.1016/j.molcel.2006.11.011; Kubicek K, 2012, GENE DEV, V26, P1891, DOI 10.1101/gad.192781.112; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Lehner B, 2004, GENOME RES, V14, P1315, DOI 10.1101/gr.2122004; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lykke-Andersen S, 2009, J CELL SCI, V122, P1487, DOI 10.1242/jcs.047399; Makino DL, 2015, NATURE, V524, P54, DOI 10.1038/nature14865; Milligan L, 2008, MOL CELL BIOL, V28, P5446, DOI 10.1128/MCB.00463-08; Mitchell P, 2003, MOL CELL BIOL, V23, P6982, DOI 10.1128/MCB.23.19.6982-6992.2003; Porrua O, 2013, NAT STRUCT MOL BIOL, V20, P884, DOI 10.1038/nsmb.2592; Rasmussen TP, 1998, MOL CELL BIOL, V18, P6885, DOI 10.1128/MCB.18.12.6885; Schilders G, 2005, NUCLEIC ACIDS RES, V33, P6795, DOI 10.1093/nar/gki982; Schilders G, 2007, NUCLEIC ACIDS RES, V35, P2564, DOI 10.1093/nar/gkm082; Schneider C, 2013, TRENDS BIOCHEM SCI, V38, P485, DOI 10.1016/j.tibs.2013.06.013; Schuch B, 2014, EMBO J, V33, P2829, DOI 10.15252/embj.201488757; Soufi B, 2009, MOL BIOSYST, V5, P1337, DOI 10.1039/b902256b; Stead JA, 2007, NUCLEIC ACIDS RES, V35, P5556, DOI 10.1093/nar/gkm614; Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090; Sung MK, 2008, YEAST, V25, P301, DOI 10.1002/yea.1588; Thiebaut M, 2006, MOL CELL, V23, P853, DOI 10.1016/j.molcel.2006.07.029; Tudek A, 2014, MOL CELL, V55, P467, DOI 10.1016/j.molcel.2014.05.031; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Vasiljeva L, 2006, MOL CELL, V21, P239, DOI 10.1016/j.molcel.2005.11.028; Vasiljeva L, 2008, NAT STRUCT MOL BIOL, V15, P795, DOI 10.1038/nsmb.1468; Wasmuth EV, 2014, NATURE, V511, P435, DOI 10.1038/nature13406; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030	38	15	15	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13229	13242		10.1074/jbc.M116.715771	http://dx.doi.org/10.1074/jbc.M116.715771			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27076633	hybrid, Green Published			2022-12-26	WOS:000379770500028
J	Pediani, JD; Ward, RJ; Godin, AG; Marsango, S; Milligan, G				Pediani, John D.; Ward, Richard J.; Godin, Antoine G.; Marsango, Sara; Milligan, Graeme			Dynamic Regulation of Quaternary Organization of the M-1 Muscarinic Receptor by Subtype-selective Antagonist Drugs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTENSITY DISTRIBUTION ANALYSIS; PROTEIN-COUPLED RECEPTORS; FLUORESCENCE CORRELATION SPECTROSCOPY; HIGHER-ORDER OLIGOMERS; ACETYLCHOLINE-RECEPTOR; LIVE CELLS; INTERFACE; SEROTONIN; DIMERIZATION; ACTIVATION	Although rhodopsin-like G protein-coupled receptors can exist as both monomers and non-covalently associated dimers/oligomers, the steady-state proportion of each form and whether this is regulated by receptor ligands are unknown. Herein we address these topics for the M-1 muscarinic acetylcholine receptor, a key molecular target for novel cognition enhancers, by using spatial intensity distribution analysis. This method can measure fluorescent particle concentration and assess oligomerization states of proteins within defined regions of living cells. Imaging and analysis of the basolateral surface of cells expressing some 50 molecules.mu m(-2) human muscarinic M-1 receptor identified a similar to 75:25 mixture of receptor monomers and dimers/oligomers. Both sustained and shorter term treatment with the selective M-1 antagonist pirenzepine resulted in a large shift in the distribution of receptor species to favor the dimeric/oligomeric state. Although sustained treatment with pirenzepine also resulted in marked up-regulation of the receptor, simple mass action effects were not the basis for ligand-induced stabilization of receptor dimers/oligomers. The related antagonist telenzepine also produced stabilization and enrichment of the M-1 receptor dimer population, but the receptor subtype non-selective antagonists atropine and N-methylscopolamine did not. In contrast, neither pirenzepine nor telenzepine altered the quaternary organization of the related M-3 muscarinic receptor. These data provide unique insights into the selective capacity of receptor ligands to promote and/or stabilize receptor dimers/oligomers and demonstrate that the dynamics of ligand regulation of the quaternary organization of G protein-coupled receptors is markedly more complex than previously appreciated. This may have major implications for receptor function and behavior.	[Pediani, John D.; Ward, Richard J.; Marsango, Sara; Milligan, Graeme] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Mol Pharmacol Grp, Glasgow G12 8QQ, Lanark, Scotland; [Godin, Antoine G.] Inst Opt, F-33405 Talence, France; [Godin, Antoine G.] CNRS, LP2N, F-33405 Talence, France; [Godin, Antoine G.] Univ Bordeaux, LP2N, UMR 5298, F-33405 Talence, France	University of Glasgow; UDICE-French Research Universities; Universite de Bordeaux; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite de Bordeaux; Universite Paris Saclay	Milligan, G (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Mol Pharmacol Grp, Glasgow G12 8QQ, Lanark, Scotland.	Graeme.Milligan@glasgow.ac.uk	Pediani, John/F-2708-2019	Pediani, John/0000-0001-6615-537X; Godin, Antoine/0000-0003-2417-2563; Milligan, Graeme/0000-0002-6946-3519	Medical Research Council [MR/L023806/1, G0900050]; MRC [MR/L023806/1, G0900050] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grants MR/L023806/1 and G0900050. The authors declare that they have no conflicts of interest with the contents of this article.	Alvarez-Curto E, 2010, ANAL BIOANAL CHEM, V398, P167, DOI 10.1007/s00216-010-3823-4; Alvarez-Curto E, 2010, J BIOL CHEM, V285, P23316, DOI 10.1074/jbc.M110.122184; Aslanoglou D, 2015, J BIOL CHEM, V290, P14785, DOI 10.1074/jbc.M115.649079; Barbeau A, 2013, METHOD ENZYMOL, V522, P109, DOI 10.1016/B978-0-12-407865-9.00007-8; Calebiro D, 2013, P NATL ACAD SCI USA, V110, P743, DOI 10.1073/pnas.1205798110; Ferre S, 2014, PHARMACOL REV, V66, P413, DOI 10.1124/pr.113.008052; Fonseca JM, 2009, MOL PHARMACOL, V75, P1296, DOI 10.1124/mol.108.053876; Ganguly S, 2011, BIOPHYS J, V100, P361, DOI 10.1016/j.bpj.2010.12.3692; Godin AG, 2015, BIOPHYS J, V109, P710, DOI 10.1016/j.bpj.2015.06.068; Godin AG, 2011, P NATL ACAD SCI USA, V108, P7010, DOI 10.1073/pnas.1018658108; Goin JC, 2006, J BIOL CHEM, V281, P5416, DOI 10.1074/jbc.M507476200; Guo W, 2005, P NATL ACAD SCI USA, V102, P17495, DOI 10.1073/pnas.0508950102; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; HAMMER R, 1980, NATURE, V283, P90, DOI 10.1038/283090a0; Harikumar KG, 2007, J BIOL CHEM, V282, P30363, DOI 10.1074/jbc.M702325200; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Herrick-Davis K, 2015, MOL PHARMACOL, V87, P660, DOI 10.1124/mol.114.096636; Herrick-Davis K, 2013, MOL PHARMACOL, V84, P630, DOI 10.1124/mol.113.087072; Herrick-Davis K, 2012, J BIOL CHEM, V287, P23604, DOI 10.1074/jbc.M112.350249; Hu JX, 2012, FASEB J, V26, P604, DOI 10.1096/fj.11-191510; Ilien B, 2009, J BIOL CHEM, V284, P19533, DOI 10.1074/jbc.M109.017145; Jastrzebska B, 2015, J BIOL CHEM, V290, P25728, DOI 10.1074/jbc.M115.662684; Johnston JM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002649; Kasai RS, 2011, J CELL BIOL, V192, P463, DOI 10.1083/jcb.201009128; Liste MJV, 2015, MOL PHARMACOL, V87, P936, DOI 10.1124/mol.114.096925; Marsango Sara, 2015, Methods Mol Biol, V1335, P95, DOI 10.1007/978-1-4939-2914-6_7; Marsango S, 2015, J BIOL CHEM, V290, P15146, DOI 10.1074/jbc.M114.630681; McMillin SM, 2011, J BIOL CHEM, V286, P28584, DOI 10.1074/jbc.M111.259788; Milligan G, 2013, MOL PHARMACOL, V84, P158, DOI 10.1124/mol.113.084780; Nenasheva TA, 2013, J MOL CELL CARDIOL, V57, P129, DOI 10.1016/j.yjmcc.2013.01.009; Patowary S, 2013, BIOCHEM J, V452, P303, DOI 10.1042/BJ20121902; Redka DS, 2014, J BIOL CHEM, V289, P24347, DOI 10.1074/jbc.M114.559294; von Stetten D, 2012, ACTA CRYSTALLOGR F, V68, P878, DOI 10.1107/S1744309112028667; Ward RJ, 2015, J BIOL CHEM, V290, P12844, DOI 10.1074/jbc.M115.644724; Ward RJ, 2011, METHODS MOL BIOL, V746, P21, DOI 10.1007/978-1-61779-126-0_2; Wess J, 1996, CRIT REV NEUROBIOL, V10, P69, DOI 10.1615/CritRevNeurobiol.v10.i1.40; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zakrys L, 2014, BIOCHEM J, V461, P61, DOI 10.1042/BJ20140190	38	33	33	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13132	13146		10.1074/jbc.M115.712562	http://dx.doi.org/10.1074/jbc.M115.712562			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27080256	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000379770500021
J	Ma, HX; Lin, Y; Zhao, ZA; Lu, XK; Yu, Y; Zhang, XX; Wang, Q; Li, L				Ma, Haixia; Lin, Yu; Zhao, Zhen-Ao; Lu, Xukun; Yu, Yang; Zhang, Xiaoxin; Wang, Qiang; Li, Lei			MicroRNA-127 Promotes Mesendoderm Differentiation of Mouse Embryonic Stem Cells by Targeting Left-Right Determination Factor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VERTEBRATE GASTRULATION; PRIMITIVE STREAK; BIOGENESIS; DICER; GENE; PLURIPOTENCY; EXPRESSION; PATTERNS; REVEALS; ROLES	Specification of the three germ layers is a fundamental process and is essential for the establishment of organ rudiments. Multiple genetic and epigenetic factors regulate this dynamic process; however, the function of specific microRNAs in germ layer differentiation remains unknown. In this study, we established that microRNA-127 (miR-127) is related to germ layer specification via microRNA array analysis of isolated three germ layers of E7.5 mouse embryos and was verified through differentiation of mouse embryonic stem cells. miR-127 is highly expressed in endoderm and primitive streak. Overexpression of miR-127 increases and inhibition of miR-127 decreases the expression of mesendoderm markers. We further show that miR-127 promotes mesendoderm differentiation through the nodal pathway, a determinative signaling pathway in early embryogenesis. Using luciferase reporter assay, left-right determination factor 2 (Lefty2), an antagonist of nodal, is identified to be a novel target of miR-127. Furthermore, the role of miR-127 in mesendoderm differentiation is attenuated by Lefty2 overexpression. Altogether, our results indicate that miR-127 accelerates mesendoderm differentiation of mouse embryonic stem cells through nodal signaling by targeting Lefty2.	[Ma, Haixia; Zhao, Zhen-Ao; Lu, Xukun; Yu, Yang; Zhang, Xiaoxin; Li, Lei] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China; [Lin, Yu; Wang, Qiang] Chinese Acad Sci, Inst Zool, State Key Lab Membrane Biol, Beijing 100101, Peoples R China; [Ma, Haixia; Li, Lei] Univ Chinese Acad Sci, Inst Zool, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; University of Chinese Academy of Sciences, CAS	Li, L (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China.; Wang, Q (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Membrane Biol, Beijing 100101, Peoples R China.; Li, L (corresponding author), Univ Chinese Acad Sci, Inst Zool, Beijing 100049, Peoples R China.	qiangwang@ioz.ac.cn; lil@ioz.ac.cn	Ma, Haixia/ABC-4707-2021	Ma, Haixia/0000-0001-9080-2004; Wang, Qiang/0000-0002-8735-8771; Li, Lei/0000-0001-5478-5681	National Natural Science Foundation of China [31590832, 31471353]; National Basic Research Program of China [2012CB944401]; Chinese Academy of Sciences [XDA01010103]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Natural Science Foundation of China Grants 31590832 and 31471353, National Basic Research Program of China Grant 2012CB944401, and Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDA01010103. The authors declare that they have no conflicts of interest with the contents of this article.	Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Betschinger J, 2013, CELL, V153, P335, DOI 10.1016/j.cell.2013.03.012; Bhaskaran M, 2009, PHYSIOL GENOMICS, V37, P268, DOI 10.1152/physiolgenomics.90268.2008; Brennan J, 2001, NATURE, V411, P965, DOI 10.1038/35082103; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Colas AR, 2012, GENE DEV, V26, P2567, DOI 10.1101/gad.200758.112; CONLON FL, 1994, DEVELOPMENT, V120, P1919; Constam DB, 2000, GENE DEV, V14, P1146; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Harfe BD, 2005, CURR OPIN GENET DEV, V15, P410, DOI 10.1016/j.gde.2005.06.012; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Heisenberg CP, 2008, CURR OPIN GENET DEV, V18, P311, DOI 10.1016/j.gde.2008.07.011; Hoodless PA, 2001, GENE DEV, V15, P1257, DOI 10.1101/gad.881501; Ito M, 2015, DEVELOPMENT, V142, P2425, DOI 10.1242/dev.121996; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kim VN, 2005, MOL CELLS, V19, P1; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Liu ZT, 2011, J BIOL CHEM, V286, P28520, DOI 10.1074/jbc.M111.236307; Meno C, 1999, MOL CELL, V4, P287, DOI 10.1016/S1097-2765(00)80331-7; Meno C, 1996, NATURE, V381, P151, DOI 10.1038/381151a0; Meno C, 2001, DEV CELL, V1, P127, DOI 10.1016/S1534-5807(01)00006-5; Mukherjee A, 2007, P NATL ACAD SCI USA, V104, P1348, DOI 10.1073/pnas.0607966104; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Sevignani C, 2006, MAMM GENOME, V17, P189, DOI 10.1007/s00335-005-0066-3; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Solnica-Krezel L, 2005, CURR BIOL, V15, pR213, DOI 10.1016/j.cub.2005.03.016; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Tam PPL, 1997, MECH DEVELOP, V68, P3, DOI 10.1016/S0925-4773(97)00123-8; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wong SSY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036121; Yates LA, 2013, CELL, V153, P516, DOI 10.1016/j.cell.2013.04.003; Ying SY, 2004, GENE, V342, P25, DOI 10.1016/j.gene.2004.07.025; Zhao ZA, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150092	40	16	17	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12126	12135		10.1074/jbc.M116.723247	http://dx.doi.org/10.1074/jbc.M116.723247			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27072135	hybrid, Green Published			2022-12-26	WOS:000378092800015
J	Emmerling, F; Schuhmann, T; Lobbestael, J; Arntz, A; Brugman, S; Sack, AT				Emmerling, Franziska; Schuhmann, Teresa; Lobbestael, Jill; Arntz, Arnoud; Brugman, Suzanne; Sack, Alexander Thomas			The Role of the Insular Cortex in Retaliation	PLOS ONE			English	Article							SUPERIOR TEMPORAL SULCUS; PROACTIVE AGGRESSION; ANTERIOR INSULA; NEURAL BASIS; BRAIN; FMRI; VALIDITY; VALENCE	The insular cortex has consistently been associated with various aspects of emotion regulation and social interaction, including anger processing and overt aggression. Aggression research distinguishes proactive or instrumental aggression from retaliation, i. e. aggression in response to provocation. Here, we investigated the specific role of the insular cortex during retaliation, employing a controlled behavioral aggression paradigm implementing different levels of provocation. Fifteen healthy male volunteers underwent whole brain functional magnetic resonance imaging (fMRI) to identify brain regions involved in interaction with either a provoking or a non-provoking opponent. FMRI group analyses were complemented by examining the parametric modulations of brain activity related to the individual level of displayed aggression. These analyses identified a hemispheric lateralization as well as an anatomical segregation of insular cortex with specifically the left posterior part being involved in retaliation. The left-lateralization of insular activity during retaliation is in accordance with evidence from electro-physiological studies, suggesting left-lateralized frontocortical dominance during anger processing and aggressive acts. The posterior localization of insular activity, on the other hand, suggests a spatial segregation within insular cortex with particularly the posterior part being involved in the processing of emotions that trigger intense bodily sensations and immediate action tendencies.	[Emmerling, Franziska; Schuhmann, Teresa; Sack, Alexander Thomas] Maastricht Univ, Dept Cognit Neurosci, NL-6200 MD Maastricht, Netherlands; [Emmerling, Franziska; Schuhmann, Teresa; Sack, Alexander Thomas] Maastricht Brain Imaging Ctr, Maastricht, Netherlands; [Lobbestael, Jill; Arntz, Arnoud; Brugman, Suzanne] Maastricht Univ, Dept Clin Psychol Sci, NL-6200 MD Maastricht, Netherlands; [Arntz, Arnoud] Univ Amsterdam, Dept Clin Psychol, NL-1018 WB Amsterdam, Netherlands	Maastricht University; Maastricht University; Maastricht University; University of Amsterdam	Emmerling, F (corresponding author), Maastricht Univ, Dept Cognit Neurosci, NL-6200 MD Maastricht, Netherlands.; Emmerling, F (corresponding author), Maastricht Brain Imaging Ctr, Maastricht, Netherlands.	franziska.emmerling@maastrichtuniversity.nl	Arntz, Arnoud/M-3011-2013	Arntz, Arnoud/0000-0002-7992-2272; Sack, Alexander/0000-0002-1471-0885; Lobbestael, Jill/0000-0001-9205-3115	Netherlands Organization for Scientific Research (NWO) [HCMI 10-19]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by a grant from the Netherlands Organization for Scientific Research (NWO; HCMI 10-19); http://www.nwo.nl/en/research-and-results/programmes/nihc/hcmi/index.html.	Anderson CA, 2002, ANNU REV PSYCHOL, V53, P27, DOI 10.1146/annurev.psych.53.100901.135231; Anderson CA, 1999, CURR DIR PSYCHOL SCI, V8, P3, DOI 10.1111/1467-8721.00002; BERNSTEIN S, 1987, AGGRESSIVE BEHAV, V13, P15, DOI 10.1002/1098-2337(1987)13:1<15::AID-AB2480130104>3.0.CO;2-K; Beyer F, 2015, CEREB CORTEX, V25, P3057, DOI 10.1093/cercor/bhu101; Beyer F, 2014, SOC COGN AFFECT NEUR, V9, P1552, DOI 10.1093/scan/nst146; Brunnlieb C, 2013, SOC NEUROSCI-UK, V8, P148, DOI 10.1080/17470919.2013.763654; Cacioppo S, 2013, CURRENT TRENDS NEURO, V7, P1; Cacioppo S, 2012, J SEX MED, V9, P1048, DOI 10.1111/j.1743-6109.2012.02651.x; Chester DS, 2016, SOCIAL COGNITIVE AFF; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Dambacher F, 2015, SOC COGN AFFECT NEUR, V10, P508, DOI 10.1093/scan/nsu077; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; GIANCOLA PR, 1995, AGGRESSIVE BEHAV, V21, P199, DOI 10.1002/1098-2337(1995)21:3<199::AID-AB2480210303>3.0.CO;2-Q; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Harmon-Jones E, 2004, BIOL PSYCHOL, V67, P51, DOI 10.1016/j.biopsycho.2004.03.003; Kramer UM, 2007, NEUROIMAGE, V38, P203, DOI 10.1016/j.neuroimage.2007.07.029; Lancaster JL, 1997, HUM BRAIN MAPP, V5, P238, DOI 10.1002/(SICI)1097-0193(1997)5:4<238::AID-HBM6>3.0.CO;2-4; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lotze M, 2007, NEUROIMAGE, V34, P470, DOI 10.1016/j.neuroimage.2006.09.028; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Nelson SM, 2010, BRAIN STRUCT FUNCT, V214, P669, DOI 10.1007/s00429-010-0260-2; Pelphrey KA, 2004, J COGNITIVE NEUROSCI, V16, P1706, DOI 10.1162/0898929042947900; Pelphrey KA, 2004, PSYCHOL SCI, V15, P598, DOI 10.1111/j.0956-7976.2004.00726.x; Poulin F, 2000, PSYCHOL ASSESSMENT, V12, P115, DOI 10.1037/1040-3590.12.2.115; Raine A, 2006, AGGRESSIVE BEHAV, V32, P159, DOI 10.1002/ab.20115; Rankin KP, 2009, NEUROIMAGE, V47, P2005, DOI 10.1016/j.neuroimage.2009.05.077; Reynolds SM, 2008, NAT NEUROSCI, V11, P423, DOI 10.1038/nn2061; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Sterzer P, 2010, BRAIN STRUCT FUNCT, V214, P611, DOI 10.1007/s00429-010-0252-2; Talairach J., 1988, COPLANAR STEREOTAXIC; TAYLOR SP, 1967, J PERS, V35, P297, DOI 10.1111/j.1467-6494.1967.tb01430.x; van Honk J, 2006, PSYCHOL SCI, V17, P963, DOI 10.1111/j.1467-9280.2006.01813.x; Zilbovicius M, 2006, TRENDS NEUROSCI, V29, P359, DOI 10.1016/j.tins.2006.06.004	34	20	20	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0152000	10.1371/journal.pone.0152000	http://dx.doi.org/10.1371/journal.pone.0152000			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9OU	27096431	Green Published, gold			2022-12-26	WOS:000374543600007
J	Moly, PK; Cooley, JR; Zeltzer, SL; Yatskievych, TA; Antin, PB				Moly, Pricila K.; Cooley, James R.; Zeltzer, Sebastian L.; Yatskievych, Tatiana A.; Antin, Parker B.			Gastrulation EMT Is Independent of P-Cadherin Downregulation	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SNAIL; EPITHELIAL-MESENCHYMAL TRANSITIONS; EXPRESSION; GENE; SLUG	Epithelial-mesenchymal transition (EMT) is an evolutionarily conserved process during which cells lose epithelial characteristics and gain a migratory phenotype. Although downregulation of epithelial cadherins by Snail and other transcriptional repressors is generally considered a prerequisite for EMT, recent studies have challenged this view. Here we investigate the relationship between E-cadherin and P-cadherin expression and localization, Snail function and EMT during gastrulation in chicken embryos. Expression analyses show that while E-cadherin transcripts are detected in the epiblast but not in the primitive streak or mesoderm, P-cadherin mRNA and protein are present in the epiblast, primitive and mesoderm. Antibodies that specifically recognize E-cadherin are not presently available. During EMT, P-cadherin relocalizes from the lateral surfaces of epithelial epiblast cells to a circumferential distribution in emerging mesodermal cells. Cells electroporated with an E-cadherin expression construct undergo EMT and migrate into the mesoderm. An examination of Snail function showed that reduction of Slug (SNAI2) protein levels using a morpholino fails to inhibit EMT, and expression of human or chicken Snail in epiblast cells fails to induce EMT. In contrast, cells expressing the Rho inhibitor peptide C3 rapidly exit the epiblast without activating Slug or the mesoderm marker N-cadherin. Together, these experiments show that epiblast cells undergo EMT while retaining P-cadherin, and raise questions about the mechanisms of EMT regulation during avian gastrulation.	[Moly, Pricila K.; Cooley, James R.; Zeltzer, Sebastian L.; Yatskievych, Tatiana A.; Antin, Parker B.] Univ Arizona, Dept Cellular & Mol Med, 1656 E Mabel St,POB 245217, Tucson, AZ 85724 USA	University of Arizona	Antin, PB (corresponding author), Univ Arizona, Dept Cellular & Mol Med, 1656 E Mabel St,POB 245217, Tucson, AZ 85724 USA.	pba@email.arizona.edu		Antin, Parker/0000-0001-9066-7412	NIH [P41 HD064559]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P41HD064559, P41HD088362] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by NIH grant P41 HD064559 to PBA.	Acloque H, 2011, DEV CELL, V21, P546, DOI 10.1016/j.devcel.2011.07.005; AKTORIES K, 1989, TRENDS PHARMACOL SCI, V10, P415, DOI 10.1016/0165-6147(89)90191-0; Alves CC, 2007, J PATHOL, V211, P507, DOI 10.1002/path.2138; Nieto MA, 2012, SEMIN CANCER BIOL, V22, P361, DOI 10.1016/j.semcancer.2012.05.003; Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Conacci-Sorrell M, 2003, J CELL BIOL, V163, P847, DOI 10.1083/jcb.200308162; GRAU Y, 1984, GENETICS, V108, P347; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hardy KM, 2008, DEV BIOL, V320, P391, DOI 10.1016/j.ydbio.2008.05.546; Hardy KM, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-20; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Lim J, 2012, DEVELOPMENT, V139, P3471, DOI 10.1242/dev.071209; Liu JP, 1998, DEVELOPMENT, V125, P5055; Nakaya Y, 2008, NAT CELL BIOL, V10, P765, DOI 10.1038/ncb1739; NEW DAT, 1955, J EMBRYOL EXP MORPH, V3, P320; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; NIETO MA, 1994, SCIENCE, V264, P835, DOI 10.1126/science.7513443; Ohkubo T, 2004, J CELL SCI, V117, P1675, DOI 10.1242/jcs.01004; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Schafer G, 2014, J CELL SCI, V127, P1511, DOI 10.1242/jcs.139485; Shamir ER, 2014, J CELL BIOL, V204, P839, DOI 10.1083/jcb.201306088; Straub BK, 2011, J CELL BIOL, V195, P873, DOI 10.1083/jcb.201106023; Takeichi M, 2011, DEV CELL, V21, P24, DOI 10.1016/j.devcel.2011.06.002; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Williams M, 2014, DEV CELL, V29, P34, DOI 10.1016/j.devcel.2014.02.007; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	32	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153591	10.1371/journal.pone.0153591	http://dx.doi.org/10.1371/journal.pone.0153591			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097030	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000374543600044
J	Tien, SM; Hsu, CY; Chen, BS				Tien, Shin-Ming; Hsu, Chih-Yuan; Chen, Bor-Sen			Engineering Bacteria to Search for Specific Concentrations of Molecules by a Systematic Synthetic Biology Design Method	PLOS ONE			English	Article							CHEMOTAXIS; MODEL; POPULATIONS; COLI; CELL	Bacteria navigate environments full of various chemicals to seek favorable places for survival by controlling the flagella's rotation using a complicated signal transduction pathway. By influencing the pathway, bacteria can be engineered to search for specific molecules, which has great potential for application to biomedicine and bioremediation. In this study, genetic circuits were constructed to make bacteria search for a specific molecule at particular concentrations in their environment through a synthetic biology method. In addition, by replacing the "brake component" in the synthetic circuit with some specific sensitivities, the bacteria can be engineered to locate areas containing specific concentrations of the molecule. Measured by the swarm assay qualitatively and microfluidic techniques quantitatively, the characteristics of each "brake component" were identified and represented by a mathematical model. Furthermore, we established another mathematical model to anticipate the characteristics of the "brake component". Based on this model, an abundant component library can be established to provide adequate component selection for different searching conditions without identifying all components individually. Finally, a systematic design procedure was proposed. Following this systematic procedure, one can design a genetic circuit for bacteria to rapidly search for and locate different concentrations of particular molecules by selecting the most adequate "brake component" in the library. Moreover, following simple procedures, one can also establish an exclusive component library suitable for other cultivated environments, promoter systems, or bacterial strains.	[Tien, Shin-Ming; Hsu, Chih-Yuan; Chen, Bor-Sen] Natl Tsing Hua Univ, Dept Elect Engn, Lab Control & Syst Biol, Hsinchu, Taiwan	National Tsing Hua University	Chen, BS (corresponding author), Natl Tsing Hua Univ, Dept Elect Engn, Lab Control & Syst Biol, Hsinchu, Taiwan.	bschen@ee.nthu.edu.tw	Chen, Bor-Sen/D-9114-2017		Ministry of Science and Technology, Taiwan [MOST 103-2745-E-007-001-ASP]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	The authors are grateful for the support provided by the Ministry of Science and Technology, Taiwan, through grant no. MOST 103-2745-E-007-001-ASP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed T, 2008, BIOPHYS J, V95, P4481, DOI 10.1529/biophysj.108.134510; Ahmed T, 2010, INTEGR BIOL-UK, V2, P604, DOI 10.1039/c0ib00049c; Anderson JC, 2006, J MOL BIOL, V355, P619, DOI 10.1016/j.jmb.2005.10.076; Chen BS, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-136; Derr P, 2006, J MOL BIOL, V355, P923, DOI 10.1016/j.jmb.2005.11.025; Dyer CM, 2004, J MOL BIOL, V342, P1325, DOI 10.1016/j.jmb.2004.07.084; Goldberg SD, MOL SYSTEMS BIOL, V5; Hazelbauer GL, 2007, TRENDS BIOCH SCI, V33; Hsu CY, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S5-S7; Hsu CY, IEEE ACM T IN PRESS; Hwang IY, 2014, ACS SYNTH BIOL, V3, P228, DOI 10.1021/sb400077j; KELLER EF, 1971, J THEOR BIOL, V30, P225, DOI 10.1016/0022-5193(71)90050-6; Lee YY, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-109; Levin-Karp A, 2013, ACS SYNTH BIOL, V2, P327, DOI 10.1021/sb400002n; Lin B, 2012, CURR OPIN CHEM BIOL, V16, P307, DOI 10.1016/j.cbpa.2012.04.012; LOVELY PS, 1975, J THEOR BIOL, V50, P477, DOI 10.1016/0022-5193(75)90094-6; Mishler DM, 2010, CURR OPIN BIOTECH, V21, P653, DOI 10.1016/j.copbio.2010.05.007; RIVERO MA, 1989, CHEM ENG SCI, V44, P2881, DOI 10.1016/0009-2509(89)85098-5; Scharf BE, 1998, J BACTERIOL, V180, P5123, DOI 10.1128/JB.180.19.5123-5128.1998; Scharf BE, 1998, P NATL ACAD SCI USA, V95, P201, DOI 10.1073/pnas.95.1.201; Schuster M, 1998, MOL MICROBIOL, V27, P1065, DOI 10.1046/j.1365-2958.1998.00756.x; Sinha J, 2010, NAT CHEM BIOL, V6, P464, DOI 10.1038/nchembio.369; Sourjik V, 2012, CURR OPIN CELL BIOL, V24, P262, DOI 10.1016/j.ceb.2011.11.008; Taghavi S, 1997, RES MICROBIOL, V148, P536, DOI 10.1016/S0923-2508(97)88361-1; Tindall MJ, 2008, B MATH BIOL, V70, P1570, DOI 10.1007/s11538-008-9322-5; Tindall MJ, 2008, B MATH BIOL, V70, P1525, DOI 10.1007/s11538-008-9321-6; Topp S, 2007, J AM CHEM SOC, V129, P6807, DOI 10.1021/ja0692480; Weiss LE, 2008, BIOTECHNOLOGY BIOENG, V100; WOLFE AJ, 1989, P NATL ACAD SCI USA, V86, P6973, DOI 10.1073/pnas.86.18.6973; Zhu XY, 1996, J BACTERIOL, V178, P4208, DOI 10.1128/jb.178.14.4208-4215.1996	30	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0152146	10.1371/journal.pone.0152146	http://dx.doi.org/10.1371/journal.pone.0152146			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096615	gold, Green Published, Green Submitted			2022-12-26	WOS:000374543600008
J	Biering-Sorensen, T; Mogelvang, R; de Knegt, MC; Olsen, FJ; Galatius, S; Jensen, JS				Biering-Sorensen, Tor; Mogelvang, Rasmus; de Knegt, Martina Chantal; Olsen, Flemming Javier; Galatius, Soren; Jensen, Jan Skov			Cardiac Time Intervals by Tissue Doppler Imaging M-Mode: Normal Values and Association with Established Echocardiographic and Invasive Measures of Systolic and Diastolic Function	PLOS ONE			English	Article							MYOCARDIAL PERFORMANCE INDEX; LEFT-VENTRICULAR FUNCTION; HEART-FAILURE; GENERAL-POPULATION; PROGNOSTIC VALUE; SURFACE-AREA; STRAIN-RATE; INFARCTION; RECOMMENDATIONS; MEN	Purpose To define normal values of the cardiac time intervals obtained by tissue Doppler imaging (TDI) M-mode through the mitral valve (MV). Furthermore, to evaluate the association of the myocardial performance index (MPI) obtained by TDI M-mode (MPITD1) and the conventional method of obtaining MPI (MPIconv), with established echocardiographic and invasive measures of systolic and diastolic function. Methods In a large community based population study (n = 974), where all are free of any cardiovascular disease and cardiovascular risk factors, cardiac time intervals, including isovolumic relaxation time (IVRT), isovolumic contraction time (IVCT), and ejection time (ET) were obtained by TDI M-mode through the MV. IVCT/ET, IVRT/ET and the MPI ((IVRT+IVCT)/ET) were calculated. We also included a validation population (n = 44) of patients who underwent left heart catheterization and had the MPH! and MPIconv measured. Results IVRT, IVRT/ET and MPI all increased significantly with increasing age in both genders (p<0.001 for all). IVCT, ET, IVRT/ET, and MPI differed significantly between males and females, displaying that women, in general exhibit better cardiac function. MPITDI was significantly associated with invasive (dP/dt max) and echocardiographic measures of systolic (LVEF, global longitudinal strain and global strainrate s) and diastolic function (e', global strainrate e)(p<0.05 for all), whereas MPIconv was significantly associated with LVEF, e' and global strainrate e (p<0.05 for all). Conclusion Normal values of cardiac time intervals differed between genders and deteriorated with increasing age. The MPH! (but not MPIconv) is associated with most invasive and established echocardiographic measures of systolic and diastolic function.	[Biering-Sorensen, Tor; Mogelvang, Rasmus; de Knegt, Martina Chantal; Olsen, Flemming Javier; Galatius, Soren; Jensen, Jan Skov] Univ Copenhagen, Herlev & Gentofte Hosp, Dept Cardiol, Copenhagen, Denmark; [Biering-Sorensen, Tor; Mogelvang, Rasmus; Jensen, Jan Skov] Univ Copenhagen, Frederiksberg Hosp, Copenhagen City Heart Study, Copenhagen, Denmark; [Biering-Sorensen, Tor; Jensen, Jan Skov] Univ Copenhagen, Inst Clin Med, Fac Hlth Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Biering-Sorensen, T (corresponding author), Univ Copenhagen, Herlev & Gentofte Hosp, Dept Cardiol, Copenhagen, Denmark.; Biering-Sorensen, T (corresponding author), Univ Copenhagen, Frederiksberg Hosp, Copenhagen City Heart Study, Copenhagen, Denmark.; Biering-Sorensen, T (corresponding author), Univ Copenhagen, Inst Clin Med, Fac Hlth Sci, Copenhagen, Denmark.	tor.biering@gmail.com	Olsen, Flemming/AAS-8127-2021	Olsen, Flemming Javier/0000-0001-9511-8375; Biering-Sorensen, Tor/0000-0003-4209-2778; de Knegt, Martina/0000-0001-7668-0338	Faculty of Health Sciences, University of Copenhagen, Denmark	Faculty of Health Sciences, University of Copenhagen, Denmark	This study was financially supported by the Faculty of Health Sciences, University of Copenhagen, Denmark. The sponsor had no role in the study design, data collection, data analysis, data interpretation, or writing of the manuscript.	Arnlov J, 2004, EUR HEART J, V25, P2220, DOI 10.1016/j.ehj.2004.10.021; Biering-Sorensen T, 2016, INT J CARDIOVAS IMAG, V32, P789, DOI 10.1007/s10554-016-0839-7; Biering-Sorensen T, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002687; Biering-Sorensen T, 2015, HEART, V101, P954, DOI 10.1136/heartjnl-2014-307137; Biering-Sorensen T, 2013, CIRC-CARDIOVASC IMAG, V6, P457, DOI 10.1161/CIRCIMAGING.112.000230; Biering-Sorensen T, 2011, AM J CARDIOL, V107, P478, DOI 10.1016/j.amjcard.2010.09.044; Chung AK, 2006, CIRCULATION, V113, P1597, DOI 10.1161/CIRCULATIONAHA.105.574400; Cui W, 2008, J AM SOC ECHOCARDIOG, V21, P361, DOI 10.1016/j.echo.2007.05.034; Dalen H, 2010, EUR J ECHOCARDIOGR, V11, P176, DOI 10.1093/ejechocard/jep194; DUBOIS D, 1989, NUTRITION, V5, P303; Duzenli MA, 2009, HEART VESSELS, V24, P8, DOI 10.1007/s00380-008-1069-2; Harada K, 2001, AM J CARDIOL, V88, P927, DOI 10.1016/S0002-9149(01)01912-9; Kaya MG, 2014, J THORAC DIS, V6, P429, DOI 10.3978/j.issn.2072-1439.2014.03.19; Kjaergaard J, 2005, J AM SOC ECHOCARDIOG, V18, P1058, DOI 10.1016/j.echo.2005.03.043; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Meric M, 2014, INT J CARDIOVAS IMAG, V30, P1057, DOI 10.1007/s10554-014-0449-1; Mogelvang R, 2015, EUR HEART J-CARD IMG, V16, P1331, DOI 10.1093/ehjci/jev180; Mogelvang R, 2009, EUR HEART J, V30, P731, DOI 10.1093/eurheartj/ehn596; Moller JE, 2003, AM HEART J, V145, P147, DOI 10.1067/mhj.2003.46; Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007; Ruggiero A, 2013, INT J CLIN ONCOL, V18, P927, DOI 10.1007/s10147-012-0458-9; Su HM, 2007, ECHOCARDIOGR-J CARD, V24, P252, DOI 10.1111/j.1540-8175.2007.00382.x; Tei C, 1995, J Cardiol, V26, P135; Tei C, 1995, J Cardiol, V26, P357; Tei C, 1997, J AM SOC ECHOCARDIOG, V10, P169, DOI 10.1016/S0894-7317(97)70090-7; Tekten T, 2003, ECHOCARDIOGR-J CARD, V20, P503, DOI 10.1046/j.1540-8175.2003.03086.x; Tekten T, 2003, JPN HEART J, V44, P403, DOI 10.1536/jhj.44.403; Varol E, 2010, HEART VESSELS, V25, P400, DOI 10.1007/s00380-009-1225-3; Voigt JV, 2003, J AM SOC ECHOCARDIOG, V16, P415, DOI 10.1016/S0894-7317(03)00111-1; Weidemann F, 2002, AM J PHYSIOL-HEART C, V283, pH792, DOI 10.1152/ajpheart.00025.2002; WEISSLER AM, 1968, CIRCULATION, V37, P149, DOI 10.1161/01.CIR.37.2.149	31	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153636	10.1371/journal.pone.0153636	http://dx.doi.org/10.1371/journal.pone.0153636			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093636	Green Published, gold			2022-12-26	WOS:000374541200035
J	Hampel, M; Jakobi, M; Schmitz, L; Meyer, U; Finkernagel, F; Doehlemann, G; Heimel, K				Hampel, Martin; Jakobi, Mareike; Schmitz, Lara; Meyer, Ute; Finkernagel, Florian; Doehlemann, Gunther; Heimel, Kai			Unfolded Protein Response (UPR) Regulator Cib1 Controls Expression of Genes Encoding Secreted Virulence Factors in Ustilago maydis	PLOS ONE			English	Article							PATHOGENIC DEVELOPMENT; TRANSCRIPTION FACTOR; ENDOPLASMIC-RETICULUM; REPLACEMENT MUTANTS; FUNGAL EFFECTOR; MESSENGER-RNA; CLP1 PROTEIN; ER-STRESS; IRE1; GENOME	The unfolded protein response (UPR), a conserved eukaryotic signaling pathway to ensure protein homeostasis in the endoplasmic reticulum (ER), coordinates biotrophic development in the corn smut fungus Ustilago maydis. Exact timing of UPR activation is required for virulence and presumably connected to the elevated expression of secreted effector proteins during infection of the host plant Zea mays. In the baker's yeast Saccharomyces cerevisiae, expression of UPR target genes is induced upon binding of the central regulator Hac1 to unfolded protein response elements (UPREs) in their promoters. While a role of the UPR in effector secretion has been described previously, we investigated a potential UPR-dependent regulation of genes encoding secreted effector proteins. In silico prediction of UPREs in promoter regions identified the previously characterized effector genes pit2 and tin1-1, as bona fide UPR target genes. Furthermore, direct binding of the Hac1-homolog Cib1 to the UPRE containing promoter fragments of both genes was confirmed by quantitative chromatin immunoprecipitation (qChIP) analysis. Targeted deletion of the UPRE abolished Cib1-dependent expression of pit2 and significantly affected virulence. Furthermore, ER stress strongly increased Pit2 expression and secretion. This study expands the role of the UPR as a signal hub in fungal virulence and illustrates, how biotrophic fungi can coordinate cellular physiology, development and regulation of secreted virulence factors.	[Hampel, Martin; Jakobi, Mareike; Schmitz, Lara; Heimel, Kai] Inst Microbiol & Genet, Dept Mol Microbiol & Genet, Gottingen, Germany; [Hampel, Martin; Heimel, Kai] Univ Gottingen, Ctr Mol Biosci GZMB, D-37073 Gottingen, Germany; [Meyer, Ute; Doehlemann, Gunther] Univ Cologne, Inst Bot, Gyrhofstr 15, Cologne, Germany; [Meyer, Ute; Doehlemann, Gunther] Univ Cologne, Cluster Excellence Plant Sci, D-50931 Cologne, Germany; [Finkernagel, Florian] Univ Marburg, Inst Mol Biol & Tumor Res IMT, Marburg, Germany	University of Gottingen; University of Cologne; University of Cologne; Philipps University Marburg	Heimel, K (corresponding author), Inst Microbiol & Genet, Dept Mol Microbiol & Genet, Gottingen, Germany.; Heimel, K (corresponding author), Univ Gottingen, Ctr Mol Biosci GZMB, D-37073 Gottingen, Germany.	kheimel@gwdg.de	Doehlemann, Gunther/C-1777-2008	Heimel, Kai/0000-0002-1396-8622; Doehlemann, Gunther/0000-0002-7353-8456	Deutsche Forschungsgemeinschaft [HE6977/2-1]; German Research Foundation; Gottingen University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Research Foundation(German Research Foundation (DFG)); Gottingen University	This work was supported by Deutsche Forschungsgemeinschaft grant (HE6977/2-1), www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank members of the Heimel lab for constructive comments on the manuscript, Anika Klewing for support during the initial screening procedure, J. Kamper and J. Ulrich for expert advice on ChIP analysis and G. Braus for generous support. We thank Daniela Assmann for excellent technical support. We acknowledge support by the German Research Foundation and the Open Access Publication Funds of the Gottingen University.	Basse CW, 2002, MOL MICROBIOL, V43, P75, DOI 10.1046/j.1365-2958.2002.02742.x; Basse CW, 2000, MOL CELL BIOL, V20, P329, DOI 10.1128/MCB.20.1.329-339.2000; Baumann S, 2012, J CELL SCI, V125, P2740, DOI 10.1242/jcs.101212; Brachmann A, 2004, MOL GENET GENOMICS, V272, P216, DOI 10.1007/s00438-004-1047-z; Brefort T, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003866; Cheon SA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002177; Chujo T, 2014, MOL MICROBIOL, V92, P413, DOI 10.1111/mmi.12567; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; de Jonge R, 2011, CURR OPIN PLANT BIOL, V14, P400, DOI 10.1016/j.pbi.2011.03.005; Djamei A, 2011, NATURE, V478, P395, DOI 10.1038/nature10454; Doehlemann G, 2011, MOL MICROBIOL, V81, P751, DOI 10.1111/j.1365-2958.2011.07728.x; Doehlemann G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000290; Dolinski K, 1997, P NATL ACAD SCI USA, V94, P13093, DOI 10.1073/pnas.94.24.13093; Flor-Parra I, 2006, PLANT CELL, V18, P2369, DOI 10.1105/tpc.106.042754; Fordyce PM, 2012, P NATL ACAD SCI USA, V109, pE3084, DOI 10.1073/pnas.1212457109; Freitag J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002044; Heimel K, 2013, PLANT CELL, V25, P4262, DOI 10.1105/tpc.113.115899; Heimel K, 2010, PLANT CELL, V22, P2908, DOI 10.1105/tpc.110.076265; Heimel K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001035; Hemetsberger C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002684; Holliday R., 1974, HDB GENETICS, P575, DOI 10.1007/978-1-4899-1710-2_31; Joubert A, 2011, MOL MICROBIOL, V79, P1305, DOI 10.1111/j.1365-2958.2010.07522.x; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kamper J, 2004, MOL GENET GENOMICS, V271, P103, DOI 10.1007/s00438-003-0962-8; Khrunyk Y, 2010, NEW PHYTOL, V187, P957, DOI 10.1111/j.1469-8137.2010.03413.x; Kimata Y, 2007, J CELL BIOL, V179, P75, DOI 10.1083/jcb.200704166; Kleemann J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002643; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Lanver D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004272; Lanver D, 2010, PLANT CELL, V22, P2085, DOI 10.1105/tpc.109.073734; Laurie JD, 2012, PLANT CELL, V24, P1733, DOI 10.1105/tpc.112.097261; Lo Presti L, 2015, NEW PHYTOL; Lo Presti L, 2015, ANNU REV PLANT BIOL, V66, P513, DOI 10.1146/annurev-arplant-043014-114623; Mahlert M, 2006, MOL MICROBIOL, V59, P567, DOI 10.1111/j.1365-2958.2005.04952.x; Moore KA, 2012, ANNU REV GENET, V46, P165, DOI 10.1146/annurev-genet-110711-155644; MORI K, 1992, EMBO J, V11, P2583, DOI 10.1002/j.1460-2075.1992.tb05323.x; Mori K, 1996, GENES CELLS, V1, P803, DOI 10.1046/j.1365-2443.1996.d01-274.x; Mueller AN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003177; Mueller O, 2008, FUNGAL GENET BIOL, V45, pS63, DOI 10.1016/j.fgb.2008.03.012; Mulder HJ, 2004, MOL GENET GENOMICS, V271, P130, DOI 10.1007/s00438-003-0965-5; O'Connell RJ, 2012, NAT GENET, V44, P1060, DOI 10.1038/ng.2372; Ogawa N, 2004, GENES CELLS, V9, P95, DOI 10.1111/j.1365-2443.2004.00704.x; Redkar A, 2015, PLANT CELL, V27, P1332, DOI 10.1105/tpc.114.131086; Richie DL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000258; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rubio C, 2011, J CELL BIOL, V193, P171, DOI 10.1083/jcb.201007077; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Scherer M, 2006, PLANT CELL, V18, P2388, DOI 10.1105/tpc.106.043521; SCHULZ B, 1990, CELL, V60, P295, DOI 10.1016/0092-8674(90)90744-Y; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Skibbe DS, 2010, SCIENCE, V328, P89, DOI 10.1126/science.1185775; Soyer JL, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004227; Stergiopoulos I, 2009, ANNU REV PHYTOPATHOL, V47, P233, DOI 10.1146/annurev.phyto.112408.132637; Tanaka S, 2014, ELIFE, V3, DOI 10.7554/eLife.01355; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; TSUKUDA T, 1988, MOL CELL BIOL, V8, P3703, DOI 10.1128/MCB.8.9.3703; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	58	12	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153861	10.1371/journal.pone.0153861	http://dx.doi.org/10.1371/journal.pone.0153861			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093436	Green Published, Green Submitted, gold			2022-12-26	WOS:000374541200052
J	Cui, TX; Wang, YJ; Sun, R; Qiao, C; Fan, WJ; Jiang, GQ; Hao, LY; Zhang, L				Cui, Tianxiang; Wang, Yujie; Sun, Rui; Qiao, Chen; Fan, Wenjie; Jiang, Guoqing; Hao, Lvyuan; Zhang, Lei			Estimating Vegetation Primary Production in the Heihe River Basin of China with Multi-Source and Multi-Scale Data	PLOS ONE			English	Article							NET PRIMARY PRODUCTIVITY; GROSS PRIMARY PRODUCTION; PRIMARY PRODUCTION GPP; LEAF-AREA INDEX; EDDY-COVARIANCE; ECOSYSTEM MODEL; USE EFFICIENCY; CLIMATE-CHANGE; SURFACE; FOREST	Estimating gross primary production (GPP) and net primary production (NPP) are significant important in studying carbon cycles. Using models driven by multi-source and multi-scale data is a promising approach to estimate GPP and NPP at regional and global scales. With a focus on data that are openly accessible, this paper presents a GPP and NPP model driven by remotely sensed data and meteorological data with spatial resolutions varying from 30 m to 0.25 degree and temporal resolutions ranging from 3 hours to 1 month, by integrating remote sensing techniques and eco-physiological process theories. Our model is also designed as part of the Multi-source data Synergized Quantitative (MuSyQ) Remote Sensing Production System. In the presented MuSyQ-NPP algorithm, daily GPP for a 10-day period was calculated as a product of incident photosynthetically active radiation (PAR) and its fraction absorbed by vegetation (FPAR) using a light use efficiency (LUE) model. The autotrophic respiration (Ra) was determined using eco-physiological process theories and the daily NPP was obtained as the balance between GPP and Ra. To test its feasibility at regional scales, our model was performed in an arid and semi-arid region of Heihe River Basin, China to generate daily GPP and NPP during the growing season of 2012. The results indicated that both GPP and NPP exhibit clear spatial and temporal patterns in their distribution over Heihe River Basin during the growing season due to the temperature, water and solar influx conditions. After validated against ground-based measurements, MODIS GPP product (MOD17A2H) and results reported in recent literature, we found the MuSyQ-NPP algorithm could yield an RMSE of 2.973 gC m(-2) d(-1) and an R of 0.842 when compared with ground-based GPP while an RMSE of 8.010 gC m(-2) d(-1) and an R of 0.682 can be achieved for MODIS GPP, the estimated NPP values were also well within the range of previous literature, which proved the reliability of our modelling results. This research suggested that the utilization of multi-source data with various scales would help to the establishment of an appropriate model for calculating GPP and NPP at regional scales with relatively high spatial and temporal resolution.	[Cui, Tianxiang; Sun, Rui; Qiao, Chen; Jiang, Guoqing; Hao, Lvyuan; Zhang, Lei] Beijing Normal Univ, State Key Lab Remote Sensing Sci, Beijing, Peoples R China; [Cui, Tianxiang; Sun, Rui; Qiao, Chen; Jiang, Guoqing; Hao, Lvyuan; Zhang, Lei] Chinese Acad Sci, State Key Lab Remote Sensing Sci, Inst Remote Sensing & Digital Earth, Beijing, Peoples R China; [Cui, Tianxiang; Sun, Rui; Qiao, Chen; Jiang, Guoqing; Hao, Lvyuan; Zhang, Lei] Beijing Normal Univ, Sch Geog & Remote Sensing Sci, Beijing 100875, Peoples R China; [Cui, Tianxiang; Sun, Rui; Qiao, Chen; Jiang, Guoqing; Hao, Lvyuan; Zhang, Lei] Beijing Key Lab Remote Sensing Environm & Digital, Beijing, Peoples R China; [Wang, Yujie] Northwest Reg Climate Ctr, Lanzhou, Peoples R China; [Wang, Yujie] Nanjing Univ, Sch Atmospher Sci, Nanjing 210008, Jiangsu, Peoples R China; [Fan, Wenjie] Peking Univ, Inst Remote Sensing & Geog Informat Syst, Beijing 100871, Peoples R China	Beijing Normal University; Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS; Beijing Normal University; Nanjing University; Peking University	Sun, R (corresponding author), Beijing Normal Univ, State Key Lab Remote Sensing Sci, Beijing, Peoples R China.; Sun, R (corresponding author), Chinese Acad Sci, State Key Lab Remote Sensing Sci, Inst Remote Sensing & Digital Earth, Beijing, Peoples R China.; Sun, R (corresponding author), Beijing Normal Univ, Sch Geog & Remote Sensing Sci, Beijing 100875, Peoples R China.; Sun, R (corresponding author), Beijing Key Lab Remote Sensing Environm & Digital, Beijing, Peoples R China.	sunrui@bnu.edu.cn	Cui, Tianxiang/ABA-4631-2020	Cui, Tianxiang/0000-0001-7546-1408	National Natural Science Foundation of China [41471349]; National Key Project of Scientific and Technical Supporting Programs - Ministry of Science AMP; Technology of China [2013BAC03B02]; National High Technology Research and Development Program of China (863 Program) [2012AA12A304]; Fundamental Research Funds for the Central Universities [2014kJJCA02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Project of Scientific and Technical Supporting Programs - Ministry of Science AMP; Technology of China; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was funded by the National Natural Science Foundation of China (41471349), the National Key Project of Scientific and Technical Supporting Programs Funded by Ministry of Science & Technology of China (2013BAC03B02), the National High Technology Research and Development Program of China (863 Program, 2012AA12A304), and the Fundamental Research Funds for the Central Universities (2014kJJCA02).	Chen JM, 1999, ECOL MODEL, V124, P99, DOI 10.1016/S0304-3800(99)00156-8; [陈正华 CHEN Zhenghua], 2008, [自然资源学报, Journal of Natural Resources], V23, P263; Coops NC, 2007, REMOTE SENS ENVIRON, V107, P385, DOI 10.1016/j.rse.2006.09.010; Falge E, 2002, AGR FOREST METEOROL, V113, P53, DOI 10.1016/S0168-1923(02)00102-8; Fan L, 2015, REMOTE SENS-BASEL, V7, P3114, DOI 10.3390/rs70303114; Fan WJ, 2014, IEEE J-STARS, V7, P3945, DOI 10.1109/JSTARS.2014.2325673; Feng X, 2007, J ENVIRON MANAGE, V85, P563, DOI 10.1016/j.jenvman.2006.09.021; FIELD CB, 1995, REMOTE SENS ENVIRON, V51, P74, DOI 10.1016/0034-4257(94)00066-V; [卢玲 LU Ling], 2005, [中国沙漠, Journal of Desert Research], V25, P823; FROUIN R, 1995, REMOTE SENS ENVIRON, V51, P98, DOI 10.1016/0034-4257(94)00068-X; Leith H., 1975, PRIMARY PRODUCTIVITY, DOI [10.1007/978-3-642-80913-2_12, DOI 10.1007/978-3-642-80913-2_12]; Leuning R, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006562; Li X, 2001, J ARID ENVIRON, V48, P521, DOI 10.1006/jare.2000.0715; Li X. B., 2013, THESIS; Li XQ, 2013, APPL GEOCHEM, V35, P99, DOI 10.1016/j.apgeochem.2013.04.001; Li X, 2013, B AM METEOROL SOC, V94, P1145, DOI 10.1175/BAMS-D-12-00154.1; Liao YR, 2013, INT GEOSCI REMOTE SE, P169, DOI 10.1109/IGARSS.2013.6721118; Liu B, 2010, ENVIRON EARTH SCI, V59, P1235, DOI 10.1007/s12665-009-0112-7; Liu J, 1997, REMOTE SENS ENVIRON, V62, P158, DOI 10.1016/S0034-4257(97)00089-8; Liu J, 1999, J GEOPHYS RES-ATMOS, V104, P27735, DOI 10.1029/1999JD900768; Liu SM, 2011, HYDROL EARTH SYST SC, V15, P1291, DOI 10.5194/hess-15-1291-2011; Los SO, 2000, J HYDROMETEOROL, V1, P183, DOI 10.1175/1525-7541(2000)001<0183:AGYBLS>2.0.CO;2; Lu DS, 2006, INT J REMOTE SENS, V27, P1297, DOI 10.1080/01431160500486732; Ma MG, 2006, INT J REMOTE SENS, V27, P3473, DOI 10.1080/01431160600593031; Matsushita B, 2004, ECOL MODEL, V178, P371, DOI 10.1016/j.ecolmodel.2004.03.012; Matsushita B, 2002, REMOTE SENS ENVIRON, V81, P58, DOI 10.1016/S0034-4257(01)00331-5; McGuire AD, 1995, J BIOGEOGR, V22, P785, DOI 10.2307/2845980; MELILLO JM, 1993, NATURE, V363, P234, DOI 10.1038/363234a0; Monteith J L, 1965, Symp Soc Exp Biol, V19, P205; MONTEITH JL, 1972, J APPL ECOL, V9, P747, DOI 10.2307/2401901; Mu QZ, 2011, REMOTE SENS ENVIRON, V115, P1781, DOI 10.1016/j.rse.2011.02.019; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Pachavo G, 2014, INT J APPL EARTH OBS, V30, P217, DOI 10.1016/j.jag.2014.02.007; Pan XD, 2014, J HYDROMETEOROL, V15, P1560, DOI 10.1175/JHM-D-13-0202.1; PARTON WJ, 1993, GLOBAL BIOGEOCHEM CY, V7, P785, DOI 10.1029/93GB02042; Piao S.L., 2001, CHIN J PLANT ECOL, V25, P603, DOI DOI 10.3321/J.ISSN:1005-264X.2001.05.015; POTTER CS, 1993, GLOBAL BIOGEOCHEM CY, V7, P811, DOI 10.1029/93GB02725; PRIESTLEY CHB, 1972, MON WEATHER REV, V100, P81, DOI 10.1175/1520-0493(1972)100<0081:OTAOSH>2.3.CO;2; Prieto-Blanco A, 2009, REMOTE SENS ENVIRON, V113, P137, DOI 10.1016/j.rse.2008.09.002; Prince SD, 1995, J BIOGEOGR, V22, P815, DOI 10.2307/2845983; Propastin P, 2009, REMOTE SENS-BASEL, V1, P159, DOI 10.3390/rs1030159; Qiao C, 2015, IEEE GEOSCI REMOTE S, V12, P369, DOI 10.1109/LGRS.2014.2342219; Rodell M, 2004, B AM METEOROL SOC, V85, P381, DOI 10.1175/BAMS-85-3-381; Ruimy A, 1994, J GEOPHYS RES-ATMOS, V99, P5263, DOI 10.1029/93JD03221; Running S. W., 2015, USERS GUIDE DAILY GP; Running S.W., 1993, SCALING PHYSL PROCES, P141, DOI DOI 10.1016/B978-0-12-233440-5.50014-2; RUNNING SW, 1988, ECOL MODEL, V42, P125, DOI 10.1016/0304-3800(88)90112-3; SINCLAIR TR, 1989, CROP SCI, V29, P90, DOI 10.2135/cropsci1989.0011183X002900010023x; Sun R., 1999, CHINESE J APPL ECOLO, V10, P757; Turner DP, 2003, REMOTE SENS ENVIRON, V88, P256, DOI 10.1016/j.rse.2003.06.005; Turner DP, 2003, GLOBAL CHANGE BIOL, V9, P383, DOI 10.1046/j.1365-2486.2003.00573.x; Uchijima Z., 1985, J AGROMETEOROL, V40, P343, DOI DOI 10.2480/AGRMET.40.343; Wang HM, 2004, ATMOS ENVIRON, V38, P7021, DOI 10.1016/j.atmosenv.2004.02.071; Wang P, 2007, J ENVIRON MANAGE, V85, P607, DOI 10.1016/j.jenvman.2006.08.017; Wang XF, 2012, INT J APPL EARTH OBS, V17, P94, DOI 10.1016/j.jag.2011.09.009; Wen J, 2012, HIWATER VISIBLE NEAR; Weng DM, 1984, GEOPHYS RES, V3, P24; WOFSY SC, 1993, SCIENCE, V260, P1314, DOI 10.1126/science.260.5112.1314; Xiao XM, 2004, REMOTE SENS ENVIRON, V91, P256, DOI 10.1016/j.rse.2004.03.010; Xu ZW, 2013, J GEOPHYS RES-ATMOS, V118, P13140, DOI 10.1002/2013JD020260; Zhang Hongyi, 2006, THESIS; ZHANG K, 2006, WATER RESOUR RES, V46; Zhang K, 2009, J HYDROL, V379, P92, DOI 10.1016/j.jhydrol.2009.09.047; Zhang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120660; Zhang Yushun, 2014, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V34, P2085, DOI 10.7606/j.issn.1000-4025.2014.10.2085; Zhong B, 2014, SCI CHINA EARTH SCI, V57, P1790, DOI 10.1007/s11430-014-4877-5; Zhou LM, 2001, J GEOPHYS RES-ATMOS, V106, P20069, DOI 10.1029/2000JD000115; Zhou Y, 2007, J ENVIRON MANAGE, V85, P574, DOI 10.1016/j.jenvman.2006.04.024; Zhu HZ, 2006, THESIS; Zhu Wen-Quan, 2007, Zhiwu Shengtai Xuebao, V31, P413	70	26	31	7	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153971	10.1371/journal.pone.0153971	http://dx.doi.org/10.1371/journal.pone.0153971			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088356	Green Published, gold, Green Submitted			2022-12-26	WOS:000374527000059
J	Liang, H; Zhang, Q; Lu, JJ; Yang, GL; Tian, N; Wang, XJ; Tan, Y; Tan, DM				Liang, Hao; Zhang, Qian; Lu, Junjie; Yang, Genling; Tian, Na; Wang, Xiaojie; Tan, Yi; Tan, Dongmei			MSX2 Induces Trophoblast Invasion in Human Placenta	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GENE-EXPRESSION; DIFFERENTIATION; PREECLAMPSIA; IMPLANTATION; PREGNANCY; CELLS; ADENOCARCINOMA; 1ST-TRIMESTER; METHYLATION	Normal implantation depends on appropriate trophoblast growth and invasion. Inadequate trophoblast invasion results in pregnancy-related disorders, such as early miscarriage and pre-eclampsia, which are dangerous to both the mother and fetus. Msh Homeobox 2 (MSX2), a member of the MSX family of homeobox proteins, plays a significant role in the proliferation and differentiation of various cells and tissues, including ectodermal organs, teeth, and chondrocytes. Recently, MSX2 was found to play important roles in the invasion of cancer cells into adjacent tissues via the epithelial-mesenchymal transition (EMT). However, the role of MSX2 in trophoblastic invasion during placental development has yet to be explored. In the present study, we detected MSX2 expression in cytotrophoblast, syncytiotrophoblast, and extravillous cytotrophoblast cells of first or third trimester human placentas via immunohistochemistry analysis. Furthermore, we found that the in vitro invasive ability of HTR8/SVneo cells was enhanced by exogenous overexpression of MSX2, and that this effect was accompanied by increased protein expression of matrix metalloproteinase-2 (MMP-2), vimentin, and beta-catenin. Conversely, treatment of HTR8/SVneo cells with MSX2-specific siRNAs resulted in decreased protein expression of MMP-2, vimentin, and beta-catenin, and reduced invasion levels in a Matrigel invasion test. Notably, however, treatment with the MSX2 overexpression plasmid and the MSX2 siRNAs had no effect on the mRNA expression levels of beta-catenin. Meanwhile, overexpression of MSX2 and treatment with the MSX2-specific siRNA resulted in decreased and increased E-cadherin expression, respectively, in JEG-3 cells. Lastly, the protein expression levels of MSX2 were significantly lower in human pre-eclamptic placental villi than in the matched control placentas. Collectively, our results suggest that MSX2 may induce human trophoblast cell invasion, and dysregulation of MSX2 expression may be associated with pre-eclampsia.	[Liang, Hao; Zhang, Qian; Lu, Junjie; Yang, Genling; Tian, Na; Wang, Xiaojie; Tan, Yi; Tan, Dongmei] Chongqing Med Univ, Lab Anim Ctr, Chongqing, Peoples R China	Chongqing Medical University	Tan, DM (corresponding author), Chongqing Med Univ, Lab Anim Ctr, Chongqing, Peoples R China.	dongmei_tan@yeah.net	tian, na/GVR-9226-2022		National Natural Science Foundation of China [31171436, 81501259]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (31171436 to Y.T, 81501259 to Q.Z) (http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelova M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002959; Bai Q, 2012, STEM CELL REV REP, V8, P150, DOI 10.1007/s12015-011-9301-3; Carson DD, 2002, MOL HUM REPROD, V8, P871, DOI 10.1093/molehr/8.9.871; Catron KM, 1996, MECH DEVELOP, V55, P185, DOI 10.1016/0925-4773(96)00503-5; Cha J, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130035; Daikoku T, 2011, DEV CELL, V21, P1014, DOI 10.1016/j.devcel.2011.09.010; Di Bari MG, 2009, J CELL PHYSIOL, V219, P659, DOI 10.1002/jcp.21712; Fisher SJ, 2015, AM J OBSTET GYNECOL, V213, pS115, DOI 10.1016/j.ajog.2015.08.042; Fritz R, 2014, INT J DEV BIOL, V58, P261, DOI 10.1387/ijdb.140011da; Fu JJ, 2010, J BIOL CHEM, V285, P10870, DOI 10.1074/jbc.M109.004200; Gauster M, 2009, PLACENTA, V30, pS49, DOI 10.1016/j.placenta.2008.10.011; Hamada S, 2007, J CELL PHYSIOL, V213, P768, DOI 10.1002/jcp.21148; James JL, 2005, REPRODUCTION, V130, P95, DOI 10.1530/rep.1.00723; Jay PY, 2005, J CARDIOVASC ELECTR, V16, P82, DOI 10.1046/j.1540-8167.2005.04365.x; JOWETT AK, 1993, DEVELOPMENT, V117, P461; Knoefler Martin, 2013, Frontiers in Genetics, V4, P190, DOI 10.3389/fgene.2013.00190; Lanigan F, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2621; Lyall F, 2006, AUST NZ J OBSTET GYN, V46, P266, DOI 10.1111/j.1479-828X.2006.00589.x; Mohamed OA, 2005, P NATL ACAD SCI USA, V102, P8579, DOI 10.1073/pnas.0500612102; Nallasamy S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002500; Nissi R, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-2; Novakovic B, 2008, MOL HUM REPROD, V14, P547, DOI 10.1093/molehr/gan046; Pennington KA, 2012, DIS MODEL MECH, V5, P9, DOI 10.1242/dmm.008516; Phippard DJ, 1996, DEVELOPMENT, V122, P2729; Pollheimer J, 2006, AM J PATHOL, V168, P1134, DOI 10.2353/ajpath.2006.050686; Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991; Renfree MB, 2014, INT J DEV BIOL, V58, P175, DOI 10.1387/ijdb.140059mr; Richter A, 2014, STEM CELLS, V32, P636, DOI 10.1002/stem.1592; Sagomonyants K, 2014, CONNECT TISSUE RES, V55, P53, DOI 10.3109/03008207.2014.923867; Satoh K, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00430; Sonderegger S, 2007, PLACENTA, V28, pS97, DOI 10.1016/j.placenta.2006.11.003; Sonderegger S, 2010, PLACENTA, V31, P839, DOI 10.1016/j.placenta.2010.07.011; Sonderegger S, 2010, ENDOCRINOLOGY, V151, P211, DOI 10.1210/en.2009-0557; Van der Auwera I, 2008, BRIT J CANCER, V99, P1735, DOI 10.1038/sj.bjc.6604705; van Dijk Marie, 2014, Front Genet, V5, P38, DOI 10.3389/fgene.2014.00038; Vicovac L, 1996, ACTA ANAT, V156, P202; Yeh J, 2009, WOUND REPAIR REGEN, V17, P639, DOI 10.1111/j.1524-475X.2009.00535.x; Zhai Y, 2011, ONCOGENE, V30, P4152, DOI 10.1038/onc.2011.123; Zhang HL, 1997, MOL CELL BIOL, V17, P2920, DOI 10.1128/MCB.17.5.2920; Zhang Z, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-17; Zhou Z, 2009, PLACENTA, V30, P929, DOI 10.1016/j.placenta.2009.09.003	41	15	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153656	10.1371/journal.pone.0153656	http://dx.doi.org/10.1371/journal.pone.0153656			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088357	gold, Green Published, Green Submitted			2022-12-26	WOS:000374527000039
J	Chen, ZM; Wang, HY; Liu, XW; Liu, YZ; Gao, SS; Zhou, JM				Chen, Zhaoming; Wang, Huoyan; Liu, Xiaowei; Liu, Yongzhe; Gao, Shuaishuai; Zhou, Jianmin			The Effect of N Fertilizer Placement on the Fate of Urea-N-15 and Yield of Winter Wheat in Southeast China	PLOS ONE			English	Article							NITROGEN USE EFFICIENCY; SUMMER MAIZE ROTATION; CROPPING SYSTEM; N-15-LABELED FERTILIZER; MICROBIAL COMMUNITY; SOIL PROPERTIES; SPRING WHEAT; BREAD WHEAT; ROOT-ZONE; RECOVERY	A field micro-plot experiment using nitrogen isotope (N-15) labeling was conducted to determine the effects of placement methods (broadcast and band) and N rates (60, 150 and 240 kg ha(-1)) on the fate of urea(-15)N in the wheat-soil system in Guangde County of Anhui Province, China. N fertilizer applied in bands increased grain yield by 15% compared with broadcast application. The N fertilizer application rate had a significant effect on grain yield, straw yield and aboveground biomass, as well as on N uptake and N concentration of wheat. The recovery of urea-N-15 was a little higher for broadcast (34.0-39.0%) than for band treatment (31.2-38.2%). Most of the soil residual N was retained in the 0-20 cm soil layer. At the N rates of 60 and 240 kg ha(-1), the residual N-15 was higher for band (34.4 and 108.7 kg ha(-1), respectively) than for broadcast application (29.6 and 88.4 kg ha(-1), respectively). Compared with broadcast treatment, banded placement of N fertilizer decreased the N loss in the wheat-soil system. Band application one time is an alternative N management practice for winter wheat in this region.	[Chen, Zhaoming; Wang, Huoyan; Liu, Xiaowei; Liu, Yongzhe; Gao, Shuaishuai; Zhou, Jianmin] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing 210018, Jiangsu, Peoples R China; [Chen, Zhaoming; Liu, Xiaowei; Gao, Shuaishuai] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Soil Science, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, HY (corresponding author), Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing 210018, Jiangsu, Peoples R China.	hywang@issas.ac.cn			National Basic Research Program of China [2013CB127401]; National Department Public Benefit Research Foundation of China [201203013]; National Natural Science Foundation of China [41271309]; Program of the 13th Five-Year Plan in the Institute of Soil Science, Chinese Academy of Sciences [ISSASIP1649]	National Basic Research Program of China(National Basic Research Program of China); National Department Public Benefit Research Foundation of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of the 13th Five-Year Plan in the Institute of Soil Science, Chinese Academy of Sciences	This work was supported by the National Basic Research Program of China (2013CB127401), the National Department Public Benefit Research Foundation of China (201203013), the National Natural Science Foundation of China (41271309), and the Program of the 13th Five-Year Plan in the Institute of Soil Science, Chinese Academy of Sciences (ISSASIP1649).	Angus JF, 2014, CROP PASTURE SCI, V65, P337, DOI 10.1071/CP13337; Blankenau K, 2000, J PLANT NUTR SOIL SC, V163, P475, DOI 10.1002/1522-2624(200010)163:5<475::AID-JPLN475>3.0.CO;2-W; Cui ZL, 2011, SOIL SCI SOC AM J, V75, P976, DOI 10.2136/sssaj2010.0117; Dai XL, 2014, PLANT SOIL, V384, P141, DOI 10.1007/s11104-014-2190-x; Duan W, 2015, INT J PLANT PROD, V9, P237; Engel R, 2010, J ENVIRON QUAL, V39, P115, DOI 10.2134/jeq2009.0130; Fan MS, 2007, NUTR CYCL AGROECOSYS, V79, P255, DOI 10.1007/s10705-007-9112-8; Fuertes-Mendizabal T, 2010, EUR J AGRON, V33, P52, DOI 10.1016/j.eja.2010.03.001; Grant CA, 2001, CAN J PLANT SCI, V81, P17, DOI 10.4141/P00-091; Guo RY, 2008, PLANT SOIL, V313, P55, DOI 10.1007/s11104-008-9679-0; Haile D, 2012, J SOIL SCI PLANT NUT, V12, P389, DOI 10.4067/S0718-95162012005000002; HAMID A, 1995, BIOL FERT SOILS, V20, P185, DOI 10.1007/BF00336556; Hartmann TE, 2015, FIELD CROP RES, V174, P30, DOI 10.1016/j.fcr.2015.01.006; Ichir LL, 2003, NUTR CYCL AGROECOSYS, V66, P201, DOI 10.1023/A:1023976600760; Jayasundara S, 2007, NUTR CYCL AGROECOSYS, V79, P141, DOI 10.1007/s10705-007-9103-9; Jayasundara S, 2010, CAN J SOIL SCI, V90, P55, DOI 10.4141/CJSS08085; Jia SL, 2011, NUTR CYCL AGROECOSYS, V90, P331, DOI 10.1007/s10705-011-9433-5; Ju XT, 2007, PEDOSPHERE, V17, P52, DOI 10.1016/S1002-0160(07)60007-1; Lam SK, 2012, NUTR CYCL AGROECOSYS, V92, P133, DOI 10.1007/s10705-011-9477-6; Liang B, 2013, BIOL FERT SOILS, V49, P977, DOI 10.1007/s00374-013-0789-3; Lopez-Bellido L, 2005, FIELD CROP RES, V94, P86, DOI 10.1016/j.fcr.2004.11.004; Ma BL, 2006, J PLANT NUTR, V29, P469, DOI 10.1080/01904160500525065; MAHLER RL, 1994, AGRON J, V86, P637, DOI 10.2134/agronj1994.00021962008600040010x; Malhi SS, 1996, CAN J SOIL SCI, V76, P93, DOI 10.4141/cjss96-013; Mooleki SP, 2010, CAN J PLANT SCI, V90, P319, DOI 10.4141/CJPS09075; Ottman MJ, 2000, SOIL SCI SOC AM J, V64, P1883, DOI 10.2136/sssaj2000.6451883x; Peng YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037726; Petersen J, 2002, COMMUN SOIL SCI PLAN, V33, P163, DOI 10.1081/CSS-120002385; Petersen J, 2001, NUTR CYCL AGROECOSYS, V61, P215, DOI 10.1023/A:1013756715438; Rees RM, 1997, NUTR CYCL AGROECOSYS, V47, P81; Shen JB, 2013, J EXP BOT, V64, P1181, DOI 10.1093/jxb/ers342; Shi ZL, 2012, EUR J AGRON, V40, P86, DOI 10.1016/j.eja.2012.01.006; Shi ZL, 2012, FIELD CROP RES, V127, P241, DOI 10.1016/j.fcr.2011.11.025; Tran TS, 2000, CAN J SOIL SCI, V80, P533, DOI 10.4141/S99-098; Wang D, 2011, ACTA AGR SCAND B-S P, V61, P681, DOI 10.1080/09064710.2010.534108; [王火焰 Wang Huoyan], 2013, [土壤, Soils], V45, P785; Wang Q, 2010, PLANT SOIL, V337, P325, DOI 10.1007/s11104-010-0530-z; Xue LH, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/11/115010; Yang JB, 2013, BIOL FERT SOILS, V49, P23, DOI 10.1007/s00374-012-0692-3; Yevdokimov I, 2008, BIOL FERT SOILS, V44, P1103, DOI 10.1007/s00374-008-0315-1; Zhao SC, 2014, AGR ECOSYST ENVIRON, V194, P29, DOI 10.1016/j.agee.2014.05.006; Zhao X, 2009, PLANT SOIL, V319, P225, DOI 10.1007/s11104-008-9865-0; Zhou SL, 2008, ENVIRON POLLUT, V152, P723, DOI 10.1016/j.envpol.2007.06.047; Zhu ZL, 2002, NUTR CYCL AGROECOSYS, V63, P117, DOI 10.1023/A:1021107026067	44	25	27	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153701	10.1371/journal.pone.0153701	http://dx.doi.org/10.1371/journal.pone.0153701			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082246	gold, Green Published, Green Submitted			2022-12-26	WOS:000374291800047
J	Huleihel, M; Shufan, E; Zeiri, L; Salman, A				Huleihel, Mahmoud; Shufan, Elad; Zeiri, Leila; Salman, Ahmad			Detection of Vero Cells Infected with Herpes Simplex Types 1 and 2 and Varicella Zoster Viruses Using Raman Spectroscopy and Advanced Statistical Methods	PLOS ONE			English	Article							COLORECTAL-CANCER RELAPSE; INFRARED-SPECTROSCOPY; IN-VIVO; BREAST-CANCER; BIOCHEMICAL DIFFERENCES; EPITHELIAL CANCERS; FTIR SPECTROSCOPY; OPTICAL DIAGNOSIS; TISSUE; MICROSPECTROSCOPY	Of the eight members of the herpes family of viruses, HSV1, HSV2, and varicella zoster are the most common and are mainly involved in cutaneous disorders. These viruses usually are not life-threatening, but in some cases they might cause serious infections to the eyes and the brain that can lead to blindness and possibly death. An effective drug (acyclovir and its derivatives) is available against these viruses. Therefore, early detection and identification of these viral infections is highly important for an effective treatment. Raman spectroscopy, which has been widely used in the past years in medicine and biology, was used as a powerful spectroscopic tool for the detection and identification of these viral infections in cell culture, due to its sensitivity, rapidity and reliability. Our results showed that it was possible to differentiate, with a 97% identification success rate, the uninfected Vero cells that served as a control, from the Vero cells that were infected with HSV-1, HSV-2, and VZV. For that, linear discriminant analysis (LDA) was performed on the Raman spectra after principal component analysis (PCA) with a leave one out (LOO) approach. Raman spectroscopy in tandem with PCA and LDA enable to differentiate among the different herpes viral infections of Vero cells in time span of few minutes with high accuracy rate. Understanding cell molecular changes due to herpes viral infections using Raman spectroscopy may help in early detection and effective treatment.	[Huleihel, Mahmoud] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Microbiol Immunol & Genet, Beer Sheva, Israel; [Shufan, Elad; Salman, Ahmad] SCE, Dept Phys, Beer Sheva, Israel; [Zeiri, Leila] Ben Gurion Univ Negev, Dept Chem, Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Salman, A (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Microbiol Immunol & Genet, Beer Sheva, Israel.	mahmoudh@bgu.ac.il; ahmad@sce.ac.il		Salman, Ahmad/0000-0003-4953-8648				Agarwal R, 2006, J ORGANOMET CHEM, V691, P2902, DOI 10.1016/j.jorganchem.2006.02.032; Argov S, 2002, J BIOMED OPT, V7, P248, DOI 10.1117/1.1463051; Bergholt MS, 2011, INT J CANCER, V128, P2673, DOI 10.1002/ijc.25618; Bergholt MS, 2010, ANALYST, V135, P3162, DOI 10.1039/c0an00336k; Bishop CM, 2006, PATTERN RECOGN, Vxx; Bodanese B, 2010, PHOTOMED LASER SURG, V28, pS119, DOI 10.1089/pho.2009.2565; Carter EA, 2001, PRACT SPECTROSC SERI, V24, P421; Chan JW, 2006, BIOPHYS J, V90, P648, DOI 10.1529/biophysj.105.066761; Chayavichitsilp P, 2009, PEDIATR REV, V30, P119, DOI 10.1542/pir.30-4-119; Cheng WT, 2005, MICROSC RES TECHNIQ, V68, P75, DOI 10.1002/jemt.20229; Diem M, 2000, BIOPOLYMERS, V57, P282, DOI 10.1002/1097-0282(2000)57:5<282::AID-BIP50>3.0.CO;2-R; Dovbeshko GI, 2002, BIOPOLYMERS, V67, P470, DOI 10.1002/bip.10165; Draux F, 2009, ANALYST, V134, P542, DOI 10.1039/b812610k; Duda R.O., 2006, PATTERN CLASSIFICATI; Dukor RK, 2006, HANDBOOK OF VIBRATIO; EBERLE R, 1989, J MED VIROL, V27, P309, DOI 10.1002/jmv.1890270410; Eckel R, 2001, VIB SPECTROSC, V27, P165, DOI 10.1016/S0924-2031(01)00134-5; Elisseeff A, 2002, LEARNING THEORY AND; Ellis DI, 2006, ANALYST, V131, P875, DOI 10.1039/b602376m; Erukhimovitch V, 2011, ANALYST, V136, P2818, DOI 10.1039/c1an15319f; Erukhimovitch V, 2002, PHOTOCHEM PHOTOBIOL, V76, P446, DOI 10.1562/0031-8655(2002)076<0446:SCOHAM>2.0.CO;2; Evgeniou T, 2004, MACH LEARN, V55, P71, DOI 10.1023/B:MACH.0000019805.88351.60; Faolain EO, 2005, J HISTOCHEM CYTOCHEM, V53, P121, DOI 10.1177/002215540505300114; Farquharson S, 2005, J RAMAN SPECTROSC, V36, P208, DOI 10.1002/jrs.1277; Feofanov AV, 2000, BIOPHYS J, V78, P499, DOI 10.1016/S0006-3495(00)76612-4; Fujioka N, 2004, CANCER DETECT PREV, V28, P32, DOI 10.1016/j.cdp.2003.11.004; Georgakoudi I, 2002, CANCER RES, V62, P682; Gniadecka M, 2004, J INVEST DERMATOL, V122, P443, DOI 10.1046/j.0022-202X.2004.22208.x; Gupta R, 2007, LANCET, V370, P2127, DOI 10.1016/S0140-6736(07)61908-4; Haka AS, 2005, P NATL ACAD SCI USA, V102, P12371, DOI 10.1073/pnas.0501390102; Hawi SR, 1997, J LIPID RES, V38, P1591; Huang Y, 2009, NANO LETT, V9, P2914, DOI 10.1021/nl901234x; Huang ZW, 2003, INT J CANCER, V107, P1047, DOI 10.1002/ijc.11500; Huleihel M, 2001, J APPL PHYCOL, V13, P127, DOI 10.1023/A:1011178225912; Kamemoto LE, 2010, APPL SPECTROSC, V64, P255, DOI 10.1366/000370210790918364; Kazanci M, 2006, J STRUCT BIOL, V156, P489, DOI 10.1016/j.jsb.2006.06.011; Keller MD, 2008, DIS MARKERS, V25, P323, DOI 10.1155/2008/230307; Kos G, 2003, ANAL CHEM, V75, P1211, DOI 10.1021/ac0260903; Krafft C, 2004, ANAL BIOANAL CHEM, V378, P60, DOI 10.1007/s00216-003-2266-6; Krishna CM, 2004, APPL SPECTROSC, V58, P1128, DOI 10.1366/0003702041959460; Lau DP, 2003, LASER SURG MED, V32, P210, DOI 10.1002/lsm.10084; Lieber CA, 2008, LASER SURG MED, V40, P461, DOI 10.1002/lsm.20653; Mariani MM, 2010, ANAL CHEM, V82, P4259, DOI 10.1021/ac1006987; Markoulatos P, 1997, J CLIN LAB ANAL, V11, P146, DOI 10.1002/(SICI)1098-2825(1997)11:3&lt;146::AID-JCLA5&gt;3.0.CO;2-8; Matthaus C, 2006, APPL SPECTROSC, V60, P1, DOI 10.1366/000370206775382758; Meqdam MM, 2001, MICROBIOS, V105, P111; Min YK, 2005, J RAMAN SPECTROSC, V36, P73, DOI 10.1002/jrs.1280; Moor K, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.6.067003; Mourant JR, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1928050; Mourant JR, 2003, BIOPHYS J, V85, P1938, DOI 10.1016/S0006-3495(03)74621-9; Naumann A, 2009, ANALYST, V134, P1215, DOI 10.1039/b821286d; Naumann D, 1998, P SPIE; Notingher I, 2002, MATER CHARACT, V49, P255, DOI 10.1016/S1044-5803(03)00029-9; O Faolain E, 2005, VIB SPECTROSC, V38, P121, DOI 10.1016/j.vibspec.2005.02.013; Pomerantz A, 2014, J PHOTOCH PHOTOBIO B, V141, P308, DOI 10.1016/j.jphotobiol.2014.10.005; PUPPELS GJ, 1990, NATURE, V347, P301, DOI 10.1038/347301a0; Ruiz-Chica AJ, 2004, J RAMAN SPECTROSC, V35, P93, DOI 10.1002/jrs.1107; Salman A, 2016, VIB SPECTROSC, V83, P17, DOI 10.1016/j.vibspec.2016.01.002; Salman A, 2015, ANALYST, V140, P3098, DOI [10.1039/c5an00213c, 10.1039/C5AN00213C]; Salman A, 2014, METHODS, V68, P325, DOI 10.1016/j.ymeth.2014.02.021; Salman A, 2014, METHODS, V68, P364, DOI 10.1016/j.ymeth.2014.02.022; Salman A, 2013, BBA-GEN SUBJECTS, V1830, P2720, DOI 10.1016/j.bbagen.2012.11.023; Salman A, 2003, J BIOCHEM BIOPH METH, V55, P141, DOI 10.1016/S0165-022X(02)00182-3; Salman A, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.7.075007; Salman A, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.1.017002; Salman Ahmad, 2001, Cellular and Molecular Biology Online Papers, V47, pOL159; Schulz H, 2007, VIB SPECTROSC, V43, P13, DOI 10.1016/j.vibspec.2006.06.001; Shafer-Peltier KE, 2002, J RAMAN SPECTROSC, V33, P552, DOI 10.1002/jrs.877; Shaw RA, 1999, J MOL STRUCT, V481, P1, DOI 10.1016/S0022-2860(98)00648-6; SHI YF, 1993, J IMMUNOL METHODS, V164, P149, DOI 10.1016/0022-1759(93)90307-S; Silveira L, 2003, J CLIN LASER MED SUR, V21, P203, DOI 10.1089/104454703768247774; Smith E, 2005, MODERN RAMAN SPECTROSCOPY: A PRACTICAL APPROACH, P1; Stone N, 2004, FARADAY DISCUSS, V126, P141, DOI 10.1039/b304992b; Stone N, 2002, J RAMAN SPECTROSC, V33, P564, DOI 10.1002/jrs.882; van Manen HJ, 2008, ANAL CHEM, V80, P9576, DOI 10.1021/ac801841y; VERMA SP, 1977, CANCER RES, V37, P3490; Vogel R, 2012, J VIROL, V86, P143, DOI 10.1128/JVI.05694-11; Wu HW, 2011, P NATL ACAD SCI USA, V108, P3809, DOI 10.1073/pnas.1009043108; Yoshida S, 1997, BIOSPECTROSCOPY, V3, P281, DOI 10.1002/(SICI)1520-6343(1997)3:4<281::AID-BSPY3>3.0.CO;2-7; Zonios GI, 1996, IEEE T BIO-MED ENG, V43, P113, DOI 10.1109/10.481980	80	5	5	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153599	10.1371/journal.pone.0153599	http://dx.doi.org/10.1371/journal.pone.0153599			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078266	Green Published, gold, Green Submitted			2022-12-26	WOS:000374131700089
J	Navarro-Retamal, C; Gaete-Eastman, C; Herrera, R; Caballero, J; Alzate-Morales, JH				Navarro-Retamal, Carlos; Gaete-Eastman, Carlos; Herrera, Raul; Caballero, Julio; Alzate-Morales, Jans H.			Structural and Affinity Determinants in the Interaction between Alcohol Acyltransferase from F. x ananassa and Several Alcohol Substrates: A Computational Study	PLOS ONE			English	Article							PROTEIN STRUCTURES; STRUCTURE PREDICTION; PROPOSED MECHANISM; MOLECULAR-DYNAMICS; VINORINE SYNTHASE; STRAWBERRY; AROMA; BAHD; ACETYLTRANSFERASE; SIMULATION	Aroma and flavor are important factors of fruit quality and consumer preference. The specific pattern of aroma is generated during ripening by the accumulation of volatiles compounds, which are mainly esters. Alcohol acyltransferase (AAT) (EC 2.3.1.84) catalyzes the esterification reaction of aliphatic and aromatic alcohols and acyl-CoA into esters in fruits and flowers. In Fragaria x ananassa, there are different volatiles compounds that are obtained from different alcohol precursors, where octanol and hexanol are the most abundant during fruit ripening. At present, there is not structural evidence about the mechanism used by the AAT to synthesize esters. Experimental data attribute the kinetic role of this enzyme to 2 amino acidic residues in a highly conserved motif (HXXXD) that is located in the middle of the protein. With the aim to understand the molecular and energetic aspects of volatiles compound production from F. x ananassa, we first studied the binding modes of a series of alcohols, and also different acyl-CoA substrates, in a molecular model of alcohol acyltransferase from Fragaria x ananassa (SAAT) using molecular docking. Afterwards, the dynamical behavior of both substrates, docked within the SAAT binding site, was studied using routine molecular dynamics (MD) simulations. In addition, in order to correlate the experimental and theoretical data obtained in our laboratories, binding free energy calculations were performed; which previous results suggested that octanol, followed by hexanol, presented the best affinity for SAAT. Finally, and concerning the SAAT molecular reaction mechanism, it is suggested from molecular dynamics simulations that the reaction mechanism may proceed through the formation of a ternary complex, in where the Histidine residue at the HXXXD motif deprotonates the alcohol substrates. Then, a nucleophilic attack occurs from alcohol charged oxygen atom to the carbon atom at carbonyl group of the acyl CoA. This mechanism is in agreement with previous results, obtained in our group, in alcohol acyltransferase from Vasconcellea pubescens (VpAAT1).	[Navarro-Retamal, Carlos; Caballero, Julio; Alzate-Morales, Jans H.] Univ Talca, Fac Ingn, Ctr Bioinformat & Simulac Mol, 2 Norte 685,Casilla 721, Talca, Chile; [Gaete-Eastman, Carlos; Herrera, Raul] Univ Talca, Inst Ciencias Biol, Lab Fisiol Vegetal & Genet Mol, Casilla 747, Talca, Chile	Universidad de Talca; Universidad de Talca	Alzate-Morales, JH (corresponding author), Univ Talca, Fac Ingn, Ctr Bioinformat & Simulac Mol, 2 Norte 685,Casilla 721, Talca, Chile.; Herrera, R (corresponding author), Univ Talca, Inst Ciencias Biol, Lab Fisiol Vegetal & Genet Mol, Casilla 747, Talca, Chile.	raherrera@utalca.cl; jalzate@utalca.cl	Caballero, Julio/G-3654-2014; Herrera, Raul/T-6935-2017; Jans, Alzate-Morales/A-5407-2008	Caballero, Julio/0000-0003-0182-1444; Herrera, Raul/0000-0002-3369-0939; Jans, Alzate-Morales/0000-0001-9624-7849	Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT); Anillos Cientificos de Ciencia y Tecnologia [ACT-1110]; Proyecto Bicentenario de Ciencia y Tecnologia (PBCT) [PSD-17]; Government of Chile through CONICYT;  [Anillo ACT-1110]	Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Anillos Cientificos de Ciencia y Tecnologia; Proyecto Bicentenario de Ciencia y Tecnologia (PBCT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/PBCT); Government of Chile through CONICYT; 	CNR thanks Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) for a doctoral fellowship. RH thanks Anillos Cientificos de Ciencia y Tecnologia, ACT-1110, for financial support. CGE thanks Proyecto Bicentenario de Ciencia y Tecnologia (PBCT), PSD-17, for a postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. l; The authors thank to "Centro de Bioinformatica y Simulacion Molecular" at Universidad de Talca for providing the computational time and resources to successfully accomplish all computational simulations reported in this work. Carlos Navarro-Retamal thanks Government of Chile for a doctoral fellowship awarded through CONICYT. R.H. thanks to Anillo ACT-1110 for financial support and C. Gaete-Eastman acknowledges the PBCT PSD-17 Postdoctoral program. The authors thank Dr. Luis Morales-Quintana for useful discussions and technical assistance.	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Aharoni A, 2000, PLANT CELL, V12, P647, DOI 10.1105/tpc.12.5.647; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2009, DESM MOL DYN SYST VE; [Anonymous], 2012, PRIM VERS 3 1; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Balbontin C, 2007, POSTHARVEST BIOL TEC, V43, P67, DOI 10.1016/j.postharvbio.2006.08.005; Bayer A, 2004, BIOORGAN MED CHEM, V12, P2787, DOI 10.1016/j.bmc.2004.02.029; Beekwilder J, 2004, PLANT PHYSIOL, V135, P1865, DOI 10.1104/pp.104.042580; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; D'Auria JC, 2006, CURR OPIN PLANT BIOL, V9, P331, DOI 10.1016/j.pbi.2006.03.016; Galaz S, 2013, FEBS J, V280, P1344, DOI 10.1111/febs.12127; Gonzalez M, 2009, J AGR FOOD CHEM, V57, P9123, DOI 10.1021/jf901693j; Hancock JF, 1999, HORTSCIENCE, V34, P814, DOI 10.21273/HORTSCI.34.5.814; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jorgensen WL, 1998, J COMPUT CHEM, V19, P1179, DOI 10.1002/(SICI)1096-987X(19980730)19:10<1179::AID-JCC6>3.0.CO;2-J; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lewinsohn E, 2001, PLANT PHYSIOL, V127, P1256, DOI 10.1104/pp.127.3.1256; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Melo F, 1997, J MOL BIOL, V267, P207, DOI 10.1006/jmbi.1996.0868; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Morales-Quintana L, 2013, J CHEM INF MODEL, V53, P2689, DOI 10.1021/ci400409s; Morales-Quintana L, 2012, MOL SIMULAT, V38, P912, DOI 10.1080/08927022.2012.672738; Morales-Quintana L, 2011, J MOL GRAPH MODEL, V29, P635, DOI 10.1016/j.jmgm.2010.11.011; Moya-Leon MA, 2004, POSTHARVEST BIOL TEC, V34, P211, DOI 10.1016/j.postharvbio.2004.05.005; NEMETHY G, 1983, J PHYS CHEM-US, V87, P1883, DOI 10.1021/j100234a011; Olias R, 2002, J AGR FOOD CHEM, V50, P4031, DOI 10.1021/jf011460u; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shalit M, 2001, J AGR FOOD CHEM, V49, P794, DOI 10.1021/jf001075p; SHAW WV, 1991, ANNU REV BIOPHYS BIO, V20, P363, DOI 10.1146/annurev.biophys.20.1.363; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Suzuki H, 2003, BIOCHEMISTRY-US, V42, P1764, DOI 10.1021/bi020618g; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ulrich D, 2007, GENET RESOUR CROP EV, V54, P1185, DOI 10.1007/s10722-006-9009-4; Unno H, 2007, J BIOL CHEM, V282, P15812, DOI 10.1074/jbc.M700638200; Xiang ZX, 2006, CURR PROTEIN PEPT SC, V7, P217, DOI 10.2174/138920306777452312	41	12	12	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153057	10.1371/journal.pone.0153057	http://dx.doi.org/10.1371/journal.pone.0153057			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078149	Green Submitted, Green Published, gold			2022-12-26	WOS:000374131700018
J	Bernard, JB; Aguilar, C; Castet, E				Bernard, Jean-Baptiste; Aguilar, Carlos; Castet, Eric			A New Font, Specifically Designed for Peripheral Vision, Improves Peripheral Letter and Word Recognition, but Not Eye-Mediated Reading Performance	PLOS ONE			English	Article							LETTER IDENTIFICATION; SIMULATED SCOTOMAS; VISUAL SPAN; SPEED; PSYCHOPHYSICS; CONFUSION; SIMILARITY; LEGIBILITY; CHARACTERS; MOVEMENTS	Reading speed is dramatically reduced when readers cannot use their central vision. This is because low visual acuity and crowding negatively impact letter recognition in the periphery. In this study, we designed a new font (referred to as the Eido font) in order to reduce inter-letter similarity and consequently to increase peripheral letter recognition performance. We tested this font by running five experiments that compared the Eido font with the standard Courier font. Letter spacing and x-height were identical for the two monospaced fonts. Six normally-sighted subjects used exclusively their peripheral vision to run two aloud reading tasks (with eye movements), a letter recognition task (without eye movements), a word recognition task (without eye movements) and a lexical decision task. Results show that reading speed was not significantly different between the Eido and the Courier font when subjects had to read single sentences with a round simulated gaze-contingent central scotoma (10 degrees diameter). In contrast, Eido significantly decreased perceptual errors in peripheral crowded letter recognition (-30% errors on average for letters briefly presented at 6 degrees eccentricity) and in peripheral word recognition (-32% errors on average for words briefly presented at 6 degrees eccentricity).	[Bernard, Jean-Baptiste; Aguilar, Carlos; Castet, Eric] Aix Marseille Univ, Marseille, France; [Bernard, Jean-Baptiste; Aguilar, Carlos; Castet, Eric] CNRS, Lab Psychol Cognit, UMR 7920, Federat Rech 3C, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Bernard, JB (corresponding author), Aix Marseille Univ, Marseille, France.; Bernard, JB (corresponding author), CNRS, Lab Psychol Cognit, UMR 7920, Federat Rech 3C, Marseille, France.	jean-baptiste.bernard@univ-amu.fr			Agence Nationale de la recherche low vision [ANR-11-BSH2-0005]; ANR low vision [ANR-11-BSH2-0005]	Agence Nationale de la recherche low vision(French National Research Agency (ANR)); ANR low vision(French National Research Agency (ANR))	This study was funded by: Agence Nationale de la recherche low vision ANR-11-BSH2-0005; This work was supported by the ANR low vision ANR-11-BSH2-0005.	Aguilar C, 2011, VISION RES, V51, P997, DOI 10.1016/j.visres.2011.02.010; Beckmann PJ, 2002, J OPT SOC AM A, V19, P2349, DOI 10.1364/JOSAA.19.002349; Bernard JB, 2007, VISION RES, V47, P3447, DOI 10.1016/j.visres.2007.10.005; Bernard JB, 2013, VISION RES, V84, P33, DOI 10.1016/j.visres.2013.03.005; Bernard JB, 2012, VISION RES, V66, P17, DOI 10.1016/j.visres.2012.06.012; Bernard JB, 2011, J VISION, V11, DOI 10.1167/11.8.1; Blackmore-Wright S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080325; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; BOUMA H, 1971, VISION RES, V11, P459, DOI 10.1016/0042-6989(71)90087-3; BOUMA H, 1970, NATURE, V226, P177, DOI 10.1038/226177a0; Calabrese A, 2014, INVEST OPHTH VIS SCI, V55, P3638, DOI 10.1167/iovs.13-13408; Carver R. P., 1990, READING RATE REV RES; Chanceaux M, 2014, J VISION, V14, DOI 10.1167/14.6.7; Cheung SH, 2005, VISUAL NEUROSCI, V22, P187, DOI 10.1017/S0952523805222071; Cheung SH, 2008, INVEST OPHTH VIS SCI, V49, P828, DOI 10.1167/iovs.07-0555; Chung STL, 2004, OPTOMETRY VISION SCI, V81, P525, DOI 10.1097/00006324-200407000-00014; Chung STL, 2004, VISION RES, V44, P695, DOI 10.1016/j.visres.2003.09.028; Chung STL, 2002, INVEST OPHTH VIS SCI, V43, P1270; Chung STL, 1998, VISION RES, V38, P2949, DOI 10.1016/S0042-6989(98)00072-8; Chung STL, 2012, OPTOMETRY VISION SCI, V89, P1288, DOI 10.1097/OPX.0b013e318264c9dd; Chung STL, 2009, VISION RES, V49, P2782, DOI 10.1016/j.visres.2009.08.013; Coates D, 2013, AM AC OPHT ANN M OCT; COLTHEART M, 1974, B PSYCHONOMIC SOC, V3, P102; DUNNRANK.P, 1968, J VERB LEARN VERB BE, V7, P990, DOI 10.1016/S0022-5371(68)80057-X; Freeman J, 2012, ATTEN PERCEPT PSYCHO, V74, P379, DOI 10.3758/s13414-011-0229-0; Fromer R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121986; Gauthier I, 2006, PERCEPTION, V35, P541, DOI 10.1068/p5313; GERVAIS MJ, 1984, J EXP PSYCHOL HUMAN, V10, P655, DOI 10.1037/0096-1523.10.5.655; GEYER LH, 1977, PERCEPT PSYCHOPHYS, V22, P487, DOI 10.3758/BF03199515; GEYER LH, 1973, PERCEPT PSYCHOPHYS, V14, P471, DOI 10.3758/BF03211185; GRAINGER J, 1990, J MEM LANG, V29, P228, DOI 10.1016/0749-596X(90)90074-A; Harrison WJ, 2013, J NEUROSCI, V33, P2927, DOI 10.1523/JNEUROSCI.4172-12.2013; Higgins E, 2015, ATTEN PERCEPT PSYCHO, V77, P3, DOI 10.3758/s13414-014-0751-y; KUENNAPA.T, 1969, PERCEPT MOTOR SKILL, V28, P3, DOI 10.2466/pms.1969.28.1.3; LEGGE GE, 1985, VISION RES, V25, P239, DOI 10.1016/0042-6989(85)90117-8; LEGGE GE, 1989, OPTOMETRY VISION SCI, V66, P843, DOI 10.1097/00006324-198912000-00008; Legge GE, 2001, VISION RES, V41, P725, DOI 10.1016/S0042-6989(00)00295-9; Legge GE, 2007, J VISION, V7, DOI 10.1167/7.2.9; Legge GE, 2011, J VISION, V11, DOI 10.1167/11.5.8; Levi DM, 2008, VISION RES, V48, P635, DOI 10.1016/j.visres.2007.12.009; Liu L, 2001, OPTOMETRY VISION SCI, V78, P50, DOI 10.1097/00006324-200101010-00014; LOOMIS JM, 1982, PERCEPT PSYCHOPHYS, V31, P41, DOI 10.3758/BF03206199; MacKeben M, 2000, VISUAL IMPAIRMENT RE, V2, P95, DOI [10.1076/vimr.2.2.95.4427, DOI 10.1076/VIMR.2.2.95.4427]; MCCONKIE GW, 1975, PERCEPT PSYCHOPHYS, V17, P578, DOI 10.3758/BF03203972; Mueller ST, 2012, ACTA PSYCHOL, V139, P19, DOI 10.1016/j.actpsy.2011.09.014; Paterson KB, 2010, MEM COGNITION, V38, P502, DOI 10.3758/MC.38.4.502; Pelli DG, 2007, J VISION, V7, DOI 10.1167/7.2.i; Pelli DG, 2006, VISION RES, V46, P4646, DOI 10.1016/j.visres.2006.04.023; Pelli DG, 2004, J VISION, V4, P1136, DOI 10.1167/4.12.12; Pelli DG, 2003, NATURE, V423, P752, DOI 10.1038/nature01516; Perea M, 2015, COGNITION, V142, P39, DOI 10.1016/j.cognition.2015.05.007; Pinheiro J, 2000, MIXED EFFECTS MODELS; R Core Team, 2021, R LANGUAGE ENV STAT; Reich LN, 2000, OPTOMETRY VISION SCI, V77, P270, DOI 10.1097/00006324-200005000-00014; Reingold EM, 2010, J EXP PSYCHOL HUMAN, V36, P1677, DOI 10.1037/a0019959; Risse S, 2014, J VISION, V14, DOI 10.1167/14.8.11; Sanocki T, 2012, ATTEN PERCEPT PSYCHO, V74, P132, DOI 10.3758/s13414-011-0220-9; Scherlen AC, 2008, VISION RES, V48, P1870, DOI 10.1016/j.visres.2008.06.005; Schotter ER, 2012, ATTEN PERCEPT PSYCHO, V74, P5, DOI 10.3758/s13414-011-0219-2; STRASBURGER H, 1991, PERCEPT PSYCHOPHYS, V49, P495, DOI 10.3758/BF03212183; Strasburger H, 2005, J VISION, V5, P1024, DOI 10.1167/5.11.8; Strasburger H, 2013, J VISION, V13, DOI 10.1167/13.1.24; Wang H, 2014, J VISION, V14, DOI 10.1167/14.8.6; Watson AB, 2012, J VISION, V12, DOI 10.1167/12.10.19; Watson AB, 2008, J VISION, V8, DOI 10.1167/8.4.17; WHITE JM, 1990, INVEST OPHTH VIS SCI, V31, P1149; WHITTAKER SG, 1991, VISION RES, V31, P2209, DOI 10.1016/0042-6989(91)90173-3; Yu DY, 2014, J VISION, V14, DOI 10.1167/14.6.3; Yu DY, 2010, VISION RES, V50, P860, DOI 10.1016/j.visres.2010.02.006; Yu DY, 2007, J VISION, V7, DOI 10.1167/7.2.2; Zhang JY, 2007, INVEST OPHTH VIS SCI, V48, P2383, DOI 10.1167/iovs.06-1195; Zhang JY, 2012, J VISION, V12, DOI 10.1167/12.7.5	72	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152506	10.1371/journal.pone.0152506	http://dx.doi.org/10.1371/journal.pone.0152506			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UC	27074013	Green Published, Green Submitted, gold			2022-12-26	WOS:000374131200028
J	dos Santos, JPR; Vasconcellos, RCD; Pires, LPM; Balestre, M; Von Pinho, RG				Rigal dos Santos, Jhonathan Pedroso; de Castro Vasconcellos, Renato Coelho; Miranda Pires, Luiz Paulo; Balestre, Marcio; Von Pinho, Renzo Garcia			Inclusion of Dominance Effects in the Multivariate GBLUP Model	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; LINEAR UNBIASED PREDICTION; GENOMIC SELECTION; PLANT; REGRESSION; EPISTASIS; PROSPECTS; MAIZE	New proposals for models and applications of prediction processes with data on molecular markers may help reduce the financial costs of and identify superior genotypes in maize breeding programs. Studies evaluating Genomic Best Linear Unbiased Prediction (GBLUP) models including dominance effects have not been performed in the univariate and multivariate context in the data analysis of this crop. A single cross hybrid construction procedure was performed in this study using phenotypic data and actual molecular markers of 4,091 maize lines from the public database Panzea. A total of 400 simple hybrids resulting from this process were analyzed using the univariate and multivariate GBLUP model considering only additive effects additive plus dominance effects. Historic heritability scenarios of five traits and other genetic architecture settings were used to compare models, evaluating the predictive ability and estimation of variance components. Marginal differences were detected between the multivariate and univariate models. The main explanation for the small discrepancy between models is the low-to moderate-magnitude correlations between the traits studied and moderate heritabilities. These conditions do not favor the advantages of multivariate analysis. The inclusion of dominance effects in the models was an efficient strategy to improve the predictive ability and estimation quality of variance components.	[Rigal dos Santos, Jhonathan Pedroso; de Castro Vasconcellos, Renato Coelho] Univ Fed Lavras, Dept Biol DBI, Lavras, MG, Brazil; [Balestre, Marcio] Univ Fed Lavras, Dept Exact Sci DEX, Lavras, MG, Brazil; [Miranda Pires, Luiz Paulo; Von Pinho, Renzo Garcia] Univ Fed Lavras, Dept Agr DAG, Lavras, MG, Brazil	Universidade Federal de Lavras; Universidade Federal de Lavras; Universidade Federal de Lavras	Balestre, M (corresponding author), Univ Fed Lavras, Dept Exact Sci DEX, Lavras, MG, Brazil.	marciobalestre@dex.ufla.br	Santos, Jhonathan Pedroso Rigal dos/AAF-7570-2019	Santos, Jhonathan Pedroso Rigal dos/0000-0001-9030-702X; Coelho de Castro Vasconcellos, Renato/0000-0002-2610-601X	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [APQ-01745-13]	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	We acknowledge the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais for supporting this research, Grant # APQ-01745-13. We also acknowledge the two anonymous reviewers for their constructive comments, which helped us to improve the manuscript.	Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Balestre M, 2013, EUPHYTICA, V189, P225, DOI 10.1007/s10681-012-0790-1; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Calinski T, 2005, BIOMETRICS, V61, P448, DOI 10.1111/j.1541-0420.2005.00334.x; Calus MPL, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-26; CALVIN JA, 1991, ANN STAT, V19, P850, DOI 10.1214/aos/1176348124; COCKERHAM CC, 1954, GENETICS, V39, P859; Da Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087666; de los Campos G, 2014, GENETICS, P1; de los Campos G, 2013, GENETICS, V193, P327, DOI 10.1534/genetics.112.143313; de Oliveira EJ, 2012, EUPHYTICA, V187, P263, DOI 10.1007/s10681-012-0722-0; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Falconer D. S., 1996, INTRO QUANTITATIVE G; Gianola D., 2014, P 10 WORLD C GEN APP, P6; Gianola D, 2009, GENETICS, V183, P347, DOI 10.1534/genetics.109.103952; Guo G, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-30; Hallauer AR, 2010, HANDB PLANT BREED, V6, P1, DOI 10.1007/978-1-4419-0766-0; Henderson C. R, 1984, APPL LINEAR MODELS A; HENDERSON CR, 1976, J ANIM SCI, V43, P1188, DOI 10.2527/jas1976.4361188x; HENDERSON CR, 1985, J ANIM SCI, V60, P111, DOI 10.2527/jas1985.601111x; Heslot N, 2014, CROP SCI IN PRESS; Heslot N, 2012, CROP SCI, V52, P146, DOI 10.2135/cropsci2011.06.0297; Jaccoud D, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.4.e25; Jia Y, 2012, GENETICS, V192, P1513, DOI 10.1534/genetics.112.144246; Kao CH, 2002, GENETICS, V160, P1243; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Malosetti M, 2008, EUPHYTICA, V161, P241, DOI 10.1007/s10681-007-9594-0; Massman JM, 2013, THEOR APPL GENET, V126, P13, DOI 10.1007/s00122-012-1955-y; Meuwissen THE, 2001, GENETICS, V157, P1819; Morota G, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00363; Munoz PR, 2014, GENETICS, V198, P1759, DOI 10.1534/genetics.114.171322; Nishio M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085792; Ober U, 2011, GENETICS, V188, P695, DOI 10.1534/genetics.111.128694; Piepho HP, 2008, EUPHYTICA, V161, P209, DOI 10.1007/s10681-007-9449-8; Romay MC, GENOME BIOL, V14, P1; Stranger BE, 2011, GENETICS, V187, P367, DOI 10.1534/genetics.110.120907; Team R Core, R LANG ENV STAT COMP; Technow F, 2014, GENETICS, V197, P1343, DOI 10.1534/genetics.114.165860; Vitezica ZG, 2013, GENETICS, V195, P1223, DOI 10.1534/genetics.113.155176; Yang RC, 2004, GENETICS, V167, P1493, DOI 10.1534/genetics.103.020016; Zeng ZB, 2005, GENETICS, V169, P1711, DOI 10.1534/genetics.104.035857	43	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152045	10.1371/journal.pone.0152045	http://dx.doi.org/10.1371/journal.pone.0152045			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074056	Green Published, Green Submitted, gold			2022-12-26	WOS:000374131200014
J	Yang, RY; Xue, HT; Yu, L; Velayos-Baeza, A; Monaco, AP; Liu, FT				Yang, Ri-Yao; Xue, Huiting; Yu, Lan; Velayos-Baeza, Antonio; Monaco, Anthony P.; Liu, Fu-Tong			Identification of VPS13C as a Galectin-12-Binding Protein That Regulates Galectin-12 Protein Stability and Adipogenesis	PLOS ONE			English	Article							QUALITY-CONTROL; LIPID DROPLETS; TRANSCRIPTIONAL COMPLEX; INSULIN-RESISTANCE; GLYCEMIC TRAITS; AUTOPHAGY; CELLS; EXPRESSION; SECRETION; DISEASE	Galectin-12, a member of the galectin family of beta-galactoside-binding animal lectins, is preferentially expressed in adipocytes and required for adipocyte differentiation in vitro. This protein was recently found to regulate lipolysis, whole body adiposity, and glucose homeostasis in vivo. Here we identify VPS13C, a member of the VPS13 family of vacuolar protein sorting-associated proteins highly conserved throughout eukaryotic evolution, as a major galectin-12-binding protein. VPS13C is upregulated during adipocyte differentiation, and is required for galectin-12 protein stability. Knockdown of Vps13c markedly reduces the steady-state levels of galectin-12 by promoting its degradation through primarily the lysosomal pathway, and impairs adipocyte differentiation. Our studies also suggest that VPS13C may have a broader role in protein quality control. The regulation of galectin-12 stability by VPS13C could potentially be exploited for therapeutic intervention of obesity and related metabolic diseases.	[Yang, Ri-Yao; Xue, Huiting; Yu, Lan; Liu, Fu-Tong] Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA; [Xue, Huiting] NE Normal Univ, Sch Life Sci, Changchun 130024, Peoples R China; [Velayos-Baeza, Antonio; Monaco, Anthony P.] Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Liu, Fu-Tong] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Yang, Ri-Yao] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA	University of California System; University of California Davis; Northeast Normal University - China; University of Oxford; Wellcome Centre for Human Genetics; Academia Sinica - Taiwan; University of Texas System; UTMD Anderson Cancer Center	Yang, RY; Liu, FT (corresponding author), Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA.; Liu, FT (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan.; Yang, RY (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.	ryang@mdanderson.org; ftliu@ibms.sinica.edu.tw	Yang, Riyao/R-7593-2019; Liu, FU-TONG/A-5749-2019; Velayos-Baeza, Antonio/K-6310-2019; Monaco, Anthony P/A-4495-2010	Yang, Riyao/0000-0002-0278-4385; Liu, FU-TONG/0000-0002-3354-1001; Velayos-Baeza, Antonio/0000-0002-7717-4477; Monaco, Anthony P/0000-0001-7480-3197	National Institutes of Health [R01 AI020958, R01 AR56343]; Harrison Endowed Chair for Diabetes Research Award; Wellcome Trust [075491/Z/04]; Advocacy for Neuroacanthocytosis Patients; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056343] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harrison Endowed Chair for Diabetes Research Award; Wellcome Trust(Wellcome TrustEuropean Commission); Advocacy for Neuroacanthocytosis Patients; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported by National Institutes of Health Grant R01 AI020958 and R01 AR56343 (to FTL), the Harrison Endowed Chair for Diabetes Research Award (to RYY), the Wellcome Trust core grant 075491/Z/04 and the Advocacy for Neuroacanthocytosis Patients (to APM and AVB).	Alexeyev MF, 2010, MOL BIOL REP, V37, P1987, DOI 10.1007/s11033-009-9647-7; An CH, 2012, HUM PATHOL, V43, P40, DOI 10.1016/j.humpath.2010.03.015; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Bird LE, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-13; Boscher C, 2011, CURR OPIN CELL BIOL, V23, P383, DOI 10.1016/j.ceb.2011.05.001; Bras J, 2015, CELL, V160, P570, DOI 10.1016/j.cell.2015.01.019; Brasaemle DL, 2006, CURR PROTOC CELL BIO, P3151; Brickner JH, 1997, J CELL BIOL, V139, P23, DOI 10.1083/jcb.139.1.23; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Delacour D, 2009, TRAFFIC, V10, P1405, DOI 10.1111/j.1600-0854.2009.00960.x; Filimonenko M, 2010, MOL CELL, V38, P265, DOI 10.1016/j.molcel.2010.04.007; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Furukawa T, 2011, SCI REP-UK, V1, DOI 10.1038/srep00161; Grarup N, 2011, DIABETOLOGIA, V54, P789, DOI 10.1007/s00125-010-2031-2; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hotta K, 2001, J BIOL CHEM, V276, P34089, DOI 10.1074/jbc.M105097200; Hsu DK, 2015, METHODS MOL BIOL, V1207, P451, DOI 10.1007/978-1-4939-1396-1_29; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Huyghe JR, 2013, NAT GENET, V45, P197, DOI 10.1038/ng.2507; Isakson P, 2013, CELL DEATH DIFFER, V20, P12, DOI 10.1038/cdd.2012.66; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Lamark Trond, 2012, Int J Cell Biol, V2012, P736905, DOI 10.1155/2012/736905; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Liu FT, 2002, BBA-GEN SUBJECTS, V1572, P263, DOI 10.1016/S0304-4165(02)00313-6; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; McCray BA, 2010, HUM MOL GENET, V19, P1033, DOI 10.1093/hmg/ddp567; Meda SA, 2012, NEUROIMAGE, V60, P1608, DOI 10.1016/j.neuroimage.2011.12.076; Mehul B, 1997, J CELL SCI, V110, P1169; Menon RP, 1999, EUR J BIOCHEM, V264, P569, DOI 10.1046/j.1432-1327.1999.00671.x; Moldavski O, 2015, DEV CELL, V33, P603, DOI 10.1016/j.devcel.2015.04.015; Munoz-Braceras S, 2015, AUTOPHAGY, V11, P918, DOI 10.1080/15548627.2015.1034413; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Park JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124836; Rabinovich GA, 2012, IMMUNITY, V36, P322, DOI 10.1016/j.immuni.2012.03.004; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Schekman R, 2011, CELL            0909; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Strawbridge RJ, 2011, DIABETES, V60, P2624, DOI 10.2337/db11-0415; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Velayos-Baeza A, 2004, GENOMICS, V84, P536, DOI 10.1016/j.ygeno.2004.04.012; Velikkakath AKG, 2012, MOL BIOL CELL, V23, P896, DOI 10.1091/mbc.E11-09-0785; Wang CH, 2015, BBA-MOL BASIS DIS, V1852, P188, DOI 10.1016/j.bbadis.2014.07.028; Watanabe Y, 2012, J BIOL CHEM; Williams A, 2006, CURR TOP DEV BIOL, V76, P89, DOI 10.1016/S0070-2153(06)76003-3; Windholz J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022101; Wolff S, 2014, CELL, V157, P52, DOI 10.1016/j.cell.2014.03.007; Wu C, 2014, IMMUNITY, V41, P270, DOI 10.1016/j.immuni.2014.06.011; Yang RY, 2012, ADIPOCYTE, V1, P96, DOI 10.4161/adip.19465; Yang RY, 2011, P NATL ACAD SCI USA, V108, P18696, DOI 10.1073/pnas.1109065108; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Yang RY, 1996, P NATL ACAD SCI USA, V93, P6737, DOI 10.1073/pnas.93.13.6737; Yang RY, 2004, J BIOL CHEM, V279, P29761, DOI 10.1074/jbc.M401303200; Yang RY, 2001, J BIOL CHEM, V276, P20252, DOI 10.1074/jbc.M010914200; Zebisch K, 2012, ANAL BIOCHEM, V425, P88, DOI 10.1016/j.ab.2012.03.005	58	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153534	10.1371/journal.pone.0153534	http://dx.doi.org/10.1371/journal.pone.0153534			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073999	Green Published, gold			2022-12-26	WOS:000374131200104
J	Lim, SY; Yuzhalin, AE; Gordon-Weeks, AN; Muschel, RJ				Lim, S. Y.; Yuzhalin, A. E.; Gordon-Weeks, A. N.; Muschel, R. J.			Tumor-infiltrating monocytes/macrophages promote tumor invasion and migration by upregulating S100A8 and S100A9 expression in cancer cells	ONCOGENE			English	Article							CALCIUM-BINDING PROTEINS; MYELOID CELLS; MATRIX METALLOPROTEINASES; OXIDATIVE MODIFICATIONS; ROLES; METASTASIS; DIFFERENTIATION; INFLAMMATION; RECRUITMENT; PROGRESSION	Myeloid cells promote the development of distant metastases, but little is known about the molecular mechanisms underlying this process. Here we have begun to uncover the effects of myeloid cells on cancer cells in a mouse model of liver metastasis. Monocytes/macrophages, but not granulocytes, isolated from experimental liver metastases stimulated migration and invasion of MC38 colon and Lewis lung carcinoma cells. In response to conditioned media from tumor-infiltrating monocytes/macrophages, cancer cells upregulated S100a8 and S100a9 messenger RNA expression through an extracellular signal-related kinase-dependent mechanism. Suppression of S100A8 and S100A9 in cancer cells using short hairpin RNA significantly diminished migration and invasion in culture. Downregulation of S100A8 and S100A9 had no effect on subcutaneous tumor growth. However, colony size was greatly reduced in liver metastases with decreased invasion into adjacent tissue. In tissue culture and in the liver colonies derived from cancer cells with knockdown of S100A8 and S100A9, MMP2 and MMP9 expression was decreased, consistent with the reduction in migration and invasion. Our findings demonstrate that monocytes/macrophages in the metastatic liver microenvironment induce S100A8 and S100A9 in cancer cells, and that these proteins are essential for tumor cell migration and invasion. S100A8 and S100A9, however, are not responsible for stimulation of proliferation. This study implicates S100A8 and S100A9 as important mediators of tumor cell aggressiveness, and highlights the therapeutic potential of S100A8 and S100A9 for interference of metastasis.	[Lim, S. Y.; Yuzhalin, A. E.; Gordon-Weeks, A. N.; Muschel, R. J.] Univ Oxford, CRUK MRC Oxford Inst Radiat Oncol, Oxford, England	University of Oxford	Muschel, RJ (corresponding author), Univ Oxford, Dept Oncol, Old Rd Campus,Res Bldg,Roosevelt Dr, Oxford OX3 7DQ, England.	ruth.muschel@oncology.ox.ac.uk	Gordon-Weeks, Alex/L-1831-2019; Yuzhalin, Arseniy E./J-3951-2013	Gordon-Weeks, Alex/0000-0003-2997-4194; Yuzhalin, Arseniy E./0000-0001-7454-6653; Lim, Su Yin/0000-0001-9576-5441; Muschel, Ruth/0000-0002-5656-5970	CRUK; CRUK Oxford Cancer Centre; Cancer Research UK [20407] Funding Source: researchfish	CRUK(Cancer Research UK); CRUK Oxford Cancer Centre; Cancer Research UK(Cancer Research UK)	This study was supported by CRUK funding to the Oxford Institute for Radiation Oncology and Biology and by the CRUK Oxford Cancer Centre.	Allavena P, 2008, CRIT REV ONCOL HEMAT, V66, P1, DOI 10.1016/j.critrevonc.2007.07.004; Allavena P, 2008, IMMUNOL REV, V222, P155, DOI 10.1111/j.1600-065X.2008.00607.x; Arai K, 2008, CURR CANCER DRUG TAR, V8, P243, DOI 10.2174/156800908784533445; Bozzuto G, 2010, ANN I SUPER SANITA, V46, P66, DOI 10.4415/ANN_10_01_09; Souto JC, 2011, MED RES REV, V31, P311, DOI 10.1002/med.20185; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Cheng PY, 2008, J EXP MED, V205, P2235, DOI 10.1084/jem.20080132; Cross SS, 2005, HISTOPATHOLOGY, V46, P256, DOI 10.1111/j.1365-2559.2005.02097.x; DeNardo D, 2010, CANCER METAST REV, V29, P309, DOI 10.1007/s10555-010-9223-6; Duan L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062092; Finger EC, 2010, CANCER METAST REV, V29, P285, DOI 10.1007/s10555-010-9224-5; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; Hermani A, 2005, CLIN CANCER RES, V11, P5146, DOI 10.1158/1078-0432.CCR-05-0352; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Ichikawa M, 2011, MOL CANCER RES, V9, P133, DOI 10.1158/1541-7786.MCR-10-0394; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Koblinski JE, 2000, CLIN CHIM ACTA, V291, P113, DOI 10.1016/S0009-8981(99)00224-7; KOHN EC, 1994, J BIOL CHEM, V269, P21505; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Leukert N, 2006, J MOL BIOL, V359, P961, DOI 10.1016/j.jmb.2006.04.009; Lim SY, 2008, J IMMUNOL, V181, P5627, DOI 10.4049/jimmunol.181.8.5627; Lim SY, 2015, HEPATOLOGY, V62, P521, DOI 10.1002/hep.27838; Lim SY, 2011, ANTIOXID REDOX SIGN, V15, P2235, DOI 10.1089/ars.2010.3641; Lim SY, 2010, J BIOL CHEM, V285, P14377, DOI 10.1074/jbc.M109.075242; Lim SY, 2009, J LEUKOCYTE BIOL, V86, P577, DOI 10.1189/jlb.1008608; LOHI J, 1995, J BIOL CHEM, V270, P17602, DOI 10.1074/jbc.270.29.17602; Luschen S, 2005, EXP CELL RES, V310, P33, DOI 10.1016/j.yexcr.2005.07.022; Moon A, 2008, MOL CANCER RES, V6, P1544, DOI 10.1158/1541-7786.MCR-08-0189; Nabeshima K, 2002, PATHOL INT, V52, P255, DOI 10.1046/j.1440-1827.2002.01343.x; Piccard H, 2012, CRIT REV ONCOL HEMAT, V82, P296, DOI 10.1016/j.critrevonc.2011.06.004; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; Raymond E, 2014, CANCER CHEMOTH PHARM, V73, P1, DOI 10.1007/s00280-013-2321-8; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Srikrishna G, 2012, J INNATE IMMUN, V4, P31, DOI 10.1159/000330095; Strupat K, 2000, J AM SOC MASS SPECTR, V11, P780, DOI 10.1016/S1044-0305(00)00150-1; TEIGELKAMP S, 1991, J BIOL CHEM, V266, P13462; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wu CY, 2009, GLIA, V57, P1775, DOI 10.1002/glia.20890; Yong HY, 2007, ARCH PHARM RES, V30, P75, DOI 10.1007/BF02977781; Zhao L, 2013, HEPATOLOGY, V57, P829, DOI 10.1002/hep.26094	44	110	114	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 3	2016	35	44					5735	5745		10.1038/onc.2016.107	http://dx.doi.org/10.1038/onc.2016.107			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EA9XQ	27086923	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000386998400005
J	Cardinaels, EPM; Altintas, S; Versteylen, MO; Joosen, IA; Jellema, LJC; Wildberger, JE; Das, M; Crijns, HJ; Bekers, O; van Dieijen-Visser, MP; Kietselaer, BL; Mingels, AMA				Cardinaels, Eline P. M.; Altintas, Sibel; Versteylen, Mathijs O.; Joosen, Ivo A.; Jellema, Laurens-Jan C.; Wildberger, Joachim E.; Das, Marco; Crijns, Harry J.; Bekers, Otto; van Dieijen-Visser, Marja P.; Kietselaer, Bastiaan L.; Mingels, Alma M. A.			High-Sensitivity Cardiac Troponin Concentrations in Patients with Chest Discomfort: Is It the Heart or the Kidneys As Well?	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; ACUTE MYOCARDIAL-INFARCTION; GLOMERULAR-FILTRATION-RATE; RENAL-INSUFFICIENCY; NATRIURETIC PEPTIDE; COMPUTED-TOMOGRAPHY; AORTIC-STENOSIS; EARLY-DIAGNOSIS; CYSTATIN C; T ASSAY	Background High-sensitivity cardiac troponins (hs-cTn) are the preferred biomarkers to detect myocardial injury, making them promising risk-stratifying tools for patients with symptoms of chest pain. However, circulating hs-cTn are also elevated in other conditions like renal dysfunction, complicating appropriate interpretation of low-level hs-cTn concentrations. Methods A cross-sectional analysis was performed in 1864 patients with symptoms of chest discomfort from the cardiology outpatient department who underwent cardiac computed tomographic angiography (CCTA). Serum samples were analyzed using hs-cTnT and hs-cTnI assays. Renal function was measured by the estimated glomerular filtration rate (eGFR), established from serum creatinine and cystatin C. On follow-up, the incidence of adverse events was assessed. Results Median hs-cTnT and hs-cTnI concentrations were 7.2(5.8-9.2) ng/L and 2.6(1.8-4.1) ng/L, respectively. Multivariable regression analysis revealed that both assay results were more strongly associated with eGFR (hs-cTnT: st beta:-0.290; hs-cTnI: st beta:-0.222) than with cardiac imaging parameters, such as coronary calcium score, CCTA plaque severity score and left ventricular mass (all p< 0.01). Furthermore, survival analysis indicated lower relative risks in patients with normal compared to reduced renal function for hs-cTnT [HR(95% CI), 1.02 (1.00-1.03) compared to 1.07(1.05-1.09)] and hs-cTnI [1.01(1.00-1.01) compared to 1.02 (1.01-1.02)] (all p< 0.001). Conclusion In patients with chest discomfort, we identified an independent influence of renal function on hs-cTn concentrations besides CAD, that affected the association of hs-cTn concentrations with adverse events. Estimating renal function is therefore warranted when interpreting baseline hs-cTn concentrations.	[Cardinaels, Eline P. M.; Bekers, Otto; van Dieijen-Visser, Marja P.; Mingels, Alma M. A.] Maastricht Univ, Cent Diagnost Lab, Dept Clin Chem, Cardiovasc Res Inst Maastricht CARIM,Med Ctr, NL-6200 MD Maastricht, Netherlands; [Altintas, Sibel; Versteylen, Mathijs O.; Joosen, Ivo A.; Crijns, Harry J.; Kietselaer, Bastiaan L.] Maastricht Univ, CARIM, Dept Cardiol, Med Ctr, NL-6200 MD Maastricht, Netherlands; [Jellema, Laurens-Jan C.] Gelre Hosp, Dept Clin Chem & Hematol, Apeldoorn, Netherlands; [Wildberger, Joachim E.; Das, Marco; Kietselaer, Bastiaan L.] Maastricht Univ, Dept Radiol, CARIM, Med Ctr, NL-6200 MD Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); Gelre Hospitals; Maastricht University; Maastricht University Medical Centre (MUMC)	Mingels, AMA (corresponding author), Maastricht Univ, Cent Diagnost Lab, Dept Clin Chem, Cardiovasc Res Inst Maastricht CARIM,Med Ctr, NL-6200 MD Maastricht, Netherlands.	alma.mingels@mumc.nl		Wildberger, Joachim/0000-0002-4810-6854	Stichting De Weijerhorst	Stichting De Weijerhorst	This work was supported by a research grant from Stichting De Weijerhorst (http://www.deweijerhorst.nl/weijerhorst/home) to M.Pv.D-V. The hs-cTnI kits were kindly provided by Abbott Diagnostics. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Alcalai R, 2007, ARCH INTERN MED, V167, P276, DOI 10.1001/archinte.167.3.276; Anavekar NS, 2004, KIDNEY INT S; Bansal N, 2015, J AM SOC NEPHROL, V26, P946, DOI 10.1681/ASN.2014010108; Beatty AL, 2013, JAMA INTERN MED, V173, P763, DOI 10.1001/jamainternmed.2013.116; Bonaca M, 2010, J AM COLL CARDIOL, V55, P2118, DOI 10.1016/j.jacc.2010.01.044; Cardinaels EP, 2015, J AM MED DIR ASS; Chenevier-Gobeaux C, 2013, AM J CARDIOL, V111, P1701, DOI 10.1016/j.amjcard.2013.02.024; Chin CWL, 2014, EUR HEART J, V35, P2312, DOI 10.1093/eurheartj/ehu189; de Lemos JA, 2010, JAMA-J AM MED ASSOC, V304, P2503, DOI 10.1001/jama.2010.1768; deFilippi C, 2003, JAMA-J AM MED ASSOC, V290, P353, DOI 10.1001/jama.290.3.353; deFilippi C, 2012, CLIN CHEM, V58, P1342, DOI 10.1373/clinchem.2012.185322; Dubin RF, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-229; Freda BJ, 2002, J AM COLL CARDIOL, V40, P2065, DOI 10.1016/S0735-1097(02)02608-6; Galiuto L, 2011, THE EAE TEXTBOOK OF; Giannitsis E, 2013, NAT REV CARDIOL, V10, P623, DOI 10.1038/nrcardio.2013.129; Giannitsis E, 2010, CLIN CHEM, V56, P254, DOI 10.1373/clinchem.2009.132654; Hassan HC, 2014, CLIN CHEM, V60, P389, DOI 10.1373/clinchem.2013.207142; Hermann LK, 2010, AM J CARDIOL, V105, P1561, DOI 10.1016/j.amjcard.2010.01.014; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Irfan A, 2012, AM J MED, V125, P491, DOI 10.1016/j.amjmed.2011.10.031; Januzzi JL, 2010, CIRCULATION, V121, P1227, DOI 10.1161/CIRCULATIONAHA.109.893826; Joosen IA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047267; Korosoglou G, 2011, HEART, V97, P823, DOI 10.1136/hrt.2010.193201; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Laufer EM, 2010, ARTERIOSCL THROM VAS, V30, P1269, DOI 10.1161/ATVBAHA.109.200394; Mingels AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035059; Mishra RK, 2013, AM J KIDNEY DIS, V61, P701, DOI 10.1053/j.ajkd.2012.11.034; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Omland T, 2013, J AM COLL CARDIOL, V61, P1240, DOI 10.1016/j.jacc.2012.12.026; Omland T, 2009, NEW ENGL J MED, V361, P2538, DOI 10.1056/NEJMoa0805299; Reichlin T, 2011, CIRCULATION, V124, P136, DOI 10.1161/CIRCULATIONAHA.111.023937; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; Rosjo H, 2011, AM J CARDIOL, V108, P88, DOI 10.1016/j.amjcard.2011.02.346; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Scheven L, 2012, EUR HEART J, V33, P2272, DOI 10.1093/eurheartj/ehs163; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; Tsutamoto T, 2009, EUR J HEART FAIL, V11, P653, DOI 10.1093/eurjhf/hfp072; Voskoboev NV, 2011, CLIN CHEM, V57, P1209, DOI 10.1373/clinchem.2011.164798; Wildi K, 2015, CIRCULATION, V131, P2032, DOI 10.1161/CIRCULATIONAHA.114.014129; Ziebig R, 2003, CLIN CHEM, V49, P1191, DOI 10.1373/49.7.1191	41	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153300	10.1371/journal.pone.0153300	http://dx.doi.org/10.1371/journal.pone.0153300			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096420	Green Published, gold			2022-12-26	WOS:000374543600031
J	Hurtt, GC; Thomas, RQ; Fisk, JP; Dubayah, RO; Sheldon, SL				Hurtt, G. C.; Thomas, R. Q.; Fisk, J. P.; Dubayah, R. O.; Sheldon, S. L.			The Impact of Fine-Scale Disturbances on the Predictability of Vegetation Dynamics and Carbon Flux	PLOS ONE			English	Article							LARGE-FOOTPRINT LIDAR; TROPICAL RAIN-FOREST; BIOMASS; MODEL; TOPOGRAPHY; LANDSCAPE	Predictions from forest ecosystem models are limited in part by large uncertainties in the current state of the land surface, as previous disturbances have important and lasting influences on ecosystem structure and fluxes that can be difficult to detect. Likewise, future disturbances also present a challenge to prediction as their dynamics are episodic and complex and occur across a range of spatial and temporal scales. While large extreme events such as tropical cyclones, fires, or pest outbreaks can produce dramatic consequences, small fine-scale disturbance events are typically much more common and may be as or even more important. This study focuses on the impacts of these smaller disturbance events on the predictability of vegetation dynamics and carbon flux. Using data on vegetation structure collected for the same domain at two different times, i.e. "repeat lidar data", we test high-resolution model predictions of vegetation dynamics and carbon flux across a range of spatial scales at an important tropical forest site at La Selva Biological Station, Costa Rica. We found that predicted height change from a height-structured ecosystem model compared well to lidar measured height change at the domain scale (similar to 150 ha), but that the model-data mismatch increased exponentially as the spatial scale of evaluation decreased below 20 ha. We demonstrate that such scale-dependent errors can be attributed to errors predicting the pattern of fine-scale forest disturbances. The results of this study illustrate the strong impact fine-scale forest disturbances have on forest dynamics, ultimately limiting the spatial resolution of accurate model predictions.	[Hurtt, G. C.; Fisk, J. P.; Dubayah, R. O.; Sheldon, S. L.] Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA; [Thomas, R. Q.] Virginia Tech, Dept Forest Resources & Environm Conservat, Blacksburg, VA USA; [Fisk, J. P.] Appl Geosolut, Durham, NH USA	University System of Maryland; University of Maryland College Park; Virginia Polytechnic Institute & State University	Hurtt, GC (corresponding author), Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA.	gchurtt@umd.edu	Hurtt, George/A-8450-2012; Thomas, R Quinn/B-1611-2013	Hurtt, George/0000-0001-7278-202X; Thomas, R Quinn/0000-0003-1282-7825; Fisk, Justin/0000-0002-7232-3832	NASA	NASA(National Aeronautics & Space Administration (NASA))	This work was supported by research grants from the NASA Terrestrial Ecology and Interdisciplinary Science Research Programs.	Antokarakis AS, 2011, ECOLOGICAL APPL, V21; Antonarakis AS, 2014, GEOPHYS RES LETT, V41, P2535, DOI 10.1002/2013GL058373; Blair JB, 1999, ISPRS J PHOTOGRAMM, V54, P115, DOI 10.1016/S0924-2716(99)00002-7; BOTKIN DB, 1972, J ECOL, V60, P849, DOI 10.2307/2258570; Chambers JQ, 2007, SCIENCE, V318, P1107, DOI 10.1126/science.1148913; Chambers JQ, 2013, P NATL ACAD SCI USA, V110, P3949, DOI 10.1073/pnas.1202894110; Chambers JQ, 2009, ECOL LETT, V12, pE22, DOI 10.1111/j.1461-0248.2009.01398.x; Clark DB, 2000, FOREST ECOL MANAG, V137, P185, DOI 10.1016/S0378-1127(99)00327-8; Drake JB, 2003, GLOBAL ECOL BIOGEOGR, V12, P147, DOI 10.1046/j.1466-822X.2003.00010.x; Drake JB, 2002, REMOTE SENS ENVIRON, V79, P305, DOI 10.1016/S0034-4257(01)00281-4; Drake JB, 2002, REMOTE SENS ENVIRON, V81, P378, DOI 10.1016/S0034-4257(02)00013-5; Dubayah RO, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG000933; Dwyer E, 2000, INT J REMOTE SENSING, V21; Fisher JI, 2008, ECOL LETT, V11, P554, DOI 10.1111/j.1461-0248.2008.01169.x; Fisk JP, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/045017; Frolking S, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000911; Hofton MA, 2002, J GEODYN, V34, P491, DOI 10.1016/S0264-3707(02)00046-7; Hurtt GC, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG000937; Hurtt GC, 1998, GLOBAL CHANGE BIOL, V4, P581, DOI 10.1046/j.1365-2486.1998.t01-1-00203.x; Hurtt GC, 2004, ECOL APPL, V14, P873, DOI 10.1890/02-5317; Kellner JR, 2009, ECOL LETT, V12, P887, DOI 10.1111/j.1461-0248.2009.01345.x; Kellner JR, 2009, ECOL LETT, V12, P155, DOI 10.1111/j.1461-0248.2008.01274.x; MCDADE L. A., 1994, SELVA ECOLOGY NATURA; Moorcroft PR, 2001, ECOL MONOGR, V71, P557, DOI 10.1890/0012-9615(2001)071[0557:AMFSVD]2.0.CO;2; Randerson JT, 2009, GLOBAL CHANGE BIOL, V15, P2462, DOI 10.1111/j.1365-2486.2009.01912.x; Sellers PJ, 1995, OVERVIEW ISLSCP I GL, V1-5; Shugart H.H., 1984, THEORY FOREST DYNAMI; Thomas RQ, 2008, CAN J REMOTE SENS, V34, pS351, DOI 10.5589/m08-036	28	16	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0152883	10.1371/journal.pone.0152883	http://dx.doi.org/10.1371/journal.pone.0152883			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093157	Green Submitted, Green Published, gold			2022-12-26	WOS:000374541200010
J	Klein, SR; Jiang, H; Hossain, MB; Fan, XJ; Gumin, J; Dong, A; Alonso, MM; Gomez-Manzano, C; Fueyo, J				Klein, Sarah R.; Jiang, Hong; Hossain, Mohammad B.; Fan, Xuejun; Gumin, Joy; Dong, Andrew; Alonso, Marta M.; Gomez-Manzano, Candelaria; Fueyo, Juan			Critical Role of Autophagy in the Processing of Adenovirus Capsid-Incorporated Cancer-Specific Antigens	PLOS ONE			English	Article							MHC CLASS-II; NUCLEAR ANTIGEN; PHOSPHORYLATION; COMBINATION; EXPRESSION; MATURATION; PROTEIN; FUSION; VECTOR; GROWTH	Adenoviruses are highly immunogenic and are being examined as potential vectors for immunotherapy. Infection by oncolytic adenovirus is followed by massive autophagy in cancer cells. Here, we hypothesize that autophagy regulates the processing of adenoviral proteins for antigen presentation. To test this hypothesis, we first examined the presentation of viral antigens by infected cells using an antibody cocktail of viral capsid proteins. We found that viral antigens were processed by JNK-mediated autophagy, and that autophagy was required for their presentation. Consistent with these results, splenocytes isolated from virus-immunized mice were activated by infected cells in an MHC II-dependent manner. We then hypothesize that this mechanism can be utilized to generate an efficient cancer vaccine. To this end, we constructed an oncolytic virus encompassing an EGFRvIII cancer-specific epitope in the adenoviral fiber. Infection of cancer cells with this fiber-modified adenovirus resulted in recognition of infected cancer cells by a specific anti-EGFRvIII antibody. However, inhibition of autophagy drastically decreased the capability of the specific antibody to detect the cancer-related epitope in infected cells. Our data suggest that combination of adenoviruses with autophagy inducers may enhance the processing and presentation of cancer-specific antigens incorporated into capsid proteins.	[Klein, Sarah R.; Jiang, Hong; Hossain, Mohammad B.; Fan, Xuejun; Dong, Andrew; Gomez-Manzano, Candelaria; Fueyo, Juan] Univ Texas MD Anderson Canc Ctr, Brain Tumor Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Klein, Sarah R.; Gomez-Manzano, Candelaria; Fueyo, Juan] Univ Texas Grad Sch Biomed Sci Houston, Canc Biol Program, Houston, TX USA; [Gumin, Joy; Fueyo, Juan] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Brain Tumor Ctr, Houston, TX 77030 USA; [Alonso, Marta M.] Univ Navarra, Univ Navarra Clin, Dept Med Oncol, E-31080 Pamplona, Spain; [Gomez-Manzano, Candelaria] Univ Texas MD Anderson Canc Ctr, Dept Genet, Brain Tumor Ctr, Houston, TX 77030 USA; [Klein, Sarah R.] Dana Farber Canc Inst, Dept Neurooncol, Boston, MA USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Navarra; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Dana-Farber Cancer Institute	Fueyo, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Brain Tumor Ctr, Dept Neurooncol, Houston, TX 77030 USA.; Fueyo, J (corresponding author), Univ Texas Grad Sch Biomed Sci Houston, Canc Biol Program, Houston, TX USA.; Fueyo, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Brain Tumor Ctr, Houston, TX 77030 USA.	jfueyo@mdanderson.org	Alonso, Marta M/AAI-9457-2020	Alonso, Marta M/0000-0002-7520-7351; Fueyo, Juan/0000-0001-6941-2335; Gomez-Manzano, Candelaria/0000-0002-1259-2133	NIH (Cancer Center Support Grant-Sequencing and Microarray Facility and Research Animal Support Facilities) [P30CA016672, P50CA127001, R01NS069964]; Marnie Rose Foundation; Will Power Foundation; Schissler Foundation; American Legion Auxiliary; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA127001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069964] Funding Source: NIH RePORTER	NIH (Cancer Center Support Grant-Sequencing and Microarray Facility and Research Animal Support Facilities)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marnie Rose Foundation; Will Power Foundation; Schissler Foundation; American Legion Auxiliary; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the NIH (P50CA127001; R01NS069964; Cancer Center Support Grant P30CA016672-Sequencing and Microarray Facility and Research Animal Support Facilities), the Marnie Rose Foundation, the Will Power Foundation, the Schissler Foundation, and the American Legion Auxiliary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso MM, 2007, CANCER GENE THER, V14, P756, DOI 10.1038/sj.cgt.7701067; Alonso MM, 2008, MOL THER, V16, P487, DOI 10.1038/sj.mt.6300400; ANDERSSON M, 1985, CELL, V43, P215, DOI 10.1016/0092-8674(85)90026-1; Basner-Tschakarjan E, 2006, J GENE MED, V8, P1300, DOI 10.1002/jgm.964; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bessis N, 2004, GENE THER, V11, pS10, DOI 10.1038/sj.gt.3302364; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Birmingham CL, 2008, NATURE, V451, P350, DOI 10.1038/nature06479; Dengjel J, 2005, P NATL ACAD SCI USA, V102, P7922, DOI 10.1073/pnas.0501190102; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Fueyo J, 2000, ONCOGENE, V19, P2, DOI 10.1038/sj.onc.1203251; Fueyo J, 2003, J NATL CANCER I, V95, P652, DOI 10.1093/jnci/95.9.652; HECHT TT, 1983, J IMMUNOL, V131, P1049; HUMPHREY PA, 1990, P NATL ACAD SCI USA, V87, P4207, DOI 10.1073/pnas.87.11.4207; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Ito H, 2006, JNCI-J NATL CANCER I, V98, P625, DOI 10.1093/jnci/djj161; Jiang H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097407; Jiang H, 2011, J VIROL, V85, P4720, DOI 10.1128/JVI.02032-10; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Klein SR, 2015, ONCOGENE, V34, P5295, DOI 10.1038/onc.2014.452; Krause A, 2006, J VIROL, V80, P5523, DOI 10.1128/JVI.02667-05; Mahasreshti PJ, 2006, GYNECOL ONCOL, V100, P521, DOI 10.1016/j.ygyno.2005.08.042; Martins I, 2007, EUR J IMMUNOL, V37, P788, DOI 10.1002/eji.200636620; Matthews QL, 2011, MOL PHARMACEUT, V8, P3, DOI 10.1021/mp100214b; Minamitani T, 2011, J VIROL, V85, P4035, DOI 10.1128/JVI.02160-10; Munz C, 2000, J EXP MED, V191, P1649, DOI 10.1084/jem.191.10.1649; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Piao Y, 2009, CANCER GENE THER, V16, P256, DOI 10.1038/cgt.2008.75; Piya S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029467; Russell SJ, 2012, NAT BIOTECHNOL, V30, P658, DOI 10.1038/nbt.2287; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; Sumpter R, 2011, AUTOPHAGY, V7, P260, DOI 10.4161/auto.7.3.14281; Suzuki K, 2001, CLIN CANCER RES, V7, P120; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Worgall S, 2004, J VIROL, V78, P2572, DOI 10.1128/JVI.78.5.2572-2580.2004; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33	40	16	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153814	10.1371/journal.pone.0153814	http://dx.doi.org/10.1371/journal.pone.0153814			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093696	Green Submitted, gold, Green Published			2022-12-26	WOS:000374541200045
J	Tian, N; Guo, QY; Zhou, Q; Cao, PY; Hong, LY; Chen, MH; Yang, X; Yu, XQ				Tian, Na; Guo, Qunying; Zhou, Qian; Cao, Peiyi; Hong, Lingyao; Chen, Menghua; Yang, Xiao; Yu, Xueqing			The Impact of Fluid Overload and Variation on Residual Renal Function in Peritoneal Dialysis Patient	PLOS ONE			English	Article							EXTRACELLULAR VOLUME EXPANSION; BIOELECTRICAL-IMPEDANCE ANALYSIS; LEFT-VENTRICULAR HYPERTROPHY; BODY-COMPOSITION; PREDICTORS; ADEQUACY; DECLINE; BIOIMPEDANCE; REMOVAL; SODIUM	Background The effect of fluid overload and variation on residual renal function (RRF) in peritoneal dialysis (PD) patients is controversial. Methods Retrospective cohort study was designed. One-hundred and ninety PD patients with measured glomerular filtration rate (mGFR). >= 3ml/min/1.73m(2) were recruit. Fluid status of every participant was assessed by bioelectrical impedance analysis (BIA) every 3 months for 1 year. The cohort was divided into three hydration groups, namely persistent overhydration (PO) group, intermittent overhydration (IO) group and normal hydration (NH) group. Additionally, participants were also divided into high or low fluid variation groups. The decline rate of RRF and the event of anuria were followed up for 1 year. The association of fluid overload with RRF loss was evaluated by Cox proportional hazard models adjusted for confounders. Results Thirty-six (18.9%) patients developed anuria. The decline rate of mGFR in both PO and IO groups were significantly faster than that of NH group (PO vs NH: -0.2 vs -0.1 ml/min/1.73m(2)/month, p < 0.01; IO vs NH: -0.2 vs -0.1 ml/min/1.73m(2)/month, p < 0.01). Kaplan-Meier analysis showed poorer RRF outcome in both PO and IO groups compared with that of NH group (PO vs NH: p < 0.001; IO vs NH: p = 0.006). Patients with high fluid variation had worse RRF survival than those with low fluid variation (p = 0.04). Adjusted Cox regression models indicated the hazard ratio of RRF loss in PO group was 8.90-folds higher (95% confidence interval 3.07-31.89) than that in NH group. Conclusions These findings suggested fluid overload was independently associated with the decline of RRF in PD patients.	[Tian, Na; Guo, Qunying; Zhou, Qian; Cao, Peiyi; Hong, Lingyao; Yang, Xiao; Yu, Xueqing] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Nephrol, Key Lab Nephrol,Minist Hlth & Guangdong Prov, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Menghua] Ningxia Med Univ, Gen Hosp, Dept Nephrol, Ningxia, Peoples R China	Sun Yat Sen University; Ningxia Medical University	Yu, XQ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Nephrol, Key Lab Nephrol,Minist Hlth & Guangdong Prov, Guangzhou 510275, Guangdong, Peoples R China.	yuxq@mail.sysu.edu.cn	tian, na/GVR-9226-2022	Qian, Zhou/0000-0003-3954-5449; Yang, Xiao/0000-0003-0437-2015				Avila-Diaz M, 2006, PERITON DIALYSIS INT, V26, P574; Bargman JM, 2001, J AM SOC NEPHROL, V12, P2158, DOI 10.1681/ASN.V12102158; Burke SW, 2000, ADV RENAL REPLACE TH, V7, P210, DOI 10.1053/jarr.2000.8120; Cheng LT, 2006, NEPHRON CLIN PRACT, V104, pC47, DOI 10.1159/000093670; Cooper BA, 2000, KIDNEY INT, V58, P408, DOI 10.1046/j.1523-1755.2000.00180.x; Davenport A, 2011, BLOOD PURIFICAT, V32, P226, DOI 10.1159/000329732; Davenport A, 2010, NEPHRON CLIN PRACT, V114, pC60, DOI 10.1159/000245070; Dell'Aqulla R, 2008, NEFROLOGIA, V28, P67; Fan S, 2012, INT J ARTIF ORGANS, V35, P338, DOI 10.5301/ijao.5000080; Foley RN, 1998, J AM SOC NEPHROL, V9, P267; Fouque D, 2007, NEPHROL DIAL TRANSPL, V22, P45, DOI 10.1093/ndt/gfm020; Gunal AI, 2004, RENAL FAILURE, V26, P405, DOI 10.1081/JDI-120039825; Guo QY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053294; Haapio M, 2012, CONTRIB NEPHROL, V178, P238, DOI 10.1159/000337885; Herget-Rosenthal S, 2012, KIDNEY BLOOD PRESS R, V35, P233, DOI 10.1159/000332887; Ignace S, 2009, NEPHROL DIAL TRANSPL, V24, P1685, DOI 10.1093/ndt/gfp077; Jansen MAM, 2002, KIDNEY INT, V62, P1046, DOI 10.1046/j.1523-1755.2002.00505.x; Johnson DW, 2003, PERITON DIALYSIS INT, V23, P276; Jones CH, 1998, NEPHROL DIAL TRANSPL, V13, P393, DOI 10.1093/oxfordjournals.ndt.a027836; Lameire N, 1997, PERITON DIALYSIS INT, V17, pS102; Liao CT, 2008, PERITON DIALYSIS INT, V28, pS191; Lopez-Menchero R, 1999, NEPHRON, V83, P219, DOI 10.1159/000045514; McCafferty K, 2014, KIDNEY INT, V85, P151, DOI 10.1038/ki.2013.273; Moissl UM, 2006, PHYSIOL MEAS, V27, P921, DOI 10.1088/0967-3334/27/9/012; Morinaga H, 2012, PERITON DIALYSIS INT, V32, P453, DOI 10.3747/pdi.2011.00032; Piraino B, 2005, PERITON DIALYSIS INT, V25, P107; RALLISON LR, 1993, J AM COLL NUTR, V12, P66; Rodriguez-Carmona A, 2004, AM J KIDNEY DIS, V44, P132, DOI 10.1053/j.ajkd.2004.03.035; Van Biesen W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017148; Van Biesen W, 2008, J NEPHROL, V21, P299; Van den Ham ECH, 1999, J AM SOC NEPHROL, V10, P1067; vanOlden RW, 1996, J AM SOC NEPHROL, V7, P745; Wang AYM, 2002, KIDNEY INT, V62, P639, DOI 10.1046/j.1523-1755.2002.00471.x; Wang AYM, 2005, AM J KIDNEY DIS, V45, P715, DOI 10.1053/j.ajkd.2004.12.012; Wang AYM, 2001, J AM SOC NEPHROL, V12, P2450, DOI 10.1681/ASN.V12112450; Weiner DE, 2014, AM J KIDNEY DIS, V64, P685, DOI 10.1053/j.ajkd.2014.07.003	36	23	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153115	10.1371/journal.pone.0153115	http://dx.doi.org/10.1371/journal.pone.0153115			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093429	Green Published, Green Submitted, gold			2022-12-26	WOS:000374541200012
J	Dreger, S; Krille, L; Maier, W; Pokora, R; Blettner, M; Zeeb, H				Dreger, Steffen; Krille, Lucian; Maier, Werner; Pokora, Roman; Blettner, Maria; Zeeb, Hajo			Regional Deprivation and Non-Cancer Related Computed Tomography Use in Pediatric Patients in Germany: Cross-Sectional Analysis of Cohort Data	PLOS ONE			English	Article							RADIATION-EXPOSURE; CT SCANS; SUBSEQUENT RISK; BRAIN-TUMORS; LEUKEMIA; CHILDREN; TRAUMA	Background Conflicting findings were observed in recent studies assessing the association between patients' area-level socio-economic status and the received number of computed tomography (CT) examinations in children. The aim was to investigate the association between area-level socio-economic status and variation in CT examination practice for pediatric patients in Germany. Methods Data from Radiology Information Systems for children aged 0 to <15 years without cancer who had at least one CT examination between 2001 and 2010 were extracted in 20 hospitals across Germany. The small-area German Index of Multiple Deprivation (GIMD) was used to assess regional deprivation. The GIMD scores were classified into least, medium and most deprived areas and linked with the patient's last known postal code. A multinomial logistic regression model was used to assess the association between patients' CT numbers and regional deprivation adjusting for age, sex, and location of residence (urban/rural). Results A total of 37,810 pediatric patients received 59,571 CT scans during the study period. 27,287 (72%) children received only one CT, while n = 885 (2.3%) received six or more. Increasing numbers of CT examinations in non-cancer patients were significantly associated with higher regional deprivation, which increased, although CI overlap, for higher CT categories: '2-3 CT' odds ratio (OR) = 1.45, 95% CI: 1.40-1.50; '4-5 CT' OR = 1.48, 95% CI: 1.38-1.59; '6+CT' OR = 1.54, 95% CI: 1.41-1.69. In addition, male sex, higher age categories, and specific body regions were positively associated with increased numbers of CT examinations. Conclusion We observed a positive association between regional deprivation and CT numbers in non-cancer pediatric patients. Limitations of the ecological approach and the lack of differentiation of CT details have to be acknowledged. More information on CT indications is necessary for a full assessment of this finding. In addition, further work on ways to assess socioeconomic status more accurately may be required.	[Dreger, Steffen; Zeeb, Hajo] Leibniz Inst Prevent Res & Epidemiol BIPS, Bremen, Germany; [Krille, Lucian; Pokora, Roman; Blettner, Maria] Univ Med Ctr Mainz, Inst Med Biostat Epidemiol & Informat, Mainz, Germany; [Krille, Lucian] Int Agcy Res Canc, 150 Cours Albert Thomas, F-69372 Lyon, France; [Maier, Werner] German Res Ctr Environm Hlth GmbH, Inst Hlth Econ & Hlth Care Management, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Zeeb, Hajo] Univ Bremen, Hlth Sci Bremen, D-28359 Bremen, Germany	Leibniz Institute for Prevention Research & Epidemiology (BIPS); Johannes Gutenberg University of Mainz; World Health Organization; International Agency for Research on Cancer (IARC); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Bremen	Dreger, S (corresponding author), Leibniz Inst Prevent Res & Epidemiol BIPS, Bremen, Germany.	dreger@bips.uni-bremen.de	Zeeb, Hajo/I-2701-2019; Pokora, Roman/AAG-4753-2022; Pokora, Roman/AFK-6503-2022	Zeeb, Hajo/0000-0001-7509-242X; Maier, Werner/0000-0003-4356-7296	German Federal Ministry of Education and Research [02NUK016A, 02NUK016CX]; French Embassy	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); French Embassy	This work was supported by the German Federal Ministry of Education and Research (http://www.bmbf.de/en/), grant numbers 02NUK016A and 02NUK016CX. LK received a research-stipend from the French Embassy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brix G, 2005, RADIOLOGE, V45, P340, DOI 10.1007/s00117-005-1184-3; Bundesamt fuer Strahlenschutz, 2013, ENV RAD RAD EXP 2011; Edwards P, 2008, ARCH DIS CHILD, V93, P485, DOI 10.1136/adc.2007.116541; Ellsaesser G, 2014, ACCIDENTS VIOLENCE S; Galanski M, 2006, RESULTS NATION WIDE; Huang WY, 2014, BRIT J CANCER, V110, P2354, DOI 10.1038/bjc.2014.103; Janssens L, 2014, INJURY, V45, P1190, DOI 10.1016/j.injury.2014.04.027; Journy N, 2015, BRIT J CANCER, V112, P185, DOI 10.1038/bjc.2014.526; Krille L, 2015, RADIAT ENVIRON BIOPH, V54, P1, DOI 10.1007/s00411-014-0580-3; Krille L, 2011, EUR J EPIDEMIOL, V26, P249, DOI 10.1007/s10654-011-9549-6; Kuznetsov L, 2012, INT J PUBLIC HEALTH, V57, P827, DOI 10.1007/s00038-012-0342-4; Licaj I, 2011, J SAFETY RES, V42, P171, DOI 10.1016/j.jsr.2011.05.004; Maier W, 2013, DIABETIC MED, V30, pE78, DOI 10.1111/dme.12062; Maier W, 2012, GESUNDHEITSWESEN, V74, P416, DOI 10.1055/s-0031-1280846; Maier W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089661; Malik K., 2013, HUMAN DEV REPORT 201; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Mettler F. A., 2008, HEALTH PHYS, V95, P502, DOI DOI 10.1097/01.HP; Mettler FA, 2008, RADIOLOGY, V248, P254, DOI 10.1148/radiol.2481071451; Meulepas JM, 2014, EUR J EPIDEMIOL, V29, P293, DOI 10.1007/s10654-014-9900-9; Noble M, 2006, ENVIRON PLANN A, V38, P169, DOI 10.1068/a37168; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Pearce MS, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-24; Rattay P, 2013, BUNDESGESUNDHEITSBLA, V56, P832, DOI 10.1007/s00103-013-1665-x; United Nations Scientific Committee on Atomic Radiation (UNSCEAR), 2013, UNSCEAR 20202021 REP, V2	25	5	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153644	10.1371/journal.pone.0153644	http://dx.doi.org/10.1371/journal.pone.0153644			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27089125	Green Published, gold, Green Submitted			2022-12-26	WOS:000374527000035
J	Grecka, E; Statkiewicz, M; Gorska, A; Biernacka, M; Grygorowicz, MA; Masnyk, M; Chmielewski, M; Gawarecka, K; Chojnacki, T; Swiezewska, E; Malecki, M				Grecka, Emilia; Statkiewicz, Malgorzata; Gorska, Agnieszka; Biernacka, Marzena; Grygorowicz, Monika Anna; Masnyk, Marek; Chmielewski, Marek; Gawarecka, Katarzyna; Chojnacki, Tadeusz; Swiezewska, Ewa; Malecki, Maciej			Prenyl Ammonium Salts - New Carriers for Gene Delivery: A B16-F10 Mouse Melanoma Model	PLOS ONE			English	Article							LINKED CATIONIC LIPIDS; IN-VITRO; TISSUE INHIBITOR; DRUG CARRIERS; TRANSFECTION; COMPLEXES; LIPOPLEX; THERAPY; VECTORS; DOTAP	Purpose Prenyl ammonium iodides (Amino-Prenols, APs), semi-synthetic polyprenol derivatives were studied as prospective novel gene transfer agents. Methods AP-7, -8, -11 and -15 (aminoprenols composed of 7, 8, 11 or 15 isoprene units, respectively) were examined for their capacity to form complexes with pDNA, for cytotoxicity and ability to transfect genes to cells. Results All the carriers were able to complex DNA. The highest, comparable to commercial reagents, transfection efficiency was observed for AP-15. Simultaneously, AP-15 exhibited the lowest negative impact on cell viability and proliferation-considerably lower than that of commercial agents. AP-15/DOPE complexes were also efficient to introduce pDNA to cells, without much effect on cell viability. Transfection with AP-15/DOPE complexes influenced the expression of a very few among 44 tested genes involved in cellular lipid metabolism. Furthermore, complexes containing AP-15 and therapeutic plasmid, encoding the TIMP metallopeptidase inhibitor 2 (TIMP2), introduced the TIMP2 gene with high efficiency to B16-F10 melanoma cells but not to B16-F10 melanoma tumors in C57BL/6 mice, as confirmed by TIMP2 protein level determination. Conclusion Obtained results indicate that APs have a potential as non-viral vectors for cell transfection.	[Grecka, Emilia] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Mol & Translat Oncol, Warsaw, Poland; [Grecka, Emilia] Natl Res Inst Mother & Child, Dept Pharmacol, Warsaw, Poland; [Statkiewicz, Malgorzata] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Genet, Warsaw, Poland; [Gorska, Agnieszka; Malecki, Maciej] Med Univ Warsaw, Dept Appl Pharm & Bioengn, Warsaw, Poland; [Biernacka, Marzena; Grygorowicz, Monika Anna] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Immunol, Warsaw, Poland; [Masnyk, Marek; Chmielewski, Marek] Inst Organ Chem PAS, Warsaw, Poland; [Gawarecka, Katarzyna; Chojnacki, Tadeusz; Swiezewska, Ewa] Inst Biochem & Biophys PAS, Warsaw, Poland	Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Medical University of Warsaw; Maria Sklodowska-Curie National Research Institute of Oncology; Polish Academy of Sciences; Institute of Organic Chemistry of the Polish Academy of Sciences; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Grecka, E (corresponding author), Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Mol & Translat Oncol, Warsaw, Poland.	emilia.grecka@outlook.com	Gawarecka, Katarzyna/N-6184-2014; Górska, Agnieszka/N-9664-2018	Górska, Agnieszka/0000-0002-5562-6903; Statkiewicz, Malgorzata/0000-0003-2170-1909; Swiezewska, Ewa/0000-0002-3439-8948	Polish National Cohesion Strategy Innovative Economy Grant [UDA-POIG 01.03.01-14-036/09]	Polish National Cohesion Strategy Innovative Economy Grant	This work was supported by Polish National Cohesion Strategy Innovative Economy Grant UDA-POIG 01.03.01-14-036/09 (ES, MC, M. Malecki). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari SS, 2015, HEAT SHOCK PROTEINS, V9, P219, DOI 10.1007/978-3-319-17211-8_12; Al-Dosari MS, 2009, AAPS J, V11, P671, DOI 10.1208/s12248-009-9143-y; BARTHEL F, 1993, DNA CELL BIOL, V12, P553, DOI 10.1089/dna.1993.12.553; Bentinger M, 2008, J BIOL CHEM, V283, P14645, DOI 10.1074/jbc.M710202200; Bourboulia D, 2011, AM J PATHOL, V179, P2589, DOI 10.1016/j.ajpath.2011.07.035; Bouxsein NF, 2007, BIOCHEMISTRY-US, V46, P4785, DOI 10.1021/bi062138l; Brand K, 2000, CANCER RES, V60, P5723; Brandwijk RJMGE, 2007, TRENDS MOL MED, V13, P200, DOI 10.1016/j.molmed.2007.03.001; Bryant LM, 2013, HUM GENE THER CL DEV, V24, P55, DOI 10.1089/humc.2013.087; Butler GS, 1999, J BIOL CHEM, V274, P20391, DOI 10.1074/jbc.274.29.20391; Giron-Gonzalez MD, 2016, BIOCONJUGATE CHEM, V27, P549, DOI 10.1021/acs.bioconjchem.5b00576; Eastman SJ, 1997, BBA-BIOMEMBRANES, V1325, P41, DOI 10.1016/S0005-2736(96)00242-8; FARHOOD H, 1995, BBA-BIOMEMBRANES, V1235, P289, DOI 10.1016/0005-2736(95)80016-9; FELGNER JH, 1994, J BIOL CHEM, V269, P2550; Furuhata M, 2008, J NANOSCI NANOTECHNO, V8, P2308, DOI 10.1166/jnn.2008.170; Gashti AB, 2012, J PHARM RES, V5, P4361; Gawrys O, 2014, PHARMACOL REP, V66, P273, DOI 10.1016/j.pharep.2013.09.009; Gawrys O, 2014, EUR J LIPID SCI TECH, V116, P659, DOI 10.1002/ejlt.201300489; Goyal R, 2012, NANOMED-NANOTECHNOL, V8, P167, DOI 10.1016/j.nano.2011.06.001; Haq M, 2000, CANCER RES, V60, P3207; Hartley MD, 2012, ARCH BIOCHEM BIOPHYS, V517, P83, DOI 10.1016/j.abb.2011.10.018; Jacobsen LB, 2009, BIOTECHNIQUES, V47, P617, DOI 10.2144/000113132; Jones MB, 2009, BBA-GEN SUBJECTS, V1790, P485, DOI 10.1016/j.bbagen.2009.03.030; Kawakami S, 2004, INT J PHARMACEUT, V278, P255, DOI 10.1016/j.ijpharm.2004.03.013; Kearns MD, 2010, CHEM PHYS LIPIDS, V163, P755, DOI 10.1016/j.chemphyslip.2010.08.001; Lichtinghagen R, 2002, EUR UROL, V42, P398, DOI 10.1016/S0302-2838(02)00324-X; Liu D, GENE THER MOL BIOL, P59; Lonez C, 2012, ADV DRUG DELIVER REV, V64, P1749, DOI 10.1016/j.addr.2012.05.009; Louis MH, 2006, CANCER GENE THER, V13, P367, DOI 10.1038/sj.cgt.7700893; Madeja Z, 2007, ACTA BIOCHIM POL, V54, P873, DOI 10.18388/abp.2007_3191; Massing U, 2000, CHEM PHYS LIPIDS, V105, P189, DOI 10.1016/S0009-3084(00)00121-3; Miloszewska J, 2010, CELL PROLIFERAT, V43, P229, DOI 10.1111/j.1365-2184.2010.00671.x; Misra SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068305; Mochizuki S, 2013, BBA-BIOMEMBRANES, V1828, P412, DOI 10.1016/j.bbamem.2012.10.017; Nguyen HK, 2000, GENE THER, V7, P126, DOI 10.1038/sj.gt.3301052; Nguyen LT, 2007, BIOL PHARM BULL, V30, P751, DOI 10.1248/bpb.30.751; Obata Y, 2010, NANOMED-NANOTECHNOL, V6, P70, DOI 10.1016/j.nano.2009.04.005; Paecharoenchai O, 2012, AAPS PHARMSCITECH, V13, P1302, DOI 10.1208/s12249-012-9857-5; Palizban AA, 2007, J DRUG TARGET, V15, P351, DOI 10.1080/10611860701349364; Parvizi P, 2014, INT J PHARMACEUT, V461, P145, DOI 10.1016/j.ijpharm.2013.11.045; Podgornik R, 2004, GENE THERAPY THERAPE, P301; Qiao WH, 2013, EUR J LIPID SCI TECH, V115, P483, DOI 10.1002/ejlt.201200265; Regelin AE, 2000, BBA-BIOMEMBRANES, V1464, P151, DOI 10.1016/S0005-2736(00)00126-7; Rosenzweig HS, 2001, BIOCONJUGATE CHEM, V12, P258, DOI 10.1021/bc000099z; Rubanyi Gabor M., 2001, Molecular Aspects of Medicine, V22, P113, DOI 10.1016/S0098-2997(01)00004-8; Saito Y, 2006, BIOL PHARM BULL, V29, P1986, DOI 10.1248/bpb.29.1986; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sato M, 1999, MOL CELL BIOL, V19, P471; Scarzello M, 2005, J AM CHEM SOC, V127, P10420, DOI 10.1021/ja0515147; Shi J, 2016, COLLOID SURFACE B, V141, P417, DOI 10.1016/j.colsurfb.2016.02.018; Sun S, 2013, NANOMED-NANOTECHNOL, V9, P849, DOI 10.1016/j.nano.2013.01.006; Templeton NS, 2012, J DRUG DELIV, V2012, DOI 10.1155/2012/173465; Templeton NS, 1997, NAT BIOTECHNOL, V15, P647, DOI 10.1038/nbt0797-647; de Ilarduya CT, 2010, EUR J PHARM SCI, V40, P159, DOI 10.1016/j.ejps.2010.03.019; Valente P, 1998, INT J CANCER, V75, P246, DOI 10.1002/(SICI)1097-0215(19980119)75:2<246::AID-IJC13>3.0.CO;2-B; VALTERSSON C, 1985, J BIOL CHEM, V260, P2742; Vogel C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.59; Walker S, 1998, ADV DRUG DELIVER REV, V30, P61, DOI 10.1016/S0169-409X(97)00107-5; Wasungu L, 2006, J CONTROL RELEASE, V116, P255, DOI 10.1016/j.jconrel.2006.06.024; Weinberg R. A., 2013, BIOL CANC; Xu YH, 1996, BIOCHEMISTRY-US, V35, P5616, DOI 10.1021/bi9602019; Zakharova LY, 2016, COLLOID SURFACE B, V140, P269, DOI 10.1016/j.colsurfb.2015.12.045; Zhi DF, 2012, BIOORG MED CHEM LETT, V22, P3837, DOI 10.1016/j.bmcl.2012.01.097	63	4	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153633	10.1371/journal.pone.0153633	http://dx.doi.org/10.1371/journal.pone.0153633			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088717	Green Published, gold, Green Submitted			2022-12-26	WOS:000374527000032
J	Perez, GIP; Gao, Z; Jourdain, R; Ramirez, J; Gany, F; Clavaud, C; Demaude, J; Breton, L; Blaser, MJ				Perez, Guillermo I. Perez; Gao, Zhan; Jourdain, Roland; Ramirez, Julia; Gany, Francesca; Clavaud, Cecile; Demaude, Julien; Breton, Lionel; Blaser, Martin J.			Body Site Is a More Determinant Factor than Human Population Diversity in the Healthy Skin Microbiome	PLOS ONE			English	Article							BACTERIAL COMMUNITIES; CUTANEOUS BACTERIAL; FUNGAL POPULATIONS; ABCC11 ALLELE; ODOR; QUANTITATION; GREENGENES; PSORIASIS; DISEASE; PROFILE	We studied skin microbiota present in three skin sites (forearm, axilla, scalp) in men from six ethnic groups living in New York City. Methods. Samples were obtained at baseline and after four days following use of neutral soap and stopping regular hygiene products, including shampoos and deodorants. DNA was extracted using the MoBio Power Lyzer kit and 16S rRNA gene sequences determined on the IIlumina MiSeq platform, using QIIME for analysis. Results. Our analysis confirmed skin swabbing as a useful method for sampling different areas of the skin because DNA concentrations and number of sequences obtained across subject libraries were similar. We confirmed that skin location was the main factor determining the composition of bacterial communities. Alpha diversity, expressed as number of species observed, was greater in arm than on scalp or axilla in all studied groups. We observed an unexpected increase in a-diversity on arm, with similar tendency on scalp, in the South Asian group after subjects stopped using their regular shampoos and deodorants. Significant differences at phylum and genus levels were observed between subjects of the different ethnic origins at all skin sites. Conclusions. We conclude that ethnicity and particular soap and shampoo practices are secondary factors compared to the ecological zone of the human body in determining cutaneous microbiota composition.	[Perez, Guillermo I. Perez; Gao, Zhan; Blaser, Martin J.] NYU, Dept Med, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA; [Jourdain, Roland; Clavaud, Cecile; Demaude, Julien; Breton, Lionel] LOreal Res & Innovat, Aulnay Sous Bois, France; [Ramirez, Julia; Gany, Francesca] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Demaude, Julien] LOreal Res & Innovat, Clark, NJ USA; [Blaser, Martin J.] Vet Affairs Med Ctr, New York Harbor Dept, New York, NY USA	New York University; NYU Langone Medical Center; L'Oreal Group; Memorial Sloan Kettering Cancer Center; L'Oreal Group; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Perez, GIP (corresponding author), NYU, Dept Med, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA.	perezg02@med.nyu.edu	Perez, Guillermo Perez/AAJ-3761-2020	Gao, Zhan/0000-0003-0976-8836; Perez Perez, Guillermo/0000-0002-0131-5798	Diane Belfer program in Human Microbial Ecology from the National Institutes of Health [UH2 AR057506-01S1]; L'Oreal Research and Innovation grant; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [UH2AR057506] Funding Source: NIH RePORTER	Diane Belfer program in Human Microbial Ecology from the National Institutes of Health; L'Oreal Research and Innovation grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by the Diane Belfer program in Human Microbial Ecology, UH2 AR057506-01S1 from the National Institutes of Health, and L'Oreal Research and Innovation grant. Cecile Clavaud, Roland Jourdain, Julien Demaude, and Lionel Breton are employees of L'Oreal Research & Innovation.	Aagaard K, 2013, FASEB J, V27, P1012, DOI 10.1096/fj.12-220806; Akaza N, 2015, J DERMATOL; Alekseyenko AV, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-31; Alexeyev OA, 2013, EXP DERMATOL, V22, P443, DOI 10.1111/exd.12160; Alexis AE, 2012, J DRUGS DERMATOL, V11, pS30; Belkaid Y, 2014, SCIENCE, V346, P954, DOI 10.1126/science.1260144; Blaser MJ, 2013, ISME J, V7, P85, DOI 10.1038/ismej.2012.81; Callewaert C, 2014, APPL ENVIRON MICROB, V80, P6611, DOI 10.1128/AEM.01422-14; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Clavaud C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058203; Clemente JC, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500183; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eilers KG, 2012, SOIL BIOL BIOCHEM, V50, P58, DOI 10.1016/j.soilbio.2012.03.011; EVANS CA, 1976, J CLIN MICROBIOL, V3, P576; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Gao Z, 2010, J CLIN MICROBIOL, V48, P3575, DOI 10.1128/JCM.00597-10; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Grice EA, 2012, ANNU REV GENOM HUM G, V13, P151, DOI 10.1146/annurev-genom-090711-163814; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Harker M, 2014, J DERMATOL SCI, V73, P23, DOI 10.1016/j.jdermsci.2013.08.016; Hospodsky D, 2014, MICROBIOL-SGM, V160, P1144, DOI 10.1099/mic.0.075390-0; Kong HH, 2012, J INVEST DERMATOL, V132, P933, DOI 10.1038/jid.2011.417; Li W, 2014, MICROBIOL RES, V169, P686, DOI 10.1016/j.micres.2014.02.008; Marples M. J., 1965, ECOLOGY HUMAN SKIN; Martin A, 2010, J INVEST DERMATOL, V130, P529, DOI 10.1038/jid.2009.254; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Oh J, 2014, NATURE, V514, P59, DOI 10.1038/nature13786; Oh J, 2012, GENOME MED, V4, DOI 10.1186/gm378; Pappas A, 2013, DERM-ENDOCRINOL, V5, P319, DOI 10.4161/derm.25366; Picardo M, 2014, J CLIN GASTROENTEROL, V48, pS85, DOI 10.1097/MCG.0000000000000241; SanMiguel A, 2015, CELL MOL LIFE SCI, V72, P1499, DOI 10.1007/s00018-014-1812-z; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Stanford JA, 2013, SEMIN IMMUNOL, V25, P370, DOI [10.1016/j.smim.2013.09.005, DOI 10.1016/J.SMIM.2013.09.005]; Statnikov A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02620; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; Wang LL, 2015, EXP DERMATOL, V24, P398, DOI 10.1111/exd.12684; Weyrich LS, 2015, AUSTRALAS J DERMATOL, V56, P268, DOI 10.1111/ajd.12253; Wylie KM, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0071-7; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yoshiura K, 2006, NAT GENET, V38, P324, DOI 10.1038/ng1733	46	85	85	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0151990	10.1371/journal.pone.0151990	http://dx.doi.org/10.1371/journal.pone.0151990			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088867	Green Submitted, gold, Green Published			2022-12-26	WOS:000374527000003
J	Bianchi, E; Boekelheide, K; Sigman, M; Lamb, DJ; Hall, SJ; Hwang, K				Bianchi, Enrica; Boekelheide, Kim; Sigman, Mark; Lamb, Dolores J.; Hall, Susan J.; Hwang, Kathleen			Ghrelin Inhibits Post-Operative Adhesions via Blockage of the TGF-beta Signaling Pathway	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; PLASMINOGEN-ACTIVATOR; SMAD7 EXPRESSION; FIBROSIS; RECEPTOR; TGF-BETA-1; MICE; FIBROGENESIS; CELLS; MODEL	Post-operative adhesions are a critical problem in pelvic and abdominal surgery despite a multitude of studies dedicated to finding modalities to prevent their occurrence. Ghrelin administration promotes an anti-fibrotic response in a surgical mouse model of adhesion-induction, but the mechanisms mediating this effect have not been established. In the current study, the molecular mechanisms that underlie the anti-adhesion effect of ghrelin were investigated. Post-surgical adhesions were experimentally created in C57BL/6 wild-type mice via a combination of ischemic peritoneal buttons and cecal multiple abrasions. Ghrelin or saline intraperitoneal injections were given twice daily from two days before surgery to selected time points post-surgically to assess the phenotypic and molecular effects of treatment (1 day (n = 20), 4 days (n = 20) and 20 days (n = 40) after surgery). Endpoints included the scoring of adhesions and gene and protein expression analysis of pro-fibrogenic factors conducted on peritoneal ischemic tissue by quantitative PCR and Western blot. Ghrelin administration significantly reduced post-surgical adhesions and down-regulated pro-inflammatory gene and protein expression, including Tgfb3 and Tgfbr2. The up-regulation of inhibitory proteins Smad6 and Smad7 confirmed the ghrelin-induced blockage of TGF-beta signaling. Ghrelin is a candidate therapeutic drug for post-operative adhesion prevention, inhibiting inflammatory responses via blockage of the TGF-beta signaling pathway at the onset of surgery before the occurrence of the granulation-remodeling phase.	[Bianchi, Enrica; Sigman, Mark; Hwang, Kathleen] Brown Univ, Div Urol, Providence, RI 02912 USA; [Bianchi, Enrica; Boekelheide, Kim; Sigman, Mark; Hall, Susan J.; Hwang, Kathleen] Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA; [Lamb, Dolores J.] Baylor Coll Med, Dept Mol & Cellular Biol, Scott Dept Urol, Ctr Reprod Med, Houston, TX 77030 USA	Brown University; Brown University; Baylor College of Medicine	Hwang, K (corresponding author), Brown Univ, Div Urol, Providence, RI 02912 USA.; Hwang, K (corresponding author), Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA.	Kathleen_Hwang@brown.edu	Sigman, Mark/P-3343-2019; Hwang, Kathleen/ABE-1339-2021	Bianchi, Enrica/0000-0002-8135-9730	American Society for Reproductive Medicine and Lifespan Hospital System Research Funds	American Society for Reproductive Medicine and Lifespan Hospital System Research Funds	This work was supported by a grant from The American Society for Reproductive Medicine and Lifespan Hospital System Research Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianchi E, 2016, J SURG RES, V201, P226, DOI 10.1016/j.jss.2015.10.044; Branton MH, 1999, MICROBES INFECT, V1, P1349, DOI 10.1016/S1286-4579(99)00250-6; Cheong YC, 2001, HUM REPROD UPDATE, V7, P556, DOI 10.1093/humupd/7.6.556; Cieslik KA, 2011, AM J PATHOL, V179, P1792, DOI 10.1016/j.ajpath.2011.06.022; Delporte C, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/518909; Derynck R, 1997, BBA-REV CANCER, V1333, pF105, DOI 10.1016/S0304-419X(97)00017-6; Desbiens KM, 2003, BIOCHEM J, V372, P631, DOI 10.1042/BJ20021565; Di Filippo C, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/13901; Dooley S, 2008, GASTROENTEROLOGY, V135, P642, DOI 10.1053/j.gastro.2008.04.038; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Fukasawa H, 2004, P NATL ACAD SCI USA, V101, P8687, DOI 10.1073/pnas.0400035101; Fukui N, 2000, J ORTHOPAED RES, V18, P212, DOI 10.1002/jor.1100180208; Gnanapavan S, 2002, J CLIN ENDOCR METAB, V87, P2988, DOI 10.1210/jc.87.6.2988; Gorvy DA, 2005, AM J PATHOL, V167, P1005, DOI 10.1016/S0002-9440(10)61190-X; Hellebrekers BWJ, 2011, BRIT J SURG, V98, P1503, DOI 10.1002/bjs.7657; Holmdahl L, 1997, EUR J SURG, V163, P24; Holmdahl L, 2001, SURGERY, V129, P626, DOI 10.1067/msy.2001.113039; Homdahl L, 1999, EUR J SURG, V165, P1012; Imazu Y, 2011, EUR J PHARMACOL, V672, P153, DOI 10.1016/j.ejphar.2011.09.183; Jung SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3562; Koca SS, 2014, CLIN EXP DERMATOL, V39, P176, DOI 10.1111/ced.12195; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Lee CG, 2001, J EXP MED, V194, P809, DOI 10.1084/jem.194.6.809; Li WG, 2004, CIRCULATION, V109, P2221, DOI 10.1161/01.CIR.0000127956.43874.F2; Liu T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/276850; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Mao YQ, 2015, INT J MOL SCI, V16, P21911, DOI 10.3390/ijms160921911; MAZUJI MK, 1964, ARCH SURG-CHICAGO, V89, P1011; MENZIES D, 1991, SURG GYNECOL OBSTET, V172, P362; Meyer-ter-Vehn T, 2006, INVEST OPHTH VIS SCI, V47, P1500, DOI 10.1167/iovs.05-0361; MONTZ FJ, 1991, AM J OBSTET GYNECOL, V165, P1539; Nakao A, 1999, J CLIN INVEST, V104, P5, DOI 10.1172/JCI6094; Robertson D, 2010, J OBSTET GYNAECOL CA, V32, P598, DOI 10.1016/S1701-2163(16)34530-3; Schnaper HW, 2003, AM J PHYSIOL-RENAL, V284, pF243, DOI 10.1152/ajprenal.00300.2002; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Sulaiman H, 2002, BIOCHEM SOC T, V30, P126, DOI 10.1042/BST0300126; Sun GX, 2015, J UROLOGY, V193, P2107, DOI 10.1016/j.juro.2014.11.098; Takeda R, 2006, J AM SOC NEPHROL, V17, P113, DOI 10.1681/ASN.2004080626; Taya Y, 1999, DEVELOPMENT, V126, P3869; Tesauro M, 2010, CURR DIABETES REV, V6, P228, DOI 10.2174/157339910791658871; Wang G, 2014, WOUND REPAIR REGEN, V22, P631, DOI 10.1111/wrr.12203; Wang J, 2013, INT J MOL SCI, V14, P10369, DOI 10.3390/ijms140510369; Wu R, 2007, AM J RESP CRIT CARE, V176, P805, DOI 10.1164/rccm.200604-511OC; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Yue JB, 2000, METH MOL B, V142, P125; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	46	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153968	10.1371/journal.pone.0153968	http://dx.doi.org/10.1371/journal.pone.0153968			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082244	gold, Green Published, Green Submitted			2022-12-26	WOS:000374291800065
J	Jiang, F; Zhou, XY; Huang, J				Jiang, Feng; Zhou, Xiangyu; Huang, Jing			Long Non-Coding RNA-ROR Mediates the Reprogramming in Cardiac Hypertrophy	PLOS ONE			English	Article							CARDIOMYOCYTE HYPERTROPHY; HEART-FAILURE; MICRORNAS; TRANSCRIPTION; ROLES; CELLS	Background Cardiac hypertrophy associated with various cardiovascular diseases results in heart failure and sudden death. A clear understanding of the mechanisms of hypertrophy will benefit the development of novel therapies. Long non-coding RNAs (lncRNAs) have been shown to play essential roles in many biological process, however, whether lncRNA-ROR plays functional roles in the reprogramming of cardiomyocyte remains unclear. Methodology/Principal Findings Here we show that lncRNA-ROR plays important roles in the pathogenesis of cardiac hypertrophy. In hypertrophic heart and cardiomyocytes, the expression of lncRNA-ROR is dramatically increased, downregulation of which attenuates the hypertrophic responses. Furthermore, the expression of lncRNA-ROR negatively correlates with miR-133, whose expression is increased when lncRNA-ROR is knocked down. In line with this, overexpression of miR-133 prevents the elevation of lncRNA-ROR and re-expression of ANP and BNP in cardiomyocytes subject to phenylephrine treatment. Conclusions/Significance Taken together, our study demonstrates that lncRNA-ROR promotes cardiac hypertrophy via interacting with miR-133, indicating that lncRNA-ROR could be targeted for developing novel antihypertrophic therapeutics.	[Jiang, Feng; Huang, Jing] Chongqing Med Univ, Affiliated Hosp 2, Dept Cardiol, Chongqing, Peoples R China; [Zhou, Xiangyu] Southwest Med Univ, Affiliated Hosp, Dept Vasc & Thyroid Surg, Luzhou, Sichuan, Peoples R China	Chongqing Medical University; Southwest Medical University	Huang, J (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Dept Cardiol, Chongqing, Peoples R China.	huangjing_201511@163.com						Abdellatif M, 2010, CIRC RES, V106, P16, DOI 10.1161/CIRCRESAHA.109.212183; Akazawa H, 2003, CIRC RES, V92, P1079, DOI 10.1161/01.RES.0000072977.86706.23; Bang C, 2014, J CLIN INVEST, V124, P2136, DOI 10.1172/JCI70577; BISHOPRIC NH, 1991, P NATL ACAD SCI USA, V88, P2132, DOI 10.1073/pnas.88.6.2132; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Carreno JE, 2006, REV ESP CARDIOL, V59, P473, DOI 10.1016/S1885-5857(06)60796-2; Chen HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064757; CHIEN KR, 1991, FASEB J, V5, P3037, DOI 10.1096/fasebj.5.15.1835945; Gardner DG, 2003, TRENDS ENDOCRIN MET, V14, P411, DOI 10.1016/S1043-2760(03)00113-9; Hilfiker-Kleiner D, 2006, CARDIOVASC RES, V71, P108, DOI 10.1016/j.cardiores.2006.02.032; KOREN MJ, 1991, ANN INTERN MED, V114, P345, DOI 10.7326/0003-4819-114-5-345; Liu ZH, 2015, EURASIP J WIREL COMM, P1, DOI 10.1186/s13638-015-0367-5; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Martins PAD, 2012, CARDIOVASC RES, V93, P563, DOI 10.1093/cvr/cvs013; Matkovich SJ, 2014, P NATL ACAD SCI USA, V111, P12264, DOI 10.1073/pnas.1410622111; Qureshi IA, 2012, NAT REV NEUROSCI, V13, P528, DOI 10.1038/nrn3234; SADOSHIMA J, 1992, J BIOL CHEM, V267, P10551; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Thum T, 2015, CIRC RES, V116, P751, DOI 10.1161/CIRCRESAHA.116.303549; Wang N, 2009, IUBMB LIFE, V61, P566, DOI 10.1002/iub.204; Wang Y, 2013, DEV CELL, V25, P69, DOI 10.1016/j.devcel.2013.03.002; Yue TL, 2000, J BIOL CHEM, V275, P37895, DOI 10.1074/jbc.M007037200; Zhang A, 2013, CELL RES, V23, P340, DOI 10.1038/cr.2012.164	23	89	94	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0152767	10.1371/journal.pone.0152767	http://dx.doi.org/10.1371/journal.pone.0152767			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082978	Green Published, gold, Green Submitted			2022-12-26	WOS:000374291800008
J	Kihal-Talantikite, W; Vigneau, C; Deguen, S; Siebert, M; Couchoud, C; Bayat, S				Kihal-Talantikite, Wahida; Vigneau, Cecile; Deguen, Severine; Siebert, Muriel; Couchoud, Cecile; Bayat, Sahar			Influence of Socio-Economic Inequalities on Access to Renal Transplantation and Survival of Patients with End-Stage Renal Disease	PLOS ONE			English	Article							DONOR KIDNEY-TRANSPLANTATION; UNITED-STATES; WAITING-LIST; NEIGHBORHOOD POVERTY; SOCIAL INEQUALITIES; DIABETES-MELLITUS; DIALYSIS PATIENTS; DISPARITIES; RECIPIENTS; MORTALITY	Background Public and scientific concerns about the social gradient of end-stage renal disease and access to renal replacement therapies are increasing. This study investigated the influence of social inequalities on the (i) access to renal transplant waiting list, (ii) access to renal transplantation and (iii) patients' survival. Methods All incident adult patients with end-stage renal disease who lived in Bretagne, a French region, and started dialysis during the 2004-2009 period were geocoded in census-blocks. To each census-block was assigned a level of neighborhood deprivation and a degree of urbanization. Cox proportional hazards models were used to identify factors associated with each study outcome. Results Patients living in neighborhoods with low level of deprivation had more chance to be placed on the waiting list and less risk of death (HR = 1.40 95% CI: [1.1-1.7]; HR = 0.82 95% CI: [0.7-0.98]), but this association did not remain after adjustment for the patients' clinical features. The likelihood of receiving renal transplantation after being waitlisted was not associated with neighborhood deprivation in univariate and multivariate analyses. Conclusions In a mixed rural and urban French region, patients living in deprived or advantaged neighborhoods had the same chance to be placed on the waiting list and to undergo renal transplantation. They also showed the same mortality risk, when their clinical features were taken into account.	[Kihal-Talantikite, Wahida; Deguen, Severine] Sorbonne Paris Cite, EHESP Sch Publ Hlth, Rennes, France; [Vigneau, Cecile; Siebert, Muriel] CHU Pontchaillou, Serv Nephrol, Rennes, France; [Vigneau, Cecile] Univ Rennes 1, UMR 6290, Equipe Kyca, Rennes, France; [Couchoud, Cecile] REIN Registry, Agence Biomed, La Plaine St Denis, France; [Bayat, Sahar] EA MOS, Sorbonne Paris Cite, EHESP Sch Publ Hlth, Rennes, France	CHU Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes	Kihal-Talantikite, W (corresponding author), Sorbonne Paris Cite, EHESP Sch Publ Hlth, Rennes, France.	Wahida.kihal@ehesp.fr	vigneau, cecile/I-3178-2015		French Biomedicine Agency	French Biomedicine Agency	This study was supported by grants from French Biomedicine Agency.	Alexander GC, 1998, JAMA-J AM MED ASSOC, V280, P1148, DOI 10.1001/jama.280.13.1148; Axelrod DA, 2010, CLIN J AM SOC NEPHRO, V5, P2276, DOI 10.2215/CJN.04940610; Bayat S, 2015, AM J TRANSPLANT, V15, P1050, DOI 10.1111/ajt.13095; Couchoud C, 2006, NEPHROL DIAL TRANSPL, V21, P411, DOI 10.1093/ndt/gfi198; Couchoud C, 2012, TRANSPLANTATION, V94, P513, DOI 10.1097/TP.0b013e31825d156a; Dudley CRK, 2009, TRANSPLANTATION, V88, P96, DOI 10.1097/TP.0b013e3181aa901a; Evans JMM, 2000, DIABETIC MED, V17, P478, DOI 10.1046/j.1464-5491.2000.00309.x; Garg J, 2012, NEPHROL DIAL TRANSPL, V27, P1239, DOI 10.1093/ndt/gfr445; Garg PP, 2000, J AM SOC NEPHROL, V11, P958, DOI 10.1681/ASN.V115958; Garg PP, 1999, NEW ENGL J MED, V341, P1653, DOI 10.1056/NEJM199911253412205; Goldfarb-Rumyantzev AS, 2011, CLIN TRANSPLANT, V25, P834, DOI 10.1111/j.1399-0012.2010.01391.x; Halla YN, 2008, AM J TRANSPLANT, V8, P2402, DOI 10.1111/j.1600-6143.2008.02413.x; Hommel K, 2010, NEPHROL DIAL TRANSPL, V25, P2624, DOI 10.1093/ndt/gfq110; Joshi S, 2012, CLIN TRANSPLANT, V26, pE337, DOI 10.1111/j.1399-0012.2012.01679.x; Keith D, 2008, CLIN J AM SOC NEPHRO, V3, P463, DOI 10.2215/CJN.02220507; Kihal-Talantikite W, 2015, CLIN KIDNEY J, V8, P7, DOI 10.1093/ckj/sfu131; Kihal-Talantikite W, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-109; Kihal-Talantikite W, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-191; Lalloue B, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-21; Laupacis A, 1996, KIDNEY INT, V50, P235, DOI 10.1038/ki.1996.307; Mathur AK, 2010, AM J TRANSPLANT, V10, P1069, DOI 10.1111/j.1600-6143.2010.03043.x; Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P1662, DOI 10.1111/j.1600-6143.2004.00573.x; Miskulin DC, 2003, AM J KIDNEY DIS, V41, P149, DOI 10.1053/ajkd.2003.50034; Morton RL, 2016, NEPHROL DIAL TRANSPL, V31, P46, DOI 10.1093/ndt/gfu394; O'Hare AM, 2006, KIDNEY INT, V69, P343, DOI 10.1038/sj.ki.5000044; Oniscu GC, 2003, BRIT MED J, V327, P1261, DOI 10.1136/bmj.327.7426.1261; Organisation for Economic Co-operation and Development, 1994, CREAT RUR IND SHAP T; Patzer RE, 2009, J AM SOC NEPHROL, V20, P1333, DOI 10.1681/ASN.2008030335; PERNEGER TV, 1994, ANN INTERN MED, V121, P912, DOI 10.7326/0003-4819-121-12-199412150-00002; PORT FK, 1993, JAMA-J AM MED ASSOC, V270, P1339, DOI 10.1001/jama.270.11.1339; Roodnat JI, 2012, TRANSPLANTATION, V93, P518, DOI 10.1097/TP.0b013e318243030f; Sandhu GS, 2013, CLIN TRANSPLANT, V27, P598, DOI 10.1111/ctr.12177; Satayathum S, 2005, KIDNEY INT, V68, P330, DOI 10.1111/j.1523-1755.2005.00412.x; Saunders MR, 2010, AM J TRANSPLANT, V10, P1912, DOI 10.1111/j.1600-6143.2010.03206.x; Schaeffner ES, 2008, AM J KIDNEY DIS, V51, P811, DOI 10.1053/j.ajkd.2008.01.019; Schold JD, 2011, CLIN J AM SOC NEPHRO, V6, P1760, DOI 10.2215/CJN.08620910; Sequist TD, 2004, AM J KIDNEY DIS, V44, P344, DOI 10.1053/j.ajkd.2004.04.039; Strang WN, 2005, ST HEAL T, V116, P77; Tonelli M, 2009, JAMA-J AM MED ASSOC, V301, P1681, DOI 10.1001/jama.2009.545; van Eupen M, 2012, LAND USE POLICY, V29, P473, DOI 10.1016/j.landusepol.2011.07.007; Vard T, 2005, 21669 EUR; Wolfe RA, 2000, AM J KIDNEY DIS, V36, P1025, DOI 10.1053/ajkd.2000.19106; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; YOUNG EW, 1994, KIDNEY INT, V45, P907, DOI 10.1038/ki.1994.120	44	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153431	10.1371/journal.pone.0153431	http://dx.doi.org/10.1371/journal.pone.0153431			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082113	Green Published, Green Submitted, gold			2022-12-26	WOS:000374291800019
J	Smith, JN; Emlen, DJ; Pearson, DE				Smith, Jennifer N.; Emlen, Douglas J.; Pearson, Dean E.			Linking Native and Invader Traits Explains Native Spider Population Responses to Plant Invasion	PLOS ONE			English	Article							IMPACTS; DIVERSITY; ABUNDANCE; RESOURCE; COMMUNITIES; COMPETITION; LIMITATION; PATTERNS; BEHAVIOR	Theoretically, the functional traits of native species should determine how natives respond to invader-driven changes. To explore this idea, we simulated a large-scale plant invasion using dead spotted knapweed (Centaurea stoebe) stems to determine if native spiders' web-building behaviors could explain differences in spider population responses to structural changes arising from C. stoebe invasion. After two years, irregular web-spiders were >30 times more abundant and orb weavers were >23 times more abundant on simulated invasion plots compared to controls. Additionally, irregular web-spiders on simulated invasion plots built webs that were 4.4 times larger and 5.0 times more likely to capture prey, leading to >2-fold increases in recruitment. Orb-weavers showed no differences in web size or prey captures between treatments. Web-spider responses to simulated invasion mimicked patterns following natural invasions, confirming that C. stoebe's architecture is likely the primary attribute driving native spider responses to these invasions. Differences in spider responses were attributable to differences in web construction behaviors relative to historic web substrate constraints. Orb-weavers in this system constructed webs between multiple plants, so they were limited by the overall quantity of native substrates but not by the architecture of individual native plant species. Irregular web-spiders built their webs within individual plants and were greatly constrained by the diminutive architecture of native plant substrates, so they were limited both by quantity and quality of native substrates. Evaluating native species traits in the context of invader-driven change can explain invasion outcomes and help to identify factors limiting native populations.	[Smith, Jennifer N.; Emlen, Douglas J.; Pearson, Dean E.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Pearson, Dean E.] US Forest Serv, Rocky Mt Res Stn, USDA, Missoula, MT USA; [Smith, Jennifer N.] Natl Ecol Observ Network NEON Inc, Prairie Peninsula Domain, Field Operat, Manhattan, KS USA	University of Montana System; University of Montana; United States Department of Agriculture (USDA); United States Forest Service	Smith, JN (corresponding author), Univ Montana, Div Biol Sci, Missoula, MT 59812 USA.; Smith, JN (corresponding author), Natl Ecol Observ Network NEON Inc, Prairie Peninsula Domain, Field Operat, Manhattan, KS USA.	jsmith@neoninc.org		Smith, Jennifer/0000-0001-8671-6103	Rocky Mountain Research Station; University of Montana; Sigma Xi; Mazamas Graduate Student Research Grant; USDA Forest Service	Rocky Mountain Research Station(United States Department of Agriculture (USDA)United States Forest Service); University of Montana; Sigma Xi; Mazamas Graduate Student Research Grant; USDA Forest Service(United States Department of Agriculture (USDA)United States Forest Service)	This work was funded by the Rocky Mountain Research Station, USDA Forest Service (DEP); The University of Montana (JNS, DJE); Sigma Xi Grants-in-Aid of Research, https://www.sigmaxi.org/programs/grants-in-aid (JNS); and the Mazamas Graduate Student Research Grant, http://mazamas.org/resources/research-grants/ (JNS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bially A, 2000, FRESHWATER BIOL, V43, P85, DOI 10.1046/j.1365-2427.2000.00526.x; Bruggisser OT, 2012, BASIC APPL ECOL, V13, P706, DOI 10.1016/j.baae.2012.10.001; Callaway RM, 2011, ECOLOGY, V92, P2208, DOI 10.1890/11-0518.1; Callaway RM, 2010, POSITIVE PLANT INTERACTIONS AND COMMUNITY DYNAMICS, P1; Cardoso P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021710; CHAMBERLIN RALPH V., 1958, BULL AMER MUS NAT HIST, V116, P1; Cunha ER, 2012, WETLANDS, V32, P369, DOI 10.1007/s13157-012-0272-1; DONDALE CD, 2003, ORB WEAVING SPIDERS; Hesselberg T, 2015, CURR ZOOL, V61, P313, DOI 10.1093/czoolo/61.2.313; Hesselberg T, 2010, ETHOLOGY, V116, P535, DOI 10.1111/j.1439-0310.2010.01760.x; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jackson R.A., 1978, Revue Arachnologique, V1, P133; Jensen GL, 2005, SPIDER IDENTIFICATIO; Kreiter NA, 2001, OECOLOGIA, V127, P417, DOI 10.1007/s004420000607; Krink T, 1998, P ROY SOC B-BIOL SCI, V265, P2051, DOI 10.1098/rspb.1998.0539; Lau JA, 2013, OIKOS, V122, P474, DOI 10.1111/j.1600-0706.2012.20774.x; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; LEVI H W, 1981, Bulletin of the Museum of Comparative Zoology, V149, P271; LEVI H W, 1977, Bulletin of the Museum of Comparative Zoology, V148, P185; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Maron JL, 2008, J ECOL, V96, P1187, DOI 10.1111/j.1365-2745.2008.01440.x; Maron JL, 2008, AM NAT, V172, pS18, DOI 10.1086/588303; McNett BJ, 2000, ECOL ENTOMOL, V25, P423, DOI 10.1046/j.1365-2311.2000.00279.x; Mitchell CE, 2003, NATURE, V421, P625, DOI 10.1038/nature01317; MIYASHITA T, 1991, Acta Arachnologica, V40, P17, DOI 10.2476/asjaa.40.17; Moya-Larano J, 2003, OIKOS, V101, P539, DOI 10.1034/j.1600-0706.2003.12316.x; Nentwig W., 1987, P249; Oksanen J, 2013, PACKAGE VEGAN COMMUN, P2; Ortega YK, 2005, ECOL APPL, V15, P651, DOI 10.1890/04-0119; Ortega YK, 2014, BIOL INVASIONS, V16, P1757, DOI 10.1007/s10530-013-0625-6; Ortega YK, 2006, OECOLOGIA, V149, P340, DOI 10.1007/s00442-006-0438-8; Parker JD, 2006, SCIENCE, V311, P1459, DOI 10.1126/science.1121407; Pearson DE, 2008, ECOL APPL, V18, P321, DOI 10.1890/07-0766.1; Pearson DE, 2012, BIOL INVASIONS, V14, P901, DOI 10.1007/s10530-011-0126-4; Pearson DE, 2010, AM NAT, V176, P394, DOI 10.1086/656274; Pearson DE, 2009, OECOLOGIA, V159, P549, DOI 10.1007/s00442-008-1241-5; Petillon J, 2010, BIOL INVASIONS, V12, P3219, DOI 10.1007/s10530-010-9714-y; Petillon J, 2010, ANN ZOOL FENN, V47, P79, DOI 10.5735/086.047.0201; Pinheiro J., 2011, NLME LINEAR NONLINEA; Poulsen JR, 2007, AM NAT, V170, P167, DOI 10.1086/518945; Pysek Petr, 2007, V193, P97; R Core Team, 2021, R LANGUAGE ENV STAT; Ridenour WM, 2001, OECOLOGIA, V126, P444, DOI 10.1007/s004420000533; Rodriguez LF, 2006, BIOL INVASIONS, V8, P927, DOI 10.1007/s10530-005-5103-3; SAS, 2009, SAS STAT US GUID VER; Schirmel J, 2013, BIOL INVASIONS, V15, P1089, DOI 10.1007/s10530-012-0352-4; Tingle CCD, 2002, ECOLOGICAL MONITORIN, P159; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; VOLLRATH F, 1992, ADV STUD BEHAV, V21, P147, DOI 10.1016/S0065-3454(08)60144-8; Weiher E, 1999, OIKOS, V87, P355, DOI 10.2307/3546751; WHEELER GS, 1990, AM MIDL NAT, V123, P124, DOI 10.2307/2425765; White EM, 2006, DIVERS DISTRIB, V12, P443, DOI 10.1111/j.1366-9516.2006.00265.x; Wise DH, 2006, ANNU REV ENTOMOL, V51, P441, DOI 10.1146/annurev.ento.51.110104.150947; Wise DH, 1993, SPIDERS ECOLOGICAL W	54	6	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153661	10.1371/journal.pone.0153661	http://dx.doi.org/10.1371/journal.pone.0153661			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082240	Green Published, Green Submitted, gold			2022-12-26	WOS:000374291800038
J	Wallace, J; Hu, R; Mosbruger, TL; Dahlem, TJ; Stephens, WZ; Rao, DS; Round, JL; O'Connell, RM				Wallace, Jared; Hu, Ruozhen; Mosbruger, Timothy L.; Dahlem, Timothy J.; Stephens, W. Zac; Rao, Dinesh S.; Round, June L.; O'Connell, Ryan M.			Genome-Wide CRISPR-Cas9 Screen Identifies MicroRNAs That Regulate Myeloid Leukemia Cell Growth	PLOS ONE			English	Article							DOWN-REGULATION; FLT3 MUTATIONS; EXPRESSION; MIR-150; SIGNATURES; NETWORK; CANCER; LINES; P53	Mammalian microRNA expression is dysregulated in human cancer. However, the functional relevance of many microRNAs in the context of tumor biology remains unclear. Using CRISPR-Cas9 technology, we performed a global loss-of-function screen to simultaneously test the functions of individual microRNAs and protein-coding genes during the growth of a myeloid leukemia cell line. This approach identified evolutionarily conserved human microRNAs that suppress or promote cell growth, revealing that microRNAs are extensively integrated into the molecular networks that control tumor cell physiology. miR-155 was identified as a top microRNA candidate promoting cellular fitness, which we confirmed with two distinct miR-155-targeting CRISPR-Cas9 lentiviral constructs. Further, we performed anti-correlation functional profiling to predict relevant microRNA-tumor suppressor gene or microRNA-oncogene interactions in these cells. This analysis identified miR-150 targeting of p53, a connection that was experimentally validated. Taken together, our study describes a powerful genetic approach by which the function of individual microRNAs can be assessed on a global level, and its use will rapidly advance our understanding of how microRNAs contribute to human disease.	[Wallace, Jared; Hu, Ruozhen; Stephens, W. Zac; Round, June L.; O'Connell, Ryan M.] Univ Utah, Dept Pathol, Salt Lake City, UT USA; [Dahlem, Timothy J.] Univ Utah, Mutat Generat & Detect Core, HSC Core Res Facil, Salt Lake City, UT USA; [Mosbruger, Timothy L.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [Rao, Dinesh S.] Univ Calif Los Angeles, Dept Pathol, Los Angeles, CA 90024 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of California System; University of California Los Angeles	O'Connell, RM (corresponding author), Univ Utah, Dept Pathol, Salt Lake City, UT USA.	ryan.oconnell@path.utah.edu	Rao, Dinesh/AAE-9625-2019; Rao, Dinesh/ABG-1257-2021	Rao, Dinesh/0000-0002-0794-9337	University of Utah [5P30CA042014-24]; NIH [DP2GM111099-01]; Gabrielle Angel's Foundation Award; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP2GM111099] Funding Source: NIH RePORTER	University of Utah; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gabrielle Angel's Foundation Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the University of Utah Flow Cytometry Facility in addition to the National Cancer Institute through Award Number 5P30CA042014-24. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. This work was also supported by the NIH New Innovator Award DP2GM111099-01 (R.M.O.) and the Gabrielle Angel's Foundation Award http://www.gabriellesangels.org (R.M.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson A, 2005, LEUKEMIA, V19, P1042, DOI 10.1038/sj.leu.2403749; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chen Y, 2013, J CLIN INVEST, V123, P2395, DOI 10.1172/JCI66553; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Garzon R, 2008, P NATL ACAD SCI USA, V105, P3945, DOI 10.1073/pnas.0800135105; Gerloff D, 2015, LEUKEMIA, V29, P535, DOI 10.1038/leu.2014.231; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Han YC, 2010, J EXP MED, V207, P475, DOI 10.1084/jem.20090831; He Y, 2014, ONCOGENE, V33, P3887, DOI 10.1038/onc.2013.346; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marcucci G, 2011, BLOOD, V117, P1121, DOI 10.1182/blood-2010-09-191312; Mizuki M, 2000, BLOOD, V96, P3907, DOI 10.1182/blood.V96.12.3907; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; O'Connell RM, 2010, P NATL ACAD SCI USA, V107, P14235, DOI 10.1073/pnas.1009798107; Pedranzini L, 2010, LEUKEMIA RES, V34, P1287, DOI 10.1016/j.leukres.2010.02.012; Quentmeier H, 2003, LEUKEMIA, V17, P120, DOI 10.1038/sj.leu.2402740; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Starczynowski DT, 2010, NAT MED, V16, P49, DOI 10.1038/nm.2054; Wang DT, 2013, ONCOL REP, V30, P492, DOI 10.3892/or.2013.2453; Whitman SP, 2010, BLOOD, V116, P3622, DOI 10.1182/blood-2010-05-283648; Zhang N, 2013, FEBS LETT, V587, P2346, DOI 10.1016/j.febslet.2013.05.059	23	37	39	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153689	10.1371/journal.pone.0153689	http://dx.doi.org/10.1371/journal.pone.0153689			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27081855	Green Published, gold			2022-12-26	WOS:000374291800045
J	Hall, JA; MacLeay, J; Yerramilli, M; Obare, E; Yerramilli, M; Schiefelbein, H; Paetau-Robinson, I; Jewell, DE				Hall, Jean A.; MacLeay, Jennifer; Yerramilli, Maha; Obare, Edward; Yerramilli, Murthy; Schiefelbein, Heidi; Paetau-Robinson, Inke; Jewell, Dennis E.			Positive Impact of Nutritional Interventions on Serum Symmetric Dimethylarginine and Creatinine Concentrations in Client-Owned Geriatric Cats	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; L-CARNITINE SUPPLEMENTATION; OXIDATIVE STRESS; RENAL-INSUFFICIENCY; FUNCTION BIOMARKERS; DOGS; SURVIVAL; SDMA	A prospective study was conducted in client-owned geriatric cats to evaluate the short- term effects of a test food on serum symmetric dimethylarginine (SDMA) and creatinine (Cr) concentrations. Test food contained functional lipids (fish oil), antioxidants (vitamins C and E), L-carnitine, botanicals (vegetables), highly bioavailable protein, and amino acid supplements. Cats (n = 80) were fed either test food or owner's-choice foods (non-nutritionally controlled cohort). Cats were included based on age (>= 9 years), indoor only, neutered, and free of chronic disease. At baseline, all cats had serum Cr concentrations within the reference interval. Renal function biomarkers and urinalysis results at baseline and after consuming test food or owner's-choice foods for 3 and 6 months were evaluated. Cats consuming test food showed significant decreases in serum Cr and BUN concentrations across time. Overall, cats consuming owner's-choice foods showed significant increases in serum SDMA concentrations at 3 and 6 months compared with baseline (P <= 0.05), whereas in cats consuming test food serum SDMA concentrations did not change. At baseline or during the 6-month feeding trial, 23 (28.8%) cats had increased serum SDMA, but normal serum Cr consistent with IRIS Stage 1 chronic kidney disease. This included 6 cats fed test food and 17 cats fed owner's-choice foods. In the 6 cats fed test food, serum SDMA decreased in 3 cats and remained stable in 1 cat, whereas in the 17 cats fed owner's-choice foods, serum SDMA increased in 13 cats and decreased or remained stable in 4 cats. The increase in serum SDMA concentration was significant (P = 0.02) only for cats fed owner's-choice foods. These results suggest that nonazotemic cats with elevated serum SDMA (early renal insufficiency) when fed a food designed to promote healthy aging are more likely to demonstrate stable renal function compared with cats fed owner's-choice foods. Cats fed owner's-choice foods were more likely to demonstrate progressive renal insufficiency.	[Hall, Jean A.] Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA; [MacLeay, Jennifer; Schiefelbein, Heidi; Paetau-Robinson, Inke; Jewell, Dennis E.] Hills Pet Nutr Inc, Pet Nutr Ctr, Topeka, KS USA; [Yerramilli, Maha; Obare, Edward; Yerramilli, Murthy] IDEXX Labs Inc, One IDEXX Dr, Westbrook, ME USA	Oregon State University	Hall, JA (corresponding author), Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA.	Jean.Hall@oregonstate.edu	Jewell, Dennis/AAS-8563-2020	Jewell, Dennis/0000-0003-2305-1014	Pet Nutrition Center, Hill's Pet Nutrition, Inc., Topeka, KS	Pet Nutrition Center, Hill's Pet Nutrition, Inc., Topeka, KS	The work presented in this study was funded by and performed at the Pet Nutrition Center, Hill's Pet Nutrition, Inc., Topeka, KS (http://www.hillspet.com/our-company.html). The funding decision makers had no role in study design, data collection and analysis, or preparation of the manuscript.	Allen T., 2010, SMALL ANIMAL CLIN NU, P765; Bartges JW, 2012, VET CLIN N AM-SMALL, V42, P669, DOI 10.1016/j.cvsm.2012.04.008; Boudouris G, 2013, INT UROL NEPHROL, V45, P1137, DOI 10.1007/s11255-012-0334-6; Brown SA, 1998, J LAB CLIN MED, V131, P447, DOI 10.1016/S0022-2143(98)90146-9; Brown SA, 2000, J LAB CLIN MED, V135, P275, DOI 10.1067/mlc.2000.105178; Brown SA, 2008, VET CLIN N AM-SMALL, V38, P157, DOI 10.1016/j.cvsm.2007.11.001; Calder PC, 2009, POSTGRAD MED, V121, P148, DOI 10.3810/pgm.2009.11.2083; Elliott J, 2000, J SMALL ANIM PRACT, V41, P235, DOI 10.1111/j.1748-5827.2000.tb03932.x; Hall JA, 2014, VET J, V202, P588, DOI 10.1016/j.tvjl.2014.10.021; Hall JA, 2014, J VET INTERN MED, V28, P1676, DOI 10.1111/jvim.12445; Hall JA, 2016, J VET INTERN MED; Hall JA, 2015, J VET INTERN MED, V29, P808, DOI 10.1111/jvim.12607; Hall JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054405; International Renal Interest Society, IRIS 2009 STAG CKD; Kielstein JT, 2006, NEPHROL DIAL TRANSPL, V21, P2446, DOI 10.1093/ndt/gfl292; Kielstein JT, 2002, J AM SOC NEPHROL, V13, P170, DOI 10.1681/ASN.V131170; Kovesdy CP, 2012, NEPHROL DIAL TRANSPL, V27, P891, DOI 10.1093/ndt/gfs038; Lin JL, 2011, AM J KIDNEY DIS, V57, P245, DOI 10.1053/j.ajkd.2010.09.027; Moffitt TA, 2013, J NEPHROL, V26, P403, DOI 10.5301/jn.5000135; Plantinga EA, 2005, VET REC, V157, P185, DOI 10.1136/vr.157.7.185; Polzin DJ, 2013, J VET EMERG CRIT CAR, V23, P205, DOI 10.1111/vec.12034; Ringseis R, 2013, EUR J NUTR, V52, P1421, DOI 10.1007/s00394-013-0511-0; Ross SJ, 2006, JAVMA-J AM VET MED A, V229, P949, DOI 10.2460/javma.229.6.949; Sahebkar A, 2015, J MED BIOCHEM, V34, P151, DOI 10.2478/jomb-2014-0030; Schwedhelm E, 2011, NAT REV NEPHROL, V7, P275, DOI 10.1038/nrneph.2011.31; Small DM, 2012, NEPHROLOGY, V17, P311, DOI 10.1111/j.1440-1797.2012.01572.x; Sung CC, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/301982; Veldink H, 2013, NEPHROL DIAL TRANSPL, V28, P1434, DOI 10.1093/ndt/gfs554; Vlassara H, 2009, KIDNEY INT, V76, pS3, DOI 10.1038/ki.2009.401; Xu H, 2015, J NUTR, V145, P729, DOI 10.3945/jn.114.205187	30	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153654	10.1371/journal.pone.0153654	http://dx.doi.org/10.1371/journal.pone.0153654			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078852	gold, Green Published			2022-12-26	WOS:000374131700101
J	Kwon, SG; Hwang, JH; Park, DH; Kim, TW; Kang, DG; Kang, KH; Kim, IS; Park, HC; Na, CS; Ha, J; Kim, CW				Kwon, Seul Gi; Hwang, Jung Hye; Park, Da Hye; Kim, Tae Wan; Kang, Deok Gyeong; Kang, Kyung Hee; Kim, Il-Suk; Park, Hwa Chun; Na, Chong-Sam; Ha, Jeongim; Kim, Chul Wook			Identification of Differentially Expressed Genes Associated with Litter Size in Berkshire Pig Placenta	PLOS ONE			English	Article							ENDOTHELIAL LIPASE; ENDOMETRIUM; MEISHAN; LIPOPROTEIN; GESTATION; PREGNANCY; TRANSPORT; OVULATION; BINDING; TRAITS	Improvement in litter size has become of great interest in the pig industry because fecundity is directly related to sow reproductive life. Improved reproduction has thus been achieved by elucidating the molecular functions of genes associated with fecundity. In the present study, we identified differentially expressed genes (DEGs) via transcriptomic analysis using RNA-sequencing (RNA-Seq) in Berkshire pig placentas from larger (LLG, mean litter size >12) and smaller (SLG, mean litter size < 6.5) litter size groups. In total 588 DEGs were identified (p < 0.05, > 1.5-fold change), of which 98 were upregulated, while 490 were downregulated in the LLG compared with the SLG. Gene Ontology (GO) enrichment was also performed. We concluded that 129 of the 588 DEGs were closely related to litter size according to reproduction related genes selected based on previous reports, as 110 genes were downregulated and 19 upregulated in the LLG compared with the SLG. RT-qPCR utilizing specific primers targeting the early growth response 2 (EGR2), pheromaxein c subunit (PHEROC) and endothelial lipase (LIPG) genes showed high accordance with RNA-Seq results. Furthermore, we investigated the upstream regulators of these three genes in the placenta. We found that WNT9B, a Wnt signaling pathway molecule, and IL-6, known inducers of EGR2 and LIPG, respectively, were significantly increased in LLG compared with SLG. We believe that the induction of IL-6 and LIPG may play an important role in increasing nutrition supply through the placenta from the sow to the piglet during gestation. These results provide novel molecular insights into pig reproduction.	[Kwon, Seul Gi; Hwang, Jung Hye; Park, Da Hye; Kim, Tae Wan; Kang, Deok Gyeong; Kang, Kyung Hee; Ha, Jeongim; Kim, Chul Wook] Gyeongnam Natl Univ Sci & Technol, Swine Sci & Technol Ctr, Jinju, South Korea; [Kim, Il-Suk] Gyeongnam Natl Univ Sci & Technol, Dept Anim Resource Technol, Jinju, South Korea; [Park, Hwa Chun] Dasan Pig Breeding Co, Namwon, South Korea; [Na, Chong-Sam] Chonbuk Natl Univ, Dept Anim Biotechnol, Jeonju 561756, South Korea	Gyeongnam National University of Science and Technology; Gyeongnam National University of Science and Technology; Jeonbuk National University	Ha, J; Kim, CW (corresponding author), Gyeongnam Natl Univ Sci & Technol, Swine Sci & Technol Ctr, Jinju, South Korea.	jiha@gntech.ac.kr; cwkim@gntech.ac.kr			Priority Research Centers Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2011-0022965]; Export Promotion Technology Development Program of Ministry of Food, Agriculture, Forestry and Fisheries, Republic of Korea [313012-05]; Dasan Pig Breeding Co.	Priority Research Centers Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; Export Promotion Technology Development Program of Ministry of Food, Agriculture, Forestry and Fisheries, Republic of Korea; Dasan Pig Breeding Co.	This work was supported by grants from the Priority Research Centers Program (no.2011-0022965) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology, from the Export Promotion Technology Development Program (no. 313012-05) of Ministry of Food, Agriculture, Forestry and Fisheries, Republic of Korea. The Dasan Pig Breeding Co. provided support in the form of a salary for author HCP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Anders S, 2014, BIOINFORMATICS; Badellino KO, 2008, CIRCULATION, V117, P678, DOI 10.1161/CIRCULATIONAHA.107.707349; Chen X, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.123075; CHRISTENSON RK, 1993, J ANIM SCI, V71, P3060, DOI 10.2527/1993.71113060x; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fernandez-Rodriguez A, 2011, BIOL REPROD, V84, P299, DOI 10.1095/biolreprod.110.085589; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Franczak A, 2013, REPROD BIOL, V13, P229, DOI 10.1016/j.repbio.2013.07.001; Fu Yanfeng, 2014, Yichuan, V36, P1243, DOI 10.3724/SP.J.1005.2014.1243; Gauster M, 2007, J CLIN ENDOCR METAB, V92, P2256, DOI 10.1210/jc.2006-2403; HALEY CS, 1993, J REPROD FERTIL, P247; Hernandez SC, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.104679; Hsieh M, 2007, MOL CELL BIOL, V27, P1914, DOI 10.1128/MCB.01919-06; Humaidan P, 2011, FERTIL STERIL, V95, P2034, DOI 10.1016/j.fertnstert.2011.02.013; Knoefler Martin, 2013, Frontiers in Genetics, V4, P190, DOI 10.3389/fgene.2013.00190; Lager S, 2011, PLACENTA, V32, P121, DOI 10.1016/j.placenta.2010.10.012; Leclerc N, 2008, J CELL BIOCHEM, V103, P1938, DOI 10.1002/jcb.21587; Lee JH, 2015, ASIAN AUSTRAL J ANIM, V28, P1388, DOI 10.5713/ajas.15.0097; Noguera JL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-636; Park SJ, 2015, GENE, V558, P152, DOI 10.1016/j.gene.2014.12.052; Quesnel H, 2008, ANIMAL, V2, P1842, DOI 10.1017/S175173110800308X; Robert J, 2013, ARTERIOSCL THROM VAS, V33, P2699, DOI 10.1161/ATVBAHA.113.301363; ROBERTSON AF, 1976, SOUTHERN MED J, V69, P1358, DOI 10.1097/00007611-197610000-00031; Rothschild M, 1996, P NATL ACAD SCI USA, V93, P201, DOI 10.1073/pnas.93.1.201; Rozen S, 2000, Methods Mol Biol, V132, P365; SaintJeannet JP, 1997, P NATL ACAD SCI USA, V94, P13713, DOI 10.1073/pnas.94.25.13713; Sonderegger S, 2007, PLACENTA, V28, pS97, DOI 10.1016/j.placenta.2006.11.003; Spencer T E, 2004, J Anim Sci, V82 E-Suppl, pE4; Spotter A, 2006, VET J, V172, P234, DOI 10.1016/j.tvjl.2005.11.013; Spotter A, 2002, ANIM GENET, V33, P166, DOI 10.1046/j.1365-2052.2002.0831i.x; Su LJ, 2010, REPROD FERT DEVELOP, V22, P1175, DOI 10.1071/RD10046; Sun JQ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-219; Vallet JL, 2007, J ANIM SCI, V85, P3267, DOI 10.2527/jas.2007-0368; Vallet JL, 2005, ANIM GENET, V36, P97, DOI 10.1111/j.1365-2052.2005.01233.x; Vonnahme KA, 2002, J ANIM SCI, V80, P1311; Xie H, 2007, P NATL ACAD SCI USA, V104, P18315, DOI 10.1073/pnas.0707909104; Zaman G, 2012, J BIOL CHEM, V287, P3946, DOI 10.1074/jbc.M111.252742	37	37	37	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153311	10.1371/journal.pone.0153311	http://dx.doi.org/10.1371/journal.pone.0153311			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078025	Green Published, gold, Green Submitted			2022-12-26	WOS:000374131700037
J	Unterseher, M; Siddique, A; Brachmann, A; Persoh, D				Unterseher, Martin; Siddique, Abu Bakar; Brachmann, Andreas; Persoh, Derek			Diversity and Composition of the Leaf Mycobiome of Beech (Fagus sylvatica) Are Affected by Local Habitat Conditions and Leaf Biochemistry	PLOS ONE			English	Article							PHYLLOSPHERE FUNGAL ASSEMBLAGES; INHABITING ENDOPHYTIC FUNGI; SPECIES RICHNESS; COMMUNITY; ELEVATION; LITTER; COLONIZATION; BIODIVERSITY; MICROBIOME; GRADIENT	Comparative investigations of plant-associated fungal communities (mycobiomes) in distinct habitats and under distinct climate regimes have been rarely conducted in the past. Nowadays, high-throughput sequencing allows routine examination of mycobiome responses to environmental changes and results at an unprecedented level of detail. In the present study, we analysed Illumina-generated fungal ITS1 sequences from European beech (Fagus sylvatica) originating from natural habitats at two different altitudes in the German Alps and from a managed tree nursery in northern Germany. In general, leaf-inhabiting mycobiome diversity and composition correlated significantly with the origin of the trees. Under natural condition the mycobiome was more diverse at lower than at higher elevation, whereas fungal diversity was lowest in the artificial habitat of the tree nursery. We further identified significant correlation of leaf chlorophylls and flavonoids with both habitat parameters and mycobiome biodiversity. The present results clearly point towards a pronounced importance of local stand conditions for the structure of beech leaf mycobiomes and for a close interrelation of phyllosphere fungi and leaf physiology.	[Unterseher, Martin; Siddique, Abu Bakar] Ernst Moritz Arndt Univ Greifswald, Inst Bot & Landschaftsokol, Greifswald, Germany; [Brachmann, Andreas] LMU Munchen, Biozentrum, Bereich Genet, Martinsried, Germany; [Persoh, Derek] Ruhr Univ Bochum, AG Geobot, Univ Str 150, Bochum, Germany	Ernst Moritz Arndt Universitat Greifswald; University of Munich; Ruhr University Bochum	Unterseher, M (corresponding author), Ernst Moritz Arndt Univ Greifswald, Inst Bot & Landschaftsokol, Greifswald, Germany.	martin.unterseher@uni-greifswald.de	Brachmann, Andreas/I-2241-2013; , Abu Bakar Siddique/R-1776-2018; Persoh, Derek/G-4527-2010	Brachmann, Andreas/0000-0001-7980-8173; , Abu Bakar Siddique/0000-0002-3178-523X; Persoh, Derek/0000-0001-5561-0189	Deutsche Forschungsgemeinschaft (DFG) [UN262/9-1, PE1673/4-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was funded by the Deutsche Forschungsgemeinschaft (DFG) as part of the full research project grant "Patterns and processes in endophyte ecology - studies in optimal and extreme habitats of European Beech to reveal the underlying principles" to MU (UN262/9-1) and DP (PE1673/4-1). Project description is available at http://gepris.dfg.de/gepris/projekt/245215303?language=en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan E, 2014, P NATL ACAD SCI USA, V111, P308, DOI 10.1073/pnas.1312213111; Bahnweg G, 2005, PLANT BIOLOGY, V7, P659, DOI 10.1055/s-2005-872943; Balint M, 2015, MOL ECOL, V24, P235, DOI 10.1111/mec.13018; Balint M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053987; Bazzicalupo AL, 2013, FUNGAL ECOL, V6, P102, DOI 10.1016/j.funeco.2012.09.003; Bengtsson-Palme J, 2013, METHODS ECOL EVOL, V4, P914, DOI 10.1111/2041-210X.12073; Blaalid R, 2013, MOL ECOL RESOUR, V13, P218, DOI 10.1111/1755-0998.12065; Blaalid R, 2014, MOL ECOL, V23, P649, DOI 10.1111/mec.12622; Bresson CC, 2011, TREE PHYSIOL, V31, P1164, DOI 10.1093/treephys/tpr084; Brown SP, 2015, FUNGAL ECOL, V13, P221, DOI 10.1016/j.funeco.2014.08.006; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Collado J, 2007, FEMS MICROBIOL ECOL, V60, P521, DOI 10.1111/j.1574-6941.2007.00294.x; Cordier T, 2012, NEW PHYTOL, V196, P510, DOI 10.1111/j.1469-8137.2012.04284.x; Cordier T, 2012, FUNGAL ECOL, V5, P509, DOI 10.1016/j.funeco.2011.12.004; de Hoog GS, 1998, MYCOSES, V41, P183, DOI 10.1111/j.1439-0507.1998.tb00321.x; Gazis R, 2010, FUNGAL ECOL, V3, P240, DOI 10.1016/j.funeco.2009.12.001; Gloor GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015406; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Hartig S.M., 2013, CURR PROTOC MOL BIOL, DOI [10.1002/0471142727.mb1415-102, DOI 10.1002/0471142727.MB1415S102, DOI 10.1002/0471142727.MB1415-102]; Hashizume Y, 2008, FOREST PATHOL, V38, P218, DOI 10.1111/j.1439-0329.2008.00547.x; Helander M, 2007, NEW PHYTOL, V175, P547, DOI 10.1111/j.1469-8137.2007.02110.x; Higginbotham SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073192; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Horn K, 2013, AM J BOT, V100, P2158, DOI 10.3732/ajb.1300011; Jumpponen A, 2010, NEW PHYTOL, V186, P496, DOI 10.1111/j.1469-8137.2010.03197.x; Kemler M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081718; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Korner C, 2005, SCIENCE, V309, P1360, DOI 10.1126/science.1113977; Korner C, 1998, OECOLOGIA, V115, P445, DOI 10.1007/s004420050540; Koskimaki JJ, 2009, EUROPEAN J PLANT PAT; Matulich KL, 2015, ISME J, V9, P2477, DOI 10.1038/ismej.2015.58; Meyer S, 2006, PLANT CELL ENVIRON, V29, P1338, DOI 10.1111/j.1365-3040.2006.01514.x; Navas-Molina JA, 2013, METHOD ENZYMOL, V531, P371, DOI 10.1016/B978-0-12-407863-5.00019-8; Nilsson RH, 2015, MICROBES ENVIRON, V30, P145, DOI 10.1264/jsme2.ME14121; Olbrich M, 2010, ENVIRON POLLUT, V158, P1043, DOI 10.1016/j.envpol.2009.09.020; Osono T, 2011, FUNGAL ECOL, V4, P375, DOI 10.1016/j.funeco.2011.02.004; Persoh D, 2015, FUNGAL DIVERS, V75, P1, DOI 10.1007/s13225-015-0334-9; Persoh D, 2013, FUNGAL DIVERS, V60, P55, DOI 10.1007/s13225-013-0225-x; Persoh D, 2013, PLANT SOIL, V362, P175, DOI 10.1007/s11104-012-1271-y; Petrini O., 1991, MICROBIOLOGY PHYLLOS, P175; Porras-Alfaro A, 2011, ANNU REV PHYTOPATHOL, V49, P291, DOI 10.1146/annurev-phyto-080508-081831; Reissinger A, 2001, MYCOL RES, V105, P563, DOI 10.1017/S0953756201003823; Richardson AD, 2004, PLANT SOIL, V260, P291, DOI 10.1023/B:PLSO.0000030179.02819.85; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Saikkonen K, 2013, J CHEM ECOL, V39, P962, DOI 10.1007/s10886-013-0310-3; Scholtysik A, 2013, MYCOL PROG, V12, P291, DOI 10.1007/s11557-012-0835-9; SCHULZ B, 1993, MYCOL RES, V97, P1447, DOI 10.1016/S0953-7562(09)80215-3; Siddique AB, 2016, FUNGAL ECOL, V20, P175, DOI 10.1016/j.funeco.2015.12.009; SIMBERLOFF DS, 1969, ECOLOGY, V50, P278, DOI 10.2307/1934856; Solis MJL, 2015, MYCOL PROG, V14, DOI 10.1007/s11557-014-1019-6; Tedersoo L, 2014, SCIENCE, V346, P1078, DOI 10.1126/science.1256688; U'Ren JM, 2012, AM J BOT, V99, P898, DOI 10.3732/ajb.1100459; Unterseher M, 2007, MYCOL PROG, V6, P201, DOI 10.1007/s11557-007-0541-1; Unterseher M, 2008, FEMS MICROBIOL LETT, V282, P205, DOI 10.1111/j.1574-6968.2008.01128.x; Unterseher M, 2013, FUNGAL DIVERS, V60, P43, DOI 10.1007/s13225-013-0222-0; Unterseher M, 2012, FUNGAL DIVERS, V54, P133, DOI 10.1007/s13225-012-0167-8; Unterseher M, 2011, FOR SCI, V80, P31, DOI 10.1007/978-94-007-1599-8_2; Unterseher M, 2009, MYCOL RES, V113, P645, DOI 10.1016/j.mycres.2009.02.002; Vohnik M, 2013, FUNGAL ECOL, V6, P281, DOI 10.1016/j.funeco.2013.03.006; Wang Y, 2012, METHODS ECOL EVOL, V3, P471, DOI 10.1111/j.2041-210X.2012.00190.x; Warton DI, 2012, METHODS ECOL EVOL, V3, P89, DOI 10.1111/j.2041-210X.2011.00127.x; Weig AR, 2013, MYCOL PROG, V12, P719, DOI 10.1007/s11557-012-0883-1; Weiss M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016793; White TJ., 1990, PCR PROTOCOLS GUIDE, P315	65	30	34	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0152878	10.1371/journal.pone.0152878	http://dx.doi.org/10.1371/journal.pone.0152878			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078859	Green Submitted, Green Published, gold			2022-12-26	WOS:000374131700011
J	Brureau, L; Moningo, D; Emeville, E; Ferdinand, S; Punga, A; Lufuma, S; Blanchet, P; Romana, M; Multigner, L				Brureau, Laurent; Moningo, Dieudonne; Emeville, Elise; Ferdinand, Severine; Punga, Augustin; Lufuma, Simon; Blanchet, Pascal; Romana, Marc; Multigner, Luc			Polymorphisms of Estrogen Metabolism-Related Genes and Prostate Cancer Risk in Two Populations of African Ancestry	PLOS ONE			English	Article							COMT VAL158MET POLYMORPHISM; CYP17 GENE; TEA POLYPHENOLS; NO ASSOCIATION; HORMONE-LEVELS; REPEAT; MEN; AGGRESSIVENESS; COMBINATION; EXPRESSION	Background Estrogens are thought to play a critical role in prostate carcinogenesis. It has been suggested that polymorphisms of genes encoding enzymes involved in estrogen metabolism are risk factors for prostate cancer. However, few studies have been performed on populations of African ancestry, which are known to have a high risk of prostate cancer. Objective We investigated whether functional polymorphisms of CYP17, CYP19, CYP1B1, COMT and UGT1A1 affected the risk of prostate cancer in two different populations of African ancestry. Methods In Guadeloupe (French West Indies), we compared 498 prostate cancer patients and 565 control subjects. In Kinshasa (Democratic Republic of Congo), 162 prostate cancer patients were compared with 144 controls. Gene polymorphisms were determined by the SNaPshot technique or short tandem repeat PCR analysis. Logistic regression was used to estimate adjusted odds ratios (OR) and 95% confidence intervals (CI). Results The AA genotype and the A allele of rs4680 (COMT) appeared to be inversely associated with the risk of prostate cancer in adjusted models for both Afro-Caribbean and native African men. For the A allele, a significant inverse association was observed among cases with low-grade Gleason scores and localized clinical stage, in both populations. Conclusions These preliminary results support the hypothesis that polymorphisms of genes encoding enzymes involved in estrogen metabolism may modulate the risk of prostate cancer in populations of African ancestry.	[Brureau, Laurent; Emeville, Elise; Blanchet, Pascal; Multigner, Luc] INSERM, U1085, IRSET, Pointe A Pitre, Guadeloupe, France; [Brureau, Laurent; Blanchet, Pascal] CHU Pointe A Pitre, Serv Urol, Pointe A Pitre, Guadeloupe, France; [Brureau, Laurent; Ferdinand, Severine; Blanchet, Pascal; Romana, Marc] Univ Antilles, Pointe A Pitre, Guadeloupe, France; [Moningo, Dieudonne; Punga, Augustin; Lufuma, Simon] Clin Univ Kinshasa, Serv Urol, Kinshasa, DEM REP CONGO; [Emeville, Elise; Multigner, Luc] Univ Rennes 1, Rennes, France; [Ferdinand, Severine; Romana, Marc] INSERM, U1134, Pointe A Pitre, Guadeloupe, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Guadeloupe; Universite des Antilles; Universite de Kinshasa; Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Multigner, L (corresponding author), INSERM, U1085, IRSET, Pointe A Pitre, Guadeloupe, France.; Multigner, L (corresponding author), Univ Rennes 1, Rennes, France.	luc.multigner@inserm.fr	Multigner, Luc/AAA-6214-2020; Multigner, Luc/I-2926-2015; Romana, Marc/K-6442-2017	Multigner, Luc/0000-0003-3205-8568; Multigner, Luc/0000-0003-3205-8568; Romana, Marc/0000-0002-8715-9836; FERDINAND, Severine/0000-0001-8258-5089	French Health Directorate; Ligue contre le cancer	French Health Directorate; Ligue contre le cancer(Ligue nationale contre le cancer)	This work was supported by the French Health Directorate (LM) (no grant number), and Ligue contre le cancer (EE) (a doctoral fellowship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, CANCER FACTS FIGURES; Ben-Shlomo Y, 2008, EUR UROL, V53, P99, DOI 10.1016/j.eururo.2007.02.047; Beuten J, 2009, CANCER EPIDEM BIOMAR, V18, P1869, DOI 10.1158/1055-9965.EPI-09-0076; Bosland M C, 2000, J Natl Cancer Inst Monogr, P39; BOSMA PJ, 1995, NEW ENGL J MED, V333, P1171, DOI 10.1056/NEJM199511023331802; Cancel-Tassin G, 2005, BJU INT, V96, P1380, DOI 10.1111/j.1464-410X.2005.05836.x; Carruba G, 2007, J CELL BIOCHEM, V102, P899, DOI 10.1002/jcb.21529; Center MM, 2012, EUR UROL, V61, P1079, DOI 10.1016/j.eururo.2012.02.054; Cheng ZQ, 1998, TOXICOL SCI, V45, P52, DOI 10.1006/toxs.1998.2494; Cicek MS, 2004, PROSTATE, V59, P69, DOI 10.1002/pros.10358; Cui LL, 2012, MOL BIOL REP, V39, P7465, DOI 10.1007/s11033-012-1579-y; Cussenot O, 2007, J CLIN ONCOL, V25, P3596, DOI 10.1200/JCO.2007.11.0908; Damber JE, 2008, LANCET, V371, P1710, DOI 10.1016/S0140-6736(08)60729-1; dos Santos A, 2002, PROSTATE CANCER P D, V5, P28, DOI 10.1038/sj/pcan/4500550; Hanna IH, 2000, CANCER RES, V60, P3440; Hsing AW, 2006, FRONT BIOSCI-LANDMRK, V11, P1388, DOI 10.2741/1891; Inoue-Choi M, 2010, INT J MOL EPIDEMIOL, V1, P114; Karatzas A, 2010, CANCER EPIDEMIOL, V34, P345, DOI 10.1016/j.canep.2010.02.009; Kittles RA, 2001, CANCER EPIDEM BIOMAR, V10, P943; La surveillance des cancers dans les Antilles et en Guyane, 2011, BULLETIN DE VEILLE S; Li L, 2004, CANCER EPIDEM BIOMAR, V13, P2280; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; Lunn RM, 1999, CARCINOGENESIS, V20, P1727, DOI 10.1093/carcin/20.9.1727; Morgan TO, 1996, NEW ENGL J MED, V335, P304, DOI 10.1056/NEJM199608013350502; Multigner L, 2010, J CLIN ONCOL, V28, P3457, DOI 10.1200/JCO.2009.27.2153; Olson SH, 2007, AM J EPIDEMIOL, V165, P235, DOI 10.1093/aje/kwk015; Ragin CC, 2010, GENET MED, V12, P12, DOI 10.1097/GIM.0b013e3181c8e160; Rogan EG, 2004, ADV CLIN CHEM, V38, P135, DOI 10.1016/S0065-2423(04)38005-4; Rothman K., 1998, MODERN EPIDEMIOLOGY, P253; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Sarma AV, 2008, PROSTATE, V68, P296, DOI 10.1002/pros.20696; Sharp L, 2004, AM J EPIDEMIOL, V160, P729, DOI 10.1093/aje/kwh287; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Stanford JL, 2002, CANCER EPIDEM BIOMAR, V11, P243; Suzuki K, 2003, ANTICANCER RES, V23, P4941; Taioli E, 2013, PROSTATE, V73, P668, DOI 10.1002/pros.22612; Tang L, 2011, CARCINOGENESIS, V32, P1500, DOI 10.1093/carcin/bgr139; Tsuchiya N, 2006, J CLIN ONCOL, V24, P1982, DOI 10.1200/JCO.2005.02.9439; Wang F, 2011, PROSTATE, V71, P1167, DOI 10.1002/pros.21332; Wu AH, 2003, CANCER RES, V63, P7526; Xiao L, 2013, MOL BIOL REP, V40, P1835, DOI 10.1007/s11033-012-2238-z; Yuen MT, 2005, INT J ONCOL, V27, P1685; Zhang HT, 2013, UROL INT, V91, P213, DOI 10.1159/000345633; Zhu BT, 2000, DRUG METAB DISPOS, V28, P1024; Zhu GS, 2004, PSYCHOPHARMACOLOGY, V177, P178, DOI 10.1007/s00213-004-1938-z; Zou LW, 2013, GENET TEST MOL BIOMA, V17, P78, DOI 10.1089/gtmb.2012.0216	46	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153609	10.1371/journal.pone.0153609	http://dx.doi.org/10.1371/journal.pone.0153609			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074016	gold, Green Published, Green Submitted			2022-12-26	WOS:000374131200111
J	Cho, H; Yu, H; Shin, E; Kim, YH; Park, SK; Jo, MW				Cho, Hyungjin; Yu, Hoon; Shin, Eunhye; Kim, Young Hoon; Park, Su-Kil; Jo, Min-Woo			Risk Factors for Graft Failure and Death following Geriatric Renal Transplantation	PLOS ONE			English	Article							QUALITY-OF-LIFE; CYTOMEGALOVIRUS-INFECTION; KIDNEY-TRANSPLANTATION; ELDERLY-PATIENTS; RECIPIENTS; AGE; SURVIVAL; EXPERIENCE; MORTALITY; DIALYSIS	Background Population aging is a major health concern in Asian countries and it has affected the age distribution of patients with end-stage renal disease (ESRD). As a consequence, the need for kidney transplantation in the geriatric population has increased, but the shortage of donors is an obstacle for geriatric renal transplantation. The aim of this study was to evaluate risk factors for graft failure and death in geriatric renal transplantation. Methods Kidney transplantations performed in a tertiary hospital in South Korea from May 1995 to December 2014 were retrospectively reviewed. Recipients younger than 60 years of age or who underwent other organ transplantations were excluded. The Kaplan-Meier method was used to assess patient and graft survival. A Cox regression analysis was used to evaluate risk factors for graft failure and patient death. Results A total of 229 kidney transplantation patients were included. Graft survival at 1, 5, and 10 years were 93.2%, 82.9%, and 61.2% respectively. Patient survival at 1, 5, and 10 years were 94.6%, 86.9%, and 68.8%, respectively. According to the Cox multivariate analysis, ABO incompatibility (hazard ratio [HR] 3.91, p < 0.002), DGF (HR 3.544, p < 0.004), CMV infection (HR 2.244, p < 0.011), and HBV infection (HR 6.349, p < 0.015) were independent risk factors for graft survival. Recipient age (HR 1.128, p < 0.024), ABO incompatibility (HR 3.014, p < 0.025), CMV infection (HR 2.532, p < 0.010), and the number of HLA mismatches (HR 1.425, p < 0.007) were independent risk factors for patient death. Conclusion Kidney transplantation in the geriatric population showed good clinical outcomes. ABO incompatibility, DGF, CMV infection, and HBV infection were risk factors for graft failure and the recipient age, ABO incompatibility, CMV infection, and the number of HLA mismatches were risk factors for patient death in geriatric renal transplantation.	[Cho, Hyungjin; Yu, Hoon; Park, Su-Kil] Univ Ulsan, Coll Med, Asan Med Ctr, Div Nephrol,Dept Internal Med, Seoul, South Korea; [Shin, Eunhye] Natl Rehabil Ctr, Dept Internal Med, Seoul, South Korea; [Kim, Young Hoon] Asan Med Ctr, Dept Surg, Seoul, South Korea; [Kim, Young Hoon] Univ Ulsan, Coll Med, Seoul, South Korea; [Jo, Min-Woo] Univ Ulsan, Coll Med, Dept Prevent Med, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; University of Ulsan	Jo, MW (corresponding author), Univ Ulsan, Coll Med, Dept Prevent Med, Seoul, South Korea.	mdjominwoo@gmail.com						[Anonymous], 2014, ANN REP TRANSPL 2013; Boesmueller C, 2011, TRANSPLANTATION, V92, P210, DOI 10.1097/TP.0b013e318222ca2f; Castle SC, 2000, CLIN INFECT DIS, V31, P578, DOI 10.1086/313947; Cornella C, 2008, TRANSPL P, V40, P1865, DOI 10.1016/j.transproceed.2008.05.050; Eckardt KU, 2009, AM J TRANSPLANT, V9, pS1, DOI 10.1111/j.1600-6143.2009.02834.x; FIETZE E, 1994, TRANSPLANTATION, V58, P675; Hatakeyama S, 2013, THESCIENTIFICWORLDJO; Heldal K, 2008, NEPHROL DIAL TRANSPL, V23, P1026, DOI 10.1093/ndt/gfm719; Huang H, 2014, JAMA-J AM MED ASSOC, V312, P2521, DOI 10.1001/jama.2014.15704; Kinsella K, 2009, INT POPULATION REPOR; Lai XQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112938; Meier-Kriesche HU, 2001, KIDNEY INT, V59, P1539, DOI 10.1046/j.1523-1755.2001.0590041539.x; Ojo AO, 1997, TRANSPLANTATION, V63, P968, DOI 10.1097/00007890-199704150-00011; Oniscu GC, 2004, NEPHROL DIAL TRANSPL, V19, P945, DOI 10.1093/ndt/gfh022; Opelz G, 2015, TRANSPLANTATION, V99, P400, DOI 10.1097/TP.0000000000000312; REINKE P, 1994, LANCET, V344, P1737, DOI 10.1016/S0140-6736(94)92887-8; Sagedal S, 2004, KIDNEY INT, V66, P329, DOI 10.1111/j.1523-1755.2004.00735.x; Sagedal S, 2007, CLIN TRANSPLANT, V21, P309, DOI 10.1111/j.1399-0012.2006.00639.x; Shin E, 2015, TRANSPL P, V47, P1720, DOI 10.1016/j.transproceed.2015.05.026; Shrestha LB, 2000, HEALTH AFFAIR, V19, P204, DOI 10.1377/hlthaff.19.3.204; Trouillhet I, 2005, TRANSPLANTATION, V80, P989, DOI 10.1097/01.TP.0000173822.05877.D7; Uchida J, 2012, INT UROL NEPHROL, V44, P1563, DOI 10.1007/s11255-012-0231-z; van der Bij W, 2001, CLIN INFECT DIS, V33, pS32, DOI 10.1086/320902; Veroux M, 2012, NEPHROL DIAL TRANSPL, V27, P1663, DOI 10.1093/ndt/gfr524; Weber M, 2014, J AM GERIATR SOC, V62, P1877, DOI 10.1111/jgs.13065; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303	26	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153410	10.1371/journal.pone.0153410	http://dx.doi.org/10.1371/journal.pone.0153410			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074003	Green Published, gold, Green Submitted			2022-12-26	WOS:000374131200087
J	Goh, CJ; Choi, D; Park, DB; Kim, H; Hahn, Y				Goh, Chul Jun; Choi, Dongjin; Park, Dong-Bin; Kim, Hyein; Hahn, Yoonsoo			MOXD2, a Gene Possibly Associated with Olfaction, Is Frequently Inactivated in Birds	PLOS ONE			English	Article							EVOLUTION; INSIGHTS; TRANSDUCTION; COMPONENT; PRIMATES; ECOLOGY; MAMMALS; MOUSE; TREE	Vertebrate MOXD2 encodes a monooxygenase DBH-like 2 protein that could be involved in neurotransmitter metabolism, potentially during olfactory transduction. Loss of MOXD2 in apes and whales has been proposed to be associated with evolution of olfaction in these clades. We analyzed 57 bird genomes to identify MOXD2 sequences and found frequent loss of MOXD2 in 38 birds. Among the 57 birds, 19 species appeared to have an intact MOXD2 that encoded a full-length protein; 32 birds had a gene with open reading frame-disrupting point mutations and/or exon deletions; and the remaining 6 species did not show any MOXD2 sequence, suggesting a whole-gene deletion. Notably, among 10 passerine birds examined, 9 species shared a common genomic deletion that spanned several exons, implying the gene loss occurred in a common ancestor of these birds. However, 2 closely related penguin species, each of which had an inactive MOXD2, did not share any mutation, suggesting an independent loss after their divergence. Distribution of the 38 birds without an intact MOXD2 in the bird phylogenetic tree clearly indicates that MOXD2 loss is widespread and independent in bird lineages. We propose that widespread MOXD2 loss in some bird lineages may be implicated in the evolution of olfactory perception in these birds.	[Goh, Chul Jun; Choi, Dongjin; Park, Dong-Bin; Kim, Hyein; Hahn, Yoonsoo] Chung Ang Univ, Res Ctr Biomol & Biosyst, Dept Life Sci, Seoul 156756, South Korea	Chung Ang University	Hahn, Y (corresponding author), Chung Ang Univ, Res Ctr Biomol & Biosyst, Dept Life Sci, Seoul 156756, South Korea.	hahny@cau.ac.kr		HAHN, YOONSOO/0000-0003-4273-9842	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology, Republic of Korea [2012R1A1B3001513]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology, Republic of Korea	This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1B3001513), Republic of Korea. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton RA, 2006, AM J PRIMATOL, V68, P545, DOI 10.1002/ajp.20251; Combarros O, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-162; Corfield JR, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00102; Cubells JF, 2011, HUM GENET, V130, P635, DOI 10.1007/s00439-011-0989-6; Dong D, 2009, GENOME BIOL EVOL, V1, P258, DOI 10.1093/gbe/evp026; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Hahn Y, 2006, HUM GENET, V119, P169, DOI 10.1007/s00439-005-0125-6; Hahn Y, 2005, BIOINFORMATICS, V21, pI186, DOI 10.1093/bioinformatics/bti1000; Hahn Y, 2007, MOL BIOL EVOL, V24, P2203, DOI 10.1093/molbev/msm146; Hayden S, 2010, GENOME RES, V20, P1, DOI 10.1101/gr.099416.109; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jarvis ED, 2014, SCIENCE, V346, P1320, DOI 10.1126/science.1253451; Jiang PH, 2012, P NATL ACAD SCI USA, V109, P4956, DOI 10.1073/pnas.1118360109; Khan I, 2015, MOL BIOL EVOL, V32, P2832, DOI 10.1093/molbev/msv155; Kim DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104085; Kiselyov K, 2010, VITAM HORM, V83, P197, DOI 10.1016/S0083-6729(10)83008-0; Kishida T, 2007, BIOLOGY LETT, V3, P428, DOI 10.1098/rsbl.2007.0191; Li C, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-27; Liman ER, 2003, P NATL ACAD SCI USA, V100, P3328, DOI 10.1073/pnas.0636123100; McGowen MR, 2008, SYST BIOL, V57, P574, DOI 10.1080/10635150802304787; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pierleoni A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-392; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Timmers HJLM, 2004, ANN NY ACAD SCI, V1018, P520, DOI 10.1196/annals.1296.064; Yim HS, 2014, NAT GENET, V46, P88, DOI 10.1038/ng.2835; Yu L, 2010, MOL BIOL EVOL, V27, P1467, DOI 10.1093/molbev/msq027; Zhang GJ, 2014, SCIENCE, V346, P1311, DOI 10.1126/science.1251385; Zhao HB, 2015, CURR BIOL, V25, pR141, DOI 10.1016/j.cub.2015.01.026; Zhao HB, 2011, MOL BIOL EVOL, V28, P7, DOI 10.1093/molbev/msq207	31	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152431	10.1371/journal.pone.0152431	http://dx.doi.org/10.1371/journal.pone.0152431			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074048	Green Submitted, gold, Green Published			2022-12-26	WOS:000374131200024
J	Rosenthal, J; Belfort, G; Isaacson, D				Rosenthal, Joseph; Belfort, Georges; Isaacson, David			Early Treatment Critical: Bexarotene Reduces Amyloid-Beta Burden In Silico	PLOS ONE			English	Article							AD MOUSE MODELS; ALZHEIMERS-DISEASE; REVERSE DEFICITS; PATHOLOGY; MICE	Amyloid-beta peptides have long been implicated in the pathology of Alzheimer's disease. Bexarotene, a drug approved by the U.S. Food and Drug Administration for treating a class of non-Hodgkin's lymphoma, has been reported to facilitate the removal of amyloid-beta. We have developed a mathematical model to explore the efficacy of bexarotene treatment in reducing amyloid-beta load, and simulate amyloid-beta production throughout the lifespan of diseased mice. Both aspects of the model are based on and consistent with previous experimental results. Beyond what is known empirically, our model shows that low dosages of bexarotene are unable to reverse symptoms in diseased mice, but dosages at and above an age-dependent critical concentration can recover healthy brain cells. Further, early treatment was shown to have significantly improved efficacy versus treatment in older mice. Relevance with respect to bexarotene-based amyloid-beta-clearance mechanism and direct treatment for Alzheimer's disease is emphasized.	[Rosenthal, Joseph; Isaacson, David] Rensselaer Polytech Inst, Dept Math Sci, Troy, NY 12180 USA; [Belfort, Georges] Rensselaer Polytech Inst, Howard P Isermann Dept Chem & Biol Engn, Troy, NY 12180 USA; [Belfort, Georges] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Rosenthal, Joseph] SURVICE Engn, Appl Technol Operat, Pittsburgh, PA USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Rosenthal, J (corresponding author), Rensselaer Polytech Inst, Dept Math Sci, Troy, NY 12180 USA.; Belfort, G (corresponding author), Rensselaer Polytech Inst, Howard P Isermann Dept Chem & Biol Engn, Troy, NY 12180 USA.; Belfort, G (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.; Rosenthal, J (corresponding author), SURVICE Engn, Appl Technol Operat, Pittsburgh, PA USA.	joseph.rosenthal@survice.com; belfog@rpi.edu		Rosenthal, Joseph/0000-0001-8500-4032	Rensselaer Polytechnic Institute (RPI) [140124]	Rensselaer Polytechnic Institute (RPI)	GB acknowledges Rensselaer Polytechnic Institute for financial support from his endowed chair (RPI# 140124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the reviewers for pointing out that the critical dosage of bexarotene increases exponentially with mouse age, and Dr. Lawrence T. Friedhoff for advice and helpful discussion. GB acknowledges RPI for financial support from his endowed chair (RPI# 140124).	Balducci C, 2015, J ALZHEIMERS DIS, V46, P471, DOI 10.3233/JAD-150029; Boehm-Cagan A, 2014, J NEUROSCI, V34, P7293, DOI 10.1523/JNEUROSCI.5198-13.2014; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Cummings JL, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0173-2; Edelstein-Keshet L., 1988, MATH MODELS BIOL; Fitz NF, 2013, SCIENCE, V340, DOI 10.1126/science.1235809; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Keener J., 2009, MATH PHYSL; LaClair KD, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-18; Landreth GE, 2013, SCIENCE, V340, DOI 10.1126/science.1234114; Pierrot N, 2016, J ALZHEIMERS DIS, V49, P271, DOI 10.3233/JAD-150405; Price AR, 2013, SCIENCE, V340, DOI 10.1126/science.1234089; Tesseur I, 2013, SCIENCE, V340, DOI 10.1126/science.1233937; Trinchese F, 2004, ANN NEUROL, V55, P801, DOI 10.1002/ana.20101; Veeraraghavalu K, 2013, SCIENCE, V340, DOI 10.1126/science.1235505	15	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153150	10.1371/journal.pone.0153150	http://dx.doi.org/10.1371/journal.pone.0153150			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073866	gold, Green Published			2022-12-26	WOS:000374131200054
J	Xu, WG; Shen, H; Qi, XF; Wang, ZY; Wang, YF; Hu, QG; Han, W				Xu Wenguang; Shen Hao; Qi Xiaofeng; Wang Zhiyong; Wang Yufeng; Hu Qingang; Han Wei			Prognostic Factors of Primary Intraosseous Squamous Cell Carcinoma (PIOSCC): A Retrospective Review	PLOS ONE			English	Review							NECK-CANCER; ODONTOGENIC CYST; PHASE-II; HEAD; CHEMOTHERAPY; CISPLATIN; TRIAL; FLUOROURACIL; DOCETAXEL	Objectives To delineate clinical and pathological features and determine the prognostic factors of primary intraosseous squamous cell carcinoma (PIOSCC). Materials and methods Patients diagnosed with PIOSCC, attending the department of oral and maxillofacial surgery, Nanjing stomatological hospital between 2005 and 2015, were identified and retrospectively reviewed for clinical and pathological characteristics. Therapeutic modalities were measured and related follow-up data recorded, in order to determine prognostic factors of PIOSSC. Results A total of 77 patients with PIOSCC were included in the study. Mean age at diagnosis was 58.8 years, (range, 37 - 81 years). Of the 77 patients, there were 58 men and 19 women. The most common location of disease was the mandible (71.42%), particularly the posterior mandible. The common presenting symptoms included jaw swelling (79.2%) and ulceration (42.65%). The estimated 2-year and 5-year overall survival were 68.9% and 38.8%, respectively. Univariate analysis identified the following as negative prognostic factors: histological grade, N classification, nodal status and treatment modalities. However, multivariate analysis determined positive nodal status, high histological grade and advanced N classification as the independent significant prognostic factors. Conclusion Our results demonstrate several clinical and pathological features of PIOSCC and identify important prognostic factors associated with overall survival in PIOSCC. These prognostic factors include nodal status, histological grade, N classification, and treatment modalities, all of which are important for patient counseling and may be useful for the development of new treatment approaches.	[Xu Wenguang; Shen Hao; Qi Xiaofeng; Wang Zhiyong; Wang Yufeng; Hu Qingang; Han Wei] Nanjing Univ, Sch Med, Nanjing Stomatol Hosp, Dept Oral & Maxillofacial Surg, Nanjing 210008, Jiangsu, Peoples R China; [Xu Wenguang; Shen Hao; Qi Xiaofeng; Wang Zhiyong; Wang Yufeng; Hu Qingang; Han Wei] Nanjing Univ, Sch Med, Nanjing Stomatol Hosp, Cent Lab Stomatol, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Han, W (corresponding author), Nanjing Univ, Sch Med, Nanjing Stomatol Hosp, Dept Oral & Maxillofacial Surg, Nanjing 210008, Jiangsu, Peoples R China.; Han, W (corresponding author), Nanjing Univ, Sch Med, Nanjing Stomatol Hosp, Cent Lab Stomatol, Nanjing 210008, Jiangsu, Peoples R China.	doctorhanwei@hotmail.com	Xu, Wenguang/GSD-4983-2022		National Natural Science Foundation of China [81302351]; Jiangsu provincial natural science foundation [BK2012075, BK 20131080]; Distinguished young investigator project of Nanjing [JQX14010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu provincial natural science foundation(Natural Science Foundation of Jiangsu Province); Distinguished young investigator project of Nanjing	This work was supported by the National Natural Science Foundation of China (81302351, HW) (http://www.nsfc.gov.cn/); Jiangsu provincial natural science foundation (Grant No BK2012075, BK 20131080, HW) (http://www.jstd.gov.cn/); and Distinguished young investigator project of Nanjing (JQX14010, HW) (http://www.jstd.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes L., 2005, PATHOLOGY GENETICS H, V9; Bodner L, 2011, J ORAL PATHOL MED, V40, P733, DOI 10.1111/j.1600-0714.2011.01058.x; Boni P, 2016, J ORAL MAXIL SURG, V74, P541, DOI 10.1016/j.joms.2015.09.009; Chaisuparat R, 2006, ORAL SURG ORAL MED O, V101, P196, DOI 10.1016/j.tripleo.2005.03.037; Dimitrakopoulos I, 2005, J ORAL MAXIL SURG, V63, P1227, DOI 10.1016/j.joms.2005.04.009; Domenge C, 2000, BRIT J CANCER, V83, P1594, DOI 10.1054/bjoc.2000.1512; Edge SB, 2010, AJCC CANC STAGING MA; Eversole LR, 2005, WHO CLASSIFICATION T, P290; Garden AS, 2004, J CLIN ONCOL, V22, P2856, DOI 10.1200/JCO.2004.12.012; Geetha P, 2015, J CANCER RES THER, V11, DOI 10.4103/0973-1482.140814; Gibson MK, 2005, J CLIN ONCOL, V23, P3562, DOI 10.1200/JCO.2005.01.057; Huang JW, 2009, ARCH PATHOL LAB MED, V133, P1834, DOI 10.1043/1543-2165-133.11.1834; PACCAGNELLA A, 1994, J NATL CANCER I, V86, P265, DOI 10.1093/jnci/86.4.265; Pignon JP, 2000, LANCET, V355, P949, DOI 10.1016/S0140-6736(00)90011-4; Pindborg JJ, 1972, HISTOLOGIC TYPING OD, P35; Posner MR, 2007, NEW ENGL J MED, V357, P1705, DOI 10.1056/NEJMoa070956; Rapidis AD, 2006, ORAL ONCOL, V42, P675, DOI 10.1016/j.oraloncology.2005.12.006; SHEAR M, 1969, J PATHOL, V97, P645, DOI 10.1002/path.1710970409; SUEI Y, 1994, J ORAL MAXIL SURG, V52, P580, DOI 10.1016/0278-2391(94)90094-9; Vermorken JB, 2007, NEW ENGL J MED, V357, P1695, DOI 10.1056/NEJMoa071028; WALDRON CA, 1989, ORAL SURG ORAL MED O, V67, P716, DOI 10.1016/0030-4220(89)90014-5; Woolgar JA, 2013, HEAD NECK-J SCI SPEC, V35, P906, DOI 10.1002/hed.22922; Yamada T, 2009, J CRANIO MAXILL SURG, V37, P448, DOI 10.1016/j.jcms.2009.05.006	23	12	14	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153646	10.1371/journal.pone.0153646	http://dx.doi.org/10.1371/journal.pone.0153646			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074366	Green Submitted, Green Published, gold			2022-12-26	WOS:000374131200114
J	Liu, QH; Babadjouni, R; Radwanski, R; Cheng, H; Patel, A; Hodis, DM; He, SH; Baumbacher, P; Russin, JJ; Morgan, TE; Sioutas, C; Finch, CE; Mack, WJ				Liu, Qinghai; Babadjouni, Robin; Radwanski, Ryan; Cheng, Hank; Patel, Arati; Hodis, Drew M.; He, Shuhan; Baumbacher, Peter; Russin, Jonathan J.; Morgan, Todd E.; Sioutas, Constantinos; Finch, Caleb E.; Mack, William J.			Stroke Damage Is Exacerbated by Nano-Size Particulate Matter in a Mouse Model	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; AMBIENT AIR-POLLUTION; OXIDATIVE STRESS; ULTRAFINE PARTICLES; POLLUTANTS; EXHAUST; MARKERS; NEURONS; RISK; NEUROINFLAMMATION	This study examines the effects of nano-size particulate matter (nPM) exposure in the setting of murine reperfused stroke. Particulate matter is a potent source of inflammation and oxidative stress. These processes are known to influence stroke progression through recruitment of marginally viable penumbral tissue into the ischemic core. nPM was collected in an urban area in central Los Angeles, impacted primarily by traffic emissions. Re-aerosolized nPM or filtered air was then administered to mice through whole body exposure chambers for forty-five cumulative hours. Exposed mice then underwent middle cerebral artery occlusion/reperfusion. Following cerebral ischemia/reperfusion, mice exposed to nPM exhibited significantly larger infarct volumes and less favorable neurological deficit scores when compared to mice exposed to filtered air. Mice exposed to nPM also demonstrated increases in markers of inflammation and oxidative stress in the region of the ischemic core. The findings suggest a detrimental effect of urban airborne particulate matter exposure in the setting of acute ischemic stroke.	[Liu, Qinghai; Babadjouni, Robin; Radwanski, Ryan; Patel, Arati; Hodis, Drew M.; He, Shuhan; Mack, William J.] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Baumbacher, Peter; Russin, Jonathan J.; Mack, William J.] Univ So Calif, Keck Sch Med, Dept Neurosurg, Los Angeles, CA 90033 USA; [Cheng, Hank; Morgan, Todd E.; Finch, Caleb E.] Univ So Calif, Davis Sch Gerontol, Los Angeles, CA USA; [Sioutas, Constantinos] Univ So Calif, Viterbi Sch Engn, Los Angeles, CA USA; [Finch, Caleb E.] Univ So Calif, Dept Neurobiol, Los Angeles, CA USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Mack, WJ (corresponding author), Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA.	William.Mack@med.usc.edu	Sioutas, Constantinos/R-1968-2019; Radwanski, Ryan E./AAP-1255-2020; He, Shuhan/AAF-1764-2020; Finch, Caleb/AAA-7250-2022	Radwanski, Ryan E./0000-0003-1389-4691; He, Shuhan/0000-0002-9902-5077; Cheng, Hank/0000-0003-3793-0394; Sioutas, Constantinos/0000-0001-5146-0857	National Institutes of Health/ National Institute of Environmental Health Science Southern California Environmental Health Sciences Center (SCEHSC) [5P30ES007048]; SC CTSI (NIH/NCRR/NCATS) [KL2TR000131]; NIH/NIEHS [R01ES024936]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES024936, P30ES007048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005142] Funding Source: NIH RePORTER	National Institutes of Health/ National Institute of Environmental Health Science Southern California Environmental Health Sciences Center (SCEHSC); SC CTSI (NIH/NCRR/NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by a grant through the National Institutes of Health/ National Institute of Environmental Health Science Southern California Environmental Health Sciences Center (SCEHSC): grant # 5P30ES007048, a grant through the SC CTSI (NIH/NCRR/NCATS) grant # KL2TR000131, and a grant through the NIH/NIEHS: grant # R01ES024936. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo JA, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-24; Arenillas JF, 2002, STROKE, V33, P2197, DOI 10.1161/01.STR.0000027861.75884.DF; Block ML, 2009, TRENDS NEUROSCI, V32, P506, DOI 10.1016/j.tins.2009.05.009; Block ML, 2004, FASEB J, V18, P1618, DOI 10.1096/fj.04-1945fje; Bos I, 2012, INHAL TOXICOL, V24, P676, DOI 10.3109/08958378.2012.714004; Calderon-Garciduenas L, 2002, TOXICOL PATHOL, V30, P373, DOI 10.1080/01926230252929954; Campbell A, 2005, NEUROTOXICOLOGY, V26, P133, DOI 10.1016/j.neuro.2004.08.003; Campbell A, 2009, J NANOSCI NANOTECHNO, V9, P5099, DOI 10.1166/jnn.2009.GR07; Cheng HS A., ENV HLTH PE IN PRESS; Choi K, 2009, CURR NEUROVASC RES, V6, P213, DOI 10.2174/156720209789630375; Clark WM, 1997, NEUROL RES, V19, P641; Connolly ES, 1996, NEUROSURGERY, V38, P523, DOI 10.1097/00006123-199603000-00021; Craig L, 2008, J TOXICOL ENV HEAL A, V71, P588, DOI 10.1080/15287390801997732; Davis DA, 2013, J NEUROCHEM, V127, P509, DOI 10.1111/jnc.12395; Davis DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064128; Ducruet AF, 2008, J CEREBR BLOOD F MET, V28, P1048, DOI 10.1038/sj.jcbfm.9600608; Fruin S, 2008, ATMOS ENVIRON, V42, P207, DOI 10.1016/j.atmosenv.2007.09.057; Gerlofs-Nijland ME, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-12; Gidday JM, 2005, AM J PHYSIOL-HEART C, V289, pH558, DOI 10.1152/ajpheart.01275.2004; Guo L, 2014, CHEM RES TOXICOLOGY; Hong YC, 2002, STROKE, V33, P2165, DOI 10.1161/01.STR.0000026865.52610.5B; Iannuzzi A, 2010, CARDIOL YOUNG, V20, P186, DOI 10.1017/S1047951109992010; Kam W, 2012, ATMOS ENVIRON, V55, P90, DOI 10.1016/j.atmosenv.2012.03.028; Kam W, 2012, ATMOS ENVIRON, V61, P378, DOI 10.1016/j.atmosenv.2012.07.072; Kim GH, 2008, NEUROSURGERY, V63, P122, DOI 10.1227/01.NEU.0000335079.70222.8D; Kunzli N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009096; Levesque S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-105; Levesque S, 2011, ENVIRON HEALTH PERSP, V119, P1149, DOI 10.1289/ehp.1002986; Li N, 2003, ENVIRON HEALTH PERSP, V111, P455, DOI 10.1289/ehp.6000; Li RS, 2013, J LIPID RES, V54, P1608, DOI 10.1194/jlr.M035014; Li R, 2009, FREE RADICAL BIO MED, V46, P775, DOI 10.1016/j.freeradbiomed.2008.11.025; Li Y, 1998, STROKE, V29, P1972, DOI 10.1161/01.STR.29.9.1972; Liu QY, 2013, PROCEEDINGS OF THE 2013 INTERNATIONAL CONFERENCE ON ENERGY, P8; Mack WJ, 2006, J NEUROSCI RES, V83, P883, DOI 10.1002/jnr.20775; Misra C, 2002, J AEROSOL SCI, V33, P735, DOI 10.1016/S0021-8502(01)00210-5; Mocco J, 2006, CIRC RES, V99, P209, DOI 10.1161/01.RES.0000232544.90675.42; Morgan TE, 2011, ENVIRON HEALTH PERSP, V119, P1003, DOI 10.1289/ehp.1002973; Ning Z, 2007, ENVIRON SCI TECHNOL, V41, P6000, DOI 10.1021/es070653g; Schauer JJ, 2003, J EXPO ANAL ENV EPID, V13, P443, DOI 10.1038/sj.jea.7500298; Shah ASV, 2015, BMJ-BRIT MED J, V350, DOI [10.1136/bmj.i4851, 10.1136/bmj.h1295]; Shin HH, 2014, EPIDEMIOLOGY, V25, P835, DOI 10.1097/EDE.0000000000000162; Wang Y, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000983; Wellenius GA, 2012, ARCH INTERN MED, V172, P229, DOI 10.1001/archinternmed.2011.732; Wilker EH, 2013, J STROKE CEREBROVASC, V22, pE366, DOI 10.1016/j.jstrokecerebrovasdis.2013.03.034; Yilmaz G, 2010, NEUROMOL MED, V12, P193, DOI 10.1007/s12017-009-8074-1	45	19	19	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153376	10.1371/journal.pone.0153376	http://dx.doi.org/10.1371/journal.pone.0153376			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27071057	Green Submitted, Green Published, gold			2022-12-26	WOS:000373900700058
J	Raes, F; Sobilo, J; Le Mee, M; Retif, S; Natkunarajah, S; Lerondel, S; Le Pape, A				Raes, Florian; Sobilo, Julien; Le Mee, Marilyne; Retif, Stephanie; Natkunarajah, Sharuja; Lerondel, Stephanie; Le Pape, Alain			High Resolution Ultrasound and Photoacoustic Imaging of Orthotopic Lung Cancer in Mice: New Perspectives for Onco-Pharmacology	PLOS ONE			English	Article							SOFT-TISSUE; HYPOXIA; TUMOR; COMBINATION; TH-302; TOOL	Objectives We have developed a relevant preclinical model associated with a specific imaging protocol dedicated to onco-pharmacology studies in mice. Materials and Methods We optimized both the animal model and an ultrasound imaging procedure to follow up longitudinally the lung tumor growth in mice. Moreover we proposed to measure by photoacoustic imaging the intratumoral hypoxia, which is a crucial parameter responsible for resistance to therapies. Finally, we compared ultrasound data to x-ray micro computed tomography and volumetric measurements to validate the relevance of this approach on the NCI-H460 human orthotopic lung tumor. Results This study demonstrates the ability of ultrasound imaging to detect and monitor the in vivo orthotopic lung tumor growth by high resolution ultrasound imaging. This approach enabled us to characterize key biological parameters such as oxygenation, perfusion status and vascularization of tumors. Conclusion Such an experimental approach has never been reported previously and it would provide a nonradiative tool for assessment of anticancer therapeutic efficacy in mice. Considering the absence of ultrasound propagation through the lung parenchyma, this strategy requires the implantation of tumors strictly located in the superficial posterior part of the lung.	[Raes, Florian; Sobilo, Julien; Le Mee, Marilyne; Retif, Stephanie; Natkunarajah, Sharuja; Lerondel, Stephanie; Le Pape, Alain] CNRS Orleans, CIPA, PHENOMIN TAAM UPS44, Orleans, France; [Le Pape, Alain] Univ Tours, INSERM, U1100, CEPR, F-37041 Tours, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours	Raes, F (corresponding author), CNRS Orleans, CIPA, PHENOMIN TAAM UPS44, Orleans, France.	florian.raes@cnrs-orleans.fr	Raes, Florian/ABD-8845-2020	Raes, Florian/0000-0003-2898-995X				Andouard S, 2011, COMMUNICATION; Borad MJ, 2015, J CLIN ONCOL, V33, P1475, DOI 10.1200/JCO.2014.55.7504; Brulle L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052653; Chawla SP, 2014, J CLIN ONCOL, V32, P3299, DOI 10.1200/JCO.2013.54.3660; Colella S, 2014, ENDOSC ULTRASOUND, V3, P205, DOI 10.4103/2303-9027.144510; Foster FS, 2011, INTERFACE FOCUS, V1, P576, DOI 10.1098/rsfs.2011.0037; Fushiki H, 2013, ANTICANCER RES, V33, P4741; Gagnadoux F, 2005, EUR RESPIR J, V26, P657, DOI 10.1183/09031936.05.00017305; Gargani L, 2011, CARDIOVASC ULTRASOUN, V9, DOI 10.1186/1476-7120-9-6; Graves EE, 2010, CLIN CANCER RES, V16, P4843, DOI 10.1158/1078-0432.CCR-10-1206; Hyvelin JM, 2013, INVEST RADIOL, V48, P570, DOI 10.1097/RLI.0b013e318289f854; Jiang YY, 2015, LUNG CANCER, V90, P191, DOI 10.1016/j.lungcan.2015.08.009; Kagadis GC, 2010, MED PHYS, V37, P6421, DOI 10.1118/1.3515456; Kaneko OF, 2012, QUANT IMAGING MED SU, V2, P87, DOI 10.3978/j.issn.2223-4292.2012.06.06; Khalil Ashraf A, 2013, Int J Mol Imaging, V2013, P287697, DOI 10.1155/2013/287697; Le QT, 2006, CLIN CANCER RES, V12, P1507, DOI 10.1158/1078-0432.CCR-05-2049; Lerondel S., 2013, CURRENT MOL IMAGING, V2, P18, DOI [10.2174/2211555211302010004, DOI 10.2174/2211555211302010004]; Lichtenstein DA, 2014, ANN INTENSIVE CARE, V4, DOI 10.1186/2110-5820-4-1; Maillet A, 2011, PHARM RES-DORDR, V28, P2147, DOI 10.1007/s11095-011-0442-5; Needles A., 2010, 2010 International Ultrasonics Symposium, P390, DOI 10.1109/ULTSYM.2010.0095; Paulus MJ, 2000, NEOPLASIA, V2, P62, DOI 10.1038/sj.neo.7900069; Peeters SGJA, 2015, CLIN CANCER RES, V21, P2984, DOI 10.1158/1078-0432.CCR-15-0018; van Rooij T, 2015, INT J HYPERTHER, V31, P90, DOI 10.3109/02656736.2014.997809; Wallace MB, 2008, JAMA-J AM MED ASSOC, V299, P540, DOI 10.1001/jama.299.5.540; Walsh JC, 2014, ANTIOXID REDOX SIGN, V21, P1516, DOI 10.1089/ars.2013.5378; Wathen CA, 2013, SENSORS-BASEL, V13, P6957, DOI 10.3390/s130606957; Willekens I, 2010, CONTRAST MEDIA MOL I, V5, P201, DOI 10.1002/cmmi.394; Zegers CML, 2014, CLIN CANCER RES, V20, P6389, DOI 10.1158/1078-0432.CCR-14-1524	28	28	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153532	10.1371/journal.pone.0153532	http://dx.doi.org/10.1371/journal.pone.0153532			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070548	Green Published, Green Submitted, gold			2022-12-26	WOS:000373900700078
J	Lee, SC; Min, HY; Jung, HJ; Park, KH; Hyun, SY; Cho, J; Woo, JK; Kwon, SJ; Lee, HJ; Johnson, FM; Lee, HY				Lee, S. C.; Min, H-Y; Jung, H. J.; Park, K. H.; Hyun, S. Y.; Cho, J.; Woo, J. K.; Kwon, S. J.; Lee, H-J; Johnson, F. M.; Lee, H-Y			Essential role of insulin-like growth factor 2 in resistance to histone deacetylase inhibitors	ONCOGENE			English	Article							SUBEROYLANILIDE HYDROXAMIC ACID; FACTOR RECEPTOR; VORINOSTAT; ACTIVATION; STAT3; IGF2; METHYLATION; PROMOTERS; CANCER; TRIAL	Histone deacetylase (HDAC) inhibitors (HDIs) are promising anticancer therapies and have been clinically used for the treatment of hematological malignancy. However, their efficacy in solid tumors is marginal and drug resistance hampers their further clinical utility. To develop novel strategies for the HDI-based anticancer therapeutics in non-small cell lung cancer (NSCLC), in the present study, we investigated the mechanisms underlying resistance to HDI treatment in NSCLC cells. We show the STAT3-mediated IGF2/IGF-1R signaling cascade as a key modulator for both acquired and primary HDI resistance. The treatment with HDI upregulated IGF2 transcription in NSCLC cells carrying intrinsic or acquired drug resistance via direct binding of STAT3 in IGF2 P3 and P4 promoters. Acetylated STAT3 emerged upon HDAC inhibition was protected from the proteasome-mediated degradation of STAT3 and functioned as a direct transcription factor for IGF2 expression. Genomic or pharmacological strategies targeting STAT3 diminished the HDI-induced IGF2 mRNA expression and overcame the resistance to HDI treatment in HDI-resistant NSCLC-or patient-derived tumor xenograft models. These findings provide new insights into the role of acetylated STAT3-mediated activation of IGF2 transcription in HDI resistance, suggesting IGF2 or STAT3 as novel targets to overcome HDI resistance in NSCLC.	[Lee, S. C.; Min, H-Y; Park, K. H.; Hyun, S. Y.; Cho, J.; Woo, J. K.; Lee, H-Y] Seoul Natl Univ, Coll Pharm, 1 Gwanak Ro, Seoul 08826, South Korea; [Lee, S. C.; Min, H-Y; Park, K. H.; Hyun, S. Y.; Cho, J.; Woo, J. K.; Lee, H-Y] Seoul Natl Univ, Pharmaceut Sci Res Inst, 1 Gwanak Ro, Seoul 08826, South Korea; [Jung, H. J.; Lee, H-Y] Seoul Natl Univ, Interdisciplinary Program Genet Engn, Seoul, South Korea; [Kwon, S. J.; Lee, H-J] Inje Univ, Coll Pharm, Gimhae, South Korea; [Johnson, F. M.] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Inje University; University of Texas System; UTMD Anderson Cancer Center	Lee, HY (corresponding author), Seoul Natl Univ, Coll Pharm, 1 Gwanak Ro, Seoul 08826, South Korea.; Lee, HY (corresponding author), Seoul Natl Univ, Pharmaceut Sci Res Inst, 1 Gwanak Ro, Seoul 08826, South Korea.	hylee135@snu.ac.kr		Lee, Ho-Young/0000-0001-7556-9312; Lee, Hyo-Jong/0000-0003-4826-7954	National Research Foundation of Korea (NRF); Ministry of Science, ICT and Future Planning (MSIP), Republic of Korea [NRF-2011-0017639, NRF-2011-0030001]; Ministry of Science, ICT and Future Planning (MSIP), Republic of Korea (National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea) [1520250]; National Institutes of Health [R01 CA100816]; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA100816] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Science, ICT and Future Planning (MSIP), Republic of Korea; Ministry of Science, ICT and Future Planning (MSIP), Republic of Korea (National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Tomas Ekstrom (Karolinska Hospital, Sweden) to kindly provide the information on the structure and sequence of IGF2 promoters. This work was supported by grants from the National Research Foundation of Korea (NRF), the Ministry of Science, ICT and Future Planning (MSIP), Republic of Korea ((Nos. NRF-2011-0017639 and NRF-2011-0030001), the National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea (1520250)) and the National Institutes of Health (R01 CA100816).	Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Dallas NA, 2009, CANCER RES, V69, P1951, DOI 10.1158/0008-5472.CAN-08-2023; Desbois-Mouthon C, 2006, INT J CANCER, V119, P2557, DOI 10.1002/ijc.22221; Dhe-Paganon Sirano, 2011, Int J Biochem Mol Biol, V2, P58; Duvic M, 2007, BLOOD, V109, P31, DOI 10.1182/blood-2006-06-025999; Eckstein N, 2009, CANCER RES, V69, P2996, DOI 10.1158/0008-5472.CAN-08-3153; Fantin VR, 2008, CANCER RES, V68, P3785, DOI 10.1158/0008-5472.CAN-07-6091; Fantin VR, 2007, CLIN CANCER RES, V13, P7237, DOI 10.1158/1078-0432.CCR-07-2114; Garcia-Manero G, 2008, BLOOD, V111, P1060, DOI 10.1182/blood-2007-06-098061; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Huang GS, 2010, CLIN CANCER RES, V16, P2999, DOI 10.1158/1078-0432.CCR-09-3233; Jin QR, 2014, CARCINOGENESIS, V35, P2232, DOI 10.1093/carcin/bgu129; Kim JS, 2015, CANCER LETT, V361, P197, DOI 10.1016/j.canlet.2015.02.038; Kirschbaum M, 2014, BRIT J HAEMATOL, V167, P185, DOI 10.1111/bjh.13016; Kohda M, 2001, MOL CARCINOGEN, V31, P184, DOI 10.1002/mc.1053; Lawson EA, 2009, J CLIN ENDOCR METAB, V94, P2226, DOI 10.1210/jc.2009-0153; Lee H, 2012, P NATL ACAD SCI USA, V109, P7765, DOI 10.1073/pnas.1205132109; Lee JG, 2015, BIG DATA RES, V2, P74, DOI 10.1016/j.bdr.2015.01.003; Lee JH, 2012, ADV CANCER RES, V116, P39, DOI 10.1016/B978-0-12-394387-3.00002-1; Licciardi PV, 2013, CURR MOL MED, V13, P640; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lui JC, 2013, P NATL ACAD SCI USA, V110, P6181, DOI 10.1073/pnas.1219079110; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Mayo MW, 2003, J BIOL CHEM, V278, P18980, DOI 10.1074/jbc.M211695200; McCue J, 2005, CURR PROTOC TOXICOL; Min HY, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0392-3; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Nordin M, 2014, CELL PROLIFERAT, V47, P189, DOI 10.1111/cpr.12106; O'Connor OA, 2006, J CLIN ONCOL, V24, P166, DOI 10.1200/JCO.2005.01.9679; Olsen EA, 2007, J CLIN ONCOL, V25, P3109, DOI 10.1200/JCO.2006.10.2434; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Sakatani T, 2005, SCIENCE, V307, P1976, DOI 10.1126/science.1108080; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schoenherr CJ, 2003, NAT GENET, V33, P66, DOI 10.1038/ng1057; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Shan JJ, 2012, HEPATOLOGY, V56, P1004, DOI 10.1002/hep.25745; Shin DH, 2013, JNCI-J NATL CANCER I, V105, P1558, DOI 10.1093/jnci/djt263; Shin DH, 2011, MOL CANCER THER, V10, P2437, DOI 10.1158/1535-7163.MCT-11-0235; Singh P, 1998, GASTROENTEROLOGY, V114, P1221, DOI 10.1016/S0016-5085(98)70428-7; SUZUKI H, 1994, NAT GENET, V6, P332, DOI 10.1038/ng0494-332; Tada Y, 2015, ONCOGENE, V34, P752, DOI 10.1038/onc.2013.599; Traynor AM, 2009, J THORAC ONCOL, V4, P522, DOI 10.1097/JTO.0b013e3181952478; VANDIJK MA, 1991, MOL CELL ENDOCRINOL, V81, P81, DOI 10.1016/0303-7207(91)90207-9; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wang KP, 2008, J BIOL CHEM, V283, P34029, DOI 10.1074/jbc.M803012200; Wang XC, 2012, INT J ONCOL, V41, P1181, DOI 10.3892/ijo.2012.1568; Yee D, 2012, JNCI-J NATL CANCER I, V104, P975, DOI 10.1093/jnci/djs258; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Zhang XD, 2008, NAT METHODS, V5, P163, DOI [10.1038/nmeth1170, 10.1038/NMETH1170]	50	19	22	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 20	2016	35	42					5515	5526		10.1038/onc.2016.92	http://dx.doi.org/10.1038/onc.2016.92			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EA9XO	27086926	Green Accepted			2022-12-26	WOS:000386998200006
J	Wen, J; Lee, J; Malhotra, A; Nahta, R; Arnold, AR; Buss, MC; Brown, BD; Maier, C; Kenney, AM; Remke, M; Ramaswamy, V; Taylor, MD; Castellino, RC				Wen, J.; Lee, J.; Malhotra, A.; Nahta, R.; Arnold, A. R.; Buss, M. C.; Brown, B. D.; Maier, C.; Kenney, A. M.; Remke, M.; Ramaswamy, V.; Taylor, M. D.; Castellino, R. C.			WIP1 modulates responsiveness to Sonic Hedgehog signaling in neuronal precursor cells and medulloblastoma	ONCOGENE			English	Article							PHOSPHATASE; PATHWAY; PPM1D; SUPPRESSOR; CHILDREN; TUMORS; GROWTH; MODEL; MDM2; MICE	High-level amplification of the protein phosphatase PPM1D (WIP1) is present in a subset of medulloblastomas (MBs) that have an expression profile consistent with active Sonic Hedgehog (SHH) signaling. We found that WIP1 overexpression increased expression of Shh target genes and cell proliferation in response to Shh stimulation in NIH3T3 and cerebellar granule neuron precursor cells in a p53-independent manner. Thus, we developed a mouse in which WIP1 is expressed in the developing brain under control of the Neurod2 promoter (ND2:WIP1). The external granule layer (EGL) in early postnatal ND2:WIP1 mice exhibited increased proliferation and expression of Shh downstream targets. MB incidence increased and survival decreased when ND2:WIP1 mice were crossed with an Shh-activated MB mouse model. Conversely, Wip1 knockout significantly suppressed MB formation in two independent mouse models of Shh-activated MB. Furthermore, Wip1 knockdown or treatment with a WIP1 inhibitor suppressed the effects of Shh stimulation and potentiated the growth inhibitory effects of SHH pathway-inhibiting drugs in Shh-activated MB cells in vitro. This suggests an important cross-talk between SHH and WIP1 pathways that accelerates tumorigenesis and supports WIP1 inhibition as a potential treatment strategy for MB.	[Wen, J.; Lee, J.; Malhotra, A.; Arnold, A. R.; Buss, M. C.; Brown, B. D.; Maier, C.; Kenney, A. M.; Castellino, R. C.] Aflac Canc & Blood Disorders Ctr, Dept Pediat, Atlanta, GA USA; [Nahta, R.; Kenney, A. M.; Castellino, R. C.] Winship Canc Ctr, Atlanta, GA USA; [Nahta, R.; Kenney, A. M.; Castellino, R. C.] Emory Univ, Sch Med, Atlanta, GA USA; [Nahta, R.] Dept Pharmacol, Atlanta, GA USA; [Remke, M.; Taylor, M. D.] Arthur & Sonia Labatt Brain Tumour Res Ctr, Div Neurosurg, Toronto, ON, Canada; [Remke, M.; Taylor, M. D.] Program Dev & Stem Cell Biol, Toronto, ON, Canada; [Ramaswamy, V.] Univ Toronto, Hosp Sick Children, Div Haematol Oncol, Toronto, ON, Canada; [Castellino, R. C.] Childrens Healthcare Atlanta, Atlanta, GA USA	Emory University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Children's Healthcare of Atlanta (CHOA)	Castellino, RC (corresponding author), 1760 Haygood Dr,NE,Room E394, Atlanta, GA 30322 USA.	rccaste@emory.edu	Arnold, Amanda/AAH-6678-2020; Castellino, Robert/GRF-7847-2022	Ramaswamy, Vijay/0000-0002-6557-895X; Taylor, Michael/0000-0001-7009-3466; Malhotra, Anshu/0000-0002-0255-2680; Roe, Caroline/0000-0003-4680-9553; Remke, Marc/0000-0002-9404-9993	NIH [1R01CA172392, CA159859]; St Baldrick's Foundation; CURE Childhood Cancer Foundation; Dr Mildred-Scheel Foundation; NATIONAL CANCER INSTITUTE [R01CA148699, R01CA159859, R01CA172392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061070] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St Baldrick's Foundation; CURE Childhood Cancer Foundation; Dr Mildred-Scheel Foundation(Deutsche Krebshilfe); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We acknowledge Drs James Olson and Xiongbin Lu for providing mice and expression constructs, and Dr Oskar Laur in the Emory University CCCF for plasmid construction. This work was supported by the NIH (1R01CA172392, RCC; CA159859, MDT), St Baldrick's Foundation (RCC), CURE Childhood Cancer Foundation (RCC) and the Dr Mildred-Scheel Foundation (MR).	Abe Y, 2008, P NATL ACAD SCI USA, V105, P4838, DOI 10.1073/pnas.0712216105; Bhatia B, 2010, CELL CYCLE, V9, P4307, DOI 10.4161/cc.9.21.13441; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Burnett ME, 1997, CANCER GENET CYTOGEN, V97, P25, DOI 10.1016/S0165-4608(96)00319-6; Buss MC, 2015, ONCOGENE, V34, P1126, DOI 10.1038/onc.2014.37; Buss MC, 2012, NEURO-ONCOLOGY, V14, P440, DOI 10.1093/neuonc/nos001; Castellino RC, 2008, J NEURO-ONCOL, V86, P245, DOI 10.1007/s11060-007-9470-8; Castellino RC, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-127; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Choi J, 2002, MOL CELL BIOL, V22, P1094, DOI 10.1128/MCB.22.4.1094-1105.2002; Demidov ON, 2007, ONCOGENE, V26, P2502, DOI 10.1038/sj.onc.1210032; Doucette TA, 2012, NEUROSURGERY, V70, P1003, DOI 10.1227/NEU.0b013e31823e5332; Ellison D, 2002, NEUROPATH APPL NEURO, V28, P257, DOI 10.1046/j.1365-2990.2002.00419.x; Ellison DW, 2011, ACTA NEUROPATHOL, V121, P381, DOI 10.1007/s00401-011-0800-8; Emelyanov A, 2015, ONCOGENE, V34, P4429, DOI 10.1038/onc.2014.375; Frank AJ, 2004, MOL BRAIN RES, V121, P137, DOI 10.1016/j.molbrainres.2003.11.016; Gilmartin AG, 2014, NAT CHEM BIOL, V10, P181, DOI [10.1038/NCHEMBIO.1427, 10.1038/nchembio.1427]; Hallahan AR, 2004, CANCER RES, V64, P7794, DOI 10.1158/0008-5472.CAN-04-1813; Hatton BA, 2008, CANCER RES, V68, P1768, DOI 10.1158/0008-5472.CAN-07-5092; Hyman JM, 2009, P NATL ACAD SCI USA, V106, P14132, DOI 10.1073/pnas.0907134106; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Lu XB, 2008, CELL CYCLE, V7, P164, DOI 10.4161/cc.7.2.5299; Marino S, 2000, GENE DEV, V14, P994; Nannenga B, 2006, MOL CARCINOGEN, V45, P594, DOI 10.1002/mc.20195; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Oliver TG, 2005, DEVELOPMENT, V132, P2425, DOI 10.1242/dev.01793; Pandolfi S, 2013, ONCOGENE, V32, P4737, DOI 10.1038/onc.2012.502; Parathath SR, 2008, DEVELOPMENT, V135, P3291, DOI 10.1242/dev.022871; Rayter S, 2008, ONCOGENE, V27, P1036, DOI 10.1038/sj.onc.1210729; Rodon J, 2014, CLIN CANCER RES, V20, P1900, DOI 10.1158/1078-0432.CCR-13-1710; Saito-Ohara F, 2003, CANCER RES, V63, P1876; Samkari A, 2015, EXPERT REV NEUROTHER, V15, P763, DOI 10.1586/14737175.2015.1052796; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Stecca B, 2009, EMBO J, V28, P663, DOI 10.1038/emboj.2009.16; Suresh Kp, 2011, J Hum Reprod Sci, V4, P8, DOI 10.4103/0974-1208.82352; Tabori U, 2010, J CLIN ONCOL, V28, P1345, DOI 10.1200/JCO.2009.23.5952; TORRES CF, 1994, NEW ENGL J MED, V330, P892, DOI 10.1056/NEJM199403313301303; Vanner RJ, 2014, CANCER CELL, V26, P33, DOI 10.1016/j.ccr.2014.05.005; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; von Hoff K, 2009, EUR J CANCER, V45, P1209, DOI 10.1016/j.ejca.2009.01.015; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Yoda A, 2008, J BIOL CHEM, V283, P18969, DOI 10.1074/jbc.M800560200	46	14	14	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 20	2016	35	42					5552	5564		10.1038/onc.2016.96	http://dx.doi.org/10.1038/onc.2016.96			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EA9XO	27086929	Green Accepted			2022-12-26	WOS:000386998200009
J	Wu, JJ; Gao, B; Zhu, SY				Wu, Jiajia; Gao, Bin; Zhu, Shunyi			Single-point mutation-mediated local amphipathic adjustment dramatically enhances antibacterial activity of a fungal defensin	FASEB JOURNAL			English	Article						micasin; peptide structure; MRSA	PRECURSOR LIPID II; ANTIMICROBIAL PEPTIDES; STAPHYLOCOCCUS-WARNERI; EPITHELIAL-CELLS; NATURAL-PRODUCTS; CYSTIC-FIBROSIS; ALPHA-DEFENSINS; BINDING; ANTIBIOTICS; PLECTASIN	The emergence and rapid spread of multiresistant bacteria has lead to an urgent need for novel anti-microbials. Based on single-point substitutions, we generated a series of mutants of micasin, a dermatophytic defensin, with enhanced activities against multiple clinical isolates of Staphylococcus species, including 4 antibiotic-resistant strains. We first mapped the functional surface of micasin by alanine-scanning mutational analysis of its highly exposed residues, through which we found that substitution of site 8 (acidic Glu) dramatically enhanced bacterial killing of this peptide. Structural analysis indicates that this single point mutation could result in a functional local amphipathic architecture. Four different types of side chains (hydrophobic, cationic polar, neutral polar, and acidic polar) were introduced at site 8 to clarify the role of this local architecture in micasin function. The results show that all mutants displayed increased antibacterial activity with the exception of the acidic replacement. These mutants with enhanced activity exhibited low hemolysis and cytotoxicity and showed high serum stability, indicating their therapeutic potential. Our work represents the first example of structural fine-tuning to largely improve the antibacterial potency of a dermatophytic defensin.	[Wu, Jiajia; Gao, Bin; Zhu, Shunyi] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Grp Peptide Biol & Evolut, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS	Zhu, SY (corresponding author), Chinese Acad Sci, 1 Beichen West Rd, Beijing 100101, Peoples R China.	zhusy@ioz.ac.cn			National Natural Science Foundation of China [31570773]; State Key Laboratory of Integrated Management of Pest Insects and Rodents [ChineseIPM1307, ChineseIPM1405, ChineseIPM1512]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Integrated Management of Pest Insects and Rodents	This work was supported by National Natural Science Foundation of China (Grant 31570773) and State Key Laboratory of Integrated Management of Pest Insects and Rodents (Grants ChineseIPM1307, ChineseIPM1405, and ChineseIPM1512). The authors declare no conflicts of interest.	Announ N, 2004, JOINT BONE SPINE, V71, P240, DOI 10.1016/S1297-319X(03)00126-X; Ashitani J, 2004, LIFE SCI, V75, P1123, DOI 10.1016/j.lfs.2004.01.028; Breukink E, 2006, NAT REV DRUG DISCOV, V5, P321, DOI 10.1038/nrd2004; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Butler MS, 2006, BIOCHEM PHARMACOL, V71, P919, DOI 10.1016/j.bcp.2005.10.012; Carlier L, 2015, BIOPHYS CHEM, V196, P40, DOI 10.1016/j.bpc.2014.09.004; Clinical and Laboratory Standards Institute, 2006, M7A7 CLIN LAB STAND; Coates ARM, 2011, BRIT J PHARMACOL, V163, P184, DOI 10.1111/j.1476-5381.2011.01250.x; DAN M, 1984, CAN MED ASSOC J, V131, P211; Dathe M, 1999, BBA-BIOMEMBRANES, V1462, P71, DOI 10.1016/S0005-2736(99)00201-1; Deslouches B, 2005, ANTIMICROB AGENTS CH, V49, P316, DOI 10.1128/AAC.49.1.316-322.2005; Eckert R, 2011, FUTURE MICROBIOL, V6, P635, DOI [10.2217/fmb.11.27, 10.2217/FMB.11.27]; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Gao B, 2010, DEV COMP IMMUNOL, V34, P659, DOI 10.1016/j.dci.2010.01.012; Gao B, 2009, FASEB J, V23, P1230, DOI 10.1096/fj.08-122317; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hasper HE, 2006, SCIENCE, V313, P1636, DOI 10.1126/science.1129818; Hsu STD, 2004, NAT STRUCT MOL BIOL, V11, P963, DOI 10.1038/nsmb830; HULTMARK D, 1982, EUR J BIOCHEM, V127, P207, DOI 10.1111/j.1432-1033.1982.tb06857.x; Hultmark D., 1998, TECHNIQUES INSECT IM, P103; Jain VP, 2011, INT J MOL SCI, V12, P1431, DOI 10.3390/ijms12031431; JENSEN T, 1987, J ANTIMICROB CHEMOTH, V19, P831, DOI 10.1093/jac/19.6.831; KAMATH U, 1992, J CLIN MICROBIOL, V30, P261, DOI 10.1128/JCM.30.2.261-264.1992; Landon C, 2008, PROTEINS, V72, P229, DOI 10.1002/prot.21912; LEHRER RI, 1993, ANNU REV IMMUNOL, V11, P105, DOI 10.1146/annurev.iy.11.040193.000541; Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098; Marr AK, 2006, CURR OPIN PHARMACOL, V6, P468, DOI 10.1016/j.coph.2006.04.006; Matsuzaki K, 1999, BBA-BIOMEMBRANES, V1462, P1, DOI 10.1016/S0005-2736(99)00197-2; Mishra B, 2012, J AM CHEM SOC, V134, P12426, DOI 10.1021/ja305644e; Monk BC, 2014, P NATL ACAD SCI USA, V111, P3865, DOI 10.1073/pnas.1324245111; Mukae H, 2002, THORAX, V57, P623, DOI 10.1136/thorax.57.7.623; Mygind PH, 2005, NATURE, V437, P975, DOI 10.1038/nature04051; NEU HC, 1992, SCIENCE, V257, P1064, DOI 10.1126/science.257.5073.1064; Oeemig JS, 2012, J BIOL CHEM, V287, P42361, DOI 10.1074/jbc.M112.382028; OKRENT DG, 1990, AM REV RESPIR DIS, V141, P179, DOI 10.1164/ajrccm/141.1.179; Romestand B, 2003, EUR J BIOCHEM, V270, P2805, DOI 10.1046/j.1432-1033.2003.03657.x; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; Schroeder BO, 2011, NATURE, V469, P419, DOI 10.1038/nature09674; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Shi N, 2014, ONCOTARGET, V5, P11333, DOI 10.18632/oncotarget.2416; Singh SB, 2006, BIOCHEM PHARMACOL, V71, P1006, DOI 10.1016/j.bcp.2005.12.016; Smrt ST, 2015, J BIOL CHEM, V290, P228, DOI 10.1074/jbc.M114.611657; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Vaara M, 2009, CURR OPIN PHARMACOL, V9, P571, DOI 10.1016/j.coph.2009.08.002; VanWetering S, 1997, J LEUKOCYTE BIOL, V62, P217, DOI 10.1002/jlb.62.2.217; vanWetering S, 1997, AM J PHYSIOL-LUNG C, V272, pL888, DOI 10.1152/ajplung.1997.272.5.L888; WEISS MA, 1990, NATURE, V347, P575, DOI 10.1038/347575a0; Wiedemann I, 2001, J BIOL CHEM, V276, P1772, DOI 10.1074/jbc.M006770200; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Xiong YQ, 2011, ANTIMICROB AGENTS CH, V55, P5325, DOI 10.1128/AAC.00453-11; Yount NY, 2006, BBA-BIOMEMBRANES, V1758, P1373, DOI 10.1016/j.bbamem.2006.03.027; Yount NY, 2004, P NATL ACAD SCI USA, V101, P7363, DOI 10.1073/pnas.0401567101; Zhang LJ, 2005, ANTIMICROB AGENTS CH, V49, P2921, DOI 10.1128/AAC.49.7.2921-2927.2005; Zhu SY, 2008, MOL IMMUNOL, V45, P828, DOI 10.1016/j.molimm.2007.06.354; Zhu SY, 2012, P NATL ACAD SCI USA, V109, P8495, DOI 10.1073/pnas.1201263109	55	14	15	0	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2016	30	7					2602	2614		10.1096/fj.201500157	http://dx.doi.org/10.1096/fj.201500157			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DQ5MM	27084888				2022-12-26	WOS:000379249500015
J	Sadredini, M; Danielsen, TK; Aronsen, JM; Manotheepan, R; Hougen, K; Sjaastad, I; Stokke, MK				Sadredini, Mani; Danielsen, Tore Kristian; Aronsen, Jan Magnus; Manotheepan, Ravinea; Hougen, Karina; Sjaastad, Ivar; Stokke, Mathis Korseberg			Beta-Adrenoceptor Stimulation Reveals Ca2+ Waves and Sarcoplasmic Reticulum Ca2+ Depletion in Left Ventricular Cardiomyocytes from Post-Infarction Rats with and without Heart Failure	PLOS ONE			English	Article							RYANODINE RECEPTOR FUNCTION; SUDDEN CARDIAC DEATH; CALCIUM-RELEASE; DILATED CARDIOMYOPATHY; MYOCARDIAL-INFARCTION; PHOSPHORYLATION; MYOCYTES; CONTRACTILITY; SENSITIVITY; ARRHYTHMOGENESIS	Abnormal cellular Ca2+ handling contributes to both contractile dysfunction and arrhythmias in heart failure. Reduced Ca2+ transient amplitude due to decreased sarcoplasmic reticulum Ca2+ content is a common finding in heart failure models. However, heart failure models also show increased propensity for diastolic Ca2+ release events which occur when sarcoplasmic reticulum Ca2+ content exceeds a certain threshold level. Such Ca2+ release events can initiate arrhythmias. In this study we aimed to investigate if both of these aspects of altered Ca2+ homeostasis could be found in left ventricular cardiomyocytes from rats with different states of cardiac function six weeks after myocardial infarction when compared to sham-operated controls. Video edge-detection, whole-cell Ca2+ imaging and confocal linescan imaging were used to investigate cardiomyocyte contractile properties, Ca2+ transients and Ca2+ waves. In baseline conditions, i. e. without beta-adrenoceptor stimulation, cardiomyocytes from rats with large myocardial infarction, but without heart failure, did not differ from sham-operated animals in any of these aspects of cellular function. However, when exposed to beta-adrenoceptor stimulation, cardiomyocytes from both non-failing and failing rat hearts showed decreased sarcoplasmic reticulum Ca2+ content, decreased Ca2+ transient amplitude, and increased frequency of Ca2+ waves. These results are in line with a decreased threshold for diastolic Ca2+ release established by other studies. In the present study, factors that might contribute to a lower threshold for diastolic Ca2+ release were increased THR286 phosphorylation of Ca2+/calmodulin-dependent protein kinase II and increased protein phosphatase 1 abundance. In conclusion, this study demonstrates both decreased sarcoplasmic reticulum Ca2+ content and increased propensity for diastolic Ca2+ release events in ventricular cardiomyocytes from rats with heart failure after myocardial infarction, and that these phenomena are also found in rats with large myocardial infarctions without heart failure development. Importantly, beta-adrenoceptor stimulation is necessary to reveal these perturbations in Ca2+ handling after a myocardial infarction.	[Sadredini, Mani; Danielsen, Tore Kristian; Aronsen, Jan Magnus; Manotheepan, Ravinea; Hougen, Karina; Sjaastad, Ivar; Stokke, Mathis Korseberg] Oslo Univ Hosp, Expt Med Res Inst, Oslo, Norway; [Sadredini, Mani; Danielsen, Tore Kristian; Aronsen, Jan Magnus; Manotheepan, Ravinea; Hougen, Karina; Sjaastad, Ivar; Stokke, Mathis Korseberg] Univ Oslo, Oslo, Norway; [Sadredini, Mani; Danielsen, Tore Kristian; Manotheepan, Ravinea; Hougen, Karina; Sjaastad, Ivar; Stokke, Mathis Korseberg] Univ Oslo, KG Jebsen Cardiac Res Ctr, Oslo, Norway; [Sadredini, Mani; Danielsen, Tore Kristian; Manotheepan, Ravinea; Hougen, Karina; Sjaastad, Ivar; Stokke, Mathis Korseberg] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway; [Aronsen, Jan Magnus] Bjorknes Coll, Oslo, Norway; [Stokke, Mathis Korseberg] Lovisenberg Diakonale Hosp, Clin Internal Med, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo	Sadredini, M (corresponding author), Oslo Univ Hosp, Expt Med Res Inst, Oslo, Norway.; Sadredini, M (corresponding author), Univ Oslo, Oslo, Norway.; Sadredini, M (corresponding author), Univ Oslo, KG Jebsen Cardiac Res Ctr, Oslo, Norway.; Sadredini, M (corresponding author), Univ Oslo, Ctr Heart Failure Res, Oslo, Norway.	mani.sadredini@medisin.uio.no	Stokke, Mathis/AAJ-9111-2020	Stokke, Mathis/0000-0002-8869-8153; Sadredini, Mani/0000-0001-6015-7411				Ahmmed GU, 2000, CIRC RES, V86, P558, DOI 10.1161/01.RES.86.5.558; Alter P, 2012, INT J CARDIOL, V157, P233, DOI 10.1016/j.ijcard.2011.07.092; Anand IS, 1997, CIRCULATION, V96, P3974, DOI 10.1161/01.cir.96.11.3974; Belevych AE, 2012, CIRC RES, V110, P569, DOI 10.1161/CIRCRESAHA.111.260455; Belevych AE, 2011, CARDIOVASC RES, V90, P493, DOI 10.1093/cvr/cvr025; Bers DM, 2003, CIRC RES, V93, P487, DOI 10.1161/01.RES.0000091871.54907.6B; Bers DM., 2006, ALTERED CARDIAC MYOC, P380; BEUCKELMANN DJ, 1992, CIRCULATION, V85, P1046, DOI 10.1161/01.CIR.85.3.1046; Bokenes J, 2008, BASIC RES CARDIOL, V103, P328, DOI 10.1007/s00395-008-0719-y; Chandrashekhar Y, 1999, J AM COLL CARDIOL, V34, P594, DOI 10.1016/S0735-1097(99)00222-3; Chen WQ, 2014, NAT MED, V20, P184, DOI 10.1038/nm.3440; Chu GX, 2002, CARDIOVASC RES, V54, P105, DOI 10.1016/S0008-6363(02)00230-4; Diaz ME, 2005, CELL CALCIUM, V38, P391, DOI 10.1016/j.ceca.2005.06.017; Eisner DA, 2009, J MOL CELL CARDIOL, V46, P474, DOI 10.1016/j.yjmcc.2008.12.005; Fischer TH, 2014, EUR J HEART FAIL, V16, P1292, DOI 10.1002/ejhf.163; Fujisawa H, 2001, J BIOCHEM-TOKYO, V129, P193, DOI 10.1093/oxfordjournals.jbchem.a002843; Gomez AM, 1997, SCIENCE, V276, P800, DOI 10.1126/science.276.5313.800; Gupta RC, 2003, CARDIAC SR COUPLED P, pH2373; Hobai IA, 2001, CIRCULATION, V103, P1577; Huke S, 2007, J MOL CELL CARDIOL, V42, P590, DOI 10.1016/j.yjmcc.2006.12.007; Ishitani T, 2001, J PHARMACOL EXP THER, V298, P613; Kilic A, 2006, J THORAC CARDIOV SUR, V132, P900, DOI 10.1016/j.jtcvs.2006.07.016; Kubalova Z, 2005, P NATL ACAD SCI USA, V102, P14104, DOI 10.1073/pnas.0504298102; Lehnart SE, 2006, P NATL ACAD SCI USA, V103, P7906, DOI 10.1073/pnas.0602133103; Li M, 2004, CIRCULATION, V109, P120, DOI 10.1161/01.CIR.0000105721.71640.DA; Liu B, 2014, J PHYSIOL-LONDON, V592, P1957, DOI 10.1113/jphysiol.2013.264689; Louch WE, 2013, J MOL CELL CARDIOL, V58, P41, DOI 10.1016/j.yjmcc.2013.01.014; Louch WE, 2011, J MOL CELL CARDIOL, V51, P288, DOI 10.1016/j.yjmcc.2011.06.012; Lunde IG, 2012, CARDIAC O GLCNAC SIG, P162; MacLennan DH, 2009, J PHYSIOL-LONDON, V587, P3113, DOI 10.1113/jphysiol.2009.172155; Marston SB, 2008, J MOL CELL CARDIOL, V45, P603, DOI 10.1016/j.yjmcc.2008.07.004; MUKHARJI J, 1984, AM J CARDIOL, V54, P31, DOI 10.1016/0002-9149(84)90299-6; MUSCH TI, 1986, CIRCULATION, V74, P431, DOI 10.1161/01.CIR.74.2.431; Myles RC, 2015, J PHYSIOL-LONDON, V593, P1479, DOI 10.1113/jphysiol.2014.279638; Neumann J, 1997, J MOL CELL CARDIOL, V29, P265, DOI 10.1006/jmcc.1996.0271; Oda T, 2015, J MOL CELL CARDIOL, V85, P240, DOI 10.1016/j.yjmcc.2015.06.009; Piacentino V, 2003, CIRC RES, V92, P651, DOI 10.1161/01.RES.0000062469.83985.9B; Ribeiro AJS, 2014, ACS APPL MATER INTER, V6, P15516, DOI 10.1021/am5042324; Sanders P, 2004, CIRCULATION, V110, P897, DOI 10.1161/01.CIR.0000139336.69955.AB; SELYE H., 1960, ANGIOLOGY, V11, P398, DOI 10.1177/000331976001100505; Sjaastad I, 2000, J APPL PHYSIOL, V89, P1445, DOI 10.1152/jappl.2000.89.4.1445; Terentyev D, 2003, J PHYSIOL-LONDON, V552, P109, DOI 10.1113/jphysiol.2003.046367; Venetucci LA, 2008, CARDIOVASC RES, V77, P285, DOI 10.1093/cvr/cvm009; Wang QL, 2015, J MOL CELL CARDIOL, V89, P177, DOI 10.1016/j.yjmcc.2015.11.009; Wasserstrom JA, 2000, AM J PHYSIOL-HEART C, V279, pH798, DOI 10.1152/ajpheart.2000.279.2.H798; Wehrens XHT, 2006, P NATL ACAD SCI USA, V103, P511, DOI 10.1073/pnas.0510113103; Wehrens XHT, 2003, CELL, V113, P829, DOI 10.1016/S0092-8674(03)00434-3; Wisloff U, 2001, CARDIOVASC RES, V50, P495, DOI 10.1016/S0008-6363(01)00210-3; Young AA, 2001, CARDIOVASC RES, V49, P308, DOI 10.1016/S0008-6363(00)00248-0; Zhao ZZ, 2012, AM J PHYSIOL-HEART C, V302, pH1636, DOI 10.1152/ajpheart.00742.2011	50	11	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153887	10.1371/journal.pone.0153887	http://dx.doi.org/10.1371/journal.pone.0153887			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096943	Green Published, gold, Green Submitted			2022-12-26	WOS:000374543600066
J	Schmidt-Richberg, A; Ledig, C; Guerrero, R; Molina-Abril, H; Frangi, A; Rueckert, D				Schmidt-Richberg, Alexander; Ledig, Christian; Guerrero, Ricardo; Molina-Abril, Helena; Frangi, Alejandro; Rueckert, Daniel		Alzheimer's Dis Neuroimaging	Learning Biomarker Models for Progression Estimation of Alzheimer's Disease	PLOS ONE			English	Article							TRANSITION-PROBABILITIES; QUANTILE REGRESSION; TIME; ATLAS; CLASSIFICATION; CONSTRUCTION; ATROPHY; POINT; RATES	Being able to estimate a patient's progress in the course of Alzheimer's disease and predicting future progression based on a number of observed biomarker values is of great interest for patients, clinicians and researchers alike. In this work, an approach for disease progress estimation is presented. Based on a set of subjects that convert to a more severe disease stage during the study, models that describe typical trajectories of biomarker values in the course of disease are learned using quantile regression. A novel probabilistic method is then derived to estimate the current disease progress as well as the rate of progression of an individual by fitting acquired biomarkers to the models. A particular strength of the method is its ability to naturally handle missing data. This means, it is applicable even if individual biomarker measurements are missing for a subject without requiring a retraining of the model. The functionality of the presented method is demonstrated using synthetic and -employing cognitive scores and image-based biomarkers-real data from the ADNI study. Further, three possible applications for progress estimation are demonstrated to underline the versatility of the approach: classification, construction of a spatio-temporal disease progression atlas and prediction of future disease progression.	[Schmidt-Richberg, Alexander; Ledig, Christian; Guerrero, Ricardo; Rueckert, Daniel] Univ London Imperial Coll Sci Technol & Med, Biomed Image Anal Grp, London, England; [Molina-Abril, Helena; Frangi, Alejandro] Univ Sheffield, Ctr Computat Imaging & Simulat Technol Biomed CIS, Sheffield, S Yorkshire, England	Imperial College London; University of Sheffield	Schmidt-Richberg, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Biomed Image Anal Grp, London, England.	alexander.schmidt-richberg@philips.com	Frangi, Alejandro F/C-6500-2008	Frangi, Alejandro F/0000-0002-2675-528X; Molina-Abril, Helena/0000-0001-5595-132X; Ledig, Christian/0000-0003-4862-3138	VPH-DARE@IT [FP7-ICT-2011-9-601055]	VPH-DARE@IT	This work was supported by VPH-DARE@IT, project identifier: FP7-ICT-2011-9-601055 (funding of ASR).	Bron E, 2015, NEUROIMAGE UNPUB; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Caro JJ, 2001, NEUROLOGY, V57, P964, DOI 10.1212/WNL.57.6.964; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Coley N, 2011, ALZHEIMERS DEMENT, V7, P602, DOI 10.1016/j.jalz.2011.01.005; Cuingnet R, 2011, NEUROIMAGE, V56, P766, DOI 10.1016/j.neuroimage.2010.06.013; Davis BC, 2010, INT J COMPUT VISION, V90, P255, DOI 10.1007/s11263-010-0367-1; Delor I, 2013, CPT-PHARMACOMET SYST, V2, DOI 10.1038/psp.2013.54; Donohue MC, 2014, ALZHEIMERS DEMENT, V10, pS400, DOI 10.1016/j.jalz.2013.10.003; Doody RS, 2010, ALZHEIMERS RES THER, V2, DOI [10.1186/alzrt25, 10.1186/alzrt38]; Doody RS, 2001, ARCH NEUROL-CHICAGO, V58, P449, DOI 10.1001/archneur.58.3.449; Durrleman S, 2013, INT J COMPUT VISION, V103, P22, DOI 10.1007/s11263-012-0592-x; Fonteijn HM, 2012, NEUROIMAGE, V60, P1880, DOI 10.1016/j.neuroimage.2012.01.062; Gaser C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067346; Gray KR, 2013, NEUROIMAGE, V65, P167, DOI 10.1016/j.neuroimage.2012.09.065; Green C, 2011, VALUE HEALTH, V14, P621, DOI 10.1016/j.jval.2010.12.008; Grundman M, 2004, ARCH NEUROL-CHICAGO, V61, P59, DOI 10.1001/archneur.61.1.59; Guerrero R, 2014, NEUROIMAGE, V94, P275, DOI 10.1016/j.neuroimage.2014.03.036; Guerrero R, 2014, LECT NOTES COMPUT SC, V8679, P77, DOI 10.1007/978-3-319-10581-9_10; Hastie T., 1986, STAT SCI, V1, P297; Henneman WJP, 2009, NEUROLOGY, V72, P999, DOI 10.1212/01.wnl.0000344568.09360.31; Hua X, 2010, NEUROIMAGE, V51, P63, DOI 10.1016/j.neuroimage.2010.01.104; Jack CR, 2013, NEURON, V80, P1347, DOI 10.1016/j.neuron.2013.12.003; Jack CR, 2012, ARCH NEUROL-CHICAGO, V69, P856, DOI 10.1001/archneurol.2011.3405; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jack CR, 2004, NEUROLOGY, V62, P591, DOI 10.1212/01.WNL.0000110315.26026.EF; Joshi S, 2004, NEUROIMAGE, V23, pS151, DOI 10.1016/j.neuroimage.2004.07.068; Kazemi K, 2007, NEUROIMAGE, V37, P463, DOI 10.1016/j.neuroimage.2007.05.004; Koenker R., 2010, ECONOMETRIC SOC MONO, V2005, P295; Ledig C, 2015, MED IMAGE ANAL, V21, P40, DOI 10.1016/j.media.2014.12.003; Li CX, 2015, BIOMETRICS, V71, P625, DOI 10.1111/biom.12313; Lorenzi M, 2015, NEUROIMAGE, V115, P224, DOI 10.1016/j.neuroimage.2015.04.051; Lorenzi M, 2015, NEUROBIOL AGING, V36, pS42, DOI 10.1016/j.neurobiolaging.2014.07.046; Moradi E, 2014, NEUROIMAGE IN PRESS; Neumann PJ, 2001, NEUROLOGY, V57, P957, DOI 10.1212/WNL.57.6.957; Razlighi QR, 2014, J ALZHEIMERS DIS, V38, P661, DOI 10.3233/JAD-131142; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Sabuncu MR, 2014, NEUROIMAGE, V97, P9, DOI 10.1016/j.neuroimage.2014.04.015; Schmidt-Richberg Alexander, 2015, Inf Process Med Imaging, V24, P387, DOI 10.1007/978-3-319-19992-4_30; Schuh A, 2014, SPATIO TEMP IN PRESS; Serag A, 2012, NEUROIMAGE, V59, P2255, DOI 10.1016/j.neuroimage.2011.09.062; Sherwood B, 2015, ALZHEIMERS DEMENTIA; Singh N, 2014, MED IMAGE ANAL, V18, P616, DOI 10.1016/j.media.2014.01.001; Spackman DE, 2012, CURR ALZHEIMER RES, V9, P1050; Stallard E, 2010, MED DECIS MAKING, V30, P625, DOI 10.1177/0272989X10363479; Wolz R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025446; Yang E, 2011, J ALZHEIMERS DIS, V26, P745, DOI 10.3233/JAD-2011-110551; Yee TW, 2004, STAT MED, V23, P2295, DOI 10.1002/sim.1822; Yeo IK, 2000, BIOMETRIKA, V87, P954, DOI 10.1093/biomet/87.4.954; Young AL, 2014, BRAIN, V137, P2564, DOI 10.1093/brain/awu176	50	15	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153040	10.1371/journal.pone.0153040	http://dx.doi.org/10.1371/journal.pone.0153040			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096739	Green Published, Green Accepted, gold			2022-12-26	WOS:000374543600025
J	Sun, DL; Lee, TMC; Wang, ZX; Chan, CCH				Sun, Delin; Lee, Tatia M. C.; Wang, Zhaoxin; Chan, Chetwyn C. H.			Unfolding the Spatial and Temporal Neural Processing of Making Dishonest Choices	PLOS ONE			English	Article							ERROR-RELATED NEGATIVITY; SOCIAL DECISION-MAKING; RISK-TAKING; SOURCE RECONSTRUCTION; DECEPTIVE RESPONSES; EXECUTIVE PROCESSES; PREFRONTAL CORTEX; HUMAN AWARENESS; INSULA; GAME	To understand the neural processing that underpins dishonest behavior in an economic exchange game task, this study employed both functional magnetic resonance imaging (fMRI) and event-related potential (ERP) methodologies to examine the neural conditions of 25 participants while they were making either dishonest or honest choices. It was discovered that dishonest choices, contrary to honest choices, elicited stronger fMRI activations in bilateral striatum and anterior insula. It also induced fluctuations in ERP amplitudes within two time windows, which are 270-30 milliseconds before and 110-290 milliseconds after the response, respectively. Importantly, when making either dishonest or honest choices, human and computer counterparts were associated with distinct fMRI activations in the left insula and different ERP amplitudes at medial and right central sites from 80 milliseconds before to 250 milliseconds after the response. These results support the hypothesis that there would be distinct neural processing during making dishonest decisions, especially when the subject considers the interests of the counterpart. Furthermore, the fMRI and ERP findings, together with ERP source reconstruction, clearly delineate the temporal sequence of the neural processes of a dishonest decision: the striatum is activated before response, then the left insula is involved around the time of response, and finally the thalamus is activated after response.	[Sun, Delin; Lee, Tatia M. C.] Univ Hong Kong, Neuropsychol Lab, Hong Kong, Hong Kong, Peoples R China; [Sun, Delin; Lee, Tatia M. C.] Univ Hong Kong, Lab Cognit Affect Neurosci, Hong Kong, Hong Kong, Peoples R China; [Lee, Tatia M. C.] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China; [Wang, Zhaoxin] E China Normal Univ, Sch Psychol & Cognit Sci, Inst Cognit Neurosci, Key Lab Brain Funct Genom MOE & STCSM, Shanghai 200062, Peoples R China; [Chan, Chetwyn C. H.] Hong Kong Polytech Univ, Dept Rehabil Sci, Appl Cognit Neurosci Lab, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; East China Normal University; Hong Kong Polytechnic University	Lee, TMC (corresponding author), Univ Hong Kong, Neuropsychol Lab, Hong Kong, Hong Kong, Peoples R China.; Lee, TMC (corresponding author), Univ Hong Kong, Lab Cognit Affect Neurosci, Hong Kong, Hong Kong, Peoples R China.; Lee, TMC (corresponding author), Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China.; Chan, CCH (corresponding author), Hong Kong Polytech Univ, Dept Rehabil Sci, Appl Cognit Neurosci Lab, Hong Kong, Hong Kong, Peoples R China.	tmclee@hku.hk; chetwyn.chan@polyu.edu.hk	Sun, Delin/H-8070-2019	Sun, Delin/0000-0003-3283-423X; Chan, Chetwyn C. H./0000-0003-0307-6337	University of Hong Kong; National Natural Science Fund of China [31070986]; KKHo International Charitable Foundation	University of Hong Kong(University of Hong Kong); National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); KKHo International Charitable Foundation	This work was supported by The University of Hong Kong May Endowed Professorship in Neuropsychology and the National Natural Science Fund of China (Ref: 31070986). The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding to pay the Open Access publication charges for this article was provided by the the KKHo International Charitable Foundation.	Abe N, 2014, BRAIN COGNITION, V90, P41, DOI 10.1016/j.bandc.2014.06.005; Baumgartner T, 2009, NEURON, V64, P756, DOI 10.1016/j.neuron.2009.11.017; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; BERG P, 1994, ELECTROEN CLIN NEURO, V90, P229, DOI 10.1016/0013-4694(94)90094-9; Bernhardt BC, 2012, ANNU REV NEUROSCI, V35, P1, DOI 10.1146/annurev-neuro-062111-150536; Craig AD, 2011, ANN NY ACAD SCI, V1225, P72, DOI 10.1111/j.1749-6632.2011.05990.x; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; de Vignemont F, 2006, TRENDS COGN SCI, V10, P435, DOI 10.1016/j.tics.2006.08.008; Duerden EG, 2013, NEUROIMAGE, V78, P159, DOI 10.1016/j.neuroimage.2013.04.014; Fehr E, 2007, TRENDS COGN SCI, V11, P419, DOI 10.1016/j.tics.2007.09.002; Friston KJ, 2008, NEUROIMAGE, V39, P1104, DOI 10.1016/j.neuroimage.2007.09.048; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Greene JD, 2009, P NATL ACAD SCI USA, V106, P12506, DOI 10.1073/pnas.0900152106; Haxby JV, 2002, BIOL PSYCHIAT, V51, P59, DOI 10.1016/S0006-3223(01)01330-0; Henson RN, 2010, HUM BRAIN MAPP, V31, P1512, DOI 10.1002/hbm.20956; Hilbig BE, 2009, J RES PERS, V43, P516, DOI 10.1016/j.jrp.2009.01.003; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Johnson R, 2005, COGNITIVE BRAIN RES, V24, P386, DOI 10.1016/j.cogbrainres.2005.02.011; Johnson R, 2008, NEUROIMAGE, V39, P469, DOI 10.1016/j.neuroimage.2007.08.032; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Knutson B, 2007, J NEUROSCI, V27, P8174, DOI 10.1523/JNEUROSCI.1564-07.2007; Knutson B, 2007, NEURON, V53, P147, DOI 10.1016/j.neuron.2006.11.010; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Krajbich I, 2009, J NEUROSCI, V29, P2188, DOI 10.1523/JNEUROSCI.5086-08.2009; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Lee TMC, 2009, CEREB CORTEX, V19, P1303, DOI 10.1093/cercor/bhn172; Litvak V, 2008, NEUROIMAGE, V42, P1490, DOI 10.1016/j.neuroimage.2008.06.022; Montague PR, 2007, NEURON, V56, P14, DOI 10.1016/j.neuron.2007.09.020; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Platt ML, 2008, NAT NEUROSCI, V11, P398, DOI 10.1038/nn2062; Rilling JK, 2008, NEUROPSYCHOLOGIA, V46, P1256, DOI 10.1016/j.neuropsychologia.2007.11.033; Rilling JK, 2011, ANNU REV PSYCHOL, V62, P23, DOI 10.1146/annurev.psych.121208.131647; ROGERS CR, 1964, J ABNORM SOC PSYCH, V68, P160, DOI 10.1037/h0046419; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; SAXE L, 1991, AM PSYCHOL, V46, P409, DOI 10.1037/0003-066X.46.4.409; Schiff ND, 2008, ANN NY ACAD SCI, V1129, P105, DOI 10.1196/annals.1417.029; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x; Sip KE, 2010, NEUROPSYCHOLOGIA, V48, P3619, DOI 10.1016/j.neuropsychologia.2010.08.013; Sun DL, 2015, CEREB CORTEX, V25, P927, DOI 10.1093/cercor/bht284; Sun DL, 2015, NEUROPSYCHOLOGIA, V68, P148, DOI 10.1016/j.neuropsychologia.2015.01.013; van den Bos W, 2009, SOC COGN AFFECT NEUR, V4, P294, DOI 10.1093/scan/nsp009; Vrij A., 2004, DETECTION DECEPTION; Wager TD, 2005, NEUROIMAGE, V26, P99, DOI 10.1016/j.neuroimage.2005.01.011; Wu DC, 2011, BRAIN RES, V1389, P115, DOI 10.1016/j.brainres.2011.02.084; Yu RJ, 2009, J COGNITIVE NEUROSCI, V21, P684, DOI 10.1162/jocn.2009.21034; Zhang HJ, 2012, BRAIN BEHAV, V2, P415, DOI 10.1002/brb3.62	48	10	11	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153660	10.1371/journal.pone.0153660	http://dx.doi.org/10.1371/journal.pone.0153660			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9OU	27096474	gold, Green Published			2022-12-26	WOS:000374543600048
J	Verstraelen, H; Vervaet, C; Remon, JP				Verstraelen, Hans; Vervaet, Chris; Remon, Jean-Paul			Rationale and Safety Assessment of a Novel Intravaginal Drug-Delivery System with Sustained DL-Lactic Acid Release, Intended for Long-Term Protection of the Vaginal Microbiome	PLOS ONE			English	Article							MUCOSAL IRRITATION TEST; BACTERIAL-VAGINOSIS; ORAL METRONIDAZOLE; LOCAL TOLERANCE; HEALTH; MECHANISMS; GLYCOGEN; FLUID; FORMULATIONS; NONOXYNOL-9	Bacterial vaginosis is a prevalent state of dysbiosis of the vaginal microbiota with wide-ranging impact on human reproductive health. Based on recent insights in community ecology of the vaginal microbiome, we hypothesize that sustained vaginal DL-lactic acid enrichment will enhance the recruitment of lactobacilli, while counteracting bacterial vaginosis-associated bacteria. We therefore aimed to develop an intravaginal device that would be easy to insert and remove, while providing sustained DL-lactic acid release into the vaginal lumen. The final prototype selected is a vaginal ring matrix system consisting of a mixture of ethylene vinyl acetate and methacrylic acid -methyl methacrylate copolymer loaded with 150 mg DL -lactic acid with an UD-lactic acid ratio of 1:1. Preclinical safety assessment was performed by use of the Slug Mucosal Irritation test, a non-vertebrate assay to evaluate vaginal mucosal irritation, which revealed no irritation. Clinical safety was evaluated in a phase I trial with six healthy nulliparous premenopausal volunteering women, with the investigational drug left in place for 7 days. Colposcopic monitoring according to the WHO/CONRAD guidelines for the evaluation of vaginal products, revealed no visible cervicovaginal mucosal changes. No adverse events related to the investigational product occurred. Total release from the intravaginal ring over 7 days was estimated through high performance liquid chromatography at 37.1 (standard deviation 0.9) mg DL -lactic acid. Semisolid lactic acid formulations have been studied to a limited extent in the past and typically consist of a large volume of excipients and very high doses of lactic acid, which is of major concern to mucosal safety. We have documented the feasability of enriching the vaginal environment with pure DL -lactic acid with a prototype intravaginal ring. Though the efficacy of this platform remains to be established possibly requiring further development, this approach may offer a novel avenue to modulate and protect the vaginal microbiota.	[Verstraelen, Hans] Univ Ghent, Dept Obstet & Gynaecol, Fac Med & Hlth Sci, B-9000 Ghent, Belgium; [Vervaet, Chris; Remon, Jean-Paul] Univ Ghent, Dept Pharmaceut, Lab Pharmaceut Technol, Fac Pharmaceut Sci, B-9000 Ghent, Belgium	Ghent University; Ghent University	Verstraelen, H (corresponding author), Univ Ghent, Dept Obstet & Gynaecol, Fac Med & Hlth Sci, B-9000 Ghent, Belgium.	hans.verstraelen@ugent.be	Verstraelen, Hans/A-5602-2008; Verstraelen, Hans/AAA-8694-2019	Verstraelen, Hans/0000-0002-4070-1587	Ghent University Industrial Research Fund (IOF) [F2011/IOF-Advanced/131]	Ghent University Industrial Research Fund (IOF)	The study was funded by the Ghent University Industrial Research Fund (IOF) under grant number F2011/IOF-Advanced/131, http://www.techtransfer.ugent.be/en/support-for-academics/industrial-research-fund. HV, CV, and JPR obtained funding through this grant for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaens E, 2002, TOXICOL APPL PHARM, V182, P169, DOI 10.1006/taap.2002.9444; Adriaens E, 2008, SEX TRANSM DIS, V35, P512, DOI 10.1097/OLQ.0b013e3181644669; Aldunate M, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00164; Aldunate M, 2013, J ANTIMICROB CHEMOTH, V68, P2015, DOI 10.1093/jac/dkt156; ANDERSCH B, 1990, GYNECOL OBSTET INVES, V30, P114, DOI 10.1159/000293230; Aroutcheva A, 2001, AM J OBSTET GYNECOL, V185, P375, DOI 10.1067/mob.2001.115867; Bilardi JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074378; Blaser MJ, 2009, NAT REV MICROBIOL, V7, P887, DOI 10.1038/nrmicro2245; BOEKE AJP, 1993, GENITOURIN MED, V69, P388; Brache V, 2010, CONTRACEPTION, V82, P418, DOI 10.1016/j.contraception.2010.04.012; Bradshaw CS, 2006, J INFECT DIS, V193, P1478, DOI 10.1086/503780; Brotman RM, 2011, J CLIN INVEST, V121, P4610, DOI 10.1172/JCI57172; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Decena DCD, 2006, J OBSTET GYNAECOL RE, V32, P243, DOI 10.1111/j.1447-0756.2006.00383.x; Des Jarlais DC, 2004, AM J PUBLIC HEALTH, V94, P361, DOI 10.2105/AJPH.94.3.361; Dhondt MMM, 2005, EUR J PHARM BIOPHARM, V60, P419, DOI 10.1016/j.ejpb.2005.01.012; Dhondt MMM, 2004, SEX TRANSM DIS, V31, P229, DOI 10.1097/01.OLQ.0000118422.62336.FA; Fichorova RN, 2015, TOXICOL APPL PHARM, V285, P198, DOI 10.1016/j.taap.2015.02.017; Fichorova RN, 2001, J INFECT DIS, V184, P418, DOI 10.1086/322047; Gong Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107758; GREAVES WL, 1988, OBSTET GYNECOL, V72, P799; Hay P, 2009, CURR OPIN INFECT DIS, V22, P82, DOI 10.1097/QCO.0b013e32832180c6; Hladik F, 2015, ELIFE, V4, DOI 10.7554/eLife.04525; HOLST E, 1990, SCAND J INFECT DIS, V22, P625, DOI 10.3109/00365549009027109; Homayouni A, 2014, J LOW GENIT TRACT DI, V18, P79, DOI 10.1097/LGT.0b013e31829156ec; Huang HH, 2014, ARCH GYNECOL OBSTET, V289, P1225, DOI 10.1007/s00404-013-3117-0; Hussain A, 2005, J CONTROL RELEASE, V103, P301, DOI 10.1016/j.jconrel.2004.11.034; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Karlyshev AV, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01221-13; Koumans EH, 2007, SEX TRANSM DIS, V34, P864, DOI 10.1097/OLQ.0b013e318074e565; Linhares I. M., 2011, AM J OBSTET GYNECOL, V120, P1, DOI [10.1016/j.ajog.2010.07.010, DOI 10.1016/J.AJOG.2010.07.010, DOI 10.1016/J.AJ0G.2010.07.010]; Lopes dos Santos Santiago G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045281; Macklaim JM, 2011, P NATL ACAD SCI USA, V108, P4688, DOI 10.1073/pnas.1000086107; Martin DH, 2012, AM J MED SCI, V343, P2, DOI 10.1097/MAJ.0b013e31823ea228; Martin R, 2009, INT MICROBIOL, V11, P261, DOI 10.2436/20.1501.01.70; Mastromarino P, 2013, NEW MICROBIOL, V36, P229; Mendes-Soares H, 2014, J BACTERIOL, V196, P1458, DOI 10.1128/JB.01439-13; Mirmonsef P, 2015, MENOPAUSE, V22, P702, DOI 10.1097/GME.0000000000000397; Mirmonsef P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102467; Mirmonsef P, 2012, AIDS RES HUM RETROV, V28, P76, DOI [10.1089/AID.2011.0071, 10.1089/aid.2011.0071]; Nasioudis D, 2015, REPROD SCI, V22, P1393, DOI 10.1177/1933719115581000; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; O'Hanlon DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080074; O'Hanlon DE, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-200; Ojala T, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1070; Payne SC, 2010, J AM ACAD NURSE PRAC, V22, P101, DOI 10.1111/j.1745-7599.2009.00474.x; PHEIFER TA, 1978, NEW ENGL J MED, V298, P1429, DOI 10.1056/NEJM197806292982601; Power SE, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.01070-13; Ravel J, 2012, MBIO, V3, DOI 10.1128/mBio.00370-12; Reid G, 2015, AM J REPROD IMMUNOL, V73, P1, DOI 10.1111/aji.12319; Senok AC, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006289.pub2; Sirota I, 2014, SEMIN REPROD MED, V32, P35, DOI 10.1055/s-0033-1361821; Smith-McCune K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129769; Sobel JD, 2006, AM J OBSTET GYNECOL, V194, P1283, DOI 10.1016/j.ajog.2005.11.041; Spear GT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132646; Spear GT, 2014, J INFECT DIS, V210, P1019, DOI 10.1093/infdis/jiu231; Srinivasan S, 2015, MBIO, V6, DOI 10.1128/mBio.00204-15; Stumpf RM, 2013, AM J PHYS ANTHROPOL, V152, P119, DOI 10.1002/ajpa.22395; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; van de Wijgert JHHM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105998; van Oostrum N, 2013, HUM REPROD, V28, P1809, DOI 10.1093/humrep/det096; Verstraelen H, 2013, CURR OPIN INFECT DIS, V26, P86, DOI 10.1097/QCO.0b013e32835c20cd; Verstraelen H, 2009, EXPERT REV ANTI-INFE, V7, P1109, DOI [10.1586/eri.09.87, 10.1586/ERI.09.87]; Verstraelen H, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-116; WHO/CONRAD, 2004, MAN STAND COLP EV VA; Witkin SS, 2015, BJOG-INT J OBSTET GY, V122, P213, DOI 10.1111/1471-0528.13115; Witkin SS, 2013, MBIO, V4, DOI 10.1128/mBio.00460-13; Yeoman CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056111; Yildirim S, 2014, ISME J, V8, P2431, DOI 10.1038/ismej.2014.90	69	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153441	10.1371/journal.pone.0153441	http://dx.doi.org/10.1371/journal.pone.0153441			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093291	Green Published, gold, Green Submitted			2022-12-26	WOS:000374541200021
J	Corkrey, R; McMeekin, TA; Bowman, JP; Ratkowsky, DA; Olley, J; Ross, T				Corkrey, Ross; McMeekin, Tom A.; Bowman, John P.; Ratkowsky, David A.; Olley, June; Ross, Tom			The Biokinetic Spectrum for Temperature	PLOS ONE			English	Article							PROTEIN-FOLDING THERMODYNAMICS; SACCHAROMYCES-CEREVISIAE; QUANTILE REGRESSION; METABOLIC THEORY; SYSTEMS BIOLOGY; GROWTH-RATE; LIFE; THERMOSTABILITY; ADAPTATION; HYPOTHESIS	We identify and describe the distribution of temperature-dependent specific growth rates for life on Earth, which we term the biokinetic spectrum for temperature. The spectrum has the potential to provide for more robust modeling in thermal ecology since any conclusions derived from it will be based on observed data rather than using theoretical assumptions. It may also provide constraints for systems biology model predictions and provide insights in physiology. The spectrum has Delta-shape with a sharp peak at around 42 degrees C. At higher temperatures up to 60 degrees C there was a gap of attenuated growth rates. We found another peak at 67 degrees C and a steady decline in maximum rates thereafter. By using Bayesian quantile regression to summarise and explore the data we were able to conclude that the gap represented an actual biological transition between mesophiles and thermophiles that we term the Mesophile-Thermophile Gap ( MTG). We have not identified any organism that grows above the maximum rate of the spectrum. We used a thermodynamic model to recover the Delta-shape, suggesting that the growth rate limits arise from a trade-off between activity and stability of proteins. The spectrum provides underpinning principles that will find utility in models concerned with the thermal responses of biological processes.	[Corkrey, Ross; McMeekin, Tom A.; Bowman, John P.; Ratkowsky, David A.; Olley, June; Ross, Tom] Univ Tasmania, Sch Land & Food, Tasmanian Inst Agr, Hobart, Tas, Australia	University of Tasmania	Corkrey, R (corresponding author), Univ Tasmania, Sch Land & Food, Tasmanian Inst Agr, Hobart, Tas, Australia.	scorkrey@utas.edu.au	Bowman, John P/C-2414-2014; Bowman, John P./ABF-5108-2020; Corkrey, Stephen/C-2424-2014	Bowman, John P/0000-0002-4528-9333; Bowman, John P./0000-0002-4528-9333; Corkrey, Stephen/0000-0002-2242-2891; Ross, Tom/0000-0001-9916-7772				BALDWIN RL, 1986, P NATL ACAD SCI USA, V83, P8069, DOI 10.1073/pnas.83.21.8069; Bissinger JE, 2008, LIMNOL OCEANOGR, V53, P487, DOI 10.4319/lo.2008.53.2.0487; Brocchieri L, 2005, NUCLEIC ACIDS RES, V33, P3390, DOI 10.1093/nar/gki615; Brooks SP, 1998, J ROY STAT SOC D-STA, V47, P69, DOI 10.1111/1467-9884.00117; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Clarke A, 2006, FUNCT ECOL, V20, P405, DOI 10.1111/j.1365-2435.2006.01109.x; Clarke A, 2014, INT J ASTROBIOL, V13, P141, DOI 10.1017/S1473550413000438; Corkrey R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096100; Corkrey R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032003; Cruz ALB, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-151; Das Rajdeep, 2000, Functional and Integrative Genomics, V1, P76, DOI 10.1007/s101420050009; Davies PCW, 2005, ASTROBIOLOGY, V5, P154, DOI 10.1089/ast.2005.5.154; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; EPPLEY RW, 1972, FISH B-NOAA, V70, P1063; Gilks W.R., 1996, MARKOV CHAIN MONTE C, P89; GILKS WR, 1994, STATISTICIAN, V43, P179, DOI 10.2307/2348942; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Haario H, 2001, BERNOULLI, V7, P223, DOI 10.2307/3318737; Hulbert AJ, 2014, SYSTEMS, V2, P186, DOI 10.3390/systems2020186; Iyer-Biswas S, 2014, P NATL ACAD SCI USA, V111, P15912, DOI 10.1073/pnas.1403232111; Kirk PDW, 2015, SCIENCE, V350, P386, DOI 10.1126/science.aac9505; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; KOCH AL, 1988, CAN J MICROBIOL, V34, P421, DOI 10.1139/m88-074; Kumar S, 2001, CELL MOL LIFE SCI, V58, P1216, DOI 10.1007/PL00000935; LIESACK W, 1992, BIODIVERS CONSERV, V1, P250, DOI 10.1007/BF00693763; MAKHATADZE GI, 1993, J MOL BIOL, V232, P639, DOI 10.1006/jmbi.1993.1416; MURPHY KP, 1990, SCIENCE, V247, P559, DOI 10.1126/science.2300815; PIRT SJ, 1982, ARCH MICROBIOL, V133, P300, DOI 10.1007/BF00521294; Postmus J, 2008, J BIOL CHEM, V283, P23524, DOI 10.1074/jbc.M802908200; Postmus J, 2011, MICROBIOL-SGM, V157, P3500, DOI 10.1099/mic.0.050039-0; PRIVALOV PL, 1988, ADV PROTEIN CHEM, V39, P191; PRIVALOV PL, 1993, J MOL BIOL, V232, P660, DOI 10.1006/jmbi.1993.1417; Ratkowsky DA, 2005, J THEOR BIOL, V233, P351, DOI 10.1016/j.jtbi.2004.10.016; RATKOWSKY DA, 1983, J BACTERIOL, V154, P1222, DOI 10.1128/JB.154.3.1222-1226.1983; Ross T, 1993, THESIS U TASMANIA HO; Ross T., 1997, INT INST REFRIG, P64; Sabath N, 2013, GENOME BIOL EVOL, V5, P966, DOI 10.1093/gbe/evt050; Thompson MJ, 1999, J MOL BIOL, V290, P595, DOI 10.1006/jmbi.1999.2889; Torsvik V, 2002, SCIENCE, V296, P1064, DOI 10.1126/science.1071698; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; WIEGEL J, 1990, FEMS MICROBIOL LETT, V75, P155, DOI 10.1016/0378-1097(90)90529-Y; Yu KM, 2001, STAT PROBABIL LETT, V54, P437, DOI 10.1016/S0167-7152(01)00124-9; Zhang JZ, 2000, TRENDS GENET, V16, P107, DOI 10.1016/S0168-9525(99)01922-8	43	19	19	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153343	10.1371/journal.pone.0153343	http://dx.doi.org/10.1371/journal.pone.0153343			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088362	gold, Green Published, Green Submitted			2022-12-26	WOS:000374527000019
J	Huang, KH; Mychack, A; Tchorzewski, L; Janakiraman, A				Huang, Kuo-Hsiang; Mychack, Aaron; Tchorzewski, Lukasz; Janakiraman, Anuradha			Characterization of the FtsZ C-Terminal Variable (CTV) Region in Z-Ring Assembly and Interaction with the Z-Ring Stabilizer ZapD in E. coli Cytokinesis	PLOS ONE			English	Article							CELL-DIVISION PROTEIN; CRYSTAL-STRUCTURE; FUNCTIONAL ANALYSES; IN-VITRO; ZIPA; PROMOTES; BINDING; TAIL; SUPERRESOLUTION; LOCALIZATION	Polymerization of a ring-like cytoskeletal structure, the Z-ring, at midcell is a highly conserved feature in virtually all bacteria. The Z-ring is composed of short protofilaments of the tubulin homolog FtsZ, randomly arranged and held together through lateral interactions. In vitro, lateral associations between FtsZ protofilaments are stabilized by crowding agents, high concentrations of divalent cations, or in some cases, low pH. In vivo, the last 4-10 amino acid residues at the C-terminus of FtsZ (the C-terminal variable region, CTV) have been implicated in mediating lateral associations between FtsZ protofilaments through charge shielding. Multiple Z-ring associated proteins (Zaps), also promote lateral interactions between FtsZ protofilaments to stabilize the FtsZ ring in vivo. Here we characterize the complementary role/s of the CTV of E. coli FtsZ and the FtsZ-ring stabilizing protein ZapD, in FtsZ assembly. We show that the net charge of the FtsZ CTV not only affects FtsZ protofilament bundling, confirming earlier observations, but likely also the length of the FtsZ protofilaments in vitro. The CTV residues also have important consequences for Z-ring assembly and interaction with ZapD in the cell. ZapD requires the FtsZ CTV region for interaction with FtsZ in vitro and for localization to midcell in vivo. Our data suggest a mechanism in which the CTV residues, particularly K380, facilitate a conformation for the conserved carboxy-terminal residues in FtsZ, that lie immediately N-terminal to the CTV, to enable optimal contact with ZapD. Further, phylogenetic analyses suggest a correlation between the nature of FtsZ CTV residues and the presence of ZapD in the beta-gamma-proteobacterial species.	[Huang, Kuo-Hsiang; Mychack, Aaron; Tchorzewski, Lukasz; Janakiraman, Anuradha] CUNY City Coll, Dept Biol, 160 Convent Ave,MR 526, New York, NY USA; [Huang, Kuo-Hsiang; Mychack, Aaron; Janakiraman, Anuradha] CUNY, Grad Ctr, 365 Fifth Ave, New York, NY USA; [Tchorzewski, Lukasz] Alpha Labs LLC, 14-26 28th Ave, Long Isl City, NY USA	City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System	Janakiraman, A (corresponding author), CUNY City Coll, Dept Biol, 160 Convent Ave,MR 526, New York, NY USA.	anuj@ccny.cuny.edu			National Science Foundation [MCB 1158059]; National Institute on Minority Health and Health Disparities award [8G12MD007603-29]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003060] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007603] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute on Minority Health and Health Disparities award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was funded by a National Science Foundation grant (MCB 1158059) to AJ. A National Institute on Minority Health and Health Disparities award (8G12MD007603-29) provides core facility support to the City College of New York. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernhardt TG, 2003, MOL MICROBIOL, V48, P1171, DOI 10.1046/j.1365-2958.2003.03511.x; Bhattacharya A, 2015, INT J BIOL MACROMOL, V81, P435, DOI 10.1016/j.ijbiomac.2015.08.030; Buske PJ, 2013, MOL MICROBIOL, V89, P249, DOI 10.1111/mmi.12272; Buske PJ, 2012, J BIOL CHEM, V287, P10945, DOI 10.1074/jbc.M111.330324; Buss J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005128; Buss J, 2013, MOL MICROBIOL, V89, P1099, DOI 10.1111/mmi.12331; Camberg JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094964; Dajkovic A, 2010, MOL MICROBIOL, V78, P651, DOI 10.1111/j.1365-2958.2010.07352.x; de Boer PAJ, 2010, CURR OPIN MICROBIOL, V13, P730, DOI 10.1016/j.mib.2010.09.015; DEBOER P, 1992, NATURE, V359, P254, DOI 10.1038/359254a0; Du SS, 2015, MOL MICROBIOL, V95, P173, DOI 10.1111/mmi.12854; Du SS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004460; Durand-Heredia J, 2012, J BACTERIOL, V194, P3189, DOI 10.1128/JB.00176-12; Durand-Heredia JM, 2011, J BACTERIOL, V193, P1405, DOI 10.1128/JB.01258-10; Ebersbach G, 2008, MOL MICROBIOL, V68, P720, DOI 10.1111/j.1365-2958.2008.06190.x; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Galli E, 2012, J BACTERIOL, V194, P292, DOI 10.1128/JB.05821-11; Galli E, 2010, MOL MICROBIOL, V76, P1514, DOI 10.1111/j.1365-2958.2010.07183.x; Gardner KAJA, 2013, MOL MICROBIOL, V89, P264, DOI 10.1111/mmi.12279; Goehring NW, 2006, MOL MICROBIOL, V61, P33, DOI 10.1111/j.1365-2958.2006.05206.x; Gueiros FJ, 2002, GENE DEV, V16, P2544, DOI 10.1101/gad.1014102; Guo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012680; Hale CA, 2000, J BACTERIOL, V182, P5153, DOI 10.1128/JB.182.18.5153-5166.2000; Hale CA, 2011, J BACTERIOL, V193, P1393, DOI 10.1128/JB.01245-10; Haney SA, 2001, J BIOL CHEM, V276, P11980, DOI 10.1074/jbc.M009810200; Huang KH, 2013, J BACTERIOL, V195, P1859, DOI 10.1128/JB.02157-12; Rico AI, 2010, MOL MICROBIOL, V76, P760, DOI 10.1111/j.1365-2958.2010.07134.x; Janakiraman A, 2004, P NATL ACAD SCI USA, V101, P835, DOI 10.1073/pnas.0305747101; Krol E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043293; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Lutkenhaus J, 2012, CYTOSKELETON, V69, P778, DOI 10.1002/cm.21054; Ma XL, 1999, J BACTERIOL, V181, P7531, DOI 10.1128/JB.181.24.7531-7544.1999; Mingorance J, 2010, TRENDS MICROBIOL, V18, P348, DOI 10.1016/j.tim.2010.06.001; Mohammadi T, 2009, BIOCHEMISTRY-US, V48, P11056, DOI 10.1021/bi901461p; Mosyak L, 2000, EMBO J, V19, P3179, DOI 10.1093/emboj/19.13.3179; MUKHERJEE A, 1993, P NATL ACAD SCI USA, V90, P1053, DOI 10.1073/pnas.90.3.1053; Oliva MA, 2004, NAT STRUCT MOL BIOL, V11, P1243, DOI 10.1038/nsmb855; Ortiz C, 2016, FEMS MICROBIOL REV, V40, P57, DOI 10.1093/femsre/fuv040; Ortiz C, 2015, FEBS LETT, V589, P3822, DOI 10.1016/j.febslet.2015.11.030; Osawa M, 2008, SCIENCE, V320, P792, DOI 10.1126/science.1154520; Osawa M, 2009, EMBO J, V28, P3476, DOI 10.1038/emboj.2009.277; Pacheco-Gomez R, 2013, BIOCHEM J, V449, P795, DOI 10.1042/BJ20120140; Pazos M, 2013, J BIOL CHEM, V288, P3219, DOI 10.1074/jbc.M112.434944; PHOENIX P, 1988, J BACTERIOL, V170, P4338, DOI 10.1128/jb.170.9.4338-4342.1988; Pichoff S, 2002, EMBO J, V21, P685, DOI 10.1093/emboj/21.4.685; Popp D, 2009, BIOPOLYMERS, V91, P340, DOI 10.1002/bip.21136; Powell BS, 1998, J BACTERIOL, V180, P1053, DOI 10.1128/JB.180.5.1053-1062.1998; RayChaudhuri D, 1999, EMBO J, V18, P2372, DOI 10.1093/emboj/18.9.2372; RAYCHAUDHURI D, 1994, J BIOL CHEM, V269, P22941; RAYCHAUDHURI D, 1992, NATURE, V359, P251, DOI 10.1038/359251a0; Roach EJ, 2014, J BIOL CHEM, V289, P23276, DOI 10.1074/jbc.M114.561928; Romberg L, 2001, J BIOL CHEM, V276, P11743, DOI 10.1074/jbc.M009033200; Rowlett VW, 2014, BIOPHYS J, V107, pL17, DOI 10.1016/j.bpj.2014.08.024; Schmitz AM, 2009, NAT METHODS, V6, P500, DOI 10.1038/nmeth.1337; Schumacher MA, 2016, J BIOL CHEM, V291, P2485, DOI 10.1074/jbc.M115.697037; Shen B, 2009, MOL MICROBIOL, V72, P410, DOI 10.1111/j.1365-2958.2009.06651.x; Si FW, 2013, BIOPHYS J, V105, P1976, DOI 10.1016/j.bpj.2013.09.030; Szwedziak P, 2014, ELIFE, V3, DOI 10.7554/eLife.04601; Szwedziak P, 2012, EMBO J, V31, P2249, DOI 10.1038/emboj.2012.76; Uversky VN, 2013, FEBS LETT, V587, P1891, DOI 10.1016/j.febslet.2013.04.042; Wang XD, 1997, J BACTERIOL, V179, P5551, DOI 10.1128/jb.179.17.5551-5559.1997; Weiss DS, 1999, J BACTERIOL, V181, P508, DOI 10.1128/JB.181.2.508-520.1999; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Yu XC, 2000, J BACTERIOL, V182, P6203, DOI 10.1128/JB.182.21.6203-6213.2000	64	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153337	10.1371/journal.pone.0153337	http://dx.doi.org/10.1371/journal.pone.0153337			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088231	Green Published, Green Submitted, gold			2022-12-26	WOS:000374527000018
J	Firouzabadi, N; Ghazanfari, N; Shoushtari, AA; Erfani, N; Fathi, F; Bazrafkan, M; Bahramali, E				Firouzabadi, Negar; Ghazanfari, Nima; Shoushtari, Ali Alavi; Erfani, Nasrallah; Fathi, Farshid; Bazrafkan, Mozhdeh; Bahramali, Ehsan			Genetic Variants of Angiotensin-Converting Enzyme Are Linked to Autism: A Case-Control Study	PLOS ONE			English	Article							PERVASIVE DEVELOPMENTAL DISORDERS; SERUM ACE ACTIVITY; ALZHEIMERS-DISEASE; SPECTRUM DISORDER; INSERTION/DELETION POLYMORPHISM; IRANIAN POPULATION; MAJOR DEPRESSION; OXIDATIVE STRESS; BLOOD-PRESSURE; BRAIN	Background Autism is a disease of complex nature with a significant genetic component. The importance of renin-angiotensin system (RAS) elements in cognition and behavior besides the interaction of angiotensin II (Ang II), the main product of angiotensin-converting enzyme (ACE), with neurotransmitters in CNS, especially dopamine, proposes the involvement of RAS in autism. Since the genetic architecture of autism has remained elusive, here we postulated that genetic variations in RAS are associated with autism. Methods Considering the relation between the three polymorphisms of ACE (I/D, rs4343 and rs4291) with the level of ACE activity, we have investigated this association with autism, in a case-control study. Genotype and allele frequencies of polymorphisms were determined in DNAs extracted from venous blood of 120 autistic patients and their age and sex-matched healthy controls, using polymerase chain reaction (PCR) and PCR-restriction fragment length polymorphism (PCR-RFLP) methods. Results There were strong associations between both DD genotype of ACE I/D and the D allele, with autism (P = 0.006, OR = 2.9, 95% CI = 1.64-5.13 and P = 0.006, OR = 2.18, 95% CI = 1.37-3.48 respectively). Furthermore, a significant association between the G allele of rs4343 and autism was observed (P = 0.006, OR = 1.84, 95% CI = 1.26-2.67). Moreover, haplotype analysis revealed an association between DTG haplotype and autism (P = 0.008). Conclusion Our data suggests the involvement of RAS genetic diversity in increasing the risk of autism.	[Firouzabadi, Negar] Shiraz Univ Med Sci, Sch Pharm, Dept Pharmacol & Toxicol, Shiraz, Iran; [Ghazanfari, Nima] Shiraz Univ Med Sci, Int Branch, Sch Pharm, Dept Pharmacol, Shiraz, Iran; [Shoushtari, Ali Alavi] Shiraz Univ Med Sci, Hafez Hosp, Sch Med, Dept Psychiat, Shiraz, Iran; [Erfani, Nasrallah; Fathi, Farshid] Shiraz Univ Med Sci, Sch Med, Shiraz Inst Canc Res, Canc Immunol Grp, Shiraz, Iran; [Bazrafkan, Mozhdeh] Shiraz Univ Med Sci, Sch Rehabil, Dept Speech Therapy, Shiraz, Iran; [Firouzabadi, Negar; Bahramali, Ehsan] Fasa Univ Med Sci, Noncommunicable Dis Res Ctr, Fasa, Iran	Shiraz University of Medical Science; Shiraz University of Medical Science; Shiraz University of Medical Science; Shiraz University of Medical Science; Shiraz University of Medical Science	Firouzabadi, N (corresponding author), Shiraz Univ Med Sci, Sch Pharm, Dept Pharmacol & Toxicol, Shiraz, Iran.; Firouzabadi, N (corresponding author), Fasa Univ Med Sci, Noncommunicable Dis Res Ctr, Fasa, Iran.	Firouzabadi@sums.ac.ir	bahramali, ehsan/M-2673-2017; Erfani, Nasrollah/C-9376-2011; Firouzabadi, Negar/M-3046-2016; Firouzabadi, Negar/GLU-7552-2022	Erfani, Nasrollah/0000-0002-4158-9128; Firouzabadi, Negar/0000-0002-9293-9845; Fathi, Farshid/0000-0002-0280-7612				American Psychiatric Association, 2000, DIAGNOSTIC STAT MANU; Amouyel P, 2000, ANN NY ACAD SCI, V903, P437, DOI 10.1111/j.1749-6632.2000.tb06395.x; Baghai TC, 2004, NEUROSCI LETT, V363, P38, DOI 10.1016/j.neulet.2004.03.052; Baghai TC, 2002, NEUROSCI LETT, V328, P299, DOI 10.1016/S0304-3940(02)00527-X; Bahramali E, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010282; Benicky J, 2011, NEUROPSYCHOPHARMACOL, V36, P857, DOI 10.1038/npp.2010.225; Bohus B, 1998, PROG BRAIN RES, V119, P555; Boucher J, 2012, PSYCHOL BULL, V138, P458, DOI 10.1037/a0026869; Curin JM, 2003, J AUTISM DEV DISORD, V33, P443, DOI 10.1023/A:1025019030121; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Deverman BE, 2009, NEURON, V64, P61, DOI 10.1016/j.neuron.2009.09.002; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Firouzabadi N, 2012, PSYCHIAT RES, V200, P336, DOI 10.1016/j.psychres.2012.05.002; Firouzabadi N, 2011, EUR J PHARMACOL, V668, P241, DOI 10.1016/j.ejphar.2011.07.023; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; Gadow KD, 2008, J CHILD PSYCHOL PSYC, V49, P1331, DOI 10.1111/j.1469-7610.2008.01952.x; Gard PR, 2004, EXPERT OPIN THER TAR, V8, P7, DOI 10.1517/eott.8.1.7.26409; Gard PR, 2002, EUR J PHARMACOL, V438, P1, DOI 10.1016/S0014-2999(02)01283-9; Ghanizadeh A, 2012, CURR MED CHEM, V19, P4000, DOI 10.2174/092986712802002572; GILLBERG C, 1987, BRIT J PSYCHIAT, V151, P89, DOI 10.1192/bjp.151.1.89; Guy W, 1976, ECDEU ASSESSMENT MAN, DOI DOI 10.1037/E591322011-001; Hamilton PJ, 2013, MOL PSYCHIATR, V18, P1315, DOI 10.1038/mp.2013.102; Henley SJ, 2014, MMWR-MORBID MORTAL W, V63, P1; Hidding E, 2016, CLIN GENETICS; Hou DR, 2008, CHINESE MED J-PEKING, V121, P2320, DOI 10.1097/00029330-200811020-00019; JASPARD E, 1993, J BIOL CHEM, V268, P9496; Jesner O. S., 2007, COCHRANE DATABASE SY, V1; Katzung BG, 2004, BASIC CLIN PHARM; Kehoe PG, 2003, J RENIN-ANGIO-ALDO S, V4, P80, DOI 10.3317/jraas.2003.017; Krug DA, 1978, ABC AUTISM BEHAV CHE; Luna B, 2002, NEUROLOGY, V59, P834, DOI 10.1212/WNL.59.6.834; Makkonen I, 2008, DEV MED CHILD NEUROL, V50, P593, DOI 10.1111/j.1469-8749.2008.03027.x; Mandell DS, 2008, PEDIATRICS, V121, pE441, DOI 10.1542/peds.2007-0984; Mateos L, 2011, UPREGULATION BRAIN R; McDougle CJ, 1998, ARCH GEN PSYCHIAT, V55, P633, DOI 10.1001/archpsyc.55.7.633; McKinley MJ, 2003, INT J BIOCHEM CELL B, V35, P901, DOI 10.1016/S1357-2725(02)00306-0; MEDELSOHN FA, 1993, BRAIN RES, V613, P221, DOI DOI 10.1016/0006-8993(93)90902-Y; Mertens B, 2009, J RENIN ANGIOTENSIN; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Muhle R, 2004, PEDIATRICS, V113, pE472, DOI 10.1542/peds.113.5.e472; Nakamura K, 2010, ARCH GEN PSYCHIAT, V67, P59, DOI 10.1001/archgenpsychiatry.2009.137; Nakanishi M, 2007, EUR J NEUROSCI, V25, P649, DOI 10.1111/j.1460-9568.2007.05309.x; Nakasato A, 2008, BRAIN RES, V1193, P128, DOI 10.1016/j.brainres.2007.11.043; Nietzel MT, 1996, CONTEMP PSYCHOL, V41, P642; Pastores S M, 1996, New Horiz, V4, P252; POUSSET F, 1994, BIOMED PHARMACOTHER, V48, P425, DOI 10.1016/0753-3322(94)90003-5; Reiersen Angela M, 2008, Expert Rev Neurother, V8, P657, DOI 10.1586/14737175.8.4.657; RIGAT B, 1992, NUCLEIC ACIDS RES, V20, P1433, DOI 10.1093/nar/20.6.1433-a; Rodriguez-Pallares J, 2008, NEUROBIOL DIS, V31, P58, DOI 10.1016/j.nbd.2008.03.003; Rossignol DA, 2012, MOL PSYCHIATR, V17, P389, DOI 10.1038/mp.2011.165; Rutter M, 1999, J CHILD PSYCHOL PSYC, V40, P19, DOI 10.1111/1469-7610.00423; Saavedra JM, 2006, NEUROPSYCHOPHARMACOL, V31, P1123, DOI 10.1038/sj.npp.1300921; Saavedra JM, 2011, PSYCHONEUROENDOCRINO, V36, P1, DOI 10.1016/j.psyneuen.2010.10.001; Salmon B, 1999, AM J MED GENET, V88, P551, DOI 10.1002/(SICI)1096-8628(19991015)88:5<551::AID-AJMG21>3.3.CO;2-R; Samadi SA, 2012, AUTISM, V16, P5, DOI 10.1177/1362361311407091; Schieffer B, 2000, CIRCULATION, V101, P1372, DOI 10.1161/01.CIR.101.12.1372; SHANMUGAM V, 1993, PCR METH APPL, V3, P120; Struthers AD, 2004, CARDIOVASC RES, V61, P663, DOI 10.1016/j.cardiores.2003.11.037; Theoharides TC, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-168; Toma C, 2013, WORLD J BIOL PSYCHIA, V14, P516, DOI 10.3109/15622975.2011.602719; Volkow ND, 2011, MOL PSYCHIATR, V16, P1147, DOI 10.1038/mp.2010.97; Wright JW, 2008, PROG NEUROBIOL, V84, P157, DOI 10.1016/j.pneurobio.2007.10.009; Wright JW, 2011, PROG NEUROBIOL, V95, P49, DOI 10.1016/j.pneurobio.2011.07.001; Wright JW, 2004, PROG NEUROBIOL, V72, P263, DOI 10.1016/j.pneurobio.2004.03.003; Wu J, 2012, MOL NEUROBIOL, V45, P605, DOI 10.1007/s12035-012-8278-5; YOKOSAWA H, 1983, BIOCHEM BIOPH RES CO, V116, P735, DOI 10.1016/0006-291X(83)90586-7; Zhu XF, 2001, AM J HUM GENET, V68, P1139, DOI 10.1086/320104	67	12	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153667	10.1371/journal.pone.0153667	http://dx.doi.org/10.1371/journal.pone.0153667			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ6AH	27082637	Green Published, Green Submitted, gold			2022-12-26	WOS:000374291800040
J	Ahn, H; Lee, K; Kim, JM; Kwon, SH; Lee, SH; Lee, SY; Jeong, D				Ahn, Heejin; Lee, Kyunghee; Kim, Jin Man; Kwon, So Hyun; Lee, Seoung Hoon; Lee, Soo Young; Jeong, Daewon			Accelerated Lactate Dehydrogenase Activity Potentiates Osteoclastogenesis via NFATc1 Signaling	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; BONE-RESORPTION; DIFFERENTIATION; FUSION; IDENTIFICATION; ACTIVATION; PRECURSORS; ACIDOSIS; ATPASE; CELLS	Osteoclasts seem to be metabolic active during their differentiation and bone-resorptive activation. However, the functional role of lactate dehydrogenase (LDH), a tetrameric enzyme consisting of an A and/or B subunit that catalyzes interconversion of pyruvate to lactate, in RANKL-induced osteoclast differentiation is not known. In this study, RANKL treatment induced gradual gene expression and activation of the LDH A(2)B(2) isotype during osteoclast differentiation as well as the LDH A(1)B(3) and B-4 isotypes during osteoclast maturation after pre-osteoclast formation. Glucose consumption and lactate production in growth media were accelerated during osteoclast differentiation, together with enhanced expression of H+-lactate co-transporter and increased extracellular acidification, demonstrating that glycolytic metabolism was stimulated during differentiation. Further, oxygen consumption via mitochondria was stimulated during osteoclast differentiation. On the contrary, depletion of LDH-A or LDH-B subunit suppressed both glycolytic and mitochondrial metabolism, resulting in reduced mature osteoclast formation via decreased osteoclast precursor fusion and down-regulation of the osteoclastogenic critical transcription factor NFATc1 and its target genes. Collectively, our findings suggest that RANKL-induced LDH activation stimulates glycolytic and mitochondrial respiratory metabolism, facilitating mature osteoclast formation via osteoclast precursor fusion and NFATc1 signaling.	[Ahn, Heejin; Lee, Kyunghee; Kim, Jin Man; Kwon, So Hyun; Jeong, Daewon] Yeungnam Univ, Dept Microbiol, Coll Med, Lab Bone Metab & Control, Daegu, South Korea; [Lee, Seoung Hoon] Wonkwang Univ, Dept Oral Microbiol & Immunol, Coll Dent, Iksan, South Korea; [Lee, Soo Young] Ewha Womans Univ, Dept Life Sci, Seoul, South Korea; [Lee, Soo Young] Ewha Womans Univ, Res Ctr Cellular Homeostasis, Seoul, South Korea	Yeungnam University; Wonkwang University; Ewha Womans University; Ewha Womans University	Jeong, D (corresponding author), Yeungnam Univ, Dept Microbiol, Coll Med, Lab Bone Metab & Control, Daegu, South Korea.	dwjeong@ynu.ac.kr			Yeungnam University Research Grant	Yeungnam University Research Grant	This study was supported by the 2014 Yeungnam University Research Grant.	Ahmed N, 1997, BIOCHEM J, V327, P369, DOI 10.1042/bj3270369; Ahn H, 2012, BIOCHEM BIOPH RES CO, V418, P144, DOI 10.1016/j.bbrc.2011.12.149; Arnett TR, 2010, ARCH BIOCHEM BIOPHYS, V503, P103, DOI 10.1016/j.abb.2010.07.021; BARON R, 1986, AM J PATHOL, V122, P363; Baumgart E, 1996, J BIOL CHEM, V271, P3846; Bottero V, 2006, CELL DEATH DIFFER, V13, P785, DOI 10.1038/sj.cdd.4401888; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brown D, 1996, J EXP BIOL, V199, P2345; Czupalla C, 2005, PROTEOMICS, V5, P3868, DOI 10.1002/pmic.200402059; Francis MJO, 2002, INT J BIOCHEM CELL B, V34, P459, DOI 10.1016/S1357-2725(01)00142-X; Ganapathy-Kanniappan S, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-152; Ha BG, 2008, PROTEOMICS, V8, P2625, DOI 10.1002/pmic.200701192; Halestrap AP, 2012, IUBMB LIFE, V64, P109, DOI 10.1002/iub.572; Huh YJ, 2006, CELL DEATH DIFFER, V13, P1138, DOI 10.1038/sj.cdd.4401793; Indo Y, 2013, J BONE MINER RES, V28, P2392, DOI 10.1002/jbmr.1976; Jang M, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.85; Jeong DW, 2001, BIOCHEM BIOPH RES CO, V289, P1141, DOI 10.1006/bbrc.2001.6091; Kim JM, 2007, CELL PHYSIOL BIOCHEM, V20, P935, DOI 10.1159/000110454; Kim K, 2008, MOL ENDOCRINOL, V22, P176, DOI 10.1210/me.2007-0237; Kwak HB, 2010, BONE, V46, P724, DOI 10.1016/j.bone.2009.10.042; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; Miyazaki T, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.385369; Morrison MS, 1998, J PHYSIOL-LONDON, V511, P495, DOI 10.1111/j.1469-7793.1998.495bh.x; Oursler MJ, 2010, J CELL BIOCHEM, V110, P1058, DOI 10.1002/jcb.22640; Palokangas H, 1997, J CELL SCI, V110, P1767; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Sun-Wada GH, 2004, BBA-BIOENERGETICS, V1658, P106, DOI 10.1016/j.bbabio.2004.04.013; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Vignery A, 2000, INT J EXP PATHOL, V81, P291, DOI 10.1046/j.1365-2613.2000.00164.x; Wilson SR, 2009, J BIOL CHEM, V284, P2584, DOI 10.1074/jbc.M805280200	33	23	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153886	10.1371/journal.pone.0153886	http://dx.doi.org/10.1371/journal.pone.0153886			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077737	Green Published, gold, Green Submitted			2022-12-26	WOS:000374131700115
J	Berlin, C; Juni, P; Endrich, O; Zwahlen, M				Berlin, Claudia; Juni, Peter; Endrich, Olga; Zwahlen, Marcel			Revascularization Treatment of Emergency Patients with Acute ST-Segment Elevation Myocardial Infarction in Switzerland: Results from a Nationwide, Cross-Sectional Study in Switzerland for 2010-2011	PLOS ONE			English	Article							MANAGEMENT; MORTALITY; HOSPITALS; PHYSICIAN; OUTCOMES; GENDER; ACCESS; IMPACT; CARE	Background Cardiovascular diseases are the leading cause of death worldwide and in Switzerland. When applied, treatment guidelines for patients with acute ST-segment elevation myocardial infarction (STEMI) improve the clinical outcome and should eliminate treatment differences by sex and age for patients whose clinical situations are identical. In Switzerland, the rate at which STEMI patients receive revascularization may vary by patient and hospital characteristics. Aims To examine all hospitalizations in Switzerland from 2010-2011 to determine if patient or hospital characteristics affected the rate of revascularization (receiving either a percutaneous coronary intervention or a coronary artery bypass grafting) in acute STEMI patients. Data and Methods We used national data sets on hospital stays, and on hospital infrastructure and operating characteristics, for the years 2010 and 2011, to identify all emergency patients admitted with the main diagnosis of acute STEMI. We then calculated the proportion of patients who were treated with revascularization. We used multivariable multilevel Poisson regression to determine if receipt of revascularization varied by patient and hospital characteristics. Results Of the 9,696 cases we identified, 71.6% received revascularization. Patients were less likely to receive revascularization if they were female, and 80 years or older. In the multivariable multilevel Poisson regression analysis, there was a trend for small-volume hospitals performing fewer revascularizations but this was not statistically significant while being female (Relative Proportion = 0.91, 95% CI: 0.86 to 0.97) and being older than 80 years was still associated with less frequent revascularization. Conclusion Female and older patients were less likely to receive revascularization. Further research needs to clarify whether this reflects differential application of treatment guidelines or limitations in this kind of routine data.	[Berlin, Claudia; Zwahlen, Marcel] Univ Bern, ISPM, Bern, Switzerland; [Juni, Peter] Univ Toronto, AHRC, Li Ka Shing Knowledge Inst, St Michaels Hosp, Toronto, ON, Canada; [Juni, Peter] Univ Toronto, Dept Med, Toronto, ON, Canada; [Juni, Peter] Univ Bern, Inst Primary Hlth Care BIHAM, Bern, Switzerland; [Endrich, Olga] Univ Hosp Bern, Inselspital, CH-3010 Bern, Switzerland	University of Bern; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Bern; University of Bern; University Hospital of Bern	Zwahlen, M (corresponding author), Univ Bern, ISPM, Bern, Switzerland.	marcel.zwahlen@ispm.unibe.ch	Zwahlen, Marcel/AFF-8559-2022; Juni, Peter/Q-8700-2016	Zwahlen, Marcel/0000-0002-6772-6346; Juni, Peter/0000-0002-5985-0670; Berlin, Claudia/0000-0003-3505-348X; Endrich, Olga/0000-0003-0839-9821	Swiss National Science Foundation (SNSF) [32473B_138056]; SFSO [11362]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); SFSO	This study was funded by the Swiss National Science Foundation (SNSF), grant number 32473B_138056 (www.snf.ch). Grant holder was MZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Special thanks goes to Prof. Andre Busato who developed the original design of the study and was responsible for data and funding acquisition. Unfortunately, he died November 2013. We thank the SFSO for their persistent support in conducting the study (contract number: 11362). We also thank Kali Tal for her editorial assistance. The comments of the reviewers had a great influence in improving our analysis. We really appreciated their help. Thank you.	Alexandrescu Roxana, 2012, Acute Card Care, V14, P5, DOI 10.3109/17482941.2012.655291; Alter DA, 2001, JAMA-J AM MED ASSOC, V285, P2101, DOI 10.1001/jama.285.16.2101; Birkhead J, 2006, BMJ-BRIT MED J, V332, P1306, DOI 10.1136/bmj.38849.440914.AE; Blais C, 2012, CAN J CARDIOL, V28, P169, DOI 10.1016/j.cjca.2011.10.009; Claassen M, 2012, WORLD J CARDIOL, V4, P36, DOI 10.4330/wjc.v4.i2.36; Gnavi R, 2014, INT J CARDIOL, V176, P724, DOI 10.1016/j.ijcard.2014.07.107; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Insam C, 2014, EUR J PREV CARDIOL, V21, P541, DOI 10.1177/2047487312469122; Insam C, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-270; Leurent G, 2014, ARCH CARDIOVASC DIS, V107, P291, DOI 10.1016/j.acvd.2014.04.005; O'Flaherty M, 2013, HEART, V99, P159, DOI 10.1136/heartjnl-2012-302300; Pilgrim T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137047; Pilote L, 2003, AM HEART J, V146, P1030, DOI 10.1016/S0002-8703(03)00448-4; Radovanovic D, 2014, HEART, V100, P288, DOI 10.1136/heartjnl-2013-304588; Radovanovic D, 2012, EUR HEART J-ACUTE CA, V1, P183, DOI 10.1177/2048872612454021; Radovanovic D, 2010, SWISS MED WKLY, V140, P314, DOI smw-12986; SFSO, 2006, KRANK; SFSO, 2014, TOD STERBL DER HAUPT; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Tung YC, 2014, MED CARE, V52, P519, DOI 10.1097/MLR.0000000000000132; Weiss J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106845; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/ejcts/ezu366, 10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224]; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	23	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153326	10.1371/journal.pone.0153326	http://dx.doi.org/10.1371/journal.pone.0153326			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078262	Green Submitted, Green Published, gold			2022-12-26	WOS:000374131700039
J	Freitas, HR; Ferraz, G; Ferreira, GC; Ribeiro-Resende, VT; Chiarini, LB; do Nascimento, JLM; Oliveira, KRHM; Pereira, TD; Ferreira, LGB; Kubrusly, RC; Faria, RX; Herculano, AM; Reis, RAD				Freitas, Hercules R.; Ferraz, Gabriel; Ferreira, Gustavo C.; Ribeiro-Resende, Victor T.; Chiarini, Luciana B.; do Nascimento, Jose Luiz M.; Matos Oliveira, Karen Renata H.; Pereira, Tiago de Lima; Ferreira, Leonardo G. B.; Kubrusly, Regina C.; Faria, Robson X.; Herculano, Anderson Manoel; de Melo Reis, Ricardo A.			Glutathione-Induced Calcium Shifts in Chick Retinal Glial Cells	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; MULLER GLIA; RELEASE; NEURONS; GLUTAMATE; GLIOTRANSMISSION; IDENTIFICATION; DYSREGULATION; HOMEOSTASIS; RECEPTORS	Neuroglia interactions are essential for the nervous system and in the retina Muller cells interact with most of the neurons in a symbiotic manner. Glutathione (GSH) is a low-molecular weight compound that undertakes major antioxidant roles in neurons and glia, however, whether this compound could act as a signaling molecule in neurons and/or glia is currently unknown. Here we used embryonic avian retina to obtain mixed retinal cells or purified Muller glia cells in culture to evaluate calcium shifts induced by GSH. A dose response curve (0.1-10mM) showed that 5-10mM GSH, induced calcium shifts exclusively in glial cells (later labeled and identified as 2M6 positive cells), while neurons responded to 50mM KCl (labeled as beta(III) tubulin positive cells). BBG 100nM, a P2X7 blocker, inhibited the effects of GSH on Muller glia. However, addition of DNQX 70 mu M and MK-801 20 mu M, non-NMDA and NMDA blockers, had no effect on GSH calcium induced shift. Oxidized glutathione (GSSG) at 5mM failed to induce calcium mobilization in glia cells, indicating that the antioxidant and/or structural features of GSH are essential to promote elevations in cytoplasmic calcium levels. Indeed, a short GSH pulse (60s) protects Muller glia from oxidative damage after 30 min of incubation with 0.1% H2O2. Finally, GSH induced GABA release from chick embryonic retina, mixed neuron-glia or from Muller cell cultures, which were inhibited by BBG or in the absence of sodium. GSH also induced propidium iodide uptake in Muller cells in culture in a P2X7 receptor dependent manner. Our data suggest that GSH, in addition to antioxidant effects, could act signaling calcium shifts at the millimolar range particularly in Muller glia, and could regulate the release of GABA, with additional protective effects on retinal neuron-glial circuit.	[Freitas, Hercules R.; Ferreira, Gustavo C.; Ribeiro-Resende, Victor T.; de Melo Reis, Ricardo A.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Neurochem Lab, Rio De Janeiro, RJ, Brazil; [Ferraz, Gabriel] Univ Fed Rio de Janeiro, Ctr Hlth Sci, Inst Biol Sci, Rio De Janeiro, RJ, Brazil; [Ferreira, Gustavo C.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Rio De Janeiro, RJ, Brazil; [Chiarini, Luciana B.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Lab Neurogenesis, Rio De Janeiro, RJ, Brazil; [do Nascimento, Jose Luiz M.; Matos Oliveira, Karen Renata H.; Pereira, Tiago de Lima; Herculano, Anderson Manoel] Fed Univ Para, Inst Biol, BR-66059 Belem, Para, Brazil; [Kubrusly, Regina C.] Univ Fed Fluminense, Dept Physiol & Pharmacol, Neuropharmacol Lab, Niteroi, RJ, Brazil; [Ferreira, Leonardo G. B.] Oswaldo Cruz Fdn FIOCRUZ, Inst Oswaldo Cruz, Lab Inflammat, Rio De Janeiro, Brazil; [Faria, Robson X.] Oswaldo Cruz Fdn FIOCRUZ, Inst Oswaldo Cruz, Lab Toxoplasmosis, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Para; Universidade Federal Fluminense; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Reis, RAD (corresponding author), Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Neurochem Lab, Rio De Janeiro, RJ, Brazil.	ramreis@biof.ufrj.br	Herculano, Anderson M/M-9016-2017; de Melo Reis, Ricardo A/E-9962-2011; Kubrusly, Regina C C/E-2626-2018; Chiarini, Luciana B/J-3644-2015; Freitas, Hércules Rezende/M-7198-2015	de Melo Reis, Ricardo A/0000-0001-9689-4085; Kubrusly, Regina C C/0000-0002-6016-2197; Freitas, Hércules Rezende/0000-0003-1584-9157; do Nascimento, jose/0000-0003-3647-9124	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Instituto Nacional de Ciencia e Tecnologia de Neurociencia Translacional INCT-INNT; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); CAPES [PRO-AMAZONIA - 3288/2013]; CNPq; Instituto Nacional de Ciencia e Tecnologia de Neurocienca Translacional INCT-INNT; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES [PRO-AMAZONIA - 3288/2013]	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia de Neurociencia Translacional INCT-INNT; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia de Neurocienca Translacional INCT-INNT; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), (Instituto Nacional de Ciencia e Tecnologia de Neurociencia Translacional INCT-INNT), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) to RAMR, VTRR, GCF and CAPES (PRO-AMAZONIA - 3288/2013) to AMH. HRF is recipient of a CAPES M.Sc. fellowship; RAMR, AMH, JLMN and GCF have a research fellowship (CNPq).; Grants from Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), (Instituto Nacional de Ciencia e Tecnologia de Neurocienca Translacional INCT-INNT), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES (PRO-AMAZONIA - 3288/2013) and CAPES supported this work. Hercules R. Freitas is recipient of a CAPES M.Sc. fellowship; RAMR, AMH, JLMN and GCF have a research fellowship (CNPq). We are indebted to the technical support of Luciano C. Ferreira.	Agulhon C, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00139; Anccasi RM, 2013, PURINERG SIGNAL, V9, P15, DOI 10.1007/s11302-012-9324-5; Aoyama K, 2015, MOLECULES, V20, P8742, DOI 10.3390/molecules20058742; Ballatori N, 2009, BIOL CHEM, V390, P191, DOI 10.1515/BC.2009.033; Bringmann A, 2009, NEUROCHEM INT, V54, P143, DOI 10.1016/j.neuint.2008.10.014; Browne R W, 1998, Methods Mol Biol, V108, P347; Chin TY, 2006, ACTA PHARMACOL SIN, V27, P853, DOI 10.1111/j.1745-7254.2006.00379.x; Reis RAD, 2011, CELL MOL NEUROBIOL, V31, P835, DOI 10.1007/s10571-011-9673-6; Reis RAD, 2008, NEUROCHEM RES, V33, P1466, DOI 10.1007/s11064-008-9604-1; Schitine CS, 2007, NEUROTOX RES, V12, P145, DOI 10.1007/BF03033923; Dickinson DA, 2002, BIOCHEM PHARMACOL, V64, P1019, DOI 10.1016/S0006-2952(02)01172-3; DONASCIMENTO JLM, 1985, J NEUROCHEM, V45, P1820; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Dringen R, 2003, BIOL CHEM, V384, P505, DOI 10.1515/BC.2003.059; DUARTE CB, 1992, BRAIN RES, V591, P27, DOI 10.1016/0006-8993(92)90974-E; Faria RX, 2016, J BIOENERG BIOMEMBR, V48, P309, DOI 10.1007/s10863-016-9649-9; Garcia TB, 2011, NEUROCHEM RES, V36, P412, DOI 10.1007/s11064-010-0356-3; Golovanevsky V, 1999, J BIOL CHEM, V274, P23020, DOI 10.1074/jbc.274.33.23020; Guimaraes-Souza EM, 2011, NEUROSCIENCE, V179, P23, DOI 10.1016/j.neuroscience.2011.01.035; Halassa MM, 2007, TRENDS MOL MED, V13, P54, DOI 10.1016/j.molmed.2006.12.005; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hewinson J, 2008, J IMMUNOL, V180, P8410, DOI 10.4049/jimmunol.180.12.8410; HOFMANN HD, 1991, J NEUROCHEM, V56, P923, DOI 10.1111/j.1471-4159.1991.tb02010.x; Janaky R, 1999, J NEUROCHEM, V73, P889, DOI 10.1046/j.1471-4159.1999.0730889.x; Janaky R, 2000, NEUROSCIENCE, V95, P617; Janaky R, 2007, NEUROCHEM RES, V32, P1357, DOI 10.1007/s11064-007-9315-z; Johnson WM, 2012, NUTRIENTS, V4, P1399, DOI 10.3390/nu4101399; Keelan J, 2001, J NEUROSCI RES, V66, P873, DOI 10.1002/jnr.10085; LOPEZCOLOME AM, 1993, GLIA, V9, P127, DOI 10.1002/glia.440090206; Maggesissi RS, 2009, VISION RES, V49, P2494, DOI 10.1016/j.visres.2009.08.004; Molz S, 2015, PURINERG SIGNAL, V11, P117, DOI 10.1007/s11302-014-9438-z; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; PETIT JM, 1993, BIOL CELL, V78, P1, DOI 10.1016/0248-4900(93)90109-R; Portugal CC, 2009, J NEUROCHEM, V108, P507, DOI 10.1111/j.1471-4159.2008.05786.x; Reis RAM, 2002, J NEUROBIOL, V50, P13, DOI 10.1002/neu.10008; Rice ME, 2000, TRENDS NEUROSCI, V23, P209, DOI 10.1016/S0166-2236(99)01543-X; Rice ME, 1998, NEUROSCIENCE, V82, P1213; Sarthy V., 2001, PERSP VIS R; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schitine CS, 2015, NEUROCHEM INT, V82, P42, DOI 10.1016/j.neuint.2015.02.004; SCHLOSSHAUER B, 1991, DEVELOPMENT, V111, P789; Schuck PF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126606; Ventura Ana Lucia Marques, 2013, Methods Mol Biol, V964, P25, DOI 10.1007/978-1-62703-251-3_3	43	28	28	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153677	10.1371/journal.pone.0153677	http://dx.doi.org/10.1371/journal.pone.0153677			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078878	Green Published, Green Submitted, gold			2022-12-26	WOS:000374131700102
J	Salvoza, NC; Klinzing, DC; Gopez-Cervantes, J; Baclig, MO				Salvoza, Noel C.; Klinzing, David C.; Gopez-Cervantes, Juliet; Baclig, Michael O.			Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease	PLOS ONE			English	Article							CONTROLLED ATTENUATION PARAMETER; AMERICAN ASSOCIATION; HEPATIC STEATOSIS; MICRORNAS; STEATOHEPATITIS; EXPRESSION; DIAGNOSIS; MARKERS; PCR; RECOMMENDATIONS	Non-alcoholic fatty liver disease (NAFLD) covers a spectrum of diseases from simple steatosis to non-alcoholic steatohepatitis, with approximately 20% risk of progressing to fibrosis and cirrhosis. The aim of this study was to compare the relative expression levels of circulating miR-21, miR-34a, miR-122, miR-125b and miR-375 between healthy controls and NAFLD patients, and to assess the feasibility of microRNAs as potential biomarkers for NAFLD. A cross-sectional study was conducted to evaluate circulating serum miRNAs as potential diagnostic markers for NAFLD. Twenty-eight clinically diagnosed and histologically-confirmed NAFLD patients, as well as 36 healthy controls were enrolled in this study. The relative expression of serum microRNAs were calculated using the comparative cycle threshold with spiked-in C. elegans miR-39 as exogenous internal control. Serum levels of miR-34a and miR-122 were significantly higher in NAFLD patients than in healthy controls (P = <0.0001). Positive correlations were observed between serum miR-34a with very low density lipoprotein cholesterol (VLDL-C) and triglyceride levels. However, the expression levels of miR-34a and miR-122 did not correlate with the histological features of NAFLD. Interestingly, receiver operating characteristic (ROC) curve analysis revealed that miR-34a and miR-122 are potential markers for discriminating NAFLD patients from healthy controls with an area under the curve (AUC) values of 0.781 and 0.858, respectively. Serum levels of miR-34a and miR-122 were found to be significantly higher among NAFLD patients, and were positively correlated with VLDL-C and triglyceride levels. Thus, circulating miR-34a and miR-122 can be used as potential biomarkers for discriminating NAFLD patients from healthy controls. Larger cohorts are required to validate the utility of miR-34a and miR-122 in monitoring liver injury.	[Salvoza, Noel C.; Klinzing, David C.; Baclig, Michael O.] St Lukes Med Ctr, Res & Biotechnol, 279 E Rodriguez Sr Blvd, Quezon City 1112, Philippines; [Gopez-Cervantes, Juliet] St Lukes Med Ctr, Liver Dis & Transplant Ctr, 279 E Rodriguez Sr Blvd, Quezon City 1112, Philippines; [Salvoza, Noel C.] West Visayas State Univ, Coll Med, Iloilo 5000, Philippines; [Klinzing, David C.] AIT Biotech Pte Ltd, Sci Pk 1, Singapore 118261, Singapore	Saint Lukes Medical Center - Philippines; Saint Lukes Medical Center - Philippines	Baclig, MO (corresponding author), St Lukes Med Ctr, Res & Biotechnol, 279 E Rodriguez Sr Blvd, Quezon City 1112, Philippines.	mobaclig@stluke.com.ph	Baclig, Michael O./AAS-3749-2020; Baclig, Michael/G-5458-2014	Baclig, Michael O./0000-0001-6733-3916; Baclig, Michael/0000-0001-6733-3916; Salvoza, Noel/0000-0002-6394-2383	Research and Biotechnology, St. Luke's Medical Center-Quezon City [12-002a]	Research and Biotechnology, St. Luke's Medical Center-Quezon City	This work was supported by a research grant to the St. Luke's Liver Diseases Study Group (Project no. 12-002a) through the Research and Biotechnology, St. Luke's Medical Center-Quezon City. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a research grant to the St. Luke's Liver Diseases Study Group (Project no. 12-002a) through the Research and Biotechnology, St. Luke's Medical Center-Quezon City. The authors thank Cynthia A. Mapua and Dr. Jun Reandelar for their help in the statistical analysis.	Agrawal S, 2012, J CLIN EXP HEPATOL, V2, P122, DOI 10.1016/S0973-6883(12)60101-7; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P645, DOI 10.1038/nrgastro.2013.182; Blachier M, 2013, J HEPATOL, V58, P593, DOI 10.1016/j.jhep.2012.12.005; Cermelli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023937; Chalasani N, 2012, AM J GASTROENTEROL, V107, P811, DOI 10.1038/ajg.2012.128; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cheung O, 2008, HEPATOLOGY, V48, P1810, DOI 10.1002/hep.22569; Farina NH, 2014, J CELL BIOCHEM, V115, P805, DOI 10.1002/jcb.24745; Ferreira DMS, 2014, FEBS J, V281, P2503, DOI 10.1111/febs.12806; Hyysalo J, 2014, J HEPATOL, V60, P839, DOI 10.1016/j.jhep.2013.12.009; Koberle V, 2013, EUR J CANCER, V49, P3442, DOI 10.1016/j.ejca.2013.06.002; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Leti F, 2015, TRANSL RES, V166, P304, DOI 10.1016/j.trsl.2015.04.014; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Meyer SU, 2010, BIOTECHNOL LETT, V32, P1777, DOI 10.1007/s10529-010-0380-z; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Miyaaki H, 2014, LIVER INT, V34, pE302, DOI 10.1111/liv.12429; Myers RP, 2012, LIVER INT, V32, P902, DOI 10.1111/j.1478-3231.2012.02781.x; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; Petta S, 2011, ALIMENT PHARM THER, V33, P1350, DOI 10.1111/j.1365-2036.2011.04668.x; Piscaglia F, 2014, EUR J RADIOL, V83, P450, DOI 10.1016/j.ejrad.2013.06.009; Qi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028486; Roderburg C, 2014, J HEPATOL, V61, P1434, DOI 10.1016/j.jhep.2014.07.017; Rottiers V, 2012, NAT REV MOL CELL BIO, V13, P239, DOI 10.1038/nrm3313; Sanyal AJ, 2015, HEPATOLOGY, V61, P1392, DOI 10.1002/hep.27678; Sasso M, 2010, ULTRASOUND MED BIOL, V36, P1825, DOI 10.1016/j.ultrasmedbio.2010.07.005; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shen F, 2014, WORLD J GASTROENTERO, V20, P4702, DOI 10.3748/wjg.v20.i16.4702; Spengler EK, 2015, MAYO CLIN PROC, V90, P1233, DOI 10.1016/j.mayocp.2015.06.013; Szabo G, 2013, NAT REV GASTRO HEPAT, V10, P542, DOI 10.1038/nrgastro.2013.87; Tannapfel A, 2011, VIRCHOWS ARCH, V458, P511, DOI 10.1007/s00428-011-1066-1; WHO, A HLTH LIF; Yamada H, 2015, CLIN CHIM ACTA, V446, P267, DOI 10.1016/j.cca.2015.05.002; Yamada H, 2013, CLIN CHIM ACTA, V424, P99, DOI 10.1016/j.cca.2013.05.021; Zelber-Sagi S, 2014, LIVER INT, V34, pE128, DOI 10.1111/liv.12318	38	91	97	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153497	10.1371/journal.pone.0153497	http://dx.doi.org/10.1371/journal.pone.0153497			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077736	Green Published, gold, Green Submitted			2022-12-26	WOS:000374131700065
J	Kim, JH; Huh, YH; Kim, HR				Kim, Ju Hwan; Huh, Yang Hoon; Kim, Hak Rim			Induction of Autophagy in the Striatum and Hypothalamus of Mice after 835 MHz Radiofrequency Exposure	PLOS ONE			English	Article							MOBILE PHONE; ELECTROMAGNETIC-FIELDS; COGNITIVE IMPAIRMENT; CELL SURVIVAL; DISEASE; LC3; APOPTOSIS; BRAIN; PERFORMANCE; ACTIVATION	The extensive use of wireless mobile phones and associated communication devices has led to increasing public concern about potential biological health-related effects of the exposure to electromagnetic fields (EMFs). EMFs emitted by a mobile phone have been suggested to influence neuronal functions in the brain and affect behavior. However, the affects and phenotype of EMFs exposure are unclear. We applied radiofrequency (RF) of 835 MHz at a specific absorption rate (SAR) of 4.0 W/kg for 5 hours/day for 4 and 12 weeks to clarify the biological effects on mouse brain. Interestingly, microarray data indicated that a variety of autophagic related genes showed fold-change within small range after 835 MHz RF exposure. qRT-PCR revealed significant up-regulation of the autophagic genes Atg5, LC3A and LC3B in the striatum and hypothalamus after a 12-week RF. In parallel, protein expression of LC3B-II was also increased in both brain regions. Autophagosomes were observed in the striatum and hypothalamus of RF-exposed mice, based on neuronal transmission electron microscopy. Taken together, the results indicate that RF exposure of the brain can induce autophagy in neuronal tissues, providing insight into the protective mechanism or adaptation to RF stress.	[Kim, Ju Hwan; Kim, Hak Rim] Dankook Univ, Dept Pharmacol, Coll Med, Cheonan, Chungnam, South Korea; [Huh, Yang Hoon] Korea Basic Sci Inst, Nanobio EM Res Grp, Gwahak Ro, Daejeon, South Korea	Dankook University; Korea Basic Science Institute (KBSI)	Kim, HR (corresponding author), Dankook Univ, Dept Pharmacol, Coll Med, Cheonan, Chungnam, South Korea.	hrkim@dankook.ac.kr			Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning [NRF-2014R1A2A2A04003616]	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, and Future Planning (NRF-2014R1A2A2A04003616).	Abdel-Rassoul G, 2007, NEUROTOXICOLOGY, V28, P434, DOI 10.1016/j.neuro.2006.07.012; Arendash GW, 2010, J ALZHEIMERS DIS, V19, P191, DOI 10.3233/JAD-2010-1228; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Banaceur S, 2013, BEHAV BRAIN RES, V240, P197, DOI 10.1016/j.bbr.2012.11.021; Barron J, 2010, HLTH NEWSLETTER EN 1; Biran J, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00047; Bourthoumieu S, 2013, BIOELECTROMAGNETICS, V34, P52, DOI 10.1002/bem.21744; Chen S, 2012, BRAIN PATHOL, V22, P110, DOI 10.1111/j.1750-3639.2011.00546.x; Chen YQ, 2011, J CELL SCI, V124, P161, DOI 10.1242/jcs.064576; Christ A, 2010, PHYS MED BIOL, V55, P1767, DOI 10.1088/0031-9155/55/7/001; Chughtai B, 2009, INTERNET J UROL, V6, P1; Consales C, 2012, INT J CELL BIOL; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Dubreuil D, 2002, BEHAV BRAIN RES, V129, P203, DOI 10.1016/S0166-4328(01)00344-8; Gherardini L, 2014, INT J MOL SCI, V15, P5366, DOI 10.3390/ijms15045366; Greenway FL, 2015, INT J OBESITY, V39, P1188, DOI 10.1038/ijo.2015.59; Hamblin DL, 2002, INT J RADIAT BIOL, V78, P659, DOI 10.1080/09553000210132298; Humphries P, 2008, EUR J CLIN NUTR, V62, P451, DOI 10.1038/sj.ejcn.1602866; Hutter HP, 2006, OCCUP ENVIRON MED, V63, P307, DOI 10.1136/oem.2005.020784; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kleinlogel H, 2008, BIOELECTROMAGNETICS, V29, P488, DOI 10.1002/bem.20418; Koivisto M, 2000, NEUROREPORT, V11, P1641, DOI 10.1097/00001756-200006050-00009; Koivisto M, 2000, NEUROREPORT; Kokturk S, 2013, EXP THER MED, V6, P52, DOI 10.3892/etm.2013.1123; Leszczynski D, 2002, DIFFERENTIATION, V70, P120, DOI 10.1046/j.1432-0436.2002.700207.x; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Marchesi N, 2014, J CELL PHYSIOL, V229, P1776, DOI 10.1002/jcp.24631; Marino G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735; Markov MS, 2007, ELECTROMAGN BIOL MED, V26, P257, DOI 10.1080/15368370701580806; Martiny K, 2010, BIOL PSYCHIAT, V68, P163, DOI 10.1016/j.biopsych.2010.02.017; Maskey D, 2010, BRAIN RES, V1313, P232, DOI 10.1016/j.brainres.2009.11.079; Maskey D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3130; Mehrpour M, 2012, ATLAS GENETICS CYTOG; Meijer AJ, 2004, INT J BIOCHEM CELL B, V36, P2445, DOI 10.1016/j.biocel.2004.02.002; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nassif M, 2014, AUTOPHAGY, V10, P1256, DOI 10.4161/auto.28784; Nittby Henrietta, 2009, Pathophysiology, V16, P103, DOI 10.1016/j.pathophys.2009.01.001; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Pardo JCT, 2012, ELECTROMAGN BIOL MED, V31, P1, DOI 10.3109/15368378.2011.596251; Park MR, 2013, SCI REP-UK, V3, DOI 10.1038/srep01384; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Pyo JO, 2012, EXP MOL MED, V44, P73, DOI 10.3858/emm.2012.44.2.029; Salford LG, 2003, ENVIRON HEALTH PERSP, V111, P881, DOI 10.1289/ehp.6039; Salminen A, 2013, AGEING RES REV, V12, P520, DOI 10.1016/j.arr.2012.11.004; Santini R, 2002, PATHOL BIOL, V50, P369, DOI 10.1016/S0369-8114(02)00311-5; Scherz-Shouval R, 2010, P NATL ACAD SCI USA, V107, P18511, DOI 10.1073/pnas.1006124107; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Surmeier DJ, 2014, CURR OPIN NEUROBIOL, V29, P109, DOI 10.1016/j.conb.2014.07.008; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Taylor SB, 2013, SUBST ABUSE REHABIL, V4, P29, DOI 10.2147/SAR.S39684; Tooze SA, 2010, NAT CELL BIOL, V12, P831, DOI 10.1038/ncb0910-831; Tyler Christina R, 2014, Curr Environ Health Rep, V1, P132; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Yager LM, 2015, NEUROSCIENCE, V301, P529, DOI 10.1016/j.neuroscience.2015.06.033; Yang C, 2008, AM J PHYSIOL-RENAL, V294, pF777, DOI 10.1152/ajprenal.00590.2007	58	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153308	10.1371/journal.pone.0153308	http://dx.doi.org/10.1371/journal.pone.0153308			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073885	Green Submitted, Green Published, gold			2022-12-26	WOS:000374131200073
J	Lilly, DG; Latham, SL; Webb, CE; Doggett, SL				Lilly, David G.; Latham, Sharissa L.; Webb, Cameron E.; Doggett, Stephen L.			Cuticle Thickening in a Pyrethroid-Resistant Strain of the Common Bed Bug, Cimex lectularius L. (Hemiptera: Cimicidae)	PLOS ONE			English	Article							COLORADO POTATO BEETLE; INSECTICIDE RESISTANCE; CUTICULAR PENETRATION; HELICOVERPA-ARMIGERA; GERMAN-COCKROACH; MUSCA-DOMESTICA; HOUSE FLY; DELTAMETHRIN; MECHANISMS; STARVATION	Thickening of the integument as a mechanism of resistance to insecticides is a well recognised phenomenon in the insect world and, in recent times, has been found in insects exhibiting pyrethroid-resistance. Resistance to pyrethroid insecticides in the common bed bug, Cimex lectularius L., is widespread and has been frequently inferred as a reason for the pest's resurgence. Overexpression of cuticle depositing proteins has been demonstrated in pyrethroid-resistant bed bugs although, to date, no morphological analysis of the cuticle has been undertaken in order to confirm a phenotypic link. This paper describes examination of the cuticle thickness of a highly pyrethroid-resistant field strain collected in Sydney, Australia, in response to time-to-knockdown upon forced exposure to a pyrethroid insecticide. Mean cuticle thickness was positively correlated to time-to-knockdown, with significant differences observed between bugs knocked-down at 2 hours, 4 hours, and those still unaffected at 24 hours. Further analysis also demonstrated that the 24 hours survivors possessed a statistically significantly thicker cuticle when compared to a pyrethroid-susceptible strain of C. lectularius. This study demonstrates that cuticle thickening is present within a pyrethroid-resistant strain of C. lectularius and that, even within a stable resistant strain, cuticle thickness will vary according to time-to-knockdown upon exposure to an insecticide. This response should thus be considered in future studies on the cuticle of insecticide-resistant bed bugs and, potentially, other insects.	[Lilly, David G.; Webb, Cameron E.; Doggett, Stephen L.] Univ Sydney, Dept Med Entomol, Westmead, NSW 2415, Australia; [Lilly, David G.; Webb, Cameron E.; Doggett, Stephen L.] Westmead Hosp, Pathol West ICPMR Westmead, Westmead, NSW 2415, Australia; [Latham, Sharissa L.] Univ Sydney, Australian Ctr Microscopy & Microanal, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; University of Sydney	Doggett, SL (corresponding author), Univ Sydney, Dept Med Entomol, Westmead, NSW 2415, Australia.; Doggett, SL (corresponding author), Westmead Hosp, Pathol West ICPMR Westmead, Westmead, NSW 2415, Australia.	stephen.doggett@health.nsw.gov.au	Latham, Sharissa/B-2353-2016	Latham, Sharissa/0000-0003-1128-5315; Webb, Cameron/0000-0003-1029-5140	Australian Postgraduate Award from Department of Industry, Innovation, Science, Research and Tertiary Education, Australian Government; Bayer CropScience Pty Ltd, Australia; Bayer CropScience Pty Ltd; University of Sydney	Australian Postgraduate Award from Department of Industry, Innovation, Science, Research and Tertiary Education, Australian Government; Bayer CropScience Pty Ltd, Australia; Bayer CropScience Pty Ltd; University of Sydney(University of Sydney)	The study was largely funded by an Australian Postgraduate Award from the Department of Industry, Innovation, Science, Research and Tertiary Education, Australian Government and administered by the University of Sydney as a student stipend. Partial funding through a postgraduate industry grant was received from Bayer CropScience Pty Ltd, Australia (www.bayercropscience.com.au) and was administered by the University of Sydney. DGL received partial funding from Bayer CropScience Pty Ltd. DGL, CEW and SLD received insecticide for use in this study free of charge from Syngenta Crop Protection Pty Limited. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman ZN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026228; Ahmad M, 2006, PEST MANAG SCI, V62, P805, DOI 10.1002/ps.1225; Alyokhin A, 2008, AM J POTATO RES, V85, P395, DOI 10.1007/s12230-008-9052-0; ARGENTINE JA, 1994, PESTIC BIOCHEM PHYS, V48, P63, DOI 10.1006/pest.1994.1008; Balvin O, 2012, PARASITOL RES, V111, P457, DOI 10.1007/s00436-012-2862-5; Boase C., 2006, PROFESSIONAL PES SUM, V8, P6; Choe DH, 2014, J ECON ENTOMOL, V107, P1206, DOI 10.1603/EC13478; Dang K, 2015, PEST MANAG SCI, V71, P914, DOI 10.1002/ps.3861; Dang K, 2015, PEST MANAG SCI, V71, P1015, DOI 10.1002/ps.3880; Dang K, 2015, AUSTRAL ENTOMOL, V54, P191, DOI 10.1111/aen.12109; DeVries ZC, 2015, INSECTS, V6, P102, DOI 10.3390/insects6010102; DeVries ZC, 2015, PHYSIOL BIOCHEM ZOOL, V88, P53, DOI 10.1086/679499; Doggett S, 2004, ENVIRON HEALTH-GLOB, V4, P30; Doggett SL, 2012, CLIN MICROBIOL REV, V25, P164, DOI 10.1128/CMR.05015-11; Feldlaufer MF, 2013, J ECON ENTOMOL, V106, P988, DOI 10.1603/EC12378; Feyereisen R, 1995, TOXICOL LETT, V82-3, P83, DOI 10.1016/0378-4274(95)03470-6; ffrench-Constant RH, 2004, TRENDS GENET, V20, P163, DOI 10.1016/j.tig.2004.01.003; FINE BC, 1963, NATURE, V199, P927, DOI 10.1038/199927b0; FORGASH AJ, 1962, J ECON ENTOMOL, V55, P544, DOI 10.1093/jee/55.4.544; GEORGHIOU G, 1961, J ECON ENTOMOL, V54, P132, DOI 10.1093/jee/54.1.132; GUNNING RV, 1991, PESTIC SCI, V33, P473, DOI 10.1002/ps.2780330410; Hoy MA, 1998, PHILOS T ROY SOC B, V353, P1787, DOI 10.1098/rstb.1998.0331; Kilpinen O, 2011, PARASITOL RES, V109, P1461, DOI 10.1007/s00436-011-2423-3; Koganemaru R, 2013, PESTIC BIOCHEM PHYS, V106, P190, DOI 10.1016/j.pestbp.2013.01.001; Lilly DG, 2015, AUSTRAL ENTOMOL, V54, P96, DOI 10.1111/aen.12098; Mamidala P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-6; MATSUMURA F., 1963, MOSQUITO NEWS, V23, P26; MATSUMURA F., 1961, MOSQUITO NEWS, V21, P192; MCDONALD IC, 1968, J ECON ENTOMOL, V61, P670, DOI 10.1093/jee/61.3.670; Moore DJ, 2006, J ECON ENTOMOL, V99, P2080, DOI 10.1603/0022-0493-99.6.2080; Myamba J, 2002, MED VET ENTOMOL, V16, P448, DOI 10.1046/j.1365-2915.2002.00389.x; OPPENOORTH FJ, 1984, PESTIC BIOCHEM PHYS, V22, P187, DOI 10.1016/0048-3575(84)90088-9; PATIL VL, 1979, PESTIC SCI, V10, P399, DOI 10.1002/ps.2780100506; PATIL VL, 1978, CHEMOSPHERE, V7, P707, DOI 10.1016/0045-6535(78)90107-8; PLAPP FW, 1968, J ECON ENTOMOL, V61, P1298; Rasband WS, 1997, IMAGEJ IMAGE J; Romero A, 2007, J MED ENTOMOL, V44, P175, DOI 10.1603/0022-2585(2007)44[175:IRITBB]2.0.CO;2; Romero A, 2010, PEST MANAG SCI, V66, P1243, DOI 10.1002/ps.2002; Romero A, 2009, J ECON ENTOMOL, V102, P2310, DOI 10.1603/029.102.0637; SAWICKI R. M., 1970, Pesticide Science, V1, DOI 10.1002/ps.2780010302; SAWICKI R. M., 1970, Pesticide Science, V1, P213, DOI 10.1002/ps.2780010512; Sawicki R.M., 1987, COMBATING RESISTANCE, P105; Scott J.G., 1990, PESTICIDE RESISTANCE, P39, DOI DOI 10.1007/978-1-4684-6429-0_3; SELLERS L G, 1973, Environmental Entomology, V2, P296, DOI 10.1093/ee/2.2.296; Tawatsin A, 2011, J MED ENTOMOL, V48, P1023, DOI 10.1603/ME11003; Terriere LC, 1980, BIOCH TOXICOLOGY INS; Usinger R. L., 1966, MONOGRAPH CIMICIDAE; Valles SM, 2000, PESTIC BIOCHEM PHYS, V66, P195, DOI 10.1006/pest.1999.2462; VINSON SB, 1966, J ECON ENTOMOL, V59, P600, DOI 10.1093/jee/59.3.600; VINSON SB, 1971, J ECON ENTOMOL, V64, P1387, DOI 10.1093/jee/64.6.1387; Wang CL, 2011, URBAN PEST MANAGEMENT: AN ENVIRONMENTAL PERSPECTIVE, P44, DOI 10.1079/9781845938031.0044; Wiesmann VR, 1947, MITT SCHWEIZ ENTOMOL, V20, P484; Wood OR, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-67; Yoon KS, 2008, J MED ENTOMOL, V45, P1092, DOI 10.1603/0022-2585(2008)45[1092:BAMAOD]2.0.CO;2; Yu S., 2008, TOXICOLOGY BIOCH INS, DOI 10.1201/9781420059762; Yu SJ, 1996, PESTIC BIOCHEM PHYS, V56, P69, DOI 10.1006/pest.1996.0060; Zhang X., 2013, SCI REP, V3; Zhu F, 2010, ARCH INSECT BIOCHEM, V73, P245, DOI 10.1002/arch.20355; Zhu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039782	59	59	62	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153302	10.1371/journal.pone.0153302	http://dx.doi.org/10.1371/journal.pone.0153302			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073871	gold, Green Published, Green Submitted			2022-12-26	WOS:000374131200072
J	Martinez, EJ; Gil, MV; Fernandez, C; Rosas, JG; Gomez, X				Martinez, E. J.; Gil, M. V.; Fernandez, C.; Rosas, J. G.; Gomez, X.			Anaerobic Codigestion of Sludge: Addition of Butcher's Fat Waste as a Cosubstrate for Increasing Biogas Production	PLOS ONE			English	Article							GREASE TRAP SLUDGE; CO-DIGESTION; SEWAGE-SLUDGE; ACTIVATED-SLUDGE; ORGANIC-MATTER; ACIDS; FTIR; SPECTROSCOPY; INHIBITION; ENHANCEMENT	Fat waste discarded from butcheries was used as a cosubstrate in the anaerobic codigestion of sewage sludge (SS). The process was evaluated under mesophilic and thermophilic conditions. The codigestion was successfully attained despite some inhibitory stages initially present that had their origin in the accumulation of volatile fatty acids (VFA) and adsorption of long-chain fatty acids (LCFA). The addition of a fat waste improved digestion stability and increased biogas yields thanks to the higher organic loading rate (OLR) applied to the reactors. However, thermophilic digestion was characterized by an effluent of poor quality and high VFA content. Results from spectroscopic analysis suggested the adsorption of lipid components onto the anaerobic biomass, thus disturbing the complete degradation of substrate during the treatment. The formation of fatty aggregates in the thermophilic reactor prevented process failure by avoiding the exposure of biomass to the toxic effect of high LCFA concentrations.	[Martinez, E. J.; Fernandez, C.; Rosas, J. G.; Gomez, X.] Univ Leon, Chem & Environm Bioprocess Engn Grp, Nat Resources Inst IRENA, E-24071 Leon, Spain; [Gil, M. V.] INCAR CSIC, Inst Nacl Carbon, Oviedo, Asturias, Spain	Universidad de Leon; Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Ciencia Tecnologia del Carbono INCAR-CSIC	Gomez, X (corresponding author), Univ Leon, Chem & Environm Bioprocess Engn Grp, Nat Resources Inst IRENA, E-24071 Leon, Spain.	xagomb@unileon.es	Rosas Mayoral, Jose Guillermo/ABE-8287-2021; TORRES, E. JUDITH MARTINEZ/P-4308-2019; GIL, MARÍA V/A-2774-2017; ELIA JUDITH Martinez, E. J. MARTINEZ TORRES/M-8654-2013; Fernandez, Camino/P-6170-2017; Gomez, Xiomar/C-9031-2014	Rosas Mayoral, Jose Guillermo/0000-0002-3235-8555; TORRES, E. JUDITH MARTINEZ/0000-0002-4426-4353; GIL, MARÍA V/0000-0002-2258-3011; ELIA JUDITH Martinez, E. J. MARTINEZ TORRES/0000-0002-4426-4353; Gomez, Xiomar/0000-0001-9595-8825	Ministerio de Economia y Competitividad [CTQ2015-68925-R]	Ministerio de Economia y Competitividad(Spanish Government)	This work was financially supported by the Ministerio de Economia y Competitividad through the project CTQ2015-68925-R (http://www.mineco.gob.es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGELIDAKI I, 1992, APPL MICROBIOL BIOT, V37, P808, DOI 10.1007/BF00174850; [Anonymous], 2008, AGR SYST, V98, P126, DOI [10.1016/j.agsy.2008.05.003, DOI 10.1016/J.AGSY.2008.05.003]; [Anonymous], 2006, LIVESTOCKS LONG SHAD, V3, P1, DOI [10.1007/s10666-008-9149-3, DOI 10.1007/S10666-008-9149-3]; APHA, 2005, STANDARD METHODS EXA, V21st; Bolzonella D, 2012, WASTE MANAGE, V32, P1196, DOI 10.1016/j.wasman.2012.01.006; Borowski S, 2015, WASTE MANAGE, V40, P119, DOI 10.1016/j.wasman.2015.03.021; Carballo T, 2008, BIODEGRADATION, V19, P815, DOI 10.1007/s10532-008-9184-4; Cavaleiro AJ, 2008, BIORESOURCE TECHNOL, V99, P4086, DOI 10.1016/j.biortech.2007.09.005; Davidsson A, 2008, WASTE MANAGE, V28, P986, DOI 10.1016/j.wasman.2007.03.024; De Oliveira Silva J, 2012, THERMOCHIM ACTA, V528, P72, DOI [DOI 10.1016/J.TCA.2011.11.010, 10.1016/j.tca.2011.11.010]; Drewnowski A, 1997, J AM DIET ASSOC, V97, pS58, DOI 10.1016/S0002-8223(97)00732-3; Fernandez C, 2015, BIOMASS BIOENERG, V81, P55, DOI 10.1016/j.biombioe.2015.05.024; Francioso O, 2010, J HAZARD MATER, V175, P740, DOI 10.1016/j.jhazmat.2009.10.071; Guillen MD, 1997, J AM OIL CHEM SOC, V74, P1281, DOI 10.1007/s11746-997-0058-4; HANAKI K, 1981, BIOTECHNOL BIOENG, V23, P1591, DOI 10.1002/bit.260230717; Hernandez-Martinez M, 2013, LWT-FOOD SCI TECHNOL, V52, P12, DOI 10.1016/j.lwt.2013.01.001; Hidalgo D, 2015, INT J ENVIRON SCI TE, V12, P1727, DOI 10.1007/s13762-014-0560-9; Cuetos MJ, 2010, BIODEGRADATION, V21, P543, DOI 10.1007/s10532-009-9322-7; Jouraiphy A, 2008, BIORESOURCE TECHNOL, V99, P1066, DOI 10.1016/j.biortech.2007.02.031; Kim M, 2002, WATER RES, V36, P4369, DOI 10.1016/S0043-1354(02)00147-1; Kim SH, 2004, J CHEM TECHNOL BIOT, V79, P63, DOI 10.1002/jctb.939; Lalman JA, 2001, WATER RES, V35, P2975, DOI 10.1016/S0043-1354(00)00593-5; Luostarinen S, 2009, BIORESOURCE TECHNOL, V100, P79, DOI 10.1016/j.biortech.2008.06.029; Martinez EJ, 2012, INT BIODETER BIODEGR, V75, P1, DOI 10.1016/j.ibiod.2012.07.015; Mata-Alvarez J, 2000, BIORESOURCE TECHNOL, V74, P3, DOI 10.1016/S0960-8524(00)00023-7; Meissl K, 2007, TALANTA, V72, P791, DOI 10.1016/j.talanta.2006.12.005; Naumann A, 2010, FIELD CROP RES, V119, P78, DOI 10.1016/j.fcr.2010.06.017; Pereira MA, 2005, BIOTECHNOL BIOENG, V92, P15, DOI 10.1002/bit.20548; Pereira MA, 2004, BIOTECHNOL BIOENG, V88, P502, DOI 10.1002/bit.20278; Provenzano MR, 2014, WASTE MANAGE, V34, P653, DOI 10.1016/j.wasman.2013.12.001; Rasit N, 2015, RENEW SUST ENERG REV, V45, P351, DOI 10.1016/j.rser.2015.01.066; Sage M, 2008, J DAIRY SCI, V91, P4062, DOI 10.3168/jds.2007-0931; Silvestre G, 2014, APPL ENERG, V117, P87, DOI 10.1016/j.apenergy.2013.11.075; Socrates G., 2004, INFRARED RAMAN CHARA; Tandon P, 2000, J MOL STRUCT, V524, P201, DOI 10.1016/S0022-2860(00)00378-1; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Wu LJ, 2015, INT BIODETER BIODEGR, V104, P315, DOI 10.1016/j.ibiod.2015.06.020; Yirong C, 2015, WASTE BIOMASS VALORI, V6, P1, DOI 10.1007/s12649-014-9327-2; Zhang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066845; Zonta Z, 2013, WATER RES, V47, P1369, DOI 10.1016/j.watres.2012.12.007	40	34	34	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153139	10.1371/journal.pone.0153139	http://dx.doi.org/10.1371/journal.pone.0153139			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27071074	gold, Green Published			2022-12-26	WOS:000373900700034
J	Rubab, K; Mustafa, M				Rubab, Khansa; Mustafa, M.			Cattaneo-Christov Heat Flux Model for MHD Three-Dimensional Flow of Maxwell Fluid over a Stretching Sheet	PLOS ONE			English	Article							BOUNDARY-LAYER-FLOW; MIXED CONVECTION; MAGNETIC-FIELD; NANOFLUID; CHANNEL; SLIP	This letter investigates the MHD three-dimensional flow of upper -convected Maxwell (UCM) fluid over a bi-directional stretching surface by considering the Cattaneo-Christov heat flux model. This model has tendency to capture the characteristics of thermal relaxation time. The governing partial differential equations even after employing the boundary layer approximations are non linear. Accurate analytic solutions for velocity and temperature distributions are computed through well-known homotopy analysis method (HAM). It is noticed that velocity decreases and temperature rises when stronger magnetic field strength is accounted. Penetration depth of temperature is a decreasing function of thermal relaxation time. The analysis for classical Fourier heat conduction law can be obtained as a special case of the present work. To our knowledge, the Cattaneo-Christov heat flux model law for three-dimensional viscoelastic flow problem is just introduced here.	[Rubab, Khansa; Mustafa, M.] NUST, SNS, Islamabad 44000, Pakistan	National University of Sciences & Technology - Pakistan	Mustafa, M (corresponding author), NUST, SNS, Islamabad 44000, Pakistan.	meraj_mm@hotmail.com	Mustafa Hashmi, Meraj/P-1769-2014					Cattaneo C., 1948, ATTI SEMIN MAT FIS, V3, P83, DOI DOI 10.1007/978-3-642-11051-1_5; Christov CI, 2009, MECH RES COMMUN, V36, P481, DOI 10.1016/j.mechrescom.2008.11.003; Ciarletta M, 2010, MECH RES COMMUN, V37, P445, DOI 10.1016/j.mechrescom.2010.06.002; Dhanai R, 2016, POWDER TECHNOL, V288, P140, DOI 10.1016/j.powtec.2015.11.004; Fetecau C, 2009, INT J NONLIN MECH, V44, P1085, DOI 10.1016/j.ijnonlinmec.2009.08.003; Fourier J.-B.J., 1822, THEORIE ANAL CHALEUR; Gul T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126698; Gul T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103843; Gul T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097552; Hakeem AKA, 2015, J MAGN MAGN MATER, V381, P243, DOI 10.1016/j.jmmm.2014.12.010; Han SH, 2014, APPL MATH LETT, V38, P87, DOI 10.1016/j.aml.2014.07.013; Hayat T, 2016, J MAGN MAGN MATER, V401, P733, DOI 10.1016/j.jmmm.2015.10.107; Hayat T, 2015, J MAGN MAGN MATER, V395, P48, DOI 10.1016/j.jmmm.2015.07.027; Hayat T, 2012, INT J NUMER METH FL, V68, P233, DOI 10.1002/fld.2503; Hayat T, 2016, J MAGN MAGN MATER, V401, P296, DOI 10.1016/j.jmmm.2015.10.039; Hayat T, 2010, Z NATURFORSCH A, V65, P401, DOI 10.1515/zna-2010-0505; Hsiao KL, 2014, ARAB J SCI ENG, V39, P4325, DOI 10.1007/s13369-014-1065-z; Hsiao KL, 2011, INT J NONLIN MECH, V46, P1, DOI 10.1016/j.ijnonlinmec.2010.06.005; Karra S, 2011, INT J NONLIN MECH, V46, P819, DOI 10.1016/j.ijnonlinmec.2011.02.013; Khan JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137363; Kumari M, 2009, INT J NONLIN MECH, V44, P1048, DOI 10.1016/j.ijnonlinmec.2009.08.002; Liao S, 2004, APPL MATH COMPUT, V147, P499, DOI [10.1016/S0096-3003(02)00790-7, 10.1016/50096-3003(02)00790-7]; Liao S., 2012, HOMOTOPY ANAL METHOD; Mabood F, 2015, J MAGN MAGN MATER, V374, P569, DOI 10.1016/j.jmmm.2014.09.013; Mushtaq A, 2014, J AEROSPACE ENG, V27, DOI 10.1061/(ASCE)AS.1943-5525.0000361; Mustafa M, 2015, AIP ADV, V5, DOI 10.1063/1.4907927; Mustafa M, 2015, AIP ADV, V5, DOI 10.1063/1.4917306; Rashidi MM, 2016, J MAGN MAGN MATER, V401, P159, DOI 10.1016/j.jmmm.2015.10.034; Shateyi S, 2013, BOUND VALUE PROBL, DOI 10.1186/1687-2770-2013-196; Straughan B, 2010, INT J HEAT MASS TRAN, V53, P95, DOI 10.1016/j.ijheatmasstransfer.2009.10.001; Tibullo V, 2011, MECH RES COMMUN, V38, P77, DOI 10.1016/j.mechrescom.2010.10.008; Zheng LC, 2012, MATH COMPUT MODEL, V56, P133, DOI 10.1016/j.mcm.2011.11.080	32	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153481	10.1371/journal.pone.0153481	http://dx.doi.org/10.1371/journal.pone.0153481			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093542	Green Published, gold, Green Submitted			2022-12-26	WOS:000374541200023
J	Seraphin, MN; Lauzardo, M; Doggett, RT; Zabala, J; Morris, JG; Blackburn, JK				Seraphin, Marie Nancy; Lauzardo, Michael; Doggett, Richard T.; Zabala, Jose; Morris, J. Glenn, Jr.; Blackburn, Jason K.			Spatiotemporal Clustering of Mycobacterium tuberculosis Complex Genotypes in Florida: Genetic Diversity Segregated by Country of Birth	PLOS ONE			English	Article							DRUG-RESISTANT TUBERCULOSIS; POPULATION-GENETICS; UNITED-STATES; TRANSMISSION; IMMIGRATION; OUTBREAK; STRAINS; DATABASE; LINEAGE; REGION	Background Tuberculosis (TB) is caused by members of the Mycobacterium tuberculosis complex (MTBC). Although the MTBC is highly clonal, between -strain genetic diversity has been observed. In low TB incidence settings, immigration may facilitate the importation of MTBC strains with a potential to complicate TB control efforts. Methods We investigated the genetic diversity and spatiotemporal clustering of 2,510 MTBC strains isolated in Florida, United States, between 2009 and 2013 and genotyped using spoligotyping and 24 -locus MIRU-VNTR. We mapped the genetic diversity to the centroid of patient residential zip codes using a geographic information system (GIS). We assessed transmission dynamics and the influence of immigration on genotype clustering using space-time permutation models adjusted for foreign-born population density and county-level HIV risk and multinomial models stratified by country of birth and timing of immigration in SaTScan. Principal Findings Among the 2,510 strains, 1,245 were reported among foreign-born persons; including 408 recent immigrants (<5 years). Strain allelic diversity (h) ranged from low to medium in most locations and was most diverse in urban centers where foreign -born population density was also high. Overall, 21.5% of cases among U.S.-born persons and 4.6% among foreign-born persons clustered genotypically and spatiotemporally and involved strains of the Haarlem family. One Haarlem space-time cluster identified in the mostly rural northern region of Florida included US/Canada-born individuals incarcerated at the time of diagnosis; two clusters in the mostly urban southern region of Florida were composed predominantly of foreign born persons. Both groups had HIV prevalence above twenty percent. Conclusions/Significance Almost five percent of TB cases reported in Florida during 2009-2013 were potentially due to recent transmission. Improvements to TB screening practices among the prison population and recent immigrants are likely to impact TB control. Due to the monomorphic nature of available markers, whole genome sequencing is needed to conclusively delineate recent transmission events between U.S. and foreign-born persons.	[Seraphin, Marie Nancy; Lauzardo, Michael; Morris, J. Glenn, Jr.] Univ Florida, Coll Med, Dept Med, Div Infect Dis & Global Med, Gainesville, FL USA; [Seraphin, Marie Nancy; Lauzardo, Michael; Morris, J. Glenn, Jr.; Blackburn, Jason K.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Seraphin, Marie Nancy] Univ Florida, Coll Med, Dept Epidemiol, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA; [Doggett, Richard T.; Zabala, Jose] Florida Dept Hlth, TB Control Sect, Bur Communicable Dis, Tallahassee, FL USA; [Blackburn, Jason K.] Univ Florida, Dept Geog, Spatial Epidemiol & Ecol Res Lab, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Florida Department of Health; State University System of Florida; University of Florida	Seraphin, MN (corresponding author), Univ Florida, Coll Med, Dept Med, Div Infect Dis & Global Med, Gainesville, FL USA.; Seraphin, MN (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.; Seraphin, MN (corresponding author), Univ Florida, Coll Med, Dept Epidemiol, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA.	nseraphin@ufl.edu	Seraphin, Marie/AAQ-4366-2020; Blackburn, Jason/AAV-9445-2020	Seraphin, Marie/0000-0002-2120-6011; Blackburn, Jason/0000-0003-0928-4831	College of Medicine, University of Florida [00107788]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001427, KL2TR001429] Funding Source: NIH RePORTER	College of Medicine, University of Florida; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	MNS is supported by a grant from the College of Medicine, University of Florida (grant number 00107788), to ML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, MMWR Recomm Rep, V48, P1; [Anonymous], 2010, PLOS MED, V7, DOI [10.1371/journal.pmed.1000383, DOI 10.1371/JOURNAL.PMED.1000383]; Asghar RJ, 2009, J URBAN HEALTH, V86, P776, DOI 10.1007/s11524-009-9378-z; Bamrah S, 2013, INT J TUBERC LUNG D, V17, P1414, DOI 10.5588/ijtld.13.0270; Barro AS, 2015, APPL GEOGR, V60, P29, DOI 10.1016/j.apgeog.2015.02.014; Braden CR, 1997, J INFECT DIS, V175, P1446, DOI 10.1086/516478; Brites D, 2012, INFECT GENET EVOL, V12, P678, DOI 10.1016/j.meegid.2011.08.010; Brudey K, 2006, J CLIN MICROBIOL, V44, P183, DOI 10.1128/JCM.44.1.183-191.2006; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Cain KP, 2008, JAMA-J AM MED ASSOC, V300, P405, DOI 10.1001/jama.300.4.405; Cavanaugh JS, 2012, AM J PSYCHIAT, V169, P569, DOI 10.1176/appi.ajp.2011.11081311; Centers for Disease Control and Prevention (CDC), 2012, MMWR Morb Mortal Wkly Rep, V61, P539; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P101; Centers for Disease Control and Prevention (CDC), 2016, REP TUB US; Chaoui I, 2014, INFECT GENET EVOL, V21, P463, DOI 10.1016/j.meegid.2013.05.023; Click ES, 2012, CLIN INFECT DIS, V54, P211, DOI 10.1093/cid/cir788; Coscolla M, 2014, SEMIN IMMUNOL, V26, P431, DOI 10.1016/j.smim.2014.09.012; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Farnia P, 2006, J INFECTION, V53, P331, DOI 10.1016/j.jinf.2005.12.020; Fenner L, 2012, J CLIN MICROBIOL, V50, P388, DOI 10.1128/JCM.05392-11; Ferdinand S, 2003, J CLIN MICROBIOL, V41, P694, DOI 10.1128/JCM.41.2.694-702.2003; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2012, PHILOS T R SOC B, V367, P850, DOI 10.1098/rstb.2011.0316; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Garzelli C, 2010, CLIN MICROBIOL INFEC, V16, P1691, DOI [10.1111/j.1469-0691.2009.03149.x, 10.1111/j.1469-0691.2010.03149.x]; Ghosh S, 2012, INFECT GENET EVOL, V12, P782, DOI 10.1016/j.meegid.2011.10.013; Haase I, 2007, INT J TUBERC LUNG D, V11, P632; Hawthorne B., 2009, GEOSPATIAL MODELLING; Hightower J, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0453-2; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Jasmer RM, 2002, NEW ENGL J MED, V347, P1860, DOI 10.1056/NEJMcp021045; Keshavjee S, 2012, NEW ENGL J MED, V367, P931, DOI 10.1056/NEJMra1205429; Kulaga S, 2004, AM J EPIDEMIOL, V159, P507, DOI 10.1093/aje/kwh065; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Kulldorff M., 2014, SATSCAN US GUID VERS; Lillebaek T, 2001, J CLIN MICROBIOL, V39, P855, DOI 10.1128/JCM.39.3.855-861.2001; Malakmadze N, 2005, CLIN INFECT DIS, V40, P366, DOI 10.1086/427112; Marais BJ, 2006, J CLIN MICROBIOL, V44, P3539, DOI 10.1128/JCM.01291-06; Mardassi H, 2005, EMERG INFECT DIS, V11, P957; Martins MC, 2013, INFECT GENET EVOL, V14, P39, DOI 10.1016/j.meegid.2012.10.015; Mazars E, 2001, P NATL ACAD SCI USA, V98, P1901, DOI 10.1073/pnas.98.4.1901; Millet JP, 2013, EUR SPINE J, V22, P539, DOI 10.1007/s00586-012-2334-8; Moonan PK, 2012, EMERG INFECT DIS, V18, P458, DOI 10.3201/eid1803.111107; Oren E, 2011, AM J PUBLIC HEALTH, V101, P1256, DOI 10.2105/AJPH.2010.300030; Ricks PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027405; Rodwell TC, 2012, INFECT GENET EVOL, V12, P1917, DOI 10.1016/j.meegid.2012.08.022; Root ED, 2009, SOC SCI MED, V68, P1361, DOI 10.1016/j.socscimed.2009.01.034; SELANDER RK, 1986, APPL ENVIRON MICROB, V51, P873, DOI 10.1128/AEM.51.5.873-884.1986; Sterling TR, 2006, CLIN INFECT DIS, V42, P1711, DOI 10.1086/504332; Svensson K, 2009, EMERG INFECT DIS, V15, P1937, DOI 10.3201/eid1512.090487; Teeter LD, 2013, TUBERCULOSIS, V93, pS38, DOI 10.1016/S1472-9792(13)70009-X; Tuite AR, 2013, INT J TUBERC LUNG D, V17, P1322, DOI 10.5588/ijtld.13.0145; United States Census Bureau, 2015, POP EST JUL 1 2014 V; University of Florida, ZIP COD AR 5 DIG FLO; Vanhomwegen J, 2011, J CLIN MICROBIOL, V49, P834, DOI 10.1128/JCM.01952-10; Walker TM, 2014, LANCET RESP MED, V2, P285, DOI 10.1016/S2213-2600(14)70027-X; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; World Health Organization, GLOB TUB REP 2015; World Health Organization, 2014, GLOB TUB CONTR 2014; Yimer SA, 2015, J CLIN MICROBIOL, V53, P1301, DOI 10.1128/JCM.03566-14	60	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153575	10.1371/journal.pone.0153575	http://dx.doi.org/10.1371/journal.pone.0153575			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9NW	27093156	gold, Green Published, Green Submitted			2022-12-26	WOS:000374541200030
J	Zuberi, M; Khan, I; Mir, R; Gandhi, G; Ray, PC; Saxena, A				Zuberi, Mariyam; Khan, Imran; Mir, Rashid; Gandhi, Gauri; Ray, Prakash Chandra; Saxena, Alpana			Utility of Serum miR-125b as a Diagnostic and Prognostic Indicator and Its Alliance with a Panel of Tumor Suppressor Genes in Epithelial Ovarian Cancer	PLOS ONE			English	Article							MICRORNA EXPRESSION; LUNG-CANCER; UP-REGULATION; CELLS; PROLIFERATION; RESISTANCE; HYPERMETHYLATION; METHYLATION; BIOMARKERS; CARCINOMA	MicroRNAs (miRNAs) have been found to be dysregulated in epithelial ovarian cancer (EOC) and may function as either tumor suppressor genes (TSGs) or as oncogenes. Hypermethylation of miRNA silences the tumour suppressive function of a miRNA or hypermethylation of a TSG regulating that miRNA (or vice versa) leads to its loss of function. The present study aims to evaluate the impact of aberrant microRNA-125b (miR-125b) expression on various clinicopathological features in epithelial ovarian cancer and its association with anomalous methylation of several TSGs. We enrolled 70 newly diagnosed cases of epithelial ovarian cancer, recorded their clinical history and 70 healthy female volunteers. Serum miR-125b levels were determined by quantitative reverse transcription polymerase chain reaction (qRT-PCR) and the methylation status of various TSGs was investigated by methylation specific PCR. ROC curves were constructed to estimate the diagnostic and prognostic usefulness of miR-125b. The Kaplan-Meier method was applied to compare survival curves. Expression of miR-125b was found to be significantly upregulated (p<0.0001) in comparison with healthy controls. The expression level of miR-125b was found to be significantly associated with FIGO stage, lymph node and distant metastasis. ROC curve for diagnostic potential yielded significant AUC with an equitable sensitivity and specificity. ROC curves for prognosis yielded significant AUCs for histological grade, distal metastasis, lymph node status and survival. The expression of miR-125b also correlated significantly with the hypermethylation of TSGs. Our results indicate that DNA hypermethylation may be involved in the inactivation of miR-125b and miR-125b may function as a potential independent biomarker for clinical outcome in EOC.	[Zuberi, Mariyam; Ray, Prakash Chandra; Saxena, Alpana] Maulana Azad Med Coll & Associated Hosp, Dept Biochem, New Delhi, India; [Khan, Imran] Univ Illinois, Dept Surg, Chicago, IL 60680 USA; [Mir, Rashid] Univ Tabuk, Fac Appl Med Sci, Tabuk 71491, Saudi Arabia; [Gandhi, Gauri] Lok Nayak Hosp, Dept Obstet & Gynaecol, New Delhi, India	Maulana Azad Medical College; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Tabuk	Saxena, A (corresponding author), Maulana Azad Med Coll & Associated Hosp, Dept Biochem, New Delhi, India.	alpanasaxena@hotmail.com	Mir, Rashid/AAH-1895-2019; Mir, Rashid/GOV-3522-2022; Zuberi, Mariyam/Q-6524-2019	Zuberi, Mariyam/0000-0001-6104-1365				Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; Banno K, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/738274; Banzhaf-Strathmann J, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-30; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Budd WT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142373; Catto JWF, 2011, EUR UROL, V59, P671, DOI 10.1016/j.eururo.2011.01.044; Chen H, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/345080; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Gadducci A, 2014, GYNECOL ENDOCRINOL, V30, P266, DOI 10.3109/09513590.2013.871525; Giray BG, 2014, MOL BIOL REP, V41, P4513, DOI 10.1007/s11033-014-3322-3; Guan Y, 2011, INT J CANCER, V128, P2274, DOI 10.1002/ijc.25575; He J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056647; Heinzelmann J, 2014, ANN SURG ONCOL, V21, P1046, DOI 10.1245/s10434-013-3361-3; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Jiang FZ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-425; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kinose Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/249393; Kong FF, 2011, J HUAZHONG U SCI-MED, V31, P543, DOI 10.1007/s11596-011-0487-z; Lee M, 2015, ONCOTARGET; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lujambio A, 2007, CELL CYCLE, V6, P1455; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Luo S, 2015, BIOCHEM BIOPH RES CO, V462, P85, DOI 10.1016/j.bbrc.2015.04.023; Ma YX, 2012, J CANCER RES CLIN, V138, P2045, DOI 10.1007/s00432-012-1285-0; Nelson PT, 2006, RNA, V12, P187, DOI 10.1261/rna.2258506; Nishida N, 2011, INT J ONCOL, V38, P1437, DOI 10.3892/ijo.2011.969; Nishida N, 2011, CLIN CANCER RES, V17, P2725, DOI 10.1158/1078-0432.CCR-10-2132; Pallares J, 2008, MODERN PATHOL, V21, P691, DOI 10.1038/modpathol.2008.38; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Prueitt RL, 2008, PROSTATE, V68, P1152, DOI 10.1002/pros.20786; Ribeiro J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/304584; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Romero PV, 2015, LEUKEMIA, V29, P2442, DOI 10.1038/leu.2015.117; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Sorrentino A, 2008, GYNECOL ONCOL, V111, P478, DOI 10.1016/j.ygyno.2008.08.017; Suzuki H, 2012, MOL ONCOL, V6, P567, DOI 10.1016/j.molonc.2012.07.007; Takakura S, 2008, CANCER SCI, V99, P1147, DOI 10.1111/j.1349-7006.2008.00800.x; Urdinguio RG, 2010, EPIGENETICS-US, V5, P656, DOI 10.4161/epi.5.7.13055; Vilquin P, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0515-1; Wan Y, 2014, NEUROREPORT, V25, P289, DOI 10.1097/WNR.0000000000000085; Wang F., 2016, TECHNOL CANC RES TRE; Wang H, 2012, PLOS ONE, V7, P34210, DOI DOI 10.1371/J0URNAL.P0NE.0034210; Wang M, 2015, BRIT J CANCER, V112, P874, DOI 10.1038/bjc.2015.3; Wang XK, 2015, MOL MED REP, V11, P3880, DOI 10.3892/mmr.2014.3142; Wu N, 2013, BRIT J CANCER, V109, P2853, DOI 10.1038/bjc.2013.672; WU SH, 2015, BIOMED RES INT; Xie XH, 2015, TUMOR BIOL, V36, P7185, DOI 10.1007/s13277-015-3438-7; Yamada A, 2015, CLIN CANCER RES, V21, P4234, DOI 10.1158/1078-0432.CCR-14-2793; Yang QL, 2015, ONCOTARGET, V6, P3268, DOI 10.18632/oncotarget.3065; Zang B, 2015, INT J CLIN EXP PATHO, V8, P13687; Zhao X, 2015, AM J TRANSL RES, V7, P2346; Zhou JN, 2015, HEPATOLOGY, V62, P801, DOI 10.1002/hep.27887	56	54	56	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153902	10.1371/journal.pone.0153902	http://dx.doi.org/10.1371/journal.pone.0153902			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27092777	gold, Green Published			2022-12-26	WOS:000374541200057
J	Noor, Z; Burgess, SL; Watanabe, K; Petri, WA				Noor, Zannatun; Burgess, Stacey L.; Watanabe, Koji; Petri, William A., Jr.			Interleukin-25 Mediated Induction of Angiogenin-4 Is Interleukin-13 Dependent	PLOS ONE			English	Article							INNATE IMMUNITY; EXPRESSION; INFECTION	The intestinal surface is directly exposed to both commensal microorganisms as well as pathogens with a single layer of epithelium separating luminal microorganisms from internal tissues. Antimicrobial peptides play a crucial role in allowing epithelial cells to contain in the lumen beneficial and pathogenic microorganisms. The commensal dependent, epithelial produced, Th2 cytokine IL-25 can induce IL-13 and potentially the antimicrobial peptide angiogenin- 4. Here we show that IL-13 downstream of IL-25 is required to induce angiogenin-4. IL25 mediated induction of angiogenin-4 is furthermore not dependent on IL-22 or IL-17.	[Noor, Zannatun; Burgess, Stacey L.; Watanabe, Koji; Petri, William A., Jr.] Univ Virginia Hlth Syst, Div Infect Dis & Int Hlth, Dept Med, Charlottesville, VA USA; [Watanabe, Koji] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan	University of Virginia; National Center for Global Health & Medicine - Japan	Petri, WA (corresponding author), Univ Virginia Hlth Syst, Div Infect Dis & Int Hlth, Dept Med, Charlottesville, VA USA.	wap3g@virginia.edu	Burgess, Stacey L./ABC-5292-2021; Petri, William A./D-3639-2019; Petri, William/AAL-3642-2020	Petri, William/0000-0002-7268-1218; Noor, Zannatun/0000-0002-9431-358X	NIH [5R01 AI026649]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026649, R01AI043596] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant 5R01 AI026649. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angkasekwinai P, 2013, INFECT IMMUN, V81, P3731, DOI 10.1128/IAI.00646-13; Angkasekwinai P, 2010, NAT IMMUNOL, V11, P250, DOI 10.1038/ni.1846; Datta R, 2005, INFECT IMMUN, V73, P4025, DOI 10.1128/IAI.73.7.4025-4033.2005; Forman RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042248; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Steenwinckel V, 2009, J IMMUNOL, V182, P4737, DOI 10.4049/jimmunol.0801941; Stockinger S, 2014, J INNATE IMMUN, V6, P530, DOI 10.1159/000357644; Walker CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084553; Zaph C, 2008, J EXP MED, V205, P2191, DOI 10.1084/jem.20080720; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	12	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153572	10.1371/journal.pone.0153572	http://dx.doi.org/10.1371/journal.pone.0153572			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27089535	gold, Green Submitted, Green Published			2022-12-26	WOS:000374527000027
J	Araujo, OC; Rosa, AS; Fernandes, A; Niel, C; Villela-Nogueira, CA; Pannain, V; Araujo, NM				Araujo, Oscar C.; Rosa, Agatha S.; Fernandes, Arlete; Niel, Christian; Villela-Nogueira, Cristiane A.; Pannain, Vera; Araujo, Natalia M.			RASSF1A and DOK1 Promoter Methylation Levels in Hepatocellular Carcinoma, Cirrhotic and Non-Cirrhotic Liver, and Correlation with Liver Cancer in Brazilian Patients	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; DNA METHYLATION; TUMOR-SUPPRESSOR; HYPERMETHYLATION; ASSOCIATION; BLOOD	Hepatocellular carcinoma (HCC) is the second most common cause of cancer mortality worldwide. Most cases of HCC are associated with cirrhosis related to chronic hepatitis B virus or hepatitis C virus infections. Hypermethylation of promoter regions is the main epigenetic mechanism of gene silencing and has been involved in HCC development. The aim of this study was to determine whether aberrant methylation of RASSF1A and DOK1 gene promoters is associated with the progression of liver disease in Brazilian patients. Methylation levels were measured by pyrosequencing in 41 (20 HCC, 9 cirrhotic, and 12 non-cirrhotic) liver tissue samples. Mean rates of methylation in RASSF1A and DOK1 were 16.2% and 12.0% in non-cirrhotic, 26.1% and 19.6% in cirrhotic, and 59.1% and 56.0% in HCC tissues, respectively, showing a gradual increase according to the progression of the disease, with significantly higher levels in tumor tissues. In addition, hypermethylation of RASSF1A and DOK1 was found in the vast majority (88%) of the HCC cases. Interestingly, DOK1 methylation levels in HCC samples were significantly higher in the group of younger (<40 years) patients, and higher in moderately differentiated than in poorly differentiated tumors (p < 0.05). Our results reinforce the hypothesis that hypermethylation of RASSF1A and DOK1 contributes to hepatocarcinogenesis and is associated to clinicopathological characteristics. RASSF1A and DOK1 promoter hypermethylation may be a valuable biomarker for early diagnosis of HCC and a potential molecular target for epigenetic-based therapy.	[Araujo, Oscar C.; Rosa, Agatha S.; Niel, Christian; Araujo, Natalia M.] Fiocruz MS, Inst Oswaldo Cruz, Mol Virol Lab, BR-21045900 Rio De Janeiro, Brazil; [Fernandes, Arlete; Pannain, Vera] Univ Fed Rio de Janeiro, Clementino Fraga Filho Univ Hosp, Dept Pathol, Rio De Janeiro, Brazil; [Villela-Nogueira, Cristiane A.] Univ Fed Rio de Janeiro, Clementino Fraga Filho Univ Hosp, Hepatol Div, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Araujo, NM (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Mol Virol Lab, BR-21045900 Rio De Janeiro, Brazil.	nmaraujo@ioc.fiocruz.br	nogueira, cristiane villela/G-7002-2012; Araujo, Natalia M/B-6596-2013; Araujo, Oscar/N-3146-2013	nogueira, cristiane villela/0000-0003-1355-2368; Araujo, Oscar/0000-0002-9681-2980	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [444071/2014-8]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro [E-26/111.528/2013]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://cnpq.br/), grant number 444071/2014-8, to NMA, and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (http://www.faperj.br/), grant number E-26/111.528/2013, to NMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agathanggelou A, 2005, CANCER RES, V65, P3497, DOI 10.1158/0008-5472.CAN-04-4088; Ascha MS, 2010, HEPATOLOGY, V51, P1972, DOI 10.1002/hep.23527; Carrilho FJ, 2010, CLINICS, V65, P1285, DOI 10.1590/S1807-59322010001200010; Colombo M, 2015, LIVER INT, V35, P129, DOI 10.1111/liv.12713; de Vogel S, 2009, CANCER EPIDEM BIOMAR, V18, P3086, DOI 10.1158/1055-9965.EPI-09-0289; Di Gioia S, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-89; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Gao W, 2008, CARCINOGENESIS, V29, P1901, DOI 10.1093/carcin/bgn170; Herceg Z, 2007, MUTAGENESIS, V22, P91, DOI 10.1093/mutage/gel068; Hernandez-Vargas H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009749; Hsiung DT, 2007, CANCER EPIDEM BIOMAR, V16, P108, DOI 10.1158/1055-9965.EPI-06-0636; INCA, 2015, CANC DE FIG; Issa JP, 1999, CRIT REV ONCOL HEMAT, V32, P31, DOI 10.1016/S1040-8428(99)00019-0; Lambert MP, 2011, J HEPATOL, V54, P705, DOI 10.1016/j.jhep.2010.07.027; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Mashima R, 2009, IMMUNOL REV, V232, P273, DOI 10.1111/j.1600-065X.2009.00844.x; Park IY, 2007, GASTROENTEROLOGY, V132, P1476, DOI 10.1053/j.gastro.2007.01.034; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Saulnier A, 2012, INT J CANCER, V130, P2484, DOI 10.1002/ijc.26299; Tischoff I, 2008, WORLD J GASTROENTERO, V14, P1741, DOI 10.3748/wjg.14.1741; Um TH, 2011, J HEPATOL, V54, P939, DOI 10.1016/j.jhep.2010.08.021; Waki T, 2003, ONCOGENE, V22, P4128, DOI 10.1038/sj.onc.1206651; WHO/IARC, 2015, GLOBOCAN 2012 EST CA; Zhang FF, 2011, EPIGENETICS-US, V6, P623, DOI 10.4161/epi.6.5.15335; Zhang XY, 2013, J GASTROENTEROL, V48, P132, DOI 10.1007/s00535-012-0621-0; Zhang YJ, 2002, MOL CARCINOGEN, V35, P85, DOI 10.1002/mc.10076; Zhao ZH, 2013, WORLD J GASTROENTERO, V19, P7189, DOI 10.3748/wjg.v19.i41.7189	28	17	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153796	10.1371/journal.pone.0153796	http://dx.doi.org/10.1371/journal.pone.0153796			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078152	Green Published, gold, Green Submitted			2022-12-26	WOS:000374131700108
J	Sun, XP; Wang, Z; Guo, XX; Li, HY; Gu, ZL				Sun, Xuepeng; Wang, Zhe; Guo, Xiaoxian; Li, Hongye; Gu, Zhenglong			Coordinated Evolution of Transcriptional and Post-Transcriptional Regulation for Mitochondrial Functions in Yeast Strains	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE STRAINS; QUANTITATIVE TRAIT LOCUS; GENE-EXPRESSION; BUDDING YEAST; ADAPTIVE EVOLUTION; PROTEIN EXPRESSION; CELL-CYCLE; NUCLEAR; TRANSLATION; GENOMES	Evolution of gene regulation has been proposed to play an important role in environmental adaptation. Exploring mechanisms underlying coordinated evolutionary changes at various levels of gene regulation could shed new light on how organism adapt in nature. In this study, we focused on regulatory differences between a laboratory Saccharomyces cerevisiae strain BY4742 and a pathogenic S. cerevisiae strain, YJM789. The two strains diverge in many features, including growth rate, morphology, high temperature tolerance, and pathogenicity. Our RNA-Seq and ribosomal footprint profiling data showed that gene expression differences are pervasive, and genes functioning in mitochondria are mostly divergent between the two strains at both transcriptional and translational levels. Combining functional genomics data from other yeast strains, we further demonstrated that significant divergence of expression for genes functioning in the electron transport chain (ETC) was likely caused by differential expression of a transcriptional factor, HAP4, and that post-transcriptional regulation mediated by an RNA-binding protein, PUF3, likely led to expression divergence for genes involved in mitochondrial translation. We also explored mitonuclear interactions via mitochondrial DNA replacement between strains. Although the two mitochondrial genomes harbor substantial sequence divergence, neither growth nor gene expression were affected by mitochondrial DNA replacement in both fermentative and respiratory growth media, indicating compatible mitochondrial and nuclear genomes between these two strains in the tested conditions. Collectively, we used mitochondrial functions as an example to demonstrate for the first time that evolution at both transcriptional and post-transcriptional levels could lead to coordinated regulatory changes underlying strain specific functional variations.	[Sun, Xuepeng; Wang, Zhe; Guo, Xiaoxian; Gu, Zhenglong] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Sun, Xuepeng; Li, Hongye] Zhejiang Univ, Coll Agr & Biotechnol, Hangzhou 310058, Zhejiang, Peoples R China	Cornell University; Zhejiang University	Gu, ZL (corresponding author), Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.	zg27@cornell.edu	Wang, Zhe/H-9269-2019; Li, Hong-Ye/AAX-2736-2020	Li, Hong-Ye/0000-0001-7427-0706	Cornell University; NSF [MCB-1243588]; NIH [1R01AI085286]; China Scholarship Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085286] Funding Source: NIH RePORTER	Cornell University; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by startup funds from Cornell University, NSF MCB-1243588 and NIH 1R01AI085286 awarded to ZG. XS is supported by a visiting student fellowship from China Scholarship Council.	Artieri CG, 2014, GENOME RES, V24, P2011, DOI 10.1101/gr.175893.114; Artieri CG, 2014, GENOME RES, V24, P411, DOI 10.1101/gr.165522.113; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779; Brion C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-681; Bullard JH, 2010, P NATL ACAD SCI USA, V107, P5058, DOI 10.1073/pnas.0912959107; Dimitrov LN, 2009, GENETICS, V183, P365, DOI 10.1534/genetics.109.104497; Dori-Bachash M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001106; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Fay JC, 2005, PLOS GENET, V1, P66, DOI 10.1371/journal.pgen.0010005; Ferea TL, 1999, P NATL ACAD SCI USA, V96, P9721, DOI 10.1073/pnas.96.17.9721; Field Y, 2009, NAT GENET, V41, P438, DOI 10.1038/ng.324; Fraser HB, 2010, P NATL ACAD SCI USA, V107, P2977, DOI 10.1073/pnas.0912245107; Freel KC, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov023; Gaisne M, 1999, CURR GENET, V36, P195, DOI 10.1007/s002940050490; Garcia-Rodriguez LJ, 2007, J CELL BIOL, V176, P197, DOI 10.1083/jcb.200606054; Gardin J, 2014, ELIFE, V3, DOI 10.7554/eLife.03735; Gerashchenko MV, 2012, P NATL ACAD SCI USA, V109, P17394, DOI 10.1073/pnas.1120799109; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Hickman MJ, 2007, MOL CELL BIOL, V27, P7414, DOI 10.1128/MCB.00887-07; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ingolia NT, 2014, NAT REV GENET, V15, P205, DOI 10.1038/nrg3645; Ingolia NT, 2010, METHOD ENZYMOL, V470, P119, DOI 10.1016/S0076-6879(10)70006-9; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jiang HF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001030; Kemmeren P, 2014, CELL, V157, P740, DOI 10.1016/j.cell.2014.02.054; Khan Z, 2013, SCIENCE, V342, P1100, DOI 10.1126/science.1242379; Khan Z, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.34; Kurtzman CP, 2006, TOP CURR GENET, V15, P29, DOI 10.1007/b106654; Kvitek DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000223; LANCASHIRE WE, 1979, MOL GEN GENET, V170, P333, DOI 10.1007/BF00267067; Lee HY, 2008, CELL, V135, P1065, DOI 10.1016/j.cell.2008.10.047; Levin L, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00448; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Luo DP, 2013, NAT GENET, V45, P573, DOI 10.1038/ng.2570; MCCUSKER JH, 1994, GENETICS, V136, P1261; McManus CJ, 2014, GENOME RES, V24, P422, DOI 10.1101/gr.164996.113; Meiklejohn CD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003238; Moqtaderi Z, 2013, P NATL ACAD SCI USA, V110, P11073, DOI 10.1073/pnas.1309384110; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Oleksiak MF, 2002, NAT GENET, V32, P261, DOI 10.1038/ng983; Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50; Paliwal S, 2014, GENETICS, V198, P1251, DOI 10.1534/genetics.114.168575; Pesole G, 1999, J MOL EVOL, V48, P427, DOI 10.1007/PL00006487; Quenault T, 2011, TRENDS CELL BIOL, V21, P104, DOI 10.1016/j.tcb.2010.09.013; Raghevendran V, 2006, J BIOL CHEM, V281, P12308, DOI 10.1074/jbc.M512972200; Saveanu C, 2001, J BIOL CHEM, V276, P15861, DOI 10.1074/jbc.M010864200; Schacherer J, 2009, NATURE, V458, P342, DOI 10.1038/nature07670; Sinha H, 2006, PLOS GENET, V2, P140, DOI 10.1371/journal.pgen.0020013; Skelly DA, 2013, GENOME RES, V23, P1496, DOI 10.1101/gr.155762.113; Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083; Stanke M, 2006, NUCLEIC ACIDS RES, V34, pW435, DOI 10.1093/nar/gkl200; Stebbins JL, 2004, EUKARYOT CELL, V3, P339, DOI 10.1128/EC.3.2.339-347.2004; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; TAWFIK OW, 1989, J CLIN MICROBIOL, V27, P1689, DOI 10.1128/JCM.27.7.1689-1691.1989; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Treu L, 2014, ENVIRON MICROBIOL, V16, P1378, DOI 10.1111/1462-2920.12327; TRUMBLY RJ, 1983, J BACTERIOL, V156, P36, DOI 10.1128/JB.156.1.36-48.1983; Tsankov AM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000414; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Veatch JR, 2009, CELL, V137, P1247, DOI 10.1016/j.cell.2009.04.014; Wang Z, 2015, GENOME BIOL EVOL, V7, P1155, DOI 10.1093/gbe/evv059; Wei W, 2007, P NATL ACAD SCI USA, V104, P12825, DOI 10.1073/pnas.0701291104; Zheng W, 2010, NATURE, V464, P1187, DOI 10.1038/nature08934; Zhong Silin, 2011, Cold Spring Harb Protoc, V2011, P940, DOI 10.1101/pdb.prot5652	70	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153523	10.1371/journal.pone.0153523	http://dx.doi.org/10.1371/journal.pone.0153523			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077367	gold, Green Submitted, Green Published			2022-12-26	WOS:000374131700073
J	Yu, FQ; Zhang, XG; Huang, Z; Chu, MG; Song, T; Falk, KC; Deora, A; Chen, QL; Zhang, Y; McGregor, L; Gossen, BD; McDonald, MR; Peng, G				Yu, Fengqun; Zhang, Xingguo; Huang, Zhen; Chu, Mingguang; Song, Tao; Falk, Kevin C.; Deora, Abhinandan; Chen, Qilin; Zhang, Yan; McGregor, Linda; Gossen, Bruce D.; McDonald, Mary Ruth; Peng, Gary			Identification of Genome-Wide Variants and Discovery of Variants Associated with Brassica rapa Clubroot Resistance Gene Rcr1 through Bulked Segregant RNA Sequencing	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; SINGLE NUCLEOTIDE POLYMORPHISMS; PLASMODIOPHORA-BRASSICAE; CHINESE-CABBAGE; RFLP MARKERS; CONFERRING RESISTANCE; ARABIDOPSIS-THALIANA; DISEASE-RESISTANCE; CAMPESTRIS L; NAPUS	Clubroot, caused by Plasmodiophora brassicae, is an important disease on Brassica species worldwide. A clubroot resistance gene, Rcr1, with efficacy against pathotype 3 of P. brassicae, was previously mapped to chromosome A03 of B. rapa in pak choy cultivar "Flower Nabana". In the current study, resistance to pathotypes 2, 5 and 6 was shown to be associated with Rcr1 region on chromosome A03. Bulked segregant RNA sequencing was performed and short read sequences were assembled into 10 chromosomes of the B. rapa reference genome v1.5. For the resistant (R) bulks, a total of 351.8 million (M) sequences, 30,836.5 million bases (Mb) in length, produced 120-fold coverage of the reference genome. For the susceptible (S) bulks, 322.9 M sequences, 28,216.6 Mb in length, produced 109-fold coverage. In total, 776.2 K single nucleotide polymorphisms (SNPs) and 122.2 K insertion / deletion (InDels) in R bulks and 762.8 K SNPs and 118.7 K InDels in S bulks were identified; each chromosome had about 87% SNPs and 13% InDels, with 78% monomorphic and 22% polymorphic variants between the R and S bulks. Polymorphic variants on each chromosome were usually below 23%, but made up 34% of the variants on chromosome A03. There were 35 genes annotated in the Rcr1 target region and variants were identified in 21 genes. The numbers of poly variants differed significantly among the genes. Four out of them encode Toll-Interleukin-1 receptor / nucleotide-binding site / leucine- rich-repeat proteins; Bra019409 and Bra019410 harbored the higher numbers of polymorphic variants, which indicates that they are more likely candidates of Rcr1. Fourteen SNP markers in the target region were genotyped using the Kompetitive Allele Specific PCR method and were confirmed to associate with Rcr1. Selected SNP markers were analyzed with 26 recombinants obtained from a segregating population consisting of 1587 plants, indicating that they were completely linked to Rcr1. Nine SNP markers were used for marker-assisted introgression of Rcr1 into B. napus canola from B. rapa, with 100% accuracy in this study.	[Yu, Fengqun; Zhang, Xingguo; Huang, Zhen; Chu, Mingguang; Song, Tao; Falk, Kevin C.; Chen, Qilin; Zhang, Yan; McGregor, Linda; Gossen, Bruce D.; Peng, Gary] Agr & Agri Food Canada, Saskatoon Res Ctr, Saskatoon, SK, Canada; [Deora, Abhinandan; McDonald, Mary Ruth] Univ Guelph, Dept Plant Agr, Guelph, ON N1G 2W1, Canada; [Zhang, Xingguo] Henan Agr Univ, Zhengzhou, Peoples R China; [Huang, Zhen] Northwest A&F Univ, Yangling, Shaanxi, Peoples R China; [Deora, Abhinandan] Syngenta Canada Inc, Plattsville, ON, Canada	Agriculture & Agri Food Canada; University of Guelph; Henan Agricultural University; Northwest A&F University - China; Syngenta	Yu, FQ (corresponding author), Agr & Agri Food Canada, Saskatoon Res Ctr, Saskatoon, SK, Canada.	fengqun.yu@agr.gc.ca	McDonald, Mary Ruth/R-8809-2019; Gossen, Bruce/W-3414-2019	McDonald, Mary Ruth/0000-0002-2881-815X; Gossen, Bruce/0000-0001-5869-930X				Bancroft I, 2011, NAT BIOTECHNOL, V29, P762, DOI 10.1038/nbt.1926; Beissinger TM, 2013, GENETICS, V193, P1073, DOI 10.1534/genetics.112.147710; Bolger ME, 2014, CURR OPIN BIOTECH, V26, P31, DOI 10.1016/j.copbio.2013.08.019; Chen JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085307; Cho KH, 2012, J HORTIC SCI BIOTECH, V87, P325, DOI 10.1080/14620316.2012.11512872; Chu MG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1166; CRETE R., 1963, CANADIAN JOUR PLANT SCI, V43, P349; Diederichsen E, 2006, ACTA HORTIC, P307, DOI 10.17660/ActaHortic.2006.706.35; Diederichsen E, 2009, J PLANT GROWTH REGUL, V28, P265, DOI 10.1007/s00344-009-9100-0; Dixon GR, 2009, J PLANT GROWTH REGUL, V28, P194, DOI 10.1007/s00344-009-9090-y; FIGDORE SS, 1993, EUPHYTICA, V69, P33, DOI 10.1007/BF00021723; Fuchs H, 1996, MOL PLANT MICROBE IN, V9, P91, DOI 10.1094/MPMI-9-0091; Gao F, 2014, J AM SOC HORTIC SCI, V139, P247, DOI 10.21273/JASHS.139.3.247; Gautam M, 2013, ALIEN GENE TRANSFER, V2, P207; GOWERS S, 1982, EUPHYTICA, V31, P971, DOI 10.1007/BF00039237; Grandclement C, 1996, THEOR APPL GENET, V93, P86, DOI 10.1007/BF00225731; Harper AL, 2012, NAT BIOTECHNOL, V30, P798, DOI 10.1038/nbt.2302; Hasan MJ, 2012, CAN J PLANT SCI, V92, P501, DOI [10.4141/CJPS2010-006, 10.4141/cjps2010-006]; Hatakeyama K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054745; Hayashida N, 2008, J JPN SOC HORTIC SCI, V77, P150, DOI 10.2503/jjshs1.77.150; Hirai M, 2004, THEOR APPL GENET, V108, P639, DOI 10.1007/s00122-003-1475-x; Howard RJ, 2010, CAN J PLANT PATHOL, V32, P43, DOI 10.1080/07060661003621761; Hu ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034253; Iversen GR, 1997, SPRINGER UNDERGRADUA; JOHNSTON TD, 1974, EUPHYTICA, V23, P681, DOI 10.1007/BF00022490; Kageyama K, 2009, J PLANT GROWTH REGUL, V28, P203, DOI 10.1007/s00344-009-9101-z; Kamei A, 2010, THEOR APPL GENET, V120, P1021, DOI 10.1007/s00122-009-1230-z; Kato T, 2013, BREEDING SCI, V63, P116, DOI 10.1270/jsbbs.63.116; Kuginuki Y, 1997, EUPHYTICA, V98, P149, DOI 10.1023/A:1003147815692; LANDRY BS, 1992, GENOME, V35, P409, DOI 10.1139/g92-061; Li QF, 2013, THEOR APPL GENET, V126, P2073, DOI 10.1007/s00122-013-2119-4; Liu SY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036406, 10.1371/journal.pone.0030349]; Mammadov Jafar, 2012, Int J Plant Genomics, V2012, P728398, DOI 10.1155/2012/728398; Manzanares-Dauleux MJ, 2000, THEOR APPL GENET, V101, P885, DOI 10.1007/s001220051557; Marian AJ, 2010, CURR OPIN CARDIOL, V25, P182, DOI 10.1097/HCO.0b013e3283389683; Matsumoto E, 1998, EUPHYTICA, V104, P79, DOI 10.1023/A:1018370418201; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Moriguchi K, 1999, BREEDING SCI, V49, P257, DOI 10.1270/jsbbs.49.257; Nagaoka T, 2010, THEOR APPL GENET, V120, P1335, DOI 10.1007/s00122-010-1259-z; Nikolaev SI, 2004, P NATL ACAD SCI USA, V101, P8066, DOI 10.1073/pnas.0308602101; Nomura K, 2005, PLANT BREEDING, V124, P371, DOI 10.1111/j.1439-0523.2005.01105.x; Pang WX, 2014, HORTIC ENVIRON BIOTE, V55, P540, DOI 10.1007/s13580-014-0079-5; Paritosh K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-463; Peng G, 2014, CAN J PLANT PATHOL, V36, P99, DOI 10.1080/07060661.2013.860398; Pfender WF, 2011, THEOR APPL GENET, V122, P1467, DOI 10.1007/s00122-011-1546-3; Piao ZY, 2004, THEOR APPL GENET, V108, P1458, DOI 10.1007/s00122-003-1577-5; Rafalski A, 2002, CURR OPIN PLANT BIOL, V5, P94, DOI 10.1016/S1369-5266(02)00240-6; Rahman H, 2011, CAN J PLANT SCI, V91, P447, DOI [10.4141/CJPS10073, 10.4141/cjps10073]; Riahi L, 2013, GENET RESOUR CROP EV, V60, P1139, DOI 10.1007/s10722-012-9910-y; Rocherieux J, 2004, THEOR APPL GENET, V108, P1555, DOI 10.1007/s00122-003-1580-x; Saito M, 2006, THEOR APPL GENET, V114, P81, DOI 10.1007/s00122-006-0412-1; Sakamoto K, 2008, THEOR APPL GENET, V117, P759, DOI 10.1007/s00122-008-0817-0; Sathya B, 2015, APPL TRANSL GENOM, V4, P4, DOI 10.1016/j.atg.2014.12.003; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Semagn K, 2014, MOL BREEDING, V33, P1, DOI 10.1007/s11032-013-9917-x; Strelkov SE, 2007, J PHYTOPATHOL, V155, P706, DOI 10.1111/j.1439-0434.2007.01303.x; Strelkov SE, 2006, CAN J PLANT PATHOL, V28, P467, DOI 10.1080/07060660609507321; Strelkov SE, 2014, CAN J PLANT PATHOL, V36, P27, DOI 10.1080/07060661.2013.863807; Suwabe K, 2003, THEOR APPL GENET, V107, P997, DOI 10.1007/s00122-003-1309-x; Suwabe K, 2006, GENETICS, V173, P309, DOI 10.1534/genetics.104.038968; Takagi H, 2013, PLANT J, V74, P174, DOI 10.1111/tpj.12105; Takano S, 2014, MOL BREEDING, V34, P1007, DOI 10.1007/s11032-014-0093-4; Tomita H, 2013, MOL BREEDING, V32, P889, DOI 10.1007/s11032-013-9918-9; Trick M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-14; Trick M, 2009, PLANT BIOTECHNOL J, V7, P334, DOI 10.1111/j.1467-7652.2008.00396.x; Ueno H, 2012, PLANT MOL BIOL, V80, P621, DOI 10.1007/s11103-012-9971-5; Voorrips RE, 1997, THEOR APPL GENET, V94, P75, DOI 10.1007/s001220050384; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Werner S, 2008, THEOR APPL GENET, V116, P363, DOI 10.1007/s00122-007-0674-2; WILLIAMS PH, 1966, PHYTOPATHOLOGY, V56, P624; Xue S, 2008, PLANT DIS, V92, P456, DOI 10.1094/PDIS-92-3-0456; Yang HA, 2013, THEOR APPL GENET, V126, P511, DOI 10.1007/s00122-012-1997-1; Yang HA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-318; Yu F, 2012, MOL BREEDING, V30, P1495, DOI 10.1007/s11032-012-9735-6; Zhang H, 2015, PLANT PATHOL; Zhang T, 2014, MOL BREEDING, V34, P1173, DOI 10.1007/s11032-014-0108-1	76	41	46	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153218	10.1371/journal.pone.0153218	http://dx.doi.org/10.1371/journal.pone.0153218			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078023	Green Submitted, gold, Green Published			2022-12-26	WOS:000374131700027
J	Barmchi, MP; Samarasekera, G; Gilbert, M; Auld, VJ; Zhang, B				Barmchi, Mojgan Padash; Samarasekera, Gayathri; Gilbert, Mary; Auld, Vanessa J.; Zhang, Bing			Magi Is Associated with the Par Complex and Functions Antagonistically with Bazooka to Regulate the Apical Polarity Complex	PLOS ONE			English	Article							TIGHT JUNCTION PROTEIN; DROSOPHILA EPITHELIAL-CELLS; SCAFFOLDING PROTEIN; PDZ-PROTEIN; KINASE-C; SYNAPTIC LOCALIZATION; GUANYLATE KINASE; CHOLERA-TOXIN; APKC; NEUROBLASTS	The mammalian MAGI proteins play important roles in the maintenance of adherens and tight junctions. The MAGI family of proteins contains modular domains such as WW and PDZ domains necessary for scaffolding of membrane receptors and intracellular signaling components. Loss of MAGI leads to reduced junction stability while overexpression of MAGI can lead to increased adhesion and stabilization of epithelial morphology. However, how Magi regulates junction assembly in epithelia is largely unknown. We investigated the single Drosophila homologue of Magi to study the in vivo role of Magi in epithelial development. Magi is localized at the adherens junction and forms a complex with the polarity proteins, Par3/Bazooka and aPKC. We generated a Magi null mutant and found that Magi null mutants were viable with no detectable morphological defects even though the Magi protein is highly conserved with vertebrate Magi homologues. However, overexpression of Magi resulted in the displacement of Baz/Par3 and aPKC and lead to an increase in the level of PIP3. Interestingly, we found that Magi and Baz functioned in an antagonistic manner to regulate the localization of the apical polarity complex. Maintaining the balance between the level of Magi and Baz is an important determinant of the levels and localization of apical polarity complex.	[Barmchi, Mojgan Padash; Samarasekera, Gayathri; Gilbert, Mary; Auld, Vanessa J.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Barmchi, Mojgan Padash; Zhang, Bing] Univ Oklahoma, Dept Biol, Norman, OK 73019 USA; [Barmchi, Mojgan Padash; Zhang, Bing] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA	University of British Columbia; University of Oklahoma System; University of Oklahoma - Norman; University of Missouri System; University of Missouri Columbia	Auld, VJ (corresponding author), Univ British Columbia, Dept Zool, Vancouver, BC, Canada.; Zhang, B (corresponding author), Univ Oklahoma, Dept Biol, Norman, OK 73019 USA.; Zhang, B (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.	auld@zoology.ubc.ca; zhangbing@missouri.edu		Padash Barmchi, Mojgan/0000-0003-1505-8953; Auld, Vanessa/0000-0003-3976-9186	Canadian Institute of Health Research [MOP-82862]; National Institute of Neurological Disorders and Stroke [RO1-NS060878]; University of Missouri; National Institutes of Health/National Institute of Neurological Disorders and Stroke [RO1-NS060878]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060878] Funding Source: NIH RePORTER	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); University of Missouri; National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding provided by Canadian Institute of Health Research, http://www.cihr-irsc.gc.ca/e/193.html, grant number: MOP-82862 to VA, National Institute of Neurological Disorders and Stroke, http://www.ninds.nih.gov/, grant number: RO1-NS060878 to BZ and University of Missouri, http://missouri.edu/ to BZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Drs. Dave Bilder, Chris Doe, Denise Montell, Gregory Longmore, Vivian Budnik, Herbert Jackle and Andreas Wordarz for generously providing reagents, the Bloomington Drosophila Stock Center, and Dr. Jody Summers for the generous permission to use her Olympus FV1000 confocal microscope. We thank Kate O'Connor-Giles and Scott Gratz for advice on CRISPR/Cas9 and for providing their U6-3 vector. We thank the TRiP at Harvard Medical School (NIH/NIGMS R01-GM084947) for providing stocks and the Developmental Studies Hybridoma Bank (University of Iowa, Department of Biology, Iowa City) for antibodies. This research was supported by grants from the Canadian Institute of Health Research (MOP-82862 to VJA) and in part from the National Institutes of Health/National Institute of Neurological Disorders and Stroke (RO1-NS060878 to BZ) and by an internal fund from the University of Missouri (to BZ).	Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Beller M, 2002, MECH DEVELOP, V119, pS253, DOI 10.1016/S0925-4773(03)00125-4; Berger S, 2007, GENETICS, V176, P2189, DOI 10.1534/genetics.107.071449; Bilder D, 2003, NAT CELL BIOL, V5, P53, DOI 10.1038/ncb897; Blank N, 2007, IMMUNOL CELL BIOL, V85, P378, DOI 10.1038/sj.icb.7100045; Blow NS, 2005, PLOS PATHOG, V1, P92, DOI 10.1371/journal.ppat.0010008; Brodsky MH, 2004, MOL CELL BIOL, V24, P1219, DOI 10.1128/MCB.24.3.1219-1231.2004; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; Claret S, 2014, CURR BIOL, V24, P1071, DOI 10.1016/j.cub.2014.03.056; Danielson E, 2012, J NEUROSCI, V32, P6967, DOI 10.1523/JNEUROSCI.0025-12.2012; de Haan L, 2004, MOL MEMBR BIOL, V21, P77, DOI 10.1080/09687680410001663267; Dobrosotskaya I, 1997, J BIOL CHEM, V272, P31589, DOI 10.1074/jbc.272.50.31589; Dobrosotskaya IY, 2000, BIOCHEM BIOPH RES CO, V270, P903, DOI 10.1006/bbrc.2000.2471; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Emtage L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004613; Georgiou M, 2008, CURR BIOL, V18, P1631, DOI 10.1016/j.cub.2008.09.029; Gervais L, 2008, DEVELOPMENT, V135, P3829, DOI 10.1242/dev.029009; Glaunsinger BA, 2000, ONCOGENE, V19, P5270, DOI 10.1038/sj.onc.1203906; Gratz SJ, 2013, FLY, V7, P249, DOI 10.4161/fly.26566; Gray A, 1999, BIOCHEM J, V344, P929, DOI 10.1042/0264-6021:3440929; Gregorc U, 2007, APOPTOSIS, V12, P343, DOI 10.1007/s10495-006-0579-6; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; HAY BA, 1994, DEVELOPMENT, V120, P2121; Hebbar S, 2008, J LIPID RES, V49, P1077, DOI 10.1194/jlr.M700543-JLR200; Hirabayashi S, 2003, MOL CELL BIOL, V23, P4267, DOI 10.1128/MCB.23.12.4267-4282.2003; Hirao K, 1998, J BIOL CHEM, V273, P21105, DOI 10.1074/jbc.273.33.21105; Hirose T, 2002, J CELL SCI, V115, P2485; Hutterer A, 2004, DEV CELL, V6, P845, DOI 10.1016/j.devcel.2004.05.003; Ide N, 1999, ONCOGENE, V18, P7810, DOI 10.1038/sj.onc.1203153; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Johnson K, 2002, CURR BIOL, V12, P1675, DOI 10.1016/S0960-9822(02)01180-6; Jokhi V, 2013, CELL REP, V3, P988, DOI 10.1016/j.celrep.2013.03.015; Koh YH, 1999, CELL, V98, P353, DOI 10.1016/S0092-8674(00)81964-9; Kotelevets L, 2004, FASEB J, V18, P115, DOI 10.1096/fj.04-1942fje; Krahn MP, 2010, CURR BIOL, V20, P636, DOI 10.1016/j.cub.2010.01.065; Kranjec C, 2014, J VIROL, V88, P7155, DOI 10.1128/JVI.03247-13; Kranjec C, 2011, J VIROL, V85, P1757, DOI 10.1128/JVI.01756-10; Langton PF, 2007, DEV CELL, V13, P773, DOI 10.1016/j.devcel.2007.11.005; Langton PF, 2009, CURR BIOL, V19, P1969, DOI 10.1016/j.cub.2009.10.027; Latorre IJ, 2005, J CELL SCI, V118, P4283, DOI 10.1242/jcs.02560; Laura RP, 2002, EXP CELL RES, V275, P155, DOI 10.1006/excr.2002.5475; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lehtonen S, 2005, P NATL ACAD SCI USA, V102, P9814, DOI 10.1073/pnas.0504166102; Leibfried A, 2008, CURR BIOL, V18, P1639, DOI 10.1016/j.cub.2008.09.063; Lida J, 2004, MOL CELL NEUROSCI, V27, P497, DOI 10.1016/j.mcn.2004.08.006; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Lynch AM, 2012, CURR BIOL, V22, P1891, DOI 10.1016/j.cub.2012.08.024; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; Nagashima S, 2015, J BIOCHEM, V157, P177, DOI 10.1093/jb/mvv009; Patrie KM, 2002, J BIOL CHEM, V277, P30183, DOI 10.1074/jbc.M203072200; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Pinal N, 2006, CURR BIOL, V16, P140, DOI 10.1016/j.cub.2005.11.068; Pinheiro EM, 2004, DEVELOPMENT, V131, P5243, DOI 10.1242/dev.01412; Ramachandran P, 2009, DEV NEUROBIOL, V69, P583, DOI 10.1002/dneu.20728; Ren XJ, 2013, P NATL ACAD SCI USA, V110, P19012, DOI 10.1073/pnas.1318481110; Rolls MM, 2003, J CELL BIOL, V163, P1089, DOI 10.1083/jcb.200306079; Sakurai A, 2006, MOL BIOL CELL, V17, P966, DOI 10.1091/mbc.E05-07-0647; Shewan A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004796; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Stetak A, 2011, DEV BIOL, V350, P24, DOI 10.1016/j.ydbio.2010.10.026; Subauste MC, 2005, J BIOL CHEM, V280, P5676, DOI 10.1074/jbc.M405561200; Suzuki A, 2001, J CELL BIOL, V152, P1183, DOI 10.1083/jcb.152.6.1183; Tanemoto M, 2008, J BIOL CHEM, V283, P12241, DOI 10.1074/jbc.M707738200; Tanentzapf G, 2003, NAT CELL BIOL, V5, P46, DOI 10.1038/ncb896; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Thomas M, 2002, ONCOGENE, V21, P5088, DOI 10.1038/sj.onc.1205668; Tian AG, 2008, DEVELOPMENT, V135, P463, DOI 10.1242/dev.016253; Vidal M, 2006, CURR OPIN GENET DEV, V16, P10, DOI 10.1016/j.gde.2005.12.004; von Stein W, 2005, DEVELOPMENT, V132, P1675, DOI 10.1242/dev.01720; Warner SJ, 2010, CURR BIOL, V20, P677, DOI 10.1016/j.cub.2010.03.025; Wasserscheid I, 2007, DEV DYNAM, V236, P1064, DOI 10.1002/dvdy.21089; Wichmann A, 2010, DEV BIOL, V346, P80, DOI 10.1016/j.ydbio.2010.07.023; WIEGANDT H, 1992, BIOCHIM BIOPHYS ACTA, V1123, P117, DOI 10.1016/0005-2760(92)90101-Z; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; Xu ZG, 2008, J NEUROSCI, V28, P11269, DOI 10.1523/JNEUROSCI.3833-08.2008; Yamada Y, 2008, DEVELOPMENT, V135, P207, DOI 10.1242/dev.010389; Yamagata M, 2010, J NEUROSCI, V30, P3579, DOI 10.1523/JNEUROSCI.6319-09.2010; Yu ZS, 2013, GENETICS, V195, P289, DOI 10.1534/genetics.113.153825; Zaessinger S, 2015, DEVELOPMENT, V142, P1102, DOI 10.1242/dev.116277; Zaric J, 2012, ONCOGENE, V31, P48, DOI 10.1038/onc.2011.218	82	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153259	10.1371/journal.pone.0153259	http://dx.doi.org/10.1371/journal.pone.0153259			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074039	gold, Green Submitted, Green Published			2022-12-26	WOS:000374131200067
J	Fox, L; Walsh, JC; Morrison, TG; O' Gorman, D; Ruane, N; Mitchell, C; Carey, JJ; Coughlan, R; McGuire, BE				Fox, Lisa; Walsh, Jane C.; Morrison, Todd G.; O' Gorman, David; Ruane, Nancy; Mitchell, Caroline; Carey, John J.; Coughlan, Robert; McGuire, Brian E.			Cognitive Coping Style and the Effectiveness of Distraction or Sensation-Focused Instructions in Chronic Pain Patients	PLOS ONE			English	Article							SELF-EFFICACY BELIEFS; CHRONIC BACK-PAIN; FEAR-AVOIDANCE; TRAIT ANXIETY; META-ANALYSIS; ATTENTION; QUESTIONNAIRE; EXPECTANCIES; PERCEPTION; STRATEGIES	Aim This study set out to investigate whether cognitive coping strategies that match participants' preferred coping style effectively reduce pain intensity and situational anxiety in a population of people with chronic pain. Method Chronic pain patients (N = 43) completed questionnaires on coping style, pain intensity, self-efficacy, and situational/trait anxiety. Participants were classified as Monitors (n = 16) or Blunters (n = 19) based on their Miller Behavioural Style Scale score. Participants were then provided with an audiotaped intervention in which they were instructed to focus on pain sensations or to engage in a distraction task and then to rate the pain intensity and their anxiety during and after the attentional focus and distraction conditions. The two interventions were each completed by all participants, having been presented in counterbalanced order. Results Findings revealed that Monitors' level of anxiety decreased following a congruent (i.e., sensation-focused) intervention. No effects were obtained in terms of perceived pain. For blunters, however, their perceived levels of anxiety and pain did not attenuate following a congruent, distraction-focused intervention. Conclusion Among persons experiencing chronic pain, tailoring coping strategies to match an individual's preferred coping style-in particular, those with a high level of monitoring-may enhance the benefit of psychological approaches to management of anxiety.	[Fox, Lisa; Walsh, Jane C.; McGuire, Brian E.] Natl Univ Ireland, Sch Psychol, Galway, Ireland; [Morrison, Todd G.] Univ Saskatchewan, Dept Psychol, Saskatoon, SK S7N 0W0, Canada; [O' Gorman, David; Ruane, Nancy; Mitchell, Caroline; McGuire, Brian E.] Natl Univ Ireland, Ctr Pain Res, Galway, Ireland; [O' Gorman, David; Ruane, Nancy; Mitchell, Caroline] Galway Univ Hosp, Div Pain Med, Galway, Ireland; [Carey, John J.; Coughlan, Robert] Galway Univ Hosp, Dept Rheumatol, Galway, Ireland; [Carey, John J.; Coughlan, Robert] Natl Univ Ireland, Sch Med, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway; University of Saskatchewan; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway	McGuire, BE (corresponding author), Natl Univ Ireland, Sch Psychol, Galway, Ireland.; McGuire, BE (corresponding author), Natl Univ Ireland, Ctr Pain Res, Galway, Ireland.	brian.mcguire@nuigalway.ie	Carey, John/AAF-5461-2019; Walsh, Jane/AAP-6870-2021	Walsh, Jane/0000-0001-5476-1348; Carey, John/0000-0001-7292-2328; Morrison, Todd/0000-0001-8033-3822				Antony MM, 2001, BEHAV RES THER, V39, P1137; ARNTZ A, 1994, PAIN, V56, P307, DOI 10.1016/0304-3959(94)90169-4; Asghari A, 2001, PAIN, V94, P85, DOI 10.1016/S0304-3959(01)00344-X; Barnes LLB, 2002, EDUC PSYCHOL MEAS, V62, P603, DOI 10.1177/0013164402062004005; BIEDERMAN JJ, 1994, BEHAV MODIF, V18, P89; BROWN GK, 1987, PAIN, V31, P53, DOI 10.1016/0304-3959(87)90006-6; Claes N, 2015, PAIN, V156, P1449, DOI 10.1097/j.pain.0000000000000116; CORNWALL A, 1988, PAIN, V35, P105, DOI 10.1016/0304-3959(88)90282-5; COUNCIL JR, 1988, PAIN, V33, P323, DOI 10.1016/0304-3959(88)90291-6; DOLCE JJ, 1986, PAIN, V24, P365, DOI 10.1016/0304-3959(86)90122-3; ECCLESTON C, 1995, BEHAV RES THER, V33, P391, DOI 10.1016/0005-7967(94)00057-Q; Forys KL, 2007, HEALTH PSYCHOL, V26, P22, DOI 10.1037/0278-6133.26.1.22; Gatchel R., 2002, PSYCHOL APPROACHES P; Gibson L, 1996, J OCCUP REHABIL, V6, P159, DOI 10.1007/BF02110753; Harvey AG, 2000, BEHAV RES THER, V38, P1117, DOI 10.1016/S0005-7967(99)00150-3; Hilzenrat N, 2006, CAN J GASTROENTEROL, V20, P597, DOI 10.1155/2006/610489; James JE, 2002, BRIT J HEALTH PSYCH, V7, P149, DOI 10.1348/135910702169411; JENSEN MP, 1991, PAIN, V44, P263, DOI 10.1016/0304-3959(91)90095-F; Kabat-Zinn J, 1984, REVISIONS, V7, P66; Keogh E, 2002, PAIN, V97, P195, DOI 10.1016/S0304-3959(01)00427-4; Kerns RD, 2014, HEALTH PSYCHOL, V33, P938, DOI 10.1037/a0034406; Legrain V, 2009, PAIN, V144, P230, DOI 10.1016/j.pain.2009.03.020; LETHEM J, 1983, BEHAV RES THER, V21, P401, DOI 10.1016/0005-7967(83)90009-8; MARTELLI MF, 1987, J CONSULT CLIN PSYCH, V55, P201, DOI 10.1037/0022-006X.55.2.201; MCCAUL KD, 1984, PSYCHOL BULL, V95, P516, DOI 10.1037/0033-2909.95.3.516; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; MILLER SM, 1987, J PERS SOC PSYCHOL, V52, P345, DOI 10.1037/0022-3514.52.2.345; Moriarty O, 2011, PROG NEUROBIOL, V93, P385, DOI 10.1016/j.pneurobio.2011.01.002; MULLEN B, 1982, J PSYCHOSOM RES, V26, P43, DOI 10.1016/0022-3999(82)90061-7; Nicholas MK, 2007, EUR J PAIN, V11, P153, DOI 10.1016/j.ejpain.2005.12.008; Nicholas MK, 1989, ANN C BRIT PSYCH SOC; Nordin K, 2002, J MED GENET, V39, P689, DOI 10.1136/jmg.39.9.689; Price DD, 2001, HDB PAIN ASSESSMENT, P53; Sarda J, 2007, STRESS HEALTH, V23, P185, DOI 10.1002/smi.1135; Spielberger C. D., 1973, MANUAL STATE TRAIT I; SULS J, 1985, HEALTH PSYCHOL, V4, P249, DOI 10.1037/0278-6133.4.3.249; Turk DC, 1987, PAIN BEHAV MED COGNI; Van Damme S, 2010, NEUROSCI BIOBEHAV R, V34, P204, DOI 10.1016/j.neubiorev.2009.01.005; Verhoeven K, 2010, PAIN, V149, P229, DOI 10.1016/j.pain.2010.01.019; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; Williamson A, 2005, J CLIN NURS, V14, P798, DOI 10.1111/j.1365-2702.2005.01121.x; Wright DB, 2003, BRIT J EDUC PSYCHOL, V73, P123, DOI 10.1348/000709903762869950	42	6	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0142285	10.1371/journal.pone.0142285	http://dx.doi.org/10.1371/journal.pone.0142285			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ0NI	27071028	Green Published, gold, Green Submitted			2022-12-26	WOS:000373900700001
J	Otto, S; Pappalardo, SE; Cardinali, A; Masin, R; Zanin, G; Borin, M				Otto, Stefan; Pappalardo, Salvatore E.; Cardinali, Alessandra; Masin, Roberta; Zanin, Giuseppe; Borin, Maurizio			Vegetated Ditches for the Mitigation of Pesticides Runoff in the Po Valley	PLOS ONE			English	Article							AGRICULTURAL DRAINAGE DITCHES; LAMBDA-CYHALOTHRIN; MISSISSIPPI DELTA; HERBICIDE RUNOFF; FUGACITY MODEL; SURFACE WATERS; LANDSCAPES; MESOTRIONE; FATE; SULCOTRIONE	In intensive agricultural systems runoff is one of the major potential diffuse pollution pathways for pesticides and poses a risk to surface water. Ditches are common in the Po Valley and can potentially provide runoff mitigation for the protection of watercourses. The effectiveness depends on ditch characteristics, so there is an urgent need for site-specific field trials. The use of a fugacity model (multimedia model) can allows recognition of the mitigation main processes. A field experiment was conducted in order to evaluate the mitigation capacity of a typical vegetated ditch, and results were compared with predictions by a fugacity model. To evaluate herbicide mitigation after an extreme runoff, the ditch was flooded with water containing mesotrione, S-metolachlor and terbuthylazine. Two other subsequent floods with uncontaminated water were applied 27 and 82 days later to evaluate herbicides release. Results show that the ditch can immediately reduce runoff concentration of herbicides by at least 50% even in extreme flooding conditions. The half-distances were about 250 m. As a general rule, a runoff of 1 mm from 5 ha is mitigated by 99% in 100 m of vegetated ditch. Herbicides retention in the vegetated ditch was reversible, and the second flood mobilized 0.03-0.2% of the previous one, with a concentration below the drinking water limit of 0.1 mu g L-1. No herbicide was detected in the third flood, because the residual amount in the ditch was too low. Fugacity model results show that specific physical-chemical parameters may be used and a specific soil-sediment-plant compartment included for modelling herbicides behaviour in a vegetated ditch, and confirm that accumulation is low or negligible for herbicides with a half-life of 40 days or less. Shallow vegetated ditches can thus be included in a general agri-environment scheme for the mitigation of pesticides runoff together with wetlands and linear buffer strips. These structures are present in the landscape, and their environmental role can be exploited by proper management.	[Otto, Stefan] CNR, Inst Agroenvironm & Forest Biol, Viale Univ 16, Legnaro, PD, Italy; [Pappalardo, Salvatore E.; Cardinali, Alessandra; Masin, Roberta; Zanin, Giuseppe; Borin, Maurizio] Univ Padua, Dept Agron Food Nat Resources Anim & Environm, Viale Univ 16, Legnaro, PD, Italy	Consiglio Nazionale delle Ricerche (CNR); University of Padua	Otto, S (corresponding author), CNR, Inst Agroenvironm & Forest Biol, Viale Univ 16, Legnaro, PD, Italy.	stefan.otto@ibaf.cnr.it	borin, maurizio/AAY-1399-2021	Otto, Stefan/0000-0002-4341-8517; borin, maurizio/0000-0002-4074-2098	GRIMiCID project, within the Plan for the Rural Development (Piano per lo Sviluppo Rurale, PSR Misura 124) of the Veneto Region	GRIMiCID project, within the Plan for the Rural Development (Piano per lo Sviluppo Rurale, PSR Misura 124) of the Veneto Region	This research was conducted with financial support of GRIMiCID project 2013-2015, within the Plan for the Rural Development (Piano per lo Sviluppo Rurale, PSR Misura 124) of the Veneto Region.; This research was conducted with financial support of GRIMiCID project 2013-2015, within the Plan for the Rural Development (Piano per lo Sviluppo Rurale, PSR Misura 124) of the Veneto Region.	Aslam S, 2013, CHEMOSPHERE, V91, P1447, DOI 10.1016/j.chemosphere.2012.12.005; Barchanska H, 2012, ENVIRON MONIT ASSESS, V184, P321, DOI 10.1007/s10661-011-1970-5; Bennett ER, 2005, ENVIRON TOXICOL CHEM, V24, P2121, DOI 10.1897/04-357R.1; Bereswill R, 2012, AGR ECOSYST ENVIRON, V146, P81, DOI 10.1016/j.agee.2011.10.010; Boithias L, 2014, CHEMOSPHERE, V99, P134, DOI 10.1016/j.chemosphere.2013.10.050; Bouldin JL, 2004, ENVIRON POLLUT, V132, P403, DOI 10.1016/j.envpol.2004.05.026; CALAMARI D, 1987, CHEMOSPHERE, V16, P2359, DOI 10.1016/0045-6535(87)90293-1; Caracciolo A. Barra, 2005, Environmental Pollution, V134, P525; Cardinali A, 2013, INT J ENVIRON AN CH, V93, P1628, DOI 10.1080/03067319.2013.841151; Chaabane H, 2008, PEST MANAG SCI, V64, P86, DOI 10.1002/ps.1456; Cooper CM, 2004, WATER SCI TECHNOL, V49, P117, DOI 10.2166/wst.2004.0176; DI GUARDO A, 1994, CHEMOSPHERE, V28, P511, DOI 10.1016/0045-6535(94)90295-X; Fava L, 2007, MICROCHEM J, V86, P204, DOI 10.1016/j.microc.2007.03.003; Freitas LG, 2004, J CHROMATOGR A, V1028, P277, DOI 10.1016/j.chroma.2003.11.094; Ghirardello D, 2014, ENVIRON POLLUT, V184, P502, DOI 10.1016/j.envpol.2013.10.002; Gregoire C, 2009, ENVIRON CHEM LETT, V7, P205, DOI 10.1007/s10311-008-0167-9; Hackett M, MULTIFUNCTIONAL ROLE; Hand LH, 2001, ENVIRON TOXICOL CHEM, V20, P1740, DOI [10.1897/1551-5028(2001)020&lt;1740:IOAPOT&gt;2.0.CO;2, 10.1002/etc.5620200817]; Herzon I, 2008, BIOL CONSERV, V141, P1171, DOI 10.1016/j.biocon.2008.03.005; Laabs V, 2000, CHEMOSPHERE, V41, P1441, DOI 10.1016/S0045-6535(99)00546-9; Macbean C., 2012, ENDOSULFAN PESTICIDE, V16th, P414; MACKAY D, 1982, ENVIRON SCI TECHNOL, V16, pA654, DOI 10.1021/es00106a724; MacLeod M, 2010, ENVIRON SCI TECHNOL, V44, P8360, DOI [10.1021/es100968w, 10.1021/es103297w]; Mahabali S, 2014, WATER AIR SOIL POLL, V225, DOI 10.1007/s11270-013-1771-2; Merlin G, 2002, ENVIRON TOXICOL CHEM, V21, P1236, DOI [10.1897/1551-5028(2002)021<1236:FABOII>2.0.CO;2, 10.1897/1551-5028(2002)021&lt;1236:FABOII&gt;2.0.CO;2]; Moore MT, 2008, J ENVIRON QUAL, V37, P486, DOI 10.2134/jeq2007.0172; Moore MT, 2001, AGR ECOSYST ENVIRON, V87, P309, DOI 10.1016/S0167-8809(01)00148-7; Morselli M, 2015, SCI TOTAL ENVIRON, V526, P338, DOI 10.1016/j.scitotenv.2015.04.072; Otto S, 2008, CHEMOSPHERE, V71, P74, DOI 10.1016/j.chemosphere.2007.10.029; Otto S, 2015, J ENVIRON MANAGE, V162, P290, DOI 10.1016/j.jenvman.2015.07.060; Otto S, 2012, CHEMOSPHERE, V88, P113, DOI 10.1016/j.chemosphere.2012.02.081; Pappalardo SE, 2016, HYDROBIOLOGIA, V774, P193, DOI 10.1007/s10750-015-2375-1; Tomlin C.D.S., 2006, PESTICIDE MANUAL; Tournebize J, 2013, ECOL ENG, V56, P52, DOI 10.1016/j.ecoleng.2012.06.001; Vymazal J, 2015, ENVIRON INT, V75, P11, DOI 10.1016/j.envint.2014.10.026; Zhang XY, 2011, SCI TOTAL ENVIRON, V409, P1949, DOI 10.1016/j.scitotenv.2011.02.012; Zollo LA, 2015, INT J CLIMA IN PRESS	37	18	18	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153287	10.1371/journal.pone.0153287	http://dx.doi.org/10.1371/journal.pone.0153287			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070781	Green Published, Green Submitted, gold			2022-12-26	WOS:000373900700047
J	Su, R; Dong, L; Zou, D; Zhao, H; Ren, Y; Li, F; Yi, P; Li, L; Zhu, Y; Ma, Y; Wang, J; Wang, F; Yu, J				Su, R.; Dong, L.; Zou, D.; Zhao, H.; Ren, Y.; Li, F.; Yi, P.; Li, L.; Zhu, Y.; Ma, Y.; Wang, J.; Wang, F.; Yu, J.			microRNA-23a,-27a and-24 synergistically regulate JAK1/Stat3 cascade and serve as novel therapeutic targets in human acute erythroid leukemia	ONCOGENE			English	Article							ACUTE MYELOID-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; DIFFERENTIATION; ERYTHROLEUKEMIA; PATHWAY; GATA-1; CELLS; ERYTHROPOIESIS; PROLIFERATION; RUXOLITINIB	Acute erythroid leukemia (AEL) is characterized by lower incidence, poorer prognosis and worse survival than other types of leukemia and results from collaboration of malignant proliferation and erythroid differentiation blockage. The expression, function and therapeutic significance of noncoding RNAs in AEL have not been well studied. Here, we show that one miRNA cluster, including miR-23a,-27a and -24, is dramatically downregulated in AEL patients. Restoration of miR-23a,-27a and -24 expression induces apoptosis and erythropoiesis, inhibits adverse growth and partly relieves the leukemic symptoms of AEL patients. At the whole-genome scale, we identify that miR-23a,-27a and -24 synergistically target multiple members of the oncogenic gp130-JAK1-Stat3 pathway, and thus reinforce their inhibition on the cascade to regulate cell proliferation and apoptosis. Importantly, Ruxolitinib, a JAK1 inhibitor, could rescue the phenotypic changes induced by miR-23a,-27a and -24 inhibitors. Furthermore, miR-23a cluster-mediated-inactivation of the JAK1-Stat3 pathway promotes the expression and activity of GATA1 via inhibiting PU. 1, thereby improving erythroid differentiation. Collectively, we reveal an important regulatory circuit comprising GATA1, the miR-23a cluster and gp130-JAK1-Stat3 pathway, that synergistically facilitates apoptosis and erythropoiesis and restrains adverse proliferation, indicating the therapeutic significance of miR-23a,-27a and -24 for AEL treatment.	[Su, R.; Dong, L.; Zou, D.; Zhao, H.; Ren, Y.; Li, F.; Zhu, Y.; Ma, Y.; Wang, F.; Yu, J.] Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Med Mol Biol, Dept Biochem, Beijing, Peoples R China; [Su, R.; Dong, L.; Zou, D.; Zhao, H.; Ren, Y.; Li, F.; Zhu, Y.; Ma, Y.; Wang, J.; Wang, F.; Yu, J.] Peking Union Med Coll, Beijing, Peoples R China; [Su, R.] Univ Cincinnati, Coll Med, Dept Canc Biol, Cincinnati, OH 45219 USA; [Zou, D.] Chongqing Canc Inst, Dept Gynecol Oncol, Chongqing, Peoples R China; [Yi, P.; Li, L.] Third Millitary Med Univ, Dept Obstet & Gynecol, Daping Hosp, Inst Surg Res, Chongqing, Peoples R China; [Wang, J.] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Pathophysiol, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University System of Ohio; University of Cincinnati; Army Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Su, R (corresponding author), Univ Cincinnati, Coll Med, Dept Canc Biol, Cincinnati, OH 45219 USA.; Wang, F; Yu, J (corresponding author), Peking Union Med Coll, Inst Basic Med Sci, New Res Bldg,Room 608,5 Dong Dan San Tiao, Beijing 100005, Peoples R China.	suri@ucmail.uc.edu; wo_wfang@hotmail.com; j-yu@ibms.pumc.edu.cn	Su, Rui/Y-8157-2018; Dong, Lei/AAA-9495-2020	Dong, Lei/0000-0001-9574-0148; Yu, Jia/0000-0003-3499-5133; Su, Rui/0000-0002-4807-6229	National Key Basic Research Program of China [2011CBA01100]; National Natural Science Foundation of China [81530007, 31040021, 31171311, 31471227, 30970616]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank for Dr Jianjun Chen for his assistance and constructive suggestions. This work was supported by the National Key Basic Research Program of China (2011CBA01100 to JY); National Natural Science Foundation of China (81530007 to JY, 31040021 to JY, 31171311 to FW, 31471227 to FW and 30970616 to FW).	BENNETT JM, 1985, ANN INTERN MED, V103, P620, DOI 10.7326/0003-4819-103-4-620; Blum S, 2012, BLOOD, V120, P1974, DOI 10.1182/blood-2011-11-390047; Cui JW, 2007, BLOOD, V110, P2631, DOI 10.1182/blood-2006-10-053850; de Thonel A, 2010, BLOOD, V116, P85, DOI 10.1182/blood-2009-09-241778; Eaves CJ, 2010, NEW ENGL J MED, V362, P2326, DOI 10.1056/NEJMcibr1003522; Fan CQ, 2011, LEUKEMIA LYMPHOMA, V52, P502, DOI 10.3109/10428194.2010.543712; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Gallipoli P, 2014, BLOOD, V124, P1492, DOI 10.1182/blood-2013-12-545640; Gao XN, 2011, LEUKEMIA RES, V35, P1226, DOI 10.1016/j.leukres.2011.06.010; Goldberg SL, 1998, AM J CLIN ONCOL-CANC, V21, P42, DOI 10.1097/00000421-199802000-00010; Grossmann V, 2013, LEUKEMIA, V27, P1940, DOI 10.1038/leu.2013.144; Hasserjian RP, 2010, BLOOD, V115, P1985, DOI 10.1182/blood-2009-09-243964; Hegde S, 2009, ONCOGENE, V28, P3349, DOI 10.1038/onc.2009.202; Jiang X, 2012, CANCER CELL, V22, P524, DOI 10.1016/j.ccr.2012.08.028; Kadri Z, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000123; Kayali S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046799; Lo MC, 2013, LEUKEMIA, V27, P2272, DOI 10.1038/leu.2013.197; Lunghi P, 2005, LEUKEMIA, V19, P234, DOI 10.1038/sj.leu.2403585; Ma YN, 2015, EMBO J, V34, P361, DOI 10.15252/embj.201489957; Ma YN, 2013, MOL CELL BIOL, V33, P3994, DOI 10.1128/MCB.00623-13; Mancini E, 2012, EMBO J, V31, P351, DOI 10.1038/emboj.2011.390; Mascarenhas J, 2012, CLIN CANCER RES, V18, P3008, DOI 10.1158/1078-0432.CCR-11-3145; Maude SL, 2015, BLOOD, V125, P1759, DOI 10.1182/blood-2014-06-580480; McCubrey JA, 2014, LEUKEMIA, V28, P15, DOI 10.1038/leu.2013.184; Monaghan KA, 2011, LEUKEMIA, V25, P1891, DOI 10.1038/leu.2011.175; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Neri LM, 2014, LEUKEMIA, V28, P739, DOI 10.1038/leu.2013.226; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Ren JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012520; Rhodes J, 2005, DEV CELL, V8, P97, DOI 10.1016/j.devcel.2004.11.014; Santos FPS, 2009, LEUKEMIA, V23, P2275, DOI 10.1038/leu.2009.181; Steelman LS, 2008, LEUKEMIA, V22, P686, DOI 10.1038/leu.2008.26; Steelman LS, 2011, LEUKEMIA, V25, P1080, DOI 10.1038/leu.2011.66; Su R, 2015, ONCOGENE, V34, P3226, DOI 10.1038/onc.2014.274; Suzuki M, 2013, GENES CELLS, V18, P921, DOI 10.1111/gtc.12086; Teramo A, 2013, BLOOD, V121, P3843, DOI 10.1182/blood-2012-07-441378; Vainchenker W, 2013, ONCOGENE, V32, P2601, DOI 10.1038/onc.2012.347; Vannucchi AM, 2013, LEUKEMIA, V27, P1861, DOI 10.1038/leu.2013.119; Wang F, 2014, NUCLEIC ACIDS RES, V42, P442, DOI 10.1093/nar/gkt848; Wells AW, 2001, J CLIN PATHOL, V54, P608, DOI 10.1136/jcp.54.8.608; Zhang P, 2000, BLOOD, V96, P2641; Zhou T, 2014, LEUKEMIA, V28, P471, DOI 10.1038/leu.2013.299; Zhu Y, 2013, NUCLEIC ACIDS RES, V41, P4129, DOI 10.1093/nar/gkt093	44	25	25	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 17	2016	35	46					6001	6014		10.1038/onc.2016.127	http://dx.doi.org/10.1038/onc.2016.127			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ED0CA	27086927				2022-12-26	WOS:000388509400007
J	Fremin, C; Guegan, JP; Plutoni, C; Mahaffey, J; Philips, MR; Emery, G; Meloche, S				Fremin, C.; Guegan, J-P; Plutoni, C.; Mahaffey, J.; Philips, M. R.; Emery, G.; Meloche, S.			ERK1/2-induced phosphorylation of R-Ras GTPases stimulates their oncogenic potential	ONCOGENE			English	Article							P21(RAS) S-NITROSYLATION; GENE-EXPRESSION; BCL-XL; K-RAS; TC21; PROTEIN; PHOSPHOPROTEOMICS; OVEREXPRESSION; TRANSFORMATION; M-RAS/R-RAS3	The Ras-related (R-Ras) isoforms TC21, R-Ras and M-Ras are members of the Ras superfamily of small GTPases. R-Ras family proteins are frequently overexpressed in human cancers, and expression of activated mutants of these GTPases is sufficient to induce cell transformation. Unlike Ras, few activating mutations of R-Ras proteins have been reported in human cancer, and very little is known about the regulation of their activity. In this study, we report that TC21 and R-Ras are phosphorylated on a conserved serine, Ser186 and Ser201, respectively, in intact cells. This residue is located in the C-terminal hypervariable region of the proteins and is not conserved in M-Ras. We show that the MAP kinases ERK1/2 phosphorylate TC21 and R-Ras on this C-terminal serine residue both in vitro and in vivo. Phosphorylation of R-Ras proteins does not affect their subcellular localization or stability but rather stimulates their activation. Phosphorylation-defective mutants of R-Ras and TC21 are compromised in their ability to promote cancer cell adhesion and migration/invasion, respectively. Importantly, we show that phosphorylation of TC21 and R-Ras potentiates their tumorigenic activity in immunodeficient mice. Our results identify a novel regulatory mechanism of the small GTPases TC21 and R-Ras that controls their oncogenic potential.	[Fremin, C.; Guegan, J-P; Plutoni, C.; Emery, G.; Meloche, S.] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ, Canada; [Mahaffey, J.; Philips, M. R.] NYU, Dept Med, Perlmutter Canc Inst, 550 1St Ave, New York, NY 10016 USA; [Mahaffey, J.; Philips, M. R.] NYU, Dept Cell Biol & Pharmacol, Perlmutter Canc Inst, 550 1St Ave, New York, NY 10016 USA; [Emery, G.; Meloche, S.] Univ Montreal, Program Mol Biol, Montreal, PQ, Canada; [Emery, G.] Univ Montreal, Dept Pathol & Cell Biol, Montreal, PQ, Canada; [Meloche, S.] Univ Montreal, Dept Pharmacol, Montreal, PQ, Canada	Universite de Montreal; New York University; New York University; Universite de Montreal; Universite de Montreal; Universite de Montreal	Meloche, S (corresponding author), Inst Res Immunol & Canc, 2950 Chemin Polytech, Montreal, PQ H3C 3J7, Canada.	sylvain.meloche@umontreal.ca		Mark, Philips/0000-0002-1179-8156; Guegan, Jean-Philippe/0000-0002-3993-0956; Emery, Gregory/0000-0002-6874-6875	Cole Foundation; Association pour la Recherche centre le Cancer (ARC); Fonds de la recherche en sante du Quebec (FRSQ); Fondation pour la Recherche Medicale (FRM); Canadian Institutes of Health Research; NATIONAL CANCER INSTITUTE [R01CA116034] Funding Source: NIH RePORTER	Cole Foundation; Association pour la Recherche centre le Cancer (ARC); Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank B Alarcon (CBMSO, Madrid) for pGex-4T3-TC21 and pEGFP-TC21 plasmids. CF is a recipient of fellowships from the Cole Foundation, the Association pour la Recherche centre le Cancer (ARC) and the Fonds de la recherche en sante du Quebec (FRSQ). JPG is a recipient of fellowships from the Fondation pour la Recherche Medicale (FRM), the Cole Foundation and the Fonds de la recherche en sante du Quebec (FRSQ). SM and GE hold the Canada Research Chairs in Cellular Signaling and Vesicle Transport and Cell Signaling, respectively. This work was supported by grants from the Canadian Institutes of Health Research to SM and GE.	Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Arora S, 2005, MOL CARCINOGEN, V42, P97, DOI 10.1002/mc.20048; Barcelo C, 2014, CANCER RES, V74, P1190, DOI 10.1158/0008-5472.CAN-13-1750; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Castro AF, 2012, J CELL BIOCHEM, V113, P1253, DOI 10.1002/jcb.23458; Clark GJ, 1996, ONCOGENE, V12, P169; Courcelles M, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.25; COX AD, 1994, ONCOGENE, V9, P3281; Delgado P, 2009, NAT IMMUNOL, V10, P880, DOI 10.1038/ni.1749; Ehrhardt A, 2002, EXP HEMATOL, V30, P1089, DOI 10.1016/S0301-472X(02)00904-9; Fremin C, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-8; Graham SM, 1999, ONCOGENE, V18, P2107, DOI 10.1038/sj.onc.1202517; Grosstessner-Hain K, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008540; Guo X, 2006, ONCOGENE, V25, P4241, DOI 10.1038/sj.onc.1209452; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; Heo JY, 2004, BIOCHEMISTRY-US, V43, P2314, DOI 10.1021/bi035275g; Humphrey SJ, 2013, CELL METAB, V17, P1009, DOI 10.1016/j.cmet.2013.04.010; Kim JY, 2013, P NATL ACAD SCI USA, V110, P12414, DOI 10.1073/pnas.1220674110; Larive RM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4881; Lee JH, 2011, INT J DERMATOL, V50, P956, DOI 10.1111/j.1365-4632.2010.04846.x; Louahed J, 1999, BLOOD, V94, P1701, DOI 10.1182/blood.V94.5.1701.417k29_1701_1710; LOWE DG, 1987, MOL CELL BIOL, V7, P2845, DOI 10.1128/MCB.7.8.2845; Luo HR, 2010, INT J ONCOL, V37, P853, DOI 10.3892/ijo_00000736; Macha MA, 2010, J ORAL PATHOL MED, V39, P477, DOI 10.1111/j.1600-0714.2009.00854.x; Nishigaki M, 2005, CANCER RES, V65, P2115, DOI 10.1158/0008-5472.CAN-04-3340; Quilliam LA, 1999, J BIOL CHEM, V274, P23850, DOI 10.1074/jbc.274.34.23850; Radich JP, 2006, P NATL ACAD SCI USA, V103, P2794, DOI 10.1073/pnas.0510423103; Robitaille AM, 2013, SCIENCE, V339, P1320, DOI 10.1126/science.1228771; Sandri C, 2012, CELL RES, V22, P1479, DOI 10.1038/cr.2012.110; Sasaki AT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001518; Sawada J, 2012, CANCER CELL, V22, P235, DOI 10.1016/j.ccr.2012.06.013; Sung PJ, 2013, P NATL ACAD SCI USA, V110, P20593, DOI 10.1073/pnas.1306431110; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Williams JG, 2003, P NATL ACAD SCI USA, V100, P6376, DOI 10.1073/pnas.1037299100; Yang MH, 2012, P NATL ACAD SCI USA, V109, P10843, DOI 10.1073/pnas.1201487109	35	11	11	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 27	2016	35	43					5692	5698		10.1038/onc.2016.122	http://dx.doi.org/10.1038/onc.2016.122			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EA9XP	27086924				2022-12-26	WOS:000386998300012
J	Tian, J; Geng, QZ; Ding, YH; Liao, J; Dong, MQ; Xu, XZ; Li, J				Tian, Jie; Geng, Qizhi; Ding, Yuehe; Liao, Ji; Dong, Meng-Qiu; Xu, Xingzhi; Li, Jing			O-GlcNAcylation Antagonizes Phosphorylation of CDH1 (CDC20 Homologue 1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-N-ACETYLGLUCOSAMINE; ANAPHASE-PROMOTING COMPLEX; GLCNAC; PROTEINS; IDENTIFICATION; APC/C-CDH1; ACTIVATION; DEGRADATION; INHIBITION; SITE	The anaphase promoting complex/ cyclosome (APC/C) orchestrates various aspects of the eukaryotic cell cycle. One of its co-activators, Cdh1, is subject to myriad post-translational modifications, such as phosphorylation and ubiquitination. Herein we identify the O-linkedN-acetylglucosamine (O-GlcNAc) modification that occurs on Cdh1. Cdh1 is O-GlcNAcylated in cultured cells and mouse brain extracts. Mass spectrometry identifies an O-GlcNAcylated peptide that neighbors a known phosphorylation site. Cell synchronization and mutation studies reveal that O-GlcNAcylation of Cdh1 may antagonize its phosphorylation. Our results thus reveal a pivotal role of O-GlcNAcylation in regulating APC/ C activity.	[Tian, Jie; Geng, Qizhi; Liao, Ji; Xu, Xingzhi; Li, Jing] Capital Normal Univ, Beijing Key Lab DNA Damage Response, Beijing 100048, Peoples R China; [Tian, Jie; Geng, Qizhi; Liao, Ji; Xu, Xingzhi; Li, Jing] Capital Normal Univ, Coll Life Sci, Beijing 100048, Peoples R China; [Ding, Yuehe; Dong, Meng-Qiu] Natl Inst Biol Sci, Beijing 102206, Peoples R China	Capital Normal University; Capital Normal University; National Institute of Biological Sciences, Beijing	Xu, XZ; Li, J (corresponding author), Capital Normal Univ, Beijing Key Lab DNA Damage Response, Beijing 100048, Peoples R China.; Xu, XZ; Li, J (corresponding author), Capital Normal Univ, Coll Life Sci, Beijing 100048, Peoples R China.	xingzhi_xu@cnu.edu.cn; jing_li@cnu.edu.cn	Tian, Jie/AAN-7225-2021; ding, yuehe/AAZ-6994-2021; Li, Jing/C-2031-2013; Xu, Xingzhi/E-8158-2012	Tian, Jie/0000-0003-3926-820X; Li, Jing/0000-0002-3977-1641; Xu, Xingzhi/0000-0002-4459-2082	NSFC (National Science Foundation of China) [31271446]; NSFC [31461143012, 31130017]; 973 projects [2013CB911002, 2015CB910601]; Young Talent Development Plan in Institutions of Higher Learning under the Jurisdiction of Beijing Municipality [CITTCD201404158]; Beijing Nova Program Interdisciplinary Cooperation Project [XXJC201614]	NSFC (National Science Foundation of China)(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC)); 973 projects(National Basic Research Program of China); Young Talent Development Plan in Institutions of Higher Learning under the Jurisdiction of Beijing Municipality; Beijing Nova Program Interdisciplinary Cooperation Project	This work was supported by NSFC (National Science Foundation of China) fund (31271446; to J. Liao). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by NSFC funds (31461143012 and 31130017), the 973 projects 2013CB911002 and 2015CB910601. To whom correspondence may be addressed: Beijing Key Laboratory of DNA Damage Response and College of Life Sciences, Capital Normal University, Beijing 100048, China. Tel.: 86-10-68901692; Fax: 86-10-68906307; E-mail: xingzhi_xu@cnu.edu.cn.r Supported by Young Talent Development Plan in Institutions of Higher Learning under the Jurisdiction of Beijing Municipality (CIT&TCD201404158) and Beijing Nova Program Interdisciplinary Cooperation Project (XXJC201614). To whom correspondence may be addressed: Beijing Key Laboratory of DNA Damage Response and College of Life Sciences, Capital Normal University, Beijing 100048, China. Tel.: 86-10-68901692; Fax: 86-10-68906307; E-mail: jing_li@cnu.edu.cn	Almeida A, 2005, J NEUROSCI, V25, P8115, DOI 10.1523/JNEUROSCI.1143-05.2005; Almeida A, 2012, MOL NEUROBIOL, V46, P547, DOI 10.1007/s12035-012-8309-2; Benmaamar R, 2005, CELL CYCLE, V4, P1230, DOI 10.4161/cc.4.9.2048; Chang LF, 2015, NATURE, V522, P450, DOI 10.1038/nature14471; Dehennaut V, 2007, J BIOL CHEM, V282, P12527, DOI 10.1074/jbc.M700444200; Delgado-Esteban M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3879; Drougat L, 2012, BBA-GEN SUBJECTS, V1820, P1839, DOI 10.1016/j.bbagen.2012.08.024; Fardini Y, 2015, BIOCHEM BIOPH RES CO, V462, P151, DOI 10.1016/j.bbrc.2015.04.114; Fong JJ, 2012, J BIOL CHEM, V287, P12195, DOI 10.1074/jbc.M111.315804; Fukushima H, 2013, CELL REP, V4, P803, DOI 10.1016/j.celrep.2013.07.031; Hahne H, 2012, MOL CELL PROTEOMICS, V11, P843, DOI 10.1074/mcp.M112.019463; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; HOLT GD, 1986, J BIOL CHEM, V261, P8049; Janetzko J, 2014, J BIOL CHEM, V289, P34424, DOI 10.1074/jbc.R114.604405; Kim HS, 2011, CANCER CELL, V20, P487, DOI 10.1016/j.ccr.2011.09.004; Kimata Y, 2008, MOL CELL, V32, P576, DOI 10.1016/j.molcel.2008.09.023; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; Listovsky T, 2004, EMBO J, V23, P1619, DOI 10.1038/sj.emboj.7600149; Lukas C, 1999, NATURE, V401, P815, DOI 10.1038/44611; Pathak S, 2015, NAT STRUCT MOL BIOL, V22, P744, DOI 10.1038/nsmb.3063; Puram SV, 2011, SEMIN CELL DEV BIOL, V22, P586, DOI 10.1016/j.semcdb.2011.03.006; Ramakrishnan P, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004097; Sivakumar S, 2015, NAT REV MOL CELL BIO, V16, P82, DOI 10.1038/nrm3934; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Slawson C, 2008, MOL BIOL CELL, V19, P4130, DOI 10.1091/mbc.E07-11-1146; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tan EP, 2013, J BIOL CHEM, V288, P27085, DOI 10.1074/jbc.M113.470187; Tang Zhanyun, 2004, Methods Mol Biol, V281, P227; TORRES CR, 1984, J BIOL CHEM, V259, P3308; van Roessel P, 2004, CELL, V119, P707, DOI 10.1016/j.cell.2004.11.028; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; de Tudela MVP, 2015, SCI REP-UK, V5, DOI 10.1038/srep18180; Wan Y, 2001, P NATL ACAD SCI USA, V98, P13066, DOI 10.1073/pnas.231487598; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; Xu T, 2006, MOL CELL PROTEOMICS, V5, pS174; Xu XZ, 2002, MOL CELL BIOL, V22, P4419, DOI 10.1128/MCB.22.12.4419-4432.2002; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; Zhao P, 2011, J PROTEOME RES, V10, P4088, DOI 10.1021/pr2002726; Zhu YP, 2014, J BIOL CHEM, V289, P34472, DOI 10.1074/jbc.R114.601351	41	8	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12136	12144		10.1074/jbc.M116.717850	http://dx.doi.org/10.1074/jbc.M116.717850			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27080259	Green Published, hybrid			2022-12-26	WOS:000378092800016
J	Gebremariam, G; Asmamaw, G; Hussen, M; Hailemariam, MZ; Asegu, D; Astatkie, A; Amsalu, AG				Gebremariam, Gebreslassie; Asmamaw, Getachew; Hussen, Muktar; Hailemariam, Mengistu Z.; Asegu, Demissie; Astatkie, Ayalew; Amsalu, Anteneh G.			Impact of HIV Status on Treatment Outcome of Tuberculosis Patients Registered at Arsi Negele Health Center, Southern Ethiopia: A Six Year Retrospective Study	PLOS ONE			English	Article							TB PATIENTS; COHORT; NONADHERENCE	Background Despite implementation of different strategies, the burden and mortality of human immunodeficiency virus (HIV)-associated tuberculosis (TB) remains a challenge in Ethiopia. The aim of this study was to assess the impact of HIV status on treatment outcome of tuberculosis patients registered at Arsi Negele Health Center, Southern Ethiopia. Methods A six-year retrospective data (from September 2008 to August 2014) of tuberculosis patients (n = 1649) registered at the directly observed therapy short-course (DOTS) clinic of Arsi Negele Health Center was reviewed. Treatment outcome and tuberculosis type were categorized according to the national tuberculosis control program guideline. Data were entered and analyzed using SPSS version 20. Multinomial logistic regression analysis was used to examine the effect of HIV status separately on default/failure and death in relation to those who were successfully treated. Odds ratios with 95% confidence intervals were used to check the presence and strength of association between TB treatment outcome and HIV status and other independent variables. Results Out of the 1649 TB patients, 94.7% (1562) have been tested for HIV of whom 156(10%) were HIV co-infected. The mean (standard deviation) age of the patients was 28.5(15.5) years. The majority were new TB cases (96.7%), male (53.7%), urban (54.7%), and had smear negative pulmonary TB (44.1%). Overall, the treatment success rate of TB patients with or without HIV was 87.3%. Using cure/completion as reference, patients without known HIV status had significantly higher odds of default /failure [aOR, 4.26; 95% CI, 1.684-10.775] and transfer-out [aOR, 2.92; 95% CI, 1.545-5.521] whereas those who tested positive for HIV had a significantly higher odds of death [aOR, 6.72; 95% CI, 3.704-12.202] and transferout [aOR, 2.02; 95% CI, 1.111-3.680]. Conclusion Overall, treatment outcome and HIV testing coverage for TB patients is promising to reach the WHO target in the study area. However, default/failure among patients without known HIV status, and higher rate of mortality among HIV positive TB patients and transfer-out cases deserves concern. Therefore further prospective studies on quality of services, socioeconomics and psychology of this group should be conducted.	[Gebremariam, Gebreslassie; Asmamaw, Getachew; Hussen, Muktar; Hailemariam, Mengistu Z.; Asegu, Demissie] Hawassa Univ, Dept Med Lab Sci, Hawassa, Ethiopia; [Astatkie, Ayalew] Hawassa Univ, Sch Publ & Environm Hlth, Hawassa, Ethiopia; [Amsalu, Anteneh G.] Univ Gondar, Dept Med Microbiol, Gondar, Ethiopia	Hawassa University; Hawassa University; University of Gondar	Amsalu, AG (corresponding author), Univ Gondar, Dept Med Microbiol, Gondar, Ethiopia.	ant.amsalu@gmail.com	HAILEMARIAM, MENGISTU/AAL-4397-2021; Astatkie, Ayalew/I-1167-2019; zenebe, MENGISTU Hailemariam/GSE-3937-2022	Astatkie, Ayalew/0000-0002-4840-9601; Assegu, Demissie/0000-0003-3914-838X; Amsalu, Anteneh/0000-0001-7919-4546				Addis Z, 2013, IJBAR; Ambadekar NN, 2015, PUBLIC HEALTH, V129, P783, DOI 10.1016/j.puhe.2015.03.006; Biadglegne F, 2013, INT J BIOL MED RES, V4, P2942; Cheru F, 2013, J PHARM BIOMED SCI, V34, P1606; ENDRIS M, 2014, TUBERC RES TREAT, V2014, DOI DOI 10.1155/2014/726193; Falvo JV, 2011, AM J RESP CELL MOL, V45, P1116, DOI 10.1165/rcmb.2011-0186TR; Federal Democratic Republic of Ethiopia Ministry of Health/Ethiopian Public Health Institute, 2014, IMPLEMENTATION GUIDE; Federal Ministry of Health of Ethiopia, 2008, MAN TUB LEPR TB HIV; Federal Ministry of Health of Ethiopia, 2013, NAT TB HIV SENT SURV; Federal Ministry of Health of Ethiopia, 2010, FED MIN HLTH ETH TUB; Fiseha T, 2015, J BIOENG BIOMED SCI, V2015, P1, DOI DOI 10.4172/2155-9538.1000139; Garrido MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039134; Gebremariam MK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-651; Getahun B, 2013, BRAZ J INFECT DIS, V17, P521, DOI 10.1016/j.bjid.2012.12.010; Hamusse SD, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25382; Harries AD, 2009, SAFRJ EPID INFECT, V24; Ifebunandu NA, 2012, TROP DOCT, V42, P74, DOI 10.1258/td.2011.110421; Kittikraisak W, 2009, T ROY SOC TROP MED H, V103, P59, DOI 10.1016/j.trstmh.2008.09.003; Maruza M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-351; Mayer KH, 2010, CLIN INFECT DIS, V50, pS67, DOI 10.1086/651475; Munoz-Sellart M, 2010, INT J TUBERC LUNG D, V14, P973; Nahid P, 2007, AM J RESP CRIT CARE, V175, P1199, DOI 10.1164/rccm.200509-1529OC; Naidoo P, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-396; Ngamvithayapong J, 2000, AIDS, V14, P1413, DOI 10.1097/00002030-200007070-00015; Ofoegbu OS, 2015, S AFR FAM PRACT, V57, P50, DOI 10.1080/20786190.2014.995913; Oshi Daniel Chukwunweolu, 2014, Tuberc Res Treat, V2014, P202983, DOI 10.1155/2014/202983; Ruiz-Navarro MD, 2005, ARCH BRONCONEUMOL, V41, P363; Sanchez M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033129; Shaweno Debebe, 2012, BMC Res Notes, V5, P682, DOI 10.1186/1756-0500-5-682; Stop TB partnership, 2010, GLOB PLAN STOP TB 20; Tessema B, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-371; Tola HH, 2015, IRAN J PUBLIC HEALTH, V44, P1; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; WHO, 2014, GLOB TUB REP 2014; World health organization, 2015, UPD SHEET EP HIV AID; Yone EWP, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-190	37	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153239	10.1371/journal.pone.0153239	http://dx.doi.org/10.1371/journal.pone.0153239			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096159	Green Submitted, gold, Green Published			2022-12-26	WOS:000374543600030
J	Moriyama, M; Hosokawa, T; Tanahashi, M; Nikoh, N; Fukatsu, T				Moriyama, Minoru; Hosokawa, Takahiro; Tanahashi, Masahiko; Nikoh, Naruo; Fukatsu, Takema			Suppression of Bedbug's Reproduction by RNA Interference of Vitellogenin	PLOS ONE			English	Article							BED-BUG; TRAUMATIC INSEMINATION; MOLECULAR CHARACTERIZATION; HEMIPTERA; GENES; RESISTANCE; COCKROACH; RECEPTOR; PROTEIN; FUTURE	Recent resurgence of the bedbug Cimex lectularius is a global problem on the public health. On account of the worldwide rise of insecticide-resistant bedbug populations, exploration of new approaches to the bedbug control and management is anticipated. In this context, gene silencing by RNA interference (RNAi) has been considered for its potential application to pest control and management, because RNAi enables specific suppression of target genes and thus flexible selection of target traits to be disrupted. In this study, in an attempt to develop a control strategy targeting reproduction of the bedbug, we investigated RNAi-mediated gene silencing of vitellogenin (Vg), a major yolk protein precursor essential for oogenesis. From the bedbug transcriptomes, we identified a typical Vg gene and a trun-cated Vg gene, which were designated as ClVg and ClVg-like, respectively. ClVg gene was highly expressed mainly in the fat body of adult females, which was more than 100 times higher than the expression level of ClVg-like gene, indicating that ClVg gene is the primary functional Vg gene in the bedbug. RNAi-mediated suppression of ClVg gene expression in adult females resulted in drastically reduced egg production, atrophied ovaries, and inflated abdomen due to hypertrophied fat bodies. These phenotypic consequences are expected not only to suppress the bedbug reproduction directly but also to deteriorate its feeding and survival indirectly via behavioral modifications. These results suggest the potential of ClVg gene as a promising target for RNAi-based population management of the bedbug.	[Moriyama, Minoru; Hosokawa, Takahiro; Tanahashi, Masahiko; Fukatsu, Takema] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki, Japan; [Hosokawa, Takahiro] Kyushu Univ, Fac Sci, Fukuoka 812, Japan; [Nikoh, Naruo] Open Univ Japan, Dept Liberal Arts, Chiba, Japan; [Fukatsu, Takema] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan; [Fukatsu, Takema] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Kyushu University; University of Tokyo; University of Tsukuba	Moriyama, M (corresponding author), Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki, Japan.	m-moriyama@aist.go.jp		Hosokawa, Takahiro/0000-0001-7618-1774	Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry (BRAIN); Japan Society for the Promotion of Science KAKENHI [25221107]; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [14J09621] Funding Source: KAKEN	Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry (BRAIN); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was financially supported by the Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry (BRAIN) to TF and NN, and by the Japan Society for the Promotion of Science KAKENHI grant no. 25221107 to TF and NN. MM and MT were supported by the Japan Society for the Promotion of Science Fellowship for Young Scientists.	Araujo RN, 2006, INSECT BIOCHEM MOLEC, V36, P683, DOI 10.1016/j.ibmb.2006.05.012; Avarre JC, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-3; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Boldbaatar D, 2010, J INSECT PHYSIOL, V56, P1587, DOI 10.1016/j.jinsphys.2010.05.019; Burand JP, 2013, J INVERTEBR PATHOL, V112, pS68, DOI 10.1016/j.jip.2012.07.012; Christiaens O, 2014, CURR OPIN INSECT SCI, V6, P15, DOI 10.1016/j.cois.2014.09.012; Ciudad L, 2006, FEBS J, V273, P325, DOI 10.1111/j.1742-4658.2005.05066.x; Crawley MJ, 2005, STAT INTRO USING R; Davies TGE, 2012, MED VET ENTOMOL, V26, P241, DOI 10.1111/j.1365-2915.2011.01006.x; DAVIS NT, 1964, J INSECT PHYSIOL, V10, P947, DOI 10.1016/0022-1910(64)90083-6; Delaunay P, 2011, CLIN INFECT DIS, V52, P200, DOI 10.1093/cid/ciq102; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gade G, 2003, PEST MANAG SCI, V59, P1063, DOI 10.1002/ps.755; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gu JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021329; Gu LQ, 2013, CROP PROT, V45, P36, DOI 10.1016/j.cropro.2012.10.004; Guidugli KR, 2005, FEBS LETT, V579, P4961, DOI 10.1016/j.febslet.2005.07.085; HAGEDORN HH, 1979, ANNU REV ENTOMOL, V24, P475, DOI 10.1146/annurev.en.24.010179.002355; Hall M, 1999, P NATL ACAD SCI USA, V96, P1965, DOI 10.1073/pnas.96.5.1965; Harlan Harold J., 2006, American Entomologist, V52, P99; Hirai M, 1998, INSECT BIOCHEM MOLEC, V28, P537, DOI 10.1016/S0965-1748(98)00052-6; Hoffmann KH, 1998, PHYTOPARASITICA, V26, P323, DOI 10.1007/BF02981447; Hosokawa T, 2010, P NATL ACAD SCI USA, V107, P769, DOI 10.1073/pnas.0911476107; Johnson CG, 1941, J HYG-CAMBRIDGE, V41, P345, DOI 10.1017/S0022172400012560; Kim YH, 2015, PESTIC BIOCHEM PHYS, V120, P109, DOI 10.1016/j.pestbp.2015.01.002; Lee JM, 2000, INSECT BIOCHEM MOLEC, V30, P189, DOI 10.1016/S0965-1748(99)00127-7; Li J, 2013, INSECT SCI, V20, P31, DOI [10.1111/j.1744-7917.2012.01558.x, 10.1111/j.1744-7917.2012.01550.x]; Lu HL, 2009, FEBS J, V276, P3110, DOI 10.1111/j.1742-4658.2009.07029.x; Mamidala P, 2013, COMP BIOCHEM PHYS B, V164, P275, DOI 10.1016/j.cbpb.2013.02.002; Mamidala P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-6; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Martin D, 2006, J INSECT PHYSIOL, V52, P410, DOI 10.1016/j.jinsphys.2005.12.002; Melo ACA, 2000, INSECT BIOCHEM MOLEC, V30, P549, DOI 10.1016/S0965-1748(00)00023-0; Mitchell RD, 2007, INSECT BIOCHEM MOLEC, V37, P375, DOI 10.1016/j.ibmb.2007.01.005; Moriyama M, 2012, APPL ENTOMOL ZOOL, V47, P233, DOI 10.1007/s13355-012-0112-z; Morrow EH, 2003, P ROY SOC B-BIOL SCI, V270, P2377, DOI 10.1098/rspb.2003.2514; Provost-Javier KN, 2010, INSECT MOL BIOL, V19, P423, DOI 10.1111/j.1365-2583.2010.00999.x; R Core Team, 2021, R LANGUAGE ENV STAT; Reinhardt K, 2005, ECOL ENTOMOL, V30, P607, DOI 10.1111/j.0307-6946.2005.00730.x; Reinhardt K, 2003, P ROY SOC B-BIOL SCI, V270, P2371, DOI 10.1098/rspb.2003.2515; Reinhardt K, 2007, ANNU REV ENTOMOL, V52, P351, DOI 10.1146/annurev.ento.52.040306.133913; Robinson-Rechavi M, 2000, BIOINFORMATICS, V16, P296, DOI 10.1093/bioinformatics/16.3.296; Santos D, 2014, CURR OPIN INSECT SCI, V6, P9, DOI 10.1016/j.cois.2014.09.013; Sappington TW, 1998, INSECT BIOCHEM MOLEC, V28, P277, DOI 10.1016/S0965-1748(97)00110-0; Siva-Jothy MT, 2006, PHILOS T ROY SOC B, V361, P269, DOI 10.1098/rstb.2005.1789; Smagghe G, 2014, CURR OPIN INSECT SCI, V6, pIV, DOI 10.1016/j.cois.2014.11.001; Stutt AD, 2001, P NATL ACAD SCI USA, V98, P5683, DOI 10.1073/pnas.101440698; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tian HG, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006225, 10.1371/journal.pone.0005157]; Tufail M, 2001, ARCH INSECT BIOCHEM, V48, P72, DOI 10.1002/arch.1059; Tufail M, 2008, J INSECT PHYSIOL, V54, P1447, DOI 10.1016/j.jinsphys.2008.08.007; Tufail M, 2007, ARCH INSECT BIOCHEM, V66, P190, DOI 10.1002/arch.20212; Tufail M, 2014, ENTOMOL SCI, V17, P269, DOI 10.1111/ens.12086; Usinger R. L., 1966, MONOGRAPH CIMICIDAE; Weeks ENI, 2011, PEST MANAG SCI, V67, P10, DOI 10.1002/ps.2024; Yu N, 2013, INSECT SCI, V20, P4, DOI 10.1111/j.1744-7917.2012.01534.x; Zhang H, 2013, INSECT SCI, V20, P15, DOI 10.1111/j.1744-7917.2012.01513.x; Zhang SC, 2011, INT J BIOCHEM CELL B, V43, P303, DOI 10.1016/j.biocel.2010.11.003; Zhu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031037	59	38	40	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153984	10.1371/journal.pone.0153984	http://dx.doi.org/10.1371/journal.pone.0153984			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096422	Green Published, gold, Green Submitted			2022-12-26	WOS:000374543600079
J	Schulten, HJ; Hussein, D; Al-Adwani, F; Karim, S; Al-Maghrabi, J; Al-Sharif, M; Jamal, A; Al-Ghamdi, F; Baeesa, SS; Bangash, M; Chaudhary, A; Al-Qahtani, M				Schulten, Hans-Juergen; Hussein, Deema; Al-Adwani, Fatima; Karim, Sajjad; Al-Maghrabi, Jaudah; Al-Sharif, Mona; Jamal, Awatif; Al-Ghamdi, Fahad; Baeesa, Saleh S.; Bangash, Mohammed; Chaudhary, Adeel; Al-Qahtani, Mohammed			Microarray Expression Data Identify DCC as a Candidate Gene for Early Meningioma Progression	PLOS ONE			English	Article							THERAPEUTIC TARGET; NETRIN-1; GLIOBLASTOMA; REVEALS; METHYLATION; MIGRATION; PROFILES; PROTEINS; NETWORK; COMPLEX	Meningiomas are the most common primary brain tumors bearing in a minority of cases an aggressive phenotype. Although meningiomas are stratified according to their histology and clinical behavior, the underlying molecular genetics predicting aggressiveness are not thoroughly understood. We performed whole transcript expression profiling in 10 grade I and four grade II meningiomas, three of which invaded the brain. Microarray expression analysis identified deleted in colorectal cancer (DCC) as a differentially expressed gene (DEG) enabling us to cluster meningiomas into DCC low expression (3 grade I and 3 grade II tumors), DCC medium expression (2 grade I and 1 grade II tumors), and DCC high expression (5 grade I tumors) groups. Comparison between the DCC low expression and DCC high expression groups resulted in 416 DEGs (p-value < 0.05; fold change > 2). The most significantly downregulated genes in the DCC low expression group comprised DCC, phosphodiesterase 1C (PDE1C), calmodulin-dependent 70kDa olfactomedin 2 (OLFM2), glutathione S-transferase mu 5 (GSTM5), phosphotyrosine interaction domain containing 1 (PID1), sema domain, transmembrane domain (TM) and cytoplasmic domain, (semaphorin) 6D (SEMA6D), and indolethylamine N-methyltransferase (INMT). The most significantly upregulated genes comprised chromosome 5 open reading frame 63 (C5orf63), homeodomain interacting protein kinase 2 (HIPK2), and basic helix-loop-helix family, member e40 (BHLHE40). Biofunctional analysis identified as predicted top upstream regulators beta-estradiol, TGFB1, Tgf beta complex, LY294002, and dexamethasone and as predicted top regulator effectors NFkB, PIK3R1, and CREBBP. The microarray expression data served also for a comparison between meningiomas from female and male patients and for a comparison between brain invasive and non-invasive meningiomas resulting in a number of significant DEGs and related biofunctions. In conclusion, based on its expression levels, DCC may constitute a valid biomarker to identify those benign meningiomas at risk for progression.	[Schulten, Hans-Juergen; Al-Adwani, Fatima; Karim, Sajjad; Chaudhary, Adeel; Al-Qahtani, Mohammed] King Abdulaziz Univ, Ctr Excellence Genom Med Res, Jeddah 21413, Saudi Arabia; [Schulten, Hans-Juergen; Karim, Sajjad; Chaudhary, Adeel; Al-Qahtani, Mohammed] King Abdulaziz Univ, KACST Technol Innovat Ctr Personalized Med, Jeddah 21413, Saudi Arabia; [Hussein, Deema] King Abdulaziz Univ, King Fahad Med Res Ctr, Jeddah 21413, Saudi Arabia; [Al-Adwani, Fatima; Al-Sharif, Mona] King Abdulaziz Univ, Dept Biol, Jeddah 21413, Saudi Arabia; [Al-Maghrabi, Jaudah; Jamal, Awatif; Al-Ghamdi, Fahad] King Abdulaziz Univ Hosp, Fac Med, Dept Pathol, Jeddah, Saudi Arabia; [Al-Maghrabi, Jaudah] King Faisal Specialist Hosp & Res Ctr, Dept Pathol, Jeddah, Saudi Arabia; [Baeesa, Saleh S.; Bangash, Mohammed] King Abdulaziz Univ Hosp, Dept Surg, Div Neurosurg, Jeddah, Saudi Arabia	King Abdulaziz University; King Abdulaziz University; King Abdulaziz University; King Abdulaziz University; King Abdulaziz University; King Abdulaziz University Hospital - Jeddah; King Saud University; King Abdulaziz University Hospital - Riyadh; King Faisal Specialist Hospital & Research Center; King Abdulaziz University; King Abdulaziz University Hospital - Jeddah; King Saud University; King Abdulaziz University Hospital - Riyadh	Schulten, HJ (corresponding author), King Abdulaziz Univ, Ctr Excellence Genom Med Res, Jeddah 21413, Saudi Arabia.; Schulten, HJ (corresponding author), King Abdulaziz Univ, KACST Technol Innovat Ctr Personalized Med, Jeddah 21413, Saudi Arabia.	hschulten@kau.edu.sa	Baeesa, Saleh S/G-5519-2011; Schulten, Hans-Juergen/AAP-4754-2021; Al-Maghrabi, Jaudah/L-4367-2013; Schulten, Hans-Juergen/H-9854-2012; Al-Qahtani, Mohammed Hussain/AAZ-1729-2020; Karim, Sajjad/H-9897-2012; Hussein, Deema/AAW-1297-2020	Baeesa, Saleh S/0000-0002-3053-7912; Schulten, Hans-Juergen/0000-0002-4907-3222; Al-Maghrabi, Jaudah/0000-0002-0812-9592; Karim, Sajjad/0000-0003-0907-2097; Hussein, Deema/0000-0002-8316-489X; AL-Sharif, Mona/0000-0002-7138-4203	King Abdulaziz City for Science and Technology (KACST) [AT-32-98]; KACST Technology Innovation Center in Personalized Medicine [13-CIPM-07]	King Abdulaziz City for Science and Technology (KACST); KACST Technology Innovation Center in Personalized Medicine	HJS (PI), and DH, SK, JM, AJ, SSB, MB (Co-Is) were supported by King Abdulaziz City for Science and Technology (KACST) grant AT-32-98, and DH (PI) and MB (Co-I) by KACST Technology Innovation Center in Personalized Medicine grant 13-CIPM-07.	Aarhus M, 2011, ACTA NEUROCHIR, V153, P447, DOI 10.1007/s00701-010-0906-0; Berezovsky AD, 2014, NEOPLASIA, V16, DOI 10.1016/j.neo.2014.03.006; Carvalho LH, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-64; Castets M, 2012, NATURE, V482, P534, DOI 10.1038/nature10708; Celis-Aguilar E, 2012, GENET RES INT, V2012, DOI 10.1155/2012/856157; Chen DQ, 2015, INT J BREAST CANCER, V2015, DOI 10.1155/2015/539721; Chu UB, 2014, BIOCHEMISTRY-US, V53, P2956, DOI 10.1021/bi500175p; Cirulli V, 2007, NAT REV MOL CELL BIO, V8, P296, DOI 10.1038/nrm2142; Collier Fiona M, 2009, J Cell Death, V2, P9; Cooper LAD, 2012, AM J PATHOL, V180, P2108, DOI 10.1016/j.ajpath.2012.01.040; D'Orazi G, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-63; Day BW, 2013, CANCER CELL, V23, P238, DOI 10.1016/j.ccr.2013.01.007; Deshmukh H, 2008, ONCOGENE, V27, P4745, DOI 10.1038/onc.2008.110; Ekstrand BC, 1995, ONCOGENE, V11, P2393; Engstrom PG, 2012, GENOME MED, V4, DOI 10.1186/gm377; Erdreich-Epstein A, 2014, NEURO-ONCOLOGY, V16, DOI 10.1093/neuonc/nou208.11; Etcheverry A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-701; Finci LI, 2014, NEURON, V83, P839, DOI 10.1016/j.neuron.2014.07.010; Haddick PCG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084823; Hara A, 2001, J CLIN PATHOL, V54, P860, DOI 10.1136/jcp.54.11.860; Domingues PH, 2014, NEURO-ONCOLOGY, V16, P735, DOI 10.1093/neuonc/not325; Domingues PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074798; Hibi K, 2009, WORLD J SURG, V33, P1053, DOI 10.1007/s00268-008-9909-x; Jarjour AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025408; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kim KK, 2014, NAT STRUCT MOL BIOL, V21, P901, DOI 10.1038/nsmb.2892; Kim KK, 2013, J CELL BIOL, V200, P443, DOI 10.1083/jcb.201206146; Krimpenfort P, 2012, NATURE, V482, P538, DOI 10.1038/nature10790; Latini FRM, 2008, ENDOCR-RELAT CANCER, V15, P787, DOI 10.1677/ERC-08-0079; Lee HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084201; Lee ICJ, 2014, J BIOL CHEM, V289, P26989, DOI 10.1074/jbc.M114.588079; Lee Y, 2010, BRAIN PATHOL, V20, P751, DOI 10.1111/j.1750-3639.2009.00356.x; Liu Y, 2013, INT J MOL MED, V31, P855, DOI 10.3892/ijmm.2013.1279; Luo Y, 2015, ONCOTARGET, V6, P22564, DOI 10.18632/oncotarget.4197; Lusis EA, 2005, CANCER RES, V65, P7121, DOI 10.1158/0008-5472.CAN-05-0043; Mehlen P, 1998, NATURE, V395, P801, DOI 10.1038/27441; Mille F, 2009, CELL DEATH DIFFER, V16, P1344, DOI 10.1038/cdd.2009.75; Nakaya N, 2012, J BIOL CHEM, V287, P37171, DOI 10.1074/jbc.M112.389916; Ozmadenci D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8398; Pechenino AS, 2009, NEUROBIOL LEARN MEM, V91, P313, DOI 10.1016/j.nlm.2008.09.017; Perez-Magan E, 2012, J NEUROPATH EXP NEUR, V71, P882, DOI 10.1097/NEN.0b013e31826bf704; Perez-Magan E, 2010, NEURO-ONCOLOGY, V12, P1278, DOI 10.1093/neuonc/noq081; Pujol-Gimenez J, 2015, J CANCER, V6, P139, DOI 10.7150/jca.10429; Qu XH, 2002, J BIOL CHEM, V277, P35574, DOI 10.1074/jbc.M206451200; Reyes-Mugica M, 1998, LAB INVEST, V78, P669; ReyesMugica M, 1997, CANCER RES, V57, P382; Roforth MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095987; Rowther FB, 2016, MOL CARCINOGEN, V55, P268, DOI 10.1002/mc.22276; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schulten HJ, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S1-S6; Senchenko VN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015612; Shibuya M, 2015, NEUROL MED-CHIR, V55, P14, DOI 10.2176/nmc.ra.2014-0233; Shin K, 2007, EMBO REP, V8, P158, DOI 10.1038/sj.embor.7400890; Sidoryk M, 2004, NEUROREPORT, V15, P575, DOI 10.1097/00001756-200403220-00001; Tamada Y, 2011, IEEE ACM T COMPUT BI, V8, P683, DOI 10.1109/TCBB.2010.68; Torres-Martin M, 2014, ONCOL REP, V32, P2327, DOI 10.3892/or.2014.3526; Torres-Martin M, 2013, INT J ONCOL, V42, P848, DOI 10.3892/ijo.2013.1798; Trabzuni D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3771; van den Boom J, 2003, AM J PATHOL, V163, P1033, DOI 10.1016/S0002-9440(10)63463-3; Wang XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040084, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0036663, 10.1371/journal.pone.0045380, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0045036]; Wei P, 2012, J NEUROCHEM, V121, P717, DOI 10.1111/j.1471-4159.2012.07648.x; Yan W, 2014, DIGEST DIS SCI, V59, P1213, DOI 10.1007/s10620-013-3016-z; Yang J, 2015, ONCOTARGET, V6, P11125, DOI 10.18632/oncotarget.3575; Zhang CM, 2009, ACTA PHARMACOL SIN, V30, P120, DOI 10.1038/aps.2008.9; Zhang L, 2011, MED ONCOL, V28, P907, DOI 10.1007/s12032-010-9537-9	65	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153681	10.1371/journal.pone.0153681	http://dx.doi.org/10.1371/journal.pone.0153681			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096627	Green Published, Green Submitted, gold			2022-12-26	WOS:000374543600049
J	Yue, JQ; Mao, XH; Xu, K; Lu, LS; Liu, SJ; Chen, F; Wang, JM				Yue, Jiqiang; Mao, Xuhua; Xu, Kun; Lu, Lingshuang; Liu, Sijun; Chen, Feng; Wang, Jianming			Prevalence, Awareness, Treatment and Control of Diabetes Mellitus in a Chinese Population	PLOS ONE			English	Article							GLUCOSE CONTROL; RISK-FACTORS; ADULTS; COMPLICATIONS; HYPERTENSION; INTERASIA; CHILDREN; EXERCISE; WEIGHT; BURDEN	Objective The purpose of this study is to evaluate the prevalence, awareness, treatment and glycemic control of diabetes mellitus (DM) in a Chinese population. The findings from this study are expected to offer scientific evidence to better prevent and control the growing number of reported and untreated cases. Methods A cross-sectional survey was conducted in Jiangsu, China. We recruited permanent residents over 18 years of age from eight towns in Jintan (JT) and six towns in Yangzhong (YZ) using a three-stage stratified cluster sampling method. The rates of DM prevalence, awareness, treatment and control as well as their related factors were analyzed. Results A total number of 15404 people were entered into the analysis. The DM prevalence, awareness, treatment and control rates were 7.31%, 58.35%, 51.87% and 14.12%, respectively. Multivariable logistic regression analysis showed that being female was positively related to prevalence (OR = 1.21, 95% CI: 1.07-1.37), awareness (OR = 1.52, 95% CI: 1.19-1.93), treatment (OR = 1.48, 95% CI: 1.17-1.88) and control (OR = 1.87, 95% CI: 1.30-2.67) of DM. Having a family history of diabetes was significantly correlated with DM risk (OR = 1.86, 95% CI: 1.37-2.54) and increased awareness (OR = 3.12, 95% CI: 2.19-4.47), treatment (OR = 3.47, 95% CI: 2.45-4.90) and control (OR = 1.81, 95% CI: 1.22-2.68) of DM. Former smoking status (OR = 1.82, 95% CI: 1.23-2.71), overweight (OR = 2.11, 95% CI: 1.72-2.60) and obesity (OR = 3.46, 95% CI: 2.67-4.50) were related to the risk of DM. Additionally, we found current drinking status to be positively correlated with DM risk (OR = 1.30, 95% CI: 1.01-1.66) and negatively correlated with DM awareness (OR = 0.41, 95% CI: 0.29-0.59) and treatment (OR = 0.41, 95% CI: 0.29-0.59). Our study highlights the high prevalence and inadequate awareness, treatment and control of DM in the Chinese population. Conclusions Management and prevention of DM-related complications should be considered an essential strategy by governments and society. This study assessed the reasons why DM has been increasing and established the first step in determining where to start regarding preventative methods.	[Yue, Jiqiang; Xu, Kun; Liu, Sijun; Chen, Feng; Wang, Jianming] Nanjing Med Univ, Sch Publ Hlth, Dept Social Med & Hlth Educ, Nanjing 211166, Jiangsu, Peoples R China; [Mao, Xuhua] Yixing Peoples Hosp, Dept Clin Lab, Wuxi 214200, Peoples R China; [Lu, Lingshuang; Wang, Jianming] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol, Nanjing 211166, Jiangsu, Peoples R China; [Wang, Jianming] Nanjing Med Univ, Sch Publ Hlth, Innovat Ctr Social Risk Governance Hlth, Nanjing 211166, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Wang, JM (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Social Med & Hlth Educ, Nanjing 211166, Jiangsu, Peoples R China.; Wang, JM (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol, Nanjing 211166, Jiangsu, Peoples R China.; Wang, JM (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Innovat Ctr Social Risk Governance Hlth, Nanjing 211166, Jiangsu, Peoples R China.	jmwang@njmu.edu.cn	lu, lu/HII-7530-2022	Wang, Jianming/0000-0002-9151-284X	Qing Lan Project; Philosophy and Social Science Research Fund of Jiangsu College [2014SJB164]; Top-notch Academic Programs Project of Jiangsu Higher Education Institutions [PPZY2015A067]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Qing Lan Project(Jiangsu Polytech Institute); Philosophy and Social Science Research Fund of Jiangsu College; Top-notch Academic Programs Project of Jiangsu Higher Education Institutions; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	The Qing Lan Project (2014), Philosophy and Social Science Research Fund of Jiangsu College (2014SJB164), Top-notch Academic Programs Project of Jiangsu Higher Education Institutions (PPZY2015A067) and Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) supported this study. The funders had no role in the study design, data collection and analysis, decision to publish, or in the preparation of the manuscript.	Ades PA, 2015, PREV MED, V80, P50, DOI 10.1016/j.ypmed.2015.03.014; Aljoudi AS, 2009, ANN SAUDI MED, V29, P15, DOI 10.4103/0256-4947.51813; Arakawa S, 2015, DIABETOL INT, V6, P19, DOI 10.1007/s13340-014-0166-y; Chan JCN, 2001, DIABETES RES CLIN PR, V54, pS19; Chen HM, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-69; Collison KS, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-234; Dajani R, 2012, J DIABETES COMPLICAT, V26, P175, DOI 10.1016/j.jdiacomp.2012.03.009; Danne T, 2005, DIABETES CARE, V28, P2100, DOI 10.2337/diacare.28.9.2100; Rodrigues AMD, 2016, JAMA PEDIATR, V170, P487, DOI 10.1001/jamapediatrics.2015.4365; Faeh D, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-163; Gupta A, 2014, BMJ OPEN DIAB RES CA, V2, DOI 10.1136/bmjdrc-2014-000048; Hu DS, 2008, DIABETES RES CLIN PR, V81, P250, DOI 10.1016/j.diabres.2008.04.008; Hu DS, 2009, DIABETES RES CLIN PR, V84, P288, DOI 10.1016/j.diabres.2009.02.021; Hu HM, 2015, DIABETES THER, V6, P7, DOI 10.1007/s13300-015-0096-0; Ji LN, 2015, J DIABETES, V7, P166, DOI 10.1111/1753-0407.12165; Ji LN, 2012, DIABETES RES CLIN PR, V98, P173, DOI 10.1016/j.diabres.2012.10.002; Kemp TM, 2005, DIABETES CARE, V28, P1490, DOI 10.2337/diacare.28.6.1490; Kim CR, 2016, KOREAN J FAM MED, V37, P51, DOI 10.4082/kjfm.2016.37.1.51; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Li H, 2012, DIABETES RES CLIN PR, V98, P226, DOI 10.1016/j.diabres.2012.05.010; Li MZ, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/753150; McDonald M, 2009, J GERONTOL A-BIOL, V64, P256, DOI 10.1093/gerona/gln016; Porapakkham Y, 2008, SINGAP MED J, V49, P868; Rahman MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118365; Rampal S, 2010, ASIA-PAC J PUBLIC HE, V22, P194, DOI 10.1177/1010539509334816; Sims M, 2011, ANN EPIDEMIOL, V21, P892, DOI 10.1016/j.annepidem.2011.05.006; Singh Arvind Kumar, 2012, Indian J Community Med, V37, P236, DOI 10.4103/0970-0218.103472; SONGER TJ, 1992, DIABETES METAB REV, V8, P389, DOI 10.1002/dmr.5610080406; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vijan S, 1997, J GEN INTERN MED, V12, P567, DOI 10.1046/j.1525-1497.1997.07111.x; Wang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103594; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yang YN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035270; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P245	34	34	37	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153791	10.1371/journal.pone.0153791	http://dx.doi.org/10.1371/journal.pone.0153791			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096738	gold, Green Published, Green Submitted			2022-12-26	WOS:000374543600057
J	Sabler, IM; Berkovitch, M; Sandbank, J; Kozer, E; Dagan, Z; Goldman, M; Bahat, H; Stav, K; Zisman, A; Klin, B; Abu-Kishk, I				Sabler, Itay M.; Berkovitch, Matitiahu; Sandbank, Judith; Kozer, Eran; Dagan, Zahi; Goldman, Michael; Bahat, Hilla; Stav, Kobi; Zisman, Amnon; Klin, Baruch; Abu-Kishk, Ibrahim			Exposure to Hyperbaric Oxygen Intensified Vancomycin-Induced Nephrotoxicity in Rats	PLOS ONE			English	Article							OXIDATIVE STRESS; SUPEROXIDE-DISMUTASE; CEREBRAL-ISCHEMIA; RENAL-FUNCTION; HIGH-PRESSURE; CELLS; DYSFUNCTION; MECHANISMS; EXPRESSION; PROTECTION	It has been suggested that oxidative stress is a potential mechanism for vancomycin-induced nephrotoxicity and hyperbaric oxygen therapy (HBO) has been shown to be effective in treating renal toxicity that has been pharmacologically induced in animal models. The aim of this study was to investigate the effect of HBO therapy on vancomycin-induced nephrotoxicity in rats. The study group comprised 36 Sprague Dawley male rats. We treated 30 with 500 mg/kg of intraperitoneal vancomycin once a day for 7 days. Half of these rats received a daily 1-hour treatment with HBO at 2 Atmospheres (ATM) on the same 7 days and formed the HBO+ group. The other 15 subjects received no HBO treatment (HBO-group). The remaining six rats served as the control group, three received HBO treatments alone and no treatment was administered to the other three rats. Laboratory results were obtained on day 8 and the intervention and control groups were compared. Rats in the HBO + group gained less weight than the HBO-group (11.6 grams vs 22.6 grams; P = 0,008) and had significantly higher serum blood urea nitrogen (99.6 vs 52.6 mg/dL; P< 0.001), serum creatinine (0.42 vs 0.16 mg/dL; P = 0.001) and magnesium (3.6 vs 3.1mg/dL; P = 0.014). The vancomycin blood levels were also higher in the HBO+ group (27.8 vs 6.7 mu g/mL; P = 0.078). There were no pathological kidney changes in the control group. All the kidneys from the treated groups (vancomycin + HBO and vancomycin HBO-) showed moderate to severe histopathological changes with no statistical significance between them. This study demonstrated that exposure to hyperbaric oxygen intensified vancomycin-induced nephrotoxicity in rats.	[Sabler, Itay M.; Stav, Kobi; Zisman, Amnon] Tel Aviv Univ, Sackler Sch Med, Dept Urol, Assaf Harofeh Med Ctr, IL-69978 Tel Aviv, Israel; [Berkovitch, Matitiahu; Dagan, Zahi] Tel Aviv Univ, Sackler Sch Med, Clin Pharmacol Unit, Assaf Harofeh Med Ctr, IL-69978 Tel Aviv, Israel; [Sandbank, Judith] Tel Aviv Univ, Sackler Sch Med, Dept Pathol, Assaf Harofeh Med Ctr, IL-69978 Tel Aviv, Israel; [Kozer, Eran; Klin, Baruch; Abu-Kishk, Ibrahim] Tel Aviv Univ, Sackler Sch Med, Div Pediat, Assaf Harofeh Med Ctr, IL-69978 Tel Aviv, Israel; [Goldman, Michael; Bahat, Hilla] Tel Aviv Univ, Sackler Sch Med, Pediat Nephrol Serv, Assaf Harofeh Med Ctr, IL-69978 Tel Aviv, Israel	Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Sackler Faculty of Medicine; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Sackler Faculty of Medicine; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Sackler Faculty of Medicine; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Sackler Faculty of Medicine; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Sackler Faculty of Medicine	Abu-Kishk, I (corresponding author), Tel Aviv Univ, Sackler Sch Med, Div Pediat, Assaf Harofeh Med Ctr, IL-69978 Tel Aviv, Israel.	abukishki@gmail.com	Stav, Kobi/AAH-1523-2019					APPEL GB, 1986, AM J KIDNEY DIS, V8, P75, DOI 10.1016/S0272-6386(86)80116-0; ARONOFF GR, 1981, ANTIMICROB AGENTS CH, V19, P306, DOI 10.1128/AAC.19.2.306; Aydinoz S, 2007, RENAL FAILURE, V29, P257, DOI 10.1080/08860220601166487; Berkovitch M, 2014, SCI WORLD J, DOI 10.1155/2014/105069; Chen LF, 2014, J FORMOS MED ASSOC, V113, P620, DOI 10.1016/j.jfma.2014.03.012; Cisek LJ, 1998, J ENDOUROL, V12, P95, DOI 10.1089/end.1998.12.95; Dieterich C, 2009, TOXICOL SCI, V107, P258, DOI 10.1093/toxsci/kfn203; Djurhuus R, 1999, UNDERSEA HYPERBAR M, V26, P75; Gill AL, 2004, QJM-INT J MED, V97, P385, DOI 10.1093/qjmed/hch074; Gregorevic P, 2001, EUR J APPL PHYSIOL, V86, P24, DOI 10.1007/s004210100503; Hong S, 2007, AM J MED SCI, V334, P296, DOI 10.1097/MAJ.0b013e3180a6ec1e; Huang SHS, 2011, TRANSL RES, V157, P357, DOI 10.1016/j.trsl.2011.01.002; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Kellum John A, 2002, Curr Opin Crit Care, V8, P509, DOI 10.1097/00075198-200212000-00005; KIM YS, 1991, J NEUROSCI RES, V29, P100, DOI 10.1002/jnr.490290111; King DW, 2004, TOXICOL IN VITRO, V18, P797, DOI 10.1016/j.tiv.2004.03.013; Levine DP, 2006, CLIN INFECT DIS, V42, pS5, DOI 10.1086/491709; Lin H, 2012, J TRAUMA ACUTE CARE, V72, P1220, DOI 10.1097/TA.0b013e318246ee70; MARRE R, 1984, J ANTIMICROB CHEMOTH, V14, P253, DOI 10.1093/jac/14.3.253; Mrsic-Pelcic J, 2004, NEUROCHEM INT, V44, P585, DOI 10.1016/j.neuint.2003.10.004; Nakamura T, 1996, J PHARM PHARMACOL, V48, P1197, DOI 10.1111/j.2042-7158.1996.tb03920.x; Nishino Y, 2003, FREE RADICAL RES, V37, P373, DOI 10.1080/1071576031000061002; Oktem F, 2005, TOXICOLOGY, V215, P227, DOI 10.1016/j.tox.2005.07.009; Piantadosi CA, 2008, FREE RADICAL BIO MED, V45, P562, DOI 10.1016/j.freeradbiomed.2008.05.013; Rachmilewitz D, 1998, GUT, V43, P512, DOI 10.1136/gut.43.4.512; SOKOL PP, 1991, J PHARMACOL EXP THER, V259, P1283; THOM SR, 1987, UNDERSEA BIOMED RES, V14, P485; Tibbles PM, 1996, NEW ENGL J MED, V334, P1642, DOI 10.1056/NEJM199606203342506; Wada K, 2000, ACT NEUR S, V76, P285; ZAMBONI WA, 1993, PLAST RECONSTR SURG, V91, P1110, DOI 10.1097/00006534-199305000-00022	30	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0152554	10.1371/journal.pone.0152554	http://dx.doi.org/10.1371/journal.pone.0152554			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27092557	Green Published, Green Submitted, gold			2022-12-26	WOS:000374541200006
J	Vernerova, L; Spoutil, F; Vlcek, M; Krskova, K; Penesova, A; Meskova, M; Marko, A; Raslova, K; Vohnout, B; Rovensky, J; Killinger, Z; Jochmanova, I; Lazurova, I; Steiner, G; Smolen, J; Imrich, R				Vernerova, Lucia; Spoutil, Frantisek; Vlcek, Miroslav; Krskova, Katarina; Penesova, Adela; Meskova, Milada; Marko, Andrea; Raslova, Katarina; Vohnout, Branislav; Rovensky, Jozef; Killinger, Zdenko; Jochmanova, Ivana; Lazurova, Ivica; Steiner, Guenter; Smolen, Josef; Imrich, Richard			A Combination of CD28 (rs1980422) and IRF5 (rs10488631) Polymorphisms Is Associated with Seropositivity in Rheumatoid Arthritis: A Case Control Study	PLOS ONE			English	Article							GENE-ENVIRONMENT INTERACTIONS; GENOME-WIDE ASSOCIATION; HLA-DRB1 SHARED EPITOPE; SUSCEPTIBILITY LOCI; RISK; ANTIBODIES; COHORT; PROGRESSION; VARIANTS; PREDICTION	Introduction The aim of the study was to analyse genetic architecture of RA by utilizing multiparametric statistical methods such as linear discriminant analysis (LDA) and redundancy analysis (RDA). Methods A total of 1393 volunteers, 499 patients with RA and 894 healthy controls were included in the study. The presence of shared epitope (SE) in HLA-DRB1 and 11 SNPs (PTPN22 C/T (rs2476601), STAT4 G/T (rs7574865), CTLA4 A/G (rs3087243), TRAF1/C5 A/G (rs3761847), IRF5 T/C (rs10488631), TNFAIP3 C/T (rs5029937), AFF3 A/T (rs11676922), PADI4 C/T (rs2240340), CD28 T/C (rs1980422), CSK G/A (rs34933034) and FCGR3A A/C (rs396991), rheumatoid factor (RF), anti-citrullinated protein antibodies (ACPA) and clinical status was analysed using the LDA and RDA. Results HLA-DRB1, PTPN22, STAT4, IRF5 and PADI4 significantly discriminated between RA patients and healthy controls in LDA. The correlation between RA diagnosis and the explanatory variables in the model was 0.328 (Trace = 0.107; F = 13.715; P = 0.0002). The risk variants of IRF5 and CD28 genes were found to be common determinants for seropositivity in RDA, while positivity of RF alone was associated with the CTLA4 risk variant in heterozygous form. The correlation between serologic status and genetic determinants on the 1st ordinal axis was 0.468, and 0.145 on the 2nd one (Trace = 0.179; F = 6.135; P = 0.001). The risk alleles in AFF3 gene together with the presence of ACPA were associated with higher clinical severity of RA. Conclusions The association among multiple risk variants related to T cell receptor signalling with seropositivity may play an important role in distinct clinical phenotypes of RA. Our study demonstrates that multiparametric analyses represent a powerful tool for investigation of mutual relationships of potential risk factors in complex diseases such as RA.	[Vernerova, Lucia; Vlcek, Miroslav; Krskova, Katarina; Penesova, Adela; Meskova, Milada; Marko, Andrea; Imrich, Richard] Slovak Acad Sci, Inst Clin & Translat Res, Biomed Ctr, Bratislava, Slovakia; [Spoutil, Frantisek] Acad Sci Czech Republ, Inst Mol Genet, Prague, Czech Republic; [Spoutil, Frantisek] Acad Sci Czech Republ, Inst Expt Med, Prague, Czech Republic; [Krskova, Katarina; Raslova, Katarina; Vohnout, Branislav] Slovak Med Univ, Bratislava, Slovakia; [Rovensky, Jozef] Natl Inst Rheumat Dis, Piestany, Slovakia; [Killinger, Zdenko] Comenius Univ, Fac Med, Dept Internal Med 5, Bratislava, Slovakia; [Jochmanova, Ivana; Lazurova, Ivica] Safarik Univ, Fac Med, Dept Internal Med 1, Kosice, Slovakia; [Steiner, Guenter; Smolen, Josef] Med Univ Vienna, Div Rheumatol, Dept Internal Med 3, Vienna, Austria; [Vernerova, Lucia] Inst Rheumatol, Prague, Czech Republic	Slovak Academy of Sciences; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Slovak Medical University Bratislava; Comenius University Bratislava; University of Pavol Jozef Safarik Kosice; Medical University of Vienna; Institute of Rheumatology	Vernerova, L (corresponding author), Slovak Acad Sci, Inst Clin & Translat Res, Biomed Ctr, Bratislava, Slovakia.; Vernerova, L (corresponding author), Inst Rheumatol, Prague, Czech Republic.	vernerova@revma.cz	Jochmanova, Ivana/I-9011-2016; Imrich, Richard/ABC-7247-2021; Jochmanova, Ivana/AAG-1856-2020; Vernerova, Lucia/N-9976-2019; Vernerova, Lucia/G-4735-2015; Vlček, Miroslav/H-5833-2018; Spoutil, Frantisek/I-6725-2019; Penesova, Adela/ABH-4065-2020	Jochmanova, Ivana/0000-0003-2346-461X; Imrich, Richard/0000-0002-1747-7150; Vernerova, Lucia/0000-0001-6087-2175; Vernerova, Lucia/0000-0001-6087-2175; Vlček, Miroslav/0000-0002-6845-3167; Spoutil, Frantisek/0000-0002-7310-3487; Lazurova, Ivica/0000-0002-3163-1097; Steiner, Guenter/0000-0002-5089-7405	Ministry of Education, Science, Research and Sport of the Slovak Republic [VEGA 2/0084/12, VEGA 2/0018/12]; grant Genetics and Mechanisms of Rheumatoid Arthritis RASGENAS by Austria-Slovakia Cross-border Cooperation Operational Programme [ATMOS N00024];  [N00024 RASGENAS]	Ministry of Education, Science, Research and Sport of the Slovak Republic; grant Genetics and Mechanisms of Rheumatoid Arthritis RASGENAS by Austria-Slovakia Cross-border Cooperation Operational Programme; 	This work was supported by the grants VEGA 2/0084/12 and VEGA 2/0018/12 awarded by The Ministry of Education, Science, Research and Sport of the Slovak Republic to RI and MV. Further it was supported by the grant Genetics and Mechanisms of Rheumatoid Arthritis RASGENAS (ATMOS N00024) awarded to RI by Austria-Slovakia Cross-border Cooperation Operational Programme 2007-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank particularly all the study participants and collaborating rheumatologists from outpatient clinics. This work was supported by the grants VEGA 2/0084/12, VEGA 2/0018/12 and N00024 RASGENAS.	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Barton A, 2009, HUM MOL GENET, V18, P2518, DOI 10.1093/hmg/ddp177; Burr ML, 2010, ANN RHEUM DIS, V69, P666, DOI 10.1136/ard.2009.111294; Chibnik LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024380; Costenbader KH, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2421; De Rycke L, 2004, ANN RHEUM DIS, V63, P1587, DOI 10.1136/ard.2003.017574; Dieguez-Gonzalez R, 2008, ARTHRITIS RHEUM-US, V58, P1264, DOI 10.1002/art.23426; Ding B, 2009, ARTHRITIS RHEUM, V60, P30, DOI 10.1002/art.24135; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; Foreman HCC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033098; Fransen J, 2005, CLIN EXP RHEUMATOL, V23, pS93; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; Gough SCL, 2005, IMMUNOL REV, V204, P102, DOI 10.1111/j.0105-2896.2005.00249.x; Han TU, 2009, ARTHRITIS RHEUM-US, V60, P2577, DOI 10.1002/art.24759; Holoshitz J, 2010, CURR OPIN RHEUMATOL, V22, P293, DOI 10.1097/BOR.0b013e328336ba63; Huizinga TWJ, 2005, ARTHRITIS RHEUM, V52, P3433, DOI 10.1002/art.21385; Ioannidis JPA, 2007, HUM HERED, V64, P203, DOI 10.1159/000103512; Iwamoto T, 2006, RHEUMATOLOGY, V45, P804, DOI 10.1093/rheumatology/kel023; Janssens ACJW, 2004, AM J HUM GENET, V74, P585, DOI 10.1086/382052; Karlson EW, 2008, ANN RHEUM DIS, V67, P358, DOI 10.1136/ard.2007.071662; Karlson EW, 2013, ARTHRIT CARE RES, V65, P1147, DOI 10.1002/acr.22005; Karlson EW, 2010, ANN RHEUM DIS, V69, P1077, DOI 10.1136/ard.2009.120170; Kerekes G, 2014, NAT REV RHEUMATOL, V10, P691, DOI 10.1038/nrrheum.2014.121; Knevel R, 2013, ARTHRITIS RHEUM-US, V65, P1684, DOI 10.1002/art.37938; Kurreeman F, 2011, AM J HUM GENET, V88, P57, DOI 10.1016/j.ajhg.2010.12.007; Li CW, 2015, J GENET GENOMICS, V42, P107, DOI 10.1016/j.jgg.2015.02.003; Liu CY, 2011, HUM GENET, V129, P473, DOI 10.1007/s00439-010-0943-z; Lu Qing, 2009, BMC Proc, V3 Suppl 7, pS49; Martinez A, 2005, RHEUMATOLOGY, V44, P1263, DOI 10.1093/rheumatology/kei008; McClure A, 2009, RHEUMATOLOGY, V48, P1369, DOI 10.1093/rheumatology/kep272; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Meyer O, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1896; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Padyukov L, 2011, ANN RHEUM DIS, V70, P259, DOI 10.1136/ard.2009.126821; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Plant D, 2010, ANN RHEUM DIS, V69, P1548, DOI 10.1136/ard.2009.121020; Plenge RM, 2005, AM J HUM GENET, P77; Plenge RM, 2009, CURR OPIN RHEUMATOL, V21, P262, DOI 10.1097/BOR.0b013e32832a2e2d; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Romo-Tena J, 2013, AUTOIMMUN REV, V12, P1171, DOI 10.1016/j.autrev.2013.07.002; Sandholm N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002921; Scott IC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003808; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Stark K, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2699; STASTNY P, 1976, J CLIN INVEST, V57, P1148, DOI 10.1172/JCI108382; Steiner G, 2009, SEMIN ARTHRITIS RHEU, V38, P372, DOI 10.1016/j.semarthrit.2008.01.015; Ursini F, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002552; van der Helm-van Mil AHM, 2005, ARTHRITIS RES THER, V7, pR949, DOI 10.1186/ar1767; van der Helm-van Mil AHM, 2006, ARTHRITIS RHEUM-US, V54, P1117, DOI 10.1002/art.21739; van der Helm-van Mil AHM, 2010, ANN RHEUM DIS, V69, P1694, DOI 10.1136/ard.2009.123828; Viatte S, 2016, ARTHRITIS RHEUMATOLO; Viatte S, 2012, ANN RHEUM DIS, V71, P1984, DOI 10.1136/annrheumdis-2011-201225; Wang C, 2011, J RHEUMATOL, V38, P2130, DOI 10.3899/jrheum.110322; Weir BS, 2005, GENOME RES, V15, P1468, DOI 10.1101/gr.4398405	55	16	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153316	10.1371/journal.pone.0153316	http://dx.doi.org/10.1371/journal.pone.0153316			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27092776	gold, Green Submitted, Green Published			2022-12-26	WOS:000374541200017
J	Bispo, PD; dos Santos, JR; Valeriano, MD; Graca, PMLD; Balzter, H; Franca, H; Bispo, PD				Bispo, Polyanna da Conceicao; dos Santos, Joao Roberto; Valeriano, Marcio de Morisson; Lima de Alencastro Graca, Paulo Mauricio; Balzter, Heiko; Franca, Helena; Bispo, Pitagoras da Conceicao			Predictive Models of Primary Tropical Forest Structure from Geomorphometric Variables Based on SRTM in the Tapajos Region, Brazilian Amazon	PLOS ONE			English	Article							RAIN-FOREST; SOIL PROPERTIES; VEGETATION COVER; CLIMATE-CHANGE; TOPOGRAPHY; BIODIVERSITY; DIVERSITY; NITROGEN; BIOMASS; HETEROGENEITY	Surveying primary tropical forest over large regions is challenging. Indirect methods of relating terrain information or other external spatial datasets to forest biophysical parameters can provide forest structural maps at large scales but the inherent uncertainties need to be evaluated fully. The goal of the present study was to evaluate relief characteristics, measured through geomorphometric variables, as predictors of forest structural characteristics such as average tree basal area (BA) and height (H) and average percentage canopy openness (CO). Our hypothesis is that geomorphometric variables are good predictors of the structure of primary tropical forest, even in areas, with low altitude variation. The study was performed at the Tapajos National Forest, located in the Western State of Para, Brazil. Forty-three plots were sampled. Predictive models for BA, H and CO were parameterized based on geomorphometric variables using multiple linear regression. Validation of the models with nine independent sample plots revealed a Root Mean Square Error (RMSE) of 3.73 m(2)/ha (20%) for BA, 1.70 m (12%) for H, and 1.78% (21%) for CO. The coefficient of determination between observed and predicted values were r(2) = 0.32 for CO, r(2) = 0.26 for H and r(2) = 0.52 for BA. The models obtained were able to adequately estimate BA and CO. In summary, it can be concluded that relief variables are good predictors of vegetation structure and enable the creation of forest structure maps in primary tropical rainforest with an acceptable uncertainty.	[Bispo, Polyanna da Conceicao; Franca, Helena] UFABC, Ciencia & Tecnol Ambiental, Sao Paulo, Brazil; [Bispo, Polyanna da Conceicao; Balzter, Heiko] Univ Leicester, Dept Geog, Ctr Landscape & Climate Res, Leicester LE1 7RH, Leics, England; [dos Santos, Joao Roberto; Valeriano, Marcio de Morisson] Inst Nacl Pesquisas Espaciais, Div Sensoriamento Remoto, Sao Paulo, Brazil; [Lima de Alencastro Graca, Paulo Mauricio] INPA, Coordenacao Dinam Ambiental, Manaus, Amazonas, Brazil; [Balzter, Heiko] Univ Leicester, Natl Ctr Earth Observat, Leicester, Leics, England; [Bispo, Pitagoras da Conceicao] Univ Estadual Paulista UNESP, Dept Ciencias Biol, Fac Ciencias & Letras Assis, Sao Paulo, Brazil	Universidade Federal do ABC (UFABC); University of Leicester; Instituto Nacional de Pesquisas Espaciais (INPE); Institute Nacional de Pesquisas da Amazonia; University of Leicester; Universidade Estadual Paulista	Bispo, PD (corresponding author), UFABC, Ciencia & Tecnol Ambiental, Sao Paulo, Brazil.; Bispo, PD (corresponding author), Univ Leicester, Dept Geog, Ctr Landscape & Climate Res, Leicester LE1 7RH, Leics, England.	polybispo@gmail.com	de Alencastro Graça, Paulo Maurício L/B-3375-2013; França, Helena/K-2344-2016; Balzter, Heiko/B-5976-2008	Balzter, Heiko/0000-0002-9053-4684; Graca, Paulo/0000-0003-2173-1518; /0000-0002-7356-8882	Universidade Federal do ABC (PNPD-CAPES, Council for Advanced Professional Training); European Union [660020]; CNPq (National Council for Scientific and Technological Development); Instituto Nacional de Ciencia e Tecnologia dos Servicos Ambientais da Amazonia (SERVAMB); Royal Society [2011/R3]; Natural Environment Research Council; Sao Paulo State University (UNESP, Brazil); Natural Environment Research Council [nceo020005] Funding Source: researchfish; NERC [nceo020005] Funding Source: UKRI	Universidade Federal do ABC (PNPD-CAPES, Council for Advanced Professional Training); European Union(European Commission); CNPq (National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia dos Servicos Ambientais da Amazonia (SERVAMB); Royal Society(Royal Society of London); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Sao Paulo State University (UNESP, Brazil); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	PolCB was supported by Universidade Federal do ABC (PNPD-CAPES, Council for Advanced Professional Training) in 2015 and currently is supported by European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 660020. JRS, MMV and PitCB were supported by CNPq (National Council for Scientific and Technological Development), PMLG was supported by Instituto Nacional de Ciencia e Tecnologia dos Servicos Ambientais da Amazonia (SERVAMB) and HB was supported by Royal Society Wolfs on Research Merit Award (2011/R3) and by Natural Environment Research Council, which support the National Centre for Earth Observation. The Sao Paulo State University (UNESP, Brazil) funded the publication fee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba SI, 2002, J TROP ECOL, V18, P215, DOI 10.1017/S0266467402002146; Anselin L., 1996, SPATIAL ANAL PERSPEC, P111, DOI [10.1201/9780203739051-8, DOI 10.1201/9780203739051-8]; Bispo PC, 2014, CAN J REMOTE SENS, V40, P26, DOI 10.1080/07038992.2014.913477; Bispo PD, 2012, AUSTRAL ECOL, V37, P491, DOI 10.1111/j.1442-9993.2011.02310.x; Bispo Polyanna da Conceição, 2009, Acta Amaz., V39, P81, DOI 10.1590/S0044-59672009000100008; Boncina A, 2000, GLOBAL ECOL BIOGEOGR, V9, P201, DOI 10.1046/j.1365-2699.2000.00155.x; Catterall CP, 2001, AUSTRAL ECOL, V26, P56, DOI 10.1111/j.1442-9993.2001.01074.pp.x; CHAUVEL A, 1987, EXPERIENTIA, V43, P234, DOI 10.1007/BF01945546; Chen ZS, 1997, PLANT ECOL, V132, P229, DOI 10.1023/A:1009762704553; Cramer W, 2001, GLOBAL CHANGE BIOL, V7, P357, DOI 10.1046/j.1365-2486.2001.00383.x; Danson FM, 2007, IEEE GEOSCI REMOTE S, V4, P157, DOI 10.1109/LGRS.2006.887064; de Castilho CV, 2006, FOREST ECOL MANAG, V234, P85, DOI 10.1016/j.foreco.2006.06.024; Diaz L, 2006, FOREST ECOL MANAG, V223, P54, DOI 10.1016/j.foreco.2005.10.061; Dikau R., 1989, 3 DIMENSIONAL APPL G, V1st, P51, DOI 10.1201/9781003069454-5; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fisk MC, 1998, ECOLOGY, V79, P2253, DOI 10.1890/0012-9658(1998)079[2253:TPOAAB]2.0.CO;2; Florinsky IV, 1996, CATENA, V27, P123, DOI 10.1016/0341-8162(96)00005-7; Franklin J, 1995, PROG PHYS GEOG, V19, P474, DOI 10.1177/030913339501900403; Frazer GW, 1999, GAP LIGHT ANAL GLA V; Galvao LS, 2011, REMOTE SENS ENVIRON, V115, P2350, DOI 10.1016/j.rse.2011.04.035; Gao T, 2014, FOREST ECOL MANAG, V330, P82, DOI 10.1016/j.foreco.2014.07.007; Giller PS, 1984, COMMUNITY STRUCTURE; Gonçalves Fábio Guimarães, 2008, Acta Amaz., V38, P229, DOI 10.1590/S0044-59672008000200006; Griffiths RP, 2009, FOREST ECOL MANAG, V257, P1, DOI 10.1016/j.foreco.2008.08.010; Hunter MO, 2013, BIOGEOSCIENCES, V10, P8385, DOI 10.5194/bg-10-8385-2013; IBAMA (Instituto Brasileiro do Meio Ambiente e dos Recursos Naturais Renovaveis), 2004, FLOR NAC TAP PLAN MA; Jarvis A, 2009, TERRAIN CONTROLS TRE; Kafkenscheid RLLJ, 2000, THESIS VRIJE U JAMAI; Lambin EF, 2003, ANNU REV ENV RESOUR, V28, P205, DOI 10.1146/annurev.energy.28.050302.105459; LAUENROTH WK, 1993, ECOL MODEL, V67, P49, DOI 10.1016/0304-3800(93)90099-E; Liu J, 2014, FOREST ECOL MANAG, V330, P75, DOI 10.1016/j.foreco.2014.06.045; MOORE ID, 1993, SOIL SCI SOC AM J, V57, P443, DOI 10.2136/sssaj1993.03615995005700020026x; Neter J., 1996, APPL LINEAR STAT MOD; NOSS RF, 1990, CONSERV BIOL, V4, P355, DOI 10.1111/j.1523-1739.1990.tb00309.x; Orians G, 2011, BIODIVERSITY ECOSYST; Pardini R, 2005, BIOL CONSERV, V124, P253, DOI 10.1016/j.biocon.2005.01.033; Pereira HM, 2013, SCIENCE, V339, P277, DOI 10.1126/science.1229931; Qi F, 2003, INT J GEOGR INF SCI, V17, P771, DOI 10.1080/13658810310001596049; RADAMBRASIL Departamento Nacional de Producao Mineral, 1976, FOLH AS 21 SANT GEOL, V10; RAGHUBANSHI AS, 1992, SOIL BIOL BIOCHEM, V24, P145, DOI 10.1016/0038-0717(92)90270-8; Rawi CSM, 2013, AQUAT ECOL, V47, P75, DOI 10.1007/s10452-012-9426-8; RUNNING SW, 1988, ECOL MODEL, V42, P125, DOI 10.1016/0304-3800(88)90112-3; Schmidt J, 2003, INT J GEOGR INF SCI, V17, P797, DOI 10.1080/13658810310001596058; Seibert J, 2007, GEODERMA, V141, P139, DOI 10.1016/j.geoderma.2007.05.013; Shary PA, 2013, RUSS J ECOL+, V44, P9, DOI 10.1134/S1067413613010116; Shary PA, 2002, GEODERMA, V107, P1, DOI 10.1016/S0016-7061(01)00136-7; Silver WL, 1999, BIOGEOCHEMISTRY, V44, P301, DOI 10.1007/BF00996995; Tateno R, 2003, ECOL RES, V18, P559, DOI 10.1046/j.1440-1703.2003.00578.x; Valeriano MD, 2012, APPL GEOGR, V32, P300, DOI 10.1016/j.apgeog.2011.05.004; Valeriano MM, 2008, INPE15318RPE818 COOR; Valeriano MM, 2010, INPE16702RPQ854 COOR; Valeriano MM., 2000, REV BRASILEIRA AGROM, V8, P255; Velaquez-Rosas N, 2002, BIOTROPICA, V34, P534, DOI 10.1646/0006-3606(2002)034[0534:EVOLTI]2.0.CO;2; Veloso R B, 1991, CLASSIFICACAO VEGETA; VITOUSEK PM, 1986, ANNU REV ECOL SYST, V17, P137, DOI 10.1146/annurev.es.17.110186.001033; Webb EL, 1999, J BIOGEOGR, V26, P887, DOI 10.1046/j.1365-2699.1999.00326.x; Williams M, 2002, ECOSYSTEMS, V5, P692, DOI 10.1007/s10021-002-0165-x; Wilson J.P., 2000, TERRAIN ANAL PRINCIP; Xin ZB, 2008, SCI CHINA SER D, V51, P67, DOI 10.1007/s11430-007-0137-2	59	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0152009	10.1371/journal.pone.0152009	http://dx.doi.org/10.1371/journal.pone.0152009			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9IK	27089013	Green Published, gold, Green Submitted			2022-12-26	WOS:000374527000004
J	Duan, XP; Zhang, ZD; Wang, J; Zuo, KJ				Duan, Xingpeng; Zhang, Zhidong; Wang, Jin; Zuo, Kaijing			Characterization of a Novel Cotton Subtilase Gene GbSBT1 in Response to Extracellular Stimulations and Its Role in Verticillium Resistance	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; PROTEASE INHIBITOR; SERINE-PROTEASE; TOMATO PLANTS; DAHLIAE; PATHOGENESIS; EXPRESSION; TARGETS; VE1; IDENTIFICATION	Verticillium wilt is a disastrous vascular disease in plants caused by Verticillium dahliae. Verticillium pathogens secrete various disease-causing effectors in cotton. This study identified a subtilase gene GbSBT1 from Gossypium babardense and investigated the roles against V. dahliae infection. GbSBT1 gene expression is responsive to V. dahliae defense signals, jasmonic acid, and ethylene treatments. Moreover, the GbSBT1 protein is mainly localized in the cell membrane and moves into the cytoplasm following jasmonic acid and ethylene treatments. Silencing GbSBT1 gene expression through virus-induced GbSBT1 gene silencing reduced the tolerance of Pima-90 (resistant genotype), but not facilitated the infection process of V. dahliae in Coker-312 (sensitive genotype). Moreover, the ectopically expressed GbSBT1 gene enhanced the resistance of Arabidopsis to Fusarium oxysporum and V. dahliae infection and activated the expression levels of defense-related genes. Furthermore, pull-down, yeast two-hybrid assay, and BiFC analysis revealed that GbSBT1 interacts with a prohibitin (PHB)-like protein expressed in V. dahliae pathogens during infection. In summary, GbSBT1 recognizes the effector PHB protein secreted from V. dahliae and is involved in Verticillium-induced resistance in cotton.	[Duan, Xingpeng; Zhang, Zhidong; Zuo, Kaijing] Shanghai Jiao Tong Univ, Sch Agr & Life Sci, Plant Biotechnol Res Ctr, Shanghai 200030, Peoples R China; [Wang, Jin] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Zuo, KJ (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Life Sci, Plant Biotechnol Res Ctr, Shanghai 200030, Peoples R China.	kjzuo@sjtu.edu.cn			Basic Research Project of MOST in China (973 Project) [2013CB733903]; National High-Tech (863) Program of China [2012AA02A703]; Natural Science Foundation of China [31071458]; China Transgenic Program [2013AA08005-003]	Basic Research Project of MOST in China (973 Project); National High-Tech (863) Program of China(National High Technology Research and Development Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Transgenic Program	This work was supported by the Basic Research Project of MOST in China (973 Project) (2013CB733903), the National High-Tech (863) Program of China (No. 2012AA02A703), the Natural Science Foundation of China (31071458) and China Transgenic Program (2013AA08005-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckers GJM, 2009, PLANT CELL, V21, P944, DOI 10.1105/tpc.108.062158; Che P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001140; Christians MJ, 2007, J EXP BOT, V58, P2237, DOI 10.1093/jxb/erm086; de Jonge R, 2012, P NATL ACAD SCI USA, V109, P5110, DOI 10.1073/pnas.1119623109; Dodson G, 1998, TRENDS BIOCHEM SCI, V23, P347, DOI 10.1016/S0968-0004(98)01254-7; El-Bebany AF, 2010, PROTEOMICS, V10, P289, DOI 10.1002/pmic.200900426; Figueiredo A, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00739; Fradin EF, 2011, PLANT PHYSIOL, V156, P2255, DOI 10.1104/pp.111.180067; Fradin EF, 2009, PLANT PHYSIOL, V150, P320, DOI 10.1104/pp.109.136762; Gao W, 2013, MOL CELL PROTEOMICS, V12, P3690, DOI 10.1074/mcp.M113.031013; Gao XQ, 2011, PLANT J, V66, P293, DOI 10.1111/j.1365-313X.2011.04491.x; Huang YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066160; Jorda L, 1999, J BIOL CHEM, V274, P2360, DOI 10.1074/jbc.274.4.2360; Kim BA, 2016, J INFECT DIS, V213, P131, DOI 10.1093/infdis/jiv362; Klosterman SJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002137; Kruger J, 2002, SCIENCE, V296, P744, DOI 10.1126/science.1069288; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Li C, 2014, PLANT PHYSIOL, V166, P2179, DOI 10.1104/pp.114.246694; Liu TL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5686; Penninckx IAMA, 1998, PLANT CELL, V10, P2103, DOI 10.1105/tpc.10.12.2103; Ramirez V, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003445; SAUPE S, 1994, P NATL ACAD SCI USA, V91, P5927, DOI 10.1073/pnas.91.13.5927; Sharma A, 2004, P NATL ACAD SCI USA, V101, P17492, DOI 10.1073/pnas.0407536101; Sheen J., 2002, TRANSIENT EXPRESSION; Srivastava R, 2008, PLANT J, V56, P219, DOI 10.1111/j.1365-313X.2008.03598.x; Thomma BPHJ, 1998, P NATL ACAD SCI USA, V95, P15107, DOI 10.1073/pnas.95.25.15107; Tian MY, 2007, PLANT PHYSIOL, V143, P364, DOI 10.1104/pp.106.090050; Tian MY, 2004, J BIOL CHEM, V279, P26370, DOI 10.1074/jbc.M400941200; Tian MY, 2005, PLANT PHYSIOL, V138, P1785, DOI 10.1104/pp.105.061226; Tornero P, 1997, J BIOL CHEM, V272, P14412, DOI 10.1074/jbc.272.22.14412; Tornero P, 1996, PLANT J, V10, P315, DOI 10.1046/j.1365-313X.1996.10020315.x; van der Hoorn RAL, 2008, ANNU REV PLANT BIOL, V59, P191, DOI 10.1146/annurev.arplant.59.032607.092835; Wang Y, 2010, PLANT CELL, V22, P249, DOI 10.1105/tpc.109.072066; Xie CJ, 2013, J GEN PLANT PATHOL, V79, P335, DOI 10.1007/s10327-013-0467-1; Xu J, 2014, PLANT J, V77, P222, DOI 10.1111/tpj.12382; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97; Zhao ZT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-274; Zuo KJ, 2005, MOL BIOL+, V39, P191, DOI 10.1007/s11008-005-0028-6	38	32	38	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153988	10.1371/journal.pone.0153988	http://dx.doi.org/10.1371/journal.pone.0153988			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088499	Green Published, Green Submitted, gold			2022-12-26	WOS:000374527000060
J	Liu, Y; Bouhenni, RA; Dufresne, CP; Semba, RD; Edward, DP				Liu, Ying; Bouhenni, Rachida A.; Dufresne, Craig P.; Semba, Richard D.; Edward, Deepak P.			Differential Expression of Vitreous Proteins in Young and Mature New Zealand White Rabbits	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; DIABETIC-RETINOPATHY; CRYSTALLINS; HUMOR; IDENTIFICATION; LOCALIZATION; MODEL	Different anatomical regions have been defined in the vitreous humor including central vitreous, basal vitreous, vitreous cortex, vitreoretinal interface and zonule. In this study we sought to characterize changes in the proteome of vitreous humor (VH) related to compartments or age in New Zealand white rabbits (NZW). Vitreous humor was cryo-collected from young and mature New Zealand white rabbit eyes, and dissected into anterior and posterior compartments. All samples were divided into 4 groups: Young Anterior (YA), Young Posterior (YP), Mature Anterior (MA) and Mature Posterior (MP) vitreous. Tryptic digests of total proteins were analyzed by liquid chromatography followed by tandem mass spectrometry. Spectral count was used to determine the relative protein abundances and identify proteins with statistical differences between compartment and age groups. Western blotting was performed to validate some of the differentially expressed proteins. Our results showed that 231, 375, 273 and 353 proteins were identified in the YA, YP, MA and MP respectively. Fifteen proteins were significantly differentially expressed between YA and YP, and 11 between MA and MP. Carbonic anhydrase III, lambda crystallin, alpha crystallin A and B, beta crystallin B1 and B2 were more abundant in the anterior region, whereas vimentin was less abundant in the anterior region. For comparisons between age groups, 4 proteins were differentially expressed in both YA relative to MA and YP relative to MP. Western blotting confirmed the differential expression of carbonic anhydrase III, alpha crystallin B and beta crystallin B2. The protein profiles of the vitreous humor showed age-and compartmentrelated differences. This differential protein profile provides a baseline for understanding the vitreous compartmentalization in the rabbit and suggests that further studies profiling proteins in different compartments of the vitreous in other species may be warranted.	[Liu, Ying; Semba, Richard D.; Edward, Deepak P.] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA; [Edward, Deepak P.] King Khalid Eye Specialist Hosp, Riyadh, Saudi Arabia; [Bouhenni, Rachida A.] Summa Hlth Syst, Akron, OH USA; [Dufresne, Craig P.] Thermo Fisher Sci, W Palm Beach, FL USA; [Liu, Ying] Changsha Aier Eye Hosp, Changsha, Hunan, Peoples R China	Johns Hopkins University; Johns Hopkins Medicine; King Khaled Eye Specialist Hospital; Summa Health System; Thermo Fisher Scientific	Edward, DP (corresponding author), Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA.; Edward, DP (corresponding author), King Khalid Eye Specialist Hosp, Riyadh, Saudi Arabia.	dedwar39@jhmi.edu			Air Force Medical Support Agency [FA8650-13-2-6370]; National Institutes of Health [R01 EY024596]; Thermo Fisher Scientific Company; NATIONAL EYE INSTITUTE [R01EY024596, P30EY001765] Funding Source: NIH RePORTER	Air Force Medical Support Agency; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thermo Fisher Scientific Company; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study is sponsored by Air Force Medical Support Agency under agreement number FA8650-13-2-6370 and National Institutes of Health grant (R01 EY024596). The funders provided financial support in the form of salaries for authors [YL, RAB, RDS and DPE] as well as research materials, and Thermo Fisher Scientific Company provided support in the form of salaries for author [CPD], but they did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the author are articulated in the 'author contributions' section.	Angi M, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/148039; Aretz S, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-22; Bahk SC, 2007, J PROTEOME RES, V6, P3891, DOI 10.1021/pr070133k; Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Bishop PN, 2000, PROG RETIN EYE RES, V19, P323, DOI 10.1016/S1350-9462(99)00016-6; Bouhenni RA, 2011, EXP EYE RES, V92, P67, DOI 10.1016/j.exer.2010.11.004; del Amo EM, 2015, EXP EYE RES, V137, P111, DOI 10.1016/j.exer.2015.05.003; Dunmire JJ, 2011, MOL VIS, V17, P779; Fort PE, 2011, EXP EYE RES, V92, P98, DOI 10.1016/j.exer.2010.11.008; Gao BB, 2008, J PROTEOME RES, V7, P2516, DOI 10.1021/pr800112g; Grossniklaus HE, 2013, INVEST OPHTH VIS SCI, V54, DOI 10.1167/iovs.13-12711; HAGEMAN GS, 1991, P NATL ACAD SCI USA, V88, P2716, DOI 10.1073/pnas.88.7.2716; Hendrickson EL, 2006, ANALYST, V131, P1335, DOI 10.1039/b610957h; Jester JV, 2008, SEMIN CELL DEV BIOL, V19, P82, DOI 10.1016/j.semcdb.2007.09.015; Kannan R, 2012, PROG RETIN EYE RES, V31, P576, DOI 10.1016/j.preteyeres.2012.06.001; Kim T, 2007, PROTEOMICS, V7, P4203, DOI 10.1002/pmic.200700745; Kodama M., 2013, J BIOMED SCI ENG, V6, P739; Le Goff MM, 2008, EYE, V22, P1214, DOI 10.1038/eye.2008.21; LOVICU FJ, 1995, INVEST OPHTH VIS SCI, V36, P1459; MACARI M, 1978, LAB ANIM, V12, P37, DOI 10.1258/002367778780953305; Meng E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107142; Murthy KR, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-29; Nakanishi T, 2002, J CHROMATOGR B, V776, P89, DOI 10.1016/S1570-0232(02)00078-8; Ouchi M, 2005, EXP EYE RES, V81, P176, DOI 10.1016/j.exer.2005.01.020; Rocha AS, 2014, ELECTROPHORESIS, V35, P2495, DOI 10.1002/elps.201400049; Semba RD, 2013, PROTEOMICS, V13, P2500, DOI 10.1002/pmic.201300075; Shitama T, 2008, PROTEOM CLIN APPL, V2, P1265, DOI 10.1002/prca.200800017; SJOSTRAND J, 1992, ACTA OPHTHALMOL, V70, P814; Skeie JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082140; Skeie JM, 2011, JOVE-J VIS EXP, DOI 10.3791/2455; Spencer WH, 1996, OPHTHALMIC PATHOLOGY, P334; Sreekumar PG, 2013, INVEST OPHTH VIS SCI, V54, P2787, DOI 10.1167/iovs.12-11571; WISTRAND PJ, 1986, INVEST OPHTH VIS SCI, V27, P419; Wu CW, 2004, AM J OPHTHALMOL, V137, P655, DOI 10.1016/j.ajo.2003.11.009; Yasukawa M, 2013, INT J BIOL SCI, V9, P382, DOI 10.7150/ijbs.5510; Yee KMP, 2015, INVEST OPHTH VIS SCI, V56, P7036, DOI 10.1167/iovs.15-16809; Yu J, 2008, PROTEOMICS, V8, P3667, DOI 10.1002/pmic.200700824; Zernii EY, 2015, CNS NEUROLOGICAL DIS	38	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153560	10.1371/journal.pone.0153560	http://dx.doi.org/10.1371/journal.pone.0153560			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27089221	gold, Green Published			2022-12-26	WOS:000374527000025
J	Nam, BH; Jung, M; Subramaniyam, S; Yoo, SI; Markkandan, K; Moon, JY; Kim, YO; Kim, DG; An, CM; Shin, Y; Jung, HJ; Park, JH				Nam, Bo-Hye; Jung, Myunghee; Subramaniyam, Sathiyamoorthy; Yoo, Seung-il; Markkandan, Kesavan; Moon, Ji-Young; Kim, Young-Ok; Kim, Dong-Gyun; An, Cheul Min; Shin, Younhee; Jung, Ho-jin; Park, Jun-hyung			Transcriptome Analysis Revealed Changes of Multiple Genes Involved in Haliotis discus hannai Innate Immunity during Vibrio parahemolyticus Infection	PLOS ONE			English	Article							RNA-SEQ DATA; DISK ABALONE; MOLECULAR CHARACTERIZATION; EXPRESSION ANALYSIS; CLONING; POLYMORPHISMS; FERRITIN; TOOL	Abalone (Haliotis discus hannai) is one of the most valuable marine aquatic species in Korea, Japan and China. Tremendous exposure to bacterial infection is common in aquaculture environment, especially by Vibrio sp. infections. It's therefore necessary and urgent to understand the mechanism of H. discus hannai host defense against Vibrio parahemolyticus infection. However studies on its immune system are hindered by the lack of genomic resources. In the present study, we sequenced the transcriptome of control and bacterial challenged H. discus hannai tissues. Totally, 138 MB of reference transcriptome were obtained from de novo assembly of 34 GB clean bases from ten different libraries and annotated with the biological terms (GO and KEGG). A total of 10,575 transcripts exhibiting the differentially expression at least one pair of comparison and the functional annotations highlight genes related to immune response, cell adhesion, immune regulators, redox molecules and mitochondrial coding genes. Mostly, these groups of genes were dominated in hemocytes compared to other tissues. This work is a prerequisite for the identification of those physiological traits controlling H. discus hannai ability to survive against Vibrio infection.	[Nam, Bo-Hye; Moon, Ji-Young; Kim, Young-Ok; Kim, Dong-Gyun; An, Cheul Min] Natl Fisheries Res & Dev Inst, Biotechnol Res Div, Aquaculture Ind Dept, Busan 619902, South Korea; [Jung, Myunghee; Subramaniyam, Sathiyamoorthy; Yoo, Seung-il; Markkandan, Kesavan; Shin, Younhee; Jung, Ho-jin; Park, Jun-hyung] Insilicogen Inc, Codes Div, Suwon 441813, Gyeonggi Do, South Korea		Park, JH (corresponding author), Insilicogen Inc, Codes Div, Suwon 441813, Gyeonggi Do, South Korea.	jhpark@insilicogen.com		Park, Junhyung/0000-0002-0805-6362	National Fisheries Research and Development Institute, Republic of Korea [RP-2015-BT-013]; Insilicogen Inc.	National Fisheries Research and Development Institute, Republic of Korea; Insilicogen Inc.	This study was funded by a grant from the National Fisheries Research and Development Institute (RP-2015-BT-013), Republic of Korea. Insilicogen Inc. provided support in the form of salaries for authors [MHJ, SS, SIY, KM, YHS, HJJ and JHP], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bathige SDNK, 2014, FISH SHELLFISH IMMUN, V39, P263, DOI 10.1016/j.fsi.2014.05.012; Bester-Van der Merwe A, 2013, INT J MOL SCI, V14, P19341, DOI 10.3390/ijms140919341; Cardinaud M, 2014, APPL ENVIRON MICROB, V80, P6328, DOI 10.1128/AEM.01036-14; Cheng PZ, 2007, FISH SHELLFISH IMMUN, V22, P77, DOI 10.1016/j.fsi.2006.03.014; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cook PA., 2014, MOD EC, V5, P1181, DOI DOI 10.4236/ME.2014.513110; De Wit P, 2013, MOL ECOL, V22, P2884, DOI 10.1111/mec.12081; De Zoysa M, 2007, FISH SHELLFISH IMMUN, V23, P624, DOI 10.1016/j.fsi.2007.01.013; De Zoysa M, 2011, FISH SHELLFISH IMMUN, V31, P155, DOI 10.1016/j.fsi.2011.04.001; Ding JF, 2015, FISH SHELLFISH IMMUN, V42, P379, DOI 10.1016/j.fsi.2014.11.005; Ding JF, 2011, FISH SHELLFISH IMMUN, V30, P163, DOI 10.1016/j.fsi.2010.10.008; Ekanayake PM, 2008, FISH SHELLFISH IMMUN, V24, P267, DOI 10.1016/j.fsi.2007.11.007; Franchini Paolo, 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-59; Ghosh J, 2011, DEV COMP IMMUNOL, V35, P959, DOI 10.1016/j.dci.2010.12.009; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Huang ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051279; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Jackson DJ, 2010, MOL BIOL EVOL, V27, P591, DOI 10.1093/molbev/msp278; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jing X, 2011, FISH SHELLFISH IMMUN, V30, P851, DOI 10.1016/j.fsi.2011.01.007; Joung HJ, 2014, FISH SHELLFISH IMMUN, V38, P184, DOI 10.1016/j.fsi.2014.03.018; Kim Dong-Gyun, 2012, [Journal of Life Science, 생명과학회지], V22, P642, DOI 10.5352/JLS.2012.22.5.642; Kim KY, 2007, FISH SHELLFISH IMMUN, V23, P1043, DOI 10.1016/j.fsi.2007.04.010; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li HF, 2010, J INVERTEBR PATHOL, V103, P116, DOI 10.1016/j.jip.2009.11.009; Li XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068233; Maynard BT, 2005, MAR BIOTECHNOL, V7, P645, DOI 10.1007/s10126-005-0013-z; Premachandra HKA, 2012, DEV COMP IMMUNOL, V38, P495, DOI 10.1016/j.dci.2012.06.010; Qiu R, 2013, FISH SHELLFISH IMMUN, V34, P1376, DOI 10.1016/j.fsi.2013.02.025; Ren HL, 2009, DEV COMP IMMUNOL, V33, P980, DOI 10.1016/j.dci.2009.04.003; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Robinson NA, 2014, MITOCHONDRIAL DNA; Salinas-Clarot K, 2011, FISH SHELLFISH IMMUN, V30, P430, DOI 10.1016/j.fsi.2010.09.009; Shiel BP, 2015, MAR BIOTECHNOL, V17, P23, DOI 10.1007/s10126-014-9591-y; Sokolova IM, 2009, ISJ-INVERT SURVIV J, V6, P49; Valenzuela-Munoz V, 2014, AQUAC RES, V45, P1026, DOI 10.1111/are.12044; Wan Q, 2008, COMP BIOCHEM PHYS B, V150, P187, DOI 10.1016/j.cbpb.2008.03.002; Wan Q, 2009, COMP BIOCHEM PHYS C, V150, P558, DOI 10.1016/j.cbpc.2009.08.003; Wang KJ, 2008, DEV COMP IMMUNOL, V32, P1326, DOI 10.1016/j.dci.2008.04.007; Wu CL, 2010, COMP BIOCHEM PHYS C, V152, P424, DOI 10.1016/j.cbpc.2010.07.002; Yang EC, 2014, MITOCHONDR DNA, P1; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang J, 2014, FISH SHELLFISH IMMUN, V41, P466, DOI 10.1016/j.fsi.2014.09.032	44	24	24	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153474	10.1371/journal.pone.0153474	http://dx.doi.org/10.1371/journal.pone.0153474			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088873	Green Submitted, Green Published, gold			2022-12-26	WOS:000374527000023
J	Cacioppo, CN; Chandler, AE; Towne, MC; Beggs, AH; Holm, IA				Cacioppo, Cara N.; Chandler, Ariel E.; Towne, Meghan C.; Beggs, Alan H.; Holm, Ingrid A.			Expectation versus Reality: The Impact of Utility on Emotional Outcomes after Returning Individualized Genetic Research Results in Pediatric Rare Disease Research, a Qualitative Interview Study	PLOS ONE			English	Article							INFORMED-CONSENT; ETHICAL-ISSUES; CHILDREN; ATTITUDES; PERSPECTIVES; PARTICIPANTS; EXPERIENCES; BELIEFS; PARENTS; COHORT	Purpose Much information on parental perspectives on the return of individual research results (IRR) in pediatric genomic research is based on hypothetical rather than actual IRR. Our aim was to understand how the expected utility to parents who received IRR on their child from a genetic research study compared to the actual utility of the IRR received. Methods We conducted individual telephone interviews with parents who received IRR on their child through participation in the Manton Center for Orphan Disease Research Gene Discovery Core (GDC) at Boston Children's Hospital (BCH). Results Five themes emerged around the utility that parents expected and actually received from IRR: predictability, management, family planning, finding answers, and helping science and/or families. Parents expressing negative or mixed emotions after IRR return were those who did not receive the utility they expected from the IRR. Conversely, parents who expressed positive emotions were those who received as much or greater utility than expected. Conclusions Discrepancies between expected and actual utility of IRR affect the experiences of parents and families enrolled in genetic research studies. An informed consent process that fosters realistic expectations between researchers and participants may help to minimize any negative impact on parents and families.	[Cacioppo, Cara N.; Chandler, Ariel E.; Towne, Meghan C.; Beggs, Alan H.; Holm, Ingrid A.] Harvard Univ, Sch Med, Boston Childrens Hosp, Manton Ctr Orphan Dis Res,Div Genet & Genom, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard Medical School	Holm, IA (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Manton Ctr Orphan Dis Res,Div Genet & Genom, Boston, MA USA.	Ingrid.holm@childrens.harvard.edu		Holm, Ingrid/0000-0003-4712-8821; Beggs, Alan/0000-0001-8818-0568; Towne, Meghan/0000-0001-9460-2368	National Human Genome Research Institute (NHGRI) [R01HG006615, RCHG005491, U01HG006828]; National Institute of Child Health and Human Development (NICHD); NHGRI [U19HD077671]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U19HD077671] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006615, U01HG006828] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the National Human Genome Research Institute (NHGRI) grants R01HG006615, RCHG005491, and U01HG006828, and by the National Institute of Child Health and Human Development (NICHD) and NHGRI grant U19HD077671. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burke W, 2014, AM J MED GENET C, V166, P105, DOI 10.1002/ajmg.c.31393; Dorval M, 2007, CANCER EPIDEM BIOMAR, V16, P157, DOI 10.1158/1055-9965.EPI-06-0340; Fernandez CV, 2009, J CLIN ONCOL, V27, P878, DOI 10.1200/JCO.2008.18.5223; Harris ED, 2012, GENET MED, V14, P330, DOI 10.1038/gim.2011.25; Heaney C, 2010, GENET TEST MOL BIOMA, V14, P821, DOI 10.1089/gtmb.2010.0066; Jenkins MM, 2008, AM J MED GENET C, V148C, P40, DOI 10.1002/ajmg.c.30157; Kaufman D, 2006, GENET MED, V14, P1170; Kleiderman E, 2014, J MED ETHICS, V40, P691, DOI 10.1136/medethics-2013-101648; Lakes KD, 2013, AM J MED GENET A, V161A, P38, DOI 10.1002/ajmg.a.35673; Meltzer LA, 2006, AM J BIOETHICS, V6, P28, DOI 10.1080/15265160600935811; Murphy J, 2008, AM J BIOETHICS, V8, P36, DOI 10.1080/15265160802513093; Ramoni RB, 2013, GENET MED, V15, P882, DOI 10.1038/gim.2013.58; Reilly PR, 1997, NAT GENET, V15, P16, DOI 10.1038/ng0197-16; Ries NM, 2010, BMC MED ETHICS, V11, DOI 10.1186/1472-6939-11-4; Rigter T, 2014, CLIN GENET, V85, P417, DOI 10.1111/cge.12299; Sapp JC, 2014, CLIN GENET, V85, P120, DOI 10.1111/cge.12254; Taylor HA, 2013, AM J BIOETHICS, V13, P61, DOI 10.1080/15265161.2013.828523; Wade CH, 2013, ANNU REV GENOM HUM G, V14, P535, DOI 10.1146/annurev-genom-091212-153425; Zawati MH, 2014, BMC MED ETHICS, V15, DOI 10.1186/1472-6939-15-72	19	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153597	10.1371/journal.pone.0153597	http://dx.doi.org/10.1371/journal.pone.0153597			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082877	Green Published, gold			2022-12-26	WOS:000374291800033
J	Cripps, G; Flynn, KJ; Lindeque, PK				Cripps, Gemma; Flynn, Kevin J.; Lindeque, Penelope K.			Ocean Acidification Affects the Phyto-Zoo Plankton Trophic Transfer Efficiency	PLOS ONE			English	Article							FOOD QUALITY; CO2 CONCENTRATIONS; HATCHING SUCCESS; EGG-PRODUCTION; ELEVATED CO2; PHYTOPLANKTON; TEMPERATURE; GROWTH; CARBON; SIZE	The critical role played by copepods in ocean ecology and biogeochemistry warrants an understanding of how these animals may respond to ocean acidification (OA). Whilst an appreciation of the potential direct effects of OA, due to elevated pCO(2), on copepods is improving, little is known about the indirect impacts acting via bottom-up (food quality) effects. We assessed, for the first time, the chronic effects of direct and/or indirect exposures to elevated pCO(2) on the behaviour, vital rates, chemical and biochemical stoichiometry of the calanoid copepod Acartia tonsa. Bottom-up effects of elevated pCO(2) caused species-specific biochemical changes to the phytoplanktonic feed, which adversely affected copepod population structure and decreased recruitment by 30%. The direct impact of elevated pCO(2) caused gender-specific respiratory responses in A. tonsa adults, stimulating an enhanced respiration rate in males (> 2-fold), and a suppressed respiratory response in females when coupled with indirect elevated pCO(2) exposures. Under the combined indirect +direct exposure, carbon trophic transfer efficiency from phytoplankton-to-zooplankton declined to < 50% of control populations, with a commensurate decrease in recruitment. For the first time an explicit role was demonstrated for biochemical stoichiometry in shaping copepod trophic dynamics. The altered biochemical composition of the CO2-exposed prey affected the biochemical stoichiometry of the copepods, which could have ramifications for production of higher tropic levels, notably fisheries. Our work indicates that the control of phytoplankton and the support of higher trophic levels involving copepods have clear potential to be adversely affected under future OA scenarios.	[Cripps, Gemma] Univ Southampton, Natl Oceanog Ctr, Ocean & Earth Sci, Southampton, Hants, England; [Flynn, Kevin J.] Swansea Univ, Biosci, Swansea, W Glam, Wales; [Lindeque, Penelope K.] Plymouth Marine Lab, Marine Ecol & Biodivers, Plymouth, Devon, England	NERC National Oceanography Centre; University of Southampton; Swansea University; Plymouth Marine Laboratory	Flynn, KJ (corresponding author), Swansea Univ, Biosci, Swansea, W Glam, Wales.	K.J.Flynn@swansea.ac.uk	Lindeque, Penelope/AAE-9193-2019; Flynn, Kevin/AAA-3253-2021	Flynn, Kevin/0000-0001-6913-5884; Lindeque, Penelope/0000-0003-1789-7515	Natural Environment Research Council (UK); Defra [NE/F003455/1, NE/H01750X/1]; Natural Environment Research Council PhD studentship; NERC [NE/F003455/1, NE/H01750X/1, pml010009] Funding Source: UKRI; Natural Environment Research Council [NE/F003455/1, pml010009, NE/H01750X/1] Funding Source: researchfish	Natural Environment Research Council (UK)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Defra(Department for Environment, Food & Rural Affairs (DEFRA)); Natural Environment Research Council PhD studentship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded in part by Natural Environment Research Council (UK) and Defra grants NE/F003455/1 and NE/H01750X/1 to KJF, and by a Natural Environment Research Council PhD studentship to GC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGGREEN U, 1988, MAR BIOL, V99, P341, DOI 10.1007/BF02112126; Boersma M, 2008, INT REV HYDROBIOL, V93, P479, DOI 10.1002/iroh.200811066; Burkhardt S, 1999, LIMNOL OCEANOGR, V44, P683, DOI 10.4319/lo.1999.44.3.0683; Calosi P, 2013, PHIL T R SOC B, V368; CHESSON J, 1983, ECOLOGY, V64, P1297, DOI 10.2307/1937838; COWLES TJ, 1988, MAR BIOL, V100, P41, DOI 10.1007/BF00392953; Cripps G, 2014, GLOBAL CHANGE BIOL, V20, P3377, DOI 10.1111/gcb.12582; Cripps IL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022736; Dodd LF, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0333; EDERINGTON MC, 1995, LIMNOL OCEANOGR, V40, P860, DOI 10.4319/lo.1995.40.5.0860; Feng Y, 2008, EUR J PHYCOL, V43, P87, DOI 10.1080/09670260701664674; Fitzer SC, 2012, J EXP MAR BIOL ECOL, V418, P30, DOI 10.1016/j.jembe.2012.03.009; Flynn KJ, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2604; Flynn KJ, 1996, J EXP MAR BIOL ECOL, V196, P357, DOI 10.1016/0022-0981(95)00140-9; Frangoulis C, 2010, PROG OCEANOGR, V84, P43, DOI 10.1016/j.pocean.2009.09.005; FROST BW, 1972, LIMNOL OCEANOGR, V17, P805, DOI 10.4319/lo.1972.17.6.0805; Fu FX, 2007, J PHYCOL, V43, P485, DOI 10.1111/j.1529-8817.2007.00355.x; HANSEN B, 1994, LIMNOL OCEANOGR, V39, P395, DOI 10.4319/lo.1994.39.2.0395; Henriksen CI, 2007, MAR ECOL PROG SER, V331, P119, DOI 10.3354/meps331119; Hildebrandt N, 2014, MAR POLLUT BULL, V80, P59, DOI 10.1016/j.marpolbul.2014.01.050; HOUDE SEL, 1987, MAR ECOL PROG SER, V40, P69, DOI 10.3354/meps040069; Iglesias-Rodriguez MD, 2008, SCIENCE, V320, P336, DOI 10.1126/science.1154122; Isari S, 2016, ICES J MAR SCI, V73, P650, DOI 10.1093/icesjms/fsv078; Isari S, 2015, J PLANKTON RES, V37, P912, DOI 10.1093/plankt/fbv057; Isari S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084742; Jonasdottir SH, 2009, MAR ECOL PROG SER, V382, P139, DOI 10.3354/meps07985; Jones RH, 2002, MAR ECOL PROG SER, V235, P147, DOI 10.3354/meps235147; KLEPPEL GS, 1993, MAR ECOL PROG SER, V99, P183, DOI 10.3354/meps099183; LANDRY MR, 1988, B MAR SCI, V43, P509; Lewis CN, 2013, P NATL ACAD SCI USA, V110, pE4960, DOI 10.1073/pnas.1315162110; Li W, 2012, MAR POLLUT B, V64, P1; Manriquez PH, 2014, MAR ECOL PROG SER, V502, P157, DOI 10.3354/meps10703; Mauchline J., 1998, ADV MARINE BIOL; Mayers JJ, 2013, BIORESOURCE TECHNOL, V148, P215, DOI 10.1016/j.biortech.2013.08.133; Mayor DJ, 2007, MAR ECOL PROG SER, V350, P91, DOI 10.3354/meps07142; Mitra A, 2005, J PLANKTON RES, V27, P393, DOI 10.1093/plankt/fbi022; Mitra A, 2006, BIOL LETTERS, V2, P194, DOI 10.1098/rsbl.2006.0447; Montechiaro F, 2010, J PLANT PHYSIOL, V167, P110, DOI 10.1016/j.jplph.2009.07.013; Pedersen SA, 2014, ENVIRON SCI TECHNOL, V48, P12275, DOI 10.1021/es501581j; Pedersen SA, 2014, J TOXICOL ENV HEAL A, V77, P535, DOI 10.1080/15287394.2014.887421; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Portner H-O, 2013, CLIMATE CHANGE 201 A; Riebesell U, 2007, NATURE, V450, P545, DOI 10.1038/nature06267; Rossoll D, 2013, MAR ECOL PROG SER, V486, P37, DOI 10.3354/meps10352; Rossoll D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034737; Schoo KL, 2013, MAR BIOL, V160, P2145, DOI 10.1007/s00227-012-2121-4; Schultz M, 2009, J PLANKTON RES, V31, P553, DOI 10.1093/plankt/fbp010; Stehfest K, 2005, PLANT PHYSIOL BIOCH, V43, P717, DOI 10.1016/j.plaphy.2005.07.001; Thor P, 2015, GLOBAL CHANGE BIOL, V21, P2261, DOI 10.1111/gcb.12815; Thor P, 2015, MAR BIOL, V162, P799, DOI 10.1007/s00227-015-2625-9; Thornton DCO, 2009, ECOL LETT; Todgham AE, 2009, J EXP BIOL, V212, P2579, DOI 10.1242/jeb.032540; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P5, DOI [10.1007/s10584-011-0148-z, 10.1007/s10584-011-0157-y]; Verity PG, 1996, MAR ECOL PROG SER, V130, P277, DOI 10.3354/meps130277; Verschoor AM, 2013, FRESHWATER BIOL, V58, P597, DOI 10.1111/j.1365-2427.2012.02833.x; Verspagen JMH, 2014, ECOL LETT, V17, P951, DOI 10.1111/ele.12298; Wood HL, 2008, P ROY SOC LON B, V275, P1967; Wynn-Edwards C, 2014, WATER-SUI, V6, P1840, DOI 10.3390/w6061840; Zervoudaki S, 2014, MEDITERR MAR SCI, V15, P74, DOI 10.12681/mms.553; Zhang DJ, 2011, ACTA OCEANOL SIN, V30, P86, DOI 10.1007/s13131-011-0165-9	60	39	39	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0151739	10.1371/journal.pone.0151739	http://dx.doi.org/10.1371/journal.pone.0151739			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082737	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000374291800005
J	Falcone, E; Grandoni, L; Garibaldi, F; Manni, I; Filligoi, G; Piaggio, G; Gurtner, A				Falcone, Emmanuela; Grandoni, Luca; Garibaldi, Francesca; Manni, Isabella; Filligoi, Giancarlo; Piaggio, Giulia; Gurtner, Aymone			Infinity: An In-Silico Tool for Genome-Wide Prediction of Specific DNA Matrices in miRNA Genomic Loci	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; COLORECTAL-CANCER; MUTANT P53; MICRORNAS; DATABASE; RNA; EXPRESSION; GENE; REPRESSION; PROMOTERS	Motivation miRNAs are potent regulators of gene expression and modulate multiple cellular processes in physiology and pathology. Deregulation of miRNAs expression has been found in various cancer types, thus, miRNAs may be potential targets for cancer therapy. However, the mechanisms through which miRNAs are regulated in cancer remain unclear. Therefore, the identification of transcriptional factor-miRNA crosstalk is one of the most update aspects of the study of miRNAs regulation. Results In the present study we describe the development of a fast and user-friendly software, named infinity, able to find the presence of DNA matrices, such as binding sequences for transcriptional factors, on similar to 65kb (kilobase) of 939 human miRNA genomic sequences, simultaneously. Of note, the power of this software has been validated in vivo by performing chromatin immunoprecipitation assays on a subset of new in silico identified target sequences (CCAAT) for the transcription factor NF-Y on colon cancer deregulated miRNA loci. Moreover, for the first time, we have demonstrated that NF-Y, through its CCAAT binding activity, regulates the expression of miRNA-181a, -181b, -21, -17, -130b, -301b in colon cancer cells. Conclusions The infinity software that we have developed is a powerful tool to underscore new TF/miRNA regulatory networks. Availability and Implementation Infinity was implemented in pure Java using Eclipse framework, and runs on Linux and MS Windows machine, with MySQL database. The software is freely available on the web at https://github.com/bio-devel/infinity. The website is implemented in JavaScript, PHP and HTML with all major browsers supported.	[Falcone, Emmanuela; Garibaldi, Francesca; Manni, Isabella; Piaggio, Giulia; Gurtner, Aymone] Regina Elena Inst Canc Res, Dept Res Adv Diagnost & Technol Innovat, Rome, Italy; [Grandoni, Luca; Filligoi, Giancarlo] Univ Roma La Sapienza, Fac Informat Engn Stat & Informat, Dept Informat Engn Elect & Telecommun DIET, Piazzale Aldo Moro 5, I-00185 Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Sapienza University Rome	Piaggio, G; Gurtner, A (corresponding author), Regina Elena Inst Canc Res, Dept Res Adv Diagnost & Technol Innovat, Rome, Italy.	piaggio@ifo.it; gurtner@ifo.it	Gurtner, Aymone/J-7217-2018; Manni, Isabella/ABH-6460-2020; Piaggio, Giulia/J-7214-2018; gurtner, aymone/AAB-8843-2020; Piaggio, Giulia/AAD-7336-2022	Gurtner, Aymone/0000-0002-7661-9059; Manni, Isabella/0000-0003-4823-0596; Piaggio, Giulia/0000-0003-2114-1892; gurtner, aymone/0000-0002-7661-9059; 	AIRC, Associazione Italiana per la Ricerca sul Cancro [MFAG11752, IG13234]; Fondazione Umberto Veronesi Fellowship	AIRC, Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Fondazione Umberto Veronesi Fellowship(Fondazione Umberto Veronesi)	This work has been supported by grant from AIRC, Associazione Italiana per la Ricerca sul Cancro, to A.G. and G.P. (grant number MFAG11752, IG13234), www.AIRC.IT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr C. D'annunzio for critically reading the article, Maria Pia Gentileschi for technical advice, Daniela Bona for secretary assistance. Aymone Gurtner was supported by a Fondazione Umberto Veronesi Fellowship.	Arndt GM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-374; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Bhattacharya A, 2003, CANCER RES, V63, P8167; Bhattacharyya Malay, 2012, Genomics Proteomics & Bioinformatics, V10, P310, DOI 10.1016/j.gpb.2012.08.005; BOYER RS, 1977, COMMUN ACM, V20, P762, DOI 10.1145/359842.359859; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chan P, 1999, JAVA CLASS LIB SUPPL, V2; Chien CH, 2011, NUCLEIC ACIDS RES, V39, P9345, DOI 10.1093/nar/gkr604; Di Agostino S, 2006, CANCER CELL, V10, P191, DOI 10.1016/j.ccr.2006.08.013; Dolfini D, 2013, CELL DEATH DIFFER, V20, P676, DOI 10.1038/cdd.2013.13; Dolfini D, 2009, CELL CYCLE, V8, P4127, DOI 10.4161/cc.8.24.10240; Dong GZ, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0057-x; Fabbri M, 2007, EXPERT OPIN BIOL TH, V7, P1009, DOI 10.1517/14712598.7.7.1009; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Fleming JD, 2013, GENOME RES, V23, P1195, DOI 10.1101/gr.148080.112; Friard O, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-435; Garibaldi F, 2016, ONCOGENE, V35, P3760, DOI 10.1038/onc.2016.51; Georgakilas G, 2016, NUCLEIC ACIDS RES, V44, pD190, DOI 10.1093/nar/gkv1254; Gurtner A, 2003, MOL BIOL CELL, V14, P2706, DOI 10.1091/mbc.E02-09-0600; Gurtner A, 2010, CANCER RES, V70, P9711, DOI 10.1158/0008-5472.CAN-10-0721; Gurtner A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002047; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hamed M, 2015, NUCLEIC ACIDS RES, V43, pW283, DOI 10.1093/nar/gkv418; Imbriano C, 2005, MOL CELL BIOL, V25, P3737, DOI 10.1128/MCB.25.9.3737-3751.2005; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lee J, 2007, PLOS COMPUT BIOL, V3, P721, DOI 10.1371/journal.pcbi.0030067; Li XL, 2014, FEBS LETT, V588, P2610, DOI 10.1016/j.febslet.2014.03.054; Liao JM, 2014, J MOL CELL BIOL, V6, P206, DOI 10.1093/jmcb/mju018; Lin PL, 2014, CARCINOGENESIS, V35, P2175, DOI 10.1093/carcin/bgu110; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Mantovani R, 1998, NUCLEIC ACIDS RES, V26, P1135, DOI 10.1093/nar/26.5.1135; MANTOVANI R, 1994, J BIOL CHEM, V269, P20340; Monzo M, 2008, CELL RES, V18, P823, DOI 10.1038/cr.2008.81; Mosakhani N, 2012, GENE CHROMOSOME CANC, V51, P1, DOI 10.1002/gcc.20925; Motoyama K, 2009, INT J ONCOL, V34, P1069, DOI 10.3892/ijo_00000233; Nagel R, 2008, CANCER RES, V68, P5795, DOI 10.1158/0008-5472.CAN-08-0951; Navon R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008003; Pichler M, 2014, J CLIN PATHOL, V67, DOI 10.1136/jclinpath-2013-201904; Psathas JN, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014175; Sarver AL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-401; Schetter AJ, 2011, SEMIN ONCOL, V38, P734, DOI 10.1053/j.seminoncol.2011.08.009; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Speir ML, 2016, NUCLEIC ACIDS RES, V44, pD717, DOI 10.1093/nar/gkv1275; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Vlachos IS, 2013, CLIN BIOCHEM, V46, P879, DOI 10.1016/j.clinbiochem.2013.03.006; Wang J, 2010, NUCLEIC ACIDS RES, V38, pD119, DOI 10.1093/nar/gkp803; Wang SP, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004665; Wang YX, 2010, J DIGEST DIS, V11, P50, DOI 10.1111/j.1751-2980.2009.00413.x; Woods K, 2007, J BIOL CHEM, V282, P2130, DOI 10.1074/jbc.C600252200; Xi YG, 2006, BIOMARK INSIGHTS, V1, P113; Yamanaka K, 2009, GENOMICS, V94, P219, DOI 10.1016/j.ygeno.2009.06.003; Yang JH, 2013, NUCLEIC ACIDS RES, V41, pD177, DOI 10.1093/nar/gks1060	54	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153658	10.1371/journal.pone.0153658	http://dx.doi.org/10.1371/journal.pone.0153658			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082112	gold, Green Published, Green Submitted			2022-12-26	WOS:000374291800037
J	Helms, JA; Godfrey, A				Helms, Jackson A.; Godfrey, Aaron			Dispersal Polymorphisms in Invasive Fire Ants	PLOS ONE			English	Article							ALTERNATIVE REPRODUCTIVE TACTICS; SOLENOPSIS-INVICTA; GEMINATA HYMENOPTERA; SOCIAL PARASITISM; FLIGHT ENERGETICS; QUEEN DIMORPHISM; ATTA-TEXANA; ORCHID BEES; EVOLUTION; SIZE	In the Found or Fly (FoF) hypothesis ant queens experience reproduction-dispersal tradeoffs such that queens with heavier abdomens are better at founding colonies but are worse flyers. We tested predictions of FoF in two globally invasive fire ants, Solenopsis geminata (FABRICIUS, 1804) and S. invicta (BUREN, 1972). Colonies of these species may produce two different monogyne queen types-claustral queens with heavy abdomens that found colonies independently, and parasitic queens with small abdomens that enter conspecific nests. Claustral and parasitic queens were similarly sized, but the abdomens of claustral queens weighed twice as much as those of their parasitic counterparts. Their heavier abdomens adversely impacted morphological predictors of flight ability, resulting in 32-38% lower flight muscle ratios, 55-63% higher wing loading, and 32-33% higher abdomen drag. In lab experiments maximum flight durations in claustral S. invicta queens decreased by about 18 minutes for every milligram of abdomen mass. Combining our results into a simple fitness tradeoff model, we calculated that an average parasitic S. invicta queen could produce only 1/3 as many worker offspring as a claustral queen, but could fly 4 times as long and have a 17-to 36-fold larger potential colonization area. Investigations of dispersal polymorphisms and their associated tradeoffs promises to shed light on range expansions in invasive species, the evolution of alternative reproductive strategies, and the selective forces driving the recurrent evolution of parasitism in ants.	[Helms, Jackson A.] Univ Oklahoma, Dept Biol, Norman, OK 73019 USA; [Godfrey, Aaron] ZIN Technol Inc, Middleburg Hts, OH USA	University of Oklahoma System; University of Oklahoma - Norman	Helms, JA (corresponding author), Univ Oklahoma, Dept Biol, Norman, OK 73019 USA.	jackson.a.helms-1@ou.edu	Helms, Jackson/J-5667-2019	Helms, Jackson/0000-0001-6709-6770	National Science Foundation Graduate Research Fellowship; University of Oklahoma Alumni Fellowship	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); University of Oklahoma Alumni Fellowship	This work was supported by the National Science Foundation Graduate Research Fellowship to JAH, and University of Oklahoma Alumni Fellowship to JAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS C T, 1976, Florida Entomologist, V59, P411, DOI 10.2307/3494191; ALEXANDER DE, 1990, BIOL BULL, V179, P186, DOI 10.2307/1541768; Bernasconi G, 1999, ANIM BEHAV, V57, P371, DOI 10.1006/anbe.1998.0955; BOURKE AFG, 1991, BIOL J LINN SOC, V43, P157, DOI 10.1111/j.1095-8312.1991.tb00591.x; Brown MJF, 2003, EVOL ECOL RES, V5, P305; Bruna EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022937; BUSCHINGER A, 1986, TRENDS ECOL EVOL, V1, P155, DOI 10.1016/0169-5347(86)90044-3; Buschinger A, 2009, MYRMECOL NEWS, V12, P219; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; CHAI P, 1990, AM NAT, V135, P748, DOI 10.1086/285072; Darveau CA, 2005, J EXP BIOL, V208, P3581, DOI 10.1242/jeb.01776; DAVIDSON DW, 1982, BEHAV ECOL SOCIOBIOL, V10, P245, DOI 10.1007/BF00302813; DAVIS MA, 1984, ECOLOGY, V65, P230, DOI 10.2307/1939475; DeHeer CJ, 2002, ANIM BEHAV, V64, P655, DOI 10.1006/anbe.2002.3095; DeHeer CJ, 1998, BEHAV ECOL, V9, P130, DOI 10.1093/beheco/9.2.130; Dillon ME, 2004, J EXP BIOL, V207, P417, DOI 10.1242/jeb.00777; Duckworth RA, 2008, AM NAT, V172, pS4, DOI 10.1086/588289; Dudley R., 2000, BIOMECHANICS INSECT; ELLINGTON CP, 1991, J EXP BIOL, V160, P71; Fjerdingstad EJ, 2004, EVOLUTION, V58, P1056, DOI 10.1111/j.0014-3820.2004.tb00439.x; Fjerdingstad EJ, 1997, INSECT SOC, V44, P209, DOI 10.1007/s000400050042; Gotzek D, 2015, MOL ECOL, V24, P374, DOI 10.1111/mec.13040; GU H, 1995, ENTOMOL EXP APPL, V76, P25, DOI 10.1007/BF02382308; HARRISON RG, 1980, ANNU REV ECOL SYST, V11, P95, DOI 10.1146/annurev.es.11.110180.000523; HEDENSTROM A, 1992, J THEOR BIOL, V158, P535, DOI 10.1016/S0022-5193(05)80714-3; Heinze J, 1995, RES POPUL ECOL, V37, P135, DOI 10.1007/BF02515814; Heinze J, 2000, TRENDS ECOL EVOL, V15, P508, DOI 10.1016/S0169-5347(00)01995-9; Helms JA, 2015, INSECT SOC, V62, P171, DOI 10.1007/s00040-015-0391-9; Helms JA, 2014, MYRMECOL NEWS, V19, P85; Holldobler B., 1990, pi; HOLM S, 1979, SCAND J STAT, V6, P65; HUNG A C F, 1978, Southwestern Naturalist, V23, P205, DOI 10.2307/3669769; KELLER L, 1989, OECOLOGIA, V80, P236, DOI 10.1007/BF00380157; Keller RA, 2014, ELIFE, V3, DOI 10.7554/eLife.01539; King JR, 2009, BIOL INVASIONS, V11, P373, DOI 10.1007/s10530-008-9254-x; KOENKER R., 2013, QUANTREG QUANTILE RE; Lachaud JP, 1999, OECOLOGIA, V120, P515, DOI 10.1007/s004420050885; Marden JH, 2000, ANNU REV PHYSIOL, V62, P157, DOI 10.1146/annurev.physiol.62.1.157; MARDEN JH, 1987, J EXP BIOL, V130, P235; MARKIN G P, 1971, Journal of the Georgia Entomological Society, V6, P145; MARTINEZ T, 1994, J INSECT PHYSIOL, V40, P723, DOI 10.1016/0022-1910(94)90100-7; MCINNES DA, 1995, BEHAV ECOL SOCIOBIOL, V36, P367; Mezey JG, 2005, EVOLUTION, V59, P1027; MINTZER AC, 1987, INSECT SOC, V34, P108, DOI 10.1007/BF02223829; MORRILL WL, 1974, ENVIRON ENTOMOL, V3, P265, DOI 10.1093/ee/3.2.265; MOSER JC, 1967, INSECT SOC, V14, P295, DOI 10.1007/BF02252831; Norberg U, 2002, BIOL J LINN SOC, V77, P445, DOI 10.1046/j.1095-8312.2002.00115.x; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; PEAKIN G J, 1972, Ekologia polska, V20, P55; Peeters C, 2001, ANNU REV ENTOMOL, V46, P601, DOI 10.1146/annurev.ento.46.1.601; Peeters C, 2012, MYRMECOL NEWS, V16, P75; PORTER SD, 1986, ANN ENTOMOL SOC AM, V79, P723, DOI 10.1093/aesa/79.4.723; PORTER SD, 1985, BEHAV ECOL SOCIOBIOL, V16, P323, DOI 10.1007/BF00295545; R Core Team, 2012, R LANG ENV STAT COMP; Rayner J.M.V., 1988, Current Ornithology, V5, P1; ROSS KG, 1995, ANNU REV ECOL SYST, V26, P631, DOI 10.1146/annurev.es.26.110195.003215; Ross KG, 1997, HEREDITY, V78, P590; Ruppell O, 1998, INSECT SOC, V45, P67, DOI 10.1007/s000400050069; Ruppell O, 1999, INSECT SOC, V46, P6, DOI 10.1007/s000400050106; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shelton TG, 2006, J INSECT BEHAV, V19, P115, DOI 10.1007/s10905-005-9012-1; Shik JZ, 2013, ENTOMOL EXP APPL, V149, P99, DOI 10.1111/eea.12117; Srygley RB, 2008, INTEGR COMP BIOL, V48, P119, DOI 10.1093/icb/icn011; SUNDSTROM L, 1995, BEHAV ECOL, V6, P132, DOI 10.1093/beheco/6.2.132; TRAGER JC, 1991, J NEW YORK ENTOMOL S, V99, P141; Tschinkel W. R, 2013, FIRE ANTS; Tschinkel WR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079559; TSCHINKEL WR, 1993, ECOL MONOGR, V63, P425, DOI 10.2307/2937154; TSCHINKEL WR, 1988, ANN ENTOMOL SOC AM, V81, P76, DOI 10.1093/aesa/81.1.76; Tschinkel WR, 1996, INSECT SOC, V43, P267, DOI 10.1007/BF01242928; TSCHINKEL WR, 1988, PHYSIOL ENTOMOL, V13, P327, DOI 10.1111/j.1365-3032.1988.tb00484.x; TSCHINKEL WR, 1993, BEHAV ECOL SOCIOBIOL, V33, P209, DOI 10.1007/BF02027118; Vogel S., 1994, LIFE MOVING FLUIDS P; Vogt JT, 2000, J INSECT PHYSIOL, V46, P697, DOI 10.1016/S0022-1910(99)00158-4; WAGNER DL, 1992, TRENDS ECOL EVOL, V7, P216, DOI 10.1016/0169-5347(92)90047-F; WERNER PA, 1976, AM NAT, V110, P959, DOI 10.1086/283120; West-Eberhard MJ, 2005, P NATL ACAD SCI USA, V102, P6543, DOI 10.1073/pnas.0501844102; WESTEBERHARD MJ, 1986, P NATL ACAD SCI USA, V83, P1388, DOI 10.1073/pnas.83.5.1388; Wetterer JK, 2011, MYRMECOL NEWS, V14, P21; WHITCOMB W H, 1973, Environmental Entomology, V2, P1101, DOI 10.1093/ee/2.6.1101; WOJCIK DP, 1983, FLA ENTOMOL, V66, P101, DOI 10.2307/3494556; Zera AJ, 1997, ANNU REV ENTOMOL, V42, P207, DOI 10.1146/annurev.ento.42.1.207	82	9	9	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153955	10.1371/journal.pone.0153955	http://dx.doi.org/10.1371/journal.pone.0153955			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082115	gold, Green Published			2022-12-26	WOS:000374291800064
J	Sehgal, IS; Dhooria, S; Gupta, N; Bal, A; Ram, B; Aggarwal, AN; Behera, D; Agarwal, R				Sehgal, Inderpaul Singh; Dhooria, Sahajal; Gupta, Nalini; Bal, Amanjit; Ram, Babu; Aggarwal, Ashutosh Nath; Behera, Digambar; Agarwal, Ritesh			Impact of Endobronchial Ultrasound (EBUS) Training on the Diagnostic Yield of Conventional Transbronchial Needle Aspiration for Lymph Node Stations 4R and 7	PLOS ONE			English	Article							EXPERIENCE; BRONCHOSCOPY; SARCOIDOSIS	Background There is sparse literature on whether training in endobronchial ultrasound (EBUS)-guided transbronchial needle aspiration (TBNA) improves the diagnostic yield of conventional TBNA (cTBNA). Objectives The aim of this study was to evaluate the diagnostic yield of cTBNA before and after the introduction of EBUS. Methods This was a retrospective analysis of patients who underwent cTBNA at our center. The study was divided into two periods, before and after the introduction of EBUS at our facility. The diagnostic yield of cTBNA was compared between the study periods. Rapid on-site cytological examination was not available. Results A total of 1,050 patients (61.6% men; mean age 45.6 years) underwent cTBNA during the study period (849 before EBUS; 201 after EBUS). Sarcoidosis (n = 527) followed by bronchogenic carcinoma (n = 222) formed the most common indications for performing cTBNA. There was a significant increase in both the success of obtaining a representative sample (from 71% to 85%), and the diagnostic yield (from 33% to 49.5%) of cTBNA, after the introduction of EBUS. The increase in the diagnostic yield of cTBNA after introduction of EBUS remained significant even after adjusting for years of performing cTBNA and the type of anesthesia (topical vs. sedation and topical) on a multivariate analysis. Conclusion The diagnostic yield of cTBNA at our facility increased after the introduction of EBUS-TBNA. However, given the retrospective nature of the study, prospective studies are required to confirm our findings.	[Sehgal, Inderpaul Singh; Dhooria, Sahajal; Ram, Babu; Aggarwal, Ashutosh Nath; Behera, Digambar; Agarwal, Ritesh] Postgrad Inst Med Educ & Res, Dept Pulm Med, Chandigarh 160012, India; [Gupta, Nalini] Postgrad Inst Med Educ & Res, Dept Cytol & Gynecol Pathol, Chandigarh 160012, India; [Bal, Amanjit] Postgrad Inst Med Educ & Res, Dept Histopathol, Chandigarh 160012, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Agarwal, R (corresponding author), Postgrad Inst Med Educ & Res, Dept Pulm Med, Chandigarh 160012, India.	agarwal.ritesh@outlook.in	Sehgal, Inderpaul/AAA-8165-2021; Sehgal, Inderpaul/GYE-2441-2022; Agarwal, Ritesh/A-3063-2009	Sehgal, Inderpaul/0000-0002-6505-6019; Agarwal, Ritesh/0000-0003-2547-7668				Agarwal R, 2014, J BRONCHOL INTERN PU, V21, P284, DOI 10.1097/LBR.0000000000000096; Agarwal R, 2013, RESP CARE, V58, P683, DOI 10.4187/respcare.02101; Baldi M, 2015, CHEST, V147, pE113, DOI 10.1378/chest.14-2705; Bonifazi M, 2013, RESPIRATION, V86, P123, DOI 10.1159/000350466; Chokhani Ramesh, 2004, Nepal Med Coll J, V6, P24; Cordovilla R, 2014, J BRONCHOL INTERN PU, V21, P322, DOI 10.1097/LBR.0000000000000097; Dhooria S, 2015, ANN THORAC SURG, V99, P1894, DOI 10.1016/j.athoracsur.2015.02.055; Dhooria S, 2015, THORAX, V70, P587, DOI 10.1136/thoraxjnl-2015-206805; Dhooria S, 2014, J THORAC CARDIOV SUR, V148, P662, DOI 10.1016/j.jtcvs.2014.01.028; Feller-Kopman David J, 2013, Ann Am Thorac Soc, V10, P127, DOI 10.1513/AnnalsATS.201208-052OC; Goyal A, 2014, J BRONCHOL INTERN PU, V21, P220, DOI 10.1097/LBR.0000000000000081; Gupta D, 2014, CHEST, V146, P547, DOI 10.1378/chest.13-2339; Hermens FHW, 2008, RESPIRATION, V75, P189, DOI 10.1159/000112793; Herth FJF, 2006, THORAX, V61, P795, DOI 10.1136/thx.2005.047829; Kaur H, 2015, CHEST, V148, P739, DOI 10.1378/chest.15-0022; Khan A, 2011, NATL MED J INDIA, V24, P136; Krasnik M, 2003, THORAX, V58, P1083, DOI 10.1136/thorax.58.12.1083; Kupeli E, 2012, J BRONCHOL INTERN PU, V19, P115, DOI 10.1097/LBR.0b013e31824dd19a; Mehta Atul C, 2013, Ann Am Thorac Soc, V10, P685, DOI 10.1513/AnnalsATS.201308-272ED; Sehgal IS, 2016, J BRONCHOL INTERN PU, V23, pE1, DOI 10.1097/LBR.0000000000000242; Srinivasan A, 2013, INDIAN J MED RES, V137, P803	21	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153793	10.1371/journal.pone.0153793	http://dx.doi.org/10.1371/journal.pone.0153793			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27083009	Green Published, gold			2022-12-26	WOS:000374291800053
J	Almeida, JL; Gil-Santana, L; Oliveira, CAM; Castro, S; Cafezeiro, AS; Daltro, C; Netto, EM; Kornfeld, H; Andrade, BB				Almeida-Junior, Jilson L.; Gil-Santana, Leonardo; Oliveira, Carolina A. M.; Castro, Simone; Cafezeiro, Aparecida S.; Daltro, Carla; Netto, Eduardo M.; Kornfeld, Hardy; Andrade, Bruno B.			Glucose Metabolism Disorder Is Associated with Pulmonary Tuberculosis in Individuals with Respiratory Symptoms from Brazil	PLOS ONE			English	Article							DIABETES-MELLITUS; DISEASE; TRENDS; RISK; TB	Background Diabetes mellitus (DM) has been associated with increased risk for pulmonary tuberculosis (PTB) in endemic settings but it is unknown whether PTB risk is also increased by pre-DM. Here, we prospectively examined the association between glucose metabolism disorder (GMD) and PTB in patients with respiratory symptoms at a tuberculosis primary care reference center in Brazil. Methods Oral glucose tolerance test was performed and levels of fasting plasma glucose and glycohemoglobin (HbA1c) were measured in a cohort of 892 individuals presenting with respiratory symptoms of more than two weeks duration. Patients were also tested for PTB with sputum cultures. Prevalence of pre-DM and DM (based on HbA1c) was estimated and tested for association with incident PTB. Other TB risk factors including smoking history were analyzed. Results The majority of the study population (63.1%) exhibited GMD based on HbA1c >= 5.7%. Patients with GMD had higher prevalence of PTB compared to normoglycemic patients. Individuals with DM exhibited increased frequency of TB-related symptoms and detection of acid-fast bacilli in sputum smears. Among patients with previous DM diagnosis, sustained hyperglycemia (HbA1c >= 7.0%) was associated with increased TB prevalence. Smoking history alone was not significantly associated with TB in our study population but the combination of smoking and HbA1c >= 7.0% was associated with 6 times higher odds for PTB. Conclusions Sustained hyperglycemia and pre-DM are independently associated with active PTB. This evidence raises the question whether improving glycemic control in diabetic TB patients would reduce the risk of TB transmission and simultaneously reduce the clinical burden of disease. A better understanding of mechanisms underlying these associations, especially those suggesting that pre-DM may be a factor driving susceptibility to TB is warranted.	[Almeida-Junior, Jilson L.; Gil-Santana, Leonardo; Andrade, Bruno B.] Fundacao Oswaldo Cruz FIOCRUZ, Ctr Pesquisas Goncalo Moniz CPqGM, LIMI, UMI, BR-40296710 Salvador, BA, Brazil; [Almeida-Junior, Jilson L.; Gil-Santana, Leonardo; Andrade, Bruno B.] FTC, Curso Med, BR-41741590 Salvador, BA, Brazil; [Almeida-Junior, Jilson L.; Gil-Santana, Leonardo; Andrade, Bruno B.] Fundacao Jose Silveira, Multinatl Org Network Sponsoring Translat & Epide, BR-40210320 Salvador, BA, Brazil; [Oliveira, Carolina A. M.; Castro, Simone; Cafezeiro, Aparecida S.; Netto, Eduardo M.; Andrade, Bruno B.] Fundacao Jose Silveira, IBIT, Ctr Pesquisa, BR-40210320 Salvador, BA, Brazil; [Daltro, Carla; Netto, Eduardo M.] Univ Fed Bahia, Hosp Univ Prof Edgard Santos, BR-40110060 Salvador, BA, Brazil; [Kornfeld, Hardy] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01655 USA	Fundacao Oswaldo Cruz; Universidade Federal da Bahia; University of Massachusetts System; University of Massachusetts Worcester	Andrade, BB (corresponding author), Fundacao Oswaldo Cruz FIOCRUZ, Ctr Pesquisas Goncalo Moniz CPqGM, LIMI, UMI, BR-40296710 Salvador, BA, Brazil.; Andrade, BB (corresponding author), FTC, Curso Med, BR-41741590 Salvador, BA, Brazil.; Andrade, BB (corresponding author), Fundacao Jose Silveira, Multinatl Org Network Sponsoring Translat & Epide, BR-40210320 Salvador, BA, Brazil.; Andrade, BB (corresponding author), Fundacao Jose Silveira, IBIT, Ctr Pesquisa, BR-40210320 Salvador, BA, Brazil.	Bruno.andrade@bahia.fiocruz.br	Andrade, Bruno/AAI-2248-2020; Netto, Eduardo/D-1432-2013; Kornfeld, Hardy/AAS-2903-2021	Netto, Eduardo/0000-0003-1691-6761; 	Conselho Nacional de Pesquisa e Tecnologia - CNPq, Brazil [559276/2009-5]; Fundacao Jose Silveira (intramural program), Brazil; Fundacao de Amparo a Pesquisa do Estado da Bahia; Government of India's Department of Biotechnology; Indian Council of Medical Research; United States National Institutes of Health [USB1-31149-XX-13]	Conselho Nacional de Pesquisa e Tecnologia - CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Jose Silveira (intramural program), Brazil; Fundacao de Amparo a Pesquisa do Estado da Bahia; Government of India's Department of Biotechnology; Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by Conselho Nacional de Pesquisa e Tecnologia - CNPq (grant number: 559276/2009-5), Brazil and Fundacao Jose Silveira (intramural program), Brazil. The authors JLA-J and LG-S received research fellowships from Fundacao de Amparo a Pesquisa do Estado da Bahia. HK's participation was supported by the Government of India's Department of Biotechnology, the Indian Council of Medical Research, the United States National Institutes of Health distributed by CRDF Global through grant #USB1-31149-XX-13.	Alisjahbana B, 2007, CLIN INFECT DIS, V45, P428, DOI 10.1086/519841; American Diabetes Association, 2015, Clin Diabetes, V33, P97, DOI 10.2337/diaclin.33.2.97; Azzurri A, 2005, MICROBES INFECT, V7, P1, DOI 10.1016/j.micinf.2004.09.004; Baker MA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-81; Conde MB, 2009, J BRAS PNEUMOL, V35, P1018, DOI 10.1590/S1806-37132009001000011; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Gil-Santana L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146876; International Diabetes Federation, 2013, IDF DIAB ATLT; Jee SH, 2009, AM J EPIDEMIOL, V170, P1478, DOI 10.1093/aje/kwp308; Kumar NP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112108; Lonnroth K, 2014, LANCET DIABETES ENDO, V2, P730, DOI 10.1016/S2213-8587(14)70109-3; Lohmann EM, 2012, INT J TUBERC LUNG D, V16, P1477, DOI 10.5588/ijtld.12.0129; Mahishale Vinay, 2015, Chonnam Med J, V51, P86, DOI 10.4068/cmj.2015.51.2.86; Marais BJ, 2013, LANCET INFECT DIS, V13, P436, DOI 10.1016/S1473-3099(13)70015-X; Martinez N, 2014, EUR J IMMUNOL, V44, P617, DOI 10.1002/eji.201344301; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; Milman S, 2011, MED CLIN N AM, V95, P309, DOI 10.1016/j.mcna.2010.11.004; Odone A, 2014, LANCET DIABETES ENDO, V2, P754, DOI 10.1016/S2213-8587(14)70164-0; Oni T, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0750-1; Reed GW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058044; Reis-Santos B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100082; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; Sen Tiyas, 2009, J Assoc Physicians India, V57, P660; Slam K, 2007, INT J TUBERC LUNG D, V11, P1049; Slatery E, 2014, NEGLECTED NONCOMPLIA; Sullivan T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001269; Viswanathan AA, 2014, LUNG INDIA, V31, P244, DOI 10.4103/0970-2113.135764; Viswanathan V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041367; Wang JY, 2015, CHEST, V147, P520, DOI 10.1378/chest.14-0918; World Health Organization, 2013, SYST SCREEN ACT TUB; World Health Organization, 2015, 2015 GLOB TUB REP; Yip J, 1998, J CLIN ENDOCR METAB, V83, P2773, DOI 10.1210/jc.83.8.2773	33	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153590	10.1371/journal.pone.0153590	http://dx.doi.org/10.1371/journal.pone.0153590			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078026	Green Published, Green Submitted, gold			2022-12-26	WOS:000374131700087
J	Guzy, G; Polczyk, R; Szpitalak, M; Vernon, H				Guzy, Grazyna; Polczyk, Romuald; Szpitalak, Malwina; Vernon, Howard			Age Moderates the Relationships between Family Functioning and Neck Pain/Disability	PLOS ONE			English	Article							SELF-RATED DISABILITY; CHRONIC PAIN; PSYCHOLOGICAL-FACTORS; GENERAL-POPULATION; COPING STYLES; FEAR; ACCEPTANCE; BELIEFS; IMPACT; MODEL	This cross-sectional clinical study was designed to explore the relationships between family functioning, coping styles, and neck pain and neck disability. It was hypothesized that better family functioning and more effective coping styles would be associated with less pain and pain-related disability. It also was hypothesized that these relationships would be stronger in older people because they have fewer resources, more limited coping styles, and may depend more on their family for support. In this study, 88 women with chronic non-traumatic neck pain completed the Family Assessment Measure (FAM), Coping Inventory for Stressful Situations (CISS), Neck Disability Index (NDI), and a Visual-Analogue Scale (VAS) measuring the subjective intensity of neck pain. Zero-order and partial correlations and hierarchical stepwise regression were performed. CISS was not correlated with the NDI orVAS. Good family functioning was correlated with lower NDI and VAS scores. Age was found to moderate the relationship between the FAM and both NDI and VAS. This relationship was significant and positive in older patients, but non-significant in younger patients. It was concluded that better family functioning is associated with lower neck disability and pain intensity, especially in the case of older women suffering from non-traumatic neck pain.	[Guzy, Grazyna] Univ Phys Educ, Dept Physiotherapy, Krakow, Poland; [Polczyk, Romuald; Szpitalak, Malwina] Jagiellonian Univ, Inst Psychol, Krakow, Poland; [Vernon, Howard] Canadian Mem Chiropract Coll, Toronto, ON, Canada	Jagiellonian University	Guzy, G (corresponding author), Univ Phys Educ, Dept Physiotherapy, Krakow, Poland.	grazyna.guzy@fizjoterapia.eu			University of Physical Education in Cracow, Poland [257/KF/2009]	University of Physical Education in Cracow, Poland	This work was supported by University of Physical Education in Cracow, Poland; 257/KF/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakhtadze MA, 2012, J MANIP PHYSIOL THER, V35, P76, DOI 10.1016/j.jmpt.2011.12.006; Beauvale Andrzej, 2002, Psychiatr Pol, V36, P29; Berg CA, 2007, PSYCHOL BULL, V133, P920, DOI 10.1037/0033-2909.133.6.920; Buitenhuis J, 2008, SPINE, V33, P2427, DOI 10.1097/BRS.0b013e318183c6ca; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Cierpka M, 1994, DIE FAMILIENBOGEN; Connidis I, 1983, CANADIAN J AGING, V2, P91; Cote P, 2004, PAIN, V112, P267, DOI 10.1016/j.pain.2004.09.004; Cui JA, 2009, PSYCHIAT CLIN NEUROS, V63, P147, DOI 10.1111/j.1440-1819.2009.01934.x; den Hollander M, 2010, EXPERT REV NEUROTHER, V10, P1733, DOI [10.1586/ERN.10.115, 10.1586/ern.10.115]; Endler NS., 1999, COPING INVENTORY STR, V2; Esteve R, 2007, ANN BEHAV MED, V33, P179, DOI 10.1007/BF02879899; Guzy G, 2013, DISABIL REHABIL, V35, P2132, DOI 10.3109/09638288.2013.771706; Hart S, 2000, PSYCHOL HEALTH, V15, P869, DOI 10.1080/08870440008405588; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Higgins NC, 2015, J PSYCHOL, V149, P737, DOI 10.1080/00223980.2014.977759; Hogg-Johnson S, 2009, J MANIP PHYSIOL THER, V32, pS46, DOI 10.1016/j.jmpt.2008.11.010; Howell ER, 2012, J MUSCULOSKELET PAIN, V20, P18, DOI 10.3109/10582452.2011.635849; Hoy DG, 2010, BEST PRACT RES CL RH, V24, P783, DOI 10.1016/j.berh.2011.01.019; Hurwitz EL, 2006, DISABIL REHABIL, V28, P1319, DOI 10.1080/09638280600641509; Jagger C, 2008, LANCET, V372, P2124, DOI 10.1016/S0140-6736(08)61594-9; Kemler MA, 2002, J PAIN SYMPTOM MANAG, V23, P433, DOI 10.1016/S0885-3924(02)00386-X; Kerns R. D., 2002, PSYCHOL APPROACHES P, P256; Kerns RD, 2003, SEMIN PAIN MED, V1, P79, DOI DOI 10.1016/S1537-5897(03)00007-7; Lewandowski Wendy, 2007, Issues Ment Health Nurs, V28, P1019, DOI 10.1080/01612840701522200; Luo XM, 2004, VALUE HEALTH, V7, P61, DOI 10.1111/j.1524-4733.2004.71264.x; Lutz W, 2008, NATURE, V451, P716, DOI 10.1038/nature06516; Mackenbach JP, 2013, LANCET, V381, P1125, DOI 10.1016/S0140-6736(12)62082-0; McCarthy MJH, 2007, EUR SPINE J, V16, P2111, DOI 10.1007/s00586-007-0503-y; McCracken LA, 2003, PAIN, V105, P197, DOI 10.1016/S0304-3959(03)00202-1; McCracken LM, 2014, PRIM HEALTH CARE RES, V15, P312, DOI 10.1017/S1463423613000273; Nieto R, 2008, SPINE, V33, pE630, DOI 10.1097/BRS.0b013e31817eb836; Nieto R, 2011, DISABIL REHABIL, V33, P389, DOI 10.3109/09638288.2010.491576; Nieto R, 2009, EUR J PAIN, V13, P518, DOI 10.1016/j.ejpain.2008.06.005; Nolte E, 2002, SOC SCI MED, V55, P1905, DOI 10.1016/S0277-9536(01)00320-3; Riddle DL, 1998, PHYS THER, V78, P951, DOI 10.1093/ptj/78.9.951; Romano JM, 2001, HDB PAIN ASSESSMENT, P346; Skinner H, 2000, J FAM THER, V22, P190, DOI 10.1111/1467-6427.00146; Skinner H.A., 1983, CANADIAN J COMMUNITY, V2, P91, DOI [10.7870/cjcmh-1983-0018, DOI 10.7870/CJCMH-1983-0018]; Strelau J, 2007, CISS KWESRIONARIUSZ; TAYLOR R, 1990, J DIAGN MED SONOG, V6, P35, DOI 10.1177/875647939000600106; Thomas MR, 1991, HEADACHE Q-CURR TREA, V2, P307; Turk DC, 2002, J CONSULT CLIN PSYCH, V70, P678, DOI 10.1037//0022-006X.70.3.678; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; Vernon H, 2011, J MANIP PHYSIOL THER, V34, P506, DOI 10.1016/j.jmpt.2011.08.011; Vernon H, 2010, SPINE, V35, pE16, DOI 10.1097/BRS.0b013e3181b135aa; Vlaeyen JWS, 2012, PAIN, V153, P1144, DOI 10.1016/j.pain.2011.12.009; Voerman JS, 2015, EUR J PAIN, V19, P1544, DOI 10.1002/ejp.689; Vos CJ, 2008, BRIT J GEN PRACT, V58, P624, DOI 10.3399/bjgp08X330762; Williamson A, 2005, J CLIN NURS, V14, P798, DOI 10.1111/j.1365-2702.2005.01121.x; Young SB, 2009, PAIN MED, V10, P310, DOI 10.1111/j.1526-4637.2009.00571.x	51	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153606	10.1371/journal.pone.0153606	http://dx.doi.org/10.1371/journal.pone.0153606			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UH	27078854	Green Published, Green Submitted, gold			2022-12-26	WOS:000374131700091
J	Montalbano, M; Curcuru, G; Shirafkan, A; Vento, R; Rastellini, C; Cicalese, L				Montalbano, Mauro; Curcuru, Giuseppe; Shirafkan, Ali; Vento, Renza; Rastellini, Cristiana; Cicalese, Luca			Modeling of Hepatocytes Proliferation Isolated from Proximal and Distal Zones from Human Hepatocellular Carcinoma Lesion	PLOS ONE			English	Article							CELL; TOXICITY; CULTURE	Isolation of hepatocytes from cirrhotic human livers and subsequent primary culture are important new tools for laboratory research and cell-based therapeutics in the study of hepatocellular carcinoma (HCC). Using such techniques, we have previously identified different subpopulations of human hepatocytes and among them one is showing a progressive transformation of hepatocytes in HCC-like cells. We have hypothesized that increasing the distance from the neoplastic lesion might affect hepatocyte function and transformation capacity. However, limited information is available in comparing the growth and proliferation of human hepatocytes obtained from different areas of the same cirrhotic liver in relation to their distance from the HCC lesion. In this study, hepatocytes from 10 patients with cirrhosis and HCC undergoing surgical resections from specimens obtained at a proximal (CP) and distal (CD) distance from the HCC lesion were isolated and placed in primary culture. CP hepatocytes (CP-Hep) were isolated between 1 to 3 cm (leaving at least 1cm margin to avoid cancer cells and/or satellite lesions), while CD hepatocytes (CD-Hep) were isolated from more than 5 cm or from the contralateral-lobe. A statistical model was built to analyze the proliferation rates of these cells and we evaluated expression of HCC markers (Glypican-3 (GPC3), alpha Smooth Muscle Actin (alpha-SMA) and PCNA). We observed a significant difference in proliferation and in-vitro growth showing that CP-Hep had a proliferation pattern and rate significantly different than CD-Hep. Based on these data, this model can provide information to predict growth of human hepatocytes in primary culture in relation to their precancerous state with significant differences in the HCC markers expression. This model provides an important innovative tool for in-vitro analysis of HCC.	[Montalbano, Mauro; Shirafkan, Ali; Rastellini, Cristiana; Cicalese, Luca] Univ Texas Med Branch, Dept Surg, Galveston, TX 77555 USA; [Montalbano, Mauro] Univ Palermo, Dept Expt Biomed & Clin Neurosci, Via Vespro 129, I-90127 Palermo, Italy; [Curcuru, Giuseppe] Univ Palermo, Dept Chem Management Informat & Mech Engn, Palermo, Italy; [Vento, Renza] Univ Palermo, Dept Biol Chem & Pharmaceut Sci & Technol, Biochem Lab, Palermo, Italy; [Vento, Renza] Temple Univ, Inst Canc Res & Mol Med, Philadelphia, PA 19122 USA; [Vento, Renza] Temple Univ, Ctr Biotechnol, Coll Sci & Biotechnol, Philadelphia, PA 19122 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Palermo; University of Palermo; University of Palermo; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Cicalese, L (corresponding author), Univ Texas Med Branch, Dept Surg, Galveston, TX 77555 USA.	lucicale@utmb.edu	Montalbano, Mauro/AAA-6833-2021	Montalbano, Mauro/0000-0002-0456-452X				Bhogal RH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018222; Corlu A, 2015, METHODS MOL BIOL, V1250, P27, DOI 10.1007/978-1-4939-2074-7_3; De Bruyn T, 2013, EXPERT OPIN DRUG MET, V9, P589, DOI 10.1517/17425255.2013.773973; Gomez-Lechon MJ, 2003, CURR DRUG METAB, V4, P292, DOI 10.2174/1389200033489424; Haruyama Y, 2016, WORLD J GASTROENTERO, V22, P275, DOI 10.3748/wjg.v22.i1.275; Hughes RD, 2006, LIVER TRANSPLANT, V12, P713, DOI 10.1002/lt.20732; Kawahara T, 2010, LIVER TRANSPLANT, V16, P974, DOI 10.1002/lt.22099; Levy G, 2015, NAT BIOTECHNOL, V33, P1264, DOI 10.1038/nbt.3377; Ma S, 2015, TUMOR BIOL, DOI [10.1007/s13277-015-4582, DOI 10.1007/S13277-015-4582-]; Montalbano M, 2015, INT J ONCOL, DOI [10.3892/ijo.2015.3312, DOI 10.3892/IJ0.2015.3312]; Portolani N, 2006, ANN SURG, V243, P229, DOI 10.1097/01.sla.0000197706.21803.a1; Ramboer E, 2014, J HEPATOL, V61, P925, DOI 10.1016/j.jhep.2014.05.046; RATANASAVANH D, 1988, XENOBIOTICA, V18, P765, DOI 10.3109/00498258809041715; Wilkening S, 2003, DRUG METAB DISPOS, V31, P1035, DOI 10.1124/dmd.31.8.1035; Xu YP, 2016, ONCOTARGET, V7, P8866, DOI 10.18632/oncotarget.6839; Yoshizato Katsutoshi, 2012, Curr Drug Discov Technol, V9, P63; Zhang XL, 2015, ANTI-CANCER AGENT ME, V15, P755, DOI 10.2174/1871520615666150202111721	17	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153613	10.1371/journal.pone.0153613	http://dx.doi.org/10.1371/journal.pone.0153613			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074018	gold, Green Published, Green Submitted			2022-12-26	WOS:000374131200112
J	Mueller, S; Martin, S; Schwarz, M; Grunwald, M				Mueller, Stephanie; Martin, Sven; Schwarz, Michael; Grunwald, Martin			Temporal Modulations of Contact Force during Haptic Surface Exploration	PLOS ONE			English	Article							ANOREXIA-NERVOSA; FINGERTIP FORCES; THETA-POWER; GRIP FORCE; LOAD FORCE; PERCEPTION; ROUGHNESS; DISCRIMINATION; MOVEMENTS	Individuals constantly modulate their exploratory movements and adapt their internal hypotheses to incoming sensory information to achieve a thorough and realistic percept. Perception depends on the exploratory movements as well as influencing them. While this seems to be common sense, scientifically we know very little about the temporal dynamics during haptic exploration. To address this, we investigated the exploratory force modulations of two groups of healthy young adults during the exploration of grated surfaces with differing detection difficulty during successive (n = 20) and random stimulus presentation (n = 20). Results showed that exploratory force depended on stimulus properties and increased with increasing detection difficulty. Both experiments yielded the same direction of results with slightly smaller effects in the random stimulus presentation group. Across exploration time average fingertip force also increased. The biggest increase occurred systematically at the beginning (within the first 40 percent) of exploration time per stimulus indicating that most critical information is received during the initial contact phase and is directly transformed into the exploration procedure and force application. Furthermore, video-analyses and comparisons to our high temporal resolution data revealed strong dynamic changes in pressure application during test stimulus exploration with differences in the force dynamics and exploration strategies of simple and difficult stimuli.	[Mueller, Stephanie; Martin, Sven; Schwarz, Michael; Grunwald, Martin] Univ Leipzig, Hapt Res Lab, Paul Flechsig Inst Brain Res, Fac Med, D-04109 Leipzig, Germany	Leipzig University	Grunwald, M (corresponding author), Univ Leipzig, Hapt Res Lab, Paul Flechsig Inst Brain Res, Fac Med, D-04109 Leipzig, Germany.	mgrun@medizin.uni-leipzig.de	Mueller, Stephanie/A-6742-2017		DFE. e.V.; Haptic Forschungszentrum GmbH, Leipzig; German Research Foundation (DFG); Universitaet Leipzig	DFE. e.V.; Haptic Forschungszentrum GmbH, Leipzig; German Research Foundation (DFG)(German Research Foundation (DFG)); Universitaet Leipzig	This research project was funded in part by DFE. e.V.; Haptic Forschungszentrum GmbH, Leipzig. Publication was supported by German Research Foundation (DFG) and Universitaet Leipzig within the program of Open Access Publishing.	[Anonymous], 2009, EUROHAPTICS C 2009 S; BELL J, 1994, PROG NEUROBIOL, V42, P79, DOI 10.1016/0301-0082(94)90022-1; Chen J, 1998, HUMAN HAPTIC INTERAC; COLE KJ, 1988, J NEUROPHYSIOL, V60, P1513, DOI 10.1152/jn.1988.60.4.1513; Cole KJ, 1999, J NEUROSCI, V19, P3238; FLANAGAN JR, 1993, NEUROSCI LETT, V152, P53, DOI 10.1016/0304-3940(93)90481-Y; Frings S, 2012, PHYSIOLOGIE, P624; Gregory RL, 1973, EYE BRAIN; Grunwald M, 2002, ARCH CLIN NEUROPSYCH, V17, P485, DOI 10.1016/S0887-6177(01)00131-7; Grunwald M, 2001, J CLIN EXP NEUROPSYC, V23, P520, DOI 10.1076/jcen.23.4.520.1229; Grunwald M, 2001, INT J EAT DISORDER, V29, P417, DOI 10.1002/eat.1038; Grunwald M, 2001, COGNITIVE BRAIN RES, V11, P33, DOI 10.1016/S0926-6410(00)00061-6; Grunwald M, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00292; Halata Zdenek, 2008, P85, DOI 10.1007/978-3-7643-7612-3_6; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; JOHANSSON RS, 1992, CURR OPIN NEUROBIOL, V2, P815, DOI 10.1016/0959-4388(92)90139-C; Kaim LR, 2009, WORLD HAPTICS 2009: THIRD JOINT EUROHAPTICS CONFERENCE AND SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P565, DOI 10.1109/WHC.2009.4810830; Katz D, 1969, AUFBAU TASTWELT REPR; Keenan KG, 2009, J NEUROSCI, V29, P8784, DOI 10.1523/JNEUROSCI.0853-09.2009; Klatzky RL, 1999, ATTENTION PERFORM, V17, P165; LEDERMAN SJ, 1981, B PSYCHONOMIC SOC, V18, P253; LEDERMAN SJ, 1974, PERCEPT PSYCHOPHYS, V16, P385, DOI 10.3758/BF03203958; LEDERMAN SJ, 1972, PERCEPT PSYCHOPHYS, V12, P401, DOI 10.3758/BF03205850; Matsui K, 2014, ADV ROBOTICS, V28, P883, DOI 10.1080/01691864.2014.894939; Mueller S, 2014, EXP BRAIN RES, V232, P1905, DOI 10.1007/s00221-014-3882-4; Mueller S, 2014, INT NEUROPSYCHIATRIC, V2, P141, DOI DOI 10.9734/INDJ/2014/8102; Mueller S, 2014, PT Z PHYSIOTHERAPEUT, V66, P91; Mueller S, 2013, EXP BRAIN RES, V231, P415, DOI 10.1007/s00221-013-3706-y; Nefs HT, 2002, PERCEPT PSYCHOPHYS, V64, P969, DOI 10.3758/BF03196800; Osterberg G., 1935, ACTA OPHTHALMOL, V13, P6; Parikh PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124137; RADWIN RG, 1992, ERGONOMICS, V35, P275, DOI 10.1080/00140139208967813; Ross H. E., 2008, HUMAN HAPTIC PERCEPT, DOI [10.1007/978-3-7643-7612-3_22, DOI 10.1007/978-3-7643-7612-3_22]; Smith AM, 2002, EXP BRAIN RES, V147, P209, DOI 10.1007/s00221-002-1240-4; Smith AM, 1996, J NEUROPHYSIOL, V75, P1957, DOI 10.1152/jn.1996.75.5.1957; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, pVII; Tanaka Yoshihiro, 2012, Haptics: Perception, Devices, Mobility, and Communication. Proceedings International Conference (EuroHaptics 2012), P163, DOI 10.1007/978-3-642-31404-9_28; Tanaka Y, 2014, PLOS ONE, V9; Westling G., 1981, SOC NEUR ABSTR, V247	39	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152897	10.1371/journal.pone.0152897	http://dx.doi.org/10.1371/journal.pone.0152897			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UC	27073843	gold, Green Published, Green Submitted			2022-12-26	WOS:000374131200043
J	Shearstone, JR; Golonzhka, O; Chonkar, A; Tamang, D; van Duzer, JH; Jones, SS; Jarpe, MB				Shearstone, Jeffrey R.; Golonzhka, Olga; Chonkar, Apurva; Tamang, David; van Duzer, John H.; Jones, Simon S.; Jarpe, Matthew B.			Chemical Inhibition of Histone Deacetylases 1 and 2 Induces Fetal Hemoglobin through Activation of GATA2	PLOS ONE			English	Article							SICKLE-CELL-DISEASE; GLOBIN GENE-EXPRESSION; ACUTE MYELOID-LEUKEMIA; GAMMA-GLOBIN; TRANSCRIPTIONAL REPRESSION; BETA-THALASSEMIA; BCL11A; ERYTHROPOIESIS; HYDROXYUREA; POTENT	Therapeutic intervention aimed at reactivation of fetal hemoglobin protein (HbF) is a promising approach for ameliorating sickle cell disease (SCD) and beta-thalassemia. Previous studies showed genetic knockdown of histone deacetylase (HDAC) 1 or 2 is sufficient to induce HbF. Here we show that ACY-957, a selective chemical inhibitor of HDAC1 and 2 (HDAC1/2), elicits a dose and time dependent induction of.-globin mRNA (HBG) and HbF in cultured primary cells derived from healthy individuals and sickle cell patients. Gene expression profiling of erythroid progenitors treated with ACY-957 identified global changes in gene expression that were significantly enriched in genes previously shown to be affected by HDAC1 or 2 knockdown. These genes included GATA2, which was induced greater than 3-fold. Lentiviral overexpression of GATA2 in primary erythroid progenitors increased HBG, and reduced adult beta-globin mRNA (HBB). Furthermore, knockdown of GATA2 attenuated HBG induction by ACY-957. Chromatin immunoprecipitation and sequencing (ChIP-Seq) of primary erythroid progenitors demonstrated that HDAC1 and 2 occupancy was highly correlated throughout the GATA2 locus and that HDAC1/2 inhibition led to elevated histone acetylation at well-known GATA2 autoregulatory regions. The GATA2 protein itself also showed increased binding at these regions in response to ACY-957 treatment. These data show that chemical inhibition of HDAC1/2 induces HBG and suggest that this effect is mediated, at least in part, by histone acetylation-induced activation of the GATA2 gene.	[Shearstone, Jeffrey R.; Golonzhka, Olga; Chonkar, Apurva; Tamang, David; van Duzer, John H.; Jones, Simon S.; Jarpe, Matthew B.] Acetylon Pharmaceut Inc, Boston, MA USA		Shearstone, JR (corresponding author), Acetylon Pharmaceut Inc, Boston, MA USA.	jshearstone@acetylon.com		Shearstone, Jeffrey/0000-0002-6875-1826	National Heart, Lung, and Blood Institute of the National Institutes of Health [1R41HL118917-01]; Acetylon Pharmaceuticals; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R41HL118917] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Acetylon Pharmaceuticals; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the National Heart, Lung, and Blood Institute of the National Institutes of Health under Award Number 1R41HL118917-01 (http://www.nhlbi.nih.gov). The funder provided support in the form of research materials and salaries for authors JRS and MBJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding was also provided by Acetylon Pharmaceuticals (http://www.acetylon.com). The funder provided support in the form of research materials and salaries for JRS, OG, AC, DT, JHD, SSJ, and MBJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are listed in the 'Author Contributions' section.	BANK A, 1980, SCIENCE, V207, P486, DOI 10.1126/science.7352255; Bauer DE, 2011, CURR OPIN PEDIATR, V23, P1, DOI 10.1097/MOP.0b013e3283420fd0; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bradner JE, 2010, P NATL ACAD SCI USA, V107, P12617, DOI 10.1073/pnas.1006774107; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Bresnick EH, 2010, J BIOL CHEM, V285, P31087, DOI 10.1074/jbc.R110.159079; Bunn HF, 1997, NEW ENGL J MED, V337, P762, DOI 10.1056/NEJM199709113371107; Cao H, 2006, AM J HEMATOL, V81, P981, DOI 10.1002/ajh.20676; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; DESIMONE J, 1982, P NATL ACAD SCI-BIOL, V79, P4428, DOI 10.1073/pnas.79.14.4428; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Esrick EB, 2015, AM J HEMATOL; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Forget BG, 1998, ANN NY ACAD SCI, V850, P38, DOI 10.1111/j.1749-6632.1998.tb10460.x; Grass JA, 2003, P NATL ACAD SCI USA, V100, P8811, DOI 10.1073/pnas.1432147100; Grass JA, 2006, MOL CELL BIOL, V26, P7056, DOI 10.1128/MCB.01033-06; Gregory GD, 2010, BLOOD, V115, P2156, DOI 10.1182/blood-2009-10-251280; Guha M, 2015, NAT REV DRUG DISCOV, V14, P226, DOI 10.1038/nrd4583; Hahn CN, 2011, NAT GENET, V43, P1012, DOI 10.1038/ng.913; Heideman MR, 2014, HAEMATOLOGICA, V99, P1292, DOI 10.3324/haematol.2013.092643; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Hu JP, 2013, BLOOD, V121, P3246, DOI 10.1182/blood-2013-01-476390; Ikonomi P, 2000, GENE, V261, P277, DOI 10.1016/S0378-1119(00)00510-2; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Jiang J, 2006, BLOOD, V108, P1077, DOI 10.1182/blood-2006-01-008912; Kiefer CM, 2011, BLOOD, V118, P6200, DOI 10.1182/blood-2011-06-363101; Krivega I, 2015, BLOOD, V126, P665, DOI 10.1182/blood-2015-02-629972; Kupcho KR, 2014, CANCER RES, V74, DOI 10.1158/1538-7445.AM2014-4784; Kupcho KR, 2014, SELECTIVE BIOLUMINOG; Kuroyanagi Y, 2006, BIOCHEM BIOPH RES CO, V344, P1038, DOI 10.1016/j.bbrc.2006.03.203; Lauffer BEL, 2013, J BIOL CHEM, V288, P26926, DOI 10.1074/jbc.M113.490706; LEONARD M, 1993, BLOOD, V82, P1071; Liberati C, 2001, J BIOL CHEM, V276, P41700, DOI 10.1074/jbc.M102987200; LOKEN MR, 1987, BLOOD, V69, P255; Martowicz ML, 2005, J BIOL CHEM, V280, P1724, DOI 10.1074/jbc.M406038200; Methot JL, 2008, BIOORG MED CHEM LETT, V18, P973, DOI 10.1016/j.bmcl.2007.12.031; Miccio A, 2010, EMBO J, V29, P442, DOI 10.1038/emboj.2009.336; Moriguchi T, 2014, INT J HEMATOL, V100, P417, DOI 10.1007/s12185-014-1568-0; Musallam KM, 2012, BLOOD, V119, P364, DOI 10.1182/blood-2011-09-382408; Pal S, 2004, P NATL ACAD SCI USA, V101, P980, DOI 10.1073/pnas.0307612100; Petzer AL, 1996, J EXP MED, V183, P2551, DOI 10.1084/jem.183.6.2551; Renneville A, 2015, BLOOD, V126, P1930, DOI 10.1182/blood-2015-06-649087; Rivers A, 2015, EXP HEMATOL, V43, P546, DOI 10.1016/j.exphem.2015.04.005; Ronzoni L, 2014, BRIT J HAEMATOL, V165, P714, DOI 10.1111/bjh.12814; Rund D, 2005, NEW ENGL J MED, V353, P1135, DOI 10.1056/NEJMra050436; Rupon JW, 2006, P NATL ACAD SCI USA, V103, P6617, DOI 10.1073/pnas.0509322103; Sanalkumar R, 2014, P NATL ACAD SCI USA, V111, pE1091, DOI 10.1073/pnas.1400065111; Sankaran VG, 2011, NEW ENGL J MED, V365, P807, DOI 10.1056/NEJMoa1103070; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Shearstone JR., 2012, BLOOD, V120, P3259; Shi LH, 2013, NAT MED, V19, P291, DOI 10.1038/nm.3101; Shih AH, 2015, CANCER CELL, V27, P502, DOI 10.1016/j.ccell.2015.03.009; Simon R, 2007, CANCER INFORM, V3, P11; Skarpidi E, 2003, EXP HEMATOL, V31, P197, DOI 10.1016/S0301-472X(02)01030-5; Spinner MA, 2014, BLOOD, V123, P809, DOI 10.1182/blood-2013-07-515528; Sripichai O, 2009, BLOOD, V114, P2299, DOI 10.1182/blood-2009-05-219386; Steinberg MH, 2003, JAMA-J AM MED ASSOC, V289, P1645, DOI 10.1001/jama.289.13.1645; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian S, 2010, PHARMACEUTICALS, V3, P2751, DOI 10.3390/ph3092751; Suzuki T, 1999, J MED CHEM, V42, P3001, DOI 10.1021/jm980565u; Tallack MR, 2013, CURR OPIN HEMATOL, V20, P193, DOI 10.1097/MOH.0b013e32835f59ba; Tanabe O, 2007, EMBO J, V26, P2295, DOI 10.1038/sj.emboj.7601676; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Wang M, 2002, BRIT J HAEMATOL, V119, P1098, DOI 10.1046/j.1365-2141.2002.03958.x; Witt O, 2003, BLOOD, V101, P2001, DOI 10.1182/blood-2002-08-2617; Witter DJ, 2008, BIOORG MED CHEM LETT, V18, P726, DOI 10.1016/j.bmcl.2007.11.047; Xu J, 2013, P NATL ACAD SCI USA, V110, P6518, DOI 10.1073/pnas.1303976110; Xu J, 2010, GENE DEV, V24, P783, DOI 10.1101/gad.1897310; Yamamura K, 2006, BRIT J HAEMATOL, V135, P242, DOI 10.1111/j.1365-2141.2006.06275.x; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568; Zhou DW, 2010, NAT GENET, V42, P742, DOI 10.1038/ng.637	75	19	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153767	10.1371/journal.pone.0153767	http://dx.doi.org/10.1371/journal.pone.0153767			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073918	Green Submitted, Green Published, gold			2022-12-26	WOS:000374131200119
J	Chen, PT; Chen, CL; Lin, LTW; Lo, CH; Hu, CJ; Chen, RPY; Wang, SSS				Chen, Po-Ting; Chen, Chao-Long; Lin, Lilian Tsai-Wei; Lo, Chun-Hsien; Hu, Chaur-Jong; Chen, Rita P. -Y.; Wang, Steven S. -S.			Design of Peptide Substrate for Sensitively and Specifically Detecting Two A beta-Degrading Enzymes: Neprilysin and Angiotensin-Converting Enzyme	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; BRAIN; METABOLISM; PATHOLOGY; TARGETS; CELLS	Upregulation of neprilysin (NEP) to reduce A beta accumulation in the brain is a promising strategy for the prevention of Alzheimer's disease (AD). This report describes the design and synthesis of a quenched fluorogenic peptide substrate qf-A beta(12-16) AAC (with the sequence VHHQKAAC), which has a fluorophore, Alexa-350, linked to the side-chain of its C-terminal cysteine and a quencher, Dabcyl, linked to its N-terminus. This peptide emitted strong fluorescence upon cleavage. Our results showed that qf-A beta(12-16) AAC is more sensitive to NEP than the previously reported peptide substrates, so that concentrations of NEP as low as 0.03 nM could be detected at peptide concentration of 2 mu M. Moreover, qfA beta(12-16) AAC had superior enzymatic specificity for both NEP and angiotensin-converting enzyme (ACE), but was inert with other A beta-degrading enzymes. This peptide, used in conjunction with a previously reported peptide substrate qf-A beta(1-7) C [which is sensitive to NEP and insulin-degrading enzyme (IDE)], could be used for high-throughput screening of compounds that only upregulate NEP. The experimental results of cell-based activity assays using both qf-A beta(1-7) C and qf-A beta(12-16) AAC as the substrates confirm that somatostatin treatment most likely upregulates IDE, but not NEP, in neuroblastoma cells.	[Chen, Po-Ting; Chen, Rita P. -Y.] Natl Taiwan Univ, Inst Biochem Sci, Taipei 10617, Taiwan; [Chen, Po-Ting; Chen, Rita P. -Y.] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan; [Chen, Chao-Long; Lin, Lilian Tsai-Wei; Lo, Chun-Hsien; Wang, Steven S. -S.] Natl Taiwan Univ, Dept Chem Engn, Taipei 10617, Taiwan; [Hu, Chaur-Jong] Taipei Med Univ, Dept Neurol, Shuang Ho Hosp, Taipei 110, Taiwan	National Taiwan University; Academia Sinica - Taiwan; National Taiwan University; Taipei Medical University; Shuang Ho Hospital	Chen, RPY (corresponding author), Natl Taiwan Univ, Inst Biochem Sci, Taipei 10617, Taiwan.; Chen, RPY (corresponding author), Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan.; Wang, SSS (corresponding author), Natl Taiwan Univ, Dept Chem Engn, Taipei 10617, Taiwan.	pyc@gate.sinica.edu.tw; sswang@ntu.edu.tw	Chen, Rita P/M-8397-2013	Chen, Rita P/0000-0003-3987-033X; Lin, Lilian/0000-0003-2769-8763	Academia Sinica; Ministry of Science and Technology, Taiwan [NSC 97-2113-M-001-014-MY2, 102-2113-M-001-013-MY3, MOST 104-2221-E-002-172]	Academia Sinica(Academia Sinica - Taiwan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Academia Sinica and the Ministry of Science and Technology, Taiwan (project no. NSC 97-2113-M-001-014-MY2, 102-2113-M-001-013-MY3 and MOST 104-2221-E-002-172). The MALDI mass spectroscopy and the enzyme specificity and sensitivity assays were conducted in the Biophysics Instrumentation Laboratory of the Institute of Biological Chemistry, Academia Sinica.	Ayoub S, 2006, J PHARM PHARMACOL, V58, P495, DOI 10.1211/jpp.58.4.0009; Ayoub S, 2008, PHARM BIOL, V46, P425, DOI 10.1080/13880200802055891; Blurton-Jones M, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt440; Caccamo A, 2005, NEUROBIOL AGING, V26, P645, DOI 10.1016/j.neurobiolaging.2004.06.013; Chen PT, 2010, J NEUROSCI METH, V190, P57, DOI 10.1016/j.jneumeth.2010.04.024; Eckman EA, 2005, BIOCHEM SOC T, V33, P1101, DOI 10.1042/BST0331101; El-Amouri SS, 2008, AM J PATHOL, V172, P1342, DOI 10.2353/ajpath.2008.070620; Guan H, 2009, J NEUROSCI RES, V87, P1462, DOI 10.1002/jnr.21944; Hemming ML, 2007, PLOS MED, V4, P1405, DOI 10.1371/journal.pmed.0040262; Hsu RL, 2009, J AGR FOOD CHEM, V57, P503, DOI 10.1021/jf803072r; Iwata N, 2005, PHARMACOL THERAPEUT, V108, P129, DOI 10.1016/j.pharmthera.2005.03.010; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; Jakob-Roetne R, 2009, ANGEW CHEM INT EDIT, V48, P3030, DOI 10.1002/anie.200802808; Liu YX, 2010, MOL CELL NEUROSCI, V45, P101, DOI 10.1016/j.mcn.2010.05.014; Mandavilli A, 2006, NAT MED, V12, P747, DOI 10.1038/nm0706-747; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; Moreth J, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-18; Nalivaeva NN, 2012, J NEUROCHEM, V120, P167, DOI 10.1111/j.1471-4159.2011.07510.x; Park MH, 2013, BRAIN RES, V1529, P113, DOI 10.1016/j.brainres.2013.05.045; Rafii MS, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-7; Saito T, 2005, NAT MED, V11, P434, DOI 10.1038/nm1206; Tundo G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034376; Turner AJ, 2007, INT REV NEUROBIOL, V82, P113, DOI 10.1016/S0074-7742(07)82006-X; Vardy ERLC, 2005, TRENDS MOL MED, V11, P464, DOI 10.1016/j.molmed.2005.08.004; Wang DS, 2003, BIOCHEM BIOPH RES CO, V310, P236, DOI 10.1016/j.bbrc.2003.09.003; Yasojima K, 2001, NEUROSCI LETT, V297, P97, DOI 10.1016/S0304-3940(00)01675-X	26	3	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153360	10.1371/journal.pone.0153360	http://dx.doi.org/10.1371/journal.pone.0153360			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096746	gold, Green Published			2022-12-26	WOS:000374543600033
J	Dhanda, SK; Vir, P; Singla, D; Gupta, S; Kumar, S; Raghava, GPS				Dhanda, Sandeep Kumar; Vir, Pooja; Singla, Deepak; Gupta, Sudheer; Kumar, Shailesh; Raghava, Gajendra P. S.			A Web-Based Platform for Designing Vaccines against Existing and Emerging Strains of Mycobacterium tuberculosis	PLOS ONE			English	Article							T-CELL EPITOPES; PROTECTIVE EFFICACY; SUBUNIT VACCINES; MULTIDRUG-RESISTANT; SECRETION SYSTEMS; VIRULENCE FACTORS; INTERFERON-GAMMA; IMMUNE-RESPONSE; BCG; PREDICTION	Development of an effective vaccine against drug-resistant Mycobacterium tuberculosis (Mtb) is crucial for saving millions of premature deaths every year due to tuberculosis. This paper describes a web portal developed for assisting researchers in designing vaccines against emerging Mtb strains using traditional and modern approaches. Firstly, we annotated 59 genomes of Mycobacterium species to understand similarity/dissimilarity between tuberculoid, non-tuberculoid and vaccine strains at genome level. Secondly, antigen-based vaccine candidates have been predicted in each Mtb strain. Thirdly, epitopes-based vaccine candidates were predicted/discovered in above antigen-based vaccine candidates that can stimulate all arms of immune system. Finally, a database of predicted vaccine candidates at epitopes as well at antigen level has been developed for above strains. In order to design vaccine against a newly sequenced genome of Mtb strain, server integrates three modules for identification of strain-, antigen-, epitope-specific vaccine candidates. We observed that 103522 unique peptides (9mers) had the potential to induce an antibody response and/or promiscuous binder to MHC alleles and/or have the capability to stimulate T lymphocytes. In summary, this web-portal will be useful for researchers working on designing vaccines against Mtb including drug-resistant strains. Availability: The database is available freely at http://crdd.osdd.net/raghava/mtbveb/.	[Dhanda, Sandeep Kumar; Vir, Pooja; Singla, Deepak; Gupta, Sudheer; Kumar, Shailesh; Raghava, Gajendra P. S.] Inst Microbial Technol, Bioinformat Ctr, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Raghava, GPS (corresponding author), Inst Microbial Technol, Bioinformat Ctr, Chandigarh 160036, India.	raghava@imtech.res.in	Raghava, Gajendra P.S./AAA-2413-2022; Raghava, Gajendra/B-1717-2009; Vir, Pooja/ABI-3569-2020; Dhanda, Sandeep Kumar/J-8471-2016; Singla, Deepak/C-9629-2015	Raghava, Gajendra P.S./0000-0002-8902-2876; Vir, Pooja/0000-0002-6816-5122; Dhanda, Sandeep Kumar/0000-0003-1381-7434; Singla, Deepak/0000-0003-0131-7950; Kumar, Shailesh/0000-0002-1872-9903; Gupta, Sudheer/0000-0002-6836-6696	Council of Scientific and Industrial Research through OSDD consortium; Council of Scientific and Industrial Research through GENESIS projects; Department of Biotechnology, Government of India through BTISNET; Indian Council of Medical Research	Council of Scientific and Industrial Research through OSDD consortium; Council of Scientific and Industrial Research through GENESIS projects; Department of Biotechnology, Government of India through BTISNET; Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	The authors acknowledge the Council of Scientific and Industrial Research funding through OSDD consortium and GENESIS projects. The authors are also thankful to Department of Biotechnology, Government of India for funding the project through BTISNET. SKD acknowledges the Indian Council of Medical Research for a fellowship.	Abebe F, 2009, CLIN EXP IMMUNOL, V157, P235, DOI 10.1111/j.1365-2249.2009.03967.x; Akhter Y, 2012, BIOCHIMIE, V94, P110, DOI 10.1016/j.biochi.2011.09.026; Amanna IJ, 2011, VIROLOGY, V411, P206, DOI 10.1016/j.virol.2010.12.016; Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Andersen P, 2005, MICROBES INFECT, V7, P911, DOI 10.1016/j.micinf.2005.03.013; Andersen P, 2007, NAT REV MICROBIOL, V5, P484, DOI 10.1038/nrmicro1703; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Behr MA, 2002, LANCET INFECT DIS, V2, P86, DOI 10.1016/S1473-3099(02)00182-2; Bentley SD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001552; Bertholet S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001094; Bhasin M, 2004, VACCINE, V22, P3195, DOI 10.1016/j.vaccine.2004.02.005; Bhasin M, 2007, J BIOSCIENCES, V32, P31, DOI 10.1007/s12038-007-0004-5; Bottai D, 2015, VACCINE, V33, P2710, DOI 10.1016/j.vaccine.2015.03.083; Caminero JA, 2010, LANCET INFECT DIS, V10, P621, DOI 10.1016/S1473-3099(10)70139-0; Champion PAD, 2007, CELL MICROBIOL, V9, P1376, DOI 10.1111/j.1462-5822.2007.00943.x; Chaudhuri Rupanjali, 2014, Syst Synth Biol, V8, P27, DOI 10.1007/s11693-014-9135-9; Collins DM, 2000, IMMUNOL CELL BIOL, V78, P342, DOI 10.1046/j.1440-1711.2000.00937.x; Dalton T, 2012, LANCET, V380, P1406, DOI 10.1016/S0140-6736(12)60734-X; Dhanda SK, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/263952; Dhanda SK, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-30; Doherty TM, 2007, EXPERT OPIN BIOL TH, V7, P1539, DOI 10.1517/14712598.7.10.1539; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; Elhay MJ, 1997, IMMUNOL CELL BIOL, V75, P595, DOI 10.1038/icb.1997.94; Foged C, 2011, THER DELIV, V2, P1057, DOI 10.4155/TDE.11.68; Forrellad MA, 2013, VIRULENCE, V4, P3, DOI 10.4161/viru.22329; Galagan JE, 2014, NAT REV GENET, V15, P307, DOI 10.1038/nrg3664; Ganguly N, 2008, TUBERCULOSIS, V88, P510, DOI 10.1016/j.tube.2008.05.002; Gunawardena HP, 2013, J PROTEOME RES, V12, P5463, DOI 10.1021/pr400334k; He YQ, 2014, NUCLEIC ACIDS RES, V42, pD1124, DOI 10.1093/nar/gkt1133; Jalapathy KV, 2004, FEMS IMMUNOL MED MIC, V40, P139, DOI 10.1016/S0928-8244(03)00303-1; Kalra M, 2007, CLIN IMMUNOL, V125, P173, DOI 10.1016/j.clim.2007.07.007; Kaufmann SHE, 2012, TRENDS IMMUNOL, V33, P373, DOI 10.1016/j.it.2012.03.004; McShane H, 2011, NAT MED, V17, P1185, DOI 10.1038/nm.2503; Mukai T, 2009, J IMMUNOL, V183, P6561, DOI 10.4049/jimmunol.0803857; MURRAY HW, 1994, AM J MED, V97, P459, DOI 10.1016/0002-9343(94)90326-3; Okkels LM, 2003, INFECT IMMUN, V71, P6116, DOI 10.1128/IAI.71.11.6116-6123.2003; Olsen AW, 2004, INFECT IMMUN, V72, P6148, DOI 10.1128/IAI.72.10.6148-6150.2004; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ritz N, 2012, AM J RESP CRIT CARE, V185, P213, DOI 10.1164/rccm.201104-0714OC; Romano M, 2008, VACCINE, V26, P6053, DOI 10.1016/j.vaccine.2008.09.025; Rook GAW, 2005, VACCINE, V23, P2115, DOI 10.1016/j.vaccine.2005.01.069; Rowland R, 2011, EXPERT REV VACCINES, V10, P645, DOI [10.1586/ERV.11.28, 10.1586/erv.11.28]; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Simeone R, 2015, TUBERCULOSIS, V95, pS150, DOI 10.1016/j.tube.2015.02.019; Singh H, 2003, BIOINFORMATICS, V19, P1009, DOI 10.1093/bioinformatics/btg108; Singh H, 2001, BIOINFORMATICS, V17, P1236, DOI 10.1093/bioinformatics/17.12.1236; Singh H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062216; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; Wang JL, 2010, MOL BIOL REP, V37, P1793, DOI 10.1007/s11033-009-9613-4; WIKER HG, 1992, MICROBIOL REV, V56, P648, DOI 10.1128/MMBR.56.4.648-661.1992; Wong EB, 2013, TRENDS MICROBIOL, V21, P493, DOI 10.1016/j.tim.2013.05.002; Young DB, 2003, NAT MED, V9, P503, DOI 10.1038/nm868; Young SL, 2010, IMMUNOL CELL BIOL, V88, P651, DOI 10.1038/icb.2010.25; Zwerling A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001012	55	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153771	10.1371/journal.pone.0153771	http://dx.doi.org/10.1371/journal.pone.0153771			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096425	Green Submitted, Green Published, gold			2022-12-26	WOS:000374543600055
J	van Lier, A; McDonald, SA; Bouwknegt, M; Kretzschmar, ME; Havelaar, AH; Mangen, MJJ; Wallinga, J; de Melker, HE				van Lier, Alies; McDonald, Scott A.; Bouwknegt, Martijn; Kretzschmar, Mirjam E.; Havelaar, Arie H.; Mangen, Marie-Josee J.; Wallinga, Jacco; de Melker, Hester E.		EPI Grp	Disease Burden of 32 Infectious Diseases in the Netherlands, 2007-2011	PLOS ONE			English	Article							ADJUSTED LIFE YEARS; COMMUNITY-ACQUIRED PNEUMONIA; PUBLIC-HEALTH POLICY; LEGIONNAIRES-DISEASE; GLOBAL BURDEN; FUTURE BURDEN; HEPATITIS-B; EUROPE; PATHOGENS; PERTUSSIS	Background Infectious disease burden estimates provided by a composite health measure give a balanced view of the true impact of a disease on a population, allowing the relative impact of diseases that differ in severity and mortality to be monitored over time. This article presents the first national disease burden estimates for a comprehensive set of 32 infectious diseases in the Netherlands. Methods and Findings The average annual disease burden was computed for the period 2007-2011 for selected infectious diseases in the Netherlands using the disability-adjusted life years (DALY) measure. The pathogen-and incidence-based approach was adopted to quantify the burden due to both morbidity and premature mortality associated with all short and long-term consequences of infection. Natural history models, disease progression probabilities, disability weights, and other parameters were adapted from previous research. Annual incidence was obtained from statutory notification and other surveillance systems, which was corrected for under-ascertainment and under-reporting. The highest average annual disease burden was estimated for invasive pneumococcal disease (9444 DALYs/year; 95% uncertainty interval [UI]: 8911-9961) and influenza (8670 DALYs/year; 95% UI: 8468-8874), which represents 16% and 15% of the total burden of all 32 diseases, respectively. The remaining 30 diseases ranked by number of DALYs/year from high to low were: HIV infection, legionellosis, toxoplasmosis, chlamydia, campylobacteriosis, pertussis, tuberculosis, hepatitis C infection, Q fever, norovirus infection, salmonellosis, gonorrhoea, invasive meningococcal disease, hepatitis B infection, invasive Haemophilus influenzae infection, shigellosis, listeriosis, giardiasis, hepatitis A infection, infection with STEC O157, measles, cryptosporidiosis, syphilis, rabies, variant Creutzfeldt-Jakob disease, tetanus, mumps, rubella, diphtheria, and poliomyelitis. The very low burden for the latter five diseases can be attributed to the National Immunisation Programme. The average disease burden per individual varied from 0.2 (95% UI: 0.1-0.4) DALYs per 100 infections for giardiasis, to 5081 and 3581 (95% UI: 3540-3611) DALYs per 100 infections for rabies and variant Creutz-feldt-Jakob disease, respectively. Conclusions For guiding and supporting public health policy decisions regarding the prioritisation of interventions and preventive measures, estimates of disease burden and the comparison of burden between diseases can be informative. Although the collection of disease-specific parameters and estimation of incidence is a process subject to continuous improvement, the current study established a baseline for assessing the impact of future public health initiatives.	[van Lier, Alies; McDonald, Scott A.; Bouwknegt, Martijn; Kretzschmar, Mirjam E.; Mangen, Marie-Josee J.; Wallinga, Jacco; de Melker, Hester E.; EPI Grp] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands; [Kretzschmar, Mirjam E.; Mangen, Marie-Josee J.] UMCU, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Havelaar, Arie H.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA	Netherlands National Institute for Public Health & the Environment; Unilever; Utrecht University; Utrecht University Medical Center; State University System of Florida; University of Florida	McDonald, SA (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands.	scott.mcdonald@rivm.nl	Wallinga, Jacco/C-4382-2018; Siebert, Uwe/M-5057-2019; Havelaar, Arie H./P-8495-2014; Cassini, Alessandro/A-5122-2019; Ricciardi, Walter/K-3342-2018	Wallinga, Jacco/0000-0003-1725-5627; Siebert, Uwe/0000-0001-6425-7671; Havelaar, Arie H./0000-0002-6456-5460; Cassini, Alessandro/0000-0002-7973-6445; Colzani, Edoardo/0000-0001-8105-5027; de Wit, G. Ardine/0000-0002-1375-7657; Mangen, Marie-Josee J./0000-0001-8914-2045; Ricciardi, Walter/0000-0002-5655-688X; Franco, Elisabetta/0000-0002-1179-4411; Friesema, Ingrid/0000-0001-9943-0518; Kretzschmar, Mirjam/0000-0002-4394-7697	National Institute for Public Health and the Environment (RIVM); Pfizer; National Institute for Public Health and the Environment (RIVM); Pfizer	National Institute for Public Health and the Environment (RIVM); Pfizer(Pfizer); National Institute for Public Health and the Environment (RIVM); Pfizer(Pfizer)	This study was supported by the National Institute for Public Health and the Environment (RIVM). No additional funding has been acquired. M-JM's research funding is partially supported by grants provided to UMCU by Pfizer. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbink F, 2004, 210021001 RIVM; [Anonymous], EURO SURVEILL; Beaute J, 2013, EUROSURVEILLANCE, V18, P6; Beaute J, 2013, EUR RESPIR J, V42, P1454, DOI 10.1183/09031936.00089113; Beaute J, 2012, EMERG INFECT DIS, V18, P1811, DOI 10.3201/eid1811.120496; Begg S., 2007, BURDEN DIS INJURY AU; Bijkerk P, 2013, 150205001 RIVM; Bouwknegt M, 2013, INT J ENV RES PUB HE, V10, P2888, DOI 10.3390/ijerph10072888; Bradshaw D, 2003, SAMJ S AFR MED J, V93, P682; Brandsema PS, 2014, EPIDEMIOL INFECT, V142, P2360, DOI 10.1017/S0950268813003476; Braun J J, 2004, Ned Tijdschr Geneeskd, V148, P836; Bundhamcharoen K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-53; Cassini A, 2013, LANCET S2, V381, pS27; Crowcroft NS, 2002, ARCH DIS CHILD, V86, P336, DOI 10.1136/adc.86.5.336; de Wit GA, 2015, SEX TRANSM INFECT; Devleesschauwer B, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1196; Devleesschauwer B, 2014, INT J PUBLIC HEALTH, V59, P565, DOI 10.1007/s00038-014-0552-z; European Centre for Disease Prevention and Control, 2010, METH PROT EST BURD C; European Centre for Disease Prevention and Control (ECDC), 2011, CURR FUT BURD COMM D; European Centre for Disease Prevention and Control (ECDC)/WHO Regional Office for Europe, 2012, TUB SURV MON EUR 201; Evaluation team RIVM, 2010, 210261008 RIVM; Gibbons CL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-147; Gold MR, 2002, MED CARE, V40, P260, DOI 10.1097/00005650-200203000-00009; Gommer AM, 2010, VERLOREN LEVENSJAREN; Haagsma JA, 2009, 330331001 RIVM; Hahne S, 2005, EUROSURVEILLANCE, V10; Hahne S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067866; Havelaar AH, 2012, INT J FOOD MICROBIOL, V156, P231, DOI 10.1016/j.ijfoodmicro.2012.03.029; Jankovic S, 2007, EUR J PUBLIC HEALTH, V17, P80, DOI 10.1093/eurpub/ckl072; Karagiannis I, 2009, EPIDEMIOL INFECT, V137, P181, DOI 10.1017/S095026880800099X; Knol MJ, 2013, EUROSURVEILLANCE, V18; Kramer MA, 2008, INFECTIEZIEKTENBULLE, V19, P161; Kretzschmar M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001205; Kwong JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044103; Lai T, 2009, EUR J PUBLIC HEALTH, V19, P541, DOI 10.1093/eurpub/ckp038; Lobue P, 2010, RESPIROLOGY, V15, P603, DOI 10.1111/j.1440-1843.2010.01751.x; Mangen MJJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079740; Mangen MJJ, 2014, 210474001 RIVM; Mathers CD, 2001, B WORLD HEALTH ORGAN, V79, P1076; McDonald SA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1046; McKenna MT, 2005, AM J PREV MED, V28, P415, DOI 10.1016/j.amepre.2005.02.009; Melse JM, 1998, 431501028 RIVM; Mokdad AH, 2014, LANCET, V383, P309, DOI 10.1016/S0140-6736(13)62189-3; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Murray CJ, 1996, GLOBAL BURDEN DIS; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P495; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; Naghavi M, 2003, POPUL HEALTH METR, V7, P9, DOI DOI 10.1186/1478-7954-7-9; Plass D, 2014, EPIDEMIOL INFECT, V142, P2024, DOI 10.1017/S0950268813003312; Plass D, 2014, DTSCH ARZTEBL INT, V111, P629, DOI 10.3238/arztebl.2014.0629; Public Health Group, 2005, VICT BURD DIS STUD M; Rahamat-Langendoen J, 2006, 210211003 RIVM; Schmid BV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058674; Schneeberger PM, 2004, SCAND J INFECT DIS, V36, P269, DOI 10.1080/00365540410020127; Slump E, 2012, TUBERCULOSE IN NEDER; Soetens LC, 2013, 150002003 RIVM; Statistics Netherlands (CBS), 2007, DEATHS MAIN PRIM CAU; Stout JE, 1997, NEW ENGL J MED, V337, P682, DOI 10.1056/NEJM199709043371006; van den Hof S, 2001, EMERG INFECT DIS, V7, P593; van den Hof S, 1998, 213676008 RIVM; van den Wijngaard CC, EUR J PUBLIC H UNPUB; van der Hoek W, 2012, EUROSURVEILLANCE, V17, P11; van der Maas NAT, 2013, VACCINE, V31, P4541, DOI 10.1016/j.vaccine.2013.07.060; van Deursen AMM, 2012, EMERG INFECT DIS, V18, P1729, DOI 10.3201/eid1811.120329; van Lier A, 2014, STATE INFECT DIS NET; van Lier E Alies, 2009, Ned Tijdschr Geneeskd, V153, P950; von Baum H, 2008, CLIN INFECT DIS, V46, P1356, DOI 10.1086/586741; Vose D., 2008, RISK ANAL QUANTITATI; Wiersinga WJ, 2011, DUTCH GUIDELINES ON; World Health Organization, 2008, GLOB BURD DIS 2004 U	71	52	53	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153106	10.1371/journal.pone.0153106	http://dx.doi.org/10.1371/journal.pone.0153106			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097024	Green Published, Green Submitted, gold			2022-12-26	WOS:000374543600027
J	Valdovinos-Flores, C; Gaspar-Ramirez, O; Heras-Ramirez, ME; Lara-Alvarez, C; Dorantes-Ugalde, JA; Saldana-Loza, LM				Valdovinos-Flores, Cesar; Gaspar-Ramirez, Octavio; Elena Heras-Ramirez, Maria; Lara-Alvarez, Carlos; Antonio Dorantes-Ugalde, Jose; Maria Saldana-Loza, Luz			Boron and Coumaphos Residues in Hive Materials Following Treatments for the Control of Aethina tumida Murray	PLOS ONE			English	Article							COLEOPTERA; BEETLE; FOODS	In the search of alternatives for controlling Aethina tumida Murray, we recently proposed the BAA trap which uses boric acid and an attractant which mimics the process of fermentation caused by Kodamaea ohmeri in the hive. This yeast is excreted in the feces of A. tumida causing the fermentation of pollen and honey of infested hives and releasing compounds that function as aggregation pheromones to A. tumida. Since the boron is the toxic element in boric acid, the aim of this article is to assess the amount of boron residues in honey and beeswax from hives treated with the BAA trap. For this aim, the amount of bioaccumulated boron in products of untreated hives was first determined and then compared with the amount of boron of products from hives treated with the BAA trap in two distinct climatic and soil conditions. The study was conducted in the cities of Padilla, Tamaulipas, and Valladolid, Yucatan (Mexico) from August 2014 to March 2015. The quantity of boron in honey was significantly less in Yucatan than in Tamaulipas; this agrees with the boron deficiency among Luvisol and Leptosol soils found in Yucatan compared to the Vertisol soil found in Tamaulipas. In fact, the honey from Yucatan has lower boron levels than those reported in the literature. The BAA treatment was applied for four months, results show that the BAA trap does not have any residual effect in either honey or wax; i.e., there is no significant difference in boron content before and after treatment. On the other hand, the organophosphate pesticide coumaphos was found in 100% of wax samples and in 64% of honey samples collected from Yucatan. The concentration of coumaphos in honey ranges from 0.005 to 0.040 mg/kg, which are below Maximum Residue Limit (MRL) allowed in the European Union (0.1 mg/kg) but 7.14% of samples exceeded the MRL allowed in Canada (0.02 mg/kg).	[Valdovinos-Flores, Cesar] Univ Nacl Autonoma Mexico, Dept Med Genom & Toxicol Ambiental, Inst Invest Biomed, Mexico City 04510, DF, Mexico; [Gaspar-Ramirez, Octavio; Elena Heras-Ramirez, Maria] Ctr Invest & Asistencia Tecnol & Diseno Estado Ja, Unidad Noroeste Apodaca, Nuevo Leon, Mexico; [Lara-Alvarez, Carlos] Ctr Invest Matemat, Unidad Zacatecas, Zacatecas, Mexico; [Antonio Dorantes-Ugalde, Jose; Maria Saldana-Loza, Luz] Serv Apicolas Queretaro, Queretaro, Mexico	Universidad Nacional Autonoma de Mexico	Lara-Alvarez, C (corresponding author), Ctr Invest Matemat, Unidad Zacatecas, Zacatecas, Mexico.	carlos.lara@cimat.mx	Lara-Alvarez, Carlos A/I-2214-2017; Lara-Alvarez, Carlos/AAC-1374-2019	Lara-Alvarez, Carlos A/0000-0001-7856-7398; Lara-Alvarez, Carlos/0000-0001-7856-7398; Valdovinos-Flores, Cesar/0000-0002-8153-5394	Secretaria de Agriculture, Ganaderia, Desarrollo Rural, Pesca y Alimentacion, Mexico (SAGARPA); Consejo Nacional de Ciencia y Tecnologia, Mexico (CONACYT) [CATEDRAS-3163]	Secretaria de Agriculture, Ganaderia, Desarrollo Rural, Pesca y Alimentacion, Mexico (SAGARPA); Consejo Nacional de Ciencia y Tecnologia, Mexico (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Funding was received from Secretaria de Agriculture, Ganaderia, Desarrollo Rural, Pesca y Alimentacion, Mexico (SAGARPA). The work was partially supported by grant CATEDRAS-3163 from Consejo Nacional de Ciencia y Tecnologia, Mexico (CONACYT), http://www.conacyt.mx (to CLA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency CPMR, 2009, EMRL200918 AG CPMR P; ALCANTARA EA, 2007, SOIL FERTILITY CALCA; Anderson David L., 1994, Journal of Food Composition and Analysis, V7, P59, DOI 10.1006/jfca.1994.1006; [Anonymous], 2014, NOM000SAGZOO2014; Berry JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076536; Buchholz S, 2008, J APICULT RES, V47, P202, DOI 10.1080/00218839.2008.11101460; CHENG C, 1993, DEV PLANT SOIL SCI, V45, P405; CICOPLAFEST, 2004, CAT OF PLAG; Eischen FA, 1999, AM BEE J US; EPA (Environmental Protection Agency), 2008, 815R08012 EPA; EPA (Environmental Protection Agency), 2007, COUM HUM HLTH RISK A; Gobierno del Estado de Tamaulipas, 2011, ATL RIEG MUN GUEM HI; Haarmann T, 2002, J ECON ENTOMOL, V95, P28, DOI 10.1603/0022-0493-95.1.28; Harari R, 2010, ENVIRON HEALTH PERSP, V118, P890, DOI 10.1289/ehp.0901582; Hood WMM, 2004, BEE WORLD, V85, P51, DOI 10.1080/0005772X.2004.11099624; HUNT CD, 1991, J AM DIET ASSOC, V91, P558; INEGI, 2009, PRONT INF GEOGR MUN; Kamel F, 2004, ENVIRON HEALTH PERSP, V112, P950, DOI 10.1289/ehp.7135; Karazafiris E, 2008, PEST MANAG SCI, V64, P165, DOI 10.1002/ps.1493; Lehotay SJ, 2007, J AOAC INT, V90, P485; Lloyd J. E., 2002, AM BEETLES VOLUME 2, P187; Mutinelli F, 2014, J APICULT RES, V53, P569, DOI 10.3896/IBRA.1.53.5.13; Nastassiades M, 2002, 18 ANN WAST TEST QUA, P231; Neumann P, 2004, APIDOLOGIE, V35, P229, DOI 10.1051/apido:2004010; Neumann P, 2008, J APICULT RES, V47, P181, DOI 10.1080/00218839.2008.11101453; Norma Oficial Mexicana, 1995, NOM117SSA11994; Reyes-Escobar O, 2015, J APICULT RES, V54, P226, DOI 10.1080/00218839.2015.1137704; Saldana L.M, 2014, MANUAL NUEVOS MANEJO; SERA, 2006, HUM HLTH EC RISK ASS; SIACON (Sistema de Informacin Agroalimentaria de Consulta), 2010, BAS DAT ACT AGR PEC; Siede R, 2013, J APPL ENTOMOL, V137, P661, DOI 10.1111/jen.12048; Spiewok S, 2006, J APICULT RES, V45, P47, DOI 10.1080/00218839.2006.11101313; Torto B, 2007, P NATL ACAD SCI USA, V104, P8374, DOI 10.1073/pnas.0702813104; Zhu WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0077547	34	11	11	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153551	10.1371/journal.pone.0153551	http://dx.doi.org/10.1371/journal.pone.0153551			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27092938	Green Submitted, Green Published, gold			2022-12-26	WOS:000374541200028
J	Hames, SC; Ardigo, M; Soyer, HP; Bradley, AP; Prow, TW				Hames, Samuel C.; Ardigo, Marco; Soyer, H. Peter; Bradley, Andrew P.; Prow, Tarl W.			Automated Segmentation of Skin Strata in Reflectance Confocal Microscopy Depth Stacks	PLOS ONE			English	Article								Reflectance confocal microscopy (RCM) is a powerful tool for in-vivo examination of a variety of skin diseases. However, current use of RCM depends on qualitative examination by a human expert to look for specific features in the different strata of the skin. Developing approaches to quantify features in RCM imagery requires an automated understanding of what anatomical strata is present in a given en-face section. This work presents an automated approach using a bag of features approach to represent en-face sections and a logistic regression classifier to classify sections into one of four classes (stratum corneum, viable epidermis, dermal-epidermal junction and papillary dermis). This approach was developed and tested using a dataset of 308 depth stacks from 54 volunteers in two age groups (2030 and 50-70 years of age). The classification accuracy on the test set was 85.6%. The mean absolute error in determining the interface depth for each of the stratum corneum/viable epidermis, viable epidermis/dermal-epidermal junction and dermal-epidermal junction/papillary dermis interfaces were 3.1 mu m, 6.0 mu m and 5.5 mu m respectively. The probabilities predicted by the classifier in the test set showed that the classifier learned an effective model of the anatomy of human skin.	[Hames, Samuel C.; Soyer, H. Peter; Prow, Tarl W.] Univ Queensland, Sch Med, Dermatol Res Ctr, Translat Res Inst, Brisbane, Qld, Australia; [Ardigo, Marco] San Gallicano Dermatol Inst IRCCS, Rome, Italy; [Bradley, Andrew P.] Univ Queensland, Sch Informat Technol & Elect Engn, Brisbane, Qld, Australia	University of Queensland; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); University of Queensland	Prow, TW (corresponding author), Univ Queensland, Sch Med, Dermatol Res Ctr, Translat Res Inst, Brisbane, Qld, Australia.	t.prow@uq.edu.au	Bradley, Andrew P./C-5685-2009; Ardigo, Marco/E-5741-2018; Bradley, Andrew P./O-8516-2019; Soyer, H. Peter/W-3791-2017; Soyer, H. Peter/E-6000-2010; Prow, Tarl/AAB-8359-2019; Prow, Tarl W/A-4764-2010	Bradley, Andrew P./0000-0003-0109-6844; Ardigo, Marco/0000-0002-5772-4937; Bradley, Andrew P./0000-0003-0109-6844; Soyer, H. Peter/0000-0002-4770-561X; Soyer, H. Peter/0000-0002-4770-561X; Prow, Tarl/0000-0003-2892-6238; Prow, Tarl W/0000-0003-2892-6238	Cancer Council Queensland [APP1058641]	Cancer Council Queensland(Cancer Council Queensland)	This work was supported by Cancer Council Queensland (www.cancerqld.org.au) through grant APP1058641. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avni U, 2011, IEEE T MED IMAGING, V30, P733, DOI 10.1109/TMI.2010.2095026; Caicedo JC, 2009, LECT NOTES ARTIF INT, V5651, P126, DOI 10.1007/978-3-642-02976-9_17; Coates Adam, 2012, Neural Networks: Tricks of the Trade. Second Edition: LNCS 7700, P561, DOI 10.1007/978-3-642-35289-8_30; Dhillon IS, 2001, MACH LEARN, V42, P143, DOI 10.1023/A:1007612920971; Fulkerson B, 2008, LECT NOTES COMPUT SC, V5302, P179, DOI 10.1007/978-3-540-88682-2_15; Gareau D, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3552639; Gareau D, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3524301; Gerger A, 2005, J INVEST DERMATOL, V124, P493, DOI 10.1111/j.0022-202X.2004.23569.x; Guitera P, 2012, J INVEST DERMATOL, V132, P2386, DOI 10.1038/jid.2012.172; Hames S, DRYAD DIGITAL REPOSI, DOI [10.5061/dryad.rg58m, DOI 10.5061/DRYAD.RG58M]; Hames S, 2015, DIG IM COMP IN PRESS; Hyvarinen A., 2009, NATURAL IMAGE STAT P; Koller S, 2011, J EUR ACAD DERMATOL, V25, P554, DOI 10.1111/j.1468-3083.2010.03834.x; Koller S, 2009, EXP DERMATOL, V18, P536, DOI 10.1111/j.1600-0625.2008.00822.x; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Kurugol S, 2015, J INVEST DERMATOL, V135, P710, DOI 10.1038/jid.2014.379; Nguyen MH, 2009, IEEE I CONF COMP VIS, P1925, DOI 10.1109/ICCV.2009.5459426; Ng A. Y., 2004, P 21 INT C MACH LEAR, DOI [10.1145/1015330.1015435, DOI 10.1145/1015330.1015435]; Nister D., 2006, IEEE COMP SOC C COMP, P2161, DOI DOI 10.1109/CVPR.2006.264; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Puig S, 2012, REFLECTANCE CONFOCAL, P23; RAJADHYAKSHA M, 1995, J INVEST DERMATOL, V104, P946, DOI 10.1111/1523-1747.ep12606215; Raphael AP, 2013, EXP DERMATOL, V22, P458, DOI 10.1111/exd.12176; Somoza E, 2014, LECT NOTES COMPUT SC, V8815, P141, DOI 10.1007/978-3-319-11755-3_16; Tamaki T, 2013, MED IMAGE ANAL, V17, P78, DOI 10.1016/j.media.2012.08.003; Wurm EMT, 2012, BRIT J DERMATOL, V167, P270, DOI 10.1111/j.1365-2133.2012.10943.x	26	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153208	10.1371/journal.pone.0153208	http://dx.doi.org/10.1371/journal.pone.0153208			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088865	Green Submitted, Green Published, gold			2022-12-26	WOS:000374527000013
J	Krishna, KH; Vadlamudi, Y; Kumar, MS				Krishna, K. Hari; Vadlamudi, Yallamandayya; Kumar, Muthuvel Suresh			Viral Evolved Inhibition Mechanism of the RNA Dependent Protein Kinase PKR's Kinase Domain, a Structural Perspective	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; HUMAN-IMMUNODEFICIENCY-VIRUS; MOLECULAR-DYNAMICS; ENERGY LANDSCAPES; ANTIRETROVIRAL THERAPY; SUBSTRATE RECOGNITION; HIGH-THROUGHPUT; WEB SERVER; ACTIVATION; EIF2-ALPHA	The protein kinase PKR activated by viral dsRNA, phosphorylates the eIF2 alpha, which inhibit the mechanism of translation initiation. Viral evolved proteins mimicking the eIF2 alpha block its phosphorylation and help in the viral replication. To decipher the molecular basis for the PKR's substrate and inhibitor interaction mechanisms, we carried the molecular dynamics studies on the catalytic domain of PKR in complex with substrate eIF2 alpha a, and inhibitors TAT and K3L. The studies conducted show the altered domain movements of N lobe, which confers open and close state to the substrate-binding cavity. In addition, PKR exhibits variations in the secondary structural transition of the activation loop residues, and inter molecular contacts with the substrate and the inhibitors. Phosphorylation of the P+1 loop at the Thr-451 increases the affinity of the binding proteins exhibiting its role in the phosphorylation events. The implications of structural mechanisms uncovered will help to understand the basis of the evolution of the host-viral and the viral replication mechanisms.	[Krishna, K. Hari; Vadlamudi, Yallamandayya; Kumar, Muthuvel Suresh] Pondicherry Univ, Ctr Bioinformat, Pondicherry, India	Pondicherry University	Kumar, MS (corresponding author), Pondicherry Univ, Ctr Bioinformat, Pondicherry, India.	suresh.bic@pondiuni.edu.in		Hari Krishna, K/0000-0001-7037-7485; Hari Krishna, K/0000-0001-8676-2046				Alakent B, 2004, J CHEM PHYS, V121, P4759, DOI 10.1063/1.1778377; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Bakan A, 2011, BIOINFORMATICS, V27, P1575, DOI 10.1093/bioinformatics/btr168; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; Boehm M, 1998, SOLUTION ST IN PRESS; Brand SR, 1997, J BIOL CHEM, V272, P8388, DOI 10.1074/jbc.272.13.8388; Cai RR, 2000, ARCH BIOCHEM BIOPHYS, V373, P361, DOI 10.1006/abbi.1999.1583; Cheshire JL, 1999, J BIOL CHEM, V274, P4801, DOI 10.1074/jbc.274.8.4801; Clemens MJ, 2004, ONCOGENE, V23, P3180, DOI 10.1038/sj.onc.1207544; Cole JL, 2007, TRENDS BIOCHEM SCI, V32, P57, DOI 10.1016/j.tibs.2006.12.003; COX S, 1994, CURR OPIN STRUC BIOL, V4, P893, DOI 10.1016/0959-440X(94)90272-0; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; Dar AC, 2002, MOL CELL, V10, P295, DOI 10.1016/S1097-2765(02)00590-7; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Esterhuyse T, 1993, Nurs RSA, V8, P14; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Goh KC, 2000, EMBO J, V19, P4292, DOI 10.1093/emboj/19.16.4292; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2000, PHYS REV E, V62, P8438, DOI 10.1103/PhysRevE.62.8438; Hinnebusch AG, 2005, NAT STRUCT MOL BIOL, V12, P835, DOI 10.1038/nsmb1005-835; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HUNENBERGER PH, 1995, J MOL BIOL, V252, P492, DOI 10.1006/jmbi.1995.0514; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; ICHIYE T, 1991, PROTEINS, V11, P205, DOI 10.1002/prot.340110305; Ito T, 2004, STRUCTURE, V12, P1693, DOI 10.1016/j.str.2004.07.010; Johnson LN, 1998, FEBS LETT, V430, P1, DOI 10.1016/S0014-5793(98)00606-1; Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KawagishiKobayashi M, 1997, MOL CELL BIOL, V17, P4146, DOI 10.1128/MCB.17.7.4146; Kumari R, 2014, J CHEM INF MODEL, V54, P1951, DOI 10.1021/ci500020m; Li L, 2012, BMC BIOPHYS, V5, DOI 10.1186/2046-1682-5-9; Loo YM, 2007, CURR TOP MICROBIOL, V316, P295; Margreitter C, 2013, NUCLEIC ACIDS RES, V41, pW422, DOI 10.1093/nar/gkt416; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; MCMILLAN NAJ, 1995, VIROLOGY, V213, P413, DOI 10.1006/viro.1995.0014; MEURS E, 1990, CELL, V62, P379, DOI 10.1016/0092-8674(90)90374-N; Muehlberger N, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-34; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Petrov D, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003154; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; Romano PR, 1998, MOL CELL BIOL, V18, P2282, DOI 10.1128/MCB.18.4.2282; Sharp TV, 1997, EUR J BIOCHEM, V250, P85, DOI 10.1111/j.1432-1033.1997.00085.x; Tavernelli I, 2003, BIOPHYS J, V85, P2641, DOI 10.1016/S0006-3495(03)74687-6; Taylor SS, 2005, CELL, V122, P823, DOI 10.1016/j.cell.2005.09.007; Thein HH, 2008, AIDS, V22, P1979, DOI 10.1097/QAD.0b013e32830e6d51; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Wales DJ, 2005, PHYS BIOL, V2, pS86, DOI 10.1088/1478-3975/2/4/S02; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; Wriggers W, 1997, PROTEINS, V29, P1; Zhang F, 2001, J BIOL CHEM, V276, P24946, DOI 10.1074/jbc.M102108200	59	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153680	10.1371/journal.pone.0153680	http://dx.doi.org/10.1371/journal.pone.0153680			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088597	Green Submitted, gold, Green Published			2022-12-26	WOS:000374527000041
J	Yan, B; Yang, LM; Hao, LP; Yang, C; Quan, L; Wang, LH; Wu, Z; Li, XP; Gao, YT; Sun, Q; Yuan, JM				Yan, Bei; Yang, Li-Ming; Hao, Li-Peng; Yang, Chen; Quan, Lei; Wang, Li-Hong; Wu, Zheng; Li, Xiao-Pan; Gao, Yu-Tang; Sun, Qiao; Yuan, Jian-Min			Determinants of Quality of Life for Breast Cancer Patients in Shanghai, China	PLOS ONE			English	Article							LONG-TERM; SOCIAL SUPPORT; FUNCTIONAL ASSESSMENT; SURVIVORS; THERAPY; WOMEN; CHEMOTHERAPY; MEDICINE; POPULATION; DIAGNOSIS	Purpose To evaluate the association of social support status, health insurance and clinical factors with the quality of life of Chinese women with breast cancer. Methods Information on demographics, clinical characteristics, and social support status was collected from 1,160 women with newly diagnosed breast cancer in Shanghai, China. The Perceived Social Support Scale was used to assess different sources of social support for breast cancer patients. The quality of life was evaluated using the Functional Assessment of Cancer Therapy-Breast Cancer that consisted of five domains: breast cancer-specific, emotional, functional, physical, and social & family well-being. Multivariate linear regression models were used to evaluate the associations of demographic variables, clinical characteristics, and social support status with the quality of life measures. Results Adequate social support from family members, friends and neighbors, and higher scores of Perceived Social Support Scale were associated with significantly improved quality of life of breast cancer patients. Higher household income, medical insurance plans with low copayment, and treatment with traditional Chinese medicine for breast cancer all were associated with higher (better) scores of quality of life measures whereas patients receiving chemotherapy had significantly lower scores of quality of life. Conclusion Social support and financial aids may significantly improve the quality of life of breast cancer survivors.	[Yan, Bei; Yang, Li-Ming; Hao, Li-Peng; Yang, Chen; Wang, Li-Hong; Wu, Zheng; Li, Xiao-Pan; Sun, Qiao] Shanghai Pudong New Area Ctr Dis Control & Preven, Shanghai, Peoples R China; [Yan, Bei; Quan, Lei; Yuan, Jian-Min] Univ Pittsburgh, Inst Canc, Div Canc Control & Populat Sci, Pittsburgh, PA USA; [Quan, Lei] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou 510641, Guangdong, Peoples R China; [Gao, Yu-Tang] Shanghai Jiao Tong Univ, Dept Epidemiol, Shanghai Canc Inst, Renji Hosp, Shanghai 200030, Peoples R China; [Yuan, Jian-Min] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA	Shanghai Center for Disease Control & Prevention; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; South China University of Technology; Shanghai Jiao Tong University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sun, Q (corresponding author), Shanghai Pudong New Area Ctr Dis Control & Preven, Shanghai, Peoples R China.; Yuan, JM (corresponding author), Univ Pittsburgh, Inst Canc, Div Canc Control & Populat Sci, Pittsburgh, PA USA.; Yuan, JM (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA.	qsun@pdcdc.sh.cn; yuanj@upmc.edu	Quan, Lei/GXN-1280-2022; Gao, Y./GWZ-3665-2022; Gao, Yu/HGE-1937-2022; Li, xiaopan/X-5965-2019; gao, yi/HCI-8298-2022	Li, xiaopan/0000-0002-9625-478X; 	Young Medical Talents Training Program of the Pudong Health Bureau of Shanghai [PWRq2012-24]; National Cancer Institute of the National Institutes of Health [R01CA144034, UM1CA182876]; Pudong Health and Family Planning Commission of Shanghai Funding;  [PWZz2013-15]; NATIONAL CANCER INSTITUTE [UM1CA182876, R01CA144034] Funding Source: NIH RePORTER	Young Medical Talents Training Program of the Pudong Health Bureau of Shanghai; National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pudong Health and Family Planning Commission of Shanghai Funding; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by award number PWRq2012-24 of the Young Medical Talents Training Program of the Pudong Health Bureau of Shanghai (BY). Research reported in this publication was also partially supported by the National Cancer Institute of the National Institutes of Health under award numbers R01CA144034 and UM1CA182876 (J-MY). Grant number: PWZz2013-15. Funding agency: Pudong Health and Family Planning Commission of Shanghai Funding to QS.	Ahles TA, 2005, J CLIN ONCOL, V23, P4399, DOI 10.1200/JCO.2005.03.343; Al-Naggar RA, 2011, ASIAN PAC J CANCER P, V12, P2335; Allemani C, 2014, LANCET, DOI S0140-6736(14)62038-9; [Anonymous], 1996, J CLIN ONCOL, V14, P671; Ashing-Giwa K, 1999, CANCER, V85, P418, DOI 10.1002/(SICI)1097-0142(19990115)85:2<418::AID-CNCR20>3.0.CO;2-9; Baker F, 2005, CANCER, V104, P2565, DOI 10.1002/cncr.21488; Bloom JR, 2007, PSYCHO-ONCOLOGY, V16, P691, DOI 10.1002/pon.1208; Bloom JR, 2004, PSYCHO-ONCOL, V13, P147, DOI 10.1002/pon.794; Brady MJ, 1997, J CLIN ONCOL, V15, P974, DOI 10.1200/JCO.1997.15.3.974; Broeckel JA, 2000, BREAST CANCER RES TR, V62, P141, DOI 10.1023/A:1006401914682; Cancer IAFRO, 2012, GLOBOCAN 2012 EST CA; Carlsson M, 1996, QUAL LIFE RES, V5, P265, DOI 10.1007/BF00434748; Casso D, 2004, HEALTH QUAL LIFE OUT, V2, P1; CELLA DF, 1994, J PAIN SYMPTOM MANAG, V9, P186, DOI 10.1016/0885-3924(94)90129-5; Cella DF, 1993, J CLIN ONCOL, V11, P5709; Costanzo ES, 2007, BRIT J CANCER, V97, P1625, DOI 10.1038/sj.bjc.6604091; Ediebah DE, 2014, BRIT J CANCER, V110, P2427, DOI 10.1038/bjc.2014.208; Fang QY, 2012, CHIN J SOCIAL MED, V295, P333; Ferrell BR, 1997, CANCER NURS, V20, P398, DOI 10.1097/00002820-199712000-00003; Ferrell BR, 1998, CANCER NURS, V21, P1, DOI 10.1097/00002820-199802000-00001; Ganz PA, 2002, JNCI-J NATL CANCER I, V94, P39; Ganz PA, 2003, J CLIN ONCOL, V21, P4184, DOI 10.1200/JCO.2003.04.196; Kroenke CH, 2013, BREAST CANCER RES TR, V139, P515, DOI 10.1007/s10549-013-2477-2; Kwan ML, 2010, BREAST CANCER RES TR, V123, P507, DOI 10.1007/s10549-010-0764-8; Lee H L, 2001, J Nurs Res, V9, P57; Lee YW, 2014, CANCER-AM CANCER SOC, V120, P1338, DOI 10.1002/cncr.28579; Liang WJ, 2011, CHIN MATERNAL CHILD, V26, P1472; Lo LC, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-232; Lu W, 2009, BREAST CANCER RES TR, V114, P357, DOI 10.1007/s10549-008-0008-3; Manning-Walsh J, 2005, JOGNN-J OBST GYN NEO, V34, P482, DOI 10.1177/0884217505278310; Movsas B, 2003, SEMIN RADIAT ONCOL, V13, P235, DOI 10.1016/S1053-4296(03)00029-8; Parkin DM, 2005, CANC INCIDENCE 5 CON, VI-VIII; Peuckmann V, 2007, BREAST CANCER RES TR, V104, P39, DOI 10.1007/s10549-006-9386-6; [裘佳佳 QIU Jia-jia], 2010, [中华护理杂志, Chinese Journal of Nursing], V45, P47; Quinten C, 2014, CANCER-AM CANCER SOC, V120, P302, DOI 10.1002/cncr.28382; Ng R, 2012, BREAST CANCER RES TR, V131, P619, DOI 10.1007/s10549-011-1764-z; Schou I, 2005, QUAL LIFE RES, V14, P1813, DOI 10.1007/s11136-005-4344-z; Sharma A, 2013, INT J SURG ONCOL, V2013, DOI 10.1155/2013/269510; Shimozuma Kojiro, 2002, Breast Cancer, V9, P100, DOI 10.1007/BF02967573; Trejo-Ochoa Jose Luis, 2013, Ginecol Obstet Mex, V81, P510; Xiao CH, 2005, NANFANG J NURS, V12, P80, DOI DOI 10.3969/J.ISSN.1008-9969.2005.05.038; Xu L, 2007, INTEGR CANCER THER, V6, P208, DOI 10.1177/1534735407305705; Yan YL, 2012, CHIN HLTH EC, V31, P30; You J, 2014, SUPPORT CARE CANCER, V22, P697, DOI 10.1007/s00520-013-2024-z; ZIMET GD, 1990, J PERS ASSESS, V55, P610, DOI 10.1207/s15327752jpa5503&4_17	45	50	53	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153714	10.1371/journal.pone.0153714	http://dx.doi.org/10.1371/journal.pone.0153714			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ6AH	27082440	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000374291800048
J	Reis, JGC; Reis, CSM; da Costa, DCS; Lucena, MM; Schubach, AD; Oliveira, RDC; Rolla, VC; Conceicao-Silva, F; Valete-Rosalino, CM				Correa Reis, Joao Gustavo; Mota Reis, Clarissa Souza; Silva da Costa, Daniel Cesar; Lucena, Marcia Mendonca; Schubach, Armando de Oliveira; Carvalhaes Oliveira, Raquel de Vasconcellos; Rolla, Valeria Cavalcanti; Conceicao-Silva, Fatima; Valete-Rosalino, Claudia Maria			Factors Associated with Clinical and Topographical Features of Laryngeal Tuberculosis	PLOS ONE			English	Article							LARYNGITIS	Introduction Laryngeal tuberculosis (LTB) is the most frequent granulomatous disease of the larynx and represents less than 2% of extrapulmonary TB cases. There are no pathognomonic clinical and endoscopic features of this disease and studies on LTB that can assist in its diagnostic characterization are lacking. Objective To identify factors associated with clinical and topographical features of LTB. Method a retrospective cross-sectional study was conducted from the medical records of 36 patients with confirmed LTB diagnosis. Results Dysphonia and cough were the main symptoms presented by patients and the true vocal folds the most frequently affected site. The average of the duration of the disease evolution was significantly higher in patients with dysphonia than in patients without this symptom. We observed association between dysphonia and true vocal fold lesions and between odynophagia and lesions in the epiglottis, arytenoids and aryepiglottic folds. Odynophagia was more frequent in individuals with lesions in four or more laryngeal sites. Weight loss equal or above 10% of the body weight was more frequent in patients with odynophagia as first symptom and in patients with ulcerated lesion. Dyspnea on exertion was more frequent in individuals with more extensive laryngeal lesions. The percentage of smokers with lesions in four or more laryngeal sites was greater than that found in non-smokers. Laryngeal tissue fragment bacilloscopy and culture examinations were less positive than sputum ones. Conclusions Smoking appears to be associated with the development of more extensive LTB lesions, and LTB with dyspnea on exertion and odynophagia with consequent impairment of nutritional status. We emphasize the need for histopathologic confirmation, once positive sputum bacteriological examinations seem not to necessarily reflect laryngeal involvement.	[Correa Reis, Joao Gustavo; Mota Reis, Clarissa Souza; Silva da Costa, Daniel Cesar; Lucena, Marcia Mendonca; Schubach, Armando de Oliveira; Carvalhaes Oliveira, Raquel de Vasconcellos; Rolla, Valeria Cavalcanti; Valete-Rosalino, Claudia Maria] Oswaldo Cruz Fdn FIOCRUZ, Evandro Chagas Natl Inst Infect Dis INI, Rio De Janeiro, RJ, Brazil; [Correa Reis, Joao Gustavo; Silva da Costa, Daniel Cesar; Conceicao-Silva, Fatima] Oswaldo Cruz Fdn FIOCRUZ, Lab Immunoparasitol, Rio De Janeiro, RJ, Brazil; [Correa Reis, Joao Gustavo] Bonsucesso Fed Hosp, Dept Bronchoesophagolaryngol & Head & Neck Surg, Rio De Janeiro, RJ, Brazil; [Lucena, Marcia Mendonca; Valete-Rosalino, Claudia Maria] Univ Fed Rio de Janeiro, Fac Med, Dept Otorhinolaryngol & Ophthalmol, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	Valete-Rosalino, CM (corresponding author), Oswaldo Cruz Fdn FIOCRUZ, Evandro Chagas Natl Inst Infect Dis INI, Rio De Janeiro, RJ, Brazil.; Conceicao-Silva, F (corresponding author), Oswaldo Cruz Fdn FIOCRUZ, Lab Immunoparasitol, Rio De Janeiro, RJ, Brazil.; Valete-Rosalino, CM (corresponding author), Univ Fed Rio de Janeiro, Fac Med, Dept Otorhinolaryngol & Ophthalmol, Rio De Janeiro, Brazil.	fconcei@ioc.fiocruz.br; claudia.valete@ini.fiocruz.br	Valete-Rosalino, Cláudia Maria/AAR-4293-2021; Rolla, Valeria Cavalcanti/AAI-6078-2021; Oliveira, Raquel de V C de/S-7443-2016	Rolla, Valeria Cavalcanti/0000-0002-0841-1408; Oliveira, Raquel de V C de/0000-0001-9387-8645	National Scientific and Technological Development Board -CNPq-Proep-IOC [402557/2011-5]; Research Support Foundation of the State of Rio de Janeiro-FAPERJ [E26/111.230/2014]; Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State (FAPERJ), Brazil [PAEF/IOC- Codigo IOC-008-FIO-15-47, E-26/102.183/2013, E-26/111.717/2012]; CNPq, Brazil; FAPERJ, Brazil; FAPERJ	National Scientific and Technological Development Board -CNPq-Proep-IOC; Research Support Foundation of the State of Rio de Janeiro-FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State (FAPERJ), Brazil(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ, Brazil(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by the National Scientific and Technological Development Board -CNPq-Proep-IOC (402557/2011-5); Research Support Foundation of the State of Rio de Janeiro-FAPERJ (E26/111.230/2014); Projeto PAEF/IOC- Codigo IOC-008-FIO-15-47: Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State (FAPERJ) (E-26/102.183/2013; E-26/111.717/2012), Brazil. AOS is the recipient of fellowships from CNPq and FAPERJ, Brazil. CMVR is the recipient of fellowships from FAPERJ. The funders had no role in study design data collection and analysis, decision to publish, or preparing the manuscript.; National Scientific and Technological Development Board -CNPq-Proep-IOC (402557/2011-5); Research Support Foundation of the State of Rio de Janeiro-FAPERJ (E26/111.230/2014); Projeto PAEF/IOC- Codigo IOC-008-FIO-15-47. Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State (FAPERJ) (E-26/102.183/2013; E-26/111.717/2012), Brazil. AOS is the recipient of fellowships from CNPq and FAPERJ, Brazil. CMVR is the recipient of fellowships from FAPERJ. The funders had no role in study design data collection and analysis, decision to publish, or preparing the manuscript.	Agarwal P, 1998, J LARYNGOL OTOL, V112, P45, DOI 10.1017/S0022215100139878; BAILEY CM, 1981, LARYNGOSCOPE, V91, P93; Barbosa de S A Leonardo Conrado, 2007, Braz J Otorhinolaryngol, V73, P862, DOI 10.1016/S1808-8694(15)31188-5; Bhat VK, 2009, AM J OTOLARYNG, V30, P327, DOI 10.1016/j.amjoto.2008.07.005; Brasil, 2014, B EP CONTR TUB BRAS; COULDERY AD, 1990, J LARYNGOL OTOL, V104, P255, DOI 10.1017/S0022215100112423; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; GALIETTI F, 1989, EUR RESPIR J, V2, P731; Gandhi S, 2012, INDIAN J OTOLARYNGOL, V64, P244, DOI 10.1007/s12070-011-0333-4; Garcia Roberta I. D., 2004, Rev. Bras. Otorrinolaringol., V70, P255, DOI 10.1590/S0034-72992004000200017; Hasibi Mehrdad, 2013, Acta Med Iran, V51, P638; Kandiloros DC, 1997, J LARYNGOL OTOL, V111, P619, DOI 10.1017/S0022215100138137; LEVENSON MJ, 1984, LARYNGOSCOPE, V94, P1094; Lim JY, 2006, EUR ARCH OTO-RHINO-L, V263, P838, DOI 10.1007/s00405-006-0063-5; Ling L, 2010, INT J INFECT DIS, V14, pE230, DOI 10.1016/j.ijid.2009.05.002; Loehrl TA, 2001, AM J MED, V111, P113, DOI 10.1016/S0002-9343(01)00856-7; Lucena MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126876; Ministerio da Saude (BR), 2008, MAN NAC VIG LAB TUB; Ministerio da Saude Secretaria de Vigilancia^ em Saude Programa Nacional de Controle da Tuberculose, 2013, MAN REC TUB, P288; Morales Puebla J M, 2006, An Otorrinolaringol Ibero Am, V33, P591; Nalini B, 2006, AM J OTOLARYNG, V27, P39, DOI 10.1016/j.amjoto.2005.07.005; Nishiike S, 2002, ANN OTO RHINOL LARYN, V111, P916, DOI 10.1177/000348940211101010; Oliveira AGL, 2013, ACTA TROP, V128, P36, DOI 10.1016/j.actatropica.2013.06.005; Porras Alonso E, 2002, Rev Laryngol Otol Rhinol (Bord), V123, P47; Prasad KC, 2007, J LARYNGOL OTOL, V121, P979, DOI 10.1017/S0022215107006913; RAMADAN HH, 1993, J OTOLARYNGOL, V22, P39; Ricciardiello F, 2006, Acta Otorhinolaryngol Ital, V26, P38; Rizzo Paolo Boscolo, 2003, International Journal of Infectious Diseases, V7, P129, DOI 10.1016/S1201-9712(03)90008-7; Sataloff RT, 2007, OTOLARYNG CLIN N AM, V40, P909, DOI 10.1016/j.otc.2007.05.002; Shin JE, 2000, LARYNGOSCOPE, V110, P1950, DOI 10.1097/00005537-200011000-00034; da Costa DCS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109790; Silva L, 2008, EUR ARCH OTO-RHINO-L, V265, P675, DOI 10.1007/s00405-007-0533-4; SODA A, 1989, LARYNGOSCOPE, V99, P1147; Topak M, 2008, EUR ARCH OTO-RHINO-L, V265, P327, DOI 10.1007/s00405-007-0459-x; Wang CC, 2007, OTOLARYNG HEAD NECK, V137, P582, DOI 10.1016/j.otohns.2007.04.002; WHO, 2013, QUEST ANSW 2013 REV; WHO, 2015, TUBERCULOSIS; World Health Organization, 2007, UN MON TB TOB CONTR	38	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153450	10.1371/journal.pone.0153450	http://dx.doi.org/10.1371/journal.pone.0153450			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077734	gold, Green Published, Green Submitted			2022-12-26	WOS:000374131700055
J	Groschel, M; Gotze, R; Muller, S; Ernst, A; Basta, D				Groeschel, Moritz; Goetze, Romy; Mueller, Susanne; Ernst, Arne; Basta, Dietmar			Central Nervous Activity upon Systemic Salicylate Application in Animals with Kanamycin-Induced Hearing Loss - A Manganese-Enhanced MRI (MEMRI) Study	PLOS ONE			English	Article							RAT INFERIOR COLLICULUS; GUINEA-PIG COCHLEA; PRIMARY AUDITORY-CORTEX; OUTER HAIR-CELLS; NOISE-INDUCED HYPERACTIVITY; ANTI-INFLAMMATORY DRUGS; RESONANCE-IMAGING MEMRI; NEURAL ACTIVITY; INDUCED TINNITUS; BEHAVIORAL PARADIGM	This study investigated the effect of systemic salicylate on central auditory and non-auditory structures in mice. Since cochlear hair cells are known to be one major target of salicylate, cochlear effects were reduced by using kanamycin to remove or impair hair cells. Neuronal brain activity was measured using the non-invasive manganese-enhanced magnetic resonance imaging technique. For all brain structures investigated, calcium-related neuronal activity was increased following systemic application of a sodium salicylate solution: probably due to neuronal hyperactivity. In addition, it was shown that the central effect of salicylate was not limited to the auditory system. A general alteration of calcium-related activity was indicated by an increase in manganese accumulation in the preoptic area of the anterior hypothalamus, as well as in the amygdala. The present data suggest that salicylate-induced activity changes in the auditory system differ from those shown in studies of noise trauma. Since salicylate action is reversible, central pharmacological effects of salicylate compared to those of (permanent) noise-induced hearing impairment and tinnitus might induce different pathophysiologies. These should therefore, be treated as different causes with the same symptoms.	[Groeschel, Moritz; Goetze, Romy; Ernst, Arne; Basta, Dietmar] Charite, Unfallkrankenhaus Berlin, Dept Otolaryngol, Berlin, Germany; [Mueller, Susanne] Charite, Neurosci Res Ctr NWFZ, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Basta, D (corresponding author), Charite, Unfallkrankenhaus Berlin, Dept Otolaryngol, Berlin, Germany.	dietmar.basta@rz.hu-berlin.de		Mueller, Susanne/0000-0002-5053-2211				BANNWARTH B, 1989, BIOMED PHARMACOTHER, V43, P121, DOI 10.1016/0753-3322(89)90140-6; Basta D, 2004, NEUROSCI RES, V50, P237, DOI 10.1016/j.neures.2004.07.003; Basta D, 2008, HEARING RES, V240, P42, DOI 10.1016/j.heares.2008.02.005; Bauer CA, 1999, OTOLARYNG HEAD NECK, V121, P457, DOI 10.1016/S0194-5998(99)70237-8; Bauer CA, 2000, HEARING RES, V147, P175, DOI 10.1016/S0378-5955(00)00130-1; BOETTCHER FA, 1991, AM J OTOLARYNG, V12, P33, DOI 10.1016/0196-0709(91)90071-M; Brennan JF, 1996, DEV PSYCHOBIOL, V29, P69, DOI 10.1002/(SICI)1098-2302(199601)29:1<69::AID-DEV4>3.3.CO;2-R; Brozoski TJ, 2007, HEARING RES, V228, P168, DOI 10.1016/j.heares.2007.02.003; Caperton KK, 2011, OTOL NEUROTOL, V32, P301, DOI 10.1097/MAO.0b013e3182009d46; Cazals Y, 1998, J NEUROPHYSIOL, V80, P2113, DOI 10.1152/jn.1998.80.4.2113; Chen GD, 2003, HEARING RES, V177, P81, DOI 10.1016/S0378-5955(02)00802-X; CHEN GD, 1995, HEARING RES, V82, P158, DOI 10.1016/0378-5955(94)00174-O; Chen GD, 2013, HEARING RES, V295, P100, DOI 10.1016/j.heares.2012.11.016; Chen GY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108659; Chen YC, 2015, ELIFE, V4, DOI 10.7554/eLife.06576; CORY D A, 1987, Magnetic Resonance Imaging, V5, P65, DOI 10.1016/0730-725X(87)90485-1; DAY RO, 1989, BRIT J CLIN PHARMACO, V28, P695, DOI 10.1111/j.1365-2125.1989.tb03562.x; DIDIER A, 1993, HEARING RES, V69, P199, DOI 10.1016/0378-5955(93)90108-D; DRAPEAU P, 1984, J PHYSIOL-LONDON, V348, P493, DOI 10.1113/jphysiol.1984.sp015121; Eddy L B, 1975, Biomed Sci Instrum, V11, P51; Eggermont JJ, 1998, HEARING RES, V117, P149, DOI 10.1016/S0378-5955(98)00008-2; Evans E F, 1982, Br J Audiol, V16, P101, DOI 10.3109/03005368209081454; Evans E F, 1981, Ciba Found Symp, V85, P108; GRAHAM JDP, 1948, Q J MED, V17, P153; Groschel M, 2011, NEUROIMAGE, V57, P190, DOI 10.1016/j.neuroimage.2011.04.022; Guitton MJ, 2003, J NEUROSCI, V23, P3944; HALLA JT, 1991, ANN RHEUM DIS, V50, P682, DOI 10.1136/ard.50.10.682; HALLA JT, 1988, ANN RHEUM DIS, V47, P134, DOI 10.1136/ard.47.2.134; Holt AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014260; Hu SS, 2015, EUROPEAN ARCH OTORHI; JAGER BV, 1946, AM J MED SCI, V211, P273, DOI 10.1097/00000441-194603000-00004; Jansen TTG, 2013, OTOL NEUROTOL, V34, P1496, DOI 10.1097/MAO.0b013e318291c610; JASTREBOFF PJ, 1986, ARCH OTOLARYNGOL, V112, P1050; JASTREBOFF PJ, 1988, BEHAV NEUROSCI, V102, P811, DOI 10.1037/0735-7044.102.6.811; JASTREBOFF PJ, 1986, J ACOUST SOC AM, V80, P1384, DOI 10.1121/1.394391; Jin Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126956; Jin YM, 2006, HEARING RES, V216, P168, DOI 10.1016/j.heares.2006.02.002; Jung DJ, 2014, NEUROIMAGE, V100, P642, DOI 10.1016/j.neuroimage.2014.06.055; Kakehata S, 1996, J NEUROSCI, V16, P4881; Kaltenbach JA, 2000, HEARING RES, V147, P282, DOI 10.1016/S0378-5955(00)00138-6; KANG YS, 1984, INVEST RADIOL, V19, P399, DOI 10.1097/00004424-198409000-00012; Kenmochi M, 1997, HEARING RES, V113, P110, DOI 10.1016/S0378-5955(97)00137-8; Kimitsuki T, 2011, NEUROSCI LETT, V504, P28, DOI 10.1016/j.neulet.2011.08.050; Kimitsuki T, 2009, AURIS NASUS LARYNX, V36, P152, DOI 10.1016/j.anl.2008.05.005; KITA H, 1981, BRAIN RES, V205, P111, DOI 10.1016/0006-8993(81)90723-X; Lee JH, 2005, MAGN RESON MED, V53, P640, DOI 10.1002/mrm.20368; Liberman M C, 1978, Acta Otolaryngol Suppl, V358, P1; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Lin YJ, 1997, MAGN RESON MED, V38, P378, DOI 10.1002/mrm.1910380305; Liu YX, 2007, NEUROPHARMACOLOGY, V53, P870, DOI 10.1016/j.neuropharm.2007.08.015; Liu YX, 2005, HEARING RES, V205, P271, DOI 10.1016/j.heares.2005.03.028; Liu YX, 2004, NEUROSCI LETT, V369, P115, DOI 10.1016/j.neulet.2004.07.037; Liu YX, 2004, HEARING RES, V193, P68, DOI 10.1016/j.heares.2004.03.006; Lobarinas E, 2006, ACTA OTO-LARYNGOL, V126, P13, DOI 10.1080/03655230600895408; Lobarinas E, 2004, HEARING RES, V190, P109, DOI 10.1016/S0378-5955(04)00019-X; Lu J, 2011, NEUROSCIENCE, V189, P187, DOI 10.1016/j.neuroscience.2011.04.073; Lue AJC, 1999, HEARING RES, V135, P163, DOI 10.1016/S0378-5955(99)00102-1; Ma WLD, 2006, HEARING RES, V212, P9, DOI 10.1016/j.heares.2005.10.003; Mahlke C, 2004, HEARING RES, V195, P17, DOI 10.1016/j.heares.2004.03.005; Manabe Y, 1997, HEARING RES, V103, P192, DOI 10.1016/S0378-5955(96)00181-5; Manzoor NF, 2013, HEARING RES, V295, P114, DOI 10.1016/j.heares.2012.04.003; MCCAIN HW, 1987, CAN J PHYSIOL PHARM, V65, P558, DOI 10.1139/y87-094; MCFADDEN D, 1984, AM J OTOLARYNG, V5, P235, DOI 10.1016/S0196-0709(84)80033-2; MONGAN E, 1973, JAMA-J AM MED ASSOC, V226, P142, DOI 10.1001/jama.226.2.142; Mulders WHAM, 2009, NEUROSCIENCE, V164, P733, DOI 10.1016/j.neuroscience.2009.08.036; Muller M, 2003, HEARING RES, V183, P37, DOI 10.1016/S0378-5955(03)00217-X; Muly SM, 2004, J NEUROSCI RES, V75, P585, DOI 10.1002/jnr.20011; MYERS EN, 1965, NEW ENGL J MED, V273, P587, DOI 10.1056/NEJM196509092731104; NARITA K, 1990, BRAIN RES, V510, P289, DOI 10.1016/0006-8993(90)91379-U; Norena AJ, 2010, NEUROSCIENCE, V166, P1194, DOI 10.1016/j.neuroscience.2009.12.063; Ochi K, 1997, HEARING RES, V105, P105, DOI 10.1016/S0378-5955(96)00201-8; Patel CR, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00235; Paxinos G., 2001, MOUSE BRAIN STEREOTA; REED JR, 1975, CLIN TOXICOL, V8, P623, DOI 10.3109/15563657508990087; Ruttiger L, 2003, HEARING RES, V180, P39, DOI 10.1016/S0378-5955(03)00075-3; Salvi RJ, 2000, HEARING RES, V147, P261, DOI 10.1016/S0378-5955(00)00136-2; SATINOFF E, 1972, SCIENCE, V176, P532, DOI 10.1126/science.176.4034.532; Seki S, 2003, HEARING RES, V180, P28, DOI 10.1016/S0378-5955(03)00074-1; SHEHATA WE, 1991, ACTA OTO-LARYNGOL, V111, P707, DOI 10.3109/00016489109138403; Silva AC, 2004, NMR BIOMED, V17, P532, DOI 10.1002/nbm.945; Stolzberg D, 2011, NEUROSCIENCE, V180, P157, DOI 10.1016/j.neuroscience.2011.02.005; Stolzberg D, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00028; Sun W, 2009, NEUROSCIENCE, V159, P325, DOI 10.1016/j.neuroscience.2008.12.024; Takeda A, 2003, BRAIN RES REV, V41, P79, DOI 10.1016/S0165-0173(02)00234-5; Taylor RR, 2008, JARO-J ASSOC RES OTO, V9, P44, DOI 10.1007/s10162-007-0105-8; TUNSTALL MJ, 1995, J PHYSIOL-LONDON, V485, P739, DOI 10.1113/jphysiol.1995.sp020765; Wallhausser-Franke E, 2003, EXP BRAIN RES, V153, P649, DOI 10.1007/s00221-003-1614-2; Wang HT, 2008, HEARING RES, V236, P42, DOI 10.1016/j.heares.2007.11.015; Wu JL, 2003, HEARING RES, V176, P80, DOI 10.1016/S0378-5955(02)00747-5; Yang G, 2007, HEARING RES, V226, P244, DOI 10.1016/j.heares.2006.06.013; Yu X, 2005, NAT NEUROSCI, V8, P961, DOI 10.1038/nn1477; Zacharek MA, 2002, HEARING RES, V172, P137, DOI 10.1016/S0378-5955(02)00575-0; Zhang FY, 2014, CELL PHYSIOL BIOCHEM, V34, P753, DOI 10.1159/000363040; Zheng YW, 2006, BRAIN RES, V1123, P201, DOI 10.1016/j.brainres.2006.09.045	94	5	5	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153386	10.1371/journal.pone.0153386	http://dx.doi.org/10.1371/journal.pone.0153386			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078034	gold, Green Published, Green Submitted			2022-12-26	WOS:000374131700047
J	Hao, WR; Friedman, A				Hao, Wenrui; Friedman, Avner			Serum uPAR as Biomarker in Breast Cancer Recurrence: A Mathematical Model	PLOS ONE			English	Article							UROKINASE-PLASMINOGEN-ACTIVATOR; TUMOR-ASSOCIATED MACROPHAGES; ENDOTHELIAL GROWTH-FACTOR; CARCINOMA IN-SITU; TISSUE FACTOR; FACTOR EXPRESSION; INHIBITOR; RECEPTOR; CELLS; FIBROBLASTS	There are currently over 2.5 million breast cancer survivors in the United States and, according to the American Cancer Society, 10 to 20 percent of these women will develop recurrent breast cancer. Early detection of recurrence can avoid unnecessary radical treatment. However, self-examination or mammography screening may not discover a recurring cancer if the number of surviving cancer cells is small, while biopsy is too invasive and cannot be frequently repeated. It is therefore important to identify non-invasive biomarkers that can detect early recurrence. The present paper develops a mathematical model of cancer recurrence. The model, based on a system of partial differential equations, focuses on tissue biomarkers that include the plasminogen system. Among them, only uPAR is known to have significant correlation to its concentration in serum and could therefore be a good candidate for serum biomarker. The model includes uPAR and other associated cytokines and cells. It is assumed that the residual cancer cells that survived primary cancer therapy are concentrated in the same location within a region with a very small diameter. Model simulations establish a quantitative relation between the diameter of the growing cancer and the total uPAR mass in the cancer. This relation is used to identify uPAR as a potential serum biomarker for breast cancer recurrence.	[Hao, Wenrui; Friedman, Avner] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Friedman, Avner] Ohio State Univ, Dept Math, 231 W 18th Ave, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Hao, WR (corresponding author), Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA.	hao.50@mbi.osu.edu		HAO, WENRUI/0000-0002-6925-7424	Mathematical Biosciences Institute; National Science Foundation [DMS 0931642]	Mathematical Biosciences Institute; National Science Foundation(National Science Foundation (NSF))	The authors have been supported by the Mathematical Biosciences Institute and the National Science Foundation under Grant DMS 0931642.; The authors have been supported by the Mathematical Biosciences Institute and the National Science Foundation under Grant DMS 0931642. The authors thank J.F. Rabajante for this many comments that helped improve the presentation of the paper.	Acker T, 2001, MECH DEVELOP, V108, P45, DOI 10.1016/S0925-4773(01)00471-3; Benz CC, 2008, CRIT REV ONCOL HEMAT, V66, P65, DOI 10.1016/j.critrevonc.2007.09.001; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; BLASI F, 1987, J CELL BIOL, V104, P801, DOI 10.1083/jcb.104.4.801; Bluff JE, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1871; Ceruti P, 2013, EXP HEMATOL ONCOL, V2, DOI 10.1186/2162-3619-2-12; Chen D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107511; Chen D, 2012, B MATH BIOL, V74, P2752, DOI 10.1007/s11538-012-9776-3; Chorostowska-Wynimko J, 2003, MOL CANCER THER, V2, P19; Chung LP, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3676; COLLEN D, 1979, BLOOD, V53, P313; Connolly BM, 2010, BLOOD, V116, P1593, DOI 10.1182/blood-2010-03-276642; Curino A, 2002, ONCOGENE, V21, P8830, DOI 10.1038/sj.onc.1205951; Degnim AC, 2014, BREAST CANCER RES TR, V144, P539, DOI 10.1007/s10549-014-2896-8; Delozier T, 2000, ANN ONCOL, V11, P515, DOI 10.1023/A:1008321415065; Didiasova M, 2014, INT J MOL SCI, V15, P21229, DOI 10.3390/ijms151121229; Dublin E, 2000, AM J PATHOL, V157, P1219, DOI 10.1016/S0002-9440(10)64637-8; Duffy MJ, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0428-4; Enderling H, 2007, J THEOR BIOL, V246, P245, DOI 10.1016/j.jtbi.2006.12.010; ESTREICHER A, 1990, J CELL BIOL, V111, P783, DOI 10.1083/jcb.111.2.783; Eubank TD, 2009, CANCER RES, V69, P2133, DOI 10.1158/0008-5472.CAN-08-1405; Foundation BCR, 2016, BREAST CANC STAT RES; Foundation USBCR, 2016, US BREAST CANC STAT; Freedman GM, 2000, ONCOLOGY-NY, V14, P1561; Fujimoto H, 2009, INT J CANCER, V125, P1276, DOI 10.1002/ijc.24378; Gandhari M, 2006, INT J ONCOL, V28, P1463; Guney N, 2006, MED ONCOL, V23, P335, DOI 10.1385/MO:23:3:335; Hao WR, 2014, P NATL ACAD SCI USA, V111, P14193, DOI 10.1073/pnas.1413970111; Hao WR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090497; Harbeck N, 1999, BRIT J CANCER, V80, P419, DOI 10.1038/sj.bjc.6690373; Harbeck N, 2008, BREAST CARE, V3, P11, DOI 10.1159/000151734; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Hildenbrand R, 1999, J LEUKOCYTE BIOL, V66, P40, DOI 10.1002/jlb.66.1.40; Hildenbrand R, 2008, HISTOL HISTOPATHOL, V23, P227, DOI 10.14670/HH-23.227; Hildenbrand R, 2009, HISTOL HISTOPATHOL, V24, P869, DOI 10.14670/HH-24.869; HOFLAND LJ, 1995, INT J CANCER, V60, P93, DOI 10.1002/ijc.2910600114; Hu Q, 2013, ONCOGENE, V32, P3933, DOI 10.1038/onc.2012.414; Illemann M, 2014, CANCER MED-US, V3, P855, DOI 10.1002/cam4.242; Jesneck JL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-164; Kantelhardt EJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-140; Kariko K, 1999, GENE THER, V6, P1092, DOI 10.1038/sj.gt.3300930; Kim Y, 2010, J MATH BIOL, V61, P401, DOI 10.1007/s00285-009-0307-2; Kwaan Hau C., 2009, V148, P43, DOI 10.1007/978-0-387-79962-9_4; Kwon Gui Young, 2005, Cancer Res Treat, V37, P103, DOI 10.4143/crt.2005.37.2.103; LeBeau AM, 2013, CANCER RES, V73, P2070, DOI 10.1158/0008-5472.CAN-12-3526; Leek RD, 2002, J MAMMARY GLAND BIOL, V7, P177, DOI 10.1023/A:1020304003704; Li WY, 2003, WOUND REPAIR REGEN, V11, P239, DOI 10.1046/j.1524-475X.2003.11402.x; Liao KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110126; Lijnen HR, 2000, BIOCHEMISTRY-US, V39, P479, DOI 10.1021/bi992014r; LINDHOUT T, 1992, BLOOD, V79, P2909; Louzoun Y, 2014, J THEOR BIOL, V351, P74, DOI 10.1016/j.jtbi.2014.02.028; Lwaleed BA, 2000, SAUDI MED J, V21, P722; Mallmann MR, 2012, PLOS ONE, V7; Mantovani A, 2006, CANCER METAST REV, V25, P315, DOI 10.1007/s10555-006-9001-7; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Mego M, 2015, BREAST J, V21, P155, DOI 10.1111/tbj.12388; Memarzedeh S, 2002, P NATL ACAD SCI USA, V99, P10647, DOI 10.1073/pnas.152127499; Mirabelli P, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/685641; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Nielsen BS, 2001, LAB INVEST, V81, P1485, DOI 10.1038/labinvest.3780363; Olson MW, 1997, J BIOL CHEM, V272, P29975, DOI 10.1074/jbc.272.47.29975; PABORSKY LR, 1989, BIOCHEMISTRY-US, V28, P8072, DOI 10.1021/bi00446a016; Pultz BD, 2014, J CANCER, V5, P559, DOI 10.7150/jca.8925; Quillin ML, 2000, ACTA CRYSTALLOGR D, V56, P791, DOI 10.1107/S090744490000679X; Rha SY, 2000, CANCER LETT, V150, P137, DOI 10.1016/S0304-3835(99)00376-6; Romero L, 2004, AM J SURG, V188, P371, DOI 10.1016/j.amjsurg.2004.06.034; RONNOVJESSEN L, 1995, J CLIN INVEST, V95, P859, DOI 10.1172/JCI117736; Rubinstein WS, 2002, ONCOLOGY-NY, V16, P1082; Ruf W, 2010, THROMB RES, V125, pS36, DOI 10.1016/S0049-3848(10)70010-4; Sadlonova A, 2005, BREAST CANCER RES, V7, pR46, DOI 10.1186/bcr949; Samoszuk M, 2005, BREAST CANCER RES, V7, pR274, DOI 10.1186/bcr995; Seghezzi G, 1998, J CELL BIOL, V141, P1659, DOI 10.1083/jcb.141.7.1659; Shui YB, 2003, INVEST OPHTH VIS SCI, V44, P3911, DOI 10.1167/iovs.02-1226; Sieuwerts AM, 1998, INT J CANCER, V76, P829, DOI 10.1002/(SICI)1097-0215(19980610)76:6<829::AID-IJC11>3.0.CO;2-Y; Soon PSH, 2013, ENDOCR-RELAT CANCER, V20, P1, DOI 10.1530/ERC-12-0227; Stillfried GE, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1647; Strojan P, 1998, EUR J CANCER, V34, P1193, DOI 10.1016/S0959-8049(98)00029-X; Szomolay B, 2012, J THEOR BIOL, V303, P141, DOI 10.1016/j.jtbi.2012.03.024; Thielemann A, 2013, WSPOLCZESNA ONKOL, V17, P440, DOI 10.5114/wo.2013.38567; Ueno T, 2000, BRIT J CANCER, V83, P164; Zhang XX, 2011, J BIOL CHEM, V286, P1429, DOI 10.1074/jbc.M110.146530	81	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153508	10.1371/journal.pone.0153508	http://dx.doi.org/10.1371/journal.pone.0153508			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078836	Green Published, gold, Green Submitted			2022-12-26	WOS:000374131700071
J	LeBlanc, S; Tobalske, B; Quinton, M; Springthorpe, D; Szkotnicki, B; Wuerbel, H; Harlander-Matauschek, A				LeBlanc, Stephanie; Tobalske, Bret; Quinton, Margaret; Springthorpe, Dwight; Szkotnicki, Bill; Wuerbel, Hanno; Harlander-Matauschek, Alexandra			Physical Health Problems and Environmental Challenges Influence Balancing Behaviour in Laying Hens	PLOS ONE			English	Article							KEEL BONE DEFORMITIES; OLDER-PEOPLE; RISK-FACTORS; POSTURAL STABILITY; HORIZONTAL PERCHES; HOUSING SYSTEMS; VISUAL CONTROL; SPINAL-CORD; BIRDS; LOCOMOTION	With rising public concern for animal welfare, many major food chains and restaurants are changing their policies, strictly buying their eggs from non-cage producers. However, with the additional space in these cage-free systems to perform natural behaviours and movements comes the risk of injury. We evaluated the ability to maintain balance in adult laying hens with health problems (footpad dermatitis, keel damage, poor wing feather cover; n = 15) using a series of environmental challenges and compared such abilities with those of healthy birds (n = 5). Environmental challenges consisted of visual and spatial constraints, created using a head mask, perch obstacles, and static and swaying perch states. We hypothesized that perch movement, environmental challenges, and diminished physical health would negatively impact perching performance demonstrated as balance (as measured by time spent on perch and by number of falls of the perch) and would require more exaggerated correctional movements. We measured perching stability whereby each bird underwent eight 30-second trials on a static and swaying perch: with and without disrupted vision (head mask), with and without space limitations (obstacles) and combinations thereof. Video recordings (600 Hz) and a three-axis accelerometer/gyroscope (100 Hz) were used to measure the number of jumps/falls, latencies to leave the perch, as well as magnitude and direction of both linear and rotational balance-correcting movements. Laying hens with and without physical health problems, in both challenged and unchallenged environments, managed to perch and remain off the ground. We attribute this capacity to our training of the birds. Environmental challenges and physical state had an effect on the use of accelerations and rotations to stabilize themselves on a perch. Birds with physical health problems performed a higher frequency of rotational corrections to keep the body centered over the perch, whereas, for both health categories, environmental challenges required more intense and variable movement corrections. Collectively, these results provide novel empirical support for the effectiveness of training, and highlight that overcrowding, visual constraints, and poor physical health all reduce perching performance.	[LeBlanc, Stephanie; Quinton, Margaret; Szkotnicki, Bill; Harlander-Matauschek, Alexandra] Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada; [Tobalske, Bret] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Springthorpe, Dwight] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Wuerbel, Hanno] Univ Bern, VPH Inst, Div Anim Welf, Bern, Switzerland	University of Guelph; University of Montana System; University of Montana; University of California System; University of California Berkeley; University of Bern	Harlander-Matauschek, A (corresponding author), Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada.	aharland@uoguelph.ca	Wuerbel, Hanno/D-6281-2012	Wuerbel, Hanno/0000-0002-2934-3010	Swiss Federal Food Safety and Veterinary Office [2.13.09]; AgrilInnovation Program under the Growing Forward 2 Policy [CPC2-3.2.2]	Swiss Federal Food Safety and Veterinary Office; AgrilInnovation Program under the Growing Forward 2 Policy	This work was supported by Grant number 2.13.09 Swiss Federal Food Safety and Veterinary Office http://www.blv.admin.ch/?lang=en to AH and CPC2-3.2.2 AgrilInnovation Program under the Growing Forward 2 Policy, http://www.agr.gc.ca/eng/about-us/key-departmental-initiatives/growing-forward-2/?id=1294780620963 to AH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M., 2012, PATHOLOGIC BASIS VET, P89; Alerstam T, 1993, BIRD MIGRATION, P69; Birn-Jeffery AV, 2014, J EXP BIOL, V217, P3786, DOI 10.1242/jeb.102640; Borghuis J, 2008, SPORTS MED, V38, P893, DOI 10.2165/00007256-200838110-00002; Brauer SG, 2001, J GERONTOL A-BIOL, V56, pM489, DOI 10.1093/gerona/56.8.M489; BUTLER PJ, 1991, J EXP BIOL, V160, P233; Carrano MT, 1999, J MORPHOL, V240, P237, DOI 10.1002/(SICI)1097-4687(199906)240:3<237::AID-JMOR3>3.3.CO;2-E; CARSTENS P., 1936, Arch. Geflugelk., V10, P97; Carter SE, 1997, AGE AGEING, V26, P195, DOI 10.1093/ageing/26.3.195; Clark WD, 2008, POULTRY SCI, V87, P1964, DOI 10.3382/ps.2008-00115; DAANJE A, 1950, BEHAVIOUR, V3, P48, DOI 10.1163/156853951X00214; Daley MA, 2011, PHILOS T R SOC B, V366, P1580, DOI 10.1098/rstb.2010.0338; Davis H, 2004, BIPEDS ASCENDING AVI; Day BL, 2005, CURR BIOL, V15, pR583, DOI 10.1016/j.cub.2005.07.053; Dial KP, 2011, P ROY SOC B-BIOL SCI, V278, P1610, DOI 10.1098/rspb.2010.1984; Dial TR, 2012, J EXP BIOL, V215, P3693, DOI 10.1242/jeb.062018; Fleming RH, 2006, BRIT POULTRY SCI, V47, P742, DOI 10.1080/00071660601077949; Fleming RH, 2004, BRIT POULTRY SCI, V45, P320, DOI 10.1080/00071660410001730815; Galton PM, 2012, J EXP ZOOL PART A, V317A, P205, DOI 10.1002/jez.1714; GIBSON JJ, 1958, BRIT J PSYCHOL, V49, P182, DOI 10.1111/j.2044-8295.1958.tb00656.x; GIESBRECHT FG, 1985, BIOMETRICS, V41, P477, DOI 10.2307/2530872; Greenewalt C.H., 1962, SMITHSON MISC COLLNS, V144, P1, DOI DOI 10.1007/S00360-016-1016-Y; Grossi B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088458; Habig C, 2013, BRIT POULTRY SCI, V54, P413, DOI 10.1080/00071668.2013.792405; Harlander-Matauschek A, 2009, ANIM BEHAV, V78, P485, DOI 10.1016/j.anbehav.2009.05.020; HASAN SS, 1990, J BIOMECH, V23, P783, DOI 10.1016/0021-9290(90)90025-X; Heers AM, 2011, J EXP BIOL, V214, P717, DOI 10.1242/jeb.051177; HODOS W, 1990, VISION RES, V30, P653, DOI 10.1016/0042-6989(90)90091-X; Horak FB, 2006, AGE AGEING, V35, P7, DOI 10.1093/ageing/afl077; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; Horak FB, 1997, PHYS THER, V77, P517, DOI 10.1093/ptj/77.5.517; Kappeli S, 2011, BRIT POULTRY SCI, V52, P531, DOI 10.1080/00071668.2011.615059; Kambic RE, 2014, J EXP BIOL, V217, P2770, DOI 10.1242/jeb.101428; LEE DN, 1980, PHILOS T R SOC B, V290, P169, DOI 10.1098/rstb.1980.0089; LEE DN, 1977, SCAND J PSYCHOL, V18, P224, DOI 10.1111/j.1467-9450.1977.tb00281.x; Lord SR, 2006, AGE AGEING, V35, P55, DOI 10.1093/ageing/afl088; Martin GR, 2009, J VISION, V9, DOI 10.1167/9.11.14; Mathie MJ, 2004, PHYSIOL MEAS, V25, pR1, DOI 10.1088/0967-3334/25/2/R01; Mayagoitia RE, 2002, J BIOMECH, V35, P537, DOI 10.1016/S0021-9290(01)00231-7; Moe-Nilssen R, 2002, GAIT POSTURE, V16, P60, DOI 10.1016/S0966-6362(01)00200-4; Moinard C, 2004, BRIT POULTRY SCI, V45, P578, DOI 10.1080/00071660400006321; Morrison A, 2013, CLINICOECONOMIC OUTC, V5, P9, DOI 10.2147/CEOR.S38721; Muir GD, 2000, BRAIN RES BULL, V53, P719, DOI 10.1016/S0361-9230(00)00404-4; Muller W, 1998, J EXP BIOL, V201, P2591; Nasr MAF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042420; Necker R, 1999, EUR J MORPHOL, V37, P211, DOI 10.1076/ejom.37.2.211.4758; Necker R, 2000, J COMP PHYSIOL A, V186, P409, DOI 10.1007/s003590050440; Necker R, 2006, J COMP PHYSIOL A, V192, P439, DOI 10.1007/s00359-006-0105-x; Necker Reinhold, 2000, P57, DOI 10.1016/B978-012747605-6/50005-5; Park JW, 2014, J PHYS THER SCI, V26, P381, DOI 10.1589/jpts.26.381; Patel M, 2014, NEUROSCI LETT, V579, P97, DOI 10.1016/j.neulet.2014.07.010; Perrin PP, 1997, GERONTOLOGY, V43, P223; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Pradels A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065510; Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011; Provini P, 2014, J EXP BIOL, V217, P2659, DOI 10.1242/jeb.104588; Provini P, 2012, J EXP BIOL, V215, P4115, DOI 10.1242/jeb.074484; QUINN TH, 1990, ZOOMORPHOLOGY, V109, P281, DOI 10.1007/BF00312195; Redfern MS, 2001, J ANXIETY DISORD, V15, P81, DOI 10.1016/S0887-6185(00)00043-8; Ritchie B.W., 1997, AVIAN MED PRINCIPLES; Rodenburg TB, 2008, ANIM WELFARE, V17, P363; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Sandilands V, 2009, BRIT POULTRY SCI, V50, P395, DOI 10.1080/00071660903110844; SAVORY CJ, 1995, WORLD POULTRY SCI J, V51, P215, DOI 10.1079/WPS19950016; Scott GB, 1997, BRIT POULTRY SCI, V38, P48, DOI 10.1080/00071669708417939; Sturnieks DL, 2008, NEUROPHYSIOL CLIN, V38, P467, DOI 10.1016/j.neucli.2008.09.001; SULLIVAN G. E., 1962, AUSTRALIAN JOUR ZOOL, V10, P458, DOI 10.1071/ZO9620458; Szulc P, 2005, J BONE MINER RES, V20, P721, DOI 10.1359/JBMR.041230; Taylor PE, 2003, APPL ANIM BEHAV SCI, V83, P99, DOI 10.1016/S0168-1591(03)00127-8; Tobalske BW, 2008, J EXP BIOL, V211, P170, DOI 10.1242/jeb.007476; Uhlenberg, 2002, ENCY AGING; Wang G, 1998, BRIT POULTRY SCI, V39, P191, DOI 10.1080/00071669889114; Wang Z, 2004, CAN J ANIM SCI, V84, P1, DOI 10.4141/A03-123; Wearing SC, 2006, OBES REV, V7, P13, DOI 10.1111/j.1467-789X.2006.00215.x; Wilkins LJ, 2011, VET REC, V169, P414, DOI 10.1136/vr.d4831; Wilkins LJ, 2004, VET REC, V155, P547, DOI 10.1136/vr.155.18.547	76	21	21	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153477	10.1371/journal.pone.0153477	http://dx.doi.org/10.1371/journal.pone.0153477			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078835	Green Published, Green Submitted, gold			2022-12-26	WOS:000374131700061
J	Zhang, QL; Cox, M; Liang, ZK; Brinkmann, F; Cardenas, PA; Duff, R; Bhavsar, P; Cookson, W; Moffatt, M; Chung, KF				Zhang, Qingling; Cox, Michael; Liang, Zhike; Brinkmann, Folke; Cardenas, Paul A.; Duff, Rachael; Bhavsar, Pankaj; Cookson, William; Moffatt, Miriam; Chung, Kian Fan			Airway Microbiota in Severe Asthma and Relationship to Asthma Severity and Phenotypes	PLOS ONE			English	Article							RELATIVE CORTICOSTEROID INSENSITIVITY; CHILDHOOD ASTHMA; INDUCED SPUTUM; INFLAMMATION; CELLS; HYPERRESPONSIVENESS; INFECTIONS; DIVERSITY; BACTERIA; COUNTS	Background The lower airways harbor a community of bacterial species which is altered in asthma. Objectives We examined whether the lower airway microbiota were related to measures of asthma severity. Methods We prospectively recruited 26 severe asthma, 18 non-severe asthma and 12 healthy subjects. DNA was extracted from induced sputum and PCR amplification of the V3-V5 region of bacterial 16S rRNA gene was performed. Results We obtained 138,218 high quality sequences which were rarefied at 133 sequences/sample. Twenty OTUs had sequences >= 1% of total. There were marked differences in the distribution of Phyla between groups (P = 2.8x10(-118)). Bacteroidetes and Fusobacteria were reduced in non-severe and severe asthmatic groups. Proteobacteria were more common in non-severe asthmatics compared to controls (OR = 2.26; 95% CI = 1.94-2.64) and Firmicutes were increased in severe asthmatics compared to controls (OR = 2.15; 95% CI = 1.89-2.45). Streptococcal OTUs amongst the Firmicutes were associated with recent onset asthma, rhinosinusitis and sputum eosinophilia. Conclusions Sputum microbiota in severe asthma differs from healthy controls and non-severe asthmatics, and is characterized by the presence of Streptococcus spp with eosinophilia. Whether these organisms are causative for the pathophysiology of asthma remains to be determined.	[Zhang, Qingling; Cox, Michael; Liang, Zhike; Brinkmann, Folke; Cardenas, Paul A.; Duff, Rachael; Bhavsar, Pankaj; Cookson, William; Moffatt, Miriam; Chung, Kian Fan] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Zhang, Qingling; Liang, Zhike; Bhavsar, Pankaj; Cookson, William; Moffatt, Miriam; Chung, Kian Fan] Royal Brompton & Harefield NHS Trust, Resp Biomed Res Unit, London, England; [Zhang, Qingling; Liang, Zhike; Bhavsar, Pankaj; Cookson, William; Moffatt, Miriam; Chung, Kian Fan] Imperial Coll London, London, England; [Zhang, Qingling; Liang, Zhike; Chung, Kian Fan] Guangzhou Med Univ, Affiliated Hosp 1, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China	Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton Hospital; Imperial College London; Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Chung, KF (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England.	f.chung@imperial.ac.uk	Chung, Kian Fan/B-1872-2012; Cookson, William/HHC-1790-2022; Brinkmann, Folke/GQA-9081-2022	Chung, Kian Fan/0000-0001-7101-1426; Brinkmann, Folke/0000-0002-4307-4232; Cardenas, Paul/0000-0001-9626-4489; Cox, Michael/0000-0002-4002-1506	NIHR Respiratory Biomedical Research Unit; Asmarley Trust; Centre for Respiratory Infection Basic Science Fellowship; Guangzhou Respiratory Institute; Royal Brompton & Harefield NHS Trust; Imperial College London, UK; Medical Research Council [G1000758] Funding Source: researchfish; National Institute for Health Research [NF-SI-0515-10016, NF-SI-0512-10126, NF-SI-0509-10080] Funding Source: researchfish; Asthma UK [MRC-AsthmaUKCentre, MRC-Asthma UK Centre] Funding Source: researchfish	NIHR Respiratory Biomedical Research Unit; Asmarley Trust; Centre for Respiratory Infection Basic Science Fellowship; Guangzhou Respiratory Institute; Royal Brompton & Harefield NHS Trust; Imperial College London, UK; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK	This work was supported by the NIHR Respiratory Biomedical Research Unit, Royal Brompton & Harefield NHS Trust and Imperial College London, UK, and by the Asmarley Trust. WC and MF are Senior Investigators of the Wellcome Trust. KFC is an NIHR Senior Investigator. MC was supported by the Centre for Respiratory Infection Basic Science Fellowship. QZ and ZL were supported by the Guangzhou Respiratory Institute, and KFC is a Visiting Professor of the Guangzhou Respiratory Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, Am J Respir Crit Care Med, V162, P2341; Berry MA, 2005, CLIN EXP ALLERGY, V35, P1175, DOI 10.1111/j.1365-2222.2005.02314.x; Bhavsar P, 2008, THORAX, V63, P784, DOI 10.1136/thx.2007.090027; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardenas PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046803; CAZZOLA M, 1991, CLIN THER, V13, P157; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Chung KF, 2014, DRUGS, V74, P719, DOI 10.1007/s40265-014-0213-9; Chung KF, 2013, LANCET RESP MED, V1, P639, DOI 10.1016/S2213-2600(13)70128-0; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; Deykin A, 2005, J ALLERGY CLIN IMMUN, V115, P720, DOI 10.1016/j.jaci.2004.12.1129; Donnelly D, 2007, THORAX, V62, P80, DOI 10.1136/thx.2006.058933; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Goleva E, 2013, AM J RESP CRIT CARE, V188, P1193, DOI 10.1164/rccm.201304-0775OC; Green BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100645; Hew M, 2006, AM J RESP CRIT CARE, V174, P134, DOI 10.1164/rccm.200512-1930OC; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Huang YJ, 2015, J ALLERGY CLIN IMMUN; Huang YJ, 2015, J ALLERGY CLIN IMMUN, V135, P25, DOI 10.1016/j.jaci.2014.11.011; Huang YJ, 2013, AM J RESP CRIT CARE, V187, P1382, DOI 10.1164/rccm.201303-0488WS; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; Jatakanon A, 1998, AM J RESP CRIT CARE, V157, pA875; Johnston SL, 2006, NEW ENGL J MED, V354, P1589, DOI 10.1056/NEJMoa044080; Kraft M, 2002, CHEST, V121, P1782, DOI 10.1378/chest.121.6.1782; Kraft M, 2000, CLIN CHEST MED, V21, P301, DOI 10.1016/S0272-5231(05)70268-9; Lemon KP, 2010, MBIO, V1, DOI 10.1128/mBio.00129-10; Marri PR, 2013, J ALLERGY CLIN IMMUN, V131, P346, DOI 10.1016/j.jaci.2012.11.013; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Morris A, 2013, AM J RESP CRIT CARE, V187, P1067, DOI 10.1164/rccm.201210-1913OC; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Peters MC, 2014, J ALLERGY CLIN IMMUN, V133, P388, DOI 10.1016/j.jaci.2013.07.036; PIN I, 1992, THORAX, V47, P25, DOI 10.1136/thx.47.1.25; Pragman AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047305; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Ramesh R, 2014, J EXP MED, V211, P89, DOI 10.1084/jem.20130301; Robinson DS, 2003, EUR RESPIR J, V22, P478, DOI 10.1183/09031936.03.00017003; Schwerk N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027913; Wenzel SE, 2006, LANCET, V368, P804, DOI 10.1016/S0140-6736(06)69290-8; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; Wood LG, 2010, FREE RADICAL RES, V44, P146, DOI 10.3109/10715760903362576; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; Xu X, 2014, ENV MICROBIOLOGY; Yadav V, 2013, INT J PHARMACEUT, V457, P268, DOI 10.1016/j.ijpharm.2013.09.007; Zhang QL, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-35	50	113	115	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0152724	10.1371/journal.pone.0152724	http://dx.doi.org/10.1371/journal.pone.0152724			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078029	gold, Green Published, Green Submitted			2022-12-26	WOS:000374131700007
J	Hardison, DR; Holland, WC; McCall, JR; Bourdelais, AJ; Baden, DG; Darius, HT; Chinain, M; Tester, PA; Shea, D; Quintana, HAF; Morris, JA; Litaker, RW				Hardison, D. Ransom; Holland, William C.; McCall, Jennifer R.; Bourdelais, Andrea J.; Baden, Daniel G.; Darius, H. Taiana; Chinain, Mireille; Tester, Patricia A.; Shea, Damian; Quintana, Harold A. Flores; Morris, James A., Jr.; Litaker, R. Wayne			Fluorescent Receptor Binding Assay for Detecting Ciguatoxins in Fish	PLOS ONE			English	Article							SENSITIVE SODIUM-CHANNELS; SITE 5; CIGUATERA; BREVETOXINS; TOXICITY; TOXINS	Ciguatera fish poisoning is an illness suffered by > 50,000 people yearly after consumption of fish containing ciguatoxins (CTXs). One of the current methodologies to detect ciguatoxins in fish is a radiolabeled receptor binding assay (RBA((R))). However, the license requirements and regulations pertaining to radioisotope utilization can limit the applicability of the RBA((R)) in certain labs. A fluorescence based receptor binding assay (RBA((F))) was developed to provide an alternative method of screening fish samples for CTXs in facilities not certified to use radioisotopes. The new assay is based on competition binding between CTXs and fluorescently labeled brevetoxin-2 (BODIPY (R)-PbTx-2) for voltage-gated sodium channel receptors at site 5 instead of a radiolabeled brevetoxin. Responses were linear in fish tissues spiked from 0.1 to 1.0 ppb with Pacific ciguatoxin-3C (P-CTX-3C) with a detection limit of 0.075 ppb. Carribean ciguatoxins were confirmed in Caribbean fish by LC-MS/MS analysis of the regional biomarker (C-CTX-1). Fish (N = 61) of six different species were screened using the RBA((F)). Results for corresponding samples analyzed using the neuroblastoma cell-based assay (CBA-N2a) correlated well (R-2 = 0.71) with those of the RBA((F)), given the low levels of CTX present in positive fish. Data analyses also showed the resulting toxicity levels of P-CTX-3C equivalents determined by CBA-N2a were consistently lower than the RBA((F)) affinities expressed as% binding equivalents, indicating that a given amount of toxin bound to the site 5 receptors translates into corresponding lower cytotoxicity. Consequently, the RBA((F)), which takes approximately two hours to perform, provides a generous estimate relative to the widely used CBA-N2a which requires 2.5 days to complete. Other RBA((F)) advantages include the long-term(> 5 years) stability of the BODIPY (R)-PbTx-2 and having similar results as the commonly used RBA((R)). The RBA((F)) is cost-effective, allows high sample throughput, and is well-suited for routine CTX monitoring programs.	[Hardison, D. Ransom; Holland, William C.; Tester, Patricia A.; Morris, James A., Jr.; Litaker, R. Wayne] NOAA, Ctr Coastal Fisheries & Habitat Res, Beaufort, NC USA; [McCall, Jennifer R.; Bourdelais, Andrea J.; Baden, Daniel G.] Univ N Carolina, MARBIONC CREST Res Pk, Wilmington, NC 28401 USA; [McCall, Jennifer R.] SeaTox Res Inc, UNCW CREST Res Pk, Wilmington, NC USA; [Darius, H. Taiana; Chinain, Mireille] ILM, UMR EIO 241, Lab Tox Microalgae, Papeete, Tahiti, France; [Tester, Patricia A.] JHT Inc, Orlando, FL USA; [Shea, Damian] N Carolina State Univ, Environm Chem & Toxicol Lab, Raleigh, NC 27695 USA; [Quintana, Harold A. Flores] US FDA, Div Seafood Sci & Technol, Gulf Coast Seafood Lab, Dauphin Isl, AL USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of North Carolina; University of North Carolina Wilmington; Ifremer; University of North Carolina; North Carolina State University; US Food & Drug Administration (FDA)	Hardison, DR (corresponding author), NOAA, Ctr Coastal Fisheries & Habitat Res, Beaufort, NC USA.	rance.hardison@noaa.gov	Shea, Damian/K-1360-2014; CHINAIN, Mireille/G-7055-2017; DARIUS, Hélène Taiana/J-6163-2015; Litaker, Richard Wayne/AAH-2036-2021	Shea, Damian/0000-0003-1348-6639; CHINAIN, Mireille/0000-0001-6560-1278; DARIUS, Hélène Taiana/0000-0002-1184-7034; Litaker, Richard Wayne/0000-0001-6293-8000	National Oceanic and Atmospheric Administration's Ecology and Oceanography of Harmful Algae Blooms contribution [843]; National Oceanic and Atmospheric Administration; National Ocean Service; Centers for Coastal Ocean Science; Center for Coastal Fisheries and Habitat Research; Cooperative Institute for Ocean Exploration, Research, and Technology CIOERT [NA14OAR4320260]; NOAA; DOC	National Oceanic and Atmospheric Administration's Ecology and Oceanography of Harmful Algae Blooms contribution; National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); National Ocean Service; Centers for Coastal Ocean Science; Center for Coastal Fisheries and Habitat Research; Cooperative Institute for Ocean Exploration, Research, and Technology CIOERT; NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); DOC	Funding was provided by the National Oceanic and Atmospheric Administration's Ecology and Oceanography of Harmful Algae Blooms contribution #843 - http://coastalscience.noaa.gov/research/habs/ecohab RWL PAT DRH WCH DS. Program funds were provided by the National Oceanic and Atmospheric Administration, National Ocean Service, Centers for Coastal Ocean Science, Center for Coastal Fisheries and Habitat Research-DRH WCH RWL PAT JAM. The UNCW partnership is in part funded through the Cooperative Institute for Ocean Exploration, Research, and Technology CIOERT, award number NA14OAR4320260, NOAA, DOC. Authors associated with this are DGB, AJB, and JRM. NOAA National Marine Fisheries, Office of International Affairs-United States Department of State-JAM. The commercial partner SeaTox Research Inc. was not responsible the design or execution of the project, nor did they provide salary support to any of the collaborators. Their role was limited to providing reagents and running the radioactive receptor binding assay using extracts prepared by DRH and WCH. JHT provided support in the form of salary for PT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham A, 2012, FOOD CHEM, V131, P192, DOI 10.1016/j.foodchem.2011.08.059; [Anonymous], 2011, FISH FISH PROD HAZ C; BAGNIS R, 1979, AM J TROP MED HYG, V28, P1067, DOI 10.4269/ajtmh.1979.28.1067; Caillaud A, 2012, FOOD ADDIT CONTAM A, V29, P1000, DOI 10.1080/19440049.2012.660707; Caillaud A, 2010, MAR DRUGS, V8, P1838, DOI 10.3390/md8061838; Darius HT, 2007, TOXICON, V50, P612, DOI 10.1016/j.toxicon.2007.05.007; Dechraoui MYB, 2007, TOXICON, V49, P100, DOI 10.1016/j.toxicon.2006.10.002; Dechraoui MYB, 2005, TOXICON, V46, P261, DOI 10.1016/j.toxicon.2005.04.006; Dickey Robert W., 2008, P479; Dickey RW, 2010, TOXICON, V56, P123, DOI 10.1016/j.toxicon.2009.09.008; Ledreux A, 2014, HARMFUL ALGAE, V39, P165, DOI 10.1016/j.hal.2014.07.009; Lewis RJ, 2000, THER DRUG MONIT, V22, P61, DOI 10.1097/00007691-200002000-00013; LOMBET A, 1987, FEBS LETT, V219, P355, DOI 10.1016/0014-5793(87)80252-1; MANGER RL, 1993, ANAL BIOCHEM, V214, P190, DOI 10.1006/abio.1993.1476; Mattei C, 1999, J NEUROSCI RES, V55, P666, DOI 10.1002/(SICI)1097-4547(19990315)55:6<666::AID-JNR2>3.3.CO;2-8; McCall JR, 2014, J AOAC INT, V97, P307, DOI 10.5740/jaoacint.SGEMcCall; McCall JR, 2012, HARMFUL ALGAE, V19, P85, DOI 10.1016/j.hal.2012.06.003; Pawlowiez R, 2013, FOOD ADDIT CONTAM A, V30, P567, DOI 10.1080/19440049.2012.755644; POLI MA, 1986, MOL PHARMACOL, V30, P129; Solino L, 2015, TOXICON, V102, P62, DOI 10.1016/j.toxicon.2015.05.015; Van Dolah F. M., 1994, Natural Toxins, V2, P189, DOI 10.1002/nt.2620020407; Van Dolah FM, 2001, J AOAC INT, V84, P1617; Vetter I., 2014, SEAFOOD FRESHWATER T, P925; Wilcox CL, 2015, ENVIRON BIOL FISH, V98, P961, DOI 10.1007/s10641-014-0313-0	24	50	50	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153348	10.1371/journal.pone.0153348	http://dx.doi.org/10.1371/journal.pone.0153348			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073998	Green Published, Green Submitted, gold			2022-12-26	WOS:000374131200077
J	Lee, JS; Lee, DC; Ha, DH; Kim, SW; Cho, DW				Lee, Jung-Seob; Lee, Dong Chang; Ha, Dong-Heon; Kim, Sung Won; Cho, Dong-Woo			Redefining the Septal L-Strut to Prevent Collapse	PLOS ONE			English	Article							BIOMECHANICAL PROPERTIES; CARTILAGE; EAR	During septorhinoplasty, septal cartilage is frequently resected for various purposes but the L-strut is preserved. Numerous materials are inserted into the nasal dorsum during dorsal augmenation rhinoplasty without considering nasal structural safety. This study used a finite element method (FEM) to redefine the septal L-strut, to prevent collapse as pressure moved from the rhinion to the supratip breakpoint on the nasal dorsum and as the contact percentage between the caudal L-strut and the maxillary crest changed. We designed a 1cm- wide L-strut model based on computed tomography data. At least 45% of the width of the L-strut in the inferior portion of the caudal strut must be preserved during septoplasty to stabilize the septum. In augmentation rhinoplasty, the caudal L-strut must either be preserved perfectly or reinforced to prevent collapse or distortion of the L-strut. The dorsal augmentation material must be fixed in an augmentation pocket to prevent movement of graft material toward the supratip breakpoint, which can disrupt the L-strut. We conducted a numerical analysis using a FEM to predict tissue/organ behavior and to help clinicians understand the reasons for target tissue/organ collapse and deformation.	[Lee, Jung-Seob; Ha, Dong-Heon; Cho, Dong-Woo] POSTECH, Dept Mech Engn, Pohang, South Korea; [Lee, Dong Chang; Kim, Sung Won] Catholic Univ Korea, Dept Otolaryngol Head & Neck Surg, Coll Med, Seoul, South Korea	Pohang University of Science & Technology (POSTECH); Catholic University of Korea	Cho, DW (corresponding author), POSTECH, Dept Mech Engn, Pohang, South Korea.; Kim, SW (corresponding author), Catholic Univ Korea, Dept Otolaryngol Head & Neck Surg, Coll Med, Seoul, South Korea.	kswent@catholic.ac.kr; dwcho@postech.ac.kr			National Research Foundation of Korea (NRF) grant - Ministry of Science, ICT and Future Planning [2010-0018294, 2014R1A2A2A01004325]; Korea Health Industry Development Institute - Ministry of Health and Welfare [HI14C3228]	National Research Foundation of Korea (NRF) grant - Ministry of Science, ICT and Future Planning; Korea Health Industry Development Institute - Ministry of Health and Welfare	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Ministry of Science, ICT and Future Planning (No. 2010-0018294, No. 2014R1A2A2A01004325) and the Korea Health Industry Development Institute funded by the Ministry of Health and Welfare (HI14C3228).	Gan RZ, 2004, ANN BIOMED ENG, V32, P847, DOI 10.1023/B:ABME.0000030260.22737.53; GLASGOLD MJ, 1988, OTOLARYNG HEAD NECK, V99, P374, DOI 10.1177/019459988809900404; Jang YJ, 2014, FACIAL PLAST SURG CL, V22, P357, DOI 10.1016/j.fsc.2014.04.001; Jin HR, 2011, AURIS NASUS LARYNX, V38, P157, DOI 10.1016/j.anl.2010.05.014; Jung JW, 2014, INT J PRECIS ENG MAN, V15, P2611, DOI 10.1007/s12541-014-0634-0; Jung JW, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4024570; Killlan G., 1905, ANN OTO RHINOL LARYN, V14, P363; Kim David W, 2006, Facial Plast Surg, V22, P9, DOI 10.1055/s-2006-939948; Kim JS, 2010, ANN PLAS SURG, V65, P519, DOI 10.1097/SAP.0b013e3181d59f95; Koike T, 2002, J ACOUST SOC AM, V111, P1306, DOI 10.1121/1.1451073; Kundu J, 2015, J TISSUE ENG REGEN M, V9, P1286, DOI 10.1002/term.1682; Lee JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119996; Lee SJ, 2010, LARYNGOSCOPE, V120, P1931, DOI 10.1002/lary.21072; Lee SJ, 2010, LARYNGOSCOPE, V120, P1508, DOI 10.1002/lary.20976; Liong Kyrin, 2013, J Med Eng, V2013, P250274, DOI 10.1155/2013/250274; Manuel CT, 2014, LARYNGOSCOPE, V124, P649, DOI 10.1002/lary.24321; Mau T, 2007, LARYNGOSCOPE, V117, P1902, DOI 10.1097/MLG.0b013e3181255ec4; Planas J, 1977, Clin Plast Surg, V4, P55; Richmon JD, 2005, AM J RHINOL, V19, P617, DOI 10.1177/194589240501900616; Richmon JD, 2006, AM J RHINOL, V20, P496, DOI 10.2500/ajr.2006.20.2932; Shamouelian D, 2015, LARYNGOSCOPE, V125, P326, DOI 10.1002/lary.24845; Toriumi DM, 2010, CLIN PLAST SURG, V37, P335, DOI 10.1016/j.cps.2009.12.008; Toriumi Dean M, 2007, Facial Plast Surg Clin North Am, V15, P293, DOI 10.1016/j.fsc.2007.04.003; Vampola T, 2011, J ACOUST SOC AM, V129, P310, DOI 10.1121/1.3506347	24	34	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153056	10.1371/journal.pone.0153056	http://dx.doi.org/10.1371/journal.pone.0153056			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073993	Green Published, Green Submitted, gold			2022-12-26	WOS:000374131200048
J	Li, CT; Chen, FM; Qi, FG; Liu, M; Li, Z; Liang, FL; Jing, XJ; Lu, GH; Wang, JQ				Li, Chuantao; Chen, Fuming; Qi, Fugui; Liu, Miao; Li, Zhao; Liang, Fulai; Jing, Xijing; Lu, Guohua; Wang, Jianqi			Searching for Survivors through Random Human-Body Movement Outdoors by Continuous-Wave Radar Array	PLOS ONE			English	Article							VITAL SIGN DETECTION; LIFE DETECTION; CANCELLATION; SYSTEM; SUPPRESSION; RADIATION; NOISE	It is a major challenge to search for survivors after chemical or nuclear leakage or explosions. At present, biological radar can be used to achieve this goal by detecting the survivor's respiration signal. However, owing to the random posture of an injured person at a rescue site, the radar wave may directly irradiate the person's head or feet, in which it is difficult to detect the respiration signal. This paper describes a multichannel-based antenna array technology, which forms an omnidirectional detection system via 24-GHz Doppler biological radar, to address the random positioning relative to the antenna of an object to be detected. Furthermore, since the survivors often have random body movement such as struggling and twitching, the slight movements of the body caused by breathing are obscured by these movements. Therefore, a method is proposed to identify random human-body movement by utilizing multichannel information to calculate the background variance of the environment in combination with a constant-false-alarm-rate detector. The conducted outdoor experiments indicate that the system can realize the omnidirectional detection of random human-body movement and distinguish body movement from environmental interference such as movement of leaves and grass. The methods proposed in this paper will be a promising way to search for survivors outdoors.	[Li, Chuantao; Chen, Fuming; Qi, Fugui; Liu, Miao; Li, Zhao; Liang, Fulai; Jing, Xijing; Lu, Guohua; Wang, Jianqi] Fourth Mil Med Univ, Dept Biomed Engn, Xian 710032, Peoples R China; [Wang, Jianqi] Shaanxi Univ Technol, Hanzhong, Peoples R China	Air Force Military Medical University; Shaanxi University of Technology	Lu, GH; Wang, JQ (corresponding author), Fourth Mil Med Univ, Dept Biomed Engn, Xian 710032, Peoples R China.; Wang, JQ (corresponding author), Shaanxi Univ Technol, Hanzhong, Peoples R China.	lugh1976@fmmu.edu.cn; wangjq@fmmu.edu.cn			National Natural Science Foundation of China [61327805, 61271102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work is supported by the National Natural Science Foundation of China (No. 61327805, No. 61271102). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chioukh L, 2014, IEEE T MICROW THEORY, V62, P1847, DOI 10.1109/TMTT.2014.2343934; Diebold S, 2012, J INFRARED MILLIM TE, V33, P1250, DOI 10.1007/s10762-012-9941-7; Gu CZ, 2013, IEEE T MICROW THEORY, V61, P4678, DOI 10.1109/TMTT.2013.2288226; Kazemi S, 2014, BIOMED SIGNAL PROCES, V13, P79, DOI 10.1016/j.bspc.2014.03.012; Lazaro A, 2014, SENSORS-BASEL, V14, P2595, DOI 10.3390/s140202595; Li CZ, 2008, IEEE T MICROW THEORY, V56, P3143, DOI 10.1109/TMTT.2008.2007139; Li CT, 2015, SENSORS-BASEL, V15, P14830, DOI 10.3390/s150714830; Li Z, 2013, IEEE T MICROW THEORY, V61, P2086, DOI 10.1109/TMTT.2013.2247054; Lin JC, 2006, IEEE ANTENN PROPAG M, V48, P157, DOI 10.1109/MAP.2006.1645601; Mikhelson IV, 2011, IEEE T BIO-MED ENG, V58, P1671, DOI 10.1109/TBME.2011.2111371; Nicholls B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006246; Rohling H, 1983, AEROSPACE ELECT SYST, P608; Sachs J, 2014, AD HOC NETW, V13, P42, DOI 10.1016/j.adhoc.2012.07.002; Wang FK, 2011, IEEE T MICROW THEORY, V59, P3577, DOI 10.1109/TMTT.2011.2171712; Wiesner S, 2007, ENG MED BIOL SOC 200; Yu X, 2011, MICR S MTT 2011 IEEE; Zhang Y, 2015, IEEE GEOSCI REMOTE S, V12, P482, DOI 10.1109/LGRS.2014.2347294	17	9	9	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152201	10.1371/journal.pone.0152201	http://dx.doi.org/10.1371/journal.pone.0152201			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073860	Green Published, gold			2022-12-26	WOS:000374131200017
J	Nillius, D; von Muller, L; Wagenpfeil, S; Klein, R; Herrmann, M				Nillius, Dorothea; von Mueller, Lutz; Wagenpfeil, Stefan; Klein, Renate; Herrmann, Mathias			Methicillin-Resistant Staphylococcus aureus in Saarland, Germany: The Long-Term Care Facility Study	PLOS ONE			English	Article							NURSING-HOMES; MRSA INFECTION; RISK-FACTORS; METICILLIN-RESISTANT; MOLECULAR EPIDEMIOLOGY; NOSOCOMIAL INFECTION; HOSPITAL ADMISSION; GERIATRIC UNIT; COLONIZATION; PREVALENCE	Background Multiresistant organisms pose a threat for patients and care recipients. Control interventions need to be tailored to region, the type of institution considered, and risk factors. The German state of Saarland is ideally suited to study colonisation epidemiology throughout its various health and care institutions. After conclusion of a large admission prevalence study in acute care hospitals, we now performed a methicillin-resistant Staphylococcus aureus (MRSA) point prevalence study in Saarland long term care facilities (LTCF), allowing for a direct comparison with respect of MRSA prevalence and associated risk factors between these two institutional types located within a confined region. Methodology and Principal Findings Of all LTCF of the region, 65/136 participated in the study performed between 09/2013 and 07/2014. Overall, complete microbiological specimen and questionnaires of 2,858 of 4,275 (66.8%) LTCF residents were obtained. 136/2,858 (4.8%) screened residents revealed MRSA carrier status. Multivariate risk factor analysis yielded ulcer/deep soft tissue infection, urinary tract catheter, and MRSA history with multiple MRSA decolonisation cycles to be independently associated with MRSA carrier status. Conclusion As already known from previous studies, colonisation with MRSA is common in LTCF residents even in an area with relatively low MRSA prevalence. This found prevalence can now be related to the acute care admission prevalence (2.2%) as well as to the admission prevalence in acute care geriatric departments (7.6%). The common clonal attribution (spa type) of MRSA isolates prevalent in the LTCF population as well as in the acute care admission population points towards a close relationship between both types of institutions. However, the ostensible absence of risk factors such as "previous hospitalisation" in conjunction with newly identified factors such as "multiple decolonisation cycles" refers to MRSA colonisation risks independent of contact with acute care facilities. Overall, this large LTCF point prevalence study allows data-based, region-tailored decisions on MRSA screening policies and provides a basis for additional preventative measures.	[Nillius, Dorothea; von Mueller, Lutz; Herrmann, Mathias] Univ Saarland, Inst & State Lab Med Microbiol & Hyg, Homburg, Germany; [Nillius, Dorothea; von Mueller, Lutz; Herrmann, Mathias] Univ Saarland, Med Ctr, Homburg, Germany; [Wagenpfeil, Stefan] Univ Saarland, Inst Med Biometry Epidemiol & Med Informat, Homburg, Germany; [Klein, Renate] Saarland Minist Social Affairs Hlth Women & Famil, Saarbrucken, Germany; [von Mueller, Lutz] Christophorus Kliniken GmbH, Inst Lab Med Microbiol & Hyg LMH, Coesfeld, Germany	Saarland University; Saarland University; Saarland University	Nillius, D (corresponding author), Univ Saarland, Inst & State Lab Med Microbiol & Hyg, Homburg, Germany.; Nillius, D (corresponding author), Univ Saarland, Med Ctr, Homburg, Germany.	dorothea.nillius@gmx.de	Herrmann, Mathias/B-6475-2013	Herrmann, Mathias/0000-0003-2638-2257; von Muller, Lutz/0000-0001-9013-4245	State of Saarland; German Minister of Health [IIA5-2512FSB101]	State of Saarland; German Minister of Health	This study was supported by a fund of the State of Saarland, and a grant of the German Minister of Health, grant IIA5-2512FSB101. Neither funding body had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The acknowledgment of one of the coauthors (RK) is solely for the purpose of declaring her employment by the State of Saarland Ministry of Social Affairs, Health, Women and Families (part of the State of Saarland Government); it does not impede the above statement.	Andersson H, 2012, SCAND J INFECT DIS, V44, P641, DOI 10.3109/00365548.2012.671956; [Anonymous], 2005, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V48, P1061; Barr B, 2007, INFECT CONT HOSP EP, V28, P853, DOI 10.1086/516795; Becker K, 2016, J CLIN MICROBIOL, V54, P180, DOI 10.1128/JCM.02081-15; Bellini C, 2015, INFECT CONT HOSP EP, V36, P401, DOI 10.1017/ice.2014.74; Bourbeau PP, 2009, J CLIN MICROBIOL, V47, P1101, DOI 10.1128/JCM.01963-08; Bradley SF, 1997, DRUG AGING, V10, P185, DOI 10.2165/00002512-199710030-00003; Cassone M, 2015, CURR GERIATR REP, V4, P87, DOI 10.1007/s13670-015-0120-2; Cheng VCC, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-205; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; Couderc C, 2014, CLIN INFECT DIS, V59, P206, DOI 10.1093/cid/ciu236; Datta R, 2008, CLIN INFECT DIS, V47, P176, DOI 10.1086/589241; Davis KA, 2004, CLIN INFECT DIS, V39, P776, DOI 10.1086/422997; de Kraker MEA, 2011, ANTIMICROB AGENTS CH, V55, P1598, DOI 10.1128/AAC.01157-10; Eveillard M, 2008, AGE AGEING, V37, P294, DOI 10.1093/ageing/afn021; Fallon EO, 2009, J GERONTOL A-BIOL, V64, P138, DOI 10.1093/gerona/gln020; Grabe C, 2010, EPIDEMIOL B, V18, P163; Greenland K, 2011, J AM GERIATR SOC, V59, P768, DOI 10.1111/j.1532-5415.2011.03325.x; Greub G, 2011, CLIN MICROBIOL INFEC, V17, P655, DOI 10.1111/j.1469-0691.2011.03513.x; Gruber I, 2013, INT J MED MICROBIOL, V303, P405, DOI 10.1016/j.ijmm.2013.05.002; Hamed M, 2015, INFECT GENET EVOL, V36, P475, DOI 10.1016/j.meegid.2015.08.020; Harbarth S, 2008, JAMA-J AM MED ASSOC, V299, P1149, DOI 10.1001/jama.299.10.1149; Herrmann M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073876; Hetem DJ, 2013, EMERG INFECT DIS, V19, P1797, DOI 10.3201/eid1911.121085; Heudorf U, 2014, BUNDESGESUNDHEITSBLA, V57, P414, DOI 10.1007/s00103-013-1927-7; Ho KM, 2009, ANAESTH INTENS CARE, V37, P457, DOI 10.1177/0310057X0903700320; Hogardt M, 2015, EURO SURVEILL, V20; Huang SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024340; Jans B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064908; Kock R, 2009, J HOSP INFECT, V71, P320, DOI 10.1016/j.jhin.2008.12.001; Kommission fur Krankenhaushygiene und Infektionspravention (KRINKO) beim Robert Koch-Institut, 2014, BUNDESGESUNDHEITSBLA, V57, P696; KRINKO, 1999, BUNDESGESUNDHEITSBLA, V42, P954; Manzur A, 2008, CLIN MICROBIOL INFEC, V14, P867, DOI 10.1111/j.1469-0691.2008.02060.x; March A, 2010, CLIN MICROBIOL INFEC, V16, P934, DOI 10.1111/j.1469-0691.2009.03024.x; Mehraj J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107937; Mellmann A, 2006, PLOS MED, V3, P348, DOI 10.1371/journal.pmed.0030033; Meyer E, 2014, DTSCH ARZTEBL INT, V111, P331, DOI 10.3238/arztebl.2014.0331; Morgan M, 2008, J ANTIMICROB CHEMOTH, V62, P1181, DOI 10.1093/jac/dkn405; Mossong J, 2013, EPIDEMIOL INFECT, V141, P1199, DOI 10.1017/S0950268812001999; Neuhaus B, 2002, BUNDESGESUNDHEITSBLA, V45, P894; Pfingsten-Wurzburg S, 2011, J HOSP INFECT, V78, P108, DOI 10.1016/j.jhin.2011.02.011; Pujol M, 1996, AM J MED, V100, P509, DOI 10.1016/S0002-9343(96)00014-9; Rabinowitz RP, 2012, PM&R, V4, P18, DOI 10.1016/j.pmrj.2011.09.011; Reynolds C, 2011, INFECT CONT HOSP EP, V32, P91, DOI 10.1086/657637; Robinson JO, 2014, CLIN MICROBIOL INFEC, V20, P530, DOI 10.1111/1469-0691.12388; Schaumburg F, 2012, J CLIN MICROBIOL, V50, P3186, DOI 10.1128/JCM.01174-12; Schoevaerdts D, 2012, J INFECTION, V65, P109, DOI 10.1016/j.jinf.2012.02.004; STAMM AM, 1993, AM J INFECT CONTROL, V21, P70, DOI 10.1016/0196-6553(93)90227-U; Stenehjem E, 2013, AM J INFECT CONTROL, V41, P405, DOI 10.1016/j.ajic.2012.07.017; Trick WE, 2001, J AM GERIATR SOC, V49, P270, DOI 10.1046/j.1532-5415.2001.4930270.x; von Baum H, 2002, INFECT CONT HOSP EP, V23, P511, DOI 10.1086/502098; Warnke P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111627; Warnke P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089667; Whitby M, 2003, CLIN INFECT DIS, V37, P459, DOI 10.1086/375846; Whitby M, 2001, MED J AUSTRALIA, V175, P264, DOI 10.5694/j.1326-5377.2001.tb143562.x; Woltering R, 2008, DEUT MED WOCHENSCHR, V133, P999, DOI 10.1055/s-2008-1075683; Yaw LK, 2014, LANCET INFECT DIS, V14, P967, DOI 10.1016/S1473-3099(14)70876-X; Yoshida Junichi, 2013, Infect Drug Resist, V6, P59, DOI 10.2147/IDR.S45843	58	18	18	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153030	10.1371/journal.pone.0153030	http://dx.doi.org/10.1371/journal.pone.0153030			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073899	Green Submitted, Green Published, gold			2022-12-26	WOS:000374131200046
J	Xerxa, E; Barbisin, M; Chieppa, MN; Krmac, H; Vallino Costassa, E; Vatta, P; Simmons, M; Caramelli, M; Casalone, C; Corona, C; Legname, G				Xerxa, Elena; Barbisin, Maura; Chieppa, Maria Novella; Krmac, Helena; Vallino Costassa, Elena; Vatta, Paolo; Simmons, Marion; Caramelli, Maria; Casalone, Cristina; Corona, Cristiano; Legname, Giuseppe			Whole Blood Gene Expression Profiling in Preclinical and Clinical Cattle Infected with Atypical Bovine Spongiform Encephalopathy	PLOS ONE			English	Article							LONG NONCODING RNAS; MICROARRAY ANALYSIS; X-CHROMOSOME; PRION; IDENTIFICATION; PROTEIN; BSE; TRANSMISSION; SCRAPIE; DISEASE	Prion diseases, such as bovine spongiform encephalopathies (BSE), are transmissible neurodegenerative disorders affecting humans and a wide variety of mammals. Variant Creutzfeldt-Jakob disease (vCJD), a prion disease in humans, has been linked to exposure to BSE prions. This classical BSE (cBSE) is now rapidly disappearing as a result of appropriate measures to control animal feeding. Besides cBSE, two atypical forms (named Hand L-type BSE) have recently been described in Europe, Japan, and North America. Here we describe the first wide-spectrum microarray analysis in whole blood of atypical BSE-infected cattle. Transcriptome changes in infected animals were analyzed prior to and after the onset of clinical signs. The microarray analysis revealed gene expression changes in blood prior to the appearance of the clinical signs and during the progression of the disease. A set of 32 differentially expressed genes was found to be in common between clinical and preclinical stages and showed a very similar expression pattern in the two phases. A 22-gene signature showed an oscillating pattern of expression, being differentially expressed in the preclinical stage and then going back to control levels in the symptomatic phase. One gene, SEL1L3, was downregulated during the progression of the disease. Most of the studies performed up to date utilized various tissues, which are not suitable for a rapid analysis of infected animals and patients. Our findings suggest the intriguing possibility to take advantage of whole blood RNA transcriptional profiling for the preclinical identification of prion infection. Further, this study highlighted several pathways, such as immune response and metabolism that may play an important role in peripheral prion pathogenesis. Finally, the gene expression changes identified in the present study may be further investigated as a fingerprint for monitoring the progression of disease and for developing targeted therapeutic interventions.	[Xerxa, Elena; Barbisin, Maura; Krmac, Helena; Vatta, Paolo; Legname, Giuseppe] SISSA, Funct & Struct Genom Sect, Trieste, Italy; [Chieppa, Maria Novella; Vallino Costassa, Elena; Caramelli, Maria; Casalone, Cristina; Corona, Cristiano] Ist Zooprofilatt Sperimentale Piemonte Liguria &, Turin, Italy; [Simmons, Marion] Anim & Plant Hlth Agcy Weybridge, Dept Pathol, Addlestone, Surrey, England	International School for Advanced Studies (SISSA); IZS Piemonte Liguria e Valle D'aosta; Animal & Plant Health Agency UK	Legname, G (corresponding author), SISSA, Funct & Struct Genom Sect, Trieste, Italy.	legname@sissa.it	Legname, Giuseppe/C-1723-2012; Casalone, Cristina/J-6763-2018; Costassa, Elena Vallino/N-7639-2019; Vallino Costassa, Elena/J-4026-2018	Legname, Giuseppe/0000-0003-0716-4393; Casalone, Cristina/0000-0001-5271-832X; Costassa, Elena Vallino/0000-0001-8582-1294; Vallino Costassa, Elena/0000-0001-8582-1294	European Regional Development Fund; Cross-Border Cooperation Italy-Slovenia, Programme; Strategic Project TRANS2CARE; Italian Ministry of University and Research under the FIRB program [RBAP11FRE9, IZSPLV 24/07RC, RF-2009-1474758, IZSPLV 05/11RC]	European Regional Development Fund(European Commission); Cross-Border Cooperation Italy-Slovenia, Programme; Strategic Project TRANS2CARE; Italian Ministry of University and Research under the FIRB program	Funded by European Regional Development Fund, Cross-Border Cooperation Italy-Slovenia, Programme 2007-2013, Strategic Project TRANS2CARE and by the Italian Ministry of University and Research under the FIRB program RBAP11FRE9 to G. Legname as well as IZSPLV 24/07RC to MC, RF-2009-1474758 to C. Casalone, and IZSPLV 05/11RC to C. Corona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2000, CELL DEATH DIFFER, V7, P889, DOI 10.1038/sj.cdd.4400737; Almeida LM, 2011, GENET MOL RES, V10, P3948, DOI 10.4238/2011.October.25.5; Balkema-Buschmann A, 2011, PREV VET MED, V102, P112, DOI 10.1016/j.prevetmed.2011.04.006; Barbisin M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-434; Baron TGM, 2006, EMERG INFECT DIS, V12, P1125; Basu U, 2012, CURR GENOMICS, V13, P369, DOI 10.2174/138920212801619223; Basu U, 2012, PRION, V6, P282, DOI 10.4161/pri.19915; Beringue V, 2007, J NEUROSCI, V27, P6965, DOI 10.1523/JNEUROSCI.0693-07.2007; Biacabe AG, 2004, EMBO REP, V5, P110, DOI 10.1038/sj.embor.7400054; Biagioli M, 2009, P NATL ACAD SCI USA, V106, P15454, DOI 10.1073/pnas.0813216106; BLOMSTROM DC, 1986, J BIOL CHEM, V261, P8811; Booth S, 2004, J GEN VIROL, V85, P3459, DOI 10.1099/vir.0.80110-0; Borovecki F, 2005, P NATL ACAD SCI USA, V102, P11023, DOI 10.1073/pnas.0504921102; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Buschmann A, 2006, VET MICROBIOL, V117, P103, DOI 10.1016/j.vetmic.2006.06.016; Calingasan NY, 2002, NEUROBIOL AGING, V23, P31, DOI 10.1016/S0197-4580(01)00246-9; Capobianco R, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030031; Casalone C, 2004, P NATL ACAD SCI USA, V101, P3065, DOI 10.1073/pnas.0305777101; Colby DW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a006833; Dudas S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010638; Filali H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-59; Filali H, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-14; Filali H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-399; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Henderson ST, 2008, NEUROTHERAPEUTICS, V5, P470, DOI 10.1016/j.nurt.2008.05.004; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jacobs JG, 2007, J CLIN MICROBIOL, V45, P1821, DOI 10.1128/JCM.00160-07; Johnson R, 2012, NEUROBIOL DIS, V46, P245, DOI 10.1016/j.nbd.2011.12.006; Kabanova S, 2009, INT J MED SCI, V6, P156; Khaniya B, 2009, J TOXICOL ENV HEAL A, V72, P1008, DOI 10.1080/15287390903084199; Kim Hyeon O, 2008, Adv Appl Bioinform Chem, V1, P29; Kong QZ, 2008, J VIROL, V82, P3697, DOI 10.1128/JVI.02561-07; Konold T, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-22; Lloyd S, 2011, TOP CURR CHEM, V305, P1, DOI 10.1007/128_2011_157; Loeuillet C, 2010, J INFECT DIS, V202, P648, DOI 10.1086/654818; Lombardi G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000075; Lyahyai J, 2010, ANIM BIOTECHNOL, V21, P1, DOI 10.1080/10495390903323851; Masujin K, 2008, PRION, V2, P123, DOI 10.4161/pri.2.3.7437; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; Ness SA, 2007, MOL BIOTECHNOL, V36, P205, DOI 10.1007/s12033-007-0012-6; Nguyen DK, 2006, NAT GENET, V38, P47, DOI 10.1038/ng1705; Okada H, 2012, VET PATHOL, V49, P819, DOI 10.1177/0300985811427150; Panelli S, 2011, J TOXICOL ENV HEAL A, V74, P96, DOI 10.1080/15287394.2011.529059; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Polak MP, 2012, VET J, V191, P128, DOI 10.1016/j.tvjl.2010.12.019; Priemer G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067599; Prusiner SB, 2001, NEW ENGL J MED, V344, P1516, DOI 10.1056/NEJM200105173442006; Reger MA, 2004, NEUROBIOL AGING, V25, P311, DOI 10.1016/S0197-4580(03)00087-3; Richt JA, 2007, J VET DIAGN INVEST, V19, P142, DOI 10.1177/104063870701900202; Sanges R, 2007, BIOINFORMATICS, V23, P3406, DOI 10.1093/bioinformatics/btm469; Sawiris GP, 2007, J GEN VIROL, V88, P1356, DOI 10.1099/vir.0.82387-0; Seipelt M, 1999, J NEUROL NEUROSUR PS, V66, P172, DOI 10.1136/jnnp.66.2.172; Shephard F, 2014, MITOCHONDRION, V14, P64, DOI 10.1016/j.mito.2013.12.001; Simmons MM, 2011, VET PATHOL, V48, P948, DOI 10.1177/0300985810387072; Skinner PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-114; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Straub AC, 2012, NATURE, V491, P473, DOI 10.1038/nature11626; Sun YZ, 2013, MED HYPOTHESES, V81, P319, DOI 10.1016/j.mehy.2013.04.010; Szutowicz A, 2013, NEUROCHEM RES, V38, P1523, DOI 10.1007/s11064-013-1060-x; Tan J, 1999, SCIENCE, V286, P2352, DOI 10.1126/science.286.5448.2352; Tang Y, 2009, J VIROL, V83, P9464, DOI 10.1128/JVI.00352-09; Team C, 2013, R LANG ENV STAT COMP; Tester S, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-64; Torres JM, 2011, EMERG INFECT DIS, V17, P1636, DOI 10.3201/eid1709.101403; Tortosa R, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-109; Tylee DS, 2013, AM J MED GENET B, V162, P595, DOI 10.1002/ajmg.b.32150; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang Ren-Gang, 2012, Shengli Xuebao, V64, P577; Wang RG, 2011, GLIA, V59, P946, DOI 10.1002/glia.21167; Warnes Gregory R., 2014, GPLOTS VARIOUS RPROG; WELLS GAH, 1987, VET REC, V121, P419, DOI 10.1136/vr.121.18.419; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Wilson R, 2013, J GEN VIROL, V94, P2819, DOI 10.1099/vir.0.052738-0; Yamakawa Y, 2003, JPN J INFECT DIS, V56, P221; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhang S, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-10	80	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153425	10.1371/journal.pone.0153425	http://dx.doi.org/10.1371/journal.pone.0153425			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073865	Green Published, gold, Green Submitted			2022-12-26	WOS:000374131200090
J	Dewa, CS; Trojanowski, L; Tamminga, SJ; Ringash, J; McQuestion, M; Hoch, JS				Dewa, Carolyn S.; Trojanowski, Lucy; Tamminga, Sietske J.; Ringash, Jolie; McQuestion, Maurene; Hoch, Jeffrey S.			Advice about Work-Related Issues to Peers and Employers from Head and Neck Cancer Survivors	PLOS ONE			English	Article							META-SYNTHESIS; RETURN; EXPERIENCES; DISABILITY; INTERVIEWS	Purpose The purpose of this exploratory and descriptive study is to contribute to the sparse return-towork literature on head and neck cancer (HNC) survivors. Interview participants were asked to reflect upon their work-related experience with cancer by answering two specific questions: (1) What advice would you give someone who has been newly diagnosed with head and neck cancer? (2) What advice would you give to employers of these people? Methods Data were gathered through 10 individual semi-structured in-depth interviews with HNC clinic patients at a regional cancer center's head and neck clinic in Ontario, Canada. A constant comparative method of theme development was used. Codes identified in and derived from the data were discussed by research team members until consensus was reached. Codes with similar characteristics were grouped together and used to develop overarching themes. Results Work-related advice for peers focused on personal self-care and interactions within workplaces. Work-related advice to employers focused on demonstrating basic human values as well as the importance of communication. Discussion The study results suggest HNC clinic patients should be proactive with employers and help to set reasonable expectations and provide a realistic plan for work to be successfully completed. HNC clinic patients should develop communication skills to effectively disclose their cancer and treatment to employers. Conclusions In this exploratory study, HNC clinic patients' advice was solution-focused underscoring the importance of self-care and pro-active communication and planning with employers. Employers were advised to demonstrate core human values throughout all phases of the work disability episode beginning at diagnosis.	[Dewa, Carolyn S.; Trojanowski, Lucy] Ctr Addict & Mental Hlth, Ctr Res Employment & Workpl Hlth, Toronto, ON, Canada; [Dewa, Carolyn S.] Univ Calif Davis, Dept Psychiat & Behav Sci, Sacramento, CA 95817 USA; [Dewa, Carolyn S.; Hoch, Jeffrey S.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Tamminga, Sietske J.] Univ Amsterdam, Acad Med Ctr, Coronel Inst Occupat Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Ringash, Jolie; McQuestion, Maurene] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Hoch, Jeffrey S.] Univ Calif Davis, Dept Publ Hlth Sci, Davis, CA 95616 USA	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of California System; University of California Davis; University of Toronto; University of Amsterdam; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of California System; University of California Davis	Dewa, CS (corresponding author), Ctr Addict & Mental Hlth, Ctr Res Employment & Workpl Hlth, Toronto, ON, Canada.; Dewa, CS (corresponding author), Univ Calif Davis, Dept Psychiat & Behav Sci, Sacramento, CA 95817 USA.; Dewa, CS (corresponding author), Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.	csdewa@ucdavis.ca	Hoch, Jeffrey/O-3406-2017	Hoch, Jeffrey/0000-0002-4880-4281; Ringash, Jolie/0000-0002-7337-0411; Dewa, Carolyn/0000-0001-5647-3905; Tamminga, Sietske/0000-0002-2228-1187	Canadian Centre for Applied Research in Cancer Control [19789]; Dr. Dewa's Canadian Institutes of Health Research/Public Health Agency of Canada Applied Public Health Chair [86895]	Canadian Centre for Applied Research in Cancer Control; Dr. Dewa's Canadian Institutes of Health Research/Public Health Agency of Canada Applied Public Health Chair	This study was funded by Canadian Centre for Applied Research in Cancer Control (Grant #19789) and Dr. Dewa's Canadian Institutes of Health Research/Public Health Agency of Canada Applied Public Health Chair (Grant # 86895). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Canadian Partnership Against Cancer, 2012, RES REL WORKPL SUPP; Creswell J. W., 2014, RES DESIGN QUALITATI, V4th; Dewa CS, 2016, CAN J PSYCHIAT, V61, P176, DOI 10.1177/0706743716632515; DiCicco-Bloom B, 2006, MED EDUC, V40, P314, DOI 10.1111/j.1365-2929.2006.02418.x; Feuerstein M, 2005, J OCCUP REHABIL, V15, P1, DOI 10.1007/s10926-005-0868-x; Forte T, 2012, CANCER CAUSE CONTROL, V23, P1343, DOI 10.1007/s10552-012-0013-z; Garnaes E, 2015, INT J CANCER, V136, P2196, DOI 10.1002/ijc.29254; GLASER BG, 1965, SOC PROBL, V12, P436, DOI 10.1525/sp.1965.12.4.03a00070; Government of Canada, 2014, SICK LEAV WORK REL I; Grunfeld EA, 2010, OCCUP MED-OXFORD, V60, P611, DOI 10.1093/occmed/kqq143; Grunfeld EA, 2008, J OCCUP REHABIL, V18, P381, DOI 10.1007/s10926-008-9152-1; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Harry B., 2005, ED RES, V34, P3, DOI [10.3102/0013189X034002003, DOI 10.3102/0013189X034002003]; Huang SH, 2015, J CLIN ONCOL, V33, P836, DOI 10.1200/JCO.2014.58.6412; Isaksson J, 2016, SUPPORT CARE CANCER, V24, P205, DOI 10.1007/s00520-015-2769-7; Johnson-Obaseki S, 2012, OTOLARYNG HEAD NECK, V147, P74, DOI 10.1177/0194599812437332; Kennedy F, 2007, EUR J CANCER CARE, V16, P17, DOI 10.1111/j.1365-2354.2007.00729.x; Loisel P, 2005, J OCCUP REHABIL, V15, P507, DOI 10.1007/s10926-005-8031-2; McDonald JT, 2014, J OTOLARYNGOL-HEAD N, V43, DOI 10.1186/1916-0216-43-2; McKay G, 2013, J OCCUP REHABIL, V23, P93, DOI 10.1007/s10926-012-9386-9; Mehnert A, 2011, CRIT REV ONCOL HEMAT, V77, P109, DOI 10.1016/j.critrevonc.2010.01.004; National Cancer Institute, 2004, NAT ACT PLAN CANC SU; Nilsson M, 2011, EUR J ONCOL NURS, V15, P267, DOI 10.1016/j.ejon.2011.03.005; Patton M. Q., 1990, QUALITATIVE EVALUATI; Pryce J, 2007, J OCCUP REHABIL, V17, P83, DOI 10.1007/s10926-006-9040-5; Richardson A, 2011, BRIT J CANCER, V105, pS82, DOI 10.1038/bjc.2011.425; Saldana J., 2021, CODING MANUAL QUALIT, P1; Service Canada, 2014, GEN INF EMPL INS PRE; Spelten ER, 2002, PSYCHO-ONCOL, V11, P124, DOI 10.1002/pon.585; Stergiou-Kita M, 2014, J CANCER SURVIV, V8, P657, DOI 10.1007/s11764-014-0377-z; Tamminga SJ, 2012, SCAND J WORK ENV HEA, V38, P144, DOI 10.5271/sjweh.3199; Tiedtke C, 2014, J OCCUP REHABIL, V24, P399, DOI 10.1007/s10926-013-9465-6; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Verdonck-de Leeuw IM, 2010, ORAL ONCOL, V46, P56, DOI 10.1016/j.oraloncology.2009.11.001; Wells M, 2013, PSYCHO-ONCOLOGY, V22, P1208, DOI 10.1002/pon.3148	35	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0152944	10.1371/journal.pone.0152944	http://dx.doi.org/10.1371/journal.pone.0152944			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ0NI	27070654	Green Published, gold			2022-12-26	WOS:000373900700022
J	Sharpe, RM; Koepke, T; Harper, A; Grimes, J; Galli, M; Satoh-Cruz, M; Kalyanaraman, A; Evans, K; Kramer, D; Dhingra, A				Sharpe, Richard M.; Koepke, Tyson; Harper, Artemus; Grimes, John; Galli, Marco; Satoh-Cruz, Mio; Kalyanaraman, Ananth; Evans, Katherine; Kramer, David; Dhingra, Amit			CisSERS: Customizable In Silico Sequence Evaluation for Restriction Sites	PLOS ONE			English	Article							MARKER DEVELOPMENT; SNP DISCOVERY; TOOL; DESIGN; PROGRAM; DNA; PCR	High-throughput sequencing continues to produce an immense volume of information that is processed and assembled into mature sequence data. Data analysis tools are urgently needed that leverage the embedded DNA sequence polymorphisms and consequent changes to restriction sites or sequence motifs in a high-throughput manner to enable biological experimentation. CisSERS was developed as a standalone open source tool to analyze sequence datasets and provide biologists with individual or comparative genome organization information in terms of presence and frequency of patterns or motifs such as restriction enzymes. Predicted agarose gel visualization of the custom analyses results was also integrated to enhance the usefulness of the software. CisSERS offers several novel functionalities, such as handling of large and multiple datasets in parallel, multiple restriction enzyme site detection and custom motif detection features, which are seamlessly integrated with real time agarose gel visualization. Using a simple fasta-formatted file as input, CisSERS utilizes the REBASE enzyme database. Results from CisSERS enable the user to make decisions for designing genotyping by sequencing experiments, reduced representation sequencing, 3'UTR sequencing, and cleaved amplified polymorphic sequence (CAPS) molecular markers for large sample sets. CisSERS is a java based graphical user interface built around a perl backbone. Several of the applications of CisSERS including CAPS molecular marker development were successfully validated using wet-lab experimentation. Here, we present the tool CisSERS and results from in-silico and corresponding wet-lab analyses demonstrating that CisSERS is a technology platform solution that facilitates efficient data utilization in genomics and genetics studies.	[Sharpe, Richard M.; Koepke, Tyson; Dhingra, Amit] Washington State Univ, Mol Plant Sci Grad Program, Pullman, WA 99164 USA; [Koepke, Tyson; Harper, Artemus; Galli, Marco; Evans, Katherine; Dhingra, Amit] Washington State Univ, Dept Hort, Pullman, WA 99164 USA; [Sharpe, Richard M.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; [Grimes, John; Kalyanaraman, Ananth] Washington State Univ, Elect Engn & Comp Sci, Pullman, WA 99164 USA; [Satoh-Cruz, Mio; Kramer, David] Michigan State Univ, MSU DOE Plant Res Lab, E Lansing, MI 48824 USA	Washington State University; Washington State University; Washington State University; Washington State University; Michigan State University; United States Department of Energy (DOE)	Dhingra, A (corresponding author), Washington State Univ, Mol Plant Sci Grad Program, Pullman, WA 99164 USA.; Dhingra, A (corresponding author), Washington State Univ, Dept Hort, Pullman, WA 99164 USA.	adhingra@wsu.edu	Dhingra, Amit/E-7369-2010; Dhingra, Amit/AAX-9566-2020; Kramer, David/B-9588-2016	Dhingra, Amit/0000-0002-4464-2502; Kramer, David/0000-0003-2181-6888; Sharpe, Richard/0000-0002-8513-4862; EVANS, KATE/0000-0002-2184-7433	WSU Agriculture Research Center Hatch funds; Department of Agriculture National Research Initiative (USDA-NRI) [2008 -35300-04676]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008336] Funding Source: NIH RePORTER	WSU Agriculture Research Center Hatch funds; Department of Agriculture National Research Initiative (USDA-NRI); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by WSU Agriculture Research Center Hatch funds to AD and KE. US Department of Agriculture National Research Initiative (USDA-NRI) grant 2008 -35300-04676 to AD and AK supported AH and JG. TAK acknowledges the National Institutes of Health Protein Biotechnology Training Grant T32GM008336 and ARCS Fellowship Program. RMS's work was supported by the National Science Foundation under Grants IOS 0641232 and MCB 1146928 and by Civilian Research and Development Foundation Grant RUB1-2982-ST-10 to Gerald E. Edwards, WSU. Work related to characterization of the cfq mutant was supported by US Department of Energy, Office of Science, Basic Energy Sciences Program DE-FG02-04ERl5559 to DMK.	Agarwal M, 2008, PLANT CELL REP, V27, P617, DOI 10.1007/s00299-008-0507-z; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Chang HW, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-173; Chang HW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-30; Chutimanitsakun Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-4; Eveland AL, 2008, PLANT PHYSIOL, V146, P32, DOI 10.1104/pp.107.108597; Gaudet M, 2007, PLANT MOL BIOL REP, V25, P1, DOI 10.1007/s11105-007-0003-6; Ilic K, 2004, TRENDS GENET, V20, P280, DOI 10.1016/j.tig.2004.04.012; Koepke T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-18; Krishnan V, 2009, COMPUTATIONAL APPROA; Neff MM, 2002, TRENDS GENET, V18, P613, DOI 10.1016/S0168-9525(02)02820-2; Sanchez CC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-559; Shu YJ, 2011, MOL BIOL REP, V38, P1841, DOI 10.1007/s11033-010-0300-2; Taylor J, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-27; Thiel T, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh006; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Vincze T, 2003, NUCLEIC ACIDS RES, V31, P3688, DOI 10.1093/nar/gkg526; Williams G, EMBOSS TRIMEST; Zhang RF, 2005, NUCLEIC ACIDS RES, V33, pW489, DOI 10.1093/nar/gki358	20	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0152404	10.1371/journal.pone.0152404	http://dx.doi.org/10.1371/journal.pone.0152404			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27071032	Green Published, Green Submitted, gold			2022-12-26	WOS:000373900700009
J	Ferdous, Z; Qureshi, MA; Jayaprakash, P; Parekh, K; John, A; Oz, M; Raza, H; Dobrzynski, H; Adrian, TE; Howarth, FC				Ferdous, Zannatul; Qureshi, Muhammad Anwar; Jayaprakash, Petrilla; Parekh, Khatija; John, Annie; Oz, Murat; Raza, Haider; Dobrzynski, Halina; Adrian, Thomas Edward; Howarth, Frank Christopher			Different Profile of mRNA Expression in Sinoatrial Node from Streptozotocin-Induced Diabetic Rat	PLOS ONE			English	Article							ATRIAL-NATRIURETIC-PEPTIDE; RECEPTOR POTENTIAL CHANNELS; VENTRICULAR MYOCYTES; GENE-EXPRESSION; HEART-FAILURE; INTRACELLULAR CALCIUM; CONDUCTING SYSTEM; BEATING RATE; CA2+; CONTRACTION	Background Experiments in isolated perfused heart have shown that heart rate is lower and sinoatrial node (SAN) action potential duration is longer in streptozotocin (STZ)-induced diabetic rat compared to controls. In sino-atrial preparations the pacemaker cycle length and sino-atrial conduction time are prolonged in STZ heart. To further clarify the molecular basis of electrical disturbances in the diabetic heart the profile of mRNA encoding a wide variety of proteins associated with the generation and transmission of electrical activity has been evaluated in the SAN of STZ-induced diabetic rat heart. Methodology/Principal Findings Heart rate was measured in isolated perfused heart with an extracellular suction electrode. Expression of mRNA encoding a variety of intercellular proteins, intracellular Ca2+-transport and regulatory proteins, cell membrane transport proteins and calcium, sodium and potassium channel proteins were measured in SAN and right atrial (RA) biopsies using real-time reverse transcription polymerase chain reaction techniques. Heart rate was lower in STZ (203 +/- 7 bpm) compared to control (239 +/- 11 bpm) rat. Among many differences in the profile of mRNA there are some worthy of particular emphasis. Expression of genes encoding some proteins were significantly downregulated in STZ-SAN: calcium channel, Cacng4 (7-fold); potassium channel, Kcnd2 whilst genes encoding some other proteins were significantly upregulated in STZ-SAN: gap junction, Gjc1; cell membrane transport, Slc8a1, Trpc1, Trpc6 (4-fold); intracellular Ca2+-transport, Ryr3; calcium channel Cacna1g, Cacna1h, Cacnb3; potassium channels, Kcnj5, Kcnk3 and natriuretic peptides, Nppa (5-fold) and Nppb (7-fold). Conclusions/Significance Collectively, this study has demonstrated differences in the profile of mRNA encoding a variety of proteins that are associated with the generation, conduction and regulation of electrical signals in the SAN of STZ-induced diabetic rat heart. Data from this study will provide a basis for a substantial range of future studies to investigate whether these changes in mRNA translate into changes in electrophysiological function.	[Ferdous, Zannatul; Qureshi, Muhammad Anwar; Jayaprakash, Petrilla; Parekh, Khatija; Adrian, Thomas Edward; Howarth, Frank Christopher] UAE Univ, Coll Med & Hlth Sci, Dept Physiol, Al Ain, U Arab Emirates; [John, Annie; Raza, Haider] UAE Univ, Coll Med & Hlth Sci, Dept Biochem, Al Ain, U Arab Emirates; [Oz, Murat] UAE Univ, Coll Med & Hlth Sci, Dept Pharmacol, Al Ain, U Arab Emirates; [Dobrzynski, Halina] Univ Manchester, Inst Cardiovasc Sci, Manchester, Lancs, England	United Arab Emirates University; United Arab Emirates University; United Arab Emirates University; University of Manchester	Howarth, FC (corresponding author), UAE Univ, Coll Med & Hlth Sci, Dept Physiol, Al Ain, U Arab Emirates.	chris.howarth@uaeu.ac.ae	Ferdous, Zannatul/GZA-6825-2022	Ferdous, Zannatul/0000-0002-6007-2183; Adrian, Thomas/0000-0002-5051-1111; Jayaprakash, Petrilla/0000-0001-5433-6587; Dobrzynski, Halina/0000-0003-4754-5975; Raza, Haider/0000-0001-9680-5388	UAE University; LABCO, a partner of SIGMA-ALDRICH	UAE University; LABCO, a partner of SIGMA-ALDRICH	This work was supported by UAE University and LABCO, a partner of SIGMA-ALDRICH. UAE University provided a grant to support this research project. LABCO did not provide any funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksnes TA, 2008, AM J CARDIOL, V101, P634, DOI 10.1016/j.amjcard.2007.10.025; Azer J, 2012, J MOL CELL CARDIOL, V53, P715, DOI 10.1016/j.yjmcc.2012.08.020; Benvenuti LA, 1997, ACTA HISTOCHEM, V99, P187, DOI 10.1016/S0065-1281(97)80041-4; Bon RS, 2013, BRIT J PHARMACOL, V170, P459, DOI 10.1111/bph.12274; Burgess DL, 1999, GENOME RES, V9, P1204, DOI 10.1101/gr.9.12.1204; Colecraft HM, 2002, J PHYSIOL-LONDON, V541, P435, DOI 10.1113/jphysiol.2002.018515; D'Souza A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4775; Duffy HS, 2006, ADV CARDIOL, V42, P1, DOI 10.1159/000092550; Gaber EM, 2014, EXP PHYSIOL, V99, P881, DOI 10.1113/expphysiol.2013.077594; Guinamard R, 2007, BBA-MOL BASIS DIS, V1772, P885, DOI 10.1016/j.bbadis.2007.02.007; Harper MT, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003701; Howarth FC, 2007, MOL CELL BIOCHEM, V305, P145, DOI 10.1007/s11010-007-9537-z; Howarth FC, 2007, MOL CELL BIOCHEM, V300, P39, DOI 10.1007/s11010-006-9366-5; Howarth FC, 2006, MOL CELL BIOCHEM, V289, P21, DOI 10.1007/s11010-006-9143-5; Howarth FC, 2012, MOL CELL BIOCHEM, V361, P267, DOI 10.1007/s11010-011-1112-y; Howarth FC, 2009, MOL CELL BIOCHEM, V328, P57, DOI 10.1007/s11010-009-0074-9; Howarth FC, 2005, EXP PHYSIOL, V90, P827, DOI 10.1113/expphysiol.2005.031252; Howarth FC, 2005, PEPTIDES, V26, P691, DOI 10.1016/j.peptides.2004.12.003; Howarth FC, 2009, J MED SCI, V2, P108; Howarth FC, 2008, EXP PHYSIOL, V93, P362, DOI 10.1113/expphysiol.2007.040055; Howarth FC, 2006, ANN NY ACAD SCI, V1084, P155, DOI 10.1196/annals.1372.007; Jansen JA, 2010, J MOL CELL CARDIOL, V48, P76, DOI 10.1016/j.yjmcc.2009.08.018; Jones SA, 2004, J PHYSIOL-LONDON, V560, P429, DOI 10.1113/jphysiol.2004.072108; Laing SP, 2003, DIABETOLOGIA, V46, P760, DOI 10.1007/s00125-003-1116-6; Li JN, 2012, J APPL MATH, DOI 10.1155/2012/809243; Maltsev VA, 2004, BIOPHYS J, V86, P2596, DOI 10.1016/S0006-3495(04)74314-3; Mangoni ME, 2006, CIRC RES, V98, P1422, DOI 10.1161/01.RES.0000225862.14314.49; McGrath MF, 2005, TRENDS ENDOCRIN MET, V16, P469, DOI 10.1016/j.tem.2005.10.007; Monfredi O, 2010, PACE, V33, P1392, DOI 10.1111/j.1540-8159.2010.02838.x; Movahed MR, 2007, DIABETES OBES METAB, V9, P276, DOI 10.1111/j.1463-1326.2006.00609.x; Nishida M, 2008, N-S ARCH PHARMACOL, V378, P395, DOI 10.1007/s00210-008-0321-8; Nishida M, 2010, J BIOL CHEM, V285, P13244, DOI 10.1074/jbc.M109.074104; Nishida M, 2010, YAKUGAKU ZASSHI, V130, P295, DOI 10.1248/yakushi.130.295; Perrin MJ, 2012, HEART RHYTHM, V9, P610, DOI 10.1016/j.hrthm.2011.11.019; Piccini JP, 2004, AM J MED, V116, P64, DOI 10.1016/j.amjmed.2003.10.021; Potter Lincoln R., 2009, V191, P341, DOI 10.1007/978-3-540-68964-5_15; Raza H, 2015, CELL PHYSIOL BIOCHEM, V35, P1241, DOI 10.1159/000373947; Rowell J, 2010, J CARDIOVASC TRANSL, V3, P516, DOI 10.1007/s12265-010-9208-4; Salem KA, 2013, MOL CELL BIOCHEM, V380, P83, DOI 10.1007/s11010-013-1662-2; Salem KA, 2012, EXP PHYSIOL, V97, P1281, DOI 10.1113/expphysiol.2012.066639; SKEPPER JN, 1989, HISTOCHEM J, V21, P72, DOI 10.1007/BF01005982; Springer J, 2012, J MOL CELL CARDIOL, V52, P1122, DOI 10.1016/j.yjmcc.2012.01.018; Sun YH, 2010, BIOCHEM BIOPH RES CO, V394, P955, DOI 10.1016/j.bbrc.2010.03.096; Verheijck EE, 2001, CARDIOVASC RES, V52, P40, DOI 10.1016/S0008-6363(01)00364-9; Vespasiani G, 1996, COMPUT METH PROG BIO, V51, P211, DOI 10.1016/S0169-2607(96)01774-9; Vindis C, 2010, BIOCHEM BIOPH RES CO, V391, P979, DOI 10.1016/j.bbrc.2009.12.001; Vinogradova TM, 2010, CIRC RES, V107, P767, DOI 10.1161/CIRCRESAHA.110.220517; Volpe M, 2014, EUR HEART J, V35, P419, DOI 10.1093/eurheartj/eht466; Ward ML, 2008, PROG BIOPHYS MOL BIO, V97, P232, DOI 10.1016/j.pbiomolbio.2008.02.009; Watanabe H, 2009, CIRC J, V73, P419, DOI 10.1253/circj.CJ-08-1153; Watanabe M, 2012, AM J PHYSIOL-HEART C, V303, pH86, DOI 10.1152/ajpheart.00010.2012; Yamamoto M, 2006, CARDIOVASC RES, V72, P271, DOI 10.1016/j.cardiores.2006.07.026; Yang L, 2011, FASEB J, V25, P928, DOI 10.1096/fj.10-172353; Yanni J, 2010, J MOL CELL CARDIOL, V48, P653, DOI 10.1016/j.yjmcc.2009.08.023; Yanni J, 2011, CIRC-HEART FAIL, V4, P496, DOI 10.1161/CIRCHEARTFAILURE.110.957647; Yuill KH, 2010, EXP PHYSIOL, V95, P508, DOI 10.1113/expphysiol.2009.050286	56	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153934	10.1371/journal.pone.0153934	http://dx.doi.org/10.1371/journal.pone.0153934			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096430	Green Submitted, Green Published, gold			2022-12-26	WOS:000374543600071
J	Ruggajo, P; Svarstad, E; Leh, S; Marti, HP; Reisaether, AV; Vikse, BE				Ruggajo, Paschal; Svarstad, Einar; Leh, Sabine; Marti, Hans-Peter; Reisaether, Anna Varberg; Vikse, Bjorn Egil			Low Birth Weight and Risk of Progression to End Stage Renal Disease in IgA Nephropathy-A Retrospective Registry-Based Cohort Study	PLOS ONE			English	Article							INTRAUTERINE GROWTH-RETARDATION; GLOMERULAR-FILTRATION-RATE; YOUNG-ADULT AGE; BLOOD-PRESSURE; GESTATIONAL-AGE; PROGNOSTIC FACTORS; SALT SENSITIVITY; CLINICAL-COURSE; KIDNEY-DISEASE; IMMUNE-SYSTEM	Background Low Birth Weight (LBW) is a surrogate for fetal undernutrition and is associated with impaired nephron development in utero. In this study, we investigate whether having been born LBW and/or small for gestational age (SGA) predict progression to ESRD in IgA nephropathy (IgAN) patients. Study Design Retrospective registry-based cohort study. Settings & Participants The Medical Birth Registry has recorded all births since 1967 and the Norwegian Renal Registry has recorded all patients with ESRD since 1980. Based on data from the Norwegian Kidney Biopsy Registry we included all patients diagnosed with IgAN in Norway from 1988-2013. These registries were linked and we analysed risk of progression to ESRD associated with LBW(defined as birth weight less than the 10th percentile) and/or SGA (defined as birth weight less than the 10th percentile for gestational week) by Cox regression statistics. Results We included 471 patients, of whom 74 developed ESRD. As compared to patients without LBW, patients with LBW had a hazard ratio (HR) of 2.0 (95% confidence interval 1.1-3.7) for the total cohort, 2.2 (1.1-4.4) for males and 1.3 (0.30-5.8) for females. Corresponding HRs for SGA were 2.2 (1.1-4.2), 2.7 (1.4-5.5) and 0.8 (0.10-5.9). Further analyses showed that as compared to patients with neither LBW nor SGA, patients with either SGA or LBW did not have significantly increased risks (HRs of 1.3/1.4) but patients who were both LBW and SGA had an increased risk (HR 3.2 (1.5-6.8). Limitation Mean duration of follow-up only 10 years and maximum age only 46 years. Conclusion Among IgAN patients, LBW and/or SGA was associated with increased risk for progression to ESRD, the association was stronger in males.	[Ruggajo, Paschal] MUHAS, Dept Internal Med, Dar Es Salaam, Tanzania; [Ruggajo, Paschal; Svarstad, Einar; Leh, Sabine; Marti, Hans-Peter; Vikse, Bjorn Egil] Univ Bergen, Dept Clin Med, Bergen, Norway; [Svarstad, Einar; Marti, Hans-Peter] Haukeland Hosp, Dept Med, N-5021 Bergen, Norway; [Leh, Sabine] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway; [Reisaether, Anna Varberg] Norwegian Inst Publ Hlth, Med Birth Registry Norway, Bergen, Norway; [Reisaether, Anna Varberg] Oslo Univ Hosp, Dept Transplantat Med, Rikshosp, N-0450 Oslo, Norway; [Vikse, Bjorn Egil] Haugesund Hosp, Dept Med, Haugesund, Norway	Muhimbili University of Health & Allied Sciences; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; Norwegian Institute of Public Health (NIPH); University of Oslo; National Hospital Norway	Ruggajo, P (corresponding author), MUHAS, Dept Internal Med, Dar Es Salaam, Tanzania.; Ruggajo, P (corresponding author), Univ Bergen, Dept Clin Med, Bergen, Norway.	prugajo@yahoo.com	Leh, Sabine/E-6053-2011; Ruggajo, Paschal/R-2018-2019	Leh, Sabine/0000-0002-0764-2941; 				ALAMARTINE E, 1991, AM J KIDNEY DIS, V18, P12, DOI 10.1016/S0272-6386(12)80284-8; Bacchetta J, 2009, KIDNEY INT, V76, P445, DOI 10.1038/ki.2009.201; Barbour SJ, 2012, AM J KIDNEY DIS, V59, P865, DOI 10.1053/j.ajkd.2012.02.326; BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; Barratt J, 2005, J AM SOC NEPHROL, V16, P2088, DOI 10.1681/ASN.2005020134; Bellinger DL, 2008, J IMMUNOTOXICOL, V5, P419, DOI 10.1080/15476910802483415; Bjorksten B, 2009, CURR OPIN ALLERGY CL, V9, P185, DOI 10.1097/ACI.0b013e32832abfc2; Botha JH, 1998, EUR J CLIN PHARMACOL, V53, P337, DOI 10.1007/s002280050389; BRENNER BM, 1994, AM J KIDNEY DIS, V23, P171, DOI 10.1016/S0272-6386(12)80967-X; Canetta PA, 2014, CLIN J AM SOC NEPHRO, V9, P617, DOI 10.2215/CJN.07260713; Chacko B, 2005, NEPHROLOGY, V10, P496, DOI 10.1111/j.1440-1797.2005.00445.x; Chandra RK, 1999, P NUTR SOC, V58, P681, DOI 10.1017/S0029665199000890; Curhan GC, 1996, CIRCULATION, V94, P3246, DOI 10.1161/01.CIR.94.12.3246; Dahlstrom BL, 2006, ACTA OBSTET GYN SCAN, V85, P916, DOI 10.1080/00016340500442449; DAMICO G, 1987, Q J MED, V64, P709; DAMICO G, 1985, MEDICINE, V64, P49, DOI 10.1097/00005792-198501000-00004; DAMICO G, 1992, AM J KIDNEY DIS, V20, P315, DOI 10.1016/S0272-6386(12)70293-7; de Boer MP, 2008, HYPERTENSION, V51, P928, DOI 10.1161/HYPERTENSIONAHA.107.101881; Fan ZJ, 2006, PUBLIC HEALTH REP, V121, P239, DOI 10.1177/003335490612100304; Ferguson LR, 2010, MUTAT RES-FUND MOL M, V690, P3, DOI 10.1016/j.mrfmmm.2010.03.007; Floege J, 2000, J AM SOC NEPHROL, V11, P2395, DOI 10.1681/ASN.V11122395; Glinianaia SV, 2000, ACTA OBSTET GYN SCAN, V79, P450, DOI 10.1034/j.1600-0412.2000.079006450.x; Goto M, 2009, NEPHROL DIAL TRANSPL, V24, P3068, DOI 10.1093/ndt/gfp273; Hallan S, 2008, AM J KIDNEY DIS, V51, P10, DOI 10.1053/j.ajkd.2007.09.013; HANNEDOUCHE T, 1993, CLIN NEPHROL, V39, P312; HINCHLIFFE SA, 1991, LAB INVEST, V64, P777; HOOD SA, 1981, CLIN NEPHROL, V16, P55; Hoy WE, 2006, KIDNEY INT, V70, P104, DOI 10.1038/sj.ki.5000397; Hoy WE, 1999, KIDNEY INT, V56, P1072, DOI 10.1046/j.1523-1755.1999.00633.x; Hoy WE, 2012, KIDNEY INT, V82, P1321, DOI 10.1038/ki.2012.307; Hughson M, 2006, KIDNEY INT, V69, P671, DOI 10.1038/sj.ki.5000041; Hughson M, 2003, KIDNEY INT, V63, P2113, DOI 10.1046/j.1523-1755.2003.00018.x; Irgens LM, 2000, ACTA OBSTET GYN SCAN, V79, P435, DOI 10.1034/j.1600-0412.2000.079006435.x; Ji H, 2007, GENDER MED, V4, P56, DOI 10.1016/S1550-8579(07)80009-X; Keijzer-Veen MG, 2007, AM J KIDNEY DIS, V50, P542, DOI 10.1053/j.ajkd.2007.06.015; Keijzer-Veen MG, 2005, J AM SOC NEPHROL, V16, P2762, DOI 10.1681/ASN.2004090783; KITAJIMA T, 1983, JPN J MED, V22, P219; Knoop T, 2015, AM J NEPHROL, V41, P210, DOI 10.1159/000381403; Knoop T, 2013, AM J KIDNEY DIS, V62, P883, DOI 10.1053/j.ajkd.2013.04.019; Komatsu H, 2015, CLIN EXP NEPHROL, P1; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Lackland D T, 2001, J Clin Hypertens (Greenwich), V3, P29, DOI 10.1111/j.1524-6175.2001.00828.x; Lee H, 2013, AM J NEPHROL, V37, P74, DOI 10.1159/000345960; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; LEVY M, 1988, AM J KIDNEY DIS, V12, P340, DOI 10.1016/S0272-6386(88)80021-0; Luyckx VA, 2005, KIDNEY INT, V68, pS68, DOI 10.1111/j.1523-1755.2005.09712.x; Luyckx VA, 2015, NAT REV NEPHROL, V11, P135, DOI 10.1038/nrneph.2014.251; Luyckx VA, 2013, LANCET, V382, P273, DOI 10.1016/S0140-6736(13)60311-6; Manalich R, 2000, KIDNEY INT, V58, P770, DOI 10.1046/j.1523-1755.2000.00225.x; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; MERLETBENICHOU C, 1994, PEDIATR NEPHROL, V8, P175, DOI 10.1007/BF00865473; Mu M, 2012, ARCH CARDIOVASC DIS, V105, P99, DOI 10.1016/j.acvd.2011.10.006; Palmer AC, 2011, ADV NUTR, V2, P377, DOI 10.3945/an.111.000570; Radford MG, 1997, J AM SOC NEPHROL, V8, P199; Rodriguez MM, 2004, PEDIATR DEVEL PATHOL, V7, P17, DOI 10.1007/s10024-003-3029-2; Ruggajo P, 2015, AM J KIDNEY DIS; Schmidt IM, 2005, KIDNEY INT, V68, P731, DOI 10.1111/j.1523-1755.2005.00451.x; Schreuder MF, 2009, CLIN J AM SOC NEPHRO, V4, P1774, DOI 10.2215/CJN.02230409; SILBIGER SR, 1995, AM J KIDNEY DIS, V25, P515, DOI 10.1016/0272-6386(95)90119-1; Simonetti GD, 2008, HYPERTENSION, V52, P625, DOI 10.1161/HYPERTENSIONAHA.108.114983; Skjaerven R, 2000, ACTA OBSTET GYN SCAN, V79, P440, DOI 10.1034/j.1600-0412.2000.079006440.x; Treluyer JM, 2002, ANTIMICROB AGENTS CH, V46, P1381, DOI 10.1128/AAC.46.5.1381-1387.2002; Tsuboi N, 2010, CLIN J AM SOC NEPHRO, V5, P39, DOI 10.2215/CJN.04680709; VANDERPEET J, 1977, CLIN NEPHROL, V8, P335; Vikse BE, 2002, NEPHROL DIAL TRANSPL, V17, P1603, DOI 10.1093/ndt/17.9.1603; Vikse BE, 2010, NEPHROL DIAL TRANSPL; Vikse BE, 2008, J AM SOC NEPHROL, V19, P151, DOI 10.1681/ASN.2007020252; White SL, 2009, AM J KIDNEY DIS, V54, P248, DOI 10.1053/j.ajkd.2008.12.042; Wyatt RJ, 2013, NEW ENGL J MED, V368, P2402, DOI 10.1056/NEJMra1206793; Yiu V, 1999, AM J KIDNEY DIS, V33, P253, DOI 10.1016/S0272-6386(99)70297-0; Zidar N, 1998, NEPHRON, V79, P28, DOI 10.1159/000044987; Zidar N, 1998, KIDNEY INT, V54, P1320, DOI 10.1046/j.1523-1755.1998.00121.x	72	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153819	10.1371/journal.pone.0153819	http://dx.doi.org/10.1371/journal.pone.0153819			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27092556	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000374541200046
J	Zhang, M; Hutter, G; Kahn, SA; Azad, TD; Gholamin, S; Xu, CY; Liu, J; Achrol, AS; Richard, C; Sommerkamp, P; Schoen, MK; McCracken, MN; Majeti, R; Weissman, I; Mitra, SS; Cheshier, SH				Zhang, Michael; Hutter, Gregor; Kahn, Suzana A.; Azad, Tej D.; Gholamin, Sharareh; Xu, Chelsea Y.; Liu, Jie; Achrol, Achal S.; Richard, Chase; Sommerkamp, Pia; Schoen, Matthew Kenneth; McCracken, Melissa N.; Majeti, Ravi; Weissman, Irving; Mitra, Siddhartha S.; Cheshier, Samuel H.			Anti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In Vivo	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; REGULATORY PROTEIN-ALPHA; HEMATOPOIETIC STEM-CELLS; SIRP-ALPHA; APOPTOTIC CELLS; CANCER-CELLS; GM-CSF; CD47; SURVIVAL; PROGRESSION	Tumor-associated macrophages (TAMs) represent an important cellular subset within the glioblastoma (WHO grade IV) microenvironment and are a potential therapeutic target. TAMs display a continuum of different polarization states between antitumorigenic M1 and protumorigenic M2 phenotypes, with a lower M1/M2 ratio correlating with worse prognosis. Here, we investigated the effect of macrophage polarization on anti-CD47 antibody-mediated phagocytosis of human glioblastoma cells in vitro, as well as the effect of anti-CD47 on the distribution of M1 versus M2 macrophages within human glioblastoma cells grown in mouse xenografts. Bone marrow -derived mouse macrophages and peripheral blood derived human macrophages were polarized in vitro toward M1 or M2 phenotypes and verified by flow cytometry. Primary human glioblastoma cell lines were offered as targets to mouse and human M1 or M2 polarized macrophages in vitro. The addition of an anti-CD47 monoclonal antibody led to enhanced tumor -cell phagocytosis by mouse and human M1 and M2 macrophages. In both cases, the anti-CD47-induced phagocytosis by M1 was more prominent than that for M2. Dissected tumors from human glioblastoma xenografted within NOD.Cg-Prkdcscid 112rgtmlwil ISzJ mice and treated with anti-CD47 showed a significant increase of M1 macrophages within the tumor. These data show that anti-CD47 treatment leads to enhanced tumor cell phagocytosis by both M1 and M2 macrophage subtypes with a higher phagocytosis rate by M1 macrophages. Furthermore, these data demonstrate that anti-CD47 treatment alone can shift the phenotype of macrophages toward the M1 subtype in vivo.	[Zhang, Michael; Hutter, Gregor; Kahn, Suzana A.; Azad, Tej D.; Gholamin, Sharareh; Xu, Chelsea Y.; Achrol, Achal S.; Richard, Chase; Sommerkamp, Pia; Schoen, Matthew Kenneth; Mitra, Siddhartha S.; Cheshier, Samuel H.] Stanford Univ, Div Pediat Neurosurg, Dept Neurosurg, Lucile Packard Childrens Hosp,Sch Med, Stanford, CA 94305 USA; [Hutter, Gregor; Kahn, Suzana A.; Gholamin, Sharareh; Liu, Jie; Sommerkamp, Pia; McCracken, Melissa N.; Majeti, Ravi; Weissman, Irving; Mitra, Siddhartha S.; Cheshier, Samuel H.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA; [Hutter, Gregor; Kahn, Suzana A.; Gholamin, Sharareh; Sommerkamp, Pia; Majeti, Ravi; Weissman, Irving; Mitra, Siddhartha S.; Cheshier, Samuel H.] Stanford Univ, Ludwig Ctr Canc Stem Cell Res & Med Stanford, Sch Med, Stanford, CA 94305 USA	Lucile Packard Children's Hospital (LPCH); Stanford University; Stanford University; Stanford University	Mitra, SS; Cheshier, SH (corresponding author), Stanford Univ, Div Pediat Neurosurg, Dept Neurosurg, Lucile Packard Childrens Hosp,Sch Med, Stanford, CA 94305 USA.; Mitra, SS; Cheshier, SH (corresponding author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA.; Mitra, SS; Cheshier, SH (corresponding author), Stanford Univ, Ludwig Ctr Canc Stem Cell Res & Med Stanford, Sch Med, Stanford, CA 94305 USA.	ssmitra@stanford.edu; cheshier@stanford.edu	Hutter, Gregor/A-1254-2011; Hutter, Gregor/Q-6698-2019	Hutter, Gregor/0000-0002-7570-3902; Hutter, Gregor/0000-0002-7570-3902; Gholamin, Sharareh/0000-0001-7425-6074; Sommerkamp, Pia/0000-0002-1148-2493; Xu, Chelsea/0000-0001-5153-4625; Majeti, Ravindra/0000-0002-5814-0984; Azad, Tej/0000-0001-7823-4294; Zhang, Michael/0000-0002-7067-0689	Lucile Packard Foundation for Children's Health; Stanford NIH-NCATS-CTSA [UL1 TR001085]; Child Health Research Institute of Stanford University; Seibel Scholar's Fellowship; Siebel Stem Cell Institute; University of California; Berkeley-Stanford Consortium; Ludwig Center for Cancer Stem Cell Research and Medicine at Stanford; American Brain Tumor Association; Neurosurgery Research Foundation; Stanford Medical Scholars Research Program; St. Baldrick's Foundation; Swiss National Science Foundation [P-155336]; Novartis Foundation for medical-biological research; NATIONAL CANCER INSTITUTE [T32CA009151] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001085] Funding Source: NIH RePORTER	Lucile Packard Foundation for Children's Health; Stanford NIH-NCATS-CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Child Health Research Institute of Stanford University; Seibel Scholar's Fellowship; Siebel Stem Cell Institute; University of California(University of California System); Berkeley-Stanford Consortium; Ludwig Center for Cancer Stem Cell Research and Medicine at Stanford; American Brain Tumor Association; Neurosurgery Research Foundation; Stanford Medical Scholars Research Program; St. Baldrick's Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Foundation for medical-biological research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was funded by the Lucile Packard Foundation for Children's Health, Stanford NIH-NCATS-CTSA UL1 TR001085 and Child Health Research Institute of Stanford University (http://chri.stanford.edu/) to SHC; Seibel Scholar's Fellowship, The Siebel Stem Cell Institute, A University of California, Berkeley-Stanford Consortium to SSM; Ludwig Center for Cancer Stem Cell Research and Medicine at Stanford (http://med.stanford.edu/ludwigcenter.html) to SSM, SHC; American Brain Tumor Association (http://www.abta.org/) to MZ; Neurosurgery Research Foundation (http://www.nref.org/) to MZ; Stanford Medical Scholars Research Program (http://med.stanford.edu/medscholars.html) to MZ; St. Baldrick's Foundation (http://www.stbaldricks.org/ to SHC; Price Charities to SSM, SHC; Swiss National Science Foundation Grant P-155336 (www.snf.ch) to GH; and Novartis Foundation for medical-biological research (www.stiftungmedbiol.novartis.com) to GH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenghat FJ, 2012, J CELL SCI, V125, P5535, DOI 10.1242/jcs.111260; Alifieris C, 2015, PHARMACOL THERAPEUT, V152, P63, DOI 10.1016/j.pharmthera.2015.05.005; Badie B, 2000, NEUROSURGERY, V46, P957, DOI 10.1097/00006123-200004000-00035; BIGNER DD, 1981, J NEUROPATH EXP NEUR, V40, P201, DOI 10.1097/00005072-198105000-00001; Boukhari A, 2015, ANTICANCER RES, V35, P149; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; Burger P, 2012, BLOOD, V119, P5512, DOI 10.1182/blood-2011-10-386805; da Fonseca ACC, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/264124; Casulo C, 2013, LEUKEMIA RES, V37, P1178, DOI 10.1016/j.leukres.2013.03.021; Chao MP, 2012, CURR OPIN IMMUNOL, V24, P225, DOI 10.1016/j.coi.2012.01.010; Chao MP, 2012, NAT REV CANCER, V12, P58, DOI 10.1038/nrc3171; Chao MP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001375; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Ding P, 2014, CELL BIOCHEM BIOPHYS, V70, P1625, DOI 10.1007/s12013-014-0105-3; dos Santos MA, 2015, J NEURO-ONCOL, V123, P307, DOI 10.1007/s11060-015-1802-5; Durafourt BA, 2012, GLIA, V60, P717, DOI 10.1002/glia.22298; Engstrom A, 2014, INT J ONCOL, V44, P385, DOI 10.3892/ijo.2013.2203; Feng MY, 2015, P NATL ACAD SCI USA, V112, P2145, DOI 10.1073/pnas.1424907112; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Ghassabeh GH, 2006, BLOOD, V108, P575, DOI 10.1182/blood-2005-04-1485; Goerdt S, 1999, PATHOBIOLOGY, V67, P222, DOI 10.1159/000028096; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Iizuka A, 2014, IMMUNOL LETT, V159, P15, DOI 10.1016/j.imlet.2014.02.004; Jaguin M, 2013, CELL IMMUNOL, V281, P51, DOI 10.1016/j.cellimm.2013.01.010; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Kim MJ, 2008, TUMOR BIOL, V29, P28, DOI 10.1159/000132568; Kioi M, 2010, J CLIN INVEST, V120, P694, DOI 10.1172/JCI40283; Kushchayev SV, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2012.11.059; Lee JH, 2013, CANCER RES, V73, P3604, DOI 10.1158/0008-5472.CAN-12-4563; Liu CY, 2013, LAB INVEST, V93, P844, DOI 10.1038/labinvest.2013.69; Liu J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137345; Ma JL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-112; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Moestrup SK, 2004, ANN MED, V36, P347, DOI 10.1080/07853890410033171; Morganti JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093650; Nuvolone M, 2013, J EXP MED, V210, P2539, DOI 10.1084/jem.20131274; Pan YF, 2013, HEPATOLOGY, V58, P680, DOI 10.1002/hep.26391; Parney IF, 2006, J NEURO-ONCOL, V78, P71, DOI 10.1007/s11060-005-9058-0; Poli A, 2013, ONCOTARGET, V4, P1527, DOI 10.18632/oncotarget.1291; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Sarkar S, 2014, NAT NEUROSCI, V17, P46, DOI 10.1038/nn.3597; Sayegh ET, 2014, J NEURO-ONCOL, V119, P531, DOI 10.1007/s11060-014-1502-6; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385; Soto-Pantoja DR, 2012, P NATL ACAD SCI USA, V109, pE2842, DOI 10.1073/pnas.1205441109; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Wang FQ, 2013, J CLIN PATHOL, V66, P1058, DOI 10.1136/jclinpath-2012-201286; Weiskopf K, 2013, SCIENCE, V341, P88, DOI 10.1126/science.1238856; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Wong ASL, 2014, J IMMUNOL, V193, P4833, DOI 10.4049/jimmunol.1401984; Zen K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3436; Zhang MY, 2014, J OVARIAN RES, V7, DOI 10.1186/1757-2215-7-19; Zhao XW, 2012, P NATL ACAD SCI USA, V109, pE2843, DOI 10.1073/pnas.1209265109; Zhao XW, 2011, P NATL ACAD SCI USA, V108, P18342, DOI 10.1073/pnas.1106550108	59	151	159	5	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153550	10.1371/journal.pone.0153550	http://dx.doi.org/10.1371/journal.pone.0153550			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27092773	Green Submitted, Green Published, gold			2022-12-26	WOS:000374541200027
J	Rosca, L; Duguleana, M				Rosca, Lucian; Duguleana, Mihai			An Online Observer for Minimization of Pulsating Torque in SMPM Motors	PLOS ONE			English	Article							LITHIUM-ION BATTERY; COGGING TORQUE; RIPPLE REDUCTION; IDENTIFICATION; DESIGN; DRIVES	A persistent problem of surface mounted permanent magnet (SMPM) motors is the non-uniformity of the developed torque. Either the motor design or the motor control needs to be improved in order to minimize the periodic disturbances. This paper proposes a new control technique for reducing periodic disturbances in permanent magnet (PM) electro-mechanical actuators, by advancing a new observer/estimator paradigm. A recursive estimation algorithm is implemented for online control. The compensating signal is identified and added as feedback to the control signal of the servo motor. Compensation is evaluated for different values of the input signal, to show robustness of the proposed method.	[Rosca, Lucian] Univ Lucian Blaga Sibiu, Fac Engn, Sibiu, Romania; [Duguleana, Mihai] Univ Transilvania Brasov, Dept Prod Design & Robot, Brasov, Romania	Lucian Blaga University of Sibiu; Transylvania University of Brasov	Duguleana, M (corresponding author), Univ Transilvania Brasov, Dept Prod Design & Robot, Brasov, Romania.	mihai.duguleana@unitbv.ro	Duguleana, Mihai/AAA-5482-2019	Duguleana, Mihai/0000-0002-7009-356X	Ministry of Labor, Family and Social Protection, Romania [POSDRU/159/1.5/S/137070]; European Social Fund	Ministry of Labor, Family and Social Protection, Romania; European Social Fund(European Social Fund (ESF))	The work performed by MD was supported by the strategic grant POSDRU/159/1.5/S/137070 (2014) of the Ministry of Labor, Family and Social Protection, Romania (http://www.mmuncii.ro/j33/index.php/en/), co-financed by the European Social Fund (http://ec.europa.eu/esf/home.jsp) - Investing in People, within the Sectoral Operational Programme Human Resources Development 2007-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreescu GD, 2008, IEEE T ENERGY CONVER, V23, P393, DOI 10.1109/TEC.2007.914386; Ashabani M, 2011, IEEE T MAGN, V47, P795, DOI 10.1109/TMAG.2010.2104327; Berendsen C. S., 1993, IEEE Transactions on Power Electronics, V8, P231, DOI 10.1109/63.223976; Bianchi N, 2000, IND APPL C 2000 2000, V1; Branan C, 2002, RULES THUMB CHEM ENG; Butterworth S., 1930, EXP WIRELESS WIRELES, V7, P536; Chapman S. J., 2007, MATLAB PROGRAMMING E; Cros J, 1993, POW EL APPL 1993 5 E; Eom JB, 2001, J MAGN MAGN MATER, V226, P1229, DOI 10.1016/S0304-8853(01)00053-1; Fang JC, 2012, IEEE T POWER ELECTR, V27, P4630, DOI 10.1109/TPEL.2011.2176143; Gieras J. F., 2009, PERMANENT MAGNET MOT, V3rd; Hanselman DC, 1997, ELECT POWER APPL IEE, V144; Hasanien HM, 2010, ENERG CONVERS MANAGE, V51, P98, DOI 10.1016/j.enconman.2009.08.027; HOANG LH, 1986, IEEE T IND APPL, V22, P748, DOI 10.1109/TIA.1986.4504787; Holtz J, 1996, IEEE T IND ELECTRON, V43, P309, DOI 10.1109/41.491355; Hu XS, 2011, J CENT SOUTH UNIV T, V18, P1525, DOI 10.1007/s11771-011-0869-1; Hu XS, 2013, SIMUL MODEL PRACT TH, V34, P1, DOI 10.1016/j.simpat.2013.01.001; Isermann R., 2005, MECHATRONIC SYSTEMS; Islam MR, 2009, THESIS U AKRON; Jahns TM, 1996, IEEE T IND ELECTRON, V43, P321, DOI 10.1109/41.491356; Kim TS, 2001, IND EL SOC 2001 IECO, V2; Lateb R, 2006, IEEE T MAGN, V42, P442, DOI 10.1109/TMAG.2005.862756; Levi E, 2008, IEEE T IND ELECTRON, V55, P1893, DOI 10.1109/TIE.2008.918488; Ljung L., 1998, SYSTEM IDENTIFICATIO; Lu HF, 2008, IEEE T POWER ELECTR, V23, P950, DOI 10.1109/TPEL.2007.915667; Martins CA, 2002, IEEE T POWER ELECTR, V17, P286, DOI 10.1109/63.988948; MATSUI N, 1993, IEEE T IND APPL, V29, P187, DOI 10.1109/28.195906; Matsui N., 1993, MOT CONTR P 1993 AS; MURAI Y, 1989, IEEE T IND APPL, V25, P441, DOI 10.1109/28.31214; PILLAY P, 1989, IEEE T IND APPL, V25, P274, DOI 10.1109/28.25542; Pope J. E., 1996, RULES THUMB MECH ENG; Rakib I, 2009, IND APPL IEEE T, V45.1, P152; Renato C, 1989, INT APPL SOC ANN M 1; Ruderman M, 2008, P 17 WORLD C IFAC; Seguritan A., 2002, P 15 IFAC WORLD C AU, P6; Sun FC, 2011, ENERGY, V36, P3531, DOI 10.1016/j.energy.2011.03.059; Talaba D, 2012, ROBOT CIM-INT MANUF, V28, P637, DOI 10.1016/j.rcim.2012.03.005; Vivier S, 2006, INT C EL MACH ICEM; Weeks M, 2010, DIGITAL SIGNAL PROCE; Yang Y, 2005, EL MACH SYST 2005 IC, V1; Yang Y, 2007, IND EL APPL 2007 ICI; Yang YB, 2006, IEEE T MAGN, V42, P1135, DOI 10.1109/TMAG.2006.871452; Zhang JZ, 2008, ENERG CONVERS MANAGE, V49, P2100, DOI 10.1016/j.enconman.2008.02.017; Zhang L, 2014, ENERGIES, V7, P3204, DOI 10.3390/en7053204; Zhu ZQ, 2000, IEEE T ENERGY CONVER, V15, P407, DOI 10.1109/60.900501	46	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153255	10.1371/journal.pone.0153255	http://dx.doi.org/10.1371/journal.pone.0153255			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27089182	Green Submitted, Green Published, gold			2022-12-26	WOS:000374527000015
J	Wang, Y; Zekveld, AA; Naylor, G; Ohlenforst, B; Jansma, EP; Lorens, A; Lunner, T; Kramer, SE				Wang, Yang; Zekveld, Adriana A.; Naylor, Graham; Ohlenforst, Barbara; Jansma, Elise P.; Lorens, Artur; Lunner, Thomas; Kramer, Sophia E.			Parasympathetic Nervous System Dysfunction, as Identified by Pupil Light Reflex, and Its Possible Connection to Hearing Impairment	PLOS ONE			English	Article							NEURAL FUNCTION-TESTS; AUTONOMIC DYSFUNCTION; RATE-VARIABILITY; PUPILLOMETRIC EVALUATION; RHEUMATOID-ARTHRITIS; DYNAMIC PUPILLOMETRY; PARKINSONS-DISEASE; MULTIPLE-SCLEROSIS; AGE; RESPONSES	Context Although the pupil light reflex has been widely used as a clinical diagnostic tool for autonomic nervous system dysfunction, there is no systematic review available to summarize the evidence that the pupil light reflex is a sensitive method to detect parasympathetic dysfunction. Meanwhile, the relationship between parasympathetic functioning and hearing impairment is relatively unknown. Objectives To 1) review the evidence for the pupil light reflex being a sensitive method to evaluate parasympathetic dysfunction, 2) review the evidence relating hearing impairment and parasympathetic activity and 3) seek evidence of possible connections between hearing impairment and the pupil light reflex. Methods Literature searches were performed in five electronic databases. All selected articles were categorized into three sections: pupil light reflex and parasympathetic dysfunction, hearing impairment and parasympathetic activity, pupil light reflex and hearing impairment. Results Thirty-eight articles were included in this review. Among them, 36 articles addressed the pupil light reflex and parasympathetic dysfunction. We summarized the information in these data according to different types of parasympathetic-related diseases. Most of the studies showed a difference on at least one pupil light reflex parameter between patients and healthy controls. Two articles discussed the relationship between hearing impairment and parasympathetic activity. Both studies reported a reduced parasympathetic activity in the hearing impaired groups. The searches identified no results for pupil light reflex and hearing impairment. Discussion and Conclusions As the first systematic review of the evidence, our findings suggest that the pupil light reflex is a sensitive tool to assess the presence of parasympathetic dysfunction. Maximum constriction velocity and relative constriction amplitude appear to be the most sensitive parameters. There are only two studies investigating the relationship between parasympathetic activity and hearing impairment, hence further research is needed. The pupil light reflex could be a candidate measurement tool to achieve this goal.	[Wang, Yang; Zekveld, Adriana A.; Ohlenforst, Barbara; Kramer, Sophia E.] Vrije Univ Amsterdam Med Ctr, Sect Ear & Hearing, Dept Otolaryngol Head & Neck Surg, Amsterdam, Netherlands; [Wang, Yang; Zekveld, Adriana A.; Ohlenforst, Barbara; Kramer, Sophia E.] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Wang, Yang; Ohlenforst, Barbara; Lunner, Thomas] Oticon AS, Eriksholm Res Ctr, Snekkersten, Denmark; [Zekveld, Adriana A.] Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden; [Zekveld, Adriana A.; Lunner, Thomas] Linkoping Univ, Linnaeus Ctr HEAD, Swedish Inst Disabil Res, Linkoping, Sweden; [Zekveld, Adriana A.; Lunner, Thomas] Univ Orebro, Linnaeus Ctr HEAD, Swedish Inst Disabil Res, Linkoping, Sweden; [Naylor, Graham] MRC CSO Inst Hearing Res, Scottish Sect, Glasgow, Lanark, Scotland; [Jansma, Elise P.] Vrije Univ Amsterdam, Med Lib, Amsterdam, Netherlands; [Lorens, Artur] Inst Physiol & Pathol Hearing, Warsaw, Poland; [Lunner, Thomas] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Oticon; Linkoping University; Linkoping University; Orebro University; Vrije Universiteit Amsterdam; Institute of Physiology & Hearing Pathology; Linkoping University	Wang, Y (corresponding author), Vrije Univ Amsterdam Med Ctr, Sect Ear & Hearing, Dept Otolaryngol Head & Neck Surg, Amsterdam, Netherlands.; Wang, Y (corresponding author), Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands.; Wang, Y (corresponding author), Oticon AS, Eriksholm Res Ctr, Snekkersten, Denmark.	y.wang@vumc.nl	Lorens, Artur/AAO-7553-2020; Naylor, Graham/S-2902-2018; Jansma, Elise P/E-8358-2016; Jansma, Elise/AAG-7983-2020; Naylor, Graham/AAN-7408-2021	Naylor, Graham/0000-0003-1544-1944; Jansma, Elise P/0000-0002-1516-2171; Naylor, Graham/0000-0003-1544-1944; Kramer, Sophia E./0000-0002-0451-8179; Zekveld, Adriana/0000-0003-1320-6908	LISTEN [607373]; Chief Scientist Office [IHR] Funding Source: researchfish	LISTEN; Chief Scientist Office	Support was provided by LISTEN 607373 under FP7-PEOPLE [http://cordis.europa.eu/project/rcn/109214_en.html]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlan AM, 2014, AUTONOMIC FUNCTION R; Bar KJ, 2008, CLIN NEUROPHYSIOL, V119, P2209, DOI 10.1016/j.clinph.2008.06.012; Bainbridge KE, 2008, ANN INTERN MED, V149, P1, DOI 10.7326/0003-4819-149-1-200807010-00231; BAKES A, 1990, BRIT J CLIN PHARMACO, V30, P377, DOI 10.1111/j.1365-2125.1990.tb03787.x; BARBUR JL, 1992, OPHTHAL PHYSL OPT, V12, P137, DOI 10.1111/j.1475-1313.1992.tb00276.x; Barendregt PJ, 1996, ANN RHEUM DIS, V55, P612, DOI 10.1136/ard.55.9.612; Baum P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054546; Bergamin O, 1998, GRAEF ARCH CLIN EXP, V236, P567, DOI 10.1007/s004170050122; Bergamin O, 2003, INVEST OPHTH VIS SCI, V44, P1546, DOI 10.1167/iovs.02-0468; Bitsios P, 1996, AGE AGEING, V25, P432, DOI 10.1093/ageing/25.6.432; Bitsios P, 1996, J PSYCHOPHARMACOL, V10, P279, DOI 10.1177/026988119601000404; Bittner DM, 2014, J ALZHEIMERS DIS, V42, P1469, DOI 10.3233/JAD-140969; Bittner DM, 2014, J ALZHEIMERS DIS; Bremner F, 2006, J NEUROL NEUROSUR PS, V77, P1163, DOI 10.1136/jnnp.2006.092833; Bremner FD, 2012, INVEST OPHTH VIS SCI, V53, P7343, DOI 10.1167/iovs.12-10881; Bumke O., 1911, PHYSL PATHOLOGIE IRI; Calabresi P, 2006, LANCET NEUROL, V5, P974, DOI 10.1016/S1474-4422(06)70600-7; Davis BC, 2013, PHYSIOL MEAS, V34, P873, DOI 10.1088/0967-3334/34/8/873; DEVOS A, 1989, DIABETES RES CLIN EX, V10, P191; DRUMMOND PD, 1988, BRAIN, V111, P1199, DOI 10.1093/brain/111.5.1199; Dutsch M, 2004, J NEUROL SCI, V222, P75, DOI 10.1016/j.jns.2004.04.008; Dutsch M, 2002, J NEUROL SCI, V195, P77, DOI 10.1016/S0022-510X(01)00686-4; Fan XF, 2011, IEEE T BIO-MED ENG, V58, P36, DOI 10.1109/TBME.2010.2080678; Fan XF, 2009, AUTON NEUROSCI-BASIC, V147, P9, DOI 10.1016/j.autneu.2008.12.010; Fan XF, 2009, INVEST OPHTH VIS SCI, V50, P1137, DOI 10.1167/iovs.08-2329; Feinberg Richard, 1965, LATENCY PUPILLARY RE; FERNANDEZ C, 1960, Laryngoscope, V70, P363; Ferrari GL, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-26; Flachenecker P, 2001, MULT SCLER, V7, P327, DOI 10.1177/135245850100700509; Fotiou DF, 2009, INT J PSYCHOPHYSIOL, V73, P143, DOI 10.1016/j.ijpsycho.2009.01.011; Fotiou F, 2000, INT J PSYCHOPHYSIOL, V37, P111, DOI 10.1016/S0167-8760(00)00099-4; Giza E, 2011, INT J NEUROSCI, V121, P37, DOI 10.3109/00207454.2010.526730; HAKEREM G, 1964, ANN NY ACAD SCI, V105, P820, DOI 10.1111/j.1749-6632.1964.tb42965.x; Harle DE, 2005, OPHTHAL PHYSL OPT, V25, P240, DOI 10.1111/j.1475-1313.2005.00291.x; Hasson D, 2009, INT J PSYCHOPHYSIOL, V74, P93, DOI 10.1016/j.ijpsycho.2009.07.009; Hicks CB, 2002, J SPEECH LANG HEAR R, V45, P573, DOI 10.1044/1092-4388(2002/046); Horner KC, 2003, NEUROSCI BIOBEHAV R, V27, P437, DOI 10.1016/S0149-7634(03)00071-X; Hotta H, 2010, GERIATR GERONTOL INT, V10, pS127, DOI 10.1111/j.1447-0594.2010.00592.x; INOUE H, 1988, ACTA OTO-LARYNGOL, V105, P582, DOI 10.3109/00016488809119524; Kaltsatou A, 2011, EUR J APPL PHYSIOL, V111, P2079, DOI 10.1007/s00421-011-1836-0; Kang P, 2012, CLIN AUTON RES, V22, P161, DOI 10.1007/s10286-012-0158-6; Keivanidou A, 2010, CARDIOL J, V17, P65; Kleiger RE, 2005, ANN NONINVAS ELECTRO, V10, P88, DOI 10.1111/j.1542-474X.2005.10101.x; Kramer SE, 1997, AUDIOLOGY, V36, P155; Kramer SE, 2013, LANG COGNITIVE PROC, V28, P426, DOI 10.1080/01690965.2011.642267; Kramer SE, 2006, INT J AUDIOL, V45, P503, DOI 10.1080/14992020600754583; KURODA N, 1989, DIABETES RES CLIN PR, V6, P89, DOI 10.1016/0168-8227(89)90111-3; LANTING P, 1988, J NEUROL, V235, P245, DOI 10.1007/BF00314357; LEDEN I, 1983, SCAND J RHEUMATOL, V12, P166, DOI 10.3109/03009748309102905; Lensch E, 2011, AUTOIMMUN DIS, V2011, DOI 10.4061/2011/803841; Levy D M, 1992, Clin Auton Res, V2, P335, DOI 10.1007/BF01824304; Liberati A, 2009, BMJ, V339, pb2700, DOI DOI 10.1136/BMJ.B2700; Loewenfeld I. E., 1999, PUPIL ANATOMY PHYSL; LOWENSTEIN O, 1956, ARCH OPHTHALMOL-CHIC, V55, P565, DOI 10.1001/archopht.1956.00930030569015; LOWENSTEIN O, 1964, AM J OPHTHALMOL, V57, P569, DOI 10.1016/0002-9394(64)92504-8; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Micieli G, 1995, FUNCT NEUROL, V10, P273; Micieli G, 1991, Clin Auton Res, V1, P55, DOI 10.1007/BF01826058; Micieli G, 1989, Funct Neurol, V4, P105; Morte A, 2005, NEUROPSYCHOBIOLOGY, V52, P169, DOI 10.1159/000088859; Muppidi S, 2013, CLIN AUTON RES, V23, P297, DOI 10.1007/s10286-013-0209-7; Mylius V, 2003, CLIN AUTON RES, V13, P16, DOI 10.1007/s10286-003-0065-y; Nachtegaal J, 2009, EAR HEARING, V30, P302, DOI 10.1097/AUD.0b013e31819c6e01; Nanas S, 2006, INT J CARDIOL, V110, P393, DOI 10.1016/j.ijcard.2005.10.032; Ofte HK, 2014, REDUCED CRANIAL PARA; Parikh SM, 2002, J NEUROL SCI, V200, P1, DOI 10.1016/S0022-510X(02)00126-0; PERRY F, 1989, PAIN, V39, P77, DOI 10.1016/0304-3959(89)90177-2; PFEIFER MA, 1985, DIABETES CARE, V8, P576, DOI 10.2337/diacare.8.6.576; PFEIFER MA, 1982, DIABETES CARE, V5, P518, DOI 10.2337/diacare.5.5.518; PIHA SJ, 1994, INT J OBESITY, V18, P547; Pozzessere G, 1996, AGING-CLIN EXP RES, V8, P55, DOI 10.1007/BF03340116; Pozzessere G, 1997, CLIN AUTON RES, V7, P315, DOI 10.1007/BF02267724; Pronk M, 2011, INT J AUDIOL, V50, P594, DOI 10.3109/14992027.2011.582165; Purves D., 2004, NEUROSCIENCE, VThird; Ramaekers D, 1998, EUR HEART J, V19, P1334, DOI 10.1053/euhj.1998.1084; Robertson D, 2004, PRIMER AUTONOMIC NER; Ross M.D., 1981, NEURONAL MECH HEARIN, P31, DOI [10.1007/978-1-4684-3908-3_3, DOI 10.1007/978-1-4684-3908-3_3]; ROSSI M, 1989, CLIN SCI, V76, P567, DOI 10.1042/cs0760567; RUBIN LS, 1980, INT J NEUROSCI, V11, P301, DOI 10.3109/00207458009147594; Saraswathi P V, 2013, Indian J Physiol Pharmacol, V57, P23; Seaward BL, 2006, MANAGING STRESS PRIN; Shechter A, 2002, NEUROLOGY, V58, P422, DOI 10.1212/WNL.58.3.422; Staal MA, 2004, STRESS COGNITION HUM; Steinhauer S. R., 1993, PSYCHOL MED, V5, P687; Steinhauer SR, 2004, INT J PSYCHOPHYSIOL, V52, P77, DOI 10.1016/j.ijpsycho.2003.12.005; Steinhauer SR, 2000, INT J PSYCHOPHYSIOL, V39, P21, DOI 10.1016/S0167-8760(00)00119-7; Stratton JR, 2003, J AM COLL CARDIOL, V41, P2077, DOI 10.1016/S0735-1097(03)00418-2; Strawbridge WJ, 2000, GERONTOLOGIST, V40, P320, DOI 10.1093/geront/40.3.320; Tales A, 2001, AGING CLIN EXP RES, V13, P473; Terluin B, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-34; THOMSEN LL, 1995, CLIN AUTON RES, V5, P243, DOI 10.1007/BF01818887; UHLMANN RF, 1989, JAMA-J AM MED ASSOC, V261, P1916, DOI 10.1001/jama.261.13.1916; USUI S, 1995, ANN BIOMED ENG, V23, P375, DOI 10.1007/BF02584438; Vinik AI, 2003, DIABETES CARE, V26, P1553, DOI 10.2337/diacare.26.5.1553; Westphal, 1907, DTSCH MED WOCHENS, P1080; Yamada M, 1999, Auris Nasus Larynx, V26, P419, DOI 10.1016/S0385-8146(99)00021-8; Yamaji K., 2000, Systems and Computers in Japan, V31, P22, DOI 10.1002/(SICI)1520-684X(200004)31:4<22::AID-SCJ3>3.0.CO;2-W; Yarnitsky D, 2003, HEADACHE, V43, P704, DOI 10.1046/j.1526-4610.2003.03127.x; Yuan D, 2014, NEUROLOGY, V82; ZAHORSKAMARKIEWICZ B, 1993, INT J OBESITY, V17, P21; Zangemeister WH, 2009, NEUROL INT, V1, P65, DOI 10.4081/ni.2009.e19; Zekveld AA, 2011, EAR HEARING, V32, P498, DOI 10.1097/AUD.0b013e31820512bb; Zekveld AA, 2010, EAR HEARING, V31, P480, DOI 10.1097/AUD.0b013e3181d4f251	103	46	46	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153566	10.1371/journal.pone.0153566	http://dx.doi.org/10.1371/journal.pone.0153566			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9IK	27089436	Green Submitted, gold, Green Published			2022-12-26	WOS:000374527000026
J	Ji, WB; Arnst, C; Tipton, AR; Bekier, ME; Taylor, WR; Yen, TJ; Liu, ST				Ji, Wenbin; Arnst, Christopher; Tipton, Aaron R.; Bekier, Michael E., II; Taylor, William R.; Yen, Tim J.; Liu, Song-Tao			OTSSP167 Abrogates Mitotic Checkpoint through Inhibiting Multiple Mitotic Kinases	PLOS ONE			English	Article							LEUCINE-ZIPPER KINASE; CLOSED MAD2 C-MAD2; AURORA-B; STEM-CELL; CHROMOSOMAL INSTABILITY; MICROTUBULE ATTACHMENT; THR-3 PHOSPHORYLATION; TARGETING CANCER; GENE-EXPRESSION; PROTEIN-KINASE	OTSSP167 was recently characterized as a potent inhibitor for maternal embryonic leucine zipper kinase (MELK) and is currently tested in Phase I clinical trials for solid tumors that have not responded to other treatment. Here we report that OTSSP167 abrogates the mitotic checkpoint at concentrations used to inhibit MELK. The abrogation is not recapitulated by RNAi mediated silencing of MELK in cells. Although OTSSP167 indeed inhibits MELK, it exhibits off-target activity against Aurora B kinase in vitro and in cells. Furthermore, OTSSP167 inhibits BUB1 and Haspin kinases, reducing phosphorylation at histones H2A(T120) and H3(T3) and causing mislocalization of Aurora B and associated chromosomal passenger complex from the centromere/kinetochore. The results suggest that OTSSP167 may have additional mechanisms of action for cancer cell killing and caution the use of OTSSP167 as a MELK specific kinase inhibitor in biochemical and cellular assays.	[Ji, Wenbin; Arnst, Christopher; Tipton, Aaron R.; Bekier, Michael E., II; Taylor, William R.; Liu, Song-Tao] Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA; [Yen, Tim J.] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Tipton, Aaron R.] Oklahoma Med Res Fdn, Cell Cycle & Canc Biol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA; [Bekier, Michael E., II] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University System of Ohio; University of Toledo; Fox Chase Cancer Center; Oklahoma Medical Research Foundation; University of Michigan System; University of Michigan	Liu, ST (corresponding author), Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA.	sliu@utnet.utoledo.edu	Liu, Song-Tao/Y-4732-2019	Liu, Song-Tao/0000-0002-9623-8579	National Institutes of Health [CA06927, CA182651, CA16970, R15 GM084410, R15 GM100440, R01CA169500]; DoD [OC100172]; Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE [P30CA006927, R01CA169500, R21CA182651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM100440, R15GM084410] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DoD(United States Department of Defense); Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Core Grants CA06927, CA182651, and CA16970 to TJY, R15 GM084410 and R15 GM100440 to WRT, and R01CA169500 to STL. TJY was also supported by DoD OC100172, an Appropriation from the Commonwealth of Pennsylvania, and generous gifts from Mrs. C Greenberg and the Bucks County Board of Associates. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badouel C, 2006, CELL CYCLE, V5, P883, DOI 10.4161/cc.5.8.2683; Badouel C, 2010, EXP CELL RES, V316, P2166, DOI 10.1016/j.yexcr.2010.04.019; Barford D, 2011, PHILOS T R SOC B, V366, P3605, DOI 10.1098/rstb.2011.0069; Beke L, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150194; Bekier ME, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7775; Blot J, 2002, DEV BIOL, V241, P327, DOI 10.1006/dbio.2001.0525; Canevari G, 2013, BIOCHEMISTRY-US, V52, P6380, DOI 10.1021/bi4005864; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Chan GKT, 1999, J CELL BIOL, V146, P941, DOI 10.1083/jcb.146.5.941; Chartrain I, 2006, BIOL CELL, V98, P253, DOI 10.1042/BC20050041; Chartrain I, 2007, CELL BIOL INT, V31, P196, DOI 10.1016/j.cellbi.2006.10.005; Chung S, 2013, CELL CYCLE, V12, P1655, DOI 10.4161/cc.24988; Chung SY, 2012, ONCOTARGET, V3, P1629; Collin P, 2013, NAT CELL BIOL, V15, P1378, DOI 10.1038/ncb2855; Cordes S, 2006, DEVELOPMENT, V133, P2747, DOI 10.1242/dev.02447; Dai J, 2005, GENE DEV, V19, P472, DOI 10.1101/gad.1267105; Davezac N, 2002, ONCOGENE, V21, P7630, DOI 10.1038/sj.onc.1205870; Dick AE, 2013, NAT CELL BIOL, V15, P1370, DOI 10.1038/ncb2842; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Du T, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-100; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Fukumoto Y, 2010, CYTOTECHNOLOGY, V62, P73, DOI 10.1007/s10616-010-9259-z; Ganguly R, 2015, CLIN TRANSL MED, V4, DOI 10.1186/s40169-014-0045-y; Ganguly R, 2014, MOL CANCER THER, V13, P1393, DOI 10.1158/1535-7163.MCT-13-0764; Gil M, 1997, GENE, V195, P295, DOI 10.1016/S0378-1119(97)00181-9; Gray D, 2005, CANCER RES, V65, P9751, DOI 10.1158/0008-5472.CAN-04-4531; Gross S, 2015, J CLIN INVEST, V125, P1780, DOI 10.1172/JCI76094; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Hebbard LW, 2010, CANCER RES, V70, P8863, DOI 10.1158/0008-5472.CAN-10-1295; Heyer BS, 1997, MOL REPROD DEV, V47, P148, DOI 10.1002/(SICI)1098-2795(199706)47:2&lt;148::AID-MRD4&gt;3.0.CO;2-M; Jia LY, 2013, TRENDS BIOCHEM SCI, V38, P302, DOI 10.1016/j.tibs.2013.03.004; Jiang PF, 2013, INT J MOL SCI, V14, P21551, DOI 10.3390/ijms141121551; Joshi K, 2013, STEM CELLS, V31, P1051, DOI 10.1002/stem.1358; Kappadakunnel M, 2010, J NEURO-ONCOL, V96, P359, DOI 10.1007/s11060-009-9983-4; Kawashima SA, 2007, GENE DEV, V21, P420, DOI 10.1101/gad.1497307; Kawashima SA, 2010, SCIENCE, V327, P172, DOI 10.1126/science.1180189; Kelly AE, 2010, SCIENCE, V330, P235, DOI 10.1126/science.1189505; Kuner R, 2013, J MOL MED, V91, P237, DOI 10.1007/s00109-012-0949-1; Lara-Gonzalez P, 2011, J CELL SCI, V124, P4332, DOI 10.1242/jcs.094763; Le Page Y, 2011, J CELL SCI, V124, P958, DOI 10.1242/jcs.069567; Liu H, 2013, CURR BIOL, V23, P1927, DOI 10.1016/j.cub.2013.07.078; Mahasenan KV, 2012, J CHEM INF MODEL, V52, P1345, DOI 10.1021/ci300040c; Murata-Hori M, 2002, MOL BIOL CELL, V13, P1099, DOI 10.1091/mbc.01-09-0467; Nakano I, 2005, J CELL BIOL, V170, P413, DOI 10.1083/jcb.200412115; Nakano I, 2008, J NEUROSCI RES, V86, P48, DOI 10.1002/jnr.21471; Nakano I, 2009, METHODS MOL BIOL, V568, P37, DOI 10.1007/978-1-59745-280-9_4; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pickard MR, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2350; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Takeuchi K, 2011, BIOL PHARM BULL, V34, P1774, DOI 10.1248/bpb.34.1774; Tassan Jean-Pierre, 2011, Commun Integr Biol, V4, P483, DOI 10.4161/cib.4.4.15669; Tipton AR, 2013, J BIOL CHEM, V288, P35149, DOI 10.1074/jbc.M113.522375; Tipton AR, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-15; Tipton AR, 2011, CELL CYCLE, V10, P3740, DOI 10.4161/cc.10.21.17919; Tipton AR, 2011, J BIOL CHEM, V286, P21173, DOI 10.1074/jbc.M111.238543; TIWARI RK, 1987, EMBO J, V6, P3373, DOI 10.1002/j.1460-2075.1987.tb02659.x; Vagnarelli P, 2004, CHROMOSOMA, V113, P211, DOI 10.1007/s00412-004-0307-3; Wang FW, 2010, SCIENCE, V330, P231, DOI 10.1126/science.1189435; Wang JH, 2015, MOL CELL, V58, P708, DOI 10.1016/j.molcel.2015.05.001; Wang KX, 2014, J BIOL CHEM, V289, P23928, DOI 10.1074/jbc.M114.585315; Wang YB, 2014, ELIFE, V3, DOI 10.7554/eLife.01763; Waters JC, 1998, J CELL BIOL, V141, P1181, DOI 10.1083/jcb.141.5.1181; Westhorpe FG, 2011, J CELL SCI, V124, P3905, DOI 10.1242/jcs.093286; Yamagishi Y, 2012, NAT CELL BIOL, V14, P746, DOI 10.1038/ncb2515; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	67	33	37	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153518	10.1371/journal.pone.0153518	http://dx.doi.org/10.1371/journal.pone.0153518			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082996	Green Submitted, gold, Green Published			2022-12-26	WOS:000374291800026
J	Admoni-Elisha, L; Nakdimon, I; Shteinfer, A; Prezma, T; Arif, T; Arbel, N; Melkov, A; Zelichov, O; Levi, I; Shoshan-Barmatz, V				Admoni-Elisha, Lee; Nakdimon, Itay; Shteinfer, Anna; Prezma, Tal; Arif, Tasleem; Arbel, Nir; Melkov, Anna; Zelichov, Ori; Levi, Itai; Shoshan-Barmatz, Varda			Novel Biomarker Proteins in Chronic Lymphocytic Leukemia: Impact on Diagnosis, Prognosis and Treatment	PLOS ONE			English	Article							ANION CHANNEL VDAC; APOPTOTIC CELL-DEATH; IN-VIVO; CASPASE ACTIVATION; CYTOCHROME-C; CATHEPSIN-S; B-CELLS; EXPRESSION; CANCER; BCL-2	In many cancers, cells undergo re-programming of metabolism, cell survival and anti-apoptotic defense strategies, with the proteins mediating this reprogramming representing potential biomarkers. Here, we searched for novel biomarker proteins in chronic lymphocytic leukemia (CLL) that can impact diagnosis, treatment and prognosis by comparing the protein expression profiles of peripheral blood mononuclear cells from CLL patients and healthy donors using specific antibodies, mass spectrometry and binary logistic regression analyses and other bioinformatics tools. Mass spectrometry (LC-HR-MS/MS) analysis identified 1,360 proteins whose expression levels were modified in CLL-derived lymphocytes. Some of these proteins were previously connected to different cancer types, including CLL, while four other highly expressed proteins were not previously reported to be associated with cancer, and here, for the first time, DDX46 and AK3 are linked to CLL. Down-regulation expression of two of these proteins resulted in cell growth inhibition. High DDX46 expression levels were associated with shorter survival of CLL patients and thus can serve as a prognosis marker. The proteins with modified expression include proteins involved in RNA splicing and translation and particularly mitochondrial proteins involved in apoptosis and metabolism. Thus, we focused on several metabolism-and apoptosis-modulating proteins, particularly on the voltage-dependent anion channel 1 (VDAC1), regulating both metabolism and apoptosis. Expression levels of Bcl-2, VDAC1, MAVS, AIF and SMAC/Diablo were markedly increased in CLL-derived lymphocytes. VDAC1 levels were highly correlated with the amount of CLL-cancerous CD19+/CD5+ cells and with the levels of all other apoptosis-modulating proteins tested. Binary logistic regression analysis demonstrated the ability to predict probability of disease with over 90% accuracy. Finally, based on the changes in the levels of several proteins in CLL patients, as revealed from LC-HR-MS/MS, we could distinguish between patients in a stable disease state and those who would be later transferred to anti-cancer treatments. The over-expressed proteins can thus serve as potential biomarkers for early diagnosis, prognosis, new targets for CLL therapy, and treatment guidance of CLL, forming the basis for personalized therapy.	[Admoni-Elisha, Lee; Nakdimon, Itay; Shteinfer, Anna; Prezma, Tal; Arif, Tasleem; Arbel, Nir; Melkov, Anna; Shoshan-Barmatz, Varda] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Admoni-Elisha, Lee; Nakdimon, Itay; Shteinfer, Anna; Prezma, Tal; Arif, Tasleem; Arbel, Nir; Melkov, Anna; Shoshan-Barmatz, Varda] Ben Gurion Univ Negev, Natl Inst Biotechnol, IL-84105 Beer Sheva, Israel; [Zelichov, Ori; Levi, Itai] Ben Gurion Univ Negev, Soroka Univ Med Ctr, Dept Hematol, IL-84105 Beer Sheva, Israel; [Zelichov, Ori; Levi, Itai] Ben Gurion Univ Negev, Fac Hlth Sci, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University; Soroka Medical Center; Ben Gurion University	Shoshan-Barmatz, V (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	vardasb@bgu.ac.il	Arif, Tasleem/AAA-2741-2020	Arif, Tasleem/0000-0001-9881-0076	Leukemia & Lymphoma Society, LLS TRP Grant [6336-11]; Leukemia & Lymphoma Society	Leukemia & Lymphoma Society, LLS TRP Grant; Leukemia & Lymphoma Society(Leukemia and Lymphoma Society)	This work was supported by a grant from the Leukemia & Lymphoma Society, LLS TRP Grant #6336-11.; This research was supported by a grant from the Leukemia & Lymphoma Society.	Abu-Hamad S, 2008, J BIOL CHEM, V283, P13482, DOI 10.1074/jbc.M708216200; Abu-Hamad S, 2009, J CELL SCI, V122, P1906, DOI 10.1242/jcs.040188; Agrawal SG, 2008, BLOOD, V111, P2790, DOI 10.1182/blood-2007-10-110460; Arbel N, 2012, J BIOL CHEM, V287, P23152, DOI 10.1074/jbc.M112.345918; Arbel N, 2010, J BIOL CHEM, V285, P6053, DOI 10.1074/jbc.M109.082990; Arellano-Llamas A, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-256; Arif T, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.9; Arzoine L, 2009, J BIOL CHEM, V284, P3946, DOI 10.1074/jbc.M803614200; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Azoulay-Zohar H, 2004, BIOCHEM J, V377, P347, DOI 10.1042/BJ20031465; Baig RM, 2013, DIS MARKERS, V34, P71, DOI [10.3233/DMA-120952, 10.1155/2013/795410]; Bao Shi-Ting, 2006, Hepatobiliary Pancreat Dis Int, V5, P580; Belgnaoui SM, 2011, CURR OPIN IMMUNOL, V23, P564, DOI 10.1016/j.coi.2011.08.001; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Blaveri E, 2005, CLIN CANCER RES, V11, P7012, DOI 10.1158/1078-0432.CCR-05-0177; Bleeker FE, 2009, HUM MUTAT, V30, P7, DOI 10.1002/humu.20937; Brahimi-Horn MC, 2012, CANCER RES, V72, P2140, DOI 10.1158/0008-5472.CAN-11-3940; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Butrym A, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0560-5; Campbell AM, 2008, J BIOENERG BIOMEMBR, V40, P193, DOI 10.1007/s10863-008-9138-x; Catalina-Rodriguez O, 2012, ONCOTARGET, V3, P1220; Chang PY, 2014, J CELL PHYSIOL, V229, P309, DOI 10.1002/jcp.24448; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Chowdhury I, 2006, CELL MOL BIOL LETT, V11, P506, DOI 10.2478/s11658-006-0041-3; Cowling VH, 2014, ONCOGENE, V33, P3519, DOI 10.1038/onc.2013.338; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Deng SS, 2007, BREAST CANCER RES TR, V104, P21, DOI 10.1007/s10549-006-9393-7; Di Pietro SM, 2006, MOL BIOL CELL, V17, P4027, DOI 10.1091/mbc.E06-05-0379; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Dupont WD, 2010, CANCER, V116, P8, DOI 10.1002/cncr.24702; Dutta B, 2014, MOL CELL PROTEOMICS, V13, P3236, DOI 10.1074/mcp.M114.038232; Feng G, 2014, LEUKEMIA LYMPHOMA, V55, P2699, DOI 10.3109/10428194.2014.891026; Flannery T, 2003, AM J PATHOL, V163, P175, DOI 10.1016/S0002-9440(10)63641-3; Frezza C, 2009, SEMIN CANCER BIOL, V19, P4, DOI 10.1016/j.semcancer.2008.11.008; Gormley JA, 2011, BRIT J CANCER, V105, P1487, DOI 10.1038/bjc.2011.408; Gottardi D, 1996, BRIT J HAEMATOL, V94, P612, DOI 10.1046/j.1365-2141.1996.d01-1856.x; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Guan K, 2013, MOL CELL BIOL, V33, P3137, DOI 10.1128/MCB.00030-13; Guryca V, 2012, PROTEOMICS, V12, P1207, DOI 10.1002/pmic.201100430; Ha SA, 2008, INT J CANCER, V122, P501, DOI 10.1002/ijc.23146; HANADA M, 1993, BLOOD, V82, P1820; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hangen E, 2010, TRENDS BIOCHEM SCI, V35, P278, DOI 10.1016/j.tibs.2009.12.008; Hirabayashi R, 2013, STEM CELLS DEV, V22, P2532, DOI 10.1089/scd.2012.0623; Hoog JO, 2001, J BIOMED SCI, V8, P71, DOI 10.1159/000054015; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang HY, 2013, J BIOL CHEM, V288, P19870, DOI 10.1074/jbc.M112.448290; Hudler P, 2014, SCI WORLD J, DOI 10.1155/2014/260348; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Kaemmerer D, 2014, CLIN EXP METASTAS, V31, P817, DOI 10.1007/s10585-014-9672-3; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kelstrup CD, 2012, J PROTEOME RES, V11, P3487, DOI 10.1021/pr3000249; Kempkensteffen C, 2008, J CANCER RES CLIN, V134, P543, DOI 10.1007/s00432-007-0317-7; Kitada S, 1998, BLOOD, V91, P3379, DOI 10.1182/blood.V91.9.3379; Kitada S, 2004, JNCI-J NATL CANCER I, V96, P642, DOI 10.1093/jnci/djh153; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Kusano H, 2000, ONCOGENE, V19, P4807, DOI 10.1038/sj.onc.1203868; Lee CEH, 2007, LEUKEMIA RES, V31, P1247, DOI 10.1016/j.leukres.2006.10.013; Lei Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005466; Lemasters JJ, 2006, BBA-MOL BASIS DIS, V1762, P181, DOI 10.1016/j.bbadis.2005.10.006; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Lokamani I, 2014, PATHOL ONCOL RES, V20, P119, DOI 10.1007/s12253-013-9670-9; Ma MPC, 2012, J CELL SCI, V125, P4372, DOI 10.1242/jcs.105981; McKenney AS, 2013, J CLIN INVEST, V123, P3672, DOI 10.1172/JCI67266; Meldrum Cliff, 2011, Clin Biochem Rev, V32, P177; Miretti S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001828; Noma T, 2001, BIOCHEM J, V358, P225, DOI 10.1042/0264-6021:3580225; Oktem G, 2014, ONCOL REP, V32, P641, DOI 10.3892/or.2014.3252; Parker WB, 2011, CANCER GENE THER, V18, P390, DOI 10.1038/cgt.2011.4; Pedersen PL, 2008, J BIOENERG BIOMEMBR, V40, P123, DOI 10.1007/s10863-008-9165-7; Pepper C, 1997, BRIT J CANCER, V76, P935, DOI 10.1038/bjc.1997.487; Perez-Andres M, 2010, CYTOM PART B-CLIN CY, V78B, pS47, DOI 10.1002/cyto.b.20547; Placzek WJ, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.18; Prezma T, 2013, CELL DEATH IN PRESS; Rajkumar T, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-80; Ren SR, 2000, ONCOGENE, V19, P1419, DOI 10.1038/sj.onc.1203462; Rossi D, 2012, EXPERT REV HEMATOL, V5, P593, DOI [10.1586/EHM.12.58, 10.1586/ehm.12.58]; Schimmer Aaron D, 2003, Curr Treat Options Oncol, V4, P211, DOI 10.1007/s11864-003-0022-y; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sevrioukova IF, 2011, ANTIOXID REDOX SIGN, V14, P2545, DOI 10.1089/ars.2010.3445; Shibata T, 2007, DIAGN MOL PATHOL, V16, P1, DOI 10.1097/01.pdm.0000213471.92925.51; Shinohara Y, 2000, EUR J BIOCHEM, V267, P6067, DOI 10.1046/j.1432-1327.2000.01687.x; Shoshan-Barmatz V, 2012, CURR MED CHEM, V19, P714, DOI 10.2174/092986712798992110; Shoshan-Barmatz V., 2014, BIOCH BIOPHYS ACTA; Shoshan-Barmatz V, 2010, BBA-BIOENERGETICS, V1797, P1281, DOI 10.1016/j.bbabio.2010.03.003; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Shoshan-Barmatzt V, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00164; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Sotgia F, 2012, CELL CYCLE, V11, P4390, DOI 10.4161/cc.22777; Spender LC, 2009, CELL DEATH DIFFER, V16, P593, DOI 10.1038/cdd.2008.183; Stacchini A, 1999, LEUKEMIA RES, V23, P127, DOI 10.1016/S0145-2126(98)00154-4; Starczynski J, 2005, J CLIN ONCOL, V23, P1514, DOI 10.1200/JCO.2005.02.192; Tainsky MA, 2009, BBA-REV CANCER, V1796, P176, DOI 10.1016/j.bbcan.2009.04.004; Tommasino M, 2003, HUM MUTAT, V21, P307, DOI 10.1002/humu.10178; Tritschler I, 2009, INT J CANCER, V125, P530, DOI 10.1002/ijc.24443; Ueda K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018567; Viatour P, 2003, LEUKEMIA, V17, P1349, DOI 10.1038/sj.leu.2402982; Vogler M, 2009, BLOOD, V113, P4403, DOI 10.1182/blood-2008-08-173310; Wade R, 2011, HAEMATOL-HEMATOL J, V96, P1496, DOI 10.3324/haematol.2011.043471; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Yeh CS, 2006, CANCER LETT, V233, P297, DOI 10.1016/j.canlet.2005.03.050; Zaid H, 2005, CELL DEATH DIFFER, V12, P751, DOI 10.1038/sj.cdd.4401599; Zha S, 2005, PROSTATE, V63, P316, DOI 10.1002/pros.20177	104	11	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0148500	10.1371/journal.pone.0148500	http://dx.doi.org/10.1371/journal.pone.0148500			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078856	Green Submitted, Green Published, gold			2022-12-26	WOS:000374131700001
J	Alcaide, ML; Strbo, N; Romero, L; Jones, DL; Rodriguez, VJ; Arheart, K; Martinez, O; Bolivar, H; Podack, ER; Fischl, MA				Alcaide, Maria L.; Strbo, Natasa; Romero, Laura; Jones, Deborah L.; Rodriguez, Violeta J.; Arheart, Kristopher; Martinez, Octavio; Bolivar, Hector; Podack, Eckhard R.; Fischl, Margaret A.			Bacterial Vaginosis Is Associated with Loss of Gamma Delta T Cells in the Female Reproductive Tract in Women in the Miami Women Interagency HIV Study (WIHS): A Cross Sectional Study	PLOS ONE			English	Article							HIGH-RISK; INTRAVAGINAL PRACTICES; VAGINAL INFECTIONS; UNINFECTED WOMEN; CYTOKINE LEVELS; AFRICAN WOMEN; MUCOSAL; VIRUS; TRANSMISSION; ACQUISITION	Bacterial vaginosis (BV) is the most common female reproductive tract infection and is associated with an increased risk of acquiring and transmitting HIV by a mechanism that is not well understood. Gamma delta (GD) T cells are essential components of the adaptive and innate immune system, are present in the female reproductive tract, and play an important role in epithelial barrier protection. GD1 cells predominate in the mucosal tissue and are important in maintaining mucosal integrity. GD2 cells predominate in peripheral blood and play a role in humoral immunity and in the immune response to pathogens. HIV infection is associated with changes in GD T cells frequencies in the periphery and in the female reproductive tract. The objective of this study is to evaluate if changes in vaginal flora occurring with BV are associated with changes in endocervical GD T cell responses, which could account for increased susceptibility to HIV. Seventeen HIV-infected (HIV+) and 17 HIV-uninfected (HIV-) pre-menopausal women underwent collection of vaginal swabs and endocervical cytobrushes. Vaginal flora was assessed using the Nugent score. GD T cells were assessed in cytobrush samples by flow cytometry. Median Nugent score was 5.0 and 41% of women had abnormal vaginal flora. In HIV uninfected women there was a negative correlation between Nugent score and cervical GD1 T cells (b for interaction = -0.176, p<0.01); cervical GD1 T cells were higher in women with normal vaginal flora than in those with abnormal flora (45.00% vs 9.95%, p = 0.005); and cervical GD2 T cells were higher in women with abnormal flora than in those with normal flora (1.70% vs 0.35%, p = 0.023). GD T cells in the genital tract are protective (GD1) and are targets for HIV entry (GD2). The decrease in cervical GD1 and increase in GD2 T cells among women with abnormal vaginal flora predisposes women with BV to HIV acquisition. We propose to use GD T cell as markers of female genital tract vulnerability to HIV.	[Alcaide, Maria L.; Bolivar, Hector; Fischl, Margaret A.] Univ Miami, Miller Sch Med, Dept Med, Div Infect Dis, Miami, FL 33136 USA; [Strbo, Natasa; Romero, Laura; Podack, Eckhard R.] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA; [Jones, Deborah L.; Rodriguez, Violeta J.] Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Miami, FL 33136 USA; [Arheart, Kristopher] Univ Miami, Miller Sch Med, Dept Epidemiol & Publ Hlth, Miami, FL 33136 USA; [Martinez, Octavio] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami; University of Miami; University of Miami	Alcaide, ML (corresponding author), Univ Miami, Miller Sch Med, Dept Med, Div Infect Dis, Miami, FL 33136 USA.	malcaide@med.miami.edu	Rodriguez, Violeta J/I-6290-2019	Rodriguez, Violeta J/0000-0001-8543-2061; , Octavio/0000-0002-0254-6854; Alcaide, Maria/0000-0003-4648-0145	National Institutes of Health though: the Miami Center for AIDS Research (CFAR) at the University of Miami Miller School of Medicine [P30AI073961]; Miami Women's Interagency HIV Infection Study (WIHS) [U01 AI103397]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [K23HD074489]; University of Miami National Center for Advancing Translational Sciences; National Institute on Minority Health and Health Disparities [UL1TR000460, 1KL2TR000461]; National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Cancer Institute (NCI); National Institute on Drug Abuse (NIDA); National Institute on Mental Health (NIMH); National Institute of Dental and Craniofacial Research (NIDCR); National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institute on Deafness and other Communication Disorders (NIDCD); NIH Office of Research on Women's Health; UCSF CTSA [UL1-TR000004]; Atlanta CTSA [UL1-TR000454]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD074489, U01HD032632] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454, UL1TR000004, UL1TR000460, KL2TR000461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI103390, U01AI103397, P30AI073961, U01AI103408, U01AI103401, U01AI031834, U01AI034994, U01AI035004, U01AI034989, U01AI034993, U01AI042590] Funding Source: NIH RePORTER	National Institutes of Health though: the Miami Center for AIDS Research (CFAR) at the University of Miami Miller School of Medicine; Miami Women's Interagency HIV Infection Study (WIHS); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); University of Miami National Center for Advancing Translational Sciences; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute on Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Deafness and other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIH Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); UCSF CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Atlanta CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the National Institutes of Health though: the Miami Center for AIDS Research (CFAR) at the University of Miami Miller School of Medicine [P30AI073961], Miami Women's Interagency HIV Infection Study (WIHS) [U01 AI103397], the Eunice Kennedy Shriver National Institute of Child Health and Human Development [K23HD074489], University of Miami National Center for Advancing Translational Sciences and the National Institute on Minority Health and Health Disparities [UL1TR000460 and 1KL2TR000461]. The WIHS is funded primarily by the National Institute of Allergy and Infectious Diseases (NIAID), with additional co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Cancer Institute (NCI), the National Institute on Drug Abuse (NIDA), and the National Institute on Mental Health (NIMH). Targeted supplemental funding for specific projects is also provided by the National Institute of Dental and Craniofacial Research (NIDCR), the National Institute on Alcohol Abuse and Alcoholism (NIAAA), the National Institute on Deafness and other Communication Disorders (NIDCD), and the NIH Office of Research on Women's Health. WIHS data collection is also supported by UL1-TR000004 (UCSF CTSA) and UL1-TR000454 (Atlanta CTSA). Data in this manuscript were collected by the Women's Interagency HIV Study (WIHS). The contents of this publication are solely the responsibility of the authors and do not represent the official views of the National Institutes of Health (NIH). WIHS (Principal Investigators): UAB-MS WIHS (Michael Saag, Mirjam-Colette Kempf, and Deborah Konkle-Parker), U01-AI-103401; Atlanta WIHS (Ighovwerha Ofotokun and Gina Wingood), U01-AI-103408; Bronx WIHS (Kathryn Anastos), U01-AI-035004; Brooklyn WIHS (Howard Minkoff and Deborah Gustafson), U01-AI-031834; Chicago WIHS (Mardge Cohen and Audrey French), U01-AI-034993; Metropolitan Washington WIHS (Mary Young), U01-AI-034994; Miami WIHS (Margaret Fischl and Lisa Metsch), U01-AI-103397; UNC WIHS (Adaora Adimora), U01-AI-103390; Connie Wofsy Women's HIV Study, Northern California (Ruth Greenblatt, Bradley Aouizerat, and Phyllis Tien), U01-AI-034989; WIHS Data Management and Analysis Center (Stephen Gange and Elizabeth Golub), U01-AI-042590; Southern California WIHS (Alexandra Levine and Marek Nowicki), U01-HD-032632 (WIHS I - WIHS IV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsworth JE, 2007, OBSTET GYNECOL, V109, P114, DOI 10.1097/01.AOG.0000247627.84791.91; Anahtar MN, 2015, IMMUNITY, V42, P965, DOI 10.1016/j.immuni.2015.04.019; AUTRAN B, 1989, CLIN EXP IMMUNOL, V75, P206; Bloom BS, 1996, NEW ENGL J MED, V334, P1338; Brotman RM, 2008, AM J EPIDEMIOL, V168, P188, DOI 10.1093/aje/kwn103; Carding SR, 2002, NAT REV IMMUNOL, V2, P336, DOI 10.1038/nri797; Cohen CR, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001251; Eade CR, 2015, PROTEIN PEPTIDE LETT, V22, P672, DOI 10.2174/0929866522666150309155735; Farquhar C, 2010, AIDS, V24, P153, DOI 10.1097/QAD.0b013e32832326d8; Fethers KA, 2008, CLIN INFECT DIS, V47, P1426, DOI 10.1086/592974; Ghosh M, 2014, AM J REPROD IMMUNOL, V71, P575, DOI 10.1111/aji.12250; Greenblatt RM, 1999, SEX TRANSM DIS, V26, P143, DOI 10.1097/00007435-199903000-00004; Hayday A, 2003, NAT REV IMMUNOL, V3, P233, DOI 10.1038/nri1030; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; Hedges SR, 2006, J INFECT DIS, V193, P556, DOI 10.1086/499824; Hilber AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009119; Hladik F, 2007, IMMUNITY, V26, P257, DOI 10.1016/j.immuni.2007.01.007; Holmes KK, 2008, SEXUALLY TRANSMITTED, V4th; Klebanoff MA, 2010, SEX TRANSM DIS, V37, P184, DOI 10.1097/OLQ.0b013e3181c04865; Koumans EH, 2007, SEX TRANSM DIS, V34, P864, DOI 10.1097/OLQ.0b013e318074e565; Kyongo JK, 2015, CLIN VACCINE IMMUNOL, V22, P526, DOI 10.1128/CVI.00762-14; Laxmi U, 2012, J MATERN-FETAL NEO M, V25, P64, DOI 10.3109/14767058.2011.565390; Low N, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000416; Mares D, 2008, J REPROD IMMUNOL, V77, P91, DOI 10.1016/j.jri.2007.04.004; McClelland RS, 2006, AIDS, V20, P269, DOI 10.1097/01.aids.0000196165.48518.7b; Mincheva-Nilsson L, 2000, INT IMMUNOL, V12, P585, DOI 10.1093/intimm/12.5.585; Mincheva-Nilsson Lucia, 2003, Reprod Biol Endocrinol, V1, P120, DOI 10.1186/1477-7827-1-120; Mirmonsef P, 2012, CURR HIV RES, V10, P202, DOI 10.2174/157016212800618165; Mitchell CM, 2008, AIDS RES HUM RETROV, V24, P667, DOI [10.1089/aid.2007.0268, 10.1089/aid.2008.0268]; Mukura LR, 2012, AIDS RES HUM RETROV, V28, P1533, DOI [10.1089/aid.2011.0394, 10.1089/AID.2011.0394]; Muzny CA, 2014, SEX TRANSM DIS, V41, P58, DOI 10.1097/OLQ.0000000000000057; Myer L, 2005, LANCET INFECT DIS, V5, P786, DOI 10.1016/S1473-3099(05)70298-X; Nakasone C, 2007, MICROBES INFECT, V9, P251, DOI 10.1016/j.micinf.2006.11.015; Novak RM, 2007, CLIN VACCINE IMMUNOL, V14, P1102, DOI 10.1128/CVI.00386-06; Pauza CD, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00687; Poles MA, 2003, J VIROL, V77, P10456, DOI 10.1128/JVI.77.19.10456-10467.2003; Saba E, 2010, MUCOSAL IMMUNOL, V3, P280, DOI 10.1038/mi.2010.2; Shires J, 2001, IMMUNITY, V15, P419, DOI 10.1016/S1074-7613(01)00192-3; Strbo N, 2016, AM J REPROD IMMUNOL, V75, P134, DOI 10.1111/aji.12458; Thurman AR, 2015, AIDS RES HUM RETROV, V31, P1139, DOI 10.1089/aid.2015.0006; Watts DH, 2006, JAIDS-J ACQ IMM DEF, V43, P161, DOI 10.1097/01.qai.0000242448.90026.13; Zariffard MR, 2005, J INFECT DIS, V191, P1913, DOI 10.1086/429922	42	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153045	10.1371/journal.pone.0153045	http://dx.doi.org/10.1371/journal.pone.0153045			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078021	Green Submitted, Green Published, gold			2022-12-26	WOS:000374131700017
J	Guo, YM; Zhou, HJ; Qin, LY; Pang, ZZ; Qin, T; Ren, HY; Pan, Z; Zhou, JK				Guo, Yumei; Zhou, Haijian; Qin, Liyun; Pang, Zhizhao; Qin, Tian; Ren, Hongyu; Pan, Zhuo; Zhou, Jikun			Frequency, Antimicrobial Resistance and Genetic Diversity of Klebsiella pneumoniae in Food Samples	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; MEDIATED QUINOLONE RESISTANCE; EXTENDED-SPECTRUM; FLUOROQUINOLONE RESISTANCE; MOLECULAR CHARACTERIZATION; CARBAPENEM RESISTANCE; ESCHERICHIA-COLI; CHICKEN MEAT; PREVALENCE; GYRA	This study aimed to assess the frequency of Klebsiella pneumoniae in food samples and to detect antibiotic resistance phenotypes, antimicrobial resistance genes and the molecular subtypes of the recovered isolates. A total of 998 food samples were collected, and 99 (9.9%) K. pneumoniae strains were isolated; the frequencies were 8.2% (4/49) in fresh raw seafood, 13.8% (26/188) in fresh raw chicken, 11.4% (34/297) in frozen raw food and 7.5% (35/464) in cooked food samples. Antimicrobial resistance was observed against 16 antimicrobials. The highest resistance rate was observed for ampicillin (92.3%), followed by tetracycline (31.3%), trimethoprim-sulfamethoxazole (18.2%), and chloramphenicol (10.1%). Two K. pneumoniae strains were identified as extended-spectrum beta-lactamase (ESBL)-one strain had three beta-lactamases genes (bla(SHV), bla(CTX-M-1), and bla(CTX-M-10)) and one had only the bla(SHV) gene. Nineteen multidrug-resistant (MDR) strains were detected; the percentage of MDR strains in fresh raw chicken samples was significantly higher than in other sample types (P<0.05). Six of the 18 trimethoprim-sulfamethoxazole-resistant strains carried the folate pathway inhibitor gene (dhfr). Four isolates were screened by PCR for quinolone resistance genes; aac(6')-Ib-cr, qnrB, qnrA and qnrS were detected. In addition, gyrA gene mutations such as T247A (Ser83Ile), C248T (Ser83Phe), and A260C (Asp87Ala) and a parC C240T (Ser80Ile) mutation were identified. Five isolates were screened for aminoglycosides resistance genes; aacA4, aacC2, and aadA1 were detected. Pulsed-field gel electrophoresis-based subtyping identified 91 different patterns. Our results indicate that food, especially fresh raw chicken, is a reservoir of antimicrobial-resistant K. pneumoniae, and the potential health risks posed by such strains should not be underestimated. Our results demonstrated high prevalence, antibiotic resistance rate and genetic diversity of K. pneumoniae in food in China. Improved control and prevention strategies are urgently needed.	[Guo, Yumei; Qin, Liyun; Pang, Zhizhao; Pan, Zhuo; Zhou, Jikun] Shijiazhuang Ctr Dis Control & Prevent, Shijiazhuang, Peoples R China; [Zhou, Haijian; Qin, Tian; Ren, Hongyu] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Zhou, Haijian; Qin, Tian] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Zhou, JK (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	zhouhaijian@icdc.cn; zhoujikun@vip.inhe.net			National Health and Family Planning Commission of the People's Republic of China [2012ZX10004215, 2008ZX10004-008]	National Health and Family Planning Commission of the People's Republic of China	This work was supported by 2012ZX10004215, 2008ZX10004-008 from National Health and Family Planning Commission of the People's Republic of China (http://www.nhfpc.gov.cn/). HZ received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aathithan S, 2010, INT J ANTIMICROB AG, V36, P239, DOI 10.1016/j.ijantimicag.2010.04.010; An SC, 2012, FEMS MICROBIOL LETT, V332, P137, DOI 10.1111/j.1574-6968.2012.02586.x; Anderl JN, 2000, ANTIMICROB AGENTS CH, V44, P1818, DOI 10.1128/AAC.44.7.1818-1824.2000; BISSONNETTE L, 1992, J BACTERIOL, V174, P1248, DOI 10.1128/jb.174.4.1248-1257.1992; Calbo E, 2011, CLIN INFECT DIS, V52, P743, DOI 10.1093/cid/ciq238; Campos CB, 2014, INT J MED MICROBIOL, V304, P678, DOI 10.1016/j.ijmm.2014.04.012; Casella T, 2015, INT J FOOD MICROBIOL, V197, P88, DOI 10.1016/j.ijfoodmicro.2014.12.001; Cavaco LM, 2009, ANTIMICROB AGENTS CH, V53, P603, DOI 10.1128/AAC.00997-08; Chen FJ, 2003, MICROB DRUG RESIST, V9, P265, DOI 10.1089/107662903322286472; Chon JW, 2015, FOODBORNE PATHOG DIS, V12, P190, DOI 10.1089/fpd.2014.1847; Clinical and Laboratory Standards Institute (CLSI), 2014, M100S242014 CLSI; Coudron PE, 2003, J CLIN MICROBIOL, V41, P772, DOI 10.1128/JCM.41.2.772-777.2003; Deguchi T, 1997, ANTIMICROB AGENTS CH, V41, P699, DOI 10.1128/AAC.41.3.699; Dhillon RHP, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/625170; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Espedido BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059920; Gao Wei, 2009, Zhongguo Kangshengsu Zazhi, V34, P48; Han H, 2013, INT J ENV RES PUB HE, V10, P2720, DOI 10.3390/ijerph10072720; Hernandez-Alles S, 1999, ANTIMICROB AGENTS CH, V43, P937, DOI 10.1128/AAC.43.4.937; Hopkins KL, 2005, INT J ANTIMICROB AG, V25, P358, DOI 10.1016/j.ijantimicag.2005.02.006; Hujer KM, 2006, ANTIMICROB AGENTS CH, V50, P4114, DOI 10.1128/AAC.00778-06; Kawakami S, 2000, Kansenshogaku Zasshi, V74, P24; Kim HK, 2009, J AM COLL CARDIOL, V53, P2009, DOI 10.1016/j.jacc.2009.01.066; Krishnarnurthy V, 2013, J CLIN DIAGN RES, V7, P1975, DOI 10.7860/JCDR/2013/6544.3376; Kuchenmulller T, 2013, REV SCI TECH OIE, V32, P459; Leavitt A, 2010, J ANTIMICROB CHEMOTH, V65, P243, DOI 10.1093/jac/dkp417; Li B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042280; Ma L, 2009, ANTIMICROB AGENTS CH, V53, P104, DOI 10.1128/AAC.00852-08; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Marchaim D, 2008, ANTIMICROB AGENTS CH, V52, P1413, DOI 10.1128/AAC.01103-07; McLinden T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-509; Meier S, 2011, INFECTION, V39, P333, DOI 10.1007/s15010-011-0132-6; Messai Y, 2008, PATHOL BIOL, V56, P319, DOI 10.1016/j.patbio.2008.05.008; Nawaz M, 2012, INT J FOOD MICROBIOL, V155, P179, DOI 10.1016/j.ijfoodmicro.2012.02.002; Oliver A, 2001, ANTIMICROB AGENTS CH, V45, P616, DOI 10.1128/AAC.45.2.616-620.2001; Park CH, 2006, ANTIMICROB AGENTS CH, V50, P3953, DOI 10.1128/AAC.00915-06; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Pfeifer Y, 2010, INT J MED MICROBIOL, V300, P371, DOI 10.1016/j.ijmm.2010.04.005; Falomir MP, 2013, FOODBORNE PATHOG DIS, V10, P1002, DOI 10.1089/fpd.2013.1552; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Robicsek A, 2006, NAT MED, V12, P83, DOI 10.1038/nm1347; Robicsek A, 2005, ANTIMICROB AGENTS CH, V49, P3001, DOI 10.1128/AAC.49.7.3001-3003.2005; Schlesinger J, 2005, ANTIMICROB AGENTS CH, V49, P1150, DOI 10.1128/AAC.49.3.1150-1156.2005; Schneiders T, 2003, ANTIMICROB AGENTS CH, V47, P2831, DOI 10.1128/AAC.47.9.2831-2837.2003; Struve C, 2004, ENVIRON MICROBIOL, V6, P584, DOI 10.1111/j.1462-2920.2004.00590.x; Tumbarello M, 2007, ANTIMICROB AGENTS CH, V51, P1987, DOI 10.1128/AAC.01509-06; Turner MS, 2009, J ANTIMICROB CHEMOTH, V64, P960, DOI 10.1093/jac/dkp338; Velhner M, 2014, ZOONOSES PUBLIC HLTH, V61, P364, DOI 10.1111/zph.12081; Weigel LM, 1998, ANTIMICROB AGENTS CH, V42, P2661, DOI 10.1128/AAC.42.10.2661; Woodford N, 2010, J CLIN MICROBIOL, V48, P2999, DOI 10.1128/JCM.00341-10; Wu H, 2012, GENET MOL RES, V11, P3357, DOI 10.4238/2012.September.24.1; Wu HY, 2015, FOODBORNE PATHOG DIS, V12, P228, DOI 10.1089/fpd.2014.1859; Yang JY, 2011, MICROB DRUG RESIST, V17, P363, DOI 10.1089/mdr.2011.0034; Younes A, 2011, J ANTIMICROB CHEMOTH, V66, P313, DOI 10.1093/jac/dkq453; [张永标 Zhang Yongbiao], 2004, [中华微生物学和免疫学杂志, Chinese Journal of Microbiology and Immunology], V24, P577; Zimhony O, 2006, ANTIMICROB AGENTS CH, V50, P3179, DOI 10.1128/AAC.00218-06	57	37	42	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153561	10.1371/journal.pone.0153561	http://dx.doi.org/10.1371/journal.pone.0153561			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078494	Green Submitted, Green Published, gold			2022-12-26	WOS:000374131700079
J	Kasi, P; Wright, J; Khamis, H; Birznieks, I; van Schaik, A				Kasi, Patrick; Wright, James; Khamis, Heba; Birznieks, Ingvars; van Schaik, Andre			The Bayesian Decoding of Force Stimuli from Slowly Adapting Type I Fibers in Humans	PLOS ONE			English	Article							HUMAN TACTILE AFFERENTS; TIME-RESCALING THEOREM; GLABROUS SKIN AREA; HUMAN HAND; STATISTICAL-MODELS; NEURAL SPIKING; PRECISION GRIP; POPULATION; RESPONSES; SIGNALS	It is well known that signals encoded by mechanoreceptors facilitate precise object manipulation in humans. It is therefore of interest to study signals encoded by the mechanoreceptors because this will contribute further towards the understanding of fundamental sensory mechanisms that are responsible for coordinating force components during object manipulation. From a practical point of view, this may suggest strategies for designing sensory-controlled biomedical devices and robotic manipulators. We use a two-stage nonlinear decoding paradigm to reconstruct the force stimulus given signals from slowly adapting type one (SA-I) tactile afferents. First, we describe a nonhomogeneous Poisson encoding model which is a function of the force stimulus and the force's rate of change. In the decoding phase, we use a recursive nonlinear Bayesian filter to reconstruct the force profile, given the SA-I spike patterns and parameters described by the encoding model. Under the current encoding model, the mode ratio of force to its derivative is: 1.26 to 1.02. This indicates that the force derivative contributes significantly to the rate of change to the SA-I afferent spike modulation. Furthermore, using recursive Bayesian decoding algorithms is advantageous because it can incorporate past and current information in order to make predictions-consistent with neural systems-with little computational resources. This makes it suitable for interfacing with prostheses.	[Kasi, Patrick; Wright, James; Birznieks, Ingvars; van Schaik, Andre] Univ Western Sydney, MARCS Inst Brain Behav & Dev, Sydney, NSW, Australia; [Khamis, Heba] Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW, Australia; [Birznieks, Ingvars] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Birznieks, Ingvars] Neurosci Res Australia, Sydney, NSW, Australia	Western Sydney University; University of New South Wales Sydney; University of New South Wales Sydney; Neuroscience Research Australia	Kasi, P (corresponding author), Univ Western Sydney, MARCS Inst Brain Behav & Dev, Sydney, NSW, Australia.	p.kasi@ywesternsydney.edu.au	Birznieks, Ingvars/D-4181-2012; B, Ingvars/Q-8634-2019	Birznieks, Ingvars/0000-0003-4916-1254; B, Ingvars/0000-0003-4916-1254; van Schaik, Andre/0000-0001-6140-017X	Western Sydney University and Australian	Western Sydney University and Australian	This work was supported by Western Sydney University and Australian (PhD Scholarship to Patrick Kasi), http://www.westernsydney.edu.au/marcs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimonetti JM, 2007, J PHYSIOL-LONDON, V580, P649, DOI 10.1113/jphysiol.2006.123075; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Barbieri R, 2004, NEURAL COMPUT, V16, P277, DOI 10.1162/089976604322742038; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; Birznieks I, 2001, J NEUROSCI, V21, P8222, DOI 10.1523/JNEUROSCI.21-20-08222.2001; Birznieks I, 2010, J PHYSIOL-LONDON, V588, P1057, DOI 10.1113/jphysiol.2009.185314; BOLANOWSKI SJ, 1988, J ACOUST SOC AM, V84, P1680, DOI 10.1121/1.397184; Brisben AJ, 1999, J NEUROPHYSIOL, V81, P1548, DOI 10.1152/jn.1999.81.4.1548; Brockwell AE, 2004, J NEUROPHYSIOL, V91, P1899, DOI 10.1152/jn.00438.2003; Brown EN, 2002, NEURAL COMPUT, V14, P325, DOI 10.1162/08997660252741149; Brown EN, 1998, J NEUROSCI, V18, P7411; Cajigas I, 2012, J NEUROSCI METH, V211, P245, DOI 10.1016/j.jneumeth.2012.08.009; Chen Z, 2013, COMPUT INTEL NEUROSC, V2013, DOI 10.1155/2013/251905; Dandekar K, 2003, J BIOMECH ENG-T ASME, V125, P682, DOI 10.1115/1.1613673; Eden UT, 2008, INT CONF ACOUST SPEE, P5201, DOI 10.1109/ICASSP.2008.4518831; Eden UT, 2004, NEURAL COMPUT, V16, P971, DOI 10.1162/089976604773135069; Georgopoulos AP, 1999, J COMPUT NEUROSCI, V6, P279, DOI 10.1023/A:1008810007672; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Goodwin AW, 2004, ANNU REV NEUROSCI, V27, P53, DOI 10.1146/annurev.neuro.26.041002.131032; Haslinger R, 2010, NEURAL COMPUT, V22, P2477, DOI 10.1162/NECO_a_00015; Jenmalm P, 2003, EUR J NEUROSCI, V18, P164, DOI 10.1046/j.1460-9568.2003.02721.x; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; JOHANSSON RS, 1987, EXP BRAIN RES, V66, P141; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; JOHANSSON RS, 1978, J PHYSIOL-LONDON, V281, P101, DOI 10.1113/jphysiol.1978.sp012411; JOHANSSON RS, 1982, BRAIN RES, V244, P17, DOI 10.1016/0006-8993(82)90899-X; Kasi PK, 2009, I IEEE EMBS C NEUR E, P10, DOI 10.1109/NER.2009.5109222; Kass RE, 2005, J NEUROPHYSIOL, V94, P8, DOI 10.1152/jn.00648.2004; Kass RE, 2014, ANALYSIS OF NEURAL D; Khamis H, 2015, J NEUROPHYSIOL, V114, P474, DOI 10.1152/jn.00040.2015; Kim SS, 2010, J NEUROPHYSIOL, V104, P1484, DOI 10.1152/jn.00187.2010; Kim SS, 2009, IEEE T BIOMED CIRC S, V3, P398, DOI 10.1109/TBCAS.2009.2032396; KNIBESTOL M, 1975, J PHYSIOL-LONDON, V245, P63, DOI 10.1113/jphysiol.1975.sp010835; Koyama S, 2010, ANN I STAT MATH, V62, P37, DOI 10.1007/s10463-009-0249-x; LOEWENSTEIN WR, 1966, J PHYSIOL-LONDON, V182, P346, DOI 10.1113/jphysiol.1966.sp007827; LOFVENBERG J, 1984, BRAIN RES, V301, P65, DOI 10.1016/0006-8993(84)90403-7; Macefield V.G., 2008, ENCY NEUROSCIENCE, P914; Macefield VG, 1996, EXP BRAIN RES, V108, P172; McGill KC, 2005, J NEUROSCI METH, V149, P121, DOI 10.1016/j.jneumeth.2005.05.015; McGill KC, 2002, IEEE T BIO-MED ENG, V49, P640, DOI 10.1109/TBME.2002.1010847; Mendel J.M., 1995, LESSONS ESTIMATION T; Meng L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085269; Meyers EM, 2008, J NEUROPHYSIOL, V100, P1407, DOI 10.1152/jn.90248.2008; OGATA Y, 1988, J AM STAT ASSOC, V83, P9, DOI 10.1080/01621459.1988.10478560; Pawitan Y, 2001, ALL LIKELIHOOD STAT; PHILLIPS JR, 1981, J NEUROPHYSIOL, V46, P1204, DOI 10.1152/jn.1981.46.6.1204; Rieke F., 1997, SPIKES EXPLORING NEU; RUIZ S, 1995, J NEUROPHYSIOL, V73, P525, DOI 10.1152/jn.1995.73.2.525; Saal HP, 2014, TRENDS NEUROSCI, V37, P689, DOI 10.1016/j.tins.2014.08.012; Salinas E, 1994, J Comput Neurosci, V1, P89, DOI 10.1007/BF00962720; Scott SH, 2001, NATURE, V413, P161, DOI 10.1038/35093102; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Srinivasan L, 2007, J NEUROPHYSIOL, V98, P2456, DOI 10.1152/jn.01118.2006; Sripati AP, 2006, J NEUROPHYSIOL, V95, P3852, DOI 10.1152/jn.01240.2005; Stanley GB, 1999, J NEUROSCI, V19, P8036, DOI 10.1523/jneurosci.19-18-08036.1999; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; VALLBO AB, 1968, EXP NEUROL, V21, P270, DOI 10.1016/0014-4886(68)90041-1; Vallbo AB, 2004, J APPL PHYSIOL, V96, P1262, DOI 10.1152/japplphysiol.00470.2003; Warland DK, 1997, J NEUROPHYSIOL, V78, P2336, DOI 10.1152/jn.1997.78.5.2336; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Wu W, 2006, NEURAL COMPUT, V18, P80, DOI 10.1162/089976606774841585; Zhang Y, 2012, IEEE ENG MED BIO, P2740, DOI 10.1109/EMBC.2012.6346531	62	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153366	10.1371/journal.pone.0153366	http://dx.doi.org/10.1371/journal.pone.0153366			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077750	Green Published, gold			2022-12-26	WOS:000374131700045
J	Yabu, JM; Siebert, JC; Maecker, HT				Yabu, Julie M.; Siebert, Janet C.; Maecker, Holden T.			Immune Profiles to Predict Response to Desensitization Therapy in Highly HLA-Sensitized Kidney Transplant Candidates	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; RENAL-TRANSPLANTATION; RECIPIENTS; TOLERANCE; SIGNATURE; RITUXIMAB; HUMANS	Background Kidney transplantation is the most effective treatment for end-stage kidney disease. Sensitization, the formation of human leukocyte antigen (HLA) antibodies, remains a major barrier to successful kidney transplantation. Despite the implementation of desensitization strategies, many candidates fail to respond. Current progress is hindered by the lack of biomarkers to predict response and to guide therapy. Our objective was to determine whether differences in immune and gene profiles may help identify which candidates will respond to desensitization therapy. Methods and Findings Single-cell mass cytometry by time-of-flight (CyTOF) phenotyping, gene arrays, and phosphoepitope flow cytometry were performed in a study of 20 highly sensitized kidney transplant candidates undergoing desensitization therapy. Responders to desensitization therapy were defined as 5% or greater decrease in cumulative calculated panel reactive antibody (cPRA) levels, and non-responders had 0% decrease in cPRA. Using a decision tree analysis, we found that a combination of transitional B cell and regulatory T cell (Treg) frequencies at baseline before initiation of desensitization therapy could distinguish responders from non-responders. Using a support vector machine (SVM) and longitudinal data, TRAF3IP3 transcripts and HLA-DR-CD38+CD4+T cells could also distinguish responders from non-responders. Combining all assays in a multivariate analysis and elastic net regression model with 72 analytes, we identified seven that were highly interrelated and eleven that predicted response to desensitization therapy. Conclusions Measuring baseline and longitudinal immune and gene profiles could provide a useful strategy to distinguish responders from non-responders to desensitization therapy. This study presents the integration of novel translational studies including CyTOF immunophenotyping in a multivariate analysis model that has potential applications to predict response to desensitization, select candidates, and personalize medicine to ultimately improve overall outcomes in highly sensitized kidney transplant candidates.	[Yabu, Julie M.] Stanford Univ, Sch Med, Dept Med, Palo Alto, CA 94304 USA; [Siebert, Janet C.] CytoAnalytics, Denver, CO USA; [Maecker, Holden T.] Stanford Univ, Sch Med, Inst Immun Transplantat & Infect, Palo Alto, CA 94304 USA	Stanford University; Stanford University	Yabu, JM (corresponding author), Stanford Univ, Sch Med, Dept Med, Palo Alto, CA 94304 USA.	jyabu@cal.berkeley.edu			National Institute of Allergy and Infectious Diseases of the National Institutes of Health [K23AI104401]; Institute for Immunity, Transplantation and Infection (ITI) Seed Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI104401] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Institute for Immunity, Transplantation and Infection (ITI) Seed Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award number K23AI104401 (JMY) and the Institute for Immunity, Transplantation and Infection (ITI) Seed Grant (JMY) supported research reported in this publication. JCS (CytoAnalytics) performed data analysis as work-for-hire, which was paid for via a gift from the Moore Foundation. The funders provided support in the form of salaries for authors (JMY and JCS), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles are articulated in the author contributions' section.	Borrego F, 2006, IMMUNOL RES, V35, P263, DOI 10.1385/IR:35:3:263; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Hadad U, 2014, IMMUNOL RES, V58, P259, DOI 10.1007/s12026-014-8493-4; Leibler C, 2014, AM J TRANSPLANT, V14, P1173, DOI 10.1111/ajt.12721; Leipold MD, 2015, METHODS MOL BIOL, V1343, P81, DOI 10.1007/978-1-4939-2963-4_7; Lemy A, 2010, NEPHROL DIAL TRANSPL, V25, P3480, DOI 10.1093/ndt/gfq502; Mallone R, 2011, CLIN EXP IMMUNOL, V163, P33, DOI 10.1111/j.1365-2249.2010.04272.x; Newell KA, 2015, AM J TRANSPLANT, V15, P2908, DOI 10.1111/ajt.13480; Newell KA, 2010, J CLIN INVEST, V120, P1836, DOI 10.1172/JCI39933; Peng S, 2015, CLIN EXP IMMUNOL, V182, P57, DOI 10.1111/cei.12658; Pinheiro JC, 2009, MIXED EFFECTS MODELS; Resch T, 2015, TRANSPLANTATION, V99, P1335, DOI 10.1097/TP.0000000000000757; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sagoo P, 2010, J CLIN INVEST, V120, P1848, DOI 10.1172/JCI39922; Sidner Richard A, 2004, Hum Antibodies, V13, P55; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stegall MD, 2009, AM J TRANSPLANT, V9, P998, DOI 10.1111/j.1600-6143.2009.02612.x; TOYODA M, 1994, J CLIN IMMUNOL, V14, P178, DOI 10.1007/BF01533367; Vieira CA, 2004, TRANSPLANTATION, V77, P542, DOI 10.1097/01.TP.0000112934.12622.2B; Vo AA, 2008, NEW ENGL J MED, V359, P242, DOI 10.1056/NEJMoa0707894; Witten IH, 2011, MOR KAUF D, P1; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; Woodle ES, 2015, AM J TRANSPLANT, V15, P101, DOI 10.1111/ajt.13050; Zou Q, 2015, J EXP MED, V212, P1323, DOI 10.1084/jem.20150110	25	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153355	10.1371/journal.pone.0153355	http://dx.doi.org/10.1371/journal.pone.0153355			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078882	Green Published, Green Submitted, gold			2022-12-26	WOS:000374131700042
J	Barenholz, U; Keren, L; Segal, E; Milo, R				Barenholz, Uri; Keren, Leeat; Segal, Eran; Milo, Ron			A Minimalistic Resource Allocation Model to Explain Ubiquitous Increase in Protein Expression with Growth Rate	PLOS ONE			English	Article							ESCHERICHIA-COLI; GENE-EXPRESSION; BACTERIAL-GROWTH; YEAST; COORDINATION; TRANSLATION; CULTURE; LAWS	Most proteins show changes in level across growth conditions. Many of these changes seem to be coordinated with the specific growth rate rather than the growth environment or the protein function. Although cellular growth rates, gene expression levels and gene regulation have been at the center of biological research for decades, there are only a few models giving a base line prediction of the dependence of the proteome fraction occupied by a gene with the specific growth rate. We present a simple model that predicts a widely coordinated increase in the fraction of many proteins out of the proteome, proportionally with the growth rate. The model reveals how passive redistribution of resources, due to active regulation of only a few proteins, can have proteome wide effects that are quantitatively predictable. Our model provides a potential explanation for why and how such a coordinated response of a large fraction of the proteome to the specific growth rate arises under different environmental conditions. The simplicity of our model can also be useful by serving as a baseline null hypothesis in the search for active regulation. We exemplify the usage of the model by analyzing the relationship between growth rate and proteome composition for the model microorganism E. coli as reflected in recent proteomics data sets spanning various growth conditions. We find that the fraction out of the proteome of a large number of proteins, and from different cellular processes, increases proportionally with the growth rate. Notably, ribosomal proteins, which have been previously reported to increase in fraction with growth rate, are only a small part of this group of proteins. We suggest that, although the fractions of many proteins change with the growth rate, such changes may be partially driven by a global effect, not necessarily requiring specific cellular control mechanisms.	[Barenholz, Uri; Milo, Ron] Weizmann Inst Sci, Dept Plant & Environm Sci, IL-76100 Rehovot, Israel; [Keren, Leeat; Segal, Eran] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Milo, R (corresponding author), Weizmann Inst Sci, Dept Plant & Environm Sci, IL-76100 Rehovot, Israel.	ron.milo@weizmann.ac.il	Segal, Eran/AAF-4855-2019	Keren, Leeat/0000-0002-6799-6303; Barenholz, Uri/0000-0002-3097-9681; Milo, Ron/0000-0003-1641-2299; Segal, Eran/0000-0002-6859-1164	European Research Council - NOVCARBFIX [646827]; Alternative sustainable Energy Research Initiative; Alternative Sustainable Energy Research PhD fellowships program	European Research Council - NOVCARBFIX; Alternative sustainable Energy Research Initiative; Alternative Sustainable Energy Research PhD fellowships program	This work was supported by European Research Council, 646827 - NOVCARBFIX, (https://erc.europa.eu/, RM) and Alternative sustainable Energy Research Initiative, Alternative Sustainable Energy Research PhD fellowships program (http://www.weizmann.ac.il/AERI/, UB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthoumieux S, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.70; Bosdriesz E, 2015, FEBS J, V282, P2029, DOI 10.1111/febs.13258; Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779; Bremer H, 1996, ESCHERICHIA COLI SAL; Castrillo Juan I, 2007, J Biol, V6, P4, DOI 10.1186/jbiol54; Chatterji D, 2001, CURR OPIN MICROBIOL, V4, P160, DOI 10.1016/S1369-5274(00)00182-X; Christiano R, 2014, CELL REP, V9, P1959, DOI 10.1016/j.celrep.2014.10.065; Dennis PP, 2004, MICROBIOL MOL BIOL R, V68, P639, DOI 10.1128/MMBR.68.4.639-668.2004; European Council, 2011, OFFICIAL J EUROPEAN, VL 054, P0001; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gerosa L, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.14; Hui S, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145697; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Ingraham J. L., 1983, GROWTH BACTERIAL CEL; Kaneko K, 2014, UNIVERSAL RELATIONSH, P7; Keren L, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.59; Klumpp S, 2014, CURR OPIN BIOTECH, V28, P96, DOI 10.1016/j.copbio.2014.01.001; Klumpp S, 2009, CELL, V139, P1366, DOI 10.1016/j.cell.2009.12.001; Klumpp S, 2008, P NATL ACAD SCI USA, V105, P20245, DOI 10.1073/pnas.0804953105; Li ZP, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-45; Maaloe O, 1969, DEVELOP BIOL       S, V3, P33; McKinney W., 2011, PYTHON HIGH PERFORMA, P1; Molenaar D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.82; Murray HD, 2003, MOL CELL, V12, P125, DOI 10.1016/S1097-2765(03)00266-1; Neidhardt FC, 1999, J BACTERIOL, V181, P7405, DOI 10.1128/JB.181.24.7405-7408.1999; NOMURA M, 1984, ANNU REV BIOCHEM, V53, P75, DOI 10.1146/annurev.bi.53.070184.000451; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Paalme T, 1995, J MICROBIOL METH, V24, P145, DOI 10.1016/0167-7012(95)00064-X; PEDERSEN S, 1978, CELL, V14, P179, DOI 10.1016/0092-8674(78)90312-4; Peebo K, 2015, MOL BIOSYST, V11, P1184, DOI 10.1039/c4mb00721b; Regenberg B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r107; Saldanha AJ, 2004, MOL BIOL CELL, V15, P4089, DOI 10.1091/mbc.e04-04-0306; Salgado H, 2013, NUCLEIC ACIDS RES, V41, pD203, DOI 10.1093/nar/gks1201; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; Schmidt A, 2016, NAT BIOTECHNOL, V34, P104, DOI 10.1038/nbt.3418; Scott M, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145379; Scott M, 2011, CURR OPIN BIOTECH, V22, P559, DOI 10.1016/j.copbio.2011.04.014; Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588; Srivatsan A, 2008, CURR OPIN MICROBIOL, V11, P100, DOI 10.1016/j.mib.2008.02.001; Tao H, 1999, J BACTERIOL, V181, P6425, DOI 10.1128/JB.181.20.6425-6440.1999; Valgepea K, 2013, MOL BIOSYST, V9, P2344, DOI 10.1039/c3mb70119k; Weisse AY, 2015, P NATL ACAD SCI USA, V112, pE1038, DOI 10.1073/pnas.1416533112; You CH, 2013, NATURE, V500, P301, DOI 10.1038/nature12446; Zaslaver A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000545	44	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153344	10.1371/journal.pone.0153344	http://dx.doi.org/10.1371/journal.pone.0153344			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073913	Green Published, Green Submitted, gold			2022-12-26	WOS:000374131200076
J	De Pasquale, I; Di Cagno, R; Buchin, S; De Angelis, M; Gobbetti, M				De Pasquale, Ilaria; Di Cagno, Raffaella; Buchin, Solange; De Angelis, Maria; Gobbetti, Marco			Spatial Distribution of the Metabolically Active Microbiota within Italian PDO Ewes' Milk Cheeses	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; STARTER CULTURES; ECOLOGY DYNAMICS; PUGLIESE CHEESE; RAW-MILK; SURFACE; SYSTEMS	Italian PDO (Protected Designation of Origin) Fiore Sardo (FS), Pecorino Siciliano (PS) and Pecorino Toscano (PT) ewes' milk cheeses were chosen as hard cheese model systems to investigate the spatial distribution of the metabolically active microbiota and the related effects on proteolysis and synthesis of volatile components (VOC). Cheese slices were divided in nine sub-blocks, each one separately subjected to analysis and compared to whole cheese slice (control). Gradients for moisture, and concentrations of salt, fat and protein distinguished sub-blocks, while the cell density of the main microbial groups did not differ. Secondary proteolysis differed between sub-blocks of each cheese, especially when the number and area of hydrophilic and hydrophobic peptide peaks were assessed. The concentration of free amino acids (FAA) agreed with these data. As determined through Purge and Trap (PT) coupled with Gas Chromatography-Mass Spectrometry (PT-GC/MS), and regardless of the cheese variety, the profile with the lowest level of VOC was restricted to the region identified by the letter E defined as core. As shown through pyrosequencing of the 16S rRNA targeting RNA, the spatial distribution of the metabolically active microbiota agreed with the VOC distribution. Differences were highlighted between core and the rest of the cheese. Top and bottom under rind sub-blocks of all three cheeses harbored the widest biodiversity. The cheese sub-block analysis revealed the presence of a microbiota statistically correlated with secondary proteolysis events and/or synthesis of VOC.	[De Pasquale, Ilaria; Di Cagno, Raffaella; De Angelis, Maria; Gobbetti, Marco] Univ Bari Aldo Moro, Dept Soil Plant & Food Sci, Bari, Italy; [Buchin, Solange] INRA, UR 342, Technol & Anal Laitieres, Poligny, France	Universita degli Studi di Bari Aldo Moro; INRAE	Di Cagno, R (corresponding author), Univ Bari Aldo Moro, Dept Soil Plant & Food Sci, Bari, Italy.	raffaella.dicagno@uniba.it	De Pasquale, Ilaria/ABD-1371-2021; De Angelis, Maria/AAA-9909-2019	De Pasquale, Ilaria/0000-0003-2582-4367; 				Albenzio M, 2001, INT J FOOD MICROBIOL, V67, P35, DOI 10.1016/S0168-1605(00)00533-X; ANDREWS AT, 1983, J DAIRY RES, V50, P45, DOI 10.1017/S0022029900032519; Arfi K, 2003, J BIOTECHNOL, V105, P245, DOI 10.1016/j.jbiotec.2003.07.003; Bockelmann W, 2002, INT DAIRY J, V12, P123, DOI 10.1016/S0958-6946(01)00152-2; Bockelmann W., 1997, 5th Cheese Symposium, 11-13th March 1997., P121; Bonnarme P, 2001, J DAIRY RES, V68, P663, DOI 10.1017/S002202990100509X; Buccioni A, 2010, INT DAIRY J, V20, P190, DOI 10.1016/j.idairyj.2009.10.001; Callon C, 2011, FOOD CONTROL, V22, P1911, DOI 10.1016/j.foodcont.2011.05.003; Callon C, 2011, INT J FOOD MICROBIOL, V145, P379, DOI 10.1016/j.ijfoodmicro.2010.12.019; Charlet M, 2009, INT J FOOD MICROBIOL, V131, P10, DOI 10.1016/j.ijfoodmicro.2008.08.022; Coda R, 2006, J DAIRY SCI, V89, P4126, DOI 10.3168/jds.S0022-0302(06)72458-4; Corsetti A, 2001, INT J FOOD MICROBIOL, V69, P1, DOI 10.1016/S0168-1605(01)00567-0; CROW VL, 1990, APPL ENVIRON MICROB, V56, P1656, DOI 10.1128/AEM.56.6.1656-1665.1990; De Filippis F, 2013, PLOS ONE, V9; De Filippis F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070222; De Pasquale I, 2014, APPL ENVIRON MICROB, V80, P6243, DOI 10.1128/AEM.02097-14; De Pasquale I, 2014, APPL ENVIRON MICROB, V80, P4085, DOI 10.1128/AEM.00757-14; Di Cagno R, 2007, J DAIRY SCI, V90, P2689, DOI 10.3168/jds.2006-654; Di Cagno R, 2006, INT DAIRY J, V16, P119, DOI 10.1016/j.idairyj.2005.01.012; Dolci P, 2014, INT J FOOD MICROBIOL, V185, P127, DOI 10.1016/j.ijfoodmicro.2014.05.021; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ercolini D, 2000, APPL ENVIRON MICROB, V69, P3540; Ercolini D, 2013, APPL ENVIRON MICROB, V79, P3148, DOI 10.1128/AEM.00256-13; Fitzsimons NA, 2001, J APPL MICROBIOL, V90, P600, DOI 10.1046/j.1365-2672.2001.01285.x; Fleurot I, 2014, APPL ENVIRON MICROB, V80, P5106, DOI 10.1128/AEM.01042-14; FOX PF, 1963, J DAIRY SCI, V46, P744, DOI 10.3168/jds.S0022-0302(63)89134-1; Fox PF, 2000, FUNDAMENTALS CHEESES; Fuka MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080734; Gobbetti M, 2007, WOODHEAD PUBL FOOD S, P121, DOI 10.1533/9781845693053.1.121; Gobbetti M, 1997, INT DAIRY J, V7, P519, DOI 10.1016/S0958-6946(97)00047-2; Gobbetti M, 2002, INT DAIRY J, V12, P511, DOI 10.1016/S0958-6946(02)00042-0; GOBBETTI M, 2004, CHEESE CHEM PHYS MIC, V2, P51; Gobbetti M, 2015, TRENDS FOOD SCI TECH, V45, P167, DOI 10.1016/j.tifs.2015.07.016; Hayaloglu AA, 2007, INT J FOOD SCI TECH, V42, P930, DOI 10.1111/j.1365-2621.2006.01312.x; Institute for Industrial Research and Standards, 1955, 69 I IND RES STAND; International Dairy Federation, 1964, 25 INT DAIR FED; International Dairy Federation, 1982, 4A IDF; Irlinger F, 2009, CURR OPIN BIOTECH, V20, P142, DOI 10.1016/j.copbio.2009.02.016; Jeanson S, 2011, APPL ENVIRON MICROB, V77, P1493, DOI 10.1128/AEM.02233-10; Lessard MH, 2012, APPL ENVIRON MICROB, V78, P1813, DOI 10.1128/AEM.06645-11; Mangia NP, 2008, FOOD MICROBIOL, V25, P366, DOI 10.1016/j.fm.2007.09.009; McSweeney PLH, 2000, LAIT, V80, P293, DOI 10.1051/lait:2000127; Minervini F, 2012, APPL ENVIRON MICROB, V78, P1251, DOI 10.1128/AEM.07721-11; Monfredini L, 2012, SYST APPL MICROBIOL, V35, P54, DOI 10.1016/j.syapm.2011.07.002; Montel MC, 2014, INT J FOOD MICROBIOL, V177, P136, DOI 10.1016/j.ijfoodmicro.2014.02.019; Mounier J, 2009, INT J FOOD MICROBIOL, V133, P31, DOI 10.1016/j.ijfoodmicro.2009.04.020; O'Sullivan DJ, 2015, APPL ENVIRON MICROB, V81, P2525, DOI 10.1128/AEM.04054-14; Ogier JC, 2004, APPL ENVIRON MICROB, V70, P5628, DOI 10.1128/AEM.70.9.5628-5643.2004; Ottogalli G, 2001, ATLANTE DEI FORMAGGI, P72; Pelaez C, 2005, INT DAIRY J, V15, P831, DOI 10.1016/j.idairyj.2004.12.001; Quigley L, 2013, FEMS MICROBIOL REV, V37, P664, DOI 10.1111/1574-6976.12030; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Savijoki K, 2006, APPL MICROBIOL BIOT, V71, P394, DOI 10.1007/s00253-006-0427-1; Sheehan A, 2009, INT DAIRY J, V19, P321, DOI 10.1016/j.idairyj.2008.11.008; Smit G, 2005, FEMS MICROBIOL REV, V29, P591, DOI 10.1016/j.femsre.2005.04.002; Wolfe BE, 2014, CELL, V158, P422, DOI 10.1016/j.cell.2014.05.041; Wouters JTM, 2002, INT DAIRY J, V12, P91, DOI 10.1016/S0958-6946(01)00151-0	58	24	24	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153213	10.1371/journal.pone.0153213	http://dx.doi.org/10.1371/journal.pone.0153213			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073835	Green Submitted, Green Published, gold			2022-12-26	WOS:000374131200061
J	Walper, E; Weiste, C; Mueller, MJ; Hamberg, M; Droge-Laser, W				Walper, Elisabeth; Weiste, Christoph; Mueller, Martin J.; Hamberg, Mats; Droge-Laser, Wolfgang			Screen Identifying Arabidopsis Transcription Factors Involved in the Response to 9-Lipoxygenase-Derived Oxylipins	PLOS ONE			English	Article							AMINO-ACID-METABOLISM; OXIDATIVE STRESS; LIPID-PEROXIDATION; DEFENSE RESPONSES; SIGNALING PATHWAY; GENE-EXPRESSION; PLANT DEFENSE; JASMONATE; ACTIVATION; RESISTANCE	13-Lipoxygenase-derived oxylipins, such as jasmonates act as potent signaling molecules in plants. Although experimental evidence supports the impact of oxylipins generated by the 9-Lipoxygenase (9-LOX) pathway in root development and pathogen defense, their signaling function in plants remains largely elusive. Based on the root growth inhibiting properties of the 9-LOX-oxylipin 9-HOT (9-hydroxy-10,12,15-octadecatrienoic acid), we established a screening approach aiming at identifying transcription factors (TFs) involved in signaling and/or metabolism of this oxylipin. Making use of the AtTORF-Ex (Arabidopsis thaliana Transcription Factor Open Reading Frame Expression) collection of plant lines overexpressing TF genes, we screened for those TFs which restore root growth on 9-HOT. Out of 6,000 lines, eight TFs were recovered at least three times and were therefore selected for detailed analysis. Overexpression of the basic leucine Zipper (bZIP) TF TGA5 and its target, the monoxygenase CYP81D11 reduced the effect of added 9-HOT, presumably due to activation of a detoxification pathway. The highly related ETHYLENE RESPONSE FACTORs ERF106 and ERF107 induce a broad detoxification response towards 9-LOX-oxylipins and xenobiotic compounds. From a set of 18 related group S-bZIP factors isolated in the screen, bZIP11 is known to participate in auxin-mediated root growth and may connect oxylipins to root meristem function. The TF candidates isolated in this screen provide starting points for further attempts to dissect putative signaling pathways involving 9-LOX-derived oxylipins.	[Walper, Elisabeth; Weiste, Christoph; Mueller, Martin J.; Droge-Laser, Wolfgang] Univ Wurzburg, Julius von Sachs Inst, Julius von Sachs Pl 2, D-97082 Wurzburg, Germany; [Hamberg, Mats] Karolinska Inst, Div Physiol Chem 2, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden	University of Wurzburg; Karolinska Institutet	Droge-Laser, W (corresponding author), Univ Wurzburg, Julius von Sachs Inst, Julius von Sachs Pl 2, D-97082 Wurzburg, Germany.	wolfgang.droege-laser@uni-wuerzburg.de	mueller, martin j/C-7616-2019	Hamberg, Mats/0000-0002-8910-7810	Graduate School "Lipid Signaling" (Deutsche Forschungsgemeinschaft) [GK1342]; DFG; University of Wuerzburg	Graduate School "Lipid Signaling" (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); University of Wuerzburg	The project was funded by the Graduate School "Lipid Signaling" (Deutsche Forschungsgemeinschaft, GK1342) (http://www.dfg.de/en/). Recipient: EW. Project leaders: MJM, WDL. This publication was funded by DFG and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Christiane Gatz (University of Gottingen, Germany) for sharing seeds and Sarah Frosch for technical assistance. The project was funded by the Graduate School "Lipid Signaling" (Deutsche Forschungsgemeinschaft, GK1342) (http://www.dfg.de/en/). Recipient: EW. Project leaders: MJM, WDL. This publication was funded by DFG and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird L, 2013, P NATL ACAD SCI USA, V110, P15259, DOI 10.1073/pnas.1305687110; Bannenberg G, 2009, LIPIDS, V44, P85, DOI 10.1007/s11745-008-3245-7; Bethke G, 2009, P NATL ACAD SCI USA, V106, DOI 10.1073/pnas.0810206106; Blee E, 2014, PLANT PHYSIOL, V166, P109, DOI 10.1104/pp.114.245316; Blee E, 2012, FEBS J, V279, P3981, DOI 10.1111/j.1742-4658.2012.08757.x; Browse J, 2009, ANNU REV PLANT BIOL, V60, P183, DOI 10.1146/annurev.arplant.043008.092007; Bruce TJA, 2008, P NATL ACAD SCI USA, V105, P4553, DOI 10.1073/pnas.0710305105; Catinot J, 2015, PLANT CELL ENVIRON, V38, P2721, DOI 10.1111/pce.12583; Christensen SA, 2015, P NATL ACAD SCI USA, V112, P11407, DOI 10.1073/pnas.1511131112; Cookson SJ, 2015, PLANT CELL IN PRESS; Cutcliffe JW, 2011, J EXP BOT, V62, P4995, DOI 10.1093/jxb/err199; Dietrich K, 2011, PLANT CELL, V23, P381, DOI 10.1105/tpc.110.075390; Dubois M, 2013, PLANT PHYSIOL, V162, P319, DOI 10.1104/pp.113.216341; Farmer EE, 2007, CURR OPIN PLANT BIOL, V10, P380, DOI 10.1016/j.pbi.2007.04.019; Farmer EE, 2013, ANNU REV PLANT BIOL, V64, P429, DOI 10.1146/annurev-arplant-050312-120132; Fischer BB, 2012, P NATL ACAD SCI USA, V109, pE1302, DOI 10.1073/pnas.1116843109; Fode B, 2008, PLANT CELL, V20, P3122, DOI 10.1105/tpc.108.058974; Hamberg M, 2003, J BIOL CHEM, V278, P51796, DOI 10.1074/jbc.M310514200; Hanson J, 2008, PLANT J, V53, P935, DOI 10.1111/j.1365-313X.2007.03385.x; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Koster J, 2012, PLANT PHYSIOL, V159, P391, DOI 10.1104/pp.112.194274; Lauxmann M, 2015, PLANT CELL IN PRESS; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llorca CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139884; Lopez MA, 2011, PLANT J, V67, P447, DOI 10.1111/j.1365-313X.2011.04608.x; Ma JK, 2011, NEW PHYTOL, V191, P733, DOI 10.1111/j.1469-8137.2011.03735.x; Ma Q, 2008, CHEM RES TOXICOL, V21, P1651, DOI 10.1021/tx800156s; Mair A, 2015, ELIFE, V4, DOI 10.7554/eLife.05828; Marcos R, 2015, PLANT PHYSIOL, V169, P2324, DOI 10.1104/pp.15.00992; Meng XZ, 2013, PLANT CELL, V25, P1126, DOI 10.1105/tpc.112.109074; Mosblech A, 2009, PLANT PHYSIOL BIOCH, V47, P511, DOI 10.1016/j.plaphy.2008.12.011; Mueller S, 2008, PLANT CELL, V20, P768, DOI 10.1105/tpc.107.054809; Muller B, 2008, NATURE, V453, P1094, DOI 10.1038/nature06943; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Pauwels L, 2011, PLANT CELL, V23, P3089, DOI 10.1105/tpc.111.089300; Ramel F, 2012, J EXP BOT, V63, P3999, DOI 10.1093/jxb/ers102; Rashotte AM, 2006, P NATL ACAD SCI USA, V103, P11081, DOI 10.1073/pnas.0602038103; Stotz HU, 2013, J EXP BOT, V64, P963, DOI 10.1093/jxb/ers389; Vellosillo T, 2007, PLANT CELL, V19, P831, DOI 10.1105/tpc.106.046052; Vellosillo T, 2010, PLANT PHYSIOL, V154, P444, DOI 10.1104/pp.110.161273; Vicente J, 2012, MOL PLANT, V5, P914, DOI 10.1093/mp/ssr105; Vollenweider S, 2000, PLANT J, V24, P467, DOI 10.1046/j.1365-313x.2000.00897.x; Wehner N, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00068; Weigel R., 2002, ARABIDOPSIS LAB MANU; Weiste C, 2007, PLANT J, V52, P382, DOI 10.1111/j.1365-313X.2007.03229.x; Weiste C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4883; Zander M, 2010, PLANT J, V61, P200, DOI 10.1111/j.1365-313X.2009.04044.x; Zhang YL, 2003, PLANT CELL, V15, P2647, DOI 10.1105/tpc.014894; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	52	8	8	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153216	10.1371/journal.pone.0153216	http://dx.doi.org/10.1371/journal.pone.0153216			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073862	Green Submitted, Green Published, gold			2022-12-26	WOS:000374131200062
J	Elebro, J; Heby, M; Warfvinge, CF; Nodin, B; Eberhard, J; Jirstrom, K				Elebro, Jacob; Heby, Margareta; Warfvinge, Carl Fredrik; Nodin, Bjorn; Eberhard, Jakob; Jirstrom, Karin			Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1, 2 and 3 in Periampullary Adenocarcinoma	PLOS ONE			English	Article							COLORECTAL-CANCER; AMPULLARY CARCINOMA; PROTEIN EXPRESSION; PANCREATIC-CANCER; PREDICTIVE SIGNIFICANCE; HER3 OVEREXPRESSION; TISSUE MICROARRAY; INTESTINAL-TYPE; SOLID TUMORS; COPY NUMBER	Periampullary adenocarcinoma, including pancreatic cancer, is a heterogeneous group of tumours with dismal prognosis, for which there is an urgent need to identify novel treatment strategies. The human epithelial growth factor receptors EGFR, HER2 and HER3 have been studied in several tumour types, and HER-targeting drugs have a beneficial effect on survival in selected types of cancer. However, these effects have not been evident in pancreatic cancer, and remain unexplored in other types of periampullary cancer. The prognostic impact of HER-expression in these cancers also remains unclear. The aim of this study was therefore to examine the expression and prognostic value of EGFR, HER2 and HER3 in periampullary cancer, with particular reference to histological subtype. To this end, protein expression of EGFR, HER2 and HER3, and HER2 gene amplification was assessed by immunohistochemistry and silver in situ hybridization, respectively, on tissue microarrays with tumours from 175 periampullary adenocarcinomas, with follow-up data on recurrence-free survival (RFS) and overall survival (OS) for up to 5 years. EGFR expression was similar in pancreatobiliary (PB) and intestinal (I) type tumours, but high HER2 and HER3 expression was significantly more common in I-type tumours. In PB-type cases receiving adjuvant gemcitabine, but not in untreated cases, high EGFR expression was significantly associated with a shorter OS and RFS, with a significant treatment interaction in relation to OS (p(interaction) = 0.042). In I-type cases, high EGFR expression was associated with a shorter OS and RFS in univariable, but not in multivariable, analysis. High HER3 expression was associated with a prolonged RFS in univariable, but not in multivariable, analysis. Neither HER2 protein expression nor gene amplification was prognostic. The finding of a potential interaction between the expression of EGFR and response to adjuvant chemotherapy in PB-type tumours needs validation, and merits further study.	[Elebro, Jacob; Heby, Margareta; Warfvinge, Carl Fredrik; Nodin, Bjorn; Eberhard, Jakob; Jirstrom, Karin] Lund Univ, Dept Clin Sci, Div Oncol & Pathol, Skane Univ Hosp, S-22185 Lund, Sweden	Lund University; Skane University Hospital	Elebro, J (corresponding author), Lund Univ, Dept Clin Sci, Div Oncol & Pathol, Skane Univ Hosp, S-22185 Lund, Sweden.	jacob.elebro@med.lu.se		Elebro, Jacob/0000-0002-9550-8012	Swedish Research Council; Swedish Cancer Society; Gunnar Nilsson Cancer Foundation; Mrs Berta Kamprad Foundation; Swedish Government Grant for Clinical Research; Lund University Faculty of Medicine; University Hospital Research Grants	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Gunnar Nilsson Cancer Foundation; Mrs Berta Kamprad Foundation; Swedish Government Grant for Clinical Research; Lund University Faculty of Medicine; University Hospital Research Grants	This study was supported by grants from the Swedish Research Council, the Swedish Cancer Society, the Gunnar Nilsson Cancer Foundation, the Mrs Berta Kamprad Foundation, the Swedish Government Grant for Clinical Research, Lund University Faculty of Medicine and University Hospital Research Grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloysius MM, 2009, HISTOPATHOLOGY, V55, P236, DOI 10.1111/j.1365-2559.2009.03351.x; Ata A, 2015, PATHOL ONCOL RES, V21, P831, DOI 10.1007/s12253-014-9847-x; Baiocchi G, 2009, INT J COLORECTAL DIS, V24, P1059, DOI 10.1007/s00384-009-0702-6; Baumhoer D, 2008, VIRCHOWS ARCH, V453, P579, DOI 10.1007/s00428-008-0669-7; Begnami MD, 2011, J CLIN ONCOL, V29, P3030, DOI 10.1200/JCO.2010.33.6313; Beji A, 2012, CLIN CANCER RES, V18, P956, DOI 10.1158/1078-0432.CCR-11-1186; Bloomston M, 2006, DIGEST SURG, V23, P74, DOI 10.1159/000093497; Bronsert P, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-428; Cappuzzo F, 2008, ANN ONCOL, V19, P717, DOI 10.1093/annonc/mdm492; Carpelan-Holmstrom M, 2005, GUT, V54, P385, DOI 10.1136/gut.2004.047191; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; Chou A, 2013, GENOME MED, V5, DOI 10.1186/gm482; Chung KY, 2005, J CLIN ONCOL, V23, P1803, DOI 10.1200/JCO.2005.08.037; Day JD, 1996, HUM PATHOL, V27, P119, DOI 10.1016/S0046-8177(96)90364-0; Ekblad L, 2012, ANTICANCER RES, V32, P783; Elebro J, 2015, ACTA ONCOL, P1; Elebro J, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0289-8; Elebro J, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-80; Engholm GFJ, 2015, NORDCAN CANC INCIDEN; Fristedt R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112728; Garrett JT, 2011, P NATL ACAD SCI USA, V108, P5021, DOI 10.1073/pnas.1016140108; Hayashi M, 2008, CLIN CANCER RES, V14, P7843, DOI 10.1158/1078-0432.CCR-08-1064; Heby M, 2015, BMC CLIN PATHOL, V15, DOI 10.1186/s12907-015-0009-1; Hechtman JF, 2015, MODERN PATHOL, V28, P1123, DOI 10.1038/modpathol.2015.57; Hedner C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148101; HICKEY K, 1994, CANCER, V74, P1693, DOI 10.1002/1097-0142(19940915)74:6<1693::AID-CNCR2820740609>3.0.CO;2-#; Hirakawa T, 2011, ONCOLOGY-BASEL, V81, P192, DOI 10.1159/000333825; Jarde T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138336; Kawamoto T, 2015, J GASTROENTEROL, V50, P467, DOI 10.1007/s00535-014-0984-5; Koeppen HKW, 2001, HISTOPATHOLOGY, V38, P96, DOI 10.1046/j.1365-2559.2001.01084.x; Koka V, 2002, ANTICANCER RES, V22, P1593; Komoto M, 2009, CANCER SCI, V100, P1243, DOI 10.1111/j.1349-7006.2009.01176.x; Lazrek Y, 2013, NEOPLASIA, V15, P335, DOI 10.1593/neo.121960; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Linderoth J, 2007, EUR J HAEMATOL, V79, P146, DOI 10.1111/j.1600-0609.2007.00892.x; LoRusso P, 2013, CLIN CANCER RES, V19, P3078, DOI 10.1158/1078-0432.CCR-12-3051; Luo GP, 2011, PANCREATOLOGY, V11, P595, DOI 10.1159/000334465; Mikhitarian K, 2014, MODERN PATHOL, V27, P665, DOI 10.1038/modpathol.2013.185; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Moroni M, 2005, LANCET ONCOL, V6, P279, DOI 10.1016/S1470-2045(05)70102-9; Nishio M, 2015, LUNG CANCER, V88, P275, DOI 10.1016/j.lungcan.2015.03.010; O'Hayer K, 2015, J PANCREATIC CANCER, V1, P7, DOI 10.1089/crpc.2015.29004.koh; Ocana A, 2013, JNCI-J NATL CANCER I, V105, P266, DOI 10.1093/jnci/djs501; Potti A, 2003, ANTICANCER RES, V23, P2671; QUINN CM, 1994, HISTOPATHOLOGY, V25, P247, DOI 10.1111/j.1365-2559.1994.tb01324.x; Roskoski R, 2014, PHARMACOL RES, V79, P34, DOI 10.1016/j.phrs.2013.11.002; Ruschoff J, 2012, MODERN PATHOL, V25, P637, DOI 10.1038/modpathol.2011.198; Safran H, 2004, CANCER INVEST, V22, P706, DOI 10.1081/CNV-200032974; Safran H, 2001, AM J CLIN ONCOL-CANC, V24, P496, DOI 10.1097/00000421-200110000-00016; Seo AN, 2015, VIRCHOWS ARCH, V466, P645, DOI 10.1007/s00428-015-1747-2; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; SOLTOFF SP, 1994, MOL CELL BIOL, V14, P3550, DOI 10.1128/MCB.14.6.3550; Stoecklein NH, 2004, J CLIN ONCOL, V22, P4737, DOI 10.1200/JCO.2004.05.142; Swain SM, 2015, NEW ENGL J MED, V372, P724, DOI 10.1056/NEJMoa1413513; Tobita K, 2003, INT J MOL MED, V11, P305; Torhorst J, 2001, AM J PATHOL, V159, P2249, DOI 10.1016/S0002-9440(10)63075-1; Uegaki K, 1997, ANTICANCER RES, V17, P3841; Westgaard A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-5; Westgaard A, 2013, ANN SURG ONCOL, V20, P430, DOI 10.1245/s10434-012-2603-0; Xia M, 2015, HUM PATHOL, V46, P1315, DOI 10.1016/j.humpath.2015.05.012	60	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153533	10.1371/journal.pone.0153533	http://dx.doi.org/10.1371/journal.pone.0153533			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070783	gold, Green Submitted, Green Published			2022-12-26	WOS:000373900700079
J	Gaisl, T; Wons, AM; Rossi, V; Bratton, DJ; Schlatzer, C; Schwarz, EI; Camen, G; Kohler, M				Gaisl, Thomas; Wons, Annette M.; Rossi, Valentina; Bratton, Daniel J.; Schlatzer, Christian; Schwarz, Esther I.; Camen, Giovanni; Kohler, Malcolm			Simulated Obstructive Sleep Apnea Increases P-Wave Duration and P-Wave Dispersion	PLOS ONE			English	Article							PRESSURE; ASSOCIATION; ARRHYTHMIAS; ACTIVATION; HYPOPNEA; TIMES; DELAY	Background A high P-wave duration and dispersion (Pd) have been reported to be a prognostic factor for the occurrence of paroxysmal atrial fibrillation (PAF), a condition linked to obstructive sleep apnea (OSA). We tested the hypothesis of whether a short-term increase of P-wave duration and Pd can be induced by respiratory manoeuvres simulating OSA in healthy subjects and in patients with PAF. Methods 12-lead-electrocardiography (ECG) was recorded continuously in 24 healthy subjects and 33 patients with PAF, while simulating obstructive apnea (Mueller manoeuvre, MM), obstructive hypopnea (inspiration through a threshold load, ITH), central apnea (AP), and during normal breathing (BL) in randomized order. The P-wave duration and Pd was calculated by using dedicated software for ECG-analysis. Results P-wave duration and Pd significantly increased during MM and ITH compared to BL in all subjects (+13.1ms and +13.8ms during MM; +11.7ms and +12.9ms during ITH; p<0.001 for all comparisons). In MM, the increase was larger in healthy subjects when compared to patients with PAF (p<0.05). Conclusion Intrathoracic pressure swings through simulated obstructive sleep apnea increase P-wave duration and Pd in healthy subjects and in patients with PAF. Our findings imply that intrathoracic pressure swings prolong the intra-atrial and inter-atrial conduction time and therefore may represent an independent trigger factor for the development for PAF.	[Gaisl, Thomas; Wons, Annette M.; Rossi, Valentina; Bratton, Daniel J.; Schlatzer, Christian; Schwarz, Esther I.; Camen, Giovanni; Kohler, Malcolm] Univ Zurich Hosp, Dept Pulmonol, CH-8091 Zurich, Switzerland; [Gaisl, Thomas] Spital Zollikerberg, Zollikerberg, Switzerland; [Kohler, Malcolm] Univ Zurich, Ctr Integrat Human Physiol, Zurich, Switzerland; [Kohler, Malcolm] Univ Zurich, Ctr Interdisciplinary Sleep Res, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich	Kohler, M (corresponding author), Univ Zurich Hosp, Dept Pulmonol, CH-8091 Zurich, Switzerland.; Kohler, M (corresponding author), Univ Zurich, Ctr Integrat Human Physiol, Zurich, Switzerland.; Kohler, M (corresponding author), Univ Zurich, Ctr Interdisciplinary Sleep Res, Zurich, Switzerland.	Malcolm.Kohler@usz.ch	Gaisl, Thomas/I-7762-2019; Schwarz, Esther/AAA-2325-2021	Gaisl, Thomas/0000-0002-9017-6143; Schwarz, Esther Irene/0000-0001-8840-981X; Bratton, Daniel/0000-0002-6135-0894	Clinical Research Priority Program Sleep and Health of the University of Zurich, Switzerland	Clinical Research Priority Program Sleep and Health of the University of Zurich, Switzerland	This work was supported by the Clinical Research Priority Program Sleep and Health of the University of Zurich, Switzerland.	Bayir PT, 2014, ANN NONINVAS ELECTRO, V19, P226, DOI 10.1111/anec.12106; Brown DA, 2010, CARDIOVASC RES, V88, P241, DOI 10.1093/cvr/cvq231; Cagirci G, 2011, J ELECTROCARDIOL, V44, P478, DOI 10.1016/j.jelectrocard.2011.03.009; Camen G, 2013, EUR J APPL PHYSIOL, V113, P489, DOI 10.1007/s00421-012-2457-y; Cicek D, 2012, AM J MED SCI, V344, P180, DOI 10.1097/MAJ.0b013e318239a67f; Clarenbach CF, 2013, J APPL PHYSIOL, V115, P613, DOI 10.1152/japplphysiol.00439.2013; Gaisl T, 2015, EUR RESP J; Gupta S, 2012, J CLIN SLEEP MED, V8, P649, DOI 10.5664/jcsm.2256; Jazi MH, 2014, SLEEP BREATH, V18, P549, DOI 10.1007/s11325-013-0917-1; Kohler M, 2010, NAT REV CARDIOL, V7, P677, DOI 10.1038/nrcardio.2010.145; LEIER CV, 1979, AM J CARDIOL, V44, P442, DOI 10.1016/0002-9149(79)90394-1; Li Li, 2014, Europace, V16, P1309, DOI 10.1093/europace/euu066; Linz D, 2011, HEART RHYTHM, V8, P1436, DOI 10.1016/j.hrthm.2011.03.053; Maeno K, 2013, HEART VESSELS, V28, P639, DOI 10.1007/s00380-012-0288-8; Maeno K, 2013, CIRC-ARRHYTHMIA ELEC, V6, P287, DOI 10.1161/CIRCEP.113.000266; Magnani JW, 2009, CIRC-ARRHYTHMIA ELEC, V2, P72, DOI 10.1161/CIRCEP.108.806828; Mehra R, 2006, AM J RESP CRIT CARE, V173, P910, DOI 10.1164/rccm.200509-1442OC; Narkiewicz K, 1999, CIRCULATION, V100, P2332, DOI 10.1161/01.CIR.100.23.2332; Oliveira W, 2008, J AM SOC ECHOCARDIOG, V21, P1355, DOI 10.1016/j.echo.2008.09.007; Rossi VA, 2013, EUR RESPIR J, V41, P1439, DOI 10.1183/09031936.00128412; Schlatzer C, 2015, EUROPACE; Stowhas AC, 2011, CHEST, V140, P675, DOI 10.1378/chest.10-2799; Suzuki Masaaki, 2005, Sleep Breath, V9, P64, DOI 10.1007/s11325-005-0015-0; VIROLAINEN J, 1995, J APPL PHYSIOL, V79, P455, DOI 10.1152/jappl.1995.79.2.455	24	7	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0152994	10.1371/journal.pone.0152994	http://dx.doi.org/10.1371/journal.pone.0152994			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27071039	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000373900700025
J	Dowdy, NJ; Conner, WE				Dowdy, Nicolas J.; Conner, William E.			Acoustic Aposematism and Evasive Action in Select Chemically Defended Arctiine (Lepidoptera: Erebidae) Species: Nonchalant or Not?	PLOS ONE			English	Article							BIG BROWN BATS; CYCNIA-TENERA; MOTH SOUNDS; BEHAVIOR; DISCRIMINATION; SEQUESTRATION; CLICKS	Tiger moths (Erebidae: Arctiinae) have experienced intense selective pressure from echolocating, insectivorous bats for over 65 million years. One outcome has been the evolution of acoustic signals that advertise the presence of toxins sequestered from the moths' larval host plants, i. e. acoustic aposematism. Little is known about the effectiveness of tiger moth anti-bat sounds in their natural environments. We used multiple infrared cameras to reconstruct bat-moth interactions in three-dimensional (3-D) space to examine how functional sound-producing organs called tymbals affect predation of two chemically defended tiger moth species: Pygarctia roseicapitis (Arctiini) and Cisthene martini (Lithosiini). P. roseicapitis and C. martini with intact tymbals were 1.8 and 1.6 times less likely to be captured by bats relative to those rendered silent. 3-D flight path and acoustic analyses indicated that bats actively avoided capturing sound-producing moths. Clicking behavior differed between the two tiger moth species, with P. roseicapitis responding in an earlier phase of bat attack. Evasive flight behavior in response to bat attacks was markedly different between the two tiger moth species. P. roseicapitis frequently paired evasive dives with aposematic sound production. C. martini were considerably more nonchalant and employed evasion in fewer interactions. Our results show that acoustic aposematism is effective at deterring bat predation in a natural context and that this strategy is likely to be the ancestral function of tymbal organs within the Arctiinae.	[Dowdy, Nicolas J.; Conner, William E.] Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA	Wake Forest University	Dowdy, NJ (corresponding author), Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA.	njdowdy@gmail.com	Dowdy, Nicolas/AAT-1537-2021	Dowdy, Nicolas/0000-0002-5453-2569	National Science Foundation [IOS 0951160]	National Science Foundation(National Science Foundation (NSF))	This material is based upon work supported by the National Science Foundation [IOS 0951160 to WEC]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHARYA L, 1992, CAN J ZOOL, V70, P1292, DOI 10.1139/z92-180; Barber JR, 2006, J EXP BIOL, V209, P2637, DOI 10.1242/jeb.02295; Barber JR, 2007, P NATL ACAD SCI USA, V104, P9331, DOI 10.1073/pnas.0703627104; Barber JR, 2009, J EXP BIOL, V212, P2141, DOI 10.1242/jeb.029991; Bernays EA, 2004, J INSECT BEHAV, V17, P41, DOI 10.1023/B:JOIR.0000025131.16275.0f; BLEST AD, 1963, PROC R SOC SER B-BIO, V158, P196, DOI 10.1098/rspb.1963.0042; COHEN JA, 1983, J CHEM ECOL, V9, P521, DOI 10.1007/BF00990224; Conner WE, 2012, ANNU REV ENTOMOL, V57, P21, DOI 10.1146/annurev-ento-121510-133537; Corcoran AJ, 2012, J EXP BIOL, V215, P4278, DOI 10.1242/jeb.076943; Corcoran AJ, 2011, J EXP BIOL, V214, P2416, DOI 10.1242/jeb.054783; Corcoran AJ, 2010, CURR ZOOL, V56, P358, DOI 10.1093/czoolo/56.3.358; Dawson JW, 2004, J COMP PHYSIOL A, V190, P69, DOI 10.1007/s00359-003-0474-3; Dunning D. C., 1968, Zeitschrift fuer Tierpsychologie, V25, P129; DUNNING DC, 1965, SCIENCE, V147, P173, DOI 10.1126/science.147.3654.173; DUNNING DC, 1995, BIOTROPICA, V27, P227, DOI 10.2307/2388998; DUNNING DC, 1992, CAN J ZOOL, V70, P2218, DOI 10.1139/z92-298; FULLARD JH, 1984, J COMP PHYSIOL, V154, P249, DOI 10.1007/BF00604990; FULLARD JH, 1977, CAN J ZOOL, V55, P1213, DOI 10.1139/z77-160; Gamberale-Stille G, 2004, P ROY SOC B-BIOL SCI, V271, P2621, DOI 10.1098/rspb.2004.2893; Gastwirth JL, LAWSTAT R PACKAGE BI; Ghose K, 2009, J EXP BIOL, V212, P693, DOI 10.1242/jeb.019380; Hesbacher S, 1995, J CHEM ECOL, V21, P2079, DOI 10.1007/BF02033864; Hristov N, 2005, CHEMOECOLOGY, V15, P105, DOI 10.1007/s00049-005-0301-0; Hristov NI, 2005, NATURWISSENSCHAFTEN, V92, P164, DOI 10.1007/s00114-005-0611-7; KNOWLTON CARROL B., 1967, TRANS AMER ENTOMOL SOC, V93, P41; Masters WM, 1996, J COMP PHYSIOL A, V179, P703, DOI 10.1007/BF00216134; MILLER LA, 1991, J COMP PHYSIOL A, V168, P571, DOI 10.1007/BF00215079; R Core Team, R LANG ENV STAT COMP; Ratcliffe JM, 2005, J EXP BIOL, V208, P4689, DOI 10.1242/jeb.01927; ROEDER K. D., 1962, ANIMAL BEHAVIOUR, V10, P300, DOI 10.1016/0003-3472(62)90053-2; Scott CH, 2014, SYST ENTOMOL, V39, P286, DOI 10.1111/syen.12047; Svoboda T, 2005, PRESENCE-VIRTUAL AUG, V14, P407, DOI 10.1162/105474605774785325; Tougaard J., 2004, ECHOLOCATION BATS DO, P365; Triblehorn JD, 2008, J EXP BIOL, V211, P555, DOI 10.1242/jeb.005736; Yack JE, 2008, SENSES COMPREHENSIVE, V3, P35, DOI DOI 10.1016/B978-012370880-9.00003-7; Zaspel JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101975	36	19	19	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0152981	10.1371/journal.pone.0152981	http://dx.doi.org/10.1371/journal.pone.0152981			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096408	Green Published, Green Submitted, gold			2022-12-26	WOS:000374543600023
J	Hayat, T; Jabeen, S; Shafiq, A; Alsaedi, A				Hayat, T.; Jabeen, Sumaira; Shafiq, Anum; Alsaedi, A.			Radiative Squeezing Flow of Second Grade Fluid with Convective Boundary Conditions	PLOS ONE			English	Article							HEAT-TRANSFER; THERMAL-RADIATION; NANOFLUID FLOW; AXISYMMETRICAL FLOW; STAGNATION POINT; SURFACE; SIMULATION; ANNULUS	Influence of magnetohydrodynamic (MHD) flow between two parallel disks is considered. Heat transfer analysis is disclosed due to thermal radiation and convective boundary condition. Appropriate transformations are invoked to obtain the ordinary differential system. This system is solved using homotopic approach. Convergence of the obtained solution is discussed. Variations of embedded parameters into the governing problems are graphically discussed. Skin friction coefficient and Nusselt number are numerically computed and analyzed. It is noticed that temperature profile is increasing function of radiation parameter.	[Hayat, T.; Jabeen, Sumaira; Shafiq, Anum] Quaid I Azam Univ, Dept Math, Islamabad 44000, Pakistan; [Hayat, T.; Alsaedi, A.] King Abdulaziz Univ, Nonlinear Anal & Appl Math NAAM Res Grp, Dept Math, Fac Sci, Jeddah 21589, Saudi Arabia	Quaid I Azam University; King Abdulaziz University	Shafiq, A (corresponding author), Quaid I Azam Univ, Dept Math, Islamabad 44000, Pakistan.	anumshafiq@ymail.com	Hayat, Tasawar/Y-2524-2019; Shafiq, Anum/F-9967-2018; Alsaedi, Ahmed/A-2094-2013	Shafiq, Anum/0000-0001-7186-7216; Alsaedi, Ahmed/0000-0003-3452-8922				Bachok N, 2013, J FRANKLIN I, V350, P2736, DOI 10.1016/j.jfranklin.2013.07.002; Bhattacharyya, 2013, J THERMODYN, V2013; Bhattacharyya K, 2012, INT J HEAT MASS TRAN, V55, P2945, DOI 10.1016/j.ijheatmasstransfer.2012.01.051; Domairry G, 2009, MATH PROBL ENG, V2009, DOI 10.1155/2009/603916; Farooq U, 2014, APPL MATH COMPUT, V242, P528, DOI 10.1016/j.amc.2014.05.126; Ganji DD, 2014, FRONT MECH ENG-PRC, V9, P270, DOI 10.1007/s11465-014-0303-0; Hashmi MM, 2012, NONLINEAR ANAL-MODEL, V17, P418, DOI 10.15388/NA.17.4.14048; Hayat T, 2015, ALEX ENG J, V54, P205, DOI 10.1016/j.aej.2015.03.013; Hayat T, 2015, AIP ADV, V5, DOI 10.1063/1.4928321; Hayat T, 2014, J AEROSPACE ENG, V27, DOI 10.1061/(ASCE)AS.1943-5525.0000360; Hayat T, 2013, J MECH, V29, P403, DOI 10.1017/jmech.2013.6; Hayat T, 2013, EUR PHYS J PLUS, V128, DOI 10.1140/epjp/i2013-13085-1; Hayat T, 2012, INT J NUMER METH FL, V69, P399, DOI 10.1002/fld.2565; Hayat T., 2013, WALAILAK J SCI TECH, V10, P29; Hayat T., 2013, J EGYPTIAN MATH SOC, V21, P379, DOI [10.1016/j.joems.2013.02.009, DOI 10.1016/J.JOEMS.2013.02.009]; Hayat T, 2015, Z NATURFORSCH A, V70, P333, DOI 10.1515/zna-2014-0280; Hayat T, 2015, AIP ADV, V5, DOI 10.1063/1.4927209; Kandelousi MS, 2014, PHYS LETT A, V378, P3331, DOI 10.1016/j.physleta.2014.09.046; Liao S., 2012, HOMOTOPY ANAL METHOD; Lin YH, 2015, POWDER TECHNOL, V274, P324, DOI 10.1016/j.powtec.2015.01.039; Mahmood M, 2007, HEAT MASS TRANSFER, V44, P165, DOI 10.1007/s00231-006-0218-3; Mirzaee F, 2015, J TAIBAH UNIV SCI, V9, P104, DOI 10.1016/j.jtusci.2014.06.006; Noeiaghdam S., 2015, AIN SHAMS E IN PRESS; Pal D, 2013, COMPUT MATH APPL, V66, P1161, DOI 10.1016/j.camwa.2013.07.010; Qayyum A, 2012, CHINESE PHYS LETT, V29, DOI 10.1088/0256-307X/29/3/034701; Rashidi MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109404; Rashidi MM, 2014, ABSTR APPL ANAL, DOI 10.1155/2014/923487; Shafiq A, 2013, BRAZ J CHEM ENG, V30, P599, DOI 10.1590/S0104-66322013000300017; Sheikholeslami M, 2015, COMPUT METHOD APPL M, V294, P299, DOI 10.1016/j.cma.2015.06.010; Sheikholeslami M, 2015, INT J HEAT MASS TRAN, V89, P799, DOI 10.1016/j.ijheatmasstransfer.2015.05.110; Sheikholeslami M, 2015, EUR PHYS J PLUS, V130, DOI 10.1140/epjp/i2015-15115-4; Sheikholeslami M, 2016, INT J HEAT MASS TRAN, V92, P339, DOI 10.1016/j.ijheatmasstransfer.2015.08.066; Sheikholeslami M, 2015, J TAIWAN INST CHEM E, V56, P6, DOI 10.1016/j.jtice.2015.03.035; Sheikholeslami M, 2015, IEEE T NANOTECHNOL, V14, P561, DOI 10.1109/TNANO.2015.2416318; Sheikholeslami M, 2015, COMPUT METHOD APPL M, V283, P651, DOI 10.1016/j.cma.2014.09.038; Sheikholeslami M, 2015, J MAGN MAGN MATER, V374, P36, DOI 10.1016/j.jmmm.2014.08.021; Sheikholeslami M, 2015, PHYSICA A, V417, P273, DOI 10.1016/j.physa.2014.09.053; Sheikholeslami M, 2014, ENERGY, V75, P400, DOI 10.1016/j.energy.2014.07.089; Stefan M.J., 1874, MATH NATURWISSENCHAF, V69, P713; Sui JZ, 2015, INT J HEAT MASS TRAN, V85, P1023, DOI 10.1016/j.ijheatmasstransfer.2015.02.014	40	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0152555	10.1371/journal.pone.0152555	http://dx.doi.org/10.1371/journal.pone.0152555			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096616	gold, Green Submitted, Green Published			2022-12-26	WOS:000374543600016
J	Ullah, R; Shah, MA; Tufail, S; Ismat, F; Imran, M; Iqbal, M; Mirza, O; Rhaman, M				Ullah, Raheem; Shah, Majid Ali; Tufail, Soban; Ismat, Fouzia; Imran, Muhammad; Iqbal, Mazhar; Mirza, Osman; Rhaman, Moazur			Activity of the Human Rhinovirus 3C Protease Studied in Various Buffers, Additives and Detergents Solutions for Recombinant Protein Production	PLOS ONE			English	Article							ETCH VIRUS PROTEASE; AFFINITY PURIFICATION; EXPRESSION; STABILITY; CLONING	Proteases are widely used to remove affinity and solubility tags from recombinant proteins to avoid potential interference of these tags with the structure and function of the fusion partner. In recent years, great interest has been seen in use of the human rhinovirus 3C protease owing to its stringent sequence specificity and enhanced activity. Like other proteases, activity of the human rhinovirus 3C protease can be affected in part by the buffer components and additives that are generally employed for purification and stabilization of proteins, hence, necessitate their removal by tedious and time-consuming procedures before proteolysis can occur. To address this issue, we examined the effect of elution buffers used for common affinity based purifications, salt ions, stability/solubility and reducing agents, and detergents on the activity of the human rhinovirus 3C protease using three different fusion proteins at 4 degrees C, a temperature of choice for purification of many proteins. The results show that the human rhinovirus 3C protease performs better at 4 degrees C than the frequently used tobacco etch virus protease and its activity was insensitive to most of the experimental conditions tested. Though number of fusion proteins tested is limited, we expect that these finding will facilitate the use of the human rhinovirus 3C protease in recombinant protein production for pharmaceutical and biotechnological applications.	[Ullah, Raheem; Shah, Majid Ali; Tufail, Soban; Ismat, Fouzia; Imran, Muhammad; Iqbal, Mazhar; Rhaman, Moazur] NIBGE, Hlth Biotechnol Div, Drug Discovery & Struct Biol Grp, Faisalabad, Pakistan; [Ullah, Raheem; Shah, Majid Ali; Iqbal, Mazhar; Rhaman, Moazur] Pakistan Inst Engn & Appl Sci, PO Nilore, Islamabad, Pakistan; [Mirza, Osman] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Copenhagen, Denmark; [Imran, Muhammad] Forman Christian Coll, Lahore, Pakistan	Pakistan Institute of Engineering & Applied Science; Pakistan Institute of Engineering & Applied Science; University of Copenhagen	Rhaman, M (corresponding author), NIBGE, Hlth Biotechnol Div, Drug Discovery & Struct Biol Grp, Faisalabad, Pakistan.; Rhaman, M (corresponding author), Pakistan Inst Engn & Appl Sci, PO Nilore, Islamabad, Pakistan.	moazur.rahman@fulbrightmail.org	Iqbal, Mazhar/C-5536-2019; Rahman, Moazur/C-5515-2019	Iqbal, Mazhar/0000-0002-8675-1125; Rahman, Moazur/0000-0003-2892-1250; Mirza, Osman Asghar/0000-0001-9435-0690	International Centre for Genetic Engineering and Biotechnology, Italy [CRP/PAK10-01]; Higher Education Commission of Pakistan	International Centre for Genetic Engineering and Biotechnology, Italy; Higher Education Commission of Pakistan(Higher Education Commission of Pakistan)	We thank Samar Hasnain, University of Liverpool, UK for provision of TEV protease construct and Andreas Engel, Case Western Reserve University, USA for HRV 3C construct. We thank Gerard Huysmans for critical comments and for improving the manuscript. This work was supported by the International Centre for Genetic Engineering and Biotechnology, Italy [ grant No. CRP/PAK10-01; ( awarded to M. Rahman)] and PhD studentships by Higher Education Commission of Pakistan ( awarded to Raheem Ullah and Majid Ali Shah).	Block H, 2009, METHOD ENZYMOL, V463, P439, DOI 10.1016/S0076-6879(09)63027-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chi EY, 2003, PHARM RES-DORDR, V20, P1325, DOI 10.1023/A:1025771421906; CORDINGLEY MG, 1990, J BIOL CHEM, V265, P9062; Iram N, 2014, APPL MICROBIOL BIOT, V98, P1691, DOI 10.1007/s00253-013-5043-2; Leibly DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052482; Leong LEC, 1999, MOL BIOTECHNOL, V12, P269, DOI 10.1385/MB:12:3:269; Lundback AK, 2008, ANAL BIOCHEM, V382, P69, DOI 10.1016/j.ab.2008.07.018; Mao Yong-Jin, 2007, BMC Biochemistry, V8, P28, DOI 10.1186/1471-2091-8-28; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Mohanty AK, 2003, PROTEIN EXPRES PURIF, V27, P109, DOI 10.1016/S1046-5928(02)00589-2; RIGGS P, 2001, CURR PROTOC MOL BIOL, P16; Rocco CJ, 2008, PLASMID, V59, P231, DOI 10.1016/j.plasmid.2008.01.001; Ruckenstein E, 2006, ADV COLLOID INTERFAC, V123, P97, DOI 10.1016/j.cis.2006.05.018; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Shah MS, 2016, BIOLOGICALS, V44, P19, DOI 10.1016/j.biologicals.2015.10.002; Simons P C, 1981, Methods Enzymol, V77, P235; Smyth DR, 2003, PROTEIN SCI, V12, P1313, DOI 10.1110/ps.0243403; Sun CS, 2012, PROTEIN EXPRES PURIF, V82, P226, DOI 10.1016/j.pep.2012.01.005; Vergis JM, 2011, PROTEIN EXPRES PURIF, V78, P139, DOI 10.1016/j.pep.2011.04.011; WALKER PA, 1994, BIO-TECHNOL, V12, P601, DOI 10.1038/nbt0694-601; Wang QM, 2001, VIROLOGY, V280, P80, DOI 10.1006/viro.2000.0760; Waugh DS, 2011, PROTEIN EXPRES PURIF, V80, P283, DOI 10.1016/j.pep.2011.08.005; Young CL, 2012, BIOTECHNOL J, V7, P620, DOI 10.1002/biot.201100155	24	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153436	10.1371/journal.pone.0153436	http://dx.doi.org/10.1371/journal.pone.0153436			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093053	gold, Green Submitted, Green Published			2022-12-26	WOS:000374541200019
J	Wilkinson, JM; Ladinig, A; Bao, H; Kommadath, A; Stothard, P; Lunney, JK; Harding, JCS; Plastow, GS				Wilkinson, Jamie M.; Ladinig, Andrea; Bao, Hua; Kommadath, Arun; Stothard, Paul; Lunney, Joan K.; Harding, John C. S.; Plastow, Graham S.			Differences in Whole Blood Gene Expression Associated with Infection Time-Course and Extent of Fetal Mortality in a Reproductive Model of Type 2 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Infection	PLOS ONE			English	Article							IMMUNE-RESPONSES; PREGNANT GILTS; VIRAL LOAD; RNA-SEQ; ACTIVATION; PLATELETS; PIGS; APOPTOSIS; PROTEINS; IDENTIFICATION	Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) infection of pregnant females causes fetal death and increased piglet mortality, but there is substantial variation in the extent of reproductive pathology between individual dams. This study used RNA sequencing to characterize the whole blood transcriptional response to type 2 PRRSV in pregnant gilts during the first week of infection (at 0, 2, and 6 days post-inoculation), and attempted to identify gene expression signatures associated with a low or high level of fetal mortality rates (LFM and HFM; n = 8/group) at necropsy, 21 days post-inoculation. The initial response to infection measured at 2 days post -inoculation saw an upregulation of genes involved in innate immunity, such as interferon-stimulated antiviral genes and inflammatory markers, and apoptosis. A concomitant decrease in expression of protein synthesis and T lymphocyte markers was observed. By day 6 the pattern had reversed, with a drop in innate immune signaling and an increase in the expression of genes involved in cell division and T cell signaling. Differentially expressed genes (DEGs) associated with extremes of litter mortality rate were identified at all three time -points. Among the 15 DEGs upregulated in LFM gilts on all three days were several genes involved in platelet function, including integrins ITGA2B and ITGB3, and the chemokine PF4 (CXCL4). LFM gilts exhibited a higher baseline expression of interferon-stimulated and pro -inflammatory genes prior to infection, and of T cell markers two days post-infection, indicative of a more rapid progression of the immune response to PRRSV. This study has increased our knowledge of the early response to PRRSV in the blood of pregnant gilts, and could ultimately lead to the development of a biomarker panel that can be used to predict PRRSV-associated reproductive pathology.	[Wilkinson, Jamie M.; Bao, Hua; Kommadath, Arun; Stothard, Paul; Plastow, Graham S.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Ladinig, Andrea; Harding, John C. S.] Univ Saskatchewan, Western Coll Vet Med, Dept Large Anim Clin Sci, Saskatoon, SK S7N 0W0, Canada; [Lunney, Joan K.] ARS, Anim Parasit Dis Lab, Beltsville Agr Res Ctr, USDA, Beltsville, MD USA; [Ladinig, Andrea] Univ Vet Med, Dept Farm Anim & Vet Publ Hlth, Univ Clin Swine, Vienna, Austria	University of Alberta; University of Saskatchewan; United States Department of Agriculture (USDA); University of Veterinary Medicine Vienna	Wilkinson, JM (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	jamie.wilkinson@ualberta.ca	Kommadath, Arun/I-4644-2019	Kommadath, Arun/0000-0003-3587-6670; Plastow, Graham/0000-0002-3774-3110; Ladinig, Andrea/0000-0001-5037-7269	Genome Canada; Genome Prairie; Alberta Livestock and Meat Agency; Alberta Innovates - Bio Solutions	Genome Canada(Genome Canada); Genome Prairie; Alberta Livestock and Meat Agency; Alberta Innovates - Bio Solutions	This work was funded by grants from Genome Canada (genomecanada.ca) and Genome Prairie (genomeprairie.ca) to support the following project: "Application of Genomics to Improve Swine Health and Welfare". Administrative support was provided by Genome Alberta (genomealberta.ca). HB and PS are grateful for financial support from the Alberta Livestock and Meat Agency (alma.alberta.ca) and Alberta Innovates - Bio Solutions (bio.albertainnovates.ca), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albina E, 1998, VET IMMUNOL IMMUNOP, V61, P49, DOI 10.1016/S0165-2427(97)00134-7; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arceo Maria E., 2013, Frontiers in Genetics, V3, P321, DOI 10.3389/fgene.2012.00321; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; CALVETE JJ, 1994, THROMB HAEMOSTASIS, V72, P1; Cao J, 2013, VET MICROBIOL, V164, P261, DOI 10.1016/j.vetmic.2013.03.001; Choi I, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-954; Davenport EE, 2015, J MOL MED, V93, P105, DOI 10.1007/s00109-014-1212-8; Diaz I, 2005, J GEN VIROL, V86, P1943, DOI 10.1099/vir.0.80959-0; Elzey BD, 2003, IMMUNITY, V19, P9, DOI 10.1016/S1074-7613(03)00177-8; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; FREEMAN GJ, 1992, J IMMUNOL, V149, P3795; Genini S, 2008, J GEN VIROL, V89, P2550, DOI 10.1099/vir.0.2008/003244-0; Gnatenko DV, 2003, BLOOD, V101, P2285, DOI 10.1182/blood-2002-09-2797; Gomez-Laguna J, 2013, TRANSBOUND EMERG DIS, V60, P273, DOI 10.1111/j.1865-1682.2012.01338.x; Gomez-Laguna J, 2009, VIRAL IMMUNOL, V22, P261, DOI 10.1089/vim.2009.0003; Hu J, 2014, TRANSBOUND EMERG DIS, V61, P109, DOI 10.1111/tbed.12016; Iannacone M, 2008, P NATL ACAD SCI USA, V105, P629, DOI 10.1073/pnas.0711200105; Karniychuk UU, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-95; Karniychuk UU, 2011, MICROB PATHOGENESIS, V51, P194, DOI 10.1016/j.micpath.2011.04.001; Kommadath A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-452; Kunishima S, 2014, EUR J HAEMATOL, V92, P276, DOI 10.1111/ejh.12252; Labarque G, 2003, VET RES, V34, P249, DOI 10.1051/vetres:2003001; Ladinig A, 2015, VET RES, V46, DOI 10.1186/s13567-015-0251-7; Ladinig A, 2014, VET RES, V45, DOI 10.1186/s13567-014-0113-8; Ladinig A, 2014, VET RES, V45, DOI 10.1186/s13567-014-0128-1; Ladinig A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096104; Lewis CRG, 2009, J ANIM SCI, V87, P876, DOI 10.2527/jas.2008-0892; Li YM, 2014, VIRUS RES, V189, P29, DOI 10.1016/j.virusres.2014.04.011; McMorran BJ, 2012, SCIENCE, V338, P1348, DOI 10.1126/science.1228892; McMorran BJ, 2009, SCIENCE, V323, P797, DOI 10.1126/science.1166296; Miller LC, 2010, ADV VIROL, V2010, DOI 10.1155/2010/864181; Miller LC, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-208; Nascimento EJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007892; RILEY FL, 1977, TEX REP BIOL MED, V35, P239; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodriguez-Gomez IM, 2014, VET MICROBIOL, V172, P186, DOI 10.1016/j.vetmic.2014.05.025; Rossow KD, 1998, VET PATHOL, V35, P1, DOI 10.1177/030098589803500101; SAMUEL CE, 1991, VIROLOGY, V183, P1, DOI 10.1016/0042-6822(91)90112-O; Sener A, 2012, FOLIA BIOL-PRAGUE, V58, P193; Serao NVL, 2014, J ANIM SCI, V92, P2905, DOI 10.2527/jas.2014-7821; Smedley D, 2015, NUCLEIC ACIDS RES, V43, pW589, DOI 10.1093/nar/gkv350; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; STENBERG PE, 1984, J CELL BIOL, V98, P748, DOI 10.1083/jcb.98.2.748; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang G, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-2; Wang R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/315470; WARGNIER A, 1995, P NATL ACAD SCI USA, V92, P6930, DOI 10.1073/pnas.92.15.6930; Wysocki M, 2012, ANIM GENET, V43, P328, DOI 10.1111/j.1365-2052.2011.02251.x; Xiao SQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011377; Yamaji S, 2002, BIOCHEM BIOPH RES CO, V297, P1324, DOI 10.1016/S0006-291X(02)02381-1; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582; Youssefian T, 2002, BLOOD, V99, P4021, DOI 10.1182/blood-2001-12-0191	58	10	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153615	10.1371/journal.pone.0153615	http://dx.doi.org/10.1371/journal.pone.0153615			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093427	gold, Green Published, Green Submitted			2022-12-26	WOS:000374541200032
J	Jasial, S; Hu, Y; Bajorath, J				Jasial, Swarit; Hu, Ye; Bajorath, Juergen			Determining the Degree of Promiscuity of Extensively Assayed Compounds	PLOS ONE			English	Article							DRUG DISCOVERY; POLYPHARMACOLOGY; DATABASE; PUBCHEM	In the context of polypharmacology, an emerging concept in drug discovery, promiscuity is rationalized as the ability of compounds to specifically interact with multiple targets. Promiscuity of drugs and bioactive compounds has thus far been analyzed computationally on the basis of activity annotations, without taking assay frequencies or inactivity records into account. Most recent estimates have indicated that bioactive compounds interact on average with only one to two targets, whereas drugs interact with six or more. In this study, we have further extended promiscuity analysis by identifying the most extensively assayed public domain compounds and systematically determining their promiscuity. These compounds were tested in hundreds of assays against hundreds of targets. In our analysis, assay promiscuity was distinguished from target promiscuity and separately analyzed for primary and confirmatory assays. Differences between the degree of assay and target promiscuity were surprisingly small and average and median degrees of target promiscuity of 2.6 to 3.4 and 2.0 were determined, respectively. Thus, target promiscuity remained at a low level even for most extensively tested active compounds. These findings provide further evidence that bioactive compounds are less promiscuous than drugs and have implications for pharmaceutical research. In addition to a possible explanation that drugs are more extensively tested for additional targets, the results would also support a "promiscuity enrichment model" according to which promiscuous compounds might be preferentially selected for therapeutic efficacy during clinical evaluation to ultimately become drugs.	[Jasial, Swarit; Hu, Ye; Bajorath, Juergen] Univ Bonn, Dept Life Sci Informat, B IT, LIMES Program Unit Chem Biol & Med Chem, Bonn, Germany	University of Bonn	Bajorath, J (corresponding author), Univ Bonn, Dept Life Sci Informat, B IT, LIMES Program Unit Chem Biol & Med Chem, Bonn, Germany.	bajorath@bit.uni-bonn.de		Jasial, Swarit/0000-0003-1415-8151				Baell J, 2014, NATURE, V513, P481, DOI 10.1038/513481a; Baell JB, 2015, ACS MED CHEM LETT, V6, P229, DOI 10.1021/acsmedchemlett.5b00032; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Bajorath J, 2014, DRUG DISCOV TODAY, V19, P357, DOI 10.1016/j.drudis.2014.02.004; Bento AP, 2014, NUCLEIC ACIDS RES, V42, pD1083, DOI 10.1093/nar/gkt1031; Boran ADW, 2010, CURR OPIN DRUG DISC, V13, P297; Canny SA, 2012, BIOINFORMATICS, V28, P140, DOI 10.1093/bioinformatics/btr622; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Hu Ye, 2013, F1000Res, V2, P144, DOI 10.12688/f1000research.2-144.v1; Hu Ye, 2015, F1000Res, V4, P118, DOI 10.12688/f1000research.6473.1; Hu Ye, 2014, F1000Res, V3, P218, DOI 10.12688/f1000research.5250.1; Hu Y, 2013, DRUG DISCOV TODAY, V18, P644, DOI 10.1016/j.drudis.2013.03.002; Hu Y, 2013, AAPS J, V15, P808, DOI 10.1208/s12248-013-9488-0; Jacoby E, 2006, MOL BIOSYST, V2, P218, DOI 10.1039/b603004c; Jalencas X, 2013, MEDCHEMCOMM, V4, P80, DOI 10.1039/c2md20242e; Jasial S, 2016, ZENODO, DOI [10.5281/zenodo.44593, DOI 10.5281/ZENODO.44593]; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068; Lu JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040262; Lusher SJ, 2014, DRUG DISCOV TODAY, V19, P859, DOI 10.1016/j.drudis.2013.12.004; Mestres J, 2008, NAT BIOTECHNOL, V26, P983, DOI 10.1038/nbt0908-983; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Sterling T, 2015, J CHEM INF MODEL, V55, P2324, DOI 10.1021/acs.jcim.5b00559; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1132, 10.1093/nar/gkr1293]; Wassermann AM, 2015, NAT CHEM BIOL, V11, P958, DOI 10.1038/nchembio.1936	25	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153873	10.1371/journal.pone.0153873	http://dx.doi.org/10.1371/journal.pone.0153873			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082988	gold, Green Published, Green Submitted			2022-12-26	WOS:000374291800062
J	Abuli, A; Castells, A; Bujanda, L; Lozano, JJ; Bessa, X; Hernandez, C; Alvarez-Urturi, C; Pellise, M; Esteban-Jurado, C; Hijona, E; Buron, A; Macia, F; Grau, J; Guayta, R; Castellvi-Bel, S; Andreu, M				Abuli, Anna; Castells, Antoni; Bujanda, Luis; Jose Lozano, Juan; Bessa, Xavier; Hernandez, Cristina; Alvarez-Urturi, Cristina; Pellise, Maria; Esteban-Jurado, Clara; Hijona, Elizabeth; Buron, Andrea; Macia, Francesc; Grau, Jaume; Guayta, Rafael; Castellvi-Bel, Sergi; Andreu, Montserrat		PROCOLON Res Grp	Genetic Variants Associated with Colorectal Adenoma Susceptibility	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; AMERICAN-CANCER-SOCIETY; TASK-FORCE; RISK; LOCI; METAANALYSIS; POPULATION; POLYPS; SURVEILLANCE; POLYPECTOMY	Background Common low-penetrance genetic variants have been consistently associated with colorectal cancer risk. Aim To determine if these genetic variants are associated also with adenoma susceptibility and may improve selection of patients with increased risk for advanced adenomas and/or multiplicity (>= 3 adenomas). Methods We selected 1,326 patients with increased risk for advanced adenomas and/or multiplicity and 1,252 controls with normal colonoscopy from population-based colorectal cancer screening programs. We conducted a case-control association study analyzing 30 colorectal cancer susceptibility variants in order to investigate the contribution of these variants to the development of subsequent advanced neoplasia and/or multiplicity. Results We found that 14 of the analyzed genetic variants showed a statistically significant association with advanced adenomas and/or multiplicity: the probability of developing these lesions increased with the number of risk alleles reaching a 2.3-fold risk increment in individuals with >= 17 risk alleles. Conclusions Nearly half of the genetic variants associated with colorectal cancer risk are also related to advanced adenoma and/or multiplicity predisposition. Assessing the number of risk alleles in individuals within colorectal cancer screening programs may help to identify better a subgroup with increased risk for advanced neoplasia and/or multiplicity in the general population.	[Abuli, Anna; Bessa, Xavier; Alvarez-Urturi, Cristina; Andreu, Montserrat] Pompeu Fabra Univ, Hosp Mar, Dept Gastroenterol, IMIM Hosp Mar Med Res Inst, Passeig Maritim 25-29, Barcelona 08003, Catalonia, Spain; [Castells, Antoni; Pellise, Maria; Esteban-Jurado, Clara; Castellvi-Bel, Sergi] Univ Barcelona, Dept Gastroenterol, Hosp Clin, CIBERehd,IDIBAPS, Villarroel 170, E-08036 Barcelona, Catalonia, Spain; [Bujanda, Luis; Hijona, Elizabeth] Univ Pais Vasco UPV EHU, Dept Gastroenterol, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Hosp Donostia,Inst Biodonostia, Doctor Begiristain Kalea, Donostia Gipuzkoa 20014, Spain; [Jose Lozano, Juan] CIBERehd, Plataforma Bioinformat, Villarroel 170, Barcelona 08036, Catalonia, Spain; [Hernandez, Cristina; Buron, Andrea; Macia, Francesc] Hosp Mar, Dept Epidemiol & Evaluat, IMIM Hosp Mar Med Res Inst, Passeig Maritim 25-29, Barcelona 08003, Catalonia, Spain; [Grau, Jaume] Hosp Clin Barcelona, Unitat Avaluacio Suport & Prevent, Rosello 138, E-08036 Barcelona, Catalonia, Spain; [Guayta, Rafael] Consell Collegis Farmaceut Catalunya, Planning & Res Unit, Barcelona 08009, Catalonia, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Investigacion Sanitaria Biodonostia; University Hospital Donostia; University of Basque Country; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University of Barcelona; Hospital Clinic de Barcelona	Andreu, M (corresponding author), Pompeu Fabra Univ, Hosp Mar, Dept Gastroenterol, IMIM Hosp Mar Med Res Inst, Passeig Maritim 25-29, Barcelona 08003, Catalonia, Spain.	mandreu@parcdesalutmar.cat	Moreira, Leticia/AAN-9863-2021; Castells, Antoni/ABC-1002-2021; Bujanda, Luis/AAB-2485-2021; Grau, Jaume/K-9869-2019; Serrano, Merce Comas/O-3825-2014; Buron, Andrea/E-5705-2016; Castells, Xavier/S-7798-2016; Pellise, Maria/ABC-3246-2021; Grau, Jaume/E-3570-2019; Macià, Francesc/N-2776-2017	Moreira, Leticia/0000-0002-4518-8591; Castells, Antoni/0000-0001-8431-2033; Bujanda, Luis/0000-0002-4353-9968; Serrano, Merce Comas/0000-0003-1926-2740; Buron, Andrea/0000-0003-3590-1303; Castells, Xavier/0000-0002-2528-0382; Grau, Jaume/0000-0002-6811-2215; Macià, Francesc/0000-0002-6090-5894; Lozano, Juan Jose/0000-0001-7613-3908; Esteban, Clara/0000-0002-4403-8073; Lopez-Ceron, Maria/0000-0002-7968-9204; Castellvi-Bel, Sergi/0000-0003-1217-5097; Bessa Caserras, Xavier/0000-0003-4680-1228; Balaguer, Francesc/0000-0002-0206-0539; Pellise, Maria/0000-0001-9739-4998; Seoane Urgorri, Agustin/0000-0001-8023-4445; Rodriguez de Miguel, Cristina/0000-0002-5576-0854	Instituto de Salud Carlos III-FEDER [RD09/0076/00036]; Pla Director d'Oncologia de Catalunya (XBTC); Fondo de Investigacion Sanitaria/FEDER [PI10/00918, PI11/00219, PI14/00173, PI14/00441]; Ministerio de Economia y Competitividad [SAF2010-19273]; Asociacion Espanola contra el Cancer (Fundacion Cientifica) [GCB13131592CAST]; COST Action [BM1206]; Fondo de Investigacion Sanitaria [CP 03-0070]; Agencia de Gestio d'Ajuts Universitaris i de Recerca (Generalitat de Catalunya) [2014SGR255, 2014SGR135]; Instituto de Salud Carlos III	Instituto de Salud Carlos III-FEDER(Instituto de Salud Carlos IIIEuropean Commission); Pla Director d'Oncologia de Catalunya (XBTC); Fondo de Investigacion Sanitaria/FEDER(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Economia y Competitividad(Spanish Government); Asociacion Espanola contra el Cancer (Fundacion Cientifica); COST Action(European Cooperation in Science and Technology (COST)); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Agencia de Gestio d'Ajuts Universitaris i de Recerca (Generalitat de Catalunya)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by grants from: Instituto de Salud Carlos III-FEDER (RD09/0076/00036), the Xarxa de Bancs de tumors sponsored by Pla Director d'Oncologia de Catalunya (XBTC), Fondo de Investigacion Sanitaria/FEDER (PI10/00918, PI11/00219, PI14/00173, PI14/00441), Ministerio de Economia y Competitividad (SAF2010-19273), Asociacion Espanola contra el Cancer (Fundacion Cientifica GCB13131592CAST), and COST Action BM1206 (SCB). SCB is supported by a contract from the Fondo de Investigacion Sanitaria (CP 03-0070) and Agencia de Gestio d'Ajuts Universitaris i de Recerca (Generalitat de Catalunya, 2014SGR255, 2014SGR135). CIBERehd is funded by the Instituto de Salud Carlos III.	Abuli A, 2010, GASTROENTEROLOGY, V139, P788, DOI 10.1053/j.gastro.2010.05.072; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berndt SI, 2008, HUM MOL GENET, V17, P2665, DOI 10.1093/hmg/ddn166; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Burnett-Hartman AN, 2014, AM J EPIDEMIOL, V180, P223, DOI 10.1093/aje/kwu114; Carvajal-Carmona LG, 2013, GASTROENTEROLOGY, V144, P53, DOI 10.1053/j.gastro.2012.09.016; Cheng THT, 2015, EUR J HUM GENET, V23, P260, DOI 10.1038/ejhg.2014.74; Dunlop MG, 2012, NAT GENET, V44, P770, DOI 10.1038/ng.2293; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Fernandez-Rozadilla C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-55; Fletcher O, 2010, NAT REV CANCER, V10, P353, DOI 10.1038/nrc2840; Guittet L, 2007, GUT, V56, P210, DOI 10.1136/gut.2006.101428; HARDCASTLE JD, 1989, LANCET, V1, P1160; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Jaeger E, 2008, NAT GENET, V40, P26, DOI 10.1038/ng.2007.41; Jia WH, 2013, NAT GENET, V45, P191, DOI 10.1038/ng.2505; Jones AM, 2012, GUT, V61, P248, DOI 10.1136/gut.2011.239772; Kinnersley B, 2012, BRIT J CANCER, V107, P1001, DOI 10.1038/bjc.2012.329; Kundu S, 2011, EUR J EPIDEMIOL, V26, P261, DOI 10.1007/s10654-011-9567-4; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Neugut A I, 1997, Gastrointest Endosc Clin N Am, V7, P387; Peters U, 2013, GASTROENTEROLOGY, V144, P799, DOI 10.1053/j.gastro.2012.12.020; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rex DK, 2012, AM J GASTROENTEROL, V107, P1315, DOI 10.1038/ajg.2012.161; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tenesa A, 2009, NAT REV GENET, V10, P353, DOI 10.1038/nrg2574; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tomlinson IPM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002105; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; van Rossum LG, 2008, GASTROENTEROLOGY, V135, P82, DOI 10.1053/j.gastro.2008.03.040; Whitlock EP, 2008, ANN INTERN MED, V149, P638, DOI 10.7326/0003-4819-149-9-200811040-00245; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Winawer SJ, 2006, GASTROENTEROLOGY, V130, P1872, DOI 10.1053/j.gastro.2006.03.012; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370; Zhang B, 2012, CARCINOGENESIS, V33, P2417, DOI 10.1093/carcin/bgs308	38	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153084	10.1371/journal.pone.0153084	http://dx.doi.org/10.1371/journal.pone.0153084			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078840	Green Published, gold, Green Submitted			2022-12-26	WOS:000374131700021
J	Alagna, F; Cirilli, M; Galla, G; Carbone, F; Daddiego, L; Facella, P; Lopez, L; Colao, C; Mariotti, R; Cultrera, N; Rossi, M; Barcaccia, G; Baldoni, L; Muleo, R; Perrotta, G				Alagna, Fiammetta; Cirilli, Marco; Galla, Giulio; Carbone, Fabrizio; Daddiego, Loretta; Facella, Paolo; Lopez, Loredana; Colao, Chiara; Mariotti, Roberto; Cultrera, Nicol; Rossi, Martina; Barcaccia, Gianni; Baldoni, Luciana; Muleo, Rosario; Perrotta, Gaetano			Transcript Analysis and Regulative Events during Flower Development in Olive (Olea europaea L.)	PLOS ONE			English	Article							MADS-BOX GENES; CYTOPLASMIC MALE-STERILITY; POLLEN-PISTIL INTERACTIONS; SPERMIDINE SYNTHASE GENES; SELF-INCOMPATIBLE POLLEN; PROGRAMMED-CELL-DEATH; POLYAMINE METABOLISM; RECEPTOR KINASE; INFLORESCENCE DEVELOPMENT; EXPRESSION ANALYSIS	The identification and characterization of transcripts involved in flower organ development, plant reproduction and metabolism represent key steps in plant phenotypic and physiological pathways, and may generate high-quality transcript variants useful for the development of functional markers. This study was aimed at obtaining an extensive characterization of the olive flower transcripts, by providing sound information on the candidate MADS-box genes related to the ABC model of flower development and on the putative genetic and molecular determinants of ovary abortion and pollen-pistil interaction. The overall sequence data, obtained by pyrosequencing of four cDNA libraries from flowers at different developmental stages of three olive varieties with distinct reproductive features (Leccino, Frantoio and Dolce Agogia), included approximately 465,000 ESTs, which gave rise to more than 14,600 contigs and approximately 92,000 singletons. As many as 56,700 unigenes were successfully annotated and provided gene ontology insights into the structural organization and putative molecular function of sequenced transcripts and deduced proteins in the context of their corresponding biological processes. Differentially expressed genes with potential regulatory roles in biosynthetic pathways and metabolic networks during flower development were identified. The gene expression studies allowed us to select the candidate genes that play well-known molecular functions in a number of biosynthetic pathways and specific biological processes that affect olive reproduction. A sound understanding of gene functions and regulatory networks that characterize the olive flower is provided.	[Alagna, Fiammetta; Mariotti, Roberto; Cultrera, Nicol; Rossi, Martina; Baldoni, Luciana] CNR, Inst Biosci & Bioresources, Perugia, Italy; [Cirilli, Marco; Colao, Chiara; Muleo, Rosario] Univ Tuscia, Lab Mol Ecophysiol & Biotechnol Woody Plants, Dept Agr & Forestry Sci, Viterbo, Italy; [Galla, Giulio; Barcaccia, Gianni] Univ Padua, DAFNAE, Lab Plant Genet & Genom, Legnaro, PD, Italy; [Carbone, Fabrizio; Daddiego, Loretta; Facella, Paolo; Lopez, Loredana; Perrotta, Gaetano] Italian Natl Agcy New Technol Energy & Sustainabl, TRISAIA Res Ctr, Rotondella, MT, Italy; [Alagna, Fiammetta] Council Agr Res & Econ, Res Unit Table Grapes & Wine Growing Mediterranea, Bari, Italy; [Cirilli, Marco] Univ Milan, Dept Agr & Environm Sci, Milan, Italy; [Carbone, Fabrizio] Council Agr Res & Econ, Olive Growing & Olive Prod Ind Res Ctr, Arcavacata Di Rende, CS, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR); Tuscia University; University of Padua; Italian National Agency New Technical Energy & Sustainable Economics Development; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); University of Milan; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA)	Muleo, R (corresponding author), CNR, Inst Biosci & Bioresources, Perugia, Italy.	luciana.baldoni@ibbr.cnr.it; muleo@unitus.it	Galla, Giulio/GPK-8561-2022; Facella, Paolo/HHC-1895-2022; Carbone, Fabrizio/O-2443-2017; Cultrera, Nicolò G/P-7376-2018; Muleo, Rosario/AAI-7439-2020; Baldoni, Luciana/A-4411-2016; Alagna, Fiammetta/AAF-3169-2020; Carbone, Fabrizio/AAE-1065-2019; mariotti, roberto/AAG-7294-2021	Facella, Paolo/0000-0001-9076-3754; Carbone, Fabrizio/0000-0002-0393-7099; Cultrera, Nicolò G/0000-0003-1361-7539; Baldoni, Luciana/0000-0002-3221-333X; Carbone, Fabrizio/0000-0002-0393-7099; mariotti, roberto/0000-0002-9111-5123; Alagna, Fiammetta/0000-0003-1878-2023; BALDONI, LUCIANA/0000-0002-6636-0055; Perrotta, Gaetano/0000-0003-2037-1063; BARCACCIA, GIANNI/0000-0001-7478-5048; Galla, Giulio/0000-0002-4573-0897	"OLEA - Genomics and Breeding of Olive" Project - Italian Ministero delle politiche agricole alimentari e forestali [D.M. 27011/7643/10]; "Dondazione Anna Maria Catalano - ONLUS", Italy	"OLEA - Genomics and Breeding of Olive" Project - Italian Ministero delle politiche agricole alimentari e forestali; "Dondazione Anna Maria Catalano - ONLUS", Italy	This research was financed by the "OLEA - Genomics and Breeding of Olive" Project, funded by the Italian Ministero delle politiche agricole alimentari e forestali, D.M. 27011/7643/10. The grant from "Dondazione Anna Maria Catalano - ONLUS", Italy, also provided partial financial support. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2007, P NATL ACAD SCI USA, V104, P6484, DOI 10.1073/pnas.0610717104; Aharoni A, 2001, PLANT J, V28, P319, DOI 10.1046/j.1365-313X.2001.01154.x; Alagna F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-399; Albert NW, 2014, PLANT CELL, V26, P962, DOI 10.1105/tpc.113.122069; ARIBAUD M, 1994, PHYTOCHEMISTRY, V37, P927, DOI 10.1016/S0031-9422(00)89506-0; Barcaccia G, 1012, ACTA HORTIC, V967, P43; Ben Sadok I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062831; Besnard G, 2000, THEOR APPL GENET, V100, P1018, DOI 10.1007/s001220051383; Bogs J, 2007, PLANT PHYSIOL, V143, P1347, DOI 10.1104/pp.106.093203; Bosch M, 2005, PLANT PHYSIOL, V138, P1334, DOI 10.1104/pp.105.059865; Bouranis DL, 1999, J PLANT NUTR, V22, P245, DOI 10.1080/01904169909365623; Breton CM, 2012, CR BIOL, V335, P563, DOI 10.1016/j.crvi.2012.07.006; Breton CM, 2014, TREE GENET GENOMES, V10, P1055, DOI 10.1007/s11295-014-0742-0; Carmona R, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00625; Cavallotti A, 2003, PLANT SCI, V164, P241, DOI 10.1016/S0168-9452(02)00406-5; Chae K, 2009, PLANT CELL, V21, P3902, DOI 10.1105/tpc.109.070854; Chalivendra SC, 2013, J EXP BOT, V64, P265, DOI 10.1093/jxb/ers324; Chapman LA, 2010, J EXP BOT, V61, P1987, DOI 10.1093/jxb/erq021; Chia T, 2004, PLANT J, V37, P853, DOI 10.1111/j.1365-313X.2003.02012.x; Clement C, 1996, AM J BOT, V83, P459, DOI 10.2307/2446215; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Collani S, 2012, ACTA HORTIC, V967, P133, DOI 10.17660/ActaHortic.2012.967.15; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cuevas J, 2004, ANN BOT-LONDON, V93, P547, DOI 10.1093/aob/mch079; D'Aoust MA, 1999, PLANT CELL, V11, P2407, DOI 10.1105/tpc.11.12.2407; Danilevskaya ON, 2008, PLANT PHYSIOL, V147, P2054, DOI 10.1104/pp.107.115261; de Groot P, 2004, PLANT MOL BIOL, V55, P715, DOI 10.1007/s11103-004-1964-6; de la Rosa R, 2003, THEOR APPL GENET, V106, P1273, DOI 10.1007/s00122-002-1189-5; Diaz A, 2006, J AM SOC HORTIC SCI, V131, P250, DOI 10.21273/JASHS.131.2.250; Diaz-Riquelme J, 2009, PLANT PHYSIOL, V149, P354, DOI 10.1104/pp.108.131052; Doidy J, 2012, TRENDS PLANT SCI, V17, P413, DOI 10.1016/j.tplants.2012.03.009; Draie R, 2011, MOL PLANT PATHOL, V12, P638, DOI 10.1111/J.1364-3703.2010.00702.X; Gonzalez ME, 2011, PLANT PHYSIOL, V156, P2266, DOI 10.1104/pp.110.171413; EVANS PT, 1989, ANNU REV PLANT PHYS, V40, P235, DOI 10.1146/annurev.pp.40.060189.001315; Fernandez-Escobar R, 2008, ENVIRON EXP BOT, V64, P113, DOI 10.1016/j.envexpbot.2008.04.007; Galla G, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-128; Gao X. Q., 2010, FRONT BIOL, V5, P156, DOI [10.1007/s11515-010-0024-7, DOI 10.1007/S11515-010-0024-7]; GERATS AGM, 1988, PLANT PHYSIOL, V86, P390, DOI 10.1104/pp.86.2.390; Gil-Amado JA, 2012, PLANT CELL PHYSIOL, V54, P244, DOI DOI 10.1093/pcp/pcs179; Gil-Amado JA, 2012, PLANTA, V235, P1221, DOI 10.1007/s00425-011-1570-1; Gomez-Jimenez MC, 2010, PLANTA, V232, P629, DOI 10.1007/s00425-010-1198-6; Guo DP, 2003, PLANT GROWTH REGUL, V41, P33, DOI 10.1023/A:1027328416042; Hadfield KA, 1998, PLANT PHYSIOL, V117, P337, DOI 10.1104/pp.117.2.337; Heyer AG, 2004, PLANT J, V39, P161, DOI 10.1111/j.1365-313X.2004.02124.x; Higashiyama T, 2010, PLANT CELL PHYSIOL, V51, P177, DOI 10.1093/pcp/pcq008; Huang CK, 2004, J PLANT PHYSIOL, V161, P709, DOI 10.1078/0176-1617-01256; Huang JC, 2011, PLANT CELL PHYSIOL, V52, P1546, DOI 10.1093/pcp/pcr095; Imai A, 2004, PLANT PHYSIOL, V135, P1565, DOI 10.1104/pp.104.041699; Irish VF, 2010, PLANT J, V61, P1014, DOI 10.1111/j.1365-313X.2009.04065.x; Iwano M, 2012, CURR OPIN PLANT BIOL, V15, P78, DOI 10.1016/j.pbi.2011.09.003; Kakita M, 2007, PLANT CELL, V19, P3961, DOI 10.1105/tpc.106.049999; Kater MM, 2006, J EXP BOT, V57, P3433, DOI 10.1093/jxb/erl097; Keck E, 2003, EMBO J, V22, P1058, DOI 10.1093/emboj/cdg097; Kim J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9r87; Koonjul PK, 2005, J EXP BOT, V56, P179, DOI 10.1093/jxb/eri018; Kumar A, 2010, J EXP BOT, V61, P2001, DOI 10.1093/jxb/erq065; Lavee S, 1999, SCI HORTIC-AMSTERDAM, V82, P181, DOI 10.1016/S0304-4238(99)00057-6; Lebon G, 2008, J EXP BOT, V59, P2565, DOI 10.1093/jxb/ern135; Li ZN, 2012, J PLANT RES, V125, P381, DOI 10.1007/s10265-011-0456-4; Lombardo N., 2006, Advances in Horticultural Science, V20, P247; Losada JM, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-1; Lu Y, 2004, PLANTA, V218, P466, DOI 10.1007/s00425-003-1127-z; Madey E, 2002, PLANTA, V214, P625, DOI 10.1007/s004250100649; Mahajan M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028315; Marin-Rodriguez MC, 2002, J EXP BOT, V53, P2115, DOI 10.1093/jxb/erf089; Matus JT, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-83; Mollet JC, 2000, PLANT CELL, V12, P1737, DOI 10.1105/tpc.12.9.1737; Mookerjee S, 2005, THEOR APPL GENET, V111, P1174, DOI 10.1007/s00122-005-0049-5; Munoz-Merida A, 2013, DNA RES, V20, P93, DOI 10.1093/dnares/dss036; Murase K, 2004, SCIENCE, V303, P1516, DOI 10.1126/science.1093586; Naghiloo S, 2013, AM J BOT, V100, P647, DOI 10.3732/ajb.1200171; Nakamura Y, 2009, PLANT PHYSIOL BIOCH, V47, P535, DOI 10.1016/j.plaphy.2008.12.018; Nakatsuka A, 2008, SCI HORTIC-AMSTERDAM, V118, P314, DOI 10.1016/j.scienta.2008.06.016; Nandy S, 2013, CELL DEV BIOL, V2, P117; Oliver SN, 2005, PLANT CELL ENVIRON, V28, P1534, DOI 10.1111/j.1365-3040.2005.01390.x; Ozgenturk NO, 2010, COMP FUNCT GENOM, DOI 10.1155/2010/757512; Park SY, 2000, PLANT CELL, V12, P151, DOI 10.1105/tpc.12.1.151; Piotrowski M, 2003, J BIOL CHEM, V278, P1708, DOI 10.1074/jbc.M205699200; Rapoport HF, 2012, ENVIRON EXP BOT, V77, P227, DOI 10.1016/j.envexpbot.2011.11.021; RASTOGI R, 1990, PLANT PHYSIOL, V93, P439, DOI 10.1104/pp.93.2.439; Reale L, 2006, SEX PLANT REPROD, V19, P151, DOI 10.1007/s00497-006-0032-6; Reale L, 2009, SEX PLANT REPROD, V22, P109, DOI 10.1007/s00497-009-0096-1; Reinhold H, 2011, PLANT CELL, V23, P1391, DOI 10.1105/tpc.110.081950; Ren G, 2007, PLANT SCI, V173, P621, DOI 10.1016/j.plantsci.2007.08.012; Rodrigo J, 2000, PHYSIOL PLANTARUM, V108, P35, DOI 10.1034/j.1399-3054.2000.108001035.x; Roitsch T, 2004, TRENDS PLANT SCI, V9, P606, DOI 10.1016/j.tplants.2004.10.009; Rosati A, 2011, SCI HORTIC-AMSTERDAM, V127, P515, DOI 10.1016/j.scienta.2010.12.002; Samuel MA, 2009, PLANT CELL, V21, P2655, DOI 10.1105/tpc.109.069740; Saumitou-Laprade P, 2010, SCIENCE, V327, P1648, DOI 10.1126/science.1186687; Serrano I, 2008, SEX PLANT REPROD, V21, P99, DOI 10.1007/s00497-008-0075-y; Serrano I, 2012, J EXP BOT, V63, P1479, DOI 10.1093/jxb/err392; Serrano I, 2010, PLANT CELL REP, V29, P561, DOI [10.1007/s00299-010-0845-5, 10.1007/s00299-010-0858-0]; Sgromo C, 2010, PLANT BIOSYST, V144, P733, DOI 10.1080/11263501003764343; Shan HY, 2009, MOL BIOL EVOL, V26, P2229, DOI 10.1093/molbev/msp129; Shi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047810; Sinha R, 2013, PLANT MOL BIOL, V82, P169, DOI 10.1007/s11103-013-0051-2; Stekel DJ, 2000, GENOME RES, V10, P2055, DOI 10.1101/gr.GR-1325RR; Suarez C, 2013, PLANTA, V237, P305, DOI 10.1007/s00425-012-1774-z; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang WH, 2002, PLANT CELL, V14, P2277, DOI 10.1105/tpc.003103; Tani E, 2009, PLANT PHYSIOL BIOCH, V47, P690, DOI 10.1016/j.plaphy.2009.03.013; Turktas M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059876; TWELL D, 1989, MOL GEN GENET, V217, P240, DOI 10.1007/BF02464887; Valdivia ER, 2009, SEX PLANT REPROD, V22, P141, DOI 10.1007/s00497-009-0099-y; van der Linden CG, 2002, J EXP BOT, V53, P1025, DOI 10.1093/jexbot/53.371.1025; Wan LL, 2011, PLANTA, V233, P309, DOI 10.1007/s00425-010-1301-z; Wang K, 2015, CARBOHYD POLYM, V127, P264, DOI 10.1016/j.carbpol.2015.03.081; Wang Y, 2013, PLANT CELL, V25, P1383, DOI 10.1105/tpc.112.108993; Wu SB, 2002, J HORTIC SCI BIOTECH, V77, P665, DOI 10.1080/14620316.2002.11511554; Wu YJ, 2001, PLANT PHYSIOL, V126, P222, DOI 10.1104/pp.126.1.222; Yang S, 2008, ANN BOT-LONDON, V102, P483, DOI 10.1093/aob/mcn116; Yanik H, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-10; Yeats TH, 2008, PROTEIN SCI, V17, P191, DOI 10.1110/ps.073300108; Zafra A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-36; Zanor MI, 2009, PLANT PHYSIOL, V150, P1204, DOI 10.1104/pp.109.136598; Zhang D, 2008, PLANT PHYSIOL, V148, P1368, DOI 10.1104/pp.108.124420; Zhang JS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-314; Zhao DQ, 2012, MOL BIOL REP, V39, P11263, DOI 10.1007/s11033-012-2036-7; Zienkiewicz K, 2010, J EXP BOT, V61, P1537, DOI 10.1093/jxb/erq022	119	31	31	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0152943	10.1371/journal.pone.0152943	http://dx.doi.org/10.1371/journal.pone.0152943			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077738	Green Published, gold, Green Submitted			2022-12-26	WOS:000374131700015
J	Correa, MA; Okamoto, CK; Goncalves-de-Andrade, RM; van den Berg, CW; Tambourgi, DV				Correa, Mara A.; Okamoto, Cinthya K.; Goncalves-de-Andrade, Rute M.; van den Berg, Carmen W.; Tambourgi, Denise V.			Sphingomyelinase D from Loxosceles laeta Venom Induces the Expression of MMP7 in Human Keratinocytes: Contribution to Dermonecrosis	PLOS ONE			English	Article							ACUTE LUNG INJURY; MATRIX METALLOPROTEINASES; CATALYTIC MECHANISM; MOLECULAR-CLONING; SPIDER VENOM; MATRILYSIN; TETRACYCLINES; PROTEOGLYCAN; DEGRADATION; GELATINASES	Envenomation by Loxosceles spider is characterized by the development of dermonecrosis. In previous studies, we have demonstrated that increased expression/secretion of matrix metalloproteinases 2 and 9, induced by Loxosceles intermedia venom Class 2 SMases D (the main toxin in the spider venom), contribute to the development of cutaneous loxoscelism. In the present study we show that the more potent venom containing the Class 1 SMase D from Loxosceles laeta, in addition to increasing the expression/secretion of MMP2 and MMP9, also stimulates the expression of MMP7 (Matrilysin-1), which was associated with keratinocyte cell death. Tetracycline, a matrix metalloproteinase inhibitor, prevented cell death and reduced MMPs expression. Considering that L. laeta venom is more potent at inducing dermonecrosis than L. intermedia venom, our results suggest that MMP7 may play an important role in the severity of dermonecrosis induced by L. laeta spider venom SMase D. In addition, the inhibition of MMPs by e.g. tetracyclines may be considered for the treatment of the cutaneous loxoscelism.	[Correa, Mara A.; Okamoto, Cinthya K.; Goncalves-de-Andrade, Rute M.; Tambourgi, Denise V.] Butantan Inst, Immunochem Lab, Sao Paulo, Brazil; [van den Berg, Carmen W.] Cardiff Univ, Sch Med, Inst Mol & Expt Med, Cardiff CF10 3AX, S Glam, Wales	Instituto Butantan; Cardiff University	Tambourgi, DV (corresponding author), Butantan Inst, Immunochem Lab, Sao Paulo, Brazil.	denise.tambourgi@butantan.gov.br	Tambourgi, Denise/H-7114-2016; Instituto Butantan, Center of Toxins Immune Response and Cell Signaling CeTICS/J-5731-2015	Tambourgi, Denise/0000-0003-1896-9074; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (FAPESP); CeTICS Program FAPESP [2013/07467-1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CeTICS Program FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by funds from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (FAPESP), CeTICS Program FAPESP (2013/07467-1) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINS JA, 1958, AM J TROP MED HYG, V7, P165, DOI 10.4269/ajtmh.1958.7.165; BUCHERL W, 1969, AM ZOOL, V9, P157; Burke B, 2004, IMMUNOBIOLOGY, V209, P51, DOI 10.1016/j.imbio.2004.04.005; de Oliveira KC, 2005, TOXICON, V45, P421, DOI 10.1016/j.toxicon.2004.08.022; Ferrara GID, 2009, TOXICON, V53, P743, DOI 10.1016/j.toxicon.2009.02.013; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; FORRESTER LJ, 1978, ARCH BIOCHEM BIOPHYS, V187, P355, DOI 10.1016/0003-9861(78)90046-2; FUTRELL JM, 1992, AM J MED SCI, V304, P261, DOI 10.1097/00000441-199210000-00008; Golub L M, 1998, Adv Dent Res, V12, P12; GOLUB LM, 1991, CRIT REV ORAL BIOL M, V2, P297, DOI 10.1177/10454411910020030201; Golub LM, 2011, PHARMACOL RES, V63, P99, DOI 10.1016/j.phrs.2010.10.003; Halpert I, 1996, P NATL ACAD SCI USA, V93, P9748, DOI 10.1073/pnas.93.18.9748; Hanemaaijer R, 1998, Adv Dent Res, V12, P114; Hartmann-Petersen S, 2009, BRIT J DERMATOL, V160, P1251, DOI 10.1111/j.1365-2133.2009.09031.x; Ii M, 2006, EXP BIOL MED, V231, P20; Jarvinen TM, 2007, BRIT J DERMATOL, V157, P970, DOI 10.1111/j.1365-2133.2007.08166.x; Kang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057658; KLEINER DE, 1994, ANAL BIOCHEM, V218, P325, DOI 10.1006/abio.1994.1186; KURPIEWSKI G, 1981, BIOCHIM BIOPHYS ACTA, V678, P467, DOI 10.1016/0304-4165(81)90128-8; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Mitsui H, 2014, J INVEST DERMATOL, V134, P1418, DOI 10.1038/jid.2013.494; Mochizuki S, 2004, BIOCHEM BIOPH RES CO, V315, P79, DOI 10.1016/j.bbrc.2004.01.022; Murakami MT, 2006, BIOCHEM BIOPH RES CO, V342, P323, DOI 10.1016/j.bbrc.2006.01.123; Murakami MT, 2005, J BIOL CHEM, V280, P13658, DOI 10.1074/jbc.M412437200; MURPHY G, 1991, BIOCHEM J, V277, P277, DOI 10.1042/bj2770277; Nieman GF, 2001, CURR MED CHEM, V8, P317, DOI 10.2174/0929867013373570; Paixao-Cavalcante D, 2007, J INVEST DERMATOL, V127, P1410, DOI 10.1038/sj.jid.5700688; Paixao-Cavalcante D, 2006, J INVEST DERMATOL, V126, P61, DOI 10.1038/sj.jid.5700049; Pedrosa MD, 2002, BIOCHEM BIOPH RES CO, V298, P638, DOI 10.1016/S0006-291X(02)02521-4; Pedroso A, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0561-4; Rivera IG, 2015, TOXINS, V7, P1457, DOI 10.3390/toxins7051457; Shapiro SD, 2003, NATURE, V421, P223, DOI 10.1038/421223a; SIRES UI, 1993, J BIOL CHEM, V268, P2069; Skiba B, 2005, PHOTODERMATOL PHOTO, V21, P173, DOI 10.1111/j.1600-0781.2005.00162.x; SMITH CW, 1970, LAB INVEST, V22, P90; Tambourgi DV, 2010, TOXICON, V56, P1113, DOI 10.1016/j.toxicon.2010.01.021; Tambourgi DV, 1998, BIOCHEM BIOPH RES CO, V251, P366, DOI 10.1006/bbrc.1998.9474; Tambourgi DV, 2005, J INVEST DERMATOL, V124, P725, DOI 10.1111/j.0022-202X.2005.23654.x; Tambourgi DV, 2004, MOL IMMUNOL, V41, P831, DOI 10.1016/j.molimm.2004.03.027; Vaalamo M, 1996, BRIT J DERMATOL, V135, P52; van Meeteren LA, 2004, J BIOL CHEM, V279, P10833, DOI 10.1074/jbc.C300563200; WASSERMAN GS, 1984, J TOXICOL-CLIN TOXIC, V21, P451, DOI 10.3109/15563658308990434; Wilson CL, 1996, INT J BIOCHEM CELL B, V28, P123, DOI 10.1016/1357-2725(95)00121-2	43	19	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153090	10.1371/journal.pone.0153090	http://dx.doi.org/10.1371/journal.pone.0153090			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078876	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000374131700022
J	Goldstein, JD; Burlion, A; Zaragoza, B; Sendeyo, K; Polansky, JK; Huehn, J; Piaggio, E; Salomon, BL; Marodon, G				Goldstein, Jeremie D.; Burlion, Aude; Zaragoza, Bruno; Sendeyo, Kelhia; Polansky, Julia K.; Huehn, Jochen; Piaggio, Eliane; Salomon, Benoit L.; Marodon, Gilles			Inhibition of the JAK/STAT Signaling Pathway in Regulatory T Cells Reveals a Very Dynamic Regulation of Foxp3 Expression	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXP3; GENE-EXPRESSION; IN-VIVO; LYMPHOPROLIFERATIVE DISORDER; CIS-ELEMENT; TREG; INTERLEUKIN-2; SCURFY; LOCUS; MOUSE	The IL-2/JAK3/STAT-5 signaling pathway is involved on the initiation and maintenance of the transcription factor Foxp3 in regulatory T cells (Treg) and has been associated with demethylation of the intronic Conserved Non Coding Sequence-2 (CNS2). However, the role of the JAK/STAT pathway in controlling Foxp3 in the short term has been poorly investigated. Using two different JAK/STAT pharmacological inhibitors, we observed a detectable loss of Foxp3 after 10 min. of treatment that affected 70% of the cells after one hour. Using cycloheximide, a general inhibitor of mRNA translation, we determined that Foxp3, but not CD25, has a high turnover in IL-2 stimulated Treg. This reduction was correlated with a rapid reduction of Foxp3 mRNA. This loss of Foxp3 was associated with a loss in STAT-5 binding to the CNS2, which however remains demethylated. Consequently, Foxp3 expression returns to normal level upon restoration of basal JAK/STAT signaling in vivo. Reduced expression of several genes defining Treg identity was also observed upon treatment. Thus, our results demonstrate that Foxp3 has a rapid turn over in Treg partly controlled at the transcriptional level by the JAK/STAT pathway.	[Goldstein, Jeremie D.; Burlion, Aude; Zaragoza, Bruno; Sendeyo, Kelhia; Salomon, Benoit L.; Marodon, Gilles] Univ Paris 06, Sorbonne Univ, UMR S CR7, CIMI,INSERM,U1135,CNRS,ERL 8255, Paris, France; [Polansky, Julia K.; Huehn, Jochen] Helmholtz Ctr Infect Res, Dept Expt Immunol, Braunschweig, Germany; [Piaggio, Eliane] Inst Curie, INSERM, U932, Paris, France; [Goldstein, Jeremie D.] Inst Biomed, Bellinzona, Switzerland; [Polansky, Julia K.] German Rheumatism Res Ctr, Expt Rheumatol, Charitepl 1, Berlin, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Helmholtz Association; Helmholtz-Center for Infection Research; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Deutsches Rheuma-Forschungszentrum (DRFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Marodon, G (corresponding author), Univ Paris 06, Sorbonne Univ, UMR S CR7, CIMI,INSERM,U1135,CNRS,ERL 8255, Paris, France.	gilles.marodon@upmc.fr	marodon, gilles/E-7202-2017; Polansky-Biskup, Julia K./J-5937-2017; Salomon, Benoit L/M-2421-2017; Piaggio, Eliane/E-5260-2016; Salomon, Benoit/AAP-5209-2021	marodon, gilles/0000-0003-4889-6785; Polansky-Biskup, Julia K./0000-0003-4727-2540; Salomon, Benoit L/0000-0001-9673-5578; Piaggio, Eliane/0000-0002-2455-8442; Salomon, Benoit/0000-0001-9673-5578	ANR (Agence Nationale de la Recherche); AFM (Association Francaise contre les Myopathies); ANRS (Agence Nationale pour la Recherche contre le SIDA); German Research Foundation [CRC738, CRC854]	ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); AFM (Association Francaise contre les Myopathies)(Association Francaise contre les Myopathies); ANRS (Agence Nationale pour la Recherche contre le SIDA); German Research Foundation(German Research Foundation (DFG))	This study was funded by grants from the ANR (Agence Nationale de la Recherche), the AFM (Association Francaise contre les Myopathies) and the ANRS (Agence Nationale pour la Recherche contre le SIDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors wish to thank Dr Sylvie Gregoire, Mr Claude Baillou and Mr Bruno Gouritin (UMR 7211, CIMI) for cell sorting, Beatrice Levacher (INSERM U959) for quantitative qPCR, Dr Nicolas Cagnard (INSERM U580 and Bioinformatics Platform, Faculty of Medicine Paris Descartes, Paris) for transcriptome analysis, Dr Thierry Rose (Pasteur Institute) for sharing reagents, Dr Antonio Bandeira (Institut Pasteur) for the Scurfy samples, and Dr Nicolas Petit, Dr Audrey Baeyens, Dr Gaelle Martin, Dr Yenkel Grinberg-Bleyer for their help in various aspects of the work. DNA methylation experiments were developed and performed by Udo Baron and Sven Olek at Epiontis GmbH. This study was funded by grants from the ANR (Agence Nationale de la Recherche to BLS and GM), the AFM (Association Francaise contre les Myopathies to GM), the ANRS (Agence Nationale pour la Recherche contre le SIDA to GM) and by the German Research Foundation (CRC738 and CRC854 to JH).	Bailey-Bucktrout SL, 2013, IMMUNITY, V39, P949, DOI 10.1016/j.immuni.2013.10.016; Baron U, 2007, EUR J IMMUNOL, V37, P2378, DOI 10.1002/eji.200737594; Bending D, 2014, J IMMUNOL, V193, P2699, DOI 10.4049/jimmunol.1400599; Brown GR, 2000, BIOORG MED CHEM LETT, V10, P575, DOI 10.1016/S0960-894X(00)00051-2; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Chen Q, 2011, J IMMUNOL, V186, P6329, DOI 10.4049/jimmunol.1100061; Chen ZJ, 2013, IMMUNITY, V39, P272, DOI 10.1016/j.immuni.2013.08.006; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Duarte JH, 2009, EUR J IMMUNOL, V39, P948, DOI 10.1002/eji.200839196; Feng YQ, 2014, CELL, V158, P749, DOI 10.1016/j.cell.2014.07.031; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Goldstein JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019038; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lee SM, 2008, BLOOD, V111, P3599, DOI 10.1182/blood-2007-09-115014; Li XD, 2014, CELL, V158, P734, DOI 10.1016/j.cell.2014.07.030; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Liu B, 2010, SCIENCE, V330, P521, DOI 10.1126/science.1193787; Liu ZD, 2015, NATURE, V528, P225, DOI 10.1038/nature16169; Luo XR, 2008, J IMMUNOL, V180, P2757, DOI 10.4049/jimmunol.180.5.2757; Mouly E, 2010, J EXP MED, V207, P2113, DOI 10.1084/jem.20092153; Murawski MR, 2006, ANN NY ACAD SCI, V1079, P198, DOI 10.1196/annals.1375.031; Ochs HD, 2001, NAT GENET, V27, P20, DOI DOI 10.1038/83713; Ogawa C, 2014, J IMMUNOL, V192, P475, DOI 10.4049/jimmunol.1301892; Ohkura N, 2013, IMMUNITY, V38, P414, DOI 10.1016/j.immuni.2013.03.002; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Pan F, 2009, SCIENCE, V325, P1142, DOI 10.1126/science.1176077; Passerini L, 2008, INT IMMUNOL, V20, P421, DOI 10.1093/intimm/dxn002; Pesu M, 2008, NATURE, V455, P246, DOI 10.1038/nature07210; Rouas R, 2009, EUR J IMMUNOL, V39, P1608, DOI 10.1002/eji.200838509; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Soper DM, 2007, EUR J IMMUNOL, V37, P1817, DOI 10.1002/eji.200737101; Stittrich AB, 2010, NAT IMMUNOL, V11, P1057, DOI 10.1038/ni.1945; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; van Loosdregt J, 2013, IMMUNITY, V39, P259, DOI 10.1016/j.immuni.2013.05.018; van Loosdregt J, 2010, BLOOD, V115, P965, DOI 10.1182/blood-2009-02-207118; Wang Y, 2008, J IMMUNOL, V180, P1565, DOI 10.4049/jimmunol.180.3.1565; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zorn E, 2006, BLOOD, V108, P1571, DOI 10.1182/blood-2006-02-004747	46	24	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153682	10.1371/journal.pone.0153682	http://dx.doi.org/10.1371/journal.pone.0153682			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077371	Green Submitted, Green Published, gold			2022-12-26	WOS:000374131700103
J	Korlimarla, A; Prabhu, JS; Remacle, J; Rajarajan, S; Raja, U; Anupama, CE; Srinath, BS; Manjunath, S; Gopinath, KS; Correa, M; Prasad, MSN; Sridhar, TS				Korlimarla, Aruna; Prabhu, Jyothi S.; Remacle, Jose; Rajarajan, Savitha; Raja, Uma; Anupama, C. E.; Srinath, B. S.; Manjunath, Suraj; Gopinath, K. S.; Correa, Marjorrie; Prasad, M. S. N.; Sridhar, T. S.			Identification of BRCA1 Deficiency Using Multi-Analyte Estimation of BRCA1 and Its Repressors in FFPE Tumor Samples from Patients with Triple Negative Breast Cancer	PLOS ONE			English	Article							OVARIAN-CANCER; MUTATION STATUS; PHENOTYPE; EXPRESSION; BRCANESS; PROTEIN; ID4; CHEMOTHERAPY; FEATURES; CELLS	Purpose Apart from germ-line BRCA1-mutated breast cancers, a significant proportion of women with sporadic triple negative breast cancer (TNBC) sub-type are known to harbour varying levels of BRCA1-dysfuction. There is currently no established diagnostic method to identify these patients. Methods The analysis was performed on 183 primary breast cancer tumor specimens from our longitudinal case-series archived as formalin-fixed-paraffin-embedded (FFPE) blocks comprising 71 TNBCs and 112 Hormone receptor positive HER2 negative (HR+HER2-) tumors. Transcript levels of BRCA1 and two of its repressors ID4 and microRNA182 were determined by TaqMan quantitative PCR. BRCA1 protein was detected immunohistochemically with the MS110 antibody. Results The representation of BRCA1 and its repressor ID4 as a ratio led to improved separation of TNBCs from HR(+)HER2-compared to either measure by itself. We then dichotomised the continuous distribution of each of the three measurements (Protein, MIRNA and transcript: repressor ratio) into categories of deficient (0) and adequate (1). A composite BRCA1 Deficiency Score (BDS) was computed by the addition of the score for all three measures. Samples deficient on 2 or more measures were deemed to be BRCA1 deficient; and 40% of all TNBCs met this criterion. Conclusion We propose here a simple multi-level assay of BRCA1 deficiency using the BRCA1:ID4 ratio as a critical parameter that can be performed on FFPE samples in clinical laboratories by the estimation of only 3 bio-markers. The ease of testing will hopefully encourage adoption and clinical validation.	[Korlimarla, Aruna; Prabhu, Jyothi S.; Remacle, Jose; Rajarajan, Savitha; Raja, Uma; Anupama, C. E.; Sridhar, T. S.] St Johns Res Inst, Div Mol Med, Bangalore, Karnataka, India; [Srinath, B. S.; Prasad, M. S. N.] Sri Shankara Canc Hosp & Res Ctr, Bangalore, Karnataka, India; [Manjunath, Suraj] St Johns Med Coll & Hosp, Dept Surg Oncol, Bangalore, Karnataka, India; [Gopinath, K. S.] Rangadore Mem Hosp, Bangalore, Karnataka, India; [Correa, Marjorrie] St Johns Med Coll & Hosp, Dept Pathol, Bangalore, Karnataka, India	St. John's National Academy of Health Sciences; St. John's Research Institute; St. John's National Academy of Health Sciences; St. John's Medical College; St. John's National Academy of Health Sciences; St. John's Medical College	Korlimarla, A (corresponding author), St Johns Res Inst, Div Mol Med, Bangalore, Karnataka, India.	aruna@sjri.res.in	Prabhu, Jyothi/AAW-6361-2020	Prabhu, Jyothi/0000-0002-2269-3704; Manjunath, Suraj/0000-0002-4760-7366	Nadathur Estates Pvt Ltd, Bangalore, India; Bagaria Education Trust, Bangalore, India	Nadathur Estates Pvt Ltd, Bangalore, India; Bagaria Education Trust, Bangalore, India	The authors gratefully acknowledge Nadathur Estates Pvt Ltd, Bangalore, India for their generous funding which enabled this reasearch. The patient follow-up was supported by The Bagaria Education Trust, Bangalore, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinyemiju T, 2015, BREAST CANCER RES TR, V153, P211, DOI 10.1007/s10549-015-3528-7; Beger C, 2001, P NATL ACAD SCI USA, V98, P130, DOI 10.1073/pnas.98.1.130; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; Cheang MCU, 2008, CLIN CANCER RES, V14, P1368, DOI 10.1158/1078-0432.CCR-07-1658; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Foulkes WD, 2004, CANCER RES, V64, P830, DOI 10.1158/0008-5472.CAN-03-2970; Gapstur SM, 1996, CANCER, V77, P1465, DOI 10.1002/(SICI)1097-0142(19960415)77:8<1465::AID-CNCR7>3.0.CO;2-B; Gazinska P, 2013, MODERN PATHOL, V26, P955, DOI 10.1038/modpathol.2012.244; Huo DZ, 2009, J CLIN ONCOL, V27, P4515, DOI 10.1200/JCO.2008.19.6873; Junankar S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7548; Konstantinopoulos PA, 2010, J CLIN ONCOL, V28, P3555, DOI 10.1200/JCO.2009.27.5719; Korlimarla A, 2014, J MOL DIAGN, V16, P253, DOI 10.1016/j.jmoldx.2013.11.003; Li S, 1998, J BIOL CHEM, V273, P6183, DOI 10.1074/jbc.273.11.6183; Lips EH, 2013, BRIT J CANCER, V108, P2172, DOI 10.1038/bjc.2013.144; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Milner R, 2013, VIRCHOWS ARCH, V462, P269, DOI 10.1007/s00428-012-1368-y; Moskwa P, 2011, MOL CELL, V41, P210, DOI 10.1016/j.molcel.2010.12.005; Prabhu JS, 2014, J CANCER, V5, P156, DOI 10.7150/jca.7668; Prat A, 2014, BREAST CANCER RES TR, V147, P185, DOI 10.1007/s10549-014-3056-x; Rakha EA, 2008, J CLIN ONCOL, V26, P2568, DOI 10.1200/JCO.2007.13.1748; Rakha EA, 2008, HUM PATHOL, V39, P857, DOI 10.1016/j.humpath.2007.10.011; Sikov WM, 2015, J CLIN ONCOL, V33, P13, DOI 10.1200/JCO.2014.57.0572; Spurdle AB, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0474-y; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Turner NC, 2007, ONCOGENE, V26, P2126, DOI 10.1038/sj.onc.1210014; Turner NC, 2006, ONCOGENE, V25, P5846, DOI 10.1038/sj.onc.1209876; Vollebergh MA, 2011, ANN ONCOL, V22, P1561, DOI 10.1093/annonc/mdq624; Welcsh PL, 2001, HUM MOL GENET, V10, P705, DOI 10.1093/hmg/10.7.705; Wen YH, 2012, BREAST CANCER RES TR, V135, P93, DOI 10.1007/s10549-012-2070-0	29	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153113	10.1371/journal.pone.0153113	http://dx.doi.org/10.1371/journal.pone.0153113			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077368	Green Published, Green Submitted, gold			2022-12-26	WOS:000374131700023
J	Lai, MJ; Chang, KC; Huang, SW; Luo, CH; Chiou, PY; Wu, CC; Lin, NT				Lai, Meng-Jiun; Chang, Kai-Chih; Huang, Shiuan-Wen; Luo, Cheng-Hung; Chiou, Pei-Yu; Wu, Chao-Chuan; Lin, Nien-Tsung			The Tail Associated Protein of Acinetobacter baumannii Phage phi AB6 Is the Host Specificity Determinant Possessing Exopolysaccharide Depolymerase Activity	PLOS ONE			English	Article							BACTERIOPHAGE-LAMBDA; RECEPTOR SPECIFICITY; GENOMIC ANALYSIS; BINDING; IDENTIFICATION; SITE; CELL; ADSORPTION; PATHOGEN; TP901-1	Acinetobacter baumannii is a non-fermenting, gram-negative bacterium. In recent years, the frequency of A. baumannii infections has continued to increase, and multidrug-resistant strains are emerging in hospitalized patients. Therefore, as therapeutic options become limited, the potential of phages as natural antimicrobial agents to control infections is worth reconsidering. In our previous study, we isolated ten virulent double-stranded DNA A. baumannii phages, phi AB1-9 and phi AB11, and found that each has a narrow host range. Many reports indicate that receptor-binding protein of phage mediates host recognition; however, understanding of the specific interactions between A. baumannii and phages remains very limited. In this study, host determinants of A. baumannii phages were investigated. Sequence comparison of phi AB6 and phi AB1 revealed high degrees of conservation among their genes except the tail fiber protein (ORF41 in phi AB1 and ORF40 in phi AB6). Furthermore, we found that ORF40(phi AB6) has polysaccharide depolymerase activity capable of hydrolyzing the A. baumannii exopolysaccharide and is a component of the phage tail apparatus determining host specificity. Thus, the lytic phages and their associated depolymerase not only have potential as alternative therapeutic agents for treating A. baumannii infections but also provide useful and highly specific tools for studying host strain exopolysaccharides and producing glycoconjugate vaccines.	[Lai, Meng-Jiun; Chang, Kai-Chih] Tzu Chi Univ, Dept Lab Med & Biotechnol, Hualien, Taiwan; [Huang, Shiuan-Wen; Lin, Nien-Tsung] Tzu Chi Univ, Sch Med, Master Program Microbiol & Immunol, Hualien, Taiwan; [Luo, Cheng-Hung; Chiou, Pei-Yu; Lin, Nien-Tsung] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Wu, Chao-Chuan] Buddhist Tzu Chi Gen Hosp, Dept Surg, Taipei, Taiwan	Tzu Chi University; Tzu Chi University; Tzu Chi University; Buddhist Tzu Chi General Hospital	Lin, NT (corresponding author), Tzu Chi Univ, Sch Med, Master Program Microbiol & Immunol, Hualien, Taiwan.; Lin, NT (corresponding author), Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan.	ntlin@mail.tcu.edu.tw			Buddhist Tzu Chi General Hospital [TCSP98-03-01]; Tzu Chi University [TCIRP98003-02]	Buddhist Tzu Chi General Hospital; Tzu Chi University	This work was supported by grants TCSP98-03-01 from Buddhist Tzu Chi General Hospital and TCIRP98003-02 from Tzu Chi University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres D, 2010, BIOCHEM SOC T, V38, P1386, DOI 10.1042/BST0381386; Ceyssens PJ, 2006, J BACTERIOL, V188, P6924, DOI 10.1128/JB.00831-06; Chang KC, 2011, GENOMICS, V97, P249, DOI 10.1016/j.ygeno.2011.01.002; Chatterjee S, 2012, VIRUSES-BASEL, V4, P3162, DOI 10.3390/v4113162; Duplessis M, 2001, MOL MICROBIOL, V41, P325, DOI 10.1046/j.1365-2958.2001.02521.x; Dupont K, 2004, APPL ENVIRON MICROB, V70, P5818, DOI 10.1128/AEM.70.10.5818-5824.2004; Glonti T, 2010, J APPL MICROBIOL, V108, P695, DOI 10.1111/j.1365-2672.2009.04469.x; HELLER KJ, 1984, VIROLOGY, V139, P11, DOI 10.1016/0042-6822(84)90325-8; Jakobsson E, 2007, BIOCHEM J, V405, P465, DOI 10.1042/BJ20070177; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Jones C, 2005, AN ACAD BRAS CIENC, V77, P293, DOI 10.1590/S0001-37652005000200009; Le S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068562; Lin NT, 2010, RES MICROBIOL, V161, P308, DOI 10.1016/j.resmic.2010.03.007; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Mahichi F, 2009, FEMS MICROBIOL LETT, V295, P211, DOI 10.1111/j.1574-6968.2009.01588.x; Montefour K, 2008, CRIT CARE NURSE, V28, P15; Muller JJ, 2008, STRUCTURE, V16, P766, DOI 10.1016/j.str.2008.01.019; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Rakhuba DV, 2010, POL J MICROBIOL, V59, P145, DOI 10.33073/pjm-2010-023; RIEDE I, 1985, EMBO J, V4, P2343, DOI 10.1002/j.1460-2075.1985.tb03936.x; Schwarzer D, 2012, J VIROL, V86, P10384, DOI 10.1128/JVI.00801-12; Smith NL, 2005, P NATL ACAD SCI USA, V102, P17652, DOI 10.1073/pnas.0504782102; Spinelli S, 2006, J BIOL CHEM, V281, P14256, DOI 10.1074/jbc.M600666200; Veesler D, 2012, P NATL ACAD SCI USA, V109, P8954, DOI 10.1073/pnas.1200966109; Verma V, 2009, CURR MICROBIOL, V59, P274, DOI 10.1007/s00284-009-9430-y; Wang J, 2000, J BACTERIOL, V182, P508, DOI 10.1128/JB.182.2.508-512.2000; Yan JL, 2014, BIODRUGS, V28, P265, DOI 10.1007/s40259-013-0081-y; Zivanovic Y, 2014, J VIROL, V88, P1162, DOI 10.1128/JVI.02262-13	28	39	41	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153361	10.1371/journal.pone.0153361	http://dx.doi.org/10.1371/journal.pone.0153361			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077375	gold, Green Submitted, Green Published			2022-12-26	WOS:000374131700043
J	Qi, Q; Yeung, TPC; Lee, TY; Bauman, G; Crukley, C; Morrison, L; Hoffman, L; Yartsev, S				Qi, Qi; Yeung, Timothy Pok Chi; Lee, Ting-Yim; Bauman, Glenn; Crukley, Cathie; Morrison, Laura; Hoffman, Lisa; Yartsev, Slav			Evaluation of CT Perfusion Biomarkers of Tumor Hypoxia	PLOS ONE			English	Article							MELANOMA XENOGRAFTS; GLIOMAS; CANCER; EXPRESSION	Background Tumor hypoxia is associated with treatment resistance to cancer therapies. Hypoxia can be investigated by immunohistopathologic methods but such procedure is invasive. A non-invasive method to interrogate tumor hypoxia is an attractive option as such method can provide information before, during, and after treatment for personalized therapies. Our study evaluated the correlations between computed tomography (CT) perfusion parameters and immunohistopathologic measurement of tumor hypoxia. Methods Wistar rats, 18 controls and 19 treated with stereotactic radiosurgery (SRS), implanted with the C6 glioma tumor were imaged using CT perfusion on average every five days to monitor tumor growth. A final CT perfusion scan and the brain were obtained on average 14 days (8-22 days) after tumor implantation. Tumor hypoxia was detected immunohistopathologically with pimonidazole. The tumor, necrotic, and pimonidazole-positive areas on histology samples were measured. Percent necrotic area and percent hypoxic areas were calculated. Tumor volume (TV), blood flow (BF), blood volume (BV), and permeability-surface area product (PS) were obtained from the CT perfusion studies. Correlations between CT perfusion parameters and histological parameters were assessed by Spearman's rho correlation. A Bonferroni-corrected P value < 0.05 was considered significant. Results BF and BV showed significant correlations with percent hypoxic area rho = -0.88, P < 0.001 and rho = -0.81, P < 0.001, respectively, for control animals and rho = -0.7, P < 0.001 and rho = -0.6, P = 0.003, respectively, for all animals, while TV and BV were correlated (rho = -0.64, P = 0.01 and rho = -0.43, P = 0.043, respectively) with percent necrotic area. PS was not correlated with either percent necrotic or percent hypoxic areas. Conclusions Percent hypoxic area provided significant correlations with BF and BV, suggesting that CT perfusion parameters are potential non-invasive imaging biomarkers of tumor hypoxia.	[Qi, Qi; Yeung, Timothy Pok Chi; Lee, Ting-Yim; Bauman, Glenn; Hoffman, Lisa; Yartsev, Slav] Univ Western Ontario, Dept Med Biophys, London, ON, Canada; [Yeung, Timothy Pok Chi; Lee, Ting-Yim; Crukley, Cathie] Univ Western Ontario, Robarts Res Inst, London, ON, Canada; [Lee, Ting-Yim; Morrison, Laura; Hoffman, Lisa] Lawson Hlth Res Inst, Lawson Imaging, London, ON, Canada; [Lee, Ting-Yim] Univ Western Ontario, Dept Med Imaging, London, ON, Canada; [Lee, Ting-Yim; Bauman, Glenn; Yartsev, Slav] Univ Western Ontario, Dept Oncol, London, ON, Canada; [Bauman, Glenn; Yartsev, Slav] London Reg Canc Program, London, ON, Canada; [Hoffman, Lisa] Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Yartsev, S (corresponding author), Univ Western Ontario, Dept Med Biophys, London, ON, Canada.; Yartsev, S (corresponding author), Univ Western Ontario, Dept Oncol, London, ON, Canada.; Yartsev, S (corresponding author), London Reg Canc Program, London, ON, Canada.	slav.yartsev@lhsc.on.ca	Hoffman, Lisa/B-5324-2015; Bauman, Glenn S/D-5986-2011; Yartsev, Slav/AAN-6279-2021; Lee, Ting-Yim/M-1721-2013	Bauman, Glenn/0000-0002-5279-7360				Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Boucher Y, 1997, BRIT J CANCER, V75, P829, DOI 10.1038/bjc.1997.148; Du LY, 2007, PHYS MED BIOL, V52, P7087, DOI 10.1088/0031-9155/52/23/021; Egeland TAM, 2006, MAGN RESON MED, V55, P874, DOI 10.1002/mrm.20852; Gulliksrud K, 2010, RADIOTHER ONCOL, V97, P233, DOI 10.1016/j.radonc.2010.09.005; Halle C, 2012, CANCER RES, V72, P5285, DOI 10.1158/0008-5472.CAN-12-1085; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Jankovic B, 2006, CYTOM PART B-CLIN CY, V70B, P45, DOI 10.1002/cyto.b.20086; Kondziolka D, 1996, J NEUROSURG, V84, P1033, DOI 10.3171/jns.1996.84.6.1033; Lehtio K, 2004, INT J RADIAT ONCOL, V59, P971, DOI 10.1016/j.ijrobp.2003.12.014; O'Connor JPB, 2016, CANCER RES, V76, P787, DOI 10.1158/0008-5472.CAN-15-2062; Overgaard J, 2011, RADIOTHER ONCOL, V100, P22, DOI 10.1016/j.radonc.2011.03.004; Ragnum HB, 2015, BRIT J CANCER, V112, P382, DOI 10.1038/bjc.2014.604; Rosenberger Christian, 2009, V466, P161, DOI 10.1007/978-1-59745-352-3_12; Schuuring J, 2005, INT J RADIAT ONCOL, V61, P529, DOI 10.1016/j.ijrobp.2004.09.063; Sun XL, 2011, MOL IMAGING BIOL, V13, P399, DOI 10.1007/s11307-010-0420-z; Tozer GM, 2005, NAT REV CANCER, V5, P423, DOI 10.1038/nrc1628; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Yeung TPC, 2015, EUR J RADIOL, V84, P2386, DOI 10.1016/j.ejrad.2015.02.012; Yeung TPC, 2015, J NEURO-ONCOL, V123, P93, DOI 10.1007/s11060-015-1766-5; Yeung TPC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109781	22	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153569	10.1371/journal.pone.0153569	http://dx.doi.org/10.1371/journal.pone.0153569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078858	Green Published, gold, Green Submitted			2022-12-26	WOS:000374131700081
J	Rosato, R; Testa, S; Bertolotto, A; Confalonieri, P; Patti, F; Lugaresi, A; Grasso, MG; Toscano, A; Giordano, A; Solari, A				Rosato, Rosalba; Testa, Silvia; Bertolotto, Antonio; Confalonieri, Paolo; Patti, Francesco; Lugaresi, Alessandra; Grasso, Maria Grazia; Toscano, Anna; Giordano, Andrea; Solari, Alessandra			Development of a Short Version of MSQOL-54 Using Factor Analysis and Item Response Theory	PLOS ONE			English	Article							QUALITY-OF-LIFE; CROSS-CULTURAL ADAPTATION; REPORTED OUTCOME MEASURES; MULTIPLE-SCLEROSIS; QUESTIONNAIRE MSQOL-54; RASCH ANALYSIS; VALIDATION; GUIDELINES; CRITERIA; IMPACT	Background The Multiple Sclerosis Quality of Life-54 (MSQOL-54, 52 items grouped in 12 subscales plus two single items) is the most used MS specific health related quality of life inventory. Objective To develop a shortened version of the MSQOL-54. Methods MSQOL-54 dimensionality and metric properties were investigated by confirmatory factor analysis (CFA) and Rasch modelling (Partial Credit Model, PCM) on MSQOL-54s completed by 473 MS patients. Their mean age was 41 years, 65% were women, and median Expanded Disability Status Scale (EDSS) score was 2.0 (range 0-9.5). Differential item functioning (DIF) was evaluated for gender, age and EDSS. Dimensionality of the resulting short version was assessed by exploratory factor analysis (EFA) and CFA. Cognitive debriefing of the short instrument (vs. the original) was then performed on 12 MS patients. Results CFA of MSQOL-54 subscales showed that the data fitted the overall model well. Two subscales (Role Limitations-Physical, Role Limitations-Emotional) did not fit the PCM, and were removed; two other subscales (Health Perceptions, Social Function) did not fit the model, but were retained as single items. Sexual Satisfaction (single-item subscale) was also removed. The resulting MSQOL-29 consisted of 25 items grouped in 7 subscales, plus 4 single items. PCM fit statistics were within the acceptability range for all MSQOL-29 items except one which had significant DIF by age. EFA and CFA indicated adequate fit to the original two-factor (Physical and Mental Health Composites) hypothesis. Cognitive debriefing confirmed that MSQOL-29 was acceptable and had lost no key items. Conclusions The proposed MSQOL-29 is 50% shorter than MSQOL-54, yet preserves key quality of life dimensions. Prospective validation on a large, independent MS patient sample is ongoing.	[Rosato, Rosalba; Testa, Silvia; Toscano, Anna] Univ Turin, Dept Psychol, Turin, Italy; [Bertolotto, Antonio] Univ Hosp San Luigi Gonzaga, Clin Neurobiol Unit, Reg Referral Multiple Sclerosis Ctr CReSM, Orbassano, Italy; [Confalonieri, Paolo] Fdn IRCCS Neurol Inst C Besta, Unit Neuroimmunol, Milan, Italy; [Patti, Francesco] Univ Hosp Policlin Vittorio Emanuele, MS Ctr, Neurol Clin, Catania, Italy; [Lugaresi, Alessandra] G dAnnunzio Univ Chieti Pescara, Dept Neurosci Imaging & Clin Sci, Chieti, Italy; [Grasso, Maria Grazia] IRCCS S Lucia Fdn, Multiple Sclerosis Unit, Rome, Italy; [Giordano, Andrea; Solari, Alessandra] Fdn IRCCS Neurol Inst C Besta, Unit Neuroepidemiol, Milan, Italy	University of Turin; Azienda Ospedaliero-Universitaria San Luigi Gonzaga; Azienda Ospedaliera Universitaria Policlinico Vittorio Emanuele Presidio Ferraotto; University of Catania; G d'Annunzio University of Chieti-Pescara; IRCCS Santa Lucia	Solari, A (corresponding author), Fdn IRCCS Neurol Inst C Besta, Unit Neuroepidemiol, Milan, Italy.	solari@istituto-besta.it	Solari, Alessandra/AAO-1741-2021; Bertolotto, Antonio/K-8346-2015; Testa, Silvia/AAH-2129-2021; Confalonieri, Paolo/AAS-8513-2021; Lugaresi, Alessandra/C-7743-2012; Giordano, Andrea/AAN-3738-2021	Solari, Alessandra/0000-0001-9930-7579; Bertolotto, Antonio/0000-0002-7052-1907; Testa, Silvia/0000-0002-8732-4790; Confalonieri, Paolo/0000-0001-8030-5725; Lugaresi, Alessandra/0000-0003-2902-5589; Giordano, Andrea/0000-0003-4466-9788; patti, francesco/0000-0002-6923-0846; ROSATO, Rosalba/0000-0002-4921-374X	Fondazione Italiana Sclerosi Multipla (FISM) [2013/R/20]	Fondazione Italiana Sclerosi Multipla (FISM)(Fondazione Italiana Sclerosi Multipla (FISM))	This study was supported by the Fondazione Italiana Sclerosi Multipla (FISM, www.aism.it, grant No. 2013/R/20 to RR). The funding sources had no role in study design, data collection, data analysis, data interpretation, or report writing.	Acquadro Catherine, 2003, Health Qual Life Outcomes, V1, P70, DOI 10.1186/1477-7525-1-70; Ashley L, 2014, J PSYCHOSOM RES, V77, P322, DOI 10.1016/j.jpsychores.2014.07.007; Bollen KA, 1989, STRUCTURAL EQUATIONS; Cella DF, 1996, NEUROLOGY, V47, P129, DOI 10.1212/WNL.47.1.129; Coons SJ, 2009, VALUE HEALTH, V12, P419, DOI 10.1111/j.1524-4733.2008.00470.x; Coste J, 1997, J CLIN EPIDEMIOL, V50, P247, DOI 10.1016/S0895-4356(96)00363-0; De Ayala R.J., 2009, THEORY PRACTICE ITEM; Denzin N., 2000, HDB QUALITATIVE RES; Duncan PW, 2003, ARCH PHYS MED REHAB, V84, P950, DOI 10.1016/S0003-9993(03)00035-2; Floyd FJ, 1995, PSYCHOL ASSESSMENT, V7, P286, DOI 10.1037/1040-3590.7.3.286; Fuvesi J, 2008, MULT SCLER J, V14, P391, DOI 10.1177/1352458507082724; Giordano A, 2009, J NEUROL NEUROSUR PS, V80, P1023, DOI 10.1136/jnnp.2008.171181; Goetz C, 2013, J CLIN EPIDEMIOL, V66, P710, DOI 10.1016/j.jclinepi.2012.12.015; Greenhalgh J, 2005, SOC SCI MED, V60, P833, DOI 10.1016/j.socscimed.2004.06.022; Hamel JF, 2015, STAT METHODS MED RES; Hays R. D., 1990, PSYCHOL ASSESSMENT J, V2, P22, DOI DOI 10.1037/1040-3590.2.1.22; Hu L T., 1995, STRUCTURAL EQUATION, P76, DOI DOI 10.1080/10705519909540118; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Idiman E, 2006, J NEUROL SCI, V240, P77, DOI 10.1016/j.jns.2005.09.009; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Hayas CL, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-29; Linacre JM, USERS GUIDE WINSTEPS; Lundstrom M, 2009, J CATARACT REFR SURG, V35, P504, DOI 10.1016/j.jcrs.2008.11.038; Massacesi L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113371; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Mitchell AJ, 2005, LANCET NEUROL, V4, P556, DOI 10.1016/S1474-4422(05)70166-6; Moore F, 2015, CAN J NEUROL SCI, V42, P55, DOI 10.1017/cjn.2014.128; Pekmezovic T, 2007, QUAL LIFE RES, V16, P1383, DOI 10.1007/s11136-007-9234-0; Polman Chris H, 2011, Ann Neurol, V69, P292, DOI 10.1002/ana.22366; POTENZA MT, 1995, APPL PSYCH MEAS, V19, P23, DOI 10.1177/014662169501900104; Rasch G., 1960, PROBABILISTIC MODELS; Satorra A, 2001, PSYCHOMETRIKA, V66, P507, DOI 10.1007/BF02296192; Smith AB, 2006, PSYCHO-ONCOLOGY, V15, P817, DOI 10.1002/pon.1015; Smith AB, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-33; Solari A, 2004, J NEUROL SCI, V222, P99, DOI 10.1016/j.jns.2004.04.027; Solari A, 1999, J NEUROL NEUROSUR PS, V67, P158, DOI 10.1136/jnnp.67.2.158; Solari Alessandra, 2005, Health Qual Life Outcomes, V3, P16, DOI 10.1186/1477-7525-3-16; Taft C, 2004, QUAL LIFE RES, V13, P251, DOI 10.1023/B:QURE.0000015290.76254.a5; Taoussi KE, 2012, REV NEUROL-FRANCE, V168, P444, DOI 10.1016/j.neurol.2011.10.011; VICKREY BG, 1995, QUAL LIFE RES, V4, P187, DOI 10.1007/BF02260859; Vickrey BG, 1997, J CLIN EPIDEMIOL, V50, P557, DOI 10.1016/S0895-4356(97)00001-2; Ware J.E., 2000, SF 36 HLTH SURVEY MA; Wright BD., 1994, RASCH MEASUREMENT T, V8, P370, DOI DOI 10.1177/01461672012710004; Wyrwich KW, 1999, J CLIN EPIDEMIOL, V52, P861, DOI 10.1016/S0895-4356(99)00071-2; Yamamoto Toshiyuki, 2004, Rinsho Shinkeigaku, V44, P417	46	21	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153466	10.1371/journal.pone.0153466	http://dx.doi.org/10.1371/journal.pone.0153466			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UH	27078146	Green Published, Green Submitted, gold			2022-12-26	WOS:000374131700058
J	Yang, Z; Qdaisat, A; Hu, ZH; Wagar, EA; Reyes-Gibby, C; Meng, QH; Yeung, SCJ				Yang, Zhi; Qdaisat, Aiham; Hu, Zhihuang; Wagar, Elizabeth A.; Reyes-Gibby, Cielito; Meng, Qing H.; Yeung, Sai-Ching J.			Cardiac Troponin Is a Predictor of Septic Shock Mortality in Cancer Patients in an Emergency Department: A Retrospective Cohort Study	PLOS ONE			English	Article							SURVIVING SEPSIS CAMPAIGN; CHRONIC HEALTH EVALUATION; ORGAN DYSFUNCTION; PROGNOSTIC VALUE; ACUTE PHYSIOLOGY; SEVERITY SCORE; PROCALCITONIN; ELEVATION; MEDS; INSULT/INFECTION	Background Septic shock may be associated with myocardial damage; however, the prognostic value of cardiac enzymes in cancer patients with septic shock is unknown. In this study, we evaluated the prognostic significance of cardiac enzymes in combination with established prognostic factors in predicting the 7-day mortality rate of patients with septic shock, and we constructed a new scoring system, Septic Oncologic Patients in Emergency Department (SOPED), which includes cardiac enzymes, to predict 7-day mortality rates. Methods and Findings We performed a retrospective cohort study of 375 adult cancer patients with septic shock who visited the emergency department of a comprehensive cancer center between 01/01/2004 and 12/31/2013. The 7-day and 28-day mortality rates were 19.7% and 37.6%, respectively. The creatine kinase myocardial band fraction and troponin-I were significantly higher in patients who died in <= 7 days and <= 28 days than in those who did not. In Cox regression models, troponin-I >0.05 ng/mL plus Predisposition, Infection, Response, and Organ Failure (PIRO2011) or Mortality in Emergency Department Sepsis (MEDS) score was a significant predictor of survival for <= 7 days. With our new SOPED scoring system, the receiver operating characteristic area under the curve was 0.836, higher than those for PIRO2011 and MEDS. Conclusions Troponin-I >0.05 ng/mL was an important predictor of short-term mortality (<= 7 days). The SOPED scoring system, which incorporated troponin-I, was more prognostically accurate than were other scores for 7-day mortality. Large multicenter studies are needed to verify our results and prospectively validate the prognostic performance of the SOPED score.	[Yang, Zhi; Qdaisat, Aiham; Hu, Zhihuang; Reyes-Gibby, Cielito; Yeung, Sai-Ching J.] Univ Texas MD Anderson Canc Ctr, Dept Emergency Med, 1515 Holcombe Blvd, Houston, TX 77030 USA; [Yang, Zhi] Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Dept Intens Care, 1 Panfu Rd, Guangzhou, Guangdong, Peoples R China; [Hu, Zhihuang] Sun Yat Sen Univ, Dept Med Oncol, Ctr Canc, 651 Dongfeng East Rd,West F16, Guangzhou 510060, Guangdong, Peoples R China; [Wagar, Elizabeth A.; Meng, Qing H.] Univ Texas MD Anderson Canc Ctr, Lab Med, 1515 Holcombe Blvd, Houston, TX 77030 USA; [Yeung, Sai-Ching J.] Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, 1515 Holcombe Blvd, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Guangzhou Medical University; Sun Yat Sen University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Yeung, SCJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Emergency Med, 1515 Holcombe Blvd, Houston, TX 77030 USA.; Meng, QH (corresponding author), Univ Texas MD Anderson Canc Ctr, Lab Med, 1515 Holcombe Blvd, Houston, TX 77030 USA.; Yeung, SCJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, 1515 Holcombe Blvd, Houston, TX 77030 USA.	qhmeng@mdanderson.org; syeung@mdanderson.org	Yeung, Sai-Ching/AAP-8079-2020; Meng, Q./GSI-6185-2022; Yeung, Sai-Ching/AAI-6178-2021; Qdaisat, Aiham/AAF-8763-2021; Qdaisat, Aiham/AHE-6024-2022	Yeung, Sai-Ching/0000-0001-5170-0822; Qdaisat, Aiham/0000-0003-0063-8461	Guangzhou First People's Hospital, Guangzhou Medical University; China Scholarship Council	Guangzhou First People's Hospital, Guangzhou Medical University; China Scholarship Council(China Scholarship Council)	Dr. Z Yang is supported by Guangzhou First People's Hospital, Guangzhou Medical University. Dr. ZH Hu is supported by China Scholarship Council.; Dr. Z. Yang is supported by Guangzhou First People's Hospital, Guangzhou Medical University. Dr. Z.H. Hu is supported by the China Scholarship Council. We thank Ms. Jeanie F. Woodruff and Ms. Ann M. Sutton of The University of Texas MD Anderson Cancer Center for editorial assistance.	[Anonymous], 2008, J CRIT CARE, DOI DOI 10.1016/j.jcrc.2007.08.003; Bessiere F, 2013, INTENS CARE MED, V39, P1181, DOI 10.1007/s00134-013-2902-3; Bion J, 2008, INTENS CARE MED, V34, P1163, DOI 10.1007/s00134-008-1090-z; Cardoso T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070806; Carpenter CR, 2009, J EMERG MED, V37, P319, DOI 10.1016/j.jemermed.2009.03.016; Chen YX, 2014, AM J EMERG MED, V32, P982, DOI 10.1016/j.ajem.2014.05.025; Cildir E, 2013, INTERN EMERG MED, V8, P255, DOI 10.1007/s11739-012-0890-x; Crowe Colleen A, 2010, J Emerg Trauma Shock, V3, P342, DOI 10.4103/0974-2700.70761; de Kruif MD, 2010, CRIT CARE MED, V38, P457, DOI 10.1097/CCM.0b013e3181b9ec33; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Favory R, 2006, CRIT CARE, V10, DOI 10.1186/cc4991; Furian T, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.06.017; Geier F, 2013, WIEN KLIN WOCHENSCHR, V125, P508, DOI 10.1007/s00508-013-0407-2; Howell MD, 2011, CRIT CARE MED, V39, P322, DOI 10.1097/CCM.0b013e3182037a8e; John J, 2010, J CRIT CARE, V25, P270, DOI 10.1016/j.jcrc.2009.12.001; Jones AE, 2008, AM J EMERG MED, V26, P689, DOI 10.1016/j.ajem.2008.01.009; Jones AE, 2014, ANN EMERG MED, V63, P35, DOI 10.1016/j.annemergmed.2013.08.004; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kuo SH, 2013, AM J EMERG MED, V31, P916, DOI 10.1016/j.ajem.2013.02.045; Landesberg G, 2014, CRIT CARE MED, V42, P790, DOI 10.1097/CCM.0000000000000107; Lee CC, 2008, SHOCK, V29, P322, DOI 10.1097/SHK.0b013e31815077ca; Levy Mitchell M, 2003, Intensive Care Med, V29, P530; Macdonald SPJ, 2014, ACAD EMERG MED, V21, P1257, DOI 10.1111/acem.12515; Marshall JC, 2003, CRIT CARE MED, V31, P1560, DOI 10.1097/01.CCM.0000065186.67848.3A; Mehta NJ, 2004, INT J CARDIOL, V95, P13, DOI 10.1016/j.ijcard.2003.02.005; Nguyen HB, 2012, J CRIT CARE, V27, P362, DOI 10.1016/j.jcrc.2011.08.013; Osborn TM, 2014, CRIT CARE MED, V42, P1969, DOI 10.1097/CCM.0000000000000416; Povoa P, 2011, CRIT CARE, V15, DOI 10.1186/cc10242; Rubulotta F, 2009, CRIT CARE MED, V37, P1329, DOI 10.1097/CCM.0b013e31819d5db1; Scott EC, 2008, ANAESTH INTENS CARE, V36, P51, DOI 10.1177/0310057X0803600109; Shapiro NI, 2003, CRIT CARE MED, V31, P670, DOI 10.1097/01.CCM.0000054867.01688.D1; Sheyin O, 2014, HEART LUNG, V44, P75, DOI 10.1016/j.hrtlng.2014.10.002; ter Avest E, 2013, INT J EMERG MED, V6, DOI 10.1186/1865-1380-6-9; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wang F, 2012, CRIT CARE, V16, DOI 10.1186/cc11331; Zhao YZ, 2013, AM J EMERG MED, V31, P1086, DOI 10.1016/j.ajem.2013.04.008; [No title captured]; [No title captured]	39	3	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153492	10.1371/journal.pone.0153492	http://dx.doi.org/10.1371/journal.pone.0153492			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077648	Green Published, gold, Green Submitted			2022-12-26	WOS:000374131700064
J	Freitas, AC; Wylezinska, M; Birch, MJ; Petersen, SE; Miquel, ME				Freitas, Andreia C.; Wylezinska, Marzena; Birch, Malcolm J.; Petersen, Steffen E.; Miquel, Marc E.			Comparison of Cartesian and Non-Cartesian Real-Time MRI Sequences at 1.5T to Assess Velar Motion and Velopharyngeal Closure during Speech	PLOS ONE			English	Article							VOCAL-TRACT; 3 T; VIDEOFLUOROSCOPY; RECONSTRUCTION; FLASH	Dynamic imaging of the vocal tract using real-time MRI has been an active and growing area of research, having demonstrated great potential to become routinely performed in the clinical evaluation of speech and swallowing disorders. Although many technical advances have been made in regards to acquisition and reconstruction methodologies, there is still no consensus in best practice protocols. This study aims to compare Cartesian and non-Cartesian real-time MRI sequences, regarding image quality and temporal resolution trade-off, for dynamic speech imaging. Five subjects were imaged at 1.5T, while performing normal phonation, in order to assess velar motion and velopharyngeal closure. Data was acquired using both Cartesian and non-Cartesian (spiral and radial) real-time sequences at five different spatial-temporal resolution sets, between 10 fps (1.7x1.7x10 mm(3)) and 25 fps (1.5x1.5x10 mm(3)). Only standard scanning resources provided by the MRI scanner manufacturer were used to ensure easy applicability to clinical evaluation and reproducibility. Data sets were evaluated by comparing measurements of the velar structure, dynamic contrast-to-noise ratio and image quality visual scoring. Results showed that for all proposed sequences, FLASH spiral acquisitions provided higher contrast-to-noise ratio, up to a 170.34% increase at 20 fps, than equivalent bSSFP Cartesian acquisitions for the same spatial-temporal resolution. At higher frame rates (22 and 25 fps), spiral protocols were optimal and provided higher CNR and visual scoring than equivalent radial protocols. Comparison of dynamic imaging at 10 and 22 fps for radial and spiral acquisitions revealed no significant difference in CNR performance, thus indicating that temporal resolution can be doubled without compromising spatial resolution (1.9x1.9 mm(2)) or CNR. In summary, this study suggests that the use of FLASH spiral protocols should be preferred over bSSFP Cartesian for the dynamic imaging of velopharyngeal closure, as it allows for an improvement in CNR and overall image quality without compromising spatial-temporal resolution.	[Freitas, Andreia C.; Wylezinska, Marzena; Petersen, Steffen E.; Miquel, Marc E.] Queen Mary Univ London, NIHR Cardiovasc Biomed Res Unit Barts, William Harvey Res Inst, London, England; [Freitas, Andreia C.; Birch, Malcolm J.; Miquel, Marc E.] Barts Hlth NHS Trust, Clin Phys, London, England; [Wylezinska, Marzena] UCL Inst Neurol, Neuroradiol Acad Unit, Dept Brain Repair & Rehabil, London, England	University of London; Queen Mary University London; Barts Health NHS Trust; University of London; University College London	Freitas, AC (corresponding author), Queen Mary Univ London, NIHR Cardiovasc Biomed Res Unit Barts, William Harvey Res Inst, London, England.; Freitas, AC (corresponding author), Barts Hlth NHS Trust, Clin Phys, London, England.	a.freitas@qmul.ac.uk	Petersen, Steffen E/A-8389-2011; Freitas, Andreia/AAK-3194-2020	Petersen, Steffen E/0000-0003-4622-5160; Freitas, Andreia/0000-0001-5340-1471	CLEFT [CLEFT-2013-1]; Institute of Physics and Engineering in Medicine (IPEM) Innovation and Research Award; National Institute for Health Research Cardiovascular Biomedical Research Unit at Barts	CLEFT; Institute of Physics and Engineering in Medicine (IPEM) Innovation and Research Award; National Institute for Health Research Cardiovascular Biomedical Research Unit at Barts	This project is funded by CLEFT (CLEFT-2013-1) and an Institute of Physics and Engineering in Medicine (IPEM) Innovation and Research Award for computer equipment. MEM is partly (20%) funded by the National Institute for Health Research Cardiovascular Biomedical Research Unit at Barts. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bae Y, 2011, CLEFT PALATE-CRAN J, V48, P695, DOI 10.1597/09-158; Beer AJ, 2004, J MAGN RESON IMAGING, V20, P791, DOI 10.1002/jmri.20197; Breyer T, 2009, MAGN RESON IMAGING, V27, P48, DOI 10.1016/j.mri.2008.05.018; Burdumy M, 2015, J MAGN RESON IMAGING, V42, P925, DOI 10.1002/jmri.24857; Delattre BMA, 2010, MAGN RESON IMAGING, V28, P862, DOI 10.1016/j.mri.2010.03.036; Demolin D, 2002, CR BIOL, V325, P547, DOI 10.1016/S1631-0691(02)01458-0; Drissi C, 2011, EUR RADIOL, V21, P1462, DOI 10.1007/s00330-011-2069-7; Echternach M, 2008, LOGOP PHONIATR VOCO, V33, P67, DOI 10.1080/14015430701875653; Echternach M, 2010, J VOICE, V24, P133, DOI 10.1016/j.jvoice.2008.06.004; Freitas AC, 2015, P ISMRM 23 SCI SESS, P655; Fu MJ, 2015, IEEE ENG MED BIO, P1568, DOI 10.1109/EMBC.2015.7318672; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Havstam C, 2005, BRIT J PLAST SURG, V58, P922, DOI 10.1016/j.bjps.2005.02.012; HENNINGSSON G, 1991, CLEFT PALATE-CRAN J, V28, P413, DOI 10.1597/1545-1569(1991)028<0413:CBMVAN>2.3.CO;2; HOLSINGER AE, 1990, MAGNET RESON MED, V14, P547, DOI 10.1002/mrm.1910140312; KUEHN DP, 1976, CLEFT PALATE J, V13, P88; Kulinna-Cosentini C, 2015, EUR RADIOL; Lingala SG, 2016, J MAGN RESON IMAGING, V43, P28, DOI 10.1002/jmri.24997; Lingala SG, 2016, MAGN RESON MED; Martins P., 2012, P IBERSPEECH 7 JORN, P231; Miquel ME, 2014, PEDIATR RADIOL, V73, P1820; Narayanan S, 2004, J ACOUST SOC AM, V115, P1771, DOI 10.1121/1.1652588; Niebergall A, 2013, MAGN RESON MED, V69, P477, DOI 10.1002/mrm.24276; Perry JL, 2011, CLEFT PALATE-CRAN J, V48, P123, DOI 10.1597/09-256; Proctor M, 2013, J ACOUST SOC AM, V133, P1043, DOI 10.1121/1.4773865; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Ramanarayanan V, 2013, J ACOUST SOC AM, V134, P510, DOI 10.1121/1.4807639; Sagar P, 2015, PEDIATR RADIOL, V45, P217, DOI 10.1007/s00247-014-3141-7; Scott AD, 2012, BRIT J RADIOL, V85, pE1083, DOI 10.1259/bjr/32938996; Scott AD, 2014, PHYS MEDICA, V30, P604, DOI 10.1016/j.ejmp.2014.05.001; Sell D, 2011, CLEFT PALATE SPEECH: ASSESSMENT AND INTERVENTION, P145; Silver AL, 2011, ARCH OTOLARYNGOL, V137, P258, DOI 10.1001/archoto.2011.11; Sutton BP, 2010, J MAGN RESON IMAGING, V32, P1228, DOI 10.1002/jmri.22369; Uecker M, 2008, MAGN RESON MED, V60, P674, DOI 10.1002/mrm.21691; Wylezinska M, 2015, P ISMRM 23 SCI SESS, P2302	35	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153322	10.1371/journal.pone.0153322	http://dx.doi.org/10.1371/journal.pone.0153322			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073905	gold, Green Published, Green Submitted			2022-12-26	WOS:000374131200074
J	Park, CH; Han, DS; Jeong, JY; Eun, CS; Yoo, KS; Jeon, YC; Sohn, JH				Park, Chan Hyuk; Han, Dong Soo; Jeong, Jae Yoon; Eun, Chang Soo; Yoo, Kyo-Sang; Jeon, Yong Cheol; Sohn, Joo Hyun			The Optimal Cut-Off Value of Neutrophil-to-Lymphocyte Ratio for Predicting Prognosis in Adult Patients with Henoch-Schonlein Purpura	PLOS ONE			English	Article								Background The development of gastrointestinal (GI) bleeding and end-stage renal disease (ESRD) can be a concern in the management of Henoch-Schonlein purpura (HSP). We aimed to evaluate whether the neutrophil-to-lymphocyte ratio (NLR) is associated with the prognosis of adult patients with HSP. Methods Clinical data including the NLR of adult patients with HSP were retrospectively analyzed. Patients were classified into three groups as follows: (a) simple recovery, (b) wax & wane without GI bleeding, and (c) development of GI bleeding. The optimal cut-off value was determined using a receiver operating characteristics curve and the Youden index. Results A total of 66 adult patients were enrolled. The NLR was higher in the GI bleeding group than in the simple recovery or wax & wane group (simple recovery vs. wax & wane vs. GI bleeding; median [IQR], 2.32 [1.61-3.11] vs. 3.18 [2.16-3.71] vs. 7.52 [4.91-10.23], P < 0.001). For the purpose of predicting simple recovery, the optimal cut-off value of NLR was 3.18, and the sensitivity and specificity were 74.1% and 75.0%,respectively. For predicting development of GI bleeding, the optimal cut-off value was 3.90 and the sensitivity and specificity were 87.5% and 88.6%, respectively. Conclusions The NLR is useful for predicting development of GI bleeding as well as simple recovery without symptom relapse. Two different cut-off values of NLR, 3.18 for predicting an easy HSPrecovery without symptom relapse and 3.90 for predicting GI bleeding can be used in adult patients with HSP.	[Park, Chan Hyuk; Han, Dong Soo; Jeong, Jae Yoon; Eun, Chang Soo; Yoo, Kyo-Sang; Jeon, Yong Cheol; Sohn, Joo Hyun] Hanyang Univ, Guri Hosp, Dept Internal Med, Coll Med, Guri, South Korea	Hanyang University	Han, DS (corresponding author), Hanyang Univ, Guri Hosp, Dept Internal Med, Coll Med, Guri, South Korea.	hands@hanyang.ac.kr	Park, Chan Hyuk/I-1794-2016; Han, Dong Soo/P-1753-2015; Han, Dong Soo/AHD-6285-2022	Park, Chan Hyuk/0000-0003-3824-3481; Han, Dong Soo/0000-0001-7103-3318; Jeong, Jae Yoon/0000-0002-3624-3261	Basic Science Research Program through National Research Foundation of Korea - Ministry of Education [NRF-2011-0010841]; Grant of Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A120176]	Basic Science Research Program through National Research Foundation of Korea - Ministry of Education; Grant of Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education (NRF-2011-0010841) and a Grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A120176) (DSH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education (NRF-2011-0010841) and a Grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A120176) (DSH).	Balta S, 2013, BRIT J CANCER, V109, P3125, DOI 10.1038/bjc.2013.598; Blanco R, 1997, ARTHRITIS RHEUM, V40, P859, DOI 10.1002/art.1780400513; Hong J, 2015, PEDIATR GASTROENTERO, V18, P39, DOI 10.5223/pghn.2015.18.1.39; Jauhola O, 2012, PEDIATR NEPHROL, V27, P933, DOI 10.1007/s00467-012-2106-z; JENNETTE JC, 1994, ARTHRITIS RHEUM-US, V37, P187, DOI 10.1002/art.1780370206; Kellerman PS, 2006, AM J KIDNEY DIS, V48, P1009, DOI 10.1053/j.ajkd.2006.08.031; Kwon JH, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0378-z; Lin Syh-Jae, 1998, Acta Paediatrica Sinica, V39, P94; Makay B, 2014, RHEUMATOL INT, V34, P1323, DOI 10.1007/s00296-014-2986-2; MARTINEZFRONTANILLA LA, 1984, J PEDIATR SURG, V19, P434, DOI 10.1016/S0022-3468(84)80269-9; MICHEL BA, 1992, J RHEUMATOL, V19, P721; MILLS JA, 1990, ARTHRITIS RHEUM, V33, P1114; Nam EJ, 2014, ENDOSCOPY, V46, P981, DOI 10.1055/s-0034-1377757; Pillebout E, 2002, J AM SOC NEPHROL, V13, P1271, DOI 10.1097/01.ASN.0000013883.99976.22; Proctor MJ, 2012, BRIT J CANCER, V107, P695, DOI 10.1038/bjc.2012.292; Rieu P, 1999, ANN MED INTERNE, V150, P151; Ronkainen J, 2006, J PEDIATR-US, V149, P241, DOI 10.1016/j.jpeds.2006.03.024; SAULSBURY FT, 1983, CLIN PEDIATR, V22, P185, DOI 10.1177/000992288302200305; TancredeBohin E, 1997, ARCH DERMATOL, V133, P438, DOI 10.1001/archderm.133.4.438; Turkmen K, 2012, RENAL FAILURE, V34, P155, DOI 10.3109/0886022X.2011.641514; Uppal SS, 2006, CLIN EXP RHEUMATOL, V24, pS26; Weiss PF, 2010, PEDIATRICS, V126, P674, DOI 10.1542/peds.2009-3348	22	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153238	10.1371/journal.pone.0153238	http://dx.doi.org/10.1371/journal.pone.0153238			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073884	gold, Green Published, Green Submitted			2022-12-26	WOS:000374131200064
J	Reid, N; Daly, RM; Winkler, EAH; Gardiner, PA; Eakin, EG; Owen, N; Dunstan, DW; Healy, GN				Reid, Natasha; Daly, Robin M.; Winkler, Elisabeth A. H.; Gardiner, Paul A.; Eakin, Elizabeth G.; Owen, Neville; Dunstan, David W.; Healy, Genevieve N.			Associations of Monitor-Assessed Activity with Performance-Based Physical Function	PLOS ONE			English	Article							MEASURED SEDENTARY TIME; MUSCLE STRENGTH; BODY-COMPOSITION; ELDERLY-WOMEN; LIFE-STYLE; FITNESS; RELIABILITY; VALIDITY; BEHAVIOR; HEALTH	The purpose of this study was to investigate the cross-sectional associations of monitorderived measures of sedentary time and physical activity with performance-based physical function in healthy Australian adults. Data from 602 participants (mean age 58.1 +/- 10.0 years; 58% female) from the 2011/12 wave of the Australian Diabetes, Obesity and Lifestyle (AusDiab3) study were analyzed. The thigh-worn activPAL3 T monitor (7-days continuous wear) was used to derive time during waking hours spent: sitting/reclining; standing; and, stepping (overall, and separately as light [<3 METs] and moderate-to-vigorous physical activity [ MVPA; >= 3 METs]), and number of sit-stand transitions. Associations of these (in hours/day, or 15 transitions/ day) with physical function measures (8ft Timed Up and Go [ TUG-8; log-transformed seconds] and Knee Extensor Strength [ KES; kg]) were tested via linear regression, adjusting for confounders. Interactions by sex and age-category (< 45; 45-54; 55-64; >= 65 years) were tested. In all participants, KES was significantly (p<0.05) associated with stepping and MVPA stepping only; none of the activity measures were associated with TUG-8. However, subgroup analysis revealed that in older adults (>= 65 years), TUG-8 was associated with stepping and MVPA stepping (both p<0.05). All associations with sitting time, standing, sit-stand transition and sex interactions were not statistically significant. In summary, sitting time was not significantly associated with impaired muscle strength or gait/mobility in Australian adults aged 36-80 years, but light-to moderate activity (stepping) was positively associated with muscle strength, and gait/mobility in older adults aged >= 65 years. The direction of causation is not known and remains important to investigate considering the high prevalence of both poor function and limited activity in older age.	[Reid, Natasha; Winkler, Elisabeth A. H.; Gardiner, Paul A.; Eakin, Elizabeth G.; Owen, Neville; Dunstan, David W.; Healy, Genevieve N.] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia; [Daly, Robin M.; Dunstan, David W.] Deakin Univ, Ctr Phys Act & Nutr Res, Melbourne, Vic, Australia; [Gardiner, Paul A.] Univ Queensland, Mater Res Inst, South Brisbane, Australia; [Owen, Neville; Dunstan, David W.; Healy, Genevieve N.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Owen, Neville] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Owen, Neville; Dunstan, David W.] Monash Univ, Alfred Hosp, Dept Med, Melbourne, Vic 3181, Australia; [Dunstan, David W.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3181, Australia; [Dunstan, David W.] Univ Western Australia, Sch Sport Sci Exercise & Hlth, Perth, WA 6009, Australia; [Healy, Genevieve N.] Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Melbourne, Vic, Australia; [Healy, Genevieve N.] Curtin Univ, Sch Physiotherapy, Perth, WA 6845, Australia; [Gardiner, Paul A.] Univ Queensland, Sch Med, Ctr Res Geriatr Med, Brisbane, Qld, Australia	University of Queensland; Deakin University; Mater Research; University of Queensland; Baker Heart and Diabetes Institute; University of Melbourne; Florey Institute of Neuroscience & Mental Health; Monash University; Monash University; University of Western Australia; Australian Catholic University; Curtin University; University of Queensland	Reid, N (corresponding author), Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia.	n.reid@uq.edu.au	Reid, Natasha/I-2092-2019; Gardiner, Paul A/F-2751-2010; Winkler, Elisabeth/AAD-7153-2022; Dunstan, David Wayne/E-8473-2010; Daly, Robin/AAN-2353-2020; Healy, Genevieve/A-7408-2008; Eakin, Elizabeth G/F-7918-2010	Reid, Natasha/0000-0002-8528-9741; Gardiner, Paul A/0000-0002-8072-2673; Winkler, Elisabeth/0000-0003-1452-6102; Dunstan, David Wayne/0000-0003-2629-9568; Daly, Robin/0000-0002-9897-1598; Healy, Genevieve/0000-0001-7093-7892; Eakin, Elizabeth G/0000-0002-8835-9995	National Health and Medical Research Council of Australia (NHMRC Program) [APP566940]; Centre of Research Excellence grant [APP1057608, APP1000986]; Senior Principal Research Fellowship [1003960]; Dementia Research Development Fellowship [1103311]; Australian Research Council Research Fellowship [FT100100918]; Heart Foundation Postdoctoral Fellowship [PH 12B 7054]; Victorian Government's OIS Program; Australian Federal Government (Australian Postgraduate Award Scholarship); Victorian Government's OIS Programme; National Health and Medical Research Council (NHMRC) [233200]; Australian Government Department of Health and Ageing; Abbott Australasia Pty Ltd; Alphapharm Pty Ltd; AstraZeneca, Bristol-Myers Squibb; City Health Centre-Diabetes Service-Canberra; Department of Health and Community Services-Northern Territory; Department of Health and Human ServicesTasmania; Department of Health-New South Wales; Department of Health-Western Australia; Department of Health-South Australia; Department of Human Services-Victoria; Diabetes Australia; Diabetes Australia Northern Territory; Eli Lilly Australia; Estate of the Late Edward Wilson; GlaxoSmithKline; Jack Brockhoff Foundation; Janssen-Cilag; Kidney Health Australia; Marian FH Flack Trust; Menzies Research Institute; Merck Sharp Dohme; Novartis Pharmaceuticals; Novo Nordisk Pharmaceuticals; Pfizer Pty Ltd; Pratt Foundation; Queensland Health; Roche Diagnostics Australia; Royal Prince Alfred Hospital, Sydney; Sanofi Aventis; Sanofi Synthelabo	National Health and Medical Research Council of Australia (NHMRC Program)(National Health and Medical Research Council (NHMRC) of Australia); Centre of Research Excellence grant; Senior Principal Research Fellowship; Dementia Research Development Fellowship; Australian Research Council Research Fellowship(Australian Research Council); Heart Foundation Postdoctoral Fellowship; Victorian Government's OIS Program; Australian Federal Government (Australian Postgraduate Award Scholarship); Victorian Government's OIS Programme; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Abbott Australasia Pty Ltd(Abbott Laboratories); Alphapharm Pty Ltd; AstraZeneca, Bristol-Myers Squibb(Bristol-Myers SquibbAstraZeneca); City Health Centre-Diabetes Service-Canberra; Department of Health and Community Services-Northern Territory; Department of Health and Human ServicesTasmania; Department of Health-New South Wales; Department of Health-Western Australia; Department of Health-South Australia; Department of Human Services-Victoria; Diabetes Australia; Diabetes Australia Northern Territory; Eli Lilly Australia(Eli Lilly); Estate of the Late Edward Wilson; GlaxoSmithKline(GlaxoSmithKline); Jack Brockhoff Foundation; Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Kidney Health Australia; Marian FH Flack Trust; Menzies Research Institute; Merck Sharp Dohme(Merck & Company); Novartis Pharmaceuticals(Novartis); Novo Nordisk Pharmaceuticals(Novo Nordisk); Pfizer Pty Ltd(Pfizer); Pratt Foundation; Queensland Health; Roche Diagnostics Australia; Royal Prince Alfred Hospital, Sydney(University of Sydney); Sanofi Aventis(Sanofi-Aventis); Sanofi Synthelabo	This work was supported by: National Health and Medical Research Council of Australia (NHMRC Program Grant #APP566940 to NO; Centre of Research Excellence grant #APP1057608 to GNH, NO, DWD, EGE with funding support provided to EAHW; Senior Principal Research Fellowship #1003960 to NO; funding support to PAG from Centre of Research Excellence grant #APP1000986; Dementia Research Development Fellowship #1103311 to PG); Australian Research Council Research Fellowship (#FT100100918 to DWD); Heart Foundation Postdoctoral Fellowship (#PH 12B 7054 to GNH); the Victorian Government's OIS Program (to NO and DWD); and by the Australian Federal Government (Australian Postgraduate Award Scholarship to NR). The Australian Diabetes, Obesity and Lifestyle study (AusDiab), co-coordinated by the Baker IDI Heart and Diabetes Institute, was supported in part by the Victorian Government's OIS Programme, and gratefully acknowledges the generous support given by National Health and Medical Research Council (NHMRC grant 233200), Australian Government Department of Health and Ageing. Abbott Australasia Pty Ltd, Alphapharm Pty Ltd, AstraZeneca, Bristol-Myers Squibb, City Health Centre-Diabetes Service-Canberra, Department of Health and Community Services-Northern Territory, Department of Health and Human ServicesTasmania, Department of Health-New South Wales, Department of Health-Western Australia, Department of Health-South Australia, Department of Human Services-Victoria, Diabetes Australia, Diabetes Australia Northern Territory, Eli Lilly Australia, Estate of the Late Edward Wilson, GlaxoSmithKline, Jack Brockhoff Foundation, Janssen-Cilag, Kidney Health Australia, Marian & FH Flack Trust, Menzies Research Institute, Merck Sharp & Dohme, Novartis Pharmaceuticals, Novo Nordisk Pharmaceuticals, Pfizer Pty Ltd, Pratt Foundation, Queensland Health, Roche Diagnostics Australia, Royal Prince Alfred Hospital, Sydney, Sanofi Aventis and Sanofi Synthelabo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; [Anonymous], 2014, AUSTR PHYS ACT SED B; Aoyagi Y, 2009, GERONTOLOGY, V55, P523, DOI 10.1159/000236326; Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; Bohannon RW, 2001, AM J PHYS MED REHAB, V80, P13, DOI 10.1097/00002060-200101000-00004; Buman MP, 2010, AM J EPIDEMIOL, V172, P1155, DOI 10.1093/aje/kwq249; Chastin SFM, 2012, AGE AGEING, V41, P111, DOI 10.1093/ageing/afr075; Cohen J.E., 1988, STAT POWER ANAL BEHA; Daly RM, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-71; Dunstan DW, 2002, DIABETES RES CLIN PR, V57, P119, DOI 10.1016/S0168-8227(02)00025-6; Edwardson CL, 2016, J SPORT HLTH SCI; Ervin RB, 2006, PREVALENCE FUNCTIONA; Gianoudis J, 2015, OSTEOPOROSIS INT, V26, P571, DOI 10.1007/s00198-014-2895-y; Granat MH, 2012, PHYSIOL MEAS, V33, P1785, DOI 10.1088/0967-3334/33/11/1785; Grant PM, 2006, BRIT J SPORT MED, V40, P992, DOI 10.1136/bjsm.2006.030262; Grant PM, 2008, J AGING PHYS ACTIV, V16, P201, DOI 10.1123/japa.16.2.201; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Ikezoe T, 2013, ARCH GERONTOL GERIAT, V57, P221, DOI 10.1016/j.archger.2013.04.004; Ireland P, 1994, Asia Pac J Clin Nutr, V3, P19; JENKINSON C, 1994, QUAL LIFE RES, V3, P7, DOI 10.1007/BF00647843; Kozey-Keadle S, 2011, MED SCI SPORT EXER, V43, P1561, DOI 10.1249/MSS.0b013e31820ce174; Lyden K, 2015, MED SCI SPORTS EXERC; Lyden K, 2012, MED SCI SPORT EXER, V44, P2243, DOI 10.1249/MSS.0b013e318260c477; Paterson DH, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-38; Pijnappels M, 2008, EUR J APPL PHYSIOL, V102, P585, DOI 10.1007/s00421-007-0613-6; Pillay JD, 2014, J PHYS ACT HEALTH, V11, P10, DOI 10.1123/jpah.2011-0288; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rikli RE, 1999, J AGING PHYS ACTIV, V7, P162, DOI 10.1123/japa.7.2.162; Rikli RE, 1999, J AGING PHYS ACTIV, V7, P129, DOI 10.1123/japa.7.2.129; Ruiz JR, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a439; Ryan CG, 2006, BRIT J SPORT MED, V40, P779, DOI 10.1136/bjsm.2006.027276; Santos DA, 2012, EXP GERONTOL, V47, P908, DOI 10.1016/j.exger.2012.07.011; Sardinha LB, 2015, J GERONTOL A-BIOL, V70, P119, DOI 10.1093/gerona/glu193; Sole G, 2007, ARCH PHYS MED REHAB, V88, P626, DOI 10.1016/j.apmr.2007.02.006; Spittaels H, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-149; Stevens Judy A., 2000, Morbidity and Mortality Weekly Report, V49, P3; Tanamas SK., 2013, AUSDIAB 2012 AUSTR D; Tikkanen O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052228; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Vallance JK, 2014, CANCER-AM CANCER SOC, V120, P2919, DOI 10.1002/cncr.28779; Visser M, 2005, J GERONTOL A-BIOL, V60, P324, DOI 10.1093/gerona/60.3.324; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Yoshida D, 2010, J PHYSIOL ANTHROPOL, V29, P211, DOI 10.2114/jpa2.29.211	43	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153398	10.1371/journal.pone.0153398	http://dx.doi.org/10.1371/journal.pone.0153398			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UC	27073888	Green Published, gold			2022-12-26	WOS:000374131200082
J	Tape, KD; Gustine, DD; Ruess, RW; Adams, LG; Clark, JA				Tape, Ken D.; Gustine, David D.; Ruess, Roger W.; Adams, Layne G.; Clark, Jason A.			Range Expansion of Moose in Arctic Alaska Linked to Warming and Increased Shrub Habitat	PLOS ONE			English	Article							PERMAFROST DEGRADATION; NORTHERN ALASKA; CLIMATE; VEGETATION; TEMPERATURE; STRATEGIES; FOREST; HETEROGENEITY; EXTINCTION; MEGAFAUNA	Twentieth century warming has increased vegetation productivity and shrub cover across northern tundra and treeline regions, but effects on terrestrial wildlife have not been demonstrated on a comparable scale. During this period, Alaskan moose (Alces alces gigas) extended their range from the boreal forest into tundra riparian shrub habitat; similar extensions have been observed in Canada (A. a. andersoni) and Eurasia (A. a. alces). Northern moose distribution is thought to be limited by forage availability above the snow in late winter, so the observed increase in shrub habitat could be causing the northward moose establishment, but a previous hypothesis suggested that hunting cessation triggered moose establishment. Here, we use recent changes in shrub cover and empirical relationships between shrub height and growing season temperature to estimate available moose habitat in Arctic Alaska c. 1860. We estimate that riparian shrubs were approximately 1.1 m tall c. 1860, greatly reducing the available forage above the snowpack, compared to 2 m tall in 2009. We believe that increases in riparian shrub habitat after 1860 allowed moose to colonize tundra regions of Alaska hundreds of kilometers north and west of previous distribution limits. The northern shift in the distribution of moose, like that of snowshoe hares, has been in response to the spread of their shrub habitat in the Arctic, but at the same time, herbivores have likely had pronounced impacts on the structure and function of these shrub communities. These northward range shifts are a bellwether for other boreal species and their associated predators.	[Tape, Ken D.; Clark, Jason A.] Univ Alaska, Inst Northern Engn, Fairbanks, AK 99701 USA; [Gustine, David D.; Adams, Layne G.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK USA; [Ruess, Roger W.] Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99775 USA	University of Alaska System; University of Alaska Fairbanks; United States Department of the Interior; United States Geological Survey; University of Alaska System; University of Alaska Fairbanks	Tape, KD (corresponding author), Univ Alaska, Inst Northern Engn, Fairbanks, AK 99701 USA.	kdtape@alaska.edu		Clark, Jason/0000-0002-4810-5261	EPSCoR NSF award [OIA-1208927]; U.S. Geological Survey's Changing Arctic Ecosystem Initiative within the Wildlife Program of the Ecosystem Mission Area; Division Of Environmental Biology [1026415] Funding Source: National Science Foundation	EPSCoR NSF award; U.S. Geological Survey's Changing Arctic Ecosystem Initiative within the Wildlife Program of the Ecosystem Mission Area; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	KDT was supported by EPSCoR NSF award #OIA-1208927. DDG and LGA received support from U.S. Geological Survey's Changing Arctic Ecosystem Initiative within the Wildlife Program of the Ecosystem Mission Area. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anchukaitis KJ, 2013, J CLIMATE, V26, P3001, DOI 10.1175/JCLI-D-11-00139.1; Beck PSA, 2011, ARCT ANTARCT ALP RES, V43, P355, DOI 10.1657/1938-4246-43.3.355; Bieniek PA, 2014, J CLIMATE, V27, P2800, DOI 10.1175/JCLI-D-13-00342.1; Boer AH, 2007, ECOLOGY MANAGEMENT N, P337; Boertje RD, 1996, J WILDLIFE MANAGE, V60, P474, DOI 10.2307/3802065; Bowyer RT, 1999, J MAMMAL, V80, P1070, DOI 10.2307/1383161; Brower CD, 1942, FIFTY YEARS BELOW ZE; Brown R, 2010, JOURNAL OF GEOPHYSIC, P115; BRYANT JP, 1985, ECOLOGY, V66, P1564, DOI 10.2307/1938018; Burch ES, 2012, CARIBOU HERDS OF NORTHWEST ALASKA, 1850-2000, P1; Carroll G, 2011, UNIT 26A MOOSE MANAG, P643; Christie KS, 2015, BIOSCIENCE, V65, P1123, DOI 10.1093/biosci/biv137; COADY JW, 1980, CAN FIELD NAT, V94, P61; Cook JA, 2009, RECENT MAMMALS OF AL; Cooper A, 2015, SCIENCE, V349, P602, DOI 10.1126/science.aac4315; den Herder M, 2008, BASIC APPL ECOL, V9, P324, DOI 10.1016/j.baae.2007.03.005; Frost GV, 2014, GLOBAL CHANGE BIOL, V20, P1264, DOI 10.1111/gcb.12406; Glaser FS, 1950, PREDATOR AND GAME SU; Gorn T, 2010, UNIT 22 MOOSE MANAGE, P522; Guthrie RD, 2006, NATURE, V441, P207, DOI 10.1038/nature04604; Hall ER, 1956, MAMMALS OF NORTHERN; HALL ES, 1973, J MAMMAL, V54, P294, DOI 10.2307/1378902; Hollingsworth TN, 2010, CAN J FOREST RES, V40, P1273, DOI 10.1139/X10-094; Jorgenson MT, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/035017; Jorgenson MT, 2001, CLIMATIC CHANGE, V48, P551, DOI 10.1023/A:1005667424292; Kantner S, 2015, SWALLOWED BY THE GRE; Karns Patrick D., 1998, P125; Kaufman DS, 2009, SCIENCE, V325, P1236, DOI 10.1126/science.1173983; Kay CE, 1997, ALCES N AM, V33, P141; KELSALL J P, 1974, Naturaliste Canadien (Quebec), V101, P117; Kielland K., 2006, ALASKAS CHANGING BOR, P211; Kitti H, 2009, POLAR BIOL, V32, P253, DOI 10.1007/s00300-008-0526-9; Lachenbruch A.H, 1959, US GEOL SURV B C, P73; Leffingwell EdK, 1919, THE CANNING RIVER RE; LeResche R.E., 1974, Naturaliste Canadien, V101, P143; Lowry TS, 2013, RECONSTRUCTION OF A, P1; Makarova Olga A., 2009, Alces, V45, P13; Mann DH, 2015, P NATL ACAD SCI USA, V112, P14301, DOI 10.1073/pnas.1516573112; Mann DH, 2013, QUATERNARY SCI REV, V70, P91, DOI 10.1016/j.quascirev.2013.03.015; Mech LD, 1966, THE WOLVES OF ISLE R; Moskvitina NS, 2011, CONTEMP PROBL ECOL+, V4, P444, DOI 10.1134/S1995425511040163; Mould E, 1977, P N AM MOOS C WORKSH, V13, P144; Murray DL, 2006, WILDLIFE MONOGR, P1, DOI 10.2193/0084-0173(2006)166[1:PNDACI]2.0.CO;2; Myers-Smith IH, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045509; Naito AT, 2015, ECOL EVOL, V5, P87, DOI 10.1002/ece3.1341; Naito AT, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045506; Nelson RK, 1982, TRACKS IN THE WILDLA; Nossov DR, 2011, J ECOL, V99, P621, DOI 10.1111/j.1365-2745.2010.01792.x; Pajunen A, 2008, POLAR BIOL, V31, P1233, DOI 10.1007/s00300-008-0462-8; Pomeroy JW, 2006, HYDROL PROCESS, V20, P923, DOI 10.1002/hyp.6124; Rausch R., 1951, Arctic Montreal, V4, P146; Rearden J, 1998, ALASKAS WOLF MAN THE; Rearden J, 1993, SHADOWS ON THE KOYUK; Rearden J, 2006, WHITE ALASKAN TALES; Ruess RW, 2013, ECOL MONOGR, V83, P177, DOI 10.1890/12-0782.1; Sable EG, 1961, ARCTIC, V14, P176; Schickhoff U, 2002, PHYTOCOENOLOGIA, V32, P145, DOI 10.1127/0340-269X/2002/0032-0145; SNAP, 2015, SCENARIOS NETWORK FO; STEPHENS PW, 1984, HOLARCTIC ECOL, V7, P239; Sturm M, 2001, NATURE, V411, P546, DOI 10.1038/35079180; Sturm M, 2004, ANN GLACIOL-SER, V38, P253, DOI 10.3189/172756404781815112; Swanson DK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138387; Tape K, 2006, GLOBAL CHANGE BIOL, V12, P686, DOI 10.1111/j.1365-2486.2006.01128.x; Tape KD, 2010, THE CHANGING ARCTIC; Tape KD, 2016, GLOBAL CHANGE BIOL, V22, P208, DOI 10.1111/gcb.13058; Tape KD, 2012, ECOSYSTEMS, V15, P711, DOI 10.1007/s10021-012-9540-4; Telfer E.S., 1984, P145; Turetsky MR, 2006, GEOPHYSICAL RESEARCH, V33; WALKER DA, 1987, CAN J BOT, V65, P988, DOI 10.1139/b87-136; Walker DA, 1985, VEGETATION AND ENVIR; Walsh JE, 2008, J CLIMATE, V21, P6156, DOI 10.1175/2008JCLI2163.1; White KS, 2001, CAN J ZOOL, V79, P2055, DOI 10.1139/cjz-79-11-2055; Xu L, 2013, NAT CLIM CHANGE, V3, P581, DOI [10.1038/nclimate1836, 10.1038/NCLIMATE1836]; YESNER DR, 1989, ARCTIC, V42, P97	74	64	71	0	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152636	10.1371/journal.pone.0152636	http://dx.doi.org/10.1371/journal.pone.0152636			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074023	gold, Green Published			2022-12-26	WOS:000374131200031
J	Weiderhold, KN; Fadri-Moskwik, M; Pan, J; Nishino, M; Chuang, C; Deeraksa, A; Lin, SH; Yu-Lee, LY				Weiderhold, Kimberly N.; Fadri-Moskwik, Maria; Pan, Jing; Nishino, Michiya; Chuang, Carol; Deeraksa, Arpaporn; Lin, Sue-Hwa; Yu-Lee, Li-Yuan			Dynamic Phosphorylation of NudC by Aurora B in Cytokinesis	PLOS ONE			English	Article							CHROMOSOMAL PASSENGER COMPLEX; NUCLEAR-MOVEMENT PROTEIN; MEDIATED ABSCISSION CHECKPOINT; SPINDLE MIDZONE FORMATION; MIGRATION GENE NUDC; CELL-DIVISION; ASPERGILLUS-NIDULANS; NEURONAL MIGRATION; CHAPERONE ACTIVITY; MOLECULAR-CLONING	Nuclear distribution protein C (NudC) is a mitotic regulator that plays a role in cytokinesis. However, how NudC is regulated during cytokinesis remains unclear. Here, we show that NudC is phosphorylated by Aurora B, a kinase critical for cell abscission. NudC is co-localized with Aurora B at the midbody and co-immunoprecipitated with Aurora B in mitosis. Inhibition of Aurora B by ZM447439 reduced NudC phosphorylation, suggesting that NudC is an Aurora B substrate in vivo. We identified T40 on NudC as an Aurora B phosphorylation site. NudC depletion resulted in cytokinesis failure with a dramatic elongation of the intercellular bridge between daughter cells, sustained Aurora B activity at the midbody, and reduced cell abscission. These cytokinetic defects can be rescued by the ectopic expression of wild-type NudC. Reconstitution with T40A phospho-defective NudC was found to rescue the cytokinesis defect. In contrast, reconstitution with the T40D phospho-mimetic NudC was inefficient in supporting the completion of cytokinesis. These results suggest that that dynamic phosphorylation of NudC by Aurora B regulates cytokinesis.	[Weiderhold, Kimberly N.; Nishino, Michiya; Yu-Lee, Li-Yuan] Baylor Coll Med, Program Integrat Mol & Biomed Sci, Houston, TX 77030 USA; [Fadri-Moskwik, Maria; Pan, Jing; Deeraksa, Arpaporn; Yu-Lee, Li-Yuan] Baylor Coll Med, Dept Med, Sect Allergy Immunol & Rheumatol, Houston, TX 77030 USA; [Chuang, Carol; Yu-Lee, Li-Yuan] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Lin, Sue-Hwa] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; [Nishino, Michiya; Yu-Lee, Li-Yuan] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Yu-Lee, LY (corresponding author), Baylor Coll Med, Program Integrat Mol & Biomed Sci, Houston, TX 77030 USA.; Yu-Lee, LY (corresponding author), Baylor Coll Med, Dept Med, Sect Allergy Immunol & Rheumatol, Houston, TX 77030 USA.; Yu-Lee, LY (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.; Yu-Lee, LY (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA.	yulee@bcm.edu		Nishino, Michiya/0000-0003-4692-4981	NIH [NRSA F31-GM084695, IRACDA K12-GM084897, T32-AI07495, T32-DK07696, P50-CA140388, RO1-CA174798, RO1-DK53176, U19-AI071130]; Cancer Prevention and Research Institute of Texas [CPRIT RP110327, CPRIT RP150282, CPRIT RP150179]; Dan L. Duncan Cancer Center; Alkek Award in Experimental Therapeutics; Biology of Inflammation Award; NATIONAL CANCER INSTITUTE [R01CA174798, P50CA140388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI071130, T32AI007495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053176, T32DK007696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM084897, F31GM084695] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; Dan L. Duncan Cancer Center; Alkek Award in Experimental Therapeutics; Biology of Inflammation Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH fellowships (NRSA F31-GM084695 to K.N.W.; IRACDA K12-GM084897 to M.F.-M.), NIH training grants (T32-AI07495 for M.F.-M. and A.D.; T32-DK07696 for A.D. and C.C.), and grants from the NIH (P50-CA140388, RO1-CA174798 to S.-H.L.; RO1-DK53176, U19-AI071130 to L.-Y.Y.-L.), Cancer Prevention and Research Institute of Texas (CPRIT RP110327, CPRIT RP150282 to S.-H.L.; CPRIT RP150179 to S.-H.L. and L.-Y.Y.-L.), Dan L. Duncan Cancer Center (L.-Y.Y.-L. and S.-H.L.), Alkek Award in Experimental Therapeutics (L.-Y.Y.-L. and S.-H.L.) and Biology of Inflammation Award (L.-Y.Y.-L.).	Aumais JP, 2003, J CELL SCI, V116, P1991, DOI 10.1242/jcs.00412; Aumais JP, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-24-j0002.2001; Bastos RN, 2013, J CELL BIOL, V202, P605, DOI 10.1083/jcb.201301094; Bieling P, 2010, CELL, V142, P420, DOI 10.1016/j.cell.2010.06.033; BRENNER S, 1981, J CELL BIOL, V91, P95, DOI 10.1083/jcb.91.1.95; Cappello S, 2011, DEV BIOL, V357, P326, DOI 10.1016/j.ydbio.2011.07.001; Carlton JG, 2012, SCIENCE, V336, P220, DOI 10.1126/science.1217180; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Chuang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073841; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Cunniff J, 1997, MECH DEVELOP, V66, P55, DOI 10.1016/S0925-4773(97)00085-3; D'Avino PP, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00221; Dawe AL, 2001, DEV GENES EVOL, V211, P434, DOI 10.1007/s004270100176; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Fadri-Moskwik M, 2012, FASEB J, V26, P4057, DOI 10.1096/fj.12-206656; Faircloth LM, 2009, CELL STRESS CHAPERON, V14, P95, DOI 10.1007/s12192-008-0061-1; Fededa JP, 2012, NAT CELL BIOL, V14, P440, DOI 10.1038/ncb2482; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Garcia-Ranea JA, 2002, FEBS LETT, V529, P162, DOI 10.1016/S0014-5793(02)03321-5; Glotzer M, 2009, NAT REV MOL CELL BIO, V10, P9, DOI 10.1038/nrm2609; Gocke CD, 2000, HISTOCHEM CELL BIOL, V114, P293; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; Gruneberg U, 2004, J CELL BIOL, V166, P167, DOI 10.1083/jcb.200403084; Guizetti J, 2012, TRENDS CELL BIOL, V22, P133, DOI 10.1016/j.tcb.2011.11.007; Guse A, 2005, CURR BIOL, V15, P778, DOI 10.1016/j.cub.2005.03.041; Hoffman DB, 2001, MOL BIOL CELL, V12, P1995, DOI 10.1091/mbc.12.7.1995; Hu CK, 2012, MOL BIOL CELL, V23, P1024, DOI 10.1091/mbc.E11-08-0721; Hu CK, 2011, CURR BIOL, V21, P815, DOI 10.1016/j.cub.2011.04.019; Kitagawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064826; Kitzen JJEM, 2010, CRIT REV ONCOL HEMAT, V73, P99, DOI 10.1016/j.critrevonc.2009.03.009; Knowlton AL, 2006, CURR BIOL, V16, P1705, DOI 10.1016/j.cub.2006.07.057; Kurasawa Y, 2004, EMBO J, V23, P3237, DOI 10.1038/sj.emboj.7600347; Kurasawa Y, 2010, MOL BIOL CELL, V21, P1188, DOI 10.1091/mbc.E09-11-0950; Lampson MA, 2011, TRENDS CELL BIOL, V21, P133, DOI 10.1016/j.tcb.2010.10.007; Lee SH, 2015, FRONT CELL DEV BIOL, V3, P1; Lewellyn L, 2011, J CELL BIOL, V193, P155, DOI 10.1083/jcb.201008138; Li XY, 2004, J BIOL CHEM, V279, P47201, DOI 10.1074/jbc.M403029200; Lin SH, 2004, ONCOGENE, V23, P2499, DOI 10.1038/sj.onc.1207343; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; MASTRONARDE DN, 1993, J CELL BIOL, V123, P1475, DOI 10.1083/jcb.123.6.1475; Matsumoto N, 1999, HUM GENET, V104, P498, DOI 10.1007/s004390050994; Matuliene J, 2004, MOL BIOL CELL, V15, P3083, DOI 10.1091/mbc.E03-12-0888; McCleland ML, 2004, CURR BIOL, V14, P131, DOI 10.1016/j.cub.2003.12.058; Mendoza M, 2009, NAT CELL BIOL, V11, P477, DOI 10.1038/ncb1855; Mierzwa B, 2014, DEV CELL, V31, P525, DOI 10.1016/j.devcel.2014.11.006; Miller BA, 1999, EXP HEMATOL, V27, P742, DOI 10.1016/S0301-472X(98)00074-5; Moreau N, 2001, INT J DEV BIOL, V45, P839; Morris NR, 2000, J CELL BIOL, V148, P1097, DOI 10.1083/jcb.148.6.1097; Morris SM, 1998, EXP CELL RES, V238, P23, DOI 10.1006/excr.1997.3822; Morris SM, 1997, MOL ENDOCRINOL, V11, P229, DOI 10.1210/me.11.2.229; Morris SM, 1998, CURR BIOL, V8, P603, DOI 10.1016/S0960-9822(98)70232-5; Morrow CJ, 2005, J CELL SCI, V118, P3639, DOI 10.1242/jcs.02487; MULLINS JM, 1982, J CELL BIOL, V94, P654, DOI 10.1083/jcb.94.3.654; Nakajima Y, 2011, J CELL BIOL, V194, P137, DOI 10.1083/jcb.201009137; Neef R, 2006, CURR BIOL, V16, P301, DOI 10.1016/j.cub.2005.12.030; Neto H, 2011, J CELL SCI, V124, P3199, DOI 10.1242/jcs.083949; Nishino M, 2006, CURR BIOL, V16, P1414, DOI 10.1016/j.cub.2006.05.052; Ohashi S, 2006, ONCOGENE, V25, P7691, DOI 10.1038/sj.onc.1209754; OSMANI AH, 1990, J CELL BIOL, V111, P543, DOI 10.1083/jcb.111.2.543; Ozlu N, 2010, MOL CELL PROTEOMICS, V9, P336, DOI 10.1074/mcp.M900308-MCP200; Rosasco-Nitcher SE, 2008, SCIENCE, V319, P469, DOI 10.1126/science.1148980; Rozelle DK, 2011, J CELL BIOL, V193, P285, DOI 10.1083/jcb.201011002; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Salimian KJ, 2011, CURR BIOL, V21, P1158, DOI 10.1016/j.cub.2011.06.015; Schiel JA, 2013, CURR OPIN CELL BIOL, V25, P92, DOI 10.1016/j.ceb.2012.10.012; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; Slattery SD, 2008, CELL CYCLE, V7, P787, DOI 10.4161/cc.7.6.5563; Steigemann P, 2009, TRENDS CELL BIOL, V19, P606, DOI 10.1016/j.tcb.2009.07.008; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Suzuki SO, 2007, ACTA NEUROPATHOL, V113, P591, DOI 10.1007/s00401-006-0180-7; Taipale M, 2014, CELL, V158, P434, DOI 10.1016/j.cell.2014.05.039; Tan L, 2011, P NATL ACAD SCI USA, V108, P16675, DOI 10.1073/pnas.1106748108; Toba S, 2012, NEUROPATHOLOGY, V32, P432, DOI 10.1111/j.1440-1789.2012.01301.x; Uehara R, 2013, J CELL BIOL, V202, P623, DOI 10.1083/jcb.201302123; van der Waal MS, 2012, EXP CELL RES, V318, P1407, DOI 10.1016/j.yexcr.2012.03.015; Wang EX, 2011, J CELL BIOL, V194, P538, DOI 10.1083/jcb.201103044; Wei MX, 2006, J CELL BIOCHEM, V98, P429, DOI 10.1002/jcb.20803; Yamada M, 2010, EMBO J, V29, P517, DOI 10.1038/emboj.2009.378; Yasui Y, 2004, J BIOL CHEM, V279, P12997, DOI 10.1074/jbc.M311128200; Zheng MY, 2011, J MOL BIOL, V409, P722, DOI 10.1016/j.jmb.2011.04.018; Zhou T, 2003, DEV CELL, V5, P127, DOI 10.1016/S1534-5807(03)00186-2; Zhou TH, 2006, P NATL ACAD SCI USA, V103, P9039, DOI 10.1073/pnas.0602916103; Zhu CJ, 2005, P NATL ACAD SCI USA, V102, P343, DOI 10.1073/pnas.0408438102; Zhu CJ, 2006, P NATL ACAD SCI USA, V103, P6196, DOI 10.1073/pnas.0506926103; Zhu XJ, 2010, J BIOL CHEM, V285, P29903, DOI 10.1074/jbc.M110.105494	87	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153455	10.1371/journal.pone.0153455	http://dx.doi.org/10.1371/journal.pone.0153455			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074040	Green Submitted, gold, Green Published			2022-12-26	WOS:000374131200096
J	Lu, C; Thoeni, C; Connor, A; Kawabe, H; Gallinger, S; Rotin, D				Lu, C.; Thoeni, C.; Connor, A.; Kawabe, H.; Gallinger, S.; Rotin, D.			Intestinal knockout of Nedd4 enhances growth of Apc(min) tumors	ONCOGENE			English	Article							UBIQUITIN LIGASE NEDD4-1; COLORECTAL-CANCER; BETA-CATENIN; STEM-CELLS; C2 DOMAIN; EXPRESSION; PROTEIN; MOTIF; PHOSPHORYLATION; DEGRADATION	Nedd4 (Nedd4-1) is an E3 ubiquitin ligase that belongs to the HECT family and comprises a C2-WW(n)-HECT domain architecture. Although it has been reported to regulate growth factor receptors and cellular signaling, its role in cancer development has been controversial, with some studies proposing that it promotes cancer while others suggest it inhibits tumor growth. Here, we tested the effect of Nedd4 on intestinal tumor formation and growth using Nedd4-knockout mice (Nedd4 floxed (fl) mice crossed to villin-Cre mice). Although we find that knockout of Nedd4 on its own does not cause tumor growth, its knockout in the context of Apc(+/min)-derived colorectal tumors leads to augmentation of tumor growth, suggesting that Nedd4 normally suppresses intestinal WNT signaling and growth of colonic tumors. WNT signaling microarray, immunoblotting and immunohistochemistry analyses of tumors derived from the Villin-Cre; Nedd4(fl/fl); Apc(+/min) colons demonstrated elevated expression of the WNT upstream effectors LEF1 (full length) and YY1 in these tumors relative to control (Apc(+/min) alone) tumors. Together, these results suggest that Nedd4 suppresses colonic WNT signaling and tumor growth, at least in part, by suppressing the transcription factors LEF1 and YY1.	[Lu, C.; Thoeni, C.; Rotin, D.] Hosp Sick Children, Cell Biol Program, PGCRL 19-9715,686 Bay St, Toronto, ON M5G 0A4, Canada; [Lu, C.; Thoeni, C.; Rotin, D.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Connor, A.; Gallinger, S.] Univ Toronto, Univ Hlth Network, Mt Sinai Hosp, Toronto, ON, Canada; [Kawabe, H.] Max Planck Inst Expt Med, Dept Mol Neurobiol, Gottingen, Germany	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University Health Network Toronto; Max Planck Society	Rotin, D (corresponding author), Hosp Sick Children, Cell Biol Program, PGCRL 19-9715,686 Bay St, Toronto, ON M5G 0A4, Canada.	drotin@sickkids.ca	Gallinger, Steven/E-4575-2013; Kawabe, Hiroshi/U-7325-2018	Kawabe, Hiroshi/0000-0001-5650-8696; Connor, Ashton/0000-0002-7596-3771	Canadian Institute of Health Research [MOP-130422]; German Research Foundation [SPP1365/KA3423/1-1]; Fritz Thyssen Foundation; Canada Research Chair form the Canadian Foundation for Innovation (CFI)	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); German Research Foundation(German Research Foundation (DFG)); Fritz Thyssen Foundation; Canada Research Chair form the Canadian Foundation for Innovation (CFI)	We would like to thank Kazuko Hay for technical support and Dr Sylvie Robine for the Vil-Cre<SUP>ERT2</SUP> mice. This grant was supported by the Canadian Institute of Health Research (MOP-130422, to DR), the German Research Foundation SPP1365/KA3423/1-1 (to HK) and the Fritz Thyssen Foundation (to HK). DR is a recipient of a Canada Research Chair form the Canadian Foundation for Innovation (CFI).	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Adegboyega PA, 2004, CLIN CANCER RES, V10, P5870, DOI 10.1158/1078-0432.CCR-0431-03; Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; Barker N, 2010, CELL STEM CELL, V7, P656, DOI 10.1016/j.stem.2010.11.016; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Buller NVJA, 2015, GASTROENTEROLOGY, V148, P170, DOI 10.1053/j.gastro.2014.10.006; Cadigan KM, 2012, COLD SPRING HARB PER, V4, P6; Chinnappan D, 2009, INT J ONCOL, V34, P1417, DOI 10.3892/ijo_00000270; Eide PW, 2013, CELL SIGNAL, V25, P12, DOI 10.1016/j.cellsig.2012.08.012; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; Fouladkou F, 2010, J BIOL CHEM, V285, P6770, DOI 10.1074/jbc.M109.082347; Harty RN, 2000, P NATL ACAD SCI USA, V97, P13871, DOI 10.1073/pnas.250277297; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Hsia HE, 2014, P NATL ACAD SCI USA, V111, P13205, DOI 10.1073/pnas.1400737111; Huang Z, 2015, ONCOGENE, V34, P1105, DOI 10.1038/onc.2014.56; Ing B, 2007, MOL CELL BIOL, V27, P481, DOI 10.1128/MCB.00463-06; Isella C, 2015, NAT GENET, V47, P312, DOI 10.1038/ng.3224; Kanelis V, 2001, NAT STRUCT BIOL, V8, P407, DOI 10.1038/87562; Kanelis V, 2006, STRUCTURE, V14, P543, DOI 10.1016/j.str.2005.11.018; Katz M, 2002, TRAFFIC, V3, P740, DOI 10.1034/j.1600-0854.2002.31006.x; Kawabe H, 2010, NEURON, V65, P358, DOI 10.1016/j.neuron.2010.01.007; Kim SS, 2008, APMIS, V116, P779, DOI 10.1111/j.1600-0463.2008.00999.x; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Leykauf K, 2006, J CELL SCI, V119, P3634, DOI 10.1242/jcs.03149; Liu Y, 2009, DEV BIOL, V330, P153, DOI 10.1016/j.ydbio.2009.03.023; Lucero OM, 2010, CURR ONCOL REP, V12, P314, DOI 10.1007/s11912-010-0114-3; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; March HN, 2011, NAT GENET, V43, P1202, DOI 10.1038/ng.990; Martin ES, 2007, CANCER RES, V67, P10736, DOI 10.1158/0008-5472.CAN-07-2742; MOOLENBEEK C, 1981, LAB ANIM, V15, P57, DOI 10.1258/002367781780958577; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Murdaca J, 2004, J BIOL CHEM, V279, P26754, DOI 10.1074/jbc.M311802200; Najdi Rani, 2011, J Carcinog, V10, P5, DOI 10.4103/1477-3163.78111; Owens BMJ, 2013, MUCOSAL IMMUNOL, V6, P224, DOI 10.1038/mi.2012.125; Pali-Scholl I, 2008, EXP TOXICOL PATHOL, V60, P337, DOI 10.1016/j.etp.2008.03.004; Persaud A, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005290; Persaud A, 2011, EMBO J, V30, P3259, DOI 10.1038/emboj.2011.234; Persaud A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.85; Pinchuk I V, 2010, Curr Gastroenterol Rep, V12, P310, DOI 10.1007/s11894-010-0135-y; Plant PJ, 1997, J BIOL CHEM, V272, P32329, DOI 10.1074/jbc.272.51.32329; Porfiri E, 1997, ONCOGENE, V15, P2833, DOI 10.1038/sj.onc.1201462; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Tanksley JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081514; van Noort M, 2002, DEV BIOL, V244, P1, DOI 10.1006/dbio.2001.0566; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Wang J, 2010, J BIOL CHEM, V285, P12279, DOI 10.1074/jbc.M109.086405; Wang WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076596; Wend P, 2010, SEMIN CELL DEV BIOL, V21, P855, DOI 10.1016/j.semcdb.2010.09.004; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Yang BL, 2008, NAT IMMUNOL, V9, P1356, DOI 10.1038/ni.1670; Yokoyama NN, 2010, NUCLEIC ACIDS RES, V38, P6375, DOI 10.1093/nar/gkq492; Zaravinos A, 2010, CELL CYCLE, V9, P512, DOI 10.4161/cc.9.3.10588; Zhou PH, 2014, NATURE, V506, P52, DOI 10.1038/nature12988	55	16	17	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 10	2016	35	45					5839	5849		10.1038/onc.2016.125	http://dx.doi.org/10.1038/onc.2016.125			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EB7IR	27086928				2022-12-26	WOS:000387560800003
J	Pang, YL; Li, Y; Lv, Y; Sun, LL; Zhang, SY; Li, Y; Wang, YH; Liu, G; Xu, MJ; Wang, X; Jiang, CT				Pang, Yanli; Li, Yang; Lv, Ying; Sun, Lulu; Zhang, Songyang; Li, Yin; Wang, Yuhui; Liu, George; Xu, Ming-Jiang; Wang, Xian; Jiang, Changtao			Intermedin Restores Hyperhomocysteinemia-induced Macrophage Polarization and Improves Insulin Resistance in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-REPERFUSION INJURY; ACTIVATED PROTEIN-KINASE; ADIPOSE-TISSUE; OXIDATIVE STRESS; APOLIPOPROTEIN-E; FAMILY PEPTIDE; DEFICIENT MICE; BONE-MARROW; OBESITY; INFLAMMATION	Hyperhomocysteinemia (HHcy) is a condition characterized by an abnormally high level of homocysteine, an inflammatory factor. This condition has been suggested to promote insulin resistance. To date, the underlying molecular mechanism remains largely unknown, and identifying novel therapeutic targets for HHcy-induced insulin resistance is of high priority. It is well known that intermedin (IMD), a calcitonin family peptide, exerts potent anti-inflammatory effects. In this study, the effects of IMD on HHcy-induced insulin resistance were investigated. Glucose tolerance and insulin tolerance tests were performed on mice treated with IMD by minipump implantation (318 ng/kg/h for 4 weeks) or adipocyte-specific IMD overexpression mice (Adipo-IMD transgenic mice). The expression of genes and proteins related to M1/M2 macrophages and endoplasmic reticulum stress (ERS) was evaluated in adipose tissues or cells. The expression of IMD was identified to be lower in the plasma and adipose tissues of HHcy mice. In both IMD treatment by minipump implantation and Adipo-IMD transgenic mice, IMD reversed HHcy-induced insulin resistance, as revealed by glucose tolerance and insulin tolerance tests. Further mechanistic study revealed that IMD reversed the Hcy-elevated ratio of M1/M2 macrophages by inhibiting AMP-activated protein kinase activity. Adipo-IMD transgenic mice displayed reduced ERS and lower inflammation in adipose tissues with HHcy. Soluble factors from Hcy-treated macrophages induced adipocyte ERS, which was reversed by IMD treatment. These findings revealed that IMD treatment restores the M1/M2 balance, inhibits chronic inflammation in adipose tissues, and improves systemic insulin sensitivity of HHcy mice.	[Pang, Yanli; Li, Yang; Lv, Ying; Sun, Lulu; Zhang, Songyang; Li, Yin; Wang, Yuhui; Liu, George; Xu, Ming-Jiang; Wang, Xian; Jiang, Changtao] Peking Univ, Minist Educ, Key Lab Mol Cardiovasc Sci, Dept Physiol & Pathophysiol,Basic Med Coll, Beijing 100191, Peoples R China; [Pang, Yanli] Peking Univ, Hosp 3, Ctr Reprod Med, Beijing 100191, Peoples R China	Peking University; Peking University	Wang, X; Jiang, CT (corresponding author), Peking Univ, Basic Med Coll, Dept Physiol & Pathophysiol, Beijing 100191, Peoples R China.	xwang@bjmu.edu.cn; jiangchangtao@bjmu.edu.cn	Li, Yin/P-9296-2016; 王, 宇慧/GXZ-7548-2022	Li, Yin/0000-0002-4019-3391; Jiang, Changtao/0000-0002-5206-2372; Song-Yang, Zhang/0000-0002-4356-897X; Sun, Lulu/0000-0001-8876-5099	National Natural Science Foundation of China [31230035, 81470554, 81401168]; National Basic Research Program (973 Program) of China [2012CB518002]; Chinese Ministry of Education [B07001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program (973 Program) of China(National Basic Research Program of China); Chinese Ministry of Education(Ministry of Education, China)	This work was supported by the National Natural Science Foundation of China Grants 31230035 ( to X. W.), 81470554 ( to C. J.), and 81401168 ( to Y. P.); National Basic Research Program (973 Program) of China Grant 2012CB518002 ( to M. X.); and 111 Project of the Chinese Ministry of Education Grant B07001. The authors declare that they have no conflicts of interest with the contents of this article.	Bell D, 2008, BRIT J PHARMACOL, V153, pS247, DOI 10.1038/sj.bjp.0707494; Chang CL, 2004, PEPTIDES, V25, P1633, DOI 10.1016/j.peptides.2004.05.021; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Dai J, 2006, FREE RADICAL BIO MED, V41, P1566, DOI 10.1016/j.freeradbiomed.2006.08.020; Dai XY, 2014, CARDIOVASC RES, V101, P297, DOI 10.1093/cvr/cvt254; Dai XY, 2012, J MOL CELL CARDIOL, V53, P509, DOI 10.1016/j.yjmcc.2012.07.006; Fadini GP, 2013, DIABETOLOGIA, V56, P1856, DOI 10.1007/s00125-013-2918-9; Fernandez-Real JM, 2012, DIABETOLOGIA, V55, P273, DOI 10.1007/s00125-011-2387-y; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Galic S, 2011, J CLIN INVEST, V121, P4903, DOI 10.1172/JCI58577; Gao SS, 2014, J INFLAMM-LOND, V11, DOI 10.1186/1476-9255-11-13; Heilbronn LK, 2008, CURR PHARM DESIGN, V14, P1225, DOI 10.2174/138161208784246153; Hong YG, 2012, BRIT J PHARMACOL, V166, P110, DOI 10.1111/j.1476-5381.2011.01530.x; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huang T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-867; Kindt F, 2007, J INVEST DERMATOL, V127, P605, DOI 10.1038/sj.jid.5700576; Kraakman MJ, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00470; Lee CH, 2014, INT J MOL SCI, V15, P10334, DOI 10.3390/ijms150610334; Lee YS, 2014, CELL, V157, P1339, DOI 10.1016/j.cell.2014.05.012; Li H, 2013, CARDIOVASC DIABETOL, V12, DOI [10.1186/1475-2840-12-133, 10.1186/1475-2840-12-91]; Li L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065278; Li Y, 2013, J BIOL CHEM, V288, P9583, DOI 10.1074/jbc.M112.431627; Li Y, 2008, DIABETES, V57, P817, DOI 10.2337/db07-0617; Li Y, 2007, PEPTIDES, V28, P1129, DOI 10.1016/j.peptides.2007.03.005; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Mounier R, 2013, CELL METAB, V18, P251, DOI 10.1016/j.cmet.2013.06.017; Nomura I, 2009, REGUL PEPTIDES, V158, P127, DOI 10.1016/j.regpep.2009.08.003; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Omar B, 2009, CELL SIGNAL, V21, P760, DOI 10.1016/j.cellsig.2009.01.015; Pilon G, 2004, J BIOL CHEM, V279, P20767, DOI 10.1074/jbc.M401390200; Qiao X, 2013, AM J PHYSIOL-RENAL, V304, pF112, DOI 10.1152/ajprenal.00054.2012; Roh J, 2004, J BIOL CHEM, V279, P7264, DOI 10.1074/jbc.M305332200; Ruderman NB, 2013, J CLIN INVEST, V123, P2764, DOI 10.1172/JCI67227; Sell H, 2012, NAT REV ENDOCRINOL, V8, P709, DOI 10.1038/nrendo.2012.114; Shimosawa T, 2003, HYPERTENSION, V41, P1080, DOI 10.1161/01.HYP.0000066846.46422.2C; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Sugii S, 2009, P NATL ACAD SCI USA, V106, P22504, DOI 10.1073/pnas.0912487106; Takei Y, 2004, PEPTIDES, V25, P1643, DOI 10.1016/j.peptides.2004.06.026; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Zeng XK, 2003, CIRC RES, V93, P311, DOI 10.1161/01.RES.0000087642.01082.E4; Zhang DQ, 2012, CIRC RES, V111, P37, DOI [10.1161/CIRCRESAHA.112.269472, 10.1161/circresaha.112.269472]; Zhang DQ, 2009, CIRCULATION, V120, P1893, DOI 10.1161/CIRCULATIONAHA.109.866889; Zhang H, 2016, INT J OBESITY, V40, P852, DOI 10.1038/ijo.2016.2; Zhao L, 2012, PEPTIDES, V33, P329, DOI 10.1016/j.peptides.2011.12.016	46	19	21	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12336	12345		10.1074/jbc.M115.702654	http://dx.doi.org/10.1074/jbc.M115.702654			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27080257	Green Published, hybrid			2022-12-26	WOS:000378092800032
J	Hiremath, J; Kang, KI; Xia, M; Elaish, M; Binjawadagi, B; Ouyang, K; Dhakal, S; Arcos, J; Torrelles, JB; Jiang, X; Lee, CW; Renukaradhya, GJ				Hiremath, Jagadish; Kang, Kyung-il; Xia, Ming; Elaish, Mohamed; Binjawadagi, Basavaraj; Ouyang, Kang; Dhakal, Santosh; Arcos, Jesus; Torrelles, Jordi B.; Jiang, X.; Lee, Chang Won; Renukaradhya, Gourapura J.			Entrapment of H1N1 Influenza Virus Derived Conserved Peptides in PLGA Nanoparticles Enhances T Cell Response and Vaccine Efficacy in Pigs	PLOS ONE			English	Article							RESPIRATORY SYNDROME VIRUS; CROSS-PROTECTIVE IMMUNITY; SWINE INFLUENZA; CYTOTOXIC-T; MYCOBACTERIUM-VACCAE; PSEUDORABIES VIRUS; ANTIGEN; MUCOSAL; EXPRESSION; DELIVERY	Pigs are believed to be one of the important sources of emerging human and swine influenza viruses (SwIV). Influenza virus conserved peptides have the potential to elicit cross- protective immune response, but without the help of potent adjuvant and delivery system they are poorly immunogenic. Biodegradable polylactic-co-glycolic acid (PLGA) nanoparticle (PLGA-NP) based vaccine delivery system enhances cross-presentation of antigens by the professional antigen presenting cells. In this study, Norovirus P particle containing SwIV M2e (extracellular domain of the matrix protein 2) chimera and highly conserved two each of H1N1 peptides of pandemic 2009 and classical human influenza viruses were entrapped in PLGA-NPs. Influenza antibody-free pigs were vaccinated with PLGA-NPs peptides cocktail vaccine twice with or without an adjuvant, Mycobacterium vaccae whole cell lysate, intranasally as mist. Vaccinated pigs were challenged with a virulent heterologous zoonotic SwIV H1N1, and one week later euthanized and the lung samples were analyzed for the specific immune response and viral load. Clinically, pigs vaccinated with PLGA-NP peptides vaccine had no fever and flu symptoms, and the replicating challenged SwIV was undetectable in the bronchoalveolar lavage fluid. Immunologically, PLGA-NP peptides vaccination (without adjuvant) significantly increased the frequency of antigen-specific IFN. secreting CD4 and CD8 T cells response in the lung lymphocytes, despite not boosting the antibody response both at pre-and post-challenge. In summary, our data indicated that nanoparticlemediated delivery of conserved H1N1 influenza peptides induced the virus specific T cell response in the lungs and reduced the challenged heterologous virus load in the airways of pigs.	[Hiremath, Jagadish; Kang, Kyung-il; Elaish, Mohamed; Binjawadagi, Basavaraj; Ouyang, Kang; Dhakal, Santosh; Lee, Chang Won; Renukaradhya, Gourapura J.] Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, 1680 Madison Ave, Wooster, OH 44691 USA; [Hiremath, Jagadish; Kang, Kyung-il; Elaish, Mohamed; Binjawadagi, Basavaraj; Ouyang, Kang; Dhakal, Santosh; Lee, Chang Won; Renukaradhya, Gourapura J.] Ohio State Univ, Coll Vet Med, Dept Vet Prevent Med, Columbus, OH 43210 USA; [Arcos, Jesus; Torrelles, Jordi B.] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA; [Xia, Ming; Jiang, X.] Univ Cincinnati, Coll Med, Div Infect Dis, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Lee, CW; Renukaradhya, GJ (corresponding author), Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, 1680 Madison Ave, Wooster, OH 44691 USA.; Lee, CW; Renukaradhya, GJ (corresponding author), Ohio State Univ, Coll Vet Med, Dept Vet Prevent Med, Columbus, OH 43210 USA.	lee.2854@osu.edu; gourapura.1@osu.edu	Elaish, Mohamed/AAT-4642-2020; Xia, Ming/AAY-7154-2021; Dhakal, Santosh/J-2906-2019	Dhakal, Santosh/0000-0002-4494-8608; Elaish, Mohamed/0000-0003-3628-5856	Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [2013-67015-20476]; Indian Council for Agricultural Research, India	Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture; Indian Council for Agricultural Research, India	This project was supported by Agriculture and Food Research Initiative Competitive Grant no. 2013-67015-20476 from the USDA National Institute of Food and Agriculture. The first author of this paper was supported by International Fellowship (2010-11), by Indian Council for Agricultural Research, India.	AGUADO MT, 1992, IMMUNOBIOLOGY, V184, P113, DOI 10.1016/S0171-2985(11)80470-5; Bacon A, 2000, INFECT IMMUN, V68, P5764, DOI 10.1128/IAI.68.10.5764-5770.2000; Bertram U, 2010, DRUG DEV IND PHARM, V36, P581, DOI 10.3109/03639040903382673; Binjawadagi B, 2014, INT J NANOMED, V9, P1519, DOI 10.2147/IJN.S59924; Binjawadagi B, 2014, INT J NANOMED, V9, P679, DOI 10.2147/IJN.S56127; Blank F, 2013, AM J RESP CELL MOL, V49, P67, DOI 10.1165/rcmb.2012-0387OC; Chen Qi, 2012, Anim Health Res Rev, V13, P181, DOI 10.1017/S1466252312000175; Daum LT, 2002, EMERG INFECT DIS, V8, P408, DOI 10.3201/eid0804.010311; De Bruin TGM, 2000, VIRAL IMMUNOL, V13, P511; Denyer MS, 2006, VET IMMUNOL IMMUNOP, V110, P279, DOI 10.1016/j.vetimm.2005.10.005; Dwivedi V, 2013, VET MICROBIOL, V166, P47, DOI 10.1016/j.vetmic.2013.04.029; Dwivedi V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051794; Dwivedi V, 2011, VACCINE, V29, P4058, DOI 10.1016/j.vaccine.2011.03.006; Guo YJ, 2004, VACCINE, V22, P3841, DOI 10.1016/j.vaccine.2004.07.012; Heath WR, 2001, NAT REV IMMUNOL, V1, P126, DOI 10.1038/35100512; Heinen PP, 2002, J GEN VIROL, V83, P1851, DOI 10.1099/0022-1317-83-8-1851; Heit A, 2007, EUR J IMMUNOL, V37, P2063, DOI 10.1002/eji.200737169; Hernandez-Pando R, 2008, CLIN VACCINE IMMUNOL, V15, P1730, DOI 10.1128/CVI.00286-08; Ho CS, 2009, TISSUE ANTIGENS, V73, P307, DOI 10.1111/j.1399-0039.2009.01213.x; Hossain MJ, 2010, J CLIN MICROBIOL, V48, P2515, DOI 10.1128/JCM.02286-09; Ito F, 2008, COLLOID SURFACE B, V61, P25, DOI 10.1016/j.colsurfb.2007.06.029; Jung K, 2007, J VIROL, V81, P13681, DOI 10.1128/JVI.01702-07; Khatri M, 2010, J VIROL, V84, P11210, DOI 10.1128/JVI.01211-10; Kim B, 2002, J CONTROL RELEASE, V85, P191, DOI 10.1016/S0168-3659(02)00280-8; KIMMAN TG, 1995, IMMUNOLOGY, V86, P372; LEDERER E, 1975, MOL CELL BIOCHEM, V7, P87, DOI 10.1007/BF01792076; Lee CW, 2004, J VIROL METHODS, V119, P151, DOI 10.1016/j.jviromet.2004.03.014; Lu JM, 2009, EXPERT REV MOL DIAGN, V9, P325, DOI 10.1586/ERM.09.15; MNneil SE, 2005, J LEUKOCYTE BIOL, V78, P585, DOI 10.1189/jlb.0205074; Myers KP, 2007, CLIN INFECT DIS, V44, P1084, DOI 10.1086/512813; Panyam J, 2003, ADV DRUG DELIVER REV, V55, P329, DOI 10.1016/S0169-409X(02)00228-4; Purcell AW, 2007, NAT REV DRUG DISCOV, V6, P404, DOI 10.1038/nrd2224; Rajapaksa TE, 2010, J BIOL CHEM, V285, P23739, DOI 10.1074/jbc.M110.126359; Silva MSE, 2012, AVIAN DIS, V56, P601, DOI 10.1637/10087-022312-ResNote.1; Saalmuller A, 2002, VET IMMUNOL IMMUNOP, V87, P137, DOI 10.1016/S0165-2427(02)00045-4; Saini V, 2011, INT J PHARMACEUT, V408, P50, DOI 10.1016/j.ijpharm.2011.01.045; Schliehe C, 2011, J IMMUNOL, V187, P2112, DOI 10.4049/jimmunol.1002084; Shi Libin, 2008, V465, P23, DOI 10.1007/978-1-59745-207-6_3; Skinner MA, 2001, IMMUNOLOGY, V102, P225, DOI 10.1046/j.1365-2567.2001.01174.x; Talker SC, 2013, DEV COMP IMMUNOL, V40, P51, DOI 10.1016/j.dci.2013.01.003; Thomas C, 2011, MOL PHARMACEUT, V8, P405, DOI 10.1021/mp100255c; Vergara-Alert J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040524; Vincent AL, 2008, ADV VIRUS RES, V72, P127, DOI 10.1016/S0065-3527(08)00403-X; Woodrow KA, 2012, ANNU REV BIOMED ENG, V14, P17, DOI 10.1146/annurev-bioeng-071811-150054; Xia M, 2011, VACCINE, V29, P7670, DOI 10.1016/j.vaccine.2011.07.139; Yassine HM, 2009, VET MICROBIOL, V139, P132, DOI 10.1016/j.vetmic.2009.04.028; Yoshida M, 2006, J BIOMED MATER RES A, V79A, P393, DOI 10.1002/jbm.a.30798; Zhang LH, 2007, INT IMMUNOPHARMACOL, V7, P1732, DOI 10.1016/j.intimp.2007.09.012; Zhang NZ, 2011, J VIROL, V85, P11709, DOI 10.1128/JVI.05040-11; Zuckermann FA, 1996, IMMUNOLOGY, V87, P500, DOI 10.1046/j.1365-2567.1996.494570.x	50	53	56	0	159	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0151922	10.1371/journal.pone.0151922	http://dx.doi.org/10.1371/journal.pone.0151922			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093541	Green Published, gold, Green Submitted			2022-12-26	WOS:000374541200003
J	Khungwanmaythawee, K; Sornjai, W; Paemanee, A; Jaratsittisin, J; Fucharoen, S; Svasti, S; Lithanatudom, P; Roytrakul, S; Smith, DR				Khungwanmaythawee, Kornpat; Sornjai, Wannapa; Paemanee, Atchara; Jaratsittisin, Janejira; Fucharoen, Suthat; Svasti, Saovaros; Lithanatudom, Pathrapol; Roytrakul, Sittiruk; Smith, Duncan R.			Mitochondrial Changes in beta degrees-Thalassemia/Hb E Disease	PLOS ONE			English	Article							MOLECULAR-BIOLOGY; ERYTHROPOIESIS; APOPTOSIS; AUTOPHAGY; MASS	The compound beta degrees-thalassemia/Hb E hemoglobinopathy is characterized by an unusually large range of presentation from essentially asymptomatic to a severe transfusion dependent state. While a number of factors are known that moderate presentation, these factors do not account for the full spectrum of presentation. Mitochondria are subcellular organelles that are pivotal in a number of cellular processes including oxidative phosphorylation and apoptosis. A mitochondrial protein enriched proteome was determined and validated from erythroblasts from normal controls and beta degrees-thalassemia/Hb E patients of different severities. Mitochondria were evaluated through the use of mitotracker staining, analysis of relative mitochondrial genome number and evaluation of mitochondrial gene expression in addition to assay of overall cellular redox status through the use of alamarBlue assays. Fifty differentially regulated mitochondrial proteins were identified. Mitotracker staining revealed significant differences in staining between normal control erythroblasts and those from beta degrees-thalassemia/Hb E patients. Differences in relative mitochondria number and gene expression were seen primarily in day 10 cells. Significant differences were seen in redox status as evaluated by alamarBlue staining in newly isolated CD34+ cells. Mitochondria mediate oxidative phosphorylation and apoptosis, both of which are known to be dysregulated in differentiating erythrocytes from V-thalassemia/Hb E patients. The evidence presented here suggest that there are inherent differences in these cells as early as the erythroid progenitor cell stage, and that maximum deficit is seen coincident with high levels of globin gene expression.	[Khungwanmaythawee, Kornpat; Sornjai, Wannapa; Paemanee, Atchara; Jaratsittisin, Janejira; Fucharoen, Suthat; Svasti, Saovaros; Smith, Duncan R.] Mahidol Univ, Inst Mol Biosci, Salaya Campus,25-25 Phuttamontol Sai 4, Salaya 73170, Nakorn Pathom, Thailand; [Paemanee, Atchara; Roytrakul, Sittiruk] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol BIOTEC, 113 Thailand Sci Pk,Phahonyothin Rd, Khlong Luang 12120, Pathum Thani, Thailand; [Lithanatudom, Pathrapol] Chiang Mai Univ, Fac Sci, Dept Biol, 239 Huay Kaew Rd, Chiang Mai 50202, Thailand	Mahidol University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Chiang Mai University	Smith, DR (corresponding author), Mahidol Univ, Inst Mol Biosci, Salaya Campus,25-25 Phuttamontol Sai 4, Salaya 73170, Nakorn Pathom, Thailand.	duncan.smi@mahidol.ac.th	Svasti, Saovaros/AAH-6111-2020; LITHANATUDOM, PATHRAPOL/AAQ-1131-2021; Smith, Duncan R/C-6891-2011	Smith, Duncan R/0000-0002-6592-9852; Paemanee, Atchara/0000-0001-9206-3153; Jaratsittisin, Janejira/0000-0002-0651-5377; Roytrakul, Sittiruk/0000-0003-3696-8390	Research Chair Grant from the National Science and Technology Development Agency; Thailand Research Fund [BRG5780004, IRG5780009]; Thai Royal Golden Jubilee Research Scholarship; Thailand Graduate Institute of Science and Technology (TGIST)	Research Chair Grant from the National Science and Technology Development Agency; Thailand Research Fund(Thailand Research Fund (TRF)); Thai Royal Golden Jubilee Research Scholarship; Thailand Graduate Institute of Science and Technology (TGIST)	This work was supported by a Research Chair Grant from the National Science and Technology Development Agency and by the Thailand Research Fund ( BRG5780004 and IRG5780009). W. S. is supported by a Thai Royal Golden Jubilee Research Scholarship, J. J. is supported by a Thailand Graduate Institute of Science and Technology (TGIST) M. Sc. scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanen DK, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0438; Agnello M, 2008, CYTOTECHNOLOGY, V56, P145, DOI 10.1007/s10616-008-9143-2; Chaisiripoomkere Watana, 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P786; Cotter D, 2004, NUCLEIC ACIDS RES, V32, pD463, DOI 10.1093/nar/gkh048; Czarnecka AM, 2006, CANCER BIOL THER, V5, P714, DOI 10.4161/cbt.5.7.2975; Dong HJ, 2013, ELECTROPHORESIS, V34, P1957, DOI 10.1002/elps.201200557; Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985; Fucharoen S, 1997, HEMOGLOBIN, V21, P299, DOI 10.3109/03630269709000664; Gobeill J, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat041; Johnson DT, 2007, AM J PHYSIOL-CELL PH, V292, pC689, DOI 10.1152/ajpcell.00108.2006; Kholmukhamedov A, 2013, SHOCK, V39, P543, DOI 10.1097/SHK.0b013e318292300d; Kirchhoff SR, 2002, CIRCULATION, V105, P2899, DOI 10.1161/01.CIR.0000019403.35847.23; Leecharoenkiat A, 2011, BLOOD CELL MOL DIS, V47, P143, DOI 10.1016/j.bcmd.2011.06.005; Lithanatudom P, 2011, ANN HEMATOL, V90, P747, DOI 10.1007/s00277-010-1152-5; Mathias LA, 2000, EXP HEMATOL, V28, P1343, DOI 10.1016/S0301-472X(00)00555-5; Meisinger C, 2008, CELL, V134, P22, DOI 10.1016/j.cell.2008.06.043; Mortensen M, 2010, CELL CYCLE, V9, P1901, DOI 10.4161/cc.9.10.11603; NATHAN DG, 1966, AM J MED, V41, P815, DOI 10.1016/0002-9343(66)90039-8; Ney PA, 2011, CURR OPIN HEMATOL, V18, P152, DOI 10.1097/MOH.0b013e328345213e; Peng YT, 2015, APOPTOSIS, V20, P1135, DOI 10.1007/s10495-015-1143-z; Rampersad SN, 2012, SENSORS-BASEL, V12, P12347, DOI 10.3390/s120912347; Rodriguez-Enriquez S, 2006, AUTOPHAGY, V2, P39, DOI 10.4161/auto.2229; Samali A, 1999, EMBO J, V18, P2040, DOI 10.1093/emboj/18.8.2040; Schirle M, 2003, MOL CELL PROTEOMICS, V2, P1297, DOI 10.1074/mcp.M300087-MCP200; Wang JF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0104882, 10.1371/journal.pone.0094096]; Wannatung T, 2009, BRIT J HAEMATOL, V146, P557, DOI 10.1111/j.1365-2141.2009.07794.x; Weatherall DJ, 1998, BAILLIERE CLIN HAEM, V11, P127, DOI 10.1016/S0950-3536(98)80072-3; Wikan N, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-96	28	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153831	10.1371/journal.pone.0153831	http://dx.doi.org/10.1371/journal.pone.0153831			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27092778	Green Published, gold			2022-12-26	WOS:000374541200047
J	Zhu, WY; Zhou, KY; Zha, Y; Chen, DD; He, JY; Ma, HJ; Liu, XG; Le, HB; Zhang, YK				Zhu, WangYu; Zhou, KaiYu; Zha, Yao; Chen, DongDong; He, JianYing; Ma, HaiJie; Liu, XiaoGuang; Le, HanBo; Zhang, YongKui			Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer	PLOS ONE			English	Article							NONINVASIVE BIOMARKERS; CIRCULATING MICRORNAS; PLASMA MICRORNAS; EXPRESSION; QUANTIFICATION; IDENTIFICATION; PROGNOSIS; MARKERS; FAMILY; BLOOD	Blood-circulating miRNAs could be useful as a biomarker to detect lung cancer early. We investigated the serum levels of four different miRNAs in patients with non-small cell lung cancer (NSCLC) and assessed their diagnostic value for NSCLC. Serum samples from 112 NSCLC patients and 104 controls (20 current smokers without lung cancer, 23 pneumonia patients, 21 gastric cancer patients, and 40 healthy controls) were subjected to Taqman probe-based quantitative reverse transcription-polymerase chain reaction (RT-PCR). The data showed that the serum levels of miR-182, miR-183, and miR-210 were significantly upregulated and that the miR-126 level was significantly downregulated in NSCLC patients, compared with the healthy controls. Further receiver operating characteristic (ROC) curve analysis revealed that the serum miR-182, miR-183, miR-210, or miR-126 level could serve as a diagnostic biomarker for NSCLC early detection, with a high sensitivity and specificity. The combination of these four miRNAs with carcinoembryonic antigen (CEA) further increased the diagnostic value, with an area under the curve (AUC) of 0.965 (sensitivity, 81.3%; specificity, 100.0%; and accuracy, 90.8%) using logistic regression model analysis. In addition, the relative levels of serum miR-182, miR-183, miR-210, and miR-126 could distinguish NSCLC or early-stage NSCLC from current tobacco smokers without lung cancer and pneumonia or gastric cancer patients with a high sensitivity and specificity. Data from the current study validated that the four serum miRNAs could serve as a tumor biomarker for NSCLC early diagnosis.	[Zhu, WangYu; Zhou, KaiYu; Zha, Yao; Chen, DongDong; He, JianYing; Ma, HaiJie; Liu, XiaoGuang] Wenzhou Med Univ, Lab Cytobiol & Mol Biol, Zhoushan Hosp, Zhoushan 316021, Zhejiang, Peoples R China; [Le, HanBo; Zhang, YongKui] Wenzhou Med Univ, Dept Cardiothorac Surg, Zhoushan Hosp, Zhoushan 316021, Zhejiang, Peoples R China; [Zhu, WangYu; Liu, XiaoGuang; Le, HanBo; Zhang, YongKui] Wenzhou Med Univ, Lung Canc Res Ctr, Zhoushan Hosp, Zhoushan 316021, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Le, HB; Zhang, YK (corresponding author), Wenzhou Med Univ, Dept Cardiothorac Surg, Zhoushan Hosp, Zhoushan 316021, Zhejiang, Peoples R China.; Le, HB; Zhang, YK (corresponding author), Wenzhou Med Univ, Lung Canc Res Ctr, Zhoushan Hosp, Zhoushan 316021, Zhejiang, Peoples R China.	zslehanbo@163.com; zyk801801@126.com			Science and Technology Bureau of Zhoushan [2011C12039, 2011C12040]; Medical Bureau of Zhejiang Province [2015ZDA032, 2016143029]; Health Ministry-Medical Bureau of Zhejiang province [WKJ2014-2-021]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents	Science and Technology Bureau of Zhoushan; Medical Bureau of Zhejiang Province; Health Ministry-Medical Bureau of Zhejiang province; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents	This research was supported in part by grants from the Science and Technology Bureau of Zhoushan (# 2011C12039, # 2011C12040) to YKZ and WYZ, the Medical Bureau of Zhejiang Province (# 2015ZDA032, # 2016143029) to HBL and WYZ, the Health Ministry-Medical Bureau of Zhejiang province (# WKJ2014-2-021) to YKZ, and the Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents to XGL. These funding agencies did not have any roles in the study design, data collection, data analysis, decision to publish, or preparation of the manuscript.	Abd-El-Fattah AA, 2013, CELL BIOCHEM BIOPHYS, V67, P875, DOI 10.1007/s12013-013-9575-y; Aberle DR, 2013, NEW ENGL J MED, V369, P920, DOI 10.1056/NEJMoa1208962; Ajani JA, 2013, J NATL COMPR CANC NE, V11, P531, DOI 10.6004/jnccn.2013.0070; Asamura Hisao, 2008, J Thorac Oncol, V3, P46, DOI 10.1097/JTO.0b013e31815e8577; Balgkouranidou I, 2014, BRIT J CANCER, V110, P2054, DOI 10.1038/bjc.2014.104; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen L, 2015, TUMOR BIOL, V36, P7439, DOI 10.1007/s13277-015-3430-2; Chen X, 2012, INT J CANCER, V130, P1620, DOI 10.1002/ijc.26177; Sebastien S, 2014, CLIN CANCER RES, V20, P4613, DOI 10.1158/1078-0432.CCR-13-3063; Crawford M, 2008, BIOCHEM BIOPH RES CO, V373, P607, DOI 10.1016/j.bbrc.2008.06.090; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Donnem T, 2011, CANCER-AM CANCER SOC, V117, P3193, DOI 10.1002/cncr.25907; Eilertsen M, 2014, LUNG CANCER, V83, P272, DOI 10.1016/j.lungcan.2013.11.005; Ettinger DS, 2014, J NATL COMPR CANC NE, V12, P1738, DOI 10.6004/jnccn.2014.0176; Fedorko M, 2015, INT J MOL SCI, V16, P23382, DOI 10.3390/ijms161023382; Han HS, 2013, INT J CANCER, V133, P645, DOI 10.1002/ijc.28054; Heegaard NHH, 2012, INT J CANCER, V130, P1378, DOI 10.1002/ijc.26153; Hu J, 2014, INT J CANCER, V135, P1187, DOI 10.1002/ijc.28757; Huang X, 2010, TRENDS MOL MED, V16, P230, DOI 10.1016/j.molmed.2010.03.004; Jusufovic E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045577; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Le HB, 2012, MED ONCOL, V29, P3190, DOI 10.1007/s12032-012-0303-z; Li GM, 2008, CELL RES, V18, P1, DOI 10.1038/cr.2008.9; Li Q, 2015, BIOMED REP, V3, P792, DOI 10.3892/br.2015.524; Lin QF, 2012, J CANCER RES CLIN, V138, P85, DOI 10.1007/s00432-011-1068-z; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Markou A, 2013, LUNG CANCER, V81, P388, DOI 10.1016/j.lungcan.2013.05.007; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Roa WH, 2012, CLIN INVEST MED, V35, pE271, DOI 10.25011/cim.v35i5.18700; Sarver AL, 2010, CANCER RES, V70, P9570, DOI 10.1158/0008-5472.CAN-10-2074; Shen J, 2011, LAB INVEST, V91, P579, DOI 10.1038/labinvest.2010.194; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Tang DF, 2013, EUR J CANCER PREV, V22, P540, DOI 10.1097/CEJ.0b013e32835f3be9; Tang Xiaoqiong, 2015, Med Sci Monit, V21, P3427; Tomasetti M, 2012, CLIN BIOCHEM, V45, P575, DOI 10.1016/j.clinbiochem.2012.02.009; Wang P, 2015, CLIN LUNG CANCER, V16, P313, DOI 10.1016/j.cllc.2014.12.006; Wang PY, 2013, ONCOL LETT, V6, P1681, DOI 10.3892/ol.2013.1593; Wang Y, 2015, NEOPLASMA, V62, P798, DOI 10.4149/neo_2015_096; Weeraratne SD, 2012, ACTA NEUROPATHOL, V123, P539, DOI 10.1007/s00401-012-0969-5; Yang YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135168; Zhang CX, 2015, INT J CLIN EXP PATHO, V8, P655; Zhang QH, 2013, GENE, V527, P26, DOI 10.1016/j.gene.2013.06.006; Zheng DL, 2011, INT J CLIN EXP PATHO, V4, P575; Zheng G WH, 2013, PLOS ONE, V8; Zhu WY, 2014, CANCER INVEST, V32, P394, DOI 10.3109/07357907.2014.922569; Zhu WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087780; Zhu WY, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-393	47	92	94	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153046	10.1371/journal.pone.0153046	http://dx.doi.org/10.1371/journal.pone.0153046			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093275	Green Published, Green Submitted, gold			2022-12-26	WOS:000374541200011
J	Nakano, T; Kamei, R; Fujimura, T; Takaoka, Y; Hori, A; Lai, CY; Chiang, KC; Shimada, Y; Ohmori, N; Goto, T; Ono, K; Chen, CL; Goto, S; Kawamoto, S				Nakano, Toshiaki; Kamei, Rikiya; Fujimura, Takashi; Takaoka, Yuki; Hori, Ayane; Lai, Chia-Yun; Chiang, Kuei-Chen; Shimada, Yayoi; Ohmori, Naoya; Goto, Takeshi; Ono, Kazuhisa; Chen, Chao-Long; Goto, Shigeru; Kawamoto, Seiji			Impact of Histone H1 on the Progression of Allergic Rhinitis and Its Suppression by Neutralizing Antibody in Mice	PLOS ONE			English	Article							GROUP BOX-1 PROTEIN; CELLS; HMGB1; AUTOANTIBODIES; INHIBITION; EXPRESSION; REJECTION; ALLOGRAFT; THERAPY; VACCINE	Nuclear antigens are known to trigger off innate and adaptive immune responses. Recent studies have found that the complex of nucleic acids and core histones that are derived from damaged cells may regulate allergic responses. However, no fundamental study has been performed concerning the role of linker histone H1 in mast cell-mediated type I hyperreactivity. In this study, we explored the impact of histone H1 on mast cell-mediated allergic responses both in vitro and in vivo. In the course of a bona-fide experimental allergen sensitization model upon co-injection with alum adjuvant, ovalbumin (OVA), but not PBS, induced elevated levels of circulating histone H1. Intranasal challenge with histone H1 to OVA/alum-(but not PBS/alum)-sensitized mice induced significantly severer symptoms of allergic rhinitis than those in mice sensitized and challenged with OVA. A monoclonal antibody against histone H1 not only suppressed mast cell degranulation, but also ameliorated OVA-induced nasal hyperreactivity and IgE-mediated passive cutaneous anaphylaxis. Our present data suggest that nuclear histone H1 represents an alarmin-like endogenous mediator acting on mast cells, and that its blockage has a therapeutic potential for mast cellmediated type I hyperreactivity.	[Nakano, Toshiaki] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Kaohsiung, Taiwan; [Nakano, Toshiaki; Takaoka, Yuki; Lai, Chia-Yun; Chen, Chao-Long; Goto, Shigeru] Kaohsiung Chang Gung Mem Hosp, Inst Translat Res Biomed, Liver Transplantat Ctr, Kaohsiung, Taiwan; [Nakano, Toshiaki; Takaoka, Yuki; Lai, Chia-Yun; Chen, Chao-Long; Goto, Shigeru] Kaohsiung Chang Gung Mem Hosp, Inst Translat Res Biomed, Div Transplant Immunol, Kaohsiung, Taiwan; [Kamei, Rikiya; Fujimura, Takashi; Hori, Ayane; Ono, Kazuhisa; Kawamoto, Seiji] Hiroshima Univ, Dept Mol Biotechnol, Grad Sch Adv Sci Matter, Higashihiroshima 724, Japan; [Takaoka, Yuki] Hiroshima Univ, Ctr Gene Sci, Higashihiroshima 724, Japan; [Chiang, Kuei-Chen; Shimada, Yayoi; Ohmori, Naoya; Goto, Takeshi] Josai Int Univ, Kazusa Inst Drug Discovery, Kisarazu, Japan; [Ohmori, Naoya; Goto, Takeshi; Goto, Shigeru] Josai Int Univ, Fac Nursing, Dept Nursing, Basic Med Sci Nursing, Togane, Japan; [Ono, Kazuhisa] Hiroshima Inst Technol, Dept Food Sci & Biotechnol, Fac Life Sci, Hiroshima, Japan; [Goto, Shigeru] Fukuoka Inst Occupat Hlth, Fukuoka, Japan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Hiroshima University; Hiroshima University; Hiroshima Institute of Technology	Nakano, T (corresponding author), Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Kaohsiung, Taiwan.; Nakano, T (corresponding author), Kaohsiung Chang Gung Mem Hosp, Inst Translat Res Biomed, Liver Transplantat Ctr, Kaohsiung, Taiwan.; Nakano, T (corresponding author), Kaohsiung Chang Gung Mem Hosp, Inst Translat Res Biomed, Div Transplant Immunol, Kaohsiung, Taiwan.; Kawamoto, S (corresponding author), Hiroshima Univ, Dept Mol Biotechnol, Grad Sch Adv Sci Matter, Higashihiroshima 724, Japan.	toshi.nakano@msa.hinet.net; skawa@hiroshima-u.ac.jp	Kawamoto, Seiji/F-3423-2015; Goto, Takeshi/GZL-7972-2022; Fujimura, Takashi/V-5310-2017	Kawamoto, Seiji/0000-0002-2056-4802; Fujimura, Takashi/0000-0001-7442-5974; Nakano, Toshiaki/0000-0003-3701-3449	Ministry of Science and Technology [NSC101-2320-B-182-037-MY3, MOST104-2320-B-182-030]; Chang Gung Memorial Hospital [CMRPD8C0561, CMRPD8D1381]; Japan Society for the Promotion of Science [G2404]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Ministry of Science and Technology (NSC101-2320-B-182-037-MY3 and MOST104-2320-B-182-030 to T.N.), Chang Gung Memorial Hospital (CMRPD8C0561 and CMRPD8D1381 to T.N.), and Japan Society for the Promotion of Science (Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation: G2404 to S.K. and K.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LC, 2007, J ALLERGY CLIN IMMUN, V120, P462, DOI 10.1016/j.jaci.2007.04.019; Andersson U, 2002, J LEUKOCYTE BIOL, V72, P1084; Bellussi LM, 2013, J BIOL REG HOMEOS AG, V27, P791; Chiang KC, 2009, J IMMUNOL, V182, P4282, DOI 10.4049/jimmunol.0800641; Gong QA, 2010, J MOL MED, V88, P1289, DOI 10.1007/s00109-010-0681-7; Guibas GV, 2014, EXP TOXICOL PATHOL, V66, P469, DOI 10.1016/j.etp.2014.09.001; Hatada T, 2005, THROMB HAEMOSTASIS, V94, P975, DOI 10.1160/TH05-05-0316; Hong SM, 2013, AM J RHINOL ALLERGY, V27, P278, DOI 10.2500/ajra.2013.27.3909; Hsu LW, 2008, CLIN EXP IMMUNOL, V152, P576, DOI 10.1111/j.1365-2249.2008.03652.x; Hsu LW, 2012, J CELL PHYSIOL, V227, P3417, DOI 10.1002/jcp.24042; Hsu LW, 2005, MOL IMMUNOL, V42, P1155, DOI 10.1016/j.molimm.2004.11.010; Imanishi T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4566; Kusano T, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/491649; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Marichal T, 2011, NAT MED, V17, P996, DOI 10.1038/nm.2403; Matsuoka N, 2010, J CLIN INVEST, V120, P735, DOI 10.1172/JCI41360; Mishra B, 2010, J NEUROSCI, V30, P12400, DOI 10.1523/JNEUROSCI.6407-09.2010; Miyahara S, 2005, J ALLERGY CLIN IMMUN, V116, P1020, DOI 10.1016/j.jaci.2005.08.020; Monticelli LA, 2012, CURR OPIN IMMUNOL, V24, P284, DOI 10.1016/j.coi.2012.03.012; Nakano T, 2006, TRANSPLANT P, V38, P3605, DOI 10.1016/j.transproceed.2006.10.076; Nakano T, 2005, TRANSPL P, V37, P80, DOI 10.1016/j.transproceed.2004.12.290; Nakano T, 2004, TRANSPLANTATION, V77, P1595, DOI 10.1097/01.tp.0000123079.10650.71; Nakano T, 2008, TRANSPL IMMUNOL, V19, P87, DOI 10.1016/j.trim.2008.04.001; Nakano T, 2007, TRANSPL IMMUNOL, V17, P147, DOI 10.1016/j.trim.2007.01.003; Nakano T, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/413928; Nakano T, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/267156; Nakano T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037202; Nakano T, 2010, IMMUNOLOGY, V129, P547, DOI 10.1111/j.1365-2567.2009.03149.x; Okuma Y, 2012, ANN NEUROL, V72, P373, DOI 10.1002/ana.23602; Onishi N, 2007, BIOSCI BIOTECH BIOCH, V71, P2551, DOI 10.1271/bbb.70378; Pawankar R, 2005, CHEM IMMUNOL ALLERGY, V87, P111, DOI 10.1159/000087639; Salpietro C, 2013, INT ARCH ALLERGY IMM, V161, P116, DOI 10.1159/000345246; Shang GH, 2009, RESP MED, V103, P1949, DOI 10.1016/j.rmed.2009.05.019; Tan BK, 2011, J ALLERGY CLIN IMMUN, V128, P1198, DOI 10.1016/j.jaci.2011.08.037; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Wang HC, 2009, SHOCK, V32, P348, DOI 10.1097/SHK.0b013e3181a551bd; Wang KY, 2012, CLIN CHIM ACTA, V413, P1737, DOI 10.1016/j.cca.2012.07.002; Xu J, 2011, J IMMUNOL, V187, P2626, DOI 10.4049/jimmunol.1003930; Zhang K, 2004, J ALLERGY CLIN IMMUN, V114, P321, DOI 10.1016/j.jaci.2004.03.058; Zou H, 2014, AM J TRANSPLANT, V14, P1765, DOI 10.1111/ajt.12781	40	7	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153630	10.1371/journal.pone.0153630	http://dx.doi.org/10.1371/journal.pone.0153630			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088594	Green Submitted, Green Published, gold			2022-12-26	WOS:000374527000031
J	Bettinazzi, S; Plazzi, F; Passamonti, M				Bettinazzi, Stefano; Plazzi, Federico; Passamonti, Marco			The Complete Female- and Male-Transmitted Mitochondrial Genome of Meretrix lamarckii	PLOS ONE			English	Article							DOUBLY UNIPARENTAL INHERITANCE; WATER MUSSELS BIVALVIA; TRANSFER-RNA GENES; OXIDASE-II GENE; TRANSMEMBRANE TOPOLOGY; DNA TRANSMISSION; ROLE-REVERSALS; CONTROL REGION; TRNASCAN-SE; BLUE MUSSEL	Bivalve mitochondrial genomes show many uncommon features, like additional genes, high rates of gene rearrangement, high A-T content. Moreover, Doubly Uniparental Inheritance (DUI) is a distinctive inheritance mechanism allowing some bivalves to maintain and transmit two separate sex-linked mitochondrial genomes. Many bivalve mitochondrial features, such as gene extensions or additional ORFs, have been proposed to be related to DUI but, up to now, this topic is far from being understood. Several species are known to show this unusual organelle inheritance but, being widespread only among Unionidae and Mytilidae, DUI distribution is unclear. We sequenced and characterized the complete female- (F) and male-transmitted (M) mitochondrial genomes of Meretrix lamarckii, which, in fact, is the second species of the family Veneridae where DUI has been demonstrated so far. The two mitochondrial genomes are comparable in length and show roughly the same gene content and order, except for three additional tRNAs found in the M one. The two sex-linked genomes show an average nucleotide divergence of 16%. A 100-aminoacid insertion in M. lamarckii M-cox2 gene was found; moreover, additional ORFs have been found in both F and M Long Unassigned Regions of M. lamarckii. Even if no direct involvement in DUI process has been demonstrated so far, the finding of cox2 insertions and supernumerary ORFs in M. lamarckii both strengthens this hypothesis and widens the taxonomical distribution of such unusual features. Finally, the analysis of inter-sex genetic variability shows that DUI species form two separate clusters, namely Unionidae and Mytilidae+Veneridae; this dichotomy is probably due to different DUI regimes acting on separate taxa.	[Bettinazzi, Stefano; Plazzi, Federico; Passamonti, Marco] Univ Bologna, Dept Biol Geol & Environm Sci BiGeA, Bologna, Italy	University of Bologna	Plazzi, F (corresponding author), Univ Bologna, Dept Biol Geol & Environm Sci BiGeA, Bologna, Italy.	federico.plazzi@unibo.it		Plazzi, Federico/0000-0001-5920-7557; Bettinazzi, Stefano/0000-0002-1129-0678				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arunkumar KP, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000110; Beitz E, 2000, BIOINFORMATICS, V16, P135, DOI 10.1093/bioinformatics/16.2.135; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boyle EE, 2013, MAR BIOL, V160, P413, DOI 10.1007/s00227-012-2099-y; Breton S, 2007, TRENDS GENET, V23, P465, DOI 10.1016/j.tig.2007.05.011; Breton S, 2011, MOL BIOL EVOL, V28, P1645, DOI 10.1093/molbev/msq345; Breton S, 2010, MAR GENOM, V3, P11, DOI 10.1016/j.margen.2010.01.001; Breton S, 2009, GENETICS, V183, P1575, DOI 10.1534/genetics.109.110700; Cao LQ, 2004, GENETICS, V167, P835, DOI 10.1534/genetics.103.026187; Chakrabarti R, 2007, FEBS LETT, V581, P5213, DOI 10.1016/j.febslet.2007.10.006; Chapman EG, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-165; Conant GC, 2008, BIOINFORMATICS, V24, P861, DOI 10.1093/bioinformatics/btm598; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; Curole JP, 2002, MOL BIOL EVOL, V19, P1323, DOI 10.1093/oxfordjournals.molbev.a004193; Curole JP, 2005, J MOL EVOL, V61, P381, DOI 10.1007/s00239-004-0192-7; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; Degletagne C, 2016, MOL BIOL EVOL, V33, P375, DOI 10.1093/molbev/msv224; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Diz AP, 2013, MOL CELL PROTEOMICS, V12, P3068, DOI 10.1074/mcp.M113.031401; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; DODA JN, 1981, P NATL ACAD SCI-BIOL, V78, P6116, DOI 10.1073/pnas.78.10.6116; Doucet-Beaupre H, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-50; Dreyer Hermann, 2006, Front Zool, V3, P13, DOI 10.1186/1742-9994-3-13; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Faith JJ, 2003, GENETICS, V165, P735; FEARNLEY IM, 1986, EMBO J, V5, P2003, DOI 10.1002/j.1460-2075.1986.tb04456.x; Fischer D, 1999, BIOINFORMATICS, V15, P759, DOI 10.1093/bioinformatics/15.9.759; Fonseca MM, 2008, MOL BIOL EVOL, V25, P805, DOI 10.1093/molbev/msn050; Fonseca MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106654; Francino MP, 1997, TRENDS GENET, V13, P240, DOI 10.1016/S0168-9525(97)01118-9; GAREY JR, 1989, J MOL EVOL, V28, P374, DOI 10.1007/BF02603072; Ghiselli F, 2013, GENOME BIOL EVOL, V5, P1535, DOI 10.1093/gbe/evt112; Ghiselli F, 2012, MOL BIOL EVOL, V29, P771, DOI 10.1093/molbev/msr248; Ghiselli F, 2011, MOL BIOL EVOL, V28, P949, DOI 10.1093/molbev/msq271; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Guerra D, 2014, GENE, V536, P316, DOI 10.1016/j.gene.2013.12.005; Hanada T, 2001, GENES CELLS, V6, P1019, DOI 10.1046/j.1365-2443.2001.00491.x; Hoeh WR, 2002, EVOLUTION, V56, P2252; Hoeh WR, 1997, MOL BIOL EVOL, V14, P959, DOI 10.1093/oxfordjournals.molbev.a025839; HOFFMANN RJ, 1992, GENETICS, V131, P397; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; JIN L, 1990, MOL BIOL EVOL, V7, P82; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kappner I, 2006, MOL PHYLOGENET EVOL, V40, P317, DOI 10.1016/j.ympev.2006.02.006; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kimura M., 1983, NEUTRAL THEORY MOL E, DOI [10.1017/CBO9780511623486, DOI 10.1017/CBO9780511623486]; Kosiol C, 2005, MOL BIOL EVOL, V22, P193, DOI 10.1093/molbev/msi005; Kyriakou E, 2014, GENE, V546, P448, DOI 10.1016/j.gene.2014.06.031; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; LIS JT, 1975, NUCLEIC ACIDS RES, V2, P383, DOI 10.1093/nar/2.3.383; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Milani L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137468; Milani L, 2014, CURR GENET, V60, P163, DOI 10.1007/s00294-014-0420-7; Milani L, 2014, GENOME BIOL EVOL, V6, P391, DOI 10.1093/gbe/evu021; Milani L, 2013, J EXP ZOOL PART B, V320, P442, DOI 10.1002/jez.b.22520; Milani L, 2012, J EXP ZOOL PART B, V318B, P182, DOI 10.1002/jez.b.22004; Milbury CA, 2005, MAR BIOTECHNOL, V7, P697, DOI 10.1007/s10126-005-0004-0; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Passamonti M, 2001, CURR GENET, V39, P117, DOI 10.1007/s002940100188; Passamonti M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-442; Passamonti M, 2009, DNA CELL BIOL, V28, P79, DOI 10.1089/dna.2008.0807; Plazzi F, 2015, J ZOOL SYST EVOL RES, V53, P205, DOI 10.1111/jzs.12097; Plazzi F, 2015, J ZOOL SYST EVOL RES, V53, P87, DOI 10.1111/jzs.12078; Plazzi F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-409; Plazzi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027147; Pons JL, 2009, NUCLEIC ACIDS RES, V37, pW485, DOI 10.1093/nar/gkp368; Qi Z., 2004, SEASHELLS CHINA, P306; Quesada H, 1999, MOL BIOL EVOL, V16, P655, DOI 10.1093/oxfordjournals.molbev.a026148; R Core Team, 2021, R LANGUAGE ENV STAT; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Reyes A, 1998, MOL BIOL EVOL, V15, P957, DOI 10.1093/oxfordjournals.molbev.a026011; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rodakis GC, 2007, J MOL EVOL, V65, P124, DOI 10.1007/s00239-005-0298-6; Rozen S, 2000, Methods Mol Biol, V132, P365; Saccone C, 2002, GENE, V286, P3, DOI 10.1016/S0378-1119(01)00807-1; Sambrook J., 2006, COMMONLY USED TECHNI, DOI 10.1101/pdb.prot4455; Saunier A, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0259-z; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Seligmann H, 2006, J THEOR BIOL, V241, P321, DOI 10.1016/j.jtbi.2005.11.035; SKIBINSKI DOF, 1994, NATURE, V368, P817, DOI 10.1038/368817b0; SKIBINSKI DOF, 1994, GENETICS, V138, P801; Smietanka B, 2010, J MOL EVOL, V71, P385, DOI 10.1007/s00239-010-9393-4; Smith SA, 2008, BIOINFORMATICS, V24, P715, DOI 10.1093/bioinformatics/btm619; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sun SE, 2015, GENE, V557, P61, DOI 10.1016/j.gene.2014.12.011; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tatusov T, ORF FINDER; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Theologidis I, 2008, EVOLUTION, V62, P959, DOI 10.1111/j.1558-5646.2008.00329.x; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Wang HX, 2011, MAR GENOM, V4, P263, DOI 10.1016/j.margen.2011.06.006; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Xu KF, 2011, MOL BIOL REP, V38, P3067, DOI 10.1007/s11033-010-9974-8; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW6, DOI 10.1093/nar/gkl164; Zhuang Q., 2001, FAUNA SINICA PHYLLUM, P229; ZOUROS E, 1994, P NATL ACAD SCI USA, V91, P7463, DOI 10.1073/pnas.91.16.7463; ZOUROS E, 1994, NATURE, V368, P818, DOI 10.1038/368818a0; Zouros E, 2013, EVOL BIOL, V40, P1, DOI 10.1007/s11692-012-9195-2; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	111	29	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153631	10.1371/journal.pone.0153631	http://dx.doi.org/10.1371/journal.pone.0153631			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27083010	Green Published, gold, Green Submitted			2022-12-26	WOS:000374291800035
J	Smit, J; Thomsen, RW; Schonheyder, HC; Nielsen, H; Froslev, T; Sogaard, M				Smit, Jesper; Thomsen, Reimar Wernich; Schonheyder, Henrik Carl; Nielsen, Henrik; Froslev, Trine; Sogaard, Mette			Outcome of Community-Acquired Staphylococcus aureus Bacteraemia in Patients with Diabetes: A Historical Population-Based Cohort Study	PLOS ONE			English	Article							MORTALITY; COMORBIDITY; PREVALENCE; PREDICTORS; MANAGEMENT; RISK	Background Patients with diabetes (DM) experience increased risk of Staphylococcus aureus bacteraemia (SAB), but the prognostic impact of diabetes in patients with SAB remain unclear. Therefore, we investigated 30-day all-cause mortality in patients with and without DM. Methods Population-based medical databases were used to conduct a cohort study of all adult patients with community-acquired SAB in Northern Denmark, 2000-2011. Using Cox proportional hazards regression, we computed hazard ratios as estimates of 30-day mortality rate ratios (MRRs) among patients with and without DM. We further investigated whether the prognostic impact of DM differed among patients with and without recent preadmission healthcare contacts (within 30 days of the current hospitalization) and by age, sex, marital status, level of comorbidity, and DM-related characteristics (e.g., duration of DM and presence of DM complications). Results Among 2638 SAB patients, 713 (27.0%) had DM. Thirty-day cumulative mortality was 25.8% in patients with DM and 24.3% in patients without DM, for an adjusted MRR (aMRR) of 1.01 (95% confidence interval (CI), 0.84-1.20). In analyses with and without recent healthcare contacts, the corresponding aMRRs were 0.84 (95% CI, 0.62-1.14) and 1.13 (95% CI, 0.91-1.41), respectively. Compared to patients without DM, the aMRR was 0.94 (95% CI, 0.74-1.20) for male patients with DM and 1.13 (95% CI, 0.87-1.47) for female patients with DM. The prognostic influence of DM on mortality did not differ notably with age, level of comorbidity, or characteristics of patients with DM. Conclusion Patients with DM and community-acquired SAB did not experience higher 30-day mortality than patients without DM.	[Smit, Jesper; Schonheyder, Henrik Carl] Aalborg Univ Hosp, Dept Clin Microbiol, Aalborg, Denmark; [Smit, Jesper; Nielsen, Henrik] Aalborg Univ Hosp, Dept Infect Dis, Aalborg, Denmark; [Smit, Jesper; Thomsen, Reimar Wernich; Froslev, Trine; Sogaard, Mette] Aalborg Univ Hosp, Dept Clin Epidemiol, Aalborg, Denmark; [Schonheyder, Henrik Carl; Nielsen, Henrik] Aalborg Univ, Dept Clin Med, Aalborg, Denmark	Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; Aalborg University	Smit, J (corresponding author), Aalborg Univ Hosp, Dept Clin Microbiol, Aalborg, Denmark.; Smit, J (corresponding author), Aalborg Univ Hosp, Dept Infect Dis, Aalborg, Denmark.; Smit, J (corresponding author), Aalborg Univ Hosp, Dept Clin Epidemiol, Aalborg, Denmark.	jesm@rn.dk		Thomsen, Reimar/0000-0001-9135-3474; Sogaard, Mette/0000-0002-2830-4968	Heinrich Kopp Foundation; Hertha Christensen Foundation; North Denmark Health Sciences Research Foundation; Danish Agency for Science [09-067009, 09-075724]; Danish Health and Medicines Authority; Danish Diabetes Association	Heinrich Kopp Foundation; Hertha Christensen Foundation; North Denmark Health Sciences Research Foundation; Danish Agency for Science; Danish Health and Medicines Authority; Danish Diabetes Association	This study was supported by research grants from The Heinrich Kopp, Hertha Christensen, and North Denmark Health Sciences Research Foundations. The Department of Clinical Epidemiology is a member of the Danish Centre for Strategic Research in Type 2 Diabetes (DD2), supported by the Danish Agency for Science (grant nos. 09-067009 and 09-075724). DD2 is also supported by the Danish Health and Medicines Authority, the Danish Diabetes Association, and an unrestricted donation from Novo Nordisk A/S. Partners in the DD2 project are listed on the project website at www.DD2.nu. The sponsors did not have a role in any phase of the study conduct.	CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Ehrenstein Vera, 2010, Clin Epidemiol, V2, P273, DOI 10.2147/CLEP.S13458; Grann Anne Fia, 2011, Clin Epidemiol, V3, P133, DOI 10.2147/CLEP.S17901; Hill PC, 2001, INTERN MED J, V31, P97, DOI 10.1111/j.1444-0903.2001.00029.x; Kaasch AJ, 2014, J INFECTION, V68, P242, DOI 10.1016/j.jinf.2013.10.015; Kaech C, 2006, CLIN MICROBIOL INFEC, V12, P345, DOI 10.1111/j.1469-0691.2005.01359.x; Kanafani ZA, 2009, EUR J CLIN MICROBIOL, V28, P1477, DOI 10.1007/s10096-009-0808-3; Kern WV, 2010, CURR OPIN INFECT DIS, V23, P346, DOI 10.1097/QCO.0b013e32833bcc8a; Koch K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070082; Laupland KB, 2003, J INFECT DIS, V187, P1452, DOI 10.1086/374621; LEIBOVICI L, 1991, DIABETES CARE, V14, P89, DOI 10.2337/diacare.14.2.89; Lenz R, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-85; Lesens O, 2003, INFECT CONT HOSP EP, V24, P890, DOI 10.1086/502156; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Lopez-Cortes LE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082958; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Mejer N, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-260; Mylotte JM, 2000, CLIN INFECT DIS, V31, P1170, DOI 10.1086/317421; Patterson C, 2014, DIABETES RES CLIN PR, V103, P161, DOI 10.1016/j.diabres.2013.11.005; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Shorr AF, 2006, CRIT CARE MED, V34, P2588, DOI 10.1097/01.CCM.0000239121.09533.09; Smit J, 2016, INFECT CONT HOSP EP, V37, P208, DOI 10.1017/ice.2015.259; Sogaard M, 2011, EPIDEMIOL INFECT, V139, P772, DOI 10.1017/S095026881000169X; Thomsen RW, 2004, DIABETES CARE, V27, P70, DOI 10.2337/diacare.27.1.70; Thomsen RW, 2012, OPEN INFECT DIS J S1, V6, P27, DOI DOI 10.2174/1874279301206010027; Thwaites GE, 2011, LANCET INFECT DIS, V11, P208, DOI 10.1016/S1473-3099(10)70285-1; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; Valles J, 2008, J INFECTION, V56, P27, DOI 10.1016/j.jinf.2007.10.001; van Hal SJ, 2012, CLIN MICROBIOL REV, V25, P362, DOI 10.1128/CMR.05022-11; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Wiese L, 2013, J INFECTION, V67, P199, DOI 10.1016/j.jinf.2013.04.018	33	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153766	10.1371/journal.pone.0153766	http://dx.doi.org/10.1371/journal.pone.0153766			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082873	Green Published, gold, Green Submitted			2022-12-26	WOS:000374291800051
J	Theriault, G; Michael, P; Nkongolo, K				Theriault, Gabriel; Michael, Paul; Nkongolo, Kabwe			Comprehensive Transcriptome Analysis of Response to Nickel Stress in White Birch (Betula papyrifera)	PLOS ONE			English	Article							METAL; POPULATIONS; GLUTATHIONE; TOLERANCE; REGION; ENZYME; MECHANISMS; TOXICITY; CADMIUM; SUDBURY	White birch (Betula papyrifera) is a dominant tree species of the Boreal Forest. Recent studies have shown that it is fairly resistant to heavy metal contamination, specifically to nickel. Knowledge of regulation of genes associated with metal resistance in higher plants is very sketchy. Availability and annotation of the dwarf birch (B. nana) enables the use of high throughout sequencing approaches to understanding responses to environmental challenges in other Betula species such as B. papyrifera. The main objectives of this study are to 1) develop and characterize the B. papyrifera transcriptome, 2) assess gene expression dynamics of B. papyrifera in response to nickel stress, and 3) describe gene function based on ontology. Nickel resistant and susceptible genotypes were selected and used for transcriptome analysis. A total of 208,058 trinity genes were identified and were assembled to 275,545 total trinity transcripts. The transcripts were mapped to protein sequences and based on best match; we annotated the B. papyrifera genes and assigned gene ontology. In total, 215,700 transcripts were annotated and were compared to the published B. nana genome. Overall, a genomic match for 61% transcripts with the reference genome was found. Expression profiles were generated and 62,587 genes were found to be significantly differentially expressed among the nickel resistant, susceptible, and untreated libraries. The main nickel resistance mechanism in B. papyrifera is a downregulation of genes associated with translation (in ribosome), binding, and transporter activities. Five candidate genes associated to nickel resistance were identified. They include Glutathione S-transferase, thioredoxin family protein, putative transmembrane protein and two Nramp transporters. These genes could be useful for genetic engineering of birch trees.	[Theriault, Gabriel; Michael, Paul; Nkongolo, Kabwe] Laurentian Univ, Biomol Sci Program, Sudbury, ON P3E 2C6, Canada; [Nkongolo, Kabwe] Laurentian Univ, Dept Biol, Sudbury, ON P3E 2C6, Canada	Laurentian University; Laurentian University	Nkongolo, K (corresponding author), Laurentian Univ, Biomol Sci Program, Sudbury, ON P3E 2C6, Canada.; Nkongolo, K (corresponding author), Laurentian Univ, Dept Biol, Sudbury, ON P3E 2C6, Canada.	knkongolo@laurentian.ca			Natural Sciences and Engineering Council of Canada (NSERC)	Natural Sciences and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by the Natural Sciences and Engineering Council of Canada (NSERC).	AMIRO BD, 1981, CAN J BOT, V59, P1623, DOI 10.1139/b81-221; Barghini E, 2015, GENOM DATA, V3, P143, DOI 10.1016/j.gdata.2015.01.004; Clemens S, 2001, PLANTA, V212, P475, DOI 10.1007/s004250000458; Dixon David P, 2010, Arabidopsis Book, V8, pe0131, DOI 10.1199/tab.0131; Dos Santos CV, 2006, TRENDS PLANT SCI, V11, P329, DOI 10.1016/j.tplants.2006.05.005; FREEDMAN B, 1980, CAN J BOT, V58, P2123, DOI 10.1139/b80-245; Freeman JL, 2004, PLANT CELL, V16, P2176, DOI 10.1105/tpc.104.023036; Gajewska E, 2008, PLANT GROWTH REGUL, V54, P179, DOI 10.1007/s10725-007-9240-9; Gajewska E, 2007, BIOMETALS, V20, P27, DOI 10.1007/s10534-006-9011-5; Halimaa P, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00213; Hossain MA, 2012, J BOT; Hossain MZ, 2006, BIOL PLANTARUM, V50, P210, DOI 10.1007/s10535-006-0009-1; Iannelli MA, 2002, PLANT PHYSIOL BIOCH, V40, P977, DOI 10.1016/S0981-9428(02)01455-9; Jozefczak M, 2012, INT J MOL SCI, V13, P3145, DOI 10.3390/ijms13033145; Kalubi KN, 2015, ECOTOXICOLOGY, V24, P636, DOI 10.1007/s10646-014-1411-7; Kirkey FM, 2012, ENVIRON POLLUT, V164, P53, DOI 10.1016/j.envpol.2012.01.012; Kramer U, 2007, FEBS LETT, V581, P2263, DOI 10.1016/j.febslet.2007.04.010; Lemaire S, 1999, PLANT PHYSIOL, V120, P773, DOI 10.1104/pp.120.3.773; Mehes-Smith M, 2015, WATER AIR SOIL POLL, V226, DOI 10.1007/s11270-015-2382-x; Merlot S, 2014, J EXP BOT, V65, P1551, DOI 10.1093/jxb/eru025; Mizuno T, 2005, PLANT PHYSIOL BIOCH, V43, P793, DOI 10.1016/j.plaphy.2005.07.006; Molas J., 2001, Plant nutrition: food security and sustainability of agro-ecosystems through basic and applied research. Fourteenth International Plant Nutrition Colloquium, Hannover, Germany, P464; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nevo Y, 2006, BBA-MOL CELL RES, V1763, P609, DOI 10.1016/j.bbamcr.2006.05.007; PANDOLFINI T, 1992, PLANT CELL ENVIRON, V15, P719, DOI 10.1111/j.1365-3040.1992.tb01014.x; PERALA DA, 1990, FOREST ECOL MANAG, V32, P1, DOI 10.1016/0378-1127(90)90104-J; Schickler H, 1999, PHYSIOL PLANTARUM, V105, P39, DOI 10.1034/j.1399-3054.1999.105107.x; Seregin IV, 2006, RUSS J PLANT PHYSL+, V53, P257, DOI 10.1134/S1021443706020178; Sevilla F, 2015, J EXP BOT; Skorzynska-Polit E, 2003, BIOL PLANTARUM, V47, P71, DOI 10.1023/A:1027332915500; Theriault G, 2015, P SUDB MIN ENV INT C; Theriault G, 2014, ECOL EVOL, V4, P3435, DOI 10.1002/ece3.1195; VANASSCHE F, 1990, PLANT CELL ENVIRON, V13, P195, DOI 10.1111/j.1365-3040.1990.tb01304.x; Wang N, 2013, MOL ECOL, V22, P3098, DOI 10.1111/mec.12131; Wei W, 2009, MOL BIOTECHNOL, V41, P15, DOI 10.1007/s12033-008-9088-x; Williams LE, 2000, BBA-BIOMEMBRANES, V1465, P104, DOI 10.1016/S0005-2736(00)00133-4; Winterhalder Keith, 1996, Environmental Reviews, V4, P185, DOI 10.1139/a96-011; Yan R, 2008, PLANT SOIL ENVIRON, V54, P294, DOI 10.17221/423-PSE	38	16	16	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153762	10.1371/journal.pone.0153762	http://dx.doi.org/10.1371/journal.pone.0153762			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082755	Green Published, gold, Green Submitted			2022-12-26	WOS:000374291800050
J	Felker, A; Nieuwenhuize, S; Dolbois, A; Blazkova, K; Hess, C; Low, LWL; Burger, S; Samson, N; Carney, TJ; Bartunek, P; Nevado, C; Mosimann, C				Felker, Anastasia; Nieuwenhuize, Susan; Dolbois, Aymeric; Blazkova, Kristyna; Hess, Christopher; Low, Larry W. L.; Burger, Sibylle; Samson, Natasha; Carney, Tom J.; Bartunek, Petr; Nevado, Cristina; Mosimann, Christian			In Vivo Performance and Properties of Tamoxifen Metabolites for CreERT2 Control	PLOS ONE			English	Article							SITE-SPECIFIC RECOMBINATION; BREAST-CANCER-CELLS; ZEBRAFISH; ISOMERS; HYDROXYTAMOXIFEN; ANTIESTROGEN	Mutant Estrogen Receptor (ERT2) ligand-binding domain fusions with Cre recombinase are a key tool for spatio-temporally controlled genetic recombination with the Cre/lox system. CreERT2 is efficiently activated in a concentration-dependent manner by the Tamoxifen metabolite trans-4-OH-Tamoxifen (trans-4-OHT). Reproducible and efficient Cre/lox experimentation is hindered by the gradual loss of CreERT2 induction potency upon prolonged storage of dissolved trans-4-OHT, which potentially results from gradual trans-to-cis isomerization or degradation. Here, we combined zebrafish CreERT2 recombination experiments and cell culture assays to document the gradual activity loss of trans-4-OHT and describe the alternative Tamoxifen metabolite Endoxifen as more stable alternative compound. Endoxifen retains potent activation upon prolonged storage (3 months), yet consistently induces half the ERT2 domain fusion activity compared to fresh trans-4-OHT. Using H-1-NMR analysis, we reveal that trans-4-OHT isomerization is undetectable upon prolonged storage in either DMSO or Ethanol, ruling out isomer transformation as cause for the gradual loss of trans-4-OHT activity. We further establish that both trans-4-OHT and Endoxifen are insensitive to light exposure under regular laboratory handling conditions. We attribute the gradual loss of trans-4-OHT potency to precipitation over time, and show that heating of aged trans-4-OHT aliquots reinstates their CreERT2 induction potential. Our data establish Endoxifen as potent and reproducible complementary compound to 4-OHT to control ERT2 domain fusion proteins in vivo, and provide a framework for efficient chemically controlled recombination experiments.	[Felker, Anastasia; Nieuwenhuize, Susan; Hess, Christopher; Burger, Sibylle; Samson, Natasha; Mosimann, Christian] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Dolbois, Aymeric; Nevado, Cristina] Univ Zurich, Dept Chem, Zurich, Switzerland; [Blazkova, Kristyna; Bartunek, Petr] ASCR, Inst Mol Genet, CZ OPENSCREEN, Vvi, Prague, Czech Republic; [Low, Larry W. L.; Carney, Tom J.] ASTAR, Inst Mol & Cell Biol IMCB, Biopolis Dr, Singapore, Singapore; [Carney, Tom J.] Nanyang Technol Univ, Lee Kong Chian Sch Med, 50 Nanyang Ave, Singapore 639798, Singapore	University of Zurich; University of Zurich; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Mosimann, C (corresponding author), Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland.	christian.mosimann@imls.uzh.ch	Nevado, Cristina/AAV-5962-2020; Blažková, Kristýna/S-4587-2017; Carney, Tom J/H-4389-2011; Bartunek, Petr/J-3897-2014	Blažková, Kristýna/0000-0002-7146-5177; Carney, Tom J/0000-0003-2371-1924; Bartunek, Petr/0000-0002-6202-7650; Mosimann, Christian/0000-0002-0749-2576	Canton of Zurich; Swiss National Science Foundation; Marie Curie CIG; Ministry of Education, Youth and Sports of the Czech Republic [LO1220]; Swiss National Science Foundation [00020_157083]	Canton of Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Marie Curie CIG; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work is supported by the Canton of Zurich, a Swiss National Science Foundation Professorship and Marie Curie CIG to C. M.; Ministry of Education, Youth and Sports of the Czech Republic (LO1220) to P. B.; and Swiss National Science Foundation grant 00020_157083 to A. D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Dickschen K, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-285; Fauq AH, 2010, BIOORG MED CHEM LETT, V20, P3036, DOI 10.1016/j.bmcl.2010.03.117; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Felker A, 2016, METHOD CELL BIOL, V135, P219, DOI 10.1016/bs.mcb.2016.01.009; Hans S, 2011, DEV DYNAM, V240, P108, DOI 10.1002/dvdy.22497; Hans S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004640; Helland T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122339; Johnson MD, 2004, BREAST CANCER RES TR, V85, P151, DOI 10.1023/B:BREA.0000025406.31193.e8; KATZENELLENBOGEN BS, 1984, CANCER RES, V44, P112; Lawrence C, 2011, METHOD CELL BIOL, V104, P431, DOI 10.1016/B978-0-12-374814-0.00023-9; Lim YC, 2005, CANCER CHEMOTH PHARM, V55, P471, DOI 10.1007/s00280-004-0926-7; MacGregor JI, 1998, PHARMACOL REV, V50, P151; Manns J. E., 1993, Analytical Proceedings, V30, P161; Mosimann C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9146; Mosimann C, 2011, METHOD CELL BIOL, V104, P175, DOI 10.1016/B978-0-12-374814-0.00010-0; Mosimann C, 2011, DEVELOPMENT, V138, P169, DOI 10.1242/dev.059345; ROBERTSON DW, 1982, J ORG CHEM, V47, P2387, DOI 10.1021/jo00133a030; ROBERTSON DW, 1982, J STEROID BIOCHEM, V16, P1, DOI 10.1016/0022-4731(82)90137-6; Sinha DK, 2010, CHEMBIOCHEM, V11, P653, DOI 10.1002/cbic.201000008; WAKELING AE, 1991, CANCER RES, V51, P3867; Yu DD, 2003, J ORG CHEM, V68, P9489, DOI 10.1021/jo035164n	23	19	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0152989	10.1371/journal.pone.0152989	http://dx.doi.org/10.1371/journal.pone.0152989			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077909	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000374131700016
J	Aubert, AH; Breuer, L				Aubert, Alice H.; Breuer, Lutz			New Seasonal Shift in In-Stream Diurnal Nitrate Cycles Identified by Mining High-Frequency Data	PLOS ONE			English	Article							WATER-QUALITY; DESERT STREAM; DYNAMICS; RIVER; SITU; VARIABILITY; CATCHMENTS; TRANSPORT; INSIGHTS; SYSTEMS	The recent development of in-situ monitoring devices, such as UV-spectrometers, makes the study of short-term stream chemistry variation relevant, especially the study of diurnal cycles, which are not yet fully understood. Our study is based on high-frequency data from an agricultural catchment (Studienlandschaft Schwingbachtal, Germany). We propose a novel approach, i.e. the combination of cluster analysis and Linear Discriminant Analysis, to mine from these data nitrate behavior patterns. As a result, we observe a seasonality of nitrate diurnal cycles, that differs from the most common cycle seasonality described in the literature, i.e. pre-dawn peaks in spring. Our cycles appear in summer and the maximum and minimum shift to a later time in late summer/autumn. This is observed both for water-and energy-limited years, thus potentially stressing the role of evapotranspiration. This concluding hypothesis on the role of evapotranspiration on nitrate stream concentration, which was obtained through data mining, broadens the perspective on the diurnal cycling of stream nitrate concentrations.	[Aubert, Alice H.; Breuer, Lutz] Univ Giessen, Inst Landscape Ecol & Resources Management ILR, Res Ctr BioSyst Land Use & Nutr IFZ, Heinrich Buff Ring 26, Giessen, Germany; [Aubert, Alice H.] Eawag, ESS, Uberlandstr 133, Dubendorf, Switzerland	Justus Liebig University Giessen; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG)	Aubert, AH (corresponding author), Univ Giessen, Inst Landscape Ecol & Resources Management ILR, Res Ctr BioSyst Land Use & Nutr IFZ, Heinrich Buff Ring 26, Giessen, Germany.; Aubert, AH (corresponding author), Eawag, ESS, Uberlandstr 133, Dubendorf, Switzerland.	alice.aubert@eawag.ch	Aubert, Alice/AAN-3797-2020; Aubert, Alice/Q-2753-2016; Aubert, Alice/AAX-8878-2021; Breuer, Lutz/C-6652-2013	Aubert, Alice/0000-0001-6613-5942; Aubert, Alice/0000-0001-6613-5942; Aubert, Alice/0000-0001-6613-5942; Breuer, Lutz/0000-0001-9720-1076				ABROL YP, 1983, PLANT CELL ENVIRON, V6, P595; Aubert AH, 2013, HYDROL EARTH SYST SC, V17, P1379, DOI 10.5194/hess-17-1379-2013; Aubert AH, 2014, ENVIRON SCI TECHNOL, V48, P930, DOI 10.1021/es403723r; Babovic V, 2005, HYDROL PROCESS, V19, P1511, DOI 10.1002/hyp.5862; Bende-Michl U, 2013, ENVIRON MONIT ASSESS, V185, P9191, DOI 10.1007/s10661-013-3246-8; Borken W, 2009, GLOBAL CHANGE BIOL, V15, P808, DOI 10.1111/j.1365-2486.2008.01681.x; Campbell JM, 2015, HYDROL EARTH SYST SC, V19, P453, DOI 10.5194/hess-19-453-2015; Cohen MJ, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001715; Fovet O, 2014, CAHIER TECHNIQUE INR, V82, P1; Godsey SE, 2014, HYDROL PROCESS, V28, P5791, DOI 10.1002/hyp.10310; Graham CB, 2013, HYDROL PROCESS, V27, P2541, DOI 10.1002/hyp.9334; Gribovszki Z, 2010, J HYDROL, V385, P371, DOI 10.1016/j.jhydrol.2010.02.001; GRIMM NB, 1987, ECOLOGY, V68, P1157, DOI 10.2307/1939200; Halliday SJ, 2013, BIOGEOSCIENCES, V10, P8013, DOI 10.5194/bg-10-8013-2013; Halliday SJ, 2014, WATER-SUI, V6, P150, DOI 10.3390/w6010150; Heffernan JB, 2010, LIMNOL OCEANOGR, V55, P677, DOI 10.4319/lo.2009.55.2.0677; Jeong JJ, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG001999; Kessler AJ, 2015, J GEOPHYS RES-BIOGEO, V120, P538, DOI 10.1002/2014JG002852; Kirchner JW, 2004, HYDROL PROCESS, V18, P1353, DOI 10.1002/hyp.5537; Krause S, 2015, ECOHYDROLOGY, V8, P529, DOI 10.1002/eco.1646; Lauer F, 2013, WATER RESOUR RES, V49, P400, DOI 10.1029/2012WR012537; MANNY B A, 1973, Freshwater Biology, V3, P31, DOI 10.1111/j.1365-2427.1973.tb00060.x; Nimick DA, 2011, CHEM GEOL, V283, P3, DOI 10.1016/j.chemgeo.2010.08.017; Nippgen F, 2015, WATER RESOUR RES, V51, P4550, DOI 10.1002/2014WR016719; Orlowski N, 2014, WATER-SUI, V6, P3085, DOI 10.3390/w6103085; Pellerin BA, 2012, BIOGEOCHEMISTRY, V108, P183, DOI 10.1007/s10533-011-9589-8; Pellerin BA, 2009, FRESHWATER BIOL, V54, P376, DOI 10.1111/j.1365-2427.2008.02111.x; Pinay G, 2015, ECOSYSTEMS, V18, P1101, DOI 10.1007/s10021-015-9878-5; Roberts BJ, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2007JG000422; Rusjan S, 2010, BIOGEOCHEMISTRY, V97, P123, DOI 10.1007/s10533-009-9361-5; Sandford RC, 2007, ENVIRON SCI TECHNOL, V41, P8420, DOI 10.1021/es071447b; Skeffington RA, 2015, HYDROL EARTH SYST SC, V19, P2491, DOI 10.5194/hess-19-2491-2015; Trauth N, 2014, J GEOPHYS RES-BIOGEO, V119, P910, DOI 10.1002/2013JG002586; TriOS, 2011, USERAND INSTALLATION; VALETT HM, 1993, HYDROBIOLOGIA, V259, P133, DOI 10.1007/BF00006593; Wade AJ, 2012, HYDROL EARTH SYST SC, V16, P4323, DOI 10.5194/hess-16-4323-2012; WARWICK JJ, 1986, WATER RES, V20, P1325, DOI 10.1016/0043-1354(86)90165-X; Worrall F, 2015, J HYDROL, V523, P830, DOI 10.1016/j.jhydrol.2015.01.075	38	24	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153138	10.1371/journal.pone.0153138	http://dx.doi.org/10.1371/journal.pone.0153138			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073838	gold, Green Published			2022-12-26	WOS:000374131200052
J	Guo, W; Guan, X; Pan, XD; Sun, XS; Wang, FJ; Ji, Y; Huang, P; Deng, YF; Zhang, Q; Han, Q; Yi, P; Namaka, M; Liu, Y; Deng, YC; Li, XH				Guo, Wei; Guan, Xiao; Pan, Xiaodong; Sun, Xiongshan; Wang, Fangjie; Ji, Yan; Huang, Pei; Deng, Yafei; Zhang, Qi; Han, Qi; Yi, Ping; Namaka, Michael; Liu, Ya; Deng, Youcai; Li, Xiaohui			Post-Natal Inhibition of NF-kappa B Activation Prevents Renal Damage Caused by Prenatal LPS Exposure	PLOS ONE			English	Article							SMOOTH MUSCLE ACTIN; ANGIOTENSIN-II; KIDNEY-DISEASE; RISK-FACTORS; RATS; EXPRESSION; LIPOPOLYSACCHARIDE; FIBROSIS; INJURY; CELLS	Prenatal exposure to an inflammatory stimulus has been shown to cause renal damage in offspring. Our present study explored the role of intra-renal NF-kappa B activation in the development of progressive renal fibrosis in offspring that underwent prenatal exposure to an inflammatory stimulus. Time-dated pregnant rats were treated with saline (control group) or 0.79 mg/kg lipopolysaccharide (LPS) through intra-peritoneal injection on gestational day 8, 10 and 12. At the age of 7 weeks, offspring from control or LPS group were treated with either tap water (Con+Ve or LPS+Ve group) or pyrollidine dithiocarbamate (PDTC, 120mg/L), a NF-kappa B inhibitor, via drinking water starting (Con+PDTC or LPS+PDTC group), respectively, till the age of 20 or 68 weeks. The gross structure of kidney was assessed by hematoxylin-eosin, periodic acid-Schiff staining and Sirius red staining. The expression levels of TNF-alpha, IL-6, alpha-smooth muscle actin (alpha-SMA) and renin-angiotensin system (RAS) genes were determined by real time polymerase chain reaction and/or immunohistochemical staining. Our data showed that post-natal persistent PDTC administration efficiently repressed intra-renal NF-kappa B activation, TNF-alpha and IL-6 expression. Post-natal PDTC also prevented intra-renal glycogen deposition and collagenous fiber generation as evident by the reduced expression of collagen III and interstitial alpha-SMA in offspring of prenatal LPS exposure. Furthermore, post-natal PDTC administration reversed the intra-renal reninangiotensin system (RAS) over-activity in offspring of prenatal LPS exposure. In conclusion, prenatal inflammatory exposure results in offspring's intra-renal NF-kappa B activation along with inflammation which cross-talked with excessive RAS activation that caused exacerbation of renal fibrosis and dysfunction in the offspring. Thus, early life prevention of NF-kappa B activation may be a potential preventive strategy for chronic renal inflammation and progressive renal damage.	[Guo, Wei; Guan, Xiao; Pan, Xiaodong; Sun, Xiongshan; Wang, Fangjie; Ji, Yan; Huang, Pei; Deng, Yafei; Zhang, Qi; Han, Qi; Liu, Ya; Deng, Youcai; Li, Xiaohui] Third Mil Med Univ, Inst Mat Med, Coll Pharm, Chongqing 400038, Peoples R China; [Guo, Wei] Third Mil Med Univ, Southwest Hosp, Dept Pharm, Chongqing 400038, Peoples R China; [Guan, Xiao; Pan, Xiaodong; Sun, Xiongshan; Wang, Fangjie; Ji, Yan; Huang, Pei; Deng, Yafei; Zhang, Qi; Han, Qi; Liu, Ya; Deng, Youcai; Li, Xiaohui] Third Mil Med Univ, Coll Pharm, Ctr Translat Med, Chongqing 400038, Peoples R China; [Yi, Ping] Third Mil Med Univ, Daping Hosp, Dept Obstet & Gynecol, Chongqing 400038, Peoples R China; [Namaka, Michael] Univ Manitoba, Apotex Ctr 750, Coll Pharm, McDermot Ave, Winnipeg, MB R3E 0T5, Canada; [Namaka, Michael] Univ Manitoba, Apotex Ctr 750, Coll Med, McDermot Ave, Winnipeg, MB R3E 0T5, Canada; [Namaka, Michael] Shantou Univ Med Coll & Coll Med Univ Manitoba, Joint Lab Biol Psychiat, Shantou 515063, Peoples R China	Army Medical University; Army Medical University; Army Medical University; Army Medical University; University of Manitoba; University of Manitoba	Liu, Y; Deng, YC; Li, XH (corresponding author), Third Mil Med Univ, Inst Mat Med, Coll Pharm, Chongqing 400038, Peoples R China.; Liu, Y; Deng, YC; Li, XH (corresponding author), Third Mil Med Univ, Coll Pharm, Ctr Translat Med, Chongqing 400038, Peoples R China.	liuya1979@hotmail.com; dengyc125@hotmail.com; lpsh008@aliyun.com	Deng, Youcai/GZK-9548-2022	Deng, Youcai/0000-0001-5488-8576; Xiongshan, Sun/0000-0002-7958-0620; Guo, Wei/0000-0002-6938-9005	Natural Science Foundation of China [81520108029, 81273507, 81473210, 81503083, 81170580]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation of China [81520108029, 81273507, 81473210, 81503083, 81170580]; http://www.nsfc.gov.cn/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arends NJT, 2005, CLIN ENDOCRINOL, V62, P44, DOI 10.1111/j.1365-2265.2004.02171.x; Bagshaw SM, 2008, CRIT CARE MED, V36, pS172, DOI 10.1097/CCM.0b013e318168c92f; Benigni A, 2010, EMBO MOL MED, V2, P247, DOI 10.1002/emmm.201000080; Blank U, 2007, IMMUNOL REV, V217, P79, DOI 10.1111/j.1600-065X.2007.00503.x; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Boukhalfa G, 1996, EXP NEPHROL, V4, P241; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Cuzzocrea S, 2003, INTENS CARE MED, V29, P2016, DOI 10.1007/s00134-003-1887-8; de Steenwinkel FDO, 2013, ANN RHEUM DIS, V72, P1995, DOI 10.1136/annrheumdis-2012-202539; Deng YC, 2016, SCI REP-UK, V6, DOI 10.1038/srep21692; Deng YC, 2015, IMMUNITY, V42, P457, DOI 10.1016/j.immuni.2015.02.006; Deng YC, 2014, J IMMUNOL, V193, P2994, DOI 10.4049/jimmunol.1302600; Elbe H, 2015, HUM EXP TOXICOL, V34, P100, DOI 10.1177/0960327114531995; Elks CM, 2009, AM J PHYSIOL-RENAL, V296, pF298, DOI 10.1152/ajprenal.90628.2008; Gorgas DL, 2008, EMERG MED CLIN N AM, V26, P345, DOI 10.1016/j.emc.2008.01.007; Hao XQ, 2013, EXP TOXICOL PATHOL, V65, P433, DOI 10.1016/j.etp.2012.01.001; Hao XQ, 2010, HYPERTENS RES, V33, P76, DOI 10.1038/hr.2009.185; HAY PE, 1994, BRIT MED J, V308, P295, DOI 10.1136/bmj.308.6924.295; Kawasaki Y, 2008, PEDIATR NEPHROL, V23, P913, DOI 10.1007/s00467-008-0749-6; Kim J, 2014, AM J PHYSIOL-RENAL, V307, pF971, DOI 10.1152/ajprenal.00256.2014; Klahr S, 2000, KIDNEY INT, V57, pS7, DOI 10.1046/j.1523-1755.2000.07509.x; Koeners MP, 2011, J HYPERTENS, V29, P1160, DOI 10.1097/HJH.0b013e3283468344; Kurts C, 2013, NAT REV IMMUNOL, V13, P738, DOI 10.1038/nri3523; LAZARIDES E, 1975, CELL, V6, P289, DOI 10.1016/0092-8674(75)90180-4; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Lin TH, 2014, ACTA BIOMATER, V10, P1, DOI 10.1016/j.actbio.2013.09.034; Liu SF, 1999, CIRCULATION, V100, P1330, DOI 10.1161/01.CIR.100.12.1330; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Mezzano SA, 2001, HYPERTENSION, V38, P635, DOI 10.1161/hy09t1.094234; Muller DN, 2000, HYPERTENSION, V35, P193, DOI 10.1161/01.HYP.35.1.193; Nilsson C, 2001, ENDOCRINOLOGY, V142, P2622, DOI 10.1210/en.142.6.2622; Noronha IL, 2002, NEPHROL DIAL TRANSPL, V17, P363, DOI 10.1093/ndt/17.3.363; ORNOY A, 1976, AM J OBSTET GYNECOL, V124, P196, DOI 10.1016/S0002-9378(16)33298-7; Palinski W, 2014, CIRCULATION, V129, P2066, DOI 10.1161/CIRCULATIONAHA.113.001805; RAIJ L, 1984, KIDNEY INT, V26, P137, DOI 10.1038/ki.1984.147; Rangan GK, 1999, KIDNEY INT, V56, P118, DOI 10.1046/j.1523-1755.1999.00529.x; Rosenbaugh EG, 2013, AM J PHYSIOL-REG I, V304, pR917, DOI 10.1152/ajpregu.00395.2012; Roson MI, 2006, KIDNEY INT, V70, P1439, DOI 10.1038/sj.ki.5001831; Ruiz-Ortega M, 2006, NEPHROL DIAL TRANSPL, V21, P16, DOI 10.1093/ndt/gfi265; Safir A, 2010, LIVER INT, V30, P765, DOI 10.1111/j.1478-3231.2010.02218.x; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; Tamada S, 2003, KIDNEY INT, V63, P306, DOI 10.1046/j.1523-1755.2003.00714.x; Wang XQ, 2014, FREE RADICAL BIO MED, V76, P242, DOI 10.1016/j.freeradbiomed.2014.08.010; Wang ZC, 2014, AM J PHYSIOL-RENAL, V306, pF1236, DOI 10.1152/ajprenal.00673.2013; Wei YL, 2007, ACTA PHARMACOL SIN, V28, P651, DOI 10.1111/j.1745-7254.2007.00593.x; Zhao SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102273; Zhou JZ, 2013, MOL MED REP, V8, P95, DOI 10.3892/mmr.2013.1498	48	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153434	10.1371/journal.pone.0153434	http://dx.doi.org/10.1371/journal.pone.0153434			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073902	Green Published, Green Submitted, gold			2022-12-26	WOS:000374131200092
J	Sawada, R; Sato, W; Uono, S; Kochiyama, T; Kubota, Y; Yoshimura, S; Toichi, M				Sawada, Reiko; Sato, Wataru; Uono, Shota; Kochiyama, Takanori; Kubota, Yasutaka; Yoshimura, Sayaka; Toichi, Motomi			Neuroticism Delays Detection of Facial Expressions	PLOS ONE			English	Article							VISUAL-SEARCH; ANTI-EXPRESSIONS; PERSONALITY; DEPRESSION; FACES; EXTRAVERSION; EMOTION; ANXIETY; PEOPLE; ME	The rapid detection of emotional signals from facial expressions is fundamental for human social interaction. The personality factor of neuroticism modulates the processing of various types of emotional facial expressions; however, its effect on the detection of emotional facial expressions remains unclear. In this study, participants with high- and low-neuroticism scores performed a visual search task to detect normal expressions of anger and happiness, and their anti-expressions within a crowd of neutral expressions. Anti-expressions contained an amount of visual changes equivalent to those found in normal expressions compared to neutral expressions, but they were usually recognized as neutral expressions. Subjective emotional ratings in response to each facial expression stimulus were also obtained. Participants with high-neuroticism showed an overall delay in the detection of target facial expressions compared to participants with low-neuroticism. Additionally, the high-neuroticism group showed higher levels of arousal to facial expressions compared to the low-neuroticism group. These data suggest that neuroticism modulates the detection of emotional facial expressions in healthy participants; high levels of neuroticism delay overall detection of facial expressions and enhance emotional arousal in response to facial expressions.	[Sawada, Reiko; Sato, Wataru] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan; [Uono, Shota; Yoshimura, Sayaka; Toichi, Motomi] Kyoto Univ, Grad Sch Med, Kyoto, Japan; [Kochiyama, Takanori] Adv Telecommun Res Inst Int, Brain Act Imaging Ctr, Seika, Kyoto, Japan; [Kubota, Yasutaka] Shiga Univ, Hlth & Med Serv Ctr, Otsu, Shiga, Japan; [Sawada, Reiko; Sato, Wataru] Kyoto Univ, Grad Sch Med, Kyoto, Japan	Kyoto University; Kyoto University; Advanced Telecommunications Research Institute International; Shiga University; Kyoto University	Sato, W (corresponding author), Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan.; Sato, W (corresponding author), Kyoto Univ, Grad Sch Med, Kyoto, Japan.	sato.wataru.4v@kyoto-u.ac.jp	Sato, Wataru/E-7503-2017; Yoshimura, Sayaka/GQY-9131-2022	Sato, Wataru/0000-0002-5335-1272; Yoshimura, Sayaka/0000-0003-4273-8575; Uono, Shota/0000-0003-0547-0522; Kochiyama, Takanori/0000-0002-4023-0674	Japan Society for the Promotion of Science Funding Program for Next Generation World-Leading Researchers [LZ008]	Japan Society for the Promotion of Science Funding Program for Next Generation World-Leading Researchers	This study was supported by funds from the Japan Society for the Promotion of Science Funding Program for Next Generation World-Leading Researchers (LZ008). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andric S, 2016, EARLY INTERV PSYCHIA, V10, P160, DOI 10.1111/eip.12212; Canli T, 2000, J NEUROSCI, V20; Cave KR, 2006, VIS COGN, V14, P629, DOI 10.1080/13506280500193107; COSTA PT, 1980, J PERS SOC PSYCHOL, V38, P668, DOI 10.1037/0022-3514.38.4.668; Costa PT, 2007, REVISED NEO PERSONAL; DeYoung CG, 2007, J PERS SOC PSYCHOL, V93, P880, DOI 10.1037/0022-3514.93.5.880; Di Simplicio M, 2014, NEUROPSYCHOPHARMACOL, V39, P3059, DOI 10.1038/npp.2014.159; Doty TJ, 2013, EMOTION, V13, P183, DOI 10.1037/a0031373; EKMAN P, 1994, PSYCHOL BULL, V115, P268, DOI 10.1037/0033-2909.115.2.268; Ekman P., 1997, INNOVATIONS SOCIAL S, V10, P333, DOI [DOI 10.1080/13511610.1997.9968538, 10.1080/13511610.1997.9968538]; Ekman P., 1976, PICTURES FACIAL AFFE; Elfenbein HA, 2003, J PERS SOC PSYCHOL, V85, P276, DOI 10.1037/0022-3514.85.2.276; Haas BW, 2008, NEUROIMAGE, V42, P385, DOI 10.1016/j.neuroimage.2008.04.027; Hadwin JA, 2003, J CHILD PSYCHOL PSYC, V44, P432, DOI 10.1111/1469-7610.00133; HANSEN CH, 1988, J PERS SOC PSYCHOL, V54, P917, DOI 10.1037/0022-3514.54.6.917; Kendler KS, 2006, ARCH GEN PSYCHIAT, V63, P1113, DOI 10.1001/archpsyc.63.10.1113; Kirk R., 2014, EXPT DESIGN PROCEDUR, DOI [10.4135/9781483384733, DOI 10.4135/9781483384733]; Lang PJ, 1998, J CLIN NEUROPHYSIOL, V15, P397, DOI 10.1097/00004691-199809000-00004; LARSEN RJ, 1989, PERS INDIV DIFFER, V10, P1221, DOI 10.1016/0191-8869(89)90233-X; MCCRAE RR, 1987, J PERS SOC PSYCHOL, V52, P81, DOI 10.1037/0022-3514.52.1.81; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Perlman SB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005952; Saito Takako, 2005, Shinrigaku Kenkyu, V75, P517; Sato W, 2010, VIS COGN, V18, P369, DOI 10.1080/13506280902767763; Sato W, 2009, SOC BEHAV PERSONAL, V37, P491, DOI 10.2224/sbp.2009.37.4.491; Sawada R, 2015, SCI REP-UK, V5, DOI 10.1038/srep14042; Sawada R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094747; Sawada R, 2014, BRAIN RES, V1560, P60, DOI 10.1016/j.brainres.2014.02.046; Seidel EM, 2010, PSYCHIAT RES, V177, P124, DOI 10.1016/j.psychres.2010.02.001; Shimonaka Y., 1999, REVISED NEO PERSONAL; Tong F, 1999, J EXP PSYCHOL HUMAN, V25, P1016, DOI 10.1037/0096-1523.25.4.1016; Williams MA, 2005, VIS COGN, V12, P29, DOI 10.1080/13506280444000193	32	9	9	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153400	10.1371/journal.pone.0153400	http://dx.doi.org/10.1371/journal.pone.0153400			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UC	27073904	Green Published, gold, Green Submitted			2022-12-26	WOS:000374131200083
J	Tsao, PC; Shiau, YS; Chiang, SH; Ho, HC; Liu, YL; Chung, YF; Lin, LJ; Chen, MR; Chang, JK; Soong, WJ; Lin, HL; Hwang, B; Hsiao, KJ				Tsao, Pei-Chen; Shiau, Yu-Shih; Chiang, Szu-Hui; Ho, Hui-Chen; Liu, Yu-Ling; Chung, Yuan-Fang; Lin, Li-Ju; Chen, Ming-Ren; Chang, Jia-Kan; Soong, Wen-Jue; Lin, Hsiu-Lian; Hwang, Betau; Hsiao, Kwang-Jen			Development of a Newborn Screening Program for Critical Congenital Heart Disease (CCHD) in Taipei	PLOS ONE			English	Article							PULSE OXIMETRY; DEFECTS; PREVALENCE; IMPACT	Background Early detection of critical congenital heart disease (CCHD) can significantly reduce morbidity and mortality among newborns. We investigate the feasibility of implementing a community-based newborn CCHD screening program in Taipei. Methods Twelve birthing facilities in Taipei participated in a trial screening program between October 1, 2013, and March 31, 2014. Newborns underwent pulse oximetry at 24-36 h old, with probes attached to the right hand and one lower limb. Any screening saturation >= 95% in either extremity, with an absolute difference of <= 3% between the right hand and foot, was accepted as a screening pass. A screening result was considered as a fail if the oxygen saturation was <95% at either probe site, on 3 separate occasions, each separated by 30 min or the first result was <95% at either probe site, and any subsequent oxygen saturation measurement was <90%. Public health nurses would follow up all missed or refused cases. Results Of the 6,387 live births, 6,296 newborns (coverage rate: 6,296/6,387 = 98.6%) underwent appropriate pulse oximetry screening. Sixteen newborns (0.25%) were reported to have a failed screening result. Five of these screen positive newborns were confirmed with CCHD; two of them were diagnosed solely attributed to the failed screening results. The false-positive rate was 0.18%. Implementing a 6-month screening program for CCHD produced good case detection rate, while using efficient screening and referral systems. Conclusion This program was successful in integrating screening, referral and public health tracking systems. The protocol outlined in this report could provide a community-based model for worldwide implementation.	[Tsao, Pei-Chen; Soong, Wen-Jue] Taipei Vet Gen Hosp, Dept Pediat, Div Gen Pediat, Taipei, Taiwan; [Tsao, Pei-Chen; Soong, Wen-Jue; Hwang, Betau] Natl Yang Ming Univ, Sch Med, Dept Pediat, Taipei 112, Taiwan; [Tsao, Pei-Chen] Natl Yang Ming Univ, Inst Physiol, Sch Med, Taipei 112, Taiwan; [Tsao, Pei-Chen] Natl Yang Ming Univ, Sch Med, Inst Emergency & Crit Care Med, Taipei 112, Taiwan; [Shiau, Yu-Shih; Chiang, Szu-Hui; Hsiao, Kwang-Jen] Prevent Med Fdn, Taipei, Taiwan; [Ho, Hui-Chen] Taipei Inst Pathol, Taipei, Taiwan; [Liu, Yu-Ling; Chung, Yuan-Fang; Lin, Li-Ju; Lin, Hsiu-Lian] Taipei City Govt, Dept Hlth, Taipei, Taiwan; [Chen, Ming-Ren] MacKay Childrens Hosp, Taipei, Taiwan; [Chang, Jia-Kan] Cheng Hsin Gen Hosp, Dept Pediat, Taipei, Taiwan; [Hwang, Betau] Taipei City Hosp, Zhongxiao Branch, Taipei, Taiwan; [Hwang, Betau] Tungs Taichung Metroharbor Hosp, Cardiac Med Ctr, Taichung, Taiwan; [Hsiao, Kwang-Jen] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Cheng Hsin General Hospital; Taipei City Hospital; Tungs' Taichung MetroHarbor Hospital; Taipei City Hospital	Hwang, B (corresponding author), Natl Yang Ming Univ, Sch Med, Dept Pediat, Taipei 112, Taiwan.; Hsiao, KJ (corresponding author), Prevent Med Fdn, Taipei, Taiwan.; Hwang, B (corresponding author), Taipei City Hosp, Zhongxiao Branch, Taipei, Taiwan.; Hwang, B (corresponding author), Tungs Taichung Metroharbor Hosp, Cardiac Med Ctr, Taichung, Taiwan.; Hsiao, KJ (corresponding author), Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan.	bthwang@vghtpe.gov.tw; hsiao@pmf.tw			United Way of Taiwan	United Way of Taiwan	This project was partially funded by the United Way of Taiwan.; We thank the entire staff of the 12 birthing facilities involved in collecting the screening data throughout the project, including Taipei City hospital Zhongxing Branch, Renai Branch, Heping Fuyou Branch, Zhongxiao Branch, Yang-Ming Branch; Taipei Veterans General Hospital; MacKay Memorial Hospital; Tri-Service General Hospital; Cheng Hsin General Hospital; West Garden Hospital; Taipei Union Hospital for Women and Children; and Dr. Hsu Obs-Gyn Clinic. We thank the data manager of Taipei Institute of Pathology, who didn't involve in the research, anonymized all the patient's record and information. This project was partially funded by the United Way of Taiwan. We thank Professor Yu-Ru Kou (Institute of Physiology, School of Medicine, National Yang-Ming University) for his advice; and the public health nurses who worked hard with case follow-up.	Botto LD, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.3.e32; Brown KL, 2006, HEART, V92, P1298, DOI 10.1136/hrt.2005.078097; Daubeney PEF, 1996, ARCH PEDIAT ADOL MED, V150, P109; de-Wahl Granelli Anne, 2009, BMJ, V338, pa3037, DOI 10.1136/bmj.a3037; Ewer AK, 2013, CURR OPIN CARDIOL, V28, P92, DOI 10.1097/HCO.0b013e32835d7e42; Garg LF, 2013, PEDIATRICS, V132, pE314, DOI 10.1542/peds.2013-0269; Granelli AD, 2014, ACTA PAEDIATR, V103, P1136, DOI 10.1111/apa.12758; Huang HM, 2013, INT J PEDIATR OTORHI, V77, P1734, DOI 10.1016/j.ijporl.2013.08.004; Kemper AR, 2011, PEDIATRICS, V128, pE1259, DOI 10.1542/peds.2011-1317; Mahle WT, 2009, CIRCULATION, V120, P447, DOI 10.1161/CIRCULATIONAHA.109.192576; Mellander M, 2006, ACTA PAEDIATR, V95, P407, DOI 10.1080/08035250500541910; Niu DM, 2010, J INHERIT METAB DIS, V33, pS295, DOI 10.1007/s10545-010-9129-z; Peterson C, 2014, JAMA PEDIATR, V168, P361, DOI 10.1001/jamapediatrics.2013.4779; Reller MD, 2008, J PEDIATR-US, V153, P807, DOI 10.1016/j.jpeds.2008.05.059; Richmond S, 2002, ARCH DIS CHILD-FETAL, V87, pF83, DOI 10.1136/fn.87.2.F83; Riede FT, 2010, EUR J PEDIATR, V169, P975, DOI 10.1007/s00431-010-1160-4; Silberbach M, 2007, PEDIATR REV, V28, P123, DOI 10.1542/pir.28-4-123; Singh A, 2014, ARCH DIS CHILD-FETAL, V99, pF297, DOI [10.1136/archdischild-2013-303968, 10.1136/archdischild-2013-305657]; Thangaratinam S, 2007, ARCH DIS CHILD-FETAL, V92, pF176, DOI 10.1136/adc.2006.107656; Thangaratinam S, 2012, LANCET, V379, P2459, DOI 10.1016/S0140-6736(12)60107-X; Woodward GA, 1996, PEDIATR EMERG CARE, V12, P317, DOI 10.1097/00006565-199608000-00021; Wu MH, 2010, J PEDIATR-US, V156, P782, DOI 10.1016/j.jpeds.2009.11.062; Yeh SJ, 2013, PEDIATR NEONATOL, V54, P113, DOI 10.1016/j.pedneo.2012.11.010; Yilmazer MM, 2010, INDIAN J PEDIATR, V77, P813, DOI 10.1007/s12098-010-0105-2; Zhao QM, 2014, LANCET, V384, P747, DOI 10.1016/S0140-6736(14)60198-7	25	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153407	10.1371/journal.pone.0153407	http://dx.doi.org/10.1371/journal.pone.0153407			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073996	Green Submitted, Green Published, gold			2022-12-26	WOS:000374131200086
J	Roksandic, M; Alarie, K; Suarez, RR; Huebner, E; Roksandic, I				Roksandic, Mirjana; Alarie, Kaitlynn; Rodriguez Suarez, Roberto; Huebner, Erwin; Roksandic, Ivan			Not of African Descent: Dental Modification among Indigenous Caribbean People from Canimar Abajo, Cuba	PLOS ONE			English	Article							TOOTH MUTILATION; SKELETAL REMAINS; CONSUMPTION; TEETH	Dental modifications in the Caribbean are considered to be an African practice introduced to the Caribbean archipelago by the influx of enslaved Africans during colonial times. Skeletal remains which exhibited dental modifications are by default considered to be Africans, African descendants, or post-contact indigenous people influenced by an African practice. Individual E-105 from the site of Canmar Abajo (Cuba), with a direct C-14 AMS date of 990800 cal BC, provides the first unequivocal evidence of dental modifications in the Antilles prior to contact with Europeans in AD 1492. Central incisors showing evidence of significant crown reduction (loss of crown volume regardless of its etiology) were examined macroscopically and with a scanning electron microscope (SEM) to determine if the observed alterations were due to deliberate modification or other (unintentional) factors considered: postmortem breakage, violent accidental breakage, non-dietary use of teeth, and wear caused by habitual or repeated actions. The pattern of crown reduction is consistent with deliberate dental modification of the type commonly encountered among African and African descendent communities in post-contact Caribbean archaeological assemblages. Six additional individuals show similar pattern of crown reduction of maxillary incisors with no analogous wear in corresponding mandibular dentition.	[Roksandic, Mirjana; Roksandic, Ivan] Univ Winnipeg, Dept Anthropol, 515 Portage Ave, Winnipeg, MB R3B 2E9, Canada; [Roksandic, Mirjana; Alarie, Kaitlynn] Univ Manitoba, Dept Anthropol, 66 Chancellors Circle, Winnipeg, MB R3T 2N2, Canada; [Rodriguez Suarez, Roberto] Univ La Habana, Museo Antropol Montane, Calle 25 455 Vedado, Havana 10400, Cuba; [Huebner, Erwin] Univ Manitoba, Dept Biol, 66 Chancellors Circle, Winnipeg, MB R3T 2N2, Canada	University of Winnipeg; University of Manitoba; Universidad de la Habana; University of Manitoba	Roksandic, M (corresponding author), Univ Winnipeg, Dept Anthropol, 515 Portage Ave, Winnipeg, MB R3B 2E9, Canada.; Roksandic, M (corresponding author), Univ Manitoba, Dept Anthropol, 66 Chancellors Circle, Winnipeg, MB R3T 2N2, Canada.	m.roksandic@uwinnipeg.ca	Roksandic, Mirjana/B-1812-2019	Roksandic, Mirjana/0000-0003-0291-6357	SSHRC Standard Research Grant SSHRC [410-2011-1179]	SSHRC Standard Research Grant SSHRC	The research was funded under SSHRC Standard Research Grant SSHRC - 410-2011-1179 to MR and IR (http://www.sshrc-crsh.gc.ca/homeaccueil-eng.aspx).	Alt KW, 1998, DENTAL ANTHROPOLOGY, P387; Andrefsky W., 2005, CAMB MAN ARCHAEOL, DOI DOI 10.1017/CBO9780511810244; [Anonymous], 1997, BONES MAYA STUDIES A; [Anonymous], 2003, ESTUD ANTHR BIOL, V11, P951; Bonfiglioli B, 2004, INT J OSTEOARCHAEOL, V14, P448, DOI 10.1002/oa.726; Buikstra J. E., 1994, RES SERIES ARKANSAS, V44; Buxton LHD, 1938, MAN, V38, P49, DOI 10.2307/2791870; de Armas YC, 2015, J ARCHAEOL SCI, V58, P121, DOI 10.1016/j.jas.2015.03.003; Constantino PJ, 2010, BIOL LETTERS, V6, P826, DOI 10.1098/rsbl.2010.0304; Constenla Umana A., 2012, INDIGENOUS LANGUAGES, P391, DOI 10.1515/9783110258035.391; de la Borbolla DFR, 1940, AM J PHYS ANTHROPOL, V26, P349, DOI 10.1002/ajpa.1330260136; Farabee WC, 1918, AM J PHYS ANTHROPOL, V1, P427, DOI 10.1002/ajpa.1330010403; Giusti Juan B., 1992, REV SALUS CULT, V4, P95; Goose, 1963, MAN, V63, P91; HANDLER JS, 1982, J HUM EVOL, V11, P297, DOI 10.1016/S0047-2484(82)80021-3; HANDLER JS, 1994, HIST ARCHAEOL, V28, P113, DOI 10.1007/BF03374193; Herrmann N.P., 1999, DENT ANTHR, V13, P9; IRISH JD, 1987, AM J PHYS ANTHROPOL, V73, P209, DOI 10.1002/ajpa.1330730207; Irish JD, 1997, AM J PHYS ANTHROPOL, V102, P141; Klein Herbert S., 2010, ATLANTIC SLAVE TRADE, V2nd; Lee JJW, 2011, BIOL REV, V86, P959, DOI 10.1111/j.1469-185X.2011.00181.x; MILNER GR, 1991, ADVANCES IN DENTAL ANTHROPOLOGY, P357; Molnar P, 2011, CLIN ORAL INVEST, V15, P681, DOI 10.1007/s00784-010-0447-1; ORTNER DJ, 1966, AM J PHYS ANTHROPOL, V25, P177, DOI 10.1002/ajpa.1330250212; Pagan-Jimenez JR, 2015, QUATERNARY SCI REV, V123, P231, DOI 10.1016/j.quascirev.2015.07.005; Price TD, 2006, AM J PHYS ANTHROPOL, V130, P485, DOI 10.1002/ajpa.20390; Rodriguez Ramos R., 2013, OXFORD HDB CARIBBEAN, P155, DOI 10.1093/OXFORDHB/9780195392302.013.0058; Roksandic I, 2015, P C INT ASS CAR ARCH; Roksandic M., 2002, ADV FORENSIC TAPHONO, P99; Roksandic M, 2015, RADIOCARBON, V57, P755, DOI 10.2458/azu_rc.57.18313; Roksandic M, 2011, AM J PHYS ANTHROPOL, V145, P337, DOI 10.1002/ajpa.21508; Romero Molina J., 1970, HDB MIDDLE AM INDIAN, V9, P50; Saul Julie Mather, 1997, BONES MAYA STUDIES A, P28; Sawyer D R, 1992, Ann Dent, V51, P24; Schroeder H, 2014, INT J OSTEOARCHAEOL, V24, P688, DOI 10.1002/oa.2253; Schroeder H, 2006, SAFA P; Schroeder H, 2015, P NATL ACAD SCI USA, V112, P3669, DOI 10.1073/pnas.1421784112; Scott GR, 2011, INT J OSTEOARCHAEOL, V21, P723, DOI 10.1002/oa.1184; Singer R, 1953, S AFR J SCI, V50, P116; Stewart TD, 1939, MAN, V39, P49, DOI 10.2307/2793034; Stewart TD, 1942, AM ANTHROPOL, V44, P328, DOI 10.1525/aa.1942.44.2.02a00260; STEWART TD, 1968, AM J PHYS ANTHROPOL, V28, P31, DOI 10.1002/ajpa.1330280112; Tiesler V, 2001, HOMO, V52, P277; TURNER CG, 1983, AM J PHYS ANTHROPOL, V61, P125, DOI 10.1002/ajpa.1330610113; van Duijvenbode Anne, 2011, COMMUNITIES CONTACT, P225; Van Reenen J.F., 1986, VARIATION CULTURE EV, P159; Wasterlain SN, 2016, INT J OSTEOARCHAEOL, V26, P621, DOI 10.1002/oa.2453	47	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153536	10.1371/journal.pone.0153536	http://dx.doi.org/10.1371/journal.pone.0153536			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ0NI	27071012	Green Published, gold, Green Submitted			2022-12-26	WOS:000373900700081
J	Chen, YW; Wang, HC; Gao, LH; Liu, C; Jiang, YX; Qu, H; Li, CY; Jiang, JH				Chen, Ya-Wen; Wang, Hai-Cheng; Gao, Long-Hua; Liu, Chang; Jiang, Yu-Xi; Qu, Hong; Li, Cui-Ying; Jiang, Jiu-Hui			Osteoclastogenesis in Local Alveolar Bone in Early Decortication-Facilitated Orthodontic Tooth Movement	PLOS ONE			English	Article							ACCELERATED OSTEOGENIC ORTHODONTICS; TRANSCRIPTION FACTOR; DIFFERENTIATION; EXPRESSION; REPAIR; CELLS; JDP2	Objective In the current study, we aimed to investigate the effects of alveolar decortication on local bone remodeling, and to explore the possible mechanism by which decortication facilitates tooth movement. Materials and Methods Forty rabbits were included in the experiment. The left mandible was subjected to decortication-facilitated orthodontics, and the right mandible underwent traditional orthodontics as a control. The animals were sacrificed on the days 1, 3, 5, 7 and 14, after undergoing orthodontic procedures. Tooth movement was measured by Micro-CT, and the local periodontal tissues were investigated using H&E, Masson's trichrome and tartrate-resistant acid phosphatase (TRAP) staining. The mRNA levels of genes related to bone remodeling in the alveolar bone were analyzed using real-time PCR. Result On days 3, 5, 7 and 14, tooth movement was statistically accelerated by decortication (P < 0.05) and was accompanied by increased hyperemia. Despite the lack of new bone formation in both groups, more osteoclasts were noted in the decorticated group, with two peak counts (P < 0.05). The first peak count was consistent with the maximum values of ctsk and TRAP expression, and the second peak counts accompanied the maximum nfatc1 and jdp2 expression. The increased fra2 expression and the ratio of rankl/ opg also accompanied the second peak counts. Conclusions Following alveolar decortication, osteoclastogenesis was initially induced to a greater degree than the new bone formation which was thought to have caused a regional acceleratory phenomenon (RAP). The amount of steoclastogenesis in the decorticated alveolar bone was found to have two peaks, perhaps due to attenuated local resistance. The first peak count in osteoclasts may have been due to previously existing osteoclast precursors, whereas the second may represent the differentiation of peripheral blood mononuclear cells which came from circulation as the result of hyperemia.	[Chen, Ya-Wen; Jiang, Jiu-Hui] Peking Univ, Sch & Hosp Stomatol, Dept Orthodont, 22 South Zhongguancun Ave, Beijing 100081, Peoples R China; [Chen, Ya-Wen] First Hosp Jiaxing, Dept Stomatol, 1882 Zhonghuan South Rd, Jiaxing 314001, Peoples R China; [Wang, Hai-Cheng] Tongji Univ, Sch & Hosp Stomatol, Dept Pathol, Shanghai Engn Res Ctr Tooth Restorat & Regenerat, Shanghai 200072, Peoples R China; [Gao, Long-Hua; Qu, Hong] Dalian Med Univ, Dept Orthodont, Coll Stomatol, 9 Lushun South Rd West, Dalian 116044, Peoples R China; [Liu, Chang] Shandong Univ, Sch Stomatol, Dept Orthodont, 44 Wenhua West Rd, Jinan 250012, Peoples R China; [Jiang, Yu-Xi] Binzhou Med Univ, Dept Stomatol, 346 Guanhai Rd, Yantai 264003, Peoples R China; [Li, Cui-Ying] Peking Univ, Sch & Hosp Stomatol, Cent Lab, 22 South Zhongguancun Ave, Beijing 100081, Peoples R China	Peking University; Tongji University; Dalian Medical University; Shandong University; Binzhou Medical University; Peking University	Jiang, JH (corresponding author), Peking Univ, Sch & Hosp Stomatol, Dept Orthodont, 22 South Zhongguancun Ave, Beijing 100081, Peoples R China.; Qu, H (corresponding author), Dalian Med Univ, Dept Orthodont, Coll Stomatol, 9 Lushun South Rd West, Dalian 116044, Peoples R China.; Li, CY (corresponding author), Peking Univ, Sch & Hosp Stomatol, Cent Lab, 22 South Zhongguancun Ave, Beijing 100081, Peoples R China.	hongqu22@hotmail.com; licuiying_67@163.com; drjiangw@163.com		Jiang, Yu-Xi/0000-0001-8261-2905	National Natural Science Foundation of China [81171006, 81571002]; Beijing Natural Science Foundation [7162203]; Beijing Science and Technology Committee [Z121107001012024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Science and Technology Committee	The authors appreciated the help from the Center lab of the Peking University, School of Stomatology. This study was supported by the National Natural Science Foundation of China (No. 81171006, 81571002) and Beijing Natural Science Foundation (No. 7162203) and also by the Beijing Science and Technology Committee. (No. Z121107001012024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abtahi M, 2014, J CLIN PEDIATR DENT, V38, P285, DOI 10.17796/jcpd.38.3.n04h7105121663t6; Amit Goyal, 2012, J Clin Exp Dent, V4, pe292, DOI 10.4317/jced.50822; Baloul SS, 2011, AM J ORTHOD DENTOFAC, V139, pS83, DOI 10.1016/j.ajodo.2010.09.026; Belibasakis GN, 2012, J CLIN PERIODONTOL, V39, P239, DOI 10.1111/j.1600-051X.2011.01810.x; Faienza MF, 2014, INT J MED SCI, V11, P356, DOI 10.7150/ijms.7793; Helali AM, 2013, CURR DRUG TARGETS, V14, P1591, DOI 10.2174/13894501113149990202; HERMANSON PC, 1972, ANGLE ORTHOD, V42, P107; Jin L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096519; Kawaida R, 2003, J EXP MED, V197, P1029, DOI 10.1084/jem.20021321; Kogawa M, 2013, J STEROID BIOCHEM, V136, P59, DOI 10.1016/j.jsbmb.2012.09.008; Lee W, 2008, J DENT RES, V87, P861, DOI 10.1177/154405910808700904; Liem AML, 2015, BRIT J ORAL MAX SURG, V53, P491, DOI 10.1016/j.bjoms.2015.03.009; Maruyama K, 2012, IMMUNITY, V37, P1024, DOI 10.1016/j.immuni.2012.08.022; Ming LG, 2013, ENDOCRINOLOGY, V154, P1202, DOI 10.1210/en.2012-2086; Mostafa YA, 2009, AM J ORTHOD DENTOFAC, V136, P570, DOI 10.1016/j.ajodo.2007.10.052; Mouline CC, 2010, EUR CELLS MATER, V20, P379; Murphy KG, 2009, J ORAL MAXIL SURG, V67, P2160, DOI 10.1016/j.joms.2009.04.124; Nozawa K, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2863; Owen Helen C, 2015, Intensive Care Med Exp, V3, P52, DOI 10.1186/s40635-015-0052-3; Park JW, 2013, J BIOMED MATER RES A, V101, P298, DOI 10.1002/jbm.a.34433; Puvaneswary S, 2013, INT J MED SCI, V10, P1608, DOI 10.7150/ijms.6496; Reifenrath J, 2014, J BIOMED MATER RES A, V102, P2884, DOI 10.1002/jbm.a.34920; Roberts-Harry D, 2004, BRIT DENT J, V196, P391, DOI 10.1038/sj.bdj.4811129; Schilling T, 1998, CALCIFIED TISSUE INT, V63, P160, DOI 10.1007/s002239900508; Sebaoun JD, 2008, J PERIODONTOL, V79, P1679, DOI [10.1902/jop.2008.080024, 10.1902/jop.2008.080024 ]; Teng GYY, 2014, J ORAL MAXIL SURG, V72, P19, DOI 10.1016/j.joms.2013.09.012; Wang HC, 2015, ORAL DIS, V21, P170, DOI 10.1111/odi.12231; Wang HC, 2013, ORAL DIS, V19, P162, DOI 10.1111/j.1601-0825.2012.01966.x; Wang L, 2009, AM J ORTHOD DENTOFAC, V136, DOI 10.1016/j.ajodo.2009.05.015; Wang ZL, 2015, MOL MED REP, V12, P3345, DOI 10.3892/mmr.2015.3795; Wattanaroonwong N, 2011, ARCH ORAL BIOL, V56, P212, DOI 10.1016/j.archoralbio.2010.10.004; Wilcko MT, 2009, J ORAL MAXIL SURG, V67, P2149, DOI 10.1016/j.joms.2009.04.095; Wilcko WM, 2001, INT J PERIODONT REST, V21, P9; Yamauchi K, 2015, CLIN IMPLANT DENT R, V17, pE376, DOI 10.1111/cid.12250; Yao C, 2014, J BIOL CHEM, V289, P6775, DOI 10.1074/jbc.M113.499210	35	19	20	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153937	10.1371/journal.pone.0153937	http://dx.doi.org/10.1371/journal.pone.0153937			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096621	gold, Green Published			2022-12-26	WOS:000374543600072
J	Piou, V; Tabart, J; Urrutia, V; Hemptinne, JL; Vetillard, A				Piou, Vincent; Tabart, Jeremy; Urrutia, Virginie; Hemptinne, Jean-Louis; Vetillard, Angelique			Impact of the Phoretic Phase on Reproduction and Damage Caused by Varroa destructor (Anderson and Trueman) to Its Host, the European Honey Bee (Apis mellifera L.)	PLOS ONE			English	Article							DEFORMED-WING VIRUS; JACOBSONI OUD; BROOD CELLS; FINDING BEHAVIOR; PCR ANALYSIS; DRONE BROOD; MITE; PARASITE; WORKER; INFESTATION	Varroa destructor is a parasitic mite of the honeybee that causes thousands of colony losses worldwide. The parasite cycle is composed of a phoretic and a reproductive phase. During the former, mites stay on adult bees, mostly on nurses, to feed on hemolymph. During the latter, the parasites enter brood cells and reproduce. We investigated if the type of bees on which Varroa stays during the phoretic phase and if the duration of this stay influenced the reproductive success of the parasite and the damage caused to bees. For that purpose, we used an in vitro rearing method developed in our laboratory to assess egg laying rate and the presence and number of fully molted daughters. The expression level of two Varroa vitellogenin genes (VdVg1 and VdVg2), known to vary throughout reproduction, was also quantified. Results showed that the status of the bees or time spent during the phoretic phase impacts neither reproduction parameters nor the Varroa vitellogenin genes levels of expression. However, we correlated these parameters to the gene expression and demonstrated that daughters expressed the vitellogenin genes at lower levels than their mother. Regarding the damage to bees, the data indicated that a longer stay on adult bees during the phoretic phase resulted in more frequent physical deformity in newborn bees. We showed that those mites carry more viral loads of the Deformed Wing Virus and hence trigger more frequently overt infections. This study provides new perspectives towards a better understanding of the Varroa-honeybee interactions.	[Piou, Vincent; Tabart, Jeremy; Urrutia, Virginie; Vetillard, Angelique] Ctr Univ Jean Francois Champoll, Lab Venins & Act Biol, EA 4357, PRES Univ Toulouse, Albi, France; [Hemptinne, Jean-Louis] Univ Toulouse 3, Lab Evolut & Divers Biol, ENFA, CNRS,UMR5174, F-31062 Toulouse, France	Universite Federale Toulouse Midi-Pyrenees (ComUE); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Ecole Nationale Formation Agronomique (ENSFEA)	Vetillard, A (corresponding author), Ctr Univ Jean Francois Champoll, Lab Venins & Act Biol, EA 4357, PRES Univ Toulouse, Albi, France.	angelique.vetillard@univ-jfc.fr			Region Midi-Pyrenees; CUFR JFC; Labex TULIP	Region Midi-Pyrenees(Region Provence-Alpes-Cote d'AzurRegion Occitanie); CUFR JFC; Labex TULIP	Financial support for this study was provided by Region Midi-Pyrenees and CUFR JFC. VP was supported by a grant from Region Midi-Pyrenees. JLH was supported by a grant from Labex TULIP. No additional external funding received for this study. The funders has no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adjlane N., 2014, Mellifera, V14, P3; Al-Ghzawi S., 1992, Apidologie, V23, P369; Anderson DL, 2000, EXP APPL ACAROL, V24, P165, DOI 10.1023/A:1006456720416; ANDERSON RM, 1978, J ANIM ECOL, V47, P219, DOI 10.2307/3933; Aupinel Pierrick, 2005, Bulletin of Insectology, V58, P107; Beetsma J, 1999, APIDOLOGIE, V30, P125, DOI 10.1051/apido:19990204; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; BOOT WJ, 1995, ENTOMOL EXP APPL, V75, P1, DOI 10.1007/BF02382773; Borst DW, 2000, INSECT BIOCHEM MOLEC, V30, P813, DOI 10.1016/S0965-1748(00)00053-9; Cabrera AR, 2013, INSECT MOL BIOL, V22, P505, DOI 10.1111/imb.12040; Cabrera AR, 2014, ARCH INSECT BIOCHEM, V85, P61, DOI 10.1002/arch.21143; Cabrera AR, 2009, J INSECT PHYSIOL, V55, P1079, DOI 10.1016/j.jinsphys.2009.08.007; Calderon RA, 2012, EXP APPL ACAROL, V56, P297, DOI 10.1007/s10493-012-9518-0; Chen YP, 2005, APPL ENVIRON MICROB, V71, P436, DOI 10.1128/AEM.71.1.436-441.2005; Cordon ARC, 2013, INSECT MOL BIOL, V22, P88, DOI 10.1111/imb.12006; Dainat B, 2013, J INVERTEBR PATHOL, V112, P278, DOI 10.1016/j.jip.2012.12.009; de Guzman LI, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.5.14; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS48, DOI 10.1016/j.jip.2009.06.012; Del Piccolo F, 2010, PARASITOLOGY, V137, P967, DOI 10.1017/S0031182009991867; DERUIJTER A, 1987, APIDOLOGIE, V18, P321, DOI 10.1051/apido:19870403; Di Prisco G, 2011, VIRUSES-BASEL, V3, P2425, DOI 10.3390/v3122425; Dietemann V, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.09; DONZE G, 1994, BEHAV ECOL SOCIOBIOL, V34, P305, DOI 10.1007/BF00197001; Donze G, 1996, ECOL ENTOMOL, V21, P17, DOI 10.1111/j.1365-2311.1996.tb00261.x; Francis RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057540; Frey E, 2013, J INVERTEBR PATHOL, V113, P56, DOI 10.1016/j.jip.2013.01.007; FUCHS S, 1989, APIDOLOGIE, V20, P257, DOI 10.1051/apido:19890308; FUCHS S, 1994, EXP APPL ACAROL, V18, P309, DOI 10.1007/BF00132320; Gisder S, 2009, J GEN VIROL, V90, P463, DOI 10.1099/vir.0.005579-0; IFANTIDIS MD, 1983, J APICULT RES, V22, P200, DOI 10.1080/00218839.1983.11100588; Khongphinitbunjong K, 2015, J INSECT PHYSIOL, V72, P28, DOI 10.1016/j.jinsphys.2014.11.005; Kirrane MJ, 2011, J ECON ENTOMOL, V104, P1146, DOI 10.1603/EC11035; Klowden MJ, 2013, PHYSIOLOGICAL SYSTEMS IN INSECTS, 3RD EDITION, P1; KUNKEL JG, 1976, J INSECT PHYSIOL, V22, P809, DOI 10.1016/0022-1910(76)90248-1; Lanzi G, 2006, J VIROL, V80, P4998, DOI 10.1128/JVI.80.10.4998-5009.2006; Martin S, 1997, EXP APPL ACAROL, V21, P539, DOI 10.1023/A:1018492231639; Martin S, 1998, ECOL MODEL, V109, P267, DOI 10.1016/S0304-3800(98)00059-3; MARTIN SJ, 1995, EXP APPL ACAROL, V19, P199, DOI 10.1007/BF00130823; MAY RM, 1978, J ANIM ECOL, V47, P249, DOI 10.2307/3934; NAZZI F, 1994, APIDOLOGIE, V25, P579, DOI 10.1051/apido:19940608; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Nordstrom S, 2003, EXP APPL ACAROL, V29, P293, DOI 10.1023/A:1025853731214; Oldroyd BP, 1999, TRENDS ECOL EVOL, V14, P312, DOI 10.1016/S0169-5347(99)01613-4; PAIN JANINE, 1966, ANN ABEILLE [PARIS], V9, P71, DOI 10.1051/apido:19660106; Pernal SF, 2005, EXP APPL ACAROL, V37, P1, DOI 10.1007/s10493-005-1117-x; Roberts JMK, 2015, MOL ECOL, V24, P2379, DOI 10.1111/mec.13185; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Ryabov EV, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004230; Samsinak K., 1972, Vcelarstvi, V25, P268; SCHULZ AE, 1984, APIDOLOGIE, V15, P401, DOI 10.1051/apido:19840404; SEELEY TD, 1991, ETHOLOGY, V87, P284; Solignac M, 2005, P ROY SOC B-BIOL SCI, V272, P411, DOI 10.1098/rspb.2004.2853; STEINER J, 1995, EXP APPL ACAROL, V19, P411, DOI 10.1007/BF00145158; Sturmer M., 1994, Apidologie, V25, P453; Tabart J, 2013, EXP APPL ACAROL, V61, P107, DOI 10.1007/s10493-013-9675-9; Tentcheva D, 2006, APIDOLOGIE, V37, P41, DOI 10.1051/apido:2005057; van Dooremalen C, 2013, J INSECT PHYSIOL, V59, P487, DOI 10.1016/j.jinsphys.2013.02.006; van Esch J., 1988, P57; Vetillard A, 2014, Liquid-tight and gas-permeable membrane, method for the production thereof, and use of such a membrane for the in vitro breeding of arthropods, Patent No. [WO2014086922A1, 2014086922]; Yue C, 2005, J GEN VIROL, V86, P3419, DOI 10.1099/vir.0.81401-0	60	18	20	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153482	10.1371/journal.pone.0153482	http://dx.doi.org/10.1371/journal.pone.0153482			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096154	gold, Green Published, Green Submitted			2022-12-26	WOS:000374543600038
J	Gao, SW; Yang, YY; Wang, CF; Guo, JL; Zhou, DG; Wu, QB; Su, YC; Xu, LP; Que, YX				Gao, Shiwu; Yang, Yingying; Wang, Chunfeng; Guo, Jinlong; Zhou, Dinggang; Wu, Qibin; Su, Yachun; Xu, Liping; Que, Youxiong			Transgenic Sugarcane with a cry1Ac Gene Exhibited Better Phenotypic Traits and Enhanced Resistance against Sugarcane Borer	PLOS ONE			English	Article							REAL-TIME PCR; COPY NUMBER; FIELD PERFORMANCE; PLANTS; EXPRESSION; RICE; TRANSFORMATION; REGENERATION; BAR; SELECTION	We developed sugarcane plants with improved resistance to the sugarcane borer, Diatraea saccharalis (F). An expression vector pGcry1Ac0229, harboring the cry1Ac gene and the selectable marker gene, bar, was constructed. This construct was introduced into the sugarcane cultivar FN15 by particle bombardment. Transformed plantlets were identified after selection with Phosphinothricin (PPT) and Basta. Plantlets were then screened by PCR based on the presence of cry1Ac and 14 cry1Ac positive plantlets were identified. Real-time quantitative PCR (RT-qPCR) revealed that the copy number of cry1Ac gene in the transgenic lines varied from 1 to 148. ELISA analysis showed that Cry1Ac protein levels in 7 transgenic lines ranged from 0.85 mu g/FWg to 70.92 mu g/FWg in leaves and 0.04 mu g/FWg to 7.22 mu g/FWg in stems, and negatively correlated to the rate of insect damage that ranged from 36.67% to 13.33%, respectively. Agronomic traits of six transgenic sugarcane lines with medium copy numbers were similar to the non-transgenic parental line. However, phenotype was poor in lines with high or low copy numbers. Compared to the non-transgenic control plants, all transgenic lines with medium copy numbers had relatively equal or lower sucrose yield and significantly improved sugarcane borer resistance, which lowered susceptibility to damage by insects. This suggests that the transgenic sugarcane lines harboring medium copy numbers of the cry1Ac gene may have significantly higher resistance to sugarcane borer but the sugarcane yield in these lines is similar to the non-transgenic control thus making them superior to the control lines.	[Gao, Shiwu; Yang, Yingying; Wang, Chunfeng; Guo, Jinlong; Zhou, Dinggang; Wu, Qibin; Su, Yachun; Xu, Liping; Que, Youxiong] Fujian Agr & Forestry Univ, Minist Agr, Key Lab Sugarcane Biol & Genet Breeding, Fuzhou 350002, Fujian, Peoples R China	Fujian Agriculture & Forestry University; Ministry of Agriculture & Rural Affairs	Xu, LP; Que, YX (corresponding author), Fujian Agr & Forestry Univ, Minist Agr, Key Lab Sugarcane Biol & Genet Breeding, Fuzhou 350002, Fujian, Peoples R China.	xlpmail@126.com; queyouxiong@126.com		Zhou, Dinggang/0000-0001-5665-9312; Que, Youxiong/0000-0003-1111-5834	National Nature Science Foundation of China [31271782]; earmarked fund for the Modern Agriculture Technology of China [CARS-20]; Scientific Research Fund of Fujian Provincial Education Department [JA12124]; Science and Technology Major Project of Fujian Province [2015NZ0002-2]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); earmarked fund for the Modern Agriculture Technology of China; Scientific Research Fund of Fujian Provincial Education Department; Science and Technology Major Project of Fujian Province	This work was supported by National Nature Science Foundation of China ( 31271782), the earmarked fund for the Modern Agriculture Technology of China (CARS-20) and Scientific Research Fund of Fujian Provincial Education Department (JA12124) and Science and Technology Major Project of Fujian Province (2015NZ0002-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arencibia A, 1997, MOL BREEDING, V3, P247, DOI 10.1023/A:1009616318854; Arvinth S, 2010, PLANT CELL REP, V29, P383, DOI 10.1007/s00299-010-0829-5; Chen H, 2005, THEOR APPL GENET, V111, P1330, DOI 10.1007/s00122-005-0062-8; D'Hont A, 2001, INTERNATIONAL SOCIETY OF SUGAR CANE TECHNOLOGISTS, VOL II, PROCEEDINGS, P556; De Bolle MFC, 2007, PLANT MOL BIOL, V63, P533, DOI 10.1007/s11103-006-9107-x; De Paepe A, 2009, PLANT J, V59, P517, DOI 10.1111/j.1365-313X.2009.03889.x; DELANNAY X, 1989, BIO-TECHNOL, V7, P1265; Dominguez A, 2000, PLANT CELL REP, V19, P427, DOI 10.1007/s002990050751; Falco MC, 2003, PLANT PHYSIOL BIOCH, V41, P761, DOI 10.1016/S0981-9428(03)00100-1; Fischer G, 2008, SUGARCANE ETHANOL: CONTRIBUTIONS TO CLIMATE CHANGE MITIGATION AND THE ENVIRONMENT, P29; FUJIMOTO H, 1993, BIO-TECHNOL, V11, P1151, DOI 10.1038/nbt1093-1151; GalloMeagher M, 1996, CROP SCI, V36, P1367, DOI 10.2135/cropsci1996.0011183X003600050047x; Gao SW, 2008, THESIS FUJIAN AGR FO; GORDONKAMM WJ, 1990, PLANT CELL, V2, P603, DOI 10.1105/tpc.2.7.603; Guo JL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/904769; Hansom S., 1999, Proceedings of the XXIII ISSCT Congress, New Delhi, India, 22-26 February, 1999. Volume 2, P278; Kalunke R. M., 2009, Sugar Tech, V11, P355, DOI 10.1007/s12355-009-0061-1; KNOWLES BH, 1986, J CELL SCI, V83, P89; KOZIEL MG, 1993, BIO-TECHNOL, V11, P194, DOI 10.1038/nbt0293-194; Li HF, 2010, J SHANXI AGR U, V30, P332; Luo SL, 2003, J HAINAN U NAT SCI, V21, P259; Manickavasagam M, 2004, PLANT CELL REP, V23, P134, DOI 10.1007/s00299-004-0794-y; Milligan SB, 2003, CROP SCI, V43, P1729, DOI 10.2135/cropsci2003.1729; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; PERLAK FJ, 1993, PLANT MOL BIOL, V22, P313, DOI 10.1007/BF00014938; PERLAK FJ, 1990, BIO-TECHNOL, V8, P939, DOI 10.1038/nbt1090-939; Raza G, 2010, AFR J BIOTECHNOL, V9, P8739; Ricaud C., 1989, DIS SUGARCANE MAJOR; Setamou M, 2002, J ECON ENTOMOL, V95, P469, DOI 10.1603/0022-0493-95.2.469; Song P, 2002, PLANT CELL REP, V20, P948, DOI 10.1007/s00299-001-0432-x; Suo GL, 2006, PLANT CELL REP, V25, P689, DOI 10.1007/s00299-006-0133-6; THOMPSON CJ, 1987, EMBO J, V6, P2519, DOI 10.1002/j.1460-2075.1987.tb02538.x; Tomkins JP, 1999, THEOR APPL GENET, V99, P419, DOI 10.1007/s001220051252; VAECK M, 1987, NATURE, V328, P33, DOI 10.1038/328033a0; VASIL V, 1992, BIO-TECHNOL, V10, P667, DOI 10.1038/nbt0692-667; Wei HR, 2003, J PLANT PHYSIOL, V160, P1241, DOI 10.1078/0176-1617-01086; Weng H, 2004, PLANT MOL BIOL REP, V22, P289, DOI 10.1007/BF02773139; Weng LX, 2011, TRANSGENIC RES, V20, P759, DOI 10.1007/s11248-010-9456-8; Weng LX, 2006, PEST MANAG SCI, V62, P178, DOI 10.1002/ps.1144; White WH, 2001, CROP SCI, V41, P1706, DOI 10.2135/cropsci2001.1706; Xue BT, 2014, INT J MOL SCI, V15, P8846, DOI 10.3390/ijms15058846; Yan Zhao, 2007, Journal of Genetics and Genomics, V34, P824, DOI 10.1016/S1673-8527(07)60093-9; Yang LT, 2005, PLANT CELL REP, V23, P759, DOI 10.1007/s00299-004-0881-0; Yang XiaoJie, 2011, Journal of Agricultural Biotechnology, V19, P221; Yang XiaoJie, 2010, Genomics and Applied Biology, V29, P125; Yi CX, 2008, ANAL BIOCHEM, V375, P150, DOI 10.1016/j.ab.2007.11.022; Zhangsun D, 2007, BIOLOGIA, V62, P386, DOI 10.2478/s11756-007-0096-2; Zhou DG, 2014, SCI REP-UK, V4, DOI 10.1038/srep04912	49	24	29	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153929	10.1371/journal.pone.0153929	http://dx.doi.org/10.1371/journal.pone.0153929			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093437	Green Published, Green Submitted, gold			2022-12-26	WOS:000374541200062
J	Wang, ZF; Chen, YP; Xie, SY; Lv, HK				Wang, Zhifang; Chen, Yaping; Xie, Shuyun; Lv, Huakun			Changing Epidemiological Characteristics of Hepatitis A in Zhejiang Province, China: Increased Susceptibility in Adults	PLOS ONE			English	Article							VACCINATION; DISEASES; ERA	Background Hepatitis A is a common acute hepatitis caused by hepatitis A virus (HAV). Annually, it affects 1.4 million people worldwide. Between 1991 and 1994, HAV infections were highly endemic in Zhejiang Province (China), with 78,720 reported HAV infections per year. Hepatitis A vaccine came on the market in 1995 and was implemented for voluntary immunization. Since 2008, hepatitis A vaccine has been integrated into the national childhood routine immunization program. Objective To understand the current epidemiological profile of hepatitis A in Zhejiang Province since hepatitis A vaccine has been available for nearly two decades. Methods This study used the 2005-2014 National Notifiable Diseases Reporting System data to evaluate the incidence rate of notified hepatitis A cases in Zhejiang Province. Results The overall trend of incidence rate of notified hepatitis A cases significantly decreased from 2005 to 2014 (P<0.001). During the study period, the reported incidence rate in individuals aged <= 19 years declined to the historically lowest record in 2014. Compared with individuals aged <= 19 years, those aged >= 20 years showed the highest incidence rate (P<0.001). Majority of HAV infected cases were Laborers, accounting for approximately 70% of reported cases. Conclusions Childhood immunization strategy with hepatitis A vaccine seemed to be effective in decreasing notified hepatitis A incidence rate in individuals aged <= 19 years. Those aged >= 20 years were observed to be the most susceptible population. The vast majority of hepatitis A cases were notified among Laborers. Therefore, we strongly suggest that future preventive and control measures should focus more on adults, particularly Laborers, in addition to the current childhood hepatitis A vaccination programme.	[Wang, Zhifang; Chen, Yaping; Xie, Shuyun; Lv, Huakun] Zhejiang Prov Ctr Dis Control & Prevent, Dept Immunizat Programme, Hangzhou, Zhejiang, Peoples R China; [Wang, Zhifang] Zhejiang Prov Ctr Dis Control & Prevent, Dept Environm & Occupat Hlth, Hangzhou, Zhejiang, Peoples R China	Zhejiang Provincial Center for Disease Control & Prevention; Zhejiang Provincial Center for Disease Control & Prevention	Lv, HK (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Dept Immunizat Programme, Hangzhou, Zhejiang, Peoples R China.	chinachichi@hotmail.com		Lv, Huakun/0000-0002-3420-6942	National Science Foundation for Young Scientists of China [31500751]	National Science Foundation for Young Scientists of China	This project was supported by the National Science Foundation for Young Scientists of China (grant no. 31500751, https://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list). Z.W. received this funding.	Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Brown GR, 2002, SOUTH MED J, V95, P826, DOI 10.1097/00007611-200295080-00010; Bruni R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149642; Cao JY, 2009, HEPATOL INT, V3, P356, DOI 10.1007/s12072-008-9116-8; Center for Disease Control and Prevention, 2015, SURV VIR HEP US 2012; Centers for Disease Control and Prevention, 2015, EPIDEMIOLOGY PREVENT, V13th, P135; Centre for Health Protection Department of Health Hong Kong Special Administrative Region, 2006, SCI COMM ENT INF FOO; Chen H, 1991, Zhonghua Liu Xing Bing Xue Za Zhi, V12, P87; Cui FQ, 2009, J EPIDEMIOL, V19, P189, DOI 10.2188/jea.JE20080087; Dai Y, 2003, CHIN J DIS CONTROL P, V7, P63; Division of viral hepatitis Centre for Disease Prevention and Control, 2013, SURVEILLANCE OF VIRA; Dong PM, 2012, J ZHENGZHOU U MED SC, V47, P94; European Centre for Disease Prevention and Control, 2014, ANN EP REP 2014 FOOD; Franco E, 2012, WORLD J HEPATOL, V4, P68, DOI 10.4254/wjh.v4.i3.68; Gossner C. M., 2015, EURO SURVEILL, V20; Jacobsen KH, 2005, INT J EPIDEMIOL, V34, P600, DOI 10.1093/ije/dyi062; Kong ZF, 2009, DIS SURVEILLANCE, V24, P301; Kong ZF, 2008, SHANGHAI J PREVENTIV, V20, P325; Lam E, 2015, HUM VACC IMMUNOTHER, V11, P2627, DOI 10.1080/21645515.2015.1096457; Liu Y, 2011, S CHINA J PREV MED, V37, P39; Mantovani SAS, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1164-9; Mao JS, 1991, VIRAL HEPATITIS CHIN, P111; Naing N N, 2000, Malays J Med Sci, V7, P10; Omar B. A, 2001, AGE STANDARDIZATION; SUI HT, 2007, CHINESE J VACCINES I, V13, P466; Tavoschi L, 2015, EUROSURVEILLANCE, V20, P20, DOI 10.2807/1560-7917.ES2015.20.29.21193; Tsou TP, 2011, VACCINE, V29, P2956, DOI 10.1016/j.vaccine.2011.02.001; Wang X.J., 2004, DIS SURVEILLANCE, V19, P290; Wasley A, 2006, EPIDEMIOL REV, V28, P101, DOI 10.1093/epirev/mxj012; Wick Jeannette Y, 2012, Consult Pharm, V27, P472, DOI 10.4140/TCP.n.2012.472; World Health Organization, 2015, HEP A; Xu SS, 2013, REV CONSTRUCTING URB; Xu ZY, 2008, J VIRAL HEPATITIS, V15, P33, DOI 10.1111/j.1365-2893.2008.01026.x; Yang H, 2009, OCCUP HLTH, V25, P953; Yao J, 2000, CHINA PLANNED IMMUNI, V6, P138; Zhang LJ, 2009, EPIDEMIOL INFECT, V137, P428, DOI 10.1017/S0950268808001337; Zhu CJ, 2014, ZHEJIANG PROVINCIAL; Zhuang FC, 2012, HEPAT MON, V12, P100, DOI 10.5812/hepatmon.838	38	12	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153804	10.1371/journal.pone.0153804	http://dx.doi.org/10.1371/journal.pone.0153804			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093614	Green Published, gold, Green Submitted			2022-12-26	WOS:000374541200044
J	Boca, SM; Nishida, M; Harris, M; Rao, S; Cheema, AK; Gill, K; Seol, H; Morgenroth, LP; Henricson, E; McDonald, C; Mah, JK; Clemens, PR; Hoffman, EP; Hathout, Y; Madhavan, S				Boca, Simina M.; Nishida, Maki; Harris, Michael; Rao, Shruti; Cheema, Amrita K.; Gill, Kirandeep; Seol, Haeri; Morgenroth, Lauren P.; Henricson, Erik; McDonald, Craig; Mah, Jean K.; Clemens, Paula R.; Hoffman, Eric P.; Hathout, Yetrib; Madhavan, Subha			Discovery of Metabolic Biomarkers for Duchenne Muscular Dystrophy within a Natural History Study	PLOS ONE			English	Article							DISEASE PROGRESSION; PROTEOMICS	Serum metabolite profiling in Duchenne muscular dystrophy (DMD) may enable discovery of valuable molecular markers for disease progression and treatment response. Serum samples from 51 DMD patients from a natural history study and 22 age-matched healthy volunteers were profiled using liquid chromatography coupled to mass spectrometry (LC-MS) for discovery of novel circulating serum metabolites associated with DMD. Fourteen metabolites were found significantly altered (1% false discovery rate) in their levels between DMD patients and healthy controls while adjusting for age and study site and allowing for an interaction between disease status and age. Increased metabolites included arginine, creatine and unknown compounds at m/z of 357 and 312 while decreased metabolites included creatinine, androgen derivatives and other unknown yet to be identified compounds. Furthermore, the creatine to creatinine ratio is significantly associated with disease progression in DMD patients. This ratio sharply increased with age in DMD patients while it decreased with age in healthy controls. Overall, this study yielded promising metabolic signatures that could prove useful to monitor DMD disease progression and response to therapies in the future.	[Boca, Simina M.; Nishida, Maki; Harris, Michael; Rao, Shruti; Madhavan, Subha] Georgetown Univ, Med Ctr, Innovat Ctr Biomed Informat, Washington, DC 20007 USA; [Boca, Simina M.; Cheema, Amrita K.; Gill, Kirandeep; Madhavan, Subha] Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20007 USA; [Boca, Simina M.] Georgetown Univ, Med Ctr, Dept Biostat Bioinformat & Biomath, Washington, DC 20007 USA; [Cheema, Amrita K.] Georgetown Univ, Med Ctr, Dept Biochem & Mol & Cellular Biol, Washington, DC 20007 USA; [Seol, Haeri; Morgenroth, Lauren P.; Hoffman, Eric P.; Hathout, Yetrib] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Seol, Haeri; Morgenroth, Lauren P.; Hoffman, Eric P.; Hathout, Yetrib] George Washington Univ, Washington, DC USA; [Henricson, Erik; McDonald, Craig] Univ Calif Davis, Sch Med, Dept Phys Med & Rehabil, Davis, CA 95616 USA; [Mah, Jean K.] Univ Calgary, Dept Pediat, Alberta Childrens Hosp, Calgary, AB T2N 1N4, Canada; [Clemens, Paula R.] Dept Veteran Affairs Med Ctr, Neurol Serv, Pittsburgh, PA USA; [Clemens, Paula R.] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA	Georgetown University; Georgetown University; Georgetown University; Georgetown University; Children's National Health System; George Washington University; University of California System; University of California Davis; Alberta Childrens Hospital; University of Calgary; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Boca, SM (corresponding author), Georgetown Univ, Med Ctr, Innovat Ctr Biomed Informat, Washington, DC 20007 USA.; Boca, SM (corresponding author), Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20007 USA.; Boca, SM (corresponding author), Georgetown Univ, Med Ctr, Dept Biostat Bioinformat & Biomath, Washington, DC 20007 USA.	smb310@georgetown.edu	Boca, Simina/ABE-3747-2020	Boca, Simina/0000-0002-1400-3398; Rao, Shruti/0000-0002-7235-0777; McDonald, Craig/0000-0002-8779-3220; Cheema, Amrita/0000-0003-4877-7583; Harris, Michael/0000-0001-8789-0912; Hoffman, Eric/0000-0001-6470-5139	National Institutes of Health/National Cancer Institute [P30CA051008]; National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01AR062380, P50AR060836]; NIH/NCI [P30CA051008]; NIH/NIAMS [R01AR062380, P50AR060836]; NATIONAL CANCER INSTITUTE [P30CA051008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062380, P50AR060836, R01AR061875] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The following grants contributed to the funding of this study: National Institutes of Health/National Cancer Institute grant P30CA051008 (for the Proteomics and Metabolomics shared resource), https://taggs.hhs.gov/AwardDetail.cfm?s_Award_Num=P30CA051008& National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases grant R01AR062380 (PI: CM, funded authors: SMB, HS, LPM, EH, CM, SM), https://taggs.hhs.gov/AwardDetail.cfm?s_Award_Num=R01AR062380& National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases grant P50AR060836 (PI: PRC, funded authors: PRC, EPH), https://taggs.hhs.gov/AwardDetail.cfm?s_Award_Num=P50AR060836&n_Prog_Office_Code=106.; We wish to acknowledge the advice provided by Difei Wang and Hilary Parker. The authors would also like to acknowledge the Proteomics and Metabolomics shared resource partially supported by NIH/NCI grant P30CA051008. This work was supported by the NIH/NIAMS grants R01AR062380 (PI: Craig McDonald) and partially by the P50AR060836 (PI: Paula Clemens). The authors take full responsibility for the contents of this manuscript, which do not represent the views of the Department of Veterans Affairs or the U.S. Government. The authors would like to thank the patients and families who have volunteered their time to take part in this project. We would also like to thank the dedicated CINRG researchers who continue to commit countless hours. The CINRG network sites that contributed to this project include: University of California, Davis-Ted Abresch, Michelle Cregan, Erica Goude, Merete Glick, Linda Johnson, Jay Han, Erik Henricson, Nanette Joyce; Holland Bloorview Kids Rehabilitation-Laila Eliasoph, Elizabeth Hosaki, Angela Gonzales, Vivienne Harris; Alberta Children's Hospital-Angela Chiu, Karla Sanchez, Natalia Rincon, Tiffany Haig; Queen Silvia Children's Hospital-Anne-Christine Alhander, Lisa Wahlgren, Anne-Berit Ekstrom, AnnaKarin Kroksmark, Ulrika Sterky; Children's National Medical Center-Marissa Birkmeier, Sarah Kaminski, Allyn Toles; Royal Children's Hospital-Kate Carroll, Katy DeValle, Rachel Kennedy, Andrew Kornberg, Dani Villano; Hadassah Hebrew University Hospital-Adina Bar Leve, Elana Wisband, Debbie Yaffe; Instituto de Neurosciencias Fundacion Favaloro-Luz Andreone, Jose Corderi, Lilia Mesa, Lorena Levi; Children's Hospital of Pittsburgh of UPMC and the University of Pittsburgh-Hoda Abdel-Hamid, Christopher Bise, Ann Craig, Casey Nguyen, Andrea Smith, Jason Weimer; Washington University, St. Louis-M. Al-Lozi, Julaine Florence, Betsy Malkus, Renee Renna, Jeanine Schierbacker, Catherine Seiner, Charlie Wulf; Children's Hospital of Virginia-Susan Blair, Barbara Grillo, Karen Jones, Eugenio Monasterio; University of Tennessee, Memphis-Meegan Barrett-Adair, Judy Clift, Cassandra Feliciano, Rachel Young; Children's Hospital of Westmead-Kristy Rose, Richard Webster, Stephanie Wicks; University of Alberta-Lucia Chen, Cameron Kennedy; The CINRG Coordinating Center- Adrienne Arrieta, Tanisha Brown-Caines, Avital Cnaan, Tina Duong, Fengming Hu, Lauren Morgenroth, Wenze Tang.	Abate-Shen C, 2009, NATURE, V457, P799, DOI 10.1038/457799a; Ayoglu B, 2014, EMBO MOL MED, V6, P918, DOI 10.15252/emmm.201303724; Bello L, 2015, NEUROLOGY S, V84; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; Cacchiarelli D, 2011, EMBO MOL MED, V3, P258, DOI 10.1002/emmm.201100133; DANIELI GA, 1977, HUM GENET, V35, P225, DOI 10.1007/BF00393974; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; Griffin JL, 2009, GENOME MED, V1, DOI 10.1186/gm32; Guertin KA, 2014, AM J CLIN NUTR; Hathout Y, 2014, HUM MOL GENET; Hathout Y, 2015, P NATL ACAD SCI USA, V112, P7153, DOI 10.1073/pnas.1507719112; Henricson EK, 2013, MUSCLE NERVE, V48, P55, DOI 10.1002/mus.23808; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hoffman EP, 2013, DISCOV MED, V16, P233; Jansson J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006386; Kamburov A, 2013, NUCLEIC ACIDS RES, V41, pD793, DOI 10.1093/nar/gks1055; Kuhl C, 2012, ANAL CHEM, V84, P283, DOI 10.1021/ac202450g; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Mah JK, 2014, NEUROMUSCULAR DISORD, V24, P482, DOI 10.1016/j.nmd.2014.03.008; Martin FC, 2014, PROTEOM CLIN APPL, V8, P269, DOI 10.1002/prca.201300072; McAdam Laura C, 2012, Acta Myol, V31, P16; McDonald CM, 2013, MUSCLE NERVE, V48, P32, DOI 10.1002/mus.23807; MORRISON D, 1994, RESP MED, V88, P659, DOI 10.1016/S0954-6111(05)80062-9; Nadarajah VD, 2011, NEUROMUSCULAR DISORD, V21, P569, DOI 10.1016/j.nmd.2011.05.011; OKINAKA S, 1961, ARCH NEUROL-CHICAGO, V4, P520, DOI 10.1001/archneur.1961.00450110050006; PEARL J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; PLAUCHU H, 1981, J GENET HUM, V29, P59; Rouillon J, 2014, NEUROMUSCULAR DISORD, V24, P563, DOI 10.1016/j.nmd.2014.03.012; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Suhre K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013953; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wishart DS, 2012, NUCLEIC ACIDS RES; Zaharieva IT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080263; Zhang H, 2015, DIS MARKERS	39	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153461	10.1371/journal.pone.0153461	http://dx.doi.org/10.1371/journal.pone.0153461			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082433	Green Submitted, gold, Green Accepted, Green Published			2022-12-26	WOS:000374291800021
J	Churbanov, AY; Karafet, TM; Morozov, IV; Mikhalskaia, VY; Zytsar, MV; Bondar, AA; Posukh, OL				Churbanov, Alexander Y.; Karafet, Tatiana M.; Morozov, Igor V.; Mikhalskaia, Valeriia Yu; Zytsar, Marina V.; Bondar, Alexander A.; Posukh, Olga L.			Whole Exome Sequencing Reveals Homozygous Mutations in RAI1, OTOF, and SLC26A4 Genes Associated with Nonsyndromic Hearing Loss in Altaian Families (South Siberia)	PLOS ONE			English	Article							SMITH-MAGENIS-SYNDROME; ENLARGED VESTIBULAR AQUEDUCT; ACID-INDUCED 1; RETINOIC ACID; 17P11.2 DELETIONS; PENDRED-SYNDROME; PDS MUTATIONS; MOUSE MODELS; INNER-EAR; PROTEIN	Hearing loss (HL) is one of the most common sensorineural disorders and several dozen genes contribute to its pathogenesis. Establishing a genetic diagnosis of HL is of great importance for clinical evaluation of deaf patients and for estimating recurrence risks for their families. Efforts to identify genes responsible for HL have been challenged by high genetic heterogeneity and different ethnic-specific prevalence of inherited deafness. Here we present the utility of whole exome sequencing (WES) for identifying candidate causal variants for previously unexplained nonsyndromic HL of seven patients from four unrelated Altaian families (the Altai Republic, South Siberia). The WES analysis revealed homozygous missense mutations in three genes associated with HL. Mutation c.2168A>G (SLC26A4) was found in one family, a novel mutation c.1111G>C (OTOF) was revealed in another family, and mutation c.5254G>A (RAI1) was found in two families. Sanger sequencing was applied for screening of identified variants in an ethnically diverse cohort of other patients with HL (n = 116) and in Altaian controls (n = 120). Identified variants were found only in patients of Altaian ethnicity (n = 93). Several lines of evidences support the association of homozygosity for discovered variants c.5254G>A (RAI1), c.1111C>G (OTOF), and c.2168A>G (SLC26A4) with HL in Altaian patients. Local prevalence of identified variants implies possible founder effect in significant number of HL cases in indigenous population of the Altai region. Notably, this is the first reported instance of patients with RAI1 missense mutation whose HL is not accompanied by specific traits typical for Smith-Magenis syndrome. Presumed association of RAI1 gene variant c.5254G>A with isolated HL needs to be proved by further experimental studies.	[Churbanov, Alexander Y.; Karafet, Tatiana M.] Univ Arizona, Arizona Res Labs, Div Biotechnol, Tucson, AZ USA; [Morozov, Igor V.; Bondar, Alexander A.] Russian Acad Sci, Siberian Branch, Inst Chem Biol & Fundamental Med, SB RAS Genom Core Facil, Novosibirsk, Russia; [Morozov, Igor V.; Mikhalskaia, Valeriia Yu; Zytsar, Marina V.; Posukh, Olga L.] Novosibirsk State Univ, Novosibirsk 630090, Russia; [Mikhalskaia, Valeriia Yu; Zytsar, Marina V.; Posukh, Olga L.] Russian Acad Sci, Siberian Branch, Fed Res Ctr Inst Cytol & Genet, Lab Human Mol Genet, Novosibirsk, Russia	University of Arizona; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Novosibirsk State University; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS	Posukh, OL (corresponding author), Novosibirsk State Univ, Novosibirsk 630090, Russia.; Posukh, OL (corresponding author), Russian Acad Sci, Siberian Branch, Fed Res Ctr Inst Cytol & Genet, Lab Human Mol Genet, Novosibirsk, Russia.	posukh@bionet.nsc.ru	Morozov, Igor/AAH-5352-2021; Danilchenko, Valeriia/AAD-8799-2020; Posukh, Olga L/Q-6065-2016; Bondar, Alexander/AAA-7087-2020; Zytzar, Marina/AAG-1707-2021	Morozov, Igor/0000-0002-0307-4203; Danilchenko, Valeriia/0000-0001-5658-5974; Posukh, Olga L/0000-0003-1352-3591; Bondar, Alexander/0000-0001-9181-0487; 	Chinese Academy of Sciences Fellowship for Young International Scientists [2011Y1SA09]; NSFC [31150110466]; Siberian Branch of the Russian Academy of Sciences [0324-2015-0004, 0324-2015-0031]	Chinese Academy of Sciences Fellowship for Young International Scientists; NSFC(National Natural Science Foundation of China (NSFC)); Siberian Branch of the Russian Academy of Sciences(Russian Academy of Sciences)	This work was supported by grant #2011Y1SA09 from the Chinese Academy of Sciences Fellowship for Young International Scientists and NSFC grant #31150110466 (to AYC), by the State Project #0324-2015-0004, and by grant #0324-2015-0031 from the Siberian Branch of the Russian Academy of Sciences (to OLP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bi WM, 2007, HUM MOL GENET, V16, P1802, DOI 10.1093/hmg/ddm128; Bi W, 2006, AM J MED GENET A, V140A, P2454, DOI 10.1002/ajmg.a.31510; Bi WM, 2005, HUM MOL GENET, V14, P983, DOI 10.1093/hmg/ddi085; Bi WM, 2004, HUM GENET, V115, P515, DOI 10.1007/s00439-004-1187-6; Bok J, 2011, P NATL ACAD SCI USA, V108, P161, DOI 10.1073/pnas.1010547108; Carmona-Mora P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045155; Carmona-Mora P, 2010, CURR GENOMICS, V11, P607, DOI 10.2174/138920210793360952; Carmona-Mora P, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-63; Choi BY, 2009, CLIN GENET, V75, P237, DOI 10.1111/j.1399-0004.2008.01128.x; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Di Cicco M, 2001, INT J PEDIATR OTORHI, V59, P147, DOI 10.1016/S0165-5876(01)00475-X; Diaz-Horta O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050628; Du W, 2013, INT J PEDIATR OTORHI, V77, P1670, DOI 10.1016/j.ijporl.2013.07.023; Edelman EA, 2007, CLIN GENET, V71, P540, DOI 10.1111/j.1399-0004.2007.00815.x; Elsea SH, 2008, EUR J HUM GENET, V16, P412, DOI 10.1038/sj.ejhg.5202009; Elsea SH, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001827; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; Fragoso YD, 2015, BRAIN STRUCT FUNCT, V220, P1195, DOI 10.1007/s00429-014-0712-1; Frenz DA, 2010, AM J MED GENET A, V152A, P2947, DOI 10.1002/ajmg.a.33670; Girirajan S, 2005, J MED GENET, V42, P820, DOI 10.1136/jmg.2005.031211; Girirajan S, 2009, CLIN GENET, V75, P364, DOI 10.1111/j.1399-0004.2008.01135.x; Girirajan S, 2006, GENET MED, V8, P417, DOI 10.1097/01.gim.0000228215.32110.89; Girotto G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080323; GREENBERG F, 1991, AM J HUM GENET, V49, P1207; Hayes S, 2000, HUM MOL GENET, V9, P1753, DOI 10.1093/hmg/9.12.1753; IMAI Y, 1995, MOL BRAIN RES, V31, P1, DOI 10.1016/0169-328X(95)00020-S; Joober R, 1999, AM J MED GENET, V88, P694, DOI 10.1002/(SICI)1096-8628(19991215)88:6<694::AID-AJMG20>3.3.CO;2-9; KELLEY MW, 1993, DEVELOPMENT, V119, P1041; Kim HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079063; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lacaria M, 2013, AM J MED GENET A, V161A, P1561, DOI 10.1002/ajmg.a.35941; Liburd N, 2001, HUM GENET, V109, P535, DOI 10.1007/s004390100604; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Mahdieh N, 2012, INT J PEDIATR OTORHI, V76, P1610, DOI 10.1016/j.ijporl.2012.07.030; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Pangrsic T, 2012, TRENDS NEUROSCI, V35, P671, DOI 10.1016/j.tins.2012.08.002; Park HJ, 2003, J MED GENET, V40, P242, DOI 10.1136/jmg.40.4.242; Posukh O, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-12; Potapov L.P., 1969, ETHNICAL STRUCTURE O; Potocki L, 2007, AM J HUM GENET, V80, P633, DOI 10.1086/512864; Raz Y, 1999, DEV BIOL, V213, P180, DOI 10.1006/dbio.1999.9364; Redin C, 2014, J MED GENET, V51, P724, DOI 10.1136/jmedgenet-2014-102554; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rodriguez-Ballesteros M, 2008, HUM MUTAT, V29, P823, DOI 10.1002/humu.20708; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shearer AE, 2010, P NATL ACAD SCI USA, V107, P21104, DOI 10.1073/pnas.1012989107; Slager RE, 2003, NAT GENET, V33, P466, DOI 10.1038/ng1126; Smith R.J.H., 1993, GENEREVIEWS; Toulouse A, 2003, GENOMICS, V82, P162, DOI 10.1016/S0888-7543(03)00101-0; Truong HT, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-142; Tsukamoto K, 2003, EUR J HUM GENET, V11, P916, DOI 10.1038/sj.ejhg.5201073; Usami S, 1999, HUM GENET, V104, P188, DOI 10.1007/s004390050933; van der Zwaag B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005324; Vieira GH, 2012, EUR J HUM GENET, V20, P148, DOI 10.1038/ejhg.2011.167; Walsh T, 2010, AM J HUM GENET, V87, P90, DOI 10.1016/j.ajhg.2010.05.010; Wang DY, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-79; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Williams SR, 2012, AM J HUM GENET, V90, P941, DOI 10.1016/j.ajhg.2012.04.013; Woo HM, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-72; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Yasunaga S, 2000, AM J HUM GENET, V67, P591, DOI 10.1086/303049; YLIKOSKI J, 1994, J COMP NEUROL, V349, P596, DOI 10.1002/cne.903490407	63	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153841	10.1371/journal.pone.0153841	http://dx.doi.org/10.1371/journal.pone.0153841			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082237	Green Submitted, Green Published, gold			2022-12-26	WOS:000374291800056
J	Rume, FI; Affuso, A; Serrecchia, L; Rondinone, V; Manzulli, V; Campese, E; Di Taranto, P; Biswas, PK; Ahsan, CR; Yasmin, M; Fasanella, A; Hugh-Jones, M				Rume, Farzana Islam; Affuso, Alessia; Serrecchia, Luigina; Rondinone, Valeria; Manzulli, Viviana; Campese, Emanuele; Di Taranto, Pietro; Biswas, Paritosh Kumar; Ahsan, Chowdhury Rafiqul; Yasmin, Mahmuda; Fasanella, Antonio; Hugh-Jones, Martin			Genotype Analysis of Bacillus anthracis Strains Circulating in Bangladesh	PLOS ONE			English	Article							OUTBREAK	In Bangladesh, anthrax, caused by the bacterium Bacillus anthracis, is considered an endemic disease affecting ruminants with sporadic zoonotic occurrences in humans. Due to the lack of knowledge about risks from an incorrect removal of infected carcasses, the disease is not properly monitored, and because of the socio-economic conditions, the situation is under-reported and under-diagnosed. For sensitive species, anthrax represents a fatal outcome with sudden death and sometimes bleeding from natural orifices. The most common source of infection for ruminants is ingestion of spores during grazing in contaminated pastures or through grass and water contaminated with anthrax spores. Domestic cattle, sheep and goats can also become infected through contaminated bone meal (used as feed) originating from anthrax-infected carcasses. The present investigation was conducted to isolate B. anthracis organisms from 169 samples (73 soil, 1 tissue, 4 bone and 91 bone meal samples) collected from 12 different districts of Bangladesh. The sampling was carried out from 2012 to 2015. Twelve samples resulted positive for B. anthracis. Biomolecular analyses were conducted starting from the Canonical Single Nucleotide Polymorphism (CanSNP) to analyze the phylogenetic origin of strains. The analysis of genotype, obtained through the Multiple Locus Variable Number Tandem Repeat Analysis (MLVA) with the analysis of 15 Variable Number Tandem Repeats (VNTR), demonstrated four different genotypes: two of them were previously identified in the district of Sirajganj. The sub-genotyping, conducted with Single Nucleotide Repeats analysis, revealed the presence of eight subgenotypes. The data of the present study concluded that there was no observed correlation between imported cattle feed and anthrax occurrence in Bangladesh and that the remarkable genetic variations of B. anthracis were found in the soil of numerous outbreaks in this country.	[Affuso, Alessia; Serrecchia, Luigina; Rondinone, Valeria; Manzulli, Viviana; Campese, Emanuele; Di Taranto, Pietro; Fasanella, Antonio] Anthrax Reference Inst Italy, Ist Zooprofilatt Sperimentale Puglia & Basilicata, Foggia, Italy; [Rume, Farzana Islam; Ahsan, Chowdhury Rafiqul; Yasmin, Mahmuda] Univ Dhaka, Dept Microbiol, Dhaka 1000, Bangladesh; [Biswas, Paritosh Kumar] Chittagong Vet & Anim Sci Univ, Dept Microbiol & Vet Publ Hlth, Chittagong, Bangladesh; [Rume, Farzana Islam] Patuakhali Sci & Technol Univ, Dept Microbiol & Virol, Patuakhali, Bangladesh; [Hugh-Jones, Martin] Louisiana State Univ, Sch Coast & Environm, Baton Rouge, LA 70803 USA	IZS Puglia e Basilicata; University of Dhaka; Louisiana State University System; Louisiana State University	Affuso, A (corresponding author), Anthrax Reference Inst Italy, Ist Zooprofilatt Sperimentale Puglia & Basilicata, Foggia, Italy.	alessia.affuso@gmail.com	Manzulli, Viviana/AAC-4932-2022	RONDINONE, VALERIA/0000-0001-7842-8697; Di Taranto, Pietro/0000-0002-0805-9360	Ministry of Health of Italy [IZSPB 06/13]; Bangladesh Academy of Sciences under BAS-USDA Program in Agricultural and Life Sciences	Ministry of Health of Italy(Ministry of Health, Italy); Bangladesh Academy of Sciences under BAS-USDA Program in Agricultural and Life Sciences	This study was funded by the Ministry of Health of Italy, Current Research 2013 "IZSPB 06/13" that supported the work of Istituto Zooprofilattico Sperimentale of Puglia and Basilicata. Work of FIR in Bangladesh was funded by the Bangladesh Academy of Sciences under BAS-USDA Program in Agricultural and Life Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed BN, 2010, BANG J MED MICROBIOL, V4, P46, DOI [10.3329/bjmm.v4i1.8470, DOI 10.3329/BJMM.V4I1.8470]; Ahsan MM, 2013, THAI J VET MED, V43, P449; Biswas PK, 2012, EPIDEMIOL INFECT, V140, P1888, DOI 10.1017/S0950268811002408; DAVIES DG, 1972, J HYG-CAMB, V70, P455, DOI 10.1017/S0022172400063038; DRAGON DC, 1995, CAN VET J, V36, P295; Fasanella A, 2013, EPIDEMIOL INFECT, V141, P1021, DOI 10.1017/S0950268812001227; Fasanella A, 2001, VACCINE, V19, P4214, DOI 10.1016/S0264-410X(01)00159-1; Fasanella A, 2013, VIRULENCE, V4, P659, DOI 10.4161/viru.26517; Fasanella A, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-167; Fowler R. A., 2011, Journal of Bioterrorism and Biodefense, V2, P107; Hugh-Jones M, 2009, MOL ASPECTS MED, V30, P356, DOI 10.1016/j.mam.2009.08.003; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Jayedul Hassan, 2015, Journal of Advanced Veterinary and Animal Research, V2, P158; Keim P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000; Kenefic LJ, 2008, LETT APPL MICROBIOL, V46, P600, DOI 10.1111/j.1472-765X.2008.02353.x; Mongoh MN, 2008, ZOONOSES PUBLIC HLTH, V55, P279, DOI 10.1111/j.1863-2378.2008.01135.x; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461; WHO, 2008, ANTHRAX HUMANS ANIMA	18	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153548	10.1371/journal.pone.0153548	http://dx.doi.org/10.1371/journal.pone.0153548			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082248	gold, Green Published, Green Submitted			2022-12-26	WOS:000374291800029
J	Biedron, R; Perun, A; Jozefowski, S				Biedron, Rafal; Perun, Angelika; Jozefowski, Szczepan			CD36 Differently Regulates Macrophage Responses to Smooth and Rough Lipopolysaccharide	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTOR; LOW-DENSITY-LIPOPROTEIN; SCAVENGER RECEPTOR; ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS; ANCHORED PROTEINS; SR-A; LPS; CD14; ENDOCYTOSIS	Lipopolysaccharide (LPS) is the major pathogen-associated molecular pattern of Gram-negative bacterial infections, and includes smooth (S-LPS) and rough (R-LPS) chemotypes. Upon activation by LPS through CD14, TLR4/MD-2 heterodimers sequentially induce two waves of intracellular signaling for macrophage activation: the MyD88-dependent pathway from the plasma membrane and, following internalization, the TRIF-dependent pathway from endosomes. We sought to better define the role of scavenger receptors CD36 and CD204/SR-A as accessory LPS receptors that can contribute to pro-inflammatory and microbicidal activation of macrophages. We have found that CD36 differently regulates activation of mouse macrophages by S-LPS versus R-LPS. The ability of CD36 to substitute for CD14 in loading R-LPS, but not S-LPS onto TLR4/MD-2 allows CD14-independent macrophage responses to R-LPS. Conversely, S-LPS, but not R-LPS effectively stimulates CD14 binding to CD36, which favors S-LPS transfer from CD14 onto TLR4/MD-2 under conditions of low CD14 occupancy with S-LPS in serum-free medium. In contrast, in the presence of serum, CD36 reduces S-LPS binding to TLR4/MD-2 and the subsequent MyD88-dependent signaling, by mediating internalization of S-LPS/CD14 complexes. Additionally, CD36 positively regulates activation of TRIF-dependent signaling by both S-LPS and R-LPS, by promoting TLR4/MD-2 endocytosis. In contrast, we have found that SR-A does not function as a S-LPS receptor. Thus, by co-operating with CD14 in both R-and S-LPS loading onto TLR4/MD-2, CD36 can enhance the sensitivity of tissue-resident macrophages in detecting infections by Gram-negative bacteria. However, in later phases, following influx of serum to the infection site, the CD36-mediated negative regulation of MyD88-dependent branch of S-LPS-induced TLR4 signaling might constitute a mechanism to prevent an excessive inflammatory response, while preserving the adjuvant effect of S-LPS for adaptive immunity.	[Biedron, Rafal; Perun, Angelika; Jozefowski, Szczepan] Jagiellonian Univ, Coll Med, Dept Immunol, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University	Jozefowski, S (corresponding author), Jagiellonian Univ, Coll Med, Dept Immunol, Krakow, Poland.	szczepan.jozefowski@uj.edu.pl	Biedron, Rafal/AAN-9034-2020		National Science Centre, Poland [2012/05/B/NZ6/00813]; Jagiellonian University Medical College [K/ZDS/004602]; Leading National Research Centre (KNOW)	National Science Centre, Poland(National Science Centre, Poland); Jagiellonian University Medical College; Leading National Research Centre (KNOW)	This study was supported by grants from the National Science Centre, Poland (grant no. 2012/05/B/NZ6/00813) and from the Jagiellonian University Medical College (grant no. K/ZDS/004602). The publication fee was covered by the Leading National Research Centre (KNOW) 2012-2017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi S, 2003, J EXP MED, V198, P1035, DOI 10.1084/jem.20031076; Aksoy E, 2012, NAT IMMUNOL, V13, P1045, DOI 10.1038/ni.2426; ASHKENAS J, 1993, J LIPID RES, V34, P983; Baranova IN, 2008, J IMMUNOL, V181, P7147, DOI 10.4049/jimmunol.181.10.7147; Biedron R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123293; Bjorkbacka H, 2004, PHYSIOL GENOMICS, V19, P319, DOI 10.1152/physiolgenomics.00128.2004; Chadda R, 2007, TRAFFIC, V8, P702, DOI 10.1111/j.1600-0854.2007.00565.x; Chiang CY, 2012, J BIOL CHEM, V287, P3704, DOI 10.1074/jbc.C111.328559; Collins RF, 2009, J BIOL CHEM, V284, P30288, DOI 10.1074/jbc.M109.045104; Cotena A, 2004, J IMMUNOL, V173, P6427, DOI 10.4049/jimmunol.173.10.6427; Czerkies M, 2013, IMMUNOBIOLOGY, V218, P1217, DOI 10.1016/j.imbio.2013.04.005; Drummond R, 2013, INNATE IMMUN-LONDON, V19, P30, DOI 10.1177/1753425912449548; Durrbach A, 1996, J CELL SCI, V109, P457; Fujimoto LM, 2000, TRAFFIC, V1, P161, DOI 10.1034/j.1600-0854.2000.010208.x; Gandhapudi SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056855; Gangloff SC, 2005, J IMMUNOL, V175, P3940, DOI 10.4049/jimmunol.175.6.3940; Gauthier NC, 2007, J CELL BIOL, V177, P343, DOI 10.1083/jcb.200609061; GOLDMAN RC, 1982, J BACTERIOL, V151, P1210, DOI 10.1128/JB.151.3.1210-1221.1982; HAILMAN E, 1994, J EXP MED, V179, P269, DOI 10.1084/jem.179.1.269; HAMPTON RY, 1991, NATURE, V352, P342, DOI 10.1038/352342a0; Heit B, 2013, DEV CELL, V24, P372, DOI 10.1016/j.devcel.2013.01.007; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Huber M, 2006, EUR J IMMUNOL, V36, P701, DOI 10.1002/eji.200535593; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Husebye H, 2010, IMMUNITY, V33, P583, DOI 10.1016/j.immuni.2010.09.010; Jaqaman K, 2011, CELL, V146, P593, DOI 10.1016/j.cell.2011.06.049; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Jozefowski S, 2014, INNATE IMMUN-LONDON, V20, P826, DOI 10.1177/1753425913510960; Jozefowski S, 2011, ANAL BIOCHEM, V413, P185, DOI 10.1016/j.ab.2011.02.031; Jozefowski S, 2010, INFLAMM RES, V59, P277, DOI 10.1007/s00011-009-0096-5; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; Layoun A, 2012, AM J PATHOL, V180, P2340, DOI 10.1016/j.ajpath.2012.01.046; Luk JM, 1995, ANAL BIOCHEM, V232, P217, DOI 10.1006/abio.1995.0010; Lukacova M, 2008, CLIN MICROBIOL INFEC, V14, P200, DOI 10.1111/j.1469-0691.2007.01876.x; Maldonado-Baez L, 2013, EXP CELL RES, V319, P2759, DOI 10.1016/j.yexcr.2013.08.008; Muller-Loennies S, 2003, J BIOL CHEM, V278, P34090, DOI 10.1074/jbc.M303985200; Ono K, 2006, J IMMUNOL, V177, P5517, DOI 10.4049/jimmunol.177.8.5517; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Patel SN, 2007, J IMMUNOL, V178, P3954, DOI 10.4049/jimmunol.178.6.3954; Peiser L, 2002, INFECT IMMUN, V70, P5346, DOI 10.1128/IAI.70.10.5346-5354.2002; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Poussin C, 1998, J BIOL CHEM, V273, P20285, DOI 10.1074/jbc.273.32.20285; PUGIN J, 1994, IMMUNITY, V1, P509, DOI 10.1016/1074-7613(94)90093-0; Pupo E, 2013, FEBS J, V280, P1095, DOI 10.1111/febs.12104; Refaei M, 2011, TRAFFIC, V12, P1012, DOI 10.1111/j.1600-0854.2011.01206.x; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; SCHMIDT G, 1973, Journal of General Microbiology, V77, P151; Seimon TA, 2006, P NATL ACAD SCI USA, V103, P19794, DOI 10.1073/pnas.0609671104; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Stuart LM, 2005, J CELL BIOL, V170, P477, DOI 10.1083/jcb.200501113; Tanimura N, 2008, BIOCHEM BIOPH RES CO, V368, P94, DOI 10.1016/j.bbrc.2008.01.061; Vasselon T, 1999, J EXP MED, V190, P509, DOI 10.1084/jem.190.4.509; Watanabe S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060078; Xiang Q, 2009, J INT MED RES, V37, P491, DOI 10.1177/147323000903700225; Xu WY, 2007, MOL IMMUNOL, V44, P2315, DOI 10.1016/j.molimm.2006.11.013; Yu HH, 2012, BBA-MOL CELL RES, V1823, P1192, DOI 10.1016/j.bbamcr.2012.05.004; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; Zeng YC, 2003, J BIOL CHEM, V278, P45931, DOI 10.1074/jbc.M307722200	61	10	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153558	10.1371/journal.pone.0153558	http://dx.doi.org/10.1371/journal.pone.0153558			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073833	Green Published, gold			2022-12-26	WOS:000374131200106
J	Waniewski, J; Debowska, M; Wojcik-Zaluska, A; Ksiazek, A; Zaluska, W				Waniewski, Jacek; Debowska, Malgorzata; Wojcik-Zaluska, Alicja; Ksiazek, Andrzej; Zaluska, Wojciech			Quantification of Dialytic Removal and Extracellular Calcium Mass Balance during a Weekly Cycle of Hemodialysis	PLOS ONE			English	Article							DIALYSIS ADEQUACY INDEXES; CHRONIC KIDNEY-DISEASE; PERITONEAL-DIALYSIS; PARATHYROID-HORMONE; MATHEMATICAL-MODEL; KINETIC-MODEL; SERUM-CALCIUM; HOMEOSTASIS; PHOSPHATE; OUTCOMES	Objectives The removal of calcium during hemodialysis with low calcium concentration in dialysis fluid is generally slow, and the net absorption of calcium from dialysis fluid is often reported. The details of the calcium transport process during dialysis and calcium mass balance in the extracellular fluid, however, have not been fully studied. Methods Weekly cycle of three dialysis sessions with interdialytic breaks of 2-2-3 days was monitored in 25 stable patients on maintenance hemodialysis with calcium concentration in dialysis fluid of 1.35 mmol/L. Total and ionic calcium were frequently measured in blood and dialysate. The volume of fluid compartments was measured by bioimpedance. Results Weekly dialytic removal of 12.79 +/- 8.71 mmol calcium was found in 17 patients, whereas 9.48 +/- 8.07 mmol calcium was absorbed per week from dialysis fluid in 8 patients. Ionic calcium was generally absorbed from dialysis fluid, whereas complexed calcium (the difference of total and ionic calcium in dialysis fluid) was removed from the body. The concentration of total calcium in plasma increased slightly during dialysis. The mass of total and ionic calcium in extracellular fluid decreased during dialysis in patients with the dialytic removal of calcium from the body and did not change in patients with the absorption of calcium from dialysis fluid. Conclusions We conclude that about one third of patients on dialysis with calcium 1.35 mmol/L in dialysis fluid may absorb calcium from dialysis fluid and therefore individual prescriptions of calcium concentration in dialysis fluid should be considered for such patients.	[Waniewski, Jacek; Debowska, Malgorzata] Polish Acad Sci, Inst Biocybernet & Biomed Engn, Dept Math Modelling Physiol Proc, Warsaw, Poland; [Wojcik-Zaluska, Alicja] Med Univ Lublin, Dept Phys Therapy & Rehabil, Lublin, Poland; [Ksiazek, Andrzej; Zaluska, Wojciech] Med Univ Lublin, Dept Nephrol, Lublin, Poland	Polish Academy of Sciences; Nalecz Institute of Biocybernetics & Biomedical Engineering of the Polish Academy of Sciences; Medical University of Lublin; Medical University of Lublin	Debowska, M (corresponding author), Polish Acad Sci, Inst Biocybernet & Biomed Engn, Dept Math Modelling Physiol Proc, Warsaw, Poland.	mdebowska@ibib.waw.pl	Debowska, Malgorzata/F-3035-2015	Debowska, Malgorzata/0000-0001-8741-7930	National Science Centre (Poland) [N N518 289840]	National Science Centre (Poland)	This study was supported by the National Science Centre (Poland), grant no N N518 289840. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agar BU, 2011, CLIN J AM SOC NEPHRO, V6, P2854, DOI 10.2215/CJN.03860411; Basile C, 2011, INT J NEPHROL, V2011, DOI 10.4061/2011/540592; Basile C, 2012, AM J KIDNEY DIS, V59, P92, DOI 10.1053/j.ajkd.2011.08.033; Basile C, 2010, NEPHROL DIAL TRANSPL, V25, P1356, DOI 10.1093/ndt/gfp700; Casino FG, 1996, NEPHROL DIAL TRANSPL, V11, P1574; Casino FG, 2004, NEPHROL DIAL TRANSPL, V19, P1454, DOI 10.1093/ndt/gfh218; Debowska M., 2011, PROGR HEMODIALYSIS F, P3; Debowska M, 2007, ASAIO J, V53, P566, DOI 10.1097/MAT.0b013e31810c06d2; Debowska M, 2007, ARTIF ORGANS, V31, P61, DOI 10.1111/j.1525-1594.2007.00341.x; Debowska M, 2015, ARTIF ORGANS, V39, P1005, DOI 10.1111/aor.12489; Debowska M, 2015, NEPHROL DIAL TRANSPL, V30, P129, DOI 10.1093/ndt/gfu266; Debowska M, 2010, ARTIF ORGANS, V34, P412, DOI 10.1111/j.1525-1594.2009.00873.x; Drueke TB, 2009, NEPHROL DIAL TRANSPL, V24, P2990, DOI 10.1093/ndt/gfp365; Goldsmith DJA, 2010, NEPHROL DIAL TRANSPL, V25, P3823, DOI 10.1093/ndt/gfq513; Gonzalez-Parra E, 2014, BLOOD PURIFICAT, V38, P224, DOI 10.1159/000366126; Gotch F, 2007, BLOOD PURIFICAT, V25, P139, DOI 10.1159/000096891; Gotch F, 2010, BLOOD PURIFICAT, V29, P163, DOI 10.1159/000245924; Gotch FA, 2010, KIDNEY INT, V78, P343, DOI 10.1038/ki.2010.157; Gotch FA, 2009, NEPHROL DIAL TRANSPL, V24, P2994, DOI 10.1093/ndt/gfp360; Guyton A.C., 2006, TXB MED PHYSL; Jean G, 2013, NEPHROL DIAL TRANSPL, V28, P176, DOI 10.1093/ndt/gfs119; Karohl C, 2010, NEPHROL DIAL TRANSPL, V25, P1244, DOI 10.1093/ndt/gfp597; Leypoldt JK, 2003, NEPHROL DIAL TRANSPL, V18, P769, DOI 10.1093/ndt/gfg019; Malberti F, 2003, NEPHROL DIAL TRANSPL, V18, P37, DOI 10.1093/ndt/gfg1077; Messa P, 2009, BLOOD PURIFICAT, V27, P360, DOI 10.1159/000209249; Nikolov IG, 2009, BLOOD PURIFICAT, V27, P350, DOI 10.1159/000209248; NORDIN BEC, 1990, CLIN BIOCHEM, V23, P3, DOI 10.1016/0009-9120(90)90309-I; Peterson MC, 2010, BONE, V46, P49, DOI 10.1016/j.bone.2009.08.053; Pun PH, 2016, HEMODIAL INT, V20, P421, DOI 10.1111/hdi.12382; Raposo JF, 2002, J CLIN ENDOCR METAB, V87, P4330, DOI 10.1210/jc.2002-011870; Ross Morton A, 1997, NUTR MANAGMENT RENAL, P341; Tentori F, 2008, AM J KIDNEY DIS, V52, P519, DOI 10.1053/j.ajkd.2008.03.020; Toussaint Nigel, 2006, Hemodial Int, V10, P326, DOI 10.1111/j.1542-4758.2006.00125.x; WANIEWSKI J, 1992, NEPHROL DIAL TRANSPL, V7, P50; Waniewski J, 2006, BLOOD PURIFICAT, V24, P355, DOI 10.1159/000093199; Waniewski J, 2014, ASAIO J, V60, P90, DOI 10.1097/MAT.0000000000000017; Waniewski J, 2010, BLOOD PURIFICAT, V30, P257, DOI 10.1159/000320764	37	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153285	10.1371/journal.pone.0153285	http://dx.doi.org/10.1371/journal.pone.0153285			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073861	Green Published, gold, Green Submitted			2022-12-26	WOS:000374131200071
J	Lin, CH; Hsieh, SC; Keng, LT; Lee, HS; Chang, HT; Liao, WY; Ho, CC; Yu, CJ				Lin, Chou-Han; Hsieh, Song-Chou; Keng, Li-Ta; Lee, Ho-Sheng; Chang, Hou-Tai; Liao, Wei-Yu; Ho, Chao-Chi; Yu, Chong-Jen			Prospective Evaluation of Procalcitonin, Soluble Triggering Receptor Expressed on Myeloid Cells-1 and C-Reactive Protein in Febrile Patients with Autoimmune Diseases	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; CRITICALLY-ILL PATIENTS; BACTERIAL-INFECTION; SERUM PROCALCITONIN; DIAGNOSTIC-ACCURACY; STREM-1; MARKERS; SEPSIS; FLARES	Background Both procalcitonin (PCT) and soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) have been investigated separately as indicators of infection in patients with autoimmune diseases. Our study simultaneously evaluated both PCT and sTREM-1 along with C-reactive protein (CRP) in febrile patients with autoimmune diseases. Methods Fifty-nine patients were enrolled in the study. The patients were categorized into the infection group (n = 24) or the disease flare group (n = 35). sTREM-1, PCT and CRP concentrations at fever onset were compared between the two groups of patients. Results sTREM-1 and CRP did not differ between the two groups. PCT [median (range), ng/ml] was higher in the infection group than in the disease flare group [0.53 (0.02-12.85) vs. 0.12 (0.02-19.23), p = 0.001]. The area under the receiver-operating characteristic (ROC) for diagnosis of infection was 0.75 for PCT (p = 0.001), 0.63 for CRP (p = 0.09) and 0.52 for sTREM-1 (p = 0.79). Using 0.2 ng/ml as the cutoff value for PCT, sensitivity was 0.75 and specificity was 0.77. Negative predictive values for PCT were 92%, 87% and 82% for a prevalence of infection of 20%, 30%, and 40%, respectively. Neither immunosuppressants nor biomodulators affected the level of the three biomarkers. However, in patients treated with corticosteroids, the levels of sTREM-1 and CRP were significantly decreased compared with the untreated patients. Conclusions Setting PCT at a lower cutoff value could provide useful information on excluding infection in febrile patients with autoimmune diseases. The possible effect of corticosteroids on the level of sTREM-1 as an infection marker deserves further study.	[Lin, Chou-Han; Chang, Hou-Tai] Far Eastern Mem Hosp, Dept Internal Med, New Taipei, Taiwan; [Hsieh, Song-Chou; Liao, Wei-Yu; Ho, Chao-Chi; Yu, Chong-Jen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Keng, Li-Ta] Natl Taiwan Univ Hosp, Dept Internal Med, Hsin Chu Branch, Hsinchu, Taiwan; [Lee, Ho-Sheng] E Da Hosp, Dept Internal Med, Kaohsiung, Taiwan	Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; E-Da Hospital	Ho, CC (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	ccho1203@ntu.edu.tw	Liao, Wei-Yu/HGE-3881-2022; houtai, chang/AAB-1479-2019	Yu, Chong-Jen/0000-0001-5664-9392; HO, CHAO-CHI/0000-0002-8156-2413; LIAO, WEI-YU/0000-0001-6383-3470; LI-TA, KENG/0000-0003-2772-8037				Barati M, 2010, J CRIT CARE, V25, DOI 10.1016/j.jcrc.2009.10.004; Borchers AT, 2010, AUTOIMMUN REV, V9, pA277, DOI 10.1016/j.autrev.2009.12.008; Brunkhorst R, 2000, INTENS CARE MED, V26, pS199, DOI 10.1007/BF02900738; Buhaescu I, 2010, SEMIN ARTHRITIS RHEU, V40, P176, DOI 10.1016/j.semarthrit.2009.10.004; Collins CE, 2009, ANN RHEUM DIS, V68, P1768, DOI 10.1136/ard.2008.089557; Cooper GS, 2009, J AUTOIMMUN, V33, P197, DOI 10.1016/j.jaut.2009.09.008; de Kruif MD, 2008, INTENS CARE MED, V34, P518, DOI 10.1007/s00134-007-0955-x; Eberhard OK, 1997, ARTHRITIS RHEUM, V40, P1250, DOI 10.1002/1529-0131(199707)40:7<1250::AID-ART9>3.0.CO;2-A; Gibot S, 2004, NEW ENGL J MED, V350, P451, DOI 10.1056/NEJMoa031544; Gibot S, 2004, ANN INTERN MED, V141, P9, DOI 10.7326/0003-4819-141-1-200407060-00009; Hirayama K, 2011, NEPHROL DIAL TRANSPL, V26, P868, DOI 10.1093/ndt/gfq506; Joo K, 2011, J KOREAN MED SCI, V26, P1147, DOI 10.3346/jkms.2011.26.9.1147; Kim J, 2009, CLIN EXP RHEUMATOL, V27, P773; Kivity S, 2009, TRENDS IMMUNOL, V30, P409, DOI 10.1016/j.it.2009.05.005; Latour-Perez J, 2010, CLIN BIOCHEM, V43, P720, DOI 10.1016/j.clinbiochem.2010.03.001; Limper M, 2010, J INFECTION, V60, P409, DOI 10.1016/j.jinf.2010.03.016; Lin CH, 2011, CRIT CARE MED, V39, P993, DOI 10.1097/CCM.0b013e31820a92dc; Mihailidou Ira, 2013, Front Public Health, V1, P50, DOI 10.3389/fpubh.2013.00050; Mok CC, 2011, ARTHRITIS RHEUM-US, V63, P1182, DOI 10.1002/art.30277; Molad Y, 2013, INFLAMMATION, V36, P1519, DOI 10.1007/s10753-013-9694-z; Moosig F, 1998, ARTHRITIS RHEUM, V41, P566, DOI 10.1002/1529-0131(199803)41:3<566::AID-ART30>3.0.CO;2-U; Muller B, 2002, J LEUKOCYTE BIOL, V72, P643; Peschken CA, 2012, ARTHRITIS RES THER, V14; Pihusch M, 2006, EUR J HAEMATOL, V76, P93, DOI 10.1111/j.0902-4441.2005.00568.x; Rinaldi S, 2006, CRIT CARE MED, V34, P2334, DOI 10.1097/01.CCM.0000233872.04706.BB; Schwenger V, 1998, INFECTION, V26, P274, DOI 10.1007/BF02962246; Sciascia S, 2012, AUTOIMMUN REV, V12, P157, DOI 10.1016/j.autrev.2012.03.009; Sciascia S, 2013, BEST PRACT RES CL RH, V27, P377, DOI 10.1016/j.berh.2013.07.002; Scire CA, 2006, CLIN EXP RHEUMATOL, V24, P123; Seam N, 2012, CRIT CARE MED, V40, P495, DOI 10.1097/CCM.0b013e318232da5e; Seror R, 2010, ANN RHEUM DIS, V69, P1103, DOI 10.1136/ard.2009.110619; Shi Y, 2013, INTENS CARE MED, V39, P2233, DOI 10.1007/s00134-013-3103-9; Sitter T, 2002, J NEPHROL, V15, P297; Stevens RJ, 2005, RHEUMATOLOGY, V44, P402, DOI 10.1093/rheumatology/keh509; Tamaki K, 2008, J RHEUMATOL, V35, P114; Valentini G, 2001, ANN RHEUM DIS, V60, P592, DOI 10.1136/ard.60.6.592; Wu JY, 2012, ARTHRITIS RHEUM-US, V64, P3034, DOI 10.1002/art.34512	37	5	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153938	10.1371/journal.pone.0153938	http://dx.doi.org/10.1371/journal.pone.0153938			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096761	gold, Green Published			2022-12-26	WOS:000374543600073
J	Hempel, RJ; Bannantine, JP; Stabel, JR				Hempel, Randy J.; Bannantine, John P.; Stabel, Judith R.			Transcriptional Profiling of Ileocecal Valve of Holstein Dairy Cows Infected with Mycobacterium avium subsp Paratuberculosis	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; GENE-EXPRESSION; DIFFERENTIAL EXPRESSION; SSP PARATUBERCULOSIS; MACROPHAGE RESPONSE; IMMUNE-RESPONSES; RECEPTOR; TUBERCULOSIS; IMMUNOGLOBULIN; RECOGNITION	Johne's disease is a chronic infection of the small intestine caused by Mycobacterium avium subspecies paratuberculosis (MAP), an intracellular bacterium. The events of pathogen survival within the host cell(s), chronic inflammation and the progression from asymptomatic subclinical stage to an advanced clinical stage of infection, are poorly understood. This study examines gene expression in the ileocecal valve (ICV) of Holstein dairy cows at different stages of MAP infection. The ICV is known to be a primary site of MAP colonization and provides an ideal location to identify genes that are relevant to the progression of this disease. RNA was prepared from ICV tissues and RNA-Seq was used to compare gene transcription between clinical, subclinical, and uninfected control animals. Interpretation of the gene expression data was performed using pathway analysis and gene ontology categories containing multiple differentially expressed genes. Results demonstrated that many of the pathways that had strong differential gene expression between uninfected control and clinical cows were related to the immune system, such as the T-and B-cell receptor signaling, apoptosis, NOD-like receptor signaling, and leukocyte transendothelial migration pathways. In contrast, the comparison of gene transcription between control and subclinical cows identified pathways that were primarily involved in metabolism. The results from the comparison between clinical and subclinical animals indicate recruitment of neutrophils, up regulation of lysosomal peptidases, increase in immune cell transendothelial migration, and modifications of the extracelluar matrix. This study provides important insight into how cattle respond to a natural MAP infection at the gene transcription level within a key target tissue for infection.	[Hempel, Randy J.; Bannantine, John P.; Stabel, Judith R.] USDA ARS, Natl Anim Dis Ctr, POB 70, Ames, IA 50010 USA	United States Department of Agriculture (USDA)	Stabel, JR (corresponding author), USDA ARS, Natl Anim Dis Ctr, POB 70, Ames, IA 50010 USA.	judy.stabel@ars.usda.gov		Bannantine, John/0000-0002-5692-7898				ALARCON B, 1991, EMBO J, V10, P903, DOI 10.1002/j.1460-2075.1991.tb08023.x; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bandaru A, 2014, EUR J IMMUNOL, V44, P2013, DOI 10.1002/eji.201343680; Bassey EOE, 1997, INFECT IMMUN, V65, P4869, DOI 10.1128/IAI.65.11.4869-4872.1997; Casey ME, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00023; Cho J, 2012, J DAIRY SCI, V95, P1855, DOI 10.3168/jds.2011-4787; COCITO C, 1994, CLIN MICROBIOL REV, V7, P328, DOI 10.1128/CMR.7.3.328-345.1994; Collins MT, 2003, ACTA VET SCAND, V44, P217; Coussens PM, 2002, INFECT IMMUN, V70, P5494, DOI 10.1128/IAI.70.10.5494-5502.2002; De Buck J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111872; Dudemaine PL, 2014, J DAIRY SCI, V97, P3382, DOI 10.3168/jds.2013-7059; Foy TM, 1996, ANNU REV IMMUNOL, V14, P591, DOI 10.1146/annurev.immunol.14.1.591; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Gansert JL, 2003, J IMMUNOL, V170, P3154, DOI 10.4049/jimmunol.170.6.3154; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kabara E, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00215; KAPLAN R, 1990, P NATL ACAD SCI USA, V87, P7000, DOI 10.1073/pnas.87.18.7000; Khalifeh MS, 2013, CLIN VACCINE IMMUNOL, V20, P1274, DOI 10.1128/CVI.00246-13; Khare S, 2009, VET PATHOL, V46, P717, DOI 10.1354/vp.08-VP-0187-G-FL; Khare S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042127; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Koets A, 2002, INFECT IMMUN, V70, P3856, DOI 10.1128/IAI.70.7.3856-3864.2002; Koul A, 2004, NAT REV MICROBIOL, V2, P189, DOI 10.1038/nrmicro840; Kuehnel MP, 2001, CELL MICROBIOL, V3, P551, DOI 10.1046/j.1462-5822.2001.00139.x; Kusner DJ, 1996, J EXP MED, V184, P585, DOI 10.1084/jem.184.2.585; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li FJ, 2014, CURR TOP MICROBIOL, V382, P29, DOI 10.1007/978-3-319-07911-0_2; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Ma J, 2015, GENE THER, V22, P968, DOI 10.1038/gt.2015.73; MacHugh DE, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-25; Maattanen P, 2013, INFECT IMMUN, V81, P2861, DOI 10.1128/IAI.00339-13; Moreira LO, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00328; Nalpas NC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-230; Nalubamba K, 2008, MICROBES INFECT, V10, P598, DOI 10.1016/j.micinf.2008.02.005; Plain KM, 2011, INFECT IMMUN, V79, P3821, DOI 10.1128/IAI.05204-11; Pott J, 2009, CELL MICROBIOL, V11, P1802, DOI 10.1111/j.1462-5822.2009.01372.x; RETH M, 1992, ANNU REV IMMUNOL, V10, P97, DOI 10.1146/annurev.iy.10.040192.000525; Richardson ET, 2015, INFECT IMMUN, V83, P2242, DOI 10.1128/IAI.00135-15; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roderfeld M, 2012, MICROBES INFECT, V14, P545, DOI 10.1016/j.micinf.2012.01.004; Rue-Albrecht K, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00536; Sahoo M, 2011, THESCIENTIFICWORLDJO, V11, P2037, DOI 10.1100/2011/212680; SANCHEZ M, 1993, J EXP MED, V178, P1049, DOI 10.1084/jem.178.3.1049; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Seth M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005478; Siguroardottir OG, 2004, ADV DRUG DELIVER REV, V56, P819, DOI 10.1016/j.addr.2003.10.032; Smeed JA, 2010, VET IMMUNOL IMMUNOP, V135, P218, DOI 10.1016/j.vetimm.2009.11.015; Stabel JR, 2011, CLIN VACCINE IMMUNOL, V18, P1139, DOI 10.1128/CVI.00058-11; Stabel JR, 1998, J DAIRY SCI, V81, P283, DOI 10.3168/jds.S0022-0302(98)75577-8; Stabel JR, 2000, VET MICROBIOL, V77, P465, DOI 10.1016/S0378-1135(00)00331-X; Subharat S, 2012, VET IMMUNOL IMMUNOP, V149, P225, DOI 10.1016/j.vetimm.2012.07.005; Team RC, 2014, R LANG ENV STAT COMP; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102; Waters WR, 1999, INFECT IMMUN, V67, P1593; Xu ZW, 2010, CELL MOL IMMUNOL, V7, P11, DOI 10.1038/cmi.2009.108; Zhong L, 2009, VET IMMUNOL IMMUNOP, V131, P177, DOI 10.1016/j.vetimm.2009.04.007; ZURBRICK BG, 1988, INFECT IMMUN, V56, P1692, DOI 10.1128/IAI.56.7.1692-1697.1988	60	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153932	10.1371/journal.pone.0153932	http://dx.doi.org/10.1371/journal.pone.0153932			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093613	Green Published, gold, Green Submitted			2022-12-26	WOS:000374541200064
J	Sebald, J; Willi, M; Schoberleitner, I; Krogsdam, A; Orth-Holler, D; Trajanoski, Z; Lusser, A				Sebald, Johanna; Willi, Michaela; Schoberleitner, Ines; Krogsdam, Anne; Orth-Hoeller, Dorothea; Trajanoski, Zlatko; Lusser, Alexandra			Impact of the Chromatin Remodeling Factor CHD1 on Gut Microbiome Composition of Drosophila melanogaster	PLOS ONE			English	Article							LIFE-SPAN; IMMUNE HOMEOSTASIS; HOST GENOTYPE; BACTERIA; MODEL; DIVERSITY; DYSBIOSIS; SEQUENCE; INSIGHTS; DEFENSE	The composition of the intestinal microbiota of Drosophila has been studied in some detail in recent years. Environmental, developmental and host -specific genetic factors influence microbiome composition in the fly. Our previous work has indicated that intestinal bacterial load can be affected by chromatin-targeted regulatory mechanisms. Here we studied a potential role of the conserved chromatin assembly and remodeling factor CHD1 in the shaping of the gut microbiome in Drosophila melanogaster. Using high -throughput sequencing of 16S rRNA gene amplicons, we found that Chdl deletion mutant flies exhibit significantly reduced microbial diversity compared to rescued control strains. Specifically, although Acetobacteraceae dominated the microbiota of both Chdl wild -type and mutant guts, Chdl mutants were virtually monoassociated with this bacterial family, whereas in control flies other bacterial taxa constituted -20% of the microbiome. We further show age linked differences in microbial load and microbiota composition between Chdl mutant and control flies. Finally, diet supplementation experiments with Lactobacillus plantarum revealed that, in contrast to wild -type flies, Chdl mutant flies were unable to maintain higher L. plantarum titres over time. Collectively, these data provide evidence that loss of the chromatin remodeler CHD1 has a major impact on the gut microbiome of Drosophila melanogaster.	[Sebald, Johanna; Schoberleitner, Ines; Lusser, Alexandra] Med Univ Innsbruck, Div Mol Biol, Bioctr, A-6020 Innsbruck, Austria; [Willi, Michaela; Krogsdam, Anne; Trajanoski, Zlatko] Med Univ Innsbruck, Div Bioinformat, Bioctr, A-6020 Innsbruck, Austria; [Krogsdam, Anne] Med Univ Innsbruck, I Med GenomeSeq Core, Bioctr, A-6020 Innsbruck, Austria; [Orth-Hoeller, Dorothea] Med Univ Innsbruck, Div Hyg & Med Microbiol, A-6020 Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Lusser, A (corresponding author), Med Univ Innsbruck, Div Mol Biol, Bioctr, A-6020 Innsbruck, Austria.	alexandra.lusser@i-med.ac.at	Trajanoski, Zlatko/AAT-6703-2021; Krogsdam, Anne/AAM-7278-2020	Krogsdam, Anne/0000-0002-5478-0511; Schoberleitner, Ines/0000-0001-7988-722X; Willi, Michaela/0000-0002-2248-1998; Lusser, Alexandra/0000-0002-2226-9081; Orth-Holler, Dorothea/0000-0003-2904-5192	Austrian Science Fund (FWF); START [Y275-B12]; Austrian Academy of Sciences, DOC fellowship; Daniel Swarovski Fund [D-110410-022-011]; Austrian Science Fund (FWF) [Y 275] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); START(Austrian Science Fund (FWF)); Austrian Academy of Sciences, DOC fellowship; Daniel Swarovski Fund; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Austrian Science Fund (FWF; https://www.fwf.ac.at); START Y275-B12 to AL. Austrian Academy of Sciences, DOC fellowship to JS; Daniel Swarovski Fund, D-110410-022-011 to JS.	Blum JE, 2013, MBIO, V4, DOI 10.1128/mBio.00860-13; Bonnay F, 2014, EMBO J, V33, P2349, DOI 10.15252/embj.201488456; Bouazoune K, 2006, CHROMOSOME RES, V14, P433, DOI 10.1007/s10577-006-1067-0; Broderick NA, 2014, MBIO, V5, DOI 10.1128/mBio.01117-14; Bron PA, 2004, J BACTERIOL, V186, P5721, DOI 10.1128/JB.186.17.5721-5729.2004; Brummel T, 2004, P NATL ACAD SCI USA, V101, P12974, DOI 10.1073/pnas.0405207101; Buchon N, 2013, NAT REV MICROBIOL, V11, P615, DOI 10.1038/nrmicro3074; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Carmody RN, 2015, CELL HOST MICROBE, V17, P72, DOI 10.1016/j.chom.2014.11.010; Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272; Charroux B, 2012, SEMIN IMMUNOL, V24, P17, DOI 10.1016/j.smim.2011.11.003; Clark RI, 2015, CELL REP, V12, P1656, DOI 10.1016/j.celrep.2015.08.004; Cleenwerck I, 2008, INT J SYST EVOL MICR, V58, P2180, DOI 10.1099/ijs.0.65778-0; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Clooney AG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148028; Corby-Harris V, 2007, APPL ENVIRON MICROB, V73, P3470, DOI 10.1128/AEM.02120-06; Cox CR, 2007, INFECT IMMUN, V75, P1565, DOI 10.1128/IAI.01496-06; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Erkosar B, 2014, FEBS LETT, V588, P4250, DOI 10.1016/j.febslet.2014.06.041; Guo LL, 2014, CELL, V156, P109, DOI 10.1016/j.cell.2013.12.018; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Konev AY, 2007, SCIENCE, V317, P1087, DOI 10.1126/science.1145339; Landis GN, 2004, P NATL ACAD SCI USA, V101, P7663, DOI 10.1073/pnas.0307605101; Lee KA, 2014, DEV COMP IMMUNOL, V42, P102, DOI 10.1016/j.dci.2013.05.005; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Morettini S, 2011, NUCLEIC ACIDS RES, V39, P3103, DOI 10.1093/nar/gkq1298; Natoli G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000224; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ren C, 2007, CELL METAB, V6, P144, DOI 10.1016/j.cmet.2007.06.006; Rera M, 2012, P NATL ACAD SCI USA, V109, P21528, DOI 10.1073/pnas.1215849110; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Salipante SJ, 2014, APPL ENVIRON MICROB, V80, P7583, DOI 10.1128/AEM.02206-14; Sebald J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043144; Sharon G, 2010, P NATL ACAD SCI USA, V107, P20051, DOI 10.1073/pnas.1009906107; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Staubach F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070749; Storelli G, 2011, CELL METAB, V14, P403, DOI 10.1016/j.cmet.2011.07.012; Team RC, 2014, R LANG ENV STAT COMP; Vodovar N, 2005, P NATL ACAD SCI USA, V102, P11414, DOI 10.1073/pnas.0502240102; Vodovar N, 2006, NAT BIOTECHNOL, V24, P673, DOI 10.1038/nbt1212; Warnes M, 2014, PACKAGE GPLOTS; Wong ACN, 2013, ISME J, V7, P1922, DOI 10.1038/ismej.2013.86; Wong CNA, 2011, ENVIRON MICROBIOL, V13, P1889, DOI 10.1111/j.1462-2920.2011.02511.x	48	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153476	10.1371/journal.pone.0153476	http://dx.doi.org/10.1371/journal.pone.0153476			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093431	Green Published, Green Submitted, gold			2022-12-26	WOS:000374541200022
J	Primativo, S; Spinelli, D; Zoccolotti, P; De Luca, M; Martelli, M				Primativo, Silvia; Spinelli, Donatella; Zoccolotti, Pierluigi; De Luca, Maria; Martelli, Marialuisa			Perceptual and Cognitive Factors Imposing "Speed Limits" on Reading Rate: A Study with the Rapid Serial Visual Presentation	PLOS ONE			English	Article							RESOURCE DEPLETION; ATTENTIONAL BLINK; WORD RECOGNITION; CONTEXT; SPAN; TIME; PSYCHOPHYSICS; INFORMATION; MECHANISMS; MOVEMENTS	Adults read at high speed, but estimates of their reading rate vary greatly, i.e., from 100 to 1500 words per minute (wpm). This discrepancy is likely due to different recording methods and to the different perceptual and cognitive processes involved in specific test conditions. The present study investigated the origins of these notable differences in RSVP reading rate (RR). In six experiments we investigated the role of many different perceptual and cognitive variables. The presence of a mask caused a steep decline in reading rate, with an estimated masking cost of about 200 wpm. When the decoding process was isolated, RR approached values of 1200 wpm. When the number of stimuli exceeded the short-term memory span, RR decreased to 800 wpm. The semantic context contributed to reading speed only by a factor of 1.4. Finally, eye movements imposed an upper limit on RR (around 300 wpm). Overall, data indicate a speed limit of 300 wpm, which corresponds to the time needed for eye movement execution, i.e., the most time consuming mechanism. Results reconcile differences in reading rates reported by different laboratories and thus provide suggestions for targeting different components of reading rate.	[Primativo, Silvia; Spinelli, Donatella; Zoccolotti, Pierluigi; De Luca, Maria; Martelli, Marialuisa] IRCCS Fdn Santa Lucia, Rome, Italy; [Primativo, Silvia; Zoccolotti, Pierluigi; Martelli, Marialuisa] Univ Roma La Sapienza, Dipartimento Psicol, I-00185 Rome, Italy; [Primativo, Silvia] UCL, Dementia Res Ctr, UCL Inst Neurol, London, England; [Spinelli, Donatella] Univ Rome Foro Ital, Rome, Italy	IRCCS Santa Lucia; Sapienza University Rome; University of London; University College London; Foro Italico University of Rome	Primativo, S; Martelli, M (corresponding author), IRCCS Fdn Santa Lucia, Rome, Italy.; Primativo, S; Martelli, M (corresponding author), Univ Roma La Sapienza, Dipartimento Psicol, I-00185 Rome, Italy.; Primativo, S (corresponding author), UCL, Dementia Res Ctr, UCL Inst Neurol, London, England.	s.primativo@ucl.ac.uk; marialuisa.martelli@uniroma1.it	Zoccolotti, Pierluigi/H-4437-2019; De Luca, Maria/A-7169-2010; Martelli, Marialuisa/J-5757-2012	Zoccolotti, Pierluigi/0000-0002-6351-2455; De Luca, Maria/0000-0003-0084-3772; Martelli, Marialuisa/0000-0001-7806-9540; Primativo, Silvia/0000-0001-9632-850X	Department of Health; Sapienza University	Department of Health; Sapienza University	This work was supported by grants from the Department of Health and Sapienza University.	Ambinder MS, 2009, ATTEN PERCEPT PSYCHO, V71, P1495, DOI 10.3758/APP.71.7.1495; Ariga A, 2008, PSYCHOL RES-PSYCH FO, V72, P192, DOI 10.1007/s00426-006-0100-4; Baddeley A, 1986, DEVELOPMENT, V77, P1; BALOTA DA, 1985, COGNITIVE PSYCHOL, V17, P364, DOI 10.1016/0010-0285(85)90013-1; Barca L, 2002, BEHAV RES METH INS C, V34, P424, DOI 10.3758/BF03195471; Benedetto S, 2015, COMPUT HUM BEHAV, V45, P352, DOI 10.1016/j.chb.2014.12.043; Bonneh YS, 2007, VISION RES, V47, P1950, DOI 10.1016/j.visres.2007.02.015; Breitmeyer B.G., 1984, VISUAL MASKING INTEG; Buswell GT, 1921, J EDUC PSYCHOL, V12, P217, DOI 10.1037/h0070548; Carpenter P. A., 1983, EYE MOVEMENTS READIN, P275; Carver R. P., 1997, SCI STUD READ, V1, P3, DOI [10.1207/S1532799XSSR0101_2, DOI 10.1207/S1532799XSSR0101_2, DOI 10.1207/S1532799XSSR01012]; CARVER RP, 1982, READ RES QUART, V18, P56, DOI 10.2307/747538; CARVER RP, 1992, J READING, V36, P84; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; Chung STL, 2002, INVEST OPHTH VIS SCI, V43, P1270; Chung STL, 1998, VISION RES, V38, P2949, DOI 10.1016/S0042-6989(98)00072-8; Cohn HE, 2012, U.S. Patent Application, Patent No. [13/718,941, 13718941]; Colombo L, 2002, BRAIN LANG, V81, P398, DOI 10.1006/brln.2001.2533; Coltheart V, 2004, J EXP PSYCHOL LEARN, V30, P815, DOI 10.1037/0278-7393.30.4.815; Crutch SJ, 2011, NEUROCASE, V17, P160, DOI 10.1080/13554794.2010.504729; De Luca M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00696; Di Lollo V, 2005, PSYCHOL RES-PSYCH FO, V69, P191, DOI 10.1007/s00426-004-0173-x; Dux PE, 2008, PSYCHON B REV, V15, P809, DOI 10.3758/PBR.15.4.809; Dux PE, 2006, NEURON, V52, P1109, DOI 10.1016/j.neuron.2006.11.009; Dux PE, 2009, PSYCHON B REV, V16, P219, DOI 10.3758/PBR.16.1.219; Enns JT, 2000, TRENDS COGN SCI, V4, P345, DOI 10.1016/S1364-6613(00)01520-5; FELSTEN G, 1980, PSYCHOL BULL, V88, P329, DOI 10.1037/0033-2909.88.2.329; Fine EM, 1997, VISION RES, V37, P2639, DOI 10.1016/S0042-6989(97)00051-5; Fine EM, 1999, OPTOMETRY VISION SCI, V76, P764, DOI 10.1097/00006324-199911000-00025; Fine EM, 1996, OPTOMETRY VISION SCI, V73, P533, DOI 10.1097/00006324-199608000-00003; FORSTER KI, 1970, PERCEPT PSYCHOPHYS, V8, P215, DOI 10.3758/BF03210208; Freeman J, 2012, ATTEN PERCEPT PSYCHO, V74, P379, DOI 10.3758/s13414-011-0229-0; GILBERT LC, 1959, J EDUC PSYCHOL, V50, P8, DOI 10.1037/h0045592; GILBERT LC, 1959, J EDUC PSYCHOL, V50, P15, DOI 10.1037/h0040752; Gomez P, 2008, PSYCHOL REV, V115, P577, DOI 10.1037/a0012667; He YC, 2013, J VISION, V13, DOI 10.1167/13.7.14; Holcomb PJ, 2006, J COGNITIVE NEUROSCI, V18, P1631, DOI 10.1162/jocn.2006.18.10.1631; Inhoff AW, 2011, J COGN PSYCHOL, V23, P543, DOI 10.1080/20445911.2011.546782; Kwon M, 2007, VISION RES, V47, P2889, DOI 10.1016/j.visres.2007.08.002; Kwon M, 2012, VISION RES, V62, P139, DOI 10.1016/j.visres.2012.03.025; Latham K, 1996, VISION RES, V36, P2665, DOI 10.1016/0042-6989(96)00022-3; Lee HW, 2010, J VISION, V10, DOI 10.1167/10.6.18; Legge GE, 2001, VISION RES, V41, P725, DOI 10.1016/S0042-6989(00)00295-9; Lev M, 2014, SCI REPORTS, V4; Martelli M, 2014, EXP BRAIN RES, V232, P237, DOI 10.1007/s00221-013-3735-6; McDowell ME, 2010, U.S. Patent Application, Patent No. [12/873,787, 12873787]; MORTON J, 1964, Q J EXP PSYCHOL, V16, P340, DOI 10.1080/17470216408416390; Neath I, 1996, MEMORY, V4, P225, DOI 10.1080/09658211.1996.9753032; Pelli DG, 2008, NAT NEUROSCI, V11, P1129, DOI 10.1038/nn.2187; Pelli DG, 2007, J VISION, V7, DOI 10.1167/7.2.20; Pelli DG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000680; Pelli DG, 2004, J VISION, V4, P1136, DOI 10.1167/4.12.12; Perea M, 2002, PERCEPT PSYCHOPHYS, V64, P785, DOI 10.3758/BF03194745; Perea M, 2012, Q J EXP PSYCHOL, V65, P911, DOI 10.1080/17470218.2011.636151; Perry C, 2010, COGNITIVE PSYCHOL, V61, P106, DOI 10.1016/j.cogpsych.2010.04.001; Polat U, 2006, VISION RES, V46, P953, DOI 10.1016/j.visres.2005.09.031; Polat U, 2005, VISION RES, V45, P1471, DOI 10.1016/j.visres.2004.12.014; Potter M.C., 1984, NEW METHODS READING, P91; POTTER MC, 1982, B PSYCHONOMIC SOC, V20, P134; RAYNER K, 1976, VISION RES, V16, P829, DOI 10.1016/0042-6989(76)90143-7; Rayner K, 2016, PSYCHOL SCI PUBL INT, V17, P4, DOI 10.1177/1529100615623267; Rayner K, 2009, Q J EXP PSYCHOL, V62, P1457, DOI 10.1080/17470210902816461; Rohenkohl G, 2011, J NEUROSCI, V31, P14076, DOI 10.1523/JNEUROSCI.3387-11.2011; RUBIN GS, 1992, VISION RES, V32, P895, DOI 10.1016/0042-6989(92)90032-E; Sass SM, 2006, OPTOMETRY VISION SCI, V83, P166, DOI 10.1097/01.opx.0000204752.43520.17; Schotter ER, 2014, PSYCHOL SCI; Song S, 2014, J VISION, V14, DOI 10.1167/14.5.3; Traficante D., 2004, GIORNALE ITALIANO PS, V31, P821; Traficante D., 2003, TRENDS LING STUD MON, V151, P45; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Whitney D, 2011, TRENDS COGN SCI, V15, P160, DOI 10.1016/j.tics.2011.02.005; Yager D, 1998, VISION RES, V38, P2527, DOI 10.1016/S0042-6989(98)00116-3; Yeshurun Y, 2015, J VISION, V15, DOI 10.1167/15.3.11; Yong KXX, 2015, NEUROLOGY, V85, P339, DOI 10.1212/WNL.0000000000001782; Yu DY, 2010, J VISION, V10, DOI 10.1167/10.2.21; Yu DY, 2007, J VISION, V7, DOI 10.1167/7.2.2; Zoccolotti P, 2013, CHILD NEUROPSYCHOL, V19, P639, DOI 10.1080/09297049.2012.718325	77	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153786	10.1371/journal.pone.0153786	http://dx.doi.org/10.1371/journal.pone.0153786			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9IK	27088226	Green Submitted, gold, Green Published			2022-12-26	WOS:000374527000048
J	Kollimada, SA; Kulkarni, AH; Ravan, A; Gundiah, N				Kollimada, Somanna A.; Kulkarni, Ankur H.; Ravan, Aniket; Gundiah, Namrata			Advancing Edge Speeds of Epithelial Monolayers Depend on Their Initial Confining Geometry	PLOS ONE			English	Article							COLLECTIVE CELL-MIGRATION; SIGNALING PATHWAYS; LEADER CELLS; ADHESION; GUIDANCE; FORCES; STIMULATION; ACTIVATION; MECHANICS; DYNAMICS	Collective cell migrations are essential in several physiological processes and are driven by both chemical and mechanical cues. The roles of substrate stiffness and confinement on collective migrations have been investigated in recent years, however few studies have addressed how geometric shapes influence collective cell migrations. Here, we address the hypothesis that the relative position of a cell within the confinement influences its motility. Monolayers of two types of epithelial cells-MCF7, a breast epithelial cancer cell line, and MDCK, a control epithelial cell line-were confined within circular, square, and cross-shaped stencils and their migration velocities were quantified upon release of the constraint using particle image velocimetry. The choice of stencil geometry allowed us to investigate individual cell motility within convex, straight and concave boundaries. Cells located in sharp, convex boundaries migrated at slower rates than those in concave or straight edges in both cell types. The overall cluster migration occurred in three phases: an initial linear increase with time, followed by a plateau region and a subsequent decrease in cluster speeds. An acto-myosin contractile ring, present in the MDCK but absent in MCF7 monolayer, was a prominent feature in the emergence of leader cells from the MDCK clusters which occurred every similar to 125 mu m from the vertex of the cross. Further, coordinated cell movements displayed vorticity patterns in MDCK which were absent in MCF7 clusters. We also used cytoskeletal inhibitors to show the importance of acto-myosin bounding cables in collective migrations through translation of local movements to create long range coordinated movements and the creation of leader cells within ensembles. To our knowledge, this is the first demonstration of how bounding shapes influence long-term migratory behaviours of epithelial cell monolayers. These results are important for tissue engineering and may also enhance our understanding of cell movements during developmental patterning and cancer metastasis.	[Kollimada, Somanna A.; Ravan, Aniket; Gundiah, Namrata] Indian Inst Sci, Dept Mech Engn, Bangalore 560012, Karnataka, India; [Kulkarni, Ankur H.] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Gundiah, N (corresponding author), Indian Inst Sci, Dept Mech Engn, Bangalore 560012, Karnataka, India.	namrata@mecheng.iisc.ernet.in		Kulkarni, Ankur/0000-0002-5207-3346	Department of Biotechnology, Government of India [DBT: BT/PR13926/MED/31/97/2010]; Department of Science and Technology, Government of India [DST: SR/S2/RJN-42/2009]; Department of Science and Technology	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Science and Technology, Government of India(Department of Science & Technology (India)); Department of Science and Technology(Department of Science & Technology (India))	This work was supported by the Department of Biotechnology, Government of India (DBT: BT/PR13926/MED/31/97/2010); and the Department of Science and Technology, Government of India (DST: SR/S2/RJN-42/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Dr TS Sridhar, St John's Research Institute for donation of MCF7 cells and Prof. S. Mayor, National Center for Biological Sciences (NCBS) for the MDCK cells used in this study. We are thankful to Prof Pramod Pullarkat, Raman Research Institute and Prof Sanjay Sane, NCBS for many helpful discussions. NG gratefully acknowledges the Department of Science and Technology for the Ramanujan fellowship and research grant and the Department of Biotechnology (Bioengineering and Biodesign) for program support.	Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Bameta T, 2012, EPL-EUROPHYS LETT, V99, DOI 10.1209/0295-5075/99/18004; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Chicurel ME, 1998, CURR OPIN CELL BIOL, V10, P232, DOI 10.1016/S0955-0674(98)80145-2; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Doxzen K, 2013, INTEGR BIOL-UK, V5, P1026, DOI 10.1039/c3ib40054a; Fenteany G, 2000, CURR BIOL, V10, P831, DOI 10.1016/S0960-9822(00)00579-0; GIERTHY JF, 1991, J CELL BIOCHEM, V45, P177, DOI 10.1002/jcb.240450209; Hidalgo-Carcedo C, 2011, NAT CELL BIOL, V13, P49, DOI 10.1038/ncb2133; Jasaitis A, 2012, BIOPHYS J, V103, P175, DOI 10.1016/j.bpj.2012.06.009; Kabla AJ, 2012, J R SOC INTERFACE, V9, P3268, DOI 10.1098/rsif.2012.0448; Lecuit T, 2008, HFSP J, V2, P72, DOI 10.2976/1.2896332; Lee P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002007; Mark S, 2010, BIOPHYS J, V98, P361, DOI 10.1016/j.bpj.2009.10.022; Meghana C, 2011, P NATL ACAD SCI USA, V108, P9107, DOI 10.1073/pnas.1018652108; Mogilner A, 2009, CURR BIOL, V19, pR762, DOI 10.1016/j.cub.2009.06.053; Petitjean L, 2010, BIOPHYS J, V98, P1790, DOI 10.1016/j.bpj.2010.01.030; Poujade M, 2007, P NATL ACAD SCI USA, V104, P15988, DOI 10.1073/pnas.0705062104; Puliafito A, 2012, P NATL ACAD SCI USA, V109, P739, DOI 10.1073/pnas.1007809109; Rangamani P, 2011, BIOPHYS J, V100, P845, DOI 10.1016/j.bpj.2010.12.3732; Rausch S, 2013, BIOINTERPHASES, V8, DOI 10.1186/1559-4106-8-32; Reffay M, 2014, NAT CELL BIOL, V16, P217, DOI 10.1038/ncb2917; Reffay M, 2011, BIOPHYS J, V100, P2566, DOI 10.1016/j.bpj.2011.04.047; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Sepulveda N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002944; Serra-Picamal X, 2012, NAT PHYS, V8, P628, DOI [10.1038/NPHYS2355, 10.1038/nphys2355]; Tambe DT, 2011, NAT MATER, V10, P469, DOI [10.1038/NMAT3025, 10.1038/nmat3025]; Tarle V, 2015, INTEGR BIOL-UK, V7, P1218, DOI 10.1039/c5ib00092k; Thery M, 2006, CELL MOTIL CYTOSKEL, V63, P341, DOI 10.1002/cm.20126; Thompson D.W, 1917, GROWTH FORM; Trepat X, 2011, TRENDS CELL BIOL, V21, P638, DOI 10.1016/j.tcb.2011.06.006; Vedula SRK, 2012, P NATL ACAD SCI USA, V109, P12974, DOI 10.1073/pnas.1119313109; Wang XB, 2010, NAT CELL BIOL, V12, P591, DOI 10.1038/ncb2061; Yamaguchi N, 2015, SCI REP-UK, V5, DOI 10.1038/srep07656	34	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153471	10.1371/journal.pone.0153471	http://dx.doi.org/10.1371/journal.pone.0153471			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078632	Green Published, Green Accepted, gold			2022-12-26	WOS:000374131700060
J	Lafranca, JA; van Bruggen, M; Kimenai, HJAN; Tran, TCK; Terkivatan, T; Betjes, MGH; IJzermans, JNM; Dor, FJMF				Lafranca, Jeffrey A.; van Bruggen, Mark; Kimenai, Hendrikus J. A. N.; Tran, Thi C. K.; Terkivatan, Turkan; Betjes, Michiel G. H.; IJzermans, Jan N. M.; Dor, Frank J. M. F.			Vascular Multiplicity Should Not Be a Contra-Indication for Live Kidney Donation and Transplantation	PLOS ONE			English	Article							LAPAROSCOPIC-DONOR-NEPHRECTOMY; SINGLE RENAL-ARTERIES; COMPLICATIONS; PROCUREMENT; EXPERIENCE; MANAGEMENT; RECIPIENTS; OUTCOMES; GRAFTS; IMPACT	Background Whether vascular multiplicity should be considered as contraindication and therefore 'extended donor criterion' is still under debate. Methods Data from all live kidney donors from 2006-2013 (n = 951) was retrospectively reviewed. Vascular anatomy as imaged by MRA, CTA or other modalities was compared with intraoperative findings. Furthermore, the influence of vascular multiplicity on outcome of donors and recipients was studied. Results In 237 out of 951 donors (25%), vascular multiplicity was present. CTA had the highest accuracy levels regarding vascular anatomy assessment. Regarding outcome of donors with vascular multiplicity, warm ischemia time (WIT) and skin-to-skin time were significantly longer if arterial multiplicity (AM) was present (5.1 vs. 4.0 mins and 202 vs. 178 mins). Skin-to-skin time was significantly longer, and complication rates were higher in donors with venous multiplicity (203 vs. 180 mins and 17.2% vs. 8.4%). Outcome of renal transplant recipients showed a significantly increased WIT (30 vs. 26.7 minutes), higher rate of DGF (13.9% vs. 6.9%) and lower rate of BPAR (6.9% vs. 13.9%) in patients receiving a kidney with AM compared to kidneys with singular anatomy. Conclusions We conclude that vascular multiplicity should not be a contra-indication, since it has little impact on clinical outcome in the donor as well as in renal transplant recipients.	[Lafranca, Jeffrey A.; van Bruggen, Mark; Kimenai, Hendrikus J. A. N.; Tran, Thi C. K.; Terkivatan, Turkan; IJzermans, Jan N. M.; Dor, Frank J. M. F.] Univ Med Ctr Rotterdam, Erasmus MC, Div HPB & Transplant Surg, Dept Surg, Rotterdam, Netherlands; [Betjes, Michiel G. H.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Internal Med, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Dor, FJMF (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Div HPB & Transplant Surg, Dept Surg, Rotterdam, Netherlands.	frank.dor@imperial.nhs.uk	van Eijck, casper/K-5983-2019	Betjes, Michiel/0000-0001-9435-6208; Lafranca, Jeffrey/0000-0002-2727-0524				Abbasi Eslamloo MA, 2011, EUR UROL SUPPL, V10, P608; Ahmadi AR, 2015, KIDNEY INT, V87, P31, DOI 10.1038/ki.2014.118; Andrews PA, 2012, TRANSPLANTATION, V93, P666, DOI 10.1097/TP.0b013e318247a7b7; Bessede T, 2012, TRANSPL INT, V25, P994, DOI 10.1111/j.1432-2277.2012.01533.x; Carter JT, 2005, AM J TRANSPLANT, V5, P1312, DOI 10.1111/j.1600-6143.2005.00859.x; Cooper M, 2013, CLIN TRANSPLANT; Del Pizzo JJ, 1999, J UROLOGY, V162, P31, DOI 10.1097/00005392-199907000-00008; Desai MR, 2007, UROLOGY, V69, P824, DOI 10.1016/j.urology.2007.01.026; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Dutch Transplantation Foundation, 2013, YEAR REP 2013; Fettouh HA, 2008, J ENDOUROL, V22, P77, DOI 10.1089/end.2007.0115; Fuller TF, 2014, TRANSPLANTATION, V98, P1144, DOI 10.1097/TP.0000000000000324; Genc V, 2011, J KOREAN SURG SOC, V80, P272, DOI 10.4174/jkss.2011.80.4.272; Hsu THS, 2003, UROLOGY, V61, P323, DOI 10.1016/S0090-4295(02)02124-6; Hung CJ, 2012, TRANSPL P, V44, P36, DOI 10.1016/j.transproceed.2011.12.027; Husted TL, 2005, TRANSPL P, V37, P629, DOI 10.1016/j.transproceed.2004.12.128; Kadotani Y, 2005, SURG TODAY, V35, P459, DOI 10.1007/s00595-004-2967-2; Keller JE, 2009, SURG ENDOSC, V23, P2327, DOI 10.1007/s00464-009-0330-9; Kok NFM, 2008, TRANSPLANTATION, V85, P1760, DOI 10.1097/TP.0b013e318172802d; Nath J, 2015, TRANSPL P, V47, P373, DOI 10.1016/j.transproceed.2015.01.006; Omoto K, 2011, AM J TRANSPLANT, V11, P459; Paragi PR, 2011, WORLD J SURG, V35, P2159, DOI 10.1007/s00268-011-1168-6; Paramesh A, 2009, TRANSPLANTATION, V88, P1203, DOI 10.1097/TP.0b013e3181ba343a; ROZA AM, 1989, TRANSPLANTATION, V47, P397; Saidi R, 2009, ARCH SURG-CHICAGO, V144, P472, DOI 10.1001/archsurg.2009.49; Satyapal KS, 2001, SURG RADIOL ANAT, V23, P33, DOI 10.1007/s00276-001-0033-y; Tyson MD, 2011, UROLOGY, V77, P1116, DOI 10.1016/j.urology.2010.07.503; U.S. Renal Data System USRDS, 2013, ANN DAT REP ATL CHRO	28	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153460	10.1371/journal.pone.0153460	http://dx.doi.org/10.1371/journal.pone.0153460			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077904	gold, Green Published, Green Submitted			2022-12-26	WOS:000374131700056
J	Xie, N; Chen, LN; Wong, KM; Cui, YZ; Yang, HQ				Xie, Ning; Chen, Ling-Na; Wong, Khoon-Meng; Cui, Yong-Zhong; Yang, Han-Qi			Seed Set and Natural Regeneration of Dendrocalamus membranaceus Munro after Mass and Sporadic Flowering in Yunnan, China	PLOS ONE			English	Article							TEMPERATE FOREST; SOUTH-AMERICA; BAMBOO; PATAGONIA; GERMINATION; ARGENTINA; DEATH	The flowering periods of woody bamboos, seed set, natural regeneration and death after flowering have been rarely observed and evaluated in the field. Dendrocalamus membranaceus Munro, a tropical woody bamboo mainly distributed in the Yunnan, displayed both sporadic as well as gregarious (mass) flowering and fruited from 2006 to 2013 following severe droughts. The aim of this study is to examine potential differences in seed set and natural regeneration between the two flowering patterns in natural D. membranaceus forests. We investigated and analyzed seed set, seed germination, seedling growth and mortality in both mass and sporadic flowering populations. Observations were made over a period of three years to record changes in bamboo seedling density, height and culm diameter. We observed a low natural seed set ranging from 1.76% to 7.49%, and a relatively high seed germination rate in the nursery from 59.6% to 71.0% for both types of flowering populations. Seeds germinated in 5-7 days after sowing and the germination period lasted 10-15 days. Seed set and germination rates in mass-flowering populations were significantly higher than those of sporadically flowering stands. The seedlings within sporadically flowering populations died within two years. In comparison, seedling mortality in the mass flowering population increased over two periods of observation from 64.92% to 98.89%, yet there was good seedling establishment left over, which showed mean height and mean culm diameter increasing by 1053.25% and 410.71%, respectively, in the second year of observations, and 137.10%, and 217.48%, respectively, in the third year. There are significant differences in seed set, natural regeneration ability and sustainability of bamboo populations between the mass flowering and sporadically flowering populations of D. membranaceus. Sporadic flowering populations failed to produce effective regeneration, while mass flowering populations were able to regenerate successfully. This study provides useful insights for conservation and natural forest management of D. membranaceus. We consider the merits of introducing other genetic provenances towards long-term maintenance of the stand features at sporadically flowering sites; meanwhile, the most economic option for mass	[Xie, Ning; Chen, Ling-Na; Cui, Yong-Zhong; Yang, Han-Qi] Chinese Acad Forestry, Res Inst Resources Insects, Kunming 650224, Yunnan, Peoples R China; [Wong, Khoon-Meng] Singapore Bot Gardens, 1 Cluny Rd, Singapore 259569, Singapore	Chinese Academy of Forestry; Research Institute of Resources Insects, CAF	Yang, HQ (corresponding author), Chinese Acad Forestry, Res Inst Resources Insects, Kunming 650224, Yunnan, Peoples R China.	yanghanqikm@aliyun.com		Chen, LingNa/0000-0002-1051-0253	National Natural Science Foundation of China [31270662]; Department of Science and Technology of Yunnan Province [2014HB041, 2008OC001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Yunnan Province	This work was supported by National Natural Science Foundation of China (31270662), http://www.nsfc.gov.cn/; Department of Science and Technology of Yunnan Province (2014HB041, 2008OC001), http://www.ynstc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2014, J FOREST RES-JPN, V19, P166, DOI 10.1007/s10310-013-0397-y; An MY, 2010, SHANDONG FORESTRY SC, V4, P111, DOI [10.3969/j.issn.1002-2724.2010.04.033, DOI 10.3969/J.ISSN.1002-2724.2010.04.033]; Austin AT, 2012, FUNCT ECOL, V26, P265, DOI 10.1111/j.1365-2435.2011.01910.x; Budke JC, 2010, FOREST ECOL MANAG, V260, P1345, DOI 10.1016/j.foreco.2010.07.028; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Demissew Sertse, 2011, Journal of Biodiversity and Environmental Sciences (JBES), V1, P16; Du Fan, 2000, Scientia Silvae Sinicae, V36, P57; Giordano CV, 2009, NEW PHYTOL, V181, P880, DOI 10.1111/j.1469-8137.2008.02708.x; Guerreiro C, 2014, J PLANT RES, V127, P307, DOI 10.1007/s10265-013-0593-z; Hui CM, 1989, J SW FORESTRY COLL, V9, P108; Hui CM, 1987, THESIS SW FORESTRY C; JANZEN DH, 1976, ANNU REV ECOL SYST, V7, P347, DOI 10.1146/annurev.es.07.110176.002023; Judziewicz EJ, 1999, AM BAMBOOS; Kitamura K, 2011, J PLANT RES, V124, P683, DOI 10.1007/s10265-010-0398-2; Koenig WD, 2003, TRENDS ECOL EVOL, V18, P157, DOI 10.1016/S0169-5347(03)00034-X; Li DZ, 2006, FLORA CHINA, V9, P1; MAKITA A, 1992, ECOL RES, V7, P245, DOI 10.1007/BF02347093; Marchesini VA, 2009, J VEG SCI, V20, P424, DOI 10.1111/j.1654-1103.2009.05768.x; Mizuki I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105051; Ramanayake SMSD, 1998, ANN BOT-LONDON, V82, P779, DOI 10.1006/anbo.1998.0754; Sun BX, 2003, FLORA OF YUNNAN, V9; Wong K. M., 1981, Malaysian Forester, V44, P453; Xue JR, 1995, BAMBOO RESOURCES DEV; Yang Han-qi, 2013, Forest Research, V26, P710; Yang HQ, 2012, INT J MOL SCI, V13, P4446, DOI 10.3390/ijms13044446; Yang YM, 2008, STUDY MASTER PLANNIN; ZHANG W, 1990, Forest Research, V3, P250; Zhu Hua, 2007, Acta Botanica Yunnanica, V29, P377	28	28	30	6	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153845	10.1371/journal.pone.0153845	http://dx.doi.org/10.1371/journal.pone.0153845			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077651	Green Submitted, Green Published, gold			2022-12-26	WOS:000374131700114
J	Alsaweed, M; Lai, CT; Hartmann, PE; Geddes, DT; Kakulas, F				Alsaweed, Mohammed; Lai, Ching Tat; Hartmann, Peter E.; Geddes, Donna T.; Kakulas, Foteini			Human Milk Cells and Lipids Conserve Numerous Known and Novel miRNAs, Some of Which Are Differentially Expressed during Lactation	PLOS ONE			English	Article							BREAST-MILK; MAMMARY-GLAND; MICRORNA BIOGENESIS; GENE-EXPRESSION; STEM-CELLS; INFANT; RNA; IDENTIFICATION; PATHWAYS; ENDOCYTOSIS	Human milk (HM) is rich in miRNAs, which are thought to contribute to infant protection and development. We used deep sequencing to profile miRNAs in the cell and lipid fractions of HM obtained post-feeding from 10 lactating women in months 2, 4, and 6 postpartum. In both HM fractions, 1,195 mature known miRNAs were identified, which were positively associated with the cell (p = 0.048) and lipid (p = 0.010) content of HM. An additional 5,167 novel miRNA species were predicted, of which 235 were high-confidence miRNAs. HM cells contained more known miRNAs than HM lipids (1,136 and 835 respectively, p<0.001). Although the profile of the novel miRNAs was very different between cells and lipids, with the majority conserved in the cell fraction and being mother-specific, 2/3 of the known miRNAs common between cells and lipids were similarly expressed (p>0.05). Great similarities between the two HM fractions were also found in the profile of the top 20 known miRNAs. These were largely similar also between the three lactation stages examined, as were the total miRNA concentration, and the number and expression of the known miRNAs common between cells and lipids (p>0.05). Yet, approximately a third of all known miRNAs were differentially expressed during the first 6 months of lactation (p<0.05), with more pronounced miRNA upregulation seen in month 4. These findings indicate that although the total miRNA concentration of HM cells and lipids provided to the infant does not change in first 6 months of lactation, the miRNA composition is altered, particularly in month 4 compared to months 2 and 6. This may reflect the remodeling of the gland in response to infant feeding patterns, which usually change after exclusive breastfeeding, suggesting adaptation to the infant's needs.	[Alsaweed, Mohammed; Lai, Ching Tat; Hartmann, Peter E.; Geddes, Donna T.; Kakulas, Foteini] Univ Western Australia, Sch Chem & Biochem, Crawley, WA, Australia; [Alsaweed, Mohammed] Majmaah Univ, Coll Appl Med Sci, Riyadh, Saudi Arabia	University of Western Australia; Majmaah University	Kakulas, F (corresponding author), Univ Western Australia, Sch Chem & Biochem, Crawley, WA, Australia.	foteini.kakulas@uwa.edu.au	Lai, ching tat/M-2452-2018; Geddes, Donna/H-9254-2014	Lai, ching tat/0000-0002-9025-4922; Geddes, Donna/0000-0002-0431-7078; Hartmann, Peter/0000-0002-7709-0740	Medela AG (Switzerland); Majmaah University, Riyadh, Saudi Arabia	Medela AG (Switzerland); Majmaah University, Riyadh, Saudi Arabia	FK, CTL, PEH and DTG received an unrestricted research grant from Medela AG (Switzerland). The company had no input in designing or conducting the study or the decision to publish the manuscript. MA received a PhD scholarship from Majmaah University, Riyadh, Saudi Arabia.	Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Adam J, 2015, EUR PHYS J C, V75, DOI 10.1140/epjc/s10052-015-3422-9; Alsaweed M, 2015, DEV BIOL IN PRESS; Alsaweed M, 2015, SCI REPORTS IN PRESS; Alsaweed M, 2015, INT J ENV RES PUB HE, V12, P13981, DOI 10.3390/ijerph121113981; Alsaweed M, 2015, J CELL BIOCHEM, V116, P2397, DOI 10.1002/jcb.25207; Arntz OJ, 2015, MOL NUTR FOOD RES, V59, P1701, DOI 10.1002/mnfr.201500222; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baier SR, 2014, J NUTR, V144, P1495, DOI 10.3945/jn.114.196436; Ballard O, 2013, PEDIATR CLIN N AM, V60, P49, DOI 10.1016/j.pcl.2012.10.002; Bode L, 2014, ADV NUTR, V5, P571, DOI 10.3945/an.114.006643; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; CATASSI C, 1995, J PEDIATR GASTR NUTR, V21, P383, DOI 10.1097/00005176-199511000-00003; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen T, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-100; Chen X, 2010, CELL RES, V20, P1128, DOI 10.1038/cr.2010.80; Fallingborg J, 1999, DAN MED BULL, V46, P183; Gailhouste L, 2013, HEPATOLOGY, V58, P1153, DOI 10.1002/hep.26422; Gu YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043691; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hassiotou F, 2014, BI ANN C INT SOC RES; Hassiotou F, 2015, FASEB J S, V29; Hassiotou F, 2015, ADV NUTR, V6, P267, DOI 10.3945/an.114.007377; Hassiotou F, 2014, ADV NUTR, V5, P770, DOI 10.3945/an.114.006924; Hassiotou F, 2013, CLIN TRANSL IMMUNOL, V2, DOI 10.1038/cti.2013.1; Hassiotou F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078232; Hassiotou F, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00079; Hassiotou F, 2013, J HUM LACT, V29, P171, DOI 10.1177/0890334413477242; Hassiotou F, 2013, CLIN ANAT, V26, P29, DOI 10.1002/ca.22165; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; JAIN L, 1989, ARCH DIS CHILD-FETAL, V64, P930, DOI 10.1136/adc.64.7_Spec_No.930; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; KernSmooth S, 2015, PACKAGE LATTICE LATT; Kloosterman WP, 2007, PLOS BIOL, V5, P1738, DOI 10.1371/journal.pbio.0050203; Kosaka Nobuyoshi, 2010, Silence, V1, P7, DOI 10.1186/1758-907X-1-7; Kramer MS, 2010, EARLY HUM DEV, V86, P729, DOI 10.1016/j.earlhumdev.2010.08.005; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lemay DG, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-872; Liu HJ, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-433, 10.1186/1471-2164-15-25]; Melnik BC, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-43; Mitoulas LR, 2003, BRIT J NUTR, V90, P979, DOI 10.1079/BJN2003979; Mitoulas LR, 2002, BRIT J NUTR, V88, P29, DOI [10.1079/BJN2002579, 10.1079/BJNBJN2002579]; Modepalli V, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1012; Moore SE, 2009, ACTA PAEDIATR, V98, P1168, DOI 10.1111/j.1651-2227.2009.01292.x; Munch EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050564; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; Pieters BCH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121123; Pinheiro J., 2019, NLME LINEAR NONLINEA; PRENTICE A, 1987, ACTA PAEDIATR SCAND, V76, P592, DOI 10.1111/j.1651-2227.1987.tb10526.x; Rai D, 2014, CRIT REV FOOD SCI, V54, P1539, DOI 10.1080/10408398.2011.642422; Rstudio Team, 2015, RSTUDIO INT DEV R; Stevens EE, 2009, J PERINAT EDUC, V18, P32, DOI 10.1624/105812409X426314; Tanaka T, 2009, DIFFERENTIATION, V77, P181, DOI 10.1016/j.diff.2008.10.001; Tian T, 2014, J BIOL CHEM, V289, P22258, DOI 10.1074/jbc.M114.588046; Tordonato C, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00072; Twigger AJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep12933; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; WEILER IJ, 1983, AM J REPROD IMMUNOL, V4, P95, DOI 10.1111/j.1600-0897.1983.tb00261.x; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wolf T, 2015, J NUTR, V145, P2201, DOI 10.3945/jn.115.218586; Yang J, 2015, CELL RES, V25, P517, DOI 10.1038/cr.2015.26; Yi SK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-754; Zhang CL, 2014, J NUTR, V144, P1142, DOI 10.3945/jn.114.192575; Zhang L, 2012, CELL RES, V22, P107, DOI 10.1038/cr.2011.158; Zhou L, 2000, IMMUNOLOGY, V101, P570, DOI 10.1046/j.1365-2567.2000.00144.x; Zhou Q, 2012, INT J BIOL SCI, V8, P118, DOI 10.7150/ijbs.8.118; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707	70	41	41	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152610	10.1371/journal.pone.0152610	http://dx.doi.org/10.1371/journal.pone.0152610			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074017	Green Published, Green Submitted, gold			2022-12-26	WOS:000374131200030
J	Benoit, RM; Ostermeier, C; Geiser, M; Li, JSZ; Widmer, H; Auer, M				Benoit, Roger M.; Ostermeier, Christian; Geiser, Martin; Li, Julia Su Zhou; Widmer, Hans; Auer, Manfred			Seamless Insert-Plasmid Assembly at High Efficiency and Low Cost	PLOS ONE			English	Article							LIGATION-INDEPENDENT CLONING; INCOMPLETE PRIMER EXTENSION; ESCHERICHIA-COLI; PCR PRODUCTS; IN-VITRO; RAPID METHOD; ENZYME-FREE; DNA; RECOMBINATION; MUTAGENESIS	Seamless cloning methods, such as co-transformation cloning, sequence-and ligation-independent cloning (SLIC) or the Gibson assembly, are essential tools for the precise construction of plasmids. The efficiency of co-transformation cloning is however low and the Gibson assembly reagents are expensive. With the aim to improve the robustness of seamless cloning experiments while keeping costs low, we examined the importance of complementary single-stranded DNA ends for co-transformation cloning and the influence of single-stranded gaps in circular plasmids on SLIC cloning efficiency. Most importantly, our data show that single-stranded gaps in double-stranded plasmids, which occur in typical SLIC protocols, can drastically decrease the efficiency at which the DNA transforms competent E. coli bacteria. Accordingly, filling-in of single-stranded gaps using DNA polymerase resulted in increased transformation efficiency. Ligation of the remaining nicks did not lead to a further increase in transformation efficiency. These findings demonstrate that highly efficient insert-plasmid assembly can be achieved by using only T5 exonuclease and Phusion DNA polymerase, without Taq DNA ligase from the original Gibson protocol, which significantly reduces the cost of the reactions. We successfully used this modified Gibson assembly protocol with two short insert-plasmid overlap regions, each counting only 15 nucleotides.	[Benoit, Roger M.] Paul Scherrer Inst, Lab Biomol Res, Villigen, Switzerland; [Ostermeier, Christian] Novartis Pharma AG, Basel, Switzerland; [Geiser, Martin; Widmer, Hans] Novartis Inst BioMed Res, Basel, Switzerland; [Li, Julia Su Zhou] Scripps Res Inst, Kellog Sch Sci & Technol, La Jolla, CA 92037 USA; [Auer, Manfred] Univ Edinburgh, Sch Biol Sci CSE, Edinburgh, Midlothian, Scotland; [Auer, Manfred] Univ Edinburgh, Sch Biomed Sci CMVM, Edinburgh, Midlothian, Scotland	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Novartis; Novartis; Scripps Research Institute; University of Edinburgh; University of Edinburgh	Benoit, RM (corresponding author), Paul Scherrer Inst, Lab Biomol Res, Villigen, Switzerland.; Auer, M (corresponding author), Univ Edinburgh, Sch Biol Sci CSE, Edinburgh, Midlothian, Scotland.; Auer, M (corresponding author), Univ Edinburgh, Sch Biomed Sci CMVM, Edinburgh, Midlothian, Scotland.	roger.benoit@psi.ch; manfred.auer@ed.ac.uk		Auer, Manfred/0000-0001-8920-3522; Benoit, Roger/0000-0001-9420-7739	Novartis Institutes for BioMedical Research; Paul Scherrer Institute; Scottish Universities Life Sciences Alliance (SULSA); Medical Research Council (MRC) [J54359]; European Community's 7th Framework Program "PRIMES" [278568]; Biotechnology and Biological Sciences Research Council [998839] Funding Source: researchfish	Novartis Institutes for BioMedical Research; Paul Scherrer Institute; Scottish Universities Life Sciences Alliance (SULSA); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Community's 7th Framework Program "PRIMES"; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Novartis Institutes for BioMedical Research, Paul Scherrer Institute, the Scottish Universities Life Sciences Alliance (SULSA- http://www.sulsa.ac.uk), the Medical Research Council (MRC- www.mrc.ac.uk, J54359), and by the European Community's 7th Framework Program (FP7/2007-2013, www.primesfp7.eu) under grant agreement no 278568 "PRIMES". The funders provided support in the form of salaries for authors [RMB, CO, MG, HW, MA], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; ASLANIDIS C, 1994, PCR METH APPL, V4, P172; Benoit RM, 2006, PROTEIN EXPRES PURIF, V45, P66, DOI 10.1016/j.pep.2005.09.022; Bieniossek Christoph, 2009, Journal of Structural and Functional Genomics, V10, P37, DOI 10.1007/s10969-008-9047-6; Blanusa M, 2010, ANAL BIOCHEM, V406, P141, DOI 10.1016/j.ab.2010.07.011; BUBECK P, 1993, NUCLEIC ACIDS RES, V21, P3601, DOI 10.1093/nar/21.15.3601; Casali Nicola, 2003, Methods Mol Biol, V235, P27; Chen GJ, 2002, BIOTECHNIQUES, V32, P516, DOI 10.2144/02323st02; Donahue WF, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf094; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Howorka S, 1998, BIOTECHNIQUES, V25, P764, DOI 10.2144/98255bm03; Howorka Stefan, 2002, Methods Mol Biol, V182, P139; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; JONES DH, 1991, BIOTECHNIQUES, V10, P62; JONES DH, 1990, NATURE, V344, P793, DOI 10.1038/344793a0; KARU AE, 1973, J BIOL CHEM, V248, P4874; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Kuzminov A, 1997, J BACTERIOL, V179, P880, DOI 10.1128/jb.179.3.880-888.1997; Li CA, 1997, NUCLEIC ACIDS RES, V25, P4165, DOI 10.1093/nar/25.20.4165; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Li Mamie Z, 2012, Methods Mol Biol, V852, P51, DOI 10.1007/978-1-61779-564-0_5; Lu Q, 2005, TRENDS BIOTECHNOL, V23, P199, DOI 10.1016/j.tibtech.2005.02.008; Olieric N, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-56; OLINER JD, 1993, NUCLEIC ACIDS RES, V21, P5192, DOI 10.1093/nar/21.22.5192; OLSEN DB, 1989, NUCLEIC ACIDS RES, V17, P9613, DOI 10.1093/nar/17.23.9613; SCHILDKRAUT C, 1965, BIOPOLYMERS, V3, P195, DOI 10.1002/bip.360030207; Tillett D, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.19.e26; ULLMANN A, 1967, J MOL BIOL, V24, P339, DOI 10.1016/0022-2836(67)90341-5; Xia YZ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1189; Zhu DW, 2010, ANAL BIOCHEM, V397, P162, DOI 10.1016/j.ab.2009.10.018	31	23	30	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153158	10.1371/journal.pone.0153158	http://dx.doi.org/10.1371/journal.pone.0153158			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073895	Green Published, Green Submitted, gold			2022-12-26	WOS:000374131200055
J	Deng, YT; Ye, JQ; Luo, Q; Huang, ZK; Peng, YP; Xiong, GL; Guo, Y; Jiang, H; Li, JM				Deng, Yating; Ye, Jianqing; Luo, Qing; Huang, Zhikun; Peng, Yiping; Xiong, Guoliang; Guo, Yang; Jiang, Hong; Li, Junming			Low-Density Granulocytes Are Elevated in Mycobacterial Infection and Associated with the Severity of Tuberculosis	PLOS ONE			English	Article							NEUTROPHILS; PATHOGENESIS; INFLAMMATION; IMMUNITY	Tuberculosis remains a global health problem caused by infection with Mycobacterium tuberculosis. Numerous studies have established a close correlation between the development of tuberculosis and the roles of neutrophils. Recently, a distinct population of CD15(+) granulocytes was found to be present in the peripheral blood mononuclear cell (PBMC) fraction in humans. This population of granulocytes, termed low-density granulocytes (LDGs), was reported to be elevated and associated with disease activity or severity in a number of different conditions including SLE, asthma and HIV infection. However, both the frequency and clinical significance of LDGs associated with tuberculosis are unclear. Here we determined LDG levels and made comparisons between subjects with active pulmonary tuberculosis (PTB) and healthy controls, between PTB patients with mild-to-moderate disease and patients with advanced disease, and among PTB patients following anti-tuberculous therapy of varying durations. The direct correlation between M. tuberculosis infection and LDG levels was confirmed by in vitro infection of whole peripheral blood and isolated granulocytes with mycobacteria. Our results demonstrated that PBMCs in PTB patients contained significantly elevated percentages of LDGs compared with control subjects. LDGs in tuberculosis expressed higher levels of activation markers compared to normal-density granulocytes (NDGs). M. tuberculosis induced the generation of LDGs in both whole blood and isolated NDGs from control subjects, which suggests that LDGs associated with M. tuberculosis infection are likely to originate from in situ activation. Furthermore, our results revealed that the frequency of LDGs is associated with the severity of tuberculosis.	[Deng, Yating; Ye, Jianqing; Luo, Qing; Huang, Zhikun; Guo, Yang; Jiang, Hong; Li, Junming] Nanchang Univ, Dept Clin Lab, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China; [Peng, Yiping] Jiangxi Chest Hosp, Dept TB, Nanchang, Jiangxi, Peoples R China; [Xiong, Guoliang] Jiangxi Chest Hosp, Dept Clin Lab, Nanchang, Jiangxi, Peoples R China	Nanchang University	Li, JM (corresponding author), Nanchang Univ, Dept Clin Lab, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China.	lisir361@163.com		Li, Junming/0000-0003-1409-3634	National Natural Science Foundation of China [81060001, 81170006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grant numbers: 81060001 and 81170006 to L.J.-M.). URL of NSFC: http://www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman M, 2002, AM J RESP CELL MOL, V27, P583, DOI 10.1165/rcmb.2002-0038OC; Beisiegel M, 2009, J INFECT DIS, V199, P1222, DOI 10.1086/597421; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Carmona-Rivera C, 2013, SEMIN IMMUNOPATHOL, V35, P455, DOI 10.1007/s00281-013-0375-7; Chinese Medical Association, 2005, GUID CLIN DIAGN TREA; Cloke T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048939; Cloke T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072034; Corleis B, 2012, CELL MICROBIOL, V14, P1109, DOI 10.1111/j.1462-5822.2012.01783.x; Denny MR, 2010, J IMMUNOL, V184, P3284, DOI 10.4049/jimmunol.0902199; Dey B, 2014, SEMIN IMMUNOL, V26, P486, DOI 10.1016/j.smim.2014.09.002; Elghetany MT, 2002, BLOOD CELL MOL DIS, V28, P260, DOI 10.1006/bcmd.2002.0513; Eruslanov EB, 2005, INFECT IMMUN, V73, P1744, DOI 10.1128/IAI.73.3.1744-1753.2005; Eum SY, 2010, CHEST, V137, P122, DOI 10.1378/chest.09-0903; Fu J, 2014, ANN ALLERG ASTHMA IM, V113, P635, DOI 10.1016/j.anai.2014.08.024; Grayson PC, 2015, ARTHRITIS RHEUMATOL, V67, P1922, DOI 10.1002/art.39153; Kaplan MJ, 2011, NAT REV RHEUMATOL, V7, P691, DOI 10.1038/nrrheum.2011.132; Korbel DS, 2008, MICROBES INFECT, V10, P995, DOI 10.1016/j.micinf.2008.07.039; Peiper S. C., 1997, LEUCOCYTE TYPING, P972; Philips JA, 2012, ANNU REV PATHOL-MECH, V7, P353, DOI 10.1146/annurev-pathol-011811-132458; Ralph AP, 2010, THORAX, V65, P863, DOI 10.1136/thx.2010.136242; Seiler P, 2000, J INFECT DIS, V181, P671, DOI 10.1086/315278; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Ssemaganda A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085696	23	51	54	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153567	10.1371/journal.pone.0153567	http://dx.doi.org/10.1371/journal.pone.0153567			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073889	Green Published, gold			2022-12-26	WOS:000374131200107
J	Bai, L; Li, MQ; Sun, JL; Yang, XG; Lu, YQ; Lu, SS; Lu, KH				Bai, Lin; Li, Mengqi; Sun, Junli; Yang, Xiaogan; Lu, Yangqing; Lu, Shengsheng; Lu, Kehuan			RNA-Seq Profiling of Intact and Enucleated Oocyte SCNT Embryos Reveals the Role of Pig Oocyte Nucleus in Somatic Reprogramming	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; DEVELOPMENTAL COMPETENCE; MICE; FIBROBLASTS; TOOL	The specific molecular mechanisms involved in somatic reprogramming remain unidentified. Removal of the oocyte genome is one of the primary causes of developmental failure in cloned embryos, whereas intact oocyte shows stronger reprogramming capability than enucleated oocyte. To identify the reason for the low efficiency of cloning and elucidate the mechanisms involved in somatic reprogramming by the oocyte nucleus, we injected pig cumulus cells into 539 intact MII oocytes and 461 enucleated MII oocytes. Following activation, 260 polyploidy embryos developed to the blastocyst stage whereas only 93 traditionally cloned embryos (48.2% vs. 20.2%, P < 0.01) reached blastocyst stage. Blastocysts generated from intact oocytes also had more cells than those generated from enucleated oocytes (60.70 vs. 46.65, P < 0.01). To identify the genes that contribute to this phenomenon, two early embryos in 2-cell and 4-cell stages were collected for single-cell RNA sequencing. The two kinds of embryos were found to have dramatically different transcriptome profiles. Intact oocyte nuclear transfer embryos showed 1,738 transcripts that were up-regulated relative to enucleated cloned embryos at the 2-cell stage and 728 transcripts that were down-regulated (vertical bar log2Ratio vertical bar >= 5). They showed 2,941 transcripts that were upregulated during the 4-cell stage and 1,682 that were down-regulated (vertical bar log2Ratio vertical bar >= 5). The most significantly enriched gene ontology categories were those involved in the regulation of binding, catalytic activity, and molecular transducer activity. Other genes that were notably up-regulated and expressed in intact oocyte nuclear transfer embryos were metabolic process. This study provides a comprehensive profile of the differences in gene expression between intact oocyte nuclear transfer embryos and traditional nuclear transfer embryos. This work thus paves the way for further research on the mechanisms underlying somatic reprogramming by oocytes.	[Bai, Lin; Li, Mengqi; Sun, Junli; Yang, Xiaogan; Lu, Yangqing; Lu, Shengsheng; Lu, Kehuan] Guangxi Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, 100 Daxue Rd, Nanning 530004, Guangxi Zhuang, Peoples R China; [Bai, Lin; Li, Mengqi; Sun, Junli; Yang, Xiaogan; Lu, Yangqing; Lu, Shengsheng; Lu, Kehuan] Guangxi Univ, Guangxi High Educ Lab Anim Reprod & Biotechnol, 100 Daxue Rd, Nanning 530004, Guangxi Zhuang, Peoples R China	Guangxi University; Guangxi University	Lu, SS; Lu, KH (corresponding author), Guangxi Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, 100 Daxue Rd, Nanning 530004, Guangxi Zhuang, Peoples R China.; Lu, SS; Lu, KH (corresponding author), Guangxi Univ, Guangxi High Educ Lab Anim Reprod & Biotechnol, 100 Daxue Rd, Nanning 530004, Guangxi Zhuang, Peoples R China.	sslu@gxu.edu.cn; khlu@gxu.edu.cn			National Natural Science Foundation of China [31260553]; Guangxi High Education Innovative Research Group and Eminent Scholar Project [2014-7]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi High Education Innovative Research Group and Eminent Scholar Project	This work was supported by the National Natural Science Foundation of China (Award Number: 31260553; Recipient: Kehuan Lu; URL: http://www.nsfc.gov.cn/); Guangxi High Education Innovative Research Group and Eminent Scholar Project (Award Number: 2014-7 Recipient: Yangqing Lu URL: http://www.gxedu.gov.cn/).	cells Cloned pigs produced by nuclear transfer from adult somatic, 2000, NATURE, V407, P86; Chesne P, 2002, NAT BIOTECHNOL, V20, P366, DOI 10.1038/nbt0402-366; Chung Y, 2009, CLONING STEM CELLS, V11, P213, DOI 10.1089/clo.2009.0004; Cibelli JB, 1998, SCIENCE, V280, P1256, DOI 10.1126/science.280.5367.1256; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Do JT, 2004, STEM CELLS, V22, P941, DOI 10.1634/stemcells.22-6-941; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; Hall VJ, 2007, HUM REPROD, V22, P52, DOI 10.1093/humrep/del345; Heindryckx B, 2007, HUM REPROD, V22, P1982, DOI 10.1093/humrep/dem106; Hooper SD, 2005, BIOINFORMATICS, V21, P4432, DOI 10.1093/bioinformatics/bti696; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Hunter RB, 2004, J CLIN INVEST, V114, P1504, DOI 10.1172/JCI200421696; Inoue A, 2008, HUM REPROD, V23, P1377, DOI 10.1093/humrep/den096; Jaenisch Rudolf, 2002, Cloning and Stem Cells, V4, P389, DOI 10.1089/153623002321025069; Jouneau A, 2003, CURR OPIN GENET DEV, V13, P486, DOI 10.1016/j.gde.2003.08.007; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kubota C, 2000, P NATL ACAD SCI USA, V97, P990, DOI 10.1073/pnas.97.3.990; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Ling L, 2001, CLONING, V3, P51; Ma H, 2014, NATURE, V511, P177, DOI 10.1038/nature13551; Maeda I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2780; Noggle S, 2011, NATURE, V478, P70, DOI 10.1038/nature10397; Ogushi S, 2008, SCIENCE, V319, P613, DOI 10.1126/science.1151276; Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188; Pereira L, 2006, MOL CELL BIOL, V26, P7479, DOI 10.1128/MCB.00368-06; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shin T, 2002, NATURE, V415, P859, DOI 10.1038/nature723; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vassena R, 2007, DEV BIOL, V304, P75, DOI 10.1016/j.ydbio.2006.12.015; Wakayama S, 2007, CURR BIOL, V17, pR120, DOI 10.1016/j.cub.2006.12.020; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 1999, P NATL ACAD SCI USA, V96, P14984, DOI 10.1073/pnas.96.26.14984; Wrenzycki C, 2006, GENE EXPRESSION METH, P285; Yang H, 2010, CELL RES, V20, P1034, DOI 10.1038/cr.2010.97; Zhou WP, 2013, CELL REPROGRAM, V15, P92, DOI 10.1089/cell.2012.0043	37	5	5	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153093	10.1371/journal.pone.0153093	http://dx.doi.org/10.1371/journal.pone.0153093			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070804	gold, Green Submitted, Green Published			2022-12-26	WOS:000373900700031
J	Kong, L; Zhao, YP; Tian, QY; Feng, JQ; Kobayashi, T; Merregaert, J; Liu, CJ				Kong, Li; Zhao, Yun-Peng; Tian, Qing-Yun; Feng, Jian-Quan; Kobayashi, Tatsuya; Merregaert, Joseph; Liu, Chuan-Ju			Extracellular matrix protein 1, a direct targeting molecule of parathyroid hormone-related peptide, negatively regulates chondrogenesis and endochondral ossification via associating with progranulin growth factor	FASEB JOURNAL			English	Article						ECM1; PTHrP; PGRN	GRANULIN-EPITHELIN PRECURSOR; LIPOID PROTEINOSIS; INDIAN HEDGEHOG; PTH/PTHRP RECEPTOR; HOST-DEFENSE; GENE; ECM1; ADAMTS-7; AUTOANTIBODIES; MUTATIONS	Chondrogenesis and endochondral ossification are precisely controlled by cellular interactions with surrounding matrix proteins and growth factors that mediate cellular signaling pathways. Here, we report that extracellular matrix protein 1 (ECM1) is a previously unrecognized regulator of chondrogenesis. ECM1 is induced in the course of chondrogenesis and its expression in chondrocytes strictly depends on parathyroid hormone-related peptide (PTHrP) signaling pathway. Overexpression of ECM1 suppresses, whereas suppression of ECM1 enhances, chondrocyte differentiation and hypertrophy in vitro and ex vivo. In addition, target transgene of ECM1 in chondrocytes or osteoblasts in mice leads to striking defects in cartilage development and endochondral bone formation. Of importance, ECM1 seems to be critical for PTHrP action in chondrogenesis, as blockage of ECM1 nearly abolishes PTHrP regulation of chondrocyte hypertrophy, and overexpression of ECM1 rescues disorganized growth plates of PTHrP-null mice. Furthermore, ECM1 and progranulin chondrogenic growth factor constitute an interaction network and act in concert in the regulation of chondrogenesis.	[Kong, Li; Zhao, Yun-Peng; Tian, Qing-Yun; Liu, Chuan-Ju] NYU, Sch Med, Dept Orthoped Surg, New York, NY USA; [Liu, Chuan-Ju] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Feng, Jian-Quan] Texas A&M Baylor Coll Dent, Dept Biomed Sci, Dallas, TX USA; [Kobayashi, Tatsuya] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Merregaert, Joseph] Univ Antwerp, Mol Biotechnol Lab, Antwerp, Belgium	New York University; New York University; Harvard University; Massachusetts General Hospital; University of Antwerp	Liu, CJ (corresponding author), NYU, Med Ctr, Dept Orthoped Surg, Rm 1608,HJD,301 E 17th St, New York, NY 10003 USA.	chuanju.liu@med.nyu.edu	Liu, Chuan-ju/AAT-8165-2021	liu, chuanju/0000-0002-7181-8032; Kobayashi, Tatsuya/0000-0003-4264-5117	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01-AR062207, R01-AR061484]; Rheumatology Research Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061484, R01AR062207, R01AR056645] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Rheumatology Research Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Dr. Brendan Lee (Baylor College of Medicine, Houston, TX, USA) for providing both Col II- and Col I-specific transgenic constructs used for generating ECM1 transgenic mice in this study, and Aubryanna Hettinghouse (New York University School of Medicine) for assistance in preparing the manuscript. This work was supported in part by U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (Grants R01-AR062207 and R01-AR061484), and a Disease Targeted Research Grant from the Rheumatology Research Foundation (to C.-J.L.).	AMIZUKA N, 1994, J CELL BIOL, V126, P1611, DOI 10.1083/jcb.126.6.1611; Bai XH, 2009, MOL CELL BIOL, V29, P4201, DOI 10.1128/MCB.00056-09; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Bateman A, 2009, BIOESSAYS, V31, P1245, DOI 10.1002/bies.200900086; Buckland Jenny, 2013, Nat Rev Rheumatol, V9, P566, DOI 10.1038/nrrheum.2013.135; Chamoto K, 2013, STEM CELL RES, V10, P267, DOI 10.1016/j.scr.2012.12.006; Chan I, 2004, CLIN EXP DERMATOL, V29, P499, DOI 10.1111/j.1365-2230.2004.01573.x; Correa D, 2010, DEV CELL, V19, P533, DOI 10.1016/j.devcel.2010.09.008; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Deckers MML, 2001, BONE, V28, P14, DOI 10.1016/S8756-3282(00)00428-2; Edmonds E, 2011, INT J EXP PATHOL, V92, P320, DOI 10.1111/j.1365-2613.2011.00779.x; Feng JAQ, 2010, FASEB J, V24, P1879, DOI 10.1096/fj.09-144659; Fisher SA, 2008, NAT GENET, V40, P710, DOI 10.1038/ng.145; Fujimoto N, 2006, EXP DERMATOL, V15, P300, DOI 10.1111/j.0906-6705.2006.00409.x; Guo FJ, 2010, ARTHRITIS RHEUM-US, V62, P2023, DOI 10.1002/art.27491; Guo J, 2002, DEV CELL, V3, P183, DOI 10.1016/S1534-5807(02)00218-6; Guo J, 2010, ENDOCRINOLOGY, V151, P3502, DOI 10.1210/en.2009-1494; Hamada T, 2003, J INVEST DERMATOL, V120, P345, DOI 10.1046/j.1523-1747.2003.12073.x; Hamada T, 2002, HUM MOL GENET, V11, P833, DOI 10.1093/hmg/11.7.833; He ZH, 2003, NAT MED, V9, P225, DOI 10.1038/nm816; Hirai T, 2011, P NATL ACAD SCI USA, V108, P191, DOI 10.1073/pnas.1005011108; Hoogendam J, 2007, HORM RES, V67, P159, DOI 10.1159/000096586; Jung C, 2009, GASTROEN CLIN BIOL, V33, pS123, DOI 10.1016/S0399-8320(09)73147-1; KARAPLIS AC, 1994, GENE DEV, V8, P277, DOI 10.1101/gad.8.3.277; Karaplis AC, 1996, VITAM HORM, V52, P177, DOI 10.1016/S0083-6729(08)60411-2; Kessenbrock K, 2008, J CLIN INVEST, V118, P2438, DOI 10.1172/JCI34694; Kobayashi T, 2002, DEVELOPMENT, V129, P2977; Kong L, 2010, MATRIX BIOL, V29, P276, DOI 10.1016/j.matbio.2010.01.007; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lai YJ, 2014, ANN RHEUM DIS, V73, P1575, DOI 10.1136/annrheumdis-2013-203561; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; Li ZH, 2011, NAT IMMUNOL, V12, P178, DOI 10.1038/ni.1983; Liu CJ, 2012, PHARMACOL THERAPEUT, V133, P124, DOI 10.1016/j.pharmthera.2011.10.003; Liu CJ, 2011, FEBS LETT, V585, P3675, DOI 10.1016/j.febslet.2011.04.065; Luan Y, 2008, OSTEOARTHR CARTILAGE, V16, P1413, DOI 10.1016/j.joca.2008.03.017; Mongiat M, 2003, J BIOL CHEM, V278, P17491, DOI 10.1074/jbc.M210529200; Napierala D, 2012, J BONE MINER RES, V27, P1735, DOI 10.1002/jbmr.1636; Oyama N, 2004, J CLIN INVEST, V113, P1550, DOI 10.1172/GCI200420373; Oyama N, 2003, LANCET, V362, P118, DOI 10.1016/S0140-6736(03)13863-9; Paroly SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084155; Quirici MB, 2013, NEUROLOGY, V80, pE93, DOI 10.1212/WNL.0b013e3182840741; Sercu S, 2008, CANCER INVEST, V26, P375, DOI 10.1080/07357900701788148; Sercu S, 2008, J INVEST DERMATOL, V128, P1397, DOI 10.1038/sj.jid.5701231; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Tian QY, 2012, JOVE-J VIS EXP, DOI 10.3791/3562; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wils H, 2012, J PATHOL, V228, P67, DOI 10.1002/path.4043; Wu H, 2011, SCIENCE, V332, P427, DOI 10.1126/science.1205992; Xu K, 2007, J BIOL CHEM, V282, P11347, DOI 10.1074/jbc.M608744200; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Zhao YP, 2013, FEBS LETT, V587, P1805, DOI 10.1016/j.febslet.2013.04.037; Zhao YP, 2013, BIOMATERIALS, V34, P6412, DOI 10.1016/j.biomaterials.2013.05.030; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	53	10	10	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2741	2754		10.1096/fj.201600261R	http://dx.doi.org/10.1096/fj.201600261R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27075243	Green Published			2022-12-26	WOS:000380994000011
J	Singh, NS; Rutkowska, E; Plazinska, A; Khadeer, M; Moaddel, R; Jozwiak, K; Bernier, M; Wainer, IW				Singh, Nagendra S.; Rutkowska, Ewelina; Plazinska, Anita; Khadeer, Mohammed; Moaddel, Ruin; Jozwiak, Krzysztof; Bernier, Michel; Wainer, Irving W.			Ketamine Metabolites Enantioselectively Decrease Intracellular D-Serine Concentrations in PC-12 Cells	PLOS ONE			English	Article							MAMMALIAN TARGET; NMDA RECEPTORS; RACEMASE; RELEASE; INHIBITION; GABAPENTIN; ACTIVATION; EXPRESSION; INDUCTION; RAPAMYCIN	D-Serine is an endogenous NMDA receptor co-agonist that activates synaptic NMDA receptors modulating neuronal networks in the cerebral cortex and plays a key role in long-term potentiation of synaptic transmission. D-serine is associated with NMDA receptor neurotoxicity and neurodegeneration and elevated D-serine concentrations have been associated with Alzheimer's and Parkinsons' diseases and amyotrophic lateral sclerosis. Previous studies have demonstrated that the ketamine metabolites (rac)-dehydronorketamine and (2S, 6S)-hydroxynorketamine decrease intracellular D-serine concentrations in a concentration dependent manner in PC-12 cells. In the current study, PC-12 cells were incubated with a series of ketamine metabolites and the IC50 values associated with attenuated intracellular D-serine concentrations were determined. The results demonstrate that structural and stereochemical features of the studied compounds contribute to the magnitude of the inhibitory effect with (2S, 6S)-hydroxynorketamine and (2R, 6R)-hydroxynorketamine displaying the most potent inhibition with IC50 values of 0.18 +/- 0.04 nM and 0.68 +/- 0.09 nM. The data was utilized to construct a preliminary 3D-QSAR/pharmacophore model for use in the design of new and more efficient modulators of D-serine.	[Singh, Nagendra S.; Khadeer, Mohammed; Moaddel, Ruin; Wainer, Irving W.] NIA, Clin Invest Lab, NIH, Baltimore, MD 21224 USA; [Rutkowska, Ewelina; Plazinska, Anita; Jozwiak, Krzysztof] Med Univ Lublin, Dept Biopharm, Lublin, Poland; [Bernier, Michel] NIA, Translat Gerontol Branch, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Medical University of Lublin; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Wainer, IW (corresponding author), NIA, Clin Invest Lab, NIH, Baltimore, MD 21224 USA.	iwwainer@gmail.com	Moaddel, Ruin/AAE-3378-2020; Singh, Nagendra/B-6646-2018; Bernier, Michel/AAO-3983-2021; Bernier, Michel/Y-7139-2019; Singh, Nagendra S/K-8966-2015	Bernier, Michel/0000-0002-5948-368X; Jozwiak, Krzysztof/0000-0001-6018-5092; Plazinska, Anita/0000-0002-3698-2574; Moaddel, Ruin/0000-0002-6812-0127	Intramural Research Programs of the National Institute on Aging; Foundation for Polish Science [2009 - 4/5]; NATIONAL INSTITUTE ON AGING [ZIAAG000297] Funding Source: NIH RePORTER	Intramural Research Programs of the National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work was funded by the Intramural Research Programs of the National Institute on Aging and by The Foundation for Polish Science (TEAM Programme 2009 - 4/5).	ADAMS JD, 1981, BIOMED MASS SPECTROM, V8, P527, DOI 10.1002/bms.1200081103; Balu DT, 2012, NEUROBIOL DIS, V45, P671, DOI 10.1016/j.nbd.2011.10.006; Cook SP, 2002, J BIOL CHEM, V277, P27782, DOI 10.1074/jbc.M111814200; Crow JP, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/625245; Desta Z, 2012, XENOBIOTICA, V42, P1076, DOI 10.3109/00498254.2012.685777; Domino EF, 2010, ANESTHESIOLOGY, V113, P678, DOI 10.1097/ALN.0b013e3181ed09a2; Dwyer JM, 2013, BIOL PSYCHIAT, V73, P1189, DOI 10.1016/j.biopsych.2012.11.011; Fossat P, 2012, CEREB CORTEX, V22, P595, DOI 10.1093/cercor/bhr130; Henneberger C, 2013, NEUROCHEM RES, V38, P1156, DOI 10.1007/s11064-013-0987-2; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hirota K, 2011, BRIT J ANAESTH, V107, P123, DOI 10.1093/bja/aer221; Jiraskova-Vanickova J, 2011, CURR DRUG TARGETS, V12, P1037, DOI 10.2174/138945011795677755; Kartvelishvily E, 2006, J BIOL CHEM, V281, P14151, DOI 10.1074/jbc.M512927200; LEUNG LY, 1986, J MED CHEM, V29, P2396, DOI 10.1021/jm00161a043; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Moaddel R, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.157; Moaddel R, 2015, PSYCHOPHARMACOLOGY, V232, P399, DOI 10.1007/s00213-014-3669-0; Moaddel R, 2013, EUR J PHARMACOL, V698, P228, DOI 10.1016/j.ejphar.2012.11.023; Moaddel R, 2010, TALANTA, V82, P1892, DOI 10.1016/j.talanta.2010.08.005; Papouin T, 2012, CELL, V150, P633, DOI 10.1016/j.cell.2012.06.029; Paul RK, 2014, ANESTHESIOLOGY, V121, P149, DOI 10.1097/ALN.0000000000000285; Sethuraman R, 2009, MINI-REV MED CHEM, V9, P813, DOI 10.2174/138955709788452630; Shleper M, 2005, J NEUROSCI, V25, P9413, DOI 10.1523/JNEUROSCI.3190-05.2005; Singh NS, 2015, BRIT J PHARMACOL, V172, P4546, DOI 10.1111/bph.13239; Singh NS, 2013, CELL SIGNAL, V25, P2634, DOI 10.1016/j.cellsig.2013.08.025; Singh NS, 2013, NEUROSCI LETT, V535, P90, DOI 10.1016/j.neulet.2012.12.024; Singh NS, 2012, ANAL BIOCHEM, V421, P460, DOI 10.1016/j.ab.2011.10.003; Taylor CP, 2009, PAIN, V142, P13, DOI 10.1016/j.pain.2008.11.019; Wolosker H, 2008, FEBS J, V275, P3514, DOI 10.1111/j.1742-4658.2008.06515.x; Wu SZ, 2007, CURR ALZHEIMER RES, V4, P243; Wu SZ, 2004, ANN NY ACAD SCI, V1035, P133, DOI 10.1196/annals.1332.009; Zarate CA, 2012, BIOL PSYCHIAT, V72, P331, DOI 10.1016/j.biopsych.2012.03.004	32	20	20	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0149499	10.1371/journal.pone.0149499	http://dx.doi.org/10.1371/journal.pone.0149499			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096720	Green Published, Green Submitted, gold			2022-12-26	WOS:000374543600001
J	Brim, S; Groschup, MH; Kuczius, T				Brim, Svetlana; Groschup, Martin H.; Kuczius, Thorsten			Copper and Zinc Interactions with Cellular Prion Proteins Change Solubility of Full-Length Glycosylated Isoforms and Induce the Occurrence of Heterogeneous Phenotypes	PLOS ONE			English	Article							TRUNCATED FORMS; BINDING; OCTAREPEAT; COORDINATION; MEMBRANE; PEPTIDES; DOMAIN; PRP	Prion diseases are characterized biochemically by protein aggregation of infectious prion isoforms (PrPSc), which result from the conformational conversion of physiological prion proteins (PrPC). PrPC are variable post-translationally modified glycoproteins, which exist as full length and as aminoterminally truncated glycosylated proteins and which exhibit differential detergent solubility. This implicates the presence of heterogeneous phenotypes, which overlap as protein complexes at the same molecular masses. Although the biological function of PrPC is still enigmatic, evidence reveals that PrPC exhibits metal-binding properties, which result in structural changes and decreased solubility. In this study, we analyzed the yield of PrPC metal binding affiliated with low solubility and changes in protein banding patterns. By implementing a high-speed centrifugation step, the interaction of zinc ions with PrPC was shown to generate large quantities of proteins with low solubility, consisting mainly of full-length glycosylated PrPC; whereas unglycosylated PrPC remained in the supernatants as well as truncated glycosylated proteins which lack of octarepeat sequence necessary for metal binding. This effect was considerably lower when PrPC interacted with copper ions; the presence of other metals tested exhibited no effect under these conditions. The binding of zinc and copper to PrPC demonstrated differentially soluble protein yields within distinct PrPC subtypes. PrPC-Zn2+-interaction may provide a means to differentiate glycosylated and unglycosylated subtypes and offers detailed analysis of metal-bound and metal-free protein conversion assays.	[Brim, Svetlana; Kuczius, Thorsten] Univ Munster, Inst Hyg, Robert Koch Str 41, D-48149 Munster, Germany; [Groschup, Martin H.] FLI, Inst Novel & Emerging Infect Dis, Boddenblick 5a, D-17493 Greifswald, Insel Riems, Germany	University of Munster; Friedrich Loeffler Institute	Kuczius, T (corresponding author), Univ Munster, Inst Hyg, Robert Koch Str 41, D-48149 Munster, Germany.	thorsten.kuczius@ukmuenster.de						Brown DR, 1999, BIOCHEM J, V344, P1, DOI 10.1042/0264-6021:3440001; Brown DR, 1997, EXP NEUROL, V146, P104, DOI 10.1006/exnr.1997.6505; Brown LR, 2003, J NEUROCHEM, V87, P353, DOI 10.1046/j.1471-4159.2003.01996.x; Bush AI, 2000, CURR OPIN CHEM BIOL, V4, P184, DOI 10.1016/S1367-5931(99)00073-3; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Demart S, 1999, BIOCHEM BIOPH RES CO, V265, P652, DOI 10.1006/bbrc.1999.1730; Estibeiro JP, 1996, TRENDS NEUROSCI, V19, P257, DOI 10.1016/S0166-2236(96)30010-6; Gaggelli E, 2005, J AM CHEM SOC, V127, P996, DOI 10.1021/ja045958z; Garnett AP, 2006, DALTON T, P509, DOI 10.1039/b511553a; GASSET M, 1993, P NATL ACAD SCI USA, V90, P1, DOI 10.1073/pnas.90.1.1; Gonzalez-Iglesias R, 2004, FEBS LETT, V556, P161, DOI 10.1016/S0014-5793(03)01397-8; HORNSHAW MP, 1995, BIOCHEM BIOPH RES CO, V207, P621, DOI 10.1006/bbrc.1995.1233; Hu W, 2008, J NEUROL SCI, V264, P1, DOI 10.1016/j.jns.2007.06.019; Jobling MF, 2001, BIOCHEMISTRY-US, V40, P8073, DOI 10.1021/bi0029088; Kenward AG, 2007, BIOCHEMISTRY-US, V46, P4261, DOI 10.1021/bi602473r; Kuczius T, 2007, EUR J NEUROSCI, V25, P2649, DOI 10.1111/j.1460-9568.2007.05518.x; Kuczius T, 2011, EXP NEUROL, V227, P188, DOI 10.1016/j.expneurol.2010.10.014; Lasmezas CI, 2003, BRIT MED BULL, V66, P61, DOI 10.1093/bmb/66.1.61; Leliveld SR, 2006, J BIOL CHEM, V281, P3268, DOI 10.1074/jbc.M510606200; Morante S, 2004, J BIOL CHEM, V279, P11753, DOI 10.1074/jbc.M312860200; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Neuendorf E, 2004, J BIOL CHEM, V279, P53306, DOI 10.1074/jbc.M410796200; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Pauly PC, 1998, J BIOL CHEM, V273, P33107, DOI 10.1074/jbc.273.50.33107; Prusiner SB, 1997, SCIENCE, V278, P245, DOI 10.1126/science.278.5336.245; Pushie MJ, 2007, ANAL CHEM, V79, P5659, DOI 10.1021/ac070312l; Pushie M, 2009, BIOMETALS, V22, P159, DOI 10.1007/s10534-008-9196-x; Qin KF, 2000, J BIOL CHEM, V275, P19121, DOI 10.1074/jbc.275.25.19121; Quaglio E, 2001, J BIOL CHEM, V276, P11432, DOI 10.1074/jbc.M009666200; Rachidi W, 2003, J BIOL CHEM, V278, P9064, DOI 10.1074/jbc.M211830200; STAHL N, 1990, BIOCHEMISTRY-US, V29, P8879, DOI 10.1021/bi00490a001; Stockel J, 1998, BIOCHEMISTRY-US, V37, P7185, DOI 10.1021/bi972827k; Viles JH, 1999, P NATL ACAD SCI USA, V96, P2042, DOI 10.1073/pnas.96.5.2042; Walter ED, 2007, J AM CHEM SOC, V129, P15440, DOI 10.1021/ja077146j; Watanabe Y, 2010, BIOCHEM BIOPH RES CO, V394, P522, DOI 10.1016/j.bbrc.2010.03.003; Whittal RM, 2000, PROTEIN SCI, V9, P332; Zhu F, 2008, BIOCHEMISTRY-US, V47, P2510, DOI 10.1021/bi7022893	37	6	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153931	10.1371/journal.pone.0153931	http://dx.doi.org/10.1371/journal.pone.0153931			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093554	Green Submitted, gold, Green Published			2022-12-26	WOS:000374541200063
J	Guo, YJ; Qi, Y; Yang, XF; Zhao, LH; Wen, S; Liu, YH; Tang, L				Guo, Yanjie; Qi, Yane; Yang, Xuefei; Zhao, Lihui; Wen, Shu; Liu, Yinhui; Tang, Li			Association between Polycystic Ovary Syndrome and Gut Microbiota	PLOS ONE			English	Article							PERIODONTAL PATHOGENS; INSULIN SENSITIVITY; BARRIER FUNCTION; DISEASE; OBESITY; WOMEN; PCOS; SEX; DYSBIOSIS; ETIOLOGY	Polycystic ovary syndrome (PCOS) is the most frequent endocrinopathy in women of reproductive age. It is difficult to treat PCOS because of its complex etiology and pathogenesis. Here, we characterized the roles of gut microbiota on the pathogenesis and treatments in letrozole (a nonsteroidal aromatase inhibitor) induced PCOS rat model. Changes in estrous cycles, hormonal levels, ovarian morphology and gut microbiota by PCR-DGGE and real-time PCR were determined. The results showed that PCOS rats displayed abnormal estrous cycles with increasing androgen biosynthesis and exhibited multiple large cysts with diminished granulosa layers in ovarian tissues. Meanwhile, the composition of gut microbiota in letrozole-treated rats was different from that in the controls. Lactobacillus, Ruminococcus and Clostridium were lower while Prevotella was higher in PCOS rats when compared with control rats. After treating PCOS rats with Lactobacillus and fecal microbiota transplantation (FMT) from healthy rats, it was found that the estrous cycles were improved in all 8 rats in FMT group, and in 6 of the 8 rats in Lactobacillus transplantation group with decreasing androgen biosynthesis. Their ovarian morphologies normalized. The composition of gut microbiota restored in both FMT and Lactobacillus treated groups with increasing of Lactobacillus and Clostridium, and decreasing of Prevotella. These results indicated that dysbiosis of gut microbiota was associated with the pathogenesis of PCOS. Microbiota interventions through FMT and Lactobacillus transplantation were beneficial for the treatments of PCOS rats.	[Guo, Yanjie; Qi, Yane; Yang, Xuefei; Zhao, Lihui; Wen, Shu; Liu, Yinhui; Tang, Li] Dalian Med Univ, Sch Basic Med Sci, Dept Microecol, Dalian, Liaoning, Peoples R China	Dalian Medical University	Tang, L (corresponding author), Dalian Med Univ, Sch Basic Med Sci, Dept Microecol, Dalian, Liaoning, Peoples R China.	tangli_2015cn@sina.com			National Program on Key Basic Research Project (973 Program) [2013CB531405]; National Program on Key Basic Research Project (863 Program) [2014AA022200]; National Natural Science Foundation of China [81370113]; education Department of Liaoning Province [L2015143]	National Program on Key Basic Research Project (973 Program)(National Basic Research Program of China); National Program on Key Basic Research Project (863 Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); education Department of Liaoning Province	This study was supported by grants from the National Program on Key Basic Research Project (973 Program) ( NO. 2013CB531405), the National Program on Key Basic Research Project (863 Program) ( NO. 2014AA022200), the National Natural Science Foundation of China ( No. 81370113) and funds from education Department of Liaoning Province ( NO. L2015143). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcali A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108074; Akkol EK, 2015, J ETHNOPHARMACOL, V168, P25, DOI 10.1016/j.jep.2015.03.029; Andreasen AS, 2010, BRIT J NUTR, V104, P1831, DOI 10.1017/S0007114510002874; Balen A, 2004, BEST PRACT RES CL OB, V18, P685, DOI 10.1016/j.bpobgyn.2004.05.004; Brook I, 2005, J LARYNGOL OTOL, V119, P251, DOI 10.1258/0022215054020304; Chen J, 2015, J OVARIAN RES, V8, DOI 10.1186/s13048-015-0139-1; Clarke G, 2013, MOL PSYCHIATR, V18, P666, DOI 10.1038/mp.2012.77; Corbin CJ, 1999, ENDOCRINOLOGY, V140, P5202, DOI 10.1210/en.140.11.5202; Diamanti-Kandarakis Evanthia, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000598; Dokras A, 2013, STEROIDS, V78, P773, DOI 10.1016/j.steroids.2013.04.009; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; Flak MB, 2013, SCIENCE, V339, P1044, DOI 10.1126/science.1236226; Fox Robert, 2002, Hum Fertil (Camb), V5, pS28, DOI 10.1080/1464727022000199881; Franks S, 1997, HUM REPROD, V12, P2641, DOI 10.1093/humrep/12.12.2641; Fuhrman BJ, 2014, J CLIN ENDOCR METAB, V99, P4632, DOI 10.1210/jc.2014-2222; Goodarzi MO, 2011, NAT REV ENDOCRINOL, V7, P219, DOI 10.1038/nrendo.2010.217; Haag LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035988; Homburg R, 2008, BEST PRACT RES CL OB, V22, P261, DOI 10.1016/j.bpobgyn.2007.07.009; Hsu MI, 2013, STEROIDS, V78, P761, DOI 10.1016/j.steroids.2013.04.005; Hulston CJ, 2015, BRIT J NUTR, V113, P596, DOI 10.1017/S0007114514004097; Johnson-Henry KC, 2008, INFECT IMMUN, V76, P1340, DOI 10.1128/IAI.00778-07; Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263; Kafali H, 2004, ARCH MED RES, V35, P103, DOI 10.1016/j.arcmed.2003.10.005; Kumar PS, 2013, PERIODONTOL 2000, V61, P103, DOI 10.1111/j.1600-0757.2011.00398.x; Lebbe M, 2013, MOL HUM REPROD, V19, P828, DOI 10.1093/molehr/gat065; Li M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00692; Lim SS, 2013, OBES REV, V14, P95, DOI 10.1111/j.1467-789X.2012.01053.x; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; McFarland LV, 2000, EUR J GASTROEN HEPAT, V12, P1069, DOI 10.1097/00042737-200012100-00001; MCNEIL NI, 1984, AM J CLIN NUTR, V39, P338, DOI 10.1093/ajcn/39.2.338; Moran CP, 2014, BEST PRACT RES CL GA, V28, P585, DOI 10.1016/j.bpg.2014.07.005; Nilsson ME, 2015, ENDOCRINOLOGY, V156, P2492, DOI 10.1210/en.2014-1890; Norman RJ, 2007, LANCET, V370, P685, DOI 10.1016/S0140-6736(07)61345-2; Oakley BB, 2008, APPL ENVIRON MICROB, V74, P4898, DOI 10.1128/AEM.02884-07; Parassol N, 2005, RES MICROBIOL, V156, P256, DOI 10.1016/j.resmic.2004.09.013; SOORY M, 1995, J PERIODONTAL RES, V30, P124, DOI 10.1111/j.1600-0765.1995.tb01261.x; Soory M, 1997, ARCH ORAL BIOL, V42; Sun J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079382; Tremellen K, 2012, MED HYPOTHESES, V79, P104, DOI 10.1016/j.mehy.2012.04.016; Umeda M, 1998, J PERIODONTOL, V69, P1111, DOI 10.1902/jop.1998.69.10.1111; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Yang S, AM J OBSTET GYNECOL, V211, p44 e1; ZAMBON JJ, 1981, INFECT IMMUN, V32, P198, DOI 10.1128/IAI.32.1.198-203.1981	45	62	81	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153196	10.1371/journal.pone.0153196	http://dx.doi.org/10.1371/journal.pone.0153196			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093642	Green Submitted, Green Published, gold			2022-12-26	WOS:000374541200015
J	Qian, C; Li, PC; Jiao, Y; Yao, HH; Chen, YC; Yang, J; Ding, J; Yang, XY; Teng, GJ				Qian, Cheng; Li, Pei-Cheng; Jiao, Yun; Yao, Hong-Hong; Chen, Yu-Chen; Yang, Jian; Ding, Jie; Yang, Xiang-Yu; Teng, Gao-Jun			Precise Characterization of the Penumbra Revealed by MRI: A Modified Photothrombotic Stroke Model Study	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; PERFUSION COMPUTED-TOMOGRAPHY; ISCHEMIC PENUMBRA; PLASMINOGEN-ACTIVATOR; TISSUE; BRAIN; VOLUME; REPERFUSION; MISMATCH; INJURY	Aims To precisely characterize the penumbra by MRI based on a modified photothrombotic stroke mouse model. Methods The proximal middle cerebral artery was occluded by a convenient laser system in conjunction with an intravenous injection of Rose Bengal in mice. And the suture MCAO model was performed in seven mice as a comparison of the reproducibility. One hour after occlusion, the penumbra was defined in six random photothrombotic stroke mice by mismatch between perfusion-weighted imaging and the apparent diffusion coefficient map on a home-made workstation. After imaging, three random mice of them were chosen to perform the reperfusion surgery. And the other three mice were sacrificed to stain for several potential penumbra markers, such as c-fos and heart shock protein 90. In the remaining mice, the evolution of the lesions was detected on the apparent diffusion coefficient map, diffusion-weighted imaging and T2-weighted imaging at 1, 3, 6, 12 and 24 hours. After evaluating the neurological deficit scores, the brains were sectioned and stained by triphenyltetrazolium chloride and Nissl. Results The mice subjected to photothrombosis showed significant behavioral deficits. One hour after occlusion, the low perfusion areas on the perfusion-weighted imaging interlaced with the hypointense areas on the apparent diffusion coefficient map, demonstrating that the penumbra was located both surrounding and inside the lesions. This phenomenon was subsequently confirmed by the c-fos and heart shock protein 90 staining. The final T2-weighted images of the mice subjected to the reperfusion surgery were also consistent with the penumbra images at one hour. At early stages, the lesions were clearly identified on the apparent diffusion coefficient map; the volumes of the lesions on the diffusion-weighted imaging and T2-weighted imaging did not reach a maximum until 12 hours. The coefficient of variation (CV) of the final lesions in the photothrombotic stroke mice was 21.7% (0.08 of 0.37) on T2-weighted imaging and 27.8%(0.10 of 0.35) on triphenyltetrazolium chloride, representing a high reproducibility (n = 7). While the CV of the lesions in the MCAO stroke mice was only 70% 0.24 of 0.34, n = 4). Conclusions This study has provided a precise imaging definition of the penumbra based on a reproducible photothrombotic stroke mouse model.	[Qian, Cheng; Li, Pei-Cheng; Jiao, Yun; Chen, Yu-Chen; Yang, Jian; Ding, Jie; Yang, Xiang-Yu; Teng, Gao-Jun] Southeast Univ, Zhongda Hosp, Jiangsu Key Lab Mol & Funct Imaging, Dept Radiol,Med Sch, Nanjing, Jiangsu, Peoples R China; [Yao, Hong-Hong] Southeast Univ, Sch Med, Dept Pharmacol, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China	Teng, GJ (corresponding author), Southeast Univ, Zhongda Hosp, Jiangsu Key Lab Mol & Funct Imaging, Dept Radiol,Med Sch, Nanjing, Jiangsu, Peoples R China.	gjteng@seu.edu.cn		Ding, Jie/0000-0001-9162-7850	National Key Basic Research Program of China (973 Program) [2013CB733800, 013CB733803]; National Natural Science Foundation of China [81230034]; Jiangsu Provincial Special Program of Medical Science [BL2013029]	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Special Program of Medical Science	The National Key Basic Research Program of China (973 Program; 2013CB733800, 013CB733803, URLs: http://www.nsfc.gov.cn/), CQ PCL YJ HHY YCC JY JD XYY GJT; the National Natural Science Foundation of China (81230034, URLs: http://www.nsfc.gov.cn/), CQ PCL YJ YCC JY JD XYY GJT; the Jiangsu Provincial Special Program of Medical Science (BL2013029, URLs: www.jswst.gov.cn), CQ PCL YJ JY JD XYY GJT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agulla J, 2014, THERANOSTICS, V4, P90, DOI 10.7150/thno.7088; Boehm-Sturm P, 2014, BIOMATERIALS, V35, P2218, DOI 10.1016/j.biomaterials.2013.11.085; Chemmanam T, 2010, NEUROLOGY, V75, P1040, DOI 10.1212/WNL.0b013e3181f39ab6; Chen F, 2007, RADIOLOGY, V244, P429, DOI 10.1148/radiol.2442061316; Chen XP, 2015, NAT CHEM BIOL, V11, P19, DOI 10.1038/nchembio.1657; Del Bene A, 2013, STROKE, V44, P3000, DOI 10.1161/STROKEAHA.113.002227; Ezura M, 2006, MINIMALLY INVASIVE NEUROSURGERY AND MULTIDISCIPLINARY NEUROTRAUMATOLOGY, P85, DOI 10.1007/4-431-28576-8_13; Ginsberg MD, 1996, ARCH NEUROL-CHICAGO, V53, P1065, DOI 10.1001/archneur.1996.00550100151024; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Jiang W, 2006, J CEREBR BLOOD F MET, V26, P927, DOI 10.1038/sj.jcbfm.9600245; Jung S, 2013, BRAIN, V136, P3554, DOI 10.1093/brain/awt246; Karatas H, 2011, J CEREBR BLOOD F MET, V31, P1452, DOI 10.1038/jcbfm.2011.8; Kidwell CS, 2003, STROKE, V34, P2729, DOI 10.1161/01.STR.0000097608.38779.CC; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Langer D, 2009, STROKE, V40, P2761, DOI 10.1161/STROKEAHA.108.544957; Li PY, 2014, STROKE, V45, P857, DOI 10.1161/STROKEAHA.113.004100; Markus R, 2004, BRAIN, V127, P1427, DOI 10.1093/brain/awh162; McCabe C, 2009, STROKE, V40, P3864, DOI 10.1161/STROKEAHA.109.559021; McLeod DD, 2015, INT J STROKE, V10, P553, DOI 10.1111/ijs.12147; McLeod DD, 2011, INT J STROKE, V6, P284, DOI 10.1111/j.1747-4949.2010.00564.x; Morris GP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148503; Muir KW, 2006, J NEUROL NEUROSUR PS, V77, P334, DOI 10.1136/jnnp.2005.074179; Orset C, 2007, STROKE, V38, P2771, DOI 10.1161/STROKEAHA.107.487520; Ramos-Cabrer P, 2011, STROKE, V42, pS7, DOI 10.1161/STROKEAHA.110.596684; Reid E, 2012, J CEREBR BLOOD F MET, V32, P1765, DOI 10.1038/jcbfm.2012.69; Risher WC, 2010, J NEUROSCI, V30, P9859, DOI 10.1523/JNEUROSCI.1917-10.2010; Robertson CA, 2015, INT J STROKE, V10, P42, DOI 10.1111/ijs.12327; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Rosso C, 2014, CURR OPIN NEUROL, V27, P35, DOI 10.1097/WCO.0000000000000047; Rosso C, 2009, RADIOLOGY, V250, P184, DOI 10.1148/radiol.2493080107; Schaefer PW, 2008, STROKE, V39, P2986, DOI 10.1161/STROKEAHA.107.513358; UMEMURA K, 1993, STROKE, V24, P1077, DOI 10.1161/01.STR.24.7.1077; Weinstein PR, 2004, STROKE, V35, P2666, DOI 10.1161/01.STR.0000144052.10644.ed; Wu LJ, 2012, NAT NEUROSCI, V15, P565, DOI 10.1038/nn.3059; Xu JH, 2003, STROKE, V34, P1287, DOI 10.1161/01.STR.0000066308.25088.64; Yang ST, 2015, NEUROLOGY, V84, P2381, DOI 10.1212/WNL.0000000000001669; Yao H, 2003, STROKE, V34, P2716, DOI 10.1161/01.STR.0000094730.38343.73; Yao H, 2002, NEUROREPORT, V13, P1005, DOI 10.1097/00001756-200206120-00004; Yao H, 1996, STROKE, V27, P333, DOI 10.1161/01.STR.27.2.333; Zhang YC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044465, 10.1155/2012/583417]	40	24	24	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153756	10.1371/journal.pone.0153756	http://dx.doi.org/10.1371/journal.pone.0153756			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093556	Green Published, Green Submitted, gold			2022-12-26	WOS:000374541200043
J	Shen, TC; Lin, CL; Wei, CC; Chen, CH; Tu, CY; Hsia, TC; Shih, CM; Hsu, WH; Sung, FC; Kao, CH				Shen, Te-Chun; Lin, Cheng-Li; Wei, Chang-Ching; Chen, Chia-Hung; Tu, Chih-Yen; Hsia, Te-Chun; Shih, Chuen-Ming; Hsu, Wu-Huei; Sung, Fung-Chang; Kao, Chia-Hung			Bidirectional Association between Asthma and Irritable Bowel Syndrome: Two Population-Based Retrospective Cohort Studies	PLOS ONE			English	Article							FUNCTIONAL GASTROINTESTINAL DISORDERS; GENERAL-POPULATION; BRONCHIAL-ASTHMA; PRIMARY-CARE; RISK; CRITERIA; DISEASES; ALLERGY; VALIDATION; DIAGNOSIS	Background There is a demonstrated association between asthma and irritable bowel syndrome (IBS). In this study, we examined the bidirectional association between asthma and IBS using a nationwide database. Methods We conducted two retrospective cohort studies using data obtained from the National Health Insurance of Taiwan. Study 1 included 29,648 asthma patients newly diagnosed between 2000 and 2010. Study 2 included 29,875 IBS patient newly diagnosed between 2000 and 2010. For each study, four subjects without asthma and IBS were selected, respectively, frequency-matched by sex, age, and the diagnosis date. All four cohorts were followed up until the end of 2011 to estimate incident IBS for Study 1 and incident asthma for study 2. Adjusted hazard ratios (aHRs) were estimated using the Cox proportional hazards model after controlling for sex, age and comorbidities. Results The incidence of IBS was 1.89 times higher in the asthma cohort than in the comparison cohort (8.26 vs. 4.36 per 1,000 person-years), with an aHR of 1.57 [95% confidence interval (CI) = 1.47-1.68]. The aHRs remained significant in all subgroups measured by sex, age and the presence of comorbidities. In contrast, the incidence of asthma was 1.76 times higher in the IBS cohort than the comparison cohort (7.09 vs. 4.03 per 1,000 person-years), with an aHR of 1.54 (95% CI = 1.44 -1.64). Similarly, aHRs remained significant in all subgroups measured by sex, age and the presence of comorbidities. Conclusion The present study suggests a bidirectional association between asthma and IBS. Atopy could be a shared pathophysiology underlying this association, deserving a further investigation.	[Shen, Te-Chun; Chen, Chia-Hung; Kao, Chia-Hung] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Shen, Te-Chun; Chen, Chia-Hung; Tu, Chih-Yen; Hsia, Te-Chun; Shih, Chuen-Ming; Hsu, Wu-Huei] China Med Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Taichung, Taiwan; [Lin, Cheng-Li; Sung, Fung-Chang; Kao, Chia-Hung] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Wei, Chang-Ching] China Med Univ, China Med Univ Hosp, Childrens Hosp, Taichung, Taiwan; [Sung, Fung-Chang] China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan; [Sung, Fung-Chang] Mahidol Univ, Fac Publ Hlth, Bangkok 10700, Thailand; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Mahidol University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Kao, CH (corresponding author), China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan.; Sung, FC; Kao, CH (corresponding author), China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan.; Sung, FC (corresponding author), China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan.; Sung, FC (corresponding author), Mahidol Univ, Fac Publ Hlth, Bangkok 10700, Thailand.; Kao, CH (corresponding author), China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ Hosp, PET Ctr, Taichung, Taiwan.	fcsung.tw@gmail.com; d10040@mail.cmuh.org.tw		Shen, Te-Chun/0000-0002-9427-1068	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]; China Medical University Hospital; Academia Sinica Taiwan Biobank; Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST 104-2325-B-039-005]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]; China Medical University Hospital; Academia Sinica Taiwan Biobank; Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST 104-2325-B-039-005]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital; Academia Sinica Taiwan Biobank; Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital; Academia Sinica Taiwan Biobank; Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	This study was supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019), China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST 104-2325-B-039-005), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan.	Amra B, 2006, RESP MED, V100, P110, DOI 10.1016/j.rmed.2005.03.036; Andersen ABT, 2015, CLIN EPIDEMIOL, V7, P37, DOI 10.2147/CLEP.S73662; Begum T, 2014, INT ARCH INTEGRATED, V1, P34; Boulet LP, 2009, EUR RESPIR J, V33, P897, DOI 10.1183/09031936.00121308; Brassard P, 2015, EUR RESPIR J, V45, P962, DOI 10.1183/09031936.00079414; Caffarelli C, 2007, EUR J PEDIATR, V166, P1245, DOI 10.1007/s00431-006-0410-y; Chao CH, 2013, ANDROLOGY-US, V1, P793, DOI 10.1111/j.2047-2927.2013.00120.x; Chung WS, 2014, EUR J INTERN MED, V25, P941, DOI 10.1016/j.ejim.2014.10.023; Cole JA, 2007, DIGEST DIS SCI, V52, P329, DOI 10.1007/s10620-006-9530-5; Cruz AA, 2007, ALLERGY, V62, P1, DOI 10.1111/j.1398-9995.2007.01551.x; Drossman DA, 2002, GASTROENTEROLOGY, V123, P2108, DOI 10.1053/gast.2002.37095; Drossman DA, 2006, GASTROENTEROLOGY, V130, P1377, DOI 10.1053/j.gastro.2006.03.008; Ekici A, 2005, DIGEST LIVER DIS, V37, P773, DOI 10.1016/j.dld.2005.05.006; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Ford AC, 2013, GASTROENTEROLOGY, V145, P1262, DOI 10.1053/j.gastro.2013.08.048; Ford AC, 2011, J GASTROENTEROL, V46, P421, DOI 10.1007/s00535-011-0379-9; Global Initiative for Asthma, 2015, GLOB STRAT ASTHM MAN; Goodwin RD, 2003, ARCH GEN PSYCHIAT, V60, P1125, DOI 10.1001/archpsyc.60.11.1125; Huerta C, 2002, PHARMACOEPIDEM DR S, V11, P31, DOI 10.1002/pds.666; Jellema P, 2009, ALIMENT PHARM THER, V30, P695, DOI 10.1111/j.1365-2036.2009.04087.x; Jones MP, 2014, ALIMENT PHARM THER, V40, P382, DOI 10.1111/apt.12846; Kennedy TM, 1998, GUT, V43, P770, DOI 10.1136/gut.43.6.770; Ludvigsson JF, 2011, J ALLERGY CLIN IMMUN, V127, DOI 10.1016/j.jaci.2010.12.1076; Magnusson J, 2003, J ALLERGY CLIN IMMUN, V112, P45, DOI 10.1067/mai.2003.1604; Olen O, 2014, ALIMENT PHARM THER, V40, P1349, DOI 10.1111/apt.12965; Ozol D, 2006, J ASTHMA, V43, P773, DOI 10.1080/02770900601031789; Panicker R, 2010, ANN THORAC MED, V5, P37, DOI 10.4103/1817-1737.58958; Pearson JS, 2015, THER ADV GASTROENTER, V8, P270, DOI 10.1177/1756283X15588875; PETITPIERRE M, 1985, ANN ALLERGY, V54, P538; Philpott H, 2011, ASIA PAC ALLERGY, V1, P36, DOI 10.5415/apallergy.2011.1.1.36; Roussos A, 2003, RESP MED, V97, P75, DOI 10.1053/rmed.2001.1409; SACKETT DL, 1979, J CHRON DIS, V32, P51, DOI 10.1016/0021-9681(79)90012-2; Shen TC, 2014, QJM-INT J MED, V107, P435, DOI 10.1093/qjmed/hcu008; Shen TC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116608; Tobin MC, 2008, ANN ALLERG ASTHMA IM, V100, P49, DOI 10.1016/S1081-1206(10)60404-8; Walker MM, 2014, EXPERT REV GASTROENT, V8, P289, DOI 10.1586/17474124.2014.881716; Westreich D, 2012, EPIDEMIOLOGY, V23, P159, DOI 10.1097/EDE.0b013e31823b6296; Whitehead WE, 2010, AM J GASTROENTEROL, V105, P814, DOI 10.1038/ajg.2010.56; Yang TY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000616; Yazar A, 2001, AM J GASTROENTEROL, V96, P1511, DOI 10.1111/j.1572-0241.2001.03748.x; Yilmaz A, 2011, CLINICS, V66, P591, DOI 10.1590/S1807-59322011000400012	41	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153911	10.1371/journal.pone.0153911	http://dx.doi.org/10.1371/journal.pone.0153911			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093172	Green Published, Green Submitted, gold			2022-12-26	WOS:000374541200060
J	Yang, SH; Luo, C; Song, YJ; Wang, JH				Yang, Shaohui; Luo, Cui; Song, Yingjin; Wang, Jiehua			Two Groups of Thellungiella salsuginea RAVs Exhibit Distinct Responses and Sensitivity to Salt and ABA in Transgenic Arabidopsis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; DORMANCY RELEASE; DOMAIN; GENE; EVOLUTION; SEQUENCE; PROTEIN; EXPRESSION; DROUGHT; ANNOTATION	Containing both AP2 domain and B3 domain, RAV (Related to ABI3NP1) transcription factors are involved in diverse functions in higher plants. A total of eight TsRAV genes were isolated from the genome of Thellungiella salsuginea and could be divided into two groups (A and B-group) based on their sequence similarity. The mRNA abundance of all Thellungiella salsuginea TsRAVs followed a gradual decline during seed germination. In Thellungiella salsuginea seedling, transcripts of TsRAVs in the group A (A-TsRAVs) were gradually and moderately reduced by salt treatment but rapidly and severely repressed by ABA treatment. In comparison, with a barely detectable constitutive expression, the transcriptional level of TsRAVs in the group B (B-TsRAVs) exhibited a moderate induction in cotyledons when confronted with ABA. We then produced the "gain-of-function" transgenicArabidopsis plants for each TsRAV gene and found that only 35S:A-TsRAVs showed weak growth retardation including reduced root elongation, suggesting their roles in negatively controlling plant growth. Under normal conditions, the germination process of all TsRAVs overexpressing transgenic seeds was inhibited with a stronger effect observed in 35S:A-TsRAVs seeds than in 35S:B-TsRAVs seeds. With the presence of NaCI, seed germination and seedling root elongation of all plants including wild type and 35S:TsRAVs plants were retarded and a more severe inhibition occurred to the 35S:A-TsRAVtransgenic plants. ABA treatment only negatively affected the germination rates of 35S:A-TsRAV transgenic seeds but not those of 35S:B-TsRAV transgenic seeds. All 35S:TsRAVs transgenic plants showed a similar degree of reduction in root growth compared with untreated seedlings in the presence of ABA. Furthermore, the cotyledon greening/expansion was more severely inhibited 35S:A-TsRAVs than in 35S:B-TsRAVs seedlings. Upon water deficiency, with a wider opening of stomata, 35SA-TsRAVs plants experienced a faster transpirational water loss than wild type and 35S:B-TsRAVs lines. Taken together, our results suggest that two groups of TsRAVs perform distinct regulating roles during plant growth and abiotic defense including drought and salt, and A-TsRAVs are more likely than B-TsRAVs to act as negative regulators in the above -mentioned biological processes.	[Yang, Shaohui; Luo, Cui; Song, Yingjin; Wang, Jiehua] Tianjin Univ, Sch Environm Sci & Engn, Tianjin 300072, Peoples R China	Tianjin University	Wang, JH (corresponding author), Tianjin Univ, Sch Environm Sci & Engn, Tianjin 300072, Peoples R China.	jiehuawang@tju.edu.cn			National Transgenic Major Project [2014ZX0800404B]; Central Government Shared Marine Appropriation Expenditure by State Oceanic Administration [HYSYJ-HB-2010-BH-3]	National Transgenic Major Project; Central Government Shared Marine Appropriation Expenditure by State Oceanic Administration	This work was supported by the National Transgenic Major Project (2014ZX0800404B) and Central Government Shared Marine Appropriation Expenditure by State Oceanic Administration (HYSYJ-HB-2010-BH-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali-Rachedi S, 2004, PLANTA, V219, P479, DOI 10.1007/s00425-004-1251-4; Amtmann A, 2009, MOL PLANT, V2, P3, DOI 10.1093/mp/ssn094; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Castillejo C, 2008, CURR BIOL, V18, P1338, DOI 10.1016/j.cub.2008.07.075; Chen XF, 2009, GENES GENET SYST, V84, P101, DOI 10.1266/ggs.84.101; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Feng CZ, 2014, PLANT J, V80, P654, DOI 10.1111/tpj.12670; Feng JX, 2005, PLANT MOL BIOL, V59, P853, DOI 10.1007/s11103-005-1511-0; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Finkelstein RR, 2000, PLANT PHYSIOL, V122, P1179, DOI 10.1104/pp.122.4.1179; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Fu M, 2014, PLANT CELL PHYSIOL, V55, P1892, DOI 10.1093/pcp/pcu118; GIRAUDAT J, 1992, PLANT CELL, V4, P1251, DOI 10.1105/tpc.4.10.1251; Gong QQ, 2005, PLANT J, V44, P826, DOI 10.1111/j.1365-313X.2005.02587.x; Gubler F, 2005, CURR OPIN PLANT BIOL, V8, P183, DOI 10.1016/j.pbi.2005.01.011; Hauser F, 2011, CURR BIOL, V21, pR346, DOI 10.1016/j.cub.2011.03.015; Hu YX, 2004, CELL RES, V14, P8, DOI 10.1038/sj.cr.7290197; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Ikeda M, 2009, PLANT CELL PHYSIOL, V50, P970, DOI 10.1093/pcp/pcp048; Inan G, 2004, PLANT PHYSIOL, V135, P1718, DOI 10.1104/pp.104.041723; Kagaya Y, 1999, NUCLEIC ACIDS RES, V27, P470, DOI 10.1093/nar/27.2.470; Kang JY, 2002, PLANT CELL, V14, P343, DOI 10.1105/tpc.010362; Kim S, 2006, MOL BIOL EVOL, V23, P107, DOI 10.1093/molbev/msj014; Lee D, 2005, NEW PHYTOL, V165, P429, DOI 10.1111/j.1469-8137.2004.01238.x; Li CW, 2011, PLANT PHYSIOL, V156, P213, DOI 10.1104/pp.111.174268; Li X, 2015, SHOCK VIB, V2015, DOI 10.1155/2015/431476; Liu ZN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083444; Lu QY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089145; Magnani E, 2004, PLANT CELL, V16, P2265, DOI 10.1105/tpc.104.023135; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; MCCARTY DR, 1991, CELL, V66, P895, DOI 10.1016/0092-8674(91)90436-3; Mittal A, 2012, THESIS TEXAS TU, P161; Mittal A, 2014, PLANT BIOTECHNOL J, V12, P578, DOI 10.1111/pbi.12162; Nambara E, 2003, TRENDS PLANT SCI, V8, P213, DOI 10.1016/S1360-1385(03)00060-8; Okamuro JK, 1997, P NATL ACAD SCI USA, V94, P7076, DOI 10.1073/pnas.94.13.7076; Osnato M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1810; Schroeder JI, 2001, ANNU REV PLANT PHYS, V52, P627, DOI 10.1146/annurev.arplant.52.1.627; Sohn KH, 2006, PLANT MOL BIOL, V61, P897, DOI 10.1007/s11103-006-0057-0; Suzuki M, 1997, PLANT CELL, V9, P799, DOI 10.1105/tpc.9.5.799; Taji T, 2004, PLANT PHYSIOL, V135, P1697, DOI 10.1104/pp.104.039909; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Woo HR, 2010, J EXP BOT, V61, P3947, DOI 10.1093/jxb/erq206; Zhao L, 2008, PLANTA, V227, P1389, DOI 10.1007/s00425-008-0711-7; Zhao L, 2012, J EXP BOT, V63, P3257, DOI 10.1093/jxb/ers056; Zhuang J, 2011, MOL BIOL REP, V38, P3921, DOI 10.1007/s11033-010-0508-1	47	9	11	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153517	10.1371/journal.pone.0153517	http://dx.doi.org/10.1371/journal.pone.0153517			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093611	Green Submitted, gold, Green Published			2022-12-26	WOS:000374541200024
J	Yang, SK; Zhang, JQ; Lu, D				Yang Shunkun; Zhang Jiaquan; Lu Dan			Prediction of Cascading Failures in Spatial Networks	PLOS ONE			English	Article							RELIABILITY	Cascading overload failures are widely found in large-scale parallel systems and remain a major threat to system reliability; therefore, they are of great concern to maintainers and managers of different systems. Accurate cascading failure prediction can provide useful information to help control networks. However, for a large, gradually growing network with increasing complexity, it is often impractical to explore the behavior of a single node from the perspective of failure propagation. Fortunately, overload failures that propagate through a network exhibit certain spatial-temporal correlations, which allows the study of a group of nodes that share common spatial and temporal characteristics. Therefore, in this study, we seek to predict the failure rates of nodes in a given group using machine-learning methods. We simulated overload failure propagations in a weighted lattice network that start with a center attack and predicted the failure percentages of different groups of nodes that are separated by a given distance. The experimental results of a feedforward neural network (FNN), a recurrent neural network (RNN) and support vector regression (SVR) all show that these different models can accurately predict the similar behavior of nodes in a given group during cascading overload propagation.	[Yang Shunkun; Zhang Jiaquan; Lu Dan] Beihang Univ, Sch Reliabil & Syst Engn, Beijing 100191, Peoples R China	Beihang University	Yang, SK (corresponding author), Beihang Univ, Sch Reliabil & Syst Engn, Beijing 100191, Peoples R China.	ysk@buaa.edu.cn						Brandes U, 2008, SOC NETWORKS, V30, P136, DOI 10.1016/j.socnet.2007.11.001; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Helbing D, 2013, NATURE, V497, P51, DOI 10.1038/nature12047; HORNIK K, 1989, NEURAL NETWORKS, V2, P359, DOI 10.1016/0893-6080(89)90020-8; Jung-Hua Lo, 2010, Proceedings Second International Conference on Computer Research and Development (ICCRD 2010), P765, DOI 10.1109/ICCRD.2010.144; KARUNANITHI N, 1992, IEEE SOFTWARE, V9, P53, DOI 10.1109/52.143107; Kinney R, 2005, EUR PHYS J B, V46, P101, DOI 10.1140/epjb/e2005-00237-9; Li D, 2015, P NATL ACAD SCI, V112; Li D, 2008, PHYS REV LETT, V101, P3958; Li DQ, 2015, RELIAB ENG SYST SAFE, V142, P556, DOI 10.1016/j.ress.2015.05.021; Li DQ, 2014, SCI REP-UK, V4, DOI 10.1038/srep05381; Li DQ, 2011, NAT PHYS, V7, P481, DOI [10.1038/NPHYS1932, 10.1038/nphys1932]; Schaul T, 2010, J MACH LEARN RES, V11, P743; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499; Wei Z, 2013, RELIAB ENG SYST SAFE, V119, P109, DOI 10.1016/j.ress.2013.05.021; Williams RJ, 1989, NEURAL COMPUT, V1, P270, DOI 10.1162/neco.1989.1.2.270; Zhao JC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10094; Zheng J, 2009, EXPERT SYST APPL, V36, P2116, DOI 10.1016/j.eswa.2007.12.029	19	3	3	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153904	10.1371/journal.pone.0153904	http://dx.doi.org/10.1371/journal.pone.0153904			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093054	Green Published, gold			2022-12-26	WOS:000374541200059
J	Enke, M; Meyer, P; Flor, H				Enke, Martin; Meyer, Patric; Flor, Herta			From Memory to Attitude: The Neurocognitive Process beyond Euthanasia Acceptance	PLOS ONE			English	Article							PHYSICIAN-ASSISTED SUICIDE; EMOTIONAL FACIAL EXPRESSIONS; OF-LIFE DECISIONS; AUTOMATIC ACTIVATION; IMPLICIT ATTITUDES; TRAIT ANXIETY; ELECTROPHYSIOLOGICAL EVIDENCE; SOCIAL COGNITION; SELF-ESTEEM; BRAIN	Numerous questionnaire studies on attitudes towards euthanasia produced conflicting results, precluding any general conclusion. This might be due to the fact that human behavior can be influenced by automatically triggered attitudes, which represent ingrained associations in memory and cannot be assessed by standard questionnaires, but require indirect measures such as reaction times (RT) or electroencephalographic recording (EEG). Event related potentials (ERPs) of the EEG and RT during an affective priming task were assessed to investigate the impact of automatically triggered attitudes and were compared to results of an explicit questionnaire. Explicit attitudes were ambivalent. Reaction time data showed neither positive nor negative associations towards euthanasia. ERP analyses revealed an N400 priming effect with lower mean amplitudes when euthanasia was associated with negative words. The euthanasia-related modulation of the N400 component shows an integration of the euthanasia object in negatively valenced associative neural networks. The integration of all measures suggests a bottom-up process of attitude activation, where automatically triggered negative euthanasia-relevant associations can become more ambiguous with increasing time in order to regulate the bias arising from automatic processes. These data suggest that implicit measures may make an important contribution to the understanding of euthanasia-related attitudes.	[Enke, Martin; Meyer, Patric; Flor, Herta] Heidelberg Univ, Cent Inst Mental Hlth, Med Fac Mannheim, Dept Cognit & Clin Neurosci, Mannheim, Germany	Central Institute of Mental Health; Ruprecht Karls University Heidelberg	Enke, M (corresponding author), Heidelberg Univ, Cent Inst Mental Hlth, Med Fac Mannheim, Dept Cognit & Clin Neurosci, Mannheim, Germany.	martin.enke@zi-mannheim.de		Flor, Herta/0000-0003-4809-5398	Marsilius-Kolleg, Heidelberg University, Germany	Marsilius-Kolleg, Heidelberg University, Germany	This work was funded by the Marsilius-Kolleg, Heidelberg University (http://www.marsilius-kolleg.uni-heidelberg.de/index_en.html), Germany (excellence initia-tive of the federal and state governments) to HF. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado L, 2012, COGN AFFECT BEHAV NE; Allen Jen, 2006, J SOCIOLOGY SOCIAL W, V33, P5; Banaji MR, 2001, SCI CON SER, P117; Bartholow BD, 2009, J EXP SOC PSYCHOL, V45, P655, DOI 10.1016/j.jesp.2009.02.015; Berner MP, 2004, EXP PSYCHOL, V51, P180, DOI 10.1027/1618-3169.51.3.180; Blendon RJ, 2005, ARCH INTERN MED, V165, P2580, DOI 10.1001/archinte.165.22.2580; Bower GH, 2000, OXFORD HDB MEMORY, P135; Bridger EK, 2012, NEUROIMAGE, V63, P1334, DOI 10.1016/j.neuroimage.2012.07.047; Buiting HM, 2012, J MED ETHICS, V38, P267, DOI 10.1136/medethics-2011-100066; CACIOPPO JT, 1993, PSYCHOL SCI, V4, P108, DOI 10.1111/j.1467-9280.1993.tb00470.x; Chong AML, 2009, SOC WORK HEALTH CARE, V48, P119, DOI 10.1080/00981380802533298; Cohen J, 2006, EUR J PUBLIC HEALTH, V16, P663, DOI 10.1093/eurpub/ckl042; De Houwer J., 2009, ATTITUDES INSIGHTS N, P361; Duncan OD, 2006, J MED ETHICS, V32, P266, DOI 10.1136/jme.2004.011072; Eder AB, 2012, SOC COGN AFFECT NEUR, V7, P436, DOI 10.1093/scan/nsr033; Fazio RH, 2001, COGNITION EMOTION, V15, P115, DOI 10.1080/02699930125908; Fazio RH, 2003, ANNU REV PSYCHOL, V54, P297, DOI 10.1146/annurev.psych.54.101601.145225; FAZIO RH, 1995, J PERS SOC PSYCHOL, V69, P1013, DOI 10.1037/0022-3514.69.6.1013; FAZIO RH, 1986, J PERS SOC PSYCHOL, V50, P229, DOI 10.1037/0022-3514.50.2.229; FAZIO RH, 1982, J EXP SOC PSYCHOL, V18, P339, DOI 10.1016/0022-1031(82)90058-0; Federmeier KD, 2001, J EXP PSYCHOL LEARN, V27, P202, DOI 10.1037/0278-7393.27.1.202; Ganis G, 1996, J COGNITIVE NEUROSCI, V8, P89, DOI 10.1162/jocn.1996.8.2.89; Gielen J, 2008, J PALLIAT CARE, V24, P173, DOI 10.1177/082585970802400307; Glaser J, 1999, J PERS SOC PSYCHOL, V77, P669, DOI 10.1037/0022-3514.77.4.669; Greenwald AG, 2002, PSYCHOL REV, V109, P3, DOI 10.1037/0033-295X.109.1.3; GREENWALD AG, 1995, PSYCHOL REV, V102, P4, DOI 10.1037/0033-295X.102.1.4; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Hagemann D, 2001, PSYCHOPHYSIOLOGY, V38, P847, DOI 10.1111/1469-8986.3850847; Herring DR, 2011, EMOTION, V11, P794, DOI 10.1037/a0022804; Hinojosa JA, 2009, EMOTION, V9, P164, DOI 10.1037/a0014680; Ito TA, 2000, J EXP SOC PSYCHOL, V36, P660, DOI 10.1006/jesp.2000.1430; Ito TA, 1998, J PERS SOC PSYCHOL, V75, P887, DOI 10.1037/0022-3514.75.4.887; Ivo K, 2012, J MED ETHICS, V38, P310, DOI 10.1136/medethics-2011-100153; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kissler J, 2011, BIOL PSYCHOL, V86, P254, DOI 10.1016/j.biopsycho.2010.12.006; Klauer KC, 2007, J EXP SOC PSYCHOL, V43, P648, DOI 10.1016/j.jesp.2006.06.003; Klauer KC, 2009, J PERS SOC PSYCHOL, V96, P265, DOI 10.1037/a0013248; Klauer KC, 2001, Q J EXP PSYCHOL-A, V54, P727, DOI 10.1080/02724980042000444; Klauer KC, 2003, PSYCHOLOGY OF EVALUATION, P7; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Li W, 2008, J COGNITIVE NEUROSCI, V20, P95; Long SO, 2002, THEOR MED BIOETH, V23, P305, DOI 10.1023/A:1021243805657; Luck S.J., 2005, INTRO EVENT RELATED; Maier MA, 2003, EXP PSYCHOL, V50, P116, DOI 10.1026//1618-3169.50.2.116; Maitra Robin T, 2005, Eur J Gen Pract, V11, P94; Makeig S, 1996, ADV NEUR IN, V8, P145; McCormack R, 2012, PALLIATIVE MED, V26, P23, DOI 10.1177/0269216311397688; Moehring B, 2011, J PALLIAT MED, V14, P1206, DOI 10.1089/jpm.2011.0184; Morris JP, 2003, POLIT PSYCHOL, V24, P727, DOI 10.1046/j.1467-9221.2003.00349.x; Muller-Busch H C, 2004, Med Health Care Philos, V7, P333; Nilstun T, 2000, SCAND J PUBLIC HEALT, V28, P111, DOI 10.1080/713797391; Nosek BA, 2005, J EXP PSYCHOL GEN, V134, P565, DOI 10.1037/0096-3445.134.4.565; Okishiro N, 2009, AM J HOSP PALLIAT ME, V26, P98, DOI 10.1177/1049909108327027; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; Silvoniemi M, 2010, PALLIATIVE MED, V24, P744, DOI 10.1177/0269216310376556; Slotnick SD, 2010, COGN NEUROSCI-UK, V1, P8, DOI 10.1080/17588920903474263; Spruyt A, 2007, MEM COGNITION, V35, P95, DOI 10.3758/BF03195946; Stanley D, 2008, CURR DIR PSYCHOL SCI, V17, P164, DOI 10.1111/j.1467-8721.2008.00568.x; Stocke V. C, 2007, SOCIAL METHODOLOGY, V3, P125, DOI DOI 10.1027/1614-2241.3.3.125; Storbeck J, 2004, PERS SOC PSYCHOL B, V30, P81, DOI 10.1177/0146167203258855; STORMARK KM, 1995, COGNITION EMOTION, V9, P507, DOI 10.1080/02699939508408978; Stronegger WJ, 2011, J MED ETHICS, V37, P227, DOI 10.1136/jme.2010.039792; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; Tulving E., 2000, OXFORD HDB MEMORY, P33; Vo MLH, 2009, BEHAV RES METHODS, V41, P534, DOI 10.3758/BRM.41.2.534; Voss JL, 2011, PSYCHOPHYSIOLOGY, V48, P532, DOI 10.1111/j.1469-8986.2010.01085.x; Wang L, 2011, BRAIN RES, V1375, P103, DOI 10.1016/j.brainres.2010.12.021; Werheid K, 2005, INT J PSYCHOPHYSIOL, V55, P209, DOI 10.1016/j.ijpsycho.2004.07.006; White KR, 2009, SOC COGN AFFECT NEUR, V4, P191, DOI 10.1093/scan/nsp004; Whitney SN, 2001, J GEN INTERN MED, V16, P290, DOI 10.1046/j.1525-1497.2001.04159.x; Yaguchi A, 2005, ARCH INTERN MED, V165, P1970, DOI 10.1001/archinte.165.17.1970; Zhang Q, 2006, BRAIN RES BULL, V71, P316, DOI 10.1016/j.brainresbull.2006.09.023; Zhang Q, 2012, BRAIN RES, V1474, P60, DOI 10.1016/j.brainres.2012.07.023; Zhang Q, 2010, BRAIN RES, V1329, P142, DOI 10.1016/j.brainres.2010.03.021	76	0	0	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153910	10.1371/journal.pone.0153910	http://dx.doi.org/10.1371/journal.pone.0153910			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9IK	27088244	Green Published, gold			2022-12-26	WOS:000374527000058
J	Jee, YH; Lebenthal, Y; Chaemsaithong, P; Yan, G; Peran, I; Wellstein, A; Romero, R; Baron, J				Jee, Youn Hee; Lebenthal, Yael; Chaemsaithong, Piya; Yan, Gai; Peran, Ivana; Wellstein, Anton; Romero, Roberto; Baron, Jeffrey			Midkine and Pleiotrophin Concentrations in Amniotic Fluid in Healthy and Complicated Pregnancies	PLOS ONE			English	Article							GROWTH-FACTOR PLEIOTROPHIN; ACID-RESPONSIVE GENE; PRETERM DELIVERY; ADULT-RAT; EXPRESSION; MK; DIFFERENTIATION; FETAL; PREDICTION; FAMILY	Background Midkine (MDK) and pleiotrophin (PTN) are heparin-binding growth factors that, in rodents, are highly expressed in early life and decrease to undetectable levels by adulthood. The potential roles of MDK and PTN in human growth and development are not completely elucidated. Method and Findings To delineate the role of MDK and PTN in human development, we developed high sensitivity assays to measure their concentrations in amniotic fluid (AF) at various gestational ages in both healthy and complicated pregnancies. We found that both of these growth factors could be readily measured in AF and that the concentrations were higher than most cytokines previously reported in AF. Conclusion The concentration of MDK but not that of PTN declined with gestational age. Both MDK and PTN concentrations were found to be lower in pregnancies that were complicated by chorioamnionitis at term, raising the possibility that these growth factors might be useful as markers for infection.	[Jee, Youn Hee; Lebenthal, Yael; Baron, Jeffrey] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Growth & Dev, Program Dev Endocrinol & Genet, NIH, Bethesda, MD USA; [Lebenthal, Yael] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Chaemsaithong, Piya; Romero, Roberto] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, Program Perinatal Res & Obstet, Div Intramural Res, Detroit, MI USA; [Yan, Gai; Peran, Ivana; Wellstein, Anton] Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20007 USA; [Yan, Gai; Peran, Ivana; Wellstein, Anton] Lombardi Comprehens Canc Ctr, Washington, DC USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Tel Aviv University; Sackler Faculty of Medicine; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Georgetown University	Baron, J (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Growth & Dev, Program Dev Endocrinol & Genet, NIH, Bethesda, MD USA.	jeffrey.baron@nih.gov	Lebenthal, Yael/AAW-7891-2020; Lebenthal, Yael/AAZ-5216-2020; Peran, Ivana/AAL-7480-2020; Romero, Roberto/A-5268-2019	Lebenthal, Yael/0000-0001-5963-0574; Peran, Ivana/0000-0001-7399-7452; Chaemsaithong, piya/0000-0002-5398-6868; chaemsaithong, piya/0000-0003-1750-9834; Romero, Roberto/0000-0002-4448-5121	Thrasher Research Fund; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000640, ZIAHD002400] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009686] Funding Source: NIH RePORTER	Thrasher Research Fund; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the Thrasher Research Fund and by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [https://www.thrasherresearch.org/default.aspx].	Ball M, 2009, PLACENTA, V30, P649, DOI 10.1016/j.placenta.2009.05.001; BLOCH B, 1992, DEV BRAIN RES, V70, P267, DOI 10.1016/0165-3806(92)90206-C; Chaemsaithong P, 2016, J MATERN-FETAL NEO M, V29, P360, DOI 10.3109/14767058.2015.1006621; Erguven M, 2012, MIDKINE EMBRYOGENESI; Fan QW, 2000, DEV GROWTH DIFFER, V42, P113; Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59; Finkielstain GP, 2009, ENDOCRINOLOGY, V150, P1791, DOI 10.1210/en.2008-0868; GIBBS RS, 1988, OBSTET GYNECOL, V72, P823, DOI 10.1097/00006250-198812000-00001; Goebel-Stengel M, 2011, ANAL BIOCHEM, V414, P38, DOI 10.1016/j.ab.2011.02.009; Hando Atsushi, 2008, Rinsho Byori, V56, P221; Heikkinen J, 2001, SCAND J IMMUNOL, V53, P310, DOI 10.1046/j.1365-3083.2001.00872.x; Hong SN, 2015, ARCH GYNECOL OBSTET, V291, P265, DOI 10.1007/s00404-014-3439-6; Ishimoto H, 2006, J CLIN ENDOCR METAB, V91, P4050, DOI 10.1210/jc.2006-1139; Jee YH, 2014, CLIN ENDOCR IN PRESS; Jones DR, 2014, BRIT J PHARMACOL, V171, P2925, DOI 10.1111/bph.12601; KADOMATSU K, 1990, J CELL BIOL, V110, P607, DOI 10.1083/jcb.110.3.607; Kadomatsu K, 2013, J BIOCHEM, V153, P511, DOI 10.1093/jb/mvt035; Liedert A, 2014, BRIT J PHARMACOL, V171, P870, DOI 10.1111/bph.12412; Lui JC, 2010, FASEB J, V24, P3083, DOI 10.1096/fj.09-152835; MATSUBARA S, 1990, J BIOL CHEM, V265, P9441; MITSIADIS TA, 1995, DEVELOPMENT, V121, P37; MURAMATSU H, 1993, DEV BIOL, V159, P392, DOI 10.1006/dbio.1993.1250; Muramatsu H, 2006, GENES CELLS, V11, P1405, DOI 10.1111/j.1365-2443.2006.01028.x; Muramatsu T, 2014, BRIT J PHARMACOL, V171, P814, DOI 10.1111/bph.12353; Muramatsu T, 2010, P JPN ACAD B-PHYS, V86, P410, DOI 10.2183/pjab.86.410; NAKAMOTO M, 1992, J BIOCHEM-TOKYO, V112, P346, DOI 10.1093/oxfordjournals.jbchem.a123903; OBAMA H, 1995, J BIOCHEM-TOKYO, V118, P88, DOI 10.1093/oxfordjournals.jbchem.a124896; Ozgu-Erdinc AS, 2014, J OBSTET GYNAECOL RE, V40, P1540, DOI 10.1111/jog.12371; Qi MS, 2000, J BIOCHEM, V127, P269, DOI 10.1093/oxfordjournals.jbchem.a022604; Redline RW, 2005, PLACENTA, V26, pS114, DOI 10.1016/j.placenta.2005.02.009; SATOH J, 1993, DEV BRAIN RES, V75, P201, DOI 10.1016/0165-3806(93)90024-5; Schulte AM, 1996, P NATL ACAD SCI USA, V93, P14759, DOI 10.1073/pnas.93.25.14759; Schulte AM, 1998, J VIROL, V72, P6065, DOI 10.1128/JVI.72.7.6065-6072.1998; Schulte AM, 2000, ONCOGENE, V19, P3988, DOI 10.1038/sj.onc.1203742; UEHARA K, 1992, J BIOCHEM-TOKYO, V111, P563, DOI 10.1093/oxfordjournals.jbchem.a123797; Underwood Mark A, 2005, J Perinatol, V25, P341, DOI 10.1038/sj.jp.7211290; VANDERWINDEN JM, 1992, ANAT EMBRYOL, V186, P387; Winkler C, 2014, BRIT J PHARMACOL, V171, P905, DOI 10.1111/bph.12462; Zou P, 2006, LAB INVEST, V86, P645, DOI 10.1038/labinvest.3700428	39	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153325	10.1371/journal.pone.0153325	http://dx.doi.org/10.1371/journal.pone.0153325			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27089523	Green Published, Green Submitted, gold			2022-12-26	WOS:000374527000017
J	Liu, BJ; Chen, HL; Fang, F; Tillander, A; Wirdefeldt, K				Liu, Bojing; Chen, Honglei; Fang, Fang; Tillander, Annika; Wirdefeldt, Karin			Early-Life Factors and Risk of Parkinson's Disease: A Register-Based Cohort Study	PLOS ONE			English	Article							EXPOSURE; CHILDHOOD; INFLUENZA; EPIDEMIOLOGY; ASSOCIATION; INFECTIONS; SIBLINGS	Parkinson's disease (PD) may take decades to develop and early life exposures such as infection may be important. However, few epidemiological studies have evaluated early life risk factors in relation to PD risk. We therefore examined such associations in a prospective analysis of 3 545 612 individuals born in Sweden between 1932 and 1970 without PD on January 1, 2002. Incident PD cases were identified using the Swedish Patient Register during 2002-2010. Information on sibship size, number of older and younger siblings, multiple births, parental age, birth month and season was obtained from the Swedish Multi-Generation Register. Monthly data on national burden of influenza-like illness during 1932-1970 were obtained from the Swedish Public Health Agency. Hazard ratios with 95% confidence intervals (CI) were estimated using Cox proportional hazards regression. During the follow-up, 8779 incident PD cases were identified. As expected, older age, male sex, parental occupation as farmers, and family history of PD were associated with higher PD risk. Overall, early life factors, including flu burden in the year of birth, were not associated with PD risk, although we did find a lower PD risk among participants with older siblings than those without (HR = 0.93, 95% CI: 0.89, 0.98). Our study therefore provided little support for important etiological contributions of early life factors to the PD risk late in life. The finding of a lower PD risk among individuals with older siblings will need confirmation and further investigation.	[Liu, Bojing; Fang, Fang; Tillander, Annika; Wirdefeldt, Karin] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Chen, Honglei] NIEHS, Epidemiol Branch, Res Triangle Pk, NC 27709 USA; [Wirdefeldt, Karin] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden	Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Karolinska Institutet	Liu, BJ (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	bojing.liu@ki.se		Liu, Bojing/0000-0002-0366-6989; Chen, Honglei/0000-0003-3446-7779; Fang, Fang/0000-0002-3310-6456	Swedish Research Council for Health, Working Life and Welfare [2013-1350]; KI-NIH Doctoral Partnership Program in Neuroscience; Swedish Society for Medical Research; Karolinska Institutet; NIH, the National Institute of Environmental Health Sciences [Z01-ES-101986]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101986, Z01ES101986] Funding Source: NIH RePORTER	Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); KI-NIH Doctoral Partnership Program in Neuroscience; Swedish Society for Medical Research; Karolinska Institutet(Karolinska Institutet); NIH, the National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	KW received funding from Swedish Research Council for Health, Working Life and Welfare (www.forte.se, 2013-1350), KI-NIH Doctoral Partnership Program in Neuroscience (www.ki.se). FF received funding from Swedish Society for Medical Research (www.ssmf.se) and Karolinska Institutet (www.ki.se). HC received funding from the intramural research program of the NIH, the National Institute of Environmental Health Sciences (www.niehs.nih.gov, Z01-ES-101986). The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.	Ball TM, 2000, NEW ENGL J MED, V343, P538, DOI 10.1056/NEJM200008243430803; Cardwell CR, 2011, INT J EPIDEMIOL, V40, P363, DOI 10.1093/ije/dyq207; Crow JF, 1997, P NATL ACAD SCI USA, V94, P8380, DOI 10.1073/pnas.94.16.8380; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; EBMEIER KP, 1989, J NEUROL NEUROSUR PS, V52, P911, DOI 10.1136/jnnp.52.7.911; Fang F, 2008, AM J EPIDEMIOL, V167, P1281, DOI 10.1093/aje/kwn056; Feldman AL, 2012, NEUROEPIDEMIOLOGY, V38, P186, DOI 10.1159/000336356; Gardener H, 2010, MOVEMENT DISORD, V25, P1560, DOI 10.1002/mds.23339; Godfrey KM, 2000, AM J CLIN NUTR, V71, p1344S, DOI 10.1093/ajcn/71.5.1344s; Gronnesby J K, 1996, Lifetime Data Anal, V2, P315, DOI 10.1007/BF00127305; Harris MA, 2012, MOVEMENT DISORD, V27, P1111, DOI 10.1002/mds.25077; Ling ZD, 2002, MOVEMENT DISORD, V17, P116, DOI 10.1002/mds.10078; Logroscino G, 2005, ENVIRON HEALTH PERSP, V113, P1234, DOI 10.1289/ehp.7573; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; MARTYN CN, 1995, J NEUROL SCI, V132, P201, DOI 10.1016/0022-510X(95)00148-U; MATTOCK C, 1988, J NEUROL NEUROSUR PS, V51, P753, DOI 10.1136/jnnp.51.6.753; Moceri VM, 2000, NEUROLOGY, V54, P415, DOI 10.1212/WNL.54.2.415; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Postuma RB, 2007, MOVEMENT DISORD, V22, P1097, DOI 10.1002/mds.21272; Skog L, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-378; Statistics Sweden, 2009, MULT REG 2009 A DESC; Statistics Sweden, 2014, POP POP CHANG 1749 2; Statistics Sweden, 2015, NAT PAT REG; Statistics Sweden (SCB), 1982, MEDD SAM, P5; Stiles J, 2010, NEUROPSYCHOL REV, V20, P327, DOI 10.1007/s11065-010-9148-4; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Torrey EF, 2000, NEUROEPIDEMIOLOGY, V19, P177, DOI 10.1159/000026253; Westergaard T, 1999, ARCH GEN PSYCHIAT, V56, P993, DOI 10.1001/archpsyc.56.11.993; Wirdefeldt K, 2011, EUR J EPIDEMIOL, V26, pS1, DOI 10.1007/s10654-011-9581-6	29	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0152841	10.1371/journal.pone.0152841	http://dx.doi.org/10.1371/journal.pone.0152841			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082111	Green Published, gold, Green Submitted			2022-12-26	WOS:000374291800010
J	Shen, KL; Xiong, TB; Tan, SC; Wu, JH				Shen, Kunling; Xiong, Tengbin; Tan, Seng Chuen; Wu, Jiuhong			Oseltamivir Treatment for Children with Influenza-Like Illness in China: A Cost-Effectiveness Analysis	PLOS ONE			English	Article							VIRUS; MORTALITY; TRIAL	Background Influenza is a common viral respiratory infection that causes epidemics and pandemics in the human population. Oseltamivir is a neuraminidase inhibitor-a new class of antiviral therapy for influenza. Although its efficacy and safety have been established, there is uncertainty regarding whether influenza-like illness (ILI) in children is best managed by oseltamivir at the onset of illness, and its cost-effectiveness in children has not been studied in China. Objective To evaluate the cost-effectiveness of post rapid influenza diagnostic test (RIDT) treatment with oseltamivir and empiric treatment with oseltamivir comparing with no antiviral therapy against influenza for children with ILI. Methods We developed a decision-analytic model based on previously published evidence to simulate and evaluate 1-year potential clinical and economic outcomes associated with three managing strategies for children presenting with symptoms of influenza. Model inputs were derived from literature and expert opinion of clinical practice and research in China. Outcome measures included costs and quality-adjusted life year (QALY). All the interventions were compared with incremental cost-effectiveness ratios (ICER). Results In base case analysis, empiric treatment with oseltamivir consistently produced the greatest gains in QALY. When compared with no antiviral therapy, the empiric treatment with oseltamivir strategy is very cost effective with an ICER of RMB 4,438. When compared with the post RIDT treatment with oseltamivir, the empiric treatment with oseltamivir strategy is dominant. Probabilistic sensitivity analysis projected that there is a 100% probability that empiric oseltamivir treatment would be considered as a very cost-effective strategy compared to the no antiviral therapy, according to the WHO recommendations for cost-effectiveness thresholds. The same was concluded with 99% probability for empiric oseltamivir treatment being a very cost-effective strategy compared to the post RIDT treatment with oseltamivir. Conclusion In the Chinese setting of current health system, our modelling based simulation analysis suggests that empiric treatment with oseltamivir to be a cost-saving and very cost-effective strategy in managing children with ILI.	[Shen, Kunling] Beijing Childrens Hosp, Dept Resp Care, Beijing, Peoples R China; [Xiong, Tengbin] IMS Hlth China, Hlth Econ & Outcomes Res, Shanghai, Peoples R China; [Tan, Seng Chuen] IMS Hlth Asia Pacific, Hlth Econ & Outcomes Res, Singapore, Singapore; [Wu, Jiuhong] 306th Hosp PLA, Dept Pharm, Beijing, Peoples R China	Capital Medical University	Xiong, TB (corresponding author), IMS Hlth China, Hlth Econ & Outcomes Res, Shanghai, Peoples R China.	tbxiong@cn.imshealth.com			HEC Pharm, a subsidiary of HEC Group	HEC Pharm, a subsidiary of HEC Group	This project was sponsored by HEC Pharm, a subsidiary of HEC Group. The funder provided support in the form of salaries for authors Tengbin Xiong and Seng Chuen Tan, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Cai J, 2013, THESIS FUDAN U SHANG; [CDC CDC], 2011, FLU VIEW; Chen HongYi, 2013, Modern Preventive Medicine, V40, P1560; Chen L, 2015, CONT MED, V10, P136; Chen L, 2005, CHINESE GEN PRACTICE, V13, P1088; Chen W, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001086; [陈旭岩 CHEN Xuyan], 2007, [中国全科医学, Chinese General Practice], V10, P272; Chen Y, 2013, HERALD MED, V32, P264; Chen Y, 2015, CHINA PHARM, V11, P101; Epperson S., 2008, Morbidity and Mortality Weekly Report, V57, P692; Gilbert SA, 2013, VALUE HEALTH, V16, P953, DOI 10.1016/j.jval.2013.06.014; Guan Wenda, 2014, Zhonghua Jie He He Hu Xi Za Zhi, V37, P16; Gubareva LV, 2000, LANCET, V355, P827, DOI 10.1016/S0140-6736(99)11433-8; Holm MV, 2004, PHARM WORLD SCI, V26, P339, DOI 10.1007/s11096-004-0559-2; Huang Ting, 2014, Modern Preventive Medicine, V41, P1108; Huang WJ, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0317-1; Husereau DR, 2001, 212001 CAN COORD OFF; Lavelle TA, 2012, J PEDIATR-US, V160, P67, DOI 10.1016/j.jpeds.2011.07.001; Li TCM, 2015, VIRUSES-BASEL, V7, P4929, DOI 10.3390/v7092850; Liu Z, 2013, MED J IND ENTERPRISE, V2, P150; Lu X. S., 2015, J PEDIAT PHARM, V21, P24; Luo C, 2007, CHINA PHARM, V32, P2486; Ma J, 2015, NINGXIA MED J, V37, P235, DOI 10.13621/j.1001-5949.2015.03.0235; Muthuri SG, 2014, LANCET RESP MED, V2, P395, DOI 10.1016/S2213-2600(14)70041-4; Nagase H, 2009, VALUE HEALTH, V12, pS62, DOI 10.1111/j.1524-4733.2009.00629.x; O'Brien BJ, 2003, VALUE HEALTH, V6, P116, DOI 10.1046/j.1524-4733.2003.00213.x; Peters PH, 2001, J AM GERIATR SOC, V49, P1025, DOI 10.1046/j.1532-5415.2001.49204.x; Reisinger K, 2004, CLIN DRUG INVEST, V24, P395, DOI 10.2165/00044011-200424070-00003; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Wang B, 2008, HEALTH POLICY, V87, P223, DOI 10.1016/j.healthpol.2008.01.001; Wang C, 2014, CHINA PHARM, V24, P48; Wang D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069035; Wang Q, 2012, QINGHAI MED J, V12, P63; Wang S, 2012, CHINESE J PHARMACOEP, V3, P140; Wang S, 2006, J PEDIAT PHARM, V2, P24; Wang Xiang-Shi, 2013, Zhonghua Er Ke Za Zhi, V51, P356; WHO Macroeconomics, 2001, HLTH INV HLTH EC DEV; Wilschut JC, 2011, RAPID REFERENCE INFL; Xing J, 2007, CHINA PHARM, V11, P806; Xing Yi, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P368; [杨景秀 Yang Jingxiu], 2013, [中国药房, China Pharmacy], V24, P3634; [杨婷婷 Yang Tingting], 2014, [中华传染病杂志, Chinese Journal of Infections Diseases], V32, P7; Yu G, 2014, J APPL PREVENTIVE ME, V20, P249; Yue Y, 2012, J N PHARM, V6, P91; Zheng H, 2010, MOD PREV MED, V2, P201; Zhong N, 2011, CHINESE J TUBERCULOS, V34, P725; Zhu Q, 2011, FUDAN U J MED SCI, V38; [邹丽容 Zou Lirong], 2011, [中华检验医学杂志, Chinese Journal of Laboratory Medicine], V34, P940	48	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153664	10.1371/journal.pone.0153664	http://dx.doi.org/10.1371/journal.pone.0153664			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082431	Green Published, gold			2022-12-26	WOS:000374291800039
J	Boguta, P; Sokolowska, Z				Boguta, Patrycja; Sokolowska, Zofia			Interactions of Zn(II) Ions with Humic Acids Isolated from Various Type of Soils. Effect of pH, Zn Concentrations and Humic Acids Chemical Properties	PLOS ONE			English	Article							BUFFER CAPACITY; FLUORESCENCE SPECTROSCOPY; ORGANIC-LIGANDS; FULVIC-ACID; METAL-IONS; COMPLEXATION; SUBSTANCES; COPPER(II); MATTER; WATER	The main aim of this study was the analysis of the interaction between humic acids (HAs) from different soils and Zn(II) ions at wide concentration ranges and at two different pHs, 5 and 7, by using fluorescence and FTIR spectroscopy, as well as potentiometric measurements. The presence of a few areas of HAs structures responsible for Zn(II) complexing was revealed. Complexation at alpha-sites (low humified structures of low-molecular weight and aromatic polycondensation) and beta-sites (weakly humified structures) was stronger at pH 7 than 5. This trend was not observed for gamma-sites (structures with linearly-condensed aromatic rings, unsaturated bonds and large molecular weight). The amount of metal complexed at pH5 and 7 by alpha and gamma-structures increased with a decrease in humification and aromaticity of HAs, contrary to beta-areas where complexation increased with increasing content of carboxylic groups. The stability of complexes was higher at pH 7 and was the highest for gamma-structures. At pH 5, stability decreased with C/N increase for alpha-areas and -COOH content increase for beta-sites; stability increased with humification decrease for gamma-structures. The stability of complexes at a and beta-areas at pH 7 decreased with a drop in HAs humification. FTIR spectra at pH 5 revealed that the most-humified HAs tended to cause bidentate bridging coordination, while in the case of the least-humified HAs, Zn caused bidentate bridging coordination at low Zn additions and bidentate chelation at the highest Zn concentrations. Low Zn doses at pH 7 caused formation of unidentate complexes while higher Zn doses caused bidentate bridging. Such processes were noticed for HAs characterized by high oxidation degree and high oxygen functional group content; where these were low, HAs displayed bidentate bridging or even bidentate chelation. To summarize, the above studies have showed significant impact of Zn concentration, pH and some properties of HAs on complexation reactions of humic acids with zinc.	[Boguta, Patrycja; Sokolowska, Zofia] Polish Acad Sci, Inst Agrophys, Dept Phys Chem Porous Mat, PL-20236 Lublin, Poland	Polish Academy of Sciences; Bohdan Dobrzanski Institute of Agrophysics of the Polish Academy of Sciences	Boguta, P (corresponding author), Polish Acad Sci, Inst Agrophys, Dept Phys Chem Porous Mat, PL-20236 Lublin, Poland.	p.boguta@ipan.lublin.pl	Boguta, Patrycja/AAL-9890-2020	Boguta, Patrycja/0000-0003-4996-8795; Sokolowska, Zofia/0000-0003-2309-0785	National Science Centre [DEC-2013/11/D/NZ9/02545]	National Science Centre(National Science Centre, Poland)	The studies were partly carried out within the framework of a research project. The project was financed from funds of National Science Centre on the base of decision number DEC-2013/11/D/NZ9/02545. Granted to PB (www: https://www.ncn.gov.pl/?language=en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate G, 2001, J BRAZIL CHEM SOC, V12, P109, DOI 10.1590/S0103-50532001000100015; Aryal Rupak Kumar, 2014, Sustainable Environment Research, V24, P81; Baker BJ, 2012, THESIS FACULTY BOARD; Bednarek R, 2011, ECOLOGICAL SOIL SCI; Boguta P, 2012, INT AGROPHYS, V26, P7, DOI 10.2478/v10247-012-0002-1; Boguta P, 2013, ACTA AGROPH, V20, P253; Boguta P., 2013, ACTA AGROPHYS MONOGR, V2, P1; Boguta P, 2014, INT AGROPHYS, V28, P269, DOI 10.2478/intag-2014-0017; Cao J, 2004, CHEMOSPHERE, V54, P507, DOI 10.1016/j.chemosphere.2003.08.027; Chassapis K, 2010, FUEL, V89, P1480, DOI 10.1016/j.fuel.2009.10.005; Chen J, 2003, CHEMOSPHERE, V50, P639, DOI 10.1016/S0045-6535(02)00616-1; CHEN Y, 1977, SOIL SCI SOC AM J, V41, P352, DOI 10.2136/sssaj1977.03615995004100020037x; Dang-Vu T, 2009, COLLOID SURFACE A, V337, P80, DOI 10.1016/j.colsurfa.2008.11.055; Debska B, 2012, POL J ENVIRON STUD, V21, P603; Erdogan S, 2007, POL J ENVIRON STUD, V16, P671; Garcia-Gil JC, 2004, GEODERMA, V121, P135, DOI 10.1016/j.geoderma.2003.11.004; Golonka I, 2005, GEODERMA, V127, P237, DOI 10.1016/j.geoderma.2004.12.005; Guan XH, 2007, J ENVIRON SCI-CHINA, V19, P438, DOI 10.1016/S1001-0742(07)60073-4; He XS, 2014, ENVIRON SCI POLLUT R, V21, P7973, DOI 10.1007/s11356-014-2751-9; Kononova M.M., 1969, SOIL ORGANIC MATTER, DOI DOI 10.1016/B978-0-08-011470-5.50007-1; Korodi G., 2012, ACAD APPL RES MILIT, V11, P61; Kostic I, 2011, J SERB CHEM SOC, V76, P1325, DOI 10.2298/JSC110310115K; Lippold H, 2007, CHEMOSPHERE, V67, P1050, DOI 10.1016/j.chemosphere.2006.10.045; Ma MG, 2014, INT J ENV PROTECTION, V10, P230; Parvan L, 2013, ROM AGRIC RES, V30, P205; Pehlivan E, 2006, ENERG SOURCE PART A, V28, P1099, DOI 10.1080/009083190910451; Pertusatti J, 2007, J COLLOID INTERF SCI, V314, P484, DOI 10.1016/j.jcis.2007.06.006; Piccolo A, 2002, ADV AGRON, V75, P57, DOI 10.1016/S0065-2113(02)75003-7; Plaza C, 2006, ENVIRON SCI TECHNOL, V40, P917, DOI 10.1021/es051687w; Rahman MA, 2010, PAK J ANAL ENV CHEM, V11, P42; RYAN DK, 1982, ANAL CHEM, V54, P986, DOI 10.1021/ac00243a033; Sakellariadou F, 2006, MEDITERR MAR SCI, V7, P11, DOI 10.12681/mms.166; SENESI N, 1991, SOIL SCI, V152, P259, DOI 10.1097/00010694-199110000-00004; Swift RS, 1996, METHODS SOIL ANAL 3, V23, P1018, DOI [10.2136/sssabookser5.3.c35, DOI 10.2136/SSSABOOKSER5.3.C35]; Tipping E, 2004, CATION BINDING HUMIC; Wu FC, 2004, ANAL CHEM, V76, P110, DOI 10.1021/ac030005p; Wu FC, 2001, GEOCHEM J, V35, P333, DOI 10.2343/geochemj.35.333; Zheng YA, 2010, DESALINATION, V263, P170, DOI 10.1016/j.desal.2010.06.054; Zhou P, 2005, CHEMOSPHERE, V58, P1327, DOI 10.1016/j.chemosphere.2004.10.017	39	68	71	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153626	10.1371/journal.pone.0153626	http://dx.doi.org/10.1371/journal.pone.0153626			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077915	Green Published, gold, Green Submitted			2022-12-26	WOS:000374131700096
J	Cottinet, D; Condamine, F; Bremond, N; Griffiths, AD; Rainey, PB; de Visser, JAGM; Baudry, J; Bibette, J				Cottinet, Denis; Condamine, Florence; Bremond, Nicolas; Griffiths, Andrew D.; Rainey, Paul B.; de Visser, J. Arjan G. M.; Baudry, Jean; Bibette, Jerome			Lineage Tracking for Probing Heritable Phenotypes at Single-Cell Resolution	PLOS ONE			English	Article							ESCHERICHIA-COLI K-12; LONG-TERM SURVIVAL; EXPERIMENTAL EVOLUTION; STATIONARY-PHASE; MICROBIAL-POPULATIONS; ADAPTIVE RADIATION; BACTERIAL-GROWTH; GENE-EXPRESSION; ADAPTATION; MUTATIONS	Determining the phenotype and genotype of single cells is central to understand microbial evolution. DNA sequencing technologies allow the detection of mutants at high resolution, but similar approaches for phenotypic analyses are still lacking. We show that a drop-based millifluidic system enables the detection of heritable phenotypic changes in evolving bacterial populations. At time intervals, cells were sampled and individually compartmentalized in 100 nL drops. Growth through 15 generations was monitored using a fluorescent protein reporter. Amplification of heritable changes-via growth-over multiple generations yields phenotypically distinct clusters reflecting variation relevant for evolution. To demonstrate the utility of this approach, we follow the evolution of Escherichia coli populations during 30 days of starvation. Phenotypic diversity was observed to rapidly increase upon starvation with the emergence of heritable phenotypes. Mutations corresponding to each phenotypic class were identified by DNA sequencing. This scalable lineage-tracking technology opens the door to large-scale phenotyping methods with special utility for microbiology and microbial population biology.	[Cottinet, Denis; Condamine, Florence; Bremond, Nicolas; Griffiths, Andrew D.; Rainey, Paul B.; Baudry, Jean; Bibette, Jerome] PSL Res Univ, Ecole Super Phys & Chim Ind Ville Paris ESPCI Par, Chem Biol Innovat, CNRS,UMR 8231, Paris, France; [Rainey, Paul B.] Massey Univ, New Zealand Inst Adv Study, Auckland, New Zealand; [Rainey, Paul B.] Max Planck Inst Evolutionary Biol, Plon, Germany; [de Visser, J. Arjan G. M.] Wageningen Univ, Genet Lab, NL-6700 AP Wageningen, Netherlands	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Massey University; Max Planck Society; Wageningen University & Research	Bibette, J (corresponding author), PSL Res Univ, Ecole Super Phys & Chim Ind Ville Paris ESPCI Par, Chem Biol Innovat, CNRS,UMR 8231, Paris, France.	denis.cottinet@espci.org; Jerome.bibette@espci.fr	Griffiths, Andrew D/A-1370-2010; Baudry, Jean/A-7344-2016; Rainey, Paul/A-3207-2008; de Visser, Arjan/GLU-3870-2022; Baudry, Jean/AAX-6267-2020	Griffiths, Andrew D/0000-0002-0808-3539; Baudry, Jean/0000-0002-5526-499X; Rainey, Paul/0000-0003-0879-5795; Baudry, Jean/0000-0002-5526-499X	European Community [225167]; Universite Pierre Marie Curie (Paris, France); French State; Ile-de-France	European Community(European Commission); Universite Pierre Marie Curie (Paris, France); French State; Ile-de-France	This work was supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. [225167] (eFlux), by a PhD grant from Universite Pierre Marie Curie (Paris, France). PBR holds an International Blaise Pascal Research Chair funded by the French State and the Ile-de-France, managed by the Fondation de l'Ecole Normale Superieure.; We thank C. Beloin (Institut Pasteur Paris), D. Schneider and T. Hindre (Universite Joseph Fourier, Grenoble) for useful discussions; J Vinh, Y. Verdier and I. Addad (Proteomic facility, Ecole Superieure de Physique et Chimie Industrielle, Paris, France) for their help in exploratory experiments, E. Mordret for his help in preliminary experiments; J. Garnica-Rodriquez for producing movies; and the Genomic facility of Institut Curie (Paris, France) for performing the sequencing. This work was supported by the European Community's Seventh Framework Programme (FP7/20072013) under grant agreement no. [225167] (eFlux), by a PhD grant from Universite Pierre Marie Curie (Paris, France). PBR holds an International Blaise Pascal Research Chair funded by the French State and the Ile-de-France, managed by the Fondation de l'Ecole Normale Superieure.	Bachmann H, 2013, P NATL ACAD SCI USA, V110, P14302, DOI 10.1073/pnas.1308523110; Baraban L, 2011, LAB CHIP, V11, P4057, DOI 10.1039/c1lc20545e; Barrick JE, 2013, NAT REV GENET, V14, P827, DOI 10.1038/nrg3564; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Beaumont HJE, 2009, NATURE, V462, P90, DOI 10.1038/nature08504; BEISER SM, 1957, J BACTERIOL, V74, P303, DOI 10.1128/JB.74.3.303-307.1957; Boedicker JQ, 2009, ANGEW CHEM INT EDIT, V48, P5908, DOI 10.1002/anie.200901550; Brenner N, 2006, PHYS BIOL, V3, P172, DOI 10.1088/1478-3975/3/3/002; Callahan BJ, 2014, EVOLUTION, V68, P3307, DOI 10.1111/evo.12512; Camacho MI, 2015, J BACTERIOL, V197, P983, DOI 10.1128/JB.02325-14; Choi K, 2012, ANNU REV ANAL CHEM, V5, P413, DOI 10.1146/annurev-anchem-062011-143028; Clausell-Tormos J, 2008, CHEM BIOL, V15, P427, DOI 10.1016/j.chembiol.2008.04.004; Damodaran SP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118987; de Visser JAGM, 2006, GENETICS, V172, P2093, DOI 10.1534/genetics.105.052373; Desai MM, 2013, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2013/01/P01003; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Finkel SE, 2006, NAT REV MICROBIOL, V4, P113, DOI 10.1038/nrmicro1340; Gallie J, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002109; Habets MGJL, 2006, ECOL LETT, V9, P1041, DOI 10.1111/j.1461-0248.2006.00955.x; Hansen SK, 2007, NATURE, V445, P533, DOI 10.1038/nature05514; Hegreness M, 2006, SCIENCE, V311, P1615, DOI 10.1126/science.1122469; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Jakiela S, 2013, ANGEW CHEM INT EDIT, V52, P8908, DOI 10.1002/anie.201301524; Kawecki TJ, 2012, TRENDS ECOL EVOL, V27, P547, DOI 10.1016/j.tree.2012.06.001; Klumpp S, 2009, CELL, V139, P1366, DOI 10.1016/j.cell.2009.12.001; Koch R., 1881, MITTHEILUNGEN KAISER, V2, P1; Koster S, 2008, LAB CHIP, V8, P1110, DOI 10.1039/b802941e; Kram KE, 2014, APPL ENVIRON MICROB, V80, P1732, DOI 10.1128/AEM.03150-13; Lang GI, 2013, NATURE, V500, P571, DOI 10.1038/nature12344; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; Levin-Reisman I, 2010, NAT METHODS, V7, P737, DOI 10.1038/nmeth.1485; Levy SF, 2015, NATURE, V519, P181, DOI 10.1038/nature14279; Lind PA, 2015, ELIFE, V4, DOI 10.7554/eLife.07074; Miskinyte M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003802; Mukhopadhyay S, 2000, MOL MICROBIOL, V37, P371, DOI 10.1046/j.1365-2958.2000.01999.x; NAAS T, 1994, GENETICS, V136, P721; Obadia B, 2007, J MOL BIOL, V367, P42, DOI 10.1016/j.jmb.2006.12.048; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; PIRT SJ, 1967, J GEN MICROBIOL, V47, P181, DOI 10.1099/00221287-47-2-181; Plucain J, 2014, SCIENCE, V343, P1366, DOI 10.1126/science.1248688; Poltak SR, 2011, ISME J, V5, P369, DOI 10.1038/ismej.2010.136; Prosser JI, 2007, NAT REV MICROBIOL, V5, P384, DOI 10.1038/nrmicro1643; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Romeo T, 1998, MOL MICROBIOL, V29, P1321, DOI 10.1046/j.1365-2958.1998.01021.x; Shimada T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020081; Suzuki K, 2002, J BACTERIOL, V184, P5130, DOI 10.1128/JB.184.18.5130-5140.2002; Theberge AB, 2010, ANGEW CHEM INT EDIT, V49, P5846, DOI 10.1002/anie.200906653; Wichman HA, 1999, SCIENCE, V285, P422, DOI 10.1126/science.285.5426.422; WIMPENNY JWT, 1979, J GEN MICROBIOL, V114, P483, DOI 10.1099/00221287-114-2-483; ZAMBRANO MM, 1993, SCIENCE, V259, P1757, DOI 10.1126/science.7681219; Zinser ER, 2003, GENETICS, V164, P1271; Zinser ER, 2000, J BACTERIOL, V182, P4361, DOI 10.1128/JB.182.15.4361-4365.2000	53	19	19	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0152395	10.1371/journal.pone.0152395	http://dx.doi.org/10.1371/journal.pone.0152395			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077662	Green Published, gold			2022-12-26	WOS:000374131700004
J	Goncalves-de-Albuquerque, CF; Medeiros-de-Moraes, IM; Oliveira, FMD; Burth, P; Bozza, PT; Faria, MVC; Silva, AR; de Castro-Faria-Neto, HC				Goncalves-de-Albuquerque, Cassiano Felippe; Medeiros-de-Moraes, Isabel Matos; de Jesus Oliveira, Flora Magno; Burth, Patricia; Bozza, Patricia Torres; Castro Faria, Mauro Velho; Silva, Adriana Ribeiro; de Castro-Faria-Neto, Hugo Caire			Omega-9 Oleic Acid Induces Fatty Acid Oxidation and Decreases Organ Dysfunction and Mortality in Experimental Sepsis	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; CRITICALLY-ILL PATIENTS; OLIVE OIL; UNCOUPLING PROTEIN-2; LIPID-METABOLISM; ENDOTOXIC-SHOCK; MEDITERRANEAN DIET; SIGNALING PATHWAY; NUCLEAR RECEPTORS; CECAL LIGATION	Sepsis is characterized by inflammatory and metabolic alterations, which lead to massive cytokine production, oxidative stress and organ dysfunction. In severe systemic inflammatory response syndrome, plasma non-esterified fatty acids (NEFA) are increased. Several NEFA are deleterious to cells, activate Toll-like receptors and inhibit Na+/K+-ATPase, causing lung injury. A Mediterranean diet rich in olive oil is beneficial. The main component of olive oil is omega-9 oleic acid (OA), a monounsaturated fatty acid (MUFA). We analyzed the effect of OA supplementation on sepsis. OA ameliorated clinical symptoms, increased the survival rate, prevented liver and kidney injury and decreased NEFA plasma levels in mice subjected to cecal ligation and puncture (CLP). OA did not alter food intake and weight gain but diminished reactive oxygen species (ROS) production and NEFA plasma levels. Carnitine palmitoyltransferase IA (CPT1A) mRNA levels were increased, while uncoupling protein 2 (UCP2) liver expression was enhanced in mice treated with OA. OA also inhibited the decrease in 5' AMP-activated protein kinase (AMPK) expression and increased the enzyme expression in the liver of OA-treated mice compared to septic animals. We showed that OA pretreatment decreased NEFA concentration and increased CPT1A and UCP2 and AMPK levels, decreasing ROS production. We suggest that OA has a beneficial role in sepsis by decreasing metabolic dysfunction, supporting the benefits of diets high in monounsaturated fatty acids (MUFA).	[Goncalves-de-Albuquerque, Cassiano Felippe; Medeiros-de-Moraes, Isabel Matos; de Jesus Oliveira, Flora Magno; Bozza, Patricia Torres; Silva, Adriana Ribeiro; de Castro-Faria-Neto, Hugo Caire] Fiocruz MS, Inst Oswaldo Cruz, Lab Imunofarmacol, BR-21040900 Rio De Janeiro, RJ, Brazil; [Burth, Patricia] Univ Fed Fluminense, Inst Biol, Dept Biol Celular & Mol, BR-2402015 Niteroi, RJ, Brazil; [Castro Faria, Mauro Velho] Univ Estado Rio de Janeiro, Fac Ciencias Med, Dept Med Interna, BR-20550900 Rio De Janeiro, RJ, Brazil; [de Castro-Faria-Neto, Hugo Caire] Univ Estacio Sa, Programa Produtividade Cient, Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz; Universidade Federal Fluminense; Universidade do Estado do Rio de Janeiro; Universidade Estacio de Sa	de Castro-Faria-Neto, HC (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Imunofarmacol, BR-21040900 Rio De Janeiro, RJ, Brazil.	arsilva71@gmail.com; hugocfneto@gmail.com	Silva, Adriana R/C-5931-2014; Burth, Patricia/N-8180-2017; Bozza, Patricia T./AAM-4537-2021; Bozza, Patricia T./AAE-2933-2021; Gonçalves-de-Albuquerque, Cassiano Felippe/ABH-2409-2020; Gonçalves-de-Albuquerque, Cassiano Felippe/N-2815-2014; Silva, Adriana/U-7811-2019	Silva, Adriana R/0000-0002-5137-4251; Burth, Patricia/0000-0003-4433-9375; Bozza, Patricia T./0000-0001-8349-9529; Gonçalves-de-Albuquerque, Cassiano Felippe/0000-0002-4458-3055; Gonçalves-de-Albuquerque, Cassiano Felippe/0000-0002-4458-3055; Silva, Adriana/0000-0002-5137-4251	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Programa Estrategico de Apoio a Pesquisa em Saude (PAPES)-FIOCRUZ; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Programa Estrategico de Apoio a Pesquisa em Saude (PAPES)-FIOCRUZ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)-MVCF, PB, HCCFN; Programa Estrategico de Apoio a Pesquisa em Saude (PAPES)-FIOCRUZ- PTB, ARS, HCCFN; and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)-PB, PTB, ARS, MVCF, HCCFN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo CV, 2012, MICROVASC RES, V84, P218, DOI 10.1016/j.mvr.2012.05.006; Armstrong MB, 2001, AM J PHYSIOL-ENDOC M, V281, pE1197, DOI 10.1152/ajpendo.2001.281.6.E1197; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Burth P, 2005, J INFECT DIS, V191, P51, DOI 10.1086/426455; Canbay A, 2007, Z GASTROENTEROL, V45, P35, DOI 10.1055/s-2006-927368; Casanova E, 2014, J NUTR BIOCHEM, V25, P1003, DOI 10.1016/j.jnutbio.2014.05.003; Collins P, 2005, LIVER INT, V25, P880, DOI 10.1111/j.1478-3231.2005.01104.x; Curry S, 1998, NAT STRUCT BIOL, V5, P827, DOI 10.1038/1869; Djousse L, 2013, CIRC-HEART FAIL, V6, P964, DOI 10.1161/CIRCHEARTFAILURE.113.000521; Drechsler Susanne, 2015, Intensive Care Med Exp, V3, P48, DOI 10.1186/s40635-015-0048-z; Eaton SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072457; Eisen DP, 2012, INTENS CARE MED, V38, P1249, DOI 10.1007/s00134-012-2570-8; Erlanson-Albertsson C, 2003, ACTA PHYSIOL SCAND, V178, P405, DOI 10.1046/j.1365-201X.2003.01159.x; Feige JN, 2006, PROG LIPID RES, V45, P120, DOI 10.1016/j.plipres.2005.12.002; Feingold KR, 2009, J LIPID RES, V50, P2055, DOI 10.1194/jlr.M800655-JLR200; Fink MP, 2002, CURR OPIN CLIN NUTR, V5, P167, DOI 10.1097/00075197-200203000-00009; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Foster DW, 2004, ANN NY ACAD SCI, V1033, P1, DOI 10.1196/annals.1320.001; Gaieski DF, 2013, CRIT CARE MED, V41, P1167, DOI 10.1097/CCM.0b013e31827c09f8; de Albuquerque CFG, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/601032; Guerreiro MO, 2010, J TRAUMA, V69, pE102, DOI 10.1097/TA.0b013e3181dbb289; Guirgis FW, 2014, J CRIT CARE, V29, P320, DOI 10.1016/j.jcrc.2013.10.020; HALUSHKA PV, 1981, J PHARMACOL EXP THER, V218, P464; HALUSHKA PV, 1983, AM J MED, V74, P91, DOI 10.1016/0002-9343(83)90535-1; HOSTMARK AT, 1995, MED HYPOTHESES, V44, P539, DOI 10.1016/0306-9877(95)90520-0; Hubbard WJ, 2005, SHOCK, V24, P52, DOI 10.1097/01.shk.0000191414.94461.7e; Hwang J, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-184; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2014.26371850096, DOI 10.1001/JAMA.2014.26371850096]; Kerner J, 2000, BBA-MOL CELL BIOL L, V1486, P1, DOI 10.1016/S1388-1981(00)00044-5; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Kim YI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031317; Klenzak J, 2005, CRIT CARE CLIN, V21, P211, DOI 10.1016/j.ccc.2005.01.002; Krishan S, 2014, J CLIN PATHOL, V67, P758, DOI 10.1136/jclinpath-2014-202422; Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200; Leite MS, 2005, SHOCK, V23, P173, DOI 10.1097/01.shk.0000148072.12094.77; Li XW, 2013, CELL BIOCHEM BIOPHYS, V67, P1157, DOI 10.1007/s12013-013-9629-1; Mailloux RJ, 2011, FREE RADICAL BIO MED, V51, P1106, DOI 10.1016/j.freeradbiomed.2011.06.022; Maitra U, 2009, MOL IMMUNOL, V47, P420, DOI 10.1016/j.molimm.2009.08.023; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; Marik PE, 2008, INTENS CARE MED, V34, P1980, DOI 10.1007/s00134-008-1213-6; Mattiasson G, 2006, ANTIOXID REDOX SIGN, V8, P1, DOI 10.1089/ars.2006.8.1; Mayer K, 2003, AM J RESP CRIT CARE, V167, P1321, DOI 10.1164/rccm.200207-674OC; Maynard ND, 1997, CHEST, V111, P180, DOI 10.1378/chest.111.1.180; Mori Yutaka, 2004, J Atheroscler Thromb, V11, P224; Munford RS, 2006, ANNU REV PATHOL-MECH, V1, P467, DOI 10.1146/annurev.pathol.1.110304.100200; Nakbi A, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-80; Niu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030782; Nogueira AC, 2008, SHOCK, V29, P342, DOI 10.1097/SHK.0b013e31815abbc6; Ohhira M, 2007, J GASTROENTEROL, V42, P969, DOI 10.1007/s00535-007-2119-8; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Puertollano MA, 2007, BRIT J NUTR, V98, pS54, DOI 10.1017/S0007114507832934; PUTTMANN M, 1993, CLIN CHEM, V39, P825; Rajaram S, 2010, BRIT J NUTR, V103, P907, DOI 10.1017/S0007114509992480; Rakhshandehroo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006796; Regueira T, 2011, MED INTENSIVA, V35, P424, DOI 10.1016/j.medin.2011.03.011; Reis PA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003099; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; Ritter C, 2003, INTENS CARE MED, V29, P1782, DOI 10.1007/s00134-003-1789-9; Schwingshackl L, 2011, ANN NUTR METAB, V59, P176, DOI 10.1159/000334071; Schwingshackl L, 2011, ANN NUTR METAB, V58, P290, DOI 10.1159/000331214; Sofi F, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1344; Sztefko K, 2001, PANCREATOLOGY, V1, P230, DOI 10.1159/000055816; Teshima Y, 2003, CIRC RES, V93, P192, DOI 10.1161/01.RES.0000085581.60197.4D; Urpi-Sarda M, 2012, PHARMACOL RES, V65, P577, DOI 10.1016/j.phrs.2012.03.006; Varga T, 2011, BBA-MOL BASIS DIS, V1812, P1007, DOI 10.1016/j.bbadis.2011.02.014; Wang HP, 2010, AM J PHYSIOL-RENAL, V298, pF754, DOI 10.1152/ajprenal.00439.2009; Waterman E, 2007, ALTERN MED REV, V12, P331; Wood LG, 2009, PROG LIPID RES, V48, P27, DOI 10.1016/j.plipres.2008.10.001; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Yang K, 2015, TOXICOL LETT, V234, P110, DOI 10.1016/j.toxlet.2015.01.021; Yang ZH, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-16; Yates CM, 2014, PHARMACOL THERAPEUT, V141, P272, DOI 10.1016/j.pharmthera.2013.10.010; Yoo SH, 2011, TOXICOL LETT, V202, P23, DOI 10.1016/j.toxlet.2011.01.013	74	48	50	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153607	10.1371/journal.pone.0153607	http://dx.doi.org/10.1371/journal.pone.0153607			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078880	Green Published, Green Submitted, gold			2022-12-26	WOS:000374131700092
J	Savers, A; Rasid, O; Parlato, M; Brock, M; Jouvion, G; Ryffel, B; Cavaillon, JM; Eberl, G; Ibrahim-Granet, O				Savers, Amelie; Rasid, Orhan; Parlato, Marianna; Brock, Matthias; Jouvion, Gregory; Ryffel, Bernhard; Cavaillon, Jean-Marc; Eberl, Gerard; Ibrahim-Granet, Oumaima			Infection-Mediated Priming of Phagocytes Protects against Lethal Secondary Aspergillus fumigatus Challenge	PLOS ONE			English	Article							ALVEOLAR MACROPHAGES; NEUTROPHIL RECRUITMENT; CXC CHEMOKINE; RECEPTOR; DEFENSE; CONIDIA	Phagocytes restrict the germination of Aspergillus fumigatus conidia and prevent the establishment of invasive pulmonary aspergillosis in immunecompetent mice. Here we report that immunecompetent mice recovering from a primary A. fumigatus challenge are protected against a secondary lethal challenge. Using RAG gamma c knock-out mice we show that this protection is independent of T, B and NK cells. In protected mice, lung phagocytes are recruited more rapidly and are more efficient in conidial phagocytosis and killing. Protection was also associated with an enhanced expression of CXCR2 and Dectin-1 on bone marrow phagocytes. We also show that protective lung cytokine and chemokine responses are induced more rapidly and with enhanced dynamics in protected mice. Our findings support the hypothesis that following a first encounter with a non-lethal dose of A. fumigatus conidia, the innate immune system is primed and can mediate protection against a secondary lethal infection.	[Savers, Amelie; Rasid, Orhan; Cavaillon, Jean-Marc; Ibrahim-Granet, Oumaima] Inst Pasteur, Unite Cytokines & Inflammat, Paris, France; [Savers, Amelie; Brock, Matthias] Univ Nottingham, Sch Life Sci, Fungal Genet & Biol, Nottingham NG7 2RD, England; [Parlato, Marianna] Inst Imagine, INSERM, UMR S1163, Lab Immun Intestinale, Paris, France; [Jouvion, Gregory] Inst Pasteur, Unite Histopathol Humaine & Modeles Animaux, Paris, France; [Ryffel, Bernhard] Univ Orleans, Inst Transgenose, Immunol Mol, INSERM,UMR 7355, Orleans, France; [Ryffel, Bernhard] CNRS, F-45071 Orleans, France; [Eberl, Gerard] Inst Pasteur, Lymphoid Tissue Dev Unit, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Nottingham; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Orleans; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Ibrahim-Granet, O (corresponding author), Inst Pasteur, Unite Cytokines & Inflammat, Paris, France.	ogranet@pasteur.fr	Brock, Matthias/AAX-1430-2021; Jouvion, Grégory/AAL-2620-2021; Parlato, Marianna/H-9467-2017; Eberl, Gerard/A-1160-2013	Rasid, Orhan/0000-0002-7040-9587; Eberl, Gerard/0000-0002-1119-5638; Brock, Matthias/0000-0003-2774-1856	Institut Pasteur [PTR 468];  [Transregio 124]	Institut Pasteur(European Commission); 	This work was supported by funding from Institut Pasteur PTR 468 to OIG and AS, and the Transregio 124 "FungiNet" project A3 to AS and MB.	Bonnett CR, 2006, INFECT IMMUN, V74, P6528, DOI 10.1128/IAI.00909-06; Brock M, 2008, APPL ENVIRON MICROB, V74, P7023, DOI 10.1128/AEM.01288-08; Dubourdeau M AR, 2006, J IMMUNOLOGY; Dubourdeau M, 2006, J IMMUNOL, V177, P3994, DOI 10.4049/jimmunol.177.6.3994; Galiger C, 2013, ANTIMICROB AGENTS CH, V57, P3046, DOI 10.1128/AAC.01660-12; Ibrahim-Granet O, 2003, INFECT IMMUN, V71, P891, DOI 10.1128/IAI.71.2.891-903.2003; Ibrahim-Granet O, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-105; Mehrad B, 1999, J IMMUNOL, V163, P6086; Mircescu MM, 2009, J INFECT DIS, V200, P647, DOI 10.1086/600380; Philippe B, 2003, INFECT IMMUN, V71, P3034, DOI 10.1128/IAI.71.6.3034-3042.2003; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; Roussel L, 2010, J IMMUNOL, V184, P4531, DOI 10.4049/jimmunol.0903162; Shepardson KM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004378; Shoham S, 2012, FUTURE MICROBIOL, V7, P639, DOI [10.2217/FMB.12.28, 10.2217/fmb.12.28]; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Taylor PR, 2014, NAT IMMUNOL, V15, P143, DOI 10.1038/ni.2797; Werner JL, 2011, INFECT IMMUN, V79, P3966, DOI 10.1128/IAI.05493-11; Werner JL, 2009, J IMMUNOL, V182, P4938, DOI 10.4049/jimmunol.0804250; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519	20	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153829	10.1371/journal.pone.0153829	http://dx.doi.org/10.1371/journal.pone.0153829			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078879	Green Published, Green Submitted, gold			2022-12-26	WOS:000374131700112
J	Wu, LZ; Chaudhary, SC; Atigadda, VR; Belyaeva, OV; Harville, SR; Elmets, CA; Muccio, DD; Athar, M; Kedishvili, NY				Wu, Lizhi; Chaudhary, Sandeep C.; Atigadda, Venkatram R.; Belyaeva, Olga V.; Harville, Steven R.; Elmets, Craig A.; Muccio, Donald D.; Athar, Mohammad; Kedishvili, Natalia Y.			Retinoid X Receptor Agonists Upregulate Genes Responsible for the Biosynthesis of All-Trans-Retinoic Acid in Human Epidermis	PLOS ONE			English	Article							LIGAND-BINDING DOMAIN; VITAMIN-A METABOLISM; T-CELL LYMPHOMA; SKIN-CANCER; SIGNALING PATHWAY; NUCLEAR RECEPTORS; 9-CIS-RETINOIC ACID; MAMMARY CANCERS; SYSTEMIC RETINOIDS; GROWTH-INHIBITION	UAB30 is an RXR selective agonist that has been shown to have potential cancer chemopreventive properties. Due to high efficacy and low toxicity, it is currently being evaluated in human Phase I clinical trials by the National Cancer Institute. While UAB30 shows promise as a low toxicity chemopreventive drug, the mechanism of its action is not well understood. In this study, we investigated the effects of UAB30 on gene expression in human organotypic skin raft cultures and mouse epidermis. The results of this study indicate that treatment with UAB30 results in upregulation of genes responsible for the uptake and metabolism of all-trans-retinol to all-trans-retinoic acid (ATRA), the natural agonist of RAR nuclear receptors. Consistent with the increased expression of these genes, the steady-state levels of ATRA are elevated in human skin rafts. In ultraviolet B (UVB) irradiated mouse skin, the expression of ATRA target genes is found to be reduced. A reduced expression of ATRA sensitive genes is also observed in epidermis of mouse models of UVB-induced squamous cell carcinoma and basal cell carcinomas. However, treatment of mouse skin with UAB30 prior to UVB irradiation prevents the UVB-induced decrease in expression of some of the ATRA-responsive genes. Considering its positive effects on ATRA signaling in the epidermis and its low toxicity, UAB30 could be used as a chemoprophylactic agent in the treatment of non-melanoma skin cancer, particularly in organ transplant recipients and other high risk populations.	[Wu, Lizhi; Belyaeva, Olga V.; Kedishvili, Natalia Y.] Univ Alabama Birmingham, Sch Med, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Chaudhary, Sandeep C.; Elmets, Craig A.; Athar, Mohammad] Univ Alabama Birmingham, Dept Dermatol, Sch Med, Birmingham, AL 35294 USA; [Atigadda, Venkatram R.; Harville, Steven R.; Muccio, Donald D.] Univ Alabama Birmingham, Dept Chem, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Kedishvili, NY (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA.	nkedishvili@uab.edu		Kedishvili, Natalia/0000-0001-6917-4891	National Institutes of Health [AA12153, P30AR050948, P30CA013148, CA138998, P50 CA089019]; NATIONAL CANCER INSTITUTE [R01CA138998, R01CA193885, P30CA013148, P50CA089019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES026219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the National Institutes of Health Grants AA12153 (N. Y. K.), P30AR050948 (N. Y. K. and C. A. E.), P30CA013148 (C. A. E.), CA138998 (M. A.), and P50 CA089019 (D. D. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MK, 2014, J BIOL CHEM, V289, P14868, DOI 10.1074/jbc.M114.552257; Alvarez R, 2014, CHEM REV, V114, P1, DOI 10.1021/cr400126u; Arumugam A, 2012, BIOCHEM BIOPH RES CO, V425, P177, DOI 10.1016/j.bbrc.2012.07.062; ASSELINEAU D, 1989, DEV BIOL, V133, P322, DOI 10.1016/0012-1606(89)90037-7; Atigadda VR, 2015, J MED CHEM, V58, P7763, DOI 10.1021/acs.jmedchem.5b00829; Atigadda VR, 2003, J MED CHEM, V46, P3766, DOI 10.1021/jm030095q; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; BAVINCK JNB, 1995, J CLIN ONCOL, V13, P1933, DOI 10.1200/JCO.1995.13.8.1933; Boerma LJ, 2014, J BIOL CHEM, V289, P814, DOI 10.1074/jbc.M113.476861; Boorjian S, 2004, CLIN CANCER RES, V10, P3429, DOI 10.1158/1078-0432.CCR-03-0756; Campbell RM, 2006, DERMATOL THER, V19, P306, DOI 10.1111/j.1529-8019.2006.00088.x; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chapellier B, 2002, EMBO J, V21, P3402, DOI 10.1093/emboj/cdf331; Chaudhary SC, 2015, ONCOTARGET, V6, P36789, DOI 10.18632/oncotarget.5103; Chaudhary SC, 2014, CANCER PREV RES, V7, P186, DOI 10.1158/1940-6207.CAPR-13-0276; CHEN LC, 1994, CARCINOGENESIS, V15, P2383, DOI 10.1093/carcin/15.10.2383; Clagett-Dame M, 2011, NUTRIENTS, V3, P385, DOI 10.3390/nu3040385; Dawson MI, 2012, BBA-MOL CELL BIOL L, V1821, P21, DOI 10.1016/j.bbalip.2011.09.014; de Urquiza AM, 2000, SCIENCE, V290, P2140, DOI 10.1126/science.290.5499.2140; Desphande A, 2014, BIOORGAN MED CHEM, V22, P178, DOI 10.1016/j.bmc.2013.11.039; Di-Poi N, 2003, J STEROID BIOCHEM, V85, P257, DOI 10.1016/S0960-0760(03)00215-2; Di-Poi N, 2002, MOL CELL, V10, P721, DOI 10.1016/S1097-2765(02)00646-9; Doldo E, 2014, ANTICANCER RES, V34, P3303; Dragnev KH, 2011, CANCER PREV RES, V4, P818, DOI 10.1158/1940-6207.CAPR-10-0376; Duvic M, 2001, ARCH DERMATOL, V137, P581; Elabdeen HRZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070838; Evans RM, 2014, CELL, V157, P255, DOI 10.1016/j.cell.2014.03.012; Fu YS, 2012, MOL ONCOL, V6, P48, DOI 10.1016/j.molonc.2011.11.004; Fujimura S, 1998, LEUKEMIA RES, V22, P611, DOI 10.1016/S0145-2126(98)00049-6; Gericke J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062643; Germain P, 2006, PHARMACOL REV, V58, P760, DOI 10.1124/pr.58.4.7; Goverse G, 2015, EUR J IMMUNOL, V45, P89, DOI 10.1002/eji.201343340; Grubbs CJ, 2003, CANCER LETT, V201, P17, DOI 10.1016/S0304-3835(03)00461-0; Grubbs CJ, 2006, CARCINOGENESIS, V27, P1232, DOI 10.1093/carcin/bgi308; Guo XJ, 2002, CANCER RES, V62, P1654; Guo XJ, 2001, CANCER RES, V61, P2774; Guo XJ, 2000, CARCINOGENESIS, V21, P1925, DOI 10.1093/carcin/21.11.1925; Hsu SL, 1999, EXP CELL RES, V252, P332, DOI 10.1006/excr.1999.4625; Huang PX, 2014, CHEM REV, V114, P233, DOI 10.1021/cr400161b; Jiang W, 2009, CANCER BIOL THER, V8, P285, DOI 10.4161/cbt.8.3.7486; Kane MA, 2010, P NATL ACAD SCI USA, V107, P21884, DOI 10.1073/pnas.1008859107; Kane MA, 2010, METHODS MOL BIOL, V652, P1, DOI 10.1007/978-1-60327-325-1_1; KANG SW, 1995, J INVEST DERMATOL, V105, P549, DOI 10.1111/1523-1747.ep12323445; Kawaguchi R, 2015, MEMBRANES, V5, P425, DOI 10.3390/membranes5030425; Kedishvili NY, 2013, J LIPID RES, V54, P1744, DOI 10.1194/jlr.R037028; Kim ES, 2011, CANCER DISCOV, V1, P44, DOI 10.1158/2159-8274.CD-10-0010; Kitareewan S, 1996, MOL BIOL CELL, V7, P1153, DOI 10.1091/mbc.7.8.1153; Kolesar JM, 2010, CANCER PREV RES, V3, P1565, DOI 10.1158/1940-6207.CAPR-10-0149; KRAEMER KH, 1988, NEW ENGL J MED, V318, P1633, DOI 10.1056/NEJM198806233182501; Kurlandsky SB, 1996, J BIOL CHEM, V271, P15346, DOI 10.1074/jbc.271.26.15346; Langenfeld J, 1997, P NATL ACAD SCI USA, V94, P12070, DOI 10.1073/pnas.94.22.12070; Lansigan F, 2010, DRUGS, V70, P273, DOI 10.2165/11532190-000000000-00000; Laursen KB, 2015, J BIOL CHEM, V290, P4356, DOI 10.1074/jbc.M114.613968; Lee SA, 2011, J BIOL CHEM, V286, P13550, DOI 10.1074/jbc.M110.181065; Lemotte PK, 1996, EUR J BIOCHEM, V236, P328, DOI 10.1111/j.1432-1033.1996.00328.x; Li Y, 2013, J BIOL CHEM, V288, P10490, DOI 10.1074/jbc.M112.429852; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Mark Manuel, 2009, Nucl Recept Signal, V7, pe002, DOI 10.1621/nrs.07002; Matsuo T, 1998, ONCOGENE, V16, P3337, DOI 10.1038/sj.onc.1201830; MATSUURA T, 1993, ARCH BIOCHEM BIOPHYS, V301, P221, DOI 10.1006/abbi.1993.1137; McKenna DB, 1999, BRIT J DERMATOL, V140, P656; Mevorah B, 1996, J AM ACAD DERMATOL, V34, P379, DOI 10.1016/S0190-9622(07)80013-2; Mihaly J, 2011, EXP DERMATOL, V20, P326, DOI 10.1111/j.1600-0625.2010.01225.x; Miller VA, 1997, J CLIN ONCOL, V15, P790, DOI 10.1200/JCO.1997.15.2.790; Muccio DD, 1998, J MED CHEM, V41, P1679, DOI 10.1021/jm970635h; Napoli JL, 1998, METH MOL B, V89, P29; Niles RM, 2004, MUTAT RES-FUND MOL M, V555, P81, DOI 10.1016/j.mrfmmm.2004.05.020; O'Byrne SM, 2013, J LIPID RES, V54, P1731, DOI 10.1194/jlr.R037648; Otley CC, 2006, DERMATOL SURG, V32, P562, DOI 10.1111/j.1524-4725.2006.32115.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reijntjes S, 2010, INT J DEV BIOL, V54, P1267, DOI 10.1387/ijdb.093009sr; Revill K, 2013, GASTROENTEROLOGY, V145, P1424, DOI 10.1053/j.gastro.2013.08.055; Roos TC, 1998, PHARMACOL REV, V50, P315; Ruhl R, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005213; Saurat JH, 1999, J AM ACAD DERMATOL, V41, pS2, DOI 10.1016/S0190-9622(99)70358-0; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Shaw N, 2003, J BIOL CHEM, V278, P41589, DOI 10.1074/jbc.C300368200; Strate I, 2009, DEVELOPMENT, V136, P461, DOI 10.1242/dev.024901; Sun J, 2014, J BIOL CHEM, V289, P33118, DOI 10.1074/jbc.M114.610501; Szklenar M, 2013, J VASC RES, V50, P372, DOI 10.1159/000350865; Tang XH, 2009, CANCER BIOL THER, V8, P1214, DOI 10.4161/cbt.8.13.8630; Teixeira C, 1997, MOL ENDOCRINOL, V11, P1191, DOI 10.1210/me.11.9.1191; Vedell PT, 2013, MOL PHARMACOL, V83, P698, DOI 10.1124/mol.112.082404; Walsh SB, 2011, MOL CARCINOGEN, V50, P516, DOI 10.1002/mc.20744; Waters AM, 2015, MOL CANCER THER, V14, P1559, DOI 10.1158/1535-7163.MCT-14-1103; Wolf G, 2006, NUTR REV, V64, P532, DOI 10.1111/j.1753-4887.2006.tb00186.x; Xia G, 2011, BIOCHEMISTRY-US, V50, P93, DOI 10.1021/bi101288y; Xu J, 2011, BIOCHEM BIOPH RES CO, V408, P363, DOI 10.1016/j.bbrc.2011.02.039; XU XC, 1995, CANCER RES, V55, P5507	89	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153556	10.1371/journal.pone.0153556	http://dx.doi.org/10.1371/journal.pone.0153556			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078158	Green Submitted, Green Published, gold			2022-12-26	WOS:000374131700078
J	Feng, YM; Zhao, D; Zhang, N; Yu, CG; Zhang, Q; Thijs, L; Staessen, JA				Feng, Ying-Mei; Zhao, Dong; Zhang, Ning; Yu, Cai-Guo; Zhang, Qiang; Thijs, Lutgarde; Staessen, Jan A.			Insulin Resistance in Relation to Lipids and Inflammation in Type-2 Diabetic Patients and Non-Diabetic People	PLOS ONE			English	Article							BLOOD-CELL COUNT; ADIPOSE-TISSUE; OBESITY; DYSLIPIDEMIA; ASSOCIATIONS; MACROPHAGES; DYSFUNCTION; CYTOKINES	Background We demonstrated in experimental studies that hypercholesterolaemia enhances the proliferation of haematopoietic stem cells and the subsequent differentiation to neutrophils, whereas HDL-cholesterol inhibits these processes. To translate our experimental findings to clinical practice, we investigated in Chinese type-2 diabetic patients and in Flemish nondiabetic people the independent and joint associations of insulin resistance with markers of dyslipidaemia and inflammation, while looking for consistency between ethnicities and across the spectrum of insulin resistance. Methods We studied 798 Chinese patients with type-2 diabetes (53.6% women; mean age, 60.6 years) admitted to a tertiary referral centre and 1060 white Flemish (50.5%; 51.1 years) randomly recruited in Northern Belgium. Fasting insulin resistance (HOMA-IR) was derived from C-peptide in Chinese and from insulin in Flemish using the Homeostasis Model of Assessment algorithm. In multivariable-adjusted analyses, HOMA-IR was regressed on triglycerides, HDL-cholesterol and neutrophil count. Results In Chinese patients, the percentage changes in HOMA-IR associated with triglycerides, HDL-cholesterol and neutrophils (per 1-SD increment) amounted to 8.1 (95% confidence interval, 3.0 to 13.4; p = 0.0015), -8.7 (-13.0 to -4.2; p = 0.0002) and 5.6 (1.0 to 10.4; p = 0.017). In non-diabetic Flemish, the corresponding estimates were 11.7 (8.3 to 15.1; p<0.0001), -1.7 (-4.6 to 1.4; p = 0.28) and 3.3% (0.5 to 6.3; p = 0.022), respectively. None of the interaction terms between the three explanatory variables reached significance in Chinese or Flemish (p >= 0.10).	[Feng, Ying-Mei; Zhao, Dong; Zhang, Ning; Yu, Cai-Guo; Zhang, Qiang] Capital Med Univ, Lu He Hosp, Dept Endocrinol, Beijing, Peoples R China; [Feng, Ying-Mei; Zhao, Dong; Zhang, Ning; Yu, Cai-Guo; Zhang, Qiang] Capital Med Univ, Beijing Key Lab Diabet Prevent & Res, Beijing, Peoples R China; [Thijs, Lutgarde; Staessen, Jan A.] Univ Leuven, Studies Coordinating Ctr, Res Unit Hypertens & Cardiovasc Epidemiol, KU Leuven Dept Cardiovasc Dis, Leuven, Belgium; [Staessen, Jan A.] Maastricht Univ, R&D Grp VitaK, NL-6200 MD Maastricht, Netherlands	Capital Medical University; Capital Medical University; KU Leuven; Maastricht University	Feng, YM (corresponding author), Capital Med Univ, Lu He Hosp, Dept Endocrinol, Beijing, Peoples R China.; Feng, YM (corresponding author), Capital Med Univ, Beijing Key Lab Diabet Prevent & Res, Beijing, Peoples R China.	yingmeif13@sina.com	Staessen, Jan A/A-1065-2011	Staessen, Jan A/0000-0002-3026-1637; Thijs, Lutgarde/0000-0002-8108-2356	National Science Funding in China [81470566]; Beijing Municipal Science & Technology Commission [Z131100006813018]; Health and Research Bureau of Tongzhou District; European Union [HEALTH-2011.2.4.2-2-EU-MASCARA, HEALTH-F7-305507 HOMAGE]; European Union (European Re-search Council Advanced Researcher) [2011-294713-EPLORE]; Fonds voor Wetenschappelijk Onderzoek Vlaanderen; Ministry of the Flemish Community, Brussels, Belgium [G.0881.13, G.088013]	National Science Funding in China; Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission); Health and Research Bureau of Tongzhou District; European Union(European Commission); European Union (European Re-search Council Advanced Researcher); Fonds voor Wetenschappelijk Onderzoek Vlaanderen(FWO); Ministry of the Flemish Community, Brussels, Belgium	The study in Chinese patients received support from the National Science Funding in China (81470566), the Beijing Municipal Science & Technology Commission (Z131100006813018), and the Health and Research Bureau of Tongzhou District (R5). The European Union (HEALTH-2011.2.4.2-2-EU-MASCARA, HEALTH-F7-305507 HOMAGE and the European Re-search Council Advanced Researcher Grant-2011-294713-EPLORE) and the Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium (G.0881.13 and G.088013) currently support the Studies Coordinating Centre in Leuven.	Andrade VL, 2012, CLIN BIOCHEM, V45, P412, DOI 10.1016/j.clinbiochem.2012.01.008; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Dalmas E, 2014, DIABETES, V63, P1966, DOI 10.2337/db13-1511; de Vries MA, 2015, METABOLISM, V64, P213, DOI 10.1016/j.metabol.2014.10.011; Feng YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047286; Gower BA, 2015, J NUTR, V145, P177, DOI 10.3945/jn.114.195065; Hong EG, 2009, DIABETES, V58, P2525, DOI 10.2337/db08-1261; Hu M, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/154014; Johnson R, 1997, CLIN CHEM, V43, P2183; Kontush A, 2014, CARDIOVASC RES, V103, P341, DOI 10.1093/cvr/cvu147; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lastra G, 2013, HORM MOL BIOL CLIN I, V15, P49, DOI 10.1515/hmbci-2013-0025; Lee CTC, 2014, CLIN ENDOCRINOL, V81, P536, DOI 10.1111/cen.12390; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li Y, 2007, HYPERTENSION, V49, P1291, DOI 10.1161/HYPERTENSIONAHA.106.085498; Liu LF, 2015, DIABETOLOGIA, V58, P1579, DOI 10.1007/s00125-015-3603-y; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Mansuy-Aubert V, 2013, CELL METAB, V17, P534, DOI 10.1016/j.cmet.2013.03.005; McCann JC, 2015, FASEB J, V29, P3287, DOI 10.1096/fj.15-271833; Mooradian AD, 2009, NAT CLIN PRACT ENDOC, V5, P150, DOI 10.1038/ncpendmet1066; Perry RJ, 2015, CELL, V160, P745, DOI 10.1016/j.cell.2015.01.012; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Shim WS, 2006, DIABETES RES CLIN PR, V73, P284, DOI 10.1016/j.diabres.2006.02.001; Siebel AL, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00258; Sloan-Lancaster J, 2013, DIABETES CARE, V36, P2239, DOI 10.2337/dc12-1835; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Taskinen MR, 2015, ATHEROSCLEROSIS, V239, P483, DOI 10.1016/j.atherosclerosis.2015.01.039; Tian JY, 2008, DIABETES RES CLIN PR, V82, P132, DOI 10.1016/j.diabres.2008.05.014; Tong PC, 2004, DIABETES CARE, V27, P216, DOI 10.2337/diacare.27.1.216; Van Gassen N, 2015, STEM CELL TRANSL MED, V4, P555, DOI 10.5966/sctm.2014-0272; Vella CA, 2013, DIABETES CARE, V36, P1377, DOI 10.2337/dc12-1550; Wang QL, 2014, DIABETES, V63, P4172, DOI 10.2337/db14-0026; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972	33	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153171	10.1371/journal.pone.0153171	http://dx.doi.org/10.1371/journal.pone.0153171			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073920	Green Published, Green Submitted, gold			2022-12-26	WOS:000374131200056
J	Banko, AV; Lazarevic, IB; Folic, MM; Djukic, VB; Cirkovic, AM; Karalic, DZ; Cupic, MD; Jovanovic, TP				Banko, Ana V.; Lazarevic, Ivana B.; Folic, Miljan M.; Djukic, Vojko B.; Cirkovic, Andja M.; Karalic, Danijela Z.; Cupic, Maja D.; Jovanovic, Tanja P.			Characterization of the Variability of Epstein-Barr Virus Genes in Nasopharyngeal Biopsies: Potential Predictors for Carcinoma Progression	PLOS ONE			English	Article							LATENT MEMBRANE PROTEIN-1; 30-BP DELETION; SEQUENCE VARIATION; HIGH-FREQUENCY; LMP1; POLYMORPHISM; DISEASE; TUMORS; EPIDEMIOLOGY; PATHOGENESIS	Epstein-Barr virus (EBV) infection is a significant factor in the pathogenesis of nasopharyngeal carcinoma, especially in the undifferentiated carcinoma of nasopharyngeal type (UCNT, World Health Organization type III), which is the dominant histopathological type in high-risk areas. The major EBV oncogene is latent membrane protein 1 (LMP1). LMP1 gene shows variability with different tumorigenic and immunogenic potentials. EBV nuclear antigen 1 (EBNA1) regulates progression of EBV-related tumors; however, the influence of EBNA1 sequence variability on tumor pathogenesis is controversial. The aims of this study were to characterize polymorphisms of EBV genes in non-endemic nasopharyngeal carcinoma biopsies and to investigate potential sequence patterns that correlate with the clinical presentation of nasopharyngeal carcinoma. In total, 116 tumor biopsies of undifferentiated carcinoma of nasopharyngeal type (UCNT), collected from 2008 to 2014, were evaluated in this study. The genes EBNA2, LMP1, and EBNA1 were amplified using nested-PCR. EBNA2 genotyping was performed by visualization of PCR products using gel electrophoresis. Investigation of LMP1 and EBNA1 included sequence, phylogenetic, and statistical analyses. The presence of EBV DNA was significantly distributed between TNM stages. LMP1 variability showed six variants, with the detection of the first China1 and North Carolina variants in European nasopharyngeal carcinoma biopsies. Newly discovered variants Srb1 and Srb2 were UCNT-specific LMP1 polymorphisms. The B95-8 and North Carolina variants are possible predictors for favorable TNM stages. In contrast, deletions in LMP1 are possible risk factors for the most disfavorable TNM stage, independent of EBNA2 or EBNA1 variability. A newly discovered EBNA1 subvariant, P-thr-sv-5, could be a potential diagnostic marker, as it represented a UCNT-specific EBNA1 subvariant. A particular combination of EBNA2, LMP1, and EBNA1 polymorphisms, type 1/Med/P-thr was identified as a possible risk factor for TNM stage IVB or progression to the N3 stage.	[Banko, Ana V.; Lazarevic, Ivana B.; Karalic, Danijela Z.; Cupic, Maja D.; Jovanovic, Tanja P.] Univ Belgrade, Inst Microbiol & Immunol, Fac Med, Belgrade, Serbia; [Folic, Miljan M.; Djukic, Vojko B.] Univ Belgrade, Clin Ctr Serbia, Fac Med, Clin Otorhinolaryngol & Maxillofacial Surg, Belgrade, Serbia; [Cirkovic, Andja M.] Univ Belgrade, Inst Med Stat & Informat, Fac Med, Belgrade, Serbia	University of Belgrade; Clinical Centre of Serbia; University of Belgrade; University of Belgrade	Banko, AV (corresponding author), Univ Belgrade, Inst Microbiol & Immunol, Fac Med, Belgrade, Serbia.	ana.banko@mfub.bg.ac.rs	Banko, Ana/GQQ-2011-2022	Cirkovic, Andja/0000-0002-7542-5690; Lazarevic, Ivana/0000-0001-6795-1378; Banko, Ana/0000-0002-6829-096X; Miljanovic, Danijela/0000-0001-9446-8701; Cupic, Maja/0000-0003-4482-9251	Ministry of Education, Science and Technological Development, Republic of Serbia [175073]	Ministry of Education, Science and Technological Development, Republic of Serbia	The study was supported by the Ministry of Education, Science and Technological Development, Republic of Serbia, Grant No. 175073 (http://www.mpn.gov.rs/).	Aga M, 2014, ONCOGENE, V33, P4613, DOI 10.1038/onc.2014.66; Ai Junhong, 2012, Virol J, V9, P13, DOI 10.1186/1743-422X-9-13; Lorenzetti MA, 2010, J MED VIROL, V82, P1730, DOI 10.1002/jmv.21871; Banko A, 2012, J MED VIROL, V84, P632, DOI 10.1002/jmv.23217; Bhatia K, 1996, ONCOGENE, V13, P177; Busson P, 2004, TRENDS MICROBIOL, V12, P356, DOI 10.1016/j.tim.2004.06.005; Chang CM, 2009, VIRUS RES, V143, P209, DOI 10.1016/j.virusres.2009.07.005; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Chen JP, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-170; Dardari R, 2006, INT J CANCER, V118, P1977, DOI 10.1002/ijc.21595; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dawson CW, 2012, SEMIN CANCER BIOL, V22, P144, DOI 10.1016/j.semcancer.2012.01.004; Edwards RH, 2004, J VIROL, V78, P868, DOI 10.1128/JVI.78.2.868-881.2004; Edwards RH, 1999, VIROLOGY, V261, P79, DOI 10.1006/viro.1999.9855; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Ikegaya H, 2008, J VIROL METHODS, V147, P78, DOI 10.1016/j.jviromet.2007.08.010; Jia WH, 2012, SEMIN CANCER BIOL, V22, P117, DOI 10.1016/j.semcancer.2012.01.009; Kennedy G, 2003, P NATL ACAD SCI USA, V100, P14269, DOI 10.1073/pnas.2336099100; KNECHT H, 1993, BLOOD, V82, P2937; Kulwichit W, 1998, P NATL ACAD SCI USA, V95, P11963, DOI 10.1073/pnas.95.20.11963; Li DJ, 2009, J MED VIROL, V81, P1253, DOI 10.1002/jmv.21503; Longnecker R, 2013, FIELDS VIROLOGY, V2, P1898; Lyons SF, 1998, SEMIN ONCOL, V25, P461; Mendes TM, 2008, BRAZ J INFECT DIS, V12, P186, DOI 10.1590/S1413-86702008000300005; MILLER WE, 1994, J GEN VIROL, V75, P2729, DOI 10.1099/0022-1317-75-10-2729; MOORTHY RK, 1993, J VIROL, V67, P1638, DOI 10.1128/JVI.67.3.1638-1646.1993; Morris MA, 2016, SCI REP-UK, V6, DOI 10.1038/srep19533; PATHMANATHAN R, 1995, NEW ENGL J MED, V333, P693, DOI 10.1056/NEJM199509143331103; Perez-Ordonez B, 2007, HEAD NECK PATHOL, V1, P141, DOI 10.1007/s12105-007-0020-7; Puchhammer-Stockl E, 2006, J CLIN VIROL, V36, P239, DOI 10.1016/j.jcv.2006.03.004; Rambaut A., 2007, FIGTREE V1; Rosales-Perez S, 2014, ARCH MED RES, V45, P229, DOI 10.1016/j.arcmed.2014.02.002; ROWE M, 1994, J VIROL, V68, P5602, DOI 10.1128/JVI.68.9.5602-5612.1994; SAMPLE J, 1990, J VIROL, V64, P4084, DOI 10.1128/JVI.64.9.4084-4092.1990; SANDVEJ K, 1994, BLOOD, V84, P4053, DOI 10.1182/blood.V84.12.4053.bloodjournal84124053; Sandvej K, 2000, J PATHOL, V191, P127, DOI 10.1002/(SICI)1096-9896(200006)191:2<127::AID-PATH614>3.0.CO;2-E; Senyuta N, 2014, J MED VIROL, V86, P290, DOI 10.1002/jmv.23729; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan EL, 2003, J MED VIROL, V69, P251, DOI 10.1002/jmv.10282; Tiwawech D, 2008, J CLIN VIROL, V42, P1, DOI 10.1016/j.jcv.2007.11.011; Vallat-Decouvelaere AV, 2002, NEUROPATH APPL NEURO, V28, P471, DOI 10.1046/j.1365-2990.2002.t01-1-00418.x; WANG D, 1985, CELL, V43, P831, DOI 10.1016/0092-8674(85)90256-9; Wang JT, 2003, J MED VIROL, V69, P417, DOI 10.1002/jmv.10305; Xu J, 2013, NANOSCALE RES LETT, V8, P1, DOI 10.1186/1556-276X-8-54; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zeng YX, 2002, SEMIN CANCER BIOL, V12, P443, DOI 10.1016/S1044579X02000871	47	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153498	10.1371/journal.pone.0153498	http://dx.doi.org/10.1371/journal.pone.0153498			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27071030	Green Submitted, gold, Green Published			2022-12-26	WOS:000373900700073
J	Dedic, E; Alsarraf, H; Welner, DH; Ostergaard, O; Klychnikov, OI; Hensbergen, PJ; Corver, J; van Leeuwen, HC; Jorgensen, R				Dedic, Emil; Alsarraf, Husam; Welner, Ditte Hededam; Ostergaard, Ole; Klychnikov, Oleg I.; Hensbergen, Paul J.; Corver, Jeroen; van Leeuwen, Hans C.; Jorgensen, Rene			A Novel Fic (Filamentation Induced by cAMP) Protein from Clostridium difficile Reveals an Inhibitory Motif-independent Adenylylation/AMPylation Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXIN-B; DOMAIN; AMPYLATION; SCATTERING; PROGRAM; BINDING; SYSTEM; RHO; MACROMOLECULES; EXPRESSION	Filamentation induced by cAMP (Fic) domain proteins have been shown to catalyze the transfer of the AMP moiety from ATP onto a protein target. This type of post-translational modification was recently shown to play a crucial role in pathogenicity mediated by two bacterial virulence factors. Herein we characterize a novel Fic domain protein that we identified from the human pathogen Clostridium difficile. The crystal structure shows that the protein adopts a classical all-helical Fic fold, which belongs to class II of Fic domain proteins characterized by an intrinsic N-terminal autoinhibitory alpha-helix. A conserved glutamate residue in the inhibitory helix motif was previously shown in other Fic domain proteins to prevent proper binding of the ATP gamma-phosphate. However, here we demonstrate that both ATP binding and autoadenylylation activity of the C. difficile Fic domain protein are independent of the inhibitory motif. In support of this, the crystal structure of a mutant of this Fic protein in complex with ATP reveals that the gamma-phosphate adopts a conformation unique among Fic domains that seems to override the effect of the inhibitory helix. These results provide important structural insight into the adenylylation reaction mechanism catalyzed by Fic domains. Our findings reveal the presence of a class II Fic domain protein in the human pathogen C. difficile that is not regulated by autoinhibition and challenge the current dogma that all class I-III Fic domain proteins are inhibited by the inhibitory alpha-helix.	[Dedic, Emil; Alsarraf, Husam; Welner, Ditte Hededam; Jorgensen, Rene] Statens Serum Inst, Dept Microbiol & Infect Control, Artillerivej 5, DK-2300 Copenhagen S, Denmark; [Ostergaard, Ole] Statens Serum Inst, Dept Autoimmunol & Biomarkers, DK-2300 Copenhagen S, Denmark; [Klychnikov, Oleg I.; Hensbergen, Paul J.] Leiden Univ, Med Ctr, Ctr Prote & Metabol, NL-2300 RC Leiden, Netherlands; [Corver, Jeroen; van Leeuwen, Hans C.] Leiden Univ, Med Ctr, Dept Med Microbiol, Sect Expt Bacteriol, NL-2300 RC Leiden, Netherlands; [Dedic, Emil] ETH, Dept Biol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Statens Serum Institut; Statens Serum Institut; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Swiss Federal Institutes of Technology Domain; ETH Zurich	Jorgensen, R (corresponding author), Statens Serum Inst, Dept Microbiol & Infect Control, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	renj@ssi.dk	Alsarraf, Husam/G-2918-2017; Klychnikov, Oleg I./AAN-6167-2020; Jørgensen, René/P-5619-2014	Klychnikov, Oleg I./0000-0002-0383-9237; Jørgensen, René/0000-0003-0672-466X; Welner, Ditte Hededam/0000-0001-9297-4133; Alsarraf, Husam/0000-0001-8147-9647; Ostergaard, Ole/0000-0003-3160-8548; Corver, Jeroen/0000-0002-9262-5475; Hensbergen, Paul/0000-0002-3193-5445	Det Frie Forskningsrad Sapere Aude Starting Grant/Medical Sciences from the Danish Council for Independent Research [11-104831]	Det Frie Forskningsrad Sapere Aude Starting Grant/Medical Sciences from the Danish Council for Independent Research	This work was supported by Det Frie Forskningsrad Sapere Aude Starting Grant 11-104831/Medical Sciences from the Danish Council for Independent Research. Access to synchrotron beam time was made possible by support from DANSCATT. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Boivin S, 2013, PROTEIN EXPRES PURIF, V91, P192, DOI 10.1016/j.pep.2013.08.002; Bunney TD, 2014, STRUCTURE, V22, P1831, DOI 10.1016/j.str.2014.10.007; Campanacci V, 2013, EMBO J, V32, P1469, DOI 10.1038/emboj.2013.82; Castro-Roa D, 2013, NAT CHEM BIOL, V9, P811, DOI [10.1038/NCHEMBIO.1364, 10.1038/nchembio.1364]; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Elliott B, 2007, INTERN MED J, V37, P561, DOI 10.1111/j.1445-5994.2007.01403.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engel P, 2012, NATURE, V482, P107, DOI 10.1038/nature10729; Feng F, 2012, NATURE, V485, P114, DOI 10.1038/nature10962; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Garcia-Pino A, 2014, TRENDS BIOCHEM SCI, V39, P121, DOI 10.1016/j.tibs.2014.01.001; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Goepfert A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064901; Goody PR, 2012, EMBO J, V31, P1774, DOI 10.1038/emboj.2012.16; Ham H, 2014, J BIOL CHEM, V289, P36059, DOI 10.1074/jbc.M114.612515; Harms A, 2015, CELL REP, V12, P1497, DOI 10.1016/j.celrep.2015.07.056; JUST I, 1995, J CLIN INVEST, V95, P1026, DOI 10.1172/JCI117747; JUST I, 1995, J BIOL CHEM, V270, P13932, DOI 10.1074/jbc.270.23.13932; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kinch LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005818; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Li Y, 2011, J AM SOC MASS SPECTR, V22, P752, DOI 10.1007/s13361-011-0084-1; Luong P, 2010, J BIOL CHEM, V285, P20155, DOI 10.1074/jbc.M110.114884; LYERLY DM, 1985, INFECT IMMUN, V47, P349, DOI 10.1128/IAI.47.2.349-352.1985; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; Matte A, 1998, STRUCT FOLD DES, V6, P413, DOI 10.1016/S0969-2126(98)00043-4; Mattoo S, 2011, J BIOL CHEM, V286, P32834, DOI 10.1074/jbc.M111.227603; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McFarland LV, 2007, AM J INFECT CONTROL, V35, P237, DOI 10.1016/j.ajic.2006.06.004; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Muller MP, 2010, SCIENCE, V329, P946, DOI 10.1126/science.1192276; Mukherjee S, 2011, NATURE, V477, P103, DOI 10.1038/nature10335; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Palanivelu DV, 2011, PROTEIN SCI, V20, P492, DOI 10.1002/pro.581; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poornam GP, 2009, PROTEINS, V76, P201, DOI 10.1002/prot.22339; Poutanen SM, 2004, CAN MED ASSOC J, V171, P51, DOI 10.1503/cmaj.1031189; Quesada-Gomez C, 2015, J CLIN MICROBIOL, V53, P1216, DOI 10.1128/JCM.03058-14; Rahman M, 2012, NAT NEUROSCI, V15, P871, DOI 10.1038/nn.3102; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Sanyal A, 2015, J BIOL CHEM, V290, P8482, DOI 10.1074/jbc.M114.618348; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Stanger FV, 2016, P NATL ACAD SCI USA, V113, pE529, DOI 10.1073/pnas.1516930113; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Welner D, 2014, ACTA CRYSTALLOGR F, V70, P827, DOI 10.1107/S2053230X1400987X; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3; Xiao JY, 2010, NAT STRUCT MOL BIOL, V17, P1004, DOI 10.1038/nsmb.1867; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382	66	9	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13286	13300		10.1074/jbc.M115.705491	http://dx.doi.org/10.1074/jbc.M115.705491			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27076635	Green Published, hybrid			2022-12-26	WOS:000379770500032
J	Abasht, B; Mutryn, MF; Michalek, RD; Lee, WR				Abasht, Behnam; Mutryn, Marie F.; Michalek, Ryan D.; Lee, William R.			Oxidative Stress and Metabolic Perturbations in Wooden Breast Disorder in Chickens	PLOS ONE			English	Article							PECTORALIS MAJOR MUSCLE; UDP-GLUCOSE DEHYDROGENASE; GLUTATHIONE CONSUMPTION; HYALURONAN SYNTHASE; ASCORBIC-ACID; PATHWAY; PROTEIN; LIVER; MEAT; OVEREXPRESSION	This study was conducted to characterize metabolic features of the breast muscle (pectoralis major) in chickens affected with the Wooden Breast myopathy. Live birds from two purebred chicken lines and one crossbred commercial broiler population were clinically examined by manual palpation of the breast muscle (pectoralis major) at 47-48 days of age. Metabolite abundance was determined by gas chromatography/mass spectrometry (GC/MS) and liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) using breast muscle tissue samples from 16 affected and 16 unaffected chickens. Muscle glycogen content was also quantified in breast muscle tissue samples from affected and unaffected chickens. In total, levels of 140 biochemicals were significantly different (FDR < 0.1 and fold-change A/U > 1.3 or < 0.77) between affected and unaffected chickens. Glycogen content measurements were considerably lower (1.7-fold) in samples taken from Wooden Breast affected birds when compared with samples from unaffected birds. Affected tissues exhibited biomarkers related to increased oxidative stress, elevated protein levels, muscle degradation, and altered glucose utilization. Affected muscle also showed elevated levels of hypoxanthine, xanthine, and urate molecules, the generation of which can contribute to altered redox homeostasis. In conclusion, our findings show that Wooden Breast affected tissues possess a unique metabolic signature. This unique profile may identify candidate biomarkers for diagnostic utilization and provide mechanistic insight into altered biochemical processes contributing to tissue hardening associated with the Wooden Breast myopathy in commercial chickens.	[Abasht, Behnam; Mutryn, Marie F.] Univ Delaware, Dept Anim & Food Sci, Newark, DE USA; [Michalek, Ryan D.] Metabolon Inc, Durham, NC USA; [Lee, William R.] Maple Leaf Farms, Leesburg, IN USA	University of Delaware; Metabolon	Abasht, B (corresponding author), Univ Delaware, Dept Anim & Food Sci, Newark, DE USA.	abasht@UDel.edu			University of Delaware; Maple Leaf Farms; Metabolon Inc.	University of Delaware; Maple Leaf Farms; Metabolon Inc.	The study was financially supported by the University of Delaware. Maple Leaf Farms provided support in the form of salaries for William R. Lee, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Metabolon Inc. provided support in the form of salaries for Ryan D. Michalek and conducted metabolomics profiling of samples, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abasht B, P 22 EUR S QUAL POUL; Alexander D, 2011, EUR J CLIN INVEST, V41, P527, DOI 10.1111/j.1365-2362.2010.02441.x; Aschenbach WG, 2002, DIABETES, V51, P567, DOI 10.2337/diabetes.51.3.567; Bailey RA, 2015, POULTRY SCI, V94, P2870, DOI 10.3382/ps/pev304; Banhegyi G, 1996, FEBS LETT, V381, P39, DOI 10.1016/0014-5793(96)00077-4; Banhegyi G, 1997, FREE RADICAL BIO MED, V23, P793, DOI 10.1016/S0891-5849(97)00062-2; Berri C, 2007, J ANIM SCI, V85, P2005, DOI 10.2527/jas.2006-398; Berri C, 2001, POULTRY SCI, V80, P833, DOI 10.1093/ps/80.7.833; Bond MR, 2013, ANNU REV NUTR, V33, P205, DOI 10.1146/annurev-nutr-071812-161240; BRAUN L, 1994, FEBS LETT, V352, P4, DOI 10.1016/0014-5793(94)00905-8; Breiman L, 2001, MACH LEARN, V45, P261, DOI 10.1023/A:1017934522171; Brinck J, 1999, EXP CELL RES, V252, P342, DOI 10.1006/excr.1999.4645; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Bucciante G, G CLIN MED, V66, P451; BURG MB, 1988, J CLIN INVEST, V81, P635, DOI 10.1172/JCI113366; Cheng HT, 2014, ATLAS NEUROMUSCULAR, P37; Chung SSM, 2003, J AM SOC NEPHROL, V14, pS233, DOI 10.1097/01.ASN.0000077408.15865.06; DIMAURO S, 1987, J INHERIT METAB DIS, V10, P113, DOI 10.1007/BF01812852; Egger S, 2010, BIOCHEM SOC T, V38, P1378, DOI 10.1042/BST0381378; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Fu WX, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0098-4; GIESECKE K, 1989, METABOLISM, V38, P1196, DOI 10.1016/0026-0495(89)90159-5; Goldstein BA, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-49; Ishikawa Y, 2013, BBA-MOL CELL RES, V1833, P2479, DOI 10.1016/j.bbamcr.2013.04.008; Itoh T, 2008, NAT STRUCT MOL BIOL, V15, P924, DOI 10.1038/nsmb.1474; KINOSHIT.JH, 1974, INVEST OPHTH VISUAL, V13, P713; Kristal BS, 1999, ARCH BIOCHEM BIOPHYS, V370, P22, DOI 10.1006/abbi.1999.1387; Kuttappan VA, 2012, POULTRY SCI, V91, P3230, DOI 10.3382/ps.2012-02397; Li P, 2015, INT J CLIN EXP PATHO, V8, P12101; Liaw A., 2015, PACKAGE RANDOMFOREST; Lorentzen KA, 2016, ATHEROSCLEROSIS, V244, P195, DOI 10.1016/j.atherosclerosis.2015.11.016; Luptak I, 2007, J CLIN INVEST, V117, P1432, DOI 10.1172/JCI30658; Ma C, 2014, BRIT J PHARMACOL, V171, P3352, DOI 10.1111/bph.12594; Mazzoni M, 2015, POULTRY SCI, V94, P123, DOI 10.3382/ps/peu043; MEIJER AEFH, 1991, PROG HISTOCHEM CYTOC, V22, P1; Mudalal S, 2015, ANIMAL, V9, P728, DOI 10.1017/S175173111400295X; Mudalal S, 2014, POULTRY SCI, V93, P2108, DOI 10.3382/ps.2014-03911; Mutryn M, P 22 EUR S QUAL POUL; Mutryn MF, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1623-0; Owens C.M, 2014, WATT POULTRY US, P42; Pongratz D, 1999, J MUSCULOSKELET PAIN, V7, P93, DOI 10.1300/J094v07n01_09; Reitman ZJ, 2011, P NATL ACAD SCI USA, V108, P3270, DOI 10.1073/pnas.1019393108; Sansbury BE, 2014, CIRC-HEART FAIL, V7, P634, DOI 10.1161/CIRCHEARTFAILURE.114.001151; Schuller-Levis GB, 2004, NEUROCHEM RES, V29, P117, DOI 10.1023/B:NERE.0000010440.37629.17; Sihvo HK, 2014, VET PATHOL, V51, P619, DOI 10.1177/0300985813497488; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; STIRPE F, 1965, BIOCHEM J, V97, P561, DOI 10.1042/bj0970561; Taylor KR, 2006, FASEB J, V20, P9, DOI 10.1096/fj.05-4682rev; Velleman SG, 2015, HISTOPATHOLOGIC MYOG; Vigetti D, 2006, J BIOL CHEM, V281, P8254, DOI 10.1074/jbc.M508516200; Viola M, 2015, GLYCOCONJUGATE J, V32, P93, DOI 10.1007/s10719-015-9586-6; Wasner G, 2004, EUR J PAIN, V8, P179, DOI 10.1016/S1090-3801(03)00099-5; Wilkinson TS, 2006, J CELL PHYSIOL, V206, P378, DOI 10.1002/jcp.20468	53	140	145	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153750	10.1371/journal.pone.0153750	http://dx.doi.org/10.1371/journal.pone.0153750			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097013	Green Submitted, Green Published, gold			2022-12-26	WOS:000374543600051
J	Costello, R; Winthrop, KL; Pye, SR; Brown, B; Dixon, WG				Costello, Ruth; Winthrop, Kevin L.; Pye, Stephen R.; Brown, Benjamin; Dixon, William G.			Influenza and Pneumococcal Vaccination Uptake in Patients with Rheumatoid Arthritis Treated with Immunosuppressive Therapy in the UK: A Retrospective Cohort Study Using Data from the Clinical Practice Research Datalink	PLOS ONE			English	Article							AUDIT; INFECTION	Introduction Guidelines for the management of rheumatoid arthritis (RA) recommend using influenza and pneumococcal vaccinations to mitigate infection risk. The level of adherence to these guidelines is not well known in the UK. The aims of this study were to describe the uptake of influenza and pneumococcal vaccinations in patients with RA in the UK, to compare the characteristics of those vaccinated to those not vaccinated and to compare vaccination rates across regions of the UK. Methods A retrospective cohort study of adults diagnosed with incident RA and treated with non-biologic immunosuppressive therapy, using data from a large primary care database. For the influenza vaccination, patients were considered unvaccinated on 1st September each year and upon vaccination their status changed to vaccinated. For pneumococcal vaccination, patients were considered vaccinated after their first vaccination until the end of follow-up. Patients were stratified by age 65 at the start of follow-up, given differences in vaccination guidelines for the general population. Results Overall (N = 15,724), 80% patients received at least one influenza vaccination, and 50% patients received a pneumococcal vaccination, during follow-up (mean 5.3 years). Of those aged below 65 years (N = 9,969), 73% patients had received at least one influenza vaccination, and 43% patients received at least one pneumococcal vaccination. Of those aged over 65 years (N = 5,755), 91% patients received at least one influenza vaccination, and 61% patients had received at least one pneumococcal vaccination. Those vaccinated were older, had more comorbidity and visited the GP more often. Regional differences in vaccination rates were seen with the highest rates in Northern Ireland, and the lowest rates in London. Conclusions One in five patients received no influenza vaccinations and one in two patients received no pneumonia vaccine over five years of follow-up. There remains significant scope to improve uptake of vaccinations in patients with RA.	[Costello, Ruth; Pye, Stephen R.; Dixon, William G.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Inst Inflammat & Repair, Arthrit Res UK Ctr Epidemiol,Ctr Musculoskeletal, Manchester, Lancs, England; [Winthrop, Kevin L.] Oregon Hlth & Sci Univ, Div Infect Dis, Portland, OR 97201 USA; [Brown, Benjamin; Dixon, William G.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Hlth eRes Ctr, Manchester, Lancs, England	University of Manchester; Oregon Health & Science University; University of Manchester	Costello, R (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Inst Inflammat & Repair, Arthrit Res UK Ctr Epidemiol,Ctr Musculoskeletal, Manchester, Lancs, England.	ruth.costello@manchester.ac.uk	Dixon, William/L-8408-2019; Costello, Ruth/GWR-0357-2022; Pye, Stephen R/D-9236-2011	Dixon, William/0000-0001-5881-4857; Pye, Stephen R/0000-0002-7263-2897; Costello, Ruth/0000-0003-2709-6666	Arthritis Research UK Centre for Epidemiology [20380]; MRC [G0902272]; Wellcome Trust [104438/Z/14/Z]; MRC [MR/K006665/1] Funding Source: UKRI; Medical Research Council [MR/K006665/1, MC_PC_13042, G0902272] Funding Source: researchfish	Arthritis Research UK Centre for Epidemiology(Versus Arthritis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Arthritis Research UK Centre for Epidemiology (20380). WD was supported by an MRC clinican scientist fellowship (G0902272). BB was supported by a Wellcome Trust Research Training fellowship (104438/Z/14/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, NHS IMM STAT 2013 14; Bennett Nancy M., 2012, Morbidity and Mortality Weekly Report, V61, P816; Bridges MJ, 2003, ANN RHEUM DIS, V62, P685, DOI 10.1136/ard.62.7.685; Clarke AJ, 2011, CLIN EXP RHEUMATOL, V29, P596; Desai SP, 2011, RHEUMATOLOGY, V50, P366, DOI 10.1093/rheumatology/keq297; Doe S, 2007, RHEUMATOLOGY, V46, P715, DOI 10.1093/rheumatology/kel410; Doran MF, 2002, ARTHRITIS RHEUM, V46, P2294, DOI 10.1002/art.10529; Doran MF, 2002, ARTHRITIS RHEUM, V46, P2287, DOI 10.1002/art.10524; England : PH, 2014, INFLUENZA GREEN BOOK; England PH, 2013, PNEUMOCOCCAL GREEN B; England PH, 2014, SEASONAL FLU UPTAKE; Feuchtenberger M, 2012, RHEUMATOL INT, V32, P1533, DOI 10.1007/s00296-011-1808-z; Haroon M, 2011, JOINT BONE SPINE, V78, P374, DOI 10.1016/j.jbspin.2010.10.012; Hmamouchi I, 2015, VACCINE, V33, P1446, DOI 10.1016/j.vaccine.2015.01.065; Lanternier F, 2008, ANN RHEUM DIS, V67, P1047, DOI 10.1136/ard.2007.081703; McCarthy E M, 2011, Ir Med J, V104, P208; Moberley S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000422.pub3; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Pradeep J, 2007, ANN RHEUM DIS, V66, P837, DOI 10.1136/ard.2006.060285; Saravana S, 2004, RHEUMATOLOGY, V43, P1055, DOI 10.1093/rheumatology/keh263; Sowden E, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-58; Thomas LM, 2005, RHEUMATOLOGY, V44, P131, DOI 10.1093/rheumatology/keh452; Thomas SL, 2008, ARTHRIT RHEUM-ARTHR, V59, P1314, DOI 10.1002/art.24015; van Assen S, 2011, ANN RHEUM DIS, V70, P414, DOI 10.1136/ard.2010.137216; Williams T, 2012, THER ADV DRUG SAF, V3, P89, DOI 10.1177/2042098611435911	25	33	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153848	10.1371/journal.pone.0153848	http://dx.doi.org/10.1371/journal.pone.0153848			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096429	Green Submitted, gold, Green Published			2022-12-26	WOS:000374543600063
J	Miller, S; Masuya, H; Zhang, J; Walsh, E; Zhang, N				Miller, Stephen; Masuya, Hayato; Zhang, Jian; Walsh, Emily; Zhang, Ning			Real-Time PCR Detection of Dogwood Anthracnose Fungus in Historical Herbarium Specimens from Asia	PLOS ONE			English	Article							DISCULA-DESTRUCTIVA; POPULATION-STRUCTURE; FLOWERING DOGWOOD; NORTH-AMERICA; ENDOPHYTES; PHYLOGENY; PATTERNS; DISEASE	Cornus species (dogwoods) are popular ornamental trees and important understory plants in natural forests of northern hemisphere. Dogwood anthracnose, one of the major diseases affecting the native North American Cornus species, such as C. florida, is caused by the fungal pathogen Discula destructiva. The origin of this fungus is not known, but it is hypothesized that it was imported to North America with its host plants from Asia. In this study, a TaqMan real-time PCR assay was used to detect D. destructiva in dried herbarium and fresh Cornus samples. Several herbarium specimens fromJapan and China were detected positive for D. destructiva, some of which were collected before the first report of the dogwood anthracnose in North America. Our findings further support that D. destructiva was introduced to North America from Asia where the fungus likely does not cause severe disease.	[Miller, Stephen; Walsh, Emily; Zhang, Ning] Rutgers State Univ, Dept Plant Biol & Pathol, 201 Foran Hall,59 Dudley Rd, New Brunswick, NJ 08901 USA; [Masuya, Hayato] Tohoku Res Ctr, Forestry & Forest Prod Res Inst, 92-25 Nabeyashiki, Morioka, Iwate 0200123, Japan; [Zhang, Jian] Chinese Med Hosp Gaomi, Weifang 261500, Shandong, Peoples R China; [Zhang, Ning] Rutgers State Univ, Dept Biochem & Microbiol, 76 Lipman Dr, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Forestry & Forest Products Research Institute - Japan; Rutgers State University New Brunswick	Zhang, N (corresponding author), Rutgers State Univ, Dept Plant Biol & Pathol, 201 Foran Hall,59 Dudley Rd, New Brunswick, NJ 08901 USA.; Zhang, N (corresponding author), Rutgers State Univ, Dept Biochem & Microbiol, 76 Lipman Dr, New Brunswick, NJ 08901 USA.	zhang@aesop.rutgers.edu	Zhang, Ning/K-3046-2012; Masuya, Hayato/AAN-8998-2021	Zhang, Ning/0000-0002-2680-1354; 	Mycological Society of America; Rutgers University	Mycological Society of America; Rutgers University	This work was supported by the Clark T. Rogerson Student Research Award of the Mycological Society of America to Miller and a startup fund to Zhang from Rutgers University. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RL, 2001, 23 ANN TENN NURS SHO, P14; [Anonymous], 2004, NPS             0205; Arnold AE, 2001, MYCOL RES, V105, P1502, DOI 10.1017/S0953756201004956; Arnold AE, 2003, MYCOLOGIA, V95, P388, DOI 10.2307/3761880; BRASIER CM, 1995, CAN J BOT, V73, pS1213, DOI 10.1139/b95-381; Byther RS, 1979, ORNAMENTALS NW NEWSL, V3, P20; Caetano-Anolles G, 2001, CURR GENET, V39, P346, DOI 10.1007/s002940100223; CaetanoAnolles G, 1996, FEMS MICROBIOL LETT, V145, P377; Daughtrey ML, 1996, PLANT DIS, V80, P349, DOI 10.1094/PD-80-0349; DAUGHTREY ML, 1994, ANNU REV PHYTOPATHOL, V32, P61, DOI 10.1146/annurev.py.32.090194.000425; Davis EC, 2008, AM J BOT, V95, P914, DOI 10.3732/ajb.2006463; FARR DF, 1991, MYCOLOGIA, V83, P611, DOI 10.2307/3760216; Guo LD, 2001, MOL PHYLOGENET EVOL, V20, P1, DOI 10.1006/mpev.2001.0942; Lacap DC, 2003, FUNGAL DIVERS, V12, P53; Lay DW, 1961, P 15 ANN M SE GAM FI, P30; Pirone PP, 1980, NY TIMES, V24, P34; Pirone PP, 1980, NY TIMES NEW YO 0224, P37; REDLIN SC, 1991, MYCOLOGIA, V83, P633, DOI 10.2307/3760218; Rossell IM, 2001, AM MIDL NAT, V146, P379, DOI 10.1674/0003-0031(2001)146[0379:IODADD]2.0.CO;2; Schneeberger NF, 1989, PLANT DIAGNOSTICIANS, V10, P30; Schulz B, 2005, MYCOL RES, V109, P661, DOI 10.1017/S095375620500273X; Sherald JL, 1996, PLANT DIS, V80, P310, DOI 10.1094/PD-80-0310; Stinzing A, 2003, NACHRICHTENBL DEUT P, V55, pS1; Tantardini A, 2004, INFORM FITOPATOLOGIC, V12, P44; THOMAS WA, 1969, ECOL MONOGR, V39, P101, DOI 10.2307/1950739; Toofanee SB, 2002, FUNGAL DIVERS, V11, P169; TRIGIANO RN, 1995, MYCOLOGIA, V87, P490, DOI 10.2307/3760766; USDA, 2009, 2007 CENS AGR; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Xiang QYJ, 2006, TAXON, V55, P9, DOI 10.2307/25065525; Zhang N, 2002, PHYTOPATHOLOGY, V92, P1276, DOI 10.1094/PHYTO.2002.92.12.1276; Zhang N, 2001, MYCOLOGIA, V93, P355, DOI 10.2307/3761657; Zhang N, 2011, EUR J PLANT PATHOL, V130, P551, DOI 10.1007/s10658-011-9777-3	33	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0154030	10.1371/journal.pone.0154030	http://dx.doi.org/10.1371/journal.pone.0154030			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096929	gold, Green Published			2022-12-26	WOS:000374543600082
J	Cheung, MY; Almukhtar, A; Keeling, A; Hsung, TC; Ju, XY; McDonald, J; Ayoub, A; Khambay, BS				Cheung, Man Yan; Almukhtar, Anas; Keeling, Andrew; Hsung, Tai-Chiu; Ju, Xiangyang; McDonald, James; Ayoub, Ashraf; Khambay, Balvinder Singh			The Accuracy of Conformation of a Generic Surface Mesh for the Analysis of Facial Soft Tissue Changes	PLOS ONE			English	Article								Purpose Three dimensional analysis of the face is required for the assessment of complex changes following surgery, pathological conditions and to monitor facial growth. The most suitable method may be "dense surface correspondence". Materials and Methods This method utilizes a generic facial mesh and " conformation process" to establish anatomical correspondences between two facial images. The aim of this study was to validate the use of conformed meshes to measure simulated maxillary and mandibular surgical movements. The " simulation" was performed by deforming the actual soft tissues of the participant during image acquisition. The study was conducted on 20 volunteers and used 77 facial landmarks pre-marked over six anatomical regions; left cheek, right cheek, left upper lip, philtrum, right upper lip and chin region. Each volunteer was imaged at rest and after performing 5 different simulated surgical procedures using 3D stereophotogrammetry. The simulated surgical movement was determined by measuring the Euclidean distances and the mean absolute x, y and z distances of the landmarks making up the six regions following digitization. A generic mesh was then conformed to each of the aligned six facial 3D images. The same six regions were selected on the aligned conformed simulated meshes and the surgical movement determined by determining the Euclidean distances and the mean absolute x, y and z distances of the mesh points making up the six regions were determined. Results In all cases the mean Euclidian distance between the simulated movement and conformed region was less than 0.7mm. For the x, y and z directions the majority of differences in the mean absolute distances were less than 1.0mm except in the x-direction for the left and right cheek regions, which was above 2.0mm. Conclusions This concludes that the conformation process has an acceptable level of accuracy and is a valid method of measuring facial change between two images i.e. pre- and post-surgery. The conformation accuracy is higher toward the center of the face than the peripheral regions.	[Cheung, Man Yan; Hsung, Tai-Chiu; Khambay, Balvinder Singh] Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China; [Keeling, Andrew; Khambay, Balvinder Singh] Univ Leeds, Sch Dent, Leeds, W Yorkshire, England; [Almukhtar, Anas; Ju, Xiangyang; McDonald, James; Ayoub, Ashraf] Univ Glasgow, Glasgow Dent Sch, Glasgow, Lanark, Scotland	University of Hong Kong; University of Leeds; University of Glasgow	Khambay, BS (corresponding author), Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China.; Khambay, BS (corresponding author), Univ Leeds, Sch Dent, Leeds, W Yorkshire, England.	b.s.khambay@leeds.ac.uk	Keeling, Andrew/N-7794-2019; Almukhtar, Anas/G-4217-2019	Keeling, Andrew/0000-0003-4598-3744; Ju, Xiangyang/0000-0003-3471-7256; Hsung, Tai-Chiu/0000-0001-7699-1937; Ayoub, Ashraf/0000-0002-2760-6008; Almukhtar, Anas/0000-0003-3696-6424				Almukhtar A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131540; Aynechi N, 2011, ANGLE ORTHOD, V81, P245, DOI 10.2319/041810-210.1; Baik HS, 2007, AM J ORTHOD DENTOFAC, V131, P759, DOI 10.1016/j.ajodo.2005.08.038; Baik HS, 2010, AM J ORTHOD DENTOFAC, V138, P167, DOI 10.1016/j.ajodo.2010.02.022; Bozic M, 2009, ANGLE ORTHOD, V79, P640, DOI 10.2319/081608-432.1; Claes P, 2012, INT J ORAL MAX SURG, V41, P324, DOI 10.1016/j.ijom.2011.10.019; Heymann GC, 2010, AM J ORTHOD DENTOFAC, V137, P274, DOI 10.1016/j.ajodo.2009.07.009; Kau CH, 2010, AM J ORTHOD DENTOFAC, V137, DOI [10.1016/j.ajodo.2009.04.022, 10.1016/j.ajodo.2010.01.022]; Luximon Y, 2010, P TMCE APR 12 16 AN, P1; Mao ZL, 2006, PATTERN RECOGN LETT, V27, P597, DOI 10.1016/j.patrec.2005.09.025; Miller L, 2007, EUR J ORTHODONT, V29, P14, DOI 10.1093/ejo/cjl037; Toma AM, 2008, ORTHOD CRANIOFAC RES, V11, P180, DOI 10.1111/j.1601-6343.2008.00428.x; Ullah R, 2015, BRIT J ORAL MAX SURG, V53, P153, DOI 10.1016/j.bjoms.2014.11.001; Verze L, 2012, J CRANIOFAC SURG, V23, P1448, DOI 10.1097/SCS.0b013e31824e25fc	14	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0152381	10.1371/journal.pone.0152381	http://dx.doi.org/10.1371/journal.pone.0152381			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093637	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000374541200005
J	Klein, H; Abu-Arish, A; Trinh, NTN; Luo, YS; Wiseman, PW; Hanrahan, JW; Brochiero, E; Sauve, R				Klein, Helene; Abu-Arish, Asmahan; Nguyen Thu Ngan Trinh; Luo, Yishan; Wiseman, Paul W.; Hanrahan, John W.; Brochiero, Emmanuelle; Sauve, Remy			Investigating CFTR and KCa3.1 Protein/Protein Interactions	PLOS ONE			English	Article							IMAGE CORRELATION SPECTROSCOPY; ACTIVATED PROTEIN-KINASE; CYSTIC-FIBROSIS; PLASMA-MEMBRANE; K+ CHANNELS; CHLORIDE SECRETION; AIRWAY; CONDUCTANCE; INHIBITION; IDENTIFICATION	In epithelia, Cl-channels play a prominent role in fluid and electrolyte transport. Of particular importance is the cAMP-dependent cystic fibrosis transmembrane conductance regulator Cl-channel (CFTR) with mutations of the CFTR encoding gene causing cystic fibrosis. The bulk transepithelial transport of Cl-ions and electrolytes needs however to be coupled to an increase in K+ conductance in order to recycle K+ and maintain an electrical driving force for anion exit across the apical membrane. In several epithelia, this r efflux is ensured by K+ channels, including KCa3.1, which is expressed at both the apical and basolateral membranes. We show here for the first time that CFTR and KCa3.1 can physically interact. We first performed a two -hybrid screen to identify which KCa3.1 cytosolic domains might mediate an interaction with CFTR. Our results showed that both the N-terminal fragment M1-M40 of KCa3.1 and part of the KCa3.1 calmodulin binding domain (residues L345-A400) interact with the NBD2 segment (G1237-Y1420) and C-region of CFTR (residues T1387 L1480), respectively. An association of CFTR and F508de1-CFTR with KCa3.1 was further confirmed in co-immunoprecipitation experiments demonstrating the formation of immunoprecipitable CFTR/KCa3.1 complexes in CFBE cells. Co-expression of KCa3.1 and CFTR in HEK cells did not impact CFTR expression at the cell surface, and KCa3.1 trafficking appeared independent of CFTR stimulation. Finally, evidence is presented through cross correlation spectroscopy measurements that KCa3.1 and CFTR colocalize at the plasma membrane and that KCa3.1 channels tend to aggregate consequent to an enhanced interaction with CFTR channels at the plasma membrane following an increase in intracellular Ca2+ concentration. Altogether, these results suggest 1) that the physical interaction KCa3.1/CFTR can occur early during the biogenesis of both proteins and 2) that KCa3.1 and CFTR form a dynamic complex, the formation of which depends on internal Ca2+.	[Klein, Helene; Sauve, Remy] Univ Montreal, Dept Physiol Mol & Integrat, Montreal, PQ H3C 3J7, Canada; [Klein, Helene; Sauve, Remy] Univ Montreal, Membrane Prot Res Grp, Montreal, PQ H3C 3J7, Canada; [Abu-Arish, Asmahan; Luo, Yishan; Hanrahan, John W.] McGill Univ, Dept Physiol, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada; [Nguyen Thu Ngan Trinh; Brochiero, Emmanuelle] CRCHUM, 900 Rue St Denis, Montreal, PQ H2X 0A9, Canada; [Nguyen Thu Ngan Trinh; Brochiero, Emmanuelle] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Wiseman, Paul W.] McGill Univ, Chem & Phys, Montreal, PQ H3G 1Y6, Canada	Universite de Montreal; Universite de Montreal; McGill University; Universite de Montreal; Universite de Montreal; McGill University	Sauve, R (corresponding author), Univ Montreal, Dept Physiol Mol & Integrat, Montreal, PQ H3C 3J7, Canada.; Sauve, R (corresponding author), Univ Montreal, Membrane Prot Res Grp, Montreal, PQ H3C 3J7, Canada.	remy.sauve@umontreal.ca	Hanrahan, John/AGG-1926-2022	Hanrahan, John/0000-0001-9080-2039	Cystic Fibrosis Canada; Natural Science and Engineering Research Council; Canadian Institutes of Health Research; Groupe d'Etude des Proteines Membranaires (Universite de Montreal); Natural Sciences and Engineering Research Council	Cystic Fibrosis Canada; Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Groupe d'Etude des Proteines Membranaires (Universite de Montreal); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grants from the Cystic Fibrosis Canada (R.S. and E.B.), the Natural Science and Engineering Research Council (P.W.W.), the Canadian Institutes of Health Research (J.W.H.), and by a Projet novateur grant from the Groupe d'Etude des Proteines Membranaires (Universite de Montreal). A.A-A. was supported by postdoctoral fellowships from Cystic Fibrosis Canada and the Natural Sciences and Engineering Research Council. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Arish A, 2015, BIOPHYS J, V109, P85, DOI 10.1016/j.bpj.2015.04.042; Balghi H, 2011, FASEB J, V25, P4274, DOI 10.1096/fj.11-187682; Bardou O, 2009, AM J PHYSIOL-LUNG C, V296, pL145, DOI 10.1152/ajplung.90525.2008; Bates IR, 2006, BIOPHYS J, V91, P1046, DOI 10.1529/biophysj.106.084830; Bernard K, 2003, J MEMBRANE BIOL, V196, P15, DOI 10.1007/s00232-003-0621-3; BOUCHER RC, 1994, AM J RESP CRIT CARE, V150, P581, DOI 10.1164/ajrccm.150.2.8049852; BOUCHER RC, 1994, AM J RESP CRIT CARE, V150, P271, DOI 10.1164/ajrccm.150.1.8025763; Cahill P, 2000, J BIOL CHEM, V275, P16697, DOI 10.1074/jbc.M910205199; COOK DI, 1989, J MEMBRANE BIOL, V110, P139, DOI 10.1007/BF01869469; Devor DC, 1996, AM J PHYSIOL-LUNG C, V271, pL775, DOI 10.1152/ajplung.1996.271.5.L775; Duffy SM, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0112-z; Frizzell RA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009563; Girault A, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0263-x; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Hallows KR, 2003, J BIOL CHEM, V278, P998, DOI 10.1074/jbc.M210621200; Hebert B, 2005, BIOPHYS J, V88, P3601, DOI 10.1529/biophysj.104.054874; Hollenhorst MI, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/174306; Klein H, 2009, AM J PHYSIOL-CELL PH, V296, pC285, DOI 10.1152/ajpcell.00418.2008; Ko SBH, 2004, NAT CELL BIOL, V6, P343, DOI 10.1038/ncb1115; Kolin DL, 2007, CELL BIOCHEM BIOPHYS, V49, P141, DOI 10.1007/s12013-007-9000-5; KUNZELMANN K, 1993, AM J RESP CELL MOL, V8, P522, DOI 10.1165/ajrcmb/8.5.522; Lee RJ, 2010, J CLIN INVEST, V120, P3137, DOI 10.1172/JCI42992; Luo Y, 2009, BIOCHEM J, V419, P211, DOI 10.1042/BJ20081869; McNicholas CM, 1996, P NATL ACAD SCI USA, V93, P8083, DOI 10.1073/pnas.93.15.8083; Morales P, 2013, J GEN PHYSIOL, V142, P37, DOI 10.1085/jgp.201210933; Moser SL, 2008, J MEMBRANE BIOL, V221, P153, DOI 10.1007/s00232-008-9093-9; Nguyen TNT, 2012, EUR RESPIR J, V40, P1390, DOI 10.1183/09031936.00221711; Ousingsawat J, 2009, J BIOL CHEM, V284, P28698, DOI 10.1074/jbc.M109.012120; Pilewski Joseph M., 1999, Physiological Reviews, V79, pS215; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rock JR, 2009, J BIOL CHEM, V284, P14875, DOI 10.1074/jbc.C109.000869; Roth EK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024445; Singh S, 2001, J PHARMACOL EXP THER, V296, P600; Sorensen JB, 2001, PFLUG ARCH EUR J PHY, V442, P1, DOI 10.1007/s004240000493; Thompson J, 2009, CHANNELS, V3, P194, DOI 10.4161/chan.3.3.9043; Treharne KJ, 2009, CELL PHYSIOL BIOCHEM, V24, P347, DOI 10.1159/000257427; Wang J, 2013, AM J PHYSIOL-CELL PH, V304, pC673, DOI 10.1152/ajpcell.00196.2012; Wu XY, 2000, MOL THER, V2, P47, DOI 10.1006/mthe.2000.0095	38	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153665	10.1371/journal.pone.0153665	http://dx.doi.org/10.1371/journal.pone.0153665			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27092946	gold, Green Published, Green Submitted			2022-12-26	WOS:000374541200038
J	Prakash, S; Kuang, SQ; Regalado, E; Guo, DC; Milewicz, D				Prakash, Siddharth; Kuang, Shao-Qing; Regalado, Ellen; Guo, Dongchuan; Milewicz, Dianna		GenTAC Registry Investigators	Recurrent Rare Genomic Copy Number Variants and Bicuspid Aortic Valve Are Enriched in Early Onset Thoracic Aortic Aneurysms and Dissections	PLOS ONE			English	Article							GENETIC-BASIS; COARCTATION; RESOLUTION; PHENOTYPE; COMMUNITY; REGISTRY; MODEL; SNP	Thoracic Aortic Aneurysms and Dissections (TAAD) are a major cause of death in the United States. The spectrum of TAAD ranges from genetic disorders, such as Marfan syndrome, to sporadic isolated disease of unknown cause. We hypothesized that genomic copy number variants (CNVs) contribute causally to early onset TAAD (ETAAD). We conducted a genome-wide SNP array analysis of ETAAD patients of European descent who were enrolled in the National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC). Genotyping was performed on the Illumina Omni -Express platform, using PennCNV, Nexus and CNVPartition for CNV detection. ETAAD patients (n = 108, 100% European American, 28% female, average age 20 years, 55% with bicuspid aortic valves) were compared to 7013 dbGAP controls without a history of vascular disease using downsampled Omni 2.5 data. For comparison, 805 sporadic TAAD patients with late onset aortic disease (STAAD cohort) and 192 affected probands from families with at least two affected relatives (FTAAD cohort) from our institution were screened for additional CNVs at these loci with SNP arrays. We identified 47 recurrent CNV regions in the ETAAD, FTAAD and STAAD groups that were absent or extremely rare in controls. Nine rare CNVs that were either very large (>1 Mb) or shared by ETAAD and STAAD or FTAAD patients were also identified. Four rare CNVs involved genes that cause arterial aneurysms when mutated. The largest and most prevalent of the recurrent CNVs were at Xq28 (two duplications and two deletions) and 17q25.1 (three duplications). The percentage of individuals harboring rare CNVs was significantly greater in the ETAAD cohort (32%) than in the FTAAD (23%) or STAAD (17%) cohorts. We identified multiple loci affected by rare CNVs in one-third of ETAAD patients, confirming the genetic heterogeneity of TAAD. Alterations of candidate genes at these loci may contribute to the pathogenesis of TAAD.	[Prakash, Siddharth; Kuang, Shao-Qing; Regalado, Ellen; Guo, Dongchuan; Milewicz, Dianna; GenTAC Registry Investigators] Univ Texas Hlth Sci Ctr Houston, Div Med Genet, Dept Internal Med, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Prakash, S (corresponding author), Univ Texas Hlth Sci Ctr Houston, Div Med Genet, Dept Internal Med, Houston, TX 77030 USA.	Siddharth.K.Prakash@uth.tmc.edu	Asch, Federico/AAS-7653-2021	Asch, Federico/0000-0002-1744-5271; Regalado, Ellen/0000-0002-5859-218X; Morris, Shaine/0000-0002-8056-0934	US Federal Government from the National Heart Lung and Blood Institute [HHSN268200648199C, HHSN268201000048C]; National Institute of Arthritis and Musculoskeletal and Skin Diseases (Bethesda, MD); National Institute on Aging [U01AG009740, RC2AG036495, RC4AG039029]; National Eye Institute; National Institutes of Health [HHSN268200782096C]; Collaborative Genetic Study of Nicotine Dependence (COGEND) [P01 CA089392]; University of Wisconsin Transdisciplinary Tobacco Use Research Center [P50 DA019706, P50 CA084724];  [1U54HD083092];  [5R01HD039056];  [5R01HL090506];  [5R01HL091771];  [5R01HL109758];  [R01EY016514];  [R01EY016482];  [1X01HG006619-01];  [1 X01HG005274-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083092] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039056] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA089392, P50CA084724] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000370, UL1TR000371] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY016482, R01EY016514] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109758, R01HL091771, R01HL109942, P50HL083794] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC2AG036495, U01AG009740, RC4AG039029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA019706] Funding Source: NIH RePORTER	US Federal Government from the National Heart Lung and Blood Institute; National Institute of Arthritis and Musculoskeletal and Skin Diseases (Bethesda, MD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Collaborative Genetic Study of Nicotine Dependence (COGEND); University of Wisconsin Transdisciplinary Tobacco Use Research Center; ; ; ; ; ; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	John W. Belmont was supported by 1U54HD083092, 5R01HD039056, 5R01HL090506 and 5R01HL091771. Kim McBride was supported by 5R01HL109758. The GenTAC Registry has been supported by US Federal Government contracts HHSN268200648199C and HHSN268201000048C from the National Heart Lung and Blood Institute and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (Bethesda, MD). FECD was primarily supported by grants R01EY016514 (DUEC, PI: Gordon Klintworth), R01EY016482 (CWRU, PI: Sudha Iyengar) and 1X01HG006619-01 (PI: Sudha Iyengar, Natalie Afshar). The HRS genetic data was sponsored by the National Institute on Aging (grants U01AG009740, RC2AG036495 and RC4AG039029) and was conducted by the University of Michigan. Funding support for NEIREC was provided by the National Eye Institute. Genotyping for the Genetic Architecture of Smoking and Smoking Cessation Study, which was performed at the Center for Inherited Disease Research (CIDR), was funded by 1 X01HG005274-01. CIDR is fully funded through a federal contract from the National Institutes of Health to The Johns Hopkins University, contract number HHSN268200782096C. Assistance with genotype cleaning, as well as with general study coordination for the Genetic Architecture of Smoking and Smoking Cessation Study was provided by the Gene Environment Association Studies (GENEVA) Coordinating Center (U01 HG004446). Funding support for collection of the Genetic Architecture of Smoking and Smoking Cessation Study datasets and samples was provided by the Collaborative Genetic Study of Nicotine Dependence (COGEND; P01 CA089392) and the University of Wisconsin Transdisciplinary Tobacco Use Research Center (P50 DA019706, P50 CA084724).	Beaton AZ, 2009, AM J CARDIOL, V103, P266, DOI 10.1016/j.amjcard.2008.09.062; Brandler WM, 2015, ANNU REV MED, V66, P487, DOI 10.1146/annurev-med-091113-024550; Carlson M, 2012, CIRCULATION, V126, P2220, DOI 10.1161/CIRCULATIONAHA.111.088633; Chen J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-392; Costain G, 2013, HUM MOL GENET, V22, P4485, DOI 10.1093/hmg/ddt297; Dykes IM, 2014, CIRC RES, V115, P23, DOI 10.1161/CIRCRESAHA.115.303300; Elefteriades John A., 2008, Yale Journal of Biology and Medicine, V81, P175; Frieden LA, 2010, DEV DYNAM, V239, P3226, DOI 10.1002/dvdy.22458; GILLUM RF, 1995, J CLIN EPIDEMIOL, V48, P1289, DOI 10.1016/0895-4356(95)00045-3; Heegaard AM, 2007, CIRCULATION, V115, P2731, DOI 10.1161/CIRCULATIONAHA.106.653980; Hoebeeck J, 2005, LAB INVEST, V85, P24, DOI 10.1038/labinvest.3700209; Hooli BV, 2014, MOL PSYCHIATR, V19, P676, DOI 10.1038/mp.2013.77; Januzzi JL, 2004, J AM COLL CARDIOL, V43, P665, DOI 10.1016/j.jacc.2003.08.054; Jurecka A, 2013, AM J MED GENET A, V161A, P1291, DOI 10.1002/ajmg.a.35905; Kameda Y, 2009, CELL TISSUE RES, V336, P165, DOI 10.1007/s00441-009-0760-7; McBride KL, 2011, BIRTH DEFECTS RES A, V91, P162, DOI 10.1002/bdra.20764; McBride KL, 2009, EUR J HUM GENET, V17, P811, DOI 10.1038/ejhg.2008.255; Michelena HI, 2008, CIRCULATION, V117, P2776, DOI 10.1161/CIRCULATIONAHA.107.740878; Milewicz DM, 2008, ANNU REV GENOM HUM G, V9, P283, DOI 10.1146/annurev.genom.8.080706.092303; Milewicz DM, 1998, AM J CARDIOL, V82, P474, DOI 10.1016/S0002-9149(98)00364-6; Prakash SK, 2014, J AM COLL CARDIOL, V64, P832, DOI 10.1016/j.jacc.2014.04.073; Prakash SK, 2010, AM J HUM GENET, V87, P743, DOI 10.1016/j.ajhg.2010.09.015; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raychaudhuri S, 2010, PLOS GENET, V6; Schaefer BM, 2008, HEART, V94, P1634, DOI 10.1136/hrt.2007.132092; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Singh R, 2007, FRONT BIOSCI-LANDMRK, V12, P4504, DOI 10.2741/2405; Tadros TM, 2009, CIRCULATION, V119, P880, DOI 10.1161/CIRCULATIONAHA.108.795401; Tomatsu S, 2008, HUM MOL GENET, V17, P815, DOI 10.1093/hmg/ddm353; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Weaver S, 2010, METHODS, V50, P271, DOI 10.1016/j.ymeth.2010.01.003; Wheeler E, 2013, NAT GENET, V45, P513, DOI 10.1038/ng.2607	32	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153543	10.1371/journal.pone.0153543	http://dx.doi.org/10.1371/journal.pone.0153543			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27092555	gold, Green Published, Green Submitted			2022-12-26	WOS:000374541200026
J	Ren, JW; Chen, GG; Liu, Y; Su, XW; Hu, BG; Leung, BCS; Wang, Y; Ho, RLK; Yang, SL; Lu, G; Lee, CG; Lai, PBS				Ren, Jianwai; Chen, George G.; Liu, Yi; Su, Xianwei; Hu, Baoguang; Leung, Billy C. S.; Wang, Y.; Ho, Rocky L. K.; Yang, Shengli; Lu, Gang; Lee, C. G.; Lai, Paul B. S.			Cytochrome P450 1A2 Metabolizes 17 beta-Estradiol to Suppress Hepatocellular Carcinoma	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; HISTONE DEACETYLASES; GENDER DISPARITY; CANCER CELLS; GROWTH; 2-METHOXYESTRADIOL; EXPRESSION; APOPTOSIS; ACTIVATION; PROLIFERATION	Hepatocellular carcinoma (HCC) occurs more frequently in men than in women. It is commonly agreed that estrogen plays important roles in suppressing HCC development, however, the underlying mechanism remains largely unknown. Since estrogen is mainly metabolized in liver and its metabolites affect cell proliferation, we sought to investigate if the liver-specific cytochrome P450 1A2 (CYP1A2) mediated the inhibitory effect of estrogen on HCC. In this study, the expression of estrogen-metabolizing enzyme CYP1A2 was determined in HCC tissues and cell lines. Cell proliferation and apoptosis were assessed in cells with or without CYP1A2 overexpression. The levels of 17 beta-estradiol (E2) and its metabolite 2-methoxyestradiol (2-ME) were determined. A xenograft tumor model in mice was established to confirm the findings. It was found that CYP1A2 expression was greatly repressed in HCC. E2 suppressed HCC cell proliferation and xenograft tumor development by inducing apoptosis. The inhibitory effect was significantly enhanced in cells with CYP1A2 overexpression, which effectively conversed E2 to the cytotoxic 2-ME. E2 in combination with sorafenib showed an additive effect on HCC. The anti-HCC effect of E2 was not associated with estrogen receptors ER alpha and ER beta as well as tumor suppressor P53 but enhanced by the approved anti-HCC drug sorafenib. In addition, HDAC inhibitors greatly induced CYP1A2 promoter activities in cancer cells, especially liver cancer cells, but not in non-tumorigenic cells. Collectively, CYP1A2 metabolizes E2 to generate the potent anti-tumor agent 2-ME in HCC. The reduction of CYP1A2 significantly disrupts this metabolic pathway, contributing the progression and growth of HCC and the gender disparity of this malignancy.	[Ren, Jianwai; Chen, George G.; Liu, Yi; Su, Xianwei; Hu, Baoguang; Leung, Billy C. S.; Ho, Rocky L. K.; Yang, Shengli; Lu, Gang; Lai, Paul B. S.] Chinese Univ Hong Kong, Fac Med, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Ren, Jianwai; Chen, George G.] CUHK Shenzhen Res Inst SZRI, Shenzhen 518057, Peoples R China; [Liu, Yi] Guangdong Med Univ, Guangdong Key Lab Res & Dev Nat Drugs, Zhanjiang, Guangdong, Peoples R China; [Wang, Y.; Lee, C. G.] Natl Canc Ctr, Div Med Sci, Singapore, Singapore	Chinese University of Hong Kong; Guangdong Medical University; National Cancer Centre Singapore (NCCS)	Chen, GG (corresponding author), Chinese Univ Hong Kong, Fac Med, Dept Surg, Hong Kong, Hong Kong, Peoples R China.; Chen, GG (corresponding author), CUHK Shenzhen Res Inst SZRI, Shenzhen 518057, Peoples R China.	gchen@cuhk.edu.hk; paulai@cuhk.edu.hk	Lai, Paul BS/K-8556-2015; Chen, George Gong/I-2757-2016; Lee, Caroline G/M-8918-2019	Lai, Paul BS/0000-0002-9469-6728; Lee, Caroline G/0000-0002-4323-3635; Hu, Baoguang/0000-0002-6065-7720	Shenzhen SZSIA foundation [JCYJ20140425184428469]; Chinese University of Hong Kong [4054222]	Shenzhen SZSIA foundation; Chinese University of Hong Kong(Chinese University of Hong Kong)	This work was supported by Shenzhen SZSIA foundation under grant No. JCYJ20140425184428469, and a direct grant ( Ref No 4054222) from the Chinese University of Hong Kong.	Balasubramanian S, 2008, LEUKEMIA, V22, P1026, DOI 10.1038/leu.2008.9; BARBIERI RL, 1978, STEROIDS, V32, P529, DOI 10.1016/0039-128X(78)90064-8; BATRA S, 1980, BIOL REPROD, V22, P430, DOI 10.1095/biolreprod22.3.430; Bertani S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067756; Bigsby RM, 2011, CARCINOGENESIS, V32, P1162, DOI 10.1093/carcin/bgr094; Boniol M, 2010, EUR J CANCER, V46, P2534, DOI 10.1016/j.ejca.2010.07.049; Chan QKY, 2010, CELL DEATH DIFFER, V17, P1511, DOI 10.1038/cdd.2010.20; Chang I, 2012, CARCINOGENESIS, V33, P420, DOI 10.1093/carcin/bgr294; Chen H, 2014, WORLD J GASTROENTERO, V20, P8681, DOI 10.3748/wjg.v20.i26.8681; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Ding QM, 2009, AM J PHYSIOL-CELL PH, V297, pC1178, DOI 10.1152/ajpcell.00185.2009; Du B, 2011, TUMORI J, V97, P660, DOI 10.1700/989.10728; El Naga RNA, 2009, PHARMACOLOGY, V84, P9, DOI 10.1159/000221062; ElSaadany S, 2002, CAN J PUBLIC HEALTH, V93, P443, DOI 10.1007/BF03405035; Folkerd EJ, 2014, J CLIN ONCOL, V32, P1396, DOI 10.1200/JCO.2013.53.9411; Galmiche A, 2014, CANCER LETT, V346, P159, DOI 10.1016/j.canlet.2013.12.028; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Huang EJ, 2006, MOL CELL BIOCHEM, V290, P1, DOI 10.1007/s11010-005-9000-y; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kar S, 2008, CANCER CHEMOTH PHARM, V62, P831, DOI 10.1007/s00280-007-0670-x; LaVallee TM, 2002, CANCER RES, V62, P3691; Lee CGL, 2003, ONCOGENE, V22, P2592, DOI 10.1038/sj.onc.1206337; Li Z, 2012, CELL, V148, P72, DOI 10.1016/j.cell.2011.11.026; Lin YM, 2013, ONCOL REP, V30, P3027, DOI 10.3892/or.2013.2793; Liu Jun, 2004, Hepatobiliary Pancreat Dis Int, V3, P110; Miceli V, 2011, OMICS, V15, P313, DOI 10.1089/omi.2010.0108; Moser C, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-206; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Park SJ, 2006, CANCER GENET CYTOGEN, V166, P56, DOI 10.1016/j.cancergencyto.2005.08.022; Renaud HJ, 2011, TOXICOL SCI, V124, P261, DOI 10.1093/toxsci/kfr240; Ruggieri A, 2010, INT J CANCER, V127, P499, DOI 10.1002/ijc.25298; Seli E, 2006, J CLIN ENDOCR METAB, V91, P4995, DOI 10.1210/jc.2006-1225; Shi L, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-93; Shimizu I, 2007, WORLD J GASTROENTERO, V13, P4295, DOI 10.3748/wjg.v13.i32.4295; Verenich S, 2010, MOL PHARMACEUT, V7, P2030, DOI 10.1021/mp100190f; Wang CJ, 2014, MOL MED REP, V10, P3125, DOI 10.3892/mmr.2014.2595; Wang SH, 2012, GASTROENTEROLOGY, V142, P989, DOI 10.1053/j.gastro.2011.12.045; Wang YC, 2011, HEPATO-GASTROENTEROL, V58, P2032, DOI 10.5754/hge10685; Wang YC, 2012, INFLAMMATION, V35, P143, DOI 10.1007/s10753-011-9299-3; Wardell SE, 2011, BIOCHEM PHARMACOL, V82, P122, DOI 10.1016/j.bcp.2011.03.031; Wu MH, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001143; Xu HW, 2012, J PATHOL, V228, P216, DOI 10.1002/path.4009; Yang WW, 2012, J BIOL CHEM, V287, P40140, DOI 10.1074/jbc.M112.348763; Yeh SH, 2010, ONCOLOGY-BASEL, V78, P172, DOI 10.1159/000315247; Zhou SF, 2009, AAPS J, V11, P481, DOI 10.1208/s12248-009-9127-y; Zhu BT, 2005, STEROIDS, V70, P225, DOI 10.1016/j.steroids.2005.01.002; Zhu BT, 1998, CARCINOGENESIS, V19, P1, DOI 10.1093/carcin/19.1.1; Zoller AL, 2006, J IMMUNOL, V176, P7371, DOI 10.4049/jimmunol.176.12.7371	50	28	31	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153863	10.1371/journal.pone.0153863	http://dx.doi.org/10.1371/journal.pone.0153863			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093553	Green Submitted, Green Published, gold			2022-12-26	WOS:000374541200053
J	Tran, TB; Baek, C; Min, J				Trong Binh Tran; Baek, Changyoon; Min, Junhong			Electric Cell-Substrate Impedance Sensing (ECIS) with Microelectrode Arrays for Investigation of Cancer Cell - Fibroblasts Interaction	PLOS ONE			English	Article							TUMOR MICROENVIRONMENT; PROLIFERATION; DIFFERENTIATION; CYTOTOXICITY; INHIBITION; ATTACHMENT	The tumor microenvironment, including stromal cells, surrounding blood vessels and extracellular matrix components, has been defined as a crucial factor that influences the proliferation, drug-resistance, invasion and metastasis of malignant epithelial cells. Among other factors, the communications and interaction between cancer cells and stromal cells have been reported to play pivotal roles in cancer promotion and progression. To investigate these relationships, an on-chip co-culture model was developed to study the cellular interaction between A549-human lung carcinoma cells and MRC-5-human lung epithelial cells in both normal proliferation and treatment conditions. In brief, a co-culture device consisting of 2 individual fluidic chambers in parallel, which were separated by a 100 mu m fence was utilized for cell patterning. Microelectrodes arrays were installed within each chamber including electrodes at various distances away from the confrontation line for the electrochemical impedimetric sensing assessment of cell-to-cell influence. After the fence was removed and cell-to-cell contact occurred, by evaluating the impedance signal responses representing cell condition and behavior, both direct and indirect cell-to-cell interactions through conditioned media were investigated. The impact of specific distances that lead to different influences of fibroblast cells on cancer cells in the co-culture environment was also defined.	[Trong Binh Tran; Baek, Changyoon; Min, Junhong] Chung Ang Univ, Sch Integrat Engn, Seoul 156756, South Korea	Chung Ang University	Min, J (corresponding author), Chung Ang Univ, Sch Integrat Engn, Seoul 156756, South Korea.	junmin@cau.ac.kr			BioNano Health-Guard Research Center; Ministry of Science, ICT & Future Planning (MSIP) of Korea as Global Frontier Project [H-GUARD 2015M3A6B2063548]; NanoMaterial Technology Development Program through the National Research Foundation of Korea (NRF); Korea government (MSIP) [NRF-2014M3A7B4051907]	BioNano Health-Guard Research Center; Ministry of Science, ICT & Future Planning (MSIP) of Korea as Global Frontier Project; NanoMaterial Technology Development Program through the National Research Foundation of Korea (NRF); Korea government (MSIP)	This research was supported by the BioNano Health-Guard Research Center, funded by the Ministry of Science, ICT & Future Planning (MSIP) of Korea as Global Frontier Project (H-GUARD 2015M3A6B2063548) and was supported by the NanoMaterial Technology Development Program through the National Research Foundation of Korea (NRF), funded by the Korea government (MSIP) (NRF-2014M3A7B4051907).	Albini A, 2007, NAT REV CANCER, V7, P139, DOI 10.1038/nrc2067; Alexeyenko A, 2015, J EXP CLIN CANC RES, V18, P34; Alkasalias T, 2014, P NATL ACAD SCI USA, V111, P17188, DOI 10.1073/pnas.1419554111; Campbell CE, 2007, BIOSENS BIOELECTRON, V23, P536, DOI 10.1016/j.bios.2007.06.015; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Flaberg E, 2012, INT J CANCER, V131, P2274, DOI 10.1002/ijc.27521; Flaberg E, 2011, INT J CANCER, V128, P2793, DOI 10.1002/ijc.25612; Fukumura D, 2007, MICROVASC RES, V74, P72, DOI 10.1016/j.mvr.2007.05.003; Hadjout N, 2001, BIOTECHNIQUES, V31, P1130, DOI 10.2144/01315rr02; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Iacopino F, 2012, ANTICANCER RES, V32, P1579; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Lorusso G, 2008, HISTOCHEM CELL BIOL, V130, P1091, DOI 10.1007/s00418-008-0530-8; Mishra DK, 2015, ANN THORAC SURG, V100, P1167, DOI 10.1016/j.athoracsur.2015.05.014; MITRA P, 1991, BIOTECHNIQUES, V11, P504; Pillai GR, 2004, CANCER LETT, V208, P163, DOI 10.1016/j.canlet.2004.01.008; Raof NA, 2011, BIOMATERIALS, V32, P4130, DOI 10.1016/j.biomaterials.2011.02.035; Riahi R, 2012, JALA-J LAB AUTOM, V17, P59, DOI 10.1177/2211068211426550; RODEMANN HP, 1991, AM J KIDNEY DIS, V17, P684, DOI 10.1016/S0272-6386(12)80352-0; Sadlonova A, 2005, BREAST CANCER RES, V7, pR46, DOI 10.1186/bcr949; Spink BC, 2006, CELL BIOL INT, V30, P227, DOI 10.1016/j.cellbi.2005.11.006; STOKER MGP, 1966, J CELL SCI, V1, P297; Szulcek R, 2014, JOVE-J VIS EXP, DOI 10.3791/51300; Tlsty TD, 2001, CURR OPIN GENET DEV, V11, P54, DOI 10.1016/S0959-437X(00)00156-8; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Tran TB, 2013, BIOSENS BIOELECTRON, V50, P453, DOI 10.1016/j.bios.2013.07.019; Tran TB, 2016, BIOSENS BIOELECTRON, V77, P631, DOI 10.1016/j.bios.2015.10.030; Wadlow RC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006888; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431; Xiao C, 2002, ANAL CHEM, V74, P1333, DOI 10.1021/ac011104a; Xie FB, 2012, ANALYST, V137, P1343, DOI 10.1039/c2an16141a; Xing JZ, 2005, CHEM RES TOXICOL, V18, P154, DOI 10.1021/tx049721s; Zeisberg M, 2000, J NEPHROL, V13, pS111; Zhang J, 2010, BIOCHEM BIOPH RES CO, V399, P1, DOI 10.1016/j.bbrc.2010.07.013	34	31	34	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153813	10.1371/journal.pone.0153813	http://dx.doi.org/10.1371/journal.pone.0153813			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088611	Green Submitted, Green Published, gold			2022-12-26	WOS:000374527000051
J	Hasanuzzaman, AM; Islam, MN; Zhang, Y; Zhang, CY; Liu, TX				Hasanuzzaman, Abu Tayeb Mohammad; Islam, Md Nazrul; Zhang, Yi; Zhang, Chen-Yang; Liu, Tong-Xian			Leaf Morphological Characters Can Be a Factor for Intra-Varietal Preference of Whitefly Bemisia tabaci (Hemiptera: Aleyrodidae) among Eggplant Varieties	PLOS ONE			English	Article							TRIALEURODES-VAPORARIORUM; ARGENTIFOLII HOMOPTERA; HOST PREFERENCE; B-BIOTYPE; TRAP CROP; RESISTANCE; COTTON; OVIPOSITION; ATTRACTION; ENEMIES	The sweetpotato whitefly, Bemisia tabaci (Hemiptera: Aleyrodidae) MEAM1, is considered a serious pest of horticultural and many other crops. While eggplant (Solanum melongena) is one of the most favored host plants, the whiteflies exhibit preferences among different varieties. We hypothesized that certain morphological leaf characteristics of different varieties, like leaf trichome density, trichome length, leaf lamina thickness and leaf color, may affect whitefly landing, feeding and oviposition. In this study, we investigated the variation in leaf morphological characters among selected eggplant varieties and evaluated the effect of these leaf characteristics in rendering eggplant varieties either susceptible or resistant to B. tabaci. We evaluated eight eggplant varieties in choice feeding tests, and we found that the varieties JinSheng Zilongchangqie (JSZ) and H149 were the highly preferred varieties with the highest numbers of whitefly adults and eggs. Significantly lower numbers of whitefly adult eggs were found on the resistant variety Tuo Lu Bamu (TLB). The varieties Jin-Guangbo Luqie (JGL), JinGuangbo Ziquanqie (JGZ), DaYang Ziguanqie (DYZ), QinXing Ziguanqie (QXZ), and QinXing Niuxinqie (QXN) were moderately favored by B. tabaci. Leaf trichome density, trichome length and leaf lamina thickness were positively correlated with numbers of whitefly adults and eggs. B. tabaci was less attracted to the leaves that reflect long and middle wavelength light (higher R and G values) than to the bright green leaves (medium G value), but the short wavelength light (higher B value) had no significant effect on whitefly preference. The degree of hue had a positive effect, and saturation and brightness had a negative effect on whitefly attraction.	[Hasanuzzaman, Abu Tayeb Mohammad; Islam, Md Nazrul; Zhang, Yi; Zhang, Chen-Yang; Liu, Tong-Xian] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China; [Hasanuzzaman, Abu Tayeb Mohammad; Islam, Md Nazrul; Zhang, Yi; Zhang, Chen-Yang; Liu, Tong-Xian] Northwest A&F Univ, Minist Agr, Key Lab Integrated Pest Management Loess Plateau, Yangling 712100, Shaanxi, Peoples R China; [Hasanuzzaman, Abu Tayeb Mohammad] Bangladesh Agr Res Inst, Vertebrate Pest Div, Gazipur 1701, Bangladesh; [Islam, Md Nazrul] Atom Energy Res Estab, Inst Food & Radiat Biol, Agrochem & Environm Res Div, Dhaka, Bangladesh	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Bangladesh Agricultural Research Institute (BARI)	Liu, TX (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China.; Liu, TX (corresponding author), Northwest A&F Univ, Minist Agr, Key Lab Integrated Pest Management Loess Plateau, Yangling 712100, Shaanxi, Peoples R China.	txliu@nwsuaf.edu.cn			National Natural Science Foundation of China [31272089]; National Basic Research Program of China (973 Project) [2013CB127600]; China Agriculture Research System [CARS-25-B-06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Project)(National Basic Research Program of China); China Agriculture Research System	This work was supported by National Natural Science Foundation of China (No. 31272089), National Basic Research Program of China (973 Project No. 2013CB127600), and China Agriculture Research System (No. CARS-25-B-06).	Acharya VS, 2008, INDIAN J AGR SCI, V78, P818; Ayyasamy R., 2005, Journal of Food Agriculture & Environment, V3, P333; BERLINGER MJ, 1980, ENTOMOL EXP APPL, V27, P98, DOI 10.1007/BF00377246; BERLINGER MJ, 1986, AGR ECOSYST ENVIRON, V17, P69, DOI 10.1016/0167-8809(86)90028-9; Boykin LM, 2014, PEST MANAG SCI, V70, P1454, DOI 10.1002/ps.3709; BUTTER NS, 1989, PHYTOPARASITICA, V17, P251, DOI 10.1007/BF02980754; Byrne FJ, 2010, CROP PROT, V29, P260, DOI 10.1016/j.cropro.2009.11.007; Cavanagh A, 2009, J ECON ENTOMOL, V102, P1101, DOI 10.1603/029.102.0331; CHU CC, 1995, ENVIRON ENTOMOL, V24, P354, DOI 10.1093/ee/24.2.354; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Oriani MAD, 2011, SCI AGR, V68, P37, DOI 10.1590/S0103-90162011000100006; DeBarro PJ, 1997, AUST J ENTOMOL, V36, P149; Dharmendar Singh, 2002, Haryana Journal of Horticultural Sciences, V31, P289; Dicke M, 2010, TRENDS PLANT SCI, V15, P167, DOI 10.1016/j.tplants.2009.12.002; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; ELSEY KD, 1994, HORTSCIENCE, V29, P814, DOI 10.21273/HORTSCI.29.7.814; Feng YT, 2010, PEST MANAG SCI, V66, P313, DOI 10.1002/ps.1877; Frisbie RE, 1994, INTRO INSECT PEST MA, P421; Frohlich DR, 1999, MOL ECOL, V8, P1683, DOI 10.1046/j.1365-294x.1999.00754.x; Halitschke R, 2008, ECOL LETT, V11, P24, DOI 10.1111/j.1461-0248.2007.01123.x; HEINZ KM, 1995, J ECON ENTOMOL, V88, P1494, DOI 10.1093/jee/88.5.1494; Islam MT, 2010, ACTA AGR SCAND B-S P, V60, P320, DOI 10.1080/09064710902976974; Kennedy GG, 2003, ANNU REV ENTOMOL, V48, P51, DOI 10.1146/annurev.ento.48.091801.112733; KISHABA AN, 1992, HORTSCIENCE, V27, P1217, DOI 10.21273/HORTSCI.27.11.1217; Lakshminarayan S., 2008, Environment and Ecology, V26, P978; Lee DH, 2009, ENTOMOL EXP APPL, V133, P105, DOI 10.1111/j.1570-7458.2009.00920.x; Li SJ, 2011, INSECT SCI, V18, P101, DOI 10.1111/j.1744-7917.2010.01395.x; Lin Ke-Jian, 2003, Acta Ecologica Sinica, V23, P870; Liu SS, 2007, SCIENCE, V318, P1769, DOI 10.1126/science.1149887; Lu YH, 2009, CROP PROT, V28, P77, DOI 10.1016/j.cropro.2008.08.018; Luo Chen, 2002, Acta Entomologica Sinica, V45, P759; Maskato Y, 2014, ARTHROPOD-PLANT INTE, V8, P285, DOI 10.1007/s11829-014-9307-2; MISRA C. S., 1929, Bull. Agric. Res. Inst. Pusa; MOUND LAURENCE A., 1962, ENTOMOL EXPTL ET APPL, V5, P99, DOI 10.1111/j.1570-7458.1962.tb00571.x; Mouttet R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018840; Mumm R, 2010, CAN J ZOOL, V88, P628, DOI 10.1139/Z10-032; Oriani MAD, 2005, NEOTROP ENTOMOL, V34, P97, DOI 10.1590/S1519-566X2005000100014; Oriani MAD, 2010, NEOTROP ENTOMOL, V39, P1002, DOI 10.1590/S1519-566X2010000600024; OZGUR AF, 1986, AGR ECOSYST ENVIRON, V17, P83, DOI 10.1016/0167-8809(86)90029-0; PERRING TM, 1993, SCIENCE, V259, P74, DOI 10.1126/science.8418497; Petro L, 2002, PREFERENCE PERFORMAN; Petro LO, 2000, HOST PLANT PREFERENC; Polston JE, 1999, MANEJO INTEGRADO PLA, V53, P24; Rustamani M. A., 2014, Sindh University Research Journal -Science Series, V46, P351; Schuster DJ, 2010, PEST MANAG SCI, V66, P186, DOI 10.1002/ps.1853; Shah MMR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077368; Shelton AM, 2006, ANNU REV ENTOMOL, V51, P285, DOI 10.1146/annurev.ento.51.110104.150959; Shepherd RW, 2005, PLANT CELL, V17, P1851, DOI 10.1105/tpc.105.031559; Shibuya T, 2009, J ECON ENTOMOL, V102, P2265, DOI 10.1603/029.102.0631; Silva GFD, 2012, CHIL J AGR RES, V72, P516; Soundararajan R. P., 2001, Madras Agricultural Journal, V88, P657; Taggar GK, 2012, PHYTOPARASITICA, V40, P461, DOI 10.1007/s12600-012-0247-z; Unsicker SB, 2009, CURR OPIN PLANT BIOL, V12, P479, DOI 10.1016/j.pbi.2009.04.001; Wan FH, 2009, SCI CHINA SER C, V52, P88, DOI 10.1007/s11427-008-0135-4; Wang ZY, 2009, PEST MANAG SCI, V65, P1189, DOI 10.1002/ps.1808; White J., 1998, CALIF AGR, V52, P6; Zhao L. R., 2000, XINJIANG AGR SCI, V1, P27; ZHOU Y, 1949, ENTOMOL SINICA, V3, P1	58	31	34	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153880	10.1371/journal.pone.0153880	http://dx.doi.org/10.1371/journal.pone.0153880			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27081849	Green Submitted, Green Published, gold			2022-12-26	WOS:000374291800063
J	Lin, WL; Quintero, A; Zhang, YX				Lin, Weilin; Quintero, Andres; Zhang, Yixin			Conformational Heterogeneity of Cyclosporin A in Cyclophilin 18 Binding	PLOS ONE			English	Article							PEPTIDE CONFORMATIONS; CRYSTAL-STRUCTURE; INHIBITION	The immunosuppressive drug cyclosporin A (CsA) binds to its receptor protein cyclophilin 18 (Cyp18) in two distinct kinetic phases, while the mechanism remains elusive. Stopped-flow measurements coupled with titration and competition experiments were used to investigate the puzzling two-phase process of CsA and Cyp18 interaction. This study leads to the dissection of different conformational fractions of either direct fast binding or slow binding with rate-limiting conformational inter-conversion and the real-time measurement of k(on) value (8.34 +/- 0.22 x10(6) M(-1)s(-1)) in solution. Furthermore, our study indicates that the structure of CsA during dissociation from the protein possesses a distribution of conformations different from those in solution under equilibrium condition.	[Lin, Weilin; Quintero, Andres; Zhang, Yixin] Tech Univ Dresden, B CUBE Ctr Mol Bioengn, Arnoldstr 18, D-01307 Dresden, Germany	Technische Universitat Dresden	Zhang, YX (corresponding author), Tech Univ Dresden, B CUBE Ctr Mol Bioengn, Arnoldstr 18, D-01307 Dresden, Germany.	yixin.zhang@bcube-dresden.de		Lin, Weilin/0000-0002-2262-5859	German Bundesministerium fur Bildung und Forschung (BMBF) [03Z2EN12]	German Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	This work is supported by the German Bundesministerium fur Bildung und Forschung (BMBF) Grant 03Z2EN12.	Baumgrass R, 2004, J BIOL CHEM, V279, P2470, DOI 10.1074/jbc.M304754200; Eckert B, 2005, NAT STRUCT MOL BIOL, V12, P619, DOI 10.1038/nsmb946; Fanghanel J, 2003, BIOPHYS CHEM, V100, P351, DOI 10.1016/S0301-4622(02)00292-2; Gaither LA, 2010, VIROLOGY, V397, P43, DOI 10.1016/j.virol.2009.10.043; Huai Q, 2002, P NATL ACAD SCI USA, V99, P12037, DOI 10.1073/pnas.192206699; Janowski B, 1997, BIOORGAN MED CHEM, V5, P179, DOI 10.1016/S0968-0896(96)00198-8; Jin L, 2002, P NATL ACAD SCI USA, V99, P13522, DOI 10.1073/pnas.212504399; KESSLER H, 1985, HELV CHIM ACTA, V68, P661, DOI 10.1002/hlca.19850680318; KESSLER H, 1990, HELV CHIM ACTA, V73, P1818, DOI 10.1002/hlca.19900730703; KOFRON JL, 1992, J AM CHEM SOC, V114, P2670, DOI 10.1021/ja00033a047; LIU J, 1991, BIOCHEMISTRY-US, V30, P2306, DOI 10.1021/bi00223a003; LOOSLI HR, 1985, HELV CHIM ACTA, V68, P682, DOI 10.1002/hlca.19850680319; Macey R., 2000, BERKELEY MADONNA USE; Mallis RJ, 2002, NAT STRUCT BIOL, V9, P900, DOI 10.1038/nsb864; Zhang YX, 2009, NAT CHEM BIOL, V5, P724, DOI 10.1038/nchembio.214; Zhang YX, 2004, CHEMBIOCHEM, V5, P1006, DOI 10.1002/cbic.200400020	16	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153669	10.1371/journal.pone.0153669	http://dx.doi.org/10.1371/journal.pone.0153669			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082870	Green Submitted, Green Published, gold			2022-12-26	WOS:000374291800042
J	Pedersen, MK; Andersen, AB; Andersen, PH; Svensson, E; Jensen, SG; Lillebaek, T				Pedersen, Mathias Klok; Andersen, Aase Bengaard; Andersen, Peter Henrik; Svensson, Erik; Jensen, Sidse Graff; Lillebaek, Troels			Occupational Tuberculosis in Denmark through 21 Years Analysed by Nationwide Genotyping	PLOS ONE			English	Article							HEALTH-CARE WORKERS; MYCOBACTERIUM-TUBERCULOSIS; TRANSMISSION; OUTBREAK; STRAIN; RISK	Tuberculosis (TB) is a well-known occupational hazard. Based on more than two decades (1992-2012) of centralized nationwide genotyping of all Mycobacterium tuberculosis culture-positive TB patients in Denmark, we compared M. tuberculosis genotypes from all cases notified as presumed occupational (N = 130) with M. tuberculosis genotypes from all TB cases present in the country (N = 7,127). From 1992 through 2006, the IS6110 Restriction Fragment Length Polymorphism (RFLP) method was used for genotyping, whereas from 2005 to present, the 24-locus-based Mycobacterial Interspersed Repetitive Unit-Variable Number of Tandem Repeat (MIRU-VNTR) was used. An occupational TB case was classified as clustered if the genotype was 100% identical to at least one other genotype. Subsequently, based on genotype, time period, smear positivity, geography, susceptibility pattern, and any reported epidemiological links between the occupational cases and any potential source cases, the occupational case was categorized as confirmed, likely, possible or unlikely occupationally infected. Among the 130 notified presumed occupational cases, 12 (9.2%) could be classified as confirmed and 46 (35.4%) as unlikely, accounting for nearly half of all cases (44.6%). The remaining 72 cases (55.4%) were categorized as possible. Within this group, 15 cases (11.5%) were assessed to be likely occupational. Our study shows that genotyping can serve as an important tool for disentangle occupational TB in high-income low incidence settings, but still needs to be combined with good epidemiological linkage information.	[Pedersen, Mathias Klok; Svensson, Erik; Lillebaek, Troels] Statens Serum Inst, Int Reference Lab Mycobacteriol, DK-2300 Copenhagen, Denmark; [Andersen, Aase Bengaard] Copenhagen Univ Hosp, Dept Infect Dis, Copenhagen, Denmark; [Andersen, Peter Henrik] Statens Serum Inst, Dept Infect Dis Epidemiol, DK-2300 Copenhagen, Denmark; [Jensen, Sidse Graff] Gentofte Univ Hosp, Dept Pulm Med, Hellerup, Denmark	Statens Serum Institut; University of Copenhagen; Statens Serum Institut; University of Copenhagen; Herlev & Gentofte Hospital	Pedersen, MK (corresponding author), Statens Serum Inst, Int Reference Lab Mycobacteriol, DK-2300 Copenhagen, Denmark.	makp@ssi.dk	; Svensson, Erik/Q-5926-2018	Lillebaek, Troels/0000-0002-2601-2718; Svensson, Erik/0000-0003-0797-1080; Andersen, Aase Bengaard/0000-0003-4779-7603				BergmireSweat D, 1996, EPIDEMIOL INFECT, V117, P485, DOI 10.1017/S095026880005915X; Danish Health Authority, 2015, GUID PREV TUB; Danish Society of Respiratory Medicine Danish Society of Infectious Diseases Danish Paediatric Society Danish Society of Clinical Microbiology and Statens Serum Institut, 2010, TUB CONTR DENM NAT T; de Vries G, 2006, EUR RESPIR J, V28, P1216, DOI 10.1183/09031936.06.00039906; Diel R, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-35; Field MJ, 2001, TUBERCULOSIS IN THE WORKPLACE, P13; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Johnson KR, 2000, JAMA-J AM MED ASSOC, V284, P1683, DOI 10.1001/jama.284.13.1683; Jones TF, 1999, ANN INTERN MED, V131, P557, DOI 10.7326/0003-4819-131-8-199910190-00002; Kamper-Jorgensen Z, 2009, CLIN RESPIR J, V3, P55, DOI 10.1111/j.1752-699X.2008.00074.x; Lauzardo M, 2001, CHEST, V119, P640, DOI 10.1378/chest.119.2.640; Lillebaek T, 2013, J CLIN MICROBIOL, V51, P4040, DOI 10.1128/JCM.01916-13; Menzies D, 2007, INT J TUBERC LUNG D, V11, P593; MENZIES D, 1995, NEW ENGL J MED, V332, P92, DOI 10.1056/NEJM199501123320206; Oelemann MC, 2007, J CLIN MICROBIOL, V45, P691, DOI 10.1128/JCM.01393-06; Roetzer A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001387; SEPKOWITZ KA, 1995, CLIN INFECT DIS, V21, P1098, DOI 10.1093/clinids/21.5.1098; Statens Serum Institut, 2015, EPI NEWS NEWSL TUB; Sterling TR, 2000, NEW ENGL J MED, V342, P246, DOI 10.1056/NEJM200001273420404; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; vanDeutekom H, 1997, CLIN INFECT DIS, V25, P1071, DOI 10.1086/516072; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993	22	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153668	10.1371/journal.pone.0153668	http://dx.doi.org/10.1371/journal.pone.0153668			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082745	Green Published, gold			2022-12-26	WOS:000374291800041
J	Zhu, R; Yang, TJ; Kobeissy, F; Mouhieddine, TH; Raad, M; Nokkari, A; Gold, MS; Wang, KK; Mechref, Y				Zhu, Rui; Yang, Tianjiao; Kobeissy, Firas; Mouhieddine, Tarek H.; Raad, Mohamad; Nokkari, Amaly; Gold, Mark S.; Wang, Kevin K.; Mechref, Yehia			The Effect of Chronic Methamphetamine Exposure on the Hippocampal and Olfactory Bulb Neuroproteomes of Rats	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; GRAY-MATTER VOLUME; NEURONAL APOPTOSIS; MOUSE-BRAIN; DOPAMINERGIC-NEURONS; MEDIATED PROTEOLYSIS; PARKINSONS-DISEASE; MOLECULAR-BASES; CELL-LINE; FETUIN-A	Nowadays, drug abuse and addiction are serious public health problems in the USA. Methamphetamine (METH) is one of the most abused drugs and is known to cause brain damage after repeated exposure. In this paper, we conducted a neuroproteomic study to evaluate METH-induced brain protein dynamics, following a two-week chronic regimen of an escalating dose of METH exposure. Proteins were extracted from rat brain hippocampal and olfactory bulb tissues and subjected to liquid chromatography-mass spectrometry (LCMS/MS) analysis. Both shotgun and targeted proteomic analysis were performed. Protein quantification was initially based on comparing the spectral counts between METH exposed animals and their control counterparts. Quantitative differences were further confirmed through multiple reaction monitoring (MRM) LC-MS/MS experiments. According to the quantitative results, the expression of 18 proteins (11 in the hippocampus and 7 in the olfactory bulb) underwent a significant alteration as a result of exposing rats to METH. 13 of these proteins were up-regulated after METH exposure while 5 were down-regulated. The altered proteins belonging to different structural and functional families were involved in processes such as cell death, inflammation, oxidation, and apoptosis.	[Zhu, Rui; Yang, Tianjiao; Mechref, Yehia] Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA; [Kobeissy, Firas; Gold, Mark S.; Wang, Kevin K.] Univ Florida, Dept Psychiat, Ctr Neuroprote & Biomarkers Res, Gainesville, FL 32611 USA; [Mouhieddine, Tarek H.; Raad, Mohamad] Amer Univ Beirut, Med Ctr, Fac Med, Beirut, Lebanon; [Nokkari, Amaly] Amer Univ Beirut, Med Ctr, Dept Biochem & Mol Genet, Fac Med, Beirut, Lebanon	Texas Tech University System; Texas Tech University; State University System of Florida; University of Florida; American University of Beirut; American University of Beirut	Mechref, Y (corresponding author), Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA.; Wang, KK (corresponding author), Univ Florida, Dept Psychiat, Ctr Neuroprote & Biomarkers Res, Gainesville, FL 32611 USA.	kwang@psychiatry.ufl.edu; yehia.mechref@ttu.edu	Kobeissy, Firas/E-7042-2017; Mechref, Yehia/I-5126-2013	Kobeissy, Firas/0000-0002-5008-6944; Mechref, Yehia/0000-0002-6661-6073; Raad, Mohamad/0000-0002-5446-3786; Wang, Kevin/0000-0002-9343-6473; Mouhieddine, Tarek/0000-0002-1190-5978	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112490] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR001427] Funding Source: Medline; NIGMS NIH HHS [R01 GM112490] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adinoff B, 2004, HARVARD REV PSYCHIAT, V12, P305, DOI 10.1080/10673220490910844; Adler V, 1999, EMBO J, V18, P1321, DOI 10.1093/emboj/18.5.1321; Akiyama K, 2008, PROG NEURO-PSYCHOPH, V32, P1957, DOI 10.1016/j.pnpbp.2008.09.021; Cadet JL, 2009, INT REV NEUROBIOL, V88, P101, DOI 10.1016/S0074-7742(09)88005-7; Cadet JL, 2003, FASEB J, V17, P1775, DOI 10.1096/fj.03-0073rev; Cecchi GA, 2001, J COMPUT NEUROSCI, V11, P175, DOI 10.1023/A:1012849801892; Chen Q, 2007, AM J PHYSIOL-CELL PH, V292, pC137, DOI 10.1152/ajpcell.00270.2006; Cho H, 2007, J CELL BIOL, V178, P245, DOI 10.1083/jcb.200604114; Choi HJ, 2002, MOL CELLS, V13, P221; Crochemore C, 2009, MUSCLE NERVE, V39, P548, DOI 10.1002/mus.21260; Daulatzai MA, 2015, J NEURAL TRANSM, V122, P1475, DOI 10.1007/s00702-015-1404-6; Davidson C, 2001, BRAIN RES REV, V36, P1, DOI 10.1016/S0165-0173(01)00054-6; Deng XL, 2007, BIOL PSYCHIAT, V61, P1235, DOI 10.1016/j.biopsych.2006.09.010; Deng XL, 2002, MOL PHARMACOL, V62, P993, DOI 10.1124/mol.62.5.993; Deng XL, 2002, NEUROPHARMACOLOGY, V42, P837, DOI 10.1016/S0028-3908(02)00034-5; DEVITO MJ, 1989, NEUROPHARMACOLOGY, V28, P1145, DOI 10.1016/0028-3908(89)90130-5; Sanchez-Nino MD, 2010, J AM SOC NEPHROL, V21, P610, DOI 10.1681/ASN.2009020227; Elsas J, 2013, DEV NEUROBIOL, V73, P354, DOI 10.1002/dneu.22064; Ernst T, 2000, NEUROLOGY, V54, P1344, DOI 10.1212/WNL.54.6.1344; Fan JW, 2011, CLIN CANCER RES, V17, P2908, DOI 10.1158/1078-0432.CCR-10-2552; Finnegan S, 2010, MOL VIS, V16, P7; Freese TE, 2000, J PSYCHOACTIVE DRUGS, V32, P177, DOI 10.1080/02791072.2000.10400226; Galinato MH, 2015, NEUROSCIENCE, V286, P97, DOI 10.1016/j.neuroscience.2014.11.042; Gluck MR, 2001, J NEUROCHEM, V79, P152, DOI 10.1046/j.1471-4159.2001.00549.x; Granado N, 2010, NEUROTOX RES, V18, P48, DOI 10.1007/s12640-009-9106-1; Groman SM, 2013, PSYCHOPHARMACOLOGY, V229, P527, DOI 10.1007/s00213-013-3159-9; Halestrap AP, 2007, BBA-BIOENERGETICS, V1767, P1007, DOI 10.1016/j.bbabio.2007.05.008; Hanaya R, 2012, NEUROSCIENCE, V221, P12, DOI 10.1016/j.neuroscience.2012.06.058; Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881; Huh GY, 2001, NEUROSCI LETT, V316, P41, DOI 10.1016/S0304-3940(01)02371-0; Huisman E, 2004, MOVEMENT DISORD, V19, P687, DOI 10.1002/mds.10713; Ivanova M, 2014, ACTA NEUROBIOL EXP, V74, P317; IWANAMI A, 1994, ACTA PSYCHIAT SCAND, V89, P428, DOI 10.1111/j.1600-0447.1994.tb01541.x; Jayanthi S, 2014, BIOL PSYCHIAT, V76, P47, DOI 10.1016/j.biopsych.2013.09.034; Johnston CA, 2007, P NATL ACAD SCI USA, V104, P2001, DOI 10.1073/pnas.0608599104; Katzenschlager R, 2004, J NEUROL NEUROSUR PS, V75, P1749, DOI 10.1136/jnnp.2003.035287; Keller CM, 2011, PSYCHOPHARMACOLOGY, V215, P513, DOI 10.1007/s00213-011-2301-9; Keverne EB, 2005, NAT NEUROSCI, V8, P1637, DOI 10.1038/nn1205-1637; Kitanaka N, 2010, NEUROCHEM RES, V35, P749, DOI 10.1007/s11064-010-0132-4; Kobeissy FH, 2008, EXPERT REV PROTEOMIC, V5, P293, DOI 10.1586/14789450.5.2.293; Kobeissy FH, 2012, METHODS MOL BIOL, V829, P269, DOI 10.1007/978-1-61779-458-2_17; Krasnova IN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008790; Kriebel M, 2011, J BIOL CHEM, V286, P24385, DOI 10.1074/jbc.M110.212191; Larsen KE, 2002, J NEUROSCI, V22, P8951; Lee DH, 2010, ANAT CELL BIOL, V43, P194, DOI 10.5115/acb.2010.43.3.194; Lee JM, 2000, J CLIN INVEST, V106, P723, DOI 10.1172/JCI11003; Lee KH, 2011, J NEUROSCI RES, V89, P96, DOI 10.1002/jnr.22525; Matsubara M, 2004, EMBO J, V23, P712, DOI 10.1038/sj.emboj.7600093; Moberg Paul J, 2003, Curr Psychiatry Rep, V5, P311, DOI 10.1007/s11920-003-0061-x; Molz S, 2008, NEUROCHEM RES, V33, P27, DOI 10.1007/s11064-007-9402-1; Morales AM, 2015, MOL PSYCHIATR, V20, P764, DOI 10.1038/mp.2015.47; Morales AM, 2012, DRUG ALCOHOL DEPEN, V125, P230, DOI 10.1016/j.drugalcdep.2012.02.017; Moratalla R, 1996, P NATL ACAD SCI USA, V93, P14928, DOI 10.1073/pnas.93.25.14928; Negoias S, 2016, BRAIN IMAGING BEHAV, V10, P367, DOI 10.1007/s11682-015-9400-x; North A, 2013, SYNAPSE, V67, P245, DOI 10.1002/syn.21635; O'Callaghan JP, 2008, ANN NY ACAD SCI, V1139, P318, DOI 10.1196/annals.1432.032; Orikabe L, 2011, SCHIZOPHR RES, V132, P183, DOI 10.1016/j.schres.2011.07.006; OTMAKHOVA NA, 1992, PHYSIOL BEHAV, V52, P441, DOI 10.1016/0031-9384(92)90329-Z; Ramkissoon A, 2013, FREE RADICAL BIO MED, V65, P620, DOI 10.1016/j.freeradbiomed.2013.07.043; Riddle EL, 2002, EUR J PHARMACOL, V435, P181, DOI 10.1016/S0014-2999(01)01592-8; Robison AJ, 2011, NAT REV NEUROSCI, V12, P623, DOI 10.1038/nrn3111; Rodriguez-Rodriguez P, 2012, CELL DEATH DIFFER, V19, P1582, DOI 10.1038/cdd.2012.33; Romero L, 2006, BIOCHEM J, V400, P135, DOI 10.1042/BJ20060110; Ryoo K, 2004, J BIOL CHEM, V279, P43589, DOI 10.1074/jbc.M404359200; Sailasuta N, 2010, J CEREBR BLOOD F MET, V30, P950, DOI 10.1038/jcbfm.2009.261; Sapolsky RM, 2001, P NATL ACAD SCI USA, V98, P12320, DOI 10.1073/pnas.231475998; Schoch KM, 2012, EXP NEUROL, V236, P371, DOI 10.1016/j.expneurol.2012.04.022; Schwartz DL, 2010, NEUROIMAGE, V50, P1392, DOI 10.1016/j.neuroimage.2010.01.056; Schwendt M, 2009, J PHARMACOL EXP THER, V331, P555, DOI 10.1124/jpet.109.155770; Seo JY, 2009, J NEUROL SCI, V285, P88, DOI 10.1016/j.jns.2009.05.029; Sokolov BP, 2004, PHARMACOL BIOCHEM BE, V77, P319, DOI 10.1016/j.pbb.2003.11.006; Song C, 2005, NEUROSCI BIOBEHAV R, V29, P627, DOI 10.1016/j.neubiorev.2005.03.010; Stumm G, 1999, FASEB J, V13, P1065, DOI 10.1096/fasebj.13.9.1065; Sun KH, 2011, J NEUROCHEM, V118, P902, DOI 10.1111/j.1471-4159.2011.07343.x; Takaichi R, 2012, J NEUROSCI RES, V90, P21, DOI 10.1002/jnr.22740; Teodoro RO, 2013, EMBO J, V32, P2039, DOI 10.1038/emboj.2013.147; Tew KD, 2007, BIOCHEM PHARMACOL, V73, P1257, DOI 10.1016/j.bcp.2006.09.027; Thiriet N, 2001, MOL BRAIN RES, V90, P202, DOI 10.1016/S0169-328X(01)00093-6; Thompson PM, 2004, J NEUROSCI, V24, P6028, DOI 10.1523/JNEUROSCI.0713-04.2004; THORNE BM, 1993, ANN NY ACAD SCI, V702, P131, DOI 10.1111/j.1749-6632.1993.tb17245.x; Tokunaga I, 2008, J MED INVESTIG, V55, P241, DOI 10.2152/jmi.55.241; Turetsky BI, 2003, ARCH GEN PSYCHIAT, V60, P1193, DOI 10.1001/archpsyc.60.12.1193; Urbina A, 2004, CLIN INFECT DIS, V38, P890, DOI 10.1086/381975; VANGROEN T, 1990, J COMP NEUROL, V302, P515, DOI 10.1002/cne.903020308; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Volkow ND, 2001, AM J PSYCHIAT, V158, P377, DOI 10.1176/appi.ajp.158.3.377; Volkow ND, 2001, J NEUROSCI, V21, P9414, DOI 10.1523/JNEUROSCI.21-23-09414.2001; Wang HC, 2010, J CEREBR BLOOD F MET, V30, P493, DOI 10.1038/jcbfm.2009.247; Warren MW, 2007, ACTA NEUROPATHOL, V114, P277, DOI 10.1007/s00401-007-0259-9; Warren MW, 2005, LIFE SCI, V78, P301, DOI 10.1016/j.lfs.2005.04.058; White NM, 1998, P NATL ACAD SCI USA, V95, P6486, DOI 10.1073/pnas.95.11.6486; Yamamoto H, 2006, ANN NY ACAD SCI, V1074, P97, DOI 10.1196/annals.1369.009; Yan XX, 2012, CURR GERIATR REP, V1, P85, DOI 10.1007/s13670-012-0009-2; Yokobori S, 2015, WORLD NEUROSURG, V83, P867, DOI 10.1016/j.wneu.2013.03.012; Yoon HY, 2005, CELL, V123, P669, DOI 10.1016/j.cell.2005.08.039; Yuan TF, 2014, PROG NEURO-PSYCHOPH, V54, P26, DOI 10.1016/j.pnpbp.2014.05.013; Zhou P, 2012, J NEUROSCI, V32, P583, DOI 10.1523/JNEUROSCI.2849-11.2012; Zipfel GJ, 2000, J NEUROTRAUM, V17, P857, DOI 10.1089/neu.2000.17.857; Zuloaga DG, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00178	99	13	14	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0151034	10.1371/journal.pone.0151034	http://dx.doi.org/10.1371/journal.pone.0151034			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082425	Green Published, Green Submitted, gold			2022-12-26	WOS:000374291800003
J	Castro, NP; Merchant, AS; Saylor, KL; Anver, MR; Salomon, DS; Golubeva, YG				Castro, Nadia P.; Merchant, Anand S.; Saylor, Karen L.; Anver, Miriam R.; Salomon, David S.; Golubeva, Yelena G.			Adaptation of Laser Microdissection Technique for the Study of a Spontaneous Metastatic Mammary Carcinoma Mouse Model by NanoString Technologies	PLOS ONE			English	Article							GENE-EXPRESSION ANALYSIS; MICROCAPILLARY ELECTROPHORESIS TRACES; CAPTURE MICRODISSECTION; BREAST-CANCER; RNA QUALITY; TISSUE SAMPLES; IMPACT; TARGET	Laser capture microdissection (LCM) of tissue is an established tool in medical research for collection of distinguished cell populations under direct microscopic visualization for molecular analysis. LCM samples have been successfully analyzed in a number of genomic and proteomic downstream molecular applications. However, LCM sample collection and preparation procedure has to be adapted to each downstream analysis platform. In this present manuscript we describe in detail the adaptation of LCM methodology for the collection and preparation of fresh frozen samples for NanoString analysis based on a study of a model of mouse mammary gland carcinoma and its lung metastasis. Our adaptation of LCM sample preparation and workflow to the requirements of the NanoString platform allowed acquiring samples with high RNA quality. The NanoString analysis of such samples provided sensitive detection of genes of interest and their associated molecular pathways. NanoString is a reliable gene expression analysis platform that can be effectively coupled with LCM.	[Castro, Nadia P.; Saylor, Karen L.; Salomon, David S.] NCI, Tumor Growth Factor Sect, Mouse Canc Genet Program, Frederick, MD 21702 USA; [Merchant, Anand S.] NCI, CCRIFX Bioinformat Core, Bethesda, MD 20892 USA; [Anver, Miriam R.; Golubeva, Yelena G.] Leidos Biomed Res Inc, Pathol Histotechnol Lab, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Castro, NP (corresponding author), NCI, Tumor Growth Factor Sect, Mouse Canc Genet Program, Frederick, MD 21702 USA.; Golubeva, YG (corresponding author), Leidos Biomed Res Inc, Pathol Histotechnol Lab, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA.	castron2@mail.nih.gov; yelena.golubeva@gmail.com			Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research; National Cancer Institute, National Institutes of Health [HHSN261200800001E]	Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported (in part) by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldelli E, 2015, PROTEOM CLIN APPL, V9, P928, DOI 10.1002/prca.201400056; Bidarimath M, 2015, METHODS MOL BIOL, V1219, P115, DOI 10.1007/978-1-4939-1661-0_10; Castro NP, 2015, ONCOTARGET, V6, P11910, DOI 10.18632/oncotarget.4182; Clement-Ziza M, 2008, RNA, V14, P2698, DOI 10.1261/rna.1261708; Copois V, 2007, J BIOTECHNOL, V127, P549, DOI 10.1016/j.jbiotec.2006.07.032; Ehrig T, 2001, J MOL DIAGN, V3, P22, DOI 10.1016/S1525-1578(10)60645-9; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Erickson HS, 2009, NAT PROTOC, V4, P902, DOI 10.1038/nprot.2009.61; Espina V, 2006, NAT PROTOC, V1, P586, DOI 10.1038/nprot.2006.85; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Golubeva Yelena, 2013, Methods Mol Biol, V931, P213, DOI 10.1007/978-1-62703-056-4_12; Golubeva Yelena, 2009, V511, P3, DOI 10.1007/978-1-59745-447-6_1; Golubeva YG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066854; Huang LE, 2002, METHOD ENZYMOL, V356, P49; Imbeaud S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni054; Institute of Laboratory Animal Resources CoLS National Research Council, 1996, GUIDE CARE USE LAB A; Jacquet R, 2005, ANAL BIOCHEM, V337, P22, DOI 10.1016/j.ab.2004.09.033; Ma XJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2222; Melis M, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0230-1; Nakazono M, 2003, PLANT CELL, V15, P583, DOI 10.1105/tpc.008102; Ojaniemi H, 2003, BIOTECHNIQUES, V35, P968, DOI 10.2144/03355st04; Strand C, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-38; Wang HY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-97; Wulfkuhle JD, 2008, J PROTEOME RES, V7, P1508, DOI 10.1021/pr7008127	24	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153270	10.1371/journal.pone.0153270	http://dx.doi.org/10.1371/journal.pone.0153270			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077656	Green Published, Green Submitted, gold			2022-12-26	WOS:000374131700034
J	Hayashi, G; Cortopassi, G				Hayashi, Genki; Cortopassi, Gino			Lymphoblast Oxidative Stress Genes as Potential Biomarkers of Disease Severity and Drug Effect in Friedreich's Ataxia	PLOS ONE			English	Article							FRATAXIN DEFICIENCY LEADS; SULFUR TRANSFER; EXPRESSION; NRF2; TRANSCRIPTION; CONTRIBUTES; MODELS; GROWTH; CELLS	There is no current approved therapy for the ultimately lethal neuro- and cardio-degenerative disease Friedreich's ataxia (FA). Finding minimally-invasive molecular biomarkers of disease progression and drug effect could support smaller, shorter clinical trials. Since we and others have noted a deficient oxidative stress response in FA, we investigated the expression of 84 genes involved in oxidative stress, signaling, and protection in control and FA lymphoblasts ranging from 460 to 1122 GAA repeats. Several antioxidant genes responded in a dose-dependent manner to frataxin expression at the mRNA and protein levels, which is inversely correlated with disease progression and severity. We tested the effect of experimental Friedreich's ataxia therapies dimethyl fumarate (DMF) and type 1 histone deacetylase inhibitor (HDACi) on biomarker mRNA expression. We observed that exposure of lymphoblasts to DMF and HDACi dose-dependently unsilenced frataxin expression and restored the potential biomarkers NCF2 and PDLIM1 expression to control levels. We suggest that in addition to frataxin expression, blood lymphoblast levels of NCF2 and PDLIM1 could be useful biomarkers for disease progression and drug effect in future clinical trials of Friedreich's ataxia.	[Hayashi, Genki; Cortopassi, Gino] Univ Calif Davis, Dept Mol Biosci, Davis, CA 95616 USA	University of California System; University of California Davis	Cortopassi, G (corresponding author), Univ Calif Davis, Dept Mol Biosci, Davis, CA 95616 USA.	gcortopassi@ucdavis.edu			NIH [R01 NS077777]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077777] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support was provided by NIH R01 NS077777. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeti R, 2015, PHARMACOL RES, V99, P344, DOI 10.1016/j.phrs.2015.05.015; Al-Mahdawi S, 2008, HUM MOL GENET, V17, P735, DOI 10.1093/hmg/ddm346; Al-Mahdawi S, 2006, GENOMICS, V88, P580, DOI 10.1016/j.ygeno.2006.06.015; Angeloni C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083283; Bradley J, 1999, HUM MOL GENET, V9, P8; Bridwell-Rabb J, 2014, BIOCHEMISTRY-US, V53, P4904, DOI 10.1021/bi500532e; Calabrese V, 2005, J NEUROL SCI, V233, P145, DOI 10.1016/j.jns.2005.03.012; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Chantrel-Groussard K., 2001, HUM MOL GENET, V10, P8; Cossee M, 1997, P NATL ACAD SCI USA, V94, P7452, DOI 10.1073/pnas.94.14.7452; Cox AG, 2010, BIOCHEM J, V425, P313, DOI 10.1042/BJ20091541; D'Oria V, 2013, INT J MOL SCI, V14, P7853, DOI 10.3390/ijms14047853; Durr A., 1996, NEW ENGL J MED, V335, P7; Durr A., 2000, CURR OPIN NEUROL, V13, P7; Emond M, 2000, INCREASED LEVELS PLA, V55, P2; Hasegawa T, 2010, NEUROSCI LETT, V476, P53, DOI 10.1016/j.neulet.2010.03.081; Haugen AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000812; Jain D, 2008, AM J RESP CRIT CARE, V178, P805, DOI 10.1164/rccm.200804-582OC; Kim E, 2011, NUCLEIC ACIDS RES, V39, P8366, DOI 10.1093/nar/gkr542; Koeppen AH, 2011, J NEUROL SCI, V303, P1, DOI 10.1016/j.jns.2011.01.010; Kropotov A, 2006, FEBS J, V273, P2607, DOI 10.1111/j.1742-4658.2006.05265.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mine Y, 2015, MOL NUTR FOOD RES, V59, P303, DOI 10.1002/mnfr.201400381; Parent A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6686; Paupe V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004253; Piemonte F, 2001, EUR J CLIN INVEST, V31, P1007, DOI 10.1046/j.1365-2362.2001.00922.x; Rai M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008825; Ristow M, 2003, J CLIN INVEST, V112, P527, DOI 10.1172/JCI200318107; Rotig A, 1997, NAT GENET, V17, P3; Sahdeo S, 2014, HUM MOL GENET, V23, P6848, DOI 10.1093/hmg/ddu408; Sandi C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089488; Sandi C, 2011, NEUROBIOL DIS, V42, P496, DOI 10.1016/j.nbd.2011.02.016; Schulz J., 2000, NEUROLOGY, V55, P3; Seyer L, 2015, ACTA NEUROL SCAND, V132, P7, DOI 10.1111/ane.12337; Shan YX, 2013, ANTIOXID REDOX SIGN, V19, P1481, DOI 10.1089/ars.2012.4537; SMALL JR, 1993, NEUROSCI LETT, V163, P182, DOI 10.1016/0304-3940(93)90377-W; Soragni E, 2014, ANN NEUROL, V76, P489, DOI 10.1002/ana.24260; Strawser CJ, 2014, EXPERT REV NEUROTHER, V14, P949, DOI 10.1586/14737175.2014.939173; Tammariello SP, 2000, J NEUROSCI, V20; Thierbach R, 2005, HUM MOL GENET, V14, P3857, DOI 10.1093/hmg/ddi410; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Wong A, 1999, HUM MOL GENET, V8, P425, DOI 10.1093/hmg/8.3.425; Yuzawa S, 2009, J INNATE IMMUN, V1, P543, DOI 10.1159/000235656	44	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153574	10.1371/journal.pone.0153574	http://dx.doi.org/10.1371/journal.pone.0153574			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078885	Green Published, Green Submitted, gold			2022-12-26	WOS:000374131700082
J	Schleicher, N; Tomkins, AJ; Kampschulte, M; Hyvelin, JM; Botteron, C; Juenemann, M; Yeniguen, M; Krombach, GA; Kaps, M; Spratt, NJ; Gerriets, T; Nedelmann, M				Schleicher, Nadine; Tomkins, Amelia J.; Kampschulte, Marian; Hyvelin, Jean-Marc; Botteron, Catherine; Juenemann, Martin; Yeniguen, Mesut; Krombach, Gabriele A.; Kaps, Manfred; Spratt, Neil J.; Gerriets, Tibo; Nedelmann, Max			Sonothrombolysis with BR38 Microbubbles Improves Microvascular Patency in a Rat Model of Stroke	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; CEREBRAL-ARTERY OCCLUSION; ISCHEMIC-STROKE; ULTRASOUND; REPERFUSION; RECANALIZATION; THROMBOLYSIS; BLOOD; TOMOGRAPHY; TRIAL	Background Early recanalization of large cerebral vessels in ischemic stroke is associated with improved clinical outcome, however persisting hypoperfusion leads to poor clinical recovery despite large vessel recanalization. Limited experimental sonothrombolysis studies have shown that addition of microbubbles during treatment can improve microvascular patency. We aimed to determine the effect of two different microbubble formulations on microvascular patency in a rat stroke model. Methods We tested BR38 and SonoVue (R) microbubble-enhanced sonothrombolysis in Wistar rats submitted to 90-minute filament occlusion of the middle cerebral artery. Rats were randomized to treatment (n = 6/group): control, rt-PA, or rt-PA+3-MHz ultrasound insonation with BR38 or SonoVue (R) at full or 1/3 dose. Treatment duration was 60 minutes, beginning after withdrawal of the filament, and sacrifice was immediately after treatment. Vascular volumes were evaluated with microcomputed tomography. Results Total vascular volume of the ipsilateral hemisphere was reduced in control and rt-PA groups (p<0.05), but was not significantly different from the contralateral hemisphere in all microbubble-treated groups (p>0.1). Conclusions Microbubble-enhanced sonothrombolysis improves microvascular patency. This effect is not dose-or microbubble formulation-dependent suggesting a class effect of microbubbles promoting microvascular reopening. This study demonstrates that microbubble-enhanced sonothrombolysis may be a therapeutic strategy for patients with persistent hypoperfusion of the ischemic territory.	[Schleicher, Nadine; Tomkins, Amelia J.; Juenemann, Martin; Yeniguen, Mesut; Gerriets, Tibo] Univ Giessen, Heart & Brain Res Grp, D-35390 Giessen, Germany; [Schleicher, Nadine; Juenemann, Martin; Yeniguen, Mesut; Kaps, Manfred; Gerriets, Tibo] Univ Giessen, Dept Neurol, D-35390 Giessen, Germany; [Schleicher, Nadine] Kerckhoff Clin, Dept Cardiac Surg, Bad Nauheim, Germany; [Tomkins, Amelia J.; Spratt, Neil J.] Univ Newcastle, Sch Biomed Sci & Pharm, Newcastle, NSW 2300, Australia; [Tomkins, Amelia J.; Spratt, Neil J.] Hunter Med Res Inst, Newcastle, NSW, Australia; [Kampschulte, Marian; Krombach, Gabriele A.] Univ Giessen, Dept Diagnost & Intervent Radiol, D-35390 Giessen, Germany; [Hyvelin, Jean-Marc; Botteron, Catherine] Bracco Suisse SA, Geneva, Switzerland; [Spratt, Neil J.] Hunter New England Local Hlth Dist, New Lambton, NSW, Australia; [Gerriets, Tibo] Buergerhosp Friedberg, Dept Neurol, Friedberg, Germany; [Nedelmann, Max] Sana Regio Klinkum, Pinneberg, Germany; [Nedelmann, Max] Univ Hosp Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; Kerckhoff Clinic; University of Newcastle; Hunter Medical Research Institute; University of Newcastle; Justus Liebig University Giessen; Bracco; University of Hamburg; University Medical Center Hamburg-Eppendorf	Nedelmann, M (corresponding author), Sana Regio Klinkum, Pinneberg, Germany.; Nedelmann, M (corresponding author), Univ Hosp Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany.	max.nedelmann@sana.de	Spratt, Neil J/K-4208-2012	Spratt, Neil J/0000-0002-9023-6177; Botteron, Catherine/0000-0001-9525-1723	Heart Foundation Australia; Hunter Medical Research Institute Travel Scholarship; Australian National Health and Medical Research Council [APP1035465]; Bracco Suisse SA, Geneva, Switzerland; Faculty of Human Medicine, Justus-Liebig University, Giessen; German Research Foundation [NST 162/291-1 FUGG]	Heart Foundation Australia; Hunter Medical Research Institute Travel Scholarship; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Bracco Suisse SA, Geneva, Switzerland; Faculty of Human Medicine, Justus-Liebig University, Giessen; German Research Foundation(German Research Foundation (DFG))	Ms. Amelia Tomkins was supported by a Heart Foundation Australia post-graduate scholarship cofounded by the National Stroke Foundation Australia, and by a Hunter Medical Research Institute Travel Scholarship funded by Mrs. Jennie Thomas. Dr. Neil Spratt was supported by an Australian National Health and Medical Research Council Career Development Fellowship (APP1035465). The study was in part supported by Bracco Suisse SA, Geneva, Switzerland and in part from the Faculty of Human Medicine, Justus-Liebig University, Giessen and the German Research Foundation (NST 162/291-1 FUGG). The co-authors, Jean-Marc Hyvelin and Catherine Botteron, are employees of Bracco Suisse SA, Geneva, Switzerland. Their contribution was histology and histological analysis and manuscript preparation in conjunction with all other co-authors. All other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blinder P, 2010, P NATL ACAD SCI USA, V107, P12670, DOI 10.1073/pnas.1007239107; Cho TH, 2015, STROKE, V46, P1582, DOI 10.1161/STROKEAHA.114.007964; Daffertshofer M, 2005, STROKE, V36, P1441, DOI 10.1161/01.STR.0000170707.86793.1a; Dalkara T, 2012, J CEREBR BLOOD F MET, V32, P2091, DOI 10.1038/jcbfm.2012.139; Dawson DA, 1997, BRAIN RES, V749, P200, DOI 10.1016/S0006-8993(96)01166-3; Eilaghi A, 2013, RADIOLOGY, V269, P240, DOI 10.1148/radiol.13122327; Kampschulte M, 2016, ROFO-FORTSCHR RONTG, V188, P146, DOI 10.1055/s-0041-106541; Langheinrich AC, 2004, RADIOLOGY, V233, P165, DOI 10.1148/radiol.2331031340; Langheinrich AC, 2010, NEURORADIOLOGY, V52, P815, DOI 10.1007/s00234-009-0617-5; Miller MW, 1996, ULTRASOUND MED BIOL, V22, P1131, DOI 10.1016/S0301-5629(96)00089-0; Molina CA, 2006, STROKE, V37, P425, DOI 10.1161/01.STR.0000199064.94588.39; Molina CA, 2009, ANN NEUROL, V66, P28, DOI 10.1002/ana.21723; Nedelmann M, 2010, J CEREBR BLOOD F MET, V30, P1712, DOI 10.1038/jcbfm.2010.82; Nedelmann M, 2008, ULTRASOUND MED BIOL, V34, P2019, DOI 10.1016/j.ultrasmedbio.2008.06.003; OKADA Y, 1994, STROKE, V25, P1847, DOI 10.1161/01.STR.25.9.1847; Perren F, 2008, J THROMB THROMBOLYS, V25, P219, DOI 10.1007/s11239-007-0044-6; Petit B, 2012, ULTRASOUND MED BIOL, V38, P1222, DOI 10.1016/j.ultrasmedbio.2012.02.023; Porter TR, 2001, PROG CARDIOVASC DIS, V44, P101, DOI 10.1053/pcad.2001.26441; Rubiera M, 2008, ULTRASOUND MED BIOL, V34, P1573, DOI 10.1016/j.ultrasmedbio.2008.02.011; Saqqur M, 2014, J NEUROIMAGING, V24, P209, DOI 10.1111/jon.12026; Schneider M, 2011, INVEST RADIOL, V46, P486, DOI 10.1097/RLI.0b013e318217b821; Soares BP, 2010, STROKE, V41, pE34, DOI 10.1161/STROKEAHA.109.568766; Soehle M, 2001, J NEUROSCI METH, V110, P91, DOI 10.1016/S0165-0270(01)00422-8; Tsivgoulis G, 2010, STROKE, V41, P280, DOI 10.1161/STROKEAHA.109.563304; Viguier A, 2005, J THROMB THROMBOLYS, V19, P55, DOI 10.1007/s11239-005-0940-6	25	23	25	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0152898	10.1371/journal.pone.0152898	http://dx.doi.org/10.1371/journal.pone.0152898			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077372	gold, Green Published, Green Submitted			2022-12-26	WOS:000374131700013
J	Todd, VLG; Warley, JC; Todd, IB				Todd, Victoria Louise Georgia; Warley, Jane Clare; Todd, Ian Boyer			Meals on Wheels? A Decade of Megafaunal Visual and Acoustic Observations from Offshore Oil & Gas Rigs and Platforms in the North and Irish Seas	PLOS ONE			English	Article							TO-REEFS; HARBOR PORPOISES; ECHOLOCATION SIGNALS; PHOCOENA-PHOCOENA; FISH	A decade of visual and acoustic detections of marine megafauna around offshore Oil & Gas (O&G) installations in the North and Irish Seas are presented. Marine megafauna activity was monitored visually and acoustically by Joint Nature Conservation Committee (JNCC) qualified and experienced Marine Mammal Observers (MMO) and Passive Acoustic Monitoring (PAM) Operators respectively, with real-time towed PAM in combination with industry standard software, PAMGuard. Monitoring was performed during routine O&G industrial operations for underwater noise mitigation purposes, and to ensure adherence to regulatory guidelines. Incidental sightings by off-effort MMOs and installation crew were also reported. Visual and acoustic monitoring spanned 55 non-consecutive days between 2004 and 2014. A total of 47 marine mammal sightings were recorded by MMOs on dedicated watch, and 10 incidental sightings of marine megafauna were reported over 10 years. Species included: harbour porpoise (Phocoena phocoena), Atlantic white-sided dolphin (Lagenorhynchus acutus), white beaked dolphin (Lagenorhynchus albirostris), common dolphin (Delphinus delphis), minke whale (Balaenoptera acutorostrata), common seal (Phoca vitulina), grey seal (Halichoerus grypus) and, basking shark (Cetorhinus maximus). Passive Acoustic Monitoring was conducted on two occasions in 2014; 160 PAM hours over 12 days recorded a total of 308 individual clicks identified as harbour porpoises. These appear to be the first such acoustic detections obtained from a North Sea drilling rig whilst using a typically configured hydrophone array designed for towing in combination with real-time PAMGuard software. This study provides evidence that marine megafauna are present around mobile and stationary offshore O&G installations during routine operational activities. On this basis, Environmental Impact Assessments (EIAs) for decommissioning O&G platforms should be carried-out on a case-by-case basis, and must include provisions for hitherto overlooked marine megafauna.	[Todd, Victoria Louise Georgia; Warley, Jane Clare; Todd, Ian Boyer] Ocean Sci Consulting, Ocean House,4 Brewery Lane, Dunbar, East Lothian, England; [Todd, Victoria Louise Georgia] Univ Southampton, Inst Sound & Vibrat Res, Highfield, Hants, England	University of Southampton	Todd, VLG (corresponding author), Ocean Sci Consulting, Ocean House,4 Brewery Lane, Dunbar, East Lothian, England.; Todd, VLG (corresponding author), Univ Southampton, Inst Sound & Vibrat Res, Highfield, Hants, England.	vt@osc.co.uk		Todd, Victoria/0000-0002-9639-1661; Warley, Jane/0000-0002-6813-0296	Ocean Science Consulting	Ocean Science Consulting	Funding was provided by Ocean Science Consulting. Ocean Science Consulting provided support in the form of salaries for authors [VLGT, JCW, IBT], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au WWL, 1999, J ACOUST SOC AM, V106, P3699, DOI 10.1121/1.428221; Baine M, 2002, ICES J MAR SCI, V59, pS277, DOI 10.1006/jmsc.2002.1216; Baine M, 2003, AM FISHERIES SOC S; Bergmark P, 2014, MAR ECOL PROG SER, V516, P275, DOI 10.3354/meps10997; Bernstein BB, 2010, EVALUATING ALTERNATI; Callahan E, 2015, 1 INT C DEC OFFSH SU; Centre SP, 2016, BEAUF WIND SCAL NOAA; Cripps SJ, 2002, ICES J MAR SCI, V59, pS300, DOI 10.1006/jmsc.2002.1293; Evans PGH, 2004, MAMMAL REV, V34, P131, DOI 10.1046/j.0305-1838.2003.00027.x; Fowler AM, 2014, OCEAN COAST MANAGE, V87, P20, DOI 10.1016/j.ocecoaman.2013.10.019; Frumkes DR, 2002, ICES J MAR SCI, V59, pS272, DOI 10.1006/jmsc.2002.1289; Fujii T., 2014, SOC PETR ENG INT C H; Fujii T, 2015, MAR ENVIRON RES, V108, P69, DOI 10.1016/j.marenvres.2015.03.013; Goodson AD, 1996, ICES J MAR SCI, V53, P465, DOI 10.1006/jmsc.1996.0066; Guerin A., 2009, MARINE COMMUNITIES N; Guerin AJ, 2007, ARTIFICIAL REEF PROP, P795; HEINEMANN D, 1981, J WILDLIFE MANAGE, V45, P489, DOI 10.2307/3807930; Hume R, 2002, BIRDS BRITAIN EUROPE; IWindsurf, 2016, WIND OBS FOR; Jepson PU, 2001, DENMARK PROGR REPORT; JNCC, 2010, STAT NAT CONS AG PRO, P14; JNCC, 2010, JNCC GUID MIN RISK I; Jorgensen D, 2012, OCEAN COAST MANAGE, V58, P57, DOI 10.1016/j.ocecoaman.2011.12.012; Jorgensen D, 2009, HIST TECHNOL, V25, P343, DOI 10.1080/07341510903313030; Kastelein RA, 1997, FOOD CONSUMPTION BOD; Koopman HN, 1994, THESIS U GUELPH GUEL; Linnenschmidt M, 2013, MAR MAMMAL SCI, V29, pE77, DOI 10.1111/j.1748-7692.2012.00592.x; Macreadie PI, 2012, FRONT ECOL ENVIRON, V10, P179, DOI 10.1890/12.WB.013; Macreadie PI, 2011, FRONT ECOL ENVIRON, V9, P455, DOI 10.1890/100112; Offshore Technology, 2016, WING GAS FIELD; Oil and Gas UK, 2015, ACT SURV 2015; Otani S, 2000, MAR MAMMAL SCI, V16, P811, DOI 10.1111/j.1748-7692.2000.tb00973.x; Palka Debra, 1996, Report of the International Whaling Commission, V46, P575; Picken G, 2000, ARTIFICIAL REEFS IN EUROPEAN SEAS, P331; Quantum GIS Development Team, 2014, 281 QUANT GIS DEV TE; Rigzone, 2016, PAR HZ1; Rijkswaterstaat, 2016, WAT RIJKSW; Robinson DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058255; Rothbach D, 2007, ENV L POLY F, V17; Russell DJF, 2014, CURR BIOL, V24, pR638, DOI 10.1016/j.cub.2014.06.033; Sayer MDJ, 2002, UNDERWATER TECHNOL, V25, P93, DOI 10.3723/175605402783219181; Soldal AV, 2002, ICES J MAR SCI, V59, pS281, DOI 10.1006/jmsc.2002.1279; Systat Software Inc, 2011, SIGMPL 12 0 BUILD 12; Teilmann Jonas, 2003, Journal of Cetacean Research and Management, V5, P85; Teilmann Jonas, 2002, Aquatic Mammals, V28, P275; Todd V., 2015, MARINE MAMMAL OBSERV; Todd VLG, 2009, ICES J MAR SCI, V66, P734, DOI 10.1093/icesjms/fsp035; Triossi F, 2013, MAR ECOL-EVOL PERSP, V34, P373, DOI 10.1111/maec.12020; Twomey B, 2012, WORKSH END CONC DEC, P37; Villadsgaard A, 2007, J EXP BIOL, V210, P56, DOI 10.1242/jeb.02618; Wilson B, 2013, ENDANGER SPECIES RES, V22, P125, DOI 10.3354/esr00538; Zawawi N. A. W. A., 2012, 2012 IEEE Colloquium on Humanities, Science and Engineering Research (CHUSER 2012), P26, DOI 10.1109/CHUSER.2012.6504275	52	22	22	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153320	10.1371/journal.pone.0153320	http://dx.doi.org/10.1371/journal.pone.0153320			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078153	Green Published, Green Submitted, gold			2022-12-26	WOS:000374131700038
J	Charles, MK; Lindegren, ML; Wester, CW; Blevins, M; Sterling, TR; Dung, NT; Dusingize, JC; Avit-Edi, D; Durier, N; Castelnuovo, B; Nakigozi, G; Cortes, CP; Ballif, M; Fenner, L				Charles, M. Katherine; Lindegren, Mary Lou; Wester, C. William; Blevins, Meridith; Sterling, Timothy R.; Nguyen Thi Dung; Dusingize, Jean Claude; Avit-Edi, Divine; Durier, Nicolas; Castelnuovo, Barbara; Nakigozi, Gertrude; Cortes, Claudia P.; Ballif, Marie; Fenner, Lukas		Int Epidemiology Databases	Implementation of Tuberculosis Intensive Case Finding, Isoniazid Preventive Therapy, and Infection Control ("Three I's") and HIV-Tuberculosis Service Integration in Lower Income Countries	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; SOUTH-AFRICA; CARE; RISK; CHALLENGES; EXPERIENCE; OUTCOMES; LESSONS	Setting World Health Organization advocates for integration of HIV-tuberculosis (TB) services and recommends intensive case finding (ICF), isoniazid preventive therapy (IPT), and infection control ("Three I's") for TB prevention and control among persons living with HIV. Objective To assess the implementation of the "Three I's" of TB-control at HIV treatment sites in lower income countries. Design Survey conducted between March-July, 2012 at 47 sites in 26 countries: 6 (13%) Asia Pacific, 7 (15%), Caribbean, Central and South America, 5 (10%) Central Africa, 8 (17%) East Africa, 14 (30%) Southern Africa, and 7 (15%) West Africa.	[Charles, M. Katherine; Lindegren, Mary Lou; Wester, C. William; Blevins, Meridith; Sterling, Timothy R.] Vanderbilt Univ, Sch Med, VIGH, Nashville, TN USA; [Nguyen Thi Dung] Natl Hosp Trop Dis, Hanoi, Vietnam; [Dusingize, Jean Claude] Womens Equ Access Care & Treatment, Kigali, Rwanda; [Avit-Edi, Divine] MTCTPlus, Abidjan, Cote Ivoire; [Durier, Nicolas] AmfAR, TREAT Asia, Bangkok, Thailand; [Castelnuovo, Barbara] Infect Dis Inst, Kampala, Uganda; [Nakigozi, Gertrude] Rakai Hlth Sci Program, Kalisizo, Uganda; [Cortes, Claudia P.] Univ Chile, Sch Med, Santiago, Chile; [Ballif, Marie; Fenner, Lukas] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Fenner, Lukas] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Fenner, Lukas] Univ Basel, Basel, Switzerland	Vanderbilt University; National Hospital of Tropical Diseases; Rakai Health Sciences Program; Universidad de Chile; University of Bern; University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Charles, MK (corresponding author), Vanderbilt Univ, Sch Med, VIGH, Nashville, TN USA.	katie.charles@vanderbilt.edu	Ostergaard, Lars/AAA-3020-2020; Rabie, Helena/ABH-1437-2020; Prozesky, Hans Walter/ABE-6956-2020; Adebamowo, Clement/C-8778-2011; Cortes, Claudia P/AAF-7326-2020; Wejse, Christian/C-8468-2014; Wehbe, Firas/Q-6176-2019; Yotebieng, Marcel/L-2083-2013; Boulle, Andrew/C-1413-2008	Ostergaard, Lars/0000-0003-2459-0511; Rabie, Helena/0000-0001-6336-2963; Prozesky, Hans Walter/0000-0001-9715-3449; Adebamowo, Clement/0000-0002-6571-2880; Cortes, Claudia P/0000-0001-9101-9783; Wejse, Christian/0000-0002-2534-2942; Wehbe, Firas/0000-0002-3984-9584; Egger, Matthias/0000-0001-7462-5132; Fomsgaard, Anders/0000-0003-4304-0603; Gottlieb, Geoffrey/0000-0002-5749-481X; Erikstrup, Christian/0000-0001-6551-6647; Yunihastuti, Evy/0000-0001-6650-0559; Boettiger, David/0000-0002-5951-4503; Chaiwarith, Romanee/0000-0002-1241-5954; Yotebieng, Marcel/0000-0003-2110-2631; Fenner, Lukas/0000-0003-3309-4835; Dusingize, Jean Claude/0000-0001-5721-100X; Technau, Karl-Gunter/0000-0001-7367-7512; Ruxrungtham, Kiat/0000-0001-7348-2352; Ostergaard, Lars/0000-0002-7619-605X; Eugen-Olsen, Jesper/0000-0002-4630-4275; Aaby, Peter/0000-0001-8331-1389; Boulle, Andrew/0000-0002-7713-8062; Law, Matthew/0000-0002-3540-8837; MASKEW, MHAIRI/0000-0003-4238-0200; Egger, Matthias/0000-0002-1791-1842; HEMA, Arsene/0000-0002-5279-643X; Mofenson, Lynne/0000-0002-2818-9808; Cornell, Morna/0000-0001-7149-8799; Anglaret, Xavier/0000-0003-3319-8423	National Institute of Allergy and Infectious Diseases (NIAID) of National Institutes of Health (NIH) [U01AI069924, U01AI069907, U01A096299, U01AI069911, U01AI069923, U01AI069919]; IeDEA Network Coordinating Center (INCC) at Vanderbilt University [U01AI096186]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069919, UM1AI069476, U01AI069924, U01AI069907, U01AI069923, U01AI069911, UM1AI069421, U01AI096186] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID) of National Institutes of Health (NIH); IeDEA Network Coordinating Center (INCC) at Vanderbilt University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) under the following grant award numbers: Southern Africa (U01AI069924), Asia-Pacific (U01AI069907), Central Africa (U01A096299), East Africa (U01AI069911), the Caribbean, Central and South America (U01AI069923), West Africa (U01AI069919) and the IeDEA Network Coordinating Center (INCC) at Vanderbilt University (U01AI096186). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balcells ME, 2006, EMERG INFECT DIS, V12, P744; Corbett EL, 2006, LANCET, V367, P926, DOI 10.1016/S0140-6736(06)68383-9; Durovni B, 2010, AIDS, V24, pS49, DOI 10.1097/01.aids.0000391022.95412.a6; Fenner L, 2011, INT J TUBERC LUNG D, V15, P620, DOI 10.5588/ijtld.10.0249; Fenner L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077697; Friedland G, 2007, J INFECT DIS, V196, pS114, DOI 10.1086/518664; Gandhi NR, 2009, JAIDS-J ACQ IMM DEF, V50, P37, DOI 10.1097/QAI.0b013e31818ce6c4; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; Golub JE, 2013, INT J TUBERC LUNG D, V17, P856, DOI 10.5588/ijtld.13.0059; Golub JE, 2009, AIDS, V23, P631, DOI 10.1097/QAD.0b013e328327964f; Harris JB, 2008, INT J TUBERC LUNG D, V12, P773; Hermans SM, 2012, JAIDS-J ACQ IMM DEF, V60, pE29, DOI 10.1097/QAI.0b013e318251aeb4; Howard AA, 2010, CLIN INFECT DIS, V50, pS238, DOI 10.1086/651497; Lawn SD, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-258; Njozing BN, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-328; Organization WH, 2012, WHO POL COLL TB HIV; Phiri S, 2011, TROP MED INT HEALTH, V16, P1397, DOI 10.1111/j.1365-3156.2011.02848.x; Reid MJA, 2012, INT J TUBERC LUNG D, V16, P1605, DOI 10.5588/ijtld.12.0033; Saito S, 2012, JAIDS-J ACQ IMM DEF, V61, P216, DOI 10.1097/QAI.0b013e3182638ec7; van Halsema CL, 2010, AIDS, V24, P1051, DOI 10.1097/QAD.0b013e32833849df; WHO, 2009, WHO POL INF CONTR HL; WHO, 2008, EPI SEM 2008; World Health Organization, 2012, GUID INT TUB CAS FIN	23	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153243	10.1371/journal.pone.0153243	http://dx.doi.org/10.1371/journal.pone.0153243			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073928	Green Published, Green Accepted, gold			2022-12-26	WOS:000374131200066
J	Danto, M; Witzmann, F; Frobisch, NB				Danto, Marylene; Witzmann, Florian; Froebisch, Nadia B.			Vertebral Development in Paleozoic and Mesozoic Tetrapods Revealed by Paleohistological Data	PLOS ONE			English	Article							METOPOSAURUS-DIAGNOSTICUS TEMNOSPONDYLI; PLAGIOSAURID GERROTHORAX PULCHERRIMUS; BONE-HISTOLOGY; POSTCRANIAL SKELETON; TRIASSIC TEMNOSPONDYL; CRANIAL MORPHOLOGY; EXTANT AMPHIBIANS; EVOLUTION; GERMANY; KRASIEJOW	Basal tetrapods display a wide spectrum of vertebral centrum morphologies that can be used to distinguish different tetrapod groups. The vertebral types range from multipartite centra in stem-tetrapods, temnospondyls, and seymouriamorphs up to monospondylous centra in lepospondyls and have been drawn upon for reconstructing major evolutionary trends in tetrapods that are now considered textbook knowledge. Two modes of vertebral formation have been postulated: the multipartite vertebrae formed first as cartilaginous elements with subsequent ossification. The monospondylous centrum, in contrast, was formed by direct ossification without a cartilaginous precursor. This study describes centrum morphogenesis in basal tetrapods for the first time, based on bone histology. Our results show that the intercentra of the investigated stem-tetrapods consist of a small band of periosteal bone and a dense network of endochondral bone. In stereospondyl temnospondyls, high amounts of calcified cartilage are preserved in the endochondral trabeculae. Notably, the periosteal region is thickened and highly vascularized in the plagiosaurid stereospondyls. Among "microsaur" lepospondyls, the thickened periosteal region is composed of compact bone and the notochordal canal is surrounded by large cell lacunae. In nectridean lepospondyls, the periosteal region has a spongy structure with large intertrabecular spaces, whereas the endochondral region has a highly cancellous structure. Our observations indicate that regardless of whether multipartite or monospondylous, the centra of basal tetrapods display first endochondral and subsequently periosteal ossification. A high interspecific variability is observed in growth rate, organization, and initiation of periosteal ossification. Moreover, vertebral development and structure reflect different lifestyles. The bottom-dwelling Plagiosauridae increase their skeletal mass by hyperplasy of the periosteal region. In nectrideans, the skeletal mass decreases, as the microstructure is spongy and lightly built. Additionally, we observed that vertebral structure is influenced by miniaturization in some groups. The phylogenetic information that can be drawn from vertebral development, however, is limited.	[Danto, Marylene; Witzmann, Florian; Froebisch, Nadia B.] Leibniz Inst Evolut & Biodiversitatsforsch, Museum Nat Kunde, Invalidenstr 43, D-10115 Berlin, Germany; [Witzmann, Florian] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA	Leibniz Institut fur Evolutions und Biodiversitatsforschung; Brown University	Danto, M (corresponding author), Leibniz Inst Evolut & Biodiversitatsforsch, Museum Nat Kunde, Invalidenstr 43, D-10115 Berlin, Germany.	marylene.danto@mfn-berlin.de			Leibniz Association	Leibniz Association	MD was founded by the Deutsche Forschungsgemeinschaft (DFG WI 3144/3-1). The publication of this article was funded by the Open Access fund of the Leibniz Association.	Amprino R, 1947, ARCH BIOL, V58, P317; Anderson JS, 2001, SYST BIOL, V50, P170; ANDREWS SM, 1991, T ROY SOC EDIN-EARTH, V82, P239, DOI 10.1017/S0263593300005332; [Anonymous], 1966, VERTEBRATE PALEONTOL; Boisvert CA, 2009, J EXP ZOOL PART B, V312B, P1, DOI 10.1002/jez.b.21238; BOLT JR, 1969, SCIENCE, V166, P888, DOI 10.1126/science.166.3907.888; Bolt JR, 1968, THESIS U CHICAGO; Borkhvardt V. G., 1969, PALEONTOL ZH, V3, P146; Bossy Kathleen A., 1998, P73; CARROLL R, 1998, ENCY PALEOHERPETOL 1, P1; Carroll R.L., 1978, Memoirs of the American Philosophical Society, V126, P1; Carroll R.L., 1989, Historical Biology, V3, P1; Carroll RL, 1999, EVOL DEV, V1, P36; CARROLL RL, 1995, J VERTEBR PALEONTOL, V15, P37, DOI 10.1080/02724634.1995.10011206; CARROLL RL, 1968, CAN J ZOOLOG, V46, P1175, DOI 10.1139/z68-168; Carroll RL, 2007, ZOOL J LINN SOC-LOND, V150, P1, DOI 10.1111/j.1096-3642.2007.00246.x; Carroll Robert L., 2000, Amphibian Biology, V4, P1198; Carroll Robert L., 2000, Amphibian Biology, V4, P973; Castanet J., 2003, Amphibian Biology, V5, P1598; Clack J.A., 2012, GAINING GROUND, VSecond; Clack JA, 2009, SPEC PAP PALAEONTOL, P15, DOI 10.1111/j.1475-4983.2009.00867.x; CRUICKSHANK ARI, 1980, PROC R SOC SER B-BIO, V209, P513, DOI 10.1098/rspb.1980.0110; de Ricqles A., 1981, Annales de Paleontologie Vertebres, V67, P141; de Ricqles Armand, 2001, P289; DERICQLES A, 1979, CR ACAD SCI D NAT, V288, P1147; Enlow D. H., 1956, Texas Journal of Science, V8, P405; Francillon-Vieillot H., 1990, P471; Frobisch NB, 2009, SYST BIOL, V58, P312, DOI 10.1093/sysbio/syp029; GARDINER BG, 1983, ZOOL J LINN SOC-LOND, V79, P1, DOI 10.1111/j.1096-3642.1983.tb01160.x; GODFREY SJ, 1989, PHILOS T ROY SOC B, V323, P75, DOI 10.1098/rstb.1989.0002; Golubev V. K., 1998, PALEONTOL J, V32, P278; Hall B.K., 2015, BONES CARTILAGE DEV; Hellrung Hanna, 2003, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V330, P1; HOLMES R, 1984, PHILOS T ROY SOC B, V306, P431, DOI 10.1098/rstb.1984.0103; Holmes R., 1989, Historical Biology, V2, P111; Houssaye A, 2009, INTEGR ZOOL, V4, P325, DOI 10.1111/j.1749-4877.2009.00146.x; Jarvik E., 1980, BASIC STRUCTURE EVOL, V1; Kirschbaum F., 1988, Monographs in Developmental Biology, V21, P112; Klembara J, 2000, T ROY SOC EDIN-EARTH, V90, P287; Konietzko-Meier D, 2013, NETH J GEOSCI, V92, P97, DOI 10.1017/S0016774600000020; Konietzko-Meier D, 2012, EARTH ENV SCI T R SO, V103, P237, DOI 10.1017/S1755691013000273; Konietzko-Meier D, 2014, BIOL J LINN SOC, V112, P747, DOI 10.1111/bij.12301; Konietzko-Meier D, 2013, J VERTEBR PALEONTOL, V33, P1003, DOI 10.1080/02724634.2013.765886; Konietzko-Meier D, 2013, PALAEOGEOGR PALAEOCL, V370, P145, DOI 10.1016/j.palaeo.2012.12.003; Laurin M, 1998, ANN SCI NAT ZOOL, V19, P1, DOI 10.1016/S0003-4339(98)80132-9; Laurin Michel, 2000, Amphibian Biology, V4, P1064; LAWSON R, 1966, J MORPHOL, V118, P137, DOI 10.1002/jmor.1051180109; LOMBARD RE, 1995, PALAEONTOLOGY, V38, P471; Marjanovic D, 2008, ACTA PALAEONTOL POL, V53, P413, DOI 10.4202/app.2008.0305; Marjanovic D, 2013, GEODIVERSITAS, V35, P207, DOI 10.5252/g2013n1a8; Marjanovic D, 2008, CONTRIB ZOOL, V77, P149, DOI 10.1163/18759866-07703002; Miall L. C., 1875, M BRIT ASS ADV SCI, V44, P149; Milner A.R., 1990, Systematics Association Special Volume Series, P321; Milner A.R., 2000, HDB PALAOHERPETOLO B, V3B, P1; Mukherjee D, 2010, J VERTEBR PALEONTOL, V30, P78, DOI 10.1080/02724630903409121; Novikov I.V., 2000, PALEONTOL J+, V34, P165; Novikov Igor V., 2000, P60; Olori JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128333; Panchen A. L., 1977, PROBLEMS VERTEBRATE, P289; Pawley Kat, 2004, Palaeontologia Africana, V40, P1; Pyron RA, 2011, SYST BIOL, V60, P466, DOI 10.1093/sysbio/syr047; Reisz RR, 2009, NATURWISSENSCHAFTEN, V96, P789, DOI 10.1007/s00114-009-0533-x; Romer A, 1956, OSTEOLOGY REPTILES; ROMER A. S., 1947, BULL MUS COMP ZOOL HARVARD UNIV, V99, P1; ROMER ALFRED S., 1964, BULL MUS COMP ZOOL [HARVARD UNIV], V131, P87; Ruta M, 2003, BIOL REV, V78, P251, DOI 10.1017/S1464793102006103; Ruta M, 2007, J SYST PALAEONTOL, V5, P69, DOI 10.1017/S1477201906002008; Ruta M, 2006, T ROY SOC EDIN-EARTH, V97, P31, DOI 10.1017/S0263593300001395; Sanchez S, 2013, EVOL BIOL, V40, P627, DOI 10.1007/s11692-013-9238-3; Sanchez S, 2010, J EVOLUTION BIOL, V23, P2076, DOI 10.1111/j.1420-9101.2010.02081.x; Sanchez S, 2008, BIOL LETTERS, V4, P411, DOI 10.1098/rsbl.2008.0159; Sanchez S, 2010, EVOL DEV, V12, P315, DOI 10.1111/j.1525-142X.2010.00417.x; Schultze H-P., 1970, Am. Mus. Novit., VNo. 2408, P1; Schoch RR, 2014, PALAEONTOLOGY, V57, P1045, DOI 10.1111/pala.12101; Schoch RR, 2013, J SYST PALAEONTOL, V11, P673, DOI 10.1080/14772019.2012.699006; Schoch RR, 2012, LETHAIA, V45, P371, DOI 10.1111/j.1502-3931.2011.00290.x; Schoch RR, 2010, ZOOL J LINN SOC-LOND, V160, P515, DOI 10.1111/j.1096-3642.2009.00613.x; Schoch Rainer R., 1999, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V278, P1; Schoch RR, 2009, ANNU REV EARTH PL SC, V37, P135, DOI 10.1146/annurev.earth.031208.100113; Schoch RR, 2014, HDB PALAOHERPETOLOGI, V3A2, P1; SCHULTZE HP, 1986, J MORPHOL, V190, P215, DOI 10.1002/jmor.1051900206; Sigurdsen T, 2011, ZOOL J LINN SOC-LOND, V162, P457, DOI 10.1111/j.1096-3642.2010.00683.x; Sigurdsen T, 2010, J VERTEBR PALEONTOL, V30, P1360, DOI 10.1080/02724634.2010.501445; Sigurdsen T, 2009, J MORPHOL, V270, P1443, DOI 10.1002/jmor.10769; Smithson Tim, 2000, Amphibian Biology, V4, P1053; Steen MC, 1938, P ZOOL SOC LOND B-SY, V108, P205, DOI 10.1111/j.1096-3642.1938.tb00027.x; Sulej Tomasz, 2007, Palaeontologia Polonica, V64, P29; Vallin G, 2004, J VERTEBR PALEONTOL, V24, P56, DOI 10.1671/5.1; Vorobyeva E., 1991, P68; WAKE DB, 1973, J MORPHOL, V139, P251, DOI 10.1002/jmor.1051390302; WARREN A, 1991, ALCHERINGA, V15, P43, DOI 10.1080/03115519108619009; Warren Anne, 1997, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V247, P1; Watson DMS, 1920, PHILOS T R SOC LON B, V209, P1, DOI 10.1098/rstb.1920.0001; White T. E., 1939, Bulletin of the Museum of Comparative Zoology, V85, P325; WILLIAMS EE, 1959, Q REV BIOL, V34, P1; Witzmann F, 2006, J VERTEBR PALEONTOL, V26, P7, DOI 10.1671/0272-4634(2006)26[7:DPAOSI]2.0.CO;2; Witzmann F, 2008, NATURWISSENSCHAFTEN, V95, P67, DOI 10.1007/s00114-007-0291-6; Witzmann F, 2012, PALAEONTOLOGY, V55, P31, DOI 10.1111/j.1475-4983.2011.01116.x; Witzmann Florian, 2009, Palaeodiversity, P233; Witzmann F, 2010, ACTA ZOOL-STOCKHOLM, V91, P96, DOI 10.1111/j.1463-6395.2008.00385.x; Woodward HN, 2013, BONE HISTOLOGY OF FOSSIL TETRAPODS: ADVANCING METHODS, ANALYSIS, AND INTERPRETATION, P195; ZHANG FK, 1984, VERTEBRAT PALASIATIC, V22, P294	102	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152586	10.1371/journal.pone.0152586	http://dx.doi.org/10.1371/journal.pone.0152586			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074015	Green Published, gold			2022-12-26	WOS:000374131200029
J	Regier, T; Carstensen, A; Kemp, C				Regier, Terry; Carstensen, Alexandra; Kemp, Charles			Languages Support Efficient Communication about the Environment: Words for Snow Revisited	PLOS ONE			English	Article							REDUNDANCY; CLIMATE	The claim that Eskimo languages have words for different types of snow is well-known among the public, but has been greatly exaggerated through popularization and is therefore viewed with skepticism by many scholars of language. Despite the prominence of this claim, to our knowledge the line of reasoning behind it has not been tested broadly across languages. Here, we note that this reasoning is a special case of the more general view that language is shaped by the need for efficient communication, and we empirically test a variant of it against multiple sources of data, including library reference works, Twitter, and large digital collections of linguistic and meteorological data. Consistent with the hypothesis of efficient communication, we find that languages that use the same linguistic form for snow and ice tend to be spoken in warmer climates, and that this association appears to be mediated by lower communicative need to talk about snow and ice. Our results confirm that variation in semantic categories across languages may be traceable in part to local communicative needs. They suggest moreover that despite its awkward history, the topic of "words for snow" may play a useful role as an accessible instance of the principle that language supports efficient communication.	[Regier, Terry] Univ Calif Berkeley, Dept Linguist, Cognit Sci Program, Berkeley, CA 94720 USA; [Carstensen, Alexandra] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Kemp, Charles] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Carnegie Mellon University	Regier, T (corresponding author), Univ Calif Berkeley, Dept Linguist, Cognit Sci Program, Berkeley, CA 94720 USA.	terry.regier@berkeley.edu		Kemp, Charles/0000-0001-9683-8737; Carstensen, Alexandra/0000-0003-0582-9152	National Science Foundation [SBE-1041707, DGE-1106400]; Berkeley Research Impact Initiative (BRII) - UC Berkeley Library	National Science Foundation(National Science Foundation (NSF)); Berkeley Research Impact Initiative (BRII) - UC Berkeley Library	This research was supported by the National Science Foundation (www.nsf.gov) under grants SBE-1041707 (TR) and DGE-1106400 (AC). Publication was made possible in part by support from the Berkeley Research Impact Initiative (BRII) sponsored by the UC Berkeley Library.	[Anonymous], 2013, APPROACHES MEASURING, DOI DOI 10.1515/9783110305258.285; Baddeley R, 2009, PSYCHOL SCI, V20, P1100, DOI 10.1111/j.1467-9280.2009.02412.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boas Franz, 1911, HDB AM INDIAN LANGUA, V1, P1; Bybee JoanL., 1994, EVOLUTION GRAMMAR TE; Cancho RFI, 2003, P NATL ACAD SCI USA, V100, P788, DOI 10.1073/pnas.0335980100; Dediu D., 2015, LANGUAGE FAMILY CLAS; Eisenstein J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113114; EMBER M, 1978, AM ANTHROPOL, V80, P364, DOI 10.1525/aa.1978.80.2.02a00100; Everett C, 2015, P NATL ACAD SCI USA, V112, P1322, DOI 10.1073/pnas.1417413112; Fedzechkina M, 2012, P NATL ACAD SCI USA, V109, P17897, DOI 10.1073/pnas.1215776109; Greenberg JH, 2005, LANGUAGE UNIVERSALS: WITH SPECIAL REFERENCE TO FEATURE HIERARCHIES, P72; Hammarstrom H, 2015, GLOTTOLOG 2 4; Haspelmath M., 2009, WORLD LOANWORD DATAB; Hawkins J, 2003, EFFICIENCY COMPLEXIT; Jaeger TF, 2010, COGNITIVE PSYCHOL, V61, P23, DOI 10.1016/j.cogpsych.2010.02.002; Kemp C, 2012, SCIENCE, V336, P1049, DOI 10.1126/science.1218811; Kirby S, 2015, COGNITION, V141, P87, DOI 10.1016/j.cognition.2015.03.016; Krupnik I, 2010, SIKU: KNOWING OUR ICE: DOCUMENTING INUIT SEA-ICE KNOWLEDGE AND USE, P377, DOI 10.1007/978-90-481-8587-0_16; Levy R, 2008, COGNITION, V106, P1126, DOI 10.1016/j.cognition.2007.05.006; LIST J, 2013, P 10 INT C COMP SEM; Maddieson I, 2015, 170 M AC SOC AM; MARTIN L, 1986, AM ANTHROPOL, V88, P418, DOI 10.1525/aa.1986.88.2.02a00080; Nichols Johanna, 2013, AUTOTYP GENEALOGY GE; Piantadosi ST, 2011, P NATL ACAD SCI USA, V108, P3526, DOI 10.1073/pnas.1012551108; Pullum G., 1991, GREAT ESKIMO VOCABUL, P159; Regier T, 2015, BLACKW HBK LINGUIST, P237; Roberts S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070902; Sapir E, 1912, AM ANTHROPOL, V14, P226, DOI 10.1525/aa.1912.14.2.02a00020; Saxton D., 1969, DICT PAPAGO PIMA ENG; Voegelin CharlesFrederick., 1977, CLASSIFICATION INDEX; Whorf Benjamin., 1956, LANGUAGE THOUGHT REA; WITKOWSKI SR, 1978, ANNU REV ANTHROPOL, V7, P427, DOI 10.1146/annurev.an.07.100178.002235; WITKOWSKI SR, 1985, ETHNOLOGY, V24, P197, DOI 10.2307/3773610; Youn H, 2016, P NATL ACAD SCI USA, V113, P1766, DOI 10.1073/pnas.1520752113; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	37	39	39	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0151138	10.1371/journal.pone.0151138	http://dx.doi.org/10.1371/journal.pone.0151138			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UC	27073981	Green Published, gold			2022-12-26	WOS:000374131200006
J	Ruggeri, P; Splendiani, A; Occhipinti, G; Fioravanti, T; Santojanni, A; Leonori, I; De Felice, A; Arneri, E; Procaccini, G; Catanese, G; Ticina, V; Bonanno, A; Cerioni, PN; Giovannotti, M; Grant, WS; Barucchi, VC				Ruggeri, Paolo; Splendiani, Andrea; Occhipinti, Giulia; Fioravanti, Tatiana; Santojanni, Alberto; Leonori, Iole; De Felice, Andrea; Arneri, Enrico; Procaccini, Gabriele; Catanese, Gaetano; Ticina, Vjekoslav; Bonanno, Angelo; Cerioni, Paola Nisi; Giovannotti, Massimo; Grant, William Stewart; Barucchi, Vincenzo Caputo			Biocomplexity in Populations of European Anchovy in the Adriatic Sea	PLOS ONE			English	Article							POLYMORPHIC MICROSATELLITE LOCI; ENGRAULIS-ENCRASICOLUS; GENETIC DIFFERENTIATION; SEASCAPE GENETICS; GENERAL-CIRCULATION; MAXIMUM-LIKELIHOOD; MITOCHONDRIAL-DNA; MARINE FISH; SELECTION; SOFTWARE	The sustained exploitation of marine populations requires an understanding of a species' adaptive seascape so that populations can track environmental changes from short-and long-term climate cycles and from human development. The analysis of the distributions of genetic markers among populations, together with correlates of life-history and environmental variability, can provide insights into the extent of adaptive variation. Here, we examined genetic variability among populations of mature European anchovies (n = 531) in the Adriatic (13 samples) and Tyrrhenian seas (2 samples) with neutral and putative non-neutral microsatellite loci. These genetic markers failed to confirm the occurrence of two anchovy species in the Adriatic Sea, as previously postulated. However, we found fine-scale population structure in the Adriatic, especially in northern areas, that was associated with four of the 13 environmental variables tested. Geographic gradients in sea temperature, salinity and dissolved oxygen appear to drive adaptive differences in spawning time and early larval development among populations. Resolving adaptive seascapes in Adriatic anchovies provides a means to understand mechanisms underpinning local adaptation and a basis for optimizing exploitation strategies for sustainable harvests.	[Ruggeri, Paolo; Splendiani, Andrea; Occhipinti, Giulia; Fioravanti, Tatiana; Cerioni, Paola Nisi; Giovannotti, Massimo; Barucchi, Vincenzo Caputo] Univ Politecn Marche, Dipartimento Sci Vita & Ambiente, Via Brecce Bianche, I-60131 Ancona, Italy; [Santojanni, Alberto; Leonori, Iole; De Felice, Andrea] CNR, Ist Sci Marine, Sez Pesca Marittima, I-60125 Ancona, Italy; [Arneri, Enrico] FAO FIRF, Dept Fisheries & Aquaculture, AdriaMed Project, Viale Terme di Caracalla, I-00153 Rome, Italy; [Procaccini, Gabriele; Catanese, Gaetano] Anton Dohrn, Stn Zool, I-80121 Naples, Italy; [Ticina, Vjekoslav] Inst Oceanog & Fisheries, Lab Fisheries Sci & Management Pelag & Demersal R, Setaliste I Mestrovica 63, Split 21000, Croatia; [Bonanno, Angelo] CNR, IAMC, Detached Unit Capo Granitola TP, Via Mare 3, I-91021 Torretta Granitola Fraz, TP, Italy; [Grant, William Stewart] Alaska Dept Fish & Game, Commercial Fishery Div, Commercial Fisheries Div, Anchorage, AK 99518 USA	Marche Polytechnic University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR); Stazione Zoologica Anton Dohrn di Napoli; Croatian Institute of Oceanography & Fisheries (IZOR); Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR); Alaska Department of Fish & Game	Barucchi, VC (corresponding author), Univ Politecn Marche, Dipartimento Sci Vita & Ambiente, Via Brecce Bianche, I-60131 Ancona, Italy.	v.caputo@univpm.it	De+Felice, Andrea/AHA-1500-2022; CATANESE, GAETANO/A-7510-2009; Procaccini, Gabriele/A-6618-2010; Leonori, Iole/AAF-6681-2020; De Felice, Andrea/L-9465-2014; Bonanno, Angelo/H-9025-2013; Leonori, Iole/AAD-7901-2020; Giovannotti, Massimo/AAZ-3563-2020; Procaccini, Gabriele/AAA-7040-2019	De+Felice, Andrea/0000-0002-0051-2052; CATANESE, GAETANO/0000-0001-6219-4494; Procaccini, Gabriele/0000-0002-6179-468X; Leonori, Iole/0000-0001-7673-1684; De Felice, Andrea/0000-0002-0051-2052; Bonanno, Angelo/0000-0002-3868-751X; Leonori, Iole/0000-0001-7673-1684; Procaccini, Gabriele/0000-0002-6179-468X; SANTOJANNI, ALBERTO/0000-0003-4947-3004; NISI CERIONI, Paola/0000-0001-5074-9843; Ruggeri, Paolo/0000-0002-5433-508X; Giovannotti, Massimo/0000-0001-7622-3583	RITMARE National Flagship Project (Italian Ministry for University and Research) [SP2_WP1_AZ4_UO02]; Universita Politecnica delle Marche (Ancona, Italy)	RITMARE National Flagship Project (Italian Ministry for University and Research); Universita Politecnica delle Marche (Ancona, Italy)	This work was supported by RITMARE National Flagship Project (Italian Ministry for University and Research), SP2_WP1_AZ4_UO02; and annual funds provided by Universita Politecnica delle Marche (Ancona, Italy) to Vincenzo Caputo Barucchi.	Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Artegiani A, 1997, J PHYS OCEANOGR, V27, P1492, DOI 10.1175/1520-0485(1997)027<1492:TASGCP>2.0.CO;2; Artegiani A, 1997, J PHYS OCEANOGR, V27, P1515, DOI 10.1175/1520-0485(1997)027<1515:TASGCP>2.0.CO;2; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803; Bembo DG, 1996, MAR BIOL, V126, P529, DOI 10.1007/BF00354635; Biktashev VN, 2003, J PLANKTON RES, V25, P21, DOI 10.1093/plankt/25.1.21; Bird CE, 2011, CRUSTACEAN ISS, V19, P31; Borrell YJ, 2012, ICES J MAR SCI, V69, P1357, DOI 10.1093/icesjms/fss129; Borsa P, 2004, CR BIOL, V327, P1113, DOI 10.1016/j.crvi.2004.09.003; Borsa P, 2002, BIOL J LINN SOC, V75, P261, DOI 10.1111/j.1095-8312.2002.tb01426.x; Brookfield JFY, 1996, MOL ECOL, V5, P453, DOI 10.1046/j.1365-294X.1996.00098.x; BULJAN M., 1976, OCEANOGR MAR BIOL AN, V14, P11; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Charlesworth B, 2009, NAT REV GENET, V10, P195, DOI 10.1038/nrg2526; Chistiakov DA, 2006, AQUACULTURE, V255, P1, DOI 10.1016/j.aquaculture.2005.11.031; Chiu TS, 2002, MOL ECOL NOTES, V2, P49, DOI 10.1046/j.1471-8286.2002.00142.x; Cognetti G., 2000, SEAS MILLENN ENV EVA, V1, P267; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Gaggiotti OE, 2009, EVOLUTION, V63, P2939, DOI 10.1111/j.1558-5646.2009.00779.x; Giani M, 2012, ESTUAR COAST SHELF S, V115, P1, DOI 10.1016/j.ecss.2012.08.023; Giannoulaki M, 2013, FISH OCEANOGR, V22, P69, DOI 10.1111/fog.12005; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hedgecock D, 2011, B MAR SCI, V87, P971, DOI 10.5343/bms.2010.1051; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Hilborn R, 2003, P NATL ACAD SCI USA, V100, P6564, DOI 10.1073/pnas.1037274100; ILES TD, 1982, SCIENCE, V215, P627, DOI 10.1126/science.215.4533.627; Irigoien X, 2009, J PLANKTON RES, V31, P1, DOI 10.1093/plankt/fbn096; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kauer MO, 2003, GENETICS, V165, P1137; Kelly RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008594; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Lamichhaney S, 2012, P NATL ACAD SCI USA, V109, P19345, DOI 10.1073/pnas.1216128109; Landi M, 2005, MOL ECOL NOTES, V5, P266, DOI 10.1111/j.1471-8286.2005.00892.x; Lin L, 2011, GENET MOL RES, V10, P764, DOI 10.4238/vol10-2gmr1085; Manel S, 2013, TRENDS ECOL EVOL, V28, P614, DOI 10.1016/j.tree.2013.05.012; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; Meier K, 2011, HEREDITY, V106, P488, DOI 10.1038/hdy.2010.164; Milano I, 2014, MOL ECOL, V23, P118, DOI 10.1111/mec.12568; Morello EB, 2009, OCEANOGR MAR BIOL, V47, P209; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Olsen EM, 2008, EVOL APPL, V1, P524, DOI 10.1111/j.1752-4571.2008.00024.x; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Pakaki V, 2009, MOL ECOL RESOUR, V9, P1406, DOI 10.1111/j.1755-0998.2009.02681.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pritchard JK, 2000, GENETICS, V155, P945; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Riccioni G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080105; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Riginos C, 2013, GEOGR COMPASS, V7, P197, DOI 10.1111/gec3.12032; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ruggeri P, PLOS ONE, V11, DOI [10.1371/journal.pone.0151507, DOI 10.1371/J0URNAL.P0NE.0151507]; Russello MA, 2012, EVOL APPL, V5, P39, DOI 10.1111/j.1752-4571.2011.00206.x; Ruzzante DE, 2006, P ROY SOC B-BIOL SCI, V273, P1459, DOI 10.1098/rspb.2005.3463; Santojanni A, 2006, CLIM RES, V31, P181, DOI 10.3354/cr031181; Schlotterer C, 2000, CHROMOSOMA, V109, P365, DOI 10.1007/s004120000089; Selkoe KA, 2011, MAR ECOL PROG SER, V436, P291, DOI 10.3354/meps09238; Selkoe KA, 2008, FISH FISH, V9, P363, DOI 10.1111/j.1467-2979.2008.00300.x; Selkoe KA, 2010, MOL ECOL, V19, P3708, DOI 10.1111/j.1365-294X.2010.04658.x; Silva G, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1093; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; TAGGART JB, 1992, J FISH BIOL, V40, P963, DOI 10.1111/j.1095-8649.1992.tb02641.x; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Tortonese E., 1970, FAUNA D ITALIA 1, VX; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vasemagi A, 2005, MOL BIOL EVOL, V22, P1067, DOI 10.1093/molbev/msi093; Vucetic T., 1964, Acta Adriatica, V11, P277; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; Warner RR, 2002, B MAR SCI, V70, P245; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; White C, 2010, P ROY SOC B-BIOL SCI, V277, P1685, DOI 10.1098/rspb.2009.2214; Zarraonaindia I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042201; Zarraonaindia I, 2009, ICES J MAR SCI, V66, P2176, DOI 10.1093/icesjms/fsp187; Zorica B, 2013, FISH OCEANOGR, V22, P32, DOI 10.1111/fog.12002	86	11	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153061	10.1371/journal.pone.0153061	http://dx.doi.org/10.1371/journal.pone.0153061			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074008	Green Submitted, gold, Green Published			2022-12-26	WOS:000374131200050
J	Tomizawa, M; Shinozaki, F; Motoyoshi, Y; Sugiyama, T; Yamamoto, S; Ishige, N				Tomizawa, Minoru; Shinozaki, Fuminobu; Motoyoshi, Yasufumi; Sugiyama, Takao; Yamamoto, Shigenori; Ishige, Naoki			Improved Survival and Initiation of Differentiation of Human Induced Pluripotent Stem Cells to Hepatocyte-Like Cells upon Culture in William's E Medium followed by Hepatocyte Differentiation Inducer Treatment	PLOS ONE			English	Article							EFFICIENT GENERATION; HUMAN LIVER; AMINO-ACID; GROWTH; PCR; FIBROBLASTS; ARGININE	Background Hepatocyte differentiation inducer (HDI) lacks both glucose and arginine, but is supplemented with galactose and ornithine, and is added together with other reagents such as apoptosis inhibitor and oncostatin M. Although human induced pluripotent stem (iPS) cells initiate hepatocyte differentiation, most die within 7 days. In this study, we investigated both HDI and conventional media for their potential to improve cell survival. Materials and Methods 201B7 iPS cells were cultured in conventional media. This consisted of three cycles of 5-day culture in William's E (WE) medium, followed by a 2-day culture in HDI. Results Expression levels of a-feto protein (AFP) were higher in cells cultured in WE and in Dulbecco's Modified Eagle's Medium/Nutrient F-12 Ham (DF12). 201B7 cells expressed the highest AFP and albumin (ALB) when cultured in HDI for 2 days following 7-day culture in WE. After three cycles of 5-day culture in WE followed by 2 days in HDI, 201B7 cells expressed AFP and ALB 54 +/- 2.3 (average +/- standard deviation) and 73 +/- 15.1 times higher, respectively, than those cultured in ReproFF (feeder-free condition). Conclusion 201B7 cells survived culture in WE for 7 days followed HDI for 2 days. After three cycles of culture under these conditions, hepatocyte differentiation was enhanced, as evidenced by increased AFP and ALB expression.	[Tomizawa, Minoru] Shimoshizu Hosp, Natl Hosp Org, Dept Gastroenterol, 934-5 Shikawatashi, Yotsukaido, Chiba 2840003, Japan; [Shinozaki, Fuminobu] Shimoshizu Hosp, Natl Hosp Org, Dept Radiol, 934-5 Shikawatashi, Yotsukaido, Chiba 2840003, Japan; [Motoyoshi, Yasufumi] Shimoshizu Hosp, Natl Hosp Org, Dept Neurol, 934-5 Shikawatashi, Yotsukaido, Chiba 2840003, Japan; [Sugiyama, Takao] Shimoshizu Hosp, Natl Hosp Org, Dept Rheumatol, 934-5 Shikawatashi, Yotsukaido, Chiba 2840003, Japan; [Yamamoto, Shigenori] Shimoshizu Hosp, Natl Hosp Org, Dept Pediat, 934-5 Shikawatashi, Yotsukaido, Chiba 2840003, Japan; [Ishige, Naoki] Shimoshizu Hosp, Natl Hosp Org, Dept Neurosurg, 934-5 Shikawatashi, Yotsukaido, Chiba 2840003, Japan		Tomizawa, M (corresponding author), Shimoshizu Hosp, Natl Hosp Org, Dept Gastroenterol, 934-5 Shikawatashi, Yotsukaido, Chiba 2840003, Japan.	nihminor-cib@umin.ac.jp						AI YJ, 1995, GENOME RES, V5, P53, DOI 10.1101/gr.5.1.53; Chang HM, 2012, INT J MOL SCI, V13, P3598, DOI 10.3390/ijms13033598; Dabos KJ, 2004, CELL TRANSPLANT, V13, P213, DOI 10.3727/000000004783984007; DAVIES B, 1995, GENOMICS, V25, P372, DOI 10.1016/0888-7543(95)80036-L; DeLaForest A, 2011, DEVELOPMENT, V138, P4143, DOI 10.1242/dev.062547; Farghali H, 2002, PHARMACOL RES, V46, P511, DOI 10.1016/S1043661802002347; Gallagher RC, 2014, J PEDIATR-US, V164, P720, DOI 10.1016/j.jpeds.2013.12.024; Ghodsizadeh A, 2014, BIOTECHNOL LETT, V36, P1095, DOI 10.1007/s10529-014-1454-0; Hirschi KK, 2014, ANNU REV BIOMED ENG, V16, P277, DOI 10.1146/annurev-bioeng-071813-105108; Husson A, 2003, EUR J BIOCHEM, V270, P1887, DOI 10.1046/j.1432-1033.2003.03559.x; Inamura M, 2011, MOL THER, V19, P400, DOI 10.1038/mt.2010.241; Kondo Y, 2014, DRUG METAB PHARMACOK, V29, P407, DOI 10.2133/dmpk.DMPK-14-RG-022; MITAKA T, 1991, HEPATOLOGY, V13, P21, DOI 10.1016/0270-9139(91)90211-D; MITAKA T, 1991, J CELL PHYSIOL, V147, P495, DOI 10.1002/jcp.1041470316; NAKAMURA T, 1984, BIOCHEM BIOPH RES CO, V122, P884, DOI 10.1016/0006-291X(84)91173-2; Nava S, 2005, DIFFERENTIATION, V73, P249, DOI 10.1111/j.1432-0436.2005.00019.x; Ohira RH, 2005, BIOCHEM BIOPH RES CO, V331, P239, DOI 10.1016/j.bbrc.2005.03.143; Raggi CC, 2005, CLIN CHEM LAB MED, V43, P542, DOI 10.1515/CCLM.2005.094; Shan J, 2013, NAT CHEM BIOL, V9, P514, DOI 10.1038/nchembio.1270; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Song ZH, 2009, CELL RES, V19, P1233, DOI 10.1038/cr.2009.107; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takayama K, 2012, MOL THER, V20, P127, DOI 10.1038/mt.2011.234; Takeba Y, 2011, J PHARMACOL SCI, V115, P516, DOI 10.1254/jphs.10215FP; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Tam S, 2009, J VIROL METHODS, V161, P183, DOI 10.1016/j.jviromet.2009.04.033; Tellinghuisen J, 2015, ANAL CHEM, V87, P8925, DOI 10.1021/acs.analchem.5b02057; Tomizawa M, 1998, BIOCHEM BIOPH RES CO, V249, P1, DOI 10.1006/bbrc.1998.8999; Tomizawa M, 2008, CELL TISSUE RES, V333, P17, DOI 10.1007/s00441-008-0618-4; Tomizawa M, 2013, BIOMED REP, V1, P18, DOI 10.3892/br.2012.2; Tomizawa M, 2015, J CELL BIOCHEM, V116, P1479, DOI 10.1002/jcb.25139; Tomizawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071897; Vasanthan KS, 2015, ANAL CHIM ACTA, V890, P83, DOI 10.1016/j.aca.2015.06.057; Wheatley DN, 2000, CELL PHYSIOL BIOCHEM, V10, P37, DOI 10.1159/000016333; Wu DF, 1997, MOL CELL BIOCHEM, V173, P103, DOI 10.1023/A:1006831811622; Zaret KS, 2008, COLD SH Q B, V73, P119, DOI 10.1101/sqb.2008.73.040; Zimmermann B, 2005, CLIN CHEM, V51, P1598, DOI 10.1373/clinchem.2005.051235	37	3	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153435	10.1371/journal.pone.0153435	http://dx.doi.org/10.1371/journal.pone.0153435			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073925	gold, Green Published, Green Submitted			2022-12-26	WOS:000374131200093
J	Van Schuerbeek, P; Baeken, C; De Mey, J				Van Schuerbeek, Peter; Baeken, Chris; De Mey, Johan			The Heterogeneity in Retrieved Relations between the Personality Trait 'Harm Avoidance' and Gray Matter Volumes Due to Variations in the VBM and ROI Labeling Processing Settings	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; TEMPERAMENT; SEGMENTATION; DIMENSIONS; DEPRESSION; MODEL	Concerns are raising about the large variability in reported correlations between gray matter morphology and affective personality traits as 'Harm Avoidance' (HA). A recent review study (Mincic 2015) stipulated that this variability could come from methodological differences between studies. In order to achieve more robust results by standardizing the data processing procedure, as a first step, we repeatedly analyzed data from healthy females while changing the processing settings (voxel-based morphology (VBM) or region-of-interest (ROI) labeling, smoothing filter width, nuisance parameters included in the regression model, brain atlas and multiple comparisons correction method). The heterogeneity in the obtained results clearly illustrate the dependency of the study outcome to the opted analysis settings. Based on our results and the existing literature, we recommended the use of VBM over ROI labeling for whole brain analyses with a small or intermediate smoothing filter (5-8mm) and a model variable selection step included in the processing procedure. Additionally, it is recommended that ROI labeling should only be used in combination with a clear hypothesis and that authors are encouraged to report their results uncorrected for multiple comparisons as supplementary material to aid review studies.	[Van Schuerbeek, Peter; De Mey, Johan] Vrije Univ VUB, UZ Brussel, Dept Radiol, Brussels, Belgium; [Baeken, Chris] Vrije Univ Brussel, UZ Brussel, Dept Psychiat, Brussels, Belgium; [Baeken, Chris] Univ Ghent, Dept Psychiat & Med Psychol, B-9000 Ghent, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel; University Hospital Brussels; University Hospital Brussels; Vrije Universiteit Brussel; Ghent University	Van Schuerbeek, P (corresponding author), Vrije Univ VUB, UZ Brussel, Dept Radiol, Brussels, Belgium.	Peter.VanSchuerbeek@uzbrussel.be	de Mey, Johan/AAL-9312-2021; Baeken, Chris/D-6790-2013; de Mey, Johan/F-3602-2011	Van Schuerbeek, Peter/0000-0003-3647-4446; de Mey, Johan/0000-0002-3601-3212				Aleman-Gomez Y., 2006, 12 ANN M ORG HUM BRA; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; BECK AT, 1984, J CLIN PSYCHOL, V40, P1365, DOI 10.1002/1097-4679(198411)40:6<1365::AID-JCLP2270400615>3.0.CO;2-D; Bohland JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007200; Callaert DV, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00124; Cloninger CR, 2006, J AFFECT DISORDERS, V92, P35, DOI 10.1016/j.jad.2005.12.034; CLONINGER CR, 1987, ARCH GEN PSYCHIAT, V44, P573; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; CLONINGER CR, 1986, PSYCHIAT DEV, V4, P167; De Fruyt F, 2000, PERS INDIV DIFFER, V29, P441, DOI 10.1016/S0191-8869(99)00204-4; de la Rie SM, 1998, J PERS DISORD, V12, P362, DOI 10.1521/pedi.1998.12.4.362; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Gardini S, 2009, BRAIN RES BULL, V79, P265, DOI 10.1016/j.brainresbull.2009.03.005; Giuliani NR, 2005, SCHIZOPHR RES, V74, P135, DOI 10.1016/j.schres.2004.08.019; Hu XC, 2011, NEUROIMAGE, V54, P1994, DOI 10.1016/j.neuroimage.2010.10.024; Iidaka T, 2006, BRAIN RES, V1125, P85, DOI 10.1016/j.brainres.2006.09.015; Ioannidis JPA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001747; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jylha P, 2013, EUR PSYCHIAT, V28, P483, DOI 10.1016/j.eurpsy.2013.06.003; Jylha P, 2006, EUR PSYCHIAT, V21, P389, DOI 10.1016/j.eurpsy.2005.09.003; Klein A, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00171; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Miettunen J, 2008, PSYCHIAT RES, V160, P106, DOI 10.1016/j.psychres.2007.05.003; Mincic AM, 2015, NEUROPSYCHOLOGIA, V77, P97, DOI 10.1016/j.neuropsychologia.2015.08.007; Pujol J, 2002, NEUROIMAGE, V15, P847, DOI 10.1006/nimg.2001.1004; Ridgway GR, 2008, NEUROIMAGE, V40, P1429, DOI 10.1016/j.neuroimage.2008.01.003; Sacher J, 2013, MAGN RESON IMAGING, V31, P366, DOI 10.1016/j.mri.2012.06.007; Shattuck DW, 2002, MED IMAGE ANAL, V6, P129, DOI 10.1016/S1361-8415(02)00054-3; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Shen S, 2013, J MAGN RESON IMAGING, V37, P1468, DOI 10.1002/jmri.23927; Takao H, 2013, J MAGN RESON IMAGING, V38, P1283, DOI 10.1002/jmri.24038; Tardif CL, 2009, NEUROIMAGE, V44, P827, DOI 10.1016/j.neuroimage.2008.09.053; Van Schuerbeek P, 2011, BRAIN RES, V1371, P32, DOI 10.1016/j.brainres.2010.11.073; VANSTRIEN JW, 2001, NEUROPRAXIS, V2, P10; Voormolen EHJ, 2010, NEUROIMAGE, V49, P587, DOI 10.1016/j.neuroimage.2009.07.018; Wood J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2215; World Medical Association General Assembly, 2004, J Int Bioethique, V15, P124; Yamasue H, 2008, CEREB CORTEX, V18, P46, DOI 10.1093/cercor/bhm030	40	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153865	10.1371/journal.pone.0153865	http://dx.doi.org/10.1371/journal.pone.0153865			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9OU	27096608	Green Submitted, Green Published, gold			2022-12-26	WOS:000374543600064
J	Ailabouni, NJ; Nishtala, PS; Mangin, D; Tordoff, JM				Ailabouni, Nagham J.; Nishtala, Prasad S.; Mangin, Dee; Tordoff, June M.			Challenges and Enablers of Deprescribing: A General Practitioner Perspective	PLOS ONE			English	Article							PRIMARY-CARE; MULTIPLE CONDITIONS; OLDER-PEOPLE; MEDICATION; POLYPHARMACY; IMPACT; MULTIMORBIDITY; FEASIBILITY; GUIDELINES; BENEFITS	Aims Deprescribing is the process of reducing or discontinuing medicines that are unnecessary or deemed to be harmful. We aimed to investigate general practitioner (GP) perceived challenges to deprescribing in residential care and the possible enablers that support GPs to implement deprescribing. Methods A qualitative study was undertaken using semi-structured, face-to-face interviews from two cities in New Zealand and a purpose-developed pilot-tested interview schedule. Interviews were recorded with permission and transcribed verbatim. Transcripts were read and re-read and themes were identified with iterative building of a coding list until all data was accounted for. Interviews continued until saturation of ideas occurred. Analysis was carried out with the assistance of a Theoretical Domains Framework (TDF) and constant comparison techniques. Several themes were identified. Challenges and enablers of deprescribing were determined based on participants' answers. Results Ten GPs agreed to participate. Four themes were identified to define the issues around prescribing for older people, from the GPs' perspectives. Theme 1, the 'recognition of the problem', discusses the difficulties involved with prescribing for older people. Theme 2 outlines the identified behaviour change factors relevant to the problem. Deprescribing challenges were drawn from these factors and summarised in Theme 3 under three major headings; 'prescribing factors', 'social influences' and 'policy and processes'. Deprescribing enablers, based on the opinions and professional experience of GPs, were retrieved and summarised in Theme 4. Conclusion The process of deprescribing is laced with many challenges for GPs. The uncertainty of research evidence in older people and social factors such as specialists' and nurses' influences were among the major challenges identified. Deprescribing enablers encompassed support for GPs' awareness and knowledge, improvement of communication between multiple prescribers, adequate reimbursement and pharmacists being involved in the multidisciplinary team.	[Ailabouni, Nagham J.; Nishtala, Prasad S.; Tordoff, June M.] Univ Otago, Sch Pharm, Dunedin, New Zealand; [Mangin, Dee] McMaster Univ, David Braley Chair Family Med, Hamilton, ON, Canada; [Mangin, Dee] Univ Otago, Christchurch, New Zealand	University of Otago; McMaster University; University of Otago	Ailabouni, NJ (corresponding author), Univ Otago, Sch Pharm, Dunedin, New Zealand.	Nagham.ailabouni@otago.ac.nz	Nishtala, Prasad/B-6988-2012; Ailabouni, Nagham J/AAE-9720-2021	Nishtala, Prasad/0000-0002-4155-8540; Ailabouni, Nagham J/0000-0002-6732-745X; Tordoff, June/0000-0001-5571-7592; Mangin, Dee/0000-0003-2149-9376	New Zealand Lottery Health Research; New Zealand Pharmacy Education and Research Foundation (NZPERF)	New Zealand Lottery Health Research; New Zealand Pharmacy Education and Research Foundation (NZPERF)	New Zealand Lottery Health Research provided the scholarship for this PhD (http://www.communitymatters.govt.nz/Funding-and-grants-Lottery-grants-Lottery-Health-Research); and the New Zealand Pharmacy Education and Research Foundation (NZPERF) provided funding for the employment of a transcriber for the interviews in this study (http://www.psnz.org.nz/Category?Action=View&Category_id=155). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson K, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006544; Betteridge TM, 2012, INTERN MED J, V42, P208, DOI 10.1111/j.1445-5994.2011.02690.x; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Campbell AJ, 1999, J AM GERIATR SOC, V47, P850, DOI 10.1111/j.1532-5415.1999.tb03843.x; Cumming RG, 2003, CNS DRUGS, V17, P825, DOI 10.2165/00023210-200317110-00004; Farrell B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122246; Fried TR, 2011, ARCH INTERN MED, V171, P75, DOI 10.1001/archinternmed.2010.318; Garfinkel D, 2010, ARCH INTERN MED, V170, P1648, DOI 10.1001/archinternmed.2010.355; Gheewala PA, 2014, DRUG AGING, V31, P825, DOI 10.1007/s40266-014-0208-y; Gnjidic D, 2012, J CLIN EPIDEMIOL, V65, P989, DOI 10.1016/j.jclinepi.2012.02.018; Gnjidic D, 2012, CLIN GERIATR MED, V28, P237, DOI 10.1016/j.cger.2012.01.006; Guba E.G., 1994, HDB QUALITATIVE RES, P110; Herzog A, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0249-2; Lincoln YS, 1986, IS IT RIGOROUS TRUST; Luijks HD, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X652373; McLarin PE, 2015, CURR MED RES OPIN, V10, P1; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Ministry of Health, 2015, HEALTHCERT B INF SEC; Nishtala PS, 2009, DRUG AGING, V26, P677, DOI 10.2165/11316440-000000000-00000; Olazaran J, 2013, J AM MED DIR ASSOC, V14, P213, DOI 10.1016/j.jamda.2012.10.020; Reeve E, 2015, ANN PHARMACOTHER, V49, P29, DOI 10.1177/1060028014558290; Reeve E, 2014, MED J AUSTRALIA, V201, P386, DOI 10.5694/mja13.00200; Reeve E, 2014, INT J CLIN PHARM-NET, V36, P26, DOI 10.1007/s11096-013-9871-z; Schoen C, 2011, HEALTH AFFAIR, V30, P2437, DOI 10.1377/hlthaff.2011.0923; Schuling J, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-56; Scott IA, 2015, INTERN MED J, V45, P352, DOI 10.1111/imj.12693; Sinnott C, 2015, BRIT J GEN PRACT, V65, pE184, DOI 10.3399/bjgp15X684001; Sinnott C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003610; Sloane PD, 2004, ARCH INTERN MED, V164, P2031, DOI 10.1001/archinte.164.18.2031; Solomon J, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X636119; Tinetti ME, 2004, NEW ENGL J MED, V351, P2870, DOI 10.1056/NEJMsb042458	31	104	105	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0151066	10.1371/journal.pone.0151066	http://dx.doi.org/10.1371/journal.pone.0151066			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093289	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000374541200001
J	Garfield, S; Jheeta, S; Husson, F; Lloyd, J; Taylor, A; Boucher, C; Jacklin, A; Bischler, A; Norton, C; Hayles, R; Franklin, BD				Garfield, Sara; Jheeta, Seetal; Husson, Fran; Lloyd, Jill; Taylor, Alex; Boucher, Charles; Jacklin, Ann; Bischler, Anna; Norton, Christine; Hayles, Rob; Franklin, Bryony Dean			The Role of Hospital Inpatients in Supporting Medication Safety: A Qualitative Study	PLOS ONE			English	Article							PATIENT INVOLVEMENT; PRESCRIBING ERRORS	Background Inpatient medication errors are a significant concern. An approach not yet widely studied is to facilitate greater involvement of inpatients with their medication. At the same time, electronic prescribing is becoming increasingly prevalent in the hospital setting. In this study we aimed to explore hospital inpatients' involvement with medication safety-related behaviours, facilitators and barriers to this involvement, and the impact of electronic prescribing. Methods We conducted ethnographic observations and interviews in two UK hospital organisations, one with established electronic prescribing and one that changed from paper to electronic prescribing during our study. Researchers and lay volunteers observed nurses' medication administration rounds, pharmacists' ward rounds, doctor-led ward rounds and drug history taking. We also conducted interviews with healthcare professionals, patients and carers. Interviews were audio-recorded and transcribed. Observation notes and transcripts were coded thematically. Results Paper or electronic medication records were shown to patients in only 4 (2%) of 247 cases. However, where they were available during patient-healthcare professional interactions, healthcare professionals often viewed them in order to inform patients about their medicines and answer any questions. Interprofessional discussions about medicines seemed more likely to happen in front of the patient where paper or electronic drug charts were available near the bedside. Patients and carers had more access to paper-based drug charts than electronic equivalents. However, interviews and observations suggest there are potentially more significant factors that affect patient involvement with their inpatient medication. These include patient and healthcare professional beliefs concerning patient involvement, the way in which healthcare professionals operate as a team, and the underlying culture. Conclusion Patients appear to have more access to paper-based records than electronic equivalents. However, to develop interventions to increase patient involvement with medication safety behaviours, a wider range of factors needs to be considered.	[Garfield, Sara; Jheeta, Seetal; Husson, Fran; Lloyd, Jill; Taylor, Alex; Jacklin, Ann; Norton, Christine; Franklin, Bryony Dean] Imperial Coll Healthcare NHS Trust, Ctr Medicat Safety & Serv Qual, London, England; [Garfield, Sara; Franklin, Bryony Dean] UCL Sch Pharm, Res Dept Practice & Policy, BMA House,Tavistock Sq, London, England; [Bischler, Anna] Chelsea & Westminster Healthcare NHS Fdn Trust, Dept Pharm, London, England; [Norton, Christine] Kings Coll London, Fac Nursing & Midwifery, London WC2R 2LS, England; [Norton, Christine] Imperial Coll Healthcare NHS Trust, London, England; [Boucher, Charles] Patients Participat Grp, Walm Lane Surg, London, England; [Hayles, Rob] Meeting Minds, London, England; [Hayles, Rob] Collaborat Leadership Appl Healthcare Res Northwe, London, England	Imperial College London; University of London; University College London; University of London; King's College London; Imperial College London	Garfield, S (corresponding author), Imperial Coll Healthcare NHS Trust, Ctr Medicat Safety & Serv Qual, London, England.; Garfield, S (corresponding author), UCL Sch Pharm, Res Dept Practice & Policy, BMA House,Tavistock Sq, London, England.	sara.garfield@imperial.nhs.uk	Garfield, Sara/F-9941-2019	Garfield, Sara/0000-0002-9980-0520	Health Foundation [7205]	Health Foundation	This study was funded by The Health Foundation (Grant number 7205). The Health Foundation is an independent charity working to continuously improve the quality of healthcare in the UK (http://www.health.org.uk). The Health Foundation funded the roles of SG, AJ, BDF, AB, CN, FH, JL, AT, CB and RH. The Centre for Medication Safety and Service Quality is affiliated with the National Institute for Health Research Imperial Patient Safety Translational Research Centre and the National Institute for Healthcare Research Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance at Imperial College London in partnership with Public Health England (PHE). The views expressed are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research, The PHE or the Department of Health. A member of the Health Foundation was on the patient and clinical engagement group, which met quarterly and provided general contextual information and advice to the research team. Neither the Health Foundation nor the National Institute for Health Research had any specific role in the design, data collection and analysis, decision to publish, or preparation of the manuscript.	Academy of Royal Medical Colleges, 2011, STAND DES HOSP IN PA; Ahmed Z, 2013, PLOS ONE, V8; [Anonymous], 2010, EQ EXC LIB NHS; Brock TP, 2007, AM J HEALTH-SYST PH, V64, P1541, DOI 10.2146/ajhp060444; Caldwell G., 2010, PHARM MANAGE, V26, P3; Cumbler E, 2010, J HOSP MED, V5, P83, DOI 10.1002/jhm.566; Davis RE, 2011, BMJ QUAL SAF, V20, P108, DOI 10.1136/bmjqs.2010.041871; Davis RE, 2012, J PATIENT SAF, V8, P182, DOI 10.1097/PTS.0b013e318267c4aa; de Lusignan S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006021; Entwistle VA, 2010, BMJ QUAL SAF, V19, P33; Fereday J., 2006, INT J QUAL METH, V5, P80, DOI [DOI 10.1177/160940690600500107, 10.1177/160940690600500107]; Franklin BD, 2007, QUAL SAF HEALTH CARE, V16, P279, DOI 10.1136/qshc.2006.019497; Franklin BD, 2011, POSTGRAD MED J, V87, P739, DOI 10.1136/pgmj.2011.117879; Garfield Sara, 2015, Res Involv Engagem, V1, P8, DOI 10.1186/s40900-015-0006-7; Hall J, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2009.032748; Hibbard JH, 2005, MED CARE RES REV, V62, P601, DOI 10.1177/1077558705279313; Lawton R, 2012, ROLE PATIENT CLIN SA; Lee Lisa, 2015, J Innov Health Inform, V22, P391, DOI 10.14236/jhi.v22i4.176; Manias E, 2015, HEALTH EXPECT, V18, P850, DOI 10.1111/hex.12057; McLeod M, 2015, PLOSONE IN PRESS MAR; McLeod MC, 2013, BMJ QUAL SAF, V22, P278, DOI 10.1136/bmjqs-2012-001330; Milne H, 2016, HEALTH EXPECT, V19, P602, DOI 10.1111/hex.12320; Mohsin-Shaikh S, 2014, INT J CLIN PHARM-NET, V36, P657, DOI 10.1007/s11096-014-9951-8; O'Grady K., 2006, BJHC&IM-British Journal of Healthcare Computing & Information Management, V23, P15; Schwappach D. L., 2010, QUAL SAF HEALTH CARE, V19, P9; Schwappach DLB, 2011, ANN ONCOL, V22, P424, DOI 10.1093/annonc/mdq346; Schwappach DLB, 2010, ONCOLOGIST, V15, P903, DOI 10.1634/theoncologist.2010-0117; Schwappach DLB, 2010, J CLIN ONCOL, V28, P2896, DOI 10.1200/JCO.2009.27.6626; Vincent C., 2010, PATIENT SAFETY, V2nd Ed.; Watt I, 2009, REV STRATEGIES PROMO; Westbrook JI, 2015, INT J QUAL HEALTH C, V27, P1, DOI 10.1093/intqhc/mzu098	31	19	19	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153721	10.1371/journal.pone.0153721	http://dx.doi.org/10.1371/journal.pone.0153721			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093438	Green Published, Green Submitted, gold			2022-12-26	WOS:000374541200042
J	Wang, DF; Qin, YL; Fang, JJ; Yuan, SJ; Peng, LX; Zhao, JF; Li, XY				Wang, Daofeng; Qin, Yanling; Fang, Jingjing; Yuan, Shoujiang; Peng, Lixiang; Zhao, Jinfeng; Li, Xueyong			A Missense Mutation in the Zinc Finger Domain of OsCESA7 Deleteriously Affects Cellulose Biosynthesis and Plant Growth in Rice	PLOS ONE			English	Article							SYNTHASE CATALYTIC SUBUNITS; ENCODES; RESISTANCE; ISOXABEN; PROTEIN; GENES; FORM	Rice is a model plant species for the study of cellulose biosynthesis. We isolated a mutant, S1-24, from ethyl methanesulfonate (EMS)-treated plants of the japonica rice cultivar, Nipponbare. The mutant exhibited brittle culms and other pleiotropic phenotypes such as dwarfism and partial sterility. The brittle culms resulted from reduced mechanical strength due to a defect in thickening of the sclerenchyma cell wall and reduced cellulose content in the culms of the S1-24 mutant. Map-based gene cloning and a complementation assay showed that phenotypes of the S1-24 mutant were caused by a recessive point mutation in the OsCESA7 gene, which encodes cellulose synthase A subunit 7. The missense mutation changed the highly conserved C40 to Y in the zinc finger domain. The OsCESA7 gene is expressed predominantly in the culm at the mature stage, particularly in mechanical tissues such as vascular bundles and sclerenchyma cells, consistent with the brittle phenotype in the culm. These results indicate that OsCESA7 plays an important role in cellulose biosynthesis and plant growth.	[Wang, Daofeng; Qin, Yanling; Fang, Jingjing; Peng, Lixiang; Zhao, Jinfeng; Li, Xueyong] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China; [Yuan, Shoujiang] Shandong Rice Res Inst, Jinan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Li, XY (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China.	lixueyong@caas.cn			Ministry of Agriculture of China [2016ZX08009-003]; Agricultural Science and Technology Innovation Program of China	Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); Agricultural Science and Technology Innovation Program of China	This work was supported by grants from the Ministry of Agriculture of China (2016ZX08009-003) and the Agricultural Science and Technology Innovation Program of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aohara T, 2009, PLANT CELL PHYSIOL, V50, P1886, DOI 10.1093/pcp/pcp133; Arioli T, 1998, SCIENCE, V279, P717, DOI 10.1126/science.279.5351.717; Chu ZQ, 2007, PLANT PHYSIOL, V143, P213, DOI 10.1104/pp.106.088393; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Desprez T, 2002, PLANT PHYSIOL, V128, P482, DOI 10.1104/pp.010822; Doblin MS, 2002, PLANT CELL PHYSIOL, V43, P1407, DOI 10.1093/pcp/pcf164; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Fagard M, 2000, PLANT CELL, V12, P2409, DOI 10.1105/tpc.12.12.2409; Gardiner JC, 2003, PLANT CELL, V15, P1740, DOI 10.1105/tpc.012815; Hiei Y, 2008, NAT PROTOC, V3, P824, DOI 10.1038/nprot.2008.46; Kotake T, 2011, J EXP BOT, V62, P2053, DOI 10.1093/jxb/erq395; Kurek I, 2002, P NATL ACAD SCI USA, V99, P11109, DOI 10.1073/pnas.162077099; Li Shundai, 2014, Arabidopsis Book, V12, pe0169, DOI 10.1199/tab.0169; Li YH, 2003, PLANT CELL, V15, P2020, DOI 10.1105/tpc.011775; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Richmond TA, 2000, PLANT PHYSIOL, V124, P495, DOI 10.1104/pp.124.2.495; Saxena IM, 2005, ANN BOT-LONDON, V96, P9, DOI 10.1093/aob/mci155; Scheible WR, 2001, P NATL ACAD SCI USA, V98, P10079, DOI 10.1073/pnas.191361598; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; Song XQ, 2013, MOL PLANT, V6, P768, DOI 10.1093/mp/sst025; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanaka K, 2003, PLANT PHYSIOL, V133, P73, DOI 10.1104/pp.103.022442; Taylor NG, 2004, CELLULOSE, V11, P329, DOI 10.1023/B:CELL.0000046405.11326.a8; Taylor NG, 1999, PLANT CELL, V11, P769, DOI 10.1105/tpc.11.5.769; Taylor NG, 2003, P NATL ACAD SCI USA, V100, P1450, DOI 10.1073/pnas.0337628100; Taylor NG, 2000, PLANT CELL, V12, P2529, DOI 10.1105/tpc.12.12.2529; Timmers J, 2009, FEBS LETT, V583, P978, DOI 10.1016/j.febslet.2009.02.035; Wang DF, 2012, PLANT SCI, V196, P117, DOI 10.1016/j.plantsci.2012.08.002; Yan Changjie, 2007, Journal of Genetics and Genomics, V34, P1019, DOI 10.1016/S1673-8527(07)60115-5; Zhang BC, 2011, J INTEGR PLANT BIOL, V53, P136, DOI 10.1111/j.1744-7909.2010.01011.x; Zhang BC, 2009, PLANT MOL BIOL, V71, P509, DOI 10.1007/s11103-009-9536-4; Zhong RQ, 2003, PLANT PHYSIOL, V132, P786, DOI 10.1104/pp.102.019331	32	20	23	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153993	10.1371/journal.pone.0153993	http://dx.doi.org/10.1371/journal.pone.0153993			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27092937	Green Published, gold, Green Submitted			2022-12-26	WOS:000374541200068
J	Kwok, MK; Leung, GM; Schooling, CM				Kwok, Man Ki; Leung, Gabriel M.; Schooling, C. Mary			Associations of Birth Order with Early Adolescent Growth, Pubertal Onset, Blood Pressure and Size: Evidence from Hong Kong's "Children of 1997" Birth Cohort	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; HEART-DISEASE; EARLY ORIGINS; FAMILY-SIZE; EARLY-LIFE; WEIGHT; CHILDHOOD; AGE; IMPUTATION; PATTERNS	Background Birth order has been proposed as a cardiovascular risk factor, because the lower birth weight and greater infant weight gain typical of firstborns could programme metabolism detrimentally. Methods We examined the associations of birth order (firstborn or laterborn) with birth weight-for-gestational age, length/height and body mass index (BMI) z-scores during infancy, childhood, and puberty using generalized estimating equations, with age at pubertal onset using interval-censored regression and with age-, sex-and height-standardized blood pressure, height and BMI z-scores at 13 years using linear regression in a population-representative Chinese birth cohort: "Children of 1997" (n = 8,327). Results Compared with laterborns, firstborns had lower birth weight-for-gestational age (mean difference = -0.18 z-score, 95% confidence interval (CI) -0.23, -0.14), lower infant BMI (-0.09 z-score, 95% CI -0.14, -0.04), greater childhood height (0.10 z-score, 95% CI 0.05, 0.14) and BMI (0.08 z-score, 95% CI 0.03, 0.14), but not greater pubertal BMI (0.05 z-score, 95% CI -0.02, 0.11), adjusted for sex, parental age, birthplace, education and income. Firstborns had earlier onset of pubic hair (time ratio = 0.988, 95% CI 0.980, 0.996), but not breast or genitalia, development. Firstborns had greater BMI (0.07 z-score, 95% CI 0.002, 0.15), but not height (0.05 z-score, 95% CI -0.01, 0.11), at 13 years, but similar blood pressure. Conclusions Differences by birth order continue into early adolescence with firstborns being heavier with earlier pubic hair development, which could indicate long-term cardiovascular risk.	[Kwok, Man Ki; Leung, Gabriel M.; Schooling, C. Mary] Univ Hong Kong, Sch Publ Hlth, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Schooling, C. Mary] CUNY, Sch Publ Hlth, New York, NY 10021 USA; [Schooling, C. Mary] CUNY Hunter Coll, New York, NY 10021 USA	University of Hong Kong; City University of New York (CUNY) System; City University of New York (CUNY) System; Hunter College (CUNY)	Schooling, CM (corresponding author), Univ Hong Kong, Sch Publ Hlth, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China.; Schooling, CM (corresponding author), CUNY, Sch Publ Hlth, New York, NY 10021 USA.; Schooling, CM (corresponding author), CUNY Hunter Coll, New York, NY 10021 USA.	cms1@hku.hk		Kwok, Man Ki/0000-0003-3777-4766; Leung, Gabriel/0000-0002-2503-6283	Health Care and Promotion Fund; Health and Welfare Bureau; Government of the Hong Kong SAR [HCPF] [216106]; Health and Health Services Research Fund [HHSRF], Government of the Hong Kong SAR [03040771, 07080841, 07080751, 08090761, 09101061]; University Research Committee Strategic Research Theme (SRT) of Public Health, The University of Hong Kong	Health Care and Promotion Fund; Health and Welfare Bureau; Government of the Hong Kong SAR [HCPF]; Health and Health Services Research Fund [HHSRF], Government of the Hong Kong SAR; University Research Committee Strategic Research Theme (SRT) of Public Health, The University of Hong Kong(University of Hong Kong)	This work is a sub-study of the "Children of 1997" birth cohort which was initially supported by the Health Care and Promotion Fund, Health and Welfare Bureau, Government of the Hong Kong SAR [HCPF Grant # 216106] and re-established in 2005 funded by the Health and Health Services Research Fund [HHSRF Grant # 03040771] and the University Research Committee Strategic Research Theme (SRT) of Public Health, The University of Hong Kong. This sub-study was funded by the Health and Health Services Research Fund [HHSRF Grants # 07080841, # 07080751, # 08090761 and # 09101061], Government of the Hong Kong SAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboderin I., 2002, LIFE COURSE PERSPECT; Adair LS, 2013, LANCET, V382, P525, DOI 10.1016/S0140-6736(13)60103-8; Adair LS, 1999, J NUTR, V129, P1140, DOI 10.1093/jn/129.6.1140; Apraiz AG, 1999, AM J HUM BIOL, V11, P779, DOI 10.1002/(SICI)1520-6300(199911/12)11:6<779::AID-AJHB8>3.0.CO;2-7; Barker DJP, 1997, BRIT MED BULL, V53, P96; Cheung YB, 2001, SOC SCI MED, V52, P1135, DOI 10.1016/S0277-9536(00)00228-8; D'Aloisio AA, 2013, EPIDEMIOLOGY, V24, P277, DOI 10.1097/EDE.0b013e31828062b7; Euling SY, 2008, PEDIATRICS, V121, pS172, DOI 10.1542/peds.2007-1813D; Floyd B, 2005, J BIOSOC SCI, V37, P287, DOI 10.1017/S0021932004006674; Fok TF, 2003, ARCH DIS CHILD-FETAL, V88, P229, DOI 10.1136/fn.88.3.F229; Frejka T, 2010, POPUL DEV REV, V36, P579, DOI 10.1111/j.1728-4457.2010.00347.x; Harrell FE, 2001, REGRESSION MODELING; Haugaard LK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056357; Hemminki K, 2001, BRIT J CANCER, V84, P1466, DOI 10.1054/bjoc.2001.1811; Howe LD, 2013, INT J OBES LOND, DOI [10.1038/ijo.2013.189, DOI 10.1038/IJ0.2013.189]; Hui LL, 2012, ANN EPIDEMIOL, V22, P43, DOI 10.1016/j.annepidem.2011.10.003; Huxley R, 2007, AM J CLIN NUTR, V85, P1244, DOI 10.1093/ajcn/85.5.1244; Jelenkovic A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063361; Kamp GA, 2002, ARCH DIS CHILD, V87, P215, DOI 10.1136/adc.87.3.215; Karlberg J, 1989, Acta Paediatr Scand Suppl, V350, P70; Khong TY, 2003, PLACENTA, V24, P348, DOI 10.1053/plac.2002.0922; Koziel S, 2001, COLLEGIUM ANTROPOL, V25, P555; Kristensen P, 2007, SCIENCE, V316, P1717, DOI 10.1126/science.1141493; Kwok MK, 2013, J HYPERTENS, V31, P1785, DOI 10.1097/HJH.0b013e3283622ea0; Kwok MK, 2013, AM J EPIDEMIOL, V178, P928, DOI 10.1093/aje/kwt076; Kwok MK, 2013, ANN EPIDEMIOL, V23, P475, DOI 10.1016/j.annepidem.2013.05.016; Kwok MK, 2012, PEDIATRICS, V130, pE631, DOI 10.1542/peds.2011-3697; Lawlor DA, 2004, CIRCULATION, V110, P2417, DOI 10.1161/01.CIR.0000145165.80130.B5; Luo ZC, 2001, J PEDIATR ENDOCR MET, V14, P757; Mathai M, 1996, Indian Pediatr, V33, P203; Mongraw-Chaffin ML, 2015, LANCET DIABETES ENDO, V3, P437, DOI 10.1016/S2213-8587(15)00086-8; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Ochiai H, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-766; Ong KKL, 2002, PEDIATR RES, V52, P863, DOI 10.1203/00006450-200212000-00009; Pang MW, 2000, AUST NZ J OBSTET GYN, V40, P161, DOI 10.1111/j.1479-828X.2000.tb01139.x; PETO R, 1973, ROY STAT SOC C-APP, V22, P86; PRENTICE A, 1987, HUM NUTR-CLIN NUTR, V41C, P319; Savage T, 2013, CLIN ENDOCRINOL, V79, P379, DOI 10.1111/cen.12156; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Schooling CM, 2010, J EPIDEMIOL COMMUN H, V64, DOI 10.1136/jech.2008.086553; Schooling CM, 2012, INT J EPIDEMIOL, V41, P611, DOI 10.1093/ije/dyq243; Schooling CM, 2010, ARCH DIS CHILD, V95, P437, DOI 10.1136/adc.2009.168542; Siervo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013907; Singhal A, 2004, LANCET, V363, P1642, DOI 10.1016/S0140-6736(04)16210-7; Tu YK, 2010, EPIDEMIOLOGY, V21, P440, DOI 10.1097/EDE.0b013e3181d62123; Urquia ML, 2010, J EPIDEMIOL COMMUN H, V64, P243, DOI 10.1136/jech.2008.083535; Verropoulou G, 2014, J BIOSOC SCI, V46, P316, DOI 10.1017/S0021932013000321; Wells JCK, 2011, AM J EPIDEMIOL, V174, P1028, DOI 10.1093/aje/kwr232; WHINCUP PH, 1989, BMJ-BRIT MED J, V299, P587, DOI 10.1136/bmj.299.6699.587; Whiting S., 2011, POPULATION MATTERS; WHO, 2007, WHO GROWTH REF 5 19; Wilcox MA, 1996, ACTA OBSTET GYN SCAN, V75, P459, DOI 10.3109/00016349609033354; Wong KC, 2006, DIABETES RES CLIN PR, V73, P126, DOI 10.1016/j.diabres.2006.01.007; Wong SN, 2006, BLOOD PRESS MONIT, V11, P281, DOI 10.1097/01.mbp.0000209082.09623.b4; World Health Organization, 2005, WHO CHILD GROWTH STA; World Health Organization (WHO), 2013, STRAT PRIOR WHO CARD; World Health Organization (WHO), 2015, CARD DIS CVDS 2015; Worthman CM, 2005, AM J HUM BIOL, V17, P95, DOI 10.1002/ajhb.20096	59	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153787	10.1371/journal.pone.0153787	http://dx.doi.org/10.1371/journal.pone.0153787			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9IK	27088360	gold, Green Published			2022-12-26	WOS:000374527000049
J	Ribeiro, BG; Alves, AN; dos Santos, LAD; Cantero, TM; Fernandes, KPS; Dias, DD; Bernardes, N; De Angelis, K; Mesquita-Ferrari, RA				Ribeiro, Beatriz Guimaraes; Alves, Agnelo Neves; Dias dos Santos, Lucas Andreo; Cantero, Tatiane Matarazzo; Santos Fernandes, Kristianne Porta; Dias, Danielle da Silva; Bernardes, Nathalia; De Angelis, Katia; Mesquita-Ferrari, Raquel Agnelli			Red and Infrared Low-Level Laser Therapy Prior to Injury with or without Administration after Injury Modulate Oxidative Stress during the Muscle Repair Process	PLOS ONE			English	Article							TIBIALIS ANTERIOR MUSCLE; INTENSITY LIGHT THERAPY; SKELETAL-MUSCLE; MAMMALIAN-CELLS; EXPRESSION; FIBROSIS; DAMAGE; MODEL	Introduction Muscle injury is common among athletes and amateur practitioners of sports. Following an injury, the production of reactive oxygen species (ROS) occurs, which can harm healthy muscle fibers (secondary damage) and delay the repair process. Low-level laser therapy (LLLT) administered prior to or following an injury has demonstrated positive and protective effects on muscle repair, but the combination of both administration times together has not been clarified. Aim To evaluate the effect of LLLT (660 nm and 780 nm, 10 J/cm(2), 40 mW, 3.2 J) prior to injury with or without the administration after injury on oxidative stress during the muscle repair process. Methods Wistar rats were divided into following groups: control; muscle injury alone; LLLT 660 nm + injury; LLLT 780 nm + injury; LLLT 660 nm before and after injury; and LLLT 780 nm before and after injury. The rats were euthanized on days 1, 3 and 7 following cryoinjury of the tibialis anterior (TA) muscle, which was then removed for analysis. Results Lipid peroxidation decreased in the 660+injury group after one day. Moreover, red and infrared LLLT employed at both administration times induced a decrease in lipid peroxidation after seven days. CAT activity was altered by LLLT in all periods evaluated, with a decrease after one day in the 780+injury+780 group and after seven days in the 780+injury group as well as an increase in the 780+injury and 780+injury+780 groups after three days. Furthermore, increases in GPx and SOD activity were found after seven days in the 780+injury+780 group. Conclusion The administration of red and infrared laser therapy at different times positively modulates the activity of antioxidant enzymes and reduces stress markers during the muscle repair process.	[Ribeiro, Beatriz Guimaraes; Alves, Agnelo Neves; Cantero, Tatiane Matarazzo; Dias, Danielle da Silva; De Angelis, Katia; Mesquita-Ferrari, Raquel Agnelli] Univ Nove de Julho UNINOVE, Rehabil Dept, Sao Paulo, SP, Brazil; [Dias dos Santos, Lucas Andreo; Santos Fernandes, Kristianne Porta; Mesquita-Ferrari, Raquel Agnelli] Univ Nove de Julho UNINOVE, Biophoton Dept, Sao Paulo, SP, Brazil; [Bernardes, Nathalia] Univ Sao Paulo, Sch Med, Hypertens Unit, Heart Inst InCor, Sao Paulo, SP, Brazil; [De Angelis, Katia] Univ Nove de Julho UNINOVE, Dept Med, Sao Paulo, SP, Brazil	Universidade Nove de Julho; Universidade Nove de Julho; Universidade de Sao Paulo; Universidade Nove de Julho	Mesquita-Ferrari, RA (corresponding author), Univ Nove de Julho UNINOVE, Rehabil Dept, Sao Paulo, SP, Brazil.; Mesquita-Ferrari, RA (corresponding author), Univ Nove de Julho UNINOVE, Biophoton Dept, Sao Paulo, SP, Brazil.	raquel.mesquita@gmail.com	da Silva Dias, Danielle/AAN-7618-2020; Bernardes, Nathalia/L-7460-2015; Ferrari, Raquel/I-4419-2016; Alves, Agnelo N/C-2775-2013; Andreo, Lucas/GQB-0944-2022; Fernandes, Kristianne Porta Santos/I-4417-2016; DE ANGELIS, KATIA/I-6098-2016	da Silva Dias, Danielle/0000-0003-4152-0849; Bernardes, Nathalia/0000-0001-9555-4134; Ferrari, Raquel/0000-0001-5142-9526; Alves, Agnelo N/0000-0003-2586-4377; Fernandes, Kristianne Porta Santos/0000-0001-7156-9286; DE ANGELIS, KATIA/0000-0002-3640-9049	UNINOVE; National Council for Scientific and Technological Development [305739/2014 RAMF, 303662/2012 RAMF]; Coordination for the Improvement of Higher Education Personnel [1510536 BGR]; Sao Paulo Research Foundation [2013/21540-3 ANA, 2014/12381-1 RAMF]	UNINOVE; National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by UNINOVE and the Brazilian fostering agencies: National Council for Scientific and Technological Development (www.cnpq.br; process numbers: 305739/2014 RAMF, 303662/2012 RAMF); Coordination for the Improvement of Higher Education Personnel (www.capes.gov.br; process number: 1510536 BGR); Sao Paulo Research Foundation (www.fapesp.br; process numbers: 2013/21540-3 ANA; 2014/12381-1 RAMF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida P, 2011, PHOTOCHEM PHOTOBIOL, V87, P1159, DOI DOI 10.1111/J.1751-1097.2011.00968.X; Alves AN, 2014, LASER MED SCI, V29, P813, DOI 10.1007/s10103-013-1428-9; Alves AN, 2014, AM J PHYS MED REHAB, V93, P1073, DOI 10.1097/PHM.0000000000000158; Assis L, 2013, LASER MED SCI, V28, P947, DOI 10.1007/s10103-012-1183-3; Assis L, 2012, LASER SURG MED, V44, P726, DOI 10.1002/lsm.22077; Baptista J, 2011, PHOTOMED LASER SURG, V29, P11, DOI 10.1089/pho.2009.2737; Barbieri Elena, 2012, J Signal Transduct, V2012, P982794, DOI 10.1155/2012/982794; Brunelli RM, 2014, LASER MED SCI, V29, P91, DOI 10.1007/s10103-013-1277-6; Conti FF, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-185; de Souza TOF, 2011, LASER MED SCI, V26, P803, DOI 10.1007/s10103-011-0951-9; Ferraresi Cleber, 2012, Photonics Lasers Med, V1, P267; FLECHA BG, 1991, FREE RADICAL BIO MED, V10, P93; Gao XJ, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-4; Garg K, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00087; Gharaibeh B, 2012, BIRTH DEFECTS RES C, V96, P82, DOI 10.1002/bdrc.21005; Irigoyen MC, 2005, HYPERTENSION, V46, P998, DOI 10.1161/01.HYP.0000176238.90688.6b; Karu TI, 2008, PHOTOCHEM PHOTOBIOL, V84, P1091, DOI 10.1111/j.1751-1097.2008.00394.x; Karu TI, 2010, IUBMB LIFE, V62, P607, DOI 10.1002/iub.359; Liu XG, 2009, PHOTOMED LASER SURG, V27, P863, DOI 10.1089/pho.2008.2443; Silveira PCL, 2013, LASER MED SCI, V28, P431, DOI 10.1007/s10103-012-1075-6; Luo L, 2013, LASER MED SCI, V28, P725, DOI 10.1007/s10103-012-1133-0; Mann CJ, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-21; Mesquita-Ferrari RA, 2011, LASER MED SCI, V26, P335, DOI 10.1007/s10103-010-0850-5; Leal ECP, 2015, LASER MED SCI, V30, P925, DOI 10.1007/s10103-013-1465-4; Pisoschi AM, 2015, EUR J MED CHEM, V97, P55, DOI 10.1016/j.ejmech.2015.04.040; Quinteiro H, 2015, MENOPAUSE, V22, P534, DOI [10.1097/GME.0000000000000344, 10.1097/gme.0000000000000344]; REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357; Ribeiro BG, 2015, LASER SURG MED, DOI [10.1002/Ism.22381, DOI 10.1002/ISM.22381]; Rizzi CF, 2006, LASER SURG MED, V38, P704, DOI 10.1002/lsm.20371; Fernandes KPS, 2013, LASER MED SCI, V28, P1043, DOI 10.1007/s10103-012-1233-x; Schaur RJ, 2015, BIOMOLECULES, V5, P2247, DOI 10.3390/biom5042247; Tafur J, 2008, PHOTOMED LASER SURG, V26, P323, DOI 10.1089/pho.2007.2184; Tafur J, 2010, PHOTOMED LASER SURG, V28, P23, DOI 10.1089/pho.2008.2373; Urish KL, 2009, MOL BIOL CELL, V20, P509, DOI 10.1091/mbc.E08-03-0274; Vatansever Fatma, 2012, Photonics Lasers Med, V1, P287	35	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153618	10.1371/journal.pone.0153618	http://dx.doi.org/10.1371/journal.pone.0153618			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082964	Green Published, gold			2022-12-26	WOS:000374291800034
J	Deligianni, F; Carmichael, DW; Zhang, GH; Clark, CA; Clayden, JD				Deligianni, Fani; Carmichael, David W.; Zhang, Gary H.; Clark, Chris A.; Clayden, Jonathan D.			NODDI and Tensor-Based Microstructural Indices as Predictors of Functional Connectivity	PLOS ONE			English	Article							CANONICAL CORRELATION-ANALYSIS; MULTISHELL DIFFUSION MRI; WHITE-MATTER; SPHERICAL-DECONVOLUTION; ORIENTATION DISPERSION; TISSUE-MICROSTRUCTURE; WATER DIFFUSION; BRAIN; TRACTOGRAPHY; ARTIFACT	In Diffusion Weighted MR Imaging (DWI), the signal is affected by the biophysical properties of neuronal cells and their relative placement, as well as extra-cellular tissue compartments. Typically, microstructural indices, such as fractional anisotropy (FA) and mean diffusivity (MD), are based on a tensor model that cannot disentangle the influence of these parameters. Recently, Neurite Orientation Dispersion and Density Imaging (NODDI) has exploited multi-shell acquisition protocols to model the diffusion signal as the contribution of three tissue compartments. NODDI microstructural indices, such as intra-cellular volume fraction (ICVF) and orientation dispersion index (ODI) are directly related to neuronal density and orientation dispersion, respectively. One way of examining the neurophysiological role of these microstructural indices across neuronal fibres is to look into how they relate to brain function. Here we exploit a statistical framework based on sparse Canonical Correlation Analysis (sCCA) and randomised Lasso to identify structural connections that are highly correlated with resting-state functional connectivity measured with simultaneous EEG-fMRI. Our results reveal distinct structural fingerprints for each microstructural index that also reflect their inter-relationships.	[Deligianni, Fani; Carmichael, David W.; Clark, Chris A.; Clayden, Jonathan D.] UCL, Inst Child Hlth, Dev Imaging & Biophys Sect, London, England; [Zhang, Gary H.] UCL, Dept Comp Sci, Ctr Med Image Comp, London, England	University of London; University College London; University of London; University College London	Deligianni, F (corresponding author), UCL, Inst Child Hlth, Dev Imaging & Biophys Sect, London, England.	f.deligianni@ucl.ac.uk	Clayden, Jonathan D/C-1894-2008; Carmichael, David/A-5391-2009; Deligianni, Fani/M-9116-2018	Clayden, Jonathan D/0000-0002-6608-0619; Carmichael, David/0000-0001-9972-0718; Deligianni, Fani/0000-0003-1306-5017	Engineering and Physical Sciences Research Council [EP/J016292/1]; EPSRC [EP/J016292/1]; MRC [G0701782] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Engineering and Physical Sciences Research Council, EP/J016292/1, JC (https://www.epsrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this study comes from the EPSRC (EP/J016292/1).	Alexander DC, 2008, MAGN RESON MED, V60, P439, DOI 10.1002/mrm.21646; Allen PJ, 1998, NEUROIMAGE, V8, P229, DOI 10.1006/nimg.1998.0361; Allen PJ, 2000, NEUROIMAGE, V12, P230, DOI 10.1006/nimg.2000.0599; Barnes GR, 2003, HUM BRAIN MAPP, V18, P1, DOI 10.1002/hbm.10072; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Brookes MJ, 2012, NEUROIMAGE, V63, P910, DOI 10.1016/j.neuroimage.2012.03.048; Brookes MJ, 2011, P NATL ACAD SCI USA, V108, P16783, DOI 10.1073/pnas.1112685108; Brookes MJ, 2011, NEUROIMAGE, V56, P1082, DOI 10.1016/j.neuroimage.2011.02.054; Chowdhury MEH, 2014, NEUROIMAGE, V84, P307, DOI 10.1016/j.neuroimage.2013.08.039; Clayden JD, 2013, FUNCT NEUROL, V28, P197, DOI 10.11138/FNeur/2013.28.3.197; Clayden JD, 2012, CEREB CORTEX, V22, P1738, DOI 10.1093/cercor/bhr243; Clayden JD, 2011, J STAT SOFTW, V44, P1; Deco G, 2013, J NEUROSCI, V33, P11239, DOI 10.1523/JNEUROSCI.1091-13.2013; Deco G, 2012, J NEUROSCI, V32, P3366, DOI 10.1523/JNEUROSCI.2523-11.2012; Deligianni Fani, 2013, Multimodal Brain Image Analysis. Third International Workshop, MBIA 2013. Held in Conjunction with MICCAI 2013. Proceedings: LNCS 8159, P211, DOI 10.1007/978-3-319-02126-3_21; Deligianni F, 2011, PROBABILISTIC FRAMEW, P296; Deligianni F, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00258; Deligianni F, 2013, IEEE T MED IMAGING, V32, P2200, DOI 10.1109/TMI.2013.2276916; Deligianni F, 2010, I S BIOMED IMAGING, P1113, DOI 10.1109/ISBI.2010.5490188; Dell'Acqua F, 2013, HUM BRAIN MAPP, V34, P2464, DOI 10.1002/hbm.22080; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Horowitz A, 2014, BRAIN STRUCT FUNCT, P1; Jeurissen B, 2014, NEUROIMAGE, V103, P411, DOI 10.1016/j.neuroimage.2014.07.061; Jones D.K., 2010, IMAGING MED, V2, P341, DOI [10.2217/iim.10.21, DOI 10.2217/IIM.10.21]; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Kunz N, 2014, NEUROIMAGE, V96, P288, DOI 10.1016/j.neuroimage.2014.03.057; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Ledoit O, 2004, J MULTIVARIATE ANAL, V88, P365, DOI 10.1016/S0047-259X(03)00096-4; Luo QF, 2012, MAGN RESON MED, V68, P807, DOI 10.1002/mrm.23299; LUTZ JG, 1994, EDUC PSYCHOL MEAS, V54, P666, DOI 10.1177/0013164494054003009; Mackey AP, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00032; Meinshausen N, 2010, J R STAT SOC B, V72, P417, DOI 10.1111/j.1467-9868.2010.00740.x; Messe A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003530; Mullinger K, 2008, INT J PSYCHOPHYSIOL, V67, P178, DOI 10.1016/j.ijpsycho.2007.06.008; Nilsson M, 2013, MAGN RESON MATER PHY, V26, P345, DOI 10.1007/s10334-013-0371-x; Parker CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111262; Raffelt D, 2012, NEUROIMAGE, V59, P3976, DOI 10.1016/j.neuroimage.2011.10.045; Reisert M, 2011, NEUROIMAGE, V54, P955, DOI 10.1016/j.neuroimage.2010.09.016; Reveley C, 2015, P NATL ACAD SCI USA, V112, pE2820, DOI 10.1073/pnas.1418198112; Roine T, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00028; Sagi Y, 2012, NEURON, V73, P1195, DOI 10.1016/j.neuron.2012.01.025; Smith RE, 2013, NEUROIMAGE, V67, P298, DOI 10.1016/j.neuroimage.2012.11.049; Smith RE, 2012, NEUROIMAGE, V62, P1924, DOI 10.1016/j.neuroimage.2012.06.005; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sun Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096505; SZAFER A, 1995, MAGNET RESON MED, V33, P697, DOI 10.1002/mrm.1910330516; Szczepankiewicz F, 2015, NEUROIMAGE, V104, P241, DOI 10.1016/j.neuroimage.2014.09.057; Tewarie P, 2014, NEUROIMAGE, V97, P296, DOI 10.1016/j.neuroimage.2014.04.038; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; van den Heuvel MP, 2013, JAMA PSYCHIAT, V70, P783, DOI 10.1001/jamapsychiatry.2013.1328; Varoquaux G, 2013, NEUROIMAGE, V80, P405, DOI 10.1016/j.neuroimage.2013.04.007; Wang ZQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126310; Wildie M, 2012, CHAOS, V22, DOI 10.1063/1.4766592; Wilkins B, 2015, NEUROIMAGE, V109, P341, DOI 10.1016/j.neuroimage.2014.12.060; Winston GP, 2014, EPILEPSY RES, V108, P336, DOI 10.1016/j.eplepsyres.2013.11.004; Witten DM, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1470; Witten DM, 2009, BIOSTATISTICS, V10, P515, DOI 10.1093/biostatistics/kxp008; Yuan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045476; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072; Zhang H, 2011, NEUROIMAGE, V56, P1301, DOI 10.1016/j.neuroimage.2011.01.084	65	35	36	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153404	10.1371/journal.pone.0153404	http://dx.doi.org/10.1371/journal.pone.0153404			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078862	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000374131700051
J	Simidjievski, N; Todorovski, L; Dzeroski, S				Simidjievski, Nikola; Todorovski, Ljupco; Dzeroski, Saso			Modeling Dynamic Systems with Efficient Ensembles of Process-Based Models	PLOS ONE			English	Article							POPULATION-DYNAMICS; LIBRARY; KNOWLEDGE; OPTIMIZATION; LAKES	Ensembles are a well established machine learning paradigm, leading to accurate and robust models, predominantly applied to predictive modeling tasks. Ensemble models comprise a finite set of diverse predictive models whose combined output is expected to yield an improved predictive performance as compared to an individual model. In this paper, we propose a new method for learning ensembles of process-based models of dynamic systems. The process-based modeling paradigm employs domain-specific knowledge to automatically learn models of dynamic systems from time-series observational data. Previous work has shown that ensembles based on sampling observational data (i.e., bagging and boosting), significantly improve predictive performance of process-based models. However, this improvement comes at the cost of a substantial increase of the computational time needed for learning. To address this problem, the paper proposes a method that aims at efficiently learning ensembles of process-based models, while maintaining their accurate long-term predictive performance. This is achieved by constructing ensembles with sampling domain-specific knowledge instead of sampling data. We apply the proposed method to and evaluate its performance on a set of problems of automated predictive modeling in three lake ecosystems using a library of process-based knowledge for modeling population dynamics. The experimental results identify the optimal design decisions regarding the learning algorithm. The results also show that the proposed ensembles yield significantly more accurate predictions of population dynamics as compared to individual process-based models. Finally, while their predictive performance is comparable to the one of ensembles obtained with the state-of-the-art methods of bagging and boosting, they are substantially more efficient.	[Simidjievski, Nikola; Dzeroski, Saso] Jozef Stefan Inst, Dept Knowledge Technol, Ljubljana, Slovenia; [Simidjievski, Nikola; Dzeroski, Saso] Jozef Stefan Inst, Postgrad Sch, Ljubljana, Slovenia; [Todorovski, Ljupco] Univ Ljubljana, Fac Adm, Ljubljana, Slovenia	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Ljubljana	Simidjievski, N (corresponding author), Jozef Stefan Inst, Dept Knowledge Technol, Ljubljana, Slovenia.; Simidjievski, N (corresponding author), Jozef Stefan Inst, Postgrad Sch, Ljubljana, Slovenia.	nikola.simidjievski@ijs.si	Dzeroski, Saso/ABH-2758-2021	Dzeroski, Saso/0000-0003-2363-712X; Simidjievski, Nikola/0000-0003-3948-6370	Slovenian Research Agency [P2-0103, P5-0093(B)]; European Commission [ICT-2013-604102 HBP, ICT-2013-612944 MAESTRA]	Slovenian Research Agency(Slovenian Research Agency - Slovenia); European Commission(European CommissionEuropean Commission Joint Research Centre)	NS received funding from the Slovenian Research Agency (https://www.arrs.gov.si, Grant P2-0103) and the European Commission (http://ec.europa.eu, Grant ICT-2013-604102 HBP). LT received funding from the Slovenian Research Agency (https://www.arrs.gov.si, Grant P5-0093(B)). SD received funding from the Slovenian Research Agency (https://www.arrs.gov.si, Grant P2-0103) and the European Commission (http://ec.europa.eu, Grants ICT-2013-612944 MAESTRA and ICT-2013-604102 HBP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040916; [Anonymous], 1963, DISTRIBUTION FREE MU; Atanasova N, 2006, ECOL MODEL, V194, P37, DOI 10.1016/j.ecolmodel.2005.10.029; Atanasova N, 2006, ECOL MODEL, V194, P14, DOI 10.1016/j.ecolmodel.2005.10.002; Atanasova N, 2006, ECOLOGICAL INFORM, P409; Bauer E, 1999, MACH LEARN, V36, P105, DOI 10.1023/A:1007515423169; Blockeel H, 1998, ARTIF INTELL, V101, P285, DOI 10.1016/S0004-3702(98)00034-4; Borrett SR, 2007, ECOL COMPLEX, V4, P1, DOI 10.1016/j.ecocom.2007.02.017; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Breiman L., 1984, CLASSIFICATION REGRE; Bridewell W, 2005, P 22 INT C MACHINE L, P81, DOI DOI 10.1145/1102351.1102362; Bridewell W, 2008, MACH LEARN, V71, P1, DOI 10.1007/s10994-007-5042-6; Brown G., 2005, Information Fusion, V6, P5, DOI 10.1016/j.inffus.2004.04.004; Cao HQ, 2008, ECOL INFORM, V3, P181, DOI 10.1016/j.ecoinf.2008.02.001; Cerepnalkoski D., 2013, PROCESS BASED MODELS; Cerepnalkoski D, 2012, ECOL MODEL, V245, P136, DOI 10.1016/j.ecolmodel.2012.06.001; Chen JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19062; Cohen S. D., 1996, Computers in Physics, V10, P138; Demsar J, 2006, J MACH LEARN RES, V7, P1; Dietterich TG, 2000, LECT NOTES COMPUT SC, V1857, P1, DOI 10.1007/3-540-45014-9_1; Dietzel A, 2013, FRESHWATER BIOL, V58, P10, DOI 10.1111/fwb.12031; Drucker H., 1997, P INT C MACH LEARN N, VVolume 97, P107; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Durillo JJ, 2011, ADV ENG SOFTW, V42, P760, DOI 10.1016/j.advengsoft.2011.05.014; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Friedman M, 1940, ANN MATH STAT, V11, P86, DOI 10.1214/aoms/1177731944; Ho TK, 1998, IEEE T PATTERN ANAL, V20, P832, DOI 10.1109/34.709601; Ho TK, 2000, LECT NOTES COMPUT SC, V1857, P97; IMAN RL, 1980, COMMUN STAT A-THEOR, V9, P571, DOI 10.1080/03610928008827904; Knudby A, 2010, ECOL MODEL, V221, P503, DOI 10.1016/j.ecolmodel.2009.11.008; Kocev D, 2013, ECOL INFORM, V18, P79, DOI 10.1016/j.ecoinf.2013.06.003; Kuncheva LI, 2003, MACH LEARN, V51, P181, DOI 10.1023/A:1022859003006; Langley P., 1987, SCI DISCOVERY COMPUT; Liu B, 2017, BIOINFORMATICS, V33, P35, DOI [10.1093/bioinformatics/btv604, 10.1093/bioinformatics/btw539]; Okun O., 2011, ENSEMBLES MACHINE LE, V373; Opitz D., 1999, J ARTIF INTELL RES, V11, P169, DOI [10.1613/jair.614, DOI 10.1613/JAIR.614]; Panov P, 2007, LECT NOTES COMPUT SC, V4723, P118; Rokach L, 2010, ARTIF INTELL REV, V33, P1, DOI 10.1007/s10462-009-9124-7; Schapire RE, 2003, LECT NOTES STAT, V171, P149, DOI 10.1007/978-0-387-21579-2_9; Schapire RE, 1999, IJCAI-99: PROCEEDINGS OF THE SIXTEENTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, VOLS 1 & 2, P1401; Simidjievski N, 2015, EXPERT SYST APPL, V42, P8484, DOI 10.1016/j.eswa.2015.07.004; Simidjievski N, 2015, ECOL MODEL, V306, P305, DOI 10.1016/j.ecolmodel.2014.08.019; Skerjanec M, 2014, ENVIRON MODELL SOFTW, V54, P60, DOI 10.1016/j.envsoft.2013.12.017; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Tanevski J, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0273-4; Tanevski J, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-015-0175-x; Tashkova K, 2012, ECOL MODEL, V226, P36, DOI 10.1016/j.ecolmodel.2011.11.029; Tashkova K, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-159; Todorovski Ljupco, 2007, Computational Discovery of Scientific Knowledge. Introduction, Techniques, and Applications in Environmental and Life Sciences, P69; Todorovski L, 2003, ECOL MODEL, V170, P141, DOI 10.1016/S0304-3800(03)00222-9; Todorovski L., 2005, P 20 NAT C ART INT, P892; Washio T, 2000, P 17 INT C MACH LEAR, P1127; Whigham PA, 2001, ECOL MODEL, V146, P243, DOI 10.1016/S0304-3800(01)00310-6; WOLPERT DH, 1992, NEURAL NETWORKS, V5, P241, DOI 10.1016/S0893-6080(05)80023-1	54	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153507	10.1371/journal.pone.0153507	http://dx.doi.org/10.1371/journal.pone.0153507			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078633	Green Published, gold, Green Submitted			2022-12-26	WOS:000374131700070
J	Cronlein, T; Langguth, B; Eichhammer, P; Busch, V				Croenlein, Tatjana; Langguth, Berthold; Eichhammer, Peter; Busch, Volker			Impaired Recognition of Facially Expressed Emotions in Different Groups of Patients with Sleep Disorders	PLOS ONE			English	Article							PSYCHIATRIC-DISORDERS; DEPRESSIVE SYMPTOMS; GENERAL-POPULATION; DAYTIME SLEEPINESS; APNEA; DEPRIVATION; INSOMNIA; STIMULI; DISTURBANCES; THERAPY	Introduction Recently it has been shown that acute sleep loss has a direct impact on emotional processing in healthy individuals. Here we studied the effect of chronically disturbed sleep on emotional processing by investigating two samples of patients with sleep disorders. Methods 25 patients with psychophysiologic insomnia (23 women and 2 men, mean age: 51.6 SD; 10.9 years), 19 patients with sleep apnea syndrome (4 women and 15 men, mean age: 51.9; SD 11.1) and a control sample of 24 subjects with normal sleep (15 women and 9 men, mean age 45.3; SD 8.8) completed a Facial Expressed Emotion Labelling (FEEL) task, requiring participants to categorize and rate the intensity of six emotional expression categories: anger, anxiety, fear, happiness, disgust and sadness. Differences in FEEL score and its subscales among the three samples were analysed using ANOVA with gender as a covariate. Results Both patients with psychophysiologic insomnia and patients with sleep apnea showed significantly lower performance in the FEEL test as compared to the control group. Differences were seen in the scales happiness and sadness. Patient groups did not differ from each other. Conclusion By demonstrating that previously known effects of acute sleep deprivation on emotional processing can be extended to persons experiencing chronically disturbed sleep, our data contribute to a deeper understanding of the relationship between sleep loss and emotions.	[Croenlein, Tatjana; Langguth, Berthold; Eichhammer, Peter] Univ Regensburg, Dept Psychiat & Psychotherapy, D-93053 Regensburg, Germany	University of Regensburg	Cronlein, T (corresponding author), Univ Regensburg, Dept Psychiat & Psychotherapy, D-93053 Regensburg, Germany.	tatjana.croenlein@medbo.de	Langguth, Berthold/AAP-2638-2021					American Academy of Sleep Medicine, 2005, DIAGN COD MAN ICSD 2, V2nd ed.; Anderson C, 2011, BEHAV BRAIN RES, V217, P463, DOI 10.1016/j.bbr.2010.09.020; Baglioni C, 2014, SLEEP, V37, P1907, DOI 10.5665/sleep.4240; Baglioni C, 2010, SLEEP MED REV, V14, P227, DOI 10.1016/j.smrv.2009.10.007; Beattie L, 2015, SLEEP MED REV, V24, P83, DOI 10.1016/j.smrv.2014.12.005; Buysse Daniel J, 2011, Drug Discov Today Dis Models, V8, P129; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cronlein T, 2014, PSYCHOTHER PSYCHOSOM, V83, P255, DOI 10.1159/000360706; Dahl R E, 1996, Semin Pediatr Neurol, V3, P44, DOI 10.1016/S1071-9091(96)80028-3; Di Giannantonio M, 2012, EUR NEUROPSYCHOPHARM, V22, pS505, DOI 10.1016/j.euroneuro.2012.07.004; FORD DE, 1989, JAMA-J AM MED ASSOC, V262, P1479, DOI 10.1001/jama.262.11.1479; Franzen PL, 2009, BIOL PSYCHOL, V80, P300, DOI 10.1016/j.biopsycho.2008.10.010; Genzel L, 2015, NEUROBIOL LEARN MEM, V122, P110, DOI 10.1016/j.nlm.2015.01.008; Goel N, 2009, SEMIN NEUROL, V29, P320, DOI 10.1055/s-0029-1237117; Habukawa M, 2010, SLEEP MED, V11, P552, DOI 10.1016/j.sleep.2010.02.007; Sanchez AI, 2009, SLEEP MED REV, V13, P223, DOI 10.1016/j.smrv.2008.07.002; Ishman SL, 2010, LARYNGOSCOPE, V120, P2331, DOI 10.1002/lary.21111; Kessler H, 2006, INT J EAT DISORDER, V39, P245, DOI 10.1002/eat.20228; Kessler H, 2002, VERHALTENSTHERAPIE V, V23, P297; Kret ME, 2015, NEUROSCI BIOBEHAV R, V52, P153, DOI 10.1016/j.neubiorev.2015.02.011; Kyle SD, 2014, SLEEP, V37, P775, DOI 10.5665/sleep.3588; Ma N, 2015, SLEEP, V38, P233, DOI 10.5665/sleep.4404; Martinotti G, 2012, J CLIN PSYCHOPHARM, V32, P487, DOI 10.1097/JCP.0b013e31825d6c25; Nofzinger EA, 2004, AM J PSYCHIAT, V161, P2126, DOI 10.1176/appi.ajp.161.11.2126; Ohayon MM, 2010, J PSYCHOSOM RES, V69, P565, DOI 10.1016/j.jpsychores.2010.03.010; Ohayon MM, 2003, J CLIN PSYCHIAT, V64, P1195, DOI 10.4088/JCP.v64n1009; Palagini L, 2013, SLEEP MED REV, V17, P377, DOI 10.1016/j.smrv.2012.11.001; Pallesen S, 2004, PERCEPT MOTOR SKILL, V98, P1305, DOI 10.2466/PMS.98.3.1305-1314; Riemann D, 2009, DRUGS, V69, P43, DOI 10.2165/11531130-000000000-00000; Rosales-Lagarde A, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00025; Schwartz DJ, 2005, J CLIN SLEEP MED, V1, P35; Sharafkhaneh A, 2005, SLEEP, V28, P1405, DOI 10.1093/sleep/28.11.1405; Tempesta D, 2010, BRAIN RES BULL, V82, P104, DOI 10.1016/j.brainresbull.2010.01.014; van der Helm E, 2011, CURR BIOL, V21, P2029, DOI 10.1016/j.cub.2011.10.052; van der Helm E, 2010, SLEEP, V33, P335, DOI 10.1093/sleep/33.3.335; Walker MP, 2009, PSYCHOL BULL, V135, P731, DOI 10.1037/a0016570; Yoo SS, 2007, CURR BIOL, V17, pR877, DOI 10.1016/j.cub.2007.08.007; Zohar D, 2005, SLEEP, V28, P47, DOI 10.1093/sleep/28.1.47	38	19	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152754	10.1371/journal.pone.0152754	http://dx.doi.org/10.1371/journal.pone.0152754			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UC	27073852	Green Published, Green Submitted, gold			2022-12-26	WOS:000374131200035
J	Nowrouzi, S; Andersen, AN; Macfadyen, S; Staunton, KM; VanDerWal, J; Robson, SKA				Nowrouzi, Somayeh; Andersen, Alan N.; Macfadyen, Sarina; Staunton, Kyran M.; VanDerWal, Jeremy; Robson, Simon K. A.			Ant Diversity and Distribution along Elevation Gradients in the Australian Wet Tropics: The Importance of Seasonal Moisture Stability	PLOS ONE			English	Article							RAIN-FOREST BIRDS; SPECIES-RICHNESS; CLIMATE-CHANGE; LATITUDINAL GRADIENTS; COMMUNITY STRUCTURE; FUNCTIONAL-GROUPS; WATER-BALANCE; HUMID TROPICS; RANGE SHIFTS; BIODIVERSITY	The threat of anthropogenic climate change has seen a renewed focus on understanding contemporary patterns of species distribution. This is especially the case for the biota of tropical mountains, because tropical species often have particularly narrow elevational ranges and there are high levels of short-range endemism. Here we describe geographic patterns of ant diversity and distribution in the World Heritage-listed rainforests of the Australian Wet Tropics (AWT), revealing seasonal moisture stability to be an important environmental correlate of elevational patterns of species composition. We sampled ants in leaf litter, on the litter surface and on tree trunks at 26 sites from six subregions spanning five degrees of latitude and elevation ranges from 100-1,300 m. A total of 296 species from 63 genera were recorded. Species richness showed a slight peak at mid elevations, and did not vary significantly with latitude. Species composition varied substantially between subregions, and many species have highly localised distributions. There was very marked species turnover with elevation, with a particularly striking compositional disjunction between 600 m and 800 m at each subregion. This disjunction coincides with a strong environmental threshold of seasonal stability in moisture associated with cloud 'stripping'. Our study therefore provides further support for climatic stability as a potential mechanism underlying patterns of diversity. The average height of orographic cloud layers is predicted to rise under global warming, and associated shifts in seasonal moisture stability may exacerbate biotic change caused by rising temperature alone.	[Nowrouzi, Somayeh; Staunton, Kyran M.; VanDerWal, Jeremy; Robson, Simon K. A.] James Cook Univ, Coll Marine & Ecosyst Sci, Ctr Trop Biodivers & Climate Change, Townsville, Qld 4811, Australia; [Andersen, Alan N.] CSIRO Land & Water Flagship, Darwin, NT 0822, Australia; [Nowrouzi, Somayeh; Macfadyen, Sarina] CSIRO Land & Water Flagship, Canberra, ACT 2601, Australia; [VanDerWal, Jeremy] James Cook Univ, Div Res & Innovat, ERes Ctr, Townsville, Qld 4811, Australia	James Cook University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); James Cook University	Nowrouzi, S (corresponding author), James Cook Univ, Coll Marine & Ecosyst Sci, Ctr Trop Biodivers & Climate Change, Townsville, Qld 4811, Australia.; Nowrouzi, S (corresponding author), CSIRO Land & Water Flagship, Canberra, ACT 2601, Australia.	sarah.nowrouzi@csiro.au	Robson, Simon KA/D-1168-2011; Staunton, Kyran/W-2263-2019; Andersen, Alan N/F-8763-2010; Macfadyen, Sarina/C-1511-2008	Robson, Simon KA/0000-0001-8870-1933; Staunton, Kyran/0000-0001-6812-3320; Andersen, Alan N/0000-0003-1487-3323; Macfadyen, Sarina/0000-0003-3553-4910	National Environmental Research Program of Australian Government	National Environmental Research Program of Australian Government	SN was supported by a PhD scholarship from the National Environmental Research Program of Australian Government (https://www.environment.gov.au/science/nerp). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Stephen Williams played a key role in establishing the project. Jodie Hayward, Magen Pettit, Celenie Christophe, Maxence Plouviez, Antoine Esnouf, Clemence Roldan, Carina Svensson and Arnaud Gourret provided valuable field and laboratory assistance, and Nick Nicholls gave valuable advice on R software. We thank them all. SN was supported by a PhD scholarship from the National Environmental Research Program of Australian Government.	Agosti D, 2000, BIOL DIVERSITY HDB S; Andersen AN, 2012, INSECT SOC, V59, P433, DOI 10.1007/s00040-012-0238-6; Andersen A.N., 1991, P333; Andersen AN, 2015, J BIOGEOGR, V42, P2313, DOI 10.1111/jbi.12599; ANDERSEN AN, 1995, J BIOGEOGR, V22, P15, DOI 10.2307/2846070; Andersen AN, 2000, ANTS NO AUSTR GUIDE; Anderson AS, 2012, GLOBAL CHANGE BIOL, V18, P2126, DOI 10.1111/j.1365-2486.2012.02683.x; Anderson MJ, 2005, PERMANOVA FORTRAN CO; Aristophanous M., 2014, UNDERSTANDING PATTER; Aristophanous M, 2010, ZOOKEYS, P1, DOI 10.3897/zookeys.34.215; Barron EJ, 1995, STUDIES GEOPHYSICS, P108; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Benzing D.H., 1998, POTENTIAL IMPACTS CL, P379; Bharti H, 2013, ASIAN MYRMECOL, V5, P79; Bolton B, 2007, TAXONOMY DOLICHODERI; Botes A, 2006, J BIOGEOGR, V33, P71, DOI 10.1111/j.1365-2699.2005.01336.x; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Brown KS, 1997, J INSECT CONSERV, V1, P25, DOI 10.1023/A:1018422807610; Bruhl CA, 1998, J TROP ECOL, V14, P285, DOI 10.1017/S0266467498000224; Bruhl CA, 1999, J TROP ECOL, V15, P265, DOI 10.1017/S0266467499000802; Bruijnzeel L. A, 1990, HYDROLOGY MOIST TROP; Burwell Chris J., 2011, Memoirs of the Queensland Museum, V55, P391; Bush MB, 2002, GLOBAL ECOL BIOGEOGR, V11, P463, DOI 10.1046/j.1466-822X.2002.00305.x; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Chao AN, 2013, METHODS ECOL EVOL, V4, P1091, DOI 10.1111/2041-210X.12108; Chao A, 2012, ECOLOGY, V93, P2533, DOI 10.1890/11-1952.1; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Colwell RK, 2004, AM NAT, V163, pE1, DOI 10.1086/382056; CUSHMAN JH, 1993, OECOLOGIA, V95, P30, DOI 10.1007/BF00649503; Dale A, 2007, PRELIMINARY ASSESSME; Davidson DW, 2003, SCIENCE, V300, P969, DOI 10.1126/science.1082074; Del Toro I, 2015, DIVERS DISTRIB, V21, P781, DOI 10.1111/ddi.12331; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Diamond SE, 2012, GLOBAL CHANGE BIOL, V18, P448, DOI 10.1111/j.1365-2486.2011.02542.x; Dunn RR, 2009, ECOL LETT, V12, P324, DOI 10.1111/j.1461-0248.2009.01291.x; Fisher BL, 1999, FIELD ZOOL, P129; Gibson-Reinemer DK, 2015, ECOL EVOL, V5, P2340, DOI 10.1002/ece3.1518; Goosem S, 2002, UPDATE ORIGINAL WET; Graham CH, 2014, ECOGRAPHY, V37, P711, DOI 10.1111/ecog.00578; Graham CH, 2010, ECOGRAPHY, V33, P1062, DOI 10.1111/j.1600-0587.2010.06430.x; Graham CH, 2006, P NATL ACAD SCI USA, V103, P632, DOI 10.1073/pnas.0505754103; Grimbacher PS, 2009, BIOTROPICA, V41, P328, DOI 10.1111/j.1744-7429.2008.00477.x; Grytnes J.-A., 2010, ELEVATIONAL GRADIENT; Heterick BE, 2001, INVERTEBR TAXON, V15, P353, DOI 10.1071/IT00003; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hilbert D. W., 2008, LIVING DYNAMIC TROPI, P107; Hilbert DW, 2001, AUSTRAL ECOL, V26, P590, DOI 10.1046/j.1442-9993.2001.01137.x; Holldobler B., 1990, pi; Hutley LB, 1997, AUST J BOT, V45, P311, DOI 10.1071/BT96014; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Jenkins CN, 2011, DIVERS DISTRIB, V17, P652, DOI 10.1111/j.1472-4642.2011.00770.x; Kanowski J, 2001, AUSTRAL ECOL, V26, P165, DOI 10.1046/j.1442-9993.2001.01103.x; Kaspari M, 2004, OECOLOGIA, V140, P407, DOI 10.1007/s00442-004-1607-2; Kaufmann E, 2006, NATURWISSENSCHAFTEN, V93, P216, DOI 10.1007/s00114-005-0081-y; KERSHAW AP, 1994, PALAEOGEOGR PALAEOCL, V109, P399, DOI 10.1016/0031-0182(94)90188-0; Laurance WF, 2011, BIOL CONSERV, V144, P548, DOI 10.1016/j.biocon.2010.10.010; Longino JT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104030; Longino JT, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00200.1; Longino JT, 2002, ECOLOGY, V83, P689, DOI 10.1890/0012-9658(2002)083[0689:TAFOAT]2.0.CO;2; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; McDonald TE, 2000, SECURING WET TROPICS; McJannet D, 2008, LIVING DYNAMIC TROPI; McJannet D, 2007, HYDROL PROCESS, V21, P1703, DOI 10.1002/hyp.6346; Menendez R, 2014, GLOBAL ECOL BIOGEOGR, V23, P646, DOI 10.1111/geb.12142; Meteorology ABo, 2015, SEV TROP CYCL YAS 20; MONTEITH G. B, 2008, LIVING DYNAMIC TROPI, P178, DOI DOI 10.1002/9781444300321.CH13; Munyai TC, 2012, J INSECT CONSERV, V16, P677, DOI 10.1007/s10841-011-9449-9; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; OLSON DM, 1994, J TROP ECOL, V10, P129, DOI 10.1017/S0266467400007793; Parsons SA, 2008, J TROP ECOL, V24, P317, DOI 10.1017/S0266467408004963; Patrick M, 2012, BIOTROPICA, V44, P472, DOI 10.1111/j.1744-7429.2012.00855.x; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; PIANKA ER, 1966, AM NAT, V100, P33, DOI 10.1086/282398; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Prather CM, 2013, BIOL REV, V88, P327, DOI 10.1111/brv.12002; R Development Core Team, R LANG ENV STAT COMP; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; Rapp JM, 2014, F1000RESEARCH, P3; Reichel H, 1996, AUST J ZOOL, V44, P81, DOI 10.1071/ZO9960081; Robertson HG, 2002, BIODIVERS CONSERV, V11, P1637, DOI 10.1023/A:1016883901065; ROSENBERG DM, 1986, ENVIRON MANAGE, V10, P773, DOI 10.1007/BF01867730; Sanders NJ, 2002, ECOGRAPHY, V25, P25, DOI 10.1034/j.1600-0587.2002.250104.x; Shattuck SO, 2013, ZOOTAXA, V3669, P287, DOI 10.11646/zootaxa.3669.3.5; Shattuck S, 2009, ZOOTAXA, P1; Shattuck SO, 2012, ZOOTAXA, P1; Sheldon KS, 2014, ECOLOGY, V95, P2134, DOI 10.1890/13-1703.1; Shoo LP, 2005, BIOL CONSERV, V125, P335, DOI 10.1016/j.biocon.2005.04.003; Smith DJ, 2009, ZOOTAXA, P57, DOI 10.11646/zootaxa.2142.1.5; Smith MA, 2014, ECOGRAPHY, V37, P720, DOI 10.1111/j.1600-0587.2013.00631.x; Staunton KM, 2013, VULNERABILITY FLIGTL; Staunton KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088635; Taylor R.W., 1985, Zoological Catalogue of Australia, V2, P1; TAYLOR RW, 1977, AUST J ZOOL, V25, P581, DOI 10.1071/ZO9770581; Taylor RW, 1972, BIOGEOGRAPHY INSECTS; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tracey J, 1994, RAINFORESTS NO AUSTR, P87; Turton SM, 2012, GEOGR RES-AUST, V50, P15, DOI 10.1111/j.1745-5871.2011.00724.x; van Ingen LT, 2008, J TROP ECOL, V24, P445, DOI 10.1017/S0266467408005166; Wallace J, 2012, J HYDROL, V475, P84, DOI 10.1016/j.jhydrol.2012.09.032; Wang Minsheng, 2003, Bulletin of the Museum of Comparative Zoology, V157, P383; Welbergen J, 2015, CLIMATE CHANGE IMPAC; Williams SE, 2009, P NATL ACAD SCI USA, V106, P19737, DOI 10.1073/pnas.0901640106; Williams SE, 2008, DIVERS DISTRIB, V14, P69, DOI 10.1111/j.1472-4642.2007.00418.x; Williams SE, 2010, AUSTRAL ECOL, V35, P650, DOI 10.1111/j.1442-9993.2009.02073.x; Williams YM, 2006, BIOL LETT-UK, V2, P532, DOI 10.1098/rsbl.2006.0541; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Wilson, 1988, BIODIVERSITY, P170; WTMA, 2013, ANN REP STAT WET TRO; Yek SH, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.1201	111	25	25	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153420	10.1371/journal.pone.0153420	http://dx.doi.org/10.1371/journal.pone.0153420			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073848	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000374131200088
J	Silbiger, NJ; Guadayol, O; Thomas, FIM; Donahue, MJ				Silbiger, Nyssa J.; Guadayol, Oscar; Thomas, Florence I. M.; Donahue, Megan J.			A Novel mu CT Analysis Reveals Different Responses of Bioerosion and Secondary Accretion to Environmental Variability	PLOS ONE			English	Article							GREAT-BARRIER-REEF; REUNION INDIAN-OCEAN; CORAL-REEFS; INTERNAL BIOEROSION; CONTINENTAL-SHELF; CLIMATE-CHANGE; RATES; ACIDIFICATION; PACIFIC; DISSOLUTION	Corals build reefs through accretion of calcium carbonate (CaCO3) skeletons, but net reef growth also depends on bioerosion by grazers and borers and on secondary calcification by crustose coralline algae and other calcifying invertebrates. However, traditional field methods for quantifying secondary accretion and bioerosion confound both processes, do not measure them on the same time-scale, or are restricted to 2D methods. In a prior study, we compared multiple environmental drivers of net erosion using pre- and post-deployment micro-computed tomography scans (mu CT; calculated as the % change in volume of experimental CaCO3 blocks) and found a shift from net accretion to net erosion with increasing ocean acidity. Here, we present a novel mu CT method and detail a procedure that aligns and digitally subtracts pre- and post-deployment mu CT scans and measures the simultaneous response of secondary accretion and bioerosion on blocks exposed to the same environmental variation over the same time-scale. We tested our method on a dataset from a prior study and show that it can be used to uncover information previously unattainable using traditional methods. We demonstrated that secondary accretion and bioerosion are driven by different environmental parameters, bioerosion is more sensitive to ocean acidity than secondary accretion, and net erosion is driven more by changes in bioerosion than secondary accretion.	[Silbiger, Nyssa J.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Silbiger, Nyssa J.; Thomas, Florence I. M.; Donahue, Megan J.] Univ Hawaii Manoa, Hawaii Inst Marine Biol, Kaneohe, HI USA; [Guadayol, Oscar] Lincoln Univ, Sch Life Sci, Joseph Banks Labs, Lincoln, NE USA	University of California System; University of California Irvine; University of Hawaii System; University of Hawaii Manoa	Silbiger, NJ (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA.; Silbiger, NJ (corresponding author), Univ Hawaii Manoa, Hawaii Inst Marine Biol, Kaneohe, HI USA.	nyssa.silbiger@uci.edu	Guadayol, Òscar/N-2940-2013; Donahue, Megan/Q-3528-2017	Guadayol, Òscar/0000-0001-9552-1041; Silbiger, Nyssa/0000-0003-4916-3217; Donahue, Megan/0000-0002-7529-001X; Thomas, Florence/0000-0003-4347-6474	NOAA Office of National Marine Sanctuaries-HIMB partnership (MOA) [2009-039/7932]; National Science Foundation EPSCoR Hawai'i; NOAA Dr. Nancy Foster Scholarship; Sigma-Xi GIAR; Hawai'i Sea [1889, 1847]; National Oceanic and Atmospheric Administration [R/IR-18]; University of Hawai'i Sea Grant College Program, School of Ocean and Earth Science and Technology, Office of Sea Grant, Department of Commerce [NA09OAR4170060]	NOAA Office of National Marine Sanctuaries-HIMB partnership (MOA); National Science Foundation EPSCoR Hawai'i; NOAA Dr. Nancy Foster Scholarship; Sigma-Xi GIAR; Hawai'i Sea; National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); University of Hawai'i Sea Grant College Program, School of Ocean and Earth Science and Technology, Office of Sea Grant, Department of Commerce	Funding for this project came from NOAA Office of National Marine Sanctuaries-HIMB partnership (MOA #2009-039/7932), National Science Foundation EPSCoR Hawai'i, NOAA Dr. Nancy Foster Scholarship to N.J.S., Sigma-Xi GIAR to N.J.S., and by Hawai'i Sea Grants #1889 to F.I.M.T and #1847 to M.J.D. and F.I.M.T. This paper is funded in part by a grant/cooperative agreement from the National Oceanic and Atmospheric Administration, Project No. R/IR-18, which is sponsored by the University of Hawai'i Sea Grant College Program, School of Ocean and Earth Science and Technology, under Institutional Grant No. NA09OAR4170060 Office of Sea Grant, Department of Commerce. The views expressed herein are those of the authors and do not necessarily reflect the views of NOAA or any of its subagencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson A, 1997, ANNU REV ECOL SYST, V28, P317, DOI 10.1146/annurev.ecolsys.28.1.317; Alwany MA, 2009, J EXP MAR BIOL ECOL, V371, P170, DOI 10.1016/j.jembe.2009.01.019; Anderson D. R., 2008, MODEL BASED INFERENC; Andersson AJ, 2013, ANNU REV MAR SCI, V5, P321, DOI 10.1146/annurev-marine-121211-172241; Barkley HC, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500328; Becker L, 1996, P 8 INT COR S SPRING, V2, P1819; BELLWOOD DR, 1995, MAR BIOL, V121, P419, DOI 10.1007/BF00349451; Beuck L, 2007, FACIES, V53, P157, DOI 10.1007/s10347-006-0094-9; Marquez JC, 2012, MAR ECOL-EVOL PERSP, V33, P417, DOI 10.1111/j.1439-0485.2011.00506.x; Carreiro-Silva M, 2005, CORAL REEFS, V24, P214, DOI 10.1007/s00338-004-0445-3; Carreiro-Silva M, 2009, MAR ECOL PROG SER, V392, P1, DOI 10.3354/meps08251; Castillo KD, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1856; CHAZOTTES V, 1995, PALAEOGEOGR PALAEOCL, V113, P189, DOI 10.1016/0031-0182(95)00043-L; Chazottes V, 2002, CORAL REEFS, V21, P375, DOI 10.1007/s00338-002-0259-0; Comeau S, 2013, LIMNOL OCEANOGR, V58, P388, DOI 10.4319/lo.2013.58.1.0388; Crook ED, 2013, P NATL ACAD SCI USA, V110, P11044, DOI 10.1073/pnas.1301589110; Davidson TM, 2013, J EXP MAR BIOL ECOL, V446, P115, DOI 10.1016/j.jembe.2013.05.008; DeCarlo TM, 2014, GEOLOGY; Drupp P, 2011, AQUAT GEOCHEM, V17, P473, DOI 10.1007/s10498-010-9115-y; Duarte CM, 2013, ESTUAR COAST, V36, P221, DOI 10.1007/s12237-013-9594-3; Dumont CP, 2013, J EXP MAR BIOL ECOL, V441, P71, DOI 10.1016/j.jembe.2013.01.018; Edinger EN, 1996, LETHAIA, V29, P275, DOI 10.1111/j.1502-3931.1996.tb01660.x; Edinger EN, 2000, MAR POLLUT BULL, V40, P404, DOI 10.1016/S0025-326X(99)00237-4; Erez J, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P151, DOI 10.1007/978-94-007-0114-4_10; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Fang JKH, 2013, GLOBAL CHANGE BIOL, V19, P3581, DOI 10.1111/gcb.12334; FRECHETTE M, 1989, LIMNOL OCEANOGR, V34, P19, DOI 10.4319/lo.1989.34.1.0019; Godinot C, 2012, BIOGEOSCIENCES, V9, P2377, DOI 10.5194/bg-9-2377-2012; GOLUBIC S, 1970, LETHAIA, V3, P203, DOI 10.1111/j.1502-3931.1970.tb01858.x; Grange JS, 2015, ENVIRON SCI POLLUT R, V22, P13625, DOI 10.1007/s11356-014-4069-z; Guadayol O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085213; Harney JN, 2003, J SEDIMENT RES, V73, P856, DOI 10.1306/051503730856; Hassan M., 1997, P1813; HEIN FJ, 1975, B MAR SCI, V25, P133; Hernandez-Ballesteros LM, 2013, J EXP MAR BIOL ECOL, V441, P23, DOI 10.1016/j.jembe.2013.01.016; HIGHSMITH RC, 1981, INT REV GES HYDROBIO, V66, P335, DOI 10.1002/iroh.19810660307; HIGHSMITH RC, 1981, AM NAT, V117, P193, DOI 10.1086/283698; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Holmes KE, 2000, MAR POLLUT BULL, V40, P606, DOI 10.1016/S0025-326X(00)00067-9; Hutchings P, 2005, MAR POLLUT BULL, V51, P438, DOI 10.1016/j.marpolbul.2004.10.044; Hutchings P., 1995, OCEANOGRAPHIC LIT RE, V9, P781; HUTCHINGS PA, 1986, CORAL REEFS, V4, P239, DOI 10.1007/BF00298083; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; KIENE WE, 1994, CORAL REEFS, V13, P91, DOI 10.1007/BF00300767; Kuffner IB, 2008, NAT GEOSCI, V1, P114, DOI 10.1038/ngeo100; Le Grand HM, 2011, CORAL REEFS, V30, P97, DOI 10.1007/s00338-010-0670-x; Legland David, 2007, Image Analysis & Stereology, V26, P83, DOI 10.5566/ias.v26.p83-92; Londono-Cruz E, 2003, MAR ECOL PROG SER, V265, P289, DOI 10.3354/meps265289; MacGeachy J. K., 1977, Proceedings int Coral Reef Symp, V3, P477; Manzello DP, 2008, P NATL ACAD SCI USA, V105, P10450, DOI 10.1073/pnas.0712167105; Massaro RFS, 2012, AQUAT GEOCHEM, V18, P357, DOI 10.1007/s10498-012-9170-7; Mattes D, 2001, PROC SPIE, V4322, P1609, DOI 10.1117/12.431046; MORAN DP, 1988, MAR ECOL PROG SER, V44, P249, DOI 10.3354/meps044249; Nava H, 2008, J EXP BIOL, V211, P2827, DOI 10.1242/jeb.019216; NOWELL ARM, 1984, ANNU REV ECOL SYST, V15, P303, DOI 10.1146/annurev.es.15.110184.001511; Ong L, 2010, MAR BIOL, V157, P1313, DOI 10.1007/s00227-010-1411-y; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Pari N, 2002, J EXP MAR BIOL ECOL, V276, P109, DOI 10.1016/S0022-0981(02)00243-5; Perry CT, 1998, CORAL REEFS, V17, P277, DOI 10.1007/s003380050129; Peyrot-Clausade M, 1999, B GEOL SOC DENMARK, V45, P151; Przeslawski R, 2008, GLOBAL CHANGE BIOL, V14, P2773, DOI 10.1111/j.1365-2486.2008.01693.x; ReakaKudla ML, 1996, CORAL REEFS, V15, P101; Reyes-Nivia C, 2013, GLOBAL CHANGE BIOL, V19, P1919, DOI 10.1111/gcb.12158; RISK MJ, 1995, CORAL REEFS, V14, P79, DOI 10.1007/BF00303427; Rivest EB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121742; Rodolfo-Metalpa R, 2011, NAT CLIM CHANGE, V1, P308, DOI 10.1038/NCLIMATE1200; ROSE CS, 1985, PSZNI MAR ECOL, V6, P345, DOI 10.1111/j.1439-0485.1985.tb00142.x; RUTZLER K, 1975, OECOLOGIA, V19, P203, DOI 10.1007/BF00345306; SAMMARCO PW, 1990, MAR ECOL PROG SER, V59, P145, DOI 10.3354/meps059145; SAMMARCO PW, 1987, J EXP MAR BIOL ECOL, V112, P185, DOI 10.1016/0022-0981(87)90116-X; Schonberg CHL, 2008, CURRENT DEVELOPMENTS IN BIOEROSION, P147, DOI 10.1007/978-3-540-77598-0_8; Schonberg CHL, 2002, MAR ECOL-P S Z N I, V23, P313, DOI 10.1046/j.1439-0485.2002.02811.x; SCOTT PJB, 1988, CORAL REEFS, V7, P145, DOI 10.1007/BF00300974; Shamberger KEF, 2014, GEOPHYS RES LETT, V41, P499, DOI 10.1002/2013GL058489; Silbiger NJ, 2015, BIOGEOSCIENCES, V12, P567, DOI 10.5194/bg-12-567-2015; Silbiger NJ, 2014, MAR ECOL PROG SER, V515, P33, DOI 10.3354/meps10999; Silverman J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036282; Smith JE, 2013, MAR BIOL, V160, P2437, DOI 10.1007/s00227-013-2239-z; SMITH SV, 1984, LIMNOL OCEANOGR, V29, P1149, DOI 10.4319/lo.1984.29.6.1149; Styner M, 2000, IEEE T MED IMAGING, V19, P153, DOI 10.1109/42.845174; Tribollet A, 2006, J PHYCOL, V42, P292, DOI 10.1111/j.1529-8817.2006.00198.x; Tribollet A, 2005, CORAL REEFS, V24, P422, DOI 10.1007/s00338-005-0003-7; Tribollet A, 2002, CORAL REEFS, V21, P424, DOI 10.1007/s00338-002-0267-0; Tribollet A, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003286; Tribollet A, 2008, CURRENT DEVELOPMENTS IN BIOEROSION, P67, DOI 10.1007/978-3-540-77598-0_4; Vogel N, 2016, CORAL REEFS, P1; Wisshak M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045124; Yates KK, 2007, MAR CHEM, V104, P110, DOI 10.1016/j.marchem.2006.12.008; Zubia M, 2001, OCEANOL ACTA, V24, P251, DOI 10.1016/S0399-1784(01)01144-6	90	21	22	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153058	10.1371/journal.pone.0153058	http://dx.doi.org/10.1371/journal.pone.0153058			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074001	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000374131200049
J	Ziegenhorn, MA				Ziegenhorn, Morgan A.			Best Dressed Test: A Study of the Covering Behavior of the Collector Urchin Tripneustes gratilla	PLOS ONE			English	Article							SEA-URCHIN; PREDATION	Many sea urchin genera exhibit cryptic covering behaviors. One such behavior has been documented in the sea urchin Tripneustes gratilla, and previous studies have theorized that this behavior serves as protection from UV radiation. However, other hypotheses have been presented such as protection from predators or added weight to help T. gratilla resist strong currents. A field study was conducted in October-November 2015 in Moorea, French Polynesia to assess urchin covering behavior in natural habitats. The study found that urchins partially underneath rocks covered more, and with more algae, than urchins totally underneath rocks. To test if this behavior was driven by light intensity, a series of 30-minute experimental trials were run on 10 individuals in bright and dim conditions. Individuals were given red and clear plastic, and percent cover of each was recorded. These tests were repeated once fifty percent of spines had been removed from the urchin, in order to determine whether spine loss affects T. gratilla covering behavior. The study found that urchins had a distinct preference for cover that best protects them from UV radiation. Spine loss did not significantly affect urchin ability to cover, and urchins with removed spines still preferred opaque cover. Additionally, covering behavior was mapped onto a phylogeny of echinoderms to determine how it might have evolved. Understanding urchin covering behavior more fully is a step towards an understanding of the evolution of cryptic behavior across species.	[Ziegenhorn, Morgan A.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Ziegenhorn, MA (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	maziggy@berkeley.edu						Adams NL, 2001, MAR ECOL PROG SER, V213, P87, DOI 10.3354/meps213087; Agatsuma Y, 2001, FISHERIES SCI, V67, P1181, DOI 10.1046/j.1444-2906.2001.00379.x; Amato KR, 2008, B MAR SCI, V82, P255; Ambrose HW, 2002, HDB BIOL INVESTIGATI; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Belleza Dominic Franco C., 2012, Philippine Scientist, V49, P34; Crook AC, 1999, J MAR BIOL ASSOC UK, V79, P1117, DOI 10.1017/S002531549900137X; Cruz C, 1994, BIOL GEOMORPHOLOGY T, V4, P22; DAYTON PK, 1977, MAR BIOL, V39, P361, DOI 10.1007/BF00391939; DIX TG, 1970, PAC SCI, V24, P187; Dubois P, 2001, MICROSC RES TECHNIQ, V55, P427, DOI 10.1002/jemt.1188; Dumont CP, 2007, ANIM BEHAV, V73, P979, DOI 10.1016/j.anbehav.2006.11.008; FORSTER GR, 1959, J MAR BIOL ASSOC UK, V38, P361, DOI 10.1017/S0025315400006147; James DW, 2000, MAR BIOL, V137, P913, DOI 10.1007/s002270000423; Kehas AJ, 2005, MAR BIOL, V146, P1111, DOI 10.1007/s00227-004-1514-4; LEWIS JOHN B., 1958, CANADIAN JOUR ZOOL, V36, P607; LITTLEWOOD DTJ, 1995, PHILOS T R SOC B, V347, P213, DOI 10.1098/rstb.1995.0023; Maddison W.P., MESQUITE MODULAR SYS; Milligan HN, 1915, ZOOLOGIST, V894, P441; MILLOTT N, 1975, ADV MAR BIOL, V13, P1, DOI 10.1016/S0065-2881(08)60279-5; MILLOTT N, 1956, J EXP BIOL, V33, P508; Moore HB, 1966, ECOLOGY ECHINOIDS PH, P73; OGDEN NB, 1989, B MAR SCI, V45, P539; Pawson DL, 2013, DEEP-SEA RES PT II, V92, P207, DOI 10.1016/j.dsr2.2013.01.023; Pederson HG, 2006, J EXP MAR BIOL ECOL, V336, P120, DOI 10.1016/j.jembe.2006.04.010; Portmann A, 1959, ANIMAL CAMOUFLAGE; R Core Team, 2021, R LANGUAGE ENV STAT; SMITH AB, 1988, MOL BIOL EVOL, V5, P345; Stevens M, 2009, PHILOS T R SOC B, V364, P423, DOI 10.1098/rstb.2008.0217; Thet MM, 2004, ZOOL SCI, V21, P265, DOI 10.2108/zsj.21.265; Unger B, 1993, P 8 INT ECH C DIJ FR, P913; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; YANAGISAWA Y, 1972, Publications of the Seto Marine Biological Laboratory, V19, P431; Yoshida M., 1966, P435; Zhao CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093709; Zhao C, 2014, MAR FRESHW BEHAV PHY, V47, P11, DOI 10.1080/10236244.2013.868075	36	8	8	5	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153581	10.1371/journal.pone.0153581	http://dx.doi.org/10.1371/journal.pone.0153581			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073915	Green Published, gold, Green Submitted			2022-12-26	WOS:000374131200108
J	Meyer, V; Holden, MR; Weismiller, HA; Eaton, GR; Eaton, SS; Margittai, M				Meyer, Virginia; Holden, Michael R.; Weismiller, Hilary A.; Eaton, Gareth R.; Eaton, Sandra S.; Margittai, Martin			Fracture and Growth Are Competing Forces Determining the Fate of Conformers in Tau Fibril Populations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; PROGRESSIVE SUPRANUCLEAR PALSY; ALPHA-SYNUCLEIN; ALZHEIMERS-DISEASE; AMYLOID FIBRILS; BETA-STRUCTURE; PRION STRAIN; NEURODEGENERATIVE DISEASES; SEEDING BARRIER; MOLECULAR-BASIS	Tau fibrils are pathological aggregates that can transfer between neurons and then recruit soluble Tau monomers by template-assisted conversion. The propagation of different fibril polymorphs is thought to be a contributing factor to phenotypic diversity in Alzheimer disease and other Tauopathies. We found that a homogeneous population of Tau fibrils composed of the truncated version K18 (residues 244-372) gradually converted to a new set of fibril conformers when subjected to multiple cycles of seeding and growth. Using double electronelectron resonance (DEER) spectroscopy, we observed that the distances between spin labels at positions 311 and 328 in the fibril core progressively decreased. The findings were corroborated by changes in turbidity, morphology, and protease sensitivity. Fibrils that were initially formed under stirring conditions exhibited an increased fragility compared with fibrils formed quiescently after multiple cycles of seeding. The quiescently formed fibrils were marked by accelerated growth. The difference in fragility and growth between the different conformers explains how the change in incubation condition could lead to the amplification of a minor subpopulation of fibrils. Under quiescent conditions where fibril breakage is minimal, faster growing fibrils have a selective advantage. The findings are of general importance as they suggest that changes in selective pressures during fibril propagation in the human brain could result in the emergence of new fibril conformers with varied clinicopathological consequences.	[Meyer, Virginia; Holden, Michael R.; Weismiller, Hilary A.; Eaton, Gareth R.; Eaton, Sandra S.; Margittai, Martin] Univ Denver, Dept Chem & Biochem, 2190 East Iliff Ave, Denver, CO 80208 USA	University of Denver	Margittai, M (corresponding author), Univ Denver, Dept Chem & Biochem, 2190 East Iliff Ave, Denver, CO 80208 USA.	martin.margittai@du.edu	Margittai, Martin/D-5039-2014; Meyer, Virginia/ABF-6246-2021	Margittai, Martin/0000-0003-1903-5927; Eaton, Gareth R/0000-0001-7429-8469; Eaton, Sandra S/0000-0002-2731-7986	National Institutes of Health [R01NS076619]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076619] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant R01NS076619 ( to M. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Altenbach C, 2001, BIOCHEMISTRY-US, V40, P15471, DOI 10.1021/bi011544w; Angers RC, 2010, SCIENCE, V328, P1154, DOI 10.1126/science.1187107; Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; Bedrood S, 2012, J BIOL CHEM, V287, P5235, DOI 10.1074/jbc.M111.327817; Berliner L. J., 2000, BIOL MAGNETIC RESONA; BERLINER LJ, 1982, ANAL BIOCHEM, V119, P450, DOI 10.1016/0003-2697(82)90612-1; Berriman J, 2003, P NATL ACAD SCI USA, V100, P9034, DOI 10.1073/pnas.1530287100; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Buee L, 1999, BRAIN PATHOL, V9, P681; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; Clavaguera F, 2013, P NATL ACAD SCI USA, V110, P9535, DOI 10.1073/pnas.1301175110; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Daebel V, 2012, J AM CHEM SOC, V134, P13982, DOI 10.1021/ja305470p; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Dinkel PD, 2011, BIOCHEMISTRY-US, V50, P4330, DOI 10.1021/bi2004685; Dujardin S, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-14; Elbaum-Garfinkle S, 2012, J AM CHEM SOC, V134, P16607, DOI 10.1021/ja305206m; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Frost B, 2009, J BIOL CHEM, V284, P3546, DOI 10.1074/jbc.M805627200; Gao XC, 2015, MOL CELL, V59, P781, DOI 10.1016/j.molcel.2015.07.012; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; Helsen CW, 2012, PRION, V6, P234, DOI 10.4161/pri.19913; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Iba M, 2013, J NEUROSCI, V33, P1024, DOI 10.1523/JNEUROSCI.2642-12.2013; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2000, BIO MAGN RE, V19, P493; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Karyagina I, 2011, BIOPHYS J, V101, pL1, DOI 10.1016/j.bpj.2011.05.052; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; LANSBURY PT, 1995, CHEM BIOL, V2, P1, DOI 10.1016/1074-5521(95)90074-8; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Mahal SP, 2010, P NATL ACAD SCI USA, V107, P22653, DOI 10.1073/pnas.1013014108; Makarava N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003759; Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101; Margittai M, 2006, METHOD ENZYMOL, V413, P122, DOI 10.1016/S0076-6879(06)13007-4; Meyer V, 2016, METHODS MOL BIOL, V1345, P185, DOI 10.1007/978-1-4939-2978-8_12; Meyer V, 2014, BIOCHEMISTRY-US, V53, P5804, DOI 10.1021/bi501050g; Meyer V, 2014, ANGEW CHEM INT EDIT, V53, P1590, DOI 10.1002/anie.201308473; MILOV AD, 1981, FIZ TVERD TELA+, V23, P975; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; Murray ME, 2011, LANCET NEUROL, V10, P785, DOI 10.1016/S1474-4422(11)70156-9; NOVAK M, 1993, EMBO J, V12, P365, DOI 10.1002/j.1460-2075.1993.tb05665.x; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Pornsuwan S, 2013, ANGEW CHEM INT EDIT, V52, P10290, DOI 10.1002/anie.201304747; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; RABENSTEIN MD, 1995, P NATL ACAD SCI USA, V92, P8239, DOI 10.1073/pnas.92.18.8239; Saito Y, 2004, J NEUROPATH EXP NEUR, V63, P911, DOI 10.1093/jnen/63.9.911; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Shorter J, 2006, MOL CELL, V23, P425, DOI 10.1016/j.molcel.2006.05.042; Siddiqua A, 2012, J AM CHEM SOC, V134, P10271, DOI 10.1021/ja303498q; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; Sweeny EA, 2016, J MOL BIOL, V428, P1870, DOI 10.1016/j.jmb.2015.11.016; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Tycko R, 2015, NEURON, V86, P632, DOI 10.1016/j.neuron.2015.03.017; Verny M, 1996, BRAIN, V119, P1123, DOI 10.1093/brain/119.4.1123; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; von Bergen M, 2006, BIOCHEMISTRY-US, V45, P6446, DOI 10.1021/bi052530j; Walker LC, 2013, JAMA NEUROL, V70, P304, DOI 10.1001/jamaneurol.2013.1453; Weissmann C, 2011, EMBO REP, V12, P1109, DOI 10.1038/embor.2011.192; Williams DR, 2009, LANCET NEUROL, V8, P270, DOI 10.1016/S1474-4422(09)70042-0; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4884, DOI 10.1073/pnas.85.13.4884; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; Wu JW, 2013, J BIOL CHEM, V288, P1856, DOI 10.1074/jbc.M112.394528; Yu X, 2012, J BIOL CHEM, V287, P14950, DOI 10.1074/jbc.M112.340794	76	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12271	12281		10.1074/jbc.M116.715557	http://dx.doi.org/10.1074/jbc.M116.715557			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27080260	Green Published, hybrid			2022-12-26	WOS:000378092800027
J	del Cerro, P; Rolla-Santos, AAP; Valderrama-Fernandez, R; Gil-Serrano, A; Bellogin, RA; Gomes, DF; Perez-Montano, F; Megias, M; Hungria, M; Ollero, FJ				del Cerro, Pablo; Rolla-Santos, Amanda A. P.; Valderrama-Fernandez, Rocio; Gil-Serrano, Antonio; Bellogin, Ramon A.; Fabiano Gomes, Douglas; Perez-Montano, Francisco; Megias, Manuel; Hungria, Mariangela; Javier Ollero, Francisco			NrcR, a New Transcriptional Regulator of Rhizobium tropici CIAT 899 Involved in the Legume Root-Nodule Symbiosis	PLOS ONE			English	Article							BEAN PHASEOLUS-VULGARIS; BROAD-HOST-RANGE; NODULATION FACTORS; BRADYRHIZOBIUM-JAPONICUM; GENE-EXPRESSION; STRAINS; SIGNALS; NOLR; COMPETITIVENESS; IDENTIFICATION	The establishment of nitrogen-fixing rhizobium-legume symbioses requires a highly complex cascade of events. In this molecular dialogue the bacterial NodD transcriptional regulators in conjunction with plant inducers, mostly flavonoids, are responsible for the biosynthesis and secretion of Nod factors which are key molecules for successful nodulation. Other transcriptional regulators related to the symbiotic process have been identified in rhizobial genomes, including negative regulators such as NolR. Rhizobium tropici CIAT 899 is an important symbiont of common bean (Phaseolus vulgaris L.), and its genome encompasses intriguing features such as five copies of nodD genes, as well as other possible transcriptional regulators including the NolR protein. Here we describe and characterize a new regulatory gene located in the non-symbiotic plasmid pRtrCIAT899c, that shows homology (46% identity) with the nolR gene located in the chromosome of CIAT 899. The mutation of this gene, named nrcR (nolR-like plasmid c Regulator), enhanced motility and exopolysaccharide production in comparison to the wild-type strain. Interestingly, the number and decoration of Nod Factors produced by this mutant were higher than those detected in the wildtype strain, especially under salinity stress. The nrcR mutant showed delayed nodulation and reduced competitiveness with P. vulgaris, and reduction in nodule number and shoot dry weight in both P. vulgaris and Leucaena leucocephala. Moreover, the mutant exhibited reduced capacity to induce the nodC gene in comparison to the wild-type CIAT 899. The finding of a new nod-gene regulator located in a non-symbiotic plasmid may reveal the existence of even more complex mechanisms of regulation of nodulation genes in R. tropici CIAT 899 that may be applicable to other rhizobial species.	[del Cerro, Pablo; Bellogin, Ramon A.; Perez-Montano, Francisco; Megias, Manuel; Javier Ollero, Francisco] Univ Seville, Fac Biol, Dept Microbiol, Seville, Spain; [Rolla-Santos, Amanda A. P.; Fabiano Gomes, Douglas; Hungria, Mariangela] Embrapa Soja, Cx Postal 231, BR-86001970 Londrina, Parana, Brazil; [Valderrama-Fernandez, Rocio; Gil-Serrano, Antonio] Univ Seville, Fac Quim, Dept Quim Organ, E-41071 Seville, Spain	University of Sevilla; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); University of Sevilla	Ollero, FJ (corresponding author), Univ Seville, Fac Biol, Dept Microbiol, Seville, Spain.	fjom@us.es	Pérez-Montaño, Francisco/K-8971-2014; del Cerro Sánhez, Pablo PdC/H-7198-2016; Gil-Serrano, Antonio M/L-2002-2014; del Cerro Sánchez, Pablo/ABG-1194-2020; Hungria, Mariangela/D-8540-2013; Ollero Marquez, Francisco Javier/G-3271-2015	Pérez-Montaño, Francisco/0000-0002-6272-2063; del Cerro Sánhez, Pablo PdC/0000-0002-8030-7226; Gil-Serrano, Antonio M/0000-0001-9503-0891; del Cerro Sánchez, Pablo/0000-0002-8030-7226; Ollero Marquez, Francisco Javier/0000-0002-3641-7946	Ministerio de Economia y Competitividad (Spanish Government) [AGL2012-38831, FPU14/00160]; CNPq (National Council for Scientific and Technological Development) [400205/2012-5]; VPP (University of Seville)	Ministerio de Economia y Competitividad (Spanish Government); CNPq (National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); VPP (University of Seville)	This work was supported by the Project AGL2012-38831 of the Ministerio de Economia y Competitividad (Spanish Government, www.mineco.gob.es), CNPq (National Council for Scientific and Technological Development, http://cnpq.br/, Science without Borders 400205/2012-5). AAPR-S acknowledges a postdoctoral fellowship from CNPq (National Council for Scientific and Technological Development, http://cnpq.br/, Science without Borders 400205/2012-5). MH a research fellow from CNPq (NPq (National Council for Scientific and Technological Development, http://cnpq.br/). FPM a postdoctoral fellowship from VPP (University of Seville, https://investigacion.us.es/secretariado-investigacion/plan-propio). PdC a FPU fellowship from Ministerio de Economia y Competitividad (FPU14/00160, Spanish Government, www.mineco.gob.es). The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	[Anonymous], 2013, J PLANT BIOL SOIL HL; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Brencic A, 2005, MICROBIOL MOL BIOL R, V69, P155, DOI 10.1128/MMBR.69.1.155-194.2005; Chen HC, 2005, MOL PLANT MICROBE IN, V18, P1340, DOI 10.1094/MPMI-18-1340; Chen HC, 2000, ELECTROPHORESIS, V21, P3823, DOI 10.1002/1522-2683(200011)21:17&lt;3823::AID-ELPS3823&gt;3.0.CO;2-K; CREN M, 1995, MOL MICROBIOL, V15, P733, DOI 10.1111/j.1365-2958.1995.tb02381.x; del Cerro P, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2033-z; del Cerro P, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1458-8; Denarie J, 1996, ANNU REV BIOCHEM, V65, P503, DOI 10.1146/annurev.bi.65.070196.002443; Downie JA, 2010, FEMS MICROBIOL REV, V34, P150, DOI 10.1111/j.1574-6976.2009.00205.x; Estevez J, 2009, FEMS MICROBIOL LETT, V293, P220, DOI 10.1111/j.1574-6968.2009.01540.x; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; GENIAUX E, 1995, INT J SYST BACTERIOL, V45, P392, DOI 10.1099/00207713-45-2-392; Geurts R, 2002, PLANT CELL, V14, pS239, DOI 10.1105/tpc.002451; GILSERRANO A, 1990, CARBOHYD RES, V204, P103, DOI 10.1016/0008-6215(90)84025-P; Gomes DF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-643; Guasch-Vidal B, 2013, MOL PLANT MICROBE IN, V26, P451, DOI 10.1094/MPMI-09-12-0213-R; HERNANDEZLUCAS I, 1995, APPL ENVIRON MICROB, V61, P2775, DOI 10.1128/AEM.61.7.2775-2779.1995; HUNGRIA M, 1993, MOL PLANT MICROBE IN, V6, P418, DOI 10.1094/MPMI-6-418; Hungria M, 2001, BIOL FERT SOILS, V33, P387, DOI 10.1007/s003740100338; HUNGRIA M, 1992, MOL PLANT MICROBE IN, V5, P199, DOI 10.1094/MPMI-5-199; Hungria M, 2000, SOIL BIOL BIOCHEM, V32, P1515, DOI 10.1016/S0038-0717(00)00063-8; Janczarek M, 2011, INT J MOL SCI, V12, P7898, DOI 10.3390/ijms12117898; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kearns DB, 2010, NAT REV MICROBIOL, V8, P634, DOI 10.1038/nrmicro2405; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kiss E, 1998, MOL PLANT MICROBE IN, V11, P1186, DOI 10.1094/MPMI.1998.11.12.1186; KONDOROSI E, 1989, EMBO J, V8, P1331, DOI 10.1002/j.1460-2075.1989.tb03513.x; KONDOROSI E, 1991, J MOL BIOL, V222, P885, DOI 10.1016/0022-2836(91)90583-R; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lamrabet Y, 1999, MOL PLANT MICROBE IN, V12, P207, DOI 10.1094/MPMI.1999.12.3.207; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee SG, 2014, P NATL ACAD SCI USA, V111, P6509, DOI 10.1073/pnas.1402243111; LIU RL, 1989, APPL ENVIRON MICROB, V55, P1895, DOI 10.1128/AEM.55.8.1895-1900.1989; Lopez-Baena FJ, 2008, MICROBIOL-SGM, V154, P1825, DOI 10.1099/mic.0.2007/016337-0; Marks BB, 2015, AMB EXPRESS, V5, DOI 10.1186/s13568-015-0154-z; MARTINEZROMERO E, 1991, INT J SYST BACTERIOL, V41, P417, DOI 10.1099/00207713-41-3-417; MCDERMOTT TR, 1990, APPL ENVIRON MICROB, V56, P3035, DOI 10.1128/AEM.56.10.3035-3039.1990; Mendes IC, 2004, BIOL FERT SOILS, V40, P28, DOI 10.1007/s00374-004-0739-1; Moron B, 2005, CHEM BIOL, V12, P1029, DOI 10.1016/j.chembiol.2005.06.014; Oldroyd GED, 2013, NAT REV MICROBIOL, V11, P252, DOI 10.1038/nrmicro2990; Ormen ~o-Orrillo E., 2013, PROKARYOTES, P427, DOI [10.1007/978-3-642-30141-4_72, DOI 10.1007/978-3-642-30141-4_72]; Ormeno-Orrillo E, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-735; Osman D, 2010, NAT PROD REP, V27, P668, DOI 10.1039/b906682a; Perez-Montano F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105901; POUPOT R, 1993, BIOCHEMISTRY-US, V32, P10430, DOI 10.1021/bi00090a019; Rodriguez-Navarro DN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115391; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schlaman H. R. M., 1998, The Rhizobiaceae: molecular biology of model plant-associated bacteria., P361; SHI WP, 1994, J BIOL CHEM, V269, P19826; Pinto FGS, 2007, SOIL BIOL BIOCHEM, V39, P1851, DOI 10.1016/j.soilbio.2007.01.001; SIMON R, 1984, MOL GEN GENET, V196, P413, DOI 10.1007/BF00436188; SPAINK HP, 1992, MOL PLANT MICROBE IN, V5, P72, DOI 10.1094/MPMI-5-072; SPAINK HP, 1992, PLANT MOL BIOL, V20, P977, DOI 10.1007/BF00027167; Spaink HP, 2000, ANNU REV MICROBIOL, V54, P257, DOI 10.1146/annurev.micro.54.1.257; STREETER JG, 1994, CAN J MICROBIOL, V40, P513, DOI 10.1139/m94-084; Sugawara M, 2014, MOL PLANT MICROBE IN, V27, P328, DOI 10.1094/MPMI-10-13-0312-R; Tomlinson AD, 2010, MICROBIOL-SGM, V156, P2670, DOI 10.1099/mic.0.039032-0; Toro N, 1996, WORLD J MICROB BIOT, V12, P157, DOI 10.1007/BF00364680; TRIPLETT EW, 1992, ANNU REV MICROBIOL, V46, P399, DOI 10.1146/annurev.mi.46.100192.002151; Vargas MAT, 2000, BIOL FERT SOILS, V32, P228, DOI 10.1007/s003740000240; Vinardell JM, 2004, MOL PLANT MICROBE IN, V17, P676, DOI 10.1094/MPMI.2004.17.6.676; Vincent JM, 1970, MANUAL PRACTICAL STU, P144	64	14	14	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0154029	10.1371/journal.pone.0154029	http://dx.doi.org/10.1371/journal.pone.0154029			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096734	Green Published, gold			2022-12-26	WOS:000374543600081
J	Caverly, LJ; Carmody, LA; Haig, SJ; Kotlarz, N; Kalikin, LM; Raskin, L; LiPuma, JJ				Caverly, Lindsay J.; Carmody, Lisa A.; Haig, Sarah-Jane; Kotlarz, Nadine; Kalikin, Linda M.; Raskin, Lutgarde; LiPuma, John J.			Culture-Independent Identification of Nontuberculous Mycobacteria in Cystic Fibrosis Respiratory Samples	PLOS ONE			English	Article							AIRWAY MICROBIOTA; SPUTUM; DNA; TUBERCULOSIS; DIAGNOSIS; EFFICIENT; DYNAMICS	Respiratory tract infections with nontuberculous mycobacteria (NTM) are increasing in prevalence and are a significant cause of lung function decline in individuals with cystic fibrosis (CF). NTM have been detected in culture-independent analyses of CF airway microbiota at lower rates than would be expected based on published prevalence data, likely due to poor lysing of the NTM cell wall during DNA extraction. We compared a standard bacterial lysis protocol with a modified method by measuring NTM DNA extraction by qPCR and NTM detection with bacterial 16S rRNA gene sequencing. The modified method improved NTM DNA recovery from spiked CF sputum samples by a mean of 0.53 log10 copies/mL for M. abscessus complex and by a mean of 0.43 log10 copies/mL for M. avium complex as measured by qPCR targeting the atpE gene. The modified method also improved DNA sequence based NTM detection in NTM culture-positive CF sputum and bronchoalveolar lavage samples; however, both qPCR and 16S rRNA gene sequencing remained less sensitive than culture for NTM detection. We highlight the limitations of culture-independent identification of NTM from CF respiratory samples, and illustrate how alterations in the bacterial lysis and DNA extraction process can be employed to improve NTM detection with both qPCR and 16S rRNA gene sequencing.	[Caverly, Lindsay J.; Carmody, Lisa A.; Kalikin, Linda M.; LiPuma, John J.] Univ Michigan, Sch Med, Dept Pediat & Communicable Dis, Ann Arbor, MI USA; [Haig, Sarah-Jane; Kotlarz, Nadine; Raskin, Lutgarde] Univ Michigan, Dept Civil & Environm Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Caverly, LJ (corresponding author), Univ Michigan, Sch Med, Dept Pediat & Communicable Dis, Ann Arbor, MI USA.	caverlyl@med.umich.edu	Haig, Sarah/H-5986-2019	Haig, Sarah/0000-0002-0004-8894	National Institute of Child Heath and Human Development [HD 028820]; Cystic Fibrosis Foundation [CAVERL15I0]; University of Michigan Department of Pediatrics and Communicable Diseases; Elizabeth E. Kennedy Children's Research Fund Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD028820] Funding Source: NIH RePORTER	National Institute of Child Heath and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); University of Michigan Department of Pediatrics and Communicable Diseases; Elizabeth E. Kennedy Children's Research Fund Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institute of Child Heath and Human Development, https://www.nichd.nih.gov/Pages/index.aspx, grant number: HD 028820, to LJC; Cystic Fibrosis Foundation, https://www.cff.org/, grant number: CAVERL15I0 to LJC; University of Michigan Department of Pediatrics and Communicable Diseases, https://medicine.umich.edu/dept/pediatrics/, Elizabeth E. Kennedy Children's Research Fund Award to LJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaro A, 2008, LETT APPL MICROBIOL, V47, P8, DOI 10.1111/j.1472-765X.2008.02372.x; BERCOVIER H, 1986, BIOCHEM BIOPH RES CO, V136, P1136, DOI 10.1016/0006-291X(86)90452-3; Carmody LA, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0074-9; Carmody Lisa A, 2013, Ann Am Thorac Soc, V10, P179, DOI 10.1513/AnnalsATS.201211-107OC; Chakravorty S, 2001, FEMS MICROBIOL LETT, V205, P113, DOI 10.1111/j.1574-6968.2001.tb10933.x; Cheung MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054574; Clooney AG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148028; Coenye T, 2003, FEMS MICROBIOL LETT, V228, P45, DOI 10.1016/S0378-1097(03)00717-1; Cui ZL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-276; Esther CR, 2010, J CYST FIBROS, V9, P117, DOI 10.1016/j.jcf.2009.12.001; Esther CR, 2005, PEDIATR PULM, V40, P39, DOI 10.1002/ppul.20222; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Hanauer DA, 2015, J BIOMED INFORM, V55, P290, DOI 10.1016/j.jbi.2015.05.003; Johnson EJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147643; Kaser M, 2009, APPL ENVIRON MICROB, V75, P414, DOI 10.1128/AEM.01358-08; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Levy I, 2008, EMERG INFECT DIS, V14, P378, DOI 10.3201/eid1403.061405; Madiraju MVVS, 2000, LETT APPL MICROBIOL, V30, P38, DOI 10.1046/j.1472-765x.2000.00619.x; Mahboubi MA, 2016, J CLIN MICROBIOL, V54, P613, DOI 10.1128/JCM.02299-15; Martiniano Stacey L, 2014, Ann Am Thorac Soc, V11, P36, DOI 10.1513/AnnalsATS.201309-310OC; MCNEIL MR, 1991, RES MICROBIOL, V142, P451, DOI 10.1016/0923-2508(91)90120-Y; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nessar R, 2012, J ANTIMICROB CHEMOTH, V67, P810, DOI 10.1093/jac/dkr578; Odumeru J, 2001, CAN J VET RES, V65, P201; Olivier KN, 2003, AM J RESP CRIT CARE, V167, P828, DOI 10.1164/rccm.200207-678OC; Plain KM, 2015, J CLIN MICROBIOL, V53, P1121, DOI 10.1128/JCM.03521-14; POLLOCK HM, 1977, J CLIN MICROBIOL, V5, P329; R Foundation for Statistical Computing, 2015, R LANG ENV STAT COMP; Radomski N, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-277; Radomski N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078749; Rubin BK, 2009, RESP CARE, V54, P726, DOI 10.4187/002013209790983269; Salsgiver EL, 2016, CHEST, V149, P390, DOI 10.1378/chest.15-0676; Stressmann FA, 2011, J CYST FIBROS, V10, P357, DOI 10.1016/j.jcf.2011.05.002; Tell LA, 2003, AVIAN DIS, V47, P1486, DOI 10.1637/7070; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Wu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083445; Zhao JC, 2015, J CYST FIBROS, V14, P468, DOI 10.1016/j.jcf.2015.02.004; Zhao JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033127; Zhao JC, 2012, P NATL ACAD SCI USA, V109, P5809, DOI 10.1073/pnas.1120577109	39	18	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153876	10.1371/journal.pone.0153876	http://dx.doi.org/10.1371/journal.pone.0153876			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093603	Green Published, gold, Green Submitted			2022-12-26	WOS:000374541200054
J	Mok, Y; Matsushita, K; Sang, YY; Ballew, SH; Grams, M; Shin, SY; Jee, SH; Coresh, J				Mok, Yejin; Matsushita, Kunihiro; Sang, Yingying; Ballew, Shoshana H.; Grams, Morgan; Shin, Sang Yop; Jee, Sun Ha; Coresh, Josef			Association of Kidney Disease Measures with Cause-Specific Mortality: The Korean Heart Study	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE; POOLED ANALYSIS; CYSTATIN-C; RISK; CANCER; ALBUMINURIA; DEATH; PREVALENCE	Background The link of low estimated glomerular filtration rate (eGFR) and high proteinuria to cardiovascular disease (CVD) mortality is well known. However, its link to mortality due to other causes is less clear. Methods We studied 367,932 adults (20-93 years old) in the Korean Heart Study (baseline between 1996-2004 and follow-up until 2011) and assessed the associations of creatinine-based eGFR and dipstick proteinuria with mortality due to CVD (1,608 cases), cancer (4,035 cases), and other (non-CVD/non-cancer) causes (3,152 cases) after adjusting for potential confounders. Results Although cancer was overall the most common cause of mortality, in participants with chronic kidney disease (CKD), non-CVD/non-cancer mortality accounted for approximately half of cause of death (47.0% for eGFR >= 60 ml/min/1.73m(2) and 54.3% for proteinuria >= 1+). Lower eGFR (< 60 vs. >= 60 ml/min/1.73m2) was significantly associated with mortality due to CVD (adjusted hazard ratio 1.49 [95% CI, 1.24-1.78]) and non-CVD/non-cancer causes (1.78 [1.54-2.05]). The risk of cancer mortality only reached significance at eGFR < 45 ml/min/1.73m2 when eGFR 45-59 ml/min/1.73m(2) was set as a reference (1.62 [1.10-2.39]). High proteinuria (dipstick >= 1+ vs. negative/trace) was consistently associated with mortality due to CVD (1.93 [1.66-2.25]), cancer (1.49 [1.32-1.68]), and other causes (2.19 [1.96-2.45]). Examining finer mortality causes, low eGFR and high proteinuria were commonly associated with mortality due to coronary heart disease, any infectious disease, diabetes, and renal failure. In addition, proteinuria was also related to death from stroke, cancers of stomach, liver, pancreas, and lung, myeloma, pneumonia, and viral hepatitis. Conclusion Low eGFR was associated with CVD and non-CVD/non-cancer mortality, whereas higher proteinuria was consistently related to mortality due to CVD, cancer, and other causes. These findings suggest the need for multidisciplinary prevention and management strategies in individuals with CKD, particularly when proteinuria is present.	[Mok, Yejin; Matsushita, Kunihiro; Sang, Yingying; Ballew, Shoshana H.; Grams, Morgan; Coresh, Josef] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Mok, Yejin; Jee, Sun Ha] Yonsei Univ, Dept Epidemiol & Hlth Promot, Grad Sch Publ Hlth, Seoul 120749, South Korea; [Mok, Yejin; Jee, Sun Ha] Yonsei Univ, Inst Hlth Promot, Grad Sch Publ Hlth, Seoul 120749, South Korea; [Shin, Sang Yop] Korea Med Inst, Dept Internal Med, Seoul, South Korea	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Jee, SH (corresponding author), Yonsei Univ, Dept Epidemiol & Hlth Promot, Grad Sch Publ Hlth, Seoul 120749, South Korea.; Jee, SH (corresponding author), Yonsei Univ, Inst Hlth Promot, Grad Sch Publ Hlth, Seoul 120749, South Korea.	jsunha@yuhs.ac	Matsushita, Kunihiro/AAJ-5817-2020; Matsushita, Kunihiro/B-1021-2018	Matsushita, Kunihiro/0000-0002-7179-718X; Matsushita, Kunihiro/0000-0002-7179-718X; Ballew, Shoshana/0000-0002-7547-3764; Jee, Sun Ha/0000-0001-9519-3068	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI13C0715]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100446] Funding Source: NIH RePORTER	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI13C0715).	Aguilar MI, 2010, NEUROLOGY, V75, P1343, DOI 10.1212/WNL.0b013e3181f73638; Arora P, 2013, CAN MED ASSOC J, V185, pE417, DOI 10.1503/cmaj.120833; Chun JH, 2000, KOREAN J EPIDEMIOL, V22, P124; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Davis AM, 2014, JAMA-J AM MED ASSOC, V312, P1248, DOI 10.1001/jama.2014.12272; Di Angelantonio Emanuele, 2010, BMJ, V341, pc4986, DOI 10.1136/bmj.c4986; Franses JW, 2013, INT J CANCER, V133, P1334, DOI 10.1002/ijc.28146; Fried LF, 2005, J AM SOC NEPHROL, V16, P3728, DOI 10.1681/ASN.2005040384; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Hallan S, 2007, ARCH INTERN MED, V167, P2490, DOI 10.1001/archinte.167.22.2490; Hallan SI, 2012, JAMA-J AM MED ASSOC, V308, P2349, DOI 10.1001/jama.2012.16817; Harteloh P, 2010, EUR J EPIDEMIOL, V25, P531, DOI 10.1007/s10654-010-9445-5; Health NIo, 2013, HLTH NIO USRDS 2013; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; Herget-Rosenthal S, 2000, AM J NEPHROL, V20, P97, DOI 10.1159/000013564; Iff S, 2014, AM J KIDNEY DIS, V63, P23, DOI 10.1053/j.ajkd.2013.07.008; Imai E, 2009, CLIN EXP NEPHROL, V13, P621, DOI 10.1007/s10157-009-0199-x; Janus N, 2008, NEPHROL DIAL TRANSPL, V23, P800, DOI 10.1093/ndt/gfm851; Jee SH, 2014, EUR J PREV CARDIOL, V21, P1484, DOI 10.1177/2047487313497602; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Kidney Disease Improving Global Outcomes Working Group, 2013, KDIGO CLIN PRACT GUI; Lee DH, 2000, J KOREAN CANC ASS, V32, P210; Leung WK, 2008, LANCET ONCOL, V9, P279, DOI 10.1016/S1470-2045(08)70072-X; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lowrance WT, 2014, J AM SOC NEPHROL, V25, P2327, DOI 10.1681/ASN.2013060604; Lu TH, 2000, INT J EPIDEMIOL, V29, P336, DOI 10.1093/ije/29.2.336; Mahmoodi BK, 2014, STROKE, V45, P1925, DOI 10.1161/STROKEAHA.114.004900; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Myers GL, 2006, CLIN CHEM, V52, P5, DOI 10.1373/clinchem.2005.0525144; Nagata M, 2013, AM J EPIDEMIOL, V178, P1, DOI 10.1093/aje/kws447; National Bureau of Statistics, 2010, RES 2010 POP HOUS CE; National Bureau of Statistics, 2012, ANN REP CAUS DEATH S; Navaneethan SD, 2015, J AM SOC NEPHROL, V26, P2512, DOI 10.1681/ASN.2014101034; Pedersen LM, 1998, EUR J CANCER, V34, P76, DOI 10.1016/S0959-8049(97)10003-X; SAWYER N, 1988, BMJ-BRIT MED J, V296, P1295, DOI 10.1136/bmj.296.6632.1295; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Song YM, 2001, EPIDEMIOLOGY, V12, P173, DOI 10.1097/00001648-200103000-00008; Stehouwer CDA, 2002, DIABETES, V51, P1157, DOI 10.2337/diabetes.51.4.1157; Stevens PE, 2007, KIDNEY INT, V72, P92, DOI 10.1038/sj.ki.5002273; Thompson S, 2015, J AM SOC NEPHROL, V26, P2504, DOI 10.1681/ASN.2014070714; Tisdale MJ, 2002, NAT REV CANCER, V2, P862, DOI 10.1038/nrc927; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; Ueshima H, 2008, CIRCULATION, V118, P2702, DOI 10.1161/CIRCULATIONAHA.108.790048; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; Wang HE, 2011, AM J NEPHROL, V34, P330, DOI 10.1159/000330673; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; Weng PH, 2011, CLIN J AM SOC NEPHRO, V6, P1121, DOI 10.2215/CJN.09011010; Winkler V, 2010, INT J PUBLIC HEALTH, V55, P43, DOI 10.1007/s00038-009-0053-7; World Health Organization, 2014, CAUS DEATH MORT HLTH; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6	56	23	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153429	10.1371/journal.pone.0153429	http://dx.doi.org/10.1371/journal.pone.0153429			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27092943	Green Published, gold, Green Submitted			2022-12-26	WOS:000374541200018
J	Wang, L; Kang, S; Zou, DQ; Zhan, L; Li, ZX; Zhu, W; Su, H				Wang, Liang; Kang, Shuai; Zou, Dingquan; Zhan, Lei; Li, Zhengxi; Zhu, Wan; Su, Hua			Bone Fracture Pre-Ischemic Stroke Exacerbates Ischemic Cerebral Injury in Mice	PLOS ONE			English	Article							HIP FRACTURE; COGNITIVE DYSFUNCTION; TNF-ALPHA; NEUROINFLAMMATION; INFLAMMATION; RISK; SENSORIMOTOR; RECOVERY; DECLINE; DISEASE	Ischemic stroke is a devastating complication of bone fracture. Bone fracture shortly after stroke enhances stroke injury by augmenting inflammation. We hypothesize that bone fracture shortly before ischemic stroke also exacerbates ischemic cerebral injury. Tibia fracture was performed 6 or 24 hours before permanent middle cerebral artery occlusion (pMCAO) on C57BL/6J mice or Ccr2(RFP/+)Cx3cr1(GFP/+) mice that have the RFP gene knocked into one allele of Ccr2 gene and GFP gene knocked into one allele of Cx3cr1 gene. Behavior was tested 3 days after pMCAO. Infarct volume, the number of CD68(+) cells, apoptotic neurons, bone marrow-derived macrophages (RFP+), and microgila (GFP(+)) in the peri-infarct region were quantified. Compared to mice subjected to pMCAO only, bone fracture 6 or 24 hours before pMCAO increased behavioral deficits, the infarct volume, and the number of CD68(+) cells and apoptotic neurons in the peri-infarct area. Both bone marrow-derived macrophages (CCR2(+)) and microglia (CX3CR1(+)) increased in the peri-infarct regions of mice subjected to bone fracture before pMCAO compared to stroke-only mice. The mice subjected to bone fracture 6 hours before pMCAO had more severe injury than mice that had bone fracture 24 hours before pMCAO. Our data showed that bone fracture shortly before stroke also increases neuroinflammation and exacerbates ischemic cerebral injury. Our findings suggest that inhibition of neuroinflammation or management of stroke risk factors before major bone surgery would be beneficial for patients who are likely to suffer from stroke.	[Wang, Liang; Kang, Shuai; Zou, Dingquan; Zhan, Lei; Li, Zhengxi; Zhu, Wan; Su, Hua] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, Ctr Cerebrovasc Res, San Francisco, CA 94143 USA; [Wang, Liang] Tianjin Fifth Ctr Hosp, Dept Neurosurg, Tianjin, Peoples R China; [Kang, Shuai] Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Li, Zhengxi] Shanghai Ninth Peoples Hosp, Dept Neurol, Shanghai, Peoples R China	University of California System; University of California San Francisco; Capital Medical University; Shanghai Jiao Tong University	Su, H (corresponding author), Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, Ctr Cerebrovasc Res, San Francisco, CA 94143 USA.	hua.su@ucsf.edu			National Institutes of Health [R01 NS027713, R01 HL122774, R21 NS083788]; Michael Ryan Zodda Foundation; UCSF Research Evaluation and Allocation Committee (REAC); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS083788, R01NS027713] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael Ryan Zodda Foundation; UCSF Research Evaluation and Allocation Committee (REAC); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health R01 NS027713, R01 HL122774 and R21 NS083788 (to HS); Michael Ryan Zodda Foundation (to HS); and UCSF Research Evaluation and Allocation Committee (REAC) (to HS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti A, 2011, INTERN EMERG MED, V6, P119, DOI 10.1007/s11739-011-0675-7; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Bouet V, 2007, EXP NEUROL, V203, P555, DOI 10.1016/j.expneurol.2006.09.006; Chamorro A, 2006, STROKE, V37, P291, DOI 10.1161/01.STR.0000200561.69611.f8; Chisholm NC, 2016, NEUROBIOL DIS, V85, P245, DOI 10.1016/j.nbd.2015.03.028; Choy FC, 2015, J CEREB BLOOD FLOW M, DOI [10.1177/0271678X15606146, DOI 10.1177/0271678X15606146]; Cibelli M, 2010, ANN NEUROL, V68, P360, DOI 10.1002/ana.22082; Cunningham C, 2009, BIOL PSYCHIAT, V65, P304, DOI 10.1016/j.biopsych.2008.07.024; Degos V, 2013, ANESTHESIOLOGY, V118, P1362, DOI 10.1097/ALN.0b013e31828c23f8; Emsley HC, 2008, LANCET NEUROL, V7, P341, DOI 10.1016/S1474-4422(08)70061-9; Ferguson AR, 2008, J NEUROSCI, V28, P11391, DOI 10.1523/JNEUROSCI.3708-08.2008; Han ZY, 2014, J NEUROCHEM, V131, P498, DOI 10.1111/jnc.12817; Han ZY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105711; Hankey GJ, 2014, LANCET NEUROL, V13, P178, DOI 10.1016/S1474-4422(13)70255-2; Hayakawa K, 2010, ANN NY ACAD SCI, V1207, P50, DOI 10.1111/j.1749-6632.2010.05728.x; Inacio AR, 2011, J CEREBR BLOOD F MET, V31, P1093, DOI 10.1038/jcbfm.2010.194; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Lakhan SE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-97; Langdon KD, 2010, J CEREBR BLOOD F MET, V30, P1450, DOI 10.1038/jcbfm.2010.23; Lo EH, 2009, NAT MED, V15, P844, DOI 10.1038/nm0809-844; Mathew RO, 2013, AM J PHYS MED REHAB, V92, P686, DOI 10.1097/PHM.0b013e318282bc67; Nguyen ND, 2007, J BONE MINER RES, V22, P781, DOI 10.1359/JBMR.070315; Palan J, 2007, INJURY, V38, P1279, DOI 10.1016/j.injury.2007.05.014; Rosi S, 2009, BRAIN, V132, P2464, DOI 10.1093/brain/awp148; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Sathiyakumar V, 2016, INT ORTHOP, V40, P439, DOI 10.1007/s00264-015-2832-5; Sennerby U, 2009, JAMA-J AM MED ASSOC, V302, P1666, DOI 10.1001/jama.2009.1463; Swanson RA, 2004, CURR MOL MED, V4, P193, DOI 10.2174/1566524043479185; Terrando N, 2011, ANN NEUROL, V70, P986, DOI 10.1002/ana.22664; Terrando N, 2010, P NATL ACAD SCI USA, V107, P20518, DOI 10.1073/pnas.1014557107; Terrando N, 2010, CRIT CARE, V14, DOI 10.1186/cc9019; Vidal Sarkis Morales, 2013, Hosp Pract (1995), V41, P108, DOI 10.3810/hp.2013.04.1060; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0	33	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153835	10.1371/journal.pone.0153835	http://dx.doi.org/10.1371/journal.pone.0153835			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27089041	Green Published, gold			2022-12-26	WOS:000374527000054
J	Li, DY; Zhang, YW; Cui, ZL; He, LW; Chen, WB; Meng, QX; Ren, LP				Li, Deyong; Zhang, Yawei; Cui, Zhenliang; He, Liwen; Chen, Wanbao; Meng, Qingxiang; Ren, Liping			Effects of Phytoecdysteroids (PEDS) Extracted from Cyanotis arachnoidea on Rumen Fermentation, Enzyme Activity and Microbial Efficiency in a Continuous-Culture System	PLOS ONE			English	Article							PLANT-EXTRACTS; METHANE PRODUCTION; GAS-PRODUCTION; AMINO-ACIDS; ECDYSTEROIDS; FEED; NITROGEN; PROTEIN; DIGESTIBILITY; METABOLISM	The objective of this study was to evaluate the effects of supplementation of phytoecdysteroids (PEDS) extracted from Cyanotis arachnoidea on rumen fermentation, enzymes activity and microbial efficiency in a dual flow continuous-culture system. A single-factor experimental design was used with twelve fermenters in 4 groups with 3 replicates each. Fermenters were incubated for a total of 7 days that included first 4 days for adaptation and last 3 days for sampling. PEDS was added at levels of zero (as control), 5, 10, and 15 mg/g of the substrate (DM). The results showed that increasing supplementation levels of PEDS resulted in incremental digestibility of dry matter (DMD) (quadratic, P = 0.001) and organic matter (OMD) (quadratic, P = 0.031), but unchanged digestibility of neutral detergent fiber (NDFD), crude protein (CPD) and acid detergent acid (ADFD). As supplementation levels of PEDS increased, there were decreased response in the concentration of ammonia nitrogen (NH3-N) (linear, P = 0.015) and increased response in molar proportions of butyrate (linear, P = 0.004), but unchanged response in total volatile fatty acid (TVFA) and the molar proportion of acetate and propionate, respectively. Increasing PEDS supplementation levels decreased the ratio of acetate to propionate (linear, P = 0.038), suggesting an alteration of rumen fermentation pattern occurring due to PEDS supplementation in the diet. Supplementation of PEDS significantly increased activities of glutamate dehydrogenase (quadratic, P = 0.001), alanine dehydrogenase (quadratic, P = 0.004), glutamate synthase (linear, P = 0.038), glutamine synthetase (quadratic, P = 0.011), respectively. There were no discernible differences in the activity of carboxymethyl cellulose (CMCase), xylanase and protease regardless of the treatments. The daily production of microbial nitrogen (linear, P = 0.002) and microbial efficiency (MOEEF) (linear, P = 0.001) increased linearly as supplementation levels of PEDS increased. The decreased response of fluid NH3-N and the increased response of MN indicated that PEDS positively increased the synthesis of microbial proteins.	[Li, Deyong; Zhang, Yawei; Cui, Zhenliang; He, Liwen; Chen, Wanbao; Meng, Qingxiang; Ren, Liping] China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing 100094, Peoples R China; [Li, Deyong; Zhang, Yawei; Cui, Zhenliang; He, Liwen; Chen, Wanbao; Meng, Qingxiang; Ren, Liping] China Agr Univ, Coll Anim Sci & Technol, Yuanmingyuan West Rd 2, Beijing 100193, Peoples R China	China Agricultural University; China Agricultural University	Ren, LP (corresponding author), China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing 100094, Peoples R China.; Ren, LP (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Yuanmingyuan West Rd 2, Beijing 100193, Peoples R China.	lideyong200713@126.com	Meng, Q./GSI-6185-2022	Zhang, Yawei/0000-0002-0571-8383; He, Liwen/0000-0002-8578-710X	National Natural Science Foundation of China [31172231]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant No. 31172231) and the website is: http://www.nsfc.gov.cn/. The corresponding author LPR host the program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad V. U., 1996, Fitoterapia, V67, P88; Alexander G, 2008, ANIM FEED SCI TECH, V145, P229, DOI 10.1016/j.anifeedsci.2007.05.036; AOAC, 2007, OFFICIAL METHODS ANA, V18th; Appuhamy JADRN, 2013, J DAIRY SCI, V96, P5161, DOI 10.3168/jds.2012-5923; Baker SK, 1994, PCT Int. Appl, Patent No. [AU Appl. 93/ 7,397, 937397]; Baker SK, 1994, PCT Int. Appl, Patent No. [Wo 94 18, 984, 9418984, WO 94 18,984]; BENSADOUN A, 1962, J DAIRY SCI, V45, P1203, DOI 10.3168/jds.S0022-0302(62)89597-6; Blake JS, 1983, BR J NUTR, P769; BRODERICK GA, 1980, J DAIRY SCI, V63, P64, DOI 10.3168/jds.S0022-0302(80)82888-8; Broudiscou LP, 2002, ANIM FEED SCI TECH, V101, P183, DOI 10.1016/S0377-8401(02)00221-3; Casewell M, 2003, J ANTIMICROB CHEMOTH, V52, P159, DOI 10.1093/jac/dkg313; Chadin I, 2003, BIOCHEM SYST ECOL, V31, P407, DOI 10.1016/S0305-1978(02)00172-2; Chattopadhyay MK, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00334; CHAUDHARY KD, 1969, EXPERIENTIA, V25, P250, DOI 10.1007/BF02034373; Dinan L, 2001, PHYTOCHEMISTRY, V57, P325, DOI 10.1016/S0031-9422(01)00078-4; Dinan L, 2001, PHYTOCHEMISTRY, V56, P569, DOI 10.1016/S0031-9422(00)00438-6; Dinan L, 2006, J ENDOCRINOL, V191, P1, DOI 10.1677/joe.1.06900; Golder HM, 2014, J DAIRY SCI, V97, P985, DOI 10.3168/jds.2013-7166; Hu J, 2014, PHYTOCHEM LETT, V8, P73, DOI 10.1016/j.phytol.2014.02.003; Kim JN, 2014, APPL ENVIRON MICROB, V80, P3095, DOI 10.1128/AEM.00029-14; Kratky F, 1997, ZIVOCISNA VYROBA, V42, P445; Kung L, 2014, J DAIRY SCI, V97, P1707, DOI 10.3168/jds.2013-7469; Le Bizec B, 2002, ANAL CHIM ACTA, V473, P89, DOI 10.1016/S0003-2670(02)00874-7; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mamadalieva NZ, 2012, B LATINOAM CARIBE PL, V11, P474; Meng QX, 2000, ASIAN AUSTRAL J ANIM, V13, P1399, DOI 10.5713/ajas.2000.1399; MENKE KH, 1979, J AGR SCI, V93, P217, DOI 10.1017/S0021859600086305; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Minato H., 1993, P MIE BIOF GEN BIOCH, P139; Morrison M, 1996, AUST J AGR RES, V47, P227, DOI 10.1071/AR9960227; NEWBOLD CJ, 1995, LETT APPL MICROBIOL, V21, P230, DOI 10.1111/j.1472-765X.1995.tb01048.x; ORKOV ER, 1994, LIVEST PROD SCI, V39, P53, DOI 10.1016/0301-6226(94)90153-8; Patil N, 2012, FEEDING MANAGEMENT L; Patra AK, 2006, ANIM FEED SCI TECH, V128, P276, DOI 10.1016/j.anifeedsci.2005.11.001; Patra AK, 2009, ANTON LEEUW INT J G, V96, P363, DOI 10.1007/s10482-009-9364-1; Shabi Z, 2000, J DAIRY SCI, V83, P2326, DOI 10.3168/jds.S0022-0302(00)75120-4; Shirshova T.I., 2006, PHARM CHEM J+, V40, P268; Slama K, 1996, EXPERIENTIA, V52, P702, DOI 10.1007/BF01925578; SLAMA K, 1995, EUR J ENTOMOL, V92, P355; STUMM CK, 1986, MICROBIOL SCI, V3, P100; Todorov I. N., 2000, Khimiko-Farmatsevticheskii Zhurnal, V34, P3; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Wall EH, 2014, J DAIRY SCI, V97, P5709, DOI 10.3168/jds.2014-7896; Wang PP, 2013, ANIM BIOTECHNOL, V24, P107, DOI 10.1080/10495398.2012.756402; Wei ML, 2012, J ANIM VET ADV, V11, P4304; WELLER RA, 1974, BRIT J NUTR, V32, P341, DOI 10.1079/BJN19740087; Wu N, 2010, ENVIRON SCI TECHNOL, V44, P6933, DOI 10.1021/es1007802; ZINN RA, 1986, CAN J ANIM SCI, V66, P157, DOI 10.4141/cjas86-017	48	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153584	10.1371/journal.pone.0153584	http://dx.doi.org/10.1371/journal.pone.0153584			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082647	gold, Green Published, Green Submitted			2022-12-26	WOS:000374291800031
J	Balint, R; Lowe, T; Shearer, T				Balint, Richard; Lowe, Tristan; Shearer, Tom			Optimal Contrast Agent Staining of Ligaments and Tendons for X-Ray Computed Tomography	PLOS ONE			English	Article							ANTERIOR CRUCIATE LIGAMENT; STRAIN-ENERGY FUNCTION; PATELLAR TENDON; MICRO-CT; ARRANGEMENT; TOOL	X-ray computed tomography has become an important tool for studying the microstructures of biological soft tissues, such as ligaments and tendons. Due to the low X-ray attenuation of such tissues, chemical contrast agents are often necessary to enhance contrast during scanning. In this article, the effects of using three different contrast agents-iodine potassium iodide solution, phosphotungstic acid and phosphomolybdic acid-are evaluated and compared. Porcine anterior cruciate ligaments, patellar tendons, medial collateral ligaments and lateral collateral ligaments were used as the basis of the study. Three samples of each of the four ligament/tendon types were each assigned a different contrast agent (giving a total of twelve samples), and the progression of that agent through the tissue was monitored by performing a scan every day for a total period of five days (giving a total of sixty scans). Since the samples were unstained on day one, they had been stained for a total of four days by the time of the final scans. The relative contrast enhancement and tissue deformation were measured. It was observed that the iodine potassium iodide solution penetrated the samples fastest and caused the least sample shrinkage on average (although significant deformation was observed by the time of the final scans), whereas the phosphomolybdic acid caused the greatest sample shrinkage. Equations describing the observed behaviour of the contrast agents, which can be used to predict optimal staining times for ligament and tendon X-ray computed tomography, are presented.	[Balint, Richard; Shearer, Tom] Univ Manchester, Sch Mat, Manchester, Lancs, England; [Lowe, Tristan] Univ Manchester, Sch Mat, Henry Moseley Xray Imaging Facil, Manchester, Lancs, England; [Shearer, Tom] Univ Manchester, Sch Math, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester	Shearer, T (corresponding author), Univ Manchester, Sch Mat, Manchester, Lancs, England.	tom.shearer@manchester.ac.uk	Shearer, Tom/H-7048-2019	Shearer, Tom/0000-0001-7536-5547	Engineering and Physical Sciences Research Council (EPSRC) [EP/L017997/1]; EPSRC [EP/F007906/1, EP/F001452/1, EP/I02249X/1]; EPSRC [EP/L017997/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/L017997/1, EP/F007906/1, EP/I02249X/1, EP/F001452/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	TS would like to thank the Engineering and Physical Sciences Research Council (EPSRC - https://www.epsrc.ac.uk/) for supporting this work via his Fellowship grant EP/L017997/1. All the authors would like to acknowledge the assistance provided by the Manchester X-ray Imaging Facility, which was funded in part by the EPSRC (grants EP/F007906/1, EP/F001452/1 and EP/I02249X/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslanidi OV, 2013, IEEE T MED IMAGING, V32, P8, DOI 10.1109/TMI.2012.2209183; Butters TD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105552; de Crespigny A, 2008, J NEUROSCI METH, V171, P207, DOI 10.1016/j.jneumeth.2008.03.006; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Dewulf W, 2012, CIRP ANN-MANUF TECHN, V61, P495, DOI 10.1016/j.cirp.2012.03.013; Eleswarapu SV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026178; Elsheikh A, 2013, MED ENG PHYS, V35, P211, DOI 10.1016/j.medengphy.2012.09.006; Jeffery NS, 2011, J BIOMECH, V44, P189, DOI 10.1016/j.jbiomech.2010.08.027; Kalson NS, 2012, J HAND SURG-EUR VOL, V37E, P550, DOI 10.1177/1753193411433228; KASTELIC J, 1978, CONNECT TISSUE RES, V6, P11, DOI 10.3109/03008207809152283; LIU SQ, 1988, J BIOMECH ENG-T ASME, V110, P82, DOI 10.1115/1.3108410; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Metscher BD, 2009, DEV DYNAM, V238, P632, DOI 10.1002/dvdy.21857; Pauwels E, 2013, J MICROSC-OXFORD, V250, P21, DOI 10.1111/jmi.12013; Roberts N, 2012, AM J PATHOL, V180, P1835, DOI 10.1016/j.ajpath.2012.01.033; Screen HRC, 2004, STRAIN, V40, P157, DOI 10.1111/j.1475-1305.2004.00164.x; Shearer T, 2015, J BIOMECH, V48, P3017, DOI 10.1016/j.jbiomech.2015.07.032; Shearer T, 2015, J BIOMECH, V48, P290, DOI 10.1016/j.jbiomech.2014.11.031; Shearer Tom, 2014, Muscles Ligaments Tendons J, V4, P238; Stephenson RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035299; Vickerton P, 2013, J ANAT, V223, P185, DOI 10.1111/joa.12068; Wong MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084321; Wong MD, 2012, DEVELOPMENT, V139, P3248, DOI 10.1242/dev.082016; YAHIA LH, 1989, J ORTHOPAED RES, V7, P243, DOI 10.1002/jor.1100070212; YAHIA LH, 1988, J MATER SCI, V23, P3750, DOI 10.1007/BF00540523	25	36	36	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153552	10.1371/journal.pone.0153552	http://dx.doi.org/10.1371/journal.pone.0153552			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078030	Green Submitted, Green Published, gold			2022-12-26	WOS:000374131700077
J	Tomas, D; Stanic, D; Chua, HK; White, K; Boon, WC; Horne, M				Tomas, D.; Stanic, D.; Chua, H. K.; White, K.; Boon, W. C.; Horne, M.			Restoration of the Dopamine Transporter through Cell Therapy Improves Dyskinesia in a Rat Model of Parkinson's Disease	PLOS ONE			English	Article							MOTOR FLUCTUATIONS; LEVODOPA; NEURONS; TERMINALS; EVOLUTION; LESIONS; PHARMACODYNAMICS; FRACTIONATOR; MICE; SNPC	The dyskinesia of Parkinson's Disease is most likely due to excess levels of dopamine in the striatum. The mechanism may be due to aberrant synthesis but also, a deficiency or absence of the Dopamine Transporter. In this study we have examined the proposition that reinstating Dopamine Transporter expression in the striatum would reduce dyskinesia. We transplanted c17.2 cells that stably expressed the Dopamine Transporter into dyskinetic rats. There was a reduction in dyskinesia in rats that received grafts expressing the Dopamine Transporter. Strategies designed to increase Dopamine Transporter in the striatum may be useful in treating the dyskinesia associated with human Parkinson's Disease.	[Tomas, D.; Stanic, D.; Chua, H. K.; White, K.; Boon, W. C.; Horne, M.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3010, Australia; [Horne, M.] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; St Vincent's Hospital Melbourne; University of Melbourne	Horne, M (corresponding author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3010, Australia.; Horne, M (corresponding author), Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia.	malcolm.horne@florey.edu.au	Horne, Malcolm/AAL-5214-2020	Horne, Malcolm/0000-0001-9427-2100; Stanic, Davor/0000-0002-4310-7030; White, Kylie/0000-0003-1963-6140				Carta M, 2007, BRAIN, V130, P1819, DOI 10.1093/brain/awm082; Cenci MA, 1998, EUR J NEUROSCI, V10, P2694, DOI 10.1046/j.1460-9568.1998.t01-1-00285.x; Cenci MA, 1999, NEUROSCIENCE, V94, P515, DOI 10.1016/S0306-4522(99)00294-8; Chen LN, 2008, J NEUROSCI, V28, P425, DOI 10.1523/JNEUROSCI.3602-07.2008; COTZIAS GC, 1967, NEW ENGL J MED, V276, P374, DOI 10.1056/NEJM196702162760703; Finkelstein DI, 2000, NEUROSCIENCE, V97, P99, DOI 10.1016/S0306-4522(00)00009-9; Grammatopoulos TN, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt36; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; HELY MA, 1994, J NEUROL NEUROSUR PS, V57, P903, DOI 10.1136/jnnp.57.8.903; Lee J, 2008, BRAIN, V131, P1574, DOI 10.1093/brain/awn085; McColl CD, 2002, MOVEMENT DISORD, V17, P1227, DOI 10.1002/mds.10244; Metman LV, 1997, NEUROLOGY, V49, P711, DOI 10.1212/WNL.49.3.711; MOURADIAN MM, 1988, ANN NEUROL, V24, P372, DOI 10.1002/ana.410240304; Nutt JG, 2002, ANN NEUROL, V51, P686, DOI 10.1002/ana.10189; Nutt JG, 2001, PARKINSONISM RELAT D, V8, P101, DOI 10.1016/S1353-8020(01)00024-4; NUTT JG, 1995, CLIN EXP PHARMACOL P, V22, P837, DOI 10.1111/j.1440-1681.1995.tb01946.x; NUTT JG, 1992, ARCH NEUROL-CHICAGO, V49, P1123, DOI 10.1001/archneur.1992.00530350037016; Ourednik J, 2002, NAT BIOTECHNOL, V20, P1103, DOI 10.1038/nbt750; Parish CL, 2005, NEUROBIOL DIS, V19, P301, DOI 10.1016/j.nbd.2005.01.009; Parish CL, 2001, J NEUROSCI, V21, P5147, DOI 10.1523/JNEUROSCI.21-14-05147.2001; Reardon KA, 1999, MOVEMENT DISORD, V14, P605, DOI 10.1002/1531-8257(199907)14:4<605::AID-MDS1009>3.0.CO;2-H; RYDER EF, 1990, J NEUROBIOL, V21, P356, DOI 10.1002/neu.480210209; Sossi V, 2007, ANN NEUROL, V62, P468, DOI 10.1002/ana.21204; Stanic D, 2003, J NEUROCHEM, V86, P329, DOI 10.1046/j.1471-4159.2003.01843.x; Stanic D, 2003, EUR J NEUROSCI, V18, P1175, DOI 10.1046/j.1460-9568.2003.02800.x; Sui Y, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00013; Vinuela A, 2008, BRAIN, V131, P3361, DOI 10.1093/brain/awn192; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411	28	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153424	10.1371/journal.pone.0153424	http://dx.doi.org/10.1371/journal.pone.0153424			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077649	gold, Green Published			2022-12-26	WOS:000374131700054
J	Zurawski, G; Zurawski, S; Flamar, AL; Richert, L; Wagner, R; Tomaras, GD; Montefiori, DC; Roederer, M; Ferrari, G; Lacabaratz, C; Bonnabau, H; Klucar, P; Wang, ZQ; Foulds, KE; Kao, SF; Yates, NL; LaBranche, C; Jacobs, BL; Kibler, K; Asbach, B; Kliche, A; Salazar, A; Reed, S; Self, S; Gottardo, R; Galmin, L; Weiss, D; Cristillo, A; Thiebaut, R; Pantaleo, G; Levy, Y				Zurawski, Gerard; Zurawski, Sandra; Flamar, Anne-Laure; Richert, Laura; Wagner, Ralf; Tomaras, Georgia D.; Montefiori, David C.; Roederer, Mario; Ferrari, Guido; Lacabaratz, Christine; Bonnabau, Henri; Klucar, Peter; Wang, Zhiqing; Foulds, Kathryn E.; Kao, Shing-Fen; Yates, Nicole L.; LaBranche, Celia; Jacobs, Bertram L.; Kibler, Karen; Asbach, Benedikt; Kliche, Alexander; Salazar, Andres; Reed, Steve; Self, Steve; Gottardo, Raphael; Galmin, Lindsey; Weiss, Deborah; Cristillo, Anthony; Thiebaut, Rodolphe; Pantaleo, Giuseppe; Levy, Yves			Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques	PLOS ONE			English	Article							T-CELL RESPONSES; DENDRITIC CELLS; IMMUNOLOGICAL CHARACTERIZATION; EFFICACY TRIAL; VACCINE; ANTIBODIES; PROTEIN; ANTIGENS; PRIME; ALVAC	Improved antigenicity against HIV-1 envelope (Env) protein is needed to elicit vaccine-induced protective immunity in humans. Here we describe the first tests in non-human primates (NHPs) of Env gp140 protein fused to a humanized anti-LOX-1 recombinant antibody for delivering Env directly to LOX-1-bearing antigen presenting cells, especially dendritic cells (DC). LOX-1, or 1ectin-like oxidized low-density lipoprotein (LDL) receptor-1, is expressed on various antigen presenting cells and endothelial cells, and is involved in promoting humoral immune responses. The anti-LOX-1 Env gp140 fusion protein was tested for priming immune responses and boosting responses in animals primed with replication competent NYVAC-KC Env gp140 vaccinia virus. Anti-LOX-1 Env gp140 vaccination elicited robust cellular and humoral responses when used for either priming or boosting immunity. Co-administration with Poly ICLC, a TLR3 agonist, was superior to GLA, a TLR4 agonist. Both CD4(+) and CD8(+) Env-specific T cell responses were elicited by anti-LOX-1 Env gp140, but in particular the CD4(+) T cells were multifunctional and directed to multiple epitopes. Serum IgG and IgA antibody responses induced by anti-LOX-1 Env gp140 against various gp140 domains were cross-reactive across HIV-1 clades; however, the sera neutralized only HIV-1 bearing sequences most similar to the clade C 96ZM651 Env gp140 carried by the anti-LOX-1 vehicle. These data, as well as the safety of this protein vaccine, justify further exploration of this DC-targeting vaccine approach for protective immunity against HIV-1.	[Zurawski, Gerard; Zurawski, Sandra; Flamar, Anne-Laure; Lacabaratz, Christine; Klucar, Peter; Wang, Zhiqing; Levy, Yves] Univ Paris Est, Vaccine Res Inst, Fac Med, INSERM,U955, Creteil, France; [Zurawski, Gerard; Zurawski, Sandra; Flamar, Anne-Laure; Lacabaratz, Christine; Klucar, Peter; Wang, Zhiqing; Levy, Yves] Grp Henri Mondor Albert Chenevier, AP HP, Serv Immunol Clin, INRIA SISTM, Creteil, France; [Zurawski, Gerard; Zurawski, Sandra; Flamar, Anne-Laure; Klucar, Peter; Wang, Zhiqing] Baylor Inst Immunol Res, Dallas, TX USA; [Zurawski, Gerard; Zurawski, Sandra; Flamar, Anne-Laure; Klucar, Peter; Wang, Zhiqing] INSERM, U955, Dallas, TX USA; [Richert, Laura; Bonnabau, Henri; Thiebaut, Rodolphe] Univ Bordeaux Segalen, INSERM, U897, INRIA SISTM, Bordeaux, France; [Wagner, Ralf; Asbach, Benedikt; Kliche, Alexander] Univ Regensburg, Inst Med Microbiol & Hyg, Mol Microbiol & Gene Therapy Unit, D-93053 Regensburg, Germany; [Tomaras, Georgia D.; Montefiori, David C.; Ferrari, Guido; Yates, Nicole L.; LaBranche, Celia] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Tomaras, Georgia D.; Montefiori, David C.] Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC USA; [Roederer, Mario; Foulds, Kathryn E.; Kao, Shing-Fen] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Jacobs, Bertram L.; Kibler, Karen] Arizona State Univ, Sch Life Sci, Ctr Infect Dis & Vaccinol, Tempe, AZ USA; [Self, Steve; Gottardo, Raphael] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Self, Steve; Gottardo, Raphael] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Salazar, Andres] Oncovir, Washington, DC USA; [Reed, Steve] Infect Dis Res Inst, Seattle, WA USA; [Galmin, Lindsey; Weiss, Deborah; Cristillo, Anthony] Adv BioSci Labs Inc, Rockville, MD USA; [Pantaleo, Giuseppe] CHU Vaudois, CH-101 Lausanne, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Baylor Scott & White Health; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; University of Regensburg; Duke University; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Arizona State University; Arizona State University-Tempe; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Zurawski, G (corresponding author), Univ Paris Est, Vaccine Res Inst, Fac Med, INSERM,U955, Creteil, France.; Zurawski, G (corresponding author), Grp Henri Mondor Albert Chenevier, AP HP, Serv Immunol Clin, INRIA SISTM, Creteil, France.; Zurawski, G (corresponding author), Baylor Inst Immunol Res, Dallas, TX USA.	gerardz@baylorhealth.edu	Gottardo, Raphael/HCH-3169-2022; Thiebaut, Rodolphe/T-6803-2019; Ferrari, Guido/Z-2137-2019; Ferrari, Guido/A-6088-2015; Pantaleo, Giuseppe/K-6163-2016; Roederer, Mario/G-1887-2011; Richert, Laura/T-5801-2019; Tomaras, Georgia/J-5041-2016	Thiebaut, Rodolphe/0000-0002-5235-3962; Ferrari, Guido/0000-0001-7747-3349; Gottardo, Raphael/0000-0002-3867-0232; Richert, Laura/0000-0002-7682-2225; Zurawski, Gerard/0000-0002-0168-3523; Lacabaratz, Christine/0000-0001-6925-0225	Vaccine Research Institute HIV vaccine program (ANRS/INSERM); Vaccine Research Institute HIV vaccine program (Investissements d'Avenir program) [ANR-10-LABX-77]; Poxvirus T-cell Vaccine Consortium - Bill & Melinda Gates Foundation [OPP38599]; Vaccine Immune Monitoring Centers - Bill & Melinda Gates Foundation [OPP1032325, OPP1032144]; Vaccine Immunology Statistical Center - Bill & Melinda Gates Foundation [OPP1032317]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI005103, ZIAAI005021, ZIAAI005020] Funding Source: NIH RePORTER	Vaccine Research Institute HIV vaccine program (ANRS/INSERM)(French National Research Agency (ANR)); Vaccine Research Institute HIV vaccine program (Investissements d'Avenir program)(French National Research Agency (ANR)); Poxvirus T-cell Vaccine Consortium - Bill & Melinda Gates Foundation; Vaccine Immune Monitoring Centers - Bill & Melinda Gates Foundation; Vaccine Immunology Statistical Center - Bill & Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was funded within the Vaccine Research Institute HIV vaccine program (ANRS/INSERM and was supported by the Investissements d'Avenir program managed by the ANR under reference ANR-10-LABX-77). Support from the Poxvirus T-cell Vaccine Consortium funded by the Bill & Melinda Gates Foundation (OPP38599) for the development of NYVAC-KC vector. Support for the ICS and antibody immune monitoring assays was provided by the Vaccine Immune Monitoring Centers (OPP1032325 & OPP1032144), and support for the statistical analysis from the Vaccine Immunology Statistical Center (OPP1032317), all part of the Collaboration for AIDS Vaccine Discovery (CAVD) funded by the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was funded within the Vaccine Research Institute HIV vaccine program (ANRS/INSERM and was supported by the Investissements d'Avenir program managed by the ANR under reference ANR-10-LABX-77). Support from the Poxvirus T-cell Vaccine Consortium funded by the Bill & Melinda Gates Foundation (OPP38599) for the development of NYVAC-KC vector. Support for the ICS and antibody immune monitoring assays was provided by the Vaccine Immune Monitoring Centers (OPP1032325 & OPP1032144), and support for the statistical analysis from the Vaccine Immunology Statistical Center (OPP1032317), all part of the Collaboration for AIDS Vaccine Discovery (CAVD) funded by the Bill & Melinda Gates Foundation. Alicia Sato (Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center) and Jason Skinner (BIIR) are thanked for valuable edits. Matthew Baker (Antitope, Ltd) provided humanization of the alpha LOX-1 15C4 mAb. Lauren Hudacik (ABL), Cecile Peltekian (INSERM U955) and Song Ding (EuroVacc Foundation) are thanked for excellent project coordination.	Donaldson MM, 2012, J IMMUNOL METHODS, V386, P10, DOI 10.1016/j.jim.2012.08.011; Edmonds TG, 2010, VIROLOGY, V408, P1, DOI 10.1016/j.virol.2010.08.028; Epaulard O, 2014, J IMMUNOL, V193, P2416, DOI 10.4049/jimmunol.1303339; Flamar AL, 2013, AIDS, V27, P2041, DOI 10.1097/QAD.0b013e3283624305; Flamar AL, 2012, J IMMUNOL, V189, P2645, DOI 10.4049/jimmunol.1102390; Flynn BJ, 2011, P NATL ACAD SCI USA, V108, P7131, DOI 10.1073/pnas.1103869108; Foulds KE, 2012, CYTOM PART A, V81A, P360, DOI 10.1002/cyto.a.22008; Garcia-Arriaza J, 2015, J VIROL, V89, P8525, DOI 10.1128/JVI.01265-15; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Joo H, 2014, IMMUNITY, V41, P592, DOI 10.1016/j.immuni.2014.09.009; Kibler KV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025674; Lewis GK, 2010, EXPERT REV VACCINES, V9, P683, DOI [10.1586/erv.10.70, 10.1586/ERV.10.70]; Li DP, 2012, J EXP MED, V209, P109, DOI 10.1084/jem.20110399; Liao HX, 2006, VIROLOGY, V353, P268, DOI 10.1016/j.virol.2006.04.043; Liao HX, 2013, IMMUNITY, V38, P176, DOI 10.1016/j.immuni.2012.11.011; Lin L, 2015, NAT BIOTECHNOL, V33, P610, DOI 10.1038/nbt.3187; Lumsden JM, 2011, INFECT IMMUN, V79, P3492, DOI 10.1128/IAI.05257-11; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Nkolola JP, 2014, VACCINE, V32, P2109, DOI 10.1016/j.vaccine.2014.02.001; Park H, 2013, J IMMUNOL, V190, P4103, DOI 10.4049/jimmunol.1202958; Perdiguero B, 2015, J VIROL, V89, P970, DOI 10.1128/JVI.02469-14; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Pollara J, 2014, J VIROL, V88, P7715, DOI 10.1128/JVI.00156-14; Pollara J, 2011, CYTOM PART A, V79A, P603, DOI 10.1002/cyto.a.21084; Reed SG, 2013, NAT MED, V19, P1597, DOI 10.1038/nm.3409; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Robb ML, 2012, LANCET INFECT DIS, V12, P531, DOI 10.1016/S1473-3099(12)70088-9; Rose R De, 2014, NOVEL APPROACHES STR; Schneider LP, 2012, VACCINE, V30, P4216, DOI 10.1016/j.vaccine.2012.04.051; Skinner JA, 2014, CLIN VACCINE IMMUNOL, V21, P1668, DOI 10.1128/CVI.00547-14; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; Tewari K, 2010, VACCINE, V28, P7256, DOI 10.1016/j.vaccine.2010.08.098; Tomaras GD, 2013, P NATL ACAD SCI USA, V110, P9019, DOI 10.1073/pnas.1301456110; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Vaure C, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00316; Vingert B, 2010, PLOS PATHOG, V6; White SD, 2011, BIOTECHNIQUES, V50, P303, DOI 10.2144/000113667; Yates NL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007730; Zolla-Pazner S, 2014, EBIOMEDICINE, V1, P37, DOI 10.1016/j.ebiom.2014.10.022; Zolla-Pazner S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087572	43	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153484	10.1371/journal.pone.0153484	http://dx.doi.org/10.1371/journal.pone.0153484			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077384	Green Published, Green Submitted, gold			2022-12-26	WOS:000374131700063
J	Han, D; Hartaigh, BO; Lee, JH; Cho, IJ; Shim, CY; Chang, HJ; Hong, GR; Ha, JW; Chung, N				Han, Donghee; Hartaigh, Briain O.; Lee, Ji Hyun; Cho, In-Jeong; Shim, Chi Young; Chang, Hyuk-Jae; Hong, Geu-Ru; Ha, Jong-Won; Chung, Namsik			Impact of D-Dimer for Prediction of Incident Occult Cancer in Patients with Unprovoked Venous Thromboembolism	PLOS ONE			English	Article							DEEP-VEIN THROMBOSIS; PULMONARY-EMBOLISM; POOR-PROGNOSIS; RISK; MANAGEMENT; DIAGNOSIS	Background Unprovoked venous thromboembolism (VTE) is related to a higher incidence of occult cancer. D-dimer is clinically used for screening VTE, and has often been shown to be present in patients with malignancy. We explored the predictive value of D-dimer for detecting occult cancer in patients with unprovoked VTE. Methods We retrospectively examined data from 824 patients diagnosed with deep vein thrombosis or pulmonary thromboembolism. Of these, 169 (20.5%) patients diagnosed with unprovoked VTE were selected to participate in this study. D-dimer was categorized into three groups as: <2,000, 2,000-4,000, and >4,000 ng/ml. Cox regression analysis was employed to estimate the odds of occult cancer and metastatic state of cancer according to D-dimer categories. Results During a median 5.3 (interquartile range: 3.4-6.7) years of follow-up, 24 (14%) patients with unprovoked VTE were diagnosed with cancer. Of these patients, 16 (67%) were identified as having been diagnosed with metastatic cancer. Log transformed D-dimer levels were significantly higher in those with occult cancer as compared with patients without diagnosis of occult cancer (3.5 +/- 0.5 vs. 3.2 +/- 0.5, P-value = 0.009, respectively). D-dimer levels >4,000 ng/ml was independently associated with occult cancer (HR: 4.12, 95% CI: 1.54-11.04, P-value = 0.005) when compared with D-dimer levels <2,000 ng/ml, even after adjusting for age, gender, and type of VTE (e.g., deep vein thrombosis or pulmonary thromboembolism). D-dimer levels >4000 ng/ml were also associated with a higher likelihood of metastatic cancer (HR: 9.55, 95% CI: 2.46-37.17, P-value <0.001). Conclusion Elevated D-dimer concentrations >4000 ng/ml are independently associated with the likelihood of occult cancer among patients with unprovoked VTE.	[Han, Donghee; Lee, Ji Hyun; Cho, In-Jeong; Shim, Chi Young; Chang, Hyuk-Jae; Hong, Geu-Ru; Ha, Jong-Won; Chung, Namsik] Yonsei Univ, Coll Med, Severance Hosp, Dept Internal Med,Div Cardiol, Seoul, South Korea; [Hartaigh, Briain O.] New York Presbyterian Hosp, Dalio Inst Cardiovasc Imaging, New York, NY USA; [Hartaigh, Briain O.] Weill Cornell Med Ctr, New York, NY USA	Yonsei University; Yonsei University Health System; NewYork-Presbyterian Hospital; Cornell University	Hong, GR (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Dept Internal Med,Div Cardiol, Seoul, South Korea.	grhong@yuhs.ac	Shim, Chi Young/AAK-1057-2021	Shim, Chi Young/0000-0002-6136-0136; Chang, Hyuk-Jae/0000-0002-6139-7545; Hong, Geu-Ru/0000-0003-4981-3304; Ha, Jong-Won/0000-0002-8260-2958				Ay C, 2012, HAEMATOL-HEMATOL J, V97, P1158, DOI 10.3324/haematol.2011.054718; Carrier M, 2008, ANN INTERN MED, V149, P323, DOI 10.7326/0003-4819-149-5-200809020-00007; Carrier M, 2015, NEW ENGL J MED, V373, P697, DOI 10.1056/NEJMoa1506623; Carrier M, 2009, THROMB HAEMOSTASIS, V101, P886, DOI 10.1160/TH-08-10-0689; Cushman M, 2003, BLOOD, V101, P1243, DOI 10.1182/blood-2002-05-1416; Douketis JD, 2009, J THROMB HAEMOST, V7, P546, DOI 10.1111/j.1538-7836.2008.03268.x; Heit JA, 2002, ARCH INTERN MED, V162, P1245, DOI 10.1001/archinte.162.11.1245; Konstantinides SV, 2014, EUR HEART J, V35, P3033, DOI 10.1093/eurheartj/ehu283; Palareti G, 2006, NEW ENGL J MED, V355, P1780, DOI 10.1056/NEJMoa054444; Palumbo JS, 2000, BLOOD, V96, P3302, DOI 10.1182/blood.V96.10.3302; Piccioli A, 2004, J THROMB HAEMOST, V2, P884, DOI 10.1111/j.1538-7836.2004.00720.x; Rege KR, 2004, THROMB HAEMOSTASIS, V91, P1219, DOI 10.1160/TH03-11-0699; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Sakurai M, 2015, INT J GYNECOL CANCER, V25, P593, DOI 10.1097/IGC.0000000000000415; Schutgens REG, 2005, HAEMATOLOGICA, V90, P214; Sorensen HT, 1998, NEW ENGL J MED, V338, P1169, DOI 10.1056/NEJM199804233381701; Timp JF, 2013, BLOOD, V122, P1712, DOI 10.1182/blood-2013-04-460121; van Doormaal FF, 2011, J THROMB HAEMOST, V9, P79, DOI 10.1111/j.1538-7836.2010.04101.x	18	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153514	10.1371/journal.pone.0153514	http://dx.doi.org/10.1371/journal.pone.0153514			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073982	Green Published, gold, Green Submitted			2022-12-26	WOS:000374131200102
J	Plessow, R; Arora, NK; Brunner, B; Wieser, S				Plessow, Rafael; Arora, Narendra Kumar; Brunner, Beatrice; Wieser, Simon			Cost-Effectiveness of Price Subsidies on Fortified Packaged Infant Cereals in Reducing Iron Deficiency Anemia in 6-23-Month-Old-Children in Urban India	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; EXPERIMENTAL AUCTIONS; BIAS	Introduction Iron deficiency anaemia (IDA) is a major public health problem in India and especially harmful in early childhood due to its impact on cognitive development and increased all-cause mortality. We estimate the cost-effectiveness of price subsidies on fortified packaged infant cereals (F-PICs) in reducing IDA in 6-23-monthold children in urban India. Materials and Methods Cost-effectiveness is estimated by comparing the net social cost of price subsidies with the disability-adjusted life-years (DALYs) averted with price subsidies. The net social costs correspond to the cost of the subsidy minus the monetary costs saved by reducing IDA. The estimation proceeds in three steps: 1) the current lifetime costs of IDA are assessed with a health economic model combining the prevalence of anemia, derived from a large population survey, with information on the health consequences of IDA and their costs in terms of mortality, morbidity, and DALYs. 2) The effects of price subsidies on the demand for F-PICs are assessed with a market survey among 4801 households in 12 large Indian cities. 3) The cost-effectiveness is calculated by combining the findings of the first two steps with the results of a systematic review on the effectiveness of F-PICs in reducing IDA. We compare the cost-effectiveness of interventions that differ in the level of the subsidy and in the socioeconomic strata (SES) eligible for the subsidy. Results The lifetime social costs of IDA in 6-23-month-old children in large Indian cities amount to production losses of 3222 USD and to 726,000 DALYs. Poor households incur the highest costs, yet even wealthier households suffer substantial losses. The market survey reveals that few households currently buy F-PICs, with the share ranging from 14% to 36%. Wealthier households are generally more likely to buy FPICs. The costs of the subsidies per DALY averted range from 909 to 3649 USD. Interventions targeted at poorer households are most effective. Almost all interventions are cost saving from a societal perspective when taking into account the reduction of future production losses. Return per DALY averted ranges between gains of 1655 USD to a cost of 411 USD. Conclusion Price subsidies on F-PICs are a cost-effective way to reduce the social costs of IDA in 6-23-month-old children in large Indian cities. Interventions targeting poorer households are especially cost-effective.	[Plessow, Rafael; Brunner, Beatrice; Wieser, Simon] Zurich Univ Appl Sci, Winterthur Inst Hlth Econ, Winterthur, Switzerland; [Arora, Narendra Kumar] INCLEN, Int Clin Epidemiol Network, New Delhi, India	Zurich University of Applied Sciences	Wieser, S (corresponding author), Zurich Univ Appl Sci, Winterthur Inst Hlth Econ, Winterthur, Switzerland.	simon.wieser@zhaw.ch	Wieser, Simon/AAC-1589-2022; Wieser, Simon/AAH-6581-2020	Wieser, Simon/0000-0003-1821-2944	Nestle Research Center (Switzerland)	Nestle Research Center (Switzerland)	The study was partially funded by the Nestle Research Center (Switzerland) and speaker honorarium and conference travel grants were provided to SW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NKA has received no funding for this study.	Agarwal R, 2013, NEONATOLOGY, V103, P54, DOI 10.1159/000342227; Alvarez-Uria G, 2014, ANEMIA, V2014, DOI 10.1155/2014/176182; Anand T, 2014, NUTRITION, V30, P764, DOI 10.1016/j.nut.2013.11.022; [Anonymous], 2015, WORLD EC OUTLOOK DAT; Ashraf N, 2010, AM ECON REV, V100, P2383, DOI 10.1257/aer.100.5.2383; Blumenschein K, 2008, ECON J, V118, P114; Cohen J, 2010, Q J ECON, V125, P1, DOI 10.1162/qjec.2010.125.1.1; Corrigan JR, 2009, AM J AGR ECON, V91, P837, DOI 10.1111/j.1467-8276.2009.01267.x; De Groote H, 2011, AGR ECON-BLACKWELL, V42, P1, DOI 10.1111/j.1574-0862.2010.00466.x; Dewey KG, 2013, J NUTR, V143, P2050, DOI 10.3945/jn.113.182527; Dewey KG., 2013, STRATEGIES ENSURING; Eichler K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-506; Fiszbein A, 2009, CONDITIONAL CASH TRA; Global Alliance for Improved Nutrition (GAIN), 2015, GAIN IYCN WORK PAP S; Government of India, 2014, CENS OF IND 2011; Institute for Health Metrics and Evaluation (IHME), 2013, GBD PROF; International Institute for Population Sciences (IIPS) and Macro International, 2007, NAT FAM HLTH SURV NF; Jha R, 2011, J ASIAN ECON, V22, P189, DOI 10.1016/j.asieco.2010.11.004; Kotecha Prakash V, 2011, Indian J Community Med, V36, P8, DOI 10.4103/0970-0218.80786; Lozoff B, 2006, ARCH PEDIAT ADOL MED, V160, P1108, DOI 10.1001/archpedi.160.11.1108; Lutter Chessa K., 2003, Food and Nutrition Bulletin, V24, P83; Morwitz VG, 2007, INT J FORECASTING, V23, P347, DOI 10.1016/j.ijforecast.2007.05.015; Nestle India, 2013, CHART ETH RESP BEH S; Pasricha SR, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-617; Plessow R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136581; Poverty Action Lab, 2011, PRIC IS WRONG J PAL; Ram, 2009, EC POLITICAL WEEKLY, VXLIV; Rutstein S. O., 2004, DHS WEALTH INDEX; Sachdev HPS, 2013, EUR J CLIN NUTR, V67, P475, DOI 10.1038/ejcn.2012.212; Sridhar T, 2014, INT J SOCIOL SOC POL, V34, P107; Stekhoven D.J, 2013, MISSFOREST NONPARAME; Stekhoven DJ, 2012, BIOINFORMATICS, V28, P112, DOI 10.1093/bioinformatics/btr597; Webb J.R., 2002, UNDERSTANDING DESIGN; Whitehead JC, 2007, RESOUR ENERGY ECON, V29, P247, DOI 10.1016/j.reseneeco.2006.10.001; World Bank, WORLD BANK DAT 2015; World Health Organization, 2002, COST EFF STRAT PLANN; World Health Organization, 2003, UN GLOB STRAT INF YO; World Health Organization, 2008, INT COD MARK BREAST; Yip R, 2002, J NUTR, V132, p859S, DOI 10.1093/jn/132.4.859S	39	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152800	10.1371/journal.pone.0152800	http://dx.doi.org/10.1371/journal.pone.0152800			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UC	27073892	Green Published, Green Submitted, gold			2022-12-26	WOS:000374131200038
J	Tang, CZ; Zhao, ZY; Chen, C; Zheng, XH; Sun, FF; Zhang, XL; Tian, J; Fan, MX; Wu, Y; Jia, J				Tang, Chaozheng; Zhao, Zhiyong; Chen, Chuang; Zheng, Xiaohui; Sun, Fenfen; Zhang, Xiaoli; Tian, Jing; Fan, Mingxia; Wu, Yi; Jia, Jie			Decreased Functional Connectivity of Homotopic Brain Regions in Chronic Stroke Patients: A Resting State fMRI Study	PLOS ONE			English	Article							UPPER-EXTREMITY FUNCTION; HUMAN CEREBELLUM; MOTOR RECOVERY; REORGANIZATION; TOPOGRAPHY; PREDICTION; DOMAINS; SYSTEMS; TASKS	The recovery of motor functions is accompanied by brain reorganization, and identifying the inter-hemispheric interaction post stroke will conduce to more targeted treatments. However, the alterations of bi-hemispheric coordination pattern between homologous areas in the whole brain for chronic stroke patients were still unclear. The present study focuses on the functional connectivity (FC) of mirror regions of the whole brain to investigate the inter-hemispheric interaction using a new fMRI method named voxel-mirrored homotopic connectivity (VMHC). Thirty left subcortical chronic stroke patients with pure motor deficits and 37 well-matched healthy controls (HCs) underwent resting-state fMRI scans. We employed a VMHC analysis to determine the brain areas showed significant differences between groups in FC between homologous regions, and we explored the relationships between the mean VMHC of each survived area and clinical tests within patient group using Pearson correlation. In addition, the brain areas showed significant correlations between the mean VMHC and clinical tests were defined as the seed regions for whole brain FC analysis. Relative to HCs, patients group displayed lower VMHC in the precentral gyrus, postcentral gyrus, inferior frontal gyrus, middle temporal gyrus, calcarine gyrus, thalamus, cerebellum anterior lobe, and cerebellum posterior lobe (CPL). Moreover, the VMHC of CPL was positively correlated with the Fugl-Meyer Score of hand (FMA-H), while a negative correlation between illness duration and the VMHC of this region was also detected. Furthermore, we found that when compared with HCs, the right CPL exhibited reduced FC with the left precentral gyrus, inferior frontal gyrus, inferior parietal lobule, middle temporal gyrus, thalamus and hippocampus. Our results suggest that the functional coordination across hemispheres is impaired in chronic stroke patients, and increased VMHC of the CPL is significantly associated with higher FMA-H scores. These findings may be helpful in understanding the mechanism of hand deficit after stroke, and the CPL may serve as a target region for hand rehabilitation following stroke.	[Tang, Chaozheng; Zhang, Xiaoli; Tian, Jing; Wu, Yi; Jia, Jie] Fudan Univ, Dept Rehabil Med, Huashan Hosp, Shanghai 200433, Peoples R China; [Zhao, Zhiyong; Zheng, Xiaohui; Fan, Mingxia] E China Normal Univ, Shanghai Key Lab Magnet Resonance, Shanghai 200062, Peoples R China; [Chen, Chuang] Fujian Univ Tradit Chinese Med, Coll Rehabil Med, Fuzhou, Peoples R China; [Sun, Fenfen] E China Normal Univ, Sch Psychol & Cognit Sci, Shanghai 200062, Peoples R China; [Jia, Jie] Jingan Dist Ctr Hosp, Dept Rehabil Med, Shanghai, Peoples R China	Fudan University; East China Normal University; Fujian University of Traditional Chinese Medicine; East China Normal University	Jia, J (corresponding author), Fudan Univ, Dept Rehabil Med, Huashan Hosp, Shanghai 200433, Peoples R China.; Jia, J (corresponding author), Jingan Dist Ctr Hosp, Dept Rehabil Med, Shanghai, Peoples R China.	shannonjj@126.com		Tang, Chaozheng/0000-0002-2021-9988	12th Five-Year Supporting Project of Ministry of Science and Technology of the People's Republic of China [2013BAI10B03]; Research Plan of National Natural Science Foundation of China (NSFC) Awarded Project [31450110072]; Development Program of China (863 program) [SS2015AA020501]	12th Five-Year Supporting Project of Ministry of Science and Technology of the People's Republic of China; Research Plan of National Natural Science Foundation of China (NSFC) Awarded Project(National Natural Science Foundation of China (NSFC)); Development Program of China (863 program)(National High Technology Research and Development Program of China)	This work was granted by the 12th Five-Year Supporting Project of Ministry of Science and Technology of the People's Republic of China (2013BAI10B03), the Research Plan of National Natural Science Foundation of China (NSFC) Awarded Project (31450110072) and the Development Program of China (863 program, SS2015AA020501). JJ received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J. S., 2010, CEREB CORTEX; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Avenanti A, 2012, NEUROLOGY, V78, P256, DOI 10.1212/WNL.0b013e3182436558; Beebe JA, 2009, STROKE, V40, P1772, DOI 10.1161/STROKEAHA.108.536763; Carter AR, 2010, ANN NEUROL, V67, P365, DOI 10.1002/ana.21905; Dacosta-Aguayo R, 2014, HUM BRAIN MAPP, V35, P3819, DOI 10.1002/hbm.22439; Elsner B, 2013, COCHRANE LIB; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Guo WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071368; Hoptman MJ, 2012, SCHIZOPHR RES, V141, P1, DOI 10.1016/j.schres.2012.07.027; Hu XF, 2015, J NEUROL, V262, P760, DOI 10.1007/s00415-014-7627-x; Inman CS, 2012, NEUROIMAGE, V59, P227, DOI 10.1016/j.neuroimage.2011.07.083; Kelly C, 2011, BIOL PSYCHIAT, V69, P684, DOI 10.1016/j.biopsych.2010.11.022; Krienen FM, 2009, CEREB CORTEX, V19, P2485, DOI 10.1093/cercor/bhp135; Liang BS, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00645; Loubinoux I, 2003, NEUROIMAGE, V20, P2166, DOI 10.1016/j.neuroimage.2003.08.017; Loubinoux I, 2007, CEREB CORTEX, V17, P2980, DOI 10.1093/cercor/bhm023; MacIntosh BJ, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00060; Milenkovic S, 2013, LATERALITY, V18, P340, DOI 10.1080/1357650X.2012.683196; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; O'Reilly JX, 2010, CEREB CORTEX, V20, P953, DOI 10.1093/cercor/bhp157; Park CH, 2011, STROKE, V42, P1357, DOI 10.1161/STROKEAHA.110.596155; Puh U, 2007, INT J PSYCHOPHYSIOL, V63, P173, DOI 10.1016/j.ijpsycho.2006.03.011; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Schlaug G, 2013, FRONT NEUROL, V4, DOI [10.3389/fneur.2013.00004, DOI 10.3389/FNEUR.2013.00004]; Schmahmann JD, 2009, NEUROSCIENCE, V162, P852, DOI 10.1016/j.neuroscience.2009.06.023; Schoch B, 2006, NEUROIMAGE, V30, P36, DOI 10.1016/j.neuroimage.2005.09.018; Stinear C, 2010, LANCET NEUROL, V9, P1228, DOI 10.1016/S1474-4422(10)70247-7; Stinear CM, 2012, BRAIN, V135, P2527, DOI 10.1093/brain/aws146; Stoodley CJ, 2012, NEUROIMAGE, V59, P1560, DOI 10.1016/j.neuroimage.2011.08.065; Stoodley CJ, 2010, CORTEX, V46, P831, DOI 10.1016/j.cortex.2009.11.008; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Sun HX, 2013, J STROKE, V15, P109, DOI 10.5853/jos.2013.15.2.109; Thiel A, 2015, STROKE, V46, P296, DOI 10.1161/STROKEAHA.114.006307; Urbin MA, 2014, NEUROREHAB NEURAL RE, V28, P761, DOI 10.1177/1545968314522349; Veerbeek JM, 2011, STROKE, V42, P1482, DOI 10.1161/STROKEAHA.110.604090; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060191; Ward NS, 2004, ARCH NEUROL-CHICAGO, V61, P1844, DOI 10.1001/archneur.61.12.1844; Ward NS, 2003, BRAIN, V126, P1430, DOI 10.1093/brain/awg145; Xu HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084729; Yin D, 2013, AM J NEURORADIOL, V34, P1341, DOI 10.3174/ajnr.A3410; Yin DZ, 2013, NEURORADIOLOGY, V55, P761, DOI 10.1007/s00234-013-1146-9; Zuo XN, 2014, NEUROSCI BIOBEHAV R, V45, P100, DOI 10.1016/j.neubiorev.2014.05.009; Zuo XN, 2010, J NEUROSCI, V30, P15034, DOI 10.1523/JNEUROSCI.2612-10.2010	44	41	48	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152875	10.1371/journal.pone.0152875	http://dx.doi.org/10.1371/journal.pone.0152875			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074031	Green Submitted, Green Published, gold			2022-12-26	WOS:000374131200041
J	Bergman, PS; Schumer, G; Blankenship, S; Campbell, E				Bergman, Paul S.; Schumer, Gregg; Blankenship, Scott; Campbell, Elizabeth			Detection of Adult Green Sturgeon Using Environmental DNA Analysis	PLOS ONE			English	Article							SURVEY TOOL; EDNA	Environmental DNA (eDNA) is an emerging sampling method that has been used successfully for detection of rare aquatic species. The Identification of sampling tools that are less stressful for target organisms has become increasingly important for rare and endangered species. A decline in abundance of the Southern Distinct Population Segment (DPS) of North American Green Sturgeon located in California's Central Valley has led to its listing as Threatened under the Federal Endangered Species Act in 2006. While visual surveys of spawning Green Sturgeon in the Central Valley are effective at monitoring fish densities in concentrated pool habitats, results do not scale well to the watershed level, providing limited spatial and temporal context. Unlike most traditional survey methods, environmental DNA analysis provides a relatively quick, inexpensive tool that could efficiently monitor the presence and distribution of aquatic species. We positively identified Green Sturgeon DNA at two locations of known presence in the Sacramento River, proving that eDNA can be effective for monitoring the presence of adult sturgeon. While further study is needed to understand uncertainties of the sampling method, our study represents the first documented detection of Green Sturgeon eDNA, indicating that eDNA analysis could provide a new tool for monitoring Green Sturgeon distribution in the Central Valley, complimenting traditional on-going survey methods.	[Bergman, Paul S.; Schumer, Gregg; Blankenship, Scott] Cramer Fish Sci, West Sacramento, CA USA; [Campbell, Elizabeth] US Fish & Wildlife Serv, Anadromous Fish Restorat Program, Lodi, CA USA	United States Department of the Interior; US Fish & Wildlife Service	Bergman, PS (corresponding author), Cramer Fish Sci, West Sacramento, CA USA.	pbergman@fishsciences.net		Blankenship, Scott/0000-0001-6371-9475	U.S. Fish and Wildlife (USFWS) Service grant [813329G011]	U.S. Fish and Wildlife (USFWS) Service grant	This study was funded exclusively through a U.S. Fish and Wildlife (USFWS) Service grant, award number 813329G011. Except for USFWS employee and author EB, no other funders played a role in the study to develop study design, conduct data collection and analysis, decision to publish, or prepare the manuscript. Cramer Fish Sciences provided support in the form of salaries for authors PB, SB, and GS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bergman PS, 2011, 813329G011 US FISH W; Brandl S, 2015, MOL ECOL RESOUR, V15, P278, DOI 10.1111/1755-0998.12305; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; Fukumoto S, 2015, J APPL ECOL, V52, P358, DOI 10.1111/1365-2664.12392; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Jane SF, 2015, MOL ECOL RESOUR, V15, P216, DOI 10.1111/1755-0998.12285; Janosik AM, 2015, ENVIRON BIOL FISH, V98, P1889, DOI 10.1007/s10641-015-0405-5; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Klymus KE, 2015, BIOL CONSERV, V183, P77, DOI 10.1016/j.biocon.2014.11.020; Laramie MB, 2015, BIOL CONSERV, V183, P29, DOI 10.1016/j.biocon.2014.11.025; Mora EA, 2009, J APPL ICHTHYOL, V25, P39, DOI 10.1111/j.1439-0426.2009.01297.x; National Marine Fisheries Service (NMFS), 2005, GREEN STURG AC MED S; NMFS (National Marine Fisheries Service), 2006, FED REGISTER, V71, P17757; NMFS (National Marine Fisheries Service), 2015, SO DIST POP SEGM N A; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; Poytress WR, 2008, ANN REPORT; Poytress WR, 2012, ANN REPORT; Poytress WR, 2010, ANN REPORT; Rees HC, 2014, J APPL ECOL, V51, P1450, DOI 10.1111/1365-2664.12306; Roussel JM, 2015, J APPL ECOL, V52, P823, DOI 10.1111/1365-2664.12428; SEESHOLTZ A, 2014, ENVIRON BIOL FISH, V98, P905; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x	23	29	30	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153500	10.1371/journal.pone.0153500	http://dx.doi.org/10.1371/journal.pone.0153500			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096433	Green Published, gold, Green Submitted			2022-12-26	WOS:000374543600040
J	Hays, J; Shonkoff, SBC				Hays, Jake; Shonkoff, Seth B. C.			Toward an Understanding of the Environmental and Public Health Impacts of Unconventional Natural Gas Development: A Categorical Assessment of the Peer-Reviewed Scientific Literature, 2009-2015	PLOS ONE			English	Article							SHALE GAS; OIL; AIR; OPERATIONS; EXTRACTION; EMISSIONS; BASIN	The body of science evaluating the potential impacts of unconventional natural gas development (UNGD) has grown significantly in recent years, although many data gaps remain. Still, a broad empirical understanding of the impacts is beginning to emerge amidst a swell of research. The present categorical assessment provides an overview of the peer-reviewed scientific literature from 2009-2015 as it relates to the potential impacts of UNGD on public health, water quality, and air quality. We have categorized all available original research during this time period in an attempt to understand the weight and direction of the scientific literature. Our results indicate that at least 685 papers have been published in peer-reviewed scientific journals that are relevant to assessing the impacts of UNGD. 84% of public health studies contain findings that indicate public health hazards, elevated risks, or adverse health outcomes; 69% of water quality studies contain findings that indicate potential, positive association, or actual incidence of water contamination; and 87% of air quality studies contain findings that indicate elevated air pollutant emissions and/or atmospheric concentrations. This paper demonstrates that the weight of the findings in the scientific literature indicates hazards and elevated risks to human health as well as possible adverse health outcomes associated with UNGD. There are limitations to this type of assessment and it is only intended to provide a snapshot of the scientific knowledge based on the available literature. However, this work can be used to identify themes that lie in or across studies, to prioritize future research, and to provide an empirical foundation for policy decisions.	[Hays, Jake] PSE Hlth Energy, New York, NY USA; [Hays, Jake] Weill Cornell Med, Dept Healthcare Policy & Res, New York, NY USA; [Shonkoff, Seth B. C.] PSE Hlth Energy, Oakland, CA USA; [Shonkoff, Seth B. C.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Shonkoff, Seth B. C.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	Cornell University; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Hays, J (corresponding author), PSE Hlth Energy, New York, NY USA.; Hays, J (corresponding author), Weill Cornell Med, Dept Healthcare Policy & Res, New York, NY USA.	hays@psehealthyenergy.org						Adgate JL, 2014, ENVIRON SCI TECHNOL, V48, P8307, DOI 10.1021/es404621d; Bunch AG, 2014, SCI TOTAL ENVIRON, V468, P832, DOI 10.1016/j.scitotenv.2013.08.080; de Melo-Martin I, 2014, SCI TOTAL ENVIRON, V470, P1114, DOI 10.1016/j.scitotenv.2013.10.088; Edwards PM, 2014, NATURE, V514, P351, DOI 10.1038/nature13767; Ethridge S, 2015, J UNCONV OIL GAS RES, V11, P95, DOI 10.1016/j.juogr.2015.06.001; Evensen D, 2014, EXTR IND SOC, V1, P130, DOI 10.1016/j.exis.2014.06.004; Finkel ML, 2016, J EPIDEMIOL COMMUN H, V70, P221, DOI 10.1136/jech-2015-205487; Finkel ML, 2015, MED J AUST, V203; Fry M, 2015, ECOL ECON, V117, P97, DOI 10.1016/j.ecolecon.2015.06.012; Hays J, 2015, SCI TOTAL ENVIRON, V512, P36, DOI 10.1016/j.scitotenv.2015.01.004; Macey GP, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-82; Maryland Institute for Applied Environmental Health, 2014, POT PUBL HLTH IMP NA; McKenzie LM, 2012, SCI TOTAL ENVIRON, V424, P79, DOI 10.1016/j.scitotenv.2012.02.018; MILLS PK, 1984, LANCET, V1, P207; New York State Department of Health, 2014, PUBL HLTH REV HIGH V; Paulik LB, 2015, ENVIRON SCI TECHNOL, V49, P5203, DOI 10.1021/es506095e; Petron G, 2014, J GEOPHYS RES-ATMOS, V119, P6836, DOI 10.1002/2013JD021272; Shonkoff SBC, 2014, ENVIRON HEALTH PERSP, V122, P787, DOI 10.1289/ehp.1307866; Werner AK, 2015, SCI TOTAL ENVIRON, V505, P1127, DOI 10.1016/j.scitotenv.2014.10.084	19	30	31	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0154164	10.1371/journal.pone.0154164	http://dx.doi.org/10.1371/journal.pone.0154164			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096432	Green Submitted, Green Published, gold			2022-12-26	WOS:000374543600087
J	Tabas, A; Siebert, A; Supek, S; Pressnitzer, D; Balaguer-Ballester, E; Rupp, A				Tabas, Alejandro; Siebert, Anita; Supek, Selma; Pressnitzer, Daniel; Balaguer-Ballester, Emili; Rupp, Andre			Insights on the Neuromagnetic Representation of Temporal Asymmetry in Human Auditory Cortex	PLOS ONE			English	Article							TIME-DOMAIN; VIRTUAL PITCH; SINGLE UNITS; GUINEA-PIG; RESPONSES; AMPLITUDE; LATENCY; SPEECH; MODEL; LATERALIZATION	Communication sounds are typically asymmetric in time and human listeners are highly sensitive to this short-term temporal asymmetry. Nevertheless, causal neurophysiological correlates of auditory perceptual asymmetry remain largely elusive to our current analyses and models. Auditory modelling and animal electrophysiological recordings suggest that perceptual asymmetry results from the presence of multiple time scales of temporal integration, central to the auditory periphery. To test this hypothesis we recorded auditory evoked fields (AEF) elicited by asymmetric sounds in humans. We found a strong correlation between perceived tonal salience of ramped and damped sinusoids and the AEFs, as quantified by the amplitude of the N100m dynamics. The N100m amplitude increased with stimulus half-life time, showing a maximum difference between the ramped and damped stimulus for a modulation half-life time of 4 ms which is greatly reduced at 0.5 ms and 32 ms. This behaviour of the N100m closely parallels psychophysical data in a manner that: i) longer half-life times are associated with a stronger tonal percept, and ii) perceptual differences between damped and ramped are maximal at 4 ms half-life time. Interestingly, differences in evoked fields were significantly stronger in the right hemisphere, indicating some degree of hemispheric specialisation. Furthermore, the N100m magnitude was successfully explained by a pitch perception model using multiple scales of temporal integration of auditory nerve activity patterns. This striking correlation between AEFs, perception, and model predictions suggests that the physiological mechanisms involved in the processing of pitch evoked by temporal asymmetric sounds are reflected in the N100m.	[Tabas, Alejandro; Balaguer-Ballester, Emili] Bournemouth Univ, Fac Sci & Technol, Bournemouth, Dorset, England; [Siebert, Anita] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland; [Supek, Selma] Univ Zagreb, Fac Sci, Dept Phys, Zagreb 41000, Croatia; [Pressnitzer, Daniel] Ecole Normale Super, Dept Etud Cognit, 24 Rue Lhomond, F-75231 Paris, France; [Balaguer-Ballester, Emili] Bernstein Ctr Computat Neurosci Heidelberg Mannhe, Mannheim, Baden, Germany; [Rupp, Andre] Heidelberg Univ, Dept Neurol, Heidelberg, Baden Wur, Germany	Bournemouth University; University of Zurich; University of Zagreb; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Ruprecht Karls University Heidelberg	Tabas, A (corresponding author), Bournemouth Univ, Fac Sci & Technol, Bournemouth, Dorset, England.	atabas@bournemouth.ac.uk		Pressnitzer, Daniel/0000-0003-4744-5165; Balaguer-Ballester, Emili/0000-0002-0695-7191	Bournemouth University; Santander Research Mobility Award program; Deutsche Forschungsgemeinschaft [Ru-652/1-3]; Croatian Ministry of Science and Technology [0119265]	Bournemouth University; Santander Research Mobility Award program; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Croatian Ministry of Science and Technology(Ministry of Science, Education and Sports, Republic of Croatia)	AT receives funding from the Bournemouth University Doctoral Fund (bournemouth.ac.uk) and the Santander Research Mobility Award program (santander.co.uk). AR and AS were funded by the Deutsche Forschungsgemeinschaft (dfg.de) Grant Ru-652/1-3. SS was supported by the Croatian Ministry of Science and Technology (public.mzos.hr) Grant 0119265. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain C, 1997, EVOKED POTENTIAL, V104, P531, DOI 10.1016/S0168-5597(97)00057-9; Andermann M, 2011, NEUROIMAGE, V57, P1499, DOI 10.1016/j.neuroimage.2011.05.049; Balaguer-Ballester E, 2008, J ACOUST SOC AM, V124, P2186, DOI 10.1121/1.2967829; Balaguer-Ballester E, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000301; Beagley H A, 1967, J Laryngol Otol, V81, P861, DOI 10.1017/S0022215100067815; Belin P, 1998, J COGNITIVE NEUROSCI, V10, P536, DOI 10.1162/089892998562834; Bendor D, 2006, CURR OPIN NEUROBIOL, V16, P391, DOI 10.1016/j.conb.2006.07.001; BERG P, 1994, ELECTROEN CLIN NEURO, V90, P229, DOI 10.1016/0013-4694(94)90094-9; Biermann S, 2000, J NEUROPHYSIOL, V84, P2426, DOI 10.1152/jn.2000.84.5.2426; Daunizeau J, 2009, NEUROIMAGE, V47, P590, DOI 10.1016/j.neuroimage.2009.04.062; David H. A, 1963, METHOD PAIRED COMP; de Cheveigne A, 2005, SPR HDB AUD, V24, P169; Fishbach A, 2003, J NEUROPHYSIOL, V90, P3663, DOI 10.1152/jn.00654.2003; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Gerstner W, 2014, NEURONAL DYNAMICS: FROM SINGLE NEURONS TO NETWORKS AND MODELS OF COGNITION, P1, DOI 10.1017/CBO9781107447615; Gerstner W, 2002, SPIKING NEURON MODEL; GORDON JW, 1987, J ACOUST SOC AM, V82, P88, DOI 10.1121/1.395441; Grose JH, 2002, J ACOUST SOC AM, V112, P2956, DOI 10.1121/1.1514934; Gutschalk A, 2004, NEUROIMAGE, V22, P755, DOI 10.1016/j.neuroimage.2004.01.025; HALL JW, 1981, J ACOUST SOC AM, V69, P509, DOI 10.1121/1.385480; Happel MFK, 2014, J NEUROSCI, V34, P1234, DOI 10.1523/JNEUROSCI.1990-13.2014; HARTMANN WM, 1978, J ACOUST SOC AM, V63, P1105, DOI 10.1121/1.381818; Irino T, 1997, J ACOUST SOC AM, V101, P412, DOI 10.1121/1.417975; JACOBSON GP, 1992, EAR HEARING, V13, P300, DOI 10.1097/00003446-199210000-00007; Krumbholz K, 2003, CEREB CORTEX, V13, P765, DOI 10.1093/cercor/13.7.765; Kumar S, 2007, PLOS COMPUT BIOL, V3, P977, DOI 10.1371/journal.pcbi.0030100; Kumar S, 2011, J COGNITIVE NEUROSCI, V23, P3084, DOI 10.1162/jocn_a_00021; Lopez-Poveda EA, 2001, J ACOUST SOC AM, V110, P3107, DOI 10.1121/1.1416197; Lu T, 2001, J NEUROPHYSIOL, V85, P2364, DOI 10.1152/jn.2001.85.6.2364; Lutkenhoner B, 1998, AUDIOL NEURO-OTOL, V3, P191, DOI 10.1159/000013790; Meddis R, 1997, J ACOUST SOC AM, V102, P1811, DOI 10.1121/1.420088; Meddis R, 2006, J ACOUST SOC AM, V120, P3861, DOI 10.1121/1.2372595; MORTON J, 1976, PSYCHOL REV, V83, P405, DOI 10.1037/0033-295X.83.5.405; Neuert V, 2001, HEARING RES, V159, P36, DOI 10.1016/S0378-5955(01)00318-5; Okamoto H, 2011, J COGNITIVE NEUROSCI, V23, P1855, DOI 10.1162/jocn.2010.21521; Paquette C, 1997, CORTEX, V33, P689, DOI 10.1016/S0010-9452(08)70726-3; Patterson RD, 1998, J ACOUST SOC AM, V104, P2967, DOI 10.1121/1.423879; Patterson RD, 2002, NEURON, V36, P767, DOI 10.1016/S0896-6273(02)01060-7; PATTERSON RD, 1994, J ACOUST SOC AM, V96, P1409, DOI 10.1121/1.410285; PATTERSON RD, 1995, J ACOUST SOC AM, V98, P1890, DOI 10.1121/1.414456; Patterson RD, 2008, PHILOS T R SOC B, V363, P1023, DOI 10.1098/rstb.2007.2157; Penagos H, 2004, J NEUROSCI, V24, P6810, DOI 10.1523/JNEUROSCI.0383-04.2004; Plack CJ, 2000, J ACOUST SOC AM, V108, P1162, DOI 10.1121/1.1287022; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; Pressnitzer D, 2000, HEARING RES, V149, P155, DOI 10.1016/S0378-5955(00)00175-1; Ragot R, 1996, NEUROREPORT, V7, P905, DOI 10.1097/00001756-199603220-00014; RAPIN I, 1966, ELECTROEN CLIN NEURO, V21, P335, DOI 10.1016/0013-4694(66)90039-3; Ritter S, 2005, NEUROIMAGE, V27, P533, DOI 10.1016/j.neuroimage.2005.05.003; Roberts TPL, 1996, NEUROREPORT, V7, P1138, DOI 10.1097/00001756-199604260-00007; Roberts TPL, 2000, J CLIN NEUROPHYSIOL, V17, P114, DOI 10.1097/00004691-200003000-00002; Rosen S, 1982, PERCEPT PSYCHOPHYS, V31, P462, DOI [10.3758/BF03204856, DOI 10.3758/BF03204856]; Schlauch RS, 2001, J ACOUST SOC AM, V109, P2880, DOI 10.1121/1.1372913; Seither-Preisler A, 2003, AUDIOL NEURO-OTOL, V8, P322, DOI 10.1159/000073517; Seither-Preisler A, 2006, HEARING RES, V213, P88, DOI 10.1016/j.heares.2006.01.003; Stecker GC, 2000, J ACOUST SOC AM, V107, P3358, DOI 10.1121/1.429407; Suied C, 2014, J ACOUST SOC AM, V135, P1380, DOI 10.1121/1.4863659; Tailarach J., 1988, COPLANAR STEREOTAXIC; VOS J, 1981, PERCEPT PSYCHOPHYS, V29, P323, DOI 10.3758/BF03207341; Wang XG, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00114; Wiegrebe L, 2001, J ACOUST SOC AM, V109, P1082, DOI 10.1121/1.1348005; Winter IM, 2005, SPR HDB AUD, V24, P99; Yost WA, 1996, J ACOUST SOC AM, V99, P1066, DOI 10.1121/1.414593	62	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153947	10.1371/journal.pone.0153947	http://dx.doi.org/10.1371/journal.pone.0153947			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9OU	27096960	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000374543600074
J	Wu, F; Wang, PY; Zhao, QL; Kang, LQ; Xia, DG; Qiu, ZY; Tang, SM; Li, MW; Shen, XJ; Zhang, GZ				Wu, Fan; Wang, Pingyang; Zhao, Qiaoling; Kang, Lequn; Xia, Dingguo; Qiu, Zhiyong; Tang, Shunming; Li, Muwang; Shen, Xingjia; Zhang, Guozheng			Mutation of a Cuticle Protein Gene, BmCPG10, Is Responsible for Silkworm Non-Moulting in the 2nd Instar Mutant	PLOS ONE			English	Article							BOMBYX-MORI; ECDYSTEROID BIOSYNTHESIS; BEETLE TENEBRIO; NOPPERA-BO; WING DISCS; EXPRESSION; 20-HYDROXYECDYSONE; DROSOPHILA; SEQUENCE; METAMORPHOSIS	In the silkworm, metamorphosis and moulting are regulated by ecdysone hormone and juvenile hormone. The subject in the present study is a silkworm mutant that does not moult in the 2nd instar (nm2). Genetic analysis indicated that the nm2 mutation is controlled by a recessive gene and is homozygous lethal. Based on positional cloning, nm2 was located in a region approximately 275 kb on the 5th linkage group by eleven SSR polymorphism markers. In this specific range, according to the transcriptional expression of thirteen genes and cloning, the relative expression level of the BmCPG10 gene that encodes a cuticle protein was lower than the expression level of the wild-type gene. Moreover, this gene's structure differs from that of the wild-type gene: there is a deletion of 217 bp in its open reading frame, which resulted in a change in the protein it encoded. The BmCPG10 mRNA was detectable throughout silkworm development from the egg to the moth. This mRNA was low in the premoulting and moulting stages of each instar but was high in the gluttonous stage and in newly exuviated larvae. The BmCPG10 mRNA showed high expression levels in the epidermis, head and trachea, while the expression levels were low in the midgut, Malpighian tubule, prothoracic gland, haemolymph and ventral nerve cord. The ecdysone titre was determined by ELISA, and the results demonstrated that the ecdysone titre of nm2 larvae was lower than that of the wild-type larvae. The nm2 mutant could be rescued by feeding 20-hydroxyecdysone, cholesterol and 7-dehydrocholesterol (7dC), but the rescued nm2 only developed to the 4th instar and subsequently died. The moulting time of silkworms could be delayed by BmCPG10 RNAi. Thus, we speculated that the mutation of BmCPG10 was responsible for the silkworm mutant that did not moult in the 2nd instar.	[Wu, Fan; Wang, Pingyang; Zhao, Qiaoling; Kang, Lequn; Xia, Dingguo; Qiu, Zhiyong; Tang, Shunming; Li, Muwang; Shen, Xingjia; Zhang, Guozheng] Jiangsu Univ Sci & Technol, Sch Biotechnol, Zhenjiang 212018, Peoples R China; [Wu, Fan; Wang, Pingyang; Zhao, Qiaoling; Kang, Lequn; Xia, Dingguo; Qiu, Zhiyong; Tang, Shunming; Li, Muwang; Shen, Xingjia; Zhang, Guozheng] Chinese Acad Agr Sci, Sericulture Res Inst, Zhenjiang 212018, Peoples R China; [Wu, Fan] Hubei Acad Agr Sci, Ind Crops Inst, Wuhan 430064, Peoples R China	Jiangsu University of Science & Technology; Chinese Academy of Agricultural Sciences; Hubei Academy of Agricultural Sciences	Zhao, QL (corresponding author), Jiangsu Univ Sci & Technol, Sch Biotechnol, Zhenjiang 212018, Peoples R China.; Zhao, QL (corresponding author), Chinese Acad Agr Sci, Sericulture Res Inst, Zhenjiang 212018, Peoples R China.	qlzhao302@126.com		Wang, Pingyang/0000-0003-3908-6561	National Natural Science Foundation of China [31372378]; Graduate Student Innovation Program of Jiangsu province [KYLX15-1116]; Graduate Student Innovation Program of Jiangsu University of Science and Technology [YCX14B-03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Graduate Student Innovation Program of Jiangsu province; Graduate Student Innovation Program of Jiangsu University of Science and Technology	This work was supported by grants from the National Natural Science Foundation of China (No. 31372378), the Graduate Student Innovation Program of Jiangsu province (KYLX15-1116) and the Graduate Student Innovation Program of Jiangsu University of Science and Technology in 2014 (YCX14B-03).	ANDERSEN SO, 1979, ANNU REV ENTOMOL, V24, P29, DOI 10.1146/annurev.en.24.010179.000333; APPLE RT, 1991, DEV BIOL, V146, P569, DOI 10.1016/0012-1606(91)90257-4; BANNO Y, 2005, GUIDE SILKWORM MUTAN, P29; Bouhin H., 1993, Insect Molecular Biology, V2, P81, DOI 10.1111/j.1365-2583.1993.tb00128.x; Braquart C, 1996, EUR J BIOCHEM, V240, P336, DOI 10.1111/j.1432-1033.1996.0336h.x; Charles JP, 2010, INSECT BIOCHEM MOLEC, V40, P205, DOI 10.1016/j.ibmb.2009.12.005; Daimon T, 2015, P NATL ACAD SCI USA, V112, pE4226, DOI 10.1073/pnas.1506645112; DOIRA H, 1984, Journal of Sericultural Science of Japan, V53, P427; Enya S, 2015, INSECT BIOCHEM MOLEC, V61, P1, DOI 10.1016/j.ibmb.2015.04.001; Enya S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06586; Fujii T, 2013, INSECT BIOCHEM MOLEC, V43, P594, DOI 10.1016/j.ibmb.2013.03.009; Futahashi R, 2008, INSECT BIOCHEM MOLEC, V38, P1138, DOI 10.1016/j.ibmb.2008.05.007; HIRUMA K, 1991, DEV BIOL, V144, P369, DOI 10.1016/0012-1606(91)90429-7; HORODYSKI FM, 1989, DEV BIOL, V132, P292, DOI 10.1016/0012-1606(89)90226-1; Iconomidou VA, 1999, INSECT BIOCHEM MOLEC, V29, P285, DOI 10.1016/S0965-1748(99)00005-3; Kozlova T, 2003, SCIENCE, V301, P1911, DOI 10.1126/science.1087419; Lemoine A, 2004, INSECT MOL BIOL, V13, P481, DOI 10.1111/j.0962-1075.2004.00508.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Miao XX, 2005, P NATL ACAD SCI USA, V102, P16303, DOI 10.1073/pnas.0507794102; Mousavi A, 2005, APPL BIOCHEM BIOTECH, V120, P169, DOI 10.1385/ABAB:120:3:169; Nita M, 2009, COMP BIOCHEM PHYS B, V153, P101, DOI 10.1016/j.cbpb.2009.02.005; Niwa R, 2010, DEVELOPMENT, V137, P1991, DOI 10.1242/dev.045641; Noji T, 2003, INSECT BIOCHEM MOLEC, V33, P671, DOI 10.1016/S0965-1748(03)00048-1; Okamoto S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-396; Quan GX, 2002, INSECT MOL BIOL, V11, P217, DOI 10.1046/j.1365-2583.2002.00328.x; Riddiford L M, 2000, Vitam Horm, V60, P1, DOI 10.1016/S0083-6729(00)60016-X; SHIMIZU K, 1980, Journal of Sericultural Science of Japan, V49, P7; Shimizu K, 1983, 53RD M JAP SOC SER S, P64; Shimizu K, 1983, J SERICULTURAL SCI J, V52, P348; Soares MPM, 2007, INSECT BIOCHEM MOLEC, V37, P1272, DOI 10.1016/j.ibmb.2007.07.014; Suzuki Y, 2002, INSECT BIOCHEM MOLEC, V32, P599, DOI 10.1016/S0965-1748(01)00136-9; Wang HB, 2009, INSECT BIOCHEM MOLEC, V39, P624, DOI 10.1016/j.ibmb.2009.06.007; Wang HB, 2009, INSECT BIOCHEM MOLEC, V39, P615, DOI 10.1016/j.ibmb.2009.06.008; Willis Judith H., 1996, P253; Xiang Z., 2005, SILK BIOL, P374; Zhao QL, 2000, SCI SERICULTURE, V26, P63; Zhao QL, 2015, SCI SERIC, V41; Zhong YS, 2006, INSECT BIOCHEM MOLEC, V36, P99, DOI 10.1016/j.ibmb.2005.07.005	38	7	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153549	10.1371/journal.pone.0153549	http://dx.doi.org/10.1371/journal.pone.0153549			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096617	Green Published, gold			2022-12-26	WOS:000374543600041
J	Bayani, A; Tiwade, D; Dongre, A; Dongre, AP; Phatak, R; Watve, M				Bayani, Abhijeet; Tiwade, Dilip; Dongre, Ashok; Dongre, Aravind P.; Phatak, Rasika; Watve, Milind			Assessment of Crop Damage by Protected Wild Mammalian Herbivores on the Western Boundary of Tadoba-Andhari Tiger Reserve (TATR), Central India	PLOS ONE			English	Article							LOXODONTA-AFRICANA; LARGE CARNIVORES; ELEPHANTS; CONFLICT; PATTERNS; OVERCOMPENSATION; SUSCEPTIBILITY; CONSERVATION; PERCEPTIONS; LIVESTOCK	Crop raiding by wild herbivores close to an area of protected wildlife is a serious problem that can potentially undermine conservation efforts. Since there is orders of magnitude difference between farmers' perception of damage and the compensation given by the government, an objective and realistic estimate of damage was found essential. We employed four different approaches to estimate the extent of and patterns in crop damage by wild herbivores along the western boundary of Tadoba-Andhari Tiger Reserve in the state of Maharashtra, central India. These approaches highlight different aspects of the problem but converge on an estimated damage of over 50% for the fields adjacent to the forest, gradually reducing in intensity with distance. We found that the visual damage assessment method currently employed by the government for paying compensation to farmers was uncorrelated to and grossly underestimated actual damage. The findings necessitate a radical rethinking of policies to assess, mitigate as well as compensate for crop damage caused by protected wildlife species.	[Bayani, Abhijeet; Tiwade, Dilip; Dongre, Ashok; Dongre, Aravind P.; Watve, Milind] IISER, Dr Homi Bhabha Rd, Pune 411008, Maharashtra, India; [Phatak, Rasika] Abasaheb Garaware Coll, Dept Biodivers, Pune, Maharashtra, India	Indian Institute of Science Education & Research (IISER) Pune	Watve, M (corresponding author), IISER, Dr Homi Bhabha Rd, Pune 411008, Maharashtra, India.	milind@iiserpune.ac.in			NINA (Norwegian Institute for Nature Research); DST (Department of Science and Technology), Government of India; RGSTC (Rajiv Gandhi Science and Technology Commission), State Government of Maharashtra, India; Rajeev Gandhi Science and Technology Commission, Maharashtra State, India	NINA (Norwegian Institute for Nature Research); DST (Department of Science and Technology), Government of India(Department of Science & Technology (India)); RGSTC (Rajiv Gandhi Science and Technology Commission), State Government of Maharashtra, India; Rajeev Gandhi Science and Technology Commission, Maharashtra State, India	Work was partly funded by NINA (Norwegian Institute for Nature Research); DST (Department of Science and Technology), Government of India; and RGSTC (Rajiv Gandhi Science and Technology Commission), State Government of Maharashtra, India.; We acknowledge all the farmers of TATR for their support throughout the study period. The study was partially funded by Rajeev Gandhi Science and Technology Commission, Maharashtra State, India. We also thank Kajol Patel, Manawa Diwekar and Dr. Neelesh Dahanukar from IISER, Pune for helping in manuscript preparation.	Adler PB, 2014, P NATL ACAD SCI USA, V111, P740, DOI 10.1073/pnas.1315179111; *AFESG, 2007, HUM EL CONFL WORK GR; Altrichter H., 2008, TEACHERS INVESTIGATE; Bagchi S, 2006, J ZOOL, V268, P217, DOI 10.1111/j.1469-7998.2005.00030.x; BELSKY AJ, 1993, EVOL ECOL, V7, P109, DOI 10.1007/BF01237737; Bogdan Robert., 2006, QUALITATIVE RES ED I; Buckle AP, 2015, RODENT PESTS AND THEIR CONTROL, 2ND EDITION, P1; Chauhan NPS, 1990, P 14 VERT PEST C U C, P218; Delger Joshua A., 2011, Human-Wildlife Interactions, V5, P32; Dickman AJ, 2010, ANIM CONSERV, V13, P458, DOI 10.1111/j.1469-1795.2010.00368.x; Fernando P, 2005, BIODIVERS CONSERV, V14, P2465, DOI 10.1007/s10531-004-0216-z; Galvin KA, 2006, HUM ECOL, V34, P155, DOI 10.1007/s10745-006-9012-6; Graham MD, 2008, ORYX, V42, P76, DOI 10.1017/S0030605308000677; Graham MD, 2010, SYST BIODIVERS, V8, P435, DOI 10.1080/14772000.2010.533716; Guerbois C, 2012, J APPL ECOL, V49, P1149, DOI 10.1111/j.1365-2664.2012.02192.x; Gureja N, 2002, 6 WILDL TRUST IND NE; Hussain S, 2002, MT RES DEV, V2, P224; INOUYE DW, 1982, OIKOS, V39, P269, DOI 10.2307/3544495; Jackson TR, 2008, ORYX, V42, P83, DOI 10.1017/S0030605308001117; Jayson EA, 1999, STUDY CROP DAMAGE WI, P48; Karanth KK, 2013, BIOL CONSERV, V166, P175, DOI 10.1016/j.biocon.2013.06.027; Karanth KK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050433; KEAR J, 1970, Biological Conservation, V2, P206, DOI 10.1016/0006-3207(70)90110-2; King LE, 2009, AFR J ECOL, V47, P131, DOI 10.1111/j.1365-2028.2009.01114.x; Madden Francine, 2004, Human Dimensions of Wildlife, V9, P247, DOI 10.1080/10871200490505675; Mathur V. B., 2015, 2015004 TR WILDL I I, P1; MCNAUGHTON SJ, 1983, OIKOS, V40, P329, DOI 10.2307/3544305; Mehta D., 2014, THESIS SAURASHTA U G; Milind W, 2016, GLOB ECOL CONSERV, V5, P58, DOI 10.1016/j.gecco.2015.11.012; Mishra C, 1997, ENVIRON CONSERV, V24, P338, DOI 10.1017/S0376892997000441; Naughton-Treves L, 1997, GEOGR REV, V87, P27, DOI 10.2307/215656; Nepal SK, AMBIO, V199, P238; Ogra M, 2008, HUM ECOL, V36, P717, DOI 10.1007/s10745-008-9189-y; Osborn FV, 2002, PACHYDERM, V33, P32; PAIGE KN, 1987, AM NAT, V129, P407, DOI 10.1086/284645; Rangarajan M, 2010, GAJAH SECURING FUTUR, P1; Schwerdtner K, 2007, BIOL CONSERV, V134, P354, DOI 10.1016/j.biocon.2006.08.010; Sethi N, 2003, BATTLE ZONE AFTERWAR; Sillero-Zubiri Claudio, 2006, P253; Sitati N.W., 2003, THESIS U KENT CANTER; Sitati NW, 2005, J APPL ECOL, V42, P1175, DOI 10.1111/j.1365-2664.2005.01091.x; Sukumar R., 1989, ASIAN ELEPHANT ECOLO; Treves Adrian, 2006, Human Dimensions of Wildlife, V11, P383, DOI 10.1080/10871200600984265; Treves A, 2009, CONSERV BIOL, V23, P1577, DOI 10.1111/j.1523-1739.2009.01242.x; Wagner KK, 1997, WILDLIFE SOC B, V25, P312; Woodroffe R., 2005, CONSERV BIOL; Woodroffe R, 2014, SCIENCE, V344, P46, DOI 10.1126/science.1246251; ZADOKS JC, 1985, ANNU REV PHYTOPATHOL, V23, P455, DOI 10.1146/annurev.py.23.090185.002323	48	17	19	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153854	10.1371/journal.pone.0153854	http://dx.doi.org/10.1371/journal.pone.0153854			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093293	Green Published, gold, Green Submitted			2022-12-26	WOS:000374541200051
J	Habib, S; El Andaloussi, A; Hisham, A; Ismail, N				Habib, Samar; El Andaloussi, Abdeljabar; Hisham, Ahmed; Ismail, Nahed			NK Cell-Mediated Regulation of Protective Memory Responses against Intracellular Ehrlichial Pathogens	PLOS ONE			English	Article							SHOCK-LIKE-SYNDROME; INDUCED TOXIC-SHOCK; CD4 T-CELLS; MONOCYTOTROPIC EHRLICHIOSIS; ANIMAL-MODEL; CYTOMEGALOVIRUS-INFECTION; FATAL EHRLICHIOSIS; ADAPTIVE IMMUNITY; RECALL RESPONSES; IFN-GAMMA	Ehrlichiae are gram-negative obligate intracellular bacteria that cause potentially fatal human monocytic ehrlichiosis. We previously showed that natural killer (NK) cells play a critical role in host defense against Ehrlichia during primary infection. However, the contribution of NK cells to the memory response against Ehrlichia remains elusive. Primary infection of C57BL/6 mice with Ehrlichia muris provides long-term protection against a second challenge with the highly virulent Ixodes ovatus Ehrlichia (IOE), which ordinarily causes fatal disease in naive mice. Here, we show that the depletion of NK cells in E. muris-primed mice abrogates the protective memory response against IOE. Approximately, 80% of NK cell-depleted E. muris-primed mice succumbed to lethal IOE infection on days 8-10 after IOE infection, similar to naive mice infected with the same dose of IOE. The lack of a recall response in NK cell-depleted mice correlated with an increased bacterial burden, extensive liver injury, decreased frequency of Ehrlichia-specific IFN-gamma-producing memory CD4(+) and CD8(+) T-cells, and a low titer of Ehrlichia-specific antibodies. Intraperitoneal infection of mice with E. muris resulted in the production of IL-15, IL-12, and IFN-gamma as well as an expansion of activated NKG2D(+) NK cells. The adoptive transfer of purified E. muris-primed hepatic and splenic NK cells into Rag2(-/-)Il2rg(-/-) recipient mice provided protective immunity against challenge with E. muris. Together, these data suggest that E. muris-induced memory-like NK cells, which contribute to the protective, recall response against Ehrlichia.	[Hisham, Ahmed; Ismail, Nahed] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA; [Habib, Samar; El Andaloussi, Abdeljabar] Augusta Univ, Med Coll Georgia, Dept Obstet & Gynecol, Augusta, GA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Georgia; Augusta University	Ismail, N (corresponding author), Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA.	ismailn@upmc.edu	Habib, Samar/AAM-1716-2021	Habib, Samar/0000-0002-0690-8277	NIH/NIAID, National Institute of Allergy and Infectious Diseases [1R56AI097679-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI097679] Funding Source: NIH RePORTER	NIH/NIAID, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding provided by NIH/NIAID: 1R56AI097679-01, National Institute of Allergy and Infectious Diseases, PI; NI.	Achour A, 2014, J IMMUNOL, V192, P503, DOI 10.4049/jimmunol.1301951; Allen MB, 2014, J CLIN MICROBIOL, V52, P4102, DOI 10.1128/JCM.01670-14; Alsharifi M, 2008, IMMUNOL CELL BIOL, V86, P239, DOI 10.1038/sj.icb.7100159; Arase N, 2003, J IMMUNOL, V170, P3054, DOI 10.4049/jimmunol.170.6.3054; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Bakken Johan S., 2006, Morbidity and Mortality Weekly Report, V55, P1; Bellora F, 2014, IMMUNOL LETT, V161, P168, DOI 10.1016/j.imlet.2013.12.009; Bigley AB, 2012, BRAIN BEHAV IMMUN, V26, P177, DOI 10.1016/j.bbi.2011.09.004; Bitsaktsis C, 2004, J IMMUNOL, V172, P6894, DOI 10.4049/jimmunol.172.11.6894; Bitsaktsis C, 2007, INFECT IMMUN, V75, P4933, DOI 10.1128/IAI.00705-07; Bitsaktsis C, 2006, J IMMUNOL, V177, P4644, DOI 10.4049/jimmunol.177.7.4644; Carbone T, 2010, J IMMUNOL, V184, P1102, DOI 10.4049/jimmunol.0902518; Chattoraj P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058514; Dou YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121258; Gasteiger G, 2014, NAT REV IMMUNOL, V14, P631, DOI 10.1038/nri3726; Ghose P, 2011, J IMMUNOL, V187, P1333, DOI 10.4049/jimmunol.1100092; Hendricks DW, 2015, CURR TOP MICROBIOL I; Ismail N, 2005, ANN NY ACAD SCI, V1063, P383, DOI 10.1196/annals.1355.070; Ismail N, 2006, INFECT IMMUN, V74, P1846, DOI 10.1128/IAI.74.3.1846-1856.2006; Ismail N, 2004, J IMMUNOL, V172, P1786, DOI 10.4049/jimmunol.172.3.1786; Ismail N, 2007, INFECT IMMUN, V75, P4608, DOI 10.1128/IAI.00198-07; Ismail N, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-26; Ismail N, 2010, CLIN LAB MED, V30, P261, DOI 10.1016/j.cll.2009.10.004; Kalia V, 2006, CURR OPIN IMMUNOL, V18, P255, DOI 10.1016/j.coi.2006.03.020; Lanier LL, 2013, NAT REV IMMUNOL, V13, P73, DOI 10.1038/nri3389; Lassen MG, 2010, J IMMUNOL, V184, P2693, DOI 10.4049/jimmunol.0901362; Leavy O, 2013, NAT REV IMMUNOL, V13, P848, DOI 10.1038/nri3571; Leavy O, 2013, NAT REV IMMUNOL, V13, P394, DOI 10.1038/nri3471; Lee J, 2015, IMMUNITY, V42, P431, DOI 10.1016/j.immuni.2015.02.013; Min-Oo G, 2014, J EXP MED, V211, P1289, DOI 10.1084/jem.20132459; Moraru M, 2015, J IMMUNOL, V195, P1676, DOI 10.4049/jimmunol.1500872; Olano JP, 2004, AM J PATHOL, V165, P997, DOI 10.1016/S0002-9440(10)63361-5; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Romee R, 2012, BLOOD, V120, P4751, DOI 10.1182/blood-2012-04-419283; Singh AK, 2014, INFECT IMMUN, V82, P4092, DOI 10.1128/IAI.02101-14; Stevenson HL, 2008, INFECT IMMUN, V76, P1434, DOI 10.1128/IAI.01242-07; Stevenson HL, 2006, INFECT IMMUN, V74, P4856, DOI 10.1128/IAI.00246-06; Stevenson HL, 2010, AM J PATHOL, V177, P766, DOI 10.2353/ajpath.2010.091110; Strutt TM, 2011, ADV EXP MED BIOL, V780, P57, DOI 10.1007/978-1-4419-5632-3_6; Sun JC, 2011, J IMMUNOL, V186, P1891, DOI 10.4049/jimmunol.1003035; Thirumalapura NR, 2008, INFECT IMMUN, V76, P1920, DOI 10.1128/IAI.01293-07; Thirumalapura NR, 2009, INFECT IMMUN, V77, P5682, DOI 10.1128/IAI.00720-09; Walker David H, 2004, Trans Am Clin Climatol Assoc, V115, P375; Walker DH, 2008, MED CLIN N AM, V92, P1345, DOI 10.1016/j.mcna.2008.06.002; Yang Q, 2014, AM J PATHOL; Yang Q, 2015, AM J PATHOL, V185, P446, DOI 10.1016/j.ajpath.2014.10.005; Yang Q, 2013, INFECT IMMUN, V81, P1751, DOI 10.1128/IAI.01409-12; Zhang TX, 2013, J IMMUNOL, V190, P1402, DOI 10.4049/jimmunol.1203034; Zhu B, 2009, INFECT IMMUN, V77, P4243, DOI 10.1128/IAI.00376-09	50	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153223	10.1371/journal.pone.0153223	http://dx.doi.org/10.1371/journal.pone.0153223			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27092553	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000374541200016
J	Krsulovic, FAM; Lima, M				Maurin Krsulovic, Felipe Augusto; Lima, Mauricio			Tuberculosis Epidemiology at the Country Scale: Self-Limiting Process and the HIV Effects	PLOS ONE			English	Article							DYNAMICS; HISTORY; AFRICA; AGE	Background The global spread of the human immunodeficiency virus (HIV) is the main hypothesis behind tuberculosis (TB) positive trends in the last decades, according to modeling studies and World Health Organization Reports (WHO). On one hand, TB (WHO) reports do not explicitly consider a modeling approach, but cover country and global TB trends. On the other hand, modeling studies usually do not cover the scale of WHO reports, because of the amount of parameters estimated to describe TB natural history. Here we combined these two principal sources of TB studies covering TB High Burden Countries (HBCs) dynamics. Our main goals were: (i) to detect the endogenous component of TB dynamics since 1974 for TB HBCs; and (ii) to explore the HIV exogenous effects on TB models' parameters. Methods and Findings We explored the relationship between the TB per capita population rate of change (R-I) and the infectious class size following an endogenous/exogenous framework. R-I can be affected by intra-population processes (i.e. competition, predation) and exogenous variables like HIV. We found that TB dynamics had always a strong endogenous component, represented by a negative correlation between TB population size and R-I, which was captured by the discrete logistic model. Moreover, we explored the HIV exogenous effects on TB models' parameters. We found that overall the TB+HIV logistic model was more parsimonious than TB model alone, principally in the African region. Our results showed that HIV affected principally TB carrying capacity, as expected by the known HIV effects on TB natural-history. We also tested if DOTS (Directly Observed Treatment Short-Course Strategy), poverty levels and BCG (Bacillus Calmette-Guerin) coverage explained the models' residuals variances, but they did not. Conclusions Since 1974, TB dynamics were categorized in distinct chronological domains, with different dynamics but nearly the same underlying mechanism: a negative relationship between RI and infected class size (i.e. self-limiting). In the last decades, not only HIV spread represented a new TB chronological domain, but it also has been pushing TB carrying capacity (K) to higher levels. TB has a complex natural-history and imposes real challenges to model its dynamics. Yet, we were able to explore and reveal the main drivers of TB dynamics for HBCs since 1974, through a simple approach. Based on our results, we suggest that the endogenous view should be considered as a plausible hypothesis to model and explain TB dynamics and that future World Health Organization reports could include the endogenous/exogenous framework as a supplement to help to decipher the main drivers of TB dynamics and other diseases.	[Maurin Krsulovic, Felipe Augusto; Lima, Mauricio] Pontificia Univ Catolica Chile, Alameda 340, Santiago, Chile	Pontificia Universidad Catolica de Chile	Krsulovic, FAM (corresponding author), Pontificia Univ Catolica Chile, Alameda 340, Santiago, Chile.	famk@globo.com	Krsulovic, Felipe Augusto/V-6337-2018; Lima, Mauricio/F-2722-2013	Krsulovic, Felipe Augusto/0000-0002-8260-1074; Lima, Mauricio/0000-0002-3700-2945	CONICYT; Pontificia Universidad Catolica de Chile; Fondo Basal-CONICYT grant [FB- 0002]; Proyecto Fondecyt Regular [1141164]	CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Pontificia Universidad Catolica de Chile; Fondo Basal-CONICYT grant; Proyecto Fondecyt Regular(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	FAMK was supported by PhD scholarships from CONICYT and Pontificia Universidad Catolica de Chile. ML was supported by Fondo Basal-CONICYT grant FB- 0002 and Proyecto Fondecyt Regular 1141164.; FAMK was supported by PhD scholarships from CONICYT and Pontificia Universidad Catolica de Chile. Disease data and other variables were obtained from World Health Organization reports, World Bank, UNAIDS, Gapminder and UN web site. ML was supported by Fondo Basal-CONICYT grant FB- 0002 and Proyecto Fondecyt Regular 1141164.	Acemoglu D, 2010, ECON HIST DEV REG, V25, P21, DOI 10.1080/20780389.2010.505010; Allee CW, 1931, ANIMAL AGGREGATIONS; Anderson R, 1999, INFECT DIS HUMANS DY; [Anonymous], 1988, NONLINEAR REGRESSION, DOI DOI 10.1002/9780470316757; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Aziz MA, 2006, LANCET, V368, P2142, DOI 10.1016/S0140-6736(06)69863-2; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Banerjee A, 2005, AM ECON REV, V95, P1190, DOI 10.1257/0002828054825574; Bartlett M.S., 1956, P 3 BERK S MATH STAT, P81, DOI DOI 10.2307/2342553; Berryman A., 1999, PRINCIPLES POPULATIO; Berryman AA, 1992, ECOLOGY, P73; Berryman A, 2006, AM NAT, V168, P784, DOI 10.1086/508670; BLOWER SM, 1995, NAT MED, V1, P815, DOI 10.1038/nm0895-815; Blower SM, 1996, SCIENCE, V273, P497, DOI 10.1126/science.273.5274.497; Broutin H, 2010, P R SOC B, P277; Castillo-Chavez C, 1997, J MATH BIOL, P35; Colijn C, 2006, P TRIM, V20; Croissant A., 2009, ASIEN, V110, P13; Davies PDO, 2003, ANN MED, V35, P235, DOI 10.1080/07853890310005713; DeRiemer K, 2007, AM J RESP CRIT CARE, P176; Dowdy DW, 2009, B WORLD HEALTH ORGAN, V87, P296, DOI 10.2471/BLT.08.054510; Dye C, 2003, SCIENCE, P328; Gupta R, 2010, SCIENCE, P293; Lima M, 2002, ECOL LETT, P5; Lima M, 2009, ECOL LETT, V12, P302, DOI 10.1111/j.1461-0248.2009.01289.x; Nico JD, 2002, B WORLD HEALTH ORGAN, P80; Pawlowski A, 2012, PLOS PATHOG, P8; Perelson AS, 1999, SIAM REV, V41, P3, DOI 10.1137/S0036144598335107; Perelson AS, 1997, REV MOD PHYS, V69, P1219, DOI 10.1103/RevModPhys.69.1219; Perelson AS, 2002, NATURE, P2; Royama T., 1992, ANAL POPULATION ECOL; Stenseth NC, 2004, P ROY SOC B-BIOL SCI, V271, P1985, DOI 10.1098/rspb.2004.2794; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Thorne C., 2011, ELIMINATION MOTHER T; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; Vynnycky E, 1997, EPIDEMIOL INFECT, V119, P183, DOI 10.1017/S0950268897007917; Vynnycky E, 1997, INT J TUBERC LUNG D, V1, P389; *WHO, 2009, GLOB TUB CONTR SHORT; Wirth T., 2008, PLOS PATHOG, V4, P1; World Health Organization, 1995, BRIDG THE GAPS; World Health Organization, 2009, WHO HTM HIV; World Health Organization, 2009, GLOB TUB REP 2013; World Health Organization, 2009, GLOB PLAN STOP TB 20	43	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153710	10.1371/journal.pone.0153710	http://dx.doi.org/10.1371/journal.pone.0153710			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093296	Green Published, gold, Green Submitted			2022-12-26	WOS:000374541200041
J	Zou, SM; Fei, C; Song, JM; Bao, YC; He, ML; Wang, CH				Zou, Shanmei; Fei, Cong; Song, Jiameng; Bao, Yachao; He, Meilin; Wang, Changhai			Combining and Comparing Coalescent, Distance and Character-Based Approaches for Barcoding Microalgaes: A Test with Chlorella-Like Species (Chlorophyta)	PLOS ONE			English	Article							PLANT DNA BARCODES; GEN. NOV TREBOUXIOPHYCEAE; COMPARATIVE PHYSIOLOGY; MITOCHONDRIAL GENOME; INTEGRATIVE APPROACH; EVOLUTIONARY TRENDS; MOLECULAR PHYLOGENY; MAXIMUM-LIKELIHOOD; SINGLE-LOCUS; TAXONOMY	Several different barcoding methods of distinguishing species have been advanced, but which method is the best is still controversial. Chlorella is becoming particularly promising in the development of second-generation biofuels. However, the taxonomy of Chlorella-like organisms is easily confused. Here we report a comprehensive barcoding analysis of Chlorella-like species from Chlorella, Chloroidium, Dictyosphaerium and Actinastrum based on rbcL, ITS, tufA and 16S sequences to test the efficiency of traditional barcoding, GMYC, ABGD, PTP, P ID and character-based barcoding methods. First of all, the barcoding results gave new insights into the taxonomic assessment of Chlorella-like organisms studied, including the clear species discrimination and resolution of potentially cryptic species complexes in C. sorokiniana, D. ehrenbergianum and C. Vulgaris. The tufA proved to be the most efficient barcoding locus, which thus could be as potential "specific barcode" for Chlorella-like species. The 16S failed in discriminating most closely related species. The resolution of GMYC, PTP, P ID, ABGD and character-based barcoding methods were variable among rbcL, ITS and tufA genes. The best resolution for species differentiation appeared in tufA analysis where GMYC, PTP, ABGD and character-based approaches produced consistent groups while the PTP method over-split the taxa. The character analysis of rbcL, ITS and tufA sequences could clearly distinguish all taxonomic groups respectively, including the potentially cryptic lineages, with many character attributes. Thus, the character-based barcoding provides an attractive complement to coalescent and distance-based barcoding. Our study represents the test that proves the efficiency of multiple DNA barcoding in species discrimination of microalgaes.	[Zou, Shanmei; Fei, Cong; Song, Jiameng; Bao, Yachao; He, Meilin; Wang, Changhai] Nanjing Agr Univ, Coll Resources & Environm Sci, Jiangsu Prov Key Lab Marine Biol, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University	Wang, CH (corresponding author), Nanjing Agr Univ, Coll Resources & Environm Sci, Jiangsu Prov Key Lab Marine Biol, Nanjing 210095, Jiangsu, Peoples R China.	chwang@njau.edu.cn		Fei, Cong/0000-0002-7156-1230	China Postdoctoral Science Foundation [2014M561661, 2015T80558]; Natural Science Fund project in Jiangsu Province [BK20150680]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Fund project in Jiangsu Province	The financial support was from the China Postdoctoral Science Foundation ( 2014M561661, 2015T80558), and Natural Science Fund project in Jiangsu Province ( BK20150680). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RA, 2005, ALGAL CULTURING TECH; Andreyeva VM, 1975, ROD CHLORELLA MORFOL; Ashfaq M, 2013, MOL ECOL RESOUR, V13, P573, DOI 10.1111/1755-0998.12089; Avise J.C., 1990, Oxford Surveys in Evolutionary Biology, V7, P45; AVISE JC, 1989, TRENDS ECOL EVOL, V4, P279, DOI 10.1016/0169-5347(89)90203-6; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Bashan Y, 2015, J APPL PHYCOL, P1; BAUM D, 1992, TRENDS ECOL EVOL, V7, P1, DOI 10.1016/0169-5347(92)90187-G; BAUM DA, 1995, MONOG SYST BOTAN, V53, P289; BAUM DA, 1995, SYST BOT, V20, P560, DOI 10.2307/2419810; Bergmann T, 2009, BERL MUNCH TIERARZTL, V122, P446, DOI 10.2376/0005-9366-122-446; Bertolazzi P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S7; Bock C, 2011, FOTTEA, V11, P293, DOI 10.5507/fot.2011.028; Bock C, 2011, J PHYCOL, V47, P638, DOI 10.1111/j.1529-8817.2011.00989.x; Bock C, 2010, EUR J PHYCOL, V45, P267, DOI 10.1080/09670262.2010.487920; Burja AM, 2001, FEMS MICROBIOL LETT, V202, P195, DOI 10.1016/S0378-1097(01)00306-8; Carstens BC, 2007, SYST BIOL, V56, P400, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Chakraborty C, 2014, APPL MICROBIOL BIOT, V98, P3425, DOI 10.1007/s00253-014-5550-9; Chase MW, 2009, SCIENCE, V325, P682, DOI 10.1126/science.1176906; Damm S, 2010, MOL ECOL, V19, P3881, DOI 10.1111/j.1365-294X.2010.04720.x; Darienko T, 2010, EUR J PHYCOL, V45, P79, DOI 10.1080/09670260903362820; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Dong WP, 2014, MOL ECOL RESOUR, V14, P336, DOI 10.1111/1755-0998.12185; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Esselstyn JA, 2012, P ROY SOC B-BIOL SCI, V279, P3678, DOI 10.1098/rspb.2012.0705; Evans KM, 2007, PROTIST, V158, P349, DOI 10.1016/j.protis.2007.04.001; Ezard T, 2009, PACKAGE SPLITS SPECI; Fama P, 2002, J PHYCOL, V38, P1040, DOI 10.1046/j.1529-8817.2002.t01-1-01237.x; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; Ferri E, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-1; FitzJohn RG, 2010, SYST BIOL, V59, P619, DOI 10.1093/sysbio/syq053; Fontaneto D, 2014, MAR BIODIV UNPUB, P1; Fucikova K, 2013, NOVA HEDWIGIA, V96, P15, DOI 10.1127/0029-5035/2012/0067; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Gernhard T, 2008, J MATH BIOL, V57, P713, DOI 10.1007/s00285-008-0186-y; Goldstein PZ, 2011, BIOESSAYS, V33, P135, DOI 10.1002/bies.201000036; Goldstein PZ, 2000, CLADISTICS, V16, P364, DOI 10.1111/j.1096-0031.2000.tb00356.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hall JD, 2010, CRYPTOGAMIE ALGOL, V31, P529; Hamilton CA, 2014, MOL PHYLOGENET EVOL, V71, P79, DOI 10.1016/j.ympev.2013.11.007; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hudson RR, 2002, EVOLUTION, V56, P1557, DOI 10.1111/j.0014-3820.2002.tb01467.x; HUSS VAR, 1990, J MOL EVOL, V31, P432, DOI 10.1007/BF02106057; HUSS VAR, 1989, ARCH MICROBIOL, V152, P512, DOI 10.1007/BF00446939; Huss VAR, 1999, J PHYCOL, V35, P587, DOI 10.1046/j.1529-8817.1999.3530587.x; Jaen-Molina R, 2015, MOL ECOL RESOUR, V15, P42, DOI 10.1111/1755-0998.12292; Jiang Y, 2011, J MED PLANTS RES, V5, P6413, DOI 10.5897/JMPR11.545; Joly S, 2014, MOL ECOL RESOUR, V14, P221, DOI 10.1111/1755-0998.12173; KAPAUN E, 1995, PLANTA, V197, P577; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kekkonen M, 2014, MOL ECOL RESOUR, V14, P706, DOI 10.1111/1755-0998.12233; KESSLER E, 1992, J PHYCOL, V28, P550, DOI 10.1111/j.0022-3646.1992.00550.x; KESSLER E, 1976, PLANT SYST EVOL, V125, P129, DOI 10.1007/BF00986146; Kessler E, 1982, PROGR PHYCOLOGICA RE, P111; Kessler E, 1984, SYSTEMATICS GREEN AL, V27, P391; Khaybullina LS, 2010, FOTTEA, V10, P201, DOI 10.5507/fot.2010.011; Kizirian D, 2004, MOL PHYLOGENET EVOL, V32, P1072, DOI 10.1016/j.ympev.2004.05.001; Komarek J., 1983, PHYTOPLANKTON SUSSWA; Krawczyk K, 2014, MOL ECOL RESOUR, V14, P272, DOI 10.1111/1755-0998.12175; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Krienitz L, 2004, PHYCOLOGIA, V43, P529, DOI 10.2216/i0031-8884-43-5-529.1; Krienitz L, 2015, TRENDS PLANT SCI, V20, P67, DOI 10.1016/j.tplants.2014.11.005; Krienitz L, 2012, FOTTEA, V12, P231, DOI 10.5507/fot.2012.017; Kumar S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-357; Kvist S, 2013, MOL PHYLOGENET EVOL, V69, P39, DOI 10.1016/j.ympev.2013.05.012; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Li M, 2011, J SYST EVOL, V49, P271, DOI 10.1111/j.1759-6831.2011.00132.x; Li XW, 2015, BIOL REV, V90, P157, DOI 10.1111/brv.12104; Little DP, 2007, CLADISTICS, V23, P1, DOI 10.1111/j.1096-0031.2006.00126.x; Lou M, 2010, MOL PHYLOGENET EVOL, V56, P187, DOI 10.1016/j.ympev.2010.01.002; Luo W, 2010, PLANT BIOLOGY, V12, P545, DOI 10.1111/j.1438-8677.2009.00221.x; Luo W, 2006, PROTIST, V157, P315, DOI 10.1016/j.protis.2006.05.006; Ma S, 2015, HYDROBIOLOGIA, P1; Maddison WP, 2005, MACCLADE ANAL PHYLOG; Masters BC, 2011, MOL ECOL RESOUR, V11, P154, DOI 10.1111/j.1755-0998.2010.02896.x; McDevit DC, 2010, PHYCOLOGIA, V49, P235, DOI 10.2216/PH09-36.1; Meier R, 2008, SYST ASSOC SPEC VOL, V76, P95; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Miralles A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068242; Nemcova Yvonne, 2000, Archiv fuer Hydrobiologie Supplement, V136, P95; Neustupa J, 2013, PHYCOLOGIA, V52, P411, DOI 10.2216/13-142.2; Neustupa J, 2013, INT J SYST EVOL MICR, V63, P377, DOI 10.1099/ijs.0.047944-0; Nozaki H, 1995, JSMRS, V11, P11; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paz A, 2012, J BIOSCIENCES, V37, P887, DOI 10.1007/s12038-012-9255-x; Pettengill JB, 2010, AM J BOT, V97, P1391, DOI 10.3732/ajb.0900176; Phukan MM, 2011, APPL ENERG, V88, P3307, DOI 10.1016/j.apenergy.2010.11.026; Pombert JF, 2006, CURR GENET, V50, P137, DOI 10.1007/s00294-006-0076-z; Pombert JF, 2004, MOL BIOL EVOL, V21, P922, DOI 10.1093/molbev/msh099; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Proschold T, 2011, ENVIRON MICROBIOL, V13, P350, DOI 10.1111/j.1462-2920.2010.02333.x; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; R Core Team, 2021, R LANGUAGE ENV STAT; Rach J, 2008, PROY SOC LOND B, V275; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Reid BN, 2011, MOL ECOL RESOUR, V11, P956, DOI 10.1111/j.1755-0998.2011.03032.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Safi C, 2014, RENEW SUST ENERG REV, V35, P265, DOI 10.1016/j.rser.2014.04.007; Sarkar IN, 2008, MOL ECOL RESOUR, V8, P1256, DOI 10.1111/j.1755-0998.2008.02235.x; Sauer J, 2012, CLADISTICS, V28, P300, DOI 10.1111/j.1096-0031.2011.00382.x; Saunders GW, 2010, CRYPTOGAMIE ALGOL, V31, P487; Saunders GW, 2005, PHILOS T R SOC B, V360, P1879, DOI 10.1098/rstb.2005.1719; SIMPSON GG, 1951, EVOLUTION, V5, P285, DOI 10.2307/2405675; Skaloud P, 2014, FOTTEA, V14, P53, DOI 10.5507/fot.2014.004; Summerer M, 2008, J PHYCOL, V44, P77, DOI 10.1111/j.1529-8817.2007.00455.x; Sun Xue, 2009, Journal of Fisheries of China, V33, P565; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Talavera G, 2013, METHODS ECOL EVOL, V4, P1101, DOI 10.1111/2041-210X.12107; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tokusoglu O, 2003, J FOOD SCI, V68, P1144, DOI 10.1111/j.1365-2621.2003.tb09615.x; Turmel M, 2002, P NATL ACAD SCI USA, V99, P11275, DOI 10.1073/pnas.162203299; Watanabe S., 1996, P1; Waugh J, 2007, BIOESSAYS, V29, P188, DOI 10.1002/bies.20529; Weiss M, 2014, HYDROBIOLOGIA, V721, P165, DOI 10.1007/s10750-013-1658-7; Xu H, 2006, J BIOTECHNOL, V126, P499, DOI 10.1016/j.jbiotec.2006.05.002; Yang JB, 2012, MOL ECOL RESOUR, V12, P267, DOI 10.1111/j.1755-0998.2011.03095.x; Yassin A, 2010, MOL PHYLOGENET EVOL, V57, P509, DOI 10.1016/j.ympev.2010.08.020; Yu ZZ, 2015, MAR BIOTECHNOL, V17, P55, DOI 10.1007/s10126-014-9596-6; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; Zou S, 2010, PLOS ONE, V6; Zou S, 2012, PLOS ONE, V7, pe4727	127	30	30	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153833	10.1371/journal.pone.0153833	http://dx.doi.org/10.1371/journal.pone.0153833			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27092945	Green Published, gold, Green Submitted			2022-12-26	WOS:000374541200048
J	Toth, R; Sperling, D; Madabhushi, A				Toth, Robert; Sperling, Dan; Madabhushi, Anant			Quantifying Post-Laser Ablation Prostate Therapy Changes on MRI via a Domain-Specific Biomechanical Model: Preliminary Findings	PLOS ONE			English	Article							DEFORMABLE REGISTRATION; FOCAL THERAPY; ACCURACY; RADIOTHERAPY; SENSITIVITY; SIMULATION; IMAGES; MOTION	Focal laser ablation destroys cancerous cells via thermal destruction of tissue by a laser. Heat is absorbed, causing thermal necrosis of the target region. It combines the aggressive benefits of radiation treatment (destroying cancer cells) without the harmful side effects (due to its precise localization). MRI is typically used pre-treatment to determine the targeted area, and post-treatment to determine efficacy by detecting necrotic tissue, or tumor recurrence. However, no system exists to quantitatively evaluate the post-treatment effects on the morphology and structure via MRI. To quantify these changes, the pre- and post-treatment MR images must first be spatially aligned. The goal is to quantify (a) laser-induced shape-based changes, and (b) changes in MRI parameters post-treatment. The shapebased changes may be correlated with treatment efficacy, and the quantitative effects of laser treatment over time is currently poorly understood. This work attempts to model changes in gland morphology following laser treatment due to (1) patient alignment, (2) changes due to surrounding organs such as the bladder and rectum, and (3) changes due to the treatment itself. To isolate the treatment-induced shape-based changes, the changes from (1) and (2) are first modeled and removed using a finite element model (FEM). A FEM models the physical properties of tissue. The use of a physical biomechanical model is important since a stated goal of this work is to determine the physical shape-based changes to the prostate from the treatment, and therefore only physical real deformations are to be allowed. A second FEM is then used to isolate the physical, shape-based, treatmentinduced changes. We applied and evaluated our model in capturing the laser induced changes to the prostate morphology on eight patients with 3.0 Tesla, T2-weighted MRI, acquired approximately six months following treatment. Our results suggest the laser treatment causes a decrease in prostate volume, which appears to manifest predominantly at the site of ablation. After spatially aligning the images, changes to MRI intensity values are clearly visible at the site of ablation. Our results suggest that our new methodology is able to capture and quantify the degree of laser-induced changes to the prostate. The quantitative measurements reflecting of the deformation changes can be used to track treatment response over time.	[Toth, Robert; Madabhushi, Anant] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Toth, Robert] Toth Technol LLC, Long Valley, NJ USA; [Sperling, Dan] Sperling Prostate Ctr, New York, NY USA	Case Western Reserve University	Toth, R (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.; Toth, R (corresponding author), Toth Technol LLC, Long Valley, NJ USA.	robtoth@tothtechnology.com	Madabhushi, Anant/AAG-2908-2019	Madabhushi, Anant/0000-0002-5741-0399	National Cancer Institute of the National Institutes of Health [1U24CA199374-01, R21CA167811-01, R21CA179327-01, R21CA195152-01]; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK098503-02]; DOD Prostate Cancer Synergistic Idea Development Award [PC120857]; DOD Lung Cancer Idea Development New Investigator Award [LC130463]; DOD Prostate Cancer Idea Development Award; Ohio Third Frontier Technology development Grant; CTSC Coulter Annual Pilot Grant; Case Comprehensive Cancer Center Pilot Grant; VelaSano Grant from the Cleveland Clinic; Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering at Case Western Reserve University; NATIONAL CANCER INSTITUTE [R21CA179327, U24CA199374, R21CA195152, R01CA202752, R21CA167811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098503] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); DOD Prostate Cancer Synergistic Idea Development Award; DOD Lung Cancer Idea Development New Investigator Award; DOD Prostate Cancer Idea Development Award; Ohio Third Frontier Technology development Grant; CTSC Coulter Annual Pilot Grant; Case Comprehensive Cancer Center Pilot Grant; VelaSano Grant from the Cleveland Clinic; Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering at Case Western Reserve University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under award numbers 1U24CA199374-01, R21CA167811-01, R21CA179327-01; R21CA195152-01, the National Institute of Diabetes and Digestive and Kidney Diseases under award number R01DK098503-02, the DOD Prostate Cancer Synergistic Idea Development Award (PC120857); the DOD Lung Cancer Idea Development New Investigator Award (LC130463), the DOD Prostate Cancer Idea Development Award; the Ohio Third Frontier Technology development Grant, the CTSC Coulter Annual Pilot Grant, the Case Comprehensive Cancer Center Pilot Grant, VelaSano Grant from the Cleveland Clinic, the Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering at Case Western Reserve University. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Benzley S., 1995, INT MESH ROUNDT, V17, P1; Boubaker MB, 2009, J BIOMECH, V42, P1862, DOI 10.1016/j.jbiomech.2009.05.022; Brock KK, 2008, MED PHYS, V35, P4019, DOI 10.1118/1.2965263; Chi Y, 2006, MED PHYS, V33, P421, DOI 10.1118/1.2163838; Colin P, 2012, ADV UROL, V2012, DOI 10.1155/2012/589160; Crouch JR, 2007, IEEE T MED IMAGING, V26, P1379, DOI 10.1109/TMI.2007.898810; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Eggener S, 2010, EUR UROL, V58, P57, DOI 10.1016/j.eururo.2010.03.034; Foltz WD, 2013, J MAGN RESON IMAGING, V37, P909, DOI 10.1002/jmri.23885; Hensel JM, 2007, INT J RADIAT ONCOL, V68, P1522, DOI 10.1016/j.ijrobp.2007.04.004; Karacali B, 2006, IEEE T MED IMAGING, V25, P649, DOI 10.1109/TMI.2006.873221; Kitamura K, 2002, RADIOTHER ONCOL, V62, P275, DOI 10.1016/S0167-8140(02)00017-8; Kyriacou SK, 1999, IEEE T MED IMAGING, V18, P580, DOI 10.1109/42.790458; Lindner U, 2010, NAT REV UROL, V7, P562, DOI 10.1038/nrurol.2010.142; Lindner U, 2010, EUR UROL, V57, P1111, DOI 10.1016/j.eururo.2010.03.008; Mohamed A., 2002, Medical Image Computing and Computer-Assisted Intervention - MICCAI 2002. 5th International Conference. Proceedings, Part II (Lecture Notes in Computer Science Vol.2489), P452; Oto A, 2013, RADIOLOGY, V267, P932, DOI 10.1148/radiol.13121652; Raz O, 2010, EUR UROL, V58, P173, DOI 10.1016/j.eururo.2010.03.006; Rusu M, 2014, MED PHYS, V41, DOI 10.1118/1.4881515; Seppenwoolde Y, 2002, INT J RADIAT ONCOL, V53, P822, DOI 10.1016/S0360-3016(02)02803-1; Toth R, 2014, NEUROCOMPUT IN PRESS; Toth R, 2013, COMPUT VIS IMAGE UND, V117, P1051, DOI 10.1016/j.cviu.2012.11.013; VANDERVORST HA, 1992, SIAM J SCI STAT COMP, V13, P631, DOI 10.1137/0913035; Viswanath S, 2014, NEUROCOMPUT IN PRESS; Yoo TS, 2002, P MED MEETS VIRTUAL; Zacharaki EI, 2009, NEUROIMAGE, V46, P762, DOI 10.1016/j.neuroimage.2009.01.051	26	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0150016	10.1371/journal.pone.0150016	http://dx.doi.org/10.1371/journal.pone.0150016			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088600	Green Published, gold			2022-12-26	WOS:000374527000001
J	Hernandez, D; Casane, D; Chevalier-Monteagudo, P; Bernatchez, L; Garcia-Machado, E				Hernandez, Damir; Casane, Didier; Chevalier-Monteagudo, Pedro; Bernatchez, Louis; Garcia-Machado, Erik			Go West: A One Way Stepping-Stone Dispersion Model for the Cavefish Lucifuga dentata in Western Cuba	PLOS ONE			English	Article							CRYPTIC DIVERSITY; PHYLOGEOGRAPHY; POPULATIONS; ASTYANAX; COLONIZATION; DIVERGENCE; HISTORY; FISHES; WATER; SPECIATION	Consistent with the limited dispersal capacity of most troglobitic animals, almost all Lucifuga cavefish species have very narrow geographic distribution in Cuba. However, one species, L. dentata, has a wide but disjointed distribution over 300 km in the west of the island. In order to estimate the relative role of vicariance and dispersal in the unexpected L. dentata distribution, we obtained partial sequences of the mitochondrial DNA (mtDNA) cytochrome b (cytb) gene and control region (CR), and then applied Approximate Bayesian Computation (ABC), based on the identification of five genetic and geographic congruent groups of populations. The process that best explains the distribution of genetic diversity in this species is sequential range expansion from east Matanzas to the western Pinar del Rio provinces, followed by isolation of groups of populations. We found relative high haplotype diversity and low nucleotide diversity in all but the Havana group, which has high values for both diversity parameters, suggesting that this group has been demographically stable over time. For two groups of populations (Cayuco and Bolondron), the mismatch distribution analyses suggests past demographic expansion. In the case of the Cayuco region, the star like relationships of haplotypes in the network suggests a recent founding event, congruent with other evidence indicating that this is the most recently colonized region. Over all, the results suggest that a combination of habitat availability, temporal interconnections, and possibly the biological properties of this species, may have enabled its dispersal and range expansion compared to other species of the genus, which are more geographically restricted.	[Hernandez, Damir; Garcia-Machado, Erik] Univ La Habana, Ctr Invest Marinas, Calle 16,114 Entre 1ra & 3ra, Havana 11300, Cuba; [Casane, Didier] Univ Paris 11, CNRS, Lab Evolut, Genomes,Comportement,Ecol,UMR 9191,IRD UMR 247, Gif Sur Yvette, France; [Casane, Didier] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Chevalier-Monteagudo, Pedro] Acuario Nacl Cuba, Calle 60, Havana 11300, Cuba; [Bernatchez, Louis] Univ Laval, IBIS, Pavillon Charles Eugene Marchand, Quebec City, PQ G1V 0A6, Canada	Universidad de la Habana; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Laval University	Garcia-Machado, E (corresponding author), Univ La Habana, Ctr Invest Marinas, Calle 16,114 Entre 1ra & 3ra, Havana 11300, Cuba.	egarcia@cim.uh.cu		Bernatchez, Louis/0000-0002-8085-9709	Centre National de la Recherche Scientifique; University of Havana; Acuario Nacional de Cuba; University of Paris-Sud; Embassy of France in Cuba	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); University of Havana; Acuario Nacional de Cuba; University of Paris-Sud; Embassy of France in Cuba	This work was supported by institutional grants from Centre National de la Recherche Scientifique, University of Paris-Sud, Embassy of France in Cuba and University of Havana. Acuario Nacional de Cuba provided support in the form of salaries for authors [PCM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Avise J. C., 2000, PHYLOGEOGRAPHY HIST; AVISE JC, 1972, EVOLUTION, V26, P1, DOI 10.1111/j.1558-5646.1972.tb00170.x; BARR TC, 1985, ANNU REV ECOL SYST, V16, P313, DOI 10.1146/annurev.es.16.110185.001525; Bertorelle G, 2010, MOL ECOL, V19, P2609, DOI 10.1111/j.1365-294X.2010.04690.x; Borowsky RB, 2001, ENVIRON BIOL FISH, V62, P225, DOI 10.1023/A:1011857421818; Bradic M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-9; Buhay JE, 2005, MOL ECOL, V14, P4259, DOI 10.1111/j.1365-294X.2005.02755.x; Buhay JE, 2007, MOL PHYLOGENET EVOL, V42, P435, DOI 10.1016/j.ympev.2006.07.014; Burridge CP, 2008, EVOLUTION, V62, P1484, DOI 10.1111/j.1558-5646.2008.00377.x; CACCONE A, 1986, BIOCHEM SYST ECOL, V14, P215, DOI 10.1016/0305-1978(86)90066-9; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; Culver DC, 2009, FRESHWATER BIOL, V54, P918, DOI 10.1111/j.1365-2427.2007.01856.x; Dowling TE, 2002, MOL BIOL EVOL, V19, P446, DOI 10.1093/oxfordjournals.molbev.a004100; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Espinasa L, 2001, ENVIRON BIOL FISH, V62, P233, DOI 10.1023/A:1011881921023; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Finston TL, 2007, MOL ECOL, V16, P355, DOI 10.1111/j.1365-294X.2006.03123.x; Fu YX, 1997, GENETICS, V147, P915; Garcia-Machado E, 2011, MOL PHYLOGENET EVOL, V61, P470, DOI 10.1016/j.ympev.2011.06.015; Guzik MT, 2009, MOL ECOL, V18, P3683, DOI 10.1111/j.1365-294X.2009.04296.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Iturralde- Vinent M, 2003, INT GEOLOGY REV; Iturralde-Vinent MA, 2006, INT GEOL REV, V48, P791, DOI 10.2747/0020-6814.48.9.791; Ketmaier V, 2003, MOL ECOL, V12, P547, DOI 10.1046/j.1365-294X.2003.01734.x; LEE WJ, 1995, J MOL EVOL, V41, P54; Lefebure T, 2007, MOL PHYLOGENET EVOL, V42, P676, DOI 10.1016/j.ympev.2006.08.020; Lefebure T, 2006, MOL ECOL, V15, P1797, DOI 10.1111/j.1365-294X.2006.02888.x; Lejeusne C, 2006, MOL ECOL, V15, P4123, DOI 10.1111/j.1365-294X.2006.03101.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Martinsen L, 2009, HEREDITAS, V146, P33, DOI 10.1111/j.1601-5223.2008.02068.x; MEYER A, 1990, NATURE, V347, P550, DOI 10.1038/347550a0; Neuenschwander S, 2008, MOL ECOL, V17, P757, DOI 10.1111/j.1365-294X.2007.03621.x; Palandacic Anja, 2012, Mol Ecol, V21, P1658, DOI 10.1111/j.1365-294X.2012.05507.x; Poey F, 1858, MEMORIAS HIST NATURA, P95; Ponce de Leon JL, 2012, LIB ROJO VERTEBRADOS, P33; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Rosenblum EB, 2007, EVOLUTION, V61, P2971, DOI 10.1111/j.1558-5646.2007.00251.x; Schneider S, 1999, GENETICS, V152, P1079; Stepien CA, 2001, MOL ECOL, V10, P1873, DOI 10.1046/j.0962-1083.2001.01329.x; Strecker U, 2004, MOL PHYLOGENET EVOL, V33, P469, DOI 10.1016/j.ympev.2004.07.001; Strecker U, 2003, MOL ECOL, V12, P699, DOI 10.1046/j.1365-294X.2003.01753.x; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trontelj P, 2009, FRESHWATER BIOL, V54, P727, DOI 10.1111/j.1365-2427.2007.01877.x; Verovnik R, 2005, MOL ECOL, V14, P4355, DOI 10.1111/j.1365-294X.2005.02745.x; Wiens JJ, 2003, SYST BIOL, V52, P501, DOI 10.1080/10635150390218222; Zaksek V, 2009, MOL ECOL, V18, P931, DOI 10.1111/j.1365-294X.2008.04061.x	50	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153545	10.1371/journal.pone.0153545	http://dx.doi.org/10.1371/journal.pone.0153545			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082117	Green Published, gold, Green Submitted			2022-12-26	WOS:000374291800028
J	Hodges-Simeon, CR; Sobraske, KNH; Samore, T; Gurven, M; Gaulin, SJC				Hodges-Simeon, Carolyn R.; Sobraske, Katherine N. Hanson; Samore, Theodore; Gurven, Michael; Gaulin, Steven J. C.			Facial Width-To-Height Ratio (fWHR) Is Not Associated with Adolescent Testosterone Levels	PLOS ONE			English	Article							SEXUAL-DIMORPHISM; DIGIT RATIO; SALIVARY TESTOSTERONE; TSIMANE AMERINDIANS; STRUCTURE PREDICTS; FACE; AGGRESSION; 2D-4D; GROWTH; SHAPE	Facial width-to-height ratio (fWHR) has been proposed as a sexually dimorphic signal in humans that develops under the influence of pubertal testosterone (T); however, no studies have examined the association between fWHR and T during the phase in which facial growth is canalized-adolescence. In a sample of adolescent Tsimane males, we evaluate the relationship between T, known T-derived traits (i.e. strength and voice pitch), and craniofacial measurements. If fWHR variation derives from T's effect on craniofacial growth during adolescence, several predictions should be supported: 1) fWHR should increase with age as T increases, 2) fWHR should reflect adolescent T (rather than adult T per se), 3) fWHR should exhibit velocity changes during adolescence in parallel with the pubertal spurt in T, 4) fWHR should correlate with T after controlling for age and other potential confounds, and 5) fWHR should show strong associations with other T-derived traits. Only prediction 4 was observed. Additionally, we examined three alternative facial masculinity ratios: facial width/lower face height, cheekbone prominence, and facial width/full face height. In contrast to fWHR, all three alternative measures show a strong age-related trend and are associated with both T and T-dependent traits. Overall, our results question the status of fWHR as a sexually-selected signal of pubertal T and T-linked traits.	[Hodges-Simeon, Carolyn R.; Samore, Theodore] Boston Univ, Dept Anthropol, Boston, MA 02215 USA; [Sobraske, Katherine N. Hanson; Gurven, Michael; Gaulin, Steven J. C.] Univ Calif Santa Barbara, Dept Anthropol, Santa Barbara, CA 93106 USA	Boston University; University of California System; University of California Santa Barbara	Hodges-Simeon, CR (corresponding author), Boston Univ, Dept Anthropol, Boston, MA 02215 USA.	crhodges@bu.edu		Gurven, Michael/0000-0002-5661-527X	NSF [BCS-0136761]; NIH/NIA [R01AG024119-01, R56AG024119-06, R01AG024119-07]; NATIONAL INSTITUTE ON AGING [R01AG024119, R56AG024119] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a Wenner-Gren dissertation fieldwork grant to CRH (www.wennergren.org). The Tsimane Health and Life History project (MG) is supported by grants from NSF (BCS-0136761; www.nsf.gov) and NIH/NIA (R01AG024119-01, R56AG024119-06, R01AG024119-07; www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alrajih S, 2014, BRIT J PSYCHOL, V105, P153, DOI 10.1111/bjop.12035; Archer J, 2006, NEUROSCI BIOBEHAV R, V30, P319, DOI 10.1016/j.neubiorev.2004.12.007; ARCHER J, 1991, BRIT J PSYCHOL, V82, P1, DOI 10.1111/j.2044-8295.1991.tb02379.x; Bailey AA, 2005, BIOL PSYCHOL, V68, P215, DOI 10.1016/j.biopsycho.2004.05.001; Bogin B., 1999, PATTERNS HUMAN GROWT, V2nd ed.; Breedlove SM, 2010, ENDOCRINOLOGY, V151, P4116, DOI 10.1210/en.2010-0041; Bribiescas RG, 2010, AM J HUM BIOL, V22, P216, DOI 10.1002/ajhb.21012; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; BUTLER GE, 1989, CLIN ENDOCRINOL, V30, P587, DOI 10.1111/j.1365-2265.1989.tb01431.x; CAMERON N, 1981, PRACTICAL HUMAN BIOL, P25; Carre JM, 2009, PSYCHOL SCI, V20, P1194, DOI 10.1111/j.1467-9280.2009.02423.x; Carre JM, 2008, P ROY SOC B-BIOL SCI, V275, P2651, DOI 10.1098/rspb.2008.0873; Coetzee V, 2010, PERCEPTION, V39, P51, DOI 10.1068/p6560; COLLINS MA, 1995, J APPL SOC PSYCHOL, V25, P129, DOI 10.1111/j.1559-1816.1995.tb01588.x; Deaner RO, 2012, J RES PERS, V46, P235, DOI 10.1016/j.jrp.2012.01.005; Duffy DL, 2000, BEHAV ECOL, V11, P654, DOI 10.1093/beheco/11.6.654; Ellison PT, 2002, HUM REPROD, V17, P3251, DOI 10.1093/humrep/17.12.3251; Ellison PT, 2003, FERTILE GROUND NATUR; Enlow D. H., 1990, FACIAL GROWTH; Enlow DH, 1982, FACIAL GROWTH; Fink B, 2002, CURR DIR PSYCHOL SCI, V11, P154, DOI 10.1111/1467-8721.00190; Frisancho AR, 1990, ANTHROPOMETRIC STAND; Geniole SN, 2014, J EXP PSYCHOL HUMAN, V40, P1526, DOI 10.1037/a0036732; Godoy RA, 2006, ECON HUM BIOL, V4, P184, DOI 10.1016/j.ehb.2005.11.001; Gomez-Valdes J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052317; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; GRAMMER K, 1994, J COMP PSYCHOL, V108, P233, DOI 10.1037/0735-7036.108.3.233; Granger DA, 2004, PSYCHONEUROENDOCRINO, V29, P1229, DOI 10.1016/j.psyneuen.2004.02.005; Gurven M, 2008, J GERONTOL A-BIOL, V63, P196, DOI 10.1093/gerona/63.2.196; Gurven M, 2007, AM J HUM BIOL, V19, P376, DOI 10.1002/ajhb.20600; Haselhuhn MP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122637; Haselhuhn MP, 2012, P ROY SOC B-BIOL SCI, V279, P571, DOI 10.1098/rspb.2011.1193; Hilbe J., 2011, NEGATIVE BINOMIAL RE; Hodges-Simeon CR, 2015, EVOL HUM BEHAV, V36, P294, DOI 10.1016/j.evolhumbehav.2015.01.002; Hodges-Simeon CR, 2014, BEHAV ECOL, V25, P984, DOI 10.1093/beheco/aru081; Hodges-Simeon CR, 2013, ANN HUM BIOL, V40, P209, DOI 10.3109/03014460.2012.759622; Honekopp J, 2007, PSYCHONEUROENDOCRINO, V32, P313, DOI 10.1016/j.psyneuen.2007.01.007; Josephs RA, 2003, PSYCHOL SCI, V14, P158, DOI 10.1111/1467-9280.t01-1-01435; Kivlighan KT, 2004, HORM BEHAV, V46, P39, DOI 10.1016/j.yhbeh.2004.01.006; Kramer RSS, 2015, EVOL PSYCHOL-US, V13, P197, DOI 10.1177/147470491501300112; Kramer RSS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042705; Lassek WD, 2009, EVOL HUM BEHAV, V30, P322, DOI 10.1016/j.evolhumbehav.2009.04.002; Lefevre CE, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0729; Lefevre CE, 2013, EVOL HUM BEHAV, V34, P273, DOI 10.1016/j.evolhumbehav.2013.03.005; Lefevre CE, 2012, EVOL HUM BEHAV, V33, P623, DOI 10.1016/j.evolhumbehav.2012.03.002; Lewis GJ, 2012, PERS INDIV DIFFER, V52, P855, DOI 10.1016/j.paid.2011.12.030; Little AC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002106; Manning JT, 2008, AM J HUM BIOL, V20, P451, DOI 10.1002/ajhb.20767; Mazur A, 1997, EVOL HUM BEHAV, V18, P317, DOI 10.1016/S1090-5138(97)00013-5; Mazur A, 1998, BEHAV BRAIN SCI, V21, P353, DOI 10.1017/S0140525X98001228; McCormick CM, 2010, J VIS, V10, P599, DOI [10.1167/10.7.599, DOI 10.1167/10.7.599]; McDade TW, 2008, AM J PHYS ANTHROPOL, V136, P478, DOI 10.1002/ajpa.20831; McIntyre MH, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-10; Meindl K, 2012, P ROY SOC B-BIOL SCI, V279, P2457, DOI 10.1098/rspb.2011.2351; Millet K, 2007, PERS INDIV DIFFER, V43, P289, DOI 10.1016/j.paid.2006.11.024; Mitteroecker P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118374; Muehlenbein MP, 2005, AM J HUM BIOL, V17, P527, DOI 10.1002/ajhb.20419; Mueller U, 1997, BEHAV ECOL, V8, P569; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Ozener B, 2012, EVOL HUM BEHAV, V33, P169, DOI 10.1016/j.evolhumbehav.2011.08.001; Penton-Voak IS, 2006, SOC COGNITION, V24, P607, DOI 10.1521/soco.2006.24.5.607; Penton-Voak IS, 2001, P ROY SOC B-BIOL SCI, V268, P1617, DOI 10.1098/rspb.2001.1703; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Preece M, 1984, HUMAN GROWTH DEV; Puts DA, 2012, P ROY SOC B-BIOL SCI, V279, P601, DOI 10.1098/rspb.2011.0829; Rauch F, 2004, BONE, V34, P771, DOI 10.1016/j.bone.2004.01.022; Rhodes G, 2003, P ROY SOC B-BIOL SCI, V270, pS93, DOI 10.1098/rsbl.2003.0023; Rogol AD, 2012, J ADOLESCENT HEALTH, V31, P192; Rohrich RJ, 2008, PLAST RECONSTR SURG, V121, P2107, DOI 10.1097/PRS.0b013e31817123c6; Schaefer K, 2005, COLLEGIUM ANTROPOL, V29, P415; Scott IM, 2014, P NATL ACAD SCI USA, V111, P14388, DOI 10.1073/pnas.1409643111; Searcy W.N.S, 2005, EVOLUTION ANIMAL COM; Sell A, 2009, P R SOC B, V276, P575, DOI 10.1098/rspb.2008.1177; Shirtcliff EA, 2002, HORM BEHAV, V42, P62, DOI 10.1006/hbeh.2002.1798; Short LA, 2012, EVOL HUM BEHAV, V33, P121, DOI 10.1016/j.evolhumbehav.2011.07.002; Shoup ML, 2008, EVOL PSYCHOL-US, V6, P469; SLAUGHTER MH, 1988, HUM BIOL, V60, P709; SNODELL SF, 1993, AM J ORTHOD DENTOFAC, V104, P471, DOI 10.1016/0889-5406(93)70073-W; Stirrat M, 2012, PSYCHOL SCI, V23, P718, DOI 10.1177/0956797611435133; Stirrat M, 2010, PSYCHOL SCI, V21, P349, DOI 10.1177/0956797610362647; Swaddle JP, 2001, P BIOL SCI, V269, P2285; Takakura M, 1998, Int J Adult Orthodon Orthognath Surg, V13, P277; Tanner S, 2009, AM J HUM BIOL, V21, P651, DOI 10.1002/ajhb.20944; Thornhill R, 1999, TRENDS COGN SCI, V3, P452, DOI 10.1016/S1364-6613(99)01403-5; Trivers R, 2006, HORM BEHAV, V49, P150, DOI 10.1016/j.yhbeh.2005.05.023; Tsujimura H, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0140; Valentine KA, 2014, PSYCHOL SCI, V25, P806, DOI 10.1177/0956797613511823; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Verdonck A, 1999, EUR J ORTHODONT, V21, P137, DOI 10.1093/ejo/21.2.137; Weinberg SM, 2015, ORTHOD CRANIOFAC RES, V18, P21, DOI 10.1111/ocr.12055; Welker KM, 2015, ADAPT HUM BEHAV PHYS, V1, P17, DOI 10.1007/s40750-014-0003-3; Weston EM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000710; Weston EM, 2004, P ROY SOC B-BIOL SCI, V271, pS416, DOI 10.1098/rsbl.2004.0203; Whitehouse AJO, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1351; Wong EM, 2011, PSYCHOL SCI, V22, P1478, DOI 10.1177/0956797611418838; Zahavi A., 1997, HANDICAP PRINCIPLE; Zebrowitz LA, 1998, J PERS SOC PSYCHOL, V75, P1300, DOI 10.1037/0022-3514.75.5.1300; Zebrowitz LA, 2015, PERS INDIV DIFFER, V86, P312, DOI 10.1016/j.paid.2015.06.036; Zilioli S, 2015, AGGRESSIVE BEHAV, V41, P322, DOI 10.1002/ab.21544	99	64	65	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153083	10.1371/journal.pone.0153083	http://dx.doi.org/10.1371/journal.pone.0153083			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078636	gold, Green Published, Green Submitted			2022-12-26	WOS:000374131700020
J	Tiwari, S; Sl, K; Kumar, V; Singh, B; Rao, AR; Mithra, SVA; Rai, V; Singh, AK; Singh, NK				Tiwari, Sushma; Sl, Krishnamurthy; Kumar, Vinod; Singh, Balwant; Rao, A. R.; Mithra, Amitha S., V; Rai, Vandna; Singh, Ashok K.; Singh, Nagendra K.			Mapping QTLs for Salt Tolerance in Rice (Oryza sativa L.) by Bulked Segregant Analysis of Recombinant Inbred Lines Using 50K SNP Chip	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; SALINITY TOLERANCE; SEEDLING STAGE; STRESS INDEXES; IDENTIFICATION; GENES; REGIONS; MARKERS; POOLS; NA+	Soil salinity is a major constraint to rice production in large inland and coastal areas around the world. Modern high yielding rice varieties are particularly sensitive to high salt stress. There are salt tolerant landraces and traditional varieties of rice but with limited information on genomic regions (QTLs) and genes responsible for their tolerance. Here we describe a method for rapid identification of QTLs for reproductive stage salt tolerance in rice using bulked segregant analysis (BSA) of bi-parental recombinant inbred lines (RIL). The number of RILs required for the creation of two bulks with extreme phenotypes was optimized to be thirty each. The parents and bulks were genotyped using a 50K SNP chip to identify genomic regions showing homogeneity for contrasting alleles of polymorphic SNPs in the two bulks. The method was applied to 'CSR11/MI48' RILs segregating for reproductive stage salt tolerance. Genotyping of the parents and RIL bulks, made on the basis of salt sensitivity index for grain yield, revealed 6,068 polymorphic SNPs and 21 QTL regions showing homogeneity of contrasting alleles in the two bulks. The method was validated further with 'CSR27/MI48' RILs used earlier for mapping salt tolerance QTLs using low-density SSR markers. BSA with 50K SNP chip revealed 5,021 polymorphic loci and 34 QTL regions. This not only confirmed the location of previously mapped QTLs but also identified several new QTLs, and provided a rapid way to scan the whole genome for mapping QTLs for complex agronomic traits in rice.	[Tiwari, Sushma; Singh, Balwant; Mithra, Amitha S., V; Rai, Vandna; Singh, Nagendra K.] Natl Res Ctr Plant Biotechnol, New Delhi, India; [Sl, Krishnamurthy; Kumar, Vinod] Cent Soil Salin Res Inst, Karnal, India; [Rao, A. R.] Indian Agr Res Inst, New Delhi, India; [Singh, Ashok K.] Indian Agr Res Inst, Div Genet, New Delhi 110012, India	Indian Council of Agricultural Research (ICAR); ICAR - National Institute For Plant Biotechnology (NIPB); Indian Council of Agricultural Research (ICAR); ICAR - Central Soil Salinity Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute	Singh, NK (corresponding author), Natl Res Ctr Plant Biotechnol, Pusa Campus, New Delhi, India.	nksingh4@gmail.com	Singh, Ashok/HGF-2506-2022; Singh, Nouratan/N-9377-2017; Rai, Vandna/AAF-1030-2020	Singh, Nouratan/0000-0002-8063-8375; Singh, Ashok Kumar/0000-0002-9777-8163; Rao, Atmakuri Ramakrishna/0000-0002-3914-6248; Singh, Balwant/0000-0002-4958-4540; Rai, Vandna/0000-0002-6734-3169; Saraswathipura L., Krishnamurthy/0000-0002-9389-2997	Indian Council of Agriculture Research;  [NPTC 2001-3001]	Indian Council of Agriculture Research; 	Funded by Grant number is NPTC 2001-3001. All the funding or sources of support received for this work were taken by Indian Council of Agriculture Research funded in-house NPTC project "Functional genomics for salt stress in rice". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 2012, NAT BIOTECHNOL, V30, P174, DOI 10.1038/nbt.2095; Ali S, 2013, FIELD CROP RES, V154, P65, DOI 10.1016/j.fcr.2013.06.011; Ammar MHM, 2009, J PLANT BIOCHEM BIOT, V18, P139, DOI 10.1007/BF03263312; [Anonymous], 2004, GENETIC IMPROVEMENT; Austin RS, 2011, PLANT J, V67, P715, DOI 10.1111/j.1365-313X.2011.04619.x; Becker A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015993; Bonilla P, 2002, PHILIPP AGRIC SCI, V85, P68; Brauer MJ, 2006, GENETICS, V173, P1813, DOI 10.1534/genetics.106.057927; Ehrenreich IM, 2010, NATURE, V464, P1039, DOI 10.1038/nature08923; FERNANDEZ GCJ, 1993, ADAPTATION OF FOOD CROPS TO TEMPERATURE AND WATER STRESS, P257; FISCHER RA, 1978, AUST J AGR RES, V29, P897, DOI 10.1071/AR9780897; Flowers TJ, 2000, J EXP BOT, V51, P99, DOI 10.1093/jexbot/51.342.99; Gautam RK, 2000, CEREAL RES COMMUN, V28, P117; Ghomi K, 2013, OMICS, V17, P242, DOI 10.1089/omi.2012.0097; GIOVANNONI JJ, 1991, NUCLEIC ACIDS RES, V19, P6553, DOI 10.1093/nar/19.23.6553; Gomez A., 1984, STAT PROCEDURES AGR, V2nd edn, P97; Gong JM, 1999, CHINESE SCI BULL, V44, P68, DOI 10.1007/BF03182889; Hossain H, 2015, J AGRON CROP SCI, V201, P17, DOI 10.1111/jac.12086; Koyama ML, 2001, PLANT PHYSIOL, V125, P406, DOI 10.1104/pp.125.1.406; Krishnamurthy SL, 2014, CEREAL RES COMMUN, V42, P474, DOI 10.1556/CRC.2013.0067; Lee SY, 2006, MOL CELLS, V21, P192; Lin HongXuan, 1998, Chinese Journal of Rice Science, V12, P72; Lin HX, 2004, THEOR APPL GENET, V108, P253, DOI 10.1007/s00122-003-1421-y; Magwene PM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002255; Marino R, 2009, MOL GENET GENOMICS, V281, P163, DOI 10.1007/s00438-008-0401-y; MCINTOSH MS, 1983, AGRON J, V75, P153, DOI 10.2134/agronj1983.00021962007500010041x; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; MILLER P. A., 1958, AGRON JOUR, V50, P126; Mokry M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-256; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; OECD/FAO, 2012, OECD FAO AGRICULTURA, DOI 10.1787/agr_outlook-2012-en; Pandit A, 2010, MOL GENET GENOMICS, V284, P121, DOI 10.1007/s00438-010-0551-6; Parts L, 2011, GENOME RES, V21, P1131, DOI 10.1101/gr.116731.110; Porch TG, 2006, J AGRON CROP SCI, V192, P390, DOI 10.1111/j.1439-037X.2006.00229.x; Prasad SR, 2000, CURR SCI INDIA, V78, P162; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Ren ZH, 2005, NAT GENET, V37, P1141, DOI 10.1038/ng1643; Reza M, 2013, J GENET, V92, P433; Sabesan T., 2009, Electronic Journal of Plant Breeding, V1, P56; Sabouri H, 2009, BIOL PLANTARUM, V53, P657, DOI 10.1007/s10535-009-0119-7; Schlotterer C, 2014, NAT REV GENET, V15, P749, DOI 10.1038/nrg3803; Schneeberger K, 2009, NAT METHODS, V6, P550, DOI 10.1038/nmeth0809-550; SEDCOLE JR, 1977, CROP SCI, V17, P667, DOI 10.2135/cropsci1977.0011183X001700040052x; Singh N, 2015, SCI REP-UK, V5, DOI 10.1038/srep11600; Singh R. K., 2007, Physiology and Molecular Biology of Plants, V13, P87; Supriyo Chakraborty, 2010, Notulae Scientia Biologicae, V2, P117; Swinnen S, 2012, GENOME RES, V22, P975, DOI 10.1101/gr.131698.111; Takagi H, 2013, PLANT J, DOI [10.1111/tpj_12105, DOI 10.1111/TPJ_12105]; Takagi H, 2013, NEW PHYTOL, V200, P276, DOI 10.1111/nph.12369; TANKSLEY SD, 1993, ANNU REV GENET, V27, P205, DOI 10.1146/annurev.ge.27.120193.001225; Thomson MJ, 2010, RICE, V3, P148, DOI 10.1007/s12284-010-9053-8; Trick M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-14; Wenger JW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000942; Wolyn DJ, 2004, GENETICS, V167, P907, DOI 10.1534/genetics.103.024810; Yan CJ, 2007, THEOR APPL GENET, V115, P1093, DOI 10.1007/s00122-007-0635-9; Yang ZM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068433; Zeng LH, 2001, AGR WATER MANAGE, V48, P191, DOI 10.1016/S0378-3774(00)00146-3; Zheng K., 1995, RICE GENET NEWSLETT, V12, P255; Zhou Y, 2009, GENETICS, V183, P315, DOI 10.1534/genetics.109.102681	60	82	87	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153610	10.1371/journal.pone.0153610	http://dx.doi.org/10.1371/journal.pone.0153610			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077373	Green Published, Green Submitted, gold			2022-12-26	WOS:000374131700093
J	Veerman, JL; Sacks, G; Antonopoulos, N; Martin, J				Veerman, J. Lennert; Sacks, Gary; Antonopoulos, Nicole; Martin, Jane			The Impact of a Tax on Sugar-Sweetened Beverages on Health and Health Care Costs: A Modelling Study	PLOS ONE			English	Article							OBESITY; OVERWEIGHT; RISK	This paper aims to estimate the consequences of an additional 20% tax on sugar-sweetened beverages (SSBs) on health and health care expenditure. Participants were adult (aged > = 20) Australians alive in 2010, who were modelled over their remaining lifetime. We used lifetable-based epidemiological modelling to examine the potential impact of a 20% valoric tax on SSBs on total lifetime disability-adjusted life years (DALYs), incidence, prevalence, and mortality of obesity-related disease, and health care expenditure. Over the lifetime of adult Australian alive in 2010, seemingly modest estimated changes in average bodymass as a result of the SSB tax translated to gains of 112,000 health-adjusted life years for men (95% uncertainty interval [UI]: 73,000-155,000) and 56,000 (95% UI: 36,000-76,000) for women, and a reduction in overall health care expenditure of AUD609 million (95% UI: 368 million-870 million). The tax is estimated to reduce the number of new type 2 diabetes cases by approximately 800 per year. Twenty-five years after the introduction of the tax, there would be 4,400 fewer prevalent cases of heart disease and 1,100 fewer persons living with the consequences of stroke, and an estimated 1606 extra people would be alive as a result of the tax. The tax would generate an estimated AUD400 million in revenue each year. Governments should consider increasing the tax on sugared drinks. This would improve population health, reduce health care costs, as well as bring in direct revenue.	[Veerman, J. Lennert] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia; [Sacks, Gary] Deakin Univ, WHO Collaborating Ctr Obes Prevent, Melbourne, Vic, Australia; [Antonopoulos, Nicole; Martin, Jane] Canc Council Victoria, Obes Policy Coalit, Melbourne, Vic, Australia	University of Queensland; Deakin University; World Health Organization; Cancer Council Victoria	Veerman, JL (corresponding author), Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia.	l.veerman@uq.edu.au	Sacks, Gary/I-5731-2014; Veerman, Lennert/A-9973-2011	Sacks, Gary/0000-0001-9736-1539; Martin, Jane/0000-0002-9132-0928; Veerman, Lennert/0000-0002-3206-8232	Obesity Policy Coalition; NHMRC [APP1041020]; Australian Research Council [DE160100307]	Obesity Policy Coalition; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by the Obesity Policy Coalition and by NHMRC funding for the Centre for Research Excellence in Obesity Policy and Food Systems (APP1041020). GS is the recipient of an Australian Research Council Discovery Early Career Researcher Award (project number DE160100307). Two of the authors (JM, NA) are employed by the Obesity Policy Coalition. The NHMRC was not involved in the study or the reporting.	[Anonymous], 2013, GLOB BURD DIS COUNTR; Colchero MA, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6704; Australian Bureau of Statistics, 2012, AUSTR HLTH SURV 2011; Australian Bureau of Statistics, 2011, HOUSEHOLD EXPENDITUR; Briggs ADM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6189; Chisholm D, 2004, J STUD ALCOHOL, V65, P782, DOI 10.15288/jsa.2004.65.782; Crammond B, 2013, OBES REV, V14, P213, DOI 10.1111/obr.12004; Escobar MAC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1072; Forster M, 2011, INT J OBESITY, V35, P1071, DOI 10.1038/ijo.2010.246; Frisvold D, 2015, INCIDENCE TAXES SUGA; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; Long MW, 2015, AM J PREV MED, V49, P112, DOI 10.1016/j.amepre.2015.03.004; Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185; Mytton OT, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2931; NUTTAB, 2010, NUTR TABL US AUSTR 2; Preventative Health Taskforce, 2009, 1 PREV HLTH TASKF CO; Sacks G, 2011, INT J OBESITY, V35, P1001, DOI 10.1038/ijo.2010.228; Sharma A, 2014, HEALTH ECON, V23, P1159, DOI 10.1002/hec.3070; Stewart RAH, 2008, NEW ZEAL MED J, V121, P11; Thow AM, 2014, NUTR REV, V72, P551, DOI 10.1111/nure.12123; van Baal PHM, 2008, PLOS MED, V5, P242, DOI 10.1371/journal.pmed.0050029; Veerman JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026051; Veerman L., 2010, ASSESSING COST EFFEC; Villanueva T, 2011, CAN MED ASSOC J, V183, pE1229, DOI 10.1503/cmaj.109-4031; WHO Regional Office for Europe, 2015, US PRIC POL PROM HLT; World Health Organization, 2008, 2008 2013 ACT PLAN G	26	88	89	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0151460	10.1371/journal.pone.0151460	http://dx.doi.org/10.1371/journal.pone.0151460			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073855	gold, Green Published, Green Submitted			2022-12-26	WOS:000374131200008
J	Yu, HY; Yu, J; Ren, YJ; Yang, Y; Xiao, X				Yu, Haiying; Yu, Jian; Ren, Yanjun; Yang, Yun; Xiao, Xing			Serum CEACAM1 Level Is Associated with Diagnosis and Prognosis in Patients with Osteosarcoma	PLOS ONE			English	Article							CANCER; EXPRESSION; EXPERIENCE; BIOMARKER; MARKER; DOMAIN; TUMOR; INHIBITION	Carcinoembryonic antigen related cell adhesion molecule 1 (CEACAM1) is a trans-membrane multifunctional cell adhesion molecule associated with tumor cell proliferation, apoptosis, angiogenesis, invasion, and migration during tumor development. In the present study, we evaluated serum CEACAM1 level in osteosarcoma patients to explore its diagnostic and prognostic value for this particular malignancy. Sera from 113 patients with primary osteosarcoma, 98 patients with benign bone tumors and 126 healthy controls were obtained. Serum CEACAM1 level was measured with ELISA and correlation with clinicopathological characteristics was further analyzed. Receiver operating curves (ROC), Kaplan-Meier curves, and log-rank analyses as well as Cox proportional hazard models were used to evaluate diagnostic and prognostic significance. The results revealed that serum CEACAM1 level was significantly higher in osteosarcoma patients compared to benign bone tumors and healthy controls (455.2 +/- 179.9 vs 287.4 +/- 103.2, 260.8 +/- 109.7 pg/ml, respectively). Osteosarcoma patients with larger tumors, later-tumor stages, low tumor grades, and distant metastases had much higher CEACAM1 compared to those with smaller tumors, earlier tumor stages, high tumor grades and non-distant metastases (P < 0.05 for all). Multivariate logistic regression analysis confirmed that high serum CEACAM1 level was an independent risk factor for distant metastases (OR = 3.02, 95% CI 1.65-4.17). To distinguish osteosarcoma patients from those with benign bone tumor and healthy controls, ROC/AUC analysis indicated an AUC of 0.81 (sensitivity 0.61; specificity 0.89) and an AUC of 0.77 (sensitivity 0.57; specificity 0.92), respectively. Osteosarcoma patients with higher CEACAM1 had relatively lower survival compared to those with low CEACAM1 (P < 0.01), and multivariate analyses for overall survival revealed that high serum CEACAM1 level was an independent prognostic factor for osteosarcoma (HR = 1.56, 95% CI 1.23-3.28). The present study suggested that elevated serum CEACAM1 level might be a novel diagnostic and prognostic biomarker for osteosarcoma patients.	[Yu, Haiying] Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Radiol, Jinan, Shandong, Peoples R China; [Yu, Jian] Caoxian Peoples Hosp, Dept Orthoped, Jinan, Shandong, Peoples R China; [Ren, Yanjun; Yang, Yun; Xiao, Xing] Shandong Prov Qianfoshan Hosp, Dept Orthoped, Jinan, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Shandong First Medical University & Shandong Academy of Medical Sciences	Xiao, X (corresponding author), Shandong Prov Qianfoshan Hosp, Dept Orthoped, Jinan, Shandong, Peoples R China.	xiaoxbone@163.com						Bacci G, 2003, CANCER, V97, P3068, DOI 10.1002/cncr.11456; Beauchemin N, 2013, CANCER METAST REV, V32, P643, DOI 10.1007/s10555-013-9444-6; Cai HK, 2015, J SURG RES, V194, P505, DOI 10.1016/j.jss.2014.11.025; Clark JCM, 2008, J CANCER RES CLIN, V134, P281, DOI 10.1007/s00432-007-0330-x; Draberova L, 2000, IMMUNOLOGY, V101, P279, DOI 10.1046/j.1365-2567.2000.00113.x; Esmailiejah AA, 2015, TUMOUR BIOL; Fan JY, 2015, TUMOR BIOL, V11; Farlow EC, 2010, CLIN CANCER RES, V16, P3452, DOI 10.1158/1078-0432.CCR-09-3192; Fiori V, 2012, ANN I SUPER SANITA, V48, P161, DOI [10.4415/ANN_12_02.09, 10.4415/ANN_12_02_09]; Gazitt Y, 2009, INT J ONCOL, V34, P551, DOI 10.3892/ijo_00000181; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Isakoff MS, 2015, J CLIN ONCOL, V33, P3029, DOI 10.1200/JCO.2014.59.4895; Jaffe N, 2009, CANCER TREAT RES, V152, P239, DOI 10.1007/978-1-4419-0284-9_12; Kager L, 2006, J CLIN ONCOL, V24, P1535, DOI 10.1200/JCO.2005.04.2978; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; Leary SES, 2013, CANCER-AM CANCER SOC, V119, P2645, DOI 10.1002/cncr.28111; Li CX, 2009, EXP CELL RES, V315, P1225, DOI 10.1016/j.yexcr.2008.12.015; Lian F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121499; Luo W, 2015, AM J TRANSL RES, V7, P1236; Ottaviani G, 2009, CANCER TREAT RES, V152, P3, DOI 10.1007/978-1-4419-0284-9_1; Shen QJ, 2012, LANCET ONCOL, V13, P817, DOI 10.1016/S1470-2045(12)70233-4; Simeone DM, 2007, PANCREAS, V34, P436, DOI 10.1097/MPA.0b013e3180333ae3; Sivan S, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/290536; Tilki D, 2010, EUR UROL, V57, P648, DOI 10.1016/j.eururo.2009.05.040; Trieb K, 2001, INT J BIOCHEM CELL B, V33, P11, DOI 10.1016/S1357-2725(00)00066-2; Yang CC, 2015, CLIN CHIM ACTA, V450, P277, DOI 10.1016/j.cca.2015.09.005; Yang Z, 2015, BIOMED PHARMACOTHER, V75, P153, DOI 10.1016/j.biopha.2015.07.018; Zhang C, 2014, INT J CLIN EXP PATHO, V7, P4194; Zhang J, 2015, CLIN CHIM ACTA, V444, P182, DOI 10.1016/j.cca.2014.12.041; Zhou MQ, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-359	30	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153601	10.1371/journal.pone.0153601	http://dx.doi.org/10.1371/journal.pone.0153601			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074014	gold, Green Published, Green Submitted			2022-12-26	WOS:000374131200110
J	Katt, ME; Xu, ZS; Gerecht, S; Searson, PC				Katt, Moriah E.; Xu, Zinnia S.; Gerecht, Sharon; Searson, Peter C.			Human Brain Microvascular Endothelial Cells Derived from the BC1 iPS Cell Line Exhibit a Blood-Brain Barrier Phenotype	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; ADVANCE TRANSLATIONAL RESEARCH; TIGHT JUNCTION; DRUG DISCOVERY; MODEL; PERMEABILITY; TRANSPORTERS; EXPRESSION; DERIVATION; CLAUDIN	The endothelial cells that form capillaries in the brain are highly specialized, with tight junctions that minimize paracellular transport and an array of broad-spectrum efflux pumps that make drug delivery to the brain extremely challenging. One of the major limitations in blood-brain barrier research and the development of drugs to treat central nervous system diseases is the lack of appropriate cell lines. Recent reports indicate that the derivation of human brain microvascular endothelial cells (hBMECs) from human induced pluripotent stem cells (iPSCs) may provide a solution to this problem. Here we demonstrate the derivation of hBMECs extended to two new human iPSC lines: BC1 and GFP-labeled BC1. These hBMECs highly express adherens and tight junction proteins VE-cadherin, ZO-1, occludin, and claudin-5. The addition of retinoic acid upregulates VE-cadherin expression, and results in a significant increase in transendothelial electrical resistance to physiological values. The permeabilities of tacrine, rhodamine 123, and Lucifer yellow are similar to values obtained for MDCK cells. The efflux ratio for rhodamine 123 across hBMECs is in the range 2-4 indicating polarization of efflux transporters. Using the rod assay to assess cell organization in small vessels and capillaries, we show that hBMECs resist elongation with decreasing diameter but show progressive axial alignment. The derivation of hBMECs with a blood-brain barrier phenotype from the BC1 cell line highlights that the protocol is robust. The expression of GFP in hBMECs derived from the BC1-GFP cell line provides an important new resource for BBB research.	[Katt, Moriah E.; Gerecht, Sharon; Searson, Peter C.] Johns Hopkins Univ, Dept Mat Sci & Engn, 3400 North Charles St, Baltimore, MD 21218 USA; [Katt, Moriah E.; Xu, Zinnia S.; Gerecht, Sharon; Searson, Peter C.] Johns Hopkins Univ, Inst Nanobiotechnol, 100 Croft Hall,3400 North Charles St, Baltimore, MD 21218 USA; [Xu, Zinnia S.] Johns Hopkins Univ, Dept Biomed Engn, 720 Rutland Ave, Baltimore, MD 21205 USA; [Gerecht, Sharon; Searson, Peter C.] Johns Hopkins Univ, Dept Chem & Biomol Engn, 3400 North Charles St, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Searson, PC (corresponding author), Johns Hopkins Univ, Dept Mat Sci & Engn, 3400 North Charles St, Baltimore, MD 21218 USA.; Searson, PC (corresponding author), Johns Hopkins Univ, Inst Nanobiotechnol, 100 Croft Hall,3400 North Charles St, Baltimore, MD 21218 USA.; Searson, PC (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, 3400 North Charles St, Baltimore, MD 21218 USA.	searson@jhu.edu	Gerecht, Sharon/HCH-8629-2022	Gerecht, Sharon/0000-0002-8542-4835; Searson, Peter/0000-0002-5417-0828	NIH [R01CA170629]; DTRA [HDTRA1-15-1-0046]; NATIONAL CANCER INSTITUTE [R01CA170629] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DTRA(United States Department of DefenseDefense Threat Reduction Agency); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH (R01CA170629) and DTRA (HDTRA1-15-1-0046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; BUTT AM, 1990, J PHYSIOL-LONDON, V429, P47, DOI 10.1113/jphysiol.1990.sp018243; CASTRO DJ, 1992, LARYNGOSCOPE, V102, P868, DOI 10.1288/00005537-199208000-00005; Cecchelli R, 2007, NAT REV DRUG DISCOV, V6, P650, DOI 10.1038/nrd2368; Cecchelli R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099733; Chiba H, 2008, BBA-BIOMEMBRANES, V1778, P588, DOI 10.1016/j.bbamem.2007.08.017; Chou BK, 2011, CELL RES, V21, P518, DOI 10.1038/cr.2011.12; de Boer AG, 2003, ANNU REV PHARMACOL, V43, P629, DOI 10.1146/annurev.pharmtox.43.100901.140204; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Eigenmann DE, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-33; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; Hewitt KJ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-186; Irvine JD, 1999, J PHARM SCI, V88, P28, DOI 10.1021/js9803205; Keep RF, 2011, J NEUROCHEM, V119, P417, DOI 10.1111/j.1471-4159.2011.07425.x; Krause G, 2009, ANN NY ACAD SCI, V1165, P34, DOI 10.1111/j.1749-6632.2009.04057.x; Lelong-Rebel IH, 2005, ANTICANCER RES, V25, P3925; Lippmann ES, 2014, SCI REP-UK, V4, DOI 10.1038/srep04160; Lippmann ES, 2012, NAT BIOTECHNOL, V30, P783, DOI 10.1038/nbt.2247; Lundquist S, 2002, PHARMACEUT RES, V19, P976, DOI 10.1023/A:1016462205267; Matsuo H, 2000, NEUROREPORT, V11, P3507, DOI 10.1097/00001756-200011090-00021; Mizee MR, 2013, J NEUROSCI, V33, P1660, DOI 10.1523/JNEUROSCI.1338-12.2013; Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185; Neuwelt E, 2008, LANCET NEUROL, V7, P84, DOI 10.1016/S1474-4422(07)70326-5; Neuwelt EA, 2011, NAT REV NEUROSCI, V12, P169, DOI 10.1038/nrn2995; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Ohtsuki S, 2007, PHARM RES-DORDR, V24, P1745, DOI 10.1007/s11095-007-9374-5; Piontek J, 2008, FASEB J, V22, P146, DOI 10.1096/fj.07-8319com; Reichel Andreas, 2003, Methods Mol Med, V89, P307; Seetharaman S, 1998, J NEUROCHEM, V70, P1151, DOI 10.1046/j.1471-4159.1998.70031151.x; Staudt T, 2007, MICROSC RES TECHNIQ, V70, P1, DOI 10.1002/jemt.20396; Steiner O, 2011, J CEREBR BLOOD F MET, V31, P315, DOI 10.1038/jcbfm.2010.96; Summerfield SG, 2007, J PHARMACOL EXP THER, V322, P205, DOI 10.1124/jpet.107.121525; Summers WK, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P439; Sung JH, 2005, DRUG METAB DISPOS, V33, P440, DOI 10.1124/dmd.104.002220; Swenson ES, 2007, STEM CELLS, V25, P2593, DOI 10.1634/stemcells.2007-0241; Urich E, 2013, SCI REP-UK, V3, DOI 10.1038/srep01500; Vetkin DO, 2004, BIOL BULL+, V31, P121, DOI 10.1023/B:BIBU.0000022465.09009.9a; Wang Q, 2005, INT J PHARMACEUT, V288, P349, DOI 10.1016/j.ijpharm.2004.10.007; Weksler B, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-16; Wilson HK, 2015, FLUIDS BARRIERS CNS, V12, DOI 10.1186/s12987-015-0007-9; Wong Andrew D, 2013, Front Neuroeng, V6, P7, DOI 10.3389/fneng.2013.00007; Ye M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04681; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zou CL, 2012, STEM CELLS DEV, V21, P2298, DOI 10.1089/scd.2011.0688	46	79	80	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0152105	10.1371/journal.pone.0152105	http://dx.doi.org/10.1371/journal.pone.0152105			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070801	Green Published, gold, Green Submitted			2022-12-26	WOS:000373900700007
J	Zhao, NN; Maxson, JE; Zhang, RH; Wahedi, M; Enns, CA; Zhang, AS				Zhao, Ningning; Maxson, Julia E.; Zhang, Richard H.; Wahedi, Mastura; Enns, Caroline A.; Zhang, An-Sheng			Neogenin Facilitates the Induction of Hepcidin Expression by Hemojuvelin in the Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN; 1Q-LINKED JUVENILE HEMOCHROMATOSIS; REPULSIVE GUIDANCE MOLECULE; SYSTEMIC IRON HOMEOSTASIS; SOLUBLE HEMOJUVELIN; PLASMA-MEMBRANE; DOWN-REGULATION; MESSENGER-RNA; OVERLOAD; TMPRSS6	Hemojuvelin (HJV) regulates iron homeostasis by direct interaction with bone morphogenetic protein (BMP) ligands to induce hepcidin expression through the BMP signaling pathway in the liver. Crystallography studies indicate that HJV can simultaneously bind to both BMP2 and the ubiquitously expressed cell surface receptor neogenin. However, the role of the neogenin-HJV interaction in the function of HJV is unknown. Here we identify a mutation in HJV that specifically lowers its interaction with neogenin. Expression of this mutant Hjv in the liver of Hjv(-/-) mice dramatically attenuated its induction of BMP signaling and hepcidin mRNA, suggesting that interaction with neogenin is critical for the iron regulatory function of HJV. Further studies revealed that neogenin co-immunoprecipitated with ALK3, an essential type-I BMP receptor for hepatic hepcidin expression. Neogenin has also been shown to facilitate the cleavage of HJV by furin in transfected cells. Surprisingly, although cleavage of HJV by furin has been implicated in the regulation of HJV function in cell culture models and furin-cleaved soluble Hjv is detectable in the serum of mice, mutating the furin cleavage site did not alter the stimulation of hepcidin expression by Hjv in mice. In vivo studies validated the important role of HJV-BMP interaction for Hjv stimulation of BMP signaling and hepcidin expression. Together these data support a model in which neogenin acts as a scaffold to facilitate assembly of the HJV.BMP.BMP receptor complex to induce hepcidin expression.	[Zhao, Ningning; Maxson, Julia E.; Zhang, Richard H.; Wahedi, Mastura; Enns, Caroline A.; Zhang, An-Sheng] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Portland, OR 97239 USA	Oregon Health & Science University	Zhang, AS (corresponding author), 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	zhanga@ohsu.edu			National Institutes of Health [R01DK102791, R01DK072166, K99DK104066, K99CA190605]; NATIONAL CANCER INSTITUTE [K99CA190605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072166, R01DK102791, K99DK104066, R37DK054488] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK102791 ( to A. S. Z.), R01DK072166 ( to C. A. E.), K99DK104066 ( to N. Z.), and K99CA190605 ( to J. E. M.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Bell CH, 2013, SCIENCE, V341, P77, DOI 10.1126/science.1232322; Besson-Fournier C, 2012, BLOOD, V120, P431, DOI 10.1182/blood-2012-02-411470; Chen W, 2011, BLOOD, V117, P6319, DOI 10.1182/blood-2010-12-327957; D'Alessio F, 2012, J HEPATOL, V57, P1052, DOI 10.1016/j.jhep.2012.06.015; Du X, 2008, SCIENCE, V320, P1088, DOI 10.1126/science.1157121; Enns CA, 2012, J BIOL CHEM, V287, P35104, DOI 10.1074/jbc.M112.363937; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Finberg KE, 2010, BLOOD, V115, P3817, DOI 10.1182/blood-2009-05-224808; Gkouvatsos K, 2011, HEPATOLOGY, V54, P1800, DOI 10.1002/hep.24547; Gutschow P, 2015, HAEMATOLOGICA, V100, P167, DOI 10.3324/haematol.2014.116723; Healey EG, 2015, NAT STRUCT MOL BIOL, V22, P458, DOI 10.1038/nsmb.3016; Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Kuns-Hashimoto R, 2008, AM J PHYSIOL-CELL PH, V294, pC994, DOI 10.1152/ajpcell.00563.2007; Lanzara C, 2004, BLOOD, V103, P4317, DOI 10.1182/blood-2004-01-0192; Latour C, 2016, HEPATOLOGY, V63, P126, DOI 10.1002/hep.28254; Lee DH, 2010, BLOOD, V115, P3136, DOI 10.1182/blood-2009-11-251199; Lefebvre T, 2015, CLIN CHEM LAB MED, V53, P1557, DOI 10.1515/cclm-2014-1093; Lin L, 2005, BLOOD, V106, P2884, DOI 10.1182/blood-2005-05-1845; Lin L, 2008, BLOOD CELL MOL DIS, V40, P122, DOI 10.1016/j.bcmd.2007.06.023; Matsunaga E, 2004, DEV GROWTH DIFFER, V46, P481; Maxson JE, 2010, J BIOL CHEM, V285, P39021, DOI 10.1074/jbc.M110.183160; Maxson JE, 2009, BLOOD, V113, P1786, DOI 10.1182/blood-2008-08-174565; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Nai A, 2016, BLOOD, V127, P2327, DOI 10.1182/blood-2015-11-681494; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Silvestri L, 2008, BLOOD, V111, P924, DOI 10.1182/blood-2007-07-100677; Silvestri L, 2007, BLOOD, V109, P4503, DOI 10.1182/blood-2006-08-041004; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Steinbicker AU, 2011, BLOOD, V118, P4224, DOI 10.1182/blood-2011-03-339952; Valore EV, 2008, BLOOD CELL MOL DIS, V40, P132, DOI 10.1016/j.bcmd.2007.07.009; Xia Y, 2008, BLOOD, V111, P5195, DOI 10.1182/blood-2007-09-111567; Yang F, 2008, BIOCHEMISTRY-US, V47, P4237, DOI 10.1021/bi800036h; Zhang AS, 2008, J BIOL CHEM, V283, P17494, DOI 10.1074/jbc.M710527200; Zhang AS, 2007, J BIOL CHEM, V282, P12547, DOI 10.1074/jbc.M608788200; Zhang AS, 2010, J BIOL CHEM, V285, P16416, DOI 10.1074/jbc.M110.109488; Zhang AS, 2009, J BIOL CHEM, V284, P22580, DOI 10.1074/jbc.M109.027318; Zhang AS, 2005, J BIOL CHEM, V280, P33885, DOI 10.1074/jbc.M506207200	42	28	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12322	12335		10.1074/jbc.M116.721191	http://dx.doi.org/10.1074/jbc.M116.721191			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27072365	hybrid, Green Published			2022-12-26	WOS:000378092800031
J	Iakovleva, I; Begum, A; Brannstrom, K; Wijsekera, A; Nilsson, L; Zhang, J; Andersson, PL; Sauer-Eriksson, AE; Olofsson, A				Iakovleva, Irina; Begum, Afshan; Brannstrom, Kristoffer; Wijsekera, Alexandra; Nilsson, Lina; Zhang, Jin; Andersson, Patrik L.; Sauer-Eriksson, A. Elisabeth; Olofsson, Anders			Tetrabromobisphenol A Is an Efficient Stabilizer of the Transthyretin Tetramer	PLOS ONE			English	Article							BROMINATED FLAME RETARDANTS; AMYLOID FIBRIL FORMATION; THYROID-HORMONE-BINDING; INHIBITION PROPERTIES; NATIVE-STATE; POTENT; DIFLUNISAL; AMYLOIDOGENESIS; POLYNEUROPATHY; DISEASE	Amyloid formation of the human plasma protein transthyretin (TTR) is associated with several human disorders, including familial amyloidotic polyneuropathy (FAP) and senile systemic amyloidosis. Dissociation of TTR's native tetrameric assembly is the rate-limiting step in the conversion into amyloid, and this feature presents an avenue for intervention because binding of an appropriate ligand to the thyroxin hormone binding sites of TTR stabilizes the native tetrameric assembly and impairs conversion into amyloid. The desired features for an effective TTR stabilizer include high affinity for TTR, high selectivity in the presence of other proteins, no adverse side effects at the effective concentrations, and a long half-life in the body. In this study we show that the commonly used flame retardant tetrabromobisphenol A (TBBPA) efficiently stabilizes the tetrameric structure of TTR. The X-ray crystal structure shows TBBPA binding in the thyroxine binding pocket with bromines occupying two of the three halogen binding sites. Interestingly, TBBPA binds TTR with an extremely high selectivity in human plasma, and the effect is equal to the recently approved drug tafamidis and better than diflunisal, both of which have shown therapeutic effects against FAP. TBBPA consequently present an interesting scaffold for drug design. Its absorption, metabolism, and potential side-effects are discussed.	[Iakovleva, Irina; Brannstrom, Kristoffer; Wijsekera, Alexandra; Olofsson, Anders] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden; [Begum, Afshan; Nilsson, Lina; Zhang, Jin; Andersson, Patrik L.; Sauer-Eriksson, A. Elisabeth] Umea Univ, Dept Chem, Umea, Sweden	Umea University; Umea University	Olofsson, A (corresponding author), Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden.	anders.olofsson@umu.se	Brännström, Kristoffer/AAC-1204-2020	BEGUM, AFSHAN/0000-0001-5047-5168; Sauer-Eriksson, Elisabeth/0000-0003-0124-0199	Swedish Research Council; Parkinsofonden; Insamlingsstiftelsen at Umea University; Alzheimerfonden; Ahlen-stiftelsen; J.C. Kempes stiftelse; Hjarnfonden; O.E. och Edlas stiftelse; Torsten Soderbergs stiftelse; Vasterbottens Lans lasting (ALF-medel); Patientforeningen FAMY/AMYL; Medical Faculty of Umea University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Parkinsofonden; Insamlingsstiftelsen at Umea University; Alzheimerfonden; Ahlen-stiftelsen; J.C. Kempes stiftelse; Hjarnfonden; O.E. och Edlas stiftelse; Torsten Soderbergs stiftelse; Vasterbottens Lans lasting (ALF-medel); Patientforeningen FAMY/AMYL; Medical Faculty of Umea University	We thank the Swedish Research Council, Parkinsofonden, Insamlingsstiftelsen at Umea University, Alzheimerfonden, Ahlen-stiftelsen, J.C. Kempes stiftelse, Hjarnfonden, O.E. och Edlas stiftelse, Torsten Soderbergs stiftelse, Vasterbottens Lans lasting (ALF-medel), Patientforeningen FAMY/AMYL, and the Medical Faculty of Umea University for funding.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adamski-Werner SL, 2004, J MED CHEM, V47, P355, DOI 10.1021/jm030347n; Addison RS, 2000, EUR J CLIN PHARMACOL, V56, P715, DOI 10.1007/s002280000211; Alhamadsheh MM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002473; Almeida M. R., 2005, Current Drug Targets - CNS and Neurological Disorders, V4, P587, DOI 10.2174/156800705774322076; Alshehri B, 2015, J NEUROENDOCRINOL, V27, P303, DOI 10.1111/jne.12271; Arvidsson S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143456; Belluti F, 2014, EUR J MED CHEM, V78, P157, DOI 10.1016/j.ejmech.2014.03.042; Berk JL, 2013, JAMA-J AM MED ASSOC, V310, P2658, DOI 10.1001/jama.2013.283815; Bromine Science and Environmental Forum (BSEF), BSEF POST TBBPA; Bulawa CE, 2012, P NATL ACAD SCI USA, V109, P9629, DOI 10.1073/pnas.1121005109; Carvalho A, 2015, LIVER TRANSPLANT, V21, P282, DOI 10.1002/lt.24058; Cheng SB, 2015, AM J REPROD IMMUNOL; CHENG SY, 1977, BIOCHEMISTRY-US, V16, P3707, DOI 10.1021/bi00635a031; Coelho T, 2013, J NEUROL, V260, P2802, DOI 10.1007/s00415-013-7051-7; Coelho T, 2012, NEUROLOGY, V79, P785, DOI 10.1212/WNL.0b013e3182661eb1; COLON W, 1992, BIOCHEMISTRY-US, V31, P8654, DOI 10.1021/bi00151a036; Cope RB, 2015, TOXICOLOGY, V329, P49, DOI 10.1016/j.tox.2014.12.013; Cotrina EY, 2013, J MED CHEM, V56, P9110, DOI 10.1021/jm401061w; Cruz MW, 2015, NEUROL THER, V4, P61, DOI 10.1007/s40120-015-0031-3; de Wit CA, 2010, SCI TOTAL ENVIRON, V408, P2885, DOI 10.1016/j.scitotenv.2009.08.037; Dunnick JK, 2015, TOXICOL PATHOL, V43, P464, DOI 10.1177/0192623314557335; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; European Medicines Agency, 2011, VYND ASS REP EUR MED; Ferreira N, 2013, BBA-MOL BASIS DIS, V1832, P39, DOI 10.1016/j.bbadis.2012.10.007; Ferreira N, 2012, AMYLOID, V19, P39, DOI 10.3109/13506129.2012.668502; Ferreira N, 2011, FEBS LETT, V585, P2424, DOI 10.1016/j.febslet.2011.06.030; Fromme H, 2014, ENVIRON INT, V64, P61, DOI 10.1016/j.envint.2013.11.017; Gales L, 2005, BIOCHEM J, V388, P615, DOI 10.1042/BJ20042035; Gales L, 2008, BBA-PROTEINS PROTEOM, V1784, P512, DOI 10.1016/j.bbapap.2007.11.014; Gertz MA, 2015, J AM COLL CARDIOL, V66, P2451, DOI 10.1016/j.jacc.2015.09.075; Hamers T, 2006, TOXICOL SCI, V92, P157, DOI 10.1093/toxsci/kfj187; Hornberg A, 2000, J MOL BIOL, V302, P649, DOI 10.1006/jmbi.2000.4078; Iakovleva I, 2015, J MED CHEM, V58, P6507, DOI 10.1021/acs.jmedchem.5b00544; Iakovleva I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128222; Jiang X, 2001, P NATL ACAD SCI USA, V98, P14943, DOI 10.1073/pnas.261419998; Johnson SM, 2009, J MED CHEM, V52, P1115, DOI 10.1021/jm801347s; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalkunte SS, 2013, AM J PATHOL, V183, P1425, DOI 10.1016/j.ajpath.2013.07.022; Kang MJ, 2009, J TOXICOL ENV HEAL A, V72, P1439, DOI 10.1080/15287390903212907; Klabunde T, 2000, NAT STRUCT BIOL, V7, P312; Knudsen GA, 2014, TOXICOL REP, V1, P214, DOI 10.1016/j.toxrep.2014.03.005; Lai DY, 2015, FOOD CHEM TOXICOL, V80, P206, DOI 10.1016/j.fct.2015.03.023; Lindhagen-Persson M, 2008, AMYLOID, V15, P240, DOI 10.1080/13506120802524916; Maetzler W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048042; Mairal T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004124; Manral P, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20140155; Marchesini GR, 2006, ANAL CHEM, V78, P1107, DOI 10.1021/ac051399i; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Meerts IATM, 2000, TOXICOL SCI, V56, P95, DOI 10.1093/toxsci/56.1.95; Miller SR, 2004, LAB INVEST, V84, P545, DOI 10.1038/labinvest.3700059; Miroy GJ, 1996, P NATL ACAD SCI USA, V93, P15051, DOI 10.1073/pnas.93.26.15051; Morais-de-Sa E, 2004, J BIOL CHEM, V279, P53483, DOI 10.1074/jbc.M408053200; Moreira L, 2015, AMYLOID, V22, P93, DOI 10.3109/13506129.2015.1007497; Mu YS, 2015, FEBS LETT, V589, P849, DOI 10.1016/j.febslet.2015.02.020; National Toxicology Program, 2014, 587 NTP; Nencetti S, 2013, CHEMMEDCHEM, V8, P1617, DOI 10.1002/cmdc.201300245; Nyholm JR, 2010, ENVIRON POLLUT, V158, P2235, DOI 10.1016/j.envpol.2010.02.010; Palaninathan SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006290; Patel KS, 2015, J INTERN MED, V278, P126, DOI 10.1111/joim.12383; Penchala SC, 2013, P NATL ACAD SCI USA, V110, P9992, DOI 10.1073/pnas.1300761110; Raghu P, 2002, ARCH BIOCHEM BIOPHYS, V400, P43, DOI 10.1006/abbi.2002.2779; Reixach N, 2004, P NATL ACAD SCI USA, V101, P2817, DOI 10.1073/pnas.0400062101; Reixach N, 2006, BIOCHEM BIOPH RES CO, V348, P889, DOI 10.1016/j.bbrc.2006.07.109; Ruberg FL, 2012, CIRCULATION, V126, P1286, DOI 10.1161/CIRCULATIONAHA.111.078915; Sant'Anna RO, 2013, INT J MOL SCI, V14, P5284, DOI 10.3390/ijms14035284; Saraiva MJ, 2012, CURR MED CHEM, V19, P2304; Schauer UMD, 2006, TOXICOL SCI, V91, P49, DOI 10.1093/toxsci/kfj132; Sekijima Y, 2006, AMYLOID, V13, P236, DOI 10.1080/13506120600960882; Sorgjerd K, 2008, BIOCHEM BIOPH RES CO, V377, P1072, DOI 10.1016/j.bbrc.2008.10.121; Sousa MM, 2001, AM J PATHOL, V159, P1993; Sousa MM, 2002, AM J PATHOL, V161, P1935, DOI 10.1016/S0002-9440(10)64469-0; Suhr OB, 2015, TRANSPLANTATION; Sun FF, 2014, ENVIRON SCI TECHNOL, V48, P14291, DOI 10.1021/es503383h; Tojo K, 2006, NEUROSCI RES, V56, P441, DOI 10.1016/j.neures.2006.08.014; Trivella DBB, 2012, J STRUCT BIOL, V180, P143, DOI 10.1016/j.jsb.2012.07.008; Trivella DBB, 2011, J STRUCT BIOL, V173, P323, DOI 10.1016/j.jsb.2010.10.003; Vaidya B, 2014, DIAGNOSIS MANAGEMENT; Viberg H, 2011, TOXICOLOGY, V289, P59, DOI 10.1016/j.tox.2011.07.010; Vilaro M, 2015, ACS COMB SCI, V17, P32, DOI 10.1021/co5001234; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P2843, DOI 10.1073/pnas.87.7.2843; Wilce JA, 2001, J BIOL CHEM, V276, P25997, DOI 10.1074/jbc.M101228200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yanagisawa A, 2015, MODERN PATHOL, V28, P201, DOI 10.1038/modpathol.2014.102; Yokoyama T, 2014, J MED CHEM, V57, P8928, DOI 10.1021/jm500997m	86	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153529	10.1371/journal.pone.0153529	http://dx.doi.org/10.1371/journal.pone.0153529			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093678	Green Submitted, Green Published, gold			2022-12-26	WOS:000374541200025
J	Ouedraogo, N; Kaplon, J; Bonkoungou, IJO; Traore, AS; Pothier, P; Barro, N; Ambert-Balay, K				Ouedraogo, Nafissatou; Kaplon, Jerome; Bonkoungou, Isidore Juste O.; Traore, Alfred Sababenedjo; Pothier, Pierre; Barro, Nicolas; Ambert-Balay, Katia			Prevalence and Genetic Diversity of Enteric Viruses in Children with Diarrhea in Ouagadougou, Burkina Faso	PLOS ONE			English	Article							GROUP-A ROTAVIRUS; MOLECULAR EPIDEMIOLOGY; ACUTE GASTROENTERITIS; VIRAL GASTROENTERITIS; GENOMIC CHARACTERIZATION; NOROVIRUS INFECTIONS; HUMAN ASTROVIRUSES; UNITED-KINGDOM; YOUNG-CHILDREN; AICHI VIRUSES	Enteric viruses are a major cause of diarrhea in children, especially those under five years old. Identifying the viral agents is critical to the development of effective preventive measures. This study aimed to determine the prevalence and genetic diversity of common enteric viruses in children under five years old in Burkina Faso. Stool samples from children with (n = 263) and without (n = 50) diarrhea disorders were collected in Ouagadougou, Burkina Faso from November 2011 to September 2012. Rotavirus, norovirus, sapovirus, astrovirus, adenovirus and Aichivirus A were detected using real-time or end-point (RT-)PCR. Rotavirus strains were G and P genotyped by multiplex RT-PCR and other viral strains were characterized by sequencing of viral subgenomic segements. At least one viral agent was detected in 85.6% and 72% of the symptomatic and asymptomatic patients, respectively. Rotavirus (63.5%), adenovirus (31.2%) and genogroup II norovirus (18.2%) were the most prevalent viruses in symptomatic patients, but only rotavirus and genogroup II norovirus were significantly associated with diarrhea (OR: 7.9, 95`)/X1: 3.7-17; OR: 3.5, 95`)/X1: 1-11.7, respectively). Sapovirus (10.3%), astrovirus (4.9%), genogroup I norovirus (2.7%) and Aichivirus A (0.8%) were less prevalent. The predominant genotype of rotavirus was G9P[8] (36.5%), and the predominant norovirus strain was GII.4 variant 2012 (71.4%). Among sapovirus, the genogroup II (87.5%) predominated. Astrovirus type 1 (41.7%) was the most frequent astrovirus identified. Aichivirus A belonged to the three genotypes (A, B and C). Enteric adenoviruses type 40 and 41 were identified in 10.2% and 5.1% respectively. Several cases of co -infections were detected. The results highlight the high prevalence and the high diversity of enteric viruses in Burkinabe children.	[Ouedraogo, Nafissatou; Bonkoungou, Isidore Juste O.; Traore, Alfred Sababenedjo; Barro, Nicolas] Univ Ouagadougou, Lab Biol Mol Epidemiol & Surveillance Bacteries &, CRSBAN, Ouagadougou, Burkina Faso; [Kaplon, Jerome; Pothier, Pierre; Ambert-Balay, Katia] Univ Hosp Dijon, Natl Reference Ctr Enter Viruses, Dijon, France; [Bonkoungou, Isidore Juste O.] DBM, Lab Natl Sante Publ, Ouagadougou, Burkina Faso	CHU Dijon Bourgogne	Ouedraogo, N (corresponding author), Univ Ouagadougou, Lab Biol Mol Epidemiol & Surveillance Bacteries &, CRSBAN, Ouagadougou, Burkina Faso.	nafissatouedraogo@yahoo.fr	Bonkoungou, Isidore/ABC-3889-2020; Kaplon, Jerome/E-1707-2013	Bonkoungou, Isidore/0000-0002-8622-662X; Ambert-Balay, Katia/0000-0002-2624-712X; Kaplon, Jerome/0000-0002-8180-4152				Allard A, 2001, J CLIN MICROBIOL, V39, P498, DOI 10.1128/JCM.39.2.498-505.2001; Armah GE, 2003, J CLIN MICROBIOL, V41, P2317, DOI 10.1128/JCM.41.6.2317-2322.2003; Armah GE, 2006, J MED VIROL, V78, P1480, DOI 10.1002/jmv.20722; Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6; Bini J C, 2007, Bull Soc Pathol Exot, V100, P243; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bonkoungou IJO, 2011, J MED VIROL, V83, P1485, DOI 10.1002/jmv.22137; Bonkoungou IJO, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-94; Bosch A, 2014, CLIN MICROBIOL REV, V27, P1048, DOI 10.1128/CMR.00013-14; Boschi-Pinto C, 2008, B WORLD HEALTH ORGAN, V86, P710, DOI 10.2471/BLT.07.050054; Bull RA, 2006, J CLIN MICROBIOL, V44, P327, DOI 10.1128/JCM.44.2.327-333.2006; Chhabra P, 2009, J MED VIROL, V81, P922, DOI 10.1002/jmv.21458; Cunliffe NA, 2010, EMERG INFECT DIS, V16, P55, DOI 10.3201/eid1601.090401; Estes MK, 2007, FIELDS VIROLOGY, P1917; Fang Zhao-yin, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P673; Flahault A, 2010, B ACAD NAT MED PARIS, V194, P1415, DOI 10.1016/S0001-4079(19)32172-7; Fukuda S, 2008, J MED VIROL, V80, P921, DOI 10.1002/jmv.21151; Galeano ME, 2013, J CLIN VIROL, V58, P378, DOI 10.1016/j.jcv.2013.07.008; Gallimore CI, 2006, J MED VIROL, V78, P673, DOI 10.1002/jmv.20592; Gomara MI, 2004, J CLIN MICROBIOL, V42, P2541, DOI 10.1128/JCM.42.6.2541-2547.2004; Guntapong R, 2004, JPN J INFECT DIS, V57, P276; Gutierrez-Aguirre I, 2008, J CLIN MICROBIOL, V46, P2547, DOI 10.1128/JCM.02428-07; Hansman GS, 2006, EMERG INFECT DIS, V12, P141, DOI 10.3201/eid1201.050846; Huynen P, 2013, J CLIN VIROL, V58, P515, DOI 10.1016/j.jcv.2013.08.013; Iturriza-Gomara M, 2000, J CLIN MICROBIOL, V38, P4394; Japhet MO, 2012, J MED VIROL, V84, P1489, DOI 10.1002/jmv.23343; Jeong AY, 2011, CLIN MICROBIOL INFEC, V17, P404, DOI 10.1111/j.1469-0691.2010.03263.x; Jones MS, 2007, J VIROL, V81, P5978, DOI 10.1128/JVI.02650-06; Kaplon J, 2015, J CLIN MICROBIOL, V53, P3670, DOI 10.1128/JCM.01984-15; Kiulia NM, 2014, PEDIATR INFECT DIS J, V33, pS85, DOI 10.1097/INF.0000000000000059; Kojima S, 2002, J VIROL METHODS, V100, P107, DOI 10.1016/S0166-0934(01)00404-9; Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006; Le Cann P, 2004, RES MICROBIOL, V155, P11, DOI 10.1016/j.resmic.2003.09.013; Lekana-Douki SE, 2015, INT J INFECT DIS, V34, P90, DOI 10.1016/j.ijid.2015.03.009; Liu XN, 2015, J MED VIROL, V87, P2048, DOI 10.1002/jmv.24283; Loisy F, 2005, J VIROL METHODS, V123, P1, DOI 10.1016/j.jviromet.2004.08.023; Lyman WH, 2009, J PEDIATR-US, V154, P253, DOI 10.1016/j.jpeds.2008.07.057; Malasao R, 2008, J MED VIROL, V80, P1749, DOI 10.1002/jmv.21244; Martella V, 2010, VET MICROBIOL, V140, P246, DOI 10.1016/j.vetmic.2009.08.028; Matsushima Y, 2011, J GEN VIROL, V92, P2770, DOI 10.1099/vir.0.034744-0; Matussek A, 2015, INFECT GENET EVOL, V32, P396, DOI 10.1016/j.meegid.2015.03.039; Mayindou G, 2016, J MED VIROL, V88, P596, DOI 10.1002/jmv.24382; Meyer CT, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0299-z; Mihalov-Kovacs E, 2015, EMERG INFECT DIS, V21, P660, DOI 10.3201/eid2104.141370; Moreno-Espinosa Sarbelio, 2004, Semin Pediatr Infect Dis, V15, P237, DOI 10.1053/j.spid.2004.07.004; Mukherjee A, 2010, ARCH VIROL, V154, P33; Mustafa H, 2000, J CLIN MICROBIOL, V38, P1058, DOI 10.1128/JCM.38.3.1058-1062.2000; Mwenda JM, 2010, J INFECT DIS, V202, pS5, DOI 10.1086/653557; Nguyen TA, 2007, J MED VIROL, V79, P582, DOI 10.1002/jmv.20857; Nitiema LW, 2011, INT J INFECT DIS, V15, pE646, DOI 10.1016/j.ijid.2011.05.009; Noel JS, 1997, J MED VIROL, V52, P173, DOI 10.1002/(SICI)1096-9071(199706)52:2&lt;173::AID-JMV10&gt;3.0.CO;2-M; NOEL JS, 1995, J CLIN MICROBIOL, V33, P797, DOI 10.1128/JCM.33.4.797-801.1995; Nordgren J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069557; Nordgren J, 2012, EMERG INFECT DIS, V18, P589, DOI 10.3201/eid1804.110973; Oh DY, 2006, ARCH VIROL, V151, P1199, DOI 10.1007/s00705-005-0706-7; Oh DY, 2003, J MED VIROL, V71, P82, DOI 10.1002/jmv.10449; Oka T, 2006, J MED VIROL, V78, P1347, DOI 10.1002/jmv.20699; Oka T, 2015, CLIN MICROBIOL REV, V28, P32, DOI 10.1128/CMR.00011-14; Okitsu-Negishi S, 2004, PEDIATR INT, V46, P245, DOI 10.1046/j.1442-200x.2004.01896.x; Ouyang YB, 2012, ARCH VIROL, V157, P881, DOI 10.1007/s00705-012-1235-9; Page AL, 2014, EMERG INFECT DIS, V20, P573, DOI 10.3201/eid2004.131328; Patel MM, 2009, J CLIN VIROL, V44, P1, DOI 10.1016/j.jcv.2008.10.009; Pukuta ES, 2014, PEDIATR INFECT DIS J, V33, P355, DOI 10.1097/INF.0000000000000212; Rackoff LA, 2013, LANCET, V8; Ren ZZ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-412; Robinson CM, 2011, INFECT GENET EVOL, V11, P1208, DOI 10.1016/j.meegid.2011.04.031; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Sdiri-Loulizi K, 2008, J CLIN MICROBIOL, V46, P1349, DOI 10.1128/JCM.02438-07; Sdiri-Loulizi K, 2009, J CLIN MICROBIOL, V47, P2275, DOI 10.1128/JCM.00913-09; Sdiri-Loulizi K, 2009, J CLIN MICROBIOL, V47, P421, DOI 10.1128/JCM.01852-08; Simpson R, 2003, J MED VIROL, V70, P258, DOI 10.1002/jmv.10386; Steele AD, 2010, J INFECT DIS, V202, pS225, DOI 10.1086/653574; Stupka JA, 2012, J CLIN VIROL, V54, P162, DOI 10.1016/j.jcv.2012.02.011; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tcheremenskaia O, 2007, J CLIN MICROBIOL, V45, P2197, DOI 10.1128/JCM.00484-07; Trojnar E, 2013, J GEN VIROL, V94, P136, DOI 10.1099/vir.0.047381-0; Vinje J, 1996, J INFECT DIS, V174, P610, DOI 10.1093/infdis/174.3.610; Vinje J, 2015, J CLIN MICROBIOL, V53, P373, DOI 10.1128/JCM.01535-14; Wu FT, 2015, J MED VIROL, V87, P1462, DOI 10.1002/jmv.24208; Yamashita T, 2000, J CLIN MICROBIOL, V38, P2955, DOI 10.1128/JCM.38.8.2955-2961.2000; Yang XL, 2008, INT J INFECT DIS, V12, pE11, DOI 10.1016/j.ijid.2008.03.022	81	60	61	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153652	10.1371/journal.pone.0153652	http://dx.doi.org/10.1371/journal.pone.0153652			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27092779	Green Submitted, Green Published, gold			2022-12-26	WOS:000374541200037
J	Sundstrom, A; Grabocka, E; Bar-Sagi, D; Mishra, B				Sundstrom, Andrew; Grabocka, Elda; Bar-Sagi, Dafna; Mishra, Bud			Histological Image Processing Features Induce a Quantitative Characterization of Chronic Tumor Hypoxia	PLOS ONE			English	Article							OXYGEN-TRANSPORT; CANCER; FIBROBLASTS; TISSUES; IMPACT; CELLS; MODEL	Hypoxia in tumors signifies resistance to therapy. Despite a wealth of tumor histology data, including anti-pimonidazole staining, no current methods use these data to induce a quantitative characterization of chronic tumor hypoxia in time and space. We use image-processing algorithms to develop a set of candidate image features that can formulate just such a quantitative description of xenographed colorectal chronic tumor hypoxia. Two features in particular give low-variance measures of chronic hypoxia near a vessel: intensity sampling that extends radially away from approximated blood vessel centroids, and multithresholding to segment tumor tissue into normal, hypoxic, and necrotic regions. From these features we derive a spatiotemporal logical expression whose truth value depends on its predicate clauses that are grounded in this histological evidence. As an alternative to the spatiotemporal logical formulation, we also propose a way to formulate a linear regression function that uses all of the image features to learn what chronic hypoxia looks like, and then gives a quantitative similarity score once it is trained on a set of histology images.	[Sundstrom, Andrew] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Grabocka, Elda; Bar-Sagi, Dafna] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY USA; [Sundstrom, Andrew; Mishra, Bud] NYU, Courant Inst Math Sci, Dept Comp Sci, New York, NY 10012 USA	Icahn School of Medicine at Mount Sinai; New York University; New York University	Sundstrom, A (corresponding author), Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA.; Sundstrom, A (corresponding author), NYU, Courant Inst Math Sci, Dept Comp Sci, New York, NY 10012 USA.	andrew.sundstrom@mssm.edu	Sundstrom, Andrew/AAI-3621-2021	Sundstrom, Andrew/0000-0002-3378-4513; Grabocka, E/0000-0001-7196-8498; Bar-Sagi, Dafna/0000-0003-2597-8948	National Science Foundation [DGE-0333389, CNS-0926166]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation - DGE-0333389 - IGERT: Program in Computation (http.//www.nsf.gov/) (AS), and National Science Foundation - CNS-0926166 - Collaborative Research: Next-Generation Model Checking and Abstract Interpretation with a Focus on Embedded Control and Systems Biology (http://www.nsf.gov) (BM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, CELL; BEATON AE, 1974, TECHNOMETRICS, V16, P147, DOI 10.2307/1267936; Cardenas-Navia LI, 2008, CANCER RES, V68, P5812, DOI 10.1158/0008-5472.CAN-07-6387; Cirri P, 2011, AM J CANCER RES, V1, P482; Giaccia AJ, 2010, CURR TOP MICROBIOL, V345, P31, DOI 10.1007/82_2010_73; Goldman D, 2008, MICROCIRCULATION, V15, P795, DOI 10.1080/10739680801938289; Gong HJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S7-S10; Green DR, 2011, MEANS END APOPTOSIS; Grosu R, 2009, COMMUN ACM, V52, P97, DOI 10.1145/1467247.1467271; Guderlei R, 2007, IMAGE VISION COMPUT, V25, P464, DOI 10.1016/j.imavis.2006.07.019; Haijun Gong, 2010, Algebraic and Numeric Biology. 4th International Conference, ANB 2010. Revised Selected Papers, P117, DOI 10.1007/978-3-642-28067-2_7; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; Hockel M, 1996, CANCER RES, V56, P4509; Hutterer S., 2012, 2012 IEEE Symposium on Computational Intelligence in Bioinformatics and Computational Biology (CIBCB), P105, DOI 10.1109/CIBCB.2012.6217218; James W, 1961, P BERK S MATH STAT P, P316; Jha SK, 2009, LECT N BIOINFORMAT, V5688, P218, DOI 10.1007/978-3-642-03845-7_15; Kang K A, 1988, Adv Exp Med Biol, V222, P747; Kavanagh BD, 2002, INT J RADIAT ONCOL, V53, P172, DOI 10.1016/S0360-3016(02)02740-2; Kirkpatrick JP, 2003, RADIAT RES, V159, P336, DOI 10.1667/0033-7587(2003)159[0336:AMMOTO]2.0.CO;2; Kleinberg J., 2006, ALGORITHM DESIGN, P261; Krogh A, 1919, J PHYSIOL-LONDON, V52, P391, DOI 10.1113/jphysiol.1919.sp001838; Krogh A, 1919, J PHYSIOL-LONDON, V52, P457, DOI 10.1113/jphysiol.1919.sp001844; Krogh A, 1919, J PHYSIOL-LONDON, V52, P409, DOI 10.1113/jphysiol.1919.sp001839; Legland David, 2007, Image Analysis & Stereology, V26, P83, DOI 10.5566/ias.v26.p83-92; Michielsen K, 2001, PHYS REP, V347, P462; Osinsky S, 2011, CLIN TRANSL ONCOL, V13, P133, DOI 10.1007/s12094-011-0630-0; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Rath C, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/12/125010; Roque WL, 2009, BRAZILIAN J RHEUMATO, V49, P146; SECOMB TW, 1993, INT J RADIAT ONCOL, V25, P481, DOI 10.1016/0360-3016(93)90070-C; Sen A, 1990, REGRESSION ANAL THEO, P253; Simon M.C, 2010, DIVERSE EFFECTS HYPO, V345; Sundstrom A, 2012, IEEE T INF TECHNOL B, V16, P1200, DOI 10.1109/TITB.2012.2206819; TANNOCK IF, 1970, CANCER RES, V30, P2470; THOMLINSON RH, 1955, BRIT J CANCER, V9, P539, DOI 10.1038/bjc.1955.55; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Wang CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015818; Weibel ER, 2013, J EXP BIOL, V216, P4135, DOI 10.1242/jeb.076497; Zuliani P, 2010, HSSC 10: PROCEEDINGS OF THE 13TH ACM INTERNATIONAL CONFERENCE ON HYBRID SYSTEMS: COMPUTATION AND CONTROL, P243	39	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153623	10.1371/journal.pone.0153623	http://dx.doi.org/10.1371/journal.pone.0153623			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093539	Green Published, gold, Green Submitted			2022-12-26	WOS:000374541200033
J	Findlay, SD; Vincent, KM; Berman, JR; Postovit, LM				Findlay, Scott D.; Vincent, Krista M.; Berman, Jennifer R.; Postovit, Lynne-Marie			A Digital PCR-Based Method for Efficient and Highly Specific Screening of Genome Edited Cells	PLOS ONE			English	Article							EFFECTOR NUCLEASES; KNOCKOUT; GENERATION; TALENS; DESIGN; SYSTEM; TOOLS	The rapid adoption of gene editing tools such as CRISPRs and TALENs for research and eventually therapeutics necessitates assays that can rapidly detect and quantitate the desired alterations. Currently, the most commonly used assay employs "mismatch nucleases" T7E1 or "Surveyor" that recognize and cleave heteroduplexed DNA amplicons containing mismatched base-pairs. However, this assay is prone to false positives due to cancer-associated mutations and/or SNPs and requires large amounts of starting material. Here we describe a powerful alternative wherein droplet digital PCR (ddPCR) can be used to decipher homozygous from heterozygous mutations with superior levels of both precision and sensitivity. We use this assay to detect knockout inducing alterations to stem cell associated proteins, NODAL and SFRP1, generated using either TALENs or an "all-in-one" CRISPR/Cas plasmid that we have modified for one-step cloning and blue/white screening of transformants. Moreover, we highlight how ddPCR can be used to assess the efficiency of varying TALEN-based strategies. Collectively, this work highlights how ddPCR-based screening can be paired with CRISPR and TALEN technologies to enable sensitive, specific, and streamlined approaches to gene editing and validation.	[Findlay, Scott D.; Vincent, Krista M.] Univ Western Ontario, Dept Anat & Cell Biol, Fac Med & Dent, London, ON, Canada; [Findlay, Scott D.; Vincent, Krista M.; Postovit, Lynne-Marie] Univ Alberta, Dept Oncol, Fac Med & Dent, Edmonton, AB, Canada; [Berman, Jennifer R.] Biorad Labs, Digital Biol Ctr, Pleasanton, CA USA	Western University (University of Western Ontario); University of Alberta	Postovit, LM (corresponding author), Univ Alberta, Dept Oncol, Fac Med & Dent, Edmonton, AB, Canada.	postovit@ualberta.ca	Findlay, Scott D/AAP-9554-2021	Findlay, Scott D/0000-0002-0393-1623; Postovit, Lynne-Marie/0000-0002-8088-4197	Canadian Institutes for Health Research [PLS 9538, PLS 95381]; Alberta Cancer Foundation; Women and Children's Health Research Institute; Alberta Innovates Health Solutions; Natural Sciences and Engineering Research Council of Canada; Ontario Graduate Scholarship; CIHR; Sawin-Baldwin Chair in Ovarian Cancer; Dr. Anthony Noujaim Legacy Oncology Chair; AIHS translational health chair in cancer; Canadian Foundation for Innovation Leaders Opportunity Fund [32351]; Alberta Innovates [201300495] Funding Source: researchfish	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Cancer Foundation; Women and Children's Health Research Institute; Alberta Innovates Health Solutions; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Graduate Scholarship(Ontario Graduate Scholarship); CIHR(Canadian Institutes of Health Research (CIHR)); Sawin-Baldwin Chair in Ovarian Cancer; Dr. Anthony Noujaim Legacy Oncology Chair; AIHS translational health chair in cancer; Canadian Foundation for Innovation Leaders Opportunity Fund(Canada Foundation for Innovation); Alberta Innovates	This work was supported by the Canadian Institutes for Health Research (PLS 9538 and PLS 95381), the Alberta Cancer Foundation, the Women and Children's Health Research Institute and Alberta Innovates Health Solutions. SDF has been supported by a doctoral scholarship from the Natural Sciences and Engineering Research Council of Canada, and an Ontario Graduate Scholarship. KMV is a Vanier scholar. LMP is the recipient of the premier new investigator award from the CIHR, the Sawin-Baldwin Chair in Ovarian Cancer, the Dr. Anthony Noujaim Legacy Oncology Chair and the AIHS translational health chair in cancer. The droplet digital PCR platform was funded by the Canadian Foundation for Innovation Leaders Opportunity Fund (project 32351) awarded to LMP. JRB is an employee of Bio-Rad Laboratories. Funders provided support in terms of salaries for authors and grants for research materials, but did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	Bell CC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1002; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Cong L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1962; Corbisier P, 2015, ANAL BIOANAL CHEM, V407, P1831, DOI 10.1007/s00216-015-8458-z; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Flemr M, 2015, CELL REP, V12, P709, DOI 10.1016/j.celrep.2015.06.051; Frank S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-773; Hendel A, 2015, TRENDS BIOTECHNOL, V33, P132, DOI 10.1016/j.tibtech.2014.12.001; Jankele R, 2014, BRIEF FUNCT GENOMICS, V13, P409, DOI 10.1093/bfgp/elu013; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Kim Y, 2013, NAT METHODS, V10, P185, DOI [10.1038/nmeth.2364, 10.1038/NMETH.2364]; Lin YN, 2014, METHODS MOL BIOL, V1114, P203, DOI 10.1007/978-1-62703-761-7_13; Miyaoka Y, 2014, NAT METHODS, V11, P291, DOI 10.1038/nmeth.2840; Mock U, 2015, NUCLEIC ACIDS RES, V43, P5560, DOI 10.1093/nar/gkv469; Quail DF, 2013, INT J BIOCHEM CELL B, V45, P885, DOI 10.1016/j.biocel.2012.12.021; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Streubel J, 2012, NAT BIOTECHNOL, V30, P593, DOI 10.1038/nbt.2304; Sun N, 2013, BIOTECHNOL BIOENG, V110, P1811, DOI 10.1002/bit.24890; Sung YH, 2014, GENOME RES, V24, P125, DOI 10.1101/gr.163394.113; Surana R, 2014, BBA-REV CANCER, V1845, P53, DOI 10.1016/j.bbcan.2013.11.004; Vouillot L, 2015, G3-GENES GENOM GENET, V5, P407, DOI 10.1534/g3.114.015834; Wang K, 2015, J BIOTECHNOL, V214, P128, DOI 10.1016/j.jbiotec.2015.09.029; WELCH DR, 1991, INT J CANCER, V47, P227, DOI 10.1002/ijc.2910470211; Yang Z, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv126; Yu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098282	28	47	52	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153901	10.1371/journal.pone.0153901	http://dx.doi.org/10.1371/journal.pone.0153901			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27089539	gold, Green Submitted, Green Published			2022-12-26	WOS:000374527000057
J	Tzekov, R; Dawson, C; Orlando, M; Mouzon, B; Reed, J; Evans, J; Crynen, G; Mullan, M; Crawford, F				Tzekov, Radouil; Dawson, Clint; Orlando, Megan; Mouzon, Benoit; Reed, Jon; Evans, James; Crynen, Gogce; Mullan, Michael; Crawford, Fiona			Sub-Chronic Neuropathological and Biochemical Changes in Mouse Visual System after Repetitive Mild Traumatic Brain Injury	PLOS ONE			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; MICROTUBULE-ASSOCIATED PROTEINS; RETINAL GANGLION-CELLS; HEAT-SHOCK PROTEINS; OPTIC-NERVE LESION; AXONAL-TRANSPORT; BASIC-PROTEIN; ALTERED EXPRESSION; APOLIPOPROTEIN-E; CATHEPSIN-D	Repetitive mild traumatic brain injury (r-mTBI) results in neuropathological and biochemical consequences in the human visual system. Using a recently developed mouse model of r-mTBI, with control mice receiving repetitive anesthesia alone (r-sham) we assessed the effects on the retina and optic nerve using histology, immunohistochemistry, proteomic and lipidomic analyses at 3 weeks post injury. Retina tissue was used to determine retinal ganglion cell (RGC) number, while optic nerve tissue was examined for cellularity, myelin content, protein and lipid changes. Increased cellularity and areas of demyelination were clearly detectable in optic nerves in r-mTBI, but not in r-sham. These changes were accompanied by a similar to 25% decrease in the total number of Brn3a-positive RGCs. Proteomic analysis of the optic nerves demonstrated various changes consistent with a negative effect of r-mTBI on major cellular processes like depolymerization of microtubules, disassembly of filaments and loss of neurons, manifested by decrease of several proteins, including neurofilaments (NEFH, NEFM, NEFL), tubulin (TUBB2A, TUBA4A), microtubule-associated proteins (MAP1A, MAP1B), collagen (COL6A1, COL6A3) and increased expression of other proteins, including heat shock proteins (HSP90B1, HSPB1), APOE and cathepsin D. Lipidomic analysis showed quantitative changes in a number of phospholipid species, including a significant increase in the total amount of lysophosphatidylcholine (LPC), including the molecular species 16:0, a known demyelinating agent. The overall amount of some ether phospholipids, like ether LPC, ether phosphatidylcholine and ether lysophosphatidylethanolamine were also increased, while the majority of individual molecular species of ester phospholipids, like phosphatidylcholine and phosphatidylethanolamine, were decreased. Results from the biochemical analysis correlate well with changes detected by histological and immunohistochemical methods and indicate the involvement of several important molecular pathways. This will allow future identification of therapeutic targets for improving the visual consequences of r-mTBI.	[Tzekov, Radouil; Dawson, Clint; Orlando, Megan; Mouzon, Benoit; Reed, Jon; Evans, James; Crynen, Gogce; Mullan, Michael; Crawford, Fiona] Roskamp Inst, Sarasota, FL USA; [Tzekov, Radouil] Univ S Florida, Dept Ophthalmol, Tampa, FL USA; [Tzekov, Radouil; Mouzon, Benoit; Evans, James; Crawford, Fiona] James A Haley Vet Adm, Tampa, FL USA	State University System of Florida; University of South Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital	Tzekov, R (corresponding author), Roskamp Inst, Sarasota, FL USA.; Tzekov, R (corresponding author), Univ S Florida, Dept Ophthalmol, Tampa, FL USA.; Tzekov, R (corresponding author), James A Haley Vet Adm, Tampa, FL USA.	rtzekov@roskampinstitute.net	Dawson, Clint/AAH-3213-2021	Dawson, Clint/0000-0001-7273-0684; Tzekov, Radouil/0000-0002-3662-9818	Department of Defense [W81XWH-10-1-0759]; Roskamp Foundation	Department of Defense(United States Department of Defense); Roskamp Foundation	This work was supported by Department of Defense award W81XWH-10-1-0759 (to Fiona Crawford), and the Roskamp Foundation.	Abdullah L, 2014, FASEB J, V28, P5311, DOI 10.1096/fj.14-258228; ADAMCZEWSKAGONCERZEWICZ Z, 1981, J NEUROCHEM, V36, P1378, DOI 10.1111/j.1471-4159.1981.tb00575.x; Agudo-Barriuso M, 2011, MYSTERY GLAUCOMA, P91; Aquino DA, 1997, J NEUROPATH EXP NEUR, V56, P664; Atkins Edward J, 2008, Rev Neurol Dis, V5, P73; Beaulieu JM, 1999, BIOCHEM CELL BIOL, V77, P41, DOI 10.1139/bcb-77-1-41; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bilyk J R, 1994, Semin Ophthalmol, V9, P200, DOI 10.3109/08820539409060016; Blondeau N, 2002, J CEREBR BLOOD F MET, V22, P821, DOI 10.1097/00004647-200207000-00007; Bocquet A, 2009, J NEUROSCI, V29, P11043, DOI 10.1523/JNEUROSCI.1924-09.2009; CAMMER W, 1986, BRAIN RES, V364, P91, DOI 10.1016/0006-8993(86)90990-X; Carroll W M, 1983, Clin Exp Neurol, V19, P17; Chen H, 2014, SURV OPHTHALMOL, V59, P64, DOI 10.1016/j.survophthal.2013.02.005; Chidlow G, 2005, MOL VIS, V11, P387; Chidlow G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114838; Cho Y, 2015, J BIOL CHEM, V290, P22759, DOI 10.1074/jbc.M115.638445; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Cwiklinska H, 2003, INT IMMUNOL, V15, P241, DOI 10.1093/intimm/dxg022; DAS SK, 1978, LIPIDS, V13, P679, DOI 10.1007/BF02533745; de Monasterio-Schrader P, 2012, CELL MOL LIFE SCI, V69, P2879, DOI 10.1007/s00018-012-0958-9; Dieterich DC, 2002, EUR J NEUROSCI, V15, P1433, DOI 10.1046/j.1460-9568.2002.01977.x; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Galindo-Romero C, 2011, EXP EYE RES, V92, P377, DOI 10.1016/j.exer.2011.02.008; GOTO K, 1990, NEUROSCI LETT, V117, P269, DOI 10.1016/0304-3940(90)90675-Y; Greenwald BD, 2012, BRAIN INJURY, V26, P1338, DOI 10.3109/02699052.2012.706356; Grzelczyk A, 2013, BIOCHIMIE, V95, P667, DOI 10.1016/j.biochi.2012.10.009; Gupta R, 2005, J ORTHOP RES, V23, P1232, DOI 10.1016/j.orthres.2004.12.010; Hensley K, 2011, MOL NEUROBIOL, V43, P180, DOI 10.1007/s12035-011-8166-4; HERRMANN H, 1985, J BIOL CHEM, V260, P5797; Hsieh CC, 2000, ATHEROSCLEROSIS, V151, P481, DOI 10.1016/S0021-9150(00)00453-6; IGNATIUS MJ, 1986, P NATL ACAD SCI USA, V83, P1125, DOI 10.1073/pnas.83.4.1125; Ikeno Y, 2009, J NEUROSCI RES, V87, P190, DOI 10.1002/jnr.21821; Jacobs SM, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0389-5; Joachim SC, 2011, INVEST OPHTH VIS SCI, V52, P3468, DOI 10.1167/iovs.10-5763; Johnson EC, 2007, INVEST OPHTH VIS SCI, V48, P3161, DOI 10.1167/iovs.06-1282; Kim H, 2011, FEBS LETT, V585, P18, DOI 10.1016/j.febslet.2010.11.033; Kubo T, 2002, J NEUROCHEM, V82, P1129, DOI 10.1046/j.1471-4159.2002.01060.x; Kuhlmann T, 2002, J NEUROSCI RES, V67, P185, DOI 10.1002/jnr.10104; Lachapelle F, 2005, BRAIN PATHOL, V15, P198; Lavi S, 2007, CIRCULATION, V115, P2715, DOI 10.1161/CIRCULATIONAHA.106.671420; Levkovitch-Verbin H, 2000, INVEST OPHTH VIS SCI, V41, P4169; Li Y, 2011, J CELL BIOCHEM, V112, P1930, DOI 10.1002/jcb.23113; Lin PC, 2011, J BIOL CHEM, V286, P41466, DOI 10.1074/jbc.M111.283580; LIU KM, 1985, CELL TISSUE RES, V242, P245; Martin A, 2003, J NEUROSCI, V23, P5416; Maxwell WL, 2013, BRAIN SCI, V3, P1374, DOI 10.3390/brainsci3031374; MCKERRACHER L, 1990, J NEUROSCI, V10, P2834; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Nagai J, 2011, J NEUROCHEM, V118, P256, DOI 10.1111/j.1471-4159.2011.07297.x; Nguyen JV, 2011, P NATL ACAD SCI USA, V108, P1176, DOI 10.1073/pnas.1013965108; NIXON RA, 1984, J NEUROCHEM, V43, P507, DOI 10.1111/j.1471-4159.1984.tb00928.x; NIXON RA, 1990, J CELL BIOL, V110, P437, DOI 10.1083/jcb.110.2.437; Padilla ND, 2003, IMMUNOLOGY, V109, P564, DOI 10.1046/j.1365-2567.2003.01681.x; Pasvogel AE, 2010, BIOL RES NURS, V11, P325, DOI 10.1177/1099800409346056; Petratos S, 2012, BRAIN, V135, P1794, DOI 10.1093/brain/aws100; Prilloff S, 2012, INVEST OPHTH VIS SCI, V53, P1460, DOI 10.1167/iovs.11-8306; Raasakka A, 2014, NEUROSCI BULL, V30, P956, DOI 10.1007/s12264-013-1437-5; Rodemer C, 2003, HUM MOL GENET, V12, P1881, DOI 10.1093/hmg/ddg191; Rosenberger TA, 2002, J LIPID RES, V43, P59; Saab S, 2014, BIOCHIMIE, V107, P58, DOI 10.1016/j.biochi.2014.07.023; Saatman KE, 2003, J CEREBR BLOOD F MET, V23, P34, DOI 10.1097/01.WCB.0000035040.10031.B0; Salinas-Navarro M, 2009, VISION RES, V49, P637, DOI 10.1016/j.visres.2009.01.010; Saunders LL, 2009, ARCH PHYS MED REHAB, V90, P1853, DOI 10.1016/j.apmr.2009.05.020; Schilling T, 2009, J CELL PHYSIOL, V221, P325, DOI 10.1002/jcp.21857; SCHMIDTKASTNER R, 1994, RESTOR NEUROL NEUROS, V6, P145, DOI 10.3233/RNN-1994-6208; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHOENFELD TA, 1989, J NEUROSCI, V9, P1712; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Serbest G, 2007, NEUROCHEM RES, V32, P2006, DOI 10.1007/s11064-007-9318-9; Sherafat MA, 2011, NEUROCHEM RES, V36, P1887, DOI 10.1007/s11064-011-0510-6; SNYDER DS, 1985, J NEUROCYTOL, V14, P579, DOI 10.1007/BF01200799; STOLL G, 1989, GLIA, V2, P170, DOI 10.1002/glia.440020306; Surgucheva I, 2002, J NEUROSCI RES, V68, P97, DOI 10.1002/jnr.10198; Surguchov A, 2001, J NEUROSCI RES, V65, P68, DOI 10.1002/jnr.1129; Takahashi M, 2002, ATHEROSCLEROSIS, V161, P387, DOI 10.1016/S0021-9150(01)00674-8; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Teigler A, 2009, HUM MOL GENET, V18, P1897, DOI 10.1093/hmg/ddp110; Thukkani AK, 2003, CIRCULATION, V108, P3128, DOI 10.1161/01.CIR.0000104564.01539.6A; Tytell M, 2005, INT J HYPERTHER, V21, P445, DOI 10.1080/02656730500041921; Tzekov R, 2014, J NEUROPATH EXP NEUR, V73, P345, DOI 10.1097/NEN.0000000000000059; Wang JQ, 2013, J NEUROPATH EXP NEUR, V72, P768, DOI 10.1097/NEN.0b013e31829d8d9d; Wender M, 1981, Acta Neuropathol Suppl, V7, P36; Wong EV, 2003, J NEUROSCI, V23, P3112; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; You YY, 2011, INVEST OPHTH VIS SCI, V52, P6911, DOI 10.1167/iovs.11-7434; You ZR, 2007, J CEREBR BLOOD F MET, V27, P1954, DOI 10.1038/sj.jcbfm.9600497; Yuan AD, 2006, J NEUROSCI, V26, P10006, DOI 10.1523/JNEUROSCI.2580-06.2006; Zhao J, 2016, METHOD ENZYMOL, V568, P477, DOI 10.1016/bs.mie.2015.09.012; Zhou ZG, 2011, LIPIDS, V46, P879, DOI 10.1007/s11745-011-3575-8; Zhu XD, 2007, AM J RESP CELL MOL, V36, P585, DOI 10.1165/rcmb.2006-0391OC	92	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153608	10.1371/journal.pone.0153608	http://dx.doi.org/10.1371/journal.pone.0153608			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088355	Green Published, Green Submitted, gold			2022-12-26	WOS:000374527000029
J	Costantini, R; Affaitati, G; Massimini, F; Tana, C; Innocenti, P; Giamberardino, MA				Costantini, Raffaele; Affaitati, Giannapia; Massimini, Francesca; Tana, Claudio; Innocenti, Paolo; Giamberardino, Maria Adele			Laparoscopic Cholecystectomy for Gallbladder Calculosis in Fibromyalgia Patients: Impact on Musculoskeletal Pain, Somatic Hyperalgesia and Central Sensitization	PLOS ONE			English	Article							POSTOPERATIVE OPIOID CONSUMPTION; SURVEY CRITERIA; REFERRED PAIN; RISK-FACTORS; ARTHROPLASTY; WOMEN	Fibromyalgia, a chronic syndrome of diffuse musculoskeletal pain and somatic hyperalgesia from central sensitization, is very often comorbid with visceral pain conditions. In fibromyalgia patients with gallbladder calculosis, this study assessed the short and long-term impact of laparoscopic cholecystectomy on fibromyalgia pain symptoms. Fibromyalgia pain (VAS scale) and pain thresholds in tender points and control areas (skin, subcutis and muscle) were evaluated 1 week before (basis) and 1 week, 1,3,6 and 12 months after laparoscopic cholecystectomy in fibromyalgia patients with symptomatic calculosis (n = 31) vs calculosis patients without fibromyalgia (n. 26) and at comparable time points in fibromyalgia patients not undergoing cholecystectomy, with symptomatic (n = 27) and asymptomatic (n = 28) calculosis, and no calculosis (n = 30). At basis, fibromyalgia+symptomatic calculosis patients presented a significant linear correlation between the number of previously experienced biliary colics and fibromyalgia pain (direct) and muscle thresholds (inverse) (p<0.0001). After cholecystectomy, fibromyalgia pain significantly increased and all thresholds significantly decreased at 1 week and 1 month (1-way ANOVA, p<0.01-p<0.001), the decrease in muscle thresholds correlating linearly with the peak postoperative pain at surgery site (p<0.003-p<0.0001). Fibromyalgia pain and thresholds returned to preoperative values at 3 months, then pain significantly decreased and thresholds significantly increased at 6 and 12 months (p<0.05-p<0.0001). Over the same 12-month period: in non-fibromyalgia patients undergoing cholecystectomy thresholds did not change; in all other fibromyalgia groups not undergoing cholecystectomy fibromyalgia pain and thresholds remained stable, except in fibromyalgia+symptomatic calculosis at 12 months when pain significantly increased and muscle thresholds significantly decreased (p<0.05-p<0.0001). The results of the study show that biliary colics from gallbladder calculosis represent an exacerbating factor for fibromyalgia symptoms and that laparoscopic cholecystectomy produces only a transitory worsening of these symptoms, largely compensated by the long-term improvement/desensitization due to gallbladder removal. This study provides new insights into the role of visceral pain comorbidities and the effects of their treatment on fibromyalgia pain/hypersensitivity.	[Costantini, Raffaele; Innocenti, Paolo] Univ G dAnnunzio, Inst Surg Pathol, Chieti, Italy; [Affaitati, Giannapia; Giamberardino, Maria Adele] Univ G dAnnunzio, Dept Med & Sci Aging, Fibromyalgia & Musculoskeletal Pain Ctr, Chieti, Italy; [Affaitati, Giannapia; Giamberardino, Maria Adele] Univ G dAnnunzio, CeSI, Chieti, Italy; [Massimini, Francesca] Univ G dAnnunzio, Inst Clin Pathol, Chieti, Italy; [Tana, Claudio] AUSL Reggio Emilia, Guastalla Hosp, Internal Med Unit, Reggio Emilia, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Costantini, R (corresponding author), Univ G dAnnunzio, Inst Surg Pathol, Chieti, Italy.	r.costantini@unich.it	Tana, Claudio/L-5576-2019	Tana, Claudio/0000-0002-9162-7866				Abeles AM, 2007, ANN INTERN MED, V146, P726, DOI 10.7326/0003-4819-146-10-200705150-00006; Ablin JN, 2015, BEST PRACT RES CL RH, V29, P20, DOI 10.1016/j.berh.2015.04.018; Affaitati G, 2011, EUR J PAIN, V15, P61, DOI 10.1016/j.ejpain.2010.09.002; Blichfeldt-Eckhardt MR, 2014, PAIN, V155, P2400, DOI 10.1016/j.pain.2014.09.019; Brummett CM, 2013, ANESTHESIOLOGY, V119, P1434, DOI 10.1097/ALN.0b013e3182a8eb1f; Brummett CM, 2011, CURR OPIN ANESTHESIO, V24, P532, DOI 10.1097/ACO.0b013e32834a1091; Caldarella MP, 2006, AM J GASTROENTEROL, V101, P2782, DOI 10.1111/j.1572-0241.2006.00823.x; Clauw DJ, 2015, MAYO CLIN PROC, V90, P680, DOI 10.1016/j.mayocp.2015.03.014; Costantini R, 2005, J GASTROINTEST SURG, V9, P822, DOI 10.1016/j.gassur.2005.01.286; Costantini R, 2011, INT J CLIN PHARM TH, V49, P116, DOI 10.5414/CP201401; Costantini R, 2012, ANN ITAL CHIR, V83, P245; D'Apuzzo MR, 2012, ORTHOPEDICS, V35, pE175, DOI 10.3928/01477447-20120123-18; Drewes AM, 2015, POSTOPERATIVE PAIN S, P35; Fischer AA, 1998, J MUSCULOSKELET PAIN, V6, P1, DOI 10.1300/J094v06n01_01; Gerwin R, 2013, PAIN MED, V14, P777, DOI 10.1111/pme.12169; Giamberardino MA, 2005, PAIN, V114, P239, DOI 10.1016/j.pain.2004.12.024; Giamberardino MA, 2014, CURR OPIN OBSTET GYN, V26, P253, DOI 10.1097/GCO.0000000000000083; Giamberardino MA, 2011, BEST PRACT RES CL RH, V25, P185, DOI 10.1016/j.berh.2011.01.002; Giamberardino MA, 2011, CURR PAIN HEADACHE R, V15, P393, DOI 10.1007/s11916-011-0205-3; Giamberardino MA, 2010, J MUSCULOSKELET PAIN, V18, P403, DOI 10.3109/10582452.2010.502624; Giamberardino MA, 2010, PAIN, V151, P307, DOI 10.1016/j.pain.2010.06.023; Giamberardino MA, 2006, HAND CLINIC, V81, P343, DOI 10.1016/S0072-9752(06)80028-X; Janda AM, 2015, ANESTHESIOLOGY, V122, P1103, DOI 10.1097/ALN.0000000000000637; Kato K, 2006, ARCH INTERN MED, V166, P1649, DOI 10.1001/archinte.166.15.1649; Kehlet H, 2006, LANCET, V367, P1618, DOI 10.1016/S0140-6736(06)68700-X; Kehlet H, 2015, POSTOPERATIVE PAIN S, P1; Kjaer DW, 2006, WORLD J GASTROENTERO, V12, P7522, DOI 10.3748/wjg.v12.i46.7522; Obrosova IG, 2009, NEUROTHERAPEUTICS, V6, P638, DOI 10.1016/j.nurt.2009.07.004; Parkman HP, 2013, DIGEST DIS SCI, V58, P1062, DOI 10.1007/s10620-013-2596-y; Pogatzki-Zahn EM, 2009, CURR OPIN ANESTHESIO, V22, P627, DOI 10.1097/ACO.0b013e32833037d2; Souto MM, 2015, SURG LAPAROSC ENDOSC; Stawowy M, 2006, SCAND J GASTROENTERO, V41, P833, DOI 10.1080/00365520500463332; VECCHIET L, 1994, PROG PAIN RES MANAG, V2, P177; Viggiano A, 2009, PAIN PRACT, V9, P260, DOI 10.1111/j.1533-2500.2009.00287.x; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140	36	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153408	10.1371/journal.pone.0153408	http://dx.doi.org/10.1371/journal.pone.0153408			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27081848	gold, Green Published, Green Submitted			2022-12-26	WOS:000374291800018
J	Klenk, J; Dallmeier, D; Denkinger, MD; Rapp, K; Koenig, W; Rothenbacher, D				Klenk, Jochen; Dallmeier, Dhayana; Denkinger, Michael Dieter; Rapp, Kilian; Koenig, Wolfgang; Rothenbacher, Dietrich		ActiFE Study Grp	Objectively Measured Walking Duration and Sedentary Behaviour and Four-Year Mortality in Older People	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; VIGOROUS PHYSICAL-ACTIVITY; CORONARY-HEART-DISEASE; QUALITY-OF-LIFE; METAANALYSIS; ADULTS; TIME; INTENSITY; EPIDEMIOLOGY; ASSOCIATIONS	Background Physical activity is an important component of health. Recommendations based on sensor measurements are sparse in older people. The aim of this study was to analyse the effect of objectively measured walking and sedentary duration on four-year mortality in community-dwelling older people. Methods Between March 2009 and April 2010, physical activity of 1271 participants (>= 65 years, 56.4% men) from Southern Germany was measured over one week using a thigh-worn uni-axial accelerometer (activPAL; PAL Technologies, Glasgow, Scotland). Mortality was assessed during a four-year follow-up. Cox-proportional-hazards models were used to estimate the associations between walking (including low to high intensity) and sedentary duration with mortality. Models were adjusted for age and sex, additional epidemiological variables, and selected biomarkers. Results An inverse relationship between walking duration and mortality with a minimum risk for the 3rd quartile (102.2 to 128.4 minutes walking daily) was found even after multivariate adjustment with HRs for quartiles 2 to 4 compared to quartile 1 of 0.45 (95%-CI: 0.26; 0.76), 0.18 (95%-CI: 0.08; 0.41), 0.39 (95%-CI: 0.19; 0.78), respectively. For sedentary duration an age-and sex-adjusted increased mortality risk was observed for the 4th quartile (daily sedentary duration >= 1137.2 min.) (HR 2.05, 95%-CI: 1.13; 3.73), which diminished, however, after full adjustment (HR 1.63, 95%-CI: 0.88; 3.02). Furthermore, our results suggest effect modification between walking and sedentary duration, such that in people with low walking duration a high sedentary duration was noted as an independent factor for increased mortality. Conclusions In summary, walking duration was clearly associated with four-year overall mortality in community-dwelling older people.	[Klenk, Jochen; Rapp, Kilian; Rothenbacher, Dietrich] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany; [Klenk, Jochen; Rapp, Kilian] Robert Bosch Krankenhaus, Dept Geriatr & Geriatr Rehabil, Stuttgart, Germany; [Dallmeier, Dhayana; Koenig, Wolfgang] Univ Ulm, Med Ctr, Dept Internal Med Cardiol 2, D-89069 Ulm, Germany; [Dallmeier, Dhayana; Denkinger, Michael Dieter] Univ Ulm, Geriatr Res Unit, Agaples Bethesda Hosp, D-89069 Ulm, Germany; [Dallmeier, Dhayana; Denkinger, Michael Dieter] Geriatr Ctr Ulm Alb Donau, Ulm, Germany; [Koenig, Wolfgang] Tech Univ Munich, Deutsch Herzzentrum Munchen, D-80290 Munich, Germany; [Koenig, Wolfgang] DZHK German Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, Munich, Germany	Ulm University; Bosch; Robert Bosch Krankenhaus; Ulm University; Ulm University; German Heart Centre Munich; Technical University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance	Klenk, J (corresponding author), Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany.; Klenk, J (corresponding author), Robert Bosch Krankenhaus, Dept Geriatr & Geriatr Rehabil, Stuttgart, Germany.	jochen.klenk@uni-ulm.de	Klenk, Jochen/C-2164-2012; Rapp, Kilian/AAJ-3370-2020; Denkinger, Michael D/E-1814-2013; Stingl, Julia C./ABA-7201-2020; Dallmeier, Dhayana/A-1169-2015; Klenk, Jochen/R-3614-2019; Steinacker, Juergen M. M/E-6876-2015	Rapp, Kilian/0000-0003-1625-2571; Denkinger, Michael D/0000-0002-8097-060X; Stingl, Julia C./0000-0002-1566-8156; Dallmeier, Dhayana/0000-0003-3665-7023; Klenk, Jochen/0000-0002-5987-447X; Steinacker, Juergen M. M/0000-0001-8901-9450; Rothenbacher, Dietrich/0000-0002-3563-2791; Koenig, Wolfgang/0000-0002-2064-9603	Ministry of Science, Research and Arts, state of Baden-Wuerttemberg, Germany, as part of the Geriatric Competence Center, Ulm University; "Forschungskolleg Geriatrie" grant from the Robert Bosch Foundation, Stuttgart, Germany	Ministry of Science, Research and Arts, state of Baden-Wuerttemberg, Germany, as part of the Geriatric Competence Center, Ulm University; "Forschungskolleg Geriatrie" grant from the Robert Bosch Foundation, Stuttgart, Germany	The study was funded by a grant from the Ministry of Science, Research and Arts, state of Baden-Wuerttemberg, Germany, as part of the Geriatric Competence Center, Ulm University. Dhayana Dallmeier was supported by the "Hertha-Nathorff" Program at Ulm University for the professional development of female physicians in research. Kilian Rapp and Michael Denkinger were supported by a "Forschungskolleg Geriatrie" grant from the Robert Bosch Foundation, Stuttgart, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, NUTR REV, V67, P114, DOI 10.1111/j.1753-4887.2008.00136.x; Atkin AJ, 2012, INT J EPIDEMIOL, V41, P1460, DOI 10.1093/ije/dys118; Bellavia A, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-94; Bembom O, 2009, EPIDEMIOLOGY, V20, P424, DOI 10.1097/EDE.0b013e31819e3f28; Bey L, 2003, J PHYSIOL-LONDON, V551, P673, DOI 10.1113/jphysiol.2003.045591; Davis MG, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-116; Denkinger MD, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-50; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fried LP, 1996, J GERONTOL A-BIOL, V51, pM206, DOI 10.1093/gerona/51A.5.M206; Gorman E, 2014, EUR REV AGING PHYS A, V11, P35, DOI 10.1007/s11556-013-0132-x; Hamer M, 2008, BRIT J SPORT MED, V42, P238, DOI 10.1136/bjsm.2007.039974; Hamer M, 2008, SCAND J MED SCI SPOR, V18, P736, DOI 10.1111/j.1600-0838.2007.00747.x; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Janz KF, 2006, BRIT J SPORT MED, V40, P191, DOI 10.1136/bjsm.2005.023036; Jefferis BJ, 2015, MED SCI SPORT EXER, V47, P343, DOI 10.1249/MSS.0000000000000410; Jefferis BJ, 2014, J AM GERIATR SOC, V62, P599, DOI 10.1111/jgs.12748; Kelly P, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0132-x; Klenk J, 2013, J EPIDEMIOL COMMUN H, V67, P194, DOI 10.1136/jech-2012-201312; Klenk J, 2012, J EPIDEMIOL COMMUN H, V66, P474, DOI 10.1136/jech.2010.128090; Koster A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037696; Landi F, 2008, PREV MED, V47, P422, DOI 10.1016/j.ypmed.2008.06.020; Lee IM, 2000, AM J EPIDEMIOL, V151, P293, DOI 10.1093/oxfordjournals.aje.a010205; Lord S, 2011, AGE AGEING, V40, P205, DOI 10.1093/ageing/afq166; Matthews CE, 2012, AM J CLIN NUTR, V95, P437, DOI 10.3945/ajcn.111.019620; Motl RW, 2010, PHYS MED REH CLIN N, V21, P299, DOI 10.1016/j.pmr.2009.12.006; Murphy MH, 2007, PREV MED, V44, P377, DOI 10.1016/j.ypmed.2006.12.008; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI [10.1249/mss.0b013e3180616aa2, 10.1161/CIRCULATIONAHA.107.185650]; Ortlieb S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111206; Pavey TG, 2015, BRIT J SPORT MED, V49, P95, DOI 10.1136/bjsports-2012-091676; Rothenbacher D, 2003, ARCH INTERN MED, V163, P1200, DOI 10.1001/archinte.163.10.1200; Ryan CG, 2006, BRIT J SPORT MED, V40, P779, DOI 10.1136/bjsm.2006.027276; Samitz G, 2011, INT J EPIDEMIOL, V40, P1382, DOI 10.1093/ije/dyr112; Schnohr P, 2007, EUR J CARDIOV PREV R, V14, P72, DOI 10.1097/HJR.0b013e3280144470; Spirduso WW, 2001, MED SCI SPORT EXER, V33, pS598, DOI 10.1097/00005768-200106001-00028; Taraldsen K, 2012, MATURITAS, V71, P13, DOI 10.1016/j.maturitas.2011.11.003; Varo JJ, 2003, INT J EPIDEMIOL, V32, P138, DOI 10.1093/ije/dyg116; VERBRUGGE LM, 1994, SOC SCI MED, V38, P1, DOI 10.1016/0277-9536(94)90294-1; Voukelatos A, 2015, AGE AGEING, V44, P377, DOI 10.1093/ageing/afu186; Ward DS, 2005, MED SCI SPORT EXER, V37, pS582, DOI 10.1249/01.mss.0000185292.71933.91; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z; Woodcock J, 2011, INT J EPIDEMIOL, V40, P121, DOI 10.1093/ije/dyq104	41	33	34	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153779	10.1371/journal.pone.0153779	http://dx.doi.org/10.1371/journal.pone.0153779			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ6AH	27082963	Green Published, gold, Green Submitted			2022-12-26	WOS:000374291800052
J	Galvan-Quesada, S; Doadrio, I; Alda, F; Perdices, A; Reina, RG; Varela, MG; Hernandez, N; Mendoza, AC; Bermingham, E; Dominguez-Dominguez, O				Galvan-Quesada, Sesangari; Doadrio, Ignacio; Alda, Fernando; Perdices, Anabel; Gisela Reina, Ruth; Garcia Varela, Martin; Hernandez, Natividad; Campos Mendoza, Antonio; Bermingham, Eldredge; Dominguez-Dominguez, Omar			Molecular Phylogeny and Biogeography of the Amphidromous Fish Genus Dormitator Gill 1861 (Teleostei: Eleotridae)	PLOS ONE			English	Article							FRESH-WATER FISHES; EVOLUTIONARY HISTORY; POPULATION-STRUCTURE; OCEAN CURRENTS; LIFE-HISTORY; FAT SLEEPER; ATLANTIC; PHYLOGEOGRAPHY; DIVERGENCE; ISTHMUS	Species of the genus Dormitator, also known as sleepers, are representatives of the amphidromous freshwater fish fauna that inhabit the tropical and subtropical coastal environments of the Americas and Western Africa. Because of the distribution of this genus, it could be hypothesized that the evolutionary patterns in this genus, including a pair of geminate species across the Central American Isthmus, could be explained by vicariance following the break-up of Gondwana. However, the evolutionary history of this group has not been evaluated. We constructed a time-scaled molecular phylogeny of Dormitator using mitochondrial (Cytochrome b) and nuclear (Rhodopsin and beta-actin) DNA sequence data to infer and date the cladogenetic events that drove the diversification of the genus and to relate them to the biogeographical history of Central America. Two divergent lineages of Dormitator were recovered: one that included all of the Pacific samples and another that included all of the eastern and western Atlantic samples. In contrast to the Pacific lineage, which showed no phylogeographic structure, the Atlantic lineage was geographically structured into four clades: Cameroon, Gulf of Mexico, West Cuba and Caribbean, showing evidence of potential cryptic species. The separation of the Pacific and Atlantic lineages was estimated to have occurred similar to 1 million years ago (Mya), whereas the four Atlantic clades showed mean times of divergence between 0.2 and 0.4 Mya. The splitting times of Dormitator between ocean basins are similar to those estimated for other geminate species pairs with shoreline estuarine preferences, which may indicate that the common evolutionary histories of the different clades are the result of isolation events associated with the closure of the Central American Isthmus and the subsequent climatic and oceanographic changes.	[Galvan-Quesada, Sesangari] Univ Michoacana, Programa Inst Doctorado Ciencias Biol, Morelia, Michoacan, Mexico; [Galvan-Quesada, Sesangari; Campos Mendoza, Antonio; Dominguez-Dominguez, Omar] Univ Michoacana, Fac Biol, Lab Biol Acuat, Morelia, Michoacan, Mexico; [Doadrio, Ignacio; Perdices, Anabel] CSIC, Museo Nacl Ciencias Nat, Dept Biodiversidad & Biol Evolut, E-28006 Madrid, Spain; [Alda, Fernando; Perdices, Anabel; Gisela Reina, Ruth; Bermingham, Eldredge] Smithsonian Trop Res Inst, Apartado 2072, Balboa, Panama; [Garcia Varela, Martin] Univ Nacl Autonoma Mexico, Inst Biol, Mexico City 04510, DF, Mexico; [Hernandez, Natividad] Inst Med Trop Pedro Kouri, Apartado 601, Havana, Cuba; [Alda, Fernando] Louisiana State Univ, Dept Biol Sci, Museum Nat Sci, Baton Rouge, LA 70803 USA; [Bermingham, Eldredge] Patricia & Phillip Frost Museum Sci, Miami, FL USA	Universidad Michoacana de San Nicolas de Hidalgo; Universidad Michoacana de San Nicolas de Hidalgo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Smithsonian Institution; Smithsonian Tropical Research Institute; Universidad Nacional Autonoma de Mexico; Louisiana State University System; Louisiana State University	Galvan-Quesada, S (corresponding author), Univ Michoacana, Programa Inst Doctorado Ciencias Biol, Morelia, Michoacan, Mexico.; Galvan-Quesada, S; Dominguez-Dominguez, O (corresponding author), Univ Michoacana, Fac Biol, Lab Biol Acuat, Morelia, Michoacan, Mexico.	galygq@hotmail.com; goodeido@yahoo.com.mx	Doadrio, Ignacio/F-8448-2016; Alda, Fernando/C-5646-2011	Doadrio, Ignacio/0000-0003-4863-9711; Alda, Fernando/0000-0002-6858-9566	CIC-UMSNH; PIFI-UMSNH program (Mexico); PAPIIT-UNAM [IN207213]; CONACyT [179048, 216640]; Museo Nacional de Ciencias Naturales-CSIC; Spanish Ministry of Economy and Competitiveness (Spain) [CGL2013-41375-P]; Smithsonian Tropical Research Institute (Panama)	CIC-UMSNH; PIFI-UMSNH program (Mexico); PAPIIT-UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Museo Nacional de Ciencias Naturales-CSIC; Spanish Ministry of Economy and Competitiveness (Spain)(Spanish Government); Smithsonian Tropical Research Institute (Panama)(Smithsonian InstitutionSmithsonian Tropical Research Institute)	The authors are grateful for the following financial support for this research: CIC-UMSNH (2010, 2011) and PIFI-UMSNH program (Mexico) to ODD; PAPIIT-UNAM No. IN207213 and CONACyT No. 179048 (Mexico) to MGV; Museo Nacional de Ciencias Naturales-CSIC and Spanish Ministry of Economy and Competitiveness No. CGL2013-41375-P (Spain) to ID; Smithsonian Tropical Research Institute (Panama) to EB; CONACyT PhD scholarship No. 216640 granted to SGQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agorreta A, 2013, MOL PHYLOGENET EVOL, V69, P619, DOI 10.1016/j.ympev.2013.07.017; Akihito, 2000, GENE, V259, P5, DOI 10.1016/S0378-1119(00)00488-1; Alonso R, 2012, J BIOGEOGR, V39, P434, DOI 10.1111/j.1365-2699.2011.02594.x; [Anonymous], 2014, TRACER V1 6; [Anonymous], 2020, CATALOG FISHES; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; AVISE JC, 1992, OIKOS, V63, P62, DOI 10.2307/3545516; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bacon CD, 2015, P NATL ACAD SCI USA, V112, P6110, DOI 10.1073/pnas.1423853112; Beguer M, 2007, ECOL FRESHW FISH, V16, P221, DOI 10.1111/j.1600-0633.2006.00214.x; Bermingham E, 1998, MOL ECOL, V7, P499, DOI 10.1046/j.1365-294x.1998.00358.x; Bermingham Eldredge, 1997, P113, DOI 10.1016/B978-012417540-2/50009-9; Bloom DD, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2081; BOWEN BW, 1990, MAR BIOL, V107, P371, DOI 10.1007/BF01313418; Carlin JL, 2003, MAR BIOL, V143, P1057, DOI 10.1007/s00227-003-1151-3; Castro-Aguirre J. L., 1999, ICTIOFAUNA ESTUARINO; Ceron-Souza I, 2015, ECOL EVOL, V5, P3486, DOI 10.1002/ece3.1569; Chen WJ, 2003, MOL PHYLOGENET EVOL, V26, P262, DOI 10.1016/S1055-7903(02)00371-8; Chubb AL, 1998, J HERED, V89, P8, DOI 10.1093/jhered/89.1.8; Coates AG, 2005, CARIBB J SCI, V41, P374; Coats DA, 1992, PHYS OCEANOGRAPHY US; Cook BD, 2009, J N AM BENTHOL SOC, V28, P709, DOI 10.1899/09-008.1; Craig MT, 2004, J BIOGEOGR, V31, P1085, DOI 10.1111/j.1365-2699.2004.01035.x; Cronin Thomas M., 1996, P76; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Darwin C., 1872, P458; Doadrio I, 2009, MOL PHYLOGENET EVOL, V50, P16, DOI 10.1016/j.ympev.2008.09.014; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edwards SV, 2000, EVOLUTION, V54, P1839; Floeter SR, 2008, J BIOGEOGR, V35, P22, DOI 10.1111/j.1365-2699.2007.01790.x; FOLLETT WI, 1960, SYST ZOOL, V9, P212, DOI 10.2307/2411968; Froese R., 2015, FISHBASE; Ginsburg I., 1953, Journal of the Washington Academy of Sciences, V43, P18; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harrison J, 1992, FAUNE DES POISONS DE, V2; Haug GH, 1998, NATURE, V393, P673, DOI 10.1038/31447; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Iturralde-Vinent MA, 1999, B AM MUS NAT HIST, P1; Johns GC, 1998, MOL BIOL EVOL, V15, P1481, DOI 10.1093/oxfordjournals.molbev.a025875; Jordan DS, 1908, AM NAT, V42, P73, DOI 10.1086/278905; Knowlton N, 1998, P ROY SOC B-BIOL SCI, V265, P2257, DOI 10.1098/rspb.1998.0568; Kullander S. O., 2003, CHECK LIST FRESHWATE, P657; Landa A, 1977, FAO INF PESCA, V2, P106; Lara A, 2010, MOL ECOL RESOUR, V10, P421, DOI 10.1111/j.1755-0998.2009.02785.x; Leathwick JR, 2008, J BIOGEOGR, V35, P1481, DOI 10.1111/j.1365-2699.2008.01887.x; Lessios HA, 2008, ANNU REV ECOL EVOL S, V39, P63, DOI 10.1146/annurev.ecolsys.38.091206.095815; MASSAY S, 1992, J FISH BIOL, V40, P815, DOI 10.1111/j.1095-8649.1992.tb02627.x; McDowall RM, 2001, FISH FISH, V2, P278, DOI 10.1046/j.1467-2960.2001.00050.x; McDowall R.M., 1988, DIADROMY FISHES; McDowall RM, 1999, MOL ECOL, V8, P527, DOI 10.1046/j.1365-294x.1999.00560.x; McMahan CD, 2013, J BIOGEOGR, V40, P894, DOI 10.1111/jbi.12036; Miller M.A., 2010, P GAT COMP ENV WORKS; Miura O, 2010, MOL PHYLOGENET EVOL, V56, P40, DOI 10.1016/j.ympev.2010.04.012; Muss A, 2001, EVOLUTION, V55, P561, DOI 10.1554/0014-3820(2001)055[0561:POOTRO]2.0.CO;2; MYERS GS, 1949, COPEIA, P89; Nelson DJ, 1994, FISHES WORLD; NORDLIE FG, 1993, J FISH BIOL, V43, P433, DOI 10.1006/jfbi.1993.1145; NORRIS S. M., 2005, FRESHWATER FISHES ME; Ornelas-Garcia Claudia Patricia, 2008, BMC Evol Biol, V8, P340, DOI 10.1186/1471-2148-8-340; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; Palumbi Stephen R., 1996, P205; Parrish JT, 1993, AFRICA S AM CONNECTI, P8; Paz A, 2015, MOL ECOL, V24, P3723, DOI 10.1111/mec.13275; Perdices A, 2005, MOL PHYLOGENET EVOL, V37, P460, DOI 10.1016/j.ympev.2005.01.020; Perdices A, 2002, MOL PHYLOGENET EVOL, V25, P172, DOI 10.1016/S1055-7903(02)00224-5; Picq S, 2014, J BIOGEOGR, V41, P1520, DOI 10.1111/jbi.12309; RAUCHENBERGER M, 1988, SYST ZOOL, V37, P356, DOI 10.2307/2992198; Reeves RG, 2006, BIOL J LINN SOC, V88, P235, DOI 10.1111/j.1095-8312.2006.00619.x; Renner S, 2004, INT J PLANT SCI, V165, pS23, DOI 10.1086/383334; RICHARDSON PL, 1986, J GEOPHYS RES-OCEANS, V91, P537, DOI 10.1029/JC091iC09p10537; Robalo JI, 2006, MOL PHYLOGENET EVOL, V39, P276, DOI 10.1016/j.ympev.2005.08.009; ROSEN DE, 1985, ANN MO BOT GARD, V72, P636, DOI 10.2307/2399218; Robertson DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102918; Sambrook J., 1989, MOLECULAR CLONING A; Schmidt DN, 2007, DEEP-TIME PERSPECTIVES ON CLIMATE CHANGE: MARRYING THE SIGNAL FROM COMPUTER MODELS AND BIOLOGICAL PROXIES, P427; SHULMAN MJ, 1995, EVOLUTION, V49, P897, DOI 10.1111/j.1558-5646.1995.tb02325.x; Smith SA, 2005, J BIOGEOGR, V32, P1835, DOI 10.1111/j.1365-2699.2005.01317.x; Soltis DE, 2006, MOL ECOL, V15, P4261, DOI 10.1111/j.1365-294X.2006.03061.x; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stramma L, 1999, DEEP-SEA RES PT II, V46, P279, DOI 10.1016/S0967-0645(98)00109-X; Taillebois L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075465; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor MS, 2003, SCIENCE, V299, P107, DOI 10.1126/science.1079365; Thacker CE, 2005, MOL PHYLOGENET EVOL, V37, P858, DOI 10.1016/j.ympev.2005.05.004; Tringali MD, 1999, MOL PHYLOGENET EVOL, V13, P193, DOI 10.1006/mpev.1999.0624; VERGARA RR, 1992, PRINCIPALES CARACTER; Victor BC, 2010, ZOOL STUD, V49, P865; Violante-Gonzalez J, 2008, REV BIOL TROP, V56, P1419; Yang ZH, 2006, MOL BIOL EVOL, V23, P212, DOI 10.1093/molbev/msj024	90	21	22	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153538	10.1371/journal.pone.0153538	http://dx.doi.org/10.1371/journal.pone.0153538			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074006	gold, Green Submitted, Green Published			2022-12-26	WOS:000374131200105
J	Murunga, AN; Miruka, DO; Driver, C; Nkomo, FS; Cobongela, SZZ; Owira, PMO				Murunga, Alfred N.; Miruka, David O.; Driver, Christine; Nkomo, Fezile S.; Cobongela, Snazo Z. Z.; Owira, Peter M. O.			Grapefruit Derived Flavonoid Naringin Improves Ketoacidosis and Lipid Peroxidation in Type 1 Diabetes Rat Model	PLOS ONE			English	Article							OXIDATIVE STRESS; METABOLIC SYNDROME; CITRUS FLAVONOIDS; HYPERGLYCEMIA; DYSLIPIDEMIA; HESPERIDIN; DIAGNOSIS; MELLITUS	Background Hypoglycemic effects of grapefruit juice are well known but the effects of naringin, its main flavonoid on glucose intolerance and metabolic complications in type 1 diabetes are not known. Objectives To investigate the effects of naringin on glucose intolerance, oxidative stress and ketonemia in type 1 diabetic rats. Methods Sprague-Dawley rats divided into 5 groups (n = 7) were orally treated daily with 3.0 ml/kg body weight (BW)/day of distilled water (group 1) or 50 mg/kg BW of naringin (groups 2 and 4, respectively). Groups 3, 4 and 5 were given a single intra-peritoneal injection of 60 mg/kg BW of streptozotocin to induce diabetes. Group 3 was further treated with subcutaneous insulin (4.0 IU/kg BW) twice daily, respectively. Results Stretozotocin (STZ) only-treated groups exhibited hyperglycemia, polydipsia, polyuria, weight loss, glucose intolerance, low fasting plasma insulin and reduced hepatic glycogen content compared to the control group. Furthermore they had significantly elevated Malondialdehyde (MDA), acetoacetate, beta-hydroxybutyrate, anion gap and significantly reduced blood pH and plasma bicarbonate compared to the control group. Naringin treatment significantly improved Fasting Plasma Insulin (FPI), hepatic glycogen content, malondialdehyde, beta-hydroxybutyrate, acetoacetate, bicarbonate, blood pH and anion gap but not Fasting Blood Glucose (FBG) compared to the STZ only-treated group. Conclusions Naringin is not hypoglycemic but ameliorates ketoacidosis and oxidative stress. Naringin supplements could therefore mitigate complications of diabetic ketoacidosis.	[Murunga, Alfred N.; Miruka, David O.; Driver, Christine; Nkomo, Fezile S.; Cobongela, Snazo Z. Z.; Owira, Peter M. O.] Univ KwaZulu Natal, Mol & Clin Pharmacol Res Lab, Dept Pharmacol, Discipline Pharmaceut Sci,Sch Hlth Sci, POB X5401, Durban, South Africa	University of Kwazulu Natal	Owira, PMO (corresponding author), Univ KwaZulu Natal, Mol & Clin Pharmacol Res Lab, Dept Pharmacol, Discipline Pharmaceut Sci,Sch Hlth Sci, POB X5401, Durban, South Africa.	owirap@ukzn.ac.za		Cobongela, Sinazo/0000-0001-9057-3096	Career Development Award by South African Medical Research Council	Career Development Award by South African Medical Research Council	The study was funded by Career Development Award by the South African Medical Research Council to the corresponding author.	Adebiyi AO, 2016, J CARDIOVASC PHARM, V67, P136, DOI 10.1097/FJC.0000000000000325; Adebiyi OO, 2015, NUTRIENTS, V7, P10352, DOI 10.3390/nu7125540; Alam MA, 2014, ADV NUTR, V5, P404, DOI 10.3945/an.113.005603; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Ali MM, 2004, Z NATURFORSCH C, V59, P726; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Arai S, 2013, AM J CRIT CARE, V22, P328, DOI 10.4037/ajcc2013533; Babu PVA, 2006, CLIN EXP PHARMACOL P, V33, P1184, DOI 10.1111/j.1440-1681.2006.04509.x; Casteels K, 2003, REV ENDOCR METAB DIS, V4, P159, DOI 10.1023/A:1022942120000; Chiasson JL, 2003, CAN MED ASSOC J, V168, P859; Fiorentino TV, 2013, CURR PHARM DESIGN, V19, P5695, DOI 10.2174/1381612811319320005; Hayanga JA, 2016, EUR J NUTR, V55, P631, DOI 10.1007/s00394-015-0883-4; Jung UJ, 2004, J NUTR, V134, P2499, DOI 10.1093/jn/134.10.2499; Jung UJ, 2006, INT J BIOCHEM CELL B, V38, P1134, DOI 10.1016/j.biocel.2005.12.002; Kraut JA, 2007, CLIN J AM SOC NEPHRO, V2, P162, DOI 10.2215/CJN.03020906; Li PB, 2014, FOOD CHEM TOXICOL, V66, P65, DOI 10.1016/j.fct.2014.01.023; Mahmoud AM, 2012, J DIABETES COMPLICAT, V26, P483, DOI 10.1016/j.jdiacomp.2012.06.001; McPherson PAC, 2012, J PHYSIOL BIOCHEM, V68, P141, DOI 10.1007/s13105-011-0112-4; Murunga AN, 2013, TROP MED INT HEALTH, V18, P1357, DOI 10.1111/tmi.12195; Niki E, 2008, BIOFACTORS, V34, P171, DOI 10.1002/biof.5520340208; Parmar HS, 2012, DIABETES RES CLIN PR, V97, P105, DOI 10.1016/j.diabres.2012.02.011; Phulukdaree A, 2010, S AFR J SCI, V106, P54, DOI 10.4102/sajs.v106i1/2.10; Pu P, 2012, ARCH BIOCHEM BIOPHYS, V518, P61, DOI 10.1016/j.abb.2011.11.026; Punithavathi VR, 2008, J APPL TOXICOL, V28, P806, DOI 10.1002/jat.1343; Rewers A, 2012, CURR DIABETES REP, V12, P524, DOI 10.1007/s11892-012-0307-2; SEIFTER S, 1950, ARCH BIOCHEM, V25, P191; SHULMAN RG, 1995, P NATL ACAD SCI USA, V92, P8535, DOI 10.1073/pnas.92.19.8535; Stojanovic V, 2011, CAN VET J, V52, P426; Usher-Smith JA, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4092; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wolfsdorf J, 2009, PEDIATR DIABETES, V10, P118, DOI 10.1111/j.1399-5448.2009.00569.x; Xulu S, 2012, J CARDIOVASC PHARM, V59, P133, DOI 10.1097/FJC.0b013e31823827a4; Zygmunt K, 2010, BIOCHEM BIOPH RES CO, V398, P178, DOI 10.1016/j.bbrc.2010.06.048	33	25	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153241	10.1371/journal.pone.0153241	http://dx.doi.org/10.1371/journal.pone.0153241			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073901	Green Published, Green Submitted, gold			2022-12-26	WOS:000374131200065
J	Alemu, YM; Andargie, G; Gebeye, E				Alemu, Yihun Mulugeta; Andargie, Gashaw; Gebeye, Ejigu			High Incidence of Tuberculosis in the Absence of Isoniazid and Cotrimoxazole Preventive Therapy in Children Living with HIV in Northern Ethiopia: A Retrospective Follow-Up Study	PLOS ONE			English	Article							VIRUS-INFECTED CHILDREN; ANTIRETROVIRAL THERAPY; CHILDHOOD TUBERCULOSIS; COHORT; PREVALENCE; MORTALITY; ANEMIA; HEALTH; IMPACT; HAART	Objective To identify the incidence of and predictors for tuberculosis in children living with HIV in Northern Ethiopia. Design Observational, retrospective follow-up study. Methods A total of 645 HIV-infected children were observed between September 2009 and September 2014. Cox regression analysis was used to identify predictors for developing TB. Results The incidence rate of tuberculosis was 4.2 per 100 child-years. Incidence of tuberculosis was higher for subjects who were not on cotrimoxazole preventive therapy, were not on isoniazid preventive therapy, had delayed motor development, had a CD4 cell count below the threshold, had hemoglobin level less than 10 mg/dl and were assessed as World Health Organization (WHO) clinical stage III or IV. Conclusion Incidence of TB in children living with HIV was high. This study reaffirmed that isoniazid preventive therapy is one of the best strategy to reduce incidence of TB in children living with HIV. All children living with HIV should be screened for TB but for children with delayed motor development, advanced WHO clinical stage, anemia or immune suppression, intensified screening is highly recommended.	[Alemu, Yihun Mulugeta] Bahir Dar Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Bahir Dar, Ethiopia; [Andargie, Gashaw; Gebeye, Ejigu] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Gondar, Ethiopia	Bahir Dar University; University of Gondar	Alemu, YM (corresponding author), Bahir Dar Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Bahir Dar, Ethiopia.	yihun.mulugeta@yahoo.com						Abuogi LL, 2013, INT J TUBERC LUNG D, V17, P1291, DOI 10.5588/ijtld.12.0740; Assebe LF, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1719-0; Auld AF, 2014, INT J TUBERC LUNG D, V18, P381, DOI 10.5588/ijtld.13.0395; Ayele HT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1089-3; Ayieko J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-91; Bain B J, 1999, Curr Opin Hematol, V6, P89, DOI 10.1097/00062752-199903000-00006; Batista Jd, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063916, DOI 10.1371/JOURNAL.PONE.0063916]; Braitstein P, 2009, PEDIATR INFECT DIS J, V28, P626, DOI 10.1097/INF.0b013e31819665c5; Buonomo E, 2015, EPIDEMIOL PREV, V39, P108; Calis JCJ, 2008, NEW ENGL J MED, V358, P888, DOI 10.1056/NEJMoa072727; Central Statistical Agency, 2014, HIV AIDS EST PROJ ET; Creemers-Schild D, 2015, TREATMENT PNEUMOCYST; Cruz AT, 2014, LANCET GLOB HEALTH, V2, pE432, DOI 10.1016/S2214-109X(14)70269-4; Day CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094949; Dodd PJ, 2014, LANCET GLOB HEALTH, V2, pE453, DOI 10.1016/S2214-109X(14)70245-1; Edathodu J, 2009, INT J INFECT DIS, V13, P243, DOI 10.1016/j.ijid.2007.12.017; Edmonds A, 2009, INT J EPIDEMIOL, V38, P1612, DOI 10.1093/ije/dyp208; Espinal RA, 2000, LANCET, V355, P275, DOI 10.1016/S0140-6736(99)04402-5; Ezeamama AE, 2015, INT J INFECT DIS, V35, P73, DOI 10.1016/j.ijid.2015.04.008; Federal HIV/AIDS Prevention and Control Office Ministry of Health, 2007, FEDERAL HIV AIDS PRE; Federal Ministry of Health Ethiopia, 2013, GUID LIN CLIN PROGR; Fisk DT, 2003, CLIN INFECT DIS, V36, P70, DOI 10.1086/344951; Getahun H, 2010, CLIN INFECT DIS, V50, pS201, DOI 10.1086/651492; Horacio RE, 2015, J ACQUIR IMMUNE DEFI; Hussain T, 2007, TUBERCULOSIS, V87, P7, DOI 10.1016/j.tube.2006.01.001; Kassa E, 1999, AIDS, V13, P381, DOI 10.1097/00002030-199902250-00011; Kerkhoff AD, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0320-9; Li N, 2013, AIDS, V27, P1273, DOI 10.1097/QAD.0b013e32835ecb24; Martinson NA, 2009, INT J TUBERC LUNG D, V13, P862; Mocroft A, 1999, AIDS, V13, P943, DOI 10.1097/00002030-199905280-00010; Moreno S, 2008, INT J TUBERC LUNG D, V12, P1393; Moses A, 1998, BLOOD, V91, P1479, DOI 10.1182/blood.V91.5.1479.1479_1479_1495; Mu WW, 2014, AIDS CARE, V26, P1127, DOI 10.1080/09540121.2014.882492; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; Santiago-Rodriguez Eduardo J, 2014, BMC Res Notes, V7, P439, DOI 10.1186/1756-0500-7-439; Seddon JA, 2014, INFECT DRUG RESIST, V7, P153, DOI 10.2147/IDR.S45090; Suthar AB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001270; Teck R, 2005, INT J TUBERC LUNG D, V9, P258; Thomas P, 2000, PEDIATR INFECT DIS J, V19, P700, DOI 10.1097/00006454-200008000-00006; United States Agency for International Development, 2013, REP GLOB AIDS EP; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; WHO Multicentre Growth Reference, 2006, MOT DEV WIND ACH 6 G; WILKINSON D, 2000, COCHRANE DATABASE SY, V4; World Health Organisation, 2006, GUID NAT TUB PROGR M; World Health Organization, 2021, 10 THREATS GLOB HLTH; World Health Organization, 2014, GLOB TUB REP; World Health Organization and United Nations Children's Fund, 2009, WHO CHILD GROWTH STA; Yirdaw KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104557; Zachariah R, 2007, LANCET INFECT DIS, V7, P686, DOI 10.1016/S1473-3099(07)70239-6; Zammarchi L, 2014, MEDITERR J HEMATOL I, V6, DOI 10.4084/MJHID.2014.043; Zar HJ, 2007, BRIT MED J, V334, P136, DOI 10.1136/bmj.39000.486400.55	51	13	13	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0152941	10.1371/journal.pone.0152941	http://dx.doi.org/10.1371/journal.pone.0152941			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070435	Green Published, gold, Green Submitted			2022-12-26	WOS:000373900700021
J	Chang, CW; Petrie, T; Clark, A; Lin, X; Sondergaard, CS; Griffiths, LG				Chang, Chia Wei; Petrie, Tye; Clark, Alycia; Lin, Xin; Sondergaard, Claus S.; Griffiths, Leigh G.			Mesenchymal Stem Cell Seeding of Porcine Small Intestinal Submucosal Extracellular Matrix for Cardiovascular Applications	PLOS ONE			English	Article							PRELIMINARY EXPERIENCE; MYOCARDIAL-INFARCTION; PARACRINE MECHANISMS; REPAIR; TRANSPLANTATION; RECONSTRUCTION; REGENERATION; GRAFTS; TISSUE; SURGERY	In this study, we investigate the translational potential of a novel combined construct using an FDA-approved decellularized porcine small intestinal submucosa extracellular matrix (SIS-ECM) seeded with human or porcine mesenchymal stem cells (MSCs) for cardiovascular indications. With the emerging success of individual component in various clinical applications, the combination of SIS-ECM with MSCs could provide additional therapeutic potential compared to individual components alone for cardiovascular repair. We tested the in vitro effects of MSC-seeding on SIS-ECM on resultant construct structure/function properties and MSC phenotypes. Additionally, we evaluated the ability of porcine MSCs to modulate recipient graft-specific response towards SIS-ECM in a porcine cardiac patch in vivo model. Specifically, we determined: 1) in vitro loading-capacity of human MSCs on SIS-ECM, 2) effect of cell seeding on SIS-ECM structure, compositions and mechanical properties, 3) effect of SIS-ECM seeding on human MSC phenotypes and differentiation potential, and 4) optimal orientation and dose of porcine MSCs seeded SIS-ECM for an in vivo cardiac application. In this study, histological structure, biochemical compositions and mechanical properties of the FDA-approved SIS-ECM biomaterial were retained following MSCs re-population in vitro. Similarly, the cellular phenotypes and differentiation potential of MSCs were preserved following seeding on SIS-ECM. In a porcine in vivo patch study, the presence of porcine MSCs on SIS-ECM significantly reduced adaptive T cell response regardless of cell dose and orientation compared to SIS-ECM alone. These findings substantiate the clinical translational potential of combined SIS-ECM seeded with MSCs as a promising therapeutic candidate for cardiac applications.	[Chang, Chia Wei; Clark, Alycia; Griffiths, Leigh G.] Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA; [Petrie, Tye; Lin, Xin; Sondergaard, Claus S.] Univ Calif Davis, Sch Med, Dept Surg, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis	Griffiths, LG (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA.	lggriffiths@ucdavis.edu		Griffiths, Leigh/0000-0001-6147-5972	California Institute for Regenerative Medicine (CIRM) [TR3-05626, TG2-01163]	California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine)	This work was supported by funding from California Institute for Regenerative Medicine (CIRM): TR3-05626 (LGG and CSS) and TG2-01163 (CWC).	Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024; Bank RA, 1997, J CHROMATOGR B, V703, P37, DOI 10.1016/S0378-4347(97)00391-5; Boyd WD, 2010, HEART SURG FORUM, V13, pE311, DOI 10.1532/HSF98.20091184; Caione P, 2006, PEDIATR SURG INT, V22, P593, DOI 10.1007/s00383-006-1705-9; Caione P, 2012, PEDIATR SURG INT, V28, P421, DOI 10.1007/s00383-012-3063-0; Chalajour F, 2012, ANN THORAC SURG, V93, P1311, DOI 10.1016/j.athoracsur.2011.08.055; Du XF, 2012, INT J PEDIATR OTORHI, V76, P345, DOI 10.1016/j.ijporl.2011.12.005; Engelmayr GC, 2006, BIOMATERIALS, V27, P6083, DOI 10.1016/j.biomaterials.2006.07.045; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Hodde J P, 2005, J Wound Care, V14, P23; Hodde JP, 2001, ENDOTHELIUM-NEW YORK, V8, P11, DOI 10.3109/10623320109063154; Hodonsky C, 2015, ANN THORAC SURG, V99, P605, DOI 10.1016/j.athoracsur.2014.08.071; Janis AD, 2012, J BIOMATER APPL, V26, P1013, DOI 10.1177/0885328210391688; Katritsis DG, 2005, CATHETER CARDIO INTE, V65, P321, DOI 10.1002/ccd.20406; Kini S, 2001, OBES SURG, V11, P469, DOI 10.1381/096089201321209350; Lam MT, 2013, TISSUE ENG PT A, V19, P738, DOI [10.1089/ten.tea.2012.0480, 10.1089/ten.TEA.2012.0480]; Li AH, 2014, CIRC RES, V114, P916, DOI 10.1161/CIRCRESAHA.114.302819; Lin HK, 2014, TISSUE ENG PART B-RE, V20, P73, DOI 10.1089/ten.TEB.2013.0126; Lin X, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0165-3; Lopes MF, 2006, DIS ESOPHAGUS, V19, P254, DOI 10.1111/j.1442-2050.2006.00574.x; Lopes MF, 2006, J INVEST SURG, V19, P105, DOI 10.1080/08941930600569621; Makris EA, 2013, OSTEOARTHR CARTILAGE, V21, P634, DOI 10.1016/j.joca.2013.01.007; McCready RA, 2005, J VASC SURG, V41, P782, DOI 10.1016/j.jvs.2005.02.035; Mirotsou M, 2011, J MOL CELL CARDIOL, V50, P280, DOI 10.1016/j.yjmcc.2010.08.005; Mostow EN, 2005, J VASC SURG, V41, P837, DOI 10.1016/j.jvs.2005.01.042; Murphy KD, 2008, J HAND SURG-AM, V33A, P1168, DOI 10.1016/j.jhsa.2008.02.003; *NAT RES COUNC, 1996, GUID CAR US LAB AN; Niezgoda Jeffrey A, 2005, Adv Skin Wound Care, V18, P258, DOI 10.1097/00129334-200506000-00012; Nihsen Edith S, 2008, Adv Skin Wound Care, V21, P479, DOI 10.1097/01.ASW.0000323561.14144.19; Nihsen Edith S, 2007, Adv Skin Wound Care, V20, P541, DOI 10.1097/01.ASW.0000294756.97425.c9; Palmer EM, 2002, TISSUE ENG, V8, P893, DOI 10.1089/10763270260424259; Perin EC, 2003, CIRCULATION, V107, P2294, DOI 10.1161/01.CIR.0000070596.30552.8B; PREVEL CD, 1995, ANN PLAS SURG, V35, P381, DOI 10.1097/00000637-199510000-00009; Quarti A, 2011, INTERACT CARDIOV TH, V13, P569, DOI 10.1510/icvts.2011.280016; Ramaswamy S, 2010, BIOMATERIALS, V31, P1114, DOI 10.1016/j.biomaterials.2009.10.019; Ranganath SH, 2012, CELL STEM CELL, V10, P244, DOI 10.1016/j.stem.2012.02.005; Rossetto VJV, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-39; Scholl FG, 2010, WORLD J PEDIATR CONG, V1, P132, DOI 10.1177/2150135110362092; Sharma AK, 2011, STEM CELLS, V29, P241, DOI 10.1002/stem.568; Slachman FN, 2014, ANN THORAC SURG, V97, pE129, DOI 10.1016/j.athoracsur.2013.10.103; Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C; Taljaard M, 2010, AM HEART J, V159, P354, DOI 10.1016/j.ahj.2009.12.021; Tang YL, 2005, ANN THORAC SURG, V80, P229, DOI 10.1016/j.athoracsur.2005.02.072; Williams AR, 2011, CIRC RES, V108, P792, DOI 10.1161/CIRCRESAHA.111.242610; Witt RG, 2013, EUR J CARDIO-THORAC, V44, P72, DOI 10.1093/ejcts/ezs638; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9; Wong ML, 2011, BIOMATERIALS, V32, P8129, DOI 10.1016/j.biomaterials.2011.07.030; Yanagawa B, 2013, INNOVATIONS, V8, P348, DOI 10.1097/IMI.0000000000000014	48	37	38	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153412	10.1371/journal.pone.0153412	http://dx.doi.org/10.1371/journal.pone.0153412			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070546	Green Submitted, gold, Green Published			2022-12-26	WOS:000373900700062
J	Qian, YQ; He, FP; Wang, W				Qian, Yu-Qi; He, Feng-Peng; Wang, Wei			Seasonality, Rather than Nutrient Addition or Vegetation Types, Influenced Short-Term Temperature Sensitivity of Soil Organic Carbon Decomposition	PLOS ONE			English	Article							MICROBIAL COMMUNITY COMPOSITION; CLIMATE-CHANGE; PHOSPHORUS LIMITATION; NITROGEN LIMITATION; ROOT RESPIRATION; N FERTILIZATION; TROPICAL FOREST; ELEVATED CO2; MATTER; DYNAMICS	The response of microbial respiration from soil organic carbon (SOC) decomposition to environmental changes plays a key role in predicting future trends of atmospheric CO2 concentration. However, it remains uncertain whether there is a universal trend in the response of microbial respiration to increased temperature and nutrient addition among different vegetation types. In this study, soils were sampled in spring, summer, autumn and winter from five dominant vegetation types, including pine, larch and birch forest, shrubland, and grassland, in the Saihanba area of northern China. Soil samples from each season were incubated at 1, 10, and 20 degrees C for 5 to 7 days. Nitrogen (N; 0.035 mM as NH4NO3) and phosphorus (P; 0.03 mM as P2O5) were added to soil samples, and the responses of soil microbial respiration to increased temperature and nutrient addition were determined. We found a universal trend that soil microbial respiration increased with increased temperature regardless of sampling season or vegetation type. The temperature sensitivity (indicated by Q10, the increase in respiration rate with a 10 degrees C increase in temperature) of microbial respiration was higher in spring and autumn than in summer and winter, irrespective of vegetation type. The Q10 was significantly positively correlated with microbial biomass and the fungal: bacterial ratio. Microbial respiration (or Q10) did not significantly respond to N or P addition. Our results suggest that short-term nutrient input might not change the SOC decomposition rate or its temperature sensitivity, whereas increased temperature might significantly enhance SOC decomposition in spring and autumn, compared with winter and summer.	[Qian, Yu-Qi; Wang, Wei] Peking Univ, Coll Urban & Environm Sci, Dept Ecol, Beijing 100871, Peoples R China; [Qian, Yu-Qi; Wang, Wei] Peking Univ, Minist Educ, Key Lab Earth Surface Proc, Beijing 100871, Peoples R China; [He, Feng-Peng] Peking Univ, Shenzhen Grad Sch, Shenzhen 518055, Peoples R China	Peking University; Peking University; Peking University; University Town of Shenzhen	Wang, W (corresponding author), Peking Univ, Coll Urban & Environm Sci, Dept Ecol, Beijing 100871, Peoples R China.; Wang, W (corresponding author), Peking Univ, Minist Educ, Key Lab Earth Surface Proc, Beijing 100871, Peoples R China.	wangw@urban.pku.edu.cn	He, Feng/HHS-6457-2022	He, Feng/0000-0002-1996-0744	Projects of the National Natural Science Foundation of China [31222011, 31270363, 31321061]; National Basic Research Program of China [2013CB956303]; University Construction Projects from Central Authorities in Beijing and Research Fund of State Key Laboratory of Soil and Sustainable Agriculture, Nanjing Institute of Soil Science, Chinese Academy of Science [Y412201439]	Projects of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); University Construction Projects from Central Authorities in Beijing and Research Fund of State Key Laboratory of Soil and Sustainable Agriculture, Nanjing Institute of Soil Science, Chinese Academy of Science	This work was supported by Projects of the National Natural Science Foundation of China (No. 31222011, 31270363, and 31321061) http://www.nsfc.gov.cn/; National Basic Research Program of China (No. 2013CB956303) http://www.most.gov.cn/eng/programmes1/200610/t20061009_36223.htm; University Construction Projects from Central Authorities in Beijing and Research Fund of State Key Laboratory of Soil and Sustainable Agriculture, Nanjing Institute of Soil Science, Chinese Academy of Science (Y412201439) http://english.issas.cas.cn/au/bi/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2010, NAT GEOSCI, V3, P336, DOI 10.1038/NGEO846; Baath E, 2003, GLOBAL CHANGE BIOL, V9, P1788, DOI 10.1046/j.1365-2486.2003.00692.x; Balser TC, 2009, GLOBAL CHANGE BIOL, V15, P2935, DOI 10.1111/j.1365-2486.2009.01946.x; Billings SA, 2008, LANDSCAPE ECOL, V23, P581, DOI 10.1007/s10980-008-9218-7; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Bowden RD, 2004, FOREST ECOL MANAG, V196, P43, DOI 10.1016/j.foreco.2004.03.011; Bradford MA, 2008, ECOL LETT, V11, P1316, DOI 10.1111/j.1461-0248.2008.01251.x; Brzostek ER, 2011, ECOLOGY, V92, P892, DOI 10.1890/10-1803.1; Buckeridge KM, 2008, APPL SOIL ECOL, V39, P210, DOI 10.1016/j.apsoil.2007.12.010; Cleveland CC, 2002, ECOSYSTEMS, V5, P680, DOI 10.1007/s10021-002-0202-9; Cleveland CC, 2007, BIOGEOCHEMISTRY, V85, P235, DOI 10.1007/s10533-007-9132-0; Conant RT, 2008, ECOLOGY, V89, P2384, DOI 10.1890/08-0137.1; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Craine JM, 2007, ECOLOGY, V88, P2105, DOI 10.1890/06-1847.1; Dalias P, 2001, GLOBAL CHANGE BIOL, V7, P181, DOI 10.1046/j.1365-2486.2001.00386.x; Ding F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095348; Ding WX, 2010, GEODERMA, V155, P381, DOI 10.1016/j.geoderma.2009.12.023; Drake JE, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00020.1; Fierer N, 2003, SOIL BIOL BIOCHEM, V35, P167, DOI 10.1016/S0038-0717(02)00251-1; Fontaine S, 2005, ECOL LETT, V8, P1075, DOI 10.1111/j.1461-0248.2005.00813.x; Gallo M, 2004, MICROB ECOL, V48, P218, DOI 10.1007/s00248-003-9001-x; Gnankambary Z, 2008, SOIL BIOL BIOCHEM, V40, P350, DOI 10.1016/j.soilbio.2007.08.015; Gutknecht JLM, 2012, GLOBAL CHANGE BIOL, V18, P2256, DOI 10.1111/j.1365-2486.2012.02686.x; Hartley IP, 2008, SOIL BIOL BIOCHEM, V40, P1567, DOI 10.1016/j.soilbio.2008.01.007; Iyamuremye F, 1996, ADV IN AGRON USA; Janssens IA, 2003, GLOBAL CHANGE BIOL, V9, P911, DOI 10.1046/j.1365-2486.2003.00636.x; Jia SX, 2010, PLANT SOIL, V333, P325, DOI 10.1007/s11104-010-0348-8; Jones C, 2005, GLOBAL CHANGE BIOL, V11, P154, DOI 10.1111/j.1365-2486.2004.00885.x; Keiblinger KM, 2010, FEMS MICROBIOL ECOL, V73, P430, DOI 10.1111/j.1574-6941.2010.00912.x; Kirita H, 1971, JAPANESE J ECOL; Kirschbaum MUF, 2006, SOIL BIOL BIOCHEM, V38, P2510, DOI 10.1016/j.soilbio.2006.01.030; Kuzyakov Y, 2010, SOIL BIOL BIOCHEM, V42, P1363, DOI 10.1016/j.soilbio.2010.04.003; Lavoie M, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001629; Leifeld J, 2005, BIOGEOCHEMISTRY, V75, P433, DOI 10.1007/s10533-005-2237-4; Lemke P, 2007, CLIM CHANG, V2007, P337; Lipson DA, 2002, MICROB ECOL, V43, P307, DOI 10.1007/s00248-001-1057-x; Lipson DA, 2009, BIOGEOCHEMISTRY, V95, P23, DOI 10.1007/s10533-008-9252-1; Liptzin D, 2009, SOIL BIOL BIOCHEM, V41, P1696, DOI 10.1016/j.soilbio.2009.05.013; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; Mahecha MD, 2010, SCIENCE, V329, P838, DOI 10.1126/science.1189587; Malcolm GM, 2009, GLOBAL CHANGE BIOL, V15, P2485, DOI 10.1111/j.1365-2486.2008.01839.x; Malik MA, 2012, SOIL BIOL BIOCHEM, V49, P106, DOI 10.1016/j.soilbio.2012.02.013; McMahon SK, 2009, ENV MICROBIOL REP, V1, P162, DOI 10.1111/j.1758-2229.2009.00025.x; Mikan CJ, 2002, SOIL BIOL BIOCHEM, V34, P1785, DOI 10.1016/S0038-0717(02)00168-2; Mo W, 2005, AGR FOREST METEOROL, V134, P81, DOI 10.1016/j.agrformet.2005.08.015; Monson RK, 2006, NATURE, V439, P711, DOI 10.1038/nature04555; Moore-Kucera J, 2008, SOIL BIOL BIOCHEM, V40, P2485, DOI 10.1016/j.soilbio.2008.06.002; Nziguheba G, 1998, PLANT SOIL, V198, P159, DOI 10.1023/A:1004389704235; Olsson P, 2005, GLOBAL CHANGE BIOL, V11, P1745, DOI 10.1111/j.1365-2486.2005.001033.x; Paterson E, 2009, SOIL BIOL BIOCHEM, V41, P1352, DOI 10.1016/j.soilbio.2009.02.012; Pendall E, 2007, SOIL BIOL BIOCHEM, V39, P2628, DOI 10.1016/j.soilbio.2007.05.016; Phillips RP, 2007, NEW PHYTOL, V176, P655, DOI 10.1111/j.1469-8137.2007.02204.x; Reichstein M, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2003GB002035; Schadt CW, 2003, SCIENCE, V301, P1359, DOI 10.1126/science.1086940; Schadel C, 2013, OECOLOGIA, V171, P721, DOI 10.1007/s00442-012-2577-4; Schimel JP, 2003, SOIL BIOL BIOCHEM, V35, P549, DOI 10.1016/S0038-0717(03)00015-4; [石丽丽 SHI LIli], 2008, [安徽农业科学, Journal of Anhui Agricultural Sciences], V36, P4185; Singh BK, 2010, NAT REV MICROBIOL, V8, P779, DOI 10.1038/nrmicro2439; SINGH JS, 1989, NATURE, V338, P499, DOI 10.1038/338499a0; Sinsabaugh RL, 2002, BIOGEOCHEMISTRY, V60, P1, DOI 10.1023/A:1016541114786; Six J, 2006, SOIL SCI SOC AM J, V70, P555, DOI 10.2136/sssaj2004.0347; Suseela V, 2012, GLOBAL CHANGE BIOL, V18, P336, DOI 10.1111/j.1365-2486.2011.02516.x; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Trumbore S, 2000, ECOL APPL, V10, P399, DOI 10.1890/1051-0761(2000)010[0399:AOSOMA]2.0.CO;2; Vanhala P, 2011, GLOBAL CHANGE BIOL, V17, P538, DOI 10.1111/j.1365-2486.2009.02154.x; VOSE JM, 1995, CAN J FOREST RES, V25, P1243, DOI 10.1139/x95-137; Waldrop MP, 2000, SOIL BIOL BIOCHEM, V32, P1837, DOI 10.1016/S0038-0717(00)00157-7; Wallenstein MD, 2007, FEMS MICROBIOL ECOL, V59, P428, DOI 10.1111/j.1574-6941.2006.00260.x; Wang W, 2010, PLANT SOIL, V333, P391, DOI 10.1007/s11104-010-0354-x; Wang W, 2010, SOIL BIOL BIOCHEM, V42, P451, DOI 10.1016/j.soilbio.2009.11.028; Wang WJ, 2004, SOIL BIOL BIOCHEM, V36, P2045, DOI 10.1016/j.soilbio.2004.05.023; Zak DR, 2007, ECOLOGY, V88, P2630, DOI 10.1890/06-1819.1; Zelles L, 1997, CHEMOSPHERE, V35, P275, DOI 10.1016/S0045-6535(97)00155-0; Zhang XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092985; Zhou LY, 2014, GLOBAL CHANGE BIOL, V20, P2332, DOI 10.1111/gcb.12490	75	6	7	6	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153415	10.1371/journal.pone.0153415	http://dx.doi.org/10.1371/journal.pone.0153415			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070782	Green Submitted, Green Published, gold			2022-12-26	WOS:000373900700063
J	Wang, X; Liu, L				Wang, Xiao; Liu, Lin			Crystal Structure and Catalytic Mechanism of 7-Hydroxymethyl Chlorophyll a Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING COMPLEX; STRUCTURE REFINEMENT; OXYGENASE CAO; BIOSYNTHESIS; DEGRADATION; CONVERSION; GREEN; PROTEIN; IDENTIFICATION; BREAKDOWN	7-Hydroxymethyl chlorophyll a reductase (HCAR) catalyzes the second half-reaction in chlorophyll b to chlorophyll a conversion. HCAR is required for the degradation of light-harvesting complexes and is necessary for efficient photosynthesis by balancing the chlorophyll a/b ratio. Reduction of the hydroxymethyl group uses redox cofactors [4Fe-4S] cluster and FAD to transfer electrons and is difficult because of the strong carbon-oxygen bond. Here, we report the crystal structure of Arabidopsis HCAR at 2.7-angstrom resolution and reveal that two [4Fe-4S] clusters and one FAD within a very short distance form a consecutive electron pathway to the substrate pocket. In vitro kinetic analysis confirms the ferredoxin-dependent electron transport chain, thus supporting a proton-activated electron transfer mechanism. HCAR resembles a partial reconstruction of an archaeal F-420-reducing [NiFe] hydrogenase, which suggests a common mode of efficient proton-coupled electron transfer through conserved cofactor arrangements. Furthermore, the trimeric form of HCAR provides a biological clue of its interaction with light-harvesting complex II.	[Wang, Xiao; Liu, Lin] Chinese Acad Sci, Inst Bot, CAS Ctr Excellence Mol Plant Sci, Key Lab Photobiol, 20 Nanxincun, Beijing 100093, Peoples R China; [Wang, Xiao] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, L (corresponding author), Chinese Acad Sci, CAS Ctr Excellence Mol Plant Sci, Key Lab Photobiol, Inst Bot, 20 Nanxincun, Beijing 100093, Peoples R China.	liulin@ibcas.ac.cn			National Basic Research Program of China [2011CBA00901]; National Natural Science Foundation of China [31370759]; Chinese Academy of Sciences [KGZD-EW-T05]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Basic Research Program of China Grant 2011CBA00901, National Natural Science Foundation of China Grant 31370759, and Key Research Program Grant KGZD-EW-T05 from the Chinese Academy of Sciences. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Allegretti M, 2014, ELIFE, V3, DOI 10.7554/eLife.01963; Beinert H, 2000, J BIOL INORG CHEM, V5, P2, DOI 10.1007/s007750050002; Belevich I, 2006, NATURE, V440, P829, DOI 10.1038/nature04619; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cotruvo JA, 2011, ANNU REV BIOCHEM, V80, P733, DOI 10.1146/annurev-biochem-061408-095817; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Espineda CE, 1999, P NATL ACAD SCI USA, V96, P10507, DOI 10.1073/pnas.96.18.10507; Folly P, 1999, J BIOL CHEM, V274, P21811, DOI 10.1074/jbc.274.31.21811; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Hortensteiner S, 2006, ANNU REV PLANT BIOL, V57, P55, DOI 10.1146/annurev.arplant.57.032905.105212; Hortensteiner S, 2011, BBA-BIOENERGETICS, V1807, P977, DOI 10.1016/j.bbabio.2010.12.007; HOLT AS, 1959, PLANT PHYSIOL, V34, P310, DOI 10.1104/pp.34.3.310; Horie Y, 2009, J BIOL CHEM, V284, P17449, DOI 10.1074/jbc.M109.008912; Islam MR, 2008, PLANT PHYSIOL, V148, P1068, DOI 10.1104/pp.108.123117; Ito H, 1996, J BIOL CHEM, V271, P1475, DOI 10.1074/jbc.271.3.1475; Ito H, 2008, J BIOL CHEM, V283, P9002, DOI 10.1074/jbc.M708369200; Ito H, 2014, PLANT CELL PHYSIOL, V55, P593, DOI 10.1093/pcp/pct203; Kunkel A, 1998, EUR J BIOCHEM, V252, P467, DOI 10.1046/j.1432-1327.1998.2520467.x; Kunugi M, 2013, J BIOL CHEM, V288, P19330, DOI 10.1074/jbc.M113.462663; Kusaba M, 2007, PLANT CELL, V19, P1362, DOI 10.1105/tpc.106.042911; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Liu ZF, 2011, J BACTERIOL, V193, P4996, DOI 10.1128/JB.05520-11; Meguro M, 2011, PLANT CELL, V23, P3442, DOI 10.1105/tpc.111.089714; Migliore A, 2014, CHEM REV, V114, P3381, DOI 10.1021/cr4006654; Mills DJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00218; Mochizuki N, 2010, TRENDS PLANT SCI, V15, P488, DOI 10.1016/j.tplants.2010.05.012; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Peters JW, 2015, BBA-MOL CELL RES, V1853, P1350, DOI 10.1016/j.bbamcr.2014.11.021; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Pryor KD, 1997, PROTEIN EXPRES PURIF, V10, P309, DOI 10.1006/prep.1997.0759; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rudiger W, 2002, PHOTOSYNTH RES, V74, P187, DOI 10.1023/A:1020959610952; Sakuraba Y, 2013, BIOCHEM BIOPH RES CO, V430, P32, DOI 10.1016/j.bbrc.2012.11.050; Sakuraba Y, 2012, PLANT CELL, V24, P507, DOI 10.1105/tpc.111.089474; Saunders AH, 2013, BIOCHEMISTRY-US, V52, P8442, DOI 10.1021/bi401172b; Shimoda Y, 2012, PLANT J, V72, P501, DOI 10.1111/j.1365-313X.2012.05095.x; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanaka A, 1998, P NATL ACAD SCI USA, V95, P12719, DOI 10.1073/pnas.95.21.12719; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; Tanaka R, 2011, BBA-BIOENERGETICS, V1807, P968, DOI 10.1016/j.bbabio.2011.01.002; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Thauer RK, 2010, ANNU REV BIOCHEM, V79, P507, DOI 10.1146/annurev.biochem.030508.152103; Touw WG, 2015, NUCLEIC ACIDS RES, V43, pD364, DOI 10.1093/nar/gku1028; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Vitt S, 2014, J MOL BIOL, V426, P2813, DOI 10.1016/j.jmb.2014.05.024; Weinberg DR, 2012, CHEM REV, V112, P4016, DOI 10.1021/cr200177j	54	16	16	0	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 17	2016	291	25					13349	13359		10.1074/jbc.M116.720342	http://dx.doi.org/10.1074/jbc.M116.720342			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR2YT	27072131	hybrid, Green Published			2022-12-26	WOS:000379770500036
J	Dasgupta, T; Antony, J; Braithwaite, AW; Horsfield, JA				Dasgupta, Tanushree; Antony, Jisha; Braithwaite, Antony W.; Horsfield, Julia A.			HDAC8 Inhibition Blocks SMC3 Deacetylation and Delays Cell Cycle Progression without Affecting Cohesin-dependent Transcription in MCF7 Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DE-LANGE-SYNDROME; GENE-EXPRESSION; MUTATIONS; ACETYLATION; COMPLEX; CORNELIA; ESTABLISHMENT; RESISTANCE; UNDERLIE; PATHWAYS	Cohesin, a multi-subunit protein complex involved in chromosome organization, is frequently mutated or aberrantly expressed in cancer. Multiple functions of cohesin, including cell division and gene expression, highlight its potential as a novel therapeutic target. The SMC3 subunit of cohesin is acetylated (ac) during S phase to establish cohesion between replicated chromosomes. Following anaphase, ac-SMC3 is deacetylated by HDAC8. Reversal of SMC3 acetylation is imperative for recycling cohesin so that it can be reloaded in interphase for both non-mitotic and mitotic functions. We blocked deacetylation of ac-SMC3 using an HDAC8-specific inhibitor PCI-34051 in MCF7 breast cancer cells, and examined the effects on transcription of cohesin-dependent genes that respond to estrogen. HDAC8 inhibition led to accumulation of ac-SMC3 as expected, but surprisingly, had no influence on the transcription of estrogen-responsive genes that are altered by siRNA targeting of RAD21 or SMC3. Knockdown of RAD21 altered estrogen receptor alpha (ER) recruitment at SOX4 and IL20, and affected transcription of these genes, while HDAC8 inhibition did not. Rather, inhibition of HDAC8 delayed cell cycle progression, suppressed proliferation and induced apoptosis in a concentration-dependent manner. We conclude that HDAC8 inhibition does not change the estrogen-specific transcriptional role of cohesin in MCF7 cells, but instead, compromises cell cycle progression and cell survival. Our results argue that candidate inhibitors of cohesin function may differ in their effects depending on the cellular genotype and should be thoroughly tested for predicted effects on cohesin's mechanistic roles.	[Dasgupta, Tanushree; Antony, Jisha; Braithwaite, Antony W.; Horsfield, Julia A.] Univ Otago, Dunedin Sch Med, Dept Pathol, POB 913, Dunedin 9016, New Zealand; [Braithwaite, Antony W.; Horsfield, Julia A.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1010, New Zealand	University of Otago; University of Auckland	Horsfield, JA (corresponding author), Univ Otago, Dunedin Sch Med, Dept Pathol, POB 913, Dunedin 9016, New Zealand.	julia.horsfield@otago.ac.nz	Horsfield, Julia A/B-5091-2012	Horsfield, Julia A/0000-0002-9536-7790	Genesis Oncology Trust; Cancer Society of New Zealand [11-18]; Health Research Council of NZ (HRC) [10-873, 15-229]; HRC [13-61, 14-219, 15-500]	Genesis Oncology Trust; Cancer Society of New Zealand; Health Research Council of NZ (HRC); HRC	This work was supported by Genesis Oncology Trust, Cancer Society of New Zealand (11-18), and Health Research Council of NZ (HRC) (10-873, 15-229) grants (to J. A. H.), along with HRC Grants 13-61, 14-219, and 15-500) (to A. W. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Antony J., 2014, BIOCHIM BIOPHYS ACTA, V24; Atienza JM, 2005, MOL CANCER THER, V4, P361; Balasubramanian S, 2008, LEUKEMIA, V22, P1026, DOI 10.1038/leu.2008.9; Beckouet F, 2010, MOL CELL, V39, P689, DOI 10.1016/j.molcel.2010.08.008; Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Borges V, 2010, MOL CELL, V39, P677, DOI 10.1016/j.molcel.2010.08.009; Deardorff MA, 2012, NATURE, V489, P313, DOI 10.1038/nature11316; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Ha SD, 2014, J IMMUNOL, V193, P1333, DOI 10.4049/jimmunol.1400420; Horsfield Julia A., 2012, Frontiers in Genetics, V3, P171, DOI 10.3389/fgene.2012.00171; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kaiser FJ, 2014, HUM MOL GENET, V23, P2888, DOI 10.1093/hmg/ddu002; Kon A, 2013, NAT GENET, V45, P1232, DOI 10.1038/ng.2731; Leeke B, 2014, EXP HEMATOL ONCOL, V3, DOI 10.1186/2162-3619-3-13; Leiserson MDM, 2015, NAT GENET, V47, P106, DOI 10.1038/ng.3168; Lopez G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133302; Losada A, 2014, NAT REV CANCER, V14, P389, DOI 10.1038/nrc3743; Mannini L, 2013, HUM MUTAT, V34, P1589, DOI 10.1002/humu.22430; Marsman J, 2014, BBA-GENE REGUL MECH, V1839, P50, DOI 10.1016/j.bbagrm.2013.11.007; Mazumdar C, 2015, CELL STEM CELL, V17, P1, DOI 10.1016/j.stem.2015.09.017; McEwan MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049160; Merkenschlager M, 2013, CELL, V152, P1285, DOI 10.1016/j.cell.2013.02.029; Mullenders J, 2015, J EXP MED, V212, P1833, DOI 10.1084/jem.20151323; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Olson DE, 2014, ACS CHEM BIOL, V9, P2210, DOI 10.1021/cb500492r; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Qi J, 2015, CELL STEM CELL, V17, P597, DOI 10.1016/j.stem.2015.08.004; Remeseiro S, 2013, DEVELOPMENT, V140, P3715, DOI 10.1242/dev.090605; Remeseiro S, 2013, CURR OPIN CELL BIOL, V25, P63, DOI 10.1016/j.ceb.2012.10.013; Rhodes JM, 2011, MOL CANCER RES, V9, P1587, DOI 10.1158/1541-7786.MCR-11-0382; Rhodes JM, 2010, DEV BIOL, V344, P637, DOI 10.1016/j.ydbio.2010.05.493; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Scholz C, 2015, NAT BIOTECHNOL, V33, P415, DOI 10.1038/nbt.3130; Schuster K, 2015, HUM MOL GENET, V24, P7005, DOI 10.1093/hmg/ddv402; Seitan VC, 2013, GENOME RES, V23, P2066, DOI 10.1101/gr.161620.113; Sleiman SF, 2014, J NEUROSCI, V34, P14328, DOI 10.1523/JNEUROSCI.1010-14.2014; Sofueva S, 2013, EMBO J, V32, P3119, DOI 10.1038/emboj.2013.237; Solomon DA, 2014, BMB REP, V47, P299, DOI 10.5483/BMBRep.2014.47.6.092; Thol F, 2014, BLOOD, V123, P914, DOI 10.1182/blood-2013-07-518746; Thota S, 2014, BLOOD, V124, P1790, DOI 10.1182/blood-2014-04-567057; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; Viny AD, 2015, J EXP MED, V212, P1819, DOI 10.1084/jem.20151317; Wang C, 2014, AM J NUCL MED MOLEC, V4, P29; Xiong B, 2010, CURR BIOL, V20, P1660, DOI 10.1016/j.cub.2010.08.019; Xu HL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2814; Yuan B, 2015, J CLIN INVEST, V125, P636, DOI 10.1172/JCI77435; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006	47	35	36	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12761	12770		10.1074/jbc.M115.704627	http://dx.doi.org/10.1074/jbc.M115.704627			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27072133	Green Published, hybrid			2022-12-26	WOS:000378119900028
J	Cebey-Lopez, M; Herberg, J; Pardo-Seco, J; Gomez-Carballa, A; Martinon-Torres, N; Salas, A; Martinon-Sanchez, JM; Justicia, A; Rivero-Calle, I; Sumner, E; Fink, C; Martinon-Torres, F				Cebey-Lopez, Miriam; Herberg, Jethro; Pardo-Seco, Jacobo; Gomez-Carballa, Alberto; Martinon-Torres, Nazareth; Salas, Antonio; Maria Martinon-Sanchez, Jose; Justicia, Antonio; Rivero-Calle, Irene; Sumner, Edward; Fink, Colin; Martinon-Torres, Federico		GENDRES Network	Does Viral Co-Infection Influence the Severity of Acute Respiratory Infection in Children?	PLOS ONE			English	Article							INCREASED DISEASE SEVERITY; LENGTH-OF-STAY; HOSPITALIZED CHILDREN; SYNCYTIAL VIRUS; HUMAN METAPNEUMOVIRUS; STREPTOCOCCUS-PNEUMONIAE; PROSPECTIVE MULTICENTER; BOCAVIRUS INFECTION; TRACT INFECTIONS; ETIOLOGY	Background Multiple viruses are often detected in children with respiratory infection but the significance of co-infection in pathogenesis, severity and outcome is unclear. Objectives To correlate the presence of viral co-infection with clinical phenotype in children admitted with acute respiratory infections (ARI). Methods We collected detailed clinical information on severity for children admitted with ARI as part of a Spanish prospective multicenter study (GENDRES network) between 2011-2013. A nested polymerase chain reaction (PCR) approach was used to detect respiratory viruses in respiratory secretions. Findings were compared to an independent cohort collected in the UK. Results 204 children were recruited in the main cohort and 97 in the replication cohort. The number of detected viruses did not correlate with any markers of severity. However, bacterial superinfection was associated with increased severity (OR: 4.356; P-value = 0.005), PICU admission (OR: 3.342; P-value = 0.006), higher clinical score (1.988; P-value = 0.002) respiratory support requirement (OR: 7.484; P-value < 0.001) and longer hospital length of stay (OR: 1.468; P-value < 0.001). In addition, pneumococcal vaccination was found to be a protective factor in terms of degree of respiratory distress (OR: 2.917; P-value = 0.035), PICU admission (OR: 0.301; P-value = 0.011), lower clinical score (-1.499; P-value = 0.021) respiratory support requirement (OR: 0.324; P-value = 0.016) and oxygen necessity (OR: 0.328; P-value = 0.001). All these findings were replicated in the UK cohort. Conclusion The presence of more than one virus in hospitalized children with ARI is very frequent but it does not seem to have a major clinical impact in terms of severity. However bacterial superinfection increases the severity of the disease course. On the contrary, pneumococcal vaccination plays a protective role.	[Cebey-Lopez, Miriam; Pardo-Seco, Jacobo; Gomez-Carballa, Alberto; Martinon-Torres, Nazareth; Salas, Antonio; Maria Martinon-Sanchez, Jose; Justicia, Antonio; Rivero-Calle, Irene; Martinon-Torres, Federico] Hosp Clin Univ, Grp Invest Genet Vacunas Infecc & Pediat, Galicia, Spain; [Cebey-Lopez, Miriam; Pardo-Seco, Jacobo; Gomez-Carballa, Alberto; Martinon-Torres, Nazareth; Salas, Antonio; Maria Martinon-Sanchez, Jose; Justicia, Antonio; Rivero-Calle, Irene; Martinon-Torres, Federico] Univ Santiago de Compostela, Galicia, Spain; [Cebey-Lopez, Miriam; Pardo-Seco, Jacobo; Gomez-Carballa, Alberto; Martinon-Torres, Nazareth; Maria Martinon-Sanchez, Jose; Justicia, Antonio; Rivero-Calle, Irene; Martinon-Torres, Federico] Hosp Clin Univ Santiago, Dept Pediat, Translat Pediat & Infect Dis Sect, Santiago De Compostela, Galicia, Spain; [Herberg, Jethro] Univ London Imperial Coll Sci Technol & Med, Div Infect Dis, Paediat Sect, South Kensington Campus, London, England; [Pardo-Seco, Jacobo; Gomez-Carballa, Alberto; Salas, Antonio] Univ Santiago de Compostela, Dept Anat Patol & Ciencias Forenses, Unidade Xenet, Fac Med, Galicia, Spain; [Pardo-Seco, Jacobo; Gomez-Carballa, Alberto; Salas, Antonio] Univ Santiago de Compostela, Inst Ciencias Forenses, Grp Med Xenom, Fac Med, Galicia, Spain; [Sumner, Edward; Fink, Colin] Univ Warwick, Micropathol Ltd, Sci Pk, Coventry CV4 7AL, W Midlands, England	Universidade de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Imperial College London; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; University of Warwick	Cebey-Lopez, M (corresponding author), Hosp Clin Univ, Grp Invest Genet Vacunas Infecc & Pediat, Galicia, Spain.; Cebey-Lopez, M (corresponding author), Univ Santiago de Compostela, Galicia, Spain.; Cebey-Lopez, M (corresponding author), Hosp Clin Univ Santiago, Dept Pediat, Translat Pediat & Infect Dis Sect, Santiago De Compostela, Galicia, Spain.	Miriam.cebey.lopez@sergas.es	Pardo-Seco, Jacobo J/G-3752-2016; Salas, Antonio/U-2029-2019; Salas, Antonio/E-3977-2012; Gómez-Carballa, Alberto/I-4610-2014; Cebey, Miriam/K-9347-2014; rivero, irene/ABC-9006-2020; Martinon-Torres, Federico/E-4982-2016	Pardo-Seco, Jacobo J/0000-0002-8059-8908; Salas, Antonio/0000-0002-2336-702X; Salas, Antonio/0000-0002-2336-702X; Gómez-Carballa, Alberto/0000-0003-0927-1272; Cebey, Miriam/0000-0003-0599-7519; Martinon-Torres, Federico/0000-0002-9023-581X; Rivero Calle, Irene/0000-0002-3678-9264; Justicia Grande, Antonio/0000-0002-0410-3328; Herberg, Jethro/0000-0001-6941-6491	Spanish Government (Research Program Health Research Fund (FIS)) [PI10/00540]; Spanish Government (FEDER funds); Regional Galician funds [10 PXIB 918 184 PR]; Ministerio de Ciencia e Innovacion [SAF2011-26983]; Plan Galego IDT, Xunta de Galicia [EM 2012/045]; Sistema Universitario Gallego Modalidad REDES from Xunta de Galicia [2014-PG139]; Instituto de Investigacion Sanitaria de Santiago de Compostela; Instituto Carlos III (Intensificacion de la actividad investigadora); European Union [279185]; Imperial College Comprehensive Biomedical Research Centre; Wellcome Trust Centre for Respiratory Infection at Imperial College [DMPED P26077]; Micropathology Ltd.	Spanish Government (Research Program Health Research Fund (FIS)); Spanish Government (FEDER funds)(Spanish Government); Regional Galician funds; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Plan Galego IDT, Xunta de Galicia; Sistema Universitario Gallego Modalidad REDES from Xunta de Galicia; Instituto de Investigacion Sanitaria de Santiago de Compostela; Instituto Carlos III (Intensificacion de la actividad investigadora)(Instituto de Salud Carlos III); European Union(European Commission); Imperial College Comprehensive Biomedical Research Centre; Wellcome Trust Centre for Respiratory Infection at Imperial College; Micropathology Ltd.	This work was supported by the Spanish Government (Research Program Health Research Fund (FIS; PI10/00540) National Plan I + D + I and FEDER funds), by Regional Galician funds (Promotion of Research Project 10 PXIB 918 184 PR) (FMT), by Ministerio de Ciencia e Innovacion (SAF2011-26983), and by the Plan Galego IDT, Xunta de Galicia (EM 2012/045) (AS). A grant was received from the Sistema Universitario Gallego Modalidad REDES (2014-PG139) from the Xunta de Galicia (to AS and FMT). MCL research activities have been supported by grants from Instituto de Investigacion Sanitaria de Santiago de Compostela. FMT research activities have been supported by grants from Instituto Carlos III (Intensificacion de la actividad investigadora). Investigators received funding from the European Union's seventh Framework program under ECGA no. 279185 (EUCLIDS) during the production of this paper. JH was supported by the Imperial College Comprehensive Biomedical Research Centre and the Wellcome Trust Centre for Respiratory Infection at Imperial College (DMPED P26077 to JH). Micropathology Ltd. provided support in the form of salaries for authors ES and CF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aberle JH, 2005, PEDIATR INFECT DIS J, V24, P605, DOI 10.1097/01.inf.0000168741.59747.2d; Advani S, 2012, PEDIATR INFECT DIS J, V31, P1221, DOI 10.1097/INF.0b013e318265a804; Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Asner SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099392; Azzari C, 2014, PEDIATR INFECT DIS J, V33, P858, DOI 10.1097/INF.0000000000000328; Bonzel L, 2008, PEDIATR INFECT DIS J, V27, P589, DOI 10.1097/INF.0b013e3181694fb9; Bosch AATM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003057; Brand HK, 2012, PEDIATR PULM, V47, P393, DOI 10.1002/ppul.21552; Cebey-Lopez M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136526; Choi EH, 2006, CLIN INFECT DIS, V43, P585, DOI 10.1086/506350; Chorazy ML, 2013, PEDIATR INFECT DIS J, V32, P460, DOI 10.1097/INF.0b013e31828683ce; Chung JY, 2006, EMERG INFECT DIS, V12, P1254, DOI 10.3201/eid1708.060261; Freymuth F, 2006, J MED VIROL, V78, P1498, DOI 10.1002/jmv.20725; Garcia-Garcia ML, 2006, PEDIATR PULM, V41, P863, DOI 10.1002/ppul.20456; Hasegawa K, 2014, PEDIATR INFECT DIS J, V33, P809, DOI 10.1097/INF.0000000000000293; Huijskens EG, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-276; Jartti T, 2014, PEDIATR INFECT DIS J, V33, P829, DOI 10.1097/INF.0000000000000313; Kahn JS, 2007, CURR OPIN PHARMACOL, V7, P478, DOI 10.1016/j.coph.2007.07.004; Madhi SA, 2004, NAT MED, V10, P811, DOI 10.1038/nm1077; Mansbach JM, 2008, ACAD EMERG MED, V15, P111, DOI 10.1111/j.1553-2712.2007.00034.x; Mansbach JM, 2012, ARCH PEDIAT ADOL MED, V166, P700, DOI 10.1001/archpediatrics.2011.1669; Nicoli EJ, 2013, J INFECTION, V66, P512, DOI 10.1016/j.jinf.2013.02.007; Papadopoulos NG, 2002, AM J RESP CRIT CARE, V165, P1285, DOI 10.1164/rccm.200112-118BC; Peng D, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-155; Rhedin S, 2014, PEDIATRICS, V133, pE538, DOI 10.1542/peds.2013-3042; Richard N, 2008, PEDIATR INFECT DIS J, V27, P213, DOI 10.1097/INF.0b013e31815b4935; Schildgen O, 2008, CLIN MICROBIOL REV, V21, P291, DOI 10.1128/CMR.00030-07; Semple MG, 2005, J INFECT DIS, V191, P382, DOI 10.1086/426457; Smith CM, 2014, AM J RESP CRIT CARE, V190, P196, DOI 10.1164/rccm.201311-2110OC; Suryadevara M, 2011, CLIN PEDIATR, V50, P513, DOI 10.1177/0009922810394834; Tan BH, 2009, J MED VIROL, V81, P82, DOI 10.1002/jmv.21361; van der Zalm MM, 2009, J PEDIATR-US, V154, P396, DOI 10.1016/j.jpeds.2008.08.036; Weinberger DM, 2013, EMERG INFECT DIS, V19, P1084, DOI 10.3201/eid1907.121625; Wolf DG, 2006, PEDIATR INFECT DIS J, V25, P320, DOI 10.1097/01.inf.0000207395.80657.cf; Yoshida LM, 2013, EUR RESPIR J, V42, P461, DOI 10.1183/09031936.00101812	35	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0152481	10.1371/journal.pone.0152481	http://dx.doi.org/10.1371/journal.pone.0152481			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096199	Green Published, gold, Green Submitted			2022-12-26	WOS:000374543600014
J	Koo, DL; Lee, JY; Joo, EY; Hong, SB; Nam, H				Koo, Dae Lim; Lee, Jee Young; Joo, Eun Yeon; Hong, Seung Bong; Nam, Hyunwoo			Acoustic Characteristics of Stridor in Multiple System Atrophy	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; VOCAL CORD MOTION; LARYNGEAL STRIDOR; SLEEP DISORDERS; SURVIVAL	Nocturnal stridor is a breathing disorder prevalent in patients with multiple system atrophy (MSA). An improved understanding of this breathing disorder is essential since nocturnal stridor carries a poor prognosis (an increased risk of sudden death). In this study, we aimed to classify types of stridor by sound analysis and to reveal their clinical significance. Patients who met the criteria for probable MSA and had undergone polysomnography (PSG) were recruited. Patients were then assessed clinically with sleep questionnaires, including the Pittsburgh Sleep Quality Index, and the Hoehn and Yahr scale. Nocturnal stridor and snoring were analyzed with the Multi-Dimensional Voice Program. Nocturnal stridor was recorded in 22 patients and snoring in 18 patients using the PSG. Waveforms of stridors were classified into rhythmic or semirhythmic after analysis of the oscillogram. Formants and harmonics were observed in both types of stridor, but not in snoring. Of the 22 patients diagnosed with stridor during the present study, fifteen have subsequently died, with the time to death after the PSG study being 1.9 +/- 1.4 years (range 0.8 to 5.0 years). The rhythmic waveform group presented higher scores on the Hoehn and Yahr scale and the survival outcome of this group was lower compared to the semirhythmic waveform group (p = 0.030, p = 0.014). In the Kaplan Meier's survival curve, the outcome of patients with rhythmic waveform was significantly less favorable than the outcome of patients with semirhythmic waveform (log-rank test, p < 0.001). Stridor in MSA can be classified into rhythmic and semirhythmic types and the rhythmic component signifies a poorer outcome.	[Koo, Dae Lim; Lee, Jee Young; Nam, Hyunwoo] Seoul Natl Univ, Boramae Hosp, Dept Neurol, Seoul, South Korea; [Joo, Eun Yeon; Hong, Seung Bong] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol,Samsung Biomed Res Inst, Seoul, South Korea; [Joo, Eun Yeon] Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU)	Nam, H (corresponding author), Seoul Natl Univ, Boramae Hosp, Dept Neurol, Seoul, South Korea.; Joo, EY (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol,Samsung Biomed Res Inst, Seoul, South Korea.; Joo, EY (corresponding author), Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea.	ejoo@skku.edu; hwnam85@gmail.com		Lee, Jee-Young/0000-0002-9120-2075	Clinical Research Grant of Boramae Medical Center [03-2014-1]; Samsung Biomedical Research Institute [OTX0002111]	Clinical Research Grant of Boramae Medical Center; Samsung Biomedical Research Institute(Samsung)	This research was supported by the Clinical Research Grant of Boramae Medical Center (03-2014-1) and Samsung Biomedical Research Institute grant (#OTX0002111).	American Academy of Sleep Medicine, 2014, INT CLASS SLEEP DIS, V3rd; BenShlomo Y, 1997, NEUROLOGY, V48, P384, DOI 10.1212/WNL.48.2.384; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Figueroa JJ, 2014, MOVEMENT DISORD, V29, P1151, DOI 10.1002/mds.25927; Ghorayeb I, 2005, SLEEP MED, V6, P359, DOI 10.1016/j.sleep.2004.10.002; Ghorayeb I, 2002, J NEUROL NEUROSUR PS, V72, P798, DOI 10.1136/jnnp.72.6.798; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; Iranzo A, 2004, NEUROLOGY, V63, P930, DOI 10.1212/01.WNL.0000137043.76383.A4; Iranzo Alex, 2007, Curr Treat Options Neurol, V9, P347, DOI 10.1007/BF02938541; Iriarte J, 2011, SLEEP BREATH, V15, P229, DOI 10.1007/s11325-010-0420-x; Isono S, 2001, J PHYSIOL-LONDON, V536, P237, DOI 10.1111/j.1469-7793.2001.t01-1-00237.x; Kakitsuba N, 1997, ANN OTO RHINOL LARYN, V106, P380; Koo DL, 2012, SLEEP MED, V13, P961, DOI 10.1016/j.sleep.2012.04.002; Lalich IJ, 2014, LARYNGOSCOPE, V124, P730, DOI 10.1002/lary.24402; Medicine AAoS, 2007, AASM MANUAL SCORING; Ozawa T, 2016, J NEUROL SCI, V361, P243, DOI 10.1016/j.jns.2016.01.007; Ozawa T, 2010, MOVEMENT DISORD, V25, P1418, DOI 10.1002/mds.23090; SAITO Y, 1994, INTERNAL MED, V33, P321, DOI 10.2169/internalmedicine.33.321; SCHULZ JB, 1994, J NEUROL NEUROSUR PS, V57, P1047, DOI 10.1136/jnnp.57.9.1047; Shiba K, 2007, AURIS NASUS LARYNX, V34, P443, DOI 10.1016/j.anl.2007.03.006; Shimohata T, 2014, SLEEP MED, V15, P1147, DOI 10.1016/j.sleep.2014.04.013; Silber MH, 2000, MOVEMENT DISORD, V15, P699, DOI 10.1002/1531-8257(200007)15:4<699::AID-MDS1015>3.0.CO;2-L; Testa D, 1996, J NEUROL, V243, P401, DOI 10.1007/BF00868999; Vetrugno R, 2004, SLEEP MED, V5, P21, DOI 10.1016/j.sleep.2003.07.002; Vetrugno R, 2007, MOVEMENT DISORD, V22, P673, DOI 10.1002/mds.21384; Watanabe H, 2002, BRAIN, V125, P1070, DOI 10.1093/brain/awf117; Wenning GK, 1997, MOVEMENT DISORD, V12, P133, DOI 10.1002/mds.870120203; Yamaguchi M, 2003, EUR NEUROL, V49, P154, DOI 10.1159/000069077; YANAGIHARA N, 1967, J SPEECH HEAR RES, V10, P531, DOI 10.1044/jshr.1003.531	29	8	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153935	10.1371/journal.pone.0153935	http://dx.doi.org/10.1371/journal.pone.0153935			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093692	Green Submitted, Green Published, gold			2022-12-26	WOS:000374541200065
J	Wen, AP; Li, Z; Yu, JX; Li, R; Cheng, S; Duan, ML; Bai, J				Wen, Aiping; Li, Zhe; Yu, Junxian; Li, Ren; Cheng, Sheng; Duan, Meili; Bai, Jing			Clinical Validation of Therapeutic Drug Monitoring of Imipenem in Spent Effluent in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Pilot Study	PLOS ONE			English	Article							INTENSIVE-CARE UNITS; CONTINUOUS VENOVENOUS HEMOFILTRATION; INADEQUATE ANTIMICROBIAL TREATMENT; SEPTIC SHOCK; SEVERE SEPSIS; LIQUID-CHROMATOGRAPHY; HOSPITAL MORTALITY; ANTIBIOTIC-THERAPY; BETA-LACTAMS; HUMAN PLASMA	Objectives The primary objective of this pilot study was to investigate whether the therapeutic drug monitoring of imipenem could be performed with spent effluent instead of blood sampling collected from critically ill patients under continuous renal replacement therapy. Methods A prospective open-label study was conducted in a real clinical setting. Both blood and effluent samples were collected pairwise before imipenem administration and 0.5, 1, 1.5, 2, 3, 4, 6, and 8 h after imipenem administration. Plasma and effluent imipenem concentrations were determined by reversed-phase high-performance liquid chromatography with ultraviolet detection. Pharmacokinetic and pharmacodynamic parameters of blood and effluent samples were calculated. Results Eighty-three paired plasma and effluent samples were obtained from 10 patients. The Pearson correlation coefficient of the imipenem concentrations in plasma and effluent was 0.950 (P<0.0001). The average plasma-to-effluent imipenem concentration ratio was 1.044 (95% confidence interval, 0.975 to 1.114) with Bland-Altman analysis. No statistically significant difference was found in the pharmacokinetic and pharmacodynamic parameters tested in paired plasma and effluent samples with Wilcoxon test. Conclusion Spent effluent of continuous renal replacement therapy could be used for therapeutic drug monitoring of imipenem instead of blood sampling in critically ill patients.	[Wen, Aiping; Yu, Junxian; Li, Ren; Cheng, Sheng] Capital Med Univ, Beijing Friendship Hosp, Dept Pharm, Beijing, Peoples R China; [Li, Zhe] Capital Med Univ, Sch Chem Biol & Pharmaceut Sci, Beijing, Peoples R China; [Duan, Meili; Bai, Jing] Capital Med Univ, Beijing Friendship Hosp, Dept Crit Care Med, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University	Wen, AP (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Dept Pharm, Beijing, Peoples R China.; Bai, J (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Dept Crit Care Med, Beijing, Peoples R China.	wenaiping@126.com; alex_white@126.com			Research Program of the Beijing Pharmaceutical Association	Research Program of the Beijing Pharmaceutical Association	This study was funded by a grant from the Research Program of the Beijing Pharmaceutical Association.	Arzuaga A, 2005, J CLIN PHARMACOL, V45, P168, DOI 10.1177/0091270004269796; Bouman CSC, 2006, INTENS CARE MED, V32, P2013, DOI 10.1007/s00134-006-0397-x; CLARK WR, 1995, KIDNEY INT, V48, P481, DOI 10.1038/ki.1995.317; Connor MJ, 2011, ANTIMICROB AGENTS CH, V55, P557, DOI 10.1128/AAC.00548-10; Craig WA, 1998, CLIN INFECT DIS, V26, P1, DOI 10.1086/516284; Craig WA, 2003, INFECT DIS CLIN N AM, V17, P479, DOI 10.1016/S0891-5520(03)00065-5; Deepa C, 2012, J Anaesthesiol Clin Pharmacol, V28, P386, DOI 10.4103/0970-9185.98357; Dolman HS, 2015, SURGERY, V158, P1083, DOI 10.1016/j.surg.2015.05.018; Fish DN, 2005, ANTIMICROB AGENTS CH, V49, P2421, DOI 10.1128/AAC.49.6.2421-2428.2005; Galvagno SM, 2013, J CRIT CARE, V28, P1019, DOI 10.1016/j.jcrc.2013.05.018; Garnacho-Montero J, 2003, CRIT CARE MED, V31, P2742, DOI 10.1097/01.CCM.0000098031.24329.10; Garnacho-Montero J, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1000-z; Harbarth S, 2003, AM J MED, V115, P529, DOI 10.1016/j.amjmed.2003.07.005; Hayashi Y, 2013, INT J ANTIMICROB AG, V41, P162, DOI 10.1016/j.ijantimicag.2012.10.002; Hayashi Y, 2010, EXPERT OPIN DRUG MET, V6, P1017, DOI 10.1517/17425255.2010.506187; Heintz BH, 2009, PHARMACOTHERAPY, V29, P562, DOI 10.1592/phco.29.5.562; Huang CT, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002136; Ibrahim EH, 2000, CHEST, V118, P146, DOI 10.1378/chest.118.1.146; Jaramillo-Bustamante JC, 2012, PEDIATR CRIT CARE ME, V13, P501, DOI 10.1097/PCC.0b013e31823c980f; Jiao Y, 2007, J PHARMACEUT BIOMED, V43, P1804, DOI 10.1016/j.jpba.2006.11.040; Joukhadar C, 2001, CRIT CARE MED, V29, P385, DOI 10.1097/00003246-200102000-00030; Kollef MH, 1999, CHEST, V115, P462, DOI 10.1378/chest.115.2.462; Legrand T, 2008, J CHROMATOGR B, V875, P551, DOI 10.1016/j.jchromb.2008.09.020; Lipman J, 2001, INTENS CARE MED, V27, P363, DOI 10.1007/s001340000741; Lopez KJV, 2007, J CHROMATOGR B, V860, P241, DOI 10.1016/j.jchromb.2007.10.041; Marshall MR, 2006, NEPHROLOGY, V11, P181, DOI 10.1111/j.1440-1797.2006.00581.x; Mouton JW, 2000, CLIN PHARMACOKINET, V39, P185, DOI 10.2165/00003088-200039030-00002; MYERS CM, 1984, ANTIMICROB AGENTS CH, V26, P78, DOI 10.1128/AAC.26.1.78; Ogura H, 2014, J INFECT CHEMOTHER, V20, P157, DOI 10.1016/j.jiac.2013.07.006; Pannu Neesh, 2005, Ther Clin Risk Manag, V1, P141, DOI 10.2147/tcrm.1.2.141.62908; Pasko DA, 2011, BLOOD PURIFICAT, V32, P82, DOI 10.1159/000324191; Pea F, 2007, CLIN PHARMACOKINET, V46, P997, DOI 10.2165/00003088-200746120-00003; Roberts JA, 2014, CRIT CARE, V18, DOI 10.1186/cc13939; Roberts JA, 2012, BRIT J CLIN PHARMACO, V73, P27, DOI 10.1111/j.1365-2125.2011.04080.x; Roberts JA, 2010, INT J ANTIMICROB AG, V36, P332, DOI 10.1016/j.ijantimicag.2010.06.008; Roberts JA, 2010, INT J ANTIMICROB AG, V35, P419, DOI 10.1016/j.ijantimicag.2010.01.022; Roberts JA, 2009, CRIT CARE MED, V37, P840, DOI 10.1097/CCM.0b013e3181961bff; Rodloff AC, 2006, J ANTIMICROB CHEMOTH, V58, P916, DOI 10.1093/jac/dkl354; Shiber S, 2015, J ANTIMICROB CHEMOTH, V70, P41, DOI 10.1093/jac/dku351; Sime FB, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-35; Sinnollareddy MG, 2012, CLIN EXP PHARMACOL P, V39, P489, DOI 10.1111/j.1440-1681.2012.05715.x; SMITH GB, 1990, J PHARM SCI, V79, P732, DOI 10.1002/jps.2600790816; Tegeder I, 1997, ANTIMICROB AGENTS CH, V41, P2640, DOI 10.1128/AAC.41.12.2640; Tegeder I, 1999, CLIN PHARMACOL THER, V65, P50, DOI 10.1016/S0009-9236(99)70121-9; Thalhammer F, 2000, CLIN PHARMACOKINET, V39, P271, DOI 10.2165/00003088-200039040-00003; Tian Q, 2008, ANTIMICROB AGENTS CH, V52, P1009, DOI 10.1128/AAC.00858-07; Udy AA, 2012, CHEST, V142, P30, DOI 10.1378/chest.11-1671; Ulldemolins M, 2014, CRIT CARE, V18, DOI 10.1186/cc13938; Ulldemolins M, 2011, CLIN PHARMACOKINET, V50, P99, DOI 10.2165/11539220-000000000-00000; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Yamamoto T, 2011, ANTIMICROB AGENTS CH, V55, P5804, DOI 10.1128/AAC.01758-10; Zhou JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107181	53	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153927	10.1371/journal.pone.0153927	http://dx.doi.org/10.1371/journal.pone.0153927			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093294	Green Submitted, Green Published, gold			2022-12-26	WOS:000374541200061
J	Li, DD; Liu, ZC; Gao, L; Wang, LF; Gao, MJ; Jiao, ZJ; Qiao, HL; Yang, JW; Chen, M; Yao, LG; Liu, RY; Kan, YC				Li, Dandan; Liu, Zongcai; Gao, Lei; Wang, Lifang; Gao, Meijuan; Jiao, Zhujin; Qiao, Huili; Yang, Jianwei; Chen, Min; Yao, Lunguang; Liu, Renyi; Kan, Yunchao			Genome-Wide Identification and Characterization of microRNAs in Developing Grains of Zea mays L.	PLOS ONE			English	Article							COMBINED SMALL RNA; GENE-EXPRESSION; TRANSCRIPTION FACTOR; REGULATORY ROLES; LEAF POLARITY; MAIZE EMBRYO; TARGET GENES; ENDOSPERM; ROOT; MIRNAS	The development and maturation of maize kernel involves meticulous and fine gene regulation at transcriptional and post-transcriptional levels, and miRNAs play important roles during this process. Although a number of miRNAs have been identified in maize seed, the ones involved in the early development of grains and in different lines of maize have not been well studied. Here, we profiled four small RNA libraries, each constructed from groups of immature grains of Zea mays inbred line Chang 7-2 collected 4-6, 7-9, 12-14, and 18-23 days after pollination (DAP). A total of 40 known (containing 111 unique miRNAs) and 162 novel (containing 196 unique miRNA candidates) miRNA families were identified. For conserved and novel miRNAs with over 100 total reads, 44% had higher accumulation before the 9th DAP, especially miR166 family members. 42% of miRNAs had highest accumulation during 12-14 DAP (which is the transition stage from embryogenesis to nutrient storage). Only 14% of miRNAs had higher expression 18-23 DAP. Prediction of potential targets of all miRNAs showed that 165 miRNA families had 377 target genes. For miR164 and miR166, we showed that the transcriptional levels of their target genes were significantly decreased when co-expressed with their cognate miRNA precursors in vivo. Further analysis shows miR159, miR164, miR166, miR171, miR390, miR399, and miR529 families have putative roles in the embryogenesis of maize grain development by participating in transcriptional regulation and morphogenesis, while miR167 and miR528 families participate in metabolism process and stress response during nutrient storage. Our study is the first to present an integrated dynamic expression pattern of miRNAs during maize kernel formation and maturation.	[Li, Dandan; Liu, Zongcai; Wang, Lifang; Gao, Meijuan; Jiao, Zhujin; Qiao, Huili; Yang, Jianwei; Chen, Min; Yao, Lunguang; Kan, Yunchao] Nanyang Normal Univ, China UK NYNU RRes Joint Libratory Insect Biol, Nanyang, Henan, Peoples R China; [Gao, Lei; Liu, Renyi] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA	Nanyang Normal College; University of California System; University of California Riverside	Kan, YC (corresponding author), Nanyang Normal Univ, China UK NYNU RRes Joint Libratory Insect Biol, Nanyang, Henan, Peoples R China.; Liu, RY (corresponding author), Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA.	renyi.liu@ucr.edu; yckan1974@nynu.edu.cn	Liu, Renyi/AAA-6449-2020; Gao, Lei/I-4159-2013	Gao, Lei/0000-0002-6488-0292	Key Research Projects of Science and Technology Department of Henan Province [112102110158]	Key Research Projects of Science and Technology Department of Henan Province	This work is supported by the Key Research Projects of Science and Technology Department of Henan Province (112102110158).	Adam H, 2011, MOL BIOL EVOL, V28, P1439, DOI 10.1093/molbev/msq328; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Bao ML, 2014, PLANT CELL PHYSIOL, V55, P1343, DOI 10.1093/pcp/pcu058; Barrera-Figueroa BE, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-132; Barrera-Figueroa BE, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-127; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bommert P, 2001, GENE, V271, P131, DOI 10.1016/S0378-1119(01)00503-0; Boualem A, 2008, PLANT J, V54, P876, DOI 10.1111/j.1365-313X.2008.03448.x; Carraro N, 2006, PLANT MOL BIOL, V60, P811, DOI 10.1007/s11103-005-2761-6; Chen J, 2014, PLANT PHYSIOL, V166, P252, DOI 10.1104/pp.114.240689; Chen Jie, 2010, Yichuan, V32, P1175, DOI 10.3724/SP.J.1005.2010.01175; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Cheng XF, 2012, NEW PHYTOL, V195, P71, DOI 10.1111/j.1469-8137.2012.04147.x; Chitwood DH, 2007, DEVELOPMENT, V134, P813, DOI 10.1242/dev.000497; Chuck G, 2007, NAT GENET, V39, P1517, DOI 10.1038/ng.2007.20; Chuck GS, 2011, P NATL ACAD SCI USA, V108, P17550, DOI 10.1073/pnas.1113971108; Consonni G, 2005, ANN BOT-LONDON, V96, P353, DOI 10.1093/aob/mci187; CREECH RG, 1965, GENETICS, V52, P1175; Curaba J, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-120; Ding D, 2014, PLANT BIOLOGY, V16, P9, DOI 10.1111/plb.12013; Ding D, 2009, ANN BOT-LONDON, V103, P29, DOI 10.1093/aob/mcn205; Ding D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039578; Ding YF, 2009, BIOCHEM BIOPH RES CO, V386, P6, DOI 10.1016/j.bbrc.2009.05.137; Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Feng H, 2014, MOL PLANT PATHOL, V15, P284, DOI 10.1111/mpp.12089; Fujii H, 2005, CURR BIOL, V15, P2038, DOI 10.1016/j.cub.2005.10.016; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Gu Y, 2013, GENOMICS, V102, P472, DOI 10.1016/j.ygeno.2013.08.007; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Huang SQ, 2009, J INORG BIOCHEM, V103, P282, DOI 10.1016/j.jinorgbio.2008.10.019; Jiao YP, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-141; Jin XN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125800; Jin XN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059353; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kamthan A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00208; Kang MM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-360; Kang Z, 2014, APPL MICROBIOL BIOT, V98, P3413, DOI 10.1007/s00253-014-5569-y; Kanjanawattanawong S, 2014, MOL GENET GENOMICS, V289, P921, DOI 10.1007/s00438-014-0862-0; Kantar M, 2011, PLANTA, V233, P471, DOI 10.1007/s00425-010-1309-4; Kidner CA, 2004, NATURE, V428, P81, DOI 10.1038/nature02366; Kim CS, 2004, PLANT PHYSIOL, V134, P380, DOI 10.1104/pp.103.031310; Knauer S, 2013, DEV CELL, V24, P125, DOI 10.1016/j.devcel.2012.12.009; KODRZYCKI R, 1989, PLANT CELL, V1, P105, DOI 10.1105/tpc.1.1.105; Kong XP, 2014, PLANT BIOTECHNOL J, V12, P1108, DOI 10.1111/pbi.12218; LAFEMINA RL, 1988, J GEN VIROL, V69, P355, DOI 10.1099/0022-1317-69-2-355; Li De-Bing, 2013, Journal of Fisheries International, V8, P1; Li GS, 2014, P NATL ACAD SCI USA, V111, P7582, DOI 10.1073/pnas.1406383111; Li J, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-220; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072852; Lin X, 2007, CELL RES, V17, P512, DOI 10.1038/cr.2007.45; Liu HJ, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-433, 10.1186/1471-2164-15-25]; Liu QK, 2014, PLANT CELL, V26, P741, DOI 10.1105/tpc.113.120972; Liu Q, 2009, FEBS LETT, V583, P723, DOI 10.1016/j.febslet.2009.01.020; Liu XH, 2008, GENOMICS, V91, P378, DOI 10.1016/j.ygeno.2007.12.002; Lu SF, 2008, PLANT J, V55, P131, DOI 10.1111/j.1365-313X.2008.03497.x; Lu XD, 2013, PLANT PHYSIOL, V162, P440, DOI 10.1104/pp.113.214874; Luan MD, 2015, GENE, V555, P178, DOI 10.1016/j.gene.2014.11.001; Maitz M, 2000, PLANT J, V23, P29, DOI 10.1046/j.1365-313x.2000.00747.x; Mallory AC, 2004, CURR BIOL, V14, P1035, DOI 10.1016/j.cub.2004.06.022; Meng FD, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-110; Mica E, 2006, J EXP BOT, V57, P2601, DOI 10.1093/jxb/erl013; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; Paul S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00232; Pei LM, 2013, PLANT PHYSIOL BIOCH, V70, P221, DOI 10.1016/j.plaphy.2013.05.043; Peng T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054148; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shen Y, 2013, BIOCHEM BIOPH RES CO, V441, P425, DOI 10.1016/j.bbrc.2013.10.113; Sorin C, 2014, NEW PHYTOL, V202, P1197, DOI 10.1111/nph.12735; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar Ramanjulu, 2008, BMC Plant Biol, V8, P25, DOI 10.1186/1471-2229-8-25; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Teoh KT, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-19; Teotia S, 2015, MOL PLANT, V8, P359, DOI 10.1016/j.molp.2014.12.018; Thiebaut F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-766; Trevisan S, 2012, PLANT SIGNAL BEHAV, V7, P822, DOI 10.4161/psb.20462; Trevisan S, 2012, PLANT CELL ENVIRON, V35, P1137, DOI 10.1111/j.1365-3040.2011.02478.x; Vazquez F, 2006, TRENDS PLANT SCI, V11, P460, DOI 10.1016/j.tplants.2006.07.006; Wang B, 2014, PLANT PHYSIOL BIOCH, V80, P90, DOI 10.1016/j.plaphy.2014.03.020; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Wang LW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-154; Wang PF, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-014-1204-7; Wang YG, 2014, BIOCHEM GENET, V52, P474, DOI 10.1007/s10528-014-9661-x; Wu FQ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085754, 10.1371/journal.pone.0087251]; Xin MM, 2013, PLANT CELL, V25, P3212, DOI 10.1105/tpc.113.115592; Xing HY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-178; Xu ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028009; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhai LH, 2013, PHYSIOL PLANTARUM, V147, P181, DOI 10.1111/j.1399-3054.2012.01653.x; Zhang BH, 2007, J CELL PHYSIOL, V210, P279, DOI 10.1002/jcp.20869; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716; Zhao BT, 2007, BIOCHEM BIOPH RES CO, V354, P585, DOI 10.1016/j.bbrc.2007.01.022; Zhao CZ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-3; Zhao MW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001249; Zhou XF, 2008, BBA-GENE REGUL MECH, V1779, P780, DOI 10.1016/j.bbagrm.2008.04.005; Zhu HL, 2011, CELL, V145, P242, DOI 10.1016/j.cell.2011.03.024	101	36	40	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153168	10.1371/journal.pone.0153168	http://dx.doi.org/10.1371/journal.pone.0153168			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082634	Green Published, Green Submitted, gold			2022-12-26	WOS:000374291800013
J	Steinacher, A; Bates, DG; Akman, OE; Soyer, OS				Steinacher, Arno; Bates, Declan G.; Akman, Ozgur E.; Soyer, Orkun S.			Nonlinear Dynamics in Gene Regulation Promote Robustness and Evolvability of Gene Expression Levels	PLOS ONE			English	Article							NETWORKS; EVOLUTION; ADAPTATION; FLUCTUATIONS; CAPACITANCE; FEEDBACK; DESIGN; NOISE; CELL	Cellular phenotypes underpinned by regulatory networks need to respond to evolutionary pressures to allow adaptation, but at the same time be robust to perturbations. This creates a conflict in which mutations affecting regulatory networks must both generate variance but also be tolerated at the phenotype level. Here, we perform mathematical analyses and simulations of regulatory networks to better understand the potential trade-off between robustness and evolvability. Examining the phenotypic effects of mutations, we find an inverse correlation between robustness and evolvability that breaks only with nonlinearity in the network dynamics, through the creation of regions presenting sudden changes in phenotype with small changes in genotype. For genotypes embedding low levels of nonlinearity, robustness and evolvability correlate negatively and almost perfectly. By contrast, genotypes embedding nonlinear dynamics allow expression levels to be robust to small perturbations, while generating high diversity (evolvability) under larger perturbations. Thus, nonlinearity breaks the robustness-evolvability trade-off in gene expression levels by allowing disparate responses to different mutations. Using analytical derivations of robustness and system sensitivity, we show that these findings extend to a large class of gene regulatory network architectures and also hold for experimentally observed parameter regimes. Further, the effect of nonlinearity on the robustness-evolvability trade-off is ensured as long as key parameters of the system display specific relations irrespective of their absolute values. We find that within this parameter regime genotypes display low and noisy expression levels. Examining the phenotypic effects of mutations, we find an inverse correlation between robustness and evolvability that breaks only with nonlinearity in the network dynamics. Our results provide a possible solution to the robustness-evolvability trade-off, suggest an explanation for the ubiquity of nonlinear dynamics in gene expression networks, and generate useful guidelines for the design of synthetic gene circuits.	[Steinacher, Arno] MRC Biostat Unit, Cambridge, England; [Bates, Declan G.] Univ Warwick, Sch Engn, Warwick, England; [Akman, Ozgur E.] Univ Exeter, Coll Engn Math & Phys Sci, Exeter, Devon, England; [Soyer, Orkun S.] Univ Warwick, Sch Life Sci, Warwick, England	MRC Biostatistics Unit; University of Warwick; University of Exeter; University of Warwick	Akman, OE (corresponding author), Univ Exeter, Coll Engn Math & Phys Sci, Exeter, Devon, England.; Soyer, OS (corresponding author), Univ Warwick, Sch Life Sci, Warwick, England.	O.E.Akman@exeter.ac.uk; O.Soyer@warwick.ac.uk			UK Engineering and Physical Sciences Research Council [EP/I017445/1]; BBSRC [BB/M017982/1] Funding Source: UKRI; EPSRC [EP/I007563/1, EP/I017445/1, EP/I017445/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M017982/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/I017445/2, EP/I017445/1, EP/I007563/1] Funding Source: researchfish	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by the UK Engineering and Physical Sciences Research Council, grant number EP/I017445/1.	Ajo-Franklin CM, 2007, GENE DEV, V21, P2271, DOI 10.1101/gad.1586107; Akman OE, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-88; Aldana M, 2007, J THEOR BIOL, V245, P433, DOI 10.1016/j.jtbi.2006.10.027; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Bergman A, 2003, NATURE, V424, P549, DOI 10.1038/nature01765; Brookfield JFY, 2009, BIOL LETTERS, V5, P44, DOI 10.1098/rsbl.2008.0639; Buchler NE, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.30; Ciliberti S, 2007, P NATL ACAD SCI USA, V104, P13591, DOI 10.1073/pnas.0705396104; Ciliberti S, 2007, PLOS COMPUT BIOL, V3, P164, DOI 10.1371/journal.pcbi.0030015; Crombach A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000112; Daniels BC, 2008, CURR OPIN BIOTECH, V19, P389, DOI 10.1016/j.copbio.2008.06.008; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; Draghi JA, 2010, NATURE, V463, P353, DOI 10.1038/nature08694; Elf J, 2003, GENOME RES, V13, P2475, DOI 10.1101/gr.1196503; EMANCIPATOR K, 1993, CLIN CHEM, V39, P766; Garfield DA, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001696; Hayden EJ, 2011, NATURE, V474, P92, DOI 10.1038/nature10083; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Huynen MA, 1996, J MOL EVOL, V43, P165; Huynen MA, 1996, P NATL ACAD SCI USA, V93, P397, DOI 10.1073/pnas.93.1.397; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Kaneko K, 2009, J BIOSCIENCES, V34, P529, DOI 10.1007/s12038-009-0072-9; Kauffman S.A., 1993, ORIGINS ORDER; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kuwahara H, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.98; Landry CR, 2007, SCIENCE, V317, P118, DOI 10.1126/science.1140247; Lenski RE, 2006, PLOS BIOL, V4, P2190, DOI 10.1371/journal.pbio.0040428; Lomnitz JG, 2013, CHAOS, V23, DOI 10.1063/1.4809776; Marciano DC, 2014, CELL REP, V7, P1789, DOI 10.1016/j.celrep.2014.05.018; Masel J, 2010, TRENDS GENET, V26, P406, DOI 10.1016/j.tig.2010.06.002; Orr HA, 2005, NAT REV GENET, V6, P119, DOI 10.1038/nrg1523; Oyarzun DA, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0671; Pechenick DA, 2013, J THEOR BIOL, V330, P26, DOI 10.1016/j.jtbi.2013.03.019; Pigliucci M, 2008, NAT REV GENET, V9, P75, DOI 10.1038/nrg2278; Polev D, 2012, J THEOR BIOL, V293, P27, DOI 10.1016/j.jtbi.2011.10.001; Raman K, 2011, MOL BIOSYST, V7, P1081, DOI 10.1039/c0mb00165a; Rand DA, 2006, J THEOR BIOL, V238, P616, DOI 10.1016/j.jtbi.2005.06.026; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Samal A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-30; SCHUSTER P, 1994, P ROY SOC B-BIOL SCI, V255, P279, DOI 10.1098/rspb.1994.0040; Steiner CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052204; Stelling J, 2004, P NATL ACAD SCI USA, V101, P13210, DOI 10.1073/pnas.0401463101; Ten Tusscher K. H., 2011, PLOS COMPUT BIOL, V7, DOI [DOI 10.1371/JOURNAL.PCBI.1002208, 10.1371/journal.pcbi.1002208]; Tirosh I, 2006, NAT GENET, V38, P830, DOI 10.1038/ng1819; Torres-Sosa C, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002669; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Wagner A, 2008, P ROY SOC B-BIOL SCI, V275, P91, DOI 10.1098/rspb.2007.1137; Woods RJ, 2011, SCIENCE, V331, P1433, DOI 10.1126/science.1198914; Zhang Q, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130031	49	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153295	10.1371/journal.pone.0153295	http://dx.doi.org/10.1371/journal.pone.0153295			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082741	Green Submitted, Green Published, gold			2022-12-26	WOS:000374291800014
J	Bhattacharyya, S; Feferman, L; Tobacman, JK				Bhattacharyya, Sumit; Feferman, Leo; Tobacman, Joanne K.			Inhibition of Phosphatase Activity Follows Decline in Sulfatase Activity and Leads to Transcriptional Effects through Sustained Phosphorylation of Transcription Factor MITF	PLOS ONE			English	Article							GLYCOPROTEIN NONMETASTATIC B; MELANOMA PROTEIN-B; FORMYLGLYCINE-GENERATING ENZYME; P38 MAP KINASE; ARYLSULFATASE-B; CHONDROITIN SULFATE; THERAPEUTIC TARGET; HEPARAN-SULFATE; BREAST-CANCER; PROGNOSTIC INDICATOR	Arylsulfatase B (B-acetylgalactosamine 4-sulfatase; ARSB) is the enzyme that removes 4-sulfate groups from the non-reducing end of the glycosaminoglycans chondroitin 4-sulfate and dermatan sulfate. Decline in ARSB has been shown in malignant prostate, colonic, and mammary cells and tissues, and decline in ARSB leads to transcriptional events mediated by galectin-3 with AP-1 and Sp1. Increased mRNA expression of GPNMB (transmembrane glycoprotein NMB) in HepG2 cells and in hepatic tissue from ARSB-deficient mice followed decline in expression of ARSB and was mediated by the microphthalmia-associated transcription factor (MITF), but was unaffected by silencing galectin-3. Since GPNMB is increased in multiple malignancies, studies were performed to determine how decline in ARSB increased GPNMB expression. The mechanism by which decline in ARSB increased nuclear phospho-MITF was due to reduced activity of SHP2, a protein tyrosine phosphatase with Src homology (SH2) domains that regulates multiple cellular processes. SHP2 activity declined due to increased binding with chondroitin 4-sulfate when ARSB was reduced. When SHP2 activity was inhibited, phosphorylations of p38 mitogen-associated phosphokinase (MAPK) and of MITF increased, leading to GPNMB promoter activation. A dominant negative SHP2 construct, the SHP2 inhibitor PHSP1, and silencing of ARSB increased phospho-p38, nuclear MITF, and GPNMB. In contrast, constitutively active SHP2 and overexpression of ARSB inhibited GPNMB expression. The interaction between chondroitin 4-sulfate and SHP2 is a novel intersection between sulfation and phosphorylation, by which decline in ARSB and increased chondroitin 4-sulfation can inhibit SHP2, thereby regulating downstream tyrosine phosphorylations by sustained phosphorylations with associated activation of signaling and transcriptional events.	[Bhattacharyya, Sumit; Feferman, Leo; Tobacman, Joanne K.] Univ Illinois, Dept Med, Chicago, IL 60612 USA; [Bhattacharyya, Sumit; Feferman, Leo; Tobacman, Joanne K.] Jesse Brown VA Med Ctr, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Tobacman, JK (corresponding author), Univ Illinois, Dept Med, Chicago, IL 60612 USA.; Tobacman, JK (corresponding author), Jesse Brown VA Med Ctr, Chicago, IL 60612 USA.	jkt@uic.edu						Askari N, 2009, BIOCHEMISTRY-US, V48, P2497, DOI 10.1021/bi900024v; Bard-Chapeau EA, 2011, CANCER CELL, V19, P629, DOI 10.1016/j.ccr.2011.03.023; Bhattacharyya S, 2014, ONCOGENE, V33, P5467, DOI 10.1038/onc.2013.483; Bhattacharyya S, 2008, J BIOL CHEM, V283, P9523, DOI 10.1074/jbc.M707967200; Bhattacharyya S, 2008, J NUTR, V138, P469, DOI 10.1093/jn/138.3.469; Bhattacharyya S, 2007, J STEROID BIOCHEM, V103, P20, DOI 10.1016/j.jsbmb.2006.08.002; Bhattacharyya S, 2015, BBA-GENE REGUL MECH, V1849, P342, DOI 10.1016/j.bbagrm.2014.12.009; Bhattacharyya S, 2014, J BIOL CHEM, V289, P17564, DOI 10.1074/jbc.M114.561589; Bhattacharyya S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033250; Bhattacharyya S, 2010, BBA-MOL BASIS DIS, V1802, P472, DOI 10.1016/j.bbadis.2010.01.014; Bhattacharyya S, 2010, AM J RESP CELL MOL, V42, P51, DOI 10.1165/rcmb.2008-0482OC; Bhattacharyya S, 2009, CLIN EXP METASTAS, V26, P535, DOI 10.1007/s10585-009-9253-z; Catlow KR, 2008, J BIOL CHEM, V283, P5235, DOI 10.1074/jbc.M706589200; Chong ZZ, 2003, CELL MOL NEUROBIOL, V23, P561, DOI 10.1023/A:1025158314016; Feferman L, 2013, PROSTATE CANCER P D, V16, P277, DOI 10.1038/pcan.2013.18; Fiorentini C, 2014, EXP CELL RES, V323, P100, DOI 10.1016/j.yexcr.2014.02.025; Frevert CW, 2003, AM J RESP CELL MOL, V28, P464, DOI 10.1165/rcmb.2002-0084OC; Gutknecht M, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0099-5; He Z, 2013, P NATL ACAD SCI USA, V110, pE79, DOI 10.1073/pnas.1213000110; Hellmuth K, 2008, P NATL ACAD SCI USA, V105, P7275, DOI 10.1073/pnas.0710468105; Jia XL, 2012, WORLD J GASTROENTERO, V18, P3962, DOI 10.3748/wjg.v18.i30.3962; Kim SO, 1998, J BIOL CHEM, V273, P2344, DOI 10.1074/jbc.273.4.2344; Kotlo K, 2013, GLYCOCONJUGATE J, V30, P667, DOI 10.1007/s10719-013-9468-8; Kuan CT, 2006, CLIN CANCER RES, V12, P1970, DOI 10.1158/1078-0432.CCR-05-2797; Li YN, 2014, APMIS, V122, P140, DOI 10.1111/apm.12107; Loftus SK, 2009, PIGM CELL MELANOMA R, V22, P99, DOI 10.1111/j.1755-148X.2008.00518.x; Maric G, 2015, ONCOGENE, V34, P5494, DOI 10.1038/onc.2015.8; Maric G, 2013, ONCOTARGETS THER, V6, P839, DOI 10.2147/OTT.S44906; Martina JA, 2014, CELL MOL LIFE SCI, V71, P2483, DOI 10.1007/s00018-014-1565-8; Mitsunaga-Nakatsubo K, 2009, MED MOL MORPHOL, V42, P63, DOI 10.1007/s00795-009-0447-x; Mizumoto S, 2013, FEBS J, V280, P2462, DOI 10.1111/febs.12156; Mokarram P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007012; Okamoto I, 2005, NEOPLASIA, V7, P303, DOI 10.1593/neo.04514; Perera R, 2015, NATURE, V524, P361, DOI 10.1038/nature14587; Phillips JJ, 2012, J CLIN INVEST, V122, P911, DOI 10.1172/JCI58215; Pichert A, 2012, GLYCOBIOLOGY, V22, P134, DOI 10.1093/glycob/cwr120; Ploper D, 2015, P NATL ACAD SCI USA, V112, pE420, DOI 10.1073/pnas.1424576112; Prabhu SV, 2011, J HISTOCHEM CYTOCHEM, V59, P328, DOI 10.1369/0022155410395511; Prince RN, 2010, J CELL SCI, V123, P2308, DOI 10.1242/jcs.058321; Qin CP, 2014, MOL MED REP, V9, P851, DOI 10.3892/mmr.2014.1896; Rao GJ, 1994, BIOCHIM BIOPHYS ACTA, V788, P58; Rich JN, 2003, J BIOL CHEM, V278, P15951, DOI 10.1074/jbc.M211498200; Ripoll VM, 2008, GENE, V413, P32, DOI 10.1016/j.gene.2008.01.014; Roeser D, 2006, P NATL ACAD SCI USA, V103, P81, DOI 10.1073/pnas.0507592102; Roeser D, 2007, ACTA CRYSTALLOGR D, V63, P621, DOI 10.1107/S0907444907009961; Rose AAN, 2010, CLIN CANCER RES, V16, P2147, DOI 10.1158/1078-0432.CCR-09-1611; Ruan WM, 2014, INT J CLIN EXP MED, V7, P4857; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Tian F, 2012, ONCOL RES, V20, P341, DOI 10.3727/096504013X13657689382851; Tse KF, 2006, CLIN CANCER RES, V12, P1373, DOI 10.1158/1078-0432.CCR-05-2018; Whitelock JM, 2005, CHEM REV, V105, P2745, DOI 10.1021/cr010213m; WOJCZYK B, 1986, BIOL CELL, V57, P147, DOI 10.1111/j.1768-322X.1986.tb00471.x; Yamashita H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092904; Yardley DA, 2015, J CLIN ONCOL, V33, P1609, DOI 10.1200/JCO.2014.56.2959; Yee AS, 2004, GENE, V336, P1, DOI 10.1016/j.gene.2004.04.004; Zhang TY, 2015, J CELL SCI, V128, P2938, DOI 10.1242/jcs.173807; Zhang YY, 2008, J BIOL CHEM, V283, P26591, DOI 10.1074/jbc.M801703200	58	15	15	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153463	10.1371/journal.pone.0153463	http://dx.doi.org/10.1371/journal.pone.0153463			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078017	Green Published, gold, Green Submitted			2022-12-26	WOS:000374131700057
J	Majewska, R; Convey, P; De Stefano, M				Majewska, Roksana; Convey, Peter; De Stefano, Mario			Summer Epiphytic Diatoms from Terra Nova Bay and Cape Evans (Ross Sea, Antarctica) - A Synthesis and Final Conclusions	PLOS ONE			English	Article							KING-GEORGE-ISLAND; BENTHIC DIATOMS; PHYLLOPHORA-ANTARCTICA; WEDDELL SEA; ICE-EDGE; MICROBIAL COMMUNITIES; MARINE MACROALGAE; SURFACE SEDIMENTS; MCMURDO SOUND; POTTER COVE	Despite recent advances in polar marine biology and related fields, many aspects of the ecological interactions that are crucial for the functioning of Antarctic shallow water habitats remain poorly understood. Although epiphytic diatoms play an essential role in the Antarctic marine food web, basic information regarding their ecology, biodiversity and biogeography is largely unavailable. Here, we synthesise studies on Ross Sea epiphytic diatoms collected during 11 summer Antarctic expeditions between the years 1989/90 and 2011/12, presenting a full list of diatom taxa associated with three macroalgal species (Iridaea cordata, Phyllophora antarctica, and Plocamium cartilagineum) and their epiphytic sessile fauna. Diatom communities found during the three summer months at various depths and sampling stations differed significantly in terms of species composition, growth form structure and abundances. Densities ranged from 21 to >8000 cells mm(-2), and were significantly higher on the surface of epiphytic micro-fauna than on any of the macroalgal species examined. Generally, host organisms characterized by higher morphological heterogeneity (sessile micro-fauna, ramified Plocamium) supported richer diatom communities than those with more uniform surfaces (Iridaea). Differences between epiphytic communities associated with different macroalgae were reflected better in species composition than in growth form structure. The latter changed significantly with season, which was related strongly to the changing ice conditions. A general trend towards an increasing number of erect forms in deeper waters and tube-dwelling diatoms in the shallowest sites (2-5 m) was also observed. This study explores further important and largely previously unknown aspects of relationships and interactions between Antarctic epiphytic diatoms and their micro-and macro-environments.	[Majewska, Roksana; De Stefano, Mario] Univ Naples 2, Dept Environm Biol & Pharmaceut Sci & Technol, I-81100 Caserta, Italy; [Majewska, Roksana] Magna Graecia Univ Catanzaro, BioNEM Lab, Dept Expt & Clin Med, I-88100 Catanzaro, Italy; [Convey, Peter] British Antarctic Survey, Nat Environm Res Council, High Cross, Madingley Rd, Cambridge CB3 0ET, England	Universita della Campania Vanvitelli; Magna Graecia University of Catanzaro; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Majewska, R (corresponding author), Univ Naples 2, Dept Environm Biol & Pharmaceut Sci & Technol, I-81100 Caserta, Italy.; Majewska, R (corresponding author), Magna Graecia Univ Catanzaro, BioNEM Lab, Dept Expt & Clin Med, I-88100 Catanzaro, Italy.	roksana.majewska@unina2.it	Convey, Peter/AAV-5728-2020; Majewska, Roksana/P-1280-2015	Convey, Peter/0000-0001-8497-9903; Majewska, Roksana/0000-0003-2681-4304	Second University of Naples; Italian National Program of Research in Antarctica (PNRA) [2010/A1.02]; NERC; Natural Environment Research Council; NERC [bas0100036] Funding Source: UKRI; Natural Environment Research Council [bas0100036] Funding Source: researchfish	Second University of Naples; Italian National Program of Research in Antarctica (PNRA)(Ministry of Education, Universities and Research (MIUR)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the Second University of Naples (www.unina2.it) and the Italian National Program of Research in Antarctica (PNRA) co-ordinated by the Italian National Research Council (www.cnr.it/sitocnr/home.html) [grant ID: 2010/A1.02, MD]. PC is supported by the Natural Environment Research Council (www.nerc.ac.uk) core funding to the British Antarctic Survey (www.bas.ac.uk) Biodiversity, Evolution and Adaptation Team. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Second University of Naples and the Italian National Program of Research in Antarctica (PNRA) co-ordinated by the Italian National Research Council [2010/A1.02]. PC is supported by NERC core funding to the BAS Biodiversity, Evolution and Adaptation Team. We thank Lukasz Polanski, who kindly provided the sampling site map (Fig 1). This paper also contributes to the SCAR 'State of the Antarctic Ecosystem' (AntEco) research programme.	Al-Handal AY, 2008, DIATOM RES, V23, P269; Al-Handal AY, 2008, BOT MAR, V51, P411, DOI 10.1515/BOT.2008.053; Al-Handal AY, 2008, BOT MAR, V51, P51, DOI 10.1515/BOT.2008.007; Al-Handal AY, 2010, DIATOM RES, V25, P1; Amsler CD, 2005, MAR ECOL PROG SER, V294, P141, DOI 10.3354/meps294141; Amsler CD, 1998, J PHYCOL, V34, P53, DOI 10.1046/j.1529-8817.1998.340053.x; ANDERSEN OGN, 1977, OPHELIA, V16, P205; Anderson M.J, 2008, PERMANOVA1 PRIMER GU; ANDREOLI C, 1995, POLAR BIOL, V15, P465; ARRIGO KR, 1994, SCIENCE, V266, P261, DOI 10.1126/science.266.5183.261; BATHMANN U, 1991, POLAR BIOL, V11, P185; Blackburn N, 1998, SCIENCE, V282, P2254, DOI 10.1126/science.282.5397.2254; BOHATY SM, 1998, TERRA ANTARTICA, V0005; BOOTH JA, 1984, ARCTIC, V37, P234; Bouma TJ, 2009, HELGOLAND MAR RES, V63, P95, DOI 10.1007/s10152-009-0146-y; Boyd PW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063091; Bradshaw C, 2003, MAR BIOL, V143, P783, DOI 10.1007/s00227-003-1115-7; Buffen A, 2007, MAR MICROPALEONTOL, V62, P7, DOI 10.1016/j.marmicro.2006.07.002; CAMPANA G.L., 2008, BER POLARFORSCH MEER, V571, P302; Cardinale BJ, 2006, J ECOL, V94, P609, DOI 10.1111/j.1365-2745.2006.01107.x; CARPENTER E J, 1970, Phycologia, V9, P269, DOI 10.2216/i0031-8884-9-3-269.1; Catalano G, 1997, DEEP-SEA RES PT I, V44, P97, DOI 10.1016/S0967-0637(97)85248-X; Cefarelli AO, 2010, POLAR BIOL, V33, P1463, DOI 10.1007/s00300-010-0794-z; Cermeno P, 2009, SCIENCE, V325, P1539, DOI 10.1126/science.1174159; Chung Mi Hee, 2008, Algae, V23, P75; Clark GF, 2011, POLAR BIOL, V34, P781, DOI 10.1007/s00300-010-0931-8; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Convey P, 2014, ECOL MONOGR, V84, P203, DOI 10.1890/12-2216.1; Cremer H, 2003, BOT MAR, V46, P82, DOI 10.1515/BOT.2003.010; Cunningham WL, 1998, ANTARCT SCI, V10, P134, DOI 10.1017/S0954102098000182; DEACON GER, 1982, DEEP-SEA RES, V29, P1, DOI 10.1016/0198-0149(82)90058-9; DURBIN EG, 1975, MAR BIOL, V32, P271, DOI 10.1007/BF00399206; Ehrenberg C. G., 1843, ABHANDLUNGEN KONIGLI, V1841, P291; El-Sayed S.Z., 1971, ANTARCT RES SER, V17, P301; EMINSON D, 1980, BRIT PHYCOL J, V15, P429, DOI 10.1080/00071618000650431; EVERITT DA, 1986, HYDROBIOLOGIA, V139, P3, DOI 10.1007/BF00770237; Fabiano M, 2000, ROSS SEA ECOLOGY ITA, P503; Fernandes LF, 2007, DIATOM RES, V22, P45; FLOWER RJ, 1993, HYDROBIOLOGIA, V269, P473, DOI 10.1007/BF00028045; Frenguelli J., 1960, REV ALGOL, V5, P1; Frenguelli J, 1958, PUBLICATION I ANTARC, V5; FRITSEN CH, 1994, SCIENCE, V266, P782, DOI 10.1126/science.266.5186.782; Fukushima H, 1966, ANTARCTIC RECORD, V27, P99; Gambi M.C., 2000, P527; GAMBI MC, 1994, ANTARCT SCI, V6, P449, DOI 10.1017/S0954102094000696; Garrison D.L., 1985, European Marine Biology Symposium, V18, P103; GARRISON DL, 1986, BIOSCIENCE, V36, P243, DOI 10.2307/1310214; GARRISON DL, 1989, ANTARCT SCI, V1, P313, DOI 10.1017/S0954102089000477; Gili JM, 1995, OCEANOGR MAR BIOL, V33, P351; Gili JM, 1996, POLAR BIOL, V16, P507; Gili JM, 2001, POLAR BIOL, V24, P473, DOI 10.1007/s003000100257; Goffart A, 2000, J MARINE SYST, V27, P161, DOI 10.1016/S0924-7963(00)00065-8; Grotti M, 2001, MAR CHEM, V76, P189, DOI 10.1016/S0304-4203(01)00063-9; Harper James T., 1994, Diatom Research, V9, P329; Harwood DM, 2000, ANTARCT SCI, V12, P443; HASLE G R, 1968, Journal of the Royal Microscopical Society, V88, P357; Hasle G. R., 1965, SKR NOR VIDENSK AKAD, V21, P1; HASLE GR, 1994, PHYCOLOGIA, V33, P248, DOI 10.2216/i0031-8884-33-4-248.1; Heiden H., 1928, DTSCH SUDPOLAR EXPED, P447; HORNER R, 1982, ARCTIC, V35, P485; Huang YSM, 2006, J EXP MAR BIOL ECOL, V329, P55, DOI 10.1016/j.jembe.2005.08.013; Hustedt F., 1958, DSCH ANTARKT EXPED 1, P103; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; JOHN J, 1993, PHYCOLOGIA, V32, P388, DOI 10.2216/i0031-8884-32-5-388.1; KAMATANI A, 1982, MAR BIOL, V68, P91, DOI 10.1007/BF00393146; KELLOGG TB, 1979, MAR MICROPALEONTOL, V4, P137, DOI 10.1016/0377-8398(79)90011-2; KREBS WN, 1983, MICROPALEONTOLOGY, V29, P267, DOI 10.2307/1485734; Lannuzel D, 2013, POLAR BIOL, V36, P1483, DOI 10.1007/s00300-013-1368-7; Campana GL, 2009, BOT MAR, V52, P655, DOI 10.1515/BOT.2009.076; Leventer A, 1996, J GEOPHYS RES-OCEANS, V101, P18489, DOI 10.1029/96JC00204; LEVINTON J, 1972, AM NAT, V106, P472, DOI 10.1086/282788; LEWIN JC, 1961, GEOCHIM COSMOCHIM AC, V21, P182, DOI 10.1016/S0016-7037(61)80054-9; Ligowski R, 2000, POLAR BIOL, V23, P619, DOI 10.1007/s003000000131; Liu J, 2013, J BIOGEOGR, V40, P2238, DOI 10.1111/jbi.12160; Lotter AF, 2000, AQUAT SCI, V62, P125, DOI 10.1007/s000270050002; Majewska R, 2015, ANTARCT SCI, V27, P44, DOI 10.1017/S0954102014000327; Majewska R, 2015, POLAR BIOL, V38, P189, DOI 10.1007/s00300-014-1578-7; Majewska R, 2013, ANTARCT SCI, V25, P501, DOI 10.1017/S0954102012001101; Majewska R, 2013, POLAR BIOL, V36, P73, DOI 10.1007/s00300-012-1240-1; Mangin L, 1915, PHYTOPLANCTON ANTARC; Manguin E., 1960, ANN SCI NAT BOT BIOL, V12, P223; Manguin E., 1957, REV ALGOLOGIQUE, V3, P111; Martin TE, 1998, ECOLOGY, V79, P656, DOI 10.1890/0012-9658(1998)079[0656:AMPOCS]2.0.CO;2; Mazzella L., 1992, GIORN BOT ITAL, V126, P752; MCCORMICK PV, 1991, OECOLOGIA, V86, P287, DOI 10.1007/BF00317542; McLachlan DH, 2009, J PHYCOL, V45, P592, DOI 10.1111/j.1529-8817.2009.00681.x; Michalchuk BR, 2009, QUATERNARY SCI REV, V28, P3049, DOI 10.1016/j.quascirev.2009.08.012; Michels J, 2005, MAR BIOL, V146, P483, DOI 10.1007/s00227-004-1452-1; MILLER KA, 1991, AM ZOOL, V31, P35; MILLIE DF, 1983, HYDROBIOLOGIA, V99, P7, DOI 10.1007/BF00013712; MONTGOMERY WL, 1980, ENVIRON BIOL FISH, V5, P143, DOI 10.1007/BF02391621; NELSON DM, 1986, DEEP-SEA RES, V33, P1389, DOI 10.1016/0198-0149(86)90042-7; Norkko A, 2004, POLAR BIOL, V27, P482, DOI 10.1007/s00300-004-0610-8; NOWELL ARM, 1984, ANNU REV ECOL SYST, V15, P303, DOI 10.1146/annurev.es.15.110184.001511; ORTH RJ, 1984, AQUAT BOT, V18, P43, DOI 10.1016/0304-3770(84)90080-9; Pancic M, 2015, BIOGEOSCIENCES, V12, P4235, DOI 10.5194/bg-12-4235-2015; PEARSE JS, 1966, BIOL BULL, V130, P387, DOI 10.2307/1539745; PERAGALLO M, 1921, DEUXIEME EXPEDITION, P1, DOI DOI 10.1159/000511890; PEROVICH DK, 1990, J GEOPHYS RES-OCEANS, V95, P9557, DOI 10.1029/JC095iC06p09557; POFF NL, 1990, J N AM BENTHOL SOC, V9, P303, DOI 10.2307/1467898; POULIN M, 1984, Naturaliste Canadien (Quebec), V111, P275; POULIN M, 1984, Naturaliste Canadien (Quebec), V111, P45; POULIN M, 1984, Naturaliste Canadien (Quebec), V111, P349; Povero P, 2001, POLAR BIOL, V24, P875; Rajanahally MA, 2014, J EXP MAR BIOL ECOL, V461, P516, DOI 10.1016/j.jembe.2014.10.005; Reichardt W., 1985, ANTARCTIC NUTR CYCLE, P115; Riaux-Gobin C, 2011, DIATOM RES, V26, P325, DOI 10.1080/0269249X.2011.639559; ROBINSON CT, 1987, HYDROBIOLOGIA, V154, P49, DOI 10.1007/BF00026830; Romeo Oscar E., 1996, Diatom Research, V11, P317; Round F.E., 1981, ECOLOGY ALGAE; Ryan KG, 2006, ANTARCT SCI, V18, P583, DOI 10.1017/S0954102006000629; Schmidt K, 2011, LIMNOL OCEANOGR, V56, P1411, DOI 10.4319/lo.2011.56.4.1411; Schwarz AM, 2003, POLAR BIOL, V26, P789, DOI 10.1007/s00300-003-0556-2; Scott F.J., 2005, ANTARCTIC MARINE PRO, P13, DOI DOI 10.1017/S0954102005242906; SHEMESH A, 1989, QUATERNARY RES, V31, P288, DOI 10.1016/0033-5894(89)90010-0; Sicinski J, 2011, DEEP-SEA RES PT II, V58, P30, DOI 10.1016/j.dsr2.2010.09.005; SMETACEK V, 1992, DEEP-SEA RES, V39, P153, DOI 10.1016/0198-0149(92)90102-Y; SMITH WO, 1985, SCIENCE, V227, P163, DOI 10.1126/science.227.4683.163; Snoeijs Pauli, 1994, Diatom Research, V9, P189; STERRENBURG F A S, 1989, Diatom Research, V4, P143; Stickley CE, 2005, PALAEOGEOGR PALAEOCL, V227, P290, DOI 10.1016/j.palaeo.2005.05.021; SULLIVAN MJ, 1979, B MAR SCI, V29, P459; SUNDA WG, 1995, MAR CHEM, V50, P189, DOI 10.1016/0304-4203(95)00035-P; Sutherland DL, 2008, POLAR BIOL, V31, P879, DOI 10.1007/s00300-008-0426-z; Sutton JN, 2013, GEOCHIM COSMOCHIM AC, V104, P300, DOI 10.1016/j.gca.2012.10.057; Taylor F, 2001, MAR MICROPALEONTOL, V41, P25, DOI 10.1016/S0377-8398(00)00049-9; Ter Braak C. J. F., 2012, CANOCO REFERENCE MAN; THOMAS DP, 1986, HYDROBIOLOGIA, V140, P193, DOI 10.1007/BF00007435; Totti C, 2011, CELL ORIG LIFE EXTRE, V16, P327; UNDERWOOD GJC, 1993, J MAR BIOL ASSOC UK, V73, P25, DOI 10.1017/S002531540003263X; Van Heurck H., 1909, RAPP SCI BOT, P1; Venables H, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005361; VILLAREAL TA, 1983, POLAR BIOL, V2, P163, DOI 10.1007/BF00448966; WAHL M, 1989, MAR ECOL PROG SER, V58, P175, DOI 10.3354/meps058175; Zacher K, 2007, POLAR BIOL, V30, P1203, DOI 10.1007/s00300-007-0278-y; ZIELINSKI K, 1990, Polish Polar Research, V11, P95	137	21	21	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153254	10.1371/journal.pone.0153254	http://dx.doi.org/10.1371/journal.pone.0153254			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078637	gold, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000374131700030
J	Cheek, NN				Cheek, Nathan N.			Face-ism and Objectification in Mainstream and LGBT Magazines	PLOS ONE			English	Article							FACIAL PROMINENCE; PRIME-TIME; TELEVISION COMMERCIALS; MALE POLITICIANS; MEDIA IMAGES; GENDER; RACE; REPRESENTATIONS; PERCEPTIONS; PICTURE	In visual media, men are often shown with more facial prominence than women, a manifestation of sexism that has been labeled face-ism. The present research extended the study of facial prominence and gender representation in media to include magazines aimed at lesbian, gay, bisexual, and transgender (LGBT) audiences for the first time, and also examined whether overall gender differences in facial prominence can still be found in mainstream magazines. Face-ism emerged in Newsweek, but not in Time, The Advocate, or Out. Although there were no overall differences in facial prominence between mainstream and LGBT magazines, there were differences in the facial prominence of men and women among the four magazines included in the present study. These results suggest that face-ism is still a problem, but that it may be restricted to certain magazines. Furthermore, future research may benefit from considering individual magazine titles rather than broader categories of magazines, given that the present study found few similarities between different magazines in the same media category-indeed, Out and Time were more similar to each other than they were to the other magazine in their respective categories.	[Cheek, Nathan N.] Swarthmore Coll, Dept Psychol, Swarthmore, PA 19081 USA	Swarthmore College	Cheek, NN (corresponding author), Swarthmore Coll, Dept Psychol, Swarthmore, PA 19081 USA.	nathan.n.cheek@gmail.com		Cheek, Nathan/0000-0003-3515-4141				ARCHER D, 1983, J PERS SOC PSYCHOL, V45, P725, DOI 10.1037/0022-3514.45.4.725; Aubrey JS, 2004, MEDIA PSYCHOL, V6, P111, DOI 10.1207/s1532785xmep0602_1; Coltrane S, 2000, SEX ROLES, V42, P363, DOI 10.1023/A:1007046204478; COPELAND GA, 1989, J BROADCAST ELECTRON, V33, P209; Eaton AW, 2008, PHILOS COMPASS, V3, P873, DOI 10.1111/j.1747-9991.2008.00154.x; Fredrickson BL, 1997, PSYCHOL WOMEN QUART, V21, P173, DOI 10.1111/j.1471-6402.1997.tb00108.x; Glascock J, 2004, SEX ROLES, V51, P423, DOI 10.1023/B:SERS.0000049231.67432.a9; Goffman E., 1976, GENDER ADVERTISEMENT, P1; Gonsoulin ME, 2010, J HOMOSEXUAL, V57, P1158, DOI 10.1080/00918369.2010.508327; Greenwood DN, 2010, HANDBOOK OF GENDER RESEARCH IN PSYCHOLOGY, VOL 2, P643, DOI 10.1007/978-1-4419-1467-5_27; Groesz LM, 2002, INT J EAT DISORDER, V31, P1, DOI 10.1002/eat.10005; HALL CCI, 1994, SEX ROLES, V31, P329; Kapidzic S, 2015, J BROADCAST ELECTRON, V59, P278, DOI 10.1080/08838151.2015.1029127; Kenix L.J., 2011, ALTERNATIVE MAINSTRE; KITE ME, 1987, PSYCHOL WOMEN QUART, V11, P83, DOI 10.1111/j.1471-6402.1987.tb00776.x; Konrath S, 2012, PSYCHOL WOMEN QUART, V36, P476, DOI 10.1177/0361684312455317; Konrath SH, 2007, MEDIA PSYCHOL, V10, P436, DOI 10.1080/15213260701533219; Lanzieri N, 2013, BODY IMAGE, V10, P251, DOI 10.1016/j.bodyim.2012.12.003; Levesque MJ, 1999, SEX ROLES, V41, P241, DOI 10.1023/A:1018806329197; Loughnan S, 2010, EUR J SOC PSYCHOL, V40, P709, DOI 10.1002/ejsp.755; Mastro DE, 2003, J BROADCAST ELECTRON, V47, P638, DOI 10.1207/s15506878jobem4704_9; Matthews JL, 2007, SEX ROLES, V57, P515, DOI 10.1007/s11199-007-9276-3; MCARTHUR LZ, 1975, J SOC PSYCHOL, V97, P209, DOI 10.1080/00224545.1975.9923340; Melkote K., 2010, INTERRELATIONSHIP BU, P213; Milillo D, 2008, J LESBIAN STUD, V12, P381, DOI 10.1080/10894160802278267; Mulvey Laura, 2006, MEDIA CULTURAL STUDI, P342; Plous S, 1997, PSYCHOL WOMEN QUART, V21, P627, DOI 10.1111/j.1471-6402.1997.tb00135.x; Saucier JA, 2008, J HOMOSEXUAL, V55, P504, DOI 10.1080/00918360802345297; SCHWARZ N, 1989, EUR J SOC PSYCHOL, V19, P311, DOI 10.1002/ejsp.2420190405; Signorielli N, 2004, J BROADCAST ELECTRON, V48, P279, DOI 10.1207/s15506878jobem4802_7; Smith L.R., 2012, J INTERCULTURAL COMM, V41, P279, DOI DOI 10.1080/17475759.2012.728771; Smith LR, 2016, COMMUN SPORT, V4, P62, DOI 10.1177/2167479514522793; Szillis U, 2007, INT J INTERNET SCI, V2, P3; ZUCKERMAN M, 1986, J NONVERBAL BEHAV, V10, P215, DOI 10.1007/BF00987481; ZUCKERMAN M, 1994, J PERS SOC PSYCHOL, V66, P86, DOI 10.1037/0022-3514.66.1.86	35	3	3	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153592	10.1371/journal.pone.0153592	http://dx.doi.org/10.1371/journal.pone.0153592			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UC	27074012	gold, Green Published			2022-12-26	WOS:000374131200109
J	Pasztor, D; Kolozsvari, BL; Csutak, A; Berta, A; Hassan, Z; Ujhelyi, B; Gogolak, P; Fodor, M				Pasztor, Dorottya; Kolozsvari, Bence Lajos; Csutak, Adrienne; Berta, Andras; Hassan, Ziad; Ujhelyi, Bernadett; Gogolak, Peter; Fodor, Mariann			Tear Mediators in Corneal Ectatic Disorders	PLOS ONE			English	Article							PELLUCID MARGINAL DEGENERATION; CONTACT-LENS WEAR; INFLAMMATORY MOLECULES; MATRIX-METALLOPROTEINASES; THINNING DISORDERS; KERATOCONUS; EXPRESSION; TOPOGRAPHY; MANAGEMENT; INDEXES	Purpose To compare the concentrations of 11 tear mediators in order to reveal the biochemical difference between pellucid marginal degeneration (PMD) and keratoconus (KC). Methods We have designed a cross-sectional study in which patients with corneal ectasia based on slit-lamp biomicroscopy and Pentacam HR (keratometry values (K1, K2, Kmax), astigmatism, minimal radius of curvature (Rmin), corneal thickness (Apex and Min), indices (surface variation, vertical asymmetry, keratoconus, central keratoconus, height asymmetry and decentration)) were enrolled. Eyes of keratoconic patients were similar to the PMD patients in age and severity (K2, Kmax and Rmin). Non-stimulated tear samples were collected from nine eyes of seven PMD patients, 55 eyes of 55 KC patients and 24 eyes of 24 healthy controls. The mediators' (interleukin -6, -10, chemokine ligand 5, -8, -10, matrix metalloproteinase (MMP) -9, -13, tissue inhibitor of metalloproteinases (TIMP)-1, tissue plasminogen activator, plasminogen activator inhibitor, nerve growth factor) concentrations were measured using Cytometric Bead Array. Results MMP-9 was the only mediator which presented relevant variances between the two patient groups (p = 0.005). The ratios of MMP-9 and TIMP-1 were 2.45, 0.40 and 0.23 in PMD, KC and the controls, respectively. Conclusion As far as we are aware, this is the first study that aims to reveal the biochemical differences between PMD and KC. Further studies of biomarkers to investigate the precise role of these mediators need to be defined, and it is important to confirm the observed changes in a larger study to gain further insights into the molecular alterations in PMD.	[Pasztor, Dorottya; Kolozsvari, Bence Lajos; Csutak, Adrienne; Berta, Andras; Ujhelyi, Bernadett; Fodor, Mariann] Univ Debrecen, Dept Ophthalmol, Fac Med, Debrecen, Hungary; [Hassan, Ziad] Orbident Refract Surg & Med Ctr, Debrecen, Hungary; [Gogolak, Peter] Univ Debrecen, Dept Immunol, Fac Med, Debrecen, Hungary	University of Debrecen; University of Debrecen	Fodor, M (corresponding author), Univ Debrecen, Dept Ophthalmol, Fac Med, Debrecen, Hungary.	mfodor@med.unideb.hu		Fodor, Mariann/0000-0002-1089-3899				Acera A, 2013, INVEST OPHTH VIS SCI, V54, P8285, DOI 10.1167/iovs.13-12235; Alhayek A, 2015, INT J OPHTHALMOL-CHI, V8, P407, DOI 10.3980/j.issn.2222-3959.2015.02.35; Ambrosio R, 2002, J REFRACT SURG, V18, P86; Ambrosio R, 2003, J REFRACT SURG, V19, P24; Balasubramanian SA, 2012, ACTA OPHTHALMOL, V90, pE303, DOI 10.1111/j.1755-3768.2011.02369.x; Belin MW, 2011, AM J OPHTHALMOL, V152, P157, DOI 10.1016/j.ajo.2011.03.028; Belin MW, 2011, AM J OPHTHALMOL, V151, P558, DOI 10.1016/j.ajo.2010.10.037; Belin MW, 2012, ELEVATION BASED CORN; Brookes NH, 2003, EXP EYE RES, V77, P515, DOI 10.1016/S0014-4835(03)00148-9; Cao Xiaoguang, 2011, J Med Case Rep, V5, P398, DOI 10.1186/1752-1947-5-398; Collier SA, 2001, CLIN EXP OPHTHALMOL, V29, P340, DOI 10.1046/j.1442-9071.2001.d01-17.x; Fodor M, 2013, EYE CONTACT LENS, V39, P147, DOI 10.1097/ICL.0b013e318273b35f; Fodor M, 2009, J INTERF CYTOK RES, V29, P375, DOI 10.1089/jir.2008.0116; Galvis V, 2015, EYE, V29, P843, DOI 10.1038/eye.2015.63; Jinabhai A, 2012, CORNEA, V31, P500, DOI 10.1097/ICO.0b013e31820f777b; Jinabhai A, 2011, CONTACT LENS ANTERIO, V34, P56, DOI 10.1016/j.clae.2010.11.007; Jun AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016437; Karabatsas CH, 1996, EYE, V10, P451, DOI 10.1038/eye.1996.99; KAYAZAWA F, 1984, ARCH OPHTHALMOL-CHIC, V102, P895; Kenney MC, 2005, INVEST OPHTH VIS SCI, V46, P823, DOI 10.1167/iovs.04-0549; Kolozsvari BL, 2014, OPHTHALMIC RES, V51, P46, DOI 10.1159/000351626; Kolozsvari BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076333; KRACHMER JH, 1984, SURV OPHTHALMOL, V28, P293, DOI 10.1016/0039-6257(84)90094-8; KRACHMER JH, 1978, ARCH OPHTHALMOL-CHIC, V96, P1217; Lambiase A, 2005, P NATL ACAD SCI USA, V102, P16795, DOI 10.1073/pnas.0508516102; Lema I, 2005, OPHTHALMOLOGY, V112, P654, DOI 10.1016/j.ophtha.2004.11.050; Lema I, 2009, BRIT J OPHTHALMOL, V93, P820, DOI 10.1136/bjo.2008.144253; Lema I, 2008, CORNEA, V27, P758, DOI 10.1097/ICO.0b013e31816a3591; Liu Q, 2009, EYE CONTACT LENS, V35, P232, DOI 10.1097/ICL.0b013e3181b3e87f; Mackiewicz Z, 2006, CORNEA, V25, P603, DOI 10.1097/01.ico.0000208820.32614.00; MAGUIRE LJ, 1987, OPHTHALMOLOGY, V94, P519, DOI 10.1016/S0161-6420(87)33416-5; Maharana PK, 2016, BRIT J OPHTHALMOL, V100, P34, DOI 10.1136/bjophthalmol-2015-307059; Matthews FJ, 2007, EXP EYE RES, V84, P1125, DOI 10.1016/j.exer.2007.02.013; Moshirfar M, 2014, J REFRACT SURG, V30, P474, DOI 10.3928/1081597X-20140429-02; Pannebaker C, 2010, MOL VIS, V16, P1949; RABINOWITZ YS, 1995, J REFRACT SURG, V11, P371; Rabinowitz YS, 1998, SURV OPHTHALMOL, V42, P297, DOI 10.1016/S0039-6257(97)00119-7; Rao SK, 1999, CORNEA, V18, P265, DOI 10.1097/00003226-199905000-00004; Rasheed K, 2000, OPHTHALMOLOGY, V107, P1836, DOI 10.1016/S0161-6420(00)00346-8; Rebenitsch RL, 2011, AM J OPHTHALMOL, V151, P768, DOI 10.1016/j.ajo.2010.10.034; Saghizadeh M, 2001, EXP EYE RES, V73, P179, DOI 10.1006/exer.2001.1028; Sakimoto Tohru, 2012, Cornea, V31 Suppl 1, pS50, DOI 10.1097/ICO.0b013e318269ccd0; Schmitt-Bernard CFM, 2000, J REFRACT SURG, V16, P368; Sorkhabi R, 2015, INT OPHTHALMOL, V35, P467, DOI 10.1007/s10792-014-9971-3; Sridhar MS, 2004, OPHTHALMOLOGY, V111, P1102, DOI 10.1016/j.ophtha.2003.09.035; Tummanapalli SS, 2013, J CATARACT REFR SURG, V39, P56, DOI 10.1016/j.jcrs.2012.08.053; Walker RN, 2008, CORNEA, V27, P963, DOI 10.1097/ICO.0b013e318170ae98; Wisse RPL, 2015, OCUL SURF, V13, P272, DOI 10.1016/j.jtos.2015.04.006; Zhou LL, 1998, INVEST OPHTH VIS SCI, V39, P1117	49	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153186	10.1371/journal.pone.0153186	http://dx.doi.org/10.1371/journal.pone.0153186			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074131	Green Published, Green Submitted, gold			2022-12-26	WOS:000374131200058
J	Yang, EJ; Ahn, S; Lee, K; Mahmood, U; Kim, HS				Yang, Eun-Jeong; Ahn, Sangzin; Lee, Kihwan; Mahmood, Usman; Kim, Hye-Sun			Early Behavioral Abnormalities and Perinatal Alterations of PTEN/AKT Pathway in Valproic Acid Autism Model Mice	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; PRENATAL EXPOSURE; ANIMAL-MODEL; SYNAPTIC-TRANSMISSION; SPECTRUM DISORDERS; MOUSE MODELS; BRAIN VOLUME; RAT MODEL; CHILDREN; FMR1	Exposure to valproic acid (VPA) during pregnancy has been linked with increased incidence of autism, and has repeatedly been demonstrated as a useful autism mouse model. We examined the early behavioral and anatomical changes as well as molecular changes in mice prenatally exposed to VPA (VPA mice). In this study, we first showed that VPA mice showed developmental delays as assessed with self-righting, eye opening tests and impaired social recognition. In addition, we provide the first evidence that primary cultured neurons from VPA-treated embryos present an increase in dendritic spines, compared with those from control mice. Mutations in phosphatase and tensin homolog (PTEN) gene are also known to be associated with autism, and mice with PTEN knockout show autistic characteristics. Protein expression of PTEN was decreased and the ratio of p-AKT/AKT was increased in the cerebral cortex and the hippocampus, and a distinctive anatomical change in the CA1 region of the hippocampus was observed. Taken together, our study suggests that prenatal exposure to VPA induces developmental delays and neuroanatomical changes via the reduction of PTEN level and these changes were detectable in the early days of life.	[Yang, Eun-Jeong; Ahn, Sangzin; Lee, Kihwan; Kim, Hye-Sun] Seoul Natl Univ, Coll Med, Dept Pharmacol & Biomed Sci, Seoul, South Korea; [Ahn, Sangzin] Inje Univ, Coll Med, Dept Pharmacol, Busan, South Korea; [Mahmood, Usman; Kim, Hye-Sun] Seoul Natl Univ, Interdisciplinary Program Brain Sci, Coll Nat Sci, Seoul, South Korea; [Kim, Hye-Sun] Seoul Natl Univ, Coll Med, Bundang Hosp, Sungnam, South Korea	Seoul National University (SNU); Inje University; Seoul National University (SNU); Seoul National University (SNU)	Kim, HS (corresponding author), Seoul Natl Univ, Interdisciplinary Program Brain Sci, Coll Nat Sci, Seoul, South Korea.	usman.mahmood85@outlook.com; hyisun@snu.ac.kr	Ahn, Sangzin/E-8807-2016	Ahn, Sangzin/0000-0003-2749-0014; Mahmood, Usman/0000-0001-5883-5009	Korea Healthcare Technology R&D Project of Ministry for Health, Welfare and Family Affairs of the Republic of Korea [HI3C1451]; National Research Foundation of Korea (NRF) through the Ministry of Education, Science and Technology [NRF-2011-0021866]	Korea Healthcare Technology R&D Project of Ministry for Health, Welfare and Family Affairs of the Republic of Korea; National Research Foundation of Korea (NRF) through the Ministry of Education, Science and Technology(National Research Foundation of Korea)	This study was financially supported by grants from the Korea Healthcare Technology R&D Project (HI3C1451) of Ministry for Health, Welfare and Family Affairs of the Republic of Korea, by the National Research Foundation of Korea (NRF) through the Ministry of Education, Science and Technology (NRF-2011-0021866). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali IU, 1999, JNCI-J NATL CANCER I, V91, P1922, DOI 10.1093/jnci/91.22.1922; Arakawa H, 2008, BEHAV BRAIN RES, V190, P97, DOI 10.1016/j.bbr.2008.02.009; ARDINGER HH, 1988, AM J MED GENET, V29, P171, DOI 10.1002/ajmg.1320290123; Bescoby-Chambers N, 2001, DEV MED CHILD NEUROL, V43, P847, DOI 10.1017/S0012162201211542; Boukhris T, 2016, JAMA PEDIATR, V170, P117, DOI 10.1001/jamapediatrics.2015.3356; Buxbaum JD, 2007, AM J MED GENET B, V144B, P484, DOI 10.1002/ajmg.b.30493; Campbell DJ, 2014, J AM ACAD CHILD PSY, V53, P1063, DOI 10.1016/j.jaac.2014.07.008; Chen C, 2017, BRAIN IMAGING BEHAV, V11, P38, DOI 10.1007/s11682-015-9504-3; CHRISTIANSON AL, 1994, DEV MED CHILD NEUROL, V36, P361; Clipperton-Allen AE, 2014, HUM MOL GENET, V23, P3490, DOI 10.1093/hmg/ddu057; Courchesne E, 2001, NEUROLOGY, V57, P245, DOI 10.1212/WNL.57.2.245; Courchesne E, 2011, JAMA-J AM MED ASSOC, V306, P2001, DOI 10.1001/jama.2011.1638; Cullen KE, 2012, TRENDS NEUROSCI, V35, P185, DOI 10.1016/j.tins.2011.12.001; DELONG GR, 1992, NEUROSCI BIOBEHAV R, V16, P63, DOI 10.1016/S0149-7634(05)80052-1; Devlin B, 2012, CURR OPIN GENET DEV, V22, P229, DOI 10.1016/j.gde.2012.03.002; Dudova I, 2014, NEUROPSYCH DIS TREAT, V10, P277, DOI 10.2147/NDT.S57057; Dufour-Rainfray D, 2011, NEUROSCI BIOBEHAV R, V35, P1254, DOI 10.1016/j.neubiorev.2010.12.013; Elsabbagh M, 2012, AUTISM RES, V5, P160, DOI 10.1002/aur.239; Favre MR, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00088; Felix-Ortiz AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037313; Gandal MJ, 2010, BIOL PSYCHIAT, V68, P1100, DOI 10.1016/j.biopsych.2010.09.031; Goffin A, 2001, AM J MED GENET, V105, P521, DOI 10.1002/ajmg.1477; Gogolla N, 2009, J NEURODEV DISORD, V1, P172, DOI 10.1007/s11689-009-9023-x; Goldani AAS, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00100; Grossman AW, 2006, BRAIN RES, V1084, P158, DOI 10.1016/j.brainres.2006.02.044; Grossman AW, 2010, BRAIN RES, V1355, P221, DOI 10.1016/j.brainres.2010.07.090; HACK M, 1995, FUTURE CHILD, V5, P176, DOI 10.2307/1602514; Hamilton SM, 2014, BEHAV NEUROSCI, V128, P103, DOI 10.1037/a0035988; Hara Y, 2012, J PHARMACOL SCI, V118, P543, DOI 10.1254/jphs.12025SC; Hardan AY, 2001, J CHILD NEUROL, V16, P421, DOI 10.2310/7010.2001.7113; Hoeft F, 2008, ARCH GEN PSYCHIAT, V65, P1087, DOI 10.1001/archpsyc.65.9.1087; Holmes GL, 2007, NEUROLOGY, V69, pS28, DOI 10.1212/01.wnl.0000302369.24230.c6; Holmes GL, 2007, EPILEPSY BEHAV, V11, P270, DOI 10.1016/j.yebeh.2007.08.022; Howlin P, 2000, J CHILD PSYCHOL PSYC, V41, P561, DOI 10.1017/S0021963099005806; Ingram JL, 2000, NEUROTOXICOL TERATOL, V22, P319, DOI 10.1016/S0892-0362(99)00083-5; Isshiki M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5742; Kane MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048975; Kataoka S, 2013, INT J NEUROPSYCHOPH, V16, P91, DOI 10.1017/S1461145711001714; Kim HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088924; Kim KC, 2011, TOXICOL LETT, V201, P137, DOI 10.1016/j.toxlet.2010.12.018; Kolozsi E, 2009, NEUROSCIENCE, V163, P1201, DOI 10.1016/j.neuroscience.2009.07.021; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Lee K, 2012, J NEUROSCI, V32, P5678, DOI 10.1523/JNEUROSCI.6471-11.2012; Lugo JN, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00027; Martin HGS, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00023; Matelski L, 2016, J AUTOIMMUN, V67, P1, DOI 10.1016/j.jaut.2015.11.003; McFarlane L, 2013, SEX DEV, V7, P207, DOI 10.1159/000348677; Meador KJ, 2013, LANCET NEUROL, V12, P244, DOI 10.1016/S1474-4422(12)70323-X; Mehta MV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026077; Miles JH, 2011, GENET MED, V13, P278, DOI 10.1097/GIM.0b013e3181ff67ba; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Mohapatra S, 2012, EXP BRAIN RES, V217, P197, DOI 10.1007/s00221-011-2986-3; Monk CS, 2009, NEUROIMAGE, V47, P764, DOI 10.1016/j.neuroimage.2009.04.069; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Nelson PG, 2006, INT J DEV NEUROSCI, V24, P73, DOI 10.1016/j.ijdevneu.2005.10.003; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; Orrico A, 2009, CLIN GENET, V75, P195, DOI 10.1111/j.1399-0004.2008.01074.x; Ozonoff S, 2010, J AM ACAD CHILD PSY, V49, P256, DOI 10.1016/j.jaac.2009.11.009; Pyhala R, 2014, PEDIATRICS, V134, P1075, DOI 10.1542/peds.2014-1097; Riedel A, 2014, PSYCHIAT RES-NEUROIM, V223, P67, DOI 10.1016/j.pscychresns.2014.05.013; Roberts L, 2003, BRAIN RES, V991, P271, DOI 10.1016/j.brainres.2003.08.022; Rodier PM, 1996, J COMP NEUROL, V370, P247, DOI 10.1002/(SICI)1096-9861(19960624)370:2<247::AID-CNE8>3.0.CO;2-2; Ronald A, 2011, AM J MED GENET B, V156B, P255, DOI 10.1002/ajmg.b.31159; Roullet FI, 2010, NEUROSCIENCE, V170, P514, DOI 10.1016/j.neuroscience.2010.06.069; Roullet FI, 2013, NEUROTOXICOL TERATOL, V36, P47, DOI 10.1016/j.ntt.2013.01.004; Saitoh O, 2001, BRAIN, V124, P1317, DOI 10.1093/brain/124.7.1317; Sandhya T, 2012, NEUROCHEM RES, V37, P1121, DOI 10.1007/s11064-012-0717-1; Schneider T, 2005, NEUROPSYCHOPHARMACOL, V30, P80, DOI 10.1038/sj.npp.1300518; Schneider T, 2008, PSYCHONEUROENDOCRINO, V33, P728, DOI 10.1016/j.psyneuen.2008.02.011; Seltzer MM, 2004, MENT RETARD DEV D R, V10, P234, DOI 10.1002/mrdd.20038; Speed HE, 2015, J NEUROSCI, V35, P9648, DOI 10.1523/JNEUROSCI.3125-14.2015; Spencer CM, 2005, GENES BRAIN BEHAV, V4, P420, DOI 10.1111/j.1601-183X.2005.00123.x; Stoner R, 2014, NEW ENGL J MED, V370, P1209, DOI 10.1056/NEJMoa1307491; Sulis ML, 2003, TRENDS CELL BIOL, V13, P478, DOI 10.1016/S0962-8924(03)00175-2; Tang GM, 2014, NEURON, V83, P1131, DOI 10.1016/j.neuron.2014.07.040; Teitelbaum P, 1998, P NATL ACAD SCI USA, V95, P13982, DOI 10.1073/pnas.95.23.13982; Tsai NP, 2012, CELL, V151, P1581, DOI 10.1016/j.cell.2012.11.040; Varga EA, 2009, GENET MED, V11, P111, DOI 10.1097/GIM.0b013e31818fd762; Veenstra-VanderWeele J, 2012, P NATL ACAD SCI USA, V109, P5469, DOI 10.1073/pnas.1112345109; Wagner GC, 2006, J AUTISM DEV DISORD, V36, P779, DOI 10.1007/s10803-006-0117-y; Yu IT, 2009, NEUROPHARMACOLOGY, V56, P473, DOI 10.1016/j.neuropharm.2008.09.019; Zaki SA, 2010, ANN SAUDI MED, V30, P233, DOI 10.4103/0256-4947.62839; Zwaigenbaum L, 2005, INT J DEV NEUROSCI, V23, P143, DOI 10.1016/j.ijdevneu.2004.05.001	84	22	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153298	10.1371/journal.pone.0153298	http://dx.doi.org/10.1371/journal.pone.0153298			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27071011	Green Submitted, Green Published, gold			2022-12-26	WOS:000373900700049
J	Braun, C; Rehdanz, K; Schmidt, U				Braun, Carola; Rehdanz, Katrin; Schmidt, Ulrich			Validity of Willingness to Pay Measures under Preference Uncertainty	PLOS ONE			English	Article							CONTINGENT VALUATION METHOD; DISCRETE-CHOICE; COHERENT ARBITRARINESS; RESPONDENT UNCERTAINTY; STATED PREFERENCE; IMPRECISION; RELIABILITY; ELICITATION; MECHANISMS; QUESTION	Recent studies in the marketing literature developed a new method for eliciting willingness to pay (WTP) with an open-ended elicitation format: the Range-WTP method. In contrast to the traditional approach of eliciting WTP as a single value (Point-WTP), Range-WTP explicitly allows for preference uncertainty in responses. The aim of this paper is to apply Range-WTP to the domain of contingent valuation and to test for its theoretical validity and robustness in comparison to the Point-WTP. Using data from two novel large-scale surveys on the perception of solar radiation management (SRM), a little-known technique for counteracting climate change, we compare the performance of both methods in the field. In addition to the theoretical validity (i.e. the degree to which WTP values are consistent with theoretical expectations), we analyse the test-retest reliability and stability of our results over time. Our evidence suggests that the Range-WTP method clearly outperforms the Point-WTP method.	[Braun, Carola; Rehdanz, Katrin; Schmidt, Ulrich] Kiel Inst World Econ, Kiel, Germany; [Rehdanz, Katrin; Schmidt, Ulrich] Univ Kiel, Dept Econ, Kiel, Germany; [Schmidt, Ulrich] Univ Johannesburg, Dept Econ & Econometr, Johannesburg, South Africa	Institut fur Weltwirtschaft an der Universitat Kiel (IFW); University of Kiel; University of Johannesburg	Braun, C (corresponding author), Kiel Inst World Econ, Kiel, Germany.	carola.kniebes@ifw-kiel.de		Rehdanz, Katrin/0000-0002-5336-0582	German Federal Ministry for Education and Research [01LA1112A]; Leibniz Association	German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Leibniz Association	This paper is part of the project ACCEPT, which is funded by the German Federal Ministry for Education and Research (grant number 01LA1112A). The publication of this article was funded by the Open Access fund of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akter S, 2013, APPL ECON, V45, P2107, DOI 10.1080/00036846.2012.654914; Ariely D, 2003, Q J ECON, V118, P73, DOI 10.1162/00335530360535153; Arrow Kenneth., 1993, FED REGISTER, V58, P4601, DOI DOI 10.1002/QJ.49703213905; BATEMAN I, 1994, REG STUD, V28, P457, DOI 10.1080/00343409412331348396; Bateman IJ, 2005, ENVIRON RESOUR ECON, V31, P47, DOI 10.1007/s10640-004-6978-7; BATEMAN IJ, 1995, ECOL ECON, V12, P161, DOI 10.1016/0921-8009(94)00044-V; BOYLE KJ, 1988, AM J AGR ECON, V70, P20, DOI 10.2307/1241972; Broberg T, 2008, RESOUR ENERGY ECON, V30, P555, DOI 10.1016/j.reseneeco.2008.09.001; Brown TC, 1996, LAND ECON, V72, P152, DOI 10.2307/3146963; Butler D, 2011, J ECON BEHAV ORGAN, V80, P511, DOI 10.1016/j.jebo.2011.05.008; Butler DJ, 2007, AM ECON REV, V97, P277, DOI 10.1257/aer.97.1.277; Cai BL, 2010, ENVIRON RESOUR ECON, V46, P429, DOI 10.1007/s10640-010-9348-7; Carson R. T., 2011, CONTINGENT VALUATION; Champ PA, 1997, J ENVIRON ECON MANAG, V33, P151, DOI 10.1006/jeem.1997.0988; Corrigan JR, 2009, AM J AGR ECON, V91, P837, DOI 10.1111/j.1467-8276.2009.01267.x; Crutzen PJ, 2006, CLIMATIC CHANGE, V77, P211, DOI 10.1007/s10584-006-9101-y; Cubitt RP, 2015, J RISK UNCERTAINTY, V50, P1, DOI 10.1007/s11166-015-9207-6; Damschroder LJ, 2007, JUDGM DECIS MAK, V2, P96; Diener A, 1998, HEALTH ECON, V7, P313, DOI 10.1002/(SICI)1099-1050(199806)7:4<313::AID-HEC350>3.3.CO;2-2; Donaldson C, 1997, APPL ECON, V29, P79, DOI 10.1080/000368497327425; Dost F, 2012, INT J RES MARK, V29, P148, DOI 10.1016/j.ijresmar.2011.09.003; Dubourg WR, 1997, ECONOMICA, V64, P681; Ellingson L, 2009, VALUATION UNCERTAINT; Frew EJ, 2003, MED DECIS MAKING, V23, P150, DOI 10.1177/0272989X03251245; Green D, 1998, RESOUR ENERGY ECON, V20, P85, DOI 10.1016/S0928-7655(97)00031-6; GREGORY R, 1993, J RISK UNCERTAINTY, V7, P177, DOI 10.1007/BF01065813; Hakansson C, 2008, ENVIRON RESOUR ECON, V39, P175, DOI 10.1007/s10640-007-9102-y; Hanley N, 2009, LAND ECON, V85, P41, DOI 10.3368/le.85.1.41; IPCC, 2012, M REP INT PAN CLIM C; JACOWITZ KE, 1995, PERS SOC PSYCHOL B, V21, P1161, DOI 10.1177/01461672952111004; Jorgensen BS, 2004, J ECON PSYCHOL, V25, P41, DOI 10.1016/S0167-4870(02)00167-8; KAHNEMAN D, 1994, J RISK UNCERTAINTY, V9, P5, DOI 10.1007/BF01073401; KANNINEN BJ, 1995, J ENVIRON ECON MANAG, V28, P114, DOI 10.1006/jeem.1995.1008; KEALY MJ, 1993, AM J AGR ECON, V75, P321, DOI 10.2307/1242916; KEALY MJ, 1990, J ENVIRON ECON MANAG, V19, P244, DOI 10.1016/0095-0696(90)90072-7; Klepper G, 2014, REV ENV ECON POLICY, V8, P270, DOI 10.1093/reep/reu010; Klose T, 1999, HEALTH POLICY, V47, P97, DOI 10.1016/S0168-8510(99)00010-X; LI CZ, 1995, J ENVIRON ECON MANAG, V28, P256, DOI 10.1006/jeem.1995.1017; Lienhoop N, 2011, ECOL ECON, V70, P1250, DOI 10.1016/j.ecolecon.2011.02.014; LOOMES G, 1988, THEOR DECIS, V25, P1, DOI 10.1007/BF00129167; Loomis J, 1998, ECOL ECON, V27, P29, DOI 10.1016/S0921-8009(97)00126-2; LOOMIS JB, 1990, J ENVIRON ECON MANAG, V18, P78, DOI 10.1016/0095-0696(90)90053-2; Mahieu PA, 2012, J ENVIRON PLANN MAN, V55, P753, DOI 10.1080/09640568.2011.626524; MARCH JG, 1978, BELL J ECON, V9, P587, DOI 10.2307/3003600; Mentzakis E, 2010, WORKING PAPER; Mercer AM, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/044006; Merk C, 2015, CLIMATIC CHANGE, V130, P299, DOI 10.1007/s10584-014-1317-7; Mitchell R.C., 1989, USING SURVEYS VALUE; Poe GL, 2002, ENVIRON RESOUR ECON, V23, P105, DOI 10.1023/A:1020242907259; Ready RC, 1996, LAND ECON, V72, P397, DOI 10.2307/3147205; READY RC, 1995, J ENVIRON ECON MANAG, V29, P181, DOI 10.1006/jeem.1995.1040; Ressurreicao A, 2011, ECOL ECON, V70, P729, DOI 10.1016/j.ecolecon.2010.11.009; SELLER C, 1985, LAND ECON, V61, P156, DOI 10.2307/3145808; Shaikh SL, 2007, ECOL ECON, V62, P115, DOI 10.1016/j.ecolecon.2006.05.016; Smith RD, 2000, MED DECIS MAKING, V20, P194, DOI 10.1177/0272989X0002000205; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Venkatachalam L, 2004, ENVIRON IMPACT ASSES, V24, P89, DOI 10.1016/S0195-9255(03)00138-0; Voltaire L, 2013, ECOL ECON, V88, P76, DOI 10.1016/j.ecolecon.2013.01.009; Wang T, 2007, J MARKETING RES, V44, P200, DOI 10.1509/jmkr.44.2.200; Welsh MP, 1998, J ENVIRON ECON MANAG, V36, P170, DOI 10.1006/jeem.1998.1043; Whitehead JC, 1998, ENVIRON RESOUR ECON, V11, P107, DOI 10.1023/A:1008231430184; Whynes DK, 2005, HEALTH ECON, V14, P1191, DOI 10.1002/hec.1001; Whynes DK, 2004, HEALTH ECON, V13, P183, DOI 10.1002/hec.809; Yeung RYT, 2006, HEALTH ECON, V15, P1077, DOI 10.1002/hec.1107	65	7	8	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0154078	10.1371/journal.pone.0154078	http://dx.doi.org/10.1371/journal.pone.0154078			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9OU	27096163	gold, Green Published, Green Submitted			2022-12-26	WOS:000374543600086
J	Fujiwara, S; Araki, K; Matsuo, T; Yagi, H; Yamada, T; Shibata, K; Mochizuki, H				Fujiwara, Satoru; Araki, Katsuya; Matsuo, Tatsuhito; Yagi, Hisashi; Yamada, Takeshi; Shibata, Kaoru; Mochizuki, Hideki			Dynamical Behavior of Human alpha-Synuclein Studied by Quasielastic Neutron Scattering	PLOS ONE			English	Article							PROTEIN DYNAMICS; PARKINSONS-DISEASE; INTERNAL DYNAMICS; CONFORMATIONAL ENTROPY; STRUCTURAL DYNAMICS; DISORDERED PROTEIN; AMYLOID FIBRILS; FIBRILLATION; AGGREGATION; DIFFUSION	alpha-synuclein (alpha Syn) is a protein consisting of 140 amino acid residues and is abundant in the presynaptic nerve terminals in the brain. Although its precise function is unknown, the filamentous aggregates (amyloid fibrils) of alpha Syn have been shown to be involved in the pathogenesis of Parkinson's disease, which is a progressive neurodegenerative disorder. To understand the pathogenesis mechanism of this disease, the mechanism of the amyloid fibril formation of alpha Syn must be elucidated. Purified alpha Syn from bacterial expression is monomeric but intrinsically disordered in solution and forms amyloid fibrils under various conditions. As a first step toward elucidating the mechanism of the fibril formation of alpha Syn, we investigated dynamical behavior of the purified alpha Syn in the monomeric state and the fibril state using quasielastic neutron scattering (QENS). We prepared the solution sample of 9.5 mg/ml purified alpha Syn, and that of 46 mg/ml alpha Syn in the fibril state, both at pD 7.4 in D2O. The QENS experiments on these samples were performed using the near-backscattering spectrometer, BL02 (DNA), at the Materials and Life Science Facility at the Japan Accelerator Research Complex, Japan. Analysis of the QENS spectra obtained shows that diffusive global motions are observed in the monomeric state but largely suppressed in the fibril state. However, the amplitude of the side chain motion is shown to be larger in the fibril state than in the monomeric state. This implies that significant solvent space exists within the fibrils, which is attributed to the alpha Syn molecules within the fibrils having a distribution of conformations. The larger amplitude of the side chain motion in the fibril state than in the monomeric state implies that the fibril state is entropically favorable.	[Fujiwara, Satoru; Matsuo, Tatsuhito] Japan Atom Energy Agcy, Quantum Beam Sci Ctr, Tokai, Ibaraki, Japan; [Araki, Katsuya; Mochizuki, Hideki] Osaka Univ, Dept Neurol, Grad Sch Med, Suita, Osaka, Japan; [Yagi, Hisashi] Tottori Univ, Ctr Res Green Sustainable Chem, Tottori 680, Japan; [Yamada, Takeshi] CROSS Tokai, Res Ctr Neutron Sci & Technol, Tokai, Ibaraki, Japan; [Shibata, Kaoru] J PARC Ctr, Neutron Sci Sect, Tokai, Ibaraki, Japan; [Fujiwara, Satoru; Matsuo, Tatsuhito] Natl Inst Quantum & Radiol Sci & Technol, Tokai, Ibaraki, Japan	Japan Atomic Energy Agency; Osaka University; Tottori University; National Institutes for Quantum Science & Technology	Fujiwara, S (corresponding author), Japan Atom Energy Agcy, Quantum Beam Sci Ctr, Tokai, Ibaraki, Japan.; Fujiwara, S (corresponding author), Natl Inst Quantum & Radiol Sci & Technol, Tokai, Ibaraki, Japan.	fujiwara.satoru@qst.go.jp		Araki, Katsuya/0000-0001-5493-2178	Japan Society for the Promotion of Science (JSPS KAKENHI Grant) [26293210]; Takeda Science Foundation; CROSS-Tokai [2012P0502, 2013P0502, 2014P0502]	Japan Society for the Promotion of Science (JSPS KAKENHI Grant)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); CROSS-Tokai	This study is supported in part by the Grant-in-Aid for Scientific Research (B) from Japan Society for the Promotion of Science (JSPS KAKENHI Grant No. 26293210) (to HM, SF), and from Takeda Science Foundation (to HY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript" should not be changed. It is because the statement "The QENS experiments using BL02 (DNA) at MLF/J-PARC were carried out under the research project organized by J-PARC Center and CROSS-Tokai (Proposal No. 2012P0502, 2013P0502, and 2014P0502)" is not regarding funding but regarding the experimental proposals for requesting the beam time at the experiments at J-PARC.; We thank Dr. R. Inoue and Prof. M. Sugiyama for their help in the DLS measurements. The QENS experiments using BL02 (DNA) atMLF/J-PARC were carried out under the research project organized by J-PARC Center and CROSS-Tokai (Proposal No. 2012P0502, 2013P0502, and 2014P0502).	Baxa MC, 2014, P NATL ACAD SCI USA, V111, P15396, DOI 10.1073/pnas.1407768111; Bee M, 1988, QUASIELASTIC NEUTRON; Bendor JT, 2013, NEURON, V79, P1044, DOI 10.1016/j.neuron.2013.09.004; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; Borreguero JM, 2011, J PHYS CHEM B, V115, P8925, DOI 10.1021/jp201346x; Bousset L, 2014, BBA-PROTEINS PROTEOM, V1844, P1307, DOI 10.1016/j.bbapap.2014.04.010; Bu ZM, 2000, J MOL BIOL, V301, P525, DOI 10.1006/jmbi.2000.3978; Bu ZM, 2001, J MOL BIOL, V312, P865, DOI 10.1006/jmbi.2001.5006; Caronna C, 2005, BIOPHYS CHEM, V116, P219, DOI 10.1016/j.bpc.2005.02.004; Dee DR, 2011, BIOPHYS J, V101, P1699, DOI 10.1016/j.bpj.2011.08.002; Del Mar C, 2005, P NATL ACAD SCI USA, V102, P15477, DOI 10.1073/pnas.0507405102; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Fichou Y, 2015, P NATL ACAD SCI USA, V112, P6365, DOI 10.1073/pnas.1422824112; Fink AL, 2006, ACCOUNTS CHEM RES, V39, P628, DOI 10.1021/ar050073t; Fitter J, 2003, BIOPHYS J, V84, P3924, DOI 10.1016/S0006-3495(03)75120-0; Fujiwara S, 2008, BIOPHYS J, V94, P4880, DOI 10.1529/biophysj.107.125302; Fujiwara S, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJS.82SA.SA019; Fujiwara S, 2011, EUR BIOPHYS J BIOPHY, V40, P661, DOI 10.1007/s00249-011-0669-4; Gabel F, 2002, Q REV BIOPHYS, V35, P327, DOI 10.1017/S0033583502003840; Gallat FX, 2012, BIOPHYS J, V103, P129, DOI 10.1016/j.bpj.2012.05.027; Gaspar AM, 2008, EUR BIOPHYS J BIOPHY, V37, P573, DOI 10.1007/s00249-008-0266-3; Gaspar AM, 2010, BBA-PROTEINS PROTEOM, V1804, P76, DOI 10.1016/j.bbapap.2009.06.024; Gibrat G, 2008, BIOPHYS J, V95, P5247, DOI 10.1529/biophysj.107.120147; Greenwald J, 2010, STRUCTURE, V18, P1244, DOI 10.1016/j.str.2010.08.009; Grimaldo M, 2015, PHYS CHEM CHEM PHYS, V17, P4645, DOI 10.1039/c4cp04944f; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Ikenoue T, 2014, ANGEW CHEM INT EDIT, V53, P7799, DOI 10.1002/anie.201403815; Inamura Y, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJS.82SA.SA031; Jansson H, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2943199; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Lv GH, 2012, J MOL BIOL, V420, P99, DOI 10.1016/j.jmb.2012.04.009; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Parigi G, 2014, J AM CHEM SOC, V136, P16201, DOI 10.1021/ja506820r; Perez J, 1999, BIOPHYS J, V77, P454, DOI 10.1016/S0006-3495(99)76903-1; Perticaroli S, 2014, J PHYS CHEM B, V118, P7317, DOI 10.1021/jp503788r; Pieper J, 2009, BIOCHEMISTRY-US, V48, P6111, DOI 10.1021/bi900414k; Pieper J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.228103; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P213, DOI 10.1016/0010-4655(82)90173-4; Rodriguez JA, 2015, NATURE, V525, P486, DOI 10.1038/nature15368; Roosen-Runge F, 2011, P NATL ACAD SCI USA, V108, P11815, DOI 10.1073/pnas.1107287108; Sacquin-Mora S, 2007, BIOCHEMISTRY-US, V46, P14960, DOI 10.1021/bi7004416; Schiro G, 2012, J PHYS CHEM LETT, V3, P992, DOI 10.1021/jz300082x; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Shibata K., 2015, J PARC JPS C PROC, V8, DOI DOI 10.7566/JPSCP.8.036022; SMITH JC, 1991, Q REV BIOPHYS, V24, P227, DOI 10.1017/S0033583500003723; Stadler AM, 2008, BIOPHYS J, V95, P5449, DOI 10.1529/biophysj.108.138040; Stadler AM, 2015, J PHYS CHEM B, V119, P72, DOI 10.1021/jp509732q; Stadler AM, 2014, J AM CHEM SOC, V136, P6987, DOI 10.1021/ja502343b; Stadler AM, 2013, BIOPHYS J, V105, P2157, DOI 10.1016/j.bpj.2013.09.039; TEIXEIRA J, 1985, PHYS REV A, V31, P1913, DOI 10.1103/PhysRevA.31.1913; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Uversky VN, 2005, CURR PROTEIN PEPT SC, V10, P482; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; VOLINO F, 1980, MOL PHYS, V41, P271, DOI 10.1080/00268978000102761; Vrandecic K, 2015, J PHYS CHEM B, V119, P3920, DOI 10.1021/jp5112873; Wang YQ, 2012, J PHYS CHEM LETT, V3, P2703, DOI 10.1021/jz3010915; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Yagi H, 2005, J BIOL CHEM, V280, P38609, DOI 10.1074/jbc.M508623200; Yasuda T, 2013, MOL NEUROBIOL, V47, P466, DOI 10.1007/s12035-012-8327-0; Zaccai G, 2000, SCIENCE, V288, P1604, DOI 10.1126/science.288.5471.1604; Zanotti JM, 1999, BIOPHYS J, V76, P2390, DOI 10.1016/S0006-3495(99)77395-9	63	24	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0151447	10.1371/journal.pone.0151447	http://dx.doi.org/10.1371/journal.pone.0151447			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097022	Green Published, gold, Green Submitted			2022-12-26	WOS:000374543600003
J	Frankis, J; Young, I; Flowers, P; McDaid, L				Frankis, Jamie; Young, Ingrid; Flowers, Paul; McDaid, Lisa			Who Will Use Pre-Exposure Prophylaxis (PrEP) and Why?: Understanding PrEP Awareness and Acceptability amongst Men Who Have Sex with Men in the UK - A Mixed Methods Study	PLOS ONE			English	Article							AUSTRALIAN GAY; BISEXUAL MEN; CONDOM USE; HIV; WILLINGNESS	Background Recent clinical trials suggest that pre-exposure prophylaxis (PrEP) may reduce HIV transmission by up to 86% for men who have sex with men (MSM), whilst relatively high levels of PrEP acceptability have been reported to date. This study examines PrEP awareness amongst sub-groups of MSM communities and acceptability amongst MSM in a low prevalence region (Scotland, UK), using a mixed methods design. Methods Quantitative surveys of n = 690 MSM recruited online via social and sociosexual media were analysed using descriptive statistics and multivariate logistic regression. In addition, n = 10 in-depth qualitative interviews with MSM were analysed thematically. Results Under one third (29.7%) of MSM had heard of PrEP, with awareness related to living in large cities, degree level education, commercial gay scene use and reporting an HIV test in the last year. Just under half of participants (47.8%) were likely to use PrEP if it were available but there was no relationship between PrEP acceptability and previous PrEP awareness. Younger men (18-25 years) and those who report higher risk UAI were significantly more likely to say they would use PrEP. Qualitative data described specific PrEP scenarios, illustrating how risk, patterns of sexual practice and social relationships could affect motivation for and nature of PrEP use. Conclusion These findings suggest substantial interest PrEP amongst MSM reporting HIV risk behaviours in Scotland. Given the Proud results, there is a strong case to investigate PrEP implementation within the UK. However, it appears that disparities in awareness have already emerged along traditional indicators of inequality. Our research identifies the need for comprehensive support when PrEP is introduced, including a key online component, to ensure equity of awareness across diverse MSM communities (e.g. by geography, education, gay scene use and HIV proximity), as well as to responding to the diverse informational and sexual health needs of all MSM communities.	[Frankis, Jamie; Flowers, Paul] Glasgow Caledonian Univ, Sch Hlth & Life Sci, Glasgow G4 0BA, Lanark, Scotland; [Young, Ingrid; McDaid, Lisa] Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland	Glasgow Caledonian University; MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow	Frankis, J (corresponding author), Glasgow Caledonian Univ, Sch Hlth & Life Sci, Glasgow G4 0BA, Lanark, Scotland.	j.frankis@gcu.ac.uk	Flowers, Paul/H-5174-2019	Flowers, Paul/0000-0001-6239-5616; McDaid, Lisa/0000-0002-7711-8723; Frankis, Jamie/0000-0003-3350-5892; Young, Ingrid/0000-0002-1242-5992	Glasgow Caledonian University (GCU); NHS Lanarkshire Blood Bourne Viruses; UK Medical Research Council (MRC), Social Relationships and Health Improvement programme at the MRC/CSO Social and Public Health Sciences Unit, University of Glasgow [MC_U130031238/MC_UU_12017/2]; Chief Scientist Office (CSO) fellowship [PDF/14/02]; MRC [MC_UU_12017/11]; CSO [SPHSU11]; MRC [MC_UU_12017/2, MC_U130031238] Funding Source: UKRI; Medical Research Council [MC_UU_12017/2, MC_U130031238, MC_UU_12017/11] Funding Source: researchfish; Chief Scientist Office [PDF/14/02, SPHSU11] Funding Source: researchfish	Glasgow Caledonian University (GCU); NHS Lanarkshire Blood Bourne Viruses; UK Medical Research Council (MRC), Social Relationships and Health Improvement programme at the MRC/CSO Social and Public Health Sciences Unit, University of Glasgow; Chief Scientist Office (CSO) fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CSO; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	This work was supported by Glasgow Caledonian University (GCU) funds to JF and PF. NHS Lanarkshire Blood Bourne Viruses and GCU funded the Social Media, Men who have sex with men and Sexual Health (SMMASH) study, the quantitative research component of this paper, as part of the Sexual Health and Blood Borne Viruses Theme, at the Institute for Applied Health Research, GCU. HIV & the Biomedical, the qualitative research component, was funded by the UK Medical Research Council (MRC) (MC_U130031238/MC_UU_12017/2), as part of core-funding for the Sexual Health Programme (now the Social Relationships and Health Improvement programme) at the MRC/CSO Social and Public Health Sciences Unit, University of Glasgow. IY is funded by a Chief Scientist Office (CSO) fellowship (PDF/14/02). LM is funded by the MRC (MC_UU_12017/11) and CSO (SPHSU11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghaizu A, 2013, SEX TRANSM INFECT, V89, P207, DOI 10.1136/sextrans-2012-050648; Barash EA, 2010, AIDS PATIENT CARE ST, V24, P689, DOI 10.1089/apc.2010.0173; Beyrer C, 2015, LANCET, V385, P1482, DOI 10.1016/S0140-6736(15)60724-3; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Dolling D, 2014, HIV MED, V15, P15; FDA, 2012, FDA APPR 1 DRUG RED; Flowers P, 1997, PSYCHOL HEALTH, V12, P197, DOI 10.1080/08870449708407400; Golub SA, 2010, JAIDS-J ACQ IMM DEF, V54, P548, DOI 10.1097/QAI.0b013e3181e19a54; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Haberer JE, 2015, AIDS; Health Protection Scotland, 2015, HIV INF AIDS Q REP 3; Health Protection Scotland, 2015, HIV INF AIDS Q REP 3; Holt M, 2014, JAIDS-J ACQ IMM DEF, V67, P222, DOI 10.1097/QAI.0000000000000287; Holt M, 2014, SEX HEALTH, V11, P166, DOI 10.1071/SH13060; Holt M, 2012, SEX TRANSM INFECT, V88, P258, DOI 10.1136/sextrans-2011-050312; Kirby T, 2014, LANCET, V383, P399, DOI 10.1016/S0140-6736(14)60137-9; Krakower DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033119; Leonardi M, 2011, INT J STD AIDS, V22, P738, DOI 10.1258/ijsa.2011.011057; Liu AY, 2008, JAIDS-J ACQ IMM DEF, V47, P241, DOI 10.1097/QAI.0b013e31815e4041; Lorimer K, TRANSITIONS AP UNPUB; Mason J., 1996, QUALITATIVE RES; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; Molina J-M, 2015, DEMAND PREP ORAL TDF, V23LB; Okwundu CI, 2012, COCHRANE DATABASE SY; Saberi P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050061; Sigma Research, 2015, GAY MENS SEX SURV 20; Silverman D., 2017, DOING QUALITATIVE RE, V5th; Wallace LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090805; Young I, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005717; Young I, 2014, AIDS BEHAV, V18, P195, DOI 10.1007/s10461-013-0560-7; Young I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064038; Zhou F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032329; Ziebland S, 2006, MED EDUC, V40, P405, DOI 10.1111/j.1365-2929.2006.02467.x	33	37	38	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0151385	10.1371/journal.pone.0151385	http://dx.doi.org/10.1371/journal.pone.0151385			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093430	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000374541200002
J	Kuo, IY; Duong, SL; Nguyen, L; Ehrlich, BE				Kuo, Ivana Y.; Duong, Sophie L.; Nguyen, Lily; Ehrlich, Barbara E.			Decreased Polycystin 2 Levels Result in Non-Renal Cardiac Dysfunction with Aging	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; KIDNEY-DISEASE; DILATED CARDIOMYOPATHY; HEART-FAILURE; SIGNALING PATHWAYS; BLOOD-PRESSURE; RECEPTOR; MUTATIONS; BLOCKADE; RELEASE	Mutations in the gene for polycystin 2 (Pkd2) lead to polycystic kidney disease, however the main cause of mortality in humans is cardiac related. We previously showed that 5 month old Pkd2+/- mice have altered calcium-contractile activity in cardiomyocytes, but have preserved cardiac function. Here, we examined 1 and 9 month old Pkd2+/- mice to determine if decreased amounts of functional polycystin 2 leads to impaired cardiac function with aging. We observed changes in calcium handling proteins in 1 month old Pkd2+/- mice, and these changes were exacerbated in 9 month old Pkd2+/- mice. Anatomically, the 9 month old Pkd2+/- mice had thinner left ventricular walls, consistent with dilated cardiomyopathy, and the left ventricular ejection fraction was decreased. Intriguingly, in response to acute isoproterenol stimulation to examine beta-adrenergic responses, the 9 month old Pkd2+/- mice exhibited a stronger contractile response, which also coincided with preserved localization of the beta 2 adrenergic receptor. Importantly, the Pkd2+/- mice did not have any renal impairment. We conclude that the cardiac-related impact of decreased polycystin 2 progresses over time towards cardiac dysfunction and altered adrenergic signaling. These results provide further evidence that polycystin 2 provides a critical function in the heart, independent of renal involvement.	[Kuo, Ivana Y.; Duong, Sophie L.; Nguyen, Lily; Ehrlich, Barbara E.] Yale Univ, Dept Pharmacol, New Haven, CT 06510 USA; [Ehrlich, Barbara E.] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT USA	Yale University; Yale University	Ehrlich, BE (corresponding author), Yale Univ, Dept Pharmacol, New Haven, CT 06510 USA.; Ehrlich, BE (corresponding author), Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT USA.	Barbara.ehrlich@yale.edu	/AAX-8408-2021	/0000-0001-9657-9704; Kuo, Ivana/0000-0002-9867-2408; Nguyen, Lily/0000-0003-4425-2536	National Institutes of Health [K99DK101585, 5P01DK057751, P30DK090744]; Yale Imaging Core [5P30DK034989, OD020142]; Studienstiftung des deutschen Volkes (German National Academic Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090744, K99DK101585, P30DK034989, P01DK057751] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020142] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale Imaging Core; Studienstiftung des deutschen Volkes (German National Academic Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health: K99DK101585 (IYK), 5P01DK057751 and P30DK090744 (BEE), Yale Imaging Core (5P30DK034989 and OD020142) and the Studienstiftung des deutschen Volkes (German National Academic Foundation, SLD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anyatonwu GI, 2007, P NATL ACAD SCI USA, V104, P6454, DOI 10.1073/pnas.0610324104; Bers DM, 2006, PHYSIOLOGY, V21, P380, DOI 10.1152/physiol.00019.2006; Cai ZQ, 1999, J BIOL CHEM, V274, P28557, DOI 10.1074/jbc.274.40.28557; Chapman AB, 2010, CLIN J AM SOC NEPHRO, V5, P102, DOI 10.2215/CJN.04310709; Ecder T, 2009, NAT REV NEPHROL, V5, P221, DOI 10.1038/nrneph.2009.13; Geng L, 2006, J CELL SCI, V119, P1383, DOI 10.1242/jcs.02818; Harding SE, 2004, CONGEST HEART FAIL, V10, P6; Harding Sian E, 2004, Congest Heart Fail, V10, P181, DOI 10.1111/j.1527-5299.2004.02052.x; Helal I, 2012, AM J NEPHROL, V36, P362, DOI 10.1159/000343281; Hinson JT, 2015, SCIENCE, V349, P982, DOI 10.1126/science.aaa5458; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Kuo IY, 2014, P NATL ACAD SCI USA, V111, P16604, DOI 10.1073/pnas.1415933111; Li Y, 2005, J BIOL CHEM, V280, P41298, DOI 10.1074/jbc.M510082200; Martinez-Vea A, 2000, AM J NEPHROL, V20, P193, DOI 10.1159/000013583; McNally EM, 2013, J CLIN INVEST, V123, P19, DOI 10.1172/JCI62862; Mekahli D, 2012, CELL CALCIUM, V51, P452, DOI 10.1016/j.ceca.2012.03.002; Paavola J, 2013, J MOL CELL CARDIOL, V58, P199, DOI 10.1016/j.yjmcc.2013.01.015; Pedrozo Z, 2015, CIRCULATION, V131, P2131, DOI 10.1161/CIRCULATIONAHA.114.013537; Plank DM, 2003, AM J PHYSIOL-HEART C, V285, pH305, DOI 10.1152/ajpheart.00425.2002; Pott C, 2011, CURR DRUG TARGETS, V12, P737, DOI 10.2174/138945011795378559; Pugh TJ, 2014, GENET MED, V16, P601, DOI 10.1038/gim.2013.204; Qian Q, 2007, J AM SOC NEPHROL, V18, P485, DOI 10.1681/ASN.2006050501; REEDERS ST, 1992, NAT GENET, V1, P235, DOI 10.1038/ng0792-235; Reinecke H, 1996, CARDIOVASC RES, V31, P48, DOI 10.1016/0008-6363(95)00176-X; Rowell J, 2014, PHYSIOL GENOMICS, V46, P779, DOI 10.1152/physiolgenomics.00054.2014; Schrier RW, 2014, NEW ENGL J MED, V371, P2255, DOI 10.1056/NEJMoa1402685; Schrier RW, 2009, J AM SOC NEPHROL, V20, P1888, DOI 10.1681/ASN.2008080882; Schutzer WE, 2003, AGEING RES REV, V2, P169, DOI 10.1016/S1568-1637(02)00063-6; Stypmann J, 2007, INT J CARDIOL, V120, P158, DOI 10.1016/j.ijcard.2006.09.013; Torres VE, 2014, NEW ENGL J MED, V371, P2267, DOI 10.1056/NEJMoa1402686; Xiao RP, 1998, J CLIN INVEST, V101, P1273, DOI 10.1172/JCI1335	31	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153632	10.1371/journal.pone.0153632	http://dx.doi.org/10.1371/journal.pone.0153632			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27081851	Green Published, Green Submitted, gold			2022-12-26	WOS:000374291800036
J	Mei, H; Johansson, E; Hagstromer, M; Xiong, YL; Zhang, LL; Zhang, JD; Marcus, C				Mei, Hong; Johansson, Elin; Hagstromer, Maria; Xiong, Yuelin; Zhang, Lanlan; Zhang, Jianduan; Marcus, Claude			Physical Activity Levels in Chinese One-Year-Old Children and Their Parents, an Early STOPP China Study	PLOS ONE			English	Article							BODY-MASS INDEX; PRESCHOOL-CHILDREN; ACCELEROMETER; CHILDHOOD; OBESITY; WORN; VALIDATION; BMI; ASSOCIATIONS; ADOLESCENTS	Background Physical activity (PA) is associated with health benefits, already in childhood. However, little is known about actual levels, patterns and gender differences in PA level in very young children. This study examines Chinese one-year-old children and their parents' PA levels and patterns, and assesses the correlations between children's PA level and gender, body mass index standard deviation score (BMI SDS), parental BMI and parental PA level. Methods Data from 123 families participating in the Early STOPP China study were used. Families were recruited based on parental BMI and were classified as either high-risk or low-risk of obesity. Parents and children wore an ActiGraph GT3X+ to assess the average PA levels. PA levels and hourly patterns during weekdays and weekends were examined as were correlations with gender, BMI SDS, parental BMI and parental PA levels. Results There were no significant differences in children's averaged PA between risk groups, genders, or between weekdays and weekends. Children's peak average activity level was at 7 pm and they were least active at 3 pm (p<0.001). Both mothers and fathers demonstrated a similar PA pattern as their children, although paternal PA level was consistently lower than that of mothers and children. No significant association was found between children's PA and their gender, BMI SDS, parental BMI or paternal PA levels. Maternal PA was found positively associated with child PA (p<0.05). Conclusion PA in one-year-old Chinese children vary over the day but weekdays and weekends are similar. At this age, children's PA is not related to gender, BMI SDS, parental BMI or paternal PA. Larger scale studies with more contextual information are needed to improve the understanding of our findings.	[Mei, Hong; Zhang, Jianduan] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Maternal & Child Hlth Care, Wuhan 430074, Hubei, Peoples R China; [Johansson, Elin; Xiong, Yuelin; Zhang, Lanlan; Marcus, Claude] Karolinska Inst, Dept Clin Sci Technol & Intervent, Div Pediat, Stockholm, Sweden; [Hagstromer, Maria] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Physiotherapy, Stockholm, Sweden	Huazhong University of Science & Technology; Karolinska Institutet; Karolinska Institutet	Marcus, C (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Maternal & Child Hlth Care, Wuhan 430074, Hubei, Peoples R China.	jd_zh@hust.edu.cn; claude.marcus@ki.se	Marcus, Claude/ABE-1177-2020; Xiong, Yuelin/D-9988-2019	Marcus, Claude/0000-0003-0890-2650; Xiong, Yuelin/0000-0002-6204-4733	Swedish Council for Working Life and Social Research; Swedish Research Council, Karolinska Institutet; Swedish Heart-Lung Foundation; Sven Jerring Foundation; Stockholm Free Masons' Foundation for Children's Welfare; National Natural Science Fund of China [30800917]; Special Fund for Basic Scientific Research of Central Colleges [2013TS009]	Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council, Karolinska Institutet(Swedish Research Council); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Sven Jerring Foundation; Stockholm Free Masons' Foundation for Children's Welfare; National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Special Fund for Basic Scientific Research of Central Colleges	The sources of funding are as follows: The Swedish Council for Working Life and Social Research; The Swedish Research Council, Karolinska Institutet; The Swedish Heart-Lung Foundation; The Sven Jerring Foundation and Stockholm Free Masons' Foundation for Children's Welfare; National Natural Science Fund of China (30800917); The Special Fund for Basic Scientific Research of Central Colleges (2013TS009). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abbott G, 2016, J PHYS ACT HEALTH, V13, P269, DOI 10.1123/jpah.2015-0136; Baquet G, 2007, PREV MED, V44, P143, DOI 10.1016/j.ypmed.2006.10.004; Baur LA, 2004, CLIN DERMATOL, V22, P338, DOI 10.1016/j.clindermatol.2004.01.005; BENDEL RB, 1977, J AM STAT ASSOC, V72, P46, DOI 10.2307/2286904; Bonvin A, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-23; Choo V, 2002, LANCET, V360, P235, DOI 10.1016/S0140-6736(02)09512-0; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; Dieu O., 2016, CLIN PHYSL FUNCT IMA; Dossegger A, 2014, MED SCI SPORT EXER, V46, P1140, DOI 10.1249/MSS.0000000000000215; Du HD, 2013, AM J CLIN NUTR, V97, P487, DOI 10.3945/ajcn.112.046854; Ekstedt M, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-82; Fairclough SJ, 2015, MED SCI SPORTS EXERC; Felix JF, 2016, HUM MOL GENET, V25, P389, DOI 10.1093/hmg/ddv472; Finn K, 2002, J PEDIATR-US, V140, P81, DOI 10.1067/mpd.2002.120693; Freedman DS, 2004, INT J OBESITY, V28, P10, DOI 10.1038/sj.ijo.0802544; Galland BC, 2012, SLEEP MED, V13, P743, DOI 10.1016/j.sleep.2012.01.018; Hesketh KR, 2014, PEDIATRICS, V133, pE973, DOI 10.1542/peds.2013-3153; Hinkley T, 2012, AM J PREV MED, V43, P159, DOI 10.1016/j.amepre.2012.04.020; Hnatiuk J, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-123; Hnatiuk J, 2012, MED SCI SPORT EXER, V44, P1715, DOI 10.1249/MSS.0b013e31825825c4; Hussey J, 2007, BRIT J SPORT MED, V41, P311, DOI 10.1136/bjsm.2006.032045; Johansson E, 2015, PEDIATR OBES, V10, P1, DOI 10.1111/j.2047-6310.2013.00213.x; Johansson E, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0161-0; Mackintosh KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036919; Maffeis C, 2000, EUR J PEDIATR, V159, pS35, DOI 10.1007/PL00014361; Mattocks C, 2008, BMJ-BRIT MED J, V336, P26, DOI 10.1136/bmj.39385.443565.BE; Ng SW, 2014, OBES REV, V15, P27, DOI 10.1111/obr.12127; Nyberg GA, 2009, MED SCI SPORT EXER, V41, P1842, DOI 10.1249/MSS.0b013e3181a48ee6; Rowlands AV, 2014, MED SCI SPORT EXER, V46, P2308, DOI 10.1249/MSS.0000000000000365; Santos-Lozano A, 2013, INT J SPORTS MED, V34, P975, DOI 10.1055/s-0033-1337945; Senso MM, 2014, J PHYS ACT HLTH; Shen Ma BW, 2013, MODERN PREVENTIVE ME, P1065; Shiroma EJ, 2015, MED SCI SPORT EXER, V47, P2558, DOI 10.1249/MSS.0000000000000725; Sobko T, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-336; Syvaoja HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103559; Tremblay MS, 2012, APPL PHYSIOL NUTR ME, V37, P357, DOI [10.1139/h2012-026, 10.1139/H2012-026, 10.1139/H2012-018, 10.1139/h2012-018]; Vale S, 2011, INT J PEDIATR OBES, V6, P37, DOI 10.3109/17477166.2011.613663; Cauwenberghe E, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-67; Vanhelst J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-690; Wen CP, 2009, PUBLIC HEALTH NUTR, V12, P497, DOI 10.1017/S1368980008002802; Worobey J, 2014, AM J CLIN NUTR, V99, p729S, DOI 10.3945/ajcn.113.072397; Xiao Y, 2015, PLOS ONE, P10; Yang W, 2012, BMC PUBLIC HEALTH, V12, DOI [10.1186/1471-2458-12-1127, 10.1186/1471-2458-12-804]; Ying Huang SPWC, 2015, MED REV, P1409; Zong XN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046942	45	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153605	10.1371/journal.pone.0153605	http://dx.doi.org/10.1371/journal.pone.0153605			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078684	Green Submitted, gold, Green Published			2022-12-26	WOS:000374131700090
J	Perlado, S; Bustamante-Aragones, A; Donas, M; Lorda-Sanchez, I; Plaza, J; de Alba, MR				Perlado, Sara; Bustamante-Aragones, Ana; Donas, Marta; Lorda-Sanchez, Isabel; Plaza, Javier; Rodriguez de Alba, Marta			Fetal Genotyping in Maternal Blood by Digital PCR: Towards NIPD of Monogenic Disorders Independently of Parental Origin	PLOS ONE			English	Article							NONINVASIVE PRENATAL-DIAGNOSIS; SEX DETERMINATION; HUNTINGTON DISEASE; BETA-THALASSEMIA; DOWN-SYNDROME; DNA; PLASMA; MUTATION; RELIABILITY; IMPROVEMENT	Purpose To date, non-invasive prenatal diagnosis (NIPD) of monogenic disorders has been limited to cases with a paternal origin. This work shows a validation study of the Droplet Digital PCR (ddPCR) technology for analysis of both paternally and maternally inherited fetal alleles. For the purpose, single nucleotide polymorphisms (SNPs) were studied with the only intention to mimic monogenic disorders. Methods NIPD SNP genotyping was performed by ddPCR in 55 maternal plasma samples. In 19 out of 55 cases, inheritance of the paternal allele was determined by presence/absence criteria. In the remaining 36, determination of the maternally inherited fetal allele was performed by relative mutation dosage (RMD) analysis. Results ddPCR exhibited 100% accuracy for detection of paternal alleles. For diagnosis of fetal alleles with maternal origin by RMD analysis, the technology showed an accuracy of 96%. Twenty-nine out of 36 were correctly diagnosed. There was one FP and six maternal plasma samples that could not be diagnosed. Discussion In this study, ddPCR has shown to be capable to detect both paternal and maternal fetal alleles in maternal plasma. This represents a step forward towards the introduction of NIPD for all pregnancies independently of the parental origin of the disease.	[Perlado, Sara; Bustamante-Aragones, Ana; Donas, Marta; Lorda-Sanchez, Isabel; Rodriguez de Alba, Marta] IIS Fdn Jimenez Diaz UAM, CIBERER, Dept Genet, Madrid, Spain; [Plaza, Javier] Fdn Jimenez Diaz IIS, Dept Obstet & Gynecol, Madrid, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Fundacion Jimenez Diaz; Fundacion Jimenez Diaz	Bustamante-Aragones, A (corresponding author), IIS Fdn Jimenez Diaz UAM, CIBERER, Dept Genet, Madrid, Spain.	abustamante@fjd.es			Fundacion Mutua Madrilena [12114/01]; Instituto de Salud Carlos III [PI11/01014, EC11/260, II14/00015]; Fundacion Conchita Rabago de Jimenez Diaz; Fundacion Conchita Rabago	Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fundacion Conchita Rabago de Jimenez Diaz; Fundacion Conchita Rabago	This work has been supported by Fundacion Mutua Madrilena (12114/01) and Instituto de Salud Carlos III (PI11/01014; EC11/260; II14/00015). Sara Perlado has been supported by Fundacion Conchita Rabago de Jimenez Diaz.; This work has been supported by Fundacion Mutua Madrilena (12114/01) and Instituto de Salud Carlos III (PI11/01014; EC11/260; II14/00015). Sara Perlado has been supported by Fundacion Conchita Rabago. Thanks to Oliver Shaw for his collaboration with the language.	Akolekar R, 2015, ULTRASOUND OBST GYN, V45, P16, DOI 10.1002/uog.14636; Amicucci P, 2000, CLIN CHEM, V46, P301; [Anonymous], 1996, WHO SCI M; Barrett AN, 2012, CLIN CHEM, V58, P1026, DOI 10.1373/clinchem.2011.178939; Bianchi DW, 2012, OBSTET GYNECOL, V119, P890, DOI 10.1097/AOG.0b013e31824fb482; Bustamante-Aragones A, 2008, EUR J NEUROL, V15, P1338, DOI 10.1111/j.1468-1331.2008.02312.x; Bustamante-Aragones A, 2008, HAEMOPHILIA, V14, P593, DOI 10.1111/j.1365-2516.2008.01670.x; Bustamante-Aragones A, 2008, MOL GENET METAB, V95, P101, DOI 10.1016/j.ymgme.2008.05.006; Bustamante-Aragones A, 2012, GENE, V504, P144, DOI 10.1016/j.gene.2012.04.045; Bustamante-Aragones A, 2008, J CYST FIBROS, V7, P505, DOI 10.1016/j.jcf.2008.05.006; Chan KCA, 2006, CLIN CHEM, V52, P2211, DOI 10.1373/clinchem.2006.074997; Chan K, 2010, EUR J OBSTET GYN R B, V150, P28, DOI 10.1016/j.ejogrb.2010.02.016; Chitty LS, 2011, ULTRASOUND OBST GYN, V37, P283, DOI 10.1002/uog.8893; Chitty LS, 2015, PRENATAL DIAG, V35, P656, DOI 10.1002/pd.4583; Chiu RWK, 2007, AM J PATHOL, V170, P941, DOI 10.2353/ajpath.2007.060641; Chiu RWK, 2002, LANCET, V360, P998, DOI 10.1016/S0140-6736(02)11086-5; Gonzalez-Gonzalez MC, 2008, J ASSIST REPROD GEN, V25, P477, DOI 10.1007/s10815-008-9256-8; Debrand E, 2015, NONINVASIVE DROPLET, V10, DOI [10.1371/journal.pone.0142729, DOI 10.1371/JOURNAL.PONE.0142729]; Debrand E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142729; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Finning K, 2008, BRIT MED J, V336, P816, DOI 10.1136/bmj.39518.463206.25; Finning KM, 2008, SEMIN FETAL NEONAT M, V13, P69, DOI 10.1016/j.siny.2007.12.007; Gonzalez-Gonzalez MC, 2002, PRENATAL DIAG, V22, P946, DOI 10.1002/pd.439; Hill M, 2015, PRENATAL DIAG, V35, P950, DOI 10.1002/pd.4585; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Lim JH, 2011, J ASSIST REPROD GEN, V28, P167, DOI 10.1007/s10815-010-9489-1; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lun FMF, 2008, P NATL ACAD SCI USA, V105, P19920, DOI 10.1073/pnas.0810373105; Manokhina I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101500; Meaney C, 2009, PRENATAL DIAG, V29, P1218, DOI 10.1002/pd.2385; Nasis O, 2004, CLIN CHEM, V50, P694, DOI 10.1373/clinchem.2003.025981; Palomaki GE, 2012, GENET MED, V14, P296, DOI 10.1038/gim.2011.73; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; de Alba MR, 2012, EXPERT OPIN BIOL TH, V12, pS171, DOI 10.1517/14712598.2012.674509; Saito H, 2000, LANCET, V356, P1170, DOI 10.1016/S0140-6736(00)02767-7; Scheffer PG, 2010, OBSTET GYNECOL, V115, P117, DOI 10.1097/AOG.0b013e3181c3c938; Tsui NBY, 2011, BLOOD, V117, P3684, DOI 10.1182/blood-2010-10-310789; van den Oever JME, 2015, PRENATAL DIAG, V35, P945, DOI 10.1002/pd.4593; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Wulff CB, 2016, ULTRASOUND OBST GYN, V47, P38, DOI 10.1002/uog.15820	40	32	34	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153258	10.1371/journal.pone.0153258	http://dx.doi.org/10.1371/journal.pone.0153258			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078875	gold, Green Published			2022-12-26	WOS:000374131700032
J	Choi, SH; Kim, SH; Shim, KW; Han, JW; Choi, J; Kim, DS; Lyu, CJ; Kim, JW; Suh, CO; Cho, J				Choi, Seo Hee; Kim, Se Hoon; Shim, Kyu-Won; Han, Jung Woo; Choi, Junjeong; Kim, Dong-Seok; Lyu, Chuhl Joo; Kim, Jun Won; Suh, Chang-Ok; Cho, Jaeho			Treatment Outcome and Prognostic Molecular Markers of Supratentorial Primitive Neuroectodermal Tumors	PLOS ONE			English	Article							CELL LUNG-CANCER; YOUNG-CHILDREN; BRAIN-TUMORS; INTENSIVE CHEMOTHERAPY; BREAST-CANCER; RAD51; EXPRESSION; SURVIVAL; RADIOTHERAPY; RADIATION	Background To identify prognostic factors and define the optimal management of patients with supratentorial primitive neuroectodermal tumors (sPNETs), we investigated treatment outcomes and explored the prognostic value of specific molecular markers. Methods A total of 47 consecutive patients with pathologically confirmed sPNETs between May 1985 and June 2012 were included. Immunohistochemical analysis of LIN28, OLIG2, and Rad51 expression was performed and correlated with clinical outcome. Results With a median follow-up of 70 months, 5-year overall survival (OS) and progression-free survival (PFS) was 55.5% and 40%, respectively, for all patients. Age, surgical extent, and radiotherapy were significant prognostic factors for OS and PFS. Patients who received initially planned multimodal treatment without interruption (i.e., radiotherapy and surgery (>= subtotal resection), with or without chemotherapy) showed significantly higher 5-year OS (71.2%) and PFS (63.1%). In 29 patients with available tumor specimens, tumors with high expression of either LIN28 or OLIG2 or elevated level of Rad51 were significantly associated with poorer prognosis. Conclusions We found that multimodal treatment improved outcomes for sPNET patients, especially when radiotherapy and >= subtotal resection were part of the treatment regimen.	[Choi, Seo Hee; Suh, Chang-Ok; Cho, Jaeho] Yonsei Univ, Coll Med, Dept Radiat Oncol, Seoul, South Korea; [Kim, Se Hoon] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Shim, Kyu-Won; Kim, Dong-Seok] Yonsei Univ, Coll Med, Dept Neurosurg, Seoul, South Korea; [Han, Jung Woo; Lyu, Chuhl Joo] Yonsei Univ, Coll Med, Dept Pediat, Seoul, South Korea; [Choi, Junjeong] Yonsei Univ, Coll Med, Coll Pharm, Dept Pharm, Seoul, South Korea; [Kim, Jun Won] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Radiat Oncol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Cho, J (corresponding author), Yonsei Univ, Coll Med, Dept Radiat Oncol, Seoul, South Korea.	jjhmd@yuhs.ac	Choi, Seo-hee/AFL-9783-2022; Choi, Seo-hee/AAH-1969-2022	Kim, Se Hoon/0000-0001-7516-7372; Kim, Jun Won/0000-0003-1358-364X; Han, Jung Woo/0000-0001-8936-1205; Shim, Kyuwon/0000-0002-9441-7354; Cho, Jaeho/0000-0001-9966-5157; Lyu, Chuhl Joo/0000-0001-7124-7818; Choi, Seo Hee/0000-0002-4083-6414				Burnett ME, 1997, CANCER GENET CYTOGEN, V97, P25, DOI 10.1016/S0165-4608(96)00319-6; COHEN BH, 1995, J CLIN ONCOL, V13, P1687, DOI 10.1200/JCO.1995.13.7.1687; Dirks PB, 1996, J NEURO-ONCOL, V29, P75, DOI 10.1007/BF00165520; Fangusaro J, 2008, PEDIATR BLOOD CANCER, V50, P312, DOI [10.1002/pbc.21307, 10.1002/pbc.21555]; Gandhi R, 2013, J NEURO-ONCOL, V114, P141, DOI 10.1007/s11060-013-1163-x; Hansen LT, 2003, INT J CANCER, V105, P472, DOI 10.1002/ijc.11106; Jakacki RI, 1999, CHILD NERV SYST, V15, P586, DOI 10.1007/s003810050547; Johnston DL, 2008, J NEURO-ONCOL, V86, P101, DOI 10.1007/s11060-007-9440-1; Kim DG, 2002, J NEURO-ONCOL, V60, P43, DOI 10.1023/A:1020207902659; Korshunov A, 2010, ACTA NEUROPATHOL, V120, P253, DOI 10.1007/s00401-010-0688-8; Le Scodan R, 2010, INT J RADIAT ONCOL, V78, P328, DOI 10.1016/j.ijrobp.2009.07.1735; Li MH, 2009, CANCER CELL, V16, P533, DOI 10.1016/j.ccr.2009.10.025; Li Y, 2011, J SURG ONCOL, V104, P617, DOI 10.1002/jso.22018; Mason WP, 1998, J CLIN ONCOL, V16, P210, DOI 10.1200/JCO.1998.16.1.210; McBride SM, 2008, INT J RADIAT ONCOL, V72, P1319, DOI 10.1016/j.ijrobp.2008.03.033; Ohnishi T, 1998, BIOCHEM BIOPH RES CO, V245, P319, DOI 10.1006/bbrc.1998.8440; Paulino AC, 2004, INT J RADIAT ONCOL, V58, P1171, DOI 10.1016/j.ijrobp.2003.08.022; Picard D, 2012, LANCET ONCOL, V13, P838, DOI 10.1016/S1470-2045(12)70257-7; Pizer BL, 2006, EUR J CANCER, V42, P1120, DOI 10.1016/j.ejca.2006.01.039; Qiao GB, 2005, BRIT J CANCER, V93, P137, DOI 10.1038/sj.bjc.6602665; Reddy AT, 2000, CANCER, V88, P2189, DOI 10.1002/(SICI)1097-0142(20000501)88:9<2189::AID-CNCR27>3.0.CO;2-G; Richardson C, 2005, CANCER LETT, V218, P127, DOI 10.1016/j.canlet.2004.08.009; Russo C, 1999, CANCER, V86, P331, DOI 10.1002/(SICI)1097-0142(19990715)86:2<331::AID-CNCR18>3.0.CO;2-#; Soderlund K, 2007, RADIOTHER ONCOL, V84, P242, DOI 10.1016/j.radonc.2007.06.012; Tennstedt P, 2013, INT J CANCER, V132, P2118, DOI 10.1002/ijc.27907; Timmermann B, 2006, J CLIN ONCOL, V24, P1554, DOI 10.1200/JCO.2005.04.8074; Timmermann B, 2002, J CLIN ONCOL, V20, P842, DOI 10.1200/JCO.20.3.842; Vispe S, 1998, NUCLEIC ACIDS RES, V26, P2859, DOI 10.1093/nar/26.12.2859; von Bueren AO, 2012, LANCET ONCOL, V13, P753, DOI 10.1016/S1470-2045(12)70260-7; Welsh JW, 2009, INT J RADIAT ONCOL, V74, P1251, DOI 10.1016/j.ijrobp.2009.03.018	30	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153443	10.1371/journal.pone.0153443	http://dx.doi.org/10.1371/journal.pone.0153443			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074032	Green Submitted, Green Published, gold			2022-12-26	WOS:000374131200094
J	Kalinowski, M; Gradzki, Z; Jarosz, L; Kato, K; Hieda, Y; Kakuda, T; Takai, S				Kalinowski, Marcin; Gradzki, Zbigniew; Jarosz, Lukasz; Kato, Kiyoko; Hieda, Yu; Kakuda, Tsutomu; Takai, Shinji			Plasmid Profiles of Virulent Rhodococcus equi Strains Isolated from Infected Foals in Poland	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISMS; HORSE-BREEDING FARMS; 87-KB TYPE-I; CLINICAL-MANIFESTATIONS; MOLECULAR EPIDEMIOLOGY; SOIL; PREVALENCE; PATHOGENESIS; ENVIRONMENT; DIAGNOSIS	Rhodococcus equi is an important bacterial pathogen in foals up to 6 months old, widespread in horse farms all over the world. It was found that only virulent R. equi strains expressing 15-17 kDa virulence-associated protein (VapA) and having large virulence plasmid of 85-90 kb containing vapA gene are pathogenic for horses. To date, 12 plasmid types have been reported in VapA positive strains from horses. There are no data concerning plasmid types of Polish field R. equi strains isolated from horses and horse farm environment. The aim of the study is to determine plasmid profiles of virulent R. equi strains isolated in Poland from dead foals as well as from soil samples taken from horse breeding farms. Plasmid profiles of 10 clinical strains derived from 8 farms and 11 environmental strains from 3 farms, confirmed as virulent by PCR, were compared with 12 reference strains containing the known plasmid size and type. Plasmid DNAs were analysed by digestion with the restriction endonucleases BamHI, EcoRI, EcoT22I, and HindIII for detailed comparison and estimation of plasmid sizes. The results of RFLP analysis revealed that all except one isolates used in the study are classified as VapA 85 kb type I plasmid. One strain harboured VapA 87 kb type I plasmid. This is the first report of plasmid types of Polish field R. equi strains. The results of our preliminary investigations on horse farms located in central and eastern Poland indicate that the virulent R. equi strains thus far isolated from diseased foals and horse farms environment represent a highly uniform plasmid pattern.	[Kalinowski, Marcin; Gradzki, Zbigniew; Jarosz, Lukasz] Univ Life Sci Lublin, Dept Epizootiol, Fac Vet Med, Lublin, Poland; [Kalinowski, Marcin; Gradzki, Zbigniew; Jarosz, Lukasz] Univ Life Sci Lublin, Clin Infect Dis, Fac Vet Med, Lublin, Poland; [Kato, Kiyoko; Hieda, Yu; Kakuda, Tsutomu; Takai, Shinji] Kitasato Univ, Sch Vet Med & Anim Sci, Towada, Aomori 034, Japan	University of Life Sciences in Lublin; University of Life Sciences in Lublin; Kitasato University	Kalinowski, M (corresponding author), Univ Life Sci Lublin, Dept Epizootiol, Fac Vet Med, Lublin, Poland.; Kalinowski, M (corresponding author), Univ Life Sci Lublin, Clin Infect Dis, Fac Vet Med, Lublin, Poland.	marcin.kalinowski@up.lublin.pl	Grądzki, Zbigniew/R-6589-2018; Kalinowski, Marcin/AAQ-3950-2020	Grądzki, Zbigniew/0000-0002-5390-3225; Kakuda, Tsutomu/0000-0002-0951-2884; Jarosz, Lukasz/0000-0002-4914-1758; Kalinowski, Marcin/0000-0003-4769-5471				Bell KS, 1996, LETT APPL MICROBIOL, V23, P72, DOI 10.1111/j.1472-765X.1996.tb00033.x; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Cohen ND, 2014, VET CLIN N AM-EQUINE, V30, P609, DOI 10.1016/j.cveq.2014.08.010; Duquesne F, 2010, FEMS MICROBIOL LETT, V311, P76, DOI 10.1111/j.1574-6968.2010.02070.x; Giguere S, 1997, VET MICROBIOL, V56, P313, DOI 10.1016/S0378-1135(97)00099-0; Giguere S, 2011, J VET INTERN MED, V25, P1221, DOI 10.1111/j.1939-1676.2011.00804.x; Gradzki Z, 2006, MED WETER, V62, P1310; Hondalus MK, 1997, VET MICROBIOL, V56, P257, DOI 10.1016/S0378-1135(97)00094-1; Makrai L, 2002, VET MICROBIOL, V88, P377, DOI 10.1016/S0378-1135(02)00157-8; Makrai L, 2008, VET MICROBIOL, V131, P318, DOI 10.1016/j.vetmic.2008.04.009; Meijer WG, 2004, VET RES, V35, P383, DOI 10.1051/vetres:2004024; Muscatello G, 2007, EQUINE VET J, V39, P470, DOI 10.2746/042516407X209217; Muscatello G, 2012, VET J, V192, P20, DOI 10.1016/j.tvjl.2011.08.014; Nicholson VM, 1997, J CLIN MICROBIOL, V35, P738, DOI 10.1128/JCM.35.3.738-740.1997; Reuss SM, 2015, VET CLIN N AM-EQUINE, V31, P121, DOI 10.1016/j.cveq.2014.11.004; Ribeiro MG, 2005, COMP IMMUNOL MICROB, V28, P53, DOI 10.1016/j.cimid.2004.07.001; Sellon DC, 1997, AM J VET RES, V58, P1232; Son WG, 2006, J VET MED SCI, V68, P249, DOI 10.1292/jvms.68.249; Takai S, 1999, J CLIN MICROBIOL, V37, P3417, DOI 10.1128/JCM.37.10.3417-3420.1999; TAKAI S, 1991, J CLIN MICROBIOL, V29, P2887, DOI 10.1128/JCM.29.12.2887-2889.1991; TAKAI S, 1993, J CLIN MICROBIOL, V31, P1726, DOI 10.1128/JCM.31.7.1726-1729.1993; TAKAI S, 1991, INFECT IMMUN, V59, P4056, DOI 10.1128/IAI.59.11.4056-4060.1991; Takai S, 1997, VET MICROBIOL, V56, P167, DOI 10.1016/S0378-1135(97)00085-0; Takai S, 2005, J VET MED SCI, V67, P611, DOI 10.1292/jvms.67.611; Takai S, 2003, J INFECT DIS, V188, P1717, DOI 10.1086/379739; Takai S, 2003, J VET MED SCI, V65, P1313, DOI 10.1292/jvms.65.1313; Takai S, 2001, J VET DIAGN INVEST, V13, P489, DOI 10.1177/104063870101300606; Topino S, 2010, AIDS PATIENT CARE ST, V24, P211, DOI 10.1089/apc.2009.0248; Vazquez-Boland JA, 2013, VET MICROBIOL, V167, P9, DOI 10.1016/j.vetmic.2013.06.016; Venner M, 2007, RES VET SCI, V83, P311, DOI 10.1016/j.rvsc.2007.01.009; WOOLCOCK JB, 1979, J CLIN MICROBIOL, V9, P640; Zietek-Barszcz A, 2009, B VET I PULAWY, V53, P345	32	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152887	10.1371/journal.pone.0152887	http://dx.doi.org/10.1371/journal.pone.0152887			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074033	Green Published, Green Submitted, gold			2022-12-26	WOS:000374131200042
J	Kurita, T; Kikuchi, M; Yoshimura, Y; Hiraishi, H; Hasegawa, C; Takahashi, T; Hirosawa, T; Furutani, N; Higashida, H; Ikeda, T; Mutou, K; Asada, M; Minabe, Y				Kurita, Toshiharu; Kikuchi, Mitsuru; Yoshimura, Yuko; Hiraishi, Hirotoshi; Hasegawa, Chiaki; Takahashi, Tetsuya; Hirosawa, Tetsu; Furutani, Naoki; Higashida, Haruhiro; Ikeda, Takashi; Mutou, Kouhei; Asada, Minoru; Minabe, Yoshio			Atypical Bilateral Brain Synchronization in the Early Stage of Human Voice Auditory Processing in Young Children with Autism	PLOS ONE			English	Article							2-TO 5-YEAR-OLD CHILDREN; CORPUS-CALLOSUM; SPECTRUM DISORDERS; FUNCTIONAL CONNECTIVITY; STEM RESPONSES; WHITE-MATTER; DEVELOPMENTAL-CHANGES; LANGUAGE PERFORMANCE; EVOKED-RESPONSES; SPEECH SOUNDS	Autism spectrum disorder (ASD) has been postulated to involve impaired neuronal cooperation in large-scale neural networks, including cortico-cortical interhemispheric circuitry. In the context of ASD, alterations in both peripheral and central auditory processes have also attracted a great deal of interest because these changes appear to represent pathophysiological processes; therefore, many prior studies have focused on atypical auditory responses in ASD. The auditory evoked field (AEF), recorded by magnetoencephalography, and the synchronization of these processes between right and left hemispheres was recently suggested to reflect various cognitive abilities in children. However, to date, no previous study has focused on AEF synchronization in ASD subjects. To assess global coordination across spatially distributed brain regions, the analysis of Omega complexity from multichannel neurophysiological data was proposed. Using Omega complexity analysis, we investigated the global coordination of AEFs in 3-8-year-old typically developing (TD) children (n = 50) and children with ASD (n = 50) in 50-ms time-windows. Children with ASD displayed significantly higher Omega complexities compared with TD children in the time-window of 0-50 ms, suggesting lower whole brain synchronization in the early stage of the P1m component. When we analyzed the left and right hemispheres separately, no significant differences in any time-windows were observed. These results suggest lower right-left hemispheric synchronization in children with ASD compared with TD children. Our study provides new evidence of aberrant neural synchronization in young children with ASD by investigating auditory evoked neural responses to the human voice.	[Kurita, Toshiharu; Kikuchi, Mitsuru; Hirosawa, Tetsu; Furutani, Naoki; Higashida, Haruhiro; Mutou, Kouhei; Minabe, Yoshio] Kanazawa Univ, Dept Psychiat & Neurobiol, Grad Sch Med Sci, Kanazawa, Ishikawa 9208640, Japan; [Kikuchi, Mitsuru; Yoshimura, Yuko; Hiraishi, Hirotoshi; Hasegawa, Chiaki; Takahashi, Tetsuya] Kanazawa Univ, Res Ctr Child Mental Dev, Kanazawa, Ishikawa 9208640, Japan; [Ikeda, Takashi; Asada, Minoru] Osaka Univ, Dept Adapt Machine Syst, Grad Sch Engn, Suita, Osaka 5650871, Japan	Kanazawa University; Kanazawa University; Osaka University	Kikuchi, M (corresponding author), Kanazawa Univ, Dept Psychiat & Neurobiol, Grad Sch Med Sci, Kanazawa, Ishikawa 9208640, Japan.; Kikuchi, M (corresponding author), Kanazawa Univ, Res Ctr Child Mental Dev, Kanazawa, Ishikawa 9208640, Japan.	mitsuruk@med.kanazawa-u.ac.jp	Hasegawa, Chiaki/HHS-2658-2022; higashida, haruhiro/L-3773-2015	Hasegawa, Chiaki/0000-0001-8730-8769; Furutani, Naoki/0000-0001-5953-2114; higashida, haruhiro/0000-0002-1779-0606	MEXT [24000012]; Center of Innovation Program from Japan Science and Technology Agency, JST, Japan; Grants-in-Aid for Scientific Research [25461755, 26670537] Funding Source: KAKEN	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Center of Innovation Program from Japan Science and Technology Agency, JST, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	MA is supported by a Grant-in-Aid for Specially Promoted Research from MEXT (Research Number 24000012, http://www.jsps.go.jp/english/e-grants/). YM is supported by the Center of Innovation Program from the Japan Science and Technology Agency, JST, Japan (http://www.mext.go.jp/a_menu/kagaku/coi/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2007, NEUROIMAGE, V34, P61, DOI 10.1016/j.neuroimage.2006.08.032; American Psychiatric Association, 1994, DIAGNOSTIC AND STATI; Anderson JS, 2011, CEREB CORTEX, V21, P1134, DOI 10.1093/cercor/bhq190; Anderson V., 2007, JPN KOREAN LINGUIST, V15, P43; Bailey T, 2012, APPL NEUROPSYCH-CHIL, V1, P112, DOI 10.1080/21622965.2012.703890; Brito AR, 2009, J NEUROIMAGING, V19, P337, DOI 10.1111/j.1552-6569.2009.00366.x; Brock J, 2013, J AUTISM DEV DISORD, V43, P2726, DOI 10.1007/s10803-013-1805-z; Cacace AT, 1998, J SPEECH LANG HEAR R, V41, P355, DOI 10.1044/jslhr.4102.355; Cardy JEO, 2005, NEUROREPORT, V16, P521, DOI 10.1097/00001756-200504040-00021; Cardy JEO, 2005, NEUROREPORT, V16, P329, DOI 10.1097/00001756-200503150-00005; Cardy JEO, 2004, NEUROREPORT, V15, P1867, DOI 10.1097/00001756-200408260-00006; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; Cook HM, 1990, THE SENTENCE FINAL P; Demopoulos C, 2016, AUTISM RES, V9, P107, DOI 10.1002/aur.1495; Dinstein I, 2011, NEURON, V70, P1218, DOI 10.1016/j.neuron.2011.04.018; Edgar JC, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00417; Flagg EJ, 2005, NEUROSCI LETT, V386, P82, DOI 10.1016/j.neulet.2005.05.037; Gage NM, 2003, NEUROREPORT, V14, P2047, DOI 10.1097/00001756-200311140-00008; Gage NM, 2003, DEV BRAIN RES, V144, P201, DOI 10.1016/S0165-3806(03)00172-X; Ghanbari Y, 2012, LECT NOTES COMPUT SC, V7512, P231, DOI 10.1007/978-3-642-33454-2_29; Gilley PM, 2005, CLIN NEUROPHYSIOL, V116, P648, DOI 10.1016/j.clinph.2004.09.009; Hardan AY, 2000, NEUROLOGY, V55, P1033, DOI 10.1212/WNL.55.7.1033; Hiraishi H, 2015, PSYCHIAT CLIN NEUROS, V69, P153, DOI 10.1111/pcn.12261; Hitoglou M, 2010, PEDIATR NEUROL, V42, P309, DOI 10.1016/j.pediatrneurol.2009.10.009; Johnson BW, 2010, CLIN NEUROPHYSIOL, V121, P340, DOI 10.1016/j.clinph.2009.10.017; Kajikawa S, 2004, J CHILD LANG, V31, P215, DOI 10.1017/S0305000903005968; Kaufman A. S, 2004, KAUFMAN BRIEF INTELL; Keary CJ, 2009, J AUTISM DEV DISORD, V39, P834, DOI 10.1007/s10803-009-0689-4; Keller TA, 2007, NEUROREPORT, V18, P23, DOI 10.1097/01.wnr.0000239965.21685.99; Kennedy DP, 2008, NEUROIMAGE, V39, P1877, DOI 10.1016/j.neuroimage.2007.10.052; Khalfa S, 2001, EUR J NEUROSCI, V13, P628, DOI 10.1046/j.1460-9568.2001.01423.x; Kikuchi M, 2015, SOC COGN AFFECT NEUR, V10, P248, DOI 10.1093/scan/nsu049; Kikuchi M, 2013, NEUROIMAGE-CLIN, V2, P394, DOI 10.1016/j.nicl.2013.03.003; Kikuchi M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01139; Kikuchi M, 2011, J NEUROSCI, V31, P14984, DOI 10.1523/JNEUROSCI.2785-11.2011; KLIN A, 1993, J AUTISM DEV DISORD, V23, P15, DOI 10.1007/BF01066416; Lord C., 1999, DIAGNOSTIC OBSERVATI; Manes F, 1999, J NEUROPSYCH CLIN N, V11, P470, DOI 10.1176/jnp.11.4.470; Matsuzaki J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102599; Matsuzaki J, 2012, NEUROREPORT, V23, P113, DOI 10.1097/WNR.0b013e32834ebf44; Monk CS, 2009, NEUROIMAGE, V47, P764, DOI 10.1016/j.neuroimage.2009.04.069; Orekhova EV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039906; Patterson RD, 2008, PHILOS T R SOC B, V363, P1023, DOI 10.1098/rstb.2007.2157; Ponton C, 2002, CLIN NEUROPHYSIOL, V113, P407, DOI 10.1016/S1388-2457(01)00733-7; Remijn GB, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00170; Roberts T. P, 2011, BIOL PSYCHIAT; Roberts TPL, 2013, BRAIN RES, V1537, P79, DOI 10.1016/j.brainres.2013.09.011; Roberts TPL, 2010, AUTISM RES, V3, P8, DOI 10.1002/aur.111; Rosenhall U, 2003, EAR HEARING, V24, P206, DOI 10.1097/01.AUD.0000069326.11466.7E; Roth DAE, 2012, DEV MED CHILD NEUROL, V54, P23, DOI 10.1111/j.1469-8749.2011.04149.x; Schadow J, 2009, NEUROIMAGE, V47, P651, DOI 10.1016/j.neuroimage.2009.04.074; Scheich H, 2011, HEARING RES, V271, P3, DOI 10.1016/j.heares.2010.10.006; Schmidt GL, 2009, NEUROREPORT, V20, P1037, DOI 10.1097/WNR.0b013e32832e0ca7; Seither-Preisler A, 2014, J NEUROSCI, V34, P10937, DOI 10.1523/JNEUROSCI.5315-13.2014; Sharma A, 1997, EVOKED POTENTIAL, V104, P540, DOI 10.1016/S0168-5597(97)00050-6; SKOFF BF, 1980, PSYCHIAT RES, V2, P157, DOI 10.1016/0165-1781(80)90072-4; Squires T., 2009, PRAGMATICS, V4, P1; Stanfield AC, 2008, EUR PSYCHIAT, V23, P289, DOI 10.1016/j.eurpsy.2007.05.006; TANGUAY PE, 1982, ARCH GEN PSYCHIAT, V39, P174; Vidal CN, 2006, BIOL PSYCHIAT, V60, P218, DOI 10.1016/j.biopsych.2005.11.011; Wackermann J, 1996, ACTA NEUROBIOL EXP, V56, P197; Wackermann J, 1999, INT J PSYCHOPHYSIOL, V34, P65, DOI 10.1016/S0167-8760(99)00038-0; Wilson TW, 2007, BIOL PSYCHIAT, V62, P192, DOI 10.1016/j.biopsych.2006.07.002; Wing L, 2002, J CHILD PSYCHOL PSYC, V43, P307, DOI 10.1111/1469-7610.00023; Wolff JJ, 2012, AM J PSYCHIAT, V169, P589, DOI 10.1176/appi.ajp.2011.11091447; Yoshimura Y, 2014, NEUROIMAGE, V101, P440, DOI 10.1016/j.neuroimage.2014.07.034; Yoshimura Y, 2012, EUR J NEUROSCI, V35, P644, DOI 10.1111/j.1460-9568.2012.07998.x	67	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153077	10.1371/journal.pone.0153077	http://dx.doi.org/10.1371/journal.pone.0153077			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UC	27074011	Green Published, Green Submitted, gold			2022-12-26	WOS:000374131200051
J	Shrubovych, J; Bartel, D; Szucsich, NU; Resch, MC; Pass, G				Shrubovych, Julia; Bartel, Daniela; Szucsich, Nikolaus Urban; Resch, Monika Carol; Pass, Guenther			Morphological and Genetic Analysis of the Acerentomon doderoi Group (Protura: Acerentomidae) with Description of A. christiani sp nov	PLOS ONE			English	Article								Acerentomon christiani sp. nov. is described from Vienna, Austria. The new species is a member of the "doderoi" group, characterized by the presence of seta x on tergite VII. It is most similar to A. gallicum, A. brevisetosum and A. tenuisetosum, but differs from these species in the length of foretarsal sensillum c and certain other chaetotaxic measurements and indices. In addition to the morphological description, the DNA barcoding region of the mitochondrial cytochrome c oxidase subunit 1 gene (COI) and the 28S ribosomal RNA of the new species are provided. The morphological characters and the barcode of the new species are discussed in comparison to those of other Acerentomon species. An identification key to all known Acerentomon spp. of the "doderoi" group is given.	[Shrubovych, Julia] Polish Acad Sci, Inst Systemat & Evolut Anim, Krakow, Poland; [Bartel, Daniela; Szucsich, Nikolaus Urban; Resch, Monika Carol; Pass, Guenther] Univ Vienna, Dept Integrat Zool, Vienna, Austria; [Szucsich, Nikolaus Urban] Museum Nat Hist Vienna, Dept Zool 3, Vienna, Austria	Polish Academy of Sciences; Institute of Systematics & Evolution of Animals of the Polish Academy of Sciences; University of Vienna	Pass, G (corresponding author), Univ Vienna, Dept Integrat Zool, Vienna, Austria.	guenther.pass@univie.ac.at	Szucsich, Nikolaus/O-1776-2017; Shrubovych, Julia/F-9767-2014	Szucsich, Nikolaus/0000-0002-8945-5153; Shrubovych, Julia/0000-0002-8880-0007	ABOL, the Austrian Barcode of Life; FWF [P 20497-B17, P 23251-B17]; Austrian Science Fund (FWF) [P 23251] Funding Source: researchfish	ABOL, the Austrian Barcode of Life; FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	NUS is financed by ABOL, the Austrian Barcode of Life. DB and GP are supported by grant number P 23251-B17 of the FWF, and MCR by grant number P 20497-B17 of the FWF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boehm Alexander, 2011, Soil Organisms, V83, P335; Christian Erhard, 2011, P1; Francois Jean, 2006, Bulletin de la Societe Entomologique de France, V111, P5; Galli L, 2015, ITAL J ZOOL, P1; Nosek J, 1973, EUROPEAN PROTURA THE; Nosek J, 1965, ANNOTATIONES ZOOL BO, V14, P1; Pass Guenther, 2011, Soil Organisms, V83, P309; Resch MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090653; RUSEK JOSEF, 1965, VESTNIK CESK SPOLECNOSTI ZOOL, V29, P223; Rusek J, 2012, ZOOTAXA, P54, DOI 10.11646/zootaxa.3262.1.5; Shrubovych J, 2014, ZOOTAXA, V 3755, P136, DOI 10.11646/zootaxa.3755.2.2; Shrubovych Julia, 2009, Acta Zoologica Cracoviensia Ser. B - Invertebrata, V52B, P9, DOI 10.3409/azc.52b_1-2.09-15; SZEPTYCKI A, 1980, Polskie Pismo Entomologiczne, V50, P311; SZEPTYCKI A, 1988, Acta Zoologica Cracoviensia, V31, P297; Szeptycki A., 2008, Zoologiya Bespozvonochnykh, V5, P65; Szeptycki Andrzej, 2007, Acta Zoologica Cracoviensia Ser B-Invertebrata, V50B; Szeptycki Andrzej, 1993, Acta Zoologica Cracoviensia, V36, P29; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tuxen SL, 1964, PROTURA REVISION SPE	19	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0148033	10.1371/journal.pone.0148033	http://dx.doi.org/10.1371/journal.pone.0148033			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073924	Green Published, gold			2022-12-26	WOS:000374131200002
J	Vianna, CA; Horta, BL; Gigante, DP; De Barros, FCLF				Vianna, Carolina Avila; Horta, Bernardo Lessa; Gigante, Denise Petrucci; Lopes Fernandes de Barros, Fernando Celso			Pulse Wave Velocity at Early Adulthood: Breastfeeding and Nutrition during Pregnancy and Childhood	PLOS ONE			English	Article							BODY-MASS INDEX; ARTERIAL STIFFNESS; BLOOD-PRESSURE; BIRTH COHORT; YOUNG-ADULTS; WEIGHT-GAIN; FETAL ORIGINS; HEART-DISEASE; LATER LIFE; INFANCY	Background Pulse wave velocity (PWV) is an early marker of arterial stiffness. Low birthweight, infant feeding and childhood nutrition have been associated with cardiovascular disease in adulthood. In this study, we evaluated the association of PWV at 30 years of age with birth condition and childhood nutrition, among participants of the 1982 Pelotas birth cohort. Methods In 1982, the hospital births in Pelotas, southern Brazil, were identified just after delivery. Those liveborn infants whose family lived in the urban area of the city were examined and have been prospectively followed. At 30 years of age, we tried to follow the whole cohort and PWV was assessed in 1576 participants. Results Relative weight gain from 2 to 4 years was positively associated with PWV. Regarding nutritional status in childhood, PWV was higher among those whose weight-for-age z-score at 4 years was >1 standard deviation above the mean. On the other hand, height gain, birthweight and duration of breastfeeding were not associated with PWV. Conclusion Relative weight gain after 2 years of age is associated with increased PWV, while birthweight and growth in the first two years of life were not associated. These results suggest that the relative increase of weight later in childhood is associated with higher cardiovascular risk.	[Vianna, Carolina Avila; Horta, Bernardo Lessa; Gigante, Denise Petrucci; Lopes Fernandes de Barros, Fernando Celso] Univ Fed Pelotas, Dept Social Med, Pelotas, RS, Brazil; [Lopes Fernandes de Barros, Fernando Celso] Univ Catolica Pelotas, Postgrad Program Hlth & Behav, Pelotas, RS, Brazil	Universidade Federal de Pelotas; Universidade Catolica de Pelotas; Universidade Federal de Pelotas	Vianna, CA (corresponding author), Univ Fed Pelotas, Dept Social Med, Pelotas, RS, Brazil.	caruvianna@hotmail.com	Vianna, Carolina Avila/V-5088-2019; Horta, Bernardo/A-7604-2008	Vianna, Carolina Avila/0000-0002-1501-0784; Horta, Bernardo/0000-0001-9843-412X; Barros, Fernando/0000-0001-5973-1746				Adair LS, 2009, AM J CLIN NUTR, V89, P1383, DOI 10.3945/ajcn.2008.27139; Alwan A, 2011, GLOBAL STATUS REPORT ON NONCOMMUNICABLE DISEASES 2010, P1; BARKER DJP, 1989, LANCET, V2, P577; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Barros FC, 2008, REV SAUDE PUBL, V42, P7, DOI 10.1590/S0034-89102008000900003; Boutouyrie P, 2002, HYPERTENSION, V39, P10, DOI 10.1161/hy0102.099031; BRAUNWALD E, 2005, BRAUNWALDS HEART DIS; Brion MJA, 2011, INT J EPIDEMIOL, V40, P670, DOI 10.1093/ije/dyr020; de Jonge LL, 2013, J NUTR, V143, P1959, DOI 10.3945/jn.113.174326; De Onis M, 2006, WHO CHILD GROWTH STA; FARRAR DJ, 1991, CIRCULATION, V83, P1754, DOI 10.1161/01.CIR.83.5.1754; Horta BL, 2015, ACTA PAEDIATR, V104, P30, DOI 10.1111/apa.13133; Horta BL, 2015, INT J EPIDEMIOL, V44, P441, DOI 10.1093/ije/dyv017; Jarvisalo MJ, 2009, EUR J CLIN NUTR, V63, P640, DOI 10.1038/ejcn.2008.17; Kelishadi R, 2014, PAEDIATRICS AND INTE, V18; Kramer MS, 2001, JAMA-J AM MED ASSOC, V285, P413, DOI 10.1001/jama.285.4.413; Lacolley P, 2009, CARDIOVASC RES, V81, P637, DOI 10.1093/cvr/cvn353; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Leeson CPM, 2001, BRIT MED J, V322, P643, DOI 10.1136/bmj.322.7287.643; LONDON GM, 1993, KIDNEY INT, V43, pS42; Lucas A, 1999, BRIT MED J, V319, P245, DOI 10.1136/bmj.319.7204.245; Maldonado J, 2011, J HYPERTENS, V29, P669, DOI 10.1097/HJH.0b013e3283432063; Martin RM, 2005, AM J EPIDEMIOL, V161, P15, DOI 10.1093/aje/kwh338; MARTYN CN, 1995, BRIT HEART J, V73, P116; Mendis S, 2005, GLOB HEART, V1, P3, DOI DOI 10.1016/j.precon.2005.02.010; Menezes AMB, 2012, J EPIDEMIOL COMMUN H, V66, P149, DOI 10.1136/jech.2010.124842; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Montgomery AA, 2000, LANCET, V355, P2136, DOI 10.1016/S0140-6736(00)02385-0; Murray LJ, 2001, J EPIDEMIOL COMMUN H, V55, P665, DOI 10.1136/jech.55.9.665; Mzayek F, 2009, J EPIDEMIOL COMMUN H, V63, P729, DOI 10.1136/jech.2008.084475; NEWMAN WP, 1991, ANN NY ACAD SCI, V623, P16, DOI 10.1111/j.1749-6632.1991.tb43715.x; O'Rourke MF, 2005, HYPERTENSION, V46, P200, DOI 10.1161/01.HYP.0000168052.00426.65; OHTSUKA S, 1994, J AM COLL CARDIOL, V24, P1406, DOI 10.1016/0735-1097(94)90127-9; Ong KK, 2006, ACTA PAEDIATR, V95, P904, DOI 10.1080/08035250600719754; Owen CG, 2003, BMJ-BRIT MED J, V327, P1189, DOI 10.1136/bmj.327.7425.1189; Risnes KR, 2011, INT J EPIDEMIOL, V40, P647, DOI 10.1093/ije/dyq267; Sachdev HS, 2005, AM J CLIN NUTR, V82, P456, DOI 10.1093/ajcn/82.2.456; Salvi P, 2012, J ADOLESCENT HEALTH, V51, P373, DOI 10.1016/j.jadohealth.2012.01.009; Schack-Nielsen L, 2005, BRIT J NUTR, V94, P1004, DOI 10.1079/BJN20051518; Singhal A, 2004, LANCET, V363, P1642, DOI 10.1016/S0140-6736(04)16210-7; Stettler N, 2003, AM J CLIN NUTR, V77, P1374, DOI 10.1093/ajcn/77.6.1374; Tauzin L, 2014, J DEV ORIG HLTH DIS, V5, P448, DOI 10.1017/S2040174414000385; Tennant IA, 2014, HYPERTENSION, V64, P664, DOI 10.1161/HYPERTENSIONAHA.114.03230; Tomlinson LA, 2012, CURR OPIN NEPHROL HY, V21, P655, DOI 10.1097/MNH.0b013e32835856e3; Toschke AM, 2007, AM J CLIN NUTR, V85, P1578, DOI 10.1093/ajcn/85.6.1578; TRACY RE, 1995, ATHEROSCLEROSIS, V116, P163, DOI 10.1016/0021-9150(95)05525-2; WILLIAMS RL, 1982, OBSTET GYNECOL, V59, P624; Zieman SJ, 2005, ARTERIOSCL THROM VAS, V25, P932, DOI 10.1161/01.ATV.0000160548.78317.29	48	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152501	10.1371/journal.pone.0152501	http://dx.doi.org/10.1371/journal.pone.0152501			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073916	gold, Green Submitted, Green Published			2022-12-26	WOS:000374131200027
J	Zhang, XQ; Bilic, I; Marek, A; Glosmann, M; Hess, M				Zhang, Xinquan; Bilic, Ivana; Marek, Ana; Gloesmann, Martin; Hess, Michael			C-Terminal Amino Acids 471-507 of Avian Hepatitis E Virus Capsid Protein Are Crucial for Binding to Avian and Human Cells	PLOS ONE			English	Article							COMPLETE GENOMIC SEQUENCE; CROSS-SPECIES INFECTION; UNITED-STATES; GENETIC IDENTIFICATION; CHICKEN STRAIN; CDNA-CLONE; HEV; CONSTRUCTION; SEROPREVALENCE; PATHOGENICITY	The infection of chickens with avian Hepatitis E virus (avian HEV) can be asymptomatic or induces clinical signs characterized by increased mortality and decreased egg production in adult birds. Due to the lack of an efficient cell culture system for avian HEV, the interaction between virus and host cells is still barely understood. In this study, four truncated avian HEV capsid proteins (ORF2-1 - ORF2-4) with an identical 338aa deletion at the N-terminus and gradual deletions from 0, 42, 99 and 136aa at the C-terminus, respectively, were expressed and used to map the possible binding site within avian HEV capsid protein. Results from the binding assay showed that three truncated capsid proteins attached to avian LMH cells, but did not penetrate into cells. However, the shortest construct, ORF2-4, lost the capability of binding to cells suggesting that the presence of amino acids 471 to 507 of the capsid protein is crucial for the attachment. The construct ORF2-3 (aa339-507) was used to study the potential binding of avian HEV capsid protein to human and other avian species. It could be demonstrated that ORF2-3 was capable of binding to QT-35 cells from Japanese quail and human HepG2 cells but failed to bind to P815 cells. Additionally, chicken serum raised against ORF2-3 successfully blocked the binding to LMH cells. Treatment with heparin sodium salt or sodium chlorate significantly reduced binding of ORF2-3 to LMH cells. However, heparinase II treatment of LMH cells had no effect on binding of the ORF2-3 construct, suggesting a possible distinct attachment mechanism of avian as compared to human HEV. For the first time, interactions between avian HEV capsid protein and host cells were investigated demonstrating that aa471 to 507 of the capsid protein are needed to facilitate interaction with different kind of cells from different species.	[Zhang, Xinquan; Bilic, Ivana; Marek, Ana; Hess, Michael] Univ Vet Med, Dept Farm Anim & Vet Publ Hlth, Clin Poultry & Fish Med, Vienna, Austria; [Gloesmann, Martin] Univ Vet Med, VetCore Facil Res, Vienna, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Hess, M (corresponding author), Univ Vet Med, Dept Farm Anim & Vet Publ Hlth, Clin Poultry & Fish Med, Vienna, Austria.	Michael.Hess@vetmeduni.ac.at	Glösmann, Martin/F-9349-2019	Glösmann, Martin/0000-0002-2094-3247; Bilic, Ivana/0000-0003-3296-5117; Hess, Michael/0000-0002-6991-0120				Ahmad I, 2011, VIRUS RES, V161, P47, DOI 10.1016/j.virusres.2011.02.011; Bilic L, 2009, J GEN VIROL, V90, P863, DOI 10.1099/vir.0.007179-0; Billam P, 2008, J CLIN MICROBIOL, V46, P2630, DOI 10.1128/JCM.00536-08; Billam P, 2007, J GEN VIROL, V88, P1538, DOI 10.1099/vir.0.82754-0; Cong Wei, 2014, ScientificWorldJournal, V2014, P296285, DOI 10.1155/2014/296285; Guo H, 2006, J GEN VIROL, V87, P217, DOI 10.1099/vir.0.81393-0; Haqshenas G, 2001, J GEN VIROL, V82, P2449, DOI 10.1099/0022-1317-82-10-2449; He SZ, 2008, J GEN VIROL, V89, P245, DOI 10.1099/vir.0.83308-0; Huang FF, 2005, J GEN VIROL, V86, P2585, DOI 10.1099/vir.0.81070-0; Huang FF, 2004, J GEN VIROL, V85, P1609, DOI 10.1099/vir.0.79841-0; Huang FF, 2002, J CLIN MICROBIOL, V40, P4197, DOI 10.1128/JCM.40.11.4197-4202.2002; Huang YW, 2007, J VIROL, V81, P3018, DOI 10.1128/JVI.02259-06; Johne R, 2014, INFECT GENET EVOL, V27, P212, DOI 10.1016/j.meegid.2014.06.024; Kalia M, 2009, J VIROL, V83, P12714, DOI 10.1128/JVI.00717-09; Kapur N, 2012, J VIRAL HEPATITIS, V19, P436, DOI 10.1111/j.1365-2893.2011.01559.x; Kwon HM, 2012, VIRUS GENES, V45, P237, DOI 10.1007/s11262-012-0761-6; Kwon HM, 2011, VET MICROBIOL, V147, P310, DOI 10.1016/j.vetmic.2010.07.016; Li SW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000537; Marek A, 2010, VET MICROBIOL, V145, P54, DOI 10.1016/j.vetmic.2010.03.014; Meng X. J., 2013, DIS POULTRY, P494; Morrow CJ, 2008, AVIAN PATHOL, V37, P527, DOI 10.1080/03079450802356946; MOSCOVICI C, 1977, CELL, V11, P95, DOI 10.1016/0092-8674(77)90320-8; Okamoto H, 2013, J GASTROENTEROL, V48, P147, DOI 10.1007/s00535-012-0682-0; Park SJ, 2015, J GEN VIROL, V96, P1015, DOI 10.1099/vir.0.000045; Payne CJ, 1999, VET MICROBIOL, V68, P119, DOI 10.1016/S0378-1135(99)00067-X; Peralta B, 2009, VET MICROBIOL, V137, P31, DOI 10.1016/j.vetmic.2008.12.010; RALPH P, 1976, J EXP MED, V143, P1528, DOI 10.1084/jem.143.6.1528; Schneider-Schaulies J, 2000, J GEN VIROL, V81, P1413, DOI 10.1099/0022-1317-81-6-1413; Sun XM, 2013, CELL REP, V3, P769, DOI 10.1016/j.celrep.2013.01.025; Sun ZF, 2004, J CLIN MICROBIOL, V42, P2658, DOI 10.1128/JCM.42.6.2658-2662.2004; Trowbridge JM, 2002, GLYCOBIOLOGY, V12, p117R, DOI 10.1093/glycob/cwf066; Troxler S, 2014, AVIAN PATHOL, V43, P310, DOI 10.1080/03079457.2014.924616; Yamashita T, 2009, P NATL ACAD SCI USA, V106, P12986, DOI 10.1073/pnas.0903699106; Zhang W, 2008, EPIDEMIOL INFECT, V136, P1020, DOI 10.1017/S095026880700965X; Zhang XX, 2014, PAK VET J, V34, P130; Zhao Q, 2013, J VIROL METHODS, V187, P32, DOI 10.1016/j.jviromet.2012.08.026	36	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153723	10.1371/journal.pone.0153723	http://dx.doi.org/10.1371/journal.pone.0153723			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073893	gold, Green Published, Green Submitted			2022-12-26	WOS:000374131200118
J	Castillo, D; Christiansen, RH; Dalsgaard, I; Madsen, L; Espejo, R; Middelboe, M				Castillo, Daniel; Christiansen, Roi Hammershaimb; Dalsgaard, Inger; Madsen, Lone; Espejo, Romilio; Middelboe, Mathias			Comparative Genome Analysis Provides Insights into the Pathogenicity of Flavobacterium psychrophilum	PLOS ONE			English	Article							RAINBOW-TROUT; POPULATION-STRUCTURE; ONCORHYNCHUS-MYKISS; VIRULENCE FACTORS; GLIDING MOTILITY; SEQUENCE; SYSTEM; GENES; IDENTIFICATION; DIVERSITY	Flavobacterium psychrophilum is a fish pathogen in salmonid aquaculture worldwide that causes cold water disease (CWD) and rainbow trout fry syndrome (RTFS). Comparative genome analyses of 11 F. psychrophilum isolates representing temporally and geographically distant populations were used to describe the F. psychrophilum pan-genome and to examine virulence factors, prophages, CRISPR arrays, and genomic islands present in the genomes. Analysis of the genomic DNA sequences were complemented with selected phenotypic characteristics of the strains. The pan genome analysis showed that F. psychrophilum could hold at least 3373 genes, while the core genome contained 1743 genes. On average, 67 new genes were detected for every new genome added to the analysis, indicating that F. psychrophilum possesses an open pan genome. The putative virulence factors were equally distributed among isolates, independent of geographic location, year of isolation and source of isolates. Only one prophage-related sequence was found which corresponded to the previously described prophage 6H, and appeared in 5 out of 11 isolates. CRISPR array analysis revealed two different loci with dissimilar spacer content, which only matched one sequence in the database, the temperate bacteriophage 6H. Genomic Islands (GIs) were identified in F. psychrophilum isolates 950106-1/1 and CSF 259-93, associated with toxins and antibiotic resistance. Finally, phenotypic characterization revealed a high degree of similarity among the strains with respect to biofilm formation and secretion of extracellular enzymes. Global scale dispersion of virulence factors in the genomes and the abilities for biofilm formation, hemolytic activity and secretion of extracellular enzymes among the strains suggested that F. psychrophilum isolates have a similar mode of action on adhesion, colonization and destruction of fish tissues across large spatial and temporal scales of occurrence. Overall, the genomic characterization and phenotypic properties may provide new insights to the mechanisms of pathogenicity in F. psychrophilum.	[Castillo, Daniel; Christiansen, Roi Hammershaimb; Middelboe, Mathias] Univ Copenhagen, Marine Biol Sect, Helsingor, Denmark; [Christiansen, Roi Hammershaimb; Dalsgaard, Inger; Madsen, Lone] Tech Univ Denmark, Natl Vet Inst, Frederiksberg, Denmark; [Espejo, Romilio] Univ Chile, Ctr Nacl Genom & Bioinformat, Santiago, Chile; [Espejo, Romilio] Univ Chile, Inst Nutr & Tecnol Alimentos, Santiago, Chile	University of Copenhagen; Technical University of Denmark; Universidad de Chile; Universidad de Chile	Middelboe, M (corresponding author), Univ Copenhagen, Marine Biol Sect, Helsingor, Denmark.	mmiddelboe@bio.ku.dk	Middelboe, Mathias/B-9995-2009	Middelboe, Mathias/0000-0002-9587-9171; Castillo, Daniel/0000-0002-1612-5401; Dalsgaard, Inger/0000-0003-2066-1060; Madsen, Lone/0000-0001-8435-9827	Danish Directorate for Food, Fisheries and Agri Business [3414-09-02613]; Danish Strategic Research Council (ProAqua) [09-072829]; EU-IRSES (AQUAPHAGE) [69175]; EU-IRSES	Danish Directorate for Food, Fisheries and Agri Business; Danish Strategic Research Council (ProAqua); EU-IRSES (AQUAPHAGE); EU-IRSES	This work was supported by The Danish Directorate for Food, Fisheries and Agri Business, grant # 3414-09-02613; The Danish Strategic Research Council (ProAqua, grant # 09-072829); and EU-IRSES (AQUAPHAGE, grant # 69175). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a grant from The Danish Directorate for Food, Fisheries and Agri Business, The Danish Strategic Research Council (ProAqua, project # 09-072829) and by the EU-IRSES-funded project AQUAPHAGE.	Arai H, 2007, J FISH DIS, V30, P345, DOI 10.1111/j.1365-2761.2007.00809.x; Avendano-Herrera R, 2014, VET MICROBIOL, V170, P298, DOI 10.1016/j.vetmic.2014.02.009; Bernardet JF, 2002, INT J SYST EVOL MICR, V52, P1049, DOI 10.1099/00207713-52-3-1049; BERNARDET JF, 1989, APPL ENVIRON MICROB, V55, P1796, DOI 10.1128/AEM.55.7.1796-1800.1989; Bertolini J. M., 1994, Journal of Aquatic Animal Health, V6, P224, DOI 10.1577/1548-8667(1994)006&lt;0224:EDOPFS&gt;2.3.CO;2; Blom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-154; Bloomfield GA, 1997, MICROBIOL-UK, V143, P553, DOI 10.1099/00221287-143-2-553; Bruno D. W., 1992, Bulletin of the European Association of Fish Pathologists, V12, P215; Bruun MS, 2000, AQUACULTURE, V187, P201, DOI 10.1016/S0044-8486(00)00310-0; Bustos P. A., 1995, Bulletin of the European Association of Fish Pathologists, V15, P162; Castillo D, 2012, J FISH DIS, V35, P193, DOI 10.1111/j.1365-2761.2011.01336.x; Castillo D, 2015, APPL ENVIRON MICROB, V81, P1157, DOI 10.1128/AEM.03699-14; Castillo D, 2014, MICROB ECOL, V67, P748, DOI 10.1007/s00248-014-0375-8; Castillo D, 2014, FEMS MICROBIOL LETT, V351, P51, DOI 10.1111/1574-6968.12342; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Drummond AJBA, 2010, GENEIOUS V7 1 4; Duchaud E, 2007, NAT BIOTECHNOL, V25, P763, DOI 10.1038/nbt1313; Engel P, 2012, NATURE, V482, P107, DOI 10.1038/nature10729; Fouts DE, 2006, NUCLEIC ACIDS RES, V34, P5839, DOI 10.1093/nar/gkl732; Fredriksen BN, 2013, VACCINE, V31, P1994, DOI 10.1016/j.vaccine.2013.01.016; Fujiwara-Nagata E, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-34; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hesami S, 2011, APPL ENVIRON MICROB, V77, P1593, DOI 10.1128/AEM.01717-10; Hogfors-Ronnholm E, 2010, MICROB PATHOGENESIS, V49, P369, DOI 10.1016/j.micpath.2010.08.002; HORIUCHI M, 1991, FISH PATHOL, V26, P211; Ikegami A, 2004, INFECT IMMUN, V72, P4619, DOI 10.1128/IAI.72.8.4619-4627.2004; Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13; Keim P, 2009, MOL ASPECTS MED, V30, P397, DOI 10.1016/j.mam.2009.08.005; Kondo M, 2002, MICROBES INFECT, V4, P279, DOI 10.1016/S1286-4579(02)01539-3; Kuck P, 2010, MOL PHYLOGENET EVOL, V56, P1115, DOI 10.1016/j.ympev.2010.04.024; Laanto E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053157; Land M, 2015, FUNCT INTEGR GENOMIC, V15, P141, DOI 10.1007/s10142-015-0433-4; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lindsay JA, 1998, MOL MICROBIOL, V29, P527, DOI 10.1046/j.1365-2958.1998.00947.x; Lorenzen E., 1991, Bulletin of the European Association of Fish Pathologists, V11, P77; Madsen L, 2000, J FISH DIS, V23, P211, DOI 10.1046/j.1365-2761.2000.00240.x; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; Mann RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055644; McBride MJ, 2013, J BACTERIOL, V195, P270, DOI 10.1128/JB.01962-12; Nematollahi A, 2003, J FISH DIS, V26, P563, DOI 10.1046/j.1365-2761.2003.00488.x; Nicolas P, 2008, APPL ENVIRON MICROB, V74, P3702, DOI 10.1128/AEM.00244-08; Nilsen H, 2014, APPL ENVIRON MICROB, V80, P2728, DOI 10.1128/AEM.04233-13; Ostland VE, 2000, J FISH DIS, V23, P329, DOI 10.1046/j.1365-2761.2000.00251.x; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Sampson TR, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00037; Sato K, 2010, P NATL ACAD SCI USA, V107, P276, DOI 10.1073/pnas.0912010107; Soares SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030848; Soule M, 2005, DIS AQUAT ORGAN, V65, P209, DOI 10.3354/dao065209; Stenholm AR, 2008, APPL ENVIRON MICROB, V74, P4070, DOI 10.1128/AEM.00428-08; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Syvanen M, 2012, ANNU REV GENET, V46, P341, DOI 10.1146/annurev-genet-110711-155529; Tatusova T., 2013, PROKARYOTIC GENOME A; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tettelin H, 2008, CURR OPIN MICROBIOL, V11, P472, DOI 10.1016/j.mib.2008.09.006; Tomida S, 2013, MBIO, V4, DOI 10.1128/mBio.00003-13; Toranzo A.E., 1993, Bulletin of the European Association of Fish Pathologists, V13, P30; Touchon M, 2011, APPL ENVIRON MICROB, V77, P7656, DOI 10.1128/AEM.05625-11; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Whittle G, 2002, CELL MOL LIFE SCI, V59, P2044, DOI 10.1007/s000180200004; Wiens GD, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00889-14; Wiklund T., 1994, Bulletin of the European Association of Fish Pathologists, V14, P44; Wu AKK, 2015, STAND GENOMIC SCI, V10, DOI 10.1186/1944-3277-10-3; Wu HJ, 2008, CURR OPIN CHEM BIOL, V12, P93, DOI 10.1016/j.cbpa.2008.01.023; Yoon SH, 2015, NUCLEIC ACIDS RES, V43, pD624, DOI 10.1093/nar/gku985; Zegans ME, 2009, J BACTERIOL, V191, P210, DOI 10.1128/JB.00797-08; Zhou CE, 2007, NUCLEIC ACIDS RES, V35, pD391, DOI 10.1093/nar/gkl791; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	69	30	30	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0152515	10.1371/journal.pone.0152515	http://dx.doi.org/10.1371/journal.pone.0152515			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27071075	Green Published, Green Submitted, gold			2022-12-26	WOS:000373900700010
J	Pla, A; Pascual, M; Guerri, C				Pla, Antoni; Pascual, Maria; Guerri, Consuelo			Autophagy Constitutes a Protective Mechanism against Ethanol Toxicity in Mouse Astrocytes and Neurons	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME; CELL-DEATH; RECEPTOR 4; INHIBITION; TLR4; MTOR; CLEARANCE; SYSTEM	Ethanol induces brain damage and neurodegeneration by triggering inflammatory processes in glial cells through activation of Toll-like receptor 4 (TLR4) signaling. Recent evidence indicates the role of protein degradation pathways in neurodegeneration and alcoholic liver disease, but how these processes affect the brain remains elusive. We have demonstrated that chronic ethanol consumption impairs proteolytic pathways in mouse brain, and the immune response mediated by TLR4 receptors participates in these dysfunctions. We evaluate the in vitro effects of an acute ethanol dose on the autophagy-lysosome pathway (ALP) on WT and TLR4(-/-) mouse astrocytes and neurons in primary culture, and how these changes affect cell survival. Our results show that ethanol induces overexpression of several autophagy markers (ATG12, LC3-II, CTSB), and increases the number of lysosomes in WT astrocytes, effects accompanied by a basification of lysosomal pH and by lowered phosphorylation levels of autophagy inhibitor mTOR, along with activation of complexes beclin-1 and ULK1. Notably, we found only minor changes between control and ethanol- treated TLR4(-/-) mouse astroglial cells. Ethanol also triggers the expression of the inflammatory mediators iNOS and COX-2, but induces astroglial death only slightly. Blocking autophagy by using specific inhibitors increases both inflammation and cell death. Conversely, in neurons, ethanol down-regulates the autophagy pathway and triggers cell death, which is partially recovered by using autophagy enhancers. These results support the protective role of the ALP against ethanol-induced astroglial cell damage in a TLR4-dependent manner, and provide new insight into the mechanisms that underlie ethanol-induced brain damage and are neuronal sensitive to the ethanol effects.	[Pla, Antoni; Pascual, Maria; Guerri, Consuelo] Ctr Invest Principe Felipe, Dept Cellular Pathol, C Eduardo Primo Yufera 3, Valencia 46012, Spain	Prince Felipe Research Center	Guerri, C (corresponding author), Ctr Invest Principe Felipe, Dept Cellular Pathol, C Eduardo Primo Yufera 3, Valencia 46012, Spain.	cguerri@cipf.es	Guerri, Consuelo/B-5181-2014; Guerri, Consuelo/R-1171-2019; Pascual, Maria/H-5181-2015	Guerri, Consuelo/0000-0001-9485-6202; Pascual, Maria/0000-0003-1420-631X	Spanish Ministry of Economics and Competitiveness [SAF2012-33747]; FEDER funds [RD12-0028-007]; PNSD [20101037]; GV-Conselleria d'Educacio: PROMETEO [II/2014-063]; Generalitat Valenciana-Conselleria d'Educacio [ACIF/2011/30]; Spanish Ministry of Health: The Institute Carlos III	Spanish Ministry of Economics and Competitiveness(Spanish Government); FEDER funds(European Commission); PNSD; GV-Conselleria d'Educacio: PROMETEO; Generalitat Valenciana-Conselleria d'Educacio(Center for Forestry Research & Experimentation (CIEF)); Spanish Ministry of Health: The Institute Carlos III	This work has been supported by grants from the Spanish Ministry of Economics and Competitiveness (SAF2012-33747), the Spanish Ministry of Health: The Institute Carlos III and FEDER funds (RTA-Network RD12-0028-007), and PNSD (Ex. 20101037), GV-Conselleria d'Educacio: PROMETEO II/2014-063. A. Pla has been supported by a pre-doctoral fellowship from the Generalitat Valenciana-Conselleria d'Educacio (Ex. ACIF/2011/30).	Alfonso-Loeches S, 2012, GLIA, V60, P948, DOI 10.1002/glia.22327; Alfonso-Loeches S, 2010, J NEUROSCI, V30, P8285, DOI 10.1523/JNEUROSCI.0976-10.2010; Barres BA, 2000, CURR OPIN NEUROBIOL, V10, P642, DOI 10.1016/S0959-4388(00)00134-3; Blanco AM, 2005, J IMMUNOL, V175, P6893, DOI 10.4049/jimmunol.175.10.6893; Buchanan MM, 2010, J NEUROCHEM, V114, P13, DOI 10.1111/j.1471-4159.2010.06736.x; Chen G, 2012, AUTOPHAGY, V8, P1577, DOI 10.4161/auto.21376; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Ding WX, 2011, AUTOPHAGY, V7, P248, DOI 10.4161/auto.7.2.14347; Ding WX, 2010, GASTROENTEROLOGY, V139, P1740, DOI 10.1053/j.gastro.2010.07.041; Donohue TM, 2009, WORLD J GASTROENTERO, V15, P1178, DOI 10.3748/wjg.15.1178; Dooley HC, 2014, MOL CELL, V55, P238, DOI 10.1016/j.molcel.2014.05.021; Eid N, 2015, WORLD J HEPATOL, V7, P1154, DOI 10.4254/wjh.v7.i9.1154; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Fernandez-Lizarbe S, 2009, J IMMUNOL, V183, P4733, DOI 10.4049/jimmunol.0803590; Frake RA, 2015, J CLIN INVEST, V125, P65, DOI 10.1172/JCI73944; Galluzzi L, 2008, CURR MOL MED, V8, P78; Giordano S, 2014, REDOX BIOL, V2, P82, DOI 10.1016/j.redox.2013.12.013; Hayes DM, 2013, ALCOHOL CLIN EXP RES, V37, P425, DOI 10.1111/j.1530-0277.2012.01955.x; Janen SB, 2010, GLIA, V58, P1766, DOI 10.1002/glia.21047; Kaur J, 2015, NAT REV MOL CELL BIO, V16, P461, DOI 10.1038/nrm4024; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Kramer S, 2008, AM J PHYSIOL-RENAL, V294, pF440, DOI 10.1152/ajprenal.00379.2007; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Lindqvist LM, 2014, AUTOPHAGY, V10, P1474, DOI 10.4161/auto.29639; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Luo J, 2014, AUTOPHAGY, V10, P2099, DOI 10.4161/15548627.2014.981916; Vidal-Donet JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055526; Mazan-Mamczarz K, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0091-0; Menzies FM, 2015, CELL DEATH DIFFER, V22, P433, DOI 10.1038/cdd.2014.151; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Nikoletopoulou V, 2015, CELL DEATH DIFFER, V22, P398, DOI 10.1038/cdd.2014.204; Okun E, 2011, TRENDS NEUROSCI, V34, P269, DOI 10.1016/j.tins.2011.02.005; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pascual-Lucas M, 2014, J NEUROCHEM, V129, P448, DOI 10.1111/jnc.12639; Pattingre S, 2008, BIOCHIMIE, V90, P313, DOI 10.1016/j.biochi.2007.08.014; Pla A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.46; Ramachandran N, 2009, CELL, V137, P235, DOI 10.1016/j.cell.2009.01.054; Rautou PE, 2010, J HEPATOL, V53, P1123, DOI 10.1016/j.jhep.2010.07.006; Rivera JF, 2014, J CLIN INVEST, V124, P3489, DOI 10.1172/JCI71981; Shi CS, 2010, AUTOPHAGY, V6, P986, DOI 10.4161/auto.6.7.13288; Tydlacka S, 2008, J NEUROSCI, V28, P13285, DOI 10.1523/JNEUROSCI.4393-08.2008; von Haefen C, 2011, ALCOHOL CLIN EXP RES, V35, P1381, DOI 10.1111/j.1530-0277.2011.01473.x; Wang XK, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00012; Wu DF, 2012, FREE RADICAL BIO MED, V53, P1346, DOI 10.1016/j.freeradbiomed.2012.07.005; Xilouri M, 2010, CNS NEUROL DISORD-DR, V9, P701, DOI 10.2174/187152710793237421; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Zhang JB, 2013, NEUROTOX RES, V24, P478, DOI 10.1007/s12640-013-9392-5	48	47	47	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153097	10.1371/journal.pone.0153097	http://dx.doi.org/10.1371/journal.pone.0153097			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070930	Green Submitted, Green Published, gold			2022-12-26	WOS:000373900700032
J	Stodola, JL; Stith, CM; Burgers, PM				Stodola, Joseph L.; Stith, Carrie M.; Burgers, Peter M.			Proficient Replication of the Yeast Genome by a Viral DNA Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OKAZAKI FRAGMENT MATURATION; THYMINE-THYMINE DIMER; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; ACCESSORY SUBUNITS; STRUCTURAL BASIS; POL-ZETA; TRANSLESION SYNTHESIS; PROCESSIVITY FACTOR; URACIL RECOGNITION	DNA replication in eukaryotic cells requires minimally three B-family DNA polymerases: Pol alpha, Pol beta, and Pol epsilon. Pol delta replicates and matures Okazaki fragments on the lagging strand of the replication fork. Saccharomyces cerevisiae Pol delta is a three-subunit enzyme (Pol3-Pol31-Pol32). A small C-terminal domain of the catalytic subunit Pol3 carries both iron-sulfur cluster and zinc-binding motifs, which mediate interactions with Pol31, and processive replication with the replication clamp proliferating cell nuclear antigen (PCNA), respectively. We show that the entire N-terminal domain of Pol3, containing polymerase and proofreading activities, could be effectively replaced by those from bacteriophage RB69, and could carry out chromosomal DNA replication in yeast with remarkable high fidelity, provided that adaptive mutations in the replication clamp PCNA were introduced. This result is consistent with the model that all essential interactions for DNA replication in yeast are mediated through the small C-terminal domain of Pol3. The chimeric polymerase carries out processive replication with PCNA in vitro; however, in yeast, it requires an increased involvement of the mutagenic translesion DNA polymerase zeta during DNA replication.	[Stodola, Joseph L.; Stith, Carrie M.; Burgers, Peter M.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Burgers, PM (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.	burgers@biochem.wustl.edu	Burgers, Peter M/AAW-6621-2021		National Institutes of Health [GM032431]; U.S.-Israel Binational Science Foundation [2013358]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032431] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S.-Israel Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Grants GM032431 from the National Institutes of Health (to P. M. B.) and 2013358 from the U.S.-Israel Binational Science Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acharya N, 2011, P NATL ACAD SCI USA, V108, P17927, DOI 10.1073/pnas.1109981108; Aksenova A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001209; Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Baranovskiy AG, 2008, CELL CYCLE, V7, P3026, DOI 10.4161/cc.7.19.6720; Baranovskiy AG, 2016, J BIOL CHEM, V291, P10006, DOI 10.1074/jbc.M116.717405; Baranovskiy AG, 2012, J BIOL CHEM, V287, P17281, DOI 10.1074/jbc.M112.351122; Bebenek A, 2001, J BIOL CHEM, V276, P10387, DOI 10.1074/jbc.M007707200; Bruning JB, 2004, STRUCTURE, V12, P2209, DOI 10.1016/j.str.2004.09.018; Burgers PMJ, 2016, MOL CELL, V61, P492, DOI 10.1016/j.molcel.2016.01.017; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Burgers PMJ, 2001, J BIOL CHEM, V276, P43487, DOI 10.1074/jbc.R100056200; Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; Chilkova O, 2007, NUCLEIC ACIDS RES, V35, P6588, DOI 10.1093/nar/gkm741; Daigaku Y, 2015, NAT STRUCT MOL BIOL, V22, P192, DOI 10.1038/nsmb.2962; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; Dressman HK, 1997, P NATL ACAD SCI USA, V94, P8042, DOI 10.1073/pnas.94.15.8042; Fogg MJ, 2002, NAT STRUCT BIOL, V9, P922, DOI 10.1038/nsb867; Fortune JM, 2005, J BIOL CHEM, V280, P29980, DOI 10.1074/jbc.M505236200; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; Garbacz M, 2015, DNA REPAIR, V29, P23, DOI 10.1016/j.dnarep.2015.02.007; Garcia JS, 2004, NUCLEIC ACIDS RES, V32, P3005, DOI 10.1093/nar/gkh623; Gerik KJ, 1998, J BIOL CHEM, V273, P19747, DOI 10.1074/jbc.273.31.19747; Hanna M, 2007, MUTAT RES-FUND MOL M, V625, P164, DOI 10.1016/j.mrfmmm.2007.06.008; Haracska L, 2003, MOL CELL BIOL, V23, P1453, DOI 10.1128/MCB.23.4.1453-1459.2003; Hedglin M, 2016, P NATL ACAD SCI USA, V113, pE1777, DOI 10.1073/pnas.1523653113; Hopfner KP, 1999, P NATL ACAD SCI USA, V96, P3600, DOI 10.1073/pnas.96.7.3600; Huang ME, 2002, GENETICS, V160, P1409; Johansson E, 2004, J BIOL CHEM, V279, P22204, DOI 10.1074/jbc.M402652200; Johansson E, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012799; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Johnson RE, 2015, MOL CELL, V59, P163, DOI 10.1016/j.molcel.2015.05.038; Johnson RE, 2012, P NATL ACAD SCI USA, V109, P12455, DOI 10.1073/pnas.1206052109; Karam JD, 2000, PROG NUCLEIC ACID RE, V64, P65, DOI 10.1016/S0079-6603(00)64002-3; Kilkenny ML, 2012, J BIOL CHEM, V287, P23740, DOI 10.1074/jbc.M112.368951; Klinge S, 2009, EMBO J, V28, P1978, DOI 10.1038/emboj.2009.150; Kreuzer KN, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-358; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; Lee YS, 2014, P NATL ACAD SCI USA, V111, P2954, DOI 10.1073/pnas.1324001111; Liu L, 2000, J BIOL CHEM, V275, P18739, DOI 10.1074/jbc.M001217200; Lydeard JR, 2007, NATURE, V448, P820, DOI 10.1038/nature06047; Majka J, 2004, PROG NUCLEIC ACID RE, V78, P227, DOI 10.1016/S0079-6603(04)78006-X; Makarova AV, 2012, NUCLEIC ACIDS RES, V40, P11618, DOI 10.1093/nar/gks948; Makiniemi M, 1999, TRENDS BIOCHEM SCI, V24, P14, DOI 10.1016/S0968-0004(98)01327-9; McCulloch SD, 2008, CELL RES, V18, P148, DOI 10.1038/cr.2008.4; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; Miyabe I, 2015, NAT STRUCT MOL BIOL, V22, P932, DOI 10.1038/nsmb.3100; Moarefi I, 2000, J MOL BIOL, V296, P1215, DOI 10.1006/jmbi.1999.3511; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; MORRISON A, 1989, J BACTERIOL, V171, P5659, DOI 10.1128/jb.171.10.5659-5667.1989; Nelson JR, 1996, SCIENCE, V272, P1646, DOI 10.1126/science.272.5268.1646; Netz DJA, 2012, NAT CHEM BIOL, V8, P125, DOI 10.1038/nchembio.721; Noble E, 2015, VIRUSES-BASEL, V7, P3186, DOI 10.3390/v7062766; Northam MR, 2006, EMBO J, V25, P4316, DOI 10.1038/sj.emboj.7601320; Northam MR, 2014, NUCLEIC ACIDS RES, V42, P290, DOI 10.1093/nar/gkt830; Northam MR, 2010, GENETICS, V184, P27, DOI 10.1534/genetics.109.107482; Pavlov YI, 2001, GENETICS, V159, P47; Reynolds N, 1998, CURR GENET, V34, P250, DOI 10.1007/s002940050394; Shamoo Y, 1999, CELL, V99, P155, DOI 10.1016/S0092-8674(00)81647-5; SIMON M, 1991, EMBO J, V10, P2165, DOI 10.1002/j.1460-2075.1991.tb07751.x; Stith CM, 2008, J BIOL CHEM, V283, P34129, DOI 10.1074/jbc.M806668200; Stodola JL, 2016, NAT STRUCT MOL BIOL, V23, P402, DOI 10.1038/nsmb.3207; Swan MK, 2009, NAT STRUCT MOL BIOL, V16, P979, DOI 10.1038/nsmb.1663; TAN CK, 1986, J BIOL CHEM, V261, P2310; Tishkoff DX, 1997, CELL, V88, P253, DOI 10.1016/S0092-8674(00)81846-2; Wang J, 1997, CELL, V89, P1087, DOI 10.1016/S0092-8674(00)80296-2; Wardle J, 2008, NUCLEIC ACIDS RES, V36, P705, DOI 10.1093/nar/gkm1023; Wojtaszek J, 2012, J BIOL CHEM, V287, P33836, DOI 10.1074/jbc.M112.394841; Zhong XJ, 2006, NUCLEIC ACIDS RES, V34, P4731, DOI 10.1093/nar/gkl465	70	4	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11698	11705		10.1074/jbc.M116.728741	http://dx.doi.org/10.1074/jbc.M116.728741			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27072134	Green Published, hybrid			2022-12-26	WOS:000377264800020
J	Tanmoy, AM; Ahmed, ASMNU; Arumugam, R; Hossain, B; Marzan, M; Saha, S; El Arifeen, S; Baqui, AH; Black, RE; Kang, G; Saha, SK				Tanmoy, Arif Mohammad; Ahmed, A. S. M. Nawshad Uddin; Arumugam, Rajesh; Hossain, Belal; Marzan, Mahfuza; Saha, Shampa; El Arifeen, Shams; Baqui, Abdullah H.; Black, Robert E.; Kang, Gagandeep; Saha, Samir Kumar			Rotavirus Surveillance at a WHO-Coordinated Invasive Bacterial Disease Surveillance Site in Bangladesh: A Feasibility Study to Integrate Two Surveillance Systems	PLOS ONE			English	Article							CHILDREN LESS-THAN-5 YEARS; DOUBLE-BLIND; VACCINE; GENOTYPES; DIARRHEA; GASTROENTERITIS; EFFICACY; AGE; STRAINS; INFANTS	The World Health Organization (WHO) currently coordinates rotavirus diarrhea and invasive bacterial disease (IBD) surveillance at 178 sentinel sites in 60 countries. However, only 78 sites participate in both surveillance systems using a common sentinel site. Here, we explored the feasibility of extending a WHO-IBD surveillance platform to generate data on the burden of rotaviral diarrhea and its epidemiological characteristics to prepare the countries to measure the impact of rotaviral vaccine. A six-month (July to December, 2012) surveillance, managed by IBD team, collected stool samples and clinical data from underfive children with acute watery diarrhea at an IBD sentinel site. Samples were tested for rotavirus antigen by ELISA and genotyped by PCR at the regional reference laboratory (RRL). Specimens were collected from 79% (n = 297) of eligible cases (n = 375); 100% of which were tested for rotavirus by ELISA and 54% (159/297) of them were positive. At RRL, all the cases were confirmed by PCR and genotyped (99%; 158/159). The typing results revealed the predominance of G12 (40%; 64/159) genotype, followed by G1 (31%; 50/159) and G9 (19%; 31/159). All in all, this exploratory surveillance collected the desired demographic and epidemiological data and achieved almost all the benchmark indicators of WHO, starting from enrollment number to quality assurance through a number of case detection, collection, and testing of specimens and genotyping of strains at RRL. The success of thisWHO-IBD site in achieving these benchmark indicators of WHO can be used by WHO as a proof-of-concept for considering integration of rotavirus surveillance with WHO-IBD platforms, specifically in countries with well performing IBD site and no ongoing rotavirus surveillance.	[Tanmoy, Arif Mohammad; Ahmed, A. S. M. Nawshad Uddin; Hossain, Belal; Marzan, Mahfuza; Saha, Shampa; El Arifeen, Shams; Baqui, Abdullah H.; Saha, Samir Kumar] Dhaka Shishu Hosp, Dept Microbiol, Child Hlth Res Fdn, Dhaka, Bangladesh; [Ahmed, A. S. M. Nawshad Uddin] Dhaka Shishu Hosp, Bangladesh Inst Child Hlth, Dept Pediat, Dhaka, Bangladesh; [Arumugam, Rajesh; Kang, Gagandeep] Christian Med Coll & Hosp, Dept Gastrointestinal Sci, Vellore, Tamil Nadu, India; [El Arifeen, Shams] Int Ctr Diarrhoeal Dis Res, Dept Child & Adolescent Hlth, GPO Box 128, Dhaka 1000, Bangladesh; [Baqui, Abdullah H.; Black, Robert E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Saha, Samir Kumar] Dhaka Shishu Hosp, Bangladesh Inst Child Hlth, Dept Microbiol, Dhaka, Bangladesh	Christian Medical College & Hospital (CMCH) Vellore; International Centre for Diarrhoeal Disease Research (ICDDR); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Saha, SK (corresponding author), Dhaka Shishu Hosp, Dept Microbiol, Child Hlth Res Fdn, Dhaka, Bangladesh.; Saha, SK (corresponding author), Dhaka Shishu Hosp, Bangladesh Inst Child Hlth, Dept Microbiol, Dhaka, Bangladesh.	samirk.sks@gmail.com	Tanmoy, Arif Mohammad/V-8340-2019	Marzan, Mahfuza/0000-0003-4568-412X; Saha, Shampa/0000-0001-7185-9232; Tanmoy, Arif Mohammad/0000-0002-7769-8035	WHO [201233523]; World Health Organization, Geneva	WHO(World Health Organization); World Health Organization, Geneva(World Health Organization)	WHO funded the IBD project, no. 201233523.; The study was partially supported by World Health Organization, Geneva. We gratefully acknowledge the generous technical support from Mr. Zakaria M Emran, Mr. Md. Hasanuzzaman, Dr. Mohammad Anowar Uddin and Ms. Maksuda Islam.	Afrad MH, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-320; Agocs MM, 2014, MMWR-MORBID MORTAL W, V63, P634; Alkoshi S, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1400-7; [Anonymous], 2012, ROT SURV PERF IND; Babji S, 2014, VACCINE, V32, pA10, DOI 10.1016/j.vaccine.2014.03.001; Banerjee I, 2007, J MED VIROL, V79, P1413, DOI 10.1002/jmv.20872; Bhutta ZA, 2013, LANCET, V381, P1417, DOI 10.1016/S0140-6736(13)60648-0; Boom JA, 2010, PEDIATRICS, V125, pE199, DOI 10.1542/peds.2009-1021; Ciarlet M, 2009, VACCINE, V27, pG72, DOI 10.1016/j.vaccine.2009.09.107; Dennehy PH, 2000, PEDIATR INFECT DIS J, V19, pS103, DOI 10.1097/00006454-200010001-00003; Dey SK, 2009, EMERG INFECT DIS, V15, P91, DOI 10.3201/eid1501.080883; Hasing ME, 2009, J MED VIROL, V81, P2109, DOI 10.1002/jmv.21632; Giaquinto C, 2010, SCAND J INFECT DIS, V42, P142, DOI 10.3109/00365540903380495; Iturriza-Gomara M, 2004, J CLIN VIROL, V31, P259, DOI 10.1016/j.jcv.2004.04.009; Iturriza-Gomara M, 1999, J VIROL METHODS, V78, P93, DOI 10.1016/S0166-0934(98)00168-2; Kang G, 2013, VACCINE, V31, P2879, DOI 10.1016/j.vaccine.2013.04.030; Linhares AC, 2008, LANCET, V371, P1181, DOI 10.1016/S0140-6736(08)60524-3; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Matthijnssens J, 2010, MOL BIOL EVOL, V27, P2431, DOI 10.1093/molbev/msq137; Mullick S, 2014, VACCINE, V32, pA20, DOI 10.1016/j.vaccine.2014.03.018; Munos MK, 2010, INT J EPIDEMIOL, V39, P75, DOI 10.1093/ije/dyq025; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nelson EAS, 2008, VACCINE, V26, P3192, DOI 10.1016/j.vaccine.2008.03.073; Parashar UD, 2009, J INFECT DIS, V200, pS9, DOI 10.1086/605025; Patel M, 2009, JAMA-J AM MED ASSOC, V301, P2243, DOI 10.1001/jama.2009.756; Patel MM, 2011, PEDIATR INFECT DIS J, V30, pS1, DOI 10.1097/INF.0b013e3181fefa1f; Rahman M, 2007, EMERG INFECT DIS, V13, P18, DOI 10.3201/eid1301.060910; Tapisiz A, 2011, CURR MICROBIOL, V63, P517, DOI 10.1007/s00284-011-0014-2; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Vesikari T, 2007, LANCET, V370, P1757, DOI 10.1016/S0140-6736(07)61744-9; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; Ward RL, 2009, CLIN INFECT DIS, V48, P222, DOI 10.1086/595702; Widdowson MA, 2009, J INFECT DIS, V200, pS1, DOI 10.1086/605061; Zaman K, 2010, LANCET, V376, P615, DOI 10.1016/S0140-6736(10)60755-6	34	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153582	10.1371/journal.pone.0153582	http://dx.doi.org/10.1371/journal.pone.0153582			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096958	Green Published, Green Submitted, gold			2022-12-26	WOS:000374543600043
J	Rast, TJ; Kullas, AL; Southern, PJ; Davis, DA				Rast, Timothy J.; Kullas, Amy L.; Southern, Peter J.; Davis, Dana A.			Human Epithelial Cells Discriminate between Commensal and Pathogenic Interactions with Candida albicans	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; ENDOTHELIAL-CELLS; PATHWAY; INFECTIONS; ADHERENCE; PROMOTER; BINDING; GENES; SHOCK; LINE	The commensal fungus, Candida albicans, can cause life-threatening infections in at risk individuals. C. albicans colonizes mucosal surfaces of most people, adhering to and interacting with epithelial cells. At low concentrations, C. albicans is not pathogenic nor does it cause epithelial cell damage in vitro; at high concentrations, C. albicans causes mucosal infections and kills epithelial cells in vitro. Here we show that while there are quantitative dose-dependent differences in exposed epithelial cell populations, these reflect a fundamental qualitative difference in host cell response to C. albicans. Using transcriptional profiling experiments and real time PCR, we found that wild-type C. albicans induce dose-dependent responses from a FaDu epithelial cell line. However, real time PCR and Western blot analysis using a high dose of various C. albicans strains demonstrated that these dose-dependent responses are associated with ability to promote host cell damage. Our studies support the idea that epithelial cells play a key role in the immune system by monitoring the microbial community at mucosal surfaces and initiating defensive responses when this community is dysfunctional. This places epithelial cells at a pivotal position in the interaction with C. albicans as epithelial cells themselves promote C. albicans stimulated damage.	[Rast, Timothy J.; Kullas, Amy L.; Southern, Peter J.; Davis, Dana A.] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA; [Rast, Timothy J.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [Kullas, Amy L.] NIH, Lab Clin Infect Dis, Bldg 10, Bethesda, MD 20892 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Arizona; National Institutes of Health (NIH) - USA	Davis, DA (corresponding author), Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA.	dadavis@umn.edu		Kullas, Amy/0000-0003-2429-4691	University of Minnesota [18805]; National Institutes of Health [1R01 AI064054-01]; Burroughs Wellcome Fund [1004419]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064054] Funding Source: NIH RePORTER	University of Minnesota(University of Minnesota System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by University of Minnesota (http://www.research.umn.edu): #18805, National Institutes of Health (http://www.niaid.nih.gov/Pages/default.aspx): 1R01 AI064054-01, and Burroughs Wellcome Fund (http://www.bwfund.org): #1004419. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams A, 1997, METHODS YEAST GENETI; Barker KS, 2008, J INFECT DIS, V198, P193, DOI 10.1086/589516; Calderone RA., 2002, CANDIDA CANDIDIASIS; Davis D, 2000, INFECT IMMUN, V68, P5953, DOI 10.1128/IAI.68.10.5953-5959.2000; Davis DA, 2009, CURR OPIN MICROBIOL, V12, P365, DOI 10.1016/j.mib.2009.05.006; Deng WG, 2007, ARTERIOSCL THROM VAS, V27, P1752, DOI 10.1161/ATVBAHA.107.144352; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Edmond MB, 1999, CLIN INFECT DIS, V29, P239, DOI 10.1086/520192; Enache E, 1996, MICROBIOL-UK, V142, P2741, DOI 10.1099/13500872-142-10-2741; Fidel Paul L Jr, 2005, Curr Opin Infect Dis, V18, P107; FILLER SG, 1995, INFECT IMMUN, V63, P976, DOI 10.1128/IAI.63.3.976-983.1995; Fu Y, 1998, INFECT IMMUN, V66, P1783, DOI 10.1128/IAI.66.4.1783-1786.1998; Hammer M, 2006, J EXP MED, V203, P15, DOI 10.1084/jem.20051753; Howie HL, 2005, PLOS BIOL, V3, P627, DOI 10.1371/journal.pbio.0030100; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kaiser P, 2011, CURR OPIN IMMUNOL, V23, P456, DOI 10.1016/j.coi.2011.06.004; Kumamoto CA, 2005, CELL MICROBIOL, V7, P1546, DOI 10.1111/j.1462-5822.2005.00616.x; Lakshminarayanan V, 1998, J BIOL CHEM, V273, P32670, DOI 10.1074/jbc.273.49.32670; Levitz SA, 2004, MICROBES INFECT, V6, P1351, DOI 10.1016/j.micinf.2004.08.014; Liu YP, 2015, GENOME RES, V25, P679, DOI 10.1101/gr.187427.114; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Gil ML, 2009, FRONT BIOSCI-LANDMRK, V14, P570, DOI 10.2741/3263; Moyes DL, 2010, CELL HOST MICROBE, V8, P225, DOI 10.1016/j.chom.2010.08.002; Nobile CJ, 2008, CELLULAR MICROBIOLOG; Park H, 2005, CELL MICROBIOL, V7, P499, DOI 10.1111/j.1462-5822.2004.00476.x; Phan QT, 2000, INFECT IMMUN, V68, P3485, DOI 10.1128/IAI.68.6.3485-3490.2000; Phan QT, 2007, PLOS BIOL, V5, P543, DOI 10.1371/journal.pbio.0050064; RANGAN SRS, 1972, CANCER, V29, P117, DOI 10.1002/1097-0142(197201)29:1<117::AID-CNCR2820290119>3.0.CO;2-R; Rossi O, 2013, CURR TOP MICROBIOL, V358, P291, DOI 10.1007/82_2011_191; Southern P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002067; Villar CC, 2007, INFECT IMMUN, V75, P2126, DOI 10.1128/IAI.00054-07; Wolf JM, 2010, EUKARYOT CELL, V9, P1203, DOI 10.1128/EC.00056-10; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794	33	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153165	10.1371/journal.pone.0153165	http://dx.doi.org/10.1371/journal.pone.0153165			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088599	Green Submitted, Green Published, gold			2022-12-26	WOS:000374527000011
J	Deep, SN; Baitharu, I; Sharma, A; Gurjar, AKS; Prasad, D; Singh, SB				Deep, Satya Narayan; Baitharu, Iswar; Sharma, Apurva; Gurjar, Anoop Kishor Singh; Prasad, Dipti; Singh, Shashi Bala			Neuroprotective Role of L-N-G-Nitroarginine Methyl Ester (L-NAME) against Chronic Hypobaric Hypoxia with Crowding Stress (CHC) Induced Depression-Like Behaviour	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; INDUCED MEMORY IMPAIRMENT; ANTIDEPRESSANT-LIKE; MAJOR DEPRESSION; ANXIOLYTIC-LIKE; MICROGLIA; INHIBITION; ACTIVATION; PATHWAY; MODEL	Improper neuroimmune responses following chronic stress exposure have been reported to cause neuronal dysfunctions leading to memory impairment, anxiety and depression like behaviours. Though several factors affecting microglial activation and consequent alteration in neuro-inflammatory responses have been well studied, role of NO and its association with microglia in stress induced depression model is yet to be explored. In the present study, we validated combination of chronic hypobaric hypoxia and crowding (CHC) as a stress model for depression and investigated the role of chronic stress induced elevated nitric oxide (NO) level in microglia activation and its effect on neuro-inflammatory responses in brain. Further, we evaluated the ameliorative effect of L-N-G-Nitroarginine Methyl Ester (L-NAME) to reverse the stress induced depressive mood state. Four groups of male Sprague Dawley rat were taken and divided into control and CHC stress exposed group with and without treatment of L-NAME. Depression like behaviour and anhedonia in rats were assessed by Forced Swim Test (FST) and Sucrose Preference Test (SPT). Microglial activation was evaluated using Iba-1 immunohistochemistry and proinflammatory cytokines were assessed in the hippocampal region. Our result showed that exposure to CHC stress increased the number of active microglia with corresponding increase in inflammatory cytokines and altered behavioural responses. The inhibition of NO synthesis by L-NAME during CHC exposure decreased the number of active microglia in hippocampus as evident from decreased Iba-1 positive cells. Further, L-NAME administration decreased pro-inflammatory cytokines in hippocampus and improved behaviour of rats. Our study demonstrate that stress induced elevation of NO plays pivotal role in altered microglial activation and consequent neurodegenerative processes leading to depression like behaviour in rat.	[Deep, Satya Narayan; Prasad, Dipti; Singh, Shashi Bala] Def Inst Physiol & Allied Sci, Div Neurobiol, Lucknow Rd, Delhi 54, India; [Baitharu, Iswar] Sambalpur Univ, Post Grad Dept Environm Sci, Sambalpur, Odisha, India; [Sharma, Apurva] Punjab Tech Univ, Dept Pharmacol, Chandigarh, Punjab, India; [Gurjar, Anoop Kishor Singh] Bundelkhand Univ, Jhansi, Uttar Pradesh, India	Defence Research & Development Organisation (DRDO); Defence Institute of Physiology & Allied Sciences (DIPAS); Sambalpur University; I. K. Gujral Punjab Technical University; Bundelkhand University	Prasad, D (corresponding author), Def Inst Physiol & Allied Sci, Div Neurobiol, Lucknow Rd, Delhi 54, India.	drdiptinprasad@gmail.com	Singh, Shashi Bala/AAS-9889-2021; Baitharu, Iswar/AAM-3530-2021	Baitharu, Iswar/0000-0002-3046-2076	Defence Research and Development Organisation, Ministry of Defence, Government of India [DIP-13-254]; Council of Scientific and Industrial Research, New Delhi	Defence Research and Development Organisation, Ministry of Defence, Government of India(Defence Research & Development Organisation (DRDO)); Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by DIP-13-254, www.drdo.gov.in. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was supported by Defence Research and Development Organisation (Grant No. DIP-13-254), Ministry of Defence, Government of India. We are also thankful to Council of Scientific and Industrial Research, New Delhi for providing fellowship for conduction of the study smoothly.	Aloisi F., 2005, NEUROGLIA, V2nd, P285; Amiri S, 2015, PHYSIOL BEHAV, V145, P38, DOI 10.1016/j.physbeh.2015.03.032; Anisman H, 2008, PROG NEUROBIOL, V85, P1, DOI 10.1016/j.pneurobio.2008.01.004; Baitharu I, 2013, J BEHAV BRAIN SCI, V3, P591, DOI 10.4236/jbbs.2013.38063; Baitharu I, 2013, BEHAV BRAIN RES, V240, P76, DOI 10.1016/j.bbr.2012.11.005; Baitharu I, 2012, BEHAV BRAIN RES, V228, P53, DOI 10.1016/j.bbr.2011.11.030; Barhwal K, 2009, NEUROBIOL DIS, V34, P230, DOI 10.1016/j.nbd.2009.01.008; Bodet D, 2004, IMMUNO-ANAL BIOL SPE, V19, P138, DOI DOI 10.1016/J.IMMBI0.2004.03.007; Chaudhari UP, 2010, INT J PHARMACOL, V6, P183; De Vente J, 1998, NEUROSCIENCE, V87, P207, DOI 10.1016/S0306-4522(98)00171-7; Dhir A, 2007, EUR J PHARMACOL, V568, P177, DOI 10.1016/j.ejphar.2007.04.028; Faria MS, 1997, EUR J PHARMACOL, V323, P37, DOI 10.1016/S0014-2999(97)00027-7; Felger JC, 2007, BIOL PSYCHIAT, V62, P1324, DOI 10.1016/j.biopsych.2007.05.026; Garcia-Bueno B, 2008, ENDOCRINOLOGY, V149, P1969, DOI 10.1210/en.2007-0482; Gu HF, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/613879; Guillemin GJ, 2004, J LEUKOCYTE BIOL, V75, P388, DOI 10.1189/jlb.0303114; Hemmerle AM, 2012, EXP NEUROL, V233, P79, DOI 10.1016/j.expneurol.2011.09.035; Hota SK, 2009, NEUROBIOL DIS, V34, P23, DOI 10.1016/j.nbd.2008.12.006; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Jain V, 2012, CELL MOL NEUROBIOL, V32, P599, DOI 10.1007/s10571-012-9807-5; Joca SRL, 2006, PSYCHOPHARMACOLOGY, V185, P298, DOI 10.1007/s00213-006-0326-2; Kettenmann H, 2007, NATURE, V446, P987, DOI 10.1038/nature05713; Kubera M, 2011, PROG NEURO-PSYCHOPH, V35, P744, DOI 10.1016/j.pnpbp.2010.08.026; Kumar B, 2012, PHYTOTHER RES, V26, P488, DOI 10.1002/ptr.3584; Leonard BE, 2006, NEUROTOX RES, V10, P149; Levine J, 1999, NEUROPSYCHOBIOLOGY, V40, P171, DOI 10.1159/000026615; Licinio J, 1999, MOL PSYCHIATR, V4, P317, DOI 10.1038/sj.mp.4000586; Maes M, 1999, ADV EXP MED BIOL, V461, P25; Maes M, 1993, Rev Neurosci, V4, P407; MAES M, 1991, NEUROPSYCHOBIOLOGY, V24, P115, DOI 10.1159/000119472; Maes M, 2008, NEUROENDOCRINOL LETT, V29, P313; Maes M, 2011, PROG NEURO-PSYCHOPH, V35, P664, DOI 10.1016/j.pnpbp.2010.06.014; Maes M, 2009, METAB BRAIN DIS, V24, P27, DOI 10.1007/s11011-008-9118-1; Maiti P, 2010, ACTA HISTOCHEM, V112, P222, DOI 10.1016/j.acthis.2008.10.005; Muthuraju S, 2010, EXP BRAIN RES, V203, P583, DOI 10.1007/s00221-010-2266-7; Nadjar A, 2005, NEUROPSYCHOPHARMACOL, V30, P1492, DOI 10.1038/sj.npp.1300755; Nakajima K, 1998, Hum Cell, V11, P141; Napoli I, 2009, NEUROSCIENCE, V158, P1030, DOI 10.1016/j.neuroscience.2008.06.046; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; O'Connor JC, 2009, MOL PSYCHIATR, V14, P511, DOI 10.1038/sj.mp.4002148; Peng YL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-75; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Rock RB, 2004, CLIN MICROBIOL REV, V17, P942, DOI 10.1128/CMR.17.4.942-964.2004; Sevgi S, 2006, METHOD FIND EXP CLIN, V28, P95, DOI 10.1358/mf.2006.28.2.977840; Shukitt-Hale B, 1998, INT J AVIAT PSYCHOL, V8, P319, DOI 10.1207/s15327108ijap0804_1; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; SINGH SB, 1993, INT J BIOMETEOROL, V37, P200, DOI 10.1007/BF01387523; Skalisz LL, 2002, PROG NEURO-PSYCHOPH, V26, P879, DOI 10.1016/S0278-5846(01)00333-5; Sluzewska A, 1995, ANN NY ACAD SCI, V762, P474; SmithSwintosky VL, 1996, J CEREBR BLOOD F MET, V16, P585, DOI 10.1097/00004647-199607000-00008; Spiacci A, 2008, PHARMACOL BIOCHEM BE, V88, P247, DOI 10.1016/j.pbb.2007.08.008; Stefano GB, 2004, MED SCI MONITOR, V10, pBR17; Tiemeier H, 2003, EPIDEMIOLOGY, V14, P103, DOI 10.1097/00001648-200301000-00025; Tilleux S, 2007, J NEUROIMMUNOL, V189, P23, DOI 10.1016/j.jneuroim.2007.06.011; Tomaz VS, 2014, NEUROSCIENCE, V268, P236, DOI 10.1016/j.neuroscience.2014.03.025; Volke V, 2003, BEHAV BRAIN RES, V140, P141, DOI 10.1016/S0166-4328(02)00312-1; VOLKE V, 1995, NEUROREPORT, V6, P1413, DOI 10.1097/00001756-199507100-00013; Voorhees JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058488; Wang XM, 2006, CLIN PHARMACOL THER, V79, P303, DOI 10.1016/j.clpt.2005.12.306; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; WONG YN, 1994, J CHROMATOGR B, V661, P211, DOI 10.1016/0378-4347(94)00346-7; Wuwongse S, 2010, PROG NEUROBIOL, V91, P362, DOI 10.1016/j.pneurobio.2010.04.005	62	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153371	10.1371/journal.pone.0153371	http://dx.doi.org/10.1371/journal.pone.0153371			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082990	gold, Green Published, Green Submitted			2022-12-26	WOS:000374291800017
J	Vaulet, LG; Entrocassi, C; Portu, AI; Castro, E; Di Bartolomeo, S; Ruettger, A; Sachse, K; Fermepin, MR				Gallo Vaulet, Lucia; Entrocassi, Carolina; Portu, Ana I.; Castro, Erica; Di Bartolomeo, Susana; Ruettger, Anke; Sachse, Konrad; Rodriguez Fermepin, Marcelo			High Frequency of Chlamydia trachomatis Mixed Infections Detected by Microarray Assay in South American Samples	PLOS ONE			English	Article							DNA MICROARRAY; HYBRIDIZATION ASSAY; OMPA GENOTYPES; IDENTIFICATION; PCR; EPIDEMIOLOGY; SEROVARS	Chlamydia trachomatis is one of the most common sexually transmitted infections worldwide. Based on sequence variation in the ompA gene encoding the major outer membrane protein, the genotyping scheme distinguishes 17 recognized genotypes, i.e. A, B, Ba, C, D, Da, E, F, G, H, I, Ia, J, K, L1, L2, and L3. Genotyping is an important tool for epidemiological tracking of C. trachomatis infections, including the revelation of transmission pathways and association with tissue tropism and pathogenicity. Moreover, genotyping can be useful for clinicians to establish the correct treatment when LGV strains are detected. Recently a microarray assay was described that offers several advantages, such as rapidity, ease of standardization and detection of mixed infections. The aim of this study was to evaluate the performance of the DNA microarray-based assay for C. trachomatis genotyping of clinical samples already typed by PCR-RFLP from South America. The agreement between both typing techniques was 90.05% and the overall genotype distribution obtained with both techniques was similar. Detection of mixed-genotype infections was significantly higher using the microarray assay (8.4% of cases) compared to PCR-RFLP (0.5%). Among 178 samples, the microarray assay identified 10 ompA genotypes, i.e. D, Da, E, F, G, H, I, J, K and L2. The most predominant type was genotype E, followed by D and F.	[Gallo Vaulet, Lucia; Entrocassi, Carolina; Portu, Ana I.; Rodriguez Fermepin, Marcelo] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Microbiol Clin, RA-1113 Buenos Aires, DF, Argentina; [Castro, Erica] Univ San Sebastian, Fac Med, Concepcion, Chile; [Di Bartolomeo, Susana] Hosp Nacl Prof A Posadas, Serv Bioquim, Secc Bioquim Microbiol, Buenos Aires, DF, Argentina; [Ruettger, Anke; Sachse, Konrad] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Mol Pathogenesis, Jena, Germany	University of Buenos Aires; Universidad San Sebastian; University of Buenos Aires; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Friedrich Loeffler Institute	Vaulet, LG (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Catedra Microbiol Clin, RA-1113 Buenos Aires, DF, Argentina.	lgvaulet@ffyb.uba.ar	Sachse, Konrad/GWC-4999-2022; RODRIGUEZ FERMEPIN, Marcelo/AAY-7762-2021	Sachse, Konrad/0000-0003-1230-1786; RODRIGUEZ FERMEPIN, Marcelo/0000-0003-2543-4262	Universidad de Buenos Aires [UBACyT B810, UBACyT 20020090200460]; national research network "Zoonotic chlamydiae - Models of chronic and persistent infections in humans and animals"; Federal Ministry of Education and Research (BMBF) of Germany [01KI0720]	Universidad de Buenos Aires(University of Buenos Aires); national research network "Zoonotic chlamydiae - Models of chronic and persistent infections in humans and animals"; Federal Ministry of Education and Research (BMBF) of Germany(Federal Ministry of Education & Research (BMBF))	The study was financed in part by a grant of the Universidad de Buenos Aires UBACyT B810 and UBACyT 20020090200460 awarded to MRF. KS acknowledges financial support by the national research network "Zoonotic chlamydiae - Models of chronic and persistent infections in humans and animals," which was funded by the Federal Ministry of Education and Research (BMBF) of Germany under grant 01KI0720. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	BEbEar C, 2009, CLIN MICROBIOL INFEC, V15, P4, DOI 10.1111/j.1469-0691.2008.02647.x; Borel N, 2008, MOL CELL PROBE, V22, P55, DOI 10.1016/j.mcp.2007.06.003; Centers for Disease Control and Prevention [CDC], 2010, MORB MORT WKLY REP, V58, P26; Dean D, 2008, PLOS MED, V5, P57, DOI 10.1371/journal.pmed.0050014; Gallo Vaulet Lucia, 2010, BMC Res Notes, V3, P34, DOI 10.1186/1756-0500-3-34; Geisler WM, 2008, SEX TRANSM INFECT, V84, P541, DOI 10.1136/sti.2008.030825; Gharsallah H, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-333; Harris SR, 2012, NAT GENET, V44, P413, DOI 10.1038/ng.2214; Jalal H, 2007, J CLIN MICROBIOL, V45, P2649, DOI 10.1128/JCM.00451-07; Jonsdottir K, 2003, SEX TRANSM DIS, V30, P249, DOI 10.1097/00007435-200303000-00015; Joseph SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099290; Kapil R, 2015, J CLIN MICROBIOL, V53, P546, DOI 10.1128/JCM.02483-14; Klint M, 2006, J CLIN MICROBIOL, V44, P4066, DOI 10.1128/JCM.00574-06; Leinberger DM, 2005, J CLIN MICROBIOL, V43, P4943, DOI 10.1128/JCM.43.10.4943-4953.2005; Lysen M, 2004, J CLIN MICROBIOL, V42, P1641, DOI 10.1128/JCM.42.4.1641-1647.2004; Molano M, 2004, J CLIN MICROBIOL, V42, P2935, DOI 10.1128/JCM.42.7.2935-2939.2004; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Pedersen LN, 2009, FEMS IMMUNOL MED MIC, V55, P120, DOI 10.1111/j.1574-695X.2008.00526.x; Peipert JF, 2003, NEW ENGL J MED, V349, P2424, DOI 10.1056/NEJMcp030542; Psarrakos P, 2011, MOL CELL PROBE, V25, P168, DOI 10.1016/j.mcp.2011.04.003; Quint KD, 2007, J MOL DIAGN, V9, P631, DOI 10.2353/jmoldx.2007.070011; Ruettger A, 2011, MOL CELL PROBE, V25, P19, DOI 10.1016/j.mcp.2010.09.004; Ryabinin VA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017529; Sachse K, 2005, MOL CELL PROBE, V19, P41, DOI 10.1016/j.mcp.2004.09.005; Sachse K, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-63; Stevens MP, 2010, J CLIN MICROBIOL, V48, P2060, DOI 10.1128/JCM.02308-09; Stothard DR, 2001, J CLIN MICROBIOL, V39, P2655, DOI 10.1128/JCM.39.7.2655-2659.2001; White JA, 2009, CURR OPIN INFECT DIS, V22, P57, DOI 10.1097/QCO.0b013e328320a8ae; Wright HR, 2008, LANCET, V371, P1945, DOI 10.1016/S0140-6736(08)60836-3; Wylie JL, 2005, J INFECT DIS, V191, P899, DOI 10.1086/427661; Xiong LK, 2006, J CLIN MICROBIOL, V44, P1413, DOI 10.1128/JCM.44.4.1413-1418.2006; YUAN Y, 1989, INFECT IMMUN, V57, P1040, DOI 10.1128/IAI.57.4.1040-1049.1989	32	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153511	10.1371/journal.pone.0153511	http://dx.doi.org/10.1371/journal.pone.0153511			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082962	Green Published, Green Submitted, gold			2022-12-26	WOS:000374291800025
J	Saad, NS; Floyd, K; Ahmed, AAE; Mohler, PJ; Janssen, PML; Elnakish, MT				Saad, Nancy S.; Floyd, Kyle; Ahmed, Amany A. E.; Mohler, Peter J.; Janssen, Paul M. L.; Elnakish, Mohammad T.			The Effect of Sorafenib, Tadalafil and Macitentan Treatments on Thyroxin-Induced Hemodynamic Changes and Cardiac Abnormalities	PLOS ONE			English	Article							EXPERIMENTAL PULMONARY-HYPERTENSION; ENDOTHELIN RECEPTOR ANTAGONIST; ACUTE HEART-FAILURE; PROTEIN-KINASE; ANGIOTENSIN-II; BLOOD-PRESSURE; PHOSPHODIESTERASE-5 INHIBITOR; HYPERTROPHIC RESPONSE; VENTRICULAR-FUNCTION; UP-REGULATION	Multikinase inhibitors (e.g. Sorafenib), phosphodiesterase-5 inhibitors (e.g. Tadalafil), and endothelin-1 receptor blockers (e.g. Macitentan) exert influential protection in a variety of animal models of cardiomyopathy; however, their effects on thyroxin-induced cardiomyopathy have never been investigated. The goal of the present study was to assess the functional impact of these drugs on thyroxin-induced hemodynamic changes, cardiac hypertrophy and associated altered responses of the contractile myocardium both in-vivo at the whole heart level and ex-vivo at the cardiac tissue level. Control and thyroxin (500 mu g/kg/day)-treated mice with or without 2-week treatments of sorafenib (10 mg/kg/day; I.P), tadalafil (1 mg/kg/day; I.P or 4 mg/kg/day; oral), macitentan (30 and 100 mg/kg/day; oral), and their vehicles were studied. Blood pressure, echocardiography and electrocardiogram were non-invasively evaluated, followed by ex-vivo assessments of isolated multicellular cardiac preparations. Thyroxin increased blood pressure, resulted in cardiac hypertrophy and left ventricular dysfunction in-vivo. Also, it caused contractile abnormalities in right ventricular papillary muscles ex-vivo. None of the drug treatments were able to significantly attenuate theses hemodynamic changes or cardiac abnormalities in thyroxin-treated mice. We show here for the first time that multikinase (raf1/b, VEGFR, PDGFR), phosphodiesterase-5, and endothelin-1 pathways have no major role in thyroxin-induced hemodynamic changes and cardiac abnormalities. In particular, our data show that the involvement of endothelin-1 pathway in thyroxine-induced cardiac hypertrophy/dysfunction seems to be model-dependent and should be carefully interpreted.	[Saad, Nancy S.; Floyd, Kyle; Mohler, Peter J.; Janssen, Paul M. L.; Elnakish, Mohammad T.] Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Saad, Nancy S.; Floyd, Kyle; Mohler, Peter J.; Janssen, Paul M. L.; Elnakish, Mohammad T.] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Saad, Nancy S.; Ahmed, Amany A. E.; Elnakish, Mohammad T.] Helwan Univ, Dept Pharmacol & Toxicol, Fac Pharm, Cairo, Egypt	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Egyptian Knowledge Bank (EKB); Helwan University	Elnakish, MT (corresponding author), Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA.; Elnakish, MT (corresponding author), Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.; Elnakish, MT (corresponding author), Helwan Univ, Dept Pharmacol & Toxicol, Fac Pharm, Cairo, Egypt.	elnakish.1@osu.edu	Ahmed, Amany Ali Eissa/T-2497-2019	Janssen, Paul/0000-0002-9682-3014; Saad, Nancy/0000-0002-5194-7515	Ohio State University; NINDS [P30 NS045758-06]; American Heart Association [16POST27760155]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045758] Funding Source: NIH RePORTER	Ohio State University(Ohio State University); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding was provided in part through start-up funds to PMLJ from The Ohio State University, and by P30 core grant NINDS P30 NS045758-06 (PI: C. Beattie). MTE is supported by the American Heart Association Great Rivers Affiliate Post-doctoral Fellowship 16POST27760155.	Adamo CM, 2010, P NATL ACAD SCI USA, V107, P19079, DOI 10.1073/pnas.1013077107; Adiarto S, 2012, LIFE SCI, V91, P651, DOI 10.1016/j.lfs.2012.02.006; Al Husseini A, 2013, EUR RESPIR J, V41, P104, DOI 10.1183/09031936.00196511; Anand I, 2004, LANCET, V364, P347, DOI 10.1016/S0140-6736(04)16723-8; Andersen A, 2008, EUR J HEART FAIL, V10, P1158, DOI 10.1016/j.ejheart.2008.09.016; Antoun S, 2010, J CLIN ONCOL, V28, P1054, DOI 10.1200/JCO.2009.24.9730; Araujo ASR, 2007, MOL CELL BIOCHEM, V303, P89, DOI 10.1007/s11010-007-9459-9; Araujo ASR, 2011, MOL CELL ENDOCRINOL, V333, P78, DOI 10.1016/j.mce.2010.12.018; Araujo ASR, 2008, J MOL ENDOCRINOL, V41, P423, DOI 10.1677/JME-08-0024; Biondi B, 2012, EUR J ENDOCRINOL, V167, P609, DOI 10.1530/EJE-12-0627; Blasi E, 2012, CARDIOVASC THER, V30, P287, DOI 10.1111/j.1755-5922.2011.00278.x; Brandt F, 2011, EUR J ENDOCRINOL, V165, P491, DOI 10.1530/EJE-11-0299; CAMPBELL SE, 1988, J MOL CELL CARDIOL, V20, P379, DOI 10.1016/S0022-2828(88)80129-9; Araujo ASD, 2010, J CARDIOVASC PHARM, V56, P513, DOI 10.1097/FJC.0b013e3181f50a70; Dai WD, 2012, CIRCULATION, V125, P1341, DOI 10.1161/CIRCULATIONAHA.112.094912; Das A, 2009, AM J PHYSIOL-HEART C, V296, pH1236, DOI 10.1152/ajpheart.00100.2009; Dias AT, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0250-x; Dishy V, 2004, BRIT J CLIN PHARMACO, V57, P209, DOI 10.1046/j.1365-2125.2003.01974.x; Duran JM, 2014, CIRC RES, V114, P1700, DOI 10.1161/CIRCRESAHA.114.303200; ECKER T, 1989, CIRC RES, V65, P1361, DOI 10.1161/01.RES.65.5.1361; Elnakish MT, 2015, FREE RADICAL BIO MED, V83, P252, DOI 10.1016/j.freeradbiomed.2015.02.035; Elnakish MT, 2013, J CARDIOVASC PHARM, V61, P536, DOI 10.1097/FJC.0b013e31828d4b9d; Elnakish MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042500; Elnakish MT, ROLE OXIDATIVE STRES; Engel S, 2001, EUR J PHARMACOL, V421, P23, DOI 10.1016/S0014-2999(01)00993-1; Feng Y, 2007, PHARMACOL REP, V59, P306; Frey Maria Klara, 2012, Expert Opin Pharmacother, V13, P747, DOI 10.1517/14656566.2012.662220; Ghofrani HA, 2005, NEW ENGL J MED, V353, P1412, DOI 10.1056/NEJMc051946; Harris IS, 2004, CIRCULATION, V110, P718, DOI 10.1161/01.CIR.0000138190.50127.6A; Hassan Madiha A. H., 2005, BMC Pharmacology, V5, P10, DOI 10.1186/1471-2210-5-10; Heiden S, 2014, PLOS ONE, V9; Ho David, 2011, Curr Protoc Mouse Biol, V1, P123, DOI 10.1002/9780470942390.mo100159; Hocher B, 1999, HYPERTENSION, V33, P816, DOI 10.1161/01.HYP.33.3.816; Iglarz M, 2015, J CARDIOVASC PHARM, V66, P457, DOI 10.1097/FJC.0000000000000296; Iglarz M, 2014, LIFE SCI, V118, P333, DOI 10.1016/j.lfs.2014.02.018; ITO H, 1993, J CLIN INVEST, V92, P398, DOI 10.1172/JCI116579; Jin Z, 2013, J CARDIOL, V62, P110, DOI 10.1016/j.jjcc.2013.03.018; Kaddoura S, 1996, CIRCULATION, V93, P2068, DOI 10.1161/01.CIR.93.11.2068; Katz E, 2006, PEPTIDES, V27, P2276, DOI 10.1016/j.peptides.2006.04.011; Kedzierski RM, 2003, MOL CELL BIOL, V23, P8226, DOI 10.1128/MCB.23.22.8226-8232.2003; Klein M, 2008, CIRCULATION, V118, P2081, DOI 10.1161/CIRCULATIONAHA.108.779751; Kojonazarov B, 2013, INT J CARDIOL, V167, P2630, DOI 10.1016/j.ijcard.2012.06.129; Koka S, 2010, J PHARMACOL EXP THER, V334, P1023, DOI 10.1124/jpet.110.170191; Kuczynski EA, 2015, CANC RES; Kunita-Takanezawa M, 2014, J CARDIOVASC PHARM, V64, P473, DOI 10.1097/FJC.0000000000000141; Kuzman JA, 2005, J APPL PHYSIOL, V99, P1428, DOI 10.1152/japplphysiol.00515.2005; Kuzman JA, 2005, J MOL CELL CARDIOL, V39, P251, DOI 10.1016/j.yjmcc.2005.03.020; Li JS, 1996, AM J PHYSIOL-HEART C, V271, pH88, DOI 10.1152/ajpheart.1996.271.1.H88; Mahmud A, 2001, J HUM HYPERTENS, V15, P707, DOI 10.1038/sj.jhh.1001244; Maitland M, 2006, ASCO ANN M P; Milani-Nejad N, 2014, J MUSCLE RES CELL M, V35, P225, DOI 10.1007/s10974-014-9386-9; Moreno-Vinasco L, 2008, PHYSIOL GENOMICS, V33, P278, DOI 10.1152/physiolgenomics.00169.2007; Mortara L, 2014, J ENDOCRINOL INVEST, V37, P1099, DOI 10.1007/s40618-014-0177-3; Nagayama T, 2009, J AM COLL CARDIOL, V53, P207, DOI 10.1016/j.jacc.2008.08.069; Nagendran J, 2007, CIRCULATION, V116, P238, DOI 10.1161/CIRCULATIONAHA.106.655266; O'Connor CM, 2003, J AM COLL CARDIOL, V41, P1452, DOI 10.1016/S0735-1097(03)00194-3; Patrucco E, 2014, P NATL ACAD SCI USA, V111, P12925, DOI 10.1073/pnas.1414364111; Picard P, 1998, J CARDIOVASC PHARM, V31, pS294, DOI 10.1097/00005344-199800001-00082; Pieske B, 1999, CIRCULATION, V99, P1802, DOI 10.1161/01.CIR.99.14.1802; Pulido T, 2013, NEW ENGL J MED, V369, P809, DOI 10.1056/NEJMoa1213917; RODRIGUEZ EK, 1992, AM J PHYSIOL, V263, pH293, DOI 10.1152/ajpheart.1992.263.1.H293; Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212; Sakai S, 1996, CIRCULATION, V93, P1214, DOI 10.1161/01.CIR.93.6.1214; Salloum FN, 2008, AM J PHYSIOL-HEART C, V294, pH1398, DOI [10.1152/ajpheart.ajpheart.91438.2007, 10.1152/ajpheart.91438.2007]; Salloum FN, 2014, CARDIOVASC DRUG THER, V28, P493, DOI 10.1007/s10557-014-6559-0; Salloum FN, 2009, CIRCULATION, V120, pS31, DOI 10.1161/CIRCULATIONAHA.108.843979; Salonia A, 2003, CURR MED RES OPIN, V19, P241, DOI 10.1185/030079903125001839; Schermuly RT, 2005, J CLIN INVEST, V115, P2811, DOI 10.1172/JCI24838; Schwartz BG, 2012, J AM COLL CARDIOL, V59, P9, DOI 10.1016/j.jacc.2011.07.051; Shohet RV, 2004, P NATL ACAD SCI USA, V101, P2088, DOI 10.1073/pnas.0307159101; Stanley JL, 2012, HYPERTENSION, V59, P1021, DOI 10.1161/HYPERTENSIONAHA.111.186270; STEWART DJ, 1992, CIRCULATION, V85, P510, DOI 10.1161/01.CIR.85.2.510; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; Tang XY, 2008, PHARMACOL REP, V60, P524; TSE J, 1980, ENDOCRINOLOGY, V107, P6, DOI 10.1210/endo-107-1-6; Varma A, 2012, ANTIINFLAMMATORY CAR, DOI [10.1371/journal.pone.0045243 PMID: 23028874, DOI 10.1371/JOURNAL.PONE.0045243]; Wang YY, 2010, MOL CELL ENDOCRINOL, V320, P67, DOI 10.1016/j.mce.2010.01.031; Wangensteen R, 2006, AM J PHYSIOL-REG I, V291, pR1376, DOI 10.1152/ajpregu.00722.2005; WEISS HR, 1995, AM J PHYSIOL-HEART C, V268, pH686, DOI 10.1152/ajpheart.1995.268.2.H686; Xie YP, 2012, HYPERTENSION, V59, P355, DOI 10.1161/HYPERTENSIONAHA.111.180968; Yan L, 2003, CLIN EXP PHARMACOL P, V30, P943, DOI 10.1111/j.1440-1681.2003.03936.x; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Yang LL, 2004, CIRCULATION, V109, P255, DOI 10.1161/01.CIR.0000105701.98663.D4; Yogi A, 2007, ARTERIOSCL THROM VAS, V27, P1960, DOI 10.1161/ATVBAHA.107.146746; Zhang Y, 2008, INT J CARDIOL, V130, P463, DOI 10.1016/j.ijcard.2008.05.018; ZIERHUT W, 1989, J MOL CELL CARDIOL, V21, P617, DOI 10.1016/0022-2828(89)90827-4	86	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153694	10.1371/journal.pone.0153694	http://dx.doi.org/10.1371/journal.pone.0153694			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082116	Green Submitted, Green Published, gold			2022-12-26	WOS:000374291800046
J	Buell, KG; Puri, A; Demontis, MA; Short, CL; Adonis, A; Haddow, J; Martin, F; Dhasmana, D; Taylor, GP				Buell, Kevin G.; Puri, Aiysha; Demontis, Maria Antonietta; Short, Charlotte L.; Adonis, Adine; Haddow, Jana; Martin, Fabiola; Dhasmana, Divya; Taylor, Graham P.			Effect of Pulsed Methylprednisolone on Pain, in Patients with HTLV-1-Associated Myelopathy	PLOS ONE			English	Article							I-ASSOCIATED MYELOPATHY; TROPICAL SPASTIC PARAPARESIS; VIRUS TYPE-I; T-CELL LEUKEMIA; HTLV-I; DOUBLE-BLIND; THERAPY; LYMPHOCYTES; FREQUENCIES; PREDNISONE	HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is an immune mediated myelopathy caused by the human T-lymphotropic virus type 1 (HTLV-1). The efficacy of treatments used for patients with HAM/TSP is uncertain. The aim of this study is to document the efficacy of pulsed methylprednisolone in patients with HAM/TSP. Data from an open cohort of 26 patients with HAM/TSP was retrospectively analysed. 1g IV methylprednisolone was infused on three consecutive days. The outcomes were pain, gait, urinary frequency and nocturia, a range of inflammatory markers and HTLV-1 proviral load. Treatment was well tolerated in all but one patient. Significant improvements in pain were: observed immediately, unrelated to duration of disease and maintained for three months. Improvement in gait was only seen on Day 3 of treatment. Baseline cytokine concentrations did not correlate to baseline pain or gait impairment but a decrease in tumour necrosis factor-alpha (TNF-alpha) concentration after pulsed methylprednisolone was associated with improvements in both. Until compared with placebo, treatment with pulsed methylprednisolone should be offered to patients with HAM/TSP for the treatment of pain present despite regular analgesia.	[Buell, Kevin G.; Puri, Aiysha; Demontis, Maria Antonietta; Short, Charlotte L.; Taylor, Graham P.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Virol Sect, Norfolk Pl, London W2 1PG, England; [Adonis, Adine; Haddow, Jana; Dhasmana, Divya; Taylor, Graham P.] St Marys Hosp, Natl Ctr Human Retrovirol, Imperial Coll Healthcare NHS Trust, Praed St, London W2 1NY, England; [Martin, Fabiola] Univ York, Ctr Immunol & Infect, Hull York Med Sch, Dept Biol, York YO10 5DD, N Yorkshire, England	Imperial College London; Imperial College London; University of Hull; University of York - UK	Taylor, GP (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, Virol Sect, Norfolk Pl, London W2 1PG, England.; Taylor, GP (corresponding author), St Marys Hosp, Natl Ctr Human Retrovirol, Imperial Coll Healthcare NHS Trust, Praed St, London W2 1NY, England.	g.p.taylor@imperial.ac.uk	Adonis, Adine/AFR-0710-2022	Martin, Fabiola/0000-0003-4487-8803; Short, Charlotte-Eve/0000-0002-4974-8824; Buell, Kevin/0000-0001-5718-3328; Adonis, Adine/0000-0002-5372-8025				Araujo A Q, 1993, Arq Neuropsiquiatr, V51, P325; Carod-Artal FJ, 2000, REV NEUROLOGIA, V31, P32, DOI 10.33588/rn.3101.2000004; Coral LC, 1998, ARQ NEURO-PSIQUIAT, V56, P120, DOI 10.1590/S0004-282X1998000100020; Croda MG, 2008, J NEUROL SCI, V269, P133, DOI 10.1016/j.jns.2008.01.004; Daenke S, 1996, VIROLOGY, V217, P139, DOI 10.1006/viro.1996.0101; De Castro-Costa CM, 2006, AIDS RES HUM RETROV, V22, P931, DOI 10.1089/aid.2006.22.931; de Castro-Costa CM, 2009, ARQ NEURO-PSIQUIAT, V67, P866, DOI 10.1590/S0004-282X2009000500016; Demontis MA, 2013, AIDS RES HUM RETROV, V29, P359, DOI [10.1089/AID.2012.0132, 10.1089/aid.2012.0132]; ELOVAARA I, 1993, J EXP MED, V177, P1567, DOI 10.1084/jem.177.6.1567; European Centre for Disease Prevention and Control, 2015, GEOGR DISTR AR HIGH; FAUCI AS, 1976, CLIN EXP IMMUNOL, V24, P54; FAUCI AS, 1975, J CLIN INVEST, V55, P22, DOI 10.1172/JCI107914; FAUCI AS, 1975, BLOOD, V46, P235; Franzoi AC, 2007, SPINAL CORD, V45, P64, DOI 10.1038/sj.sc.3101919; FURUKAWA K, 1994, J CLIN INVEST, V94, P1830, DOI 10.1172/JCI117532; GARIN EH, 1986, EUR J PEDIATR, V145, P380, DOI 10.1007/BF00439243; GESSAIN A, 1985, LANCET, V2, P407; Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388; Goon PKC, 2003, J VIROL, V77, P9716, DOI 10.1128/JVI.77.17.9716-9722.2003; Goon PKC, 2002, BLOOD, V99, P3335, DOI 10.1182/blood.V99.9.3335; Gotuzzo E, 2004, CLIN INFECT DIS, V39, P939, DOI 10.1086/423957; Greten TF, 1998, P NATL ACAD SCI USA, V95, P7568, DOI 10.1073/pnas.95.13.7568; HARRINGTON WJ, 1991, AIDS RES HUM RETROV, V7, P1031, DOI 10.1089/aid.1991.7.1031; HINUMA Y, 1981, P NATL ACAD SCI-BIOL, V78, P6476, DOI 10.1073/pnas.78.10.6476; Hirahara K, 2013, J AM ACAD DERMATOL, V69, P496, DOI 10.1016/j.jaad.2013.04.007; Hollsberg P, 1997, ACTA NEUROL SCAND, V95, P86; IWASAKI Y, 1992, AM J PATHOL, V140, P1003; Izumo S, 1996, NEUROLOGY, V46, P1016, DOI 10.1212/WNL.46.4.1016; KAPLAN JE, 1990, J ACQ IMMUN DEF SYND, V3, P1096; KATAOKA A, 1993, J NEUROL NEUROSUR PS, V56, P1213, DOI 10.1136/jnnp.56.11.1213; KIRA J, 1991, J NEUROL SCI, V106, P41, DOI 10.1016/0022-510X(91)90192-A; Maloney EM, 1998, J ACQ IMMUN DEF SYND, V17, P167, DOI 10.1097/00042560-199802010-00011; Martin F, 2014, RETROVIROLOGY, V11, P31; Martin F, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001675; Martin F, 2010, J NEUROL NEUROSUR PS, V81, P1336, DOI 10.1136/jnnp.2009.191239; MILLIGAN NM, 1987, J NEUROL NEUROSUR PS, V50, P511, DOI 10.1136/jnnp.50.5.511; Murphy EL, 1997, NEUROLOGY, V48, P315, DOI 10.1212/WNL.48.2.315; Nagai M, 1998, J NEUROVIROL, V4, P586, DOI 10.3109/13550289809114225; NAKAGAWA M, 1995, J NEUROVIROL, V1, P50, DOI 10.3109/13550289509111010; Nakagawa M, 1996, J NEUROVIROL, V2, P345, DOI 10.3109/13550289609146899; Netto EC, 2011, CLIN J PAIN, V27, P131, DOI 10.1097/AJP.0b013e3181f195d3; Olindo S, 2006, ARCH NEUROL-CHICAGO, V63, P1560, DOI 10.1001/archneur.63.11.1560; Oliveira P, 2007, CLINICS, V62, P191, DOI 10.1590/S1807-59322007000200015; OSAME M, 1986, LANCET, V1, P1031; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Tanajura D, 2015, CLIN INFECT DIS, V61, P49, DOI 10.1093/cid/civ229; Tavares IR, 2010, SPINAL CORD, V48, P134, DOI 10.1038/sc.2009.83; Taylor GP, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-63; UMEHARA F, 1993, J NEUROPATH EXP NEUR, V52, P424, DOI 10.1097/00005072-199307000-00010; *WHO, 1989, WHO WKLY EPIDEMIOL R, V49, P382; WILLIAMS IA, 1988, ANN RHEUM DIS, V47, P930, DOI 10.1136/ard.47.11.930	51	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0152557	10.1371/journal.pone.0152557	http://dx.doi.org/10.1371/journal.pone.0152557			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077747	Green Submitted, gold, Green Published			2022-12-26	WOS:000374131700005
J	Zhang, NN; Liu, HJ; Yue, GJ; Zhang, Y; You, JF; Wang, H				Zhang, Nana; Liu, Haijing; Yue, Guanjun; Zhang, Yan; You, Jiangfeng; Wang, Hua			Molecular Heterogeneity of Ewing Sarcoma as Detected by Ion Torrent Sequencing	PLOS ONE			English	Article							CELL LUNG-CANCER; PEUTZ-JEGHERS-SYNDROME; SOMATIC MUTATIONS; GROWTH-FACTOR; TUMOR; GENE; EXPRESSION; CHEMOTHERAPY; FAMILY; BONE	Ewing sarcoma (ES) is the second most common malignant bone and soft tissue tumor in children and adolescents. Despite advances in comprehensive treatment, patients with ES metastases still suffer poor outcomes, thus, emphasizing the need for detailed genetic profiles of ES patients to identify suitable molecular biomarkers for improved prognosis and development of effective and targeted therapies. In this study, the next generation sequencing Ion AmpliSeq (TM) Cancer Hotspot Panel v2 was used to identify cancer-related gene mutations in the tissue samples from 20 ES patients. This platform targeted 207 amplicons of 2800 loci in 50 cancer-related genes. Among the 20 tissue specimens, 62 nonsynonymous hotspot mutations were identified in 26 cancer-related genes, revealing the molecular heterogeneity of ES. Among these, five novel mutations in cancer-related genes (KDR, STK11, MLH1, KRAS, and PTPN11) were detected in ES, and these mutations were confirmed with traditional Sanger sequencing. ES patients with KDR, STK11, and MLH1 mutations had higher Ki-67 proliferation indices than the ES patients lacking such mutations. Notably, more than half of the ES patients harbored one or two possible 'druggable' mutations that have been previously linked to a clinical cancer treatment option. Our results provided the foundation to not only elucidate possible mechanisms involved in ES pathogenesis but also indicated the utility of Ion Torrent sequencing as a sensitive and cost-effective tool to screen key oncogenes and tumor suppressors in order to develop personalized therapy for ES patients.	[Zhang, Nana; Liu, Haijing; Yue, Guanjun; Zhang, Yan; You, Jiangfeng; Wang, Hua] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Pathol, Beijing 100871, Peoples R China; [Zhang, Nana; Liu, Haijing; Yue, Guanjun; Zhang, Yan; You, Jiangfeng; Wang, Hua] Peking Univ, Hosp 3, Dept Pathol, Beijing 100871, Peoples R China	Peking University; Peking University	Wang, H (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Pathol, Beijing 100871, Peoples R China.; Wang, H (corresponding author), Peking Univ, Hosp 3, Dept Pathol, Beijing 100871, Peoples R China.	huawanghw@163.com			National Natural Science Foundation of China [81272945]; Beijing Natural Science Foundation of China [7122100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation of China(Beijing Natural Science Foundation)	This work was supported by the National Natural Science Foundation of China (Grant No. 81272945) and the Beijing Natural Science Foundation of China (Grant No. 7122100). Hua Wang, as a project leader of the above grand, was responsible for the study design, decision to publish and manuscript revise. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ab Mutalib Nurul-Syakima, 2014, BMC Res Notes, V7, P805, DOI 10.1186/1756-0500-7-805; Arvand A, 2001, ONCOGENE, V20, P5747, DOI 10.1038/sj.onc.1204598; Atak ZK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038463; Bacci G, 2002, EUR J CANCER, V38, P2243, DOI 10.1016/S0959-8049(02)00148-X; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Brohl AS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004475; Chen H, 2010, EJSO-EUR J SURG ONC, V36, P657, DOI 10.1016/j.ejso.2010.05.014; Chernoguz A, 2012, J SURG RES, V173, P1, DOI 10.1016/j.jss.2011.04.041; Di Nicolantonio F, 2010, J CLIN INVEST, V120, P2858, DOI 10.1172/JCI37539; Dong GL, 2012, CANCER SCI, V103, P561, DOI 10.1111/j.1349-7006.2011.02194.x; Dong SM, 1998, CANCER RES, V58, P3787; Fearnhead NS, 2001, HUM MOL GENET, V10, P721, DOI 10.1093/hmg/10.7.721; Forcet C, 2005, HUM MOL GENET, V14, P1283, DOI 10.1093/hmg/ddi139; Furcht CM, 2013, ONCOGENE, V32, P2346, DOI 10.1038/onc.2012.240; Gao Y, 2015, MOL NEUROBIOLOGY; Glubb DM, 2011, CLIN CANCER RES, V17, P5257, DOI 10.1158/1078-0432.CCR-11-0379; Hadd AG, 2013, J MOL DIAGN, V15, P234, DOI 10.1016/j.jmoldx.2012.11.006; Haluska P, 2008, MOL CANCER THER, V7, P2589, DOI 10.1158/1535-7163.MCT-08-0493; Herrero-Martin David, 2011, Sarcoma, V2011, P352580, DOI 10.1155/2011/352580; Hezel AF, 2008, ONCOGENE, V27, P6908, DOI 10.1038/onc.2008.342; Hu ZQ, 2014, ONCOL REP, V32, P205, DOI 10.3892/or.2014.3201; Huang HY, 2005, J CLIN ONCOL, V23, P548, DOI 10.1200/JCO.2005.02.081; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; Jiang J, 2013, WORLD J GASTROENTERO, V19, P575, DOI 10.3748/wjg.v19.i4.575; Kanagal-Shamanna R, 2014, MODERN PATHOL, V27, P314, DOI 10.1038/modpathol.2013.122; Kastritis E, 2009, INT J CANCER, V124, P103, DOI 10.1002/ijc.23917; Kim YM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099451; Kolb EA, 2003, J CLIN ONCOL, V21, P3423, DOI 10.1200/JCO.2003.10.033; KOVAR H, 1993, ONCOGENE, V8, P2683; Kreuter M, 2006, EUR J CANCER, V42, P1904, DOI 10.1016/j.ejca.2006.01.063; Kushner BH, 2001, J CLIN ONCOL, V19, P870, DOI 10.1200/JCO.2001.19.3.870; Lee SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090459; Lee YC, 2015, MOL CLIN ONCOL, V3, P1375, DOI 10.3892/mco.2015.642; Leppanen VM, 2011, BLOOD, V117, P1507, DOI 10.1182/blood-2010-08-301549; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Ordonez JL, 2009, CANCER RES, V69, P7140, DOI 10.1158/0008-5472.CAN-08-4041; Murray S, 2006, LUNG CANCER, V52, P225, DOI 10.1016/j.lungcan.2005.12.015; Naing A, 2012, CLIN CANCER RES, V18, P2625, DOI 10.1158/1078-0432.CCR-12-0061; Nathke I, 2004, J CELL SCI, V117, P4873, DOI 10.1242/jcs.01313; Ohsawa T, 2009, MOL MED REP, V2, P887, DOI 10.3892/mmr_00000187; Riggi N, 2008, CANCER RES, V68, P2176, DOI 10.1158/0008-5472.CAN-07-1761; Ross Keir A, 2013, ISRN Oncol, V2013, P759725, DOI 10.1155/2013/759725; Rowan AJ, 2000, P NATL ACAD SCI USA, V97, P3352, DOI 10.1073/pnas.97.7.3352; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Sand LGL, 2015, INT J MOL SCI, V16, P16176, DOI 10.3390/ijms160716176; Su GH, 1999, AM J PATHOL, V154, P1835, DOI 10.1016/S0002-9440(10)65440-5; Subbiah V, 2009, CURR TREAT OPTION ON, V10, P126, DOI 10.1007/s11864-009-0104-6; Suda K, 2010, CANCER METAST REV, V29, P49, DOI 10.1007/s10555-010-9209-4; Takyar S, 2016, ANTICANCER DRUGS; Terrier P, 1996, SEMIN DIAGN PATHOL, V13, P250; Whitehall VLJ, 2014, EPIGENETICS-US, V9, P1454, DOI 10.4161/15592294.2014.971624; Xu RF, 2011, BIOMED PHARMACOTHER, V65, P22, DOI 10.1016/j.biopha.2010.06.009; Yang F, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004147; Zhang J, 2011, DISCRETE DYN NAT SOC, V2011, DOI [10.1155/2011/958381, 10.1093/database/bar026]	54	11	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153546	10.1371/journal.pone.0153546	http://dx.doi.org/10.1371/journal.pone.0153546			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077911	gold, Green Published			2022-12-26	WOS:000374131700076
J	Zhang, Y; Xu, C; Zheng, H; Loh, HH; Law, PY				Zhang, Yue; Xu, Chi; Zheng, Hui; Loh, Horace H.; Law, Ping-Yee			Morphine Modulates Adult Neurogenesis and Contextual Memory by Impeding the Maturation of Neural Progenitors	PLOS ONE			English	Article							HIPPOCAMPAL NEUROGENESIS; CELL-PROLIFERATION; PLACE PREFERENCE; DENTATE GYRUS; GRANULE CELLS; NEURONS; SURVIVAL; COCAINE; EXPRESSION; MARKER	The regulation of adult neurogenesis by opiates has been implicated in modulating different addiction cycles. At which neurogenesis stage opiates exert their action remains unresolved. We attempt to define the temporal window of morphine's inhibition effect on adult neurogenesis by using the POMC-EGFP mouse model, in which newborn granular cells (GCs) can be visualized between days 3-28 post-mitotic. The POMC-EGFP mice were trained under the 3-chambers conditioned place preference (CPP) paradigm with either saline or morphine. We observed after 4 days of CPP training with saline, the number of EGFP-labeled newborn GCs in sub-granular zone (SGZ) hippocampus significantly increased compared to mice injected with saline in their homecage. CPP training with morphine significantly decreased the number of EGFP-labeled GCs, whereas no significant difference in the number of EGFP-labeled GCs was observed with the homecage mice injected with the same dose of morphine. Using cell-type selective markers, we observed that morphine reduced the number of late stage progenitors and immature neurons such as Doublecortin (DCX) and beta III Tubulin (TuJ1) positive cells in the SGZ but did not reduce the number of early progenitors such as Nestin, SOX2, or neurogenic differentiation-1 (NeuroD1) positive cells. Analysis of co-localization between different cell markers shows that morphine reduced the number of adult-born GCs by interfering with differentiation of early progenitors, but not by inducing apoptosis. In addition, when NeuroD1 was over-expressed in DG by stereotaxic injection of lentivirus, it rescued the loss of immature neurons and prolonged the extinction of morphine-trained CPP. These results suggest that under the condition of CPP training paradigm, morphine affects the transition of neural progenitor/stem cells to immature neurons via a mechanism involving NeuroD1.	[Zhang, Yue; Xu, Chi; Zheng, Hui; Loh, Horace H.; Law, Ping-Yee] Univ Minnesota, Dept Pharmacol, 6-120 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA; [Zheng, Hui] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, South China Inst Stem Cell Biol & Regenerat Med, 190 Kaiyuan Ave, Guangzhou 510530, Guangdong, Peoples R China	University of Minnesota System; University of Minnesota Twin Cities; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Zhang, Y (corresponding author), Univ Minnesota, Dept Pharmacol, 6-120 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	zhan0975@umn.edu	Zhang, Yue/AAC-7170-2021; Xu, Chi/N-5249-2014	Xu, Chi/0000-0001-5470-7376; Zhang, Yue/0000-0003-2128-8472	National Institutes of Health, National Institute of Drug Abuse [DA031442-02]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA031442] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health, National Institute of Drug Abuse (Grant DA031442-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arguello AA, 2008, NEUROSCIENCE, V157, P70, DOI 10.1016/j.neuroscience.2008.08.064; Arguello AA, 2009, NEUROSCIENCE, V159, P1003, DOI 10.1016/j.neuroscience.2009.01.020; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Chae JH, 2004, MOL CELLS, V18, P271; Cunningham CL, 2006, BEHAV NEUROSCI, V120, P1115, DOI 10.1037/0735-7044.120.5.1115; Dayer AG, 2003, J COMP NEUROL, V460, P563, DOI 10.1002/cne.10675; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Eisch AJ, 2000, P NATL ACAD SCI USA, V97, P7579, DOI 10.1073/pnas.120552597; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Fischer SJ, 2008, NEUROSCIENCE, V151, P1217, DOI 10.1016/j.neuroscience.2007.11.035; Gao ZL, 2009, NAT NEUROSCI, V12, P1090, DOI 10.1038/nn.2385; Guo ZY, 2014, CELL STEM CELL, V14, P188, DOI 10.1016/j.stem.2013.12.001; Harburg GC, 2007, NEUROSCIENCE, V144, P77, DOI 10.1016/j.neuroscience.2006.09.018; Hevner RF, 2006, NEUROSCI RES, V55, P223, DOI 10.1016/j.neures.2006.03.004; Hicks MP, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/283829; Hodge RD, 2008, J NEUROSCI, V28, P3707, DOI 10.1523/JNEUROSCI.4280-07.2008; Ihrie RA, 2008, CELL TISSUE RES, V331, P179, DOI 10.1007/s00441-007-0461-z; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kobilo T, 2011, LEARN MEMORY, V18, P605, DOI 10.1101/lm.2283011; Lai KO, 2009, CURR OPIN NEUROBIOL, V19, P275, DOI 10.1016/j.conb.2009.04.009; Liao D, 2005, P NATL ACAD SCI USA, V102, P1725, DOI 10.1073/pnas.0406797102; Liu M, 2000, P NATL ACAD SCI USA, V97, P865, DOI 10.1073/pnas.97.2.865; Miyachi T, 1999, MOL BRAIN RES, V69, P223, DOI 10.1016/S0169-328X(99)00112-6; Mustroph ML, 2011, EUR J NEUROSCI, V34, P1161, DOI 10.1111/j.1460-9568.2011.07828.x; Noonan MA, 2008, J NEUROSCI, V28, P2516, DOI 10.1523/JNEUROSCI.4661-07.2008; Noonan MA, 2010, J NEUROSCI, V30, P304, DOI 10.1523/JNEUROSCI.4256-09.2010; Nugent FS, 2007, NATURE, V446, P1086, DOI 10.1038/nature05726; Overstreet LS, 2004, J NEUROSCI, V24, P3251, DOI 10.1523/JNEUROSCI.5173-03.2004; Preston KL, 2011, PSYCHOPHARMACOLOGY, V218, P29, DOI 10.1007/s00213-011-2183-x; Recinto P, 2012, NEUROPSYCHOPHARMACOL, V37, P1275, DOI 10.1038/npp.2011.315; Roybon L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004779; Sastry L, 2002, GENE THER, V9, P1155, DOI 10.1038/sj.gt.3301731; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Scardigli R, 2003, DEVELOPMENT, V130, P3269, DOI 10.1242/dev.00539; Seo S, 2007, EMBO J, V26, P5093, DOI 10.1038/sj.emboj.7601923; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Sommer L, 2002, PROG NEUROBIOL, V66, P1, DOI 10.1016/S0301-0082(01)00022-3; Teuchert-Noodt G, 2000, J NEURAL TRANSM, V107, P133, DOI 10.1007/s007020050012; van Hooijdonk LWA, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-2; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; von Bohlen und Halbach O, 2007, CELL TISSUE RES, V329, P409, DOI 10.1007/s00441-007-0432-4; Willner D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103043; Xu C., 2014, SPRINGER BRIEFS COMP, P1; Xu C, 2014, STEM CELLS, V32, P2961, DOI 10.1002/stem.1774; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zheng H, 2013, NEUROPSYCHOPHARMACOL, V38, P770, DOI 10.1038/npp.2012.242; Zheng H, 2010, J NEUROSCI, V30, P8102, DOI 10.1523/JNEUROSCI.6069-09.2010	50	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153628	10.1371/journal.pone.0153628	http://dx.doi.org/10.1371/journal.pone.0153628			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078155	gold, Green Published, Green Submitted			2022-12-26	WOS:000374131700098
J	Barber, ALA; Randi, D; Muller, CA; Huber, L				Barber, Anjuli L. A.; Randi, Dania; Mueller, Corsin A.; Huber, Ludwig			The Processing of Human Emotional Faces by Pet and Lab Dogs: Evidence for Lateralization and Experience Effects	PLOS ONE			English	Article							HUMAN COMMUNICATIVE SIGNALS; CANIS-FAMILIARIS; FACIAL EXPRESSIONS; PAN-TROGLODYTES; CHIMERIC FACES; RHESUS-MONKEYS; RECOGNITION; PERCEPTION; CHIMPANZEES; DISCRIMINATION	From all non-human animals dogs are very likely the best decoders of human behavior. In addition to a high sensitivity to human attentive status and to ostensive cues, they are able to distinguish between individual human faces and even between human facial expressions. However, so far little is known about how they process human faces and to what extent this is influenced by experience. Here we present an eye-tracking study with dogs emanating from two different living environments and varying experience with humans: pet and lab dogs. The dogs were shown pictures of familiar and unfamiliar human faces expressing four different emotions. The results, extracted from several different eye-tracking measurements, revealed pronounced differences in the face processing of pet and lab dogs, thus indicating an influence of the amount of exposure to humans. In addition, there was some evidence for the influences of both, the familiarity and the emotional expression of the face, and strong evidence for a left gaze bias. These findings, together with recent evidence for the dog's ability to discriminate human facial expressions, indicate that dogs are sensitive to some emotions expressed in human faces.	[Barber, Anjuli L. A.] Med Univ Vienna, Univ Vet Med Vienna, Messerli Res Inst, Comparat Cognit, Vienna, Austria; Univ Vienna, Vienna, Austria	Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna	Barber, ALA (corresponding author), Med Univ Vienna, Univ Vet Med Vienna, Messerli Res Inst, Comparat Cognit, Vienna, Austria.	anjuli.barber@vetmeduni.ac.at		Barber, Anjuli/0000-0002-6826-960X; Huber, Ludwig/0000-0002-0217-136X	Vienna Science and Technology Funds (WWTF) [CS11-005]	Vienna Science and Technology Funds (WWTF)	The research presented here was funded by the Vienna Science and Technology Funds (WWTF), No. CS11-005; http://www.wwtf.at/) to LH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi I, 2007, ANIM COGN, V10, P17, DOI 10.1007/s10071-006-0025-8; Adolphs R, 2001, NEUROPSYCHOLOGY, V15, P516, DOI 10.1037//0894-4105.15.4.516; Althoff RR, 1999, J EXP PSYCHOL LEARN, V25, P997, DOI 10.1037/0278-7393.25.4.997; Alves Nelson Torro, 2008, Psychol. Neurosci., V1, P63, DOI 10.1590/S1983-32882008000100010; Barton JJS, 2006, PERCEPTION, V35, P1089, DOI 10.1068/p5547; Bates D, 2014, JOURNAL OF STATISTIC, pxx; Borod JC, 1983, COGNITIVE PROCESSING; Bourne VJ, 2008, LATERALITY, V13, P92, DOI 10.1080/13576500701754315; Bradshaw J., 2014, DOG SENSE NEW SCI DO; Brauer J, 2014, THE SOCIAL DOG, DOI [10.1016/B978-0-12-407818-5.00010-3, DOI 10.1016/B978-0-12-407818-5.00010-3]; Bruce V., 1998, EYE BEHOLDER SCI FAC; Butler S, 2005, NEUROPSYCHOLOGIA, V43, P52, DOI 10.1016/j.neuropsychologia.2004.06.005; de Wit TCJ, 2008, RES AUTISM SPECT DIS, V2, P651, DOI 10.1016/j.rasd.2008.01.004; DEKOSKY ST, 1980, BRAIN LANG, V9, P206, DOI 10.1016/0093-934X(80)90141-8; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; Dilks DD, 2015, PEERJ, V3, DOI 10.7717/peerj.1115; Dufour V, 2006, BEHAV PROCESS, V73, P107, DOI 10.1016/j.beproc.2006.04.006; Ehrlichman H., 1987, DUALITY UNITY BRAIN, P194, DOI DOI 10.1007/978-1-4613-1949-8_13; Ekman P, 1972, EMOTION HUMAN FACE, DOI [10.1016/B978-0-08-016643-8.50001-X, DOI 10.1016/B978-0-08-016643-8.50001-X]; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Fried I, 1997, NEURON, V18, P753, DOI 10.1016/S0896-6273(00)80315-3; Friesen WV, 1975, J PERSONALITY; Gacsi M, 2005, DEV PSYCHOBIOL, V47, P111, DOI 10.1002/dev.20082; Gacsi M, 2004, ANIM COGN, V7, P144, DOI 10.1007/s10071-003-0205-8; Gliga T, 2007, PROG BRAIN RES, V164, P323, DOI 10.1016/S0079-6123(07)64018-7; Gothard KM, 2009, ANIM COGN, V12, P155, DOI 10.1007/s10071-008-0179-7; Guo K, 2009, ANIM COGN, V12, P409, DOI 10.1007/s10071-008-0199-3; Holmqvist K., 2011, EYE TRACKING COMPREH; Horowitz A, 2014, SCI STUDY CANIS FAMI; Huber L., 2010, ENCY ANIMAL BEHAV, P261, DOI DOI 10.1016/B978-0-08-045337-8.00096-6; Huber L, 2014, J VET BEHAV, V9, pe7, DOI [10.1016/j.jveb.2014.09.026, DOI 10.1016/J.JVEB.2014.09.026]; Hunnius S, 2011, COGNITION EMOTION, V25, P193, DOI 10.1080/15298861003771189; Kalin NH, 1998, BEHAV NEUROSCI, V112, P286, DOI 10.1037/0735-7044.112.2.286; Kaminski J., 2014, SOCIAL DOG BEHAV COG; Kanazawa S, 1996, PRIMATES, V37, P25, DOI 10.1007/BF02382917; Kano F, 2010, ANIM BEHAV, V79, P227, DOI 10.1016/j.anbehav.2009.11.003; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; Kendrick KM, 1996, BEHAV PROCESS, V38, P19, DOI 10.1016/0376-6357(96)00006-X; Kendrick KM, 2006, CORTEX, V42, P96, DOI 10.1016/S0010-9452(08)70328-9; Kirchhofer KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030913; Le Grand R, 2001, NATURE, V410, P890, DOI 10.1038/35073749; Lee E, 2008, PSYCHIAT RES, V157, P77, DOI 10.1016/j.psychres.2007.02.005; Lee WY, 2011, ANIM COGN, V14, P817, DOI 10.1007/s10071-011-0415-4; Leopold DA, 2010, J COMP PSYCHOL, V124, P233, DOI 10.1037/a0019460; Liversedge S., 2011, OXFORD HDB EYE MOVEM; Marechal L, 2010, ANIM BEHAV, V79, P1157, DOI 10.1016/j.anbehav.2010.02.022; Miklosi A, 2003, CURR BIOL, V13, P763, DOI 10.1016/S0960-9822(03)00263-X; Miklosi A., 2014, DOG BEHAV EVOLUTION; Mondloch CJ, 2003, DEVELOPMENT OF FACE PROCESSING IN INFACY AND EARLY CHILDHOOD: CURRENT PERSPECTIVES, P99; Muller CA, 2015, CURR BIOL, V25, P601, DOI 10.1016/j.cub.2014.12.055; Nagasawa M, 2011, ANIM COGN, V14, P525, DOI 10.1007/s10071-011-0386-5; Nitzschner M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046880; Parr L., 1999, ANIM COGN, V2, P123, DOI [10.1007/s100710050032, DOI 10.1007/S100710050032]; Parr LA, 1999, NATURE, V399, P647, DOI 10.1038/21345; Parr LA, 2000, PHYSIOL BEHAV, V71, P363, DOI 10.1016/S0031-9384(00)00349-8; Parr LA, 2000, J COMP PSYCHOL, V114, P47, DOI 10.1037//0735-7036.114.1.47; Parr LA, 1998, J COGNITIVE NEUROSCI, V10, P615, DOI 10.1162/089892998563013; Pascalis O, 2002, SCIENCE, V296, P1321, DOI 10.1126/science.1070223; Peterson M. A., 2006, PERCEPTION FACES OBJ, DOI [10.1093/acprof:Oso/9780195313659.001.0001, DOI 10.1093/ACPROF:OSO/9780195313659.001.0001]; Peterson MF, 2012, P NATL ACAD SCI USA, V109, pE3314, DOI 10.1073/pnas.1214269109; Phillips ML, 1997, BRAIN COGNITION, V35, P225, DOI 10.1006/brcg.1997.0939; Proops L, 2009, P NATL ACAD SCI USA, V106, P947, DOI 10.1073/pnas.0809127105; Quaranta A, 2007, CURR BIOL, V17, pR199, DOI 10.1016/j.cub.2007.02.008; R Development Core Team, 2014, R LANG ENV STAT COMP, P409; Racca A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036076; Racca A, 2010, ANIM COGN, V13, P525, DOI 10.1007/s10071-009-0303-3; RYAN CME, 1994, BEHAV PROCESS, V33, P155, DOI 10.1016/0376-6357(94)90064-7; Salva OR, 2015, NEUROSCI BIOBEHAV R, V50, P150, DOI 10.1016/j.neubiorev.2014.12.015; Salva OR, 2012, COMP COGN BEHAV REV, V7, P110, DOI 10.3819/ccbr.2012.70006; Salva OR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018802; Siniscalchi M, 2010, BEHAV BRAIN RES, V208, P516, DOI 10.1016/j.bbr.2009.12.042; Siniscalchi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003349; Somppi S, 2014, ANIM COGN, V17, P793, DOI 10.1007/s10071-013-0713-0; Somppi S, 2012, ANIM COGN, V15, P163, DOI 10.1007/s10071-011-0442-1; Stephan C, 2012, AVIAN BIOL RES, V5, P75, DOI 10.3184/175815512X13350970204867; SUBERI M, 1977, NEUROPSYCHOLOGIA, V15, P757, DOI 10.1016/0028-3932(77)90006-9; Tate AJ, 2006, PHILOS T R SOC B, V361, P2155, DOI 10.1098/rstb.2006.1937; Teglas E, 2012, CURR BIOL, V22, P209, DOI 10.1016/j.cub.2011.12.018; Thieltges H, 2011, ANIM COGN, V14, P303, DOI 10.1007/s10071-010-0354-5; TOMKINS SS, 1964, PERCEPT MOTOR SKILL, V18, P119, DOI 10.2466/pms.1964.18.1.119; Topal J, 2014, THE SOCIAL DOG, P1; Tsao DY, 2008, ANNU REV NEUROSCI, V31, P411, DOI 10.1146/annurev.neuro.30.051606.094238; Udell MAR, 2011, LEARN BEHAV, V39, P318, DOI 10.3758/s13420-011-0043-5; Viranyi Z, 2008, ANIM COGN, V11, P373, DOI 10.1007/s10071-007-0127-y; Watling D, 2012, LATERALITY, V17, P389, DOI 10.1080/1357650X.2012.682160; Wobber V, 2009, INTERACT STUD, V10, P206, DOI 10.1075/is.10.2.06wob	86	36	36	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152393	10.1371/journal.pone.0152393	http://dx.doi.org/10.1371/journal.pone.0152393			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UC	27074009	Green Published, gold, Green Submitted			2022-12-26	WOS:000374131200023
J	Ranaware, PB; Mishra, A; Vijayakumar, P; Gandhale, PN; Kumar, H; Kulkarni, DD; Raut, AA				Ranaware, Pradip B.; Mishra, Anamika; Vijayakumar, Periyasamy; Gandhale, Pradeep N.; Kumar, Himanshu; Kulkarni, Diwakar D.; Raut, Ashwin Ashok			Genome Wide Host Gene Expression Analysis in Chicken Lungs Infected with Avian Influenza Viruses	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSE; CYTOKINE RESPONSES; RIG-I; ANTIVIRAL RESPONSES; A-VIRUS; EPITHELIAL-CELLS; H5N1 INFECTION; PATHOGENESIS; DUCKS; PATHOGENICITY	The molecular pathogenesis of avian influenza infection varies greatly with individual bird species and virus strain. The molecular pathogenesis of the highly pathogenic avian influenza virus (HPAIV) or the low pathogenic avian influenza virus (LPAIV) infection in avian species remains poorly understood. Thus, global immune response of chickens infected with HPAI H5N1 (A/duck/India/02CA10/2011) and LPAI H9N2 (A/duck/India/249800/2010) viruses was studied using microarray to identify crucial host genetic components responsive to these infection. HPAI H5N1 virus induced excessive expression of type I IFNs (IFNA and IFNG), cytokines (IL1B, IL18, IL22, IL13, and IL12B), chemokines (CCL4, CCL19, CCL10, and CX3CL1) and IFN stimulated genes (OASL, MX1, RSAD2, IFITM5, IFIT5, GBP 1, and EIF2AK) in lung tissues. This dysregulation of host innate immune genes may be the critical determinant of the severity and the outcome of the influenza infection in chickens. In contrast, the expression levels of most of these genes was not induced in the lungs of LPAI H9N2 virus infected chickens. This study indicated the relationship between host immune genes and their roles in pathogenesis of HPAIV infection in chickens.	[Ranaware, Pradip B.; Mishra, Anamika; Vijayakumar, Periyasamy; Gandhale, Pradeep N.; Kulkarni, Diwakar D.; Raut, Ashwin Ashok] ICAR Natl Inst High Secur Anim Dis, Pathogen Lab, OIE Reference Lab Avian Influenza, Bhopal, Madhya Pradesh, India; [Kumar, Himanshu] Indian Inst Sci Educ & Res Bhopal, Dept Biol Sci, Immunol Lab, Bhopal 462066, Madhya Pradesh, India	Indian Council of Agricultural Research (ICAR); ICAR - National Institute of High Security Animal Diseases; Indian Institute of Science Education & Research (IISER) - Bhopal	Raut, AA (corresponding author), ICAR Natl Inst High Secur Anim Dis, Pathogen Lab, OIE Reference Lab Avian Influenza, Bhopal, Madhya Pradesh, India.	ashwin.hsadl@gmail.com	Vijayakumar, Periyasamy/GLU-1992-2022; Gandhale, Pradeep/AAE-6383-2020; Kumar, Himanshu/J-4494-2012	Vijayakumar, Periyasamy/0000-0003-1170-8955; Gandhale, Pradeep/0000-0002-0807-5571; Raut, Ashwin/0000-0002-4978-901X; Kumar, Himanshu/0000-0001-5246-2694	Department of Biotechnology [BT/IN/Indo-UK/FADH/48/AM/2013]; ICAR-National Institute of High Security Animal Disease; BBSRC [BB/L004666/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L004666/1] Funding Source: researchfish	Department of Biotechnology; ICAR-National Institute of High Security Animal Disease; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Department of Biotechnology (grant number: BT/IN/Indo-UK/FADH/48/AM/2013) and ICAR-National Institute of High Security Animal Disease (Institute funded research project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Arankalle VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013099; Balachandran S, 2000, IMMUNITY, V13, P129, DOI 10.1016/S1074-7613(00)00014-5; Barber MRW, 2013, MOL IMMUNOL, V54, P89, DOI 10.1016/j.molimm.2012.10.038; Barber MRW, 2010, P NATL ACAD SCI USA, V107, P5913, DOI 10.1073/pnas.1001755107; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Burggraaf S, 2014, VIRUS RES, V185, P23, DOI 10.1016/j.virusres.2014.03.012; Cameron CM, 2008, J VIROL, V82, P11308, DOI 10.1128/JVI.00691-08; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; Cilloniz C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000604; Cornelissen JBWJ, 2013, AVIAN PATHOL, V42, P347, DOI 10.1080/03079457.2013.807325; Cornelissen JBWJ, 2012, AVIAN PATHOL, V41, P519, DOI 10.1080/03079457.2012.732691; Dallas PB, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-59; Dauber B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000473; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Gingras S, 2004, J BIOL CHEM, V279, P54702, DOI 10.1074/jbc.M411043200; GRANT CE, 1995, NUCLEIC ACIDS RES, V23, P2137, DOI 10.1093/nar/23.12.2137; Guo Y, 1999, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V13, P105; Hale BG, 2010, FUTURE MICROBIOL, V5, P23, DOI [10.2217/fmb.09.108, 10.2217/FMB.09.108]; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Huang YH, 2013, NAT GENET, V45, P776, DOI 10.1038/ng.2657; Iwasaki A, 2014, NAT REV IMMUNOL, V14, P315, DOI 10.1038/nri3665; Karpala AJ, 2011, J IMMUNOL, V186, P5397, DOI 10.4049/jimmunol.1003712; Karpala AJ, 2011, J INTERF CYTOK RES, V31, P393, DOI 10.1089/jir.2010.0069; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Kozak W, 1997, AM J PHYSIOL-REG I, V272, pR621, DOI 10.1152/ajpregu.1997.272.2.R621; Kuribayashi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068375; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Lee SMY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008072; Li YP, 2007, ARCH VIROL, V152, P463, DOI 10.1007/s00705-006-0878-9; Liniger M, 2012, J VIROL, V86, P705, DOI 10.1128/JVI.00742-11; Lipatov AS, 2005, J GEN VIROL, V86, P1121, DOI 10.1099/vir.0.80663-0; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Maughan MN, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-94; Moulin HR, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-6; Nang NT, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-64; OIE, 2009, AV INFL TERR AN HLTH, P1; Pantin-Jackwood MJ, 2009, REV SCI TECH OIE, V28, P113, DOI 10.20506/rst.28.1.1869; Pauli EK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000196; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; Post J, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-61; Pothlichet J, 2008, J IMMUNOL, V180, P2034, DOI 10.4049/jimmunol.180.4.2034; Pothlichet J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003256; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Rebel JMJ, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-10; Reemers SS, 2009, J GEN VIROL, V90, P2134, DOI 10.1099/vir.0.012401-0; Sasai M, 2010, SCIENCE, V329, P1530, DOI 10.1126/science.1187029; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Silverman RH, 2007, J VIROL, V81, P12720, DOI 10.1128/JVI.01471-07; Smith J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1778-8; STAEHELI P, 1986, CELL, V44, P147, DOI 10.1016/0092-8674(86)90493-9; Steinhauer DA, 1999, VIROLOGY, V258, P1, DOI 10.1006/viro.1999.9716; Sutejo R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033732; Suzuki K, 2009, J VIROL, V83, P7475, DOI 10.1128/JVI.01434-08; Szretter KJ, 2007, J VIROL, V81, P2736, DOI 10.1128/JVI.02336-06; Turan K, 2004, NUCLEIC ACIDS RES, V32, P643, DOI 10.1093/nar/gkh192; Vervelde L, 2013, DEV COMP IMMUNOL, V39, P198, DOI 10.1016/j.dci.2012.10.011; Vijayakumar P, 2015, GENE, V559, P77, DOI 10.1016/j.gene.2015.01.016; Watanabe T, 2010, CELL HOST MICROBE, V7, P427, DOI 10.1016/j.chom.2010.05.008; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Xing Z, 2008, J GEN VIROL, V89, P1288, DOI 10.1099/vir.0.83362-0; Yuen T, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e48	67	52	53	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153671	10.1371/journal.pone.0153671	http://dx.doi.org/10.1371/journal.pone.0153671			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27071061	gold, Green Published, Green Submitted			2022-12-26	WOS:000373900700082
J	Stec, DE; John, K; Trabbic, CJ; Luniwal, A; Hankins, MW; Baum, J; Hinds, TD				Stec, David E.; John, Kezia; Trabbic, Christopher J.; Luniwal, Amarjit; Hankins, Michael W.; Baum, Justin; Hinds, Terry D., Jr.			Bilirubin Binding to PPAR alpha Inhibits Lipid Accumulation	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; IMPROVES INSULIN SENSITIVITY; INTERVAL TRAINING INCREASES; CORONARY-ARTERY-DISEASE; SERUM BILIRUBIN; GLUCOCORTICOID-RECEPTOR; METABOLIC SYNDROME; ADIPONECTIN LEVELS; HEPATIC STEATOSIS; ADIPOSE-TISSUE	Numerous clinical and population studies have demonstrated that increased serum bilirubin levels protect against cardiovascular and metabolic diseases such as obesity and diabetes. Bilirubin is a potent antioxidant, and the beneficial actions of moderate increases in plasma bilirubin have been thought to be due to the antioxidant effects of this bile pigment. In the present study, we found that bilirubin has a new function as a ligand for PPAR alpha. We show that bilirubin can bind directly to PPAR alpha and increase transcriptional activity. When we compared biliverdin, the precursor to bilirubin, on PPAR alpha transcriptional activation to known PPAR alpha ligands, WY 14,643 and fenofibrate, it showed that fenofibrate and biliverdin have similar activation properties. Treatment of 3T3-L1 adipocytes with biliverdin suppressed lipid accumulation and upregulated PPAR alpha target genes. We treated wild-type and PPAR alpha KO mice on a high fat diet with fenofibrate or bilirubin for seven days and found that both signal through PPAR alpha dependent mechanisms. Furthermore, the effect of bilirubin on lowering glucose and reducing body fat percentage was blunted in PPAR alpha KO mice. These data demonstrate a new function for bilirubin as an agonist of PPAR alpha, which mediates the protection from adiposity afforded by moderate increases in bilirubin.	[John, Kezia; Baum, Justin; Hinds, Terry D., Jr.] Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Ctr Hypertens & Personalized Med, Toledo, OH 43614 USA; [Trabbic, Christopher J.; Luniwal, Amarjit] Univ Toledo, Coll Pharm & Pharmaceut Sci, Ctr Drug Design & Dev, Toledo, OH 43614 USA; [Hankins, Michael W.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Cardiovasc Renal Res Ctr, 2500 North State St, Jackson, MS 39216 USA; [Luniwal, Amarjit] North Amer Sci Associates Inc NAMSA, 6750 Wales Rd, Northwood, OH 43619 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University of Mississippi; University of Mississippi Medical Center	Hinds, TD (corresponding author), Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Ctr Hypertens & Personalized Med, Toledo, OH 43614 USA.	Terry.Hinds@utoledo.edu	Hinds, Terry/B-8495-2015	Hinds, Terry/0000-0002-7599-1529	National Institutes of Health [L32MD009154]; National Heart, Lung and Blood Institute [K01HL-125445, PO1HL-051971, HL088421]; National Institute of General Medical Sciences [P20GM-104357]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051971, K01HL125445, R01HL088421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104357] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health L32MD009154 (T.D.H.), the National Heart, Lung and Blood Institute [K01HL-125445] (T.D.H.) and (PO1HL-051971), [HL088421] (D.E.S.), and the National Institute of General Medical Sciences (P20GM-104357) (D.E.S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andersson C, 2009, METABOLISM, V58, P1109, DOI 10.1016/j.metabol.2009.04.003; Arner P, 2008, FEBS LETT, V582, P1725, DOI 10.1016/j.febslet.2008.04.038; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Berglund ED, 2009, ENDOCRINOLOGY, V150, P4084, DOI 10.1210/en.2009-0221; Burgomaster KA, 2005, J APPL PHYSIOL, V98, P1985, DOI 10.1152/japplphysiol.01095.2004; Chau MDL, 2010, P NATL ACAD SCI USA, V107, P12553, DOI 10.1073/pnas.1006962107; Chen WC, 2014, MED SCI SPORT EXER, V46, P1517, DOI 10.1249/MSS.0000000000000272; Chen YH, 2008, DIABETES CARE, V31, P1615, DOI 10.2337/dc07-2126; Cheriyath Pramil, 2010, J Clin Med Res, V2, P201, DOI 10.4021/jocmr425w; Choi SH, 2013, NUTR METAB CARDIOVAS, V23, P31, DOI 10.1016/j.numecd.2011.03.001; Cure E, 2013, ANATOL J CARDIOL, V13, P791, DOI 10.5152/akd.2013.266; Ghem C, 2010, INT HEART J, V51, P86, DOI 10.1536/ihj.51.86; Gonzalez Mdel C, 2012, PPAR RES, V2012, DOI [10.1155/2012/483536, DOI 10.1155/2012/483536]; Goto T, 2011, J LIPID RES, V52, P873, DOI 10.1194/jlr.M011320; Harano Y, 2006, LIVER INT, V26, P613, DOI 10.1111/j.1478-3231.2006.01265.x; Hinds TD, 2014, OBESITY, V22, P705, DOI 10.1002/oby.20559; Hinds TD, 2011, J BIOL CHEM, V286, P42911, DOI 10.1074/jbc.M111.311662; Hinds TD, 2010, MOL ENDOCRINOL, V24, P1715, DOI 10.1210/me.2009-0411; Hopkins TA, 2007, CARDIOVASC RES, V74, P11, DOI 10.1016/j.cardiores.2006.10.009; Hosick PA, 2014, INT J OBESITY, V38, P132, DOI 10.1038/ijo.2013.61; Jang BK, 2012, CLIN MOL HEPATOL, V18, P357, DOI 10.3350/cmh.2012.18.4.357; John K, 2016, AM J PHYSIOL-ENDOC M, V310, pE249, DOI 10.1152/ajpendo.00478.2015; Kim DH, 2008, J PHARMACOL EXP THER, V325, P833, DOI 10.1124/jpet.107.135285; Kobashi C, 2005, CIRC RES, V97, P1245, DOI 10.1161/01.RES.0000194328.57164.36; Kwak MS, 2012, CLIN MOL HEPATOL, V18, P383, DOI 10.3350/cmh.2012.18.4.383; Lankisch TO, 2006, HEPATOLOGY, V44, P1324, DOI 10.1002/hep.21361; Larter CZ, 2012, J GASTROEN HEPATOL, V27, P341, DOI 10.1111/j.1440-1746.2011.06939.x; Li M, 2008, DIABETES, V57, P1526, DOI 10.2337/db07-1764; Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068; O'Brien L, 2015, TRENDS ENDOCRIN MET, V26, P212, DOI 10.1016/j.tem.2015.02.001; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; Pozzi A, 2010, J BIOL CHEM, V285, P12840, DOI 10.1074/jbc.M109.081554; Ren HZ, 2010, PPAR RES, V2010, DOI 10.1155/2010/727194; Seo YS, 2008, J GASTROEN HEPATOL, V23, P102, DOI 10.1111/j.1440-1746.2006.04819.x; Sierra ML, 2007, J MED CHEM, V50, P685, DOI 10.1021/jm058056x; Stechschulte LA, 2014, MOL ENDOCRINOL, V28, P1254, DOI 10.1210/me.2014-1023; Stechschulte LA, 2014, MOL ENDOCRINOL, V28, P1265, DOI 10.1210/me.2014-1022; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Talanian JL, 2007, J APPL PHYSIOL, V102, P1439, DOI 10.1152/japplphysiol.01098.2006; Torgerson JS, 1997, OBES RES, V5, P105, DOI 10.1002/j.1550-8528.1997.tb00650.x; Tsuchida A, 2005, DIABETES, V54, P3358, DOI 10.2337/diabetes.54.12.3358; Vitek L, 2002, ATHEROSCLEROSIS, V160, P449, DOI 10.1016/S0021-9150(01)00601-3; Wang MY, 1999, J BIOL CHEM, V274, P17541, DOI 10.1074/jbc.274.25.17541; Wray J, 2008, EXP PHYSIOL, V93, P148, DOI 10.1113/expphysiol.2007.038612; Wray JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007421; Wu YH, 2011, J DIABETES, V3, P217, DOI 10.1111/j.1753-0407.2011.00138.x; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Yang XF, 2009, INTERNAL MED, V48, P1595, DOI 10.2169/internalmedicine.48.2286; Zhou YT, 1999, P NATL ACAD SCI USA, V96, P2391, DOI 10.1073/pnas.96.5.2391; Zucker SD, 1999, J BIOL CHEM, V274, P10852, DOI 10.1074/jbc.274.16.10852	50	106	108	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153427	10.1371/journal.pone.0153427	http://dx.doi.org/10.1371/journal.pone.0153427			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27071062	Green Published, gold, Green Submitted			2022-12-26	WOS:000373900700066
J	Farmer, H; Carr, EW; Svartdal, M; Winkielman, P; Hamilton, AFD				Farmer, Harry; Carr, Evan W.; Svartdal, Marita; Winkielman, Piotr; Hamilton, Antonia F. de C.			Status and Power Do Not Modulate Automatic Imitation of Intransitive Hand Movements	PLOS ONE			English	Article							AVOIDANCE MOTOR ACTIONS; INTERPERSONAL POWER; BEHAVIORAL MIMICRY; PREFRONTAL CORTEX; EMOTIONAL MIMICRY; SOCIAL HIERARCHY; EYE CONTACT; MIRROR; PERCEPTION; ATTENTION	The tendency to mimic the behaviour of others is affected by a variety of social factors, and it has been argued that such "mirroring" is often unconsciously deployed as a means of increasing affiliation during interpersonal interactions. However, the relationship between automatic motor imitation and status/power is currently unclear. This paper reports five experiments that investigated whether social status (Experiments 1, 2, and 3) or power (Experiments 4 and 5) had a moderating effect on automatic imitation (AI) in finger-movement tasks, using a series of different manipulations. Experiments 1 and 2 manipulated the social status of the observed person using an associative learning task. Experiment 3 manipulated social status via perceived competence at a simple computer game. Experiment 4 manipulated participants' power (relative to the actors) in a card-choosing task. Finally, Experiment 5 primed participants using a writing task, to induce the sense of being powerful or powerless. No significant interactions were found between congruency and social status/power in any of the studies. Additionally, Bayesian hypothesis testing indicated that the null hypothesis should be favoured over the experimental hypothesis in all five studies. These findings are discussed in terms of their implications for AI tasks, social effects on mimicry, and the hypothesis of mimicry as a strategic mechanism to promote affiliation.	[Farmer, Harry; Svartdal, Marita; Hamilton, Antonia F. de C.] UCL, Inst Cognit Neurosci, 17 Queen Sq, London WC1N 3AR, England; [Winkielman, Piotr] Univ Calif San Diego, Dept Psychol, 9500 Gilman Dr,0109, La Jolla, CA 92093 USA; [Winkielman, Piotr] Univ Warwick, Warwick Business Sch, Behav Sci Grp, Coventry CV4 7AL, W Midlands, England; [Winkielman, Piotr] SWPS Univ Social Sci & Humanities, Dept Psychol, Ul Chodakowska 19-31, PL-03815 Warsaw, Poland	University of London; University College London; University of California System; University of California San Diego; University of Warwick; SWPS University of Social Sciences & Humanities	Farmer, H (corresponding author), UCL, Inst Cognit Neurosci, 17 Queen Sq, London WC1N 3AR, England.	h.farmer@ucl.ac.uk	Hamilton, Antonia/AAC-6648-2019; Farmer, Harry/AAA-3603-2020; Winkielman, Piotr/AAT-6275-2020; Hamilton, Antonia/ABC-4196-2021	Hamilton, Antonia/0000-0001-8000-0219; Winkielman, Piotr/0000-0003-2330-1802; 	European Research Council [509573]	European Research Council(European Research Council (ERC)European Commission)	This work was supported by European Research Council (http://erc.europa.eu/) grant 509573 (CTHN) INTERACT to AH funded experiments 1,2,3 and 4. The author(s) received no specific funding for experiment 5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames DR, 2006, J RES PERS, V40, P440, DOI 10.1016/j.jrp.2005.03.002; Andreoni J, 2008, J ECON PSYCHOL, V29, P73, DOI 10.1016/j.joep.2007.07.008; Ashton-James CE, 2013, SOC PSYCHOL PERS SCI, V4, P643, DOI 10.1177/1948550613476097; Autodesk, 2013, MOT 14 0; Ball S, 2001, Q J ECON, V116, P161, DOI 10.1162/003355301556374; Belot M, 2013, P NATL ACAD SCI USA, V110, P2763, DOI 10.1073/pnas.1209981110; Bourgeois P, 2008, BIOL PSYCHOL, V77, P343, DOI 10.1016/j.biopsycho.2007.11.008; Brass M, 2000, BRAIN COGNITION, V44, P124, DOI 10.1006/brcg.2000.1225; Brass M, 2001, ACTA PSYCHOL, V106, P3, DOI 10.1016/S0001-6918(00)00024-X; Carli LL, 1999, J SOC ISSUES, V55, P81, DOI 10.1111/0022-4537.00106; Carr EW, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00505; Carr EW, 2014, J EXP PSYCHOL GEN, V143, P997, DOI 10.1037/a0034972; Chartrand TL, 2013, ANNU REV PSYCHOL, V64, P285, DOI 10.1146/annurev-psych-113011-143754; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Cheng CM, 2003, J PERS SOC PSYCHOL, V85, P1170, DOI 10.1037/0022-3514.85.6.1170; Chiao JY, 2010, CURR OPIN NEUROBIOL, V20, P803, DOI 10.1016/j.conb.2010.08.006; Cloutier J, 2013, BIOL PSYCHOL, V92, P301, DOI 10.1016/j.biopsycho.2012.09.006; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cook J, 2011, EXP BRAIN RES, V211, P601, DOI 10.1007/s00221-011-2584-4; Cook JL, 2012, J AUTISM DEV DISORD, V42, P1045, DOI 10.1007/s10803-011-1341-7; Cook JE, 2011, PERS SOC PSYCHOL B, V37, P165, DOI 10.1177/0146167210390389; Cook R, 2012, P ROY SOC B-BIOL SCI, V279, P780, DOI 10.1098/rspb.2011.1024; Cuddy AJC, 2007, J PERS SOC PSYCHOL, V92, P631, DOI 10.1037/0022-3514.92.4.631; Dalmaso M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093139; Dalmaso M, 2012, BIOL LETTERS, V8, P450, DOI 10.1098/rsbl.2011.0881; Dalton AN, 2010, J PERS SOC PSYCHOL, V98, P605, DOI 10.1037/a0017629; Dienes Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00781; Dienes Z, 2011, PERSPECT PSYCHOL SCI, V6, P274, DOI 10.1177/1745691611406920; Donne CM, 2011, NEUROSCI LETT, V489, P57, DOI 10.1016/j.neulet.2010.11.067; DOOB AN, 1968, J SOC PSYCHOL, V76, P213, DOI 10.1080/00224545.1968.9933615; Eaves DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046728; Fiske ST, 2002, J PERS SOC PSYCHOL, V82, P878, DOI 10.1037//0022-3514.82.6.878; Fiske ST, 1999, J SOC ISSUES, V55, P473, DOI 10.1111/0022-4537.00128; Fiske ST., 1996, EUR REV SOC PSYCHOL, V7, P31, DOI DOI 10.1080/14792779443000094; Flach R, 2010, BRIT J PSYCHOL, V101, P739, DOI 10.1348/000712609X484595; Friedman RS, 2002, J EXP SOC PSYCHOL, V38, P41, DOI 10.1006/jesp.2001.1488; Friedman RS, 2000, J PERS SOC PSYCHOL, V79, P477, DOI 10.1037//0022-3514.79.4.477; Galinsky AD, 2003, J PERS SOC PSYCHOL, V85, P453, DOI 10.1037/0022-3514.85.3.453; Guinote A., 2015, APA HDB PERSONALITY, V1, P547, DOI DOI 10.1037/14341-017; Guinote A, 2008, J PERS SOC PSYCHOL, V95, P237, DOI 10.1037/a0012518; Guinote A, 2007, J EXP SOC PSYCHOL, V43, P685, DOI 10.1016/j.jesp.2006.06.008; HALPERIN K, 1976, J APPL PSYCHOL, V61, P85, DOI 10.1037/0021-9010.61.1.85; Hess U, 2014, SOC PERSONAL PSYCHOL, V8, P45, DOI 10.1111/spc3.12083; Hess U, 2013, PERS SOC PSYCHOL REV, V17, P142, DOI 10.1177/1088868312472607; Heyes C, 2011, PSYCHOL BULL, V137, P463, DOI 10.1037/a0022288; Heyes C, 2010, NEUROSCI BIOBEHAV R, V34, P575, DOI 10.1016/j.neubiorev.2009.11.007; Hogeveen J, 2014, J EXP PSYCHOL GEN, V143, P755, DOI 10.1037/a0033477; Hogeveen J, 2013, EXP BRAIN RES, V224, P613, DOI 10.1007/s00221-012-3339-6; Huang L, 2011, PSYCHOL SCI, V22, P95, DOI 10.1177/0956797610391912; Iacoboni M, 2009, ANNU REV PSYCHOL, V60, P653, DOI 10.1146/annurev.psych.60.110707.163604; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Kavanagh LC, 2011, PSYCHOL SCI, V22, P1274, DOI 10.1177/0956797611418678; Keltner D, 2003, PSYCHOL REV, V110, P265, DOI 10.1037/0033-295X.110.2.265; Keutmann MK, 2015, BEHAV RES METHODS, V47, P228, DOI 10.3758/s13428-014-0464-0; Lakin JL, 2008, PSYCHOL SCI, V19, P816, DOI 10.1111/j.1467-9280.2008.02162.x; Lakin JL, 2003, J NONVERBAL BEHAV, V27, P145, DOI 10.1023/A:1025389814290; Lakin JL, 2003, PSYCHOL SCI, V14, P334, DOI 10.1111/1467-9280.14481; LARSEN KS, 1979, J SOC PSYCHOL, V108, P259, DOI 10.1080/00224545.1979.9711639; LEFFLER A, 1982, SOC PSYCHOL QUART, V45, P153, DOI 10.2307/3033648; Leighton J, 2010, J EXP SOC PSYCHOL, V46, P905, DOI 10.1016/j.jesp.2010.07.001; Leotti LA, 2011, PSYCHOL SCI, V22, P1310, DOI 10.1177/0956797611417005; Liepelt R, 2010, COGNITION, V115, P426, DOI 10.1016/j.cognition.2010.03.003; Liepelt R, 2010, EXP PSYCHOL, V57, P221, DOI 10.1027/1618-3169/a000028; Likowski KU, 2008, J EXP SOC PSYCHOL, V44, P1065, DOI 10.1016/j.jesp.2007.10.007; Longo MR, 2008, J EXP PSYCHOL HUMAN, V34, P489, DOI 10.1037/0096-1523.34.2.489; Longo MR, 2009, EXP BRAIN RES, V192, P739, DOI 10.1007/s00221-008-1649-5; Ly M, 2011, CURR BIOL, V21, P794, DOI 10.1016/j.cub.2011.03.050; MacCann C., 2003, INT J ORG ANAL, V11, P247, DOI DOI 10.1108/EB028975; Magee JC, 2008, ACAD MANAG ANN, V2, P351, DOI 10.1080/19416520802211628; Maner JK, 2008, PERS SOC PSYCHOL B, V34, P488, DOI 10.1177/0146167207311910; Marsh AA, 2009, J COGNITIVE NEUROSCI, V21, P713, DOI 10.1162/jocn.2009.21052; Mast MS, 2010, EUR REV SOC PSYCHOL, V21, P1, DOI 10.1080/10463283.2010.486942; Mathworks, 2015, MATL R2015B; McIntosh D.N., 2006, POL PSYCHOL BULL, V37, P31; Microsoft, 2008, VIS STUD 2008; Naef M, 2009, REPORT NO 167; Obhi SS, 2014, J EXP PSYCHOL HUMAN, V40, P920, DOI 10.1037/a0034056; Over H, 2009, DEVELOPMENTAL SCI, V12, pF1, DOI 10.1111/j.1467-7687.2008.00820.x; Pan XN, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00790; Psychology Software Tools Inc, 2012, E PRIM 2 0; Ratcliff NJ, 2012, SOC COGNITION, V30, P631, DOI 10.1521/soco.2012.30.5.631; Ratcliff NJ, 2011, PERS SOC PSYCHOL B, V37, P1003, DOI 10.1177/0146167211407210; Rauchbauer B, 2015, DISTINCT NEURAL PROC; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; Rudman LA, 2000, PERS SOC PSYCHOL B, V26, P1315, DOI 10.1177/0146167200263001; Russell AMT, 2008, EUR J SOC PSYCHOL, V38, P1193, DOI 10.1002/ejsp.539; Ruys KI, 2010, J EXP SOC PSYCHOL, V46, P1130, DOI 10.1016/j.jesp.2010.05.016; Shanks DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056515; Smith PK, 2015, CURR OPIN BEHAV SCI, V3, P152, DOI 10.1016/j.cobeha.2015.04.007; SNYDER M, 1974, J PERS SOC PSYCHOL, V30, P526, DOI 10.1037/h0037039; SPECTOR PE, 1994, J ORGAN BEHAV, V15, P385, DOI 10.1002/job.4030150503; Spengler S, 2010, CONSCIOUS COGN, V19, P98, DOI 10.1016/j.concog.2009.12.014; Stel M, 2010, EXP PSYCHOL, V57, P412, DOI 10.1027/1618-3169/a000050; Sturmer B, 2000, J EXP PSYCHOL HUMAN, V26, P1746, DOI 10.1037//0096-1523.26.6.1746; Tiedens LZ, 2003, J PERS SOC PSYCHOL, V84, P558, DOI 10.1037/0022-3514.84.3.558; Tomasello Michael, 1996, P319, DOI 10.1016/B978-012273965-1/50016-9; Tops M, 2006, PSYCHON B REV, V13, P229, DOI 10.3758/BF03193835; van Baaren R, 2009, PHILOS T R SOC B, V364, P2381, DOI 10.1098/rstb.2009.0057; WANG Y, 2013, PLOS ONE, V2013; Wang Y, 2012, CONTROL MIMICRY SOCI; Wang Y, 2015, SOC COGN AFFECT NEUR, V10, P486, DOI 10.1093/scan/nsu076; Wang Y, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00153; Wang Y, 2011, J NEUROSCI, V31, P12001, DOI 10.1523/JNEUROSCI.0845-11.2011; Wang Y, 2011, BIOL LETTERS, V7, P7, DOI 10.1098/rsbl.2010.0279; Wieser MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102937; Yabar Y, 2006, J NONVERBAL BEHAV, V30, P97, DOI 10.1007/s10919-006-0010-6; Zink CF, 2008, NEURON, V58, P273, DOI 10.1016/j.neuron.2008.01.025	107	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0151835	10.1371/journal.pone.0151835	http://dx.doi.org/10.1371/journal.pone.0151835			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9OU	27096167	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000374543600006
J	Foo, J; Landis, SH; Maskell, J; Oh, YM; van der Molen, T; Han, MK; Mannino, DM; Ichinose, M; Punekar, Y				Foo, Jason; Landis, Sarah H.; Maskell, Joe; Oh, Yeon-Mok; van der Molen, Thys; Han, MeiLan K.; Mannino, David M.; Ichinose, Masakazu; Punekar, Yogesh			Continuing to Confront COPD International Patient Survey: Economic Impact of COPD in 12 Countries	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; NONCOMMUNICABLE DISEASES; GLOBAL IMPACT; COSTS; BURDEN; PRODUCTIVITY; DISABILITY; LIFE	Background The Continuing to Confront COPD International Patient Survey estimated the prevalence and burden of COPD across 12 countries. Using data from this survey we evaluated the economic impact of COPD. Methods This cross-sectional, population-based survey questioned 4,343 subjects aged 40 years and older, fulfilling a case definition of COPD based on self-reported physician diagnosis or symptomatology. Direct cost measures were based on exacerbations of COPD (treated and those requiring emergency department visits and/or hospitalisation), contacts with healthcare professionals, and COPD medications. Indirect costs were calculated from work loss values using the Work Productivity and Activity Impairment scale. Combined direct and indirect costs estimated the total societal costs per patient. Results The annual direct costs of COPD ranged from $504 (South Korea) to $9,981 (USA), with inpatient hospitalisations (5 countries) and home oxygen therapy (3 countries) being the key drivers of direct costs. The proportion of patients completely prevented from working due to their COPD ranged from 6% (Italy) to 52% (USA and UK) with 8 countries reporting this to be >= 20%. Total societal costs per patient varied widely from $1,721 (Russia) to $30,826 (USA) but a consistent pattern across countries showed greater costs among those with increased burden of COPD (symptoms, health status and more severe disease) and a greater number of comorbidities. Conclusions The economic burden of COPD is considerable across countries, and requires targeted resources to optimise COPD management encompassing the control of symptoms, prevention of exacerbations and effective treatment of comorbidities. Strategies to allow COPD patients to remain in work are important for addressing the substantial wider societal costs.	[Foo, Jason] GlaxoSmithKline, Hlth Outcomes, Uxbridge, Middx, England; [Landis, Sarah H.; Maskell, Joe] GlaxoSmithKline, Real World Evidence, Uxbridge, Middx, England; [Oh, Yeon-Mok] Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea; [van der Molen, Thys] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Han, MeiLan K.] Univ Michigan, Div Pulm & Crit Care, Ann Arbor, MI 48109 USA; [Mannino, David M.] Univ Kentucky, Coll Publ Hlth, Lexington, KY USA; [Ichinose, Masakazu] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan; [Punekar, Yogesh] GlaxoSmithKline, Value Evidence Outcomes, Uxbridge, Middx, England	GlaxoSmithKline; GlaxoSmithKline; University of Ulsan; University of Groningen; University of Michigan System; University of Michigan; University of Kentucky; Tohoku University; GlaxoSmithKline	Punekar, Y (corresponding author), GlaxoSmithKline, Value Evidence Outcomes, Uxbridge, Middx, England.	yogesh.q.punekar@gsk.com		Mannino, David/0000-0003-3646-7828	GlaxoSmithKline; GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline); GlaxoSmithKline(GlaxoSmithKline)	This study was funded in full by GlaxoSmithKline. The survey was conducted by Abt SRBI, a global survey research firm that specializes in health surveys on behalf of GlaxoSmithKline. Authors were not paid for their contribution to the manuscript development. GSK provided support in the form of salaries for authors JF, SHL, JM and YP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agusti AGN, 2005, RESP MED, V99, P670, DOI 10.1016/j.rmed.2004.11.006; Bestall JC, 1999, THORAX, V54, P581, DOI 10.1136/thx.54.7.581; Chaker L, 2015, EUR J EPIDEMIOL, V30, P357, DOI 10.1007/s10654-015-0026-5; Chapman KR, 2006, EUR RESPIR J, V27, P188, DOI 10.1183/09031936.06.00024505; de Miguel-Diez J, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-8; Fletcher MJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-612; Ford ES, 2015, CHEST, V147, P31, DOI 10.1378/chest.14-0972; Jones PW, 2009, EUR RESPIR J, V34, P648, DOI 10.1183/09031936.00102509; Kigozi J, 2016, EUR J HEALTH ECON, V17, P31, DOI 10.1007/s10198-014-0652-y; Kim C, 2014, INT J TUBERC LUNG D, V18, P737, DOI 10.5588/ijtld.13.0634; KOOPMANSCHAP MA, 1995, J HEALTH ECON, V14, P171, DOI 10.1016/0167-6296(94)00044-5; Landis SH, 2014, INT J CHRONIC OBSTR, V9, P597, DOI 10.2147/COPD.S61854; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Miravitlles M, 2003, CHEST, V123, P784, DOI 10.1378/chest.123.3.784; Muka T, 2015, EUR J EPIDEMIOL, V30, P251, DOI 10.1007/s10654-014-9984-2; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nishimura S, 2004, RESPIROLOGY, V9, P466, DOI 10.1111/j.1440-1843.2004.00617.x; Polatli M, 2012, RESP MED, V106, pS75, DOI 10.1016/S0954-6111(12)70016-1; REILLY MC, 1993, PHARMACOECONOMICS, V4, P353, DOI 10.2165/00019053-199304050-00006; Rennard S, 2002, EUR RESPIR J, V20, P799, DOI 10.1183/09031936.02.03242002; Seuring T, 2015, PHARMACOECONOMICS, V33, P811, DOI 10.1007/s40273-015-0268-9; Srivastava K, 2015, PHARMACOECONOMICS, V33, P467, DOI 10.1007/s40273-015-0252-4; World Health Organization, BURD OF COPD; Wouters EFM, 2003, RESP MED, V97, pS3, DOI 10.1016/S0954-6111(03)80020-3	24	77	78	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0152618	10.1371/journal.pone.0152618	http://dx.doi.org/10.1371/journal.pone.0152618			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27092775	gold, Green Submitted, Green Published			2022-12-26	WOS:000374541200007
J	Mirmonsef, P; Hotton, AL; Gilbert, D; Gioia, CJ; Maric, D; Hope, TJ; Landay, AL; Spear, GT				Mirmonsef, Paria; Hotton, Anna L.; Gilbert, Douglas; Gioia, Casey J.; Maric, Danijela; Hope, Thomas J.; Landay, Alan L.; Spear, Gregory T.			Glycogen Levels in Undiluted Genital Fluid and Their Relationship to Vaginal pH, Estrogen, and Progesterone	PLOS ONE			English	Article							PEROXIDE-PRODUCING LACTOBACILLI; SIMPLEX-VIRUS TYPE-2; BACTERIAL VAGINOSIS; ACQUISITION; COLONIZATION; TRANSMISSION; FLORA	Background Colonization of the female lower genital tract with Lactobacillus provides protection against STIs and adverse pregnancy outcomes. Growth of genital Lactobacillus is postulated to depend on epithelial cell -produced glycogen. However, the amount of cell -free glycogen in genital fluid available for utilization by Lactobacillus is not known. Methods Eighty-five genital fluid samples from 7 pre -menopausal women taken over 4-6 weeks were obtained using the Instead SoftCupg (EvoFem, Inc., San Diego, CA, USA) by consented donors. Cell -free glycogen and glucose in genital fluids and estrogen and progesterone in blood were quantified. Findings Glycogen ranged from 0.1-32 fag/pl. There were significant differences between women in glycogen over the observation period. There was a strong negative correlation between glycogen and vaginal pH (r = -0.542, p<0.0001). In multivariable analysis, free glycogen levels were significantly negatively associated with both vaginal pH and progesterone (p < 0.001 and p = 0.004, respectively). Estrogen, glucose, age, sexual intercourse 24 hours prior to visit, and days after the initial visit were not significantly associated with free glycogen levels. Conclusion Cell -free glycogen concentrations can be very high, up to 3% of genital fluid, and are strongly associated with acidic vaginal pH. However, the fluctuations in glycogen levels in individuals and differences between individuals do not appear to be associated with estrogen.	[Mirmonsef, Paria; Gilbert, Douglas; Landay, Alan L.; Spear, Gregory T.] Rush Univ, Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA; [Hotton, Anna L.] Cook Cty Hlth & Hosp Syst, CORE Ctr, Chicago, IL USA; [Gioia, Casey J.; Maric, Danijela; Hope, Thomas J.] Northwestern Univ, Robert H Lurie Med Res Ctr, Feinberg Sch Med, Chicago, IL 60611 USA	Rush University; John H Stroger Junior Hospital Cook County; Northwestern University; Feinberg School of Medicine	Mirmonsef, P (corresponding author), Rush Univ, Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA.	Paria_Mirmonsef@rush.edu			Bill and Melinda Gates Foundation [OPP1031734]; National Institutes of Health [R33AI094584]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI094584] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by https://www.cavd.org/Pages/default.aspx; Collaboration for AIDS Vaccine Discovery grant from the Bill and Melinda Gates Foundation (OPP1031734) to TJH and http://www.nih.gov/; National Institutes of Health (R33AI094584) to TJH.	AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Atashili J, 2008, AIDS, V22, P1493, DOI 10.1097/QAD.0b013e3283021a37; Boskey ER, 1999, INFECT IMMUN, V67, P5170, DOI 10.1128/IAI.67.10.5170-5175.1999; Cherpes TL, 2008, SEX TRANSM DIS, V35, P78, DOI 10.1097/OLQ.0b013e318156a5d0; Cherpes TL, 2003, CLIN INFECT DIS, V37, P319, DOI 10.1086/375819; Cruickshank R SA, 1934, J OBSTET GYN BR COMM, V41, P208, DOI DOI 10.1111/J.1471-0528; Dezzutti CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023136; Hawes SE, 1996, J INFECT DIS, V174, P1058, DOI 10.1093/infdis/174.5.1058; Hickey RJ, 2015, MBIO, V6, DOI 10.1128/mBio.00097-15; Hild-Petito S, 1998, AIDS RES HUM RETROV, V14, pS125; Krause Megan, 2009, J Pelvic Med Surg, V15, P105; Martin R, 2009, INT MICROBIOL, V11, P261, DOI 10.2436/20.1501.01.70; Marx PA, 1996, NAT MED, V2, P1084, DOI 10.1038/nm1096-1084; Miller L, 2000, OBSTET GYNECOL, V96, P431, DOI 10.1016/S0029-7844(00)00906-6; MIRMONSEF P, 2014, MENOPAUSE, V22, P1, DOI DOI 10.1097/GME.0000000000000397; Mirmonsef P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102467; Mirmonsef P, 2014, AM J REPROD IMMUNOL, V71, P531, DOI 10.1111/aji.12232; O'Hanlon DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080074; Patton DL, 2000, AM J OBSTET GYNECOL, V183, P967, DOI 10.1067/mob.2000.108857; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Spear GT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132646; Spear GT, 2014, J INFECT DIS, V210, P1019, DOI 10.1093/infdis/jiu231; STEWARTT.DE, 1964, AM J OBSTET GYNECOL, V88, P676, DOI 10.1016/0002-9378(64)90898-1; Vallor AC, 2001, J INFECT DIS, V184, P1431, DOI 10.1086/324445; Wiesenfeld HC, 2003, CLIN INFECT DIS, V36, P663, DOI 10.1086/367658; WYLIE JG, 1969, J MED MICROBIOL, V2, P363, DOI 10.1099/00222615-2-3-363; Zendjabil M CZ, 2016, ANN ENDOCRINOL PARIS, V77	27	49	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153553	10.1371/journal.pone.0153553	http://dx.doi.org/10.1371/journal.pone.0153553			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093050	Green Published, Green Submitted, gold			2022-12-26	WOS:000374541200029
J	Singh, K; Samant, MA; Tom, MT; Prasad, NG				Singh, Karan; Samant, Manas Arun; Tom, Megha Treesa; Prasad, Nagaraj Guru			Evolution of Pre- and Post-Copulatory Traits in Male Drosophila melanogaster as a Correlated Response to Selection for Resistance to Cold Stress	PLOS ONE			English	Article							HEAT-STRESS; MATING SUCCESS; MALE SIZE; SPERM; TEMPERATURES; POPULATIONS; BEHAVIOR; HISTORY; REPRODUCTION; SPERMATOZOA	Background In Drosophila melanogaster the fitness of males depends on a broad array of reproductive traits classified as pre- and post-copulatory traits. Exposure to cold stress, can reduce sperm number, male mating ability and courtship behavior. Therefore, it is expected that the adaptation to cold stress will involve changes in pre- and post -copulatory traits. Such evolution of reproductive traits in response to cold stress is not well studied. Methods We selected replicate populations of D. melanogaster for resistance to cold shock. Over 37-46 generations of selection, we investigated pre- and post -copulatory traits such as mating latency, copulation duration, mating frequency, male fertility, fitness (progeny production) and sperm competitive ability in male flies subjected to cold shock and those not subjected to cold shock. Results We found that post cold shock, the males from the selected populations had a significantly lower mating latency along with, higher mating frequency, fertility, sperm competitive ability and number of progeny relative to the control populations. Conclusion While most studies of experimental evolution of cold stress resistance have documented the evolution of survivorship in response to selection, our study clearly shows that adaptation to cold stress involves rapid changes in the pre- and post -copulatory traits. Additionally, improved performances under stressful conditions need not necessarily trade-off with performance under benign conditions.	[Singh, Karan; Samant, Manas Arun; Tom, Megha Treesa; Prasad, Nagaraj Guru] Indian Inst Sci Educ & Res Mohali, Sect 81, Po Manauli 140306, Punjab, India	Indian Institute of Science Education & Research (IISER) - Mohali	Prasad, NG (corresponding author), Indian Inst Sci Educ & Res Mohali, Sect 81, Po Manauli 140306, Punjab, India.	prasad@iisermohali.ac.in	Singh, Karan/AAH-3752-2022	Singh, Karan/0000-0002-2496-028X; Prasad, N G/0000-0002-0410-5518; Geeta Arun, Manas/0000-0002-4433-4913	Indian Institute of Science Education and Research Mohali, Govt. of India; IISER Mohali, Govt. of India; Department of Science and Technology, Govt. of India	Indian Institute of Science Education and Research Mohali, Govt. of India; IISER Mohali, Govt. of India; Department of Science and Technology, Govt. of India(Department of Science & Technology (India))	This work was supported by the Indian Institute of Science Education and Research Mohali, Govt. of India. Karan Singh thanks IISER Mohali, Govt. of India for financial support in the form of a Senior Research Fellowship. Manas Arun Samant and Megha Treesa Tom thank the Department of Science and Technology, Govt. of India for INSPIRE Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AR, 2005, GENET RES, V85, P15, DOI 10.1017/S0016672304007281; [Anonymous], 2010, LOW TEMPERATURE BIOL; Avila FW, 2011, ANNU REV ENTOMOL, V56, P21, DOI 10.1146/annurev-ento-120709-144823; Barrios B, 2000, BIOL REPROD, V63, P1531, DOI 10.1095/biolreprod63.5.1531; BASTOCK M., 1955, BEHAVIOR, V8, P85, DOI 10.1163/156853955X00184; Bubliy OA, 2005, J EVOLUTION BIOL, V18, P789, DOI 10.1111/j.1420-9101.2005.00928.x; CAMPBELL PM, 1992, BIOL REPROD, V47, P1140, DOI 10.1095/biolreprod47.6.1140; Chapman T, 2001, HEREDITY, V87, P511, DOI 10.1046/j.1365-2540.2001.00961.x; CHEN CP, 1994, J INSECT PHYSIOL, V40, P661, DOI 10.1016/0022-1910(94)90093-0; CHIHRANE J, 1994, ENTOMOPHAGA, V39, P11, DOI 10.1007/BF02373490; Chippindale AK, 1998, EVOLUTION, V52, P1342, DOI 10.2307/2411304; Chippindale AK, 1996, EVOLUTION, V50, P753, DOI [10.2307/2410848, 10.1111/j.1558-5646.1996.tb03885.x]; DENLINGER DL, 1998, TEMPERATURE SENSITIV; Fischer K, 2003, ECOLOGY, V84, P3138, DOI 10.1890/02-0733; Froman DP, 2002, P ROY SOC B-BIOL SCI, V269, P607, DOI 10.1098/rspb.2001.1925; Gage MJG, 2003, CURR BIOL, V13, P754, DOI 10.1016/S0960-9822(03)00282-3; Gillott C, 2003, ANNU REV ENTOMOL, V48, P163, DOI 10.1146/annurev.ento.48.091801.112657; Hance T, 2007, ANNU REV ENTOMOL, V52, P107, DOI 10.1146/annurev.ento.52.110405.091333; Hansen PJ, 2009, PHILOS T R SOC B, V364, P3341, DOI 10.1098/rstb.2009.0131; IYENGAR SV, 1962, GENETICS, V47, P963; Kingsolver JG, 2009, AM NAT, V174, P755, DOI 10.1086/648310; KREBS RA, 1994, J EVOLUTION BIOL, V7, P39, DOI 10.1046/j.1420-9101.1994.7010039.x; KVELLAND I, 1965, HEREDITAS-GENETISK A, V54, P88; Lefevre GJ., 1962, DROS INFORM SERV, V1962, P86; MacMillan HA, 2009, INSECT SCI, V16, P263, DOI 10.1111/j.1744-7917.2009.01251.x; Malmendal A, 2006, AM J PHYSIOL-REG I, V291, pR205, DOI 10.1152/ajpregu.00867.2005; MARKOW TA, 1985, ANIM BEHAV, V33, P775, DOI 10.1016/S0003-3472(85)80010-5; MARKOW TA, 1992, HEREDITY, V69, P122, DOI 10.1038/hdy.1992.104; MARKOW TA, 1992, J INSECT BEHAV, V5, P375, DOI 10.1007/BF01049845; MARKOW TA, 1988, J COMP PSYCHOL, V102, P169, DOI 10.1037/0735-7036.102.2.169; Marshall KE, 2010, P ROY SOC B-BIOL SCI, V277, P963, DOI 10.1098/rspb.2009.1807; Mockett RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092228; MOORE HDM, 1977, J REPROD FERTIL, V50, P349, DOI 10.1530/jrf.0.0500349; Nandy B, 2013, EVOLUTION, V67, P2133, DOI 10.1111/evo.12076; Nicolson SW, 2004, INSECT PHYSL ECOLOGY; Overgaard Johannes, 2010, P276, DOI 10.1017/CBO9780511675997.012; PARTRIDGE L, 1987, ANIM BEHAV, V35, P555, DOI 10.1016/S0003-3472(87)80281-6; PARTRIDGE L, 1993, NATURE, V362, P305, DOI 10.1038/362305a0; Patton ZJ, 2001, PHYSIOL BIOCHEM ZOOL, V74, P783, DOI 10.1086/323327; Perez-Crespo M, 2008, MOL REPROD DEV, V75, P40, DOI 10.1002/mrd.20759; Prasad NG, 2007, AM NAT, V169, P29, DOI 10.1086/509941; Rinehart JP, 2000, PHYSIOL ENTOMOL, V25, P330, DOI 10.1046/j.1365-3032.2000.00201.x; Rohmer C, 2004, J EXP BIOL, V207, P2735, DOI 10.1242/jeb.01087; ROSE MR, 1984, EVOLUTION, V38, P1004, DOI 10.1111/j.1558-5646.1984.tb00370.x; SANTOS M, 1988, HEREDITY, V61, P255, DOI 10.1038/hdy.1988.113; Schmidt PS, 2008, EVOLUTION, V62, P1204, DOI 10.1111/j.1558-5646.2008.00351.x; SCHNEBEL EM, 1984, EVOLUTION, V38, P1296, DOI 10.1111/j.1558-5646.1984.tb05651.x; Simmons L. W., 2001, MG BEH ECOL; Simmons LW, 2012, REPRODUCTION, V144, P519, DOI 10.1530/REP-12-0285; Singh K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129992; Snook RR, 2005, TRENDS ECOL EVOL, V20, P46, DOI 10.1016/j.tree.2004.10.011; SPIETH HT, 1974, ANNU REV ENTOMOL, V19, P385, DOI 10.1146/annurev.en.19.010174.002125; Nguyen TM, 2013, J INSECT PHYSIOL, V59, P248, DOI 10.1016/j.jinsphys.2012.12.001; van Lieshout E, 2013, ECOL EVOL, V3, P2859, DOI 10.1002/ece3.667; WALES RG, 1959, J ENDOCRINOL, V19, P211, DOI 10.1677/joe.0.0190211; Wigby S, 2005, CURR BIOL, V15, P316, DOI 10.1016/j.cub.2005.01.051; Yenisetti SC, 2006, KOREAN J GENETIC, V28, P395; Zizzari ZV, 2011, J INSECT PHYSIOL, V57, P421, DOI 10.1016/j.jinsphys.2011.01.002	58	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153629	10.1371/journal.pone.0153629	http://dx.doi.org/10.1371/journal.pone.0153629			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093599	gold, Green Published			2022-12-26	WOS:000374541200034
J	Janssens, KAM; Riese, H; Van Roon, AM; Hunfeld, JAM; Groot, PFC; Oldehinkel, AJ; Rosmalen, JGM				Janssens, Karin A. M.; Riese, Harriette; Van Roon, Arie M.; Hunfeld, Joke A. M.; Groot, Paul F. C.; Oldehinkel, Albertine J.; Rosmalen, Judith G. M.			Are Cardiac Autonomic Nervous System Activity and Perceived Stress Related to Functional Somatic Symptoms in Adolescents? The TRAILS Study	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; MEDICALLY UNEXPLAINED SYMPTOMS; SOCIAL STRESS; CHRONIC PAIN; CHILDREN; METAANALYSIS; POPULATION; RESPONSES; ASSOCIATIONS; DISORDERS	Objective Stressors have been related to medically insufficiently explained or functional somatic symptoms (FSS). However, the underlying mechanism of this association is largely unclear. In the current study, we examined whether FSS are associated with different perceived stress and cardiac autonomic nervous system (ANS) levels during a standardized stressful situation, and whether these associations are symptom-specific. Methods We examined 715 adolescents (16.1 years, 51.3% girls) from the Dutch cohort study Tracking Adolescents' Individual Lives Sample during the Groningen Social Stress Test (GSST). FSS were assessed by the Youth Self-Report, and clustered into a cluster of overtiredness, dizziness and musculoskeletal pain and a cluster of headache and gastrointestinal symptoms. Perceived stress levels (i.e. unpleasantness and arousal) were assessed by the SelfAssessment Manikin, and cardiac ANS activity by assessing heart rate variability (HRV-HF) and pre-ejection period (PEP). Perceived stress and cardiac ANS levels before, during, and after the GSST were studied as well as cardiac ANS reactivity. Linear regression analyses were used to examine the associations. Results Perceived arousal levels during (beta = 0.09, p = 0.04) and after (beta = 0.07, p = 0.047) the GSST, and perceived unpleasantness levels before (beta = 0.07, p = 0.048) and during (beta = 0.12, p = 0.001) the GSST were related to FSS during the past couple of months. The association between perceived stress and FSS was stronger for the FSS cluster of overtiredness, dizziness and musculoskeletal pain than for the cluster of headache and gastrointestinal symptoms. Neither ANS activity levels before, during, and after the GSST, nor maximal HF-HRV and PEP reactivity were related to FSS. Conclusions This study suggests that perceived stress levels during social stress are related to FSS, whereas cardiac ANS activity and reactivity are not related to FSS.	[Janssens, Karin A. M.; Riese, Harriette; Oldehinkel, Albertine J.; Rosmalen, Judith G. M.] Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands; [Van Roon, Arie M.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands; [Hunfeld, Joke A. M.] Erasmus MC, Dept Med Psychol & Psychotherapy, Rotterdam, Netherlands; [Groot, Paul F. C.] Univ Amsterdam, Acad Med Ctr, Dept Radiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands	University of Groningen; University of Groningen; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam	Janssens, KAM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands.	k.a.m.janssens@umcg.nl	Rosmalen, Judith G.M./F-5375-2011; Riese, Harriëtte/E-7234-2012	Rosmalen, Judith G.M./0000-0002-6393-0032; Riese, Harriëtte/0000-0003-3661-3151	Netherlands Organization for Scientific Research NWO (Medical Research Council) [GB-MW 940-38-011]; Netherlands Organization for Scientific Research NWO (ZonMW Brainpower grant) [100-001-004]; Netherlands Organization for Scientific Research NWO (ZonMw Risk Behavior and Dependence grants) [60-60600-98-018, 60-60600-97-118]; Netherlands Organization for Scientific Research NWO (ZonMw Culture and Health grant) [261-98-710]; Netherlands Organization for Scientific Research NWO (Social Sciences Council medium-sized investment grants) [GB-MaGW 480-01-006, GB-MaGW 480-07-001]; Netherlands Organization for Scientific Research NWO (Social Sciences Council project grants) [GB-MaGW 457-03-018, GB-MaGW 452-04-314, GB-MaGW 452-06-004]; Netherlands Organization for Scientific Research NWO (NWO large-sized investment grant) [175.010.2003.005]; Sophia Foundation for Medical Research [301, 393]; Dutch Ministry of Justice (WODC); European Science Foundation (EuroSTRESS project) [FP-006]	Netherlands Organization for Scientific Research NWO (Medical Research Council)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research NWO (ZonMW Brainpower grant); Netherlands Organization for Scientific Research NWO (ZonMw Risk Behavior and Dependence grants); Netherlands Organization for Scientific Research NWO (ZonMw Culture and Health grant); Netherlands Organization for Scientific Research NWO (Social Sciences Council medium-sized investment grants); Netherlands Organization for Scientific Research NWO (Social Sciences Council project grants); Netherlands Organization for Scientific Research NWO (NWO large-sized investment grant); Sophia Foundation for Medical Research; Dutch Ministry of Justice (WODC); European Science Foundation (EuroSTRESS project)	This research is part of the TRacking Adolescents' Individual Lives Survey. Participating centers of the Tracking adolescents' individual lives survey include various departments of the University Medical Center and University of Groningen, the Erasmus University Medical Center Rotterdam, the University of Utrecht, the Radboud Medical Center Nijmegen, and the Parnassia Bavo group, all in the Netherlands. The Tracking adolescents' individual lives survey has been financially supported by various grants from the Netherlands Organization for Scientific Research NWO (Medical Research Council program grant GB-MW 940-38-011; ZonMW Brainpower grant 100-001-004; ZonMw Risk Behavior and Dependence grants 60-60600-98-018 and 60-60600-97-118; ZonMw Culture and Health grant 261-98-710; Social Sciences Council medium-sized investment grants GB-MaGW 480-01-006 and GB-MaGW 480-07-001; Social Sciences Council project grants GB-MaGW 457-03-018, GB-MaGW 452-04-314, and GB-MaGW 452-06-004; NWO large-sized investment grant 175.010.2003.005); the Sophia Foundation for Medical Research (projects 301 and 393), the Dutch Ministry of Justice (WODC), the European Science Foundation (EuroSTRESS project FP-006), and the participating universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach TM, 2003, J CLIN CHILD ADOLESC, V32, P328, DOI 10.1207/S15374424JCCP3203_02; Alfven G, 2008, J PSYCHOSOM RES, V65, P381, DOI 10.1016/j.jpsychores.2008.07.004; [Anonymous], ASSESSMENT CARDIOVAS; Bernardi L, 2000, J AM COLL CARDIOL, V35, P1462, DOI 10.1016/S0735-1097(00)00595-7; Bjorling EA, 2009, HEADACHE, V49, P1186, DOI 10.1111/j.1526-4610.2009.01406.x; Bouma EMC, 2009, PSYCHONEUROENDOCRINO, V34, P884, DOI 10.1016/j.psyneuen.2009.01.003; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Connelly M, 2011, J PEDIATR PSYCHOL, V36, P852, DOI 10.1093/jpepsy/jsr017; de Winter AF, 2005, EUR J EPIDEMIOL, V20, P173, DOI 10.1007/s10654-004-4948-6; Dietrich A, 2007, AUTONOMIC NERVOUS SY; Dietrich A, 2011, PSYCHOTHER PSYCHOSOM, V80, P62, DOI 10.1159/000318781; Ebinger F, 2006, CEPHALALGIA, V26, P295, DOI 10.1111/j.1468-2982.2005.01039.x; Gini G, 2009, PEDIATRICS, V123, P1059, DOI 10.1542/peds.2008-1215; Houtveen JH, 2007, BIOL PSYCHOL, V76, P239, DOI 10.1016/j.biopsycho.2007.08.005; Houtveen JH, 2010, PSYCHOPHYSIOLOGY, V47, P570, DOI 10.1111/j.1469-8986.2009.00951.x; Hunfeld JAM, 2002, PSYCHOL PSYCHOTHER-T, V75, P251, DOI 10.1348/147608302320365172; Janssens KAM, 2014, J PEDIATR-US, V164, P900, DOI 10.1016/j.jpeds.2013.12.003; Janssens KAM, 2012, PSYCHONEUROENDOCRINO, V37, P332, DOI 10.1016/j.psyneuen.2011.06.016; Janssens KAM, 2010, J CHILD PSYCHOL PSYC, V51, P304, DOI 10.1111/j.1469-7610.2009.02174.x; Janssens KAM, 2009, J PEDIATR-US, V154, P918, DOI 10.1016/j.jpeds.2008.12.023; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Larsson B, 1996, J PEDIATR PSYCHOL, V21, P603, DOI 10.1093/jpepsy/21.5.603; Olafsdottir E, 2001, ACTA PAEDIATR, V90, P632, DOI 10.1080/080352501750258685; Oldehinkel AJ, 2011, PSYCHOPHYSIOLOGY, V48, P441, DOI 10.1111/j.1469-8986.2010.01118.x; Paras ML, 2009, JAMA-J AM MED ASSOC, V302, P550, DOI 10.1001/jama.2009.1091; Puzanovova M, 2009, J PSYCHOSOM RES, V67, P235, DOI 10.1016/j.jpsychores.2009.02.007; Riese H, 2003, BEHAV RES METH INS C, V35, P467, DOI 10.3758/BF03195525; ROBBE HWJ, 1987, HYPERTENSION, V10, P538, DOI 10.1161/01.HYP.10.5.538; SLOAN RP, 1991, PHYSIOL BEHAV, V50, P1039, DOI 10.1016/0031-9384(91)90434-P; Stults-Kolehmainen MA, 2014, J STRENGTH COND RES, V28, P2007, DOI 10.1519/JSC.0000000000000335; Tak LM, 2011, BIOL PSYCHOL, V87, P183, DOI 10.1016/j.biopsycho.2011.02.002; Tak LM, 2010, J PSYCHOSOM RES, V68, P461, DOI 10.1016/j.jpsychores.2009.12.004; Tak LM, 2010, PSYCHOTHER PSYCHOSOM, V79, P179, DOI 10.1159/000296136; Tak LM, 2009, BIOL PSYCHOL, V82, P101, DOI 10.1016/j.biopsycho.2009.05.002; van Tilburg MAL, 2009, PEDIATRICS, V124, pE890, DOI 10.1542/peds.2009-0028; Varni JW, 1996, J BEHAV MED, V19, P515, DOI 10.1007/BF01904901; VU-DAMS, 2013, DATA ANAL MANAGEMENT; Willemsen GHM, 1996, PSYCHOPHYSIOLOGY, V33, P184, DOI 10.1111/j.1469-8986.1996.tb02122.x; Wyller VB, 2008, ANN NONINVAS ELECTRO, V13, P67, DOI 10.1111/j.1542-474X.2007.00202.x	39	1	1	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153318	10.1371/journal.pone.0153318	http://dx.doi.org/10.1371/journal.pone.0153318			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9IK	27089394	Green Published, gold, Green Submitted			2022-12-26	WOS:000374527000016
J	Klausberger, M; Tscheliessnig, R; Neff, S; Nachbagauer, R; Wohlbold, TJ; Wilde, M; Palmberger, D; Krammer, F; Jungbauer, A; Grabherr, R				Klausberger, Miriam; Tscheliessnig, Rupert; Neff, Silke; Nachbagauer, Raffael; Wohlbold, Teddy John; Wilde, Monika; Palmberger, Dieter; Krammer, Florian; Jungbauer, Alois; Grabherr, Reingard			Globular Head-Displayed Conserved Influenza H1 Hemagglutinin Stalk Epitopes Confer Protection against Heterologous H1N1 Virus	PLOS ONE			English	Article							IN-VIVO; MONOCLONAL-ANTIBODIES; SYNTHETIC PEPTIDE; INTERSUBUNIT REGION; CELL EPITOPE; INFECTION; VACCINE; MICE; CHALLENGE; RESPONSES	Significant genetic variability in the head region of the influenza A hemagglutinin, the main target of current vaccines, makes it challenging to develop a long-lived seasonal influenza prophylaxis. Vaccines based on the conserved hemagglutinin stalk domain might provide broader cross-reactive immunity. However, this region of the hemagglutinin is immunosub-dominant to the head region. Peptide-based vaccines have gained much interest as they allow the immune system to focus on relevant but less immunogenic epitopes. We developed a novel influenza A hemagglutinin-based display platform for H1 hemagglutinin stalk peptides that we identified in an epitope mapping assay using human immune sera and synthetic HA peptides. Flow cytometry and competition assays suggest that the identified stalk sequences do not recapitulate the epitopes of already described broadly neutralizing stalk antibodies. Vaccine constructs displaying 25-mer stalk sequences provided up to 75% protection from lethal heterologous virus challenge in BALB/c mice and induced antibody responses against the H1 hemagglutinin. The developed platform based on a vaccine antigen has the potential to be either used as stand-alone or as prime-vaccine in combination with conventional seasonal or pandemic vaccines for the amplification of stalk-based cross-reactive immunity in humans or as platform to evaluate the relevance of viral peptides/epitopes for protection against influenza virus infection.	[Klausberger, Miriam; Tscheliessnig, Rupert; Neff, Silke; Wilde, Monika; Palmberger, Dieter; Jungbauer, Alois; Grabherr, Reingard] Univ Nat Resources & Life Sci Vienna, Dept Biotechnol, Vienna, Austria; [Tscheliessnig, Rupert] Austrian Ctr Ind Biotechnol, Vienna, Austria; [Nachbagauer, Raffael] Univ Vienna, Fac Life Sci, Vienna, Austria; [Nachbagauer, Raffael; Wohlbold, Teddy John; Krammer, Florian] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Wohlbold, Teddy John] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA	University of Natural Resources & Life Sciences, Vienna; Austrian Centre of Industrial Biotechnology; University of Vienna; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Grabherr, R (corresponding author), Univ Nat Resources & Life Sci Vienna, Dept Biotechnol, Vienna, Austria.	reingard.grabherr@boku.ac.at	Krammer, Florian/H-3237-2019; Nachbagauer, Raffael/H-7798-2019; Klausberger, Miriam/C-7885-2017	Krammer, Florian/0000-0003-4121-776X; Nachbagauer, Raffael/0000-0001-5568-5420; Klausberger, Miriam/0000-0001-8409-454X; Grabherr, Reingard/0000-0002-4501-927X; Jungbauer, Alois/0000-0001-8182-7728	Austrian Science Foundation FWF [W1224]; FWF [P 25092-B13]; Austrian Centre of Industrial Biotechnology (ACIB); Federal Ministry of Economy, Family and Youth (BMWJF); Federal Ministry of Traffic, Innovation and Technology (BMVIT); Syrian Business Promotion Agency SFG; Standortagentur Tirol and ZIT - Technology Agency of the City of Vienna through the COMET-Funding Program; Erwin Schrodinger fellowship from the Austrian Science Fund [J 3232]; NIH (National Institutes of Health) [1P01AI097092-01A1]; PATH (Program for Appropriate Technology in Health); Austrian Centre of Industrial Biotechnology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI097092] Funding Source: NIH RePORTER	Austrian Science Foundation FWF(Austrian Science Fund (FWF)); FWF(Austrian Science Fund (FWF)); Austrian Centre of Industrial Biotechnology (ACIB); Federal Ministry of Economy, Family and Youth (BMWJF); Federal Ministry of Traffic, Innovation and Technology (BMVIT); Syrian Business Promotion Agency SFG; Standortagentur Tirol and ZIT - Technology Agency of the City of Vienna through the COMET-Funding Program; Erwin Schrodinger fellowship from the Austrian Science Fund; NIH (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PATH (Program for Appropriate Technology in Health); Austrian Centre of Industrial Biotechnology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	MK and MW received funding from the Austrian Science Foundation FWF Doctoral program BioToP-Molecular Technology of Proteins W1224 and DP also was funded by the FWF (P 25092-B13). RT was funded by the Austrian Centre of Industrial Biotechnology (ACIB). ACIB is a non-profit research centre supported by the Federal Ministry of Economy, Family and Youth (BMWJF), the Federal Ministry of Traffic, Innovation and Technology (BMVIT), the Syrian Business Promotion Agency SFG, the Standortagentur Tirol and ZIT - Technology Agency of the City of Vienna through the COMET-Funding Program managed by the Austrian Research Promotion Agency FFG. FK was supported by an Erwin Schrodinger fellowship (J 3232) from the Austrian Science Fund. This work was partially supported by NIH (National Institutes of Health) program project grant 1P01AI097092-01A1 and PATH (Program for Appropriate Technology in Health). The Austrian Centre of Industrial Biotechnology provided support in the form of salaries for authors [RT], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andrews SF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad0522; Atsmon J, 2012, J CLIN IMMUNOL, V32, P595, DOI 10.1007/s10875-011-9632-5; Berglund L, 2008, PROTEIN SCI, V17, P606, DOI 10.1110/ps.073347208; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; Condron M M, 2008, Open Biotechnol J, V2, P87, DOI 10.2174/1874070700802010087; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Crowe JE, 2012, Patent publication number, Patent No. [WO2012045001 A2, 2012045001]; DAVIES DR, 1990, ANNU REV BIOCHEM, V59, P439, DOI 10.1146/annurev.bi.59.070190.002255; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; Dreyfus C, 2013, J VIROL, V87, P7149, DOI 10.1128/JVI.02975-12; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ferko B, 1998, J INFECT DIS, V178, P1359, DOI 10.1086/314445; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; Gogolak P, 2000, BIOCHEM BIOPH RES CO, V270, P190, DOI 10.1006/bbrc.2000.2384; Heaton NS, 2013, J VIROL, V87, P8272, DOI 10.1128/JVI.00969-13; Horvath A, 1998, IMMUNOL LETT, V60, P127, DOI 10.1016/S0165-2478(97)00137-5; Huang Q, 2003, BBA-BIOMEMBRANES, V1614, P3, DOI 10.1016/S0005-2736(03)00158-5; JACKSON DC, 1986, VIROLOGY, V155, P625, DOI 10.1016/0042-6822(86)90222-9; JERRY DJ, 1993, BIOTECHNIQUES, V14, P464; Klausberger M, 2014, VACCINE, V32, P355, DOI 10.1016/j.vaccine.2013.11.036; Knittelfelder R, 2009, EXPERT OPIN BIOL TH, V9, P493, DOI [10.1517/14712590902870386, 10.1517/14712590902870386 ]; Krammer F, 2015, CURR TOP MICROBIOL, V386, P301, DOI 10.1007/82_2014_408; Krammer F, 2013, J VIROL, V87, P6542, DOI [10.1128/JVI.00641-13, 10.1128/JVI.03183-13]; Krammer F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043603; Krammer F, 2010, J VIROL METHODS, V167, P17, DOI 10.1016/j.jviromet.2010.03.003; Krammer F, 2010, MOL BIOTECHNOL, V45, P226, DOI 10.1007/s12033-010-9268-3; Margine I, 2013, J VIROL, V87, P4728, DOI 10.1128/JVI.03509-12; Moody MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025797; Mullarkey CE, 2013, EUR J IMMUNOL, V43, P1940, DOI 10.1002/eji.201242922; MULLER GM, 1982, P NATL ACAD SCI-BIOL, V79, P569, DOI 10.1073/pnas.79.2.569; MUSTER T, 1994, J VIROL, V68, P4031, DOI 10.1128/JVI.68.6.4031-4034.1994; NAGY Z, 1994, SCAND J IMMUNOL, V40, P281, DOI 10.1111/j.1365-3083.1994.tb03464.x; Nakamura G, 2013, CELL HOST MICROBE, V14, P93, DOI 10.1016/j.chom.2013.06.004; NESTOROWICZ A, 1985, MOL IMMUNOL, V22, P145, DOI 10.1016/S0161-5890(85)80008-0; Pflegerl K, 2002, J PEPT RES, V59, P174, DOI 10.1034/j.1399-3011.2002.1o965.x; Poland GA, 2008, VACCINE, V26, pD35, DOI 10.1016/j.vaccine.2008.07.065; Prabhu N, 2009, J VIROL, V83, P2553, DOI 10.1128/JVI.02165-08; RAJNAVOLGYI E, 1994, MOL IMMUNOL, V31, P1403, DOI 10.1016/0161-5890(94)90156-2; Sivalingam GN, 2012, MOL IMMUNOL, V51, P304, DOI 10.1016/j.molimm.2012.03.030; Staczek J, 1998, INFECT IMMUN, V66, P3990, DOI 10.1128/IAI.66.8.3990-3994.1998; Stanekova Z, 2012, INFLUENZA OTHER RESP, V6, P389, DOI 10.1111/j.1750-2659.2011.00328.x; STYK B, 1979, ACTA VIROL, V23, P1; Sui J, 2011, CLIN INFECT DIS, V52, P1003, DOI 10.1093/cid/cir121; Tan GS, 2012, J VIROL, V86, P6179, DOI 10.1128/JVI.00469-12; TANG XL, 1988, J VIROL, V62, P4745, DOI 10.1128/JVI.62.12.4745-4751.1988; Terajima M, 2011, J VIROL, V85, P13463, DOI 10.1128/JVI.05193-11; Tharakaraman K, 2014, CELL HOST MICROBE, V15, P644, DOI 10.1016/j.chom.2014.04.009; Wacheck V, 2010, J INFECT DIS, V201, P354, DOI 10.1086/649428; Wang TT, 2010, P NATL ACAD SCI USA, V107, P18979, DOI 10.1073/pnas.1013387107; Wang TT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000796; Wohlbold TJ, 2015, VACCINE, V33, P3314, DOI 10.1016/j.vaccine.2015.05.038	52	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153579	10.1371/journal.pone.0153579	http://dx.doi.org/10.1371/journal.pone.0153579			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088239	Green Published, Green Submitted, gold			2022-12-26	WOS:000374527000028
J	Valmasoni, M; Pierobon, ES; Ruol, A; De Pasqual, CA; Zanchettin, G; Moletta, L; Salvador, R; Costantini, M; Merigliano, S				Valmasoni, Michele; Pierobon, Elisa Sefora; Ruol, Alberto; De Pasqual, Carlo Alberto; Zanchettin, Gianpietro; Moletta, Lucia; Salvador, Renato; Costantini, Mario; Merigliano, Stefano			Endoscopic Tumor Length Should Be Reincluded in the Esophageal Cancer Staging System: Analyses of 662 Consecutive Patients	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; LONG-TERM SURVIVAL; PROGNOSTIC-FACTOR; LYMPHATIC SPREAD; LOCATION; IMPACT; GRADE; ADENOCARCINOMA; PREDICT	Esophageal cancer represents the 6th cause of cancer mortality in the World. New treatments led to outcome improvements, but patient selection and prognostic stratification is a critical aspect to gain maximum benefit from therapies. Today, patients are stratified into 9 prognostic groups, according to a staging system developed by the American Joint Committee on Cancer. Recently, trying to better select patients with curing possibilities several authors are reconsidering tumor length as a valuable prognostic parameter. Specifically, endoscopic tumor length can be easily measured with an esophageal endoscopy and, if its utility in esophageal cancer staging is demonstrated, it may represent a simple method to identify high risk patients and an easy-to-obtain variable in prognostic stratification. In this study we retrospectively analyzed 662 patients treated for esophageal cancer, stratified according to cancer histology and current staging system, to assess the possible role of endoscopic tumor length. We found a significant correlation between endoscopic tumor length, current staging parameters and 5-year survival, proving that endoscopic tumor length may be used as a simple risk stratification tool. Our results suggest a possible indication for preoperative therapy in early stage squamocellular carcinoma patients without lymph nodes involvement, who are currently treated with surgery alone.	[Valmasoni, Michele; Pierobon, Elisa Sefora; Ruol, Alberto; De Pasqual, Carlo Alberto; Zanchettin, Gianpietro; Moletta, Lucia; Salvador, Renato; Costantini, Mario; Merigliano, Stefano] Univ Hosp Padova, Dept Surg Oncol & Gastroenterol Sci, Surg Clin 3, Ctr Esophageal Dis, I-35128 Padua, Italy	University of Padua; Azienda Ospedaliera - Universita di Padova	Valmasoni, M (corresponding author), Univ Hosp Padova, Dept Surg Oncol & Gastroenterol Sci, Surg Clin 3, Ctr Esophageal Dis, I-35128 Padua, Italy.	michele.valmasoni@unipd.it	Pierobon, Elisa Sefora/AAS-9267-2021; Merigliano, Stefano/AAY-3023-2021; Valmasoni, Michele/C-7574-2014; Pierobon, Elisa Sefora/AAE-5150-2021; Moletta, Lucia/ABD-7200-2020; De Pasqual, Carlo Alberto/AAF-3368-2020	Pierobon, Elisa Sefora/0000-0002-5836-1197; Valmasoni, Michele/0000-0002-1462-8275; De Pasqual, Carlo Alberto/0000-0001-7719-258X				Arnold M, 2015, GUT, V64, P381, DOI 10.1136/gutjnl-2014-308124; Bhutani MS, 2002, ENDOSCOPY, V34, P461, DOI 10.1055/s-2002-31996; Bollschweiler E, 2006, J SURG ONCOL, V94, P355, DOI 10.1002/jso.20569; Bolton WD, 2009, J THORAC CARDIOV SUR, V138, P831, DOI 10.1016/j.jtcvs.2009.02.003; Cense HA, 2006, BEST PRACT RES CL GA, V20, P893, DOI 10.1016/j.bpg.2006.03.010; Chang WL, 2011, DIS ESOPHAGUS, V24, P590, DOI 10.1111/j.1442-2050.2011.01195.x; Cohen DJ, 2015, J CLIN ONCOL, V33, P1754, DOI 10.1200/JCO.2014.59.7765; Cools-Lartigue J, 2015, J GASTROINTEST SURG, V19, P964, DOI 10.1007/s11605-014-2701-3; Dhupar R, 2014, DIS ESOPHAGUS, V27, P770, DOI 10.1111/dote.12154; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Feng JF, 2013, UPSALA J MED SCI, V118, P145, DOI 10.3109/03009734.2013.792887; Gaur P., 2010, CANCER, V117, P63, DOI [10.1002/cncr.25373, DOI 10.1002/CNCR.25373]; Griffiths EA, 2006, J SURG ONCOL, V93, P258, DOI 10.1002/jso.20449; Hu W, 2013, EUR SURG, V45, P200, DOI 10.1007/s10353-013-0223-y; HUTTER RVP, 1987, ARCH SURG-CHICAGO, V122, P1235; Jeon HW, 2015, THORAC CARDIOV SURG, V63, P341, DOI 10.1055/s-0034-1384787; Karashima R, 2015, SURG TODAY, V45, P471, DOI 10.1007/s00595-014-0965-6; Kato H, 2013, GEN THORAC CARDIOVAS, V61, P330, DOI 10.1007/s11748-013-0246-0; Khanna LG, 2015, BEST PRACT RES CL GA, V29, P179, DOI 10.1016/j.bpg.2014.12.005; Kidane B, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001556.pub3; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mirinezhad SK, 2014, ASIAN PAC J CANCER P, V15, P691, DOI 10.7314/APJCP.2014.15.2.691; Qumseya BJ, 2015, GASTROINTEST ENDOSC, V81, P865, DOI 10.1016/j.gie.2014.08.025; Rice TW, 2013, THORAC SURG CLIN, V23, P461, DOI 10.1016/j.thorsurg.2013.07.004; Rubenstein J. H., 2015, GASTROENTEROLOGY; Schmidt T, 2015, J NATL COMPR CANC NE, V13, P239, DOI 10.6004/jnccn.2015.0030; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Situ DR, 2013, J THORAC CARDIOV SUR, V146, P45, DOI 10.1016/j.jtcvs.2013.01.034; Situ D, 2013, ANN SURG ONCOL, V20, P580, DOI 10.1245/s10434-012-2656-0; Song Zhengbo, 2012, World J Surg Oncol, V10, P273, DOI 10.1186/1477-7819-10-273; Stein HJ, 2005, ANN SURG, V242, P566, DOI 10.1097/01.sla.0000184211.75970.85; Suh YS, 2012, ANN SURG, V255, P908, DOI 10.1097/SLA.0b013e31824beb95; Tekola Bezawit D, 2014, J Gastrointest Cancer, V45, P342, DOI 10.1007/s12029-014-9616-9; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Visbal AL, 2001, ANN THORAC SURG, V71, P1803, DOI 10.1016/S0003-4975(01)02601-7; Wang BY, 2012, ANN SURG ONCOL, V19, P2149, DOI 10.1245/s10434-012-2273-y; Wang BY, 2011, ANN THORAC SURG, V91, P887, DOI 10.1016/j.athoracsur.2010.11.011; Wang J, 2014, WORLD J GASTROENTERO, V20, P18397, DOI 10.3748/wjg.v20.i48.18397; Wijnhoven BPL, 2007, ANN SURG, V245, P717, DOI 10.1097/01.sla.0000251703.35919.02; Williams B. A., 2006, MAYO CLIN TECHNICAL, V79; Worrell SG, 2014, J GASTROINTEST SURG, V18, P318, DOI 10.1007/s11605-013-2398-8; Wu N, 2012, CHINESE MED J-PEKING, V125, P4445, DOI 10.3760/cma.j.issn.0366-6999.2012.24.022; Yendamuri S, 2009, CANCER-AM CANCER SOC, V115, P508, DOI 10.1002/cncr.24062; Zeybek A, 2013, INT SURG, V98, P234, DOI 10.9738/INTSURG-D-13-00075.1	44	15	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153068	10.1371/journal.pone.0153068	http://dx.doi.org/10.1371/journal.pone.0153068			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088503	Green Published, Green Submitted, gold			2022-12-26	WOS:000374527000010
J	Weiss-Gayet, M; Starck, J; Chaabouni, A; Chazaud, B; Morle, F				Weiss-Gayet, Michele; Starck, Joelle; Chaabouni, Azza; Chazaud, Benedicte; Morle, Francois			Notch Stimulates Both Self-Renewal and Lineage Plasticity in a Subset of Murine CD9(High) Committed Megakaryocytic Progenitors	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; IN-VIVO; ERYTHROLEUKEMIA-CELLS; IMMUNE-SYSTEM; EX-VIVO; DIFFERENTIATION; MAINTENANCE; COMMITMENT; HIERARCHY; LEUKEMIA	This study aimed at reinvestigating the controversial contribution of Notch signaling to megakaryocytic lineage development. For that purpose, we combined colony assays and single cells progeny analyses of purified megakaryocyte-erythroid progenitors (MEP) after short-term cultures on recombinant Notch ligand rDLL1. We showed that Notch activation stimulated the SCF-dependent and preferential amplification of Kit(+) erythroid and bipotent progenitors while favoring commitment towards the erythroid at the expense of megakaryocytic lineage. Interestingly, we also identified a CD9(High) MEP subset that spontaneously generated almost exclusively megakaryocytic progeny mainly composed of single megakaryocytes. We showed that Notch activation decreased the extent of polyploidization and maturation of megakaryocytes, increased the size of megakaryocytic colonies and surprisingly restored the generation of erythroid and mixed colonies by this CD9(High) MEP subset. Importantly, the size increase of megakaryocytic colonies occurred at the expense of the production of single megakaryocytes and the restoration of colonies of alternative lineages occurred at the expense of the whole megakaryocytic progeny. Altogether, these results indicate that Notch activation is able to extend the number of divisions of MK-committed CD9(High) MEPs before terminal maturation while allowing a fraction of them to generate alternative lineages. This unexpected plasticity of MK-committed progenitors revealed upon Notch activation helps to better understand the functional promiscuity between megakaryocytic lineage and hematopoietic stem cells.	[Weiss-Gayet, Michele; Starck, Joelle; Chaabouni, Azza; Chazaud, Benedicte; Morle, Francois] Univ Lyon 1, Inst NeuroMyoGene INMG, F-69622 Villeurbanne, France; [Weiss-Gayet, Michele; Starck, Joelle; Chaabouni, Azza; Chazaud, Benedicte; Morle, Francois] INSERM, U1217, Villeurbanne, France; [Weiss-Gayet, Michele; Starck, Joelle; Chaabouni, Azza; Chazaud, Benedicte; Morle, Francois] CNRS, UMR 5310, Villeurbanne, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Morle, F (corresponding author), Univ Lyon 1, Inst NeuroMyoGene INMG, F-69622 Villeurbanne, France.; Morle, F (corresponding author), INSERM, U1217, Villeurbanne, France.; Morle, F (corresponding author), CNRS, UMR 5310, Villeurbanne, France.	francois.morle@univ-lyon1.fr	Chazaud, Benedicte/N-9291-2017	Chazaud, Benedicte/0000-0002-1262-502X	CNRS; Universite Claude Bernard Lyon1; Ligue Nationale contre le Cancer (Equipe labellisee); Ligue Nationale contre le Cancer (Comites du Rhone, de la Drome et du Cantal); Ligue Nationale contre le Cancer; Societe Francaise d'Hematologie	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Claude Bernard Lyon1; Ligue Nationale contre le Cancer (Equipe labellisee)(Ligue nationale contre le cancer); Ligue Nationale contre le Cancer (Comites du Rhone, de la Drome et du Cantal); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Societe Francaise d'Hematologie	This work has been supported by grants from the CNRS and Universite Claude Bernard Lyon1 and by specific grants from the Ligue Nationale contre le Cancer (Equipe labellisee 2009-2012 and Comites du Rhone, de la Drome et du Cantal). MW and JS are permanent employees of CNRS while FM and BC are permanent employees of INSERM. AC PhD student has been supported by a three years salary from the Ligue Nationale contre le Cancer (2011-2014) and by a 6 months salary from the Societe Francaise d'Hematologie (2014-2015).	Alderton GK, 2011, NAT REV CANCER, V11, P385, DOI 10.1038/nrc3071; Benveniste P, 2014, BLOOD, V123, P1167, DOI 10.1182/blood-2013-07-505099; Besancenot R, 2014, BLOOD, V124, P2104, DOI 10.1182/blood-2014-03-559815; Besseyrias V, 2007, J EXP MED, V204, P331, DOI 10.1084/jem.20061442; Bigas A, 2012, BLOOD, V119, P3226, DOI 10.1182/blood-2011-10-355826; Carlesso N, 1999, BLOOD, V93, P838, DOI 10.1182/blood.V93.3.838.403k29_838_848; Cornejo MG, 2011, BLOOD, V118, P1264, DOI 10.1182/blood-2011-01-328567; Dahlberg A, 2011, BLOOD, V117, P6083, DOI 10.1182/blood-2011-01-283606; Danahay H, 2015, CELL REP, V10, P239, DOI 10.1016/j.celrep.2014.12.017; Dando JS, 2005, STEM CELLS, V23, P550, DOI 10.1634/stemcells.2004-0205; Dore LC, 2011, BLOOD, V118, P231, DOI 10.1182/blood-2011-04-285981; Elagib KE, 2004, MOLECULAR AND CELLUL, V24, P7779, DOI [10.1128/MCB.24.17.7779-7794.2004, DOI 10.1128/MCB.24.17.7779-7794.2004]; Falk R, 2012, METHODS, V58, P69, DOI 10.1016/j.ymeth.2012.07.008; Goldenson B, 2015, BLOOD, V125, P2141, DOI 10.1182/blood-2014-12-615401; Guo GJ, 2013, CELL STEM CELL, V13, P492, DOI 10.1016/j.stem.2013.07.017; Haas S, 2015, CELL STEM CELL, V17, P422, DOI 10.1016/j.stem.2015.07.007; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Ishiko E, 2005, J BIOL CHEM, V280, P4929, DOI 10.1074/jbc.M406788200; Jang MS, 2004, J CELL PHYSIOL, V199, P418, DOI 10.1002/jcp.10467; Kageyama R, 2015, CELL TISSUE RES, V359, P125, DOI 10.1007/s00441-014-1888-7; Kalaitzidis D, 2011, NATURE, V473, P159, DOI 10.1038/473159a; Karanu FN, 2003, LEUKEMIA, V17, P1366, DOI 10.1038/sj.leu.2402973; Klinakis A, 2011, NATURE, V473, P230, DOI 10.1038/nature09999; Koch U, 2011, TRENDS IMMUNOL, V32, P434, DOI 10.1016/j.it.2011.06.005; Kumano K, 2001, BLOOD, V98, P3283, DOI 10.1182/blood.V98.12.3283; Kunisato A, 2003, BLOOD, V101, P1777, DOI 10.1182/blood-2002-07-2051; Lauret E, 2004, LEUKEMIA, V18, P788, DOI 10.1038/sj.leu.2403288; Leysi-Derilou Y, 2010, CELL CYCLE, V9, P2589, DOI 10.4161/cc.9.13.12078; Lobry C, 2011, J EXP MED, V208, P1931, DOI 10.1084/jem.20111855; Lordier L, 2012, CELL CYCLE, V11, P4385, DOI 10.4161/cc.22712; Maillard I, 2008, CELL STEM CELL, V2, P356, DOI 10.1016/j.stem.2008.02.011; Malinge S, 2010, BLOOD, V116, P5438, DOI 10.1182/blood-2010-09-308395; Mancini SJC, 2005, BLOOD, V105, P2340, DOI 10.1182/blood-2004-08-3207; Mercher T, 2008, CELL STEM CELL, V3, P314, DOI 10.1016/j.stem.2008.07.010; Ng AP, 2012, P NATL ACAD SCI USA, V109, P2364, DOI 10.1073/pnas.1121385109; Nishikii H, 2015, STEM CELLS, V33, P2196, DOI 10.1002/stem.1985; Oh P, 2013, CELL STEM CELL, V13, P190, DOI 10.1016/j.stem.2013.05.015; Ohishi K, 2002, J CLIN INVEST, V110, P1165, DOI 10.1172/JCI200216167; Pajcini KV, 2011, LEUKEMIA, V25, P1525, DOI 10.1038/leu.2011.127; Poirault-Chassac S, 2010, BLOOD, V116, P5670, DOI 10.1182/blood-2010-05-285957; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; Rieger MA, 2009, BRIT J HAEMATOL, V144, P448, DOI 10.1111/j.1365-2141.2008.07419.x; Roch A, 2015, STEM CELLS, V33, P3152, DOI 10.1002/stem.2106; Sanjuan-Pla A, 2013, NATURE, V502, P232, DOI 10.1038/nature12495; Shelly LL, 1999, J CELL BIOCHEM, V73, P164, DOI 10.1002/(SICI)1097-4644(19990501)73:2<164::AID-JCB3>3.0.CO;2-0; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Starck J, 2010, BLOOD, V116, P4795, DOI 10.1182/blood-2010-02-270405; Varnum-Finney B, 1998, BLOOD, V91, P4084, DOI 10.1182/blood.V91.11.4084.411k05_4084_4091; Varnum-Finney B, 2011, J CLIN INVEST, V121, P1207, DOI 10.1172/JCI43868; Walkley CR, 2011, CELL STEM CELL, V8, P602, DOI 10.1016/j.stem.2011.04.010; Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007; Yuan JS, 2010, ANNU REV IMMUNOL, V28, P343, DOI 10.1146/annurev.immunol.021908.132719; Zeuner A, 2011, CELL DEATH DIFFER, V18, P371, DOI 10.1038/cdd.2010.110	54	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153860	10.1371/journal.pone.0153860	http://dx.doi.org/10.1371/journal.pone.0153860			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27089435	Green Submitted, Green Published, gold			2022-12-26	WOS:000374527000056
J	Lefeuvre, D; Delmas, MC; Marguet, C; Chauvin, P; Vandentorren, S				Lefeuvre, Delphine; Delmas, Marie-Christine; Marguet, Christophe; Chauvin, Pierre; Vandentorren, Stephanie			Asthma-Like Symptoms in Homeless Children in the Greater Paris Area in 2013: Prevalence, Associated Factors and Utilization of Healthcare Services in the ENFAMS Survey	PLOS ONE			English	Article							YOUNG-CHILDREN; ATOPIC ECZEMA; DISPARITIES; CHILDHOOD; ALLERGIES; BIRTH; ENVIRONMENT; DISORDERS; RISK	Introduction Asthma remains poorly studied in homeless children. We sought to estimate the prevalence of asthma-like symptoms (ALS) and to identify the factors associated with ALS and healthcare service utilisation. Materials and Methods A cross-sectional survey of a random sample of sheltered homeless families was conducted by interviewing 801 parents of children (0-12 years) in 17 languages. ALS were defined as wheezing or night cough without fever during the previous year. Poisson regression models with robust error variance were used to compute prevalence ratios (PR) for factors associated with ALS and healthcare service utilisation for ALS. Results The prevalence of ALS among the children was 19.9%. Poor housing sanitation was significantly associated with ALS, as being born in the European Union. Most of the children with ALS had used healthcare services (85.4%). The main barriers to accessing such services were having lived in France for less than 49 months, having difficulties in French and living in poor housing conditions. Conclusion ALS prevalence seemed lower than in the general child population, possibly because of the children's origins. Environmental factors associated with ALS point to the need to improve the indoor environment of family shelters. The relatively high rate of healthcare service utilisation should not overshadow existing barriers.	[Lefeuvre, Delphine; Chauvin, Pierre; Vandentorren, Stephanie] Univ Paris 06, Sorbonne Univ, INSERM,Dept Social Epidemiol, Inst Pierre Louis Epidemiol & Sante Publ IPLESP U, Paris, France; [Delmas, Marie-Christine; Vandentorren, Stephanie] French Inst Publ Hlth Surveillance, St Maurice, France; [Marguet, Christophe] Univ Hosp Rouen, Rouen, France; [Vandentorren, Stephanie] Observ Samusocial Paris, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institute of Public Health Surveillance; CHU de Rouen	Vandentorren, S (corresponding author), Univ Paris 06, Sorbonne Univ, INSERM,Dept Social Epidemiol, Inst Pierre Louis Epidemiol & Sante Publ IPLESP U, Paris, France.; Vandentorren, S (corresponding author), French Inst Publ Hlth Surveillance, St Maurice, France.; Vandentorren, S (corresponding author), Observ Samusocial Paris, Paris, France.	Stephanie.VANDENTORREN@ars.sante.fr	Chauvin, Pierre/S-2981-2019; Chauvin, Pierre/G-1095-2015	Chauvin, Pierre/0000-0002-9183-6406; Chauvin, Pierre/0000-0002-9183-6406; VANDENTORREN, Stephanie/0000-0003-4269-8286	Agence regionale de sante d'Ile-de-France (ARS); Canceropole Ile-de-France; Caisse nationale des allocations familiales (CNAF); Fondation de France; Fondation Macif; Fondation Sanofi Espoir; Institut national de prevention et deducation pour la sante (INPES); Institut de recherche en sante publique (IReSP); Institut de veille sanitaire (InVS); Ministere de l'Interieur; Observatoire national de l'enfance en danger (ONED); Procter et Gamble; State Street	Agence regionale de sante d'Ile-de-France (ARS); Canceropole Ile-de-France(Region Ile-de-France); Caisse nationale des allocations familiales (CNAF); Fondation de France(Fondation de France); Fondation Macif; Fondation Sanofi Espoir; Institut national de prevention et deducation pour la sante (INPES); Institut de recherche en sante publique (IReSP); Institut de veille sanitaire (InVS); Ministere de l'Interieur; Observatoire national de l'enfance en danger (ONED); Procter et Gamble; State Street	This survey was supported by the Agence regionale de sante d'Ile-de-France (ARS), Canceropole Ile-de-France, Caisse nationale des allocations familiales (CNAF), Fondation de France, Fondation Macif, Fondation Sanofi Espoir, Institut national de prevention et deducation pour la sante (INPES), Institut de recherche en sante publique (IReSP), Institut de veille sanitaire (InVS), Ministere de l'Interieur, Observatoire national de l'enfance en danger (ONED), Procter et Gamble and State Street. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia SK, 2011, CURR OPIN ALLERGY CL, V11, P137, DOI 10.1097/ACI.0b013e3283445921; Akinbami LJ, 2011, NATL HLTH STAT REPOR; Almqvist C, 2008, ALLERGY, V63, P47, DOI 10.1111/j.1398-9995.2007.01524.x; Asher MI, 1998, EUR RESPIR J, V12, P315; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Berchet C., 2012, BEH, P17; Braaback L, 2011, CLIN EXP ALLERGY, V41, P1108, DOI 10.1111/j.1365-2222.2011.03744.x; Buu MC, 2014, J ASTHMA, V51, P142, DOI 10.3109/02770903.2013.857682; Cabieses B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105347; Cantarero-Arevalo L, 2013, J EPIDEMIOL COMMUN H, V67, P912, DOI 10.1136/jech-2012-202135; Chen E, 2007, BRAIN BEHAV IMMUN, V21, P993, DOI 10.1016/j.bbi.2007.03.009; Crocker D, 2009, CHEST, V136, P1063, DOI 10.1378/chest.09-0013; Currie A, 2007, J HEALTH ECON, V26, P213, DOI 10.1016/j.jhealeco.2006.08.003; Cutuli JJ, 2014, J HEALTH CARE POOR U, V25, P717, DOI 10.1353/hpu.2014.0099; Cutuli JJ, 2010, PEDIATRICS, V125, P145, DOI 10.1542/peds.2009-0103; Delmas MC, 2012, REV MAL RESPIR, V29, P688, DOI 10.1016/j.rmr.2011.11.016; Delmas MC, 2010, REV MAL RESPIR, V27, P151, DOI 10.1016/j.rmr.2009.09.001; Delmas MC, 2009, ARCH PEDIATRIE, V16, P1261, DOI 10.1016/j.arcped.2009.06.009; Delmas MC, 2014, B EPIDEMIOL HEBD, V20, P360; Flores G, 2009, J ASTHMA, V46, P392, DOI 10.1080/02770900802712971; Fung V, 2014, JAMA PEDIATR, V168, P649, DOI 10.1001/jamapediatrics.2014.79; Garcia-Marcos L, 2014, INT J EPIDEMIOL, V43, P1846, DOI 10.1093/ije/dyu145; Gehring U, 2006, EUR RESPIR J, V27, P95, DOI 10.1183/09031936.06.00017205; Grant R, 2007, AM J PUBLIC HEALTH, V97, P448, DOI 10.2105/AJPH.2005.070482; Guyavarch E, 2014, INFORM SOCIALES, V182, P142; Hammer-Helmich L, 2014, SCAND J PUBLIC HEALT, V42, P120, DOI 10.1177/1403494813505727; Herr M, 2012, REV MAL RESPIR, V29, P52, DOI 10.1016/j.rmr.2011.05.016; Illi S, 2004, J ALLERGY CLIN IMMUN, V113, P925, DOI 10.1016/j.jaci.2004.01.778; Kelley CF, 2005, PEDIATRICS, V115, P726, DOI 10.1542/peds.2004-0529; McLean DE, 2004, ARCH PEDIAT ADOL MED, V158, P244, DOI 10.1001/archpedi.158.3.244; Pearce N, 2007, THORAX, V62, P758, DOI 10.1136/thx.2006.070169; Samuels J., 2010, HOMELESS CHILDREN UP; Simoni M, 2005, OCCUP ENVIRON MED, V62, P616, DOI 10.1136/oem.2004.018291; Societe Pediatrique de Pneumologie et Allergologie, 2009, ASTHM ENF MOINS 36 M; Stingone JA, 2006, ANN ALLERG ASTHMA IM, V97, P244, DOI 10.1016/S1081-1206(10)60021-X; Strunk RC, 2002, PEDIATRICS, V109, P357; Sun YX, 2007, SCI TOTAL ENVIRON, V387, P276, DOI 10.1016/j.scitotenv.2007.07.001; Sun YX, 2011, SCI TOTAL ENVIRON, V409, P4229, DOI 10.1016/j.scitotenv.2011.07.011; van der Hulst AE, 2007, J ALLERGY CLIN IMMUN, V120, P565, DOI 10.1016/j.jaci.2007.05.042; Vandentorren S, 2016, EUR J PUBLIC HEALTH, V26, P71, DOI 10.1093/eurpub/ckv187; Venn AJ, 2003, THORAX, V58, P955, DOI 10.1136/thorax.58.11.955; Victorino CC, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-53; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	43	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153872	10.1371/journal.pone.0153872	http://dx.doi.org/10.1371/journal.pone.0153872			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ6AH	27082960	gold, Green Submitted, Green Published			2022-12-26	WOS:000374291800061
J	Mor, V; Farnoud, AM; Singh, A; Rella, A; Tanno, H; Ishii, K; Kawakami, K; Sato, T; Del Poeta, M				Mor, Visesato; Farnoud, Amir M.; Singh, Ashutosh; Rella, Antonella; Tanno, Hiromasa; Ishii, Keiko; Kawakami, Kazuyoshi; Sato, Toshiya; Del Poeta, Maurizio			Glucosylceramide Administration as a Vaccination Strategy in Mouse Models of Cryptococcosis	PLOS ONE			English	Article							TOXOID CONJUGATE VACCINE; ALPHA-GALACTOSYLCERAMIDE; PROTECTIVE IMMUNITY; LIVER-INJURY; CELL LIGAND; NEOFORMANS; MECHANISMS; PATHOGENICITY; ANTIBODIES; INFECTION	Cryptococcus neoformans is an opportunistic fungal pathogen and the causative agent of the disease cryptococcosis. Cryptococcosis is initiated as a pulmonary infection and in conditions of immune deficiency disseminates to the blood stream and central nervous system, resulting in life-threatening meningoencephalitis. A number of studies have focused on the development of a vaccine against Cryptococcus, primarily utilizing protein-conjugated components of the Cryptococcus polysaccharide capsule as antigen. However, there is currently no vaccine against Cryptococcus in the clinic. Previous studies have shown that the glycosphingolipid, glucosylceramide (GlcCer), is a virulence factor in C. neoformans and antibodies against this lipid inhibit fungal growth and cell division. In the present study, we have investigated the possibility of using GlcCer as a therapeutic agent against C. neoformans infections in mouse models of cryptococcosis. GlcCer purified from a non-pathogenic fungus, Candida utilis, was administered intraperitoneally, prior to infecting mice with a lethal dose of C. neoformans. GlcCer administration prevented the dissemination of C. neoformans from the lungs to the brain and led to 60% mouse survival. GlcCer administration did not cause hepatic injury and elicited an anti-GlcCer antibody response, which was observed independent of the route of administration and the strains of mouse. Taken together, our results suggest that fungal GlcCer can protect mice against lethal doses of C. neoformans infection and can provide a viable vaccination strategy against Cryptococcus.	[Mor, Visesato; Farnoud, Amir M.; Singh, Ashutosh; Rella, Antonella; Del Poeta, Maurizio] SUNY Stony Brook, Dept Mol Genet & Microbiol, 145 Life Sci Bldg, Stony Brook, NY 11794 USA; [Tanno, Hiromasa] Tohoku Univ, Grad Sch Med, Dept Sci Nursing Practice, Aoba Ku, 2-1 Seiryo Cho, Sendai, Miyagi 9808575, Japan; [Ishii, Keiko; Kawakami, Kazuyoshi] Tohoku Univ, Grad Sch Med, Dept Med Microbiol Mycol & Immunol, Aoba Ku, 2-1 Seiryo Cho, Sendai, Miyagi 9808575, Japan; [Sato, Toshiya] Kohjin Life Sci Co Ltd, Chiyoda Ku, 1-3 Yurakucho 1 Chome, Tokyo 1000006, Japan; [Del Poeta, Maurizio] Vet Adm Med Ctr, Northport, NY 11768 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Tohoku University; Tohoku University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Del Poeta, M (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, 145 Life Sci Bldg, Stony Brook, NY 11794 USA.; Del Poeta, M (corresponding author), Vet Adm Med Ctr, Northport, NY 11768 USA.	maurizio.delpoeta@stonybrook.edu	SINGH, ASHUTOSH/AAR-1283-2021	SINGH, ASHUTOSH/0000-0002-0995-6696	NIH [AI56168, AI100631, AI116420]; Veterans Affairs Program in Biomedical Laboratory Research and Development [I01BX002624]; Research Program on Emerging and Reemerging Infectious Diseases from Japan Agency for Medical Research and Development, AMED; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056168, R21AI100631, R01AI116420] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002624] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Program in Biomedical Laboratory Research and Development; Research Program on Emerging and Reemerging Infectious Diseases from Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by NIH grants AI56168, AI100631, AI116420 and by a Merit Review grant I01BX002624 from the Veterans Affairs Program in Biomedical Laboratory Research and Development to MDP. This work was also supported by the Research Program on Emerging and Reemerging Infectious Diseases from Japan Agency for Medical Research and Development, AMED. MDP is a Burroughs Wellcome Investigator in Infectious Diseases. The funder provided support in the form of salaries for authors [VM, AF, AR, and MD], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. TS is an employee of Kohjin Life Sciences Co., Ltd and contributed in analyzing the data.	Biburger M, 2005, J IMMUNOL, V175, P1540, DOI 10.4049/jimmunol.175.3.1540; Biondo C, 2002, INFECT IMMUN, V70, P2383, DOI 10.1128/IAI.70.5.2383-2391.2002; Casadevall A, 2005, CURR MOL MED, V5, P421, DOI 10.2174/1566524054022567; CASADEVALL A, 1992, J INFECT DIS, V165, P1086, DOI 10.1093/infdis/165.6.1086; Chaturvedi AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104316; Chow SK, 2011, VACCINE, V29, P1891, DOI 10.1016/j.vaccine.2010.12.134; Datta K, 2008, CLIN VACCINE IMMUNOL, V15, P1176, DOI 10.1128/CVI.00130-08; Datta K, 2006, FEMS YEAST RES, V6, P525, DOI 10.1111/j.1567-1364.2006.00073.x; Del Poeta M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003832; Devi SJN, 1996, VACCINE, V14, P841, DOI 10.1016/0264-410X(95)00256-Z; Fleuridor R, 2001, J IMMUNOL, V166, P1087, DOI 10.4049/jimmunol.166.2.1087; Fujii H, 2005, VIRCHOWS ARCH, V446, P663, DOI 10.1007/s00428-005-1265-8; Gonzalez-Aseguinolaza G, 2002, J EXP MED, V195, P617, DOI 10.1084/jem.20011889; Hirata M, 2012, J AGR FOOD CHEM, V60, P11473, DOI 10.1021/jf303117e; Huang YX, 2008, VACCINE, V26, P1807, DOI 10.1016/j.vaccine.2008.02.002; Inafuku M, 2012, LIPIDS, V47, P581, DOI 10.1007/s11745-012-3666-1; Kechichian TB, 2007, INFECT IMMUN, V75, P4792, DOI 10.1128/IAI.00587-07; Ko SY, 2005, J IMMUNOL, V175, P3309, DOI 10.4049/jimmunol.175.5.3309; Kopecky-Bromberg SA, 2009, VACCINE, V27, P3766, DOI 10.1016/j.vaccine.2009.03.090; Levery SB, 2002, FEBS LETT, V525, P59, DOI 10.1016/S0014-5793(02)03067-3; Murphy JW, 1998, INFECT IMMUN, V66, P2632, DOI 10.1128/IAI.66.6.2632-2639.1998; Nakagawa R, 2001, J IMMUNOL, V166, P6578, DOI 10.4049/jimmunol.166.11.6578; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Rella A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00836; Rhome R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015572; Rittershaus PC, 2006, J CLIN INVEST, V116, P1651, DOI 10.1172/JCI27890; Rodrigues ML, 2000, INFECT IMMUN, V68, P7049, DOI 10.1128/IAI.68.12.7049-7060.2000; Saito K, 2006, APPL MICROBIOL BIOT, V71, P515, DOI 10.1007/s00253-005-0187-3; Savelkoul HFJ, 2015, VACCINES-BASEL, V3, P148, DOI 10.3390/vaccines3010148; Singh A, 2012, CELL MICROBIOL, V14, P500, DOI 10.1111/j.1462-5822.2011.01735.x; Wormley FL, 2007, INFECT IMMUN, V75, P1453, DOI 10.1128/IAI.00274-06; Wozniak KL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006854	32	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153853	10.1371/journal.pone.0153853	http://dx.doi.org/10.1371/journal.pone.0153853			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082428	Green Submitted, Green Published, gold			2022-12-26	WOS:000374291800057
J	Shao, J; Gao, F; Lin, HJ; Mao, QY; Chen, P; Wu, X; Yao, X; Kong, W; Liang, ZL				Shao, Jie; Gao, Fan; Lin, Hui-Juan; Mao, Qun-Ying; Chen, Pan; Wu, Xing; Yao, Xin; Kong, Wei; Liang, Zheng-Lun			Short-Fragment DNA Residue from Vaccine Purification Processes Promotes Immune Response to the New Inactivated EV71 Vaccine by Upregulating TLR9 mRNA	PLOS ONE			English	Article							CELL RABIES VACCINE; ANTIBODY-RESPONSES; SOLUTION ASSAY; IMMUNOGENICITY; SAFETY; ADJUVANT; ANTIGEN; REAGENT	To reduce potential oncogenic long genomic DNA in vaccines, nuclease treatment has been applied in the purification processes. However, this action increased the residue of short-fragment DNA and its effect on vaccine potency was still elusive. In this study, we found residual sf-DNA in an inactivated EV71 vaccine could enhance humoral immune response in mice. Ag stimulation in vitro and vaccine injection in vivo revealed that TLR9 transcription level was elevated, indicating that sf-DNA could activate TLR9. These new findings will help us to understand the molecular mechanism induced by vero-cell culture-derived vaccines.	[Shao, Jie; Kong, Wei] Jilin Univ, Sch Life Sci, Changchun 130023, Peoples R China; [Shao, Jie; Gao, Fan; Lin, Hui-Juan; Mao, Qun-Ying; Chen, Pan; Wu, Xing; Yao, Xin; Liang, Zheng-Lun] Natl Inst Food & Drug Control, Beijing, Peoples R China	Jilin University; National Institute of Food & Drug Control - China	Kong, W (corresponding author), Jilin Univ, Sch Life Sci, Changchun 130023, Peoples R China.; Liang, ZL (corresponding author), Natl Inst Food & Drug Control, Beijing, Peoples R China.	weikong@jlu.edu.cn; lzhenglun@126.com			National 12th Five Major Special Projects Funding Program from the Ministry of Science and Technology of the People's Republic of China [2012ZX10004701]	National 12th Five Major Special Projects Funding Program from the Ministry of Science and Technology of the People's Republic of China	This work was supported by the National 12th Five Major Special Projects Funding Program (No. 2012ZX10004701) from the Ministry of Science and Technology of the People's Republic of China, URL: http://www.nmp.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichinger G, 2011, VACCINE, V29, P9376, DOI 10.1016/j.vaccine.2011.09.125; [Anonymous], 1998, DEV BIOL STAND, V93, P136; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Cannella F, 2015, IMMUNOBIOLOGY, V220, P363, DOI 10.1016/j.imbio.2014.10.012; Cao SC, 2013, HUM VACC IMMUNOTHER, V9, P413, DOI 10.4161/hv.22699; Chen J, 2011, VACCINE, V29, P706, DOI 10.1016/j.vaccine.2010.11.023; Cooper CL, 2004, VACCINE, V22, P3136, DOI 10.1016/j.vaccine.2004.01.058; Dhiman N, 2008, VACCINE, V26, P1731, DOI 10.1016/j.vaccine.2008.01.017; European Medicines Agency, 2009, ASS REP CELV; FERGUSON M, 1982, J GEN VIROL, V59, P197, DOI 10.1099/0022-1317-59-1-197; Hagen AJ, 1996, BIOTECHNOL APPL BIOC, V23, P209; Hsiao HB, 2014, J VIROL, V88, P11658, DOI 10.1128/JVI.00867-14; Iqbal J, 2013, PROTEOMICS, V13, P2455, DOI 10.1002/pmic.201300073; JOHANSSON HJ, 1990, J CHEM TECHNOL BIOT, V49, P233; Jones LJ, 1998, ANAL BIOCHEM, V265, P368, DOI 10.1006/abio.1998.2914; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Knezevic I, 2010, BIOLOGICALS, V38, P162, DOI 10.1016/j.biologicals.2009.08.019; Kulkarni PS, 2013, VACCINE, V31, P2719, DOI [10.1016/j.vaccine.2013.03.050, 10.1016/j.vaccine.201]; Kumar AAP, 2002, J BIOSCI BIOENG, V94, P375, DOI 10.1263/jbb.94.375; Lagler H, 2011, VACCINE, V29, P6888, DOI 10.1016/j.vaccine.2011.07.050; Li SM, 2014, BIOLOGICALS, V42, P271, DOI 10.1016/j.biologicals.2014.06.005; Liang ZL, 2013, HUM VACC IMMUNOTHER, V9, P1701, DOI 10.4161/hv.24949; Liang ZL, 2014, CLIN TRANSL IMMUNOL, V3, DOI 10.1038/cti.2014.24; Liang ZL, 2011, VACCINE, V29, P9668, DOI 10.1016/j.vaccine.2011.10.018; Lin YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111496; Liu ZY, 2013, BIOMACROMOLECULES, V14, P1711, DOI 10.1021/bm400426f; Manchester KL, 1996, BIOTECHNIQUES, V20, P968; Mao QY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079599; Pichon S, 2013, VACCINE, V31, P2295, DOI 10.1016/j.vaccine.2013.02.058; Pohar J, 2015, J IMMUNOL, V194, P3901, DOI 10.4049/jimmunol.1402755; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; Rallabhandi P, 2012, MBIO, V3, DOI 10.1128/mBio.00218-12; Rassa JC, 2002, P NATL ACAD SCI USA, V99, P2281, DOI 10.1073/pnas.042355399; ROUMIANTZEFF M, 1988, Southeast Asian Journal of Tropical Medicine and Public Health, V19, P549; Sehgal Saraljit, 1994, Journal of Communicable Diseases, V26, P139; Singer VL, 1997, ANAL BIOCHEM, V249, P228, DOI 10.1006/abio.1997.2177; Tambyah PA, 2012, VACCINE, V30, P329, DOI 10.1016/j.vaccine.2011.10.088; Thoelen S, 1998, VACCINE, V16, P708, DOI 10.1016/S0264-410X(97)00254-5; van der Velden MVW, 2014, J INFECT DIS, V209, P12, DOI 10.1093/infdis/jit498; WHO Expert Committee On Biological Standardization, 1998, WHO TECH REP SER, V878, P1; Yip Cyril C Y, 2013, Emerg Health Threats J, V6, P19780, DOI 10.3402/ehtj.v6i0.19780	41	2	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153867	10.1371/journal.pone.0153867	http://dx.doi.org/10.1371/journal.pone.0153867			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082865	Green Published, gold			2022-12-26	WOS:000374291800060
J	Cerritelli, S; Hirschberg, S; Hill, R; Balthasar, N; Pickering, AE				Cerritelli, Serena; Hirschberg, Stefan; Hill, Rob; Balthasar, Nina; Pickering, Anthony E.			Activation of Brainstem Pro-opiomelanocortin Neurons Produces Opioidergic Analgesia, Bradycardia and Bradypnoea	PLOS ONE			English	Article							NUCLEUS-TRACTUS-SOLITARIUS; VAGUS NERVE-STIMULATION; CARDIAC VAGAL NEURONS; STRESS-INDUCED ANALGESIA; BETA-ENDORPHIN; RETICULARIS-VENTRALIS; AFFERENT MODULATION; MEDULLA-OBLONGATA; POMC NEURONS; IN-VIVO	Opioids are widely used medicinally as analgesics and abused for hedonic effects, actions that are each complicated by substantial risks such as cardiorespiratory depression. These drugs mimic peptides such as beta-endorphin, which has a key role in endogenous analgesia. The beta-endorphin in the central nervous system originates from pro-opiomelanocortin (POMC) neurons in the arcuate nucleus and nucleus of the solitary tract (NTS). Relatively little is known about the NTSPOMC neurons but their position within the sensory nucleus of the vagus led us to test the hypothesis that they play a role in modulation of cardiorespiratory and nociceptive control. The NTSPOMC neurons were targeted using viral vectors in a POMC-Cre mouse line to express either opto-genetic (channelrhodopsin-2) or chemo-genetic (Pharmacologically Selective Actuator Modules). Opto-genetic activation of the NTSPOMC neurons in the working heart brainstem preparation (n = 21) evoked a reliable, titratable and time-locked respiratory inhibition (120% increase in inter-breath interval) with a bradycardia (125 +/- 26 beats per minute) and augmented respiratory sinus arrhythmia (58% increase). Chemo-genetic activation of NTSPOMC neurons in vivo was anti-nociceptive in the tail flick assay (latency increased by 126 +/- 65%, p<0.001; n = 8). All effects of NTSPOMC activation were blocked by systemic naloxone (opioid antagonist) but not by SHU9119 (melanocortin receptor antagonist). The NTSPOMC neurons were found to project to key brainstem structures involved in cardiorespiratory control (nucleus ambiguus and ventral respiratory group) and endogenous analgesia (periaqueductal gray and midline raphe). Thus the NTSPOMC neurons may be capable of tuning behaviour by an opioidergic modulation of nociceptive, respiratory and cardiac control.	[Cerritelli, Serena; Hirschberg, Stefan; Hill, Rob; Balthasar, Nina; Pickering, Anthony E.] Univ Bristol, Sch Physiol Pharmacol & Neurosci, Biomed Sci Bldg, Bristol BS8 1TD, Avon, England; [Pickering, Anthony E.] Univ Hosp Bristol, Dept Anaesthesia, Bristol BS2 8HW, Avon, England	University of Bristol; University of Bristol	Pickering, AE (corresponding author), Univ Bristol, Sch Physiol Pharmacol & Neurosci, Biomed Sci Bldg, Bristol BS8 1TD, Avon, England.; Pickering, AE (corresponding author), Univ Hosp Bristol, Dept Anaesthesia, Bristol BS2 8HW, Avon, England.	Tony.Pickering@bristol.ac.uk	Pickering, Anthony E/A-9929-2011; Core, Vector/CAF-4832-2022	Pickering, Anthony/0000-0003-0345-0456; Hirschberg, Stefan/0000-0002-4297-9224; Hill, Rob/0000-0003-3859-8506	Wellcome Trust [gr088373]; Medical Research Council	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust, gr088373, AEP; http://www.wellcome.ac.uk/ and Medical Research Council, in vivo PhD studentship, SC; http://www.mrc.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AICHER SA, 1990, PAIN, V42, P103, DOI 10.1016/0304-3959(90)91096-2; Anseloni VCZ, 2005, NEUROSCIENCE, V133, P231, DOI 10.1016/j.neuroscience.2005.01.055; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Appleyard SM, 2003, ENDOCRINOLOGY, V144, P1753, DOI 10.1210/en.2002-221096; Appleyard SM, 2005, J NEUROSCI, V25, P3578, DOI 10.1523/JNEUROSCI.4177-04.2005; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; BANDLER R, 1994, TRENDS NEUROSCI, V17, P379, DOI 10.1016/0166-2236(94)90047-7; Barraco IRA, 1994, NUCL SOLITARY TRACT; Benarroch EE, 2012, NEUROLOGY, V79, P807, DOI 10.1212/WNL.0b013e3182662098; Bicknell AB, 2008, J NEUROENDOCRINOL, V20, P692, DOI 10.1111/j.1365-2826.2008.01709.x; BIEGER D, 1987, J COMP NEUROL, V262, P546, DOI 10.1002/cne.902620408; Bohotin C, 2003, PAIN, V101, P3, DOI 10.1016/S0304-3959(02)00301-9; Boscan P, 2002, EXP PHYSIOL, V87, P259, DOI 10.1113/eph8702353; BRONSTEIN DM, 1992, BRAIN RES, V587, P269, DOI 10.1016/0006-8993(92)91007-2; Busch V, 2013, BRAIN STIMUL, V6, P202, DOI 10.1016/j.brs.2012.04.006; Butler RK, 2009, PROG NEUROBIOL, V88, P184, DOI 10.1016/j.pneurobio.2009.04.003; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Corbett AD, 2006, BRIT J PHARMACOL, V147, pS153, DOI 10.1038/sj.bjp.0706435; COX BM, 1976, P NATL ACAD SCI USA, V73, P1821, DOI 10.1073/pnas.73.6.1821; DUM J, 1984, PHARMACOL BIOCHEM BE, V21, P259, DOI 10.1016/0091-3057(84)90224-7; Dutschmann M, 2009, PHILOS T R SOC B, V364, P2611, DOI 10.1098/rstb.2009.0076; FANG FG, 1989, BRAIN RES, V501, P116, DOI 10.1016/0006-8993(89)91033-0; Farmer D, 2015, FASEB J, V29; Fields H, 2004, NAT REV NEUROSCI, V5, P565, DOI 10.1038/nrn1431; Frank JG, 2009, J NEUROPHYSIOL, V101, P1755, DOI 10.1152/jn.91134.2008; Griffioen KJS, 2004, BRAIN RES, V1007, P109, DOI 10.1016/j.brainres.2004.02.010; Harrison D, 2012, PEDIATRICS, V130, P918, DOI 10.1542/peds.2011-3848; Hickey L, 2014, J NEUROSCI, V34, P4148, DOI 10.1523/JNEUROSCI.4835-13.2014; HOLADAY JW, 1983, ANNU REV PHARMACOL, V23, P541, DOI 10.1146/annurev.pa.23.040183.002545; Howorth PW, 2009, J COMP NEUROL, V512, P141, DOI 10.1002/cne.21879; Irnaten M, 2003, NEUROSCIENCE, V116, P573, DOI 10.1016/S0306-4522(02)00657-7; IZZO PN, 1993, J COMP NEUROL, V327, P572, DOI 10.1002/cne.903270408; JOSEPH SA, 1983, NEUROSCI LETT, V38, P221, DOI 10.1016/0304-3940(83)90372-5; Kirchner A, 2000, NEUROLOGY, V55, P1167, DOI 10.1212/WNL.55.8.1167; Kirchner A, 2006, EUR J PAIN, V10, P449, DOI 10.1016/j.ejpain.2005.06.005; Lalley PM, 2014, J PHYSIOL-LONDON, V592, P1163, DOI 10.1113/jphysiol.2013.258830; Lalley PM, 2008, RESP PHYSIOL NEUROBI, V164, P160, DOI 10.1016/j.resp.2008.02.004; LEVINE JD, 1980, BRAIN RES, V201, P129, DOI 10.1016/0006-8993(80)90780-5; LEWIS JW, 1987, BRAIN RES, V424, P65, DOI 10.1016/0006-8993(87)91193-0; Magnus CJ, 2011, SCIENCE, V333, P1292, DOI 10.1126/science.1206606; Marsh DJ, 1999, NAT GENET, V21, P119, DOI 10.1038/5070; Mason P, 2009, ANN NY ACAD SCI, V1170, P399, DOI 10.1111/j.1749-6632.2009.04368.x; Meister B, 2006, EUR J NEUROSCI, V24, P2731, DOI 10.1111/j.1460-9568.2006.05157.x; MILLAN MJ, 1986, PAIN, V27, P303, DOI 10.1016/0304-3959(86)90158-2; Mogil JS, 2000, NEUROSCIENCE, V101, P709, DOI 10.1016/S0306-4522(00)00422-X; Montandon G, 2014, J PHYSIOL-LONDON, V592, P1159, DOI 10.1113/jphysiol.2013.261974; Montandon G, 2011, J NEUROSCI, V31, P1292, DOI 10.1523/JNEUROSCI.4611-10.2011; MORGAN MM, 1989, BRAIN RES, V486, P175, DOI 10.1016/0006-8993(89)91291-2; Mountjoy KG, 2010, ADV EXP MED BIOL, V681, P29, DOI 10.1007/978-1-4419-6354-3_3; Opland D, 2013, MOL METAB, V2, P423, DOI 10.1016/j.molmet.2013.07.008; PALKOVITS M, 1987, BRAIN RES, V436, P323, DOI 10.1016/0006-8993(87)91676-3; Paton JFR, 1996, J NEUROSCI METH, V65, P63, DOI 10.1016/0165-0270(95)00147-6; Pattinson KTS, 2008, BRIT J ANAESTH, V100, P747, DOI 10.1093/bja/aen094; Prkic I, 2012, J NEUROPHYSIOL, V108, P2430, DOI 10.1152/jn.00185.2012; RANDICH A, 1988, J NEUROSCI, V8, P4675; RANDICH A, 1992, BRAIN RES REV, V17, P77, DOI 10.1016/0165-0173(92)90009-B; REN K, 1988, BRAIN RES, V446, P285, DOI 10.1016/0006-8993(88)90887-6; Richardson J, 2013, J NEUROSCI, V33, P13286, DOI 10.1523/JNEUROSCI.0780-13.2013; Rubinstein M, 1996, P NATL ACAD SCI USA, V93, P3995, DOI 10.1073/pnas.93.9.3995; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SCHWARTZBERG DG, 1983, BRAIN RES, V276, P351, DOI 10.1016/0006-8993(83)90746-1; Stannard CF, 2013, OPIOIDS BRIEF HIST O, P1; SUH HH, 1990, J PHARMACOL EXP THER, V253, P981; Sutton AK, 2014, J NEUROSCI, V34, P15306, DOI 10.1523/JNEUROSCI.0226-14.2014; TSENG LF, 1992, EUR J PHARMACOL, V214, P59, DOI 10.1016/0014-2999(92)90096-M; Vaughan CW, 1997, NATURE, V390, P611, DOI 10.1038/37610; Venkatesan P, 2003, J NEUROPHYSIOL, V90, P1581, DOI 10.1152/jn.01117.2002; Wan S, 2008, J NEUROSCI, V28, P4957, DOI 10.1523/JNEUROSCI.5398-07.2008; Wang DQ, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00040; WATSON SJ, 1978, NATURE, V275, P226, DOI 10.1038/275226a0; Yang YL, 2011, CELL, V146, P991, DOI 10.1016/j.cell.2011.07.039; Zhan C, 2013, J NEUROSCI, V33, P3624, DOI 10.1523/JNEUROSCI.2742-12.2013; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	74	24	25	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153187	10.1371/journal.pone.0153187	http://dx.doi.org/10.1371/journal.pone.0153187			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077912	Green Published, Green Submitted, gold			2022-12-26	WOS:000374131700026
J	Ingram, NT; Khankan, RR; Phelps, PE				Ingram, Norianne T.; Khankan, Rana R.; Phelps, Patricia E.			Olfactory Ensheathing Cells Express alpha 7 Integrin to Mediate Their Migration on Laminin	PLOS ONE			English	Article							DIRECT CELLULAR CONTACT; NERVE GROWTH-FACTOR; SCHWANN-CELLS; SPINAL-CORD; NEURITE OUTGROWTH; GENE-EXPRESSION; IN-VITRO; GLIA TRANSPLANTATION; VASCULAR DEVELOPMENT; FUNCTIONAL RECOVERY	The unique glia located in the olfactory system, called olfactory ensheathing cells (OECs), are implicated as an attractive choice for transplantation therapy following spinal cord injury because of their pro-regenerative characteristics. Adult OECs are thought to improve functional recovery and regeneration after injury by secreting neurotrophic factors and making cell-to-cell contacts with regenerating processes, but the mechanisms are not well understood. We show first that alpha 7 integrin, a laminin receptor, is highly expressed at the protein level by OECs throughout the olfactory system, i.e., in the olfactory mucosa, olfactory nerve, and olfactory nerve layer of the olfactory bulb. Then we asked if OECs use the alpha 7 integrin receptor directly to promote neurite outgrowth on permissive and neutral substrates, in vitro. We co-cultured alpha 7(+/+) and alpha 7(lacZ/lacZ) postnatal cerebral cortical neurons with alpha 7(+/+) or alpha 7(lacZ/lacZ) OECs and found that genotype did not effect the ability of OECs to enhance neurite outgrowth by direct contact. Loss of alpha 7 integrin did however significantly decrease the motility of adult OECs in transwell experiments. Twice as many alpha 7(+/+) OECs migrated through laminin-coated transwells compared to alpha 7(+/+) OECs on poly-L-lysine (PLL). This is in contrast to alpha 7(lacZ/lacZ) OECs, which showed no migratory preference for laminin substrate over PLL. These results demonstrate that OECs express alpha 7 integrin, and that laminin and its alpha 7 integrin receptor contribute to adult OEC migration in vitro and perhaps also in vivo.	[Ingram, Norianne T.; Khankan, Rana R.; Phelps, Patricia E.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA USA	University of California System; University of California Los Angeles	Phelps, PE (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA USA.	pphelps@physci.ucla.edu			National Institutes of Health, National Institute of General Medical Sciences [2T32GM065823]; National Institutes of Health, National Institute of Neurological Disorders and Stroke [RO1NS076976]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD087101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076976] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support was provided by the National Institutes of Health, National Institute of General Medical Sciences, Grant number: 2T32GM065823 (NTI); National Institutes of Health, National Institute of Neurological Disorders and Stroke; Grant number: RO1NS076976 (RKK and PEP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadesco AD, 2014, EUR J NEUROSCI, V39, P579, DOI 10.1111/ejn.12416; Au WW, 2002, J COMP NEUROL, V446, P68, DOI 10.1002/cne.10182; Barnett SC, 2004, TRENDS NEUROSCI, V27, P54, DOI 10.1016/j.tins.2003.10.011; Barraud P, 2010, P NATL ACAD SCI USA, V107, P21040, DOI 10.1073/pnas.1012248107; Cao L, 2007, GLIA, V55, P897, DOI 10.1002/glia.20511; Chernousov MA, 2007, GLIA, V55, P1134, DOI 10.1002/glia.20536; Choi D, 2008, BRIT J NEUROSURG, V22, P301, DOI 10.1080/02688690701883442; Chung RS, 2004, CELL MOL LIFE SCI, V61, P1238, DOI 10.1007/s00018-004-4026-y; DOUCETTE R, 1990, GLIA, V3, P433, DOI 10.1002/glia.440030602; Flintoff-Dye NL, 2005, DEV DYNAM, V234, P11, DOI 10.1002/dvdy.20462; Forni PE, 2011, J NEUROSCI, V31, P6915, DOI 10.1523/JNEUROSCI.6087-10.2011; Franceschini IA, 1996, DEV BIOL, V173, P327, DOI 10.1006/dbio.1996.0027; Franssen EHP, 2008, GLIA, V56, P1285, DOI 10.1002/glia.20697; Gardiner NJ, 2005, MOL CELL NEUROSCI, V28, P229, DOI 10.1016/j.mcn.2004.08.017; Granger N, 2012, BRAIN, V135, P3227, DOI 10.1093/brain/aws268; Guerout N, 2010, GLIA, V58, P1570, DOI 10.1002/glia.21030; Hultgardh-Nilsson A, 2007, CURR OPIN LIPIDOL, V18, P540, DOI 10.1097/MOL.0b013e3282ef77e9; Kawano H, 2012, CELL TISSUE RES, V349, P169, DOI 10.1007/s00441-012-1336-5; Khankan RR, 2015, EXP NEUROL, V269, P93, DOI 10.1016/j.expneurol.2015.03.025; Khialeeva E, 2011, DEVELOPMENT, V138, P767, DOI 10.1242/dev.057588; Kostidou E, 2007, CLIN BIOCHEM, V40, P671, DOI 10.1016/j.clinbiochem.2007.03.011; LIESI P, 1985, EMBO J, V4, P2505, DOI 10.1002/j.1460-2075.1985.tb03963.x; Lipson AC, 2003, EXP NEUROL, V180, P167, DOI 10.1016/S0014-4886(02)00058-4; Liu QA, 2010, NEUROSCI LETT, V478, P37, DOI 10.1016/j.neulet.2010.04.065; Mercado MLT, 2004, J NEUROSCI, V24, P238, DOI 10.1523/JNEUROSCI.4519-03.2004; Monti-Graziadei G A, 1977, J Histochem Cytochem, V25, P1311; Murdoch B, 2008, J NEUROSCI, V28, P4271, DOI 10.1523/JNEUROSCI.5566-07.2008; Previtali SC, 2003, MOL CELL NEUROSCI, V23, P210, DOI 10.1016/S1044-7431(03)00014-9; Ramon-Cueto A, 2000, NEURON, V25, P425, DOI 10.1016/S0896-6273(00)80905-8; Ramon-Cueto A, 2000, PROG BRAIN RES, V128, P265; Roet KCD, 2013, J NEUROSCI, V33, P11116, DOI 10.1523/JNEUROSCI.1002-13.2013; Roet KCD, 2011, EXP NEUROL, V229, P10, DOI 10.1016/j.expneurol.2011.03.001; Rooney JE, 2006, J CELL SCI, V119, P2185, DOI 10.1242/jcs.02952; Ruitenberg MJ, 2003, J NEUROSCI, V23, P7045, DOI 10.1523/JNEUROSCI.23-18-07045.2003; Runyan SA, 2009, EXP NEUROL, V216, P95, DOI 10.1016/j.expneurol.2008.11.015; Shields SD, 2010, J COMP NEUROL, V518, P4329, DOI 10.1002/cne.22459; Su ZD, 2013, GLIA, V61, P490, DOI 10.1002/glia.22450; Tabakow P, 2014, CELL TRANSPLANT, V23, P1631, DOI 10.3727/096368914X685131; Takatoh J, 2008, EXP NEUROL, V213, P36, DOI 10.1016/j.expneurol.2008.04.041; Takeoka A, 2011, J NEUROSCI, V31, P4298, DOI 10.1523/JNEUROSCI.4967-10.2011; Toth ZE, 2007, J HISTOCHEM CYTOCHEM, V55, P545, DOI 10.1369/jhc.6A7134.2007; Velling T, 1996, DEV DYNAM, V207, P355, DOI 10.1002/(SICI)1097-0177(199612)207:4<355::AID-AJA1>3.0.CO;2-G; Wanner IB, 2008, GLIA, V56, P1691, DOI 10.1002/glia.20721; Werner A, 2000, J NEUROSCI, V20, P1822; Wewetzer K, 2002, CELL TISSUE RES, V309, P337, DOI 10.1007/s00441-002-0607-y; Whitley M, 2005, J NEUROCYTOL, V34, P81, DOI 10.1007/s11068-005-5049-5; Windus LCE, 2007, GLIA, V55, P1708, DOI 10.1002/glia.20586; Windus LCE, 2010, CELL MOL LIFE SCI, V67, P1735, DOI 10.1007/s00018-010-0280-3; Woodhall E, 2001, MOL BRAIN RES, V88, P203, DOI 10.1016/S0169-328X(01)00044-4; Yao CC, 1997, J CELL SCI, V110, P1477; Ziegler MD, 2011, EXP NEUROL, V229, P109, DOI 10.1016/j.expneurol.2011.01.007	51	9	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153394	10.1371/journal.pone.0153394	http://dx.doi.org/10.1371/journal.pone.0153394			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078717	gold, Green Published			2022-12-26	WOS:000374131700050
J	Bessa-Silva, AR; Vallinoto, M; Sodre, D; da Cunha, DB; Hadad, D; Asp, NE; Sampaio, I; Schneider, H; Sequeira, F				Bessa-Silva, Adam Rick; Vallinoto, Marcelo; Sodre, Davidson; da Cunha, Divino Bruno; Hadad, Dante; Asp, Nils Edvin; Sampaio, Iracilda; Schneider, Horacio; Sequeira, Fernando			Patterns of Genetic Variability in Island Populations of the Cane Toad (Rhinella marina) from the Mouth of the Amazon	PLOS ONE			English	Article							HOLOCENE MANGROVE DYNAMICS; SEA-LEVEL CHANGES; EVOLUTIONARY HISTORY; NORTHEASTERN PARA; NORTHERN BRAZIL; BUFO-MARINUS; FROG; BUFONIDAE; MIGRATION; INFERENCE	The Amazonian coast has several unique geological characteristics resulting from the interaction between drainage pattern of the Amazon River and the Atlantic Ocean. It is one of the most extensive and sedimentologically dynamic regions of the world, with a large number of continental islands mostly formed less than 10,000 years ago. The natural distribution of the cane toad (Rhinella marina), one of the world's most successful invasive species, in this complex Amazonian system provides an intriguing model for the investigation of the effects of isolation or the combined effects of isolation and habitat dynamic changes on patterns of genetic variability and population differentiation. We used nine fast-evolving microsatellite loci to contrast patterns of genetic variability in six coastal (three mainlands and three islands) populations of the cane toad near the mouth of the Amazon River. Results from Bayesian multilocus clustering approach and Discriminant Analyses of Principal Component were congruent in showing that each island population was genetically differentiated from the mainland populations. All FST values obtained from all pairwise comparisons were significant, ranging from 0.048 to 0.186. Estimates of both recent and historical gene flow were not significantly different from zero across all population pairs, except the two mainland populations inhabiting continuous habitats. Patterns of population differentiation, with a high level of population substructure and absence/restricted gene flow, suggested that island populations of R. marina are likely isolated since the Holocene sea-level rise. However, considering the similar levels of genetic variability found in both island and mainland populations, it is reliable to assume that they were also isolated for longer periods. Given the genetic uniqueness of each cane toad population, together with the high natural vulnerability of the coastal regions and intense human pressures, we suggest that these populations should be treated as discrete units for conservation management purposes.	[Bessa-Silva, Adam Rick; Vallinoto, Marcelo; Sodre, Davidson; da Cunha, Divino Bruno; Hadad, Dante] Fed Univ Para, Inst Estudos Costeiros IECOS, Lab Evolucao LEVO, Campus Braganca, BR-66059 Belem, Para, Brazil; [Vallinoto, Marcelo; Sodre, Davidson; da Cunha, Divino Bruno; Sequeira, Fernando] Univ Porto, CIBIO InBIO, Lab Associado, Ctr Invest Biodiversidade & Recursos Genet, Campus Agr Vairao, Vairao, Portugal; [Asp, Nils Edvin] Fed Univ Para, Lab Geol Costeira LAGECO, Inst Estudos Costeiros IECOS, Campus Braganca, BR-66059 Belem, Para, Brazil; [Sampaio, Iracilda; Schneider, Horacio] Fed Univ Para, Lab Filogenom & Bioinformat, Inst Estudos Costeiros IECOS, Campus Braganca, BR-66059 Belem, Para, Brazil	Universidade Federal do Para; Universidade do Porto; Universidade Federal do Para; Universidade Federal do Para	Vallinoto, M (corresponding author), Fed Univ Para, Inst Estudos Costeiros IECOS, Lab Evolucao LEVO, Campus Braganca, BR-66059 Belem, Para, Brazil.; Vallinoto, M (corresponding author), Univ Porto, CIBIO InBIO, Lab Associado, Ctr Invest Biodiversidade & Recursos Genet, Campus Agr Vairao, Vairao, Portugal.	mvallino@ufpa.br	Vallinoto, Marcelo/ABF-9834-2021; Asp, Nils/J-6226-2012; Vallinoto, Marcelo/J-3086-2012; Cunha, Divino Bruno da/AHD-0839-2022; SAMPAIO, IRACILDA/J-6514-2012; Sodré, Davidson/GNP-8094-2022; Sequeira, Fernando/C-3119-2012; Schneider, Horacio/J-7131-2012	Vallinoto, Marcelo/0000-0002-3465-3830; Asp, Nils/0000-0002-6468-6158; Vallinoto, Marcelo/0000-0002-3465-3830; SAMPAIO, IRACILDA/0000-0002-2137-4656; Sodré, Davidson/0000-0002-7223-3204; Sequeira, Fernando/0000-0003-0740-7981; Schneider, Horacio/0000-0002-5987-6395; Silva, Adam Bessa/0000-0002-6093-6180	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao para a Ciencia e a Tecnologia (FCT) [PTDC/BIA-BEC/105093/2008]; FCT [SFRH/BPD/87721/2012]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; MCT/CNPq; CNPq	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); MCT/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding was provided by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior through scholarships to ABS, DBC and DS; Fundacao para a Ciencia e a Tecnologia (FCT) through project PTDC/BIA-BEC/105093/2008 and FCT postdoctoral fellowships SFRH/BPD/87721/2012 to FS; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico through scholarships to DBC and DS (Ciencia Sem Fronteiras), research project and research fellowship (MCT/CNPq 14 - 2010, MCT/CNPq - 2009, Universal 14-2013, PQ 10/2012) and through a post-doctoral fellowship to MV (232916/2013-6, CNPq).	Allentoft Morten E., 2010, Diversity, V2, P47; [Anonymous], 2020, BIOL AMPHIBIANS, V28, P32; Asp NE, 2004, LONG TO SHORT TERM M; Bacon Jamie P., 2006, Applied Herpetology, V3, P39, DOI 10.1163/157075406775247049; Bacon JP, 2013, J EXP ZOOL PART B, V320B, P218, DOI 10.1002/jez.b.22496; Barbara VF, 2005, C ESQ EMS EXT I FED; Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Behling H, 2004, VEG HIST ARCHAEOBOT, V13, P73, DOI 10.1007/s00334-004-0031-1; Behling H, 2001, PALAEOGEOGR PALAEOCL, V167, P225, DOI 10.1016/S0031-0182(00)00239-X; Bell RC, 2012, J BIOGEOGR, V39, P1733, DOI 10.1111/j.1365-2699.2012.02708.x; Bessa-Silva AR, 2015, CONSERV GENET RESOUR, V7, P247, DOI 10.1007/s12686-014-0349-7; Blaustein AR, 2003, FRONT ECOL ENVIRON, V1, P87, DOI 10.1890/1540-9295(2003)001[0087:TCODA]2.0.CO;2; Branner J C, 1884, Science, V4, P488, DOI 10.1126/science.ns-4.95.488; Brown GP, 2007, P NATL ACAD SCI USA, V104, P17698, DOI 10.1073/pnas.0705057104; Nery JRC, 2011, J ENVIRON RADIOACTIV, V102, P348, DOI 10.1016/j.jenvrad.2011.01.008; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.es.18.110187.001321; Chen S-F, 2012, PLOS ONE, V7; Cohen Marcelo C. L., 2005, Wetlands Ecology and Management, V13, P433, DOI 10.1007/s11273-004-0413-2; Cohen MM, 2001, AM J MED GENET, V104, P101, DOI 10.1002/ajmg.10002; Cristescu R, 2010, CONSERV GENET, V11, P1043, DOI 10.1007/s10592-009-9949-2; Duryea MC, 2015, HEREDITY, V115, P225, DOI 10.1038/hdy.2015.31; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Emel SL, 2012, CONSERV GENET, V13, P1685, DOI 10.1007/s10592-012-0407-1; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Guimaraes JTF, 2013, HOLOCENE, V23, P528, DOI 10.1177/0959683612463097; Fernandes RD, 2007, NAVIGATION AMAZON RI; Fort Douglas J., 2006, Applied Herpetology, V3, P143, DOI 10.1163/157075406776984239; Fostier AH, 2000, SCI TOTAL ENVIRON, V260, P201, DOI 10.1016/S0048-9697(00)00564-7; Fouquet A, 2015, J TROP ECOL, V31, P361, DOI 10.1017/S0266467415000206; FRANKHAM R, 1995, CONSERV BIOL, V9, P792, DOI 10.1046/j.1523-1739.1995.09040792.x; Frankham R., 2004, PRIMER CONSERVATION, DOI [10.1017/CBO9780511817359, DOI 10.1017/CBO9780511817359]; Frankham R, 2014, BIOL CONSERV, V170, P56, DOI 10.1016/j.biocon.2013.12.036; Frost D. R., 2015, AMPHIBIAN SPECIES WO; Garcia-Munoz Enrique, 2010, Herpetology Notes, V3, P267; Gascon C, 1998, BIOTROPICA, V30, P104, DOI 10.1111/j.1744-7429.1998.tb00373.x; Grammer TC, 2005, MECH DEVELOP, V122, P263, DOI 10.1016/j.mod.2004.11.003; Grazziotin FG, 2006, MOL ECOL, V15, P3969, DOI 10.1111/j.1365-294X.2006.03057.x; Haanes H, 2013, ECOL EVOL, V3, P4230, DOI 10.1002/ece3.819; Hedges SB, 1996, HERPETOLOGICA, V52, P466; Irion G., 2011, AMAZONIAN FLOODPLAIN, VXVIII, P27; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kjerfve B., 1993, MANGROVES BRAZIL MAN, P245, DOI [10.1016/j.ocecoaman.2016.03.011, DOI 10.1016/J.OCECOAMAN.2016.03.011]; Lampert KP, 2003, MOL ECOL, V12, P3325, DOI 10.1046/j.1365-294X.2003.02016.x; LEARY RF, 1984, AM NAT, V124, P540, DOI 10.1086/284293; Li JW, 2010, MOL ECOL, V19, P494, DOI 10.1111/j.1365-294X.2009.04494.x; Li R, 2009, J ZOOL, V277, P309, DOI 10.1111/j.1469-7998.2008.00543.x; Lougheed SC, 1999, P ROY SOC B-BIOL SCI, V266, P1829, DOI 10.1098/rspb.1999.0853; Martinez-Solano I, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-38; Maslin M, 2006, QUATERNARY SCI REV, V25, P3338, DOI 10.1016/j.quascirev.2006.10.012; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Mochiutti S, 2000, WORKSHOP ECOLAB, P57; Mol JH, 2004, CONSERV BIOL, V18, P201, DOI 10.1111/j.1523-1739.2004.00080.x; Mol JH, 2001, ENVIRON RES, V86, P183, DOI 10.1006/enrs.2001.4256; Moller AP, 1997, AM NAT, V149, P916, DOI 10.1086/286030; Mortimer E, 2011, P ROY SOC B-BIOL SCI, V278, P1247, DOI 10.1098/rspb.2010.1779; Patel Yogi A., 2012, BIOS, V83, P75; Phillips BL, 2007, AUSTRAL ECOL, V32, P169, DOI 10.1111/j.1442-9993.2007.01664.x; Phillips BL, 2004, P NATL ACAD SCI USA, V101, P17150, DOI 10.1073/pnas.0406440101; PIMM SL, 1988, AM NAT, V132, P757, DOI 10.1086/284889; Pritchard JK, 2000, GENETICS, V155, P945; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rollins LA, 2015, MOL ECOL, V24, P2264, DOI 10.1111/mec.13184; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rossetti DD, 2001, J S AM EARTH SCI, V14, P77; Santana LO, 2005, AN 12 S BRAS SENS RE, P673; Sequeira F, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-264; Silva MV, 2011, AN 15 S BRAS SENS RE, P8614; Souza PWM, 2009, LECT NOTES EARTH SCI, V107, P347; Tingley R, 2014, P NATL ACAD SCI USA, V111, P10233, DOI 10.1073/pnas.1405766111; Tolledo J, 2014, HERPETOL J, V24, P237; Vallinoto M, 2010, ZOOL SCR, V39, P128, DOI 10.1111/j.1463-6409.2009.00415.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vasquez D, 2013, ZOOL STUD, V52, DOI 10.1186/1810-522X-52-35; Vedel V, 2006, VEG HIST ARCHAEOBOT, V15, P115, DOI 10.1007/s00334-005-0023-9; Velo-Anton G, 2012, MOL PHYLOGENET EVOL, V65, P965, DOI 10.1016/j.ympev.2012.08.016; Velo-Anton G, 2012, HEREDITY, V108, P410, DOI 10.1038/hdy.2011.91; Viana AP, 2012, MAR POLLUT BULL, V64, P489, DOI 10.1016/j.marpolbul.2012.01.006; Vital H, 2000, CHEM GEOL, V168, P151, DOI 10.1016/S0009-2541(00)00191-1; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wells JT, 1995, DEV SEDIMENTOL, V53, P179, DOI DOI 10.1016/S0070-4571(05)80026-3; Williams RN, 2008, BIOL LETTERS, V4, P549, DOI 10.1098/rsbl.2008.0233; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325; Wilson GA, 2003, GENETICS, V163, P1177; Wright AN, 2002, J HERPETOL, V36, P129, DOI 10.2307/1565818; Zhai SN, 2012, J BIOGEOGR, V39, P1347, DOI 10.1111/j.1365-2699.2012.02685.x; Zug P.B, 1979, MARINE TOAD BUFO MAR, DOI DOI 10.5479/SI.00810282.284	90	10	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152492	10.1371/journal.pone.0152492	http://dx.doi.org/10.1371/journal.pone.0152492			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073849	Green Published, gold			2022-12-26	WOS:000374131200025
J	Guo, HP; Hong, CT; Chen, XM; Xu, YX; Liu, Y; Jiang, DA; Zheng, BS				Guo, Haipeng; Hong, Chuntao; Chen, Xiaomin; Xu, Yanxia; Liu, Yan; Jiang, Dean; Zheng, Bingsong			Different Growth and Physiological Responses to Cadmium of the Three Miscanthus Species	PLOS ONE			English	Article							BRASSICA-JUNCEA L.; ZEA-MAYS L.; C-4 PHOTOSYNTHESIS; OXIDATIVE STRESS; STOMATAL CONDUCTANCE; MALATE-DEHYDROGENASE; PLANT-GROWTH; X GIGANTEUS; TOLERANCE; SEEDLINGS	Miscanthus has been proposed as a promising crop for phytoremediation due to its high biomass yield and remarkable adaptability to different environments. However, little is known about the resistance of Miscanthus spp. to cadmium (Cd). To determine any differences in resistance of Miscanthus to Cd, we examined plant growth, net photosynthetic rate (Pn), activities of anti-oxidant and C4 photosynthetic enzymes, concentrations of Cd in leaves and roots, and observed the chloroplast structure in three Miscanthus species treated with 0, 10, 50, 100 or 200 mu M Cd in solutions. Miscanthus sinensis showed more sensitivity to Cd, including sharp decreases in growth, Pn, PEPC activity and damage to chloroplast structure, and the highest H2O2 and Cd concentrations in leaves and roots after Cd treatments. Miscanthus sacchariflorus showed higher resistance to Cd and better growth, had the highest Pn and phosphoenolpyruvate carboxylase (PEPC) activities and integrative chloroplast structure and the lowest hydrogen peroxide (H2O2) and leaf and root Cd concentrations. The results could play an important role in understanding the mechanisms of Cd tolerance in plants and in application of phytoremediation.	[Guo, Haipeng; Xu, Yanxia; Liu, Yan; Jiang, Dean] Zhejiang Univ, Coll Life Sci, State Key Lab Plant Physiol & Biochem, Hangzhou 310003, Zhejiang, Peoples R China; [Hong, Chuntao] Acad Agr Sci Ningbo City, Ningbo, Zhejiang, Peoples R China; [Chen, Xiaomin; Zheng, Bingsong] Zhejiang A&F Univ, Nurturing Stn, State Key Lab Subtrop Silviculture, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang A&F University	Jiang, DA (corresponding author), Zhejiang Univ, Coll Life Sci, State Key Lab Plant Physiol & Biochem, Hangzhou 310003, Zhejiang, Peoples R China.; Zheng, BS (corresponding author), Zhejiang A&F Univ, Nurturing Stn, State Key Lab Subtrop Silviculture, Hangzhou, Zhejiang, Peoples R China.	dajiang@zju.edu.cn; bszheng@zafu.edu.cn	chen, xia/GYR-3948-2022; X, Yanxia/AAB-8236-2022; chen, xia/GXM-5435-2022; chen, xi/GXH-3653-2022		National Science and Technology Support Plan of China [2012BAC09B01]; National Natural Science Foundation of China [31371591, 31470683]	National Science and Technology Support Plan of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The present research was financially supported by the National Science and Technology Support Plan of China (2012BAC09B01, DAJ) and the National Natural Science Foundation of China (31371591, DAJ and 31470683, BSZ).	Andosch A, 2012, J PLANT PHYSIOL, V169, P1489, DOI 10.1016/j.jplph.2012.06.002; Arduini I, 2004, ENVIRON EXP BOT, V52, P89, DOI 10.1016/j.envexpbot.2004.01.001; Bauddh K, 2012, INT J PHYTOREMEDIAT, V14, P772, DOI 10.1080/15226514.2011.619238; Beyel V, 2005, PHYSIOL PLANTARUM, V124, P249, DOI 10.1111/j.1399-3054.2005.00508.x; Bianconi D, 2013, E3S WEB CONF, V1, DOI 10.1051/e3sconf/20130113002; Cha-um S, 2009, AGR SCI CHINA, V8, P51, DOI 10.1016/S1671-2927(09)60008-0; Chaney RL, 1997, CURR OPIN BIOTECH, V8, P279, DOI 10.1016/S0958-1669(97)80004-3; Chen ZJ, 2015, PLANT PHYSIOL, V167, P176, DOI 10.1104/pp.114.251017; Cho UH, 2005, PLANT SCI, V168, P113, DOI 10.1016/j.plantsci.2004.07.021; Cui WT, 2013, J HAZARD MATER, V260, P715, DOI 10.1016/j.jhazmat.2013.06.032; Daud MK, 2015, CHEMOSPHERE, V120, P309, DOI 10.1016/j.chemosphere.2014.07.060; Deniau AX, 2006, THEOR APPL GENET, V113, P907, DOI 10.1007/s00122-006-0350-y; Dias MC, 2013, ACTA PHYSIOL PLANT, V35, P1281, DOI 10.1007/s11738-012-1167-8; Doubnerova V, 2011, PLANT SCI, V180, P575, DOI 10.1016/j.plantsci.2010.12.005; Dudka S, 1997, J ENVIRON QUAL, V26, P590, DOI 10.2134/jeq1997.00472425002600030003x; EDWARDS GE, 1985, ANNU REV PLANT PHYS, V36, P255, DOI 10.1146/annurev.pp.36.060185.001351; Efthimiadou A, 2009, NOT BOT HORTI AGROBO, V37, P104; FARQUHAR GD, 1982, ANNU REV PLANT PHYS, V33, P317, DOI 10.1146/annurev.pp.33.060182.001533; Feng XP, 2014, CROP SCI, V54, P1645, DOI 10.2135/cropsci2013.02.0091; Feng XP, 2012, PHOTOSYNTHETICA, V50, P577, DOI 10.1007/s11099-012-0061-3; Fernandez R, 2013, J HAZARD MATER, V244, P555, DOI 10.1016/j.jhazmat.2012.10.044; Foyer CH, 2011, PLANT PHYSIOL, V155, P2, DOI 10.1104/pp.110.167569; Ghannoum O, 2009, ANN BOT-LONDON, V103, P635, DOI 10.1093/aob/mcn093; Gill SS, 2012, PLANT SCI, V182, P112, DOI 10.1016/j.plantsci.2011.04.018; Gill SS, 2011, PLANT SIGNAL BEHAV, V6, P293, DOI 10.4161/psb.6.2.15049; Grigorova B, 2012, J PLANT INTERACT, V7, P204, DOI 10.1080/17429145.2011.654134; Hassan Z, 2011, ENVIRON EXP BOT, V72, P53, DOI 10.1016/j.envexpbot.2010.04.003; He Y, 2014, PLANT PHYSIOL BIOCH, V74, P118, DOI 10.1016/j.plaphy.2013.11.008; Hodkinson TR, 2002, J PLANT RES, V115, P381, DOI 10.1007/s10265-002-0049-3; Hong C.T., 2014, ADV MATER RES-KR, V1051, P333, DOI [10.4028/www.scientific.net/AMR.1051.333, DOI 10.4028/WWW.SCIENTIFIC.NET/AMR.1051.333]; Hou WH, 2007, PLANT PHYSIOL BIOCH, V45, P62, DOI 10.1016/j.plaphy.2006.12.005; JACQUOT JPP, 1981, PLANT PHYSIOL, V68, P300, DOI 10.1104/pp.68.2.300; Ji PH, 2011, ENVIRON POLLUT, V159, P762, DOI 10.1016/j.envpol.2010.11.029; Jorgensen U, 2011, CURR OPIN ENV SUST, V3, P24, DOI 10.1016/j.cosust.2010.12.003; Kayama M, 2001, INT J PLANT SCI, V162, P1025, DOI 10.1086/322890; Khan AL, 2014, BIOL FERT SOILS, V50, P75, DOI 10.1007/s00374-013-0833-3; Lichtenthaler HK., 2001, CURRENT PROTOCOLS FO, P431, DOI DOI 10.1002/0471142913.FAF0403S01; Lin RZ, 2007, CHEMOSPHERE, V69, P89, DOI 10.1016/j.chemosphere.2007.04.041; Liu HJ, 2015, J HAZARD MATER, V286, P440, DOI 10.1016/j.jhazmat.2015.01.008; Liu J, 2010, PHOTOSYNTHETICA, V48, P127, DOI 10.1007/s11099-010-0017-4; Liu WX, 2015, ENVIRON TOXICOL CHEM, V34, P92, DOI 10.1002/etc.2760; Markelz RJC, 2011, J EXP BOT, V62, P3235, DOI 10.1093/jxb/err056; Misra V, 2005, ENVIRON INT, V31, P417, DOI 10.1016/j.envint.2004.08.005; Pavel PB, 2014, SCI TOTAL ENVIRON, V479, P125, DOI 10.1016/j.scitotenv.2014.01.097; Ray T. B., 1979, PHOTOSYNTHESIS 2, V6, P77; Sekmen AH, 2012, ENVIRON EXP BOT, V77, P63, DOI 10.1016/j.envexpbot.2011.10.012; Shao QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085996; Srivastava RK, 2014, PROTOPLASMA, V251, P1047, DOI 10.1007/s00709-014-0614-3; Stewart JR, 2009, GCB BIOENERGY, V1, P126, DOI 10.1111/j.1757-1707.2009.01010.x; VOJTECHOVA M, 1991, BIOL PLANTARUM, V33, P386, DOI 10.1007/BF02897690; Wang H, 2009, PHOTOSYNTHETICA, V47, P277, DOI 10.1007/s11099-009-0043-2; Xue ZC, 2013, BIOL PLANTARUM, V57, P587, DOI 10.1007/s10535-013-0318-0; Ye ZP, 2007, PHOTOSYNTHETICA, V45, P637, DOI 10.1007/s11099-007-0110-5; Zarcinas BA, 2004, ENVIRON GEOCHEM HLTH, V26, P343, DOI 10.1007/s10653-005-4669-0; Zhuang XL, 2007, ENVIRON INT, V33, P406, DOI 10.1016/j.envint.2006.12.005	55	66	67	6	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153475	10.1371/journal.pone.0153475	http://dx.doi.org/10.1371/journal.pone.0153475			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070918	Green Published, gold, Green Submitted			2022-12-26	WOS:000373900700072
J	Arora, H; Boulberdaa, M; Qureshi, R; Bitirim, V; Messadeq, N; Dolle, P; Nebigil, CG				Arora, Himanshu; Boulberdaa, Mounia; Qureshi, Rehana; Bitirim, Verda; Messadeq, Nadia; Dolle, Pascal; Nebigil, Canan G.			Prokineticin receptor 1 is required for mesenchymal-epithelial transition in kidney development	FASEB JOURNAL			English	Article						genetically altered mice; receptor pharmacology; renal physiology/pathophysiology	ENDOTHELIAL-CELLS; DISEASE; BRAIN; GENE; MICE; WT1	Identification of factors regulating renal development is important to understand the pathogenesis of congenital kidney diseases. Little is known about the molecular mechanism of renal development and functions triggered by the angiogenic hormone prokineticin-2 and its receptor, PKR1. Utilizing the Gata5 (G5)-Cre and Wilms tumor 1 (Wt1)(GFP)cre transgenic lines, we generated mutant mice with targeted PKR1 gene disruptions in nephron progenitors. These mutant mice exhibited partial embryonic and postnatal lethality. Kidney developmental defects in PKRG5-/- mice are manifested in the adult stage as renal atrophy with glomerular defects, nephropathy, and uremia. PKR1(wt1-/-) embryos exhibit hypoplastic kidneys with premature glomeruli and necrotic nephrons as a result of impaired proliferation and increased apoptosis in Wt1(+) renal mesenchymal cells. PKR1 regulates renal mesenchymal-epithelial transition (MET) that is involved in formation of renal progenitors, regulating glomerulogenesis toward forming nephrons during kidney development. In the isolated embryonic Wt1(+) renal cells, overexpression or activation of PKR1 promotes MET defined by the transition from elongated cell to octagonal cell morphology, and alteration of the expression of MET markers via activating NFATc3 signaling. Together, these results establish PKR1 via NFATc3 as a crucial modifier of MET processing to the development of nephron. Our study should facilitate new therapeutic opportunities in human renal disorders. Arora,	[Arora, Himanshu; Boulberdaa, Mounia; Qureshi, Rehana; Bitirim, Verda; Nebigil, Canan G.] Univ Strasbourg, CNRS, UMR7242, Ecole Super Biotechnol Strasbourg, Illkirch Graffenstaden, France; [Messadeq, Nadia; Dolle, Pascal] Univ Strasbourg, CNRS, UMR 7104, Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France; [Messadeq, Nadia; Dolle, Pascal] Univ Strasbourg, INSERM, Unite 964, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Nebigil, CG (corresponding author), Univ Strasbourg, CNRS, UMR7242, Ecole Super Biotechnol Strasbourg, Illkirch Graffenstaden, France.	nebigil@unistra.fr	Nebigil, Canan/AAK-7162-2021; BITIRIM, VERDA CEYLAN/A-6731-2018; Arora, Himanshu/I-5230-2019	Nebigil, Canan/0000-0002-2035-5795; Arora, Himanshu/0000-0003-3143-6387; bitirim, ceylan verda/0000-0002-7979-0679	Fondation pour la Recherche Medicale (Equipe Labellisee); Centre National de la Recherche Scientifique; Universite de Strasbourg; French government [(ANR)-10-LABX-0034_Medalis]	Fondation pour la Recherche Medicale (Equipe Labellisee)(Fondation pour la Recherche Medicale); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite de Strasbourg; French government	The authors thank the Mouse Clinical Institute (Illkirch, France) for generating the mouse lines and for assistance with genotyping/phenotyping and ultrastructural analyses. This work was supported in part by grants from Fondation pour la Recherche Medicale (Equipe Labellisee), Centre National de la Recherche Scientifique, and Universite de Strasbourg. This work was published within the "Investissements d'Avenir" des Laboratoires d'Excellence (Labex) Agence Nationale pour la Recherche (ANR)-10-LABX-0034_Medalis and has received financial support from the French government, managed by Agence Nationale de la Recherche under Programme d'Investissement d'Avenir.	Abrahamson DR, 2009, ORGANOGENESIS, V5, P275; Beale KEL, 2013, BRIT J PHARMACOL, V168, P403, DOI 10.1111/j.1476-5381.2012.02191.x; Boulberdaa M, 2011, CARDIOVASC RES, V92, P191, DOI 10.1093/cvr/cvr228; Boulberdaa M, 2011, ARTERIOSCL THROM VAS, V31, P842, DOI 10.1161/ATVBAHA.110.222323; Burn SF, 2011, DEV BIOL, V352, P288, DOI 10.1016/j.ydbio.2011.01.033; Dormishian M, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000411; Gao XB, 2005, DEVELOPMENT, V132, P5437, DOI 10.1242/dev.02095; Guilini C, 2010, AM J PHYSIOL-HEART C, V298, pH844, DOI 10.1152/ajpheart.00898.2009; Haney S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064946; Hartwig S, 2010, DEVELOPMENT, V137, P1189, DOI 10.1242/dev.045732; He WC, 2009, J AM SOC NEPHROL, V20, P765, DOI 10.1681/ASN.2008060566; Hendry C, 2011, PEDIATR NEPHROL, V26, P1395, DOI 10.1007/s00467-010-1750-4; Hoy WE, 2005, J AM SOC NEPHROL, V16, P2557, DOI 10.1681/ASN.2005020172; Huang RYJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.442; Kiela PR, 2003, J BIOL CHEM, V278, P5659, DOI 10.1074/jbc.M209473200; Kitamoto Y, 2002, NEPHROL DIAL TRANSPL, V17, P25, DOI 10.1093/ndt/17.suppl_9.25; Kreidberg JA, 2010, ORGANOGENESIS, V6, P61, DOI 10.4161/org.6.2.11928; Lechner MS, 1997, MECH DEVELOP, V62, P105, DOI 10.1016/S0925-4773(97)00667-9; Little MH, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008300; Masuda Y, 2002, BIOCHEM BIOPH RES CO, V293, P396, DOI 10.1016/S0006-291X(02)00239-5; Merki E, 2005, P NATL ACAD SCI USA, V102, P18455, DOI 10.1073/pnas.0504343102; Ohse T, 2008, J AM SOC NEPHROL, V19, P1879, DOI 10.1681/ASN.2007101087; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Saadi-Kheddouci S, 2001, ONCOGENE, V20, P5972, DOI 10.1038/sj.onc.1204825; Szatkowski C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081175; Toka HR, 2010, SEMIN NEPHROL, V30, P374, DOI 10.1016/j.semnephrol.2010.06.004; Urayama K, 2008, ARTERIOSCL THROM VAS, V28, P841, DOI 10.1161/ATVBAHA.108.162404; Urayama K, 2007, FASEB J, V21, P2980, DOI 10.1096/fj.07-8116com; Zhou B, 2012, METHODS MOL BIOL, V843, P155, DOI 10.1007/978-1-61779-523-7_15	29	6	6	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2733	2740		10.1096/fj.201600181R	http://dx.doi.org/10.1096/fj.201600181R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27084889				2022-12-26	WOS:000380994000010
J	Donaubauer, EM; Hunzicker-Dunn, ME				Donaubauer, Elyse M.; Hunzicker-Dunn, Mary E.			Extracellular Signal-regulated Kinase (ERK)-dependent Phosphorylation of Y-Box-binding Protein 1 (YB-1) Enhances Gene Expression in Granulosa Cells in Response to Follicle-stimulating Hormone (FSH)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; RIBOSOMAL S6 KINASE; HISTONE H3 PHOSPHORYLATION; STEROIDOGENIC FACTOR-I; OVARIAN-CANCER CELLS; GLOBIN MESSENGER-RNA; COLD SHOCK DOMAIN; BREAST-CANCER; CYCLIC ADENOSINE-3',5'-MONOPHOSPHATE; BETA-CATENIN	Within the ovarian follicle, immature oocytes are surrounded and supported by granulosa cells (GCs). Stimulation of GCs by FSH leads to their proliferation and differentiation, events that are necessary for fertility. FSH activates multiple signaling pathways to regulate genes necessary for follicular maturation. Herein, we investigated the role of Y-box-binding protein-1 (YB-1) within GCs. YB-1 is a nucleic acid binding protein that regulates transcription and translation. Our results show that FSH promotes an increase in the phosphorylation of YB-1 on Ser(102) within 15 min that is maintained at significantly increased levels until similar to 8 h post treatment. FSH-stimulated phosphorylation of YB-1(Ser(102)) is prevented by pretreatment of GCs with the PKA-selective inhibitor PKA inhibitor (PKI), the MEK inhibitor PD98059, or the ribosomal S6 kinase-2 (RSK-2) inhibitor BI-D1870. Thus, phosphorylation of YB-1 on Ser(102) is PKA-, ERK-, and RSK-2-dependent. However, pretreatment of GCs with the protein phosphatase 1 (PP1) inhibitor tautomycin increased phosphorylation of YB-1(Ser(102)) in the absence of FSH; FSH did not further increase YB-1(Ser(102)) phosphorylation. This result suggests that the major effect of RSK-2 is to inhibit PP1 rather than to directly phosphorylate YB-1 on Ser(102). YB-1 coimmunoprecipitated with PP1 beta catalytic subunit and RSK-2. Transduction of GCs with the dephospho-adenoviral-YB-1(S102A) mutant prevented the induction by FSH of Egfr, Cyp19a1, Inha, Lhcgr, Cyp11a1, Hsd17b1, and Pappa mRNAs and estradiol-17 beta production. Collectively, our results reveal that phosphorylation of YB-1 on Ser(102) via the ERK/RSK-2 signaling pathway is necessary for FSH-mediated expression of target genes required for maturation of follicles to a preovulatory phenotype.	[Donaubauer, Elyse M.; Hunzicker-Dunn, Mary E.] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA	Washington State University	Hunzicker-Dunn, ME (corresponding author), Washington State Univ, Biotechnol Life Sci Bldg,Rm 202, Pullman, WA 99164 USA.	mehd@vetmed.wsu.edu			National Institutes of Health Grant [P50HD28934]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD028934, R01HD062053, R01HD065859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM083864] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge the University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core, supported by National Institutes of Health Grant P50HD28934, for estradiol-17 beta RIAs. We thank Dr. Wenlong Bai, University of South Florida, Tampa, FL, for kindly providing the full-length human Egfr promoter-luciferase construct. We also thank Dr. John H. Nilson, Dr. Maria Herndon, and Nate Law for many helpful discussions.	Alam H, 2004, J BIOL CHEM, V279, P19431, DOI 10.1074/jbc.M401235200; Alam H, 2009, ENDOCRINOLOGY, V150, P915, DOI 10.1210/en.2008-0850; Andric N, 2006, MOL ENDOCRINOL, V20, P3308, DOI 10.1210/me.2006-0241; Bader AG, 2005, MOL CELL BIOL, V25, P2095, DOI 10.1128/MCB.25.6.2095-2106.2005; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Basaki Y, 2007, ONCOGENE, V26, P2736, DOI 10.1038/sj.onc.1210084; Bennett J, 2012, ENDOCRINOLOGY, V153, P2474, DOI 10.1210/en.2011-1969; BLOBEL G, 1972, BIOCHEM BIOPH RES CO, V47, P88, DOI 10.1016/S0006-291X(72)80014-7; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; BOUVET P, 1995, J BIOL CHEM, V270, P28297; Carlone DL, 1997, MOL ENDOCRINOL, V11, P292, DOI 10.1210/me.11.3.292; CARR DW, 1993, J BIOL CHEM, V268, P20729; Chatfield K, 2004, BIOCHEM BIOPH RES CO, V323, P1313, DOI 10.1016/j.bbrc.2004.09.003; Chen MJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep18319; Chen SY, 1999, ENDOCRINOLOGY, V140, P2100, DOI 10.1210/en.140.5.2100; Coles LS, 2005, FEBS LETT, V579, P5372, DOI 10.1016/j.febslet.2005.08.075; Cottom J, 2003, J BIOL CHEM, V278, P7167, DOI 10.1074/jbc.M203901200; Dalby KN, 1998, J BIOL CHEM, V273, P1496, DOI 10.1074/jbc.273.3.1496; Das S, 1996, ENDOCRINOLOGY, V137, P967, DOI 10.1210/en.137.3.967; DeManno DA, 1999, MOL ENDOCRINOL, V13, P91, DOI 10.1210/me.13.1.91; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; El-Hayek S, 2014, P NATL ACAD SCI USA, V111, P16778, DOI 10.1073/pnas.1414648111; El-Hefnawy T, 2001, ENDOCRINOLOGY, V142, P4357, DOI 10.1210/en.142.10.4357; Eliseeva IA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1402, DOI 10.1134/S0006297911130049; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; ERICKSON GF, 1978, ENDOCRINOLOGY, V102, P1275, DOI 10.1210/endo-102-4-1275; Evdokimova V, 2006, MOL CELL BIOL, V26, P277, DOI 10.1128/MCB.26.1.277-292.2006; Fan HY, 2009, SCIENCE, V324, P938, DOI 10.1126/science.1171396; Favre B, 1997, J BIOL CHEM, V272, P13856, DOI 10.1074/jbc.272.21.13856; Finkbeiner MR, 2009, ONCOGENE, V28, P1421, DOI 10.1038/onc.2008.485; Fisher CR, 1998, P NATL ACAD SCI USA, V95, P6965, DOI 10.1073/pnas.95.12.6965; Fukada T, 2003, EMBO J, V22, P479, DOI 10.1093/emboj/cdg067; GAY V L, 1970, Federation Proceedings, V29, P1880; Gessner C, 2004, EUR RESPIR J, V23, P14, DOI 10.1183/09031936.03.00033203; Gonzalez-Robayna IJ, 2000, MOL ENDOCRINOL, V14, P1283, DOI 10.1210/me.14.8.1283; HAGIWARA M, 1993, MOL CELL BIOL, V13, P4852, DOI 10.1128/MCB.13.8.4852; Hakkarainen J, 2015, FASEB J, V29, P3806, DOI 10.1096/fj.14-269035; Hsieh M, 2007, MOL CELL BIOL, V27, P1914, DOI 10.1128/MCB.01919-06; Hsieh M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021574; HSUEH AJW, 1984, ENDOCR REV, V5, P76, DOI 10.1210/edrv-5-1-76; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; Hunzicker-Dunn M., 2015, KNOBIL NEILLS PHYSL, V1, P1, DOI [10.1016/B978-012515400-0/50019-1, DOI 10.1016/B978-012515400-0/50019-1, 10.1016/b978-0-12-397175-3.00020-x]; Hunzicker-Dunn ME, 2012, P NATL ACAD SCI USA, V109, pE2979, DOI 10.1073/pnas.1205661109; HUNZICKERDUNN M, 1981, J BIOL CHEM, V256, P2185; Ito M, 2000, MOL ENDOCRINOL, V14, P66, DOI 10.1210/me.14.1.66; Jurchott K, 2003, J BIOL CHEM, V278, P27988, DOI 10.1074/jbc.M212966200; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; KEMP BE, 1988, METHOD ENZYMOL, V159, P173; Law NC, 2016, J BIOL CHEM, V291, P4547, DOI 10.1074/jbc.M115.698761; Law NC, 2013, MOL ENDOCRINOL, V27, P1295, DOI 10.1210/me.2013-1025; Liu XF, 2013, FEBS LETT, V587, P3995, DOI 10.1016/j.febslet.2013.10.036; Liu ZL, 2009, MOL ENDOCRINOL, V23, P649, DOI 10.1210/me.2008-0412; Miro F, 1996, ENDOCRINOLOGY, V137, P464, DOI 10.1210/en.137.2.464; MOREL C, 1971, FEBS LETT, V18, P84, DOI 10.1016/0014-5793(71)80413-1; Mukherjee A, 1996, ENDOCRINOLOGY, V137, P3234, DOI 10.1210/en.137.8.3234; Nekrasov MP, 2003, J BIOL CHEM, V278, P13936, DOI 10.1074/jbc.M209145200; Nyegaard M, 2010, BIOL REPROD, V82, P1129, DOI 10.1095/biolreprod.109.079517; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Otsuka F, 2002, P NATL ACAD SCI USA, V99, P8060, DOI 10.1073/pnas.122066899; Park Y, 2005, J BIOL CHEM, V280, P9135, DOI 10.1074/jbc.M409486200; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; PEI L, 1991, MOL ENDOCRINOL, V5, P521, DOI 10.1210/mend-5-4-521; Reipas KM, 2013, ONCOTARGET, V4, P329, DOI 10.18632/oncotarget.834; RICHARDS JS, 1995, RECENT PROG HORM RES, V50, P223; Richards JS, 2002, MOL ENDOCRINOL, V16, P580, DOI 10.1210/me.16.3.580; Salvador LM, 2001, J BIOL CHEM, V276, P40146, DOI 10.1074/jbc.M106710200; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Shen Z, 2011, MOL CELL ENDOCRINOL, V338, P58, DOI 10.1016/j.mce.2011.02.023; SPRENGEL R, 1990, MOL ENDOCRINOL, V4, P525, DOI 10.1210/mend-4-4-525; Stratford AL, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1767; Stratford AL, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2202; Sunters A, 2010, J BIOL CHEM, V285, P8743, DOI 10.1074/jbc.M109.027086; Sutherland BW, 2005, ONCOGENE, V24, P4281, DOI 10.1038/sj.onc.1208590; TAFURI SR, 1992, NEW BIOL, V4, P349; To K, 2007, MOL PHARMACOL, V72, P641, DOI 10.1124/mol.107.036111; Tremblay JJ, 2001, ENDOCRINOLOGY, V142, P977, DOI 10.1210/en.142.3.977; Tremblay JJ, 2003, J STEROID BIOCHEM, V85, P291, DOI 10.1016/S0960-0760(03)00211-5; TSAIMORRIS CH, 1995, J BIOL CHEM, V270, P7487, DOI 10.1074/jbc.270.13.7487; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Weck J, 2006, MOL ENDOCRINOL, V20, P1090, DOI 10.1210/me.2005-0199; Wu Joyce, 2007, Transl Oncogenomics, V2, P49; Wu J, 2006, CANCER RES, V66, P4872, DOI 10.1158/0008-5472.CAN-05-3561; Zeleznik AJ, 2003, ENDOCRINOLOGY, V144, P3985, DOI 10.1210/en.2003-0293; Zhang FP, 2001, MOL ENDOCRINOL, V15, P172, DOI 10.1210/me.15.1.172	84	29	31	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12145	12160		10.1074/jbc.M115.705368	http://dx.doi.org/10.1074/jbc.M115.705368			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27080258	Green Published, hybrid			2022-12-26	WOS:000378092800017
J	Yazdani, S; Yusof, R; Karimian, A; Mitsukira, Y; Hematian, A				Yazdani, Sepideh; Yusof, Rubiyah; Karimian, Alireza; Mitsukira, Yasue; Hematian, Amirshahram			Automatic Region-Based Brain Classification of MRI-T1 Data	PLOS ONE			English	Article							SEGMENTATION; IMAGE; HYBRID; MODEL; EXTRACTION	Image segmentation of medical images is a challenging problem with several still not totally solved issues, such as noise interference and image artifacts. Region-based and histogram-based segmentation methods have been widely used in image segmentation. Problems arise when we use these methods, such as the selection of a suitable threshold value for the histogram-based method and the over-segmentation followed by the time-consuming merge processing in the region-based algorithm. To provide an efficient approach that not only produce better results, but also maintain low computational complexity, a new region dividing based technique is developed for image segmentation, which combines the advantages of both regions-based and histogram-based methods. The proposed method is applied to the challenging applications: Gray matter (GM), White matter (WM) and cerebrospinal fluid (CSF) segmentation in brain MR Images. The method is evaluated on both simulated and real data, and compared with other segmentation techniques. The obtained results have demonstrated its improved performance and robustness.	[Yazdani, Sepideh; Yusof, Rubiyah] Univ Technol Malaysia, Ctr Artificial Intelligence & Robot, MJIIT, Kuala Lumpur, Malaysia; [Karimian, Alireza] Univ Isfahan, Dept Biomed Engn, Fac Engn, Esfahan, Iran; [Mitsukira, Yasue] Keio Univ, Dept Syst Design Engn, Fac Sci & Technol, Kyoto, Japan; [Hematian, Amirshahram] Towson Univ, Dept Comp & Informat Sci, Towson, MD USA	Universiti Teknologi Malaysia; University of Isfahan; Keio University; University System of Maryland; Towson University	Yusof, R (corresponding author), Univ Technol Malaysia, Ctr Artificial Intelligence & Robot, MJIIT, Kuala Lumpur, Malaysia.	rubiyah.kl@utm.my	yusof, rubiyah/AAV-9212-2020; Karimian, Alireza/AAW-3501-2021	Karimian, Alireza/0000-0003-2543-4772	Ministry of Higher Education of Malaysia (MOHE) [4L659]	Ministry of Higher Education of Malaysia (MOHE)	The authors would like to acknowledge the financial support from Ministry of Higher Education of Malaysia (MOHE) under Research Grant 4L659.; The authors would like to acknowledge the financial support from Ministry of Higher Education of Malaysia (MOHE) under Research Grant 4L659. Also, thanks are due to Research Management Center (RMC) of Universiti Teknologi Malaysia (UTM) for a great research environment to complete this work.	Ahmed MN, 2002, IEEE T MED IMAGING, V21, P193, DOI 10.1109/42.996338; Ayman A, 2010, NEW REGION GROWING S, V110, P71; Bricq S, 2008, MED IMAGE ANAL, V12, P639, DOI 10.1016/j.media.2008.03.001; Caldairou B, 2011, PATTERN RECOGN, V44, P1916, DOI 10.1016/j.patcog.2010.06.006; Cocosco C.A., 1997, NEUROIMAGE; Cocosco CA, 2003, MED IMAGE ANAL, V7, P513, DOI 10.1016/S1361-8415(03)00037-9; Collins DL, 1998, IEEE T MED IMAGING, V17, P463, DOI 10.1109/42.712135; del Fresno M, 2009, COMPUT MED IMAG GRAP, V33, P369, DOI 10.1016/j.compmedimag.2009.03.002; Fan JP, 2001, IEEE T IMAGE PROCESS, V10, P1454, DOI 10.1109/83.951532; Galdames FJ, 2012, J NEUROSCI METH, V206, P103, DOI 10.1016/j.jneumeth.2012.02.017; Hao M, 2014, IEEE GEOSCI REMOTE S, V11, P210, DOI 10.1109/LGRS.2013.2252879; Kato T., 2002, Structural, Syntactic, and Statistical Pattern Recognition. Joint IAPR International Workshops SSPR 2002 and SPR 2002 (Lecture Notes in Computer Science Vol. 2396), P405; Kwan RKS, 1999, IEEE T MED IMAGING, V18, P1085, DOI 10.1109/42.816072; Lan K, 2001, J CHROMATOGR A, V915, P1, DOI 10.1016/S0021-9673(01)00594-5; Lee JD, 2009, IEEE T MED IMAGING, V28, P894, DOI 10.1109/TMI.2009.2012896; Liew AWC, 2006, CURR MED IMAGING, V2, P91, DOI 10.2174/157340506775541604; Lui D, 2014, IEEE T BIO-MED ENG, V61, P368, DOI 10.1109/TBME.2013.2279635; Mansourvar M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138493; Murgasova M, 2007, P 23 SPRING C COMP G; Ortiz A., 2013, COMPUTATIONAL MATH M, V2013; Rajapakse JC, 1998, IMAGE VISION COMPUT, V16, P165, DOI 10.1016/S0262-8856(97)00067-X; Roy S, 2014, LECT NOTES COMPUT SC, V8679, P248, DOI 10.1007/978-3-319-10581-9_31; Shan ZY, 2002, NEUROIMAGE, V17, P1587, DOI 10.1006/nimg.2002.1287; Shattuck DW, 2001, NEUROIMAGE, V13, P856, DOI 10.1006/nimg.2000.0730; Singh WJ, 2013, COMPUT METHOD BIOMEC, V16, P758, DOI 10.1080/10255842.2011.639015; Wehner WS, 2014, INT J PATTERN RECOGN, V28, DOI 10.1142/S0218001414550088; Weizman L, 2012, MED IMAGE ANAL, V16, P177, DOI 10.1016/j.media.2011.07.001; Wells WM, 1996, IEEE T MED IMAGING, V15, P429, DOI 10.1109/42.511747; Xie M, 2015, MED BIOL ENG COMPUT, V53, P23, DOI 10.1007/s11517-014-1198-y; Yazdani S, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/829893; Yazdani S, 2015, IETE TECHNICAL REV, P1; Yazdani S, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0207-7; Yu ZQ, 2006, COMPUT MED IMAG GRAP, V30, P197, DOI 10.1016/j.compmedimag.2006.03.006; Zanaty EA, 2013, CONNECT SCI, V25, P179, DOI 10.1080/09540091.2013.854736	34	3	3	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0151326	10.1371/journal.pone.0151326	http://dx.doi.org/10.1371/journal.pone.0151326			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096925	gold, Green Published, Green Submitted			2022-12-26	WOS:000374543600002
J	Ong, QX; Guo, SL; Duan, LT; Zhang, K; Collier, EA; Cui, BX				Ong, Qunxiang; Guo, Shunling; Duan, Liting; Zhang, Kai; Collier, Eleanor Ann; Cui, Bianxiao			The Timing of Raf/ERK and AKT Activation in Protecting PC12 Cells against Oxidative Stress	PLOS ONE			English	Article							OPTOGENETIC CONTROL; ISCHEMIC-INJURY; BRAIN-INJURY; OXYGEN; MECHANISMS; DYNAMICS; TIME; REQUIREMENT; EXPRESSION; INDUCTION	Acute brain injuries such as ischemic stroke or traumatic brain injury often cause massive neural death and irreversible brain damage with grave consequences. Previous studies have established that a key participant in the events leading to neural death is the excessive production of reactive oxygen species. Protecting neuronal cells by activating their endogenous defense mechanisms is an attractive treatment strategy for acute brain injuries. In this work, we investigate how the precise timing of the Raf/ERK and the AKT pathway activation affects their protective effects against oxidative stress. For this purpose, we employed optogenetic systems that use light to precisely and reversibly activate either the Raf/ERK or the AKT pathway. We find that preconditioning activation of the Raf/ERK or the AKT pathway immediately before oxidant exposure provides significant protection to cells. Notably, a 15-minute transient activation of the Raf/ERK pathway is able to protect PC12 cells against oxidant strike that is applied 12 hours later, while the transient activation of the AKT pathway fails to protect PC12 cells in such a scenario. On the other hand, if the pathways are activated after the oxidative insult, i.e. postconditioning, the AKT pathway conveys greater protective effect than the Raf/ERK pathway. We find that postconditioning AKT activation has an optimal delay period of 2 hours. When the AKT pathway is activated 30min after the oxidative insult, it exhibits very little protective effect. Therefore, the precise timing of the pathway activation is crucial in determining its protective effect against oxidative injury. The optogenetic platform, with its precise temporal control and its ability to activate specific pathways, is ideal for the mechanistic dissection of intracellular pathways in protection against oxidative stress.	[Ong, Qunxiang; Guo, Shunling; Duan, Liting; Collier, Eleanor Ann; Cui, Bianxiao] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Zhang, Kai] Univ Illinois, Sch Mol & Cellular Biol, Dept Biochem, Urbana, IL 61801 USA	Stanford University; University of Illinois System; University of Illinois Urbana-Champaign	Cui, BX (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	bcui@stanford.edu	Zhang, Kai/ABD-1498-2021	Zhang, Kai/0000-0002-6687-4558	US National Institute of Health [DP2-NS082125]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [DP2NS082125] Funding Source: NIH RePORTER	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by US National Institute of Health (www.nih.gov) DP2-NS082125 to BC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKHULAIFI AM, 1993, CARDIOSCIENCE, V4, P163; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Barone FC, 1998, STROKE, V29, P1937, DOI 10.1161/01.STR.29.9.1937; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Bugaj LJ, 2013, NAT METHODS, V10, P249, DOI 10.1038/nmeth.2360; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Choi YS, 2007, EXP MOL MED, V39, P556, DOI 10.1038/emm.2007.61; Cohen MV, 2015, BRIT J PHARMACOL, V172, P1913, DOI 10.1111/bph.12903; DeRosa MC, 2002, COORDIN CHEM REV, V233, P351, DOI 10.1016/S0010-8545(02)00034-6; Dijkmans TF, 2008, J NEUROCHEM, V105, P2388, DOI 10.1111/j.1471-4159.2008.05338.x; Duan LT, 2015, CHEM BIOL, V22, P671, DOI 10.1016/j.chembiol.2015.04.014; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; FOOTE CS, 1968, ACCOUNTS CHEM RES, V1, P104, DOI 10.1021/ar50004a002; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; Hausenloy DJ, 2016, NAT REV CARDIOL, V13, P193, DOI 10.1038/nrcardio.2016.5; Idevall-Hagren O, 2012, P NATL ACAD SCI USA, V109, pE2316, DOI 10.1073/pnas.1211305109; Jiang H, 2005, J MOL NEUROSCI, V25, P133, DOI 10.1385/JMN:25:2:133; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Katsura Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep14589; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kim SY, 2011, ONCOL REP, V26, P1561, DOI 10.3892/or.2011.1439; Kohn AD, 1998, J BIOL CHEM, V273, P11937, DOI 10.1074/jbc.273.19.11937; Kokona D, 2015, EXP EYE RES, V136, P45, DOI 10.1016/j.exer.2015.05.007; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Loukogeorgakis SP, 2006, CIRCULATION, V113, P1015, DOI 10.1161/CIRCULATIONAHA.105.590398; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marinho HS, 2013, METHOD ENZYMOL, V526, P159, DOI 10.1016/B978-0-12-405883-5.00010-7; Martin KR, 2002, HUM EXP TOXICOL, V21, P71, DOI 10.1191/0960327102ht213oa; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; Moreira JBN, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0444-x; Muller K, 2013, MOL BIOSYST, V9, P596, DOI 10.1039/c3mb25590e; Neumann JT, 2015, J CEREBR BLOOD F MET, V35, P121, DOI 10.1038/jcbfm.2014.185; Noh MY, 2013, MOL NEUROBIOL, V47, P757, DOI 10.1007/s12035-012-8382-6; Ong Q, 2015, OPTOGENETIC CO UNPUB; Ong QX, 2015, ACS CHEM NEUROSCI, V6, P130, DOI 10.1021/cn500288n; Perez-Pinzon MA, 2005, ANTIOXID REDOX SIGN, V7, P1150, DOI 10.1089/ars.2005.7.1150; SACK S, 1993, CARDIOVASC RES, V27, P551, DOI 10.1093/cvr/27.4.551; Salinas M, 2003, J BIOL CHEM, V278, P13898, DOI 10.1074/jbc.M209164200; Schulz R, 2001, CARDIOVASC RES, V52, P181, DOI 10.1016/S0008-6363(01)00384-4; Shahzad T, 2013, J MOL CELL CARDIOL, V58, P209, DOI 10.1016/j.yjmcc.2013.01.003; Shamloo M, 1999, NEUROSCIENCE, V93, P81, DOI 10.1016/S0306-4522(99)00137-2; STEEVES G, 1994, ANN NY ACAD SCI, V723, P116, DOI 10.1111/j.1749-6632.1994.tb36721.x; Stenzel-Poore MP, 2007, STROKE, V38, P680, DOI 10.1161/01.STR.0000251444.56487.4c; Stocchetti N, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0887-8; Tischer D, 2014, NAT REV MOL CELL BIO, V15, P551, DOI 10.1038/nrm3837; Toettcher JE, 2013, CELL, V155, P1422, DOI 10.1016/j.cell.2013.11.004; Wang XT, 2000, J BIOL CHEM, V275, P14624, DOI 10.1074/jbc.275.19.14624; Wauson EM, 2013, BIOCHEMISTRY-US, V52, P5164, DOI 10.1021/bi4007644; Wegener S, 2004, STROKE, V35, P616, DOI 10.1161/01.STR.0000115767.17923.6A; Weitzman M, 2014, CURR OPIN CELL BIOL, V30, P112, DOI 10.1016/j.ceb.2014.08.004; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; YOUNGMAN RJ, 1981, FEBS LETT, V129, P265, DOI 10.1016/0014-5793(81)80180-9; Zhang K, 2015, TRENDS BIOTECHNOL, V33, P92, DOI 10.1016/j.tibtech.2014.11.007; Zhang KW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098215; Zhao H, 2009, J CEREBR BLOOD F MET, V29, P873, DOI 10.1038/jcbfm.2009.13; Zipper LM, 2003, TOXICOL SCI, V73, P124, DOI 10.1093/toxsci/kfg083	61	21	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153487	10.1371/journal.pone.0153487	http://dx.doi.org/10.1371/journal.pone.0153487			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082641	Green Published, gold, Green Submitted			2022-12-26	WOS:000374291800022
J	Patterson, BR; Mills, KJ; Middel, KR; Benson, JF; Obbard, ME				Patterson, Brent R.; Mills, Kenneth J.; Middel, Kevin R.; Benson, John F.; Obbard, Martyn E.			Does Predation Influence the Seasonal and Diel Timing of Moose Calving in Central Ontario, Canada?	PLOS ONE			English	Article							VAGINAL IMPLANT TRANSMITTERS; WHITE-TAILED DEER; ALCES-ALCES; ACTIVITY PATTERNS; BLACK BEARS; URSUS-AMERICANUS; CALF MORTALITY; WOLF ACTIVITY; SYNCHRONY; SURVIVAL	Birth synchrony is well documented among ungulates and is hypothesised to maximize neonate survival, either by minimizing the risk of predation through predator swamping or by synchronising birthing with increased seasonal food availability. We used encapsulated vaginal implant transmitters to locate and capture neonatal moose calves and document the seasonal and diel timing of parturition in two adjacent study areas with different predation pressure in central Ontario, Canada. We tested the hypothesis that predation promotes earlier and more synchronous birth of moose calves. Across both areas, proportionately more births occurred during the afternoon and fewer than expected occurred overnight. Mean date of calving averaged 1.5 days earlier and calving was also more synchronous in the study area with heavier predation pressure, despite average green-up date and peak Normalized Difference Vegetation Index date occurring 2 days later in this study area than in the area receiving lighter predation pressure. We encourage analysis of data on timing of parturition from additional study areas experiencing varying degrees of predation pressure to better clarify the influence of predation in driving seasonal and diel timing of parturition in temperate ungulates.	[Patterson, Brent R.; Mills, Kenneth J.; Middel, Kevin R.; Obbard, Martyn E.] Trent Univ, Ontario Minist Nat Resources & Forestry, Wildlife Res & Monitoring Sect, Peterborough, ON K9J 7B8, Canada; [Benson, John F.] Trent Univ, Environm & Life Sci Grad Program, Peterborough, ON K9J 7B8, Canada; [Mills, Kenneth J.] Wyoming Game & Fish Dept, Pinedale, WY USA; [Benson, John F.] Calif State Univ Los Angeles, Inst Environm & Sustainabil, La Kretz Ctr Calif Conservat Sci, Los Angeles, CA 90032 USA	Ministry of Natural Resources & Forestry; Trent University; Trent University; California State University System; California State University Los Angeles	Patterson, BR (corresponding author), Trent Univ, Ontario Minist Nat Resources & Forestry, Wildlife Res & Monitoring Sect, Peterborough, ON K9J 7B8, Canada.	brent.patterson@ontario.ca	Obbard, Martyn/AFU-0326-2022	Obbard, Martyn/0000-0003-2064-0155	Ontario Ministry of Natural Resources & Forestry through Ontario Parks; Wildlife Research and Monitoring Section; Natural Sciences & Research Council of Canada [STPGP 321950-05]; Strategic Natural Sciences and Engineering Research Council of Canada (NSERC) grant; Canadian Foundation for Innovation (CFI); Ontario Ministry of Natural Resources & Forestry, through Ontario Parks	Ontario Ministry of Natural Resources & Forestry through Ontario Parks; Wildlife Research and Monitoring Section; Natural Sciences & Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Strategic Natural Sciences and Engineering Research Council of Canada (NSERC) grant; Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Ontario Ministry of Natural Resources & Forestry, through Ontario Parks	Major funding for this work was provided by the Ontario Ministry of Natural Resources & Forestry through Ontario Parks and the Wildlife Research and Monitoring Section. Additional funding was provided by the Natural Sciences & Research Council of Canada (STPGP 321950-05 awarded to Dennis Murray). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was part of a larger assessment of moose viability funded primarily by a Strategic Natural Sciences and Engineering Research Council of Canada (NSERC) grant, and an equipment grant from the Canadian Foundation for Innovation (CFI), both granted to Dennis Murray, Trent University, Peterborough, Ontario. Primary funding for the work described here was provided by the Ontario Ministry of Natural Resources & Forestry, through Ontario Parks and the Wildlife Research and Monitoring Section. Andrew Silver and Mark Gibson assisted greatly with logistical arrangements related to calf captures. Erica Newton assisted with the calculation of NDVI values for our study areas and Sarah Jamieson assisted with the literature search regarding onset of labor. We further thank the many students, volunteers and technicians who participated in field searches for moose calves. Art Rodgers and J. Ward Testa provided useful comments on a previous draft of the manuscript.	ADAMS LG, 1995, J WILDLIFE MANAGE, V59, P584, DOI 10.2307/3802467; Addison E.M., 1990, Alces, V26, P142; ADDISON EM, 1993, ALCES N AM, V29, P27; AUSTIN MA, 1994, CAN FIELD NAT, V108, P236; Ballard W. B., 1979, ALCES, V15, P362; BENSON JF, 2013, CAN J ZOOL, V91, P1; Benson JF, 2012, MOL ECOL, V21, P5934, DOI 10.1111/mec.12045; BERGER J, 1992, ECOLOGY, V73, P323, DOI 10.2307/1938743; Berger J, 2007, BIOL LETTERS, V3, P620, DOI 10.1098/rsbl.2007.0415; BERGERUD AT, 1975, CAN J ZOOL, V53, P1213, DOI 10.1139/z75-145; Bertram MR, 2002, J WILDLIFE MANAGE, V66, P747, DOI 10.2307/3803140; Bishop CJ, 2007, J WILDLIFE MANAGE, V71, P945, DOI 10.2193/2006-123; Boer A.H., 1992, ALCES, V1, P1; Bowman JL, 1998, WILDLIFE SOC B, V26, P295; Bowyer RT, 1998, J MAMMAL, V79, P1332, DOI 10.2307/1383025; Bridges AS, 2004, WILDLIFE BIOL, V10, P277, DOI 10.2981/wlb.2004.033; BRONSON EH, 1989, MAMMALIAN REPROD BIO; BUNNELL FL, 1982, CAN J ZOOL, V60, P1, DOI 10.1139/z82-001; Canadian Association of Zoo and Wildlife Veterinarians, 2009, CHEM IMM WILDL; Crins WJ, 2008, ECOSYSTEMS ONTANO 2; EDWARDS R. Y., 1958, JOUR WILDLIFE MANAGEMENT, V22, P261, DOI 10.2307/3796458; Environment Canada, 2008, NAT CLIM DAT INF ARC; Eriksen A, 2011, ANIM BEHAV, V81, P423, DOI 10.1016/j.anbehav.2010.11.011; ESTES R D, 1976, East African Wildlife Journal, V14, P135; ESTES RD, 1979, Z TIERPSYCHOL, V50, P45; FESTABIANCHET M, 1988, J ZOOL, V214, P653, DOI 10.1111/j.1469-7998.1988.tb03764.x; Finnegan LA, 2012, EUR J WILDLIFE RES, V58, P415, DOI 10.1007/s10344-011-0590-2; FULLER TK, 1991, CAN J ZOOL, V69, P283, DOI 10.1139/z91-044; Griffin KA, 2011, J ANIM ECOL, V80, P1246, DOI 10.1111/j.1365-2656.2011.01856.x; GUNTHER KA, 1990, INT C BEAR, V8, P329; Hegel TM, 2010, J ANIM ECOL, V79, P471, DOI 10.1111/j.1365-2656.2009.01647.x; Hogg JT, 2006, P ROY SOC B-BIOL SCI, V273, P1491, DOI 10.1098/rspb.2006.3477; Howe EJ, 2013, POPUL ECOL, V55, P595, DOI 10.1007/s10144-013-0389-y; Jacoby ME, 1999, J WILDLIFE MANAGE, V63, P921, DOI 10.2307/3802806; Johnson DS, 2004, J MAMMAL, V85, P932, DOI 10.1644/BFW-009; Johnstone-Yellin TL, 2006, WILDLIFE SOC B, V34, P338, DOI 10.2193/0091-7648(2006)34[338:EOVITF]2.0.CO;2; Keech MA, 2000, J WILDLIFE MANAGE, V64, P450, DOI 10.2307/3803243; Keech MA, 2011, J WILDLIFE MANAGE, V75, P1361, DOI 10.1002/jwmg.188; LARIVIERE S, 1994, J MAMMAL, V75, P613, DOI 10.2307/1382508; LARSEN DG, 1989, J WILDLIFE MANAGE, V53, P548, DOI 10.2307/3809175; Laurian C, 2000, J APPL ECOL, V37, P515, DOI 10.1046/j.1365-2664.2000.00520.x; Lowe SJ, 2010, CAN J ZOOL, V88, P1032, DOI 10.1139/Z10-071; Marshall FHA, 1937, PROC R SOC SER B-BIO, V122, P413, DOI 10.1098/rspb.1937.0034; McLaren M., 2009, 127 ONT MIN NAT RES; McLoughlin PD, 2011, BASIC APPL ECOL, V12, P654, DOI 10.1016/j.baae.2011.09.001; Murray DL, 2012, CAN J ZOOL, V90, P422, DOI 10.1139/Z2012-002; Nathanielsz PW, 1998, EUR J OBSTET GYN R B, V78, P127, DOI 10.1016/S0301-2115(98)00058-X; Obbard Martyn E., 2000, Northeast Wildlife, V55, P57; Patterson BR, 2004, WILDLIFE SOC B, V32, P938, DOI 10.2193/0091-7648(2004)032[0938:EWDIFA]2.0.CO;2; Patterson BR, 2013, J WILDLIFE MANAGE, V77, P832, DOI 10.1002/jwmg.516; Quinn NWS, 2005, CAN FIELD NAT, V119, P330, DOI 10.22621/cfn.v119i3.142; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RAWLINGS NC, 1976, J REPROD FERTIL, V48, P355, DOI 10.1530/jrf.0.0480355; Rowe J.S., 1972, CANADIAN FOREST SERV, V1300; RUTBERG AT, 1987, AM NAT, V130, P692, DOI 10.1086/284739; Saether BE, 2003, J WILDLIFE MANAGE, V67, P455, DOI 10.2307/3802703; SCHWARTZ CC, 1993, J WILDLIFE MANAGE, V57, P454, DOI 10.2307/3809270; Schwartz Charles C., 1998, P141; Sigouin D, 1997, ALCES N AM, V33, P85; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Solberg EJ, 2007, OECOLOGIA, V154, P259, DOI 10.1007/s00442-007-0833-9; Testa JW, 2002, J MAMMAL, V83, P699, DOI 10.1644/1545-1542(2002)083<0699:DPONIS>2.0.CO;2; Testa JW, 2000, J MAMMAL, V81, P162, DOI 10.1644/1545-1542(2000)081<0162:TPITSO>2.0.CO;2; Theuerkauf J, 2003, J MAMMAL, V84, P243, DOI 10.1644/1545-1542(2003)084<0243:DPADOW>2.0.CO;2; United States Geological Survey EROS Centre, 2014, USGS CONT US 1 KM AV; Welch Ian D., 2000, Alces, V36, P93; White KS, 2001, J MAMMAL, V82, P422, DOI 10.1644/1545-1542(2001)082<0422:BAEEOD>2.0.CO;2; Whiting JC, 2011, J MAMMAL, V92, P213, DOI 10.1644/10-MAMM-A-145.1; [No title captured]	69	8	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0150730	10.1371/journal.pone.0150730	http://dx.doi.org/10.1371/journal.pone.0150730			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082234	Green Published, gold			2022-12-26	WOS:000374291800002
J	Trakman, L; Hewson, C; Burdach, J; Morris, KV				Trakman, Laura; Hewson, Chris; Burdach, Jon; Morris, Kevin V.			RNA Directed Modulation of Phenotypic Plasticity in Human Cells	PLOS ONE			English	Article							ANTISENSE RNA; TRANSCRIPTION	Natural selective processes have been known to drive phenotypic plasticity, which is the emergence of different phenotypes from one genome following environmental stimulation. Long non-coding RNAs (lncRNAs) have been observed to modulate transcriptional and epigenetic states of genes in human cells. We surmised that lncRNAs are governors of phenotypic plasticity and drive natural selective processes through epigenetic modulation of gene expression. Using heat shocked human cells as a model we find several differentially expressed transcripts with the top candidates being lncRNAs derived from retro-elements. One particular retro-element derived transcripts, Retro-EIF2S2, was found to be abundantly over-expressed in heat shocked cells. Over-expression of Retro-EIF2S2 significantly enhanced cell viability and modulated a predisposition for an adherent cellular phenotype upon heat shock. Mechanistically, we find that this retro-element derived transcript interacts directly with a network of proteins including 40S ribosomal protein S30 (FAU), Eukaryotic translation initiation factor 5A (EIF5A), and Ubiquitin-60S ribosomal protein L40 (UBA52) to affect protein modulated cell adhesion pathways. We find one motif in Retro-EIF2S2 that exhibits binding to FAU and modulates phenotypic cell transitions from adherent to suspension states. The observations presented here suggest that retroviral derived transcripts actively modulate phenotypic plasticity in human cells in response to environmental selective pressures and suggest that natural selection may play out through the action of retro-elements in human cells.	[Trakman, Laura; Hewson, Chris; Burdach, Jon; Morris, Kevin V.] Univ New S Wales, Biotechnol & Biomed Sci, Sydney, NSW 2052, Australia; [Morris, Kevin V.] City Hope Beckman Res Inst, Ctr Gene Therapy, Duarte, CA 91010 USA	University of New South Wales Sydney; City of Hope; Beckman Research Institute of City of Hope	Morris, KV (corresponding author), Univ New S Wales, Biotechnol & Biomed Sci, Sydney, NSW 2052, Australia.; Morris, KV (corresponding author), City Hope Beckman Res Inst, Ctr Gene Therapy, Duarte, CA 91010 USA.	kmorris@coh.org		Morris, Kevin/0000-0002-0157-0553	NIAID [P01 AI099783-01]; ARC [FT130100572]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI099783, R01AI111139] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ARC(Australian Research Council); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by the following: NIAID P01 AI099783-01 and ARC Future Fellow FT130100572.	Allen TA, 2004, NAT STRUCT MOL BIOL, V11, P816, DOI 10.1038/nsmb813; BARSACCHI G, 1972, J CELL BIOL, V54, P580, DOI 10.1083/jcb.54.3.580; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Hawkins PG, 2010, TRANSCR-AUSTIN, V1, P165, DOI 10.4161/trns.1.3.13332; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Johnsson P, 2013, NAT STRUCT MOL BIOL, V20, P440, DOI 10.1038/nsmb.2516; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Morris KV, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000258; Morris KV, 2009, EPIGENETICS, P4; Rossman TG, 2003, ONCOGENE, V22, P1817, DOI 10.1038/sj.onc.1206283; Saayman S, 2014, MOL THER, V22, P1164, DOI 10.1038/mt.2014.29; Thanaphum S, 1998, INSECT MOL BIOL, V7, P63, DOI 10.1046/j.1365-2583.1998.71051.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vadie N, 2015, RNA BIOL, V12, P893, DOI 10.1080/15476286.2015.1063773; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468	19	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0152424	10.1371/journal.pone.0152424	http://dx.doi.org/10.1371/journal.pone.0152424			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082860	gold, Green Published, Green Submitted			2022-12-26	WOS:000374291800006
J	Cury, DP; Dias, FJ; Miglino, MA; Watanabe, IS				Cury, Diego Pulzatto; Jose Dias, Fernando; Miglino, Maria Angelica; Watanabe, Ii-sei			Structural and Ultrastructural Characteristics of Bone-Tendon Junction of the Calcaneal Tendon of Adult and Elderly Wistar Rats	PLOS ONE			English	Article							AGE-RELATED-CHANGES; ACHILLES-TENDON; COLLAGEN-FIBERS; III COLLAGEN; ELECTRON-MICROSCOPY; INSERTION; TISSUE; METABOLISM; MORPHOLOGY; OSTEOCYTE	Tendons are transition tissues that transfer the contractile forces generated by the muscles to the bones, allowing movement. The region where the tendon attaches to the bone is called bone-tendon junction or enthesis and may be classified as fibrous or fibrocartilaginous. This study aims to analyze the collagen fibers and the cells present in the bone-tendon junction using light microscopy and ultrastructural techniques as scanning electron microscopy and transmission electron microscopy. Forty male Wistar rats were used in the experiment, being 20 adult rats at 4 months-old and 20 elderly rats at 20 months-old. The hind limbs of the rats were removed, dissected and prepared to light microscopy, transmission electron microscopy and scanning electron microscopy. The aging process showed changes in the collagen fibrils, with a predominance of type III fibers in the elderly group, in addition to a decrease in the amount of the fibrocartilage cells, fewer and shorter cytoplasmic processes and a decreased synthetic capacity due to degradation of the organelles involved in synthesis.	[Cury, Diego Pulzatto; Watanabe, Ii-sei] Univ Sao Paulo, Inst Biomed Sci, Dept Anat, Sao Paulo, Brazil; [Cury, Diego Pulzatto; Miglino, Maria Angelica; Watanabe, Ii-sei] Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Surg, Sao Paulo, Brazil; [Jose Dias, Fernando] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Surg & Anat, BR-14049 Ribeirao Preto, Brazil; [Jose Dias, Fernando] Univ La Frontera, Sch Dent, CICO Res Ctr, Temuco, Chile	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidad de La Frontera	Watanabe, IS (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Anat, Sao Paulo, Brazil.	watanabe@icb.usp.br	Miglino, Maria Angelica/B-9519-2012; Cury, Diego Pulzatto/N-9870-2015; Cury, Diego Pulzatto/AAS-5015-2021; Dias, Fernando Jose/AAP-7420-2020; Dias, Fernando Jose/D-8228-2014	Miglino, Maria Angelica/0000-0003-4979-115X; Cury, Diego Pulzatto/0000-0002-8571-7144; Dias, Fernando Jose/0000-0001-9945-9185; Watanabe, Ii-sei/0000-0002-1000-1467	FAPESP Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Sao Paulo Research Foundation) [2012/03280-1]; FAPESP [2012/03280-1]	FAPESP Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by FAPESP Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Sao Paulo Research Foundation), http://www.fapesp.br/, Grant #2012/03280-1.; The authors would like to thank FAPESP grant #2012/03280-1 for financial support and Sonia Regina Yokomizo de Almeida, Marta Maria da Silva Righetti, Kelly Patricia Nery Borges, Sebastiao Aparecido Boleta for the technical assistance and reviewers of the Plos One for all suggestions and comments.	Alves A, 2015, MICROSC RES TECHNIQ, V78, P900, DOI 10.1002/jemt.22553; Alves LC, 2008, CAD SAUDE PUBLICA, V24, P535, DOI 10.1590/S0102-311X2008000300007; Benjamin M, 1998, J ANAT, V193, P481, DOI 10.1046/j.1469-7580.1998.19340481.x; Benjamin M, 2000, INT REV CYTOL, V196, P85; BENJAMIN M, 1986, J ANAT, V149, P89; Benjamin M, 2002, COMP BIOCHEM PHYS A, V133, P931, DOI 10.1016/S1095-6433(02)00138-1; BENJAMIN M, 1991, J ANAT, V179, P127; Biancalana A, 2012, MICRON, V43, P463, DOI 10.1016/j.micron.2011.11.002; BOSCO C, 1980, EUR J APPL PHYSIOL O, V45, P209, DOI 10.1007/BF00421329; Buckley MR, 2013, CONNECT TISSUE RES, V54, P374, DOI 10.3109/03008207.2013.847096; Burger EH, 1999, FASEB J, V13, pS101, DOI 10.1096/fasebj.13.9001.s101; Claudepierre P, 2005, JOINT BONE SPINE, V72, P32, DOI 10.1016/j.jbspin.2004.02.010; CONSTANTINE VS, 1968, J INVEST DERMATOL, V50, P419, DOI 10.1038/jid.1968.68; Dapson RW, 2011, BIOTECH HISTOCHEM, V86, P133, DOI 10.3109/10520295.2011.570277; del Sol M, 2011, INT J MORPHOL, V29, P918, DOI 10.4067/S0717-95022011000300042; Dias FJ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/597863; Dias FJ, 2012, MICRON, V43, P237, DOI 10.1016/j.micron.2011.08.005; Dressler MR, 2005, J ORTHOP RES, V23, P287, DOI 10.1016/j.orthres.2004.06.017; Eriksen HA, 2002, J ORTHOPAED RES, V20, P1352, DOI 10.1016/S0736-0266(02)00064-5; Everts V, 2012, METHODS MOL BIOL, V816, P351, DOI 10.1007/978-1-61779-415-5_23; FLORIDI A, 1981, CONNECT TISSUE RES, V9, P95, DOI 10.3109/03008208109160246; Ganestam A, 2016, KNEE SURG SPORT TR A, V24, P3730, DOI 10.1007/s00167-015-3544-5; Geary MB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136351; Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002; Gopinathan PA, 2015, SCIENTIFICA, V2015, DOI 10.1155/2015/802980; IPPOLITO E, 1980, J BONE JOINT SURG AM, V62, P583, DOI 10.2106/00004623-198062040-00014; Jarvinen TAH, 2004, J ORTHOP RES, V22, P1303, DOI 10.1016/j.orthres.2004.04.003; JOZSA L, 1989, AM J SPORT MED, V17, P338, DOI 10.1177/036354658901700305; JOZSA L, 1984, ARCH ORTHOP TRAUM SU, V103, P47, DOI 10.1007/BF00451318; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; JUNQUEIRA LCU, 1979, ANAL BIOCHEM, V94, P96, DOI 10.1016/0003-2697(79)90795-4; Kannus P, 2000, SCAND J MED SCI SPOR, V10, P312, DOI 10.1034/j.1600-0838.2000.010006312.x; Kannus P, 2005, TENDON INJURIES: BASIC SCIENCE AND CLINICAL MEDICINE, P25, DOI 10.1007/1-84628-050-8_4; Kostrominova TY, 2013, AGE, V35, P2203, DOI 10.1007/s11357-013-9514-2; Lantto I, 2015, SCAND J MED SCI SPOR, V25, pE133, DOI 10.1111/sms.12253; Lattouf R, 2014, J HISTOCHEM CYTOCHEM, V62, P751, DOI 10.1369/0022155414545787; Lavagnino M, 2013, CONNECT TISSUE RES, V54, P70, DOI 10.3109/03008207.2012.744973; Maffulli N, 2000, AM J SPORT MED, V28, P499, DOI 10.1177/03635465000280040901; Manjunatha BS, 2015, J CANCER RES THER, V11, P272, DOI 10.4103/0973-1482.154061; Mendes M, 2010, KAFKAS UNIV VET FAK, V16, P711; Milz S, 2004, ANN RHEUM DIS, V63, P1015, DOI 10.1136/ard.2003.016378; MONTES GS, 1991, MEM I OSWALDO CRUZ, V86, P1; OBrien M, 1997, SCAND J MED SCI SPOR, V7, P55; Oegema TR, 1997, MICROSC RES TECHNIQ, V37, P324, DOI 10.1002/(SICI)1097-0029(19970515)37:4<324::AID-JEMT7>3.0.CO;2-K; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Rich Lillian, 2005, Brazilian Journal of Morphological Sciences, V22, P97; Ritchie RO, 2006, STRAIN, V42, P225, DOI 10.1111/j.1475-1305.2006.00282.x; Rochefort GY, 2010, OSTEOPOROSIS INT, V21, P1457, DOI 10.1007/s00198-010-1194-5; Singh Harkanwal Preet, 2012, Natl J Maxillofac Surg, V3, P15, DOI 10.4103/0975-5950.102142; SQUIER CA, 1983, CELL TISSUE RES, V234, P17; Thomopoulos S, 2010, J MUSCULOSKEL NEURON, V10, P35; Thomopoulos S, 2006, J BIOMECH, V39, P1842, DOI 10.1016/j.jbiomech.2005.05.021; van Hove RP, 2009, BONE, V45, P321, DOI 10.1016/j.bone.2009.04.238; Wang X, 2002, BONE, V31, P1, DOI 10.1016/S8756-3282(01)00697-4; WATANABE I, 1983, ARCH HISTOL JAPON, V46, P173, DOI 10.1679/aohc.46.173; Watanabe I., 1998, SCANNING ELECTRON MI; WATSON ML, 1958, J BIOPHYS BIOCHEM CY, V4, P727, DOI 10.1083/jcb.4.6.727; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646; Wopenka B, 2008, APPL SPECTROSC, V62, P1285, DOI 10.1366/000370208786822179; Yanagisawa H, 2012, J ELECTRON MICROSC, V61, P237, DOI 10.1093/jmicro/dfs044; Yang G, 2013, BIRTH DEFECTS RES C, V99, P203, DOI 10.1002/bdrc.21041; Yu TY, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-2; Zhao L, 2014, J ANAT, V224, P624, DOI 10.1111/joa.12174; Zhou ZP, 2010, AGING CELL, V9, P911, DOI 10.1111/j.1474-9726.2010.00598.x	64	18	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153568	10.1371/journal.pone.0153568	http://dx.doi.org/10.1371/journal.pone.0153568			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078690	Green Published, Green Submitted, gold			2022-12-26	WOS:000374131700080
J	Kawamoto, R; Ninomiya, D; Kasai, Y; Kusunoki, T; Ohtsuka, N; Kumagi, T; Abe, M				Kawamoto, Ryuichi; Ninomiya, Daisuke; Kasai, Yoshihisa; Kusunoki, Tomo; Ohtsuka, Nobuyuki; Kumagi, Teru; Abe, Masanori			Serum Uric Acid Is Positively Associated with Handgrip Strength among Japanese Community-Dwelling Elderly Women	PLOS ONE			English	Article							C-REACTIVE PROTEIN; INDUCED OXIDATIVE STRESS; J-SHAPED ASSOCIATION; OLDER PERSONS; METABOLIC SYNDROME; MUSCLE STRENGTH; INFLAMMATORY MARKERS; PHYSICAL FUNCTION; BLOOD-PRESSURE; ALL-CAUSE	Serum uric acid (UA) has strong anti-oxidant properties. Muscle strength and mass decrease with age, and recently, this decrease has been defined as sarcopenia. Sarcopenia may be triggered by oxidative stress. We investigated whether serum UA is associated with handgrip strength (HGS), which is a useful indicator of sarcopenia, among Japanese community-dwelling elderly persons. The present study included 602 men aged 72 +/- 7 years and 847 women aged 71 +/- 6 years from a rural village. We examined the cross-sectional relationship between serum UA and HGS. In both genders, HGS increased significantly with increased serum UA levels. A multiple linear regression analysis using HGS as an objective variable and various confounding factors as explanatory variables showed that in men age, drinking status, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and estimated glomerular filtration ratio (eGFR(CKDEPI)) were independently and significantly associated with HGS, and in women, serum UA as well as age, body mass index, drinking status, diastolic blood pressure, and eGFR(CKDEPI) were independently and significantly associated with HGS. In women, age and multivariate-adjusted HGS were significantly higher in the Quartile-3 (4.8-5.4 mg/dL) and Quartile-4 groups (5.5-9.3 mg/dL) of serum UA than in the lower groups (0.7-4.7 mg/dL). These results suggest that serum UA may have a protective role in aging-associated decline in muscle strength in community-dwelling elderly women.	[Kawamoto, Ryuichi; Ninomiya, Daisuke; Kumagi, Teru; Abe, Masanori] Ehime Univ, Grad Sch Med, Dept Community Med, Matsuyama, Ehime 7910295, Japan; [Kawamoto, Ryuichi; Ninomiya, Daisuke; Kasai, Yoshihisa; Kusunoki, Tomo; Ohtsuka, Nobuyuki] Seiyo Municipal Nomura Hosp, Dept Internal Med, Matsuyama, Ehime 7971212, Japan	Ehime University	Kawamoto, R (corresponding author), Ehime Univ, Grad Sch Med, Dept Community Med, Matsuyama, Ehime 7910295, Japan.; Kawamoto, R (corresponding author), Seiyo Municipal Nomura Hosp, Dept Internal Med, Matsuyama, Ehime 7971212, Japan.	rykawamo@m.ehime-u.ac.jp	Kumagi, Teru/AAS-7427-2021	Kumagi, Teru/0000-0002-2292-7750	Foundation for Development of Community	Foundation for Development of Community	This work was supported in part by a grant-in-aid for Scientific Research from the Foundation for Development of Community (2014). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Beavers KM, 2009, J NUTR HEALTH AGING, V13, P177, DOI 10.1007/s12603-009-0054-5; Brinkley TE, 2009, J GERONTOL A-BIOL, V64, P455, DOI 10.1093/gerona/gln038; Cesari M, 2004, J GERONTOL A-BIOL, V59, P242; Choi HK, 2005, ANN INTERN MED, V143, P499, DOI 10.7326/0003-4819-143-7-200510040-00009; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Derbre F, 2014, EUR J SPORT SCI, V14, pS98, DOI 10.1080/17461391.2011.654268; Fulle S, 2004, EXP GERONTOL, V39, P17, DOI 10.1016/j.exger.2003.09.012; Glantzounis GK, 2005, CURR PHARM DESIGN, V11, P4145, DOI 10.2174/138161205774913255; GORDON T, 1983, ARCH INTERN MED, V143, P1366, DOI 10.1001/archinte.143.7.1366; Howard C, 2007, J APPL PHYSIOL, V103, P17, DOI 10.1152/japplphysiol.00133.2007; Hsu SP, 2004, NEPHROL DIAL TRANSPL, V19, P457, DOI 10.1093/ndt/gfg563; Huang C, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-258; Johnson RJ, 2003, HYPERTENSION, V41, P1183, DOI 10.1161/01.HYP.0000069700.62727.C5; Kang DH, 2005, J AM SOC NEPHROL, V16, P3553, DOI 10.1681/ASN.2005050572; Kawamoto R, 2013, ENDOCRINE, V44, P132, DOI 10.1007/s12020-013-9912-3; Kawamoto R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065886; Kawamoto R, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-87; Kim Tae Nyun, 2013, J Bone Metab, V20, P1, DOI 10.11005/jbm.2013.20.1.1; Kohara K, 2014, ENDOCRINE, V45, P15, DOI 10.1007/s12020-013-9992-0; Llull L, 2015, STROKE, V46, P2162, DOI 10.1161/STROKEAHA.115.009960; Lyngdoh T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019901; Macchi C, 2008, MECH AGEING DEV, V129, P522, DOI 10.1016/j.mad.2008.04.008; Mazzali M, 2001, HYPERTENSION, V38, P1101, DOI 10.1161/hy1101.092839; Meisinger C, 2008, ARTERIOSCL THROM VAS, V28, P1186, DOI 10.1161/ATVBAHA.107.160184; Nakagawa T, 2005, NAT CLIN PRACT NEPHR, V1, P80, DOI 10.1038/ncpneph0019; Richette P, 2010, LANCET, V375, P318, DOI 10.1016/S0140-6736(09)60883-7; Romanos E, 2007, J CEREBR BLOOD F MET, V27, P14, DOI 10.1038/sj.jcbfm.9600312; Ruggiero C, 2006, EUR HEART J, V27, P1174, DOI 10.1093/eurheatj/ehi879; Ruggiero C, 2007, J AM GERIATR SOC, V55, P1206, DOI 10.1111/j.1532-5415.2007.01260.x; Savage PJ, 1998, ARCH INTERN MED, V158, P741, DOI 10.1001/archinte.158.7.741; Schaap LA, 2009, J GERONTOL A-BIOL, V64, P1183, DOI 10.1093/gerona/glp097; Suliman ME, 2006, AM J KIDNEY DIS, V48, P761, DOI 10.1053/j.ajkd.2006.08.019; Sundstrom J, 2005, HYPERTENSION, V45, P28, DOI 10.1161/01.HYP.0000150784.92944.9a; Waring WS, 2003, CLIN SCI, V105, P425, DOI 10.1042/CS20030149; Wu YL, 2013, GERIATR GERONTOL INT, V13, P672, DOI 10.1111/j.1447-0594.2012.00962.x; Yu ZF, 1998, J NEUROSCI RES, V53, P613, DOI 10.1002/(SICI)1097-4547(19980901)53:5<613::AID-JNR11>3.0.CO;2-1; Zoccali C, 2006, J AM SOC NEPHROL, V17, P1466, DOI 10.1681/ASN.2005090949	38	20	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0151044	10.1371/journal.pone.0151044	http://dx.doi.org/10.1371/journal.pone.0151044			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078883	Green Published, gold, Green Submitted			2022-12-26	WOS:000374131700002
J	Lipkin, E; Strillacci, MG; Eitam, H; Yishay, M; Schiavini, F; Soller, M; Bagnato, A; Shabtay, A				Lipkin, Ehud; Strillacci, Maria Giuseppina; Eitam, Harel; Yishay, Moran; Schiavini, Fausta; Soller, Morris; Bagnato, Alessandro; Shabtay, Ariel			The Use of Kosher Phenotyping for Mapping QTL Affecting Susceptibility to Bovine Respiratory Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INNATE IMMUNE-RESPONSES; SOMATIC-CELL SCORE; FEEDLOT CATTLE; PROTEIN PERCENTAGE; TREATMENT RECORDS; HOLSTEIN CATTLE; CARCASS TRAITS; MAREKS-DISEASE; BEEF-CALVES	Bovine respiratory disease (BRD) is the leading cause of morbidity and mortality in feedlot cattle, caused by multiple pathogens that become more virulent in response to stress. As clinical signs often go undetected and various preventive strategies failed, identification of genes affecting BRD is essential for selection for resistance. Selective DNA pooling (SDP) was applied in a genome wide association study (GWAS) to map BRD QTLs in Israeli Holstein male calves. Kosher scoring of lung adhesions was used to allocate 122 and 62 animals to High (Glatt Kosher) and Low (Non-Kosher) resistant groups, respectively. Genotyping was performed using the Illumina BovineHD BeadChip according to the Infinium protocol. Moving average of -logP was used to map QTLs and Log drop was used to define their boundaries (QTLRs). The combined procedure was efficient for high resolution mapping. Nineteen QTLRs distributed over 13 autosomes were found, some overlapping previous studies. The QTLRs contain polymorphic functional and expression candidate genes to affect kosher status, with putative immunological and wound healing activities. Kosher phenotyping was shown to be a reliable means to map QTLs affecting BRD morbidity.	[Lipkin, Ehud; Soller, Morris] Hebrew Univ Jerusalem, Dept Genet, IL-91904 Jerusalem, Israel; [Strillacci, Maria Giuseppina; Schiavini, Fausta; Bagnato, Alessandro] Univ Milano UNIMI, Milan, Italy; [Eitam, Harel; Yishay, Moran; Shabtay, Ariel] Agr Res Org, Dept Ruminant Sci, IL-50250 Bet Dagan, Israel	Hebrew University of Jerusalem; University of Milan; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Lipkin, E (corresponding author), Hebrew Univ Jerusalem, Dept Genet, IL-91904 Jerusalem, Israel.; Shabtay, A (corresponding author), Agr Res Org, Dept Ruminant Sci, IL-50250 Bet Dagan, Israel.	ehud.lipkin@mail.huji.ac.il; shabtay@volcani.agri.gov.il	Lipkin, Ehud/AAE-9034-2020; Bagnato, Alessandro/L-1817-2017; strillacci, maria/M-7605-2013	Bagnato, Alessandro/0000-0003-2087-1287; Lipkin, Ehud/0000-0003-2624-6765; strillacci, maria/0000-0002-8972-1730				Agbeniga B, 2013, S AFR J ANIM SCI, V43, pS98, DOI 10.4314/sajas.v43i5.18; Aich P, 2007, J GEN VIROL, V88, P2749, DOI 10.1099/vir.0.82861-0; Bagnato A, 2008, J DAIRY SCI, V91, P767, DOI 10.3168/jds.2007-0507; BISHOP SC, 2005, ENCY ANIMAL SCI, P288; Bishop SC, 2011, BREEDING DIS RESISTA; Brickner AG, J EXPT MED, V193, P195; Bryant Lonty K., 1999, Bovine Practitioner, V33, P163; Burgner D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000319; Busby D., 2014, CATTLE FEEDER CLIN, P24; Casas E, 2011, ANIM GENET, V42, P571, DOI 10.1111/j.1365-2052.2011.02189.x; Catz SD, 2014, CELL MICROBIOL, V16, P1301, DOI 10.1111/cmi.12328; Cheng H, 2008, DEV BIOLOGICALS, V132, P365, DOI 10.1159/000317187; Cobb JMT, 1996, PSYCHOSOM MED, V58, P404, DOI 10.1097/00006842-199609000-00003; Danilowicz E, 2010, ANIM GENET, V41, P424, DOI 10.1111/j.1365-2052.2009.02012.x; Druet T, 2010, GENETICS, V184, P789, DOI 10.1534/genetics.109.108431; Duff GC, 2007, J ANIM SCI, V85, P823, DOI 10.2527/jas.2006-501; Eitam H, 2010, CELL STRESS CHAPERON, V15, P865, DOI 10.1007/s12192-010-0195-9; Fernando RL, 2004, GENETICS, V166, P611, DOI 10.1534/genetics.166.1.611; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Fu Y, 2013, CELL METAB, V18, P225, DOI 10.1016/j.cmet.2013.07.003; Fulton JE, 2012, ANIM GENET, V43, P102, DOI 10.1111/j.1365-2052.2012.02384.x; Galyean ML, 1999, J ANIM SCI, V77, P1120; Gardner BA, 1999, J ANIM SCI, V77, P3168; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Hanotte O, 2003, P NATL ACAD SCI USA, V100, P7443, DOI 10.1073/pnas.1232392100; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Hayes NS, 2015, MEAT SCI, V100, P134, DOI 10.1016/j.meatsci.2014.09.145; Heifetz EM, 2007, GENETICS, V177, P2417, DOI 10.1534/genetics.107.080002; Hodgson PD, 2005, COMP FUNCT GENOM, V6, P244, DOI 10.1002/cfg.474; Hoglund JK, 2009, J DAIRY SCI, V92, P2136, DOI 10.3168/jds.2008-1104; Howard JT, 2014, INT J BIOMETEOROL, V58, P1665, DOI 10.1007/s00484-013-0773-5; John LB, 2009, J IMMUNOL, V182, P4792, DOI 10.4049/jimmunol.0802372; LEKEUX P, 1984, AM J VET RES, V45, P2003; Lipkin E, 2013, P PLANT AN GEN 21 C; Liu ML, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-253; Ma YT, 2013, IMMUNITY, V39, P211, DOI 10.1016/j.immuni.2013.07.017; Maier S, 2008, EXP CELL RES, V314, P2477, DOI 10.1016/j.yexcr.2008.05.020; Moiseeva EP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061579; Mosig MO, 2001, GENETICS, V157, P1683; MUGGLICOCKETT NE, 1992, J ANIM SCI, V70, P2013, DOI 10.2527/1992.7072013x; Neibergs H, 2011, J ANIM SCI, V89, P907, DOI 10.2527/jas.2010-3330; Neibergs HL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1164; Nicolazzi EL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-123; Paschoud S, 2014, TISSUE BARRIERS, V2, DOI 10.4161/tisb.28755; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Regenstein J M, 2003, Compr Rev Food Sci Food Saf, V2, P111, DOI 10.1111/j.1541-4337.2003.tb00018.x; Roeber D. L., 2001, Professional Animal Scientist, V17, P39; Ruteshouser EC, 2001, ONCOGENE, V20, P2050, DOI 10.1038/sj.onc.1204301; Saatchi M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-442; Saitoh T, 2010, J CELL BIOL, V189, P925, DOI 10.1083/jcb.201002021; Sakata D, 2010, IUBMB LIFE, V62, P591, DOI 10.1002/iub.356; Schneider MJ, 2010, J ANIM SCI, V88, P1220, DOI 10.2527/jas.2008-1755; Schneider MJ, 2009, J ANIM SCI, V87, P1821, DOI 10.2527/jas.2008-1283; Setta-Kaffetzi N, 2014, AM J HUM GENET, V94, P790, DOI 10.1016/j.ajhg.2014.04.005; Shi Wei, 2009, Proc Am Thorac Soc, V6, P558, DOI 10.1513/pats.200905-031RM; Snowder GD, 2007, J ANIM SCI, V85, P1885, DOI 10.2527/jas.2007-0008; Snowder GD, 2005, J ANIM SCI, V83, P1247; Sporer KRB, 2007, VET IMMUNOL IMMUNOP, V118, P19, DOI 10.1016/j.vetimm.2007.04.002; Steinfelder S, 2011, BLOOD, V117, P2839, DOI 10.1182/blood-2010-06-293027; Strillacci MG, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0106-7; Sulaiman H, 2002, BIOCHEM SOC T, V30, P126, DOI 10.1042/BST0300126; Tal-Stein R, 2010, J DAIRY SCI, V93, P4913, DOI 10.3168/jds.2010-3254; Thompson PN, 2006, J ANIM SCI, V84, P488, DOI 10.2527/2006.842488x; Tizioto PC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131459; Vannahme C, 2003, BIOCHEM J, V373, P805, DOI 10.1042/BJ20030532; Weller JI, 2009, QUANTITATIVE TRAIT LOCI ANALYSIS IN ANIMALS, 2ND EDITION, P1; Whitaker HC, 2014, ONCOGENE, V33, P5274, DOI 10.1038/onc.2013.464; Wittum TE, 1996, J AM VET MED ASSOC, V209, P814; Wu SM, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-115; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Zanella Ricardo, 2011, Frontiers in Genetics, V2, P82, DOI 10.3389/fgene.2011.00082	71	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153423	10.1371/journal.pone.0153423	http://dx.doi.org/10.1371/journal.pone.0153423			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077383	Green Submitted, gold, Green Published			2022-12-26	WOS:000374131700053
J	Peng, YF; Tang, JH; Fu, YC; Fan, IC; Hor, MK; Chan, TC				Peng, Yi-Fan; Tang, Jia-Hong; Fu, Yang-chih; Fan, I-chun; Hor, Maw-Kae; Chan, Ta-Chien			Analyzing Personal Happiness from Global Survey and Weather Data: A Geospatial Approach	PLOS ONE			English	Article							GENDER-DIFFERENCES; HEALTH; MOOD; CLIMATE; LIFE	Past studies have shown that personal subjective happiness is associated with various macro- and micro-level background factors, including environmental conditions, such as weather and the economic situation, and personal health behaviors, such as smoking and exercise. We contribute to this literature of happiness studies by using a geospatial approach to examine both macro and micro links to personal happiness. Our geospatial approach incorporates two major global datasets: representative national survey data from the International Social Survey Program (ISSP) and corresponding world weather data from the National Oceanic and Atmospheric Administration (NOAA). After processing and filtering 55,081 records of ISSP 2011 survey data from 32 countries, we extracted 5,420 records from China and 25,441 records from 28 other countries. Sensitivity analyses of different intervals for average weather variables showed that macro-level conditions, including temperature, wind speed, elevation, and GDP, are positively correlated with happiness. To distinguish the effects of weather conditions on happiness in different seasons, we also adopted climate zone and seasonal variables. The micro-level analysis indicated that better health status and eating more vegetables or fruits are highly associated with happiness. Never engaging in physical activity appears to make people less happy. The findings suggest that weather conditions, economic situations, and personal health behaviors are all correlated with levels of happiness.	[Peng, Yi-Fan; Hor, Maw-Kae] Natl Chengchi Univ, Dept Comp Sci, 64 Chihnan Rd,Sec 2 Wenshan, Taipei 11623, Taiwan; [Peng, Yi-Fan; Tang, Jia-Hong; Fan, I-chun; Chan, Ta-Chien] Acad Sinica, Res Ctr Humanities & Social Sci, Taipei 115, Taiwan; [Fu, Yang-chih] Acad Sinica, Inst Sociol, Taipei 115, Taiwan; [Fan, I-chun] Acad Sinica, Inst Hist & Philol, Taipei 115, Taiwan; [Hor, Maw-Kae] Kainan Univ, Sch Informat, Taoyuan, Taiwan	National Chengchi University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Nan Kai University Technology	Chan, TC (corresponding author), Acad Sinica, Res Ctr Humanities & Social Sci, Taipei 115, Taiwan.; Fu, YC (corresponding author), Acad Sinica, Inst Sociol, Taipei 115, Taiwan.	fuyc@sinica.edu.tw; dachianpig@gmail.com						Adan A, 2001, CHRONOBIOL INT, V18, P491, DOI 10.1081/CBI-100103971; [Anonymous], 2015, GLOBAL SURFACE SUMMA; Behr D, 2014, QUAL QUANT, V48, P127, DOI 10.1007/s11135-012-9754-8; Beute F, 2013, J ENVIRON PSYCHOL, V36, P162, DOI 10.1016/j.jenvp.2013.07.016; Chan TC, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4315; Ciucci E, 2013, INT J BIOMETEOROL, V57, P845, DOI 10.1007/s00484-012-0612-0; Connolly M, 2013, J HAPPINESS STUD, V14, P457, DOI 10.1007/s10902-012-9338-2; Drehmer JE, 2017, J SMOK CESS, V12, P6, DOI 10.1017/jsc.2015.6; Fung HH, 2008, PSYCHOL AGING, V23, P440, DOI 10.1037/0882-7974.23.2.440; Goetzmann WN, 2015, REV FINANC STUD, V28, P73, DOI 10.1093/rfs/hhu063; Graham C, 2008, HEALTH AFFAIR, V27, P72, DOI 10.1377/hlthaff.27.1.72; Green C, 2000, PHARMACOECONOMICS, V17, P151, DOI 10.2165/00019053-200017020-00004; Hagerty MR, 2003, SOC INDIC RES, V64, P1, DOI 10.1023/A:1024790530822; Holopainen J, 2014, INT J BIOMETEOROL, V58, P1039, DOI 10.1007/s00484-013-0689-0; International Social Survey Programme, 2015, HLTH HLTH CAR ISSP 2; Isaacowitz DM, 2012, PERSPECT PSYCHOL SCI, V7, P3, DOI 10.1177/1745691611424750; Khazaee-Pool M, 2015, J PSYCHIATR MENT HLT, V22, P47, DOI 10.1111/jpm.12168; Kohsaka M, 1999, PSYCHIAT CLIN NEUROS, V53, P239, DOI 10.1046/j.1440-1819.1999.00539.x; Lu L, 2006, ASIAN J SOC PSYCHOL, V9, P36, DOI 10.1111/j.1467-839X.2006.00183.x; Maddison D, 2011, ECOL ECON, V70, P2437, DOI 10.1016/j.ecolecon.2011.07.027; Rehdanz K, 2005, ECOL ECON, V52, P111, DOI 10.1016/j.ecolecon.2004.06.015; Richards J, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1391-4; Stranges S, 2006, ADDICTION, V101, P1265, DOI 10.1111/j.1360-0443.2006.01517.x; Stranges S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005878; Tesch-Romer C, 2008, SOC INDIC RES, V85, P329, DOI 10.1007/s11205-007-9133-3; Tsutsui Y, 2013, WEATHER CLIM SOC, V5, P70, DOI 10.1175/WCAS-D-11-00052.1; Veenhoven R, 2006, SOC INDIC RES, V79, P421, DOI 10.1007/s11205-005-5074-x; Zhang X, 2015, SOCIAL SCI RES NETWO	28	3	3	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153638	10.1371/journal.pone.0153638	http://dx.doi.org/10.1371/journal.pone.0153638			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UH	27078263	Green Submitted, Green Published, gold			2022-12-26	WOS:000374131700099
J	Beller, E; Klopp, D; Gottler, J; Kaesmacher, J; Zimmer, C; Kirschke, JS; Prothmann, S				Beller, Ebba; Klopp, David; Goettler, Jens; Kaesmacher, Johannes; Zimmer, Claus; Kirschke, Jan S.; Prothmann, Sascha			Closed-Cell Stent-Assisted Coiling of Intracranial Aneurysms: Evaluation of Changes in Vascular Geometry Using Digital Subtraction Angiography	PLOS ONE			English	Article							WALL SHEAR-STRESS; BIFURCATION ANEURYSMS; UNRUPTURED ANEURYSMS; CEREBRAL ANEURYSM; ARTERY ANEURYSMS; HEMODYNAMICS; FLOW; EMBOLIZATION; DEPLOYMENT; SIZE	Background Stent-assisted coil embolization (SACE) plays an important role in the treatment of intracranial aneurysms. The purpose of this study was to investigate geometrical changes caused by closed-cell design stents in bifurcation and sidewall aneurysms. Methods 31 patients with 34 aneurysms underwent SACE with closed-cell design stents. Inflow angle alpha, determined by aneurysm neck and afferent vessel, and angle between afferent and efferent vessel close to (delta(1)), respectively, more remote from the aneurysm neck (delta(2)) were graphically determined in 2D angiography projections. Results Stent assisted coiling resulted in a significant increase of all three angles from a mean value (+/- SEM) of alpha = 119 degrees (+/- 6.5 degrees) pretreatment to 130 degrees (+/- 6.6 degrees) posttreatment (P <= .001), delta(1) = 129 degrees (+/- 6.4 degrees) to 139 degrees (+/- 6.1 degrees), (P <= .001) and delta(2) = 115 degrees (+/- 8.4 degrees) to 126 degrees (+/- 7.5 degrees), (P <= .01). Angular change of d1 in AcomA aneurysms was significant greater compared to sidewall aneurysms (26 degrees +/- 4.9 degrees versus 8 degrees +/- 2.3 degrees, P <= .05). The initial angle of delta(1) and delta(2) revealed a significantly inverse relationship to the angle increase (delta(1): r = -0.41, P <= .05 and delta(2): r = -0.47, P <= .01). Moreover, angle delta(1) was significantly higher in unruptured compared to ruptured aneurysms (135 degrees +/- 7.1 degrees versus 103 degrees +/- 10.8 degrees, P <= .05). Conclusion Stent deployment modulates the geometry of the aneurysm-vessel complex, which may lead to favorable hemodynamic changes more similar to unruptured than to ruptured aneurysms. Our findings also suggest that the more acute-angled aneurysm-vessel anatomy, the larger the angular change. Further studies are needed to investigate whether these changes improve the clinical outcome.	[Beller, Ebba; Goettler, Jens; Kaesmacher, Johannes; Zimmer, Claus; Kirschke, Jan S.; Prothmann, Sascha] Tech Univ Munich, Klinikum Rechts Isar, Abt Diagnost & Intervent Neuroradiol, D-80290 Munich, Germany; [Klopp, David] Acandis GmbH & Co KG, Pforzheim, Germany	Technical University of Munich	Beller, E (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Abt Diagnost & Intervent Neuroradiol, D-80290 Munich, Germany.	Beller@tum.de	Kaesmacher, Johannes/I-6136-2019; Kirschke, Jan/E-2550-2012	Kaesmacher, Johannes/0000-0002-9177-2289; Kirschke, Jan/0000-0002-7557-0003; Beller, Ebba/0000-0002-5268-151X				[Anonymous], 2006, SURG NEUROL; Backes D, 2014, STROKE, V45, P1299, DOI 10.1161/STROKEAHA.113.004421; Baharoglu MI, 2012, J NEUROSURG, V116, P871, DOI 10.3171/2011.11.JNS11311; Balasso A, 2014, BIORHEOLOGY, V51, P341, DOI 10.3233/BIR-14019; Beck J, 2006, SURG NEUROL, V65, P18, DOI 10.1016/j.surneu.2005.05.019; Bendok BR, 2007, NEUROSURGERY, V61, P835, DOI 10.1227/01.NEU.0000298913.24625.26; Biondi A, 2007, NEUROSURGERY, V61, P460, DOI 10.1227/01.NEU.0000290890.62201.A9; Boussel L, 2008, STROKE, V39, P2997, DOI 10.1161/STROKEAHA.108.521617; Carter BS, 2006, NEUROSURGERY, V58, P217, DOI 10.1227/01.NEU.0000194639.37803.F8; Cebral JR, 2005, IEEE T MED IMAGING, V24, P457, DOI 10.1109/TMI.2005.844159; Cho WS, 2014, CLIN RADIOL, V69, pE63, DOI 10.1016/j.crad.2013.08.021; De Bock S, 2012, J BIOMECH, V45, P1353, DOI 10.1016/j.jbiomech.2012.03.012; de Rooij NK, 2009, J NEUROL, V256, P45, DOI 10.1007/s00415-009-0028-x; Gao B, 2012, AM J NEURORADIOL, V33, P649, DOI 10.3174/ajnr.A2841; Gao BL, 2013, NEUROSURGERY, V72, P739, DOI 10.1227/NEU.0b013e318286fab3; Gao BL, 2013, NEUROSURGERY, V72, P617, DOI 10.1227/NEU.0b013e3182846d9f; Hetts SW, 2014, AM J NEURORADIOL, V35, P698, DOI 10.3174/ajnr.A3755; Huang QH, 2011, AM J NEURORADIOL, V32, P1721, DOI 10.3174/ajnr.A2597; Jou LD, 2005, AM J NEURORADIOL, V26, P2357; Kono K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108033; Lauric A, 2012, NEUROSURGERY, V71, P38, DOI 10.1227/NEU.0b013e3182503bf9; Lin N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079635; Lopes D, 2005, NEUROSURGERY, V56, P416, DOI 10.1227/01.NEU.0000145867.25167.CF; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Pierot L, 2011, RADIOLOGY, V258, P546, DOI 10.1148/radiol.10100894; Piotin M, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00041; Piotin M, 2010, STROKE, V41, P110, DOI 10.1161/STROKEAHA.109.558114; Rayz VL, 2010, ANN BIOMED ENG, V38, P3058, DOI 10.1007/s10439-010-0065-8; Saglam M, 2015, DIAGN INTERV RADIOL; Seshadhri S, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004410; Shojima M, 2004, STROKE, V35, P2500, DOI 10.1161/01.STR.0000144648.89172.0f; Spiotta AM, 2011, NEUROSURGERY, V69, P421, DOI 10.1227/NEU.0b013e318214abbd; Tremmel M, 2009, NEUROSURGERY, V64, P622, DOI 10.1227/01.NEU.0000341529.11231.69; Xiang JP, 2011, STROKE, V42, P144, DOI 10.1161/STROKEAHA.110.592923; Xu JY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138648; Yoo E, 2009, AM J NEURORADIOL, V30, P1028, DOI 10.3174/ajnr.A1482; Zenteno MA, 2005, NEUROSURGERY, V57, P208, DOI 10.1227/01.NEU.0000163683.64511.24; Zenteno Marco, 2010, J Med Case Rep, V4, P64, DOI 10.1186/1752-1947-4-64; Zenteno MA, 2008, J NEUROSURG, V108, P1104, DOI 10.3171/JNS/2008/108/6/1104	39	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153403	10.1371/journal.pone.0153403	http://dx.doi.org/10.1371/journal.pone.0153403			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073908	Green Published, gold			2022-12-26	WOS:000374131200084
J	Esteves-Pereira, AP; Deneux-Tharaux, C; Nakamura-Pereira, M; Saucedo, M; Bouvier-Colle, MH; Leal, MD				Esteves-Pereira, Ana Paula; Deneux-Tharaux, Catherine; Nakamura-Pereira, Marcos; Saucedo, Monica; Bouvier-Colle, Marie-Helene; Leal, Maria do Carmo			Caesarean Delivery and Postpartum Maternal Mortality: A Population-Based Case Control Study in Brazil	PLOS ONE			English	Article							PREGNANCY OUTCOMES; PERINATAL HEALTH; VAGINAL DELIVERY; GLOBAL SURVEY; RISKS; BIRTH; RATES; HEMORRHAGE; MORBIDITY; MODE	Background Cesarean delivery rates continue to increase worldwide and reached 57% in Brazil in 2014. Although the safety of this surgery has improved in the last decades, this trend is a concern because it carries potential risks to women's health and may be a modifiable risk factor of maternal mortality. This paper aims to investigate the risk of postpartum maternal death directly associated with cesarean delivery in comparison to vaginal delivery in Brazil. Methods This was a population-based case-control study performed in eight Brazilian states. To control for indication bias, deaths due to antenatal morbidity were excluded. We included 73 cases of postpartum maternal deaths from 2009-2012. Controls were selected from the Birth in Brazil Study, a 2011 nationwide survey including 9,221 postpartum women. We examined the association of cesarean section and postpartum maternal death by multivariate logistic regression, adjusting for confounders. Results After controlling for indication bias and confounders, the risk of postpartum maternal death was almost three-fold higher with cesarean than vaginal delivery ( OR 2.87, 95% CI 1.635.06), mainly due to deaths from postpartum hemorrhage and complications of anesthesia. Conclusion Cesarean delivery is an independent risk factor of postpartum maternal death. Clinicians and patients should consider this fact in balancing the benefits and risks of the procedure.	[Esteves-Pereira, Ana Paula; Deneux-Tharaux, Catherine; Saucedo, Monica; Bouvier-Colle, Marie-Helene] Paris Descartes Univ, DHU Risks Pregnancy,Epope, Ctr Epidemiol & Stat Sorbonne Paris Cite CRESS, Inserm UMR 1153,Obstet Perinatal & Pediat Epidemi, Paris, France; [Esteves-Pereira, Ana Paula; Nakamura-Pereira, Marcos; Leal, Maria do Carmo] Fundacao Oswaldo Cruz, Sergio Arouca Natl Sch Publ Hlth, Dept Epidemiol & Quantitat Methods Hlth, Rio De Janeiro, RJ, Brazil; [Nakamura-Pereira, Marcos] Fundacao Oswaldo Cruz, Natl Inst Women Children & Adolescents Hlth Ferna, Rio De Janeiro, RJ, Brazil	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Esteves-Pereira, AP (corresponding author), Paris Descartes Univ, DHU Risks Pregnancy,Epope, Ctr Epidemiol & Stat Sorbonne Paris Cite CRESS, Inserm UMR 1153,Obstet Perinatal & Pediat Epidemi, Paris, France.; Esteves-Pereira, AP (corresponding author), Fundacao Oswaldo Cruz, Sergio Arouca Natl Sch Publ Hlth, Dept Epidemiol & Quantitat Methods Hlth, Rio De Janeiro, RJ, Brazil.	ana.pep@gmail.com	Nakamura-Pereira, Marcos/O-4496-2014; Nakamura-Pereira, Marcos/X-1107-2019; deneux-tharaux, catherine/R-1111-2016	Nakamura-Pereira, Marcos/0000-0002-4231-0205; Nakamura-Pereira, Marcos/0000-0002-4231-0205; deneux-tharaux, catherine/0000-0002-6561-3321	National Council for Scientific and Technological Development (CNPq); Sergio Arouca National School of Public Health; Oswaldo Cruz Foundation (INOVA Project); Foundation for supporting Research; State of Rio de Janeiro (FAPERJ); Ministry of Health, Brazil; Maternal Mortality Enquiry Committees	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sergio Arouca National School of Public Health; Oswaldo Cruz Foundation (INOVA Project); Foundation for supporting Research; State of Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Ministry of Health, Brazil; Maternal Mortality Enquiry Committees	The Birth in Brazil Study was funded by the National Council for Scientific and Technological Development (CNPq); Sergio Arouca National School of Public Health, Oswaldo Cruz Foundation (INOVA Project); and Foundation for supporting Research in the State of Rio de Janeiro (FAPERJ). The Ministry of Health, Brazil, funded the Maternal Mortality Enquiry Committees. APE received a post-doc scholarship from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo Bittencourt SD, 2014, CAD SAUDE PUBLICA S1, V30, pS1; Dias MAB, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00154213; Brasil. Ministerio da Saude, 2009, GUIA VIG EP OB MAT G; Brasil. Ministerio da saude, 2014, NASC RES MAE AN TIP; Camargo K R Jr, 2000, Cad Saude Publica, V16, P439; Chongsuvivatwong V, 2010, J OBSTET GYNAECOL RE, V36, P45, DOI 10.1111/j.1447-0756.2009.01100.x; de Frias PG, 2014, CAD SAUDE PUBLICA, V30, P2068, DOI 10.1590/0102-311X00196113; de Frias PG, 2010, CAD SAUDE PUBLICA, V26, P671, DOI 10.1590/S0102-311X2010000400010; Deneux-Tharaux C, 2006, OBSTET GYNECOL, V108, P541, DOI 10.1097/01.AOG.0000233154.62729.24; Fawole AO, 2012, AFR HEALTH SCI, V12, P32; Gabriel Guilherme Paiva, 2014, Rev. paul. pediatr., V32, P183, DOI 10.1590/0103-0582201432306; Kamilya G, 2010, J OBSTET GYNAECOL RE, V36, P248, DOI 10.1111/j.1447-0756.2009.01125.x; Leal MD, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-15; de Vasconcellos MTL, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00176013; LILFORD RJ, 1990, BRIT J OBSTET GYNAEC, V97, P883, DOI 10.1111/j.1471-0528.1990.tb02442.x; Liu SL, 2007, CAN MED ASSOC J, V176, P455, DOI 10.1503/cmaj.060870; Lumbiganon P, 2010, LANCET, V375, P490, DOI 10.1016/S0140-6736(09)61870-5; Macfarlane A., 2015, BJOG; Morse ML, 2011, CAD SAUDE PUBLICA, V27, P623, DOI 10.1590/S0102-311X2011000400002; Nakamura-Pereira M, 2016, REPROD HLTH IN PRESS; Ophir E, 2008, ARCH GYNECOL OBSTET, V277, P401, DOI 10.1007/s00404-007-0476-4; Pacagnella RC, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-159; Pfitscher LC, 2016, TROP MED INT HEALTH, V21, P183, DOI 10.1111/tmi.12633; de Jesus GR, 2015, BJOG-INT J OBSTET GY, V122, P606, DOI 10.1111/1471-0528.13119; Rocha EA, 2015, INT J GYNECOL OBSTET, V128, P131, DOI 10.1016/j.ijgo.2014.08.023; Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007; Schantz-Dunn Julianna, 2011, Rev Obstet Gynecol, V4, P86; Sheldon WR, 2014, BJOG-INT J OBSTET GY, V121, P5, DOI 10.1111/1471-0528.12636; Domingues RMSM, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00105113; Souza JP, 2014, BJOG-INT J OBSTET GY, V121, P1, DOI 10.1111/1471-0528.12735; Szwarcwald CL, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00125313; Vadnais M, 2006, SEMIN PERINATOL, V30, P242, DOI 10.1053/j.semperi.2006.07.014; Villar J, 2007, BRIT MED J, V335, P1025, DOI 10.1136/bmj.39363.706956.55; Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7; Vogel JP, 2015, LANCET GLOB HEALTH, V3, pE260, DOI 10.1016/S2214-109X(15)70094-X; Ye JF, 2014, BIRTH-ISS PERINAT C, V41, P237, DOI 10.1111/birt.12104	36	57	62	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153396	10.1371/journal.pone.0153396	http://dx.doi.org/10.1371/journal.pone.0153396			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073870	Green Published, Green Submitted, gold			2022-12-26	WOS:000374131200081
J	Xu, YX; Richlen, ML; Liefer, JD; Robertson, A; Kulis, D; Smith, TB; Parsons, ML; Anderson, DM				Xu, Yixiao; Richlen, Mindy L.; Liefer, Justin D.; Robertson, Alison; Kulis, David; Smith, Tyler B.; Parsons, Michael L.; Anderson, Donald M.			Influence of Environmental Variables on Gambierdiscus spp. (Dinophyceae) Growth and Distribution	PLOS ONE			English	Article							CIGUATERA-ENDEMIC AREA; NE ATLANTIC-OCEAN; GULF-OF-MEXICO; TOXIC DINOFLAGELLATE; SP-NOV; BENTHIC DINOFLAGELLATE; GENUS GAMBIERDISCUS; FRENCH-POLYNESIA; COASTAL AREAS; TEMPERATURE	Benthic dinoflagellates in the genus Gambierdiscus produce the ciguatoxin precursors responsible for the occurrence of ciguatera toxicity. The prevalence of ciguatera toxins in fish has been linked to the presence and distribution of toxin-producing species in coral reef ecosystems, which is largely determined by the presence of suitable benthic habitat and environmental conditions favorable for growth. Here using single factor experiments, we examined the effects of salinity, irradiance, and temperature on growth of 17 strains of Gambierdiscus representing eight species/phylotypes (G. belizeanus, G. caribaeus, G. carolinianus, G. carpenteri, G. pacificus, G. silvae, Gambierdiscus sp. type 4-5), most of which were established from either Marakei Island, Republic of Kiribati, or St. Thomas, United States Virgin Island (USVI). Comparable to prior studies, growth rates fell within the range of 0-0.48 divisions day(-1). In the salinity and temperature studies, Gambierdiscus responded in a near Gaussian, non-linear manner typical for such studies, with optimal and suboptimal growth occurring in the range of salinities of 25 and 45 and 21.0 and 32.5 degrees C. In the irradiance experiment, no mortality was observed; however, growth rates at 55 mu mol photons . m(-2) . s(-1) were lower than those at 110-400 mu mol photons . m(-2). s(-1). At the extremes of the environmental conditions tested, growth rates were highly variable, evidenced by large coefficients of variability. However, significant differences in intraspecific growth rates were typically found only at optimal or near-optimal growth conditions. Polynomial regression analyses showed that maximum growth occurred at salinity and temperature levels of 30.1-38.5 and 23.8-29.2 degrees C, respectively. Gambierdiscus growth patterns varied among species, and within individual species: G. belizeanus, G. caribaeus, G. carpenteri, and G. pacificus generally exhibited a wider range of tolerance to environmental conditions, which may explain their broad geographic distribution. In contrast, G. silvae and Gambierdiscus sp. types 4-5 all displayed a comparatively narrow range of tolerance to temperature, salinity, and irradiance.	[Xu, Yixiao] Guangxi Teachers Educ Univ, Key Lab Environm Change & Resources Use Beibu Gul, Minist Educ, Nanning, Guangxi, Peoples R China; [Xu, Yixiao] Nanjing Univ, Sch Geog & Oceanog Sci, Nanjing, Jiangsu, Peoples R China; [Xu, Yixiao; Richlen, Mindy L.; Kulis, David; Anderson, Donald M.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Liefer, Justin D.] Mt Allison Univ, Dept Geog & Environm, Sackville, NB E0A 3C0, Canada; [Robertson, Alison] Univ S Alabama, Dept Marine Sci, Dauphin Isl, AL USA; [Robertson, Alison] Dauphin Isl Sea Lab, Dauphin Isl, AL USA; [Smith, Tyler B.] Univ Virgin Isl, Ctr Marine & Environm Studies, St Thomas, VI USA; [Parsons, Michael L.] Florida Gulf Coast Univ, Coastal Watershed Inst, Ft Myers, FL USA	Nanning Normal University; Nanjing University; Woods Hole Oceanographic Institution; Mount Allison University; University of South Alabama; Dauphin Island Sea Lab; University of the Virgin Islands; State University System of Florida; Florida Gulf Coast University	Xu, YX (corresponding author), Guangxi Teachers Educ Univ, Key Lab Environm Change & Resources Use Beibu Gul, Minist Educ, Nanning, Guangxi, Peoples R China.; Xu, YX (corresponding author), Nanjing Univ, Sch Geog & Oceanog Sci, Nanjing, Jiangsu, Peoples R China.; Xu, YX (corresponding author), Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.	xuyixiao_77@163.com		Parsons, Michael/0000-0003-4268-567X; Robertson, Alison/0000-0002-2537-0943; Liefer, Justin/0000-0001-5161-940X	National Natural Science Foundation of China [41506137]; Guangxi Natural Science Foundation [2015GXNSFCA139003]; Centers for Disease Control and Prevention [U01 EH000421]; USFDA [F223201000060C]; NOAA NOS through the CiguaHAB program [NA11NOS4780060, NA11NOS4780028]; VI-EPSCoR Program (NSF) [346483, 081441]; System Fund from Key Laboratory of Environment Change and Resources Use in Beibu Gulf, Ministry of Education [2014BGERLXT01]; Woods Hole Center for Oceans and Human Health through National Science Foundation (NSF) [OCE-1314642]; National Institute of Environmental Health Sciences (NIEHS) [1-P01-ES021923-014]; China Scholarship Council; Lana Vento Trust; NATIONAL CENTER FOR ENVIRONMENTAL HEALTH [U01EH000421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES021923] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); USFDA; NOAA NOS through the CiguaHAB program; VI-EPSCoR Program (NSF)(National Science Foundation (NSF)NSF - Office of the Director (OD)); System Fund from Key Laboratory of Environment Change and Resources Use in Beibu Gulf, Ministry of Education; Woods Hole Center for Oceans and Human Health through National Science Foundation (NSF)(National Science Foundation (NSF)); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); China Scholarship Council(China Scholarship Council); Lana Vento Trust; NATIONAL CENTER FOR ENVIRONMENTAL HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was funded by the National Natural Science Foundation of China (41506137); Guangxi Natural Science Foundation (2015GXNSFCA139003), Centers for Disease Control and Prevention (U01 EH000421); USFDA (F223201000060C); NOAA NOS through the CiguaHAB program (Cooperative Agreement NA11NOS4780060, NA11NOS4780028); the Lana Vento Trust and VI-EPSCoR Program (NSF award # 346483 & 081441); and a System Fund from Key Laboratory of Environment Change and Resources Use in Beibu Gulf, Ministry of Education (2014BGERLXT01). Support was also provided by the Woods Hole Center for Oceans and Human Health through National Science Foundation (NSF) Grant OCE-1314642, National Institute of Environmental Health Sciences (NIEHS) Grant 1-P01-ES021923-014, as well as the China Scholarship Council. This is contribution #145 from the Center for Marine and Environmental Studies, University of the Virgin Islands, and ECOHAB publication #840.	ADACHI R, 1979, B JPN SOC SCI FISH, V45, P67; BOMBER JW, 1988, J EXP MAR BIOL ECOL, V115, P53, DOI 10.1016/0022-0981(88)90189-X; BOMBER JW, 1988, B MAR SCI, V43, P204; Boyd PW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063091; Burkholder JM, 2006, AFR J MAR SCI, V28, P177, DOI 10.2989/18142320609504143; Carlson R.D., 1985, P171; Catania D, 2012, PREVALENCE BENTHIC D; Chateau-Degat ML, 2005, HARMFUL ALGAE, V4, P1053, DOI 10.1016/j.hal.2005.03.003; Chinain M, 1999, MAR BIOL, V135, P259, DOI 10.1007/s002270050623; Chinain M, 1999, J PHYCOL, V35, P1282, DOI 10.1046/j.1529-8817.1999.3561282.x; Chinain M, 2010, TOXICON, V56, P739, DOI 10.1016/j.toxicon.2009.06.013; Delgado G, 2006, REV BIOL TROP, V54, P299; Doblin MA, 2006, HARMFUL ALGAE, V5, P665, DOI 10.1016/j.hal.2006.02.002; Faust MA, 1995, J PHYCOL, V31, P996, DOI 10.1111/j.0022-3646.1995.00996.x; Faust Maria A., 2009, Atoll Research Bulletin, P1; Fraga S, 2010, GEOHAB OP SCI M HABS, P5; Fraga S, 2014, PROTIST, V165, P839, DOI 10.1016/j.protis.2014.09.003; Fraga S, 2011, HARMFUL ALGAE, V11, P10, DOI 10.1016/j.hal.2011.06.013; Gomez F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119676; Guillard R.R.L., 1984, P391; Guillard R.R.L., 1973, HDB PHYCOLOGICAL MET, P289; Hallegraeff GM, 2010, J PHYCOL, V46, P220, DOI 10.1111/j.1529-8817.2010.00815.x; HEIL CA, 1993, DEV MAR BIO, V3, P501; Holmes MJ, 1998, J PHYCOL, V34, P661, DOI 10.1046/j.1529-8817.1998.340661.x; Ishikawa A, 2011, ORAL PRESENTATION NO; Jeong HJ, 2012, J EUKARYOT MICROBIOL, V59, P637, DOI 10.1111/j.1550-7408.2012.00645.x; Kibler SR, 2015, ECOL MODEL, V316, P194, DOI 10.1016/j.ecolmodel.2015.08.020; Kibler SR, 2012, HARMFUL ALGAE, V19, P1, DOI 10.1016/j.hal.2012.04.007; Kleypas JA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032257; Kuno S, 2010, PHYCOL RES, V58, P44, DOI 10.1111/j.1440-1835.2009.00557.x; Lartigue J, 2009, HARMFUL ALGAE, V8, P781, DOI 10.1016/j.hal.2008.05.006; Laurion I, 2009, J PHYCOL, V45, P16, DOI 10.1111/j.1529-8817.2008.00618.x; Lehane L, 2000, INT J FOOD MICROBIOL, V61, P91, DOI 10.1016/S0168-1605(00)00382-2; Litaker RW, 2010, TOXICON, V56, P711, DOI 10.1016/j.toxicon.2010.05.017; Litaker RW, 2009, PHYCOLOGIA, V48, P344, DOI 10.2216/07-15.1; Llewellyn LE, 2010, TOXICON, V56, P691, DOI 10.1016/j.toxicon.2009.08.011; MORTON SL, 1992, J EXP MAR BIOL ECOL, V157, P79, DOI 10.1016/0022-0981(92)90076-M; Morton SL, 2010, GEOHAB OP SCI M HABS, P5; Nakahara Hiroyhuki, 1996, Phycological Research, V44, P113, DOI 10.1111/j.1440-1835.1996.tb00385.x; Nishimura T, 2014, J PHYCOL, V50, P506, DOI 10.1111/jpy.12175; Nishimura T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060882; Parsons ML, 2012, HARMFUL ALGAE, V14, P107, DOI 10.1016/j.hal.2011.10.017; Parsons ML, 2010, HARMFUL ALGAE, V10, P71, DOI 10.1016/j.hal.2010.07.002; RICHARDSON K, 1983, NEW PHYTOL, V93, P157, DOI 10.1111/j.1469-8137.1983.tb03422.x; Richlen ML, 2011, MAR ECOL PROG SER, V421, P51, DOI 10.3354/meps08854; Rodriguez F, 2010, GEOHAB OP SCI M HABS, P17; Saburova Maria, 2013, Marine Biodiversity Records, V6, pe91, DOI 10.1017/S1755267213000675; Stocker T. F., 2013, CLIMATE CHANGE 2013; Tester PA, 2013, HARMFUL ALGAE, V29, P1, DOI 10.1016/j.hal.2013.07.001; Tester PA, 2010, TOXICON, V56, P698, DOI 10.1016/j.toxicon.2010.02.026; Thomas MK, 2012, SCIENCE, V338, P1085, DOI 10.1126/science.1224836; Tindall Donald R., 1998, NATO ASI Series Series G Ecological Sciences, V41, P293; Vega-Cendejas ME, 2004, ESTUAR COAST SHELF S, V60, P285, DOI 10.1016/j.ecss.2004.01.005; WATRAS CJ, 1982, J EXP MAR BIOL ECOL, V62, P25, DOI 10.1016/0022-0981(82)90214-3; Withers N.W., 1981, P 4 INT COR REEF S P, P449; Xu YX, 2014, HARMFUL ALGAE, V34, P56, DOI 10.1016/j.hal.2014.02.007; Yanez-Arancibia A, 2004, OCEAN COAST MANAGE, V47, P727, DOI 10.1016/j.ocecoaman.2004.12.010; YASUMOTO T, 1980, B JPN SOC SCI FISH, V46, P1397; Yoshimatsu T, 2014, HARMFUL ALGAE, V35, P29, DOI 10.1016/j.hal.2014.03.007	59	89	90	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153197	10.1371/journal.pone.0153197	http://dx.doi.org/10.1371/journal.pone.0153197			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074134	Green Submitted, Green Published, gold			2022-12-26	WOS:000374131200059
J	Bagavathiannan, MV; Norsworthy, JK				Bagavathiannan, Muthukumar V.; Norsworthy, Jason K.			Multiple-Herbicide Resistance Is Widespread in Roadside Palmer Amaranth Populations	PLOS ONE			English	Article							GLYPHOSATE; CONFIRMATION; CORRIDORS; HABITATS; ARKANSAS; GEORGIA	Herbicide-resistant Palmer amaranth is a widespread issue in row-crop production in the Midsouthern US. Palmer amaranth is commonly found on roadside habitats in this region, but little is known on the degree of herbicide resistance in these populations. Herbicide resistance in roadside Palmer amaranth populations can represent the spread of an adaptive trait across a selective landscape. A large-scale survey was carried out in the Mississippi Delta region of eastern Arkansas to document the level of resistance in roadside Palmer amaranth populations to pyrithiobac and glyphosate, two important herbicides with broad history of use in the region. A total of 215 Palmer amaranth populations collected across 500 random survey sites were used in the evaluations. About 89 and 73% of the surveyed populations showed >90% survival to pyrithiobac and glyphosate, respectively. Further, only 3% of the populations were completely susceptible to glyphosate, while none of the populations was completely controlled by pyrithiobac. Among the 215 populations evaluated, 209 populations showed multiple resistance to both pyrithiobac and glyphosate at varying degrees. Dose-response assays confirmed the presence of high levels of herbicide resistance in the five selected populations (>= 25-fold compared to a susceptible standard). Results demonstrate the prevalence of multiple-herbicide resistance in roadside Palmer amaranth populations in this region. Growers should be vigilant of Palmer amaranth infestation in roadsides adjacent to their fields and implement appropriate control measures to prevent likely spread of herbicide resistance into their fields.	[Bagavathiannan, Muthukumar V.] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA; [Norsworthy, Jason K.] Univ Arkansas, Dept Crop Soil & Environm Sci, Fayetteville, AR 72701 USA	Texas A&M University System; Texas A&M University College Station; University of Arkansas System; University of Arkansas Fayetteville	Bagavathiannan, MV (corresponding author), Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA.	muthu@tamu.edu	Norsworthy, Jason/GXZ-5733-2022	Norsworthy, Jason/0000-0002-7379-6201	Cotton Incorporated; Arkansas Soybean Promotion Board	Cotton Incorporated(Cotton R&D Corp); Arkansas Soybean Promotion Board	Funding was provided by Cotton Incorporated and Arkansas Soybean Promotion Board. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional funding sources for this study.; Funding for this research was provided by Cotton Incorporated and Arkansas Soybean Promotion Board. No additional funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansong M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080275; Bagavathiannan MV, SPREAD HERBICIDE RES; Burgos NR, 2001, PEST MANAG SCI, V57, P449, DOI 10.1002/ps.308; Culpepper AS, 2006, WEED SCI, V54, P620, DOI 10.1614/WS-06-001R.1; Gelbard JL, 2003, CONSERV BIOL, V17, P420, DOI 10.1046/j.1523-1739.2003.01408.x; Heap I, INT SURVEY HERBICIDE; HORAK MJ, 1995, WEED TECHNOL, V9, P192, DOI 10.1017/S0890037X00023174; Jhala AJ, 2014, WEED TECHNOL, V28, P28, DOI 10.1614/WT-D-13-00090.1; Jodoin Y, 2008, J APPL ECOL, V45, P459, DOI 10.1111/j.1365-2664.2007.01362.x; Korres NE, 2015, WEED TECHNOL, V29, P587, DOI 10.1614/WT-D-14-00130.1; Meunier G, 2012, INVAS PLANT SCI MANA, V5, P92, DOI 10.1614/IPSM-D-11-00049.1; Norsworthy JK, 2008, WEED TECHNOL, V22, P108, DOI 10.1614/WT-07-128.1; Riar DS, 2013, WEED TECHNOL, V27, P612, DOI 10.1614/WT-D-12-00167.1; Rios SI, 2014, P BELTW COTT C NEW O; SAUER J, 1957, EVOLUTION, V11, P11, DOI 10.2307/2405808; Sosnoskie LM, WEED SCI, V60, P366; Sosnoskie LM, 2011, WEED SCI, V59, P321, DOI 10.1614/WS-D-10-00132.1; Sprague C, GLYPHOSATE RESISTANT; Ward SM, 2013, WEED TECHNOL, V27, P12, DOI 10.1614/WT-D-12-00113.1; Webster TM, 2012, WEED SCI, V60, P145, DOI 10.1614/WS-D-11-00092.1	20	24	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0148748	10.1371/journal.pone.0148748	http://dx.doi.org/10.1371/journal.pone.0148748			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27071064	Green Published, Green Submitted, gold			2022-12-26	WOS:000373900700002
J	Dimov, LF; Franciosi, AC; Campos, ACP; Brunoni, AR; Pagano, RL				Dimov, Luiz Fabio; Franciosi, Adriano Cardozo; Pinheiro Campos, Ana Carolina; Brunoni, Andre Russowsky; Pagano, Rosana Lima			Top-Down Effect of Direct Current Stimulation on the Nociceptive Response of Rats	PLOS ONE			English	Article							MOTOR CORTEX STIMULATION; C-FOS EXPRESSION; MIDBRAIN PERIAQUEDUCTAL GRAY; TRANSCRANIAL DC-STIMULATION; CENTRAL-NERVOUS-SYSTEM; IMMEDIATE-EARLY GENES; SPINAL-CORD-INJURY; DORSAL-HORN; NEUROPATHIC PAIN; HIGH-DEFINITION	Transcranial direct current stimulation (tDCS) is an emerging, noninvasive technique of neurostimulation for treating pain. However, the mechanisms and pathways involved in its analgesic effects are poorly understood. Therefore, we investigated the effects of direct current stimulation (DCS) on thermal and mechanical nociceptive thresholds and on the activation of the midbrain periaqueductal gray (PAG) and the dorsal horn of the spinal cord (DHSC) in rats; these central nervous system areas are associated with pain processing. Male Wistar rats underwent cathodal DCS of the motor cortex and, while still under stimulation, were evaluated using tail-flick and paw pressure nociceptive tests. Sham stimulation and naive rats were used as controls. We used a randomized design; the assays were not blinded to the experimenter. Immunoreactivity of the early growth response gene 1 (Egr-1), which is a marker of neuronal activation, was evaluated in the PAG and DHSC, and enkephalin immunoreactivity was evaluated in the DHSC. DCS did not change the thermal nociceptive threshold; however, it increased the mechanical nociceptive threshold of both hind paws compared with that of controls, characterizing a topographical effect. DCS decreased the Egr-1 labeling in the PAG and DHSC as well as the immunoreactivity of spinal enkephalin. Altogether, the data suggest that DCS disinhibits the midbrain descending analgesic pathway, consequently inhibiting spinal nociceptive neurons and causing an increase in the nociceptive threshold. This study reinforces the idea that the motor cortex participates in the neurocircuitry that is involved in analgesia and further clarifies the mechanisms of action of tDCS in pain treatment.	[Dimov, Luiz Fabio; Franciosi, Adriano Cardozo; Pinheiro Campos, Ana Carolina; Pagano, Rosana Lima] Hosp Sirio Libanes, Lab Neuromodulat & Expt Pain, Rua Prof Daher Cutait 69, BR-01308060 Sao Paulo, SP, Brazil; [Brunoni, Andre Russowsky] Univ Sao Paulo, Fac Med, SIN, Dept & Inst Psychiat,Lab Neurosci LIM27, Rua Doutor Ovidio Pires Campos 785, BR-05403000 Sao Paulo, SP, Brazil; [Brunoni, Andre Russowsky] Univ Sao Paulo, Ctr Clin & Epidemiol Res, Univ Hosp, Ave Prof Lineu Prestes 2565,Ext 3, BR-05508000 Sao Paulo, SP, Brazil; [Brunoni, Andre Russowsky] Univ Sao Paulo, Interdisciplinary Ctr Appl Neuromodulat CINA, Univ Hosp, Ave Prof Lineu Prestes 2565,Ext 3, BR-05508000 Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Pagano, RL (corresponding author), Hosp Sirio Libanes, Lab Neuromodulat & Expt Pain, Rua Prof Daher Cutait 69, BR-01308060 Sao Paulo, SP, Brazil.	rosana.lpagano@hsl.org.br	Franciosi, Adriano C/R-3102-2016; Campos, Ana Carolina Pinheiro/AAD-7760-2019; , Ap/AAB-2985-2019; Dimov, Luiz Fabio/AAS-2616-2020; Pagano, Rosana Lima/I-1088-2013; Brunoni, Andre R./H-8394-2012	Franciosi, Adriano C/0000-0001-7172-539X; Campos, Ana Carolina Pinheiro/0000-0003-2901-5823; , Ap/0000-0002-5351-6575; Brunoni, Andre R./0000-0002-6310-3571; Dimov, Luiz Fabio/0000-0002-7264-3000	Hospital Sirio Libanes; Sao Paulo State Foundation (FAPESP); FAPESP [11/21631-3, 09/50772-4, 12/20911-5]; NARSAD Young Investigator from the Brain & Behavior Research Foundation [20493]; Brazilian National Council for Scientific and Technological Development (CNPq) [303197, 470904]	Hospital Sirio Libanes; Sao Paulo State Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NARSAD Young Investigator from the Brain & Behavior Research Foundation(NARSAD); Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was supported by the Hospital Sirio Libanes and Sao Paulo State Foundation (FAPESP). LFD, RLP and ARB were funded by FAPESP (11/21631-3, 09/50772-4 and 12/20911-5, respectively). ARB is supported by NARSAD Young Investigator from the Brain & Behavior Research Foundation (Grant Number 20493) and Brazilian National Council for Scientific and Technological Development (CNPq, Grant Numbers 303197 and 470904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann CG, 2010, CLIN NEUROPHYSIOL, V121, P2083, DOI 10.1016/j.clinph.2010.05.005; BANDLER R, 1994, TRENDS NEUROSCI, V17, P379, DOI 10.1016/0166-2236(94)90047-7; BASBAUM AI, 1984, ANNU REV NEUROSCI, V7, P309, DOI 10.1146/annurev.ne.07.030184.001521; BASBAUM AI, 1991, NEW ENGL J MED, V325, P1168, DOI 10.1056/NEJM199110173251610; BASBAUM AI, 1978, ANN NEUROL, V4, P451, DOI 10.1002/ana.410040511; Beaudry H, 2011, J NEUROSCI, V31, P13068, DOI 10.1523/JNEUROSCI.1817-11.2011; Beckmann AM, 1997, NEUROCHEM INT, V31, P477, DOI 10.1016/S0197-0186(96)00136-2; BEHBEHANI MM, 1995, PROG NEUROBIOL, V46, P575, DOI 10.1016/0301-0082(95)00009-K; Benarroch EE, 2012, NEUROLOGY, V78, P210, DOI 10.1212/WNL.0b013e31823fcdee; BENNETT GJ, 1982, BRAIN RES, V240, P162, DOI 10.1016/0006-8993(82)90656-4; Benninger DH, 2010, J NEUROL NEUROSUR PS, V81, P1105, DOI 10.1136/jnnp.2009.202556; Boggio PS, 2008, EUR J NEUROL, V15, P1124, DOI 10.1111/j.1468-1331.2008.02270.x; Bolognini N, 2015, J PAIN, V16, P657, DOI 10.1016/j.jpain.2015.03.013; Bowman BR, 2015, AUTON NEUROSCI-BASIC, V193, P84, DOI 10.1016/j.autneu.2015.08.006; Brunoni AR, 2014, EXPERT REV MED DEVIC, V11, P383, DOI 10.1586/17434440.2014.911082; Brunoni AR, 2011, REV NEUROSCIENCE, V22, P471, DOI 10.1515/RNS.2011.042; BURITOVA J, 1995, BRAIN RES, V674, P211, DOI 10.1016/0006-8993(95)00009-F; Buritova J, 2003, EUR J PAIN, V7, P241, DOI 10.1016/S1090-3801(02)00122-2; CANAVERO S, 1995, J NEUROSURG, V83, P1117; Castillo-Saavedra L, 2016, J PAIN, V17, P14, DOI 10.1016/j.jpain.2015.09.009; Chapman V, 1996, J NEUROPHYSIOL, V76, P1817, DOI 10.1152/jn.1996.76.3.1817; Chen WL, 2008, NEUROPHARMACOLOGY, V54, P944, DOI 10.1016/j.neuropharm.2008.02.002; Cioato SG, 2015, BRAIN STIMUL; D'amour FE, 1941, J PHARMACOL EXP THER, V72, P74; DaSilva AF, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00089; DaSilva AF, 2012, HEADACHE, V52, P1283, DOI 10.1111/j.1526-4610.2012.02141.x; de Andrade DC, 2011, PAIN, V152, P320, DOI 10.1016/j.pain.2010.10.032; Di Lazzaro V, 2008, BRAIN STIMUL, V1, P345, DOI 10.1016/j.brs.2008.07.004; DICKENSON AH, 1983, EXP BRAIN RES, V49, P174, DOI 10.1007/BF00238577; DosSantos MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102350; DosSantos Marcos Fabio, 2012, Front Psychiatry, V3, P93, DOI 10.3389/fpsyt.2012.00093; Fagerlund AJ, 2015, PAIN, V156, P62, DOI 10.1016/j.pain.0000000000000006; Ferrucci R, 2014, NEUROREHABILITATION, V34, P121, DOI 10.3233/NRE-131019; Foerster BR, 2015, ARTHRITIS RHEUMATOL, V67, P576, DOI 10.1002/art.38945; Fonoff ET, 2009, BEHAV BRAIN RES, V202, P138, DOI 10.1016/j.bbr.2009.03.018; Fonoff ET, 2009, BEHAV BRAIN RES, V196, P63, DOI 10.1016/j.bbr.2008.07.027; Franca NRM, 2013, BEHAV BRAIN RES, V250, P211, DOI 10.1016/j.bbr.2013.05.019; Fregni F, 2006, ARTHRITIS RHEUM-US, V54, P3988, DOI 10.1002/art.22195; Fregni F, 2007, LANCET NEUROL, V6, P188, DOI 10.1016/S1474-4422(07)70032-7; Fregni F, 2006, PAIN, V122, P197, DOI 10.1016/j.pain.2006.02.023; George A, 2000, PAIN, V88, P267, DOI 10.1016/S0304-3959(00)00333-X; Giuliani A, 2004, INT J TISSUE REACT, V26, P29; GOGAS KR, 1991, NEUROSCIENCE, V42, P617, DOI 10.1016/0306-4522(91)90031-I; Harris JA, 1998, BRAIN RES BULL, V45, P1, DOI 10.1016/S0361-9230(97)00277-3; Heinricher MM, 2009, BRAIN RES REV, V60, P214, DOI 10.1016/j.brainresrev.2008.12.009; HERDEGEN T, 1991, J COMP NEUROL, V313, P178, DOI 10.1002/cne.903130113; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; HERDEGEN T, 1990, NEUROSCI LETT, V120, P21, DOI 10.1016/0304-3940(90)90158-6; Herrera DG, 1996, PROG NEUROBIOL, V50, P83, DOI 10.1016/S0301-0082(96)00021-4; Hiscock JJ, 2001, J NEUROSCI RES, V66, P1094, DOI 10.1002/jnr.1252.abs; HOKFELT T, 1977, NEUROSCI LETT, V5, P25, DOI 10.1016/0304-3940(77)90160-4; HOKFELT T, 1979, NEUROSCI LETT, V14, P55, DOI 10.1016/0304-3940(79)95343-6; Holsheimer J, 2007, ACTA NEUROCHIR SUPPL, V97, P57; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Keay KA, 2002, EXP PHYSIOL, V87, P275, DOI 10.1113/eph8702355; Kuo MF, 2007, J NEUROSCI, V27, P14442, DOI 10.1523/JNEUROSCI.4104-07.2007; Lang N, 2005, EUR J NEUROSCI, V22, P495, DOI 10.1111/j.1460-9568.2005.04233.x; LANTERIMINET M, 1993, NEUROSCIENCE, V55, P737, DOI 10.1016/0306-4522(93)90439-M; Laste G, 2012, EXP BRAIN RES, V221, P75, DOI 10.1007/s00221-012-3149-x; LEBARS D, 1979, PAIN, V6, P283, DOI 10.1016/0304-3959(79)90049-6; Liebetanz D, 2002, BRAIN, V125, P2238, DOI 10.1093/brain/awf238; Liebetanz D, 2006, EPILEPSIA, V47, P1216, DOI 10.1111/j.1528-1167.2006.00539.x; Lima MC, 2008, NEUROLOGY, V2329, P37; Liu RJ, 1999, BRAIN RES, V830, P183, DOI 10.1016/S0006-8993(99)01293-7; Ma JY, 2001, LIFE SCI, V69, P969, DOI 10.1016/S0024-3205(01)01191-2; Maarrawi J, 2007, PAIN, V127, P183, DOI 10.1016/j.pain.2006.10.013; Maarrawi J, 2013, PAIN, V154, P2563, DOI 10.1016/j.pain.2013.07.042; Marques PR, 2016, PROG NEURO-PSYCHOPH, V64, P44, DOI 10.1016/j.pnpbp.2015.06.016; Mehta S, 2015, SPINAL CORD, V53, P780, DOI 10.1038/sc.2015.118; Mielke D, 2013, NEUROL RES, V35, P1029, DOI 10.1179/1743132813Y.0000000248; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; MOLANDER C, 1984, J COMP NEUROL, V230, P133, DOI 10.1002/cne.902300112; MORGAN JI, 1989, TRENDS NEUROSCI, V12, P459, DOI 10.1016/0166-2236(89)90096-9; Nekhendzy V, 2004, ANESTH ANALG, V98, P730, DOI 10.1213/01.ANE.0000096007.12845.70; Nguyen JP, 1999, PAIN, V82, P245, DOI 10.1016/S0304-3959(99)00062-7; Nitsche MA, 2004, CEREB CORTEX, V14, P1240, DOI 10.1093/cercor/bhh085; Nitsche MA, 2004, NEUROPSYCHOPHARMACOL, V29, P1573, DOI 10.1038/sj.npp.1300517; Nitsche MA, 2004, EUR J NEUROSCI, V19, P2720, DOI 10.1111/j.0953-816X.2004.03398.x; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2003, J PHYSIOL-LONDON, V553, P293, DOI 10.1113/jphysiol.2003.049916; Nitsche MA, 2005, J PHYSIOL-LONDON, V568, P291, DOI 10.1113/jphysiol.2005.092429; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Pagano RL, 2012, PAIN, V153, P2359, DOI 10.1016/j.pain.2012.08.002; Pagano RL, 2011, EUR J PAIN, V15, DOI 10.1016/j.ejpain.2010.08.003; Paxinos G., RAT BRAIN STEREOTAXI, VSeventh; POHL M, 1994, J NEUROCHEM, V63, P1226; RANDALL LO, 1957, ARCH INT PHARMACOD T, V111, P409; RAYNOR K, 1994, MOL PHARMACOL, V45, P330; Reidler JS, 2012, J PAIN, V13, P450, DOI 10.1016/j.jpain.2012.01.005; RUDA MA, 1982, SCIENCE, V215, P1523, DOI 10.1126/science.6121374; RUDA MA, 1986, PROG BRAIN RES, V66, P219, DOI 10.1016/S0079-6123(08)64606-3; SENBA E, 1982, J COMP NEUROL, V208, P54, DOI 10.1002/cne.902080105; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; Shiozawa P, 2014, INT J NEUROPSYCHOPH, V17, P1539, DOI 10.1017/S1461145714000807; Sohn MK, 2013, ANN REHABIL MED-ARM, V37, P759, DOI 10.5535/arm.2013.37.6.759; Song BB, 2007, BRAIN RES, V1158, P57, DOI 10.1016/j.brainres.2007.05.006; Soyguder Z, 2005, BRAIN RES, V1033, P202, DOI 10.1016/j.brainres.2004.11.044; Adachi LNS, 2015, EXP BRAIN RES, V233, P1377, DOI 10.1007/s00221-015-4212-1; Adachi LNS, 2012, BRAIN RES, V1489, P17, DOI 10.1016/j.brainres.2012.10.009; Szakacs R, 2003, BRAIN RES BULL, V59, P485, DOI 10.1016/S0361-9230(02)00965-6; Tao YX, 1997, NEUROSCI LETT, V221, P105, DOI 10.1016/S0304-3940(96)13300-0; Terney D, 2008, J PAIN SYMPTOM MANAG, V36, P79, DOI 10.1016/j.jpainsymman.2007.08.014; Vaseghi B, 2015, EUR J NEUROSCI, V42, P2426, DOI 10.1111/ejn.13043; Vaseghi B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123873; Villamar MF, 2013, J PAIN, V14, P371, DOI 10.1016/j.jpain.2012.12.007; Wachter D, 2011, EXP NEUROL, V227, P322, DOI 10.1016/j.expneurol.2010.12.005; Wassermann EM, 2005, TRENDS COGN SCI, V9, P503, DOI 10.1016/j.tics.2005.09.001; Zaghi Soroush, 2009, J Pain Manag, V2, P339; Zhang Y, 2015, J CLIN INVEST, V125, P3782, DOI 10.1172/JCI81156; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	111	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153506	10.1371/journal.pone.0153506	http://dx.doi.org/10.1371/journal.pone.0153506			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27071073	gold, Green Published, Green Submitted			2022-12-26	WOS:000373900700074
J	Ledoux, S; Guthrie, C				Ledoux, Sarah; Guthrie, Christine			Retinitis Pigmentosa Mutations in Bad Response to Refrigeration 2 (Brr2) Impair ATPase and Helicase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							U4/U6.U5 TRI-SNRNP; STRUCTURAL BASIS; DNA-BINDING; SPLICEOSOME; DOMAIN; PROTEIN; PRP8; ARCHITECTURE; HYDROLYSIS; ACTIVATION	Brr2 is an RNA-dependent ATPase required to unwind the U4/U6 snRNA duplex during spliceosome assembly. Mutations within the ratchet helix of the Brr2 RNA binding channel result in a form of degenerative human blindness known as retinitis pigmentosa (RP). The biochemical consequences of these mutations on Brr2's RNA binding, helicase, and ATPase activity have not yet been characterized. Therefore, we identified the largest construct of Brr2 that is soluble in vitro, which truncates the first 247 amino acids of the N terminus (Delta 247-Brr2), to characterize the effects of the RP mutations on Brr2 activity. The Delta 247-Brr2 RP mutants exhibit a gradient of severity of weakened RNA binding, reduced helicase activity, and reduced ATPase activity compared with wild type Delta 247-Brr2. The globular C-terminal Jab1/Mpn1-like domain of Prp8 increases the ability of Delta 247-Brr2 to bind the U4/U6 snRNA duplex at high pH and increases Delta 247-Brr2's RNA-dependent ATPase activity and the extent of RNA unwinding. However, this domain of Prp8 does not differentially affect the Delta 247-Brr2 RP mutants compared with the wild type Delta 247-Brr2. When stimulated by Prp8, wild type Delta 247-Brr2 is able to unwind long stable duplexes in vitro, and even the RP mutants capable of binding RNA with tight affinity are incapable of fully unwinding short duplex RNAs. Our data suggest that the RP mutations within the ratchet helix impair Brr2 translocation through RNA helices.	[Ledoux, Sarah; Guthrie, Christine] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Guthrie, C (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	christineguthrie@gmail.com			National Institutes of Health [GM021119-39]; American Cancer Society [118703-PF-10-061-01-RMC]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM021119, R01GM021119] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM021119-39 ( to C. G.) and American Cancer Society Postdoctoral Fellowship 118703-PF-10-061-01-RMC ( to S. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Absmeier E, 2015, GENE DEV, V29, P2576, DOI 10.1101/gad.271528.115; Absmeier E, 2015, ACTA CRYSTALLOGR D, V71, P762, DOI 10.1107/S1399004715001005; Agafonov DE, 2016, SCIENCE, V351, P1416, DOI 10.1126/science.aad2085; Bellare P, 2008, NAT STRUCT MOL BIOL, V15, P444, DOI 10.1038/nsmb.1401; Benaglio P, 2011, HUM MUTAT, V32, pE2246, DOI 10.1002/humu.21485; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Grainger RJ, 2005, RNA, V11, P533, DOI 10.1261/rna.2220705; Hahn D, 2012, GENE DEV, V26, P2408, DOI 10.1101/gad.199307.112; Johnson SJ, 2013, RNA BIOL, V10, P33, DOI 10.4161/rna.22101; Kim DH, 1999, RNA, V5, P959, DOI 10.1017/S135583829999012X; Korneta I, 2012, NUCLEIC ACIDS RES, V40, P7046, DOI 10.1093/nar/gks347; Li ND, 2010, INVEST OPHTH VIS SCI, V51, P1036, DOI 10.1167/iovs.09-3725; Maeder C, 2009, NAT STRUCT MOL BIOL, V16, P42, DOI 10.1038/nsmb.1535; Mozaffari-Jovin S, 2014, RNA BIOL, V11, P298, DOI 10.4161/rna.28353; Mozaffari-Jovin S, 2013, SCIENCE, V341, P80, DOI 10.1126/science.1237515; Mozaffari-Jovin S, 2012, GENE DEV, V26, P2422, DOI 10.1101/gad.200949.112; Pena V, 2007, MOL CELL, V25, P615, DOI 10.1016/j.molcel.2007.01.023; Raghunathan PL, 1998, CURR BIOL, V8, P847, DOI 10.1016/S0960-9822(07)00345-4; Richards JD, 2008, J BIOL CHEM, V283, P5118, DOI 10.1074/jbc.M707548200; Santos KF, 2012, P NATL ACAD SCI USA, V109, P17418, DOI 10.1073/pnas.1208098109; Small EC, 2006, MOL CELL, V23, P389, DOI 10.1016/j.molcel.2006.05.043; Taylor LL, 2014, NUCLEIC ACIDS RES, V42, P13861, DOI 10.1093/nar/gku1208; Nguyen THD, 2016, NATURE, V530, P298, DOI 10.1038/nature16940; Nguyen THD, 2015, NATURE, V523, P47, DOI 10.1038/nature14548; Nguyen THD, 2013, STRUCTURE, V21, P910, DOI 10.1016/j.str.2013.04.017; Ventura GT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115941; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wan RX, 2016, SCIENCE, V351, P466, DOI 10.1126/science.aad6466; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Woodman IL, 2007, J MOL BIOL, V374, P1139, DOI 10.1016/j.jmb.2007.10.004; Yan CY, 2015, SCIENCE, V349, P1182, DOI 10.1126/science.aac7629; Zhang LD, 2015, NUCLEIC ACIDS RES, V43, P3286, DOI 10.1093/nar/gkv062; Zhang LD, 2009, NAT STRUCT MOL BIOL, V16, P731, DOI 10.1038/nsmb.1625; Zhao C, 2006, HUM GENET, V119, P617, DOI 10.1007/s00439-006-0168-3; Zhao C, 2009, AM J HUM GENET, V85, P617, DOI 10.1016/j.ajhg.2009.09.020	36	9	10	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					11954	11965		10.1074/jbc.M115.710848	http://dx.doi.org/10.1074/jbc.M115.710848			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27072132	Green Published, hybrid			2022-12-26	WOS:000378092800001
J	Darbyshire, JL; Greig, PR; Vollam, S; Young, JD; Hinton, L				Darbyshire, Julie L.; Greig, Paul R.; Vollam, Sarah; Young, J. Duncan; Hinton, Lisa			"I Can Remember Sort of Vivid People ... but to Me They Were Plasticine." Delusions on the Intensive Care Unit: What Do Patients Think Is Going On?	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; POSTTRAUMATIC-STRESS-DISORDER; MECHANICALLY VENTILATED PATIENTS; RANDOMIZED CONTROLLED-TRIAL; CONFUSION ASSESSMENT METHOD; TERM COGNITIVE IMPAIRMENT; CRITICAL ILLNESS; QUALITATIVE DATA; FOLLOW-UP; DELIRIUM ASSESSMENT	Introduction Patients who develop intensive care unit (ICU) acquired delirium stay longer in the ICU, and hospital, and are at risk of long-term mental and physical health problems. Despite guidelines for patient assessment, risk limitation, and treatment in the ICU population, delirium and associated delusions remain a relatively common occurrence on the ICU. There is considerable information in the literature describing the incidence, suspected causes of, and discussion of the benefits and side-effects of the various treatments for delirium in the ICU. But peer-reviewed patient-focused research is almost non-existent. There is therefore a very limited understanding of the reality of delusions in the intensive care unit from the patient's point of view. Method A secondary analysis of the original interviews conducted by the University of Oxford Health Experiences Research Group was undertaken to explore themes relating specifically to sleep and delirium. Results Patients describe a liminal existence on the ICU. On the threshold of consciousness their reality is uncertain and their sense of self is exposed. Lack of autonomy in an unfamiliar environment prompts patients to develop explanations and understandings for themselves with no foothold in fact. Conclusion Patients on the ICU are perhaps more disoriented than they appear and early psychological intervention in the form of repeated orientation whilst in the ICU might improve the patient experience and defend against development of side-effects.	[Darbyshire, Julie L.; Greig, Paul R.; Vollam, Sarah; Young, J. Duncan] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England; [Young, J. Duncan] Oxford Univ Hosp Natl Hlth Serv Fdn Trust, Oxford, England; [Hinton, Lisa] Univ Oxford, Dept Primary Care, Oxford, England	University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford	Darbyshire, JL (corresponding author), Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England.	Julie.Darbyshire@ndcn.ox.ac.uk	Young, John D/M-9756-2016; Darbyshire, Julie/O-7932-2019; Hinton, Lisa/AAA-2266-2019	Darbyshire, Julie/0000-0002-7655-1963; Greig, Paul Robert/0000-0003-3161-5641; Vollam, Sarah/0000-0003-2835-6271; Hinton, Lisa/0000-0002-6082-3151; Young, John Duncan/0000-0002-6838-4835	ICNARC	ICNARC	We are grateful to the Health Experiences Research Group, Department of Primary Care Health Sciences, University of Oxford for permission to conduct a secondary analysis of interviews collected for their study of experiences of intensive care, which was funded by ICNARC. Summarised findings from the original study are available on the www.healthtalk.org website run by the DIPEx Charity.	Aaronovitch D., 2001, TIMES MAGAZINE  1112; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; [Anonymous], 2011, ANN INDIAN ACAD SS1, V14, P16; Azoulay E, 2005, AM J RESP CRIT CARE, V171, P987, DOI 10.1164/rccm.200409-1295OC; Backman CG, 2001, INTENS CARE MED, V27, P426, DOI 10.1007/s001340000692; Ballenger JC, 2000, J CLIN PSYCHIAT, V61, P60; Borowski M, 2011, COMPUT MATH METHOD M, V2011, DOI 10.1155/2011/143480; Borowski M, 2011, BIOMED TECH, V56, P73, DOI 10.1515/BMT.2011.005; Boscarino JA, 2008, PSYCHOSOM MED, V70, P668, DOI 10.1097/PSY.0b013e31817bccaf; BRADY KT, 1991, J CLIN PSYCHIAT, V52, P509; Broomhead LR, 2002, CRIT CARE, V6, P411, DOI 10.1186/cc1532; Corbett A, 2014, DONT USE ANTIPSYCHOT; Coyne IT, 1997, J ADV NURS, V26, P623, DOI 10.1046/j.1365-2648.1997.t01-25-00999.x; Cuthbertson BH, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3723; Daly J, 2007, J CLIN EPIDEMIOL, V60, P43, DOI 10.1016/j.jclinepi.2006.03.014; de Man FR, 2014, ANAESTHESIA, V69, P598, DOI 10.1111/anae.12640; Dedert EA, 2010, ANN BEHAV MED, V39, P61, DOI 10.1007/s12160-010-9165-9; Devlin JW, 2007, INTENS CARE MED, V33, P929, DOI 10.1007/s00134-007-0603-5; Dubois MJ, 2001, INTENS CARE MED, V27, P1297, DOI 10.1007/s001340101017; Elias N., 2000, CIVILIZING PROCESS; Ely EW, 2001, CRIT CARE MED, V29, P1370, DOI 10.1097/00003246-200107000-00012; Ely EW, 2001, SEMIN RESP CRIT CARE, V22, P115, DOI 10.1055/s-2001-13826; Field K, 2008, CRIT CARE, V12, DOI 10.1186/cc6795; Flacker JM, 1998, AM J GERIAT PSYCHIAT, V6, P31; Flannery AH, 2014, NEW ENGL J MED, V370, P1566, DOI 10.1056/NEJMc1402402; Frank AW, 2004, QUAL HEALTH RES, V14, P430, DOI 10.1177/1049732303261955; Freeman D, 2002, BRIT J CLIN PSYCHOL, V41, P331, DOI 10.1348/014466502760387461; Gamache K, 2012, NEUROPSYCHOPHARMACOL, V37, P2789, DOI 10.1038/npp.2012.145; Gaudreau JD, 2005, MED HYPOTHESES, V64, P471, DOI 10.1016/j.mehy.2004.08.007; Girard TD, 2010, CRIT CARE MED, V38, P1513, DOI 10.1097/CCM.0b013e3181e47be1; Goldstein D. M., 2003, J MED HUMANITIES, V24, P229; Gosden E., 2014, TELEGRAPH; Green J, 2014, QUALITATIVE METHODS; Griffiths JA, 2004, CONTIN ED ANAESTH CR, V4, P202, DOI DOI 10.1093/BJACEACCP/MKH054; Grof S., 1975, REALMS OF THE HUMAN; Heaton, 1998, SECONDARY ANAL QUALI, P22; Hinds PS, 1997, QUAL HEALTH RES, V7, P408, DOI 10.1177/104973239700700306; Hintzen A., 2010, PHARM LSD; Jackson DL, 2009, CRIT CARE, V13, DOI 10.1186/cc8212; Jackson JC, 2010, AM J RESP CRIT CARE, V182, P183, DOI 10.1164/rccm.200903-0442OC; Jakob SM, 2012, JAMA-J AM MED ASSOC, V307, P1151, DOI 10.1001/jama.2012.304; Johansson Lotta, 2012, Open Nurs J, V6, P108, DOI 10.2174/1874434601206010108; Johns A, 2001, BRIT J PSYCHIAT, V178, P116, DOI 10.1192/bjp.178.2.116; Kress JP, 2003, AM J RESP CRIT CARE, V168, P1457, DOI 10.1164/rccm.200303-455OC; Lawton J, 1998, SOCIOL HEALTH ILL, V20, P121, DOI 10.1111/1467-9566.00094; Lawton J, 2003, PARTICIPATING UK PRO, P394; Mac Sweeney R, 2010, QJM-INT J MED, V103, P243, DOI 10.1093/qjmed/hcp194; MANSCHRECK TC, 1988, YALE J BIOL MED, V61, P115; Mason J, 2007, SOCIOL RES ONLINE, V12; MATHEWS A, 1990, BEHAV RES THER, V28, P455, DOI 10.1016/0005-7967(90)90132-3; Mauthner NS, 1998, SOCIOLOGY, V32, P733, DOI 10.1177/0038038598032004006; Milbrandt EB, 2004, CRIT CARE MED, V32, P955, DOI 10.1097/01.CCM.0000119429.16055.92; MILLER NS, 1991, INT J ADDICT, V26, P1077, DOI 10.3109/10826089109058942; Moore N., 2006, METHODOLOGICAL INNOV, V1; National Institute for Health and Care Excellence, 2010, DEL DIAGN PREV MAN G; National Institute for Health and Care Excellence, 2013, POSTTR STRESS DIS PT; Ouimet S, 2007, INTENS CARE MED, V33, P66, DOI 10.1007/s00134-006-0399-8; Page V., 2011, DELIRIUM CRITICAL CA; Pandharipande P, 2006, ANESTHESIOLOGY, V104, P21, DOI 10.1097/00000542-200601000-00005; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Pandharipande PP, 2007, JAMA-J AM MED ASSOC, V298, P2644, DOI 10.1001/jama.298.22.2644; Picchioni MM, 2007, BMJ-BRIT MED J, V335, P91, DOI 10.1136/bmj.39227.616447.BE; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Pratchett T, 2013, JUDGEMENT DAY SCI DI; Prinjha S, 2009, CRIT CARE, V13, DOI 10.1186/cc7769; Rasmussen KG, 2014, ACTA NEUROPSYCHIATR, V26, P230, DOI 10.1017/neu.2013.61; Reynolds GP, 2004, J PSYCHOPHARMACOL, V18, P340, DOI 10.1177/026988110401800303; Riker RR, 2009, JAMA-J AM MED ASSOC, V301, P489, DOI 10.1001/jama.2009.56; Rozmovits L, 2004, QUAL HEALTH RES, V14, P187, DOI 10.1177/1049732303260874; Salluh J, 2015, BMJ-BRIT MED J, V350, DOI [10.1136/bmj.h3129, 10.1136/bmj.h2538]; Salluh JI, 2010, CRIT CARE, V14, DOI 10.1186/cc9333; SATEL SL, 1991, AM J PSYCHIAT, V148, P495; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Seery J, 2008, AM I CRAZY IT IS ICU; Shauna, 1934, ON PAT ICU PSYCH STO; SIEGEL RK, 1982, J PSYCHOACTIVE DRUGS, V14, P271; Strom T, 2011, CRIT CARE, V15, DOI 10.1186/cc10586; Treggiari MM, 2009, CRIT CARE MED, V37, P2527, DOI 10.1097/CCM.0b013e3181a5689f; Trzepacz PT, 1996, PSYCHIAT CLIN N AM, V19, P429, DOI 10.1016/S0193-953X(05)70299-9; TRZEPACZ PT, 1994, PSYCHOSOMATICS, V35, P374, DOI 10.1016/S0033-3182(94)71759-X; Trzepacz PT, 1999, DEMENT GERIATR COGN, V10, P330, DOI 10.1159/000017164; van den Berg H, 2015, REANALYZING QUALITAT, V2005; van Eijk MM, 2011, AM J RESP CRIT CARE, V184, P340, DOI 10.1164/rccm.201101-0065OC; van Eijk MMJ, 2009, CRIT CARE MED, V37, P1881, DOI 10.1097/CCM.0b013e3181a00118; van Gool WA, 2010, LANCET, V375, P773, DOI 10.1016/S0140-6736(09)61158-2; Various, 2015, I SURV ICU PSYCH 200; Vidan MT, 2009, J AM GERIATR SOC, V57, P2029, DOI 10.1111/j.1532-5415.2009.02485.x; Wade D, 2013, MINERVA ANESTESIOL, V79, P944; Williams Teresa A, 2008, Aust Crit Care, V21, P6, DOI 10.1016/j.aucc.2007.11.001; Ziebland S, 2006, MED EDUC, V40, P405, DOI 10.1111/j.1365-2929.2006.02467.x	90	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153775	10.1371/journal.pone.0153775	http://dx.doi.org/10.1371/journal.pone.0153775			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9OU	27096605	Green Published, gold			2022-12-26	WOS:000374543600056
J	Lin, SF; Chen, YC; Chen, RN; Chen, LC; Ho, HO; Tsung, YH; Sheu, MT; Liu, DZ				Lin, Shen-Fu; Chen, Ying-Chen; Chen, Ray-Neng; Chen, Ling-Chun; Ho, Hsiu-O; Tsung, Yu-Han; Sheu, Ming-Thau; Liu, Der-Zen			Improving the Stability of Astaxanthin by Microencapsulation in Calcium Alginate Beads	PLOS ONE			English	Article							HAEMATOCOCCUS-PLUVIALIS; FOOD INGREDIENTS; ENCAPSULATION; EMULSIFICATION; CHITOSAN; MATRIX; GEL	There has been considerable interest in the biological functions of astaxanthin and its potential applications in the nutraceutical, cosmetics, food, and feed industries in recent years. However, the unstable structure of astaxanthin considerably limits its application. Therefore, this study reports the encapsulation of astaxanthin in calcium alginate beads using the extrusion method to improve its stability. This study also evaluates the stability of the encapsulated astaxanthin under different storage conditions. The evaluation of astaxanthin stability under various environmental factors reveals that temperature is the most influential environmental factor in astaxanthin degradation. Stability analysis shows that, regardless of the formulation used, the content of astaxanthin encapsulated in alginate beads remains above 90% of the original amount after 21 days of storage at 25 degrees C. These results suggest that the proposed technique is a promising way to enhance the stability of other sensitive compounds.	[Lin, Shen-Fu; Liu, Der-Zen] Taipei Med Univ, Coll Biomed Engn, Grad Inst Biomed Mat & Tissue Engn, Taipei, Taiwan; [Chen, Ying-Chen; Chen, Ling-Chun; Ho, Hsiu-O; Tsung, Yu-Han; Sheu, Ming-Thau] Taipei Med Univ, Sch Pharm, Coll Pharm, Taipei, Taiwan; [Chen, Ray-Neng] Mackay Med Nursing & Management Coll, Dept Cosmet Sci & Management, Taipei, Taiwan; [Liu, Der-Zen] Hsuan Chuang Univ, Ctr Gen Educ, Hsinchu, Taiwan	Taipei Medical University; Taipei Medical University; Mackay Junior College of Medicine, Nursing & Management; Hsuan Chuang University	Liu, DZ (corresponding author), Taipei Med Univ, Coll Biomed Engn, Grad Inst Biomed Mat & Tissue Engn, Taipei, Taiwan.	tonyliu@tmu.edu.tw						Ausich RL, 1997, PURE APPL CHEM, V69, P2169, DOI 10.1351/pac199769102169; Bhosale P, 2005, APPL MICROBIOL BIOT, V68, P445, DOI 10.1007/s00253-005-0032-8; Desai KGH, 2005, DRY TECHNOL, V23, P1361, DOI 10.1081/DRT-200063478; Gouin S, 2004, TRENDS FOOD SCI TECH, V15, P330, DOI 10.1016/j.tifs.2003.10.005; Higuera-Ciapara I, 2006, CRIT REV FOOD SCI, V46, P185, DOI 10.1080/10408690590957188; Higuera-Ciapara I, 2004, CARBOHYD POLYM, V56, P41, DOI 10.1016/j.carbpol.2003.11.012; Kim S, 2010, J KOREAN SOC APPL BI, V53, P559, DOI 10.3839/jksabc.2010.086; Kittikaiwan P, 2007, CARBOHYD POLYM, V70, P378, DOI 10.1016/j.carbpol.2007.04.021; MARTINSEN A, 1989, BIOTECHNOL BIOENG, V33, P79, DOI 10.1002/bit.260330111; NISHIGAKI I, 1994, J CLIN BIOCHEM NUTR, V16, P161; Nishino H, 2005, ONCOLOGY-BASEL, V69, P38, DOI 10.1159/000086631; Ribeiro HS, 2005, J FOOD SCI, V70, pE117, DOI 10.1111/j.1365-2621.2005.tb07083.x; Santocono M, 2006, J PHOTOCH PHOTOBIO B, V85, P205, DOI 10.1016/j.jphotobiol.2006.07.009; SHAHIDI F, 1991, J AGR FOOD CHEM, V39, P1527, DOI 10.1021/jf00008a032; SHAHIDI F, 1993, CRIT REV FOOD SCI, V33, P501, DOI 10.1080/10408399309527645; Shilpa A, 2003, J MACROMOL SCI-POL R, VC43, P187, DOI 10.1081/MC-120020160; Shu B, 2006, J FOOD ENG, V76, P664, DOI 10.1016/j.jfoodeng.2005.05.062; SUGAWARA S, 1994, PHARMACEUT RES, V11, P272, DOI 10.1023/A:1018963626248; WAN LSC, 1992, J MICROENCAPSUL, V9, P309, DOI 10.3109/02652049209021245; Yuan C, 2008, FOOD CHEM, V109, P264, DOI 10.1016/j.foodchem.2007.07.051; Yuan JP, 2000, FOOD CHEM, V68, P443, DOI 10.1016/S0308-8146(99)00219-8	21	44	45	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153685	10.1371/journal.pone.0153685	http://dx.doi.org/10.1371/journal.pone.0153685			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093175	gold, Green Published, Green Submitted			2022-12-26	WOS:000374541200040
J	Xu, QF; Zhang, XG				Xu, Qifeng; Zhang, Xuegong			The Influence of the Global Gene Expression Shift on Downstream Analyses	PLOS ONE			English	Article							CDNA MICROARRAY EXPERIMENTS; C-MYC; CLASSIFICATION; CANCER; NORMALIZATION; PREDICTION; DISCOVERY; SELECTION; ADENOCARCINOMA; PROFILES	The assumption that total abundance of RNAs in a cell is roughly the same in different cells is underlying most studies based on gene expression analyses. But experiments have shown that changes in the expression of some master regulators such as c-MYC can cause global shift in the expression of almost all genes in some cell types like cancers. Such shift will violate this assumption and can cause wrong or biased conclusions for standard data analysis practices, such as detection of differentially expressed (DE) genes and molecular classification of tumors based on gene expression. Most existing gene expression data were generated without considering this possibility, and are therefore at the risk of having produced unreliable results if such global shift effect exists in the data. To evaluate this risk, we conducted a systematic study on the possible influence of the global gene expression shift effect on differential expression analysis and on molecular classification analysis. We collected data with known global shift effect and also generated data to simulate different situations of the effect based on a wide collection of real gene expression data, and conducted comparative studies on representative existing methods. We observed that some DE analysis methods are more tolerant to the global shift while others are very sensitive to it. Classification accuracy is not sensitive to the shift and actually can benefit from it, but genes selected for the classification can be greatly affected.	[Xu, Qifeng; Zhang, Xuegong] Tsinghua Univ, MOE, Key Lab Bioinformat, Beijing 100084, Peoples R China; [Xu, Qifeng; Zhang, Xuegong] Tsinghua Univ, TNLIST, Dept Automat, Bioinformat Div, Beijing 100084, Peoples R China; [Xu, Qifeng] Air Force Logist Coll, Dept Aircraft Spare Management, Xuzhou, Jiangsu, Peoples R China	Tsinghua University; Tsinghua University	Zhang, XG (corresponding author), Tsinghua Univ, MOE, Key Lab Bioinformat, Beijing 100084, Peoples R China.; Zhang, XG (corresponding author), Tsinghua Univ, TNLIST, Dept Automat, Bioinformat Div, Beijing 100084, Peoples R China.	zhangxg@tsinghua.edu.cn			National Basic Research Program of China [2012CB316504]	National Basic Research Program of China(National Basic Research Program of China)	This work is supported in part by the National Basic Research Program of China (2012CB316504). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Ben-Dor A, 2000, J COMPUT BIOL, V7, P559, DOI 10.1089/106652700750050943; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Butte A, 2002, NAT REV DRUG DISCOV, V1, P951, DOI 10.1038/nrd961; Coate JE, 2015, CHROMOSOMA, V124, P27, DOI 10.1007/s00412-014-0496-3; Cui HF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-641; Cui XQ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-210; Dang CV, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014217; Dudoit S, 2002, STAT SINICA, V12, P111; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Marshall E, 2012, SCIENCE, V338, P593, DOI 10.1126/science.338.6107.593; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Onskog J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-390; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; Quackenbush J, 2006, NEW ENGL J MED, V354, P2463, DOI 10.1056/NEJMra042342; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Sawyers CL, 2008, NATURE, V452, P548, DOI 10.1038/nature06913; Schena M, 1998, TRENDS BIOTECHNOL, V16, P301, DOI 10.1016/S0167-7799(98)01219-0; Schuhmacher M, 1999, CURR BIOL, V9, P1255, DOI 10.1016/S0960-9822(99)80507-7; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Zhang XG, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-197	34	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153903	10.1371/journal.pone.0153903	http://dx.doi.org/10.1371/journal.pone.0153903			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27092944	Green Submitted, gold, Green Published			2022-12-26	WOS:000374541200058
J	Lee, M; San Martin, A; Valdivia, A; Martin-Garrido, A; Griendling, KK				Lee, Minyoung; San Martin, Alejandra; Valdivia, Alejandra; Martin-Garrido, Abel; Griendling, Kathy K.			Redox-Sensitive Regulation of Myocardin-Related Transcription Factor (MRTF-A) Phosphorylation via Palladin in Vascular Smooth Muscle Cell Differentiation Marker Gene Expression	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; NUCLEAR-LOCALIZATION; PROTEIN PALLADIN; ACTIN; NOX4; POLDIP2; FAMILY	Vascular smooth muscle cells (VSMCs) undergo a phenotypic switch from a differentiated to synthetic phenotype in cardiovascular diseases such as atherosclerosis and restenosis. Our previous studies indicate that transforming growth factor-beta (TGF-beta) helps to maintain the differentiated phenotype by regulating expression of pro-differentiation genes such as smooth muscle a-actin (SMA) and Calponin (CNN) through reactive oxygen species (ROS) derived from NADPH oxidase 4 (Nox4) in VSMCs. In this study, we investigated the relationship between Nox4 and myocardin-related transcription factor-A (MRTF-A), a transcription factor known to be important in expression of smooth muscle marker genes. Previous work has shown that MRTF-A interacts with the actin-binding protein, palladin, although how this interaction affects MRTF-A function is unclear, as is the role of phosphorylation in MRTF-A activity. We found that Rho kinase (ROCK)-mediated phosphorylation of MRTF-A is a key event in the regulation of SMA and CNN in VSMCs and that this phosphorylation depends upon Nox4-mediated palladin expression. Knockdown of Nox4 using siRNA decreases TGF-beta-induced palladin expression and MRTF-A phosphorylation, suggesting redox-sensitive regulation of this signaling pathway. Knockdown of palladin also decreases MRTF-A phosphorylation. These data suggest that Nox4-dependent palladin expression and ROCK regulate phosphorylation of MRTF-A, a critical factor in the regulation of SRF responsive gene expression.	[Lee, Minyoung; San Martin, Alejandra; Valdivia, Alejandra; Martin-Garrido, Abel; Griendling, Kathy K.] Emory Univ, Dept Med, Div Cardiol, Atlanta, GA 30322 USA	Emory University	Griendling, KK (corresponding author), Emory Univ, Dept Med, Div Cardiol, Atlanta, GA 30322 USA.	kgriend@emory.edu	San Martin, Alejandra/HDN-0012-2022	Griendling, Kathy/0000-0002-9456-8582; Valdivia, Alejandra/0000-0003-1492-5066	NIH [P01HL095070, R01HL38206, R01HL113167]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL038206, R01HL038206, R01HL113167, P01HL095070] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grants P01HL095070 (KKG and ASM), R01HL38206 (KKG), and R01HL113167 (ASM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boggy GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012355; Boukhelifa M, 2001, MOL BIOL CELL, V12, P2721, DOI 10.1091/mbc.12.9.2721; Brentnall TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030219; Clempus RE, 2007, ARTERIOSCL THROM VAS, V27, P42, DOI 10.1161/01.ATV.0000251500.94478.18; DalleDonne I, 1995, BIOPHYS J, V69, P2710, DOI 10.1016/S0006-3495(95)80142-6; Datla SR, 2014, AM J PHYSIOL-HEART C, V307, pH945, DOI 10.1152/ajpheart.00918.2013; Dixon RDS, 2008, J BIOL CHEM, V283, P6222, DOI 10.1074/jbc.M707694200; Du KL, 2004, J BIOL CHEM, V279, P17578, DOI 10.1074/jbc.M400961200; Goicoechea S, 2006, J CELL SCI, V119, P3316, DOI 10.1242/jcs.03076; Hanna IR, 2004, FREE RADICAL BIO MED, V37, P1542, DOI 10.1016/j.freeradbiomed.2004.08.011; Hautmann MB, 1997, J BIOL CHEM, V272, P10948; Hilenski LL, 2004, ARTERIOSCL THROM VAS, V24, P677, DOI 10.1161/01.ATV.0000112024.13727.2c; Hinson JS, 2007, AM J PHYSIOL-HEART C, V292, pH1170, DOI 10.1152/ajpheart.00864.2006; Jin L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012823; Jin L, 2009, J MUSCLE RES CELL M, V30, P41, DOI 10.1007/s10974-009-9173-1; Jin L, 2009, J BIOL CHEM, V284, P2121, DOI 10.1074/jbc.M806095200; Lassegue B, 2012, CIRC RES, V110, P1364, DOI 10.1161/CIRCRESAHA.111.243972; Lee CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066964; Liu XS, 2007, J CELL BIOCHEM, V100, P1288, DOI 10.1002/jcb.21126; Lyle AN, 2009, CIRC RES, V105, P249, DOI 10.1161/CIRCRESAHA.109.193722; Martin-Garrido A, 2011, FREE RADICAL BIO MED, V50, P354, DOI 10.1016/j.freeradbiomed.2010.11.007; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Muehlich S, 2008, MOL CELL BIOL, V28, P6302, DOI 10.1128/MCB.00427-08; Mykkanen OM, 2001, MOL BIOL CELL, V12, P3060, DOI 10.1091/mbc.12.10.3060; Otey CA, 2005, INT REV CYTOL, V246, P31, DOI 10.1016/S0074-7696(05)46002-7; Otey CA, 2009, CELL MOTIL CYTOSKEL, V66, P618, DOI 10.1002/cm.20385; Parast MM, 2000, J CELL BIOL, V150, P643, DOI 10.1083/jcb.150.3.643; Qian XJ, 2013, ENDOCRINOLOGY, V154, P1907, DOI 10.1210/en.2012-2269; Ritz C, 2008, BIOINFORMATICS, V24, P1549, DOI 10.1093/bioinformatics/btn227; Ronty MJ, 2006, J INVEST DERMATOL, V126, P2387, DOI 10.1038/sj.jid.5700427; Vattepu R, 2015, PROTEIN SCI, V24, P70, DOI 10.1002/pro.2588; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang HV, 2008, DEV DYNAM, V237, P3342, DOI 10.1002/dvdy.21755	34	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153199	10.1371/journal.pone.0153199	http://dx.doi.org/10.1371/journal.pone.0153199			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088725	Green Published, Green Submitted, gold			2022-12-26	WOS:000374527000012
J	Sharma, M; Iyer, JK; Shih, N; Majumder, M; Mattaparthi, VSK; Mukhopadhyay, R; Doley, R				Sharma, Maitreyee; Iyer, Janaki Krishnamurthy; Shih, Norrapat; Majumder, Munmi; Mattaparthi, Venkata Satish Kumar; Mukhopadhyay, Rupak; Doley, Robin			Daboxin P, a Major Phospholipase A2 Enzyme from the Indian Daboia russelii russelii Venom Targets Factor X and Factor Xa for Its Anticoagulant Activity	PLOS ONE			English	Article							AMINO-ACID-SEQUENCE; SNAKE-VENOM; PROTEASE INHIBITOR; CAROTID-ARTERY; BINDING-SITE; I-TASSER; A(2); COAGULATION; COMPLEX; PROTEINS	In the present study a major protein has been purified from the venom of Indian Daboia russelii russelii using gel filtration, ion exchange and Rp-HPLC techniques. The purified protein, named daboxin P accounts for similar to 24% of the total protein of the crude venom and has a molecular mass of 13.597 kDa. It exhibits strong anticoagulant and phospholipase A(2) activity but is devoid of any cytotoxic effect on the tested normal or cancerous cell lines. Its primary structure was deduced by N-terminal sequencing and chemical cleavage using Edman degradation and tandem mass spectrometry. It is composed of 121 amino acids with 14 cysteine residues and catalytically active His48 -Asp49 pair. The secondary structure of daboxin P constitutes 42.73% of alpha-helix and 12.36% of beta-sheet. It is found to be stable at acidic (pH 3.0) and neutral pH (pH 7.0) and has a Tm value of 71.59 +/- 0.46 degrees C. Daboxin P exhibits anticoagulant effect under in-vitro and in-vivo conditions. It does not inhibit the catalytic activity of the serine proteases but inhibits the activation of factor X to factor Xa by the tenase complexes both in the presence and absence of phospholipids. It also inhibits the tenase complexes when active site residue (His48) was alkylated suggesting its non-enzymatic mode of anticoagulant activity. Moreover, it also inhibits prothrombinase complex when pre-incubated with factor Xa prior to factor Va addition. Fluorescence emission spectroscopy and affinity chromatography suggest the probable interaction of daboxin P with factor X and factor Xa. Molecular docking analysis reveals the interaction of the Ca+2 binding loop; helix C; anticoagulant region and C-terminal region of daboxin P with the heavy chain of factor Xa. This is the first report of a phospholipase A(2) enzyme from Indian viper venom which targets both factor X and factor Xa for its anticoagulant activity.	[Sharma, Maitreyee; Majumder, Munmi; Mattaparthi, Venkata Satish Kumar; Mukhopadhyay, Rupak; Doley, Robin] Tezpur Univ, Dept Mol Biol & Biotechnol, Tezpur 784028, Assam, India; [Iyer, Janaki Krishnamurthy; Shih, Norrapat] Natl Univ Singapore, Dept Biol Sci, Fac Sci, Singapore 117548, Singapore	Tezpur University; National University of Singapore	Doley, R (corresponding author), Tezpur Univ, Dept Mol Biol & Biotechnol, Tezpur 784028, Assam, India.	doley@tezu.ernet.in	Kumar, M.Venkata Satish/M-1379-2017; Mukhopadhyay, Rupak/Q-9168-2017	Kumar, M.Venkata Satish/0000-0002-5238-753X; Mukhopadhyay, Rupak/0000-0001-5211-1413; Majumder, Munmi/0000-0002-6545-3217	DBT, Govt. of India [BT/43/NE/TBP/2010]; DST Inspire fellowship; India Research Initiative, NUS	DBT, Govt. of India(Department of Biotechnology (DBT) India); DST Inspire fellowship; India Research Initiative, NUS	This work was supported by a grant to RD by DBT, Govt. of India under the twinning programme to NER region (BT/43/NE/TBP/2010), and also DBT, DST, and UGC for various projects to the department. MS is a recipient of DST Inspire fellowship and thanks India Research Initiative, NUS for the short term financial support to carry out part of this work in Protein Science Laboratory, Department of Biological Sciences, NUS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atanasov VN, 2009, BIOCHEMISTRY-MOSCOW+, V74, P276, DOI 10.1134/S0006297909030055; Atoda H, 1998, BIOCHEMISTRY-US, V37, P17361, DOI 10.1021/bi981177x; Banerjee Y, 2005, J BIOL CHEM, V280, P42601, DOI 10.1074/jbc.M508987200; BOFFA MC, 1976, BIOCHIM BIOPHYS ACTA, V429, P839, DOI 10.1016/0005-2744(76)90330-2; Borensztajn K, 2008, TRENDS MOL MED, V14, P429, DOI 10.1016/j.molmed.2008.08.001; Cheng AC, 2012, J BIOL CHEM, V287, P15739, DOI 10.1074/jbc.M111.323063; Crimmins DL, 2005, CURRENT PROTOCOLS PR, P1; DAVIDSON FF, 1990, J MOL EVOL, V31, P228, DOI 10.1007/BF02109500; Duhovny D, 2002, LECT NOTES COMPUT SC, V2452, P185; Dutta S, 2015, BIOCHIMIE, V110, P93, DOI 10.1016/j.biochi.2014.12.020; Eckly A, 2011, J THROMB HAEMOST, V9, P779, DOI 10.1111/j.1538-7836.2011.04218.x; FAURE G, 1988, BIOCHEMISTRY-US, V27, P730, DOI 10.1021/bi00402a036; FAURE G, 1987, TOXICON, V25, P229, DOI 10.1016/0041-0101(87)90246-7; Faure G, 2011, ACTA CHIM SLOV, V58, P671; Faure G, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-82; FLEER EAM, 1981, EUR J BIOCHEM, V113, P283, DOI 10.1111/j.1432-1033.1981.tb05064.x; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Girish V, 2012, EXACTIN A SPECIFIC I; GOWDA VT, 1994, TOXICON, V32, P665, DOI 10.1016/0041-0101(94)90336-0; GUTIERREZ JM, 1995, TOXICON, V33, P1405, DOI 10.1016/0041-0101(95)00085-Z; HEINRIKSON RL, 1977, J BIOL CHEM, V252, P4913; Joseph JS, 1999, BLOOD, V94, P621, DOI 10.1182/blood.V94.2.621.414k25_621_631; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kini R. M., 1997, VENOM PHOSPHOLIPASE, P1; Kini RM, 2005, TOXICON, V45, P1147, DOI 10.1016/j.toxicon.2005.02.018; Kini RM, 1999, J MOL EVOL, V48, P125, DOI 10.1007/PL00006450; KINI RM, 1987, J BIOL CHEM, V262, P14402; Kini RM, 1995, TOXICON, V33, P1585, DOI 10.1016/0041-0101(95)00103-4; Koh CY, 2007, J BIOL CHEM, V282, P29101, DOI 10.1074/jbc.M705600200; Kruger DM, 2010, NUCLEIC ACIDS RES, V38, pW480, DOI 10.1093/nar/gkq471; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pD266, DOI 10.1093/nar/gki001; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Ledizet Michel, 2005, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V3, P1, DOI 10.2174/1568016052773315; Louis-Jeune C, 2011, PROTEINS STRUCTURE F, V80; Lu QM, 2002, J NAT TOXINS, V11, P25; Maduwage K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003220; Maduwage Kalana, 2011, J Venom Res, V2, P17; Mathus A, 1999, J BIOL CHEM, V274, P18477, DOI 10.1074/jbc.274.26.18477; Milner SJ, 1996, BIOTECHNOL BIOENG, V50, P265, DOI 10.1002/(SICI)1097-0290(19960505)50:3<265::AID-BIT5>3.0.CO;2-E; Mukherjee AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101334; Norledge BV, 2003, PROTEINS, V53, P640, DOI 10.1002/prot.10445; OUYANG C, 1976, BIOCHIM BIOPHYS ACTA, V420, P298, DOI 10.1016/0005-2795(76)90321-4; Prasad BN, 1996, TOXICON, V34, P1173, DOI 10.1016/0041-0101(96)00033-5; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rudolph AE, 2001, J BIOL CHEM, V276, P5123, DOI 10.1074/jbc.M006961200; Saikia D, 2011, TOXICON, V57, P841, DOI 10.1016/j.toxicon.2011.02.018; Sajevic T, 2011, TOXICON, V57, P627, DOI 10.1016/j.toxicon.2011.01.006; Saul FA, 2010, J STRUCT BIOL, V169, P360, DOI 10.1016/j.jsb.2009.10.010; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Sharma M, 2015, TOXICON, V107, P266, DOI 10.1016/j.toxicon.2015.06.027; Sobolev V, 2005, NUCLEIC ACIDS RES, V33, pW39, DOI 10.1093/nar/gki398; STEFANSSON S, 1990, BIOCHEMISTRY-US, V29, P7742, DOI 10.1021/bi00485a024; STEFANSSON S, 1989, THROMB RES, V55, P481, DOI 10.1016/0049-3848(89)90056-X; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thakur R, 2014, BIOCHIMIE, V105, P149, DOI 10.1016/j.biochi.2014.07.006; Tsai IH, 2011, TOXICON, V57, P332, DOI 10.1016/j.toxicon.2010.12.012; VANDELOOSDRECHT AA, 1994, J IMMUNOL METHODS, V174, P311, DOI 10.1016/0022-1759(94)90034-5; VERHEIJ HM, 1980, EUR J BIOCHEM, V112, P25, DOI 10.1111/j.1432-1033.1980.tb04982.x; Wang X, 2005, J THROMB HAEMOST, V3, P695, DOI 10.1111/j.1538-7836.2005.01236.x; Wang YM, 2010, TOXICON, V56, P93, DOI 10.1016/j.toxicon.2010.03.015; Ward M, 2002, PROTEIN PROTOCOLS HD, P461; Wu WM, 2012, BLOOD, V120, P671, DOI 10.1182/blood-2012-03-419523; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang C, 1997, J MOL BIOL, V267, P707, DOI 10.1006/jmbi.1996.0859; Zhang Y, 1998, BIOCHEMISTRY-US, V37, P10681, DOI 10.1021/bi973050y; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	67	19	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153770	10.1371/journal.pone.0153770	http://dx.doi.org/10.1371/journal.pone.0153770			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27089306	gold, Green Published, Green Submitted			2022-12-26	WOS:000374527000046
J	Wang, L; Huang, BQ; Chiang, KP; Liu, X; Chen, BZ; Xie, YY; Xu, YP; Hu, JY; Dai, MH				Wang, Lei; Huang, Bangqin; Chiang, Kuo-Ping; Liu, Xin; Chen, Bingzhang; Xie, Yuyuan; Xu, Yanping; Hu, Jianyu; Dai, Minhan			Physical-Biological Coupling in the Western South China Sea: The Response of Phytoplankton Community to a Mesoscale Cyclonic Eddy	PLOS ONE			English	Article							SUBTROPICAL NORTH-ATLANTIC; PHOTOSYNTHETIC RATES; CLASS ABUNDANCES; EDDIES; DYNAMICS; EXPORT; OCEANOGRAPHY; VARIABILITY; SEPARATION; PIGMENTS	It is widely recognized that the mesoscale eddies play an important part in the biogeochemical cycle in ocean ecosystem, especially in the oligotrophic tropical zones. So here a heterogeneous cyclonic eddy in its flourishing stage was detected using remote sensing and in situ biogeochemical observation in the western South China Sea (SCS) in early September, 2007. The high-performance liquid chromatography method was used to identify the photosynthetic pigments. And the CHEMical TAXonomy (CHEMTAX) was applied to calculate the contribution of nine phytoplankton groups to the total chlorophyll a (TChl a) biomass. The deep chlorophyll a maximum layer (DCML) was raised to form a dome structure in the eddy center while there was no distinct enhancement for TChl a biomass. The integrated TChl a concentration in the upper 100 m water column was also constant from the eddy center to the surrounding water outside the eddy. However the TChl a biomass in the surface layer (at 5 m) in the eddy center was promoted 2.6-fold compared to the biomass outside the eddy (p < 0.001). Thus, the slight enhancement of TChl a biomass of euphotic zone integration within the eddy was mainly from the phytoplankton in the upper mixed zone rather than the DCML. The phytoplankton community was primarily contributed by diatoms, prasinophytes, and Synechococcus at the DCML within the eddy, while less was contributed by haptophytes_8 and Prochlorococcus. The TChl a biomass for most of the phytoplankton groups increased at the surface layer in the eddy center under the effect of nutrient pumping. The doming isopycnal within the eddy supplied nutrients gently into the upper mixing layer, and there was remarkable enhancement in phytoplankton biomass at the surface layer with 10.5% TChl a biomass of water column in eddy center and 3.7% at reference stations. So the slight increasing in the water column integrated phytoplankton biomass might be attributed to the stimulated phytoplankton biomass at the surface layer.	[Wang, Lei; Huang, Bangqin; Liu, Xin; Chen, Bingzhang; Xie, Yuyuan] Xiamen Univ, Minist Educ, Key Lab Coastal & Wetland Ecosyst, Xiamen, Peoples R China; [Wang, Lei; Huang, Bangqin; Liu, Xin; Chen, Bingzhang; Xie, Yuyuan; Xu, Yanping; Hu, Jianyu; Dai, Minhan] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China; [Chiang, Kuo-Ping] Natl Taiwan Ocean Univ, Inst Marine Environm Chem & Ecol, Keelung, Taiwan	Xiamen University; Xiamen University; National Taiwan Ocean University	Huang, BQ (corresponding author), Xiamen Univ, Minist Educ, Key Lab Coastal & Wetland Ecosyst, Xiamen, Peoples R China.; Huang, BQ (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China.	bqhuang@xmu.edu.cn	Dai, Minhan/G-3343-2010; Chen, Bingzhang/AAH-6784-2020; Xie, Yuyuan/CAF-6420-2022; DAI, M/GPS-8291-2022; 许, 艳苹/E-3860-2013; Liu, Xin/D-6312-2019	Dai, Minhan/0000-0003-0550-0701; Chen, Bingzhang/0000-0002-1573-7473; Liu, Xin/0000-0002-7925-9618; Huang, Bangqin/0000-0003-2279-6241; Xie, Yuyuan/0000-0001-9134-3604	Natural Science Foundation of China [41330961, 41406158]; National Programme on Global Change and Air-Sea Interaction [GASI-03-01-02-03]; Specialized Research Fund for the Doctoral Program of Higher Education [20130121110031]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Programme on Global Change and Air-Sea Interaction; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This study was funded by: (1) the Natural Science Foundation of China through grants No. 41330961 and 41406158 (http://www.nsfc.gov.cn/publish/portal1/); (2) the National Programme on Global Change and Air-Sea Interaction through grant No. GASI-03-01-02-03 (http://www.soa.gov.cn/); (3) the Specialized Research Fund for the Doctoral Program of Higher Education through grant No. 20130121110031 (http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm).	Allen CB, 1996, DEEP-SEA RES PT I, V43, P917, DOI 10.1016/0967-0637(96)00022-2; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Benitez-Nelson CR, 2007, SCIENCE, V316, P1017, DOI 10.1126/science.1136221; Bibby TS, 2011, BIOGEOSCIENCES, V8, P657, DOI 10.5194/bg-8-657-2011; Bidigare RR, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016393; Brown SL, 2008, DEEP-SEA RES PT II, V55, P1321, DOI 10.1016/j.dsr2.2008.02.012; Chelton DB, 2011, SCIENCE, V334, P328, DOI 10.1126/science.1208897; Chen BZ, 2009, LIMNOL OCEANOGR, V54, P1084, DOI 10.4319/lo.2009.54.4.1084; Chen GX, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006716; Chen GX, 2010, CONT SHELF RES, V30, P715, DOI 10.1016/j.csr.2009.11.013; Chen WF, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2010JC006460; Chen YFL, 2005, DEEP-SEA RES PT I, V52, P319, DOI 10.1016/j.dsr.2004.11.001; Chen YLL, 2007, J OCEANOGR, V63, P671, DOI 10.1007/s10872-007-0059-9; Chu P. C., 2001, J OCEANOGR, V57, P549, DOI DOI 10.1023/A:1021251519067; de Boyer Montegut C, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002378; DUGDALE RC, 1967, LIMNOL OCEANOGR, V12, P685, DOI 10.4319/lo.1967.12.4.0685; FALKOWSKI PG, 1991, NATURE, V352, P55, DOI 10.1038/352055a0; Furuya Ken, 1998, Journal of Oceanography, V54, P199, DOI 10.1007/BF02751695; Gan J, 2008, DEEP-SEA RES PT I, V55, P1, DOI 10.1016/j.dsr.2007.09.008; GOERICKE R, 1993, MAR ECOL PROG SER, V101, P307, DOI 10.3354/meps101307; Hu JY, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006810; Jeffrey S.W., 1994, Systematics Association Special Volume Series, V51, P111; Landry MR, 2008, DEEP-SEA RES PT II, V55, P1348, DOI 10.1016/j.dsr2.2008.02.001; Latasa M, 2007, MAR ECOL PROG SER, V329, P13, DOI 10.3354/meps329013; LETELIER RM, 1993, LIMNOL OCEANOGR, V38, P1420, DOI 10.4319/lo.1993.38.7.1420; Li WKW, 2002, NATURE, V419, P154, DOI 10.1038/nature00994; Mackey MD, 1996, MAR ECOL PROG SER, V144, P265, DOI 10.3354/meps144265; Martin AP, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2003JC001841; McGillicuddy DJ, 2007, SCIENCE, V316, P1021, DOI 10.1126/science.1136256; McGillicuddy DJ, 2011, SCIENCE, V334, P318, DOI 10.1126/science.1208892; McGillicuddy DJ, 1997, DEEP-SEA RES PT I, V44, P1427, DOI 10.1016/S0967-0637(97)00024-1; Mendes CR, 2007, LIMNOL OCEANOGR-METH, V5, P363, DOI 10.4319/lom.2007.5.363; Mizobata K, 2006, J GEOPHYS RES-OCEANS, V111, DOI [10.1029/2005JC003335, 10.1029/2005JC003314]; Ning X, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002365; OLAIZOLA M, 1993, MAR BIOL, V116, P533, DOI 10.1007/BF00355471; Parsons T. R., 1973, BIOL OCEANOGRAPHIC P; Raven JA, 1998, FUNCT ECOL, V12, P503, DOI 10.1046/j.1365-2435.1998.00233.x; Rii YM, 2008, DEEP-SEA RES PT II, V55, P1275, DOI 10.1016/j.dsr2.2008.01.013; Seki MP, 2001, GEOPHYS RES LETT, V28, P1583, DOI 10.1029/2000GL012439; SHERR EB, 1994, MICROBIAL ECOL, V28, P223, DOI 10.1007/BF00166812; TURPIN DH, 1979, J EXP MAR BIOL ECOL, V39, P151, DOI 10.1016/0022-0981(79)90011-X; Vaillancourt RD, 2003, DEEP-SEA RES PT I, V50, P829, DOI 10.1016/S0967-0637(03)00059-1; Wang GH, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018532; Williams RG, 2011, NAT GEOSCI, V4, P739, DOI 10.1038/ngeo1307; Wong GTF, 2007, DEEP-SEA RES PT II, V54, P1434, DOI 10.1016/j.dsr2.2007.05.012; Wong GTF, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015796; Wu CR, 1999, J GEOPHYS RES-OCEANS, V104, P29987, DOI 10.1029/1999JC900260; Zapata M, 2004, MAR ECOL PROG SER, V270, P83, DOI 10.3354/meps270083; Zapata M, 2000, MAR ECOL PROG SER, V195, P29, DOI 10.3354/meps195029	50	32	35	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153735	10.1371/journal.pone.0153735	http://dx.doi.org/10.1371/journal.pone.0153735			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088991	Green Published, gold, Green Accepted			2022-12-26	WOS:000374527000044
J	Luo, LQ; Li, DF; Zhang, W; Tu, SK; Zhu, XP; Tian, G				Luo, Longqiang; Li, Dingfang; Zhang, Wen; Tu, Shikui; Zhu, Xiaopeng; Tian, Gang			Accurate Prediction of Transposon-Derived piRNAs by Integrating Various Sequential and Physicochemical Features	PLOS ONE			English	Article							LONG NONCODING RNA; PIWI; DNA; IDENTIFICATION; BIOGENESIS; GENES; MODES	Background Piwi-interacting RNA (piRNA) is the largest class of small non-coding RNA molecules. The transposon-derived piRNA prediction can enrich the research contents of small ncRNAs as well as help to further understand generation mechanism of gamete. Methods In this paper, we attempt to differentiate transposon-derived piRNAs from non-piRNAs based on their sequential and physicochemical features by using machine learning methods. We explore six sequence-derived features, i.e. spectrum profile, mismatch profile, subsequence profile, position-specific scoring matrix, pseudo dinucleotide composition and local structure-sequence triplet elements, and systematically evaluate their performances for transposonderived piRNA prediction. Finally, we consider two approaches: direct combination and ensemble learning to integrate useful features and achieve high-accuracy prediction models. Results We construct three datasets, covering three species: Human, Mouse and Drosophila, and evaluate the performances of prediction models by 10-fold cross validation. In the computational experiments, direct combination models achieve AUC of 0.917, 0.922 and 0.992 on Human, Mouse and Drosophila, respectively; ensemble learning models achieve AUC of 0.922, 0.926 and 0.994 on the three datasets. Conclusions Compared with other state-of-the-art methods, our methods can lead to better performances. In conclusion, the proposed methods are promising for the transposon-derived piRNA prediction. The source codes and datasets are available in S1 File.	[Luo, Longqiang; Li, Dingfang] Wuhan Univ, Sch Math & Stat, Wuhan 430072, Peoples R China; [Zhang, Wen; Tian, Gang] Wuhan Univ, Sch Comp, Wuhan 430072, Peoples R China; [Zhang, Wen] Wuhan Univ, Res Inst Shenzhen, Shenzhen 518057, Peoples R China; [Tu, Shikui; Zhu, Xiaopeng] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, 368 Plantat St, Worcester, MA 01605 USA	Wuhan University; Wuhan University; Wuhan University; University of Massachusetts System; University of Massachusetts Worcester	Zhang, W (corresponding author), Wuhan Univ, Sch Comp, Wuhan 430072, Peoples R China.; Zhang, W (corresponding author), Wuhan Univ, Res Inst Shenzhen, Shenzhen 518057, Peoples R China.	zhangwen@whu.edu.cn	xiaopeng, zhu/A-6755-2011; Zhang, Wen/W-7471-2019	xiaopeng, zhu/0000-0003-2007-9820; Zhang, Wen/0000-0001-5221-2628	National Natural Science Foundation of China [61271337, 61103126, 61572368]; Shenzhen Development Foundation [JCYJ20130401160028781]; China Scholarship Council [201406275015]; Natural Science Foundation of Hubei Province, China [ZRY2014000901]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Development Foundation; China Scholarship Council(China Scholarship Council); Natural Science Foundation of Hubei Province, China(Natural Science Foundation of Hubei Province)	This work is supported by the National Natural Science Foundation of China (61271337, 61103126, 61572368), Shenzhen Development Foundation (JCYJ20130401160028781), China Scholarship Council (201406275015) and the Natural Science Foundation of Hubei Province, China (ZRY2014000901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeel T, 2009, BIOINFORMATICS, V25, pI313, DOI 10.1093/bioinformatics/btp191; Alexei A, 2006, NATURE, V442, P203; Betel D, 2007, PLOS COMPUT BIOL, V3, P2219, DOI 10.1371/journal.pcbi.0030222; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Bu DC, 2012, NUCLEIC ACIDS RES, V40, pD210, DOI 10.1093/nar/gkr1175; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Claverie JM, 2005, SCIENCE, V309, P1529, DOI 10.1126/science.1116800; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cucchiara A., 2012, TECHNOMETRICS, V34, P358, DOI DOI 10.2307/1270048; Das PP, 2008, MOL CELL, V31, P79, DOI 10.1016/j.molcel.2008.06.003; El-Manzalawy Yasser, 2008, Comput Syst Bioinformatics Conf, V7, P121, DOI 10.1142/9781848162648_0011; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Huang Y, 2012, J PHYSIOL BIOCHEM, V68, P611, DOI 10.1007/s13105-012-0166-y; Jiang H, 2008, BIOINFORMATICS, V24, P2395, DOI 10.1093/bioinformatics/btn429; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD590; Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; LESLIE C, 2002, P PSB, V7, P566; Leslie CS, 2004, BIOINFORMATICS, V20, P467, DOI 10.1093/bioinformatics/btg431; Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458; Liu B, 2015, BIOINFORMATICS, V31, P1307, DOI 10.1093/bioinformatics/btu820; Lodhi H, 2002, J MACH LEARN RES, V2, P419, DOI 10.1162/153244302760200687; Mattick JS, 2005, SCIENCE, V309, P1527, DOI 10.1126/science.1117806; Meenakshisundaram K, 2009, J BIOINFORMATICS SEQ, V1, P31; Robine N, 2009, CURR BIOL, V19, P2066, DOI 10.1016/j.cub.2009.11.064; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Seto AG, 2007, MOL CELL, V26, P603, DOI 10.1016/j.molcel.2007.05.021; Sinha S, 2006, BIOINFORMATICS, V22, pE454, DOI 10.1093/bioinformatics/btl227; Song L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-298; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Thomson T, 2009, ANNU REV CELL DEV BI, V25, P355, DOI 10.1146/annurev.cellbio.24.110707.175327; Wang K, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0419-6; Wei LY, 2014, IEEE ACM T COMPUT BI, V11, P192, DOI 10.1109/TCBB.2013.146; Wen Zhang, 2013, 2013 IEEE International Conference on Bioinformatics and Biomedicine (BIBM), P4, DOI 10.1109/BIBM.2013.6732451; Xia XH, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/917540; Xie CY, 2014, NUCLEIC ACIDS RES, V42, pD98, DOI 10.1093/nar/gkt1222; Xue CH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-310; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263; Zhang W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128194; Zhang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043575; Zhang Y, 2011, BIOINFORMATICS, V27, P771, DOI 10.1093/bioinformatics/btr016; Zou Q, 2015, MOLECULAR INFORMATIC, V2003, P2992	44	45	45	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153268	10.1371/journal.pone.0153268	http://dx.doi.org/10.1371/journal.pone.0153268			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074043	Green Submitted, Green Published, gold			2022-12-26	WOS:000374131200069
J	Mahmood, ASMA; Wu, TJ; Mazumder, R; Vijay-Shanker, K				Mahmood, A. S. M. Ashique; Wu, Tsung-Jung; Mazumder, Raja; Vijay-Shanker, K.			DiMeX: A Text Mining System for Mutation-Disease Association Extraction	PLOS ONE			English	Article							SEQUENCE VARIANTS; DATABASE; CANCER; GENES	The number of published articles describing associations between mutations and diseases is increasing at a fast pace. There is a pressing need to gather such mutation-disease associations into public knowledge bases, but manual curation slows down the growth of such databases. We have addressed this problem by developing a text-mining system (DiMeX) to extract mutation to disease associations from publication abstracts. DiMeX consists of a series of natural language processing modules that preprocess input text and apply syntactic and semantic patterns to extract mutation-disease associations. DiMeX achieves high precision and recall with F-scores of 0.88, 0.91 and 0.89 when evaluated on three different datasets for mutation-disease associations. DiMeX includes a separate component that extracts mutation mentions in text and associates them with genes. This component has been also evaluated on different datasets and shown to achieve state-of-the-art performance. The results indicate that our system outperforms the existing mutation-disease association tools, addressing the low precision problems suffered by most approaches. DiMeX was applied on a large set of abstracts from Medline to extract mutation-disease associations, as well as other relevant information including patient/cohort size and population data. The results are stored in a database that can be queried and downloaded at http://biotm.cis.udel.edu/dimex/. We conclude that this high-throughput text-mining approach has the potential to significantly assist researchers and curators to enrich mutation databases.	[Mahmood, A. S. M. Ashique; Vijay-Shanker, K.] Univ Delaware, Dept Comp & Informat Sci, Newark, DE 19716 USA; [Wu, Tsung-Jung; Mazumder, Raja] George Washington Univ, Dept Biochem & Mol Med, Washington, DC USA; [Mazumder, Raja] George Washington Univ, McCormick Genom & Prote Ctr, Washington, DC USA	University of Delaware; George Washington University; George Washington University	Mahmood, ASMA (corresponding author), Univ Delaware, Dept Comp & Informat Sci, Newark, DE 19716 USA.	ashique@udel.edu		Mazumder, Raja/0000-0001-8823-9945	National Institute of Food and Agriculture (NIFA) [2011-67015-21639]	National Institute of Food and Agriculture (NIFA)	This work was supported by National Institute of Food and Agriculture (NIFA) Award Number: 2011-67015-21639.	Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Beroud C, 2005, HUM MUTAT, V26, P184, DOI 10.1002/humu.20210; Burger JD, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau094; Caporaso JG, 2007, BIOINFORMATICS, V23, P1862, DOI 10.1093/bioinformatics/btm235; Capriotti E, 2012, BRIEF BIOINFORM, V13, P495, DOI 10.1093/bib/bbr070; Cheng D, 2008, NUCLEIC ACIDS RES, V36, pW399, DOI 10.1093/nar/gkn296; Doughty E, 2011, BIOINFORMATICS, V27, P408, DOI 10.1093/bioinformatics/btq667; Erdogmus Muge, 2007, J Bioinform Comput Biol, V5, P1261, DOI 10.1142/S021972000700317X; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Furlong LI, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-84; Hirohata K, 2008, P 3 INT JOINT C NAT, VI, P381; Horn F, 2004, BIOINFORMATICS, V20, P557, DOI 10.1093/bioinformatics/btg449; Jimeno Y. A., 2014, F1000RESEARCH, V3, P18; Kim SN, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S2-S5; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Lee LC, 2007, PLOS COMPUT BIOL, V3, P184, DOI 10.1371/journal.pcbi.0030016; Liakata M, 2012, BIOINFORMATICS, V28, P991, DOI 10.1093/bioinformatics/bts071; McDonald RT, 2004, BIOINFORMATICS, V20, P3249, DOI 10.1093/bioinformatics/bth350; McKnight Larry, 2003, AMIA Annu Symp Proc, P440; Miwa M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-108; Naderi N, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S4-S10; Narayanaswamy Meenakshi, 2003, Pac Symp Biocomput, P427; Plazzer JP, 2013, FAM CANCER, V12, P175, DOI 10.1007/s10689-013-9616-0; Rebholz-Schuhmann D, 2004, NUCLEIC ACIDS RES, V32, P135, DOI 10.1093/nar/gkh162; Saunders RE, 2008, HUM MUTAT, V29, P333, DOI 10.1002/humu.20629; Schenck M, 2013, REC HEALTH CARE INF, V04; Schwartz Ariel S, 2003, Pac Symp Biocomput, P451; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Singh A, 2008, NUCLEIC ACIDS RES, V36, pD815, DOI 10.1093/nar/gkm659; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Thomas P., 2014, SETH SNP EXTRACTION; Thomas PE, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S4-S4; Thompson P, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-393; Thorisson GA, 2009, NUCLEIC ACIDS RES, V37, pD797, DOI 10.1093/nar/gkn748; Verspoor K, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat019; Wei CH, 2013, NUCLEIC ACIDS RES, V41, pW518, DOI 10.1093/nar/gkt441; Wei CH, 2013, BIOINFORMATICS, V29, P1433, DOI 10.1093/bioinformatics/btt156; Whirl-Carrillo M, 2012, CLIN PHARMACOL THER, V92, P414, DOI 10.1038/clpt.2012.96; Winnenburg R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S8-S3; Wu TJ, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau022; Yeniterzi S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S8-S2; Yip Yum Lina, 2007, J Bioinform Comput Biol, V5, P1215, DOI 10.1142/S021972000700320X; Zhang J, 2011, J GENET GENOMICS, V38, P95, DOI 10.1016/j.jgg.2011.02.003	44	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152725	10.1371/journal.pone.0152725	http://dx.doi.org/10.1371/journal.pone.0152725			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073839	Green Submitted, gold, Green Published			2022-12-26	WOS:000374131200034
J	Niranjani, G; Murugan, R				Niranjani, Gnanapragasam; Murugan, Rajamanickam			Theory on the Mechanism of DNA Renaturation: Stochastic Nucleation and Zipping	PLOS ONE			English	Article							HELIX-COIL TRANSITION; HYBRIDIZATION KINETICS; SECONDARY STRUCTURE; NUCLEIC-ACIDS; THERMODYNAMICS; DISPLACEMENT; DEPENDENCE; MODEL	Renaturation of the complementary single strands of DNA is one of the important processes that requires better understanding in the view of molecular biology and biological physics. Here we develop a stochastic dynamical model on the DNA renaturation. According to our model there are at least three steps in the renaturation process viz. nonspecific-contact formation, correct-contact formation and nucleation, and zipping. Most of the earlier two-state models combined nucleation with nonspecific-contact formation step. In our model we suggest that it is considerably meaningful when we combine the nucleation with the zipping since nucleation is the initial step of zipping and nucleated and zipping molecules are indistinguishable. Nonspecific contact formation step is a pure three-dimensional diffusion controlled collision process. Whereas nucleation involves several rounds of one-dimensional slithering and internal displacement dynamics of one single strand of DNA on the other complementary strand in the process of searching for the correct-contact and then initiate nucleation. Upon nucleation, the stochastic zipping follows to generate a fully renatured double stranded DNA. It seems that the square-root dependency of the overall renaturation rate constant on the length of reacting single strands originates mainly from the geometric constraints in the diffusion controlled nonspecific-contact formation step. Further the inverse scaling of the renaturation rate on the viscosity of reaction medium also originates from nonspecific contact formation step. On the other hand the inverse scaling of the renaturation rate with the sequence complexity originates from the stochastic zipping which involves several rounds of crossing over the free-energy barrier at microscopic levels. When the sequence of renaturing single strands of DNA is repetitive with less complexity then the cooperative effects will not be noticeable since the parallel zipping will be a dominant enhancing factor. However for DNA strands with high sequence complexity and length one needs to consider the underlying cooperative effects both at microscopic and macroscopic levels to explain various scaling behaviours of the overall renaturation rate.	[Niranjani, Gnanapragasam; Murugan, Rajamanickam] Indian Inst Technol Madras, Dept Biotechnol, Madras, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Murugan, R (corresponding author), Indian Inst Technol Madras, Dept Biotechnol, Madras, Tamil Nadu, India.	rmurugan@gmail.com	Murugan, Rajamanickam/A-9700-2008	Murugan, Rajamanickam/0000-0002-5454-3540				Anderson MLM, 1999, NUCLEIC ACID HYBRIDI; Araque JC, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3568145; Bath J, 2007, NAT NANOTECHNOL, V2, P275, DOI 10.1038/nnano.2007.104; Benjamin L, 2000, GENES VII; Bloomfield VA, 1974, PHYSICAL CHEMISTRY O; Cantor C. R., 1980, BIOPHYSICAL CHEMISTR; Chen CL, 2007, NUCLEIC ACIDS RES, V35, P2875, DOI 10.1093/nar/gkm177; CRAIG ME, 1971, J MOL BIOL, V62, P383, DOI 10.1016/0022-2836(71)90434-7; DAVIDSON EH, 1975, CELL, V4, P217, DOI 10.1016/0092-8674(75)90170-1; de Gennes PG, 1979, SCALING CONCEPTS IN; Debye P., 1942, TRANS ELECTROCHEM SO, P265; DEGENNES PG, 1976, J PHYS-PARIS, V37, P1445, DOI 10.1051/jphys:0197600370120144500; Dirks RM, 2007, SIAM REV, V49, P65, DOI 10.1137/060651100; Gao Y, 2006, NUCLEIC ACIDS RES, V34, P3370, DOI 10.1093/nar/gkl422; Gardiner CW, 2002, HANDBOOK OF STOCHAST; Goldar A, 2004, EUR PHYS J E, V14, P211, DOI 10.1140/epje/i2004-10011-7; Lukacs GL, 2000, J BIOL CHEM, V275, P1625, DOI 10.1074/jbc.275.3.1625; MANNING GS, 1976, BIOPOLYMERS, V15, P1333, DOI 10.1002/bip.1976.360150709; MANNING GS, 1978, Q REV BIOPHYS, V11, P179, DOI 10.1017/S0033583500002031; MONTROLL EW, 1946, J CHEM PHYS, V14, P202, DOI 10.1063/1.1724118; MORRISON LE, 1993, BIOCHEMISTRY-US, V32, P3095, DOI 10.1021/bi00063a022; Murugan R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.011901; Murugan R, 2003, BIOPHYS CHEM, V104, P535, DOI 10.1016/S0301-4622(03)00043-7; Murugan R, 2010, BIOPHYS J, V99, P353, DOI 10.1016/j.bpj.2010.04.026; Murugan R, 2002, BIOCHEM BIOPH RES CO, V293, P870, DOI 10.1016/S0006-291X(02)00305-4; Niu L, 2015, CHEM COMMUN, V51, P7717, DOI 10.1039/c5cc00783f; Ouldridge TE, 2013, NUCLEIC ACIDS RES, V41, P8886, DOI 10.1093/nar/gkt687; Pinheiro AV, 2011, NAT NANOTECHNOL, V6, P763, DOI [10.1038/nnano.2011.187, 10.1038/NNANO.2011.187]; PORSCHKE D, 1973, BIOPOLYMERS, V12, P1313, DOI 10.1002/bip.1973.360120609; PORSCHKE D, 1971, J MOL BIOL, V62, P361, DOI 10.1016/0022-2836(71)90433-5; Qian L, 2011, SCIENCE, V332, P1196, DOI 10.1126/science.1200520; RAU DC, 1975, J CHEM PHYS, V62, P2354, DOI 10.1063/1.430761; Risken H., 1996, FOKKER PLANK EQUATIO; Robertson RM, 2006, P NATL ACAD SCI USA, V103, P7310, DOI 10.1073/pnas.0601903103; Sambriski EJ, 2009, P NATL ACAD SCI USA, V106, P18125, DOI 10.1073/pnas.0904721106; Sambriski EJ, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/3/034105; Sambriski EJ, 2009, BIOPHYS J, V96, P1675, DOI 10.1016/j.bpj.2008.09.061; SantaLucia J, 2004, ANNU REV BIOPH BIOM, V33, P415, DOI 10.1146/annurev.biophys.32.110601.141800; Sikorav JL, 2009, J PHYS CHEM B, V113, P3715, DOI 10.1021/jp807096z; STUDIER FW, 1969, J MOL BIOL, V41, P199, DOI 10.1016/0022-2836(69)90385-4; Van Kampen N. G., 1994, STOCHASTIC PROCESSES; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; WETMUR JG, 1968, J MOL BIOL, V31, P349, DOI 10.1016/0022-2836(68)90414-2; Woodside MT, 2006, SCIENCE, V314, P1001, DOI 10.1126/science.1133601; Zhang DY, 2009, J AM CHEM SOC, V131, P17303, DOI 10.1021/ja906987s	45	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153172	10.1371/journal.pone.0153172	http://dx.doi.org/10.1371/journal.pone.0153172			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074030	gold, Green Published, Green Submitted			2022-12-26	WOS:000374131200057
J	Rivera-Sylva, HE; Hedrick, BP; Dodson, P				Rivera-Sylva, Hector E.; Hedrick, Brandon P.; Dodson, Peter			A Centrosaurine (Dinosauria: Ceratopsia) from the Aguja Formation (Late Campanian) of Northern Coahuila, Mexico	PLOS ONE			English	Article							TRANS-PECOS TEXAS; WEST TEXAS; HADROSAURID DINOSAURIA; PHYLOGENETIC ANALYSIS; SOUTHERN COAHUILA; VERTEBRATE FAUNA; HORNED DINOSAURS; PARRAS BASIN; BIG-BEND; AGE	While centrosaurines and ceratopsids in general are abundant in the Late Campanian of northern Laramidia, they are much less commonly found in southern Laramidia. This has supported hypotheses of dinosaur provinciality and endemism in the Late Cretaceous with the delineation of at least two separate faunal zones, north and south Laramidia. There have been 12 genera of centrosaurines recognized from northern Laramidia while two genera, Diabloceratops and Nasutoceratops, have been named from southern Laramidia. We present an osteological description and taphonomic outline for a new centrosaurine ceratopsid from the Aguja Formation of northern Coahuila, Mexico that is not currently diagnosable to the generic level, but likely represents a new taxon. Further, we have included three-dimensional surface scans of all material attributed to this animal. Considering the large number of centrosaurines from northern Laramidia, it is likely that cladistic analyses are biased towards this faunal zone. New findings of southern centrosaurines are needed to correct this bias. This discovery expands the range of centrosaurines south to Coahuila, Mexico and adds new information to better characterize the morphology and taxonomy of centrosaurines from southern Laramidia and their evolution in comparison to their northern counterparts.	[Rivera-Sylva, Hector E.] Museo Desierto Carlos Abedrop Davila, Dept Paleontol, 3745 Parque Las Maravillas Saltillo, Saltillo 25022, Coahuila, Mexico; [Hedrick, Brandon P.; Dodson, Peter] Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA; [Dodson, Peter] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Hedrick, BP (corresponding author), Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA.	bphedrick1@gmail.com			University of Pennsylvania Paleobiology Stipend; Greg and Susan Walker Foundation; Consejo Estatal de Ciencia y Tecnologia (COECyT); Museo del Desierto	University of Pennsylvania Paleobiology Stipend; Greg and Susan Walker Foundation; Consejo Estatal de Ciencia y Tecnologia (COECyT); Museo del Desierto	The authors received funding support from Dr. Narayan Avadhani, the University of Pennsylvania Paleobiology Stipend, and the Greg and Susan Walker Foundation for collection and preparation of fossil material. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We would like to thank Jorge A. Ortiz Mendieta, Ruben Guzman Gutierrez, and Homero Hernandez for help collecting material and Lorena Ahedo Percastegui, Yesica Rodriguez Salinas, and Abraham I. Oyervidez Salazar for preparing the material. We also thank the Consejo Estatal de Ciencia y Tecnologia (COECyT) and the Museo del Desierto for supporting this investigation with special thanks to the authorities of Ocampo for their kind assistance and support to the Coahuila Desert Dinosaur Project. This research would not be possible without helpful discussions with Sam Cordero (University of Pennsylvania), Andrew McDonald, Eric Morschhauser (Drexel University), Michael Ryan (Cleveland Museum of Natural History), and Phil Manning (University of Manchester). We thank the Willi Hennig Society for access to TNT. We thank Eric Lund for providing photos of comparative material. We also especially thank Jorge A. Ortiz Mendieta for contributing drawings for Fig 1. Finally, we thanks reviewers Michael Ryan and Mark Loewen and editor Andy Farke for their valuable reviews and comments.	Befus KS, 2008, J VOLCANOL GEOTH RES, V173, P245, DOI 10.1016/j.jvolgeores.2008.01.021; Breyer JA, 2007, J GEOL, V115, P243, DOI 10.1086/510640; Brinkman Donald, 2002, Journal of Vertebrate Paleontology, V22, p38A; Brochu CA, 1996, J VERTEBR PALEONTOL, V16, P49, DOI 10.1080/02724634.1996.10011283; Brown B, 1937, AM MUS NOVIT, V955, P1; DODSON P, 1993, AM J SCI, V293A, P200, DOI 10.2475/ajs.293.A.200; Dodson P., 1996, THE HORNED DINOSAURS; Dodson P, 2004, DINOSAURIA, 2ND EDITION, P494; Eberth DA, 2004, REV MEX CIENC GEOL, V21, P335; Eberth D, 2003, J VERTEBR PALEONTOL, V23, p47A; Edmund G., 1985, ROYAL ONTARIO MUSEUM, V1985, P35; Evans DC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130007; Farke AA, 2011, ACTA PALAEONTOL POL, V56, P691, DOI 10.4202/app.2010.0121; Gates TA, 2007, J VERTEBR PALEONTOL, V27, P917, DOI 10.1671/0272-4634(2007)27[917:VCANLH]2.0.CO;2; GIFFIN EB, 1990, PALEOBIOLOGY, V16, P448, DOI 10.1017/S0094837300010186; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gonzales-Leon CM, 1995, SONORA GEOLOGIA DEL, V1, P20; Hatcher JB, 1907, MONOGRAPHS US GEOLOG, V49, P3; Heckert AB, 2003, NEUES JAHRB GEOL P-A, V227, P343; Hedrick B. P., 2014, GSA ABSTRACTS GRAMS, V46, P2; Kirkland J., 2000, SOC VERT PAL ANN M F, V3, P133; Kirkland James I., 2010, P117; Kirkland James I., 2006, BULLETIN OF THE NEW MEXICO MUSEUM OF NATURAL HISTORY AND SCIENCE, P299; Lambe LM., 1915, CANADA GEOLOGICAL SU, V12, P1; LANGSTON W, 1975, CAN J EARTH SCI, V12, P1576, DOI 10.1139/e75-142; Lehman T.M., 1982, THESIS; Lehman Thomas M., 2001, P310; Lehman TM, 2006, J VERTEBR PALEONTOL, V26, P922, DOI 10.1671/0272-4634(2006)26[922:FIUAFT]2.0.CO;2; Lehman Thomas M., 1997, P223; Loewen Mark A., 2013, P488; Loewen Mark A., 2010, P99; Longrich NR, 2010, CRETACEOUS RES, V31, P274, DOI 10.1016/j.cretres.2009.12.002; Maiorino L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081608; Maiorino L, 2013, J VERTEBR PALEONTOL, V33, P1385, DOI 10.1080/02724634.2013.779922; Marsh O.C., 1890, AM J SCI, V39, P418, DOI DOI 10.2475/AJS.S3-39.233.418; Marsh OC., 1888, AM J SCI, V36, P477, DOI [10.2475/ajs.s3-36.216.477, DOI 10.2475/AJS.S3-36.216.477.]; McDonald AT, 2010, NEW PERSPECTIVES ON, P156; McDonald AT, 2013, JOURNAL OF VERTE BRA, P174; MURRAY GE, 1960, J PALEONTOL, V34, P368; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; Penkalski P, 1999, J VERTEBR PALEONTOL, V19, P692, DOI 10.1080/02724634.1999.10011182; Prieto-Marquez A, 2012, HIST BIOL, V24, P607, DOI 10.1080/08912963.2012.671311; Rivera-Sylva HE, 2006, SOCIEDAD MEXICANA DE, V10, P129; Rivera-Sylva HE, 2012, B SOC GEOL MEX, V64, P155, DOI 10.18268/BSGM2012v64n1a11; Rivera-Sylva HE, 2011, REV MEX CIENC GEOL, V28, P267; Rivera-Sylva Héctor E., 2009, Bol. Soc. Geol. Mex, V61, P239; Roberts Eric M., 2013, P85; Rodriguez-de la Rosa Ruben A., 2004, Ichnos, V11, P27, DOI 10.1080/10420940490428841; Rowe T., 1992, Journal of Vertebrate Paleontology, V12, P472; Russell AP, CANADIAN J EARTH SCI, V42, P1369; Ryan MJ, 2007, J VERTEBR PALEONTOL, V27, P944, DOI 10.1671/0272-4634(2007)27[944:AROTLC]2.0.CO;2; Ryan MJ, 2007, J PALEONTOL, V81, P376, DOI 10.1666/0022-3360(2007)81[376:ANBCCF]2.0.CO;2; Ryan MJ, 2014, NATURWISSENSCHAFTEN, V101, P505, DOI 10.1007/s00114-014-1183-1; Ryan MJ, 2012, CAN J EARTH SCI, V49, P1251, DOI 10.1139/e2012-056; Sampson SD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1186; Sampson Scott D., 2010, P405; Sampson SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012292; Sampson SD, 1995, J VERTEBR PALEONTOL, V15, P743, DOI 10.1080/02724634.1995.10011259; Sankey JT, 2001, J PALEONTOL, V75, P208, DOI 10.1666/0022-3360(2001)075<0208:LCSDAF>2.0.CO;2; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; SERENO PC, 1986, NATL GEOGR RES, V2, P234; Silva-Barcenas A., 1969, PALEONTOLOGIA MEXICA, V28, P1; Sullivan Robert M., 2010, P169; Sullivan Robert M., 2006, Bulletin of the New Mexico Museum of Natural History and Science, P7; The MathWorks Inc, 2012, MATLAB STAT TOOLB RE; Wagner JR, 2009, J VERTEBR PALEONTOL, V29, P605, DOI 10.1671/039.029.0208; Weidie A. E, 1972, GULF COAST ASS GEOLO, V22, P323; Wick SL, 2013, NATURWISSENSCHAFTEN, V100, P667, DOI 10.1007/s00114-013-1063-0; Williamson T.E., 1997, NEW MEXICO MUSEUM NA, V11, P51	69	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0150529	10.1371/journal.pone.0150529	http://dx.doi.org/10.1371/journal.pone.0150529			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073969	Green Published, gold, Green Submitted			2022-12-26	WOS:000374131200004
J	Frank, CL; Ingala, MR; Ravenelle, RE; Dougherty-Howard, K; Wicks, SO; Herzog, C; Rudd, RJ				Frank, Craig L.; Ingala, Melissa R.; Ravenelle, Rebecca E.; Dougherty-Howard, Kelsey; Wicks, Samuel O.; Herzog, Carl; Rudd, Robert J.			The Effects of Cutaneous Fatty Acids on the Growth of Pseudogymnoascus destructans, the Etiological Agent of White-Nose Syndrome (WNS)	PLOS ONE			English	Article							BAT; LIPIDS; PATHOGEN; TISSUES; SURFACE; MASS	White Nose Syndrome (WNS) greatly increases the over-winter mortality of little brown (Myotis lucifugus), Indiana (Myotis sodalis), northern (Myotis septentrionalis), and tricolored (Perimyotis subflavus) bats. It is caused by a cutaneous infection with the fungus Pseudogymnoascus destructans (Pd). Big brown bats (Eptesicus fuscus) are much more resistant to cutaneous infection with Pd, however. We thus conducted analyses of wing epidermis from hibernating E. fuscus and M. lucifugus to determine their fatty acid compositions, and laboratory Pd culture experiments at 4.0-13.4 degrees C to determine the effects of these fatty acids on Pd growth. Our analyses revealed that the epidermis of both bat species contain the same 7 fatty acid types (14:0, 15:0, 16:0. 16:1, 18:0, 18:1, & 18:2), but the epidermis of M. lucifugus contains:a) more stearic (18:0) acid, b) less palmitoleic (16:1) acid, c) less myristic (14:0) acid, and, d) less oleic (18:1) acid than that of E. fuscus. The growth of Pd was inhibited by:a) myristic and stearic acids at 10.5-13.4 degrees C, but not at 4.0-5.0 degrees C, b) oleic acid at 5.0-10.6 degrees C, c) palmitoleic acid, and, d) linoleic (18:2) acid at 5.0-10.6 degrees C. One set of factors that enables E. fuscus to better resist cutaneous P. destructans infections (and thus WNS) therefore appears to be the relatively higher myristic, palmitoleic, and oleic acid contents of the epidermis.	[Frank, Craig L.; Ravenelle, Rebecca E.] Fordham Univ, Dept Biol Sci, Louis Calder Ctr, POB 887, Armonk, NY 10504 USA; [Ingala, Melissa R.; Dougherty-Howard, Kelsey; Wicks, Samuel O.] Fordham Univ, Environm Sci Program, LH 400, Bronx, NY 10458 USA; [Herzog, Carl] New York State Dept Environm Conservat, 625 Broadway, Albany, NY 12233 USA; [Rudd, Robert J.] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA	Fordham University; Fordham University; State University of New York (SUNY) System; Wadsworth Center	Frank, CL (corresponding author), Fordham Univ, Dept Biol Sci, Louis Calder Ctr, POB 887, Armonk, NY 10504 USA.	frank@fordham.edu	Frank, Craig/AFQ-3761-2022	Frank, Craig/0000-0002-4340-4422; Ingala, Melissa/0000-0002-9866-5646	National Science Foundation [IOS-0818222]	National Science Foundation(National Science Foundation (NSF))	Funded by National Science Foundation (www.nsf.gov) IOS-0818222.	Alteri C, 2009, FOOD SCI TECHNOLOGY, V44, P242; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; BRACK V, 1985, J MAMMAL, V66, P308, DOI 10.2307/1381243; BUCKNER JS, 1993, INSECT LIPIDS: CHEMISTRY, BIOCHEMISTRY AND BIOLOGY, P227; Camera E, 2010, J LIPID RES, V51, P3377, DOI 10.1194/jlr.D008391; Chaturvedi V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010783; Christie WW., 1992, ADV LIPID METHODOLOG; Dark J, 2005, ANNU REV NUTR, V25, P469, DOI 10.1146/annurev.nutr.25.050304.092514; DOBUSH GR, 1985, CAN J ZOOL, V63, P1917, DOI 10.1139/z85-285; Drake DR, 2008, J LIPID RES, V49, P4, DOI 10.1194/jlr.R700016-JLR200; Evans E, 1999, MICROBIOLOGY ACTION; Feingold KR, 2007, J LIPID RES, V48, P2531, DOI 10.1194/jlr.R700013-JLR200; Feldhamer GA, 2007, MAMMALOGY ADAPTATION; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frank CL, 2002, J MAMMAL, V83, P1013, DOI 10.1644/1545-1542(2002)083&lt;1013:STVIDF&gt;2.0.CO;2; Frank CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113958; Frank Craig L., 2012, P271; Gargas A, 2009, MYCOTAXON, V108, P147, DOI 10.5248/108.147; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; Gunstone F.D., 1996, FATTY ACID LIPID CHE; Haugen M, 2003, PHYSIOL BIOCHEM ZOOL, V76, P907, DOI 10.1086/380213; Karpovich SA, 2009, J COMP PHYSIOL B, V179, P691, DOI 10.1007/s00360-009-0350-8; Kayser C, 1965, PHYSL MAMMALOGY, P180; Kellner Amanda M.E., 2005, Northwestern Naturalist, V86, P45, DOI 10.1898/1051-1733(2005)086[0045:DOBICR]2.0.CO;2; Kunz TH, 1998, ECOSCIENCE, V5, P8, DOI 10.1080/11956860.1998.11682443; KUNZ TH, 1974, ECOLOGY, V55, P693, DOI 10.2307/1934408; Langwig KE, 2015, EMERG INFECT DIS, V21, P1023, DOI 10.3201/eid2106.150123; LAW SLS, 1995, COMP BIOCHEM PHYS B, V110, P511; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; Pannkuk EL, 2014, LIPIDS, V49, P1143, DOI 10.1007/s11745-014-3951-2; Pannkuk EL, 2013, CHEM BIODIVERS, V10, P2122, DOI 10.1002/cbdv.201300319; Park M, 2013, MYCOBIOLOGY, V41, P67, DOI 10.5941/MYCO.2013.41.2.67; Pohl C.H., 2011, SCI MICROBIAL PATHOG, V3, P61; Puechmaille SJ, 2010, EMERG INFECT DIS, V16, P290, DOI 10.3201/eid1602.091391; Reeder DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038920; Reinoso RF, 1997, J PHARMACOL TOXICOL, V38, P87, DOI 10.1016/S1056-8719(97)00053-1; Reynolds DS, 2000, ECOSCIENCE, V7, P10; Reynolds HT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086437; Smith KR, 2008, J LIPID RES, V49, P271, DOI 10.1194/jlr.R700015-JLR200; Thomas DW, 1995, SYM ZOOL S, P233; Urich K., 1994, COMP ANIMAL BIOCH; Verant ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046280; Warnecke L, 2012, P NATL ACAD SCI USA, V109, P6999, DOI 10.1073/pnas.1200374109; Wibbelt G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074105; Wibbelt G, 2010, EMERG INFECT DIS, V16, P1237, DOI 10.3201/eid1608.100002	45	16	17	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153535	10.1371/journal.pone.0153535	http://dx.doi.org/10.1371/journal.pone.0153535			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070905	Green Submitted, Green Published, gold			2022-12-26	WOS:000373900700080
J	Sato, A; Omi, T; Yamamoto, A; Satake, A; Hiramoto, A; Masutani, M; Tanuma, S; Wataya, Y; Kim, HS				Sato, Akira; Omi, Takuya; Yamamoto, Akihiro; Satake, Akito; Hiramoto, Akiko; Masutani, Mitsuko; Tanuma, Sei-ichi; Wataya, Yusuke; Kim, Hye-Sook			MicroRNA-351 Regulates Two-Types of Cell Death, Necrosis and Apoptosis, Induced by 5-fluoro-2'-deoxyuridine	PLOS ONE			English	Article							DEOXYRIBONUCLEOSIDE-TRIPHOSPHATE IMBALANCE; DOUBLE STRAND BREAKS; MOUSE FM3A CELLS; DNTP IMBALANCE; MESSENGER-RNAS; LAMIN B1; MECHANISM; 5-FLUORO-2'-DEOXYURIDINE; MODULATION; PROLIFERATION	Cell-death can be necrosis and apoptosis. We are investigating the mechanisms regulating the cell death that occurs on treatment of mouse cancer cell-line FM3A with antitumor 5-fluoro-2'-deoxyuridine (FUdR): necrosis occurs for the original clone F28-7, and apoptosis for its variant F28-7-A. Here we report that a microRNA (miR-351) regulates the cell death pattern. The miR-351 is expressed strongly in F28-7-A but only weakly in F28-7. Induction of a higher expression of miR-351 in F28-7 by transfecting an miRNA mimic into F28-7 resulted in a change of the death mode; necrosis to apoptosis. Furthermore, transfection of an miR-351 inhibitor into F28-7-A resulted in the morphology change, apoptosis to necrosis, in this death-by-FUdR. Possible mechanism involving lamin B1 in this miR-351's regulatory action is discussed.	[Sato, Akira; Tanuma, Sei-ichi] Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Biochem, Noda, Chiba 278, Japan; [Sato, Akira; Masutani, Mitsuko] Natl Canc Ctr, Div Genome Stabil Res, Chuo Ku, Tokyo, Japan; [Sato, Akira; Masutani, Mitsuko] Natl Canc Ctr, Div Chemotherapy & Clin Res, Chuo Ku, Tokyo, Japan; [Sato, Akira; Omi, Takuya; Yamamoto, Akihiro; Satake, Akito; Hiramoto, Akiko; Wataya, Yusuke; Kim, Hye-Sook] Okayama Univ, Fac Pharmaceut Sci, Dept Drug Informat, Kita Ku, Okayama 700, Japan; [Masutani, Mitsuko] Nagasaki Univ, Grad Sch Biomed Sci, Dept Frontier Life Sci, Nagasaki 852, Japan	Tokyo University of Science; National Cancer Center - Japan; National Cancer Center - Japan; Okayama University; Nagasaki University	Sato, A (corresponding author), Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Biochem, Noda, Chiba 278, Japan.; Sato, A (corresponding author), Natl Canc Ctr, Div Genome Stabil Res, Chuo Ku, Tokyo, Japan.; Sato, A (corresponding author), Natl Canc Ctr, Div Chemotherapy & Clin Res, Chuo Ku, Tokyo, Japan.; Sato, A (corresponding author), Okayama Univ, Fac Pharmaceut Sci, Dept Drug Informat, Kita Ku, Okayama 700, Japan.	akirasat@rs.tus.ac.jp		Sato, Akira/0000-0002-2239-6208	JSPS KAKENHI Grant [21790078, 24790216, 26460310]	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding provided by JSPS KAKENHI Grant Numbers 21790078 (AS (first author)), 24790216 (AS (first author)), and 26460310 (AS (first author)).	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Barde I, 2013, SCIENCE, V340, P350, DOI 10.1126/science.1232398; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BESTWICK RK, 1982, J BIOL CHEM, V257, P9300; Butin-Israeli V, 2015, MOL CELL BIOL, V35, P884, DOI 10.1128/MCB.01145-14; Chen YX, 2012, PHYSIOL GENOMICS, V44, P1042, DOI 10.1152/physiolgenomics.00052.2012; Curbo S, 2004, NUCLEOS NUCLEOT NUCL, V23, P1495, DOI 10.1081/NCN-200027709; Fiers W, 1999, ONCOGENE, V18, P7719, DOI 10.1038/sj.onc.1203249; Galluzzi L, 2015, CELL DEATH DIFFER, V22, P58, DOI 10.1038/cdd.2014.137; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Gefen N, 2010, LEUKEMIA, V24, P89, DOI 10.1038/leu.2009.208; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kakutani T, 1998, BIOCHEM BIOPH RES CO, V247, P773, DOI 10.1006/bbrc.1998.8797; Kakutani T, 1998, NUCLEOS NUCLEOT NUCL, V17, P1299, DOI 10.1080/07328319808003468; Kawahara A, 1998, GENES CELLS, V3, P297, DOI 10.1046/j.1365-2443.1998.00189.x; Lee I, 2009, GENOME RES, V19, P1175, DOI 10.1101/gr.089367.108; Li X, 2012, RNA BIOL, V9, P292, DOI 10.4161/rna.19100; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Mor E, 2011, NUCLEIC ACIDS RES, V39, P3710, DOI 10.1093/nar/gkq1325; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Oom AL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/959461; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Price C, 2014, GENES DIS, V1, P53, DOI 10.1016/j.gendis.2014.06.004; Saetrom P, 2009, CANCER RES, V69, P7459, DOI 10.1158/0008-5472.CAN-09-1201; Sato A, 2008, GENOMICS, V92, P9, DOI 10.1016/j.ygeno.2008.02.002; Sato A, 2008, NUCLEOS NUCLEOT NUCL, V27, P433, DOI 10.1080/15257770802086864; Sato A, 2014, FEBS J, V281, P1892, DOI 10.1111/febs.12752; Sato A, 2010, J PROTEOME RES, V9, P2329, DOI 10.1021/pr9010537; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Shenoy A, 2014, NAT REV MOL CELL BIO, V15, P565, DOI 10.1038/nrm3854; Shirai H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.133; Sun YM, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-6; Tang CW, 2008, J CELL SCI, V121, P1014, DOI 10.1242/jcs.020982; Thomas RL, 2013, CIRC J, V77, P2449, DOI 10.1253/circj.CJ-13-0835; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Xu PZ, 2004, TRENDS GENET, V20, P617, DOI 10.1016/j.tig.2004.09.010; YOSHIOKA A, 1987, BIOCHEM BIOPH RES CO, V146, P258, DOI 10.1016/0006-291X(87)90719-4; YOSHIOKA A, 1987, J BIOL CHEM, V262, P8235	41	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153130	10.1371/journal.pone.0153130	http://dx.doi.org/10.1371/journal.pone.0153130			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27071035	Green Published, Green Submitted, gold			2022-12-26	WOS:000373900700033
J	Zhao, C; Chen, X; Zang, D; Lan, X; Liao, S; Yang, C; Zhang, P; Wu, J; Li, X; Liu, N; Liao, Y; Huang, H; Shi, X; Jiang, L; Liu, X; He, Z; Dou, QP; Wang, X; Liu, J				Zhao, C.; Chen, X.; Zang, D.; Lan, X.; Liao, S.; Yang, C.; Zhang, P.; Wu, J.; Li, X.; Liu, N.; Liao, Y.; Huang, H.; Shi, X.; Jiang, L.; Liu, X.; He, Z.; Dou, Q. P.; Wang, X.; Liu, J.			A novel nickel complex works as a proteasomal deubiquitinase inhibitor for cancer therapy	ONCOGENE			English	Article							ANTIRHEUMATIC AGENT AURANOFIN; ACID INDUCES APOPTOSIS; MYELOID-LEUKEMIA CELLS; GAMBOGIC ACID; 26S PROTEASOME; IN-VITRO; DEGRADATION; RECRUITMENT; IMPAIRMENT; ACTIVATION	Based on the central role of the ubiquitin-proteasome system (UPS) in the degradation of cellular proteins, proteasome inhibition has been considered an attractive approach for anticancer therapy. Deubiquitinases (DUBs) remove ubiquitin conjugates from diverse substrates; therefore, they are essential regulators of the UPS. DUB inhibitors, especially the inhibitors of proteasomal DUBs are becoming a research hotspot in targeted cancer therapy. Previous studies have shown that metal complexes, such as copper and zinc complexes, can induce cancer cell apoptosis through inhibiting UPS function. Moreover, we have found that copper pyrithione inhibits both 19S proteasome-associated DUBs and 20S proteasome activity with a mechanism distinct from that of the classical 20S proteasome inhibitor bortezomib. In the present study, we reveal that (i) nickel pyrithione complex (NiPT) potently inhibits the UPS via targeting the 19S proteasome-associated DUBs (UCHL5 and USP14), without effecting on the 20S proteasome; (ii) NiPT selectively induces proteasome inhibition and apoptosis in cultured tumor cells and cancer cells from acute myeloid leukemia human patients; and (iii) NiPT inhibits proteasome function and tumor growth in nude mice. This study, for the first time, uncovers a nickel complex as an effective inhibitor of the 19S proteasomal DUBs and suggests a potentially new strategy for cancer treatment.	[Zhao, C.; Chen, X.; Zang, D.; Lan, X.; Liao, S.; Yang, C.; Zhang, P.; Wu, J.; Li, X.; Liu, N.; Liao, Y.; Huang, H.; Shi, X.; Jiang, L.; Wang, X.; Liu, J.] Guangzhou Med Univ, Dept Pathophysiol, Prot Modificat & Degradat Lab, State Key Lab Resp Dis, Dongfeng Xi Rd 195, Guangzhou 510182, Guangdong, Peoples R China; [Liu, N.] Guangzhou Med Univ, Affiliated Hosp 2, Guangzhou Res Inst Cardiovasc Dis, Guangzhou, Guangdong, Peoples R China; [Liu, X.] Henan Univ, Coll Chem & Chem Engn, Inst Environm & Analyt Sci, Kaifeng, Peoples R China; [Liu, X.] Key Lab Nat Drug & Immune Engn Henan Prov, Kaifeng, Peoples R China; [He, Z.] Guangzhou Med Univ, Canc Hosp, Guangzhou, Guangdong, Peoples R China; [He, Z.] Guangzhou Med Univ, Canc Res Inst, Guangzhou, Guangdong, Peoples R China; [Dou, Q. P.] Wayne State Univ, Barbara Ann Karmanos Canc Inst, Mol Therapeut Program, Detroit, MI USA; [Dou, Q. P.] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI USA; [Dou, Q. P.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI USA; [Dou, Q. P.] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI USA; [Wang, X.] Univ South Dakota, Sanford Sch Med, Div Basic Biomed Sci, Vermillion, SD 57069 USA	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Guangzhou Medical University; Henan University; Guangzhou Medical University; Guangzhou Medical University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; Wayne State University; Wayne State University; University of South Dakota	Liu, J (corresponding author), Guangzhou Med Univ, Dept Pathophysiol, Prot Modificat & Degradat Lab, State Key Lab Resp Dis, Dongfeng Xi Rd 195, Guangzhou 510182, Guangdong, Peoples R China.	jliu@gzhmu.edu.cn	Wang, Xuejun/K-8874-2013; Chen, Xin/ABJ-3846-2022; Wang, Xuejun/AAT-9490-2021	Wang, Xuejun/0000-0001-9267-1343; Chen, Xin/0000-0003-3668-4830; Wang, Xuejun/0000-0001-9267-1343; Dou, Qingping/0000-0002-6465-1473	National High Technology Research and Development Program of China [2006AA02Z4B5]; NSFC [81272451/H1609, 81472762/H1609]; MOE [20134423110002]; Guangdong Key Laboratory of Urology [2010A060801016]; US NIH [HL072166, HL085629]; NATIONAL CANCER INSTITUTE [R21CA184788] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072166, R01HL085629] Funding Source: NIH RePORTER	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); NSFC(National Natural Science Foundation of China (NSFC)); MOE(Ministry of Higher Education & Scientific Research (MHESR)); Guangdong Key Laboratory of Urology; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital and Sun Yat-Sen University for flow cytometry detection. This work was supported by the National High Technology Research and Development Program of China (2006AA02Z4B5), NSFC (81272451/H1609, 81472762/H1609), MOE (20134423110002) and Guangdong Key Laboratory of Urology (2010A060801016) (to JL) and in part by US NIH grants HL072166 and HL085629 (to XW).	Adams J, 2003, CANCER TREAT REV, V29, P3, DOI 10.1016/S0305-7372(03)00081-1; Adams J, 2004, CANCER CELL, V5, P417, DOI 10.1016/S1535-6108(04)00120-5; Atasever B, 2010, INVEST NEW DRUG, V28, P421, DOI 10.1007/s10637-009-9272-2; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Burger AM, 2004, EUR J CANCER, V40, P2217, DOI 10.1016/j.ejca.2004.07.006; Chen D, 2011, CURR CANCER DRUG TAR, V11, P239, DOI 10.2174/156800911794519752; Chen D, 2007, CANCER RES, V67, P9258, DOI 10.1158/0008-5472.CAN-07-1813; Chen JN, 2004, TOXICOL APPL PHARM, V197, P40, DOI 10.1016/j.taap.2004.02.004; Chen X, 2014, ONCOTARGET, V5, P9118, DOI 10.18632/oncotarget.2361; Cvek B, 2008, J MED CHEM, V51, P6256, DOI 10.1021/jm8007807; D'Arcy P, 2011, NAT MED, V17, P1636, DOI 10.1038/nm.2536; Dayal S, 2009, J BIOL CHEM, V284, P5030, DOI 10.1074/jbc.M805871200; Denkhaus E, 2002, CRIT REV ONCOL HEMAT, V42, P35, DOI 10.1016/S1040-8428(01)00214-1; Dinning AJ, 1998, J APPL MICROBIOL, V85, P132; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Florea Ana-Maria, 2011, Cancers (Basel), V3, P1351, DOI 10.3390/cancers3011351; Fraile JM, 2012, ONCOGENE, V31, P2373, DOI 10.1038/onc.2011.443; Frezza M, 2009, INORG CHEM, V48, P5928, DOI 10.1021/ic900276g; Huang HB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049062; Huang HB, 2010, CELL RES, V20, P1372, DOI 10.1038/cr.2010.123; Jamieson ER, 1999, CHEM REV, V99, P2467, DOI 10.1021/cr980421n; Koulich E, 2008, MOL BIOL CELL, V19, P1072, DOI 10.1091/mbc.E07-10-1040; Li XF, 2013, CELL REP, V3, P211, DOI 10.1016/j.celrep.2012.11.023; Liu JB, 2006, FASEB J, V20, P362, DOI 10.1096/fj.05-4869fje; Liu NN, 2014, ONCOTARGET, V5, P5453, DOI 10.18632/oncotarget.2113; Liu NN, 2014, SCI REP-UK, V4, DOI 10.1038/srep05240; Mani A, 2005, J CLIN ONCOL, V23, P4776, DOI 10.1200/JCO.2005.05.081; Milacic V, 2008, TOXICOL APPL PHARM, V231, P24, DOI 10.1016/j.taap.2008.03.009; Pabla N, 2008, J BIOL CHEM, V283, P6572, DOI 10.1074/jbc.M707568200; Paramore A, 2003, NAT REV DRUG DISCOV, V2, P611, DOI 10.1038/nrd1159; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Sacco JJ, 2010, IUBMB LIFE, V62, P140, DOI 10.1002/iub.300; Shi XP, 2015, SCI REP-UK, V5, DOI 10.1038/srep09694; Shi XP, 2014, CLIN CANCER RES, V20, P151, DOI 10.1158/1078-0432.CCR-13-1063; Singhal S, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S3; Tailler M, 2012, ONCOGENE, V31, P3536, DOI 10.1038/onc.2011.521; Tan J, 2010, BIOMETALS, V23, P1075, DOI 10.1007/s10534-010-9353-x; Tian Z, 2014, BLOOD, V123, P706, DOI 10.1182/blood-2013-05-500033; Todi SV, 2011, TRENDS NEUROSCI, V34, P370, DOI 10.1016/j.tins.2011.05.004; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Verani CN, 2012, J INORG BIOCHEM, V106, P59, DOI 10.1016/j.jinorgbio.2011.09.003; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Yang HJ, 2009, INT J CANCER, V124, P2450, DOI 10.1002/ijc.24195; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460	45	48	49	2	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 10	2016	35	45					5916	5927		10.1038/onc.2016.114	http://dx.doi.org/10.1038/onc.2016.114			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EB7IR	27086925	Green Accepted			2022-12-26	WOS:000387560800010
J	Kadiyala, V; Sasse, SK; Altonsy, MO; Berman, R; Chu, HW; Phang, TL; Gerber, AN				Kadiyala, Vineela; Sasse, Sarah K.; Altonsy, Mohammed O.; Berman, Reena; Chu, Hong W.; Phang, Tzu L.; Gerber, Anthony N.			Cistrome-based Cooperation between Airway Epithelial Glucocorticoid Receptor and NF-kappa B Orchestrates Anti-inflammatory Effects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; NEGATIVE REGULATOR; CHROMATIN ACCESSIBILITY; TRANSCRIPTION FACTORS; GENE-TRANSCRIPTION; INNATE IMMUNITY; BINDING-SITES; TARGET GENES; MAST-CELLS; CHIP-SEQ	Antagonism of pro-inflammatory transcription factors by monomeric glucocorticoid receptor (GR) has long been viewed as central to glucocorticoid (GC) efficacy. However, the mechanisms and targets through which GCs exert therapeutic effects in diseases such as asthma remain incompletely understood. We previously defined a surprising cooperative interaction between GR and NF-kappa B that enhanced expression of A20 (TNFAIP3), a potent inhibitor of NF-kappa B. Here we extend this observation to establish that A20 is required for maximal cytokine repression by GCs. To ascertain the global extent of GR and NF-kappa B cooperation, we determined genome-wide occupancy of GR, the p65 subunit of NF-kappa B, and RNA polymerase II in airway epithelial cells treated with dexamethasone, TNF, or both using chromatin immunoprecipitation followed by deep sequencing. We found that GR recruits p65 to dimeric GR binding sites across the genome and discovered additional regulatory elements in which GR-p65 cooperation augments gene expression. GR targets regulated by this mechanism include key anti-inflammatory and injury response genes such as SERPINA1, which encodes alpha 1 antitrypsin, and FOXP4, an inhibitor of mucus production. Although dexamethasone treatment reduced RNA polymerase II occupancy of TNF targets such as IL8 and TNFAIP2, we were unable to correlate specific binding sequences for GR or occupancy patterns with repressive effects on transcription. Our results suggest that cooperative anti-inflammatory gene regulation by GR and p65 contributes to GC efficacy, whereas tethering interactions between GR and p65 are not universally required for GC-based gene repression.	[Kadiyala, Vineela; Sasse, Sarah K.; Altonsy, Mohammed O.; Berman, Reena; Chu, Hong W.; Gerber, Anthony N.] Natl Jewish Hlth, Dept Med, Rm K621,1400 Jackson St, Denver, CO 80206 USA; [Altonsy, Mohammed O.] Sohag Univ, Dept Zool, Sohag 825224, Egypt; [Phang, Tzu L.; Gerber, Anthony N.] Univ Colorado, Dept Med, Denver, CO 80045 USA	National Jewish Health; Egyptian Knowledge Bank (EKB); Sohag University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Gerber, AN (corresponding author), Natl Jewish Hlth, Dept Med, Rm K621,1400 Jackson St, Denver, CO 80206 USA.	gerbera@njhealth.org			National Institutes of Health [P30-CA046934]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109557] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Katrina Diener for expert technical assistance and Robert Newton for critical review of the manuscript. ChIP sequencing was performed at the University of Colorado Cancer Center, which is supported by National Institutes of Health Grant P30-CA046934 (NCI).	Allen MA, 2014, ELIFE, V3, DOI 10.7554/eLife.02200; Altonsy MO, 2014, J BIOL CHEM, V289, P8231, DOI 10.1074/jbc.M113.545178; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Azofeifa JG, 2017, IEEE ACM T COMPUT BI, V14, P1070, DOI 10.1109/TCBB.2016.2520919; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berman R, 2014, J CLIN CELL IMMUNOL, V5, P257; Bhakta Nirav R, 2013, Clin Transl Allergy, V3, P24, DOI 10.1186/2045-7022-3-24; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Bouazza B, 2014, AM J RESP CELL MOL, V50, P301, DOI 10.1165/rcmb.2012-0522OC; Bradding P, 2016, CLIN EXP ALLERGY, V46, P194, DOI 10.1111/cea.12675; Chang I, 2013, J CLIN INVEST, V123, P2643, DOI 10.1172/JCI66735; Clark AR, 2012, PHARMACOL THERAPEUT, V134, P54, DOI 10.1016/j.pharmthera.2011.12.004; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; Deregowski V, 2002, BIOCHEM PHARMACOL, V64, P873, DOI 10.1016/S0006-2952(02)01151-6; Edwards MR, 2006, AM J RESP CELL MOL, V34, P616, DOI 10.1165/rcmb.2005-0385OC; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; Gerber AN, 2015, ADV EXP MED BIOL, V872, P279, DOI 10.1007/978-1-4939-2895-8_12; Gertz J, 2013, MOL CELL, V52, P25, DOI 10.1016/j.molcel.2013.08.037; Gong DP, 2013, J IMMUNOL, V191, P4514, DOI 10.4049/jimmunol.1202603; Hallstrand TS, 2014, CLIN IMMUNOL, V151, P1, DOI 10.1016/j.clim.2013.12.003; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Hiemstra PS, 2015, EUR RESPIR J, V45, P1150, DOI 10.1183/09031936.00141514; Holden NS, 2014, J PHARMACOL EXP THER, V348, P12, DOI 10.1124/jpet.113.204586; Horvath AJ, 2005, J BIOL CHEM, V280, P43168, DOI 10.1074/jbc.M505598200; Hosakote YM, 2011, AM J RESP CRIT CARE, V183, P1550, DOI 10.1164/rccm.201010-1755OC; Hu AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060452; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kadiyala V, 2016, ANN AM THORAC SOC, V13, pS103, DOI 10.1513/AnnalsATS.201508-534MG; Kelly MM, 2012, BRIT J PHARMACOL, V165, P1737, DOI 10.1111/j.1476-5381.2011.01620.x; King EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053936; Kraft M, 2003, CHEST, V124, P42, DOI 10.1378/chest.124.1.42; Lambert WM, 2013, MOL CELL BIOL, V33, P3700, DOI 10.1128/MCB.00150-13; Langlais D, 2012, MOL CELL, V47, P38, DOI 10.1016/j.molcel.2012.04.021; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lannan EA, 2012, ENDOCRINOLOGY, V153, P3701, DOI 10.1210/en.2012-1020; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Li SR, 2012, DEVELOPMENT, V139, P2500, DOI 10.1242/dev.079699; Liang K, 2012, BIOINFORMATICS, V28, P121, DOI 10.1093/bioinformatics/btr605; Lim HW, 2015, GENOME RES, V25, P836, DOI 10.1101/gr.188581.114; Liu T, 2014, METHODS MOL BIOL, V1150, P81, DOI 10.1007/978-1-4939-0512-6_4; Lu XQ, 2008, BLOOD, V112, P4098, DOI 10.1182/blood-2008-03-148726; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; MacIntyre NR, 2006, RESP CARE, V51, P289; Martinez FD, 2013, LANCET, V382, P1360, DOI 10.1016/S0140-6736(13)61536-6; McMaster A, 2008, NAT CLIN PRACT ENDOC, V4, P91, DOI 10.1038/ncpendmet0745; Meijsing SH, 2015, ADV EXP MED BIOL, V872, P59, DOI 10.1007/978-1-4939-2895-8_3; Miyata M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7062; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nicolaides NC, 2010, STEROIDS, V75, P1, DOI 10.1016/j.steroids.2009.09.002; Pelaia G, 2015, EXPERT OPIN PHARMACO, V16, P2009, DOI 10.1517/14656566.2015.1070826; Raney BJ, 2014, BIOINFORMATICS, V30, P1003, DOI 10.1093/bioinformatics/btt637; Rao NAS, 2011, GENOME RES, V21, P1404, DOI 10.1101/gr.118042.110; Reddy TE, 2012, MOL CELL BIOL, V32, P3756, DOI 10.1128/MCB.00062-12; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Roesler WJ, 1998, MOL CELL BIOCHEM, V178, P1, DOI 10.1023/A:1006886421795; Sacta MA, 2016, ANNU REV PHYSIOL, V78, P155, DOI 10.1146/annurev-physiol-021115-105323; Sasse SK, 2015, J BIOL CHEM, V290, P19756, DOI 10.1074/jbc.M115.668558; Sasse SK, 2013, MOL CELL BIOL, V33, P2104, DOI 10.1128/MCB.01474-12; Schaecke H, 2007, MOL CELL ENDOCRINOL, V275, P109, DOI 10.1016/j.mce.2007.05.014; SCHEINMAN RI, 1995, SCIENCE, V270, P283, DOI 10.1126/science.270.5234.283; Shipp LE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013754; Siedlinski M, 2009, EUR RESPIR J, V33, P986, DOI 10.1183/09031936.00171507; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; Stafford JM, 2001, J BIOL CHEM, V276, P3811, DOI 10.1074/jbc.M009389200; Starick SR, 2015, GENOME RES, V25, P825, DOI 10.1101/gr.185157.114; Surjit M, 2011, CELL, V145, P224, DOI 10.1016/j.cell.2011.03.027; Suzuki S, 2006, FEBS LETT, V580, P3257, DOI 10.1016/j.febslet.2006.04.086; Thun GA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003585; Uhlenhaut NH, 2013, MOL CELL, V49, P158, DOI 10.1016/j.molcel.2012.10.013; Vandevyver S, 2013, ENDOCRINOLOGY, V154, P993, DOI 10.1210/en.2012-2045; Vandevyver S, 2012, J CLIN INVEST, V122, P2130, DOI 10.1172/JCI60006; Vettorazzi S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8796; Walsh GM, 2003, J ENDOCRINOL, V178, P37, DOI 10.1677/joe.0.1780037; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; Wu Q, 2013, VIROLOGY, V446, P199, DOI 10.1016/j.virol.2013.08.005; Wu Q, 2012, J ALLERGY CLIN IMMUN, V129, P825, DOI 10.1016/j.jaci.2011.10.043; Wu Q, 2009, EXPERT REV CLIN IMMU, V5, P97, DOI 10.1586/1744666X.5.1.97; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Zhang N, 2007, J IMMUNOL, V179, P578, DOI 10.4049/jimmunol.179.1.578	81	28	30	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2016	291	24					12673	12687		10.1074/jbc.M116.721217	http://dx.doi.org/10.1074/jbc.M116.721217			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9PV	27076634	Green Published, hybrid			2022-12-26	WOS:000378119900022
J	Oh, IH; Choi, EY; Park, JS; Lee, CH				Oh, Il Hwan; Choi, Eun Young; Park, Joon-Sung; Lee, Chang Hwa			Association of Serum Ferritin and Kidney Function with Age-Related Macular Degeneration in the General Population	PLOS ONE			English	Article							METABOLIC SYNDROME; RISK-FACTORS; IRON; PATHOGENESIS; DISEASE; HEALTH	Ferritin is considered to be a marker of the body's iron stores and has a potential relationship with the systemic manifestations of inflammatory reactions. Data on the association between increased levels of serum ferritin and ocular problems are limited, particularly in relation to age-related macular degeneration (AMD). Serum ferritin levels, as a possible clinical parameter for predicting AMD, were analyzed in anthropometric, biochemical, and ophthalmologic data from a nation-wide, population-based, case-control study (KNHNES IV and V). All native Koreans aged >= 20 years and who had no medical illness were eligible to participate. Among them, 2.9% had AMD, and its prevalence was found to increase in the higher ferritin quintile groups (P-trend < 0.0001). In multiple linear regression analysis, serum ferritin level was closely related to conventional risk factors for AMD. Comparison of early AMD with a control group showed that serum ferritin levels were closely associated with AMD (OR = 1.004, 95% CI = 1.002-1.006), and further adjustment for age, gender, serum iron, and kidney function did not reduce this association (OR = 1.003, 95% CI = 1.001-1.006). Furthermore, the relationship between ferritin quintile and early AMD was dose-dependent. Thus, an increased level of serum ferritin in a healthy person may be a useful indicator of neurodegenerative change in the macula. A large population-based prospective clinical study is needed to confirm these findings.	[Oh, Il Hwan; Choi, Eun Young; Park, Joon-Sung; Lee, Chang Hwa] Hanyang Univ, Coll Med, Dept Internal Med, Seoul 133791, South Korea	Hanyang University	Park, JS; Lee, CH (corresponding author), Hanyang Univ, Coll Med, Dept Internal Med, Seoul 133791, South Korea.	sjpjoon@hanyang.ac.kr; changhwa@hanyang.ac.kr						Aoki A, 2015, INVEST OPHTH VIS SCI, V56, P2580, DOI 10.1167/iovs.14-16339; Batista-Nascimento L, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/128647; Cho E, 2001, AM J CLIN NUTR, V73, P209; Friedman A, 2011, PARKINSONISM RELAT D, V17, P423, DOI 10.1016/j.parkreldis.2011.03.016; Friedman E, 2000, AM J OPHTHALMOL, V130, P658, DOI 10.1016/S0002-9394(00)00643-7; Gao JY, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/690243; Ghosh A, 2007, EUR J CLIN NUTR, V61, P412, DOI 10.1038/sj.ejcn.1602534; Gonzalez AS, 2006, EUR J CLIN NUTR, V60, P802, DOI 10.1038/sj.ejcn.1602384; Hahn P, 2003, ARCH OPHTHALMOL-CHIC, V121, P1099, DOI 10.1001/archopht.121.8.1099; Jehn M, 2004, DIABETES CARE, V27, P2422, DOI 10.2337/diacare.27.10.2422; Kauppinen A, 2012, IMMUNOL LETT, V147, P29, DOI 10.1016/j.imlet.2012.05.005; Kell DB, 2014, METALLOMICS, V6, P748, DOI 10.1039/c3mt00347g; Kim EC, 2014, INVEST OPHTH VIS SCI, V55, P4823, DOI 10.1167/iovs.14-14763; Klein R, 2007, AM J OPHTHALMOL, V143, P473, DOI 10.1016/j.ajo.2006.11.058; Koorts A. M., 2007, Archives of Physiology and Biochemistry, V113, P30, DOI 10.1080/13813450701318583; Krenn MA, 2015, FREE RADICAL BIO MED, V80, P48, DOI 10.1016/j.freeradbiomed.2014.12.007; Lederman M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087751; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lin SC, 2014, JAMA OPHTHALMOL, V132, P1414, DOI 10.1001/jamaophthalmol.2014.2876; Loh A, 2009, BBA-GEN SUBJECTS, V1790, P637, DOI 10.1016/j.bbagen.2008.11.001; Mainous AG, 2004, AM J CARDIOL, V93, P559, DOI 10.1016/j.amjcard.2003.11.018; Maralani HG, 2015, RETINA-J RET VIT DIS, V35, P459, DOI 10.1097/IAE.0000000000000338; Moore C, 2013, JCR-J CLIN RHEUMATOL, V19, P324, DOI 10.1097/RHU.0b013e31829ce01f; Nowak JZ, 2006, PHARMACOL REP, V58, P353; Park SJ, 2014, OPHTHALMOLOGY, V121, P1756, DOI 10.1016/j.ophtha.2014.03.022; Peeters A, 2008, ARCH OPHTHALMOL-CHIC, V126, P1554, DOI 10.1001/archopht.126.11.1554; Richer Stuart, 2002, Am J Ther, V9, P25, DOI 10.1097/00045391-200201000-00006; Schipper HM, 2012, BBA-MOL BASIS DIS, V1822, P350, DOI 10.1016/j.bbadis.2011.06.016; Smith W, 1998, ARCH OPHTHALMOL-CHIC, V116, P583, DOI 10.1001/archopht.116.5.583; Sun L, 2008, J CLIN ENDOCR METAB, V93, P4690, DOI 10.1210/jc.2008-1159	30	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153624	10.1371/journal.pone.0153624	http://dx.doi.org/10.1371/journal.pone.0153624			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096155	gold, Green Published			2022-12-26	WOS:000374543600046
J	Cheung, KW; Peng, QL; He, LF; Cai, KR; Jiang, Q; Zhou, BP; To, SWC; Yam, WC; Liu, L; Chen, ZW; Wang, H				Cheung, Ka-Wai; Peng, Qiaoli; He, Liufen; Cai, Kanru; Jiang, Qiang; Zhou, Boping; To, Sabrina Wai-Chi; Yam, Wing-Cheong; Liu, Li; Chen, Zhiwei; Wang, Hui			Rapid and Simultaneous Detection of Major Drug Resistance Mutations in Reverse Transcriptase Gene for HIV-1 CRF01_AE, CRF07_BC and Subtype B in China Using Sequenom MassARRAY (R) System	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; ANTIRETROVIRAL THERAPY; GENOTYPING ASSAY; PREVALENCE; IDENTIFICATION; MORTALITY; VARIANTS; PROTEASE	`The development of a rapid, high -throughput and cost-effective HIV-1 drug resistance (HIV DR) testing system is a challenge for areas consisting different HIV-1 strains. In this study, we established a broadly reactive multiplex assay that could simultaneously detect major drug resistance mutations at 8 loci, which are associated with resistance to commonly used nucleoside reverse transcriptase inhibitors (NRTIs) and Non -nucleoside reverse transcriptase inhibitors (NNRTIs), in specimens of HIV-1 CRF01_AE, CRF07_BC and subtype B, the three major circulating strains in China, using the matrix -assisted laser desorption ionization -time of flight mass spectrometry (MALDI-TOF MS) provided by Sequenom MassARRAY system. To establish the assay, pol gene fragments were prepared from the plasma viral RNA of 159 patients by nested PCR and the presence of wild type and mutant alleles at the 8 loci were analyzed by MALDI-TOF MS. In terms of loci, the detection rate of the alleles was greater than 97% for M41L, K65R, M184V and G190A, 91.2% for K101E/Q/P, 91.2% for T215FN, 89.9% for K103N/S and 80.5% for L210W. In terms of individuals, 80% of the alleles were detected in 95.4% CRF01_AE patients, 100% CRF07_BC patients and 83.3% subtype B patients. Importantly, the MALDI-TOF MS results were concordant to the drug resistance profiles of patients obtained from conventional sequencing analysis after excluded the failed detections. Using plasmid templates, the assay was estimated to be sensitive to detect drug resistant variants at level about 20% of the circulating viral population. The capability of this assay to detect mixed viral populations was further verified by two different patient specimens. In conclusion, this study evaluated the use of Sequenom MassARRAY (R) system for high-throughput detection of HIV-DR mutations towards the commonly used reverse transcriptase inhibitors in China.	[Cheung, Ka-Wai; Liu, Li; Chen, Zhiwei] Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Infect & Immun, AIDS Inst, 21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China; [Cheung, Ka-Wai; Liu, Li; Chen, Zhiwei] Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Infect & Immun, Dept Microbiol, 21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China; [Peng, Qiaoli; He, Liufen; Cai, Kanru; Jiang, Qiang; Zhou, Boping; Wang, Hui] Guangdong Med Coll, HKU AIDS Inst Shenzhen Res Lab, Shenzhen Peoples Hosp 3, Shenzhen, Peoples R China; [Peng, Qiaoli; He, Liufen; Cai, Kanru; Jiang, Qiang; Zhou, Boping; Wang, Hui] Guangdong Med Coll, AIDS Clin Res Lab, Shenzhen Peoples Hosp 3, Guangdong Key Lab Emerging Infect Dis, Shenzhen, Peoples R China; [Peng, Qiaoli; He, Liufen; Cai, Kanru; Jiang, Qiang; Zhou, Boping; Wang, Hui] Guangdong Med Coll, Shenzhen Key Lab Infect & Immun, Shenzhen Peoples Hosp 3, Shenzhen, Peoples R China; [To, Sabrina Wai-Chi; Yam, Wing-Cheong] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; Guangdong Medical University; Guangdong Medical University; Guangdong Medical University; University of Hong Kong	Chen, ZW (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Infect & Immun, AIDS Inst, 21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.; Chen, ZW (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Infect & Immun, Dept Microbiol, 21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.; Wang, H (corresponding author), Guangdong Med Coll, HKU AIDS Inst Shenzhen Res Lab, Shenzhen Peoples Hosp 3, Shenzhen, Peoples R China.; Wang, H (corresponding author), Guangdong Med Coll, AIDS Clin Res Lab, Shenzhen Peoples Hosp 3, Guangdong Key Lab Emerging Infect Dis, Shenzhen, Peoples R China.; Wang, H (corresponding author), Guangdong Med Coll, Shenzhen Key Lab Infect & Immun, Shenzhen Peoples Hosp 3, Shenzhen, Peoples R China.	zchenai@hku.hk; huiwang98@yahoo.com	Liu, Li/ABA-8315-2020; Chen, Zhiwei/B-7793-2019	Liu, Li/0000-0003-2566-7357; Chen, Zhiwei/0000-0002-4511-2888	Hong Kong AIDS Trust Fund [MSS183R, MSS227R]; Science and Technology key projects [201001010]; University Development Fund (HKU-UDF); Li Ka Shing Faculty of Medicine Matching Fund; Shenzhen San-Ming Program	Hong Kong AIDS Trust Fund; Science and Technology key projects; University Development Fund (HKU-UDF); Li Ka Shing Faculty of Medicine Matching Fund; Shenzhen San-Ming Program	This work was supported by Hong Kong AIDS Trust Fund (MSS183R) to ZC (www.atf.gov.hk) and Science and Technology key projects (201001010) to HW. The authors thank the University Development Fund (HKU-UDF) and Li Ka Shing Faculty of Medicine Matching Fund (www.hku.hk) for financial supports to AIDS Institute. The authors also thank for the support of Hong Kong AIDS Trust Fund (MSS227R) to ZC and Shenzhen San-Ming Program to HW. KWC, supported by the fellowship from MSS183R and MSS227R, played a role in study design, data collection and analysis as well as preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, MANUAL NATL FREE ANT; Bouakaze C, 2011, J CLIN MICROBIOL, V49, P3292, DOI 10.1128/JCM.00744-11; Cao YZ, 2005, CELL RES, V15, P883, DOI 10.1038/sj.cr.7290363; Chinese Center for Disease Control and Prevention, 2012, AN HIV STD EP 2012; Dudley DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036494; Eshleman SH, 2005, J CLIN MICROBIOL, V43, P813, DOI 10.1128/JCM.43.2.813-817.2005; Grant RM, 2003, J CLIN MICROBIOL, V41, P1586, DOI 10.1128/JCM.41.4.1586-1593.2003; He X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047289; Hong SP, 2008, NAT PROTOC, V3, P1476, DOI 10.1038/nprot.2008.136; Lee JH, 2013, CLIN MICROBIOL INFEC, V19, pE263, DOI 10.1111/1469-0691.12167; Liao LJ, 2013, AIDS, V27, P1815, DOI 10.1097/QAD.0b013e3283611931; Liao LJ, 2012, CLIN INFECT DIS, V54, pS320, DOI 10.1093/cid/cir1016; Luan J, 2009, CLIN CHEM, V55, P1503, DOI 10.1373/clinchem.2009.124859; Luo MQ, 2009, JAIDS-J ACQ IMM DEF, V50, P1, DOI 10.1097/QAI.0b013e31818ffcdc; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Russell JS, 2009, COMMUN DIS INTELL, V33, P216; Rybicka M, 2014, J CLIN MICROBIOL, V52, P9, DOI 10.1128/JCM.01891-13; Schuurman R, 1999, J CLIN MICROBIOL, V37, P2291, DOI 10.1128/JCM.37.7.2291-2296.1999; Shafer RW, 2009, J INFECT DIS, V199, P610, DOI 10.1086/596737; Stenman J, 2003, BIOTECHNIQUES, V34, P172, DOI 10.2144/03341dd05; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Wang X, 2012, AIDS RES HUM RETROV, V28, P1637, DOI [10.1089/aid.2012.0164, 10.1089/AID.2012.0164]; Wheeler WH, 2010, AIDS, V24, P1203, DOI 10.1097/QAD.0b013e3283388742; Xing H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062408; Xing H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054917; Yang CF, 2010, J CLIN MICROBIOL, V48, P3158, DOI 10.1128/JCM.00564-10; Zhang FJ, 2008, CLIN INFECT DIS, V47, P825, DOI 10.1086/590945; Zhang F, 2007, JAIDS-J ACQ IMM DEF, V44, P429, DOI 10.1097/QAI.0b013e31803133ac; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4; Zhang FJ, 2009, ANN INTERN MED, V151, P241, DOI 10.7326/0003-4819-151-4-200908180-00006; Zhang GQ, 2013, J CLIN MICROBIOL, V51, P3666, DOI 10.1128/JCM.01669-13; Zhang Y, 2006, PLOS MED, V3, P2065, DOI 10.1371/journal.pmed.0030443; Zhou ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028184	36	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153641	10.1371/journal.pone.0153641	http://dx.doi.org/10.1371/journal.pone.0153641			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27092551	Green Published, gold, Green Submitted			2022-12-26	WOS:000374541200036
J	Hao, Q; Du, PC; Zhang, W; Hou, XX; Zhang, L; Zhang, YY; Liu, HX; Liu, W; Chen, C; Wan, KL				Hao, Qin; Du, Pengcheng; Zhang, Wen; Hou, Xuexia; Zhang, Lin; Zhang, Yuanyuan; Liu, Huixin; Liu, Wei; Chen, Chen; Wan, Kanglin			Genomic Characteristics of Chinese Borrelia burgdorferi Isolates	PLOS ONE			English	Article							MULTILOCUS SEQUENCE-ANALYSIS; LYME-DISEASE SPIROCHETE; SENSU-LATO; SP NOV.; IDENTIFICATION	In China, B. burgdorferi, B. garinii, B. afzelii and B. yangtze sp. nov have been reported; B. garinii and B. afzelii are the main pathogenic genotypes. But until now only one Chinese strain was reported with whole genome sequence. In order to further understand the genomic characteristics and diversity of Chinese Borrelia strains, 5 isolates from China were sequenced and compared with the whole genome sequences of strains in other areas. The results showed a high degree of conservation within the linear chromosome of Chinese strains, whereas plasmid showed a much larger diversity according to the majority genomic information of plasmids. The genome sequences of the five Chinese strains were compared with the corresponding reference strains, respectively, according to the genospecies. Pair-wise analysis demonstrates that there are only 70 SNPs between the genomes of CS4 and B31. However, there are many more SNPs between the genomes of QX-S13 and VS116, PD91 and PBi, FP1 and PKo, R9 and Pko, respectively. Gene comparison showed some important different genes. OspA was one of the important different genes. Comparative genomic studies have found that OspA gene sequences of PD91 and R9 had great differences compared with the sequence of B31. OspA gene sequence of R9 had a 96bp deletion; OspA gene of PD91 had two deletions: 9bp and 10 bp. To conclude, we showed the genomic characteristics of four genotype Chinese B. burgdorferi strains. The genomic sequence of B. yangtze sp. nov and differences from B. valaisiana were first reported. Comparative analysis of Chinese strains with the different Borrelia species from other areas will help us to understand evolution and pathogenesis of Chinese Borrelia burgdorferi strains.	[Hao, Qin; Du, Pengcheng; Zhang, Wen; Hou, Xuexia; Zhang, Lin; Zhang, Yuanyuan; Liu, Huixin; Liu, Wei; Chen, Chen; Wan, Kanglin] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing 102206, Peoples R China; [Hao, Qin; Du, Pengcheng; Zhang, Wen; Hou, Xuexia; Zhang, Lin; Zhang, Yuanyuan; Liu, Huixin; Liu, Wei; Chen, Chen; Wan, Kanglin] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Chen, C; Wan, KL (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing 102206, Peoples R China.; Chen, C; Wan, KL (corresponding author), Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China.	chenchen@celloud.cn; wankanglin@icdc.cn	chen, chen/AAQ-1805-2021; CHEN, CHEN/HDM-6657-2022	chen, chen/0000-0003-1765-8899; Du, Pengcheng/0000-0002-2930-9920	Natural Science foundation [31100105]; National Key Science and Technology Projects of China [2013ZX10004-215, 2013ZX10004001]	Natural Science foundation(National Natural Science Foundation of China (NSFC)); National Key Science and Technology Projects of China	This study was funded by Natural Science foundation ( Grant No. 31100105) and National Key Science and Technology Projects of China (2013ZX10004-215 and 2013ZX10004001).	Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Casjens SR, 2011, J BACTERIOL, V193, P6995, DOI 10.1128/JB.05951-11; Casjens SR, 2011, J BACTERIOL, V193, P1489, DOI 10.1128/JB.01521-10; Chu CY, 2008, J CLIN MICROBIOL, V46, P3130, DOI 10.1128/JCM.01195-08; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Fukunaga M, 1996, INT J SYST BACTERIOL, V46, P898, DOI 10.1099/00207713-46-4-898; Glockner G, 2004, NUCLEIC ACIDS RES, V32, P6038, DOI 10.1093/nar/gkh953; Glockner G, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-211; Hao Q, 2011, J CLIN MICROBIOL, V49, P647, DOI 10.1128/JCM.00725-10; Huang WM, 2004, J BACTERIOL, V186, P4134, DOI 10.1128/JB.186.13.4134-4141.2004; Jiang BG, 2012, J BACTERIOL, V194, P6660, DOI 10.1128/JB.01844-12; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Liang FT, 2004, INFECT IMMUN, V72, P5759, DOI 10.1128/IAI.72.10.5759-5767.2004; Masuzawa T, 2001, INT J SYST EVOL MICR, V51, P1817, DOI 10.1099/00207713-51-5-1817; Nau R, 2009, DTSCH ARZTEBL INT, V106, P72, DOI 10.3238/arztebl.2009.0072; Pavan WO, 2009, INT J MED SCI, V6, P123; Postic D, 2007, INT J MED MICROBIOL, V297, P263, DOI 10.1016/j.ijmm.2007.01.006; Richter D, 2006, INT J SYST EVOL MICR, V56, P873, DOI 10.1099/ijs.0.64050-0; Rudenko N, 2009, J CLIN MICROBIOL, V47, P134, DOI 10.1128/JCM.01183-08; Schutzer SE, 2011, J BACTERIOL, V193, P1018, DOI 10.1128/JB.01158-10; Steere AC, 2004, J CLIN INVEST, V113, P1093, DOI [10.1172/JCI200421681, 10.1172/JCI21681]; Wang GQ, 1999, CLIN MICROBIOL REV, V12, P633, DOI 10.1128/CMR.12.4.633; WILSKE B, 1992, RES MICROBIOL, V143, P583, DOI 10.1016/0923-2508(92)90116-6; Zhang Z F, 1997, Zhonghua Liu Xing Bing Xue Za Zhi, V18, P8	26	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153149	10.1371/journal.pone.0153149	http://dx.doi.org/10.1371/journal.pone.0153149			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093540	gold, Green Published, Green Submitted			2022-12-26	WOS:000374541200013
J	White, PA; Ikanda, D; Ferrante, L; Chardonnet, P; Mesochina, P; Cameriere, R				White, Paula A.; Ikanda, Dennis; Ferrante, Luigi; Chardonnet, Philippe; Mesochina, Pascal; Cameriere, Roberto			Age Estimation of African Lions Panthera leo by Ratio of Tooth Areas	PLOS ONE			English	Article							POPULATION-DYNAMICS; CANINES; SAMPLE	Improved age estimation of African lions Panthera leo is needed to address a number of pressing conservation issues. Here we present a formula for estimating lion age to within six months of known age based on measuring the extent of pulp closure from X-rays, or Ratio Of tooth AReas (ROAR). Derived from measurements taken from lions aged 3-13 years for which exact ages were known, the formula explains 92% of the total variance. The method of calculating the pulp/ tooth area ratio, which has been used extensively in forensic science, is novel in the study of lion aging. As a quantifiable measure, ROAR offers improved lion age estimates for population modeling and investigations of age-related mortality, and may assist national and international wildlife authorities in judging compliance with regulatory measures involving age.	[White, Paula A.] Univ Calif Los Angeles, Ctr Trop Res, Inst Environm & Sustainabil, Los Angeles, CA USA; [Ikanda, Dennis] Tanzania Wildlife Res Inst, Arusha, Tanzania; [Ferrante, Luigi] Polytech Univ Marche, Ctr Epidemiol Biostat & Med Informat Technol, Dept Biomed Sci & Publ Hlth, Ancona, Italy; [Chardonnet, Philippe; Mesochina, Pascal] IGF Int Fdn Wildlife Management, Paris, France; [Cameriere, Roberto] Univ Macerata, Inst Legal Med, AgEstimat Project, Macerata, Italy	University of California System; University of California Los Angeles; Marche Polytechnic University; University of Macerata	White, PA (corresponding author), Univ Calif Los Angeles, Ctr Trop Res, Inst Environm & Sustainabil, Los Angeles, CA USA.	paw@carnivoreconservation.com		FERRANTE, LUIGI/0000-0001-9444-972X; White, Paula/0000-0002-1814-6265; cameriere, roberto/0000-0002-3775-2244	Safari Club International Foundation; IGF-Foundation	Safari Club International Foundation; IGF-Foundation	Field research was funded in part by Safari Club International Foundation (PAW, DI) and IGF-Foundation (DI, PC, PM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adobe Systems Incorporated, 2015, AD PHOT CS4 V 11 0 1; Angerbjorn A, 2004, BIOLOGY AND CONSERVATION OF WILD CANIDS, P163; Baldus RD, 2004, TOURIST HUNTING ITS; Barthold JA, 2016, J APPL ECOL, V53, P295, DOI 10.1111/1365-2664.12594; Cameriere R, 2009, FORENSIC SCI INT, V193, DOI 10.1016/j.forsciint.2009.09.011; Cameriere R, 2012, FORENSIC SCI INT, V214, P105, DOI 10.1016/j.forsciint.2011.07.028; Cameriere R, 2007, J FORENSIC SCI, V52, P166, DOI 10.1111/j.1556-4029.2006.00336.x; Cheater A., 2006, USE UPPER 2 PREMOLAR; Conover M., 2002, RESOLVING HUMAN WILD; Creel S, 2004, BIOLOGY AND CONSERVATION OF WILD CANIDS, P337; De Luca S, 2011, J FORENSIC SCI, V56, P1302, DOI 10.1111/j.1556-4029.2011.01784.x; Delahay RJ, 2011, J ZOOL, V284, P183, DOI 10.1111/j.1469-7998.2011.00796.x; Efron B., 1982, CBMS NSF REGIONAL C; European Commission. Commission Regulation (EU), 2015, OFFICIAL J EUROPEAN; Fabbri PF, 2015, AM J PHYS ANTHROPOL, V158, P423, DOI 10.1002/ajpa.22796; Foresman KR, 2012, TECH ECOL CONSERVAT, P130; Frank LG, 2005, CONSERV BIOL SER, V9, P286; Groom RJ, 2014, ORYX, V48, P385, DOI 10.1017/S0030605312001457; Klevezal G.A., 1967, TRANSLATION SERIES, V1024; Lindsey PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073808; Lindsey PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029332; Loveridge AJ, 2007, BIOL CONSERV, V134, P548, DOI 10.1016/j.biocon.2006.09.010; Matson G.M., 1981, WORKBOOK CEMENTUM AN; MORRIS P, 1972, Mammal Review, V2, P69, DOI 10.1111/j.1365-2907.1972.tb00160.x; Niassa Carnivore Project, 2014, ANN REPORT; Packer C, 2005, SCIENCE, V307, P390, DOI 10.1126/science.1105122; Packer C, 2011, CONSERV BIOL, V25, P142, DOI 10.1111/j.1523-1739.2010.01576.x; PENNYCUICK CJ, 1970, J ZOOL, V160, P497; R Development Core Team, R A LANG ENV STAT CO; Schaller G. B., 1972, SERENGETI LION STUDY; Skalski J.R., 2005, WILDLIFE DEMOGRAPHY; SMUTS GL, 1978, J ZOOL, V185, P115, DOI 10.1111/j.1469-7998.1978.tb03317.x; SPINAGE C A, 1973, East African Wildlife Journal, V11, P165; Tanzania Wildlife Division, 2012, COMM ESA STAT REV AF; USFWS, 2015, FED REGISTER, V80, P80000; USFWS, 2000, FACTS FED WILDL LAWS; White PA, 2007, AFRICAN INDABA, V5, P12; White PA, WILDL BIOL IN PRESS; White PA, 2010, AFRICAN INDABA, V8, P10; Whitman K, 2004, NATURE, V428, P175, DOI 10.1038/nature02395; Whitman K. L., 2007, HUNTERS GUIDE AGING; Williams VL., 2015, BONES CONTENTION ASS; Yamazaki K, 1996, J WILDLIFE MANAGE, V60, P490, DOI 10.2307/3802066	43	11	12	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153648	10.1371/journal.pone.0153648	http://dx.doi.org/10.1371/journal.pone.0153648			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27089506	gold, Green Published			2022-12-26	WOS:000374527000037
J	Han, SS; Yang, SH; Kim, MC; Cho, JY; Min, SI; Lee, JP; Kim, DK; Ha, J; Kim, YS				Han, Seung Seok; Yang, Seung Hee; Kim, Min Chang; Cho, Joo-Youn; Min, Sang-Il; Lee, Jung Pyo; Kim, Dong Ki; Ha, Jongwon; Kim, Yon Su			Monitoring the Intracellular Tacrolimus Concentration in Kidney Transplant Recipients with Stable Graft Function	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; RENAL-TRANSPLANTATION; ACUTE REJECTION; PHARMACOKINETICS; POLYMORPHISMS	Although monitoring the intracellular concentration of immunosuppressive agents may be a promising approach to individualizing the therapy after organ transplantation, additional studies on this issue are needed prior to its clinical approval. We investigated the relationship between intracellular and whole blood concentrations of tacrolimus (IC-TAC and WB-TAC, respectively), the factors affecting this relationship, and the risk of rejection based upon IC-TAC in stable kidney recipients. Both IC-TAC and WB-TAC were measured simultaneously in 213 kidney recipients with stable graft function using LC-MS/MS. The tacrolimus ratio was defined as IC-TAC per WB-TAC. The genetic polymorphism of ABCB1 gene and flow cytometric analyses were conducted to probe the correlation between tacrolimus concentrations and the immunoreactivity status as a potential risk of rejection, respectively. The correlation between IC-TAC and WB-TAC was relatively linear (r = 0.67; P<0.001). The factors affecting the tacrolimus ratio were sex, hematocrit, and the transplant duration, as follows: a high tacrolimus ratio was noted in female patients, patients with a low hematocrit, and patients with a short transplant period. However, the tacrolimus ratio did not reflect the prior clinical outcomes (e.g., rejection) or the genetic polymorphism of ABCB1. After stimulation with phorbol-12-myristate 13-acetate and ionomycin, the proportion of T cells producing interferon-gamma or interleukin-2 was higher in the low-IC-TAC group than in the high-IC-TAC group. Further studies are required to evaluate the value of the intracellular tacrolimus concentrations in several clinical settings, such as rejection, infection, and drug toxicity.	[Han, Seung Seok; Kim, Yon Su] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Yang, Seung Hee; Lee, Jung Pyo; Kim, Dong Ki; Kim, Yon Su] Seoul Natl Univ, Kidney Res Inst, Seoul, South Korea; [Kim, Min Chang; Cho, Joo-Youn] Seoul Natl Univ, Coll Med, Dept Clin Pharmacol & Therapeut, Seoul, South Korea; [Min, Sang-Il; Ha, Jongwon] Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea; [Lee, Jung Pyo; Kim, Dong Ki; Kim, Yon Su] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kim, YS (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea.; Kim, YS (corresponding author), Seoul Natl Univ, Kidney Res Inst, Seoul, South Korea.; Kim, YS (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.	yonsukim@snu.ac.kr	Cho, Joo-Youn/J-5672-2012; Cho, Joo-Youn/ABC-2044-2021; Kim, Dong Ki/J-5389-2012; Han, Seung Seok/HGD-2825-2022	Cho, Joo-Youn/0000-0001-9270-8273; Cho, Joo-Youn/0000-0001-9270-8273; Kim, Dong Ki/0000-0002-5195-7852; 	Korean Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI13C1964]; Ministry of Health and Welfare, Republic of Korea	Korean Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea; Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	The current study was supported by grants from the Korean Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (HI13C1964).; Based on the present study, Dr. Seung Seok Han was chosen to be a member of the training program of advanced translational and clinical researcher of Korea. Thus, the current study was supported by grants from the Korean Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (HI13C1964). The biospecimens were provided by the Seoul National University Hospital Human Biobank, a member of the National Biobank of Korea, which is supported by the Ministry of Health and Welfare, Republic of Korea.	Capron A, 2012, TRANSPL INT, V25, P41, DOI 10.1111/j.1432-2277.2011.01365.x; Capron A, 2010, PHARMACOGENOMICS, V11, P703, DOI [10.2217/pgs.10.43, 10.2217/PGS.10.43]; Capron A, 2009, THER DRUG MONIT, V31, P178, DOI 10.1097/FTD.0b013e3181905aaa; Eckardt KU, 2009, AM J TRANSPLANT, V9, pS1, DOI 10.1111/j.1600-6143.2009.02834.x; Ekberg H, 2007, NEW ENGL J MED, V357, P2562, DOI 10.1056/NEJMoa067411; Gheorghian A, 2012, TRANSPLANTATION, V94, P241, DOI 10.1097/TP.0b013e318255f839; Hodges LM, 2011, PHARMACOGENET GENOM, V21, P152, DOI 10.1097/FPC.0b013e3283385a1c; JUSKO WJ, 1995, CLIN PHARMACOL THER, V57, P281, DOI 10.1016/0009-9236(95)90153-1; Kerb R, 2001, PHARMACOGENOMICS, V2, P51, DOI 10.1517/14622416.2.1.51; Lemaitre F, 2013, CLIN BIOCHEM, V46, P1538, DOI 10.1016/j.clinbiochem.2013.02.011; Matas AJ, 2014, AM J TRANSPLANT, V14, P11, DOI 10.1111/ajt.12579; Mayer AD, 1997, TRANSPLANTATION, V64, P436, DOI 10.1097/00007890-199708150-00012; Meier-Kriesche HU, 2000, TRANSPLANTATION, V70, P1098, DOI 10.1097/00007890-200010150-00018; Najafian N, 2006, J AM SOC NEPHROL, V17, P2652, DOI 10.1681/ASN.2005070707; Raviv Y, 2000, FASEB J, V14, P511, DOI 10.1096/fasebj.14.3.511; Schwartz JB, 2007, CLIN PHARMACOL THER, V82, P87, DOI 10.1038/sj.clpt.6100226; Vafadari R, 2013, THER DRUG MONIT, V35, P459, DOI 10.1097/FTD.0b013e31828c1581; van Gelder T, 2002, DRUG SAFETY, V25, P707, DOI 10.2165/00002018-200225100-00003; Velickovic-Radovanovic R, 2011, GENDER MED, V8, P23, DOI 10.1016/j.genm.2011.01.003; Webster A, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003961.pub2; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303	21	31	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153491	10.1371/journal.pone.0153491	http://dx.doi.org/10.1371/journal.pone.0153491			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082871	Green Published, gold			2022-12-26	WOS:000374291800024
J	Ward-Caviness, CK; Neas, LM; Blach, C; Haynes, CS; LaRocque-Abramson, K; Grass, E; Dowdy, E; Devlin, RB; Diaz-Sanchez, D; Cascio, WE; Miranda, ML; Gregory, SG; Shah, SH; Kraus, WE; Hauser, ER				Ward-Caviness, Cavin K.; Neas, Lucas M.; Blach, Colette; Haynes, Carol S.; LaRocque-Abramson, Karen; Grass, Elizabeth; Dowdy, Elaine; Devlin, Robert B.; Diaz-Sanchez, David; Cascio, Wayne E.; Miranda, Marie Lynn; Gregory, Simon G.; Shah, Svati H.; Kraus, William E.; Hauser, Elizabeth R.			Genetic Variants in the Bone Morphogenic Protein Gene Family Modify the Association between Residential Exposure to Traffic and Peripheral Arterial Disease	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; AIR-POLLUTION; DNA METHYLATION; CARDIOVASCULAR-DISEASE; VASCULAR CALCIFICATION; RISK-FACTOR; ATHEROSCLEROSIS; SPERMATOGENESIS; PROGRESSION; INHIBITION	There is a growing literature indicating that genetic variants modify many of the associations between environmental exposures and clinical outcomes, potentially by increasing susceptibility to these exposures. However, genome-scale investigations of these interactions have been rarely performed particularly in the case of air pollution exposures. We performed race-stratified genome-wide gene-environment interaction association studies on European-American (EA, N = 1623) and African-American (AA, N = 554) cohorts to investigate the joint influence of common single nucleotide polymorphisms (SNPs) and residential exposure to traffic ("traffic exposure")-a recognized vascular disease risk factor-on peripheral arterial disease (BMP8A eQTLs in tissue types highlight relevant for PAD such as rs755249 (tibial nerve, eQTL P = 3.6x10(-6)) and rs1180341 (tibial artery, eQTL P = 5.3x10(-6)). Together these results reveal a novel gene, and possibly gene family, associated with PAD via an interaction with traffic air pollution exposure. These results also highlight the potential for interactions studies, particularly at the genome scale, to reveal novel biology linking environmental exposures to clinical outcomes.PAD). Traffic exposure was estimated via the distance from the primary residence to the nearest major roadway, defined as the nearest limited access highways or major arterial. The rs755249-traffic exposure interaction was associated with PAD at a genome-wide significant level (P = 2.29x10(-8)) in European-Americans. Rs755249 is located in the 3' untranslated region of BMP8A, a member of the bone morphogenic protein (BMP) gene family. Further investigation revealed several variants in BMP genes associated with PAD via an interaction with traffic exposure in both the EA and AA cohorts; this included interactions with non-synonymous variants in BMP2, which is regulated by air pollution exposure. The BMP family of genes is linked to vascular growth and calcification and is a novel gene family for the study of PAD pathophysiology. Further investigation of BMP8A using the Genotype Tissue Expression Database revealed multiple variants with nominally significant (P < 0.05) interaction P-values in our EA cohort were significant BMP8A eQTLs in tissue types highlight relevant for PAD such as rs755249 (tibial nerve, eQTL P = 3.6x10(-6)) and rs1180341 (tibial artery, eQTL P = 5.3x10(-6)). Together these results reveal a novel gene, and possibly gene family, associated with PAD via an interaction with traffic air pollution exposure. These results also highlight the potential for interactions studies, particularly at the genome scale, to reveal novel biology linking environmental exposures to clinical outcomes.	[Ward-Caviness, Cavin K.; Blach, Colette; Haynes, Carol S.; LaRocque-Abramson, Karen; Grass, Elizabeth; Dowdy, Elaine; Gregory, Simon G.; Shah, Svati H.; Kraus, William E.; Hauser, Elizabeth R.] Duke Univ, Med Ctr, Duke Mol Physiol Inst, Durham, NC 27710 USA; [Ward-Caviness, Cavin K.] Helmholtz Ctr Munich, Inst Epidemiol 2, D-85764 Neuherberg, Germany; [Neas, Lucas M.; Devlin, Robert B.; Diaz-Sanchez, David; Cascio, Wayne E.] US Environm Protect Agcy, Natl Hlth & Environm Effects Res Lab, Chapel Hill, NC 27514 USA; [Miranda, Marie Lynn] Rice Univ, Natl Ctr Geospatial Med, Houston, TX 77005 USA; [Shah, Svati H.; Kraus, William E.] Duke Univ, Med Ctr, Div Cardiovasc Med, Durham, NC 27710 USA; [Hauser, Elizabeth R.] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27710 USA; [Hauser, Elizabeth R.] Vet Affairs Med Ctr, Cooperat Studies Program, Epidemiol Ctr Durham, Durham, NC 27701 USA	Duke University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; United States Environmental Protection Agency; Rice University; Duke University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Hauser, ER (corresponding author), Duke Univ, Med Ctr, Duke Mol Physiol Inst, Durham, NC 27710 USA.; Hauser, ER (corresponding author), Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27710 USA.; Hauser, ER (corresponding author), Vet Affairs Med Ctr, Cooperat Studies Program, Epidemiol Ctr Durham, Durham, NC 27701 USA.	elizabeth.hauser@gmail.com	Cascio, Wayne Eugene/GPG-0840-2022	Cascio, Wayne Eugene/0000-0003-1360-8093; Gregory, Simon/0000-0002-7805-1743; Miranda, Marie Lynn/0000-0002-5670-0837; Neas, Lucas/0000-0002-9377-8334; Hauser, Elizabeth/0000-0003-0367-9189	NIH [HL095987, HL10621, HL36587]; United States Environmental Protection Agency (EPA) [R-82811201]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095987, P01HL036587] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Environmental Protection Agency (EPA)(United States Environmental Protection Agency); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the following NIH grants: HL095987, HL10621, and HL36587. This project was supported in part by an appointment to the Research Participation Program at the Office of Research and Development, U.S. Environmental Protection Agency. Research described in this article was conducted under contract to the Health Effects Institute (HEI), and organization jointly funded by the United States Environmental Protection Agency (EPA) (Assistance Award No. R-82811201) and certain motor vehicle and engine manufacturers. The contents of this article do not necessarily reflect the views of HEI, or its sponsors, nor do they necessarily reflect the view and policies of the EPA or motor vehicle and engine manufacturers.; This work was supported by the following NIH grants: HL095987, HL10621, and HL36587. This project was supported in part by an appointment to the Research Participation Program at the Office of Research and Development, U.S. Environmental Protection Agency. The views expressed in this article are those of the authors and do not necessarily reflect the views or policies of the EPA. Mention of trade names or commercial products does not constitute endorsement or recommendation for use. The contents of this article do not necessarily reflect the views of the Health Effects Institute (HEI), an organization jointly funded by the United States Environmental Protection Agency (EPA) (Assistance Award No. R-82811201) and certain motor vehicle and engine manufacturers, nor do they necessarily reflect the views and policies of its sponsors.	Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Baccarelli A, 2009, CIRCULATION, V119, P3118, DOI 10.1161/CIRCULATIONAHA.108.836163; Baccarelli A, 2009, AM J RESP CRIT CARE, V179, P572, DOI 10.1164/rccm.200807-1097OC; Bera AK, 2001, J STAT PLAN INFER, V97, P9, DOI 10.1016/S0378-3758(00)00343-8; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Brunekreef B, 2009, RES REP HLTH EFF I, V139, P73; Brunekreef Bert, 2009, Res Rep Health Eff Inst, P5; Castro R, 2003, CLIN CHEM, V49, P1292, DOI 10.1373/49.8.1292; Chahine T, 2007, ENVIRON HEALTH PERSP, V115, P1617, DOI 10.1289/ehp.10318; Chung JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029100; Criqui MH, 2008, J AM COLL CARDIOL, V52, P1736, DOI 10.1016/j.jacc.2008.07.060; David L, 2009, CYTOKINE GROWTH F R, V20, P203, DOI 10.1016/j.cytogfr.2009.05.001; DeJarnett N, 2015, ARTERIOSCL THROM VAS, V35, P2468, DOI 10.1161/ATVBAHA.115.305724; Derwall M, 2012, ARTERIOSCL THROM VAS, V32, P613, DOI 10.1161/ATVBAHA.111.242594; Devlin B, 2004, NAT GENET, V36, P1129, DOI 10.1038/ng1104-1129; Dong CM, 2002, J NUTR, V132, p2406S, DOI 10.1093/jn/132.8.2406S; Eraso LH, 2014, EUR J PREV CARDIOL, V21, P704, DOI 10.1177/2047487312452968; ESRI, 2011, ARCGIS DESKT REL 10; Federal Highway Administration, 2015, HIGHW STAT SER; Hagler GSW, 2009, ATMOS ENVIRON, V43, P1229, DOI 10.1016/j.atmosenv.2008.11.024; Hoek G, 2002, LANCET, V360, P1203, DOI 10.1016/S0140-6736(02)11280-3; Hoffmann B, 2007, EPIDEMIOLOGY, V18, pS75; Hoffmann B, 2007, CIRCULATION, V116, P489, DOI 10.1161/CIRCULATIONAHA.107.693622; Hoffmann B, 2009, BIOMARKERS, V14, P74, DOI 10.1080/13547500902965096; Hoffmann B, 2009, EPIDEMIOLOGY, V20, P280, DOI 10.1097/EDE.0b013e3181961ac2; Hruska KA, 2005, CIRC RES, V97, P105, DOI 10.1161/01.RES.00000175571.53833.6c; Jamaluddin MS, 2007, CLIN CHEM LAB MED, V45, P1660, DOI 10.1515/CCLM.2007.350; Jardim MJ, 2011, MUTAT RES-FUND MOL M, V717, P38, DOI 10.1016/j.mrfmmm.2011.03.014; Kan HD, 2008, ENVIRON HEALTH PERSP, V116, P1463, DOI 10.1289/ehp.11290; Kim J, 2015, ARTERIOSCLEROSIS THR; Kim JH, 2015, ARTERIOSCL THROM VAS, V35, P2384, DOI 10.1161/ATVBAHA.115.306102; Knowles JW, 2007, ARTERIOSCL THROM VAS, V27, P2068, DOI 10.1161/01.ATV.0000282199.66398.8c; Kraus WE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005553; Kraus WE, 2015, J CARDIOVASC TRANSL, V8, P449, DOI 10.1007/s12265-015-9648-y; Lennon FE, 2011, AM J PHYSIOL-LUNG C, V301, pL137, DOI 10.1152/ajplung.00071.2010; Liberman M, 2011, BIOCHEM BIOPH RES CO, V413, P436, DOI 10.1016/j.bbrc.2011.08.114; London Stephanie J, 2007, Proc Am Thorac Soc, V4, P217, DOI 10.1513/pats.200701-031AW; Loveland KL, 2007, INT J ANDROL, V30, P377, DOI 10.1111/j.1365-2605.2007.00785.x; Madrigano J, 2011, ENVIRON HEALTH PERSP, V119, P977, DOI 10.1289/ehp.1002773; Mahoney SE, 2012, EPIGENETICS-US, V7, P400, DOI 10.4161/epi.19463; McGuinn LA, 2016, ENVIRON RES, V145, P9, DOI 10.1016/j.envres.2015.10.026; Mele M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355; Nawrot TS, 2009, AM J RESP CRIT CARE, V179, P523, DOI 10.1164/rccm.200812-1900ED; NCDOT (North Carolina Department of Transportation), 2015, GIS DAT LAYERS STAT; Novack DV, 2011, CELL RES, V21, P169, DOI 10.1038/cr.2010.159; OTTMAN R, 1990, GENET EPIDEMIOL, V7, P177, DOI 10.1002/gepi.1370070302; Polfus LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074642; Pollard KS, 2008, HUM GENET, V122, P625, DOI 10.1007/s00439-007-0440-1; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; R Core Development Team, 2009, R LANG ENV STAT COMP; Radhakrishna Rao C, 1948, LARGE SAMPLE TESTS S, P50; Rivas MA, 2015, SCIENCE, V348, P666, DOI 10.1126/science.1261877; Rostama B, 2015, ARTERIOSCL THROM VAS, V35, P2626, DOI 10.1161/ATVBAHA.115.306541; Sartori R, 2013, NAT GENET, V45, P1309, DOI 10.1038/ng.2772; Sheffield NC, 2013, GENOME RES, V23, P777, DOI 10.1101/gr.152140.112; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Smadja DM, 2008, ARTERIOSCL THROM VAS, V28, P2137, DOI 10.1161/ATVBAHA.108.168815; Smith FB, 2000, BLOOD COAGUL FIBRIN, V11, P43, DOI 10.1097/00001721-200011010-00005; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Townley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002; U.S. Census Bureau, 2013, TIGER LIN SHAP TIGER; Wahlgren CM, 2011, ARTERIOSCL THROM VAS, V31, P678, DOI 10.1161/ATVBAHA.110.210385; Ward-Caviness CK, 2015, ENV HLTH PERSPECT, V123, P8; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Yamawaki H, 2006, CIRC J, V70, P129, DOI 10.1253/circj.70.129; Yan MS, 2015, ARTERIOSCL THROM VAS, V35, P2297, DOI 10.1161/ATVBAHA.115.305043; Yao YC, 2010, CIRC RES, V107, P485, DOI 10.1161/CIRCRESAHA.110.219071; Zanobetti A, 2011, PROG CARDIOVASC DIS, V53, P344, DOI 10.1016/j.pcad.2011.01.001; Zhao GQ, 1998, DEVELOPMENT, V125, P1103	72	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0152670	10.1371/journal.pone.0152670	http://dx.doi.org/10.1371/journal.pone.0152670			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082954	Green Published, gold, Green Submitted			2022-12-26	WOS:000374291800007
J	Armstrong, MH; Tepole, AB; Kuhl, E; Simon, BR; Vande Geest, JP				Armstrong, Michelle Hine; Tepole, Adrian Buganza; Kuhl, Ellen; Simon, Bruce R.; Vande Geest, Jonathan P.			A Finite Element Model for Mixed Porohyperelasticity with Transport, Swelling, and Growth	PLOS ONE			English	Article							SMOOTH-MUSCLE CONTRACTION; INTERSTITIAL GROWTH; VOLUMETRIC GROWTH; BIOLOGICAL TISSUE; RESIDUAL-STRESS; ARTERIAL GROWTH; MASS-TRANSPORT; MIXTURE MODEL; SOFT-TISSUES; MECHANICS	The purpose of this manuscript is to establish a unified theory of porohyperelasticity with transport and growth and to demonstrate the capability of this theory using a finite element model developed in MATLAB. We combine the theories of volumetric growth and mixed porohyperelasticity with transport and swelling (MPHETS) to derive a new method that models growth of biological soft tissues. The conservation equations and constitutive equations are developed for both solid-only growth and solid/fluid growth. An axisymmetric finite element framework is introduced for the new theory of growing MPHETS (GMPHETS). To illustrate the capabilities of this model, several example finite element test problems are considered using model geometry and material parameters based on experimental data from a porcine coronary artery. Multiple growth laws are considered, including time-driven, concentrationdriven, and stress-driven growth. Time-driven growth is compared against an exact analytical solution to validate the model. For concentration-dependent growth, changing the diffusivity (representing a change in drug) fundamentally changes growth behavior. We further demonstrate that for stress-dependent, solid-only growth of an artery, growth of an MPHETS model results in a more uniform hoop stress than growth in a hyperelastic model for the same amount of growth time using the same growth law. This may have implications in the context of developing residual stresses in soft tissues under intraluminal pressure. To our knowledge, this manuscript provides the first full description of an MPHETS model with growth. The developed computational framework can be used in concert with novel in-vitro and in-vivo experimental approaches to identify the governing growth laws for various soft tissues.	[Armstrong, Michelle Hine; Vande Geest, Jonathan P.] Univ Arizona, Grad Interdisciplinary Program Appl Math, Tucson, AZ USA; [Tepole, Adrian Buganza; Kuhl, Ellen] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Simon, Bruce R.; Vande Geest, Jonathan P.] Univ Arizona, Dept Aerosp & Mech Engn, Tucson, AZ 85721 USA; [Vande Geest, Jonathan P.] Univ Arizona, Grad Interdisciplinary Program Biomed Engn, Tucson, AZ USA; [Vande Geest, Jonathan P.] Univ Arizona, Inst Biocollaborat Res BIO5, Tucson, AZ 85721 USA; [Vande Geest, Jonathan P.] Univ Arizona, Dept Biomed Engn, Tucson, AZ 85721 USA; [Vande Geest, Jonathan P.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15219 USA	University of Arizona; Stanford University; University of Arizona; University of Arizona; University of Arizona; University of Arizona; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Vande Geest, JP (corresponding author), Univ Arizona, Grad Interdisciplinary Program Appl Math, Tucson, AZ USA.; Vande Geest, JP (corresponding author), Univ Arizona, Dept Aerosp & Mech Engn, Tucson, AZ 85721 USA.; Vande Geest, JP (corresponding author), Univ Arizona, Grad Interdisciplinary Program Biomed Engn, Tucson, AZ USA.; Vande Geest, JP (corresponding author), Univ Arizona, Inst Biocollaborat Res BIO5, Tucson, AZ 85721 USA.; Vande Geest, JP (corresponding author), Univ Arizona, Dept Biomed Engn, Tucson, AZ 85721 USA.; Vande Geest, JP (corresponding author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15219 USA.	jpv20@pitt.edu	Kuhl, Ellen/G-4444-2011; Geest, Jonathan Vande/L-8136-2016	Kuhl, Ellen/0000-0002-6283-935X; Geest, Jonathan Vande/0000-0003-2444-1751; Buganza Tepole, Adrian/0000-0001-8531-0603; Armstrong, Michelle/0000-0003-2736-8107	National Eye Institute [1R01EY020890]; National Heart, Lung, and Blood Institute [1R21HL111990]; Whitaker International Summer Grant; National Science Foundation [0841234]; ARCS Foundation; NATIONAL EYE INSTITUTE [R01EY020890] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL111990] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Whitaker International Summer Grant; National Science Foundation(National Science Foundation (NSF)); ARCS Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Eye Institute 1R01EY020890 (http://www.nih.gov/, JPVG); National Heart, Lung, and Blood Institute 1R21HL111990 (http://www.nih.gov/, JPVG); Whitaker International Summer Grant (http://www.whitaker.org/, MHA); National Science Foundation 0841234 (http://www.nsf.gov/); and ARCS Foundation (https://www.arcsfoundation.org/, MHA). Support for MHA was partly provided by the National Science Foundation under award No 0841234.	Alford PW, 2008, COMPUT METHOD BIOMEC, V11, P525, DOI 10.1080/10255840801930710; Almeida EDGARD S., 1997, Comput Methods Biomech Biomed Engin, V1, P25, DOI 10.1080/01495739708936693; Almeida EDGARD S., 1998, Comput Methods Biomech Biomed Engin, V1, P151, DOI 10.1080/01495739708936700; Ambrosi D, 2011, J MECH PHYS SOLIDS, V59, P863, DOI 10.1016/j.jmps.2010.12.011; Ambrosi D, 2002, INT J ENG SCI, V40, P1297, DOI 10.1016/S0020-7225(02)00014-9; Armstrong MAH, 2015, THESIS U ARIZONA; Ateshian GA, 2014, BIOMECH MODEL MECHAN, V13, P1105, DOI 10.1007/s10237-014-0560-1; BIOT MA, 1972, INDIANA U MATH J, V21, P597, DOI 10.1512/iumj.1972.21.21048; Biot MA, 1941, J APPL PHYS, V12, P155, DOI 10.1063/1.1712886; BOWEN RM, 1982, INT J ENG SCI, V20, P697, DOI 10.1016/0020-7225(82)90082-9; CHUONG CJ, 1986, J BIOMECH ENG-T ASME, V108, P189, DOI 10.1115/1.3138600; Eriksson TSE, 2014, J MECH PHYS SOLIDS, V73, P134, DOI 10.1016/j.jmps.2014.09.003; Fung YC, 1990, BIOMECHANICS MOTION; Garikipati K, 2004, J MECH PHYS SOLIDS, V52, P1595, DOI 10.1016/j.jmps.2004.01.004; Gleason RL, 2004, J BIOMECH ENG-T ASME, V126, P371, DOI 10.1115/1.1762899; Gleason RL, 2004, J VASC RES, V41, P352, DOI 10.1159/000080699; Goktepe S, 2010, J MECH PHYS SOLIDS, V58, P1661, DOI 10.1016/j.jmps.2010.07.003; Grytz R, 2012, MECH MATER, V44, P99, DOI 10.1016/j.mechmat.2011.07.004; Harper JL, 2014, J MECH BEHAV BIOMED, V29, P663, DOI 10.1016/j.jmbbm.2013.04.019; Harper JL, 2012, THESIS U ARIZONA; Himpel G, 2005, CMES-COMP MODEL ENG, V8, P119; Homer RJ, 2005, PHYSIOLOGY, V20, P28, DOI 10.1152/physiol.00035.2004; Humphrey JD, 2002, MATH MOD METH APPL S, V12, P407, DOI 10.1142/S0218202502001714; Huyghe JM, 2007, J BIOMECH ENG-T ASME, V129, P776, DOI 10.1115/1.2768379; Hwang CW, 2001, CIRCULATION, V104, P600, DOI 10.1161/hc3101.092214; Kaufmann MV, 1996, THESIS U ARIZONA; Keyes JT, 2013, PHARM RES-DORDR, V30, P1147, DOI 10.1007/s11095-012-0950-y; Keyes JT, 2013, J MECH BEHAV BIOMED, V17, P296, DOI 10.1016/j.jmbbm.2012.10.002; Kuhl E, 2007, BIOMECH MODEL MECHAN, V6, P321, DOI 10.1007/s10237-006-0062-x; LAI WM, 1991, J BIOMECH ENG-T ASME, V113, P245, DOI 10.1115/1.2894880; LEE EH, 1969, J APPL MECH, V36, P1, DOI 10.1115/1.3564580; Logan DL, 1993, 1 COURSE FINITE ELEM; Lubarda VA, 2002, INT J SOLIDS STRUCT, V39, P4627, DOI 10.1016/S0020-7683(02)00352-9; Matsumoto T, 1996, AM J PHYSIOL-HEART C, V271, pH1711, DOI 10.1152/ajpheart.1996.271.4.H1711; Myers K, 2014, J MECH BEHAV BIOMED, V29, P544, DOI 10.1016/j.jmbbm.2013.03.003; Nagarajan S., 1974, Computers and Structures, V4, P1117, DOI 10.1016/0045-7949(74)90028-5; Narayanan H, 2009, BIOMECH MODEL MECHAN, V8, P167, DOI 10.1007/s10237-008-0126-1; Owen D. R. J., 1980, FINITE ELEMENT PLAST; Rachev A, 2003, J BIOMECH, V36, P661, DOI 10.1016/S0021-9290(02)00444-X; Rachev A, 1998, J BIOMECH ENG-T ASME, V120, P9, DOI 10.1115/1.2834313; Rachev A, 1999, ANN BIOMED ENG, V27, P459, DOI 10.1114/1.191; RODRIGUEZ EK, 1994, J BIOMECH, V27, P455, DOI 10.1016/0021-9290(94)90021-3; Sengers BG, 2004, J BIOMECH ENG-T ASME, V126, P82, DOI 10.1115/1.1645526; Simon BR, 1998, INT J SOLIDS STRUCT, V35, P5021, DOI 10.1016/S0020-7683(98)00107-3; Simon BR, 1996, J BIOMECH ENG-T ASME, V118, P1, DOI 10.1115/1.2795941; SIMON BR, 1984, INT J NUMER ANAL MET, V8, P381, DOI 10.1002/nag.1610080406; Simon BR, 2001, BIOMECHANICAL SYSTEM, VIV; Simon BR., 1992, APPL MECH REV, V45, P191, DOI [DOI 10.1115/1.3121397, 10.1115/1.3121397]; Skalak R, 1997, J MATH BIOL, V35, P869, DOI 10.1007/s002850050081; Skalak R, 1996, J MATH BIOL, V34, P889, DOI 10.1007/s002850050036; Skalak R, 1981, P IUTAM S FINITE ELA, P347, DOI DOI 10.1007/978-94-009-7538-5_23; SUH JK, 1991, INT J NUMER METH ENG, V32, P1411, DOI 10.1002/nme.1620320704; Sun DN, 1999, INT J NUMER METH ENG, V45, P1375, DOI 10.1002/(SICI)1097-0207(19990810)45:10<1375::AID-NME635>3.0.CO;2-7; Taber LA, 2001, J BIOMECH ENG-T ASME, V123, P528, DOI 10.1115/1.1412451; Tepole AB, 2011, J MECH PHYS SOLIDS, V59, P2177, DOI 10.1016/j.jmps.2011.05.004; TERZAGHI K, 1967, SOIL MECH ENG PRACTI; Valentin A, 2009, PHILOS T R SOC A, V367, P3585, DOI 10.1098/rsta.2009.0113; Valentin A, 2009, J R SOC INTERFACE, V6, P293, DOI 10.1098/rsif.2008.0254; Vande Geest JP, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003489; Vernerey FJ, 2015, BIOMECH MODEL MECHAN, P1; Zeller PJ, 1998, J VASC RES, V35, P8, DOI 10.1159/000025560; Zienkiewicz O. C., 1977, FINITE ELEMENT METHO, V3 rd; Zienkiewicz OC, 2005, FINITE ELEMENT METHOD FOR FLUID DYNAMICS, 6TH EDITION, P1; Zollner AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045661	64	13	13	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0152806	10.1371/journal.pone.0152806	http://dx.doi.org/10.1371/journal.pone.0152806			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078495	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000374131700009
J	Beck, G; Shinzawa, K; Hayakawa, H; Baba, K; Sumi-Akamaru, H; Tsujimoto, Y; Mochizuki, H				Beck, Goichi; Shinzawa, Koei; Hayakawa, Hideki; Baba, Kousuke; Sumi-Akamaru, Hisae; Tsujimoto, Yoshihide; Mochizuki, Hideki			Progressive Axonal Degeneration of Nigrostriatal Dopaminergic Neurons in Calcium-Independent Phospholipase A(2)beta Knockout Mice	PLOS ONE			English	Article							NEUROAXONAL DYSTROPHY; DOCOSAHEXAENOIC ACID; PLA2G6 MUTATION; MODEL; PARKINSONISM; DEFICIENCY	Calcium-independent phospholipase A(2)beta (iPLA(2)beta, PLA2G6) is essential for the remodeling of membrane glycerophospholipids. Mutations in this gene are responsible for autosomal recessive, young onset, L-dopa-responsive parkinsonism (PARK14), suggesting a neurodegenerative condition in the nigrostriatal dopaminergic system in patients with PLA2G6 mutations. We previously observed slowly progressive motor deficits in iPLA(2)beta-knockout (KO) mice. To clarify whether a deficiency of iPLA(2)beta leads to the degeneration of nigrostriatal dopaminergic neurons, we analyzed the striatum of iPLA(2)beta-KO mice. At all clinical stages, nerve terminals in the striatum were immunopositive for tyrosine hydroxylase (TH) and dopamine transporter (DAT) in wild-type (WT) control mice. In iPLA(2)beta-KO mice, focal loss of nerve terminals positive for TH and DAT was found from 56 weeks (early clinical stage), although iPLA(2)beta-KO mice at 56 weeks showed no significant decrease in the number of dopaminergic neurons in the substantia nigra compared with age-matched WT mice, as reported previously. At 100 weeks (late clinical stage), greater decreases in DAT immunoreactivity were observed in the striatum of iPLA(2)beta-KO mice. Moreover, strongly TH-positive structures, presumed to be deformed axons, were observed in the neuropils of the striatum of iPLA(2)beta-KO mice starting at 15 weeks (preclinical stage) and increased with age. These results suggest that the degeneration of dopaminergic neurons occurs mainly in the distal region of axons in iPLA(2)beta-KO mice.	[Beck, Goichi; Hayakawa, Hideki; Baba, Kousuke; Sumi-Akamaru, Hisae; Mochizuki, Hideki] Osaka Univ, Grad Sch Med, Dept Neurol, Suita, Osaka, Japan; [Shinzawa, Koei; Tsujimoto, Yoshihide] Osaka Univ, Grad Sch Med, Dept Med Genet, Suita, Osaka, Japan; [Tsujimoto, Yoshihide] Osaka Med Ctr Canc & Cardiovasc Dis, Osaka, Japan	Osaka University; Osaka University; Osaka Medical Center for Cancer & Cardiovascular Diseases	Mochizuki, H (corresponding author), Osaka Univ, Grad Sch Med, Dept Neurol, Suita, Osaka, Japan.	hmochizuki@neurol.med.osaka-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [24591294, 24591295]; JSPS [22790314]; Research on Rare and Intractable Diseases from the Ministry of Health, Labour and Welfare of Japan [H26 intractable disease 037]; Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from Japan Agency for Medical Research and development (AMED); MEXT [15H01558]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research on Rare and Intractable Diseases from the Ministry of Health, Labour and Welfare of Japan; Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from Japan Agency for Medical Research and development (AMED)(Japan Agency for Medical Research and Development (AMED)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (JSPS, https://www.jsps.go.jp) (Grant Number 24591294 to GB and Grant Number 24591295 to HSA) and a Grant-in-Aid for Young Scientists (B) (Grant Number 22790314 to KS) from JSPS, and was also partially supported by the Research on Rare and Intractable Diseases (H26 intractable disease 037 to HM) from the Ministry of Health, Labour and Welfare of Japan, the Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from Japan Agency for Medical Research and development (AMED) (to HM), and Grant-in-Aid for Scientific Research on Innovative Areas (Brain Protein Aging and Dementia Control) (15H01558 to HM) from MEXT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baburina I, 1999, J BIOL CHEM, V274, P9400, DOI 10.1074/jbc.274.14.9400; Balsinde J, 1997, J BIOL CHEM, V272, P29317, DOI 10.1074/jbc.272.46.29317; Beck G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141629; Beck G, 2011, J NEUROSCI, V31, P11411, DOI 10.1523/JNEUROSCI.0345-11.2011; Bezard E, 2001, J NEUROSCI, V21, P6853, DOI 10.1523/JNEUROSCI.21-17-06853.2001; Blesa J, 2012, NEUROBIOL DIS, V48, P79, DOI 10.1016/j.nbd.2012.05.018; COWEN D, 1963, J NEUROPATH EXP NEUR, V22, P175, DOI 10.1097/00005072-196304000-00001; Gai WP, 1995, BRAIN, V118, P1447, DOI 10.1093/brain/118.6.1447; Green JT, 2008, J LIPID RES, V49, P939, DOI 10.1194/jlr.R700017-JLR200; Hooks SB, 2008, BIOCHEM PHARMACOL, V76, P1059, DOI 10.1016/j.bcp.2008.07.044; Karkheiran S, 2015, TREMOR OTHER HYPERK, V5, DOI 10.7916/D84Q7T4W; Knab AM, 2010, INT J BIOL SCI, V6, P133; Malaguti MC, 2015, PARKINSONISM RELAT D, V21, P337, DOI 10.1016/j.parkreldis.2015.01.001; Malik I, 2008, AM J PATHOL, V172, P406, DOI 10.2353/ajpath.2008.070823; Morgan NV, 2006, NAT GENET, V38, P752, DOI 10.1038/ng1826; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Nandhagopal R, 2011, BRAIN, V134, P3290, DOI 10.1093/brain/awr233; Paisan-Ruiz C, 2009, ANN NEUROL, V65, P19, DOI 10.1002/ana.21415; Peters A., 1991, FINE STRUCTURE NERVO; Picconi B, 2012, ADV EXP MED BIOL, V970, P553, DOI 10.1007/978-3-7091-0932-8_24; Plowey ED, 2011, NEUROBIOL DIS, V43, P60, DOI 10.1016/j.nbd.2010.10.011; Schulz-Schaeffer WJ, 2010, ACTA NEUROPATHOL, V120, P131, DOI 10.1007/s00401-010-0711-0; Shi CH, 2011, NEUROLOGY, V77, P75, DOI 10.1212/WNL.0b013e318221acd3; Shinzawa K, 2003, J CELL BIOL, V163, P1219, DOI 10.1083/jcb.200306159; Shinzawa K, 2008, J NEUROSCI, V28, P2212, DOI 10.1523/JNEUROSCI.4354-07.2008; Sina F, 2009, EUR J NEUROL, V16, P101, DOI 10.1111/j.1468-1331.2008.02356.x; Strokin M, 2003, BRIT J PHARMACOL, V139, P1014, DOI 10.1038/sj.bjp.0705326; Toomey JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039041; Wilson JM, 1996, NEUROLOGY, V47, P718, DOI 10.1212/WNL.47.3.718; Yoshino H, 2010, NEUROLOGY, V75, P1356, DOI 10.1212/WNL.0b013e3181f73649	30	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153789	10.1371/journal.pone.0153789	http://dx.doi.org/10.1371/journal.pone.0153789			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078024	Green Published, Green Submitted, gold			2022-12-26	WOS:000374131700107
J	Dupervil, B; Grosse, S; Burnett, A; Parker, C				Dupervil, Brandi; Grosse, Scott; Burnett, Arthur; Parker, Christopher			Emergency Department Visits and Inpatient Admissions Associated with Priapism among Males with Sickle Cell Disease in the United States, 2006-2010	PLOS ONE			English	Article							MANAGEMENT; HEMOLYSIS	People with sickle cell disease (SCD) suffer from numerous acute complications that can result in multiple hospitalizations and emergency department (ED) and outpatient care visits. Priapism, a prolonged unwanted erection of the penis not due to sexual stimulation, is a serious complication among males with SCD. Variations in estimates of prevalence make it difficult to accurately assess the burden of this complication of SCD. We analyzed data from the Nationwide Emergency Department Sample (NEDS), a product of the Healthcare Cost and Utilization Project, for the years 2006 through 2010 to measure the numbers of ED visits and to examine patterns of subsequent hospitalizations associated with priapism among male patients with SCD. We find that among ED visits associated with males with SCD, those prompted by priapism are more likely to result in hospitalization than are those associated with pain.	[Dupervil, Brandi; Grosse, Scott; Parker, Christopher] Ctr Dis Control & Prevent, Div Blood Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA USA; [Burnett, Arthur] Johns Hopkins Med Inst, James Buchanan Brady Urol Inst, Baltimore, MD 21205 USA	Centers for Disease Control & Prevention - USA; Johns Hopkins University; Johns Hopkins Medicine	Dupervil, B (corresponding author), Ctr Dis Control & Prevent, Div Blood Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA USA.	inm4@cdc.gov	Dupervil, Brandi/AAR-1471-2021	Grosse, Scott/0000-0003-1078-6855				Addis G, 2007, CHRONIC ILLN, V3, P145, DOI 10.1177/1742395307081505; Adeyoju AB, 2002, BJU INT, V90, P898, DOI 10.1046/j.1464-410X.2002.03022.x; Ashley-Koch A, 2000, AM J EPIDEMIOL, V151, P839; Boulet SL, 2010, AM J PREV MED, V38, pS528, DOI 10.1016/j.amepre.2010.01.003; Broderick GA, 2010, J SEX MED, V7, P476, DOI 10.1111/j.1743-6109.2009.01625.x; Burnett AL, 2013, J SEX MED, V10, P180, DOI 10.1111/j.1743-6109.2012.02707.x; Burnett AL, 2011, UROL CLIN N AM, V38, P185, DOI 10.1016/j.ucl.2011.02.005; Chrouser KL, 2011, AM J SURG, V201, P468, DOI 10.1016/j.amjsurg.2010.03.017; Crane G, 2011, ANEMIA, V2011, DOI 10.1155/2011/297364; Diggs LW, 1934, SOUTH MED J, V27, P839; Hassell KL, 2010, AM J PREV MED, V38, pS512, DOI 10.1016/j.amepre.2009.12.022; Kato GJ, 2007, BLOOD REV, V21, P37, DOI 10.1016/j.blre.2006.07.001; KULMALA RV, 1995, SCAND J UROL NEPHROL, V29, P93, DOI 10.3109/00365599509180545; National Heart Lung and Blood Institute, 2009, SICKL CELL AN WHO IS; Nolan VG, 2005, BLOOD, V106, P3264, DOI 10.1182/blood-2005-04-1594; RAO JNK, 1984, ANN STAT, V12, P46, DOI 10.1214/aos/1176346391; Reeves S, 2014, ACAD PEDIATR, V14, pS61, DOI 10.1016/j.acap.2014.02.008; Roghmann F, 2013, J UROLOGY, V190, P1275, DOI 10.1016/j.juro.2013.03.118; Stein DM, 2013, J SEX MED, V10, P2418, DOI 10.1111/jsm.12251; Wolfson JA, 2011, PEDIATR BLOOD CANCER, V56, P413, DOI 10.1002/pbc.22792	20	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153257	10.1371/journal.pone.0153257	http://dx.doi.org/10.1371/journal.pone.0153257			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078839	Green Published, gold			2022-12-26	WOS:000374131700031
J	Fehrholz, M; Glaser, K; Seidenspinner, S; Ottensmeier, B; Curstedt, T; Speer, CP; Kunzmann, S				Fehrholz, Markus; Glaser, Kirsten; Seidenspinner, Silvia; Ottensmeier, Barbara; Curstedt, Tore; Speer, Christian P.; Kunzmann, Steffen			Impact of the New Generation Reconstituted Surfactant CHF5633 on Human CD4(+) Lymphocytes	PLOS ONE			English	Article							PULMONARY SURFACTANT; IMMUNOREGULATORY PROPERTIES; SYNTHETIC SURFACTANT; BOVINE SURFACTANT; HUMAN MONOCYTES; MESSENGER-RNA; T-CELLS; IMMUNOSUPPRESSION; PROLIFERATION; INFLAMMATION	Background Natural surfactant preparations, commonly isolated from porcine or bovine lungs, are used to treat respiratory distress syndrome in preterm infants. Besides biophysical effectiveness, several studies have documented additional immunomodulatory properties. Within the near future, synthetic surfactant preparations may be a promising alternative. CHF5633 is a new generation reconstituted synthetic surfactant preparation with defined composition, containing dipalmitoyl-phosphatidylcholine, palmitoyl-oleoyl-phosphatidylglycerol and synthetic analogs of surfactant protein (SP-) B and SP-C. While its biophysical effectiveness has been demonstrated in vitro and in vivo, possible immunomodulatory abilities are currently unknown. Aim The aim of the current study was to define a potential impact of CHF5633 and its single components on pro-and anti-inflammatory cytokine responses in human CD4(+) lymphocytes. Methods Purified human CD4(+) T cells were activated using anti CD3/CD28 antibodies and exposed to CHF5633, its components, or to the well-known animal-derived surfactant Poractant alfa (Curosurf (R)). Proliferative response and cell viability were assessed using flow cytometry and a methylthiazolyldiphenyltetrazolium bromide colorimetric assay. The mRNA expression of IFN gamma, IL-2, IL-17A, IL-22, IL-4, and IL-10 was measured by quantitative PCR, while intracellular protein expression was assessed by means of flow cytometry. Results Neither CHF5633 nor any of its phospholipid components with or without SP-B or SP-C analogs had any influence on proliferative ability and viability of CD4(+) lymphocytes under the given conditions. IFN gamma, IL-2, IL-17A, IL-22, IL-4, and IL-10 mRNA as well as IFN gamma, IL-2, IL-4 and IL-10 protein levels were unaffected in both non-activated and activated CD4(+) lymphocytes after exposure to CHF5633 or its constituents compared to non-exposed controls. However, in comparison to Curosurf (R), expression levels of anti-inflammatory IL-4 and IL-10 mRNA were significantly increased in CHF5633 exposed CD4(+) lymphocytes. Conclusion For the first time, the immunomodulatory capacity of CHF5633 on CD4(+) lymphocytes was evaluated. CHF5633 did not show any cytotoxicity on CD4(+) cells. Moreover, our in vitro data indicate that CHF5633 does not exert unintended pro-inflammatory effects on non-activated and activated CD4(+) T cells. As far as anti-inflammatory cytokines are concerned, it might lack an overall reductive ability in comparison to animal-derived surfactants, potentially leaving pro- and anti-inflammatory cytokine response in balance.	[Fehrholz, Markus; Glaser, Kirsten; Seidenspinner, Silvia; Ottensmeier, Barbara; Speer, Christian P.; Kunzmann, Steffen] Univ Wurzburg, Univ Childrens Hosp, D-97070 Wurzburg, Germany; [Curstedt, Tore] Karolinska Inst, Karolinska Univ Hosp, Dept Mol Med & Surg, Stockholm, Sweden	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Wurzburg; Karolinska Institutet; Karolinska University Hospital	Fehrholz, M (corresponding author), Univ Wurzburg, Univ Childrens Hosp, D-97070 Wurzburg, Germany.	markus.fehrholz@uni-wuerzburg.de			Chiesi Farmaceutici S.p.A.; Open Access Publication Fund of the University of Wuerzburg	Chiesi Farmaceutici S.p.A.(Chiesi Pharmaceuticals Inc); Open Access Publication Fund of the University of Wuerzburg	This project was supported by Chiesi Farmaceutici S.p.A., supplying CHF5633, its single components and Curosurf (R). Chiesi Farmaceutici S.p.A. participated in the review of the manuscript, but otherwise had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This publication was supported by the Open Access Publication Fund of the University of Wuerzburg.	ALLEN JN, 1995, J LAB CLIN MED, V125, P356; [Anonymous], 2015, NEONATOLOGY, V107, P372; ANSFIELD MJ, 1979, AM REV RESPIR DIS, V120, P949; ANSFIELD MJ, 1980, J IMMUNOL, V125, P1093; Antal JM, 1996, AM J RESP CELL MOL, V14, P374, DOI 10.1165/ajrcmb.14.4.8600942; Trivella DBB, 2010, CELL MOL LIFE SCI, V67, P2909, DOI 10.1007/s00018-010-0380-0; BARTMANN P, 1992, J PERINAT MED, V20, P189, DOI 10.1515/jpme.1992.20.3.189; BARTMANN P, 1992, ACTA PAEDIATR, V81, P383, DOI 10.1111/j.1651-2227.1992.tb12254.x; Baur FM, 1998, PEDIATR RES, V44, P32, DOI 10.1203/00006450-199807000-00005; Bersani I, 2013, EXPERT REV ANTI-INFE, V11, P99, DOI [10.1586/ERI.12.156, 10.1586/eri.12.156]; Bersani I, 2012, EXPERT REV ANTI-INFE, V10, P573, DOI [10.1586/eri.12.34, 10.1586/ERI.12.34]; Borger P, 1999, IMMUNOLOGY, V96, P207; CATANZARO A, 1988, J LAB CLIN MED, V112, P727; Chatterjee P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00253; Curstedt T, 2015, NEONATOLOGY, V107, P321, DOI 10.1159/000381117; Curstedt T, 2013, NEONATOLOGY, V103, P327, DOI 10.1159/000349942; GEERTSMA MF, 1994, IMMUNOLOGY, V82, P450; Glaser K, 2015, IMMUNOL LETT, V166, P19, DOI 10.1016/j.imlet.2015.05.003; Hidalgo A, 2015, EUR J PHARM BIOPHARM; Israel-Assayag E, 1997, AM J PHYSIOL-LUNG C, V273, pL1258, DOI 10.1152/ajplung.1997.273.6.L1258; Iyer SS, 2012, CRIT REV IMMUNOL, V32, P23, DOI 10.1615/CritRevImmunol.v32.i1.30; Johansson J, 1997, EUR J BIOCHEM, V244, P675, DOI 10.1111/j.1432-1033.1997.00675.x; Kallopur SG, 2006, ARCH DIS CHILD-FETAL, V91, pF132, DOI 10.1136/adc.2004.068544; Kemp MW, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.09.076; Kolls JK, 2013, IMMUNOL REV, V252, P156, DOI 10.1111/imr.12030; Kuronuma K, 2009, J BIOL CHEM, V284, P25488, DOI 10.1074/jbc.M109.040832; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Lin SM, 2014, INT J CLIN EXP PATHO, V7, P474; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luckheeram RV, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/925135; Muhl H, 2003, INT IMMUNOPHARMACOL, V3, P1247, DOI 10.1016/S1567-5769(03)00131-0; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Perez-Gil J, 2010, PHYSIOLOGY, V25, P132, DOI 10.1152/physiol.00006.2010; ROTH MD, 1993, AM J RESP CELL MOL, V9, P652, DOI 10.1165/ajrcmb/9.6.652; Salvesen B, 2014, NEONATOLOGY, V105, P128, DOI 10.1159/000356065; Sato A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039392; Seehase M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047631; Speer CR, 2013, EARLY HUM DEV, V89, pS22, DOI 10.1016/S0378-3782(13)70008-2; SPEER CP, 1991, PEDIATR RES, V30, P69, DOI 10.1203/00006450-199107000-00015; Speer CP., 2012, NEWBORN LUNG, V2nd edn, P283; Teijaro JR, 2011, J IMMUNOL, V187, P5510, DOI 10.4049/jimmunol.1102243; THOMASSEN MJ, 1992, AM J RESP CELL MOL, V7, P257, DOI 10.1165/ajrcmb/7.3.257; THOMASSEN MJ, 1994, AM J RESP CELL MOL, V10, P399, DOI 10.1165/ajrcmb.10.4.8136155; van Helden HPM, 1998, EUR RESPIR J, V12, P533, DOI 10.1183/09031936.98.12030533; Vreugdenhil HA, 2006, EXP LUNG RES, V32, P1, DOI 10.1080/01902140600575006; Walti H, 1997, PEDIATR RES, V41, P114, DOI 10.1203/00006450-199701000-00018; Weaver TE, 2001, ANNU REV PHYSIOL, V63, P555, DOI 10.1146/annurev.physiol.63.1.555; Wemhoner A, 2009, METHOD FIND EXP CLIN, V31, P317, DOI [10.1358/mf.2009.31.5.1386592, 10.1358/mf.2009.31.5.1380462]; WILSHER ML, 1988, CLIN EXP IMMUNOL, V74, P465; WILSHER ML, 1988, THORAX, V43, P354, DOI 10.1136/thx.43.5.354; WILSHER ML, 1990, THORAX, V45, P3, DOI 10.1136/thx.45.1.3; WILSHER ML, 1988, CLIN EXP IMMUNOL, V73, P117; WOERNDLE S, 1994, J PERINAT MED, V22, P119, DOI 10.1515/jpme.1994.22.2.119; Xu S, 2010, CELL MOL IMMUNOL, V7, P164, DOI 10.1038/cmi.2010.21; Yao LJ, 2001, BBA-MOL BASIS DIS, V1535, P266, DOI 10.1016/S0925-4439(01)00023-0; Zhang H, 2011, BIOCHIM BIOPHYS ACTA, V7, P23; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	57	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153578	10.1371/journal.pone.0153578	http://dx.doi.org/10.1371/journal.pone.0153578			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077658	gold, Green Published, Green Submitted			2022-12-26	WOS:000374131700084
J	Kelsey, TW; Miles, A; Mitchell, RT; Anderson, RA; Wallace, WHB				Kelsey, Thomas W.; Miles, Amy; Mitchell, Rod T.; Anderson, Richard A.; Wallace, W. Hamish B.			A Normative Model of Serum Inhibin B in Young Males	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; ANTI-MULLERIAN HORMONE; SERTOLI-CELLS; LUTEINIZING-HORMONE; DIMERIC INHIBINS; BOYS; TESTOSTERONE; MEN; PUBERTY; AGE	Inhibin B has been identified as a potential marker of Sertoli cell function in males. The aim of this study is to produce a normative model of serum inhibin B in males from birth to seventeen years. We used a well-defined search strategy to identify studies containing data that can contribute to a larger approximation of the healthy population. We combined data from four published studies (n = 709) and derived an internally validated model with high goodness-of-fit and normally distributed residuals. Our results show that inhibin B increases following birth to a post-natal peak of 270 pg/mL (IQR 210-335 pg/mL) and then decreases during childhood followed by a rise at around 8 years, peaking at a mean 305 pg/mL (IQR 240-445 pg/mL) at around age 17. Following this peak there is a slow decline to the standard mature adult normal range of 170 pg/mL (IQR 125-215 pg/mL). This normative model suggests that 35% of the variation in Inhibin B levels in young males is due to age alone, provides an age-specific reference range for inhibin B in the young healthy male population, and will be a powerful tool in evaluating the potential of inhibin B as a marker of Sertoli cell function in pre-pubertal boys.	[Kelsey, Thomas W.] Univ St Andrews, Sch Comp Sci, St Andrews KY16 9SX, Fife, Scotland; [Miles, Amy] Univ Edinburgh, Sch Med, Edinburgh EH16 4TJ, Midlothian, Scotland; [Mitchell, Rod T.; Anderson, Richard A.] Univ Edinburgh, MRC, Ctr Reprod Hlth, Edinburgh EH16 4TJ, Midlothian, Scotland; [Wallace, W. Hamish B.] Royal Hosp Sick Children, Dept Haematol Oncol, Edinburgh EH9 1LF, Midlothian, Scotland	University of St Andrews; University of Edinburgh; University of Edinburgh	Wallace, WHB (corresponding author), Royal Hosp Sick Children, Dept Haematol Oncol, Edinburgh EH9 1LF, Midlothian, Scotland.	hamish.wallace@nhs.net	Kelsey, Thomas W/H-3727-2019	Kelsey, Thomas W/0000-0002-8091-1458; Mitchell, Rod/0000-0003-4650-3765; Miles, Amy/0000-0002-9008-4599	Wellcome Trust [098522]	Wellcome Trust(Wellcome TrustEuropean Commission)	RTM is supported by a Wellcome Trust Intermediate Clinical Fellowship (Grant No: 098522), http://www.wellcome.ac.uk/Funding/Biomedical-science/Funding-schemes/Fellowships/Clinical-fellowships/wtd004402.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RA, 2000, INT J ANDROL, V23, P136, DOI 10.1046/j.1365-2605.2000.00229.x; Andersson AM, 2004, J CLIN ENDOCR METAB, V89, P2873, DOI 10.1210/jc.2003-032148; Andersson AM, 1998, J CLIN ENDOCR METAB, V83, P675, DOI 10.1210/jc.83.2.675; Andersson AM, 1997, J CLIN ENDOCR METAB, V82, P3976, DOI 10.1210/jc.82.12.3976; Barbotin AL, 2015, EUR J ENDOCRINOL, V172, P669, DOI 10.1530/EJE-14-0932; Bergada I, 1999, CLIN ENDOCRINOL, V51, P455; Bergada I, 2006, J CLIN ENDOCR METAB, V91, P4092, DOI 10.1210/jc.2006-1079; Byrd W, 1998, J CLIN ENDOCR METAB, V83, P2849, DOI 10.1210/jc.83.8.2849; Carlsen E, 1999, J CLIN ENDOCR METAB, V84, P1664, DOI 10.1210/jc.84.5.1664; Chada M, 2003, PHYSIOL RES, V52, P45; CORTES D, 1987, INT J ANDROL, V10, P589, DOI 10.1111/j.1365-2605.1987.tb00358.x; Crofton PM, 2003, CLIN ENDOCRINOL, V58, P296, DOI 10.1046/j.1365-2265.2003.01712.x; Crofton PM, 2002, CLIN ENDOCRINOL, V56, P215, DOI 10.1046/j.0300-0664.2001.01448.x; Griswold MD, 1998, SEMIN CELL DEV BIOL, V9, P411, DOI 10.1006/scdb.1998.0203; Groome NP, 1996, J CLIN ENDOCR METAB, V81, P1401, DOI 10.1210/jcem.81.4.8636341; Hafez M, 2014, J PEDIATR ENDOCR MET, V27, P891, DOI 10.1515/jpem-2013-0355; Hipler UC, 2001, ARCH ANDROLOGY, V46, P217; HRA, 2013, DOES MY PROJ REQ REV; Johansen ML, 2014, REPRODUCTION, V147, P529, DOI 10.1530/REP-13-0435; Kelsey TW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109346; Kelsey TW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071465; Kelsey TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022024; Mahmoud AM, 2000, CLIN ENDOCRINOL, V53, P141; MULLER J, 1983, INT J ANDROL, V6, P143, DOI 10.1111/j.1365-2605.1983.tb00333.x; NIELSEN CT, 1986, J CLIN ENDOCR METAB, V62, P532, DOI 10.1210/jcem-62-3-532; Radicioni AF, 2005, EUR J ENDOCRINOL, V152, P403, DOI 10.1530/eje.1.01855; Rey RA, 2013, ANDROLOGY-US, V1, P3, DOI 10.1111/j.2047-2927.2012.00008.x; Rohatgi A., 2011, WEBPLOTDIGITIZER 201; Sharpe RM, 2003, REPRODUCTION, V125, P769, DOI 10.1530/rep.0.1250769; van Beek RD, 2007, HUM REPROD, V22, P3215, DOI 10.1093/humrep/dem313; Wallace EM, 1997, J CLIN ENDOCR METAB, V82, P218, DOI 10.1210/jc.82.1.218; Wallace EM, 1997, J CLIN ENDOCR METAB, V82, P3111, DOI 10.1210/jc.82.9.3111; Wallace WHB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008772; Wohlfahrt-Veje C, 2016, J CLIN ENDOCR METAB, V101, P2667, DOI 10.1210/jc.2016-1073	34	17	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153843	10.1371/journal.pone.0153843	http://dx.doi.org/10.1371/journal.pone.0153843			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077369	Green Published, gold			2022-12-26	WOS:000374131700113
J	Yin, XY; Pang, SC; Huang, J; Cui, YH; Yan, B				Yin, Xiaoyun; Pang, Shuchao; Huang, Jian; Cui, Yinghua; Yan, Bo			Genetic and Functional Sequence Variants of the SIRT3 Gene Promoter in Myocardial Infarction	PLOS ONE			English	Article							FATTY-ACID OXIDATION; SIRT3-MEDIATED DEACETYLATION; MITOCHONDRIAL-FUNCTION; REPERFUSION INJURY; SIRTUINS; STRESS; ACETYLATION; HOMOLOG; DEFICIENCY; ACTIVATION	Coronary artery disease (CAD), including myocardial infarction (MI), is a common complex disease that is caused by atherosclerosis. Although a large number of genetic variants have been associated with CAD, only 10% of CAD cases could be explained. It has been proposed that low frequent and rare genetic variants may be main causes for CAD. SIRT3, a mitochondrial deacetylase, plays important roles in mitochondrial function and metabolism. Lack of SIRT3 in experimental animal leads to several age-related diseases, including cardiovascular diseases. Therefore, SIRT3 gene variants may contribute to the MI development. In this study, SIRT3 gene promoter was genetically and functionally analyzed in large cohorts of MI patients (n = 319) and ethnic-matched controls (n = 322). Total twenty-three DNA sequence variants (DSVs) were identified, including 10 single-nucleotide polymorphisms (SNPs). Six novel heterozygous DSVs, g.237307A>G, g.237270G>A, g.237023_25del, g. 236653C>A, g.236628G>C, g.236557T>C, and two SNPs g.237030C>T (rs12293349) and g. 237022C>G (rs369344513), were identified in nine MI patients, but in none of controls. Three SNPs, g.236473C>T (rs11246029), g.236380_81ins (rs71019893) and g.236370C>G (rs185277566), were more significantly frequent in MI patients than controls (P < 0.05). These DSVs and SNPs, except g. 236557T>C, significantly decreased the transcriptional activity of the SIRT3 gene promoter in cultured HEK-293 cells and H9c2 cells. Therefore, these DSVs identified in MI patients may change SIRT3 level by affecting the transcriptional activity of SIRT3 gene promoter, contributing to the MI development as a risk factor.	[Yin, Xiaoyun] Shandong Univ, Sch Med, Dept Med, Jinan 250100, Shandong, Peoples R China; [Pang, Shuchao; Huang, Jian; Yan, Bo] Jining Med Univ, Affiliated Hosp, Shandong Prov Key Lab Cardiac Dis Diag & Treatmen, Jining, Shandong, Peoples R China; [Cui, Yinghua] Jining Med Univ, Affiliated Hosp, Div Cardiol, Jining, Shandong, Peoples R China; [Yan, Bo] Jining Med Univ, Affiliated Hosp, Shandong Prov Sino US Cooperat Res Ctr Translat M, Jining, Shandong, Peoples R China	Shandong University; Jining Medical University; Jining Medical University; Jining Medical University	Yan, B (corresponding author), Jining Med Univ, Affiliated Hosp, Shandong Prov Key Lab Cardiac Dis Diag & Treatmen, Jining, Shandong, Peoples R China.; Yan, B (corresponding author), Jining Med Univ, Affiliated Hosp, Shandong Prov Sino US Cooperat Res Ctr Translat M, Jining, Shandong, Peoples R China.	yanbo@mail.jnmc.edu.cn	Pang, Shuchao/H-7951-2013	Pang, Shuchao/0000-0003-0495-4250; Huang, Jian/0000-0003-0149-1799	National Natural Science Foundation of China [81370271]; Taishan Scholar Program of Shandong, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Taishan Scholar Program of Shandong, China	This study was supported by National Natural Science Foundation of China (No. 81370271) and Taishan Scholar Program of Shandong, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albani D, 2014, AGE, V36, P469, DOI 10.1007/s11357-013-9559-2; Alhazzazi TY, 2011, BBA-REV CANCER, V1816, P80, DOI 10.1016/j.bbcan.2011.04.004; Alrob OA, 2014, CARDIOVASC RES, V103, P485, DOI 10.1093/cvr/cvu156; Barger JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120738; Baur JA, 2012, NAT REV DRUG DISCOV, V11, P443, DOI 10.1038/nrd3738; Bause AS, 2013, EXP GERONTOL, V48, P634, DOI 10.1016/j.exger.2012.08.007; Bellizzi D, 2005, GENOMICS, V85, P258, DOI 10.1016/j.ygeno.2004.11.003; Bellizzi D, 2007, GENOMICS, V89, P143, DOI 10.1016/j.ygeno.2006.09.004; Ben-Avraham D, 2015, ADV EXP MED BIOL, V847, P179, DOI 10.1007/978-1-4939-2404-2_9; Bochaton T, 2015, J MOL CELL CARDIOL, V84, P61, DOI 10.1016/j.yjmcc.2015.03.017; Caton PW, 2013, DIABETOLOGIA, V56, P1068, DOI 10.1007/s00125-013-2851-y; Chen CJ, 2013, BIOCHEM BIOPH RES CO, V430, P798, DOI 10.1016/j.bbrc.2012.11.066; Chen Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.14; Chen YH, 2011, EMBO REP, V12, P534, DOI 10.1038/embor.2011.65; Choudhury M, 2011, AGING-US, V3, P175, DOI 10.18632/aging.100289; de Moura MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106028; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Giblin W, 2014, TRENDS GENET, V30, P271, DOI 10.1016/j.tig.2014.04.007; Goncharov NV, 2015, CURR PHARM DESIGN, V21, P1134, DOI 10.2174/1381612820666141014142557; Gounden S, 2015, METAB SYNDR RELAT D, V13, P255, DOI 10.1089/met.2014.0140; Hafner AV, 2010, AGING-US, V2, P914, DOI 10.18632/aging.100252; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Kathiresan S, 2012, CELL, V148, P1242, DOI 10.1016/j.cell.2012.03.001; Kumari S, 2015, J BIOL CHEM, V290, P12290, DOI 10.1074/jbc.M114.615948; Li HG, 2014, ATHEROSCLEROSIS, V237, P208, DOI 10.1016/j.atherosclerosis.2014.09.001; Liang QL, 2013, BIOCHEM J, V454, P249, DOI 10.1042/BJ20130414; Liu GD, 2015, INT J CLIN EXP PATHO, V8, P353; Lombard DB, 2014, GERONTOLOGY, V60, P56, DOI 10.1159/000354382; Lu ZP, 2015, J BIOL CHEM, V290, P2466, DOI 10.1074/jbc.M114.606228; Luo X, 2017, CELL BIOL INT, V41, P932, DOI 10.1002/cbin.10291; Matsushima S, 2015, AM J PHYSIOL-HEART C, V309, pH1375, DOI 10.1152/ajpheart.00053.2015; McDonnell E, 2015, TRENDS ENDOCRIN MET, V26, P486, DOI 10.1016/j.tem.2015.06.001; Mei Y, 2015, BBA-MOL BASIS DIS, V1852, P243, DOI 10.1016/j.bbadis.2014.05.005; Merksamer PI, 2013, AGING-US, V5, P144, DOI 10.18632/aging.100544; Onyango P, 2002, P NATL ACAD SCI USA, V99, P13653, DOI 10.1073/pnas.222538099; Ozaki K, 2016, J HUM GENET, V61, P71, DOI 10.1038/jhg.2015.70; Paulin R, 2014, CELL METAB, V20, P827, DOI 10.1016/j.cmet.2014.08.011; Porter GA, 2014, AM J PHYSIOL-HEART C, V306, pH1602, DOI 10.1152/ajpheart.00027.2014; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Roberts R, 2014, CIRC RES, V114, P1890, DOI 10.1161/CIRCRESAHA.114.302692; Rose G, 2003, EXP GERONTOL, V38, P1065, DOI 10.1016/S0531-5565(03)00209-2; Samant SA, 2014, MOL CELL BIOL, V34, P807, DOI 10.1128/MCB.01483-13; Satterstrom FK, 2015, AGING CELL, V14, P818, DOI 10.1111/acel.12360; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Shi T, 2010, J DIGEST DIS, V11, P55, DOI 10.1111/j.1751-2980.2009.00416.x; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Tseng AHH, 2014, BIOCHEM J, V464, P157, DOI 10.1042/BJ20140213; Tseng AHH, 2013, FREE RADICAL BIO MED, V63, P222, DOI 10.1016/j.freeradbiomed.2013.05.002; Winnik S, 2015, EUR HEART J, V36, P3404, DOI 10.1093/eurheartj/ehv290; Wu T, 2014, ANN CLIN LAB SCI, V44, P410; Xue L, 2012, FEBS LETT, V586, P137, DOI 10.1016/j.febslet.2011.11.031; Zeng H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107011; Zhang B, 2013, AGE, V35, P2237, DOI 10.1007/s11357-013-9520-4; Zhang YX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122297	58	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153815	10.1371/journal.pone.0153815	http://dx.doi.org/10.1371/journal.pone.0153815			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078640	Green Submitted, gold, Green Published			2022-12-26	WOS:000374131700110
J	Jager, G; Chen, P; Bjork, GR				Jager, Gunilla; Chen, Peng; Bjork, Glenn R.			Transfer RNA Bound to MnmH Protein Is Enriched with Geranylated tRNA - A Possible Intermediate in Its Selenation?	PLOS ONE			English	Article							COLI DNA-POLYMERASE; ESCHERICHIA-COLI; TETRACYCLINE RESISTANCE; MOONLIGHTING PROTEINS; GENE ENCODES; SUPERFAMILY; 2-SELENOURIDINE; SUPPRESSORS; NUCLEOSIDES; MUTATIONS	The wobble nucleoside 5-methylaminomethyl-2-thio-uridine (mnm(5)s(2)U) is present in bacterial tRNAs specific for Lys and Glu and 5-carboxymethylaminomethyl-2-thio-uridine (cmnm(5)s(2)U) in tRNA specific for Gln. The sulfur of (c) mnm(5)s(2)U may be exchanged by selenium (Se)-a reaction catalyzed by the selenophosphate-dependent tRNA 2-selenouridine synthase encoded by the mnmH (ybbB, selU, sufY) gene. The MnmH protein has a rhodanese domain containing one catalytic Cys (C97) and a P-loop domain containing a Walker A motif, which is a potential nucleotide binding site. We have earlier isolated a mutant of Salmonella enterica, serovar Typhimurium with an alteration in the rhodanese domain of the MnmH protein (G67E) mediating the formation of modified nucleosides having a geranyl (ge)-group (C10H17-fragment) attached to the s(2) group of mnm(5)s(2)U and of cmnm(5)s(2)U in tRNA. To further characterize the structural requirements to increase the geranylation activity, we here report the analysis of 39 independently isolated mutants catalyzing the formation of mnm(5)ges(2)U. All these mutants have amino acid substitutions in the rhodanese domain demonstrating that this domain is pivotal to increase the geranylation activity. The wild type form of MnmH(+) also possesses geranyltransferase activity in vitro although only a small amount of the geranyl derivatives of (c) mnm(5)s(2)U is detected in vivo. The selenation activity in vivo has an absolute requirement for the catalytic Cys97 in the rhodanese domain whereas the geranylation activity does not. Clearly, MnmH has two distinct enzymatic activities for which the rhodanese domain is pivotal. An intact Walker motif in the P-loop domain is required for the geranylation activity implying that it is the binding site for geranylpyrophosphate (GePP), which is the donor molecule in vitro in the geranyltransfer reaction. Purified MnmH from wild type and from the MnmH(G67E) mutant have bound tRNA, which is enriched with geranylated tRNA. This in conjunction with earlier published data, suggests that this bound geranylated tRNA may be an intermediate in the selenation of the tRNA.	[Jager, Gunilla; Bjork, Glenn R.] Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden; [Chen, Peng] Huazhong Agr Univ, Coll Plant Sci & Technol, Biomass & Bioenergy Res Ctr, Wuhan 430070, Peoples R China	Umea University; Huazhong Agricultural University	Bjork, GR (corresponding author), Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden.	glenn.bjork@molbiol.umu.se	Björk, Glenn/AAE-8219-2022		Swedish Science Research Council [BU-2930]; Carl Trygger Foundation	Swedish Science Research Council; Carl Trygger Foundation	This work was supported by grants from the Swedish Science Research Council (BU-2930) and from the Carl Trygger Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 2001, TRENDS BIOCHEM SCI, V26, P215, DOI 10.1016/S0968-0004(01)01826-6; Armengod ME, 2012, BIOCHIMIE, V94, P1510, DOI 10.1016/j.biochi.2012.02.019; Bartos P, 2014, BIOORG CHEM, V56, P49, DOI 10.1016/j.bioorg.2014.05.012; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Bjo rk G.R., 2014, ECOSAL PLUS, V6, DOI [10.1128/ecosalplus.ESP-0007-2013, DOI 10.1128/ECOSALPLUS.ESP-0007-2013]; Bjork GR, 2007, RNA, V13, P1245, DOI 10.1261/rna.558707; BOCHNER BR, 1980, J BACTERIOL, V143, P926, DOI 10.1128/JB.143.2.926-933.1980; Bordo D, 2002, EMBO REP, V3, P741, DOI 10.1093/embo-reports/kvf150; Chen P, 2005, EMBO J, V24, P1842, DOI 10.1038/sj.emboj.7600666; Cipollone R, 2007, IUBMB LIFE, V59, P51, DOI 10.1080/15216540701206859; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DAVIS W, 1980, MANUAL GENETIC ENG A; Du T, 2004, CURRENT PROTOCOLS MO; Dumelin CE, 2012, NAT CHEM BIOL, V8, P913, DOI [10.1038/nchembio.1070, 10.1038/NCHEMBIO.1070]; EMILSSON V, 1990, EMBO J, V9, P4359, DOI 10.1002/j.1460-2075.1990.tb07885.x; GEHRKE CW, 1982, J CHROMATOGR, V230, P297, DOI 10.1016/S0378-4347(00)80479-X; Gehrke CW, 1990, J CHROMATOGRAPHY LIB, pA3; HARPAZ Y, 1994, STRUCTURE, V2, P641, DOI 10.1016/S0969-2126(00)00065-4; HONG JS, 1971, P NATL ACAD SCI USA, V68, P3158, DOI 10.1073/pnas.68.12.3158; Ikeuchi Y, 2006, MOL CELL, V21, P97, DOI 10.1016/j.molcel.2005.11.001; Jager G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060246; Janas T, 2012, RNA, V18, P2260, DOI 10.1261/rna.035352.112; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; Jeffery CJ, 2009, MOL BIOSYST, V5, P345, DOI 10.1039/b900658n; KOONIN EV, 1993, J MOL BIOL, V229, P1165, DOI 10.1006/jmbi.1993.1115; Maisnier-Patin S, 2005, NAT GENET, V37, P1376, DOI 10.1038/ng1676; MALOY SR, 1981, J BACTERIOL, V145, P1110, DOI 10.1128/JB.145.2.1110-1111.1981; Moukadiri I, 2014, NUCLEIC ACIDS RES, V42, P2602, DOI 10.1093/nar/gkt1228; Nasvall SJ, 2009, J MOL BIOL, V385, P350, DOI 10.1016/j.jmb.2008.10.069; RIDDLE DL, 1972, J MOL BIOL, V66, P483, DOI 10.1016/0022-2836(72)90428-7; RIDDLE DL, 1970, J MOL BIOL, V54, P131, DOI 10.1016/0022-2836(70)90451-1; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; Su D, 2012, FEBS LETT, V586, P717, DOI 10.1016/j.febslet.2012.01.024; Urbonavicius J, 2001, EMBO J, V20, P4863, DOI 10.1093/emboj/20.17.4863; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Wagner J, 2000, J BACTERIOL, V182, P4587, DOI 10.1128/JB.182.16.4587-4595.2000; Wagner J, 1999, MOL CELL, V4, P281, DOI 10.1016/S1097-2765(00)80376-7; Wai SN, 2003, J BACTERIOL, V185, P5491, DOI 10.1128/JB.185.18.5491-5499.2003; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wang R, 2015, CHEM COMMUN, V51, P16369, DOI 10.1039/c5cc07479g; Wolfe MD, 2004, J BIOL CHEM, V279, P1801, DOI 10.1074/jbc.M310442200	41	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153488	10.1371/journal.pone.0153488	http://dx.doi.org/10.1371/journal.pone.0153488			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073879	Green Published, Green Submitted, gold			2022-12-26	WOS:000374131200099
J	Sanchez-Alcudia, R; Garcia-Hoyos, M; Lopez-Martinez, MA; Sanchez-Bolivar, N; Zurita, O; Gimenez, A; Villaverde, C; da Silva, LRJ; Corton, M; Perez-Carro, R; Torriano, S; Kalatzis, V; Rivolta, C; Avila-Fernandez, A; Lorda, I; Trujillo-Tiebas, MJ; Garcia-Sandoval, B; Lopez-Molina, MI; Blanco-Kelly, F; Riveiro-Alvarez, R; Ayuso, C				Sanchez-Alcudia, Rocio; Garcia-Hoyos, Maria; Angel Lopez-Martinez, Miguel; Sanchez-Bolivar, Noelia; Zurita, Olga; Gimenez, Ascension; Villaverde, Cristina; Rodrigues-Jacy da Silva, Luciana; Corton, Marta; Perez-Carro, Raquel; Torriano, Simona; Kalatzis, Vasiliki; Rivolta, Carlo; Avila-Fernandez, Almudena; Lorda, Isabel; Trujillo-Tiebas, Maria J.; Garcia-Sandoval, Blanca; Isabel Lopez-Molina, Maria; Blanco-Kelly, Fiona; Riveiro-Alvarez, Rosa; Ayuso, Carmen			A Comprehensive Analysis of Choroideremia: From Genetic Characterization to Clinical Practice	PLOS ONE			English	Article							RAB GERANYLGERANYL TRANSFERASE; COMPONENT-A; MUTATIONS; FAMILIES; EXOME	Choroideremia (CHM) is a rare X-linked disease leading to progressive retinal degeneration resulting in blindness. The disorder is caused by mutations in the CHM gene encoding REP-1 protein, an essential component of the Rab geranylgeranyltransferase (GGTase) complex. In the present study, we evaluated a multi-technique analysis algorithm to describe the mutational spectrum identified in a large cohort of cases and further correlate CHM variants with phenotypic characteristics and biochemical defects of choroideremia patients. Molecular genetic testing led to the characterization of 36 out of 45 unrelated CHM families (80%), allowing the clinical reclassification of four CHM families. Haplotype reconstruction showed independent origins for the recurrent p.Arg293* and p.Lys178Argfs*5 mutations, suggesting the presence of hotspots in CHM, as well as the identification of two different unrelated events involving exon 9 deletion. No certain genotype-phenotype correlation could be established. Furthermore, all the patients' fibroblasts analyzed presented significantly increased levels of unprenylated Rabs proteins compared to control cells; however, this was not related to the genotype. This research demonstrates the major potential of the algorithm proposed for diagnosis. Our data enhance the importance of establish a differential diagnosis with other retinal dystrophies, supporting the idea of an underestimated prevalence of choroideremia. Moreover, they suggested that the severity of the disorder cannot be exclusively explained by the genotype.	[Sanchez-Alcudia, Rocio; Garcia-Hoyos, Maria; Angel Lopez-Martinez, Miguel; Sanchez-Bolivar, Noelia; Zurita, Olga; Gimenez, Ascension; Villaverde, Cristina; Rodrigues-Jacy da Silva, Luciana; Corton, Marta; Perez-Carro, Raquel; Avila-Fernandez, Almudena; Lorda, Isabel; Trujillo-Tiebas, Maria J.; Blanco-Kelly, Fiona; Riveiro-Alvarez, Rosa; Ayuso, Carmen] IIS FJD, Dept Genet, Madrid, Spain; [Sanchez-Alcudia, Rocio; Angel Lopez-Martinez, Miguel; Sanchez-Bolivar, Noelia; Zurita, Olga; Gimenez, Ascension; Villaverde, Cristina; Corton, Marta; Perez-Carro, Raquel; Avila-Fernandez, Almudena; Lorda, Isabel; Trujillo-Tiebas, Maria J.; Blanco-Kelly, Fiona; Riveiro-Alvarez, Rosa; Ayuso, Carmen] ISCIII, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain; [Torriano, Simona; Kalatzis, Vasiliki] Inst Neurosci Montpellier, INSERM, U1051, Montpellier, France; [Rivolta, Carlo] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland; [Garcia-Sandoval, Blanca; Isabel Lopez-Molina, Maria] IIS Fdn Jimenez Diaz Univ Hosp, Dept Ophthalmol, Madrid, Spain; [Garcia-Hoyos, Maria] Inst Med Genom, Valencia, Spain; [Rodrigues-Jacy da Silva, Luciana] Univ Mogi das Cruzes, Sao Paulo, Brazil	Fundacion Jimenez Diaz; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of Lausanne; Fundacion Jimenez Diaz; Universidade de Mogi das Cruzes	Ayuso, C (corresponding author), IIS FJD, Dept Genet, Madrid, Spain.; Ayuso, C (corresponding author), ISCIII, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain.	cayuso@fjd.es	Kalatzis, Vasiliki/F-6170-2019	Kalatzis, Vasiliki/0000-0002-9626-8807; Rivolta, Carlo/0000-0002-0733-9950; Ayuso, Carmen/0000-0002-9242-7065; Corton, Marta/0000-0003-0087-1626; Blanco-Kelly, Fiona/0000-0003-0052-5651	Fondo de Investigacion Sanitaria - FIS [13/00226]; Centre for Biomedical Network Research on Rare Diseases -CIBERER [06/07/0036]; Biobank of University Hospital Fundacion Jimenez Diaz Hospital [PT13/0010/0012]; ONCE; Swiss National Science Foundation [31003A_156260]; European Union Seventh Framework Programme [FP7-People-ITN] [317472]; Fundacion Conchita Rabago (FCR); association France Choroideremia; association Retina France; Association Francaise contre les Myopathies;  [CD12/00676];  [CP13/03256]	Fondo de Investigacion Sanitaria - FIS(Instituto de Salud Carlos III); Centre for Biomedical Network Research on Rare Diseases -CIBERER; Biobank of University Hospital Fundacion Jimenez Diaz Hospital; ONCE; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union Seventh Framework Programme [FP7-People-ITN]; Fundacion Conchita Rabago (FCR); association France Choroideremia; association Retina France; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); ; 	The research leading to these results has received funding from the following research grants: Fondo de Investigacion Sanitaria - FIS (PI:13/00226), the Centre for Biomedical Network Research on Rare Diseases -CIBERER (06/07/0036), the Biobank of University Hospital Fundacion Jimenez Diaz Hospital (PT13/0010/0012), ONCE, Swiss National Science Foundation (Grant Number 31003A_156260), the European Union Seventh Framework Programme [FP7-People-2012-ITN] under grant agreement 317472 (EyeTN), the patient associations France Choroideremia, Retina France and the Association Francaise contre les Myopathies. RSA is supported by Sara Borrell CD12/00676, MC by Miguel Servet CP13/03256 and RPC by Fundacion Conchita Rabago (FCR).	ANDRES DA, 1993, CELL, V73, P1091, DOI 10.1016/0092-8674(93)90639-8; Cereso N, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.11; Corton M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065574; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Dimopoulos IS, 2015, EXPERT OPIN ORPHAN D, V3, P787, DOI 10.1517/21678707.2015.1046434; DONNELLY P, 1994, HUM MOL GENET, V3, P1017, DOI 10.1093/hmg/3.6.1017; Garcia-Hoyos M, 2008, INVEST OPHTH VIS SCI, V49, P1315, DOI 10.1167/iovs.07-1169; Larijani B, 2003, J BIOL CHEM, V278, P46798, DOI 10.1074/jbc.M307799200; Li SQ, 2014, INT J MOL MED, V34, P573, DOI 10.3892/ijmm.2014.1797; Lorda-Sanchez I J, 2000, Ophthalmic Genet, V21, P185, DOI 10.1076/1381-6810(200009)21:3;1-Z;FT185; Lutsenko E, 1999, MUTAT RES-REV MUTAT, V437, P11, DOI 10.1016/S1383-5742(99)00065-4; MacDonald IM, 2003, GENEREVIEWS; McTaggart KE, 2002, HUM MUTAT, V20, P189, DOI 10.1002/humu.10114; Preising Markus, 2004, Ophthalmic Genet, V25, P101, DOI 10.1080/13816810490514333; SEABRA MC, 1992, CELL, V70, P1049, DOI 10.1016/0092-8674(92)90253-9; SEABRA MC, 1993, SCIENCE, V259, P377, DOI 10.1126/science.8380507; Sun Y, 2015, HUM MUTAT, V36, P648, DOI 10.1002/humu.22783; Trujillo M J, 1998, Hum Mutat, V12, P213; van den Hurk JAJM, 2003, HUM GENET, V113, P268, DOI 10.1007/s00439-003-0970-0	19	38	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0151943	10.1371/journal.pone.0151943	http://dx.doi.org/10.1371/journal.pone.0151943			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070432	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000373900700005
J	Gore, ML; Lute, ML; Ratsimbazafy, JH; Rajaonson, A				Gore, Meredith L.; Lute, Michelle L.; Ratsimbazafy, Jonah H.; Rajaonson, Andry			Local Perspectives on Environmental Insecurity and Its Influence on Illegal Biodiversity Exploitation	PLOS ONE			English	Article							WILDLIFE; CONSERVATION; SECURITY; MADAGASCAR; CONFLICT; TRADE	Environmental insecurity is a source and outcome of biodiversity declines and social conflict. One challenge to scaling insecurity reduction policies is that empirical evidence about local attitudes is overwhelmingly missing. We set three objectives: determine how local people rank risk associated with different sources of environmental insecurity; assess perceptions of environmental insecurity, biodiversity exploitation, myths of nature and risk management preferences; and explore relationships between perceptions and biodiversity exploitation. We conducted interviews (N = 88) with residents of Madagascar's Torotorofotsy Protected Area, 2014. Risk perceptions had a moderate effect on perceptions of environmental insecurity. We found no effects of environmental insecurity on biodiversity exploitation. Results offer one if not the first exploration of local perceptions of illegal biodiversity exploitation and environmental security. Local people's perception of risk seriousness associated with illegal biodiversity exploitation such as lemur hunting (low overall) may not reflect perceptions of policy-makers (considered to be high). Discord is a key entry point for attention.	[Gore, Meredith L.] Michigan State Univ, Dept Fisheries & Wildlife, Sch Criminal Justice, E Lansing, MI 48824 USA; [Lute, Michelle L.] Univ Nebraska, Sch Nat Resources, Lincoln, NE USA; [Ratsimbazafy, Jonah H.] Grp Etud & Rech Primates Madagascar GERP, Antananarivo, Madagascar; [Rajaonson, Andry] Malagasy Biologist Assoc, Antananarivo, Madagascar	Michigan State University; University of Nebraska System; University of Nebraska Lincoln	Gore, ML (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, Sch Criminal Justice, E Lansing, MI 48824 USA.	gorem@msu.edu	Gore, Meredith/AAY-4350-2020	Gore, Meredith/0000-0002-2613-4715				Barrett MA, 2009, NATURE, V461, P470, DOI 10.1038/461470a; Becker HS, 2001, CONT FIELD RES PERSP, V2nd, P317; Brashares JS, 2014, SCIENCE, V345, P376, DOI 10.1126/science.1256734; Brisman A, 2015, GREEN CRIMINOL, P1; Buzan B, 1995, 10 CTR PEACH CONFL R; Denzin N.K., 2013, LANDSCAPE QUALITATIV; DEUDNEY D, 1991, B ATOM SCI, V47, P22, DOI 10.1080/00963402.1991.11459957; Douglas M., 1978, 35 ROY ANTHR I GREAT; Douglas M., 1982, RISK CULTURE ESSAY S; Duffy R., 2010, NATURE CRIME WERE GE; Environmental Investigation Agency, 2015, HIGH PROF LOW RISK R; Erickson F., 1984, 81 MICH STAT U; Forsyth T., 2002, CRITICAL POLITICAL E, DOI 10.4324/9780203017562; Goodman SM, 2005, ORYX, V39, P73, DOI 10.1017/S0030605305000128; Gore M.L., 2007, HUMAN DIMENSIONS WIL, V12, P133, DOI DOI 10.1080/10871200701195985; Gore ML, 2006, WILDLIFE SOC B, V34, P36, DOI 10.2193/0091-7648(2006)34[36:SPORAW]2.0.CO;2; Gore ML, 2015, HUM DIMENS WILDL, V20, P159, DOI 10.1080/10871209.2014.992501; Gore ML, 2013, CONSERV LETT, V6, P430, DOI 10.1111/conl.12032; Gore ML, 2011, CONSERV BIOL, V25, P659, DOI 10.1111/j.1523-1739.2011.01701.x; Gore ML, 2008, CONSERV LETT, V1, P136, DOI 10.1111/j.1755-263X.2008.00017.x; Graeger N, 1996, J PEACE RES, V33, P109, DOI 10.1177/0022343396033001008; Hanisch-Kirkbride SL, 2013, J WILDLIFE DIS, V49, P841, DOI 10.7589/2013-02-031; Harvey CA, 2014, CONSERV LETT, V7, P77, DOI 10.1111/conl.12066; Heberlein T.A., 2012, NAVIGATING ENV ATTIT; Kahler JS, 2015, BIOL CONSERVATION; Lidskog R, 2013, ESSENTIALS RISK THEO, P75; Lodgaard S, 1992, ENV INT SECURITY, P11; Lonergan S, 1999, GLOBAL ENV CHANGE HU; Masse F., 2015, GEOFORUM, DOI http://doi.org/10.1016/j.geoforum.2015.03.005; Muter BA, 2012, RISK ANAL, DOI [10.1111/j.15396924.2012.01936.x, DOI 10.1111/J.15396924.2012.01936.X]; Nellemann C., 2014, ENV CRISIS THREATS S; O'Donoghue P, 2015, J APPL ECOL, DOI [10.1111/13652664.12452, DOI 10.1111/13652664.12452]; Obama B, 2013, EXECUTIVE ORDER 1364; Peng CYJ, 2002, J EDUC RES, V96, P3, DOI 10.1080/00220670209598786; Randrianja S., 2009, MADAGASCAR SHORT HIS; Ratsimbazafy J, 2013, COMMUNITY POLICING IN INDIGENOUS COMMUNITIES, P31; Robinson JE, 2015, BIOL CONSERV, V184, P42, DOI 10.1016/j.biocon.2014.12.019; Schwitzer C, 2014, SCIENCE, V343, P842, DOI 10.1126/science.1245783; Solomon JN, 2015, BIOL CONSERV, V189, P1, DOI 10.1016/j.biocon.2015.04.028; Swart R, 1996, GLOBAL ENVIRON CHANG, V6, P187, DOI 10.1016/0959-3780(96)00014-3; Swart R, 1996, GLOBAL ENV CHANGE; Transparency International, 2002, CORR PERC IND 2002; Trochim William M. K, 2001, RES METHODS KNOWLEDG, V2nd; Tschakert P, 2007, GLOBAL ENVIRON CHANG, V17, P381, DOI 10.1016/j.gloenvcha.2006.11.008; Tyson P., 2002, 8 CONTINENT LIFE DEA; Vaske J., 2008, SURVEY RES ANAL APPL; White R, 2014, INT AFF, V90, P835, DOI 10.1111/1468-2346.12143; Williams R, 2006, STATA J, V6, P58, DOI 10.1177/1536867X0600600104; World Bank, MAD DAT PROF 2007; Wyatt T., 2014, WILDLIFE TRAFFICKING	50	15	15	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0150337	10.1371/journal.pone.0150337	http://dx.doi.org/10.1371/journal.pone.0150337			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ6AH	27082106	Green Published, gold			2022-12-26	WOS:000374291800001
J	Hidaka, T; Hayakawa, T; Kakamu, T; Kumagai, T; Hiruta, Y; Hata, J; Tsuji, M; Fukushima, T				Hidaka, Tomoo; Hayakawa, Takehito; Kakamu, Takeyasu; Kumagai, Tomohiro; Hiruta, Yuhei; Hata, Junko; Tsuji, Masayoshi; Fukushima, Tetsuhito			Prevalence of Metabolic Syndrome and Its Components among Japanese Workers by Clustered Business Category	PLOS ONE			English	Article							LONG-TERM PREDICTION; CARDIOVASCULAR MORTALITY; CLINICAL-VALUE; POPULATION; OBESITY; HEALTH; DISEASE; AREA; RISK; AGE	The present study was a cross-sectional study conducted to reveal the prevalence of metabolic syndrome and its components and describe the features of such prevalence among Japanese workers by clustered business category using big data. The data of approximately 120,000 workers were obtained from a national representative insurance organization, and the study analyzed the health checkup and questionnaire results according to the field of business of each subject. Abnormalities found during the checkups such as excessive waist circumference, hypertension or glucose intolerance, and metabolic syndrome, were recorded. All subjects were classified by business field into 18 categories based on The North American Industry Classification System. Based on the criteria of the Japanese Committee for the Diagnostic Criteria of Metabolic Syndrome, the standardized prevalence ratio (SPR) of metabolic syndrome and its components by business category was calculated, and the 95% confidence interval of the SPR was computed. Hierarchical cluster analysis was then performed based on the SPR of metabolic syndrome components, and the 18 business categories were classified into three clusters for both males and females. The following business categories were at significantly high risk of metabolic syndrome: among males, Construction, Transportation, Professional Services, and Cooperative Association; and among females, Health Care and Cooperative Association. The results of the cluster analysis indicated one cluster for each gender with a higher prevalence of metabolic syndrome components; among males, a cluster consisting of Manufacturing, Transportation, Finance, and Cooperative Association, and among females, a cluster consisting of Mining, Transportation, Finance, Accommodation, and Cooperative Association. These findings reveal that, when providing health guidance and support regarding metabolic syndrome, consideration must be given to its components and the variety of its prevalence rates by business category and gender.	[Hidaka, Tomoo; Hayakawa, Takehito; Kakamu, Takeyasu; Kumagai, Tomohiro; Fukushima, Tetsuhito] Fukushima Med Univ, Sch Med, Dept Hyg & Prevent Med, Fukushima, Fukushima, Japan; [Hiruta, Yuhei; Hata, Junko] Japan Hlth Insurance Assoc, Fukushima Branch Off, Fukushima, Fukushima, Japan; [Tsuji, Masayoshi] Fukuoka Univ, Fac Med, Dept Prevent Med & Publ Hlth, Fukuoka, Fukuoka 81401, Japan	Fukushima Medical University; Fukuoka University	Hidaka, T (corresponding author), Fukushima Med Univ, Sch Med, Dept Hyg & Prevent Med, Fukushima, Fukushima, Japan.	thidaka@fmu.ac.jp	PAN, ZEQIANG/X-6341-2018; Kakamu, Takeyasu/AAP-7766-2020	Hidaka, Tomoo/0000-0003-2987-4804; Kakamu, Takeyasu/0000-0001-6920-8457	Japan Health Insurance Association	Japan Health Insurance Association	The authors received no specific funding for this work. Japan Health Insurance Association provided support in the form of salaries for authors YH and JH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adeoye AM, 2015, J CLIN HYPERTENS, V17, P880, DOI 10.1111/jch.12595; Al-Daghri NM, 2014, BMC CARDIOVASC DISOR, V14, DOI [10.1186/1471-2261-14-51, 10.1186/1471-2458-14-391]; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Cheserek MJ, 2014, J CLIN DIAGN RES, V8, P65, DOI 10.7860/JCDR/2014/6515.4010; Dunning KK, 2010, AM J IND MED, V53, P276, DOI 10.1002/ajim.20774; Farmer A, 2006, BRIT MED J, V332, P882, DOI 10.1136/bmj.332.7546.882; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Kuzuya M, 2007, ATHEROSCLEROSIS, V191, P305, DOI 10.1016/j.atherosclerosis.2006.05.043; Luckhaupt SE, 2014, AM J PREV MED, V46, P237, DOI 10.1016/j.amepre.2013.11.002; Matsuzawa Y, 2005, J ATHEROSCLER THROMB, V12, P301, DOI 10.5551/jat.12.301; Nakao YM, 2012, P JPN ACAD B-PHYS, V88, P454, DOI 10.2183/pjab.88.454; Pathania D, 2014, J FAM COMMUNITY MED, V21, P130, DOI 10.4103/2230-8229.134774; Pokharel DR, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/s40200-014-0104-3; Poulsen K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103425; Shin SY, 2013, ANN OCCUP ENVIRON ME, V25, DOI 10.1186/2052-4374-25-34; Sieber WK, 2014, AM J IND MED, V57, P615, DOI 10.1002/ajim.22293; Sundstrom J, 2006, BMJ-BRIT MED J, V332, P878, DOI 10.1136/bmj.38766.624097.1F; Tabatabaie AH, 2015, DIABETES METAB SYND, V9, P153, DOI 10.1016/j.dsx.2015.04.012; Takeuchi H, 2005, HYPERTENS RES, V28, P203, DOI 10.1291/hypres.28.203; U.S. Department of Commerce, 2015, INTR NAICS; Wild SH, 2011, METABOLIC SYNDROME, 2ND EDITION, P1; Zimmet P, 2005, J ATHEROSCLER THROMB, V12, P295, DOI 10.5551/jat.12.295	22	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153368	10.1371/journal.pone.0153368	http://dx.doi.org/10.1371/journal.pone.0153368			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082961	Green Submitted, Green Published, gold			2022-12-26	WOS:000374291800016
J	Daoud, A; Hallerod, B; Guha-Sapir, D				Daoud, Adel; Hallerod, Bjorn; Guha-Sapir, Debarati			What Is the Association between Absolute Child Poverty, Poor Governance, and Natural Disasters? A Global Comparison of Some of the Realities of Climate Change	PLOS ONE			English	Article							POLITICAL-ECONOMY; GOVERNMENT; INCOME; FLOOD	The paper explores the degree to which exposure to natural disasters and poor governance (quality of governance) is associated with absolute child poverty in sixty-seven middle-and low-income countries. The data is representative for about 2.8 billion of the world's population. Institutionalist tend to argue that many of society's ills, including poverty, derive from fragile or inefficient institutions. However, our findings show that although increasing quality of government tends to be associated with less poverty, the negative effects of natural disasters on child poverty are independent of a country's institutional efficiency. Increasing disaster victims (killed and affected) is associated with higher rates of child poverty. A child's estimated odds ratio to be in a state of absolute poverty increases by about a factor of 5.7 [95% CI: 1.7 to 18.7] when the average yearly toll of disasters in the child's country increases by one on a log-10 scale. Better governance correlates with less child poverty, but it does not modify the correlation between child poverty and natural disasters. The results are based on hierarchical regression models that partition the variance into three parts: child, household, and country. The models were cross-sectional and based on observational data from the Demographic Health Survey and the Multiple Indicator Cluster Survey, which were collected at the beginning of the twenty-first millennium. The Sustainable Development Goals are a principle declaration to halt climate change, but they lack a clear plan on how the burden of this change should be shared by the global community. Based on our results, we suggest that the development agencies should take this into account and to articulate more equitable global policies to protect the most vulnerable, specifically children.	[Daoud, Adel; Hallerod, Bjorn] Univ Cambridge, Dept Sociol, Cambridge, England; [Daoud, Adel] Univ Gothenburg, Dept Sociol & Work Sci, Gothenburg, Sweden; [Guha-Sapir, Debarati] Ctr Res Epidemiol Disasters CRED, Brussels, Belgium; [Guha-Sapir, Debarati] Univ Louvain, Sch Publ Hlth, Brussels, Belgium	University of Cambridge; University of Gothenburg; Universite Catholique Louvain	Daoud, A (corresponding author), Univ Cambridge, Dept Sociol, Cambridge, England.; Daoud, A (corresponding author), Univ Gothenburg, Dept Sociol & Work Sci, Gothenburg, Sweden.	Adel.daoud@sociology.gu.se			Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funded by Swedish Research Council. Project name is "poor governance and poor children".	Adger WN, 2006, GLOBAL ENVIRON CHANG, V16, P268, DOI 10.1016/j.gloenvcha.2006.02.006; Agnafors M, 2013, AM POLIT SCI REV, V107, P433, DOI 10.1017/S0003055413000191; Alkire S., 2007, COUNTING MULTIDIMENS; Anbarci N, 2005, J PUBLIC ECON, V89, P1907, DOI 10.1016/j.jpubeco.2004.08.002; Aneshensel C. S, 2013, THEORY BASED DATA AN; [Anonymous], 2013, QUALITY GOVT DATASET; [Anonymous], 2009, RELATIONSHIP NATURAL; Arndt C, 2008, INT PUBLIC MANAG J, V11, P275, DOI 10.1080/10967490802301278; Arndt Christiane., 2006, USES ABUSES GOVERNAN; Banerjee S., 2014, HIERARCHICAL MODELIN; Benson C., 2004, UNDERSTANDING EC FIN; Benson C., 2003, THESIS U LONDON LOND; Berry WD, 2012, J POLIT, V74, P653, DOI 10.1017/S0022381612000199; Blaikie P., 2014, RISK NATURAL HAZARDS, DOI DOI 10.4324/9780203714775; Blakely TA, 2000, J EPIDEMIOL COMMUN H, V54, P367, DOI 10.1136/jech.54.5.367; Boerma JT, 1996, CHILD SURIVIAL DEV C; Brambor T, 2006, POLIT ANAL, V14, P63, DOI 10.1093/pan/mpi014; Cannon T., 1994, DISASTERS DEV ENV, P13; Carter MR, 2007, WORLD DEV, V35, P835, DOI 10.1016/j.worlddev.2006.09.010; Daoud A, 2015, J S ASIAN DEV, V10, P148, DOI 10.1177/0973174115588844; Daoud A, 2011, BRIT J SOCIOL EDUC, V32, P603, DOI 10.1080/01425692.2011.578440; Daoud A, 2007, J CRIT REALISM, V6, P199, DOI 10.1558/jocr.v6i2.199; Daoud A, 2010, AM J ECON SOCIOL, V69, P1206, DOI 10.1111/j.1536-7150.2010.00741.x; Dobkowski M., 1998, COMING AGE SCARCITY; Goldstein H., 2011, MULTILEVEL STAT MODE, V4th; Gordon D., 2003, CHILD POVERTY DEV WO; Gordon D, 2010, MEASURING CHILD POVE; Grindle MS, 2007, DEV POLICY REV, V25, P553; Guha-Sapir D., 2004, 30 YEARS NATURAL DIS; Hallerod B, 2013, WORLD DEV, V48, P19, DOI 10.1016/j.worlddev.2013.03.007; Holmberg S, 2012, GOOD GOVERNMENT: THE RELEVANCE OF POLITICAL SCIENCE, P1; Holmberg S, 2010, HLTH EC POLICY LAW; Holmberg S, 2011, HEALTH ECON POLICY L, V6, P529, DOI 10.1017/S174413311000023X; Kahn ME, 2005, REV ECON STAT, V87, P271, DOI 10.1162/0034653053970339; Kam CD, 2013, MODELING INTERPRETIN, V44, P51; Kaufmann D, 2010, 1682130 SOC SCI RES; Kaufmann D, 1424591 SOC SCI RES; Keefer P, 2011, WORLD DEV, V39, P1530, DOI 10.1016/j.worlddev.2011.02.010; Kenny C, 2009, WHY DO PEOPLE DIE EA; Kim JJ, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.18481; Klomp J, 2014, GLOBAL ENVIRON CHANG, V26, P183, DOI 10.1016/j.gloenvcha.2014.02.006; Kron W, 2012, NAT HAZARD EARTH SYS, V12, P535, DOI 10.5194/nhess-12-535-2012; Lopez-Calva L F., 2009, EVIDENCE POLICY LESS; Luke DA, 2019, MULTILEVEL MODELING; Malthus Thomas Robert, 1826, ESSAY PRINCIPLE POPU, V6th; Masters A., 2003, J HUMAN DEV, V4, P379, DOI DOI 10.1080/1464988032000125755; Minujin A, 2006, ENVIRON URBAN, V18, P481, DOI 10.1177/0956247806069627; Nandy S, 2016, SOC SCI MED, V149, P153, DOI 10.1016/j.socscimed.2015.11.036; Neumayer E, 2007, ANN ASSOC AM GEOGR, V97, P551, DOI 10.1111/j.1467-8306.2007.00563.x; Neumayer E, 2014, GLOBAL ENVIRON CHANG, V24, P8, DOI 10.1016/j.gloenvcha.2013.03.011; Paul BK, 2011, ENVIRONMENTAL HAZARDS AND DISASTERS: CONTEXTS, PERSPECTIVES AND MANAGEMENT, P1, DOI 10.1002/9781119979616; Pogge T, 2009, INITIATIVE POLICY DI; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Ravallion M, 2010, DEBATES MEASUREMENT, P86; Reddy SG, 2015, FINANCIAL TIMES; Reddy SG, 2015, REDDYTOREAD; Richardson LF., 1960, STAT DEADLY QUARRELS, Vxlvi; Rodriguez-Oreggia E, 2010, WORKING PAPERS CTR I; Roelen K, 2008, MEASURING CHILD POVE; Rothstein B., 2011, QUALITY GOVT CORRUPT; Rowhani P, 2011, AGR FOREST METEOROL, V151, P449, DOI 10.1016/j.agrformet.2010.12.002; SEN A, 1981, Q J ECON, V96, P433, DOI 10.2307/1882681; SEN A, 1991, INTERDISCIPL SCI REV, V16, P324; Skoufias E, 2003, WORLD DEV, V31, P1087, DOI 10.1016/S0305-750X(03)00069-X; Stallings RA, 2006, SAGE DICT SOCIAL RES; Steele F, 2014, MULTILEVEL MODELLING, p[15, 1]; Stormberg D, 2007, J ECON PERSPECT, V21, P199; Sudaryo MK, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.11816; Toya H., 2005, EC DEV IMPACTS NATUR; Bich TH, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.6356; UNDP, 2015, UNDP CLIM CHANG; UNICEF, 2004, STAT WORLDS CHILDR G; United N, 1995, COP DECL PROGR ACT W; Weiss TG, 2000, THIRD WORLD Q, V21, P795, DOI 10.1080/713701075; Zhang Z, 2013, R2MLWIN V0 1 7	75	23	23	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153296	10.1371/journal.pone.0153296	http://dx.doi.org/10.1371/journal.pone.0153296			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UH	27077913	gold, Green Published, Green Submitted			2022-12-26	WOS:000374131700036
J	Kwai, NCG; Nigole, W; Poynten, AM; Brown, C; Krishnan, AV				Kwai, Natalie C. G.; Nigole, William; Poynten, Ann M.; Brown, Christopher; Krishnan, Arun V.			The Relationship between Dyslipidemia and Acute Axonal Function in Type 2 Diabetes Mellitus In Vivo	PLOS ONE			English	Article							HUMAN PERIPHERAL-NERVE; QUALITY-OF-LIFE; INTENSIVE TREATMENT; NEUROPATHY; DYSFUNCTION; HYPERGLYCEMIA; EXCITABILITY; MEMBRANE; HYPERLIPIDEMIA; COMPLICATIONS	Objectives Diabetic peripheral neuropathy (DPN) is a common and debilitating complication of diabetes mellitus. Treatment largely consists of symptom alleviation and there is a need to identify therapeutic targets for prevention and treatment of DPN. The objective of this study was to utilise novel neurophysiological techniques to investigate axonal function in patients with type 2 diabetes and to prospectively determine their relationship to serum lipids in type 2 diabetic patients. Methods Seventy-one patients with type 2 diabetes were consecutively recruited and tested. All patients underwent thorough clinical neurological assessments including nerve conduction studies, and median motor axonal excitability studies. Studies were also undertaken in age matched normal control subjects(n = 42). Biochemical studies, including serum lipid levels were obtained in all patients. Patient excitability data was compared to control data and linear regression analysis was performed to determine the relationship between serum triglycerides and low density lipoproteins and excitability parameters typically abnormal in type 2 diabetic patients. Results Patient mean age was 64.2 +/- 2.3 years, mean glycosylated haemoglobin (HbA1c%) was 7.8 +/- 0.3%, mean triglyceride concentration was 1.6 +/- 0.1 mmol/L and mean cholesterol concentration was 4.1 +/- 0.2 mmol/L. Compared to age matched controls, median motor axonal excitability studies indicated axonal dysfunction in type 2 diabetic patients as a whole (T2DM) and in a subgroup of the patients without DPN (T2DM-NN). These included reduced percentage threshold change during threshold electrotonus at 10-20ms depolarising currents (TEd10-20ms)(controls 68.4 +/- 0.8, T2DM63.9 +/- 0.8, T2DM-NN64.8 +/- 1.6%, P<0.05) and superexcitability during the recovery cycle (controls-22.5 +/- 0.9, T2DM-17.5 +/- 0.8, T2DM-NN-17.3 +/- 1.6%, P<0.05). Linear regression analysis revealed no associations between changes in axonal function and either serum triglyceride or low density lipoprotein concentration when adjusted for renal function, a separate risk factor for neuropathy development. Our findings indicate that acutely, serum lipids do not exert an acute effect on axonal function in type 2 diabetic patients: TEd(10-20ms)(1.2(-1.4,3.8); P = 0.4) and superexcitability (2.4 (-0.05, 4.8); P = 0.06). Conclusions These findings suggest that serum triglyceride levels are not related to axonal function in type 2 diabetic patients. Additional pathogenic mechanisms may play a more substantial role in axonal dysfunction prior to DPN development.	[Kwai, Natalie C. G.; Nigole, William; Krishnan, Arun V.] Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW, Australia; [Poynten, Ann M.] Prince Wales Hosp, Dept Endocrinol, Sydney, NSW, Australia; [Brown, Christopher] Univ Sydney, Natl Hlth & Med Res Council Clin Trials Ctr, Sydney, NSW 2006, Australia	University of New South Wales Sydney; University of Sydney	Krishnan, AV (corresponding author), Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW, Australia.	arun.krishnan@unsw.edu.au	Brown, Chris/H-2797-2019	Brown, Chris/0000-0003-2506-4871; Krishnan, Arun/0000-0001-8883-8825; Kwai, Natalie/0000-0003-2934-570X	Australian Government's Department of Education and Training; Australian Government's National Health and Medical Research Council of Australia [1065663]; Australian Postgraduate Award scholarship; National Health and Medical Research Council of Australia [1065663]	Australian Government's Department of Education and Training(Australian Government); Australian Government's National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award scholarship; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	NK was supported by an Australian Postgraduate Award scholarship from the Australian Government's Department of Education and Training, https://education.gov.au/australian-postgraduate-awards. AK was supported by a Career Development Fellowship from the Australian Government's National Health and Medical Research Council of Australia (#1065663), https://www.nhmrc.gov.au/grants-funding/apply-funding/career-development-fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; N. K. was supported by an Australian Postgraduate Award scholarship. A. K. was supported by a Career Development Fellowship of the National Health and Medical Research Council of Australia (#1065663). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold R, 2014, CLIN NEUROPHYSIOL, V125, P179, DOI 10.1016/j.clinph.2013.06.022; Arnold R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059055; Arnold R, 2013, DIABETES-METAB RES, V29, P53, DOI 10.1002/dmrr.2360; Bae JS, 2007, J NEUROL, V254, P53, DOI 10.1007/s00415-006-0261-5; Bae JS, 2011, DIABETES RES CLIN PR, V91, P183, DOI 10.1016/j.diabres.2010.11.008; Becker M, 2014, J MOL NEUROSCI, V54, P704, DOI 10.1007/s12031-014-0424-2; Bierhaus A, 2004, J CLIN INVEST, V114, P1741, DOI 10.1172/JCI200418058; BOSTOCK H, 1983, J PHYSIOL-LONDON, V341, P59, DOI 10.1113/jphysiol.1983.sp014792; Bostock H, 1997, J PHYSIOL-LONDON, V498, P277, DOI 10.1113/jphysiol.1997.sp021857; Bostock H, 1998, MUSCLE NERVE, V21, P137, DOI 10.1002/(SICI)1097-4598(199802)21:2<137::AID-MUS1>3.0.CO;2-C; Bril V, 2012, J PERIPHER NERV SYST, V17, P22, DOI 10.1111/j.1529-8027.2012.00391.x; Burke D, 2001, CLIN NEUROPHYSIOL, V112, P1575, DOI 10.1016/S1388-2457(01)00595-8; Callaghan BC, 2012, LANCET NEUROL, V11, P521, DOI 10.1016/S1474-4422(12)70065-0; Charles M, 2013, DIABETOLOGIA, V56, P101, DOI 10.1007/s00125-012-2744-5; Cornblath DR, 1999, NEUROLOGY, V53, P1660, DOI 10.1212/WNL.53.8.1660; Davis TME, 2008, DIABETOLOGIA, V51, P562, DOI 10.1007/s00125-007-0919-2; Devaraj S, 2008, J CLIN ENDOCR METAB, V93, P578, DOI 10.1210/jc.2007-2185; Duksal T, 2016, ACTA NEUROL SCAND, V133, P384, DOI 10.1111/ane.12474; Fernyhough P, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0671-9; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; GREENE DA, 1984, AM J PHYSIOL, V246, pE311, DOI 10.1152/ajpendo.1984.246.4.E311; Huang TJ, 2003, DIABETES, V52, P2129, DOI 10.2337/diabetes.52.8.2129; Ismail-Beigi F, 2010, LANCET, V376, P419, DOI 10.1016/S0140-6736(10)60576-4; Kiernan MC, 2000, MUSCLE NERVE, V23, P399, DOI 10.1002/(SICI)1097-4598(200003)23:3<399::AID-MUS12>3.0.CO;2-G; Kiernan MC, 2000, BRAIN, V123, P2542, DOI 10.1093/brain/123.12.2542; Kikkawa Y, 2005, CLIN NEUROPHYSIOL, V116, P270, DOI 10.1016/j.clinph.2004.08.011; Krishnan AV, 2008, BRAIN, V131, P1209, DOI 10.1093/brain/awn052; Krishnan AV, 2009, PROG NEUROBIOL, V89, P288, DOI 10.1016/j.pneurobio.2009.08.002; Kwai NCG, 2013, DIABETES CARE, V36, P1272, DOI 10.2337/dc12-1310; Lupachyk S, 2012, FREE RADICAL BIO MED, V52, P1255, DOI 10.1016/j.freeradbiomed.2012.01.029; Misawa S, 2004, CLIN NEUROPHYSIOL, V115, P2525, DOI 10.1016/j.clinph.2004.06.008; Mogyoros I, 1996, BRAIN, V119, P439, DOI 10.1093/brain/119.2.439; O'Connor AB, 2009, PHARMACOECONOMICS, V27, P95, DOI 10.2165/00019053-200927020-00002; Padilla A, 2011, BRAIN RES, V1370, P64, DOI 10.1016/j.brainres.2010.11.013; Purwata Thomas Eko, 2011, J Pain Res, V4, P169, DOI 10.2147/JPR.S21751; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Smith AG, 2013, J DIABETES COMPLICAT, V27, P436, DOI 10.1016/j.jdiacomp.2013.04.003; Sorkin LS, 1997, NEUROSCIENCE, V81, P255, DOI 10.1016/S0306-4522(97)00147-4; Sung JY, 2012, DIABETES, V61, P1592, DOI 10.2337/db11-1509; Tesfaye S, 2012, DIABETES-METAB RES, V28, P8, DOI 10.1002/dmrr.2239; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Van Acker K, 2009, DIABETES METAB, V35, P206, DOI 10.1016/j.diabet.2008.11.004; Vas PRJ, 2015, MUSCLE NERVE, V52, P113, DOI 10.1002/mus.24504; Viader A, 2013, NEURON, V77, P886, DOI 10.1016/j.neuron.2013.01.012; Vincent AM, 2011, NAT REV NEUROL, V7, P573, DOI 10.1038/nrneurol.2011.137; Vincent AM, 2009, J PERIPHER NERV SYST, V14, P257, DOI 10.1111/j.1529-8027.2009.00237.x; Wagner R, 1996, NEUROREPORT, V7, P2897, DOI 10.1097/00001756-199611250-00018; Wiggin TD, 2009, DIABETES, V58, P1634, DOI 10.2337/db08-1771	48	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153389	10.1371/journal.pone.0153389	http://dx.doi.org/10.1371/journal.pone.0153389			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078166	Green Published, Green Submitted, gold			2022-12-26	WOS:000374131700048
J	Lee, DW; Chung, S; Yoo, HJ; Kim, SJ; Woo, CW; Kim, ST; Lee, DH; Kim, KW; Kim, JK; Lee, JS; Choi, CG; Shim, WH; Choi, Y; Woo, DC				Lee, Do-Wan; Chung, Seockhoon; Yoo, Hyun Ju; Kim, Su Jung; Woo, Chul-Woong; Kim, Sang-Tae; Lee, Dong-Hoon; Kim, Kyung Won; Kim, Jeong-Kon; Lee, Jin Seong; Choi, Choong Gon; Shim, Woo Hyun; Choi, Yoonseok; Woo, Dong-Cheol			Neurochemical Changes Associated with Stress-Induced Sleep Disturbance in Rats: In Vivo and In Vitro Measurements	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; GAMMA-AMINOBUTYRIC-ACID; H-1-NMR SPECTROSCOPY; PRIMARY INSOMNIA; GLUTAMATE LEVELS; MOUSE-BRAIN; SEROTONIN; GABA; EUTHANASIA; DISORDERS	The goal of this study was to quantitatively assess the changes in the cerebral neurochemical profile and to identify those factors that contribute to the alteration of endogenous biomolecules when rats are subjected to stress-induced sleep disturbance. We exposed Sprague-Dawley rats (controls: n = 9; stress-induced sleep perturbation rats: n = 11) to a psychological stressor (cage exchange method) to achieve stress-induced sleep perturbation. In vivo magnetic resonance imaging assessments were carried out using a high-resolution 9.4 T system. For in vivo neurochemical analysis, a single voxel was localized in the right dorsal hippocampal region, and in vivo spectra were quantified for 17 cerebral neurochemical signals. Rats were sacrificed upon completion of the magnetic resonance spectroscopy protocol, and whole-brain tissue was harvested from twenty subjects. The dopamine and serotonin signals were obtained by performing in vitro liquid chromatography-tandem mass spectrometry on the harvested tissue. In the right dorsal hippocampal region, the gamma-aminobutyric-acid (GABA) and glutamine (Gln) concentrations were significantly higher in the sleep-perturbed rats than in the sham controls. The ratios of Gln/Glu (glutamate), Gln/tCr (total-creatine), and GABA/Glu were also significantly higher in the sleep-perturbed group, while serotonin concentrations were significantly lower in the sleep-perturbed rats. Pearson correlation results among individual rat data indicate that concentrations of dopamine (DA) and serotonin (5-HT) were significantly higher in SSP rats. A larger correlation coefficient was also observed for the SSP rats. Analysis of the correlation between the in vivo and in vitro signals indicated that the concentrations of Gln, 5-HT, and DA exhibited a significant negative correlation in the SSP rat data but not in that of control rats. The authors propose that the altered and correlated GABA, Gln, 5-HT, and DA concentrations/ratios could be considered key markers of neurological function in animal models of stress-induced sleep perturbation.	[Lee, Do-Wan; Lee, Dong-Hoon] Johns Hopkins Univ, Sch Med, Dept Radiol, Div MR Res, Baltimore, MD 21205 USA; [Lee, Do-Wan; Woo, Chul-Woong; Kim, Sang-Tae; Choi, Yoonseok; Woo, Dong-Cheol] Asan Med Ctr, Asan Inst Life Sci, MR Core Lab, Seoul, South Korea; [Chung, Seockhoon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Psychiat, Seoul, South Korea; [Yoo, Hyun Ju; Kim, Su Jung] Univ Ulsan, Coll Med, Biomed Res Ctr, Asan Inst Life Sci,Asan Med Ctr, Seoul, South Korea; [Kim, Kyung Won; Kim, Jeong-Kon; Lee, Jin Seong; Choi, Choong Gon; Shim, Woo Hyun] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea	Johns Hopkins University; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; University of Ulsan; Asan Medical Center	Woo, DC (corresponding author), Asan Med Ctr, Asan Inst Life Sci, MR Core Lab, Seoul, South Korea.	dcwoo@amc.seoul.kr	Chung, Seockhoon/AAS-6676-2021; Lee, Dong-Hoon/G-4959-2016	Chung, Seockhoon/0000-0002-9798-3642; Lee, Dong-Hoon/0000-0002-5013-4440	Basic Science Research Program through the National Research Foundation of Korea [NRF] - Ministry of Science, Korea [NRF-2015R1C1A1A02036526]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute [KHIDI] - Ministry of Health & Welfare, Republic of Korea [HI14C1090]	Basic Science Research Program through the National Research Foundation of Korea [NRF] - Ministry of Science, Korea; Korea Health Technology R&D Project through the Korea Health Industry Development Institute [KHIDI] - Ministry of Health & Welfare, Republic of Korea	This study was supported by grants of Basic Science Research Program through the National Research Foundation of Korea funded [NRF (www.nrf.re.kr): NRF-2015R1C1A1A02036526], by the Ministry of Science, Korea (DCW), and by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute [KHIDI (www.khidi.or.kr): HI14C1090], funded by the Ministry of Health & Welfare, Republic of Korea (DCW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOSTA GB, 1994, NEUROSCI LETT, V176, P29, DOI 10.1016/0304-3940(94)90863-X; Bekris S, 2005, BEHAV BRAIN RES, V161, P45, DOI 10.1016/j.bbr.2005.01.005; BLACKSHAW JK, 1988, LAB ANIM, V22, P67, DOI 10.1258/002367788780746674; Bonnet MH, 2010, SLEEP MED REV, V14, P9, DOI 10.1016/j.smrv.2009.05.002; Brady KT, 2005, AM J PSYCHIAT, V162, P1483, DOI 10.1176/appi.ajp.162.8.1483; Bremner JD, 1999, BIOL PSYCHIAT, V45, P797, DOI 10.1016/S0006-3223(99)00009-8; Broman J, 2000, HDB CHEM NEUROANATOM; Cano G, 2008, J NEUROSCI, V28, P10167, DOI 10.1523/JNEUROSCI.1809-08.2008; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; Close B, 1996, LAB ANIM-UK, V30, P293, DOI 10.1258/002367796780739871; Deuschle M, 2010, SLEEP, V33, P343, DOI 10.1093/sleep/33.3.343; Espie CA, 2002, ANNU REV PSYCHOL, V53, P215, DOI 10.1146/annurev.psych.53.100901.135243; Fu Y, 2012, APPL MAGN RESON, V43, P385, DOI 10.1007/s00723-012-0370-5; GILAD GM, 1990, BRAIN RES, V525, P335, DOI 10.1016/0006-8993(90)90886-G; HARTMANN E, 1971, PSYCHOPHARMACOLOGIA, V19, P114, DOI 10.1007/BF00402635; Hartmann E, 1967, PSYCHON SCI, V8, P295; Jemal M, 2000, BIOMED CHROMATOGR, V14, P422, DOI 10.1002/1099-0801(200010)14:6<422::AID-BMC25>3.0.CO;2-I; JOUVET M, 1969, SCIENCE, V163, P32, DOI 10.1126/science.163.3862.32; Kakeda S, 2011, PSYCHIAT RES-NEUROIM, V192, P55, DOI 10.1016/j.pscychresns.2010.10.011; Kim SY, 2012, NEUROCHEM RES, V37, P740, DOI 10.1007/s11064-011-0668-y; Leach MC, 2002, COMPARATIVE MED, V52, P249; Lee DW, 2013, NEUROCHEM INT, V62, P502, DOI 10.1016/j.neuint.2013.02.007; Levy LM, 2013, AM J NEURORADIOL, V34, P259, DOI 10.3174/ajnr.A2902; Lichstein KL, 2000, PSYCHOL AGING, V15, P232, DOI 10.1037/0882-7974.15.2.232; Luders JW, 1999, WILDLIFE SOC B, V27, P666; Machado RB, 2008, PSYCHONEUROENDOCRINO, V33, P1211, DOI 10.1016/j.psyneuen.2008.06.007; McCrae CS, 2001, SLEEP MED REV, V5, P47, DOI 10.1053/smrv.2000.0146; MELIA KR, 1994, J NEUROSCI, V14, P5929; Mokler DJ, 2007, BRAIN RES, V1148, P226, DOI 10.1016/j.brainres.2007.02.031; Monti JM, 2011, SLEEP MED REV, V15, P269, DOI 10.1016/j.smrv.2010.11.003; Monti JM, 2008, PROG BRAIN RES, V172, P625, DOI 10.1016/S0079-6123(08)00929-1; Moore CM, 2007, J AM ACAD CHILD PSY, V46, P524, DOI 10.1097/chi.0b013e31802f5f2c; Morgan PT, 2012, SLEEP, V35, P807, DOI 10.5665/sleep.1880; MUNCK A, 1984, ENDOCR REV, V5, P25, DOI 10.1210/edrv-5-1-25; Pawlyk AC, 2008, NEUROSCI BIOBEHAV R, V32, P99, DOI 10.1016/j.neubiorev.2007.06.001; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Pfeuffer J, 1999, J MAGN RESON, V141, P104, DOI 10.1006/jmre.1999.1895; Plante DT, 2012, NEUROPSYCHOPHARMACOL, V37, P1548, DOI 10.1038/npp.2012.4; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; Riemann D, 2010, SLEEP MED REV, V14, P19, DOI 10.1016/j.smrv.2009.04.002; Rothman DL, 1999, PHILOS T R SOC B, V354, P1165, DOI 10.1098/rstb.1999.0472; Rothman DL, 2003, ANNU REV PHYSIOL, V65, P401, DOI 10.1146/annurev.physiol.65.092101.142131; Sanacora G, 1999, ARCH GEN PSYCHIAT, V56, P1043, DOI 10.1001/archpsyc.56.11.1043; Stewart MG, 2005, NEUROSCIENCE, V131, P43, DOI 10.1016/j.neuroscience.2004.10.031; Tkac I, 2005, APPL MAGN RESON, V29, P139, DOI 10.1007/BF03166960; Tkac I, 2004, MAGN RESON MED, V52, P478, DOI 10.1002/mrm.20184; Tzika AA, 2002, J NEUROSURG, V96, P1023, DOI 10.3171/jns.2002.96.6.1023; Winkelman JW, 2008, SLEEP, V31, P1499, DOI 10.1093/sleep/31.11.1499; Woo DC, 2014, ACAD RADIOL, V21, P1072, DOI 10.1016/j.acra.2014.04.003; WYATT RJ, 1970, LANCET, V2, P840; Zarate CA, 2003, ANN NY ACAD SCI, V1003, P273, DOI 10.1196/annals.1300.017; Zhang G, 2007, J CHROMATOGR B, V858, P276, DOI 10.1016/j.jchromb.2007.08.007	53	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153346	10.1371/journal.pone.0153346	http://dx.doi.org/10.1371/journal.pone.0153346			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078855	Green Submitted, Green Published, gold			2022-12-26	WOS:000374131700041
J	Cheema, AK; Maier, I; Dowdy, T; Wang, YW; Singh, R; Ruegger, PM; Borneman, J; Fornace, AJ; Schiestl, RH				Cheema, Amrita K.; Maier, Irene; Dowdy, Tyrone; Wang, Yiwen; Singh, Rajbir; Ruegger, Paul M.; Borneman, James; Fornace, Albert J., Jr.; Schiestl, Robert H.			Chemopreventive Metabolites Are Correlated with a Change in Intestinal Microbiota Measured in A-T Mice and Decreased Carcinogenesis	PLOS ONE			English	Article							ATAXIA-TELANGIECTASIA; KYNURENIC ACID; CELLULAR-RESPONSE; GUT MICROBIOTA; ATM; CANCER; CELLS; BACTERIA; LYMPHOMA; 3-METHYLADENINE	Intestinal microbiota play a significant role in nutrient metabolism, modulation of the immune system, obesity, and possibly in carcinogenesis, although the underlying mechanisms resulting in disease or impacts on longevity caused by different intestinal microbiota are mostly unknown. Herein we use isogenic Atm-deficient and wild type mice as models to interrogate changes in the metabolic profiles of urine and feces of these mice, which are differing in their intestinal microbiota. Using high resolution mass spectrometry approach we show that the composition of intestinal microbiota modulates specific metabolic perturbations resulting in a possible alleviation of a glycolytic phenotype. Metabolites including 3-methylbutyrolactone, kyneurenic acid and 3-methyladenine known to be onco-protective are elevated in Atm-deficient and wild type mice with restricted intestinal microbiota. Thus our approach has broad applicability to study the direct influence of gut microbiome on host metabolism and resultant phenotype. These results for the first time suggest a possible correlation of metabolic alterations and carcinogenesis, modulated by intestinal microbiota in A-T mice.	[Cheema, Amrita K.; Dowdy, Tyrone; Singh, Rajbir; Fornace, Albert J., Jr.] Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20007 USA; [Cheema, Amrita K.; Fornace, Albert J., Jr.] Georgetown Univ, Med Ctr, Dept Biochem Mol & Cellular Biol, Washington, DC 20007 USA; [Maier, Irene; Schiestl, Robert H.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Environm Hlth Sci, Los Angeles, CA USA; [Wang, Yiwen] Georgetown Univ, Med Ctr, Dept Biostat Biomath & Bioinformat, Washington, DC 20007 USA; [Ruegger, Paul M.; Borneman, James] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA; [Schiestl, Robert H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA; [Schiestl, Robert H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiat Oncol, Los Angeles, CA 90095 USA	Georgetown University; Georgetown University; University of California System; University of California Los Angeles; Georgetown University; University of California System; University of California Riverside; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Schiestl, RH (corresponding author), Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Environm Hlth Sci, Los Angeles, CA USA.; Schiestl, RH (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA.; Schiestl, RH (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiat Oncol, Los Angeles, CA 90095 USA.	RSchiestl@mednet.ucla.edu	Singh, Rajbir/HHN-9064-2022	Cheema, Amrita/0000-0003-4877-7583; Maier, Irene/0000-0003-1471-6432	NIH/NCI [P30-CA051008];  [RO1ES0951907]; NATIONAL CANCER INSTITUTE [P30CA051008] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016290] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by RO1ES0951907 to RHS.; The authors would like to acknowledge the Proteomics and Metabolomics shared resource partially supported by NIH/NCI grant P30-CA051008.	ADLERCREUTZ H, 1993, J STEROID BIOCHEM, V44, P147, DOI 10.1016/0960-0760(93)90022-O; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Tran AT, 2015, EUR J NUTR, V54, P265, DOI 10.1007/s00394-014-0707-y; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Blow N, 2008, NATURE, V455, P697, DOI 10.1038/455697a; Boder E, 1975, Birth Defects Orig Artic Ser, V11, P255; Borghesani PR, 2000, P NATL ACAD SCI USA, V97, P3336, DOI 10.1073/pnas.050584897; Bowling FG, 2014, METHODS MOL BIOL, V1168, P31, DOI 10.1007/978-1-4939-0847-9_3; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; Cheema AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087079; Cheema AK, 2011, J PROTEOME RES, V10, P2651, DOI 10.1021/pr101243j; Ciappio ED, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084583; Clavel T, 2014, GUT MICROBES, V5, P544, DOI 10.4161/gmic.29331; Crawford TO, 2006, ARCH DIS CHILD, V91, P610; Delzenne NM, 2013, BRIT J NUTR, V109, pS81, DOI 10.1017/S0007114512004047; DiNatale BC, 2010, TOXICOL SCI, V115, P89, DOI 10.1093/toxsci/kfq024; Elson A, 1996, P NATL ACAD SCI USA, V93, P13084, DOI 10.1073/pnas.93.23.13084; Fujiwara D, 2008, J IMMUNOL, V180, P5843, DOI 10.4049/jimmunol.180.9.5843; Gatti RA, 2001, CLIN REV ALLERG IMMU, V20, P87, DOI 10.1385/CRIAI:20:1:87; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; HECHT F, 1990, CANCER GENET CYTOGEN, V46, P9, DOI 10.1016/0165-4608(90)90003-S; Heckmann BL, 2013, BRIT J PHARMACOL, V168, P163, DOI 10.1111/j.1476-5381.2012.02110.x; Huang T, 2005, CLIN IMMUNOL, V117, P221, DOI 10.1016/j.clim.2005.09.012; Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527; JOHNSON RK, 1976, CANCER RES, V36, P2720; Kaur P, 2013, MOL BIOSYST, V9, P307, DOI 10.1039/c2mb25384d; Kim JC, 1997, ARCH PHARM RES, V20, P253, DOI 10.1007/BF02976153; Kingma SDK, 2011, J NUTR, V141, P1023, DOI 10.3945/jn.110.135517; Li H, 2009, J BIOL CHEM, V284, P1748, DOI 10.1074/jbc.M807821200; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Liyanage M, 2000, BLOOD, V96, P1940, DOI 10.1182/blood.V96.5.1940.h8001940_1940_1946; Maier I, 2014, RADIAT RES, V181, P45, DOI 10.1667/RR13352.1; Meyn MS, 1999, CLIN GENET, V55, P289, DOI 10.1034/j.1399-0004.1999.550501.x; MORRELL D, 1986, J NATL CANCER I, V77, P89; Patterson AD, 2008, ANAL CHEM, V80, P665, DOI 10.1021/ac701807v; PETERSON RDA, 1992, LEUKEMIA, V6, P8; Petiniot LK, 2002, MOL CELL BIOL, V22, P3174, DOI 10.1128/MCB.22.9.3174-3177.2002; Presley LL, 2010, APPL ENVIRON MICROB, V76, P936, DOI 10.1128/AEM.01561-09; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Reliene R, 2006, DNA REPAIR, V5, P852, DOI 10.1016/j.dnarep.2006.05.003; Ruegger PM, 2014, J MICROBIOL METH, V105, P82, DOI 10.1016/j.mimet.2014.07.001; Sandoval C, 1998, MED PEDIATR ONCOL, V31, P491, DOI 10.1002/(SICI)1096-911X(199812)31:6<491::AID-MPO5>3.0.CO;2-B; Schubert R, 2004, HUM MOL GENET, V13, P1793, DOI 10.1093/hmg/ddh189; Schwabe RF, 2013, NAT REV CANCER, V13, P800, DOI 10.1038/nrc3610; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Swann Jonathan R., 2014, Science Progress, V97, P41, DOI 10.3184/003685014X13898807933527; Tan SS, 2015, ONCOL LETT, V9, P2056, DOI 10.3892/ol.2015.2996; Taylor AMR, 1996, BLOOD, V87, P423, DOI 10.1182/blood.V87.2.423.bloodjournal872423; Tyburski JB, 2009, RADIAT RES, V172, P42, DOI 10.1667/RR1703.1; Urenjak J, 2000, NEUROREPORT, V11, P1341, DOI 10.1097/00001756-200004270-00038; Ursell LK, 2014, GASTROENTEROLOGY, V146, P1470, DOI 10.1053/j.gastro.2014.03.001; Varghese RS, 2010, J PROTEOME RES, V9, P2786, DOI 10.1021/pr100185b; Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537; Walczak K, 2012, PHARMACOL REP, V64, P745, DOI 10.1016/S1734-1140(12)70870-8; Wang JH, 2006, J BIOL CHEM, V281, P22021, DOI 10.1074/jbc.M603503200; Want EJ, 2010, NAT PROTOC, V5, P1005, DOI 10.1038/nprot.2010.50; Wei B, 2008, EUR J IMMUNOL, V38, P3411, DOI 10.1002/eji.200838432; Westbrook AM, 2009, CANCER RES, V69, P4827, DOI 10.1158/0008-5472.CAN-08-4416; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xie GX, 2013, ELECTROPHORESIS, V34, P2787, DOI 10.1002/elps.201300017; Xu Y, 1996, GENE DEV, V10, P2401, DOI 10.1101/gad.10.19.2401; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; Yamamoto ML, 2013, CANCER RES, V73, P4222, DOI 10.1158/0008-5472.CAN-13-0022; Yang NY, 2005, J PHARMACOL EXP THER, V312, P127, DOI 10.1124/jpet.104.074104; Zhou B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040096; Zitvogel L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010473	69	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0151190	10.1371/journal.pone.0151190	http://dx.doi.org/10.1371/journal.pone.0151190			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073845	Green Published, gold, Green Submitted			2022-12-26	WOS:000374131200007
J	Ferrell, PB; Diggins, KE; Polikowsky, HG; Mohan, SR; Seegmiller, AC; Irish, JM				Ferrell, Paul Brent, Jr.; Diggins, Kirsten Elizabeth; Polikowsky, Hannah Grace; Mohan, Sanjay Ram; Seegmiller, Adam C.; Irish, Jonathan Michael			High-Dimensional Analysis of Acute Myeloid Leukemia Reveals Phenotypic Changes in Persistent Cells during Induction Therapy	PLOS ONE			English	Article							PERIPHERAL-BLOOD; HEMATOLYMPHOID NEOPLASIA; MASS CYTOMETRY; FLOW-CYTOMETRY; STEM-CELLS; CLEARANCE; HETEROGENEITY; EXPRESSION; PREDICTS; IMMUNOPHENOTYPE	The plasticity of AML drives poor clinical outcomes and confounds its longitudinal detection. However, the immediate impact of treatment on the leukemic and non-leukemic cells of the bone marrow and blood remains relatively understudied. Here, we conducted a pilot study of high dimensional longitudinal monitoring of immunophenotype in AML. To characterize changes in cell phenotype before, during, and immediately after induction treatment, we developed a 27-antibody panel for mass cytometry focused on surface diagnostic markers and applied it to 46 samples of blood or bone marrow tissue collected over time from 5 AML patients. Central goals were to determine whether changes in AML phenotype would be captured effectively by cytomic tools and to implement methods for describing the evolving phenotypes of AML cell subsets. Mass cytometry data were analyzed using established computational techniques. Within this pilot study, longitudinal immune monitoring with mass cytometry revealed fundamental changes in leukemia phenotypes that occurred over time during and after induction in the refractory disease setting. Persisting AML blasts became more phenotypically distinct from stem and progenitor cells due to expression of novel marker patterns that differed from pre-treatment AML cells and from all cell types observed in healthy bone marrow. This pilot study of single cell immune monitoring in AML represents a powerful tool for precision characterization and targeting of resistant disease.	[Ferrell, Paul Brent, Jr.; Mohan, Sanjay Ram] Vanderbilt Univ, Med Ctr, Dept Med, Div Hematol Oncol, Nashville, TN USA; [Diggins, Kirsten Elizabeth; Polikowsky, Hannah Grace; Irish, Jonathan Michael] Vanderbilt Univ, Dept Canc Biol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Seegmiller, Adam C.; Irish, Jonathan Michael] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Irish, JM (corresponding author), Vanderbilt Univ, Dept Canc Biol, 221 Kirkland Hall, Nashville, TN 37235 USA.; Irish, JM (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA.	jonathan.irish@vanderbilt.edu	Irish, Jonathan M/E-1180-2013	Irish, Jonathan M/0000-0001-9428-8866	NIH/NCI [K12 CA090625, R25 CA136440-04, R00 CA143231-03]; Vanderbilt-Ingram Cancer Center (VICC) NIH/NCI [P30 CA68485]; VICC Hematology Helping Hands award; NATIONAL CANCER INSTITUTE [R25CA136440, K12CA090625, R00CA143231, P30CA068485] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Vanderbilt-Ingram Cancer Center (VICC) NIH/NCI; VICC Hematology Helping Hands award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by NIH/NCI K12 CA090625 (PBF), NIH/NCI R25 CA136440-04 (KED), NIH/NCI R00 CA143231-03 (JMI), Vanderbilt-Ingram Cancer Center (VICC) NIH/NCI P30 CA68485 (JMI), and a VICC Hematology Helping Hands award (JMI, PBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Arellano M, 2012, CANCER-AM CANCER SOC, V118, P5278, DOI 10.1002/cncr.27494; Baer MR, 2001, BLOOD, V97, P3574, DOI 10.1182/blood.V97.11.3574; Becher B, 2014, NAT IMMUNOL, V15, P1181, DOI 10.1038/ni.3006; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bruggner RV, 2014, P NATL ACAD SCI USA, V111, pE2770, DOI 10.1073/pnas.1408792111; Diggins KE, 2015, METHODS, V82, P55, DOI 10.1016/j.ymeth.2015.05.008; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Elliott MA, 2007, BLOOD, V110, P4172, DOI 10.1182/blood-2007-07-104091; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Gianfaldoni G, 2006, BRIT J HAEMATOL, V134, P54, DOI 10.1111/j.1365-2141.2006.06100.x; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Irish JM, 2006, NAT REV CANCER, V6, P146, DOI 10.1038/nrc1804; Irish JM, 2014, NATURE IMMUNOLOGY; Klco JM, 2014, CANCER CELL, V25, P379, DOI 10.1016/j.ccr.2014.01.031; Kotecha Nikesh, 2010, Curr Protoc Cytom, VChapter 10, DOI 10.1002/0471142956.cy1017s53; Krutzik PO, 2004, CLIN IMMUNOL, V110, P206, DOI 10.1016/j.clim.2003.11.009; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Marusyk A, 2014, NATURE, V514, P54, DOI 10.1038/nature13556; Mason KD, 2006, BLOOD REV, V20, P71, DOI 10.1016/j.blre.2005.08.002; McCarthy N, 2013, NAT REV CANCER, V13, P439, DOI 10.1038/nrc3549; National Cancer Institute, 2013, SURV EP END RES SEER; Nervi B, 2009, BLOOD, V113, P6206, DOI 10.1182/blood-2008-06-162123; Nicholas KJ, 2016, CYTOM PART A, V89A, P271, DOI 10.1002/cyto.a.22799; Ornatsky OI, 2008, ANAL CHEM, V80, P2539, DOI 10.1021/ac702128m; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Sarry JE, 2011, J CLIN INVEST, V121, P384, DOI 10.1172/JCI41495; Shekhar K, 2014, P NATL ACAD SCI USA, V111, P202, DOI 10.1073/pnas.1321405111; Spoo AC, 2007, BLOOD, V109, P786, DOI 10.1182/blood-2006-05-024844; Stein EM, 2012, INT J HEMATOL, V96, P164, DOI 10.1007/s12185-012-1121-y; Stetler-Stevenson M, 2007, CYTOM PART B-CLIN CY, V72B, pS3, DOI 10.1002/cyto.b.20362; Taussig DC, 2008, BLOOD, V112, P568, DOI 10.1182/blood-2007-10-118331; Taussig DC, 2010, BLOOD, V115, P1976, DOI 10.1182/blood-2009-02-206565; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; van Dongen JJM, 2012, LEUKEMIA, V26, P1899, DOI 10.1038/leu.2012.121; van Dongen JJM, 2012, LEUKEMIA, V26, P1908, DOI 10.1038/leu.2012.120; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; Wood BL, 2007, CYTOM PART B-CLIN CY, V72B, pS14, DOI 10.1002/cyto.b.20363	39	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153207	10.1371/journal.pone.0153207	http://dx.doi.org/10.1371/journal.pone.0153207			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074138	Green Published, gold			2022-12-26	WOS:000374131200060
J	Mengersen, KL; Drovandi, CC; Robert, CP; Pyne, DB; Gore, CJ				Mengersen, Kerrie L.; Drovandi, Christopher C.; Robert, Christian P.; Pyne, David B.; Gore, Christopher J.			Bayesian Estimation of Small Effects in Exercise and Sports Science	PLOS ONE			English	Article							HEMOGLOBIN MASS; PERFORMANCE; VARIABILITY; ALTITUDE; WINBUGS; ECONOMY; TIMES	The aim of this paper is to provide a Bayesian formulation of the so-called magnitude-based inference approach to quantifying and interpreting effects, and in a case study example provide accurate probabilistic statements that correspond to the intended magnitude-based inferences. The model is described in the context of a published small-scale athlete study which employed a magnitude-based inference approach to compare the effect of two altitude training regimens (live high-train low (LHTL), and intermittent hypoxic exposure (IHE)) on running performance and blood measurements of elite triathletes. The posterior distributions, and corresponding point and interval estimates, for the parameters and associated effects and comparisons of interest, were estimated using Markov chain Monte Carlo simulations. The Bayesian analysis was shown to provide more direct probabilistic comparisons of treatments and able to identify small effects of interest. The approach avoided asymptotic assumptions and overcame issues such as multiple testing. Bayesian analysis of unscaled effects showed a probability of 0.96 that LHTL yields a substantially greater increase in hemoglobin mass than IHE, a 0.93 probability of a substantially greater improvement in running economy and a greater than 0.96 probability that both IHE and LHTL yield a substantially greater improvement in maximum blood lactate concentration compared to a Placebo. The conclusions are consistent with those obtained using a 'magnitude-based inference' approach that has been promoted in the field. The paper demonstrates that a fully Bayesian analysis is a simple and effective way of analysing small effects, providing a rich set of results that are straightforward to interpret in terms of probabilistic statements.	[Mengersen, Kerrie L.; Drovandi, Christopher C.] Queensland Univ Technol, Fac Sci & Engn, Math Sci, Brisbane, Qld 4001, Australia; [Mengersen, Kerrie L.; Drovandi, Christopher C.] Queensland Univ Technol, Inst Future Environm, Brisbane, Qld 4001, Australia; [Mengersen, Kerrie L.; Drovandi, Christopher C.] Australian Res Council, Ctr Excellence Math & Stat Frontiers Big Data Big, Brisbane, Qld, Australia; [Robert, Christian P.] Univ Paris 09, CEREMADE, F-75775 Paris, France; [Pyne, David B.; Gore, Christopher J.] Australian Inst Sport, Canberra, ACT, Australia; [Pyne, David B.; Gore, Christopher J.] Univ Canberra, Res Inst Sport & Exercise, Bruce, ACT, Australia; [Gore, Christopher J.] Flinders Univ South Australia, Exercise Physiol Lab, Bedford Pk, SA, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT); UDICE-French Research Universities; PSL Research University Paris; Universite Paris-Dauphine; Australian Institute of Sport; University of Canberra; Flinders University South Australia	Mengersen, KL (corresponding author), Queensland Univ Technol, Fac Sci & Engn, Math Sci, Brisbane, Qld 4001, Australia.; Mengersen, KL (corresponding author), Queensland Univ Technol, Inst Future Environm, Brisbane, Qld 4001, Australia.	k.mengersen@qut.edu.au	Robert, Christian/AAL-2415-2020; Mengersen, Kerrie/AHC-4096-2022; Drovandi, Christopher/J-1051-2012; Robert, Christian/D-4439-2013	Robert, Christian/0000-0001-6635-3261; Robert, Christian/0000-0001-6635-3261; Pyne, David/0000-0003-1555-5079; Mengersen, Kerrie/0000-0001-8625-9168; Drovandi, Christopher/0000-0001-9222-8763				Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Atkinson G, 2012, INT J SPORTS MED, V33, P949, DOI 10.1055/s-0032-1327755; Bacchetti P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001628; Bacchetti P, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-17; Batterham AM, 2006, INT J SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; Beck TW, 2013, J STRENGTH COND RES, V27, P2323, DOI 10.1519/JSC.0b013e318278eea0; Bonetti DL, 2010, INT J SPORT PHYSIOL, V5, P210, DOI 10.1123/ijspp.5.2.210; Burton PR, 1998, J EPIDEMIOL COMMUN H, V52, P318, DOI 10.1136/jech.52.5.318; Cohen J.E., 1988, STAT POWER ANAL BEHA; CONLEY DL, 1980, MED SCI SPORT EXER, V12, P357, DOI 10.1249/00005768-198012050-00010; DANIELS JT, 1985, MED SCI SPORT EXER, V17, P332; Dienes Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00781; Garvican LA, 2010, EUR J APPL PHYSIOL, V109, P221, DOI 10.1007/s00421-009-1349-2; Gelman A, 2013, BAYESIAN DATA ANAL, P275; Gelman A, 2013, BAYESIAN DATA ANAL, P64; Gelman A, 2006, AM STAT, V60, P328, DOI 10.1198/000313006X152649; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; Gore CJ, 2006, J APPL PHYSIOL, V101, P1386, DOI 10.1152/japplphysiol.00342.2006; Gore CJ, 2013, BRIT J SPORT MED, V47, P31, DOI 10.1136/bjsports-2013-092840; HEDGES LV, 1985, STAT METHODS METAANA, DOI [10.1016/C2009-0-03396-0, DOI 10.1016/C2009-0-03396-0]; Hopkins WG, 1999, MED SCI SPORT EXER, V31, P472, DOI 10.1097/00005768-199903000-00018; Hopkins WG, 2001, SPORTS MED, V31, P211, DOI 10.2165/00007256-200131030-00005; Hopkins WG, 2004, SPORTSCIENCE, V8, P1, DOI DOI 10.1097/00005768-199804000-00026; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Humberstone-Gough CE, 2013, J SPORT SCI MED, V12, P394; Lundby C, 2007, SCAND J MED SCI SPOR, V17, P281, DOI 10.1111/j.1600-0838.2006.00530.x; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Marin J.-M., 2014, BAYESIAN ESSENTIALS, DOI DOI 10.1007/978-1-4614-8687-9; Marin J. M., 2007, BAYESIAN CORE PRACTI; Martin AD, 2011, J STAT SOFTW, V42, P1; Ploutz-Snyder RJ, 2014, J APPL PHYSIOL, V116, P1251, DOI 10.1152/japplphysiol.01335.2013; Pyne DB, 2004, J SPORT SCI, V22, P613, DOI 10.1080/02640410310001655822; Schmidt W, 2008, SCAND J MED SCI SPOR, V18, P57, DOI 10.1111/j.1600-0838.2008.00833.x; Smith TB, 2011, MED SCI SPORT EXER, V43, P2155, DOI 10.1249/MSS.0b013e31821d3f8e; Stang A, 2010, EUR J EPIDEMIOL, V25, P225, DOI 10.1007/s10654-010-9440-x; Stapleton C, 2009, INT J SPORTS MED, V30, P773, DOI 10.1055/s-0029-1241216; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Thomas A., 2006, R NEWS, V6, P12, DOI DOI 10.1159/000323281; Verhagen J, 2014, J EXP PSYCHOL GEN, V143, P1457, DOI 10.1037/a0036731; Welsh AH, 2015, MED SCI SPORT EXER, V47, P874, DOI 10.1249/MSS.0000000000000451; Wilkinson M, 2014, SPORTS MED, V44, P295, DOI 10.1007/s40279-013-0125-y; Williams MN, 2013, PRACT ASSESS RES EVA, V18, DOI [10.7275/55hn-wk47, DOI 10.7275/55HN-WK47]	43	48	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0147311	10.1371/journal.pone.0147311	http://dx.doi.org/10.1371/journal.pone.0147311			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073897	gold, Green Published			2022-12-26	WOS:000374131200001
J	Prioreschi, A; Makda, MA; Tikly, M; McVeigh, JA				Prioreschi, Alessandra; Makda, Mohamed A.; Tikly, Mohammed; McVeigh, Joanne A.			In Patients with Established RA, Positive Effects of a Randomised Three Month WBV Therapy Intervention on Functional Ability, Bone Mineral Density and Fatigue Are Sustained for up to Six Months	PLOS ONE			English	Article							WHOLE-BODY VIBRATION; RHEUMATOID-ARTHRITIS; MUSCLE STRENGTH; MUSCULAR STRENGTH; EXERCISE; EFFICACY; IMPROVES; FRACTURE; PREVENTION; DISEASE	Functional ability is often impaired for people with rheumatoid arthritis (RA), rendering these patients highly sedentary. Additionally, patients with RA often take medication known to negatively affect bone mass. Thus improving functional ability and bone health in this group of patients is important. The aim of this study was to investigate the effects of whole body vibration (WBV) therapy in patients with stable, established RA. Thirty one females with RA were randomly assigned to a control group (CON, n = 15) who continued with their normal activities or a WBV group (n = 16) who underwent a three month WBV therapy intervention, consisting of 15 minutes of intermittent vibration, performed twice per week. Patients were assessed at baseline, three months, and three months post intervention for functional ability using the modified Health Assessment Questionnaire; for RA disease activity using the Clinical Disease Activity Index, for quality of life using self-report fatigue and pain scores; for physical activity profiles using accelerometry, and for BMD and body composition using DXA. Patients in both groups were matched for all variables at baseline. After the intervention period, functional ability was significantly improved in the WBV group (1.22(0.19) to 0.92(0.19), p = 0.02). Hip BMD was significantly reduced in the CON group (0.97(0.05) to 0.84(0.05) g.cm(-2), p = 0.01), while no decreases were seen in the WBV group (1.01(0.05) to 0.94(0.05) g.cm(-2), p = 0.50). Despite no change in RA disease activity in either group at either follow up, fatigue levels were improved in the WBV group (4.4(0.63) to 1.1(0.65), yet remained unchanged in the CON group at both follow ups (p = 0.01). Ten minute bouts of light to moderate physical activity were significantly reduced in the CON group after the intervention (2.8(0.61) to 1.8(0.64) bouts per day, p = 0.01), and were preserved in the WBV group (3.1(0.59) to 3.0(0.61) bouts per day, p = 0.70). Intermittent WBV shows promise for sustained improvements in functional ability, for attenuating loss of bone mass at the hip, as well as for decreasing fatigue in patients with established RA.	[Prioreschi, Alessandra; McVeigh, Joanne A.] Univ Witwatersrand, Fac Hlth Sci, Sch Physiol, Exercise Physiol Lab, Johannesburg, South Africa; [Prioreschi, Alessandra] Univ Witwatersrand, MRC Wits Dev Pathways Hlth Res Unit, Dept Paediat, Johannesburg, South Africa; [Makda, Mohamed A.; Tikly, Mohammed] Univ Witwatersrand, Dept Med, Chris Hani Baragwanath Acad Hosp, Div Rheumatol, ZA-2001 Johannesburg, South Africa	University of Witwatersrand; University of Witwatersrand; University of Witwatersrand	Prioreschi, A (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Physiol, Exercise Physiol Lab, Johannesburg, South Africa.; Prioreschi, A (corresponding author), Univ Witwatersrand, MRC Wits Dev Pathways Hlth Res Unit, Dept Paediat, Johannesburg, South Africa.	alessandraprioreschi@gmail.com	Taiar, Redha/Q-6769-2016; McVeigh, Joanne/C-9363-2016	Taiar, Redha/0000-0002-0227-3884; McVeigh, Joanne/0000-0002-2446-3814; Prioreschi, Alessandra/0000-0002-6913-0706	Connective Tissues Research Grant; National Research Foundation Innovation Award; Carnegie Large Research Grant; Directorate For Engineering [1130289] Funding Source: National Science Foundation; Directorate For Geosciences [1313747] Funding Source: National Science Foundation; Division Of Environmental Biology [1021840] Funding Source: National Science Foundation	Connective Tissues Research Grant; National Research Foundation Innovation Award; Carnegie Large Research Grant; Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by: Connective Tissues Research Grant (AP); National Research Foundation Innovation Award (AP); and Carnegie Large Research Grant (JAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alentorn-Geli E, 2008, J ALTERN COMPLEM MED, V14, P975, DOI 10.1089/acm.2008.0050; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Baillet A, 2010, ARTHRIT CARE RES, V62, P984, DOI 10.1002/acr.20146; Bainbridge KE, 2002, AM J EPIDEMIOL, V156, P410, DOI 10.1093/aje/kwf049; Beck BR, 2015, CURR OSTEOPOROS REP, V13, P381, DOI 10.1007/s11914-015-0294-8; Bemben DA, 2010, BONE, V47, P650, DOI 10.1016/j.bone.2010.06.019; Bredella MA, 2011, BONE, V48, P748, DOI 10.1016/j.bone.2010.12.011; Bruce B, 2005, CLIN EXP RHEUMATOL, V23, pS14; Cairns AP, 2009, RHEUMATOL INT, V30, P147, DOI 10.1007/s00296-009-1090-5; Cardinale M, 2005, BRIT J SPORT MED, V39, P585, DOI 10.1136/bjsm.2005.016857; Cooney Jennifer K, 2011, J Aging Res, V2011, P681640, DOI 10.4061/2011/681640; da Rocha OM., 2009, REV BRAS REUMATOL, V49, P288, DOI [10.1590/S0482-50042009000300010, DOI 10.1590/S0482-50042009000300010]; De Zepetnek JO, 2009, J REHABIL RES DEV, V46, P529, DOI DOI 10.1682/JRRD.2008.09.0136; Deodhar AA, 1996, BRIT J RHEUMATOL, V35, P309; El Maghraoui A, 2008, QJM-INT J MED, V101, P605, DOI 10.1093/qjmed/hcn022; Ellingson LD, 2012, MED SCI SPORT EXER, V44, P1401, DOI 10.1249/MSS.0b013e318248f648; Figueiredo CP, 2014, OSTEOPOROSIS INT, V25, P589, DOI 10.1007/s00198-013-2455-x; Hakkinen A, 2004, ANN RHEUM DIS, V63, P910, DOI 10.1136/ard.2003.013003; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Kinder J, 2013, J PAEDIAT NURS, V27, P127; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; LAAN RFJM, 1993, ANN RHEUM DIS, V52, P21, DOI 10.1136/ard.52.1.21; Leslie WD, 2007, ARCH INTERN MED, V167, P1641, DOI 10.1001/archinte.167.15.1641; Looker A. C., 2012, VITAL HLTH STAT, V11, P1; Maddalozzo G, 2009, INT J OBESITY, V32, P1348; McMeeken J, 1999, Physiother Res Int, V4, P55; Metsios GS, 2008, RHEUMATOLOGY, V47, P239, DOI 10.1093/rheumatology/kem260; Milanese C, 2013, INT J MED SCI, V10, P307, DOI 10.7150/ijms.5161; Ozcivici E, 2010, NAT REV RHEUMATOL, V6, P50, DOI 10.1038/nrrheum.2009.239; Pang MYC, 2010, WORLD J ORTHOP, V1, P20, DOI 10.5312/wjo.v1.i1.20; Park YG, 2013, ANN REHABIL MED-ARM, V37, P505, DOI 10.5535/arm.2013.37.4.505; Pate RR, 2008, EXERC SPORT SCI REV, V36, P173, DOI 10.1097/JES.0b013e3181877d1a; Premaor MO, 2011, J CLIN ENDOCR METAB, V96, P2414, DOI 10.1210/jc.2011-0076; Prioreschi A, 2012, INT J SPORTS MED, V33, P593, DOI 10.1055/s-0032-1301886; Prioreschi A, 2013, RHEUMATOLOGY, V53, P1; Prioreschi A, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-403; REDELMEIER DA, 1993, ARCH INTERN MED, V153, P1337, DOI 10.1001/archinte.153.11.1337; Rittweger J, 2010, EUR J APPL PHYSIOL, V108, P877, DOI 10.1007/s00421-009-1303-3; Rodriguez-Miguelez P, 2015, MECH AGEING DEV, V150, P12, DOI 10.1016/j.mad.2015.08.002; Rubin C, 2004, J BONE MINER RES, V19, P343, DOI 10.1359/JBMR.0301251; Sanderson T, 2010, ARTHRIT CARE RES, V62, P647, DOI 10.1002/acr.20151; Sanudo B, 2010, CLIN EXP RHEUMATOL, V28, pS40; Schneider M, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-54; Tapp LR, 2014, CLIN INTERV AGING, V9, P63, DOI 10.2147/CIA.S30048; Tremblay MS, 2010, APPL PHYSIOL NUTR ME, V35, P725, DOI 10.1139/H10-079; Tudor-Locke C, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110332; Tudor-Locke C, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-60; Turner CH, 1998, BONE, V23, P399, DOI 10.1016/S8756-3282(98)00118-5; Turner CH, 2005, BRIT J SPORT MED, V39, P188, DOI 10.1136/bjsm.2004.016923; Uzer G, 2013, J BIOMECH, V46, P2296, DOI 10.1016/j.jbiomech.2013.06.008; Verschueren SMP, 2004, J BONE MINER RES, V19, P352, DOI 10.1359/JBMR.0301245; Wysocki A, 2011, REV ANN INTERNAL MED, P155; Zhou Y, 2015, BONE, V71, P17, DOI 10.1016/j.bone.2014.09.026	53	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153470	10.1371/journal.pone.0153470	http://dx.doi.org/10.1371/journal.pone.0153470			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073832	Green Published, Green Submitted, gold			2022-12-26	WOS:000374131200097
J	Orczyk-Pawilowicz, M; Jawien, E; Deja, S; Hirnle, L; Zabek, A; Mlynarz, P				Orczyk-Pawilowicz, Magdalena; Jawien, Ewa; Deja, Stanislaw; Hirnle, Lidia; Zabek, Adam; Mlynarz, Piotr			Metabolomics of Human Amniotic Fluid and Maternal Plasma during Normal Pregnancy	PLOS ONE			English	Article							LACTATE-PYRUVATE RATIO; PRENATAL DISORDERS; NMR-SPECTROSCOPY; GESTATIONAL-AGE; BIRTH-WEIGHT; AMINO-ACIDS; FETAL; PROFILE; BLOOD; LABOR	Metabolic profiles of amniotic fluid and maternal blood are sources of valuable information about fetus development and can be potentially useful in diagnosis of pregnancy disorders. In this study, we applied 1H NMR-based metabolic profiling to track metabolic changes occurring in amniotic fluid (AF) and plasma (PL) of healthy mothers over the course of pregnancy. AF and PL samples were collected in the 2nd (T2) and 3rd (T3) trimester, prolonged pregnancy (PP) until time of delivery (TD). A multivariate data analysis of both biofluids reviled a metabolic switch-like transition between 2nd and 3rd trimester, which was followed by metabolic stabilization throughout the rest of pregnancy probably reflecting the stabilization of fetal maturation and development. The differences were further tested using univariate statistics at alpha = 0.001. In plasma the progression from T2 to T3 was related to increasing levels of glycerol, choline and ketone bodies (3-hydroxybutyrate and acetoacetate) while pyruvate concentration was significantly decreased. In amniotic fluid, T2 to T3 transition was associated with decreasing levels of glucose, carnitine, amino acids (valine, leucine, isoleucine, alanine, methionine, tyrosine, and phenylalanine) and increasing levels of creatinine, succinate, pyruvate, choline, N, N-dimethylglycine and urocanate. Lactate to pyruvate ratio was decreased in AF and conversely increased in PL. The results of our study, show that metabolomics profiling can be used to better understand physiological changes of the complex interdependencies of the mother, the placenta and the fetus during pregnancy. In the future, these results might be a useful reference point for analysis of complicated pregnancies.	[Orczyk-Pawilowicz, Magdalena] Wroclaw Med Univ, Dept Chem & Immunochem, Wroclaw, Poland; [Jawien, Ewa; Zabek, Adam; Mlynarz, Piotr] Wroclaw Univ Technol, Dept Chem, PL-50370 Wroclaw, Poland; [Hirnle, Lidia] Wroclaw Med Univ, Dept 1, Wroclaw, Poland; [Hirnle, Lidia] Wroclaw Med Univ, Clin Gynaecol & Obstet, Wroclaw, Poland; [Deja, Stanislaw] Opole Univ, Fac Chem, Opole, Poland	Wroclaw Medical University; Wroclaw University of Science & Technology; Wroclaw Medical University; Wroclaw Medical University; University of Opole	Mlynarz, P (corresponding author), Wroclaw Univ Technol, Dept Chem, PL-50370 Wroclaw, Poland.; Deja, S (corresponding author), Opole Univ, Fac Chem, Opole, Poland.	stanislaw.deja@pwr.edu.pl; piotr.mlynarz@pwr.edu.pl	Deja, Stanislaw/AAI-7526-2020; Orczyk-Pawiłowicz, Magdalena/AAV-9298-2021	Deja, Stanislaw/0000-0002-7714-2547; Hirnle, Lidia/0000-0001-9789-5370; Mlynarz, Piotr/0000-0002-8502-4022	Wroclaw University of Technology [S40531/Z0303]; WCB KNOW (Wroclaw Center for Biotechnology, Leading National Research Center)	Wroclaw University of Technology; WCB KNOW (Wroclaw Center for Biotechnology, Leading National Research Center)	This project was supported by Wroclaw University of Technology S40531/Z0303 and WCB KNOW (Wroclaw Center for Biotechnology, Leading National Research Center) 2014-2018.	Alexandre-Gouabau MC, 2013, J PROTEOME RES, V12, P2764, DOI 10.1021/pr400122v; Athanasiadis AP, 2011, J MATERN-FETAL NEO M, V24, P1033, DOI 10.3109/14767058.2010.545909; Austdal M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091923; Bahado-Singh RO, 2012, J MATERN-FETAL NEO M, V25, P1840, DOI 10.3109/14767058.2012.680254; BOCK JL, 1994, CLIN CHEM, V40, P56; Briese V, 1999, Z GEBURTSH NEONATOL, V203, P63; Ciborowski M, 2014, PRENATAL DIAG, V34, P870, DOI 10.1002/pd.4386; Cohn BR, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.01.046; Diaz SO, 2011, J PROTEOME RES, V10, P3732, DOI 10.1021/pr200352m; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Duarte IF, 2014, J PHARMACEUT BIOMED, V93, P17, DOI 10.1016/j.jpba.2013.09.025; Fanos V, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/720514; Fluhr JW, 2010, J INVEST DERMATOL, V130, P2141, DOI 10.1038/jid.2010.74; Graca G, 2008, ANAL CHEM, V80, P6085, DOI 10.1021/ac800907f; Graca G, 2007, ANAL CHEM, V79, P8367, DOI 10.1021/ac071278d; Graca G, 2013, ANAL CHIM ACTA, V764, P24, DOI 10.1016/j.aca.2012.12.023; Graca G, 2012, SPECTROSC-INT J, V27, P515, DOI 10.1155/2012/128367; Graca G, 2010, J PROTEOME RES, V9, P6016, DOI 10.1021/pr100815q; Graca G, 2009, J PROTEOME RES, V8, P4144, DOI 10.1021/pr900386f; Groenen PMW, 2004, EUR J OBSTET GYN R B, V112, P16, DOI 10.1016/S0301-2115(03)00279-3; Herrera E, 2000, EUR J CLIN NUTR, V54, pS47, DOI 10.1038/sj.ejcn.1600984; Imbard A, 2013, PRENATAL DIAG, V33, P848, DOI 10.1002/pd.4142; Krastanov A, 2010, BIOTECHNOL BIOTEC EQ, V24, P1537, DOI 10.2478/V10133-010-0001-Y; Lain KY, 2007, CLIN OBSTET GYNECOL, V50, P938, DOI 10.1097/GRF.0b013e31815a5494; LEVY HL, 1969, PEDIATR RES, V3, P113, DOI 10.1203/00006450-196903000-00002; Lind T, 1981, AMNIOTIC FLUID ITS C; Lindsay KL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145794; Luan HM, 2014, J PROTEOME RES, V13, P1527, DOI 10.1021/pr401068k; Madeira VMC, 2012, METHODS MOL BIOL, V810, P1, DOI 10.1007/978-1-61779-382-0_1; Menon R, 2014, REPROD SCI, V21, P791, DOI 10.1177/1933719113518987; Michaels JEA, 2007, J PROTEOME RES, V6, P1277, DOI 10.1021/pr060543t; Mracek T, 2013, BBA-BIOENERGETICS, V1827, P401, DOI 10.1016/j.bbabio.2012.11.014; Oliveira FR, 2002, BRAZ J MED BIOL RES, V35, P215, DOI 10.1590/S0100-879X2002000200010; OMU AE, 1984, J OBSTET GYNAECOL, V4, P151, DOI 10.3109/01443618409075703; Omu AE, 1997, ARCH GYNECOL OBSTET, V259, P59; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Pinto J, 2015, J PROTEOME RES, V14, P1263, DOI 10.1021/pr5011982; Romero R, 2010, J MATERN-FETAL NEO M, V23, P1344, DOI 10.3109/14767058.2010.482618; Sachse D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052399; Savorani F, 2010, J MAGN RESON, V202, P190, DOI 10.1016/j.jmr.2009.11.012; Silwood CJL, 2002, J DENT RES, V81, P422, DOI 10.1177/154405910208100613; Sun F, 2012, PLOS ONE, V7, P1; Tea I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029947; Underwood Mark A, 2005, J Perinatol, V25, P341, DOI 10.1038/sj.jp.7211290; Wu GY, 2010, ADV NUTR, V1, P31, DOI 10.3945/an.110.1008; Xi L, 2008, J NUTR, V138, P2356, DOI 10.3945/jn.108.095638; Zeisel SH, 2006, ANNU REV NUTR, V26, P229, DOI 10.1146/annurev.nutr.26.061505.111156; Zhang J, 2012, BBA-MOL BASIS DIS, V1822, P1807, DOI 10.1016/j.bbadis.2012.08.001	48	55	60	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0152740	10.1371/journal.pone.0152740	http://dx.doi.org/10.1371/journal.pone.0152740			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070784	gold, Green Published, Green Submitted			2022-12-26	WOS:000373900700015
J	Wang, YM; Gratzke, C; Tamalunas, A; Wiemer, N; Ciotkowska, A; Rutz, B; Waidelich, R; Strittmatter, F; Liu, CX; Stief, CG; Hennenberg, M				Wang, Yiming; Gratzke, Christian; Tamalunas, Alexander; Wiemer, Nicolas; Ciotkowska, Anna; Rutz, Beata; Waidelich, Raphaela; Strittmatter, Frank; Liu, Chunxiao; Stief, Christian G.; Hennenberg, Martin			P21-Activated Kinase Inhibitors FRAX486 and IPA3: Inhibition of Prostate Stromal Cell Growth and Effects on Smooth Muscle Contraction in the Human Prostate	PLOS ONE			English	Article							LOWER URINARY-TRACT; LIGHT-CHAIN PHOSPHORYLATION; PROTEIN-KINASE; CA2+ SENSITIVITY; MYOSIN-II; ACTIN; ACTIVATION; CANCER; PROLIFERATION; VIMENTIN	Prostate smooth muscle tone and hyperplastic growth are involved in the pathophysiology and treatment of male lower urinary tract symptoms (LUTS). Available drugs are characterized by limited efficacy. Patients' adherence is particularly low to combination therapies of 5 alpha-reductase inhibitors and alpha(1)-adrenoceptor antagonists, which are supposed to target contraction and growth simultaneously. Consequently, molecular etiology of benign prostatic hyperplasia (BPH) and new compounds interfering with smooth muscle contraction or growth in the prostate are of high interest. Here, we studied effects of p21-activated kinase (PAK) inhibitors (FRAX486, IPA3) in hyperplastic human prostate tissues, and in stromal cells (WPMY-1). In hyperplastic prostate tissues, PAK1, -2, -4, and -6 may be constitutively expressed in catecholaminergic neurons, while PAK1 was detected in smooth muscle and WPMY-1 cells. Neurogenic contractions of prostate strips by electric field stimulation were significantly inhibited by high concentrations of FRAX486 (30 mu M) or IPA3 (300 mu M), while noradrenaline-and phenylephrine-induced contractions were not affected. FRAX486 (30 mu M) inhibited endothelin-1- and -2-induced contractions. In WPMY-1 cells, FRAX486 or IPA3 (24 h) induced concentration-dependent (1-10 mu M) degeneration of actin filaments. This was paralleled by attenuation of proliferation rate, being observed from 1 to 10 mu M FRAX486 or IPA3. Cytotoxicity of FRAX486 and IPA3 in WPMY-1 cells was time-and concentration-dependent. Stimulation of WPMY-1 cells with endothelin-1 or dihydrotestosterone, but not noradrenaline induced PAK phosphorylation, indicating PAK activation by endothelin-1. Thus, PAK inhibitors may inhibit neurogenic and endothelin-induced smooth muscle contractions in the hyperplastic human prostate, and growth of stromal cells. Targeting prostate smooth muscle contraction and stromal growth at once by a single compound is principally possible, at least under experimental conditions.	[Wang, Yiming; Gratzke, Christian; Tamalunas, Alexander; Wiemer, Nicolas; Ciotkowska, Anna; Rutz, Beata; Waidelich, Raphaela; Strittmatter, Frank; Stief, Christian G.; Hennenberg, Martin] Univ Munich, Dept Urol, Munich, Germany; [Wang, Yiming; Liu, Chunxiao] Southern Med Univ, Zhujiang Hosp, Dept Urol, Guangzhou, Guangdong, Peoples R China	University of Munich; Southern Medical University - China	Gratzke, C (corresponding author), Univ Munich, Dept Urol, Munich, Germany.	christian.gratzke@med.uni-muenchen.de	Tamalunas, Alexander/AAW-3850-2021; Hennenberg, Martin/M-3474-2016	Tamalunas, Alexander/0000-0002-4659-2262; 	Deutsche Forschungsgemeinschaft [HE 5825/2-1, GR 3333/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by grants HE 5825/2-1 to MH and GR 3333/2-1 to CG from the Deutsche Forschungsgemeinschaft (DE) (http://www.dfg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Prof. Dr. E. Noessner and her coworkers for support with immunofluorescence microscopy. We thank Prof. Dr. T. Kirchner (Institute of Pathology, Ludwig-Maximilians University, Munich) and his coworkers Dr. V. Mai and Dr. C. Faber for asservation of tissue samples from prostates. This study was supported by grants from the Deutsche Forschungsgemeinschaft (grants HE 5825/2-1, and GR 3333/2-1).	Al-Azayzih A, 2015, BBA-MOL CELL RES, V1853, P1229, DOI 10.1016/j.bbamcr.2015.02.023; Alcaraz A, 2009, EUR UROL, V55, P864, DOI 10.1016/j.eururo.2008.11.011; Andersson KE, 2007, NAT CLIN PRACT UROL, V4, P368, DOI 10.1038/ncpuro0836; Baek SH, 2012, FEBS LETT, V586, P772, DOI 10.1016/j.febslet.2012.01.061; Chahdi A, 2005, J BIOL CHEM, V280, P578, DOI 10.1074/jbc.M411130200; Chan PM, 2012, PROG MOL BIOL TRANSL, V106, P171, DOI 10.1016/B978-0-12-396456-4.00011-0; Chapple CR, 2011, EUR UROL, V59, P342, DOI 10.1016/j.eururo.2010.10.046; Chu J, 2013, J BIOL CHEM, V288, P1200, DOI 10.1074/jbc.M112.370718; Cindolo L, 2015, EUR UROL, V68, P418, DOI 10.1016/j.eururo.2014.11.006; Coleman Natalia, 2012, Cell Logist, V2, P132; Davis B, 2000, BJU INT, V85, P918, DOI 10.1046/j.1464-410x.2000.00573.x; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; Delorme-Walker VD, 2011, J CELL BIOL, V193, P1289, DOI 10.1083/jcb.201010059; Diebold I, 2010, ANTIOXID REDOX SIGN, V13, P399, DOI 10.1089/ars.2009.3013; Dolan BM, 2013, P NATL ACAD SCI USA, V110, P5671, DOI [10.1073/pnas.1219383110, 10.1073/pnas.1219353110]; Even-Faitelson L, 2005, CELL SIGNAL, V17, P1137, DOI 10.1016/j.cellsig.2004.12.015; Fediuk J, 2014, AM J PHYSIOL-LUNG C, V307, pL877, DOI 10.1152/ajplung.00036.2014; Foster DB, 2000, J BIOL CHEM, V275, P1959, DOI 10.1074/jbc.275.3.1959; Fullhase C, 2013, EUR UROL, V64, P228, DOI 10.1016/j.eururo.2013.01.018; Garcia M, 2014, EUKARYOT CELL, V13, P119, DOI 10.1128/EC.00216-13; Gerthoffer WT, 2005, CAN J PHYSIOL PHARM, V83, P851, DOI 10.1139/Y05-088; Goc A, 2013, J BIOL CHEM, V288, P3025, DOI 10.1074/jbc.M112.424770; Goeckeler ZM, 2000, J BIOL CHEM, V275, P18366, DOI 10.1074/jbc.M001339200; Gratzke C, 2015, EUR UROL, V67, P1099, DOI 10.1016/j.eururo.2014.12.038; Guh JH, 1996, BRIT J PHARMACOL, V117, P1716, DOI 10.1111/j.1476-5381.1996.tb15344.x; Hayashi-Takagi A, 2014, P NATL ACAD SCI USA, V111, P6461, DOI 10.1073/pnas.1321109111; Hennenberg M, 2014, NEUROUROL URODYNAM, V33, P1074, DOI 10.1002/nau.22467; Hennenberg M, 2013, AM J PHYSIOL-RENAL, V305, pF1383, DOI 10.1152/ajprenal.00380.2013; Hinoki A, 2010, HYPERTENSION, V55, P161, DOI 10.1161/HYPERTENSIONAHA.109.143057; Hirst Stuart J, 2004, J Allergy Clin Immunol, V114, pS2, DOI 10.1016/j.jaci.2004.04.039; Kaur R, 2008, PROSTATE, V68, P1510, DOI 10.1002/pros.20787; Khare V, 2015, INFLAMM BOWEL DIS, V21, P287, DOI 10.1097/MIB.0000000000000281; Khoder WY, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-335; Khoder WY, 2012, UROLOGY, V79, P717, DOI 10.1016/j.urology.2011.11.045; Kim YB, 2015, J BIOL CHEM, V290, P21076, DOI 10.1074/jbc.M115.675124; Kortmann BBM, 2003, UROLOGY, V62, P1, DOI 10.1016/S0090-4295(02)02113-1; Kundumani-Sridharan V, 2013, J BIOL CHEM, V288, P22150, DOI 10.1074/jbc.M113.454082; Kunit T, 2014, AM J PHYSIOL-RENAL, V307, pF823, DOI 10.1152/ajprenal.00011.2014; Lee HN, 2015, INT J CLIN PRACT, V69, P444, DOI 10.1111/ijcp.12581; Levitt Jonathan M, 2007, Curr Urol Rep, V8, P269, DOI 10.1007/s11934-007-0072-y; Li QF, 2009, AM J PHYSIOL-CELL PH, V297, pC1424, DOI 10.1152/ajpcell.00324.2009; Li QF, 2009, AM J PHYSIOL-CELL PH, V297, pC299, DOI 10.1152/ajpcell.00037.2009; Madersbacher S, 2007, EUR UROL, V51, P1522, DOI 10.1016/j.eururo.2007.03.034; Matsukawa Y, 2013, J UROLOGY, V189, pS117, DOI 10.1016/j.juro.2012.11.031; McFawn PK, 2003, AM J PHYSIOL-LUNG C, V284, pL863, DOI 10.1152/ajplung.00068.2002; Oelke M, 2013, EUR UROL, V64, P118, DOI 10.1016/j.eururo.2013.03.004; Ohtakara K, 2000, BIOCHEM BIOPH RES CO, V272, P712, DOI 10.1006/bbrc.2000.2854; Ong CC, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0564-5; Orsted DD, 2013, NAT REV UROL, V10, P49, DOI 10.1038/nrurol.2012.192; Park MH, 2013, ONCOGENE, V32, P2475, DOI 10.1038/onc.2012.255; Parker NH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066892; Pradidarcheep Wisuit, 2011, Handb Exp Pharmacol, P117, DOI 10.1007/978-3-642-16499-6_7; Rane Chetan K, 2014, Small GTPases, V5, DOI 10.4161/sgtp.28003; Raymond K, 2011, EMBO J, V30, P1896, DOI 10.1038/emboj.2011.113; Shaikhibrahim Z, 2012, MOL MED REP, V5, P313, DOI 10.3892/mmr.2011.647; Shin YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071495; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Strittmatter F, 2012, BRIT J PHARMACOL, V166, P1926, DOI 10.1111/j.1476-5381.2012.01919.x; Tilki D, 2015, J UROLOGY, V193, P484, DOI 10.1016/j.juro.2014.08.096; Toumaniantz G, 2010, CARDIOVASC RES, V86, P131, DOI 10.1093/cvr/cvp387; Van den Broeke C, 2009, P NATL ACAD SCI USA, V106, P8707, DOI 10.1073/pnas.0900436106; Van Eyk JE, 1998, J BIOL CHEM, V273, P23433, DOI 10.1074/jbc.273.36.23433; Viaud J, 2009, MOL CANCER THER, V8, P2559, DOI 10.1158/1535-7163.MCT-09-0102; Vidal C, 2002, BLOOD, V100, P4462, DOI 10.1182/blood.V100.13.4462; Wang RP, 2007, AM J PHYSIOL-LUNG C, V292, pL240, DOI 10.1152/ajplung.00199.2006; Wang Y, 2015, BRIT J PHARMACOL, V172, P2905, DOI 10.1111/bph.13099; Wells CM, 2010, BIOCHEM J, V425, P465, DOI 10.1042/BJ20091173; Wen YY, 2013, BIOORG MED CHEM LETT, V23, P6636, DOI 10.1016/j.bmcl.2013.10.051; Wirth A, 2003, J PHYSIOL-LONDON, V549, P489, DOI 10.1113/jphysiol.2002.033167; Yu JS, 1998, BIOCHEM J, V334, P121, DOI 10.1042/bj3340121; Zeng Y, 2015, STEM CELLS, V33, P1630, DOI 10.1002/stem.1951; Zhang HM, 2011, NATURE, V471, P99, DOI 10.1038/nature09765; Zhang WW, 2015, CAN J PHYSIOL PHARM, V93, P129, DOI 10.1139/cjpp-2014-0388	73	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153312	10.1371/journal.pone.0153312	http://dx.doi.org/10.1371/journal.pone.0153312			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27071060	gold, Green Published, Green Submitted			2022-12-26	WOS:000373900700050
J	Zhang, M; Zhang, HY; Wang, CJ; Ren, YC; Wang, BY; Zhang, L; Yang, XY; Zhao, Y; Han, CY; Pang, C; Yin, L; Xue, Y; Zhao, JZ; Hu, DS				Zhang, Ming; Zhang, Hongyan; Wang, Chongjian; Ren, Yongcheng; Wang, Bingyuan; Zhang, Lu; Yang, Xiangyu; Zhao, Yang; Han, Chengyi; Pang, Chao; Yin, Lei; Xue, Yuan; Zhao, Jingzhi; Hu, Dongsheng			Development and Validation of a Risk-Score Model for Type 2 Diabetes: A Cohort Study of a Rural Adult Chinese Population	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; LIFE-STYLE INTERVENTIONS; MIDDLE-AGED ADULTS; IDENTIFYING INDIVIDUALS; FASTING GLUCOSE; FOLLOW-UP; MELLITUS; PREVENTION; REDUCTION; DIAGNOSIS	Some global models to predict the risk of diabetes may not be applicable to local populations. We aimed to develop and validate a score to predict type 2 diabetes mellitus (T2DM) in a rural adult Chinese population. Data for a cohort of 12,849 participants were randomly divided into derivation (n = 11,564) and validation (n = 1285) datasets. A questionnaire interview and physical and blood biochemical examinations were performed at baseline (July to August 2007 and July to August 2008) and follow-up (July to August 2013 and July to October 2014). A Cox regression model was used to weigh each variable in the derivation dataset. For each significant variable, a score was calculated by multiplying beta by 100 and rounding to the nearest integer. Age, body mass index, triglycerides and fasting plasma glucose (scores 3, 12, 24 and 76, respectively) were predictors of incident T2DM. The model accuracy was assessed by the area under the receiver operating characteristic curve (AUC), with optimal cut-off value 936. With the derivation dataset, sensitivity, specificity and AUC of the model were 66.7%, 74.0% and 0.768 (95% CI 0.760-0.776), respectively. With the validation dataset, the performance of the model was superior to the Chinese (simple), FINDRISC, Oman and IDRS models of T2DM risk but equivalent to the Framingham model, which is widely applicable in a variety of populations. Our model for predicting 6-year risk of T2DM could be used in a rural adult Chinese population.	[Zhang, Ming; Zhang, Hongyan; Ren, Yongcheng; Wang, Bingyuan; Zhang, Lu; Yang, Xiangyu; Zhao, Yang; Han, Chengyi; Hu, Dongsheng] Shenzhen Univ, Sch Med, Dept Prevent Med, Shenzhen, Guangdong, Peoples R China; [Zhang, Hongyan; Wang, Chongjian; Ren, Yongcheng; Wang, Bingyuan; Zhang, Lu; Yang, Xiangyu; Zhao, Yang; Han, Chengyi; Xue, Yuan] Zhengzhou Univ, Coll Publ Hlth, Dept Epidemiol & Hlth Stat, Zhengzhou 450052, Henan, Peoples R China; [Pang, Chao; Yin, Lei; Zhao, Jingzhi] Mil Hosp Henan Prov, Dept Prevent & Hlth Care, Zhengzhou, Henan, Peoples R China	Shenzhen University; Zhengzhou University	Hu, DS (corresponding author), Shenzhen Univ, Sch Med, Dept Prevent Med, Shenzhen, Guangdong, Peoples R China.; Zhao, JZ (corresponding author), Mil Hosp Henan Prov, Dept Prevent & Hlth Care, Zhengzhou, Henan, Peoples R China.	zhao_jingzhi@126.com; hud@szu.edu.cn	ming, zhang/ABH-2736-2020; zhao, yang/GXF-4424-2022	ming, zhang/0000-0002-2923-5335; Wang, Chongjian/0000-0001-5091-6621	National Natural Science Foundation of China [81373074]; Science and Technology Development Foundation of Shenzhen [JCYJ20120613112221107]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Foundation of Shenzhen	This study was supported by the National Natural Science Foundation of China (grant no. 81373074, URL: http://www.letpub.com.cn/?page=grant&name=&person=&no=81373074&company=&addcomment_s1=0&addcomment_s2=0&addcomment_s3=0&money1=&money2=&startTime=2011&endTime=2015&subcategory=&searchsubmit=true&submit.x=61&submit.y=7&submit= advSearch#fundlisttable) and the Science and Technology Development Foundation of Shenzhen (grant no. JCYJ20120613112221107, URL: http://apply.szsti.gov.cn/portal/dispatch/main.jsp?returnUrl=&application=11e1-902e-a1afe4b4-a70dc9b09cb3aea7&openUrl=11e2-e2f9-a3686d3f-9f5d597643551fae), and the funder designed this study and participated in the decision to publish.; This research was supported by the National Natural Science Foundation of China (grant no. 81373074) and the Science and Technology Development Foundation of Shenzhen (grant no. JCYJ20120613112221107).	Adegbija O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123788; Aekplakorn W, 2006, DIABETES CARE, V29, P1872, DOI 10.2337/dc05-2141; Al-Lawati JA, 2007, DIABETES RES CLIN PR, V77, P438, DOI 10.1016/j.diabres.2007.01.013; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; [Anonymous], 2012, DIABETES CARE S1, V35, pS4, DOI DOI 10.2337/DC12-S004; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; Bansal N, 2015, WORLD J DIABETES, V6, P296, DOI 10.4239/wjd.v6.i2.296; Barber SR, 2014, DIABETES RES CLIN PR, V105, P1, DOI 10.1016/j.diabres.2014.03.007; Bhowmik B, 2015, J DIABETES INVEST, V6, P670, DOI 10.1111/jdi.12344; Bozorgmanesh M, 2011, EUR J PUBLIC HEALTH, V21, P554, DOI 10.1093/eurpub/ckq074; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Buijsse B, 2011, EPIDEMIOL REV, V33, P46, DOI 10.1093/epirev/mxq019; Calonge N, 2008, ANN INTERN MED, V148, P846, DOI 10.7326/0003-4819-148-11-200806030-00007; Cantin B, 2002, ATHEROSCLEROSIS, V163, P261, DOI 10.1016/S0021-9150(02)00034-5; Chan JCN, 2014, LANCET DIABETES ENDO, V2, P969, DOI 10.1016/S2213-8587(14)70144-5; Chatterton H, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4624; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Chien K, 2009, DIABETOLOGIA, V52, P443, DOI 10.1007/s00125-008-1232-4; Chinese Diabetes Society, 2014, CHIN J ENDOCRINOL ME, V30, P893, DOI [10.3760/cma.j.issn.1000-6699.2014.10.020, DOI 10.3760/CMA.J.ISSN.1000-6699.2014.10.020]; Chinese Nutrition Society, 2008, CHIN DIET GUID; Danaei G, 2015, LANCET DIABETES ENDO, V3, P624, DOI 10.1016/S2213-8587(15)00129-1; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Doak CM, 2013, GLOB FOOD SECUR-AGR, V2, P65, DOI 10.1016/j.gfs.2013.02.003; Gao WG, 2010, DIABETIC MED, V27, P274, DOI 10.1111/j.1464-5491.2010.02943.x; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Gillies CL, 2007, BMJ-BRIT MED J, V334, P299, DOI 10.1136/bmj.39063.689375.55; Godino JG, 2014, DIABETES RES CLIN PR, V106, P412, DOI 10.1016/j.diabres.2014.10.004; Goldenberg R, 2013, CAN J DIABETES, V37, pS8, DOI 10.1016/j.jcjd.2013.01.011; Gray LJ, 2010, DIABETIC MED, V27, P887, DOI 10.1111/j.1464-5491.2010.03037.x; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Guasch-Ferre M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033437; He S, 2012, DIABETES RES CLIN PR, V95, P291, DOI 10.1016/j.diabres.2011.10.039; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; International Physical Activity Questionnaire, 2015, SHORT LAST 7 DAYS SE, V10, P1; Kahn HS, 2009, ANN INTERN MED, V150, P741, DOI 10.7326/0003-4819-150-11-200906020-00002; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Liu XM, 2015, EUR J EPIDEMIOL, V30, P35, DOI 10.1007/s10654-014-9973-5; Mashayekhi M, 2015, CAN J DIABETES, V39, P152, DOI 10.1016/j.jcjd.2014.10.006; Mathur R, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X656793; Misra A, 2014, DIABETIC MED, V31, P1153, DOI 10.1111/dme.12540; Muhlenbruch K, 2014, DIABETES RES CLIN PR, V104, P459, DOI 10.1016/j.diabres.2014.03.013; National Institute of Nutrition and Food Safety, 2009, CHINA FOOD COMPOSITI, V2nd; Norberg M, 2006, J INTERN MED, V260, P263, DOI 10.1111/j.1365-2796.2006.01689.x; Paulweber B, 2010, HORM METAB RES, V42, pS3, DOI 10.1055/s-0029-1240928; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Pottie K, 2012, CAN MED ASSOC J, V184, P1687, DOI 10.1503/cmaj.120732; Qiao Q, 2000, DIABETOLOGIA, V43, P1470, DOI 10.1007/s001250051557; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Ramachandran A, 2005, DIABETES RES CLIN PR, V70, P63, DOI 10.1016/j.diabres.2005.02.016; Riaz M, 2012, PRIM CARE DIABETES, V6, P297, DOI 10.1016/j.pcd.2012.04.002; Salas-Salvado J, 2011, NUTR METAB CARDIOVAS, V21, pB32, DOI 10.1016/j.numecd.2011.03.009; Schmidt MI, 2005, DIABETES CARE, V28, P2013, DOI 10.2337/diacare.28.8.2013; Schulze MB, 2007, DIABETES CARE, V30, P510, DOI 10.2337/dc06-2089; Sun F, 2009, DIABETES RES CLIN PR, V85, P228, DOI 10.1016/j.diabres.2009.05.005; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; Wang CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043834; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068; Yang F, 2016, DIABETIC MED, V33, P454, DOI 10.1111/dme.12842; Zhang YR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120382	62	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0152054	10.1371/journal.pone.0152054	http://dx.doi.org/10.1371/journal.pone.0152054			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070555	Green Published, gold, Green Submitted			2022-12-26	WOS:000373900700006
J	Zhong, MM; Zhao, XW; Li, JM; Yuan, WJ; Yan, GH; Tong, MM; Guo, SG; Zhu, YC; Jiang, Y; Liu, YJ; Jiang, Y				Zhong, Mingming; Zhao, Xuwen; Li, Jinmei; Yuan, Wenjie; Yan, Gonghong; Tong, Mingming; Guo, Shuguang; Zhu, Yichao; Jiang, Yong; Liu, Yongjian; Jiang, Yu			Tumor Suppressor Folliculin Regulates mTORC1 through Primary Cilia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOGG-DUBE-SYNDROME; POLYCYSTIC KIDNEYS; SENSORY ORGANELLE; SIGNALING CENTER; CELLS ANTENNA; GENE-PRODUCT; ACTIVATION; PATHWAY; DISEASE; PROTEIN	Folliculin (FLCN) is the tumor suppressor associated with Birt-Hogg-Dube (BHD) syndrome that predisposes patients to incident of hamartomas and cysts in multiple organs. Its inactivation causes deregulation in the mammalian target of rapamycin complex 1 (mTORC1) signaling pathway. However, the underlying mechanism is poorly defined. In this study, we show that FLCN is a ciliary protein that functions through primary cilia to regulate mTORC1. In response to flow stress, FLCN associates with LKB1 and recruits the kinase to primary cilia for activation of AMPK resided at basal bodies, which causes mTORC1 down-regulation. In cells depleted of FLCN, LKB1 fails to accumulate in primary cilia and AMPK at the basal bodies remains inactive, thus nullifying the inhibitory effect of flow stress on mTORC1 activity. Our results demonstrate that FLCN is part of a flow sensory mechanism that regulates mTORC1 through primary cilia.	[Zhong, Mingming; Zhao, Xuwen; Li, Jinmei; Jiang, Yong] Southern Med Univ, Minist Educ China, State Key Lab Organ Failure Res,Dept Pathophysiol, Key Lab Transcript & Prote,Guangdong Prov Key Lab, Guangzhou 510515, Guangdong, Peoples R China; [Zhong, Mingming; Zhao, Xuwen; Li, Jinmei; Yuan, Wenjie; Yan, Gonghong; Tong, Mingming; Guo, Shuguang; Jiang, Yu] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Zhu, Yichao; Liu, Yongjian] Nanjing Med Univ, Dept Physiol, Nanjing 211166, Jiangsu, Peoples R China	Ministry of Education, China; Southern Medical University - China; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Nanjing Medical University	Jiang, Y (corresponding author), Southern Med Univ, Minist Educ China, State Key Lab Organ Failure Res,Dept Pathophysiol, Key Lab Transcript & Prote,Guangdong Prov Key Lab, Guangzhou 510515, Guangdong, Peoples R China.; Jiang, Y (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA.	jiang48321@163.com; yuj5@pitt.edu	Liu, Yongjian/J-7852-2018		National Institutes of Health [CA169186]; National Natural Science Foundation of China [81272269, 81372030]; NATIONAL CANCER INSTITUTE [R21CA169186] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant CA169186 (to Yu J.) and National Natural Science Foundation of China Grants 81272269 (to Yu J.) and 81372030 (to Yong J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baba M, 2008, JNCI-J NATL CANCER I, V100, P140, DOI 10.1093/jnci/djm288; Baba M, 2006, P NATL ACAD SCI USA, V103, P15552, DOI 10.1073/pnas.0603781103; Baba M, 2012, BLOOD, V120, P1254, DOI 10.1182/blood-2012-02-410407; Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; BIRT AR, 1977, ARCH DERMATOL, V113, P1674, DOI 10.1001/archderm.113.12.1674; Boehlke C, 2010, NAT CELL BIOL, V12, P1115, DOI 10.1038/ncb2117; Chen JD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003581; Dere R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009239; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hartman TR, 2009, ONCOGENE, V28, P1594, DOI 10.1038/onc.2009.14; Hartman TR, 2009, HUM MOL GENET, V18, P151, DOI 10.1093/hmg/ddn325; Hasumi H, 2015, P NATL ACAD SCI USA, V112, pE1624, DOI 10.1073/pnas.1419502112; Hasumi Y, 2009, P NATL ACAD SCI USA, V106, P18722, DOI 10.1073/pnas.0908853106; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Huber TB, 2011, KIDNEY INT, V79, P502, DOI 10.1038/ki.2010.457; Hudon V, 2010, J MED GENET, V47, P182, DOI 10.1136/jmg.2009.072009; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kim S, 2013, CURR OPIN CELL BIOL, V25, P506, DOI 10.1016/j.ceb.2013.04.011; Lancaster MA, 2009, CURR OPIN GENET DEV, V19, P220, DOI 10.1016/j.gde.2009.04.008; Luijten MNH, 2013, HUM MOL GENET, V22, P4383, DOI 10.1093/hmg/ddt288; Nickerson ML, 2002, CANCER CELL, V2, P157, DOI 10.1016/S1535-6108(02)00104-6; Pan JM, 2013, CELL MOL LIFE SCI, V70, P1849, DOI 10.1007/s00018-012-1052-z; Pazour GJ, 2003, CURR OPIN CELL BIOL, V15, P105, DOI 10.1016/S0955-0674(02)00012-1; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Quinlan RJ, 2008, CURR TOP DEV BIOL, V84, P249, DOI 10.1016/S0070-2153(08)00605-4; Satir P, 2010, J CELL SCI, V123, P499, DOI 10.1242/jcs.050377; Schmidt LS, 2013, FAM CANCER, V12, P357, DOI 10.1007/s10689-012-9574-y; Scholey JM, 2008, J CELL BIOL, V180, P23, DOI 10.1083/jcb.200709133; Scholey JM, 2013, ANNU REV CELL DEV BI, V29, P443, DOI 10.1146/annurev-cellbio-101512-122335; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Takagi Y, 2008, ONCOGENE, V27, P5339, DOI 10.1038/onc.2008.261; Verhey KJ, 2011, BIOCHEM SOC T, V39, P1120, DOI 10.1042/BST0391120; Yan M, 2014, J CLIN INVEST, V124, P2640, DOI 10.1172/JCI71749; Yang Y, 2008, CANCER GENET CYTOGEN, V180, P100, DOI 10.1016/j.cancergencyto.2007.10.010	35	23	23	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11689	11697		10.1074/jbc.M116.719997	http://dx.doi.org/10.1074/jbc.M116.719997			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27072130	Green Published, hybrid			2022-12-26	WOS:000377264800019
J	Cheng, EH; Liu, JY; Lee, TH; Huang, CC; Chen, CI; Huang, LS; Lee, MS				Cheng, En-Hui; Liu, Jer-Yuh; Lee, Tsung-Hsein; Huang, Chun-Chia; Chen, Chung-I; Huang, Lii-Sheng; Lee, Maw-Sheng			Requirement of Leukemia Inhibitory Factor or Epidermal Growth Factor for Pre-Implantation Embryogenesis via JAK/STAT3 Signaling Pathways	PLOS ONE			English	Article							DEVELOPMENT IN-VITRO; MOUSE EMBRYOS; FACTOR EXPRESSION; STAT3 ACTIVATION; FACTOR-RECEPTOR; CELLS; EGFR; IMPLANTATION; COMPETENCE; CULTURE	Leukemia inhibitory factor (LIF) plays a key role in the survivability of mouse embryos during pre-implantation. In this study, we verified the role of LIF by detecting gene expression in morula stage embryos through DNA microarray. Our results showed that LIF knockdown affected expression of 369 genes. After LIF supplementation, the epidermal growth factor (EGF) is most affected by LIF expression. To observe the correlation between LIF and EGF, the LIF knockdown embryos were supplemented with various growth factors, including LIF, EGF, GM-CSF, TGF, and IGF II. Only LIF and EGF caused the rate of blastocyst development to recover significantly from 52% of control to 83% and 93%, respectively. All of the variables, including the diameter of blastocysts, the number of blastomeres, and cells in ICM and TE, were almost restored. Moreover, EGF knockdown also impaired blastocyst development, which was reversed by LIF or EGF supplementation. The treatment with various signaling suppressors revealed that both EGF and LIF promoted embryonic development through the JAK/STAT3 signaling pathway. These data suggest that the EGF and LIF can be compensatory to each other during early embryonic development, and at least one of them is necessary for sustaining the normal development of pre-implantation embryos.	[Cheng, En-Hui; Huang, Chun-Chia; Chen, Chung-I; Huang, Lii-Sheng; Lee, Maw-Sheng] Lee Womens Hosp, Div Infertil Clin, Taichung, Taiwan; [Liu, Jer-Yuh] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan; [Liu, Jer-Yuh] China Med Univ Hosp, Ctr Mol Med, Taichung, Taiwan; [Lee, Tsung-Hsein; Lee, Maw-Sheng] Chung Shan Med Univ Hosp, Dept Obstet & Gynecol, Taichung 40201, Taiwan; [Lee, Tsung-Hsein; Lee, Maw-Sheng] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Huang, Lii-Sheng] Chung Shan Med Univ, Dept Nursing, Sch Med, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University	Lee, MS (corresponding author), Lee Womens Hosp, Div Infertil Clin, Taichung, Taiwan.; Lee, MS (corresponding author), Chung Shan Med Univ Hosp, Dept Obstet & Gynecol, Taichung 40201, Taiwan.; Lee, MS (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.	msleephd@gmail.com		Lee, Tsung-Hsien/0000-0001-8858-0916	Ministry of Science and Technology, Taiwan [NSC-94-2314-B-039-013, NSC 96-2314-B-040-039, NSC 98-2314-B-040 -010 -MY3]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a research grant from the Ministry of Science and Technology, Taiwan (NSC-94-2314-B-039-013, NSC 96-2314-B-040-039 and NSC 98-2314-B-040 -010 -MY3).	Aghajanova L, 2010, CURR OPIN OBSTET GYN, V22, P213, DOI 10.1097/GCO.0b013e32833848e5; Amiri I, 2009, IRAN J REPROD MED, V7, P189; Attar Erkut, 2003, Reprod Biomed Online, V7, P71; Chan KS, 2004, CANCER RES, V64, P2382, DOI 10.1158/0008-5472.CAN-03-3197; Cheng Jr-Gang, 2002, Rev Endocr Metab Disord, V3, P119, DOI 10.1023/A:1015402811650; Cheng TC, 2004, BIOL REPROD, V70, P1270, DOI 10.1095/biolreprod.103.023283; Cheung LP, 2003, FERTIL STERIL, V80, P727, DOI 10.1016/S0015-0282(03)00772-6; Colomiere M, 2009, BRIT J CANCER, V100, P134, DOI 10.1038/sj.bjc.6604794; Dadi TD, 2009, COMPARATIVE MED, V59, P331; De la Fuente R, 1999, HUM REPROD, V14, P3060, DOI 10.1093/humrep/14.12.3060; Dunglison GF, 1996, HUM REPROD, V11, P191; FRY RC, 1992, BIOL REPROD, V46, P470, DOI 10.1095/biolreprod46.3.470; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; GEARING DP, 1993, ADV IMMUNOL, V53, P31, DOI 10.1016/S0065-2776(08)60497-6; Hardy K, 2002, J ENDOCRINOL, V172, P221, DOI 10.1677/joe.0.1720221; Hogan B, 1994, MANIPULATING MOUSE E; Hsieh YY, 2000, J ASSIST REPROD GEN, V17, P131, DOI 10.1023/A:1009426303742; Kou XJ, 2013, ONCOL LETT, V5, P1053, DOI 10.3892/ol.2012.1098; Kristensen DM, 2005, APMIS, V113, P756, DOI 10.1111/j.1600-0463.2005.apm_391.x; Lavranos TC, 1995, J REPROD FERTIL, V105, P331, DOI 10.1530/jrf.0.1050331; Lee GS, 2005, MOL REPROD DEV, V71, P45, DOI 10.1002/mrd.20098; Marquant-Le GB, 1993, J REPROD FERTIL, V12, P61; Martello G, 2013, EMBO J, V32, P2561, DOI 10.1038/emboj.2013.177; MATSUI Y, 1991, NATURE, V353, P750, DOI 10.1038/353750a0; MITCHELL MH, 1994, J SOC GYNECOL INVEST, V1, P215, DOI 10.1177/107155769400100307; Perkins J, 2002, MOL MED, V8, P847, DOI 10.1007/BF03402090; ROBINSON RC, 1994, CELL, V77, P1101, DOI 10.1016/0092-8674(94)90449-9; SMITH AG, 1992, DEV BIOL, V151, P339, DOI 10.1016/0012-1606(92)90174-F; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Terada A, 1997, J ASSIST REPROD GEN, V14, P404, DOI 10.1007/BF02766149; Viti J, 2003, J NEUROSCI, V23, P3385; Wanggren K, 2007, MOL HUM REPROD, V13, P391, DOI 10.1093/molehr/gam013; Wei ZX, 2001, MOL REPROD DEV, V60, P457, DOI 10.1002/mrd.1110; Xu JS, 2003, FERTIL STERIL, V80, P178, DOI 10.1016/S0015-0282(03)00570-3; Xu JS, 2001, BIOL REPROD, V65, P1481, DOI 10.1095/biolreprod65.5.1481; Xu JS, 2000, FERTIL STERIL, V74, P1215, DOI 10.1016/S0015-0282(00)01618-6; YAMAMORI T, 1992, NEUROSCI RES, V12, P545, DOI 10.1016/0168-0102(92)90064-J; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; Zhou P, 2008, ANIM REPROD SCI, V104, P370, DOI 10.1016/j.anireprosci.2007.02.024	40	9	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153086	10.1371/journal.pone.0153086	http://dx.doi.org/10.1371/journal.pone.0153086			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096934	Green Published, gold, Green Submitted			2022-12-26	WOS:000374543600026
J	Li, ZQ; Zhang, JL; Li, JX; Li, HJ; Zhang, GF				Li, Zeqin; Zhang, Jilong; Li, Jingxiao; Li, Hongjie; Zhang, Genfa			The Functional and Regulatory Mechanisms of the Thellungiella salsuginea Ascorbate Peroxidase 6 (TsAPX6) in Response to Salinity and Water Deficit Stresses	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; OXYGEN GENE NETWORK; ANTIOXIDANT SYSTEMS; DROUGHT TOLERANCE; ABIOTIC STRESS; SALT-TOLERANCE; ARABIDOPSIS; EXPRESSION; PLANTS; RICE	Soil salinization is a resource and ecological problem in the world. Thellungiella salsuginea is becoming a new model plant because it resembles its relative species, Arabidopsis thaliana, in small genome and short life cycle. It is highly tolerant to salinity and drought stresses. Ascorbate peroxidase (APX) is an enzyme that clears H2O2 in plants. The function and molecular and regulation mechanisms of APX in T. salsuginea have rarely been reported. In this study, an APX gene, TsApx6, was cloned from T. salsuginea and its responses to abiotic stresses in transgenic Arabidopsis were studied. Under high salinity treatment, the expression of TsApx6 was significantly induced. Under drought treatment, overexpression of TsApx6 increased the survival rate and reduced leaf water loss rate in Arabidopsis. Compared to the wild type plants, high salinity treatment reduced the concentrations of MDA, H2O2 and proline but elevated the activities of APX, GPX, CAT and SOD in the TsApx6-overexpressing plants. Meanwhile, germination rate, cotyledon greening, and root length were improved in the transgenic plants compared to the wild type plants under salt and water deficit conditions. Based on these findings, TsApx6 has an important function in the resistance of plants to certain abiotic stresses. The TsApx6 promoter sequence was obtained using Genome Walking technology. Bioinformatics analysis indicated that it contains some cis-acting elements related to stress response. The treatments of salt, dehydration, and ABA induced the expression of Gus gene under the regulation of the TsApx6 promoter. Mutation analysis showed that the MBS motif present in the TsApx6 promoter might be a key negative regulatory element which has an important effect on the growth and developmental process of plants.	[Li, Zeqin; Zhang, Jilong; Li, Jingxiao; Zhang, Genfa] Beijing Normal Univ, Coll Life Sci, Beijing Key Lab Gene Resource & Mol Dev, Beijing 100875, Peoples R China; [Li, Hongjie] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China	Beijing Normal University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Zhang, GF (corresponding author), Beijing Normal Univ, Coll Life Sci, Beijing Key Lab Gene Resource & Mol Dev, Beijing 100875, Peoples R China.; Li, HJ (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China.	lihongjie@caas.cn; gfzh@bnu.edu.cn			National Natural Science Foundation of China [31070289, 31270365]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) Grant No. 31070289 and 31270365. GZ received the funding. The funders had been used in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Bailey-Serres J, 2006, PLANT PHYSIOL, V141, P311, DOI 10.1104/pp.104.900191; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen CM, 2014, PLANT PHYSIOL, V166, P370, DOI 10.1104/pp.114.245324; Chen XH, 2014, BBA-PROTEINS PROTEOM, V1844, P818, DOI 10.1016/j.bbapap.2014.02.010; Cho SK, 2008, PLANT CELL, V20, P1899, DOI 10.1105/tpc.108.060699; Davletova S, 2005, PLANT CELL, V17, P268, DOI 10.1105/tpc.104.026971; Deinlein U, 2014, TRENDS PLANT SCI, V19, P371, DOI 10.1016/j.tplants.2014.02.001; Frank G, 2009, J EXP BOT, V60, P3891, DOI 10.1093/jxb/erp234; Hernandez JA, 2002, PHYSIOL PLANTARUM, V115, P251, DOI 10.1034/j.1399-3054.2002.1150211.x; Higashi Y, 2013, MOL PLANT, V6, P411, DOI 10.1093/mp/sst024; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jiang LY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129932; Laloi C, 2004, CURR OPIN PLANT BIOL, V7, P323, DOI 10.1016/j.pbi.2004.03.005; Lata C, 2011, J EXP BOT, V62, P4731, DOI 10.1093/jxb/err210; Li SJ, 2009, PLANT CELL REP, V28, P683, DOI 10.1007/s00299-008-0666-y; Li XY, 2013, INT J MOL SCI, V14, P12827, DOI 10.3390/ijms140612827; Li ZQ, 2015, BIOL PLANTARUM, V59, P497, DOI 10.1007/s10535-015-0533-y; [苗雨晨 Miao Yuchen], 2005, [植物学通报, Chinese Bulletin of Botany], V22, P350; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Naliwajski MR, 2014, BIOL PLANTARUM, V58, P47, DOI 10.1007/s10535-013-0378-1; Nounjan N, 2012, J PLANT PHYSIOL, V169, P596, DOI 10.1016/j.jplph.2012.01.004; Panchuk II, 2002, PLANT PHYSIOL, V129, P838, DOI 10.1104/pp.001362; Pnueli L, 2003, PLANT J, V34, P187, DOI 10.1046/j.1365-313X.2003.01715.x; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Rossel JB, 2006, PLANT CELL ENVIRON, V29, P269, DOI 10.1111/j.1365-3040.2005.01419.x; Shim D, 2009, PLANT CELL, V21, P4031, DOI 10.1105/tpc.109.066902; Stevens J, 2006, PLANT GROWTH REGUL, V49, P77, DOI 10.1007/s10725-006-0019-1; Suzuki N, 2005, PLANT PHYSIOL, V139, P1313, DOI 10.1104/pp.105.070110; Suzuki N, 2013, J EXP BOT, V64, P253, DOI 10.1093/jxb/ers335; Suzuki N, 2011, CURR OPIN PLANT BIOL, V14, P691, DOI 10.1016/j.pbi.2011.07.014; Torres MA, 2005, CURR OPIN PLANT BIOL, V8, P397, DOI 10.1016/j.pbi.2005.05.014; Volkov RA, 2006, PLANT MOL BIOL, V61, P733, DOI 10.1007/s11103-006-0045-4; Xu LH, 2014, BIOL PLANTARUM, V58, P751, DOI 10.1007/s10535-014-0442-5; Xu XJ, 2009, MOL CELLS, V27, P423, DOI 10.1007/s10059-009-0060-9; Zhang YY, 2008, J INTEGR PLANT BIOL, V50, P1327, DOI 10.1111/j.1744-7909.2008.00740.x; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	40	13	16	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0154042	10.1371/journal.pone.0154042	http://dx.doi.org/10.1371/journal.pone.0154042			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097028	Green Published, gold, Green Submitted			2022-12-26	WOS:000374543600083
J	Poulsen, JB; Lescai, F; Grove, J; Baekvad-Hansen, M; Christiansen, M; Hagen, CM; Maller, J; Stevens, C; Li, ST; Li, QB; Sun, JH; Wang, J; Nordentoft, M; Werge, TM; Mortensen, PB; Borglum, AD; Daly, M; Hougaard, DM; Bybjerg-Grauholm, J; Hollegaard, MV				Poulsen, Jesper Buchhave; Lescai, Francesco; Grove, Jakob; Baekvad-Hansen, Marie; Christiansen, Michael; Hagen, Christian Munch; Maller, Julian; Stevens, Christine; Li, Shenting; Li, Qibin; Sun, Jihua; Wang, Jun; Nordentoft, Merete; Werge, Thomas Mears; Mortensen, Preben Bo; Borglum, Anders Dupont; Daly, Mark; Hougaard, David Michael; Bybjerg-Grauholm, Jonas; Hollegaard, Mads Vilhelm			High-Quality Exome Sequencing of Whole-Genome Amplified Neonatal Dried Blood Spot DNA	PLOS ONE			English	Article							COMMON VARIANTS; NEWBORN; AMPLIFICATION; EXTRACTION; PROTEINS; CAPTURE; STORAGE	Stored neonatal dried blood spot (DBS) samples from neonatal screening programmes are a valuable diagnostic and research resource. Combined with information from national health registries they can be used in population-based studies of genetic diseases. DNA extracted from neonatal DBSs can be amplified to obtain micrograms of an otherwise limited resource, referred to as whole-genome amplified DNA (wgaDNA). Here we investigate the robustness of exome sequencing of wgaDNA of neonatal DBS samples. We conducted three pilot studies of seven, eight and seven subjects, respectively. For each subject we analysed a neonatal DBS sample and corresponding adult whole-blood (WB) reference sample. Different DNA sample types were prepared for each of the subjects. Pilot 1: wgaDNA of 2x3.2mm neonatal DBSs (DBS_ 2x3.2) and raw DNA extract of the WB reference sample (WB_ ref). Pilot 2: DBS_2x3.2, WB_ref and a WB_ref replica sharing DNA extract with the WB_ ref sample. Pilot 3: DBS_2x3.2, WB_ref, wgaDNA of 2x1.6 mm neonatal DBSs and wgaDNA of the WB reference sample. Following sequencing and data analysis, we compared pairwise variant calls to obtain a measure of similarity-the concordance rate. Concordance rates were slightly lower when comparing DBS vs WB sample types than for any two WB sample types of the same subject before filtering of the variant calls. The overall concordance rates were dependent on the variant type, with SNPs performing best. Post-filtering, the comparisons of DBS vs WB and WB vs WB sample types yielded similar concordance rates, with values close to 100%. WgaDNA of neonatal DBS samples performs with great accuracy and efficiency in exome sequencing. The wgaDNA performed similarly to matched high-quality reference-whole-blood DNA-based on concordance rates calculated from variant calls. No differences were observed substituting 2x3.2 with 2x1.6 mm discs, allowing for additional reduction of sample material in future projects.	[Poulsen, Jesper Buchhave; Baekvad-Hansen, Marie; Hougaard, David Michael; Bybjerg-Grauholm, Jonas; Hollegaard, Mads Vilhelm] Statens Serum Inst, Dept Congenital Disorders, Danish Ctr Neonatal Screening, Sect Neonatal Genet, DK-2300 Copenhagen, Denmark; [Lescai, Francesco; Grove, Jakob; Li, Shenting; Borglum, Anders Dupont] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Lescai, Francesco; Grove, Jakob; Li, Shenting; Wang, Jun; Nordentoft, Merete; Werge, Thomas Mears; Mortensen, Preben Bo; Borglum, Anders Dupont] Aarhus Univ, iPSYCH Lundbeck Fdn Initiat Integrat Psychiat Res, Aarhus, Denmark; [Lescai, Francesco; Grove, Jakob; Li, Shenting; Wang, Jun; Borglum, Anders Dupont] Aarhus Univ, iSEQ Ctr Integrat Sequencing, Aarhus, Denmark; [Grove, Jakob] Aarhus Univ, Bioinformat Res Ctr, Aarhus, Denmark; [Christiansen, Michael; Hagen, Christian Munch] Statens Serum Inst, Dept Congenital Disorders, Mol Med, DK-2300 Copenhagen, Denmark; [Maller, Julian; Stevens, Christine; Daly, Mark] Stanley Ctr, Broad Inst, Cambridge, MA USA; [Li, Qibin; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Sun, Jihua] BGI Europe AS, Copenhagen, Denmark; [Nordentoft, Merete] Univ Copenhagen, Mental Hlth Ctr Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Werge, Thomas Mears] Capital Reg Denmark, Inst Biol Psychiat, Mental Hlth Ctr Sct Hans, Roskilde, Denmark; [Mortensen, Preben Bo] Aarhus Univ, Natl Ctr Register Based Res, Sch Business & Social Sci, Aarhus, Denmark; [Hougaard, David Michael; Hollegaard, Mads Vilhelm] Statens Serum Inst, Dept Congenital Disorders, Danish Ctr Neonatal Screening, Danish Neonatal Screening Biobank, DK-2300 Copenhagen, Denmark	Statens Serum Institut; Aarhus University; Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Aarhus University; Aarhus University; Statens Serum Institut; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Beijing Genomics Institute (BGI); University of Copenhagen; Aarhus University; Statens Serum Institut	Bybjerg-Grauholm, J (corresponding author), Statens Serum Inst, Dept Congenital Disorders, Danish Ctr Neonatal Screening, Sect Neonatal Genet, DK-2300 Copenhagen, Denmark.	jogr@ssi.dk	Bybjerg-Grauholm, Jonas/AAO-5447-2020; Daly, Mark J/B-2453-2017; Hougaard, David/AAD-6368-2019; Mortensen, Preben B/D-2358-2015; Nordentoft, Merete/AAH-3253-2019; Grove, Jakob/K-8112-2015	Bybjerg-Grauholm, Jonas/0000-0003-1705-4008; Daly, Mark J/0000-0002-0949-8752; Mortensen, Preben B/0000-0002-5230-9865; Baekvad-Hansen, Marie/0000-0002-5881-1776; Lescai, Francesco/0000-0002-6399-9101; Hagen, Christian/0000-0002-0513-7722; Nordentoft, Merete/0000-0003-4895-7023; Borglum, Anders/0000-0001-8627-7219; Grove, Jakob/0000-0003-2284-5744	Lundbeck Foundation; Lundbeck Foundation [R155-2014-1724] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden)	This work is part of the 'The Lundbeck Foundation Initiative for Integrative Psychiatric Research' - iPSYCH project (http://ipsych.au.dk/), which is funded by the Lundbeck Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Kikumaro, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P80; Asan, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r95; Bainbridge MN, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r62; Borglum AD, 2014, MOL PSYCHIATR, V19, P325, DOI 10.1038/mp.2013.2; Catsburg A, 2007, J IMMUNOL METHODS, V321, P135, DOI 10.1016/j.jim.2007.01.015; Clark MJ, 2011, NAT BIOTECHNOL, V29, P908, DOI 10.1038/nbt.1975; Feenstra B, 2012, NAT GENET, V44, P334, DOI 10.1038/ng.1067; Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398; Hamvas A, 2001, PEDIATR RES, V50, P666, DOI 10.1203/00006450-200111000-00021; Hannelius U, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.032987; Hardin J, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-38; Hollegaard MV, 2007, CLIN CHEM, V53, P1161, DOI 10.1373/clinchem.2006.082313; Hollegaard MV, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-297; Hollegaard MV, 2013, MOL GENET METAB, V110, P65, DOI 10.1016/j.ymgme.2013.06.004; Hollegaard MV, 2013, HUM MUTAT, V34, P143, DOI 10.1002/humu.22173; Horikoshi M, 2013, NAT GENET, V45, P76, DOI 10.1038/ng.2477; Kahvejian A, 2008, NAT BIOTECHNOL, V26, P1125, DOI 10.1038/nbt1494; Lee S, 2014, AM J HUM GENET, V95, P5, DOI 10.1016/j.ajhg.2014.06.009; Lund AM, 2012, MOL GENET METAB, V107, P281, DOI 10.1016/j.ymgme.2012.06.006; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Norgaard-Pedersen B, 2007, J INHERIT METAB DIS, V30, P530, DOI 10.1007/s10545-007-0631-x; Norgaard-Pedersen B, 1999, ACTA PAEDIATR, V88, P106, DOI 10.1080/08035259950170736; Olney RS, 2006, J PEDIATR-US, V148, P618, DOI 10.1016/j.jpeds.2005.12.053; Parla JS, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r97; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Steinberg S, 2014, MOL PSYCHIATR, V19, P108, DOI 10.1038/mp.2012.157; Tarini BA, 2012, ANNU REV GENOM HUM G, V13, P381, DOI 10.1146/annurev-genom-090711-163741; Therrell BL, 2007, J INHERIT METAB DIS, V30, P447, DOI 10.1007/s10545-007-0690-z; Webster Dianne, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P69; Wilcken B, 2008, PATHOLOGY, V40, P104, DOI 10.1080/00313020701813743	31	28	29	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153253	10.1371/journal.pone.0153253	http://dx.doi.org/10.1371/journal.pone.0153253			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27089011	Green Published, Green Submitted, gold			2022-12-26	WOS:000374527000014
J	Lier, R; Mork, PJ; Holtermann, A; Nilsen, TIL				Lier, Ragnhild; Mork, Paul Jarle; Holtermann, Andreas; Nilsen, Tom Ivar Lund			Familial Risk of Chronic Musculoskeletal Pain and the Importance of Physical Activity and Body Mass Index: Prospective Data from the HUNT Study, Norway	PLOS ONE			English	Article							LOW-BACK-PAIN; CHRONIC WIDESPREAD PAIN; NORD-TRONDELAG HEALTH; POPULATION-BASED HUNT; PARENTAL CHRONIC PAIN; UPPER-LIMB; SOCIOECONOMIC-STATUS; LONGITUDINAL DATA; SYMPTOMS; NECK	The main objectives of the current study was i) to prospectively examine if chronic musculoskeletal pain in parents is associated with risk of chronic musculoskeletal pain in their adult offspring, and ii) to assess if these parent-offspring associations are modified by offspring body mass index and leisure time physical activity. We used data on 4,742 adult offspring linked with their parents who participated in the population-based HUNT Study in Norway in 1995-97 and in 2006-08. Family relations were established through the national Family Registry. A Poisson regression model was used to estimate relative risk (RR) with 95% confidence interval (CI). In total, 1,674 offspring (35.3%) developed chronic musculoskeletal pain during the follow-up period of approximately 11 years. Both maternal (RR: 1.26, 95% CI: 1.03, 1.55) and paternal chronic musculoskeletal pain (RR: 1.29, 95% CI: 1.06, 1.57) was associated with increased risk of offspring chronic musculoskeletal pain. Compared to offspring of parents without chronic musculoskeletal pain, the adverse effect of parental pain was somewhat stronger among offspring who reported a low (RR: 1.82, 95% CI: 1.32, 2.52) versus high (RR: 1.32, 95% CI: 0.95, 1.84) level of leisure time physical activity. Offspring of parents with chronic musculoskeletal pain and who were classified as obese had more than twofold increased risk (RR: 2.33, 95% CI: 1.68, 3.24) of chronic musculoskeletal pain compared to normal weight offspring of parents without pain. In conclusion, parental chronic musculoskeletal pain is positively associated with risk of chronic musculoskeletal pain in their adult offspring. Maintenance of normal body weight may reduce the risk of chronic musculoskeletal pain in offspring of pain-afflicted parents.	[Lier, Ragnhild; Mork, Paul Jarle; Nilsen, Tom Ivar Lund] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway; [Lier, Ragnhild] Cent Norway Reg Hlth Author RHA, Liaison Comm, Stjordal, Norway; [Lier, Ragnhild] Norwegian Univ Sci & Technol, N-7034 Trondheim, Norway; [Holtermann, Andreas] Natl Res Ctr Working Environm, Copenhagen, Denmark	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); National Research Centre for the Working Environment	Lier, R (corresponding author), Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway.; Lier, R (corresponding author), Cent Norway Reg Hlth Author RHA, Liaison Comm, Stjordal, Norway.; Lier, R (corresponding author), Norwegian Univ Sci & Technol, N-7034 Trondheim, Norway.	ragnhild.lier@ntnu.no			Liaison Committee [46054800]	Liaison Committee	This work was supported by a grant to Ragnhild Lier from the Liaison Committee between the Central Norway Regional Health Authority and the Norwegian University of Science and Technology (NTNU) (Grant number 46054800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; [Anonymous], 1995, PHYS STAT US INT ANT; Arnold LM, 2004, ARTHRITIS RHEUM-US, V50, P944, DOI 10.1002/art.20042; Benjamin S, 2000, ARTHRITIS RHEUM-US, V43, P561, DOI 10.1002/1529-0131(200003)43:3<561::AID-ANR12>3.0.CO;2-O; Blangsted AK, 2008, SCAND J WORK ENV HEA, V34, P55, DOI 10.5271/sjweh.1192; Bradley LA, 2008, J CLIN PSYCHIAT, V69, P6; Bruehl S, 2005, PAIN, V115, P390, DOI 10.1016/j.pain.2005.03.017; Buskila Dan, 2005, Curr Pain Headache Rep, V9, P313; Cimmino MA, 2011, BEST PRACT RES CL RH, V25, P173, DOI 10.1016/j.berh.2010.01.012; D'Addio Anna Cristina, 2007, EMPLOYMENT MIGRATION, V52; Descatha A, 2007, SCAND J WORK ENV HEA, V33, P58, DOI 10.5271/sjweh.1065; Devereux JJ, 2002, OCCUP ENVIRON MED, V59, P269, DOI 10.1136/oem.59.4.269; EDWARDS PW, 1985, PAIN, V21, P379, DOI 10.1016/0304-3959(85)90166-6; Edwards RR, 2005, NEUROLOGY, V65, P437, DOI 10.1212/01.wnl.0000171862.17301.84; Evans Subhadra, 2010, Int J Disabil Hum Dev, V9, P11, DOI 10.1515/IJDHD.2010.003; Gerrits MMJG, 2015, J PSYCHOSOM RES, V78, P64, DOI 10.1016/j.jpsychores.2014.10.011; GOODMAN JE, 1991, PAIN, V46, P247, DOI 10.1016/0304-3959(91)90108-A; Hagen K, 2005, SCAND J PUBLIC HEALT, V33, P268, DOI 10.1080/14034940510005699; Henchoz Y, 2008, JOINT BONE SPINE, V75, P533, DOI 10.1016/j.jbspin.2008.03.003; Hocking LJ, 2012, EUR J PAIN, V16, P1053, DOI 10.1002/j.1532-2149.2011.00095.x; Hoftun GB, 2013, JAMA PEDIATR, V167, P61, DOI 10.1001/jamapediatrics.2013.422; Holliday KL, 2011, CURR RHEUMATOL REP, V13, P521, DOI 10.1007/s11926-011-0208-4; Holth HS, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-159; Jones GT, 2004, ANN RHEUM DIS, V63, P1152, DOI 10.1136/ard.2003.014670; Joud A, 2014, RHEUMATOL INT, V34, P1291, DOI 10.1007/s00296-014-3039-6; Kato K, 2006, ARTHRITIS RHEUM-US, V54, P1682, DOI 10.1002/art.21798; Kovacs FM, 2003, PAIN, V103, P259, DOI 10.1016/S0304-3959(02)00454-2; Krismer M, 2007, BEST PRACT RES CL RH, V21, P77, DOI 10.1016/j.berh.2006.08.004; Krokstad S, 2012, INT J EPIDEMIOL, V9, P9; KUORINKA I, 1987, APPL ERGON, V18, P233, DOI 10.1016/0003-6870(87)90010-X; Kurtze N, 2007, EUR J EPIDEMIOL, V22, P379, DOI 10.1007/s10654-007-9110-9; Landmark T, 2011, PAIN, V152, P2241, DOI 10.1016/j.pain.2011.04.029; Langhammer A, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-143; Lawlor D, 2009, FAMILY MATTERS; Lier R, 2014, BMC PUBLIC HEALTH, V14, P1471; Linton SJ, 2001, SPINE, V26, P778, DOI 10.1097/00007632-200104010-00019; Livshits G, 2011, ANN RHEUM DIS, V70, P1740, DOI 10.1136/ard.2010.137836; Martin RM, 2004, EPIDEMIOLOGY, V15, P308, DOI 10.1097/01.ede.0000120042.16363.e3; Mogil JS, 2012, TRENDS GENET, V28, P258, DOI 10.1016/j.tig.2012.02.004; Mork PJ, 2013, EUR J PAIN, V17, P1252, DOI 10.1002/j.1532-2149.2013.00298.x; Mork PJ, 2012, ARTHRITIS RHEUM-US, V64, P281, DOI 10.1002/art.33346; Mork PJ, 2014, EUR J PUBLIC HEALTH, V24, P924, DOI 10.1093/eurpub/ckt198; Mustard CA, 2005, AM J EPIDEMIOL, V162, P779, DOI 10.1093/aje/kwi271; Nilsen TIL, 2011, AM J EPIDEMIOL, V174, P267, DOI 10.1093/aje/kwr087; Palmer K, 1999, OCCUP MED-OXFORD, V49, P171, DOI 10.1093/occmed/49.3.171; PAYNE B, 1986, PAIN, V26, P1, DOI 10.1016/0304-3959(86)90169-7; POLLARD CA, 1985, PSYCHOL REP, V57, P813, DOI 10.2466/pr0.1985.57.3.813; Pollard TCB, 2012, OSTEOARTHR CARTILAGE, V20, P368, DOI 10.1016/j.joca.2012.02.003; Ray L, 2011, PAIN, V152, P53, DOI 10.1016/j.pain.2010.08.043; Rothman KJ, 2013, INT J EPIDEMIOL, V42, P1012, DOI 10.1093/ije/dys223; Saunders K, 2007, CLIN J PAIN, V23, P204, DOI 10.1097/AJP.0b013e31802d7807; Serbin LA, 2004, ANNU REV PSYCHOL, V55, P333, DOI 10.1146/annurev.psych.54.101601.145228; Sitthipornvorakul E, 2011, EUR SPINE J, V20, P677, DOI 10.1007/s00586-010-1630-4; van den Heuvel SG, 2005, PREV MED, V41, P260, DOI 10.1016/j.ypmed.2004.11.006; Vik KL, 2014, INT J EPIDEMIOL, V43, P760, DOI 10.1093/ije/dyt250; Vik KL, 2013, J EPIDEMIOL COMMUN H, V67, P564, DOI 10.1136/jech-2012-201634; VIOLON A, 1984, PAIN, V18, P199, DOI 10.1016/0304-3959(84)90887-X	57	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153828	10.1371/journal.pone.0153828	http://dx.doi.org/10.1371/journal.pone.0153828			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ6AH	27082110	Green Published, gold, Green Submitted			2022-12-26	WOS:000374291800055
J	Mohan, V; Gupta, S; Thomas, S; Mickey, H; Charakana, C; Chauhan, VS; Sharma, K; Kumar, R; Tyagi, K; Sarma, S; Gupta, SK; Kilambi, HV; Nongmaithem, S; Kumari, A; Gupta, P; Sreelakshmi, Y; Sharma, R				Mohan, Vijee; Gupta, Soni; Thomas, Sherinmol; Mickey, Hanjabam; Charakana, Chaitanya; Chauhan, Vineeta Singh; Sharma, Kapil; Kumar, Rakesh; Tyagi, Kamal; Sarma, Supriya; Gupta, Suresh Kumar; Kilambi, Himabindu Vasuki; Nongmaithem, Sapana; Kumari, Alka; Gupta, Prateek; Sreelakshmi, Yellamaraju; Sharma, Rameshwar			Tomato Fruits Show Wide Phenomic Diversity but Fruit Developmental Genes Show Low Genomic Diversity	PLOS ONE			English	Article							TILLING RESOURCE; ASSOCIATION; SHAPE; INTROGRESSION; REVEALS; TOOL; POLYMORPHISMS; SOFTWARE; NETWORK; COMPLEX	Domestication of tomato has resulted in large diversity in fruit phenotypes. An intensive phenotyping of 127 tomato accessions from 20 countries revealed extensive morphological diversity in fruit traits. The diversity in fruit traits clustered the accessions into nine classes and identified certain promising lines having desirable traits pertaining to total soluble salts (TSS), carotenoids, ripening index, weight and shape. Factor analysis of the morphometric data from Tomato Analyzer showed that the fruit shape is a complex trait shared by several factors. The 100% variance between round and flat fruit shapes was explained by one discriminant function having a canonical correlation of 0.874 by stepwise discriminant analysis. A set of 10 genes (ACS2, COP1, CYC-B, RIN, MSH2, NAC-NOR, PHOT1, PHYA, PHYB and PSY1) involved in various plant developmental processes were screened for SNP polymorphism by EcoTILLING. The genetic diversity in these genes revealed a total of 36 non-synonymous and 18 synonymous changes leading to the identification of 28 haplotypes. The average frequency of polymorphism across the genes was 0.038/Kb. Significant negative Tajima'D statistic in two of the genes, ACS2 and PHOT1 indicated the presence of rare alleles in low frequency. Our study indicates that while there is low polymorphic diversity in the genes regulating plant development, the population shows wider phenotype diversity. Nonetheless, morphological and genetic diversity of the present collection can be further exploited as potential resources in future.	[Mohan, Vijee; Gupta, Soni; Thomas, Sherinmol; Mickey, Hanjabam; Charakana, Chaitanya; Chauhan, Vineeta Singh; Sharma, Kapil; Kumar, Rakesh; Tyagi, Kamal; Sarma, Supriya; Gupta, Suresh Kumar; Kilambi, Himabindu Vasuki; Nongmaithem, Sapana; Kumari, Alka; Gupta, Prateek; Sreelakshmi, Yellamaraju; Sharma, Rameshwar] Univ Hyderabad, Dept Plant Sci, Repository Tomato Genom Resources, Hyderabad 500134, Andhra Pradesh, India; [Mohan, Vijee; Gupta, Suresh Kumar] Agr Res Org, Volcani Ctr, Inst Plant Sci, IL-50250 Bet Dagan, Israel; [Gupta, Soni] CSIR, Cent Inst Med & Aromat Plants, Dept Genet & Plant Breeding, Lucknow, Uttar Pradesh, India; [Chauhan, Vineeta Singh] Tierra Seed Sci Private Ltd, Hyderabad, Andhra Pradesh, India	University of Hyderabad; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP)	Sharma, R (corresponding author), Univ Hyderabad, Dept Plant Sci, Repository Tomato Genom Resources, Hyderabad 500134, Andhra Pradesh, India.	syellamaraju@gmail.com; rameshwar.sharma@gmail.com	Gupta, Suresh/AFY-2970-2022; Mohan, Vijee/AAQ-4436-2021; Sharma, Kapil/AAM-5025-2021; Gupta, Prateek/AAM-6061-2021; Gupta, Soni/AAE-5055-2022	Mohan, Vijee/0000-0001-6472-0187; Sharma, Kapil/0000-0002-1847-4584; Gupta, Prateek/0000-0002-7296-8411; Gupta, Suresh Kumar/0000-0003-3972-6717; Sreelakshmi, Yellamaraju/0000-0003-3468-9136; Gupta, Soni/0000-0001-6857-5626; Thomas, Sherinmol/0000-0003-4068-0322; tygai, kamal/0000-0002-3706-5030; Kumar, Rakesh/0000-0001-5072-5673	Department of Biotechnology, India [BT/PR/5275/AGR/16/465/2004, BT/PR/7002/PBD/16/1009/2012]; University Grants Commission, India; Department of Science and Technology, India; Council of Scientific and Industrial Research, India; Indian Council of Medical Research, India	Department of Biotechnology, India(Department of Biotechnology (DBT) India); University Grants Commission, India(University Grants Commission, India); Department of Science and Technology, India(Department of Science & Technology (India)); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research, India(Indian Council of Medical Research (ICMR))	This work was supported by the Department of Biotechnology, India (grant no. BT/PR/5275/AGR/16/465/2004; BT/PR/7002/PBD/16/1009/2012) to RS and YS; University Grants Commission, India to YS and RS; Department of Science and Technology, India (Young Scientist grants to SG and VSC); Council of Scientific and Industrial Research, India (research fellowship to VM, HM, CC, RK, SKG, KT, SN, PG); University Grants Commission, India (research fellowship to ST, KS, SS, HVK) and Indian Council of Medical Research, India (research fellowship to AK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aflitos S, 2014, PLANT J, V80, P136, DOI 10.1111/tpj.12616; Azzi L, 2015, J EXP BOT, V66, P1075, DOI 10.1093/jxb/eru527; Bai YL, 2007, ANN BOT-LONDON, V100, P1085, DOI 10.1093/aob/mcm150; Barone Amalia, 2008, Int J Plant Genomics, V2008, P820274, DOI 10.1155/2008/820274; Bauchet G, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0279-2; Bauchet G, 2012, GENETIC DIVERSITY IN PLANTS, P133; Beecher GR, 1998, P SOC EXP BIOL MED, V218, P98, DOI 10.3181/00379727-218-44282a; Biehler E, 2010, J FOOD SCI, V75, pC55, DOI 10.1111/j.1750-3841.2009.01417.x; Blanca J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048198; Blomstedt CK, 2012, PLANT BIOTECHNOL J, V10, P54, DOI 10.1111/j.1467-7652.2011.00646.x; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brewer MT, 2006, PLANT PHYSIOL, V141, P15, DOI 10.1104/pp.106.077867; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; Chitwood DH, 2013, PLANT CELL, V25, P2465, DOI 10.1105/tpc.113.112391; Chitwood DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029570; Chusreeaeom K, 2014, MOL GENET GENOMICS, V289, P399, DOI 10.1007/s00438-014-0822-8; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Darrigues A, 2008, J AM SOC HORTIC SCI, V133, P579, DOI 10.21273/JASHS.133.4.579; DAVIES JN, 1981, CRC CR REV FOOD SCI, V15, P205, DOI 10.1080/10408398109527317; Frerichmann SLM, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-52; Goff SA, 2006, SCIENCE, V311, P815, DOI 10.1126/science.1112614; Gonzalez N, 2015, J EXP BOT, V66, P1045, DOI 10.1093/jxb/eru541; Grandillo S, 1999, THEOR APPL GENET, V99, P978, DOI 10.1007/s001220051405; Gupta SK, 2014, PLANT CELL ENVIRON, V37, P1688, DOI 10.1111/pce.12279; Ibiza VP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-631; Ichihashi Y, 2014, P NATL ACAD SCI USA, V111, pE2616, DOI 10.1073/pnas.1402835111; Ichihashi Y, 2014, CURR OPIN PLANT BIOL, V18, P9, DOI 10.1016/j.pbi.2013.12.004; Labate JA, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-133; Lin T, 2014, NAT GENET, V46, P1220, DOI 10.1038/ng.3117; Liu LH, 2015, MOL PLANT, V8, P28, DOI 10.1016/j.molp.2014.11.006; Liu RH, 2004, J NUTR, V134, p3479S, DOI 10.1093/jn/134.12.3479S; Mazzucato A, 2008, THEOR APPL GENET, V116, P657, DOI 10.1007/s00122-007-0699-6; Menda N, 2004, PLANT J, V38, P861, DOI 10.1111/j.1365-313X.2004.02088.x; Menda N, 2013, PLANT BIOTECHNOL-NAR, V30, P243, DOI 10.5511/plantbiotechnology.13.0904a; Mueller LA, 2005, PLANT PHYSIOL, V138, P1310, DOI 10.1104/pp.105.060707; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Nieto C, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-34; Ogura T, 2015, CURR OPIN PLANT BIOL, V23, P98, DOI 10.1016/j.pbi.2014.11.008; Okabe Y, 2011, PLANT CELL PHYSIOL, V52, P1994, DOI 10.1093/pcp/pcr134; Panthee DR, 2013, PLANT GENET RESOUR-C, V11, P106, DOI 10.1017/S1479262112000421; Perkel J, 2008, NAT METHODS, V5, P447, DOI 10.1038/nmeth0508-447; Quinet M, 2011, PHYSIOL PLANTARUM, V141, P166, DOI 10.1111/j.1399-3054.2010.01426.x; Rawat N, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-205; Rodriguez GR, 2010, JOVE-J VIS EXP, pe1856, DOI [DOI 10.3791/1856, 10.3791/1856]; Rodriguez GR, 2011, PLANT PHYSIOL, V156, P275, DOI 10.1104/pp.110.167577; Rodriguez-Amaya DB, 2004, HARVESTPLUS HANDBOOK; Rohlf FJ, 1992, APPLIED BIOSTATISTIC; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruggieri V, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0337-9; Sabetta W, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-20; SADLER G, 1990, J FOOD SCI, V55, P1460, DOI 10.1111/j.1365-2621.1990.tb03958.x; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Sauvage C, 2014, PLANT PHYSIOL, V165, P1120, DOI 10.1104/pp.114.241521; Schauer N, 2006, NAT BIOTECHNOL, V24, P447, DOI 10.1038/nbt1192; Shakhatreh Y, 2010, GENET RESOUR CROP EV, V57, P131, DOI 10.1007/s10722-009-9457-8; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Sreelakshmi Y, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-3; Stephenson P, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-62; Szymkowiak EJ, 2006, PLANTA, V223, P646, DOI 10.1007/s00425-005-0115-x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor NE, 2003, NUCLEIC ACIDS RES, V31, P3808, DOI 10.1093/nar/gkg574; van der Knaap E, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00227; Vankadavath RN, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-18; Wang NA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-137; Xu JX, 2013, THEOR APPL GENET, V126, P567, DOI 10.1007/s00122-012-2002-8; Yu SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030765; Zamir D, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001595	68	13	16	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0152907	10.1371/journal.pone.0152907	http://dx.doi.org/10.1371/journal.pone.0152907			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077652	gold, Green Published, Green Submitted			2022-12-26	WOS:000374131700014
J	Reuscher, S; Kolter, A; Hoffmann, A; Pillen, K; Kramer, U				Reuscher, Stefan; Kolter, Andreas; Hoffmann, Astrid; Pillen, Klaus; Kraemer, Ute			Quantitative Trait Loci and Inter-Organ Partitioning for Essential Metal and Toxic Analogue Accumulation in Barley	PLOS ONE			English	Article							VULGARE SSP SPONTANEUM; INTROGRESSION LINES; DURUM-WHEAT; ZINC BIOFORTIFICATION; CADMIUM ACCUMULATION; GENE IDENTIFICATION; ALUMINUM TOLERANCE; IRON FORTIFICATION; GRAIN PROTEIN; QTL ANALYSIS	The concentrations of both essential nutrients and chemically similar toxic analogues accumulated in cereal grains have a major impact on the nutritional quality and safety of crops. Naturally occurring genetic diversity can be exploited for the breeding of improved varieties through introgression lines (ILs). In this study, multi-element analysis was conducted on vegetative leaves, senesced flag leaves and mature grains of a set of 54 ILs of the wild ancestral Hordeum vulgare ssp. spontaneum in the cultivated variety Hordeum vulgare ssp. vulgare cv. Scarlett. Plants were cultivated on an anthropogenically heavy metal-contaminated soil collected in an agricultural field, thus allowing simultaneous localization of quantitative trait loci (QTL) for the accumulation of both essential nutrients and toxic trace elements in barley as a model cereal crop. For accumulation of the micronutrients Fe and Zn and the interfering toxin Cd, we identified 25, 16 and 5 QTL, respectively. By examining the gene content of the introgressions, we associated QTL with candidate genes based on homology to known metal homeostasis genes of Arabidopsis and rice. Global comparative analyses suggested the preferential remobilization of Cu and Fe, over Cd, from the flag leaf to developing grains. Our data identifies grain micronutrient filling as a regulated and nutrient- specific process, which operates differently from vegetative micronutrient homoeostasis. In summary, this study provides novel QTL for micronutrient accumulation in the presence of toxic analogues and supports a higher degree of metal specificity of trace element partitioning during grain filling in barley than previously reported for other cereals.	[Reuscher, Stefan; Kolter, Andreas; Kraemer, Ute] Ruhr Univ Bochum, Dept Plant Physiol, Univ Str 150, Bochum, Germany; [Hoffmann, Astrid; Pillen, Klaus] Univ Halle Wittenberg, Inst Agr & Nutr Sci, D-06108 Halle, Germany; [Reuscher, Stefan] Nagoya Univ, Biosci & Biotechnol Ctr, Furo Cho, Nagoya, Aichi 4648601, Japan; [Hoffmann, Astrid] Deutsch Saatveredelung DSV, Leutewitz 26, D-01665 Kabschutztal, Germany	Ruhr University Bochum; Martin Luther University Halle Wittenberg; Nagoya University	Kramer, U (corresponding author), Ruhr Univ Bochum, Dept Plant Physiol, Univ Str 150, Bochum, Germany.	ute.kraemer@ruhr-uni-bochum.de	Kraemer, Ute/C-5025-2008; Pillen, Klaus/I-6511-2012	Kraemer, Ute/0000-0001-7870-4508; Pillen, Klaus/0000-0003-4646-6351	Integrated Project PHIME (Public health impact of long-term, low-level mixed element exposure in susceptible population strata). [FOOD-CT2006-016253]; European Union [FOOD-CT-2006-016253]	Integrated Project PHIME (Public health impact of long-term, low-level mixed element exposure in susceptible population strata).; European Union(European Commission)	This work was supported by FOOD-CT-2006-016253, https://ec.europa.eu/research/fp6/index_en.cfm, Integrated Project PHIME (Public health impact of long-term, low-level mixed element exposure in susceptible population strata).; We thank Petra Duchting, Ruhr University Bochum, for technical support with sample digestion and multi-element analysis. We thank Erika Szakacs for plant cultivation and Michael J. Haydon for preparatory experiments. We thank Stephan Clemens, University of Bayreuth, for discussions and for sharing his calibration and measurement method for multi-element analysis as part of a standardization effort between our laboratories. We thank the LBEG (Hannover, Germany) for making available the soil. This work was funded by the European Union, FOOD-CT-2006-016253, https://ec.europa.eu/research/fp6/index_en.cfm, Integrated Project PHIME (Public health impact of long-term, low-level mixed element exposure in susceptible population strata).	Akesson AA, 2005, ENVIRON HEALTH PERSP, V113, P1627, DOI 10.1289/ehp.8033; Akesson A, 2006, ENVIRON HEALTH PERSP, V114, P830, DOI 10.1289/ehp.8763; Alloway B. J., 2005, ESSENTIALS MED GEOLO, P347; Arrivault S, 2006, PLANT J, V46, P861, DOI 10.1111/j.1365-313X.2006.02746.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bus A, 2008, THESIS R FRIEDRICH W; Clemens S, 2013, TRENDS PLANT SCI, V18, P92, DOI 10.1016/j.tplants.2012.08.003; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; Fan MS, 2008, J TRACE ELEM MED BIO, V22, P315, DOI 10.1016/j.jtemb.2008.07.002; Ferraro PM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-304; Fontecha G, 2007, THEOR APPL GENET, V114, P249, DOI 10.1007/s00122-006-0427-7; Gayomba SR, 2013, METALLOMICS, V5, P1262, DOI 10.1039/c3mt00111c; Greger M, 2004, CROP SCI, V44, P501, DOI 10.2135/cropsci2004.5010; Grotz N, 1998, P NATL ACAD SCI USA, V95, P7220, DOI 10.1073/pnas.95.12.7220; Gu JF, 2012, J EXP BOT, V63, P455, DOI 10.1093/jxb/err292; Haas JD, 2005, J NUTR, V135, P2823, DOI 10.1093/jn/135.12.2823; Harris NS, 2001, J EXP BOT, V52, P1473, DOI 10.1093/jexbot/52.360.1473; Haydon MJ, 2007, NEW PHYTOL, V174, P499, DOI 10.1111/j.1469-8137.2007.02051.x; Haydon MJ, 2012, PLANT CELL, V24, P724, DOI 10.1105/tpc.111.095042; Ishikawa S, 2005, NEW PHYTOL, V168, P345, DOI 10.1111/j.1469-8137.2005.01516.x; Ishikawa S, 2012, P NATL ACAD SCI USA, V109, P19166, DOI 10.1073/pnas.1211132109; Jarup L, 2004, BIOMETALS, V17, P505, DOI 10.1023/B:BIOM.0000045729.68774.a1; Knox RE, 2009, GENOME, V52, P741, DOI [10.1139/G09-042, 10.1139/g09-042]; Kobayashi T, 2012, ANNU REV PLANT BIOL, V63, P131, DOI 10.1146/annurev-arplant-042811-105522; Kraemer U, 2009, NEW PHYTOL, V181, P3, DOI 10.1111/j.1469-8137.2008.02699.x; Lanquar V, 2005, EMBO J, V24, P4041, DOI 10.1038/sj.emboj.7600864; Lanquar V, 2010, PLANT PHYSIOL, V152, P1986, DOI 10.1104/pp.109.150946; Lee S, 2009, P NATL ACAD SCI USA, V106, P22014, DOI 10.1073/pnas.0910950106; Leyva-Guerrero E, 2012, CURR OPIN BIOTECH, V23, P257, DOI 10.1016/j.copbio.2011.12.009; Mahone GS, 2012, CROP SCI, V52, P2198, DOI 10.2135/cropsci2011.06.0341; Maron LG, 2013, P NATL ACAD SCI USA, V110, P5241, DOI 10.1073/pnas.1220766110; Marschner P, 2012, MARSCHNER'S MINERAL NUTRITION OF HIGHER PLANTS, 3RD EDITION, P1; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Mayer KFX, 2011, PLANT CELL, V23, P1249, DOI 10.1105/tpc.110.082537; Murata Y, 2006, PLANT J, V46, P563, DOI 10.1111/j.1365-313X.2006.02714.x; Murray C.J.L., 2004, COMP QUANTIFICATION, V1, P257, DOI DOI 10.1007/S12263-011-0248-4; Newman RK, 2008, BARLEY FOOD HLTH SCI; Palmgren MG, 2008, TRENDS PLANT SCI, V13, P464, DOI 10.1016/j.tplants.2008.06.005; Pillen K, 2003, THEOR APPL GENET, V107, P340, DOI 10.1007/s00122-003-1253-9; Pure Earth Green Cross, 2015, WORLDS WORST POLL PR; Rawat N, 2011, GENOME, V54, P943, DOI [10.1139/G11-059, 10.1139/g11-059]; Rosado JL, 2009, J NUTR, V139, P1920, DOI 10.3945/jn.109.107755; Schmalenbach I, 2009, THEOR APPL GENET, V118, P483, DOI 10.1007/s00122-008-0915-z; Schmalenbach I, 2008, THEOR APPL GENET, V117, P1093, DOI 10.1007/s00122-008-0847-7; Schmalenbach I, 2011, G3-GENES GENOM GENET, V1, P187, DOI 10.1534/g3.111.000182; Schmalenbach I, 2009, THEOR APPL GENET, V118, P1411, DOI 10.1007/s00122-009-0991-8; Simic D, 2012, J HERED, V103, P47, DOI 10.1093/jhered/esr122; Sinclair SA, 2012, BBA-MOL CELL RES, V1823, P1553, DOI 10.1016/j.bbamcr.2012.05.016; Stoltzfus RJ., 2004, COMP QUANTIFICATION, pp. 163; Stomph TJ, 2009, TRENDS PLANT SCI, V14, P123, DOI 10.1016/j.tplants.2009.01.001; Sutton T, 2007, SCIENCE, V318, P1446, DOI 10.1126/science.1146853; Tezuka K, 2010, THEOR APPL GENET, V120, P1175, DOI 10.1007/s00122-009-1244-6; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tiwari VK, 2009, J HERED, V100, P771, DOI 10.1093/jhered/esp030; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Ueno D, 2009, J EXP BOT, V60, P3513, DOI 10.1093/jxb/erp191; Uraguchi S, 2013, CURR OPIN PLANT BIOL, V16, P328, DOI 10.1016/j.pbi.2013.03.012; Uraguchi S, 2011, P NATL ACAD SCI USA, V108, P20959, DOI 10.1073/pnas.1116531109; von Korff M, 2006, THEOR APPL GENET, V112, P1221, DOI 10.1007/s00122-006-0223-4; von Korff M, 2004, THEOR APPL GENET, V109, P1736, DOI 10.1007/s00122-004-1818-2; Wan Jian-Lin, 2003, Yi Chuan Xue Bao, V30, P893; Wang GW, 2010, THEOR APPL GENET, V120, P1559, DOI 10.1007/s00122-010-1276-y; Wu DZ, 2015, NEW PHYTOL, V208, P817, DOI 10.1111/nph.13512; Yordem BK, 2011, ANN BOT-LONDON, V108, P821, DOI 10.1093/aob/mcr200; Yuan L, 2013, J SCI FOOD AGR, V93, P254, DOI 10.1002/jsfa.5749; Zamir D, 2001, NAT REV GENET, V2, P983, DOI 10.1038/35103590	71	16	17	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153392	10.1371/journal.pone.0153392	http://dx.doi.org/10.1371/journal.pone.0153392			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078500	Green Published, Green Submitted, gold			2022-12-26	WOS:000374131700049
J	Sutter, K; Nonnekes, J; Dibilio, V; Geurts, AC; Weerdesteyn, V				Sutter, Katrin; Nonnekes, Jorik; Dibilio, Valeria; Geurts, Alexander C.; Weerdesteyn, Vivian			Does the StartReact Effect Apply to First-Trial Reactive Movements?	PLOS ONE			English	Article							REACTION-TIME; 1ST TRIAL; STARTLE; HUMANS; HEALTHY; POSTURE; REFLEX	Introduction StartReact is the acceleration of reaction time by a startling acoustic stimulus (SAS). The SAS is thought to release a pre-prepared motor program. Here, we investigated whether the StartReact effect is applicable to the very first trial in a series of repeated unpractised single-joint movements. Methods Twenty healthy young subjects were instructed to perform a rapid ankle dorsiflexion movement in response to an imperative stimulus. Participants were divided in two groups of ten. Both groups performed 17 trials. In one group a SAS (116 dB) was given in the first trial, whereas the other group received a non-startling sound (70 dB) as the first imperative stimulus. In the remaining 16 trials, the SAS was given as the imperative stimulus in 25% of the trials in both groups. The same measurement was repeated one week later, but with the first-trial stimuli counterbalanced between groups. Results When a SAS was given in the very first trial, participants had significantly shorter onset latencies compared to first-trial responses to a non-startling stimulus. Succeeding trials were significantly faster compared to the first trial, both for trials with and without a SAS. However, the difference between the first and succeeding trials was significantly larger for responses to a non-startling stimulus compared to responses triggered by a SAS. SAS-induced acceleration in the first trial of the second session was similar to that in succeeding trials of session 1. Discussion The present results confirm that the StartReact phenomenon also applies to movements that have not yet been practiced in the experimental context. The excessive SAS-induced acceleration in the very first trial may be due to the absence of integration of novel context-specific information with the existing motor memory for movement execution. Our findings demonstrate that StartReact enables a rapid release of motor programs in the very first trial also without previous practice, which might provide a behavioural advantage in situations that require a rapid response to a potentially threatening environmental stimulus.	[Sutter, Katrin; Nonnekes, Jorik; Dibilio, Valeria; Geurts, Alexander C.; Weerdesteyn, Vivian] Radboud Univ Nijmegen, Med Ctr, Donders Ctr Neurosci, Dept Rehabil, NL-6525 ED Nijmegen, Netherlands; [Dibilio, Valeria] Univ Catania, Sect Neurosci, Dept GF Ingrassia, Catania, Italy; [Geurts, Alexander C.; Weerdesteyn, Vivian] Sint Maartensklin Res, Nijmegen, Netherlands	Radboud University Nijmegen; University of Catania; Sint Maartens Clinic	Weerdesteyn, V (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Ctr Neurosci, Dept Rehabil, NL-6525 ED Nijmegen, Netherlands.	vivian.weerdesteyn@radboudumc.nl	Nonnekes, Jorik/P-6648-2015; Geurts, Alexander/H-8032-2014; Weerdesteyn, Vivian/A-9599-2014	Geurts, Alexander/0000-0001-7478-1119; Weerdesteyn, Vivian/0000-0003-4327-7600; Nonnekes, Jorik/0000-0003-2434-1427; Sutter, Katrin/0000-0002-5269-8573	Radboud University Nijmegen Medical Centre Research Grant; Netherlands Organization for Scientific Research Veni Research Grant [916.10.106]	Radboud University Nijmegen Medical Centre Research Grant; Netherlands Organization for Scientific Research Veni Research Grant	This research was funded by a Radboud University Nijmegen Medical Centre Research Grant to Jorik Nonnekes, and a Netherlands Organization for Scientific Research Veni Research Grant (916.10.106) to Vivian Weerdesteyn (http://www.nwo.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWN P, 1991, J NEUROL NEUROSUR PS, V54, P892, DOI 10.1136/jnnp.54.10.892; Campbell AD, 2013, J NEUROPHYSIOL, V110, P2236, DOI 10.1152/jn.00766.2012; Carlsen AN, 2004, J MOTOR BEHAV, V36, P253, DOI 10.3200/JMBR.36.3.253-264; Carlsen AN, 2012, CLIN NEUROPHYSIOL, V123, P21, DOI 10.1016/j.clinph.2011.04.028; Carlsen AN, 2011, NEUROSCI BIOBEHAV R, V35, P366, DOI 10.1016/j.neubiorev.2010.04.009; Delwaide PJ, 1995, ELECTROMYOGR MOTOR C, V97, P416, DOI 10.1016/0924-980X(95)00136-9; Hecht D, 2008, EXP BRAIN RES, V189, P133, DOI 10.1007/s00221-008-1410-0; Honeycutt CF, 2015, CLIN NEUROPHYSIOL, V126, P160, DOI 10.1016/j.clinph.2014.05.025; Iwanaga M, 2010, PSYCHOPHYSIOLOGY, V47, P281, DOI 10.1111/j.1469-8986.2009.00937.x; Maslovat D, 2011, BEHAV NEUROSCI, V125, P226, DOI 10.1037/a0022567; Nijhuis LBO, 2010, J NEUROPHYSIOL, V104, P2704, DOI 10.1152/jn.01080.2009; Nonnekes J, 2015, NEUROSCI BIOBEHAV R, V53, P131, DOI 10.1016/j.neubiorev.2015.04.002; Nonnekes J, 2014, J NEUROSCI, V34, P275, DOI 10.1523/JNEUROSCI.2948-13.2014; Nonnekes J, 2013, J NEUROL, V260, P2387, DOI 10.1007/s00415-013-7002-3; Sanegre MT, 2004, EXP BRAIN RES, V155, P527, DOI 10.1007/s00221-004-1849-6; Shemmell J, 2015, FRONT INTEGR NEUROSC, V9, DOI 10.3389/fnint.2015.00002; Valls-Sole J, 2005, EXP BRAIN RES, V165, P541, DOI 10.1007/s00221-005-2332-8; Valls-Sole J, 1999, J PHYSIOL-LONDON, V516, P931, DOI 10.1111/j.1469-7793.1999.0931u.x; Valls-Sole J, 2008, EXP BRAIN RES, V187, P497, DOI 10.1007/s00221-008-1402-0; Wessel JR, 2012, J NEUROSCI, V32, P7528, DOI 10.1523/JNEUROSCI.6352-11.2012; Wu T, 2008, J PHYSIOL-LONDON, V586, P4295, DOI 10.1113/jphysiol.2008.153445	21	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153129	10.1371/journal.pone.0153129	http://dx.doi.org/10.1371/journal.pone.0153129			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077654	Green Published, Green Submitted, gold			2022-12-26	WOS:000374131700024
J	Val, S; Poley, M; Brown, K; Choi, R; Jeong, S; Colberg-Poley, A; Rose, MC; Panchapakesan, KC; Devaney, JC; Perez-Losada, M; Preciado, D				Val, Stephanie; Poley, Marian; Brown, Kristy; Choi, Rachel; Jeong, Stephanie; Colberg-Poley, Annie; Rose, Mary C.; Panchapakesan, Karuna C.; Devaney, Joe C.; Perez-Losada, Marcos; Preciado, Diego			Proteomic Characterization of Middle Ear Fluid Confirms Neutrophil Extracellular Traps as a Predominant Innate Immune Response in Chronic Otitis Media	PLOS ONE			English	Article							QUALITY-CONTROL; CHILDREN; EXPRESSION; EFFUSION; MUCOSA; MUCIN; ELASTASE; ADULTS; MUC5B	Background Chronic Otitis Media (COM) is characterized by middle ear effusion (MEE) and conductive hearing loss. MEE reflect mucus hypersecretion, but global proteomic profiling of the mucosal components are limited. Objective This study aimed at characterizing the proteome of MEEs from children with COM with the goal of elucidating important innate immune responses. Method MEEs were collected from children (n = 49) with COM undergoing myringotomy. Mass spectrometry was employed for proteomic profiling in nine samples. Independent samples were further analyzed by cytokine multiplex assay, immunoblotting, neutrophil elastase activity, next generation DNA sequencing, and/or immunofluorescence analysis. Results 109 unique and common proteins were identified by MS. A majority were innate immune molecules, along with typically intracellular proteins such as histones and actin. 19.5% percent of all mapped peptide counts were from proteins known to be released by neutrophils. Immunofluorescence and immunoblotting demonstrated the presence of neutrophil extracellular traps (NETs) in every MEE, along with MUC5B colocalization. DNA found in effusions revealed unfragmented DNA of human origin. Conclusion Proteomic analysis of MEEs revealed a predominantly neutrophilic innate mucosal response in which MUC5B is associated with NET DNA. NETs are a primary macromolecular constituent of human COM middle ear effusions.	[Val, Stephanie; Poley, Marian; Choi, Rachel; Jeong, Stephanie; Preciado, Diego] Childrens Natl Hlth Syst, Sheikh Zayed Ctr Pediat Surg Innovat, Washington, DC USA; [Brown, Kristy; Colberg-Poley, Annie; Rose, Mary C.; Panchapakesan, Karuna C.; Devaney, Joe C.; Perez-Losada, Marcos] Childrens Natl Hlth Syst, Med Genet Res Ctr, Washington, DC USA; [Preciado, Diego] Childrens Natl Hlth Syst, Div Pediat Otolaryngol, Washington, DC USA	Children's National Health System; Children's National Health System; Children's National Health System	Preciado, D (corresponding author), Childrens Natl Hlth Syst, Sheikh Zayed Ctr Pediat Surg Innovat, Washington, DC USA.	dpreciad@cnmc.org	Perez-Losada, Marcos/I-4407-2013	Perez-Losada, Marcos/0000-0002-2585-4657	National Institute on Deafness and Communicative Diseases (NIDCD) [R01DC012377]; CRI; National Institute of Health (NIH) [P30HD040677]; NIH [2R24HD050846-06, NICHD 5P30HD040677, UL1TR000075]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD040677, R24HD050846] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012377] Funding Source: NIH RePORTER	National Institute on Deafness and Communicative Diseases (NIDCD); CRI; National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by R01DC012377 from the National Institute on Deafness and Communicative Diseases (NIDCD) to DP. Microscopic analysis was carried out at the Children's Research Institute (CRI) Light Microscopy and Image Analysis Core supported by CRI and National Institute of Health (NIH) grant P30HD040677. This work was partially supported by NIH core grants 2R24HD050846-06 (National Center for Medical Rehabilitation Research), NICHD 5P30HD040677 (Intellectual and Developmental Disabilities Research Center) and UL1TR000075 (NIH National Center for Advancing Translational Sciences).; Microscopic analysis was carried out at the Children's Research Institute (CRI) Light Microscopy and Image Analysis Core supported by CRI and National Institute of Health (NIH) grant P30HD040677. This work was partially supported by NIH core grants 2R24HD050846-06 (National Center for Medical Rehabilitation Research), NICHD 5P30HD040677 (Intellectual and Developmental Disabilities Research Center) and UL1TR000075 (NIH National Center for Advancing Translational Sciences). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Center for Advancing Translational Sciences or the National Institutes of Health.	Ahmed S, 2014, LARYNGOSCOPE, V124, P301, DOI 10.1002/lary.24190; Alles R, 2001, PEDIAT ALLERG IMM-UK, V12, P102, DOI 10.1046/j.0905-6157.2000.00008.x; [Anonymous], 1969, BMJ-BRIT MED J, V4, P578; Bartlett JA, 2015, DIS MODEL MECH, V8, P501, DOI 10.1242/dmm.019646; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; BROWN DT, 1985, ARCH OTOLARYNGOL, V111, P688; CARRIE S, 1992, ACTA OTO-LARYNGOL, V112, P504, DOI 10.3109/00016489209137432; Cheng OZ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00001; Cherry Donald K, 2002, Adv Data, P1; Davis MPA, 2013, METHODS, V63, P41, DOI 10.1016/j.ymeth.2013.06.027; Dworski R, 2011, J ALLERGY CLIN IMMUN, V127, P1260, DOI 10.1016/j.jaci.2010.12.1103; Grabcanovic-Musija F, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0221-7; Grubb MS, 2010, CLIN PEDIATR, V49, P970, DOI 10.1177/0009922810370363; Hall-Stoodley L, 2006, JAMA-J AM MED ASSOC, V296, P202, DOI 10.1001/jama.296.2.202; Hamaguchi S, 2014, EUR RESPIR J, V43, P1709, DOI 10.1183/09031936.00139813; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Hong WZ, 2009, J INNATE IMMUN, V1, P215, DOI 10.1159/000205937; Hurst DS, 2002, ARCH OTOLARYNGOL, V128, P561, DOI 10.1001/archotol.128.5.561; Joo NS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116756; Juhn SK, 2008, CLIN EXP OTORHINOLAR, V1, P117, DOI 10.3342/ceo.2008.1.3.117; Juneau RA, 2011, INFECT IMMUN, V79, P431, DOI 10.1128/IAI.00660-10; Kawano H, 2002, ANN OTO RHINOL LARYN, V111, P415; Keshari RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048111; King LB, 2013, OTOLARYNGOLOGY, V3; Klein JO, 2000, VACCINE, V19, pS2, DOI 10.1016/S0264-410X(00)00271-1; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee TH, 2013, ANN ALLERG ASTHMA IM, V111, P268, DOI 10.1016/j.anai.2013.06.028; LIM DJ, 1971, ANN OTO RHINOL LARYN, V80, P838, DOI 10.1177/000348947108000611; Lin JZ, 2003, JARO-J ASSOC RES OTO, V4, P384, DOI 10.1007/s10162-002-3023-9; Lin JZ, 2001, AM J PHYSIOL-LUNG C, V280, pL1157, DOI 10.1152/ajplung.2001.280.6.L1157; Liu Y, 2013, AM J PATHOL, V182, P1519, DOI 10.1016/j.ajpath.2013.01.050; Lous J, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001801.pub2; Luo LT, 2014, AM J PHYSIOL-LUNG C, V307, pL586, DOI 10.1152/ajplung.00365.2013; Matkovic S, 2007, EUR ARCH OTO-RHINO-L, V264, P1283, DOI 10.1007/s00405-007-0373-2; NAKAJIMA K, 1979, J BIOL CHEM, V254, P4027; Neeli I, 2008, J IMMUNOL, V180, P1895, DOI 10.4049/jimmunol.180.3.1895; Ondrey FG, 1998, OTOLARYNG HEAD NECK, V119, P342, DOI 10.1016/S0194-5998(98)70075-0; Perez GF, 2015, PEDIAT ALLERG IMM-UK, V26, P145, DOI 10.1111/pai.12346; Peters-Hall JR, 2015, AM J RESP CELL MOL, V53, P22, DOI 10.1165/rcmb.2014-0256RC; Preciado D, 2010, PEDIATR RES, V68, P231, DOI 10.1203/00006450-201011001-00451; Rahman S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00378; Remijsen Q, 2011, CELL DEATH DIFFER, V18, P581, DOI 10.1038/cdd.2011.1; Rosenfeld RM, 2001, OTOLARYNG HEAD NECK, V125, P440, DOI 10.1067/mhn.2001.119326; Roy MG, 2014, NATURE, V505, P412, DOI 10.1038/nature12807; Ryan AF, 2005, ANN OTO RHINOL LARYN, V114, P42, DOI 10.1177/00034894051140S106; Sade J, 1996, ANN OTO RHINOL LARYN, V105, P643, DOI 10.1177/000348949610500810; Saffarzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032366; Saieg A, 2015, PEDIATR RES, V77, P356, DOI 10.1038/pr.2014.187; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; SHAK S, 1990, P NATL ACAD SCI USA, V87, P9188, DOI 10.1073/pnas.87.23.9188; TEELE DW, 1984, PEDIATRICS, V74, P282; Thornton RB, 2014, PLOS ONE, V8; TOS M, 1977, ANN OTO RHINOL LARYN, V86, P209, DOI 10.1177/000348947708600212; Tseng CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041454; Ueki S, 2016, J ALLERGY CLIN IMMUN, V137, P258, DOI 10.1016/j.jaci.2015.04.041; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; Val S, 2015, OTITIS MEDIA STATE A, P53; Wu XF, 2011, AM J RESP CELL MOL, V45, P525, DOI 10.1165/rcmb.2010-0133OC; Zhou J, 2013, MOL CELL BIOCHEM, V377, P75, DOI 10.1007/s11010-013-1572-3	59	29	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0152865	10.1371/journal.pone.0152865	http://dx.doi.org/10.1371/journal.pone.0152865			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078692	gold, Green Published, Green Submitted			2022-12-26	WOS:000374131700010
J	Cheng, X; Waghulde, H; Mell, B; Smedlund, K; Vazquez, G; Joe, B				Cheng, Xi; Waghulde, Harshal; Mell, Blair; Smedlund, Kathryn; Vazquez, Guillermo; Joe, Bina			Pleiotropic Effect of a High Resolution Mapped Blood Pressure QTL on Tumorigenesis	PLOS ONE			English	Article							GENETIC-DETERMINANTS; COLORECTAL-CANCER; CONGENIC STRAINS; REVEALS; RAT; RAT-CHROMOSOME-10; HYPERTENSION; VARIANTS; GROWTH; REGION	This study is focused on a translationally significant, genome-wide-association-study (GWAS) locus for cardiovascular disease (QT-interval) on human chromosome 17. We have previously validated and high resolution mapped the homologous genomic segment of this human locus to <42.5 kb on rat chromosome 10. This <42.5 kb segment in rats regulates both QT-interval and blood pressure and contains a single protein-coding gene, rififylin (Rffl). The expression of Rffl in the hearts and kidneys is differential between Dahl S and S. LEW congenic rats, which are the strains used for mapping this locus. Our previous study points to altered rate of endocytic recycling as the underlying mechanism, through which Rffl operates to control both QT-interval and blood pressure. Interestingly, Rffl also contributes to tumorigenesis by repressing caspases and tumor suppressor genes. Moreover, the expression of Methyl-CpG Binding Domain Protein 2 (Mbd2) in the hearts and kidneys is also higher in the S. LEW congenic strain than the background (control) Dahl S strain. Mbd2 can repress methylated tumor suppressor genes. These data suggest that the S. LEW congenic strain could be more susceptible to tumorigenesis. To test this hypothesis, the S and S. LEW strains were compared for susceptibility to azoxymethane-induced colon tumors. The number of colon tumors was significantly higher in the S. LEW congenic strain compared with the S rat. Transcriptomic analysis confirmed that the chemical carcinogenesis pathway was significantly up-regulated in the congenic strain. These studies provide evidence for a GWAS-validated genomic segment on rat chromosome 10 as being important for the regulation of cardiovascular function and tumorigenesis.	[Cheng, Xi; Waghulde, Harshal; Mell, Blair; Smedlund, Kathryn; Vazquez, Guillermo; Joe, Bina] Univ Toledo, Coll Med & Life Sci, Dept Physiol & Pharmacol, Program Physiol Genom,Ctr Hypertens & Personalize, 2801 W Bancroft St, Toledo, OH 43606 USA	University System of Ohio; University of Toledo	Joe, B (corresponding author), Univ Toledo, Coll Med & Life Sci, Dept Physiol & Pharmacol, Program Physiol Genom,Ctr Hypertens & Personalize, 2801 W Bancroft St, Toledo, OH 43606 USA.	bina.joe@utoledo.edu	Waghulde, Harshal/V-6157-2019; Cheng, Xi/AAV-6176-2020	Cheng, Xi/0000-0002-0838-5094	National Institutes of Health [HL020176, HL112641]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL020176, R01HL112641, R01HL111877, R37HL020176] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by the National Institutes of Health, grant numbers HL020176 and HL112641, to BJ (Dr. Bina Joe) (Search URL: https://projectreporter.nih.gov/). The grant recipient (Dr. Bina Joe) played significant roles in the study design, data analysis, decision to publish and preparation of the manuscript.	Gan XQ, 2013, J BIOL CHEM, V288, P33978, DOI 10.1074/jbc.M113.477406; Garrett MR, 2001, HYPERTENSION, V38, P779, DOI 10.1161/hy1001.091503; Garrett MR, 1998, GENOME RES, V8, P711, DOI 10.1101/gr.8.7.711; Gopalakrishnan Kathirvel, 2012, Frontiers in Genetics, V3, P138, DOI 10.3389/fgene.2012.00138; Gopalakrishnan K, 2011, HYPERTENSION, V57, P764, DOI 10.1161/HYPERTENSIONAHA.110.165803; Grossman E, 2002, AM J MED, V112, P479, DOI 10.1016/S0002-9343(02)01049-5; Gulmann C, 2009, J PATHOL, V218, P514, DOI 10.1002/path.2561; Hamet P, 1996, HYPERTENSION, V28, P321, DOI 10.1161/01.HYP.28.3.321; Hendrich B, 2001, GENE DEV, V15, P710, DOI 10.1101/gad.194101; McDonald ER, 2004, P NATL ACAD SCI USA, V101, P6170, DOI 10.1073/pnas.0307459101; Newton-Cheh C, 2009, NAT GENET, V41, P399, DOI 10.1038/ng.364; Oshio H, 2008, J GASTROENTEROL, V43, P538, DOI 10.1007/s00535-008-2188-3; Pazienza V, 2012, PPAR RES, V2012, DOI 10.1155/2012/560846; Saad Y, 2008, MAMM GENOME, V19, P85, DOI 10.1007/s00335-007-9084-7; Saad Y, 2007, HYPERTENSION, V50, P891, DOI 10.1161/HYPERTENSIONAHA.107.097105; Saad Y, 2007, GENOMICS, V89, P343, DOI 10.1016/j.ygeno.2006.12.005; Schaffer BS, 2013, CANCER PREV RES, V6, P59, DOI 10.1158/1940-6207.CAPR-12-0346-T; Smedlund KB, 2015, P NATL ACAD SCI USA, V112, pE2201, DOI 10.1073/pnas.1505410112; Wajant H, 2009, RESULTS PROBL CELL D, V49, P1, DOI 10.1007/400_2008_26; Yang WS, 2007, J BIOL CHEM, V282, P3273, DOI 10.1074/jbc.M610793200; Yuan KF, 2013, GASTROENTEROLOGY, V145, P853, DOI 10.1053/j.gastro.2013.06.008	21	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153519	10.1371/journal.pone.0153519	http://dx.doi.org/10.1371/journal.pone.0153519			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073989	Green Published, Green Submitted, gold			2022-12-26	WOS:000374131200103
J	Kim, K; Hong, S; Kim, EY				Kim, Kirang; Hong, Sangmo; Kim, Eun Young			Reference Values of Skeletal Muscle Mass for Korean Children and Adolescents Using Data from the Korean National Health and Nutrition Examination Survey 2009-2011	PLOS ONE			English	Article							X-RAY ABSORPTIOMETRY; METABOLIC SYNDROME; BODY-COMPOSITION; VALIDATION; FITNESS; OBESITY; CURVES; RISK	Background Skeletal muscle mass (SMM) plays a crucial role in systemic glucose metabolism. Objective To obtain reference data on absolute and relative values of SMM for Korean children and adolescents. Methods Cross-sectional results from 1919 children and adolescents (1024 boys) aged 10-18 years that underwent dual-energy X-ray absorptiometry (DXA) during the Korean National Health and Nutrition Examination Survey 2009-2011 were analyzed. SMMs were evaluated as follows; absolute SMM (appendicular skeletal muscle mass [ASM]) and relative SMMs, namely, height-adjusted skeletal muscle index (SMI; ASM/height(2)), % SMM (ASM/weight x 100), and skeletal muscle-to-body fat ratio (MFR; ASM/body fat mass). Results Percentile curves illustrated the developmental patterns of the SMMs of Korean children and adolescents. ASM and SMI increased with age in both genders, and increased from age 10 throughout adolescence in boys, whereas in girls, they increased until age 13 and then stabilized. In boys, % SMM and MFR were highest at age 15 and then slowly stabilized or decreased, whereas in girls, they peaked at age 10 to 11 and then decreased through adolescence. Cut-off values for low MFR were identified and a significant association was found between a low MFR and high risk of metabolic syndrome. However, this association was found to be dependent on gender and the level of BMI. Conclusion This study provides reference values of absolute and relative SMM for Korean children and adolescents. Detailed body composition analyses including skeletal muscle and fat mass might provide improved measures of metabolic risk.	[Kim, Kirang] Dankook Univ, Dept Food Sci & Nutr, Yongin, South Korea; [Hong, Sangmo] Hanyang Univ, Guri Hosp, Dept Endocrinol & Metab, Gyeonggi Do, South Korea; [Kim, Eun Young] Gachon Univ, Gil Hosp, Dept Radiol, Inchon, South Korea	Dankook University; Hanyang University; Gachon University	Kim, EY (corresponding author), Gachon Univ, Gil Hosp, Dept Radiol, Inchon, South Korea.	oneshot0229@gmail.com	Hong, Sangmo/C-9515-2018; Hong, Sangmo/ABF-6388-2021	Hong, Sangmo/0000-0002-8535-0565	Gachon University Gil Hospital Research fund	Gachon University Gil Hospital Research fund	This study was supported by a grant from Gachon University Gil Hospital Research fund.	Baumgartner RN, 2000, ANN NY ACAD SCI, V904, P437; Benson AC, 2006, INT J PEDIATR OBES, V1, P222, DOI 10.1080/17477160600962864; Bonora E, 2012, NAT REV GASTRO HEPAT, V9, P372, DOI 10.1038/nrgastro.2012.79; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Despres JP, 2006, ANN MED, V38, P52, DOI 10.1080/07853890500383895; Ford ES, 2008, J PEDIATR-US, V152, P160, DOI 10.1016/j.jpeds.2007.07.056; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Kim J, 2002, AM J CLIN NUTR, V76, P378, DOI 10.1093/ajcn/76.2.378; Kim TN, 2011, DIABETES RES CLIN PR, V93, P285, DOI 10.1016/j.diabres.2011.06.013; Kim YS, 2015, CLIN PHYSL FUNCT IMA; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; McCarthy HD, 2014, PEDIATR OBES, V9, P249, DOI 10.1111/j.2047-6310.2013.00168.x; Mitsiopoulos N, 1998, J APPL PHYSIOL, V85, P115, DOI 10.1152/jappl.1998.85.1.115; Oh SW, 2011, DIABETES METAB J, V35, P561, DOI 10.4093/dmj.2011.35.6.561; Pan H, 2004, STAT MED, V23, P1749, DOI 10.1002/sim.1692; Park BS, 2013, DIABETES METAB J, V37, P458, DOI 10.4093/dmj.2013.37.6.458; Prevention KCfDCa, STAND GROWTH CHARTS; Prior BM, 1997, J APPL PHYSIOL, V83, P623, DOI 10.1152/jappl.1997.83.2.623; Steene-Johannessen J, 2009, MED SCI SPORT EXER, V41, P1361, DOI 10.1249/MSS.0b013e31819aaae5	19	34	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153383	10.1371/journal.pone.0153383	http://dx.doi.org/10.1371/journal.pone.0153383			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073844	gold, Green Published, Green Submitted			2022-12-26	WOS:000374131200079
J	Soe, NN; Wen, DJ; Poh, JS; Li, Y; Broekman, BFP; Chen, H; Chong, YS; Kwek, K; Saw, SM; Gluckman, PD; Meaney, MJ; Rifkin-Graboi, A; Qiu, AQ				Soe, Ni Ni; Wen, Daniel J.; Poh, Joann S.; Li, Yue; Broekman, Birit F. P.; Chen, Helen; Chong, Yap Seng; Kwek, Kenneth; Saw, Seang-Mei; Gluckman, Peter D.; Meaney, Michael J.; Rifkin-Graboi, Anne; Qiu, Anqi			Pre- and Post-Natal Maternal Depressive Symptoms in Relation with Infant Frontal Function, Connectivity, and Behaviors	PLOS ONE			English	Article							ANTENATAL DEPRESSION; PARENTS REPORTS; BRAIN; EEG; PSYCHOPATHOLOGY; TRAJECTORIES; PREGNANCY; DISORDER; CHILDREN; OUTCOMES	This study investigated the relationships between pre- and early post-natal maternal depression and their changes with frontal electroencephalogram (EEG) activity and functional connectivity in 6- and 18-month olds, as well as externalizing and internalizing behaviors in 24-month olds (n = 258). Neither prenatal nor postnatal maternal depressive symptoms independently predicted neither the frontal EEG activity nor functional connectivity in 6-and 18-month infants. However, increasing maternal depressive symptoms from the prenatal to postnatal period predicted greater right frontal activity and relative right frontal asymmetry amongst 6-month infants but these finding were not observed amongst 18-month infants after adjusted for post-conceptual age on the EEG visit day. Subsequently increasing maternal depressive symptoms from the prenatal to postnatal period predicted lower right frontal connectivity within 18-month infants but not among 6-month infants after controlling for post-conceptual age on the EEG visit day. These findings were observed in the full sample and the female sample but not in the male sample. Moreover, both prenatal and early postnatal maternal depressive symptoms independently predicted children's externalizing and internalizing behaviors at 24 months of age. This suggests that the altered frontal functional connectivity in infants born to mothers whose depressive symptomatology increases in the early postnatal period compared to that during pregnancy may reflect a neural basis for the familial transmission of phenotypes associated with mood disorders, particularly in girls.	[Soe, Ni Ni; Wen, Daniel J.; Poh, Joann S.; Li, Yue; Qiu, Anqi] Natl Univ Singapore, Dept Biomed Engn, Singapore 117548, Singapore; [Qiu, Anqi] Natl Univ Singapore, Clin Imaging Res Ctr, Singapore 117548, Singapore; [Poh, Joann S.; Broekman, Birit F. P.; Chong, Yap Seng; Gluckman, Peter D.; Meaney, Michael J.; Rifkin-Graboi, Anne; Qiu, Anqi] Agcy Sci Technol & Res, Singapore Inst Clin Sci, Singapore, Singapore; [Chong, Yap Seng] Natl Univ Singapore, Dept Obstet & Gynecol, Yong Loo Lin Sch Med, Natl Univ Hlth Syst, Singapore 117548, Singapore; [Chen, Helen; Kwek, Kenneth] KK Womens & Childrens Hosp, Singapore, Singapore; [Chen, Helen; Kwek, Kenneth] Duke Natl Univ Singapore, Singapore, Singapore; [Saw, Seang-Mei] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Gluckman, Peter D.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Meaney, Michael J.] McGill Univ, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Broekman, Birit F. P.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Psychol Med, Natl Univ Hlth Syst, Singapore 117595, Singapore	National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); National University of Singapore; KK Women's & Children's Hospital; National University of Singapore; National University of Singapore; University of Auckland; McGill University; National University of Singapore	Qiu, AQ (corresponding author), Natl Univ Singapore, Dept Biomed Engn, Singapore 117548, Singapore.; Qiu, AQ (corresponding author), Natl Univ Singapore, Clin Imaging Res Ctr, Singapore 117548, Singapore.; Qiu, AQ (corresponding author), Agcy Sci Technol & Res, Singapore Inst Clin Sci, Singapore, Singapore.	bieqa@nus.edu.sg	Qiu, Anqi/H-2267-2011; Wen, Daniel/ABA-4838-2021; Rifkin-Graboi, Anne/AFM-0959-2022; Rifkin-Graboi, Anne/AAH-3658-2022; Meaney, Michael/N-5931-2019	Qiu, Anqi/0000-0002-0215-6338; Wen, Daniel/0000-0002-6403-6075; Poh, Joann/0000-0002-4484-9028; Rifkin-Graboi, Anne/0000-0002-7641-4678; Chong, Yap Seng/0000-0002-7232-8473	Singapore National Research Foundation under its Translational and Clinical Research (TCR) Flagship Programme; NMRC [NMRC/CBRG/0039/2013]; Singapore Ministry of Education Academic Research Fund Tier 2 [MOE2012-T2-2-130]	Singapore National Research Foundation under its Translational and Clinical Research (TCR) Flagship Programme(National Research Foundation, Singapore); NMRC(National Medical Research Council, Singapore); Singapore Ministry of Education Academic Research Fund Tier 2(Ministry of Education, Singapore)	This research is supported by the Singapore National Research Foundation under its Translational and Clinical Research (TCR) Flagship Programme and administered by the Singapore Ministry of Health's National Medical Research Council (NMRC), Singapore-NMRC/TCR/004-NUS/2008; NMRC/TCR/012-NUHS/2014. Additional funding is provided by NMRC (NMRC/CBRG/0039/2013), and Singapore Ministry of Education Academic Research Fund Tier 2 (MOE2012-T2-2-130). All the funding received during this specific study was external to the authors' organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashman SB, 2008, DEV PSYCHOPATHOL, V20, P55, DOI 10.1017/S0954579408000035; BELL MA, 1992, CHILD DEV, V63, P1142, DOI 10.2307/1131523; Boyle MH, 1997, J CHILD PSYCHOL PSYC, V38, P981, DOI 10.1111/j.1469-7610.1997.tb01615.x; Braun K, 2011, DEV MED CHILD NEUROL, V53, P14, DOI 10.1111/j.1469-8749.2011.04056.x; Brennan PA, 2000, DEV PSYCHOL, V36, P759, DOI 10.1037/0012-1649.36.6.759; Bruder-Costello B, 2007, PSYCHIAT RES, V153, P145, DOI 10.1016/j.psychres.2007.02.013; Buss C, 2012, P NATL ACAD SCI USA, V109, pE1312, DOI 10.1073/pnas.1201295109; Cai SR, 2015, AM J CLIN NUTR, V101, P326, DOI 10.3945/ajcn.114.095414; Caspi A, 1996, ARCH GEN PSYCHIAT, V53, P1033; Chechko N, 2013, J AFFECT DISORDERS, V149, P136, DOI 10.1016/j.jad.2013.01.013; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Davis EP, 2004, INFANCY, V6, P319, DOI 10.1207/s15327078in0603_1; Dawson G, 1997, J CHILD PSYCHOL PSYC, V38, P179, DOI 10.1111/j.1469-7610.1997.tb01852.x; Degnan KA, 2010, J CHILD PSYCHOL PSYC, V51, P497, DOI 10.1111/j.1469-7610.2010.02228.x; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Diego MA, 2010, BIOL PSYCHOL, V83, P7, DOI 10.1016/j.biopsycho.2009.09.007; Eley TC, 1999, J CHILD PSYCHOL PSYC, V40, P1273, DOI 10.1017/S0021963099004734; Feng X, 2012, J ABNORM CHILD PSYCH, V40, P265, DOI 10.1007/s10802-011-9564-9; Field T, 2004, INFANT BEHAV DEV, V27, P533, DOI 10.1016/j.infbeh.2004.03.005; Field T, 2004, INFANT BEHAV DEV, V27, P216, DOI 10.1016/j.infbeh.2003.09.010; FIELD T, 1995, INFANT BEHAV DEV, V18, P1, DOI 10.1016/0163-6383(95)90003-9; Field T, 2011, INFANT BEHAV DEV, V34, P1, DOI 10.1016/j.infbeh.2010.09.008; Field T, 2010, INFANT BEHAV DEV, V33, P409, DOI 10.1016/j.infbeh.2010.04.005; Fingelkurts AA, 2006, NEUROSCI RES, V56, P133, DOI 10.1016/j.neures.2006.06.006; Fingelkurts AA, 2007, HUM BRAIN MAPP, V28, P247, DOI 10.1002/hbm.20275; FLEMING AS, 1988, DEV PSYCHOL, V24, P71, DOI 10.1037/0012-1649.24.1.71; Gopnik A, 1999, THE SCIENTIST IN THE; Huang WL, 2001, INT J DEV NEUROSCI, V19, P415, DOI 10.1016/S0736-5748(01)00026-0; Ivanova MY, 2010, J AM ACAD CHILD PSY, V49, P1215, DOI 10.1016/j.jaac.2010.08.019; Jones NA, 2001, J REPROD INFANT PSYC, V19, P295, DOI 10.1080/02646830127204; Langrock AM, 2002, J CLIN CHILD ADOLESC, V31, P312, DOI 10.1207/S15374424JCCP3103_03; Lindsley DB, 1974, ELECTROENCEPHALOGRAP, P3; Lusby CM, 2014, DEV PSYCHOBIOL, V56, P459, DOI 10.1002/dev.21112; MacMaster FP, 2014, BRAIN IMAGING BEHAV, V8, P119, DOI 10.1007/s11682-013-9264-x; Mars B, 2015, J AFFECT DISORDERS, V182, P32, DOI 10.1016/j.jad.2015.04.018; Matijasevich A, 2015, J AFFECT DISORDERS, V174, P424, DOI 10.1016/j.jad.2014.12.012; Matthey S, 2006, ARCH WOMEN MENT HLTH, V9, P309, DOI 10.1007/s00737-006-0152-x; McLaughlin KA, 2015, P NATL ACAD SCI USA, V112, P5637, DOI 10.1073/pnas.1423363112; Mormann F, 2000, PHYSICA D, V144, P358, DOI 10.1016/S0167-2789(00)00087-7; Pandit AS, 2014, CEREB CORTEX, V24, P2324, DOI 10.1093/cercor/bht086; Park S, 2014, INT J MENT HEALTH SY, V8, DOI 10.1186/1752-4458-8-44; Pawlby S, 2009, J AFFECT DISORDERS, V113, P236, DOI 10.1016/j.jad.2008.05.018; Pearson RM, 2013, JAMA PSYCHIAT, V70, P1312, DOI 10.1001/jamapsychiatry.2013.2163; Peltola MJ, 2014, DEV PSYCHOBIOL, V56, P1377, DOI 10.1002/dev.21223; Qiu A, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.3; Qiu A, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.79; Quraan MA, 2014, NEUROPSYCHOPHARMACOL, V39, P1270, DOI 10.1038/npp.2013.330; Rescorla L., 2010, MULTICULTURAL SUPPLE; Rescorla LA, 2011, J CLIN CHILD ADOLESC, V40, P456, DOI 10.1080/15374416.2011.563472; Sandman CA, 2012, PSYCHOL SCI, V23, P93, DOI 10.1177/0956797611422073; Santesso DL, 2006, CHILD PSYCHIAT HUM D, V36, P311, DOI 10.1007/s10578-005-0005-2; Schwarz EaP B D, 1994, PSYCHIATRIC CLINICS, V17, P16; Sheridan MA, 2012, P NATL ACAD SCI USA, V109, P12927, DOI 10.1073/pnas.1200041109; Soh SE, 2014, INT J EPIDEMIOL, V43, P1401, DOI 10.1093/ije/dyt125; Sohr-Preston SL, 2006, CLIN CHILD FAM PSYCH, V9, P65, DOI 10.1007/s10567-006-0004-2; Takahashi E, 2012, CEREB CORTEX, V22, P455, DOI 10.1093/cercor/bhr126; Waters CS, 2014, EUR CHILD ADOLES PSY, V23, P957, DOI 10.1007/s00787-014-0582-3; Wehry AM, 2015, J AFFECT DISORDERS, V171, P54, DOI 10.1016/j.jad.2014.09.004; Wu YP, 2011, J CHILD FAM STUD, V20, P414, DOI 10.1007/s10826-010-9407-2; Wyrwoll CS, 2012, NEUROENDOCRINOLOGY, V95, P47, DOI 10.1159/000331345	60	42	42	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152991	10.1371/journal.pone.0152991	http://dx.doi.org/10.1371/journal.pone.0152991			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UC	27073881	Green Published, Green Submitted, gold			2022-12-26	WOS:000374131200045
J	Musumari, PM; Tangmunkongvorakul, A; Srithanaviboonchai, K; Yungyuankul, S; Techasrivichien, T; Suguimoto, SP; Ono-Kihara, M; Kihara, M; Chariyalertsak, S				Musumari, Patou Masika; Tangmunkongvorakul, Arunrat; Srithanaviboonchai, Kriengkrai; Yungyuankul, Sawang; Techasrivichien, Teeranee; Suguimoto, S. Pilar; Ono-Kihara, Masako; Kihara, Masahiro; Chariyalertsak, Suwat			Prevalence and Correlates of HIV Testing among Young People Enrolled in Non-Formal Education Centers in Urban Chiang Mai, Thailand: A Cross-Sectional Study	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NORTHERN THAILAND; SOUTH-AFRICA; SEXUAL-BEHAVIOR; UNITED-STATES; ADOLESCENTS; MEN; PERCEPTIONS; PREVENTION; KNOWLEDGE	Background HIV testing is the gateway to HIV prevention, treatment, and care. Despite the established vulnerability of young Thai people to HIV infection, studies examining the prevalence and correlates of HIV testing among the general population of Thai youth are still very limited. This study investigates socio-demographic, behavioral, and psychosocial factors associated with HIV testing among young Thai people enrolled in Non-formal Education Centers (NFEC) in urban Chiang Mai, Northern Thailand. Methods This was a cross-sectional quantitative study conducted among young unmarried Thai youth-between the ages of 15 and 24-who were enrolled in NFEC in urban Chiang Mai. Multiple logistic regressions were used to identify correlates of "ever tested for HIV" among the sexually active participants. Findings Of the 295 sexually active participants, 27.3% reported "ever tested for HIV;" 65.4% "did not consistently use condom;" and 61.7%" had at least 2 lifetime partners." We found that "self-efficacy" (AOR, 4.92; CI, 1.22-19.73); "perception that it is easy to find a location nearby to test for HIV" (AOR, 4.67; CI, 1.21-18.06); "having at least 2 lifetime sexual partners" (AOR, 2.05; CI, 1.09-3.85); and "ever been pregnant or made someone pregnant" (AOR, 4.06; CI, 2.69-9.15); were associated with increased odds of having ever been tested. On the other hand, "fear of HIV test results" (AOR, 0.21; CI, 0.08-0.57) was associated with lower odds of ever having been tested for HIV. Conclusion The main finding is that a substantially high proportion of Thai youth is engaged in risky sexual behaviors-yet reports low rates of ever having been tested for HIV. This highlights an urgent need to develop appropriate interventions-based on the identified correlates of HIV testing. There is also an urgent need to enhance HIV testing and to promote safer sexual behaviors among young Thai people-particularly those who are out-of-school.	[Musumari, Patou Masika; Techasrivichien, Teeranee; Suguimoto, S. Pilar; Ono-Kihara, Masako; Kihara, Masahiro] Kyoto Univ, Sch Publ Hlth, Dept Global Hlth & Socioepidemiol, Kyoto, Japan; [Tangmunkongvorakul, Arunrat; Srithanaviboonchai, Kriengkrai; Yungyuankul, Sawang; Chariyalertsak, Suwat] Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50000, Thailand; [Srithanaviboonchai, Kriengkrai; Chariyalertsak, Suwat] Chiang Mai Univ, Fac Med, Chiang Mai 50000, Thailand; [Suguimoto, S. Pilar] Kyoto Univ, Grad Sch Med, Ctr Med Educ, Kyoto, Japan	Kyoto University; Chiang Mai University; Chiang Mai University; Kyoto University	Tangmunkongvorakul, A (corresponding author), Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50000, Thailand.	arunrat@rihes.org	Napierala, Joanna/AAU-1256-2020; ., ksrithan/AAO-2228-2020	., ksrithan/0000-0002-1683-4259; Suguimoto, S. Pilar/0000-0002-8447-9172	Chiang Mai University Center of Excellence in HIV/AIDS Research; National Research University Project under Thailand's Office of the Higher Education Commission	Chiang Mai University Center of Excellence in HIV/AIDS Research; National Research University Project under Thailand's Office of the Higher Education Commission	This study was part of the HIV/AIDS Prevention Program among out-of-school young people in Chiang Mai. It was supported by the Chiang Mai University Center of Excellence in HIV/AIDS Research, and by the National Research University Project under Thailand's Office of the Higher Education Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis Z, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-714; Aggleton P., 2000, SEX RELATSH THER, V15, P283, DOI DOI 10.1080/14681990050109863; [Anonymous], 1996, HIV AIDS COUNS GUID; Berendes S, 2011, J ASSOC NURSE AIDS C, V22, P215, DOI 10.1016/j.jana.2010.08.005; Bureau of Epidemiology, 2013, ANN EP SURV REP 2012, P103; Chamratrithirong A KS, 2007, NATIONAL SEXUAL BEHA; Chariyalertsak S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024295; Chemnasiri T, 2010, AIDS EDUC PREV, V22, P100, DOI 10.1521/aeap.2010.22.2.100; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Conway DP, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20221; de Paoli MM, 2004, AIDS CARE, V16, P411, DOI 10.1080/09540120410001683358; Fako TT, 2006, AIDS CARE, V18, P201, DOI 10.1080/09540120500456623; Fathalla MF, 2006, LANCET, V368, P2095, DOI 10.1016/S0140-6736(06)69483-X; Fernandez MI, 2005, J RURAL HEALTH, V21, P56, DOI 10.1111/j.1748-0361.2005.tb00062.x; Jejeebhoy S, 2002, ANN TECHNICAL REPORT, P122; John Cleland Rl, 2005, ASKING YOUNG PEOPLE; Kawichai S, 2006, JAIDS-J ACQ IMM DEF, V41, P186, DOI 10.1097/01.qai.0000179431.42284.3e; Kawichai S, 2005, AIDS BEHAV, V9, P233, DOI 10.1007/s10461-005-3904-0; Kilmarx PH, 2000, AIDS, V14, P2731, DOI 10.1097/00002030-200012010-00013; Kirakoya-Samadoulougou F, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-540; Klitzman RL, 2004, AIDS CARE, V16, P628, DOI 10.1080/09540120410001716423; Le Coeur S, 2009, SOC SCI MED, V69, P846, DOI 10.1016/j.socscimed.2009.05.042; MacPhail CL, 2008, HEALTH EDUC BEHAV, V35, P87, DOI 10.1177/1090198106286442; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Michael J., 2015, J SOCIAL ONTOLOGY, V1, P1; Ministry of Social Development and Human Security, 2010, PREGN THAI AD; Nhurod P, 2010, SE ASIAN J TROP MED, V41, P153; Office TNS, 2009, REPR HLTH SURV; Ostermann J, 2007, ARCH INTERN MED, V167, P2128, DOI 10.1001/archinte.167.19.2128; Peltzer K, 2013, AFR HEALTH SCI, V13, P1012, DOI 10.4314/ahs.v13i4.22; PHANUPHAK P, 1994, AIDS, V8, P1315, DOI 10.1097/00002030-199409000-00015; Phillips G, 2015, J ADOLESCENT HEALTH, V57, P407, DOI 10.1016/j.jadohealth.2015.06.014; Phimemon N, 2015, DHS WORKING PAPERS, V119; Scott-Sheldon LAJ, 2013, AJAR-AFR J AIDS RES, V12, P195, DOI 10.2989/16085906.2013.863219; Strauss M, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0922-0; Takahashi TA, 2005, J GEN INTERN MED, V20, P618, DOI 10.1111/j.1525-1497.2005.0112.x; Takarinda KC, 2014, DHS WORKING PAPERS, V110; Tangmunkongvorakul A, 2012, SE ASIAN J TROP MED, V43, P479; Tangmunkongvorakul A, 2012, ASIAN POPUL STUD, V8, P39, DOI 10.1080/17441730.2012.646837; Tangmunkongvorakul A, 2010, SE ASIAN J TROP MED, V41, P1475; Techasrivichien T, 2014, ARCH SEXUAL BEHAV; Thai National AIDS Committee, 2014, THAIL AIDS RESP PROG; Thepthien BO, 2015, ASIA-PAC J PUBLIC HE, V27, P765, DOI 10.1177/1010539515588942; UNAIDS, 2014, THAIL AIDS RESP PROG; UNAIDS, 2012, UNAIDS WORLD DAY REP; van Griensven F, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.1.e13; Vutthikraivit Possawat, 2014, Journal of the Medical Association of Thailand, V97, pS207; Wisanee Siltragool, 2007, THAI NONFORMAL ED CO; Wiwattanacheewin K, 2015, AIDS EDUC PREV, V27, P139, DOI 10.1521/aeap.2015.27.2.139; World Health Organization, 2006, PREV HIV AIDS YOUNG; Worthington C, 2003, QUAL HEALTH RES, V13, P636, DOI 10.1177/1049732303013005004; Young SD, 2010, JAIDS-J ACQ IMM DEF, V55, P620, DOI 10.1097/QAI.0b013e3181fc6429	52	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153452	10.1371/journal.pone.0153452	http://dx.doi.org/10.1371/journal.pone.0153452			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ0NI	27070553	gold, Green Published, Green Submitted			2022-12-26	WOS:000373900700070
J	Ahmad, S; Mokaddas, E; Al-Mutairi, N; Eldeen, HS; Mohammadi, S				Ahmad, Suhail; Mokaddas, Eiman; Al-Mutairi, Noura; Eldeen, Hanaa S.; Mohammadi, Shirin			Discordance across Phenotypic and Molecular Methods for Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates in a Low TB Incidence Country	PLOS ONE			English	Article							EMBB CODON 306; MULTIDRUG-RESISTANT; RPOB MUTATIONS; MONORESISTANT TUBERCULOSIS; NUCLEOTIDE POLYMORPHISMS; STREPTOMYCIN RESISTANCE; MULTICENTER EVALUATION; RIFAMPICIN-RESISTANCE; ETHAMBUTOL RESISTANCE; CULTURE-SYSTEM	With increasing incidence of multidrug-resistant tuberculosis (MDR-TB), accurate drug susceptibility testing (DST) of Mycobacterium tuberculosis to first-line drugs has become crucial for proper patient management. We evaluated concordance of DST results for 70 M. tuberculosis isolates across two phenotypic and two molecular methods: BACTEC 460TB, MGIT 960 system, GenoType MTBDRplus and DNA sequencing of gene segments most commonly implicated in conferring resistance to anti-TB drugs. Most (84%) M. tuberculosis isolates were multidrug-resistant. Twenty-four isolates yielded discrepant DST results. For rifampicin, isoniazid and streptomycin, 96%, 97% and 93% of isolates, respectively, were susceptible or resistant by all four methods, whereas for ethambutol, this agreement was observed for only 76% of isolates (P < 0.05 for rifampicin or isoniazid or streptomycin versus ethambutol). Occurrence of rare mutations in three isolates that confer low-level resistance caused lower agreement for rifampicin among the four methods (kappa coefficient (kappa) range, 0.84 to 0.95). For isoniazid, there was perfect agreement among phenotypic methods and molecular methods (kappa, 1.00) but lower agreement between phenotypic and molecular methods. Three isolates were detected as polydrug-resistant by MGIT 960 system but as multidrug-resistant by DNA sequence-based method. The agreement was higher for streptomycin among the two phenotypic methods (kappa, 0.97) while targeted sequencing yielded lower agreement (kappa range, 0.86 to 0.89). The discrepancy for ethambutol resulted largely due to lower concordance of MGIT 960 results (kappa range, 0.53 to 0.64). The MGIT 960 system is an accurate method for DST of M. tuberculosis against isoniazid and streptomycin while the results of rifampicin susceptibility should be complemented with DNA sequencing-based method when the suspicion for resistance is high. The possibility of false susceptibility to ethambutol with MGIT 960 system suggests that molecular or other phenotypic methods may be more useful when accurate ethambutol susceptibility results are warranted.	[Ahmad, Suhail; Mokaddas, Eiman; Al-Mutairi, Noura; Mohammadi, Shirin] Kuwait Univ, Fac Med, Dept Microbiol, Safat, Kuwait; [Mokaddas, Eiman; Eldeen, Hanaa S.] Kuwait Natl TB Reference Lab, Shuwaikh, Kuwait	Kuwait University	Ahmad, S (corresponding author), Kuwait Univ, Fac Med, Dept Microbiol, Safat, Kuwait.	Suhail_ah@hsc.edu.kw	Ahmad, Suhail/AAJ-5456-2021		Department of Microbiology, Faculty of Medicine; College of Graduate Studies, Kuwait University	Department of Microbiology, Faculty of Medicine; College of Graduate Studies, Kuwait University	The study was supported by internal departmental funding (Department of Microbiology, Faculty of Medicine) and in part by the College of Graduate Studies, Kuwait University.	Abal AT, 2002, MICROB DRUG RESIST, V8, P99, DOI 10.1089/107662902760190644; Ahmad S, 2007, TUBERCULOSIS, V87, P123, DOI 10.1016/j.tube.2006.05.004; Ahmad S, 2004, INT J ANTIMICROB AG, V23, P473, DOI 10.1016/j.ijantimicag.2003.10.004; Ahmad S, 2014, J INFECT PUBLIC HEAL, V7, P75, DOI 10.1016/j.jiph.2013.09.001; Ahmad S, 2012, INDIAN J MED RES, V135, P756; Ahmad S, 2009, RESP MED, V103, P1777, DOI 10.1016/j.rmed.2009.07.010; Ahuja SD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001300; Al-Mutairi NM, 2011, INT J TUBERC LUNG D, V15, P110; Alonso M, 2011, J CLIN MICROBIOL, V49, P2688, DOI 10.1128/JCM.00659-11; Angr PK, 2012, J CLIN MICROBIOL, V50, P1233, DOI 10.1128/JCM.06479-11; [Anonymous], 2003, AM J RESP CRIT CARE, V167, P603; Banu S, 2014, J CLIN MICROBIOL, V52, P156, DOI 10.1128/JCM.02378-13; Becton Dickinson, BACTEC MGIT 960 SIRE; Bemer P, 2002, J CLIN MICROBIOL, V40, P150, DOI 10.1128/JCM.40.1.150-154.2002; Brown AC, 2015, J CLIN MICROBIOL, V53, P2230, DOI 10.1128/JCM.00486-15; Cambau E, 2015, J ANTIMICROB CHEMOTH, V70, P686, DOI 10.1093/jac/dku438; Campbell PJ, 2011, ANTIMICROB AGENTS CH, V55, P2032, DOI 10.1128/AAC.01550-10; Dalton T, 2012, LANCET, V380, P1406, DOI 10.1016/S0140-6736(12)60734-X; Drobniewski F, 2012, INT J TUBERC LUNG D, V16, P860, DOI 10.5588/ijtld.12.0180; Gandhi NR, 2012, INT J TUBERC LUNG D, V16, P90, DOI 10.5588/ijtld.11.0153; Garrigo M, 2007, J CLIN MICROBIOL, V45, P1766, DOI 10.1128/JCM.02162-06; Hillemann D, 2007, J CLIN MICROBIOL, V45, P2635, DOI 10.1128/JCM.00521-07; Hoffner S, 2012, LANCET, V380, P1367, DOI 10.1016/S0140-6736(12)61069-1; Jacobson KR, 2010, CLIN INFECT DIS, V51, P6, DOI 10.1086/653115; Jureen P, 2010, J CLIN MICROBIOL, V48, P1853, DOI 10.1128/JCM.00240-10; Koser CU, 2013, NEW ENGL J MED, V369, P290, DOI 10.1056/NEJMc1215305; Kruuner A, 2006, J CLIN MICROBIOL, V44, P811, DOI 10.1128/JCM.44.3.811-818.2006; Kurbatova EV, 2012, INT J TUBERC LUNG D, V16, P355, DOI 10.5588/ijtld.11.0542; Liu CH, 2012, J INFECTION, V65, P412, DOI 10.1016/j.jinf.2012.06.007; Machado D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034538; Madison B, 2002, J CLIN MICROBIOL, V40, P3976, DOI 10.1128/JCM.40.11.3976-3979.2002; Mokaddas E, 2008, INT J TUBERC LUNG D, V12, P319; Mokaddas E, 2007, JPN J INFECT DIS, V60, P140; Mokaddas E, 2015, J CLIN MICROBIOL, V53, P1351, DOI 10.1128/JCM.03412-14; Mukinda FK, 2012, INT J TUBERC LUNG D, V16, P196, DOI 10.5588/ijtld.11.0116; Ocheretina O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090569; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Palomino JC, 2008, J MICROBIOL METH, V75, P161, DOI 10.1016/j.mimet.2008.06.015; Piersimoni C, 2006, J CLIN MICROBIOL, V44, P20, DOI 10.1128/JCM.44.1.20-28.2006; Plinke C, 2011, ANTIMICROB AGENTS CH, V55, P2891, DOI 10.1128/AAC.00007-10; Ramaswamy S., 1998, Tubercle and Lung Disease, V79, P3, DOI 10.1054/tuld.1998.0002; Ramaswamy SV, 2003, ANTIMICROB AGENTS CH, V47, P1241, DOI 10.1128/AAC.47.4.1241-1250.2003; Ramaswamy SV, 2000, ANTIMICROB AGENTS CH, V44, P326, DOI 10.1128/AAC.44.2.326-336.2000; Rigouts L, 2013, J CLIN MICROBIOL, V51, P2641, DOI 10.1128/JCM.02741-12; Safi H, 2008, ANTIMICROB AGENTS CH, V52, P2027, DOI 10.1128/AAC.01486-07; Scarparo C, 2004, J CLIN MICROBIOL, V42, P1109, DOI 10.1128/JCM.42.3.1109-1114.2004; Siddiqi SH, 1995, BACTEC 460TB SYSTEM; Spies FS, 2008, ANTIMICROB AGENTS CH, V52, P2947, DOI 10.1128/AAC.01570-07; Spies FS, 2011, J CLIN MICROBIOL, V49, P2625, DOI 10.1128/JCM.00168-11; Starks AM, 2009, ANTIMICROB AGENTS CH, V53, P1061, DOI 10.1128/AAC.01357-08; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; Tortoli E, 2002, J CLIN MICROBIOL, V40, P607, DOI 10.1128/JCM.40.2.607-610.2002; Van Deun A, 2015, INT J TUBERC LUNG D, V19, P185, DOI 10.5588/ijtld.14.0651; Van Deun A, 2010, INT J TUBERC LUNG D, V14, P131; Van Deun A, 2009, J CLIN MICROBIOL, V47, P3501, DOI 10.1128/JCM.01209-09; Van Deun A, 2013, J CLIN MICROBIOL, V51, P2633, DOI 10.1128/JCM.00553-13; van Ingen J, 2011, INT J TUBERC LUNG D, V15, P990, DOI 10.5588/ijtld.10.0127; Velayati AA, 2014, AM J TROP MED HYG, V90, P99, DOI 10.4269/ajtmh.13-0057; Walker TM, 2015, LANCET INFECT DIS, V15, P1193, DOI 10.1016/S1473-3099(15)00062-6; WHO, 1998, INT J TUBERC LUNG D, V2, P71; WHO, 2014, WHOHQTB201412; Witney AA, 2015, J CLIN MICROBIOL, V53, P1473, DOI 10.1128/JCM.02993-14; World Health Organization, 2011, WHOHTMTB20112; World Health Organization, 2015, WHOHTMTB201522; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7; Yakrus MA, 2014, J CLIN MICROBIOL, V52, P1932, DOI 10.1128/JCM.00417-14; Zhang HT, 2013, NAT GENET, V45, P1255, DOI 10.1038/ng.2735; Zhang Y, 2015, INT J TUBERC LUNG D, V19, P1276, DOI 10.5588/ijtld.15.0389; Zhang Y, 2009, INT J TUBERC LUNG D, V13, P1320; Zignol M, 2013, DRUG RESIST UPDATE, V16, P108, DOI 10.1016/j.drup.2014.02.003	70	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153563	10.1371/journal.pone.0153563	http://dx.doi.org/10.1371/journal.pone.0153563			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096759	gold, Green Published, Green Submitted			2022-12-26	WOS:000374543600042
J	Echternach, M; Burk, F; Burdumy, M; Traser, L; Richter, B				Echternach, Matthias; Burk, Fabian; Burdumy, Michael; Traser, Louisa; Richter, Bernhard			Morphometric Differences of Vocal Tract Articulators in Different Loudness Conditions in Singing	PLOS ONE			English	Article							REAL-TIME MRI; INTENSITY VARIATION; RESONANCE; SINGERS; VOICE; CONFIGURATIONS; FORMANT; PHONATION; PRESSURE; REGISTER	Introduction Dynamic MRI analysis of phonation has gathered interest in voice and speech physiology. However, there are limited data addressing the extent to which articulation is dependent on loudness. Material and Methods 12 professional singer subjects of different voice classifications were analysed concerning the vocal tract profiles recorded with dynamic real-time MRI with 25fps in different pitch and loudness conditions. The subjects were asked to sing ascending scales on the vowel /a/in three loudness conditions (comfortable = mf, very soft = pp, very loud = ff, respectively). Furthermore, fundamental frequency and sound pressure level were analysed from the simultaneously recorded optical audio signal after noise cancellation. Results The data show articulatory differences with respect to changes of both pitch and loudness. Here, lip opening and pharynx width were increased. While the vertical larynx position was rising with pitch it was lower for greater loudness. Especially, the lip opening and pharynx width were more strongly correlated with the sound pressure level than with pitch. Conclusion For the vowel /a/loudness has an effect on articulation during singing which should be considered when articulatory vocal tract data are interpreted.	[Echternach, Matthias; Burk, Fabian; Burdumy, Michael; Traser, Louisa; Richter, Bernhard] Univ Freiburg, Med Ctr, Inst Musicians Med, Breisacher Str 60, D-79106 Freiburg, Germany; [Burdumy, Michael] Univ Freiburg, Med Ctr, Dept Med Phys, Radiol, Breisacher Str 60, D-79106 Freiburg, Germany; [Traser, Louisa] Univ Freiburg, Med Ctr, Dept Otorhinolaryngol, Kilianstr 5, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg	Echternach, M (corresponding author), Univ Freiburg, Med Ctr, Inst Musicians Med, Breisacher Str 60, D-79106 Freiburg, Germany.	matthias.echternach@uniklinik-freiburg.de	Burdumy, Michael/M-6212-2017	Burdumy, Michael/0000-0003-4577-5515; Echternach, Matthias/0000-0003-0095-5360	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study is funded by the Deutsche Forschungsgemeinschaft. The funder had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2009, J VOICE, V23, P235, DOI 10.1016/j.jvoice.2007.08.008; Bernardoni NH, 2014, J ACOUST SOC AM, V135, P491, DOI 10.1121/1.4836255; Bjorklund S, 2016, J VOICE, V30, P15, DOI 10.1016/j.jvoice.2015.03.006; BOUHUYS A, 1968, ANN NY ACAD SCI, V155, P165, DOI 10.1111/j.1749-6632.1968.tb56760.x; Bresch E, 2006, J ACOUST SOC AM, V120, P1791, DOI 10.1121/1.2335423; Bresch E, 2010, J ACOUST SOC AM, V128, pEL335, DOI 10.1121/1.3499700; Bunch M, 2000, J VOICE, V14, P363, DOI 10.1016/S0892-1997(00)80081-8; Burdumy M, 2015, J MAGN RESON IMAGING, V42, P925, DOI 10.1002/jmri.24857; Echternach M, 2008, LOGOP PHONIATR VOCO, V33, P67, DOI 10.1080/14015430701875653; Echternach M, 2015, J ACOUST SOC AM, V137, P2586, DOI 10.1121/1.4919356; Echternach M, 2014, J VOICE, V28, DOI 10.1016/j.jvoice.2014.01.011; Echternach M, 2014, J VOICE, V28, DOI 10.1016/j.jvoice.2013.10.009; Echternach M, 2012, CURR OPIN OTOLARYNGO, V20, P450, DOI 10.1097/MOO.0b013e3283585f87; Echternach M, 2011, J VOICE, V25, P670, DOI 10.1016/j.jvoice.2010.09.008; Echternach M, 2011, LOGOP PHONIATR VOCO, V36, P109, DOI 10.3109/14015439.2011.566576; Echternach M, 2010, FOLIA PHONIATR LOGO, V62, P278, DOI 10.1159/000312668; Echternach M, 2010, J VOICE, V24, P133, DOI 10.1016/j.jvoice.2008.06.004; ESTILL J, 1988, MED PROBL PERFORM AR, V3, P37; Fant G, 1960, ACOUSTIC THEORY SPEE, P51; Fu MJ, 2015, MAGN RESON MED, V73, P1820, DOI 10.1002/mrm.25302; Garnier M, 2010, J ACOUST SOC AM, V127, P3771, DOI 10.1121/1.3419907; Garnier M, 2010, J SPEECH LANG HEAR R, V53, P588, DOI 10.1044/1092-4388(2009/08-0138); Herbst CT, 2015, J VOICE, V29, P391, DOI 10.1016/j.jvoice.2014.08.009; HIRANO M, 1970, FOLIA PHONIATR, V22, P1, DOI 10.1159/000263363; Hirano M., 1988, J VOICE, V2, P51, DOI [10.1016/S0892-1997(88)80058-4, DOI 10.1016/S0892-1997(88)80058-4]; Horacek J, 2009, FOLIA PHONIATR LOGO, V61, P137, DOI 10.1159/000219949; Inouye JM, 2014, J ACOUST SOC AM, V135, P1019, DOI 10.1121/1.4864482; ISSHIKI N, 1964, J SPEECH HEAR RES, V7, P17, DOI 10.1044/jshr.0701.17; Joliveau E, 2004, NATURE, V427, P116, DOI 10.1038/427116a; Lombard E, 1911, ANN MALADIES OREILLE, P101; Luchsinger R, 1970, HDB STIMM SPRACHHEIL, P125; Mainka A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132241; NeuschaeferRube C, 1996, FOLIA PHONIATR LOGO, V48, P201, DOI 10.1159/000266409; Niebergall A, 2013, MAGN RESON MED, V69, P477, DOI 10.1002/mrm.24276; Nunthayanon K, 2015, OR SURG OR MED OR PA, V119, P684, DOI 10.1016/j.oooo.2015.03.003; Osborne C, 1979, HIFIDELITY, V29, P57; Proctor M, 2013, J ACOUST SOC AM, V133, P1043, DOI 10.1121/1.4773865; Raol N, 2015, ADV OTO-RHINO-LARYNG, V76, P27, DOI 10.1159/000368011; Roers F, 2009, J ACOUST SOC AM, V125, P503, DOI 10.1121/1.3026326; Rothenberg M, 1981, VOCAL FOLD PHYSL, P305; Shipp T, 1984, J RES SINGING, V7, P5; SONNINEN A A, 1956, Acta Otolaryngol Suppl, V130, P1; STATHOPOULOS ET, 1993, J SPEECH HEAR RES, V36, P64, DOI 10.1044/jshr.3601.64; SUNDBERG J, 1975, ACUSTICA, V32, P89; SUNDBERG J, 1974, J ACOUST SOC AM, V55, P838, DOI 10.1121/1.1914609; SUNDBERG J, 1993, J VOICE, V7, P301, DOI 10.1016/S0892-1997(05)80118-3; Sundberg J., 1979, FRONTIERS FRONTIERS, P301; Sundberg J., 1987, SCI SINGING VOICE; Sundberg J, 2011, PROFESSIONAL MALE SI; Sundberg J, 2013, J VOICE, V27, P278, DOI 10.1016/j.jvoice.2012.12.002; Sundberg J, 2009, J VOICE, V23, P546, DOI 10.1016/j.jvoice.2008.02.003; Titze IR, 2008, J ACOUST SOC AM, V123, P2733, DOI 10.1121/1.2832337; Titze IR, 2015, J ACOUST SOC AM, V137, P3005, DOI 10.1121/1.4919349; Titze IR, 1994, PRINCIPLES VOICE PRO; Traser L, 2013, J VOICE, V27, P141, DOI 10.1016/j.jvoice.2012.11.002; WEIN B, 1995, ROFO FORTSCHR RONTG, V162, P99, DOI 10.1055/s-2007-1015844; Woo Jonghye, 2014, J Speech Lang Hear Res, V57, pS626, DOI 10.1044/2014_JSLHR-S-12-0208; Xing FX, 2013, LECT NOTES COMPUT SC, V8151, P41, DOI 10.1007/978-3-642-40760-4_6; Zanartu M, 2014, J ACOUST SOC AM, V136, P3262, DOI 10.1121/1.4901714; Zanartu M, 2011, J ACOUST SOC AM, V129, P326, DOI 10.1121/1.3514536; Zvyagintsev M, 2010, J MAGN RESON IMAGING, V32, P705, DOI 10.1002/jmri.22285	61	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153792	10.1371/journal.pone.0153792	http://dx.doi.org/10.1371/journal.pone.0153792			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9OU	27096935	gold, Green Submitted, Green Published			2022-12-26	WOS:000374543600058
J	Gurkov, R; Strobl, R; Heinlin, N; Krause, E; Olzowy, B; Koppe, C; Grill, E				Guerkov, Robert; Strobl, Ralf; Heinlin, Nina; Krause, Eike; Olzowy, Bernhard; Koppe, Christina; Grill, Eva			Atmospheric Pressure and Onset of Episodes of Meniere's Disease - A Repeated Measures Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; SUBARACHNOID HEMORRHAGE; BAROMETRIC-PRESSURE; NATRIURETIC-PEPTIDE; ENDOLYMPHATIC SAC; HEARING-LOSS; LONG-TERM; EAR; PREVALENCE; WEATHER	Background External changes of air pressure are transmitted to the middle and inner ear and may be used therapeutically in Meniere's disease, one of the most common vertigo disorders. We analyzed the possible relationship of atmospheric pressure and other meteorological parameters with the onset of MD vertigo episodes in order to determine whether atmospheric pressure changes play a role in the occurrence of MD episodes. Methods Patients of a tertiary outpatient dizziness clinic diagnosed with MD were asked to keep a daily vertigo diary to document MD episodes (2004-2009). Local air pressure, absolute temperature and dew point temperature were acquired on an hourly basis. Change in meteorological parameters was conceptualized as the maximum difference in a 24 hour time frame preceding each day. Effects were estimated using additive mixed models with a random participant effect. We included lagged air parameters, age, sex, weekday and season in the model. Results A total of 56 persons (59% female) with mean age 54 years were included. Mean follow-up time was 267 days. Persons experienced on average 10.3 episodes during the observation period (median 8). Age and change in air pressure were significantly associated with vertigo onset risk (Odds Ratio = 0.979 and 1.010). We could not show an effect of sex, weekday, season, air temperature, and dew point temperature. Conclusions Change in air pressure was significantly associated with onset of MD episodes, suggesting a potential triggering mechanism in the inner ear. MD patients may possibly use air pressure changes as an early warning system for vertigo attacks in the future.	[Guerkov, Robert; Heinlin, Nina; Krause, Eike; Olzowy, Bernhard] Univ Munich, Dept Otorhinolaryngol Head & Neck Surg, Marchioninistr 15, D-81377 Munich, Germany; [Guerkov, Robert; Strobl, Ralf; Grill, Eva] Univ Munich, German Ctr Vertigo & Balance Disorders, Marchioninistr 15, D-81377 Munich, Germany; [Strobl, Ralf; Grill, Eva] Univ Munich, Inst Med Informat Proc Biometr & Epidemiol IBE, Marchioninistr 17, D-81377 Munich, Germany; [Koppe, Christina] German Meteorol Serv, Frankfurter Str 135, D-63067 Offenbach, Germany	University of Munich; University of Munich; University of Munich; Deutscher Wetterdienst	Gurkov, R (corresponding author), Univ Munich, Dept Otorhinolaryngol Head & Neck Surg, Marchioninistr 15, D-81377 Munich, Germany.; Gurkov, R (corresponding author), Univ Munich, German Ctr Vertigo & Balance Disorders, Marchioninistr 15, D-81377 Munich, Germany.	robert.guerkov@med.uni-muenchen.de	Grill, Eva/AAF-8104-2020; Grill, Eva/D-1875-2010; Gürkov, Robert/K-3536-2013	Grill, Eva/0000-0002-0273-7984; Grill, Eva/0000-0002-0273-7984; Gürkov, Robert/0000-0002-4195-149X				Adrion C, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6816; Anderson JP, 2001, OTOL NEUROTOL, V22, P888, DOI 10.1097/00129492-200111000-00030; AULICIEMS A, 1989, INT J BIOMETEOROL, V33, P215, DOI 10.1007/BF01051080; BROWN DH, 1988, LARYNGOSCOPE, V98, P599; Buxton N, 2001, J NEUROSURG, V95, P391, DOI 10.3171/jns.2001.95.3.0391; CARLBORG B, 1982, ANN OTO RHINOL LARYN, V91, P209, DOI 10.1177/000348948209100219; CELESTINO D, 1987, Acta Oto-Rhino-Laryngologica Belgica, V41, P951; Didyk LA, 2007, HEARING RES, V223, P20, DOI 10.1016/j.heares.2006.09.009; Dornhoffer JL, 2002, ARCH OTOLARYNGOL, V128, P379, DOI 10.1001/archotol.128.4.379; Duwel P, 2003, NEUROSCIENCE, V116, P963, DOI 10.1016/S0306-4522(02)00776-5; Gates GA, 2004, ARCH OTOLARYNGOL, V130, P718, DOI 10.1001/archotol.130.6.718; Grosse E., 1992, STAT MODELS S; Gurkov R, 2012, J LARYNGOL OTOL, V128, P356, DOI 10.1017/S0022215112000102; Harris JP, 2010, AUDIOL NEURO-OTOL, V15, P318, DOI 10.1159/000286213; Havia M, 2005, OTOLARYNG HEAD NECK, V133, P762, DOI 10.1016/j.otohns.2005.06.015; Hoffmann J, 2011, J NEUROL, V258, P596, DOI 10.1007/s00415-010-5798-7; Hofman R, 2008, EUR ARCH OTO-RHINO-L, V265, P153, DOI 10.1007/s00405-007-0424-8; JEHLE D, 1994, AM J EMERG MED, V12, P90, DOI 10.1016/0735-6757(94)90209-7; JONAS J, 1986, KLIN MONATSBL AUGENH, V189, P445, DOI 10.1055/s-2008-1050850; Kinney SE, 1997, AM J OTOL, V18, P67; Landers AT, 1997, BRIT J NEUROSURG, V11, P191, DOI 10.1080/02688699746230; Levo H, 2010, ANN OTO RHINOL LARYN, V119, P583, DOI 10.1177/000348941011900903; Luo Y, 2015, BIOMED REP, V3, P159, DOI 10.3892/br.2014.400; MIZUKOSHI K, 1995, ACTA OTO-LARYNGOL, P412; MONSELL EM, 1995, OTOLARYNG HEAD NECK, V113, P181, DOI 10.1016/S0194-5998(95)70102-8; Mygind SH, 1938, ANN OTO RHINOL LARYN, V47, P768; Mygind SH, 1938, ANN OTO RHINOL LARYN, V47, P360; Mygind SH, 1938, ANN OTO RHINOL LARYN, V47, P938; Mygind SH, 1938, ANN OTO RHINOL LARYN, V47, P55; NAITO Y, 1988, ARCH OTO-RHINO-LARYN, V245, P321, DOI 10.1007/BF00464641; NISHIHARA S, 1992, AM J OTOL, V13, P364; Pereira AB, 2015, CHRONOBIOL INT, V32, P585, DOI 10.3109/07420528.2015.1014094; Preyer S, 1996, LARYNGO RHINO OTOL, V75, P443, DOI 10.1055/s-2007-997612; R Core Team, 2014, LANG ENV STAT COMP; Salt AN, 2004, HEARING RES, V191, P90, DOI 10.1016/j.heares.2003.12.018; SCHUKNECHT HAROLD F., 1963, LARYNGOSCOPE, V73, P651; Setzer M, 2007, SURG NEUROL, V67, P264, DOI 10.1016/j.surneu.2006.06.060; TONNDORF J, 1975, OTOLARYNG CLIN N AM, V8, P303; WLADISLAVOSKYWASERMAN P, 1984, LARYNGOSCOPE, V94, P1098; Yoon YJ, 2012, LARYNGOSCOPE, V122, P1605, DOI 10.1002/lary.23235; Zebenholzer K, 2011, CEPHALALGIA, V31, P391, DOI 10.1177/0333102410385580; ZECHNER G, 1980, LARYNG RHINOL OTOL V, V59, P829, DOI 10.1055/s-2007-1016415	42	10	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0152714	10.1371/journal.pone.0152714	http://dx.doi.org/10.1371/journal.pone.0152714			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096752	Green Published, gold, Green Submitted			2022-12-26	WOS:000374543600017
J	Koller, T; Kurze, D; Lange, M; Scherdin, M; Podbielski, A; Warnke, P				Koeller, Thomas; Kurze, Daniel; Lange, Mirjam; Scherdin, Martin; Podbielski, Andreas; Warnke, Philipp			Implementation and Evaluation of a Fully Automated Multiplex Real-Time PCR Assay on the BD Max Platform to Detect and Differentiate Herpesviridae from Cerebrospinal Fluids	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; VARICELLA-ZOSTER-VIRUS; POLYMERASE-CHAIN-REACTION; CENTRAL-NERVOUS-SYSTEM; MOLLARETS MENINGITIS; CLINICAL-SAMPLES; NUCLEIC-ACID; NEUROLOGICAL DISEASE; VIRAL LOAD; HSV DNA	A fully automated multiplex real-time PCR assay-including a sample process control and a plasmid based positive control-for the detection and differentiation of herpes simplex virus 1 (HSV1), herpes simplex virus 2 (HSV2) and varicella-zoster virus (VZV) from cerebrospinal fluids (CSF) was developed on the BD Max platform. Performance was compared to an established accredited multiplex real time PCR protocol utilizing the easyMAG and the LightCycler 480/II, both very common devices in viral molecular diagnostics. For clinical validation, 123 CSF specimens and 40 reference samples from national interlaboratory comparisons were examined with both methods, resulting in 97.6% and 100% concordance for CSF and reference samples, respectively. Utilizing the BD Max platform revealed sensitivities of 173 (CI 95%, 88-258) copies/ml for HSV1, 171 (CI 95%, 148-194) copies/ml for HSV2 and 84 (CI 95%, 5-163) copies/ml for VZV. Cross reactivity could be excluded by checking 25 common viral, bacterial and fungal human pathogens. Workflow analyses displayed shorter test duration as well as remarkable fewer and easier preparation steps with the potential to reduce error rates occurring when manually assessing patient samples. This protocol allows for a fully automated PCR assay on the BD Max platform for the simultaneously detection of herpesviridae from CSF specimens. Singular or multiple infections due to HSV1, HSV2 and VZV can reliably be differentiated with good sensitivities. Control parameters are included within the assay, thereby rendering its suitability for current quality management requirements.	[Koeller, Thomas; Kurze, Daniel; Lange, Mirjam; Scherdin, Martin; Podbielski, Andreas; Warnke, Philipp] Rostock Univ Hosp, Inst Med Microbiol Virol & Hyg, Rostock, Germany	University of Rostock	Warnke, P (corresponding author), Rostock Univ Hosp, Inst Med Microbiol Virol & Hyg, Rostock, Germany.	philipp.warnke@med.uni-rostock.de						Aberle SW, 2005, MED MICROBIOL IMMUN, V194, P7, DOI 10.1007/s00430-003-0202-1; Aberle SW, 2002, J CLIN VIROL, V25, pS79, DOI 10.1016/S1386-6532(02)00037-9; Bennett S, 2013, J VIROL METHODS, V189, P143, DOI 10.1016/j.jviromet.2012.08.020; BERGER JR, 1991, LANCET, V337, P1360, DOI 10.1016/0140-6736(91)93051-A; Binnicker MJ, 2014, J CLIN MICROBIOL, V52, P4361, DOI 10.1128/JCM.02623-14; Boutolleau D, 2003, J INFECT DIS, V187, P179, DOI 10.1086/367677; Buelow DR, 2013, J CLIN VIROL, V58, P84, DOI 10.1016/j.jcv.2013.05.008; Cardenas AM, 2014, J CLIN MICROBIOL, V52, P4375, DOI 10.1128/JCM.02237-14; Corey L, 2005, J MED VIROL, V76, P350, DOI 10.1002/jmv.20365; Corey L, 2009, NEW ENGL J MED, V361, P1376, DOI 10.1056/NEJMra0807633; Enbom M, 2000, J MED VIROL, V62, P498, DOI 10.1002/1096-9071(200012)62:4&lt;498::AID-JMV15&gt;3.0.CO;2-B; Enbom M, 2001, SEX TRANSM DIS, V28, P300, DOI 10.1097/00007435-200105000-00013; Fan FN, 2014, FUTURE VIROL, V9, P721, DOI 10.2217/FVL.14.61; Fan FN, 2014, J CLIN MICROBIOL, V52, P3799, DOI 10.1128/JCM.02098-14; Farazmand P, 2011, INT J STD AIDS, V22, P306, DOI 10.1258/ijsa.2010.010405; Filen F, 2004, SEX TRANSM DIS, V31, P331, DOI 10.1097/00007435-200406000-00002; Heaton PR, 2015, DIAGN MICR INFEC DIS, V81, P169, DOI 10.1016/j.diagmicrobio.2014.11.012; Hobson-Peters J, 2007, MOL CELL PROBE, V21, P24, DOI 10.1016/j.mcp.2006.07.002; Hodgson J, 2007, J CLIN VIROL, V38, P217, DOI 10.1016/j.jcv.2006.12.014; Klapper Paul E., 1998, Clin Microbiol Infect, V4, P178, DOI 10.1111/j.1469-0691.1998.tb00665.x; Letertre C, 2003, MOL CELL PROBE, V17, P307, DOI 10.1016/j.mcp.2003.08.004; Leveque N, 2014, J CLIN MICROBIOL, V52, P212, DOI 10.1128/JCM.02270-13; Lundberg R, 2006, ANTICANCER RES, V26, P3627; Mengelle C, 2004, J MED VIROL, V74, P459, DOI 10.1002/jmv.20198; Mousavi-Jazi M, 2003, J CLIN VIROL, V26, P301, DOI 10.1016/S1386-6532(02)00046-X; Murphy RF, 2009, AM J CLIN PATHOL, V132, P687, DOI 10.1309/AJCP0KN1PCHEYSIK; Nakajima H, 1998, EUR NEUROL, V39, P163, DOI 10.1159/000007927; Petersen M, 2003, TRENDS BIOTECHNOL, V21, P74, DOI 10.1016/S0167-7799(02)00038-0; PICARD FJ, 1993, NEUROLOGY, V43, P1722, DOI 10.1212/WNL.43.9.1722; Pillet S, 2015, J CLIN MICROBIOL, V53, P1921, DOI 10.1128/JCM.03692-14; Poissy J, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-356; Roizman B, 2001, Herpes, V8, P23; Rottenstreich A, 2014, DIAGN MICR INFEC DIS, V79, P174, DOI 10.1016/j.diagmicrobio.2014.02.015; Sankuntaw N, 2011, MOL CELL PROBE, V25, P114, DOI 10.1016/j.mcp.2011.03.004; Schloss L, 2003, J CLIN VIROL, V28, P175, DOI 10.1016/S1386-6532(03)00003-9; Schloss L, 2009, J MED VIROL, V81, P1432, DOI 10.1002/jmv.21563; Singh SK, 1998, CHEM COMMUN, P455, DOI 10.1039/a708608c; Stahl JP, 2012, EPIDEMIOL INFECT, V140, P372, DOI 10.1017/S0950268811000483; Steiner I, 2009, J NEUROVIROL; Steiner I, 2007, LANCET NEUROL, V6, P1015, DOI 10.1016/S1474-4422(07)70267-3; Sugita S, 2008, BRIT J OPHTHALMOL, V92, P928, DOI 10.1136/bjo.2007.133967; Sunden B, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-220; Tan TY, 2013, DIAGN MOL PATHOL, V22, P245, DOI 10.1097/PDM.0b013e3182914291; Tang JW, 2010, J MED VIROL, V82, P1911, DOI 10.1002/jmv.21903; van Nierop GP, 2014, J NEUROVIROL, V20, P412, DOI 10.1007/s13365-014-0248-4; Venkatesan A, 2013, CLIN INFECT DIS, V57, P1114, DOI 10.1093/cid/cit458; WHITLEY R, 1991, NEW ENGL J MED, V324, P450, DOI 10.1056/NEJM199102143240704; Ziyaeyan M, 2011, BRAZ J INFECT DIS, V15, P211, DOI [10.1590/S1413-86702011000300005, 10.1016/S1413-8670(11)70177-5]	48	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153991	10.1371/journal.pone.0153991	http://dx.doi.org/10.1371/journal.pone.0153991			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27092772	Green Published, gold			2022-12-26	WOS:000374541200067
J	Massolt, ET; Effraimidis, G; Korevaar, TIM; Wiersinga, WM; Visser, WE; Peeters, RP; Drexhage, HA				Massolt, Elske T.; Effraimidis, Grigoris; Korevaar, Tim I. M.; Wiersinga, Wilmar M.; Visser, W. Edward; Peeters, Robin P.; Drexhage, Hemmo A.			Aberrant Levels of Hematopoietic/Neuronal Growth and Differentiation Factors in Euthyroid Women at Risk for Autoimmune Thyroid Disease	PLOS ONE			English	Article							BIPOLAR DISORDER; SIGNALING PATHWAYS; FEMALE RELATIVES; MOOD DISORDERS; HYPOTHYROIDISM; PREVALENCE; SCHIZOPHRENIA; EPIDEMIOLOGY; DEPRESSION; BIOMARKERS	Background Subjects at risk for major mood disorders have a higher risk to develop autoimmune thyroid disease (AITD) and vice-versa, implying a shared pathogenesis. In mood disorder patients, an abnormal profile of hematopoietic/neuronal growth factors is observed, suggesting that growth/differentiation abnormalities of these cell lineages may predispose to mood disorders. The first objective of our study was to investigate whether an aberrant profile of these hematopoietic/neuronal growth factors is also detectable in subjects at risk for AITD. A second objective was to study the inter relationship of these factors with previously determined and published growth factors/cytokines in the same subjects. Methods We studied 64 TPO-Ab-negative females with at least 1 first-or second-degree relative with AITD, 32 of whom did and 32 who did not seroconvert to TPO-Ab positivity in 5-year follow-up. Subjects were compared with 32 healthy controls (HCs). We measured serum levels of brain-derived neurotrophic factor (BDNF), Stem Cell Factor (SCF), Insulin-like Growth Factor-Binding Protein 2 (IGFBP-2), Epidermal Growth Factor (EGF) and IL-7 at baseline. Results BDNF was significantly lower (8.2 vs 18.9 ng/ml, P<0.001), while EGF (506.9 vs 307.6 pg/ml, P = 0.003) and IGFBP-2 (388.3 vs 188.5 ng/ml, P = 0.028) were significantly higher in relatives than in HCs. Relatives who seroconverted in the next 5 years had significantly higher levels of SCF than non-seroconverters (26.5 vs 16.7 pg/ml, P = 0.017). In a cluster analysis with the previously published growth factors/cytokines SCF clustered together with IL-1 beta, IL-6 and CCL-3, of which high levels also preceded seroconversion. Conclusion Relatives of AITD patients show aberrant serum levels of 4 hematopoietic/ neuronal growth factors similar to the aberrancies found in mood disorder patients, suggesting that shared growth and differentiation defects in both the hematopoietic and neuronal system may underlie thyroid autoimmunity and mood disorders. A distinct pattern of four inter correlating immune factors in the relatives preceded TPO-Ab seroconversion in the next 5 years.	[Massolt, Elske T.; Korevaar, Tim I. M.; Visser, W. Edward; Peeters, Robin P.] Erasmus MC, Dept Internal Med, Div Endocrinol, NL-3000 CA Rotterdam, Netherlands; [Massolt, Elske T.; Korevaar, Tim I. M.; Visser, W. Edward; Peeters, Robin P.] Erasmus MC, Dept Internal Med, Rotterdam Thyroid Ctr, NL-3000 CA Rotterdam, Netherlands; [Effraimidis, Grigoris] Nykobing Falster Hosp, Dept Internal Med, Endocrinol Sect, Fjordvej 15, DK-4800 Nykobing, Denmark; [Wiersinga, Wilmar M.] Univ Amsterdam, Acad Med Ctr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Drexhage, Hemmo A.] Erasmus MC, Dept Immunol, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Erasmus University Rotterdam; Erasmus MC	Massolt, ET (corresponding author), Erasmus MC, Dept Internal Med, Div Endocrinol, NL-3000 CA Rotterdam, Netherlands.; Massolt, ET (corresponding author), Erasmus MC, Dept Internal Med, Rotterdam Thyroid Ctr, NL-3000 CA Rotterdam, Netherlands.	e.massolt@erasmusmc.nl	Korevaar, Tim I.M./ABF-6688-2020; Visser, W. Edward/C-4062-2015	Peeters, Robin/0000-0001-7732-9371; Visser, W. Edward/0000-0002-5248-863X	PSYCHAID, seventh framework program, IAPP [286334]; Zon-MW TOP grant [91212044]; Erasmus MC MRACE grant	PSYCHAID, seventh framework program, IAPP; Zon-MW TOP grant; Erasmus MC MRACE grant	HAD was supported by: PSYCHAID, seventh framework program, IAPP, 286334. RPP was supported by: Zon-MW TOP grant ( number 91212044) and an Erasmus MC MRACE grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelli A, 2004, J CLIN ENDOCR METAB, V89, P5496, DOI 10.1210/jc.2004-0977; Benros ME, 2013, JAMA PSYCHIAT, V70, P812, DOI 10.1001/jamapsychiatry.2013.1111; Beumer W, 2013, J CLIN ENDOCR METAB, V98, P2460, DOI 10.1210/jc.2012-4122; Brunoni AR, 2008, INT J NEUROPSYCHOPH, V11, P1169, DOI 10.1017/S1461145708009309; Canaris GJ, 2000, ARCH INTERN MED, V160, P526, DOI 10.1001/archinte.160.4.526; Carta MG, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-25; Caturegli P, 2014, AUTOIMMUN REV, V13, P391, DOI 10.1016/j.autrev.2014.01.007; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Constant EL, 2001, J CLIN ENDOCR METAB, V86, P3864, DOI 10.1210/jc.86.8.3864; Domenici E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009166; Effraimidis G, 2009, J CLIN ENDOCR METAB, V94, P1324, DOI 10.1210/jc.2008-1548; Flynn RWV, 2004, J CLIN ENDOCR METAB, V89, P3879, DOI 10.1210/jc.2003-032089; Garcez RC, 2009, CELL MOL NEUROBIOL, V29, P1087, DOI 10.1007/s10571-009-9406-2; Herberth M, 2011, PROTEOMICS, V11, P94, DOI 10.1002/pmic.201000291; Hettmer S, 2005, HUM IMMUNOL, V66, P95, DOI 10.1016/j.humimm.2004.10.014; Hillegers MHJ, 2007, EUR NEUROPSYCHOPHARM, V17, P394, DOI 10.1016/j.euroneuro.2006.10.005; Kalia M, 2015, METABOLISM, V64, pS11, DOI 10.1016/j.metabol.2014.10.026; Klecha AJ, 2008, NEUROIMMUNOMODULAT, V15, P68, DOI 10.1159/000135626; Kupka RW, 2002, BIOL PSYCHIAT, V51, P305, DOI 10.1016/S0006-3223(01)01217-3; Laurberg P, 1998, J CLIN ENDOCR METAB, V83, P765, DOI 10.1210/jc.83.3.765; Ninan I, 2014, NEUROPHARMACOLOGY, V76, P684, DOI 10.1016/j.neuropharm.2013.04.011; Padmos RC, 2004, BIOL PSYCHIAT, V56, P476, DOI 10.1016/j.biopsych.2004.07.003; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Polacchini A, 2015, SCI REP-UK, V5, DOI 10.1038/srep17989; Ray P, 2008, CELL CYCLE, V7, P2826, DOI 10.4161/cc.7.18.6752; Roberts CGP, 2004, LANCET, V363, P793, DOI 10.1016/S0140-6736(04)15696-1; Rotondi M, 2013, J CLIN ENDOCR METAB, V98, P308, DOI 10.1210/jc.2012-2555; Roux PP, 2002, PROG NEUROBIOL, V67, P203, DOI 10.1016/S0301-0082(02)00016-3; Sariola H, 2003, J CELL SCI, V116, P3855, DOI 10.1242/jcs.00786; Schmohl M, 2012, METHODS MOL BIOL, V827, P271, DOI 10.1007/978-1-61779-442-1_18; Schwarz E, 2012, MOL PSYCHIATR, V17, P494, DOI 10.1038/mp.2011.42; Stezhammer V, 2013, EUR NEUROPSYCHOPHARM, V23, P1199, DOI 10.1016/j.euroneuro.2012.10.012; Strieder TGA, 2003, CLIN ENDOCRINOL, V59, P396, DOI 10.1046/j.1365-2265.2003.01862.x; Strieder TGA, 2008, ARCH INTERN MED, V168, P1657, DOI 10.1001/archinte.168.15.1657; Su Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075562; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x; Vanderpump MPJ, 2002, THYROID, V12, P839, DOI 10.1089/105072502761016458; Vonk R, 2007, BIOL PSYCHIAT, V62, P135, DOI 10.1016/j.biopsych.2006.08.041; Yoshida T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042676; Zaiss DMW, 2013, IMMUNITY, V38, P275, DOI 10.1016/j.immuni.2012.09.023	40	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153892	10.1371/journal.pone.0153892	http://dx.doi.org/10.1371/journal.pone.0153892			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27092550	Green Published, Green Submitted, gold			2022-12-26	WOS:000374541200056
J	Shi, XF; Tian, P; Lin, RC; Huang, DY; Wang, JJ				Shi, Xiaofeng; Tian, Peng; Lin, Rongcheng; Huang, Dingyong; Wang, Jianjia			Characterization of the Complete Mitochondrial Genome Sequence of the Globose Head Whiptail Cetonurus globiceps (Gadiformes: Macrouridae) and Its Phylogenetic Analysis	PLOS ONE			English	Article							GRENADIER FISHES; EVOLUTION; PATTERNS; ASSEMBLAGES; PERSPECTIVE; ABUNDANCE; POSITION; PROGRAM; SPACER; GENES	The particular environmental characteristics of deep water such as its immense scale and high pressure systems, presents technological problems that have prevented research to broaden our knowledge of deep-sea fish. Here, we described the mitogenome sequence of a deep-sea fish, Cetonurus globiceps. The genome is 17,137 bp in length, with a standard set of 22 transfer RNA genes (tRNAs), two ribosomal RNA genes, 13 protein -coding genes, and two typical non -coding control regions. Additionally, a 70bp tRNAThr-tRNAPr intergenic spacer is present. The C. globiceps mitogenome exhibited strand-specific asymmetry in nucleotide composition. The AT-skew and GC-skew values in the whole genome of C. globiceps were 0 and -0.2877, respectively, revealing that the H-strand had equal amounts of A and T and that the overall nucleotide composition was C skewed. All of the tRNA genes could be folded into cloverleaf secondary structures, while the secondary structure of tRNAser(AGY) lacked a discernible dihydrouridine stem. By comparing this genom sequence with the recognition sites in teleost species, several conserved sequence blocks were identified in the control region. However, the GTGGG-box, the typical characteristic of conserved sequence block E (CSB-E), was absent. Notably, tandem repeats were identified in the 3' portion of the control region. No similar repetitive motifs are present in most of other gadiform species. Phylogenetic analysis based on 12 protein coding genes provided strong support that C. globiceps was the most derived in the Glade. Some relationships however, are in contrast with those presented in previous studies. This study enriches our knowledge of mitogenomes of the genus Cetonurus and provides valuable information on the evolution of Macrouridae mtDNA and deep-sea fish.	[Shi, Xiaofeng; Lin, Rongcheng; Huang, Dingyong; Wang, Jianjia] State Ocean Adm, Inst Oceanog 3, Lab Marine Biol & Ecol, Xiamen, Peoples R China; [Tian, Peng] Zhejiang Univ, Ocean Coll, Hangzhou 310003, Zhejiang, Peoples R China	State Oceanic Administration; Zhejiang University	Lin, RC (corresponding author), State Ocean Adm, Inst Oceanog 3, Lab Marine Biol & Ecol, Xiamen, Peoples R China.	linrongcheng@tio.org.cn			National Basic Research Program of China [2015CB755902]; China Ocean Mineral Resources Research and Development Association Program [DY125-22-QY-06, DY125-11-E-03]; NSFC [41406166]	National Basic Research Program of China(National Basic Research Program of China); China Ocean Mineral Resources Research and Development Association Program; NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China (2015CB755902) granted to RL, China Ocean Mineral Resources Research and Development Association Program (Grant No. DY125-22-QY-06) granted to JW, China Ocean Mineral Resources Research and Development Association Program (Grant No. DY125-11-E-03) granted to RL, and project 41406166 supported by NSFC granted to XS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Bakke I, 1999, MAR BIOTECHNOL, V1, P411, DOI 10.1007/PL00011797; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Breines R, 2008, POLAR BIOL, V31, P1245, DOI 10.1007/s00300-008-0463-7; Burland TG, 1999, DNASTARS LASERGENE S; Carr SM, 1999, CAN J ZOOL, V77, P19, DOI 10.1139/cjz-77-1-19; Chao QJ, 2014, GENET MOL RES, V13, P2739, DOI 10.4238/2014.April.14.3; Cheng J, 2012, GENE, V491, P210, DOI 10.1016/j.gene.2011.09.020; Endo Hiromitsu, 2002, Memoirs of the Graduate School of Fisheries Sciences Hokkaido University, V49, P75; Follesa MC, 2011, J APPL ICHTHYOL, V27, P129, DOI 10.1111/j.1439-0426.2010.01567.x; Fossen I, 2008, DEEP-SEA RES PT II, V55, P203, DOI 10.1016/j.dsr2.2007.09.004; Froese R, 2007, FISHBASE, V26, P27; Gao JF, 2014, GENE, V541, P92, DOI 10.1016/j.gene.2014.03.017; Hao WL, 2010, P NATL ACAD SCI USA, V107, P21576, DOI 10.1073/pnas.1016295107; Kriwet J, 2008, NATURWISSENSCHAFTEN, V95, P899, DOI 10.1007/s00114-008-0409-5; Labuschagne C, 2014, GENE, V534, P113, DOI 10.1016/j.gene.2013.09.057; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; LEE WJ, 1995, J MOL EVOL, V41, P54; Leviton AE, 1999, P CALIFORNIA ACAD SC, V51; Liu Y, 2009, MAR GENOM, V2, P133, DOI 10.1016/j.margen.2009.07.003; Lynch M, 2006, SCIENCE, V311, P1727, DOI 10.1126/science.1118884; MASSUTI E, 1995, DEEP-SEA RES PT I, V42, P307, DOI 10.1016/0967-0637(95)00003-O; Menezes GM, 2009, DEEP-SEA RES PT II, V56, P2683, DOI 10.1016/j.dsr2.2008.12.028; Miya M, 2005, BIOL J LINN SOC, V85, P289, DOI 10.1111/j.1095-8312.2005.00483.x; Miya M, 2003, MOL PHYLOGENET EVOL, V26, P121, DOI 10.1016/S1055-7903(02)00332-9; Moller PR, 2002, POLAR BIOL, V25, P342, DOI 10.1007/s00300-001-0348-5; Moranta J, 2007, PROG OCEANOGR, V72, P63, DOI 10.1016/j.pocean.2006.09.003; Morita T, 1999, MOL PHYLOGENET EVOL, V13, P447, DOI 10.1006/mpev.1999.0661; MORITZ C, 1995, PHILOS T R SOC B, V349, P113, DOI 10.1098/rstb.1995.0097; Musick JA, 1999, AM FISH S S, V23, P1; Neat F, 2010, DEEP-SEA RES PT I, V57, P434, DOI 10.1016/j.dsr.2009.12.003; Palsson S, 2008, MAR BIOTECHNOL, V10, P270, DOI 10.1007/s10126-007-9058-5; Paramo J, 2012, FISH RES, V125, P87, DOI 10.1016/j.fishres.2012.02.011; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; RAND DM, 1993, J MOL EVOL, V37, P281, DOI 10.1007/BF00175505; Roa-Varon A, 2009, MOL PHYLOGENET EVOL, V52, P688, DOI 10.1016/j.ympev.2009.03.020; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roques S, 2006, GENE, V383, P12, DOI 10.1016/j.gene.2006.06.018; Satoh TP, 2006, MOL PHYLOGENET EVOL, V40, P129, DOI 10.1016/j.ympev.2006.02.014; Schattner P, 2007, NUCLEIC ACIDS RES, V33, P686; Sima YH, 2013, GENE, V526, P309, DOI 10.1016/j.gene.2013.05.048; Speijer D, 2011, BIOESSAYS, V33, P344, DOI 10.1002/bies.201100010; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; van Wijk EM, 2000, CCAMLR SCI, V7, P171; Wu QL, 2014, GENE, V543, P76, DOI 10.1016/j.gene.2014.04.003; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xia JH, 2008, MITOCHONDR DNA, V19, P385, DOI 10.1080/19401730802350998; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Zardoya R, 1997, GENETICS, V146, P995; Zhang HL, 2013, GENE, V517, P89, DOI 10.1016/j.gene.2012.12.080; Zhang JB, 2011, BIOCHEM SYST ECOL, V39, P31, DOI 10.1016/j.bse.2010.12.017; Zhu BJ, 2013, GENE, V527, P283, DOI 10.1016/j.gene.2013.06.035; Zhuang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073561; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; Zwickl D. J, 2006, GENETIC ALGORITHM AP	57	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153666	10.1371/journal.pone.0153666	http://dx.doi.org/10.1371/journal.pone.0153666			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093057	Green Submitted, Green Published, gold			2022-12-26	WOS:000374541200039
J	Amorim, JL; Simas, DLR; Pinheiro, MMG; Moreno, DSA; Alviano, CS; da Silva, AJR; Fernandes, PD				Amorim, Jorge Luis; Reis Simas, Daniel Luiz; Gomes Pinheiro, Mariana Martins; Alviano Moreno, Daniela Sales; Alviano, Celuta Sales; Ribeiro da Silva, Antonio Jorge; Fernandes, Patricia Dias			Anti-Inflammatory Properties and Chemical Characterization of the Essential Oils of Four Citrus Species	PLOS ONE			English	Article							D-LIMONENE; INFLAMMATION; TOXICITY; VOLATILE; RELEASE; LEMON	Citrus fruits have potential health-promoting properties and their essential oils have long been used in several applications. Due to biological effects described to some citrus species in this study our objectives were to analyze and compare the phytochemical composition and evaluate the anti-inflammatory effect of essential oils (EO) obtained from four different Citrus species. Mice were treated with EO obtained from C. limon, C. latifolia, C. aurantifolia or C. limonia (10 to 100 mg/kg, p.o.) and their anti-inflammatory effects were evaluated in chemical induced inflammation (formalin-induced licking response) and carrageenan-induced inflammation in the subcutaneous air pouch model. A possible antinociceptive effect was evaluated in the hot plate model. Phytochemical analyses indicated the presence of geranial, limonene, gamma-terpinene and others. EOs from C. limon, C. aurantifolia and C. limonia exhibited anti-inflammatory effects by reducing cell migration, cytokine production and protein extravasation induced by carrageenan. These effects were also obtained with similar amounts of pure limonene. It was also observed that C. aurantifolia induced myelotoxicity in mice. Anti-inflammatory effect of C. limon and C. limonia is probably due to their large quantities of limonene, while the myelotoxicity observed with C. aurantifolia is most likely due to the high concentration of citral. Our results indicate that these EOs from C. limon, C. aurantifolia and C. limonia have a significant anti-inflammatory effect; however, care should be taken with C. aurantifolia.	[Amorim, Jorge Luis; Gomes Pinheiro, Mariana Martins; Fernandes, Patricia Dias] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Farmacol Dor & Inflamacao, Rio De Janeiro, Brazil; [Reis Simas, Daniel Luiz; Ribeiro da Silva, Antonio Jorge] Univ Fed Rio de Janeiro, Inst Pesquisa Prod Nat, Lab Anal Fitoquim, Rio De Janeiro, Brazil; [Alviano Moreno, Daniela Sales; Alviano, Celuta Sales] Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, Lab Estruturas Superficie Microorganismos, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Fernandes, PD (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Farmacol Dor & Inflamacao, Rio De Janeiro, Brazil.	patricia.dias@icb.ufrj.br	da Silva, Antonio J R/C-4476-2013; Alviano, Celuta/V-3878-2019; Alviano, Daniela/U-1556-2019; da Silva, Antonio Jorge Ribeiro/N-4020-2019; Fernandes, Patricia Dias/W-1565-2019	da Silva, Antonio J R/0000-0002-7579-420X; Alviano, Celuta/0000-0002-0806-6712; da Silva, Antonio Jorge Ribeiro/0000-0002-7579-420X; Fernandes, Patricia Dias/0000-0001-6870-6745	Conselho Nacional de Pesquisa (CNPq) [303033/2013-4, 473106/2012-4]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E-26/210.141/2014, E-26/010.002566/2014, E-26/203.018/2015]	Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work received support from Conselho Nacional de Pesquisa (CNPq): 303033/2013-4 (fellowship) to PDF, 473106/2012-4 (grant) to PDF and from Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ): E-26/210.141/2014 (grant) to PDF, E-26/010.002566/2014 (grant) to PDF, E-26/203.018/2015 (fellowship) to PDF.	Adams R.P, 2017, IDENTIFICATION ESSEN, V5th; Amantea D, 2009, INT REV NEUROBIOL, V85, P389, DOI 10.1016/S0074-7742(09)85027-7; Arias BA, 2005, J ETHNOPHARMACOL, V97, P89, DOI 10.1016/j.jep.2004.10.019; BARTHOLOMEW B, 1984, FOOD CHEM TOXICOL, V22, P541, DOI 10.1016/0278-6915(84)90224-2; Belletti N, 2004, J AGR FOOD CHEM, V52, P6932, DOI 10.1021/jf049444v; Berliocchi L, 2009, INT REV NEUROBIOL, V85, P221, DOI 10.1016/S0074-7742(09)85017-4; Bisignano G, 2011, CITRUS OILS COMPOSIT; d'Alessio PA, 2013, LIFE SCI, V92, P1151, DOI 10.1016/j.lfs.2013.04.013; Gomes NM, 2007, J ETHNOPHARMACOL, V109, P486, DOI 10.1016/j.jep.2006.08.018; Gorinstein S, 2001, FOOD CHEM, V74, P309, DOI 10.1016/S0308-8146(01)00157-1; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hirota R, 2010, J FOOD SCI, V75, pH87, DOI 10.1111/j.1750-3841.2010.01541.x; HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1; Kapoor S, 2013, HUM EXP TOXICOL, V32, P1228, DOI 10.1177/0960327113489053; Kummer R, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/859083; LORKE D, 1983, ARCH TOXICOL, V54, P275, DOI 10.1007/BF01234480; Lota ML, 2002, J AGR FOOD CHEM, V50, P796, DOI 10.1021/jf010924l; Matheus ME, 2005, J ETHNOPHARMACOL, V102, P377, DOI 10.1016/j.jep.2005.06.033; Mehl F, 2014, FOOD CHEM, V143, P325, DOI 10.1016/j.foodchem.2013.07.125; Misharina TA, 2008, APPL BIOCHEM MICRO+, V44, P438, DOI 10.1134/S0003683808040182; Moermans C, 2011, CYTOKINE, V56, P298, DOI 10.1016/j.cyto.2011.07.010; NOGUEIRA ACMA, 1995, TOXICOLOGY, V96, P105, DOI 10.1016/0300-483X(94)02915-H; Parada CA, 2001, NEUROSCIENCE, V102, P937, DOI 10.1016/S0306-4522(00)00523-6; Parodi A, 2010, TOXICOL LETT, V192, P101, DOI 10.1016/j.toxlet.2009.10.013; Pultrini ADM, 2006, LIFE SCI, V78, P1720, DOI 10.1016/j.lfs.2005.08.004; Raymundo LJRP, 2011, J ETHNOPHARMACOL, V134, P725, DOI 10.1016/j.jep.2011.01.027; Rehman MU, 2014, EXP BIOL MED, V239, P465, DOI 10.1177/1535370213520112; Ress NB, 2003, TOXICOL SCI, V71, P198, DOI 10.1093/toxsci/71.2.198; Romano L, 2005, J ANTIMICROB CHEMOTH, V55, P110, DOI 10.1093/jac/dkh503; Rouseff R, 2011, CITRUS FLAVOUR FLAVO; SAHLEY TL, 1979, PSYCHOPHARMACOLOGY, V65, P279, DOI 10.1007/BF00492216; SEDGWICK AD, 1984, J PHARM PHARMACOL, V36, P171, DOI 10.1111/j.2042-7158.1984.tb06933.x; Wehrli FW., 1979, PROGR CHEM ORGANIC N, P1	33	65	66	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153643	10.1371/journal.pone.0153643	http://dx.doi.org/10.1371/journal.pone.0153643			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088973	Green Published, Green Submitted, gold			2022-12-26	WOS:000374527000034
J	Combe, R; Mudgett, J; El Fertak, L; Champy, MF; Ayme-Dietrich, E; Petit-Demouliere, B; Sorg, T; Herault, Y; Madwed, JB; Monassier, L				Combe, Roy; Mudgett, John; El Fertak, Lahcen; Champy, Marie-france; Ayme-Dietrich, Estelle; Petit-Demouliere, Benoit; Sorg, Tania; Herault, Yann; Madwed, Jeffrey B.; Monassier, Laurent			How Does Circadian Rhythm Impact Salt Sensitivity of Blood Pressure in Mice? A Study in Two Close C57Bl/6 Substrains	PLOS ONE			English	Article							SYMPATHETIC-NERVE ACTIVITY; DAHL-S RATS; ANGIOTENSIN-II; DEOXYCORTICOSTERONE ACETATE; KNOCKOUT MICE; DIETARY SALT; HYPERTENSION; SODIUM; LACKING; RESPONSES	Background Mouse transgenesis has provided the unique opportunity to investigate mechanisms underlying sodium kidney reabsorption as well as end organ damage. However, understanding mouse background and the experimental conditions effects on phenotypic readouts of engineered mouse lines such as blood pressure presents a challenge. Despite the ability to generate high sodium and chloride plasma levels during high-salt diet, observed changes in blood pressure are not consistent between wild-type background strains and studies. Methods The present work was designed in an attempt to determine guidelines in the field of saltinduced hypertension by recording continuously blood pressure by telemetry in mice submitted to different sodium and potassium loaded diets and changing experimental conditions in both C57BL/6N and C57BL/6J mice strain (Normal salt vs. Low salt vs. High-salt/normal potassium vs. High salt/low potassium, standard vs. modified light cycle, Non-invasive tail cuff blood pressure vs. telemetry). Results In this study, we have shown that, despite a strong blood pressure (BP) basal difference between C57BL/6N and C57BL/6J mice, High salt/normal potassium diet increases BP and heart rate during the active phase only (dark period) in the same extent in both strains. On the other hand, while potassium level has no effect on salt-induced hypertension in C57BL/6N mice, high-salt/low potassium diet amplifies the effect of the high-salt challenge only in C57BL/6J mice. Indeed, in this condition, salt-induced hypertension can also be detected during light period even though this BP increase is lower compared to the one occurring during the dark period. Finally, from a methodological perspective, light cycle inversion has no effect on this circadian BP phenotype and tail-cuff method is less sensitive than telemetry to detect BP phenotypes due to salt challenges. Conclusions Therefore, to carry investigations on salt-induced hypertension in mice, chronic telemetry and studies in the active phase are essential prerequisites.	[Combe, Roy; El Fertak, Lahcen; Champy, Marie-france; Petit-Demouliere, Benoit; Sorg, Tania; Herault, Yann; Monassier, Laurent] Univ Strasbourg, Inst Clin Souris, Inst Genet & Biol Mol, Illkirch Graffenstaden, France; [Ayme-Dietrich, Estelle; Monassier, Laurent] Univ & Ctr Hosp Univ Strasbourg, Lab Neurobiol & Pharmacol Cardiovasc, Fac Med, Federat Med Translat, Strasbourg, France; [Mudgett, John; Madwed, Jeffrey B.] Merck Res Labs, Kenilworth, NJ USA; [Combe, Roy] Ecole Polytech Fed Lausanne, Ctr Phenogen, CH-1015 Lausanne, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; Merck & Company; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Combe, R (corresponding author), Univ Strasbourg, Inst Clin Souris, Inst Genet & Biol Mol, Illkirch Graffenstaden, France.; Combe, R (corresponding author), Ecole Polytech Fed Lausanne, Ctr Phenogen, CH-1015 Lausanne, Switzerland.	roy.combe@epfl.ch	AYME, Estelle/AAC-8392-2022; Herault, Yann/B-5500-2012; Monassier, Laurent/AAE-4446-2022	AYME, Estelle/0000-0002-0613-3803; Herault, Yann/0000-0001-7049-6900; 	Mouse Clinical Institute (MCI); Merck Research Laboratories (MRL)	Mouse Clinical Institute (MCI); Merck Research Laboratories (MRL)(Merck & Company)	This work was financed by the Mouse Clinical Institute (MCI) in collaboration with Merck Research Laboratories (MRL). This study has been performed in the frame of a provision service by MCI for MRL. The billing of this specific service included part of the material resources that have been recruited to conduct this study. Apart from this financial support for MCI, MRL did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. It is noteworthy that MRL had to validate the study design and the manuscript before publication, but no revisions were asked by MRL. The specific roles of these authors are articulated in the 'author contributions' section.	Alfie ME, 1997, HYPERTENSION, V29, P483, DOI 10.1161/01.HYP.29.1.483; Bagnall AJ, 2006, HYPERTENSION, V48, P286, DOI 10.1161/01.HYP.0000229907.58470.4c; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; Brochu I, 2002, CLIN SCI, V103, p380S, DOI 10.1042/CS103S380S; Carlson SH, 2002, HYPERTENSION, V39, P214, DOI 10.1161/hy0202.104267; Champy MF, 2004, MAMM GENOME, V15, P768, DOI 10.1007/s00335-004-2393-1; Chen DA, 2010, AM J HYPERTENS, V23, P481, DOI 10.1038/ajh.2010.12; DiBona GF, 2003, ACTA PHYSIOL SCAND, V177, P285, DOI 10.1046/j.1365-201X.2003.01074.x; Esler M, 2006, HYPERTENSION, V48, P787, DOI 10.1161/01.HYP.0000242642.42177.49; Fujita M, 2005, HYPERTENSION, V45, P1165, DOI 10.1161/01.HYP.0000165690.85505.37; FUJITA T, 1980, AM J MED, V69, P334, DOI 10.1016/0002-9343(80)90002-9; Gross V, 2000, J HYPERTENS, V18, P955, DOI 10.1097/00004872-200018070-00018; Guild SJ, 2012, HYPERTENSION, V59, P614, DOI 10.1161/HYPERTENSIONAHA.111.180885; Handtrack C, 2007, J MOL MED-JMM, V85, P343, DOI 10.1007/s00109-007-0166-5; Hao XZ, 2011, PFLUG ARCH EUR J PHY, V461, P345, DOI 10.1007/s00424-011-0921-x; Hartner A, 2003, NEPHROL DIAL TRANSPL, V18, P1999, DOI 10.1093/ndt/gfg299; Helkamaa T, 2003, J HYPERTENS, V21, P2365, DOI 10.1097/00004872-200312000-00026; Houghton BL, 2010, EXP PHYSIOL, V95, P282, DOI 10.1113/expphysiol.2009.049833; Huang BS, 1998, HYPERTENSION, V32, P1028, DOI 10.1161/01.HYP.32.6.1028; Huang BS, 2004, AM J PHYSIOL-HEART C, V287, pH1160, DOI 10.1152/ajpheart.00126.2004; Kennedy CRJ, 1999, NAT MED, V5, P217, DOI 10.1038/5583; KOEPKE JP, 1985, HYPERTENSION, V7, P357, DOI 10.1161/01.HYP.7.3_Pt_1.357; Koutnikova H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000591; KUROO M, 1995, CIRC RES, V76, P148, DOI 10.1161/01.RES.76.1.148; Makhanova N, 2008, HYPERTENSION, V51, P134, DOI 10.1161/HYPERTENSIONAHA.107.098897; Manolopoulou J, 2008, J ENDOCRINOL, V196, P215, DOI 10.1677/JOE-07-0134; McBryde FD, 2009, AM J PHYSIOL-REG I, V297, pR396, DOI 10.1152/ajpregu.90741.2008; Meneton P, 2000, AM J PHYSIOL-RENAL, V278, pF339, DOI 10.1152/ajprenal.2000.278.3.F339; Milia AF, 2001, HYPERTENSION, V37, P1473, DOI 10.1161/01.HYP.37.6.1473; Oliverio MI, 2000, HYPERTENSION, V35, P550, DOI 10.1161/01.HYP.35.2.550; Ono A, 1997, HYPERTENSION, V29, P808, DOI 10.1161/01.HYP.29.3.808; Osborn JW, 2010, EXP PHYSIOL, V95, P61, DOI 10.1113/expphysiol.2008.046326; Ruta LAM, 2010, AM J PHYSIOL-RENAL, V298, pF1384, DOI 10.1152/ajprenal.00049.2010; Simon MM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r82; Stocker SD, 2010, PHYSIOL BEHAV, V100, P519, DOI 10.1016/j.physbeh.2010.04.024; Strazzullo P, 2001, CLIN EXP HYPERTENS, V23, P25, DOI 10.1081/CEH-100001194; Van Huysse JW, 2011, AM J PHYSIOL-HEART C, V301, pH2147, DOI 10.1152/ajpheart.01216.2010; Wang Q, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017902.77985.84; Watanabe H, 2005, CIRC J, V69, P124, DOI 10.1253/circj.69.124; Wu XY, 1998, CLIN EXP HYPERTENS, V20, P795, DOI 10.3109/10641969809052120	40	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153472	10.1371/journal.pone.0153472	http://dx.doi.org/10.1371/journal.pone.0153472			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088730	Green Published, gold, Green Submitted			2022-12-26	WOS:000374527000022
J	Mulsow, K; Enzlein, T; Delebinski, C; Jaeger, S; Seifert, G; Melzig, MF				Mulsow, Katharina; Enzlein, Thomas; Delebinski, Catharina; Jaeger, Sebastian; Seifert, Georg; Melzig, Matthias F.			Impact of Mistletoe Triterpene Acids on the Uptake of Mistletoe Lectin by Cultured Tumor Cells	PLOS ONE			English	Article							VISCUM-ALBUM L; ACUTE LYMPHOBLASTIC-LEUKEMIA; IN-VITRO; INTRACELLULAR-TRANSPORT; MEMBRANE INTERACTIONS; HUMAN MONOCYTES; OLEANOLIC ACID; EXTRACT; APOPTOSIS; RICIN	Complementary treatment possibilities for the therapy of cancer are increasing in demand due to the severe side effects of the standard cytostatics used in the first-line therapy. A common approach as a complementary treatment is the use of aqueous extracts of Viscum album L. (Santalaceace). The therapeutic activity of these extracts is attributed to Mistletoe lectins which are Ribosome-inactivating proteins type II. Besides these main constituents the extract of Viscum album L. comprises also a mixture of lipophilic ingredients like triterpene acids of the oleanane, lupane and ursane type. However, these constituents are not contained in commercially available aqueous extracts due to their high lipophilicity and insolubility in aqueous extraction media. To understand the impact of the extract ingredients in cancer therapy, the intracellular uptake of the mistletoe lectin I (ML) by cultured tumor cells was investigated in relation to the mistletoe triterpene acids, mainly oleanolic acid. Firstly, these hydrophobic triterpene acids were solubilized using cyclodextrins ("TT" extract). Afterwards, the uptake of either single compounds (isolated ML and the aqueous "viscum" extract) or in combination with the TT extract (ML+TT, viscumTT), was analyzed. The uptake of ML was studied in THP-1-, HL-60-, 143B- and Ewing TC-71-cells and determined after 30, 60 and 120 minutes by an enzyme linked immunosorbent assay which quantifies the A-chain of the hololectin. It could be shown that the intracellular uptake after 120 minutes amounted to 20% in all cell lines after incubation with viscumTT. The studies further revealed that the uptake in THP-1-, HL-60- and Ewing TC-71-cells was independent of the addition of TT extract. Interestingly, the uptake of ML by 143B-cells could only be measured after addition of triterpenes pointing to resistance to mistletoe lectin.	[Mulsow, Katharina; Melzig, Matthias F.] Free Univ Berlin, Dept Pharmaceut Biol, Inst Pharm, Berlin, Germany; [Enzlein, Thomas] Mannheim Univ Appl Sci, Dept Biotechnol, Mannheim, Germany; [Delebinski, Catharina; Seifert, Georg] Charite, Dept Paediat, Div Oncol Haematol, Otto Heubner Ctr Paediat & Adolescent Med OHC, D-13353 Berlin, Germany; [Jaeger, Sebastian] Birken AG, Niefern Oeschelbronn, Germany	Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Melzig, MF (corresponding author), Free Univ Berlin, Dept Pharmaceut Biol, Inst Pharm, Berlin, Germany.	melzig@zedat.fu-berlin.de	Enzlein, Thomas/AFQ-4152-2022	Enzlein, Thomas/0000-0003-1789-4090; Delebinski, Catharina/0000-0003-2527-4385	Birken AG	Birken AG	Birken AG provided support in the form of salaries for authors SJ, respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of the author is articulated in the 'author contributions' section.	Broniatowski M, 2014, BBA-BIOMEMBRANES, V1838, P2530, DOI 10.1016/j.bbamem.2014.05.027; Buessing A., 1996, APOPTOSIS, V1, P25; Delebinski CI, 2012, CELL PROLIFERAT, V45, P176, DOI 10.1111/j.1365-2184.2011.00801.x; Delebinski CI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133892; Edlund U, 2000, ARZNEIMITTEL-FORSCH, V50, P645; Elsasser-Beile U, 2000, J CLIN LAB ANAL, V14, P255, DOI 10.1002/1098-2825(20001212)14:6<255::AID-JCLA1>3.0.CO;2-J; FRANZ H, 1986, ONCOLOGY, V43, P23, DOI 10.1159/000226417; FRANZ H, 1981, BIOCHEM J, V195, P481, DOI 10.1042/bj1950481; Fulda S, 2000, MED PEDIATR ONCOL, V35, P616, DOI 10.1002/1096-911X(20001201)35:6<616::AID-MPO27>3.0.CO;2-N; Han SK, 1997, LIPIDS, V32, P769, DOI 10.1007/s11745-997-0098-9; Huber R, 2005, EUR J MED RES, V10, P411; Jager S, 2007, PLANTA MED, V73, P157, DOI 10.1055/s-2007-967106; JAGGY C, 1995, ARZNEIMITTEL-FORSCH, V45-2, P905; JUNG ML, 1990, CANCER LETT, V51, P103, DOI 10.1016/0304-3835(90)90044-X; Laszczyk M, 2006, PLANTA MED, V72, P1389, DOI 10.1055/s-2006-951723; Laszczyk MN, 2009, PLANTA MED, V75, P1549, DOI 10.1055/s-0029-1186102; Lenartz D, 2000, ANTICANCER RES, V20, P2073; Li R, 2009, AAPS PHARMSCITECH, V10, P1137, DOI 10.1208/s12249-009-9317-z; Llorente A, 1998, FEBS LETT, V431, P200, DOI 10.1016/S0014-5793(98)00754-6; Manojlovic V, 2008, COLLOID SURFACE B, V64, P284, DOI 10.1016/j.colsurfb.2008.02.001; Marvibaigi M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/785479; Moisenovich M, 2003, ARZNEIMITTEL-FORSCH, V53, P470; Moisenovich M, 2002, EUR J CELL BIOL, V81, P529, DOI 10.1078/0171-9335-00263; MUSIELSKI H, 1996, GRUNDLAGEN MISTELTHE, P95; Muthing J, 2004, BIOCHEMISTRY-US, V43, P2996, DOI 10.1021/bi0301892; OLSNES S, 1982, J BIOL CHEM, V257, P13263; Pohl P, 1998, BBA-BIOMEMBRANES, V1371, P11, DOI 10.1016/S0005-2736(98)00024-8; Prades J, 2011, BBA-BIOMEMBRANES, V1808, P752, DOI 10.1016/j.bbamem.2010.12.007; Rather MA, 2013, PHYTOMEDICINE, V21, P1, DOI 10.1016/j.phymed.2013.07.015; RibereauGayon G, 1996, CANCER LETT, V109, P33, DOI 10.1016/S0304-3835(96)04401-1; Robert Koch Institute, 2015, HLTH IN GERM; Rostock M, 2005, ANTICANCER RES, V25, P1969; Safayhi H, 1997, PLANTA MED, V63, P487, DOI 10.1055/s-2006-957748; Sairafianpour M, 2003, PLANTA MED, V69, P846, DOI 10.1055/s-2003-43212; SANDVIG K, 1994, FEBS LETT, V346, P99, DOI 10.1016/0014-5793(94)00281-9; Schaller G, 1996, PHYTOTHER RES, V10, P473, DOI 10.1002/(SICI)1099-1573(199609)10:6&lt;473::AID-PTR879&gt;3.0.CO;2-Q; Seifert G, 2008, CANCER LETT, V264, P218, DOI 10.1016/j.canlet.2008.01.036; Struh CM, 2012, PHYTOTHER RES, V26, P1507, DOI 10.1002/ptr.4604; Struh CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062168; Thies A, 2008, BRIT J CANCER, V98, P106, DOI 10.1038/sj.bjc.6604106; Tonevitsky AG, 2003, BIOCHEMISTRY-MOSCOW+, V68, P275, DOI 10.1023/A:1023050132342; Tsuchiya H, 2015, MOLECULES, V20, P18923, DOI 10.3390/molecules201018923; Urech K, 2005, J PHARM PHARMACOL, V57, P101, DOI 10.1211/0022357055083; Valentiner U, 2002, TOXICOLOGY, V171, P187, DOI 10.1016/S0300-483X(01)00581-9; Vervecken W, 2000, INT J BIOCHEM CELL B, V32, P317, DOI 10.1016/S1357-2725(99)00135-1; Wagner H, 2009, PHYTOMEDICINE, V16, P97, DOI 10.1016/j.phymed.2008.12.018; Williamson EM, 2001, PHYTOMEDICINE, V8, P401, DOI 10.1078/0944-7113-00060; Zhang WS, 2014, J CANCER RES THER, V10, P14, DOI 10.4103/0973-1482.139746; ZISKA P, 1981, EXPERIENTIA, V37, P219, DOI 10.1007/BF01991618	49	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153825	10.1371/journal.pone.0153825	http://dx.doi.org/10.1371/journal.pone.0153825			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088729	Green Published, Green Submitted, gold			2022-12-26	WOS:000374527000052
J	Che, YX; Ju, Y; Xuan, P; Long, R; Xing, F				Che, Yuxin; Ju, Ying; Xuan, Ping; Long, Ren; Xing, Fei			Identification of Multi-Functional Enzyme with Multi-Label Classifier	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; TUPLE NUCLEOTIDE COMPOSITION; SEQUENCE-BASED PREDICTOR; MODIFIED MAHALANOBIS DISCRIMINANT; NEURAL P SYSTEMS; PHYSICOCHEMICAL PROPERTIES; SUBCELLULAR-LOCALIZATION; MYCOBACTERIAL PROTEINS; PSEUDO; DNA	Enzymes are important and effective biological catalyst proteins participating in almost all active cell processes. Identification of multi-functional enzymes is essential in understanding the function of enzymes. Machine learning methods perform better in protein structure and function prediction than traditional biological wet experiments. Thus, in this study, we explore an efficient and effective machine learning method to categorize enzymes according to their function. Multi-functional enzymes are predicted with a special machine learning strategy, namely, multi-label classifier. Sequence features are extracted from a position-specific scoring matrix with autocross-covariance transformation. Experiment results show that the proposed method obtains an accuracy rate of 94.1% in classifying six main functional classes through five cross-validation tests and outperforms state-of-the-art methods. In addition, 91.25% accuracy is achieved in multi-functional enzyme prediction, which is often ignored in other enzyme function prediction studies. The online prediction server and datasets can be accessed from the link http://server.malab.cn/MEC/.	[Che, Yuxin; Ju, Ying] Xiamen Univ, Sch Informat Sci & Technol, Xiamen 361005, Fujian, Peoples R China; [Xuan, Ping] Heilongjiang Univ, Sch Comp Sci & Technol, Harbin 150080, Peoples R China; [Long, Ren] Harbin Inst Technol, Shenzhen Grad Sch, Sch Comp Sci & Technol, Shenzhen 518055, Guangdong, Peoples R China; [Xing, Fei] Xiamen Univ, Sch Aerosp Engn, Xiamen 361005, Fujian, Peoples R China	Xiamen University; Heilongjiang University; Harbin Institute of Technology; University Town of Shenzhen; Xiamen University	Xing, F (corresponding author), Xiamen Univ, Sch Aerosp Engn, Xiamen 361005, Fujian, Peoples R China.	f.xing@xmu.edu.cn		Che, Yuxin/0000-0001-9818-1003	Natural Science Foundation of China [61302139]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Natural Science Foundation of China (No. 61302139), http://www.nsfc.gov.cn/.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arakaki AK, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-107; Brown P. F., 1992, Computational Linguistics, V18, P467; Cai SX, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/904267; Chen JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19062; Chen W, 2015, ANAL BIOCHEM, V490, P26, DOI 10.1016/j.ab.2015.08.021; Chen W, 2014, ANAL BIOCHEM, V462, P76, DOI 10.1016/j.ab.2014.06.022; Chen W, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/623149; Chen W, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1450; Cheng WW, 2009, MACH LEARN, V76, P211, DOI 10.1007/s10994-009-5127-5; Cheng XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038979; Chou KC, 2005, BIOINFORMATICS, V21, P10, DOI 10.1093/bioinformatics/bth466; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Ding H, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/286419; Ding H, 2011, PROTEIN PEPTIDE LETT, V18, P58, DOI 10.2174/092986611794328708; Ding H, 2009, PROTEIN PEPTIDE LETT, V16, P351, DOI 10.2174/092986609787848045; Dong QW, 2009, BIOINFORMATICS, V25, P2655, DOI 10.1093/bioinformatics/btp500; Feng P, 2015, INTERDISCIP SCI; Feng PM, 2013, ANAL BIOCHEM, V442, P118, DOI 10.1016/j.ab.2013.05.024; Feng PM, 2014, GENOMICS, V104, P229, DOI 10.1016/j.ygeno.2014.08.011; Feng PM, 2014, SCI WORLD J, DOI 10.1155/2014/740506; Feng PM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/935719; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Goryanin I, 2012, ENZML MULTILABEL PRE, V13; Guo SH, 2014, BIOINFORMATICS, V30, P1522, DOI 10.1093/bioinformatics/btu083; Huang WL, 2007, BIOSYSTEMS, V90, P405, DOI 10.1016/j.biosystems.2006.10.004; Kumar N, 2012, BIOINFORMATICS, V28, P2687, DOI 10.1093/bioinformatics/bts510; Lin C, 2014, NEUROCOMPUTING, V123, P424, DOI 10.1016/j.neucom.2013.08.004; Lin C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056499, 10.1371/journal.pone.0080883, 10.1371/journal.pone.0065734, 10.1371/journal.pone.0070187]; Lin H, 2008, PROTEIN PEPTIDE LETT, V15, P739, DOI 10.2174/092986608785133681; Lin H, 2008, J THEOR BIOL, V252, P350, DOI 10.1016/j.jtbi.2008.02.004; Lin H, 2014, NUCLEIC ACIDS RES, V42, P12961, DOI 10.1093/nar/gku1019; Lin H, 2012, J BIOMOL STRUCT DYN, V29, P643, DOI 10.1080/07391102.2011.672628; Liu B, 2017, BIOINFORMATICS, V33, P35, DOI [10.1093/bioinformatics/btv604, 10.1093/bioinformatics/btw539]; Liu B, 2015, BIOINFORMATICS, V31, P3492, DOI 10.1093/bioinformatics/btv413; Liu B, 2015, SCI REP-UK, V5, DOI 10.1038/srep15479; Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458; Liu B, 2015, BIOINFORMATICS, V31, P1307, DOI 10.1093/bioinformatics/btu820; Liu B, 2015, MOL INFORM, V34, P8, DOI 10.1002/minf.201400025; Liu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106691; Liu B, 2014, BIOINFORMATICS, V30, P472, DOI 10.1093/bioinformatics/btt709; Liu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046633; Liu J, 2015, J BIOMOL STRUCT DYN, V33, P7, DOI [10.1080/07391102.2015.1032552, 10.1080/07391102.2015.1014422]; Shen HB, 2007, BIOCHEM BIOPH RES CO, V364, P53, DOI 10.1016/j.bbrc.2007.09.098; Song L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-298; Song Tao P L, 2015, IEEE T NANOBIOSCIENC; Song Tao X J, 2016, NEUROCOMPUTING; Spyromitros E., 2008, P 5 HELL C ART INT; Tang H, 2016, MOL BIOSYSTEMS; Tian WD, 2004, NUCLEIC ACIDS RES, V32, P6226, DOI 10.1093/nar/gkh956; Wang CY, 2015, GENET MOL RES, V14, P123, DOI 10.4238/2015.January.15.15; Wei LY, 2015, IEEE T NANOBIOSCI, V14, P649, DOI 10.1109/TNB.2015.2450233; Wei LY, 2015, IEEE T NANOBIOSCI, V14, P339, DOI 10.1109/TNB.2014.2352454; Wei LY, 2014, IEEE ACM T COMPUT BI, V11, P192, DOI 10.1109/TCBB.2013.146; Xu Chen, 2015, THEORETICAL COMPUTER; Yuan LF, 2013, TOXICOL IN VITRO, V27, P852, DOI 10.1016/j.tiv.2012.12.024; Zeng XX, 2017, IEEE ACM T COMPUT BI, V14, P687, DOI 10.1109/TCBB.2016.2520947; Zeng XX, 2016, BRIEF BIOINFORM, V17, P193, DOI 10.1093/bib/bbv033; Zeng XX, 2015, FRONT COMPUT SCI-CHI, V9, P643, DOI 10.1007/s11704-014-4089-3; Zeng XX, 2014, SCI CHINA INFORM SCI, V57, DOI 10.1007/s11432-013-4848-z; Zeng XX, 2014, NEURAL COMPUT, V26, P1340, DOI 10.1162/NECO_a_00605; Zhang ML, 2007, PATTERN RECOGN, V40, P2038, DOI 10.1016/j.patcog.2006.12.019; Zhang Min-Ling, 2014, IEEE T KNOWL DATA EN, V26, P1; Zhang XY, 2015, IEEE T EVOLUT COMPUT, V19, P761, DOI 10.1109/TEVC.2014.2378512; Zhang XY, 2015, IEEE T NEUR NET LEAR, V26, P2816, DOI 10.1109/TNNLS.2015.2396940; Zhang XY, 2015, IEEE T EVOLUT COMPUT, V19, P201, DOI 10.1109/TEVC.2014.2308305; Zhang XY, 2014, INFORM SCIENCES, V278, P285, DOI 10.1016/j.ins.2014.03.053; Zhang XY, 2014, NEURAL COMPUT, V26, P974, DOI 10.1162/NECO_a_00580; Zhu PP, 2015, MOL BIOSYST, V11, P558, DOI 10.1039/c4mb00645c; Zou Q, 2016, BIG DATA RES; Zou Q, 2016, BRIEF FUNCT GENOMICS, V15, P55, DOI 10.1093/bfgp/elv024; Zou Q, 2016, NEUROCOMPUTING, V173, P346, DOI 10.1016/j.neucom.2014.12.123; Zou Q, 2015, BIOINFORMATICS, V31, P2475, DOI 10.1093/bioinformatics/btv177; Zou Q, 2014, BRIEF BIOINFORM, V15, P637, DOI 10.1093/bib/bbs088; Zou Q, 2013, BIOMED RES INT, V2013, DOI [10.1155/2013/686090, 10.1155/2013/608430]; Zou Q, 2013, J COMPUT THEOR NANOS, V10, P1038, DOI 10.1166/jctn.2013.2804	78	16	16	3	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153503	10.1371/journal.pone.0153503	http://dx.doi.org/10.1371/journal.pone.0153503			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078147	Green Published, gold, Green Submitted			2022-12-26	WOS:000374131700068
J	Jing, ZB; Xu, HB; Chen, XH; Zhong, Q; Huang, JW; Zhang, Y; Guo, W; Yang, Z; Ding, S; Chen, P; Huang, ZG				Jing, Zhibin; Xu, Hongbo; Chen, Xiaohong; Zhong, Qi; Huang, Junwei; Zhang, Yang; Guo, Wei; Yang, Zheng; Ding, Shuo; Chen, Ping; Huang, Zhigang			The Proton-Sensing G-Protein Coupled Receptor GPR4 Promotes Angiogenesis in Head and Neck Cancer	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SQUAMOUS-CELL CARCINOMA; FACTOR EXPRESSION; C-JUN; INTERLEUKIN-6; BEVACIZUMAB; RADIATION; SURVIVAL; DATABASE; THERAPY	Squamous cell carcinoma of the head and neck (SCCHN) is an aggressive disease with poor survival and is the sixth most common cancer worldwide. Gastroesophageal reflux is a common event in SCCHN patients. GPR4 is a proton-sensing G-protein coupled receptor, which can be activated by acidosis. The objective of this study was to explore the role of GPR4 in acid exposure and tumor angiogenesis in SCCHN. In this study, we confirmed that overexpressing GPR4 in SCCHN cells could increase the expression and secretion of IL6, IL8 and VEGFA at pH 5.9. This effect could be inhibited by SB203580 (a p38 inhibitor). Western blot analysis indicated that phosphorylation of p38 increased in GPR4 infected cells at pH 5.9, which could be inhibited by SB203580. In tube formation assay, HMEC-1 cells were incubated with conditioned medium (CM, pH 5.9, 6.5, 7.4) derived from control and GPR4 infected SCCHN cells. Tube length was significantly increased in HMEC-1 cells incubated with CM from GPR4 infected cells compared with control cells at pH5.9, which indicated the pro-angiogenic effect of GPR4 in acidic pH. The neutralizing antibodies of IL6, IL8 and VEGFA could inhibit tube formation of HMEC-1 cells. In vivo, the effect of GPR4 on angiogenesis was investigated with the chick chorioallantoic membrane (CAM) model. Control and GPR4 infected SCCHN cells were seeded onto the upper CAM surface (n = 5 in each group) and 5 mu L DMEM/F12 (pH 5.9, 6.5, 7.4) was added to the surface of the cell every 24 h. Four days later, the upper CAM were harvested and the ratio of the vascular area to the CAM area was quantified using Image-Pro Plus 6.0 software. GPR4 infected cells could recruit more vascular than control cells at pH5.9. In conclusion, we suggested that GPR4 induces angiogenesis via GPR4-induced p38-mediated IL6, IL8 and VEGFA secretion at acidic extracellular pH in SCCHN.	[Jing, Zhibin; Xu, Hongbo; Chen, Xiaohong; Zhong, Qi; Huang, Junwei; Zhang, Yang; Guo, Wei; Yang, Zheng; Ding, Shuo; Chen, Ping; Huang, Zhigang] Capital Med Univ, Beijing Tongren Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China	Capital Medical University	Huang, ZG (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China.	ent_huangzhigang@sina.com	xu, hong/GSD-8903-2022		Yangfan Program of Beijing Municipal Administration of Hospitals [XMLX201507]	Yangfan Program of Beijing Municipal Administration of Hospitals	This study was supported by grant from the Yangfan Program of Beijing Municipal Administration of Hospitals (no. XMLX201507). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Argiris A, 2013, ANN ONCOL, V24, P220, DOI 10.1093/annonc/mds245; Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; Cao S, 2011, ORAL ONCOL, V47, P459, DOI 10.1016/j.oraloncology.2011.04.001; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chen AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027586; Copper MP, 2000, LARYNGOSCOPE, V110, P1007, DOI 10.1097/00005537-200006000-00023; Dong LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061991; Duffy SA, 2008, CANCER-AM CANCER SOC, V113, P750, DOI 10.1002/cncr.23615; Eisma RJ, 1997, AM J SURG, V174, P513; Fury MG, 2012, CANCER-AM CANCER SOC, V118, P5008, DOI 10.1002/cncr.27498; Ge L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027529; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hsu HW, 2014, ORAL ONCOL, V50, P19, DOI 10.1016/j.oraloncology.2013.10.003; Im DS, 2005, ACTA PHARMACOL SIN, V26, P1435, DOI 10.1111/j.1745-7254.2005.00237.x; Justus CR, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00354; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kim K, 2005, FASEB J, V19, P819, DOI 10.1096/fj.04-2988fje; Kyzas PA, 2005, CLIN CANCER RES, V11, P1434, DOI 10.1158/1078-0432.CCR-04-1870; Kyzas PA, 2005, MODERN PATHOL, V18, P485, DOI 10.1038/modpathol.3800295; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Li T, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0236-4; Lingen MW, 1999, CRIT REV ORAL BIOL M, V10, P153, DOI 10.1177/10454411990100020301; Matossian M, 2014, INT J IMMUNOPATH PH, V27, P573, DOI 10.1177/039463201402700413; Papagerakis S, 2014, CANCER PREV RES, V7, P1258, DOI 10.1158/1940-6207.CAPR-14-0002; Pries R, 2006, EXPERT REV ANTICANC, V6, P1195, DOI 10.1586/14737140.6.9.1195; Ren J, 2014, CURR PHARM DESIGN, V20, P1904, DOI 10.2174/13816128113199990530; Riebe C, 2007, INT J MOL MED, V20, P883; Rofstad EK, 2006, CANCER RES, V66, P6699, DOI 10.1158/0008-5472.CAN-06-0983; Sato S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088831; Schmeck B, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-98; Shi Q, 2001, ONCOGENE, V20, P3751, DOI 10.1038/sj.onc.1204500; Sin WC, 2004, ONCOGENE, V23, P6299, DOI 10.1038/sj.onc.1207838; Smit CF, 1998, LARYNGOSCOPE, V108, P299, DOI 10.1097/00005537-199802000-00027; Sturgis EM, 2004, SEMIN ONCOL, V31, P726, DOI 10.1053/j.seminoncol.2004.09.013; Tobo M, 2007, CELL SIGNAL, V19, P1745, DOI 10.1016/j.cellsig.2007.03.009; Toohill RJ, 1997, AM J MED, V103, p100S, DOI 10.1016/S0002-9343(97)00333-1; Van Tubergen E, 2011, CANCER-AM CANCER SOC, V117, P2677, DOI 10.1002/cncr.25859; Wan Q, 2015, DATABASE J BIOL DATA, V2015; Wang PZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10370; Wang PZ, 2015, NUCLEIC ACIDS RES, V43, pD1133, DOI 10.1093/nar/gku980; Wang PZ, 2011, MOL BIOL REP, V38, P3551, DOI 10.1007/s11033-010-0465-8; Xiao WH, 2004, CANCER BIOL THER, V3, P1007, DOI 10.4161/cbt.3.10.1141; Xu HB, 2013, BIOCHEM BIOPH RES CO, V436, P96, DOI 10.1016/j.bbrc.2013.05.065; Yang LV, 2007, MOL CELL BIOL, V27, P1334, DOI 10.1128/MCB.01909-06	45	40	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0152789	10.1371/journal.pone.0152789	http://dx.doi.org/10.1371/journal.pone.0152789			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078157	Green Submitted, Green Published, gold			2022-12-26	WOS:000374131700008
J	Kowalska, A; Walczyk, A; Palyga, I; Gasior-Perczak, D; Gadawska-Juszczyk, K; Szymonek, M; Trybek, T; Lizis-Kolus, K; Szyska-Skrobot, D; Mikina, E; Hurej, S; Sluszniak, J; Mezyk, R; Gozdz, S				Kowalska, Aldona; Walczyk, Agnieszka; Palyga, Iwona; Gasior-Perczak, Danuta; Gadawska-Juszczyk, Klaudia; Szymonek, Monika; Trybek, Tomasz; Lizis-Kolus, Katarzyna; Szyska-Skrobot, Dorota; Mikina, Estera; Hurej, Stefan; Sluszniak, Janusz; Mezyk, Ryszard; Gozdz, Stanislaw			The Delayed Risk Stratification System in the Risk of Differentiated Thyroid Cancer Recurrence	PLOS ONE			English	Article							CARCINOMA PATIENTS; THERAPY; ASSOCIATION; PAPILLARY; ABLATION; INCREASE; OUTCOMES	Context There has been a marked increase in the detection of differentiated thyroid carcinoma (DTC) over the past few years, which has improved the prognosis. However, it is necessary to adjust treatment and monitoring strategies relative to the risk of an unfavourable disease course. Materials and Methods This retrospective study examined data from 916 patients with DTC who received treatment at a single centre between 2000 and 2013. The utility of the American Thyroid Association (ATA) and the European Thyroid Association (ETA) recommended systems for early assessment of the risk of recurrent/persistent disease was compared with that of the recently recommended delayed risk stratification (DRS) system. Results The PPV and NPV for the ATA (24.59% and 95.42%, respectively) and ETA (24.28% and 95.68%, respectively) were significantly lower than those for the DRS (56.76% and 98.5%, respectively) (p<0.0001). The proportion of variance for predicting the final outcome was 15.8% for ATA, 16.1% for ETA and 56.7% for the DRS. Recurrent disease was rare (1% of patients), and was nearly always identified in patients at intermediate/high risk according to the initial stratification (9/10 cases). Conclusions The DRS showed a better correlation with the risk of persistent disease than the early stratification systems and allows personalisation of follow-up. If clinicians plan to alter the intensity of surveillance, patients at intermediate/high risk according to the early stratification systems should remain within the specialized centers; however, low risk patients can be referred to endocrinologists or other appropriate practitioners for long-term follow-up, as these patients remained at low risk after risk re-stratification.	[Kowalska, Aldona; Walczyk, Agnieszka; Palyga, Iwona; Gasior-Perczak, Danuta; Gadawska-Juszczyk, Klaudia; Szymonek, Monika; Trybek, Tomasz; Lizis-Kolus, Katarzyna; Szyska-Skrobot, Dorota; Mikina, Estera; Hurej, Stefan] Holycross Canc Ctr, Dept Endocrinol, Kielce, Poland; [Sluszniak, Janusz] Holycross Canc Ctr, Dept Surg Oncol, Kielce, Poland; [Mezyk, Ryszard] Holycross Canc Ctr, Dept Canc Epidemiol, Kielce, Poland; [Gozdz, Stanislaw] Holycross Canc Ctr, Dept Clin Oncol, Kielce, Poland; [Gozdz, Stanislaw] Jan Kochanowski Univ Humanities & Sci, Fac Hlth Sci, Kielce, Poland	Jan Kochanowski University	Kowalska, A (corresponding author), Holycross Canc Ctr, Dept Endocrinol, Kielce, Poland.	aldonako@onkol.kielce.pl	Gąsior-Perczak, Danuta/AAM-2668-2020; Kielce, SCO/O-6702-2016; Walczyk, Agnieszka/ABC-3334-2020; Gozdz, Stanislaw/D-3300-2013	Gąsior-Perczak, Danuta/0000-0003-0936-4890; Walczyk, Agnieszka/0000-0002-5083-659X; Gozdz, Stanislaw/0000-0001-6902-3807; Palyga, Iwona/0000-0001-5333-6112	Holycross Cancer Centre	Holycross Cancer Centre	The study was funded by Holycross Cancer Centre. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschebrook-Kilfoy B, 2013, CANCER EPIDEM BIOMAR, V22, P1252, DOI 10.1158/1055-9965.EPI-13-0242; Brito JP, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4706; Cano-Palomares A, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/591285; Castagna MG, 2011, EUR J ENDOCRINOL, V165, P441, DOI 10.1530/EJE-11-0466; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Cordioli MICV, 2009, ARQ BRAS ENDOCRINOL, V53, P453, DOI 10.1590/S0004-27302009000400011; Davies L, 2014, JAMA OTOLARYNGOL, V140, P317, DOI 10.1001/jamaoto.2014.1; Elisei R, 2010, J CLIN ENDOCR METAB, V95, P1516, DOI 10.1210/jc.2009-1536; Enewold L, 2009, CANCER EPIDEM BIOMAR, V18, P784, DOI 10.1158/1055-9965.EPI-08-0960; Greene FL, 2002, AJCC CANC STAGING HD; Han JM, 2012, THYROID, V22, P784, DOI 10.1089/thy.2011.0322; Hughes DT, 2011, THYROID, V21, P231, DOI 10.1089/thy.2010.0137; Ito Y, 2012, ENDOCR J, V59, P119, DOI 10.1507/endocrj.EJ11-0288; Jeon MJ, 2014, EUR J ENDOCRINOL, V170, P23, DOI 10.1530/EJE-13-0524; Jung KW, 2015, CANCER RES TREAT, V47, P127, DOI 10.4143/crt.2015.060; Kowalska A, 2013, THYROID RES, V6, pA30, DOI DOI 10.1186/1756-6614-6-S2-A30; MAZZAFERRI EL, 1994, AM J MED, V97, P418, DOI 10.1016/0002-9343(94)90321-2; Momesso DP, 2014, ENDOCRIN METAB CLIN, V43, P401, DOI 10.1016/j.ecl.2014.02.010; Nascimento C, 2011, ENDOCR-RELAT CANCER, V18, pR29, DOI 10.1677/ERC-10-0292; Pacini F, 2006, EUR J ENDOCRINOL, V155, P385, DOI 10.1530/eje.1.02158e; Pitoia F, 2013, THYROID, V23, P1401, DOI 10.1089/thy.2013.0011; Scheffel RS, 2015, THYROID, V25, P883, DOI 10.1089/thy.2015.0077; Tuttle RM, 2010, THYROID, V20, P1341, DOI 10.1089/thy.2010.0178; Tuttle R Michael, 2008, Endocr Pract, V14, P764; Vaisman F, 2011, THYROID, V21, P1317, DOI 10.1089/thy.2011.0232	25	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153242	10.1371/journal.pone.0153242	http://dx.doi.org/10.1371/journal.pone.0153242			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078258	Green Published, gold, Green Submitted			2022-12-26	WOS:000374131700029
J	Larsen, SC; Angquist, L; Moldovan, M; Huikari, V; Sebert, S; Cavadino, A; Ahluwalia, TS; Skaaby, T; Linneberg, A; Husemoen, LLN; Toft, U; Pedersen, O; Hansen, T; Herzig, KH; Jarvelin, MR; Power, C; Hypponen, E; Heitmann, BL; Sorensen, TIA				Larsen, Sofus C.; Angquist, Lars; Moldovan, Max; Huikari, Ville; Sebert, Sylvain; Cavadino, Alana; Ahluwalia, Tarunveer Singh; Skaaby, Tea; Linneberg, Allan; Husemoen, Lise Lotte N.; Toft, Ulla; Pedersen, Oluf; Hansen, Torben; Herzig, Karl-Heinz; Jarvelin, Marjo-Riitta; Power, Chris; Hypponen, Elina; Heitmann, Berit L.; Sorensen, Thorkild I. A.			Serum 25-Hydroxyvitamin D Status and Longitudinal Changes in Weight and Waist Circumference: Influence of Genetic Predisposition to Adiposity	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; VITAMIN-D DEFICIENCY; BODY-MASS INDEX; BLOOD-PRESSURE; CONFER RISK; FTO GENE; OBESITY; VARIANTS; LOCI; AGE	Studies of the relationship between serum 25-hydroxyvitamin D (25(OH)D) and changes in measures of adiposity have shown inconsistent results, and interaction with genetic predisposition to obesity has rarely been examined. We examined whether 25(OH)D was associated with subsequent annual changes in body weight (Delta BW) or waist circumference (Delta WC), and whether the associations were modified by genetic predisposition to a high BMI, WC or waist-hip ratio adjusted for BMI (WHRBMI). The study was based on 10,898 individuals from the Danish Inter99, the 1958 British Birth Cohort and the Northern Finland Birth Cohort 1966. We combined 42 adiposity-associated Single Nucleotide Polymorphisms (SNPs) into four scores indicating genetic predisposition to BMI, WC and WHRBMI, or all three traits combined. Linear regression was used to examine the association between serum 25(OH)D and.BW or Delta WC, SNP-score x 25(OH)D interactions were examined, and results from the individual cohorts were meta-analyzed. In the meta-analyses, we found no evidence of an association between 25(OH)D and.BW (-9.4 gram/y per 10 nmol/L higher 25(OH)D [95% CI: -23.0, + 4.3; P = 0.18]) or Delta WC (-0.06 mm/y per 10 nmol/L higher 25(OH)D [95% CI: -0.17, + 0.06; P = 0.33]). Furthermore, we found no statistically significant interactions between the four SNP-scores and 25(OH) D in relation to Delta BW or Delta WC. Thus, in view of the narrow CIs, our results suggest that an association between 25(OH) D and changes in measures of adiposity is absent or marginal. Similarly, the study provided evidence that there is either no or very limited dependence on genetic predisposition to adiposity.	[Larsen, Sofus C.; Heitmann, Berit L.] Frederiksberg Univ Hosp, Parker Inst, Res Unit Dietary Studies, Frederiksberg, Denmark; [Larsen, Sofus C.; Heitmann, Berit L.] Bispebjerg Hosp, Parker Inst, Res Unit Dietary Studies, Frederiksberg, Denmark; [Larsen, Sofus C.; Angquist, Lars; Heitmann, Berit L.; Sorensen, Thorkild I. A.] Bispebjerg Hosp, Inst Prevent Med, DK-2400 Copenhagen, Denmark; [Larsen, Sofus C.; Angquist, Lars; Heitmann, Berit L.; Sorensen, Thorkild I. A.] Frederiksberg Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Moldovan, Max; Hypponen, Elina] Univ S Australia, Sch Hlth Sci, Ctr Populat Hlth Res, Adelaide, SA 5001, Australia; [Moldovan, Max; Hypponen, Elina] Univ S Australia, Sansom Inst, Adelaide, SA 5001, Australia; [Huikari, Ville; Sebert, Sylvain; Jarvelin, Marjo-Riitta] Univ Oulu, Fac Med, Ctr Life Course Hlth Res, POB 5000, FI-90014 Oulu, Finland; [Cavadino, Alana] Queen Mary Univ London, Barts & London Sch Med & Dent, Wolfson Inst Prevent Med, Ctr Environm & Prevent Med, London, England; [Cavadino, Alana; Power, Chris; Hypponen, Elina] UCL, UCL Inst Child Hlth, Populat Policy & Practice, London, England; [Ahluwalia, Tarunveer Singh; Pedersen, Oluf; Hansen, Torben; Sorensen, Thorkild I. A.] Univ Copenhagen, Fac Hlth & Med Sci, Sect Metab Genet, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Ahluwalia, Tarunveer Singh] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Skaaby, Tea; Linneberg, Allan; Husemoen, Lise Lotte N.; Toft, Ulla] Capital Reg Denmark, Res Ctr Prevent & Hlth, Copenhagen, Denmark; [Linneberg, Allan] Rigshosp, Dept Clin Expt Res, Glostrup, Denmark; [Linneberg, Allan] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Herzig, Karl-Heinz] Univ Oulu, Inst Biomed, Oulu, Finland; [Herzig, Karl-Heinz] Med Res Ctr Oulu, Oulu, Finland; [Herzig, Karl-Heinz] Oulu Univ Hosp, Oulu, Finland; [Herzig, Karl-Heinz; Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, POB 5000,Aapistie 5A, FI-90014 Oulu, Finland; [Herzig, Karl-Heinz] Poznan Univ Med Sci, Dept Gastroenterol & Metab, Poznan, Poland; [Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, MRC PHE Ctr Environm & Hlth, Dept Epidemiol & Biostat, London, England; [Jarvelin, Marjo-Riitta] Oulu Univ Hosp, Unit Primary Care, Kajaanintie 50,POB 20, FI-90220 Oulu, Oys, Finland; [Hypponen, Elina] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia; [Heitmann, Berit L.] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Heitmann, Berit L.] Univ Sydney, Boden Inst Obes Nutr Exercise & Eating Disorders, Sydney, NSW 2006, Australia; [Sorensen, Thorkild I. A.] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, Avon, England	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Bispebjerg Hospital; University of South Australia; University of South Australia; University of Oulu; University of London; Queen Mary University London; University of London; University College London; Novo Nordisk Foundation; University of Copenhagen; Steno Diabetes Center; Rigshospitalet; University of Copenhagen; University of Oulu; University of Oulu; University of Oulu; Poznan University of Medical Sciences; Imperial College London; University of Oulu; South Australian Health & Medical Research Institute (SAHMRI); University of Southern Denmark; University of Sydney; University of Bristol	Larsen, SC (corresponding author), Frederiksberg Univ Hosp, Parker Inst, Res Unit Dietary Studies, Frederiksberg, Denmark.; Larsen, SC (corresponding author), Bispebjerg Hosp, Parker Inst, Res Unit Dietary Studies, Frederiksberg, Denmark.; Larsen, SC (corresponding author), Bispebjerg Hosp, Inst Prevent Med, DK-2400 Copenhagen, Denmark.; Larsen, SC (corresponding author), Frederiksberg Univ Hosp, Inst Prevent Med, Copenhagen, Denmark.	sofus.christian.larsen@regionh.dk	Larsen, Sofus Christian/AAO-5894-2020; Hypponen, Elina/B-2596-2014; Cavadino, Alana/CAG-8915-2022; Pedersen, Oluf/Z-1731-2019; Ahluwalia, Tarunveer Singh/C-5549-2009; Toft, Ulla/AAH-2589-2020; Pedersen, Oluf/AAG-8015-2020; Moldovan, Max/H-7108-2014	Larsen, Sofus Christian/0000-0002-0838-9378; Hypponen, Elina/0000-0003-3670-9399; Cavadino, Alana/0000-0002-5709-367X; Pedersen, Oluf/0000-0002-3321-3972; Ahluwalia, Tarunveer Singh/0000-0002-7464-3354; Toft, Ulla/0000-0001-7770-8419; Moldovan, Max/0000-0001-9680-8474; Angquist, Lars/0000-0002-9516-4424; Skaaby, Tea/0000-0003-0031-5726; Heitmann, Berit Lilienthal/0000-0002-6809-4504; Linneberg, Allan/0000-0002-0994-0184; Jarvelin, Marjo-Riitta/0000-0002-2149-0630	Danish Council for Strategic Research [09-067111]; Danish Medical Research Council; Danish Centre for Evaluation and Health Technology Assessment; Novo Nordisk; Copenhagen County; Danish Heart Foundation; Danish Pharmaceutical Association; Agustinus foundation; Ib Henriksen foundation; Becket foundation; Finnish Academy [139900]; MRC [G0000934]; Wellcome Trust [068545/Z/02, 076113]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Allergy and Infectious Diseases; National Human Genome Research Institute; National Institute of Child Health and Human Development; Juvenile Diabetes Research Foundation International (JDRF); Department of Health Policy Research Programme through the Public Health Research Consortium (PHRC); Department of Health's National Institute for Health Research (NIHR) ('Biomedical Research Centres');  [U01 DK062418]; Lundbeck Foundation [R219-2016-471] Funding Source: researchfish; Medical Research Council [G0000934, MR/N01104X/1, G1001799] Funding Source: researchfish; MRC [MR/N01104X/1, G1001799] Funding Source: UKRI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062418] Funding Source: NIH RePORTER	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Centre for Evaluation and Health Technology Assessment; Novo Nordisk(Novo Nordisk); Copenhagen County; Danish Heart Foundation; Danish Pharmaceutical Association; Agustinus foundation; Ib Henriksen foundation; Becket foundation; Finnish Academy(Academy of Finland); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Juvenile Diabetes Research Foundation International (JDRF)(Juvenile Diabetes Research Foundation); Department of Health Policy Research Programme through the Public Health Research Consortium (PHRC); Department of Health's National Institute for Health Research (NIHR) ('Biomedical Research Centres')(National Institute for Health Research (NIHR)); ; Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was carried out as part of the research program Gene-Diet Interactions in Obesity (GENDINOB), supported by the Danish Council for Strategic Research (grant 09-067111). Data collection in the Inter99 study was supported economically by The Danish Medical Research Council, The Danish Centre for Evaluation and Health Technology Assessment, Novo Nordisk, Copenhagen County, The Danish Heart Foundation, The Danish Pharmaceutical Association, Agustinus foundation, Ib Henriksen foundation and Becket foundation. The NFBC1966 was support in part by the grants from the Finnish Academy project 139900. In 1958BC, DNA collection was funded by MRC grant G0000934 and cell-line creation by Wellcome Trust grant 068545/Z/02. This research used resources provided by the Type 1 Diabetes Genetics Consortium, a collaborative clinical study sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Allergy and Infectious Diseases, National Human Genome Research Institute, National Institute of Child Health and Human Development, and Juvenile Diabetes Research Foundation International (JDRF) and supported by U01 DK062418. This study makes use of data generated by the Wellcome Trust Case-Control Consortium. A full list of investigators who contributed to generation of the data is available from the Wellcome Trust Case-Control Consortium website. Funding for the project was provided by the Wellcome Trust under the award 076113. The work was supported by the Department of Health Policy Research Programme through the Public Health Research Consortium (PHRC). The views expressed in the publication are those of the authors and not necessarily those of the Department of Health. Information about the wider programme of the PHRC is available from http://phrc.lshtm.ac.uk. Great Ormond Street Hospital/University College London, Institute of Child Health receives a proportion of funding from the Department of Health's National Institute for Health Research (NIHR) ('Biomedical Research Centres' funding).	Aadahl M, 2009, PREV MED, V48, P326, DOI 10.1016/j.ypmed.2009.01.015; Ankarfeldt MZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110890; Bender AM, 2012, EUR J PREV CARD 1211; Benzinou M, 2008, NAT GENET, V40, P943, DOI 10.1038/ng.177; Beydoun MA, 2010, J CLIN ENDOCR METAB, V95, P3814, DOI 10.1210/jc.2010-0410; Cheng S, 2010, DIABETES, V59, P242, DOI 10.2337/db09-1011; Christakos S, 2013, ANN NY ACAD SCI, V1287, P45, DOI 10.1111/nyas.12129; Cotsapas C, 2009, HUM MOL GENET, V18, P3502, DOI 10.1093/hmg/ddp292; Dhurandhar NV, 2014, INT J OBES LOND, DOI 10.1038/ijo.2014.199; Earthman CP, 2012, INT J OBESITY, V36, P387, DOI 10.1038/ijo.2011.119; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gilbert-Diamond D, 2010, AM J CLIN NUTR, V92, P1446, DOI 10.3945/ajcn.2010.29746; Ginde AA, 2009, ARCH INTERN MED, V169, P626, DOI 10.1001/archinternmed.2008.604; Grandi NC, 2010, PREV MED, V51, P228, DOI 10.1016/j.ypmed.2010.06.013; Heard-Costa NL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000539; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Huotari A, 2008, INT J CIRCUMPOL HEAL, V67, P164, DOI 10.3402/ijch.v67i2-3.18258; Hypponen E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010801; Hypponen E, 2007, J CLIN ENDOCR METAB, V92, P4615, DOI 10.1210/jc.2007-1279; Hypponen E, 2007, AM J CLIN NUTR, V85, P860, DOI 10.1093/ajcn/85.3.860; Jarvelin MR, 2004, HYPERTENSION, V44, P838, DOI 10.1161/01.HYP.0000148304.33869.ee; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Kremer R, 2009, J CLIN ENDOCR METAB, V94, P67, DOI 10.1210/jc.2008-1575; Larsen SC, 2014, AM J CLIN NUTR; Larsen SC, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-43; Li SX, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000332; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Liu YJ, 2008, HUM MOL GENET, V17, P1803, DOI 10.1093/hmg/ddn072; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Loos RJF, 2012, BEST PRACT RES CL EN, V26, P211, DOI 10.1016/j.beem.2011.11.003; Lourenco BH, 2013, DIABETES; Mai XM, 2012, AM J EPIDEMIOL, V175, P1029, DOI 10.1093/aje/kwr456; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Mutt SJ, 2012, FASEB J, V26, P4400, DOI 10.1096/fj.12-210880; Pathak K, 2014, OBES REV; Pilz S, 2013, CURR DIABETES REP, V13, P261, DOI 10.1007/s11892-012-0358-4; Pilz S, 2013, ANTI-CANCER AGENT ME, V13, P107, DOI 10.2174/187152013804487407; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Qi QB, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1610; Qi QB, 2012, NEW ENGL J MED, V367, P1387, DOI 10.1056/NEJMoa1203039; Rukh G, 2015, INT J OBES LOND 0916; Sandholt CH, 2014, OBESITY, V22, P901, DOI 10.1002/oby.20540; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Tammelin T, 2004, INT J OBESITY, V28, P775, DOI 10.1038/sj.ijo.0802622; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Thuesen B, 2012, BONE, V50, P605, DOI 10.1016/j.bone.2011.12.016; Vieth R, 2007, AM J CLIN NUTR, V85, P649, DOI 10.1093/ajcn/85.3.649; Vimaleswaran KS, 2014, LANCET DIABETES ENDO, V2, P719, DOI 10.1016/S2213-8587(14)70113-5; Vimaleswaran KS, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-37; Vimaleswaran KS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001383; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Young KA, 2009, J CLIN ENDOCR METAB, V94, P3306, DOI 10.1210/jc.2009-0079	54	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153611	10.1371/journal.pone.0153611	http://dx.doi.org/10.1371/journal.pone.0153611			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077659	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000374131700094
J	Bassoy, EY; Chiusolo, V; Jacquemin, G; Riccadonna, C; Walker, PR; Martinvalet, D				Bassoy, Esen Yonca; Chiusolo, Valentina; Jacquemin, Guillaume; Riccadonna, Cristina; Walker, Paul R.; Martinvalet, Denis			Glioma Stemlike Cells Enhance the Killing of Glioma Differentiated Cells by Cytotoxic Lymphocytes	PLOS ONE			English	Article							CLINICAL-VALUE; CANCER; HETEROGENEITY; LESSONS; DEATH; CD133	Glioblastoma multiforme, the most aggressive primary brain tumor, is maintained by a sub-population of glioma cells with self-renewal properties that are able to recapitulate the entire tumor even after surgical resection or chemo-radiotherapy. This typifies the vast heterogeneity of this tumor with the two extremes represented on one end by the glioma stemlike cells (GSC) and on the other by the glioma differentiated cells (GDC). Interestingly, GSC are more sensitive to immune effector cells than the GDC counterpart. However, how GSC impact on the killing on the GDC and vice versa is not clear. Using a newly developed cytotoxicity assay allowing to simultaneously monitor cytotoxic lymphocytes-mediated killing of GSC and GDC, we found that although GSC were always better killed and that their presence enhanced the killing of GDC. In contrast, an excess of GDC had a mild protective effect on the killing of GSC, depending on the CTL type. Overall, our results suggest that during combination therapy, immunotherapy would be the most effective after prior treatment with conventional therapies.	[Bassoy, Esen Yonca; Chiusolo, Valentina; Jacquemin, Guillaume; Martinvalet, Denis] Univ Geneva, Dept Cell Physiol & Metab, CH-1211 Geneva, Switzerland; [Riccadonna, Cristina; Walker, Paul R.] Univ Hosp Geneva, CH-1211 Geneva, Switzerland; [Riccadonna, Cristina; Walker, Paul R.] Univ Geneva, Ctr Oncol, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva	Martinvalet, D (corresponding author), Univ Geneva, Dept Cell Physiol & Metab, CH-1211 Geneva, Switzerland.	Denis.Martinvalet@unige.ch		Bassoy, Esen Yonca/0000-0001-8870-7040; Chiusolo, Valentina/0000-0002-5470-8181	European Research Council [ERC-2010-StG_20091118]; Ambizione SNSF [PZ00P3_126710/1]; Boninchi Foundation; Carlos and Elsie de Reuter Foundation; Schmidheiny Foundation	European Research Council(European Research Council (ERC)European Commission); Ambizione SNSF; Boninchi Foundation; Carlos and Elsie de Reuter Foundation; Schmidheiny Foundation	This work was supported by European Research Council starting grant ERC-2010-StG_20091118, Ambizione SNSF PZ00P3_126710/1, grants from the Boninchi Foundation, Carlos and Elsie de Reuter Foundation and Schmidheiny Foundation.	Apetoh L, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2014.998538; Auffinger B, 2015, EXPERT REV NEUROTHER, V15, P741, DOI 10.1586/14737175.2015.1051968; Avril T, 2012, BRAIN PATHOL, V22, P159, DOI 10.1111/j.1750-3639.2011.00515.x; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Barcia C, 2009, AM J PATHOL, V175, P786, DOI 10.2353/ajpath.2009.081034; Binello E, 2011, CANCER SCI, V102, P1958, DOI 10.1111/j.1349-7006.2011.02064.x; Brown CE, 2009, CANCER RES, V69, P8886, DOI 10.1158/0008-5472.CAN-09-2687; Castriconi R, 2009, J IMMUNOL, V182, P3530, DOI 10.4049/jimmunol.0802845; Castro MG, 2003, PHARMACOL THERAPEUT, V98, P71, DOI 10.1016/S0163-7258(03)00014-7; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Chen J, 2012, CELL, V149, P36, DOI 10.1016/j.cell.2012.03.009; Chowdhury D, 2008, ANNU REV IMMUNOL, V26, P389, DOI 10.1146/annurev.immunol.26.021607.090404; Ciavardelli D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.285; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Dahlrot RH, 2014, INT J CLIN EXP PATHO, V7, P3739; Dahlrot RH, 2013, J NEURO-ONCOL, V115, P453, DOI 10.1007/s11060-013-1246-8; Dahlrot RH, 2013, INT J CLIN EXP PATHO, V6, P334; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Derouazi M, 2015, CANCER RES, V75, P3020, DOI 10.1158/0008-5472.CAN-14-3017; Dutoit V, 2012, BRAIN, V135, P1042, DOI 10.1093/brain/aws042; Ehtesham M, 2009, CANCER LETT, V274, P305, DOI 10.1016/j.canlet.2008.09.034; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Hadjipanayis CG, 2009, J MOL MED, V87, P363, DOI 10.1007/s00109-009-0440-9; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Ji Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096650; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Pellegatta S, 2006, CANCER RES, V66, P10247, DOI 10.1158/0008-5472.CAN-06-2048; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Suva ML, 2014, CELL, V157, P580, DOI 10.1016/j.cell.2014.02.030; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wu AH, 2007, J NEURO-ONCOL, V83, P121, DOI 10.1007/s11060-006-9265-3; Yang J, 2010, P NATL ACAD SCI USA, V107, P4716, DOI 10.1073/pnas.0911587107; Zeppernick F, 2008, CLIN CANCER RES, V14, P123, DOI 10.1158/1078-0432.CCR-07-0932; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	40	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153433	10.1371/journal.pone.0153433	http://dx.doi.org/10.1371/journal.pone.0153433			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073883	Green Published, Green Submitted, gold			2022-12-26	WOS:000374131200091
J	Chen, YH; Han, YY; Zhang, M; Zhou, S; Kong, XZ; Wang, W				Chen, Yanhui; Han, Yangyang; Zhang, Meng; Zhou, Shan; Kong, Xiangzhu; Wang, Wei			Overexpression of the Wheat Expansin Gene TaEXPA2 Improved Seed Production and Drought Tolerance in Transgenic Tobacco Plants	PLOS ONE			English	Article							CELL-WALL EXTENSION; MAIZE PRIMARY ROOT; BETA-EXPANSIN; STRESS-RESPONSE; PROLINE CONTENT; ALPHA-EXPANSIN; ABIOTIC STRESS; EXPRESSION; GROWTH; SALT	Expansins are cell wall proteins that are grouped into two main families, alpha-expansins and beta-expansins, and they are implicated in the control of cell extension via the disruption of hydrogen bonds between cellulose and matrix glucans. TaEXPA2 is an a-expansin gene identified in wheat. Based on putative cis-regulatory elements in the TaEXPA2 promoter sequence and the expression pattern induced when polyethylene glycol (PEG) is used to mimic water stress, we hypothesized that TaEXPA2 is involved in plant drought tolerance and plant development. Through transient expression of 35S::TaEXPA2-GFP in onion epidermal cells, TaEXPA2 was localized to the cell wall. Constitutive expression of TaEXPA2 in tobacco improved seed production by increasing capsule number, not seed size, without having any effect on plant growth patterns. The transgenic tobacco exhibited a significantly greater tolerance to water-deficiency stress than did wild-type (WT) plants. We found that under drought stress, the transgenic plants maintained a better water status. The accumulated content of osmotic adjustment substances, such as proline, in TaEXPA2 transgenic plants was greater than that in WT plants. Transgenic plants also displayed greater antioxidative competence as indicated by their lower malondialdehyde (MDA) content, relative electrical conductivity, and reactive oxygen species (ROS) accumulation than didWT plants. This result suggests that the transgenic plants suffer less damage from ROS under drought conditions. The activities of some antioxidant enzymes as well as expression levels of several genes encoding key antioxidant enzymes were higher in the transgenic plants than in the WT plants under drought stress. Collectively, our results suggest that ectopic expression of the wheat expansin gene TaEXPA2 improves seed production and drought tolerance in transgenic tobacco plants.	[Chen, Yanhui; Han, Yangyang; Zhang, Meng; Zhou, Shan; Kong, Xiangzhu; Wang, Wei] Shandong Agr Univ, Coll Life Sci, Shandong Key Lab Crop Biol, State Key Lab Crop Biol, Tai An 271018, Shandong, Peoples R China; [Han, Yangyang] Weifang Med Univ, Plast Surg Inst, Weifang 261041, Shandong, Peoples R China	Shandong Agricultural University; Weifang Medical University	Wang, W (corresponding author), Shandong Agr Univ, Coll Life Sci, Shandong Key Lab Crop Biol, State Key Lab Crop Biol, Tai An 271018, Shandong, Peoples R China.	wangw@sdau.edu.cn	han, yang/GRS-2388-2022		National Natural Science Foundation of China [31370304]; Opening Foundation of State Key Laboratory of Crop Biology [2013KF01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Opening Foundation of State Key Laboratory of Crop Biology	This research is supported by the National Natural Science Foundation of China (Grant number: 31370304) and by the Opening Foundation of State Key Laboratory of Crop Biology (Grant number: 2013KF01). The URL is http://www.nsfc.gov.cn/. W. W. received the funding.	Abuqamar S, 2013, MOL PLANT PATHOL, V14, P813, DOI 10.1111/mpp.12049; Aroca R, 2003, PHYSIOL PLANTARUM, V117, P540, DOI 10.1034/j.1399-3054.2003.00065.x; Bae JM, 2014, TRANSGENIC RES, V23, P657, DOI 10.1007/s11248-014-9804-1; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; Chaves MM, 2004, J EXP BOT, V55, P2365, DOI 10.1093/jxb/erh269; Cho HT, 2002, PLANT CELL, V14, P3237, DOI 10.1105/tpc.006437; Choi D, 2008, ADV BOT RES, V47, P47, DOI 10.1016/S0065-2296(08)00002-5; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Dai FW, 2012, PLANT PHYSIOL, V160, P2064, DOI 10.1104/pp.112.207720; Dat JF, 1998, PLANT PHYSIOL, V118, P1455, DOI 10.1104/pp.118.4.1455; Demiral T, 2005, ENVIRON EXP BOT, V53, P247, DOI 10.1016/j.envexpbot.2004.03.017; DORFFLING K, 1993, J PLANT PHYSIOL, V142, P222, DOI 10.1016/S0176-1617(11)80968-5; Duca M, 2015, BIOL MED PHYS BIOMED, P39, DOI 10.1007/978-3-319-17909-4_3; Gao Q, 2008, PROTOPLASMA, V233, P73, DOI 10.1007/s00709-008-0303-1; Goh HH, 2012, PLANT PHYSIOL, V159, P1759, DOI 10.1104/pp.112.200881; Guo D, 2014, TRANSGENIC RES, V23, P331, DOI 10.1007/s11248-013-9753-0; Guo WB, 2011, PLANT J, V66, P541, DOI 10.1111/j.1365-313X.2011.04511.x; Han YY, 2012, PLANT PHYSIOL BIOCH, V54, P49, DOI 10.1016/j.plaphy.2012.02.007; Han YY, 2015, J PLANT PHYSIOL, V173, P62, DOI 10.1016/j.jplph.2014.09.007; He XY, 2015, J EXP BOT, V66, P7405, DOI 10.1093/jxb/erv436; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hodge A, 2009, PLANT SOIL, V321, P153, DOI 10.1007/s11104-009-9929-9; Hu ZR, 2013, NEW PHYTOL, V197, P1344, DOI 10.1111/nph.12131; Jones L, 2004, FEBS LETT, V559, P61, DOI 10.1016/S0014-5793(04)00023-7; KNUDSON LL, 1977, PLANT PHYSIOL, V60, P606, DOI 10.1104/pp.60.4.606; Kong XP, 2011, PLANT CELL REP, V30, P2097, DOI 10.1007/s00299-011-1116-9; Kwon YR, 2008, BIOTECHNOL LETT, V30, P1281, DOI 10.1007/s10529-008-9678-5; Lee Y, 2001, CURR OPIN PLANT BIOL, V4, P527, DOI 10.1016/S1369-5266(00)00211-9; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Li AX, 2015, ENVIRON EXP BOT, V110, P73, DOI 10.1016/j.envexpbot.2014.10.002; Li F, 2011, J PLANT PHYSIOL, V168, P960, DOI 10.1016/j.jplph.2010.11.023; Li Q, 2011, J PLANT PHYSIOL, V168, P927, DOI 10.1016/j.jplph.2010.11.025; Li Y, 2003, CURR OPIN PLANT BIOL, V6, P603, DOI 10.1016/j.pbi.2003.09.003; Liu JP, 1997, PLANT PHYSIOL, V114, P591, DOI 10.1104/pp.114.2.591; Liu Y, 2007, GENOMICS, V90, P516, DOI 10.1016/j.ygeno.2007.06.012; Lu PT, 2013, PLANTA, V237, P1547, DOI 10.1007/s00425-013-1867-3; MCQUEENMASON S, 1992, PLANT CELL, V4, P1425, DOI 10.1105/tpc.4.11.1425; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Rao MV, 1996, PLANT PHYSIOL, V110, P125, DOI 10.1104/pp.110.1.125; Reidy B, 2001, PLANT MOL BIOL, V46, P491, DOI 10.1023/A:1010621417854; Sampedro J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-242; Sun LP, 2012, PLANT CELL REP, V31, P1473, DOI 10.1007/s00299-012-1262-8; Tian FX, 2014, PLANT SCI, V226, P92, DOI 10.1016/j.plantsci.2014.03.006; Wu LJ, 2008, PLANT PHYSIOL, V148, P1953, DOI 10.1104/pp.108.126813; Wu YJ, 1996, PLANT PHYSIOL, V111, P765, DOI 10.1104/pp.111.3.765; Wu YJ, 2001, PLANT PHYSIOL, V126, P1471, DOI 10.1104/pp.126.4.1471; Xing SC, 2009, BIOL PLANTARUM, V53, P429, DOI 10.1007/s10535-009-0082-3; Xu B, 2013, MOL PLANT, V6, P945, DOI 10.1093/mp/sss112; Xu Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100792; Yu ZM, 2011, PLANT J, V66, P725, DOI 10.1111/j.1365-313X.2011.04533.x; Yue B, 2006, GENETICS, V172, P1213, DOI 10.1534/genetics.105.045062; Zhao MR, 2012, PLANT CELL REP, V31, P671, DOI 10.1007/s00299-011-1185-9; Zhou J, 2014, PHYSIOL PLANTARUM, V150, P194, DOI 10.1111/ppl.12077; Zhou S, 2015, J PLANT PHYSIOL, V183, P64, DOI 10.1016/j.jplph.2015.05.012	54	54	59	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153494	10.1371/journal.pone.0153494	http://dx.doi.org/10.1371/journal.pone.0153494			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073898	gold, Green Published, Green Submitted			2022-12-26	WOS:000374131200100
J	Chernova, E; Pacherova, O; Kocourek, T; Jelinek, M; Dejneka, A; Tyunina, M				Chernova, E.; Pacherova, O.; Kocourek, T.; Jelinek, M.; Dejneka, A.; Tyunina, M.			Optical Properties of Ferroelectric Epitaxial K0.5Na0.5NbO3 Films in Visible to Ultraviolet Range	PLOS ONE			English	Article							THIN-FILMS; POLARIZATION; TRANSITIONS; PEROVSKITES	The complex index of refraction in the spectral range of 0.74 to 4.5 eV is studied by variable- angle spectroscopic ellipsometry in ferroelectric K0.5Na0.5NbO3 films. The 20-nm-thick cube-on-cube- type epitaxial films are grown on SrTiO3(001) and DyScO3(011) single-crystal substrates. The films are transparent and exhibit a significant difference between refractive indices Delta n = 0.5 at photon energies below 3 eV. The energies of optical transitions are in the range of 3.15-4.30 eV and differ by 0.2-0.3 eV in these films. The observed behavior is discussed in terms of lattice strain and strain-induced ferroelectric polarization in epitaxial perovskite oxide films.	[Chernova, E.; Pacherova, O.; Kocourek, T.; Jelinek, M.; Dejneka, A.; Tyunina, M.] Acad Sci Czech Republ, Inst Phys, Na Slovance 2, Prague 18221 8, Czech Republic; [Chernova, E.] Czech Tech Univ, Tech 2, Prague 16627 6, Czech Republic; [Tyunina, M.] Univ Oulu, Microelect & Mat Phys Labs, POB 4500, FI-90014 Oulu, Finland	Czech Academy of Sciences; Institute of Physics of the Czech Academy of Sciences; Czech Technical University Prague; University of Oulu	Chernova, E; Tyunina, M (corresponding author), Acad Sci Czech Republ, Inst Phys, Na Slovance 2, Prague 18221 8, Czech Republic.; Chernova, E (corresponding author), Czech Tech Univ, Tech 2, Prague 16627 6, Czech Republic.; Tyunina, M (corresponding author), Univ Oulu, Microelect & Mat Phys Labs, POB 4500, FI-90014 Oulu, Finland.	chernova@fzu.cz; marinat@ee.oulu.fi	Pacherova, Oliva/H-1859-2014; Kocourek, Tomáš/G-8432-2014; Dejneka, Alexandr/G-6384-2014; Tjunina, Marina/G-7059-2019	Kocourek, Tomáš/0000-0002-9356-5793; Dejneka, Alexandr/0000-0002-5116-8781; Tjunina, Marina/0000-0003-4149-5858; Chernova, Ekaterina/0000-0002-4422-8045; Jelinek, Miroslav/0000-0001-9824-1117	Czech Science Foundation [15-13778S]; Finnish Funding Agency for Innovation [400.31.2013]	Czech Science Foundation(Grant Agency of the Czech Republic); Finnish Funding Agency for Innovation	This work was supported by Czech Science Foundation (Grant No. 15-13778S, https://gacr.cz,recipient: AD) and Finnish Funding Agency for Innovation (Grant No. 400.31.2013, https://www.tekes.fi/en,recipient: MT).	Abel S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2695; Berger RF, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.146804; Blomqvist M, 2003, APPL PHYS LETT, V82, P439, DOI 10.1063/1.1539295; BREWS JR, 1967, PHYS REV LETT, V18, P662, DOI 10.1103/PhysRevLett.18.662; Chernova E, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4921083; Dicken MJ, 2008, NANO LETT, V8, P4048, DOI 10.1021/nl802981q; DIDOMENICO M, 1968, PHYS REV, V166, P565, DOI 10.1103/PhysRev.166.565; Dieguez O, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.144101; DOW JD, 1971, PHYS REV LETT, V26, P762, DOI 10.1103/PhysRevLett.26.762; Ederer C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.257601; Fujiwara H, 2000, PHYS REV B, V61, P10832, DOI 10.1103/PhysRevB.61.10832; Gautam LK, 2014, THIN SOLID FILMS, V571, P548, DOI 10.1016/j.tsf.2014.03.020; Guo R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2990; Kroupa J, 2005, J PHYS D APPL PHYS, V38, P679, DOI 10.1088/0022-3727/38/5/003; Lines M.E., 2001, PRINCIPLES APPL FERR; Pertsev NA, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2988263; Pertsev NA, 1998, PHYS REV LETT, V80, P1988, DOI 10.1103/PhysRevLett.80.1988; Saito Y, 2004, NATURE, V432, P84, DOI 10.1038/nature03028; Sun HQ, 2012, J APPL PHYS, V111, DOI 10.1063/1.3686193; TAUC J, 1966, PHYS STATUS SOLIDI, V15, P627, DOI 10.1002/pssb.19660150224; Tejuca L.G., 2000, PROPERTIES APPL PERO; Tellier J, 2009, SOLID STATE SCI, V11, P320, DOI 10.1016/j.solidstatesciences.2008.07.011; Tompkins H, 2005, HDB ELLIPSOMETRY; Tyunina M, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/4/043048; Tyunina M, 2015, SCI TECHNOL ADV MAT, V16, DOI 10.1088/1468-6996/16/2/026002; Wang FG, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4871707; WEMPLE SH, 1970, PHYS REV B, V2, P2679, DOI 10.1103/PhysRevB.2.2679; Woollam J., 2005, GUIDE USING WVASE32; Woollam JA, 2000, PROC SPIE, V4099, P197, DOI 10.1117/12.405820; Wu XG, 2015, ACCIDENT ANAL PREV, V78, P58, DOI 10.1016/j.aap.2015.02.003	31	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153261	10.1371/journal.pone.0153261	http://dx.doi.org/10.1371/journal.pone.0153261			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074042	Green Published, gold, Green Submitted			2022-12-26	WOS:000374131200068
J	Willot, Q; Simonis, P; Vigneron, JP; Aron, S				Willot, Quentin; Simonis, Priscilla; Vigneron, Jean-Pol; Aron, Serge			Total Internal Reflection Accounts for the Bright Color of the Saharan Silver Ant	PLOS ONE			English	Article							INTERFERENCE MICROSCOPY; BUTTERFLY SCALES; REFRACTIVE-INDEX; DISPERSION; CRYSTALS	The Saharan silver ant Cataglyphis bombycina is one of the terrestrial living organisms best adapted to tolerate high temperatures. It has recently been shown that the hairs covering the ant's dorsal body part are responsible for its silvery appearance. The hairs have a triangular cross-section with two corrugated surfaces allowing a high optical reflection in the visible and near-infrared (NIR) range of the spectrum while maximizing heat emissivity in the mid-infrared (MIR). Those two effects account for remarkable thermoregulatory properties, enabling the ant to maintain a lower thermal steady state and to cope with the high temperature of its natural habitat. In this paper, we further investigate how geometrical optical and high reflection properties account for the bright silver color of C. bombycina. Using optical ray-tracing models and attenuated total reflection (ATR) experiments, we show that, for a large range of incidence angles, total internal reflection (TIR) conditions are satisfied on the basal face of each hair for light entering and exiting through its upper faces. The reflection properties of the hairs are further enhanced by the presence of the corrugated surface, giving them an almost total specular reflectance for most incidence angles. We also show that hairs provide an almost 10-fold increase in light reflection, and we confirm experimentally that they are responsible for a lower internal body temperature under incident sunlight. Overall, this study improves our understanding of the optical mechanisms responsible for the silver color of C. bombycina and the remarkable thermoregulatory properties of the hair coat covering the ant's body.	[Willot, Quentin; Aron, Serge] Univ Libre Bruxelles, Evolutionary Biol & Ecol, Brussels, Belgium; [Simonis, Priscilla; Vigneron, Jean-Pol] Univ Namur, Res Ctr Phys Matter & Radiat PMR, Photon Living Organisms Grp, Namur, Belgium	Universite Libre de Bruxelles; University of Namur	Aron, S (corresponding author), Univ Libre Bruxelles, Evolutionary Biol & Ecol, Brussels, Belgium.	saron@ulb.ac.be			Wallonia-Brussels Federation; Universite de Namur [033]; Belgian FRIA; FRS-FNRS; Belgian Fonds National de la recherche Scientifique [FRFC 2.4516.11]; Universite Libre de Bruxelles	Wallonia-Brussels Federation; Universite de Namur; Belgian FRIA(Fonds de la Recherche Scientifique - FNRS); FRS-FNRS(Fonds de la Recherche Scientifique - FNRS); Belgian Fonds National de la recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Universite Libre de Bruxelles	This work was supported by the Wallonia-Brussels Federation (PS), the Universite de Namur (grant ARC2010-2015#033) (JPV), the Universite Libre de Bruxelles (ARC2010-2015 $5) (SA), the Belgian FRIA (QW), the FRS-FNRS (PS, SA), and the Belgian Fonds National de la recherche Scientifique (FRFC 2.4516.11) (SA). The authors acknowledge using resources from the Interuniversity Scientific Computing Facility located at the University of Namur (Belgium), which is supported by the FRS-FNRS under convention 2.4617.07. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autumn K, 2000, NATURE, V405, P681, DOI 10.1038/35015073; Bay A, 2012, PROC SPIE, V8480, DOI 10.1117/12.928696; Berthier S, 2003, OPT COMMUN, V228, P349, DOI 10.1016/j.optcom.2003.10.032; Boher P, 2011, J INF DISP, V12, P179, DOI 10.1080/15980316.2011.621313; BOULIGAND Y, 1972, TISSUE CELL, V4, P189, DOI 10.1016/S0040-8166(72)80042-9; Delye G, 1957, INSECT SOC, V4, P72; GEHRING WJ, 1995, P NATL ACAD SCI USA, V92, P2994, DOI 10.1073/pnas.92.7.2994; GHIRADELLA H, 1989, J MORPHOL, V202, P69, DOI 10.1002/jmor.1052020106; Ghiradella H, 2010, ADV INSECT PHYSIOL, V38, P135, DOI 10.1016/S0065-2806(10)38006-4; Ghiradella HT, 2009, J R SOC INTERFACE, V6, pS243, DOI 10.1098/rsif.2008.0372.focus; Goldstein Dennis H., 2005, Proceedings of the SPIE - The International Society for Optical Engineering, V5888, p58880T, DOI 10.1117/12.618546; Harrick N.J., 1967, INTERNAL REFLECTION; Hemmi JM, 2006, J EXP BIOL, V209, P4140, DOI 10.1242/jeb.02483; HOLM E, 1973, ECOLOGY, V54, P44; Kattawar G. W., 1994, P SOC PHOTOOPT INS, V5, P42; Leertouwer HL, 2011, OPT EXPRESS, V19, P24061, DOI 10.1364/OE.19.024061; Marsh, 1985, THESIS U CAPE TOWN; Moseley PL, 1997, J APPL PHYSIOL, V83, P1413, DOI 10.1152/jappl.1997.83.5.1413; NEVILLE AC, 1969, BIOL REV, V44, P531, DOI 10.1111/j.1469-185X.1969.tb00611.x; Shi NN, 2015, SCIENCE, V349, P298, DOI 10.1126/science.aab3564; Simonis P, 2013, OPT EXPRESS, V21, P6979, DOI 10.1364/OE.21.006979; Simonis P, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.011908; Sommer S, 2012, ARTHROPOD STRUCT DEV, V41, P71, DOI 10.1016/j.asd.2011.08.002; Stavenga DG, 2013, LIGHT-SCI APPL, V2, DOI 10.1038/lsa.2013.56; Vigneron JP, 2012, PHYSICA B, V407, P4032, DOI 10.1016/j.physb.2011.12.130; Vigneron JP, 2006, PROC SPIE, V6128, DOI 10.1117/12.646835; Vigneron JP, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.031907; Vigneron JP, 2010, ADV INSECT PHYSIOL, V38, P181, DOI 10.1016/S0065-2806(10)38004-0; Vukusic P, 1999, P ROY SOC B-BIOL SCI, V266, P1403, DOI 10.1098/rspb.1999.0794; WATT WB, 1968, EVOLUTION, V22, P437, DOI 10.1111/j.1558-5646.1968.tb03985.x; WEHNER R, 1992, NATURE, V357, P586, DOI 10.1038/357586a0; Whitehead L., 2008, PHYS CANADA, V64, P7; WILLMER PG, 1981, OECOLOGIA, V50, P250, DOI 10.1007/BF00348047; Withrow AP, 1956, RADIAT BIOL, V3, P125	34	27	27	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152325	10.1371/journal.pone.0152325	http://dx.doi.org/10.1371/journal.pone.0152325			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073923	Green Published, Green Submitted, gold			2022-12-26	WOS:000374131200020
J	Ayala, F; Moreno-Perez, V; Vera-Garcia, FJ; Moya, M; Sanz-Rivas, D; Fernandez-Fernandez, J				Ayala, Francisco; Moreno-Perez, Victor; Vera-Garcia, Francisco J.; Moya, Manuel; Sanz-Rivas, David; Fernandez-Fernandez, Jaime			Acute and Time-Course Effects of Traditional and Dynamic Warm-Up Routines in Young Elite Junior Tennis Players	PLOS ONE			English	Article							POST-ACTIVATION POTENTIATION; WEIGHTED VEST; POSTACTIVATION POTENTIATION; JUMPING PERFORMANCE; SPORTS-MEDICINE; STATIC STRETCH; POWER; EXERCISE; PROTOCOLS; STRENGTH	Despite the large number of studies that have examined the acute effects of different warm up modalities (WU) on physical performance, none of them have documented the time course of potential performance recovery in tennis players. The aim of this study was twofold: (a) to analyze and compare the acute effects of two different WU modalities (traditional WU [TWU] and dynamic WU [DWU]) on physical performance (i.e., CMJ, sprint, serve speed and accuracy) in elite junior players, as well as (b) to monitor the time course of any WU-induced changes after 30 and 60 min of simulated match-play. Twelve junior elite players completed both WUs modalities (TWU and DWU) in a counterbalanced order on separate days. In each experimental session, counter movement jump (CMJ), 20-m sprint, tennis serve speed and accuracy tests were performed before (immediately after TWU or DWU) during (30 min) and after 60 min of a simulated match play. Measures were compared via four factorial (WU intervention and time) repeated measures ANOVAs. There were main effects of WU (TWU and DWU) throughout the time for all the variables analysed. The results indicate that DWU routine led to significantly faster 20 m sprint times and higher CMJs as well as faster and more accurate tennis serves at both post warm-up and 30 min match-play testing moments in comparison with the scores reported by the TWU routine (p < 0.05; positive effects with a probability of > 75-99%). No significant intergroup differences were found at 60-min match-play testing moment in any variable (except for the 20 m sprint). Therefore, the findings of this study recommend for optimal performance in these elite tennis players, DWU routines should be performed prior to formal training and competition rather than TWU routines.	[Ayala, Francisco; Moreno-Perez, Victor; Vera-Garcia, Francisco J.; Moya, Manuel; Fernandez-Fernandez, Jaime] Miguel Hernandez Univ, Sports Res Ctr, Elche, Spain; [Sanz-Rivas, David; Fernandez-Fernandez, Jaime] Tennis Performance Res Grp, Madrid, Spain; [Sanz-Rivas, David] Royal Spanish Tennis Federat RFET, Madrid, Spain	Universidad Miguel Hernandez de Elche	Fernandez-Fernandez, J (corresponding author), Miguel Hernandez Univ, Sports Res Ctr, Elche, Spain.; Fernandez-Fernandez, J (corresponding author), Tennis Performance Res Grp, Madrid, Spain.	jaime.fernandez@goumh.umh.es	Fernandez-Fernandez, Jaime/AAO-9270-2020; PEREZ, VICTOR/ADL-7089-2022; MOYA, MANUEL/F-7172-2016; Sanz-Rivas, David/AAX-4630-2021; Vera-Garcia, Francisco J/L-7755-2014; Sanz-Rivas, David/J-6069-2018; Ayala, Francisco/AAB-2094-2020; Ayala, Francisco/L-2976-2014	MOYA, MANUEL/0000-0002-2291-5899; Sanz-Rivas, David/0000-0002-2577-4198; Vera-Garcia, Francisco J/0000-0003-4792-8087; Ayala, Francisco/0000-0003-2210-7389; Ayala, Francisco/0000-0003-2210-7389; Fernandez-Fernandez, Jaime/0000-0002-5284-303X				Amiri-Khorasani M, 2011, J STRENGTH COND RES, V25, P1647, DOI 10.1519/JSC.0b013e3181db9f41; Avela J, 1999, J APPL PHYSIOL, V86, P1283, DOI 10.1152/jappl.1999.86.4.1283; Avela J, 2004, J APPL PHYSIOL, V96, P2325, DOI 10.1152/japplphysiol.01010.2003; Batterham AM, 2006, INT J SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; Behm DG, 2011, APPL PHYSIOL NUTR ME, V36, P790, DOI [10.1139/h11-107, 10.1139/H11-107]; Behm DG, 2011, EUR J APPL PHYSIOL, V111, P2633, DOI 10.1007/s00421-011-1879-2; Bingul BM, 2014, ANTHROPOLOGIST, V18, P777, DOI 10.1080/09720073.2014.11891609; Bishop D, 2003, SPORTS MED, V33, P439, DOI 10.2165/00007256-200333060-00005; Bishop D, 2013, J HUM SPORT EXERC, V8, P391, DOI 10.4100/jhse.2012.82.07; BOSCO C, 1983, EUR J APPL PHYSIOL O, V50, P273, DOI 10.1007/BF00422166; Brandenburg J, 2007, INTJ SPORT PHYSIOL, V2, P170, DOI 10.1123/ijspp.2.2.170; Carvalho FLP, 2012, J STRENGTH COND RES, V26, P2447, DOI 10.1519/JSC.0b013e31823f2b36; Chaouachi A, 2010, J STRENGTH COND RES, V24, P2001, DOI 10.1519/JSC.0b013e3181aeb181; Chattong C, 2010, J STRENGTH COND RES, V24, P1751, DOI 10.1519/JSC.0b013e3181ddf665; Chatzopoulos DE, 2007, J STRENGTH COND RES, V21, P1278; Cilli M, 2014, BIOL SPORT, V31, P277, DOI 10.5604/20831862.1120935; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cramer JT, 2007, J SPORT SCI, V25, P687, DOI 10.1080/02640410600818416; Cramer JT, 2004, J STRENGTH COND RES, V18, P236, DOI 10.1519/00124278-200405000-00006; Cronin JB, 2005, J STRENGTH COND RES, V19, P349; Edwards DA, 2010, HORM BEHAV, V58, P606, DOI 10.1016/j.yhbeh.2010.06.015; Faigenbaum AD, 2006, J ATHL TRAINING, V41, P357; Fernandez-Fernandez J, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2013-093152; Fernandez-Fernandez J, 2013, J SPORT SCI MED, V12, P232; Fernandez-Fernandez J, 2009, STRENGTH COND J, V31, P15, DOI 10.1519/SSC.0b013e3181ada1cb; Fletcher IM, 2010, J STRENGTH COND RES, V24, P2096, DOI 10.1519/JSC.0b013e3181e312db; Fowles JR, 2000, J APPL PHYSIOL, V89, P1179, DOI 10.1152/jappl.2000.89.3.1179; Fukutani A, 2014, J ELECTROMYOGR KINES, V24, P240, DOI 10.1016/j.jelekin.2014.01.002; Gelen E, 2012, J SPORT SCI MED, V11, P600; Girard O, 2005, MED SCI SPORT EXER, V37, P1021, DOI 10.1249/01.mss.0000171619.99391.bb; Gourgoulis V, 2003, J STRENGTH COND RES, V17, P342, DOI 10.1519/00124278-200305000-00021; Gullich A., 1996, NEW STUDIES ATHLETIC, V11, P67; Hodgson M, 2005, SPORTS MED, V35, P585, DOI 10.2165/00007256-200535070-00004; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Hornery DJ, 2007, BRIT J SPORT MED, V41, P531, DOI 10.1136/bjsm.2006.031351; International Tennis Federation (ITF, INJ PREV WARM UP; Kay AD, 2012, MED SCI SPORT EXER, V44, P154, DOI 10.1249/MSS.0b013e318225cb27; Knudson D, 2005, EUR J APPL PHYSIOL, V94, P348, DOI 10.1007/s00421-004-1309-9; Knudson DV, 2004, J STRENGTH COND RES, V18, P654; Kovacs M, 2009, DYNAMIC STRETCHING R; Little T, 2006, J STRENGTH COND RES, V20, P203; Mizuno T, 2013, INT J SPORTS MED, V34, P484, DOI 10.1055/s-0032-1327655; Paradisis GP, 2014, J STRENGTH COND RES, V28, P154, DOI 10.1519/JSC.0b013e318295d2fb; Perrier ET, 2011, J STRENGTH COND RES, V25, P1925, DOI 10.1519/JSC.0b013e3181e73959; Pluim B, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.040865; Reiman MP, 2010, J STRENGTH COND RES, V24, P3387, DOI 10.1519/JSC.0b013e3181f159bd; Simic L, 2013, SCAND J MED SCI SPOR, V23, P131, DOI 10.1111/j.1600-0838.2012.01444.x; Stewart M, 2007, J SCI MED SPORT, V10, P403, DOI 10.1016/j.jsams.2006.10.001; Taylor KL, 2009, J SCI MED SPORT, V12, P657, DOI 10.1016/j.jsams.2008.04.004; Thompsen AG, 2007, J STRENGTH COND RES, V21, P52, DOI 10.1519/00124278-200702000-00010; Tillin NA, 2009, SPORTS MED, V39, P147, DOI 10.2165/00007256-200939020-00004; Turki O, 2012, J STRENGTH COND RES, V26, P63, DOI 10.1519/JSC.0b013e31821ef846; Yamaguchi T, 2007, J STRENGTH COND RES, V21, P1238, DOI 10.1519/00124278-200711000-00044; Young WB, 2003, J SPORT MED PHYS FIT, V43, P21; Zois J, 2011, J SCI MED SPORT, V14, P522, DOI 10.1016/j.jsams.2011.03.012	56	30	30	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0152790	10.1371/journal.pone.0152790	http://dx.doi.org/10.1371/journal.pone.0152790			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27071014	Green Published, gold, Green Submitted			2022-12-26	WOS:000373900700017
J	Basrai, HS; Christie, KJ; Turbic, A; Bye, N; Turnley, AM				Basrai, Harleen S.; Christie, Kimberly J.; Turbic, Alisa; Bye, Nicole; Turnley, Ann M.			Suppressor of Cytokine Signaling-2 (SOCS2) Regulates the Microglial Response and Improves Functional Outcome after Traumatic Brain Injury in Mice	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; CD40 GENE-EXPRESSION; SUBVENTRICULAR ZONE; NEURITE OUTGROWTH; ERYTHROPOIETIN; NEUROGENESIS; PROLIFERATION; CELLS; DIFFERENTIATION; RECOVERY	Traumatic brain injury (TBI) is frequently characterized by neuronal, axonal and myelin loss, reactive gliosis and neuroinflammation, often associated with functional deficits. Endogenous repair mechanisms include production of new neurons from precursor cells, but usually the new neurons fail to integrate and survive more than a few weeks. This is in part mediated by the toxic and inflammatory environment present in the injured brain which activates precursor cells to proliferate and differentiate but limits survival of the newborn progeny. Therefore, an understanding of mechanisms that regulate production and survival of newborn neurons and the neuroinflammatory response after brain injury may lead to therapeutic options to improve outcomes. Suppressor of Cytokine Signaling 2 (SOCS2) promotes hippocampal neurogenesis and survival of newborn neurons in the adult brain and regulates anti-inflammatory responses in the periphery, suggesting it may be a useful candidate to improve outcomes of TBI. In this study the functional and cellular responses of SOCS2 over-expressing transgenic (SOCS2Tg) mice were compared to wildtype litter-mates following mild or moderately severe TBI. Unlike wildtype controls, SOCS2Tg mice showed functional improvement on a ladder test, with a smaller lesion volume at 7d post injury and increased numbers of proliferative CD11b(+) microglia/macrophages at 35d post-injury in the mild injury paradigm. At 7d post-moderately severe injury there was an increase in the area covered by cells expressing an anti-inflammatory M2 phenotype marker (CD206(+)) but no difference in cells with a pro-inflammatory M1 phenotype marker (CD16/32(+)). No effect of SOCS2 overexpression was observed in production or survival of newborn neurons, even in the presence of the neuroprotective agent erythropoietin (EPO). Therefore, SOCS2 may improve outcome of TBI in mice by regulating aspects of the neuroinflammatory response, promoting a more anti-inflammatory environment, although this was not sufficient to enhance survival of newborn cortical neurons.	[Basrai, Harleen S.; Christie, Kimberly J.; Turbic, Alisa; Bye, Nicole; Turnley, Ann M.] Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3052, Australia	University of Melbourne	Turnley, AM (corresponding author), Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3052, Australia.	turnley@unimelb.edu.au			National Health and Medical Research Council of Australia [1045125, 628344]; Stem Cells Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Stem Cells Australia	This work was supported by funding from the National Health and Medical Research Council of Australia (www.nhmrc.gov.au): Project grant 1045125 to AMT and Fellowship 628344 to AMT, as well as support from Stem Cells Australia (www.stemcellsaustralia.edu.au) to HSB and AMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Baciu I, 2000, Rom J Physiol, V37, P3; Baker BJ, 2009, TRENDS IMMUNOL, V30, P392, DOI 10.1016/j.it.2009.07.001; Blizzard CA, 2011, CEREB CORTEX, V21, P281, DOI 10.1093/cercor/bhq091; Buffo A, 2010, BIOCHEM PHARMACOL, V79, P77, DOI 10.1016/j.bcp.2009.09.014; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Chehrehasa F, 2009, J NEUROSCI METH, V177, P122, DOI 10.1016/j.jneumeth.2008.10.006; Chen XR, 2007, J NEUROTRAUM, V24, P1119, DOI 10.1089/neu.2006.0216; Cherian L, 2007, J PHARMACOL EXP THER, V322, P789, DOI 10.1124/jpet.107.119628; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Choi JS, 2009, J NEUROTRAUM, V26, P2097, DOI [10.1089/neu.2008.0793, 10.1089/neu.2008-0793]; Chong ZZ, 2003, BRIT J PHARMACOL, V138, P1107, DOI 10.1038/sj.bjp.0705161; Christie KJ, 2013, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00070; Costine BA, 2015, DEV NEUROSCI-BASEL, V37, P115, DOI 10.1159/000369091; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Dent KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121541; Esper L, 2012, AM J PATHOL, V181, P130, DOI 10.1016/j.ajpath.2012.03.042; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Gao X, 2013, EXP NEUROL, V239, P38, DOI 10.1016/j.expneurol.2012.09.012; Goldshmit Y, 2004, J BIOL CHEM, V279, P16349, DOI 10.1074/jbc.M312873200; Goldshmit Y, 2004, EUR J NEUROSCI, V20, P2260, DOI 10.1111/j.1460-9568.2004.03698.x; Greenhalgh CJ, 2002, J BIOL CHEM, V277, P40181, DOI 10.1074/jbc.C200450200; Hellewell SC, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-156; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; HU XM, 2012, STROKE, V43, P3063, DOI DOI 10.1161/STR0KEAHA.112.659656; Iverson GL, 2005, CURRENT OPINION PSYC, DOI [10.1097/00001504-200505000-00013, DOI 10.1097/00001504-200505000-00013]; Jia XX, 2012, J TRAUMA ACUTE CARE, V73, P1168, DOI 10.1097/TA.0b013e318246eaf4; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kim YH, 2010, STEM CELLS, V28, P1816, DOI 10.1002/stem.511; Koketsu D, 2006, EXP NEUROL, V199, P92, DOI 10.1016/j.expneurol.2006.03.012; Krantz S B, 1988, Contrib Nephrol, V66, P25; Liu F, 2009, J NEUROSCI, V29, P5075, DOI 10.1523/JNEUROSCI.0201-09.2009; LONGIN A, 1993, J HISTOCHEM CYTOCHEM, V41, P1833, DOI 10.1177/41.12.8245431; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Machado FS, 2006, NAT MED, V12, P330, DOI 10.1038/nm1355; Metcalf D, 2000, NATURE, V405, P1069, DOI 10.1038/35016611; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Ng SY, 2012, J NEUROTRAUM, V29, P1410, DOI 10.1089/neu.2011.2188; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Qin HW, 2006, J IMMUNOL, V177, P7761, DOI 10.4049/jimmunol.177.11.7761; Qin HW, 2006, FASEB J, V20, P985, DOI 10.1096/fj.05-5493fje; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Ransome MI, 2008, HIPPOCAMPUS, V18, P1034, DOI 10.1002/hipo.20463; Ransome MI, 2007, J NEUROCHEM, V102, P1953, DOI 10.1111/j.1471-4159.2007.04684.x; Ransome MI, 2005, NEUROSCIENCE, V132, P673, DOI 10.1016/j.neuroscience.2004.12.041; Rico-Bautista E, 2006, CYTOKINE GROWTH F R, V17, P431, DOI 10.1016/j.cytogfr.2006.09.008; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Saha B, 2013, STEM CELL RES, V11, P965, DOI 10.1016/j.scr.2013.06.006; Salman H, 2004, J NEUROTRAUM, V21, P283, DOI 10.1089/089771504322972077; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Turnley AM, 2002, NAT NEUROSCI, V5, P1155, DOI 10.1038/nn954; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Uren RT, 2014, FRONT MOL NEUROSCI, V7, DOI [10.3389/fnmo1.2014.00039, 10.3389/fnmol.2014.00039]; Uren RT, 2014, J NEUROCHEM, V129, P614, DOI 10.1111/jnc.12671; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wang L, 2004, NEUROREPORT, V15, P1225, DOI 10.1097/01.wnr.0000127636.15181.c1; Wei ZX, 2015, NEUROSCI LETT, V606, P48, DOI 10.1016/j.neulet.2015.08.032; Xiong Y, 2011, TRANSL STROKE RES, V2, P619, DOI 10.1007/s12975-011-0120-2; Xiong Y, 2010, J NEUROTRAUM, V27, P205, DOI 10.1089/neu.2009.1001; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Yu XB, 2002, DEVELOPMENT, V129, P505; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579	64	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153418	10.1371/journal.pone.0153418	http://dx.doi.org/10.1371/journal.pone.0153418			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27071013	Green Submitted, Green Published, gold			2022-12-26	WOS:000373900700065
J	Okubo, M; Yamanaka, H; Kobayashi, K; Dai, Y; Kanda, H; Yagi, H; Noguchi, K				Okubo, Masamichi; Yamanaka, Hiroki; Kobayashi, Kimiko; Dai, Yi; Kanda, Hirosato; Yagi, Hideshi; Noguchi, Koichi			Macrophage-Colony Stimulating Factor Derived from Injured Primary Afferent Induces Proliferation of Spinal Microglia and Neuropathic Pain in Rats	PLOS ONE			English	Article							PERIPHERAL-NERVE INJURY; DORSAL-ROOT GANGLION; FACIAL NUCLEUS; PLASMINOGEN-ACTIVATOR; CELL-PROLIFERATION; LANGERHANS CELLS; MESSENGER-RNAS; CSF RECEPTOR; GM-CSF; NEURONS	Peripheral nerve injury induces proliferation of microglia in the spinal cord, which can contribute to neuropathic pain conditions. However, candidate molecules for proliferation of spinal microglia after injury in rats remain unclear. We focused on the colony-stimulating factors (CSFs) and interleukin-34 (IL-34) that are involved in the proliferation of the mononuclear phagocyte lineage. We examined the expression of mRNAs for macrophage-CSF (MCSF), granulocyte macrophage-CSF (GM-CSF), granulocyte-CSF (G-CSF) and IL-34 in the dorsal root ganglion (DRG) and spinal cord after spared nerve injury (SNI) in rats. RT-PCR and in situ hybridization revealed that M-CSF and IL-34, but not GM- or G-CSF, mRNAs were constitutively expressed in the DRG, and M-CSF robustly increased in injured-DRG neurons. M-CSF receptor mRNA was expressed in naive rats and increased in spinal microglia following SNI. Intrathecal injection of M-CSF receptor inhibitor partially but significantly reversed the proliferation of spinal microglia and in early phase of neuropathic pain induced by SNI. Furthermore, intrathecal injection of recombinant M-CSF induced microglial proliferation and mechanical allodynia. Here, we demonstrate that MCSF is a candidate molecule derived from primary afferents that induces proliferation of microglia in the spinal cord and leads to induction of neuropathic pain after peripheral nerve injury in rats.	[Okubo, Masamichi; Yamanaka, Hiroki; Kobayashi, Kimiko; Kanda, Hirosato; Yagi, Hideshi; Noguchi, Koichi] Hyogo Coll Med, Dept Anat & Neurosci, Nishinomiya, Hyogo 6638501, Japan; [Dai, Yi] Hyogo Univ Hlth Sci, Sch Pharm, Dept Pharm, Kobe, Hyogo 6508530, Japan	Hyogo College of Medicine	Noguchi, K (corresponding author), Hyogo Coll Med, Dept Anat & Neurosci, Nishinomiya, Hyogo 6638501, Japan.	noguchi@hyo-med.ac.jp		, Hirosato/0000-0003-2547-9073; Yagi, Hideshi/0000-0002-8506-8965	MEXT-supported Program for the Strategic Research Foundation at Private Universities from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [20451200]	MEXT-supported Program for the Strategic Research Foundation at Private Universities from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)	This work was supported in part by MEXT-supported Program for the Strategic Research Foundation at Private Universities (Grant #: 20451200) to KN from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT; www.mext.go.jp). This work was also supported by the Grants-in-Aid for Researchers Hyogo College of Medicine 2014-15 (www.hyo-med.ac.jp) to KO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BORYCKI AG, 1993, BIOCHIM BIOPHYS ACTA, V1174, P143, DOI 10.1016/0167-4781(93)90108-P; Bourette RP, 2000, GROWTH FACTORS, V17, P155, DOI 10.3109/08977190009001065; Chihara T, 2010, CELL DEATH DIFFER, V17, P1917, DOI 10.1038/cdd.2010.60; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; Du Yan S, 1997, P NATL ACAD SCI USA, V94, P5296; Echeverry S, 2008, PAIN, V135, P37, DOI 10.1016/j.pain.2007.05.002; Echeverry S, 2011, J NEUROSCI, V31, P10819, DOI 10.1523/JNEUROSCI.1642-11.2011; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; Guan Z, 2015, NATURE NEUROSCIENCE; Han SW, 1996, GENE, V175, P101, DOI 10.1016/0378-1119(96)00131-X; Hao AJ, 2001, J NEUROSCI RES, V64, P79, DOI 10.1002/jnr.1056; Honda S, 2001, J NEUROSCI, V21, P1975, DOI 10.1523/JNEUROSCI.21-06-01975.2001; Imai Y, 2002, GLIA, V40, P164, DOI 10.1002/glia.10149; Jenkins SJ, 2014, TRENDS IMMUNOL, V35, P358, DOI 10.1016/j.it.2014.06.006; Ji RR, 2013, PAIN, V154, pS10, DOI 10.1016/j.pain.2013.06.022; Ji RR, 2009, BRAIN RES REV, V60, P135, DOI 10.1016/j.brainresrev.2008.12.011; Jin SX, 2003, J NEUROSCI, V23, P4017; Kalmar B, 2003, EXP NEUROL, V184, P636, DOI 10.1016/S0014-4886(03)00343-1; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; KITAMURA T, 1991, P NATL ACAD SCI USA, V88, P5082, DOI 10.1073/pnas.88.12.5082; Kobayashi K, 2005, J COMP NEUROL, V481, P377, DOI 10.1002/cne.20393; Kobayashi K, 2008, J NEUROSCI, V28, P2892, DOI 10.1523/JNEUROSCI.5589-07.2008; Kobayashi K, 2006, J COMP NEUROL, V498, P443, DOI 10.1002/cne.21066; Lim TKY, 2014, PAIN, V155, P954, DOI 10.1016/j.pain.2014.01.026; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; Liu L, 2000, EXP BRAIN RES, V131, P64, DOI 10.1007/s002219900273; Luo J, 2013, J EXP MED, V210, P157, DOI 10.1084/jem.20120412; Ma XL, 2012, STRUCTURE, V20, P676, DOI 10.1016/j.str.2012.02.010; Nakamichi Y, 2013, J BONE MINER METAB, V31, P486, DOI 10.1007/s00774-013-0476-3; Nicola N A, 1990, Immunol Ser, V49, P77; Okubo M, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-57; Okubo M, 2010, GLIA, V58, P599, DOI 10.1002/glia.20948; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Papavasiliou AK, 1997, NEUROSURGERY, V41, P916, DOI 10.1097/00006123-199710000-00028; RAIVICH G, 1991, J NEUROSCI RES, V30, P682, DOI 10.1002/jnr.490300412; Reeves G, 2014, HEALTH PHYS, V106, P699, DOI 10.1097/HP.0000000000000090; Sasmono RT, 2003, BLOOD, V101, P1155, DOI 10.1182/blood-2002-02-0569; Schweizerhof M, 2009, NAT MED, V15, P802, DOI 10.1038/nm.1976; Shadduck RK, 1996, EXP HEMATOL, V24, P314; Shiratori M, 2010, J NEUROCHEM, V114, P810, DOI 10.1111/j.1471-4159.2010.06809.x; SMITH LR, 1994, IMMUNOGENETICS, V39, P80, DOI 10.1007/BF00171806; Takeuchi A, 2001, J NEUROSCI RES, V65, P38, DOI 10.1002/jnr.1125; Tozaki-Saitoh H, 2008, J NEUROSCI, V28, P4949, DOI 10.1523/JNEUROSCI.0323-08.2008; Tsujino H, 2000, MOL CELL NEUROSCI, V15, P170, DOI 10.1006/mcne.1999.0814; Trang T, 2011, NEURON GLIA BIOL, V7, P99, DOI 10.1017/S1740925X12000087; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Wen YR, 2011, J FORMOS MED ASSOC, V110, P487, DOI 10.1016/S0929-6646(11)60074-0; Yamamoto S, 2012, GLIA, V60, P570, DOI 10.1002/glia.22291; Yamamoto S, 2010, J NEUROCHEM, V115, P1057, DOI 10.1111/j.1471-4159.2010.06996.x; Yamanaka H, 2005, NEUROSCIENCE, V132, P183, DOI 10.1016/j.neuroscience.2004.12.003; Yamanaka H, 2004, EUR J NEUROSCI, V19, P93, DOI 10.1046/j.1460-9568.2003.03080.x; Yamanaka H, 2007, EUR J NEUROSCI, V25, P1097, DOI 10.1111/j.1460-9568.2007.05344.x; Zhuang ZY, 2007, BRAIN BEHAV IMMUN, V21, P642, DOI 10.1016/j.bbi.2006.11.003	54	55	57	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153375	10.1371/journal.pone.0153375	http://dx.doi.org/10.1371/journal.pone.0153375			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27071004	gold, Green Published			2022-12-26	WOS:000373900700057
J	Velie, BD; Shrestha, M; Francois, L; Schurink, A; Tesfayonas, YG; Stinckens, A; Blott, S; Ducro, BJ; Mikko, S; Thomas, R; Swinburne, JE; Sundqvist, M; Eriksson, S; Buys, N; Lindgren, G				Velie, Brandon D.; Shrestha, Merina; Francois, Liesbeth; Schurink, Anouk; Tesfayonas, Yohannes G.; Stinckens, Anneleen; Blott, Sarah; Ducro, Bart J.; Mikko, Sofia; Thomas, Ruth; Swinburne, June E.; Sundqvist, Marie; Eriksson, Susanne; Buys, Nadine; Lindgren, Gabriella			Using an Inbred Horse Breed in a High Density Genome-Wide Scan for Genetic Risk Factors of Insect Bite Hypersensitivity (IBH)	PLOS ONE			English	Article							ASSOCIATION; DERMATITIS; ECZEMA	While susceptibility to hypersensitive reactions is a common problem amongst humans and animals alike, the population structure of certain animal species and breeds provides a more advantageous route to better understanding the biology underpinning these conditions. The current study uses Exmoor ponies, a highly inbred breed of horse known to frequently suffer from insect bite hypersensitivity, to identify genomic regions associated with a type I and type IV hypersensitive reaction. A total of 110 cases and 170 controls were genotyped on the 670K Axiom Equine Genotyping Array. Quality control resulted in 452,457 SNPs and 268 individuals being tested for association. Genome-wide association analyses were performed using the GenABEL package in R and resulted in the identification of two regions of interest on Chromosome 8. The first region contained the most significant SNP identified, which was located in an intron of the DCC netrin 1 receptor gene. The second region identified contained multiple top SNPs and encompassed the PIGN, KIAA1468, TNFRSF11A, ZCCHC2, and PHLPP1 genes. Although additional studies will be needed to validate the importance of these regions in horses and the relevance of these regions in other species, the knowledge gained from the current study has the potential to be a step forward in unraveling the complex nature of hypersensitive reactions.	[Velie, Brandon D.; Shrestha, Merina; Tesfayonas, Yohannes G.; Mikko, Sofia; Eriksson, Susanne; Lindgren, Gabriella] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden; [Francois, Liesbeth; Stinckens, Anneleen; Buys, Nadine] Katholieke Univ Leuven, Dept Biosyst, Res Grp Livestock Genet, Leuven, Belgium; [Schurink, Anouk; Ducro, Bart J.] Wageningen Univ, Anim Breeding & Genom Ctr, NL-6700 AP Wageningen, Netherlands; [Blott, Sarah] Univ Nottingham, Sch Vet Med & Sci, Nottingham NG7 2RD, England; [Thomas, Ruth] Exmoor Pony Soc, Cullompton, England; [Swinburne, June E.] Anim DNA Diagnost Ltd, Cambridge, Cambs, England; [Swinburne, June E.] Anim Hlth Trust, Newmarket, Suffolk, England; [Sundqvist, Marie] Ostra Greda Res Grp, Borgholm, Sweden	Swedish University of Agricultural Sciences; KU Leuven; Wageningen University & Research; University of Nottingham; Animal Health Trust	Velie, BD (corresponding author), Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden.	brandon.velie@slu.se	Ducro, Bart/E-7012-2012; Eriksson, Susanne/F-1276-2017; Mikko, Sofia/F-1347-2017	Eriksson, Susanne/0000-0003-3357-5065; Mikko, Sofia/0000-0002-6375-1376; Lindgren, Gabriella/0000-0001-6046-9669; Sundquist, Marie/0000-0003-0766-8073; Blott, Sarah/0000-0003-0233-6846; Buys, Nadine/0000-0002-7313-3088	European Union's Seventh Framework Programme (FP7) [606142]; Exmoor Pony Society in UK; Swedish Research Council (FORMAS); European Graduate School of Animal Breeding and Genetics (EGS-ABG)	European Union's Seventh Framework Programme (FP7); Exmoor Pony Society in UK; Swedish Research Council (FORMAS)(Swedish Research CouncilSwedish Research Council Formas); European Graduate School of Animal Breeding and Genetics (EGS-ABG)	The research leading to these results has received funding from the European Union's Seventh Framework Programme managed by REA-Research Executive Agency, http://ec.europa.eu/research/rea (FP7/2007-2013) under grant agreement no. [606142], The Exmoor Pony Society in UK, The Swedish Research Council (FORMAS), and European Graduate School of Animal Breeding and Genetics (EGS-ABG). Animal DNA Diagnostics, the current employer of JES, had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section and occurred during the author's tenure at the Animal Health Trust.	Andersson LS, 2012, IMMUNOGENETICS, V64, P201, DOI 10.1007/s00251-011-0573-1; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Equus Survival Trust, 2015, 2015 EQ CONS LIST; Eriksson S, 2008, ANIMAL, V2, P360, DOI 10.1017/S1751731107001413; Everitt BS, 2010, HANDBOOK OF STATISTICAL ANALYSES USING R, 2ND EDITION, P1; Exmoor Pony Society, WELCOME TO THE WORLD; Fehlker M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-64; Jeru I, 2014, ARTHRITIS RHEUMATOL, V66, P2621, DOI 10.1002/art.38727; Jonsdottir S, 2015, VET IMMUNOL IMMUNOP, V166, P8, DOI 10.1016/j.vetimm.2015.05.002; Klumplerova M, 2013, MOL BIOL REP, V40, P3333, DOI 10.1007/s11033-012-2408-z; Larsen FS, 1996, J AM ACAD DERMATOL, V34, P760, DOI 10.1016/S0190-9622(96)90009-2; MARTI E, 1992, EQUINE VET J, V24, P113, DOI 10.1111/j.2042-3306.1992.tb02794.x; Panagiotou OA, 2012, INT J EPIDEMIOL, V41, P273, DOI 10.1093/ije/dyr178; Petersen JL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054997, 10.1371/journal.pone.0069819]; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rare Breeds Survival Trust, RAR NAT BREEDS EQ; Sargolzaei M., 2006, Proceedings of the 8th World Congress on Genetics Applied to Livestock Production, Belo Horizonte, Minas Gerais, Brazil, 13-18 August, 2006, P27; Schaffartzik A, 2012, VET IMMUNOL IMMUNOP, V147, P113, DOI 10.1016/j.vetimm.2012.03.017; Schurink A, 2013, ANIM GENET, V44, P44, DOI 10.1111/j.1365-2052.2012.02368.x; Schurink A, 2011, J ANIM SCI, V89, P1286, DOI 10.2527/jas.2010-3222; Schurink A, 2012, ANIMAL GENETICS, V44, P44; Shrestha M, 2015, J HERED, V106, P366, DOI 10.1093/jhered/esv033; Sicherer SH, 2015, J ALLERGY CLIN IMMUN, V135, P357, DOI 10.1016/j.jaci.2014.12.1906; Simpson CR, 2009, J ROY SOC MED, V102, P108, DOI 10.1258/jrsm.2009.080211; Spriggs M, 2012, J ZOO WILDLIFE MED, V43, P652, DOI 10.1638/2011-0243R2.1; Tengvall K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003475; The American Livestock Breeds Conservancy, BREED INF EXM PON; Van Grevenhof EM, 2007, EQUINE VET J, V39, P69, DOI 10.2746/042516407X153020; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wood P., 2011, UNDERSTANDING IMMUNO, V3rd; Yosipovitch G, 2002, INT J DERMATOL, V41, P212, DOI 10.1046/j.1365-4362.2002.01460.x	32	21	21	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0152966	10.1371/journal.pone.0152966	http://dx.doi.org/10.1371/journal.pone.0152966			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070818	Green Published, gold, Green Submitted			2022-12-26	WOS:000373900700023
J	Cassidy, AA; Saulnier, RJ; Lamarre, SG				Cassidy, Alicia A.; Saulnier, Roxanne J.; Lamarre, Simon G.			Adjustments of Protein Metabolism in Fasting Arctic Charr, Salvelinus alpinus	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; PROTEASOME-DEPENDENT PROTEOLYSIS; WOLFFISH ANARHICHAS-MINOR; EUROPEAN SEA BASS; RAINBOW-TROUT; FOOD-DEPRIVATION; 20S PROTEASOME; DICENTRARCHUS-LABRAX; SPAWNING MIGRATION; LOW-TEMPERATURE	Protein metabolism, including the interrelated processes of synthesis and degradation, mediates the growth of an animal. In ectothermic animals, protein metabolism is responsive to changes in both biotic and abiotic conditions. This study aimed to characterise responses of protein metabolism to food deprivation that occur in the coldwater salmonid, Arctic charr, Salvelinus alpinus. We compared two groups of Arctic charr: one fed continuously and the other deprived of food for 36 days. We measured the fractional rate of protein synthesis (K-S) in individuals from the fed and fasted groups using a flooding dose technique modified for the use of deuterium-labelled phenylalanine. The enzyme activities of the three major protein degradation pathways (ubiquitin proteasome, lysosomal cathepsins and the calpain systems) were measured in the same fish. This study is the first to measure both K-S and the enzymatic activity of protein degradation in the same fish, allowing us to examine the apparent contribution of different protein degradation pathways to protein turnover in various tissues (red and white muscle, liver, heart and gills). K-S was lower in the white muscle and in liver of the fasted fish compared to the fed fish. There were no observable effects of food deprivation on the protease activities in any of the tissues with the exception of liver, where the ubiquitin proteasome pathway seemed to be activated during fasting conditions. Lysosomal proteolysis appears to be the primary degradation pathway for muscle protein, while the ubiquitin proteasome pathway seems to predominate in the liver. We speculate that Arctic charr regulate protein metabolism during food deprivation to conserve proteins.	[Cassidy, Alicia A.; Saulnier, Roxanne J.; Lamarre, Simon G.] Univ Moncton, Dept Biol, Moncton, NB E1A 3E9, Canada	University of Moncton	Lamarre, SG (corresponding author), Univ Moncton, Dept Biol, Moncton, NB E1A 3E9, Canada.	simon.lamare@umoncton.ca	Lamarre, Simon/A-5674-2008	Lamarre, Simon/0000-0001-7038-4626	Natural Sciences and Engineering Research Council of Canada [435638-2013]; NSERC; Universite de Moncton; Natural Sciences and Engineering Research Council of Canada (NSERC) [435638-2013]; NSERC Canada; New Brunswick Innovation Fund	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Universite de Moncton; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); New Brunswick Innovation Fund	This work was supported by the Natural Sciences and Engineering Research Council of Canada [435638-2013 to SGL]. AAC was supported by a postgraduate scholarship from NSERC and Universite de Moncton.; The authors are grateful to Andre Dumas and Claude Pelletier at the Coastal Zones Research Institute (Shippagan, NB, Canada) for providing the fish and to Dr Joy Stacey for the English revision of the manuscript. This research was funded by a Natural Sciences and Engineering Research Council of Canada (NSERC) discovery grant to SGL [435638-2013], a NSERC Canada Graduate Scholarships-Master's grant to AAC and various grants from the New Brunswick Innovation Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar N., 2012, CHAPTER6 COMP PHYSL, DOI [10.1007/978-3-642-29056-5_6, DOI 10.1007/978-3-642-29056-5_6]; BLASCO J, 1992, J COMP PHYSIOL B, V162, P539; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caloin M, 2004, AM J PHYSIOL-ENDOC M, V287, pE790, DOI 10.1152/ajpendo.00414.2003; CARTER CG, 1994, J EXP BIOL, V189, P279; CIECHANOVER A, 1984, J CELL BIOCHEM, V24, P27, DOI 10.1002/jcb.240240104; Cleveland BM, 2009, AM J PHYSIOL-REG I, V297, pR1332, DOI 10.1152/ajpregu.00272.2009; DEDUVE C, 1966, ANNU REV PHYSIOL, V28, P435, DOI 10.1146/annurev.ph.28.030166.002251; Fraser KPP, 2007, ADV MAR BIOL, V52, P267, DOI 10.1016/S0065-2881(06)52003-6; Frick NT, 2008, COMP BIOCHEM PHYS A, V151, P85, DOI 10.1016/j.cbpa.2008.06.003; GARLICK PJ, 1980, BIOCHEM J, V192, P719, DOI 10.1042/bj1920719; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Guderley H, 2003, COMP BIOCHEM PHYS A, V135, P347, DOI 10.1016/S1095-6433(03)00089-8; HERSHKO A, 1985, BIOCHEM BIOPH RES CO, V128, P1079, DOI 10.1016/0006-291X(85)91050-2; HERSHKO A, 1982, ANNU REV BIOCHEM, V51, P335, DOI 10.1146/annurev.bi.51.070182.002003; Houlihan D. F., 1991, ADV COMP ENV PHYSL, P1; HOULIHAN DF, 1988, CAN J FISH AQUAT SCI, V45, P951, DOI 10.1139/f88-117; HOULIHAN DF, 1986, PHYSIOL ZOOL, V59, P482, DOI 10.1086/physzool.59.4.30158601; HOULIHAN DF, 1989, AQUACULTURE, V79, P103, DOI 10.1016/0044-8486(89)90450-X; ILIAN MA, 1992, BIOCHEM J, V287, P163, DOI 10.1042/bj2870163; Johnston IA, 2011, J EXP BIOL, V214, P1617, DOI 10.1242/jeb.038620; Jorgensen EH, 2014, MAR GENOM, V14, P71, DOI 10.1016/j.margen.2013.10.005; Jorgensen EH, 2013, J EXP BIOL, V216, P3222, DOI 10.1242/jeb.088344; Khalilieh A, 2012, AM J PHYSIOL-REG I, V303, pR551, DOI 10.1152/ajpregu.00076.2012; Ladrat C, 2000, COMP BIOCHEM PHYS B, V125, P83, DOI 10.1016/S0305-0491(99)00157-1; Lamarre SG, 2015, COMP BIOCHEM PHYS B, V182, P1, DOI 10.1016/j.cbpb.2014.11.006; Lamarre SG, 2010, J FISH BIOL, V76, P1565, DOI 10.1111/j.1095-8649.2010.02581.x; Lamarre SG, 2012, AM J PHYSIOL-REG I, V303, pR427, DOI 10.1152/ajpregu.00077.2012; Lamarre SG, 2009, J EXP BIOL, V212, P1294, DOI 10.1242/jeb.028290; Lyndon AR, 1998, COMP BIOCHEM PHYS A, V119, P27, DOI 10.1016/S1095-6433(97)00409-1; Martin SAM, 2002, PFLUG ARCH EUR J PHY, V445, P257, DOI 10.1007/s00424-002-0916-8; Martin SAM, 2001, FISH PHYSIOL BIOCHEM, V24, P259, DOI 10.1023/A:1014015530045; McCue MD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140053; McCue MD, 2010, COMP BIOCHEM PHYS A, V156, P1, DOI 10.1016/j.cbpa.2010.01.002; McKenzie DJ, 2014, J EXP BIOL, V217, P3283, DOI 10.1242/jeb.101857; MCMILLAN DN, 1988, PHYSIOL ZOOL, V61, P429, DOI 10.1086/physzool.61.5.30161265; MIGLAVS I, 1989, J FISH BIOL, V35, P1, DOI 10.1111/j.1095-8649.1989.tb03387.x; MOMMSEN TP, 1980, CAN J ZOOL, V58, P1785, DOI 10.1139/z80-246; Mommsen TP, 2004, COMP BIOCHEM PHYS B, V139, P383, DOI 10.1016/j.cbpc.2004.09.018; Mommsen TP, 2001, COMP BIOCHEM PHYS B, V129, P207, DOI 10.1016/S1096-4959(01)00312-8; MOON TW, 1983, CAN J ZOOL, V61, P802, DOI 10.1139/z83-106; Prinsen BHCMT, 2004, CLIN CHIM ACTA, V347, P1, DOI 10.1016/j.cccn.2004.04.005; Salem M, 2005, COMP BIOCHEM PHYS B, V140, P63, DOI 10.1016/j.cbpc.2004.09.007; Salem M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-328; Salmeron C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075349; Seiliez I, 2008, J NUTR, V138, P487, DOI 10.1093/jn/138.3.487; Seiliez I, 2014, AM J PHYSIOL-REG I, V307, pR1330, DOI 10.1152/ajpregu.00370.2014; Seiliez I, 2013, ZEBRAFISH, V10, P237, DOI 10.1089/zeb.2012.0835; SHIBATANI T, 1995, ARCH BIOCHEM BIOPHYS, V321, P160, DOI 10.1006/abbi.1995.1381; Simon O., 1989, PROTEIN METABOLISM F, P273; Taylor RG, 1997, J MUSCLE RES CELL M, V18, P285, DOI 10.1023/A:1018665924412; Thompson VF, 2000, ANAL BIOCHEM, V279, P170, DOI 10.1006/abio.1999.4475; TOYOHARA H, 1989, COMP BIOCHEM PHYS B, V92, P577, DOI 10.1016/0305-0491(89)90134-X; Vijayan MM, 2006, TOXICOL SCI, V91, P431, DOI 10.1093/toxsci/kfj154; Wang T, 2006, ANNU REV PHYSIOL, V68, P223, DOI 10.1146/annurev.physiol.68.040104.105739; Wright, 1995, NITROGEN METABOLISM	56	19	20	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153364	10.1371/journal.pone.0153364	http://dx.doi.org/10.1371/journal.pone.0153364			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096948	gold, Green Published			2022-12-26	WOS:000374543600034
J	Ozmen, O; Pullum, LL; Ramanathan, A; Nutaro, JJ				Ozmen, Ozgur; Pullum, Laura L.; Ramanathan, Arvind; Nutaro, James J.			Augmenting Epidemiological Models with Point-Of-Care Diagnostics Data	PLOS ONE			English	Article								Although adoption of newer Point-of-Care (POC) diagnostics is increasing, there is a significant challenge using POC diagnostics data to improve epidemiological models. In this work, we propose a method to process zip-code level POC datasets and apply these processed data to calibrate an epidemiological model. We specifically develop a calibration algorithm using simulated annealing and calibrate a parsimonious equation-based model of modified Susceptible-Infected-Recovered (SIR) dynamics. The results show that parsimonious models are remarkably effective in predicting the dynamics observed in the number of infected patients and our calibration algorithm is sufficiently capable of predicting peak loads observed in POC diagnostics data while staying within reasonable and empirical parameter ranges reported in the literature. Additionally, we explore the future use of the calibrated values by testing the correlation between peak load and population density from Census data. Our results show that linearity assumptions for the relationships among various factors can be misleading, therefore further data sources and analysis are needed to identify relationships between additional parameters and existing calibrated ones. Calibration approaches such as ours can determine the values of newly added parameters along with existing ones and enable policy-makers to make better multi-scale decisions.	[Pullum, Laura L.; Nutaro, James J.] Oak Ridge Natl Lab, Computat Sci & Engn Div, Oak Ridge, TN USA; [Ozmen, Ozgur; Ramanathan, Arvind] Oak Ridge Natl Lab, Hlth Data Sci Inst, Oak Ridge, TN USA; [Pullum, Laura L.] One Bethel Valley Rd,POB 2008, Oak Ridge, TN 37831 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory	Pullum, LL (corresponding author), Oak Ridge Natl Lab, Computat Sci & Engn Div, Oak Ridge, TN USA.; Pullum, LL (corresponding author), One Bethel Valley Rd,POB 2008, Oak Ridge, TN 37831 USA.	pullumll@ornl.gov		Pullum, Laura/0000-0001-6045-7668; Ramanathan, Arvind/0000-0002-1622-5488; Nutaro, James/0000-0001-7360-2836	DTRA (Defense Threat Reduction Agency) [2216-V387-11]; ORNL (Oak Ridge National Laboratory) [7280]; U.S. Department of Energy [DE-AC05-00OR22725]	DTRA (Defense Threat Reduction Agency)(United States Department of DefenseDefense Threat Reduction Agency); ORNL (Oak Ridge National Laboratory); U.S. Department of Energy(United States Department of Energy (DOE))	DTRA (Defense Threat Reduction Agency, contract no: 2216-V387-11) and ORNL (Oak Ridge National Laboratory, SEED project 7280) are the sources of funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank IMS Health Government Solutions, the Texas Department of Public Health, and the Knox County Public Health Department for the data used in this study. Data (used as part of this paper) can be requested through IMS Health Institute, the Texas Department of Public Health, and the Knox County Public Health Department. This manuscript has been authored by UT-Battelle, LLC under Contract No. DE-AC05-00OR22725 with the U.S. Department of Energy. The United States Government retains and the publisher, by accepting the article for publication, acknowledges that the United States Government retains a nonexclusive, paid-up, irrevocable, world-wide license to publish or reproduce the published form of this manuscript, or allow others to do so, for United States Government purposes. The Department of Energy will provide public access to these results of federally sponsored research in accordance with the DOE Public Access Plan (http://energy.gov/downloads/doe-public-access-plan).	Breban R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000282; Clark M., 2013, GEN ADDITIVE MODELS; Dreo J., 2005, METAHEURISTICS HARD; EGLESE RW, 1990, EUR J OPER RES, V46, P271, DOI 10.1016/0377-2217(90)90001-R; Gog JR, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003635; Grubesic Tony H, 2006, Int J Health Geogr, V5, P58, DOI 10.1186/1476-072X-5-58; Jhung MA, 2011, CLIN INFECT DIS, V52, pS13, DOI 10.1093/cid/ciq008; Keeling M.J., 2011, MODELING INFECT DIS, DOI 10.1111/j.1541-0420.2008.01082-_}7.x; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Nutaro J.J., 2010, BUILDING SOFTWARE SI; Pullum LL, 2012, 2012 ASE INTERNATIONAL CONFERENCE ON BIOMEDICAL COMPUTING (BIOMEDCOM), P62, DOI 10.1109/BioMedCom.2012.17; Pullum LL, 2014, VERIFICATION VALIDAT; van Boven M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011442; White LF, 2009, INFLUENZA OTHER RESP, V3, P267, DOI 10.1111/j.1750-2659.2009.00106.x; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373	16	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153769	10.1371/journal.pone.0153769	http://dx.doi.org/10.1371/journal.pone.0153769			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096162	gold, Green Published			2022-12-26	WOS:000374543600054
J	Fukuma, M; Ganmyo, Y; Miura, O; Ohyama, T; Shimizu, N				Fukuma, Miki; Ganmyo, Yuto; Miura, Osamu; Ohyama, Takashi; Shimizu, Noriaki			Cloning and Characterization of a Human Genomic Sequence that Alleviates Repeat-Induced Gene Silencing	PLOS ONE			English	Article							REPLICATION INITIATION REGION; MATRIX ATTACHMENT REGIONS; MAMMALIAN-CELLS; TRANSGENE EXPRESSION; DNA; AMPLIFICATION; SITES; IDENTIFICATION; PLASMIDS; ELEMENTS	Plasmids bearing a mammalian replication initiation region (IR) and a nuclear matrix attachment region (MAR) are spontaneously amplified in transfected mammalian cells, and such amplification generates chromosomal homogeneously staining regions (HSRs) or extrachromosomal double minutes (DMs). This method provides a novel, efficient, and rapid way to establish cells that stably produce high levels of recombinant proteins. However, because IR/MAR plasmids are amplified as repeats, they are frequently targeted by repeat-induced gene silencing (RIGS), which silences a variety of repeated sequences in transgenes and the genome. To address this problem, we developed a novel screening system using the IR/MAR plasmid to isolate human genome sequences that alleviate RIGS. The screen identified a 3,271 bp sequence (B-3-31) that elevated transgene expression without affecting the amplification process. Neither non-B structure (i.e., the inverted repeats or bending) nor known epigenetic modifier elements such as MARs, insulators, UCOEs, or STARs could explain the anti-silencing activity of B-3-31. Instead, the activity was distributed throughout the entire B-3-31 sequence, which was extremely A/T-rich and CpG-poor. Because B-3-31 effectively and reproducibly alleviated RIGS of repeated genes, it could be used to increase recombinant protein production.	[Fukuma, Miki; Ganmyo, Yuto; Shimizu, Noriaki] Hiroshima Univ, Grad Sch Biosphere Sci, Hiroshima, Japan; [Miura, Osamu; Ohyama, Takashi] Waseda Univ, Grad Sch Adv Sci & Engn, Shinjuku Ku, Tokyo, Japan	Hiroshima University; Waseda University	Shimizu, N (corresponding author), Hiroshima Univ, Grad Sch Biosphere Sci, Hiroshima, Japan.	shimizu@hiroshima-u.ac.jp			Japan Society for the Promotion of Science [23380203, 24658290, 26660293]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a Grant-in-Aid for Scientific Research (B) (23380203) and a Grant-in-Aid for Challenging Exploratory Research (24658290, 26660293), both from the Japan Society for the Promotion of Science (to NS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; Almeida R, 2005, TRENDS CELL BIOL, V15, P251, DOI 10.1016/j.tcb.2005.03.006; Araki Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041787; Bansal M, 2014, CURR OPIN STRUC BIOL, V25, P77, DOI 10.1016/j.sbi.2014.01.007; Bi CP, 2004, BIOINFORMATICS, V20, P1477, DOI 10.1093/bioinformatics/bth304; Brazda V, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-33; Dlakic M, 1998, BIOINFORMATICS, V14, P326, DOI 10.1093/bioinformatics/14.4.326; Garcia HG, 2007, BIOPOLYMERS, V85, P115, DOI 10.1002/bip.20627; Geiger T, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001090; GOUGH GW, 1986, EMBO J, V5, P191, DOI 10.1002/j.1460-2075.1986.tb04195.x; Harada S, 2011, NUCLEIC ACIDS RES, V39, P958, DOI 10.1093/nar/gkq882; Harada S, 2009, J BIOL CHEM, V284, P24320, DOI 10.1074/jbc.M109.008128; Harraghy N, 2011, J BIOTECHNOL, V154, P11, DOI 10.1016/j.jbiotec.2011.04.004; Hashizume T, 2007, J CELL BIOCHEM, V101, P552, DOI 10.1002/jcb.21210; Hyman E, 2002, CANCER RES, V62, P6240; Ide S, 2010, SCIENCE, V327, P693, DOI 10.1126/science.1179044; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kobayashi T, 1998, BIOCHEM MOL BIOL INT, V44, P683; Kwaks THJ, 2003, NAT BIOTECHNOL, V21, P553, DOI 10.1038/nbt814; Majocchi S, 2014, NUCLEIC ACIDS RES, V42, P193, DOI 10.1093/nar/gkt880; Mariati, 2014, BIOENGINEERED, V5, P340, DOI 10.4161/bioe.32111; McBurney MW, 2002, EXP CELL RES, V274, P1, DOI 10.1006/excr.2001.5443; Mondello C, 2010, MUTAT RES-REV MUTAT, V704, P29, DOI 10.1016/j.mrrev.2010.01.008; MULLER UR, 1987, J BIOL CHEM, V262, P3730; Narayanan V, 2006, CELL, V125, P1283, DOI 10.1016/j.cell.2006.04.042; Noguchi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052990; Ohyama T., 2005, DNA CONFORMATION TRA; Okada N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077350; Rudan MV, 2015, TRENDS GENET, V31, P651, DOI 10.1016/j.tig.2015.09.004; Saunders F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120096; Shimizu N, 2005, EXP CELL RES, V302, P233, DOI 10.1016/j.yexcr.2004.09.001; Shimizu N, 2004, J CELL SCI, V117, P5303, DOI 10.1242/jcs.01414; Shimizu N, 2003, CANCER RES, V63, P5281; Shimizu N, 2001, CANCER RES, V61, P6987; Shimizu N, 2007, J CELL BIOCHEM, V102, P515, DOI 10.1002/jcb.21313; Sumida N, 2006, FEBS J, V273, P5691, DOI 10.1111/j.1742-4658.2006.05557.x; Tanaka H, 2005, NAT GENET, V37, P320, DOI 10.1038/ng1515; Tanaka SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103439; Utani K, 2009, NUCLEIC ACIDS RES, V37, P393, DOI 10.1093/nar/gkn970; WAHL GM, 1989, CANCER RES, V49, P1333; Wang F, 2012, GENE, V500, P59, DOI 10.1016/j.gene.2012.03.049; Williams S, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-17; Xiao S, 2014, CURR OPIN STRUC BIOL, V26, P32, DOI 10.1016/j.sbi.2014.03.005; Yoshimura H, 2011, PROTEIN EXPRES PURIF, V80, P41, DOI 10.1016/j.pep.2011.05.009; Yusufzai TM, 2004, P NATL ACAD SCI USA, V101, P8620, DOI 10.1073/pnas.0402938101; Zhang JH, 2014, BIOTECHNOL LETT, V36, P1937, DOI 10.1007/s10529-014-1563-9	47	7	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153338	10.1371/journal.pone.0153338	http://dx.doi.org/10.1371/journal.pone.0153338			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078685	Green Published, gold, Green Submitted			2022-12-26	WOS:000374131700040
J	Kumar, J; Barhydt, T; Awasthi, A; Lithgow, GJ; Killilea, DW; Kapahi, P				Kumar, Jitendra; Barhydt, Tracy; Awasthi, Anjali; Lithgow, Gordon J.; Killilea, David W.; Kapahi, Pankaj			Zinc Levels Modulate Lifespan through Multiple Longevity Pathways in Caenorhabditis elegans	PLOS ONE			English	Article							PROTEIN HOMEOSTASIS; BEHAVIORAL DEFECTS; METALLOTHIONEIN; GENES; DAF-16; MUTATIONS; TOXICITY; KINASE; IDENTIFICATION; TRANSPORTERS	Zinc is an essential trace metal that has integral roles in numerous biological processes, including enzymatic function, protein structure, and cell signaling pathways. Both excess and deficiency of zinc can lead to detrimental effects on development and metabolism, resulting in abnormalities and disease. We altered the zinc balance within Caenorhabditis elegans to examine how changes in zinc burden affect longevity and healthspan in an invertebrate animal model. We found that increasing zinc levels in vivo with excess dietary zinc supplementation decreased the mean and maximum lifespan, whereas reducing zinc levels in vivo with a zinc-selective chelator increased the mean and maximum lifespan in C. elegans. We determined that the lifespan shortening effects of excess zinc required expression of DAF-16, HSF-1 and SKN-1 proteins, whereas the lifespan lengthening effects of the reduced zinc may be partially dependent upon this set of proteins. Furthermore, reducing zinc levels led to greater nuclear localization of DAF-16 and enhanced dauer formation compared to controls, suggesting that the lifespan effects of zinc are mediated in part by the insulin/IGF-1 pathway. Additionally, zinc status correlated with several markers of healthspan in worms, including proteostasis, locomotion and thermotolerance, with reduced zinc levels always associated with improvements in function. Taken together, these data support a role for zinc in regulating both development and lifespan in C. elegans, and that suggest that regulation of zinc homeostasis in the worm may be an example of antagonistic pleiotropy.	[Kumar, Jitendra; Barhydt, Tracy; Lithgow, Gordon J.; Kapahi, Pankaj] Buck Inst Res Aging, Novato, CA USA; [Awasthi, Anjali] Birla Inst Technol & Sci, Dept Biol Sci, Pilani, Rajasthan, India; [Killilea, David W.] Childrens Hosp Oakland, Res Inst, Nutr & Metab Ctr, Oakland, CA 94609 USA; [Kumar, Jitendra] Univ Patna, Dept Bot Biotechnol, DBT PU IPLS Programme, Patna 800005, Bihar, India	Buck Institute for Research on Aging; Birla Institute of Technology & Science Pilani (BITS Pilani); Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Patna University	Kumar, J; Kapahi, P (corresponding author), Buck Inst Res Aging, Novato, CA USA.; Killilea, DW (corresponding author), Childrens Hosp Oakland, Res Inst, Nutr & Metab Ctr, Oakland, CA 94609 USA.; Kumar, J (corresponding author), Univ Patna, Dept Bot Biotechnol, DBT PU IPLS Programme, Patna 800005, Bihar, India.	jitendratifr@gmail.com; dkillilea@chori.org; pkapahi@buckinstitute.org		Killilea, David/0000-0002-8929-6527	American Foundation for Aging Research Mid-Career Award; NIH/NIA [AG045835, AG038688]; DBT-PU-IPLS Programme, Govt. of India; DST [SB/YS/LS-166/2014]; NATIONAL INSTITUTE ON AGING [R56AG038688, R01AG045835, R01AG038688, R01AG029631] Funding Source: NIH RePORTER	American Foundation for Aging Research Mid-Career Award; NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); DBT-PU-IPLS Programme, Govt. of India; DST(Department of Science & Technology (India)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by an American Foundation for Aging Research Mid-Career Award and NIH/NIA Grants AG045835 and AG038688 (PK). Also, the authors thank DBT-PU-IPLS Programme, Govt. of India and DST for young scientist award (SB/YS/LS-166/2014) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank the members of the Kapahi and Lithgow labs for helpful advice and critical discussion. We thank Tai Holland from the CHORI Elemental Analysis Facility for technical assistance. This work was supported in part by an American Foundation for Aging Research Mid-Career Award and NIH/NIA Grants AG045835 and AG038688 (PK). Also, we thank to DBT-PU- IPLS Programme, Govt. of India and DST for young scientist award (SB/YS/LS-166/2014) for financial support.	Adlard PA, 2015, NEUROBIOL DIS, V81, P196, DOI 10.1016/j.nbd.2014.12.012; Andrews M, 1999, Adv Wound Care, V12, P137; Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; BEDWAL RS, 1994, EXPERIENTIA, V50, P626, DOI 10.1007/BF01952862; Bofill R, 2009, FEBS J, V276, P7040, DOI 10.1111/j.1742-4658.2009.07417.x; BRENNER S, 1974, GENETICS, V77, P71; Brock TJ, 2006, PLOS GENET, V2, P997, DOI 10.1371/journal.pgen.0020108; Bruinsma JJ, 2008, GENETICS, V179, P811, DOI 10.1534/genetics.107.084384; Bruinsma JJ, 2002, DEV CELL, V2, P567, DOI 10.1016/S1534-5807(02)00151-X; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Chen D, 2013, CELL REP, V5, P1600, DOI 10.1016/j.celrep.2013.11.018; Chen D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000486; Chen Y, 2001, EUR J BIOCHEM, V268, P3346, DOI 10.1046/j.1432-1327.2001.02250.x; Chi T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124150; Colvin RA, 2010, METALLOMICS, V2, P306, DOI 10.1039/b926662c; David DC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000450; Davis DE, 2009, GENETICS, V182, P1015, DOI 10.1534/genetics.109.103614; Douglas PM, 2010, J CELL BIOL, V190, P719, DOI 10.1083/jcb.201005144; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; FABIAN TJ, 1995, J GERONTOL A-BIOL, V50, pB245, DOI 10.1093/gerona/50A.5.B245; FAVIER AE, 1992, BIOL TRACE ELEM RES, V32, P363, DOI 10.1007/BF02784623; Felkai S, 1999, EMBO J, V18, P1783, DOI 10.1093/emboj/18.7.1783; FOSMIRE GJ, 1990, AM J CLIN NUTR, V51, P225, DOI 10.1093/ajcn/51.2.225; Fraga Cesar G., 2005, Molecular Aspects of Medicine, V26, P235, DOI 10.1016/j.mam.2005.07.013; Fraker PJ, 2004, ANNU REV NUTR, V24, P277, DOI 10.1146/annurev.nutr.24.012003.132454; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Frederickson CJ, 2000, J NUTR, V130, p1471S, DOI 10.1093/jn/130.5.1471S; FREEDMAN JH, 1993, J BIOL CHEM, V268, P2554; Gaither LA, 2001, BIOMETALS, V14, P251, DOI 10.1023/A:1012988914300; Garigan D, 2002, GENETICS, V161, P1101; GOTTLIEB S, 1994, GENETICS, V137, P107; Grass G, 2001, J BACTERIOL, V183, P4664, DOI 10.1128/JB.183.15.4664-4667.2001; Huang XD, 2000, J NUTR, V130, p1488S, DOI 10.1093/jn/130.5.1488S; Jacob C, 1998, P NATL ACAD SCI USA, V95, P3489, DOI 10.1073/pnas.95.7.3489; Jakubowski J, 1999, GENETICS, V153, P743; Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kapahi Pankaj, 2004, Sci Aging Knowledge Environ, V2004, pPE34, DOI 10.1126/sageke.2004.36.pe34; Kikis EA, 2010, ADV EXP MED BIOL, V694, P138; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; King JC, 2000, J NUTR, V130, p1360S, DOI 10.1093/jn/130.5.1360S; Koga H, 2011, AGEING RES REV, V10, P205, DOI 10.1016/j.arr.2010.02.001; Krebs NF, 2000, J NUTR, V130, p1374S, DOI 10.1093/jn/130.5.1374S; Kumar J, 2015, CNS NEUROL DISORD-DR, V14, P295, DOI 10.2174/1871527314666150116110212; Lansdown ABG, 2007, WOUND REPAIR REGEN, V15, P2, DOI 10.1111/j.1524-475X.2006.00179.x; Lee SJ, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-30; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Leung MCK, 2008, TOXICOL SCI, V106, P5, DOI 10.1093/toxsci/kfn121; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Lin LC, 2006, INT J RADIAT ONCOL, V65, P745, DOI 10.1016/j.ijrobp.2006.01.015; Lynch CJ, 2001, AM J PHYSIOL-ENDOC M, V281, pE25, DOI 10.1152/ajpendo.2001.281.1.E25; Maret W, 2000, J NUTR, V130, p1455S, DOI 10.1093/jn/130.5.1455S; MCCLAIN C, 1980, GASTROENTEROLOGY, V78, P272; Murakami M, 2008, CANCER SCI, V99, P1515, DOI 10.1111/j.1349-7006.2008.00854.x; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Murphy JT, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002013; Myers SA, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/173712; Myung SJ, 1998, J GASTROENTEROL, V33, P876, DOI 10.1007/s005350050192; Nishi Y, 1996, J AM COLL NUTR, V15, P340; Olsen A, 2006, ANN NY ACAD SCI, V1067, P120, DOI 10.1196/annals.1354.015; Palmiter RD, 2004, P NATL ACAD SCI USA, V101, P4918, DOI 10.1073/pnas.0401022101; Pan KZ, 2007, AGING CELL, V6, P111, DOI 10.1111/j.1474-9726.2006.00266.x; Prasad AS, 1996, NUTRITION, V12, P344, DOI 10.1016/S0899-9007(96)80058-X; Qu WB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-170; Rink L, 2000, P NUTR SOC, V59, P541, DOI 10.1017/S0029665100000781; ROGALSKI TM, 1995, GENETICS, V139, P159; Roh HC, 2012, CELL METAB, V15, P88, DOI 10.1016/j.cmet.2011.12.003; Rossi L, 2001, J NUTR, V131, P1142, DOI 10.1093/jn/131.4.1142; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; Shen LL, 2009, ENVIRON TOXICOL PHAR, V28, P125, DOI 10.1016/j.etap.2009.03.009; Sonani RR, 2014, AGE, V36, DOI 10.1007/s11357-014-9717-1; Takeda A, 2000, BRAIN RES REV, V34, P137, DOI 10.1016/S0165-0173(00)00044-8; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; UNDERWOOD EJ, 1981, J HUM NUTR, V35, P37; Uriu-Adams Janet Y., 2005, Molecular Aspects of Medicine, V26, P268, DOI 10.1016/j.mam.2005.07.015; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; VALLEE BL, 1993, P NATL ACAD SCI USA, V90, P2715, DOI 10.1073/pnas.90.7.2715; Wang DY, 2008, J ENVIRON SCI-CHINA, V20, P1132, DOI 10.1016/S1001-0742(08)62160-9; Wang D, 2007, ENVIRON TOXICOL PHAR, V24, P223, DOI 10.1016/j.etap.2007.05.009; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Yoder JH, 2004, EMBO J, V23, P111, DOI 10.1038/sj.emboj.7600025; Zeitoun-Ghandour S, 2010, FEBS J, V277, P2531, DOI 10.1111/j.1742-4658.2010.07667.x; Zhao JF, 2008, CELL CALCIUM, V44, P422, DOI 10.1016/j.ceca.2008.01.006	84	28	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153513	10.1371/journal.pone.0153513	http://dx.doi.org/10.1371/journal.pone.0153513			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078872	Green Submitted, gold, Green Published			2022-12-26	WOS:000374131700072
J	Chamaille-Jammes, S; Charbonnel, A; Dray, S; Madzikanda, H; Fritz, H				Chamaille-Jammes, Simon; Charbonnel, Anais; Dray, Stephane; Madzikanda, Hillary; Fritz, Herve			Spatial Distribution of a Large Herbivore Community at Waterholes: An Assessment of Its Stability over Years in Hwange National Park, Zimbabwe	PLOS ONE			English	Article							AFRICAN SAVANNA; ARTIFICIAL WATERHOLES; ELEPHANT POPULATION; DENSITY; AVAILABILITY; MANAGEMENT; PROVISION; ABUNDANCE; ECOSYSTEM; PATTERNS	The spatial structuring of populations or communities is an important driver of their functioning and their influence on ecosystems. Identifying the (in) stability of the spatial structure of populations is a first step towards understanding the underlying causes of these structures. Here we studied the relative importance of spatial vs. interannual variability in explaining the patterns of abundance of a large herbivore community (8 species) at waterholes in Hwange National Park (Zimbabwe). We analyzed census data collected over 13 years using multivariate methods. Our results showed that variability in the census data was mostly explained by the spatial structure of the community, as some waterholes had consistently greater herbivore abundance than others. Some temporal variability probably linked to Park-scale migration dependent on annual rainfall was noticeable, however. Once this was accounted for, little temporal variability remained to be explained, suggesting that other factors affecting herbivore abundance over time had a negligible effect at the scale of the study. The extent of spatial and temporal variability in census data was also measured for each species. This study could help in projecting the consequences of surface water management, and more generally presents a methodological framework to simultaneously address the relative importance of spatial vs. temporal effects in driving the distribution of organisms across landscapes.	[Chamaille-Jammes, Simon; Charbonnel, Anais] CNRS UMR 5175, Ctr Ecol Fonct & Evolut, 1919 Route Mende, F-34294 Montpellier 5, France; [Chamaille-Jammes, Simon; Fritz, Herve] Zone Atelier Hwange CNRS Hwange LTER, POB 62, Dete, Zimbabwe; [Dray, Stephane; Fritz, Herve] Univ Lyon 1, CNRS UMR 5558, Lab Biometrie & Biol Evolut, 43 Bd 11 Novembre 1918, F-69622 Villeurbanne, France; [Madzikanda, Hillary] Zimbabwe Pk & Wildlife Management Author, Sci Serv, POB CY 140 Causeway, Harare, Zimbabwe; [Madzikanda, Hillary] Hwange Natl Pk, Painted Dog Conservat, Dete, Zimbabwe	UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup	Chamaille-Jammes, S (corresponding author), CNRS UMR 5175, Ctr Ecol Fonct & Evolut, 1919 Route Mende, F-34294 Montpellier 5, France.; Chamaille-Jammes, S (corresponding author), Zone Atelier Hwange CNRS Hwange LTER, POB 62, Dete, Zimbabwe.	simon.chamaille@cefe.cnrs.fr	Fritz, Herve/D-1729-2014; Dray, Stéphane/B-4107-2010; Chamaillé-Jammes, Simon/B-3833-2009	Fritz, Herve/0000-0002-7106-3661; Dray, Stéphane/0000-0003-0153-1105; Chamaillé-Jammes, Simon/0000-0003-0505-6620; Anais, Charbonnel/0000-0002-0199-230X	Agence Nationale de la Recherche [ANR-08-BLAN-0022, ANR-11-CEPS-003]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the grants ANR-08-BLAN-0022 and ANR-11-CEPS-003 of the Agence Nationale de la Recherche, received by HF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, ADV ECOL RES; AYENI JSO, 1977, J APPL ECOL, V14, P369, DOI 10.2307/2402550; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; BROWN JH, 1995, ECOLOGY, V76, P2028, DOI 10.2307/1941678; Chamaille-Jammes S, 2006, INT J REMOTE SENS, V27, P5185, DOI 10.1080/01431160600702392; Chamaille-Jammes S, 2007, J TROP ECOL, V23, P725, DOI 10.1017/S0266467407004531; Chamaille-Jammes S, 2008, J ANIM ECOL, V77, P135, DOI 10.1111/j.1365-2656.2007.01307.x; Chamaille-Jammes S, 2007, DIVERS DISTRIB, V13, P663, DOI 10.1111/j.1472-4642.2007.00415.x; Chamaille-Jammes S, 2007, AUSTRAL ECOL, V32, P740, DOI 10.1111/j.1442-9993.2007.01761.x; Chamaille-Jammes S, 2007, J APPL ECOL, V44, P625, DOI 10.1111/j.1365-2664.2007.01300.x; Chamaille-Jammes S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059164; Chamaille-Jammes S, 2009, AFR J ECOL, V47, P804, DOI 10.1111/j.1365-2028.2009.01077.x; Chamaille-Jammes S, 2009, ECOGRAPHY, V32, P871, DOI 10.1111/j.1600-0587.2009.05785.x; Courbin N, 2016, OIKOS, V125, P829, DOI 10.1111/oik.02555; Doledec S., 1991, ADV ECOLOGY, V1, P133; Dray S, 2003, ECOLOGY, V84, P3078, DOI 10.1890/03-0178; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Epaphras A. M., 2008, Wetlands Ecology and Management, V16, P183, DOI 10.1007/s11273-007-9065-3; Estes R.D., 1992, BEHAV GUIDE AFRICAN; Harrington R, 1999, BIOL CONSERV, V90, P69, DOI 10.1016/S0006-3207(98)00120-7; Manly BFJ, 1997, RANDOMIZATION BOOTST; Mayor SJ, 2005, OECOLOGIA, V145, P276, DOI 10.1007/s00442-005-0114-4; OwenSmith N, 1996, S AFR J WILDL RES, V26, P107; Perez-Barberia FJ, 2013, OECOLOGIA, V173, P837, DOI 10.1007/s00442-013-2686-8; Rao C.R., 1964, SANKHYA A, V26, P329, DOI DOI 10.1214/AOMS/1177704248; Redfern JV, 2005, J ARID ENVIRON, V63, P406, DOI 10.1016/j.jaridenv.2005.03.016; Rodriguez SJ, 1995, THESIS U KENT CANTER; Smit IPJ, 2007, DIVERS DISTRIB, V13, P666, DOI 10.1111/j.1472-4642.2007.00403.x; Smit IPJ, 2009, J NAT CONSERV, V17, P61, DOI 10.1016/j.jnc.2009.01.001; Smit IPJ, 2007, BIOL CONSERV, V136, P85, DOI 10.1016/j.biocon.2006.11.009; Stien A, 2010, ECOLOGY, V91, P915, DOI 10.1890/09-0056.1; Thrash I., 1999, Koedoe, V42, P73; Valeix M, 2007, J TROP ECOL, V23, P87, DOI 10.1017/S0266467406003609; Wilson RT, 2007, AGR WATER MANAGE, V90, P1, DOI 10.1016/j.agwat.2007.03.003; Wolanski E, 2001, HYDROBIOLOGIA, V458, P169, DOI 10.1023/A:1013125321838	35	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153639	10.1371/journal.pone.0153639	http://dx.doi.org/10.1371/journal.pone.0153639			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074044	Green Published, Green Submitted, gold			2022-12-26	WOS:000374131200113
J	Fragoso, JMV; Levi, T; Oliveira, LFB; Luzar, JB; Overman, H; Read, JM; Silvius, KM				Fragoso, Jose M. V.; Levi, Taal; Oliveira, Luiz F. B.; Luzar, Jeffrey B.; Overman, Han; Read, Jane M.; Silvius, Kirsten M.			Line Transect Surveys Underdetect Terrestrial Mammals: Implications for the Sustainability of Subsistence Hunting	PLOS ONE			English	Article							MBARACAYU RESERVE; ABUNDANCE MODELS; FOREST SITES; CONSERVATION; DEER; VERTEBRATES; DENSITIES; COUNTS; AMERICANA; COMMUNITY	Conservation of Neotropical game species must take into account the livelihood and food security needs of local human populations. Hunting management decisions should therefore rely on abundance and distribution data that are as representative as possible of true population sizes and dynamics. We simultaneously applied a commonly used encounter-based method and an infrequently used sign-based method to estimate hunted vertebrate abundance in a 48,000-km(2) indigenous landscape in southern Guyana. Diurnal direct encounter data collected during three years along 216, four-kilometer - long transects consistently under-detected many diurnal and nocturnal mammal species readily detected through sign. Of 32 species analyzed, 31 were detected by both methods; however, encounters did not detect one and under-detected another 12 of the most heavily hunted species relative to sign, while sign under-detected 12 never or rarely collected species relative to encounters. The six most important game animals in the region, all ungulates, were not encountered at 11-40% of village and control sites or on 29-72% of transects where they were detected by sign. Using the sign methodology, we find that tapirs, one of the terrestrial vertebrates considered most sensitive to overexploitation, are present at many sites where they were never visually detected during distance sampling. We find that this is true for many other species as well. These high rates of under-detection suggest that behavioral changes in hunted populations may affect apparent occurrence and abundance of these populations. Accumulation curves (detection of species on transects) were much steeper for sign for 12 of 16 hunted species than for encounters, but that pattern was reversed for 12 of 16 species unhunted in our area. We conclude that collection of sign data is an efficient and effective method of monitoring hunted vertebrate populations that complements encounter and camera-trapping methods in areas impacted by hunting. Sign surveys may be the most viable method for large-scale, management-oriented studies in remote areas, particularly those focused on community-based wildlife management.	[Fragoso, Jose M. V.; Luzar, Jeffrey B.] Stanford Univ, Stanford, CA 94305 USA; [Levi, Taal] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; [Oliveira, Luiz F. B.] Univ Fed Rio de Janeiro, Museu Nacl, Dept Vertebrados, BR-20940040 Rio de Janeiro, RJ, Brazil; [Overman, Han] SUNY Coll Environm Sci & Forestry, Environm & Forest Biol, Syracuse, NY 13210 USA; [Read, Jane M.] Syracuse Univ, Dept Geog, Syracuse, NY 13244 USA; [Silvius, Kirsten M.] Virginia Tech, Dept Forest Resources & Environm Conservat, Blacksburg, VA USA; [Fragoso, Jose M. V.] Calif Acad Sci, Biodivers Sci & Sustainabil, San Francisco, CA 94118 USA	Stanford University; Oregon State University; Universidade Federal do Rio de Janeiro; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; Syracuse University; Virginia Polytechnic Institute & State University; California Academy of Sciences	Fragoso, JMV (corresponding author), Stanford Univ, Stanford, CA 94305 USA.	fragoso@stanford.edu	Fragoso, Jose Manuel V/AAF-9146-2020	Levi, Taal/0000-0003-1853-8311	US National Science Foundation [BE/CNH 05 08094]	US National Science Foundation(National Science Foundation (NSF))	This work was funded by US National Science Foundation BE/CNH 05 08094. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DR, 1979, J WILDLIFE MANAGE, V43, P70, DOI 10.2307/3800636; Benchimol M, 2015, BIOL CONSERV, V187, P61, DOI 10.1016/j.biocon.2015.04.005; Benhaiem S, 2008, ANIM BEHAV, V76, P611, DOI 10.1016/j.anbehav.2008.03.012; Bodmer RE, 1997, CONSERV BIOL, V11, P460, DOI 10.1046/j.1523-1739.1997.96022.x; Bodmer Richard E., 2004, P299; Borges S.H., 2014, EXPERIENCE PARTICIPA; Burton AC, 2015, J APPL ECOL, V52, P675, DOI 10.1111/1365-2664.12432; Carter NH, 2012, P NATL ACAD SCI USA, V109, P15360, DOI 10.1073/pnas.1210490109; Ciuti S, 2012, PLOS ONE, DOI [10.1371/journal.pone.0050611, DOI 10.1371/JOURNAL.PONE.0050611]; Constantino PAL, 2014, INT SEM PART MON BIO; Cummings AR, 2015, INT J APPL GEOSPAT R, V6, P118, DOI 10.4018/ijagr.2015010107; Danielsen F, 2005, BIODIVERS CONSERV, V14, P2507, DOI 10.1007/s10531-005-8375-0; Melo ERD, 2015, WILDLIFE BIOL, V21, P234, DOI 10.2981/wlb.00095; Di Bitetti MS, 2008, BIOTROPICA, V40, P636, DOI 10.1111/j.1744-7429.2008.00413.x; Dirzo R., 1991, PLANT ANIMAL INTERAC, P273; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Endo W, 2010, BIOTROPICA, V42, P251, DOI 10.1111/j.1744-7429.2009.00546.x; Fragoso JM, 2000, BRAZIL INTEGRATING I; Fragoso JMV, 1999, J MAMMAL, V80, P993, DOI 10.2307/1383270; Gopalaswamy AM, 2012, ANIM CONSERV, V15, P669, DOI 10.1111/j.1469-1795.2012.00565.x; Hill K, 1997, CONSERV BIOL, V11, P1339, DOI 10.1046/j.1523-1739.1997.96048.x; Hill K, 2000, BIOL RESOURCE MANAGE, P79; Ibarra JT, 2011, INT FOREST REV, V13, P318, DOI 10.1505/146554811798293935; Desbiez ALJ, 2010, BIOTROPICA, V42, P372, DOI 10.1111/j.1744-7429.2009.00601.x; Johnston A, 2015, ECOL APPL, V25, P1749, DOI 10.1890/14-1826.1; KOVNER JL, 1974, BIOMETRICS, V30, P225, DOI 10.2307/2529644; Little AR, 2014, WILDLIFE SOC B, V38, P797, DOI 10.1002/wsb.449; Longoria MP, 2007, J WILDLIFE MANAGE, V71, P652, DOI 10.2193/2005-613; Luzar JB, 2011, BIOSCIENCE, V61, P771, DOI 10.1525/bio.2011.61.10.7; Marinelli CE, 2014, BIODIVERS BRAS, V4, P47; Michalski F, 2007, CONSERV BIOL, V21, P1626, DOI 10.1111/j.1523-1739.2007.00797.x; Naranjo Eduardo J., 2004, P324; Nasi R, 2011, INT FOREST REV, V13, P355, DOI 10.1505/146554811798293872; Nogueira-Filho S. L. G., 2004, PEOPLE NATURE WILDLI, P464; Noss AJ, 2006, MAMMALIA, V70, P64, DOI 10.1515/MAMM.2006.020; Parry L, 2009, CONSERV BIOL, V23, P1270, DOI 10.1111/j.1523-1739.2009.01224.x; Pellikka J, 2005, ANN ZOOL FENN, V42, P123; Pereira FO, 2013, MONITORAMENTO SITU B; Peres CA, 2000, CONSERV BIOL, V14, P240, DOI 10.1046/j.1523-1739.2000.98485.x; Peres CA, 2003, CONSERV BIOL, V17, P521, DOI 10.1046/j.1523-1739.2003.01413.x; Peres CA, 2011, CONSERV BIOL, V25, P1124, DOI 10.1111/j.1523-1739.2011.01770.x; Read JM, 2010, J LAT AM GEOGR, V9, P213, DOI 10.1353/lag.2010.0030; REDFORD KH, 1992, BIOSCIENCE, V42, P412, DOI 10.2307/1311860; Richard-Hansen C, 2014, MAMMALIA, V78, P291, DOI 10.1515/mammalia-2013-0087; Rivero K, 2004, EUR J WILDLIFE RES, V50, P161, DOI 10.1007/s10344-004-0064-x; Robinson J., 2000, HUNTING SUSTAINABILI; Robinson J.G., 1991, NEOTROPICAL WILDLIFE; Ruiz-Perez M, 2005, AMBIO, V34, P218, DOI 10.1639/0044-7447(2005)034[0218:CADIAE]2.0.CO;2; Stander PE, 1998, J APPL ECOL, V35, P378, DOI 10.1046/j.1365-2664.1998.00313.x; Terborgh J, 2008, ECOLOGY, V89, P1757, DOI 10.1890/07-0479.1; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Thurfjell H, 2013, WILDLIFE BIOL, V19, P87, DOI 10.2981/12-027; Tobler MW, 2015, J APPL ECOL, V52, P413, DOI 10.1111/1365-2664.12399; Wright SJ, 2007, BIOTROPICA, V39, P363, DOI 10.1111/j.1744-7429.2007.00289.x	54	43	49	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152659	10.1371/journal.pone.0152659	http://dx.doi.org/10.1371/journal.pone.0152659			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074025	Green Submitted, gold, Green Published			2022-12-26	WOS:000374131200032
J	Kala, P; Hudakova, N; Jurajda, M; Kasparek, T; Ustohal, L; Parenica, J; Sebo, M; Holicka, M; Kanovsky, J				Kala, Petr; Hudakova, Nela; Jurajda, Michal; Kasparek, Tomas; Ustohal, Libor; Parenica, Jiri; Sebo, Marek; Holicka, Maria; Kanovsky, Jan			Depression and Anxiety after Acute Myocardial Infarction Treated by Primary PCI	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; MAJOR DEPRESSION; PREVALENCE; PROGNOSIS; PATTERNS; DISEASE; EVENTS	Aims The main objective of the study was to find out prevalence of depression and anxiety symptoms in the population of patients with AMI with ST-segment elevation (STEMI), treated with primary PCI (pPCI). Secondary target indicators included the incidence of sleep disorders and loss of interest in sex. Methods and results The project enrolled 79 consecutive patients with the first AMI, aged <80 years (median 61 years, 21.5% of women) with a follow-up period of 12 months. Symptoms of depression or anxiety were measured using the Beck Depression Inventory II tests (BDI-II, cut-off value >= 14) and Self-Rating Anxiety Scale (SAS, cut-off >= 45) within 24 hours of pPCI, before the discharge, and in 3, 6 and 12 months). Results with the value p<0.05 were considered as statistically significant. The BDI-II positivity was highest within 24 hours after pPCI (21.5%) with a significant decline prior to the discharge (9.2%), but with a gradual increase in 3, 6 and 12 months (10.4%; 15.4%; 13.8% respectively). The incidence of anxiety showed a relatively similar trend: 8.9% after pPCI, and 4.5%, 10.8% and 6.2% in further follow-up. Conclusions Patients with STEMI treated by primary PCI have relatively low overall prevalence of symptoms of depression and anxiety. A significant decrease in mental stress was observed before discharge from the hospital, but in a period of one year after pPCI, prevalence of both symptoms was gradually increasing, which should be given medical attention.	[Kala, Petr; Parenica, Jiri; Holicka, Maria; Kanovsky, Jan] Univ Hosp Brno, Dept Internal Med & Cardiol, Brno, Czech Republic; [Kala, Petr; Hudakova, Nela; Kasparek, Tomas; Ustohal, Libor; Parenica, Jiri; Holicka, Maria; Kanovsky, Jan] Masaryk Univ, Fac Med, Brno, Czech Republic; [Kasparek, Tomas; Ustohal, Libor] Univ Hosp Brno, Dept Psychiat, Brno, Czech Republic; [Sebo, Marek] Ctr Cardiovasc & Transplantat Surg, Brno, Czech Republic; [Jurajda, Michal] Masaryk Univ, Dept Pathol Physiol, Fac Med, Brno, Czech Republic	University Hospital Brno; Masaryk University Brno; University Hospital Brno; Masaryk University Brno	Kanovsky, J (corresponding author), Univ Hosp Brno, Dept Internal Med & Cardiol, Brno, Czech Republic.; Kanovsky, J (corresponding author), Masaryk Univ, Fac Med, Brno, Czech Republic.	jkanovsky@fnbrno.cz	Ustohal, Libor/ABF-7992-2020; Kanovsky, Jan/ABC-1404-2021; Kasparek, Tomas/D-7121-2012; Kasparek, Tomas/AAA-5109-2021	Kasparek, Tomas/0000-0002-9876-1072; Kasparek, Tomas/0000-0002-9876-1072; Kanovsky, Jan/0000-0003-1352-6274				Berkman LF, 2003, JAMA-J AM MED ASSOC, V289, P3106; Bonnet F, 2005, ATHEROSCLEROSIS, V178, P339, DOI 10.1016/j.atherosclerosis.2004.08.035; Bunde J, 2006, PSYCHOSOM MED, V68, P51, DOI 10.1097/01.psy.0000195724.58085.f0; Damen NL, 2013, INT J CARDIOL, V167, P2496, DOI 10.1016/j.ijcard.2012.04.028; Damen NL, 2011, J AFFECT DISORDERS, V134, P464, DOI 10.1016/j.jad.2011.05.026; Denollet J, 2010, J AFFECT DISORDERS, V120, P105, DOI 10.1016/j.jad.2009.04.013; Frasure-Smith N, 1999, PSYCHOSOM MED, V61, P26, DOI 10.1097/00006842-199901000-00006; FRASURESMITH N, 1993, JAMA-J AM MED ASSOC, V270, P1819, DOI 10.1001/jama.270.15.1819; Furuya RK, 2013, REV ESC ENFERM USP, V47, P1333, DOI 10.1590/S0080-623420130000600012; Glassman AH, 2002, JAMA-J AM MED ASSOC, V288, P701, DOI 10.1001/jama.288.6.701; HAVIK OE, 1990, J PSYCHOSOM RES, V34, P271, DOI 10.1016/0022-3999(90)90083-G; Hoschl C., 2002, PSYCHIATRIE; Lane D, 2000, QJM-MON J ASSOC PHYS, V93, P739, DOI 10.1093/qjmed/93.11.739; Lane D, 2002, BRIT J HEALTH PSYCH, V7, P11, DOI 10.1348/135910702169321; Mayou RA, 2000, PSYCHOSOM MED, V62, P212, DOI 10.1097/00006842-200003000-00011; Musselman DL, 1996, AM J PSYCHIAT, V153, P1313; Rajagopalan S, 2001, AM J CARDIOL, V88, P196, DOI 10.1016/S0002-9149(01)01623-X; Rieckmann N, 2006, J AM COLL CARDIOL, V48, P2218, DOI 10.1016/j.jacc.2006.07.063; Thombs BD, 2006, J GEN INTERN MED, V21, P30, DOI 10.1111/j.1525-1497.2005.00269.x; THOMPSON DR, 1987, BRIT J MED PSYCHOL, V60, P343, DOI 10.1111/j.2044-8341.1987.tb02753.x; Trotter R, 2011, HEART LUNG, V40, P185, DOI 10.1016/j.hrtlng.2010.05.054; Vacir K., 1999, BECKOVA SEBEPOSUZOVA; Vreeburg SA, 2009, ARCH GEN PSYCHIAT, V66, P617, DOI 10.1001/archgenpsychiatry.2009.50; Welin C, 2000, J INTERN MED, V247, P629, DOI 10.1046/j.1365-2796.2000.00694.x; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371	25	30	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152367	10.1371/journal.pone.0152367	http://dx.doi.org/10.1371/journal.pone.0152367			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UC	27074002	Green Submitted, Green Published, gold			2022-12-26	WOS:000374131200022
J	Krendl, AC; Kensinger, EA				Krendl, Anne C.; Kensinger, Elizabeth A.			Does Older Adults' Cognitive Function Disrupt the Malleability of Their Attitudes toward Outgroup Members?: An fMRI Investigation	PLOS ONE			English	Article							AGE-DIFFERENCES; ATTRIBUTIONAL ANALYSIS; SOURCE MEMORY; EMPATHY; PREJUDICE; STIGMA; RESPONSES; IDEOLOGY; PAIN; DISSOCIATION	In the current study we examine how individual differences in older adults' global cognitive function impacts the extent to which their attitudes toward stigmatized individuals are malleable. Because prior research has elucidated the neural processes that are involved in evaluating stigmatized individuals who are responsible or not responsible for their condition, a cognitive neuroscience approach may be well-suited to answer this question. In the current study, 36 older and 17 young adults underwent functional magnetic resonance imaging while evaluating images of homeless people who were described as being responsible or not responsible for their condition. They also indicated how much pity they felt for each of the individuals in order to determine the extent to which their attitudes were malleable (e.g., more pity for not-responsible as compared to responsible individuals). Participants' cognitive function and baseline measure of their attitudes toward stigmatized individuals (including homeless individuals) were assessed. Results revealed that although older adults' attitudes were malleable, the extent to which this was true varied due to individual differences in their global cognitive function. Specifically, the difference in the magnitude of older adults' self-reported pity for not-responsible as compared to responsible homeless individuals was predicted by their global cognitive function. Moreover, the difference in pity that older adults expressed toward not-responsible as compared to responsible homeless individuals was related to activity in the left insula and the anterior cingulate cortex (regions implicated in empathy). These results suggest that attitude malleability is affected by individual differences in global cognitive function.	[Krendl, Anne C.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA; [Kensinger, Elizabeth A.] Boston Coll, Dept Psychol, Chestnut Hills, MA USA	Indiana University System; Indiana University Bloomington	Krendl, AC (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA.	akrendl@indiana.edu		Kensinger, Elizabeth/0000-0003-1940-231X	Searle Foundation; Boston College; Ruth Kirschstein National Research Service Award from the National Institute on Aging [F32 AG034039-01A1]; NATIONAL INSTITUTE ON AGING [F32AG034039] Funding Source: NIH RePORTER	Searle Foundation; Boston College; Ruth Kirschstein National Research Service Award from the National Institute on Aging; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Support for this research was provided by the Searle Foundation and Boston College, as well as a Postdoctoral Fellowship from the Ruth Kirschstein National Research Service Award from the National Institute on Aging (F32 AG034039-01A1) to ACK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apfelbaum EP, 2010, J EXP SOC PSYCHOL, V46, P1074, DOI 10.1016/j.jesp.2010.07.017; Azevedo RT, 2014, NEUROIMAGE, V91, P109, DOI 10.1016/j.neuroimage.2013.11.041; Bailey PE, 2008, AGING MENT HEALTH, V12, P499, DOI 10.1080/13607860802224243; Bartholow BD, 2006, J PERS SOC PSYCHOL, V90, P272, DOI 10.1037/0022-3514.90.2.272; Bernhardt BC, 2012, ANNU REV NEUROSCI, V35, P1, DOI 10.1146/annurev-neuro-062111-150536; Blanchard-Fields F, 2005, J GERONTOL B-PSYCHOL, V60, pP19, DOI 10.1093/geronb/60.1.P19; BLANCHARDFIELDS F, 1994, J GERONTOL, V49, pP43, DOI 10.1093/geronj/49.2.P43; BlanchardFields F, 1996, APPL COGNITIVE PSYCH, V10, pS137; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Cheetham M, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.029.2009; CRANDALL CS, 1995, BRIT J SOC PSYCHOL, V34, P67, DOI 10.1111/j.2044-8309.1995.tb01049.x; CRANDALL CS, 1994, J PERS SOC PSYCHOL, V66, P882, DOI 10.1037/0022-3514.66.5.882; Crandall CS, 1996, PERS SOC PSYCHOL B, V22, P1165, DOI 10.1177/01461672962211007; Decety J, 2006, CURR DIR PSYCHOL SCI, V15, P54, DOI 10.1111/j.0963-7214.2006.00406.x; Decety J, 2010, J COGNITIVE NEUROSCI, V22, P985, DOI 10.1162/jocn.2009.21266; DEVINE PG, 1989, J PERS SOC PSYCHOL, V56, P5, DOI 10.1037/0022-3514.56.1.5; Fehse K, 2015, SOC NEUROSCI-UK, V10, P243, DOI 10.1080/17470919.2014.980587; Finlay KA, 2000, J APPL SOC PSYCHOL, V30, P1720, DOI 10.1111/j.1559-1816.2000.tb02464.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GLISKY EL, 1995, NEUROPSYCHOLOGY, V9, P229, DOI 10.1037/0894-4105.9.2.229; Gonsalkorale K, SOCIAL PSYCHOL PERSO; Gonsalkorale K, 2009, J EXP SOC PSYCHOL, V45, P410, DOI 10.1016/j.jesp.2008.11.004; Harris LT, 2006, PSYCHOL SCI, V17, P847, DOI 10.1111/j.1467-9280.2006.01793.x; Henry JD, 2013, PSYCHOL AGING, V28, P826, DOI 10.1037/a0030677; Hodson G, 2012, PSYCHOL SCI, V23, P187, DOI 10.1177/0956797611421206; Kramer AF, 1999, ACTA PSYCHOL, V101, P339, DOI 10.1016/S0001-6918(99)00011-6; Krendl AC, 2012, SOCIAL COGNITIVE AFF; Krendl AC, 2013, J GERONTOL B-PSYCHOL, V68, P333, DOI 10.1093/geronb/gbs070; Krendl AC, 2009, PSYCHOL AGING, V24, P530, DOI 10.1037/a0016065; KUKULL WA, 1994, J CLIN EPIDEMIOL, V47, P1061, DOI 10.1016/0895-4356(94)90122-8; Lawrence EJ, 2006, NEUROIMAGE, V29, P1173, DOI 10.1016/j.neuroimage.2005.09.001; Payne BK, 2005, J PERS SOC PSYCHOL, V89, P488, DOI 10.1037/0022-3514.89.4.488; Radvansky GA, 2010, J EXP SOC PSYCHOL, V46, P51, DOI 10.1016/j.jesp.2009.09.010; Reuter-Lorenz PA, 2008, CURR DIR PSYCHOL SCI, V17, P177, DOI 10.1111/j.1467-8721.2008.00570.x; RUSHTON JP, 1981, PERS INDIV DIFFER, V2, P293; Slotnick SD, 2003, COGNITIVE BRAIN RES, V17, P75, DOI 10.1016/S0926-6410(03)00082-X; Stewart BD, 2009, PSYCHOL SCI, V20, P164, DOI 10.1111/j.1467-9280.2009.02274.x; Von Hippel W, 2000, PERSONALITY AND SOCI, P523; Wakabayashi A, 2006, PERS INDIV DIFFER, V41, P929, DOI 10.1016/j.paid.2006.03.017; WEINER B, 1988, J PERS SOC PSYCHOL, V55, P738, DOI 10.1037/0022-3514.55.5.738; Xu XJ, 2009, J NEUROSCI, V29, P8525, DOI 10.1523/JNEUROSCI.2418-09.2009; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]; ZUCKER GS, 1993, J APPL SOC PSYCHOL, V23, P925, DOI 10.1111/j.1559-1816.1993.tb01014.x	43	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152698	10.1371/journal.pone.0152698	http://dx.doi.org/10.1371/journal.pone.0152698			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074046	Green Submitted, Green Published, gold			2022-12-26	WOS:000374131200033
J	Ogneva, IV; Biryukov, NS				Ogneva, Irina V.; Biryukov, Nikolay S.			Lecithin Prevents Cortical Cytoskeleton Reorganization in Rat Soleus Muscle Fibers under Short-Term Gravitational Disuse	PLOS ONE			English	Article							HUMAN ARP2/3 COMPLEX; ACTIN CYTOSKELETON; CHANNEL ACTIVITY; SPACE-FLIGHT; LIPID RAFTS; INCREASES; SUBUNITS; BINDING; CELLS; PHOSPHORYLATION	The aim of this study was to prevent the cortical cytoskeleton reorganization of rat soleus muscle fibers under short-term gravitational disuse. Once a day, we injected the right soleus muscle with 0.5 ml lecithin at a concentration of 200 mg/ml and the left soleus muscle with a diluted solution in an equal volume for 3 days prior to the experiment. To simulate microgravity conditions in rats, an anti-orthostatic suspension was used according to the Ilyin-Novikov method modified by Morey-Holton et al. for 6 hours. The following groups of soleus muscle tissues were examined: "C", "C+L", "HS", and "HS+L". The transversal stiffness of rat soleus muscle fibers after 6 hours of suspension did not differ from that of the control group for the corresponding legs; there were no differences between the groups without lecithin "C" and "HS" or between the groups with lecithin "C+L" and "HS+L". However, lecithin treatment for three days resulted in an increase in cell stiffness; in the "C+L" group, cell stiffness was significantly higher by 22.7% (p < 0.05) compared with that of group "C". The mRNA content of genes encoding beta-and gamma-actin and beta-tubulin did not significantly differ before and after suspension in the corresponding groups. However, there was a significant increase in the mRNA content of these genes after lecithin treatment: the beta-actin and gamma-actin mRNA content in group "C+L" increased by 200% compared with that of group "C", and beta-tubulin increased by 100% (as well as the mRNA content of tubulin-binding proteins Ckap5, Tcp1, Cct5 and Cct7). In addition, desmin mRNA content remained unchanged in all of the experimental groups. As a result of the lecithin injections, there was a redistribution of the mRNA content of genes encoding actin monomer-and filament-binding proteins in the direction of increasing actin polymerization and filament stability; the mRNA content of Arpc3 and Lcp1 increased by 3- and 5-fold, respectively, but the levels of Tmod1 and Svil decreased by 2- and 5-fold, respectively. However, gravitational disuse did not result in changes in the mRNA content of Arpc3, Tmod1, Svil or Lcp1. Antiorthostatic suspension for 6 hours resulted in a decrease in the mRNA content of alpha-actinin-4 (Actn4) and alpha-actinin-1 (Actn1) in group "HS "compared with that of group "C" by 25% and 30%, respectively, as well as a decrease and increase in the ACTN4 protein content in the membrane and cytoplasmic fractions, respectively. Lecithin injection resulted in an increase in the Actn1 and Actn4 mRNA content in group "C+L" by 1.5-fold and more than 2-fold, respectively, compared with the levels in group "C". Moreover, in group "HS+L", the mRNA content did not change in these genes compared with the levels in group "C+L", and the ACTN4 protein content in the membrane and cytoplasmic fractions also remained unchanged. Thus, lecithin prevented the reduction of Actn1 and Actn4 mRNA and the migration of ACTN4 from the cortical cytoskeleton to the cytoplasm.	[Ogneva, Irina V.; Biryukov, Nikolay S.] Russian Acad Sci, Russian Federat Inst Biomed Problems, State Sci Ctr, Dept Mol & Cell Biomed, Moscow, Russia; [Ogneva, Irina V.] IM Sechenov First Moscow State Med Univ, Moscow, Russia; [Biryukov, Nikolay S.] State Univ, Moscow Inst Phys & Technol, Moscow, Moscow Region, Russia	Russian Academy of Sciences; Institute of Biomedical Problems of the Russian Academy of Sciences; Sechenov First Moscow State Medical University; Moscow Institute of Physics & Technology	Ogneva, IV (corresponding author), Russian Acad Sci, Russian Federat Inst Biomed Problems, State Sci Ctr, Dept Mol & Cell Biomed, Moscow, Russia.; Ogneva, IV (corresponding author), IM Sechenov First Moscow State Med Univ, Moscow, Russia.	iogneva@yandex.ru	Biryukov, Nikolay/L-2955-2016; Ogneva, Irina V/Q-8783-2018; Biryukov, Nikolay/AAE-8139-2021	Biryukov, Nikolay/0000-0001-6861-3960; Ogneva, Irina V/0000-0003-0125-5876; 	Russian Fond of the Basic Research (RFBR) [13-04-00755-a]; program of the RAS Presidium	Russian Fond of the Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR)); program of the RAS Presidium	The financial support of the Russian Fond of the Basic Research (RFBR grant 13-04-00755-a) and program of the RAS Presidium "Molecular and cell biology" is greatly acknowledged.	BOOTH FW, 1973, PFLUG ARCH EUR J PHY, V342, P231, DOI 10.1007/BF00591371; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Caiozzo VJ, 1996, J APPL PHYSIOL, V81, P123, DOI 10.1152/jappl.1996.81.1.123; Cassimeris L, 2004, MOL BIOL CELL, V15, P1580, DOI 10.1091/mbc.E03-07-0544; Chubinskiy-Nadezhdin VI, 2011, BIOCHEM BIOPH RES CO, V412, P80, DOI 10.1016/j.bbrc.2011.07.046; Collinsworth AM, 2002, AM J PHYSIOL-CELL PH, V283, pC1219, DOI 10.1152/ajpcell.00502.2001; Crowley JL, 2009, MOL BIOL CELL, V20, P948, DOI 10.1091/mbc.E08-08-0867; DENNERLL TJ, 1988, J CELL BIOL, V107, P665, DOI 10.1083/jcb.107.2.665; DESPLANCHES D, 1990, J APPL PHYSIOL, V68, P48, DOI 10.1152/jappl.1990.68.1.48; DEVARAJAN P, 1994, P NATL ACAD SCI USA, V91, P2965, DOI 10.1073/pnas.91.8.2965; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; Gergely F, 2003, GENE DEV, V17, P336, DOI 10.1101/gad.245603; Ghosh D, 2010, J MASS SPECTROM, V45, P1, DOI 10.1002/jms.1696; Goffart S, 2006, CURR GENET, V49, P125, DOI 10.1007/s00294-005-0043-0; Gournier H, 2001, MOL CELL, V8, P1041, DOI 10.1016/S1097-2765(01)00393-8; Harder T, 1999, EUR J IMMUNOL, V29, P556, DOI 10.1002/(SICI)1521-4141(199902)29:02<556::AID-IMMU556>3.0.CO;2-2; Huang HD, 2004, AM J PHYSIOL-CELL PH, V287, pC1, DOI 10.1152/ajpcell.00559.2003; Infanger M, 2007, J CELL BIOCHEM, V101, P1439, DOI 10.1002/jcb.21261; Janji B, 2006, J CELL SCI, V119, P1947, DOI 10.1242/jcs.02874; Jayaraman T, 2008, SINGAP MED J, V49, P320; Knee KM, 2013, CELL STRESS CHAPERON, V18, P137, DOI 10.1007/s12192-012-0357-z; Lee K, 2004, YONSEI MED J, V45, P690; Levitan I, 2000, J GEN PHYSIOL, V115, P405, DOI 10.1085/jgp.115.4.405; Liu SC, 2000, J CELL SCI, V113, P3563; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; Mak KM, 2003, ALCOHOL CLIN EXP RES, V27, P997, DOI 10.1097/01.ALC.0000071901.62432.09; Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849; Maroto R, 2005, NAT CELL BIOL, V7, P179, DOI 10.1038/ncb1218; MATSUSHIMA K, 1988, BIOCHEMISTRY-US, V27, P3765, DOI 10.1021/bi00410a037; Maximov AV, 1997, FEBS LETT, V412, P94, DOI 10.1016/S0014-5793(97)00754-0; Maximov AV, 1997, BIOPHYS J, V72, pWPO99; MCDONALD KS, 1995, J APPL PHYSIOL, V79, P1796, DOI 10.1152/jappl.1995.79.5.1796; Morachevskaya E, 2007, CELL BIOL INT, V31, P374, DOI 10.1016/j.cellbi.2007.01.024; Morey-Holton E, 2005, ADV SPACE B, V10, P7, DOI 10.1016/S1569-2574(05)10002-1; Nebl T, 2002, J BIOL CHEM, V277, P43399, DOI 10.1074/jbc.M205386200; Negulyaev YA, 1996, MOL BIOL CELL, V7, P1857, DOI 10.1091/mbc.7.12.1857; Odde DJ, 1999, J CELL SCI, V112, P3283; Ogneva IV, 2014, J APPL PHYSIOL, V116, P1315, DOI 10.1152/japplphysiol.00134.2014; Ogneva IV, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/393405; Ogneva IV, 2010, J APPL PHYSIOL, V109, P1702, DOI 10.1152/japplphysiol.00793.2010; Ogneva I.V., 2013, APPL MATH, V4, P1, DOI [10.4236/am.2013.48A001, DOI 10.4236/AM.2013.48A001]; Ogneva IV, 2014, INT J BIOMED, V4, P162, DOI 10.21103/Article4_3_ER1; Ogneva IV, 2015, J APPL PHYSIOL, V118, P613, DOI 10.1152/japplphysiol.00812.2014; Ogneva IV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096395; Poch MT, 2004, TOXICOL APPL PHARM, V199, P239, DOI 10.1016/j.taap.2003.12.023; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Putnam AJ, 2001, AM J PHYSIOL-CELL PH, V280, pC556, DOI 10.1152/ajpcell.2001.280.3.C556; RIJKEN PJ, 1992, ADV SPACE RES-SERIES, V12, P145, DOI 10.1016/0273-1177(92)90277-5; Robinson RC, 2001, SCIENCE, V294, P1679, DOI 10.1126/science.1066333; Salmi ML, 2011, PLANTA, V233, P911, DOI 10.1007/s00425-010-1343-2; SCHWIEBERT EM, 1994, J BIOL CHEM, V269, P7081; Shlyonsky VG, 2003, AM J PHYSIOL-RENAL, V284, pF182, DOI 10.1152/ajprenal.00216.2002; STEVENS L, 1993, AM J PHYSIOL, V264, pR770, DOI 10.1152/ajpregu.1993.264.4.R770; Sukharev S, 2001, NATURE, V409, P720, DOI 10.1038/35055559; SUZUKI M, 1993, J MEMBRANE BIOL, V134, P31; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vartiainen MK, 2004, CURR OPIN CELL BIOL, V16, P174, DOI 10.1016/j.ceb.2004.02.004; Vitorino R, 2007, ANAL BIOCHEM, V366, P156, DOI 10.1016/j.ab.2007.04.009; Wear MA, 2004, TRENDS BIOCHEM SCI, V29, P418, DOI 10.1016/j.tibs.2004.06.003; Welch MD, 1997, J CELL BIOL, V138, P375, DOI 10.1083/jcb.138.2.375; Widrick JJ, 2008, AM J PHYSIOL-REG I, V295, pR1585, DOI 10.1152/ajpregu.00045.2008; Won KA, 1998, MOL CELL BIOL, V18, P7584, DOI 10.1128/MCB.18.12.7584; YAFFE MB, 1992, NATURE, V358, P245, DOI 10.1038/358245a0; Yokota S, 2001, EUR J BIOCHEM, V268, P4664, DOI 10.1046/j.1432-1327.2001.02393.x	66	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153650	10.1371/journal.pone.0153650	http://dx.doi.org/10.1371/journal.pone.0153650			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27073851	Green Submitted, Green Published, gold			2022-12-26	WOS:000374131200115
J	Yue, A; Marsh, L; Zhou, H; Medina, A; Luo, RF; Shi, YJ; Zhang, LX; Kenny, K; Rozelle, S				Yue, Ai; Marsh, Lauren; Zhou, Huan; Medina, Alexis; Luo, Renfu; Shi, Yaojiang; Zhang, Linxiu; Kenny, Kaleigh; Rozelle, Scott			Nutritional Deficiencies, the Absence of Information and Caregiver Shortcomings: A Qualitative Analysis of Infant Feeding Practices in Rural China	PLOS ONE			English	Article							CHILD HEALTH; EDUCATION; ANEMIA	Background and Objectives Development during the first two years of life is critical and has a lasting impact on a child's health. Poor infant and child nutrition can lead to deficiencies in essential micronutrients, which may cause a weakened immune system and lasting effects on children's growth and development. Recent studies in rural Shaanxi Province found an anemia prevalence of 54.3% among rural children aged six to twelve months. While new large-scale, quantitative research has begun to catalogue the extent of child malnutrition and anemia, no effort has yet been made to look more closely at the potential reasons for rural children's nutritional deficiencies through qualitative analysis. This study aims to elucidate some of the fundamental causes of poor complementary feeding practices that may lead to anemia among children in rural Shaanxi Province, China. Methodology We interviewed sixty caregivers participating in a large survey on child health and nutrition. We conducted three waves of interviews with children's primary caregivers in seventeen rural villages within four nationally-designated poverty counties in the southern part of Shaanxi Province. Results The qualitative analysis reveals that poor complementary feeding practices are common across our sample. Information gathered from our interviews suggests that complementary feeding practices are impeded by two constraints: absence of understanding topics related to infant health and nutrition under caregivers, as well as inadequate sources of information on these topics. Poverty does not appear to constrain child feeding practices. Conclusion Our results uncover lack of proper knowledge on infant and child nutrition among rural caregivers in China. This situation causes them to fail incorporating micronutrient rich foods in their children's diet. Age-appropriate complementary feeding can stimulate children's physical and cognitive development, but in its absence it leads to iron-deficiency anemia. We suggest that steps be taken to educate caregivers to improve complementary feeding of their infants and children.	[Yue, Ai; Shi, Yaojiang] Shaanxi Normal Univ, CEEE, Xian 710119, Shaanxi, Peoples R China; [Marsh, Lauren; Zhou, Huan] Sichuan Univ, West China Sch Publ Hlth, Chengdu 610041, Sichuan, Peoples R China; [Medina, Alexis; Kenny, Kaleigh; Rozelle, Scott] Stanford Univ, Rural Educ Act Program, Freeman Spogli Inst Int Studies, Stanford, CA 94305 USA; [Luo, Renfu; Zhang, Linxiu] Peking Univ, Sch Adv Agr Sci, Beijing 100871, Peoples R China	Shaanxi Normal University; Sichuan University; Stanford University; Peking University	Zhou, H (corresponding author), Sichuan Univ, West China Sch Publ Hlth, Chengdu 610041, Sichuan, Peoples R China.	zhouhuan1999@yeah.net	zhou, huan/GYJ-4398-2022; ZHANG, LIN/GYD-9123-2022		International Initiative for Impact Evaluation (3ie) [PW2.03.CH.IE]; UBS Optimus Foundation [12-6140]; China Medical Board [13-158]	International Initiative for Impact Evaluation (3ie); UBS Optimus Foundation; China Medical Board	This work was supported by funding from the International Initiative for Impact Evaluation (3ie), grant number: PW2.03.CH.IE, URL: http://www.3ieimpact.org (to RL); the UBS Optimus Foundation, grant number: 12-6140, URL: https://www.ubs.com/global/en/wealth_management/optimusfoundation.html (to HZ); and China Medical Board, grant number: 13-158, URL: http://www.chinamedicalboard.org (to YS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, REP CHIN IMPL MILL D; Block SA, 2007, OXFORD ECON PAP, V59, P330, DOI 10.1093/oep/gpm001; Chen CM, 2010, BIOMED ENVIRON SCI, V23, P83, DOI 10.1016/S0895-3988(10)60036-0; CLELAND JG, 1988, SOC SCI MED, V27, P1357, DOI 10.1016/0277-9536(88)90201-8; de Benoist B, 2008, WHO GLOBAL DATABASE; Desai S, 1998, DEMOGRAPHY, V35, P71, DOI 10.2307/3004028; Dewey K., 2003, GUID PRINC COMPL FEE; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; LIN LM, 2003, CHIN J CHILD HLTH CA, V11, P242; Ling R.E., 2010, PUBLIC HLTH, V30, P1; Liu H, 2013, ECON HUM BIOL, V11, P294, DOI 10.1016/j.ehb.2012.04.010; Luo R, 2015, MICRONUTRIE IN PRESS; Luo RF, 2014, NUTRIENTS, V6, P5975, DOI 10.3390/nu6125975; Ministry of Health, 2009, CHIN HLTH STAT YB; National Bureau of Statistics, 2011, B 2010 6 NAT CENS CH; Pelto Gretel H., 2003, Food and Nutrition Bulletin, V24, P45; Shi L, 2010, PUBLIC HEALTH NUTR, V13, P556, DOI 10.1017/S1368980009991364; State Council, 2012, 12 5 YEAR PLAN HLTH; Sylvia S, 2015, HEALTH POLICY PLANN, V30, P322, DOI 10.1093/heapol/czu014; van der Gaag J, EARLY CHILDHOOD DEV; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; WHO, 2016, COMPL FEED; Wu K., 2012, EARLY CHILD DEV CHIN; Zhang F, 2015, PUBLIC HEALTH NUTR, V18, P936, DOI 10.1017/S1368980014001001; Zhang LX, 2013, J NUTR, V143, P640, DOI 10.3945/jn.112.171959	25	31	31	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153385	10.1371/journal.pone.0153385	http://dx.doi.org/10.1371/journal.pone.0153385			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UC	27073864	Green Submitted, Green Published, gold			2022-12-26	WOS:000374131200080
J	Chang, ETY; Lin, YT; Galla, T; Clayton, RH; Eatock, J				Chang, Eugene T. Y.; Lin, Yen Ting; Galla, Tobias; Clayton, Richard H.; Eatock, Julie			A Stochastic Individual-Based Model of the Progression of Atrial Fibrillation in Individuals and Populations	PLOS ONE			English	Article							ELECTROPHYSIOLOGICAL CHARACTERISTICS; MOLECULAR-MECHANISMS; COMPUTER-MODEL; LIFETIME RISK; INITIATION; INSIGHTS; ARRHYTHMOGENESIS; PATHOPHYSIOLOGY; PREVALENCE; GUIDELINES	Models that represent the mechanisms that initiate and sustain atrial fibrillation (AF) in the heart are computationally expensive to simulate and therefore only capture short time scales of a few heart beats. It is therefore difficult to embed biophysical mechanisms into both policy-level disease models, which consider populations of patients over multiple decades, and guidelines that recommend treatment strategies for patients. The aim of this study is to link these modelling paradigms using a stylised population-level model that both represents AF progression over a long time-scale and retains a description of biophysical mechanisms. We develop a non-Markovian binary switching model incorporating three different aspects of AF progression: genetic disposition, disease/age related remodelling, and AF-related remodelling. This approach allows us to simulate individual AF episodes as well as the natural progression of AF in patients over a period of decades. Model parameters are derived, where possible, from the literature, and the model development has highlighted a need for quantitative data that describe the progression of AF in population of patients. The model produces time series data of AF episodes over the lifetimes of simulated patients. These are analysed to quantitatively describe progression of AF in terms of several underlying parameters. Overall, the model has potential to link mechanisms of AF to progression, and to be used as a tool to study clinical markers of AF or as training data for AF classification algorithms.	[Chang, Eugene T. Y.; Clayton, Richard H.] Univ Sheffield, Insigneo Inst In Silico Med, Sheffield S1 4DP, S Yorkshire, England; [Chang, Eugene T. Y.; Clayton, Richard H.] Univ Sheffield, Dept Comp Sci, Sheffield S1 4DP, S Yorkshire, England; [Lin, Yen Ting; Galla, Tobias] Univ Manchester, Sch Phys & Astron, Manchester M13 9PL, Lancs, England; [Eatock, Julie] Brunel Univ London, Dept Comp Sci, Uxbridge UB8 3PH, Middx, England	University of Sheffield; University of Sheffield; University of Manchester; Brunel University	Eatock, J (corresponding author), Brunel Univ London, Dept Comp Sci, Uxbridge UB8 3PH, Middx, England.	Julie.Eatock@brunel.ac.uk	Lin, Yen Ting/ABB-8491-2020; Chang, Eugene/I-5834-2015; Clayton, Richard/CAF-3400-2022; Galla, Tobias/R-1718-2018	Lin, Yen Ting/0000-0001-6893-8423; Chang, Eugene/0000-0002-1097-4189; Clayton, Richard/0000-0002-8438-7518; Eatock, Julie/0000-0002-8963-8312	Engineering and Physical Sciences Research Council [EP/K037145/1]; EPSRC [EP/K037145/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	ETYC, YTL, TG, RHC, and JE all received funding from Engineering and Physical Sciences Research Council (http://gow.epsrc.ac.uk/) grant number EP/K037145/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade J, 2014, CIRC RES, V114, P1453, DOI 10.1161/CIRCRESAHA.114.303211; Aslanidi OV, 2011, PROG BIOPHYS MOL BIO, V107, P156, DOI 10.1016/j.pbiomolbio.2011.06.011; Barrett TW, 2013, AM J EMERG MED, V31, P792, DOI 10.1016/j.ajem.2013.01.020; Beerenwinkel N, 2015, SYST BIOL, V64, pE1, DOI 10.1093/sysbio/syu081; Bosch RF, 2002, CARDIOVASC RES, V54, P259, DOI 10.1016/S0008-6363(01)00529-6; Briggs A, 2006, DECISION MODELLING H; Burashnikov A, 2003, CIRCULATION, V107, P2355, DOI 10.1161/01.CIR.0000065578.00869.7C; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Charitos EI, 2014, J AM COLL CARDIOL, V63, P2840, DOI 10.1016/j.jacc.2014.04.019; Charitos EI., 2013, ACP-APPL CARDIOPUL P, V17, P3; Chen SA, 1999, CIRCULATION, V100, P1879, DOI 10.1161/01.CIR.100.18.1879; Colman MA, 2013, J PHYSIOL-LONDON, V591, P4249, DOI 10.1113/jphysiol.2013.254987; Council NR, 2012, ASS REL COMPL MOD MA; de Vos CB, 2010, J AM COLL CARDIOL, V55, P725, DOI 10.1016/j.jacc.2009.11.040; Eatock J, 2015, COMPUT CARDIOL CONF, V42, P265, DOI 10.1109/CIC.2015.7408637; Everett TH, 2000, CIRCULATION, V102, P1454, DOI 10.1161/01.CIR.102.12.1454; Everett TH, 2006, AM J PHYSIOL-HEART C, V291, pH2911, DOI 10.1152/ajpheart.01128.2005; Garratt CJ, 1999, J CARDIOVASC ELECTR, V10, P1101, DOI 10.1111/j.1540-8167.1999.tb00283.x; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Goette A, 1996, CIRCULATION, V94, P2968, DOI 10.1161/01.CIR.94.11.2968; Haim M, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001486; Hasty J, 2001, NAT REV GENET, V2, P268, DOI 10.1038/35066056; Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825; Heijman J, 2014, CIRC RES, V114, P1483, DOI 10.1161/CIRCRESAHA.114.302226; Hoffmann E, 2006, CIRCULATION, V113, P1933, DOI 10.1161/CIRCULATIONAHA.105.568568; Jahangir A, 2010, J AM COLL CARDIOL, V55, P732, DOI 10.1016/j.jacc.2009.12.010; Kaemmerer WF, 2001, J CARDIOVASC ELECTR, V12, P121, DOI 10.1046/j.1540-8167.2001.00121.x; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Kneller J, 2002, CIRC RES, V90, pE73, DOI 10.1161/01.RES.0000019783.88094.BA; Lloyd-Jones DM, 2004, CIRCULATION, V110, P1042, DOI 10.1161/01.CIR.0000140263.20897.42; Lord J, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17580; McDowell KS, 2013, BIOPHYS J, V104, P2764, DOI 10.1016/j.bpj.2013.05.025; MOE GK, 1964, AM HEART J, V67, P200, DOI 10.1016/0002-8703(64)90371-0; MORILLO CA, 1995, CIRCULATION, V91, P1588, DOI 10.1161/01.CIR.91.5.1588; National Clinical Guideline Centre, 2014, ATR FIBR MAN ATR FIB, pCG180; National Collaborating Centre for Chronic Conditions, 2006, ATR FIBR MAN ATR FIB, pCG36; Nattel S, 2002, NATURE, V415, P219, DOI 10.1038/415219a; Nattel S, 2008, CIRC-ARRHYTHMIA ELEC, V1, P62, DOI 10.1161/CIRCEP.107.754564; Olesen JB, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d124; Pandozi C, 2001, EUR HEART J, V22, P541, DOI 10.1053/euhj.2000.2441; Sankaranarayanan R, 2013, CARDIOL RES PRACT, V2013, DOI 10.1155/2013/976976; Schotten U, 2003, CIRCULATION, V107, P1433, DOI 10.1161/01.CIR.0000055314.10801.4F; Schotten U, 2011, PHYSIOL REV, V91, P265, DOI 10.1152/physrev.00031.2009; Sculpher M, 2008, PHARMACOECONOMICS, V26, P799, DOI 10.2165/00019053-200826090-00009; Shehadeh LA, 2002, J CARDIOVASC ELECTR, V13, P303, DOI 10.1046/j.1540-8167.2002.00303.x; Shukla A, 2014, VASC HEALTH RISK MAN, V10, P1, DOI 10.2147/VHRM.S49334; Stewart S, 2001, HEART, V86, P516, DOI 10.1136/heart.86.5.516; Takashima Y, 2011, P NATL ACAD SCI USA, V108, P3300, DOI 10.1073/pnas.1014418108; Thijssen VLJL, 2001, CARDIOVASC RES, V52, P14, DOI 10.1016/S0008-6363(01)00367-4; Veasey RA, 2015, J INTERV CARD ELECTR, V44, P23, DOI 10.1007/s10840-015-0029-x; Voigt N, 2014, CIRCULATION, V129, P145, DOI 10.1161/CIRCULATIONAHA.113.006641; Wakili R, 2011, J CLIN INVEST, V121, P2955, DOI 10.1172/JCI46315; WIJFFELS MCEF, 1995, CIRCULATION, V92, P1954, DOI 10.1161/01.CIR.92.7.1954; Wilhelms M, 2013, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00487; Yeh YH, 2008, CIRC-ARRHYTHMIA ELEC, V1, P93, DOI 10.1161/CIRCEP.107.754788; Yu WC, 1999, CARDIOVASC RES, V42, P470, DOI 10.1016/S0008-6363(99)00030-9; Yue LX, 1999, CIRC RES, V84, P776	58	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0152349	10.1371/journal.pone.0152349	http://dx.doi.org/10.1371/journal.pone.0152349			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	27070920	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000373900700008
J	Wu, HY; Li, P; Pan, DQ; Yin, ZX; Fang, QH; Wu, WS				Wu, Hanyu; Li, Ping; Pan, Duoqiang; Yin, Zhuoxin; Fang, Qiaohui; Wu, Wangsuo			Interactions between Silicon Oxide Nanoparticles (SONPs) and U(VI) Contaminations: Effects of pH, Temperature and Natural Organic Matters	PLOS ONE			English	Article							HUMIC-ACID; AQUEOUS-SOLUTIONS; IONIC-STRENGTH; SURFACE COMPLEXATION; SORPTION-DESORPTION; URANYL SORPTION; FULVIC-ACID; URANIUM(VI); ADSORPTION; REMOVAL	The interactions between contaminations of U(VI) and silicon oxide nanoparticles (SONPs), both of which have been widely used in modern industry and induced serious environmental challenge due to their high mobility, bioavailability, and toxicity, were studied under different environmental conditions such as pH, temperature, and natural organic matters (NOMs) by using both batch and spectroscopic approaches. The results showed that the accumulation process, i.e., sorption, of U(VI) on SONPs was strongly dependent on pH and ionic strength, demonstrating that possible outer- and/or inner-sphere complexes were controlling the sorption process of U(VI) on SONPs in the observed pH range. Humic acid (HA), one dominated component of NOMs, bounded SONPs can enhance U(VI) sorption below pH -4.5, whereas restrain at high pH range. The reversible sorption of U(VI) on SONPs possibly indicated that the outer-sphere complexes were prevalent at pH 5. However, an irreversible interaction of U(VI) was observed in the presence of HA (Fig 1). It was mainly due to the ternary SONPs-HA-U(VI) complexes (Type A Complexes). After SONPs adsorbed U(VI), the particle size in suspension was apparently increased from similar to 240 nm to similar to 350 nm. These results showed that toxicity of both SONPs and U(VI) will decrease to some extent after the interaction in the environment. These findings are key for providing useful information on the possible mutual interactions among different contaminants in the environment.	[Wu, Hanyu; Pan, Duoqiang; Yin, Zhuoxin; Wu, Wangsuo] Lanzhou Univ, Sch Nucl Sci & Technol, Radiochem Lab, Lanzhou 730000, Gansu, Peoples R China; [Fang, Qiaohui] Chinese Acad Sci, Inst Geol & Geophys, Gansu Prov CAS Key Lab Petr Resources Res, Key Lab Petr Resources, Lanzhou 730000, Gansu, Peoples R China; [Li, Ping] China Acad Engn Phys, Inst Nucl Phys & Chem, Mianyang 621000, Sichuan, Peoples R China; [Wu, Hanyu; Pan, Duoqiang; Yin, Zhuoxin; Wu, Wangsuo] Minist Educ, Key Lab Special Funct Mat & Struct Design, Lanzhou 730000, Gansu, Peoples R China	Lanzhou University; Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS; Chinese Academy of Engineering Physics	Wu, WS (corresponding author), Lanzhou Univ, Sch Nucl Sci & Technol, Radiochem Lab, Lanzhou 730000, Gansu, Peoples R China.; Fang, QH (corresponding author), Chinese Acad Sci, Inst Geol & Geophys, Gansu Prov CAS Key Lab Petr Resources Res, Key Lab Petr Resources, Lanzhou 730000, Gansu, Peoples R China.; Wu, WS (corresponding author), Minist Educ, Key Lab Special Funct Mat & Struct Design, Lanzhou 730000, Gansu, Peoples R China.	fanqh@lzb.ac.cn; wuws@lzu.edu.cn			Special Foundation for High Level Waste Disposal, China [[2012] 494]; National Natural Science Foundation of China [21327801, J1210001, 41573128]; Chinese Academy of Sciences in Lanzhou Center for Oil and Gas Resources, Institute of Geology and Geophysics, CAS; Basic Scientific Research Business Expenses of the Central University [Izujbky-2015-70]; Key Laboratory for Magnetism and Magnetic Materials of the Ministry of Education, Lanzhou University [Izummm2015011]	Special Foundation for High Level Waste Disposal, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences in Lanzhou Center for Oil and Gas Resources, Institute of Geology and Geophysics, CAS; Basic Scientific Research Business Expenses of the Central University; Key Laboratory for Magnetism and Magnetic Materials of the Ministry of Education, Lanzhou University	The funding or sources of support received during this specific study (whether external or internal to the organization): 1) Special Foundation for High Level Waste Disposal, China ([2012] 494) http://www.sastind.gov.cn; 2) National Natural Science Foundation of China (21327801) http://www.nsfc.gov.cn/publish/portal1/; 3) National Natural Science Foundation of China (J1210001) http://www.nsfc.gov.cn/publish/portal1/; 4) National Natural Science Foundation of China (41573128) http://www.nsfc.gov.cn/publish/portal1/; 5) "100-Talent" Program from Chinese Academy of Sciences in Lanzhou Center for Oil and Gas Resources, Institute of Geology and Geophysics, CAS http://english.cas.cn; 6) The Basic Scientific Research Business Expenses of the Central University (Izujbky-2015-70) http://en.lzu.edu.cn; 7) Open Project of Key Laboratory for Magnetism and Magnetic Materials of the Ministry of Education, Lanzhou University (Izummm2015011) (http://en.lzu.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARROW NJ, 1986, J SOIL SCI, V37, P295, DOI 10.1111/j.1365-2389.1986.tb00031.x; Batuk DN, 2011, ACTINIDE NANOPARTICL, P315, DOI [10.1007/978-3-642-11432-8_11, DOI 10.1007/978-3-642-11432-8_11]; Bhalara PD, 2014, J ENVIRON CHEM ENG, V2, P1621, DOI 10.1016/j.jece.2014.06.007; Campos B, 2013, APPL CLAY SCI, V85, P53, DOI 10.1016/j.clay.2013.08.046; Chisholm-Brause CJ, 2001, J COLLOID INTERF SCI, V233, P38, DOI 10.1006/jcis.2000.7227; Das D, 2010, J RADIOANAL NUCL CH, V285, P447, DOI 10.1007/s10967-010-0627-0; Dinesh R, 2012, GEODERMA, V173, P19, DOI 10.1016/j.geoderma.2011.12.018; Fan QH, 2014, ENVIRON SCI-PROC IMP, V16, P534, DOI 10.1039/c3em00324h; Fan QH, 2012, APPL RADIAT ISOTOPES, V70, P13, DOI 10.1016/j.apradiso.2011.07.004; Fan QH, 2009, ENVIRON SCI TECHNOL, V43, P5776, DOI 10.1021/es901241f; Fan QH, 2011, J HAZARD MATER, V192, P1851, DOI 10.1016/j.jhazmat.2011.07.022; Fruijtier-Polloth C, 2012, TOXICOLOGY, V294, P61, DOI 10.1016/j.tox.2012.02.001; Guo ZJ, 2009, RADIOCHIM ACTA, V97, P133, DOI 10.1524/ract.2009.1589; Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5; Ivanov P, 2012, J ENVIRON MONITOR, V14, P2968, DOI 10.1039/c2em30512g; Katsoyiannis IA, 2013, DESALIN WATER TREAT, V51, P2915, DOI 10.1080/19443994.2012.748300; Kavitha D, 2007, BIORESOURCE TECHNOL, V98, P14, DOI 10.1016/j.biortech.2005.12.008; Keller AA, 2010, ENVIRON SCI TECHNOL, V44, P1962, DOI 10.1021/es902987d; Krepelova A, 2008, J COLLOID INTERF SCI, V319, P40, DOI 10.1016/j.jcis.2007.11.010; Krepelova A, 2007, ENVIRON SCI TECHNOL, V41, P6142, DOI 10.1021/es070419q; Kushwaha S, 2013, J ENVIRON RADIOACTIV, V126, P115, DOI 10.1016/j.jenvrad.2013.07.021; Li P, 2014, ENVIRON SCI-PROC IMP, V16, P2278, DOI 10.1039/c4em00301b; Massey MS, 2014, ENVIRON SCI TECHNOL, V48, P8636, DOI 10.1021/es501064m; McCarthy J, 2012, CHEM RES TOXICOL, V25, P2227, DOI 10.1021/tx3002884; Napierska D, 2009, SMALL, V5, P846, DOI 10.1002/smll.200800461; Nilchi A, 2013, DESALINATION, V321, P67, DOI 10.1016/j.desal.2012.06.022; Niu ZW, 2009, APPL RADIAT ISOTOPES, V67, P1582, DOI 10.1016/j.apradiso.2009.03.113; Okoturo-Evans O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072363; Olu-Owolabi BI, 2014, J ENVIRON MANAGE, V137, P1, DOI 10.1016/j.jenvman.2014.01.048; Ozer A, 2005, CHEM ENG J, V112, P181, DOI 10.1016/j.cej.2005.07.007; Payne TE, 2004, APPL CLAY SCI, V26, P151, DOI 10.1016/j.clay.2003.08.013; Rengaraj S, 2004, J COLLOID INTERF SCI, V273, P14, DOI 10.1016/j.jcis.2004.01.007; Rivera-Gil P, 2013, ACCOUNTS CHEM RES, V46, P743, DOI 10.1021/ar300039j; Sachs S, 2008, CHEMOSPHERE, V72, P1441, DOI 10.1016/j.chemosphere.2008.05.027; Sachs S, 2011, J RADIOANAL NUCL CH, V290, P17, DOI 10.1007/s10967-011-1084-0; Schafer T, 2012, APPL GEOCHEM, V27, P390, DOI 10.1016/j.apgeochem.2011.09.009; Schmeide K, 2003, INORG CHIM ACTA, V351, P133, DOI 10.1016/S0020-1693(03)00184-1; Sun YB, 2012, J ENVIRON RADIOACTIV, V105, P40, DOI 10.1016/j.jenvrad.2011.10.009; Tan XL, 2008, ENVIRON SCI TECHNOL, V42, P6532, DOI 10.1021/es8007062; Tan XL, 2010, MOLECULES, V15, P8431, DOI 10.3390/molecules15118431; Tang WW, 2014, SCI TOTAL ENVIRON, V468, P1014, DOI 10.1016/j.scitotenv.2013.09.044; Tian G, 2011, J HAZARD MATER, V190, P442, DOI 10.1016/j.jhazmat.2011.03.066; Tipping Edward, 1993, Analytical Proceedings, V30, P186, DOI 10.1039/ap9933000186; Weber W.J., 1963, J SANIT ENG DIV, V89, P31, DOI [10.1061/JSEDAI.0000430, DOI 10.1061/JSEDAI.0000430]; Weng LP, 2006, ENVIRON SCI TECHNOL, V40, P7494, DOI 10.1021/es060777d; Wu WS, 2007, APPL RADIAT ISOTOPES, V65, P1108, DOI 10.1016/j.apradiso.2007.05.009; Xu D, 2008, APPL CLAY SCI, V39, P133, DOI 10.1016/j.clay.2007.05.006; Yang SP, 2013, ENVIRON SCI TECHNOL, V47, P4718, DOI 10.1021/es3047334	48	32	37	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0149632	10.1371/journal.pone.0149632	http://dx.doi.org/10.1371/journal.pone.0149632			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930197	Green Published, Green Submitted, gold			2022-12-26	WOS:000371434500036
J	Hu, JS; Wu, WB; Zhu, B; Wang, HT; Liu, RY; Zhang, X; Li, M; Yang, YB; Yan, J; Niu, FN; Tian, CS; Wang, K; Yu, HP; Chen, WB; Wan, SR; Sun, Y; Zhang, B				Hu, Jisu; Wu, Wenbo; Zhu, Bin; Wang, Huiting; Liu, Renyuan; Zhang, Xin; Li, Ming; Yang, Yongbo; Yan, Jing; Niu, Fengnan; Tian, Chuanshuai; Wang, Kun; Yu, Haiping; Chen, Weibo; Wan, Suiren; Sun, Yu; Zhang, Bing			Cerebral Glioma Grading Using Bayesian Network with Features Extracted from Multiple Modalities of Magnetic Resonance Imaging	PLOS ONE			English	Article							BRAIN-TUMORS; DIAGNOSIS; SPECTROSCOPY; PRINCIPLES; SPECTRA	Many modalities of magnetic resonance imaging (MRI) have been confirmed to be of great diagnostic value in glioma grading. Contrast enhanced T1-weighted imaging allows the recognition of blood-brain barrier breakdown. Perfusion weighted imaging and MR spectroscopic imaging enable the quantitative measurement of perfusion parameters and metabolic alterations respectively. These modalities can potentially improve the grading process in glioma if combined properly. In this study, Bayesian Network, which is a powerful and flexible method for probabilistic analysis under uncertainty, is used to combine features extracted from contrast enhanced T1-weighted imaging, perfusion weighted imaging and MR spectroscopic imaging. The networks were constructed using K2 algorithm along with manual determination and distribution parameters learned using maximum likelihood estimation. The grading performance was evaluated in a leave-one-out analysis, achieving an overall grading accuracy of 92.86% and an area under the curve of 0.9577 in the receiver operating characteristic analysis given all available features observed in the total 56 patients. Results and discussions show that Bayesian Network is promising in combining features from multiple modalities of MRI for improved grading performance.	[Hu, Jisu; Wan, Suiren; Sun, Yu] Southeast Univ, Sch Biol Sci & Med Engn, Lab Med Elect, Nanjing, Jiangsu, Peoples R China; [Hu, Jisu] Chinese Acad Sci, Suzhou Inst Biomed Engn & Technol, Suzhou, Jiangsu, Peoples R China; [Wu, Wenbo; Zhu, Bin; Wang, Huiting; Liu, Renyuan; Zhang, Xin; Li, Ming; Tian, Chuanshuai; Wang, Kun; Yu, Haiping; Zhang, Bing] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Radiol, Nanjing 210008, Jiangsu, Peoples R China; [Yang, Yongbo] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Neurosurg, Nanjing 210008, Jiangsu, Peoples R China; [Yan, Jing] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Oncol, Nanjing 210008, Jiangsu, Peoples R China; [Niu, Fengnan] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Pathol, Nanjing 210008, Jiangsu, Peoples R China; [Chen, Weibo] Philips Healthcare, Shanghai, Peoples R China	Southeast University - China; Chinese Academy of Sciences; Suzhou Institute of Biomedical Engineering & Technology, CAS; Nanjing University; Nanjing University; Nanjing University; Nanjing University; Philips; Philips Healthcare	Wan, SR; Sun, Y (corresponding author), Southeast Univ, Sch Biol Sci & Med Engn, Lab Med Elect, Nanjing, Jiangsu, Peoples R China.; Zhang, B (corresponding author), Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Radiol, Nanjing 210008, Jiangsu, Peoples R China.	srwan@seu.edu.cn; yuyuly09@googlemail.com; zhangbing_nanjing@vip.163.com			National Natural Science Foundation of China [81571040, 81300925]; Provincial Natural Science Foundation of Jiangsu [BK20131085]; Key Project of Nanjing Health Bureau [ZKX14027]; Jiangsu Province Medical Key talented people; 12th five years plan for China development [RC2011013]; Philips Healthcare;  [1501076A];  [WSN-O50]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Provincial Natural Science Foundation of Jiangsu(Natural Science Foundation of Jiangsu Province); Key Project of Nanjing Health Bureau; Jiangsu Province Medical Key talented people; 12th five years plan for China development; Philips Healthcare; ; 	This work was supported by the National Natural Science Foundation of China (81571040, 81300925, B. Zhang), the Provincial Natural Science Foundation of Jiangsu (2014-2016, BK20131085, B. Zhang), the provincial postdoctoral project (1501076A, B. Zhang), the project of the sixth peak of talented people (WSN-O50, B. Zhang), the Key Project of Nanjing Health Bureau (ZKX14027 B. Zhang), and the Jiangsu Province Medical Key talented people and "the 12th five years plan for China development" (2011-2016, RC2011013, B. Zhang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Philips Healthcare provided support in the form of salary for author Weibo Chen, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	[Anonymous], 2001, COMPUTING SCI STAT, V33; Barbier EL, 2001, J MAGN RESON IMAGING, V13, P496, DOI 10.1002/jmri.1073; Callot V, 2008, EUR J RADIOL, V67, P268, DOI 10.1016/j.ejrad.2008.02.036; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; Cruz-Ramirez N, 2007, COMPUT BIOL MED, V37, P1553, DOI 10.1016/j.compbiomed.2007.02.003; Daly R, 2011, KNOWL ENG REV, V26, P99, DOI 10.1017/S0269888910000251; DKN F, 2009, PROBABILISTIC GRAPHI; Friedman N, 1997, MACH LEARN, V29, P131, DOI 10.1023/A:1007465528199; Hakyemez B, 2005, CLIN RADIOL, V60, P493, DOI 10.1016/j.crad.2004.09.009; Law M, 2003, AM J NEURORADIOL, V24, P1989; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Ludemann L, 2001, EUR RADIOL, V11, P1231; Mani S, 2005, APPL INTELL, V22, P93, DOI 10.1007/s10489-005-5599-3; Ostergaard L, 2005, J MAGN RESON IMAGING, V22, P710, DOI 10.1002/jmri.20460; Posse S, 2013, J MAGN RESON IMAGING, V37, P1301, DOI 10.1002/jmri.23945; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Qiang Ning CM, 2015, THR 23 ISMRM ANN M; Reynolds GM, 2007, BMC MED INFORM DECIS, V7, DOI 10.1186/1472-6947-7-27; Seixas FL, 2014, COMPUT BIOL MED, V51, P140, DOI 10.1016/j.compbiomed.2014.04.010; Senturk S, 2009, DIAGN INTERV RADIOL, V15, P3; Sibtain NA, 2007, CLIN RADIOL, V62, P109, DOI 10.1016/j.crad.2006.09.012; Stadlbauer A, 2004, NEUROIMAGE, V23, P454, DOI 10.1016/j.neuroimage.2004.06.022; Wang XH, 1999, INT J MED INFORM, V54, P115, DOI 10.1016/S1386-5056(98)00174-9	24	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153369	10.1371/journal.pone.0153369	http://dx.doi.org/10.1371/journal.pone.0153369			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077923	Green Published, gold, Green Submitted			2022-12-26	WOS:000374131700046
